<SEC-DOCUMENT>0001213900-23-033939.txt : 20230428
<SEC-HEADER>0001213900-23-033939.hdr.sgml : 20230428
<ACCEPTANCE-DATETIME>20230428163311
ACCESSION NUMBER:		0001213900-23-033939
CONFORMED SUBMISSION TYPE:	40-F
PUBLIC DOCUMENT COUNT:		158
CONFORMED PERIOD OF REPORT:	20221231
FILED AS OF DATE:		20230428
DATE AS OF CHANGE:		20230428

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			enCore Energy Corp.
		CENTRAL INDEX KEY:			0001500881
		STANDARD INDUSTRIAL CLASSIFICATION:	MISCELLANEOUS METAL ORES [1090]
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			A1
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		40-F
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-41489
		FILM NUMBER:		23867147

	BUSINESS ADDRESS:	
		STREET 1:		101 N. SHORELINE BLVD, SUITE 450
		CITY:			CORPUS CHRISTI
		STATE:			TX
		ZIP:			78401
		BUSINESS PHONE:		361-239-5449

	MAIL ADDRESS:	
		STREET 1:		101 N. SHORELINE BLVD, SUITE 450
		CITY:			CORPUS CHRISTI
		STATE:			TX
		ZIP:			78401

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Encore Energy Corp.
		DATE OF NAME CHANGE:	20170301

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	WOLFPACK GOLD CORP.
		DATE OF NAME CHANGE:	20130523

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	TIGRIS URANIUM CORP.
		DATE OF NAME CHANGE:	20100908
</SEC-HEADER>
<DOCUMENT>
<TYPE>40-F
<SEQUENCE>1
<FILENAME>ea177383-40f_encore.htm
<DESCRIPTION>ANNUAL REPORT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="ASCII"?>
<!-- Generated by CompSci Transform (tm) - http://www.compsciresources.com -->
<!-- Created: Fri Apr 28 19:14:45 UTC 2023 -->
<html xmlns:country="http://xbrl.sec.gov/country/2022" xmlns:dtr="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dei="http://xbrl.sec.gov/dei/2022" xmlns:ifrs-full="https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:compsci="http://compsciresources.com" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:us-types="http://fasb.org/us-types/2022" xmlns:cve="http://encoreuranium.com/20221231" xmlns:srt="http://fasb.org/srt/2022" xmlns:xl="http://www.xbrl.org/2003/XLink" xmlns:stpr="http://xbrl.sec.gov/stpr/2022" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:us-gaap="http://fasb.org/us-gaap/2022" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns="http://www.w3.org/1999/xhtml">
<head>
     <title> </title>

<meta content="text/html" http-equiv="Content-Type" />
</head>
<body><div style="font: 10pt Times New Roman, Times, Serif"><div>

</div><p style="text-align: center; margin-top: 0; margin-bottom: 0"></p><div>

</div><!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><div style="font-size: 1pt; border-top: Black 2pt solid; border-bottom: Black 1pt solid">&#160;</div></div><!-- Field: /Rule-Page --><div>

</div><p style="text-align: center; margin-top: 0; margin-bottom: 0"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>UNITED STATES</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>SECURITIES AND EXCHANGE COMMISSION</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>Washington, D.C. 20549</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>FORM <ix:nonNumeric contextRef="c0" name="dei:DocumentType">40-F</ix:nonNumeric></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><ix:nonNumeric contextRef="c0" format="ixt:fixed-false" name="dei:DocumentRegistrationStatement">&#9744;</ix:nonNumeric> <b>Registration statement pursuant to Section
12 of the Securities Exchange Act of 1934</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>or</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><ix:nonNumeric contextRef="c0" format="ixt:fixed-true" name="dei:DocumentAnnualReport">&#9746;</ix:nonNumeric> <b>Annual report pursuant to Section 13(a)
or 15(d) of the Securities Exchange Act of 1934</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 50%; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>For the fiscal year ended <span style="text-decoration:underline"><ix:nonNumeric contextRef="c0" format="ixt:date-monthname-day-year-en" name="dei:DocumentPeriodEndDate"><ix:nonNumeric contextRef="c0" format="ixt:date-monthname-day-en" name="dei:CurrentFiscalYearEndDate">December 31</ix:nonNumeric>, <ix:nonNumeric contextRef="c0" name="dei:DocumentFiscalYearFocus">2022</ix:nonNumeric></ix:nonNumeric></span></b></span></td> <td style="width: 50%; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Commission
File Number <ix:nonNumeric contextRef="c0" name="dei:EntityFileNumber"><span style="text-decoration:underline">001-41489</span></ix:nonNumeric></b></span></td></tr> </table><div>
</div><p style="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><ix:nonNumeric contextRef="c0" name="dei:EntityRegistrantName"><b>enCore Energy Corp.</b></ix:nonNumeric></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>(Exact name of Registrant as specified in its
charter)</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>&#160;</b></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="border-bottom: black 1.5pt solid; width: 32%; text-align: center"><ix:nonNumeric contextRef="c0" format="ixt-sec:edgarprovcountryen" name="dei:EntityIncorporationStateCountryCode"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Canada</b></span></ix:nonNumeric></td> <td style="width: 2%">&#160;</td> <td style="border-bottom: black 1.5pt solid; width: 32%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>1094</b></span></td> <td style="width: 2%">&#160;</td> <td style="border-bottom: black 1.5pt solid; width: 32%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>N/A</b></span></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Province or other jurisdiction of <br/>
incorporation or organization)</b></span></td> <td>&#160;</td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Primary Standard Industrial <br/>
Classification Code Number)</b></span></td> <td>&#160;</td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(I.R.S. Employer <br/>
Identification Number)</b></span></td></tr> </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b><ix:nonNumeric contextRef="c0" name="dei:EntityAddressAddressLine1">101 N. Shoreline Blvd.</ix:nonNumeric> <ix:nonNumeric contextRef="c0" name="dei:EntityAddressAddressLine2">Suite 450</ix:nonNumeric></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b><ix:nonNumeric contextRef="c0" name="dei:EntityAddressCityOrTown">Corpus Christi</ix:nonNumeric>, <ix:nonNumeric contextRef="c0" name="dei:EntityAddressStateOrProvince">TX</ix:nonNumeric> <ix:nonNumeric contextRef="c0" name="dei:EntityAddressPostalZipCode">78401</ix:nonNumeric></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>(<ix:nonNumeric contextRef="c0" name="dei:CityAreaCode">361</ix:nonNumeric>) <ix:nonNumeric contextRef="c0" name="dei:LocalPhoneNumber">239-5449</ix:nonNumeric></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>(Address and telephone number of Registrant&#8217;s
principal executive offices)</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><ix:nonNumeric contextRef="c1" name="dei:ContactPersonnelName"><b>Cogency Global Inc.</b></ix:nonNumeric></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><ix:nonNumeric contextRef="c1" name="dei:EntityAddressAddressLine1">122 E. 42<sup>nd</sup> Street</ix:nonNumeric>, <ix:nonNumeric contextRef="c1" name="dei:EntityAddressAddressLine2">18<sup>th</sup>
Floor</ix:nonNumeric></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><ix:nonNumeric contextRef="c1" name="dei:EntityAddressCityOrTown">New York</ix:nonNumeric>, <ix:nonNumeric contextRef="c1" format="ixt-sec:stateprovnameen" name="dei:EntityAddressStateOrProvince">New York</ix:nonNumeric> <ix:nonNumeric contextRef="c1" name="dei:EntityAddressPostalZipCode">10168</ix:nonNumeric></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>(<ix:nonNumeric contextRef="c1" name="dei:CityAreaCode">800</ix:nonNumeric>) <ix:nonNumeric contextRef="c1" name="dei:LocalPhoneNumber">221-0102</ix:nonNumeric></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>(Name, address (including zip code) and telephone
number (including area code) of agent for service in the United States)</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Securities registered or to be registered pursuant to Section 12(b)
of the Act:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom; background-color: white"> <td style="border-bottom: black 1.5pt solid; width: 32%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title of each class</span></td> <td style="width: 2%">&#160;</td> <td style="border-bottom: black 1.5pt solid; width: 32%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Trading Symbol(s)</span></td> <td style="width: 2%">&#160;</td> <td style="border-bottom: black 1.5pt solid; width: 32%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name of each exchange on which registered</span></td></tr> <tr style="vertical-align: top; background-color: rgb(204,238,255)"> <td style="text-align: center"><ix:nonNumeric contextRef="c0" name="dei:Security12bTitle"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Common Shares</span></ix:nonNumeric></td> <td style="text-align: center">&#160;</td> <td style="text-align: center"><ix:nonNumeric contextRef="c0" name="dei:TradingSymbol"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">EU</span></ix:nonNumeric></td> <td style="text-align: center">&#160;</td> <td style="text-align: center"><ix:nonNumeric contextRef="c0" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The NYSE American LLC</span></ix:nonNumeric></td></tr> </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Securities registered pursuant to Section 12(g) of the Act: None</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Securities for which there is a reporting obligation pursuant to Section
15(d) of the Act: None</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">For annual reports, indicate by check mark the information filed with
this Form:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 50%; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonNumeric contextRef="c0" format="ixt:fixed-true" name="dei:AnnualInformationForm">&#9746;</ix:nonNumeric>&#160;&#160;Annual information form</span></td> <td style="width: 50%; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonNumeric contextRef="c0" format="ixt:fixed-true" name="dei:AuditedAnnualFinancialStatements">&#9746;</ix:nonNumeric>&#160;&#160;Audited annual financial statements</span></td></tr> </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><!-- Field: Page; Sequence: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid">&#160;</div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt"></p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Indicate the number of outstanding shares of each
of the issuer&#8217;s classes of capital or common stock as of the close of the period covered by the annual report: <b><ix:nonFraction contextRef="c2" decimals="INF" format="ixt:num-dot-decimal" name="dei:EntityCommonStockSharesOutstanding" scale="0" unitRef="shares">108,940,051</ix:nonFraction> Common
Shares outstanding as at December 31, 2022.</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Indicate by check mark whether the Registrant:
(1) has filed all reports required to be filed by Section 13 or 15(d) of the Exchange Act during the preceding 12 months (or for such
shorter period that the registrant was required to file such reports) and (2) has been subject to such filing requirements for the past
90 days.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><ix:nonNumeric contextRef="c0" name="dei:EntityCurrentReportingStatus">Yes</ix:nonNumeric> &#9746; No &#9744;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Indicate by check mark whether the registrant
has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (&#167;232.405
of this chapter) during the preceding 12 months (or for such shorter period that the Registrant was required to submit such files).</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><ix:nonNumeric contextRef="c0" name="dei:EntityInteractiveDataCurrent">Yes</ix:nonNumeric> &#9746; No &#9744;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Indicate by check mark whether the registrant
is an emerging growth company as defined in Rule 12b-2 of the Exchange Act.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">Emerging growth company <ix:nonNumeric contextRef="c0" format="ixt:fixed-true" name="dei:EntityEmergingGrowthCompany">&#9746;</ix:nonNumeric></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: right">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If an emerging growth company that prepares its
financial statements in accordance with U.S. GAAP, indicate by check mark if the registrant has elected not to use the extended transition
period for complying with any new or revised financial accounting standards&#8224; provided pursuant to Section 13(a) of the Exchange
Act. <ix:nonNumeric contextRef="c0" format="ixt:fixed-false" name="dei:EntityExTransitionPeriod">&#9744;</ix:nonNumeric></p><div>

</div><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top">
<td style="width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8224;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
term &#8220;new or revised financial accounting standard&#8221; refers to any update issued by the Financial Accounting Standards Board
to its Accounting Standards Codification after April 5, 2012.</span></td>
</tr></table><div>
</div><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Indicate by check mark whether the registrant
has filed a report on and attestation to its management&#8217;s assessment of the effectiveness of its internal control over financial
reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C. 7262(b)) by the registered public accounting firm that prepared or
issued its audit report. <ix:nonNumeric contextRef="c0" format="ixt:fixed-false" name="dei:IcfrAuditorAttestationFlag">&#9744;</ix:nonNumeric></p><div>

</div><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If securities are registered pursuant to Section
12(b) of the Act, indicate by check mark whether the financial statements of the registrant included in the filing reflect the correction
of an error to previously issued financial statements. &#9744;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Indicate by check mark whether any of those error
corrections are restatements that required a recovery analysis of incentive-based compensation received by any of the registrant&#8217;s
executive officers during the relevant recovery period pursuant to &#167;240.10D-1(b). &#9744;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The annual report on Form 40-F shall be incorporated by reference into
or as an exhibit to, as applicable, the Registrant&#8217;s Registration Statement under the Securities Act of 1933, as amended: Form F-10
(File No. 333-269428).</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p><div>

</div><!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><div style="font-size: 1pt; border-top: Black 1pt solid; border-bottom: Black 2pt solid">&#160;</div></div><!-- Field: /Rule-Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p><div>

</div><!-- Field: Page; Sequence: 2 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid">&#160;</div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt"></p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>FORWARD-LOOKING STATEMENTS</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">This annual report on
Form 40-F (the &#8220;Annual Report&#8221;) of enCore Energy Corp. (the &#8220;Company&#8221;), including the Exhibits hereto and information
incorporated by reference herein, contains &#8220;forward-looking information&#8221; and &#8220;forward-looking statements&#8221; (collectively, &#8220;forward-looking statements&#8221;). Forward-looking statements  can generally be identified
by the use of forward-looking terminology such as &#8220;may&#8221;, &#8220;will&#8221;, &#8220;expect&#8221;, &#8220;intend&#8221;, &#8220;estimate&#8221;,
&#8220;anticipate&#8221;, &#8220;believe&#8221;, &#8220;continue&#8221;, &#8220;plans&#8221; or similar terminology. Forward-looking statements
 are not historical facts, are made as of the date of this Annual Report, and include, but are not limited to, statements
regarding discussions of results from operations (including, without limitation, statements about the Company&#8217;s opportunities, strategies,
competition, expected activities and expenditures as the Company pursues its business plan, the adequacy of the Company&#8217;s available
cash resources and other statements about future events or results), performance (both operational and financial) and business prospects,
future business plans and opportunities and statements as to management&#8217;s expectations with respect to, among other things, the
activities contemplated in this Annual Report.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">Forward-looking statements
included or incorporated by reference in this Annual Report include, without limitation, statements related to: the Company&#8217;s future
financial and operational performance; the sufficiency of the Company&#8217;s current working capital, anticipated cash flow or its ability
to raise necessary funds; the anticipated amount and timing of work programs; our expectations with respect to future exchange rates;
the estimated cost of and availability of funding necessary for sustaining capital; forecast capital and non-operating spending; the Company&#8217;s
plans and expectations for its property, exploration, development, production, and community relations operations; the use of available
funds; expectations regarding the process for and receipt of regulatory approvals, permits and licenses under governmental and other applicable
regulatory regimes, including U.S. government policies towards domestic uranium supply; expectations about future uranium market prices,
production costs and global uranium supply and demand; expectations regarding holding physical uranium for long-term investment; the establishment
of mineral resources on any of the Company&#8217;s current or future mineral properties (other than the Company&#8217;s properties that
currently have an established mineral resource estimates); future royalty and tax payments and rates; expectations regarding possible
impacts of litigation and regulatory actions; the completion of reclamation activities at former mine or extraction sites.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Such forward-looking statements reflect the Company&#8217;s
current views with respect to future events, based on information currently available to the Company and are subject to and involve certain
known and unknown risks, uncertainties, assumptions and other factors which may cause the actual results, performance or achievements
of the Company to be materially different from any future results, performance or achievements expressed in or implied by such forward-looking
statements. The forward-looking statements in this Annual Report are based on material assumptions, including the following: our budget,
including expected levels of exploration, evaluation and operations activities and costs, as well as assumptions regarding market conditions
and other factors upon which we have based our income and expenditure expectations; assumptions regarding the timing and use of our cash
resources; our ability to, and the means by which we can, raise additional capital to advance other exploration and evaluation objectives;
our operations and key suppliers are essential services, and our employees, contractors and subcontractors will be available to continue
operations; our ability to obtain all necessary regulatory approvals, permits and licenses for our planned activities under governmental
and other applicable regulatory regimes; our expectations regarding the demand for, and supply of, uranium, the outlook for long-term
contracting, changes in regulations, public perception of nuclear power, and the construction of new and ongoing operation of existing
nuclear power plants; our expectations regarding spot and long-term prices and realized prices for uranium; our expectations that our
holdings of physical uranium will be helpful in securing project financing and/or in securing long-term uranium supply agreements in
the future; our expectations regarding tax rates, currency exchange rates, and interest rates; our decommissioning and reclamation obligations
and the status and ongoing maintenance of agreements with third parties with respect thereto; our mineral resource estimates, and the
assumptions upon which they are based; our, and our contractors&#8217;, ability to comply with current and future environmental, safety
and other regulatory requirements and to obtain and maintain required regulatory approvals; and our operations are not significantly disrupted
by political instability, nationalization, terrorism, sabotage, pandemics, social or political activism, breakdown, natural disasters,
governmental or political actions, litigation or arbitration proceedings, equipment or infrastructure failure, labor shortages, transportation
disruptions or accidents, or other development or exploration risks.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><!-- Field: Page; Sequence: 3; Options: NewSection; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->i<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt"></p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The risks, uncertainties, assumptions and other
factors that could cause actual results to differ materially from any future results expressed in or implied by the forward-looking statements
in this Annual Report include, but are not limited to, the following factors: exploration and development risks; changes in commodity
prices; access to skilled mining personnel; results of exploration and development activities; uninsured risks; regulatory risks; defects
in title; availability of materials and equipment, timeliness of government approvals and unanticipated environmental impacts on operations;
risks posed by the economic and political environments in which the Company operates and intends to operate; the potential for losses
arising from the expansion of operations into new markets; increased competition; assumptions regarding market trends and the expected
demand and desires for the Company&#8217;s products and proposed products; reliance on industry manufacturers, suppliers and others; the
failure to adequately protect intellectual property; the failure to adequately manage future growth; adverse market conditions; and the
failure to satisfy ongoing regulatory requirements.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In addition, the risks, assumptions, and other
factors set out herein and in the Company&#8217;s public filings, including the most recent Annual Information Form and Management Discussion
and Analysis (&#8220;MD&amp;A&#8221;) for the year ended December 31, 2022, could cause actual results to differ materially
from any future results expressed in or implied by the forward-looking statements in this Annual Report. Should one or more of these risks
or uncertainties materialize, or should assumptions underlying the forward-looking statements prove incorrect, actual results may vary
materially from those described herein as intended, planned, anticipated, believed, estimated or expected. These risks, uncertainties,
assumptions and other factors should be considered carefully, and prospective investors and readers should not place undue reliance on
the forward-looking statements.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Any forward-looking statement speaks only as of
the date on which such statement is made, and the Company undertakes no obligation to update any forward-looking statement or information
or statements to reflect information, events, results, circumstances or otherwise after the date on which such statement is made or to
reflect the occurrence of unanticipated events, except as required by applicable laws. New factors emerge from time to time, and it is
not possible for management to predict all of such factors and to assess in advance the impact of each such fact on the Company&#8217;s
business or the extent to which any factor, or combination of factors, may cause actual results to differ materially from those contained
in any forward-looking statements or information. All of the forward-looking statements contained or incorporated into this Annual Report
are qualified by the foregoing cautionary statements.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><!-- Field: Page; Sequence: 4; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->ii<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt"></p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: white"><b>DIFFERENCES IN UNITED
STATES AND CANADIAN REPORTING PRACTICES</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company is permitted, under a multijurisdictional
disclosure system adopted by the United States, to prepare this report in accordance with Canadian disclosure requirements, which are
different from those of the United States. The Company prepares its financial statements in accordance with International Financial Reporting
Standards (&#8220;IFRS&#8221;) as issued by the International Accounting Standards Board, and the audit is subject to Canadian auditing
standards. IFRS differs in certain respects from United States generally accepted accounting principles (&#8220;U.S. GAAP&#8221;) and
from practices prescribed by the US Securities and Exchange Commission (&#8220;SEC&#8221;). Therefore, all financial statements filed
with this annual report may not be comparable to financial statements prepared in accordance with U.S. GAAP.</p><div>

</div><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company reports mineral resources on its projects
according to Canadian standards, which differs from the requirements of U.S. securities laws. Mineral resource estimates have been prepared
in accordance with National Instrument 43-101 &#8211; Standards of Disclosure for Mineral Projects (&#8220;NI 43-101&#8221;) and the Canadian
Institute of Mining, Metallurgy and Petroleum (the &#8220;CIM&#8221;) &#8211; CIM Definition Standards on Mineral Resources and Mineral
Reserves, (the &#8220;CIM Standards&#8221;). The terms &#8220;mineral reserve&#8221;, &#8220;proven mineral reserve&#8221; and &#8220;probable
mineral reserve&#8221; are Canadian mining terms as defined in accordance with NI 43-101 and the CIM Standards. Mineral property disclosure
requirements in the United States (the &#8220;U.S. Rules&#8221;) are governed by subpart 1300 of Regulation S-K of the U.S. Securities
Act of 1933, as amended (the &#8220;U.S. Securities Act&#8221;) which differ from the CIM Standards. Pursuant to the U.S. Rules, the SEC
recognizes &#8220;measured mineral resources&#8221;, &#8220;indicated mineral resources&#8221; and &#8220;inferred mineral resources&#8221;.
Mineralization described using these terms has a greater amount of uncertainty as to its existence and feasibility than mineralization
that has been characterized as reserves. Accordingly, U.S. investors are cautioned not to assume that any measured mineral resources,
indicated mineral resources, or inferred mineral resources that the Company reports are or will be economically or legally mineable. Further,
&#8220;inferred mineral resources&#8221; have a greater amount of uncertainty as to their existence and as to whether they can be mined
legally or economically. Under Canadian securities laws, estimates of &#8220;inferred mineral resources&#8221; may not generally form
the basis of feasibility or pre-feasibility studies. While the above terms are &#8220;substantially similar&#8221; to CIM Standards, there
are differences in the definitions under the U.S. Rules and the CIM Standards. The mineral resource are estimates and no assurances can
be given that the indicated levels of uranium will be produced. By their nature, mineral resource estimates are imprecise and depend,
to a certain extent, upon statistical inferences which may ultimately prove unreliable. Any inaccuracy or future reduction in such estimates
could have a material adverse impact on the Company.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>PRINCIPAL DOCUMENTS</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In accordance with General Instruction B.(1) of
Form 40-F, the Company hereby incorporates by reference the following:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in"><span style="font: normal 10pt Times New Roman, Times, Serif">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">The Company&#8217;s Annual Information Form for
the fiscal year ended December 31, 2022, filed as Exhibit 99.1 to this Annual Report.</span></td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in"><span style="font: normal 10pt Times New Roman, Times, Serif">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">The Company&#8217;s Management&#8217;s Discussion
and Analysis for the year ended December 31, 2022, filed as Exhibit 99.2 to this Annual Report.</span></td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in"><span style="font: normal 10pt Times New Roman, Times, Serif">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">The Company&#8217;s audited consolidated financial
statements for the years ended December 31, 2022 and 2021, including the report of the independent auditor thereon, filed as Exhibit 99.3
to this Annual Report.</span></td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><!-- Field: Page; Sequence: 5; Options: NewSection; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt"></p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>DISCLOSURE CONTROLS AND PROCEDURES</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><i>Report on disclosure
controls and procedures</i>. The Chief Executive Officer (&#8220;CEO&#8221;) and the Chief Financial Officer (&#8220;CFO&#8221;) have
evaluated the effectiveness of the Company&#8217;s disclosure controls and procedures and have determined that such disclosure controls
and procedures were effective during the period covered by this Annual Report to give reasonable assurance that (i) information required
to be disclosed by the Company in reports that it files or submits to the Commission under the Securities Exchange Act of 1934, as amended
(the &#8220;Exchange Act&#8221;), is recorded, processed, summarized and reported within the time periods specified in applicable rules
and forms, and (ii) material information required to be disclosed in the Company's reports filed under the Exchange Act is provided to
the Company's management, including its principal executive and principal financial officers, or persons performing similar functions,
as appropriate to allow for timely decisions regarding required disclosure.&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><i>Report on Internal
control over financial reporting</i>. This Annual Report does not include a report of management&#8217;s assessment regarding internal
control over financial reporting or an attestation report of the Company&#8217;s registered public accounting firm due to a transition
period established by the rules of the SEC for newly public companies. During the period covered by this Annual Report, no change occurred
in the Company's internal control over financial reporting that has materially affected, or is reasonably likely to materially affect,
the Company's internal control over financial reporting.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">A control system, no
matter how well conceived and operated, can provide only reasonable, not absolute, assurance that the objectives of the control system
are met. Further, the design of a control system must reflect the fact that there are resource constraints, and the benefits of controls
must be considered relative to their costs. Because of the inherent limitations in all control systems, no evaluation of controls can
provide absolute assurance that all control issues and instances of fraud, if any, within the Company have been detected. These inherent
limitations include the realities that judgments in decision-making can be faulty, and that breakdowns can occur because of simple error
or mistake. Additionally, controls can be circumvented by the individual acts of some persons, by collusion of two or more people, or
by management override of the control. The design of any system of controls also is based in part upon certain assumptions about the likelihood
of future events, and there can be no assurance that any design will succeed in achieving its stated goals under all potential future
conditions; over time, control may become inadequate because of changes in conditions, or the degree of compliance with the policies or
procedures may deteriorate. Because of the inherent limitations in a cost-effective control system, misstatements due to error or fraud
may occur and not be detected.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: white"><b>NOTICES PURSUANT TO
REGULATION BTR</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">The Company was not required
by Rule 104 of Regulation BTR to send any notices to any of its directors or executive officers during the fiscal year ended December
31, 2022.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>AUDIT COMMITTEE FINANCIAL EXPERT</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company&#8217;s board of directors has determined
that the Company has at least one audit committee financial expert serving on its audit committee, being William B. Harris, who is considered
independent, as that term is defined in the NYSE American LLC&#8217;s corporate governance standards applicable to the Company.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><!-- Field: Page; Sequence: 6; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt"></p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>CODE OF ETHICS</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company has adopted a written code of conduct
applicable to directors, officers, employees, consultants and contractors of the Company, entitled &#8220;Code of Business Conduct and
Ethics&#8221; (the &#8220;Code&#8221;). The Company monitors compliance with the Code through the Chair of the Audit Committee and the
CEO. The Code provides that each person is personally responsible for and it is their duty to report violations or suspected violations
of the Code, and that no person will be discriminated against for reporting what that person reasonably believes to be a breach of the
Code or any law or regulation. There were no waivers granted in respect of the Code during the period covered by this Annual Report. The
Code is posted on the Company&#8217;s website at https://.encoreuranium.com/corporate/governance/. The Company undertakes to provide to any person without charge,
upon request, a copy of the Code by contacting the Company via email at info@encoreuranium.com.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>PRINCIPAL ACCOUNTANT FEES AND SERVICES</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><ix:nonNumeric contextRef="c0" name="dei:AuditorName">Davidson &amp;
Company LLP</ix:nonNumeric>,&#160;<ix:nonNumeric contextRef="c0" name="dei:AuditorLocation">Vancouver, British Columbia, Canada</ix:nonNumeric>, Auditor Firm ID: <ix:nonNumeric contextRef="c0" name="dei:AuditorFirmId">731</ix:nonNumeric>, acted as the Company's independent registered public
accounting firm for the fiscal year ended December 31, 2022. See page 104 of the Company's Annual Information Form, which is
attached hereto as Exhibit 99.1, for the total amount billed to the Company by Davidson &amp; Company LLC for services performed in
the last two fiscal years by category of service (for audit fees, audit-related fees, tax fees and all other fees).</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: white"><b>OFF-BALANCE SHEET ARRANGEMENTS</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">During the year ended
December 31, 2022, the Company was not a party to any off-balance-sheet arrangements that are not discussed in the MD&amp;A.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>IDENTIFICATION OF THE AUDIT COMMITTEE</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company&#8217;s audit committee is comprised
of William B. Harris (Chair), Richard M. Cherry and Susan Hoxie-Key and is established in accordance with section 3(a)(58)(A) of the Exchange
Act of 1934. All members of the Audit Committee are, in the opinion of the Company&#8217;s board of directors, independent (as determined
under Section 803A and 803B(2) of the rules of the NYSE American LLC). All members of the audit committee are financially literate, meaning
they are able to read and understand the Company&#8217;s financial statements and to understand the breadth and level of complexity of
the issues that can reasonably be expected to be raised by the Company&#8217;s financial statements. The audit committee meets the composition
requirements described in Section 803B(2) of rules of the NYSE American LLC.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="background-color: white"><b>MINE SAFETY
DISCLOSURE</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="background-color: white">Not applicable.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>UNDERTAKING AND CONSENT TO SERVICE OF PROCESS</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>A. Undertaking.</i> The Company undertakes
to make available, in person or by telephone, representatives to respond to inquiries made by the Commission staff, and to furnish promptly,
when requested to do so by the Commission staff, information relating to: the securities registered pursuant to Form 40-F; the securities
in relation to which the obligation to file an annual report on Form 40-F arises; or transactions in said securities.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>B. Consent to Service of Process. </i>The Company
has previously filed with the SEC a written consent to service of process on Form F-X. Any change to the name or address of the Company&#8217;s
agent for service shall be communicated promptly to the Commission by amendment to the Form F-X referencing the file number of the Company.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p><div>

</div><!-- Field: Page; Sequence: 7; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt"></p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>EXHIBIT INDEX</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The following documents are being filed with the
Commission as Exhibits to this Annual Report:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: black 1.5pt solid; width: 9%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Exhibit</b></span></td>
    <td style="width: 1%">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; width: 90%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Description</b></span></td></tr>

<tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td></tr>
<tr style="background-color: rgb(204,238,255)">
    <td style="vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">99.1</span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="text-align: justify; vertical-align: bottom"><a href="ea177383ex99-1_encoreenergy.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Annual Information Form for the year ended December 31,2022</span></a></td></tr>
  <tr style="background-color: White">
    <td style="text-align: justify; vertical-align: top">&#160;</td>
    <td style="text-align: justify; vertical-align: bottom">&#160;</td>
    <td style="text-align: justify; vertical-align: bottom">&#160;</td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="text-align: justify; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">99.2</span></td>
    <td style="text-align: justify; vertical-align: bottom">&#160;</td>
    <td style="text-align: justify; vertical-align: bottom"><a href="ea177383ex99-2_encoreenergy.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Management&#8217;s Discussion and Analysis for the year ended December 31, 2022</span></a></td></tr>
  <tr style="background-color: White">
    <td style="text-align: justify; vertical-align: top">&#160;</td>
    <td style="text-align: justify; vertical-align: bottom">&#160;</td>
    <td style="text-align: justify; vertical-align: bottom">&#160;</td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="text-align: justify; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">99.3</span></td>
    <td style="text-align: justify; vertical-align: bottom">&#160;</td>
    <td style="text-align: justify; vertical-align: bottom"><a href="ea177383ex99-3_encoreenergy.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financial Statements for the years ended December 31,2022 and 2021</span></a></td></tr>
  <tr style="background-color: White">
    <td style="text-align: justify; vertical-align: top">&#160;</td>
    <td style="text-align: justify; vertical-align: bottom">&#160;</td>
    <td style="text-align: justify; vertical-align: bottom">&#160;</td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="text-align: justify; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">99.4</span></td>
    <td style="text-align: justify; vertical-align: bottom">&#160;</td>
    <td style="text-align: justify; vertical-align: bottom"><a href="ea177383ex99-4_encoreenergy.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certification of the Chief Executive Officer, pursuant to Rule 13a-14(a) or Rule 15d-14(a) of the U.S. Securities Exchange Act of 1934</span></a></td></tr>
  <tr style="background-color: White">
    <td style="text-align: justify; vertical-align: top">&#160;</td>
    <td style="text-align: justify; vertical-align: bottom">&#160;</td>
    <td style="text-align: justify; vertical-align: bottom">&#160;</td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="text-align: justify; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">99.5</span></td>
    <td style="text-align: justify; vertical-align: bottom">&#160;</td>
    <td style="text-align: justify; vertical-align: bottom"><a href="ea177383ex99-5_encoreenergy.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certification of the Chief Financial Officer, pursuant to Rule 13a-14(a) or Rule 15d-14(a) of the U.S. Securities Exchange Act of 1934</span></a></td></tr>
  <tr style="background-color: White">
    <td style="text-align: justify; vertical-align: top">&#160;</td>
    <td style="text-align: justify; vertical-align: bottom">&#160;</td>
    <td style="text-align: justify; vertical-align: bottom">&#160;</td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="text-align: justify; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">99.6</span></td>
    <td style="text-align: justify; vertical-align: bottom">&#160;</td>
    <td style="text-align: justify; vertical-align: bottom"><a href="ea177383ex99-6_encoreenergy.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certification of the Chief Executive Officer, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002</span></a></td></tr>
  <tr style="background-color: White">
    <td style="text-align: justify; vertical-align: top">&#160;</td>
    <td style="text-align: justify; vertical-align: bottom">&#160;</td>
    <td style="text-align: justify; vertical-align: bottom">&#160;</td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="text-align: justify; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">99.7</span></td>
    <td style="text-align: justify; vertical-align: bottom">&#160;</td>
    <td style="text-align: justify; vertical-align: bottom"><a href="ea177383ex99-7_encoreenergy.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certification of the Chief Financial Officer, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002</span></a></td></tr>
  <tr style="background-color: White">
    <td style="text-align: justify; vertical-align: top">&#160;</td>
    <td style="text-align: justify; vertical-align: bottom">&#160;</td>
    <td style="text-align: justify; vertical-align: bottom">&#160;</td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="text-align: justify; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">99.8</span></td>
    <td style="text-align: justify; vertical-align: bottom">&#160;</td>
    <td style="text-align: justify; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="ea177383ex99-8_encoreenergy.htm">Consent of Davidson &amp; Company LLP</a></span></td></tr>
  <tr style="background-color: White">
    <td style="text-align: justify; vertical-align: top">&#160;</td>
    <td style="text-align: justify; vertical-align: bottom">&#160;</td>
    <td style="text-align: justify; vertical-align: bottom">&#160;</td></tr>
  <tr style="background-color: #CCEEFF">
    <td style="vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">99.9</span></td>
    <td style="vertical-align: bottom; text-align: justify">&#160;</td>
    <td style="vertical-align: bottom; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="ea177383ex99-9_encoreenergy.htm">Consent of W. Paul Goranson, P.E.</a></span></td></tr>
<tr style="background-color: white">
    <td style="vertical-align: top; text-align: justify">&#160;</td>
    <td style="vertical-align: bottom; text-align: justify">&#160;</td>
    <td style="vertical-align: bottom; text-align: justify">&#160;</td></tr>
<tr style="background-color: #CCEEFF">
    <td style="vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">99.10</span></td>
    <td style="vertical-align: bottom; text-align: justify">&#160;</td>
    <td style="vertical-align: bottom; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="ea177383ex99-10_encoreenergy.htm">Consent of Terence P. McNulty, P.E., PhD</a></span></td></tr>
<tr style="background-color: white">
    <td style="vertical-align: top; text-align: justify">&#160;</td>
    <td style="vertical-align: bottom; text-align: justify">&#160;</td>
    <td style="vertical-align: bottom; text-align: justify">&#160;</td></tr>
<tr style="background-color: #CCEEFF">
    <td style="vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">99.11</span></td>
    <td style="vertical-align: bottom; text-align: justify">&#160;</td>
    <td style="vertical-align: bottom; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="ea177383ex99-11_encoreenergy.htm">Consent of Carl Warren, P.E., P.G.</a></span></td></tr>
<tr style="background-color: white">
    <td style="vertical-align: top; text-align: justify">&#160;</td>
    <td style="vertical-align: bottom; text-align: justify">&#160;</td>
    <td style="vertical-align: bottom; text-align: justify">&#160;</td></tr>
<tr style="background-color: #CCEEFF">
    <td style="vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">99.12</span></td>
    <td style="vertical-align: bottom; text-align: justify">&#160;</td>
    <td style="vertical-align: bottom; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="ea177383ex99-12_encoreenergy.htm">Consent of Douglas L. Beahm, P.E, P.G.</a></span></td></tr>
<tr style="background-color: white">
    <td style="vertical-align: top; text-align: justify">&#160;</td>
    <td style="vertical-align: bottom; text-align: justify">&#160;</td>
    <td style="vertical-align: bottom; text-align: justify">&#160;</td></tr>
<tr style="background-color: #CCEEFF">
    <td style="vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">99.13</span></td>
    <td style="vertical-align: bottom; text-align: justify">&#160;</td>
    <td style="vertical-align: bottom; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="ea177383ex99-13_encoreenergy.htm">Consent of Steve Cutler, P.G.</a></span></td></tr>
<tr style="background-color: white">
    <td style="vertical-align: top; text-align: justify">&#160;</td>
    <td style="vertical-align: bottom; text-align: justify">&#160;</td>
    <td style="vertical-align: bottom; text-align: justify">&#160;</td></tr>
<tr style="background-color: #CCEEFF">
    <td style="vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">99.14</span></td>
    <td style="vertical-align: bottom; text-align: justify">&#160;</td>
    <td style="vertical-align: bottom; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="ea177383ex99-14_encoreenergy.htm">Consent of Ray Moores, P.E.</a></span></td></tr>
<tr style="background-color: white">
    <td style="vertical-align: top; text-align: justify">&#160;</td>
    <td style="vertical-align: bottom; text-align: justify">&#160;</td>
    <td style="vertical-align: bottom; text-align: justify">&#160;</td></tr>
<tr style="background-color: #CCEEFF">
    <td style="vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">99.15</span></td>
    <td style="vertical-align: bottom; text-align: justify">&#160;</td>
    <td style="vertical-align: bottom; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="ea177383ex99-15_encoreenergy.htm">Consent of Matthew Yovich</a></span></td></tr>
  <tr style="background-color: White">
    <td style="text-align: justify; vertical-align: top">&#160;</td>
    <td style="text-align: justify; vertical-align: bottom">&#160;</td>
    <td style="text-align: justify; vertical-align: bottom">&#160;</td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="text-align: justify; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">101</span></td>
    <td style="text-align: justify; vertical-align: bottom">&#160;</td>
    <td style="text-align: justify; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Interactive Data File (formatted as iXBRL)</span></td></tr>
  <tr style="background-color: White">
    <td style="text-align: justify; vertical-align: top">&#160;</td>
    <td style="text-align: justify; vertical-align: bottom">&#160;</td>
    <td style="text-align: justify; vertical-align: bottom">&#160;</td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="text-align: justify; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">104</span></td>
    <td style="text-align: justify; vertical-align: bottom">&#160;</td>
    <td style="text-align: justify; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cover Page Interactive Data File (formatted as iXBRL and contained in Exhibit 101)</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><!-- Field: Page; Sequence: 8; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt"></p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>SIGNATURES</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Pursuant to the requirements of the Exchange Act,
the Company certifies that it meets all of the requirements for filing on Form 40-F and has duly caused this annual report to be signed
on its behalf by the undersigned, thereto duly authorized.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>ENCORE ENERGY CORP.</b></span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td colspan="2">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="width: 60%">&#160;</td>
    <td style="width: 4%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</span></td>
    <td style="width: 36%; border-bottom: black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/ W. Paul Goranson</span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name: W. Paul Goranson</span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title: Chief Executive Officer and Director</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Date: April 28, 2023</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="margin: 0">&#160;</p><div>

</div><p style="text-align: center; margin-top: 0; margin-bottom: 0">5</p><div>

</div><p style="margin: 0"></p><div>

</div><!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><div style="font-size: 1pt; border-top: Black 1.5pt solid">&#160;</div></div><!-- Field: /Rule-Page --><div>

</div><p style="margin: 0">&#160;</p><div>

</div><div style="display: none"><!-- [WMV5][XcpuxYn59dz7vgYynUDuwG7r97K2jUTysl7vcz0lJt/tSeJz73kx1cLt0ZFF2SK/vxBCY0vdSrapBeolBQDhlou4Plg3ZACHgOGjaxwoV9s22fcKeqdlVg/8vXE8BEQPw2gSl8Pfy/SjqfZKUO0G5mehrda5xVrvtHGkgNXPOUg3vb7VF4CMNIMcgg6F7hiC/dgsHya46cPL6td1bLnSV35L5jAlrEDBDi0RC0EWIRx+TpXQjl5L5FZgRjEoUSEZDPNXCVzASX5uJvrRg9ZB9A==] CSR-->
<ix:header>
<ix:references><link:schemaRef xlink:href="cve-20221231.xsd" xlink:type="simple"></link:schemaRef></ix:references>
<ix:resources></ix:resources></ix:header>

</div></div></body>
</html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>ea177383ex99-1_encoreenergy.htm
<DESCRIPTION>ANNUAL INFORMATION FORM FOR THE YEAR ENDED DECEMBER 31,2022
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0; text-align: right"><B>Exhibit 99.1</B></P>

<P STYLE="margin: 0; text-align: right">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B><IMG SRC="ex99-1_001.jpg" ALT=""></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Annual Information Form</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">For the year ended December 31, 2022</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Dated as of April 28, 2023</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>enCore Energy Corp.</B><BR>
101 N. Shoreline Blvd, Suite 450</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">Corpus Christi, TX</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">78401</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">Phone: 361-239-5449</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">www.encoreuranium.com</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<!-- Field: Page; Sequence: 1; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>TABLE OF CONTENTS</B></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 10pt">&nbsp;</P>



<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%">
  <TR STYLE="text-align: left; vertical-align: bottom; font: bold 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="width: 90%; text-align: left">PRELIMINARY NOTES</TD>
    <TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 9%; text-align: center">1</TD></TR>
  <TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="text-align: left">Date of Information</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">1</TD></TR>
  <TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Documents Incorporated by Reference</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">1</TD></TR>
  <TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="text-align: left">Forward-looking Information</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">2</TD></TR>
  <TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Currency</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">3</TD></TR>
  <TR STYLE="text-align: left; vertical-align: bottom; font: bold 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="text-align: left">GLOSSARY OF TERMS</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">3</TD></TR>
  <TR STYLE="text-align: left; vertical-align: bottom; font: bold 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">CORPORATE STRUCTURE</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">9</TD></TR>
  <TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="text-align: left">Name, Address and Incorporation</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">9</TD></TR>
  <TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Intercorporate Relationships</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">9</TD></TR>
  <TR STYLE="text-align: left; vertical-align: bottom; font: bold 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="text-align: left">GENERAL DEVELOPMENT OF THE BUSINESS</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">11</TD></TR>
  <TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Three Year History</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">11</TD></TR>
  <TR STYLE="text-align: left; vertical-align: bottom; font: bold 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="text-align: left">DESCRIPTION OF THE BUSINESS</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">16</TD></TR>
  <TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Material Mineral Properties</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">19</TD></TR>
  <TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="text-align: left">Marquez-Juan Tafoya Property</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">19</TD></TR>
  <TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Crownpoint and Hosta Butte Project</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">32</TD></TR>
  <TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="text-align: left">Dewey Burdock Project</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">46</TD></TR>
  <TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Gas Hills Project</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">55</TD></TR>
  <TR STYLE="text-align: left; vertical-align: bottom; font: bold 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="text-align: left">RISK FACTORS</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">65</TD></TR>
  <TR STYLE="text-align: left; vertical-align: bottom; font: bold 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">DIVIDENDS AND DISTRIBUTIONS</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">79</TD></TR>
  <TR STYLE="text-align: left; vertical-align: bottom; font: bold 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="text-align: left">CAPITAL STRUCTURE</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">79</TD></TR>
  <TR STYLE="text-align: left; vertical-align: bottom; font: bold 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">MARKET FOR SECURITIES</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">81</TD></TR>
  <TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="text-align: left">Trading Price and Volume</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">81</TD></TR>
  <TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Prior Sales</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">82</TD></TR>
  <TR STYLE="text-align: left; vertical-align: bottom; font: bold 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="text-align: left">ESCROWED SECURITIES AND SECURITIES SUBJECT TO CONTRACTUAL RESTRICTION ON TRANSFER</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">86</TD></TR>
  <TR STYLE="text-align: left; vertical-align: bottom; font: bold 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">DIRECTORS AND OFFICERS</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">86</TD></TR>
  <TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="text-align: left">Name, Occupation and Security Holding</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">86</TD></TR>
  <TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Cease Trade Orders, Bankruptcies, Penalties or Sanctions</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">88</TD></TR>
  <TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="text-align: left">Conflicts of Interest</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">88</TD></TR>
  <TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Audit Committee Information</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">89</TD></TR>
  <TR STYLE="text-align: left; vertical-align: bottom; font: bold 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="text-align: left">LEGAL PROCEEDINGS</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">92</TD></TR>
  <TR STYLE="text-align: left; vertical-align: bottom; font: bold 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">REGULATORY ACTIONS</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">92</TD></TR>
  <TR STYLE="text-align: left; vertical-align: bottom; font: bold 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="text-align: left">INTEREST OF MANAGEMENT AND OTHERS IN MATERIAL TRANSACTIONS</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">92</TD></TR>
  <TR STYLE="text-align: left; vertical-align: bottom; font: bold 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">TRANSFER AGENT AND REGISTRAR</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">92</TD></TR>
  <TR STYLE="text-align: left; vertical-align: bottom; font: bold 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="text-align: left">MATERIAL CONTRACTS</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">93</TD></TR>
  <TR STYLE="text-align: left; vertical-align: bottom; font: bold 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">INTERESTS OF EXPERTS</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">93</TD></TR>
  <TR STYLE="text-align: left; vertical-align: bottom; font: bold 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="text-align: left">ADDITIONAL INFORMATION</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">94</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 10pt; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; text-align: left">
  <TD STYLE="width: 12%"><B>SCHEDULE A</B><TD STYLE="text-align: center; width: 2%">&ndash;</TD>
  <TD STYLE="width: 86%"><B>Audit Committee Charter</B></TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 10pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->i<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">PRELIMINARY NOTES</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">Date of Information</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Unless otherwise indicated, all information contained
in this Annual Information Form (&ldquo;<B>AIF</B>&rdquo;) of enCore Energy Corp. (the &ldquo;<B>Company</B>&rdquo;) is current as of
December 31, 2022 with subsequent events disclosed to April 28, 2023.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">Documents Incorporated by Reference</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Incorporated by reference into this AIF are the following documents:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify">A report entitled &ldquo;MARQUEZ-JUAN TAFOYA URANIUM PROJECT&rdquo;
dated and with an effective date of June 9, 2021 prepared by Douglas L. Beahm, P.E., P.G., BRS Inc. and Terence P. McNulty, PE, PHD,
McNulty and Associates (the &ldquo;<B>Marquez-Juan Technical Report</B>&rdquo;);</TD>
</TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify">A report entitled &ldquo;Crownpoint and Hosta Butte Uranium
Project McKinley County, New Mexico, USA Mineral Resources Technical Report&rdquo; dated and with an effective date of February 25, 2022
and a revision date of March 16, 2022, prepared by Douglas L. Beahm, P.E., P.G., Carl Warren, P.E., P.G., and W. Paul Goranson, P.E.
(the &ldquo;<B>Crownpoint and Hosta Butte Technical Report</B>&rdquo;);</TD>
</TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify">A report entitled &ldquo;NI 43-101 Technical Report, Preliminary
Economic Assessment, Gas Hills Uranium Project, Fremont and Natrona Counties, Wyoming, USA&rdquo; dated August 10, 2021 with an effective
date of June 28, 2021 prepared by Ray Moores, P.E. of Western Water Consultants and Steve Cutler, P.G. of Roughstock Mining Services,
LLC (the &ldquo;<B>Gas Hills Technical Report</B>&rdquo;);</TD>
</TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify">A report entitled &ldquo;NI 43-101 Technical Report Preliminary
Economic Assessment Dewey-Burdock Uranium ISR Project South Dakota, USA&rdquo; dated December 23, 2020 and effective as of December 3,
2019 prepared by Matthew Yovich, P.E. of Woodard &amp; Curran and Steve Cutler, P.G. of Roughstock Mining Services, LLC (the &ldquo;<B>Dewey
Burdock Project Technical Report</B>&rdquo;); and</TD>
</TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify">A report entitled &ldquo;Technical Report Summary for the
Alta Mesa Uranium Project, Brooks and Jim Hogg Counties, Texas, USA&rdquo; dated effective January 19, 2023 prepared by Douglas Beahm,
P.E., P.G. of BRS Inc. (the &ldquo;<B>Alta Mesa Technical Report</B>&rdquo;)</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">(collectively, the &ldquo;<B>Technical
Reports</B>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Copies of documents incorporated by reference
are available under the profiles of the Company and Azarga Uranium Corp. on the SEDAR website at www.sedar.com.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Any statement contained in a document incorporated
or deemed to be incorporated by reference herein will be deemed to be modified or superseded for the purposes of this AIF to the extent
that a statement contained in this AIF or in any subsequently filed document that also is or is deemed to be incorporated by reference
herein modifies or supersedes such statement. Any statement so modified or superseded will not constitute a part of this AIF, except as
so modified or superseded. The modifying or superseding statement need not state that it has modified or superseded a prior statement
or include any other information set forth in the document that it modifies or supersedes. The making of such a modifying or superseding
statement will not be deemed an admission for any purpose that the modified or superseded statement, when made, constituted a misrepresentation,
an untrue statement of a material fact or an omission to state a material fact that is required to be stated or that is necessary to make
a statement not misleading in light of the circumstances in which it was made.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Technical Information</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Scientific or technical information contained
in this AIF or in a document incorporated or deemed to be incorporated by reference herein, other than technical information extracted
from the Technical Reports, was approved by John M. Seeley, PhD, PG, CPG, a &ldquo;qualified person&rdquo; for the purposes of NI 43-101
and the Manager of Geology and Exploration for the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 3; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">Forward-looking Information</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">This AIF and information
incorporated by reference herein, contains &ldquo;forward-looking information&rdquo; and &ldquo;forward-looking statements&rdquo; (referred
to together herein as &ldquo;forward- looking information&rdquo;). Forward-looking statements and information can generally be identified
by the use of forward-looking terminology such as &ldquo;may&rdquo;, &ldquo;will&rdquo;, &ldquo;expect&rdquo;, &ldquo;intend&rdquo;, &ldquo;estimate&rdquo;,
&ldquo;anticipate&rdquo;, &ldquo;believe&rdquo;, &ldquo;continue&rdquo;, &ldquo;plans&rdquo; or similar terminology. Forward-looking statements
and information are not historical facts, are made as of the date of this AIF, and include, but are not limited to, statements regarding
discussions of results from operations (including, without limitation, statements about the Company&rsquo;s opportunities, strategies,
competition, expected activities and expenditures as the Company pursues its business plan, the adequacy of the Company&rsquo;s available
cash resources and other statements about future events or results), performance (both operational and financial) and business prospects,
future business plans and opportunities and statements as to management&rsquo;s expectations with respect to, among other things, the
activities contemplated in this AIF.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">Forward-looking statements
included or incorporated by reference in this AIF include, without limitation, statements related to: the Company&rsquo;s future financial
and operational performance; the sufficiency of the Company&rsquo;s current working capital, anticipated cash flow or its ability to raise
necessary funds; the anticipated amount and timing of work programs; our expectations with respect to future exchange rates; the estimated
cost of and availability of funding necessary for sustaining capital; forecast capital and non-operating spending; the Company&rsquo;s
plans and expectations for its property, exploration, development, production, and community relations operations; the use of available
funds; expectations regarding the process for and receipt of regulatory approvals, permits and licenses under governmental and other applicable
regulatory regimes, including U.S. government policies towards domestic uranium supply; expectations about future uranium market prices,
production costs and global uranium supply and demand; expectations regarding holding physical uranium for long-term investment; the establishment
of mineral resources on any of the Company&rsquo;s current or future mineral properties (other than the Company&rsquo;s properties that
currently have an established mineral resource estimates); future royalty and tax payments and rates; expectations regarding possible
impacts of litigation and regulatory actions; the completion of reclamation activities at former mine or extraction sites.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Such forward-looking statements reflect the Company&rsquo;s
current views with respect to future events, based on information currently available to the Company and are subject to and involve certain
known and unknown risks, uncertainties, assumptions and other factors which may cause the actual results, performance or achievements
of the Company to be materially different from any future results, performance or achievements expressed in or implied by such forward-looking
statements. The forward-looking statements in this AIF are based on material assumptions, including the following: our budget, including
expected levels of exploration, evaluation and operations activities and costs, as well as assumptions regarding market conditions and
other factors upon which we have based our income and expenditure expectations; assumptions regarding the timing and use of our cash resources;
our ability to, and the means by which we can, raise additional capital to advance other exploration and evaluation objectives; our operations
and key suppliers are essential services, and our employees, contractors and subcontractors will be available to continue operations;
our ability to obtain all necessary regulatory approvals, permits and licenses for our planned activities under governmental and other
applicable regulatory regimes; our expectations regarding the demand for, and supply of, uranium, the outlook for long-term contracting,
changes in regulations, public perception of nuclear power, and the construction of new and ongoing operation of existing nuclear power
plants; our expectations regarding spot and long-term prices and realized prices for uranium; our expectations that our holdings of physical
uranium will be helpful in securing project financing and/or in securing long- term uranium supply agreements in the future; our expectations
regarding tax rates, currency exchange rates, and interest rates; our decommissioning and reclamation obligations and the status and ongoing
maintenance of agreements with third parties with respect thereto; our mineral resource estimates, and the assumptions upon which they
are based; our, and our contractors&rsquo;, ability to comply with current and future environmental, safety and other regulatory requirements
and to obtain and maintain required regulatory approvals; and our operations are not significantly disrupted by political instability,
nationalization, terrorism, sabotage, pandemics, social or political activism, breakdown, natural disasters, governmental or political
actions, litigation or arbitration proceedings, equipment or infrastructure failure, labour shortages, transportation disruptions or accidents,
or other development or exploration risks.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 4; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The risks, uncertainties, assumptions and other
factors that could cause actual results to differ materially from any future results expressed in or implied by the forward-looking statements
in this AIF include, but are not limited to, the following factors: exploration and development risks; changes in commodity prices; access
to skilled mining personnel; results of exploration and development activities; uninsured risks; regulatory risks; defects in title; availability
of materials and equipment, timeliness of government approvals and unanticipated environmental impacts on operations; risks posed by the
economic and political environments in which the Company operates and intends to operate; the potential for losses arising from the expansion
of operations into new markets; increased competition; assumptions regarding market trends and the expected demand and desires for the
Company&rsquo;s products and proposed products; reliance on industry manufacturers, suppliers and others; the failure to adequately protect
intellectual property; the failure to adequately manage future growth; adverse market conditions; and the failure to satisfy ongoing regulatory
requirements. In addition, the risks, assumptions, and other factors set out herein and in the Company&rsquo;s public filings, including
the most recent Management Discussion and Analysis (&ldquo;MD&amp;A&rdquo;) for the year ended December 31, 2022, could cause actual results
to differ materially from any future results expressed in or implied by the forward-looking statements in this AIF. Should one or more
of these risks or uncertainties materialize, or should assumptions underlying the forward-looking statements prove incorrect, actual results
may vary materially from those described herein as intended, planned, anticipated, believed, estimated or expected. These risks, uncertainties,
assumptions and other factors should be considered carefully, and prospective investors and readers should not place undue reliance on
the forward-looking statements.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Any forward-looking statement speaks only as of
the date on which such statement is made, and the Company undertakes no obligation to update any forward-looking statement or information
or statements to reflect information, events, results, circumstances or otherwise after the date on which such statement is made or to
reflect the occurrence of unanticipated events, except as required by applicable laws. New factors emerge from time to time, and it is
not possible for management to predict all of such factors and to assess in advance the impact of each such fact on the Company&rsquo;s
business or the extent to which any factor, or combination of factors, may cause actual results to differ materially from those contained
in any forward-looking statements or information. All of the forward-looking statements contained or incorporated into this AIF are qualified
by the foregoing cautionary statements.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">Currency</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">All dollar amounts in this AIF are expressed in
Canadian dollars unless otherwise indicated.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">GLOSSARY OF TERMS</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-weight: normal">For ease of
reference, the following factors for converting metric measurements into imperial equivalents are as follows:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-weight: normal"></FONT>&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: Black 1.5pt solid"><B>Metric Units</B></TD><TD STYLE="padding-bottom: 1.5pt"><B>&nbsp;</B></TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid"><B>Multiply By</B></TD><TD STYLE="padding-bottom: 1.5pt"><B>&nbsp;</B></TD><TD STYLE="padding-bottom: 1.5pt"><B>&nbsp;</B></TD>
    <TD STYLE="text-align: center; border-bottom: Black 1.5pt solid"><B>Imperial Units</B></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 33%">Hectares</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: center">&nbsp;</TD><TD STYLE="width: 31%; text-align: center">2.471</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 32%">= acres</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD>Meters</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center">3.281</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD>= feet</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD>Kilometers</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center">0.621</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">= miles (5,280 feet)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD>Grams</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center">0.032</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">= ounces (troy)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD>Tonnes</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center">1.102</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">= tons (short) (2,000 lbs)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD>grams/tonne</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center">0.029</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">= ounces (troy)/ton</TD></TR>
  </TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B></B></P>

<!-- Field: Page; Sequence: 5; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Abbreviations</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">In this AIF, the abbreviations set forth below have the following meanings:</P>

<P STYLE="text-indent: 0.25in; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="width: 9%">$</TD>
    <TD STYLE="width: 36%">Canadian dollar</TD>
    <TD STYLE="width: 8%">&nbsp;</TD>
    <TD STYLE="width: 11%">kv</TD>
    <TD STYLE="width: 36%">kilovolt</TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD>&deg;</TD>
    <TD>degrees</TD>
    <TD>&nbsp;</TD>
    <TD>m</TD>
    <TD>meter</TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD>%</TD>
    <TD>percent</TD>
    <TD>&nbsp;</TD>
    <TD>m<SUP>2</SUP></TD>
    <TD>square meter</TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD>ft</TD>
    <TD>feet</TD>
    <TD>&nbsp;</TD>
    <TD>lb</TD>
    <TD>pound</TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD>g/t</TD>
    <TD>metric gam per metric tonne </TD>
    <TD>&nbsp;</TD>
    <TD>U<SUB>3</SUB>O<SUB>8</SUB></TD>
    <TD>tri-uranium octo-oxide</TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD>kg</TD>
    <TD>kilogram</TD>
    <TD>&nbsp;</TD>
    <TD>ppm</TD>
    <TD>parts per million</TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD>kg/t</TD>
    <TD>kilograms per tonne</TD>
    <TD>&nbsp;</TD>
    <TD>U</TD>
    <TD>uranium</TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD>kl/t</TD>
    <TD>kilo liters per tonne </TD>
    <TD>&nbsp;</TD>
    <TD>ac</TD>
    <TD>acres</TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD>km<SUP>2</SUP></TD>
    <TD>square kilometer</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><FONT STYLE="font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-weight: normal">In this AIF,
the following terms have the meanings set forth herein:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-weight: normal">&ldquo;</FONT>Acquisition
Agreement<FONT STYLE="font-weight: normal">&rdquo; means the membership interest purchase agreement dated November 13, 2022, and as amended
on December 28, 2022, entered into among the Company, EFR White Canyon, and enCore Energy US for the Alta Mesa Acquisition; </FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-weight: normal">&ldquo;</FONT>AGM<FONT STYLE="font-weight: normal">&rdquo;
means the Company&rsquo;s annual general meeting of shareholders held on June 22, 2022;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-weight: normal">&ldquo;</FONT>AIF<FONT STYLE="font-weight: normal">&rdquo;
means this annual information form of the Company for the year ended December 31, 2022;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&ldquo;Alta Mesa Acquisition&rdquo; <FONT STYLE="font-weight: normal">means
the Company&rsquo;s acquisition of the Alta Mesa Uranium Project from EFR White Canyon for the Alta Mesa Consideration; </FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&ldquo;Alta Mesa Consideration&rdquo; <FONT STYLE="font-weight: normal">means
the total consideration of US$120 million for the Alta Mesa Acquisition, consisting of US$60 million in cash and the Note;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-weight: normal">&ldquo;</FONT>Alta
Mesa Entities<FONT STYLE="font-weight: normal">&rdquo; means enCore Alta Mesa LLC, Leoncito Plant, LLC and Leoncito Project, LLC; </FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&ldquo;Alta Mesa Technical Report&rdquo;
<FONT STYLE="font-weight: normal">means the technical report entitled &ldquo;Technical Report Summary for the Alta Mesa Uranium Project,
Brooks and Jim Hogg Counties, Texas, USA&rdquo; dated effective January 19, 2023 prepared by Douglas Beahm, P.E., P.G. of BRS Inc.; </FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-weight: normal">&ldquo;</FONT>Alta
Mesa Uranium Project<FONT STYLE="font-weight: normal">&rdquo; means the fully licensed and constructed in-situ recovery (ISR) mining project
and central processing facility currently on standby, located on almost 200,000 acres of private land in the State of Texas, as further
described in <I>Material Mineral Properties &ndash; Alta Mesa Uranium Project; </I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-weight: normal"><I>&nbsp;</I></FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-weight: normal">&ldquo;</FONT>Audit
Committee<FONT STYLE="font-weight: normal">&rdquo; means the Company&rsquo;s audit committee of the Board of Directors;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-weight: normal">&ldquo;</FONT>Azarga<FONT STYLE="font-weight: normal">&rdquo;
means Azarga Uranium Corp.;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-weight: normal">&ldquo;</FONT>BCBCA<FONT STYLE="font-weight: normal">&rdquo;
means the <I>Business Corporations Act</I> (British Columbia), as amended and supplemented from time to time;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-weight: normal">&ldquo;</FONT>Board
of Directors<FONT STYLE="font-weight: normal">&rdquo; means the board of directors of the Company; </FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-weight: normal">&ldquo;</FONT>Bokum<FONT STYLE="font-weight: normal">&rdquo;
means Bokum Resources Corporation; </FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-weight: normal"></FONT></P>

<!-- Field: Page; Sequence: 6; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-weight: normal">&ldquo;</FONT>Brokered
Escrow Release Conditions<FONT STYLE="font-weight: normal">&rdquo; means the following, all as satisfied and/or waived in form and substance
satisfactory to the Subscription Receipt Underwriters:</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-weight: normal">(a)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-weight: normal">the receipt of all required
board, shareholder and regulatory approvals in connection with the Subscription Receipt Offering and the Alta Mesa Acquisition, including,
without limitation the conditional approval of the TSX-V for the listing of the underlying Subscription Receipt Shares and the Subscription
Receipt Warrant Shares and any relevant listing documents having been accepted for filing with the TSX-V;</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"><FONT STYLE="font-weight: normal">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-weight: normal">(b)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-weight: normal">the completion or the satisfaction
of all conditions precedent to the Alta Mesa Acquisition substantially in accordance with the Acquisition Agreement (other than the payment
of the cash consideration), to the satisfaction of the Subscription Receipt Underwriters;</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-weight: normal">&ldquo;</FONT>Cebolleta<FONT STYLE="font-weight: normal">&rdquo;
or the &ldquo;</FONT>Project<FONT STYLE="font-weight: normal">&rdquo; means the Cebolleta Uranium Project; </FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-weight: normal">&ldquo;</FONT>CEO<FONT STYLE="font-weight: normal">&rdquo;
means the Chief Executive Officer of the Company; </FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-weight: normal">&ldquo;</FONT>CFO<FONT STYLE="font-weight: normal">&rdquo;
means the Chief Financial Officer of the Company;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-weight: normal">&ldquo;</FONT>Cibola<FONT STYLE="font-weight: normal">&rdquo;
means Cibola Resources, LLC;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-weight: normal">&ldquo;</FONT>Common
Shares<FONT STYLE="font-weight: normal">&rdquo; means the common shares without par value in the capital of the Company;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-weight: normal">&ldquo;</FONT>CRC<FONT STYLE="font-weight: normal">&rdquo;
means Core Research Center;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&ldquo;<B>Crownpoint and Hosta Butte Project</B>&rdquo;
means the Company&rsquo;s 100% interest in McKinley properties and a 60% - 100% interest in the adjacent Crownpoint and Hosta Butte properties,
all of which are located in McKinley County, New Mexico, as further described in <I>Material Mineral Properties &ndash; Crownpoint and
Hosta Butte Project</I>;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-weight: normal">&ldquo;</FONT>Crownpoint
and Hosta Butte Technical Report<FONT STYLE="font-weight: normal">&rdquo; means the technical report entitled &ldquo;Crownpoint and Hosta
Butte Uranium Project McKinley County, New Mexico, USA&rdquo; dated February 25, 2022, with an effective date of February 25, 2022 and
a revision date of March 16, 2022, prepared by Douglas L. Beahm, P.E., P.G., Carl Warren, P.E., P.G., and W. Paul Goranson, P.E.;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-weight: normal">&ldquo;</FONT>Devilliers<FONT STYLE="font-weight: normal">&rdquo;
means Devilliers Nuclear;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-weight: normal">&ldquo;</FONT>Dewey
Burdock Projec<FONT STYLE="font-weight: normal">t&rdquo; means the Company&rsquo;s advanced-stage uranium exploration project located
in South Dakota and is solely controlled by Powertech USA, Inc., a wholly-owned subsidiary of the Company, as further described in <I>Material
Mineral Properties &ndash; Dewery Burdock Project;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-weight: normal">&ldquo;</FONT>Dewey
Burdock Technical Report<FONT STYLE="font-weight: normal">&rdquo; means the technical report entitled &ldquo;NI 43-101 Technical Report
Preliminary Economic Assessment Dewey-Burdock Uranium ISR Project South Dakota, USA&rdquo; dated December 23, 2020 and effective as of
December 3, 2019 prepared by Matthew Yovich, P.E. of Woodard &amp; Curran and Steve Cutler, P.G. of Roughstock Mining Services, LLC; </FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-weight: normal">&ldquo;</FONT>EFR
White Canyon<FONT STYLE="font-weight: normal">&rdquo; means EFR White Canyon Corp.;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-weight: normal">&ldquo;</FONT>Elephant
Capital<FONT STYLE="font-weight: normal">&rdquo; means Elephant Capital Corp.;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-weight: normal">&ldquo;</FONT>enCore<FONT STYLE="font-weight: normal">&rdquo;
or &ldquo;</FONT>Company<FONT STYLE="font-weight: normal">&rdquo; means enCore Energy Corp.;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-weight: normal">&ldquo;</FONT>enCore
Energy US<FONT STYLE="font-weight: normal">&rdquo; means enCore Energy US Corp., a wholly-owned subsidiary of the Company;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-weight: normal">&ldquo;</FONT>Energy
Fuels<FONT STYLE="font-weight: normal">&rdquo; means Energy Fuels Inc.; </FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-weight: normal"></FONT></P>

<!-- Field: Page; Sequence: 7; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-weight: normal">&ldquo;</FONT>EnviroMetal<FONT STYLE="font-weight: normal">&rdquo;
means EnviroMetal Technologies Inc. (formerly, EnviroLeach Technologies Inc.);</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-weight: normal">&ldquo;</FONT>Escrow
Release Conditions<FONT STYLE="font-weight: normal">&rdquo; means, as applicable, the Brokered Escrow Release Conditions and the Non-Brokered
Escrow Release Conditions; </FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-weight: normal">&ldquo;</FONT>Exchange
Ratio<FONT STYLE="font-weight: normal">&rdquo; means the exchange ratio of the Arrangement, being 0.375 enCore shares for each common
share of Azarga;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-weight: normal">&ldquo;</FONT>Gas
Hills Project<FONT STYLE="font-weight: normal">&rdquo; means the Company&rsquo;s Gas Hills Uranium Project located approximately 45 miles
east of Riverton, Wyoming in the historic Gas Hills Uranium District, as further described in <I>Material Mineral Properties &ndash; Gas
Hills Project</I>;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-weight: normal">&ldquo;</FONT>Gas
Hills Technical Report<FONT STYLE="font-weight: normal">&rdquo; means the technical report entitled &ldquo;NI 43-101 Technical Report,
Preliminary Economic Assessment, Gas Hills Uranium Project, Fremont And Natrona Counties, Wyoming, USA&rdquo; dated August 10, 2021 with
an effective date of June 28, 2021 prepared by Ray Moores, P.E. of Western Water Consultants Inc. and Steve Cutler, P.G. of Roughstock
Mining Services, LLC; </FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-weight: normal">&ldquo;</FONT>Group
11&rdquo; <FONT STYLE="font-weight: normal">means Group 11 Technologies Inc.;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-weight: normal">&ldquo;</FONT>historical
estimate<FONT STYLE="font-weight: normal">&rdquo; means an estimate of the quantity, grade, or metal or mineral content of a deposit that
an issuer has not verified as a current mineral resource or mineral reserve, and which was prepared before the issuer acquiring, or entering
into an agreement to acquire, an interest in the property that contains the deposit;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-weight: normal">&ldquo;</FONT>Kerr-McGee<FONT STYLE="font-weight: normal">&rdquo;
means Kerr-McGee Corporation;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&ldquo;<B>Marquez-Juan Technical Report</B>&rdquo;
means the technical report entitled &ldquo;MARQUEZ-JUAN TAFOYA URANIUM PROJECT&rdquo; dated and with an effective date of June 9, 2021
prepared by Douglas L. Beahm, P.E., P.G., BRS Inc. and Terence P. McNulty, PE, PHD, McNulty and Associates;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&ldquo;<B>Marquez-Juan Project</B>&rdquo; means
the Company&rsquo;s Marquez-Juan Tafoya Uranium Project which consists of private mineral leases located in McKinley and Sandoval counties
of New Mexico, on the eastern end of the Grants Uranium District in northern New Mexico, as further described in <I>Material Mineral Properties
&ndash; Marquez-Juan Tafoya Property</I>;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&ldquo;<B>MEUS</B>&rdquo; means Metamin Enterprises
US Inc., a wholly-owned subsidiary of enCore Energy US;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&ldquo;<B>mineral reserve</B>&rdquo; means the
economically mineable part of a measured and/or indicated mineral resource. It includes diluting materials and allowances for losses,
which may occur when the material is mined or extracted and is defined by studies at pre-feasibility or feasibility level as appropriate
that include application of modifying factors;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&ldquo;<B>mineral resources</B>&rdquo; means a
concentration or occurrence of solid material of economic interest in or on the Earth&rsquo;s crust in such form, grade or quality and
quantity that there are reasonable prospects for economic extraction. The location, quantity, grade or quality, continuity and other geological
characteristics of a mineral resource are known, estimated or interpreted from specific geological evidence and knowledge, including sampling.
Mineral resources are sub-divided, in order of increasing geological confidence, into inferred, indicated and measured categories;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&ldquo;<B>mineralization</B>&rdquo; means in exploration,
a reference to a notable concentration of metals and their associated mineral compounds, or a specific mineral, within a body of rock;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&ldquo;<B>Neutron</B>&rdquo; means Neutron Energy,
Inc.;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&ldquo;<B>NI 43-101</B>&rdquo; means National
Instrument 43-101 <I>Standards of Disclosure for Mineral Projects</I>;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-weight: normal">&ldquo;</FONT>NI
52-110<FONT STYLE="font-weight: normal">&rdquo; means National Instrument 52-110 <I>Audit Committees</I>;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-weight: normal"></FONT></P>

<!-- Field: Page; Sequence: 8; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-weight: normal">&ldquo;</FONT>Non-Brokered
Escrow Release Conditions<FONT STYLE="font-weight: normal">&rdquo; means: </FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-weight: normal">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-weight: normal">(a)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-weight: normal">the receipt of all required board, shareholder and regulatory approvals
in connection with the Subscription Receipt Offering and the Alta Mesa Acquisition, including, without limitation the conditional approval
of the TSX-V for the listing of the Subscription Receipt Shares and the Subscription Receipt Warrant Shares and any relevant listing documents
having been accepted for filing with the TSX-V; (</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-weight: normal">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-weight: normal">(b)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-weight: normal">the completion or the satisfaction of all conditions precedent to the
Alta Mesa Acquisition substantially in accordance with the Acquisition Agreement (other than the payment of the cash consideration); and</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><B>&nbsp;</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-weight: normal">(c)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-weight: normal">the delivery of the applicable escrow release notice to the Subscription
Receipt Agent; </FONT></TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&ldquo;Note&rdquo; <FONT STYLE="font-weight: normal">means
the US$60 million secured convertible promissory note with EFR White Canyon;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-weight: normal">&ldquo;</FONT>NRC<FONT STYLE="font-weight: normal">&rdquo;
means US Nuclear Regulatory Commission; </FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-weight: normal">&ldquo;</FONT>NuFuels<FONT STYLE="font-weight: normal">&rdquo;
means NuFuels, Inc., a wholly-owned subsidiary of Laramide Resources Ltd.;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-weight: normal">&ldquo;</FONT>NYSE
American<FONT STYLE="font-weight: normal">&rdquo; means NYSE American LLC; </FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-weight: normal">&ldquo;</FONT>NZ<FONT STYLE="font-weight: normal">&rdquo;
means The NZ Land Company; </FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-weight: normal">&ldquo;</FONT>NZU<FONT STYLE="font-weight: normal">&rdquo;
means NZ Uranium LLC;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-weight: normal">&ldquo;</FONT>Offering<FONT STYLE="font-weight: normal">&rdquo;
means the public offering of Units for aggregate gross proceeds of $34,500,862.50 closed on February 8, 2023;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-weight: normal">&ldquo;</FONT>Offering
Prospectus<FONT STYLE="font-weight: normal">&rdquo; means the short form prospectus of the Company dated February 3, 2023 and filed in
connection with the Offering; </FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&ldquo;<B>OTCQB</B>&rdquo; means OTCQB Venture
Market;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&ldquo;<B>Red Cloud</B>&rdquo; means Red Cloud
Securities Inc. and Red Cloud Financial Services Inc.;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&ldquo;<B>Registration Statement</B>&rdquo; means
the registration statement on Form F-10 (including such Offering Prospectus) filed with the SEC for the Offering;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&ldquo;<B>Rosita Project</B>&rdquo; means the
Company&rsquo;s uranium processing plant and associated well fields located in Duval County, Texas, as further described in <I>General
Development of the Business;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&ldquo;<B>SEC</B>&rdquo; means the U.S. Securities
and Exchange Commission;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-weight: normal">&ldquo;</FONT>SEDAR<FONT STYLE="font-weight: normal">&rdquo;
means the System for Electronic Document Analysis and Retrieval; </FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-weight: normal">&ldquo;</FONT>Share
Consolidation<FONT STYLE="font-weight: normal">&rdquo; means the share consolidation of the Common Shares on the basis of one (1) post-consolidation
Common Share for every three (3) pre-consolidation Common Shares; </FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-weight: normal">&ldquo;</FONT>Stock
Option Plan<FONT STYLE="font-weight: normal">&rdquo; means the Company&rsquo;s stock option plan, as further amended from time to time;
</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-weight: normal">&ldquo;</FONT>Subscription
Receipt Agreement<FONT STYLE="font-weight: normal">&rdquo; means the subscription receipt agreement dated December 6, 2022 among the Company,
Computershare Trust Company of Canada, as subscription receipt agent, and Canaccord Genuity Corp.; </FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-weight: normal">&ldquo;</FONT>Subscription
Receipts<FONT STYLE="font-weight: normal">&rdquo; means subscription receipts of the Company; </FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-weight: normal">&ldquo;</FONT>Subscription
Receipt Brokered Offering<FONT STYLE="font-weight: normal">&rdquo; means the brokered private placement of an aggregate of 23,0000 Subscription
Receipts at a price of $3.00 per Subscription Receipt for aggregate gross proceeds of $69 million, including the full exercise of the
Subscription Receipt Underwriters&rsquo; option, closed on the Subscription Receipt Closing Date; </FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 9; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-weight: normal">&ldquo;</FONT>Subscription
Receipt Concurrent Offering<FONT STYLE="font-weight: normal">&rdquo; means the non-brokered private placement of 277,000 Subscription
Receipts for gross proceeds of $831,000, closed on the Subscription Receipt Closing Date; </FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-weight: normal">&ldquo;</FONT>Subscription
Receipt Closing Date<FONT STYLE="font-weight: normal">&rdquo; means December 6, 2022; </FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-weight: normal">&ldquo;</FONT>Subscription
Receipt Offering<FONT STYLE="font-weight: normal">&rdquo; means the Subscription Receipt Brokered Offering and Subscription Receipt Concurrent
Offering;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-weight: normal">&ldquo;</FONT>Subscription
Receipt Underwriters<FONT STYLE="font-weight: normal">&rdquo; means Canaccord Genuity Corp., Haywood Securities Inc., Cantor Fitzgerald
Canada Corporation, PI Financial Corp., Clarus Securities Inc., and Red Cloud Securities Inc.; </FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-weight: normal">&ldquo;</FONT>Subscription
Receipt Share<FONT STYLE="font-weight: normal">&rdquo; means the Common Share underlying the Subscription Unit; </FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-weight: normal">&ldquo;</FONT>Subscription
Receipt Unit<FONT STYLE="font-weight: normal">&rdquo; means one unit of the Company, issuable upon automatic conversion of the Subscription
Receipts, and is comprised of one Subscription Receipt Share and one Subscription Receipt Warrant; </FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-weight: normal">&ldquo;</FONT>Subscription
Receipt Warrant<FONT STYLE="font-weight: normal">&rdquo; means the <FONT STYLE="font-family: Times New Roman, Times, Serif">Common Share
purchase warrant, with each Subscription Receipt Warrant entitling the holder thereof to acquire one Subscription Receipt Warrant Share
at a price of $3.75 for a period of 3 years following satisfaction of the Escrow Release Conditions; </FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-weight: normal">&ldquo;</FONT>Subscription
Receipt Warrant Shares<FONT STYLE="font-weight: normal">&rdquo; means the <FONT STYLE="font-family: Times New Roman, Times, Serif">Common
Shares issuable upon exercise of the Subscription Receipt Warrants;</FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-weight: normal">&ldquo;</FONT>Technical
Reports<FONT STYLE="font-weight: normal">&rdquo; means the Marquez-Juan Technical Report, the Crownpoint and Hosta Butte Technical Report,
the Dewey Burdock Technical Report, the Gas Hills Technical Report, and the Alta Mesa Technical Report; </FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-weight: normal">&ldquo;</FONT>Tigris<FONT STYLE="font-weight: normal">&rdquo;
means Tigris Uranium US Corp.;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-weight: normal">&ldquo;</FONT>TSX-V<FONT STYLE="font-weight: normal">&rdquo;
means the TSX Venture Exchange;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-weight: normal">&ldquo;</FONT>Units<FONT STYLE="font-weight: normal">&rdquo;
means a unit of the Company, consisting of one Unit Share and one-half of one Warrant; </FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-weight: normal">&ldquo;</FONT>Unit
Share<FONT STYLE="font-weight: normal">&rdquo; means a Common Share underlying the Units; </FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&ldquo;<B>URI</B>&rdquo; means URI, Inc.;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&ldquo;<B>U.S. Securities Act</B>&rdquo; means
the United States Securities Act of 1933, as amended;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&ldquo;<B>USGS</B>&rdquo; means United States
Geological Survey;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&ldquo;<B>Vane</B>&rdquo; means VANE Minerals
(US) LLC;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&ldquo;<B>Warrants</B>&rdquo; means the Common
Share purchase warrants underlying the Units, with each Warrant exercisable into a Warrant Share at a price of $4.05 for a period of 36
months following the closing of the Offering;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&ldquo;<B>Warrant Share</B>&rdquo; means the Common
Shares issuable upon exercise of the Warrants;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&ldquo;<B>Westwater</B>&rdquo; means Westwater
Resources Inc.; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&ldquo;<B>Westwater Assets Acquisition</B>&rdquo;
means the acquisition by the Company of all of Westwater&rsquo;s United States uranium assets pursuant to a securities purchase agreement
dated December 31, 2020, as further described in <I>Three Year History and Significant Acquisitions</I>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 10; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">CORPORATE STRUCTURE</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">Name, Address and Incorporation</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">enCore was incorporated on October 30, 2009 under
the <I>Business Corporations Act</I> (British Columbia) (the &ldquo;<B>BCBCA</B>&rdquo;) under the name &ldquo;Dauntless Capital Corp.&rdquo;
The company&rsquo;s name was changed to &ldquo;Tigris Uranium Corp.&rdquo; on September 2, 2010, and changed to &ldquo;Wolfpack Gold Corp.&rdquo;
on May 15, 2013. On August 15, 2014, the company&rsquo;s name was changed to &ldquo;enCore Energy Corp.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company is a reporting issuer in the provinces
of British Columbia, Alberta, Saskatchewan, Manitoba, New Brunswick, Nova Scotia, Prince Edward Island, Newfoundland and Ontario. The
Company&rsquo;s Common Shares are listed for trading on the TSX-V and on the NYSE American under the symbol &ldquo;EU&rdquo;.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The principal offices of the Company are located
at Suite 450, 101 N. Shoreline Blvd, Corpus Christi, Texas 78401, United States of America. The Company&rsquo;s registered and records
office is located at Suite 1200, 750 West Pender Street, Vancouver, British Columbia, V6C 2T8.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">Intercorporate Relationships</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">enCore has the following subsidiaries as at the
date of this AIF:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left; border-bottom: Black 1.5pt solid; width: 25%; vertical-align: bottom"><B>Name of Subsidiary</B></TD>
    <TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="text-align: left; border-bottom: Black 1.5pt solid; width: 23%; vertical-align: bottom"><B>Jurisdiction&nbsp;of&nbsp;Incorporation</B></TD>
    <TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; width: 50%"><B>Percentage of Voting Shares/Interests beneficially owned directly or indirectly by enCore </B></TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD>Azarga Uranium Corp.</TD>
    <TD>&nbsp;</TD>
    <TD>British Columbia</TD>
    <TD>&nbsp;</TD>
    <TD>100% directly</TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD>Powertech (USA) Inc.</TD>
    <TD>&nbsp;</TD>
    <TD>South Dakota</TD>
    <TD>&nbsp;</TD>
    <TD>100% indirectly through Azarga Uranium Corp.</TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD>URZ Energy Corp.</TD>
    <TD>&nbsp;</TD>
    <TD>British Columbia</TD>
    <TD>&nbsp;</TD>
    <TD>100% indirectly through Azarga Uranium Corp.</TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD>Ucolo Exploration Corp.</TD>
    <TD>&nbsp;</TD>
    <TD>Utah</TD>
    <TD>&nbsp;</TD>
    <TD>100% indirectly through URZ Energy Corp.</TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD>Azarga Resources Limited</TD>
    <TD>&nbsp;</TD>
    <TD>British Virgin Islands</TD>
    <TD>&nbsp;</TD>
    <TD>100% indirectly through Azarga Uranium Corp.</TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD>Azarga Resources (Hong Kong) Ltd.</TD>
    <TD>&nbsp;</TD>
    <TD>Hong Kong</TD>
    <TD>&nbsp;</TD>
    <TD>100% indirectly through Azarga Resources Limited</TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD>Azarga Resources Canada Ltd.</TD>
    <TD>&nbsp;</TD>
    <TD>British Columbia</TD>
    <TD>&nbsp;</TD>
    <TD>100% indirectly through Azarga Resources (Hong Kong) Limited</TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD>Azarga Resources USA Company</TD>
    <TD>&nbsp;</TD>
    <TD>Colorado</TD>
    <TD>&nbsp;</TD>
    <TD>100% indirectly through Azarga Resources Canada Ltd.</TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD>enCore Energy US Corp.</TD>
    <TD>&nbsp;</TD>
    <TD>Nevada</TD>
    <TD>&nbsp;</TD>
    <TD>100% directly</TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD>HRI-Churchrock, Inc.</TD>
    <TD>&nbsp;</TD>
    <TD>Delaware</TD>
    <TD>&nbsp;</TD>
    <TD>100% indirectly through enCore Energy US Corp.</TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD>Metamin Enterprises US Inc.</TD>
    <TD>&nbsp;</TD>
    <TD>Nevada</TD>
    <TD>&nbsp;</TD>
    <TD>100% indirectly through enCore Energy US Corp.</TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD>Neutron Energy, Inc.</TD>
    <TD>&nbsp;</TD>
    <TD>Nevada</TD>
    <TD>&nbsp;</TD>
    <TD>100% indirectly through enCore Energy US Corp.</TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD>Tigris Uranium US Corp.</TD>
    <TD>&nbsp;</TD>
    <TD>Nevada</TD>
    <TD>&nbsp;</TD>
    <TD>100% indirectly through enCore Energy US Corp.</TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD>Uranco, Inc.</TD>
    <TD>&nbsp;</TD>
    <TD>Delaware</TD>
    <TD>&nbsp;</TD>
    <TD>100% indirectly through enCore Energy US Corp.</TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD>Uranium Resources, Inc.</TD>
    <TD>&nbsp;</TD>
    <TD>Delaware</TD>
    <TD>&nbsp;</TD>
    <TD>100% indirectly through enCore Energy US Corp.</TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD>URI, Inc.</TD>
    <TD>&nbsp;</TD>
    <TD>Delaware</TD>
    <TD>&nbsp;</TD>
    <TD>100% indirectly through enCore Energy US Corp.</TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-size: 10pt">enCore Alta Mesa LLC</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>Texas</TD>
    <TD>&nbsp;</TD>
    <TD>100% indirectly through enCore Energy US Corp.</TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD><FONT STYLE="font-size: 10pt">Leoncito Plant, LLC </FONT></TD>
    <TD>&nbsp;</TD>
    <TD>Texas</TD>
    <TD>&nbsp;</TD>
    <TD>100% indirectly through enCore Energy US Corp.</TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-size: 10pt">Leoncito Project, LLC</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>Texas</TD>
    <TD>&nbsp;</TD>
    <TD>100% indirectly through enCore Energy US Corp.</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 11; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The following organizational chart illustrates enCore&rsquo;s principal
subsidiaries as at the date of this AIF:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 14.2pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><IMG SRC="ex99-1_016.jpg" ALT="">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Notes:</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in; text-align: left">*</TD><TD STYLE="text-align: justify">POI = Place of incorporation or legal organization</TD>
</TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in; text-align: left">*</TD><TD STYLE="text-align: justify">PPB = Principal place of business</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 12; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">GENERAL DEVELOPMENT OF THE BUSINESS</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">Three Year History</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The following provides an overview of events during
the three year period prior to the date of this AIF.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On August 28, 2020, enCore acquired 40% of Group
11 Technologies Inc. (&ldquo;<B>Group 11</B>&rdquo;), a United States-based private company committed to testing and implementing non-invasive
extraction technologies of precious metals with the use of environmentally-friendly solutions. Group 11 was founded and is owned by enCore
Energy Corp. with 40% of the common stock, EnviroMetal Technologies Inc. (formerly, EnviroLeach Technologies Inc.) (&ldquo;<B>EnviroMetal</B>&rdquo;)
(CSE: ETI; OTCQB: EVLLF) with 40% of the common stock and Golden Predator Mining Corp. with 20% of the common stock. enCore contributed
$750,000 in initial funding and will provide in-situ extraction expertise. EnviroMetal entered into a license agreement with Group 11
for the use of its environmentally friendly metal recovery process and will provide chemical and metallurgical expertise.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On September 14, 2020, enCore appointed Paul Goranson
as Director and as Chief Executive Officer effective October 1, 2020. Dennis Stover stepped down as Chief Executive Officer and became
the Chief Technical Officer effective October 1, 2020.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On October 22, 2020, enCore completed a private
placement of 12,000,000 units at a price of $0.40 per unit for gross proceeds of $4,800,000. Each unit was comprised of one Common Share
and one-half of one common share purchase warrant. Each whole warrant entitles the holder to purchase one common share at an exercise
price of $0.60 until October 22, 2023, subject to acceleration of the expiry date to no less than 30 calendar days upon notice provided
by enCore, which notice may be provided following the Common Shares trading at no less than $0.90 per share for 5 consecutive trading
days on the TSX-V.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Pursuant to a securities purchase agreement dated
December 31, 2020, the Company acquired from Westwater Resources Inc. (&ldquo;<B>Westwater</B>&rdquo;) seven subsidiary entities containing
all of Westwater&rsquo;s United States uranium assets in exchange for 2,571,598 Common Shares issued for a total value of US$1,795,000
and the grant of a 2% net smelter return royalty on mineral rights held by the subsidiaries in the State of New Mexico, excluding the
Juan Tafoya and Cebolleta projects which retain a 2.5% net profits interest (the &ldquo;<B>Westwater Assets Acquisition</B>&rdquo;). The
Company assumed the existing reclamation bonds on Westwater&rsquo;s uranium projects totaling approximately US $9.25 million. The Company
retained US$3,000,000 of the cash collateral supporting these reclamation bonds with Westwater receiving US$742,642 of the cash collateral
at closing. No other payments were made for reclamation work and reclamation bond reduction. Through this transaction the Company acquired
two licensed, Texas-based uranium production facilities; mineral exploration leases in Texas; and more than 270 square miles (180,000
acres) of patented mineral rights in New Mexico, with four projects containing significant historical mineral estimates.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On February 1, 2021, Carrie Mierkey was appointed
as Chief Financial Officer and Corporate Secretary of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On March 9, 2021, enCore completed a brokered
and non-brokered private placement of 15,000,000 units at a price of $1.00 per unit for gross proceeds of $15,000,000. Each unit was comprised
of one Common Share and one-half of one common share purchase warrant. Each whole warrant entitles the holder thereof to purchase one
common share at an exercise price of $1.30 until March 9, 2024. The Company paid commissions totaling $758,001 and issued 758,001 finders&rsquo;
warrants. The finder&rsquo;s warrants are exercisable into one unit of the Company at a price of $1.00 for three years from closing. The
Company planned to use the net proceeds raised for the refurbishment of the Rosita Project to operational status, completion of ongoing
reclamation activities and for general corporate purposes.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 13; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In April 2021, the Company acquired 200,000 pounds
of U308 for a purchase price of $37.12 per pound (US$29.65 per pound) or $7,423,767 and another 100,000 of U308 for a purchase price of
$37.58 per pound (US$30.80 per pound) or $3,757,600. These spot market purchases were made to de-risk future uranium deliveries associated
with anticipated contractual production timelines from planned ISR operations. The purchase strengthens the Company&rsquo;s working capital
and provides optionality in support of future capital development of its South Texas assets.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In June 2021, the Company announced the results
of a Preliminary Economic Assessment for the Company&rsquo;s recently consolidated Juan Tafoya and Marquez projects located in the Grant&rsquo;s
Uranium District in northwest New Mexico.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In July 2021, the Company entered into a uranium
supply contract with UG USA, Inc. Pursuant to the agreement, UG USA, Inc. will purchase U<SUB>3</SUB>O<SUB>8</SUB> from the Company for
up to two million pounds from 2023 through 2027. The sales price under the agreement will be tied to spot market pricing with terms that
are more representative of current market conditions and practices. In August 2021, the Company and UG USA, Inc. agreed to terminate a
previous sales agreement which was entered into prior to the July 2021 contract (as referenced above), acquired by the Company in the
asset acquisition with Westwater in December 2020 for a cancellation fee of US$2,750,000.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On August 27, 2021, the Company entered into a
Share Purchase Agreement with Elephant Capital Corp. (&ldquo;<B>Elephant Capital</B>&rdquo;) to sell all of the outstanding share capital
of Cibola Resources, LLC (&ldquo;<B>Cibola</B>&rdquo;), held by the Company&rsquo;s wholly-owned subsidiary, Neutron Energy, Inc., to
Elephant Capital. Cibola which itself controls the rights to a lease of a mineral property comprising approximately 6,700 acres of mineral
rights and 5,700 acres of surface rights located in west-central New Mexico and commonly referred to as the &ldquo;Cebolleta Uranium Project&rdquo;
(the &ldquo;<B>Project</B>&rdquo; or &ldquo;<B>Cebolleta</B>&rdquo;). On October 29, 2021, Evolving Gold Corp. announced that it was acquiring
Elephant Capital.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In September 2021, the Company sold 200,000 pounds
U<SUB>3</SUB>O<SUB>8</SUB> to two different buyers for an average sales price of $34.88 per pound U<SUB>3</SUB>O<SUB>8</SUB>. The Company
realized revenue from these sales of $6,975,000.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On December 13, 2021, the Company announced that
it has secured a second uranium purchase agreement with a Fortune 150 United States utility. The uranium purchase agreement, which represents
the second purchase agreement executed by enCore, is a four-year agreement commencing in 2024, and it covers up to 1.3 million pounds
U<SUB>3</SUB>O<SUB>8</SUB> based on market pricing with a ceiling price significantly higher than the current uranium spot market price
at the time of the announcement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On December 31, 2021, the Company completed the
acquisition of all of the issued and outstanding common shares of Azarga in exchange for 95,419,852 Common Shares of the Company. Outstanding
and unexercised warrants and options to purchase common shares of Azarga were deemed to be exchanged for options and warrants to purchase
Common Shares of the Company on an adjusted basis. The Arrangement consolidated an industry leading pipeline of exploration and development
staged in-situ recovery (&ldquo;<B>ISR</B>&rdquo;) focused uranium projects located in the United States, including the licensed Rosita
Project and Kingsville Dome past producing uranium production facilities in South Texas, the advanced stage Dewey Burdock development
project in South Dakota, which has been issued its key federal permits, the PEA-staged Gas Hills Project located in Wyoming, and a portfolio
of resource staged projects throughout the United States. In connection with the Arrangement, the U.S. Nuclear Regulatory Commission (&ldquo;<B>NRC</B>&rdquo;)
approved the change of control over the Dewey Burdock Source and By-Product Materials License, which enables the Company to receive, acquire,
possess, and transfer natural uranium and byproduct material in any form without restriction on quantity, at the Dewey-Burdock Project
in Fall River and Custer Counties, South Dakota.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 14; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On February 15, 2022, the Company entered into
an agreement to forward purchase 200,000 pounds U<SUB>3</SUB>O<SUB>8</SUB> from a third party. The agreement allows the Company to acquire
the uranium in 2023 at a fixed price, and the Company has prepaid a portion of the forward purchase price to secure the purchase agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On March 25, 2022, the Company completed a &ldquo;bought
deal&rdquo; prospectus offering pursuant to which the Company sold an aggregate of 19,607,842 units of the Company at a price of $1.53
per unit for aggregate gross proceeds of $29,999,998.26. Each unit was comprised of one Common Share and one-half of one common share
purchase warrant of the Company. Each whole warrant entitles the holder thereof to purchase one Common Share at an exercise price of $2.00
until March 25, 2024. The Company paid the underwriters a cash commission of $1,612,499.93 and issued an aggregate of 1,053,922 compensation
options of the Company. Each compensation option is exercisable to acquire one Common Share at an exercise price of $1.53 per share until
March 25, 2024. The Company planned to use the net proceeds to maintain and advance the Company&rsquo;s material properties, acquire properties,
plant upgrades, maintenance and refurbishment, and for general corporate and working capital purposes.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On April 11, 2022, the Company announced positive
results from its on-going uranium delineation and exploration drill programs at the Rosita Project. Highlights of the Rosita South uranium
delineation and exploration drill programs include: (a) 32 drill holes reported for a total of ~11,000 feet including 20 delineation drill
holes and 12 exploration drill holes; (b) the exploration drilling has identified 8 mineralized sands plus an additional 4 potentially
mineralized sands, all within 800 feet of the surface, which provide opportunities for discovery of future uranium resources across the
entire Rosita project; and (c) Delineation drill results established an extension of mineralization in the Production Area which supports
the start-up of the Rosita Plant expected next year.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On April 18, 2022, the Company announced that
the refurbishment of the Rosita Project is 90% complete. Once the modernization and refurbishment project is complete, enCore will commence
commissioning work, expected to take approximately 30 days. Following commissioning work the Rosita Project will be ready to start receiving
loaded resin. Monitor well installation, baseline water quality analysis, and hydrological testing will be completed as part of the Production
Area Authorization (PAA) process with the Texas Commission on Environmental Quality. (TCEQ). Wellfield installation will begin immediately
following the submittal of the PAA data package to the TCEQ. All activities are on track and on budget for a projected 2023 production
start.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On May 3, 2022, the Company appointed Mr. Peter
Luthiger as Chief Operating Officer. Mr. Luthiger will be responsible for the commissioning and operation of the Rosita Uranium Processing
Plant in South Texas.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 409.95pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On May 20, 2022, the Company completed the sale
of Cibola, including its holding of Ceboletta, to Elephant Capital pursuant to the Share Purchase Agreement with Elephant Capital dated
August 27, 2021. Subsequently on May 24, 2022, the Company acquired 11,308,250 common shares of American Future Fuel Corporation (formerly
Evolving Gold Corp), representing approximately 15.90% on an undiluted basis of the outstanding shares of American Future Fuel Corporation,
and a cash payment of $250,000 USD in exchange for common shares of Elephant Capital previously held by the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On June 1, 2022, the Company appointed Susan Hoxie-Key,
MSc, P.E., as a director of the Company. Ms. Hoxie-Key brings over 40 years of engineering experience in the nuclear fuel industry.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On June 28, 2022, the Company secured a uranium
purchase sales agreement with a United States based nuclear power company. The agreement is a multi-year agreement commencing in 2025
and covers up to 600,000 pounds of U<SUB>3</SUB>O<SUB>8</SUB> based on market pricing with a floor price that assures the Company&rsquo;s
cost of product are met. The agreement includes an inflation adjusted ceiling price higher than the current uranium spot market pricing
providing the U.S. nuclear power plant assurance of cost certainty.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 15; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On July 15, 2022, the Company appointed Gregory
Zerzan as Chief Administrative Officer and General Counsel. Mr. Zerzan held several prominent government and private sector leadership
positions, including most recently as Principal Deputy Solicitor of the United States Department of the Interior.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On September 14, 2022, the Company consolidated
the Common Shares on the basis of one (1) post-consolidation Common Share for every three (3) pre-consolidation Common Shares (the &ldquo;<B>Share
Consolidation</B>&rdquo;). The exercise price and the number of Common Shares issuable under any of the outstanding warrants, stock options
or other convertible securities issued prior to the Share Consolidation was proportionately adjusted.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On November 13, 2022, the Company entered into
the Acquisition Agreement to acquire the Alta Mesa Uranium Project, a uranium project from EFR White Canyon for total Alta Mesa Consideration
of US$120 million. The Alta Mesa Uranium Project is a fully licensed and constructed ISR project and central processing facility currently
on standby, located on almost 200,000 acres of private land in the state of Texas. Total operating capacity is 1.5 million lbs U<SUB>3</SUB>O<SUB>8</SUB>
per year. The Alta Mesa Uranium Project historically produced nearly 5 million lbs U<SUB>3</SUB>O<SUB>8</SUB> between 2005 and 2013, when
full production was curtailed as a result of low uranium prices at the time. The Alta Mesa Uranium Project has not been in commercial
production since 2013. enCore intends to immediately pursue the resumption of operations following completion of the Alta Mesa Acquisition.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Pursuant to the terms of the Acquisition Agreement,
the Company, through its wholly owned subsidiary enCore Energy US Corp. (&ldquo;<B>enCore Energy US</B>&rdquo;), will acquire all of the
limited liability company membership interests in each of the three Texas limited liability companies which collectively own and control
the Project, being enCore Alta Mesa LLC, Leoncito Plant, LLC and Leoncito Project, LLC (collectively, the &ldquo;<B>Alta Mesa Entities</B>&rdquo;)
from EFR White Canyon, a wholly owned subsidiary of Energy Fuels. The Company will additionally assume the reclamation obligations and
obtain replacement surety bonds associated with the Project. The Alta Mesa Consideration payable to Energy Fuels consists of US$60 million
in cash and a US$60 million secured convertible promissory note (the &ldquo;<B>Note</B>&rdquo;) with EFR White Canyon. The obligations
under the Note will be secured by the assets of the Alta Mesa Entities and a pledge of the equity interests of the Alta Mesa Entities.
In addition, at the closing of the Alta Mesa Acquisition, the Company will provide to EFR White Canyon a parent guarantee of the obligations
under the Note. The Note will have a two (2) year term and will bear interest at a rate of 8% per annum payable on June 30th and December
31st of each year during the term. The Note will be convertible at the election of the holder, to acquire Common Shares of the Company
at a price equal to a 20% premium to the volume weighted average price of the Common Shares for the 10 consecutive trading days immediately
prior to the closing of the Alta Mesa Acquisition.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On December 6, 2022 (the &ldquo;<B>Subscription
Receipt Closing Date</B>&rdquo;) in connection with the Alta Mesa Acquisition, the Company completed a brokered private placement (the
&ldquo;<B>Subscription Receipt Brokered Offering</B>&rdquo;) and issued an aggregate of 23,000,000 subscription receipts of the Company
(&ldquo;<B>Subscription Receipts</B>&rdquo;) at a price of $3.00 per Subscription Receipt for aggregate gross proceeds of $69 million,
including the full exercise of the underwriters&rsquo; option. Concurrently, the Company completed a non-brokered private placement of
277,000 Subscription Receipts for gross proceeds of $831,000 (the &ldquo;<B>Subscription Receipt Concurrent Offering</B>&rdquo;, and together
with the Subscription Receipt Brokered Offering, the &ldquo;<B>Subscription Receipt Offering</B>&rdquo;). The Subscription Receipt Brokered
Offering was completed pursuant to an underwriting agreement entered into among the Company, Canaccord Genuity Corp., Haywood Securities
Inc., Cantor Fitzgerald Canada Corporation, PI Financial Corp., Clarus Securities Inc., and Red Cloud Securities Inc. (together with the
Lead Underwriter, the &ldquo;<B>Subscription Receipt Underwriters</B>&rdquo;). The Subscription Receipts were issued pursuant to the terms
of a subscription receipt agreement (the &ldquo;<B>Subscription Receipt Agreement</B>&rdquo;) dated December 6, 2022 among the Company,
Computershare Trust Company of Canada, as subscription receipt agent (the &ldquo;<B>Subscription Receipt Escrow Agent</B>&rdquo;), and
Canaccord Genuity Corp. Upon satisfaction of the escrow release conditions included in the Subscription Receipt Agreement (the &ldquo;<B>Escrow
Release Conditions</B>&rdquo;): (i) each of the Subscription Receipts will automatically convert into one unit of the Company (a &ldquo;<B>Subscription
Receipt Unit</B>&rdquo;); and (ii) the net proceeds of the Subscription Receipt Offering will be released from escrow and used to fund
the cash portion of the Alta Mesa Consideration payable by the Company pursuant to the Acquisition Agreement to acquire the Project from
EFR White Canyon, and for working capital purposes.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 16; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Each Subscription Receipt Unit is comprised of
one Common Share (each, a &ldquo;<B>Subscription Receipt Share</B>&rdquo;) and one Common Share purchase warrant (each, a &ldquo;<B>Subscription
Receipt Warrant</B>&rdquo;), with each Subscription Receipt Warrant entitling the holder thereof to acquire one Common Share at a price
of $3.75 for a period of 3 years following satisfaction of the Escrow Release Conditions.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On December 20, 2022, the Company announced that
it had been awarded a contract to sell 100,000 pounds of natural uranium concentrates (U<SUB>3</SUB>O<SUB>8</SUB>) to the United States
government, at a price of $70.50/pound, under the new Uranium Reserve Program.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The uranium purchase will help the United States
Government establish a strategic uranium reserve and represents the first uranium purchase by the United States government in 40 years.
The U.S. National Nuclear Security Administration, an office within the U.S. Department of Energy, is the agency tasked with purchasing
domestic U<SUB>3</SUB>O<SUB>8</SUB> and conversion services for the Uranium Reserve Program. The Uranium Reserve is intended to be a backup
source of supply for domestic nuclear power plants in the event of a significant market disruption and provide support for restarting
uranium production in the United States. The Company is one of five qualified United States based operators, with existing licensed facilities,
that is approved to sell domestically sourced natural uranium to the United States Government&rsquo;s Uranium Reserve Program.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Subsequent Events</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The following provides a summary of events involving
the Company subsequent to the financial year ended December 31, 2022.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On January 17, 2023, the NYSE American approved
the listing of the Common Shares of the Company. On January 23, 2023, the Common Shares ceased trading on the OTCQB and commenced trading
on the NYSE American under the symbol &ldquo;EU.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On February 8, 2023, the Company in connection
with the Alta Mesa Acquisition completed a public offering of units of the Company. Pursuant to the Offering, the Company issued a total
of 10,615,650 units at a price of $3.25 per unit for aggregate gross proceeds of $34,500,862.50. Each unit consists of a common share
in the capital of the Company and one-half of one common share purchase warrant, with each whole warrant being exercisable at a price
of $4.05 per share for a period of 36 months following the closing of the offering.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In connection with the Subscription Receipt Offering,
the Company filed a short form prospectus dated February 3, 2023 to qualify the distribution of the Subscription Receipt Units issuable.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On February 14, 2023, the Company announced the
closing of the Alta Mesa Acquisition for US$60 million in cash and the Note. The Note has a two (2) year term and bears interest at a
rate of 8% per annum payable on June 30th and December 31st of each year during the term. The Note is convertible at the election of the
holder, to acquire common shares of enCore at a price of US$2.9103 per share. Energy Fuels has agreed not to transact with the common
shares of enCore received on conversion of the Note, including hedging and short sales, with exceptions for sale transactions of up to
US$10 million in value in any 30-day period, block trades and underwritten distributions. In addition, Energy Fuels has agreed to standard
standstill provisions restricting additional acquisitions of enCore securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 17; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In connection with the closing of the Alta Mesa
Acquisition, 23,277,000 Subscription Receipts were automatically converted into units comprised of one Subscription Receipt Share and
one Subscription Receipt Warrant, with each warrant entitling the holder thereof to acquire one Subscription Receipt Warrant Share at
a price of $3.75 for a period of 3 years until February 14, 2026. The net proceeds from the Subscription Receipt Offering of approximately
$66 million, after deduction of fees and commissions, have been released from escrow to the Company, and were applied to fund the cash
portion of the consideration payable by the Company pursuant to the Alta Mesa Acquisition.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">DESCRIPTION OF THE BUSINESS</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">enCore holds a portfolio of uranium assets located
in New Mexico, South Dakota, Wyoming, Texas, Utah, Colorado, and Arizona in the USA, and is advancing its properties with a focus on utilizing
in-situ recovery.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">enCore&rsquo;s material properties and projects
are the Marquez-Juan Tafoya Uranium Project located in New Mexico, the Crownpoint and Hosta Butte Uranium Project located in New Mexico,
the Dewey Burdock Project located in South Dakota, the Gas Hills Project located in Wyoming, and the Alta Mesa Uranium Project in Texas.
In addition to enCore&rsquo;s material properties, enCore also holds the Rosita uranium processing plant located in Texas and various
surrounding and proximate mineral leases and claims.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><U>Marquez-Juan Tafoya Uranium Project, New Mexico</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Marquez-Juan Tafoya Uranium Project consists
of private mineral leases located in McKinley and Sandoval counties of New Mexico, on the eastern end of the Grants Uranium District in
northern New Mexico. The Marquez property comprises 14,582 acres (approximately 5,900 hectares) and includes the western extent of the
historically known &ldquo;Marquez/Bokum&rdquo; mineralized zone.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><U>Crownpoint and Hosta Butte Uranium Project,
New Mexico</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company owns a 100% interest in McKinley properties
and a 60% - 100% interest in the adjacent Crownpoint and Hosta Butte properties, all of which are located in McKinley County, New Mexico.
The Company holds a 60% interest in a portion of a certain section at Crownpoint. The Company owns a 100% interest in the rest of the
Crownpoint and Hosta Butte Uranium Project area, subject to a 3% gross profit royalty on uranium produced.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><U>Dewey Burdock Project, South Dakota</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Dewey Burdock Project is an advanced-stage
uranium exploration project located in southwest South Dakota and forms part of the northwestern extension of the Edgemont Uranium Mining
District. The Dewey Burdock Project includes federal claims, private mineral rights and private surface rights controlling the entire
area within the licensed project permit boundary as well as surrounding areas. The Company currently controls approximately 16,962 acres
of net mineral rights and 12,613 acres of surface rights. The net result of the royalty and rental payments results in a cumulative 4.85
percent surface and mineral royalty.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><U>Gas Hills Project, Wyoming </U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company&rsquo;s owns a 100% interest in the
Gas Hills Project located in the historic Gas Hills uranium district situated 45 miles east of Riverton, Wyoming. The Gas Hills Project
consists of approximately 1,280 surface acres and 12,960 net mineral acres of unpatented lode mining claims, a State of Wyoming mineral
lease, and private mineral leases, within a brownfield site which has experienced extensive development including mine and mill site production.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 18; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><U>Alta Mesa Uranium Project, Texas </U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Alta Mesa project is a fully licensed and
constructed ISR project and central processing facility currently on standby, located on over 203,000 acres of private land in the state
of Texas. Total operating capacity is 1.5 million lbs U<SUB>3</SUB>O<SUB>8</SUB> per year. Alta Mesa historically produced nearly 5 million
lbs of U<SUB>3</SUB>O<SUB>8</SUB> between 2005 and 2013, when full production was curtailed as a result of low uranium prices at the time.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><U>Rosita Plant, Texas </U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Rosita uranium processing plant and associated
well fields (the &ldquo;<B>Rosita Project</B>&rdquo;) are located in Duval County, Texas on a 200-acre tract of land owned by the Company.
The facility is located within the South Texas uranium province, about 22 miles west of the town of Alice. The Rosita plant was constructed
in 1990 and was originally designed and constructed to operate as an up-flow extraction facility, in a similar manner to the Kingsville
Dome Facility. The Rosita property holdings consist of mineral leases from private landowners covering approximately 3,475 gross and net
acres of mineral rights.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Additional Properties</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">enCore holds the following additional non-principal
properties and projects:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.3in; text-align: left">(i)</TD><TD STYLE="text-align: justify"><U>Nose Rock, New Mexico</U>. The Nose Rock project is located
in McKinley County New Mexico, USA on the northern edge of the Grants Uranium District, approximately 10 miles north-northeast of the
Crownpoint and Hosta Butte Uranium Project. The Nose Rock property consists of 42 owned unpatented lode mining claims comprising over
800 acres (approximately 335 hectares).</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.3in; text-align: left">(ii)</TD><TD STYLE="text-align: justify"><U>Metamin Properties, Arizona, Utah and Wyoming.</U> Through
its subsidiary Metamin Enterprises US Inc. (&ldquo;<B>MEUS</B>&rdquo;), the Company holds various prospective uranium mining properties
located in the States of Arizona, Utah and Wyoming, USA, along with drill core, geophysical data, drilling data and equipment related
to the properties.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.3in; text-align: left">(iii)</TD><TD STYLE="text-align: justify"><U>West Largo, New Mexico.</U> The West Largo project consist
of approximately 3,840 acres (i.e. six square miles) in McKinley County, New Mexico, along the north-central edge of the Grants Uranium
District, approximately 25 miles north of Grants. The majority of the property is held through deeded mineral rights and also includes
75 unpatented lode claims.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.3in; text-align: left">(iv)</TD><TD STYLE="text-align: justify"><U>Ambrosia Lake-Treeline, New Mexico.</U> The Ambrosia Lake
- Treeline Property consists of deeded mineral rights totaling 24,555 acres and a mining lease along with certain unpatented mining claims
covering approximately 1,700 acres. The project is located approximately 115 miles west-northwest of Albuquerque, in McKinley and Cibola
Counties, Grants Uranium District, New Mexico. The project is situated within the boundaries of the Ambrosia Lake mining district, which
is the largest uranium mining area (in terms of pounds of U<SUB>3</SUB>O<SUB>8</SUB> production) in the United States.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.3in; text-align: left">(v)</TD><TD STYLE="text-align: justify"><U>Checkerboard Mineral Rights, New Mexico.</U> The land
position covers approximately 300,000 acres of deeded &lsquo;checkerboard&rsquo; mineral rights, also known as the Frisco and Santa Fe
railroad grants. They are located within a large area of about 75 miles long by 25 miles wide along trend of the Grants Uranium District.
The properties are located primarily in McKinley County which lies in northwestern New Mexico. The properties are approximately 125 miles
northwest of Albuquerque, and as close as 4 miles from the town of Crownpoint.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 19; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.3in; text-align: left">(vi)</TD><TD STYLE="text-align: justify"><U>Kingsville Dome, Texas.</U> The Kingsville Dome property
is located in Kleberg County, Texas and is situated on several tracts of land leased from third parties. The property is situated approximately
eight miles southeast of the city of Kingsville, Texas. The project is comprised of numerous mineral leases from private landowners,
covering an area of approximately 2,434 gross and 2,227 net acres of mineral rights. The Kingsville Dome Central Processing Facility
(the &ldquo;<B>Kingsville Dome Facility</B>&rdquo;) is a licensed ISR production facility located on the property. The Company intends
to initiate review and refurbishment of the Kingsville Dome Facility for future production capacity.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.3in; text-align: left">(vii)</TD><TD STYLE="text-align: justify"><U>Vasquez Project, Texas.</U> The Vasquez project is located
in Duval County, Texas, a short distance northwest of the town of Hebbronville. The project is situated on a leased tract of land that
is being held until final restoration has been completed. The Vasquez property consists of a mineral lease on 1,023 gross and net acres.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.3in; text-align: left">(viii)</TD><TD STYLE="text-align: justify"><U>Butler Ranch Project, Texas.</U> The Butler Ranch project
is comprised of non-contiguous fee leases that cover an area of about 438 acres of mineral rights. The Butler Ranch project is located
in the southwestern end of Karnes County, Texas, about 45 miles southeast of the city of San Antonio, and 12 miles northwest of the town
of Kenedy. The project is situated in the southwestern end of the Karnes County uranium mining district, which was one of the largest
uranium production areas in Texas.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.3in; text-align: left">(ix)</TD><TD STYLE="text-align: justify"><U>Upper Spring Creek Project, Texas.</U> The Company holds
mineral properties located in South Texas described generally as the Upper Spring Creek Project area. The property is currently comprised
of non-contiguous fee leases that cover an area of about 90.32 acres of surface and 66.49 acres of net mineral rights, and the Company
is actively acquiring additional mineral properties to this project. This project area includes mineral properties that were identified
in the Signal Equities LLC database that the Company acquired in December 2020. These properties are intended to be developed as satellite
ion-exchange plants that will provide loaded resin to the central processing plant located at the Rosita Project.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.3in; text-align: left">(x)</TD><TD STYLE="text-align: justify"><U>VANE Dataset and ROFR, Arizona and Utah.</U> During the
year ended December 31, 2018, the Company entered into an agreement with VANE granting the Company exclusive access to certain VANE uranium
exploration data and information as well as a first right of refusal covering seven of VANE&rsquo;s current uranium projects in Arizona
and Utah. In exchange, the Company issued 3,000,000 common shares of the Company and granted VANE certain back-in rights for any projects
developed from the use of the data. The primary term of the agreement is five years and may be renewed by the Company by written notice
for three successive renewal periods of three years each (a total of 14 years).</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.3in; text-align: left">(xi)</TD><TD STYLE="text-align: justify"><U>Dewey Terrace Project, Wyoming</U>. This project consists
of approximately 1,874 acres of surface rights and approximately 7,514 acres of net mineral rights. The Dewey Terrace Project is located
adjacent to the Dewey Burdock Project.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.3in; text-align: left">(xii)</TD><TD STYLE="text-align: justify"><U>Juniper Ridge Project, Wyoming.</U> The Juniper Ridge
project in Carbon County, Wyoming, consists of approximately 640 surface acres and 3,240 net mineral acres of unpatented lode mining
claims and a State of Wyoming mineral lease and is located within a brownfield site which has experienced extensive exploration, development,
and mine production.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.3in; text-align: left">(xiii)</TD><TD STYLE="text-align: justify"><U>Other Properties:</U> The Company holds the Shirley Basin
Project in Wyoming the JB Project in Colorado and Utah, and the Ticaboo project in Utah.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.3in; text-align: left">(xiv)</TD><TD STYLE="text-align: justify"><U>Centennial Project, Colorado</U>. The Centennial Project
in Weld County, Colorado, is comprised of approximately 1,365 acres of surface rights and 6,238 acres of net mineral rights.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 20; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.3in; text-align: left">(xv)</TD><TD STYLE="text-align: justify"><U>Aladdin Project, Wyoming</U>. The Aladdin Project in Wyoming
is comprised of private leases that cover approximately 5,166 acres of surface rights and 4,712 acres of net mineral rights located in
Wyoming. The Aladdin Project is 80 miles northwest of the Dewey Burdock Project.</TD>
</TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">Material Mineral Properties</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><U>Marquez-Juan Tafoya Property</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The following summary of the Marquez-Juan Property
is extracted from the Marquez-Juan Technical Report and modified to conform to this AIF. This summary is qualified in its entirety by
reference to the full Marquez-Juan Technical Report which is incorporated by reference herein.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Property Description and Location</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Marquez-Juan Project is located within the
Grants Uranium Mineral District of northwest New Mexico, approximately 50 miles west-northwest of Albuquerque, New Mexico (see Figure
1.1). The property can be accessed from Interstate 40 at the town of Laguna. From Interstate 40 take Exit #114, approximately 45 miles
west of Albuquerque, and 25 miles east of Grants, and go north 12 miles on State Highway 279 to the village of Seboyeta. In Seboyeta,
turn right at the southern edge of town, continue on State Highway 279 east and northerly for 17 miles to the village of Marquez. From
there the main area of the Project (common property boundary) is about two miles west of the village.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><IMG SRC="ex99-1_002.jpg" ALT=""></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Project consists of two adjacent properties;
Marquez and Juan Tafoya, that were previously developed by separate mining companies, Kerr-McGee Corporation (&ldquo;<B>Kerr-McGee</B>&rdquo;)
and Bokum Resources Corporation (&ldquo;<B>Bokum</B>&rdquo;), respectively. This is the first time that the two properties are controlled
by one company. The Preliminary Economic Assessment (PEA) has been developed based on a combined mineral resource estimate and proposed
underground mining and on site mineral processing for the Project. The host for known uranium mineralization within the project is the
Westwater Canyon member of the Upper Jurassic Morrison Formation. The Westwater deposits dip gently 1-3&deg; to the west. The mineralization
is sandstone-type present as coffinite and uraninite within primary trend deposits, varies from 1,800 to 2,500 feet deep.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 21; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Mineralization is defined by drilling at a minimum
Grade times Thickness cutoff of 0.1, at a minimum thickness of 6 feet, the overlying C horizon covers an area of approximately 2,500 feet
along trend and 200 to 400 feet across trend. The lower D horizon has an approximate trend length of 4,000 feet and is 200 to 800 feet
across trend.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Marquez-Juan Tafoya uranium project is located
at approximately 35&deg;18&rsquo; North Latitude by 107&deg;18&rsquo; West Longitude. The site is approximately 50 miles west-northwest
of Albuquerque, New Mexico (Figure 4-1, Location and Access Map).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><IMG SRC="ex99-1_003.jpg" ALT=""></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The project is in an area of mostly un-surveyed
lands, in what would be Township 13 North, Ranges 04 and 05 West, 23rd Principal Meridian, New Mexico. enCore controls private land leases,
Marquez and Juan Tafoya, totaling some 18,712 acres (7,572 ha).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Marquez Ownership and Mineral Tenure</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Marquez property is held by a mineral lease
covering 14,501 acres; the vast majority of which lies on the western extent of the greater project area, with several small, separate
parcels to the east within the boundary of the Juan Tafoya property.&nbsp; The mineral rights are owned separately from the surface rights;
the Williams (87.5%) and Koontz (12.5%) families, and the State of New Mexico&rsquo;s Game and Fish Department, respectively.&nbsp; In
1967, the surface rights were conveyed from the Williams family to the State while the right to develop minerals from the property were
retained by the Williams family.&nbsp;&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 22; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">There is a 8% production royalty on net proceeds
from production. Annual payments are currently $50,000 per year and vary with price. The mineral lease expires on September 4, 2022.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Juan Tafoya Ownership and Mineral Tenure</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Juan Tafoya property is held by 26 mining
leases covering 4,211 acres; one lease consists of 4,096 acres (Juan Tafoya Land Company), and the other 25 smaller leases make up 115
acres, all of which are within the boundary of the larger JTLC holdings.&nbsp; The Juan Tafoya leases are on the southeastern extent of
the greater project area.&nbsp; The JTLC lease was acquired by Neutron in 2006, and the remaining 25 smaller leases were acquired in 2007.
None of the currently defined mineral resources are located on any of the 25 smaller leases.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">There is a 4% production royalty on gross proceeds
from production. If material from other sources is processed from other properties, a milling royalty of 2% would apply. Annual payments
are currently $315,825.00. The mineral lease expires on October 11, 2021, and is being renewed for another five years. Westwater Resources
holds an overriding 2.5% royalty on net profits from production.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Surface Rights</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The surface rights to the Marquez property are
owned and managed by the State of New Mexico&rsquo;s Game and Fish Department.&nbsp; The rights were acquired by the state upon transfer
from the Williams family in 1967.&nbsp; The Williams retained the mineral rights.&nbsp; The conveyance includes a provision to allow for
exploration and development of minerals beneath the land surface.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">At the Juan Tafoya project the various mineral
lease holders also own their surface rights.&nbsp; The lease provides for the use of the land to the extent necessary for mine development
and production.&nbsp; Certain payments are necessary depending on if lands are removed from agricultural or grazing use for the extent
of the mine and recovery production.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The proposed mineral processing facility and tailings
disposal cell would be located on the Juan Tafoya lease within the previously licensed footprint. Mining operations will, to the extent
practical, selectively handle and sort the mined material returning the waste product to the mine as backfill for mined out areas. This
is beneficial for mine safety as roof support in the mine and will also serve to minimize the amount of mine waste brough to the surface.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Property History</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In the 1970s to early 1980s, extensive mineral
exploration by drilling defined significant uranium resources on the two properties. Mine and mineral processing infrastructure was constructed
by Bokum on the Juan Tafoya portion of the Project, including a 14-foot production shaft (completed to within 200 feet of the mine zone),
a 5-foot ventilation shaft, and a partially built mill processing facility and tailings disposal cells. The surface facilities were dismantled
and reclaimed in the early 2000s.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Marquez History </I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Kerr-McGee entered into a mineral lease agreement
with the Williams family for the Marquez Property in the early 1970s. In 1973 exploration drilling began. In 1978, Kerr-McGee sold a 50%
interest in the project to the Tennessee Valley Authority (TVA). At that time, the joint venture proposed mining the uranium deposit by
conventional underground methods, with recovery at Kerr-McGee&rsquo;s Ambrosia Lake mill facility. However, with the decrease in the uranium
market beginning in 1980, the property was returned to the mineral lease holder. In 2007, Strathmore Minerals Corporation acquired a mineral
lease to the Marquez property. Strathmore was subsequently acquired by Energy Fuels who sold the Marquez property to enCore.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 23; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Juan Tafoya History </I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In 1969, mineral leases were acquired in the Juan
Tafoya area by Devilliers Nuclear (&ldquo;<B>Devilliers</B>&rdquo;) and began exploratory drilling. In the early 1970s, Exxon acquired
the rights to 25 small mineral leases, all within the boundary of the JTLC lease, and began exploratory drilling. In 1975, the JTLC lease
was acquired from Devilliers by Bokum, which subsequently acquired the Exxon mineral leases also. In 1976, Bokum entered into a uranium
purchase agreement with Long Island Lighting Company, a New York-based utility. However, with the decrease in the uranium market beginning
in 1980, the property was returned to the mineral lease holders. In 2006-07, Neutron Energy Inc. (&ldquo;<B>Neutron</B>&rdquo;) acquired
the mineral leases. In 2012, Neutron was acquired by Uranium Resources Inc (now Westwater Resources Inc.) and in September 2020, enCore
Energy announced the purchase of Westwater Resources&rsquo; US uranium assets, including the mineral leases to the Juan Tafoya properties.
The purchase was completed on December 31, 2020. enCore has yet to explore on the property.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Regulatory Status </I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">With the exception of an exploratory drilling
permit received by Neutron from the State of New Mexico, and currently held by the Company, no other permits have been obtained for the
Project. No mining or mineral processing has been completed on the property. A variety of Federal and State permits will be required prior
to any mine and/or mineral processing developments.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Licenses </I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The project was previously granted both a Source
Materials License from the US Nuclear Regulatory Commission (NRC). A new Source Materials License from the NRC for the uranium mill and
possibly mined material screening and sorting will be required. New mining and other permits will be required from the State of New Mexico.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Surface Rights </I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The surface rights to the Marquez property are
owned and managed by the State of New Mexico&rsquo;s Game and Fish Department. The rights were acquired by the state upon transfer from
the Williams family in 1967. The Williams retained the mineral rights. The conveyance includes a provision to allow for exploration and
development of minerals beneath the land surface.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">At the Juan Tafoya project the various mineral
lease holders also own their surface rights. The lease provides for the use of the land to the extent necessary for mine development and
production. Certain payments are necessary depending on if lands are removed from agricultural or grazing use for the extent of the mine
and recovery production.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Permits</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company only has one permit in effect at this
time. By way of Neutron&rsquo;s work on the Juan Tafoya lease, enCore holds a Subpart 4 Exploration Operation Permit (MK023ER-R4) issued
by the State of New Mexico&rsquo;s Energy, Minerals, and Natural Resources Department to conduct exploratory drilling on the Juan Tafoya
property. The terms of the permit allow for drilling of 44 holes to depths of up to 2,500 feet. In 2015, the New Mexico Energy, Minerals
and Natural Resources Department renewed Exploration Permit; Marquez Canyon Exploration Project, Permit No. MK023ER-R6. The Company has
not yet undertaken any activities under the permit.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 24; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">A right to mine permit is necessary, obtainable
from the State of New Mexico Mining and Minerals Division of the Energy, Minerals and Natural Resources Department. A source materials
license for the production and handling of radioactive materials is required from the U.S. Nuclear Regulatory Commission (NRC) if beneficiation,
heap leaching, in-situ recovery, or milling occurs on site. This may also include mine material screening and sorting. If the mined material
is transported off-site for mineral processing amendments to the existing facility source materials license may be required but a new
source materials license would not.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>State and Local Taxes</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In the State of New Mexico, three types of taxes
are imposed on the value of produced minerals, including <I>Conservation</I>, <I>Mineral Severance</I>, and <I>Resources Excise </I>taxes.
The taxes are as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Conservation Tax</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Uranium production in New Mexico is subject to
a Conservation Tax. The taxable value of uranium is 25% of the difference between the taxable value defined under Section 7-25-3 NMSA
1978 and royalties paid or due any Indian tribe, Indian pueblo, or Indian that is a ward of the United States. The tax rate is 0.19% of
the taxable value of the product sold. (source: www.tax.newmexico.gov/2020/10/23/conservation-tax/).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Mineral Severance Tax</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Uranium production in New Mexico is subject to
a Mineral Severance Tax which is currently taxed at 3.5% of 50% of the taxable value of U<SUB>3</SUB>O<SUB>8</SUB> produced. Currently
the effective severance tax rate on uranium is 1.75% (Peach, <I>et al</I>., 2008).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Resources Excise Tax</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Resources Excise Tax was imposed in 1966 at
a rate of 0.75% of the reasonable value of the severed or processed resource. There have been no significant changes since that time (Peach
<I>et al</I>., 2008).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Table 22.1 &ndash; Life of Mine Cost Summary</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><B>Cost Center</B></TD><TD STYLE="padding-bottom: 1.5pt; text-align: center"><B>&nbsp;</B></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; text-align: center"><B>Total Cost<BR>
    US$&nbsp;(x1,000)*</B></TD><TD STYLE="padding-bottom: 1.5pt; text-align: center"><B>&nbsp;</B></TD><TD STYLE="padding-bottom: 1.5pt; text-align: center"><B>&nbsp;</B></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; text-align: center"><B>Cost&nbsp;per&nbsp;Pound<BR>
    Recovered&nbsp;US$</B></TD><TD STYLE="padding-bottom: 1.5pt; text-align: center"><B>&nbsp;</B></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 76%; text-align: left">OPEX Mine</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 9%; text-align: right">308,000</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 9%; text-align: right">26.62</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">OPEX Mill</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">184,000</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">15.90</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Decommissioning and Reclamation</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">13,000</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">1.11</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Taxes and Royalties</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">53,000</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">4.55</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left"> TOTAL CAPITAL (Life-Of-Mine)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">558,000</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">15.90</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  </TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in; text-align: left">*</TD><TD STYLE="text-align: justify">rounded</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 25; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Previous Mineral Resource Estimates</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Historical mineral resource estimates for the
Marquez and Juan Tafoya uranium deposits are available from several sources. These estimates were prepared by Kerr-McGee in 1977 and Strathmore
in 2010 for the Marquez portion of the project, and Bokum in 1979 and Westwater (Carter, 2014) for Juan Tafoya. The 2010 historical mineral
resource estimate for Marquez and the 2014 mineral resource estimate for Juan Tafoya are discussed on enCore&rsquo;s web site. (https://www.enCoreenergycorp.com/projects/juan-tafoya-marquez/).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Although at the time of issuance these reports
were completed under 43-101 guidance, under &ldquo;Rules and Policies&rdquo; of NI 43-101 Standards of Disclosure the mineral resource
estimates must be reported as Historical Mineral Resource Estimates. A qualified person has not done sufficient work for enCore to classify
the historical estimates as current mineral resource estimates. The Company does not treat these historical estimates as current mineral
resource estimates, and the estimates should not be relied upon. The current mineral resource estimate for the Project is described in
Section 14 of the report.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Within the Juan Tafoya mineral lease there is
an additional area of mineralization defined by past drilling. This area is referred to as the Southeast Deposit (Carter, 2014). This
area was not evaluated as part of the PEA as it is approximately 1 mile from the Marquez and Juan Tafoya mineralization and would require
separate infrastructure, including a mine shaft, if the mineralization were exploited via conventional underground mining. Carter, 2014
estimated an inferred mineral resource of 687,500 tons containing 1,900,000 pounds of uranium at an average grade of 0.138 %eU<SUB>3</SUB>O<SUB>8</SUB>,
at a cutoff of 0.08 %eU<SUB>3</SUB>O<SUB>8</SUB> for the Southeast Deposit.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">enCore considers these mineral resource estimates
as historical estimates. A qualified person has not done sufficient work for enCore to classify the historical estimates as current mineral
resource estimates. enCore does not treat these historical estimate as current mineral resource estimates, and the estimates should not
be relied upon.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>Geological Setting and Mineralization</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Project is located in the Grants Mineral Belt,
on the Chaco Slope, which forms the southern flank of the San Juan Basin of northwestern New Mexico. The mineral belt extends for several
miles from east of the town of Laguna westerly to the Gallup area, a length of over 100 miles, and is about 25 miles wide. The region
includes the Laguna (includes Marquez-Juan Tafoya), Ambrosia Lake, Crownpoint, and Church Rock uranium districts. The property is located
in the eastern part of the mineral belt, on strike with the main mining district of Ambrosia Lake about 25 miles to the west.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The host for known uranium mineralization at the
project, present as coffinite and uraninite, is sandstone deposits within the Westwater Canyon member of the Upper Jurassic Morrison Formation.
The Westwater consists of a fluvial sedimentary sequence deposited during a period of wet subtropical climate as the San Juan Basin subsided
and filled with synorogenic deposits during a pre-Laramide orogenic event. The major source of the sandstones was from uplifted highlands
to the south and southwest; sediments were laid down by coalescing alluvial fans and associated braided streams. The Westwater deposits
dip gently 1-3<FONT STYLE="background-color: white">&deg;</FONT> to the west. Mineralization at the project varies from 1,800 to 2,500
feet deep.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Westwater sands hosting the uranium mineralization
consist of a series of fluvial stacked, quartz-rich arkosic sandstones separated by clay and mudstone beds. The Westwater is 250-325 feet
thick at the project, consisting of four main sand units. The mineralization formed by the down-gradient movement of groundwater solutions
flowing through the arkosic-rich sediments and inter-formational and overlying tuffaceous (volcanic) materials. The uranium was precipitated
where the action of pyrite-rich sediments and carbonaceous materials (humates) developed a reducing environment (oxidation-reduction contact).
The mineralization is contained within mostly primary (trend-type) mineralized bodies previously deposited synorogentically. These trend-type
deposits are similar in nature to those discovered and extensively mined in the Ambrosia Lake Uranium District 20 miles to the west. A
lesser amount of the mineralization is possibly post-faulting or redistributed mineralization; perhaps amenable to in-situ recovery methods.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 26; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I><U>Mineralization </U></I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><U>Mineralization in the Grants Mineral Belt</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Uranium mineralization in the Grants Mineral Belt
of New Mexico is sandstone-hosted as defined in the &ldquo;World Distribution of Uranium Deposits (UDEPO) with Uranium Deposit Classification&rdquo;,
(IAEA, 2009). Regionally mineralization is termed primary or re-distributed based on the character and morphology of the mineralization.
Re-distributed mineralization is typically roll front type. Primary deposits are typically tabular and range in size from small pods a
few feet in width and length to bodies several tens of feet thick, several hundred feet wide and several thousand feet long. The deposits
tend to occur in clusters and many form distinct trends that are parallel to the sedimentary trend (Fitch, 1980; Turner-Peterson, 1986;
Sandford, 1992).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Uranium occurs mostly as coffinite and uraninite
in tabular primary mineralization, and mostly as uraninite in C-shaped or roll fronts in the redistributed mineralization. Primary mineralization
is generally associated with finely disseminated carbon and indistinct organic matter, known as humates. Humates are presumed to have
formed from the breakdown and dissolving of vegetal matter and redeposition in the mineralized zones. The redistributed mineralization
is typically primary mineralization that has been redissolved and moved farther down dip and redeposited in the form of C-shaped roll
fronts. Mineralization occurs in stream channel bottoms and margins in straight channels and feeder channels, meanders, and overflow areas.
Pyrite and jordisite (black, soft molybdenum mineral, MoS2) are frequently associated minerals in the arkosic sandstone host rock. The
mineralization is found as coating on the sand grains and as filling in the interstices between grains. The interstices are also filled
with very-fine kaolin and calcium carbonate. The humates and jordisite, when present, give the mineralized rocks their dark gray to black
color.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><U>Uranium Mineralization at the Project</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The mineralized host within the project is primarily
hosted in the lower two sand units, Sands C and D, of the Westwater Canyon member of the Jurassic Morrison Formation. Lessor mineralization
is present in Sand B but was not well enough defined for inclusion in the current mineral resource estimate. The mineralization occurs
mostly as tabular primary deposits (Livingston, 1980) with lesser amounts as roll fronts. Much of the mineralization is associated with
disseminated carbon matter (humates), especially the tabular type of mineralization.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Exploration</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">enCore has not yet undertaken any activities under
the Subpart 4 Exploration Operation Permit (MK023ER-R4) issued by the State of New Mexico&rsquo;s Energy, Minerals, and Natural Resources
Department to conduct exploratory drilling on the Juan Tafoya property.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">enCore Energy has not performed any exploration
activities or drilling on the Marquez-Juan Tafoya property; all the data used to define the mineralization is historical in nature (refer
Sections 6 and 10).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Historically exploration activities included ground
and aerial radiometric reconnaissance survey and geological mapping programs. Mineralization at the project is at depth and was discovered
by drilling subsequent to the area being defined as prospective by the previous owners.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The PEA for the Marquez and Juan Tafoya project
includes an underground conventional mine operation with on-site mineral processing. The underground mine operations would be concurrent
with a mine life of approximately 15 years. This is the first time since the initial discoveries that these two adjacent areas of mineralization
have been held by the same party.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The project, given the assumptions stated herein,
would be profitable with a US$60 per pound selling price. In constant dollars the project is estimated to generate an IRR of 17% before
taxes and has an NPV of approximately US$20.5 million at a 7% discount rate.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 27; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->25<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The technical risks related to the project are
considered to be low as the mining and recovery methods are proven. The mining and mineral processing methods proposed have been employed
successfully in the vicinity and regionally for deposits of a similar nature and setting.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The project was once permitted for similar operations
but did not go forward due to falling uranium prices in the 1980&rsquo;s. The project is located on private land and the mine and mill
areas have been previously disturbed. The major permits required include a Source and Byproduct Materials License from the NRC and a mining
permit from the state of New Mexico. Based on regional opposition to similar project in the region some level of opposition to the project
should be expected. However, overall, the Fraser Institute Annual Survey of Mining Companies, 2020 ranks New Mexico as 10th out of 80
jurisdictions on their Policy Perception Index, which indicates a favorable perception by the mining industry towards New Mexico mining
policies.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Marquez-Juan Technical Report provides estimates
of mineral resources at the Marquez-Juan Tafoya project. Mineral resources are not mineral reserves and do not have demonstrated economic
viability in accordance with CIM standards. At a minimum declaration of mineral reserves would require a Preliminary Feasibility Study
(&ldquo;<B>PFS</B>&rdquo;). However, to be considered a mineral resource, reasonable prospects for economic extraction must be demonstrated.
For the purpose of the report, reasonable prospects for economic extraction are demonstrated by the positive outcome of the Preliminary
Economic Assessment (PEA) therein.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Sample Preparation, Analyses and Security
</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The principal tool for determining uranium grades
encountered by exploration and development drill holes is the gamma-ray log, a geophysical surveying technique that was, and remains the
standard in-place assaying method utilized by the global uranium industry. Equivalent uranium grades (%eU<SUB>3</SUB>O<SUB>8</SUB>), which
are radiometric assays, were and are calculated from gamma ray logs using grade determination methodologies that are standard in the uranium
mining industry. Additional data include limited chemical assays of cored intervals of the uranium mineralization.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">DOE supports the development, standardization,
and maintenance of calibration facilities for environmental radiation sensors. Radiation standards at the facilities are primarily used
to calibrate portable surface gamma-ray survey meters and borehole logging instruments used for uranium and other mineral exploration
and remedial action measurements. This is an important quality control measure used by the geophysical logging equipment operators. The
author has reviewed the geophysical logs and they have annotation of the calibration parameters necessary for the accurate conversion
of gamma measurements recorded by the logging units to radiometric equivalent uranium grade. enCore owns all the original drill data for
both the Juan Tafoya and Marquez project areas. This information includes geophysical logs, digital readouts of counts per second by &frac12;
foot intervals, lithological logs, and downhole drift surveys.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The geophysical logs generally consist of recordings
of natural gamma, self-potential, and resistivity. Self-potential and resistivity data are useful in defining bedding boundaries and for
correlation of sandstone units and mineralized zones between drill holes.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Calibration facilities for natural gamma logging
are located at DOE sites at Grand Junction Regional Airport in Grand Junction, Colorado; Grants, New Mexico; Casper, Wyoming; and George
West, Texas (https://energy.gov/lm/services/calibration-facilities). These calibration facilities were first established by the US Atomic
Energy commission (AEC) in the 1950&rsquo;s to support the domestic uranium exploration and development programs of that era. The header
information for the geophysical logs provides the calibration data and date of calibration.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 28; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->26<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Calibration procedures and standards for the geophysical
logging equipment used in the determination of radiometric equivalent uranium grade has been consistent through the various drilling campaigns
and has relied on calibration facilities maintain by the US government. It is standard practice for geophysical logging companies to rely
on these calibration facilities. These models consist of a barren zone bored in concrete and a mineralized zone constructed of a homogenous
concentration of uranium at a known grade followed by and underlying barren zone. There are different grade models to reflect the range
on uranium concentrations typically found in the US. In addition, the models can be flooded to determine a water factor and there are
models which are cased for the determination of a casing factor. Each of the models are approximately 9 feet deep consisting a 3-foot
mineralized zone with 3-foot barren zones above and below. The facilities are secure. Logging unit operators logs the holes, provide the
geophysical log data in counts per second (cps) to the facility which in turn processes the data and provides the company with standard
calibration values including dead time, K Factor, and water and casing factors (Century, 1975).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Drilling Analyses </I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Radiometric equivalent U<SUB>3</SUB>O<SUB>8</SUB>
content was calculated from gamma logs using industry-standard methods developed by the Atomic Energy Commission (now the DOE: Department
of Energy), using either manual or computer methods.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The AEC has published information on the calibration
standards for geophysical logging and on gamma log interpretation methods (Dodd and Droullard, 1967). The standard manual log interpretation
method was the half-amplitude method (Century, 1975). The AEC and its successor agency the Energy Research and Development Administration
(ERDA) conducted workshops on gamma-ray logging techniques and interpretation as did private companies including Century Geophysical.
The author attended the geophysical log interpretation workshop conducted by Century Geophysical and on November 19, 1976 received certification
in geophysical log interpretation from Century after completing their short course. The author has continued to use these techniques where
appropriate along with modern scanning and digitizing methods for the preservation and interpretation of geophysical logs.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>Security </I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The original drill data is currently in the possession
of enCore. Drill cutting samples and core samples were generally not preserved. In addition to the physical logs enCore has scanned and
digitized logs for most of the data.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>Data Verification </I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Most of the exploratory and development drilling
on the project was conducted by either Kerr-McGee or Bokum. When the drilling programs were being conducted the project there was split
ownership of the project between these former operators. Records indicate that on the Marquez property Kerr-McGee drilled at least 358
holes for 865,940 feet. On the Juan Tafoya property Bokum (with Devilliers and Exxon) drilled at least 568 holes for 1,023,200 feet.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Original geophysical and lithological logs are
in possession of enCore. Electronic scans of the drill data for Marquez and original data for Juan Tafoya were provided by enCore. Geophysical
logs for every drill hole used in the mineral resource estimate was inspected and interpreted. This included geological correlation and
interpretations to separate the mineralized zones by horizon. The C and D horizons contained mineralization of sufficient thickness, grade
and continuity for mineral resource estimation. Mineralization in other horizons and within the C and D horizon which was not of sufficient
thickness and grade or was isolated from the principal areas of mineralization was excluded from the mineral resource estimate.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 29; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->27<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">All drill logs used in the mineral resource estimation
contained header information including K Factor, Dead Time, and Water Factor necessary for determination of radiometric equivalent uranium
concentration.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">For verification purposes, 46 of the 604 drill
holes use in the mineral resource estimate were selected representing the range of mineralization observed. The Author re-calculated the
mineralized intercepts using the manual log interpretation methods prescribed by the US AEC and others for each drill holes to verify
the original log interpretation. Mineralization in the verification drill holes ranged from a high GT value of 4.27 to a low value of
0.15.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Verification by the Author confirmed that the
drill hole database reasonably reflects the depth, thickness and radiometric equivalent uranium grade from the original geophysical logs.
The only discrepancy noted was the omission of isolated mineralized intercepts of lower grade and thickness which were not included in
the database, which the author concurs with.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Re-calculation by the Author of 46 drill holes
shows the original interpretation of radiometric equivalent uranium grade is approximately 2% less the re-calculated values. Figure 12.1
is a comparison of the drill hole database values to those re-calculated by the Author using the standard half-amplitude log interpolation
method.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><IMG SRC="ex99-1_004.jpg" ALT=""></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Mineral Processing and Metallurgical Testing
</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In 1977 and 1978, comprehensive laboratory investigations
of a 3-zone composite of the Marquez Canyon resource and a separate sample of core from a nearby resource identified as MAR-241-BC were
conducted by Hazen Research, Inc., Golden, CO (&ldquo;<B>Hazen</B>&rdquo;), for Bokum. All tests were conducted with water from the Bokum
shaft. This work was coordinated by A. H. Ross &amp; Associates, Toronto, Ontario (&ldquo;<B>Ross</B>&rdquo;). A concurrent evaluation
of the process design criteria established by the Hazen program was carried out by Ross, who prepared a flowsheet and an estimate of capital
and operating costs that served adequately as the foundation for detailed engineering and plant design. During the 1970s, the combination
of Hazen and Ross was considered the gold standard for uranium process development and led to the construction and commercialization of
a large number of uranium mills.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 30; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->28<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In 1982, Kerr-McGee&rsquo;s Technology Center
conducted a fairly comprehensive laboratory leaching investigation (agitated and in-situ), and a separate analysis by Kerr-McGee Nuclear
Corporation focused on the economic potential for in-situ leaching of the Marquez Canyon resource.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The first (1977) Hazen laboratory program concluded
that the master composite and individual zone composites responded well to agitated 2-stage leaching with sulfuric acid at an elevated
temperature and with either sodium chlorate or manganese dioxide as the oxidant. This work established near-optimum conditions, within
the limitations of extrapolating laboratory data to commercial plant performance. For instance, the temperatures tested were 50&deg;C
and 80&deg;C. Recommendations included a minus 28-mesh grind, 80 grams per liter of H2SO4, 10 lb/ton NaClO3, 50&deg;C, and 12 hours retention
time. These conditions yielded 98.0-98.2 percent uranium extraction with 87-114 lb/ton acid consumption for the master composite, but
tests on individual zone composites resulted in respective uranium extractions and acid consumptions as follows: Blue, 88% and 65 lb/ton;
Red, 98% and 92 lb/ton; and Green, 98% and 111 lb/ton. Residues from the composites assayed 0.0020-0.0022 % U<SUB>3</SUB>O<SUB>8</SUB>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Hazen conducted a second study in 1978 using a
small continuous SX &ldquo;mini-plant&rdquo; to simulate conditions expected in the planned commercial facility. The objectives were (1)
to establish a procedure for controlling formation and accumulation of the stable emulsion, and (2) to confirm that a high-purity yellow
cake could be produced. The only element that approached a specification limit at the time was molybdenum at 0.079% Mo and 0.087% Mo versus
limits of 0.100% Mo for both Kerr-McGee and Allied Chemical. The author understands that the specifications imposed by current converters
of yellow cake, Cameco and ConverDyn, are essentially the same or only slightly more stringent as those for Kerr-McGee and Allied Chemical.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The study by Robertson and Shaw for Kerr-McGee
applied some sophisticated analytical techniques to the hydrocarbon constituent observed by Hazen and revealed a possible cause of the
refractory response of the uranium in the Marquez samples to standard agitated acid leaching conditions. The preliminary conclusion was
that the organic carbon responsible for the problem is &ldquo;younger&rdquo;, i.e., higher in volatile content, than the organic material
that usually accompanies tractable uranium mineralization. Actually, there may be several issues at play, since the uranium in the leach
residues could have been coffinite, U(SiO4)1-x(OH)4x, which is sometimes refractory in its own right.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 31; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->29<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Mineral Resources</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Some 926 drill holes totaling approximately 1.9
million feet drilled were completed by past operators. enCore has not completed any drilling on the project. For the report, 604 drill
holes, completed in the area of interest were used. These drill hole locations are shown on Figure 10.1, Drill Hole Map.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><IMG SRC="ex99-1_005.jpg" ALT=""></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">From the total 604 drill holes, 192 and 337 mineralized
incepts were used for the mineral resource estimates, for the &ldquo;C&rdquo; and &ldquo;D&rdquo; sands, respectively.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The principal tool for determining uranium grades
encountered by exploration and development drill holes is the gamma-ray log, a geophysical surveying technique that was, and remains the
standard in-place assaying method utilized by the global uranium industry. Equivalent uranium grades (%eU<SUB>3</SUB>O<SUB>8</SUB>), which
are radiometric assays, were and are calculated from gamma ray logs using grade determination methodologies that are standard in the uranium
mining industry.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Each drill hole used in making the mineral resource
estimate was correlated and re-interpreted by the author. Conversion of downhole CPS measurements to equivalent uranium content, eU<SUB>3</SUB>O<SUB>8</SUB>,
was verified by the author and is discussed in Section 12 of the report.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As discussed in Section 11 of the report, a positive
disequilibrium factor is stated in historic reports (Alief, 2010 and Carter, 2014) which if applied would increase the estimated average
grade and contained pounds. Although some of the chemical data cited in previous reports are available, original laboratory certificates
were generally not available. In addition, the core holes were generally completed in areas on strong mineralization and thus may not
be representative of the deposit in total. For these reasons, the author elected to assume that the mineralization was in radiometric
equilibrium, and no positive factor was applied. A disequilibrium factor (DEF) of 1.0 was utilized for the mineral resource estimate as
a conservative measure.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Mineral resources were estimated only for those
area which contained sufficient thickness, grade and continuity of mineralization to support extraction by underground mining methods.
Within these areas drill spacing was on approximate 100 foot centers with some additional closer spaced offset drilling. Mineralization
that is well defined by drilling on the C horizon covers an area of approximately 2,500 feet along trend and 200 to 400 feet across trend.
The D horizon has an approximate trend length of 4,000 feet and is 200 to 800 feet across trend. Given the dimensions of the mineralized
area, the mineralized areas are well defined by multiple data points. Although the drill data has been verified by the author, it is of
a historical nature and thus the author recommends that none of the mineralization be considered as measured mineral resource. Based on
the continuity of the mineralization and drill spacing relative to the dimensions of mineralized area the author concludes the data support
a classification of the mineral resource as indicated.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 32; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->30<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">A minimum mining thickness of 6 feet was used.
A bulk density factor of 15 ft3 /ton was used in the calculations. The mineral resources are reported at a 0.60 GT cutoff (refer to Table
1.1).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Table 1.1 Indicated Mineral Resource</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD COLSPAN="13" STYLE="border-bottom: Black 1.5pt solid"><B>Indicated Mineral Resource</B></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><B>Minimum 0.60 GT</B></TD><TD STYLE="padding-bottom: 1.5pt; text-align: center"><B>&nbsp;</B></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; text-align: center"><B>TONS</B></TD><TD STYLE="padding-bottom: 1.5pt; text-align: center"><B>&nbsp;</B></TD><TD STYLE="padding-bottom: 1.5pt; text-align: center"><B>&nbsp;</B></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; text-align: center"><B>%eU<SUB>3</SUB>O<SUB>8</SUB></B></TD><TD STYLE="padding-bottom: 1.5pt; text-align: center"><B>&nbsp;</B></TD><TD STYLE="padding-bottom: 1.5pt; text-align: center"><B>&nbsp;</B></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; text-align: center"><B>Pounds</B></TD><TD STYLE="padding-bottom: 1.5pt; text-align: center"><B>&nbsp;</B></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 64%; text-align: left">ROUNDED TOTAL (x 1,000)</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">7,100</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">0.127</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">18,100</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
  </TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Mineral resources were calculated using the Grade
times Thickness (GT) Contour method in accordance with CIM guidance (CIM, 2013). For the PEA a slightly higher GT cutoff was applied to
allow for a profit margin.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Mineral resources are not mineral reserves and
do not have demonstrated economic viability in accordance with CIM standards. At a minimum declaration of mineral reserves would require
a PFS. However, to be considered a mineral resource, reasonable prospects for economic extraction must be demonstrated. Reasonable prospects
for economic extraction are demonstrated by the positive outcome of the Preliminary Economic Assessment (PEA) herein.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Key Assumptions and Parameters </I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The PEA estimates the cost of mining and mineral
processing to be $92 per ton. A sales price of $60 per pound has been used as the base case as discussed in Section 19. For these parameters,
the breakeven grade would be approximately 0.078 %eU<SUB>3</SUB>O<SUB>8</SUB> or a GT, at a 6 foot thickness of approximately 0.50. Mineral
resources are reported at a slightly higher GT cutoff of 0.60 to meet reasonable prospects for economic extraction. In addition, areas
where the mineralization appeared to be isolated and/or drilling was limited which were estimated to contain less than 20,000 lbs eU<SUB>3</SUB>O<SUB>8</SUB>
were excluded from the reported estimated mineral resource due to economic considerations. The PEA was based on a cutoff of 0.80 to allow
for a reasonable profit margin.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">A bulk density of 15 cubic feet per ton was used
in the estimation of mineral resources. A DEF of 1 was used in the estimation of mineral resources.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Contemplated Activities </I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">A detailed closure plan will be developed for
the Project. The closure plan will be developed using the guidelines noted in the technical report. enCore will be required to post a
reclamation performance bond with the State of New Mexico prior to approval of the Permit to Mine. The New Mexico Mining and Minerals
Division (MMD) regulations allow for phased bonding, and enCore intends to prepare those cost estimates in phases of site development.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Recommendations</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The project is sensitive to mining factors including
resource recovery, dilution, and grade, and the sizing and sorting of mine materials and mineral processing and recovery. The project
is also subject to scrutiny with respect to environmental considerations. Detailed recommendations are provided in Section 26 of the report
and are summarized by mineral tenor, mine and mineral resource, mineral processing, environmental and additional studies. See Table 1.2
&ndash; Summary of Recommendations.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 33; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->31<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Table 1.2 &ndash; Summary of Recommendations</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 88%; text-align: left"><B>Mineral Tenor and Leases</B></TD><TD STYLE="width: 1%"><B>&nbsp;</B></TD>
    <TD STYLE="width: 1%; text-align: left"><B>$</B></TD><TD STYLE="width: 9%; text-align: right"><B>50,000</B></TD><TD STYLE="width: 1%; text-align: left"><B>&nbsp;</B></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD><B>&nbsp;</B></TD><TD><B>&nbsp;</B></TD>
    <TD STYLE="text-align: left"><B>&nbsp;</B></TD><TD STYLE="text-align: right"><B>&nbsp;</B></TD><TD STYLE="text-align: left"><B>&nbsp;</B></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left"><B>Mine and Mineral Resources</B></TD><TD><B>&nbsp;</B></TD>
    <TD STYLE="text-align: left"><B>$</B></TD><TD STYLE="text-align: right"><B>1,500,000</B></TD><TD STYLE="text-align: left"><B>&nbsp;</B></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD><B>&nbsp;</B></TD><TD><B>&nbsp;</B></TD>
    <TD STYLE="text-align: left"><B>&nbsp;</B></TD><TD STYLE="text-align: right"><B>&nbsp;</B></TD><TD STYLE="text-align: left"><B>&nbsp;</B></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left"><B>Mineral Processing</B></TD><TD><B>&nbsp;</B></TD>
    <TD STYLE="text-align: left"><B>$</B></TD><TD STYLE="text-align: right"><B>500,000</B></TD><TD STYLE="text-align: left"><B>&nbsp;</B></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD><B>&nbsp;</B></TD><TD><B>&nbsp;</B></TD>
    <TD STYLE="text-align: left"><B>&nbsp;</B></TD><TD STYLE="text-align: right"><B>&nbsp;</B></TD><TD STYLE="text-align: left"><B>&nbsp;</B></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD><B>Environmental</B></TD><TD><B>&nbsp;</B></TD>
    <TD STYLE="text-align: left"><B>$</B></TD><TD STYLE="text-align: right"><B>500,000</B></TD><TD STYLE="text-align: left"><B>&nbsp;</B></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD><B>&nbsp;</B></TD><TD><B>&nbsp;</B></TD>
    <TD STYLE="text-align: left"><B>&nbsp;</B></TD><TD STYLE="text-align: right"><B>&nbsp;</B></TD><TD STYLE="text-align: left"><B>&nbsp;</B></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left"><B>Southeast Deposit</B></TD><TD><B>&nbsp;</B></TD>
    <TD STYLE="text-align: left"><B>$</B></TD><TD STYLE="text-align: right"><B>50,000</B></TD><TD STYLE="text-align: left"><B>&nbsp;</B></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD><B>&nbsp;</B></TD><TD><B>&nbsp;</B></TD>
    <TD STYLE="text-align: left"><B>&nbsp;</B></TD><TD STYLE="text-align: right"><B>&nbsp;</B></TD><TD STYLE="text-align: left"><B>&nbsp;</B></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-bottom: 1.5pt; text-align: left"><B>Update Mineral Resources and PEA</B></TD><TD STYLE="padding-bottom: 1.5pt"><B>&nbsp;</B></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><B>$</B></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><B>100,000</B></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><B>&nbsp;</B></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD><B>&nbsp;</B></TD><TD><B>&nbsp;</B></TD>
    <TD STYLE="text-align: left"><B>&nbsp;</B></TD><TD STYLE="text-align: right"><B>&nbsp;</B></TD><TD STYLE="text-align: left"><B>&nbsp;</B></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-bottom: 1.5pt; text-align: left"><B>GRAND TOTAL</B></TD><TD STYLE="padding-bottom: 1.5pt"><B>&nbsp;</B></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><B>$</B></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><B>2,700,000</B></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><B>&nbsp;</B></TD></TR>
  </TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Most of the recommended costs are one time expenditures.
Maintaining environmental baselines studies as current and public outreach will have ongoing annual costs.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><U>Crownpoint and Hosta Butte Project</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The following summary of the Crownpoint and Hosta
Butte Uranium Project is extracted from the technical report, titled, &ldquo;Crownpoint and Hosta Butte Uranium Project McKinley County,
New Mexico, USA&rdquo; dated February 25, 2022, with an effective date of February 25, 2022 and a revision date of March 16, 2022, prepared
by Douglas L. Beahm, P.E., P.G., Carl Warren, P.E., P.G., and W. Paul Goranson, P.E. (the &ldquo;<B>Crownpoint and Hosta Butte Uranium
Technical Report</B>&rdquo;), and modified to conform to this AIF. This summary is qualified in its entirety by reference to the full
Crownpoint and Hosta Butte Uranium Technical Report which is incorporated into this AIF by reference.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Property Description and Location</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Crownpoint and Hosta Butte Uranium Project
is located in the Grants Uranium Region. The Grants Uranium Region is located in northwestern New Mexico and is part of the Colorado Plateau
physiographic province.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Crownpoint and Hosta Butte Uranium Project
is located in portions of Sections 24, Township 17 North, Range 13 West; Sections 19 and 29, Township 17 North, Range 12 West; and Sections,
3, 9, and 11, Township 16 North, Range 13 West, comprising approximately 3,020 acres.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Crownpoint and Hosta Butte Uranium Project
is accessed from the south by Highway 371 and from the north by Highway 57 at Crownpoint, New Mexico. Highway 9 goes west from Crownpoint,
just to the north of the project area. Paved secondary roads provide access to the NuFuels, Inc. (&ldquo;<B>NuFuels</B>&rdquo;) facility
on Section 24. From the NuFuels facility the Hosta Butte portion of the Project is accessible via a county gravel road which turns to
the south approximately 2 miles west of Crownpoint. The road continues east becoming a private dirt road then turns to the north in Section
11 and continues to the project area.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The largest nearby population center is Albuquerque,
New Mexico, with an approximate population of 565,000 residents. Albuquerque is located approximately 100 miles to the east on Highway
40 and provides a transportation and supply hub for the area. Grants, New Mexico is approximately 50 miles east of the Project and Gallup,
New Mexico lies approximately 50 miles to the west. The Project is approximately 10 miles from the Navajo Reservation and is situated
on the west and southwest of the small town of Crownpoint.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 34; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->32<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><IMG SRC="ex99-1_006.jpg" ALT=""></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Tigris Uranium US Corp. (&ldquo;<B>Tigris</B>&rdquo;)
owns the mineral estate outright. There are no annual payments, maintenance, or other requirements to be met to maintain the mineral estate
subject only to a 3% gross proceeds royalty on uranium mined from the Project.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Surface rights are held separately from the mineral
rights on the Project. The surface rights have not been removed from development and are not under other restrictions. The property is
outside of the Navajo Reservation and is situated on the western edge and to the southwest of the small town of Crownpoint, New Mexico.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 35; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->33<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt"><B><I>Chain of Title</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify">The NZ Land Company (&ldquo;<B>NZ</B>&rdquo;)
was formed in 1908 and took deed and management of the land grants. NZ Uranium LLC (&ldquo;<B>NZU</B>&rdquo;) was spun off to manage the
lands within the known uranium trend of New Mexico and Arizona in 2002. Tigris optioned the Project in May 2010 and exercised the option
in May, 2011. Tigris acquired a 60% Interest in the Section 24 Crownpoint Property and 100% of the Hosta Butte Property, the Crownpoint
Properties located in Section 19 and 29. The remaining 40% interest in the Crownpoint Section 24 property is held by NuFuels. The property
is not subject to any liens or other encumbrances.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 5.8pt 0pt 0; text-align: justify">The author has reviewed the pertinent
Quitclaim, Warranty, and Royalty deeds related to the transfer of title from NZU to Tigris. It is the author&rsquo;s opinion that the
current title is secure and would allow development of the mineral estate with the Project subject to required permitting and licensing.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Property History</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Grants Uranium Region has been the most prolific
producer of uranium in the United States (McLemore and Chenoweth, 1991). With production as early as 1948, over 347 million lbs. of U<SUB>3</SUB>O<SUB>8</SUB>
have been produced from the region. The majority of which was produced during the years 1953 through 1990.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">No current preliminary economic assessment of
the Crownpoint and Hosta Butte Uranium Project and/or feasibility study has been completed for the Crownpoint and Hosta Butte Uranium
Project. The purpose of this report is to define the in-place mineral resources. Mineral resources are not mineral reserves and do not
have demonstrated economic viability in accordance with CIM standards.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Crownpoint area of the Project is wholly within
NuFuels, Inc.&rsquo;s (a wholly owned subsidiary of Laramide Resources LTD) Source Materials License SUA-1580 for the in-situ recovery
(ISR) of uranium which was issued by the US Nuclear Regulatory Commission (NRC) (http://www.nrc.gov/infofinder/materials/uranium). Water
rights have been approved by the New Mexico State Engineer for a portion of the Crownpoint area. Other Permits will be required to operate
the at the Crownpoint area.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">There have been no permits or licenses issued
for the Hosta Butte property.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Geological Setting and Mineralization</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Uranium mineralization is typical of sandstone
hosted roll-front deposits found within the Western US. The Westwater Canyon member of the Morrison Formation is the principal host of
uranium mineralization in the vicinity of the Project and is approximately 360 feet thick. For the purposes of estimating mineral resources,
the authors subdivided the Westwater Canyon into four vertically and laterally distinct sand units/zones.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In the Crownpoint area, mineralized thickness
ranges from the minimum of 2 feet to over 40 feet. Average thickness of all intercepts was 7.6 feet. Average GT of all intercepts was
0.77 ft%. Grade varies from the minimum grade cutoff of 0.02 % eU<SUB>3</SUB>O<SUB>8</SUB> to a maximum grade by intercept of 0.38 % eU<SUB>3</SUB>O8.
Individual mineralized trends may persist for several thousand feet with trend width typically in the range from 100 up to 400 feet.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In the Hosta Butte area mineralized thickness
ranges from the minimum of 2 feet to over 33 feet. Average thickness of all intercepts was 7.4 feet. Average GT of all intercepts was
0.83 ft%. Grade varies from the minimum grade cutoff of 0.02 % eU<SUB>3</SUB>O<SUB>8</SUB> to a maximum grade by intercept of 0.52 % eU<SUB>3</SUB>O<SUB>8</SUB>.
Individual mineralized trends may persist for 2,000 thousand feet or more with trend width typically in the range of 100 to 300 feet.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 36; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->34<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Structure</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The sedimentary rocks of the San Juan Basin form
a gently dipping monocline in the Grants-Gallup area known as the Chaco Slope (Brister and Hoffman, 2002). The beds generally dip to the
north with localized variations due to undulations and minor deformation. The beds in the project area are gently dipping to the north.
Stratigraphic correlations of drill logs, by the authors, show the dip at both the Crownpoint and Hosta Butte areas to be about 3 degrees
to the north northeast. There is a mapped fault in the extreme southeast portion of Section 3, T16N, R13W which displaces mineralization
in the Hosta Butte area. No significant faulting was observed based on stratigraphic correlations in the Crownpoint area of the Project.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Mineralization </I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The mineral deposits at Crownpoint and Hosta Butte
are roll-front deposits in which uranium mineralization is concentrated at the boundary of oxidized and reduced sandstone units (i.e.
redox front) within the host formation. Figure 8.2 shows the known and/or projected location of the redox fronts in the general project
area. The Crownpoint and Hosta Butte areas occur along sub-parallel redox fronts within the Westwater Canyon and are separated by 2 to
3 miles in which the Westwater Canyon is characteristically oxidized and absent mineralization. Mineralization is locally controlled by
stratigraphic variations in the individual zones affecting permeability and consequent ground water flow and geochemical conditions relating
to the presence or absence of reluctant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Mineral Resource Summary </I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The mineral resource calculations presented herein
have been completed in accordance with CIM standards and NI 43-101. Based on the drilling density, the apparent continuity of the mineralization
along trends, geologic correlation and modeling of the deposit, the mineral resource estimate herein meets CIM standards as an Indicated
Mineral Resource. This tabulation shows the total Indicated Mineral Resource and the portion thereof controlled by enCore, i.e., 100%
of Hosta Butte and Crownpoint Sections 19 and 29, and 60% of Crownpoint Section 24. The quantity of Indicated Mineral Resource at a 0.02%
eU3O8 grade cutoff and 0.1, 0.25, and 0.5 ft% GT cutoffs is provided in Table 14.3 to illustrate the effect of varying cutoffs. The Indicated
Mineral Resource estimate at a 0.02% eU3O8 grade cutoff and variable GT cutoffs, 0.1, 0.25, and 0.5 ft% GT, is provided in Table 14.3,
to illustrate the sensitivity of GT cutoff on the estimate. Although each GT cutoff scenario has reasonable prospects for eventual economic
extraction the 0.25 ft% GT cutoff for the Indicated Mineral Resource is recommended by the authors, based upon typical US ISR industry
practices. Estimated Indicted Mineral Resources at a 0.02% eU3O8 grade cutoff and 0.25 ft% GT are summarized in Table 14.1. A discussion
of individual resource areas follows. For the summary, only the preferred cutoff criteria is shown.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 37; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->35<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Table 14.1 - Total Indicated Mineral Resources</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD COLSPAN="5" STYLE="border-bottom: Black 1.5pt solid"><B>0.02% eU3O8 Grade Cutoff and GT Cutoff* &gt;0.25 ft%</B></TD><TD STYLE="padding-bottom: 1.5pt"><B>&nbsp;</B></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; text-align: center"><B>Total Indicated <BR> Resource</B></TD><TD STYLE="padding-bottom: 1.5pt"><B>&nbsp;</B></TD><TD STYLE="padding-bottom: 1.5pt"><B>&nbsp;</B></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; text-align: center"><B>encore <BR>
Controlled</B></TD><TD STYLE="padding-bottom: 1.5pt"><B>&nbsp;</B></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="background-color: rgb(204,238,255); text-align: left; width: 41%"><B>Crownpoint</B></TD><TD STYLE="background-color: rgb(204,238,255); width: 1%">&nbsp;</TD>
    <TD STYLE="background-color: rgb(204,238,255); width: 1%; text-align: left">&nbsp;</TD><TD STYLE="background-color: rgb(204,238,255); width: 20%; text-align: center">Pounds eU<SUB>3</SUB>O<SUB>8</SUB></TD><TD STYLE="background-color: rgb(204,238,255); width: 1%; text-align: left">&nbsp;</TD><TD STYLE="background-color: rgb(204,238,255); width: 1%">&nbsp;</TD>
    <TD STYLE="background-color: rgb(204,238,255); width: 1%; text-align: left">&nbsp;</TD><TD STYLE="background-color: rgb(204,238,255); width: 15%; text-align: right">19,565,000</TD><TD STYLE="background-color: rgb(204,238,255); width: 1%; text-align: left">&nbsp;</TD><TD STYLE="background-color: rgb(204,238,255); width: 1%">&nbsp;</TD>
    <TD STYLE="background-color: rgb(204,238,255); width: 1%; text-align: left">&nbsp;</TD><TD STYLE="background-color: rgb(204,238,255); width: 15%; text-align: right">16,223,000</TD><TD STYLE="background-color: rgb(204,238,255); width: 1%; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="background-color: rgb(204,238,255); text-align: center"></TD><TD STYLE="background-color: rgb(204,238,255)">&nbsp;</TD>
    <TD STYLE="background-color: rgb(204,238,255); text-align: left">&nbsp;</TD><TD STYLE="background-color: rgb(204,238,255); text-align: center">Tons</TD><TD STYLE="background-color: rgb(204,238,255); text-align: left">&nbsp;</TD><TD STYLE="background-color: rgb(204,238,255)">&nbsp;</TD>
    <TD STYLE="background-color: rgb(204,238,255); text-align: left">&nbsp;</TD><TD STYLE="background-color: rgb(204,238,255); text-align: right">9,027,000</TD><TD STYLE="background-color: rgb(204,238,255); text-align: left">&nbsp;</TD><TD STYLE="background-color: rgb(204,238,255)">&nbsp;</TD>
    <TD STYLE="background-color: rgb(204,238,255); text-align: left">&nbsp;</TD><TD STYLE="background-color: rgb(204,238,255); text-align: right">7,321,000</TD><TD STYLE="background-color: rgb(204,238,255); text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="background-color: rgb(204,238,255); text-align: center"></TD><TD STYLE="background-color: rgb(204,238,255)">&nbsp;</TD>
    <TD STYLE="background-color: rgb(204,238,255); text-align: left">&nbsp;</TD><TD STYLE="background-color: rgb(204,238,255); text-align: center">Avg. Grade % eU<SUB>3</SUB>O<SUB>8</SUB></TD><TD STYLE="background-color: rgb(204,238,255); text-align: left">&nbsp;</TD><TD STYLE="background-color: rgb(204,238,255)">&nbsp;</TD>
    <TD STYLE="background-color: rgb(204,238,255); text-align: left">&nbsp;</TD><TD STYLE="background-color: rgb(204,238,255); text-align: right">0.108</TD><TD STYLE="background-color: rgb(204,238,255); text-align: left">&nbsp;</TD><TD STYLE="background-color: rgb(204,238,255)">&nbsp;</TD>
    <TD STYLE="background-color: rgb(204,238,255); text-align: left">&nbsp;</TD><TD STYLE="background-color: rgb(204,238,255); text-align: right">0.111</TD><TD STYLE="background-color: rgb(204,238,255); text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="background-color: White; text-align: left"><B>Hosta Butte</B></TD><TD STYLE="background-color: White">&nbsp;</TD>
    <TD STYLE="background-color: White; text-align: left">&nbsp;</TD><TD STYLE="background-color: White; text-align: center">Pounds eU<SUB>3</SUB>O<SUB>8</SUB></TD><TD STYLE="background-color: White; text-align: left">&nbsp;</TD><TD STYLE="background-color: White">&nbsp;</TD>
    <TD STYLE="background-color: White; text-align: left">&nbsp;</TD><TD STYLE="background-color: White; text-align: right">9,479,000</TD><TD STYLE="background-color: White; text-align: left">&nbsp;</TD><TD STYLE="background-color: White">&nbsp;</TD>
    <TD STYLE="background-color: White; text-align: left">&nbsp;</TD><TD STYLE="background-color: White; text-align: right">9,479,000</TD><TD STYLE="background-color: White; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="background-color: White; text-align: center"></TD><TD STYLE="background-color: White">&nbsp;</TD>
    <TD STYLE="background-color: White; text-align: left">&nbsp;</TD><TD STYLE="background-color: White; text-align: center">Tons</TD><TD STYLE="background-color: White; text-align: left">&nbsp;</TD><TD STYLE="background-color: White">&nbsp;</TD>
    <TD STYLE="background-color: White; text-align: left">&nbsp;</TD><TD STYLE="background-color: White; text-align: right">3,637,000</TD><TD STYLE="background-color: White; text-align: left">&nbsp;</TD><TD STYLE="background-color: White">&nbsp;</TD>
    <TD STYLE="background-color: White; text-align: left">&nbsp;</TD><TD STYLE="background-color: White; text-align: right">3,637,000</TD><TD STYLE="background-color: White; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="background-color: White; text-align: center"></TD><TD STYLE="background-color: White">&nbsp;</TD>
    <TD STYLE="background-color: White; text-align: left">&nbsp;</TD><TD STYLE="background-color: White; text-align: center">Avg. Grade % eU<SUB>3</SUB>O<SUB>8</SUB></TD><TD STYLE="background-color: White; text-align: left">&nbsp;</TD><TD STYLE="background-color: White">&nbsp;</TD>
    <TD STYLE="background-color: White; text-align: left">&nbsp;</TD><TD STYLE="background-color: White; text-align: right">0.130</TD><TD STYLE="background-color: White; text-align: left">&nbsp;</TD><TD STYLE="background-color: White">&nbsp;</TD>
    <TD STYLE="background-color: White; text-align: left">&nbsp;</TD><TD STYLE="background-color: White; text-align: right">0.130</TD><TD STYLE="background-color: White; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="background-color: rgb(204,238,255); text-align: left"><B>Total Indicated Mineral Resource</B></TD><TD STYLE="background-color: rgb(204,238,255)">&nbsp;</TD>
    <TD STYLE="background-color: rgb(204,238,255); text-align: left">&nbsp;</TD><TD STYLE="background-color: rgb(204,238,255); text-align: center">Pounds eU<SUB>3</SUB>O<SUB>8</SUB></TD><TD STYLE="background-color: rgb(204,238,255); text-align: left">&nbsp;</TD><TD STYLE="background-color: rgb(204,238,255)">&nbsp;</TD>
    <TD STYLE="background-color: rgb(204,238,255); text-align: left">&nbsp;</TD><TD STYLE="background-color: rgb(204,238,255); text-align: right">29,044,000</TD><TD STYLE="background-color: rgb(204,238,255); text-align: left">&nbsp;</TD><TD STYLE="background-color: rgb(204,238,255)">&nbsp;</TD>
    <TD STYLE="background-color: rgb(204,238,255); text-align: left">&nbsp;</TD><TD STYLE="background-color: rgb(204,238,255); text-align: right">25,702,000</TD><TD STYLE="background-color: rgb(204,238,255); text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="background-color: rgb(204,238,255); text-align: center"></TD><TD STYLE="background-color: rgb(204,238,255)">&nbsp;</TD>
    <TD STYLE="background-color: rgb(204,238,255); text-align: left">&nbsp;</TD><TD STYLE="background-color: rgb(204,238,255); text-align: center">Tons</TD><TD STYLE="background-color: rgb(204,238,255); text-align: left">&nbsp;</TD><TD STYLE="background-color: rgb(204,238,255)">&nbsp;</TD>
    <TD STYLE="background-color: rgb(204,238,255); text-align: left">&nbsp;</TD><TD STYLE="background-color: rgb(204,238,255); text-align: right">12,664,000</TD><TD STYLE="background-color: rgb(204,238,255); text-align: left">&nbsp;</TD><TD STYLE="background-color: rgb(204,238,255)">&nbsp;</TD>
    <TD STYLE="background-color: rgb(204,238,255); text-align: left">&nbsp;</TD><TD STYLE="background-color: rgb(204,238,255); text-align: right">10,958,000</TD><TD STYLE="background-color: rgb(204,238,255); text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="background-color: rgb(204,238,255); text-align: center"></TD><TD STYLE="background-color: rgb(204,238,255)">&nbsp;</TD>
    <TD STYLE="background-color: rgb(204,238,255); text-align: left">&nbsp;</TD><TD STYLE="background-color: rgb(204,238,255); text-align: center">Avg. Grade % eU<SUB>3</SUB>O<SUB>8</SUB></TD><TD STYLE="background-color: rgb(204,238,255); text-align: left">&nbsp;</TD><TD STYLE="background-color: rgb(204,238,255)">&nbsp;</TD>
    <TD STYLE="background-color: rgb(204,238,255); text-align: left">&nbsp;</TD><TD STYLE="background-color: rgb(204,238,255); text-align: right">0.115</TD><TD STYLE="background-color: rgb(204,238,255); text-align: left">&nbsp;</TD><TD STYLE="background-color: rgb(204,238,255)">&nbsp;</TD>
    <TD STYLE="background-color: rgb(204,238,255); text-align: left">&nbsp;</TD><TD STYLE="background-color: rgb(204,238,255); text-align: right">0.117</TD><TD STYLE="background-color: rgb(204,238,255); text-align: left">&nbsp;</TD></TR>
  </TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Pounds and tons as reported are rounded to the nearest 1,000</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in; text-align: left">*</TD><TD>GT cutoff: Minimum Grade (% eU<SUB>3</SUB>O<SUB>8</SUB>)
x Thickness (Feet) for Grade &gt; 0.02% eU<SUB>3</SUB>O<SUB>8</SUB>.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Deposit Types </I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Mineral deposits within the project area have
been described in the literature as re-distributed uranium mineralization, secondary, and roll-type uranium mineralization. (McLemore,
2010). Mineralization is discordant, asymmetrical, and irregularly shaped and is typically elongated parallel to depositional features.
Varying rates of ground water flow controlled by sedimentary facies changes in each stratigraphic zone in the Westwater Canyon produced
staked mineralized zones near one another, but not necessarily vertically above or below one another (Peterson, 1980). Mineralization
may be found as irregular pods or as the classic c-shaped roll-fronts as depicted in the following figure.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><IMG SRC="ex99-1_007.jpg" ALT=""></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Referring to Figure 8.1 (McLemore and Chenoweth,
1991), oxidation and reduction zones are shown for the project area in general and the Crownpoint and Hosta Butte areas specifically.
In the intervening area between the Crownpoint and Hosta Butte mineralization the host formation is oxidized. The Crownpoint and Hosta
Butte mineralization occurs along separate redox fronts which are sub-parallel to one another and trending generally from southeast to
northwest.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 38; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->36<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Exploration</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">No relevant exploration work has been conducted
on the property in recent years. Previous exploration drilling is described in Section 10 of the Crownpoint and Hosta Butte Technical
Report. In the Project area uranium mineralization is at depths more than 1,500 feet from the surface. The deposition of mineralization
is stratigraphically and geochemically controlled. These depositional characteristics are not easily discoverable at depth by other exploration
techniques other than drilling.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>Drilling </I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Drilling within the Crownpoint area focused on
portions of three sections 19 and 29, T17N, R12W and Section 24 T17N, R13W. Within the Crownpoint area 482 rotary drill holes and 37 core
holes were completed. Drilling within the Hosta Butte area also included three sections, 3, 9, and 11, T16N, R13W. However, the drilling
at Hosta Butte focused primarily on Section 3 with 133 rotary holes and 2 cores holes completed. In Sections 9 and 11, T16N, R13W, 14
rotary drill holes and 32 rotary drill holes were completed, respectively.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Data available for the preparation of this report
included historic data developed by previous owners of the property, predominantly Conoco Minerals Corp. This data was verified by the
author, as described in Section 12 of this report, and is considered reliable for the purposes of estimating mineral resources.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">All drill holes were logged with downhole geophysical
logging equipment for natural gamma, resistivity, and spontaneous self-potential (SP). Select intervals in the core holes were selected
for chemical assay. Sample handling and analytical procedures employed for core samples are described in Section 11 of the report. Portions
of the cores have been preserved and have been donated to the Core Research Center (&ldquo;<B>CRC</B>&rdquo;) of the United States Geological
Survey (&ldquo;<B>USGS</B>&rdquo;) located at the Denver Federal Center, Denver, Colorado. Select cores were examined by the author in
preparation of this report, as discussed in Section 12 of the report.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">All drilling was vertical. The formation is relatively
flat lying (refer to Section 7) dipping at about 3 degrees to the north northeast. Downhole drift surveys were completed on most of the
drill holes and were reviewed by the authors. Generally, the drill holes tended to drift slightly to the south southwest and perpendicular
to the regional dip. The maximum downhole drift observed in review of the drill data was approximately 30 feet in holes completed to approximately
2,500 feet. True depth corrections were made in the drill hole data bases for the project areas. The depth correction was on the order
of 10 feet for a 2,000-foot drill hole. Given that the drilling was vertical or near vertical and with a formational dip of 3 degrees
or less the thickness of mineralization as measured from the geophysical logs is below 1 percent less the true thickness and was not corrected
for while estimating mineral resources.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>Crownpoint Area</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Crownpoint data set is composed of a total
of 482 drill holes of which 93 are barren and the remaining 389 drill holes contain mineralization above the minimum cutoff. Within the
389 mineralized drill holes, 873 individual intercepts were present. Drill hole spacing within the areas of mineral resource were a nominal
average of 150 feet. The historic database, used as the primary data source, consists of eU3O8 radiometric data by half foot increments
which was originally developed by Conoco and has been verified by the authors. The dataset was screened for the mineral resource estimation.
Mineralized intercepts were diluted to a minimum thickness of 2 feet. Following dilution only those intercepts having minimum grade of
0.02 % eU3O8 and a minimum GT of 0.10 ft% were used in the estimation. A summary of mineralization reflected in the drill holes follows.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 39; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->37<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Mineralization Thickness and Grade</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Crownpoint mineralized thickness ranges from the
minimum of 2 feet to over 40 feet. Average thickness of all intercepts was 7.6 feet. Average GT of all intercepts was 0.77 ft%. Grade
varies from the minimum grade cutoff of 0.02 % eU3O8 to a maximum grade by intercept of 0.38 % eU3O8. However, individual half foot grades
did exceed 2% eU3O8. Individual mineralized trends may persist for several thousand feet along trend with a width typically in the range
from 100 up to 400 feet.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Hosta Butte Area</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Hosta Butte data set is composed of a total
of 135 drill holes. Of those 135 drill holes 42 were barren and 93 of the drill holes contained mineralization meeting cutoff criteria
as described for the Crownpoint area. Within the 93 mineralized drill holes, 155 individual intercepts were present. Drill hole spacing
within the areas of mineral resource were a nominal average of 250 feet.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Mineralization Thickness and Grade</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Hosta Butte mineralized thickness ranges from
the minimum of 2 feet to over 33 feet. Average thickness of all intercepts was 7.4 feet. Average GT of all intercepts was 0.83 ft%. Grade
varies from the minimum grade cutoff of 0.02 % eU<SUB>3</SUB>O<SUB>8</SUB> to a maximum grade by intercept of 0.52 % eU<SUB>3</SUB>O<SUB>8</SUB>.
However, individual half foot grades did exceed 2 % eU<SUB>3</SUB>O<SUB>8</SUB>. Individual mineralized trends may persist for 2,000 thousand
feet or more along the trend having a width typically in the range of 100 to 300 feet.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>Additional Areas of Mineralization &ndash; Hosta Butte Sections
9 and 11, T16N, R13W</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Drilling on Sections 9 and 11 demonstrate the
presence of uranium mineralization, but these areas are not yet adequately defined to support a CIM compliant mineral resource estimate.
However, drill data from these sections do demonstrate that the host formation, the Westwater Canyon member of the Morrison Formation,
is present and gamma anomalies are present in both sections.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>Sample Preparation, Analyses and Security </I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The majority of the sample data available for
the evaluation of resources for the Project is the historic geophysical log data. The original geophysical logs have been preserved and
were reviewed by the authors.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">With respect to historic core handling procedures,
written procedures for core handling and sample analysis were available along with the original core data records and assay sheets. The
cores were split through the zones of interest determined by the geophysical logs and scanning of the cores with a scintillometer. All
the samples were assayed using either a Beta Gamma Scaler or an X-ray fluorescence spectrometer at the mine site. Quality control of the
on-site assay equipment was provided through an independent laboratory, Hazen Research, which completed fluorometric analysis of select
samples including many of the higher grade samples. Original assay sheets were available for 32 of the 35 cores holes.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The cores were donated to the USGS Core Research
Center (CRC) located at the Denver Federal Center in Lakewood, Colorado. The author, Beahm, visited the CRC on May 7, 2012 and reviewed
the cores and selected 20 samples from core holes geographically distributed within the Project. The selected samples were sealed in plastic
sample bags and labeled by hole, depth, and original sample number. A record of this information was also created. On the same day the
samples taken the author were shipped by Federal Express to Intermountain Labs (IML) in Sheridan, Wyoming for assay. IML confirmed delivery
with a chain of custody by noon the following day. IML is a certified laboratory. Results of the confirmatory assays are provided in Section
12.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 40; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->38<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In addition to being able to examine the cores
at the CRC, the author was able to observe how the cores were preserved. Each half foot of core was sealed in plastic. The bags were labeled
for each sample with hole number and depth and stored in core boxes each containing approximately 10 feet of core. The core boxes were
also labeled as to hole number and depth. Lost core intervals were marked with wooden blocks which recorded the lost interval. In many
of the mineralized zones the bulk of the core was consumed by metallurgical testing. For these portions of the core, approximately 100
grams of prepared sample was preserved in a re-sealable envelope. The envelopes were labeled with hole number and sample number. All sample
numbers were unique.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Note that the availability of cores at the CRC
can be searched on their website (https://www.usgs.gov/coreresearch-center). When doing this the core intervals which contained the mineralized
zones are not listed. Special permission is needed to examine the cores in their &ldquo;Hot Room&rdquo; and access to this portion of
the cores required knowledge of the specific zones of interest and the respective hole and core box number.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In the authors&rsquo; opinion, the sample preparation,
security, and analytical procedures are reliable and adequate.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The author has reviewed the historic procedures
followed by the previous operator of the project, Conoco Minerals, including procedures for rotary and core drilling, geophysical logging
and log interpretation, sampling, and assays. In addition, the author has reviewed and verified the work product that was developed for
the project including the original geophysical and lithologic logs, sampling records, and original core assay records. It is the author&rsquo;s
opinion that the procedures, practices, and analytical equipment utilized and/or employed on the Project were consistent with the general
industry standards and practices at that time. The author further concludes that the data utilized in this report is accurate and reliable
for the purposes of this report.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>Mineral Processing and Metallurgical Testing</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 5.85pt 0pt 0; text-align: justify">The author has reviewed the historical
metallurgical testing and the location of the core holes in the Crownpoint portion of the project and can conclude that the core holes
were located such as to reflect the geographical distribution of the mineralization and adequately represent the deposit.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 5.85pt 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 5.85pt 0pt 0; text-align: justify">The metallurgical testing of Crownpoint
was performed by Hazen Research of Golden Colorado. In the author&rsquo;s opinion, Hazen Research is a reputable firm who was then and
is still recognized as one of the premier metallurgical research and testing facilities in the US. Leaching was tested under a variety
of conditions primarily with sulfuric acid as the leaching agent. Residual or non-soluble uranium in the test sample assays for 16 separate
tests ranged from 0.0007 to 0.024 % U<SUB>3</SUB>O<SUB>8</SUB> resulting in recoveries ranging from as high as 99.6 % to a low of 87.6%.
The testing concluded that the mineralized material is very amenable to acid leaching and estimated that recoveries would exceed 96%.
The reports did not identify any deleterious elements or constituents that could have a material effect on the economic extraction of
uranium by acid leaching. Sulfuric acid consumption was relatively low at approximately 65 pounds per ton.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 5.7pt 0pt 0; text-align: justify">All data with respect to metallurgical
testing is of a historic nature and/or may be implied by results from adjacent properties and cannot be directly verified by the author.
However, the author is familiar with the testing procedures followed and with the independent facilities that completed the testing. As
such, the author concludes that the data is reliable for the purposes of this report.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 5.85pt 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 5.85pt 0pt 0; text-align: justify">Metallurgical test results are only
available for the Crownpoint portion of the Project. The author is not aware of metallurgical test results for the Hosta Butte portion
of the Project.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 5.85pt 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 5.8pt 0pt 0; text-align: justify">No current preliminary economic assessment
of the Project and/or feasibility study has been completed for the Project. The purpose of this report is to define the in-place mineral
resources. Mineral resources are not mineral reserves and do not have demonstrated economic viability in accordance with CIM standards.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 41; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->39<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>Mineral Resources</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Indicated Mineral Resources</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The mineral resource estimates presented herein
have been completed in accordance with CIM standards and NI 43-101. The mineral resource estimation meets CIM standards as an Indicated
Mineral Resource based on the drill density, the apparent continuity of the mineralization along trends, the geologic correlation, and
the modeling of the deposit and reasonable prospects for eventual economic extraction, as discussed in Section 14.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">A summary of total Indicated Mineral Resource
is provided in Table 14.1.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Table 14.1 - Total Indicated Mineral Resources</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD COLSPAN="3" STYLE="border-bottom: Black 1.5pt solid"><B>0.02% eU3O8 Grade Cutoff and GT Cutoff* &gt;0.25 ft%</B></TD><TD STYLE="padding-bottom: 1.5pt"><B>&nbsp;</B></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; text-align: center"><B>Total Indicated <BR> Resource</B></TD><TD STYLE="padding-bottom: 1.5pt"><B>&nbsp;</B></TD><TD STYLE="padding-bottom: 1.5pt"><B>&nbsp;</B></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; text-align: center"><B>encore<BR>
 Controlled</B></TD><TD STYLE="padding-bottom: 1.5pt"><B>&nbsp;</B></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="background-color: rgb(204,238,255); text-align: left; width: 43%"><B>Crownpoint</B></TD><TD STYLE="background-color: rgb(204,238,255); width: 1%">&nbsp;</TD>
    <TD STYLE="background-color: rgb(204,238,255); text-align: center; width: 20%">Pounds eU<SUB>3</SUB>O<SUB>8</SUB></TD><TD STYLE="background-color: rgb(204,238,255); width: 1%">&nbsp;</TD>
    <TD STYLE="background-color: rgb(204,238,255); width: 1%; text-align: left">&nbsp;</TD><TD STYLE="background-color: rgb(204,238,255); width: 15%; text-align: right">19,565,000</TD><TD STYLE="background-color: rgb(204,238,255); width: 1%; text-align: left">&nbsp;</TD><TD STYLE="background-color: rgb(204,238,255); width: 1%">&nbsp;</TD>
    <TD STYLE="background-color: rgb(204,238,255); width: 1%; text-align: left">&nbsp;</TD><TD STYLE="background-color: rgb(204,238,255); width: 15%; text-align: right">16,223,000</TD><TD STYLE="background-color: rgb(204,238,255); width: 1%; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="background-color: rgb(204,238,255); text-align: center"></TD><TD STYLE="background-color: rgb(204,238,255)">&nbsp;</TD>
    <TD STYLE="background-color: rgb(204,238,255); text-align: center">Tons</TD><TD STYLE="background-color: rgb(204,238,255)">&nbsp;</TD>
    <TD STYLE="background-color: rgb(204,238,255); text-align: left">&nbsp;</TD><TD STYLE="background-color: rgb(204,238,255); text-align: right">9,027,000</TD><TD STYLE="background-color: rgb(204,238,255); text-align: left">&nbsp;</TD><TD STYLE="background-color: rgb(204,238,255)">&nbsp;</TD>
    <TD STYLE="background-color: rgb(204,238,255); text-align: left">&nbsp;</TD><TD STYLE="background-color: rgb(204,238,255); text-align: right">7,321,000</TD><TD STYLE="background-color: rgb(204,238,255); text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="background-color: rgb(204,238,255); text-align: center"></TD><TD STYLE="background-color: rgb(204,238,255)">&nbsp;</TD>
    <TD STYLE="background-color: rgb(204,238,255); text-align: center">Avg. Grade % eU<SUB>3</SUB>O<SUB>8</SUB></TD><TD STYLE="background-color: rgb(204,238,255)">&nbsp;</TD>
    <TD STYLE="background-color: rgb(204,238,255); text-align: left">&nbsp;</TD><TD STYLE="background-color: rgb(204,238,255); text-align: right">0.108</TD><TD STYLE="background-color: rgb(204,238,255); text-align: left">&nbsp;</TD><TD STYLE="background-color: rgb(204,238,255)">&nbsp;</TD>
    <TD STYLE="background-color: rgb(204,238,255); text-align: left">&nbsp;</TD><TD STYLE="background-color: rgb(204,238,255); text-align: right">0.111</TD><TD STYLE="background-color: rgb(204,238,255); text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="background-color: White; text-align: left"><B>Hosta Butte</B></TD><TD STYLE="background-color: White">&nbsp;</TD>
    <TD STYLE="background-color: White; text-align: center">Pounds eU<SUB>3</SUB>O<SUB>8</SUB></TD><TD STYLE="background-color: White">&nbsp;</TD>
    <TD STYLE="background-color: White; text-align: left">&nbsp;</TD><TD STYLE="background-color: White; text-align: right">9,479,000</TD><TD STYLE="background-color: White; text-align: left">&nbsp;</TD><TD STYLE="background-color: White">&nbsp;</TD>
    <TD STYLE="background-color: White; text-align: left">&nbsp;</TD><TD STYLE="background-color: White; text-align: right">9,479,000</TD><TD STYLE="background-color: White; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="background-color: White; text-align: center"></TD><TD STYLE="background-color: White">&nbsp;</TD>
    <TD STYLE="background-color: White; text-align: center">Tons</TD><TD STYLE="background-color: White">&nbsp;</TD>
    <TD STYLE="background-color: White; text-align: left">&nbsp;</TD><TD STYLE="background-color: White; text-align: right">3,637,000</TD><TD STYLE="background-color: White; text-align: left">&nbsp;</TD><TD STYLE="background-color: White">&nbsp;</TD>
    <TD STYLE="background-color: White; text-align: left">&nbsp;</TD><TD STYLE="background-color: White; text-align: right">3,637,000</TD><TD STYLE="background-color: White; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="background-color: White; text-align: center"></TD><TD STYLE="background-color: White">&nbsp;</TD>
    <TD STYLE="background-color: White; text-align: center">Avg. Grade % eU<SUB>3</SUB>O<SUB>8</SUB></TD><TD STYLE="background-color: White">&nbsp;</TD>
    <TD STYLE="background-color: White; text-align: left">&nbsp;</TD><TD STYLE="background-color: White; text-align: right">0.130</TD><TD STYLE="background-color: White; text-align: left">&nbsp;</TD><TD STYLE="background-color: White">&nbsp;</TD>
    <TD STYLE="background-color: White; text-align: left">&nbsp;</TD><TD STYLE="background-color: White; text-align: right">0.130</TD><TD STYLE="background-color: White; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="background-color: rgb(204,238,255); text-align: left"><B>Total Indicated Mineral Resource</B></TD><TD STYLE="background-color: rgb(204,238,255)">&nbsp;</TD>
    <TD STYLE="background-color: rgb(204,238,255); text-align: center">Pounds eU<SUB>3</SUB>O<SUB>8</SUB></TD><TD STYLE="background-color: rgb(204,238,255)">&nbsp;</TD>
    <TD STYLE="background-color: rgb(204,238,255); text-align: left">&nbsp;</TD><TD STYLE="background-color: rgb(204,238,255); text-align: right">29,044,000</TD><TD STYLE="background-color: rgb(204,238,255); text-align: left">&nbsp;</TD><TD STYLE="background-color: rgb(204,238,255)">&nbsp;</TD>
    <TD STYLE="background-color: rgb(204,238,255); text-align: left">&nbsp;</TD><TD STYLE="background-color: rgb(204,238,255); text-align: right">25,702,000</TD><TD STYLE="background-color: rgb(204,238,255); text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="background-color: rgb(204,238,255); text-align: center"></TD><TD STYLE="background-color: rgb(204,238,255)">&nbsp;</TD>
    <TD STYLE="background-color: rgb(204,238,255); text-align: center">Tons</TD><TD STYLE="background-color: rgb(204,238,255)">&nbsp;</TD>
    <TD STYLE="background-color: rgb(204,238,255); text-align: left">&nbsp;</TD><TD STYLE="background-color: rgb(204,238,255); text-align: right">12,664,000</TD><TD STYLE="background-color: rgb(204,238,255); text-align: left">&nbsp;</TD><TD STYLE="background-color: rgb(204,238,255)">&nbsp;</TD>
    <TD STYLE="background-color: rgb(204,238,255); text-align: left">&nbsp;</TD><TD STYLE="background-color: rgb(204,238,255); text-align: right">10,958,000</TD><TD STYLE="background-color: rgb(204,238,255); text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="background-color: rgb(204,238,255); text-align: center"></TD><TD STYLE="background-color: rgb(204,238,255)">&nbsp;</TD>
    <TD STYLE="background-color: rgb(204,238,255); text-align: center">Avg. Grade % eU<SUB>3</SUB>O<SUB>8</SUB></TD><TD STYLE="background-color: rgb(204,238,255)">&nbsp;</TD>
    <TD STYLE="background-color: rgb(204,238,255); text-align: left">&nbsp;</TD><TD STYLE="background-color: rgb(204,238,255); text-align: right">0.115</TD><TD STYLE="background-color: rgb(204,238,255); text-align: left">&nbsp;</TD><TD STYLE="background-color: rgb(204,238,255)">&nbsp;</TD>
    <TD STYLE="background-color: rgb(204,238,255); text-align: left">&nbsp;</TD><TD STYLE="background-color: rgb(204,238,255); text-align: right">0.117</TD><TD STYLE="background-color: rgb(204,238,255); text-align: left">&nbsp;</TD></TR>
  </TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Pounds and tons as reported are rounded to the nearest 1,000</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in; text-align: left">*</TD><TD>GT cutoff: Minimum Grade (% eU<SUB>3</SUB>O<SUB>8</SUB>)
x Thickness (Feet) for Grade &gt; 0.02% eU<SUB>3</SUB>O<SUB>8</SUB>.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">This tabulation shows the total Indicated Mineral
Resource and the portion thereof controlled by Tigris, i.e., 100% of Hosta Butte and Crownpoint Sections 19 and 29, and 60% of Crownpoint
Section 24. A discussion of individual resource areas follows in Section 14. For the summary, only the estimate for the recommended cutoff
criteria is provided.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>Inferred Mineral Resources</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In addition to the above Indicated Mineral Resource,
Inferred Mineral Resources may be projected, primarily as extensions of the Indicated Mineral Resource, along the geologic trends of the
mineralization. By CIM standards, Inferred Mineral Resources are the part of a Mineral Resource for which quantity and grade, or quality
can be calculated on the basis of geological evidence and limited sampling and reasonably assumed, but not verified, geological and grade
continuity. Based on the drill density, the apparent continuity of the mineralization along trends, geologic correlation and modeling
of the deposit, the following Mineral Resource calculation meets CIM standards as an Inferred Mineral Resource. The quantity of Inferred
Mineral Resource is projected at a 0.02% eU3O8 grade cutoff and estimated at 0.1, 0.25, and 0.5 ft% GT cutoffs using the sensitivity analyses
of the indicated portions of the resource. A summary of total Inferred Mineral Resource for the preferred scenario is provided in Table
14.2.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 42; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->40<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Table 14.2 - Total Inferred Mineral Resources</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD COLSPAN="3" STYLE="border-bottom: Black 1.5pt solid"><B>0.02% eU3O8 Grade Cutoff and GT Cutoff* &gt;0.25 ft%</B></TD><TD STYLE="padding-bottom: 1.5pt"><B>&nbsp;</B></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; text-align: center"><B>Total Inferred <BR> Resource</B></TD><TD STYLE="padding-bottom: 1.5pt"><B>&nbsp;</B></TD><TD STYLE="padding-bottom: 1.5pt"><B>&nbsp;</B></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; text-align: center"><B>encore <BR>
Controlled</B></TD><TD STYLE="padding-bottom: 1.5pt"><B>&nbsp;</B></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="background-color: rgb(204,238,255); text-align: left; width: 43%"><B>Crownpoint</B></TD><TD STYLE="background-color: rgb(204,238,255); width: 1%">&nbsp;</TD>
    <TD STYLE="background-color: rgb(204,238,255); text-align: center; width: 20%">Pounds eU<SUB>3</SUB>O<SUB>8</SUB></TD><TD STYLE="background-color: rgb(204,238,255); width: 1%">&nbsp;</TD>
    <TD STYLE="background-color: rgb(204,238,255); width: 1%; text-align: left">&nbsp;</TD><TD STYLE="background-color: rgb(204,238,255); width: 15%; text-align: right">1,445,000</TD><TD STYLE="background-color: rgb(204,238,255); width: 1%; text-align: left">&nbsp;</TD><TD STYLE="background-color: rgb(204,238,255); width: 1%">&nbsp;</TD>
    <TD STYLE="background-color: rgb(204,238,255); width: 1%; text-align: left">&nbsp;</TD><TD STYLE="background-color: rgb(204,238,255); width: 15%; text-align: right">1,388,000</TD><TD STYLE="background-color: rgb(204,238,255); width: 1%; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="background-color: rgb(204,238,255); text-align: center"></TD><TD STYLE="background-color: rgb(204,238,255)">&nbsp;</TD>
    <TD STYLE="background-color: rgb(204,238,255); text-align: center">Tons</TD><TD STYLE="background-color: rgb(204,238,255)">&nbsp;</TD>
    <TD STYLE="background-color: rgb(204,238,255); text-align: left">&nbsp;</TD><TD STYLE="background-color: rgb(204,238,255); text-align: right">708,000</TD><TD STYLE="background-color: rgb(204,238,255); text-align: left">&nbsp;</TD><TD STYLE="background-color: rgb(204,238,255)">&nbsp;</TD>
    <TD STYLE="background-color: rgb(204,238,255); text-align: left">&nbsp;</TD><TD STYLE="background-color: rgb(204,238,255); text-align: right">676,000</TD><TD STYLE="background-color: rgb(204,238,255); text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="background-color: rgb(204,238,255); text-align: center"></TD><TD STYLE="background-color: rgb(204,238,255)">&nbsp;</TD>
    <TD STYLE="background-color: rgb(204,238,255); text-align: center">Avg. Grade % eU<SUB>3</SUB>O<SUB>8</SUB></TD><TD STYLE="background-color: rgb(204,238,255)">&nbsp;</TD>
    <TD STYLE="background-color: rgb(204,238,255); text-align: left">&nbsp;</TD><TD STYLE="background-color: rgb(204,238,255); text-align: right">0.102</TD><TD STYLE="background-color: rgb(204,238,255); text-align: left">&nbsp;</TD><TD STYLE="background-color: rgb(204,238,255)">&nbsp;</TD>
    <TD STYLE="background-color: rgb(204,238,255); text-align: left">&nbsp;</TD><TD STYLE="background-color: rgb(204,238,255); text-align: right">0.103</TD><TD STYLE="background-color: rgb(204,238,255); text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="background-color: White; text-align: left"><B>Hosta Butte</B></TD><TD STYLE="background-color: White">&nbsp;</TD>
    <TD STYLE="background-color: White; text-align: center">Pounds eU<SUB>3</SUB>O<SUB>8</SUB></TD><TD STYLE="background-color: White">&nbsp;</TD>
    <TD STYLE="background-color: White; text-align: left">&nbsp;</TD><TD STYLE="background-color: White; text-align: right">4,482,000</TD><TD STYLE="background-color: White; text-align: left">&nbsp;</TD><TD STYLE="background-color: White">&nbsp;</TD>
    <TD STYLE="background-color: White; text-align: left">&nbsp;</TD><TD STYLE="background-color: White; text-align: right">4,482,000</TD><TD STYLE="background-color: White; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="background-color: White; text-align: center"></TD><TD STYLE="background-color: White">&nbsp;</TD>
    <TD STYLE="background-color: White; text-align: center">Tons</TD><TD STYLE="background-color: White">&nbsp;</TD>
    <TD STYLE="background-color: White; text-align: left">&nbsp;</TD><TD STYLE="background-color: White; text-align: right">1,712,000</TD><TD STYLE="background-color: White; text-align: left">&nbsp;</TD><TD STYLE="background-color: White">&nbsp;</TD>
    <TD STYLE="background-color: White; text-align: left">&nbsp;</TD><TD STYLE="background-color: White; text-align: right">1,712,000</TD><TD STYLE="background-color: White; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="background-color: White; text-align: center"></TD><TD STYLE="background-color: White">&nbsp;</TD>
    <TD STYLE="background-color: White; text-align: center">Avg. Grade % eU<SUB>3</SUB>O<SUB>8</SUB></TD><TD STYLE="background-color: White">&nbsp;</TD>
    <TD STYLE="background-color: White; text-align: left">&nbsp;</TD><TD STYLE="background-color: White; text-align: right">0.131</TD><TD STYLE="background-color: White; text-align: left">&nbsp;</TD><TD STYLE="background-color: White">&nbsp;</TD>
    <TD STYLE="background-color: White; text-align: left">&nbsp;</TD><TD STYLE="background-color: White; text-align: right">0.131</TD><TD STYLE="background-color: White; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="background-color: rgb(204,238,255); text-align: left"><B>Total Inferred Mineral Resource</B></TD><TD STYLE="background-color: rgb(204,238,255)">&nbsp;</TD>
    <TD STYLE="background-color: rgb(204,238,255); text-align: center">Pounds eU<SUB>3</SUB>O<SUB>8</SUB></TD><TD STYLE="background-color: rgb(204,238,255)">&nbsp;</TD>
    <TD STYLE="background-color: rgb(204,238,255); text-align: left">&nbsp;</TD><TD STYLE="background-color: rgb(204,238,255); text-align: right">5,927,000</TD><TD STYLE="background-color: rgb(204,238,255); text-align: left">&nbsp;</TD><TD STYLE="background-color: rgb(204,238,255)">&nbsp;</TD>
    <TD STYLE="background-color: rgb(204,238,255); text-align: left">&nbsp;</TD><TD STYLE="background-color: rgb(204,238,255); text-align: right">5,870,000</TD><TD STYLE="background-color: rgb(204,238,255); text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="background-color: rgb(204,238,255); text-align: center"></TD><TD STYLE="background-color: rgb(204,238,255)">&nbsp;</TD>
    <TD STYLE="background-color: rgb(204,238,255); text-align: center">Tons</TD><TD STYLE="background-color: rgb(204,238,255)">&nbsp;</TD>
    <TD STYLE="background-color: rgb(204,238,255); text-align: left">&nbsp;</TD><TD STYLE="background-color: rgb(204,238,255); text-align: right">2,420,000</TD><TD STYLE="background-color: rgb(204,238,255); text-align: left">&nbsp;</TD><TD STYLE="background-color: rgb(204,238,255)">&nbsp;</TD>
    <TD STYLE="background-color: rgb(204,238,255); text-align: left">&nbsp;</TD><TD STYLE="background-color: rgb(204,238,255); text-align: right">2,388,000</TD><TD STYLE="background-color: rgb(204,238,255); text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="background-color: rgb(204,238,255); text-align: center"></TD><TD STYLE="background-color: rgb(204,238,255)">&nbsp;</TD>
    <TD STYLE="background-color: rgb(204,238,255); text-align: center">Avg. Grade % eU<SUB>3</SUB>O<SUB>8</SUB></TD><TD STYLE="background-color: rgb(204,238,255)">&nbsp;</TD>
    <TD STYLE="background-color: rgb(204,238,255); text-align: left">&nbsp;</TD><TD STYLE="background-color: rgb(204,238,255); text-align: right">0.122</TD><TD STYLE="background-color: rgb(204,238,255); text-align: left">&nbsp;</TD><TD STYLE="background-color: rgb(204,238,255)">&nbsp;</TD>
    <TD STYLE="background-color: rgb(204,238,255); text-align: left">&nbsp;</TD><TD STYLE="background-color: rgb(204,238,255); text-align: right">0.121</TD><TD STYLE="background-color: rgb(204,238,255); text-align: left">&nbsp;</TD></TR>
  </TABLE>


<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Pounds and tons as reported are rounded to the nearest 1,000</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in; text-align: left">*</TD><TD>GT cutoff: Minimum Grade (% eU<SUB>3</SUB>O<SUB>8</SUB>)
x Thickness (Feet) for Grade &gt; 0.02% eU<SUB>3</SUB>O<SUB>8</SUB>.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">This tabulation shows the total Inferred Mineral
Resource and the portion thereof controlled by enCore, i.e., 100% of Hosta Butte and Crownpoint Sections 19 and 29, and 60% of Crownpoint
Section 24. A discussion of individual resource areas follows. The Inferred Mineral Resource tabulation was completed at a grade cutoff
of .02 % eU<SUB>3</SUB>O<SUB>8</SUB> and a GT cutoff of 0.25 ft%. The authors expect that the majority of the Inferred Mineral Resources
could be upgraded to Indicated Mineral Resources with additional drilling.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Resource Estimation Methods</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Geological Model</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Geologic interpretation of the mineralized host
sands was used, along with the intercepts that met the minimum cutoff grade and thickness, to develop a geologic framework or model within
which to quantify the mineral resources at the Project. Each intercept was evaluated based on its geophysical log expression and location
relative to adjacent intercepts. Whenever possible, geophysical logs were used to correlate and project intercepts between drill holes.
The mineralized envelope was created by using the top and bottom of each intercept that was within the geologic host sands. The intercepts
that were used to make this envelope were then used in the resource model via inverse distance squared GT contour method.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Drill spacing within the Project is not uniform.
Drill spacing in the Crownpoint Area was completed roughly on 200-foot centers with the nominal average spacing between drill holes in
the resource areas at approximately 150 feet. Drill spacing at Hosta Butte area varies from roughly 200-foot centers to over 400- foot
centers, with the nominal average drill spacing within the mineral resource areas at approximately 250 feet. Drilling depths at Crownpoint
are typically in the range of 2,000 feet. Drilling depths at Hosta Butte is deeper at approximately 2,400 feet on average.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The current geologic and resource model reflects
4 major sand zones over the stratigraphic thickness of approximately 360 feet of the Westwater Canyon. The Westwater Canyon is roughly
divided by the CP shale with the B zone immediately above the shale and the C zone immediately below the shale. The A and D zones are
the upper and lower most sands of the Westwater Canyon, respectively. Within the Crownpoint Area all four zones are mineralized with the
B and D zones being the most prolific and the A zone being the weakest. At Hosta Butte there was not sufficient mineralization in the
A zone to support a mineral resource calculation. The D zone was the most strongly mineralized followed by the C and B zones.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Once the data was separated by zone an initial
radius influence of 100 feet was applied to each drill hole to establish an initial geologic limit to the projection of mineralization.
Refinement of the geologic limit and projection of mineralization along trend was then based on specific correlation and interpretation
of geophysical logs on a hole-by-hole basis. The 100-foot radius was determined by correlating geophysical logs across or perpendicular
to the observed mineralized trend. Mineralization is clearly anisotropic and can be projected greater distances along trend. For the classification
of Indicated Mineral Resource the projection of mineralization along trend was limited to 300 feet. For Inferred Mineral Resources the
maximum projection along trend was double to 600 feet.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 43; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->41<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>GT Contour Method</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Indicated Mineral Resource model was completed
using the inverse distance squared GT (Grade x Thickness) Contour Modeling Method for each of individual mineralized zones of the deposit.
The Contour Modeling Method, also known as the Grade x Thickness (GT) method, is a well-established approach for estimating uranium resources
and has been in use since the 1950&rsquo;s in the US. The technique is most useful in estimating tonnage and average grade of relatively
planar bodies where lateral extent of the mineralized body is much greater than its thickness, as was observed with the data at Crownpoint
and Hosta Butte.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">For tabular and roll front style deposits the
GT method provides a clear illustration of the distribution of the thickness and average grade of uranium mineralization. The GT method
is particularly applicable to the Crownpoint and Hosta Butte deposits as it can be effective in reducing the undue influence of high-grade
or thick intersections as well as the effects of widely spaced, irregularly spaced, or clustered drill holes. This method also makes it
possible for the geologist to fit the contour pattern to the geologic interpretation of the deposit.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt">For each zone within
the Crownpoint and Hosta Butte areas of the project, limits of mineralization were determined by interpretation of the drill data. Within
these limits the GT and T (Grade x Thickness and Thickness) were contoured. Although an automated contouring program was used to produce
the model surface itself, 3-dimensional (3D) limits were established where appropriate to constrain the model. For example, drill holes
with GT values several times the average were limited in their influence by manually constructing a set of breaklines in the model. The
volume of the 3D model is then calculated using CAD program software. To that volume, a bulk unit weight of 15 cubic feet per ton is applied
to calculate the pounds of eU<SUB>3</SUB>O<SUB>8</SUB>. Similarly, the tons are of mineralization are calculated using the same methodology
for constructing a 3D model of mineral Thickness (T) within the same area. Grade is then calculated by dividing GT model eU3O<SUB>8</SUB>
pounds by T model calculated mineralized tons</FONT>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The GT contour method is used as common practice
for Mineral Reserve and Mineral Resource modelling for similar sandstone-hosted uranium projects (&ldquo;Estimation of Mineral Resources
and Mineral Reserves&rdquo;, adopted by CIM November 23, 2003, p 51.). It is the opinion of the author that the GT contour method, when
properly constrained by geologic interpretation, provides an accurate estimation of contained pounds of uranium.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The electronic drill hole database consists of:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify">Crownpoint Area</TD>
</TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">o</FONT></TD><TD STYLE="text-align: justify; padding-right: 0.2pt">482 drill holes in total of which 93 did not meet minimum cutoff criteria.</TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD STYLE="text-align: justify; padding-right: 0.2pt">Hosta Butte Area</TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">o</FONT></TD><TD STYLE="text-align: justify; padding-right: 0.2pt">135 drill holes in total of which 42 did not meet minimum cutoff criteria.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 44; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->42<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The uranium quantities and grades are reported
as equivalent U<SUB>3</SUB>O<SUB>8</SUB> (eU<SUB>3</SUB>O<SUB>8</SUB>), as measured by downhole gamma logging. The industry standard protocol
for reporting uranium in sandstone hosted deposits in the US has been validated for the Project as discussed in Section 12 of the report.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The current drill hole database consists of:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD STYLE="text-align: justify">Crownpoint Area</TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 57.2pt"></TD><TD STYLE="width: 18pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">o</FONT></TD><TD STYLE="text-align: justify">482 drill holes in total of which 93 did not meet minimum cutoff criteria.</TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD STYLE="text-align: justify">Hosta Butte Area</TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 57.2pt"></TD><TD STYLE="width: 18pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">o</FONT></TD><TD STYLE="text-align: justify">135 drill holes in total of which 42 did not meet minimum cutoff criteria.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The uranium quantities and grades are reported
as equivalent U<SUB>3</SUB>O<SUB>8 </SUB>(eU<SUB>3</SUB>O<SUB>8</SUB>), as measured by downhole gamma logging. The industry standard protocol
for reporting uranium in sandstone hosted deposits in the US has been validated for the Project as discussed in Section 12</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Conclusions </I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Available data used in this report has been verified
and in the opinion of the author is reliable for the purposes of estimating mineral resources for the Project. This data supports the
mineral resource estimation and categorization for the Project including an Indicated Mineral Resource of 12.664 million tons of material
containing 29.044 million pounds of uranium at an average grade of 0.115 % eU<SUB>3</SUB>O8 at the 0.25 ft% GT Cutoff, of which, the portion
of the mineral resources controlled by enCore is approximately, 25.702 million pounds of U<SUB>3</SUB>O<SUB>8</SUB> at an average grade
of 0.117% e U<SUB>3</SUB>O<SUB>8</SUB> Indicated Mineral Resource. At a 0.1 ft% GT cutoff an Inferred Mineral Resource quantity of at
3.011 million tons of material containing 6.438 million pounds of uranium at an average grade of 0.107 % eU<SUB>3</SUB>O<SUB>8</SUB> is
estimated.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The portion of the Project with defined Indicated
Mineral Resources would support a preliminary economic assessment or preliminary feasibility study (PFS).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Crownpoint and Hosta Butte Uranium Project,
including the Crownpoint and Hosta Butte areas, is considered by the author to represent a significant uranium resource and further work
to progress the project towards mine development is warranted. Current and future long-term prices for uranium are expected to rise as
a result of supply/demand changes being observed in the uranium markets, (UxC, LLC, 2021).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The technical risks related to the project are
low as the mining and recovery methods are proven. In the opinion of the author, the Project could be developed as either ISR or conventional
underground-mine operation as the economic cutoff criteria for ISR at shallow depths, under 500 feet, similar to those for conventional
underground mines and the Crownpoint property contains existing underground infrastructure. It is the opinion of the authors that the
ISR method will be more straightforward to permit and offers a lower cost of production than a conventional underground. Thus, ISR is
the preferred scenario.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Portions of the project are within NuFuels&rsquo;
ISR area, licensed by the NRC, however, an aquifer exemption, as well as other permits, described in Section 4 would be required before
the facility could be operated. The environmental data, analysis, and environmental impact assessment completed by NuFuels would be helpful
in permitting and licensing of the Project. The NuFuels licensing effort and incumbent litigation which support the licensing sets a positive
precedent for uranium mine development in the region.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The authors are not aware of any other specific
risks or uncertainties that might significantly affect the mineral resource estimates. The authors are aware of the lengthy permitting
and licensing timelines that have affected the NewFuels Crownpoint property, and any risks to the enCore property are acknowledged by
the authors. However, the impact or mitigating efforts cannot be quantified at this time. Any estimation or reference to costs and uranium
prices within the context of this report over the potential life of mine are by its nature forward-looking and subject to various risks
and uncertainties. No forward-looking statement can be guaranteed, and actual future results may vary materially.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Contemplated Activities</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">To the authors&rsquo; knowledge, no relevant exploration
work has been conducted on the property in recent years. Previous exploration drilling is described in Section 10: Drilling, of the report.
In the Project area uranium mineralization is at depths more than 1,500 feet from the surface. The deposition of mineralization is stratigraphically
and geochemically controlled. These depositional characteristics are not easily discoverable at depth by other exploration techniques
other than drilling.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 45; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->43<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Recommendations</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The following recommendations relate to potential
improvement and/or advancement of the Crownpoint and Hosta Butte Uranium Project and fall within two categories; recommendations to potentially
enhance the resource base and recommendation to advance the Crownpoint and Hosta Butte Uranium Project towards development, which may
be conducted contemporaneously.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Recommended Program to Increase Resource Base:
</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><U>Crownpoint </U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Mineralization within the Crownpoint portion of
the Project is well defined by drilling. With drilling spacing within the Indicated Mineral Resource around 150 feet on average. For this
and other considerations discussed in this report over 90% of the mineral resources are classified as Indicated Mineral Resources. Further,
in some areas additional drilling could be recommended to possibly enhance the resource base, however, current surface conditions limit
access for drilling.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><U>Hosta Butte </U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">For the Hosta Butte portion of the Project, drilling
is sparser and as a result the mineral resources are classified as approximately 70% Indicated and 30% Inferred Mineral Resources. Referring
to the GT Contour Figures 14.10, 14.12, and 14.16 for Hosta Butte, targeted drilling in the areas where Inferred Mineral Resources have
been projected along the mineralized trend could enhance the resources base by elevating the resource category. In addition, specifically
regarding the B Zone, in the southwest portion of Section 3, T16N, R13W, drilling is sparse at around 400 feet spacing or greater, which
is greater than the width of the B Zone trend. Drilling in this area has the potential of expanding the resource along some 1,500 to 2,000
feet in this area. In addition, a minimum of two core holes are recommended to be completed in Section 3. With one targeting the B Zone
and the other the D zone. In addition to evaluating radiometric equilibrium conditions, the cores should be tested for general engineering
properties including dry density and compressive strength, porosity, permeability, and for amenability to acid and alkaline leaching.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">It is anticipated that drilling will be on the
order of $11,000 to $12,000 USD per rotary drill hole at Hosta Butte including drilling and geophysical logging costs and site supervision.
Depending on the core interval lengths, core drilling would add $2,000 to $3,000 USD per hole. General sample testing, assays, engineering,
and metallurgical studies would cost a minimum of $75,000 USD. Based on a drilling program consisting of 20 rotary and 2 core holes and
allowing a contingency for items such as site clearances and access the costs including testing would be on the order of $325,000 USD.
A scoping study to assess the data recovered under this work would assess the project economics, mine plan and regulatory approach to
advance the project, and that is estimated to cost $250,000 USD.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Also, within the Hosta Butte area, historic drilling
indicates the presence of significant uranium mineralization in both the B and D Zones within Section 11, T16N, R13W. Completion of a
detailed geologic investigation of for this area is recommended to determine potential targets for exploration. Specific drilling cannot
be recommended until this investigation is complete. The cost of this investigation would be on the order of $75,000 USD. Dependent on
positive recommendations from this review a drilling program of the nature described for Section 3 would follow in a phased approach with
an estimated cost of $350,000 USD. Finally, presuming that the drilling program(s) are successful in enhancing the mineral resources the
Technical Report would need to be updated.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt">The reader is cautioned
that additional drilling may or may not enhance and/or expand the mineral resources depending upon the results of the drilling</FONT>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 46; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->44<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Recommended Programs to Advance the Project:
</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">No current preliminary economic assessment of
the Crownpoint and Hosta Butte Uranium Project and/or feasibility study has been completed for the Crownpoint and Hosta Butte Uranium
Project. The portions of the mineral resource base classified as Indicated Mineral Resource would support a preliminary economic assessment
or preliminary feasibility study (PFS). A PFS of the project would not be dependent upon the foregoing recommendations related to the
resource base as, in the authors&rsquo; opinion the resource base as defined by the Indicated Mineral Resource is adequate to support
a PFS. For the PFS it is recommended that the Crownpoint area be evaluated in greater detail as the first area to be developed followed
by Hosta Butte. It is further recommended that work towards a preliminary feasibility study be phased beginning with a scoping study to
develop a conceptual mine plan and evaluate alternatives. These alternatives should include both ISR and conventional means of recovery.
The scoping study should also define the data necessary to support the completion of a preliminary feasibility study and the determination
of probable mineral reserves. Based on the results of the scoping study a preliminary feasibility study could then be completed. Finally,
a Technical Report would be prepared which addresses the probable mineral reserves and all other required items of Form 43-101F1, Items
15 through 22.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">A summary of recommended work and estimated costs
follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Table 1.3 &ndash; Recommendation Costs Phase 1</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="border-bottom: Black 1.5pt solid; text-decoration: underline; width: 89%; font-weight: bold; text-align: left"><FONT STYLE="text-decoration: none">Recommended
    Work Item</FONT></TD><TD STYLE="width: 1%; font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; width: 1%; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; padding-bottom: 1.5pt; width: 8%; font-weight: bold; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Estimated&nbsp;Budget</B></FONT></TD><TD STYLE="width: 1%; padding-bottom: 1.5pt; font-weight: bold; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Hosta Butte Section 3 Drilling</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="text-align: right">325,000 USD</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Hosta Butte Section 11 Geologic Investigation</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">75,000
                                            USD</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Scoping Study</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">250,000
                                            USD</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold">Total:</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>$</B></FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>650,000
                                            USD</B></FONT></TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  </TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Table 1.4 &ndash; Recommendation Costs Phase
2</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="border-bottom: Black 1.5pt solid; width: 89%; font-weight: bold; text-align: left">Recommended Work Item</TD><TD STYLE="padding-bottom: 1.5pt; width: 1%; font-weight: bold">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; width: 1%; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; padding-bottom: 1.5pt; width: 8%; font-weight: bold; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Estimated&nbsp;Budget</B></FONT></TD><TD STYLE="padding-bottom: 1.5pt; width: 1%; font-weight: bold; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Hosta Butte Section 11 Drilling</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$350,000 USD</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Data Collection and Technical Studies</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$250,000 USD</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Preliminary feasibility Study</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$450,000 USD</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Technical Report</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$100,000 USD</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold">Total:</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left"><B>$</B></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>1,150,000
                                            USD</B></FONT></TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  </TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B></B></P>

<!-- Field: Page; Sequence: 47; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->45<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><U>Dewey Burdock Project</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">For a complete description of the Dewey Burdock
Project see the Dewey Burdock Technical Report, prepared by Matthew Yovich, P.E. of Woodard &amp; Curran and Steve Cutler, P.G. of Roughstock
Mining Services, LLC, as independent qualified persons under NI 43-101 Standards.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The information contained in this section has
been derived from the Dewey Burdock Project Technical Report, is subject to certain assumptions, qualifications and procedures described
in the Dewey Burdock Project Technical Report and is qualified in its entirety by the full text of the Dewey Burdock Project Technical
Report. Reference should be made to the full text of the Dewey Burdock Project Technical Report, which is incorporated by reference herein
and is available for viewing under Azarga&rsquo;s profile on SEDAR at www.sedar.com.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>Reproduction of the Summary Contained in the Dewey Burdock Technical
Report </I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">EXECUTIVE SUMMARY</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Background</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Woodard &amp; Curran (W&amp;C) and Roughstock
Mining Services (Roughstock) were retained by Azarga Uranium Corp. (Azarga) and their wholly owned subsidiary Powertech USA Inc. (Powertech),
to prepare this independent Preliminary Economic Assessment (PEA) for the Dewey-Burdock ISR Project (Project) to be located in Custer
and Fall River Counties in South Dakota, USA. The project location is shown on Figure 1.1. This PEA has been prepared for Azarga Uranium
Corp. and Powertech USA Inc. (collectively referred to as &ldquo;Azarga&rdquo;) in accordance with the guidelines set forth under National
Instrument (NI) 43-101 and NI 43- 101F1 for the submission of technical reports on mining properties.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">A NI 43-101 Technical Report Resource Estimate,
Dewey-Burdock Uranium ISR Project, South Dakota, USA was previously prepared by Roughstock Mining Service with effective November 12,
2018 (ref., Roughstock 2018). In this PEA, the entire resource estimate for the project was again reviewed. The purpose of this PEA is
to update the mineral resource estimate and update the capital and operating cost estimates and economic analysis with the most recent
market information and to account for a revised construction and operations schedule. The new schedule is discussed in Section 16.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Dewey-Burdock Project is an advanced-stage
uranium exploration project located in South Dakota and is solely controlled by Powertech USA, Inc. The Project is located in southwest
South Dakota (Figure 1.1) and forms part of the northwestern extension of the Edgemont Uranium Mining District. The project is divided
into two Resource Areas, Dewey and Burdock, as shown in Figure 1.2.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The project is within an area of low population
density characterized by an agriculture-based economy with little other types of commercial and industrial activity. The project is expected
to bring a significant economic benefit to the local area in terms of tax revenue, new jobs, and commercial activity supporting the project.
Previously, a uranium mill was located at the town of Edgemont, and a renewal of uranium production is expected to be locally favorable
form of economic development. Regionally, there are individual and other organizations that oppose the project, though typically not in
the immediate Edgemont area.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 48; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->46<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The three most significant permits/licenses are
(1) the Source and Byproduct Materials License, which was issued by the U.S. Nuclear Regulatory Agency NRC April of 2014; (2) the Large
Scale Mine Permit (LSMP), to be issued by the South Dakota Department of Environment (DENR); and (3) UIC Class III and V permits (ISR
injection and deep disposal, respectively), which draft permits were issued from the U.S. Environmental Protection Agency Region 8 (EPA)
initially in March 2017 and reissued in August 2019. Permit requirements and status are discussed in Sections 4 and 20. Public interest
in the project has extended regulatory efforts and logistics for accommodating public involvement, but at the time of this report, the
NRC license has been issued, the State of South Dakota LSMP has been recommended for approval by DENR, and draft UIC Class III and Class
V permits have been issued by EPA.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>Figure 1.1: Project Location</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><IMG SRC="ex99-1_008.jpg" ALT=""></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Sans-Serif; font-size: 9pt; color: Red"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Sans-Serif; font-size: 9pt; color: Red"><B></B></FONT></P>

<!-- Field: Page; Sequence: 49; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->47<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Sans-Serif; font-size: 9pt; color: Red"><B></B></FONT>&nbsp;</P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Figure 1.2: Project Site Map</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>&nbsp;<IMG SRC="ex99-1_009.jpg" ALT=""></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Resources</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Cautionary statement: This Preliminary Economic
Assessment is preliminary in nature, and includes inferred mineral resources that are considered too speculative geologically to have
the economic considerations applied to them that would enable them to be categorized as mineral reserves and there is no certainty that
the preliminary economic assessment will be realized. Mineral resources that are not mineral reserves do not have demonstrated economic
viability.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As further discussed in Section 14, the deposits
within the project area contain Measured ISR resources of 5,419,779 tons at an average grade of 0.132% U<SUB>3</SUB>O<SUB>8</SUB>, Indicated
ISR resources of 1,968,443 tons at a grade of 0.072% U<SUB>3</SUB>O<SUB>8</SUB> for a total M&amp;I ISR resource of 17.12M pounds U<SUB>3</SUB>O<SUB>8</SUB>
at a 0.2 GT cutoff, and Inferred resource of 654,546 tons at a grade of 0.055% U<SUB>3</SUB>O<SUB>8</SUB> for a total of 712,624 pounds
U<SUB>3</SUB>O<SUB>8</SUB> at a 0.2 GT cutoff. See Table 1.1 for a summary of the mineral resource estimate.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As discussed in Section 13, laboratory dissolution
results ranged from 71 to 97%, indicating the deposit is amenable to ISR mining methods. In addition, recoverability for operating uranium
ISR operations has been reported as high as 85% of the estimated resources under pattern. ISR PEAs for similar projects have predicted
a range of recoverability from 67 to 80% as discussed in Section 17. The average recovery head grade assumed over the life of the Project
in this PEA is 60 parts per million (ppm), as discussed in Sections&nbsp;13 and 17.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 50; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->48<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Table 1.1: 2019 Mineral Resource Estimate Summary
(Effective date-December 3, 2019)</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">ISR Resources</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Measured</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Indicated</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">M &amp; I</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Inferred</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 52%">Pounds</TD><TD STYLE="width: 1%; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; width: 1%; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; width: 9%; text-align: right">14,285,988</TD><TD STYLE="width: 1%; padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="width: 1%; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; width: 1%; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; width: 9%; text-align: right">2,836,159</TD><TD STYLE="width: 1%; padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="width: 1%; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; width: 1%; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; width: 9%; text-align: right">17,122,147</TD><TD STYLE="width: 1%; padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="width: 1%; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; width: 1%; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; width: 9%; text-align: right">712,624</TD><TD STYLE="width: 1%; padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD>Tons</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; text-align: right">5,419,779</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; text-align: right">1,968,443</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; text-align: right">7,388,222</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; text-align: right">645,546</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Avg. GT</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; text-align: right">0.733</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; text-align: right">0.413</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; text-align: right">0.655</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; text-align: right">0.324</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Avg. Grade (% U<SUB>3</SUB>O<SUB>8</SUB>)</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; text-align: right">0.132</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">%</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; text-align: right">0.072</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">%</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; text-align: right">0.116</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">%</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; text-align: right">0.055</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">%</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Avg. Thickness (ft)</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; text-align: right">5.56</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; text-align: right">5.74</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; text-align: right">5.65</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; text-align: right">5.87</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  </TABLE>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Note: Resource pounds and grades of U<SUB>3</SUB>O<SUB>8</SUB>
were calculated by individual grade-thickness contours. Tonnages were estimated using average thickness of resource zones multiplied by
the total area of those zones.</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Cautionary Statement: This Preliminary Economic
Assessment is preliminary in nature, and includes inferred mineral resources that are considered too speculative geologically to have
the economic considerations applied to them that would enable them to be categorized as mineral reserves and there is no certainty that
the preliminary economic assessment will be realized. Mineral resources that are not mineral reserves do not have demonstrated economic
viability.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">For the purpose of this PEA, it is the Qualified
Person, Matthew Yovich&rsquo;s opinion that Azarga&rsquo;s assumed uranium recovery of 80% of the estimated resource is a reasonable estimate.
Therefore, the overall potential yellowcake production is estimated to be 14.3 million pounds, as shown in Table 1.2 below. The recovery
value of 80% is an estimate based on industry experience and Azarga personnel experience at the Smith Ranch Uranium ISR mine located in
Wyoming. See Section 17 for additional discussion relative to the basis for the recovery value used in the PEA.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">It is also projected that 100% of the resource
will be placed under a mining pattern. This may require license/permit amendments where these resources extend beyond the current permit
boundary. In addition, the resource recovery assumes an average 0.5% recovery will be realized during restoration which is included in
the total estimated recovery of 80% of the mineral resource not including any plant losses.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Table 1.2: 2019 Estimated Recovery of Mineral
Resource (Effective date &ndash; December 3, 2019)</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Estimated <BR> Measured <BR> Resources</TD><TD STYLE="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Estimated <BR> Indicated <BR> Resources</TD><TD STYLE="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Estimated M &amp; I <BR> Resources</TD><TD STYLE="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Estimated <BR> Inferred <BR> Resources</TD><TD STYLE="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 52%">Pounds</TD><TD STYLE="width: 1%; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; width: 1%; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; width: 9%; text-align: right">14,285,988</TD><TD STYLE="width: 1%; padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="width: 1%; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; width: 1%; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; width: 9%; text-align: right">2,836,159</TD><TD STYLE="width: 1%; padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="width: 1%; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; width: 1%; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; width: 9%; text-align: right">17,122,147</TD><TD STYLE="width: 1%; padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="width: 1%; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; width: 1%; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; width: 9%; text-align: right">712,624</TD><TD STYLE="width: 1%; padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Estimated Recoverability</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; text-align: right">80</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">%</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; text-align: right">80</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">%</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; text-align: right">80</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">%</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; text-align: right">80</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">%</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Estimated Total Recovery</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; text-align: right">11,428,790</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; text-align: right">2,268,927</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; text-align: right">13,697,717</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; text-align: right">570,099</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  </TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>This Preliminary Economic Assessment is
preliminary in nature, and includes inferred mineral resources that are considered too speculative geologically to have the economic considerations
applied to them that would enable them to be categorized as mineral reserves. The estimated mineral recovery used in this Preliminary
Economic Assessment is based on site-specific laboratory recovery data as well as Azarga personnel and industry experience at similar
facilities. There can be no assurance that recovery at this level will be achieved.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Dewey-Burdock uranium mineralization is comprised
of &ldquo;roll-front&rdquo; type uranium mineralization hosted in several sandstone stratigraphic horizons that are hydrogeologically
isolated and therefore amenable to ISR technology. Uranium deposits in the Dewey-Burdock Project are sandstone, roll-front type. This
type of deposit is usually &ldquo;C&rdquo;-shaped in cross section, with the down gradient center of the &ldquo;C&rdquo; having the greatest
thickness and highest tenor. These &ldquo;roll fronts&rdquo; are typically a few tens of feet wide and often can be thousands of feet
long. Uranium minerals are deposited at the interface of oxidizing solutions and reducing solutions. As the uranium minerals precipitate,
they coat sand grains and partially fill the interstices between grains. Thickness of the deposits is generally a factor of the thickness
of the sandstone host unit. Mineralization may be 5 to 12 ft thick within the roll front while being 1 to 2 ft thick in the trailing tail
portions. Deposit configuration determines the geometry of the well field and is a major economic factor in ISR mining.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 51; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->49<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Dewey-Burdock mineralization is located at
depths of 184 to 927 ft below surface at Dewey and surface to 782 ft below surface at Burdock, as several stacked horizons, which are
sinuous and narrow but extend over several miles along trend of mineralization. The deposits are planned for ISR mining by development
of individual well fields for each mineralized horizon. A well field will be developed as a series of injection and recovery wells, with
a pattern to fit the mineralized horizon, typically a five spot well pattern on 50 to 150 ft drillhole spacing.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Historic exploration drilling for the project
area was extensive and is discussed in Section 6. In 2007 and 2008, Azarga conducted confirmatory exploration drilling of 91 holes including
20 monitoring wells. In addition, Azarga installed water wells for water quality testing and for hydro-stratigraphic unit testing. This
work confirmed and replicated the historic drill data and provided some in-fill definition of uranium roll fronts. In addition, the hydrogeologic
investigations defined the pre-mining water quality and determined the capacity for the uranium-bearing hydro-stratigraphic units to allow
for circulation of ISR recovery fluid, and confinement of the fluids to the hydro-stratigraphic unit.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Project</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Burdock Resource Area consists of 19 well
fields where mineral extraction will occur. The central processing plant (CPP) facility for the Project will be located at the Burdock
Resource Area along with five ponds as shown in Figure 1.2. A satellite facility will be constructed in the Dewey Resource Area. The Dewey
Resource Area consists of 32 well fields where mineral extraction will occur. A discussion of the materials required for the well field
and for the plants is provided in Sections 16 and 17, respectively.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As discussed in Section 18, the Project area is
well supported by nearby towns and services. Major power lines are located near the Project and can be accessed and upgraded for electrical
service for the mining operation. A major rail line (Burlington Northern-Santa Fe) cuts diagonally across the project area. A major railroad
siding is located at Edgemont and can be used for shipment of materials and equipment for development of the producing facilities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Project is proposed to be developed with a
gradual phased approach. The Burdock CPP Facility will be constructed to initially accept a flow rate of up to 1,000 gallons per minute
(gpm) lixiviant. Capacity will be gradually expanded to accept a flow rate of 4,000 gpm of lixiviant. Resin will be transferred from IX
vessels to resin trailers to be transported and processed at an off-site processing facility for the first few years. Once the flow rate
capacity reaches 4,000 gpm, the Burdock CPP Facility will be expanded to include processing capabilities for up to 1.0-mlbs-pa of U<SUB>3</SUB>O<SUB>8</SUB>.
Once the Burdock Resource Area has been economically depleted, the IX vessels will be removed from the CPP Facility and transported to
Dewey, where a satellite facility will be constructed to mine the Dewey Resource Area. The proposed phases are as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Phase I &ndash; Construction of two
header houses and the Burdock CPP Facility with one IX train (estimated 1,000 gpm average flow rate, 1,100 gpm maximum flow capacity)
and capability to transfer resin to a transport vehicle for off-site toll processing.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Phase II &ndash; Construction of an
additional two header houses and expansion of the Burdock CPP Facility to two IX trains (estimated 2,000 gpm average flow rate, 2,200
gpm maximum flow capacity).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Phase III &ndash; Construction and operation
of sufficient header houses to support expansion of the Burdock CPP Facility to four IX trains (estimated 4,000 gpm average flow rate,
4,400 gpm maximum flow capacity)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Phase IV &ndash; Construction and operation
of sufficient header houses to support expansion of Burdock CPP Facility to maintain four IX trains (estimated 4,000 gpm average flow
rate, 4,400 gpm maximum flow capacity) and on-site uranium processing capabilities up to approximately one million pounds per year.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Phase V &ndash; Construction of the
Dewey Satellite Facility and transfer of IX vessels from the Burdock CPP Facility to the Dewey Facility.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 52; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->50<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Figure 1.3 provides the operating and production
schedule for the Project as currently defined. Production will generally occur at each well field consecutively and the Project production
will occur over a period of approximately 16 years. Groundwater restoration and decommissioning (including site reclamation) will also
be implemented concurrently with production and will continue approximately four years beyond the production period. The overall mine
life is approximately 21 years from initiation of construction activities to completion of groundwater restoration and decommissioning.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Figure 1.3: Life of Mine Schedule</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>&nbsp;<IMG SRC="ex99-1_010.jpg" ALT=""></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Economic Analysis</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Cautionary statement: This </I>Preliminary
Economic Assessment <I>is preliminary in nature, and includes inferred mineral resources that are considered too speculative geologically
to have the economic considerations applied to them that would enable them to be categorized as mineral reserves, and there is no certainty
that the preliminary economic assessment will be realized. Mineral resources that are not mineral reserves do not have demonstrated economic
viability.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The economic analyses presented herein provide
the results of the analyses for pre-U.S. federal income tax and estimated post U.S. federal income tax. The only difference between the
two scenarios is the value of the estimated U.S. federal income tax. All other sales, property, use, severance and conservations taxes
as well as royalties are included in both scenarios. Both economic analyses presented herein assume no escalation, no debt, no debt interest
and no capital repayment. There is no State of South Dakota corporate income tax.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As described in Section 21 and summarized in Table
1.3, the estimated initial capital costs for the first two years of the Project life (Years -1 and 1) are approximately $31.7 million
with sustaining capital costs of approximately $157.7 million spread over the next 17 years (Years 2 through 18) of operation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Direct cash operating costs are approximately
$10.46 per pound of U<SUB>3</SUB>O<SUB>8</SUB> produced excluding royalties and severance and conservation taxes. U.S. federal income
tax is estimated to be $3.39 per pound. The total capital and operating costs average approximately $28.88 per pound (pre-U.S. federal
income tax) and $32.27 per pound (post-U.S. federal income tax) U<SUB>3</SUB>O<SUB>8</SUB> produced. Both the capital and operating costs
are current as of the end of 2019. The predicted level of accuracy of the cost estimate is +/- 25%.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 53; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->51<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 6pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">An average uranium price of $55 per pound of U<SUB>3</SUB>O<SUB>8</SUB>
based on an average of recent market forecasts by various professional entities was determined to be an acceptable price for the PEA,
see Table 19.1. Azarga has no contracts in place for sale of product from the project. Contracts for yellowcake transportation, handling
and sales will be developed prior to commencement of commercial production.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 6pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The estimated payback is in Quarter 4 of Year
2 with the commencement of design/procurement activities in Quarter 2 of Year -1 and construction beginning Quarter 4 of Year -1. The
Project is estimated to generate net earnings over the life of the project of $372.7 million (pre-U.S. federal income tax) and $324.4
million (post U.S. federal income tax). It is estimated that the project has an internal rate of return (IRR) of 55% and a NPV of $171.3
million (pre-U.S. federal income tax) and an IRR of 50% and a NPV of $147.5 million (post-U.S. federal income tax) applying an 8% discount
rate, see Table 1.3 below.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 6pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Table 1.3: Summary of Economics</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 6pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <TR STYLE="vertical-align: bottom">
    <TD COLSPAN="13" STYLE="border-top: Black 1.5pt solid; border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><B>Summary of Economics<SUP>1</SUP></B></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Pre-U.S. Federal<BR>
 income<BR>
 tax at $55/lb</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Post-U.S. Federal <BR> income <BR>
tax at $55/lb</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Units</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 46%; text-align: justify">Initial CAPEX</TD><TD STYLE="width: 1%; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; width: 1%; text-align: left">$</TD><TD STYLE="padding-bottom: 1.5pt; width: 15%; text-align: right">31,672</TD><TD STYLE="width: 1%; padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="width: 1%; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; width: 1%; text-align: left">$</TD><TD STYLE="padding-bottom: 1.5pt; width: 15%; text-align: right">31,672</TD><TD STYLE="width: 1%; padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="width: 1%; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; width: 1%; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; width: 15%; text-align: right">(US$000s)</TD><TD STYLE="width: 1%; padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify">Sustaining CAPEX</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; text-align: left">$</TD><TD STYLE="padding-bottom: 1.5pt; text-align: right">157,682</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; text-align: left">$</TD><TD STYLE="padding-bottom: 1.5pt; text-align: right">157,682</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; text-align: right">(US$000s)</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify">Direct Cash OPEX</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; text-align: left">$</TD><TD STYLE="padding-bottom: 1.5pt; text-align: right">10.46</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; text-align: left">$</TD><TD STYLE="padding-bottom: 1.5pt; text-align: right">10.46</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; text-align: right">$/lb U<SUB>3</SUB>O<SUB>8</SUB></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify">U.S. Federal Income Tax</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; text-align: left">$</TD><TD STYLE="padding-bottom: 1.5pt; text-align: right">0.00</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; text-align: left">$</TD><TD STYLE="padding-bottom: 1.5pt; text-align: right">3.39</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; text-align: right">$/lb U<SUB>3</SUB>O<SUB>8</SUB></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify">Total Cost per Pound U<SUB>3</SUB>O<SUB>8</SUB></TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; text-align: left">$</TD><TD STYLE="padding-bottom: 1.5pt; text-align: right">28.88</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; text-align: left">$</TD><TD STYLE="padding-bottom: 1.5pt; text-align: right">32.27</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; text-align: right">$/lb U<SUB>3</SUB>O<SUB>8</SUB></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify">Estimated U<SUB>3</SUB>O<SUB>8</SUB> Production</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; text-align: right">14,268</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; text-align: right">14,268</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; text-align: right">Mlb U<SUB>3</SUB>O<SUB>8</SUB></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify">Net Earnings</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; text-align: left">$</TD><TD STYLE="padding-bottom: 1.5pt; text-align: right">372,738</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; text-align: left">$</TD><TD STYLE="padding-bottom: 1.5pt; text-align: right">324,352</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; text-align: right">(US$000s)</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify">IRR8%</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; text-align: right">55</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">%</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; text-align: right">50</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">%</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; text-align: right">-</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify">NPV8%</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; text-align: left">$</TD><TD STYLE="padding-bottom: 1.5pt; text-align: right">171,251</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; text-align: left">$</TD><TD STYLE="padding-bottom: 1.5pt; text-align: right">147,485</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; text-align: right">(US$000s)</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify">Sensitivity to price is provided in Section 22.4</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  </TABLE>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 6pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><SUP>1</SUP> Cautionary statement: This Preliminary
Economic Assessment is preliminary in nature, and includes inferred mineral resources that are considered too speculative geologically
to have the economic considerations applied to them that would enable them to be categorized as mineral reserves and there is no certainty
that the preliminary economic assessment will be realized. Mineral resources that are not mineral reserves do not have demonstrated economic
viability.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 6pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">It should be noted that the favorable economic
indicators presented above are due to a combination of the following:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 6pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">1. Investment costs were incurred prior
to this PEA for Project exploration and permitting,</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 6pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">2. The Project will be implemented in phases
starting as an IX facility rather than a full processing plant along with initial development of high grade, consolidated well
fields (defers significant capital costs),</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 6pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">3. Contractors will be utilized for all
plant and well field construction to reduce labor costs associated with phased project development, and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 6pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">4. Favorable head grade and recovery rate
are anticipated.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 6pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">A summary of the Project economics for pre- and post- U.S. federal
income tax is presented below.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 6pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Table 1.4: Cash Flow Summary</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 6pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold">Cash Flow Line Items</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Units</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Total or <BR> Average</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">$ per <BR> Pound</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 64%; text-align: justify">Uranium Production as U<SUB>3</SUB>O<SUB>8</SUB></TD><TD STYLE="width: 1%; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="width: 11%; text-align: center; padding-bottom: 1.5pt; padding-left: 5.4pt">Lbs 000s</TD><TD STYLE="width: 1%; font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; width: 1%; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; width: 9%; font-weight: bold; text-align: right">14,268</TD><TD STYLE="width: 1%; padding-bottom: 1.5pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="width: 1%; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; width: 1%; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; width: 9%; text-align: right">-</TD><TD STYLE="width: 1%; padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify">Uranium Price per U<SUB>3</SUB>O<SUB>8</SUB></TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="text-align: center; padding-bottom: 1.5pt; padding-left: 5.4pt">US$/lb</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; font-weight: bold; text-align: left">$</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold; text-align: right">55.00</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; text-align: right">-</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; text-align: justify">Uranium Gross Revenue</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="font-weight: bold; text-align: center; padding-bottom: 1.5pt; padding-left: 5.4pt">US$000s</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; font-weight: bold; text-align: left">$</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold; text-align: right">784,740</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold; text-align: right">-</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 0.125in; text-align: justify">Less: Surface &amp; Mineral Royalties</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="text-align: center; padding-bottom: 1.5pt; padding-left: 5.4pt">US$000s</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; font-weight: bold; text-align: left">$</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold; text-align: right">38,060</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; text-align: left">$</TD><TD STYLE="padding-bottom: 1.5pt; text-align: right">2.67</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; text-align: justify">Taxable Revenue</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="font-weight: bold; text-align: center; padding-bottom: 1.5pt; padding-left: 5.4pt">US$000s</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; font-weight: bold; text-align: left">$</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold; text-align: right">746,680</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold; text-align: right">-</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 0.125in; text-align: justify">Less: Severance &amp; Conservation Tax</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="text-align: center; padding-bottom: 1.5pt; padding-left: 5.4pt">US$000s</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; font-weight: bold; text-align: left">$</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold; text-align: right">35,393</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; text-align: left">$</TD><TD STYLE="padding-bottom: 1.5pt; text-align: right">2.48</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 0.125in; text-align: justify">Less: Property Tax</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="text-align: center; padding-bottom: 1.5pt; padding-left: 5.4pt">US$000s</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; font-weight: bold; text-align: left">$</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold; text-align: right">7,201</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; text-align: left">$</TD><TD STYLE="padding-bottom: 1.5pt; text-align: right">0.50</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; text-align: justify">Net Gross Sales</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="font-weight: bold; text-align: center; padding-bottom: 1.5pt; padding-left: 5.4pt">US$000s</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; font-weight: bold; text-align: left">$</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold; text-align: right">704,086</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold; text-align: right">-</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 0.125in; text-align: justify">Less: Plant &amp; Well Field Operating Costs</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="text-align: center; padding-bottom: 1.5pt; padding-left: 5.4pt">US$000s</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; font-weight: bold; text-align: left">$</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold; text-align: right">108,084</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; text-align: left">$</TD><TD STYLE="padding-bottom: 1.5pt; text-align: right">7.58</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 0.125in; text-align: justify">Less: Product Transaction Costs</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="text-align: center; padding-bottom: 1.5pt; padding-left: 5.4pt">US$000s</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; font-weight: bold; text-align: left">$</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold; text-align: right">11,889</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; text-align: left">$</TD><TD STYLE="padding-bottom: 1.5pt; text-align: right">0.83</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 0.125in; text-align: justify">Less: Administrative Support Costs</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="text-align: center; padding-bottom: 1.5pt; padding-left: 5.4pt">US$000s</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; font-weight: bold; text-align: left">$</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold; text-align: right">5,362</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; text-align: left">$</TD><TD STYLE="padding-bottom: 1.5pt; text-align: right">0.38</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 0.125in; text-align: justify">Less: D&amp;D and Restoration Costs</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="text-align: center; padding-bottom: 1.5pt; padding-left: 5.4pt">US$000s</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; font-weight: bold; text-align: left">$</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold; text-align: right">16,659</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; text-align: left">$</TD><TD STYLE="padding-bottom: 1.5pt; text-align: right">1.17</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; text-align: justify">Net Operating Cash Flow</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="font-weight: bold; text-align: center; padding-bottom: 1.5pt; padding-left: 5.4pt">US$000s</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; font-weight: bold; text-align: left">$</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold; text-align: right">562,093</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold; text-align: right">-</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 0.125in; text-align: justify">Less: Pre-Construction Capital Costs</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="text-align: center; padding-bottom: 1.5pt; padding-left: 5.4pt">US$000s</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; font-weight: bold; text-align: left">$</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold; text-align: right">1,025</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; text-align: left">$</TD><TD STYLE="padding-bottom: 1.5pt; text-align: right">0.07</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 0.125in; text-align: justify">Less: Plant Development Costs</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="text-align: center; padding-bottom: 1.5pt; padding-left: 5.4pt">US$000s</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; font-weight: bold; text-align: left">$</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold; text-align: right">52,140</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; text-align: left">$</TD><TD STYLE="padding-bottom: 1.5pt; text-align: right">3.65</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 0.125in; text-align: justify">Less: Well Feld Development Costs</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="text-align: center; padding-bottom: 1.5pt; padding-left: 5.4pt">US$000s</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; font-weight: bold; text-align: left">$</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold; text-align: right">136,190</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; text-align: left">$</TD><TD STYLE="padding-bottom: 1.5pt; text-align: right">9.55</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; text-align: justify">Net Before-Tax Cash Flow</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="font-weight: bold; text-align: center; padding-bottom: 1.5pt; padding-left: 5.4pt">US$000s</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; font-weight: bold; text-align: left">$</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold; text-align: right">372,738</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold; text-align: right">-</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 0.125in; text-align: justify">Less: Federal Tax</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="text-align: center; padding-bottom: 1.5pt; padding-left: 5.4pt">US$000s</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; font-weight: bold; text-align: left">$</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold; text-align: right">48,386</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; text-align: left">$</TD><TD STYLE="padding-bottom: 1.5pt; text-align: right">3.39</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; text-align: justify">After Tax Cash Flow</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="font-weight: bold; text-align: center; padding-bottom: 1.5pt; padding-left: 5.4pt">US$000s</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; font-weight: bold; text-align: left">$</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold; text-align: right">324,352</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold; text-align: right">-</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&nbsp;</TD></TR>
  </TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 6pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 54; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->52<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The sensitivity to changes in capital and operating
costs and the price of uranium, have been calculated from the pre-U.S. federal income tax cash flow statements and are presented below
in Figures 1.4, 1.5 and 1.6. The sensitivity to changes in head grade and uranium recovery are also discussed below. <B>Post-U.S. federal
income tax sensitivities are discussed in Section 22.4.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Project pre-U.S. federal income tax NPV is
also slightly sensitive to changes in either capital or operating costs as shown on Figure 1.4. A 5% variation in operating cost results
in a $3.59 million variation in NPV and an impact to the IRR of approximately 1.06%. A 5% variation in capital cost results in a $5.70
million variation to the NPV and an impact to the IRR of approximately 3.45%.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Figure 1.4: Life of Mine Schedule</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B><IMG SRC="ex99-1_011.jpg" ALT=""></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Note: Based on sales price of $55.00 per pound
and 8% discount rate.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Figure 1.5: IRR v. OPEX &amp; CAPEX (Pre-U.S.
Federal Income Tax)</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><IMG SRC="ex99-1_012.jpg" ALT=""></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Note: Based on sales price of $55.00 per pound
and 8% discount rate.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Project economics are most sensitive to changes
in the price of uranium, recovery and head grade. A one-dollar change in the price of uranium can have an impact to the NPV of approximately
$7.23 million and an impact to the IRR of approximately 1.82%. See Figure 1.6.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Page; Sequence: 55; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->53<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Figure 1.6: NPV &amp; IRR v. Uranium Sales Price
(Pre-U.S. Federal Income Tax)</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B><IMG SRC="ex99-1_013.jpg" ALT=""></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>It should be noted that the economic results
presented herein are very sensitive to head grade and recovery. Significant variations in the assumptions for head grade and recovery
can have significant impacts to the economic results presented. However, there are too many variables associated with estimating the potential
impact of head grade and recovery to the economics presented herein to develop a meaningful sensitivity analysis. The operational variables
that influence head grade and recovery will be managed during operations to the extent practicable to minimize potential impacts.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The above analyses are based on an 8% discount
rate and a constant price of $55.00 per pound of U<SUB>3</SUB>O<SUB>8</SUB>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Risks</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Project is located in a region where ISR projects
have been and are operated successfully. The ISR mining method has been proven effective in geologic formations near the Project in Wyoming
and Nebraska as described herein. Six Wyoming ISR facilities are currently in operational (Smith Ranch, North Butte, Willow Creek, Lost
Creek, Ross and Nichols Ranch) and one operational facility in Nebraska (Crow Butte). Some of these projects, though operational, are
currently on a care and maintenance program.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As with any pre-development mining property, there
are risks and opportunity attached to the project that need further assessment as the project moves forward. The authors deem those risks,
on the whole, as identifiable and manageable. Some of the risks are summarized below and are discussed in detail in Section&nbsp;25.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -0.25in">Risk associated
with uranium recovery and processing,</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: 0.55pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: 0.55pt">Risk associated
with spills associated with transportation of loaded resin and packaged yellowcake uranium,</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -0.25in">Risk associated
with contracting an off-site toll milling facility,</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -0.25in">Risk associated
with delays in permitting,</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: 0.55pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: 0.55pt">Risk associated
with social and/or political issues, and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -0.25in">Risk associated
with the uranium market and sales contracts.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 56; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->54<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Recommendations</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Authors find that the development of the Project
is potentially viable based on the assumptions contained herein. There is no certainty that the mineral recovery or the economics presented
in this PEA will be realized. In order to realize the full potential benefits described in this PEA, the following activities are required,
at a minimum.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify">Complete all activities required to
obtain all necessary licenses and permits required to operate an in-situ uranium mine in the State of South Dakota. Approximate cost $400,000.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify">Obtain agreement with remote processing
facility to process loaded resin prior to completion of the Project CPP. Minimal cost.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify">Complete additional metallurgical
testing to further verify and confirm the head grade and overall resource recovery used in this analysis prior to advancing the Project.
Approximate cost $250,000.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify">Additional Permit / License amendments
and approvals necessary to realize all resources included in this PEA. Approximate potential cost up to $500,000.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify">Cost benefit analysis to determine
best available process to handle vanadium should levels be significant. Approximate cost $75,000.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify">Finalize facility and well field engineering
designs, including construction drawings and specifications. Approximate cost $950,000.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify">Identify procurement process for long
lead items and perform cost benefit analysis for any alternative equipment or materials. Cost included in design phase above.<B>&rdquo;</B></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><U>Gas Hills Project</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">For a complete description of the Gas Hills Project
see the Gas Hills Technical Report prepared by Ray Moores, P.E. of Western Water Consultants Inc. and Steve Cutler, P.G. of Roughstock
Mining Services, LLC as independent qualified persons under NI 43-101 Standards.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The information contained in this section has
been derived from the Gas Hills Technical Report, is subject to certain assumptions, qualifications and procedures described in the Gas
Hills Technical Report and is qualified in its entirety by the full text of the Gas Hills Technical Report. Reference should be made to
the full text of the Gas Hills Technical Report, which is incorporated by reference herein and is available for viewing under Azarga&rsquo;s
profile on SEDAR at www.sedar.com.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>Reproduction of the Summary Contained in the Gas Hills Technical
Report </I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>EXECUTIVE SUMMARY</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Background</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">This report titled &ldquo;NI 43-101 TECHNICAL
REPORT, PRELIMINARY ECONOMIC ASSESSMENT, GAS HILLS URANIUM PROJECT, FREMONT AND NATRONA COUNTIES, WYOMING, USA&rdquo; (the &ldquo;Report&rdquo;)
was prepared in accordance with National Instrument 43-101, Standards of Disclosure for Mineral Projects (&ldquo;NI 43-101 Standards&rdquo;).
The Mineral Resources are in accordance with Canadian Institute of Mining, Metallurgy, and Petroleum Definition Standards Mineral Resources
and Mineral Reserves, May 10, 2014 (&ldquo;CIM Definition Standards&rdquo;). The effective date of this report is June 28, 2021.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Gas Hills uranium project (the &ldquo;Project&rdquo;)
is owned by Ucolo Exploration Corp. (&ldquo;Ucolo&rdquo;), a Utah corporation, and a wholly owned subsidiary of URZ Energy Corp. (&ldquo;URZ&rdquo;).
URZ is a wholly owned subsidiary of Azarga Uranium Corp. (&ldquo;Azarga&rdquo;). Surface land ownership at the Project is managed by the
U.S. Bureau of Land Management (BLM) and the minority of the land is privately owned.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 57; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->55<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">A NI 43-101 Technical Report Resource Report,
Gas Hills Uranium Project, Fremont and Natrona Counties, Wyoming, USA was previously prepared by Roughstock Mining Services (Roughstock)
with an effective date of March 29, 2021 (Roughstock 2021). Roughstock and WWC Engineering (WWC) were retained by Azarga to prepare this
independent Preliminary Economic Assessment (PEA) for the in-situ recovery (ISR) amenable resources of the Project. The purpose of this
PEA is to provide a mineral resource estimate and capital (CAPEX) and operating (OPEX) cost estimates and economic analysis with the most
recent market information. This report is authored by Steve Cutler, P.G. of Roughstock and Ray Moores, P.E. of WWC (The Authors) as independent
qualified persons under NI 43-101 Standards.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Between 1953 and 1988 many companies explored,
developed, and produced uranium in the Gas Hills, including on lands now controlled by Azarga. Three uranium mills operated in the district
and two others nearby were also fed by ore mined from Gas Hills. Cumulative production from the Gas Hills is in excess of 100 million
pounds of uranium, mainly from open-pit mining, but also from underground mining and ISR. (Beahm, 2017)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Available data utilized in this Report includes
pre-2007 exploration and production on Azarga&rsquo;s Gas Hills Uranium Project, and drilling completed by a previous owner, Strathmore
Minerals Corporation, from 2007 to June 2013. In August 2013, Strathmore Minerals Corporation was acquired by Energy Fuels, who subsequently
sold the Project to URZ in October 2016. Azarga acquired the Project when it merged with URZ in July 2018.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Data sources for the estimation of uranium mineral
resources for the Project include radiometric equivalent data (eU<SUB>3</SUB>O<SUB>8</SUB>) for 4,569 drill holes, and eU<SUB>3</SUB>O<SUB>8</SUB>
and Prompt Fission Neutron (&ldquo;PFN&rdquo;) logging data for 272 drill holes. The intent of recent drilling between 2007 and 2013 included
verification of earlier data for drill holes and exploration.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Metallurgical studies were completed on recovered
materials including bulk samples from reverse circulation drilling and cored sections. Bottle roll and column leach tests indicate uranium
recoveries of ~90 percent and sulfuric acid consumption of ~55 pounds per ton treated, which is consistent with past mining results.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Mineral Resources</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The mineral resource estimation method utilized
in this Report is the Grade Thickness (&ldquo;GT&rdquo;) contour method. This method is considered appropriate for this type of deposit.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Mineral resources were estimated using a cutoff
grade of 0.02% eU<SUB>3</SUB>O<SUB>8</SUB>. Estimated mineral resources are summarized in Table 1.1 using both 0.1 GT and 0.2 GT cutoffs.
The 0.1 GT base case cutoffs were selected by meeting economic criteria for both ISR and open pit/heap leach methods differentiated on
the relative location to the water table. Resources labeled &ldquo;ISR&rdquo; meet the criteria of being sufficiently below the water
table to be amenable for extraction by ISR methods and as well as also meeting other hydrogeological criteria. &ldquo;Non-ISR&rdquo; resources
include those generally above the natural water table, which would typically be mined using open pit methods.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Additionally, 0.2 GT cutoffs were included for
ISR resources for additional comparison purposes only as this is a typical uranium industry standard ISR cutoff. However, average grade
of ISR resources in this estimate at a 0.1 GT cutoff compare favorably to other ISR projects in region, met economic criteria for ISR
extraction, and thus is considered the base case for this Report.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Section 14.0 provides additional details regarding
the determination of cutoff grade, GT cutoff, and the assessment of reasonable prospects for eventual economic extraction of the mineral
resource.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Project</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Project consists of four resource areas that
contain ISR amenable resources named by Azarga as the West Unit, Central Unit, South Black Mountain, and Jeep. There is an additional
non-ISR amenable resource area at the Project named the Rock Hill Unit was as well as other shallow with resources located above the water
table that were not considered in the economic assessment portion of this PEA. For the purposes of this PEA, uranium recovery was estimated
at 6,507,000 lbs at a production rate of 1.0 million pounds U<SUB>3</SUB>O<SUB>8</SUB> per year with a long-term uranium price of USD
$55.00/lb using a low pH lixiviant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 58; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->56<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Table 1.1. Mineral Resource Summary</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD COLSPAN="21">March 29, 2021 (GT cutoff 0.10)</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid">Pounds</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid">Tons</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid">Avg. Grade</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid">Avg. Thickness</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid">Avg. GT</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 45%">Measured</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 8%; text-align: right">2,051,065</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 8%; text-align: right">993,928</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 8%; text-align: right">0.103</TD><TD STYLE="width: 1%; text-align: left">%</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 8%; text-align: right">5.35</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 8%; text-align: right">0.552</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD>Indicated</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">8,714,126</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">6,031,224</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">0.072</TD><TD STYLE="text-align: left">%</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">6.13</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">0.443</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD>Inferred</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">490,072</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">514,393</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">0.048</TD><TD STYLE="text-align: left">%</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">6.16</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">0.293</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Total M&amp;I</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">10,765,191</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">7,025,152</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">0.077</TD><TD STYLE="text-align: left">%</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">6.05</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">0.463</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  </TABLE>


<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: left">March 29, 2021, ISR Only (GT cutoff 0.10)</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: right">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: right">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: right">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: right">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: right">&nbsp;</TD><TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid">Pounds</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid">Tons</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid">Avg. Grade</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid">Avg. Thickness</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid">Avg. GT</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 45%">Measured</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 8%; text-align: right">2,051,065</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 8%; text-align: right">993,928</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 8%; text-align: right">0.103</TD><TD STYLE="width: 1%; text-align: left">%</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 8%; text-align: right">5.35</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 8%; text-align: right">0.552</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD>Indicated</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">5,654,545</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2,835,339</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">0.100</TD><TD STYLE="text-align: left">%</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">4.92</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">0.491</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD>Inferred</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">427,817</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">409,330</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">0.052</TD><TD STYLE="text-align: left">%</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">5.94</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">0.310</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Total M&amp;I</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">7,705,610</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">3,829,267</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">0.101</TD><TD STYLE="text-align: left">%</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">4.99</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">0.502</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  </TABLE>


<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: left">March 29, 2021, Non-ISR Only (GT cutoff 0.10)</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: right">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: right">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: right">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: right">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: right">&nbsp;</TD><TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid">Pounds</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid">Tons</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid">Avg. Grade</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid">Avg. Thickness</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid">Avg. GT</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 45%">Indicated</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 8%; text-align: right">3,059,581</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 8%; text-align: right">3,195,885</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 8%; text-align: right">0.048</TD><TD STYLE="width: 1%; text-align: left">%</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 8%; text-align: right">8.60</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 8%; text-align: right">0.412</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD>Inferred</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">62,256</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">105,063</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">0.030</TD><TD STYLE="text-align: left">%</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">7.01</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">0.208</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Total M&amp;I</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">3,059,581</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">3,195,885</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">0.048</TD><TD STYLE="text-align: left">%</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">8.60</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">0.412</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  </TABLE>


<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: left">March 29, 2021, ISR Only (GT cutoff 0.20)</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: right">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: right">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: right">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: right">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: right">&nbsp;</TD><TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid">Pounds</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid">Tons</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid">Avg. Grade</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid">Avg. Thickness</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid">Avg. GT</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 45%">Measured</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 8%; text-align: right">1,887,847</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 8%; text-align: right">847,570</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 8%; text-align: right">0.111</TD><TD STYLE="width: 1%; text-align: left">%</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 8%; text-align: right">5.94</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 8%; text-align: right">0.661</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD>Indicated</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">4,872,128</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2,143,763</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">0.114</TD><TD STYLE="text-align: left">%</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">5.74</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">0.653</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD>Inferred</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">290,007</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">260,544</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">0.056</TD><TD STYLE="text-align: left">%</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">8.44</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">0.470</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Total M&amp;I</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">6,759,975</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2,991,333</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">0.113</TD><TD STYLE="text-align: left">%</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">5.77</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">0.653</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  </TABLE>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>Note: Mineral resources that are not mineral reserves do not have
demonstrated economic viability.</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Labor for the Project will likely come from the
nearby population centers of Jeffery City, Casper, and Riverton, WY. The Project is accessible via gravel roads and year-round access
should not be a problem. The Project is situated near electric transmission lines and access to power is not anticipated to be a problem.
As discussed in Section 18, appropriate resources, manpower, and access are available to provide services to the Project.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The proposed wellfields consist of a combination
of 5-spot and 7-spot well patterns with an average pattern area of approximately 17,000 ft<SUP>2</SUP>. Header houses will be installed
in the wellfields and each header house will operate approximately 75 wells. A satellite ion exchange (IX) plant will be located at the
West Unit and be connected to the other resource area by high density polyethylene (HDPE) pipelines to transport the lixiviant to the
satellite plant for processing. The IX resin will be transported to Azarga&rsquo;s Dewey-Burdock Uranium Project in South Dakota for processing.
A discussion of wellfields and header houses is located in Section 16 and the discussion of the satellite plant is located in Section
17.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Production will generally occur at each resource
area consecutively and the production period will occur over a period of approximately seven years. Groundwater restoration, decommissioning,
and reclamation will be implemented at each resource area immediately following the production period. The overall life of mine is approximately
11 years from initiation of construction activities to the completion of surface reclamation. The mine schedule is discussed in Section
16.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 59; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->57<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Economic Analysis</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">This PEA indicates a pre-tax NPV of $120.9 million
at an 8 percent discount rate with an IRR of 116 percent compared to an after-tax NPV of $102.6 million at an 8 percent discount rate
with an IRR of 101 percent.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The mine plan and economic analysis are based on the following assumptions:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -0.25in">NI 43-101 compliant
estimate of Mineral Resources and a recovery factor of 80 percent,</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -0.25in">A U<SUB>3</SUB>O<SUB>8
</SUB>sales price of $55.00/lb,</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -0.25in">A mine life of
11 years,</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: 0.55pt">A pre-income
tax cost including royalties, state and local taxes, operating costs, and capital costs of $28.20/lb, and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: 0.55pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -0.25in">Initial capital
costs of $26.0 million.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Costs for the Project are based on economic analyses
for similar ISR uranium projects in the Wyoming region as well as WWC&rsquo;s in house experience with mining and construction costs.
All costs are in U.S. dollars (USD). To date, no detailed design work has been completed for the wellfields or the satellite plant. The
Authors believe that general industry costs from similar projects adequately provide a &plusmn; 30 percent cost accuracy which is in accordance
with industry standards for a PEA. As additional data are collected for the Project and the wellfield and plant designs are advanced,
estimates can be refined.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">This analysis is based on measured, indicated,
and inferred mineral resources which do not have demonstrated economic viability. Given the speculative nature of mineral resources, there
is no guarantee that any or all of the mineral resources included in this PEA will be recovered. This PEA is preliminary in nature and
there is no certainty that the Project will be realized.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Conclusions and Recommendations</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Authors conclude that the ISR amenable mineral
resources as determined by this report show sufficient economic and technical viability to move to the next stage of development. The
Authors recommend that Azarga consider initiating permitting of the Project, especially as much of the work was previously completed for
a mine application prepared for the Project in 2013 by Strathmore Minerals Corporation. The Authors&rsquo; recommendations for additional
work programs are described in Section 26.0.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Summary of Risks</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Project is located in a brownfield district
where the geology is well-known and past mining and milling have successfully been completed.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Project does have some risks similar in nature
to other mineral projects and uranium projects in particular. Some risks are summarized below and are discussed in detail in Section 25:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 53.85pt; text-align: justify; text-indent: -17.85pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: 0.55pt">Variance in the
grade and continuity of mineralization from what was interpreted by drilling and estimation techniques,</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: 0.55pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: 0.55pt">Environmental,
social and political acceptance of the Project could cause delays in conducting work or increase the costs from what is assumed,</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -0.25in">Risk associated
with delays or additional requirements for regulatory authorizations,</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -0.25in">Risk associated
with the uranium market and sales contract,</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -0.25in">Risk associated
with uranium recovery and processing,</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -0.25in">Changes in the
mining and mineral processing recovery, and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: 0.55pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: 0.55pt">Due to limited
testing and operation of ISR throughout the Project, ISR operations may not be able to be successfully implemented due to hydrogeological,
environmental, or other technical issues.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 60; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->58<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">With regard to the socio-economic and political
environment of the Gas Hills Uranium Project area, Wyoming mines have produced over 200 million pounds of uranium from both conventional
and ISR mine and mill operations. Production began in the early 1950&rsquo;s and continues to the present. The state has ranked as the
number one US producer of uranium since 1994. Wyoming is considered generally favorable to mine development and provides a well-established
environmental regulatory framework for ISR which has been conducted in the state since the 1960&rsquo;s.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">To the Authors&rsquo; knowledge there are no other
significant risks that could materially affect the PEA or interfere with the recommended work programs.<B>&rdquo;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><U>Alta Mesa Uranium Project</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">For a complete description of the Alta Mesa Uranium
Project see the Alta Mesa Technical Report prepared by Douglas Beahm, P.E. P.G., BRS Inc. as independent qualified person under NI 43-101
Standards.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">This section contains the executive summary from
the Alta Mesa Technical Report and does not purport to be a complete summary of the Project and is subject to all of the assumptions,
qualifications and procedures set out in the Alta Mesa Technical Report and is qualified in its entirety with reference to the full text
of the Alta Mesa Technical Report, which is incorporated by reference herein. All statements herein are expressly made as at the effective
date of the Alta Mesa Technical Report. All references herein to tables, figures, and sections are those as included in the Alta Mesa
Technical Report. Readers should read this summary in conjunction with the Alta Mesa Technical Report which is available electronically
under the profile of the Company at www.sedar.com.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>Reproduction of the Summary Contained in the Alta Mesa Technical
Report </I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">This Technical Report has been prepared for enCore
Energy Corp. (&ldquo;<B>enCore</B>&rdquo;) by BRS Inc. for the Alta Mesa Uranium Project (&ldquo;<B>the Project</B>&rdquo;), located in
Brooks and Jim Hogg Counties, Texas, USA and is based on and supersedes previous NI 43-101 Technical Reports by independent geologic mining
consultant Douglas Beahm, PE, Principal Engineer for BRS Engineering Inc. (BRS) on the project.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Mr. Beahm is an independent consultant and Principal
Engineer of BRS Inc. This Technical Report is prepared pursuant to the requirements of the Canadian Securities Administrators National
Instrument 43-101 &ndash;Standards of Disclosure for Mineral Projects (&ldquo;NI 43-101&rdquo;) and the Canadian Institute of Mining (CIM)
Best Practice Guidelines for the Estimation of Mineral Resources and Mineral Reserves (&ldquo;<B>CIM standards</B>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">enCore is incorporated in British Columbia, Canada.
enCore Energy US Corp., a US-based subsidiary, is a uranium development and exploration company, with projects located in Colorado, Utah,
Arizona, Wyoming, Texas and New Mexico. enCore is currently advancing its production capacity in South Texas at its Rosita Project, one
of the two licensed uranium production facilities it owns in South Texas. Additionally, through its subsidiary, Azarga Uranium Corp. it
owns a licensed in-situ uranium recovery project located in South Dakota. enCore is listed on the OTCQB (symbol ENCUF), and the TSX Venture
Exchange (symbol EU) and is subject to the disclosure requirements of NI 43-101. All costs and prices are listed in US dollars (US$).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Alta Mesa Uranium Project, (the Project) is
an in-situ recovery (ISR) mining project, and past producer consisting of two distinct properties; the Alta Mesa property, which is composed
of the Alta Mesa mine area and processing facility, South Alta Mesa (SAM) and Indigo Snake. The second property is Meste&ntilde;a Grande,
which is composed of Meste&ntilde;a Grande Goliad (MGG) Meste&ntilde;a Grande North (MGN), Meste&ntilde;a Grande Central (MGC), Meste&ntilde;a
Grande Alta Vista (MGAV), and El Sordo. The Project&rsquo;s central processing facility and mine office are located at the Alta Mesa property
approximately 11 miles west of the intersection of US 281 and Ranch Road 755, which is also 22 miles south of Falfurrias, Texas. Figure
4-1 shows the location of both properties making up the project in South Texas.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Project is located within a portion of the
private land holdings of the Jones Ranch, founded in 1897 and includes surface and mineral rights as well as oil and gas and other minerals
including uranium. Active uses of the lands in addition to uranium exploration and production activities include agricultural use (cattle),
oil and gas development, and private hunting. Previous owners include Chevron Minerals, Total Minerals, Cogema, Uranium Resources Inc.,
Meste&ntilde;a Uranium LLC (MULLC), formed by landowners, and Energy Fuels Inc,. In 2016, Energy Fuels, Inc. acquired the Project from
MULLC. In November 2022, enCore and a subsidiary of Energy Fuels Inc. executed a Membership Interest Purchase Agreement whereby enCore
agreed to acquire four limited liability companies that together hold 100% of the Project. Section 6.2 (Ownership History) discusses this
in more detail.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 61; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->59<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Project consists of Uranium Mining Leases
for uranium ISR mining (4,598 acres) and Mineral Options (195,501 acres) comprising some 200,099 total acres consisting of acreage associated
with currently approved mining permits issued by the Texas Commission on Environmental Quality (TCEQ) and 9 prospect areas as described
in Section 4.2.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Project produced approximately 4.6 million
pounds of uranium oxide between 2005 and 2013 via in-situ recovery (ISR) mining using an alkaline lixiviant and is processed at a plant
located in Alta Mesa. The facility was in production from 2005 until primary production ceased February 2013. The Project operated in
a groundwater clean-up mode until February 2015; therefore, any uranium mined since 2013 remains as in-circuit inventory. The first wellfield
(PAA-1) has completed final groundwater restoration and was approved by the Texas Commission on Environmental Quality in March 2018. All
other wellfields are being maintained by a small bleed (less than 100 gpm) for permit compliance. The bleed solutions are disposed of
in the deep disposal wells.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Mineralization within the South Texas Uranium
Province is interpreted to be dominantly roll-front type mineralization and primarily of epigenetic origin (Finch, 1996). Roll-fronts
are formed along an interface between oxidizing groundwater solutions which encounter reducing conditions within the host sandstone unit.
This boundary between oxidizing and reducing conditions is often referred to as the Reduction/Oxidation (REDOX) interface or front.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">This report provides estimates of Mineral Resources
within the Project area. Only the Alta Mesa property has had previous ISR mining. No preliminary economic assessment, pre-feasibility
study or feasibility study has been completed to NI 43-101 standards; and, no mineral reserves are stated in this report.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Exploration Target(s) have been identified within
the project areas and the range of possible quantity and grade of mineralization as discussed in Section 24 of this report.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The current Mineral Resource estimate for the
Project is summarized in Table 1-1.</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>Table 1-1 Alta Mesa and Meste&ntilde;a
Grande Mineral Resource Summary</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-weight: normal">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center">COG</TD><TD STYLE="font-weight: bold">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center">Grade</TD><TD STYLE="font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center">Contained Metal</TD><TD STYLE="font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font-weight: bold; text-align: left; border-bottom: Black 1.5pt solid">Classification</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">(G.T.)</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Area</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Tonnage</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">(% UO)</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">(lbs. UO)</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 40%; text-align: justify; padding-bottom: 1.5pt">Measured</TD><TD STYLE="width: 1%; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; width: 8%; text-align: right">0.3</TD><TD STYLE="width: 1%; padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="width: 1%; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="width: 15%; text-align: center; padding-bottom: 1.5pt">Alta Mesa</TD><TD STYLE="width: 1%; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; width: 8%; text-align: right">54,000</TD><TD STYLE="width: 1%; padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="width: 1%; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; width: 8%; text-align: right">0.152</TD><TD STYLE="width: 1%; padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="width: 1%; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; width: 8%; text-align: right">164,000</TD><TD STYLE="width: 1%; padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; text-align: justify; padding-bottom: 1.5pt">Total Measured</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">0.3</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="text-align: center; padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">54,000</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">0.152</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">164,000</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify">Indicated</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">0.3</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">Alta Mesa</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,397,000</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">0.106</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2,959,000</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify; padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">0.3</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="text-align: center; padding-bottom: 1.5pt">Meste&ntilde;a Grande</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">119,000</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">0.120</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">287,000</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; text-align: justify">Total Indicated</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; text-align: right">0.3</TD><TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; text-align: right">1,516,000</TD><TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; text-align: right">0.107</TD><TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; text-align: right">3,246,000</TD><TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; text-align: justify; padding-bottom: 1.5pt">Total Measured &amp; Indicated</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">0.3</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="text-align: center; padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">1,570,000</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">0.109</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">3,410,000</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify">Inferred</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">0.3</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">Alta Mesa</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,263,000</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">0.126</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">3,192,000</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify; padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">0.3</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="text-align: center; padding-bottom: 1.5pt">Meste&ntilde;a Grande</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">5,733,000</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">0.119</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">13,601,000</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; text-align: justify; padding-bottom: 1.5pt">Total Inferred</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">0.3</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="text-align: center; padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">6,996,000</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">0.120</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">16,793,000</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&nbsp;</TD></TR>
  </TABLE>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 15.2pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left">Notes:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 15.2pt; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">1.</FONT></TD><TD STYLE="text-align: justify">NI 43-101 and CIM definitions were followed for all Mineral Resource categories.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">2.</FONT></TD><TD STYLE="text-align: justify">Mineral Resources are estimated at a 0.3 GT (0.02% UO minimum grade)</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">3.</FONT></TD><TD STYLE="text-align: justify">Mineral Resources are estimated using a long-term Uranium price of US$70 per pound</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">4.</FONT></TD><TD STYLE="text-align: justify">Total measured Mineral Resource is that portion of the in-place or in situ Mineral Resources that is estimated
to be recoverable within existing wellfields. Wellfield recovery factors have not been applied to indicated and inferred Mineral Resources
but were considered in establishing the minimum GT cutoff with respect to reasonable prospects for future economic extraction.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">5.</FONT></TD><TD STYLE="text-align: justify">Bulk density is 0.0588 tons/ft<SUP>3</SUP> (17.0 ft<SUP>3</SUP>/ton)</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">6.</FONT></TD><TD STYLE="text-align: justify">Mineral Resources that are not mineral reserves do not have demonstrated economic viability.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">7.</FONT></TD><TD STYLE="text-align: justify">Numbers may not add due to rounding</TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 62; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->60<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Conclusions</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-weight: normal">The author considers
the data and information available for this report to be accurate and reliable for the purposes of estimating Mineral Resources for the
Project. Significant Mineral Resources remain within the Project area which may be tributary to the Alta Mesa central processing facility
which is licensed and operated continuously from 2005 until production standby in February 2013.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-weight: normal">Mineral Resources
have been estimated for both the Alta Mesa and Meste&ntilde;a Grande areas in accordance with NI 43-101 and CIM standards and definitions
and are summarized in Table 1-1 in the measured, indicated and inferred mineral resource category.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-weight: normal">The author considered
the risks to put the Alta Mesa portion of the Project into production are low since all permit for operating are in place and is tributary
to the existing Alta Mesa ISR production facility, which is licensed to operate. For each new wellfield a production area authorization
(PAA) permit will need to be obtained through the permitting process with TCEQ. The Meste&ntilde;a Grande portion of the Project, which
will operate as a satellite facility to the Alta Mesa ISR facility, will require the permitting and construction of a satellite facility
and wellfields prior to operations.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-weight: normal">The Project
does have some risks similar in nature to other mining projects and uranium mining projects specifically, including:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Future commodity demand and
pricing;</FONT></TD>
</TR><TR STYLE="vertical-align: top">
<TD STYLE="text-align: justify">&nbsp;</TD><TD STYLE="text-align: justify">&nbsp;</TD><TD STYLE="text-align: justify">&nbsp;</TD></TR>
     </TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="text-align: justify; width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: justify">&#9679;</TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Environmental and political
acceptance of the project;</FONT></TD>
</TR><TR STYLE="vertical-align: top">
<TD STYLE="text-align: justify">&nbsp;</TD><TD STYLE="text-align: justify">&nbsp;</TD><TD STYLE="text-align: justify">&nbsp;</TD></TR>
     </TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="text-align: justify; width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: justify">&#9679;</TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Variance in capital and operating
costs; and</FONT></TD>
</TR><TR STYLE="vertical-align: top">
<TD STYLE="text-align: justify">&nbsp;</TD><TD STYLE="text-align: justify">&nbsp;</TD><TD STYLE="text-align: justify">&nbsp;</TD></TR>
     </TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="text-align: justify; width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: justify">&#9679;</TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Mine and mineral processing
recovery and dilution.</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-weight: normal">There is a risk
that additional drilling may not locate additional Mineral Resources and that mineralization may not be found or may not be continuous
along the REDOX boundary and that the actual grade times thickness (GT) along the trends will fall outside the estimated range, either
higher or lower. A substantial portion of the Mineral Resource is based on wide-spaced drilling and has been classified as inferred. Inferred
Mineral Resources are too speculative to have economic considerations applied to them which would enable them to be categorized as mineral
reserves. Inferred Mineral Resources can be assessed in the context of a Technical Report which is allowed under NI 43-101 standards,
the latter as a Preliminary Economic Assessment (PEA). The tonnages, grades, and contained pounds of uranium, as stated in this report,
for exploration targets should not be construed to reflect a estimated Mineral Resource (inferred, indicated, or measured). The potential
quantities and grades for exploration targets, as stated in this report, are conceptual in nature, and there has been insufficient work
to date to define a NI 43-101 compliant resource. Furthermore, it is uncertain if additional exploration will result in any of the exploration
targets being delineated as a Mineral Resource.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-weight: normal">The author is
not aware of any environmental, permitting, legal, title, taxation, socio-economic, marketing, political, or other relevant factors which
would materially affect the Mineral Resource estimates presented in this report. To the author&rsquo;s knowledge there are no other significant
factors that may affect access, title, or the right or ability to perform work on the property provided the conditions of all mineral
leases and options, and relevant operating permits and licenses, are met. The reader is cautioned that additional drilling may or may
not result in discovery of an economic Mineral Resource on the property.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Recommendations</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-weight: normal">A phased project
approach is recommended. Phase 1 would include delineation of the PAA7 and PAA8 mineral resource areas. These areas are within the aquifer
exemption area and proximate to the Alta Mesa facility. Phase 1 would include some rehabilitation and modernization of the facility and
preparation of a Potential Economic Assessment (PEA). Phase 2 would include wellfield planning, installation of baseline monitor wells,
hydrologic studies and related activities to advance permitting of the wellfields. Phase 2 would include a Preliminary Feasibility Study
(PFS). Phase 2 would be contingent on the outcome of Phase 1 and favorable market conditions.</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 63; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->61<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Phase 1 &ndash; Delineation of the PAA7 and
PAA8 Mineral Resource Areas:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-weight: normal">Phase 1a Delineation
Drilling: PAA7 is reasonably well delineated and is permitted and has baseline monitor wells in place. Additional Forty additional exploration
drill holes are recommended. PAA8 requires an estimated 330 exploration drill holes. Drilling costs for the project have been estimated
on a per hole basis in two categories.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Exploration drilling including
all costs for site preparation, drilling, geophysical logging, drill hole abandonment and sealing, and site reclamation. Estimated cost
per each $4,800.00 USD.</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Cased exploration wells including
all costs for site preparation, drilling, geophysical logging, casing and screening, and site reclamation. Estimated cost per each $16,000.00
USD.</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-weight: normal">Phase 1b Facility
Rehab: In preparation for restarting the processing facility, rehabilitation and modernization of the facility is recommended. This work
would be necessary to fully evaluate the operational readiness of the facility and determine if any additional components would need rehabilitation
or replacement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-weight: normal">Phase 1c PEA:
Following the completion of phase 1a and 1b, it is recommended that the mineral resources within PAA7 and PAA8 will be re-evaluated, and
a PEA prepared for the project.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-weight: normal">Total costs
are estimated at $2,856,000.00 USD as summarized in Table 26.1.</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Phase 2 &ndash; Permitting and Economic Evaluation:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-weight: normal">Phase 2 is contingent
on the outcome of Phase 1 and favorable market conditions. Phase 2 includes,</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-weight: normal">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Completion of cased wells for
hydrological assessment and determination of baseline water quality for PAA8,</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Permitting and related studies
of the PAA8 wellfield,</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Completion of a PFS.</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Total costs are estimated at $1,340,000.00 as
summarized in Table 26.2</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">For further information on the Company&rsquo;s
other mineral properties, please see the Company&rsquo;s SEDAR profile at www.sedar.com.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Additional Projects</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><U>Rosita Plant</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Property Description and Location</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Rosita Project is a uranium processing plant
and associated well fields located on a 200-acre tract of land owned by enCore in north-central Duval County Texas, about 14 miles southeast
of the town of Freer and 60 miles west-northwest of the city of Corpus Christi.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Rosita property holdings consist of mineral
leases from private landowners covering approximately 2,759 gross and net acres of mineral rights. All of the leases for the Rosita area
provide for payment of sliding scale royalties based on the price of uranium, ranging from 6.25% to 18.25% of uranium sales produced from
the leased lands. Under the terms of the leases the lands can be held after the expiration of their primary term and secondary terms,
if restoration and reclamation activities remain ongoing. The leases initially had primary and secondary terms ranging from 2012 to 2016,
with provisions to extend the leases beyond the initial terms. enCore holds these leases by payment of annual property rental fees ranging
from $10 to $30 per acre.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 64; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->62<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Project Highlights:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify">Licensed ISR production facility with 800,000 pounds of U<SUB>3</SUB>O<SUB>8</SUB>&nbsp;
per year capacity</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="text-align: justify; width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: justify">&#9679;</TD><TD STYLE="text-align: justify">Designed to process feed from multiple satellite operations,
current facility refurbishment and upgrade work projected for completion by Q2 2022</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="text-align: justify; width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: justify">&#9679;</TD><TD STYLE="text-align: justify">Previous production of 2.65 million pounds of U<SUB>3</SUB>O<SUB>8</SUB>&nbsp;
from ISR methods</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="text-align: justify; width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: justify">&#9679;</TD><TD STYLE="text-align: justify">Centrally located within the South Texas Uranium Belt, which
hosts an estimated ~60 million pounds of unmined U<SUB>3</SUB>O<SUB>8</SUB></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Rosita Central Processing Facility (&ldquo;<B>CPP</B>&rdquo;)
is located in Duval County, Texas about 14 miles southeast of the town of Freer and 60 miles west-northwest of the city of Corpus Christi
on a 200-acre tract of land owned by the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Access to the Rosita project and process facility
is good, including an improved company-owned private drive that connects to a maintained county road to Texas Farm to Market Road 3196
about 1 mile northeast of the intersection of State Highway 44 and FM 3196 in Duval County. Electrical power for the Rosita project is
readily available with an industrial-scale power line extending to the Rosita CPP.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In addition to the 200-acre tract of land owned
by the Company for the Rosita CPP, additional property holdings consist of mineral leases from private landowners covering approximately
3,377 acres of mineral rights. The nearby Rosita South property consists of mineral leases from private landowners covering approximately
1,479 acres of mineral rights.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><IMG SRC="ex99-1_014.jpg" ALT="">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Property History</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Initial production of uranium utilizing the ISR
process commenced in 1990 and continued until July 1999. During that time approximately 2.64 million pounds of U<SUB>3</SUB>O<SUB>8</SUB>&nbsp;were
produced. Resin was processed at the Rosita plant, and the recovered uranium was precipitated into a slurry, which was then transported
to Kingsville Dome for final purification, drying and packaging. Production was halted in July of 1999 due to depressed uranium prices.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In the 2007-2008 period upgrades were made to
the processing equipment and additions to the facility were installed, including revisions to the elution and precipitation circuits,
and the addition of a full drying system. Additional facility refurbishment and upgrade work is underway projected for completion by Q2
2022.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 65; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->63<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Production from a new wellfield, in production
area 3, at the Rosita project began in June 2008. However, technical difficulties that raised the cost of production coupled with a sharp
decline in uranium prices led to the decision to shut-in this wellfield in October 2008, after the production of 10,200 pounds of U<SUB>3</SUB>O<SUB>8</SUB>.
URI has had no production from the Rosita project since that time.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">enCore&rsquo;s satellite well field and an ion
exchange system are in place at the Rosita project, but only operated for a short period of time in 2008. A total of 10,200 pounds of
uranium were produced between June and October 2008.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">URI&rsquo;s capital expenditures at the Rosita
Project were approximately $13,000 and $9,000 in 2013and 2012, respectively.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">It is anticipated that
future production from the centrally located Rosita CPP would be primarily sourced from multiple satellite operations. There are an estimated
47 deposits with approximately 60 million pounds U<SUB>3</SUB>O<SUB>8</SUB>&nbsp;of unmined in-situ amenable mineralization within the
South Texas Uranium Belt. The USGS also estimates that there is the potential to discover an additional 220 million pounds U<SUB>3</SUB>O<SUB>8</SUB>
(&ldquo;Assessment of Undiscovered Sandstone-Hosted Uranium Resources in the Texas Coastal Plain, 2015&rdquo;, November 2015, Susan M.
Hall and Mark J. Mihalasky, USGS, Domestic Uranium Assessment).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Geological Setting and Mineralization</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">Uranium mineralization
at the Rosita project occurs as roll-front-type deposits hosted in porous and permeable sandstones of the Goliad Formation (of Pliocene
age), at depths ranging from 125 to 350 feet below the surface. The sandstones of the Goliad Formation occur in a deltaic to marginal
marine environment of the Texas Gulf Coastal Plain which dip gently easterly into the Gulf of Mexico. Rosita&rsquo;s classic C-shaped
roll-front deposits comprise highly sinuous mineralized zones occurring at the interface of oxidized and reduced sediments located in
the easterly part of the Rosita Property shown on the map below.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Licenses and Permits</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In Texas, the Texas Commission on Environmental
Quality (&ldquo;<B>TCEQ</B>&rdquo;) regulates uranium mining and issues the necessary licenses and permits. &nbsp;A Radioactive Material
License issued by TCEQ covers the Rosita, Kingsville Dome and Vasquez projects and it is in timely renewal. Each site also has class I
non-hazardous injection permits for operation of waste disposal wells on site, which are regulated by the TCEQ as well. All permits for
the disposal wells are active. &nbsp;A renewal of a Class III Underground Injection Control Permit was issued on October 20, 2014.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Rosita Project includes four TCEQ production
area authorizations (&ldquo;<B>PAA</B>&rdquo;) that could allow for low cost and accelerated timeline to production. Production areas
1 and 2 are depleted, and groundwater restoration has been completed to regulatory standards. Production areas 3 and 4 contain uranium
reserves that have yet to be produced. Production areas 1 and 2 consist of seven wellfields whose groundwater has been restored by the
circulation and processing of approximately 1.3&nbsp;billion gallons of reverse osmosis treated water. In 2013, enCore completed the final
phase of TCEQ required stabilization in production areas 1 and 2. Wells in production areas 1 and 2 were plugged and abandoned in 2014.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">A radioactive material license and an underground
injection control permit has been issued for the Rosita Project. On August&nbsp;30, 2012, enCore filed the requisite application for
renewal of the underground injection control permit. Production could resume in areas already included in existing PAA. As new areas
are proposed for production, additional authorizations under the permit will be required.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;<IMG SRC="ex99-1_015.jpg" ALT=""></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 66; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->64<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Mineral Resources</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">On March 27, 2014, URI
reported an estimated In-Place Proven Reserve for the Rosita Project (Form 10K for December 31, 2013, US Security and Exchange Commission).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><B>Table 1 &ndash; Historical
In-Place Proven Reserve* Estimate for the Rosita Project</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><B>&nbsp;</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">Categry</TD><TD STYLE="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Tonnes</TD><TD STYLE="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><B>Grade eU<SUB>3</SUB>O<SUB>8</SUB>%</B></TD><TD STYLE="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><B>U<SUB>3</SUB>O<SUB>8</SUB>&nbsp;(lbs)</B></TD><TD STYLE="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 64%; text-align: justify">In-Place Reserves</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">370,000</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">0.082</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">614,000</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
  </TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in; text-align: left">*</TD><TD STYLE="text-align: justify">URI estimates an&nbsp;ISR factor for production, and the
In-Place Reserve estimate is based on a market price of $50.00 per pound of U<SUB>3</SUB>O<SUB>8</SUB>. This estimate was produced by
URI&rsquo;s professional engineering and geologic staff.&nbsp; URI reported the term &ldquo;In-Place Reserves&rdquo; is consistent with
similar reserve classification terminology as defined under National Instrument 43-101 &ndash; <I>Standards of Disclosure</I> (&ldquo;<B>NI
43-101</B>&rdquo;).</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">Under &ldquo;Rules and
Policies&rdquo; of NI 43-101, this mineral reserve estimate must be reported as a Historical Reserve Estimate. The reported historical
In-Place Proven Reserve for the Rosita Project is equivalent to an Indicated Resource under NI 43-101. A qualified person has not done
sufficient work for enCore to classify the historical estimate as a current mineral reserve estimate. The Company does not treat this
historical estimate as a current mineral reserve estimate, and the estimate should not be relied upon. An accompanying technical report
along with parameters and methods used to calculate the historic estimate are not available. In order to verify the historic estimate
as current mineral reserves a Qualified Person would need to complete a NI 43-101 report that includes verification of historic drilling,
the reserve estimate and preparation of at least a Preliminary Feasibility Report.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Recommendations</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Production at the Rosita Project could resume
in areas already included in existing PAA. As new areas are proposed for production, additional authorizations under the permit will be
required. At present, enCore has no plans to do additional work to advance the Rosita mineral deposit to production.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">RISK FACTORS</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The securities of the Company should be considered
a highly speculative investment and investors should carefully consider all of the information disclosed in this AIF and the Company&rsquo;s
profile on the SEDAR website at www.sedar.com prior to making an investment in our securities. In addition to the other information presented
in this AIF, the following risk factors should be given special consideration when evaluating an investment in any of our securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Prior to making an investment decision, investors
should consider the investment risks set out below and those described elsewhere in this document, which are in addition to the usual
risks associated with an investment in a business at an early stage of development.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The directors of the Company consider the risks
set out below to be the most significant to potential investors in the Company but are not all of the risks associated with an investment
in securities of the Company. If any of these risks materialize into actual events or circumstances or other possible additional risks
and uncertainties of which the Directors are currently unaware, or which they consider not to be material in relation to the Company&rsquo;s
business, actually occur, the Company&rsquo;s assets, liabilities, financial condition, results of operations (including future results
of operations), business and business prospects, are likely to be materially and adversely affected. In such circumstances, the price
of the Company&rsquo;s securities could decline, and investors may lose all or part of their investment.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Risks Related to enCore&rsquo;s Business and Operations</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>Nature of Mineral Exploration and Mining</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">enCore&rsquo;s business is subject to a number
of risks and hazards, including environmental hazards; industrial accidents; labour disputes; catastrophic accidents; fires; blockades
or other acts of social activism; changes in the regulatory environment; impact of non-compliance with laws and regulations or the implementation
of new laws and regulations; natural phenomena, such as inclement weather conditions, underground floods, earthquakes, pit wall failures,
ground movements, tailings pipeline and dam failures and cave-ins; and encountering unusual or unexpected geological conditions and technological
failure of mining methods. There is no assurance that the foregoing risks and hazards will not occur or will not result in damage to,
or destruction of, the properties and assets of enCore, personal injury or death, environmental damage, delays in or interruption of or
cessation of production from the properties or impairment of enCore&rsquo;s exploration or development activities, which could result
in unforeseen costs, monetary losses and potential legal liability and adverse governmental action, all of which could have an adverse
impact on enCore&rsquo;s future cash flows, earnings, results of operations and financial condition.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 67; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->65<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Economic extraction of minerals from uranium
deposits may not be commercially viable</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Whether a uranium deposit will be commercially
viable depends on a number of factors, including the particular attributes of a deposit, such as its size and grade; costs and efficiency
of the recovery methods than can be employed; proximity to infrastructure; financing costs; and governmental regulations, including regulations
relating to prices, taxes, royalties, infrastructure, land use, importing and exporting of commodities and environmental protection. The
effect of these factors, either alone or in combination, cannot be accurately predicted and their impact may result in enCore not being
able to economically extract minerals from any identified mineral resource.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Uncertainty of Resource Estimates</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The figures presented for mineral resources in
this AIF are only estimates. The estimating of mineral resources is a subjective process and the accuracy of mineral resource estimates
is a function of the quantity and quality of available data, the accuracy of statistical computations, and the assumptions used and judgments
made in interpreting available engineering and geological information. There is significant uncertainty in any mineral resource estimate
and the actual deposits encountered and the economic viability of a deposit may differ materially from enCore&rsquo;s estimates.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Estimated mineral resources may have to be re-estimated
based on changes in uranium prices, further exploration or development activity or actual production experience. This could materially
and adversely affect estimates of the volume or grade of mineralization, estimated recovery rates or other important factors that influence
mineral resource estimates. Mineral resources are not mineral reserves and there is no assurance that any resource estimate will ultimately
be reclassified as proven or probable reserves. Mineral resources which are not mineral reserves do not have demonstrated economic viability.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>No assurances can be given that future mineral
production estimates will be achieved</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Estimates of future production for enCore&rsquo;s
mining operations as a whole are derived from enCore&rsquo;s mining plans. These estimates are subject to change. enCore cannot give any
assurance that it will achieve its production estimates. enCore&rsquo;s failure to achieve its production estimates could have a material
and adverse effect on any or all of enCore&rsquo;s future cash flows, results of operation, financial condition and prospects. The plans
are developed based on, among other things, mining experience, reserve estimates, assumptions regarding ground conditions and physical
characteristics or ores (such as hardness and presence or absence of certain metallurgical characteristics) and estimated rates and costs
of production. Actual production may vary from estimates for a variety of reasons, including risks and hazards of the types discussed
above, and as set out below, including:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD>actual ore mined varying from estimates in grade, tonnage,
and metallurgical and other characteristics;</TD>
</TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD>mining dilution;</TD>
</TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD>pit wall failures or cave-ins;</TD>
</TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD>ventilation and adverse temperature levels underground;</TD>
</TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD>accidents;</TD>
</TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD>equipment failures;</TD>
</TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD>natural phenomena such as inclement weather conditions, floods,
blizzards, droughts, rock slides and earthquakes;</TD>
</TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD>encountering unusual or unexpected geological conditions;</TD>
</TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD>changes in power costs and potential power shortages;</TD>
</TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD>shortages of principal supplies needed for operation, including
explosives fuels, chemical reagents, water, equipment parts and lubricants;</TD>
</TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD>strikes and other actions by labour at unionized locations;
and</TD>
</TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD>regulatory restrictions imposed by government agencies.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Such occurrences could, in addition to stopping
or delaying mineral production, result in damage to mineral properties, injury or death to persons, damage to enCore&rsquo;s property
or the property of others, monetary losses and legal liabilities. These factors may also cause a mineral deposit that has been mined profitably
in the past to become unprofitable. Estimates of production from properties not yet in production or from operations that are to be expanded
are based on similar factors (including, in some instances, feasibility studies prepared by enCore&rsquo;s personnel and outside consultants)
but it is possible that actual operating costs and economic returns will differ significantly from those currently estimated. It is not
unusual in new mining operations to experience unexpected problems during the start-up phase. Delays often can occur in the commencement
of production.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I></I></P>

<!-- Field: Page; Sequence: 68; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->66<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>No assurance can be given that estimates of
commodity prices used in preliminary economic assessment will actually be realized</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The estimates of uranium prices used in Technical
Reports are based on conditions prevailing at the time of the writing of such reports. Conditions can change significantly over relatively
short periods of time and, as such, there can be no assurance that the estimates of the price of uranium used in the above-named report
will actually be realized. Changes in the uranium price could have a significant impact on the viability of enCore&rsquo;s mineral projects.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Exploration</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Exploration for uranium involves many risks and
uncertainties and success in exploration is dependent on a number of factors including the quality of management, quality and availability
of geological expertise and the availability of exploration capital. Major expenses may be required to establish reserves by drilling,
constructing mining or processing facilities at a site, developing metallurgical processes and extracting uranium from ore. enCore cannot
give any assurance that its future exploration efforts will result in any economically viable mining operations or yield reserves.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Projects may not advance or achieve production
if key permits are not obtained or retained</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The advancement of mineral properties through
exploration to commercial operation normally requires securing and maintaining key permits and/or licenses (collectively, the &ldquo;<B>permits</B>&rdquo;)
from regulatory or governmental authorities. While enCore puts its best efforts into securing the permits necessary to advance its properties
(where warranted) according to the policies and guidelines applicable to each permit, approval of permits rests solely with the governing
agency and is outside of enCore&rsquo;s control. There can be no guarantee that enCore will succeed in obtaining the permits necessary
to advance its projects, and a failure to obtain necessary permits or retain permits that have been granted may result in an inability
to realize any benefit from its exploration or development activities on its properties.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The requirements for obtaining radioactive materials
licenses (&ldquo;<B>RML</B>&rdquo;) for the Company&rsquo;s mineral properties in the United States allows for public participation. Third
parties may object to the issuance of RMLs and/or permits required by the Company, which may significantly delay the Company&rsquo;s ability
to obtain an RML and/or permit. Generally, public objections can be overcome through the procedures set forth in the applicable permitting
legislation; however, significant financial resources and managerial resources are required through this process. In addition, the various
regulatory agencies must allow and fully consider the public objections/comments according to such procedures set out in the applicable
legislation and there can be no assurance that the Company will be successful in obtaining an RML and/or permit, which could have a material
adverse effect on the viability of a project.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Finalization of the state permitting process for
the Dewey Burdock Project is subject to hearings with public participation. If the state permits are not issued in a timely manner, or
at all, it could have a material adverse impact on the Company&rsquo;s financial performance, cash flows and results of operations. In
addition, the Company will have to assess whether an impairment allowance is necessary, which, if required, could be material.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Please also refer to the &ldquo;Government Regulation&rdquo;
risk factor for specific risks identified pertaining to the Dewey Burdock Project and the Centennial Project.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Native American involvement in the permitting
process</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">None of the Company&rsquo;s mineral properties
are located within the boundaries of Native American lands or other property interests that are controlled or owned by Native Americans
under the jurisdiction of the United States Federal Government. However, under Federal legislation, &ldquo;historic cultural properties
of religious significance that can be identified are to be avoided or activities are to be mitigated such that the essential nature of
the properties is not lost to a culture. Throughout the western United States, Indian tribes have had historical relationship with properties
that are now owned by private parties, the Federal Government or State Government. In any Federal permitting action on these properties,
the agency involved is required to make an effort to communicate with Native American Tribes to determine any areas of &ldquo;Traditional
Cultural Significance&rdquo;. This process involves &ldquo;Government to Government&rdquo; discussions with the potentially affected Native
American Tribes; therefore, delays in permitting may occur through this process. In the event that &ldquo;Traditional Cultural Properties&rdquo;
are identified within a project area, the Company and the agency must determine the best method of development to ensure that disturbances
are minimized or mitigated.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 69; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->67<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Permits received are subject to expiry</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Permits granted by the jurisdictions in which
enCore operates are typically issued with an expiry date requiring enCore to undertake certain activities within a given time frame in
order for the permit to remain valid. While enCore makes every attempt to satisfy the terms and conditions of the permits it is granted,
there can be no assurance that unforeseen circumstances may prevent it from doing so, and permits received may expire.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Defects in Title</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">enCore has investigated its rights to explore
and extract minerals from all of its material properties and, to the best of its knowledge, those rights are in good standing. No assurance
can be given, however, that enCore will be able to secure the grant or the renewal of existing mineral rights and tenures on terms satisfactory
to it, or that governments in the jurisdictions in which enCore operates will not revoke or significantly alter such rights or tenures
or that such rights or tenures will not be challenged or impugned by third parties, including local governments, aboriginal peoples or
other claimants. Although enCore is not currently aware of any existing title uncertainties with respect to any of its material properties,
there is no assurance that such uncertainties will not result in future losses or additional expenditures, which could have an adverse
impact on enCore&rsquo;s future cash flows, earnings, results of operations and financial condition.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Competition for Properties and Employees</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company competes with other mining companies
and individuals for capital, mining interests on exploration properties and undeveloped lands, acquisitions of mineral resources and reserves
and other mining assets. The Company also competes with other mining companies to attract and retain key executives and employees. There
can be no assurance that the Company will continue to be able to compete successfully with its competitors in acquiring such properties
and assets or in attracting and retaining skilled and experienced employees. The mining industry has been impacted by increased worldwide
demand for critical resources such as input commodities, drilling equipment, tires and skilled labor, and these shortages have caused
unanticipated cost increases and delays in delivery times, thereby impacting operating costs, capital expenditures and production schedules.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company may be at a competitive disadvantage
due to the fact that many of the Company&rsquo;s competitors have greater financial resources to source mineral properties and attract
and retain key executives and employees. Accordingly, there can be no assurance that the Company will be able to compete successfully.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Acquisitions</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">enCore evaluates from time to time opportunities
to acquire uranium mining assets and businesses. These acquisitions may be significant in size, may change the scale of enCore&rsquo;s
business and may expose it to new geographic, political, operating, financial and geological risks. enCore&rsquo;s success in its acquisition
activities depends on its ability to identify suitable acquisition candidates, acquire them on acceptable terms and integrate their operations
successfully with those of enCore. Any acquisitions would be accompanied by risks, such as the difficulty of assimilating the operations
and personnel of any acquired companies; the potential disruption of enCore&rsquo;s ongoing business; the inability of management to maximize
the financial and strategic position of enCore through the successful incorporation of acquired assets and businesses; additional expenses
associated with amortization of acquired intangible assets; the maintenance of uniform standards, controls, procedures and policies; the
impairment of relationships with employees, customers and contractors as a result of any integration of new management personnel; dilution
of enCore&rsquo;s present shareholders or of its interest in its subsidiaries as a result of the issuance of shares to pay for acquisitions;
and the potential unknown liabilities associated with acquired assets and businesses. There can be no assurance that enCore would be successful
in overcoming these risks or any other problems encountered in connection with such acquisitions and enCore&rsquo;s pursuit of any future
acquisition may accordingly have a material adverse effect on its business, results of operations, financial condition, cash flows and
liquidity.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">There may be no right for our shareholders to
evaluate the merits or risks of any future acquisition undertaken by enCore except as required by applicable laws and regulations.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Uranium Industry Competition</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The international uranium industry is highly competitive.
enCore intends to market uranium to utilities in direct competition with supplies available from a relatively small number of mining companies,
from excess inventories, including inventories made available from the decommissioning of nuclear weapons, from reprocessed uranium and
plutonium derived from used reactor fuel and from the use of excess enrichment capacity to re-enrich depleted uranium tails. The supply
of uranium from the Russian Federation is, to some extent, impeded by a number of international trade agreements and policies. These agreements
and any future agreements, governmental policies or trade restrictions are beyond the control of enCore and may affect the supply of uranium
available to the market.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I></I></P>

<!-- Field: Page; Sequence: 70; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->68<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Competition from Other Energy Sources; Public
Acceptance of Nuclear Energy</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Nuclear energy competes with other sources of
energy, including oil, natural gas, coal and hydroelectricity. These other energy sources are to some extent interchangeable with nuclear
energy, particularly over the longer term. Sustained lower prices of oil, natural gas, coal and hydro-electricity may result in lower
demand for uranium concentrates. Furthermore, growth of the uranium and nuclear power industry will depend upon continued and increased
acceptance of nuclear technology as a means of generating electricity. Because of unique political, technological and environmental factors
that affect the nuclear industry, the industry is subject to public opinion risks which could have an adverse impact on the demand for
nuclear power and increase the regulation of the nuclear power industry. An accident at a nuclear reactor anywhere in the world could
impact the continuing acceptance of nuclear energy and the future prospects for nuclear power generation, which may have a material adverse
effect on enCore.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Volatility and Sensitivity to Uranium Prices</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">enCore&rsquo;s future revenues will be directly
related to the prices of uranium as its revenues will be derived from uranium mining. The Company&rsquo;s financial condition, results
of operations, earnings and operating cash flows will be significantly affected by the market price of uranium, which is cyclical and
subject to substantial short and long-term price fluctuations. Among other factors, uranium prices also affect the value of the Company&rsquo;s
resources, as well as the market price of the Common Shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Uranium prices are and will continue to be affected
by numerous factors beyond enCore&rsquo;s control. Such factors include, among others, the demand for nuclear power; political and economic
conditions in uranium producing and consuming countries such as Canada, the U.S., Russia and other former Soviet republics; reprocessing
of used reactor fuel and the re-enrichment of depleted uranium tails; sales of excess civilian and military inventories (including from
the dismantling of nuclear weapons) by governments and industry participants; and production levels and costs of production in countries
such as Russia and former Soviet republics, Africa and Australia; international wars or conflicts (including Russia&rsquo;s military invasion
of Ukraine); geopolitical developments (including trading and tariff arrangements, sanctions and cybersecurity attacks), terrorism, natural
disasters and public health epidemics or pandemics (including the outbreak of COVID-19 globally). The extent and duration of such events
and resulting market disruptions cannot be predicted, but could be substantial and could magnify the impact of other risks to the Company.
These and other similar events could adversely affect the United States and foreign financial markets and lead to increased market volatility.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If, after the commencement of commercial production,
the uranium price falls below the costs of production at enCore&rsquo;s mines for a sustained period, it may not be economically feasible
to continue production at such sites. This would materially and adversely affect production, profitability and enCore&rsquo;s results
of operation and financial position. A decline in the uranium price may also require enCore to write down its mineral resources, which
would have a material adverse effect on its earnings and profitability.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Hedging activities may not be successful</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">enCore does not hedge any of its future uranium
production but may engage in hedging activities in the future. Hedging activities would be intended to protect enCore from the fluctuations
of the price of uranium and to minimize the effect of declines in the uranium price on results of operations for a period of time. Although
hedging activities may protect enCore against lower uranium prices, they may also limit the price that can be realized on uranium that
is subject to forward sales and call options where the market price of uranium exceeds the uranium price in a forward sale or call option
contract.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Environment, Health and Safety</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">enCore&rsquo;s activities are subject to extensive
federal, provincial, state and local laws and regulations governing environmental protection and employee health and safety. In addition,
the uranium industry is subject not only to the worker health and safety and environmental risks associated with all mining businesses
but also to additional risks uniquely associated with uranium mining and milling. enCore is required to obtain governmental permits and
provide associated financial assurance to carry on certain activities. enCore is also subject to various reclamation and other bonding
requirements under federal, state, provincial or local air, water quality and mine reclamation rules and permits. Although enCore makes
provision for reclamation costs, there is no assurance that these provisions will be adequate to discharge its obligations for these costs.
Environmental and employee health and safety laws and regulations have tended to become more stringent over time. Any changes in such
laws or in the environmental conditions at enCore&rsquo;s properties could have a material adverse effect on enCore&rsquo;s financial
condition, cash flow or results of operations.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 71; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->69<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Failure to comply with applicable environmental
and health and safety laws can result in injunctions, damages, suspension or revocation of permits and the imposition of penalties. There
can be no assurance that enCore has been or will be at all times in complete compliance with such laws, regulations and permits, or that
the costs of complying with current and future environmental and health and safety laws and permits will not adversely affect enCore&rsquo;s
business, results of operations, financial condition or prospects.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Litigation and Other Legal Proceedings</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company is subject to litigation and other
legal proceedings arising in the normal course of business and may be involved in disputes with other parties in the future, which may
result in litigation. The causes of potential future litigation and legal proceedings cannot be known and may arise from, among other
things, business activities, environmental laws, permitting and licensing activities, volatility in stock prices or failure to comply
with disclosure obligations. The results of litigation and proceedings cannot be predicted with certainty and may include potential injunctions
pending the outcome of such litigation and proceedings. If the Company is unable to resolve these disputes favorably, it may have a material
adverse impact on the Company&rsquo;s financial performance, cash flow and results of operations. Securities class-action litigation often
has been brought against companies in periods of volatility in the market price of their securities and following major corporate transactions
or mergers and acquisitions. The Company may in the future be the target of similar litigation. Securities litigation could result in
substantial costs and damages</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">and divert management&rsquo;s attention and resources.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Government Regulation</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The current and future mining operations and exploration
and development activities of enCore, particularly uranium mining, are subject to laws and regulations governing worker health and safety,
employment standards, mine development, mine safety, exports, imports, taxes and royalties, waste disposal, toxic substances, land claims
of indigenous peoples, protection and remediation of the environment, mine decommissioning and reclamation, transportation safety and
emergency response and other matters. Each jurisdiction in which enCore has properties regulates mining activities. It is possible that
future changes in applicable laws and regulations or changes in their enforcement or regulatory interpretation could result in changes
in legal requirements or in the terms of existing permits, licenses and approvals applicable to enCore or its projects, which could have
a material and adverse impact on enCore&rsquo;s current mining operations or planned development projects.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Worldwide demand for uranium is directly tied
to the demand for electricity produced by the nuclear power industry, which is also subject to extensive government regulation and policies,
and any change in these regulations or policies may have a negative impact on enCore&rsquo;s business or financial condition.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Mineral exploration and the development of mines
and related facilities is contingent upon governmental approvals, licenses and permits which are complex and time consuming to obtain
and which, depending on the location of the project, involve multiple governmental agencies. The receipt, duration, amendment or renewal
of such approvals, licenses and permits are subject to many variables outside enCore&rsquo;s control, including potential legal challenges
from various stakeholders such as environmental groups, non- governmental organizations, aboriginal groups or other claimants. The costs
and delays associated with obtaining necessary approvals, licenses and permits and complying with these approvals, licenses and permits
and applicable laws and regulations could stop or materially delay or restrict enCore from proceeding with the development of an exploration
project or the operation or further development of a mine. Any failure to comply with applicable laws and regulations or approvals, licenses
or permits, even if inadvertent, could result in interruption or closure of exploration, development or mining operations, or material
fines, penalties or other liabilities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Where required, obtaining necessary permits to
conduct exploration or mining operations can be a complex and time consuming process and enCore cannot assure whether any necessary permits
will be obtainable on acceptable terms, in a timely manner or at all.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>Dependence on Key Personnel</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">enCore is dependent on the services of key management
personnel. The loss of any of these key personnel, if not replaced, could have a material adverse effect on enCore&rsquo;s business and
operations. enCore does not currently have key-person insurance on these individuals.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 72; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->70<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>There may be conflicts of interest</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">enCore&rsquo;s directors and officers may serve
as directors or officers of other resource companies or have significant shareholdings in other resource companies and, to the extent
that such other companies may participate in ventures in which enCore may participate, the directors of enCore may have a conflict of
interest in negotiating and concluding terms respecting the extent of such participation. In the event that such a conflict of interest
arises at a meeting of enCore&rsquo;s directors, a director who has such a conflict will abstain from voting for or against the approval
of such participation or such terms in accordance with the BCBCA. From time to time several companies may participate in the acquisition,
exploration and development of natural resource properties thereby allowing for their participation in larger programs, permitting involvement
in a greater number of programs and reducing financial exposure in respect of any one program. It may also occur that a particular company
will assign all or a portion of its interest in a particular program to another of these companies due to the financial position of the
company making the assignment. In accordance with the laws of British Columbia, the directors of enCore are required to act honestly,
in good faith and in the best interests of enCore. In determining whether or not enCore will participate in a particular program and the
interest therein to be acquired by it, the directors will primarily consider the degree of risk to which enCore may be exposed and its
financial position at that time.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Insurance may not be available to cover the
gamut of risks associated with mineral exploration, development and mining</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The mining industry is subject to significant
risks that could result in damage to or destruction of property and facilities, personal injury or death, environmental damage and pollution,
delays in production, expropriation of assets and loss of title to mining claims. No assurance can be given that insurance to cover the
risks to which enCore&rsquo;s activities are subject will be available at all or at commercially reasonable premiums. enCore currently
maintains insurance within ranges of coverage that it believes to be consistent with industry practice for companies of a similar stage
of development. enCore carries liability insurance with respect to its mineral exploration operations which includes a form of environmental
liability insurance. Since insurance against environmental risks (including liability for pollution) or other hazards resulting from exploration
and development activities is prohibitively expensive, enCore&rsquo;s insurance coverage is limited. The payment of any such liabilities
would reduce the funds available to enCore. If enCore is unable to fully fund the cost of remedying an environmental problem, it might
be required to suspend operations or enter into costly interim compliance measures pending completion of a permanent remedy.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Reliance on Contractors and Experts </I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In various aspects of its operations, enCore relies
on the services, expertise and recommendations of its service providers and their employees and contractors, whom often are engaged at
significant expense to the Company. For example, the decision as to whether a property contains a commercial mineral deposit and should
be brought into production will depend in large part upon the results of exploration programs and/or feasibility studies, and the recommendations
of duly qualified third party engineers and/or geologists. In addition, while enCore emphasizes the importance of conducting operations
in a safe and sustainable manner, it cannot exert absolute control over the actions of these third parties when providing services to
enCore or otherwise operating on enCore&rsquo;s properties. Any material error, omission, act of negligence or act resulting in environmental
pollution, accidents or spills, industrial and transportation accidents, work stoppages or other actions could adversely affect the Company&rsquo;s
operations and financial condition.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Global Financial Conditions</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">There is a risk that cash flow from operations
will be insufficient to meet current and future obligations, fund development and construction projects, and that additional outside sources
of capital will be required. The volatility of global capital markets, including the general economic slowdown in the mining sector, has
generally made the raising of capital by equity or debt financing more difficult. The Company may be dependent upon capital markets to
raise additional financing in the future. As such, the Company is subject to liquidity risks in meeting its operating expenditure requirements
and future development cost requirements in instances where adequate cash positions are unable to be maintained or appropriate financing
is unavailable.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 73; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->71<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company seeks to manage its liquidity risk
through a rigorous planning, budgeting and forecasting process to help determine the funding requirements to support its current operations,
development and expansion plans. However, the factors described above may impact the ability to raise equity or obtain loans and other
credit facilities in the future and on terms favorable to the Company and its management. If these levels of volatility persist or if
there is a further economic slowdown, the Company&rsquo;s operations, the Company&rsquo;s ability to raise capital and the trading price
of the Company&rsquo;s securities could be adversely impacted.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As the Company&rsquo;s operations expand and reliance
on global supply chains increases, the impact of pandemics, significant geopolitical risk and conflict globally may have a sizeable and
unpredictable impact on the Company&rsquo;s business, financial condition and operations. The COVID-19 pandemic and the ongoing conflict
in Ukraine, including the global response to the Ukraine conflict as it relates to sanctions, trade embargos and military support, have
resulted in significant uncertainty as well as economic and supply chain disruptions. Should another significant variant of COVID-19 develop
or the Ukraine conflict go on for an extended period of time or expand beyond Ukraine, or should other geopolitical disputes and conflicts
emerge in other regions, this could result in material adverse effects to the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>General Inflationary Pressures </I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Inflationary pressure may also affect Company&rsquo;s
labour, commodity, and other input costs, which could affect the Company&rsquo;s financial condition. Throughout 2021 and 2022, global
inflationary pressures increased caused by the ongoing COVID-19 global pandemic and related lockdowns. Global energy costs have also increased
following the invasion of Ukraine by Russia in February 2022. The resulting impact of this is that the Company faces higher costs for
key inputs required for its operations. This may be directly through higher transportation costs, as well as indirectly through higher
costs of products that rely on energy.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Foreign Exchange Rates </I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company maintains its accounting records and
reports its financial position and results in Canadian dollars. Fluctuations in the U.S. currency exchange rate relative to the Canadian
currency could significantly impact the Company, including its financial results, operations or the trading value of its securities. The
price of uranium is quoted in U.S. dollars, and a decrease in value of the U.S. dollar would result in a relative decrease in the valuation
of uranium and the associated market value from a Canadian currency perspective. Exchange rate fluctuations, and any potential negative
consequences thereof, are beyond the Company&rsquo;s control.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Risks Associated with the Selection of Novel
Mining Methods</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company focuses on the ISR mining method for
production at its properties. While studies completed to date indicate that ground conditions and the mineral resources estimated to be
contained on the Company&rsquo;s Rosita, Dewey-Burdock, Gas Hills, and Crownpoint-Hosta Butte ISR uranium projects, and the Project are
amenable to extraction by way of ISR, actual conditions could be materially different from those estimated based on the Company&rsquo;s
technical studies completed to-date. While industry best practices have been utilized in the development of its estimates, actual results
from the application of the ISR mining method may differ significantly. The Company will need to complete substantial additional work
to further advance and/or confirm its current estimates for the use of the ISR mining method on its properties. As a result, it is possible
that current estimates may not be achieved on any of the Company&rsquo;s mining properties.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>No Public Market for Uranium </I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">There is no public market for the sale of uranium.
The uranium futures market on the New York Mercantile Exchange does not provide for physical delivery of uranium, only cash on settlement,
and that trading forum does not offer a formal market but rather facilitates the introduction of buyers to sellers.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company may not be able to, once produced,
sell uranium at a desired price level for a number of weeks or months. The pool of potential purchasers or sellers is limited, and each
transaction may require the negotiation of specific provisions. Accordingly, a sale cycle may take several weeks or months to complete.
If the Company determines to sell any physical uranium that it has produced, it may likewise experience difficulties in finding purchasers
that are able to accept a material quantity of physical uranium. The inability to sell on a timely basis in sufficient quantities could
have a material adverse effect on the securities of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 74; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->72<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company also intends to hold physical uranium
for long-term investment. During this term, the value of the Company&rsquo;s uranium holdings will fluctuate and accordingly the Company
will be subject to losses should it ultimately determine to sell the uranium at prices lower than the acquisition cost. In addition, the
Company may incur income statement losses, should uranium prices decrease or foreign exchange rates fluctuate unfavourably in future financial
periods. The Company may be required to sell a portion or all of the physical uranium accumulated to fund its operations should other
forms of financing not be available to fund the Company&rsquo;s capital requirements.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The ability to sell and profit from the sale of
any eventual acquired uranium or mineral production from a property will be subject to the prevailing conditions in the applicable marketplace
at the time of sale. The demand for uranium and other minerals is subject to global economic activity and changing attitudes of consumers
and other end-users&rsquo; demand.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Global Demand and International Trade Restrictions</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The international nuclear fuel industry, including
the supply of uranium concentrates, is relatively small compared to other minerals, and is generally highly competitive and heavily regulated.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Worldwide demand for uranium is directly tied
to the demand for electricity produced by the nuclear power industry, which is also subject to extensive government regulation and policies.
In addition, the international marketing of uranium is subject to governmental policies and certain trade restrictions. For example, the
supply and marketing of uranium from Russia is limited by international trade agreements.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In general, trade agreements, governmental policies
and/or trade restrictions are beyond the control of the Company and may affect the supply of uranium available for use in markets like
the United States and Europe, which are currently the largest markets for uranium in the world. Similarly, trade restrictions or foreign
policy have the potential to impact the ability to supply uranium to developing markets, such as China and India. If substantial changes
are made to regulations affecting the global marketing and supply of uranium, the Company&rsquo;s business, financial condition and results
of operations may be materially adversely affected.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Possible Amendments to the General Mining Law</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Members of the U.S. Congress have repeatedly introduced
bills which would supplant or alter the provisions of the United States Mining Law of 1872, as amended (the &ldquo;<B>General Mining Law</B>&rdquo;).
Such bills have proposed, among other things, to (i) either eliminate or greatly limit the right to a mineral patent; (ii) significantly
alter the laws and regulations relating to uranium mineral development and recovery from unpatented and patented mining claims; (iii)
impose a federal royalty on production from unpatented mining claims; (iv) impose time limits on the effectiveness of plans of operation
that may not coincide with mine or facility life; (v) impose more stringent environmental compliance and reclamation requirements on activities
on unpatented mining claims; (vi) establish a mechanism that would allow states, localities and Native American tribes to petition for
the withdrawal of identified tracts of federal land from the operation of the U.S. general mining laws; and (vii) allow for administrative
determinations that mining or similar activities would not be allowed in situations where undue degradation of the federal lands in question
could not be prevented. If enacted, such legislation could change the cost of holding unpatented mining claims and could significantly
impact our ability to develop locatable mineral resources on our patented and unpatented mining claims. Although it is impossible to predict
at this point what any legislated royalties might be, enactment could adversely affect the potential for construction and development
and the economics of existing operating mines and facilities. Passage of such legislation could adversely affect our financial performance.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The U.S. Environmental Protection Agency (the
&ldquo;<B>EPA</B>&rdquo;) has in recent years announced an intention to propose new rules that, if promulgated, could result in increases
in mine surety arrangements to cover currently non-existing and unidentified potential future environmental costs, which could severely
impact or render infeasible many existing or prospective mining operations. The EPA dropped this proposal after considering comments received
during the public participation process. Nevertheless, there is a risk that similar regulations could be proposed in the future, which
could have significant impacts on the Company and the mining industry as a whole.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 75; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->73<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Information Systems and Cyber Security </I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company&rsquo;s operations depend upon the
availability, capacity, reliability and security of its information technology (&ldquo;<B>IT</B>&rdquo;) infrastructure, and its ability
to expand and update this infrastructure as required, to conduct daily operations. enCore relies on various IT systems in all areas of
its operations, including financial reporting, contract management, exploration and development data analysis, human resource management,
regulatory compliance and communications with employees and third parties.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">These IT systems could be subject to network disruptions
caused by a variety of sources, including computer viruses, security breaches and cyber-attacks, as well as network and/or hardware disruptions
resulting from incidents such as unexpected interruptions or failures, natural disasters, fire, power loss, vandalism and theft. The Company&rsquo;s
operations also depend on the timely maintenance, upgrade and replacement of networks, equipment, IT systems and software, as well as
pre-emptive expenses to mitigate the risks of failures.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The ability of the IT function to support the
Company&rsquo;s business in the event of any such occurrence and the ability to recover key systems from unexpected interruptions cannot
be fully tested. There is a risk that, if such an event actually occurs, the Company&rsquo;s continuity plans may not be adequate to immediately
address all repercussions of the disaster. In the event of a disaster affecting a data centre or key office location, key systems may
be unavailable for a number of days, leading to inability to perform some business processes in a timely manner. As a result, the failure
of enCore&rsquo;s IT systems or a component thereof could, depending on the nature of any such failure, adversely impact the Company&rsquo;s
reputation and results of operations.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Although to date the Company has not experienced
any material losses relating to cyber-attacks or other information security breaches, there can be no assurance that the Company will
not incur such losses in the future. Unauthorized access to enCore&rsquo;s IT systems by employees or third parties could lead to corruption
or exposure of confidential, fiduciary or proprietary information, interruption to communications or operations or disruption to the Company&rsquo;s
business activities or its competitive position. Further, disruption of critical IT services, or breaches of information security, could
have a negative effect on the Company&rsquo;s operational performance and its reputation. The Company&rsquo;s risk and exposure to these
matters cannot be fully mitigated because of, among other things, the evolving nature of these threats. As a result, cyber security and
the continued development and enhancement of controls, processes and practices designed to protect systems, computers, software, data
and networks from attack, damage or unauthorized access remain a priority.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company applies technical and process controls
in line with industry-accepted standards to protect information, assets and systems; however, these controls may not adequately prevent
cyber-security breaches. There is no assurance that the Company will not suffer losses associated with cyber-security breaches in the
future, and may be required to expend significant additional resources to investigate, mitigate and remediate any potential vulnerabilities.
As cyber threats continue to evolve, the Company may be required to expend additional resources to continue to modify or enhance protective
measures or to investigate and remediate any security vulnerabilities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Anti-Bribery and Anti-Corruption Laws </I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company is subject to anti-bribery and anti-corruption
laws, including the <I>Corruption of Foreign Public Officials Act</I> (Canada) and the United States <I>Foreign Corrupt Practices Act</I>
of 1977, as amended. Failure to comply with these laws could subject the Company to, among other things, reputational damage, civil or
criminal penalties, other remedial measures and legal expenses which could adversely affect the Company&rsquo;s business, results from
operations, and financial condition. It may not be possible for the Company to ensure compliance with anti-bribery and anti-corruption
laws in every jurisdiction in which its employees, agents, sub-contractors or joint venture partners are located or may be located in
the future.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Disclosure and Internal Controls</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Disclosure controls and procedures are designed
to ensure that information required to be disclosed by a company in reports filed with securities regulatory agencies is recorded, processed,
summarized and reported on a timely basis and is accumulated and communicated to the company&rsquo;s management, including its Chief Executive
Officer and Chief Financial Officer, as appropriate, to allow timely decisions regarding required disclosure. A control system, no matter
how well designed and operated, can provide only reasonable, not absolute, assurance with respect to the reliability of reporting, including
financial reporting and financial statement preparation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 76; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->74<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We use internal controls over financial reporting
to provide reasonable assurance that we authorize transactions, safeguard assets against improper or unauthorized use, and record and
report transactions properly. This gives us reasonable assurance that our financial reporting is reliable and prepared in accordance with
IFRS. It is impossible for any system to provide absolute assurance or guarantee reliability, regardless of how well it is designed or
operated. We continue to evaluate our internal controls to identify areas for improvement and provide as much assurance as reasonably
possible.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If we do not satisfy the requirements for internal
controls on an ongoing, timely basis, it could negatively affect investor confidence in our financial reporting, which could have an impact
on our business and the trading price of our Common Shares. If a deficiency is identified and we do not introduce new or better controls,
or have difficulty implementing them, it could harm our financial results or our ability to meet reporting obligations.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Any failure of our internal controls could have
an adverse effect on our stated results of operations and harm our reputation. As a result, we may experience higher than anticipated
operating expenses, as well as higher independent auditor fees during and after the implementation of these changes. If we are unable
to implement any of the required changes to our internal control over financial reporting effectively or efficiently or are required to
do so earlier than anticipated, it could adversely affect our operations, financial reporting and results of operations. If we fail to
maintain an effective system of disclosure controls and internal control over financial reporting, our ability to produce timely and accurate
financial statements or comply with applicable regulations could be adversely impacted.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Negative Operating Cash Flows</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As an exploration company, the Company has no
source of operating cash flow and its operations to date have been funded primarily from equity financings. Accordingly, the Company had
negative operating cash flow for the financial year ended December 31, 2021 and the interim period ended September 30, 2022. As a result
of the expenses to be incurred by the Company in connection with its business objectives for the development of the Company&rsquo;s material
projects, the Company anticipates that negative operating cash flows will continue for the foreseeable future. Accordingly, the Company
will require substantial additional capital in order to fund its future exploration and development activities for its material projects.
Other than any proceeds received from the Offering, the Company does not have any arrangements in place for this funding and there is
no assurance that such funding will be achieved when required. Any failure to obtain additional financing or failure to achieve profitability
and positive operating cash flows will have a material adverse effect on its financial condition and results of operations.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Benefits Not Realized From Transactions </I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company has completed a number of transactions
over the last several years. Despite the Company&rsquo;s belief that these transactions, and others which may be completed in the future,
will be in the Company&rsquo;s best interest and benefit the Company and its shareholders, the Company may not realize the anticipated
benefits of such transactions or realize the full value of the consideration paid or received to complete the transactions. This could
result in significant accounting impairments or write-downs of the carrying values of mineral properties or other assets and could adversely
impact the Company and the prices of its securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>U.S. Foreign Private Issuer Status</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company is a foreign private issuer under
applicable U.S. federal securities laws and, therefore, is not required to comply with all of the periodic disclosure and current reporting
requirements of the U.S. Exchange Act and related rules and regulations. As a result, the Company does not file the same reports that
a U.S. domestic issuer would file with the SEC, although it will be required to file with or furnish to the SEC the continuous disclosure
documents that the Company is required to file in Canada under Canadian securities laws. In addition, the Company&rsquo;s officers, directors
and principal shareholders are exempt from the reporting and &ldquo;short swing&rdquo; profit recovery provisions of Section 16 of the
U.S. Exchange Act. Therefore, the Company&rsquo;s securityholders may not know on as timely a basis when its officers, directors and principal
shareholders purchase or sell securities of the Company as the reporting periods under the corresponding Canadian insider reporting requirements
are longer. In addition, as a foreign private issuer, the Company is exempt from the proxy rules under the U.S. Exchange Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I></I></P>

<!-- Field: Page; Sequence: 77; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->75<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In order to maintain its current status as a foreign
private issuer, 50% or more of the Company&rsquo;s Common Shares must be directly or indirectly owned of record by non-residents of the
United States unless the Company also satisfies one of the additional requirements necessary to preserve this status. The Company may
in the future lose its foreign private issuer status if a majority of the Common Shares are owned of record in the United States and the
Company fails to meet the additional requirements necessary to avoid loss of foreign private issuer status. The regulatory and compliance
costs to the Company under U.S. federal securities laws as a U.S. domestic issuer may be significantly more than the costs the Company
incurs as a Canadian foreign private issuer eligible to use the multijurisdictional disclosure system. If the Company is not a foreign
private issuer, it would not be eligible to use the multijurisdictional disclosure system or other foreign issuer forms and would be required
to file periodic and current reports and registration statements on U.S. domestic issuer forms with the SEC, which are more detailed and
extensive than the forms available to a foreign private issuer.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>United States investors may not be able to
obtain enforcement of civil liabilities against the Company</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The enforcement by investors of civil liabilities
under the United States federal or state securities laws may be affected adversely by the fact that the Company is governed by the BCBCA.
It may not be possible for investors to effect service of process within the United States on certain of its directors and officers or
enforce judgments obtained in the United States courts against the Company or certain of the Company&rsquo;s directors and officers based
upon the civil liability provisions of United States federal securities laws or the securities laws of any state of the United States.
There is some doubt as to whether a judgment of a United States court based solely upon the civil liability provisions of United States
federal or state securities laws would be enforceable in Canada against the Company or its directors and officers. There is also doubt
as to whether an original action could be brought in Canada against the Company or its directors and officers to enforce liabilities based
solely upon United States federal or state securities laws.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>If the Company is characterized as a passive
foreign investment company, U.S. Holders may be subject to adverse U.S. federal income tax consequences</I>&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Prospective U.S. investors should be aware that
they could be subject to certain adverse U.S. federal income tax consequences in the event that the Company is classified as a &ldquo;passive
foreign investment company&rdquo; (a &ldquo;<B>PFIC</B>&rdquo;) for U.S. federal income tax purposes. The determination of whether a corporation
is a PFIC for a taxable year depends, in part, on the application of complex U.S. federal income tax rules, which are subject to differing
interpretations, and the determination will depend on the composition of the corporation&rsquo;s income, expenses and assets from time
to time and the nature of the activities performed by the corporation&rsquo;s officers and employees. Based on an analysis of the Company&rsquo;s
activities and income and assets, the Company believes that it was a PFIC for its taxable year ended December 31, 2021, and may continue
to be classified as a PFIC for the taxable year ended December 31, 2022, the current taxable year and the foreseeable future. A prospective
investor should consult its own tax advisor regarding the likelihood and consequences of the Company being treated as a PFIC for U.S.
federal income tax purposes, including the advisability of making certain elections that may mitigate certain possible adverse U.S. federal
income tax consequences but that may result in an inclusion of gross income without receipt of such income.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Changes in Climate Conditions and Regulatory
Regime Could Adversely Affect our Business and Operations</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">There is significant evidence of the effects of
climate change on our planet and an intensifying focus on addressing these issues. We recognize that climate change is a global challenge
that may have both favorable and adverse affects on our business in a range of possible ways. Mining and uranium processing operations
are energy intensive and result in a carbon footprint either directly or through the purchase of fossil-fuel based electricity. As such,
we are impacted by current and emerging policy and regulation relating to greenhouse gas emission levels, energy efficiency, and reporting
of climate-change related risks. While some of the costs associated with reducing emissions may be offset by increased energy efficiency,
technological innovation, or the increased demand for our uranium and conversion services, the current regulatory trend may result in
additional transition costs at some of our operations. A number of government or governmental bodies have introduced or are contemplating
regulatory changes in response to the potential impacts of climate change. Where legislation already exists, regulations relating to emissions
levels and energy efficiency are becoming more stringent. Changes in legislation and regulation will likely increase our compliance costs.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In addition, the physical risks of climate change
may also have an adverse effect at our operations. These may include extreme weather events such as floods, droughts, forest and bush
fires, and extreme storms. These physical impacts could require us to suspend or reduce production or close operations and could prevent
us from pursuing expansion opportunities. These effects may adversely impact the cost, production, and financial performance of our operations.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We can provide no assurance that efforts to mitigate
the risks of climate change will be effective and that physical risks of climate change will not have a material and adverse effect on
our earnings, cash flows, financial condition, results of operations, or prospects.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 78; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->76<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>We May Not Realize Any or All of the Anticipated
Benefits From the Alta Mesa Acquisition</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As part of our business strategy, we expect to
see certain near-term benefits, including licensed uranium production facility with licensed and permitted mineral resources that will
add to our overall production capacity in South Texas, as well as longer-term opportunities for growth from a large contiguous mineral
property that has significant identified mineral resources and the potential for additional mineral resources that could be discovered
on that property. Any benefits and growth that we realize from such efforts may differ materially from our estimates. In particular, our
estimates of the potential benefits and growth from the Alta Mesa Acquisition are based in part on a valuation of the Project that may
differ from the performance of the Project on a going-forward basis. Achieving the benefits of the Alta Mesa Acquisition will depend,
in part, on our ability to integrate operations of the Project successfully and efficiently with our business. The challenges involved
in this integration, which may be complex and time-consuming, include the following:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify">the diversion of management attention from other important
business objective;</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="text-align: justify; width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: justify">&#9679;</TD><TD STYLE="text-align: justify">the ability to locate, hire and retain experienced staff
to construct wellfields and safely conduct operation; and</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="text-align: justify; width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: justify">&#9679;</TD><TD STYLE="text-align: justify">the ability to locate, hire and retain experienced contractors
to allow efficient delineation drilling and well installation at a necessary rate to meet production needs.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In addition, any benefits that we realize may
be offset, in whole or in part, by reductions in revenues, or through increases in other expenses, including costs to achieve our estimated
synergies and growth. Our plans for the project following the Alta Mesa Acquisition are subject to numerous risks and uncertainties that
may change at any time. We cannot assure you that our initiatives will be completed as anticipated or that the benefits we expect will
be achieved on a timely basis or at all. Even if the Alta Mesa Acquisition is consummated, it may take longer than expected to achieve
the anticipated benefits and growth and there is no guarantee that the Project will reach near-term production. If the Alta Mesa Acquisition
is completed but the Project does not achieve the anticipated benefits and growth or reach near-term production, this may adversely affect
the future financial results of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Risks Related to Financial Matters</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>enCore has a history of net losses and the
availability of additional financing is uncertain</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">enCore has received no revenue to date from the
exploration activities on its properties. enCore will require significant cash and/or alternative financing arrangements in order to develop
its assets and meet its ongoing general and administrative costs and exploration commitments and to maintain its mineral property interests,
which may require working capital and/or project financing in the future. There can be no assurance that such financing will be available
on reasonable terms, if at all, and if available, may be dilutive to existing shareholders. Any failure to obtain additional financing
or failure to achieve profitability and positive operating cash flows will have a material adverse effect on its financial condition and
results of operations.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>There are risks associated with the exploration
of, development of, and production from mineral properties</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The business of exploration for minerals involves
a high degree of risk. Few properties that are explored are ultimately developed into producing mines. There is no assurance that the
exploration programs on enCore&rsquo;s current or future mineral properties will result in the discovery of new resources or lead to the
development of a commercially viable orebody.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Development of any of enCore&rsquo;s properties
are subject to numerous risks, including, but not limited to, delays in obtaining equipment, material and services essential to developing
the projects in a timely manner; changes in environmental or other government regulations; currency exchange rates; labor shortages; and
fluctuation in metal prices. Furthermore, the economic feasibility of developing a mineral project is based on many factors such as estimation
of mineral reserves, tonnage and grade, anticipated metallurgical recoveries, environmental considerations and permitting, future metal
prices and anticipated capital and operating costs of these projects, and it is possible that actual capital and operating costs and economic
returns will differ significantly from those estimated for a project prior to production.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">enCore&rsquo;s mineral properties have no operating
history upon which estimates of future projection and cash operating costs can be based. Estimates of mineral resources, proven and probable
mineral reserves and cash operating costs are, to a large extent, based upon the interpretation of geologic data obtained from drill holes
and other sampling techniques. The results of feasibility studies that derive estimates of capital and operating costs based upon the
quantity, grade and configuration of mineral reserves as well as the expected recovery rates of metals from the mineralized material,
are subject to change. As a result, it is possible that actual capital and operating costs and economic returns will differ significantly
from those currently estimated for a project prior to development or operation. The remoteness and restrictions on access of certain of
the properties in which enCore has an interest could have an adverse effect on profitability in that infrastructure costs would be higher.
There are also physical risks to the exploration personnel working in the rugged terrain, often in poor climate conditions, which can
be abated through safety training, adherence to high safety standards and the use of modern communication technologies.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 79; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->77<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">With all mineral operations there is uncertainty
and, therefore, risk associated with operating parameters and costs resulting from the scaling up of extraction methods tested in laboratory
conditions. Development of a mineral property does not assure a profit on the investment or recovery of costs. In addition, extraction
hazards or environmental damage could greatly increase the cost of operations, and various operating conditions may adversely affect the
production from mineral properties. These conditions include delays in obtaining governmental approvals or consents, insufficient transportation
capacity or other geological, geotechnical and mechanical conditions. While diligent supervision and effective maintenance operations
can contribute to maximizing production rates over time, production delays from normal operating conditions cannot be eliminated and can
be expected to adversely affect revenue and cash flow levels to varying degrees.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Capital Intensive Industry; Uncertainty of
Funding</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The development and ongoing operation of mines
requires a substantial amount of capital prior to the commencement of, and in connection with, the production of uranium. Such capital
requirements relate to the costs of, among other things, acquiring mining rights and properties, obtaining government permits, exploration
and delineation drilling to determine the underground configuration of a deposit, designing and constructing the mine and processing facilities,
purchasing and maintaining mining equipment and complying with financial assurance requirements established by various regulatory agencies
for the future restoration and reclamation activities for each project. enCore will accordingly have further capital requirements as it
proceeds to expand its present mining activities and operations or to take advantage of opportunities for acquisitions. There can be no
assurance that enCore will be able to obtain necessary financing in a timely on acceptable terms, if at all.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Currency and exchange rate fluctuations could
impact enCore&rsquo;s financial condition</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Currency fluctuations may affect the costs that
enCore incurs at its operations which may adversely affect enCore&rsquo;s cash flows, results of operation and financial condition. enCore
raises its funds through equity issuances which are priced in Canadian dollars, and the majority of enCore&rsquo;s resource property costs
are denominated in United States dollars. enCore may suffer losses due to adverse foreign currency fluctuations.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Risks Related to enCore&rsquo;s Common Shares</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Shareholders&rsquo; interest in enCore may
be diluted in the future</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">enCore may require additional funds to fund its
exploration and development programs and potential acquisitions. If enCore raises additional funding by issuing additional equity securities,
such financing may substantially dilute the interests of its shareholders.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">enCore may issue additional common shares in the
future pursuant to proposed acquisitions described herein and on the exercise of its outstanding stock options and warrants.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Sales of substantial amounts of enCore&rsquo;s
common shares, or the availability of such common shares for sale, could adversely affect the prevailing market prices for enCore&rsquo;s
securities. A decline in the market prices of enCore&rsquo;s securities could impair its ability to raise additional capital through the
sale of new common shares should enCore desire to do so.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>The market price for common shares cannot be
assured</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Securities markets have experienced a high level
of price and volume volatility, and the market price of securities of many companies has experienced wide fluctuations which have not
necessarily been related to the operating performance, underlying asset values or prospects of such companies.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In the past, following periods of volatility in
the market price of a company&rsquo;s securities, shareholders have often instituted class action securities litigation against those
companies. Such litigation, if instituted, could result in substantial costs and diversion of management attention and resources, which
could significantly harm enCore&rsquo;s profitability and reputation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>enCore does not intend to pay dividends in
the foreseeable future</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">enCore has never paid cash dividends on its common
shares. enCore currently intends to retain its future earnings, if any, to fund the development and growth of its business, and does not
anticipate paying any cash dividends on its common shares for the foreseeable future. As a result, shareholders will have to rely on capital
appreciation, if any, to earn a return on investment in any common shares in the foreseeable future. Furthermore, enCore may in the future
become subject to contractual restrictions on, or prohibitions against, the payment of dividends.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 80; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->78<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">DIVIDENDS AND DISTRIBUTIONS</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company has not declared or paid any dividends
on its Common Shares since its inception. At the present time, the Company intends to retain any earnings for corporate purposes. The
payment of dividends in the future will depend on the earnings and financial condition of the Company and on such other facts as the board
of directors of the Company may consider appropriate. However, since the Company is currently in a development stage, it is unlikely that
earnings, if any, will be available for the payment of dividends in the foreseeable future.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">CAPITAL STRUCTURE</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The authorized capital of the Company consists
of an unlimited number of Common Shares without par value and an unlimited number of Preferred Shares without par value (referred to herein
as the &ldquo;<B>enCore Preferred Shares</B>&rdquo;). As at December 31, 2022, there were 108,940,051 Common Shares issued and outstanding.
As at the date of this AIF, there are 143,225,354 Common Shares issued and outstanding. Nil enCore Preferred Shares are issued and outstanding
as at the date of this AIF.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Common Shares are subject to the following
rights, privileges, restrictions and conditions:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">a)</TD><TD STYLE="text-align: justify">the holders of the Common Shares are entitled to receive
notice of, and attend at, and to vote in person or by proxy at general meetings of enCore shareholders and will be entitled to one vote
for each such enCore Share held;</TD>
</TR></TABLE>

<P STYLE="text-align: justify; margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="text-align: justify; width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: justify">b)</TD><TD STYLE="text-align: justify">subject to the rights of the enCore Preferred Shares as determined
by the directors and in accordance with enCore&rsquo;s Articles, the directors may, in their discretion, at any time and from time to
time declare and cause enCore to pay dividend on the Common Shares; and</TD>
</TR></TABLE>

<P STYLE="text-align: justify; margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="text-align: justify; width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: justify">c)</TD><TD STYLE="text-align: justify">subject to the rights, privileges, restrictions and conditions
attaching to the enCore Preferred Shares, in the event of liquidation or dissolution of enCore or other distribution of assets of enCore
among its shareholders for the purpose of winding up its affairs, whether voluntary or involuntary, the holders of the Common Shares
will be entitled to share equally, share for share, in the distribution of the remaining property and assets of enCore.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The rights and restrictions attached to the Common
Shares may be altered by resolutions of the enCore Board, subject to the <I>Business Corporations Act</I> (British Columbia).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The enCore Preferred Shares are subject to the
following rights, privileges, restrictions and conditions:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">a)</TD><TD STYLE="text-align: justify">the enCore Preferred Shares may from time to time be issued
in one or more series and subject to the following provisions, the directors may fix from time to time before such issue the number of
shares which is to comprise each series and the designation, rights, privileges, restrictions and conditions attaching to each series
of enCore Preferred Shares including, without limiting the generality of the foregoing, the rate or amount of dividends or the method
of calculating dividends, the dates of payment thereof, the redemption purchase and/or conversion prices and terms and conditions of
redemption, purchase and/or conversion, and any sinking fund or other provisions, and the directors may, by resolution, authorize and
cause enCore to alter its Notice of Articles to reflect any creation of one or more series or other change in the authorized shares structure
of enCore;</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">b)</TD><TD STYLE="text-align: justify">the enCore Preferred Shares of each series will, with respect
to the payment of dividends and the distribution of assets or return of capital in the event of liquidation, dissolution or winding up
of enCore, whether voluntary or involuntary, or any other return of capital or distribution of the assets of enCore among its shareholders
for the purposes of winding-up its affairs, rank on the parity with the enCore Preferred Shares of every other series and be entitled
to preference over the Common Shares and over any other shares of enCore ranking junior to the enCore Preferred Shares. The enCore Preferred
Shares of any series may also be given such other preferences, not inconsistent with enCore&rsquo;s Articles, over the Common Shares
and any other shares of enCore ranking junior to such enCore Preferred Shares as may be fixed in accordance with enCore&rsquo;s Articles;</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">c)</TD><TD STYLE="text-align: justify">if any cumulative dividends or amounts payable on the return
of capital in respect of a series of enCore Preferred Shares are not paid in full, all series of enCore Preferred Shares will participate
rateably in respect of accumulative dividends and return of capital; and</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="text-align: justify; width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: justify">d)</TD><TD STYLE="text-align: justify">unless the directors otherwise determine in the Articles
or Notice of Articles designating a series, the holder of each share of a series of enCore Preferred Shares will not, except as otherwise
specifically provided in the BCBCA, be entitled to receive notice of or vote at any meeting of the enCore shareholders.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The rights and restrictions attached to the enCore
Preferred Shares may be altered by resolutions of the enCore Board, subject to the <I>Business Corporations Act</I> (British Columbia).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Page; Sequence: 81; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->79<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="margin: 0">As at December 31, 2022, the Company had 7,235,646 stock options to purchase Common Shares outstanding as follows:</P>

<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Number Issued</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Exercise Price ($)</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Expiry Date</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 33%; text-align: center">15,000</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 33%; text-align: center">$1.920</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 32%; text-align: center">31-Dec-22</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: center">10,000</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">$1.840</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">31-Dec-22</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: center">8,750</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">$1.398</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">31-Dec-22</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: center">29,062</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">$2.400</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">31-Dec-22</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: center">50,000</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">$1.920</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">7-Feb-23</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: center">31,250</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">$1.840</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">7-Feb-23</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: center">40,624</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">$1.398</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">7-Feb-23</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: center">50,780</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">$2.400</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">7-Feb-23</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: center">125,001</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">$0.180</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">15-May-23</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: center">135,625</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">$1.920</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">22-Aug-23</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: center">35,834</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">$0.370</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">8-Jan-24</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: center">16,667</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">$0.400</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">27-Mar-24</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: center">121,875</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">$1.840</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">23-May-24</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: center">1,072,915</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">$0.450</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">3-Jun-24</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: center">166,561</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">$1.398</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">19-May-25</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: center">955,000</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">$0.615</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">20-May-25</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: center">50,000</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">$1.050</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">1-Sep-25</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: center">475,000</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">$1.349</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">10-Sep-25</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: center">25,000</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">$1.200</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">5-Oct-25</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: center">33,333</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">$1.245</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">25-Nov-25</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: center">13,333</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">$1.440</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">7-Dec-25</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: center">53,333</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">$2.820</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">28-Jan-26</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: center">145,000</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">$3.240</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">26-Feb-26</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: center">208,201</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">$2.400</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">13-May-26</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: center">145,002</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">$4.320</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">26-May-26</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: center">66,666</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">$5.760</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">19-Oct-24</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: center">33,333</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">$5.400</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">1-Dec-26</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: center">31,667</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">$5.190</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">3-Dec-26</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: center">16,667</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">$5.010</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">10-Jan-27</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: center">2,346,667</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">$4.200</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">14-Feb-27</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: center">95,833</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">$4.710</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">31-Mar-24</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: center">83,333</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">$4.320</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">2-May-27</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: center">166,667</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">$3.750</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">1-Jun-27</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: center">133,333</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">$3.210</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">15-Jul-27</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: center">148,334</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">$3.650</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">1-Nov-27</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: center">50,000</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">$3.250</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">14-Nov-27</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: center">50,000</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">$3.300</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">19-Dec-27</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As at the date of this AIF, enCore has 7,067,071
stock options issued and outstanding.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As at December 31, 2022, the Company had 8,844,506
share purchase warrants to purchase Common Shares of the Company outstanding as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Number Issued</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Exercise Price</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Expiry Date</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 33%; text-align: center">84,384</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 33%; text-align: center">$2.22</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 32%; text-align: center">31-Dec-22</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: center">67,917</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">$1.59</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">17-Apr-23</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: center">1,292,111</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">$1.80</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">22-Oct-23</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: center">158,917</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">$3.00</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">9-Mar-24<SUP>(1)</SUP></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: center">2,271,896</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">$3.90</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">9-Mar-24</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: center">3,267,974</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">$6.00</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">25-Mar-24</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: center">351,307</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">$4.59</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">25-Mar-24<SUP>(2)</SUP></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: center">283,500</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">$3.25</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">14-May-25<SUP>(3)</SUP></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: center">1,066,500</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">$3.91</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">14-May-25<SUP>(4)</SUP></TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 42.55pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0in">Notes:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 42.55pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in">(1)</TD><TD>Broker warrants exercisable into one share and one-half warrant. Each whole warrant is exercisable at $3.00 for 36 months.</TD></TR>
                                                                                                                                                                          </TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in">(2)</TD><TD>Broker warrants exercisable into one share and one-half warrant. Each whole warrant is exercisable at $4.59 for 36 months.</TD></TR></TABLE>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin-top: 0; margin-bottom: 0"></P>

<!-- Field: Page; Sequence: 82; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->80<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>


<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in">(3)</TD><TD>Broker warrants exercisable into one share and one-half warrant. Each whole warrant is exercisable at $3.25. Expiry date is May 14,
2025</TD></TR>
              </TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in">(4)</TD><TD>Broker warrants exercisable into one share and one-half warrant. Each whole warrant is exercisable at $3.91 Expiry date is May 14,
2025.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 42.55pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">As at the date of this AIF, enCore has 37,260,364 warrants issued and
outstanding</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">MARKET FOR SECURITIES</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">Trading Price and Volume</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Common Shares trade on the TSX-V under the
symbol &ldquo;EU&rdquo; and on OTCQB under the symbol &ldquo;ENCUF&rdquo;. The following table shows the high and low closing prices and
total trading volume of the Common Shares on the TSX-V on a monthly basis for the financial year ended December 31, 2022:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="5" STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><P STYLE="margin-top: 0; margin-bottom: 0">TSX-V</P>
                                                                                <P STYLE="margin-top: 0; margin-bottom: 0">(prices in
                                            Canadian dollars)</P></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold">Month</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">High</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Low</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Volume</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 25%">January 2022</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 24%; text-align: center">1.85</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 24%; text-align: center">1.30</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 24%; text-align: center">12,866,325</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD>February 2022</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">1.55</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">1.25</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">11,434,859</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD>March 2022</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">1.73</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">1.42</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">19,333,171</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD>April 2022</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">1.87</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">1.41</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">14,187,603</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD>May 2022</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">1.54</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">1.04</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">16,439,783</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD>June 2022</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">1.44</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">1.08</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">11,194,597</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD>July 2022</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">1.36</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">1.03</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">10,583,035</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD>August 2022</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">1.52</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">1.18</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">9,961,748</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD>September 2022</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">4.41</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">1.37</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">8,580,622</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD>October 2022</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">3.82</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">3.21</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">2,280,781</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD>November 2022</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">3.60</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">2.84</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">2,724,108</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD>December 2022</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">3.38</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">3.02</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">2,637,676</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The outstanding Common Shares were traded on the
OTCQB Venture Market under the symbol &ldquo;ENCUF&rdquo; during the most recently completed financial year. The following table sets
forth the closing price ranges and trading volume of the Common Shares as reported by the OTCQB Venture Market on a monthly basis for
the financial year ended December 31, 2022:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="5" STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">OTCQB<BR> (prices in US$)</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold">Month</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">High</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Low</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Volume</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 25%">January 2022</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 24%; text-align: center; padding-left: 5.4pt">1.47</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 24%; text-align: center; padding-left: 5.4pt">0.9747</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 24%; text-align: center; padding-left: 5.4pt">8,962,564</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD>February 2022</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center; padding-left: 5.4pt">1.2274</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center; padding-left: 5.4pt">0.9951</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center; padding-left: 5.4pt">5,436,237</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD>March 2022</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center; padding-left: 5.4pt">1.36</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center; padding-left: 5.4pt">1.12</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center; padding-left: 5.4pt">10,194,994</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD>April 2022</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center; padding-left: 5.4pt">1.49</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center; padding-left: 5.4pt">1.10</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center; padding-left: 5.4pt">7,872,506</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD>May 2022</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center; padding-left: 5.4pt">1.22</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center; padding-left: 5.4pt">0.8155</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center; padding-left: 5.4pt">9,583,541</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD>June 2022</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center; padding-left: 5.4pt">1.15</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center; padding-left: 5.4pt">0.837</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center; padding-left: 5.4pt">5,339,459</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD>July 2022</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center; padding-left: 5.4pt">1.06</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center; padding-left: 5.4pt">0.79</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center; padding-left: 5.4pt">4,748,587</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD>August 2022</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center; padding-left: 5.4pt">1.135</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center; padding-left: 5.4pt">0.902</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center; padding-left: 5.4pt">5,050,630</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD>September 2022</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center; padding-left: 5.4pt">1.12</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center; padding-left: 5.4pt">1.05</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center; padding-left: 5.4pt">2,701,944</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD>October 2022</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center; padding-left: 5.4pt">2.80</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center; padding-left: 5.4pt">2.35</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center; padding-left: 5.4pt">739,344</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD>November 2022</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center; padding-left: 5.4pt">2.6313</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center; padding-left: 5.4pt">2.13</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center; padding-left: 5.4pt">2,925,338</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD>December 2022</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center; padding-left: 5.4pt">2.49</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center; padding-left: 5.4pt">2.18</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center; padding-left: 5.4pt">2,466,894</TD></TR>
  </TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"></P>

<!-- Field: Page; Sequence: 83; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->81<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">Prior Sales</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The following table summarizes the issuances of
securities convertible into Common Shares in the 12-month period prior to the year ended December 31, 2022.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">Date of issue or grant</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Type of<BR>
 Securities</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Number of <BR>
Securities</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Issue or <BR> Exercise<BR>
 Price of<BR>
 Security</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; vertical-align: bottom; font-weight: bold; text-align: center">Description of Transaction</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD STYLE="font-weight: bold; text-align: center">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD STYLE="font-weight: bold; text-align: center">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD STYLE="font-weight: bold; text-align: center">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; font-weight: bold; text-align: center">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="vertical-align: top; text-align: left; width: 20%">January 10, 2022</TD><TD STYLE="text-align: center; width: 1%; vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top; width: 19%; text-align: center">Options</TD><TD STYLE="text-align: center; width: 1%; vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top; width: 19%; text-align: center">50,000</TD><TD STYLE="text-align: center; width: 1%; vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top; width: 19%; text-align: center">$1.67</TD><TD STYLE="text-align: center; width: 1%; vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top; width: 19%; text-align: left">Option Grant</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="vertical-align: top; text-align: left">&nbsp;</TD><TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">&nbsp;</TD><TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">&nbsp;</TD><TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">&nbsp;</TD><TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="vertical-align: top; text-align: left">January 11, 2022</TD><TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">Common Shares</TD><TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">15,000</TD><TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">$1.30</TD><TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="text-align: left; vertical-align: top">Warrant Exercise</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="vertical-align: top; text-align: left">&nbsp;</TD><TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">&nbsp;</TD><TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">&nbsp;</TD><TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">&nbsp;</TD><TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="text-align: left; vertical-align: top">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="vertical-align: top; text-align: left">January 28, 2022</TD><TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">Common Shares</TD><TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">580,043</TD><TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">$1.38</TD><TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="text-align: left; vertical-align: top">Shares for Debt</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="vertical-align: top; text-align: left">&nbsp;</TD><TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">&nbsp;</TD><TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">&nbsp;</TD><TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">&nbsp;</TD><TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="text-align: left; vertical-align: top">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="vertical-align: top; text-align: left">February 14, 2022</TD><TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">Options</TD><TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">7,090,000</TD><TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">$1.40</TD><TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: left">Option Grant</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="vertical-align: top; text-align: left">&nbsp;</TD><TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">&nbsp;</TD><TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">&nbsp;</TD><TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">&nbsp;</TD><TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="vertical-align: top; text-align: left">February 21, 2022</TD><TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">Common Shares</TD><TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">48,750</TD><TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">$0.74</TD><TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="text-align: left; vertical-align: top">Warrant Exercise</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="vertical-align: top; text-align: left">&nbsp;</TD><TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">&nbsp;</TD><TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">&nbsp;</TD><TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">&nbsp;</TD><TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="text-align: left; vertical-align: top">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="vertical-align: top; text-align: left">February 23, 2022</TD><TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">Common Shares</TD><TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">250,000</TD><TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">$0.225</TD><TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="text-align: left; vertical-align: top">Warrant Exercise</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="vertical-align: top; text-align: left">&nbsp;</TD><TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">&nbsp;</TD><TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">&nbsp;</TD><TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">&nbsp;</TD><TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="text-align: left; vertical-align: top">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="vertical-align: top; text-align: left">February 28, 2022</TD><TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">Common Shares</TD><TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">26,906</TD><TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">$0.82</TD><TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="text-align: left; vertical-align: top">Warrant Exercise</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="vertical-align: top; text-align: left">&nbsp;</TD><TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">&nbsp;</TD><TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">&nbsp;</TD><TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">&nbsp;</TD><TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="text-align: left; vertical-align: top">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="vertical-align: top; text-align: left">March 11, 2022</TD><TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">Common Shares</TD><TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">16.875</TD><TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">$0.853</TD><TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="text-align: left; vertical-align: top">Option Exercise</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="vertical-align: top; text-align: left">&nbsp;</TD><TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">&nbsp;</TD><TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">&nbsp;</TD><TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">&nbsp;</TD><TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="text-align: left; vertical-align: top">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="vertical-align: top; text-align: left">March 11, 2022</TD><TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">Common Shares</TD><TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">100,000</TD><TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">$0.225</TD><TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="text-align: left; vertical-align: top">Warrant Exercise</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="vertical-align: top; text-align: left">&nbsp;</TD><TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">&nbsp;</TD><TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">&nbsp;</TD><TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">&nbsp;</TD><TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="text-align: left; vertical-align: top">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="vertical-align: top; text-align: left">March 11, 2022</TD><TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">Common Shares</TD><TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">70,312</TD><TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">$0.74</TD><TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="text-align: left; vertical-align: top">Warrant Exercise</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="vertical-align: top; text-align: left">&nbsp;</TD><TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">&nbsp;</TD><TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">&nbsp;</TD><TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">&nbsp;</TD><TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="text-align: left; vertical-align: top">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="vertical-align: top; text-align: left">March 17, 2022</TD><TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">Common Shares</TD><TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">93,750</TD><TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">$0.74</TD><TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="text-align: left; vertical-align: top">Warrant Exercise</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="vertical-align: top; text-align: left">&nbsp;</TD><TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">&nbsp;</TD><TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">&nbsp;</TD><TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">&nbsp;</TD><TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="text-align: left; vertical-align: top">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="vertical-align: top; text-align: left">March 18, 2022</TD><TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">Common Shares</TD><TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">15,000</TD><TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">$0.06</TD><TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="text-align: left; vertical-align: top">Option Exercise</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="vertical-align: top; text-align: left">&nbsp;</TD><TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">&nbsp;</TD><TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">&nbsp;</TD><TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">&nbsp;</TD><TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="text-align: left; vertical-align: top">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="vertical-align: top; text-align: left">March 18, 2022</TD><TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">Common Shares</TD><TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">10,000</TD><TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">$0.125</TD><TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="text-align: left; vertical-align: top">Option Exercise</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="vertical-align: top; text-align: left">&nbsp;</TD><TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">&nbsp;</TD><TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">&nbsp;</TD><TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">&nbsp;</TD><TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="text-align: left; vertical-align: top">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="vertical-align: top; text-align: left">March 18, 2022</TD><TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">Common Shares</TD><TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">11,250</TD><TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">$0.205</TD><TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="text-align: left; vertical-align: top">Option Exercise</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="vertical-align: top; text-align: left">&nbsp;</TD><TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">&nbsp;</TD><TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">&nbsp;</TD><TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">&nbsp;</TD><TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="text-align: left; vertical-align: top">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="vertical-align: top; text-align: left">March 25, 2022</TD><TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">Common Shares</TD><TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">19,607,842</TD><TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">$1.53</TD><TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: left">Prospectus Offering</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="vertical-align: top; text-align: left">&nbsp;</TD><TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">&nbsp;</TD><TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">&nbsp;</TD><TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">&nbsp;</TD><TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="vertical-align: top; text-align: left">March 25, 2022</TD><TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">Warrants</TD><TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">9,803,921</TD><TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">$2.00</TD><TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: left">Prospectus Offering</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="vertical-align: top; text-align: left">&nbsp;</TD><TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">&nbsp;</TD><TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">&nbsp;</TD><TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">&nbsp;</TD><TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="vertical-align: top; text-align: left">March 25, 2022</TD><TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">Warrants</TD><TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">1,053,922</TD><TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">$1.53</TD><TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: left">Underwriters Compensation Options (Prospectus Offering)<SUP>(1)</SUP></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="vertical-align: top; text-align: left">&nbsp;</TD><TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">&nbsp;</TD><TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">&nbsp;</TD><TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">&nbsp;</TD><TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="vertical-align: top; text-align: left">March 30, 2022</TD><TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">Common Shares</TD><TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">25,000</TD><TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">$0.225</TD><TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="text-align: left; vertical-align: top">Warrant Exercise</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="vertical-align: top; text-align: left">&nbsp;</TD><TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">&nbsp;</TD><TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">&nbsp;</TD><TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">&nbsp;</TD><TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="text-align: left; vertical-align: top">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="vertical-align: top; text-align: left">March 31, 2022</TD><TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">Options</TD><TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">287,500</TD><TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">$1.57</TD><TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: left">Option Grant</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="vertical-align: top; text-align: left">&nbsp;</TD><TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">&nbsp;</TD><TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">&nbsp;</TD><TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">&nbsp;</TD><TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="vertical-align: top; text-align: left">April 6, 2022</TD><TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">Common Shares</TD><TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">50,000</TD><TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">$0.10</TD><TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="text-align: left; vertical-align: top">Option Exercise</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="vertical-align: top; text-align: left">&nbsp;</TD><TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">&nbsp;</TD><TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">&nbsp;</TD><TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">&nbsp;</TD><TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="text-align: left; vertical-align: top">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="vertical-align: top; text-align: left">April 6, 2022</TD><TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">Common Shares</TD><TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">938,272</TD><TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">$0.15</TD><TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="text-align: left; vertical-align: top">Broker Warrant Exercise</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="vertical-align: top; text-align: left">&nbsp;</TD><TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">&nbsp;</TD><TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">&nbsp;</TD><TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">&nbsp;</TD><TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="text-align: left; vertical-align: top">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="vertical-align: top; text-align: left">April 7, 2022</TD><TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">Common Shares</TD><TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">7,500</TD><TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">$0.853</TD><TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="text-align: left; vertical-align: top">Option Exercise</TD></TR>
</TABLE>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<!-- Field: Page; Sequence: 84; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->82<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left; width: 20%">Date of issue or grant</TD><TD STYLE="font-weight: bold; width: 1%">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center; width: 19%">Type of<BR>
 Securities</TD><TD STYLE="font-weight: bold; width: 1%">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center; width: 19%">Number of <BR>
Securities</TD><TD STYLE="font-weight: bold; width: 1%">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center; width: 19%">Issue or <BR> Exercise<BR>
 Price of<BR>
 Security</TD><TD STYLE="font-weight: bold; width: 1%">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; vertical-align: bottom; font-weight: bold; text-align: center; width: 19%">Description of Transaction</TD></TR>

<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD STYLE="font-weight: bold; text-align: center">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD STYLE="font-weight: bold; text-align: center">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD STYLE="font-weight: bold; text-align: center">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD STYLE="vertical-align: top; font-weight: bold; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="vertical-align: top; text-align: left">April 8, 2022</TD><TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">Common Shares</TD><TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">850,000</TD><TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">$0.225</TD><TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="text-align: left; vertical-align: top">Warrant Exercise</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="vertical-align: top; text-align: left">&nbsp;</TD><TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">&nbsp;</TD><TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">&nbsp;</TD><TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">&nbsp;</TD><TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="text-align: left; vertical-align: top">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="vertical-align: top; text-align: left">April 13,2022</TD><TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">Common Shares</TD><TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">25,000</TD><TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">$0.225</TD><TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="text-align: left; vertical-align: top">Warrant Exercise</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="vertical-align: top; text-align: left">&nbsp;</TD><TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">&nbsp;</TD><TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">&nbsp;</TD><TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">&nbsp;</TD><TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="text-align: left; vertical-align: top">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="vertical-align: top; text-align: left">April 18, 2022</TD><TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">Common Shares</TD><TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">31,250</TD><TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">$0.60</TD><TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="text-align: left; vertical-align: top">Warrant Exercise</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="vertical-align: top; text-align: left">&nbsp;</TD><TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">&nbsp;</TD><TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">&nbsp;</TD><TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">&nbsp;</TD><TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="text-align: left; vertical-align: top">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="vertical-align: top; text-align: left">April 18, 2022</TD><TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">Common Shares</TD><TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">18,750</TD><TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">$0.74</TD><TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="text-align: left; vertical-align: top">Warrant Exercise</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="vertical-align: top; text-align: left">&nbsp;</TD><TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">&nbsp;</TD><TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">&nbsp;</TD><TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">&nbsp;</TD><TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="text-align: left; vertical-align: top">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="vertical-align: top; text-align: left">April 19, 2022</TD><TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">Common Shares</TD><TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">154,913</TD><TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">$0.40</TD><TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="text-align: left; vertical-align: top">Broker Warrant Exercise <SUP>(2)</SUP></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="vertical-align: top; text-align: left">&nbsp;</TD><TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">&nbsp;</TD><TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">&nbsp;</TD><TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">&nbsp;</TD><TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="text-align: left; vertical-align: top">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="vertical-align: top; text-align: left">April 19, 2022</TD><TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">Warrants</TD><TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">77,456</TD><TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">$0.60</TD><TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="text-align: left; vertical-align: top">Broker Warrant Exercise <SUP>(2)</SUP></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="vertical-align: top; text-align: left">&nbsp;</TD><TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">&nbsp;</TD><TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">&nbsp;</TD><TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">&nbsp;</TD><TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="text-align: left; vertical-align: top">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="vertical-align: top; text-align: left">April 19, 2022</TD><TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">Common Shares</TD><TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">56,250</TD><TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">$0.853</TD><TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="text-align: left; vertical-align: top">Option Exercise</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="vertical-align: top; text-align: left">&nbsp;</TD><TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">&nbsp;</TD><TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">&nbsp;</TD><TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">&nbsp;</TD><TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="text-align: left; vertical-align: top">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="vertical-align: top; text-align: left">April 21, 2022</TD><TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">Common Shares</TD><TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">16,875</TD><TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">$0.853</TD><TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="text-align: left; vertical-align: top">Option Exercise</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="vertical-align: top; text-align: left">&nbsp;</TD><TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">&nbsp;</TD><TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">&nbsp;</TD><TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">&nbsp;</TD><TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="text-align: left; vertical-align: top">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="vertical-align: top; text-align: left">May 2, 2022</TD><TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">Options</TD><TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">250,000</TD><TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">$1.440</TD><TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: left">Option Grant</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="vertical-align: top; text-align: left">&nbsp;</TD><TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">&nbsp;</TD><TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">&nbsp;</TD><TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">&nbsp;</TD><TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="vertical-align: top; text-align: left">May 3, 2022</TD><TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">Common Shares</TD><TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">250,000</TD><TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">$0.225</TD><TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="text-align: left; vertical-align: top">Warrant Exercise</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="vertical-align: top; text-align: left">&nbsp;</TD><TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">&nbsp;</TD><TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">&nbsp;</TD><TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">&nbsp;</TD><TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="text-align: left; vertical-align: top">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="vertical-align: top; text-align: left">May 4, 2022</TD><TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">Common Shares</TD><TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">45,000</TD><TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">$0.20</TD><TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="text-align: left; vertical-align: top">Option Exercise</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="vertical-align: top; text-align: left">&nbsp;</TD><TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">&nbsp;</TD><TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">&nbsp;</TD><TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">&nbsp;</TD><TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="text-align: left; vertical-align: top">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="vertical-align: top; text-align: left">May 4, 2022</TD><TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">Common Shares</TD><TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">357,000</TD><TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">$0.225</TD><TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="text-align: left; vertical-align: top">Warrant Exercise</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="vertical-align: top; text-align: left">&nbsp;</TD><TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">&nbsp;</TD><TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">&nbsp;</TD><TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">&nbsp;</TD><TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="text-align: left; vertical-align: top">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="vertical-align: top; text-align: left">May 5, 2022</TD><TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">Common Shares</TD><TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">150,000</TD><TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">$0.853</TD><TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="text-align: left; vertical-align: top">Option Exercise</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="vertical-align: top; text-align: left">&nbsp;</TD><TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">&nbsp;</TD><TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">&nbsp;</TD><TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">&nbsp;</TD><TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="text-align: left; vertical-align: top">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="vertical-align: top; text-align: left">May 5, 2022</TD><TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">Common Shares</TD><TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">50,000</TD><TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">$0.225</TD><TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="text-align: left; vertical-align: top">Warrant Exercise</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="vertical-align: top; text-align: left">&nbsp;</TD><TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">&nbsp;</TD><TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">&nbsp;</TD><TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">&nbsp;</TD><TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="text-align: left; vertical-align: top">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="vertical-align: top; text-align: left">May 6, 2022</TD><TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">Common Shares</TD><TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">40,000</TD><TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">$0.10</TD><TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="text-align: left; vertical-align: top">Option Exercise</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="vertical-align: top; text-align: left">&nbsp;</TD><TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">&nbsp;</TD><TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">&nbsp;</TD><TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">&nbsp;</TD><TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="text-align: left; vertical-align: top">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="vertical-align: top; text-align: left">May 6, 2022</TD><TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">Common Shares</TD><TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">50,000</TD><TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">$0.225</TD><TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="text-align: left; vertical-align: top">Warrant Exercise</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="vertical-align: top; text-align: left">&nbsp;</TD><TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">&nbsp;</TD><TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">&nbsp;</TD><TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">&nbsp;</TD><TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="text-align: left; vertical-align: top">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="vertical-align: top; text-align: left">May 9, 2022</TD><TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">Common Shares</TD><TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">100,000</TD><TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">$0.225</TD><TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="text-align: left; vertical-align: top">Warrant Exercise</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="vertical-align: top; text-align: left">&nbsp;</TD><TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">&nbsp;</TD><TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">&nbsp;</TD><TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">&nbsp;</TD><TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="text-align: left; vertical-align: top">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="vertical-align: top; text-align: left">May 10, 2022</TD><TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">Common Shares</TD><TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">37,500</TD><TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">$0.853</TD><TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="text-align: left; vertical-align: top">Option Exercise</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="vertical-align: top; text-align: left">&nbsp;</TD><TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">&nbsp;</TD><TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">&nbsp;</TD><TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">&nbsp;</TD><TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="text-align: left; vertical-align: top">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="vertical-align: top; text-align: left">May 10, 2022</TD><TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">Common Shares</TD><TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">20,000</TD><TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">$0.10</TD><TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="text-align: left; vertical-align: top">Option Exercise</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="vertical-align: top; text-align: left">&nbsp;</TD><TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">&nbsp;</TD><TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">&nbsp;</TD><TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">&nbsp;</TD><TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="text-align: left; vertical-align: top">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="vertical-align: top; text-align: left">May 11, 2022</TD><TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">Common Shares</TD><TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">75,000</TD><TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">$0.10</TD><TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="text-align: left; vertical-align: top">Option Exercise</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="vertical-align: top; text-align: left">&nbsp;</TD><TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">&nbsp;</TD><TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">&nbsp;</TD><TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">&nbsp;</TD><TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="text-align: left; vertical-align: top">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="vertical-align: top; text-align: left">May 16, 2022</TD><TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">Common Shares</TD><TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">45,000</TD><TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">$0.853</TD><TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="text-align: left; vertical-align: top">Option Exercise</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="vertical-align: top; text-align: left">&nbsp;</TD><TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">&nbsp;</TD><TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">&nbsp;</TD><TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">&nbsp;</TD><TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="text-align: left; vertical-align: top">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="vertical-align: top; text-align: left">May 16, 2022</TD><TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">Common Shares</TD><TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">40,000</TD><TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">$0.20</TD><TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="text-align: left; vertical-align: top">Option Exercise</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="vertical-align: top; text-align: left">&nbsp;</TD><TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">&nbsp;</TD><TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">&nbsp;</TD><TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">&nbsp;</TD><TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="text-align: left; vertical-align: top">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="vertical-align: top; text-align: left">May 18, 2022</TD><TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">Common Shares</TD><TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">9,375</TD><TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">$0.853</TD><TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="text-align: left; vertical-align: top">Option Exercise</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="vertical-align: top; text-align: left">&nbsp;</TD><TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">&nbsp;</TD><TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">&nbsp;</TD><TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">&nbsp;</TD><TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="text-align: left; vertical-align: top">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="vertical-align: top; text-align: left">May 26, 2022</TD><TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">Common Shares</TD><TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">112,500</TD><TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">$0.853</TD><TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="text-align: left; vertical-align: top">Option Exercise</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="vertical-align: top; text-align: left">&nbsp;</TD><TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">&nbsp;</TD><TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">&nbsp;</TD><TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">&nbsp;</TD><TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="text-align: left; vertical-align: top">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="vertical-align: top; text-align: left">May 26, 2022</TD><TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">Common Shares</TD><TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">90,000</TD><TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">$0.20</TD><TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="text-align: left; vertical-align: top">Option Exercise</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="vertical-align: top; text-align: left">&nbsp;</TD><TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">&nbsp;</TD><TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">&nbsp;</TD><TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">&nbsp;</TD><TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="text-align: left; vertical-align: top">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="vertical-align: top; text-align: left">May 26, 2022</TD><TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">Common Shares</TD><TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">12,500</TD><TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">$0.205</TD><TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="text-align: left; vertical-align: top">Option Exercise</TD></TR>
</TABLE>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<!-- Field: Page; Sequence: 85; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->83<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left; width: 20%">Date of issue or grant</TD><TD STYLE="font-weight: bold; width: 1%">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center; width: 19%">Type of<BR>
 Securities</TD><TD STYLE="font-weight: bold; width: 1%">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center; width: 19%">Number of <BR>
Securities</TD><TD STYLE="font-weight: bold; width: 1%">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center; width: 19%">Issue or <BR> Exercise<BR>
 Price of<BR>
 Security</TD><TD STYLE="font-weight: bold; width: 1%">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center; width: 19%">Description of Transaction</TD></TR>

<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD STYLE="font-weight: bold; text-align: center">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD STYLE="font-weight: bold; text-align: center">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD STYLE="font-weight: bold; text-align: center">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD STYLE="font-weight: bold; text-align: center">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">June 1, 2022</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">Options</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">500,000</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">$1.250</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">Option Grant</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">June 3, 2022</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">Common Shares</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">40,000</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">$0.20</TD><TD>&nbsp;</TD>
    <TD>Option Exercise</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">June 8, 2022</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">Common Shares</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">110,000</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">$0.20</TD><TD>&nbsp;</TD>
    <TD>Option Exercise</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">June 13, 2022</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">Common Shares</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">50,000</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">$0.20</TD><TD>&nbsp;</TD>
    <TD>Option Exercise</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">July 15, 2022</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">Options</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">400,000</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">$1.070</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">Option Grant</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">July 27, 2022</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">Common Shares</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">61,875</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">$0.64</TD><TD>&nbsp;</TD>
    <TD>Option Exercise</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">July 29, 2022</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">Common Shares</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">131,250</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">$0.613</TD><TD>&nbsp;</TD>
    <TD>Option Exercise</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">July 29, 2022</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">Common Shares</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">121,875</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">$0.466</TD><TD>&nbsp;</TD>
    <TD>Option Exercise</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">July 29, 2022</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">Common Shares</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">152,343</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">$0.80</TD><TD>&nbsp;</TD>
    <TD>Option Exercise</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">August 8, 2022</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">Common Shares</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">31,875</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">$0.64</TD><TD>&nbsp;</TD>
    <TD>Option Exercise</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">August 8, 2022</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">Common Shares</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">48,750</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">$0.466</TD><TD>&nbsp;</TD>
    <TD>Option Exercise</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">August 8, 2022</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">Common Shares</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">37,500</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">$0.613</TD><TD>&nbsp;</TD>
    <TD>Option Exercise</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">August 31, 2022</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">Common Shares</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">5,000</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">$0.15</TD><TD>&nbsp;</TD>
    <TD>Option Exercise</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">September 8, 2022</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">Common Shares</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">300,000</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">$0.20</TD><TD>&nbsp;</TD>
    <TD>Option Exercise</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">September 9, 2022</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">Common Shares</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">84,375</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">$0.64</TD><TD>&nbsp;</TD>
    <TD>Option Exercise</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">September 9, 2022</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">Common Shares</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">56,250</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">$0.61</TD><TD>&nbsp;</TD>
    <TD>Option Exercise</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">September 9, 2022</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">Common Shares</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">73,125</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">$0.47</TD><TD>&nbsp;</TD>
    <TD>Option Exercise</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">September 9, 2022</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">Common Shares</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">91,406</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">$0.80</TD><TD>&nbsp;</TD>
    <TD>Option Exercise</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">September 14, 2022</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">n/a</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">n/a</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">n/a</TD><TD>&nbsp;</TD>
    <TD>Share Consolidation <SUP>(3)</SUP></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">November 1, 2022</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">Options</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">148,334</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">$3.65</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">Option Grant</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">November 10, 2022</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">Common Shares</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">51,368</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">$1.20</TD><TD>&nbsp;</TD>
    <TD>Broker Warrant Exercise <SUP>(3)</SUP></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">November 10, 2022</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">Warrants</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">25,819</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">$1.80</TD><TD>&nbsp;</TD>
    <TD>&nbsp;Broker Warrant Exercise <SUP>(3)</SUP></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">November 14, 2022</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">Options</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">50,000</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">$3.25</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">Option Grant</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">November 16, 2022</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">Common Shares</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">291,666</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">$1.559</TD><TD>&nbsp;</TD>
    <TD>Warrant Exercise</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">November 22, 2022</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">Common Shares</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">177,455</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">$2.22</TD><TD>&nbsp;</TD>
    <TD>Warrant Exercise</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>

<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; width: 20%">November 23, 2022</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="text-align: center; width: 19%">Common Shares</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="text-align: center; width: 19%">250,612</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="text-align: center; width: 19%">$2.22</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 19%">Warrant Exercise</TD></TR>
</TABLE>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<!-- Field: Page; Sequence: 86; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->84<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left; width: 20%">Date of issue or grant</TD><TD STYLE="font-weight: bold; width: 1%">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center; width: 19%">Type of<BR>
 Securities</TD><TD STYLE="font-weight: bold; width: 1%">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center; width: 19%">Number of <BR>
Securities</TD><TD STYLE="font-weight: bold; width: 1%">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center; width: 19%">Issue or <BR> Exercise<BR>
 Price of<BR>
 Security</TD><TD STYLE="font-weight: bold; width: 1%">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center; width: 19%">Description of Transaction</TD></TR>

<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; width: 20%">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="text-align: center; width: 19%">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="text-align: center; width: 19%">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="text-align: center; width: 19%">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 19%">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">November 24, 2022</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">Common Shares</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">4,346</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">$2.22</TD><TD>&nbsp;</TD>
    <TD>Warrant Exercise</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">November 25, 2022</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">Common Shares</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">1,125</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">$2.22</TD><TD>&nbsp;</TD>
    <TD>Warrant Exercise</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">November 25, 2022</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">Common Shares</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">28,819</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">$1.80</TD><TD>&nbsp;</TD>
    <TD>Warrant Exercise</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">November 30, 2022</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">Common Shares</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">62,500</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">$2.22</TD><TD>&nbsp;</TD>
    <TD>Warrant Exercise</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">December 2, 2022</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">Common Shares</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">117,457</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">$2.22</TD><TD>&nbsp;</TD>
    <TD>Warrant Exercise</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">December 5, 2022</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">Common Shares</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">18,750</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">$1.92</TD><TD>&nbsp;</TD>
    <TD>Option Exercise</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">December 5, 2022</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">Common Shares</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">12,500</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">$1.84</TD><TD>&nbsp;</TD>
    <TD>Option Exercise</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">December 5, 2022</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">Common Shares</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">16,250</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">$1.398</TD><TD>&nbsp;</TD>
    <TD>Option Exercise</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">December 5, 2022</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">Common Shares</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">20,312</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">$2.40</TD><TD>&nbsp;</TD>
    <TD>Option Exercise</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">December 6, 2022</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">Common Shares</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">8,861</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">$2.22</TD><TD>&nbsp;</TD>
    <TD>Warrant Exercise</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">December 9, 2022</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">Common Shares</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">3,843</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">$2.22</TD><TD>&nbsp;</TD>
    <TD>Warrant Exercise</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">December 12, 2022</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">Common Shares</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">12,500</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">$1.84</TD><TD>&nbsp;</TD>
    <TD>Option Exercise</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">December 12, 2022</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">Common Shares</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">16,250</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">$1.398</TD><TD>&nbsp;</TD>
    <TD>Option Exercise</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">December 12, 2022</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">Common Shares</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">16,250</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">$2.40</TD><TD>&nbsp;</TD>
    <TD>Option Exercise</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">December 19, 2022</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">Options</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">50,000</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">$3.30</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">Option Grant</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">December 19, 2022</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">Common Shares</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">812</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">$1.398</TD><TD>&nbsp;</TD>
    <TD>Option Exercise</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">December 19, 2022</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">Common Shares</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">1,667</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">$2.40</TD><TD>&nbsp;</TD>
    <TD>Option Exercise</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">December 22, 2022</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">Common Shares</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">62,500</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">$0.60</TD><TD>&nbsp;</TD>
    <TD>Option Exercise</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">December 22, 2022</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">Common Shares</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">18,750</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">$1.92</TD><TD>&nbsp;</TD>
    <TD>Option Exercise</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">December 22, 2022</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">Common Shares</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">12,500</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">$1.84</TD><TD>&nbsp;</TD>
    <TD>Option Exercise</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">December 22, 2022</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">Common Shares</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">16,250</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">$1.398</TD><TD>&nbsp;</TD>
    <TD>Option Exercise</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">December 22, 2022</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">Common Shares</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">30,312</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">$2.40</TD><TD>&nbsp;</TD>
    <TD>Option Exercise</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">December 22, 2022</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">Common Shares</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">6.250</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">$2.22</TD><TD>&nbsp;</TD>
    <TD>Warrant Exercise</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">December 23, 2022</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">Common Shares</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">16,718</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">$2.22</TD><TD>&nbsp;</TD>
    <TD>Warrant Exercise</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">December 28, 2022</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">Common Shares</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">12,343</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">$2.22</TD><TD>&nbsp;</TD>
    <TD>Warrant Exercise</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">December 28, 2022</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">Common Shares</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">37,500</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">$1.59</TD><TD>&nbsp;</TD>
    <TD>Warrant Exercise</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">December 30, 2022</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">Common Shares</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">18,750</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">$1.92</TD><TD>&nbsp;</TD>
    <TD>Option Exercise</TD></TR>
  </TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 87; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->85<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><U>Notes</U>:</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in">(1)</TD><TD STYLE="text-align: justify">Each Compensation Option is exercisable to acquire one common share at and exercise price of $1.53 per
share until March 25, 2024.</TD></TR>
                                     </TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in">(2)</TD><TD STYLE="text-align: justify">Each broker unit warrant is exercisable into a unit (comprised of one Common Share and one-half of one
Common Share purchase warrant) at an exercise price of $0.60 until October 22, 2023.</TD></TR>
                                                                                              </TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in">(3)</TD><TD STYLE="text-align: justify">Effective September 14, 2022, The Company completed a share consolidation on a basis of one new share
for every three former shares.</TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">ESCROWED SECURITIES AND SECURITIES SUBJECT
TO CONTRACTUAL RESTRICTION ON TRANSFER</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">There were no securities of any class of securities
issued by the Company held in escrow or otherwise subject to contractual restriction on transfer as at December 31, 2022, with the exception
that all of the directors and officers of the Company entered into lock-up agreements with the underwriters pursuant to the financing
that occurred in December of 2022, whereby they agreed not to sell or transact in their Shares for a period expiring 120 days from February
14, 2023 without the consent of the underwriters.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As of the date of the AIF, no securities of any
class of securities of enCore are held in escrow or are anticipated to be held in escrow.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">DIRECTORS AND OFFICERS</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">Name, Occupation and Security Holding</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The following table sets forth the name, municipality
of residence and principal occupation during the last five years for those persons who are currently directors and officers of enCore:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR>
    <TD STYLE="vertical-align: bottom; border-bottom: Black 1.5pt solid; width: 25%; text-align: center"><B>Name, province or state<BR>
 and country of<BR>
 residence and position,<BR>
 if any, held in the<BR>
 Company</B></TD>
    <TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="text-align: center; border-bottom: Black 1.5pt solid; width: 30%; vertical-align: bottom">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Principal occupation</B></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>during the past five years</B></P></TD>
    <TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; border-bottom: Black 1.5pt solid; width: 17%; text-align: center"><B>Served as director<BR>
 of the Company<BR>
 since</B></TD>
    <TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: center; width: 25%"><B>Number of common<BR>
 shares of the Company<BR>
 beneficially owned,<BR>
 directly or indirectly,<BR>
 or controlled or<BR>
 directed at present<SUP>(1)</SUP></B></TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Dennis E. Stover</B><SUP>(6)(7)(8)</SUP><B><BR>
    </B><I>Director and Chief Technical Officer</I></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Oklahoma, USA</P></TD>
    <TD>&nbsp;</TD>
    <TD>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT>Chief Technical Officer of enCore
    since October 2020; CEO of the Company from August 2014 to October 2020.</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">February 9, 2012</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">280,500</TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>William M. Sheriff </B><SUP>(6)(7)(9)<BR>
    </SUP><I>Director and Executive Chairman</I></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">British Columbia, Canada</P></TD>
    <TD>&nbsp;</TD>
    <TD>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT>Chairman of enCore since 2009
    and Executive Chairman of enCore since January 2019.&nbsp; Executive Chairman of Golden Predator Mining Corp from April 2014 to September
    2021. Director of Exploits Discovery Corp. since October 2020. Chairman of Sabre Gold Mines Corp. since September 2021. &nbsp;</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">October 30, 2009</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">2,025,722</TD></TR>
</TABLE>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin-top: 0; margin-bottom: 0"></P>

<!-- Field: Page; Sequence: 88; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->86<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR>
    <TD STYLE="vertical-align: bottom; border-bottom: Black 1.5pt solid; text-align: center; width: 25%"><B>Name, province or state<BR>
 and country of<BR>
 residence and position,<BR>
 if any, held in the<BR>
 Company</B></TD>
    <TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="text-align: center; border-bottom: Black 1.5pt solid; width: 30%; vertical-align: bottom">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Principal occupation</B></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>during the past five years</B></P></TD>
    <TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; border-bottom: Black 1.5pt solid; text-align: center; width: 17%"><B>Served as director<BR>
 of the Company<BR>
 since</B></TD>
    <TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: center; width: 25%"><B>Number of common<BR>
 shares of the Company<BR>
 beneficially owned,<BR>
 directly or indirectly,<BR>
 or controlled or<BR>
 directed at present<SUP>(1)</SUP></B></TD></TR>

  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>William B. Harris </B><SUP>(3)(4)(5)(7)<BR>
    </SUP><I>Director</I></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Florida, USA<BR>
    <BR>
    </P></TD>
    <TD>&nbsp;</TD>
    <TD>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Partner of Solo Management Group, LLC, an investment management and
    financial consulting company since 1998. Director of Scandium International Mining Corp. since 2007.</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B></B></P></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">October 30, 2009</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">201,111</TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Mark S. Pelizza </B><SUP>(4)(5)(8)</SUP><B><BR>
    </B><I>Director</I></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Texas, USA<BR>
    <BR>
    </P></TD>
    <TD>&nbsp;</TD>
    <TD>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Principal of M.S. Pelizza &amp; Associates since September 2014. Professional
    Geoscientist and Certified Professional Geologist.</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">December 18, 2014</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">345,000<SUP>(2)</SUP></TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Richard M. Cherry </B><SUP>(3)(4)(8)</SUP><B><BR>
    </B><I>Director</I></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Oklahoma, USA</P></TD>
    <TD>&nbsp;</TD>
    <TD>Independent consultant since April of 2006.&nbsp;&nbsp;Professional Engineer.</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">December 31, 2014</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">31,667</TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>W. Paul Goranson</B> <SUP>(6)(7)(9)</SUP><B><BR>
    </B><I>Director and CEO</I></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Texas, USA</P></TD>
    <TD>&nbsp;</TD>
    <TD>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Professional Engineer; CEO of enCore since October 2020; Chief Operating
    Officer for Energy Fuels Resources (USA) Inc. from June 2015 to August 2020.</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">September 14, 2020</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">309,195</TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Carrie Mierkey</B><SUP>(9)</SUP></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>CFO </I></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Texas, USA</P></TD>
    <TD>&nbsp;</TD>
    <TD>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Certified Public Accountant with over 13 years of experience in finance
    for both private and public companies; former corporate controller of Motion &amp; Flow Control Products, Inc.</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">-</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">297</TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Susan Hoxie-Key</B><SUP>(3)(5)</SUP></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>Director </I></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Alabama, USA</P></TD>
    <TD>&nbsp;</TD>
    <TD>Consulting Engineer, Nuclear Fuel Department, Southern Nuclear Operating Company, Inc.</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">June 22, 2022</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">Nil</TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Peter Luthiger </B></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>Chief Operating Officer</I></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Texas, USA</P></TD>
    <TD>&nbsp;</TD>
    <TD>Director of Texas Operations for Energy Fuels, Inc. </TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">-</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">Nil</TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Greg Zerzan</B><SUP>(9)</SUP></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>Chief Administrative Officer, Corporate Secretary</I></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Texas, USA</P></TD>
    <TD>&nbsp;</TD>
    <TD>Principal Deputy Solicitor of the United States Department of the Interior</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">-</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">Nil</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><U>Notes:</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in">(1)</TD><TD STYLE="text-align: justify">The information as to principal occupation, business or employment and common shares beneficially owned
or controlled has been provided by the nominees themselves or obtained through SEDI.</TD></TR>
                                                                                              </TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in">(2)</TD><TD STYLE="text-align: justify">166,667 of these Common Shares are held indirectly by Mark Pelizza through The Pelizza Family Limited
Partnership.</TD></TR>
                      </TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in">(3)</TD><TD STYLE="text-align: justify">A member of the Audit Committee.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in">(4)</TD><TD STYLE="text-align: justify">A member of the Compensation Committee.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in">(5)</TD><TD STYLE="text-align: justify">A member of the Governance and Nominating Committee</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in">(6)</TD><TD STYLE="text-align: justify">A member of the Option Grant Committee</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in">(7)</TD><TD STYLE="text-align: justify">A member of the Investment Committee.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in">(8)</TD><TD STYLE="text-align: justify">A member of the Health, Safety, Environment and Sustainability Committee.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in">(9)</TD><TD STYLE="text-align: justify">A member of the Disclosure Committee</TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"></P>

<!-- Field: Page; Sequence: 89; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->87<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">Cease Trade Orders, Bankruptcies, Penalties
or Sanctions</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">To the knowledge of the Company, no director or
executive officer of the Company, or a personal holding company of such person is, as at the date of this AIF, or has been, within 10
years before the date of this AIF, a director, chief executive officer or chief financial officer of any company that:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">(a)</TD><TD STYLE="text-align: justify">was subject to an order that was issued while the director or executive officer was acting in the capacity
as director, chief executive officer or chief financial officer, or</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">(b)</TD><TD STYLE="text-align: justify">was subject to an order that was issued after the director or executive officer ceased to be a director,
chief executive officer or chief financial officer and which resulted from an event that occurred while that person was acting in the
capacity as director, chief executive officer or chief financial officer.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">For the purposes
herein, &ldquo;order&rdquo; means</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">(a)</TD><TD STYLE="text-align: justify">a cease trade order;</TD></TR><TR STYLE="vertical-align: top">
<TD>&nbsp;</TD><TD>&nbsp;</TD><TD STYLE="text-align: justify">&nbsp;</TD></TR>
                                                                                                                               </TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">(b)</TD><TD STYLE="text-align: justify">an order similar to a cease trade order; or</TD></TR><TR STYLE="vertical-align: top">
<TD>&nbsp;</TD><TD>&nbsp;</TD><TD STYLE="text-align: justify">&nbsp;</TD></TR>
                                                                                                                                                      </TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">(c)</TD><TD STYLE="text-align: justify">an order that denied the relevant company access to any exemption under securities legislation,</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">that was in effect for a period of
more than 30 consecutive days.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">To the knowledge of the Company, no director or
executive officer of the Company, or a shareholder holding a sufficient number of securities to affect materially the control of the Company,
or a personal holding company of such person:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">(a)</TD><TD STYLE="text-align: justify">is, as at the date of the AIF, or has been within the 10 years before the date of the AIF, a director
or executive officer of any company (including your company) that, while that person was acting in that capacity, or within a year of
that person ceasing to act in that capacity, became bankrupt, made a proposal under any legislation relating to bankruptcy or insolvency
or was subject to or instituted any proceedings, arrangement or compromise with creditors or had a receiver, receiver manager or trustee
appointed to hold its assets;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">(b)</TD><TD STYLE="text-align: justify">has, within the 10 years before the date of the AIF, become bankrupt, made a proposal under any legislation
relating to bankruptcy or insolvency, or become subject to or instituted any proceedings, arrangement or compromise with creditors, or
had a receiver, receiver manager or trustee appointed to hold the assets of the director, executive officer or shareholder;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">(c)</TD><TD STYLE="text-align: justify">has been subject to any penalties or sanctions imposed by a court relating to securities legislation or
by a securities regulatory authority or has entered into a settlement agreement with a securities regulatory authority; or</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">(d)</TD><TD STYLE="text-align: justify">has been subject to any other penalties or sanctions imposed by a court or regulatory body that would
likely be considered important to a reasonable investor in making an investment decision.</TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">Conflicts of Interest</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company&rsquo;s directors and officers may
serve as directors or officers of other companies or have significant shareholdings in other resource companies and, to the extent that
such other companies may participate in ventures in which the Company may participate, the directors or officers of the Company may have
a conflict of interest in negotiating and concluding terms respecting the extent of such participation. In the event that such a conflict
of interest arises at a meeting of the Company&rsquo;s directors, a director who has such a conflict will abstain from voting for or against
the approval of such participation or such terms. From time to time, several companies may participate in the acquisition, exploration
and development of natural resource properties thereby allowing for their participation in larger programs, permitting involvement in
a greater number of programs and reducing financial exposure in respect of any one program. It may also occur that a particular company
will assign all or a portion of its interest in a particular program to another of these companies due to the financial position of the
company making the assignment. The directors of the Company are required to act honestly, in good faith and in the best interests of the
Company. In determining whether or not the Company will participate in a particular program and the interest therein to be acquired by
it, the directors will primarily consider the degree of risk to which the Company may be exposed and its financial position at that time.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 90; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->88<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The directors and officers of the Company are
aware of the existence of laws governing the accountability of directors and officers for corporate opportunity and requiring disclosures
by the directors and officers of conflicts of interest and the Company will rely upon such laws in respect of any directors&rsquo; and
officers&rsquo; conflicts of interest or in respect of any breaches of duty by any of its directors and officers. All such conflicts will
be disclosed by such directors or officers in accordance with the BCBCA and will govern themselves in respect thereof to the best of their
ability in accordance with the obligations imposed upon them by law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">To the best of the Company&rsquo;s knowledge,
and other than as disclosed above and elsewhere in this AIF, there are no known existing or potential conflicts of interest among the
Company, its subsidiaries, directors and officers or other members of management of the Company or its subsidiaries as a result of their
outside business interests.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">Audit Committee Information</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Pursuant to the Section 224(1) of the British
Columbia <I>Business Corporations Act </I>and National Instrument 52-110 of the Canadian Securities Administrators (&ldquo;<B>NI 52-110</B>&rdquo;),
the Company is required to have an audit committee (the &ldquo;<B>Audit Committee</B>&rdquo;) comprised of not less than three directors,
a majority of whom are not officers, control persons or employees of the Company or an affiliate of the Company. NI 52-110 requires the
Company as a venture issuer, to disclose annually its information circular certain information concerning the composition of its audit
committee and its relationship with its independent auditor, as set forth below.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Audit Committee Charter</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Audit Committee&rsquo;s charter is attached
as Schedule &ldquo;A&rdquo; to this AIF.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Composition of the Audit Committee and Independence
</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company&rsquo;s current Audit Committee consists
of William B. Harris (Chair), Richard M. Cherry and Susan Hoxie-Key.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">National Instrument 52-110 - <I>Audit Committees
</I>(&ldquo;<B>NI 52-110</B>&rdquo;) provides that a member of an audit committee is &ldquo;independent&rdquo; if the member has no direct
or indirect material relationship with the Company, which could, in the view of the Company&rsquo;s Board, reasonably interfere with the
exercise of the member&rsquo;s independent judgment. All of the Company&rsquo;s current Audit Committee members are &ldquo;independent&rdquo;
within the meaning of NI 52-110. NI 52-110 provides that an individual is &ldquo;financially literate&rdquo; if he or she has the ability
to read and understand a set of financial statements that present a breadth and level of complexity of accounting issues that are generally
comparable to the breadth and complexity of the issues that can reasonably be expected to be raised by the Company&rsquo;s financial statements.
All of the members of the Audit Committee are &ldquo;financially literate&rdquo; as that term is defined. The following sets out the Audit
Committee members&rsquo; education and experience that is relevant to the performance of his responsibilities as an audit committee member.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 91; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->89<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Relevant Education and Experience</B></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-style: normal">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">All members of the Audit Committee have:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD STYLE="text-align: justify">an understanding of the accounting principles used by the Company to prepare its financial statements,
and the ability to assess the general application of those principles in connection with estimates, accruals and provisions;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD STYLE="text-align: justify">experience preparing, auditing, analyzing or evaluating financial statements that present a breadth and
level of complexity of accounting issues that are generally comparable to the breadth and complexity of issues that can reasonably be
expected to be raised by the Company&rsquo;s financial statements, or experience actively supervising individuals engaged in such activities;
and</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD>an understanding of internal controls and procedures for financial reporting.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The relevant education and/or experience of each
member of the Audit Committee is described below:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>William B. Harris - </I>Mr. Harris is a partner
of Solo Management Group, LLC, an investment and management consulting firm. He is currently a director of Scandium International Mining
Corp. He was previously a board and Audit Committee member of Gold One International Limited, Potash One Inc., and Energy Metals Corporation,
Chairman and Executive Committee member of the American Fiber Manufacturers Association, and former President and CEO of Hoechst Fibers
Worldwide, the global acetate and polyester business of Hoechst AG. At Hoechst Fibers Worldwide, Mr. Harris managed the business&rsquo;
$5 billion operation, comprised of 21,000 employees and production locations in 14 different countries. Within Hoechst AG and its subsidiaries,
Mr. Harris held various positions, including Chairman of the Board of Grupo Celanese S.A., a publicly traded company in Mexico with sales
in excess of $1 billion, and VP Finance, CFO, Executive VP and Director of Celanese Canada Inc. a publicly-traded company in Canada. He
was also VP, Treasurer and Chairman of the Audit Committee of Hoechst Celanese Corporation. Mr. Harris is a graduate of Harvard College
(BA in English) and Columbia University Graduate School of Business (MBA in Finance).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Richard M. Cherry &ndash; </I>Mr. Cherry is
a veteran executive of the nuclear industry, having worked for several leading companies in the areas of uranium mining, production, conversion,
marketing and power generation operations for 40 years. He is currently a consultant to the uranium mining industry. Mr. Cherry previously
served as President and CEO of Cotter Corporation and Nuclear Fuels Corporation, both affiliates of General Atomics Corporation. Mr. Cherry
was responsible for all aspects of Cotter&rsquo;s mining and milling operations in Colorado, including uranium and vanadium ores with
over 200 employees. His participation in Nuclear Fuels Corporation made him responsible for the worldwide uranium marketing efforts for
all General Atomics&rsquo; affiliates. Mr. Cherry also served as Vice President of ConverDyn and Nuclear Fuels Corporation. ConverDyn
is a joint venture between Honeywell International and General Atomics focused on marketing uranium conversion services to large electrical
utilities worldwide. Mr. Cherry has international experience having served UG, U.S.A Inc. of Atlanta, Georgia as Vice President. UG U.S.A
Inc. is the US subsidiary of the German uranium trading company based in Frankfurt, which trades all forms of nuclear fuel. Mr. Cherry
also served as the Regional Director-Far East for Sequoyah Fuels Corporation marketing the Company&rsquo;s uranium conversion services
to clients in Japan, South Korea and Taiwan. Mr. Cherry also previously served as CEO &amp; President of Zenith Minerals, a private uranium
mining company, CEO &amp; Director of Uranium International, and served on the board of Sequoyah Fuels Corporation. Mr. Cherry held various
management and technical positions at Kansas Gas and Electric for the Wolf Creek Nuclear Generating Station as it progressed from construction
through start-up and power generation, he was responsible for all commercial and technical areas required to secure and design nuclear
fuel. Mr. Cherry holds an M.S. in Mechanical Engineering from Wichita State University and a B.S. in Engineering Physics from the University
of Oklahoma. He is a Licensed Professional Engineer (State of Kansas) and a Member of the American Nuclear Society and has made presentations
at industry conferences including the Nuclear Energy Institute.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 92; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->90<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Susan Hoxie-Key </I>&ndash; Ms. Hoxie-Key is
a proven nuclear industry leader, with more than 40 years of engineering experience covering nuclear core design, nuclear fuel-related
licensing, nuclear fuel procurement, oversight of nuclear fuel-related engineering products, and direct support of reactor operations.
She worked for Southern Nuclear Operating Company (SNC) for 31 years, where she directed and conducted complex multi-disciplinary projects
involving in-reactor fuel performance, fuel procurement, fuel-related licensing, and core design. She also served as the SNC lead for
nuclear industry efforts to increase the uranium enrichment limit above 5 weight percent and to increase the current licensed fuel burnup
limit. Ms. Hoxie-Key was a 2008 winner of the American Nuclear Society (ANS) Oestmann Achievement Award for technical achievement in the
fields of nuclear science, engineering, research or education. She has also held numerous nuclear industry leadership roles across the
years, including Chairman of the World Nuclear Fuel Market (WNFM) Board of Governors between June 2016 and June 2018, and member of the
Nuclear Energy Institute (NEI) Accident Tolerant Fuel Safety Benefits and Licensing Task Forces. Ms. Hoxie-Key earned her bachelor&rsquo;s
degree in nuclear engineering from Mississippi State University and her master&rsquo;s degree in nuclear engineering from Georgia Institute
of Technology. She is a registered Professional Engineer in Alabama and Georgia.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><B>Audit Committee Oversight</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 5.7pt 0pt 0; text-align: justify"><FONT STYLE="font-weight: normal">Since
the commencement of the Company&rsquo;s most recently completed financial year, the Audit Committee of the Company has not made any recommendations
to nominate or compensate an external auditor which were not adopted by the Board. </FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><B>Reliance on Certain Exemptions</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Since the commencement of the Company&rsquo;s most recently completed
financial year, the Company has not relied on:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">(a)</TD><TD>the exemption in section 2.4 (De Minimis Non-Audit Services) of NI 52-110;</TD></TR><TR STYLE="vertical-align: top">
<TD>&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD></TR>
                                                                                                                                                         </TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">(b)</TD><TD>the exemption in section 6.1.1(4) (Circumstance Affecting the Business or Operations of the Venture Issuer);</TD></TR><TR STYLE="vertical-align: top">
<TD>&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD></TR>
                                                                                                                                                                                           </TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">(c)</TD><TD>the exemption in section 6.1.1(5) (Events Outside Control of Member);</TD></TR><TR STYLE="vertical-align: top">
<TD>&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD></TR>
                                                                                                                                                    </TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">(d)</TD><TD>the exemption in section 6.1.1(6) (Death, Incapacity or Resignation), or</TD></TR><TR STYLE="vertical-align: top">
<TD>&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD></TR>
                                                                                                                                                       </TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">(e)</TD><TD>an exemption from NI 52-110, in whole or in part, granted under Part 8 (Exemptions).</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company has also not relied on the exemption
in subsection 3.3(2) (Controlled Companies), section 3.6 (Temporary Exemption for Limited and Exceptional Circumstances), or section 3.8
(Acquisition of Financial Literacy).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><B>Pre-Approval Policies and Procedures </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The Audit Committee has not adopted any specific policies and procedures
for the engagement of non-audit services.</P>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 93; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->91<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Audit Fees</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify"><FONT STYLE="font-weight: normal">The
following table sets forth the fees paid by the Company and its subsidiaries to Davidson &amp; Company LLP, Chartered Professional Accountants,
for services rendered in the last two financial years:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 7.5pt 0pt 0; text-align: justify"><FONT STYLE="font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 7.5pt 0pt 0; text-align: justify"><FONT STYLE="font-weight: normal"></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">Financial Year Ending</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Audit Fees<SUP>(1)</SUP></TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Audit Related Fees<SUP>(2)</SUP></TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Tax Fees<SUP>(3)</SUP></TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">All Other Fees<SUP>(4)</SUP></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 20%; text-align: left">December 31, 2022</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 19%; text-align: center">$175,110</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 19%; text-align: center">$Nil</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 19%; text-align: center">$Nil</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 19%; text-align: center">$54,154</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">December 31, 2021</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">$136,647</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">$Nil</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">$Nil</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">$Nil</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify"><FONT STYLE="font-weight: normal">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><U>Notes:</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in">(1)</TD><TD STYLE="text-align: justify">&ldquo;Audit fees&rdquo; include aggregate fees billed by the Company&rsquo;s external auditor in each
of the last two financial years for audit fees.</TD></TR>
                                                         </TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in">(2)</TD><TD STYLE="text-align: justify; padding-right: 0.2pt">&ldquo;Audit related fees&rdquo; include the aggregate fees billed in each of the
last two financial years noted above for assurance and related services by the Company&rsquo;s external auditor that are reasonably related
to the performance of the audit or review of the Company&rsquo;s financial statements and are not reported under &ldquo;Audit fees&rdquo;
above. The services provided include employee benefit audits, due diligence assistance, accounting consultations on proposed transactions,
internal control reviews and audit or attest services not required by legislation or regulation.</TD></TR>
                                                                                                          </TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in">(3)</TD><TD STYLE="text-align: justify; padding-right: 0.2pt">&ldquo;Tax fees&rdquo; include the aggregate fees billed in each of the last two
financial years for professional services rendered by the Company&rsquo;s external auditor for tax compliance, tax advice and tax planning.
The services provided include tax planning and tax advice includes assistance with tax audits and appeals, tax advice related to mergers
and acquisitions, and requests for rulings or technical advice from tax authorities.</TD></TR>
                                                                                              </TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in">(4)</TD><TD STYLE="text-align: justify; padding-right: 0.2pt">&ldquo;All other fees&rdquo; include the aggregate fees billed in each of the last
two financial years for products and services provided by the Company&rsquo;s external auditor, other than &ldquo;Audit fees&rdquo;, &ldquo;Audit
related fees&rdquo; and &ldquo;Tax fees&rdquo; above.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">LEGAL PROCEEDINGS</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company is not aware of any legal proceedings
to which the Company is or was a party, or to which the Company&rsquo;s property is or was subject of, either during the financial year
ended December 31, 2022, and as of the date hereof, nor is the Company aware that any such proceedings are contemplated.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">REGULATORY ACTIONS</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">There have been no penalties or sanctions imposed
against the Company by a court relating to securities legislation or by a securities regulatory authority during the year ended December
31, 2022.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">There have been no other penalties or sanctions
imposed by a court or regulatory body against the Company during the year ended December 31, 2022 that would likely be considered important
to a reasonable investor in making an investment decision.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">There have been no settlement agreements that
the Company has entered into before a court relating to securities legislation or with a securities regulatory authority during the year
ended December 31, 2022.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">INTEREST OF MANAGEMENT AND OTHERS IN MATERIAL
TRANSACTIONS</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">No informed person (a director, officer or holder
of more than 10% of the Company&rsquo;s issued and outstanding Common Shares) or any associate or affiliate of any informed person had
any interest, direct or indirect, in any transaction that has materially affected or is reasonably expected to materially affect the Company
or any of its subsidiaries, within the three most recently completed financial years or during the current financial year.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">TRANSFER AGENT AND REGISTRAR</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The transfer agent and Registrar for the Common
Shares is Computershare Trust Company of Canada, located at 510 Burrard Street, 3<SUP>rd</SUP> Floor, Vancouver, British Columbia V6C
3B9. enCore has not appointed a Registrar and transfer agent for the enCore Preferred Shares, and there are no such shares issued and
outstanding.</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Page; Sequence: 94; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->92<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">MATERIAL CONTRACTS</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The following is a description of each material contract entered into
by the Company since the beginning of the last financial year ended December 31, 2022, or before the last financial year, if such material
contract is still in effect:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD STYLE="text-align: justify">Warrant indenture dated as of December 6, 2022, as supplemented by a supplemental warrant indenture dated
February 3, 2023 between the Company and Computershare Trust Company of Canada;</TD></TR><TR STYLE="vertical-align: top">
<TD>&nbsp;</TD><TD>&nbsp;</TD><TD STYLE="text-align: justify">&nbsp;</TD></TR>
                                                                                         </TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD STYLE="text-align: justify">Subscription receipt agreement dated December 6, 2022, and as amended on January 25, 2023 among the Company,
Computershare Trust Company of Canada as Subscription Receipt Agent, and Canaccord Genuity Corp., on their own behalf and on behalf of
Haywood Securities Inc., Cantor Fitzgerald Canada Corporation, PI Financial Corp., Clarus Securities Inc., and Red Cloud Securities Inc.;</TD></TR><TR STYLE="vertical-align: top">
<TD>&nbsp;</TD><TD>&nbsp;</TD><TD STYLE="text-align: justify">&nbsp;</TD></TR>
                                                                                                                                                   </TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD STYLE="text-align: justify">Underwriting agreement dated December 6, 2022, and as amended on January 25, 2023 among the Company, Canaccord
Genuity Corp. and Haywood Securities Inc., Cantor Fitzgerald Canada Corporation, PI Financial Corp., Clarus Securities Inc., and Red Cloud
Securities Inc.</TD></TR><TR STYLE="vertical-align: top">
<TD>&nbsp;</TD><TD>&nbsp;</TD><TD STYLE="text-align: justify">&nbsp;</TD></TR>
                         </TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD STYLE="text-align: justify">Membership interest purchase agreement by and among EFR White Canyon Corp., enCore Energy Corp., and enCore
Energy US Corp. dated November 13, 2022;</TD></TR><TR STYLE="vertical-align: top">
<TD>&nbsp;</TD><TD>&nbsp;</TD><TD STYLE="text-align: justify">&nbsp;</TD></TR>
                                                  </TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD STYLE="text-align: justify">Warrant indenture dated as of March 25, 2022 between the Company and Computershare Trust Company of Canada;
and</TD></TR><TR STYLE="vertical-align: top">
<TD>&nbsp;</TD><TD>&nbsp;</TD><TD STYLE="text-align: justify">&nbsp;</TD></TR>
             </TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD STYLE="text-align: justify">The underwriting agreement dated March 7, 2022 among the Company, Clarus Securities Inc., as lead underwriter
and sole book-runner, together with PI Financial Corp., and Red Cloud Securities Inc.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Copies of the above noted agreements have been
filed under the Company&rsquo;s profile on www.SEDAR.com.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">A copy of any material contract or report may
be inspected during normal business hours at the Company&rsquo;s records office.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">INTERESTS OF EXPERTS</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Names of Experts</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The following experts have prepared or certified
a report, valuation, statement or opinion described or included in a filing, or referred to in a filing, made under National Instrument
51-102 <I>Continuous Disclosure Obligations</I> by the Company during, or relating to, the year ended December 31, 2021, whose profession
or business gives authority to the report, valuation, statement or opinion made by such expert.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The following are the qualified persons involved
in preparing the NI 43-101 Technical Reports or who certified a statement, report or valuation from which certain scientific and technical
information relating to the enCore&rsquo;s material mineral projects contained in this AIF has been derived, and in some instances extracted
from:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD STYLE="text-align: justify">Douglas L. Beahm, P.E., P.G., BRS Inc. and Terence P. McNulty, PE, PHD, McNulty and Associates prepared
the Marquez-Juan Technical Report;</TD></TR><TR STYLE="vertical-align: top">
<TD>&nbsp;</TD><TD>&nbsp;</TD><TD STYLE="text-align: justify">&nbsp;</TD></TR>
                                            </TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD STYLE="text-align: justify">Douglas L. Beahm, P.E., P.G., Carl Warren, P.E., P.G., and W. Paul Goranson, P.E. prepared the Crownpoint
and Hosta Butte Technical Report;</TD></TR><TR STYLE="vertical-align: top">
<TD>&nbsp;</TD><TD>&nbsp;</TD><TD STYLE="text-align: justify">&nbsp;</TD></TR>
                                           </TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD STYLE="text-align: justify">Matthew Yovich, P.E. of Woodard &amp; Curran and Steve Cutler, P.G. of Roughstock Mining Services, LLC
prepared the Dewey Burdock Technical Report;</TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="margin-top: 0; margin-bottom: 0"></P>

<!-- Field: Page; Sequence: 95; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->93<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD STYLE="text-align: justify">Ray Moores, P.E. of Western Water Consultants Inc. and Steve Cutler, P.G. of Roughstock Mining Services,
LLC prepared the Gas Hills Technical Report; and</TD></TR><TR STYLE="vertical-align: top">
<TD>&nbsp;</TD><TD>&nbsp;</TD><TD STYLE="text-align: justify">&nbsp;</TD></TR>
                                                          </TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD STYLE="text-align: justify">Douglas Beahm, P.E. P.G., BRS Inc. prepared the Altea Mesa Technical Report.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The named experts held, directly or indirectly,
less than one percent of the issued and outstanding common shares of enCore or Azarga, as applicable, at the time of the preparation of
the Technical Reports. The authors have reviewed and approved the technical and scientific information include in this AIF, which has
been summarized from the Technical Reports.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Davidson &amp; Company LLP Chartered Professional
Accountants, located at Suite 1200 &ndash; 609 Granville Street, Vancouver, BC V7Y 1G6 Canada, audited the financial statements of the
Company for its financial year ended December 31, 2020. Davidson &amp; Company LLP is independent within the meaning of the Rules of Professional
Conduct of the Chartered Professional Accountants of British Columbia.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Interests of Experts</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">To the knowledge of the Company based on information
provided by the experts, none of the experts named above, at the time of preparing the applicable report, valuation, statement or opinion,
held or has received or will receive any registered or beneficial interests, direct or indirect, in any securities or other property of
the Company or of one of the Company&rsquo;s associates or affiliates in connection with the preparation or certification of any report,
valuation, statement or opinion prepared by such person.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">ADDITIONAL INFORMATION</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Additional information relating to the Company
may be found on SEDAR at www.sedar.com.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Additional financial information is provided in
the Company&rsquo;s audited financial statements and MD&amp;A for the year ended December 31, 2022.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0">These documents may be obtained upon request from the Company&rsquo;s
head office, or may be viewed on the Company&rsquo;s website (www.enCoreresourcecorp.com) or on the SEDAR website (www.sedar.com).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 96; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->94<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Schedule A</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Charter of the Audit Committee of</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>enCore Energy Corp.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Page; Sequence: 97; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;<B>&nbsp;</B></P>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>ENCORE ENERGY CORP.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>CHARTER OF THE AUDIT COMMITTEE</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>(As approved by the Board on January 11, 2023)</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The responsibilities and composition requirements
of audit committees are as set out in the Canadian Securities Administrators&#8217; National Instrument 52-110Audit Committees (&#8220;<B>NI
52-110</B>&#8221;), the listing rules of the TSX Venture Exchange and the NYSE American LLC, as applicable (the &#8220;<B>Listing Rules</B>&#8221;)
and the rules and regulations promulgated by the Canadian Securities Administrators and the United States Securities and Exchange Commission
(&#8220;<B>SEC</B>&#8221;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Audit Committee Mandate </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Audit Committee (the &#8220;<B>Committee</B>&#8221;)
is a committee established and appointed by and among the Board of Directors (the &#8220;<B>Board</B>&#8221;) of enCore Energy Corp. (the
&#8220;<B>Company</B>&#8221;) to assist the Board in fulfilling its financial oversight responsibilities of the Company. In so doing,
the Committee provides an avenue of communication among the independent external auditor, management, and the Board. The Committee&#8217;s
purpose is to review, consider and ensure the integrity of financial reporting and the audit process, and that sound risk management and
internal control systems are developed and maintained. In pursuing these objectives, the Audit Committee oversees relations with the independent
external auditor and the accounting and financial reporting processes of the Company and audits of financial statements of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Responsibilities </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Committee&#8217;s primary duties and responsibilities
are as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">1.</TD><TD STYLE="text-align: justify">The appointment, compensation, retention and oversight of the independent external auditor engaged for
the purpose of preparing or issuing an auditor&#8217;s report or performing other audit, review or attest services for the Company, including
approval, prior to the auditor&#8217;s audit, of the auditor&#8217;s work plan and scope of the auditor&#8217;s review and all related
fees. The external auditor shall report directly to the Committee. In carrying out this duty, the Committee shall be directly responsible
for:</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in; text-align: left">(a)</TD><TD STYLE="text-align: justify">nominating the external auditor for the purpose of preparing
or issuing an auditor&#8217;s report or performing other audit, review or attest services for the Company;</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in; text-align: left">(b)</TD><TD STYLE="text-align: justify">reviewing (by discussion and enquiry) the external auditors&#8217;
proposed audit scope and approach;</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in; text-align: left">(c)</TD><TD STYLE="text-align: justify">reviewing the performance of the external auditor and determining
the appointment or discharge of the external auditors;</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in; text-align: left">(d)</TD><TD STYLE="text-align: justify">determining the compensation to be paid to the external auditors;
and</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in; text-align: left">(e)</TD><TD STYLE="text-align: justify">reviewing and confirming the independence of the external
auditors by reviewing the non-audit services (being services other than services rendered for the audit and review of the financial statements
or services that are normally provided by the external auditor in connection with statutory and regulatory filings or engagements) provided
and the external auditors&#8217; assertion of their independence in accordance with professional standards.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">2.</TD><TD STYLE="text-align: justify">Overseeing the work of the independent external auditor engaged to prepare or issue an audit report or
perform other audit, review or attest services for the Company, including the resolution of disagreements between management and the external
auditor regarding financial reporting.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">3.</TD><TD STYLE="text-align: justify">Consulting with the Company&#8217;s Chief Financial Officer for the hiring of any Member of the Audit
Engagement Team to a Financial Reporting Oversight Role in the Company (as such terms are defined in the Company&#8217;s Policy for Hiring Members
(or Former Members) of Independent Public Auditors).</TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="margin-top: 0; margin-bottom: 0"></P>

<!-- Field: Page; Sequence: 98; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">4.</TD><TD STYLE="text-align: justify">Pre-approving all non-audit services to be provided to the Company or its subsidiaries by the Company&#8217;s
external auditor.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">5.</TD><TD STYLE="text-align: justify">Delegating, at the Committee option, to one or more independent members of the Committee the authority
to approve non-audit services, provided any non-audit services approved in this manner must be presented to the Committee at its next
scheduled meeting.</TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">6.</TD><TD STYLE="text-align: justify">Reviewing the Company&#8217;s annual financial statements, management&#8217;s discussion and analysis
(&#8220;<B>MD&amp;A</B>&#8221;), auditor&#8217;s report (if any) prepared in relation to those financial statements, and annual earnings
press releases, and any other set of financial statements which will be released to shareholders, other security holders or regulatory
agencies and/or which will form part, either directly or by reference, of any registration statement, including a prospectus or prospectus
supplement, offering circular, information circular, proxy statement, annual information form (&#8220;<B>AIF</B>&#8221;), or annual report
filed with the SEC, British Columbia Securities Commission (the &#8220;<B>BCSC</B>&#8221;) or any other securities regulatory authority,
before recommending them to the Board for approval and before such documents are published and publicly disclosed by the Company. In carrying
out this duty, the Committee shall:</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><U>General</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in">(a)</TD><TD STYLE="text-align: justify">review significant accounting and financial reporting issues, especially complex, unusual and related
party transactions;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in">(b)</TD><TD STYLE="text-align: justify">review and ensure that the accounting principles selected by management in preparing financial statements
are appropriate;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><U>Annual Financial Statements </U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in">(c)</TD><TD STYLE="text-align: justify">prior to public disclosure, review the draft annual financial statements and provide a recommendation
to the Board with respect to the approval of the financial statements;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in">(d)</TD><TD STYLE="text-align: justify">meet with management and the external auditors to review the financial statements and the results of the
audit, including any difficulties encountered; and</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in; text-align: left">(e)</TD><TD STYLE="text-align: justify">review MD&amp;A respecting the annual reporting period prior
to its public disclosure.</TD>
</TR></TABLE>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">7.</TD><TD STYLE="text-align: justify">Reviewing and approving the Company&#8217;s interim financial statements, MD&amp;A and interim earnings
press releases or quarterly reports filed with the SEC, BCSC or any other securities regulatory authority and report to the Board, before
such documents are published and publicly disclosed by the Company.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">8.</TD><TD STYLE="text-align: justify">In accordance with the Company&#8217;s Corporate Disclosure Policy, reviewing all financial material documents
and certain disclosures in advance of their public release by the Company.</TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">9.</TD><TD STYLE="text-align: justify">Satisfying itself that adequate controls are in place over annual and interim financial reporting as well
as controls over assets, transactions and the creation of obligations, commitments and liabilities of the Company. In carrying out this
duty, the Committee shall:</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in">(a)</TD><TD STYLE="text-align: justify">evaluate the adequacy and effectiveness of management&#8217;s system of internal controls over the accounting
and financial reporting system within the Company; and</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in">(b)</TD><TD STYLE="text-align: justify">ensure that the external auditors discuss with the Committee any event or matter which suggests the possibility
of fraud, illegal acts or deficiencies in internal controls.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">10.</TD><TD STYLE="text-align: justify">The Committee must satisfy itself that adequate procedures are in place for the review of the Company&#8217;s
public disclosure of financial information extracted or derived from the Company&#8217;s financial statements, other than the public disclosure
referred to in 5 above, and must periodically assess the adequacy of those procedures.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></P>

<!-- Field: Page; Sequence: 99; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">11.</TD><TD STYLE="text-align: justify">Establishing procedures (the &#8220;<B>Whistleblower Policy</B>&#8221;) for:</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in; text-align: left">(a)</TD><TD STYLE="text-align: justify">the receipt, retention and treatment of complaints received
by the Company regarding accounting, internal accounting controls, or auditing matters; and</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in; text-align: left">(b)</TD><TD STYLE="text-align: justify">the confidential, anonymous submission by employees of the
Company of concerns regarding questionable accounting or auditing matters.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">12.</TD><TD STYLE="text-align: justify">Reviewing and evaluating the Company&#8217;s Whistleblower Policy on a periodic basis to determine whether
it is effective in providing a confidential and anonymous procedure to report violations or Complaints regarding accounting, internal
accounting controls or auditing matters. The Chair of the Committee will review and consider any complaints or concerns submitted in accordance
with the Whistleblower Policy and the Company&#8217;s Code of Business Conduct and Ethics.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">13.</TD><TD STYLE="text-align: justify">Reviewing and approving the Company&#8217;s hiring policies regarding partners, employees and former partners
and employees of the present and any former external auditors of the Company.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">14.</TD><TD STYLE="text-align: justify">Ensuring the receipt from the external auditor of a formal written statement delineating all relationships
between the auditor and the Company, consistent with Independence Standards Board Standard 1 or the standards set by the Public Company
Accounting Oversight Board (the &#8220;<B>PCAOB Standards</B>&#8221;), as applicable, actively engaging in a dialogue with the auditor
with respect to any disclosed relationships or services that may affect the objectivity and independence of the auditor and for taking,
or recommending that the full Board take, appropriate action to oversee the independence of the external auditor.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">15.</TD><TD STYLE="text-align: justify">Prior to the completion of the annual audit, and at any other time deemed advisable by the Committee,
reviewing and discussing with management and the external auditor the quality of the Company&#8217;s accounting policies and financial
statement presentation, including (without limitation) the following:</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in; text-align: left">(a)</TD><TD STYLE="text-align: justify">all critical accounting policies and practices to be used,
including without limitation the reasons why certain estimates or policies are or are not considered critical and how current and anticipated
future events may affect those determinations, as well as an assessment of any proposed modifications by the external auditor that were
not made;</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in; text-align: left">(b)</TD><TD STYLE="text-align: justify">all alternative accounting treatments for policies and practices
that have been discussed by management and the external auditor; and</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in; text-align: left">(c)</TD><TD STYLE="text-align: justify">other material written communications between the external
auditor and management, including (without limitation) any management letter, schedule of unadjusted differences, the management representation
letter, report on internal controls, as reported to the Committee by the Chief Financial Officer on an annual basis, or more frequently
if required (to include, at a minimum, an evaluation and status of remediation of any significant deficiencies or material weaknesses,
if any), as well as the engagement letter and the independence letter.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">16.</TD><TD STYLE="text-align: justify">Reviewing annually the accounting principles and practices followed by the Company and any changes in
the same as they occur, and reviewing new accounting principles of the Chartered Professional Accountants Canada and the International
Financial Reporting Standards or under the United States generally accepted accounting principles (&#8220;<B>GAAP</B>&#8221;), or PCAOB
Standards, as applicable, that have a significant impact on the Company&#8217;s financial reporting as reported to the Committee by management.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></P>

<!-- Field: Page; Sequence: 100; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">17.</TD><TD STYLE="text-align: justify">Reviewing the status of material contingent liabilities, potentially significant tax issues, and any errors
or omissions in the current or prior years&#8217; financial statements that appear material, as reported to the Committee by management.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">18.</TD><TD STYLE="text-align: justify">Overseeing management&#8217;s design, testing, implementation and maintenance of the Company&#8217;s internal
controls and management information systems and reviewing the adequacy and effectiveness thereof.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">19.</TD><TD STYLE="text-align: justify">Ensuring that significant findings and recommendations made by management and external auditor are received
by the Committee and discussed on a timely basis.</TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">20.</TD><TD STYLE="text-align: justify">Overseeing and enforcing the Code of Ethics for the Chief Executive Officer, senior financial officers
and other officers of the Company, subject to supervision by the Board.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">21.</TD><TD STYLE="text-align: justify">Querying management and the external auditor as to any activities that may appear to be illegal or unethical,
and review with management and the external auditor any frauds reported to the Committee, as appropriate.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">22.</TD><TD STYLE="text-align: justify">Reviewing the results of the annual fraud risk assessment conducted by executive management, with participation
from legal, finance, information systems and operations, for the purpose of ensuring that significant fraud risks, if any, are sufficiently
identified, properly prioritized, effectively mitigated by internal controls and consistently monitored.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">23.</TD><TD STYLE="text-align: justify">Confirming on an annual basis whether the objectives of the fraud risk assessment have been achieved.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">24.</TD><TD STYLE="text-align: justify">Reporting and making recommendations to the Board, as the Committee considers appropriate.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">25.</TD><TD STYLE="text-align: justify">Approving the Company&#8217;s Disclosure Controls and Procedures and review report from the Disclosure
Committee regarding the Company&#8217;s Corporate Disclosure Policy and Disclosure Controls and Procedures.</TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">26.</TD><TD STYLE="text-align: justify">Performing other oversight functions as requested by the Board.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Authority of the Committee </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Committee shall have the authority to engage
independent counsel and other advisors as it determines necessary to carry out its duties and to set and pay the compensation for any
advisors engaged by it. The Company must also provide for appropriate funding, as determined by the Audit Committee, in its capacity as
a committee of the board of directors, for payment of ordinary administrative expenses of the Audit Committee that are necessary or appropriate
in carrying out its duties.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Committee shall also have the authority to
communicate directly with the independent external auditor.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Composition </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">The
Committee members shall meet the requirements of the BCSC, the TSX Venture Exchange (the &#8220;<B>TSXV</B>&#8221;), the SEC and the NYSE
American LLC, as required. The Audit Committee shall consist of at least three (3) Directors. All members of the Audit Committee shall
be &#8220;independent&#8221; in accordance with NI 52-110, the Listing Rules and Rule 10A-3 of the United States Securities Exchange Act
of 1934, as amended (the &#8220;<B>Exchange Act</B>&#8221;) and shall meet all other requirements of the Listing Rules. All members must
be able to read and understand fundamental financial statements (including a company&#8217;s balance sheet, income statement, and cash flow
statement), the Chair of the Audit Committee shall be &#8220;financially literate&#8221; as defined by applicable legislation.</FONT>
If, upon appointment, a member of the committee is not financially literate as required, the person will be provided a three-month period
in which to achieve the required level of literacy. An individual will be considered financially literate if he or she has the ability
to understand a set of financial statements that present a breadth and level of complexity of accounting issues that are generally comparable
to the breadth and complexity of the issues that can be expected to be raised by the Company&#8217;s financial statements. <FONT STYLE="font-family: Times New Roman, Times, Serif">At
least one member of the Committee must qualify as an &#8220;Audit Committee Financial Expert,&#8221; as defined from time to time by the
SEC, which member shall also thereby qualify as &#8220;financially sophisticated,&#8221; in that he or she has past employment experience
in finance or accounting, requisite professional certification in accounting, or any other comparable experience or background which results
in the individual&#8217;s financial sophistication, including but not limited to being or having been a chief executive officer, chief financial
officer, other senior officer with financial oversight responsibilities. A quorum shall consist of not less than two (2) members of the
Audit Committee. </FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 101; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Board shall designate the Chair of the Committee
annually. Any member of the Committee may be removed or replaced at any time by the Board. Any member of the Committee ceasing to be a
director or ceasing to qualify as a member under any applicable law, rule or regulation shall cease to be a member of the Committee. Subject
to the foregoing, each Member of the Committee shall hold office as such until the next annual appointment of members to the Committee
after his or her election. Any vacancy occurring in the Committee shall be filled at the next meeting of the Board.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Remuneration </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">No member of the Committee may earn fees from
the Company or any of its subsidiaries other than directors&#8217; fees or committee member fees (which fees may include cash, options
or other in-kind consideration ordinarily available to directors). For greater certainty, no member of the Committee shall accept any
consulting, advisory or other compensatory fee from the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Meetings &amp; Operating Procedures </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Committee shall meet on
at least a quarterly basis annually (i.e., a minimum of four (4) times per year) for regular meetings, or more frequently as circumstances
dictate for special meetings. The times of and places where meetings of the Committee shall be held and the calling of and procedures
at such meetings shall be determined from time to time by the Committee. Special meetings shall be convened whenever requested by the
external auditor, the Chair, or any two (2) members of the Audit Committee.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Regular meetings shall be called
by the Chair of the Committee so as to allow the Committee to review the annual and interim consolidated financial statements and related
disclosures of the Company prior to approval of the statements by the Board, as required, and prior to the release of the annual financial
statements, the MD&amp;A or the interim reports to shareholders, as applicable. </FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Notice of the time and place
of every meeting shall be given in writing or by e-mail or facsimile communication to each member of the Committee (and to the external
auditor of the Company, when applicable, so that the auditor shall be entitled to attend) at least 48 hours prior to the time fixed for
such meeting; provided, however, that a member may waive notice of a meeting, and attendance of a member at a meeting is a waiver of notice
of the meeting, except where a member attends a meeting for the express purpose of objecting to the transaction of any business on the
grounds that the meeting is not lawfully called. </FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Committee may invite such
officers, directors and employees of the Company, as it may see fit from time to time, to attend meetings of the Committee and assist
in the discussion and consideration of any matters under consideration by the Committee. </FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A quorum shall be a majority
of the members. </FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In the absence of the Chair
of the Committee, the members shall appoint an acting Chair. </FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Committee shall, at the
start of the meeting or portion thereof, appoint a secretary, who need not be a director or officer of the Company, for the purposes of
recording the minutes of the meeting or portion of the meeting.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></P>

<!-- Field: Page; Sequence: 102; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Committee shall maintain
minutes or other records of its meetings and activities. A copy of the minutes of each meeting of the Committee shall be made available,
upon request, to each member of the Committee and to each Director of the Company. </FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Chair of the Committee shall
prepare and/or approve an agenda in advance of each meeting. </FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Committee, in consultation
with management and the external auditors, as applicable, shall develop and participate in a process for review of important financial
topics that have the potential to impact the Company&#8217;s financial policies and disclosures. </FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Committee shall communicate
its expectations to management and the external auditor with respect to the nature, timing and extent of its information needs. The Committee
expects that written materials will be received from management and the external auditor, as applicable, in advance of meeting dates.
</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Committee chair may meet
privately with the external auditor on a quarterly or as-needed basis (including any meeting at which financial statements are approved
in the absence of management) to discuss any matters that the Committee or its chair believe should be discussed. </FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD><FONT STYLE="font-size: 10pt">The Committee shall meet at least annually with the Company&#8217;s Chief Financial Officer and external
auditor in separate executive sessions.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In addition, the Committee,
or at least its Chair, should communicate with management and the external auditor, as applicable, quarterly to review the Company&#8217;s
financial statements and significant findings based upon the external auditor&#8217;s limited review procedures. </FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Committee shall annually
review, discuss and assess its own performance. In addition, the Committee shall periodically review its role and responsibilities and
make any adjustments, as needed, for the effective governance of the Committee and performance of its role and responsibilities. </FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Committee expects that the
external auditor, in discharging its responsibilities to the shareholders, shall be accountable to the Board through the Committee. The
external auditor shall promptly report all material issues or potentially material issues to the Committee. </FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Review Procedures </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Committee shall review and reassess the adequacy
of this Charter at least annually, submit any proposed changes to the Board for approval, and ensure that it is in compliance with all
applicable TSXV, BCSC, SEC and the Listing Rules, as they may change over time.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">A-7</FONT><B>&nbsp;</B></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.2
<SEQUENCE>3
<FILENAME>ea177383ex99-2_encoreenergy.htm
<DESCRIPTION>MANAGEMENT'S DISCUSSION AND ANALYSIS FOR THE YEAR ENDED DECEMBER 31, 2022
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Exhibit 99.2</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><IMG SRC="ex99-2_001.jpg" ALT=""></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Management&rsquo;s Discussion &amp; Analysis</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>For the year ended</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>December 31, 2022</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">enCore Energy Corp.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Management&rsquo;s Discussion and Analysis</P>

<P STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">For the years ended December 31,
2022 and 2021</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Set out below is management&rsquo;s assessment
and analysis of the results of operations and financial condition of </I>enCore Energy Corp. and its subsidiaries (&ldquo;enCore&rdquo;,
or the &ldquo;Company&rdquo;) for the years ended December 31, 2022 and 2021. The following information is prepared as of April 28, 2023
and should be read in conjunction with the consolidated financial statements for the years ended December 31, 2022 and 2021, and the accompanying
notes thereto, which have been prepared in accordance with International Financial Reporting Standards (&ldquo;IFRS&rdquo;). All dollar
figures included in this management&rsquo;s discussion and analysis (&ldquo;MD&amp;A&rdquo;) are quoted in United States dollars unless
otherwise indicated. Additional information related to the Company is available on SEDAR at www.sedar.com.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">This MD&amp;A contains certain statements that
may be deemed &ldquo;forward-looking statements&rdquo;. Information set forth may involve forward-looking statements under applicable securities
laws. These statements are based on available information to date, and such plans are subject to ongoing evaluation and analysis, and
to date our properties remain in the exploration stage and no economic studies have been completed with respect to any restart of operations
at our existing plants. These and other forward-looking statements in this MD&amp;A are statements that relate to future, not past, events.
In this context, forward-looking statements often address expected future business and financial performance, and often contain words
such as &ldquo;anticipate&rdquo;, &ldquo;believe&rdquo;, &ldquo;plan&rdquo;, &ldquo;estimate&rdquo;, &ldquo;expect&rdquo;, and &ldquo;intend&rdquo;,
statements that an action or event &ldquo;may&rdquo;, &ldquo;might&rdquo;, &ldquo;could&rdquo;, &ldquo;should&rdquo;, or &ldquo;will&rdquo; be taken
or occur, or other similar expressions. All statements, other than statements of historical fact, included herein including, without limitation;
are forward-looking statements. By their nature, forward-looking statements involve known and unknown risks, uncertainties and other factors
which may cause the actual results, performance or achievements, or other future events, to be materially different from any future results,
performance or achievements expressed or implied by such forward-looking statements. Such factors include, among others, the following
risks: risks identified in this MD&amp;A under the headings &ldquo;Risk Factors and Uncertainties&rdquo; and &ldquo;Cautionary Notes Regarding
Forward-Looking Statements&rdquo; and most recent annual information form or other reports and filings with applicable Canadian securities
regulators. Forward-looking statements are made based on management&rsquo;s beliefs, estimates and opinions on the date that statements are
made and the respective companies undertakes no obligation to update forward-looking statements if these beliefs, estimates and opinions
or other circumstances should change, except as required by applicable securities laws. Investors are cautioned against attributing undue
certainty to forward- looking statements.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">CAUTIONARY NOTE TO U.S. INVESTORS CONCERNING ESTIMATES
OF MEASURED, INDICATED AND INFERRED MINERAL RESOURCES: The Company reports mineral resources on its projects according to Canadian standards,
which differ from the requirements of U.S. securities laws. Mineral resource estimates have been prepared in accordance with National
Instrument 43-101 &ndash; Standards of Disclosure for Mineral Projects (&ldquo;NI 43-101&rdquo;) and the Canadian Institute of Mining,
Metallurgy and Petroleum (the &ldquo;CIM&rdquo;) &ndash; CIM Definition Standards on Mineral Resources and Mineral Reserves, (the &ldquo;CIM
Standards&rdquo;). The terms &ldquo;mineral reserve&rdquo;, &ldquo;proven mineral reserve&rdquo; and &ldquo;probable mineral reserve&rdquo;
are Canadian mining terms as defined in accordance with NI 43-101 and the CIM Standards. Mineral property disclosure requirements in the
United States (the &ldquo;U.S. Rules&rdquo;) are governed by subpart 1300 of Regulation S-K of the U.S. Securities Act of 1933, as amended
(the &ldquo;U.S. Securities Act&rdquo;) which differ from the CIM Standards. Pursuant to the U.S. Rules, the SEC recognizes &ldquo;measured
mineral resources,&rdquo; &ldquo;indicated mineral resources&rdquo; and &ldquo;inferred mineral resources.&rdquo; Mineralization described
using these terms has a greater amount of uncertainty as to its existence and feasibility than mineralization that has been characterized
as reserves. Accordingly, U.S. investors are cautioned not to assume that any measured mineral resources, indicated mineral resources,
or inferred mineral resources that the Company reports are or will be economically or legally mineable. Further, &ldquo;inferred mineral
resources&rdquo; have a greater amount of uncertainty as to their existence and as to whether they can be mined legally or economically.
Under Canadian securities laws, estimates of &ldquo;inferred mineral resources&rdquo; may not generally form the basis of feasibility
or pre-feasibility studies. While the above terms are &ldquo;substantially similar&rdquo; to CIM Standards, there are differences in the
definitions under the U.S. Rules and the CIM Standards. The mineral resources are estimates and no assurances can be given that the indicated
levels of uranium will be produced. By their nature, mineral resource estimates are imprecise and depend, to a certain extent, upon statistical
inferences which may ultimately prove unreliable. Any inaccuracy or future reduction in such estimates could have a material adverse impact
on the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The technical content disclosed in this MD&amp;A
was reviewed and approved by John Seeley, the manager of geology and exploration of the Company and a Qualified Person as defined under
National Instrument 43-101.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Our Company</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">enCore Energy Corp. was incorporated on October
30, 2009 under the Laws of British Columbia and is a reporting issuer in all of the Provinces of Canada other than Quebec. The Company
also files reports with the U.S. Securities and Exchange Commission (&ldquo;SEC&rdquo;). The Company&rsquo;s Shares are listed on the
NYSE American and the TSX Venture Exchange under the trading symbol EU.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Total issued and outstanding shares at issuance
of this report: 143,181,688 common shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>


<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">enCore Energy Corp.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Management&rsquo;s Discussion and Analysis</P>

<P STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">For the years ended December 31,
2022 and 2021</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Our Vison: Fueling the Future</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">enCore Energy Corp. (&ldquo;enCore&rdquo;) is
focused on becoming the leading domestic producer of uranium in the United States. We will utilize the proven in-situ recovery technology
(ISR) to provide fuel for the generation of clean, reliable and carbon free energy. It is our goal to build our company&rsquo;s production
capacity to 3 million pounds U<SUB>3</SUB>O<SUB>8</SUB> per year in 3 years and 5 million pounds U<SUB>3</SUB>O<SUB>8</SUB> per year in
5 years.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Our Objectives</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Focus on Production-Ready Assets: Utilizing our
production-ready ISR Central Processing Plants (CPP) in South Texas, we have created a strategy for the creation of value and
phased growth to meet an ever-growing need for nuclear energy in the United States. Our plan to start production in 2023 is a key objective
in executing our strategy. We are focused on a long-term strategy of being a vital component of the nuclear industry, an industry poised
for growth for the first time in over 45 years.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Application of In-Situ Recovery (ISR) Technical
Expertise</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The enCore team is led by industry experts with
extensive knowledge and experience in all aspects of ISR uranium operations and the nuclear fuel cycle. The safety of our people and the
environment is essential to our operations, and we remain solely focused on ISR technology to produce uranium as a proven effective and
environmentally responsible technology.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Providing Growth and Value to Shareholders</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We have demonstrated through three significant
transactions since December 2020 that we can drive growth and provide value for our shareholders through select, accretive merger and
acquisition (M&amp;A) opportunities as well as from organic growth from existing assets. We believe that the catalyst created by the commencement
of production at multiple facilities will provide further value to our shareholders as we will join a select group of peers with established
uranium production.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Reducing Risk to Shareholders and Operations</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We operate in safe, business-friendly jurisdictions
with clear regulatory environments in order to predictably advance a balanced pipeline of established projects to production.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Implementing a Non-Core Asset Divestment Strategy</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We have demonstrated the ability to derive value
for our shareholders from our non-core assets using different approaches to divestment. We maintain a number of non-core conventional
projects that are available for acquisition.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Acting with Fiscal Responsibility and Strong Governance</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We have a skilled Board of Directors and an experienced
management team with strong corporate governance values. We work to ensure that our costs are as low as practicable while being able to
leverage our assets to provide value to our shareholders. We assess supply chain risks to ensure that we are able to obtain critical components
in a manner sufficient to sustain our strategy. We have supply agreements with established trading partners that include nuclear utilities
and have negotiated sales terms to assure that we receive an effective return on investment when considering capital, operating and overhead
costs.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Our Business: Fueling the Future</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We own 3 of the 11 licensed and constructed Central
ISR Uranium Processing Plants (CPP&rsquo;s) in the United States. All of our existing facilities are located in the business-friendly,
energy-centric State of Texas. These plants are designed and permitted to process uranium from a variety of satellite plants and primary
sources within South Texas. In addition, we have several key mineral resource projects in other jurisdictions within the U.S. Our NI43-101
compliant resources are listed below:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Total indicated Mineral Resources&#9;103.79 MM
pounds U<SUB>3</SUB>O<SUB>8</SUB></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Total Inferred Mineral Resources&#9; 29.03 MM
pounds U<SUB>3</SUB>O<SUB>8</SUB></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">With the United States being the world&rsquo;s
largest consumer of uranium to produce nuclear energy, and largely dependent on imported uranium, we believe we will see increasing demand
for domestically produced uranium. Our strategy is to leverage our uranium production, expected to begin this calendar year, to drive
value for our shareholders and establish our place in the nuclear fuel cycle as a preferred supplier. With established and future sales
contracts with nuclear utilities, our product will fuel clean, reliable and carbon-free electricity generation that provides almost 20%
of the total U.S. demand. Uranium, used for nuclear energy, is an important green energy fuel source. Unlike most fossil fuels, the cost
of nuclear fuel (uranium) only constitutes a small portion of total nuclear power generating costs. This low-cost basis is important to
the ultimate electricity consumer because an increase in the uranium price has a relatively insignificant impact on the cost of electricity.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 3; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">enCore Energy Corp.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Management&rsquo;s Discussion and Analysis</P>

<P STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">For the years ended December 31,
2022 and 2021</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><IMG SRC="ex99-2_002.jpg" ALT=""></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our strategy starts in South Texas, where we
have an objective to start uranium production at our Rosita Central ISR Uranium Processing Plant (Rosita CPP) in later 2023, followed
by 2024 planned production from the Alta Mesa Central ISR Uranium Processing Plant (Alta Mesa CPP). South Texas is a key part of our
strategy for the following reasons:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Texas is a well-established U.S. uranium district
with most deposits suitable for ISR from sandstone-hosted mineralization and a total historic production of ~80 million pounds of U<SUB>3</SUB>O<SUB>8</SUB>;</FONT></TD></TR><TR STYLE="vertical-align: top">
<TD>&nbsp;</TD><TD>&nbsp;</TD><TD STYLE="text-align: justify">&nbsp;</TD></TR>
                                                                                                                                                                              </TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Texas is a long-established pro-development jurisdiction
in the U.S. for uranium production and is an energy friendly State. </FONT></TD></TR><TR STYLE="vertical-align: top">
<TD>&nbsp;</TD><TD>&nbsp;</TD><TD STYLE="text-align: justify">&nbsp;</TD></TR>
                                                                                     </TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Texas has identified deposits of approximately
141 million pounds U<SUB>3</SUB>O<SUB>8</SUB> equivalent of in-situ mineralization remaining according to the U.S. Geological Survey (&ldquo;USGS&rdquo;);</FONT></TD></TR><TR STYLE="vertical-align: top">
<TD>&nbsp;</TD><TD>&nbsp;</TD><TD STYLE="text-align: justify">&nbsp;</TD></TR>
                                                                                                                                                                           </TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">The USGS estimates there is further potential
to discover an approximate additional 220 million pounds of U<SUB>3</SUB>O<SUB>8</SUB> in the South Texas Coastal Plain where our licensed
production facilities are located. </FONT></TD></TR></TABLE>

<P STYLE="margin: 0">&nbsp;</P>


<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">enCore
owns and operates three licensed South Texas CPP&rsquo;s that are capable of production using feed from multiple regional satellite IX
systems located on outlying uranium deposits within an economic shipping radius.</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Uranium market conditions are improving due to
the realization of shifting market supply-demand fundamentals and a shift toward de-globalization in the nuclear industry. There are many
factors contributing to the change in global fundamentals including continued deferment of re-starts of existing standby and new primary
sources of supply, along with a continued increase in the number of operating nuclear reactors and reactors under construction. According
to the World Nuclear Association, globally there are 437 reactors operating, 56 reactors under construction, and 70 reactors planned for
construction. Nuclear energy, fueled by uranium, is gaining acceptance as a clean and reliable energy source, a clearly superior choice
for the world. The growing urgency to reduce carbon emissions world-wide has pushed nuclear energy generation to the forefront, with the
United States being the world&rsquo;s largest consumer of uranium. Currently, the U.S. is completely reliant on imported uranium, but
as geopolitical changes are forcing the shift to deglobalize supply chains, domestic nuclear power utilities are looking to the U.S. as
a source of uranium to secure a domestic supply chain and diversify away from Russia, Kazakhstan, Uzbekistan, and China.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">enCore&rsquo;s business objective represents a
powerful economic opportunity in the changing and growing uranium market and nuclear energy industry. Our strong technical team forms
the basis for our strength with extensive expertise in ISR operations, reclamation, permitting and exploration. We have a broad set of
uranium assets that provide a growing production pipeline that includes near-term production in Texas followed by pipeline projects in
South Dakota and Wyoming with longer term production planned from our extensive resources in New Mexico. Our team enjoys access to a large
collection of proprietary databases of United States assets allowing us exclusive benefits from historic exploration, development and
production data generated over almost 100 years by a number of major companies including Union Carbide, W.R. Grace, UV Industries, Getty
Oil, Uranium Resources and others.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 4; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">enCore Energy Corp.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Management&rsquo;s Discussion and Analysis</P>

<P STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">For the years ended December 31,
2022 and 2021</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">With our diverse portfolio of uranium projects,
enCore is prioritizing projects that will utilize ISR technology to produce uranium. ISR, when compared to conventional open pit or underground
mining, requires less capital and operating expenditures with a shorter lead time to extraction and a reduced impact on the environment,
including minimizing groundwater use. Compared to conventional underground and open pit uranium mining and milling, the historic worker
safety record in the ISR segment of the industry has been unsurpassed in the mining industry overall.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">To support our production pipeline and development
plans, we have a uranium sales strategy exposing the company to a base level of projected income while preserving significant ability
to realize opportunities in the spot market. This strategy assures that we will have committed sales to support the capital necessary
for construction of new projects while maintaining flexibility to be opportunistic as market conditions continue to change in favorable
ways. In 2021, we announced two term supply agreements, one with UG USA and one with a Fortune 150 U.S. nuclear utility. In 2022, we announced
a third term supply agreement with a U.S. based nuclear utility; subsequently, we announced a 4th sales agreement with another Fortune
500 U.S. utility in February 2023. Our utility contracts are all spot related with minimum floor and maximum ceiling prices that are adjusted
upward annually for inflation. Minimum floor prices are set at such levels to provide the Company a comfortable margin over its expected
costs of operations in Texas while giving the Company participation in anticipated escalations of the price of uranium. Combined, we have
secured 3.65 million pounds U<SUB>3</SUB>O<SUB>8</SUB> in committed uranium sales contracts from 2023 to 2030. Two of the contracts provide
the optionality to extend with an additional 1.65 million pounds U<SUB>3</SUB>O<SUB>8</SUB> to 2032. We will continue to assess opportunities
to secure future term agreements that will support our continued project and production growth strategies.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our initial production strategy over the next
3 years is centered on our three fully licensed Texas CPP&rsquo;s located at Rosita, Alta Mesa and Kingsville Dome. All of these plants
are designed for, and fully capable of, processing feed resin from relocatable satellite ion-exchange (IX) plants employed at various
deposits within a 100-mile radius of each plant. The Rosita CPP is expected to be operational in late 2023 with the Alta Mesa CPP following
in 2024. We exclusively utilize an alkaline chemistry to recover uranium that is formed using native groundwater, oxygen, and sodium bicarbonate
(baking soda). Our uranium ore bodies are highly amenable to this chemistry. As uranium-loaded groundwater is pumped to the surface, uranium
is collected on ion exchange resin and barren groundwater is refortified with oxygen and re-injected. At Alta Mesa, uranium-loaded groundwater
will be pumped directly into the CPP, whereas at the satellite production areas loaded resin will be trucked to the CPP, where the uranium
is recovered, concentrated, dried, and packaged. Barren resin is transported back to the satellite plant located at the production wellfield
for re-use. This approach provides a low-cost production model that allows us to produce from a diverse set of uranium properties in multiple
remote locations utilizing central plant locations.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our fully licensed and 100% owned Rosita CPP is
our starting point for our Texas production strategy. It is located approximately 60 miles from Corpus Christi, Texas and has an 800,000-pound
U<SUB>3</SUB>O<SUB>8</SUB> per year production capacity, having been recently modernized and refurbished in 2022. The plant is on schedule
and on budget to meet a late 2023 production target. The Rosita Plant will act as the central processing site for the Rosita Extension,
Rosita South, and Upper Spring Creek Uranium Projects.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In February 2023, we acquired 100% of the Alta
Mesa Project from Energy Fuels, Inc. Our fully licensed and 100% owned Alta Mesa ISR Uranium CPP is located approximately 100 miles southeast
of Corpus Christi, TX, and has a production capacity of 1.5 million pounds U<SUB>3</SUB>O<SUB>8</SUB> per year through its ion exchange
system located at the central plant. The facility has IX elution, precipitation, drying, and packaging capacity for 2.0 million pounds
U<SUB>3</SUB>O<SUB>8</SUB> per year. This capacity is designed to accept direct production feed to the IX columns in the plant and concurrently
accept loaded resin from satellite locations. The Alta Mesa Project includes the existing and near-term production areas, including the
fully permitted and authorized production areas 6 &amp; 7. Alta Mesa has 9 additional mineral resource areas, described in the &ldquo;Our
Assets&rdquo; section of this document. The project encompasses mineral leases on 200,000 acres of private land with a 3.5% royalty at
current uranium spot market prices.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Kingsville Dome CPP is currently maintained to be available to increase production capacity as additional
satellite plants and production wellfields are brought into production.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Simultaneous to advancing production in South
Texas, we are advancing our production pipeline in other states where we have uranium projects. Notably, the advanced stage Dewey-Burdock
Uranium Project (Dewey-Burdock) in South Dakota has demonstrated ISR resources, including a 2019 PEA citing robust economics. The project
has its source material license from the U.S. Nuclear Regulatory Commission and its injection permits from the U.S. Environmental Protection
Agency.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 5; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">enCore Energy Corp.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Management&rsquo;s Discussion and Analysis</P>

<P STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">For the years ended December 31,
2022 and 2021</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We are currently advancing work on the remaining
permitting effort with the expectation that cash flow from our Texas operations will support the buildout of Dewey-Burdock for production.
We have also started the initial permitting work to advance the Gas Hills Uranium Project (Gas Hills) as an ISR uranium recovery operation
located in central Wyoming, approximately 60 miles west of Casper, WY. Gas Hills has a current resource and robust economics as described
in a 2021 PEA. It is ideally located in the historic Gas Hills Uranium Mining District, a brownfield area of extensive previous mining.
We have Dewey-Burdock and Gas Hills as our mid-term production assets within our planned production pipeline.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our assets in New Mexico represent a major long-term
asset in our planned production pipeline. enCore has successfully acquired a dominant position in the historic Grants Uranium District
in New Mexico. We control mineral rights over approximately 500 square miles containing significant uranium resources located in several
different deposits. We are committed to the significant work necessary to overcome legacy issues related to historic uranium mining and
milling in New Mexico and its effect on indigenous and local communities. We are executing an engagement strategy with local communities
to educate one another and work together to realize economic and social benefits of collectively exploiting these significant resources
in an environmentally superior way, unlocking the value of the assets to all parties&rsquo; benefit.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Additionally, we have significant mineral holdings
in Wyoming, Arizona, Utah, and Colorado that can have their value unlocked through our non-core asset disposition program. We are amenable
to various arrangements with 3rd parties including but not limited to outright sale, lease or in rare instances potential joint ventures
of these non-core assets.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">At enCore, we have a clear pathway to production
across the United States and are focusing our expansion efforts within jurisdictions with well-established regulatory environments for
the development of ISR uranium projects such as Texas and Wyoming. Both Texas and Wyoming are NRC Agreement states whereby the Nuclear
Regulatory Commission has ceded its regulatory authority to the individual state regulators. This streamlined regulatory process is a
demonstrable benefit to the uranium industry within these select states. We are leveraging the near-term production assets in South Texas
to support our South Dakota based Dewey-Burdock and Wyoming based Gas Hills projects for mid-term production opportunities with advanced
projects and established resources. We will leverage mineral rights in historically successful mining areas that have had past exploration
and extraction activities. Our significant New Mexico uranium resource endowment provides long-term opportunities and the ability to establish
mutually beneficial relationships with indigenous and local communities. We also support communities with local hiring and capital spending
in the localities where we work.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><B>In-Situ Recovery Technology</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In-Situ Recovery (ISR) is a minimally invasive,
environmentally friendly, and economically competitive way of extracting minerals from the ground. It has proven to be a successful method
of extracting uranium and due to its cost efficiency, is economically viable to extract lower grade uranium deposits that may not justify
the cost of conventional open pit or underground mining. In addition to significantly lower capital and operating costs, ISR operates
without the open pits, waste dumps, or tailings associated with conventional mining and milling, making extraction more environmentally
responsible while also resulting in a faster and more cost-efficient permitting, development and remediation process. ISR extraction is
able to extract the uranium while leaving the surface intact, and when reclamation is completed, it is returned to its original state
and use.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Since its first appearance in the 1960s, ISR technology
has progressed considerably to the point where the process is a controllable, safe, and benign method of uranium production that is heavily
regulated in the United States. ISR now accounts for approximately 70% of all the uranium produced worldwide. While some countries, such
as Kazakhstan and Australia, still use harsh chemicals like sulfuric acid to remove the uranium from the ore body, enCore Energy only
uses a lixiviant that is a combination of oxygen and sodium bicarbonate in the native groundwater, extracting uranium at a near neutral
pH and significantly less environmental impacts.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">ISR uranium extraction usually takes place in
sandstone deposits, within a portion of the aquifer that the government has exempted from protection as an underground source of drinking
water due to its mineral content, such as uranium, radium, and other minerals preventing its use as a source of drinking water, such as uranium, radium, and other minerals. An ISR
wellfield is developed using a series of production patterns that are made up of a series of injection and recovery wells. The injection
well introduces the lixiviant, made up with native groundwater that is fortified with oxygen and sodium bicarbonate, to the uranium bearing
sandstone. As the lixiviant is injected through the uranium bearing sandstone, the uranium is solubilized by the oxygen in the lixiviant,
and the uranium-bearing lixiviant is carried through the sandstone to the recovery well. The recovery wells, equipped with submersible
pumps, recover the uranium bearing lixiviant out of the sandstone and lift it to the surface. When the uranium bearing lixiviant is lifted
to the surface, it is pumped into a surface collection system to be transferred to the ion exchange (IX) system. Surrounding the production
patterns is a network of monitor wells that are used to observe the groundwater chemistry and hydrology to assure there are no impacts
to adjacent underground sources of drinking water. The combination of the production patterns and the monitor well network constitute
what is called a wellfield.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 6; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">enCore Energy Corp.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Management&rsquo;s Discussion and Analysis</P>

<P STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">For the years ended December 31,
2022 and 2021</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">After the uranium bearing lixiviant reaches the
IX system, it flows through a bed of IX resin where the uranium is removed from the lixiviant and loaded onto the IX resin beads. This
is a process that is similar to a water softener. The barren lixiviant is returned to the wellfield, where it is refortified with oxygen
and sodium bicarbonate, and reinjected into the uranium bearing sandstone. A small portion, approximately 1% of the total volume, of the
barren lixiviant is held back from reinjection. This is called a &ldquo;process bleed&rdquo;, and it is intended to create a hydraulic
sink in the wellfield to contain lixiviant within production patterns.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">When the IX resin loads to capacity with uranium,
it is regenerated, in a manner exactly as done for a water softener, using a salt solution that is rich in sodium bicarbonate. This process
is called &ldquo;elution&rdquo;, and the product creates a uranium rich eluant. That eluant is transferred from the ion exchange system
to the precipitation system. Using a series of additions of hydrogen peroxide, acid, and sodium hydroxide, the uranium is precipitated
from the eluant and a uranium, &ldquo;yellowcake,&rdquo; slurry is created. It is then filtered and washed in a filter press, and then
the yellowcake slurry is transferred to the drying system. The drying system at enCore&rsquo;s processing facilities use a low-temperature,
zero emission, rotary vacuum drying system, exactly the same equipment used for producing pharmaceuticals. The dried yellowcake is packaged
into 55-gallon drums that are grouped in to shipping lots. Each shipping lot is then transported to a North American conversion facility,
where it is weighed, sampled, and inventoried. That is the point at which we sell our product to our customers.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">When the uranium orebody within an ISR wellfield
is depleted, we are required to clean up the groundwater. During the process of extracting uranium from the orebodies using our lixiviant,
we do change the groundwater chemistry within the production patterns. We restore the water quality of the groundwater using reverse osmosis
technology to clean the impacted groundwater to a quality consistent with the groundwater chemistry prior to the start of lixiviant injection.
This process does increase the amount of water that is consumed during wellfield operations, but for an average ISR wellfield, approximately
95% of the groundwater is preserved and retained at the end of the full production and restoration cycle. Once the government approves
the groundwater restoration effort, the injection, recovery, and monitor wells are plugged and abandoned and the surface infrastructure
is removed. The site is surveyed for residual contamination that may need to be removed, and then the wellfield is returned to its prior
use.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The use of ISR technology in the U.S. has a documented
strong environmental record. Several wellfields have been restored and released with the former wellfields indistinguishable from the
adjacent, unimpacted land. Additionally, the U.S. government, in several public documents has concluded that there have been no impacts
to underground sources of drinking water by ISR uranium extraction or restoration. In contrast, the U.S. has several historic conventional
uranium mines and mill tailings facilities that have had large and long-lasting documented impacts on the environment and drinking water.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><B>ESG Principles</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The long-term success of&nbsp;the Company requires
the integration of sustainability into all aspects of our business. Leading environmental, social and governance performance is strongly
correlated to strong financial performance and creation of long-term value for our shareholders and other stakeholders. This includes
striving to meet the highest standards, contributing toward sustainable development and serving as responsible natural resource stewards
to ensure we make positive and lasting impacts on the communities and nations where we operate. enCore is responsible to its shareholders,
governments, and community stakeholders as we advance projects forward. enCore considers appropriate best practices and innovative methods
to meet and exceed these responsibilities, within our financial means, to best serve our shareholders&rsquo; interests and align our Company
with the communities where we live and work.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><B>Environment</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">enCore is a development company that is committed
to be a uranium production company. Uranium is the only fuel that is used for the clean air generation of electricity using nuclear power.
Currently, in the U.S., nuclear power generates almost 20% of all the country&rsquo;s electricity. At the same time, it represents 55%
of the clean energy generated in the U.S. The advantage of nuclear power is that it can generate this electricity with a relatively small
footprint. As a comparison, a 40-acre nuclear power generating station will produce 1,000 MWe at nearly 100% capacity, and on a capacity
basis, an equivalent wind generation facility would require almost 400,000 acres of land. Uranium, as a source of energy, provides similar
benefits. According to the Department of Energy, one fuel pellet (the size of a pencil eraser) consisting of 4.95% U235 nuclear fuel has
the same energy content as 17,000 cubic feet of natural gas, 3 barrels of oil, or one ton of coal.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 7; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">enCore Energy Corp.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Management&rsquo;s Discussion and Analysis</P>

<P STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">For the years ended December 31,
2022 and 2021</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">enCore is committed to producing uranium in a
manner that limits environmental impacts and serves to return the environment to conditions that existed prior to commencement of production.
As a result, we are focused on in-situ recovery (&lsquo;ISR&rsquo;) technology as a means to extract uranium. ISR is a lower cost method
of uranium extraction with minimal disturbance to existing natural conditions, leaving the host rocks &lsquo;in place.&rsquo; This process
has demonstrated superior environmental performance, especially in contrast to underground and open pit mining, and milling. The ISR process
eliminates the need to blast, excavate and haul ore using large excavation equipment that can have long truck haul distances that require
the consumption of significant quantities of fossil fuels, and often require the surface discharge of large quantities of water and dust
emissions as well as large waste rock dumps. Existing uranium mills require large areas for the disposal of tailings, and significant
emissions are derived from the processing circuits that are released to the environment. In contrast, the production facilities operated
by enCore incorporate leading technologies for reducing and eliminating releases to the environment. As a result, the differences are
significant and meaningful for everything from permitting to operations to reclamation. Using ISR technology to produce uranium, enCore
is able to leverage the demonstrated environmental protections inherent in the process to produce a yellowcake uranium product that is
used to fuel America&rsquo;s nuclear fleet for the generation of 55% of the country&rsquo;s clean energy.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The ISR technology uses injection and recovery
wells constructed into a uranium ore body where a chemically benign solution of natural groundwater mixed with oxygen and sodium bicarbonate,
similar in chemical strength to club soda. Using pipelines, the resulting uranium-bearing water is returned to an ion exchange facility,
where the uranium is removed from the circulating groundwater, and the groundwater is reused for continued uranium recovery. The uranium
is removed from the resin using a regeneration process that is commonly used in the water treatment industry. Then using limited quantities
chemicals, the uranium is precipitated, dried and packaged. This process is conducted wet, and there are no measurable air emissions from
the process. Once the uranium is depleted in the ore body, the groundwater is restored to water quality that matches the quality of use
prior to mining. Then the injection and recovery wells are plugged, the infrastructure is removed, and the land and water are returned
to their prior use. Throughout this process, groundwater quality and the surrounding environment is monitored using a network of monitor
wells and environmental monitoring stations.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><BR>
The environmental advantages offered by ISR to produce uranium from construction, through production, and for reclamation ultimately allow
for a minimal residual footprint throughout the mining cycle without the need for moving massive quantities of waste rock for backfill
or a permanent impoundment containing tailings that must be monitored in perpetuity. We operate solely in the United States, where the
most advanced environmental and safety regulations are in effect compared to much of the rest of the world.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">enCore is committed to
environmental performance, and we do this by:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; background-color: white">We
will manage production operations using best practices and innovative technologies, to protect underground sources of drinking water.</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; background-color: white">We
will manage and monitor our production facilities using best practices and innovative technology to minimize and eliminate potential
emissions and releases that have the potential to impact the environment or the public.</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; background-color: white">We
will manage our activities for exploration, development, production, and reclamation to minimize our environmental footprint and limit
land disturbance.</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; background-color: white">We
will treat groundwater impacted by our uranium production activities and restore it to the water quality or class of use that existed
prior to production.</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">enCore supports nuclear
energy by reliably supplying uranium for the generation of clean air energy, which:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; background-color: white">Is
carbon-free. It is the largest source of carbon-free electricity in the United States and protects our&nbsp;air quality&nbsp;by generating
electricity without other harmful emissions.</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; background-color: white">Is
a zero-emission clean energy source. According to the Nuclear Energy Institute (NEI), the United States avoided more than 476 million
metric tons of carbon dioxide emissions in 2019.</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; background-color: white">Produces
minimal waste. All of the used nuclear fuel produced by the U.S. nuclear energy industry over the last 60 years would fit on a football
field to a height of less than 10 yards.</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; background-color: white">Is
reliable. Nuclear power plants are the most efficient source of electricity, operating 24/7 at a more than 93 percent average capacity
factor. That&rsquo;s more than two times the capacity factor of any other carbon-free source.</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 8; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">enCore Energy Corp.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Management&rsquo;s Discussion and Analysis</P>

<P STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">For the years ended December 31,
2022 and 2021</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">Social</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">At enCore, we begin by creating a strong, united
workforce with a commitment to safety as a way of life. Safety is our first value and leading measure of excellence, and our governing
Safety Principles apply to our employees, contractors, visitors, and vendors at our sites, and to any location where an employee is engaged
in work activities. We approach safety with both vigilance and humility, understanding that incident-free workplaces can be achieved only
by accountability and continuous improvement at all levels of our organization.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We seek a workforce that is comprised of diverse
backgrounds, thoughts, and experiences. Our company strives to attract and retain the best people, develop their potential, and align
their skills to important initiatives and activities. We believe in fostering an inclusive work environment built on mutual trust, respect,
and engagement. And we invest in our employees through health and wellness programs, competitive benefits, and development opportunities.
Empowered employees can empower others.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our people are at the core of enCore&rsquo;s ability
to deliver business results and benefit our communities. We recognize that we must leverage the power of inclusion and diversity to continue
to attract and retain the best people.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">At enCore, we provide an essential product that
enables economic prosperity and a better quality of life for individuals and communities worldwide. We are also providing employment opportunities,
payroll taxes, royalties, and charitable contributions for the local communities where our employees live and work. Together, that economic
activity generates throughout the value chain indirect economic benefits into the communities where we operate that supports direct contributions
that create jobs and strengthen communities, including wages, taxes, capital investments and vendor contracts.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">enCore has respect for the Indigenous people maintaining
strong relationships and communications with those communities throughout the life of mine process. We believe in consultation as required
under legislation in a dual path with community engagement. We are strong advocates for engaging with the community, governments, and
indigenous communities in proactive and innovative manners &ndash; early and often. Our proximity to communities contributes to the overall
health of these communities.&nbsp; We respect and incorporate language, spirituality, and ceremony at the request of the Indigenous community.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We support innovative economic and community engagement
programs and strategies to ensure we bring community values into our projects. At all times we seek to create spin off benefits from our
operations as a means of ensuring greater economic and social benefits from our activities.</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">Governance</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">enCore has corporate, health, safety, and environmental
policies in place to ensure a safe workplace that is respectful of our employees.&nbsp; Our health and safety policies are reviewed with
regulators to ensure compliance and to protect our employees, communities, and shareholders. Our environmental policies address important
issues including groundwater protection, waste minimization, and zero discharges. enCore will also assure that it maintains financial
responsibility for groundwater restoration, decommissioning, reclamation, and release for unrestricted use as our activities grow and
advance. &nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We seek a diverse and inclusive work force when
in development and production&nbsp;through employment of women and members of Indigenous communities. Our pay scales are competitive and
meant to be equitable and fair for all employees.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Executive compensation is managed by an independent
compensation committee with pay structures designed to reflect industry standards. Management represents a large percentage of ownership
and is motivated to make strategic business decisions designed to create benefit for all our shareholders.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Corporate governance policies range from a Code
of Conduct and social media guidelines to the prevention of insider trading and sharing of confidential information.&nbsp; We have policies
in place to ensure we do not expose the Company to bribery, extortion and money laundering.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We strive to conduct ourselves in a respectful,
professional, and accountable manner at all times.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B></B></P>

<!-- Field: Page; Sequence: 9; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">enCore Energy Corp.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Management&rsquo;s Discussion and Analysis</P>

<P STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">For the years ended December 31,
2022 and 2021</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Corporate Highlights for 2022</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On January 4, 2022, the Company announced the
closing of the Plan of Arrangement whereby the Company acquired all of the outstanding shares of Azarga Uranium. Pursuant to the Arrangement,
the Company acquired all of the issued and outstanding common shares of Azarga Uranium on the basis of 0.375 common shares of enCore for
each Azarga Uranium share. Outstanding warrants and options to purchase common shares of Azarga Uranium were deemed to be exchanged for
options and warrants to purchase common shares of enCore and were adjusted in accordance with their terms based on the exchange ratio.
The Company also announced that the U.S. Nuclear Regulatory Commission (&ldquo;NRC&rdquo;) was completing a review in connection with
the NRC&rsquo;s consent to the change of control over the Dewey-Burdock Source and By-Product Materials License.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On February 15, 2022, the Company entered into
an agreement to forward purchase 200,000 pounds U<SUB>3</SUB>O<SUB>8</SUB> from a third party. The agreement allows the Company to acquire
uranium in 2023 at a fixed price, and the Company has prepaid a portion of the forward purchase price to secure the purchase agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On February 28, 2022, the Company sold 100,000
pounds U<SUB>3</SUB>O<SUB>8</SUB> for US$42.50 per pound for a realized revenue of US$4,250,000.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In February 2022, the U.S. Nuclear Regulatory
Commission (&ldquo;NRC&rdquo;) approved the indirect change of control over the Dewey-Burdock Source and By-Product Materials License,
enabling the Company to receive, acquire, possess, and transfer natural uranium and byproduct material in any form without restriction
on quantity, at the Dewey-Burdock Project in Fall River and Custer Counties, South Dakota.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On March 1, 2022, the Company announced the filing
of the Technical Report prepared pursuant to National Instrument 43-101 &ndash; Standards of Disclosure for Mineral Projects (&ldquo;NI
43-101&rdquo;) in connection with its Crownpoint and Hosta Butte uranium project located in northwestern New Mexico.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On March 25, 2022, the Company completed a &ldquo;bought
deal&rdquo; prospectus offering pursuant to which the Company sold an aggregate of 6,535,947 units of the Company at a price of $3.53
per unit for aggregate gross proceeds of 23,057,411 ($29,999,998.26 CAD). Each unit was comprised of one Common Share and one-half of
one common share purchase warrant of the Company. Each whole warrant entitles the holder thereof to purchase one Common Share at an exercise
price of $2.00 until March 25, 2024. The Company paid the underwriters a cash commission of $1,268,157 ($1,612,500 CAD) and issued an
aggregate of 351,307 compensation options of the Company. Each compensation option is exercisable to acquire one Common Share at an exercise
price of $3.53 per share until March 25, 2024. The Company plans to use the net proceeds to maintain and advance the Company&rsquo;s material
properties, acquire properties, plant upgrades, maintenance and refurbishment, and for general corporate and working capital purposes.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On April 11, 2022, the Company announced positive
results from its on-going uranium delineation and exploration drill programs at the Rosita Project. Highlights of the Rosita South uranium
delineation and exploration drill programs include: (a) 32 drill holes reported for a total of ~11,000 feet including 20 delineation drill
holes and 12 exploration drill holes; (b) the exploration drilling has identified 8 mineralized sands plus an additional 4 potentially
mineralized sands, all within 800 feet of the surface, which provide opportunities for discovery of future uranium resources across the
entire Rosita Project; and (c) Delineation drill results established an extension of mineralization in the production area which supports
the start-up of the Rosita CPP expected next year.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On May 3, 2022, the Company appointed Mr. Peter
Luthiger as Chief Operating Officer. Mr. Luthiger is responsible for the commissioning and operation of the Rosita CPP in South Texas.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On May 20, 2022, the Company divested of Cibola
Resources, LLC to Elephant Capital (&ldquo;Elephant&rdquo;) pursuant to a Share Purchase Agreement whereby the Company received consideration
in the form of 11,308,250 common shares with a market value of $0.27 per share. Elephant was subsequently acquired by Evolving Gold, who
renamed themselves American Future Fuel Corp (&ldquo;AFFC&rdquo;). Accordingly, the 11,308,250 shares of Elephant were converted to 11,308,250
shares of AFFC (CSE: AMPS).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On June 1, 2022, the Company appointed Susan Hoxie-Key,
MSc, P.E., as a director of the Company. Ms. Hoxie-Key brings over 40 years of engineering experience in the nuclear fuel industry.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 10; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">enCore Energy Corp.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Management&rsquo;s Discussion and Analysis</P>

<P STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">For the years ended December 31,
2022 and 2021</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On June 28, 2022, the Company secured a uranium
purchase sales agreement with a United States based nuclear power company. The agreement is a multi-year agreement commencing in 2025
and covers up to 600,000 pounds of U<SUB>3</SUB>O<SUB>8</SUB> based on market pricing with a floor price that assures the Company&rsquo;s
costs of product are met. The agreement includes an inflation-adjusted ceiling price higher than the current uranium spot market pricing
providing the U.S. nuclear power plant assurance of cost certainty.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On July 15, 2022, the Company appointed Gregory
Zerzan as Chief Administrative Officer and General Counsel. Mr. Zerzan has held several prominent government and private sector leadership
positions, including most recently Principal Deputy Solicitor of the United States Department of the Interior.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On August 5, 2022, the Company entered into an
agreement to forward purchase 100,000 pounds U<SUB>3</SUB>O<SUB>8</SUB> from a third party. The agreement allows the Company to acquire
uranium in 2023 at a fixed price, and the Company has prepaid a portion of the forward purchase price to secure the purchase agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On August 10, 2022, the Company announced that
a panel of the U.S. Court of Appeals for the Circuit of the District of Columbia (DC Circuit Court) issued an opinion in a case brought
by the Oglala Sioux Tribe (the petitioners) against the U.S. Nuclear Regulatory Commission (NRC). The Oglala Sioux Tribe had challenged
the NRC&rsquo;s decision to grant Powertech Uranium (USA), Inc. (Powertech), a wholly owned subsidiary of the Company, a license to extract
uranium at its Dewey-Burdock in South Dakota. The panel ruled that the NRC&rsquo;s actions were lawful, affirming its decision to issue
the license to Powertech. The final status will be determined by whether the petitioners successfully receive an &ldquo;en banc&rdquo;
review by the entire panel of the DC Circuit Court.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On August 25, 2022, the Company announced the
installation and completion of all wellfield monitor wells for its Rosita Extension Production Area Authorization (&ldquo;PAA&rdquo;),
located less than one mile from its 100% owned and fully licensed Rosita CPP in South Texas. The Rosita Extension PAA includes uranium
mineralization extending approximately 3,000 feet in length.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On September 14, 2022, the Company consolidated
its common shares on a one (1) post-consolidation share for every three (3) current shares basis.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On November 1, 2022, the Company announced that
it has completed the refurbishment and modernization of its Rosita CPP and has subsequently commenced commissioning work. Following commissioning
work, the Rosita Project will be ready to start receiving loaded resin. Monitor well installation, baseline water quality analysis, and
hydrological testing will be completed as part of the Production Area Authorization (PAA) process with the Texas Commission on Environmental
Quality. (TCEQ). Wellfield installation will begin immediately following the submittal of the PAA data package to the TCEQ. All activities
are on track and on budget for a projected 2023 production start.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 11; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">enCore Energy Corp.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Management&rsquo;s Discussion and Analysis</P>

<P STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">For the years ended December 31,
2022 and 2021</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On November 3, 2022, the Company announced that
as a component of its on-going Non-Core Exploration Asset Divestment Strategy, that the Company entered into agreements to sell certain
uranium exploration assets to Nuclear Fuels Inc. (&ldquo;Nuclear Fuels&rdquo;), a private British Columbia company, for shares in Nuclear
Fuels, royalty interests and production back-in rights in the properties. The Company has agreed to sell its Belt Line Resources, Inc.
(&ldquo;Belt Line&rdquo;) and Hydro Restoration Corporation (&ldquo;Hydro&rdquo;) subsidiaries to Nuclear Fuels. Belt Line holds the Moonshine
Springs Uranium property in Mohave County, Arizona and Hydro holds the Kaycee Uranium property in Johnson County, Wyoming as well as the
Bootheel Uranium project in Albany County, Wyoming. Historic Resource are known on all three projects.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On November 14, 2022, the Company announced that
it had entered into a definitive agreement to acquire the Alta Mesa Project Uranium Project (&ldquo;Alta Mesa&rdquo;) from Energy Fuels
Inc. for total consideration of US$120 Million.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">o</TD><TD STYLE="text-align: justify">Pursuant to the terms of the Agreement, enCore, through its wholly owned subsidiary enCore Energy US Corp.,
will acquire all of the limited liability company membership interests in each of the three Texas limited liability companies which collectively
own and control the Alta Mesa Project, being EFR Alta Mesa LLC, Leoncito Plant, LLC and Leoncito Project, LLC from EFR White Canyon Corp.
(&ldquo;EFR White Canyon&rdquo;), a wholly owned subsidiary of Energy Fuels. enCore additionally will assume the reclamation obligations
and surety bonds associated with the Alta Mesa Project in exchange for paying Energy Fuels the cash equivalent of the existing collateral.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">o</TD><TD STYLE="text-align: justify">The Consideration payable to Energy Fuels consists of US$60 million in cash and a US$60 million secured
vendor take-back convertible promissory note (the &ldquo;Note&rdquo;) with EFR White Canyon. The Note will have a two (2) year term and
will bear interest at a rate of 8% per annum payable on June 30th and December 31st of each year during the term. The Note will be convertible
at the election of the holder, to acquire common shares of enCore at a price equal to a 20% premium to the volume weighted average price
of the enCore shares for the 20 consecutive trading days immediately prior to the closing of the Transaction. Energy Fuels has agreed
not to transact with the common shares of enCore received on conversion of the Note, including hedging and short sales, with exceptions
for sale transactions of up to US$10 million in value in any 30-day period, block trades and underwritten distributions. In addition,
Energy Fuels has agreed to standard standstill provisions restricting additional acquisitions of enCore securities.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">o</TD><TD STYLE="text-align: justify">The board of directors of enCore (the &ldquo;Board&rdquo;), after consultation with its financial and
legal advisors, and after receiving a unanimous recommendation from a special committee of the Board comprised of independent directors
(the &ldquo;Special Committee&rdquo;), has unanimously approved the Transaction. The Board, in conducting its review of the Transaction,
was advised by Haywood Securities Inc. (&ldquo;Haywood&rdquo;) and received a fairness opinion from Haywood which determined that, in
Haywood&rsquo;s opinion, based upon and subject to the assumptions, limitations and qualifications set out therein, the consideration
to be paid by enCore in connection with the Transaction is fair to enCore. The Special Committee, in its review and evaluation of the
Transaction, additionally received its own separate fairness opinion from Clarus Securities Inc. (&ldquo;Clarus&rdquo;) which determined
that, in Clarus&rsquo;s opinion, based upon and subject to the assumptions, limitations and qualifications set out therein, the consideration
to be paid by enCore in connection with the Transaction is fair to enCore.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">o</TD><TD STYLE="text-align: justify">The Transaction was subject to customary closing conditions, including enCore completing a financing to
fund the cash portion of the purchase price and approval by the TSX Venture Exchange (the &ldquo;Exchange&rdquo;).</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On December 6, 2022, the Company announced the
successful completion of its previously announced &ldquo;bought deal&rdquo; brokered private placement of an aggregate of 23,000,000 subscription
receipts (the &ldquo;Subscription Receipts&rdquo;) of enCore at a price of C$3.00 per Subscription Receipt (the &ldquo;Issue Price&rdquo;)
for aggregate gross proceeds to enCore of C$69 million (the &ldquo;Offering&rdquo;), including the full exercise of the Underwriters&rsquo;
option. Concurrently, enCore completed a non-brokered private placement of 277,000 Subscription Receipts at the Issue Price for aggregate
gross proceeds to enCore of C$831,000 (the &ldquo;Concurrent Offering&rdquo;, and collectively with the Offering, the &ldquo;Private Placements&rdquo;).
The Offering was completed pursuant to an underwriting agreement entered into among enCore, Canaccord Genuity Corp. (the &ldquo;Lead Underwriter&rdquo;),
Haywood Securities Inc., Cantor Fitzgerald Canada Corporation, PI Financial Corp., Clarus Securities Inc., and Red Cloud Securities Inc.
(together with the Lead Underwriter, the &ldquo;Underwriters&rdquo;). In consideration for their services, the Underwriters were paid a
cash commission equal to 6% of the gross proceeds of the Offering (other than in respect of subscribers on the President&rsquo;s List
for which a 2% commission was paid), subject to 50% of the cash commission payable in respect of the Subscription Receipts being held
in escrow pending the satisfaction of the Escrow Release Conditions and in accordance with the terms of the subscription receipt agreement
entered into among enCore, Computershare Trust Company of Canada, as subscription receipt agent (the &ldquo;Escrow Agent&rdquo;), and the
Lead Underwriter (the &ldquo;Subscription Receipt Agreement&rdquo;). Additionally, in consideration for their services, the Underwriters
were issued an aggregate of 1,350,000 non-transferable broker warrants (the &ldquo;Broker Warrants&rdquo;) of enCore, with each Broker Warrant
being exercisable into one common share (each, a &ldquo;Broker Warrant Share&rdquo;) of enCore at a price of C$3.25 per Broker Warrant Share
from the date hereof until 27 months following the satisfaction of the Escrow Release Conditions. In connection with the Concurrent Offering,
enCore paid an aggregate of $13,800 as finder&rsquo;s fee commissions.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 12; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">enCore Energy Corp.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Management&rsquo;s Discussion and Analysis</P>

<P STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">For the years ended December 31,
2022 and 2021</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On December 15, 2022, the Company announced that
the United States Court of Appeals for the District of Columbia Circuit denied the request of the Oglala Sioux Tribe and the group &ldquo;Aligning
for Responsible Mining&rdquo; (the petitioners) for a full panel review of a prior decision by a three-judge panel of that court. As previously
announced, the panel found that the Nuclear Regulatory Commission had adequately complied with the relevant statutory and regulatory requirements
in granting a source materials license to Powertech USA Inc., a subsidiary of the Company., for extraction of uranium from ore beds at
the company&rsquo;s Dewey-Burdock Project in South Dakota.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The petitioners may petition the United States
Supreme Court to review the ruling. They have 90 days in which to file for review, and possibly 60 additional days after that period if
the court chooses to grant an extension.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On December 20, 2022, the Company announced that
the company was awarded a contract to sell 100,000 pounds of natural uranium concentrates (U<SUB>3</SUB>O<SUB>8</SUB>) to the Government
of the United States, at a price of $70.50/pound, under the new Uranium Reserve Program. The Company is one of five qualified United States
based operators, with existing licensed facilities, approved to sell domestically sourced natural uranium to the United States government&rsquo;s
Uranium Reserve Program. Additionally, The Company announced its application for membership in the DOE&rsquo;s newly created HALEU (High
Assay Low Enrichment) Consortium.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Highlights Subsequent to December 31, 2022</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On January 18, 2023, the Company announced that
its common shares (the &ldquo;Common Shares&rdquo;) had been approved for listing and trading on the NYSE American. The Company also announced
that its Common Shares commenced trading at market open on the NYSE American on January 23, 2023, under the symbol &ldquo;EU&rdquo; and
was delisted from the OTCQX.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On February 6, 2023, the Company announced that
it had closed its public offering (the &ldquo;Offering&rdquo;), announced on January 25, 2023, of units (the &ldquo;Units&rdquo;) of the Company.
Pursuant to the Offering, the Company issued a total of 10,615,650 Units at a price of C$3.25 per Unit for aggregate gross proceeds of
C$34,500,862.50, including the full exercise of the over-allotment option granted to the Underwriters under the Offering. The Offering
was conducted through a syndicate of underwriters led by Canaccord Genuity, as lead underwriter and sole bookrunner, and including Cantor
Fitzgerald Canada Corporation and Haywood Securities Inc. (collectively, the &ldquo;Underwriters&rdquo;) pursuant to an underwriting agreement
dated January 25, 2023, entered into among the Company and the Underwriters. Each Unit consists of one common share in the capital of
the Company (each a &ldquo;Unit Share&rdquo;) and one-half of one common share purchase warrant (each a &ldquo;Warrant&rdquo;). Each Warrant
entitles the holder thereof to purchase one common share of the Company (a &ldquo;Warrant Share&rdquo;) at a price of C$4.05 per Warrant
Share for a period of 36 months following the closing of the Offering.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On February 14, 2023, the Company announced the
closing of the acquisition of the Alta Mesa Project from Energy Fuels Inc. (the &ldquo;Alta Mesa Acquisition&rdquo;) under the same terms
described in the November 14, 2022, announcement. The transaction provides the Company with its third licensed uranium in-situ recovery
(ISR) processing plants and positions the Company as a leading US-focused ISR uranium company with the proven management expertise required
to advance multiple production opportunities within its portfolio.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On February 21, the Company announced that it
had secured its fourth uranium sales agreement with the addition of a purchase sales agreement (&ldquo;Agreement&rdquo;) with a Fortune
500-listed United States (&ldquo;U.S.&rdquo;) utility. The uranium sales agreement is a multi-year agreement commencing in 2027. It covers
firm deliveries of 650,000 pounds of U308, with an option to acquire up to 400,000 pounds U308 under a two-year extended term, if exercised.
The sales agreement is based on market pricing with a floor price well above our current projected costs of production and an inflation
adjusted ceiling price significantly higher than the current uranium spot market pricing providing the U.S. with assurance of domestic
supply along with cost certainty.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On March 15, 2023, the Company announced that
it had made a formal production decision for the resumption of uranium production from the Alta Mesa CPP in early 2024. Alta Mesa will
be enCore&rsquo;s second producing location following resumption of uranium production at the South Texas Rosita CPP scheduled for 2023.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On March 20, 2023, the Company announced that
the petitioners to the Nuclear Regulatory Commission&rsquo;s (NRC) granting of a Source Materials License to enCore Energy Corp&rsquo;s
wholly owned subsidiary Powertech (USA) Inc. have declined to seek review by the U.S. Supreme Court. The NRC license is now final and
fully effective. Confirmation of the NRC license clears the way for the resumption of proceedings in two additional legal challenges by
the petitioners to the Dewey-Burdock Project final EPA Class III and V Underground well permits and aquifer exemption. Those challenges
are based on some of the same issues decided in the NRC case.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Industry Trends and Outlook</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">2022 can best be characterized as a year in which
the perception of status quo in the uranium market was cast aside with significant shifts in geopolitics and government. We believe these
events have shifted the tailwinds strongly in support of the nuclear power industry, and we believe those same events have shifted the
demand for nuclear fuel strongly in favor of U.S. uranium production, where our business is focused.</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 13; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B></B>enCore Energy Corp.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Management&rsquo;s Discussion and Analysis</P>

<P STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">For the years ended December 31,
2022 and 2021</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B></B>&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Unlike the uranium market of 2003 to 2010, which
was driven by a perfect storm of production interruptions at several major mines globally, the current market is driven by increasing
demand. This global increase of demand is a result of depletion of above ground stockpiles, growing conventional reactor demand with 437
reactors operating across the world, 56 under construction and 70 in the planning stage according to the IAEA as of December 31, 2021.
Additional upward pressure is expected to come from extended life of operating licenses, increased power output authorizations and from
the development of small modular reactors</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The new mine supply of uranium falls well short
of the annual demand and is most critical in the United States where its annual demand of approximately 47 million pounds of U<SUB>3</SUB>O<SUB>8</SUB>
is almost entirely dependent upon foreign imports as of year-end 2022.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><IMG SRC="ex99-2_003.jpg" ALT="" STYLE="height: 386px; width: 680px">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Source: UxC, LLC</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Uranium prices have risen significantly higher
than 2021, driven by a tightened uranium market and growing security of supply concerns. Beginning in early January, unrest in Kazakhstan
raised concerns about the more than 40% of global uranium supply. In late February, the Russian invasion of Ukraine, we believe, created
one of the most transformative events for our industry.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We have seen set in motion a geopolitical realignment
in energy markets that is highlighting the increasingly important role for nuclear power not just in providing clean energy, but also
providing secure and affordable energy. This shift has occurred within the global nuclear industry which has been reliant on Russian
supplies for approximately 14% of uranium concentrates<SUP>1</SUP>, 27% of conversion<SUP>2</SUP> and 39% of enrichment<SUP>3</SUP>,
and in the U.S. approximately 60% of the uranium purchased by nuclear utilities in 2021 from Russia, Kazakhstan, and Uzbekistan, transited
through the port of St. Petersburg, Russia<SUP>4</SUP>. This overreliance on a limited number of state-owned enterprises to supply
uranium on such a limited supply path highlights the security of supply risk that is already associated with the growing primary supply
gap and shrinking secondary supplies and increasing the focus on origin of supply.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Utilities continue to evaluate their nuclear fuel
supplies, as a result of heightened supply risks that have resulted from geopolitical uncertainty. Due to the level of outsized impacts
created by an exit of Russian conversion and enrichment from western supply chains, utilities continue to be focused on conversion and
enrichment services to be secured under term supply agreements. We expect them to refocus on uranium in 2023 as the near term supply for
conversion and enrichment services are firmed up. The uncertainty about where nuclear fuel supplies will come from to satisfy growing
demand led to increased long-term contracting activity in 2022. We have seen term agreement terms that are supporting U.S. uranium production
as confirmation that utilities, in particular U.S. based utilities, are reprioritizing North American and Australian sourced uranium supply.
We expect there will be continued competition to secure uranium supply under long-term contracts with proven producers and assets in geopolitically
attractive jurisdictions, such as the U.S., with strong environmental, social and governance (ESG) performance and on terms that will
ensure the availability of reliable supply to satisfy demand.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 0pt; margin-bottom: 0pt; width: 25%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in; text-align: left"><SUP>1</SUP></TD><TD STYLE="text-align: justify">Uranium Production | Uranium Output - World Nuclear Association
(world-nuclear.org), June 2022</TD>
</TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in; text-align: left"><SUP>2</SUP></TD><TD STYLE="text-align: justify">Conversion - World Nuclear Association (world-nuclear.org),
January 2022</TD>
</TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in; text-align: left"><SUP>3</SUP></TD><TD STYLE="text-align: justify">Uranium Enrichment | Enrichment of uranium - World Nuclear Association
(world-nuclear.org), October 2022</TD>
</TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in; text-align: left"><SUP>4</SUP></TD><TD STYLE="text-align: justify">2021 Uranium Market Annual Report, Energy Information Administration,
May 2022</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 14; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">enCore Energy Corp.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Management&rsquo;s Discussion and Analysis</P>

<P STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">For the years ended December 31,
2022 and 2021</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Continued Demand Growth</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We have seen the benefits of nuclear energy being
recognized both by the general public and in government policy in a manner that has not been seen since the 1970&rsquo;s. This recognition
is being manifested not only by accountability for achieving the net-zero carbon targets set by countries and companies around the world,
but also by a geopolitical realignment that is causing countries to reexamine how they approach their energy needs. The Russian invasion
of Ukraine has deepened the energy crisis experienced in some parts of the world and amplified concerns about energy security, highlighting
the role of energy policy in balancing three main objectives: providing a clean emissions profile; providing a reliable and secure baseload
profile; and providing an affordable leveled cost profile. There is increasing recognition that nuclear power meets these objectives and
has a key role to play in achieving decarbonization goals. The growth in demand is not just long-term in the form of new builds, it is
medium-term demand in the form of reactor life extensions, and it is near-term growth as early reactor retirements are prevented and new
markets continue to emerge. And we are seeing momentum building for non-traditional commercial uses of nuclear power around the world
such as development of small modular reactors and advanced reactors, with numerous companies and countries pursuing projects.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Some Highlights in Energy Policy and Demand
Growth</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify">The Biden Administration and the U.S. Congress proposed policies
to reduce reliance on Russian conversion and enrichment. In the 117<SUP>th</SUP> Congress there were bipartisan bills to impose restrictions
on Russian imports of uranium in all forms. Those bills failed to receive a floor vote, and they have been reintroduced in the 118th
Congress. Additionally, the U.S. Department of Energy (DOE) announced plans to revitalize the U.S. domestic nuclear fuel through the
proposed Low Enriched Uranium (LEU) and High Assay Low Enriched Uranium (HALEU) purchase. The estimated budget of up to $4.3 billion
had been suggested. S.452/H.R. 1086 &ndash; Nuclear Fuel Security Act companion bills were filed in both houses of Congress on a bipartisan
basis to authorize the DOE nuclear fuel supply chain revitalization proposal.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify">In December 2022, the DOE notified successful, qualified
bidders to sell uranium to the Strategic Uranium Reserve. Five U.S. uranium producers received contracts to supply the DOE, and enCore
was included as a successful recipient of a contract as announced in a December 20, 2022 press release.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify">China announced plans to accelerate new nuclear projects
to combat future electricity shortages, indicating it could raise the number of new reactor construction approvals to ten or more per
year. In 2022, there were ten approvals.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify">In December, Japan announced a new plan to maximize nuclear
power by restarting as many existing reactors as possible, prolonging the operating lives of aging reactors beyond a 60-year limit, and
building new reactors. This followed an earlier pledge by Japan&rsquo;s Prime Minister Kishida to have up to 17 reactors restarted by
the summer of 2023. Additionally, the government set a target for nuclear to make up 20% to 22% of the country&rsquo;s energy mix by
the end of the decade, and under the new policy will push for the development and construction of &ldquo;next-generation innovative reactors&rdquo;
to replace about 20 reactors now set for decommissioning.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify">South Korea finalized their 10th Basic Plan for Electricity
Supply and Demand in January 2023. The plan aims to maintain 30% of the country&rsquo;s 2030 energy mix as nuclear power, resume construction
on Units 3 and 4 at the Shin Hanul nuclear plant and sets a goal of exporting 10 nuclear power plants by 2030, as well as the development
of a Korean small modular reactor (SMR). This positive news builds from the earlier 2022 announcements that included nuclear power in
South Korea&rsquo;s green taxonomy and reversed the previous administration&rsquo;s anti-nuclear stance.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify">In July 2022, the European Parliament voted to keep nuclear
power in the European Union&rsquo;s sustainable finance taxonomy as a transitional &ldquo;green&rdquo; investment. The Complimentary
Delegated Act from this vote was entered into application on January 1, 2023. Including nuclear power in the &ldquo;transitional&rdquo;
category indicates that it will help mitigate climate change but cannot yet be replaced by economically and technologically feasible
low-carbon alternatives.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify">Following the Russian invasion, numerous European countries
announced their intention to reduce reliance on Russian supplied nuclear fuel under long-term contracts. For example, in June, Ukraine&rsquo;s
state-owned utility, Energoatom, signed an agreement with Westinghouse to supply all its nuclear fuel and increase the number of planned
AP1000 reactor new builds from five to nine. Numerous other countries have also taken steps to diversify their nuclear fuel supply.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify">In Sweden, a newly-elected coalition majority government
immediately updated the country&rsquo;s energy policy to be more pronuclear. They cited a significant shift away from the previous focus
on renewables, changing the previous goal of &ldquo;100% renewable&rdquo; electricity by 2040 to &ldquo;100% fossil free electricity,&rdquo;
and have put forward legislation to allow for the construction of more reactors.</TD>
</TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="margin-top: 0; margin-bottom: 0"></P>

<!-- Field: Page; Sequence: 15; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">enCore Energy Corp.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Management&rsquo;s Discussion and Analysis</P>

<P STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">For the years ended December 31,
2022 and 2021</P>




<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify">Belgium shut down its Doel-3 nuclear reactor in September,
but in January announced 10-year life extensions for their two newest reactors, Doel 4 and Tihange 3. These reactors were set to close
in 2025 but will now restart in November 2026 after the necessary preparation and will continue operating for 10 years.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify">In November 2022, the United Kingdom (UK) announced that
it would take a joint stake alongside French partner &Eacute;lectricit&eacute; de France (EDF) in the construction of its new Sizewell
C nuclear power station, replacing China General Nuclear&rsquo;s 20% stake. The UK will invest &pound;700 million in the project, which
will be matched by EDF.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify">In France, the government and regulator are working on conditions
to extend the operating lives of existing reactors and the start of construction around 2028 for the first two of six new reactors with
plans for eight additional reactors in the future.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify">Poland confirmed its intent to build nuclear power capacity
for the first time and is progressing plans with two western reactor builders.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify">Egypt began construction on the first two of four Russian
built reactors at the El-Dabaa Power Plant as the government looks to accelerate the project.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify">India&rsquo;s first domestically designed 700 MWe pressurized
heavy water reactor at Kakrapar is now in commercial operation, an important milestone for the country. Three more units of this design
are expected to come online in the next few years. The country is targeting an expansion to have 22.5 GWe operating by 2031.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify">In August, President Biden signed the Inflation Reduction
Act of 2022 (IRA) into law. Through $369 billion (US) in tax incentives and other investments, IRA is a major federal legislative initiative
enacted to address climate change. The IRA includes significant support for nuclear power with the establishment of a Production Tax
Credit (PTC) to support existing nuclear reactors and provides $700 million (US) to incentivize the development of domestic sources of
high-assay low-enriched uranium. The implementation of the PTC has provided the opportunity to U.S. nuclear operators to announce life
extensions and power upgrades for several existing nuclear reactors, and that creates additional uranium demand that had not been included
in previous supply/demand models. Southern Company also confirmed its plans to apply to have the operating licenses for its Farley and
Hatch reactors extended to 80 years. This followed similar announced extensions for Tennessee Valley Authority&rsquo;s Browns Ferry reactor,
Xcel Energy&rsquo;s Monticello reactor, Dominion Energy&rsquo;s Virgil C. Summer reactor, and Constellation Energy&rsquo;s Clinton and
Dresden 2 and 3 reactors.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify">In California, Governor Newsom signed a bill seeking to extend
operations at the Diablo Canyon Power Plant for five years beyond its current license, which expires in 2025. Additionally, under the
Civilian Nuclear Power Grant Program placed into law in the 2021 Bipartisan Infrastructure Law, the power plant has requested up to $1.5
billion to fund the life extension.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify">Southern Company announced fuel loading began in October
2022 for Vogtle unit 3, the first of two 1,250 MWe AP1000&rsquo;s under construction in Georgia. In March 2023, the company announced
that the plant had started criticality, and generating electricity.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify">Mexico&rsquo;s Laguna Verde nuclear plant has been granted 30-year
operating life extensions for its two units.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify">Ontario Power Generation (OPG) announced plans to extend
the life of the Pickering nuclear power plant until at least 2026 and potentially up to 30 years. Additionally, OPG announced the financing
of the refurbishment activities at its Darlington site, where life extensions to four units are in progress, as well as for maintenance
of existing nuclear facilities.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><B>&nbsp;</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify">In the EU, specific nuclear energy projects have been identified
for inclusion under its sustainable financing taxonomy and therefore eligible for access to low-cost financing. Even in countries where
phase-out policies were in place, there have been policy reversals and decisions to, at a minimum, temporarily keep reactors running,
with public opinion polls showing growing support for it.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B></B></P>

<!-- Field: Page; Sequence: 16; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">enCore Energy Corp.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Management&rsquo;s Discussion and Analysis</P>

<P STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">For the years ended December 31,
2022 and 2021</P>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Supply Uncertainty</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><IMG SRC="ex99-2_004.jpg" ALT=""></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In addition to low uranium prices, government-driven
trade policies, the COVID-19 pandemic, and ongoing supply chain challenges that were the news in 2021, the most notable factor impacting
security of supply in 2022 was geopolitical uncertainty. The geopolitical uncertainty, driven by the Russian invasion of Ukraine, has
led many governments and utilities to re-examine supply chains and procurement strategies that are reliant on nuclear fuel supplies coming
out of Russia. In addition, sanctions on Russia, government restrictions, and restrictions on and cancellations of some cargo insurance
coverage are creating transportation and further supply chain risks for fuel supplies coming out of Central Asia. Despite the recent increase
in uranium prices, years of underinvestment in new capacity and the deepening geopolitical uncertainty has shifted risk from producers
to utilities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Nowhere have those supply chain issues manifested
themselves more than with the situation in the Republic of Kazakhstan. In early January 2022, Kazakhstan saw the most significant political
instability since it became independent in 1991. The events resulted in a state of emergency being declared across the country. Order
was restored in the second half of January, and the state of emergency was gradually lifted. In November 2022, President Tokayev was re-elected
for a new 7-year term. Kazatomprom (KAP) announced in August 2022 its plan to produce 10% below its total Subsoil Use Contracts level
in 2024. This plan was expected to result in increased production in Kazakhstan of about 5 million to 8 million pounds U<SUB>3</SUB>O<SUB>8</SUB>
compared to the current 20% reduction, bringing total expected annual uranium production to about 65 million pounds in 2024. KAP stated
the decision was based on its contracting progress but that it may still face significant challenges to increase above current production
levels due to the state of global supply chains. In January 2023, KAP&rsquo;s operational update showed lower expected production in 2023
due to wellfield development, procurement and supply chain issues, resulting in forecasted production of between 53.3 million and 55.9
million pounds, compared to between 58.5 million and 59.8 million pounds previously.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Further, with the exception of deliveries to
China, KAP and its joint venture partners rely heavily on rail transportation through Russia and sea transport via the port of St. Petersburg,
Russia, to reach western markets. As a response to transportation risks related to sanctions on Russia, other government restrictions,
and the restrictions and cancellation of some cargo insurance coverage, KAP has been looking to expand and use of the Trans-Caspian International
Transport Route (TITR)<SUP>5</SUP>. The TITR is an alliance between companies across Azerbaijan, Georgia, Kazakhstan, and Turkey, with
headquarters in Ankara. In December 2022, KAP announced that it has made a delivery of uranium to Canada via the TITR, nearly 10 months
following Russia&rsquo;s invasion of Ukraine.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B></B></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 0pt; margin-bottom: 0pt; width: 25%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B></B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in; text-align: left"><SUP>5</SUP></TD><TD STYLE="text-align: justify">&ldquo;Kazakhstan&rsquo;s Uranium Industry and the Middle Corridor
Come Together&rdquo;, The Diplomat, Wilder Alejandro S&aacute;nchez, January 30, 2023</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 17; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">enCore Energy Corp.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Management&rsquo;s Discussion and Analysis</P>

<P STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">For the years ended December 31,
2022 and 2021</P>






<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Our Assets</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>A Production strategy built on existing, licensed,
and near-term ISR uranium Projects</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><IMG SRC="ex99-2_005.jpg" ALT=""></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company advises that it is not basing its
production decisions at Rosita on a feasibility study of mineral reserves demonstrating economic and technical viability. The production
decision is based on known past In-Situ Recovery (ISR) and processing operations at that production facility and surrounding lands. However,
the Company understands that there is increased uncertainty, and consequently a higher risk of failure, when production is undertaken
in advance of a feasibility study. The Company has determined to proceed with a production decision based on past operations at Rosita,
including past ISR operations on the known mineral resource areas.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 18; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">enCore Energy Corp.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Management&rsquo;s Discussion and Analysis</P>

<P STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">For the years ended December 31,
2022 and 2021</P>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR>
    <TD STYLE="white-space: nowrap; width: 66%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><BR STYLE="clear: both">
<B>NI 43-101 Mineral Resources</B></FONT></TD>
    <TD STYLE="white-space: nowrap; width: 9%">&nbsp;</TD>
    <TD STYLE="white-space: nowrap; width: 12%">&nbsp;</TD>
    <TD STYLE="white-space: nowrap; width: 13%">&nbsp;</TD></TR>
  <TR>
    <TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD STYLE="white-space: nowrap">&nbsp;</TD></TR>
  <TR>
    <TD STYLE="white-space: nowrap; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Pathway to production assets</B></FONT></TD>
    <TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD STYLE="white-space: nowrap">&nbsp;</TD></TR>
</TABLE>

<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font-weight: bold; text-align: left; border-bottom: Black 1.5pt solid">Alta Mesa Project, South Texas</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Million<BR> Tons</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; font-style: italic; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; font-style: italic; text-align: center; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><B>Grade<BR> <I>e</I>U<SUB>3</SUB>O<SUB>8</SUB>%</B></P></TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold; font-style: italic">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><B>Attributable<BR> U<SUB>3</SUB>O<SUB>8&nbsp;</SUB>(M&nbsp;lbs.*)</B></P></TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 64%; text-align: left">Indicated mineral resource (ISR)</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">1.57</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">0.109</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">3.41</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Inferred mineral resource (ISR)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">7.00</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">0.120</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">16.79</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  </TABLE>




<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font-weight: bold; text-align: left; border-bottom: Black 1.5pt solid">Dewey-Burdock Project, South Dakota</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Million<BR> Tons</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; font-style: italic; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; font-style: italic; text-align: center; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><B>Grade<BR> <I>e</I>U<SUB>3</SUB>O<SUB>8</SUB>%</B></P></TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold; font-style: italic">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><B>Attributable <BR> U<SUB>3</SUB>O<SUB>8&nbsp;</SUB>(M&nbsp;lbs.*)</B></P></TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 64%; text-align: left">Indicated mineral resource (ISR)</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">7.39</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">0.116</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">17.12</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Inferred mineral resource (ISR)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">0.65</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">0.055</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">0.71</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  </TABLE>




<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font-weight: bold; text-align: left; border-bottom: Black 1.5pt solid">Gas Hills Project, Wyoming</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Million<BR> Tons</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; font-style: italic; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; font-style: italic; text-align: center; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><B>Grade <I><BR> e</I>U<SUB>3</SUB>O<SUB>8</SUB>%</B></P></TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold; font-style: italic">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><B>Attributable <BR> U<SUB>3</SUB>O<SUB>8 </SUB>(M&nbsp;lbs.*)</B></P></TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 64%; text-align: left">Measured &amp; Indicated mineral resource (ISR)</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">3.83</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">0.101</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">7.71</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Inferred mineral resource (ISR)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">0.41</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">0.052</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">0.43</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Measured &amp; Indicated mineral resource (non-ISR)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">3.2</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">0.048</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">3.06</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Inferred mineral resource (non-ISR)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">0.12</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">0.030</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">0.06</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  </TABLE>




<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font-weight: bold; text-align: left; border-bottom: Black 1.5pt solid">Crownpoint &amp; Hosta Butte Project, New Mexico</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Million<BR> Tons</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; font-style: italic; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; font-style: italic; text-align: center; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><B>Grade <I><BR> e</I>U<SUB>3</SUB>O<SUB>8</SUB>%</B></P></TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold; font-style: italic">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><B>Attributable <BR> U<SUB>3</SUB>O<SUB>8 </SUB>(M&nbsp;lbs.*)</B></P></TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 64%; text-align: left">Indicated mineral resource (ISR)</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">12.68</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">0.105</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">26.6</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Inferred mineral resource (ISR)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2.76</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">0.110</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">6.10</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  </TABLE>



<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"><B>Other assets</B>

<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font-weight: bold; text-align: left; border-bottom: Black 1.5pt solid">Marquez-Juan Tafoya Project, New Mexico</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Million<BR> Tons</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; font-style: italic; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; font-style: italic; text-align: center; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><B>Grade<BR> <I>e</I>U<SUB>3</SUB>O<SUB>8</SUB>%</B></P></TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold; font-style: italic">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><B>Attributable <BR> U<SUB>3</SUB>O<SUB>8 </SUB>(M&nbsp;lbs.*)</B></P></TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 64%; text-align: left">Indicated mineral resource (Minimum GT = 0.60) (non-ISR)</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">7.10</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">0.127</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">18.10</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
  </TABLE>



<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">Juniper Ridge Project, Wyoming</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Million<BR> Tons</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; font-style: italic; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; font-style: italic; text-align: center"><P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><B>Grade <I><BR> e</I>U<SUB>3</SUB>O<SUB>8</SUB>%</B></P></TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold; font-style: italic">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><B>Attributable <BR> U<SUB>3</SUB>O<SUB>8 </SUB>(M&nbsp;lbs.*)</B></P></TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 64%; text-align: left">Indicated mineral resource (non-ISR)</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">5.14</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">0.058</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">6.01</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Inferred mineral resource (non-ISR)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">0.11</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">0.085</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">0.18</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  </TABLE>



<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">Aladdin Ridge Project, Wyoming</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Million<BR> Tons</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; font-style: italic; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; font-style: italic; text-align: center"><P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><B>Grade <I><BR> e</I>U<SUB>3</SUB>O<SUB>8</SUB>%</B></P></TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold; font-style: italic">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><B>Attributable <BR> U<SUB>3</SUB>O<SUB>8 </SUB>(M&nbsp;lbs.*)</B></P></TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 64%; text-align: left">Indicated mineral resource (ISR)</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">0.47</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">0.111</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">1.04</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Inferred mineral resource (ISR)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">0.04</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">0.119</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">0.10</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  </TABLE>



<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">Centennial Project, Colorado</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Million<BR> Tons</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; font-style: italic; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; font-style: italic; text-align: center"><P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><B>Grade<BR> <I>e</I>U<SUB>3</SUB>O<SUB>8</SUB>%</B></P></TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold; font-style: italic">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><B>Attributable <BR> U<SUB>3</SUB>O<SUB>8 </SUB>(M&nbsp;lbs.*)</B></P></TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 64%; text-align: left">Indicated mineral resource (ISR)</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">6.87</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">0.090</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">10.37</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Inferred mineral resource (ISR)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1.36</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">0.090</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2.33</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  </TABLE>



<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font-weight: bold; text-align: left; border-bottom: Black 1.5pt solid">Historic Mineral resources &ndash; Significant Projects</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Million<BR> Tons</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; font-style: italic; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; font-style: italic; text-align: center; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><B>Grade<BR> <I>e</I>U<SUB>3</SUB>O<SUB>8</SUB>%</B></P></TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold; font-style: italic">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><B>Attributable <BR> U<SUB>3</SUB>O<SUB>8 </SUB>(M&nbsp;lbs.*)</B></P></TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 64%; text-align: left; padding-left: 0.125in">Marquez-Juan Tafoya, Southeast Deposit</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">1.10</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">0.110</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">2.48</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-left: 0.125in">Nose Rock</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">11.80</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">0.148</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">35.00</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-left: 0.125in">West Largo</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2.90</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">0.300</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">17.20</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-left: 0.125in">Ambrosia Lake</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2.00</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">0.176</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">7.10</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; text-align: left">Total Historic Mineral Resources</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; text-align: right">61.78</TD><TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD></TR>
  </TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B></B></P>

<!-- Field: Page; Sequence: 19; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">enCore Energy Corp.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Management&rsquo;s Discussion and Analysis</P>

<P STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">For the years ended December 31,
2022 and 2021</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><IMG SRC="ex99-2_006.jpg" ALT=""></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B></B></P>

<!-- Field: Page; Sequence: 20; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">enCore Energy Corp.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Management&rsquo;s Discussion and Analysis</P>

<P STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">For the years ended December 31,
2022 and 2021</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><IMG SRC="ex99-2_007.jpg" ALT=""></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>South Texas in-Situ Recovery Uranium Processing
Plants and Projects</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">enCore Energy is focused on executing our production
plan in South Texas starting at Rosita Project in 2023 and closely followed by the Alta Mesa Project in 2024. Both of the projects have
licensed and permitted processing facilities and production areas.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Rosita Central In-Situ Recovery Uranium Processing
Plant &amp; Project (&ldquo;Rosita&rdquo;), South Texas</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Highlights:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">One
of enCore&rsquo;s key assets in advancing production in 2023, the plant is located approximately 60 miles west of Corpus Christi, Texas
and covers over 3,500 acres of mineral rights and plant facilities.</FONT></TD>
</TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">A
fully-licensed ISR production facility with a production capacity of 800,000 pounds of U<SUB>3</SUB>O<SUB>8</SUB>&nbsp;per year; anticipated
start of production in 2023 from the Rosita Extension.</FONT></TD>
</TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">The
Rosita CPP will receive uranium loaded resins from various remote South Texas projects and satellite wellfields.</FONT></TD>
</TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Historic
production - 1990 to 1999 with 2.65 million pounds U<SUB>3</SUB>O<SUB>8</SUB> pounds produced from nearby production areas.</FONT></TD>
</TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">The
Rosita CPP refurbishment and upgrades were completed in 2022 and has infrastructure in place to increase capacity substantially when
needed.</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Rosita CPP is the Company&rsquo;s initial
focus for production in 2023. The Rosita property holdings consist of mineral leases from private landowners and cover approximately 2,759
gross and net acres of mineral rights. All of the leases for the Rosita area provide for payment of sliding scale royalties based on the
price of uranium, ranging from 6.25% to 18.25% of uranium sales produced from the leased lands. Under the terms of the leases, the lands
can be held after the expiration of their primary and secondary terms, if restoration and reclamation activities remain ongoing. The leases
initially had primary and secondary terms ranging from 2012 to 2016, with provisions to extend the leases beyond the initial terms. The
Company holds these leases by payment of annual property rental fees ranging from $10 to $30 per acre.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 21; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">enCore Energy Corp.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Management&rsquo;s Discussion and Analysis</P>

<P STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">For the years ended December 31,
2022 and 2021</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Rosita Project is located in Duval County,
Texas. The facility is located within the South Texas uranium province, about 22 miles west of the town of Alice. The plant at Rosita
was constructed in 1990 and is located on a 200-acre tract of land owned by the Company. It was originally designed and constructed to
operate as an up-flow ion exchange facility, in a similar manner to the Kingsville Dome CPP. Resin was processed at the Rosita CPP, and
the recovered uranium was precipitated into slurry, which was then transported to Kingsville Dome for final drying and packaging.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Production from the Rosita CPP began in 1990 and
continued until 1999, when it was placed on standby. In the 2007-2008 period, upgrades were made to the processing equipment and additions
to the facility were installed, including revisions to the elution and precipitation circuits, and the addition of a full drying system.
Construction terminated when the plant was 95% complete due to production and price declines. The current plant is anticipated to have
an operating capacity of 800,000 pounds of U<SUB>3</SUB>O<SUB>8</SUB> per year when production commences. One satellite ion exchange system
is in place at the Rosita project, but it only operated for a short period of time in 2008. A second satellite ion exchange system will
be constructed at the Rosita project to accommodate expected production from the wellfield that is currently under construction. On November
1, 2022, the Company announced that it had completed the refurbishment of the Rosita ISR Central Processing Plant, a key step toward the
goal of the Company becoming the next producer of American uranium.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Access to the Rosita Project is good, from an
improved company-owned private drive that connects with an unpaved but maintained county road, which in turn connects with Texas Farm
to Market Road 3196, about one mile northeast of the intersection of State Highway 44 and FM 3196 in Duval County. Electrical power for
the Rosita Project is readily available, with an industrial-scale power line extending to the Rosita CPP.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Initial production of uranium from the Rosita
CPP, utilizing the ISR process, commenced in 1990 and continued until July 1999. During that time, 2.64 million pounds of U<SUB>3</SUB>O<SUB>8</SUB>
were produced. Production was halted in July of 1999 due to depressed uranium prices, and it resumed in June 2008. Technical difficulties,
coupled with a sharp decline in uranium prices, led to the decision to suspend production activities in October 2008. No production has
occurred at the Rosita Project since that time.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Uranium mineralization at the Rosita Project occurs
as roll-fronts hosted in porous and permeable sandstones of the Goliad Formation, at depths ranging from 125 to 350 feet below the surface.
Additional potential for roll-front mineralization exists between 500 and 700 feet in the Oakville Formation and is the subject of current
exploration efforts.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Rosita Project is comprised of four Texas
Commission on Environmental Quality (TCEQ) authorized production areas. Production areas 3 and 4 contain limited uranium resources that
have yet to be produced. Former production areas 1 and 2 consisted of seven wellfields whose groundwater has been restored by the circulation
and processing of approximately 1.3 billion gallons of reverse osmosis treated water. In 2013, the company completed the final phase of
TCEQ required stabilization in production areas 1 and 2. The Company began plugging wells in production areas 1 and 2 in 2014 and completed
those activities in 2016. TCEQ has accepted that plugging was completed in accordance with the approved closure plan. Remaining wells
for other uses are being transferred or reclassified in order to complete closure of the two former production areas. Completion of the
surface reclamation in production areas 1 and 2 was temporarily halted in 2019 and resumed in early 2020 with completion anticipated in
2023, pending acceptance by the TCEQ.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">A radioactive material license issued by the TCEQ
for the Rosita Project is in timely renewal, and on April 14, 2022, the renewal application was updated to meet current license and regulatory
requirements. That application has completed administrative review, and the technical review has commenced. The underground injection
control permit, issued on October 14, 2014, remains in good standing. Production could resume in areas already included in existing production
area authorizations. As new areas are proposed for production, additional authorizations from TCEQ under the permit will be required.
The waste disposal well permit has been renewed.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 22; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">enCore Energy Corp.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Management&rsquo;s Discussion and Analysis</P>

<P STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">For the years ended December 31,
2022 and 2021</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Satellite Operations for the Rosita Project</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><B><I>Rosita Project Extension, Texas</I></B>
&ndash; The Company is advancing wellfield development within the Rosita Project radioactive materials license and injection permit boundaries.
The mineral resources in this area were never produced and present a rapid opportunity for early production. The Company is completing
installation of production patterns in the production area and will be followed quickly by the installation of the necessary infrastructure
to operate with a satellite ion exchange system. This work is expected to be completed in the 3rd Quarter of 2023 to meet the Company&rsquo;s
stated goal of the start of production at the Rosita Project.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><B><I>Rosita South, Texas</I></B> &ndash;
The Company announced positive results from its on-going uranium delineation and exploration drill programs at its 100% owned Rosita South
project. The Project is adjacent to the Rosita CPP. The Rosita South Project area provides one of the most optimal sources of satellite
feed for the Rosita CPP. 32 drill holes were reported for a total of approximately 11,000 feet including 20 delineation drill holes and
12 exploration drill holes. The exploration drilling has identified 8 mineralized sands plus an additional 4 potentially mineralized sands,
all within 800 feet of the surface, which provide opportunities for discovery of future uranium resources across the entire Rosita Project.
Delineation drill results established an extension of mineralization in the future Production Area which supports the start-up of production.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><B><I>Butler Ranch Project, Texas</I></B>
- The Company acquired the Butler Ranch Project from Rio Grande Resources in 2014, as part of a larger property exchange. The property
is comprised of non-contiguous fee leases that cover an area of about 438 acres of mineral rights. The Project is in the southwestern
end of Karnes County, Texas, about 45 miles southeast of the city of San Antonio, and 12 miles northwest of the town of Kenedy. The Project
is situated in the southwestern end of the Karnes County uranium mining district, which was one of the largest uranium production areas
in Texas.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><B>Upper Spring Creek Project, Texas</B>
-The Company acquired several mineral properties located in South Texas, within the area generally described as the Upper Spring Creek
Project (USC) area. The Project is currently comprised of two distinct areas: USC-Brown Area (Live Oak County) and USC Brevard Area (Live
Oak and Bee Counties). The USC-Brown Area Project is currently comprised of both Company-owned properties and both non-contiguous and
contiguous fee leases that cover an area of approximately 510 acres of surface and mineral rights, and the Company is actively acquiring
additional mineral properties for this Project. The USC Brevard Area is currently comprised of a single lease of approximately 274 acres
of surface and mineral rights. As with USC Brown Area, the Company is actively acquiring additional mineral properties for this Project.
These properties are intended to be developed as satellite ion-exchange plants that will provide loaded resin to the central processing
plant at the Rosita CPP.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 23; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">enCore Energy Corp.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Management&rsquo;s Discussion and Analysis</P>

<P STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">For the years ended December 31,
2022 and 2021</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Alta Mesa In-Situ Recovery Uranium Processing
Plant and Project (&ldquo;Alta Mesa&rdquo;), South Texas</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Highlights:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Key
enCore asset to advance production capacity in 2024;</FONT></TD>
</TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Fully
licensed past-producing plant &amp; existing resource located 80 miles from the Rosita CPP and 75 miles from the Kingsville Dome CPP.</FONT></TD>
</TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Total
operating capacity of 1.5 million pounds of uranium/year; planned production starting in 2024;</FONT></TD>
</TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">200,000
acres of private land in South Texas uranium belt with exploration opportunities;</FONT></TD>
</TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Project
areas include all three uranium mineral bearing sandstones, and there are over 52 linear miles of stacked uranium roll-front identified;
only 5 miles have been closely drilled out to date.</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><IMG SRC="ex99-2_008.jpg" ALT=""></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The CPP is located on a 45-acre surface tract,
100% owned by enCore, within the existing mining lease area. The CPP was expanded in 2008 to allow it to operate at 7,500 gallons per
minute and recover on in exchange resin at a rate of 1.5 million pounds U<SUB>3</SUB>O<SUB>8</SUB> per year, and the yellowcake drying
and packaging system was increased to 2 million pounds U<SUB>3</SUB>O<SUB>8</SUB> per year. The CPP is connected directly to the production
areas directly through pipelines due to the proximity of the nearby uranium ore bodies. For more distant uranium ore bodies, the CPP can
be modified to accept loaded resins transported from satellite IX systems in a manner similar to the planned operations at our 100% owned
Rosita Project.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Alta Mesa Project is located in both Brooks
and Jim Hogg Counties, Texas, USA. Alta Mesa is an ISR uranium project, and past producer consisting of two distinct properties; the Alta
Mesa property, which is composed of the Alta Mesa mine area and processing facility, South Alta Mesa (SAM) and Indigo Snake. The second
property is Meste&ntilde;a Grande, which is composed of Meste&ntilde;a Grande Goliad (MGG) Meste&ntilde;a Grande North (MGN), Meste&ntilde;a
Grande Central (MGC), Meste&ntilde;a Grande Alta Vista (MGAV), and El Sordo. The Project&rsquo;s CPP and mine office are located at the
Alta Mesa property approximately 11 miles west of the intersection of US 281 and Ranch Road 755, which is also 22 miles south of Falfurrias,
Texas.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Alta Mesa Project consists of uranium mining
leases for uranium ISR mining (4,598 acres) and Mineral Options (195,501 acres) comprising some 200,099 total acres consisting of acreage
associated with currently approved mining permits issued by the Texas Commission on Environmental Quality (&ldquo;TCEQ&rdquo;) and 9 prospect
areas. The Alta Mesa Project is located within a portion of the private land holdings of the Jones Ranch, founded in 1897 and includes
surface and mineral rights as well as oil and gas and other minerals including uranium. Active uses of the lands in addition to uranium
exploration and production activities include agricultural use (cattle), oil and gas development, and private hunting. Previous owners
include Chevron Minerals, Total Minerals, Cogema Mining, Uranium Resources Inc., Meste&ntilde;a Uranium LLC (MULLC), formed by landowners,
and Energy Fuels Inc. In 2016, Energy Fuels, Inc. acquired the Project from MULLC. In November 2022, enCore and a subsidiary of Energy
Fuels Inc. executed a Membership Interest Purchase Agreement whereby enCore agreed to acquire four limited liability companies that together
hold 100% of the Project. Please see the enCore Energy Corp. press release dated November 14, 2022, for additional details on the transaction.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 24; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">enCore Energy Corp.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Management&rsquo;s Discussion and Analysis</P>

<P STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">For the years ended December 31,
2022 and 2021</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Project produced approximately 4.6 million
pounds of uranium oxide between 2005 and 2013 via in-situ recovery using an alkaline lixiviant processed at the Alta Mesa CPP. The facility
was in production from 2005 until primary production ceased February 2013. The Project operated in a groundwater clean-up mode until February
2015; therefore, any uranium mined since 2013 remains as in-circuit inventory. The first wellfield (PAA-1) has completed final groundwater
restoration and was approved by the Texas Commission on Environmental Quality in March 2018. All other wellfields are being maintained
by a small bleed (less than 100 gpm) for permit compliance. The bleed solutions are disposed of in deep disposal wells.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Mineralization within the South Texas
Uranium Province is interpreted to be dominantly roll-front type mineralization and primarily of epigenetic origin (Finch, 1996).
Roll-fronts are formed along an interface between oxidizing groundwater solutions which encounter reducing conditions within the
host sandstone unit. This boundary between oxidizing and reducing conditions is often referred to as the Reduction/Oxidation (REDOX)
interface or front. The principal host sandstones associated with Alta Mesa project are located within the Goliad, Oakville, and a
Catahoula Formations that are known uranium bearing host sandstones.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">A radioactive material license issued by the TCEQ
for the Alta Mesa project is in timely renewal. The underground injection control permit is in timely renewal and remains in good standing.
Production could resume in areas already included in existing production area authorizations, and Production Area Authorization 7 (PAA-7)
is fully authorized and ready for the installation of new production patterns. The Project has two waste disposal wells that have had
their permits recently renewed.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Kingsville Dome Central Processing Plant &amp;
Project, South Texas</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Kingsville Dome Project is located in Kleberg
County, Texas and is comprised of multiple tracts of land leased from third parties. The Kingsville Dome CPP is situated on approximately
15 acres of Company-owned land, surrounded by leased acreage located approximately eight miles southeast of the city of Kingsville, Texas.
The Project was constructed in 1987 as an up-flow uranium ion exchange circuit, with complete drying and packaging facilities within the
recovery plant. The Kingsville Dome project produced uranium between 1988 and 1990, from 1996 to 1999, and most recently from 2007 through
2009. Two independent resin processing circuits and elution systems comprise the plant&rsquo;s processing equipment, along with a single
drying circuit.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As currently configured, the Kingsville Dome CPP
has a production capacity of 800,000 pounds of U<SUB>3</SUB>O<SUB>8</SUB> per year. Uranium production at Kingsville Dome was suspended
in 2009 and the CPP has been in a standby status since that time. The CPP has two 500 gallon per minute reverse osmosis systems for groundwater
restoration. The first unit was idled in 2010 and the second unit was idled in January of 2014, when groundwater restoration was completed.
The CPP can serve as a processing facility that can accept resin from multiple satellite facilities. In addition to the CPP, there are
four satellite ion exchange systems in the project area. Each of the satellite systems is capable of processing approximately 900 gallons
per minute of uranium-bearing ISR fluids from well fields, and these satellite plants can be relocated to alternate extraction sites as
needed.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Project is comprised of numerous mineral leases
from private landowners, covering an area of approximately 2,434 gross and 2,227 net acres of mineral rights. The leases are held through
the payment of annual rents, and the leases provide for the payment of production royalties, ranging from 6.25% to 9.375%, based upon
uranium sales from the respective leases. The leases initially had expiration dates ranging from 2000 to 2007; however, the Company continues
to hold most of these leases through ongoing restoration activities. With a few minor exceptions, the leases contain clauses that permit
us to extend the leases not held by production by payment of royalties ranging from $10 to $30 per acre per year.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 25; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->25<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">enCore Energy Corp.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Management&rsquo;s Discussion and Analysis</P>

<P STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">For the years ended December 31,
2022 and 2021</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Access to the Kingsville Dome CPP is via an improved
company-owned private road connecting the facility with Texas Farm to Market Road 1118, which connects to U.S. Highway 77 at the town
of Ricardo, located about four miles to the west of the plant. Numerous county and ranch roads, some of which are only intermittently
maintained, provide access to the entire project area. Suitable electrical power is present at the site of the Kingsville Dome CPP, and
additional power lines exist throughout the areas of the wellfields across the project area.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">A radioactive material license issued by the TCEQ
is in timely renewal. On September 26, 2012, the Company filed the requisite application for renewal of its Underground Injection Control
(&ldquo;UIC&rdquo;) permit, and on December 12, 2012, the Company filed an amendment to the application that would provide for resumption
of uranium recovery activities. In June 2016, the Company requested to withdraw its UIC permit and resubmit it at a later date. The request
to withdraw was granted by the TCEQ in April 2017. As new areas are proposed for production, additional authorizations under the area
permit will be required.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Satellite Operations for the Kingsville
Dome Project</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Vasquez Project, Texas. The Vasquez Project is
located in southern Duval County, Texas, a short distance northwest of the town of Hebbronville. The project operated from 2004 through
2008 as a satellite plant operation to the Kingsville Dome CPP until the mineral resource was depleted and reclamation commenced. The
Project is situated on a leased tract of land that is being held until final restoration has been completed. The Vasquez property consists
of a mineral lease on 1,023 gross and net acres. While the primary term of the mineral lease expired in February 2008, the Company continues
to hold the lease by carrying out restoration activities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Pathway to Production Projects</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Dewey-Burdock Project, South Dakota</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Dewey-Burdock Project is one of the Company&rsquo;s
initial development priorities following the focus on production in South Texas. The Company&rsquo;s 100% owned Dewey-Burdock Project
is an ISR uranium project located in the Edgemont uranium district, in South Dakota. Through property purchase agreements, mining leases
and/or mining claims, the Project is comprised of approximately 12,613 surface acres and 16,962 net mineral acres. In December 2020, the
Company filed an amended and restated NI 43-101 compliant independent Technical Report and Preliminary Economic Assessment (PEA) for the
Project prepared by Woodard &amp; Curran and Rough Stock Mining Services (the &ldquo;Dewey- Burdock PEA&rdquo;) with an effective date
of December 3, 2019.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>2019 Mineral Resource Estimate Summary (Effective date-December
3, 2019)</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold">ISR Resources</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Measured</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Indicated</TD><TD STYLE="font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">M &amp; I</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Inferred</TD><TD STYLE="font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 54%">Pounds</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">14,285,988</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">2,836,159</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">17,122,147</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">712,624</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD>Tons</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">5,419,779</TD><TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,968,443</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">7,388,222</TD><TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">645,546</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Avg. GT</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">0.733</TD><TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">0.413</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">0.655</TD><TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">0.324</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Avg. Grade (% U<SUB>3</SUB>O<SUB>8</SUB>)</FONT></TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">0.132</TD><TD STYLE="text-align: left">%</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">0.072</TD><TD STYLE="text-align: left">%</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">0.116</TD><TD STYLE="text-align: left">%</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">0.055</TD><TD STYLE="text-align: left">%</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Avg. Thickness (ft)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">5.56</TD><TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">5.74</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">5.65</TD><TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">5.87</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 9.95pt"><I>&nbsp;</I></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt"><I>Note: Resource pounds and grades of U<SUB>3</SUB>O<SUB>8</SUB>
were calculated by individual grade-thickness contours. Tonnages were estimated using average thickness of resource zones multiplied by
the total area of those zones.</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">An average uranium price of $55 per pound of U<SUB>3</SUB>O<SUB>8</SUB>
based on an average of recent market forecasts by various professional entities was determined to be an acceptable price for the PEA.
Contracts for yellowcake transportation, handling and sales will be developed prior to commencement of commercial production. The estimated
payback is in Quarter 4 of Year 2 with the commencement of design/procurement activities in Quarter 2 of Year -1 and construction beginning
Quarter 4 of Year -1. The Project is estimated to generate net earnings over the life of the Project of $372.7 million (pre-U.S. federal
income tax). It is estimated that the project has an internal rate of return (IRR) of 55% and a NPV of $171.3 million (pre-U.S. federal
income tax) applying an 8% discount rate.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 26; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->26<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">enCore Energy Corp.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Management&rsquo;s Discussion and Analysis</P>

<P STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">For the years ended December 31,
2022 and 2021</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The estimated initial capital costs for the first
two years of the Project life (Years -1 and 1) are approximately $31.7 million with sustaining capital costs of approximately $157.7 million
spread over the next 17 years (Years 2 through 18) of operation. Direct cash operating costs are approximately $10.46 per pound of U<SUB>3</SUB>O<SUB>8</SUB>
produced excluding royalties and severance and conservation taxes. The total capital and operating costs average approximately $28.88
per pound (pre-U.S. federal income tax) U<SUB>3</SUB>O<SUB>8</SUB> produced. Both the capital and operating costs are current as of the
end of 2019. The predicted level of accuracy of the cost estimate is +/- 25%.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The PEA provides the results of the analyses for
pre-U.S. federal income tax. All other sales, property, use, severance and conservations taxes as well as royalties are included. The
PEA assumes no escalation, no debt, no debt interest and no capital repayment. There is no State of South Dakota corporate income tax.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company&rsquo;s Dewey-Burdock Project received
its Source and Byproduct Materials License SUA-1600 on April 8, 2014 from the Nuclear Regulatory Commission (NRC), covering 10,580 acres.
The Company controls the mineral and surface rights for the area pertaining to the NRC license.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company submitted applications to the Department
of Agriculture and Natural Resources (DANR) in 2012 for its Groundwater Discharge Plan (&ldquo;GDP&rdquo;), Water Rights (&ldquo;WR&rdquo;)
and Large Scale Mine Plan (&ldquo;LSM&rdquo;) permits.&nbsp; All permit applications have been deemed complete and have been recommended
for conditional approval by the DANR staff, but any advancement is pending the outcome of the appeal process on the EPA permits. &nbsp;
In November 2020, the EPA issued the Company their final Class III and Class V UIC permits, and associated aquifer exemption, for the
Dewey-Burdock Project.&nbsp; After the permits being issued, the Class III and Class V UIC permits were appealed to the Environmental
Appeals Board (the &ldquo;EAB&rdquo;).&nbsp; The aquifer exemption was appealed to the United States Court of Appeals for the Eighth Circuit
(the &ldquo;Eighth Circuit&rdquo;). The EAB and the Eighth Circuit proceedings were stayed until such time as the DC Circuit Court challenge
to the NRC license became final. In December 2020, a petition for review of contentions previously resolved in favor of the Company and
the NRC staff was filed by certain petitioners with the United States Court of Appeals for the District of Columbia Circuit (the &ldquo;DC
Circuit Court&rdquo;). On August 9, 2022, the Company announced that the DC Circuit Court issued an opinion that deemed that the actions
taken by NRC in its licensing of the Dewey- Burdock Project were lawful and denied the petitioners request for further review. On March
20, 2023, following the denial of an &ldquo;en banc review by the DC Circuit Court, the Company announced that the petitioners had decided
to not advance the appeal to a review by the Supreme Court of the United States, and therefore the NRC license is now final and effective.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 19.65pt 0pt 0; text-align: justify"><B>Gas Hills Project, Wyoming</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Gas Hills Project is one of the Company&rsquo;s
development priorities following the focus on production in South Texas. The Company&rsquo;s 100% owned Gas Hills Project is located in
the historic Gas Hills uranium district situated 45 miles east of Riverton, Wyoming. The Project consists of approximately 1,280 surface
acres and 12,960 net mineral acres of unpatented lode mining claims, a State of Wyoming mineral lease, and private mineral leases, within
a brownfield site which has experienced extensive development including mine and mill site production. In August 2021, the Company filed
a maiden NI 43-101 compliant independent Technical Report and PEA for the Gas Hills Project prepared by WWC Engineering and Rough Stock
Mining Services (the &ldquo;Gas Hills PEA&rdquo;) with an effective date of June 28, 2021. Importantly, an ISR resource estimate was established
and supported by numerous hydrology studies confirming that the resources located below the water table are ideally suited for ISR mining
techniques.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">Resource Category</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Million Tons</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Grade <I>e</I>U<SUB>3</SUB>O<SUB>8</SUB>%</B></FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Attributable U<SUB>3</SUB>O<SUB>8</SUB> (M lbs.*)</B></FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 64%; text-align: left">Measured &amp; Indicated mineral resource (ISR)</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">3.83</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">0.101</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">7.71</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Inferred mineral resource (ISR)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">0.41</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">0.052</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">0.43</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Measured &amp; Indicated mineral resource (non-ISR)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">3.20</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">0.048</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">3.06</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Inferred mineral resource (non-ISR)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">0.12</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">0.030</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">0.06</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">NI 43-101 Technical Report, Preliminary Economic
Assessment, Gas Hills Uranium Project, Fremont and Natrona Counties, Wyoming, USA, completed by WWC Engineering and Rough Stock Mining
Services (effective 28 June 2021) (&ldquo;Gas Hills Technical Report and PEA&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The PEA indicates a pre-tax NPV of $120.9 million
at an 8 percent discount rate with an IRR of 116 percent compared to an after-tax NPV of $102.6 million at an 8 percent discount rate
with an IRR of 101 percent. The mine plan and economic analysis are based on the following assumptions:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">NI
43-101 compliant estimate of Mineral Resources and a recovery factor of 80 percent,</FONT></TD>
</TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">A
U<SUB>3</SUB>O<SUB>8</SUB> sales price of $55.00/lb,</FONT></TD>
</TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">A
mine life of 11 years,</FONT></TD>
</TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 27; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->27<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">enCore Energy Corp.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Management&rsquo;s Discussion and Analysis</P>

<P STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">For the years ended December 31,
2022 and 2021</P>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">A
pre-income tax cost including royalties, state and local taxes, operating costs, and capital costs of $28.20/lb, and</FONT></TD>
</TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Initial
capital costs of $26.0 million.</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Costs for the Project are based on economic analyses
for similar ISR uranium projects in the Wyoming region as well as WWC&rsquo;s in house experience with mining and construction costs.
All costs are in U.S. dollars (USD). To date, no detailed design work has been completed for the wellfields or the satellite plant. The
Project consists of four resource areas that contain ISR amenable resources: the West Unit, Central Unit, South Black Mountain, and Jeep.
There is an additional non-ISR amenable resource area at the Project named the Rock Hill Unit as well as other shallow deposits with resources
located above the water table that were not considered in the economic assessment portion of this PEA. For the purposes of this PEA, uranium
recovery was estimated at 6,507,000 pounds U<SUB>3</SUB>O<SUB>8</SUB> at a production rate of 1.0 million pounds U<SUB>3</SUB>O<SUB>8</SUB>
per year with a long-term uranium price of USD $55.00/pound U<SUB>3</SUB>O<SUB>8</SUB>. The uranium mineralization is contained in roll-front
deposits hosted by arkosic sandstone beds of the Eocene Wind River Formation. Based on areas of wide-spaced limited historical drilling
and areas of past mine production, the Company believes that there is sufficient geological evidence to interpret that mineralization
may extend from current mineral resource areas along identified trends. The Company is now focused on commencing the permitting process
and growing the ISR-amenable resources at the Gas Hills Project.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Crownpoint and Hosta Butte Uranium Project,
New Mexico</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Crownpoint and Hosta Butte Project is located
in the Grants Uranium Region and offers a long-term development opportunity for the Company. The Grants Uranium Region is located in northwestern
New Mexico and is part of the Colorado Plateau physiographic province. The Grants Uranium Region has been the most prolific producer of
uranium in the United States. With production as early as 1948, over 347 million lbs. of U<SUB>3</SUB>O<SUB>8</SUB> have been produced
from the region. The majority was produced during the years 1953 through 1990.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Total Indicated Mineral Resources</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; vertical-align: bottom; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>0.02% eU<SUB>3</SUB>O<SUB>8</SUB> Grade Cutoff and GT Cutoff* 0.25 ft%</B></FONT></TD>
    <TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Total<BR>
 Indicated<BR>
 Resource</B></FONT></TD>
    <TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>enCore<BR>
 Controlled</B></FONT></TD></TR>
  <TR STYLE="background-color: rgb(204,238,255)">
    <TD STYLE="background-color: rgb(204,238,255); width: 50%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Crownpoint</B></FONT></TD>
    <TD STYLE="background-color: rgb(204,238,255); width: 30%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pounds eU<SUB>3</SUB>O<SUB>8</SUB></FONT></TD>
    <TD STYLE="background-color: rgb(204,238,255); width: 1%">&nbsp;</TD>
    <TD STYLE="background-color: rgb(204,238,255); width: 9%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">19,565,000</FONT></TD>
    <TD STYLE="background-color: rgb(204,238,255); width: 1%">&nbsp;</TD>
    <TD STYLE="background-color: rgb(204,238,255); width: 9%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">16,223,000</FONT></TD></TR>
  <TR STYLE="background-color: White">
    <TD STYLE="background-color: rgb(204,238,255)">&nbsp;</TD>
    <TD STYLE="background-color: rgb(204,238,255); text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Tons</FONT></TD>
    <TD STYLE="background-color: rgb(204,238,255)">&nbsp;</TD>
    <TD STYLE="background-color: rgb(204,238,255); text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">9,027,000</FONT></TD>
    <TD STYLE="background-color: rgb(204,238,255)">&nbsp;</TD>
    <TD STYLE="background-color: rgb(204,238,255); text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7,321,000</FONT></TD></TR>
  <TR STYLE="background-color: rgb(204,238,255)">
    <TD STYLE="background-color: rgb(204,238,255); padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="background-color: rgb(204,238,255); padding-bottom: 1.5pt; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Avg. Grade % eU<SUB>3</SUB>O<SUB>8</SUB></FONT></TD>
    <TD STYLE="background-color: rgb(204,238,255); padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="background-color: rgb(204,238,255); border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.108</FONT></TD>
    <TD STYLE="background-color: rgb(204,238,255); padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="background-color: rgb(204,238,255); border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.111</FONT></TD></TR>
  <TR STYLE="background-color: White">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Hosta
    Butte</B></FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pounds eU<SUB>3</SUB>O<SUB>8</SUB></FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">9,479,000</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">9,479,000</FONT></TD></TR>
  <TR STYLE="background-color: White">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Tons</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3,637,000</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3,637,000</FONT></TD></TR>
  <TR STYLE="background-color: White">
    <TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Avg. Grade % eU<SUB>3</SUB>O<SUB>8</SUB></FONT></TD>
    <TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.130</FONT></TD>
    <TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.130</FONT></TD></TR>
  <TR STYLE="background-color: rgb(204,238,255)">
    <TD STYLE="background-color: rgb(204,238,255); text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Total Indicated Mineral Resource</B></FONT></TD>
    <TD STYLE="background-color: rgb(204,238,255); text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pounds eU<SUB>3</SUB>O<SUB>8</SUB></FONT></TD>
    <TD STYLE="background-color: rgb(204,238,255)">&nbsp;</TD>
    <TD STYLE="background-color: rgb(204,238,255); text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">29,044,000</FONT></TD>
    <TD STYLE="background-color: rgb(204,238,255)">&nbsp;</TD>
    <TD STYLE="background-color: rgb(204,238,255); text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">25,702,000</FONT></TD></TR>
  <TR STYLE="background-color: White">
    <TD STYLE="background-color: rgb(204,238,255)">&nbsp;</TD>
    <TD STYLE="background-color: rgb(204,238,255); text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Tons</FONT></TD>
    <TD STYLE="background-color: rgb(204,238,255)">&nbsp;</TD>
    <TD STYLE="background-color: rgb(204,238,255); text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">12,664,000</FONT></TD>
    <TD STYLE="background-color: rgb(204,238,255)">&nbsp;</TD>
    <TD STYLE="background-color: rgb(204,238,255); text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10,958,000</FONT></TD></TR>
  <TR STYLE="background-color: rgb(204,238,255)">
    <TD STYLE="background-color: rgb(204,238,255); padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="background-color: rgb(204,238,255); padding-bottom: 1.5pt; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Avg. Grade % eU<SUB>3</SUB>O<SUB>8</SUB></FONT></TD>
    <TD STYLE="background-color: rgb(204,238,255); padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="background-color: rgb(204,238,255); border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.115</FONT></TD>
    <TD STYLE="background-color: rgb(204,238,255); padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="background-color: rgb(204,238,255); border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.117</FONT></TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Pounds and tons as reported are rounded to the nearest 1,000</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in; text-align: left">*</TD><TD STYLE="text-align: justify">GT cutoff: Minimum Grade (% eU<SUB>3</SUB>O<SUB>8</SUB>) x Thickness
(Feet) for Grade &gt; 0.02 % eU<SUB>3</SUB>O<SUB>8</SUB>.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Total Inferred Mineral Resources </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; vertical-align: bottom; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>0.02% eU<SUB>3</SUB>O<SUB>8</SUB> Grade Cutoff and GT Cutoff* &gt;0.25 ft%</B></FONT></TD>
    <TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; white-space: nowrap; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Total <BR>
Inferred <BR>
Resource</B></FONT></TD>
    <TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>enCore<BR>
Controlled</B></FONT></TD></TR>
  <TR STYLE="background-color: rgb(204,238,255)">
    <TD STYLE="background-color: rgb(204,238,255); white-space: nowrap; width: 50%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Crownpoint</B></FONT></TD>
    <TD STYLE="background-color: rgb(204,238,255); width: 30%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pounds eU<SUB>3</SUB>O<SUB>8</SUB></FONT></TD>
    <TD STYLE="background-color: rgb(204,238,255); width: 1%">&nbsp;</TD>
    <TD STYLE="background-color: rgb(204,238,255); white-space: nowrap; width: 9%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,445,000</FONT></TD>
    <TD STYLE="background-color: rgb(204,238,255); width: 1%">&nbsp;</TD>
    <TD STYLE="background-color: rgb(204,238,255); width: 9%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,388,000</FONT></TD></TR>
  <TR STYLE="background-color: White">
    <TD STYLE="background-color: rgb(204,238,255)">&nbsp;</TD>
    <TD STYLE="background-color: rgb(204,238,255); white-space: nowrap; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Tons</FONT></TD>
    <TD STYLE="background-color: rgb(204,238,255)">&nbsp;</TD>
    <TD STYLE="background-color: rgb(204,238,255); white-space: nowrap; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">708,000</FONT></TD>
    <TD STYLE="background-color: rgb(204,238,255)">&nbsp;</TD>
    <TD STYLE="background-color: rgb(204,238,255); text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">676,000</FONT></TD></TR>
  <TR STYLE="background-color: rgb(204,238,255)">
    <TD STYLE="background-color: rgb(204,238,255); padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="background-color: rgb(204,238,255); padding-bottom: 1.5pt; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Avg. Grade % eU<SUB>3</SUB>O<SUB>8</SUB></FONT></TD>
    <TD STYLE="background-color: rgb(204,238,255); padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="background-color: rgb(204,238,255); border-bottom: Black 1.5pt solid; white-space: nowrap; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.102</FONT></TD>
    <TD STYLE="background-color: rgb(204,238,255); padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="background-color: rgb(204,238,255); border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.103</FONT></TD></TR>
  <TR STYLE="background-color: White">
    <TD STYLE="white-space: nowrap; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Hosta Butte</B></FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pounds eU<SUB>3</SUB>O<SUB>8</SUB></FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="white-space: nowrap; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4,482,000</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4,482,000</FONT></TD></TR>
  <TR STYLE="background-color: White">
    <TD>&nbsp;</TD>
    <TD STYLE="white-space: nowrap; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Tons</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="white-space: nowrap; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,712,000</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,712,000</FONT></TD></TR>
  <TR STYLE="background-color: White">
    <TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Avg. Grade % eU<SUB>3</SUB>O<SUB>8</SUB></FONT></TD>
    <TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; white-space: nowrap; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.131</FONT></TD>
    <TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.131</FONT></TD></TR>
  <TR STYLE="background-color: White">
    <TD STYLE="background-color: rgb(204,238,255); white-space: nowrap; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Total Inferred Mineral Resource</B></FONT></TD>
    <TD STYLE="background-color: rgb(204,238,255); text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pounds eU<SUB>3</SUB>O<SUB>8</SUB></FONT></TD>
    <TD STYLE="background-color: rgb(204,238,255)">&nbsp;</TD>
    <TD STYLE="background-color: rgb(204,238,255); white-space: nowrap; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5,927,000</FONT></TD>
    <TD STYLE="background-color: rgb(204,238,255)">&nbsp;</TD>
    <TD STYLE="background-color: rgb(204,238,255); text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5,870,000</FONT></TD></TR>
  <TR STYLE="background-color: rgb(204,238,255)">
    <TD STYLE="background-color: rgb(204,238,255)">&nbsp;</TD>
    <TD STYLE="background-color: rgb(204,238,255); white-space: nowrap; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Tons</FONT></TD>
    <TD STYLE="background-color: rgb(204,238,255)">&nbsp;</TD>
    <TD STYLE="background-color: rgb(204,238,255); white-space: nowrap; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,420,000</FONT></TD>
    <TD STYLE="background-color: rgb(204,238,255)">&nbsp;</TD>
    <TD STYLE="background-color: rgb(204,238,255); text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,388,000</FONT></TD></TR>
  <TR STYLE="background-color: White">
    <TD STYLE="background-color: rgb(204,238,255); padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="background-color: rgb(204,238,255); padding-bottom: 1.5pt; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Avg. Grade % eU<SUB>3</SUB>O<SUB>8</SUB></FONT></TD>
    <TD STYLE="background-color: rgb(204,238,255); padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="background-color: rgb(204,238,255); border-bottom: Black 1.5pt solid; white-space: nowrap; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.122</FONT></TD>
    <TD STYLE="background-color: rgb(204,238,255); padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="background-color: rgb(204,238,255); border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.121</FONT></TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Pounds and tons as reported are rounded to the nearest 1,000</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in; text-align: left">*</TD><TD STYLE="text-align: justify">GT cutoff: Minimum Grade (% eU<SUB>3</SUB>O<SUB>8</SUB>) x Thickness
(Feet) for Grade &gt; 0.02 % eU<SUB>3</SUB>O<SUB>8</SUB>.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 28; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->28<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">enCore Energy Corp.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Management&rsquo;s Discussion and Analysis</P>

<P STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">For the years ended December 31,
2022 and 2021</P>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On February 25, 2022, and revised on March 16,
2022, the Company issued the NI-43-101 Technical Report, Crownpoint and Hosta Bute Uranium Project, McKinley County, New Mexico, USA completed
by BRS Inc. and enCore Energy Corp. The report was authored by Douglas L. Beahm, P.E., P.G., Principal, BRS, Inc. and coauthored by Carl
Warren, P.E., P.G., Project Engineer, BRS Inc. and W. Paul Goranson, P.E., CEO, enCore Energy Corp.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Project is located in portions of Sections
24, Township 17 North, Range 13 West; Sections 19 and 29, Township 17 North, Range 12 West; and Sections, 3, 9, and 11, Township 16 North,
Range 13 West, comprising approximately 3,020 acres mineral estate outright. There are no annual payments, maintenance, or other requirements
to be met to maintain the mineral estate subject only to a 3% gross proceeds royalty on uranium mined from the Project. Surface rights
are held separately from the mineral rights on the Project. The surface rights have not been removed from development and are not under
other restrictions. The property is outside of the Navajo Reservation and is situated on the western edge and to the southwest of the
small town of Crownpoint, New Mexico. A portion of the Project is included within the existing NRC source material license area that is
held by a subsidiary of Laramide Resources, Ltd.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Uranium mineralization is typical of sandstone
hosted roll-front deposits found within the Western US. The Westwater Canyon member of the Morrison Formation is the principal host of
uranium mineralization in the vicinity of the Project and is approximately 360 feet thick. For the purposes of estimating mineral resources,
the authors subdivided the Westwater Canyon into four vertically and laterally distinct sand units/zones.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In the Crownpoint area, mineralized thickness
ranges from the minimum of 2 feet to over 40 feet. The average thickness of all intercepts was 7.6 feet. Average grade &ndash; thickness
(GT) of all intercepts was 0.77 ft%. Grade varies from the minimum grade cutoff of 0.02 % eU<SUB>3</SUB>O<SUB>8</SUB> to a maximum grade
by intercept of 0.38 % eU<SUB>3</SUB>O<SUB>8</SUB>. Individual mineralized trends may persist for several thousand feet with trend width
typically in the range from 100 up to 400 feet.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In the Hosta Butte area, mineralized thickness
ranges from the minimum of 2 feet to over 33 feet. The average thickness of all intercepts was 7.4 feet. Average GT of all intercepts
was 0.83 ft%. Grade varies from the minimum grade cutoff of 0.02 % eU<SUB>3</SUB>O<SUB>8</SUB> to a maximum grade by intercept of 0.52
% eU<SUB>3</SUB>O<SUB>8</SUB>. Individual mineralized trends may persist for 2,000 thousand feet or more with trend width typically in
the range of 100 to 300 feet.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Previous drilling within the Crownpoint area focused
on portions of Sections 19 and 29 of T17N, R12W; and Section 24 of T17N, R13W. Within the Crownpoint area, 482 rotary drill holes and
37 core holes were completed. Previous drilling within the Hosta Butte area was conducted within Sections, 3, 9, and 11 of T16N, R13W.
Previous drilling at Hosta Butte focused primarily on Section 3 with 133 rotary holes and 2 cores holes completed. In Sections 9 and 11
of T16N, R13W, 14 rotary drill holes and 32 rotary drill holes were completed, respectively.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Other Assets</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Marquez-Juan Tafoya Uranium Project, New Mexico</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Marquez-Juan Tafoya Uranium Project is an
advanced-stage exploration property which has been extensively explored in the past by drilling. In the 1970s to early 1980s, extensive
mineral exploration by drilling defined significant uranium resources on the two properties. Mine and mineral processing infrastructure
was constructed by Bokum Resources on the Juan Tafoya portion of the Project, including a 14-foot production shaft (completed to within
200 feet of the mine zone), a 5-foot ventilation shaft, and a partially built mill processing facility and tailings disposal cells. The
surface facilities were dismantled and reclaimed in the early 2000s. No mining or mineral processing has occurred at the site.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 29; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->29<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">enCore Energy Corp.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Management&rsquo;s Discussion and Analysis</P>

<P STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">For the years ended December 31,
2022 and 2021</P>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Project consists of two adjacent properties;
Marquez and Juan Tafoya, that were previously developed by separate mining companies, Kerr-McGee Corporation and Bokum Resources, respectively.
This is the first time that the two properties have been controlled by one company. The host for known uranium mineralization within the
Project is the Westwater Canyon member of the Upper Jurassic Morrison Formation. The Westwater deposits dip gently 1-3&ring; to the west.
The mineralization is sandstone-type present as coffinite and uraninite within primary trend deposits and varies from 1,800 to 2,500 feet
deep.</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">Indicated Mineral Resource</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-bottom: 1.5pt; font-weight: bold">Indicated Mineral Resource</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left; font-weight: bold">Minimum 0.60 GT</TD><TD STYLE="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">TONS%</TD><TD STYLE="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>eU<SUB>3</SUB>O<SUB>8</SUB></B></FONT></TD><TD STYLE="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">Pounds</TD><TD STYLE="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 64%; text-align: left; padding-bottom: 1.5pt">ROUNDED TOTAL (x 1,000)</TD><TD STYLE="width: 1%; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="width: 1%; border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; border-bottom: Black 1.5pt solid; text-align: right">7,100</TD><TD STYLE="width: 1%; padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="width: 1%; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="width: 1%; border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; border-bottom: Black 1.5pt solid; text-align: right">0.127</TD><TD STYLE="width: 1%; padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="width: 1%; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="width: 1%; border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; border-bottom: Black 1.5pt solid; text-align: right">18,100</TD><TD STYLE="width: 1%; padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  </TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Mineral resources are not mineral reserves
and do not have demonstrated economic viability in accordance with CIM standards.</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On June 9, 2021, the Company announced that it
had filed a Preliminary Economic Assessment (PEA) Results and combined, N.I. 43-101 Technical Report for its Juan Tafoya-Marquez Project,
New Mexico. The PEA was constructed based on a combined and updated NI 43-101 Technical Report using an Indicated resource of 7.1 million
tons at a grade of 0.127% eU<SUB>3</SUB>O<SUB>8</SUB> for a total of 18.1 million pounds of U<SUB>3</SUB>O<SUB>8</SUB>. The PEA reports
the Net Present Value (&ldquo;NPV&rdquo;) for the Project that ranges from $20.9 million using $60.00 per pound of yellowcake (U<SUB>3</SUB>O<SUB>8</SUB>)
to $71.2 million using $70.00 per pound of yellowcake with internal rate of returns (&ldquo;IRR&rdquo;) ranging from 17% to 39% with corresponding
yellowcake prices; these scenarios are pre-tax and assume a 7% discount rate. The break-even price of production is estimated to be $56.00
per pound. The PEA evaluated the economics of mining at Juan Tafoya-Marquez through underground mining and on-site processing (milling)
to produce yellowcake. The study has an effective date of June 9, 2021, and was prepared by Douglas L. Beahm, P.E, P.G., of BRS Inc. in
cooperation with Terence P. McNulty, P.E., PhD, of McNulty and Associates.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Marquez-Juan Tafoya Project is approximately
50 miles west-northwest of Albuquerque, New Mexico (Figure 4-1, Location and Access Map). The project is in an area of mostly un-surveyed
lands, in what would be Township 13 North, Ranges 04 and 05 West, 23rd Principal Meridian, New Mexico. The Company controls private land
leases, Marquez and Juan Tafoya, totaling some 18,712 acres.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On June 24, 2021, the Company announced the positive
Preliminary Economic Assessment and combined N.I. 43-101 Technical Report for the Juan Tafoya-Marquez Project in New Mexico.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Historic Mineral Resources &ndash; Significant
Projects in New Mexico</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Nose Rock, New Mexico. </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Nose Rock Project is located in McKinley County
New Mexico, USA on the northern edge of the Grants Uranium District, approximately 10 miles north-northeast of the Crownpoint and Hosta
Butte Project. The Nose Rock property consists of 42 owned unpatented lode mining claims comprising over 800 acres.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>West Largo, New Mexico</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The West Largo Project consist of approximately
3,840 acres (i.e., six square miles) in McKinley County, New Mexico, along the north-central edge of the Grants Uranium District, approximately
25 miles north of Grants. The majority of the property is held through deeded mineral rights and also includes 75 unpatented lode claims.
The property is located on six contiguous sections of land: 17, 19, 20, 21, 28 and 29, all within T15N, R10W. The West Largo Project is
about 6 miles northwest of the westernmost deposits in the Ambrosia Lake District and about 5 miles east-northeast of the West Ranch area
deposits. The Project is accessed via New Mexico Highway 605 north from Grants, N.M., Highway 509 northwest from Ambrosia Lake and unimproved
roads west from Highway 509. The West Largo Project was acquired by the Company with the Westwater Assets Acquisition on December 31,
2020. There are no current Mineral Reserves or Mineral Resources on the West Largo property.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Ambrosia Lake-Treeline, New Mexico</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Ambrosia Lake - Treeline Property consists
of the Treeline Property owned by the Company and the Ambrosia Lake property that was acquired through the Westwater Assets Acquisition
on December 31, 2020. The combined property consists of deeded mineral rights totaling 24,555 acres and a mining lease along with certain
unpatented mining claims covering approximately 1,700 acres. The Project is located approximately 115 miles west-northwest of Albuquerque,
in McKinley and Cibola Counties, Grants Uranium District, New Mexico. The Project is situated within the boundaries of the Ambrosia Lake
mining district, which is the largest uranium mining area (in terms of pounds of U<SUB>3</SUB>O<SUB>8</SUB> production) in the United
States. There are no current Mineral Reserves or Mineral Resources on the Ambrosia Lake - Treeline property.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 30; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->30<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">enCore Energy Corp.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Management&rsquo;s Discussion and Analysis</P>

<P STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">For the years ended December 31,
2022 and 2021</P>






<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Checkerboard Mineral Rights, New Mexico</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The land position covers approximately 300,000
acres of deeded &lsquo;checkerboard&rsquo; mineral rights, also known as the Frisco and Santa Fe railroad grants. They are located within
a large area of about 75 miles long by 25 miles wide along trend of the Grants Uranium District. The properties are located primarily
in McKinley County in northwestern New Mexico. The properties are approximately 125 miles northwest of Albuquerque, and as close as 4
miles from the town of Crownpoint. There are no current uranium resources or reserves on the McKinley Properties.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>References</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">1.</TD><TD STYLE="text-align: justify">NI-43-101 Technical Report, Crownpoint and Hosta Bute Uranium
Project, McKinley County, New Mexico, USA completed by BRS Inc. and enCore Energy Corp. (effective February 25, 2022).</TD>
</TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">2.</TD><TD STYLE="text-align: justify">NI-43-101 Technical Report, Preliminary Economic Assessment,
Marquez-Juan Tafoya Uranium Project, McKinley County, New Mexico, USA competed by BRS, Inc. and McNulty and Associates, Inc. (effective
June 9, 2021).</TD>
</TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">3.</TD><TD STYLE="text-align: justify">S. Hall, M. Mihalasky, K. Turek, J. Hammarstrom &amp; M. Hannon &ldquo;Genetic and grade and tonnage
                                                                                  models for sandstone-hosted roll-type uranium deposits, Texas Coastal Plain, USA&rdquo;, published in Ore Geology Reviews 80
                                                                                  (2017).</TD>
</TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">4.</TD><TD STYLE="text-align: justify">M. Mihalsky and S Hall, &ldquo;Assessment of Undiscovered
Sandstone-Hosted Uranium Resources in the Texas Coastal Plain, 2015&rdquo; U.S. Department of the Interior, U.S. Geological Survey, ISSN
2327-6916 (print), Fact Sheet 2015-3069, November 2015.</TD>
</TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">5.</TD><TD STYLE="text-align: justify">McLemore, Virginia T., Prin. Senior Economic Geologist, &ldquo;Uranium
Resources in New Mexico&rdquo;, New Mexico Bureau of Geology &amp; Mineral Resources&rdquo; which incorporates a table entitled: Estimated
uranium resources in New Mexico, 2017 (updated from McLemore, et al., 2011, 2013.</TD>
</TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">6.</TD><TD STYLE="text-align: justify">NI-32-101 Technical Report, Preliminary Economic Assessment,
Marquez-Juan Tafoya Uranium Project, McKinley County, New Mexico, USA competed by BRS, Inc. and McNulty and Associates, Inc. (effective
June 9, 2021).</TD>
</TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">7.</TD><TD STYLE="text-align: justify">M. Hassan Alief, Technical Report on Section 1, T18N, R12W,
Nose Rock Uranium Property, McKinley County, New Mexico, reported an effective February 9, 2009 for Strathmore Minerals Corp.</TD>
</TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">8.</TD><TD STYLE="text-align: justify">Behre Dolbear &amp; Company (USA) Inc., 2011, Technical Report
on the Nose Rock Project of Uranium Resources Inc., prepared by Robert D. Maxwell, CPG.</TD>
</TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">9.</TD><TD STYLE="text-align: justify">Behre Dolbear &amp; Company (USA) Inc., 2011, Technical Report
on the West Largo Project of Uranium Resources Inc., prepared by Robert D. Maxwell, CPG.</TD>
</TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">10.</TD><TD STYLE="text-align: justify">Conoco Inc., Internal Memorandum, Treeline Uranium Property,
McKinley County, New Mexico, 1978.</TD>
</TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">11.</TD><TD STYLE="text-align: justify">Behre Dolbear &amp; Company (USA) Inc., 2010, Technical Report
on the Ambrosia Lake Project of Uranium Resources Inc., prepared by Robert D. Maxwell, CPG and Bernard J. Guarnera, RPG, CPG. The report
references Historic Mineral Resources with sources including:</TD>
</TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left">1.</TD><TD STYLE="text-align: justify">Sec 27-14N-10W estimated by Capitan, Melvin, Feb 25, 2008,
Uranium Resources Inc., &ldquo;Ore Reserve Calculation Sheet 3, T14N R10W Section 27&rdquo;, in Maxwell, Robert, CPG and Bernard Guarnera,
March 1, 2010, Technical Report on Ambrosia Lake Project, Section 27, et al., Behre Dolbear Report 07-019 .</TD>
</TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="margin-top: 0; margin-bottom: 0"></P>

<!-- Field: Page; Sequence: 31; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->31<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">enCore Energy Corp.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Management&rsquo;s Discussion and Analysis</P>

<P STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">For the years ended December 31,
2022 and 2021</P>








<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">12.</TD><TD STYLE="text-align: justify">Wilton, Dean T., CPG, PG, MAIG, Chief Geologist Westwater
Resources, 2018, Technical Report on the Ambrosia Lake Uranium Project, McKinley County, USA. This report outlines several Historic Mineral
Resources including:</TD>
</TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left">1.</TD><TD STYLE="text-align: justify">Sec 25-14N-10W estimated by Yancy &amp; Associates, May 1997,
Mine Plan - Sections 23 and 25 Ambrosia Lake, New Mexico, for Rio Algom Mining Corporation, Quivira Mining Company</TD>
</TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left">2.</TD><TD STYLE="text-align: justify">Sec 17-13N-9W estimated by Nelson, Jon, Uranium Resources
Inc., January 18, 2008.</TD>
</TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left">3.</TD><TD STYLE="text-align: justify">Sec 13-13N-9W estimated by Nelson, Jon, Uranium Resources
Inc., June 29, 2007.</TD>
</TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">13.</TD><TD STYLE="text-align: justify">Juniper Ridge Uranium Project, Carbon County, Wyoming, USA.
Amended and Restated NI 43-101 Mineral Resource and Preliminary Economic Assessment, completed by Douglass L. Beahm, P.E., P.G., Principal
Engineer, BRS Inc. and Terrance P. (Terry) McNulty. P.E, D.Sc., T.P McNulty and Associates (effective June 9, 2017).</TD>
</TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">14.</TD><TD STYLE="text-align: justify">NI 43-101 Preliminary Assessment, Powertech Uranium Corp.,
Centennial Uranium Project, Weld County, Colorado completed by SRK Consulting (effective June 2, 2010) (&ldquo;Centennial Technical Report
and PEA&rdquo;).</TD>
</TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">15.</TD><TD STYLE="text-align: justify">NI 43-101 Technical Report, Preliminary Economic Assessment.
Dewey-Burdock Uranium ISR Project, South Dakota, USA, completed by Woodard &amp; Curran and Rough Stock Mining Services (effective December
3, 2019) (&ldquo;Dewey Burdock Technical Report and PEA&rdquo;).</TD>
</TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">16.</TD><TD STYLE="text-align: justify">Technical Report on the Aladdin Uranium Project, Cork County,
Wyoming, completed by Jerry D.Bush, certified Professional Geologist (effective June 21, 2012).</TD>
</TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">17.</TD><TD STYLE="text-align: justify">NI 43-101 Technical Report, Preliminary Economic Assessment,
Gas Hills Uranium Project, Fremont and Natrona Counties, Wyoming, USA, completed by WWC Engineering and Rough Stock Mining Services (effective
June 28, 2021) (&ldquo;Gas Hills Technical Report and PEA&rdquo;).</TD>
</TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">18.</TD><TD STYLE="text-align: justify">NI-43-101 Technical Report Summary for the Alta Mesa Uranium
Project, Brooks and Jim Hogg Counties, Texas, USA completed by BRS Engineering. (Effective January 19, 2023).</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Use of Proceeds from Previous Financing</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On March 25, 2022, the Company completed a &ldquo;bought
deal&rdquo; prospectus offering pursuant to which the Company sold an aggregate of 6,535,947 units of the Company at a price of $3.53
per unit for aggregate gross proceeds of $23,057,411 ($29,999,998 CAD). The following table outlines the proposed use of proceeds from
the offering on the closing date and as at December 31, 2022:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center">Proposed&nbsp;use</TD><TD STYLE="font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center">Actual use</TD><TD STYLE="font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">of net<BR> proceeds</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Of net<BR> proceeds</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 76%; text-align: left">Crownpoint Hosta Butte Uranium Project</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">845,438</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">35,464</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Marquez-Juan Tafoya Uranium Project</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,345,016</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">428,759</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Dewey-Burdock Project</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,152,871</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">552,929</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Gas Hills Project</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">883,867</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">222,662</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Upper Spring Creek</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">538,006</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2,810,796</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Rosita Plant</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">3,266,467</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">3,380,618</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Rosita Satellite Projects</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,460,303</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2,252,630</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Kingsville Dome</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">3,727,615</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,394,834</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD>Contingency</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,525,248</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt">Working Capital</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">7,044,423</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">10,710,562</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-bottom: 1.5pt">Total:</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">$</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">21,789,254</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">$</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">21,789,254</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  </TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">Notes:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in; text-align: left">(1)</TD><TD STYLE="text-align: justify">The above table is not presented according to accounting standards.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in; text-align: left">(2)</TD><TD STYLE="text-align: justify">Gross proceeds from the Offering were $23,057,411 ($29,999,998
CAD). Cash commissions and other financing related expenses were $1,268,157 ($1,612,500 CAD).</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 32; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->32<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">enCore Energy Corp.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Management&rsquo;s Discussion and Analysis</P>

<P STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">For the years ended December 31,
2022 and 2021</P>








<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Variations from proposed use and impacts</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">A
delay in the Company&rsquo;s ability to acquire proper licenses and permits at its Dewey Burdock and Gas Hills Projects caused the company
to temporarily defer development of those assets.</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Increases
in costs of capital resulted in the Company having greater than anticipated expenditures at its Rosita CPP and satellite projects.</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Increased
costs of capital and the opportunity for an unplanned property acquisition resulted in increases in the amounts spent on the Company&rsquo;s
Rosita plant and Rosita Satellite projects.</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Decommissioning
activities at the Company&rsquo;s Kingsville Dome Project were deferred in 2022 to re-allocate resources to development of the Company&rsquo;s
near-term production projects.</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">The
Company took advantage of an opportunity to secure fixed pricing on its future purchase of 300,000 pounds of Uranium through two separate
purchase agreements requiring total deposits paid in 2022 of $3,000,000.</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Collectively, all of these activities allowed
the Company to focus its resources on development of its near-term production assets in South Texas and secure 2022 uranium prices on
uranium to be fully paid for and received in 2023, thus securing future fulfillment of a portion of the Company&rsquo;s sales commitments
for that period. The Company remains focused on the future development and reclamation work deferred in 2022 and believes taking advantage
of the opportunities presented in 2022 best support the Company&rsquo;s goal of becoming a leading producer of uranium.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Selected Annual Information</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The following is a summary of selected information
of the Company for the years ended December 31, 2022, 2021 and 2020:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font-weight: bold; border-bottom: Black 1.5pt solid">Continuing Operations</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2022</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2021</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2020</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Total revenues</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="width: 64%; text-align: left">Deferred exploration and evaluation expenditures</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">9,860,682</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">2,357,254</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">231,045</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Operating expenditures</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">18,744,103</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">9,214,094</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,687,169</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Other income (expense)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2,228,714</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">650,621</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">33,037</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt">Net income (loss)</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(16,515,389</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(8,563,473</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(1,654,132</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt">Basic and diluted earnings (loss) per share</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(0.16</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(0.13</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(0.03</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD></TR>
  </TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold">Financial Position</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2021</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2020</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 64%; text-align: left">Intangible assets</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">528,282</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">491,996</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">483,631</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Property, plant and equipment</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2,334,421</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,603,679</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,484,836</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Investment in associate</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">564,340</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">451,221</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Investment in uranium</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">4,210,000</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Marketable securities</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">784,832</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Mineral properties</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">145,219,086</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">136,079,578</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">6,608,060</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Reclamation deposits</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">88,500</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">88,500</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">85,500</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Right-of-use assets</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">185,614</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">244,564</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">8,867</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Deferred acquisition costs</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">6,009,303</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Deferred financing costs</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">3,162,936</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt">Restricted Cash</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">54,568,668</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">4,517,139</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">3,796,788</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; text-align: left; padding-bottom: 1.5pt">Total long-term liabilities</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">212,881,642</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">147,799,796</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">12,918,903</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&nbsp;</TD></TR>
  </TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B></B></P>

<!-- Field: Page; Sequence: 33; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->33<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">enCore Energy Corp.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Management&rsquo;s Discussion and Analysis</P>

<P STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">For the years ended December 31,
2022 and 2021</P>










<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Significant items causing variations in: </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Annual Results</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Stock
option expense for the twelve months ended December 31, 2022 was $5,744,655 for the twelve months ended December 31, 2022 compared to
$1,425,645 for the twelve months ended December 31, 2021. Significant stock option grants related to new hires and grants to existing
staff over the last 12 months have caused an expected increase in stock option expense.</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">In
2021, the company recognized a contract termination fee of $2,750,000 related to an agreement with UG USA, Inc. that the Company acquired
in its asset acquisition from Westwater Resources, Inc. In 2021 the Company and UG USA, Inc agreed to terminate the agreement for this
one-time cancellation fee. As there is no comparable event in 2022, the event creates a significant variance in the Company&rsquo;s net
loss for the year.</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Staff
costs for the twelve months ended December 31, 2022 were $4,130,741 compared to $1,582,326 for the twelve months ended December 31, 2021.
The increase reflects growth and development of the Company through its addition of key management and technical positions as well as
expansion of staff in anticipation of operation and production.</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">In
2022, the Company recognized a gain of $1,624,049 on divestment of mineral interests compared to a loss of $89,914 in the year ended
December 31, 2021 for other divestments. Divestment of non-core assets can result in significant gains and losses in the Company&rsquo;s
consolidated statement of loss and comprehensive loss but is not a routine activity.</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">In
2022, the Company received marketable securities in consideration for two of its mineral property divestment transactions. As a result,
for the twelve months ended December 31, 2022 the company recognized a gain of $1,057,405 on the fair value of its securities, while
$nil was recognized for the twelve months ended December 31, 2021.</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">In
2022, the Company recognized a loss of $586,900 as a result of the write-off of the Company&rsquo;s investment in Group 11 Technologies
Inc. in the twelve months ended December 31, compared to an unrealized loss on investment of $355,735 for the twelve months ended December
31, 2021.</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B></B><B>Quarterly Information</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The following selected financial data is prepared
in accordance with IFRS for the last eight quarters ending with the most recently completed quarter:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">December&nbsp;31,<BR> 2022</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">September&nbsp;30,<BR> 2022</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">June 30,<BR> 2022</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">March 31,<BR> 2022</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 52%; text-align: left">Operating expenses, excluding stock option expense</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">(4,898,997</TD><TD STYLE="width: 1%; text-align: left">)</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">(3,035,178</TD><TD STYLE="width: 1%; text-align: left">)</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">(2,355,429</TD><TD STYLE="width: 1%; text-align: left">)</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">(2,709,844</TD><TD STYLE="width: 1%; text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Stock option expense</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(1,143,675</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(1,578,539</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(1,827,201</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(1,195,240</TD><TD STYLE="text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Interest income</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">236,256</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">102,459</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">61,885</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">5,532</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Foreign exchange gain (loss)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(75,995</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">29,723</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">257</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(12,438</TD><TD STYLE="text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Gain on change in ARO estimate</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(157,227</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Gain on divestment of subsidiary</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,594,901</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Gain on sale of physical uranium</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">35,000</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Gain (loss) on divestment of mineral interest rights</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">53,884</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(71,915</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">47,179</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Gain (loss) from investment in associate</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(443,614</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(64,680</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(78,606</TD><TD STYLE="text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Gain (loss) on marketable securities</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">188,275</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(86,913</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">956,043</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt">Loss on write-off of GST Receivable</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(91,289</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">-</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">-</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">-</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-bottom: 1.5pt">Loss</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">$</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(5,888,770</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">$</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(5,012,062</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">$</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(1,706,140</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">$</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(3,908,416</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Basic and diluted earnings (loss) per share<SUP>1</SUP></FONT></TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">$</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(0.06</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">$</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(0.05</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">$</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(0.02</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">$</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(0.04</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD></TR>
  </TABLE>



<P STYLE="margin: 0"><B>&nbsp;</B></P>


<!-- Field: Page; Sequence: 34; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->34<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">enCore Energy Corp.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Management&rsquo;s Discussion and Analysis</P>

<P STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">For the years ended December 31,
2022 and 2021</P>










<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">December&nbsp;31,<BR> 2021</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">September&nbsp;30,<BR> 2021</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">June 30, <BR> 2021</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">March 31,<BR> 2021</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 52%; text-align: left">Operating expenses, excluding stock option expense</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">(2,237,976</TD><TD STYLE="width: 1%; text-align: left">)</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">(1,782,951</TD><TD STYLE="width: 1%; text-align: left">)</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">(1,839,895</TD><TD STYLE="width: 1%; text-align: left">)</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">(1,927,626</TD><TD STYLE="width: 1%; text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Stock option expense</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(294,018</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(325,981</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(391,073</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(414,573</TD><TD STYLE="text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Interest income</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2,920</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">3,001</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">7,481</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">7,585</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Foreign exchange gain (loss)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(854</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2,058</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">22,302</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">3,757</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Loss on contract termination</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(2,750,000</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Gain (loss) on Change in ARO estimate</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,719,943</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Gain on sale of physical uranium</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">920</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">523,155</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Gain (loss) on investment in uranium</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(87,114</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,089,987</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">551,127</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Gain (loss) on divestment of mineral interest rights</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(157</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(309</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">17,523</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(106,971</TD><TD STYLE="text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt">Gain (loss) from investment in associate</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(289,939</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(14,845</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(35,876</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(15,075</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-bottom: 1.5pt">Loss</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">$</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(1,186,275</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">$</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(3,255,885</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">$</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(1,668,411</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">$</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(2,452,903</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Basic and diluted loss per share<SUP>1</SUP></FONT></TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">$</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(0.02</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">$</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(0.05</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">$</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(0.02</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">$</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(0.04</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD></TR>
  </TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in; text-align: left"><SUP>1</SUP></TD><TD STYLE="text-align: justify">Basic and diluted loss per share has been adjusted to reflect
the share consolidation that occurred on September 14, 2022.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Significant items causing variations in: </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Quarterly Results</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Staff
costs for the three months ended December 31, 2022 were $1,586,652 compared to $529,145 for the three months ended December 31, 2021.
The increase reflects the Company&rsquo;s addition of technical and operational staff as well as management as it continues to grow and
advance toward production and operations.</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Professional
fees for the company for the three months ended December 31, 2022 were $1,189,932, compared to $39,211 for the three months ended December
31, 2021. The increase reflects the Company&rsquo;s increase investor relations activities as well as its preparation for a January 2023
United States Securities listing.</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Stock
option expense was $1,143,675 for the three months ended December 31, 2022 compared to $294,018 for the three months ended December 31,
2021. Significant stock option grants over the last 12 months have caused an expected increase in stock option expense.</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">General
and administrative costs for the three months ended December 31, 2022 were $1,423,568 compared to $883,369 for the three months ended
December 31, 2021. This increase reflects the addition of the Azarga Uranium entities, an increase in marketing activities and the addition
of office spaces and operating expenses in 2022.</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">A
change in the Company&rsquo;s asset retirement obligations at year end result in a loss of $157,227 for the three months ended December
31, 2022 compared to a gain of $1,719,943 for the three months ended December 31, 2021. These adjustments both reflect changes in the
estimates and timing of the Company&rsquo;s obligations to reclaim its properties after operating.</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><B>&nbsp;</B></P>


<!-- Field: Page; Sequence: 35; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->35<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 6pt"><B>&nbsp;</B></FONT><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">enCore Energy Corp.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Management&rsquo;s Discussion and Analysis</P>

<P STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">For the years ended December 31,
2022 and 2021</P>










<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 6pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Liquidity and Capital Resources</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 6pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As at December 31, 2022, the Company had cash
and cash equivalents of $2,512,012 (2021 - $9,188,483) and working capital of $7,017,115 (2021 - $5,632,603). The Company has no significant
source of operating cash flows and operations to date have been funded primarily from the issue of share capital. Management estimates
that it has adequate working capital to fund its planned activities for the next year. However, the Company&rsquo;s long-term continued
operations are dependent on its abilities to monetize assets, raise additional funding from loans or equity financings, or through other
arrangements. There is no assurance that future financing activities will be successful.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 6pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In March 2022, the Company issued 6,535,947 units
for a &ldquo;bought deal&rdquo; prospectus offering at a price of $3.53 per unit, for gross proceeds of $23,057,411 ($29,999,998 CAD).
Each unit consisted of one common share and one-half share purchase warrant. Each whole warrant entitles the holder to purchase one additional
share at a price of $6.00 for a period of two years. The Company paid commissions totaling $1,612,500 and issued 3,161,766 finders&rsquo;
warrants. The finder&rsquo;s warrants are exercisable into one unit of the Company at a price of $3.53 for two years from closing.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 6pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">From January 1 through December 31, 2022, the
Company issued:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 6pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">2,291,642
shares for warrants exercised for gross proceeds of $2,452,227</FONT></TD>
</TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0"><FONT STYLE="font-size: 6pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">1,016,436
shares for stock options exercised for gross proceeds of $1,177,093</FONT></TD>
</TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0"><FONT STYLE="font-size: 6pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">193,348
shares for compensation to a vendor for services rendered, valued at $611,113</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-size: 6pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Contractual Obligations</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 6pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="18" STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Payments Due by Period</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left; font-weight: bold">Contractual Obligations</TD><TD STYLE="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; font-weight: bold; border-bottom: Black 1.5pt solid">Total</TD><TD STYLE="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; font-weight: bold; border-bottom: Black 1.5pt solid">Less than<BR>
 1 year</TD><TD STYLE="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; font-weight: bold; border-bottom: Black 1.5pt solid">1-3 years</TD><TD STYLE="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; font-weight: bold; border-bottom: Black 1.5pt solid">4-5 years</TD><TD STYLE="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; font-weight: bold; border-bottom: Black 1.5pt solid">After<BR>
 5 years</TD><TD STYLE="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 40%; text-align: left">Finance Lease Obligations</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">241,736</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">127,967</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">113,769</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">&nbsp;</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">&nbsp;</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Operating Leases</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">135,873</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2,940</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">5,880</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">5,880</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">121,173</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Purchase Obligations<SUP>1</SUP></FONT></TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">8,833,750</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">4,030,000</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">395,000</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">395,000</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">4,013,750</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other Obligations<SUP>2</SUP></FONT></TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">14,696,029</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">1,476,473</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">1,938,792</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">1,904,795</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">9,375,969</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-bottom: 1.5pt; font-weight: bold; text-align: left">Total Contractual Obligations</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">23,907,388</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">5,637,380</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">2,453,442</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">2,305,675</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">13,510,891</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&nbsp;</TD></TR>
  </TABLE>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-size: 6pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in; text-align: left"><SUP>1</SUP></TD><TD STYLE="text-align: justify">&ldquo;Purchase Obligation&rdquo; means an agreement to purchase goods or services that is
                                                             enforceable and legally binding on the Company that specifies all significant terms, including: fixed or minimum quantities to be
                                                             purchased; fixed, minimum or variable price provisions; and the approximate timing of the transaction.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><FONT STYLE="font-size: 6pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in; text-align: left"><SUP>2</SUP></TD><TD STYLE="text-align: justify">&ldquo;Other Obligations&rdquo; means other financial liabilities
reflected on the Company&rsquo;s statement of financial position.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><FONT STYLE="font-size: 6pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Transactions with Related Parties</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 6pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 4.3pt 0pt 0"><B>Key management personnel and compensation</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 4.3pt 0pt 0"><FONT STYLE="font-size: 6pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Related parties include key management of the
Company and any entities controlled by these individuals as well as other entities providing key management services to the Company. Key
management personnel consist of directors and senior management including the Executive Chairman, Chief Executive Officer, Chief Financial
Officer, Chief Operating Officer, and Chief Administrative Officer.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 6pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The amounts paid to key management or entities
providing similar services are as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 6pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center; padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">December&nbsp;31,<BR>
 2022<BR>
$</TD><TD STYLE="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; font-weight: bold; border-bottom: Black 1.5pt solid">December&nbsp;31,<BR>
 2021<BR>
 $</TD><TD STYLE="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 64%">Consulting</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: center">(1)</TD><TD STYLE="width: 1%; text-align: center">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">103,514</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">61,899</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Data acquisition</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: center">(2)</TD><TD STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">55,150</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Directors&rsquo; fees</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: center">(3)</TD><TD STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">192,604</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Office and administration</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">13,402</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Staff costs</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,607,211</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,151,731</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt">Stock option expense</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; text-align: right">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">4,729,503</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">749,255</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; text-align: left; padding-bottom: 1.5pt">Total key management compensation</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold; text-align: right">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">6,687,982</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">1,976,287</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  </TABLE>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-size: 6pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in; text-align: left">(1)</TD>
    <TD STYLE="text-align: center; width: 0.25in">- </TD><TD STYLE="text-align: justify">During the year ended December 31, 2022, the Company incurred
communications &amp; community engagement consulting fees of $103,514 (2021 - $61,899) according to a contract with Tintina Holdings,
Ltd., a company owned and operated by the spouse of the Company&rsquo;s Executive Chairman.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 6pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in; text-align: left">(2)</TD>
    <TD STYLE="text-align: center; width: 0.25in">- </TD><TD STYLE="text-align: justify">In June 2022, the Company acquired access to the Getty Minerals
database pursuant to a purchase agreement with Platoro West Inc., a company owned and operated by the Company&rsquo;s Executive Chairman
(Note 7).</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 6pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in; text-align: left">(3)</TD>
    <TD STYLE="text-align: center; width: 0.25in"> &ndash;</TD><TD STYLE="text-align: justify"> Directors&rsquo; Fees are included in staff costs on
the consolidated statement of loss and other comprehensive income (loss).</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 6pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 36; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->36<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">enCore Energy Corp.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Management&rsquo;s Discussion and Analysis</P>

<P STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">For the years ended December 31,
2022 and 2021</P>












<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">During the year ended December 31, 2022, the Company
granted 2,566,667 options to key management, with a fair value of $4,729,503 (2021 &ndash; 150,000 with a fair value of $749,255).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">As at December 31, 2022 and December 31, 2021, the following amounts
were owing to related parties:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center"><B>&nbsp;</B></TD><TD STYLE="text-align: center; padding-bottom: 1.5pt"><B>&nbsp;</B></TD>
    <TD STYLE="text-align: center"><B>&nbsp;</B></TD><TD STYLE="text-align: center; font-weight: bold; padding-bottom: 1.5pt"><B>&nbsp;</B></TD>
    <TD COLSPAN="2" STYLE="text-align: center; font-weight: bold; border-bottom: Black 1.5pt solid"><B>December&nbsp;31,<BR>
    2022<BR>
    $</B></TD><TD STYLE="text-align: center; padding-bottom: 1.5pt; font-weight: bold"><B>&nbsp;</B></TD><TD STYLE="text-align: center; padding-bottom: 1.5pt"><B>&nbsp;</B></TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>December&nbsp;31,<BR>
    2021 <BR>
    $</B></FONT></TD><TD STYLE="text-align: center; padding-bottom: 1.5pt"><B>&nbsp;</B></TD><TD STYLE="text-align: center; padding-bottom: 1.5pt"><B>&nbsp;</B></TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid"><B>January 1,<BR>
    2021<BR>
    $</B></TD><TD STYLE="text-align: center; padding-bottom: 1.5pt"><B>&nbsp;</B></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 42%; text-align: left">Tintina Holdings, Ltd</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 21%; text-align: left">Consulting services</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">12,744</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">6,893</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">0</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt">Officers and Board members</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="text-align: left; padding-bottom: 1.5pt">Accrued compensation</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">428,630</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">-</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">2,319</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">441,374</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">6,893</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">2,319</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  </TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Financial Instruments and financial risk management</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Please refer to the December 31, 2022 consolidated financial statements
on www.sedar.com.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Off Balance Sheet Arrangements</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">At December 31, 2022 the Company had no material
off-balance sheet arrangements such as guarantee contracts, contingent interest in assets transferred to an entity, derivative instruments
obligations or any obligations that trigger financing, liquidity, market or credit risk to the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Accounting Policies and Critical Accounting
Estimates</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company has prepared its consolidated financial
statements in accordance with IFRS. Note 2 to the audited consolidated financial statements for the years ended December 31, 2022, and
2021 provides details of significant accounting policies and accounting policy decisions for significant or potentially significant areas
that have had an impact on the Company&rsquo;s financial statements or may have an impact in future periods. Changes resulting from the
current-year adoption of new accounting standards are described in Note 2 of the Company&rsquo;s Consolidated financial statements for
the year-ended December 31, 2022, and 2021.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The preparation of consolidated financial statements
in conformity with IFRS requires management to use estimates and assumptions that affect the reported amounts of assets and liabilities,
as well as revenues and expenses. There have been no changes to the Company&rsquo;s approach to critical accounting estimates since December
31, 2022, and readers are encouraged to refer to the critical accounting policies and estimates as described in the Company&rsquo;s audited
consolidated financial statements for the years ended December 31, 2022, and 2021.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Disclosure Controls and Procedures</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In connection with National Instrument 52-109
(Certificate of Disclosure in Issuer&rsquo;s Annual and Interim Filings) (&ldquo;NI 52-109&rdquo;), the Chief Executive Officer and Chief
Financial Officer of the Company have filed a Venture Issuer Basic Certificate with respect to the financial information contained in
the condensed consolidated interim financial statements for the period ended December 31, 2022 and this accompanying MD&amp;A (together,
the &ldquo;Filings&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In contrast to the full certificate under NI 52-109,
the Venture Issuer Basic Certificate does not include representations relating to the establishment and maintenance of disclosure controls
and procedures and internal control over financial reporting, as defined in NI 52-109. For further information the reader should refer
to the Venture Issuer Basic Certificates filed by the Company on SEDAR at www.sedar.com.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>


<!-- Field: Page; Sequence: 37; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->37<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">enCore Energy Corp.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Management&rsquo;s Discussion and Analysis</P>

<P STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">For the years ended December 31,
2022 and 2021</P>










<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Management&rsquo;s Responsibility for Financial
Statements</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The information provided in this report, including
the financial statements, is the responsibility of management. In the preparation of these statements, estimates are sometimes necessary
to make a determination of future values for certain assets or liabilities. Management believes such estimates have been based on careful
judgments and have been properly reflected in the financial statements.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Other MD&amp;A Requirements </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Additional disclosure of the Company&rsquo;s technical
reports, material change reports, news releases and other information can be obtained on SEDAR at www.sedar.com.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Contingencies</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">There are no contingent liabilities that have
not been disclosed herein.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Proposed Transactions</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">There are no proposed transactions at this time.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Risk Factors and Uncertainties</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Prior to making an investment decision, investors
should consider the investment risks set out below and those described elsewhere in this document, which are in addition to the usual
risks associated with an investment in a business at an early stage of development. The directors of the Company consider the risks set
out below to be the most significant to potential investors in the Company but are not all of the risks associated with an investment
in securities of the Company. If any of these risks materialize into actual events or circumstances or other possible additional risks
and uncertainties of which the Directors are currently unaware, or which they consider not to be material in relation to the Company&rsquo;s
business, actually occur, the Company&rsquo;s assets, liabilities, financial condition, results of operations (including future results
of operations), business and business prospects, are likely to be materially and adversely affected. In such circumstances, the price
of the Company&rsquo;s securities could decline, and investors may lose all or part of their investment.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Availability of financing</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">There is no assurance that additional funding
will be available to the Company for additional exploration or for the substantial capital that is typically required in order to bring
a mineral project to the production decision or to place a property into commercial production. There can be no assurance that enCore
will be able to obtain adequate financing in the future or that the terms of such financing will be favorable. Failure to obtain such
additional financing could result in the delay or indefinite postponement of further exploration and development of its properties.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Title matters</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">While the Company has performed its diligence
with respect to title of its properties, this should not be construed as a guarantee of title. The properties may be subject to prior
unregistered agreements of transfer or other adverse land claims, and title may be affected by undetected defects.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Management</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company is dependent on a relatively small
number of key personnel, the loss of any of whom could have an adverse effect on the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Economics of developing mineral properties</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Mineral exploration and development include a
high degree of risk and few properties which are explored are ultimately developed into producing mines.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 38; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->38<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">enCore Energy Corp.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Management&rsquo;s Discussion and Analysis</P>

<P STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">For the years ended December 31,
2022 and 2021</P>










<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">With respect to the Company&rsquo;s properties,
should any mineral resource exist, substantial expenditures will be required to confirm that mineral reserves which are sufficient to
commercially mine exist on its current properties, and to obtain the required environmental approvals and permits required to commence
commercial operations. Should any resource be defined on such properties, there can be no assurance that the mineral resources on such
properties can be commercially mined or that the metallurgical processing will produce economically viable, merchantable products. The
decision as to whether a property contains a commercial mineral deposit and should be brought into production will depend upon the results
of exploration programs and/or feasibility studies, and the recommendations of duly qualified engineers and/or geologists, all of which
involves significant expense. This decision will involve consideration and evaluation of several significant factors including, but not
limited to: (i) costs of bringing a property into production, including exploration and development work, preparation of production feasibility
studies and construction of production facilities; (ii) availability and costs of financing; (iii) ongoing costs of production; (iv) market
prices for the minerals to be produced; (v) environmental compliance regulations and restraints (including potential environmental liabilities
associated with historical exploration activities); and (vi) political climate and/ or governmental regulation and control.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The ability of the Company to sell and profit
from the sale of any eventual mineral production from any of the Company&rsquo;s properties will be subject to the prevailing conditions in
the global mineral&rsquo;s marketplace at the time of sale. The global minerals marketplace is subject to global economic activity and
changing attitudes of consumers and other end-users&rsquo; demand for mineral products. Many of these factors are beyond the control of
the Company and therefore represent a market risk which could impact the long-term viability of the Company and its operations.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Foreign Exchange Risk</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">A portion of the Company&rsquo;s financial assets
and liabilities are denominated in US dollars. The Company monitors this exposure but has no hedge positions. The Company is exposed to
foreign currency risk on fluctuations related to cash, accounts payable and accrued liabilities, and due to related parties, that are
denominated in US dollars. September 30, 2022, a 10% change in the value to the US dollar as compared to the Canadian dollar would affect
net loss and shareholders&rsquo; equity by approximately $379,930.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>Credit Risk</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Credit risk arises from cash held with banks and
financial institutions and receivables. The maximum exposure to credit risk is equal to the carrying value of these financial assets.
The Company&rsquo;s cash is primarily held with a major Canadian bank.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Interest Rate Risk</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Interest rate risk mainly arises from the Company&rsquo;s
cash, which receive interest based on market interest rates. Fluctuations in interest cash flows due to changes in market interest rates
are not significant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Liquidity Risk</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Liquidity risk is the risk that the Company will
not be able to meet its current obligations as they become due. The majority of the Company&rsquo;s accounts payable and accrued liabilities
and amounts due to related parties are payable in less than 90 days. The Company prepares annual exploration and administrative budgets
and monitors expenditures to manage short-term liquidity. Due to the nature of the Company&rsquo;s activities, funding for long-term liquidity
needs is dependent on the Company&rsquo;s ability to obtain additional financing through various means, including equity financing. There
can be no assurance that the Company will be able to obtain adequate financing in the future or that the terms of such financing will
be favorable.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Stage of Development</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company&rsquo;s properties are in the exploration
stage and the Company does not have an operating history. Exploration and development of mineral resources involve a high degree of risk
and few properties which are explored are ultimately developed into producing properties. The amounts attributed to the Company&rsquo;s
interest in its properties as reflected in its financial statements represent acquisition and exploration expenses and should not be taken
to represent realizable value. There is no assurance that the Company&rsquo;s exploration and development activities will result in any
discoveries of commercial bodies of ore. The long-term profitability of the Company&rsquo;s operations will be in part directly related
to the cost and success of its exploration programs, which may be affected by a number of factors such as unusual or unexpected geological
formations, and other conditions.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I></I></P>

<!-- Field: Page; Sequence: 39; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->39<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>&nbsp;</I><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">enCore Energy Corp.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Management&rsquo;s Discussion and Analysis</P>

<P STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">For the years ended December 31,
2022 and 2021</P>










<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Profitability of Operations</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company is not currently operating profitably,
and it should be anticipated that it will operate at a loss at least until such time as production is achieved from one of the Company&rsquo;s
properties, if production is, in fact, ever achieved. The Company has never earned a profit. Investors also cannot expect to receive any
dividends on their investment in the foreseeable future.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Uranium and Other Mineral Industries Competition
is Significant</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The international uranium and other mineral industries
are highly competitive. The Company will be competing against competitors that may be larger and better capitalized, have state support,
have access to more efficient technology, and have access to reserves of uranium and other minerals that are cheaper to extract and process.
As such, no assurance can be given that the Company will be able to compete successfully with its industry competitors.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Fluctuations in Metal Prices</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Although the Company does not hold any known mineral
reserves of any kind, its future revenues, if any, are expected to be in large part derived from the future mining and sale of uranium
and other metals or interests related thereto. The prices of these commodities have fluctuated widely, particularly in recent years, and
are affected by numerous factors beyond the Company&rsquo;s control, including international economic and political conditions, expectations
of inflation, international currency exchange rates, interest rates, global or regional consumption patterns, speculative activities,
levels of supply and demand, increased production due to new mine developments and improved mining and production methods, availability
and costs of metal substitutes, metal stock levels maintained by producers and others and inventory carrying costs. The effect of these
factors on the prices of uranium and other metals, and therefore the economic viability of the Company&rsquo;s operations, cannot be accurately
predicted. Depending on the price obtained for any minerals produced, the Company may determine that it is impractical to commence or
continue commercial production.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>The Company&rsquo;s Operations are Subject
to Operational Risks and Hazards Inherent in the Mining Industry</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company&rsquo;s business is subject to a number
of inherent risks and hazards, including environmental pollution; accidents; industrial and transportation accidents, which may involve
hazardous materials; labor disputes; power disruptions; catastrophic accidents; failure of plant and equipment to function correctly;
the inability to obtain suitable or adequate equipment; fires; blockades or other acts of social activism; changes in the regulatory environment;
impact of non-compliance with laws and regulations; natural phenomena, such as inclement weather conditions, underground floods, earthquakes,
pit wall failures, ground movements, tailings, pipeline and dam failures and cave-ins; and encountering unusual or unexpected geological
conditions and technical failure of mining methods.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">There is no assurance that the foregoing risks
and hazards will not result in damage to, or destruction of, the Company&rsquo;s uranium and other mineral properties, personal injury
or death, environmental damage, delays in the Company&rsquo;s exploration or development activities, costs, monetary losses and potential
legal liability and adverse governmental action, all of which could have a material and adverse effect on the Company&rsquo;s future cash
flows, earnings, results of operations and financial condition.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Mineral Reserve and Resource Estimates are
Only Estimates and May Not Reflect the Actual Deposits</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Reserve and resource figures included for uranium
and other minerals are estimates only and no assurances can be given that the estimated levels of uranium and other minerals will actually
be produced or that the Company will receive the uranium and other metal prices assumed in determining its reserves. Such estimates are
expressions of judgment based on knowledge, mining experience, analysis of drilling and exploration results and industry practices. Estimates
made at any given time may significantly change when new information becomes available or when parameters that were used for such estimates
change. While the Company believes that the reserve and resource estimates included are well established and reflect management&rsquo;s best
estimates, by their nature reserve and resource estimates are imprecise and depend, to a certain extent, upon statistical inferences which
may ultimately prove unreliable. Furthermore, market price fluctuations in uranium and other metals, as well as increased capital or production
costs or reduced recovery rates, may render ore reserves containing lower grades of mineralization uneconomic and may ultimately result
in a restatement of reserves. The extent to which resources may ultimately be reclassified as proven or probable reserves is dependent
upon the demonstration of their profitable recovery. The evaluation of reserves or resources is always influenced by economic and technological
factors, which may change over time.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 40; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->40<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">enCore Energy Corp.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Management&rsquo;s Discussion and Analysis</P>

<P STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">For the years ended December 31,
2022 and 2021</P>










<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Exploration, Development and Operating Risk</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The exploration for and development of uranium
and other mineral properties involves significant risks which even a combination of careful evaluation, experience and knowledge may not
eliminate. While the discovery of an ore body may result in substantial rewards, few properties which are explored are ultimately developed
into producing mines. Major expenses may be required to locate and establish mineral reserves, to develop metallurgical processes and
to construct mining and processing facilities at a particular site. Whether a mineral deposit will be commercially viable depends on a
number of factors, some of which are: the particular attributes of the deposit, such as size, grade and proximity to infrastructure; metal
prices, which are highly cyclical, drilling and other related costs which appear to be rising; and government regulations, including regulations
relating to prices, taxes, royalties, land tenure, land use, importing and exporting of minerals and environmental protection. The exact
effect of these factors cannot be accurately predicted, but the combination of these factors may result in the Company not receiving an
adequate return on invested capital.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Environmental Risks and Hazards</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">All phases of the Company&rsquo;s operations are
subject to environmental regulation in the jurisdictions in which it operates. These regulations mandate, among other things, the maintenance
of air and water quality standards and land reclamation. They also set forth limitations on the general, transportation, storage and disposal
of solid and hazardous waste. Environmental legislation is evolving in a manner which will require stricter standards and enforcement,
increased fines and penalties for non-compliance, more stringent environmental assessments of proposed projects and a heightened degree
of responsibility for companies and their officers, directors and employees. There is no assurance that future changes in environmental
regulation, if any, will not adversely affect the Company&rsquo;s operations. Environmental hazards may exist on the properties which
are unknown to the Company at present and which have been caused by previous or existing owners or operators of the properties. Reclamation
costs are uncertain and planned expenditures estimated by management may differ from the actual expenditures required.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Government Regulation</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company&rsquo;s mineral exploration and planned
development activities are subject to various laws governing prospecting, mining, development, production, taxes, labor standards and
occupational health, mine safety, toxic substances, land use, water use, land claims of local people and other matters. Although the Company
believes its exploration and development activities are currently carried out in accordance with all applicable rules and regulations,
no assurance can be given that new rules and regulations will not be enacted or that existing rules and regulations will not be applied
in a manner which could limit or curtail production or development.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Many of the mineral rights and interests of the
Company are subject to government approvals, licenses and permits. Such approvals, licenses and permits are, as a practical matter, subject
to the discretion of applicable governments or governmental officials. No assurance can be given that the Company will be successful in
maintaining any or all of the various approvals, licenses and permits in full force and effect without modification or revocation. To
the extent such approvals are required and not obtained, the Company may be curtailed or prohibited from continuing or proceeding with
planned exploration or development of mineral properties. Failure to comply with applicable laws, regulations and permitting requirements
may result in enforcement actions thereunder, including orders issued by regulatory or judicial authorities causing operations to cease
or be curtailed, and may include corrective measures requiring capital expenditures, installation of additional equipment or remedial
actions. Parties engaged in mining operations or in the exploration or development of mineral properties may be required to compensate
those suffering loss or damage by reason of the Amendments to current laws and regulation governing operations or more stringent implementation
thereof could have a substantial impact on the Company and cause increases in exploration expenses, capital expenditures or production
costs or reduction in levels of production at producing properties or require abandonment or delays in development of new mining properties.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>The Company has No History of Mineral Production
or Mining Operations</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company has never had uranium and other mineral
producing properties. There is no assurance that commercial quantities of uranium and other minerals will be discovered at the properties
or other future properties nor is there any assurance that the Company&rsquo;s exploration program thereon will yield positive results.
Even if commercial quantities of uranium and other minerals are discovered, there can be no assurance that any property of the Company
will ever be brought to a stage where uranium and other mineral resources can profitably be produced therefrom. Factors which may limit
the ability of the Company to produce uranium and other mineral resources from its properties include, but are not limited to, the spot
prices of metals, availability of additional capital and financing and the nature of any mineral deposits. The Company does not have a
history of mining operations and there is no assurance that it will produce revenue, operate profitably or provide a return on investment
in the future.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I></I></P>

<!-- Field: Page; Sequence: 41; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->41<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>&nbsp;</I><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">enCore Energy Corp.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Management&rsquo;s Discussion and Analysis</P>

<P STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">For the years ended December 31,
2022 and 2021</P>












<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>Future Sales of Common Shares by Existing Shareholders</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Sales of a large number of Common Shares in the
public markets, or the potential for such sales, could decrease the trading price of the Common Shares and could impair the Company&rsquo;s
ability to raise capital through future sales of Common Shares. Substantially all of the Common Shares can be resold without material
restriction in Canada.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>The Company could be deemed a passive foreign
investment company which could have negative consequences for U.S. investors.</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Depending upon the composition of the Company&rsquo;s
gross income or its assets, the Company could be classified as a passive foreign investment company (&ldquo;PFIC&rdquo;) under the United
States tax code. If the Company is declared a PFIC, then owners of the common shares who are U.S. taxpayers generally will be required
to treat any &ldquo;excess distribution&rdquo; received on their common shares, or any gain realized upon a disposition of common shares,
as ordinary income and to pay an interest charge on a portion of such distribution or gain, unless the taxpayer makes a qualified electing
fund (&ldquo;QEF&rdquo;) election or a mark-to-market election with respect to the common shares. A U.S. taxpayer who makes a QEF election
generally must report on a current basis its share of the Company&rsquo;s net capital gain and ordinary earnings for any year in which
the Company is classified as a PFIC, whether or not the Company distributes any amounts to its shareholders. U.S. investors should consult
with their tax advisors for advice as to the U.S. tax consequences of an investment in the common shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>The Russian invasion of Ukraine is recent and
the implications on the global economy, energy supplies, and the uranium and nuclear fuel market are uncertain but may prove to negatively
impact our operations.</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The short and long-term implications of Russia&rsquo;s
invasion of Ukraine are difficult to predict currently. In addition to the possible adverse effects on the global economy, the war may
result in impacts felt more directly by the nuclear fuel industries and uranium producers specifically. While the imposition of sanctions
and counter sanctions may have an adverse effect on energy and economic markets generally, the vast reliance by the U.S. and other nations
on uranium exported from Russia and Russian-controlled or influenced sources, including Kazakhstan and Uzbekistan, could result in an
even greater impact related to global supply and pricing. While in the short-term such a reordering of global supply could result in higher
uranium prices, the long-term impact on the global demand for uranium is uncertain and may be negative. To the extent the war in Ukraine
may adversely affect our business as discussed above, it may also have the effect of heightening many of the other risks described in
this section, such as those relating to cyber-security, supply chain, inflationary and other volatility in prices of goods and materials,
and the condition of the markets including as related to our ability to access additional capital, any of which could negatively affect
our business. Because of the highly uncertain and dynamic nature of these events, it is not currently possible to estimate the impact
of the Russian &ndash; Ukraine war on our business.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Cautionary Notes Regarding Forward-Looking
Statements</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">This MD&amp;A contains statements that, to the
extent that they are not historical fact, may constitute &ldquo;forward-looking information&rdquo; and &ldquo;forward-looking statements&rdquo;
within the meaning of applicable Canadian and United States securities legislation, respectively. Often, but not always, forward-looking
statements can be identified by the use of words such as &ldquo;plans&rdquo;, &ldquo;expects&rdquo;, &ldquo;is expected&rdquo;, &ldquo;budget&rdquo;,
&ldquo;scheduled&rdquo;, &ldquo;project&rdquo;, &ldquo;estimates&rdquo;, &ldquo;forecasts&rdquo;, &ldquo;intends&rdquo;, &ldquo;anticipates&rdquo;,
or &ldquo;believes&rdquo; or variations (including negative variations) of such words and phrases, or statements that certain actions,
events or results &ldquo;may&rdquo;, &ldquo;could&rdquo;, &ldquo;would&rdquo;, &ldquo;might&rdquo; or &ldquo;will&rdquo; be taken, occur
or be achieved. Forward-looking statements may include, but are not limited to, statements with respect to:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">the
Company&rsquo;s future financial and operational performance;</FONT></TD>
</TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">the
sufficiency of the Company&rsquo;s current working capital, anticipated cash flow or its ability to raise necessary funds;</FONT></TD>
</TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">the
anticipated amount and timing of work programs;</FONT></TD>
</TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">our
expectations with respect to future exchange rates;</FONT></TD>
</TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">the
estimated cost of and availability of funding necessary for sustaining capital;</FONT></TD>
</TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">forecast
capital and non-operating spending;</FONT></TD>
</TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">the
Company&rsquo;s plans and expectations for its property, exploration, development, production, and community relations operations;</FONT></TD>
</TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">the
use of available funds;</FONT></TD>
</TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">expectations
regarding the process for and receipt of regulatory approvals, permits and licenses under governmental and other applicable regulatory
regimes, including U.S. government policies towards domestic uranium supply;</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in"></P>

<!-- Field: Page; Sequence: 42; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->42<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">enCore Energy Corp.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Management&rsquo;s Discussion and Analysis</P>

<P STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">For the years ended December 31,
2022 and 2021</P>












<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">expectations
about future uranium market prices, production costs and global uranium supply and demand;</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">expectations
regarding holding physical uranium for long-term investment;</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">the
establishment of mineral resources on any of the Company&rsquo;s current or future mineral properties (other than the Company&rsquo;s
properties that currently have an established mineral resource estimates);</FONT></TD>
</TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">future
royalty and tax payments and rates;</FONT></TD>
</TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">expectations
regarding possible impacts of litigation and regulatory actions; and</FONT></TD>
</TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">the
completion of reclamation activities at former mine or extraction sites</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Such forward-looking statements reflect the Company&rsquo;s
current views with respect to future events, based on information currently available to the Company and are subject to and involve certain
known and unknown risks, uncertainties, assumptions and other factors which may cause the actual results, performance or achievements
of the Company to be materially different from any future results, performance or achievements expressed in or implied by such forward-looking
statements. The forward-looking statements in this MD&amp;A are based on material assumptions, including the following:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
budget, including expected levels of exploration, evaluation and operations activities and costs, as well as assumptions regarding market
conditions and other factors upon which we have based our income and expenditure expectations;</FONT></TD>
</TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">assumptions
regarding the timing and use of our cash resources;</FONT></TD>
</TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
ability to, and the means by which we can, raise additional capital to advance other exploration and evaluation objectives;</FONT></TD>
</TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
operations and key suppliers are essential services, and our employees, contractors and subcontractors will be available to continue
operations;</FONT></TD>
</TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
ability to obtain all necessary regulatory approvals, permits and licenses for our planned activities under governmental and other applicable
regulatory regimes;</FONT></TD>
</TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
expectations regarding the demand for, and supply of, uranium, the outlook for long-term contracting, changes in regulations, public
perception of nuclear power, and the construction of new and ongoing operation of existing nuclear power plants;</FONT></TD>
</TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
expectations regarding spot and long-term prices and realized prices for uranium;</FONT></TD>
</TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
expectations that our holdings of physical uranium will be helpful in securing project financing and/or in securing long- term uranium
supply agreements in the future;</FONT></TD>
</TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
expectations regarding tax rates, currency exchange rates, and interest rates;</FONT></TD>
</TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
decommissioning and reclamation obligations and the status and ongoing maintenance of agreements with third parties with respect thereto;</FONT></TD>
</TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
mineral resource estimates, and the assumptions upon which they are based;</FONT></TD>
</TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">our,
and our contractors&rsquo;, ability to comply with current and future environmental, safety and other regulatory requirements and to
obtain and maintain required regulatory approvals; and</FONT></TD>
</TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
operations are not significantly disrupted by political instability, nationalization, terrorism, sabotage, pandemics, social or political
activism, breakdown, natural disasters, governmental or political actions, litigation or arbitration proceedings, equipment or infrastructure
failure, labour shortages, transportation disruptions or accidents, or other development or exploration risks.</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 43; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->43<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">enCore Energy Corp.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Management&rsquo;s Discussion and Analysis</P>

<P STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">For the years ended December 31,
2022 and 2021</P>












<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The risks, uncertainties, assumptions and other
factors that could cause actual results to differ materially from any future results expressed in or implied by the forward-looking statements
in this MD&amp;A include, but are not limited to, the following factors:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">exploration
and development risks;</FONT></TD>
</TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">changes
in commodity prices;</FONT></TD>
</TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">access
to skilled mining personnel;</FONT></TD>
</TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">results
of exploration and development activities;</FONT></TD>
</TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">uninsured
risks;</FONT></TD>
</TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">regulatory
risks;</FONT></TD>
</TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">defects
in title;</FONT></TD>
</TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">availability
of materials and equipment, timeliness of government approvals and unanticipated environmental impacts on operations;</FONT></TD>
</TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">risks
posed by the economic and political environments in which the Company operates and intends to operate;</FONT></TD>
</TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">the
potential for losses arising from the expansion of operations into new markets;</FONT></TD>
</TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">increased
competition;</FONT></TD>
</TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">assumptions
regarding market trends and the expected demand and desires for the Company&rsquo;s products and proposed products;</FONT></TD>
</TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">reliance
on industry manufacturers, suppliers and others;</FONT></TD>
</TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">the
failure to adequately protect intellectual property;</FONT></TD>
</TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">the
failure to adequately manage future growth;</FONT></TD>
</TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">adverse
market conditions; and</FONT></TD>
</TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">the
failure to satisfy ongoing regulatory requirements.</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In addition, the risks, assumptions, and other
factors set out herein (including under Risk Factors and Uncertainties) and in the Company&rsquo;s public filings, including its most
recent Annual Information Form, could cause actual results to differ materially from any future results expressed in or implied by the
forward-looking statements in this MD&amp;A. Should one or more of these risks or uncertainties materialize, or should assumptions underlying
the forward-looking statements prove incorrect, actual results may vary materially from those described herein as intended, planned, anticipated,
believed, estimated or expected. These risks, uncertainties, assumptions and other factors should be considered carefully, and prospective
investors and readers should not place undue reliance on the forward-looking statements.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Any forward-looking statement speaks only as of
the date on which such statement is made, and the Company undertakes no obligation to update any forward-looking statement or information
or statements to reflect information, events, results, circumstances or otherwise after the date on which such statement is made or to
reflect the occurrence of unanticipated events, except as required by applicable laws. New factors emerge from time to time, and it is
not possible for management to predict all of such factors and to assess in advance the impact of each such fact on the Company&rsquo;s
business or the extent to which any factor, or combination of factors, may cause actual results to differ materially from those contained
in any forward-looking statements or information.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">All of the forward-looking statements contained
in this MD&amp;A are qualified by the foregoing cautionary statements.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 44; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->44<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B></B>enCore Energy Corp.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Management&rsquo;s Discussion and Analysis</P>

<P STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">For the years ended December 31,
2022 and 2021</P>












<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>OUTSTANDING SHARE DATA AS AT THE DATE OF THIS
MD&amp;A</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR>
<TD STYLE="width: 0.5in">a)</TD><TD STYLE="text-align: justify">Issued share capital: 143,225,354 common shares.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR>
<TD STYLE="width: 0.5in">b)</TD><TD STYLE="text-align: justify">Outstanding stock options:</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font-weight: bold; text-align: left; border-bottom: Black 1.5pt solid">Expiry Date</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Outstanding Options</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Exercise&nbsp;Price<BR> ($ CAD)</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 76%; text-align: left">May 7, 2023</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">12,500</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">4.20</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">May 15, 2023</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">108,334</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">0.18</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">August 22, 2023</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">135,625</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1.92</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">January 8, 2024</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">35,834</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">0.37</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">February 6, 2024</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">62,500</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1.84</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">February 6, 2024</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">81,250</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1.40</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">February 6, 2024</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">101,562</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2.40</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">March 27, 2024</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">16,667</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">0.40</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">March 31, 2024</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">95,833</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">4.71</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">May 23, 2024</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">59,375</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1.84</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">June 3, 2024</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,072,915</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">0.45</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">October 19, 2024</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">66,666</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">5.76</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">May 19, 2025</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">44,686</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1.40</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">May 21, 2025</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">955,000</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">0.62</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">September 1, 2025</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">50,000</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1.05</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">September 10, 2025</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">475,000</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1.35</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">October 5, 2025</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">25,000</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1.20</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">November 25, 2025</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">33,333</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1.25</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">December 7, 2025</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">13,333</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1.44</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">January 28, 2026</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">53,333</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2.82</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">February 26, 2026</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">145,000</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">3.24</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">May 13, 2026</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">106,641</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2.40</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">May 26, 2026</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">145,002</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">4.32</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">December 1, 2026</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">33,333</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">5.40</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">December 3, 2026</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">31,667</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">5.19</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">January 10, 2027</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">16,667</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">5.01</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">February 14, 2027</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2,321,667</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">4.20</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">May 2, 2027</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">83,333</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">4.32</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">June 1, 2027</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">166,667</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">3.75</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">July 15, 2027</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">133,333</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">3.21</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">November 1, 2027</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">148,334</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">3.65</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">November 14, 2027</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">50,000</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">3.25</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">December 19, 2027</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">50,000</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">3.30</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">January 5, 2028</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">15,000</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">3.10</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">January 16, 2028</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">10,000</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">3.79</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">February 14, 2028</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">44,681</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">3.10</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">April 5, 2028</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">15,000</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2.93</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt">April 19, 2028</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">52,000</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; text-align: right">2.52</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 4pt">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: right">7,067,071</TD><TD STYLE="padding-bottom: 4pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 4pt; text-align: right">&nbsp;</TD><TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD></TR>
  </TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 45; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->45<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">enCore Energy Corp.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Management&rsquo;s Discussion and Analysis</P>

<P STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">For the years ended December 31,
2022 and 2021</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR>
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">c)</TD><TD STYLE="text-align: justify">Outstanding share purchase warrants:</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 4.3pt 0pt 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font-weight: bold; border-bottom: Black 1.5pt solid">Expiry Date</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Outstanding<BR> Warrants</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Exercise<BR> Price <BR> ($ CAD)</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 76%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">October 22, 2023<SUP>1</SUP></FONT></TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">1,275,445</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">1.800</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD>March 9, 2024</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">158,917</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">3.000</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">March 9, 2024<SUP>2</SUP></FONT></TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2,271,896</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">3.900</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD>March 25, 2024</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">3,267,974</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">6.000</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD>March 25, 2024</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">351,307</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">4.590</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD>May 14, 2025</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">283,500</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">3.250</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD>May 14, 2025</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,066,500</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">3.910</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD>February 8, 2026</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">5,307,825</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">4.050</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-bottom: 1.5pt">February 14, 2026</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">23,277,000</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; text-align: right">3.750</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-bottom: 4pt">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: right">37,260,364</TD><TD STYLE="padding-bottom: 4pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 4pt; text-align: right">&nbsp;</TD><TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD></TR>
  </TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in; text-align: left"><SUP>1</SUP></TD><TD STYLE="text-align: justify">Power warrants exercisable into one share and one-half warrant.
Each whole warrant is exercisable at $1.80 for 36 months.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in; text-align: left"><SUP>2</SUP></TD><TD STYLE="text-align: justify">Power warrants exercisable into one share and one-half warrant.
Each whole warrant is exercisable at $3.90 for 36 months.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR>
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">d)</TD><TD STYLE="text-align: justify">Convertible Promissory note:</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">A portion of the consideration
paid to Energy Fuels, Inc in the Company&rsquo;s acquisition of the Alta Mesa Project was a $60,000,000 secured vendor take-back
convertible promissory note. The Promissory Note has a two year term and bears interest at 8% per annum.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">46</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>





















</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.3
<SEQUENCE>4
<FILENAME>ea177383ex99-3_encoreenergy.htm
<DESCRIPTION>FINANCIAL STATEMENTS FOR THE YEARS ENDED DECEMBER 31,2022 AND 2021
<TEXT>
<XBRL>
<?xml version="1.0" encoding="ASCII"?>
<!-- Generated by CompSci Transform (tm) - http://www.compsciresources.com -->
<!-- Created: Fri Apr 28 19:14:46 UTC 2023 -->
<html xmlns:country="http://xbrl.sec.gov/country/2022" xmlns:dtr="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dei="http://xbrl.sec.gov/dei/2022" xmlns:ifrs-full="https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:compsci="http://compsciresources.com" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:us-types="http://fasb.org/us-types/2022" xmlns:cve="http://encoreuranium.com/20221231" xmlns:srt="http://fasb.org/srt/2022" xmlns:xl="http://www.xbrl.org/2003/XLink" xmlns:stpr="http://xbrl.sec.gov/stpr/2022" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:us-gaap="http://fasb.org/us-gaap/2022" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns="http://www.w3.org/1999/xhtml">
<head>
     <title> </title>

<meta content="text/html" http-equiv="Content-Type" />
</head>
<body><div style="font: 10pt Times New Roman, Times, Serif"><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><b>Exhibit
99.3</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><img alt="" src="ex99-3_001.jpg"/></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><b>Consolidated
Financial Statements</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><b>For
the year ended</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><b>December
31, 2022</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><b>&#160;</b></span></p><div>

</div><!-- Field: Page; Sequence: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="margin: 0pt"></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><b><img alt="" src="ex99-3_002.jpg"/>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="text-transform: uppercase"><b>Report
of Independent Registered Public Accounting Firm</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">To the Shareholders and Directors of</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">enCore Energy Corp.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>Opinion on the Consolidated Financial Statements</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>&#160;</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We have audited the accompanying consolidated
statements of financial position of enCore Energy Corp. (the &#8220;Company&#8221;), as of December 31, 2022, December 31, 2021 and January
1, 2021, and the related consolidated statements of loss and comprehensive loss, changes in shareholders&#8217; equity, and cash flows
for the years ended December 31, 2022 and 2021, and the related notes (collectively referred to as the &#8220;financial statements&#8221;).
In our opinion, the consolidated financial statements present fairly, in all material respects, the financial position of the Company
as of December 31, 2022, December 31, 2021 and January 1, 2021, and the results of its operations and its cash flows for the years ended
December 31, 2022 and 2021 in conformity with International Financial Reporting Standards as issued by the International Accounting Standards
Board.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>Change in Presentation Currency </i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>&#160;</i></b></p><div>

</div><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">As discussed in Note 2 to the consolidated financial statements, during
the year ended December 31, 2022, the Company retroactively changed its presentation currency from the Canadian Dollar to the United States
Dollar.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>Basis for Opinion</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">These consolidated financial statements are the
responsibility of the Company&#8217;s management. Our responsibility is to express an opinion on the Company&#8217;s consolidated financial
statements based on our audits. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United
States) (&#8220;PCAOB&#8221;) and are required to be independent with respect to the Company in accordance with the U.S. federal securities
laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We conducted our audits in accordance with the
standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the consolidated
financial statements are free of material misstatement, whether due to error or fraud. The Company is not required to have, nor were we
engaged to perform, an audit of its internal control over financial reporting. As part of our audits we are required to obtain an understanding
of internal control over financial reporting but not for the purpose of expressing an opinion on the effectiveness of the Company&#8217;s
internal control over financial reporting. Accordingly, we express no such opinion.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our audits included performing procedures to assess
the risks of material misstatements of the financial statements, whether due to error or fraud, and performing procedures that respond
to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the consolidated
financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management,
as well as evaluating the overall presentation of the consolidated financial statements. We believe that our audits provide a reasonable
basis for our opinion.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="margin: 0pt 0; font: 10pt Times New Roman, Times, Serif">We have served as the Company&#8217;s auditor since 2016.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><b>/s/ DAVIDSON &amp; COMPANY LLP</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="width: 51%; text-align: left">Vancouver, Canada</td>
    <td style="width: 49%; text-align: right">Chartered Professional Accountants</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>April 28, 2023</td>
    <td style="text-align: left">&#160;</td></tr>
  </table><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><b><img alt="" src="ex99-3_003.jpg"/>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"><b>&#160;</b></span></p><div>




</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><!-- Field: Page; Sequence: 2; Options: NewSection; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="border-top: Black 1.5pt solid; width: 100%; padding-top: 2pt; padding-bottom: 2pt; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif"><b>enCore Energy Corp.</b></span></td></tr>
  <tr style="vertical-align: top">
    <td style="border-bottom: Black 1.5pt solid; padding-top: 2pt; padding-bottom: 2pt; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif"><b>Consolidated Statements of Financial Position</b></span></td></tr>
  <tr style="vertical-align: top">
    <td style="border-bottom: Black 1.5pt solid; padding-top: 2pt; padding-bottom: 2pt; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif"><b>For the years ended December 31, 2022 and December 31, 2021</b></span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">Note</td><td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">December 31, <br/> 2022<br/> $</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">December 31, <br/> 2021<br/> $<br/> (Note 21)</td><td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">January 1, <br/> 2021<br/> $<br/> (Note 21)</td><td style="padding-bottom: 1.5pt">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold">Assets</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold">Current assets</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 52%; padding-left: 10pt">Cash</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: center">&#160;</td><td style="width: 9%; text-align: center">&#160;</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c2" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:CashAndCashEquivalents" scale="0" unitRef="usd">2,512,012</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c3" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:CashAndCashEquivalents" scale="0" unitRef="usd">9,188,483</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c4" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:CashAndCashEquivalents" scale="0" unitRef="usd">5,182,249</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-left: 10pt">Receivables and prepaid expenses</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c2" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:TradeAndOtherReceivables" scale="0" unitRef="usd">1,244,561</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c3" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:TradeAndOtherReceivables" scale="0" unitRef="usd">627,181</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c4" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:TradeAndOtherReceivables" scale="0" unitRef="usd">254,092</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 10pt">Marketable securities - current</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: center">6</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c2" decimals="0" format="ixt:num-dot-decimal" name="cve:MarketableSecuritiecurrent" scale="0" unitRef="usd">3,162,361</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-0">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-1">-</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-left: 10pt">Deposit - uranium investment</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: center">5</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c2" decimals="0" format="ixt:num-dot-decimal" name="cve:DepositUraniumInvestment" scale="0" unitRef="usd">3,000,000</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-2">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-3">-</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt; padding-left: 10pt">Assets held for sale</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: center">11</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c2" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:NoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSaleOrAsHeldForDistributionToOwners" scale="0" unitRef="usd">728,882</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c3" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:NoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSaleOrAsHeldForDistributionToOwners" scale="0" unitRef="usd">1,741,064</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-4">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-bottom: 1.5pt">&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: center">&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><ix:nonFraction contextRef="c2" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:CurrentAssets" scale="0" unitRef="usd">10,647,816</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c3" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:CurrentAssets" scale="0" unitRef="usd">11,556,728</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c4" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:CurrentAssets" scale="0" unitRef="usd">5,436,341</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left">Non-current assets</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-left: 10pt">Intangible assets</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: center">7</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c2" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:IntangibleAssetsOtherThanGoodwill" scale="0" unitRef="usd">528,282</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c3" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:IntangibleAssetsOtherThanGoodwill" scale="0" unitRef="usd">491,996</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c4" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:IntangibleAssetsOtherThanGoodwill" scale="0" unitRef="usd">483,631</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 10pt">Property, plant, and equipment</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: center">8</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c2" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:PropertyPlantAndEquipment" scale="0" unitRef="usd">2,334,421</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c3" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:PropertyPlantAndEquipment" scale="0" unitRef="usd">1,603,679</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c4" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:PropertyPlantAndEquipment" scale="0" unitRef="usd">1,484,836</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-left: 10pt">Investment in associate</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: center">4</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-5">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c3" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:InvestmentsInAssociates" scale="0" unitRef="usd">564,340</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c4" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:InvestmentsInAssociates" scale="0" unitRef="usd">451,221</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 10pt">Investment in uranium</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: center">5</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-6">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c3" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:InvestmentsInSubsidiariesJointVenturesAndAssociates" scale="0" unitRef="usd">4,210,000</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-7">-</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-left: 10pt">Marketable securities - non-current</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: center">6</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c2" decimals="0" format="ixt:num-dot-decimal" name="cve:MarketablesSecuritiesNoncurrent" scale="0" unitRef="usd">784,832</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-8">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-9">-</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 10pt">Mineral properties</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: center">11</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c2" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:MiningAssets" scale="0" unitRef="usd">145,219,086</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c3" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:MiningAssets" scale="0" unitRef="usd">136,079,578</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c4" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:MiningAssets" scale="0" unitRef="usd">6,608,060</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-left: 10pt">Reclamation deposits</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: center">11</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c2" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:LongtermDeposits" scale="0" unitRef="usd">88,500</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c3" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:LongtermDeposits" scale="0" unitRef="usd">88,500</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c4" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:LongtermDeposits" scale="0" unitRef="usd">85,500</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 10pt">Right-of-use asset</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: center">9</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c2" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:RightofuseAssets" scale="0" unitRef="usd">185,614</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c3" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:RightofuseAssets" scale="0" unitRef="usd">244,564</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c4" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:RightofuseAssets" scale="0" unitRef="usd">8,867</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-left: 10pt">Deferred acquisition costs</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: center">22(a)</td><td style="text-align: left"></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c2" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:DeferredTaxAssets" scale="0" unitRef="usd">6,009,303</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-10">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-11">-</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 10pt">Deferred financing costs</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: center">22(b)</td><td style="text-align: left"></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c2" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:NoncurrentFinancialAssets" scale="0" unitRef="usd">3,162,936</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-12">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-13">-</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt; padding-left: 10pt">Restricted cash</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: center">2,14,22(b)</td><td style="padding-bottom: 1.5pt; text-align: left"></td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c2" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:RestrictedCashAndCashEquivalents" scale="0" unitRef="usd">54,568,668</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c3" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:RestrictedCashAndCashEquivalents" scale="0" unitRef="usd">4,517,139</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c4" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:RestrictedCashAndCashEquivalents" scale="0" unitRef="usd">3,796,788</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt">Total assets</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: center">&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><ix:nonFraction contextRef="c2" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:Assets" scale="0" unitRef="usd">223,529,458</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c3" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:Assets" scale="0" unitRef="usd">159,356,524</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c4" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:Assets" scale="0" unitRef="usd">18,355,244</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left">Liabilities and shareholders&#8217; equity</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font-weight: bold; text-align: left">Current liabilities</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 10pt">Accounts payable and accrued liabilities</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c2" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:TradeAndOtherCurrentPayables" scale="0" unitRef="usd">3,105,065</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c3" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:TradeAndOtherCurrentPayables" scale="0" unitRef="usd">5,835,116</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c4" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:TradeAndOtherCurrentPayables" scale="0" unitRef="usd">368,056</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-left: 10pt">Due to related parties</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: center">15</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c2" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:TradeAndOtherCurrentPayablesToRelatedParties" scale="0" unitRef="usd">441,374</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c3" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:TradeAndOtherCurrentPayablesToRelatedParties" scale="0" unitRef="usd">6,893</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c4" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:TradeAndOtherCurrentPayablesToRelatedParties" scale="0" unitRef="usd">2,319</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 10pt">Note payable</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: center">13</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-14">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-15">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c4" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:OtherCurrentPayables" scale="0" unitRef="usd">330,935</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt; padding-left: 10pt">Lease liability - current</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: center">9</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c2" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:CurrentLeaseLiabilities" scale="0" unitRef="usd">84,262</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c3" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:CurrentLeaseLiabilities" scale="0" unitRef="usd">82,116</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c4" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:CurrentLeaseLiabilities" scale="0" unitRef="usd">5,746</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1.5pt">&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: center">&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><ix:nonFraction contextRef="c2" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:CurrentLiabilities" scale="0" unitRef="usd">3,630,701</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c3" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:CurrentLiabilities" scale="0" unitRef="usd">5,924,125</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c4" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:CurrentLiabilities" scale="0" unitRef="usd">707,056</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font-weight: bold; text-align: left">Non-current liabilities</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 10pt">Asset retirement obligations</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: center">12</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c2" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:DefinedBenefitObligationAtPresentValue" scale="0" unitRef="usd">4,752,352</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c3" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:DefinedBenefitObligationAtPresentValue" scale="0" unitRef="usd">4,176,493</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c4" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:DefinedBenefitObligationAtPresentValue" scale="0" unitRef="usd">5,239,108</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt; padding-left: 10pt">Lease liability - non-current</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: center">9</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c2" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:NoncurrentLeaseLiabilities" scale="0" unitRef="usd">96,166</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c3" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:NoncurrentLeaseLiabilities" scale="0" unitRef="usd">167,393</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c4" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:NoncurrentLeaseLiabilities" scale="0" unitRef="usd">3,121</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt">Total liabilities</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: center">&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><ix:nonFraction contextRef="c2" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:Liabilities" scale="0" unitRef="usd">8,479,219</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c3" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:Liabilities" scale="0" unitRef="usd">10,268,011</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c4" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:Liabilities" scale="0" unitRef="usd">5,949,285</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left">Shareholders&#8217; equity</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 10pt">Share capital</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: center">14</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c2" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:IssuedCapital" scale="0" unitRef="usd">190,610,250</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c3" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:IssuedCapital" scale="0" unitRef="usd">162,582,365</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c4" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:IssuedCapital" scale="0" unitRef="usd">26,653,141</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt">Share subscriptions received</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: center">14</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c2" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:SharePremium" scale="0" unitRef="usd">51,558,624</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-16">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-17">-</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-left: 10pt">Contributed surplus</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: center">14</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c2" decimals="0" format="ixt:num-dot-decimal" name="cve:ContributedSurplus" scale="0" unitRef="usd">16,218,518</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c3" decimals="0" format="ixt:num-dot-decimal" name="cve:ContributedSurplus" scale="0" unitRef="usd">12,662,103</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c4" decimals="0" format="ixt:num-dot-decimal" name="cve:ContributedSurplus" scale="0" unitRef="usd">2,019,445</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 10pt">Accumulated other comprehensive income</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c2" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:AccumulatedOtherComprehensiveIncome" scale="0" unitRef="usd">5,530,224</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c3" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:AccumulatedOtherComprehensiveIncome" scale="0" unitRef="usd">6,196,033</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c4" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:AccumulatedOtherComprehensiveIncome" scale="0" unitRef="usd">7,521,888</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-bottom: 1.5pt; padding-left: 10pt">Deficit</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: center">&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c2" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:RetainedEarnings" scale="0" sign="-" unitRef="usd">48,867,377</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c3" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:RetainedEarnings" scale="0" sign="-" unitRef="usd">32,351,988</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c4" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:RetainedEarnings" scale="0" sign="-" unitRef="usd">23,788,515</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt">Total shareholders&#8217; equity</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: center">&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><ix:nonFraction contextRef="c2" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:Equity" scale="0" unitRef="usd">215,050,239</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c3" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:Equity" scale="0" unitRef="usd">149,088,513</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c4" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:Equity" scale="0" unitRef="usd">12,405,959</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt">Total liabilities and shareholders&#8217; equity</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: center">&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><ix:nonFraction contextRef="c2" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:EquityAndLiabilities" scale="0" unitRef="usd">223,529,458</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c3" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:EquityAndLiabilities" scale="0" unitRef="usd">159,356,524</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c4" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:EquityAndLiabilities" scale="0" unitRef="usd">18,355,244</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font-weight: bold; text-align: left">Nature of operations and going concern</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: center">1</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left">Change in presentation currency</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: center">2</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font-weight: bold; text-align: left">Events after the reporting period</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: center">22</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  </table><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b>Approved
on behalf of the Board of Directors on April 26, 2023:</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; width: 24%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#8220;William
    M. Sheriff&#8221;</i></span></td>
    <td style="width: 2%">&#160;</td>
    <td style="width: 24%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Director</b></span></td>
    <td style="border-bottom: Black 1.5pt solid; width: 24%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#8220;William
    B. Harris&#8221;</i></span></td>
    <td style="width: 2%">&#160;</td>
    <td style="width: 24%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Director</b></span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><b>The
accompanying notes are an integral part of these consolidated financial statements.&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><!-- Field: Page; Sequence: 3; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="border-top: Black 1.5pt solid; width: 100%; padding-top: 2pt; padding-bottom: 2pt; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif"><b>enCore Energy Corp.</b></span></td></tr>
  <tr style="vertical-align: top">
    <td style="border-bottom: Black 1.5pt solid; padding-top: 2pt; padding-bottom: 2pt; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif"><b>Consolidated Statements of Loss and Comprehensive Loss</b></span></td></tr>
  <tr style="vertical-align: top">
    <td style="border-bottom: Black 1.5pt solid; padding-top: 2pt; padding-bottom: 2pt; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif"><b>As
    at December 31, 2022, December 31, 2021 and January 1, 2021</b></span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">&#160;</td><td style="font-weight: bold">&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">December&#160;31,</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">December 31,</td><td style="font-weight: bold">&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">2021</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">2022</td><td style="font-weight: bold">&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">$</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: center; border-bottom: Black 1.5pt solid">Note</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">$</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid">(Note 21)</td><td style="padding-bottom: 1.5pt">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font-weight: bold; text-align: left">Expenses</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%; padding-left: 10pt">Accretion</td><td style="width: 1%">&#160;</td>
    <td style="width: 11%; text-align: center">9,12</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="cve:AccretionExpenses" scale="0" unitRef="usd">445,190</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="cve:AccretionExpenses" scale="0" unitRef="usd">408,181</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-left: 10pt">Amortization and depreciation</td><td>&#160;</td>
    <td style="text-align: center">7,8,9</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:DepreciationAndAmortisationExpense" scale="0" unitRef="usd">380,336</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:DepreciationAndAmortisationExpense" scale="0" unitRef="usd">298,666</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 10pt">Community engagement</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="cve:CommunityEngagement" scale="0" unitRef="usd">44,110</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-18">-</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 10pt">Consulting</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="cve:Consulting" scale="0" unitRef="usd">258,495</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="cve:Consulting" scale="0" unitRef="usd">72,726</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 10pt">General administrative costs</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:GeneralAndAdministrativeExpense" scale="0" unitRef="usd">4,731,367</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:GeneralAndAdministrativeExpense" scale="0" unitRef="usd">3,533,474</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-left: 10pt">Impairment charges</td><td>&#160;</td>
    <td style="text-align: center">11</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-19">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:ImpairmentLossImpairmentGainAndReversalOfImpairmentLossDeterminedInAccordanceWithIFRS9" scale="0" unitRef="usd">78,456</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 10pt">Interest expense</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:InterestExpense" scale="0" unitRef="usd">2,556</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-20">-</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-left: 10pt">Office and administrative</td><td>&#160;</td>
    <td style="text-align: center">15</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:AdministrativeExpense" scale="0" unitRef="usd">137,551</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:AdministrativeExpense" scale="0" unitRef="usd">197,391</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 10pt">Professional fees</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:ProfessionalFeesExpense" scale="0" unitRef="usd">1,944,668</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:ProfessionalFeesExpense" scale="0" unitRef="usd">581,408</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-left: 10pt">Project investigation</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="cve:ProjectInvestigationFess" scale="0" unitRef="usd">1,519</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-21">-</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 10pt">Promotion and shareholder communication</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:CommunicationExpense" scale="0" unitRef="usd">287,887</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:CommunicationExpense" scale="0" unitRef="usd">166,096</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-left: 10pt">Reclamation costs</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-22">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:ReclassificationAdjustmentsOnChangeInValueOfForwardElementsOfForwardContractsNetOfTax" scale="0" unitRef="usd">709,399</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt">Travel</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:TravelExpense" scale="0" unitRef="usd">312,236</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:TravelExpense" scale="0" unitRef="usd">26,609</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-left: 10pt">Transfer agent and filing fees</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="cve:TransferAgentAndFilingFees" scale="0" unitRef="usd">322,792</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="cve:TransferAgentAndFilingFees" scale="0" unitRef="usd">133,717</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 10pt">Staff costs</td><td>&#160;</td>
    <td style="text-align: center">15</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:WagesAndSalaries" scale="0" unitRef="usd">4,130,741</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:WagesAndSalaries" scale="0" unitRef="usd">1,582,326</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt; padding-left: 10pt">Stock option expense</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: center; padding-bottom: 1.5pt">14,15</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:ExpenseFromSharebasedPaymentTransactionsWithEmployees" scale="0" unitRef="usd">5,744,655</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:ExpenseFromSharebasedPaymentTransactionsWithEmployees" scale="0" unitRef="usd">1,425,645</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-left: 5.4pt">Loss from operating expenses</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">(<ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:ProfitLossFromOperatingActivities" scale="0" sign="-" unitRef="usd">18,744,103</ix:nonFraction></td><td style="font-weight: bold; text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:ProfitLossFromOperatingActivities" scale="0" sign="-" unitRef="usd">9,214,094</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 5.4pt">&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 10pt">Interest income</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:RevenueFromInterest" scale="0" unitRef="usd">406,132</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:RevenueFromInterest" scale="0" unitRef="usd">20,987</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-left: 10pt">Loss on write-off of sales tax recoverable</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="cve:LossOnWriteoffOfSalesTaxRecoverable" scale="0" unitRef="usd">91,289</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 10pt">Foreign exchange (loss) gain</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss" scale="0" sign="-" unitRef="usd">58,456</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss" scale="0" unitRef="usd">27,265</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-left: 10pt">Gain (loss) on divestment of mineral properties</td><td>&#160;</td>
    <td style="text-align: center">11</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:GainsLossesOnDisposalsOfPropertyPlantAndEquipment" scale="0" unitRef="usd">29,148</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:GainsLossesOnDisposalsOfPropertyPlantAndEquipment" scale="0" sign="-" unitRef="usd">89,914</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 10pt">(Loss) gain on change in asset retirement obligation estimate</td><td>&#160;</td>
    <td style="text-align: center">12</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:GainLossOnRemeasurementOfReimbursementRights" scale="0" unitRef="usd">157,227</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:GainLossOnRemeasurementOfReimbursementRights" scale="0" sign="-" unitRef="usd">1,719,943</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-left: 10pt">Gain on disposal of subsidiary</td><td>&#160;</td>
    <td style="text-align: center">11</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="cve:GainOnDisposalOfSubsidiary" scale="0" unitRef="usd">1,594,901</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 10pt">Loss on contract termination</td><td>&#160;</td>
    <td style="text-align: center">13</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="cve:LossOnContractTerminations" scale="0" unitRef="usd">2,750,000</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-left: 10pt">Unrealized gain on uranium investment</td><td>&#160;</td>
    <td style="text-align: center">5</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="cve:UnrealizedGainOnUraniumInvestment" scale="0" unitRef="usd">1,554,000</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 10pt">Gain on sale of uranium investment</td><td>&#160;</td>
    <td style="text-align: center">5</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="cve:GainOnSaleOfUraniumInvestment" scale="0" unitRef="usd">35,000</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="cve:GainOnSaleOfUraniumInvestment" scale="0" unitRef="usd">524,075</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-left: 10pt">Unrealized gain on marketable securities</td><td>&#160;</td>
    <td style="text-align: center">6</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="cve:UnrealizedGainOnMarketableSecurities" scale="0" unitRef="usd">1,057,405</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt; padding-left: 10pt">Loss on investment in associate</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: center; padding-bottom: 1.5pt">4</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:GainsLossesOnFairValueAdjustmentInvestmentProperty" scale="0" sign="-" unitRef="usd">586,900</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:GainsLossesOnFairValueAdjustmentInvestmentProperty" scale="0" sign="-" unitRef="usd">355,735</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font-weight: bold; text-align: left; padding-left: 5.4pt">Net loss for the year</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">(<ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:ProfitLoss" scale="0" sign="-" unitRef="usd">16,515,389</ix:nonFraction></td><td style="font-weight: bold; text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:ProfitLoss" scale="0" sign="-" unitRef="usd">8,563,473</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt; padding-left: 10pt">Foreign currency translation adjustment</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: center; padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:OtherComprehensiveIncomeNetOfTaxHedgesOfNetInvestmentsInForeignOperations" scale="0" sign="-" unitRef="usd">665,809</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:OtherComprehensiveIncomeNetOfTaxHedgesOfNetInvestmentsInForeignOperations" scale="0" sign="-" unitRef="usd">1,325,855</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt; padding-left: 5.4pt">Comprehensive loss for the year</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: center; padding-bottom: 1.5pt">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">(<ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:ComprehensiveIncome" scale="0" sign="-" unitRef="usd">17,181,198</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:ComprehensiveIncome" scale="0" sign="-" unitRef="usd">9,889,328</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 5.4pt">&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font-weight: bold; padding-left: 5.4pt">Loss per share</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; padding-left: 5.4pt">Weighted average number of common shares outstanding</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font-weight: bold; padding-left: 5.4pt">- basic #</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right"><ix:nonFraction contextRef="c0" decimals="INF" format="ixt:num-dot-decimal" name="ifrs-full:WeightedAverageShares" scale="0" unitRef="shares">105,529,292</ix:nonFraction></td><td style="font-weight: bold; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c5" decimals="INF" format="ixt:num-dot-decimal" name="ifrs-full:WeightedAverageShares" scale="0" unitRef="shares">65,325,525</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; padding-left: 5.4pt">- diluted #</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right"><ix:nonFraction contextRef="c0" decimals="INF" format="ixt:num-dot-decimal" name="ifrs-full:AdjustedWeightedAverageShares" scale="0" unitRef="shares">105,529,292</ix:nonFraction></td><td style="font-weight: bold; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c5" decimals="INF" format="ixt:num-dot-decimal" name="ifrs-full:AdjustedWeightedAverageShares" scale="0" unitRef="shares">65,325,525</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 5.4pt">&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-left: 10pt"><div style="-sec-ix-hidden: hidden-fact-24; -sec-ix-hidden: hidden-fact-23">Basic and diluted loss per share $</div></td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">(<ix:nonFraction contextRef="c0" decimals="2" format="ixt:num-dot-decimal" name="ifrs-full:BasicEarningsLossPerShare" scale="0" sign="-" unitRef="usdPershares">0.16</ix:nonFraction></td><td style="font-weight: bold; text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c5" decimals="2" format="ixt:num-dot-decimal" name="ifrs-full:BasicEarningsLossPerShare" scale="0" sign="-" unitRef="usdPershares">0.13</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  </table><div>



</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif"><b>The
accompanying notes are an integral part of these consolidated financial statements.&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><!-- Field: Page; Sequence: 4; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="border-top: Black 1.5pt solid; width: 100%; padding-top: 2pt; padding-bottom: 2pt; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif"><b>enCore Energy Corp.</b></span></td></tr>
  <tr style="vertical-align: top">
    <td style="border-bottom: Black 1.5pt solid; padding-top: 2pt; padding-bottom: 2pt; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif"><b>Consolidated
    Statements of Cash Flows</b></span></td></tr>
  <tr style="vertical-align: top">
    <td style="border-bottom: Black 1.5pt solid; padding-top: 2pt; padding-bottom: 2pt; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif"><b>For the years ended December 31, 2022 and December 31, 2021</b></span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td>&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center"></td><td style="font-weight: bold">&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">December&#160;31,</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td>&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">December&#160;31,</td><td style="font-weight: bold">&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">2021</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: center"></td><td>&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">2022</td><td style="font-weight: bold">&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">$</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: center">Note</td><td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; padding-bottom: 1.5pt; text-align: center"><b>$</b></td><td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">(Note 21)</td><td style="padding-bottom: 1.5pt">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left"><b>Operating activities</b></td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 65%; text-align: left; padding-left: 10pt">Net loss for the year</td><td style="width: 1%">&#160;</td>
    <td style="width: 9%; text-align: center">&#160;</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">(<ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:ProfitLoss" scale="0" sign="-" unitRef="usd">16,515,389</ix:nonFraction></td><td style="width: 1%; text-align: left">)</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">(<ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:ProfitLoss" scale="0" sign="-" unitRef="usd">8,563,473</ix:nonFraction></td><td style="width: 1%; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 5.4pt">&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 10pt">Items not affecting cash:</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: 9pt; padding-left: 10pt">Accretion</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="cve:Accretion" scale="0" unitRef="usd">445,190</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="cve:Accretion" scale="0" unitRef="usd">408,181</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; text-indent: 9pt; padding-left: 10pt">Amortization and depreciation</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:AdjustmentsForDepreciationAndAmortisationExpense" scale="0" unitRef="usd">380,338</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:AdjustmentsForDepreciationAndAmortisationExpense" scale="0" unitRef="usd">298,666</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; text-indent: 9pt; padding-left: 10pt">Impairment charges</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:AdjustmentsForImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLoss" scale="0" unitRef="usd">78,456</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; text-indent: 9pt; padding-left: 10pt">Foreign exchange loss</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:AdjustmentsForUnrealisedForeignExchangeLossesGains" scale="0" unitRef="usd">20,904</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:AdjustmentsForUnrealisedForeignExchangeLossesGains" scale="0" unitRef="usd">36,530</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; text-indent: 9pt; padding-left: 10pt">Stock option expense</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:AdjustmentsForSharebasedPayments" scale="0" unitRef="usd">5,744,656</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:AdjustmentsForSharebasedPayments" scale="0" unitRef="usd">1,425,645</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; text-indent: 9pt; padding-left: 10pt">Interest income</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:AdjustmentsForInterestIncome" scale="0" unitRef="usd">406,132</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:AdjustmentsForInterestIncome" scale="0" unitRef="usd">20,987</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; text-indent: 9pt; padding-left: 10pt">Loss on write-off of sales tax recoverable</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:AdjustmentsForDeferredTaxExpense" scale="0" unitRef="usd">91,289</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; text-indent: 9pt; padding-left: 10pt">(Gain) loss on divestment of mineral properties</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:AdjustmentsForGainLossOnDisposalsPropertyPlantAndEquipment" scale="0" unitRef="usd">29,148</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:AdjustmentsForGainLossOnDisposalsPropertyPlantAndEquipment" scale="0" sign="-" unitRef="usd">89,914</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; text-indent: 9pt; padding-left: 10pt">(Gain) loss on divestment of subsidiary</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="cve:GainOnDisposalOfSubsidiary" scale="0" unitRef="usd">1,594,901</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; text-indent: 9pt; padding-left: 10pt">Loss (gain) on change in asset retirement obligation estimate</td><td>&#160;</td>
    <td style="text-align: center">12</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:AdjustmentsForIncreaseDecreaseInEmployeeBenefitLiabilities" scale="0" unitRef="usd">157,226</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:AdjustmentsForIncreaseDecreaseInEmployeeBenefitLiabilities" scale="0" sign="-" unitRef="usd">1,719,943</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; text-indent: 9pt; padding-left: 10pt">Unrealized gain on uranium investment</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="cve:UnrealizedGainOnUraniumInvestment" scale="0" unitRef="usd">1,554,000</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; text-indent: 9pt; padding-left: 10pt">Gain on sale of uranium investment</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="cve:GainOnSaleOfUraniumInvestment" scale="0" unitRef="usd">35,000</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="cve:GainOnSaleOfUraniumInvestment" scale="0" unitRef="usd">524,075</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; text-indent: 9pt; padding-left: 10pt">Unrealized gain on marketable securities</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:AdjustmentsForFairValueGainsLosses" scale="0" sign="-" unitRef="usd">1,057,405</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; text-indent: 9pt; padding-left: 10pt">Loss on investment in associate</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:AdjustmentsForUndistributedProfitsOfAssociates" scale="0" sign="-" unitRef="usd">586,900</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:AdjustmentsForUndistributedProfitsOfAssociates" scale="0" sign="-" unitRef="usd">355,735</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 5.4pt">&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 10pt">&#160;&#160;&#160;&#160;Changes in non-cash working capital items:</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; text-indent: 9pt; padding-left: 10pt">Receivables and prepaid expenses</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:AdjustmentsForDecreaseIncreaseInOtherOperatingReceivables" scale="0" sign="-" unitRef="usd">715,928</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:AdjustmentsForDecreaseIncreaseInOtherOperatingReceivables" scale="0" sign="-" unitRef="usd">203,160</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 10pt">&#160;&#160;&#160;Deposit - uranium investment</td><td>&#160;</td>
    <td style="text-align: center">5</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:AdjustmentsForIncreaseDecreaseInDepositsFromCustomers" scale="0" sign="-" unitRef="usd">3,000,000</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; text-indent: 9pt; padding-left: 10pt">Restricted cash</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:OtherInflowsOutflowsOfCashClassifiedAsOperatingActivities" scale="0" sign="-" unitRef="usd">50,049,202</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; text-indent: 9pt; padding-left: 10pt">Accounts payable and accrued liabilities</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:AdjustmentsForIncreaseDecreaseInTradeAccountPayable" scale="0" sign="-" unitRef="usd">3,656,511</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:AdjustmentsForIncreaseDecreaseInTradeAccountPayable" scale="0" unitRef="usd">5,921,147</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt; text-indent: 9pt; padding-left: 10pt">Due to related parties</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:CashReceiptsFromRepaymentOfAdvancesAndLoansMadeToRelatedParties" scale="0" unitRef="usd">434,902</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:CashReceiptsFromRepaymentOfAdvancesAndLoansMadeToRelatedParties" scale="0" unitRef="usd">4,562</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1.5pt; padding-left: 5.4pt">&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">(<ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:CashFlowsFromUsedInOperatingActivities" scale="0" sign="-" unitRef="usd">69,198,211</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">)</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:CashFlowsFromUsedInOperatingActivities" scale="0" sign="-" unitRef="usd">3,966,802</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 5.4pt">&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-left: 5.4pt">Investing activities</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-left: 10pt">Acquisition of intangible assets</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities" scale="0" unitRef="usd">55,150</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities" scale="0" unitRef="usd">17,241</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 10pt">Acquisition of property, plant, and equipment</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities" scale="0" unitRef="usd">979,501</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities" scale="0" unitRef="usd">300,737</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-left: 10pt">Mineral property expenditures</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:PurchaseOfInvestmentProperty" scale="0" unitRef="usd">9,860,682</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:PurchaseOfInvestmentProperty" scale="0" unitRef="usd">2,357,254</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 10pt">Proceeds from divestment of mineral properties</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:ProceedsFromSalesOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities" scale="0" unitRef="usd">48,480</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:ProceedsFromSalesOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities" scale="0" unitRef="usd">105,600</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-left: 10pt">Cash acquired from Azarga asset acquisition</td><td>&#160;</td>
    <td style="text-align: center">10</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="cve:CashAcquiredFromAzargaAssetAcquisition" scale="0" sign="-" unitRef="usd">1,860,360</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 10pt">Transaction costs on Azarga asset acquisition</td><td>&#160;</td>
    <td style="text-align: center">10</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="cve:TransactionCostsOnAzargaAssetAcquisition" scale="0" sign="-" unitRef="usd">3,252,264</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-left: 10pt">Deferred acquisition costs</td><td>&#160;</td>
    <td style="text-align: center">22(a)</td><td style="text-align: left"></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:CashFlowsUsedInObtainingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities" scale="0" unitRef="usd">6,009,303</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 10pt">Interest income received</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:InterestReceivedClassifiedAsInvestingActivities" scale="0" unitRef="usd">406,132</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:InterestReceivedClassifiedAsInvestingActivities" scale="0" unitRef="usd">20,987</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-left: 10pt">Investment in uranium</td><td>&#160;</td>
    <td style="text-align: center">5</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="cve:PaymentsofInvestmentInUranium" scale="0" unitRef="usd">9,076,000</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 10pt">Proceeds received from sale of uranium investment</td><td>&#160;</td>
    <td style="text-align: center">5</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="cve:ProceedsReceivedFromSaleOfUraniumInvestment" scale="0" unitRef="usd">4,245,000</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="cve:ProceedsReceivedFromSaleOfUraniumInvestment" scale="0" unitRef="usd">6,975,000</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt; padding-left: 10pt">Settlement of asset retirement obligation</td><td>&#160;</td>
    <td style="text-align: center">12</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:GainsLossesOnFinancialAssetsAtFairValueThroughProfitOrLoss" scale="0" unitRef="usd">11,324</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:GainsLossesOnFinancialAssetsAtFairValueThroughProfitOrLoss" scale="0" unitRef="usd">11,189</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1.5pt; padding-left: 5.4pt">&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">(<ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:CashFlowsFromUsedInInvestingActivities" scale="0" sign="-" unitRef="usd">12,216,348</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">)</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:CashFlowsFromUsedInInvestingActivities" scale="0" sign="-" unitRef="usd">6,052,738</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 5.4pt">&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt; padding-left: 5.4pt">Financing activities</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt; text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt; text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-left: 10pt">Private placement proceeds</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="cve:PrivatePlacementProceeds" scale="0" unitRef="usd">23,057,411</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="cve:PrivatePlacementProceeds" scale="0" unitRef="usd">11,966,494</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt">Share issue costs</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:PaymentsForShareIssueCosts" scale="0" unitRef="usd">1,473,875</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:PaymentsForShareIssueCosts" scale="0" unitRef="usd">762,902</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 10pt">Proceeds from exercise of warrants</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:ProceedsFromExerciseOfWarrants" scale="0" unitRef="usd">2,452,227</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:ProceedsFromExerciseOfWarrants" scale="0" unitRef="usd">2,633,029</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 10pt">Proceeds from exercise of stock options</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:ProceedsFromExerciseOfOptions" scale="0" unitRef="usd">1,177,093</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:ProceedsFromExerciseOfOptions" scale="0" unitRef="usd">288,572</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 10pt">Share subscriptions received</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:ProceedsFromIssuingShares" scale="0" unitRef="usd">51,558,624</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 10pt">Deferred financing costs</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:RepaymentsOfBorrowingsClassifiedAsFinancingActivities" scale="0" unitRef="usd">1,717,268</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt; padding-left: 10pt">Lease payments</td><td>&#160;</td>
    <td style="text-align: center">9</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities" scale="0" unitRef="usd">104,815</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities" scale="0" unitRef="usd">37,588</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1.5pt; padding-left: 5.4pt">&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:CashFlowsFromUsedInFinancingActivities" scale="0" unitRef="usd">74,949,397</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:CashFlowsFromUsedInFinancingActivities" scale="0" unitRef="usd">14,087,605</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 5.4pt">&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt; padding-left: 5.4pt">Effect of foreign exchange on cash</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">(<ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:EffectOfExchangeRateChangesOnCashAndCashEquivalents" scale="0" sign="-" unitRef="usd">211,309</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">)</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:EffectOfExchangeRateChangesOnCashAndCashEquivalents" scale="0" sign="-" unitRef="usd">61,831</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font-weight: bold; text-align: left; padding-left: 5.4pt">Change in cash</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">(<ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:CashFlowsFromUsedInOperationsBeforeChangesInWorkingCapital" scale="0" sign="-" unitRef="usd">6,676,471</ix:nonFraction></td><td style="font-weight: bold; text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:CashFlowsFromUsedInOperationsBeforeChangesInWorkingCapital" scale="0" unitRef="usd">4,006,234</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt; padding-left: 5.4pt">Cash, beginning of year</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c3" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:CashAndCashEquivalents" scale="0" unitRef="usd">9,188,483</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c6" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:CashAndCashEquivalents" scale="0" unitRef="usd">5,182,249</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt; padding-left: 5.4pt">Cash, end of year</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><ix:nonFraction contextRef="c2" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:CashAndCashEquivalents" scale="0" unitRef="usd">2,512,012</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c3" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:CashAndCashEquivalents" scale="0" unitRef="usd">9,188,483</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  </table><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Supplemental disclosure with respect to cash flows (Note 19)</p><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif"><b>The
accompanying notes are an integral part of these consolidated financial statements.&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><!-- Field: Page; Sequence: 5; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="border-top: Black 1.5pt solid; width: 100%; padding-top: 2pt; padding-bottom: 2pt; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif"><b>enCore Energy Corp.</b></span></td></tr>
  <tr style="vertical-align: top">
    <td style="border-bottom: Black 1.5pt solid; padding-top: 2pt; padding-bottom: 2pt; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif"><b>Consolidated
    Statements of Changes in Shareholder&#8217;s Equity</b></span></td></tr>
  <tr style="vertical-align: top">
    <td style="border-bottom: Black 1.5pt solid; padding-top: 2pt; padding-bottom: 2pt; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif"><b>For the years ended December 31, 2022 and December 31, 2021</b></span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1.5pt; padding-left: 0.25in; text-indent: -0.125in"><span style="font-size: 9pt">&#160;</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-size: 9pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-size: 9pt">Number
    of shares<br/> #</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-size: 9pt">&#160;</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-size: 9pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-size: 9pt">Share
    capital<br/> $</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-size: 9pt">&#160;</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-size: 9pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-size: 9pt">Share
    subscriptions received<br/> $</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-size: 9pt">&#160;</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-size: 9pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-size: 9pt">Contributed
    surplus<br/> $</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-size: 9pt">&#160;</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-size: 9pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-size: 9pt">Accumulated<br/>
    other comprehensive income (loss)<br/> $</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-size: 9pt">&#160;</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-size: 9pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-size: 9pt">Deficit<br/>
    $</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-size: 9pt">&#160;</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-size: 9pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-size: 9pt">Total
    shareholders&#8217; <br/> equity<br/> $</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-size: 9pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.25in; text-indent: -0.25in; width: 16%"><span style="font-size: 9pt">January 1, 2021</span></td><td style="width: 1%"><span style="font-size: 9pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-size: 9pt"><ix:nonFraction contextRef="c7" decimals="INF" format="ixt:num-dot-decimal" name="ifrs-full:NumberOfSharesOutstanding" scale="0" unitRef="shares">59,453,218</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="width: 1%"><span style="font-size: 9pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-size: 9pt"><ix:nonFraction contextRef="c7" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:Equity" scale="0" unitRef="usd">26,653,141</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="width: 1%"><span style="font-size: 9pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="-sec-ix-hidden: hidden-fact-25; font-size: 9pt">&#160;&#160;&#160;&#160;&#160;-</span></td><td style="width: 1%; text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="width: 1%"><span style="font-size: 9pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-size: 9pt"><ix:nonFraction contextRef="c9" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:Equity" scale="0" unitRef="usd">2,019,445</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="width: 1%"><span style="font-size: 9pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-size: 9pt"><ix:nonFraction contextRef="c10" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:Equity" scale="0" unitRef="usd">7,521,888</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="width: 1%"><span style="font-size: 9pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-size: 9pt">(<ix:nonFraction contextRef="c11" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:Equity" scale="0" sign="-" unitRef="usd">23,788,515</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-size: 9pt">)</span></td><td style="width: 1%"><span style="font-size: 9pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-size: 9pt"><ix:nonFraction contextRef="c6" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:Equity" scale="0" unitRef="usd">12,405,959</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-size: 9pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.25in; text-indent: -0.125in; text-align: left"><span style="font-size: 9pt">Private placements</span></td><td><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 9pt"><ix:nonFraction contextRef="c12" decimals="INF" format="ixt:num-dot-decimal" name="cve:PrivatePlacementinShares" scale="0" unitRef="shares">5,000,000</ix:nonFraction></span></td><td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 9pt"><ix:nonFraction contextRef="c12" decimals="0" format="ixt:num-dot-decimal" name="cve:PrivatePlacement" scale="0" unitRef="usd">11,966,494</ix:nonFraction></span></td><td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-26; font-size: 9pt">-</span></td><td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-27; font-size: 9pt">-</span></td><td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-28; font-size: 9pt">-</span></td><td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-29; font-size: 9pt">-</span></td><td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 9pt"><ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="cve:PrivatePlacement" scale="0" unitRef="usd">11,966,494</ix:nonFraction></span></td><td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.25in; text-indent: -0.125in"><span style="font-size: 9pt">Share issuance costs</span></td><td><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 9pt">-</span></td><td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 9pt">(<ix:nonFraction contextRef="c12" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:ShareIssueRelatedCost" scale="0" unitRef="usd">1,191,042</ix:nonFraction></span></td><td style="text-align: left"><span style="font-size: 9pt">)</span></td><td><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-30; font-size: 9pt">-</span></td><td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 9pt"><ix:nonFraction contextRef="c14" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:ShareIssueRelatedCost" scale="0" sign="-" unitRef="usd">428,140</ix:nonFraction></span></td><td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-31; font-size: 9pt">-</span></td><td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-32; font-size: 9pt">-</span></td><td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 9pt">(<ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:ShareIssueRelatedCost" scale="0" unitRef="usd">762,902</ix:nonFraction></span></td><td style="text-align: left"><span style="font-size: 9pt">)</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.25in; text-indent: -0.125in"><span style="font-size: 9pt">Shares issued for exercise of warrants</span></td><td><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 9pt"><ix:nonFraction contextRef="c12" decimals="INF" format="ixt:num-dot-decimal" name="cve:SharesIssuedForExerciseOfWarrantsShares" scale="0" unitRef="shares">2,052,843</ix:nonFraction></span></td><td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 9pt"><ix:nonFraction contextRef="c12" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:IncreaseDecreaseThroughExerciseOfWarrantsEquity" scale="0" unitRef="usd">2,799,780</ix:nonFraction></span></td><td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-33; font-size: 9pt">-</span></td><td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 9pt">(<ix:nonFraction contextRef="c14" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:IncreaseDecreaseThroughExerciseOfWarrantsEquity" scale="0" sign="-" unitRef="usd">166,751</ix:nonFraction></span></td><td style="text-align: left"><span style="font-size: 9pt">)</span></td><td><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-34; font-size: 9pt">-</span></td><td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-35; font-size: 9pt">-</span></td><td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 9pt"><ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:IncreaseDecreaseThroughExerciseOfWarrantsEquity" scale="0" unitRef="usd">2,633,029</ix:nonFraction></span></td><td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.25in; text-indent: -0.125in"><span style="font-size: 9pt">Shares issued for exercise of stock options</span></td><td><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 9pt"><ix:nonFraction contextRef="c12" decimals="INF" format="ixt:num-dot-decimal" name="cve:SharesIssuedForExerciseOfStockOptionsShares" scale="0" unitRef="shares">590,000</ix:nonFraction></span></td><td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 9pt"><ix:nonFraction contextRef="c12" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:IncreaseDecreaseThroughExerciseOfOptions" scale="0" unitRef="usd">557,611</ix:nonFraction></span></td><td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-36; font-size: 9pt">-</span></td><td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 9pt">(<ix:nonFraction contextRef="c14" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:IncreaseDecreaseThroughExerciseOfOptions" scale="0" sign="-" unitRef="usd">269,039</ix:nonFraction></span></td><td style="text-align: left"><span style="font-size: 9pt">)</span></td><td><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-37; font-size: 9pt">-</span></td><td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-38; font-size: 9pt">-</span></td><td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 9pt"><ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:IncreaseDecreaseThroughExerciseOfOptions" scale="0" unitRef="usd">288,572</ix:nonFraction></span></td><td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.25in; text-indent: -0.125in; text-align: left"><span style="font-size: 9pt">Stock option expense</span></td><td><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 9pt">-</span></td><td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-39; font-size: 9pt">-</span></td><td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-40; font-size: 9pt">-</span></td><td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 9pt"><ix:nonFraction contextRef="c14" decimals="0" format="ixt:num-dot-decimal" name="cve:StockOptionExpense" scale="0" unitRef="usd">1,425,645</ix:nonFraction></span></td><td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-41; font-size: 9pt">-</span></td><td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-42; font-size: 9pt">-</span></td><td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 9pt"><ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="cve:StockOptionExpense" scale="0" unitRef="usd">1,425,645</ix:nonFraction></span></td><td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.25in; text-indent: -0.125in; text-align: left"><span style="font-size: 9pt">Shares issued for Azarga asset
    acquisition (Note 10)</span></td><td><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 9pt"><ix:nonFraction contextRef="c12" decimals="INF" format="ixt:num-dot-decimal" name="cve:SharesIssuedForAzargaAssetAcquisitionNote10Shares" scale="0" unitRef="shares">31,806,617</ix:nonFraction></span></td><td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 9pt"><ix:nonFraction contextRef="c12" decimals="0" format="ixt:num-dot-decimal" name="cve:SharesIssuedForAzargaAssetAcquisition" scale="0" unitRef="usd">121,796,381</ix:nonFraction></span></td><td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-43; font-size: 9pt">-</span></td><td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-44; font-size: 9pt">-</span></td><td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-45; font-size: 9pt">-</span></td><td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-46; font-size: 9pt">-</span></td><td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 9pt"><ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="cve:SharesIssuedForAzargaAssetAcquisition" scale="0" unitRef="usd">121,796,381</ix:nonFraction></span></td><td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.25in; text-indent: -0.125in; text-align: left"><span style="font-size: 9pt">Replacement options for Azarga
    asset acquisition (Note 10)</span></td><td><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 9pt">-</span></td><td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-47; font-size: 9pt">-</span></td><td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-48; font-size: 9pt">-</span></td><td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 9pt"><ix:nonFraction contextRef="c14" decimals="0" format="ixt:num-dot-decimal" name="cve:ReplacementOptionsForAzargaAssetAcquisition" scale="0" unitRef="usd">5,496,037</ix:nonFraction></span></td><td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-49; font-size: 9pt">-</span></td><td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-50; font-size: 9pt">-</span></td><td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 9pt"><ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="cve:ReplacementOptionsForAzargaAssetAcquisition" scale="0" unitRef="usd">5,496,037</ix:nonFraction></span></td><td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.25in; text-indent: -0.125in; text-align: left"><span style="font-size: 9pt">Replacement warrants for Azarga
    asset acquisition (Note 10)</span></td><td><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 9pt">-</span></td><td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-51; font-size: 9pt">-</span></td><td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-52; font-size: 9pt">-</span></td><td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 9pt"><ix:nonFraction contextRef="c14" decimals="0" format="ixt:num-dot-decimal" name="cve:ReplacementWarrantsForAzargaAssetAcquisition" scale="0" unitRef="usd">3,259,306</ix:nonFraction></span></td><td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-53; font-size: 9pt">-</span></td><td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-54; font-size: 9pt">-</span></td><td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 9pt"><ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="cve:ReplacementWarrantsForAzargaAssetAcquisition" scale="0" unitRef="usd">3,259,306</ix:nonFraction></span></td><td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.25in; text-indent: -0.125in; text-align: left"><span style="font-size: 9pt">Adjustment to investment in
    associate</span></td><td><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 9pt">-</span></td><td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-55; font-size: 9pt">-</span></td><td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-56; font-size: 9pt">-</span></td><td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 9pt"><ix:nonFraction contextRef="c14" decimals="0" format="ixt:num-dot-decimal" name="cve:AdjustmentToInvestmentInAssociate" scale="0" unitRef="usd">469,320</ix:nonFraction></span></td><td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-57; font-size: 9pt">-</span></td><td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-58; font-size: 9pt">-</span></td><td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 9pt"><ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="cve:AdjustmentToInvestmentInAssociate" scale="0" unitRef="usd">469,320</ix:nonFraction></span></td><td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.25in; text-indent: -0.125in; text-align: left"><span style="font-size: 9pt">Cumulative translation adjustment</span></td><td><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 9pt">-</span></td><td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-59; font-size: 9pt">-</span></td><td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-60; font-size: 9pt">-</span></td><td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-61; font-size: 9pt">-</span></td><td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 9pt">(<ix:nonFraction contextRef="c15" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:GainsLossesOnExchangeDifferencesOnTranslationNetOfTax" scale="0" sign="-" unitRef="usd">1,325,855</ix:nonFraction></span></td><td style="text-align: left"><span style="font-size: 9pt">)</span></td><td><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-62; font-size: 9pt">-</span></td><td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 9pt">(<ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:GainsLossesOnExchangeDifferencesOnTranslationNetOfTax" scale="0" sign="-" unitRef="usd">1,325,855</ix:nonFraction></span></td><td style="text-align: left"><span style="font-size: 9pt">)</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.25in; text-indent: -0.125in; text-align: left; padding-bottom: 1.5pt"><span style="font-size: 9pt">Loss
    for the year</span></td><td><span style="font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-size: 9pt">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-size: 9pt">&#160;</span></td><td><span style="font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-63; font-size: 9pt">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-size: 9pt">&#160;</span></td><td><span style="font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-64; font-size: 9pt">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-size: 9pt">&#160;</span></td><td><span style="font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-65; font-size: 9pt">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-size: 9pt">&#160;</span></td><td><span style="font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-66; font-size: 9pt">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-size: 9pt">&#160;</span></td><td><span style="font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-size: 9pt">(<ix:nonFraction contextRef="c16" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:ProfitLoss" scale="0" sign="-" unitRef="usd">8,563,473</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-size: 9pt">)</span></td><td><span style="font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-size: 9pt">(<ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:ProfitLoss" scale="0" sign="-" unitRef="usd">8,563,473</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-size: 9pt">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.25in; text-indent: -0.25in; padding-bottom: 1.5pt"><span style="font-size: 9pt">December 31, 2021</span></td><td><span style="font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-size: 9pt"><ix:nonFraction contextRef="c17" decimals="INF" format="ixt:num-dot-decimal" name="ifrs-full:NumberOfSharesOutstanding" scale="0" unitRef="shares">98,902,678</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-size: 9pt">&#160;</span></td><td><span style="font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-size: 9pt"><ix:nonFraction contextRef="c17" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:Equity" scale="0" unitRef="usd">162,582,365</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-size: 9pt">&#160;</span></td><td><span style="font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-67; font-size: 9pt">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-size: 9pt">&#160;</span></td><td><span style="font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-size: 9pt"><ix:nonFraction contextRef="c19" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:Equity" scale="0" unitRef="usd">12,662,103</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-size: 9pt">&#160;</span></td><td><span style="font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-size: 9pt"><ix:nonFraction contextRef="c20" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:Equity" scale="0" unitRef="usd">6,196,033</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-size: 9pt">&#160;</span></td><td><span style="font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-size: 9pt">(<ix:nonFraction contextRef="c21" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:Equity" scale="0" sign="-" unitRef="usd">32,351,988</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-size: 9pt">)</span></td><td><span style="font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-size: 9pt"><ix:nonFraction contextRef="c3" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:Equity" scale="0" unitRef="usd">149,088,513</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-size: 9pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.25in; text-indent: -0.125in"><span style="font-size: 9pt">&#160;</span></td><td><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.25in; text-indent: -0.25in"><span style="font-size: 9pt">January 1, 2022</span></td><td><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 9pt"><ix:nonFraction contextRef="c17" decimals="INF" format="ixt:num-dot-decimal" name="ifrs-full:NumberOfSharesOutstanding" scale="0" unitRef="shares">98,902,678</ix:nonFraction></span></td><td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 9pt"><ix:nonFraction contextRef="c17" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:Equity" scale="0" unitRef="usd">162,582,365</ix:nonFraction></span></td><td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-68; font-size: 9pt">-</span></td><td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 9pt"><ix:nonFraction contextRef="c19" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:Equity" scale="0" unitRef="usd">12,662,103</ix:nonFraction></span></td><td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 9pt"><ix:nonFraction contextRef="c20" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:Equity" scale="0" unitRef="usd">6,196,033</ix:nonFraction></span></td><td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 9pt">(<ix:nonFraction contextRef="c21" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:Equity" scale="0" sign="-" unitRef="usd">32,351,988</ix:nonFraction></span></td><td style="text-align: left"><span style="font-size: 9pt">)</span></td><td><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 9pt"><ix:nonFraction contextRef="c3" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:Equity" scale="0" unitRef="usd">149,088,513</ix:nonFraction></span></td><td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.25in; text-indent: -0.125in; text-align: left"><span style="font-size: 9pt">Private placements</span></td><td><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 9pt"><ix:nonFraction contextRef="c22" decimals="INF" format="ixt:num-dot-decimal" name="cve:PrivatePlacementinShares" scale="0" unitRef="shares">6,535,947</ix:nonFraction></span></td><td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 9pt"><ix:nonFraction contextRef="c22" decimals="0" format="ixt:num-dot-decimal" name="cve:PrivatePlacement" scale="0" unitRef="usd">23,057,411</ix:nonFraction></span></td><td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-69; font-size: 9pt">-</span></td><td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-70; font-size: 9pt">-</span></td><td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-71; font-size: 9pt">-</span></td><td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-72; font-size: 9pt">-</span></td><td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 9pt"><ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="cve:PrivatePlacement" scale="0" unitRef="usd">23,057,411</ix:nonFraction></span></td><td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.25in; text-indent: -0.125in"><span style="font-size: 9pt">Share issuance costs</span></td><td><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 9pt">-</span></td><td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 9pt">(<ix:nonFraction contextRef="c22" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:ShareIssueRelatedCost" scale="0" unitRef="usd">2,146,218</ix:nonFraction></span></td><td style="text-align: left"><span style="font-size: 9pt">)</span></td><td><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-73; font-size: 9pt">-</span></td><td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 9pt"><ix:nonFraction contextRef="c24" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:ShareIssueRelatedCost" scale="0" sign="-" unitRef="usd">672,343</ix:nonFraction></span></td><td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-74; font-size: 9pt">-</span></td><td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-75; font-size: 9pt">-</span></td><td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 9pt">(<ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:ShareIssueRelatedCost" scale="0" unitRef="usd">1,473,875</ix:nonFraction></span></td><td style="text-align: left"><span style="font-size: 9pt">)</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.25in; text-indent: -0.125in"><span style="font-size: 9pt">Shares issued for exercise of warrants</span></td><td><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 9pt"><ix:nonFraction contextRef="c22" decimals="INF" format="ixt:num-dot-decimal" name="cve:SharesIssuedForExerciseOfWarrantsShares" scale="0" unitRef="shares">2,291,642</ix:nonFraction></span></td><td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 9pt"><ix:nonFraction contextRef="c22" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:IncreaseDecreaseThroughExerciseOfWarrantsEquity" scale="0" unitRef="usd">2,599,999</ix:nonFraction></span></td><td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-76; font-size: 9pt">-</span></td><td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 9pt">(<ix:nonFraction contextRef="c24" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:IncreaseDecreaseThroughExerciseOfWarrantsEquity" scale="0" sign="-" unitRef="usd">147,772</ix:nonFraction></span></td><td style="text-align: left"><span style="font-size: 9pt">)</span></td><td><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-77; font-size: 9pt">-</span></td><td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-78; font-size: 9pt">-</span></td><td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 9pt"><ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:IncreaseDecreaseThroughExerciseOfWarrantsEquity" scale="0" unitRef="usd">2,452,227</ix:nonFraction></span></td><td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.25in; text-indent: -0.125in"><span style="font-size: 9pt">Shares issued for exercise of stock
    options</span></td><td><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 9pt"><ix:nonFraction contextRef="c22" decimals="INF" format="ixt:num-dot-decimal" name="cve:SharesIssuedForExerciseOfStockOptionsShares" scale="0" unitRef="shares">1,016,436</ix:nonFraction></span></td><td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 9pt"><ix:nonFraction contextRef="c22" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:IncreaseDecreaseThroughExerciseOfOptions" scale="0" unitRef="usd">3,905,580</ix:nonFraction></span></td><td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-79; font-size: 9pt">-</span></td><td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 9pt">(<ix:nonFraction contextRef="c24" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:IncreaseDecreaseThroughExerciseOfOptions" scale="0" sign="-" unitRef="usd">2,728,487</ix:nonFraction></span></td><td style="text-align: left"><span style="font-size: 9pt">)</span></td><td><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-80; font-size: 9pt">-</span></td><td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-81; font-size: 9pt">-</span></td><td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 9pt"><ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:IncreaseDecreaseThroughExerciseOfOptions" scale="0" unitRef="usd">1,177,093</ix:nonFraction></span></td><td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.25in; text-indent: -0.125in; text-align: left"><span style="font-size: 9pt">Stock option expense</span></td><td><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 9pt">-</span></td><td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-82; font-size: 9pt">-</span></td><td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-83; font-size: 9pt">-</span></td><td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 9pt"><ix:nonFraction contextRef="c24" decimals="0" format="ixt:num-dot-decimal" name="cve:StockOptionExpense" scale="0" unitRef="usd">5,744,656</ix:nonFraction></span></td><td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-84; font-size: 9pt">-</span></td><td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-85; font-size: 9pt">-</span></td><td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 9pt"><ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="cve:StockOptionExpense" scale="0" unitRef="usd">5,744,656</ix:nonFraction></span></td><td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.25in; text-indent: -0.125in; text-align: left"><span style="font-size: 9pt">Shares issued for services</span></td><td><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 9pt"><ix:nonFraction contextRef="c22" decimals="INF" format="ixt:num-dot-decimal" name="cve:SharesIssuedForServicesShares" scale="0" unitRef="shares">193,348</ix:nonFraction></span></td><td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 9pt"><ix:nonFraction contextRef="c22" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:IssueOfEquity" scale="0" unitRef="usd">611,113</ix:nonFraction></span></td><td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-86; font-size: 9pt">-</span></td><td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-87; font-size: 9pt">-</span></td><td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-88; font-size: 9pt">-</span></td><td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-89; font-size: 9pt">-</span></td><td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 9pt"><ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:IssueOfEquity" scale="0" unitRef="usd">611,113</ix:nonFraction></span></td><td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.25in; text-indent: -0.125in"><span style="font-size: 9pt">Share subscriptions received</span></td><td><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 9pt">-</span></td><td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-90; font-size: 9pt">-</span></td><td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 9pt"><ix:nonFraction contextRef="c23" decimals="0" format="ixt:num-dot-decimal" name="cve:ShareSubscriptionsReceived" scale="0" unitRef="usd">51,558,624</ix:nonFraction></span></td><td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-91; font-size: 9pt">-</span></td><td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-92; font-size: 9pt">-</span></td><td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-93; font-size: 9pt">-</span></td><td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 9pt"><ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="cve:ShareSubscriptionsReceived" scale="0" unitRef="usd">51,558,624</ix:nonFraction></span></td><td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.25in; text-indent: -0.125in; text-align: left"><span style="font-size: 9pt">Adjustment to investment in
    associate</span></td><td><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 9pt">-</span></td><td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-94; font-size: 9pt">-</span></td><td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-95; font-size: 9pt">-</span></td><td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 9pt"><ix:nonFraction contextRef="c24" decimals="0" format="ixt:num-dot-decimal" name="cve:AdjustmentToInvestmentInAssociate" scale="0" unitRef="usd">15,675</ix:nonFraction></span></td><td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-96; font-size: 9pt">-</span></td><td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-97; font-size: 9pt">-</span></td><td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 9pt"><ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="cve:AdjustmentToInvestmentInAssociate" scale="0" unitRef="usd">15,675</ix:nonFraction></span></td><td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.25in; text-indent: -0.125in; text-align: left"><span style="font-size: 9pt">Cumulative translation adjustment</span></td><td><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 9pt">-</span></td><td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-98; font-size: 9pt">-</span></td><td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-99; font-size: 9pt">-</span></td><td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-100; font-size: 9pt">-</span></td><td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 9pt">(<ix:nonFraction contextRef="c25" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:GainsLossesOnExchangeDifferencesOnTranslationNetOfTax" scale="0" sign="-" unitRef="usd">665,809</ix:nonFraction></span></td><td style="text-align: left"><span style="font-size: 9pt">)</span></td><td><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-101; font-size: 9pt">-</span></td><td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 9pt">(<ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:GainsLossesOnExchangeDifferencesOnTranslationNetOfTax" scale="0" sign="-" unitRef="usd">665,809</ix:nonFraction></span></td><td style="text-align: left"><span style="font-size: 9pt">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.25in; text-indent: -0.125in; text-align: left; padding-bottom: 1.5pt"><span style="font-size: 9pt">Loss
    for the year</span></td><td><span style="font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-size: 9pt">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-size: 9pt">&#160;</span></td><td><span style="font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-102; font-size: 9pt">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-size: 9pt">&#160;</span></td><td><span style="font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-103; font-size: 9pt">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-size: 9pt">&#160;</span></td><td><span style="font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-104; font-size: 9pt">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-size: 9pt">&#160;</span></td><td><span style="font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-105; font-size: 9pt">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-size: 9pt">&#160;</span></td><td><span style="font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-size: 9pt">(<ix:nonFraction contextRef="c26" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:ProfitLoss" scale="0" sign="-" unitRef="usd">16,515,389</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-size: 9pt">)</span></td><td><span style="font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-size: 9pt">(<ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:ProfitLoss" scale="0" sign="-" unitRef="usd">16,515,389</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-size: 9pt">)</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.25in; text-indent: -0.25in; font-weight: bold; padding-bottom: 1.5pt"><span style="font-size: 9pt">December
    31, 2022</span></td><td style="font-weight: bold"><span style="font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-size: 9pt"><ix:nonFraction contextRef="c27" decimals="INF" format="ixt:num-dot-decimal" name="ifrs-full:NumberOfSharesOutstanding" scale="0" unitRef="shares">108,940,051</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="font-weight: bold"><span style="font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-size: 9pt"><ix:nonFraction contextRef="c27" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:Equity" scale="0" unitRef="usd">190,610,250</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="font-weight: bold"><span style="font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-size: 9pt"><ix:nonFraction contextRef="c28" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:Equity" scale="0" unitRef="usd">51,558,624</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="font-weight: bold"><span style="font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-size: 9pt"><ix:nonFraction contextRef="c29" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:Equity" scale="0" unitRef="usd">16,218,518</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="font-weight: bold"><span style="font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-size: 9pt"><ix:nonFraction contextRef="c30" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:Equity" scale="0" unitRef="usd">5,530,224</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="font-weight: bold"><span style="font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-size: 9pt">(<ix:nonFraction contextRef="c31" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:Equity" scale="0" sign="-" unitRef="usd">48,867,377</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-size: 9pt">)</span></td><td style="font-weight: bold"><span style="font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-size: 9pt"><ix:nonFraction contextRef="c2" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:Equity" scale="0" unitRef="usd">215,050,239</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-size: 9pt">&#160;</span></td></tr>
  </table><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif"><b>The
accompanying notes are an integral part of these consolidated financial statements.&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><!-- Field: Page; Sequence: 6; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="border-top: Black 1.5pt solid; width: 100%; padding-top: 2pt; padding-bottom: 2pt; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif"><b>enCore Energy Corp.</b></span></td></tr>
  <tr style="vertical-align: top">
    <td style="border-bottom: Black 1.5pt solid; padding-top: 2pt; padding-bottom: 2pt; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif"><b>Notes
    to the Consolidated Financial Statements</b></span></td></tr>
  <tr style="vertical-align: top">
    <td style="border-bottom: Black 1.5pt solid; padding-top: 2pt; padding-bottom: 2pt; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif"><b>For the years ended December 31, 2022 and December 31, 2021</b></span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><ix:nonNumeric contextRef="c0" continuedAt="cve_NatureOfOperationAndGoingConcern-c0_cont_1" escape="true" name="cve:NatureOfOperationAndGoingConcern"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif"><b>1.</b></span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b>Nature
                                            of operations and going concern</b></span></td></tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p></ix:nonNumeric><div>

</div><div>

</div><ix:continuation continuedAt="cve_NatureOfOperationAndGoingConcern-c0_cont_2" id="cve_NatureOfOperationAndGoingConcern-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">enCore
Energy Corp. was incorporated on October 30, 2009 under the Laws of British Columbia, Canada. enCore Energy Corp., together with its
subsidiaries (collectively referred to as the &#8220;Company&#8221; or &#8220;enCore&#8221;), is principally engaged in the acquisition,
exploration, and development of uranium resource properties in the United States. The Company&#8217;s common shares trade on the TSX
Venture Exchange and the NYSE American Market under the symbol &#8220;EU&#8221;. The Company&#8217;s corporate headquarters is located
at 101 N Shoreline, Suite 450, Corpus Christi, TX 78401.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="cve_NatureOfOperationAndGoingConcern-c0_cont_3" id="cve_NatureOfOperationAndGoingConcern-c0_cont_2"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">On
September 14, 2022, the Company consolidated its issued and outstanding shares on a ratio of three old common shares for every one new
post-consolidated common share (the &#8220;Share Consolidation&#8221;). All current and comparative references to the number of common
shares, weighted average number of common shares, loss per share, stock options and warrants have been restated to give effect to this
Share Consolidation.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="cve_NatureOfOperationAndGoingConcern-c0_cont_4" id="cve_NatureOfOperationAndGoingConcern-c0_cont_3"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">These
consolidated financial statements (the &#8220;financial statements&#8221;) have been prepared assuming the Company will continue on a
going-concern basis, which assumes that the Company will be able to continue in operation for the foreseeable future and will be able
to realize its assets and discharge its liabilities and commitments in the normal course of operations. The Company has no source of
operating cash flow and operations to date have been funded primarily from the issue of share capital. For the year ended December 31,
2022, the Company reported a net loss of $<ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:ProfitLoss" scale="0" unitRef="usd">16,515,389</ix:nonFraction> (2021 - $<ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:ProfitLoss" scale="0" unitRef="usd">8,563,475</ix:nonFraction>), had working capital of $<ix:nonFraction contextRef="c2" decimals="0" format="ixt:num-dot-decimal" name="cve:WorkingCapital" scale="0" unitRef="usd">7,017,115</ix:nonFraction> (December 31, 2021 - $<ix:nonFraction contextRef="c3" decimals="0" format="ixt:num-dot-decimal" name="cve:WorkingCapital" scale="0" unitRef="usd">5,632,603</ix:nonFraction>),
and an accumulated deficit of $<ix:nonFraction contextRef="c2" decimals="0" format="ixt:num-dot-decimal" name="cve:AccumulatedDeficit" scale="0" unitRef="usd">48,867,377</ix:nonFraction> (December 31, 2021 - $<ix:nonFraction contextRef="c3" decimals="0" format="ixt:num-dot-decimal" name="cve:AccumulatedDeficit" scale="0" unitRef="usd">32,351,988</ix:nonFraction>). These financial statements do not reflect the adjustments
to the carrying values of assets and liabilities and the reported expenses and statement of financial position classifications that would
be necessary were the going concern assumption not appropriate. Such adjustments could be material.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="cve_NatureOfOperationAndGoingConcern-c0_cont_5" id="cve_NatureOfOperationAndGoingConcern-c0_cont_4"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">In
March 2020, the World Health Organization declared the COVID-19 outbreak a global pandemic and the Company continues to evaluate the
COVID-19 situation and monitor any impacts or any potential impacts to the business. enCore Energy Corp has implemented health and safety
measures in accordance with the health officials and guidance from local government authorities. While the pandemic has had limited impact
on the Company&#8217;s operations to date, future activities could be impacted as a result of the pandemic. As the COVID-19 health crisis
continues, the Company will continue to rely on guidance and recommendations from local health authorities, Health Canada and the Centers
for Disease Control and Prevention to update the Company&#8217;s policies.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="cve_NatureOfOperationAndGoingConcern-c0_cont_6" id="cve_NatureOfOperationAndGoingConcern-c0_cont_5"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Geopolitical
uncertainty driven by the Russian invasion of Ukraine has led many governments and utility providers to re-examine supply chains and
procurement strategies reliant on nuclear fuel supplies coming out of or through Russia. Sanctions, restrictions, and an inability to
obtain insurance on cargo have contributed to transportation and other supply chain disruptions between producers and suppliers. As a
result of this and coupled with multiple years of declining uranium production globally, uranium market fundamentals are shifting from
an inventory driven market to one more driven by production.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p></ix:continuation><div>

</div><div>

</div><ix:continuation id="cve_NatureOfOperationAndGoingConcern-c0_cont_6"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Management
estimates that it has adequate working capital to fund all of its planned activities for the next year. However, the Company&#8217;s
long-term continued operations are dependent on its abilities to monetize assets or raise additional funding from loans or equity financings,
or through other arrangements. There is no assurance that future financing activities will be successful.</span></p></ix:continuation><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"></p><div>

</div><!-- Field: Page; Sequence: 7; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"></p><div>

</div><table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="border-top: Black 1.5pt solid; width: 100%; padding-top: 2pt; padding-bottom: 2pt; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif"><b>enCore Energy Corp.</b></span></td></tr>
  <tr style="vertical-align: top">
    <td style="border-bottom: Black 1.5pt solid; padding-top: 2pt; padding-bottom: 2pt; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif"><b>Notes
    to the Consolidated Financial Statements</b></span></td></tr>
  <tr style="vertical-align: top">
    <td style="border-bottom: Black 1.5pt solid; padding-top: 2pt; padding-bottom: 2pt; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif"><b>For the years ended December 31, 2022 and December 31, 2021</b></span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><ix:nonNumeric contextRef="c0" continuedAt="_DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory-c0_cont_1" escape="true" name="ifrs-full:DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif"><b>2.</b></span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b>Significant
                                            accounting policies</b></span></td></tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif"><b>&#160;</b></span></p></ix:nonNumeric><div>

</div><div>

</div><ix:continuation continuedAt="_DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory-c0_cont_2" id="_DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory-c0_cont_1"><ix:nonNumeric contextRef="c0" continuedAt="cve_DescriptionOfAccountingPolicyForBasisOfPresentationtextBlock-c0_cont_1" escape="true" name="cve:DescriptionOfAccountingPolicyForBasisOfPresentationtextBlock"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif"><b>Basis
of presentation</b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p></ix:nonNumeric></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory-c0_cont_3" id="_DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory-c0_cont_2"><ix:continuation continuedAt="cve_DescriptionOfAccountingPolicyForBasisOfPresentationtextBlock-c0_cont_2" id="cve_DescriptionOfAccountingPolicyForBasisOfPresentationtextBlock-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">These
financial statements, including comparatives, have been prepared using accounting policies consistent with International Financial Reporting
Standards (&#8220;IFRS&#8221;) as issued by the International Accounting Standards Board (&#8220;IASB&#8221;) and interpretations of
the International Financial Reporting Interpretations Committee (&#8220;IFRIC&#8221;).</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p></ix:continuation></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory-c0_cont_4" id="_DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory-c0_cont_3"><ix:continuation continuedAt="cve_DescriptionOfAccountingPolicyForBasisOfPresentationtextBlock-c0_cont_3" id="cve_DescriptionOfAccountingPolicyForBasisOfPresentationtextBlock-c0_cont_2"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">The
policies applied in these financial statements are based on IFRS issued and effective as of December 31, 2022.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p></ix:continuation></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory-c0_cont_5" id="_DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory-c0_cont_4"><ix:continuation continuedAt="cve_DescriptionOfAccountingPolicyForBasisOfPresentationtextBlock-c0_cont_4" id="cve_DescriptionOfAccountingPolicyForBasisOfPresentationtextBlock-c0_cont_3"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">These
financial statements have been prepared on a historical cost basis except for certain financial instruments which are measured at fair
value. All dollar amounts presented are in United States Dollars (&#8220;U.S. Dollars&#8221;) unless otherwise specified. In addition,
these financial statements have been prepared using the accrual basis of accounting, except for cash flow information.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p></ix:continuation></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory-c0_cont_6" id="_DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory-c0_cont_5"><ix:continuation id="cve_DescriptionOfAccountingPolicyForBasisOfPresentationtextBlock-c0_cont_4"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">These
financial statements were approved for issuance by the audit committee of the Board of Directors on April 26, 2023.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p></ix:continuation></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory-c0_cont_7" id="_DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory-c0_cont_6"><ix:nonNumeric contextRef="c0" continuedAt="cve_DescriptionOfAccountingPolicyForChangeInPresentationCurrencytextBlock-c0_cont_1" escape="true" name="cve:DescriptionOfAccountingPolicyForChangeInPresentationCurrencytextBlock"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b>Change
in presentation currency</b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p></ix:nonNumeric></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory-c0_cont_8" id="_DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory-c0_cont_7"><ix:continuation continuedAt="cve_DescriptionOfAccountingPolicyForChangeInPresentationCurrencytextBlock-c0_cont_2" id="cve_DescriptionOfAccountingPolicyForChangeInPresentationCurrencytextBlock-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">These
financial statements are presented in U.S. Dollars, unless otherwise specified. The functional currency of enCore Energy Corp. is the
Canadian Dollar. The functional currency of the Company&#8217;s subsidiaries is the U.S. Dollar. During the year ended December 31, 2022,
the Company changed its presentation currency from Canadian Dollars to U.S. Dollars to better reflect the Company&#8217;s business activities.
Accordingly, these financial statements are presented in U.S. Dollars. The change in presentation currency is to better reflect the Company&#8217;s
business activities and to improve investors&#8217; ability to compare the Company&#8217;s financial results with other publicly traded
businesses in the exploration industry.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p></ix:continuation></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory-c0_cont_9" id="_DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory-c0_cont_8"><ix:continuation continuedAt="cve_DescriptionOfAccountingPolicyForChangeInPresentationCurrencytextBlock-c0_cont_3" id="cve_DescriptionOfAccountingPolicyForChangeInPresentationCurrencytextBlock-c0_cont_2"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">In
making this change to the U.S. Dollar presentation currency, the Company followed the guidance in IAS 21 <i>The Effects of Changes in
Foreign Exchange Rates</i> and has applied the change retrospectively as if the new presentation currency had always been the Company&#8217;s
presentation currency. In accordance with IAS 21, the financial statements for all years presented have been translated to the new U.S.
Dollar presentation currency. For 2021 and 2020 comparative balances, assets and liabilities have been translated into the U.S. Dollar
presentation currency at the rate of exchange prevailing at the reporting date. The consolidated statements of loss and comprehensive
loss were translated at the average exchange rates for the reporting period. Share capital and reserves were translated at the historical
rates prevailing at the dates of the transactions. Exchange differences arising on translation were taken to the foreign currency translation
reserve in shareholders&#8217; equity.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p></ix:continuation></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory-c0_cont_10" id="_DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory-c0_cont_9"><ix:continuation continuedAt="cve_DescriptionOfAccountingPolicyForChangeInPresentationCurrencytextBlock-c0_cont_4" id="cve_DescriptionOfAccountingPolicyForChangeInPresentationCurrencytextBlock-c0_cont_3"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">The
exchange rates used were as follows:</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify">&#160;</p></ix:continuation></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory-c0_cont_11" id="_DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory-c0_cont_10"><ix:nonNumeric contextRef="c0" escape="true" name="ifrs-full:DisclosureOfEffectOfChangesInForeignExchangeRatesExplanatory"><ix:continuation id="cve_DescriptionOfAccountingPolicyForChangeInPresentationCurrencytextBlock-c0_cont_4"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; text-align: left; font-weight: bold">U.S. Dollar/CDN Dollar exchange rate</td><td style="text-align: center; font-weight: bold">&#160;</td>
    <td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid; font-weight: bold">December 31, 2022</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="text-align: center; border-bottom: Black 1.5pt solid; font-weight: bold">&#160;</td>
    <td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid; font-weight: bold">December 31, 2021</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%; text-align: left">Closing rate at the reporting date</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c2" decimals="3" format="ixt:num-dot-decimal" name="ifrs-full:ClosingForeignExchangeRate" scale="0" unitRef="pure">0.738</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c3" decimals="3" format="ixt:num-dot-decimal" name="ifrs-full:ClosingForeignExchangeRate" scale="0" unitRef="pure">0.789</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Average rate for the year</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c0" decimals="3" format="ixt:num-dot-decimal" name="ifrs-full:AverageForeignExchangeRate" scale="0" unitRef="pure">0.769</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c5" decimals="3" format="ixt:num-dot-decimal" name="ifrs-full:AverageForeignExchangeRate" scale="0" unitRef="pure">0.798</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p></ix:continuation></ix:nonNumeric></ix:continuation><div>


</div><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify"></p><div>

</div><!-- Field: Page; Sequence: 8; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify"></p><div>

</div><table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="border-top: Black 1.5pt solid; width: 100%; padding-top: 2pt; padding-bottom: 2pt; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif"><b>enCore Energy Corp.</b></span></td></tr>
  <tr style="vertical-align: top">
    <td style="border-bottom: Black 1.5pt solid; padding-top: 2pt; padding-bottom: 2pt; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif"><b>Notes
    to the Consolidated Financial Statements</b></span></td></tr>
  <tr style="vertical-align: top">
    <td style="border-bottom: Black 1.5pt solid; padding-top: 2pt; padding-bottom: 2pt; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif"><b>For the years ended December 31, 2022 and December 31, 2021</b></span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif"><b>2.</b></span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b>Significant
                                            accounting policies </b>(continued)</span></td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify">&#160;</p><div>

</div><ix:continuation continuedAt="_DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory-c0_cont_12" id="_DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory-c0_cont_11"><ix:nonNumeric contextRef="c0" continuedAt="cve_DescriptionOfAccountingPolicyForBasisOfConsolidationtextBlock-c0_cont_1" escape="true" name="cve:DescriptionOfAccountingPolicyForBasisOfConsolidationtextBlock"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b>Basis
of consolidation</b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p></ix:nonNumeric></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory-c0_cont_13" id="_DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory-c0_cont_12"><ix:continuation continuedAt="cve_DescriptionOfAccountingPolicyForBasisOfConsolidationtextBlock-c0_cont_2" id="cve_DescriptionOfAccountingPolicyForBasisOfConsolidationtextBlock-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">These
financial statements incorporate the financial statements of the Company and its controlled subsidiaries. Control is defined as the exposure,
or rights, to variable returns from involvement with an investee and the ability to affect those returns through power over the investee.
Power over an investee exists when an investor has existing rights that give it the ability to direct the activities that significantly
affect the investee&#8217;s returns. This control is generally evidenced through owning more than <ix:nonFraction contextRef="c2" decimals="2" format="ixt:num-dot-decimal" name="ifrs-full:PercentageOfVotingEquityInterestsAcquired" scale="-2" unitRef="pure">50</ix:nonFraction>% of the voting rights or currently
exercisable potential voting rights of a Company&#8217;s share capital. All significant intercompany transactions and balances have been
eliminated.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p></ix:continuation></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory-c0_cont_14" id="_DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory-c0_cont_13"><ix:continuation continuedAt="cve_DescriptionOfAccountingPolicyForBasisOfConsolidationtextBlock-c0_cont_3" id="cve_DescriptionOfAccountingPolicyForBasisOfConsolidationtextBlock-c0_cont_2"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">These
consolidated financial statements include the financial statements of the Company and its significant subsidiaries listed in the following
table:</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify">&#160;</p></ix:continuation></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory-c0_cont_15" id="_DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory-c0_cont_14"><ix:nonNumeric contextRef="c0" continuedAt="_DisclosureOfSignificantInvestmentsInSubsidiariesExplanatory-c0_cont_1" escape="true" name="ifrs-full:DisclosureOfSignificantInvestmentsInSubsidiariesExplanatory"><ix:continuation continuedAt="cve_DescriptionOfAccountingPolicyForBasisOfConsolidationtextBlock-c0_cont_4" id="cve_DescriptionOfAccountingPolicyForBasisOfConsolidationtextBlock-c0_cont_3"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Name of <br/> Subsidiary</td><td style="font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Place of <br/> Incorporation</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Ownership<br/> Interest</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Principal<br/> Activity</td><td style="font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Functional<br/> Currency</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 30%; text-align: center">Tigris Uranium US Corp.</td><td style="width: 1%">&#160;</td>
    <td style="width: 25%; text-align: center"><ix:nonNumeric contextRef="c32" name="cve:NameofSubsidaryPlaceOfIncorporation">Nevada, USA</ix:nonNumeric></td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c32" decimals="2" format="ixt:num-dot-decimal" name="ifrs-full:ProportionOfOwnershipInterestInSubsidiary" scale="-2" unitRef="pure">100</ix:nonFraction></td><td style="width: 1%; text-align: left">%</td><td style="width: 1%">&#160;</td>
    <td style="width: 19%; text-align: center"><ix:nonNumeric contextRef="c32" name="cve:NameofSubsidaryPrincipalActivity">Mineral Exploration</ix:nonNumeric></td><td style="width: 1%">&#160;</td>
    <td style="width: 11%; text-align: center"><ix:nonNumeric contextRef="c32" name="cve:NameofSubsidaryFunctionalCurrency">USD</ix:nonNumeric></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: center">Metamin Enterprises US Inc.</td><td>&#160;</td>
    <td style="text-align: center"><ix:nonNumeric contextRef="c33" name="cve:NameofSubsidaryPlaceOfIncorporation">Nevada, USA</ix:nonNumeric></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c33" decimals="2" format="ixt:num-dot-decimal" name="ifrs-full:ProportionOfOwnershipInterestInSubsidiary" scale="-2" unitRef="pure">100</ix:nonFraction></td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: center"><ix:nonNumeric contextRef="c33" name="cve:NameofSubsidaryPrincipalActivity">Mineral Exploration</ix:nonNumeric></td><td>&#160;</td>
    <td style="text-align: center"><ix:nonNumeric contextRef="c33" name="cve:NameofSubsidaryFunctionalCurrency">USD</ix:nonNumeric></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: center">URI, Inc.</td><td>&#160;</td>
    <td style="text-align: center"><ix:nonNumeric contextRef="c34" name="cve:NameofSubsidaryPlaceOfIncorporation">Delaware, USA</ix:nonNumeric></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c34" decimals="2" format="ixt:num-dot-decimal" name="ifrs-full:ProportionOfOwnershipInterestInSubsidiary" scale="-2" unitRef="pure">100</ix:nonFraction></td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: center"><ix:nonNumeric contextRef="c34" name="cve:NameofSubsidaryPrincipalActivity">Mineral Exploration</ix:nonNumeric></td><td>&#160;</td>
    <td style="text-align: center"><ix:nonNumeric contextRef="c34" name="cve:NameofSubsidaryFunctionalCurrency">USD</ix:nonNumeric></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: center">Neutron Energy, Inc.</td><td>&#160;</td>
    <td style="text-align: center"><ix:nonNumeric contextRef="c35" name="cve:NameofSubsidaryPlaceOfIncorporation">Nevada, USA</ix:nonNumeric></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c35" decimals="2" format="ixt:num-dot-decimal" name="ifrs-full:ProportionOfOwnershipInterestInSubsidiary" scale="-2" unitRef="pure">100</ix:nonFraction></td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: center"><ix:nonNumeric contextRef="c35" name="cve:NameofSubsidaryPrincipalActivity">Mineral Exploration</ix:nonNumeric></td><td>&#160;</td>
    <td style="text-align: center"><ix:nonNumeric contextRef="c35" name="cve:NameofSubsidaryFunctionalCurrency">USD</ix:nonNumeric></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: center">Uranco, Inc.</td><td>&#160;</td>
    <td style="text-align: center"><ix:nonNumeric contextRef="c36" name="cve:NameofSubsidaryPlaceOfIncorporation">Delaware, USA</ix:nonNumeric></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c36" decimals="2" format="ixt:num-dot-decimal" name="ifrs-full:ProportionOfOwnershipInterestInSubsidiary" scale="-2" unitRef="pure">100</ix:nonFraction></td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: center"><ix:nonNumeric contextRef="c36" name="cve:NameofSubsidaryPrincipalActivity">Mineral Exploration</ix:nonNumeric></td><td>&#160;</td>
    <td style="text-align: center"><ix:nonNumeric contextRef="c36" name="cve:NameofSubsidaryFunctionalCurrency">USD</ix:nonNumeric></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: center">Uranium Resources, Inc.</td><td>&#160;</td>
    <td style="text-align: center"><ix:nonNumeric contextRef="c37" name="cve:NameofSubsidaryPlaceOfIncorporation">Delaware, USA</ix:nonNumeric></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c37" decimals="2" format="ixt:num-dot-decimal" name="ifrs-full:ProportionOfOwnershipInterestInSubsidiary" scale="-2" unitRef="pure">100</ix:nonFraction></td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: center"><ix:nonNumeric contextRef="c37" name="cve:NameofSubsidaryPrincipalActivity">Mineral Exploration</ix:nonNumeric></td><td>&#160;</td>
    <td style="text-align: center"><ix:nonNumeric contextRef="c37" name="cve:NameofSubsidaryFunctionalCurrency">USD</ix:nonNumeric></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: center">HRI-Churchrock, Inc.</td><td>&#160;</td>
    <td style="text-align: center"><ix:nonNumeric contextRef="c38" name="cve:NameofSubsidaryPlaceOfIncorporation">Delaware, USA</ix:nonNumeric></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c38" decimals="2" format="ixt:num-dot-decimal" name="ifrs-full:ProportionOfOwnershipInterestInSubsidiary" scale="-2" unitRef="pure">100</ix:nonFraction></td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: center"><ix:nonNumeric contextRef="c38" name="cve:NameofSubsidaryPrincipalActivity">Mineral Exploration</ix:nonNumeric></td><td>&#160;</td>
    <td style="text-align: center"><ix:nonNumeric contextRef="c38" name="cve:NameofSubsidaryFunctionalCurrency">USD</ix:nonNumeric></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: center">Hydro Restoration Corp.</td><td>&#160;</td>
    <td style="text-align: center"><ix:nonNumeric contextRef="c39" name="cve:NameofSubsidaryPlaceOfIncorporation">Delaware, USA</ix:nonNumeric></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c39" decimals="2" format="ixt:num-dot-decimal" name="ifrs-full:ProportionOfOwnershipInterestInSubsidiary" scale="-2" unitRef="pure">100</ix:nonFraction></td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: center"><ix:nonNumeric contextRef="c39" name="cve:NameofSubsidaryPrincipalActivity">Mineral Exploration</ix:nonNumeric></td><td>&#160;</td>
    <td style="text-align: center"><ix:nonNumeric contextRef="c39" name="cve:NameofSubsidaryFunctionalCurrency">USD</ix:nonNumeric></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: center">Belt Line Resources, Inc.</td><td>&#160;</td>
    <td style="text-align: center"><ix:nonNumeric contextRef="c40" name="cve:NameofSubsidaryPlaceOfIncorporation">Texas, USA</ix:nonNumeric></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c40" decimals="2" format="ixt:num-dot-decimal" name="ifrs-full:ProportionOfOwnershipInterestInSubsidiary" scale="-2" unitRef="pure">100</ix:nonFraction></td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: center"><ix:nonNumeric contextRef="c40" name="cve:NameofSubsidaryPrincipalActivity">Mineral Exploration</ix:nonNumeric></td><td>&#160;</td>
    <td style="text-align: center"><ix:nonNumeric contextRef="c40" name="cve:NameofSubsidaryFunctionalCurrency">USD</ix:nonNumeric></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: center">Cibola Resources, LLC (*)</td><td>&#160;</td>
    <td style="text-align: center"><ix:nonNumeric contextRef="c41" id="ix_0_fact" name="cve:NameofSubsidaryPlaceOfIncorporation">Delaware, USA</ix:nonNumeric></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c41" decimals="2" format="ixt:num-dot-decimal" id="ix_1_fact" name="ifrs-full:ProportionOfOwnershipInterestInSubsidiary" scale="-2" unitRef="pure">100</ix:nonFraction></td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: center"><ix:nonNumeric contextRef="c41" id="ix_2_fact" name="cve:NameofSubsidaryPrincipalActivity">Mineral Exploration</ix:nonNumeric></td><td>&#160;</td>
    <td style="text-align: center"><ix:nonNumeric contextRef="c41" id="ix_3_fact" name="cve:NameofSubsidaryFunctionalCurrency">USD</ix:nonNumeric></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: center">enCore Energy US Corp.</td><td>&#160;</td>
    <td style="text-align: center"><ix:nonNumeric contextRef="c42" name="cve:NameofSubsidaryPlaceOfIncorporation">Nevada, USA</ix:nonNumeric></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c42" decimals="2" format="ixt:num-dot-decimal" name="ifrs-full:ProportionOfOwnershipInterestInSubsidiary" scale="-2" unitRef="pure">100</ix:nonFraction></td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: center"><ix:nonNumeric contextRef="c42" name="cve:NameofSubsidaryPrincipalActivity">Holding Company</ix:nonNumeric></td><td>&#160;</td>
    <td style="text-align: center"><ix:nonNumeric contextRef="c42" name="cve:NameofSubsidaryFunctionalCurrency">USD</ix:nonNumeric></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: center">Azarga Uranium Corp.</td><td>&#160;</td>
    <td style="text-align: center"><ix:nonNumeric contextRef="c43" name="cve:NameofSubsidaryPlaceOfIncorporation">British Columbia, CA</ix:nonNumeric></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c43" decimals="2" format="ixt:num-dot-decimal" name="ifrs-full:ProportionOfOwnershipInterestInSubsidiary" scale="-2" unitRef="pure">100</ix:nonFraction></td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: center"><ix:nonNumeric contextRef="c43" name="cve:NameofSubsidaryPrincipalActivity">Mineral Exploration</ix:nonNumeric></td><td>&#160;</td>
    <td style="text-align: center"><ix:nonNumeric contextRef="c43" name="cve:NameofSubsidaryFunctionalCurrency">USD</ix:nonNumeric></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: center">Powertech (USA) Inc.</td><td>&#160;</td>
    <td style="text-align: center"><ix:nonNumeric contextRef="c44" name="cve:NameofSubsidaryPlaceOfIncorporation">South Dakota, USA</ix:nonNumeric></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c44" decimals="2" format="ixt:num-dot-decimal" name="ifrs-full:ProportionOfOwnershipInterestInSubsidiary" scale="-2" unitRef="pure">100</ix:nonFraction></td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: center"><ix:nonNumeric contextRef="c44" name="cve:NameofSubsidaryPrincipalActivity">Mineral Exploration</ix:nonNumeric></td><td>&#160;</td>
    <td style="text-align: center"><ix:nonNumeric contextRef="c44" name="cve:NameofSubsidaryFunctionalCurrency">USD</ix:nonNumeric></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: center">URZ Energy Corp.</td><td>&#160;</td>
    <td style="text-align: center"><ix:nonNumeric contextRef="c45" name="cve:NameofSubsidaryPlaceOfIncorporation">British Columbia, CA</ix:nonNumeric></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c45" decimals="2" format="ixt:num-dot-decimal" name="ifrs-full:ProportionOfOwnershipInterestInSubsidiary" scale="-2" unitRef="pure">100</ix:nonFraction></td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: center"><ix:nonNumeric contextRef="c45" name="cve:NameofSubsidaryPrincipalActivity">Mineral Exploration</ix:nonNumeric></td><td>&#160;</td>
    <td style="text-align: center"><ix:nonNumeric contextRef="c45" name="cve:NameofSubsidaryFunctionalCurrency">USD</ix:nonNumeric></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: center">Ucolo Exploration Corp.</td><td>&#160;</td>
    <td style="text-align: center"><ix:nonNumeric contextRef="c46" name="cve:NameofSubsidaryPlaceOfIncorporation">Utah, USA</ix:nonNumeric></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c46" decimals="2" format="ixt:num-dot-decimal" name="ifrs-full:ProportionOfOwnershipInterestInSubsidiary" scale="-2" unitRef="pure">100</ix:nonFraction></td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: center"><ix:nonNumeric contextRef="c46" name="cve:NameofSubsidaryPrincipalActivity">Mineral Exploration</ix:nonNumeric></td><td>&#160;</td>
    <td style="text-align: center"><ix:nonNumeric contextRef="c46" name="cve:NameofSubsidaryFunctionalCurrency">USD</ix:nonNumeric></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: center">Azarga Resources Limited</td><td>&#160;</td>
    <td style="text-align: center"><ix:nonNumeric contextRef="c47" name="cve:NameofSubsidaryPlaceOfIncorporation">British Virgin Islands</ix:nonNumeric></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c47" decimals="2" format="ixt:num-dot-decimal" name="ifrs-full:ProportionOfOwnershipInterestInSubsidiary" scale="-2" unitRef="pure">100</ix:nonFraction></td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: center"><ix:nonNumeric contextRef="c47" name="cve:NameofSubsidaryPrincipalActivity">Mineral Exploration</ix:nonNumeric></td><td>&#160;</td>
    <td style="text-align: center"><ix:nonNumeric contextRef="c47" name="cve:NameofSubsidaryFunctionalCurrency">USD</ix:nonNumeric></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: center">Azarga Resources (Hong Kong) Ltd.</td><td>&#160;</td>
    <td style="text-align: center"><ix:nonNumeric contextRef="c48" name="cve:NameofSubsidaryPlaceOfIncorporation">Hong Kong</ix:nonNumeric></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c48" decimals="2" format="ixt:num-dot-decimal" name="ifrs-full:ProportionOfOwnershipInterestInSubsidiary" scale="-2" unitRef="pure">100</ix:nonFraction></td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: center"><ix:nonNumeric contextRef="c48" name="cve:NameofSubsidaryPrincipalActivity">Mineral Exploration</ix:nonNumeric></td><td>&#160;</td>
    <td style="text-align: center"><ix:nonNumeric contextRef="c48" name="cve:NameofSubsidaryFunctionalCurrency">USD</ix:nonNumeric></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: center">Azarga Resources USA Company</td><td>&#160;</td>
    <td style="text-align: center"><ix:nonNumeric contextRef="c49" name="cve:NameofSubsidaryPlaceOfIncorporation">Colorado, USA</ix:nonNumeric></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c49" decimals="2" format="ixt:num-dot-decimal" name="ifrs-full:ProportionOfOwnershipInterestInSubsidiary" scale="-2" unitRef="pure">100</ix:nonFraction></td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: center"><ix:nonNumeric contextRef="c49" name="cve:NameofSubsidaryPrincipalActivity">Mineral Exploration</ix:nonNumeric></td><td>&#160;</td>
    <td style="text-align: center"><ix:nonNumeric contextRef="c49" name="cve:NameofSubsidaryFunctionalCurrency">USD</ix:nonNumeric></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: center; padding-bottom: 1.5pt">Azarga Resources Canada Ltd.</td><td>&#160;</td>
    <td style="text-align: center; padding-bottom: 1.5pt"><ix:nonNumeric contextRef="c50" name="cve:NameofSubsidaryPlaceOfIncorporation">British Columbia, CA</ix:nonNumeric></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c50" decimals="2" format="ixt:num-dot-decimal" name="ifrs-full:ProportionOfOwnershipInterestInSubsidiary" scale="-2" unitRef="pure">100</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">%</td><td>&#160;</td>
    <td style="text-align: center; padding-bottom: 1.5pt"><ix:nonNumeric contextRef="c50" name="cve:NameofSubsidaryPrincipalActivity">Mineral Exploration</ix:nonNumeric></td><td>&#160;</td>
    <td style="text-align: center; padding-bottom: 1.5pt"><ix:nonNumeric contextRef="c50" name="cve:NameofSubsidaryFunctionalCurrency">USD</ix:nonNumeric></td></tr>
  </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify">&#160;</p></ix:continuation></ix:nonNumeric></ix:continuation><div>


</div><div>

</div><ix:continuation continuedAt="_DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory-c0_cont_16" id="_DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory-c0_cont_15"><ix:continuation id="_DisclosureOfSignificantInvestmentsInSubsidiariesExplanatory-c0_cont_1"><ix:continuation id="cve_DescriptionOfAccountingPolicyForBasisOfConsolidationtextBlock-c0_cont_4"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">*
<ix:footnote id="ix_0_footnote" xml:lang="en-US">Cibola Resources, LLC was divested in May 2022 (Note 11).</ix:footnote></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p></ix:continuation></ix:continuation></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory-c0_cont_17" id="_DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory-c0_cont_16"><ix:nonNumeric contextRef="c0" continuedAt="cve_DescriptionOfAccountingPolicyForCashtextBlock-c0_cont_1" escape="true" name="cve:DescriptionOfAccountingPolicyForCashtextBlock"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b>Cash</b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p></ix:nonNumeric></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory-c0_cont_18" id="_DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory-c0_cont_17"><ix:continuation id="cve_DescriptionOfAccountingPolicyForCashtextBlock-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Cash
is comprised of cash held at banks and demand deposits.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p></ix:continuation></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory-c0_cont_19" id="_DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory-c0_cont_18"><ix:nonNumeric contextRef="c0" continuedAt="_DescriptionOfAccountingPolicyToDetermineComponentsOfCashAndCashEquivalents-c0_cont_1" escape="true" name="ifrs-full:DescriptionOfAccountingPolicyToDetermineComponentsOfCashAndCashEquivalents"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b>Restricted
cash</b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p></ix:nonNumeric></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory-c0_cont_20" id="_DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory-c0_cont_19"><ix:continuation continuedAt="_DescriptionOfAccountingPolicyToDetermineComponentsOfCashAndCashEquivalents-c0_cont_2" id="_DescriptionOfAccountingPolicyToDetermineComponentsOfCashAndCashEquivalents-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">As
of December 31, 2022, the Company deposited $<ix:nonFraction contextRef="c2" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:DepositsFromBanks" scale="0" unitRef="usd">4,517,073</ix:nonFraction> for collateralization of performance obligations. These funds are not available
for the payment of general corporate obligations. The bonds are collateralized performance bonds required for future restoration and
reclamation obligations related to the Company&#8217;s operations. (Note 11).</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p></ix:continuation></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory-c0_cont_21" id="_DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory-c0_cont_20"><ix:continuation id="_DescriptionOfAccountingPolicyToDetermineComponentsOfCashAndCashEquivalents-c0_cont_2"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">As
of December 31, 2022, the Company held in escrow CAD $<ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="cve:ShareSubscriptionsValue" scale="0" unitRef="cad">67,789,880</ix:nonFraction> ($<ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="cve:ShareSubscriptionsValue" scale="0" sign="-" unitRef="usd">50,051,595</ix:nonFraction>) in share subscriptions pertaining to a financing that
closed subsequent to year end (Note 22(b)).</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p></ix:continuation></ix:continuation><div>

</div><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><!-- Field: Page; Sequence: 9; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="border-top: Black 1.5pt solid; width: 100%; padding-top: 2pt; padding-bottom: 2pt; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif"><b>enCore Energy Corp.</b></span></td></tr>
  <tr style="vertical-align: top">
    <td style="border-bottom: Black 1.5pt solid; padding-top: 2pt; padding-bottom: 2pt; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif"><b>Notes
    to the Consolidated Financial Statements</b></span></td></tr>
  <tr style="vertical-align: top">
    <td style="border-bottom: Black 1.5pt solid; padding-top: 2pt; padding-bottom: 2pt; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif"><b>For the years ended December 31, 2022 and December 31, 2021</b></span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif"><b>2.</b></span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b>Significant
                                            accounting policies </b>(continued)</span></td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b>&#160;</b></span></p><div>

</div><ix:continuation continuedAt="_DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory-c0_cont_22" id="_DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory-c0_cont_21"><ix:nonNumeric contextRef="c0" continuedAt="cve_DescriptionOfAccountingPolicyForAssetRetirementObligationstextBlock-c0_cont_1" escape="true" name="cve:DescriptionOfAccountingPolicyForAssetRetirementObligationstextBlock"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b>Asset
retirement obligations </b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p></ix:nonNumeric></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory-c0_cont_23" id="_DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory-c0_cont_22"><ix:continuation id="cve_DescriptionOfAccountingPolicyForAssetRetirementObligationstextBlock-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Various
federal and state mining laws and regulations require the Company to reclaim the surface areas and restore underground water quality
for its ISR projects to the pre-existing or background average quality after the completion of mining. Asset retirement obligations,
consisting primarily of estimated restoration and reclamation costs at the Company&#8217;s ISR projects, are recognized in the period
incurred and recorded as liabilities at fair value. Such obligations, which are initially estimated based on discounted cash flow estimates,
are accreted to full value over time through charges to accretion expense. In addition, the asset retirement cost is capitalized as part
of the asset&#8217;s carrying value and amortized over the life of the related asset. Asset retirement obligations are periodically adjusted
to reflect changes in the estimated present value resulting from revisions to the estimated timing or amount of restoration and reclamation
costs. As the Company completes its restoration and reclamation work at its properties, the liability is reduced by the carrying value
of the related asset retirement liability which is based upon the percentage of completion of each restoration and reclamation activity.
Any gain or loss upon settlement is charged to income or expense for the period. The Company reviews and evaluates its asset retirement
obligations annually or more frequently at interim periods if deemed necessary.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p></ix:continuation></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory-c0_cont_24" id="_DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory-c0_cont_23"><ix:nonNumeric contextRef="c0" continuedAt="_DescriptionOfAccountingPolicyForAvailableforsaleFinancialAssetsExplanatory-c0_cont_1" escape="true" name="ifrs-full:DescriptionOfAccountingPolicyForAvailableforsaleFinancialAssetsExplanatory"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b>Assets
held for sale</b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p></ix:nonNumeric></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory-c0_cont_25" id="_DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory-c0_cont_24"><ix:continuation id="_DescriptionOfAccountingPolicyForAvailableforsaleFinancialAssetsExplanatory-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">The
Company classifies long-lived assets or disposal groups to be sold as held for sale in the period in which all of the following criteria
are met: management commits to a plan to sell the asset or disposal group; the asset or disposal group is available for immediate sale;
an active program to locate a buyer is initiated; the sale of the asset or disposal group is highly probable, within 12 months.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p></ix:continuation></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory-c0_cont_26" id="_DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory-c0_cont_25"><ix:nonNumeric contextRef="c0" continuedAt="cve_DescriptionOfAccountingPolicyForMineralPropertiestextBlock-c0_cont_1" escape="true" name="cve:DescriptionOfAccountingPolicyForMineralPropertiestextBlock"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif"><b>Mineral
properties</b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p></ix:nonNumeric></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory-c0_cont_27" id="_DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory-c0_cont_26"><ix:continuation continuedAt="cve_DescriptionOfAccountingPolicyForMineralPropertiestextBlock-c0_cont_2" id="cve_DescriptionOfAccountingPolicyForMineralPropertiestextBlock-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">The
Company is in the exploration stage, and records exploration and evaluation assets, which consists of the costs of acquiring licenses
for the right to explore and costs associated with exploration and evaluation activity, at cost. All direct and indirect costs related
to the acquisition, exploration and development of exploration and evaluation assets are capitalized by property.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p></ix:continuation></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory-c0_cont_28" id="_DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory-c0_cont_27"><ix:continuation continuedAt="cve_DescriptionOfAccountingPolicyForMineralPropertiestextBlock-c0_cont_3" id="cve_DescriptionOfAccountingPolicyForMineralPropertiestextBlock-c0_cont_2"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">The
exploration and evaluation assets are capitalized until the technical feasibility and commercial viability of the extraction of mineral
resources in an area of interest are demonstrable. Exploration and evaluation assets are then assessed for impairment and reclassified
to mining property and development assets within property and equipment. If an exploration and evaluation property interest is abandoned,
both the acquisition costs and the exploration and evaluation cost will be written off to net income or loss in the period of abandonment.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p></ix:continuation></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory-c0_cont_29" id="_DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory-c0_cont_28"><ix:continuation continuedAt="cve_DescriptionOfAccountingPolicyForMineralPropertiestextBlock-c0_cont_4" id="cve_DescriptionOfAccountingPolicyForMineralPropertiestextBlock-c0_cont_3"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">On
an ongoing basis, exploration and evaluation assets are reviewed on a property-by-property basis to consider if there are any indicators
of impairment, including the following:</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p></ix:continuation></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory-c0_cont_30" id="_DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory-c0_cont_29"><ix:continuation continuedAt="cve_DescriptionOfAccountingPolicyForMineralPropertiestextBlock-c0_cont_5" id="cve_DescriptionOfAccountingPolicyForMineralPropertiestextBlock-c0_cont_4"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%"><tr style="vertical-align: top">
<td style="width: 0.5in"></td><td style="width: 0.5in"><span style="font-family: Times New Roman, Times, Serif">(i)</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Whether
                                            the period during which the Company has the right to explore in the specific area has expired
                                            during the year or will expire in the near future;</span></td></tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p></ix:continuation></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory-c0_cont_31" id="_DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory-c0_cont_30"><ix:continuation continuedAt="cve_DescriptionOfAccountingPolicyForMineralPropertiestextBlock-c0_cont_6" id="cve_DescriptionOfAccountingPolicyForMineralPropertiestextBlock-c0_cont_5"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%"><tr style="vertical-align: top">
<td style="width: 0.5in"></td><td style="width: 0.5in"><span style="font-family: Times New Roman, Times, Serif">(ii)</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Whether
                                            substantive expenditure on further exploration for and evaluation of mineral resources in
                                            the specific area is neither budgeted nor planned;</span></td></tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p></ix:continuation></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory-c0_cont_32" id="_DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory-c0_cont_31"><ix:continuation continuedAt="cve_DescriptionOfAccountingPolicyForMineralPropertiestextBlock-c0_cont_7" id="cve_DescriptionOfAccountingPolicyForMineralPropertiestextBlock-c0_cont_6"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%"><tr style="vertical-align: top">
<td style="width: 0.5in"></td><td style="width: 0.5in"><span style="font-family: Times New Roman, Times, Serif">(iii)</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Whether
                                            the Company has decided to discontinue activities in an area as the exploration and evaluation
                                            activities in the area have not led to the discovery of commercially viable quantities of
                                            mineral resources; and</span></td></tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p></ix:continuation></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory-c0_cont_33" id="_DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory-c0_cont_32"><ix:continuation continuedAt="cve_DescriptionOfAccountingPolicyForMineralPropertiestextBlock-c0_cont_8" id="cve_DescriptionOfAccountingPolicyForMineralPropertiestextBlock-c0_cont_7"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%"><tr style="vertical-align: top">
<td style="width: 0.5in"></td><td style="width: 0.5in"><span style="font-family: Times New Roman, Times, Serif">(iv)</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Whether
                                            sufficient data exists to indicate that the carrying amount exceeds the recoverable amount.</span></td></tr></table><p style="margin: 0"></p></ix:continuation></ix:continuation><div>






</div><div>

</div><!-- Field: Page; Sequence: 10; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><ix:continuation continuedAt="_DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory-c0_cont_34" id="_DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory-c0_cont_33"><ix:continuation continuedAt="cve_DescriptionOfAccountingPolicyForMineralPropertiestextBlock-c0_cont_9" id="cve_DescriptionOfAccountingPolicyForMineralPropertiestextBlock-c0_cont_8"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></p></ix:continuation></ix:continuation></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><p style="margin: 0"></p><div>

</div><table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="border-top: Black 1.5pt solid; width: 100%; padding-top: 2pt; padding-bottom: 2pt; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif"><b>enCore Energy Corp.</b></span></td></tr>
  <tr style="vertical-align: top">
    <td style="border-bottom: Black 1.5pt solid; padding-top: 2pt; padding-bottom: 2pt; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif"><b>Notes
    to the Consolidated Financial Statements</b></span></td></tr>
  <tr style="vertical-align: top">
    <td style="border-bottom: Black 1.5pt solid; padding-top: 2pt; padding-bottom: 2pt; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif"><b>For the years ended December 31, 2022 and December 31, 2021</b></span></td></tr>
  </table><div>
</div><p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif"><b>2.</b></span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b>Significant
                                            accounting policies </b>(continued)</span></td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -18pt"><span style="font-family: Times New Roman, Times, Serif"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b>Mineral
properties </b>(continued)</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><ix:continuation continuedAt="_DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory-c0_cont_35" id="_DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory-c0_cont_34"><ix:continuation id="cve_DescriptionOfAccountingPolicyForMineralPropertiestextBlock-c0_cont_9"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">If
any indication of impairment exists, an estimate of the exploration and evaluation asset&#8217;s recoverable amount is calculated. The
recoverable amount is determined as the higher of the fair value less costs of disposal for the exploration and evaluation property interest
and its value in use. The fair value less costs of disposal and the value in use is determined for an individual exploration and evaluation
property interest, unless the exploration and evaluation property interest does not generate cash inflows that are largely independent
of other exploration and evaluation property interests. If this is the case, the exploration and evaluation property interests are grouped
together into cash generating units (&#8220;CGUs&#8221;) for impairment purposes. If the recoverable amount of an asset is estimated
to be less than its carrying amount, the carrying amount of the asset is reduced to its recoverable amount and the impairment loss is
recognized in net income or loss for the period. Where an impairment subsequently reverses, the carrying amount of the asset (or CGU)
is increased to the revised estimate of its recoverable amount, but to an amount that does not exceed the carrying amount that would
have been determined had no impairment loss been recognized for the asset (or CGU) in prior periods. A reversal of an impairment loss
is recognized in the period in which that determination was made in net income or loss.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p></ix:continuation></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory-c0_cont_36" id="_DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory-c0_cont_35"><ix:nonNumeric contextRef="c0" continuedAt="cve_DescriptionOfAccountingPolicyForInvestmentsInUraniumtextBlock-c0_cont_1" escape="true" name="cve:DescriptionOfAccountingPolicyForInvestmentsInUraniumtextBlock"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b>Investments
</b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt"><span style="font-family: Times New Roman, Times, Serif"><b>&#160;</b></span></p></ix:nonNumeric></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory-c0_cont_37" id="_DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory-c0_cont_36"><ix:continuation continuedAt="cve_DescriptionOfAccountingPolicyForInvestmentsInUraniumtextBlock-c0_cont_2" id="cve_DescriptionOfAccountingPolicyForInvestmentsInUraniumtextBlock-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b>Investments
in uranium</b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt"><span style="font-family: Times New Roman, Times, Serif"><b>&#160;</b></span></p></ix:continuation></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory-c0_cont_38" id="_DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory-c0_cont_37"><ix:continuation continuedAt="cve_DescriptionOfAccountingPolicyForInvestmentsInUraniumtextBlock-c0_cont_3" id="cve_DescriptionOfAccountingPolicyForInvestmentsInUraniumtextBlock-c0_cont_2"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Investments
in uranium are initially recorded at cost, on the date that control of the uranium passes to the Company. Cost is calculated as the purchase
price and any directly attributable expenditure. Subsequent to initial recognition, investments in uranium are measured at fair value
at each reporting period end. Fair value is determined based on the most recent month-end spot prices for uranium published by UxC LLC
(&#8220;UxC&#8221;). Related fair value gains and losses subsequent to initial recognition are recorded in the consolidated statement
of loss and comprehensive loss as a component of &#8220;Other Income (Expense)&#8221; in the period in which they arise.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p></ix:continuation></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory-c0_cont_39" id="_DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory-c0_cont_38"><ix:continuation continuedAt="cve_DescriptionOfAccountingPolicyForInvestmentsInUraniumtextBlock-c0_cont_4" id="cve_DescriptionOfAccountingPolicyForInvestmentsInUraniumtextBlock-c0_cont_3"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Due
to the lack of specific IFRS guidance on accounting for investments in uranium, the Company considered IAS 1 Presentation of Financial
Statements and IAS 8, Accounting Policies, Changes in Accounting Estimates and Errors, to develop and apply an accounting policy that
would result in information that is most relevant to the economic decision-making needs of users within the overall IFRS accounting framework.
Consequently, the uranium investments are presented at fair value based on the application of IAS 40, Investment Property, which allows
the use of a fair value model for assets held for long-term capital appreciation.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p></ix:continuation></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory-c0_cont_40" id="_DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory-c0_cont_39"><ix:continuation id="cve_DescriptionOfAccountingPolicyForInvestmentsInUraniumtextBlock-c0_cont_4"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">In
2022, the Company entered into fixed price agreements for future purchases of uranium. These agreements required the company to make
a deposit at the time of contract execution toward its future purchase. These deposits are recorded on the Company&#8217;s statement
of financial position in accordance with IFRS 9.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p></ix:continuation></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory-c0_cont_41" id="_DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory-c0_cont_40"><ix:nonNumeric contextRef="c0" continuedAt="_DescriptionOfAccountingPolicyForInvestmentInAssociates-c0_cont_1" escape="true" name="ifrs-full:DescriptionOfAccountingPolicyForInvestmentInAssociates"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt"><span style="font-family: Times New Roman, Times, Serif"><b>Investments
in associates</b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt"><span style="font-family: Times New Roman, Times, Serif"><b>&#160;</b></span></p></ix:nonNumeric></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory-c0_cont_42" id="_DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory-c0_cont_41"><ix:continuation continuedAt="_DescriptionOfAccountingPolicyForInvestmentInAssociates-c0_cont_2" id="_DescriptionOfAccountingPolicyForInvestmentInAssociates-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Investments
in associates are accounted for using the equity method. The equity method involves the recording of the initial investment at cost and
the subsequent adjusting of the carrying value of the investment for the Company&#8217;s proportionate share of the earnings or loss.
The cost of the investment includes transaction costs.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p></ix:continuation></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory-c0_cont_43" id="_DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory-c0_cont_42"><ix:continuation id="_DescriptionOfAccountingPolicyForInvestmentInAssociates-c0_cont_2"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Adjustments
are made to align the accounting policies of the associate with those of the Company before applying the equity method. When the Company&#8217;s
share of losses exceeds its interest in an equity-accounted investee, the carrying amount of that interest is reduced to zero, and the
recognition of further losses is discontinued except to the extent that the Company has incurred legal or constructive obligations or
made payments on behalf of the associate. If the associate subsequently reports profits, the Company resumes recognizing its share of
those profits only after its share of the profits equals the share of losses not recognized.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif"><b>&#160;</b></span></p></ix:continuation></ix:continuation><div>

</div><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><!-- Field: Page; Sequence: 11; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="border-top: Black 1.5pt solid; width: 100%; padding-top: 2pt; padding-bottom: 2pt; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif"><b>enCore Energy Corp.</b></span></td></tr>
  <tr style="vertical-align: top">
    <td style="border-bottom: Black 1.5pt solid; padding-top: 2pt; padding-bottom: 2pt; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif"><b>Notes
    to the Consolidated Financial Statements</b></span></td></tr>
  <tr style="vertical-align: top">
    <td style="border-bottom: Black 1.5pt solid; padding-top: 2pt; padding-bottom: 2pt; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif"><b>For the years ended December 31, 2022 and December 31, 2021</b></span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif"><b>2.</b></span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b>Significant
                                            accounting policies </b>(continued)</span></td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b>&#160;</b></span></p><div>

</div><ix:continuation continuedAt="_DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory-c0_cont_44" id="_DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory-c0_cont_43"><ix:nonNumeric contextRef="c0" continuedAt="_DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory-c0_cont_1" escape="true" name="ifrs-full:DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b>Property,
plant and equipment </b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b>&#160;</b></span></p></ix:nonNumeric></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory-c0_cont_45" id="_DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory-c0_cont_44"><ix:continuation continuedAt="_DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory-c0_cont_2" id="_DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Useful
lives are based on the Company&#8217;s estimate at the date of acquisition and are as follows for each class of assets:</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p></ix:continuation></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory-c0_cont_46" id="_DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory-c0_cont_45"><ix:nonNumeric contextRef="c0" escape="true" name="cve:DisclosureOfUsefulLivesOfPropertyPlantAndEquipementTextBlock"><ix:continuation id="_DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory-c0_cont_2"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom; ">
    <td style="border-bottom: Black 1.5pt solid; text-align: center; width: 49%"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><b>Category</b></span></p></td><td style="width: 2%; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; width: 49%; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Range</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Uranium Plants</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Straight-line over <ix:nonNumeric contextRef="c51" format="ixt-sec:duryear" name="cve:PropertyPlantAndEquipmentRange">15</ix:nonNumeric>-<ix:nonNumeric contextRef="c52" format="ixt-sec:duryear" name="cve:PropertyPlantAndEquipmentRange">25</ix:nonNumeric> years</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Other Property Plant and Equipment</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Straight-line over <ix:nonNumeric contextRef="c53" format="ixt-sec:duryear" name="cve:PropertyPlantAndEquipmentRange">3</ix:nonNumeric>-<ix:nonNumeric contextRef="c54" format="ixt-sec:duryear" name="cve:PropertyPlantAndEquipmentRange">5</ix:nonNumeric> years</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif">Software</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Straight-line over <ix:nonNumeric contextRef="c55" format="ixt-sec:duryear" name="cve:PropertyPlantAndEquipmentRange">2</ix:nonNumeric>-<ix:nonNumeric contextRef="c56" format="ixt-sec:duryear" name="cve:PropertyPlantAndEquipmentRange">3</ix:nonNumeric> years</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td><span style="font-family: Times New Roman, Times, Serif">Furniture</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Straight-line over <ix:nonNumeric contextRef="c57" format="ixt-sec:duryear" name="cve:PropertyPlantAndEquipmentRange">3</ix:nonNumeric>-<ix:nonNumeric contextRef="c58" format="ixt-sec:duryear" name="cve:PropertyPlantAndEquipmentRange">5</ix:nonNumeric> years</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif">Buildings</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Straight-line over <ix:nonNumeric contextRef="c59" format="ixt-sec:duryear" name="cve:PropertyPlantAndEquipmentRange">10</ix:nonNumeric>-<ix:nonNumeric contextRef="c60" format="ixt-sec:duryear" name="cve:PropertyPlantAndEquipmentRange">40</ix:nonNumeric> years</span></td></tr>
  </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b>&#160;</b></span></p></ix:continuation></ix:nonNumeric></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory-c0_cont_47" id="_DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory-c0_cont_46"><ix:nonNumeric contextRef="c0" continuedAt="cve_DescriptionOfAccountingPolicyForUraniumPlantstextBlock-c0_cont_1" escape="true" name="cve:DescriptionOfAccountingPolicyForUraniumPlantstextBlock"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b>Uranium
plants</b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b>&#160;</b></span></p></ix:nonNumeric></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory-c0_cont_48" id="_DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory-c0_cont_47"><ix:continuation id="cve_DescriptionOfAccountingPolicyForUraniumPlantstextBlock-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Uranium
plant expenditures for new facilities or equipment and expenditures that extend the useful lives of existing facilities or equipment
are capitalized and recorded at cost. Depreciation on other property is computed based upon the estimated useful lives of the assets.
Repair and maintenance costs are expensed as incurred. Gain or loss on disposal of such assets is recorded as other income or expense
as such assets are disposed.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p></ix:continuation></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory-c0_cont_49" id="_DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory-c0_cont_48"><ix:nonNumeric contextRef="c0" continuedAt="cve_DescriptionOfAccountingPolicyForOtherPropertyPlantAndEquipmenttextBlock-c0_cont_1" escape="true" name="cve:DescriptionOfAccountingPolicyForOtherPropertyPlantAndEquipmenttextBlock"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b>Other
property, plant and equipment </b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b>&#160;</b></span></p></ix:nonNumeric></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory-c0_cont_50" id="_DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory-c0_cont_49"><ix:continuation id="cve_DescriptionOfAccountingPolicyForOtherPropertyPlantAndEquipmenttextBlock-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Other
property, plant and equipment consists of office equipment, furniture and fixtures and transportation equipment. Depreciation on other
property is computed based upon the estimated useful lives of the assets. Repairs and maintenance costs are expensed as incurred. Gain
or loss on disposal of such assets is recorded as other income or expense as such assets are disposed.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p></ix:continuation></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory-c0_cont_51" id="_DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory-c0_cont_50"><ix:nonNumeric contextRef="c0" continuedAt="cve_DescriptionOfAccountingPolicyForBuildingtextBlock-c0_cont_1" escape="true" name="cve:DescriptionOfAccountingPolicyForBuildingtextBlock"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b>Buildings</b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b>&#160;</b></span></p></ix:nonNumeric></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory-c0_cont_52" id="_DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory-c0_cont_51"><ix:continuation id="cve_DescriptionOfAccountingPolicyForBuildingtextBlock-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Depreciation
on buildings is computed based upon the estimated useful lives of the asset. Repairs and maintenance costs are expensed as incurred.
Gain or loss on disposal of such assets is recorded as other income or expense as such assets are disposed.&#8195;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p></ix:continuation></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory-c0_cont_53" id="_DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory-c0_cont_52"><ix:nonNumeric contextRef="c0" continuedAt="cve_DescriptionOfAccountingPolicyForSoftwaretextBlock-c0_cont_1" escape="true" name="cve:DescriptionOfAccountingPolicyForSoftwaretextBlock"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b>Software</b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b>&#160;</b></span></p></ix:nonNumeric></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory-c0_cont_54" id="_DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory-c0_cont_53"><ix:continuation id="cve_DescriptionOfAccountingPolicyForSoftwaretextBlock-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Software
acquired in the normal course of business through a perpetual license is capitalized and depreciated over the estimated useful life of
the asset. Support and maintenance costs are expensed as incurred. Gain or loss on disposal of such assets is recorded as other income
or expense as such assets are disposed</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p></ix:continuation></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory-c0_cont_55" id="_DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory-c0_cont_54"><ix:nonNumeric contextRef="c0" continuedAt="_DescriptionOfAccountingPolicyForIntangibleAssetsAndGoodwillExplanatory-c0_cont_1" escape="true" name="ifrs-full:DescriptionOfAccountingPolicyForIntangibleAssetsAndGoodwillExplanatory"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif"><b>Intangible
assets</b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b>&#160;</b></span></p></ix:nonNumeric></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory-c0_cont_56" id="_DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory-c0_cont_55"><ix:continuation continuedAt="_DescriptionOfAccountingPolicyForIntangibleAssetsAndGoodwillExplanatory-c0_cont_2" id="_DescriptionOfAccountingPolicyForIntangibleAssetsAndGoodwillExplanatory-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Intangible
assets are recognized and measured at cost. Intangible assets with indefinite useful lives are assessed for impairment annually and whenever
there is an indication that the intangible asset may be impaired. Intangible assets that have finite useful lives are amortized over
their estimated remaining useful lives. Amortization methods and useful lives are reviewed at each reporting period and are adjusted
if appropriate.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p></ix:continuation></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory-c0_cont_57" id="_DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory-c0_cont_56"><ix:continuation continuedAt="_DescriptionOfAccountingPolicyForIntangibleAssetsAndGoodwillExplanatory-c0_cont_3" id="_DescriptionOfAccountingPolicyForIntangibleAssetsAndGoodwillExplanatory-c0_cont_2"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Useful
lives are based on the Company&#8217;s estimate at the date of acquisition and are as follows for each class of assets:</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p></ix:continuation></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory-c0_cont_58" id="_DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory-c0_cont_57"><ix:nonNumeric contextRef="c0" escape="true" name="cve:DisclosureOfUsefulLivesOfIntangibleAssetsTextBllock"><ix:continuation id="_DescriptionOfAccountingPolicyForIntangibleAssetsAndGoodwillExplanatory-c0_cont_3"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom; ">
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center; width: 49%"><span style="font-family: Times New Roman, Times, Serif">Category</span></td><td style="width: 2%; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; width: 49%; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Range</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Data Access Agreement</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><ix:nonNumeric contextRef="c61" name="cve:CategoryRange"><span style="font-family: Times New Roman, Times, Serif">Straight-line over 14 years</span></ix:nonNumeric></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Data Purchases</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><ix:nonNumeric contextRef="c62" name="cve:CategoryRange"><span style="font-family: Times New Roman, Times, Serif">Indefinite life intangible asset</span></ix:nonNumeric></td></tr>
  </table><p style="margin-top: 0; margin-bottom: 0"></p></ix:continuation></ix:nonNumeric></ix:continuation><div>


</div><div>



</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><!-- Field: Page; Sequence: 12; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="border-top: Black 1.5pt solid; width: 100%; padding-top: 2pt; padding-bottom: 2pt; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif"><b>enCore Energy Corp.</b></span></td></tr>
  <tr style="vertical-align: top">
    <td style="border-bottom: Black 1.5pt solid; text-align: left; padding-top: 2pt; padding-bottom: 2pt; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif"><b>Notes
    to the Consolidated Financial Statements</b></span></td></tr>
  <tr style="vertical-align: top">
    <td style="border-bottom: Black 1.5pt solid; padding-top: 2pt; padding-bottom: 2pt; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif"><b>For the years ended December 31, 2022 and December 31, 2021</b></span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif"><b>2.</b></span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b>Significant
                                            accounting policies </b>(continued)</span></td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt"><span style="font-family: Times New Roman, Times, Serif"><b>&#160;</b></span></p><div>

</div><ix:continuation continuedAt="_DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory-c0_cont_59" id="_DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory-c0_cont_58"><ix:nonNumeric contextRef="c0" continuedAt="_DescriptionOfAccountingPolicyForImpairmentOfNonfinancialAssetsExplanatory-c0_cont_1" escape="true" name="ifrs-full:DescriptionOfAccountingPolicyForImpairmentOfNonfinancialAssetsExplanatory"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt"><span style="font-family: Times New Roman, Times, Serif"><b>Impairment
of non-financial assets</b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt"><span style="font-family: Times New Roman, Times, Serif"><b>&#160;</b></span></p></ix:nonNumeric></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory-c0_cont_60" id="_DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory-c0_cont_59"><ix:continuation continuedAt="_DescriptionOfAccountingPolicyForImpairmentOfNonfinancialAssetsExplanatory-c0_cont_2" id="_DescriptionOfAccountingPolicyForImpairmentOfNonfinancialAssetsExplanatory-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">At
the end of each reporting period, the Company&#8217;s assets are reviewed to determine whether there is any indication that those assets
may be impaired. If such indication exists, the recoverable amount of the asset is estimated in order to determine the extent of the
impairment, if any. The recoverable amount is the higher of fair value less costs of disposal and the value in use. Fair value is the
price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at
the measurement date. In assessing value in use, the estimated future cash flows are discounted to their present value using a pre-tax
discount rate that reflects a current market assessment of the time value of money and the risks specific to the asset. If the recoverable
amount of an asset is estimated to be less than its carrying amount, the carrying amount of the asset is reduced to its recoverable amount
and the impairment loss is recognized in profit or loss for the period. For an asset that does not generate largely independent cash
flows, the recoverable amount is determined for the cash generating unit to which the asset belongs.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p></ix:continuation></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory-c0_cont_61" id="_DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory-c0_cont_60"><ix:continuation id="_DescriptionOfAccountingPolicyForImpairmentOfNonfinancialAssetsExplanatory-c0_cont_2"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">When
an impairment loss subsequently reverses, the carrying amount of the asset (or cash-generating unit) is increased to the revised estimate
of its recoverable amount, but to an amount that does not exceed the carrying amount that would have been determined had no impairment
loss been recognized for the asset (or cash generating unit) in prior years. A reversal of an impairment loss is recognized immediately
in profit or loss.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p></ix:continuation></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory-c0_cont_62" id="_DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory-c0_cont_61"><ix:nonNumeric contextRef="c0" continuedAt="_DescriptionOfAccountingPolicyForLeasesExplanatory-c0_cont_1" escape="true" name="ifrs-full:DescriptionOfAccountingPolicyForLeasesExplanatory"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt"><span style="font-family: Times New Roman, Times, Serif"><b>Leases</b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt"><span style="font-family: Times New Roman, Times, Serif"><b>&#160;</b></span></p></ix:nonNumeric></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory-c0_cont_63" id="_DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory-c0_cont_62"><ix:continuation id="_DescriptionOfAccountingPolicyForLeasesExplanatory-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">In
accordance with IFRS 16, the Company recognizes a right-of-use asset and a lease liability at the lease commencement date. The right-of-use
asset represents the Company&#8217;s right to use an underlying asset for the lease term and lease liabilities represent our obligation
to make lease payments arising from the lease. Right-of-use assets and lease liabilities are recognized at the commencement date of the
lease based on the present value of lease payments over the lease term.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p></ix:continuation></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory-c0_cont_64" id="_DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory-c0_cont_63"><ix:nonNumeric contextRef="c0" continuedAt="_DescriptionOfAccountingPolicyForIncomeTaxExplanatory-c0_cont_1" escape="true" name="ifrs-full:DescriptionOfAccountingPolicyForIncomeTaxExplanatory"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b>Income
Tax</b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b>&#160;</b></span></p></ix:nonNumeric></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory-c0_cont_65" id="_DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory-c0_cont_64"><ix:continuation continuedAt="_DescriptionOfAccountingPolicyForIncomeTaxExplanatory-c0_cont_2" id="_DescriptionOfAccountingPolicyForIncomeTaxExplanatory-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Income
tax expense comprises current and deferred tax. Income tax is recognized in profit or loss except to the extent that it relates to items
recognized directly in equity. Current tax expense is the expected tax payable on taxable income for the year, using tax rates enacted
or substantively enacted at period end, adjusted for amendments to tax payable with regards to previous years.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p></ix:continuation></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory-c0_cont_66" id="_DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory-c0_cont_65"><ix:continuation continuedAt="_DescriptionOfAccountingPolicyForIncomeTaxExplanatory-c0_cont_3" id="_DescriptionOfAccountingPolicyForIncomeTaxExplanatory-c0_cont_2"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Deferred
tax is recorded using the liability method, providing for temporary differences between the carrying amounts of assets and liabilities
for financial reporting purposes and the amounts used for taxation purposes.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p></ix:continuation></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory-c0_cont_67" id="_DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory-c0_cont_66"><ix:continuation continuedAt="_DescriptionOfAccountingPolicyForIncomeTaxExplanatory-c0_cont_4" id="_DescriptionOfAccountingPolicyForIncomeTaxExplanatory-c0_cont_3"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Temporary
differences are not provided for the initial recognition of assets or liabilities that do not affect either accounting or taxable loss
or those differences relating to investments in subsidiaries to the extent that they are not probable to reverse in the foreseeable future.
The amount of deferred tax provided is based on the expected manner of realization or settlement of the carrying amount of assets and
liabilities, using tax rates enacted or substantively enacted at the date of the statement of financial position.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p></ix:continuation></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory-c0_cont_68" id="_DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory-c0_cont_67"><ix:continuation id="_DescriptionOfAccountingPolicyForIncomeTaxExplanatory-c0_cont_4"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">A
deferred tax asset is recognized only to the extent that it is probable that future taxable profits will be available against which the
asset can be utilized. To the extent that the Company does not consider it probable that a deferred tax asset will be recovered, it is
not recorded.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p></ix:continuation></ix:continuation><div>

</div><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><!-- Field: Page; Sequence: 13; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><ix:continuation continuedAt="_DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory-c0_cont_69" id="_DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory-c0_cont_68"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></p></ix:continuation></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="border-top: Black 1.5pt solid; width: 100%; padding-top: 2pt; padding-bottom: 2pt; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif"><b>enCore Energy Corp.</b></span></td></tr>
  <tr style="vertical-align: top">
    <td style="border-bottom: Black 1.5pt solid; padding-top: 2pt; padding-bottom: 2pt; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif"><b>Notes
    to the Consolidated Financial Statements</b></span></td></tr>
  <tr style="vertical-align: top">
    <td style="border-bottom: Black 1.5pt solid; padding-top: 2pt; padding-bottom: 2pt; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif"><b>For the years ended December 31, 2022 and December 31, 2021</b></span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif"><b>2.</b></span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b>Significant
                                            accounting policies </b>(continued)</span></td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><ix:continuation continuedAt="_DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory-c0_cont_70" id="_DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory-c0_cont_69"><ix:nonNumeric contextRef="c0" continuedAt="_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock-c0_cont_1" escape="true" name="us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif"><b>Foreign
currency translation</b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b>&#160;</b></span></p></ix:nonNumeric></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory-c0_cont_71" id="_DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory-c0_cont_70"><ix:continuation continuedAt="_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock-c0_cont_2" id="_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">The
financial statements for the Company and each of its subsidiaries are prepared using their functional currencies. Functional currency
is the currency of the primary economic environment in which an entity operates.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p></ix:continuation></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory-c0_cont_72" id="_DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory-c0_cont_71"><ix:continuation continuedAt="_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock-c0_cont_3" id="_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock-c0_cont_2"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Foreign
currency transactions are translated into the functional currency using the exchange rates prevailing at the date of the transaction.
Foreign currency monetary items are translated at the period-end exchange rate. Non-monetary items measured at historical cost continue
to be carried at the exchange rate at the date of the transaction. Non-monetary items measured at fair value are reported at the exchange
rate at the date when fair values were determined.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p></ix:continuation></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory-c0_cont_73" id="_DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory-c0_cont_72"><ix:continuation continuedAt="_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock-c0_cont_4" id="_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock-c0_cont_3"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Exchange
differences arising on the translation of monetary items or on settlement of monetary items are recognized in profit or loss in the period
in which they arise, except where deferred in equity as a qualifying cash flow or net investment hedge. Exchange differences arising
on the translation of non-monetary items are recognized in other comprehensive income (loss) in the consolidated statement of loss and
comprehensive loss to the extent that gains and losses arising on those non-monetary items are also recognized in other comprehensive
income (loss). Where the non-monetary gain or loss is recognized in profit or loss, the exchange component is also recognized in profit
or loss.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p></ix:continuation></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory-c0_cont_74" id="_DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory-c0_cont_73"><ix:continuation id="_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock-c0_cont_4"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">On
consolidation, the parent Company&#8217;s financial statements are translated into the presentation currency, being the U.S. Dollar.
Assets and liabilities are translated at the period-end exchange rate. Income and expenses are translated at the average exchange rate
for the period in which they arise. Exchange differences are recognized in other comprehensive income (loss) as a separate component
of equity.	</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p></ix:continuation></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory-c0_cont_75" id="_DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory-c0_cont_74"><ix:nonNumeric contextRef="c0" continuedAt="_DescriptionOfAccountingPolicyForEarningsPerShareExplanatory-c0_cont_1" escape="true" name="ifrs-full:DescriptionOfAccountingPolicyForEarningsPerShareExplanatory"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b>Earnings
(loss) per share</b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p></ix:nonNumeric></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory-c0_cont_76" id="_DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory-c0_cont_75"><ix:continuation id="_DescriptionOfAccountingPolicyForEarningsPerShareExplanatory-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">The
Company presents basic and diluted earnings (loss) per share (&#8220;EPS&#8221;) data for its common shares. Basic EPS is calculated
by dividing the profit or loss of the Company by the weighted average number of common shares outstanding during the year, adjusted for
own shares held. Diluted EPS is determined by dividing the profit or loss attributable to common shareholders by the weighted average
number of common shares outstanding, adjusted for own shares held and for the effects of all potential dilutive common shares related
to outstanding stock options and warrants issued by the Company for the years presented, except if their inclusion proves to be anti-dilutive.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p></ix:continuation></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory-c0_cont_77" id="_DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory-c0_cont_76"><ix:nonNumeric contextRef="c0" continuedAt="_DescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory-c0_cont_1" escape="true" name="ifrs-full:DescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif"><b>Share-based
payments</b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p></ix:nonNumeric></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory-c0_cont_78" id="_DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory-c0_cont_77"><ix:continuation continuedAt="_DescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory-c0_cont_2" id="_DescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">The
fair value of all stock options granted to directors, officers, and employees is recorded as a charge to operations and a credit to contributed
surplus. The fair value of these stock options is measured at the grant date using the Black-Scholes option pricing model. The fair value
of stock options which vest immediately is recorded at the grant date. For stock options which vest in the future, the fair value of
stock options, as adjusted for the expected level of vesting of the stock options and the number of stock options which ultimately vest,
is recognized over the vesting period. Stock options granted to non-employees are measured at the fair value of goods or services rendered
or at the fair value of the instruments issued if it is determined that the fair value of the goods or services received cannot be reliably
measured. The number of shares and options expected to vest is reviewed and adjusted at the end of each reporting period such that the
amount recognized for services received as consideration for the equity instruments granted shall be based on the number of equity instruments
that eventually vest.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p></ix:continuation></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory-c0_cont_79" id="_DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory-c0_cont_78"><ix:continuation id="_DescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory-c0_cont_2"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Warrants
issued to brokers are measured at their fair value on the vesting date and are recognized as a deduction from equity and credited to
contributed surplus. The fair value of stock options and warrants issued to brokers are estimated using the Black-Scholes option pricing
model. Any consideration received on the exercise of stock options and/or warrants, together with the related portion of contributed
surplus, is credited to share capital.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif"><b>&#160;</b></span></p></ix:continuation></ix:continuation><div>

</div><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><!-- Field: Page; Sequence: 14; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="border-top: Black 1.5pt solid; width: 100%; padding-top: 2pt; padding-bottom: 2pt; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif"><b>enCore Energy Corp.</b></span></td></tr>
  <tr style="vertical-align: top">
    <td style="border-bottom: Black 1.5pt solid; padding-top: 2pt; padding-bottom: 2pt; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif"><b>Notes
    to the Consolidated Financial Statements</b></span></td></tr>
  <tr style="vertical-align: top">
    <td style="border-bottom: Black 1.5pt solid; padding-top: 2pt; padding-bottom: 2pt; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif"><b>For the years ended December 31, 2022 and December 31, 2021</b></span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif"><b>2.</b></span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b>Significant
                                            accounting policies </b>(continued)</span></td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt"><span style="font-family: Times New Roman, Times, Serif"><b>&#160;</b></span></p><div>

</div><ix:continuation continuedAt="_DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory-c0_cont_80" id="_DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory-c0_cont_79"><ix:nonNumeric contextRef="c0" continuedAt="_DescriptionOfAccountingPolicyForWarrantsExplanatory-c0_cont_1" escape="true" name="ifrs-full:DescriptionOfAccountingPolicyForWarrantsExplanatory"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt"><span style="font-family: Times New Roman, Times, Serif"><b>Warrants
issued in equity financing transactions</b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p></ix:nonNumeric></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory-c0_cont_81" id="_DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory-c0_cont_80"><ix:continuation continuedAt="_DescriptionOfAccountingPolicyForWarrantsExplanatory-c0_cont_2" id="_DescriptionOfAccountingPolicyForWarrantsExplanatory-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">The
Company engages in equity financing transactions to obtain the funds necessary to continue operations and explore its exploration and
evaluation assets. These equity financing transactions may involve the issuance of common shares or units. Each unit comprises a certain
number of common shares and a certain number of share purchase warrants.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p></ix:continuation></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory-c0_cont_82" id="_DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory-c0_cont_81"><ix:continuation id="_DescriptionOfAccountingPolicyForWarrantsExplanatory-c0_cont_2"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Depending
on the terms and conditions of each equity financing agreement, the Warrants are exercisable into additional common shares at a price
prior to expiry as stipulated by the agreement. Warrants that are part of units are valued based on the residual value method. Warrants
that are issued as payment for agency fees or other transactions costs are accounted for as share-based payments.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p></ix:continuation></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory-c0_cont_83" id="_DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory-c0_cont_82"><ix:nonNumeric contextRef="c0" continuedAt="_DescriptionOfAccountingPolicyForFinancialInstrumentsExplanatory-c0_cont_1" escape="true" name="ifrs-full:DescriptionOfAccountingPolicyForFinancialInstrumentsExplanatory"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif"><b>Financial
instruments </b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b>&#160;</b></span></p></ix:nonNumeric></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory-c0_cont_84" id="_DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory-c0_cont_83"><ix:continuation continuedAt="_DescriptionOfAccountingPolicyForFinancialInstrumentsExplanatory-c0_cont_2" id="_DescriptionOfAccountingPolicyForFinancialInstrumentsExplanatory-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">The
Company classifies its financial instruments in the following categories: at fair value through profit and loss (&#8220;FVTPL&#8221;),
at fair value through other comprehensive income (loss) (&#8220;FVTOCI&#8221;), or at amortized cost. The Company determines the classification
of financial assets at initial recognition. The classification of debt instruments is driven by the Company&#8217;s business model for
managing the financial assets and their contractual cash flow characteristics. Equity instruments that are held for trading are classified
as FVTPL. For other equity instruments, on the day of acquisition the Company can make an irrevocable election (on an instrument-by instrument
basis) to designate them as at FVTOCI. Financial liabilities are measured at amortized cost, unless they are required to be measured
at FVTPL (such as instruments held for trading or derivatives) or the Company has opted to measure them at FVTPL.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p></ix:continuation></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory-c0_cont_85" id="_DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory-c0_cont_84"><ix:continuation id="_DescriptionOfAccountingPolicyForFinancialInstrumentsExplanatory-c0_cont_2"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Financial
assets and liabilities carried at FVTPL are initially recorded at fair value and transaction costs are expensed in profit or loss. Realized
and unrealized gains and losses arising from changes in the fair value of the financial assets and liabilities held at FVTPL are included
in the consolidated statements of loss and comprehensive loss in the period in which they arise.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p></ix:continuation></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory-c0_cont_86" id="_DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory-c0_cont_85"><ix:nonNumeric contextRef="c0" continuedAt="_DescriptionOfAccountingPolicyForImpairmentOfFinancialAssetsExplanatory-c0_cont_1" escape="true" name="ifrs-full:DescriptionOfAccountingPolicyForImpairmentOfFinancialAssetsExplanatory"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif"><b>Impairment
of financial assets at amortized cost</b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b>&#160;</b></span></p></ix:nonNumeric></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory-c0_cont_87" id="_DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory-c0_cont_86"><ix:continuation continuedAt="_DescriptionOfAccountingPolicyForImpairmentOfFinancialAssetsExplanatory-c0_cont_2" id="_DescriptionOfAccountingPolicyForImpairmentOfFinancialAssetsExplanatory-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">An
&#8216;expected credit loss&#8217; impairment model applies which requires a loss allowance to be recognized based on expected credit
losses. The estimated present value of future cash flows associated with the asset is determined and an impairment loss is recognized
for the difference between this amount and the carrying amount as follows: the carrying amount of the asset is reduced to estimated present
value of the future cash flows associated with the asset, discounted at the financial asset&#8217;s original effective interest rate,
either directly or through the use of an allowance account and the resulting loss is recognized in profit or loss for the period.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p></ix:continuation></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory-c0_cont_88" id="_DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory-c0_cont_87"><ix:continuation continuedAt="_DescriptionOfAccountingPolicyForImpairmentOfFinancialAssetsExplanatory-c0_cont_3" id="_DescriptionOfAccountingPolicyForImpairmentOfFinancialAssetsExplanatory-c0_cont_2"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">In
a subsequent period, if the amount of the impairment loss related to financial assets measured at amortized cost decreases, the previously
recognized impairment loss is reversed through profit or loss to the extent that the carrying amount of the investment at the date the
impairment is reversed does not exceed what the amortized cost would have been had the impairment not been recognized.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 36pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p></ix:continuation></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory-c0_cont_89" id="_DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory-c0_cont_88"><ix:continuation id="_DescriptionOfAccountingPolicyForImpairmentOfFinancialAssetsExplanatory-c0_cont_3"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 36pt"><span style="font-family: Times New Roman, Times, Serif">The
Company&#8217;s mineral property interest impairment policy is more specifically discussed above.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 36pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p></ix:continuation></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory-c0_cont_90" id="_DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory-c0_cont_89"><ix:nonNumeric contextRef="c0" continuedAt="_DescriptionOfAccountingPolicyForDerecognitionOfFinancialInstrumentsExplanatory-c0_cont_1" escape="true" name="ifrs-full:DescriptionOfAccountingPolicyForDerecognitionOfFinancialInstrumentsExplanatory"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt"><span style="font-family: Times New Roman, Times, Serif"><b>Derecognition
of financial assets</b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt"><span style="font-family: Times New Roman, Times, Serif"><b>&#160;</b></span></p></ix:nonNumeric></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory-c0_cont_91" id="_DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory-c0_cont_90"><ix:continuation id="_DescriptionOfAccountingPolicyForDerecognitionOfFinancialInstrumentsExplanatory-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">The
Company derecognizes financial assets only when the contractual rights to cash flows from the financial assets expire, or when it transfers
the financial assets and substantially all of the associated risks and rewards of ownership to another entity. Gains and losses on derecognition
are generally recognized in profit or loss</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p></ix:continuation></ix:continuation><div>

</div><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><!-- Field: Page; Sequence: 15; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><ix:continuation continuedAt="_DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory-c0_cont_92" id="_DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory-c0_cont_91"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></p></ix:continuation></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="border-top: Black 1.5pt solid; width: 100%; padding-top: 2pt; padding-bottom: 2pt; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif"><b>enCore Energy Corp.</b></span></td></tr>
  <tr style="vertical-align: top">
    <td style="border-bottom: Black 1.5pt solid; padding-top: 2pt; padding-bottom: 2pt; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif"><b>Notes
    to the Consolidated Financial Statements</b></span></td></tr>
  <tr style="vertical-align: top">
    <td style="border-bottom: Black 1.5pt solid; padding-top: 2pt; padding-bottom: 2pt; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif"><b>For the years ended December 31, 2022 and December 31, 2021</b></span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif"><b>&#160;</b></span></p><div>

</div><table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif"><b>2.</b></span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b>Significant
                                            accounting policies </b>(continued)</span></td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b>&#160;</b></span></p><div>

</div><ix:continuation continuedAt="_DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory-c0_cont_93" id="_DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory-c0_cont_92"><ix:nonNumeric contextRef="c0" continuedAt="cve_DescriptionOfAccountingPolicyForNewStandardsAndInterpretationsNotYetAdoptedtextBlock-c0_cont_1" escape="true" name="cve:DescriptionOfAccountingPolicyForNewStandardsAndInterpretationsNotYetAdoptedtextBlock"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b>New
standards and interpretations not yet adopted</b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p></ix:nonNumeric></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory-c0_cont_94" id="_DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory-c0_cont_93"><ix:continuation continuedAt="cve_DescriptionOfAccountingPolicyForNewStandardsAndInterpretationsNotYetAdoptedtextBlock-c0_cont_2" id="cve_DescriptionOfAccountingPolicyForNewStandardsAndInterpretationsNotYetAdoptedtextBlock-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">The
following new standards, amendments to standards and interpretations have been issued but are not effective during the year ended
December 31, 2022:</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p></ix:continuation></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory-c0_cont_95" id="_DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory-c0_cont_94"><ix:continuation continuedAt="cve_DescriptionOfAccountingPolicyForNewStandardsAndInterpretationsNotYetAdoptedtextBlock-c0_cont_3" id="cve_DescriptionOfAccountingPolicyForNewStandardsAndInterpretationsNotYetAdoptedtextBlock-c0_cont_2"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">The
following amendments will be in effect for annual reporting periods beginning on or after January 1, 2023:</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p></ix:continuation></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory-c0_cont_96" id="_DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory-c0_cont_95"><ix:continuation continuedAt="cve_DescriptionOfAccountingPolicyForNewStandardsAndInterpretationsNotYetAdoptedtextBlock-c0_cont_4" id="cve_DescriptionOfAccountingPolicyForNewStandardsAndInterpretationsNotYetAdoptedtextBlock-c0_cont_3"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Disclosure
of Accounting Policies (Amendments to IAS 1 and IFRS Practice Statement 2) &#8211; the amendments </span>require that an entity
discloses its material accounting policies, instead of its significant accounting policies. <span style="font-family: Times New Roman, Times, Serif">Further
amendments explain how an entity can identify a material accounting policy.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p></ix:continuation></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory-c0_cont_97" id="_DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory-c0_cont_96"><ix:continuation continuedAt="cve_DescriptionOfAccountingPolicyForNewStandardsAndInterpretationsNotYetAdoptedtextBlock-c0_cont_5" id="cve_DescriptionOfAccountingPolicyForNewStandardsAndInterpretationsNotYetAdoptedtextBlock-c0_cont_4"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Definition
of Accounting Estimates (Amendments to IAS 8) &#8211; the amendments replace the definition of a change in accounting estimates with
a definition of accounting estimates. Under the new definition, accounting estimates are &#8220;monetary amounts in financial
statements that are subject to measurement uncertainty&#8221;. Entities develop accounting estimates if accounting policies require
items in financial statements to be measured in a way that involves measurement uncertainty. The amendments clarify that a change in
accounting estimate that results from new information or new developments is not the correction of an error.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p></ix:continuation></ix:continuation><div>

</div><div>

</div><ix:continuation id="_DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory-c0_cont_97"><ix:continuation id="cve_DescriptionOfAccountingPolicyForNewStandardsAndInterpretationsNotYetAdoptedtextBlock-c0_cont_5"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">The
Company does not anticipate that these amendments will have a material impact on the results of operations and financial position of
the Company.</span></p></ix:continuation></ix:continuation><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><ix:nonNumeric contextRef="c0" continuedAt="_DisclosureOfAccountingJudgementsAndEstimatesExplanatory-c0_cont_1" escape="true" name="ifrs-full:DisclosureOfAccountingJudgementsAndEstimatesExplanatory"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%"><tr style="vertical-align: top">
<td style="width: 18pt"></td><td style="width: 18pt"><span style="font-family: Times New Roman, Times, Serif"><b>3.</b></span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b>Critical
                                            accounting estimates and judgements</b></span></td></tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p></ix:nonNumeric><div>

</div><div>

</div><ix:continuation continuedAt="_DisclosureOfAccountingJudgementsAndEstimatesExplanatory-c0_cont_2" id="_DisclosureOfAccountingJudgementsAndEstimatesExplanatory-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">The
preparation of financial statements in conformity with IFRS requires management to use judgment in applying its accounting policies and
estimates and assumptions about the future. Estimates and other judgments are continuously evaluated and are based on management&#8217;s
experience and other factors, including expectations about future events that are believed to be reasonable under the circumstances.
Although management uses historical experience and its best knowledge of the expected amounts, events or actions to form the basis for
estimates, actual results may differ from these estimates.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b>&#160;</b></span></p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_DisclosureOfAccountingJudgementsAndEstimatesExplanatory-c0_cont_3" id="_DisclosureOfAccountingJudgementsAndEstimatesExplanatory-c0_cont_2"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b>Critical
accounting estimates:</b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b>&#160;</b></span></p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_DisclosureOfAccountingJudgementsAndEstimatesExplanatory-c0_cont_4" id="_DisclosureOfAccountingJudgementsAndEstimatesExplanatory-c0_cont_3"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b>The
assessment of the recoverable amount of mineral properties as a result of impairment indicators - </b>When indicators of impairment are
identified, recoverable amount calculations are based either on discounted estimated future cash flows or on comparable recent transactions.
The assumptions used are based on management&#8217;s best estimates of what an independent market participant would consider appropriate.
Changes in these assumptions may alter the results of impairment testing, the amount of the impairment charges recorded in the statement
of loss and comprehensive loss and the resulting carrying values of assets.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b>&#160;</b></span></p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_DisclosureOfAccountingJudgementsAndEstimatesExplanatory-c0_cont_5" id="_DisclosureOfAccountingJudgementsAndEstimatesExplanatory-c0_cont_4"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b>Share-based
payments -</b> The fair value of stock options issued is subject to the limitation of the Black-Scholes option pricing model that incorporates
market data and involves uncertainty in estimates used by management in the assumptions. Because the Black-Scholes option pricing model
requires the input of highly subjective assumptions, including the volatility of share prices, changes in subjective input assumptions
can materially affect the fair value estimate.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b>&#160;</b></span></p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_DisclosureOfAccountingJudgementsAndEstimatesExplanatory-c0_cont_6" id="_DisclosureOfAccountingJudgementsAndEstimatesExplanatory-c0_cont_5"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b>Asset
retirement obligations -</b> Significant estimates were utilized in determining future costs to complete groundwater restoration, plugging
and abandonment of wellfields and surface reclamation at the Company&#8217;s uranium in-situ recovery (ISR) sites. Estimating future
costs can be difficult and unpredictable as they are based principally on current legal and regulatory requirements and ISR site closure
plans that may change materially. The laws and regulations governing ISR site closure and remediation in a particular jurisdiction are
subject to review at any time and may be amended to impose additional requirements and conditions which may cause our provisions for
environmental liabilities to be underestimated and could materially affect our financial position or results of operations. Estimates
of future asset retirement obligation costs are also subject to operational risks such as acceptability of treatment techniques or other
operational changes.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p></ix:continuation><div>

</div><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"></p><div>

</div><!-- Field: Page; Sequence: 16; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"></p><div>

</div><table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="border-top: Black 1.5pt solid; width: 100%; padding-top: 2pt; padding-bottom: 2pt; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif"><b>enCore Energy Corp.</b></span></td></tr>
  <tr style="vertical-align: top">
    <td style="border-bottom: Black 1.5pt solid; padding-top: 2pt; padding-bottom: 2pt; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif"><b>Notes
    to the Consolidated Financial Statements</b></span></td></tr>
  <tr style="vertical-align: top">
    <td style="border-bottom: Black 1.5pt solid; padding-top: 2pt; padding-bottom: 2pt; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif"><b>For the years ended December 31, 2022 and December 31, 2021</b></span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif"><b>3.</b></span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b>Critical
                                            accounting estimates and judgements </b>(Continued)</span></td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b>&#160;</b></span></p><div>

</div><ix:continuation continuedAt="_DisclosureOfAccountingJudgementsAndEstimatesExplanatory-c0_cont_7" id="_DisclosureOfAccountingJudgementsAndEstimatesExplanatory-c0_cont_6"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b>Recovery
of deferred tax assets -</b> Judgment is required in determining whether deferred tax assets are recognized in the statement of financial
position. Deferred tax assets, including those arising from unutilized tax losses, require management to assess the likelihood that the
Company will generate taxable earnings in future periods in order to utilize recognized deferred tax assets. Estimates of future taxable
income are based on forecast cash flows from operations and the application of existing tax laws in each jurisdiction. To the extent
that future cash flows and taxable income differ significantly from estimates, the ability of the Company to realize the net deferred
tax assets recorded at the date of the statement of financial position could be impacted. Additionally, future changes in tax laws in
the jurisdictions in which the Company operates could limit the ability of the Company to obtain tax deductions in future periods. The
Company has not recorded any deferred tax assets.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b>&#160;</b></span></p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_DisclosureOfAccountingJudgementsAndEstimatesExplanatory-c0_cont_8" id="_DisclosureOfAccountingJudgementsAndEstimatesExplanatory-c0_cont_7"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b>Amortization
and impairment of intangible assets - </b>Amortization of intangible assets is dependent upon the estimated useful lives, which are determined
through the exercise of judgement. The assessment of any impairment of these assets is dependent upon estimates of recoverable amounts
that take into account factors such as economic and market conditions and the useful lives of assets.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_DisclosureOfAccountingJudgementsAndEstimatesExplanatory-c0_cont_9" id="_DisclosureOfAccountingJudgementsAndEstimatesExplanatory-c0_cont_8"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 36pt"><span style="font-family: Times New Roman, Times, Serif"><b>Critical
accounting judgments:</b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 36pt"><span style="font-family: Times New Roman, Times, Serif"><b>&#160;</b></span></p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_DisclosureOfAccountingJudgementsAndEstimatesExplanatory-c0_cont_10" id="_DisclosureOfAccountingJudgementsAndEstimatesExplanatory-c0_cont_9"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b>The
assessment of indicators of impairment for mineral properties - </b>The Company follows the guidance of IFRS 6 to determine when a mineral
property asset is impaired. This determination requires significant judgment. In making this judgment, the Company evaluates, among other
factors, the results of exploration and evaluation activities to date and the Company&#8217;s future plans to explore and evaluate a
mineral property.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_DisclosureOfAccountingJudgementsAndEstimatesExplanatory-c0_cont_11" id="_DisclosureOfAccountingJudgementsAndEstimatesExplanatory-c0_cont_10"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b>Valuation
of acquired mineral properties &#8211;</b> The valuation of mineral properties acquired by the Company requires significant judgement.
Acquired mineral properties are valued at their fair market value which can require significant estimates in future cash flows, production,
and timing.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b>&#160;</b></span></p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_DisclosureOfAccountingJudgementsAndEstimatesExplanatory-c0_cont_12" id="_DisclosureOfAccountingJudgementsAndEstimatesExplanatory-c0_cont_11"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b>Business
combinations -</b> The determination of whether a set of assets acquired and liabilities assumed constitute a business may require the
Company to make certain judgments, taking into account all facts and circumstances. A business is presumed to be an integrated set of
activities and assets capable of being conducted and managed for the purpose of providing a return in the form of dividends, lower costs
or economic benefits. The acquisition of Azarga Uranium Corporation and its subsidiary entities on December 31, 2021 (Note 10) was determined
to constitute an acquisition of assets.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b>&#160;</b></span></p></ix:continuation><div>

</div><div>

</div><ix:continuation id="_DisclosureOfAccountingJudgementsAndEstimatesExplanatory-c0_cont_12"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b>Determination
of functional currency -</b> In accordance with IAS 21, The Effects of Changes in Foreign Exchange Rates, management determined that
the functional currency of the Company is the Canadian dollar and the functional currency of its subsidiaries is the U.S. Dollar.</span></p></ix:continuation><div>




</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><!-- Field: Page; Sequence: 17; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="border-top: Black 1.5pt solid; width: 100%; padding-top: 2pt; padding-bottom: 2pt; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif"><b>enCore Energy Corp.</b></span></td></tr>
  <tr style="vertical-align: top">
    <td style="border-bottom: Black 1.5pt solid; padding-top: 2pt; padding-bottom: 2pt; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif"><b>Notes
    to the Consolidated Financial Statements</b></span></td></tr>
  <tr style="vertical-align: top">
    <td style="border-bottom: Black 1.5pt solid; padding-top: 2pt; padding-bottom: 2pt; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif"><b>For the years ended December 31, 2022 and December 31, 2021</b></span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><ix:nonNumeric contextRef="c0" continuedAt="_DisclosureOfSignificantInvestmentsInAssociatesExplanatory-c0_cont_1" escape="true" name="ifrs-full:DisclosureOfSignificantInvestmentsInAssociatesExplanatory"><table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif"><b>4.</b></span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b>Investment
                                            in associate</b></span></td></tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b>&#160;</b></span></p></ix:nonNumeric><div>

</div><div>

</div><ix:continuation continuedAt="_DisclosureOfSignificantInvestmentsInAssociatesExplanatory-c0_cont_2" id="_DisclosureOfSignificantInvestmentsInAssociatesExplanatory-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">During
the year ended December 31, 2020, the Company acquired <ix:nonFraction contextRef="c63" decimals="0" format="ixt:num-dot-decimal" name="cve:AcquiredShares" scale="0" unitRef="shares">12,000,000</ix:nonFraction> shares of Group 11 Technologies Inc. (&#8220;Group 11&#8221;), a US-based
technology firm, representing <ix:nonFraction contextRef="c63" decimals="2" format="ixt:num-dot-decimal" name="cve:IssuedAndOutstandingSharesPercentage" scale="-2" unitRef="pure">40</ix:nonFraction>% of the issued and outstanding shares of Group 11. The Company advanced $<ix:nonFraction contextRef="c63" decimals="0" format="ixt:num-dot-decimal" name="cve:AdvancedAmount" scale="0" unitRef="usd">750,000</ix:nonFraction> in accordance with
the Letter of Intent with EnviroLeach Technologies Inc. and Golden Predator Mining Corp. to establish Group 11. The Company has determined
that it exercises significant influence over Group 11 and accounts for this investment using the equity method of accounting. During
the year ended December 31, 2021, Group 11 completed a private placement financing, resulting in the issuance of additional shares and
a dilution of the Company&#8217;s ownership in the associate to <ix:nonFraction contextRef="c5" decimals="4" format="ixt:num-dot-decimal" name="ifrs-full:ProportionOfOwnershipInterestInAssociate" scale="-2" unitRef="pure">34.46</ix:nonFraction>%. During the year ended December 31, 2022, Group 11 issued additional
shares resulting in the dilution of the Company&#8217;s ownership in the associate to <ix:nonFraction contextRef="c0" decimals="4" format="ixt:num-dot-decimal" name="ifrs-full:ProportionOfOwnershipInterestInAssociate" scale="-2" unitRef="pure">33.71</ix:nonFraction>%.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_DisclosureOfSignificantInvestmentsInAssociatesExplanatory-c0_cont_3" id="_DisclosureOfSignificantInvestmentsInAssociatesExplanatory-c0_cont_2"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">As
of December 31, 2022, Group 11 has severely constrained its activities as financing is unavailable in its market. The Company, determined
its investment to be unrecoverable and wrote off the balance of its investment.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 18pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_DisclosureOfSignificantInvestmentsInAssociatesExplanatory-c0_cont_4" id="_DisclosureOfSignificantInvestmentsInAssociatesExplanatory-c0_cont_3"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 18pt; text-indent: 18pt"><span style="font-family: Times New Roman, Times, Serif">The
Company&#8217;s proportional share in the associate at the last available date, June 30<sup>th</sup>, 2022, is as follows:</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 18pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p></ix:continuation><div>

</div><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 18pt"></p><div>

</div><ix:continuation continuedAt="_DisclosureOfSignificantInvestmentsInAssociatesExplanatory-c0_cont_5" id="_DisclosureOfSignificantInvestmentsInAssociatesExplanatory-c0_cont_4"><ix:nonNumeric contextRef="c0" escape="true" name="cve:DisclosureOfProportionalShareAssociatesExplanatory"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td style="padding-left: 0.125in; text-align: center">&#160;</td><td style="text-align: center">&#160;</td>
    <td colspan="2" style="text-align: center">Assets</td><td style="text-align: center">&#160;</td><td style="text-align: center">&#160;</td>
    <td colspan="2" style="text-align: center">Liabilities</td><td style="text-align: center">&#160;</td><td style="text-align: center">&#160;</td>
    <td colspan="2" style="text-align: center">Revenues</td><td style="text-align: center">&#160;</td><td style="text-align: center">&#160;</td>
    <td colspan="2" style="text-align: center">Expenses</td><td style="text-align: center">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center; padding-left: 0.125in">&#160;</td><td style="text-align: center">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">$</td><td style="text-align: center; padding-bottom: 1.5pt">&#160;</td><td style="text-align: center">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">$</td><td style="text-align: center; padding-bottom: 1.5pt">&#160;</td><td style="text-align: center">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">$</td><td style="text-align: center; padding-bottom: 1.5pt">&#160;</td><td style="text-align: center">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">$</td><td style="text-align: center; padding-bottom: 1.5pt">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-indent: -0.125in">Year ended December 31, 2021</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.25in; text-indent: -0.125in; width: 52%">Current</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c3" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:OtherCurrentAssets" scale="0" unitRef="usd">1,078,019</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c3" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:OtherCurrentLiabilities" scale="0" unitRef="usd">120,569</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-106">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;-</div></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-107">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;-</div></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.25in; text-indent: -0.125in">Non-current</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c3" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:OtherNoncurrentAssets" scale="0" unitRef="usd">751,065</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-108">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-109">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-110">-</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.25in; text-indent: -0.125in; text-align: left; padding-bottom: 1.5pt">Loss from operating expenses</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-111">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-112">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-113">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="cve:ExpensesLossFromOperatingExpenses" scale="0" sign="-" unitRef="usd">755,943</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 1.5pt">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c3" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:OtherAssets" scale="0" unitRef="usd">1,829,084</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c3" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:OtherLiabilities" scale="0" unitRef="usd">120,569</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-114">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:OtherOperatingIncomeExpense" scale="0" sign="-" unitRef="usd">755,943</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-indent: -0.125in; font-weight: bold">Year ended December 31, 2022</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.25in; text-indent: -0.125in">Current</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c2" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:OtherCurrentAssets" scale="0" unitRef="usd">609,704</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c2" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:OtherCurrentLiabilities" scale="0" unitRef="usd">39,259</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-115">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-116">-</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.25in; text-indent: -0.125in">Non-current</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c2" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:OtherNoncurrentAssets" scale="0" unitRef="usd">729,261</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-117">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-118">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-119">-</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.25in; text-indent: -0.125in; text-align: left; padding-bottom: 1.5pt">Loss from operating expenses</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-120">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-121">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-122">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="cve:ExpensesLossFromOperatingExpenses" scale="0" sign="-" unitRef="usd">415,769</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 1.5pt">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><ix:nonFraction contextRef="c2" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:OtherAssets" scale="0" unitRef="usd">1,338,965</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><ix:nonFraction contextRef="c2" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:OtherLiabilities" scale="0" unitRef="usd">39,259</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-123">-</div></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">(<ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:OtherOperatingIncomeExpense" scale="0" sign="-" unitRef="usd">415,769</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-indent: -0.125in; font-weight: bold; text-align: left; padding-bottom: 1.5pt">The Company&#8217;s percentage ownership</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><ix:nonFraction contextRef="c0" decimals="4" format="ixt:num-dot-decimal" name="ifrs-full:TaxRateEffectOfForeignTaxRates" scale="-2" unitRef="pure">33.71</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">%</td></tr>
  </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 18pt"></p></ix:nonNumeric></ix:continuation><div>
</div><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 18pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><ix:continuation continuedAt="_DisclosureOfSignificantInvestmentsInAssociatesExplanatory-c0_cont_6" id="_DisclosureOfSignificantInvestmentsInAssociatesExplanatory-c0_cont_5"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt"><span style="font-family: Times New Roman, Times, Serif">The
investment in associate continuity summary is as follows:</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 18pt; text-align: center; text-indent: 18pt"></p></ix:continuation><div>

</div><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><ix:continuation id="_DisclosureOfSignificantInvestmentsInAssociatesExplanatory-c0_cont_6"><ix:nonNumeric contextRef="c0" escape="true" name="ifrs-full:DisclosureOfInterestsInAssociatesExplanatory"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="text-align: center">&#160;</td>
    <td colspan="2" style="text-align: center">Investment in <br/> associate</td><td style="text-align: center">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="text-align: center">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">$</td><td style="text-align: center; padding-bottom: 1.5pt">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 88%; padding-bottom: 1.5pt">Balance, December 31, 2020</td><td style="width: 1%">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; width: 9%; text-align: right"><ix:nonFraction contextRef="c6" decimals="0" format="ixt:num-dot-decimal" name="cve:InvestmentBalance1" scale="0" unitRef="usd">451,221</ix:nonFraction></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Adjustments to carrying value:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in">Proportionate share of net loss</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="cve:ProportionateShareOfNetLoss" scale="0" sign="-" unitRef="usd">260,055</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-align: left">Adjustment to investment in Group 11</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="cve:AdjustmentToInvestmentInGroup11" scale="0" unitRef="usd">469,320</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-align: left">Dilution loss</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="cve:DilutionLoss" scale="0" sign="-" unitRef="usd">95,680</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-align: left; padding-bottom: 1.5pt">Currency translation adjustment</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="cve:CurrencyTranslationAdjustment" scale="0" sign="-" unitRef="usd">466</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-bottom: 1.5pt">Balance, December 31, 2021</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c3" decimals="0" format="ixt:num-dot-decimal" name="cve:InvestmentBalance1" scale="0" unitRef="usd">564,340</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Adjustments to carrying value:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in">Proportionate share of net loss through June 30</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="cve:ProportionateShareOfNetLoss" scale="0" sign="-" unitRef="usd">143,286</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-align: left">Adjustment to investment in Group 11 through June 30</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="cve:AdjustmentToInvestmentInGroup11" scale="0" unitRef="usd">15,675</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in">Write-off of investment</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="cve:WriteoffOfInvestment" scale="0" sign="-" unitRef="usd">443,614</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-align: left; padding-bottom: 1.5pt">Currency translation adjustment</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="cve:CurrencyTranslationAdjustment" scale="0" unitRef="usd">6,885</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; padding-bottom: 1.5pt">Balance, December 31, 2022</td><td style="font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">-</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  </table></ix:nonNumeric></ix:continuation><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><!-- Field: Page; Sequence: 18; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="border-top: Black 1.5pt solid; width: 100%; padding-top: 2pt; padding-bottom: 2pt; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif"><b>enCore Energy Corp.</b></span></td></tr>
  <tr style="vertical-align: top">
    <td style="border-bottom: Black 1.5pt solid; padding-top: 2pt; padding-bottom: 2pt; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif"><b>Notes
    to the Consolidated Financial Statements</b></span></td></tr>
  <tr style="vertical-align: top">
    <td style="border-bottom: Black 1.5pt solid; padding-top: 2pt; padding-bottom: 2pt; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif"><b>For the years ended December 31, 2022 and December 31, 2021</b></span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><ix:nonNumeric contextRef="c0" continuedAt="_DisclosureOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethodExplanatory-c0_cont_1" escape="true" name="ifrs-full:DisclosureOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethodExplanatory"><table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif"><b>5.</b></span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b>Investment
                                            in uranium</b></span></td></tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -18pt"><span style="font-family: Times New Roman, Times, Serif"><b>&#160;</b></span></p></ix:nonNumeric><div>

</div><div>

</div><ix:continuation continuedAt="_DisclosureOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethodExplanatory-c0_cont_2" id="_DisclosureOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethodExplanatory-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">During
the year ended December 31, 2021, the Company entered into purchase agreements to acquire a total of <ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="cve:PurchaseAgreementsAmount" scale="0" unitRef="gbp">300,000</ix:nonFraction> pounds of physical uranium
as U<sub>3</sub>O<sub>8</sub> for a total of $<ix:nonFraction contextRef="c3" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:OtherLongTermInvestments" scale="0" unitRef="usd">9,076,000</ix:nonFraction> including associated expenses to be held as a long-term investment. </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_DisclosureOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethodExplanatory-c0_cont_3" id="_DisclosureOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethodExplanatory-c0_cont_2"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">During
the year ended December 31, 2021, the Company sold <ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="cve:SaleOfPhysicalUranium" scale="0" unitRef="gbp">200,000</ix:nonFraction> pounds of physical uranium as U<sub>3</sub>O<sub>8</sub> for gross proceeds
of $<ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="cve:GrossProceeds" scale="0" unitRef="usd">6,975,000</ix:nonFraction> and a gain of $<ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:GainsOnDisposalsOfInvestments" scale="0" unitRef="usd">524,075</ix:nonFraction>.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_DisclosureOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethodExplanatory-c0_cont_4" id="_DisclosureOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethodExplanatory-c0_cont_3"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">During
the year ended December 31, 2022, the Company sold <ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="cve:SaleOfPhysicalUranium" scale="0" unitRef="gbp">100,000</ix:nonFraction> pounds of physical uranium as U<sub>3</sub>O<sub>8</sub> for gross proceeds
of $<ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="cve:GrossProceeds" scale="0" unitRef="usd">4,245,000</ix:nonFraction> and a gain of $<ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:GainsOnDisposalsOfInvestments" scale="0" unitRef="usd">35,000</ix:nonFraction>.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_DisclosureOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethodExplanatory-c0_cont_5" id="_DisclosureOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethodExplanatory-c0_cont_4"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Investments
in uranium are categorized in Level 2 of the fair value hierarchy (Note 17).</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_DisclosureOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethodExplanatory-c0_cont_6" id="_DisclosureOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethodExplanatory-c0_cont_5"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">The
following table summarizes the fair value of the physical uranium investment:</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify">&#160;</p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_DisclosureOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethodExplanatory-c0_cont_7" id="_DisclosureOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethodExplanatory-c0_cont_6"><ix:nonNumeric contextRef="c0" escape="true" name="cve:ScheduleOfTheFairValueOfThePhysicalUraniumInvestmentTableTextBlck"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">Investment in<br/> uranium</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="text-align: center">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">$</td><td style="text-align: center; padding-bottom: 1.5pt">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1.5pt">Balance, December 31, 2020</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-124">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 88%; text-align: left">Physical uranium</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="cve:PhysicalUranium" scale="0" unitRef="usd">9,076,000</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td>Fair value adjustment</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:AdjustmentsForGainsLossesOnChangeInFairValueOfDerivatives" scale="0" unitRef="usd">1,554,000</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Gain on sale of uranium</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="cve:GainOnSaleOfUranium" scale="0" unitRef="usd">524,075</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Sale of uranium investment</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="cve:SaleOfUraniumInvestment" scale="0" sign="-" unitRef="usd">6,975,000</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">Currency translation adjustment</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:OtherComprehensiveIncomeNetOfTaxChangeInValueOfForeignCurrencyBasisSpreads" scale="0" unitRef="usd">30,925</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-bottom: 1.5pt">Balance, December 31, 2021</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c3" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:CurrentInvestments" scale="0" unitRef="usd">4,210,000</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Sale of uranium investment</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="cve:SaleOfUraniumInvestment" scale="0" sign="-" unitRef="usd">4,245,000</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Gain on sale of uranium</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="cve:GainOnSaleOfUranium" scale="0" unitRef="usd">35,000</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt">Currency translation adjustment</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-125">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; padding-bottom: 1.5pt">Balance, December 31, 2022</td><td style="font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-126">-</div></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p></ix:nonNumeric></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_DisclosureOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethodExplanatory-c0_cont_8" id="_DisclosureOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethodExplanatory-c0_cont_7"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b>Deposits
on uranium investment:</b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b>&#160;</b></span></p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_DisclosureOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethodExplanatory-c0_cont_9" id="_DisclosureOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethodExplanatory-c0_cont_8"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">On
February 15, 2022, the Company entered into a Uranium Concentrates purchase Agreement with an arm&#8217;s length party whereby the Company
will purchase <ix:nonFraction contextRef="c64" decimals="0" format="ixt:num-dot-decimal" name="cve:PurchaseAgreementsAmount" scale="0" unitRef="gbp">200,000</ix:nonFraction> pounds of uranium concentrate from the seller for total consideration of $<ix:nonFraction contextRef="c64" decimals="0" format="ixt:num-dot-decimal" name="cve:TotalConsideration" scale="0" unitRef="usd">8,750,000</ix:nonFraction> ($<ix:nonFraction contextRef="c64" decimals="2" format="ixt:num-dot-decimal" name="cve:TotalConsiderationPerShare" scale="0" unitRef="usdPershares">43.75</ix:nonFraction>/pound). The contract
required an initial payment of $<ix:nonFraction contextRef="c65" decimals="0" format="ixt:num-dot-decimal" name="cve:InitialPayment" scale="0" unitRef="usd">2,000,000</ix:nonFraction>, which was paid in March 2022, and will require a final payment of $<ix:nonFraction contextRef="c66" decimals="0" format="ixt:num-dot-decimal" name="cve:InvestmentAmount" scale="0" unitRef="usd">6,750,000</ix:nonFraction> on March 31,
2023.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_DisclosureOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethodExplanatory-c0_cont_10" id="_DisclosureOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethodExplanatory-c0_cont_9"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">On
August 4, 2022, the Company entered into a Uranium Concentrates purchase Agreement with an arm&#8217;s length party whereby the Company
will purchase <ix:nonFraction contextRef="c67" decimals="0" format="ixt:num-dot-decimal" name="cve:PurchaseAgreementsAmount" scale="0" unitRef="gbp">100,000</ix:nonFraction> pounds of uranium concentrate from the seller for total consideration of $<ix:nonFraction contextRef="c67" decimals="0" format="ixt:num-dot-decimal" name="cve:TotalConsideration" scale="0" unitRef="usd">4,900,000</ix:nonFraction> ($<ix:nonFraction contextRef="c67" decimals="2" format="ixt:num-dot-decimal" name="cve:TotalConsiderationPerShare" scale="0" unitRef="usdPershares">49.00</ix:nonFraction>/pound). The contract
required an initial payment of $<ix:nonFraction contextRef="c68" decimals="0" format="ixt:num-dot-decimal" name="cve:InitialPayment" scale="0" unitRef="usd">1,000,000</ix:nonFraction>, which was paid in August 2022, and will require a final payment of $<ix:nonFraction contextRef="c69" decimals="0" format="ixt:num-dot-decimal" name="cve:InvestmentAmount" scale="0" unitRef="usd">3,900,000</ix:nonFraction> two days prior
to the delivery date, which shall occur between May 1, 2023 and August 31, 2023.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_DisclosureOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethodExplanatory-c0_cont_11" id="_DisclosureOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethodExplanatory-c0_cont_10"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">On
December 15, 2022, the Company entered into a Uranium concentrates purchase agreement with an arm&#8217;s length party whereby the Company
will purchase <ix:nonFraction contextRef="c70" decimals="0" format="ixt:num-dot-decimal" name="cve:PurchaseAgreementsAmount" scale="0" unitRef="gbp">100,000</ix:nonFraction> pounds of uranium concentrate from the seller for total consideration of $<ix:nonFraction contextRef="c70" decimals="0" format="ixt:num-dot-decimal" name="cve:TotalConsideration" scale="0" unitRef="usd">5,922,500</ix:nonFraction> ($<ix:nonFraction contextRef="c70" decimals="3" format="ixt:num-dot-decimal" name="cve:TotalConsiderationPerShare" scale="0" unitRef="usdPershares">59.225</ix:nonFraction>/pound) in January
2023.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p></ix:continuation><div>

</div><div>

</div><ix:continuation id="_DisclosureOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethodExplanatory-c0_cont_11"><ix:nonNumeric contextRef="c0" escape="true" name="cve:ScheduleOfUraniumConcentratesPurchaseAgreementTableTextBlock"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td style="padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 1.5pt; text-align: center">&#160;</td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Purchase Commitments in Pounds</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Total Purchase Price</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; width: 76%">Fiscal 2023</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c71" decimals="0" format="ixt:num-dot-decimal" name="cve:PurchaseCommitments" scale="0" unitRef="gbp">400,000</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c71" decimals="0" format="ixt:num-dot-decimal" name="cve:TotalPurchasePrice" scale="0" unitRef="usd">19,572,500</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-indent: -0.125in">Fiscal 2024</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-127">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-128">-</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in">Fiscal 2025</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-129">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-130">-</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-indent: -0.125in">Fiscal 2026</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-131">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-132">-</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in">Fiscal 2027</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-133">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-134">-</div></td><td style="text-align: left">&#160;</td></tr>
  </table></ix:nonNumeric></ix:continuation><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><!-- Field: Page; Sequence: 19; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="border-top: Black 1.5pt solid; width: 100%; padding-top: 2pt; padding-bottom: 2pt; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif"><b>enCore Energy Corp.</b></span></td></tr>
  <tr style="vertical-align: top">
    <td style="border-bottom: Black 1.5pt solid; padding-top: 2pt; padding-bottom: 2pt; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif"><b>Notes
    to the Consolidated Financial Statements</b></span></td></tr>
  <tr style="vertical-align: top">
    <td style="border-bottom: Black 1.5pt solid; padding-top: 2pt; padding-bottom: 2pt; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif"><b>For the years ended December 31, 2022 and December 31, 2021</b></span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><ix:nonNumeric contextRef="c0" continuedAt="_DisclosureOfMarketRiskExplanatory-c0_cont_1" escape="true" name="ifrs-full:DisclosureOfMarketRiskExplanatory"><table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif"><b>6.</b></span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b>Marketable
                                            securities</b></span></td></tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -18pt"><span style="font-family: Times New Roman, Times, Serif"><b>&#160;</b></span></p></ix:nonNumeric><div>

</div><div>

</div><ix:continuation continuedAt="_DisclosureOfMarketRiskExplanatory-c0_cont_2" id="_DisclosureOfMarketRiskExplanatory-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">In
May 2022, the Company divested of Cibola Resources, LLC to Elephant Capital (&#8220;Elephant&#8221;) pursuant to a Share Purchase Agreement
whereby the Company received consideration in the form of <ix:nonFraction contextRef="c76" decimals="0" format="ixt:num-dot-decimal" name="cve:CommonShares" scale="0" unitRef="shares">11,308,250</ix:nonFraction> common shares with a market value of $<ix:nonFraction contextRef="c77" decimals="2" format="ixt:num-dot-decimal" name="cve:MarketValuePerShare" scale="0" unitRef="usdPershares">0.27</ix:nonFraction> per share. Elephant was
subsequently acquired by Evolving Gold, who renamed themselves American Future Fuel Corp (&#8220;AFFC&#8221;). Accordingly, the <ix:nonFraction contextRef="c76" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:NumberOfSharesIssuedAndFullyPaid" scale="0" unitRef="shares">11,308,250</ix:nonFraction>
shares of Elephant were converted to <ix:nonFraction contextRef="c77" decimals="0" format="ixt:num-dot-decimal" name="cve:ConvertedShares" scale="0" unitRef="shares">11,308,250</ix:nonFraction> shares of AFFC (CSE: AMPS).</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_DisclosureOfMarketRiskExplanatory-c0_cont_3" id="_DisclosureOfMarketRiskExplanatory-c0_cont_2"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">The
cost base of the Company&#8217;s shareholdings is <ix:nonNumeric contextRef="c78" name="ifrs-full:DescriptionOfKeyAssumptionsOnWhichManagementHasBasedDeterminationOfFairValueLessCostsOfDisposal">$3,085,965</ix:nonNumeric>. In accordance with the Company&#8217;s significant accounting policy, the
common shares are classified as FVTPL, with gains/losses being recognized to the consolidated statements of loss and comprehensive loss.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_DisclosureOfMarketRiskExplanatory-c0_cont_4" id="_DisclosureOfMarketRiskExplanatory-c0_cont_3"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">As
of December 31, 2022, <ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="cve:TradingShares" scale="0" unitRef="shares">9,046,600</ix:nonFraction> of the shares held are free trading (the &#8220;Trading Shares&#8221;) or will become free trading within
the next 12 months. These shares have been classified as a current asset on the consolidated statements of financial position, due to
the Company&#8217;s ability to liquidate those shareholdings within the next 12 months. These shares are carried at a fair value of $<ix:nonFraction contextRef="c79" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:FinancialLiabilitiesAtFairValue" scale="0" unitRef="usd">3,139,325</ix:nonFraction>
($<ix:nonFraction contextRef="c79" decimals="2" format="ixt:num-dot-decimal" name="ifrs-full:ParValuePerShare" scale="0" unitRef="usdPershares">0.35</ix:nonFraction> per share).</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_DisclosureOfMarketRiskExplanatory-c0_cont_5" id="_DisclosureOfMarketRiskExplanatory-c0_cont_4"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">The
Final <ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="cve:ReleasedShares" scale="0" unitRef="shares">2,261,650</ix:nonFraction> Released Shares are presented as a non-current asset due to the fact that the escrow provisions restrict the Company&#8217;s
ability to dispose of the securities within the next 12 months and are carried at a fair value of $<ix:nonFraction contextRef="c2" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:FinancialLiabilitiesAtFairValue" scale="0" unitRef="usd">784,832</ix:nonFraction> ($<ix:nonFraction contextRef="c2" decimals="2" format="ixt:num-dot-decimal" name="ifrs-full:ParValuePerShare" scale="0" unitRef="usdPershares">0.35</ix:nonFraction> per share).</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_DisclosureOfMarketRiskExplanatory-c0_cont_6" id="_DisclosureOfMarketRiskExplanatory-c0_cont_5"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">In
October 2022, the Company received <ix:nonFraction contextRef="c80" decimals="0" format="ixt:num-dot-decimal" name="cve:CommonShares" scale="0" unitRef="shares">80,000</ix:nonFraction> common shares of Uravan Minerals, Inc with a market value of $<ix:nonFraction contextRef="c81" decimals="2" format="ixt:num-dot-decimal" name="cve:MarketValuePerShare" scale="0" unitRef="usdPershares">0.12</ix:nonFraction> per share pursuant to its
previous agreement with Prime Fuels, Inc to divest of the Company&#8217;s LS mining claims. The agreement required that Prime Fuels,
Inc pay to the Company <ix:nonFraction contextRef="c81" decimals="2" format="ixt:num-dot-decimal" name="cve:PrimeFuelsConsiderationPercentage" scale="-2" unitRef="pure">10</ix:nonFraction>% of any consideration Prime Fuels, Inc received upon sale, transfer, or exchange to a third party. Uravan Minerals,
Inc acquired Prime Fuels, Inc and all of the mineral claims on October 28, 2022. The cost base of the Company&#8217;s shareholdings is
$<ix:nonFraction contextRef="c80" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:Assets" scale="0" unitRef="usd">9,530</ix:nonFraction>. The shares have been classified as a current asset on the consolidated statements of financial position, due to the Company&#8217;s
ability to liquidate those shareholdings within the next 12 months. These shares are carried at a fair value of $<ix:nonFraction contextRef="c80" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:FinancialLiabilitiesAtFairValue" scale="0" unitRef="usd">23,036</ix:nonFraction> ($<ix:nonFraction contextRef="c80" decimals="2" format="ixt:num-dot-decimal" name="ifrs-full:ParValuePerShare" scale="0" unitRef="usdPershares">0.30</ix:nonFraction> per share).</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_DisclosureOfMarketRiskExplanatory-c0_cont_7" id="_DisclosureOfMarketRiskExplanatory-c0_cont_6"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">The
following table summarizes the fair value of the Company&#8217;s marketable securities at December 31, 2022:</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p></ix:continuation><div>

</div><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"></p><div>

</div><ix:continuation id="_DisclosureOfMarketRiskExplanatory-c0_cont_7"><ix:nonNumeric contextRef="c0" escape="true" name="cve:ScheduleOfMarketableSecuritiesTableTextBlock"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="text-align: center; font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Marketable<br/> securities (current)</td><td style="text-align: center; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Marketable<br/> securities (non-current)</td><td style="text-align: center; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Total</td><td style="text-align: center; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">$</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">$</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">$</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%; padding-bottom: 1.5pt">Balance, December 31, 2020, and 2021</td><td style="border-bottom: Black 1.5pt solid; width: 1%">&#160;</td>
    <td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-135">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;-</div></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-136">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;-</div></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-137">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;-</div></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Additions</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c84" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:AdditionalProvisionsOtherProvisions" scale="0" unitRef="usd">2,443,094</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c85" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:AdditionalProvisionsOtherProvisions" scale="0" unitRef="usd">608,391</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:AdditionalProvisionsOtherProvisions" scale="0" unitRef="usd">3,051,485</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td>Fair value adjustments</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c84" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:AdjustmentsForGainsLossesOnFairValueAdjustmentInvestmentProperty" scale="0" unitRef="usd">848,814</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c85" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:AdjustmentsForGainsLossesOnFairValueAdjustmentInvestmentProperty" scale="0" unitRef="usd">208,592</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:AdjustmentsForGainsLossesOnFairValueAdjustmentInvestmentProperty" scale="0" unitRef="usd">1,057,406</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">Currency translation adjustment</td><td style="border-bottom: Black 1.5pt solid">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c84" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:RestructuringReserveTranslationAdjustment" scale="0" sign="-" unitRef="usd">129,547</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c85" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:RestructuringReserveTranslationAdjustment" scale="0" sign="-" unitRef="usd">32,151</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:RestructuringReserveTranslationAdjustment" scale="0" sign="-" unitRef="usd">161,698</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font-weight: bold; padding-bottom: 1.5pt">Balance, December 31, 2022</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><ix:nonFraction contextRef="c86" decimals="0" format="ixt:num-dot-decimal" name="cve:MarketablesSecurities" scale="0" unitRef="usd">3,162,361</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><ix:nonFraction contextRef="c87" decimals="0" format="ixt:num-dot-decimal" name="cve:MarketablesSecurities" scale="0" unitRef="usd">784,832</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><ix:nonFraction contextRef="c2" decimals="0" format="ixt:num-dot-decimal" name="cve:MarketablesSecurities" scale="0" unitRef="usd">3,947,193</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  </table></ix:nonNumeric></ix:continuation><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><!-- Field: Page; Sequence: 20; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="border-top: Black 1.5pt solid; width: 100%; padding-top: 2pt; padding-bottom: 2pt; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif"><b>enCore Energy Corp.</b></span></td></tr>
  <tr style="vertical-align: top">
    <td style="border-bottom: Black 1.5pt solid; padding-top: 2pt; padding-bottom: 2pt; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif"><b>Notes
    to the Consolidated Financial Statements</b></span></td></tr>
  <tr style="vertical-align: top">
    <td style="border-bottom: Black 1.5pt solid; padding-top: 2pt; padding-bottom: 2pt; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif"><b>For the years ended December 31, 2022 and December 31, 2021</b></span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><ix:nonNumeric contextRef="c0" continuedAt="_DisclosureOfIntangibleAssetsExplanatory-c0_cont_1" escape="true" name="ifrs-full:DisclosureOfIntangibleAssetsExplanatory"><table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif"><b>7.</b></span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b>Intangible
                                            assets</b></span></td></tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -18pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p></ix:nonNumeric><div>

</div><div>

</div><ix:continuation continuedAt="_DisclosureOfIntangibleAssetsExplanatory-c0_cont_2" id="_DisclosureOfIntangibleAssetsExplanatory-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">In
2018, the Company acquired access to certain uranium exploration data from VANE Minerals (US) LLC (&#8220;VANE&#8221;). In exchange the
Company issued <ix:nonFraction contextRef="c88" decimals="0" format="ixt:num-dot-decimal" name="cve:CommonSharesIssued" scale="0" unitRef="shares">3,000,000</ix:nonFraction> common shares at a fair value of $<ix:nonFraction contextRef="c88" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:PlanAssetsAtFairValue" scale="0" unitRef="usd">264,096</ix:nonFraction> and granted VANE certain back-in rights for any projects developed
from the use of the data. The primary term of the agreement is <ix:nonNumeric contextRef="c89" format="ixt-sec:durwordsen" name="cve:PrimaryTerm">five years</ix:nonNumeric>, and it may be renewed by the Company by written notice for
three successive renewal periods of <ix:nonNumeric contextRef="c89" format="ixt-sec:durwordsen" name="cve:RenewalPeriods">three years</ix:nonNumeric> each. Thus, the intangible asset has been determined to have a life of <ix:nonNumeric contextRef="c89" format="ixt-sec:duryear" name="cve:IntangibleAssetDeterminedLife">14</ix:nonNumeric> years.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_DisclosureOfIntangibleAssetsExplanatory-c0_cont_3" id="_DisclosureOfIntangibleAssetsExplanatory-c0_cont_2"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">In
2020, for $<ix:nonFraction contextRef="c90" decimals="0" format="ixt:num-dot-decimal" name="cve:AcquiredAmonut" scale="0" unitRef="usd">67,251</ix:nonFraction> the Company permanently acquired certain electronic data pertaining to properties and geology in South Texas from Signal
Equities, LLC. The intangible asset was determined to have an indefinite life and therefore is not being amortized but reviewed for impairment
annually and more frequently if required.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_DisclosureOfIntangibleAssetsExplanatory-c0_cont_4" id="_DisclosureOfIntangibleAssetsExplanatory-c0_cont_3"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">In
2020, the Company permanently acquired the Grants Mineral Belt database through its asset acquisition with Westwater Resources, Inc.
The intangible asset was determined to have an indefinite life and therefore is not being amortized but reviewed for impairment annually
and more frequently if required.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_DisclosureOfIntangibleAssetsExplanatory-c0_cont_5" id="_DisclosureOfIntangibleAssetsExplanatory-c0_cont_4"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">In
2021, the Company permanently acquired additional borehole logs for the Grants Mineral Belt property for $<ix:nonFraction contextRef="c91" decimals="0" format="ixt:num-dot-decimal" name="cve:AcquiredAmonut" scale="0" unitRef="usd">17,500</ix:nonFraction>. The intangible asset
was determined to have an indefinite life and therefore is not being amortized but reviewed for impairment annually or more frequently
if required.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_DisclosureOfIntangibleAssetsExplanatory-c0_cont_6" id="_DisclosureOfIntangibleAssetsExplanatory-c0_cont_5"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">In
2022, the Company acquired access to the Getty Minerals Database from Platoro West Incorporated for $<ix:nonFraction contextRef="c92" decimals="0" format="ixt:num-dot-decimal" name="cve:AcquiredAmonut" scale="0" unitRef="usd">55,500</ix:nonFraction> (Note 15). The intangible
asset was determined to have an indefinite life and therefore is not being amortized but reviewed for impairment annually and more frequently
if required.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p></ix:continuation><div>

</div><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"></p><div>

</div><ix:continuation id="_DisclosureOfIntangibleAssetsExplanatory-c0_cont_6"><ix:nonNumeric contextRef="c0" escape="true" name="ifrs-full:DisclosureOfDetailedInformationAboutIntangibleAssetsExplanatory"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td style="padding-left: 0.125in; text-align: center">&#160;</td><td style="text-align: center; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">VANE<br/> Agreement<br/> $</td><td style="text-align: center; padding-bottom: 1.5pt">&#160;</td><td style="text-align: center; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">Getty<br/> Database<br/> $</td><td style="text-align: center; padding-bottom: 1.5pt">&#160;</td><td style="text-align: center; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">Signal<br/> Equities<br/> Database<br/> $</td><td style="text-align: center; padding-bottom: 1.5pt">&#160;</td><td style="text-align: center; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">Grants<br/> Mineral Belt<br/> Database<br/> $</td><td style="text-align: center; padding-bottom: 1.5pt">&#160;</td><td style="text-align: center; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">Total<br/> $</td><td style="text-align: center; padding-bottom: 1.5pt">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; width: 40%">Balance, December 31, 2020</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c93" decimals="0" format="ixt:num-dot-decimal" name="cve:IntangibleAssetsBalance" scale="0" unitRef="usd">226,368</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">-</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c94" decimals="0" format="ixt:num-dot-decimal" name="cve:IntangibleAssetsBalance" scale="0" unitRef="usd">67,251</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c95" decimals="0" format="ixt:num-dot-decimal" name="cve:IntangibleAssetsBalance" scale="0" unitRef="usd">190,012</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c6" decimals="0" format="ixt:num-dot-decimal" name="cve:IntangibleAssetsBalance" scale="0" unitRef="usd">483,631</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-indent: -0.125in">Additions</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c96" decimals="0" format="ixt:num-dot-decimal" name="cve:Additions" scale="0" unitRef="usd">17,500</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="cve:Additions" scale="0" unitRef="usd">17,500</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in">Amortization</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c97" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill" scale="0" unitRef="usd">20,515</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill" scale="0" unitRef="usd">20,515</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left; padding-bottom: 1.5pt">Currency Translation Adjustment</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c97" decimals="0" format="ixt:num-dot-decimal" name="cve:CurrencyTranslationAdjustment1" scale="0" unitRef="usd">1,651</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c96" decimals="0" format="ixt:num-dot-decimal" name="cve:CurrencyTranslationAdjustment1" scale="0" unitRef="usd">9,729</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="cve:CurrencyTranslationAdjustment1" scale="0" unitRef="usd">11,380</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 1.5pt">Balance, December 31, 2021</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c98" decimals="0" format="ixt:num-dot-decimal" name="cve:IntangibleAssetsBalance" scale="0" unitRef="usd">207,504</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c99" decimals="0" format="ixt:num-dot-decimal" name="cve:IntangibleAssetsBalance" scale="0" unitRef="usd">67,251</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c100" decimals="0" format="ixt:num-dot-decimal" name="cve:IntangibleAssetsBalance" scale="0" unitRef="usd">217,241</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c3" decimals="0" format="ixt:num-dot-decimal" name="cve:IntangibleAssetsBalance" scale="0" unitRef="usd">491,996</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-indent: -0.125in">Additions</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c101" decimals="0" format="ixt:num-dot-decimal" name="cve:Additions" scale="0" unitRef="usd">55,500</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="cve:Additions" scale="0" unitRef="usd">55,500</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in">Amortization</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c102" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill" scale="0" unitRef="usd">19,764</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill" scale="0" unitRef="usd">19,764</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left; padding-bottom: 1.5pt">Currency Translation Adjustment</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c102" decimals="0" format="ixt:num-dot-decimal" name="cve:CurrencyTranslationAdjustment1" scale="0" unitRef="usd">900</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c101" decimals="0" format="ixt:num-dot-decimal" name="cve:CurrencyTranslationAdjustment1" scale="0" sign="-" unitRef="usd">350</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="cve:CurrencyTranslationAdjustment1" scale="0" unitRef="usd">550</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; font-weight: bold; padding-bottom: 1.5pt">Balance, December 31, 2022</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><ix:nonFraction contextRef="c103" decimals="0" format="ixt:num-dot-decimal" name="cve:IntangibleAssetsBalance" scale="0" unitRef="usd">188,640</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><ix:nonFraction contextRef="c104" decimals="0" format="ixt:num-dot-decimal" name="cve:IntangibleAssetsBalance" scale="0" unitRef="usd">55,150</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><ix:nonFraction contextRef="c105" decimals="0" format="ixt:num-dot-decimal" name="cve:IntangibleAssetsBalance" scale="0" unitRef="usd">67,251</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><ix:nonFraction contextRef="c106" decimals="0" format="ixt:num-dot-decimal" name="cve:IntangibleAssetsBalance" scale="0" unitRef="usd">217,241</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><ix:nonFraction contextRef="c2" decimals="0" format="ixt:num-dot-decimal" name="cve:IntangibleAssetsBalance" scale="0" unitRef="usd">528,282</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  </table></ix:nonNumeric></ix:continuation><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><!-- Field: Page; Sequence: 21; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="border-top: Black 1.5pt solid; width: 100%; padding-top: 2pt; padding-bottom: 2pt; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif"><b>enCore Energy Corp.</b></span></td></tr>
  <tr style="vertical-align: top">
    <td style="border-bottom: Black 1.5pt solid; padding-top: 2pt; padding-bottom: 2pt; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif"><b>Notes
    to the Consolidated Financial Statements</b></span></td></tr>
  <tr style="vertical-align: top">
    <td style="border-bottom: Black 1.5pt solid; padding-top: 2pt; padding-bottom: 2pt; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif"><b>For the years ended December 31, 2022 and December 31, 2021</b></span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><ix:nonNumeric contextRef="c0" continuedAt="_DisclosureOfPropertyPlantAndEquipmentExplanatory-c0_cont_1" escape="true" name="ifrs-full:DisclosureOfPropertyPlantAndEquipmentExplanatory"><table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif"><b>8.</b></span></td><td><span style="font-family: Times New Roman, Times, Serif"><b>Property,
                                            plant, and equipment</b></span></td></tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-indent: -18pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p></ix:nonNumeric><div>

</div><div>

</div><ix:continuation id="_DisclosureOfPropertyPlantAndEquipmentExplanatory-c0_cont_1"><ix:nonNumeric contextRef="c0" escape="true" name="ifrs-full:DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="text-align: center; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">Uranium<br/> plants<br/> $</td><td style="text-align: center; padding-bottom: 1.5pt">&#160;</td><td style="text-align: center; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">Other property,<br/> plant, and equipment<br/> $</td><td style="text-align: center; padding-bottom: 1.5pt">&#160;</td><td style="text-align: center; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">Furniture<br/> $</td><td style="text-align: center; padding-bottom: 1.5pt">&#160;</td><td style="text-align: center; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">Buildings<br/> $</td><td style="text-align: center; padding-bottom: 1.5pt">&#160;</td><td style="text-align: center; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">Software<br/> $</td><td style="text-align: center; padding-bottom: 1.5pt">&#160;</td><td style="text-align: center; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">Total<br/> $</td><td style="text-align: center; padding-bottom: 1.5pt">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 28%">Balance, December 31, 2020</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c107" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:PropertyPlantAndEquipmentCarryingAmountAtCostOfRevaluedAssets" scale="0" unitRef="usd">1,196,108</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c108" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:PropertyPlantAndEquipmentCarryingAmountAtCostOfRevaluedAssets" scale="0" unitRef="usd">288,728</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-138">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;-</div></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-139">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;-</div></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-140">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;-</div></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c6" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:PropertyPlantAndEquipmentCarryingAmountAtCostOfRevaluedAssets" scale="0" unitRef="usd">1,484,836</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td>Additions</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c112" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment" scale="0" unitRef="usd">282,339</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-141">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c114" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment" scale="0" unitRef="usd">16,471</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c115" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment" scale="0" unitRef="usd">62,946</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-142">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment" scale="0" unitRef="usd">361,756</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Disposals</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-143">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-144">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-145">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-146">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-147">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-148">-</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in">Depreciation</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c112" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:DepreciationExpense" scale="0" unitRef="usd">168,932</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c113" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:DepreciationExpense" scale="0" unitRef="usd">73,980</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c114" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:DepreciationExpense" scale="0" unitRef="usd">2,146</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-149">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-150">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:DepreciationExpense" scale="0" unitRef="usd">245,058</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in">Impairment</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-151">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-152">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-153">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-154">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-155">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-156">-</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Currency translation adjustment</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-157">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-158">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c114" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation" scale="0" unitRef="usd">2,145</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-159">&#160;</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-160">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation" scale="0" unitRef="usd">2,145</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1.5pt">Balance, December 31, 2021</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c117" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:PropertyPlantAndEquipmentCarryingAmountAtCostOfRevaluedAssets" scale="0" unitRef="usd">1,309,515</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c118" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:PropertyPlantAndEquipmentCarryingAmountAtCostOfRevaluedAssets" scale="0" unitRef="usd">214,748</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c119" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:PropertyPlantAndEquipmentCarryingAmountAtCostOfRevaluedAssets" scale="0" unitRef="usd">16,470</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c120" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:PropertyPlantAndEquipmentCarryingAmountAtCostOfRevaluedAssets" scale="0" unitRef="usd">62,946</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-161">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c3" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:PropertyPlantAndEquipmentCarryingAmountAtCostOfRevaluedAssets" scale="0" unitRef="usd">1,603,679</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-bottom: 1.5pt">Additions</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c122" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment" scale="0" unitRef="usd">758,747</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c123" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment" scale="0" unitRef="usd">172,198</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c124" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment" scale="0" unitRef="usd">8,507</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-162">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c126" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment" scale="0" unitRef="usd">60,135</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment" scale="0" unitRef="usd">999,587</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Disposals</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-163">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-164">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-165">&#160;</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-166">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-167">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-168">-</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in">Depreciation</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c122" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:DepreciationExpense" scale="0" unitRef="usd">162,208</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c123" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:DepreciationExpense" scale="0" unitRef="usd">78,646</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c124" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:DepreciationExpense" scale="0" unitRef="usd">4,377</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c125" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:DepreciationExpense" scale="0" unitRef="usd">2,316</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c126" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:DepreciationExpense" scale="0" unitRef="usd">21,298</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:DepreciationExpense" scale="0" unitRef="usd">268,845</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in">Impairment</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-169">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-170">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-171">&#160;</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-172">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-173">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-174">-</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt">Currency translation adjustment</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-175">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-176">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-177">&#160;</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-178">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-179">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-180">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; padding-bottom: 1.5pt">Balance, December 31, 2022</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><ix:nonFraction contextRef="c127" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:PropertyPlantAndEquipmentCarryingAmountAtCostOfRevaluedAssets" scale="0" unitRef="usd">1,906,054</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><ix:nonFraction contextRef="c128" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:PropertyPlantAndEquipmentCarryingAmountAtCostOfRevaluedAssets" scale="0" unitRef="usd">308,300</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><ix:nonFraction contextRef="c129" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:PropertyPlantAndEquipmentCarryingAmountAtCostOfRevaluedAssets" scale="0" unitRef="usd">20,600</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><ix:nonFraction contextRef="c130" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:PropertyPlantAndEquipmentCarryingAmountAtCostOfRevaluedAssets" scale="0" unitRef="usd">60,630</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><ix:nonFraction contextRef="c131" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:PropertyPlantAndEquipmentCarryingAmountAtCostOfRevaluedAssets" scale="0" unitRef="usd">38,837</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><ix:nonFraction contextRef="c2" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:PropertyPlantAndEquipmentCarryingAmountAtCostOfRevaluedAssets" scale="0" unitRef="usd">2,334,421</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  </table></ix:nonNumeric></ix:continuation><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-indent: -18pt"></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-indent: -18pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><ix:nonNumeric contextRef="c0" continuedAt="_DisclosureOfQuantitativeInformationAboutRightofuseAssetsExplanatory-c0_cont_1" escape="true" name="ifrs-full:DisclosureOfQuantitativeInformationAboutRightofuseAssetsExplanatory"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%"><tr style="vertical-align: top">
<td style="width: 18pt"></td><td style="width: 18pt"><span style="font-family: Times New Roman, Times, Serif"><b>9.</b></span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b>Right-of-use
                                            assets</b></span></td></tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -18pt"><span style="font-family: Times New Roman, Times, Serif"><b>&#160;</b></span></p></ix:nonNumeric><div>

</div><div>

</div><ix:continuation continuedAt="_DisclosureOfQuantitativeInformationAboutRightofuseAssetsExplanatory-c0_cont_2" id="_DisclosureOfQuantitativeInformationAboutRightofuseAssetsExplanatory-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif">The
Company had a contractual arrangement to lease a copier through August 8, 2022.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_DisclosureOfQuantitativeInformationAboutRightofuseAssetsExplanatory-c0_cont_3" id="_DisclosureOfQuantitativeInformationAboutRightofuseAssetsExplanatory-c0_cont_2"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">In
2021, the Company entered a contractual agreement to lease office space in Corpus Christi, Texas through June 30, 2025. The terms of
the lease call for a monthly lease payment of $<ix:nonFraction contextRef="c91" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:OperatingLeasePayments" scale="0" unitRef="usd">5,417</ix:nonFraction>. The Company recorded a right-of use (&#8220;ROU&#8221;) asset based on the corresponding
lease obligation of $<ix:nonFraction contextRef="c132" decimals="0" format="ixt:num-dot-decimal" name="cve:CorrespondingLeaseObligation" scale="0" unitRef="usd">221,139</ix:nonFraction> on July 1, 2021.When measuring the present value of lease obligations, the remaining lease payments were
discounted using the estimated borrowing rate of <ix:nonFraction contextRef="c133" decimals="2" format="ixt:num-dot-decimal" name="ifrs-full:BorrowingsInterestRate" scale="-2" unitRef="pure">7</ix:nonFraction>%.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_DisclosureOfQuantitativeInformationAboutRightofuseAssetsExplanatory-c0_cont_4" id="_DisclosureOfQuantitativeInformationAboutRightofuseAssetsExplanatory-c0_cont_3"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">In
2021, the Company acquired a contractual agreement to lease additional office space in Vancouver, B.C. through July 10, 2023. The terms
of the lease call for a monthly payment of $<ix:nonFraction contextRef="c91" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:OperatingLeasePayments" scale="0" unitRef="cad">4,068</ix:nonFraction> CAD. The Company recorded an ROU asset based on that corresponding lease obligation
of $<ix:nonFraction contextRef="c91" decimals="0" format="ixt:num-dot-decimal" name="cve:CorrespondingLeaseObligation" scale="0" unitRef="usd">45,444</ix:nonFraction>. When measuring the present value of lease obligations, the Company discounted the remaining lease payments using the estimated
borrowing rate of <ix:nonFraction contextRef="c3" decimals="2" format="ixt:num-dot-decimal" name="ifrs-full:BorrowingsInterestRate" scale="-2" unitRef="pure">7</ix:nonFraction>%.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_DisclosureOfQuantitativeInformationAboutRightofuseAssetsExplanatory-c0_cont_5" id="_DisclosureOfQuantitativeInformationAboutRightofuseAssetsExplanatory-c0_cont_4"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">In
2022, the Company entered a contractual agreement to lease office space in Corpus Christi, Texas through August 31, 2024. The terms of
the lease call for a monthly lease payment of $<ix:nonFraction contextRef="c92" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:OperatingLeasePayments" scale="0" unitRef="usd">1,640</ix:nonFraction>. The Company recorded an ROU asset based on the corresponding lease obligation of
$<ix:nonFraction contextRef="c92" decimals="0" format="ixt:num-dot-decimal" name="cve:CorrespondingLeaseObligation" scale="0" unitRef="usd">34,898</ix:nonFraction> on September 1, 2022. When measuring the present value of lease obligations, the remaining lease payments were discounted using
the Company&#8217;s estimated borrowing rate of <ix:nonFraction contextRef="c2" decimals="2" format="ixt:num-dot-decimal" name="ifrs-full:BorrowingsInterestRate" scale="-2" unitRef="pure">7</ix:nonFraction>%.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_DisclosureOfQuantitativeInformationAboutRightofuseAssetsExplanatory-c0_cont_6" id="_DisclosureOfQuantitativeInformationAboutRightofuseAssetsExplanatory-c0_cont_5"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
change in the ROU assets during the years ended December 31, 2021 and December 31, 2022 was as follows:</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p></ix:continuation><div>

</div><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><ix:continuation continuedAt="_DisclosureOfQuantitativeInformationAboutRightofuseAssetsExplanatory-c0_cont_7" id="_DisclosureOfQuantitativeInformationAboutRightofuseAssetsExplanatory-c0_cont_6"><ix:nonNumeric contextRef="c0" escape="true" name="cve:DisclosureOfChangeInTheROUAssetsTableTextBlock"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td style="text-align: center; padding-bottom: 1.5pt">&#160;</td><td style="text-align: center; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">Leased copier<br/> $</td><td style="text-align: center; padding-bottom: 1.5pt">&#160;</td><td style="text-align: center; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">Leased offices<br/> $</td><td style="text-align: center; padding-bottom: 1.5pt">&#160;</td><td style="text-align: center; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">Total<br/> $</td><td style="text-align: center; padding-bottom: 1.5pt">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%">Balance, December 31, 2020</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c134" decimals="0" format="ixt:num-dot-decimal" name="cve:Right-of-UseAssetsBalance" scale="0" unitRef="usd">8,867</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-181">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;-</div></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c6" decimals="0" format="ixt:num-dot-decimal" name="cve:Right-of-UseAssetsBalance" scale="0" unitRef="usd">8,867</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td>Additions</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-182">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c137" decimals="0" format="ixt:num-dot-decimal" name="cve:Right-of-UseAssetsAdditions" scale="0" unitRef="usd">266,583</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="cve:Right-of-UseAssetsAdditions" scale="0" unitRef="usd">266,583</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Depreciation</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c136" decimals="0" format="ixt:num-dot-decimal" name="cve:Right-of-UseAssetsDepreciation" scale="0" sign="-" unitRef="usd">5,451</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c137" decimals="0" format="ixt:num-dot-decimal" name="cve:Right-of-UseAssetsDepreciation" scale="0" sign="-" unitRef="usd">27,642</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="cve:Right-of-UseAssetsDepreciation" scale="0" sign="-" unitRef="usd">33,093</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt">Currency translation adjustment</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-183">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c137" decimals="0" format="ixt:num-dot-decimal" name="cve:Right-of-UseAssetsCurrencyTranslationAdjustment" scale="0" unitRef="usd">2,207</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="cve:Right-of-UseAssetsCurrencyTranslationAdjustment" scale="0" unitRef="usd">2,207</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1.5pt">Balance, December 31, 2021</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c138" decimals="0" format="ixt:num-dot-decimal" name="cve:Right-of-UseAssetsBalance" scale="0" unitRef="usd">3,416</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c139" decimals="0" format="ixt:num-dot-decimal" name="cve:Right-of-UseAssetsBalance" scale="0" unitRef="usd">241,148</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c3" decimals="0" format="ixt:num-dot-decimal" name="cve:Right-of-UseAssetsBalance" scale="0" unitRef="usd">244,564</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td>Additions</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-184">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c141" decimals="0" format="ixt:num-dot-decimal" name="cve:Right-of-UseAssetsAdditions" scale="0" unitRef="usd">34,898</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="cve:Right-of-UseAssetsAdditions" scale="0" unitRef="usd">34,898</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Depreciation</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c140" decimals="0" format="ixt:num-dot-decimal" name="cve:Right-of-UseAssetsDepreciation" scale="0" sign="-" unitRef="usd">3,416</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c141" decimals="0" format="ixt:num-dot-decimal" name="cve:Right-of-UseAssetsDepreciation" scale="0" sign="-" unitRef="usd">88,311</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="cve:Right-of-UseAssetsDepreciation" scale="0" sign="-" unitRef="usd">91,727</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt">Currency translation adjustment</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-185">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c141" decimals="0" format="ixt:num-dot-decimal" name="cve:Right-of-UseAssetsCurrencyTranslationAdjustment" scale="0" sign="-" unitRef="usd">2,121</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="cve:Right-of-UseAssetsCurrencyTranslationAdjustment" scale="0" sign="-" unitRef="usd">2,121</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; padding-bottom: 1.5pt">Balance, December 31, 2022</td><td style="font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-186">-</div></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><ix:nonFraction contextRef="c143" decimals="0" format="ixt:num-dot-decimal" name="cve:Right-of-UseAssetsBalance" scale="0" unitRef="usd">185,614</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><ix:nonFraction contextRef="c2" decimals="0" format="ixt:num-dot-decimal" name="cve:Right-of-UseAssetsBalance" scale="0" unitRef="usd">185,614</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p></ix:nonNumeric></ix:continuation><div>

</div><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><!-- Field: Page; Sequence: 22; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="border-top: Black 1.5pt solid; width: 100%; padding-top: 2pt; padding-bottom: 2pt; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif"><b>enCore Energy Corp.</b></span></td></tr>
  <tr style="vertical-align: top">
    <td style="border-bottom: Black 1.5pt solid; padding-top: 2pt; padding-bottom: 2pt; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif"><b>Notes
    to the Consolidated Financial Statements</b></span></td></tr>
  <tr style="vertical-align: top">
    <td style="border-bottom: Black 1.5pt solid; padding-top: 2pt; padding-bottom: 2pt; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif"><b>For the years ended December 31, 2022 and December 31, 2021</b></span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif"><b>9.</b></span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b>Right-of-use
                                            assets </b>(Continued)</span></td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><ix:continuation continuedAt="_DisclosureOfQuantitativeInformationAboutRightofuseAssetsExplanatory-c0_cont_8" id="_DisclosureOfQuantitativeInformationAboutRightofuseAssetsExplanatory-c0_cont_7"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">The
change in the Long-Term lease liability during the years ended December 31, 2021 and December 31, 2022 was as follows:</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p></ix:continuation><div>

</div><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"></p><div>

</div><ix:continuation continuedAt="_DisclosureOfQuantitativeInformationAboutRightofuseAssetsExplanatory-c0_cont_9" id="_DisclosureOfQuantitativeInformationAboutRightofuseAssetsExplanatory-c0_cont_8"><ix:nonNumeric contextRef="c0" escape="true" name="cve:DisclosureOfChangeInTheLongTermLeaseLiabilityTableTextBlock"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td style="text-align: center; padding-bottom: 1.5pt">&#160;</td><td style="text-align: center; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">Leased copier<br/> $</td><td style="text-align: center; padding-bottom: 1.5pt">&#160;</td><td style="text-align: center; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">Leased offices<br/> $</td><td style="text-align: center; padding-bottom: 1.5pt">&#160;</td><td style="text-align: center; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">Total<br/> $</td><td style="text-align: center; padding-bottom: 1.5pt">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%">Balance, December 31, 2020</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c134" decimals="0" format="ixt:num-dot-decimal" name="cve:Long-TermLeaseLiabilityBalance" scale="0" unitRef="usd">8,867</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-187">&#160;&#160;&#160;&#160;&#160;&#160;-</div></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c6" decimals="0" format="ixt:num-dot-decimal" name="cve:Long-TermLeaseLiabilityBalance" scale="0" unitRef="usd">8,867</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td>Additions</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-188">&#160;</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c137" decimals="0" format="ixt:num-dot-decimal" name="cve:Long-TermLeaseLiabilityAdditions" scale="0" unitRef="usd">273,001</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="cve:Long-TermLeaseLiabilityAdditions" scale="0" unitRef="usd">273,001</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Accretion</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-189">&#160;</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c137" decimals="0" format="ixt:num-dot-decimal" name="cve:Long-TermLeaseLiabilityAccretion" scale="0" unitRef="usd">7,471</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="cve:Long-TermLeaseLiabilityAccretion" scale="0" unitRef="usd">7,471</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Lease payments made</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c136" decimals="0" format="ixt:num-dot-decimal" name="cve:Long-TermLeaseLiabilityLeasePaymentsMade" scale="0" sign="-" unitRef="usd">5,451</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c137" decimals="0" format="ixt:num-dot-decimal" name="cve:Long-TermLeaseLiabilityLeasePaymentsMade" scale="0" sign="-" unitRef="usd">32,137</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="cve:Long-TermLeaseLiabilityLeasePaymentsMade" scale="0" sign="-" unitRef="usd">37,588</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">Currency translation adjustment</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-190">&#160;</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c137" decimals="0" format="ixt:num-dot-decimal" name="cve:Long-TermLeaseLiabilityCurrencyTranslationAdjustment" scale="0" sign="-" unitRef="usd">2,242</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="cve:Long-TermLeaseLiabilityCurrencyTranslationAdjustment" scale="0" sign="-" unitRef="usd">2,242</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-bottom: 1.5pt">Balance, December 31, 2021</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c138" decimals="0" format="ixt:num-dot-decimal" name="cve:Long-TermLeaseLiabilityBalance" scale="0" unitRef="usd">3,416</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c139" decimals="0" format="ixt:num-dot-decimal" name="cve:Long-TermLeaseLiabilityBalance" scale="0" unitRef="usd">246,093</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c3" decimals="0" format="ixt:num-dot-decimal" name="cve:Long-TermLeaseLiabilityBalance" scale="0" unitRef="usd">249,509</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Additions</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-191">&#160;</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c141" decimals="0" format="ixt:num-dot-decimal" name="cve:Long-TermLeaseLiabilityAdditions" scale="0" unitRef="usd">34,898</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="cve:Long-TermLeaseLiabilityAdditions" scale="0" unitRef="usd">34,898</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td>Accretion</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c140" decimals="0" format="ixt:num-dot-decimal" name="cve:Long-TermLeaseLiabilityAccretion" scale="0" unitRef="usd">77</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c141" decimals="0" format="ixt:num-dot-decimal" name="cve:Long-TermLeaseLiabilityAccretion" scale="0" unitRef="usd">15,157</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="cve:Long-TermLeaseLiabilityAccretion" scale="0" unitRef="usd">15,234</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Lease payments made</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c140" decimals="0" format="ixt:num-dot-decimal" name="cve:Long-TermLeaseLiabilityLeasePaymentsMade" scale="0" sign="-" unitRef="usd">3,493</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c141" decimals="0" format="ixt:num-dot-decimal" name="cve:Long-TermLeaseLiabilityLeasePaymentsMade" scale="0" sign="-" unitRef="usd">103,953</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="cve:Long-TermLeaseLiabilityLeasePaymentsMade" scale="0" sign="-" unitRef="usd">107,446</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt">Currency translation adjustment</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-192">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c141" decimals="0" format="ixt:num-dot-decimal" name="cve:Long-TermLeaseLiabilityCurrencyTranslationAdjustment" scale="0" sign="-" unitRef="usd">11,767</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="cve:Long-TermLeaseLiabilityCurrencyTranslationAdjustment" scale="0" sign="-" unitRef="usd">11,767</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; padding-bottom: 1.5pt">Balance, December 31, 2022</td><td style="font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-193">-</div></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><ix:nonFraction contextRef="c143" decimals="0" format="ixt:num-dot-decimal" name="cve:Long-TermLeaseLiabilityBalance" scale="0" unitRef="usd">180,428</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><ix:nonFraction contextRef="c2" decimals="0" format="ixt:num-dot-decimal" name="cve:Long-TermLeaseLiabilityBalance" scale="0" unitRef="usd">180,428</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt">Less: current lease liability</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-194">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c141" decimals="0" format="ixt:num-dot-decimal" name="cve:Long-TermLeaseLiabilityLessCurrentLeaseLiability" scale="0" sign="-" unitRef="usd">84,262</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="cve:Long-TermLeaseLiabilityLessCurrentLeaseLiability" scale="0" sign="-" unitRef="usd">84,262</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; padding-bottom: 1.5pt">Balance (Long Term), December 31, 2022</td><td style="font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-195">-</div></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><ix:nonFraction contextRef="c143" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:LongtermProvisionForDecommissioningRestorationAndRehabilitationCosts" scale="0" unitRef="usd">96,166</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><ix:nonFraction contextRef="c2" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:LongtermProvisionForDecommissioningRestorationAndRehabilitationCosts" scale="0" unitRef="usd">96,166</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p></ix:nonNumeric></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_DisclosureOfQuantitativeInformationAboutRightofuseAssetsExplanatory-c0_cont_10" id="_DisclosureOfQuantitativeInformationAboutRightofuseAssetsExplanatory-c0_cont_9"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt"><span style="font-family: Times New Roman, Times, Serif">As
of December 31, 2022, the undiscounted future lease payments are as follows:</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p></ix:continuation><div>

</div><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt"></p><div>

</div><ix:continuation id="_DisclosureOfQuantitativeInformationAboutRightofuseAssetsExplanatory-c0_cont_10"><ix:nonNumeric contextRef="c0" escape="true" name="ifrs-full:MaturityAnalysisForDerivativeFinancialLiabilities"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom; ">
    <td style="border-bottom: Black 1.5pt solid; width: 88%; font-weight: bold; text-align: left">Year</td><td style="width: 1%; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; width: 1%; padding-bottom: 1.5pt; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; width: 9%; font-weight: bold; text-align: right">&#160;&#160;&#160;&#160;&#160;&#160;&#160;</td><td style="width: 1%; padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">2023</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="cve:Right-of-UseAssetsTwoZeroTwoThree" scale="0" unitRef="usd">127,967</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">2024</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="cve:Right-of-UseAssetsTwoZeroTwoFour" scale="0" sign="-" unitRef="usd">81,267</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">2025</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="cve:Right-of-UseAssetsTwoZeroTwoFive" scale="0" unitRef="usd">32,502</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt">Total</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><ix:nonFraction contextRef="c2" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:NetInvestmentInFinanceLease" scale="0" unitRef="usd">241,736</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  </table></ix:nonNumeric></ix:continuation><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><ix:nonNumeric contextRef="c0" continuedAt="_DisclosureOfTransactionsRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombinationExplanatory-c0_cont_1" escape="true" name="ifrs-full:DisclosureOfTransactionsRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombinationExplanatory"><table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif"><b>10.</b></span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b>Asset
                                            acquisition</b></span></td></tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -18pt"><span style="font-family: Times New Roman, Times, Serif"><b>&#160;</b></span></p></ix:nonNumeric><div>

</div><div>

</div><ix:continuation continuedAt="_DisclosureOfTransactionsRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombinationExplanatory-c0_cont_2" id="_DisclosureOfTransactionsRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombinationExplanatory-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">During
the year ended December 31, 2021, the Company, and Azarga Uranium Corporation (&#8220;Azarga&#8221;) entered into an Arrangement Agreement
pursuant to which the Company acquired all of the issued and outstanding common shares of Azarga by way of a statutory Plan of Arrangement
under the Canada Business Corporations Act (the &#8220;Arrangement&#8221;). Pursuant to the terms of the Arrangement, securityholders
of Azarga received <ix:nonFraction contextRef="c0" decimals="3" format="ixt:num-dot-decimal" name="cve:MarketValuePerShare" scale="0" unitRef="usdPershares">0.375</ix:nonFraction> common shares of enCore for each Azarga common share (the &#8220;Exchange Ratio&#8221;).</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_DisclosureOfTransactionsRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombinationExplanatory-c0_cont_3" id="_DisclosureOfTransactionsRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombinationExplanatory-c0_cont_2"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">In
connection with the Arrangement, all outstanding vested and unvested stock options and share purchase warrants of Azarga were exchanged
for replacement options and warrants of enCore, adjusted for the Exchange Ratio.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_DisclosureOfTransactionsRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombinationExplanatory-c0_cont_4" id="_DisclosureOfTransactionsRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombinationExplanatory-c0_cont_3"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">The
aggregate amount of the total consideration was $<ix:nonFraction contextRef="c144" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:AcquisitiondateFairValueOfTotalConsiderationTransferred" scale="0" unitRef="usd">132,294,625</ix:nonFraction> calculated by taking into account: the issuance of <ix:nonFraction contextRef="c2" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:NumberOfSharesIssued" scale="0" unitRef="shares">31,806,617</ix:nonFraction> enCore common
shares (the &#8220;Share Consideration&#8221;) valued at $<ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="cve:ShareConsiderationAmount" scale="0" unitRef="usd">120,422,593</ix:nonFraction>, the issuance of <ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="cve:StockOptions" scale="0" unitRef="shares">1,828,960</ix:nonFraction> enCore stock options (the &#8220;Replacement
Options&#8221;) in replacement of options held by Azarga option holders, valued at $<ix:nonFraction contextRef="c145" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:ProceedsFromExerciseOfOptions" scale="0" unitRef="usd">5,434,045</ix:nonFraction> using the Black-Scholes option pricing
model, the issuance of <ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="cve:SharePurchaseWarrants" scale="0" unitRef="shares">1,403,156</ix:nonFraction> enCore share purchase warrants (the &#8220;Replacement Warrants&#8221;) in replacement of warrants held
by Azarga warrant holders, valued at $<ix:nonFraction contextRef="c145" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:ProceedsFromExerciseOfWarrants" scale="0" unitRef="usd">3,222,543</ix:nonFraction> using the Black-Scholes option pricing model, and total transaction costs of $<ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:AcquisitionrelatedCostsRecognisedAsExpenseForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination" scale="0" unitRef="usd">3,215,444</ix:nonFraction>
associated with the Arrangement.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify">&#160;</p></ix:continuation><div>

</div><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><!-- Field: Page; Sequence: 23; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="border-top: Black 1.5pt solid; width: 100%; padding-top: 2pt; padding-bottom: 2pt; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif"><b>enCore Energy Corp.</b></span></td></tr>
  <tr style="vertical-align: top">
    <td style="border-bottom: Black 1.5pt solid; padding-top: 2pt; padding-bottom: 2pt; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif"><b>Notes
    to the Consolidated Financial Statements</b></span></td></tr>
  <tr style="vertical-align: top">
    <td style="border-bottom: Black 1.5pt solid; padding-top: 2pt; padding-bottom: 2pt; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif"><b>For the years ended December 31, 2022 and December 31, 2021</b></span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif"><b>&#160;</b></span></p><div>

</div><table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif"><b>10.</b></span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b>Asset
                                            acquisition</b> (continued)</span></td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: 36pt"></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><ix:continuation continuedAt="_DisclosureOfTransactionsRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombinationExplanatory-c0_cont_5" id="_DisclosureOfTransactionsRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombinationExplanatory-c0_cont_4"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">As
Azarga did not qualify as a business according to the definition in IFRS 3 <i>Business Combinations</i>, the Arrangement had been accounted
for as an asset acquisition with the purchase price being allocated based on the estimated fair value of Azarga&#8217;s assets and liabilities
summarized as follows:</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_DisclosureOfTransactionsRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombinationExplanatory-c0_cont_6" id="_DisclosureOfTransactionsRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombinationExplanatory-c0_cont_5"><ix:nonNumeric contextRef="c0" escape="true" name="ifrs-full:DisclosureOfFairValueMeasurementOfAssetsExplanatory"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom; ">
    <td style="border-bottom: Black 1.5pt solid; width: 88%; font-weight: bold; padding-bottom: 1.5pt">Consideration</td><td style="width: 1%; font-weight: bold">&#160;</td>
    <td style="width: 1%; border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"></td><td style="border-bottom: Black 1.5pt solid; width: 9%; font-weight: bold; text-align: center">&#160;</td><td style="width: 1%; padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: 9pt">Fair value of share consideration</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c2" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:AcquisitiondateFairValueOfTotalConsiderationTransferred" scale="0" unitRef="usd">120,422,593</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: 9pt">Fair value of replacement options</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c2" decimals="0" format="ixt:num-dot-decimal" name="cve:FairValueOfReplacementOptions" scale="0" unitRef="usd">5,434,045</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: 9pt">Fair value of replacement warrants</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c2" decimals="0" format="ixt:num-dot-decimal" name="cve:FairValueOfReplacementWarrants" scale="0" unitRef="usd">3,222,543</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt; text-indent: 9pt">Transaction costs</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c2" decimals="0" format="ixt:num-dot-decimal" name="cve:TransactionCosts" scale="0" unitRef="usd">3,215,444</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; padding-bottom: 1.5pt">Total consideration value</td><td style="font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><ix:nonFraction contextRef="c2" decimals="0" format="ixt:num-dot-decimal" name="cve:TotalConsiderationValue" scale="0" unitRef="usd">132,294,625</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
</table><p style="margin: 0">&#160;</p></ix:nonNumeric></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_DisclosureOfTransactionsRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombinationExplanatory-c0_cont_7" id="_DisclosureOfTransactionsRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombinationExplanatory-c0_cont_6"><ix:nonNumeric contextRef="c0" continuedAt="_DisclosureOfRedesignatedFinancialAssetsAndLiabilitiesExplanatory-c0_cont_1" escape="true" name="ifrs-full:DisclosureOfRedesignatedFinancialAssetsAndLiabilitiesExplanatory"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom; ">
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left; padding-bottom: 1.5pt; width: 88%">Net assets acquired</td><td style="font-weight: bold; width: 1%">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left; width: 1%"></td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center; width: 9%">$</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left; width: 1%">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: 9pt">Cash</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c2" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:OtherCashAndCashEquivalents" scale="0" unitRef="usd">1,860,360</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; text-indent: 9pt">Restricted cash</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c2" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:NoncurrentRestrictedCashAndCashEquivalents" scale="0" unitRef="usd">720,039</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: 9pt">Prepaids</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c2" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:Prepayments" scale="0" unitRef="usd">169,688</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; text-indent: 9pt">Property, plant, and equipment</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c2" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate" scale="0" unitRef="usd">62,946</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; text-indent: 9pt">Right-of-use asset</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c2" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:RightofuseAssetsThatDoNotMeetDefinitionOfInvestmentProperty" scale="0" unitRef="usd">45,444</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; text-indent: 9pt">Mineral properties</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c2" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:AssetsArisingFromExplorationForAndEvaluationOfMineralResources" scale="0" unitRef="usd">129,129,302</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; text-indent: 9pt">Asset retirement obligations</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c2" decimals="0" format="ixt:num-dot-decimal" name="cve:AssetRetirementObligations" scale="0" sign="-" unitRef="usd">267,807</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; text-indent: 9pt">Lease liability</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c2" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:LeaseLiabilities" scale="0" unitRef="usd">49,339</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; text-indent: 9pt">Loan receivable (1)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c2" decimals="0" format="ixt:num-dot-decimal" id="ix_4_fact" name="ifrs-full:LoansAndReceivables" scale="0" unitRef="usd">1,845,941</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt; text-indent: 9pt">Accounts payable and accrued liabilities</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c2" decimals="0" format="ixt:num-dot-decimal" name="cve:AccountsPayableAndAccruedLiability" scale="0" sign="-" unitRef="usd">1,221,949</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt">Total net assets acquired</td><td style="font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><ix:nonFraction contextRef="c2" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:IdentifiableAssetsAcquiredLiabilitiesAssumed" scale="0" unitRef="usd">132,294,625</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  </table><p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p></ix:nonNumeric></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_DisclosureOfTransactionsRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombinationExplanatory-c0_cont_8" id="_DisclosureOfTransactionsRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombinationExplanatory-c0_cont_7"><ix:continuation id="_DisclosureOfRedesignatedFinancialAssetsAndLiabilitiesExplanatory-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt"><span style="font-family: Times New Roman, Times, Serif">(1)
- <ix:footnote id="ix_1_footnote" xml:lang="en-US">Transaction costs incurred by Azarga which were subsequently paid by the Company.</ix:footnote></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p></ix:continuation></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_DisclosureOfTransactionsRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombinationExplanatory-c0_cont_9" id="_DisclosureOfTransactionsRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombinationExplanatory-c0_cont_8"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">The
value of the Consideration Shares was calculated based on the issuance of <ix:nonFraction contextRef="c3" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:NumberOfSharesIssued" scale="0" unitRef="shares">31,806,617</ix:nonFraction> enCore common shares at a price per share of $<ix:nonFraction contextRef="c5" decimals="2" format="ixt:num-dot-decimal" name="ifrs-full:WeightedAverageSharePrice2019" scale="0" unitRef="usdPershares">3.79</ix:nonFraction>
($<ix:nonFraction contextRef="c5" decimals="2" format="ixt:num-dot-decimal" name="ifrs-full:WeightedAverageSharePrice2019" scale="0" unitRef="cadPershares">4.80</ix:nonFraction> CAD) on December 31, 2021.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_DisclosureOfTransactionsRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombinationExplanatory-c0_cont_10" id="_DisclosureOfTransactionsRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombinationExplanatory-c0_cont_9"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">The
value of the Replacement Options was derived using the Black-Scholes option pricing model. The weighted average assumptions used in the
Black-Scholes option pricing model were as follows:</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p></ix:continuation><div>

</div><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"></p><div>

</div><ix:continuation continuedAt="_DisclosureOfTransactionsRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombinationExplanatory-c0_cont_11" id="_DisclosureOfTransactionsRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombinationExplanatory-c0_cont_10"><ix:nonNumeric contextRef="c0" continuedAt="_DisclosureOfIndirectMeasurementOfFairValueOfGoodsOrServicesReceivedShareOptionsGrantedDuringPeriodExplanatory-c0_cont_1" escape="true" name="ifrs-full:DisclosureOfIndirectMeasurementOfFairValueOfGoodsOrServicesReceivedShareOptionsGrantedDuringPeriodExplanatory"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">Weighted
    average</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 88%"><span style="font-family: Times New Roman, Times, Serif">Exercise price</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c154" decimals="2" format="ixt:num-dot-decimal" name="ifrs-full:ExercisePriceShareOptionsGranted2019" scale="0" unitRef="usdPershares">1.40</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td><span style="font-family: Times New Roman, Times, Serif">Share price</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c154" decimals="2" format="ixt:num-dot-decimal" name="ifrs-full:WeightedAverageSharePriceShareOptionsGranted2019" scale="0" unitRef="usdPershares">3.79</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Discount rate</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c155" decimals="4" format="ixt:num-dot-decimal" name="ifrs-full:ActuarialAssumptionOfDiscountRates" scale="-2" unitRef="pure">1.04</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Expected life (years)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><ix:nonNumeric contextRef="c154" format="ixt-sec:duryear" name="ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019"><span style="font-family: Times New Roman, Times, Serif">3.43</span></ix:nonNumeric></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Volatility</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c154" decimals="4" format="ixt:num-dot-decimal" name="ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted" scale="-2" unitRef="pure">104.40</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Fair value of replacement
    options (per option):</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c154" decimals="2" format="ixt:num-dot-decimal" name="cve:FairValueOfReplacement" scale="0" unitRef="usdPershares">2.97</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p></ix:nonNumeric></ix:continuation><div>


</div><div>

</div><ix:continuation continuedAt="_DisclosureOfTransactionsRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombinationExplanatory-c0_cont_12" id="_DisclosureOfTransactionsRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombinationExplanatory-c0_cont_11"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">The
fair value of the Replacement Options is based on the outstanding <ix:nonFraction contextRef="c146" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:NumberOfSharesOutstanding" scale="0" unitRef="shares">14,631,709</ix:nonFraction> Azarga options adjusted for the Exchange Ratio (<ix:nonFraction contextRef="c147" decimals="3" format="ixt:num-dot-decimal" name="cve:ExchangeRatio" scale="0" unitRef="usdPershares">0.375</ix:nonFraction>) to
<ix:nonFraction contextRef="c148" decimals="0" format="ixt:num-dot-decimal" name="cve:ShareConsolidation" scale="0" unitRef="shares">5,489,881</ix:nonFraction>; <ix:nonFraction contextRef="c149" decimals="0" format="ixt:num-dot-decimal" name="cve:ShareConsolidation" scale="0" unitRef="shares">1,828,960</ix:nonFraction> enCore options after the September 2022 share consolidation.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_DisclosureOfTransactionsRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombinationExplanatory-c0_cont_13" id="_DisclosureOfTransactionsRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombinationExplanatory-c0_cont_12"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">The
value of the Replacement Warrants was derived using the Black-Scholes option pricing model. The weighted average assumptions used in
the Black-Scholes option pricing model were as follows:</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_DisclosureOfTransactionsRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombinationExplanatory-c0_cont_14" id="_DisclosureOfTransactionsRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombinationExplanatory-c0_cont_13"><ix:continuation id="_DisclosureOfIndirectMeasurementOfFairValueOfGoodsOrServicesReceivedShareOptionsGrantedDuringPeriodExplanatory-c0_cont_1"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">Weighted
    average</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 88%"><span style="font-family: Times New Roman, Times, Serif">Exercise price</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c156" decimals="2" format="ixt:num-dot-decimal" name="ifrs-full:ExercisePriceShareOptionsGranted2019" scale="0" unitRef="usdPershares">1.66</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td><span style="font-family: Times New Roman, Times, Serif">Share price</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c156" decimals="2" format="ixt:num-dot-decimal" name="ifrs-full:WeightedAverageSharePriceShareOptionsGranted2019" scale="0" unitRef="usdPershares">3.79</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Discount rate</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c157" decimals="4" format="ixt:num-dot-decimal" name="ifrs-full:ActuarialAssumptionOfDiscountRates" scale="-2" unitRef="pure">0.91</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Expected life (years)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><ix:nonNumeric contextRef="c156" format="ixt-sec:duryear" name="ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019"><span style="font-family: Times New Roman, Times, Serif">0.98</span></ix:nonNumeric></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Volatility</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c156" decimals="4" format="ixt:num-dot-decimal" name="ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted" scale="-2" unitRef="pure">77.10</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Fair
    value of replacement warrants (per warrant):</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c156" decimals="2" format="ixt:num-dot-decimal" name="cve:FairValueOfReplacement" scale="0" unitRef="usdPershares">2.30</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p></ix:continuation></ix:continuation><div>


</div><div>

</div><ix:continuation id="_DisclosureOfTransactionsRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombinationExplanatory-c0_cont_14"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">The
fair value of the Replacement Warrants is based on the outstanding <ix:nonFraction contextRef="c150" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:NumberOfSharesOutstanding" scale="0" unitRef="shares">11,225,255</ix:nonFraction> Azarga warrants adjusted for the Exchange Ratio (<ix:nonFraction contextRef="c151" decimals="3" format="ixt:num-dot-decimal" name="cve:ExchangeRatio" scale="0" unitRef="usdPershares">0.375</ix:nonFraction>)
to <ix:nonFraction contextRef="c152" decimals="0" format="ixt:num-dot-decimal" name="cve:ShareConsolidation" scale="0" unitRef="shares">4,209,471</ix:nonFraction>; <ix:nonFraction contextRef="c153" decimals="0" format="ixt:num-dot-decimal" name="cve:ShareConsolidation" scale="0" unitRef="shares">1,403,156</ix:nonFraction> enCore warrants after the September 2022 share consolidation.</span></p></ix:continuation><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"></p><div>

</div><!-- Field: Page; Sequence: 24; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"></p><div>

</div><table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="border-top: Black 1.5pt solid; width: 100%; padding-top: 2pt; padding-bottom: 2pt; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif"><b>enCore Energy Corp.</b></span></td></tr>
  <tr style="vertical-align: top">
    <td style="border-bottom: Black 1.5pt solid; padding-top: 2pt; padding-bottom: 2pt; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif"><b>Notes
    to the Consolidated Financial Statements</b></span></td></tr>
  <tr style="vertical-align: top">
    <td style="border-bottom: Black 1.5pt solid; padding-top: 2pt; padding-bottom: 2pt; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif"><b>For the years ended December 31, 2022 and December 31, 2021</b></span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><ix:nonNumeric contextRef="c0" continuedAt="cve_DisclosureOfMineralProperties-c0_cont_1" escape="true" name="cve:DisclosureOfMineralProperties"><table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif"><b>11.</b></span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b>Mineral
                                            properties</b></span></td></tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 18pt; text-align: justify; text-indent: -18pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p></ix:nonNumeric><div>

</div><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 18pt; text-align: justify; text-indent: -18pt"></p><div>

</div><ix:continuation continuedAt="cve_DisclosureOfMineralProperties-c0_cont_2" id="cve_DisclosureOfMineralProperties-c0_cont_1"><ix:nonNumeric contextRef="c0" escape="true" name="cve:ScheduleOfMineralProperties"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td style="padding-left: 0.125in; padding-bottom: 1.5pt; text-align: center"></td><td style="padding-bottom: 1.5pt; text-align: center"></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><span style="font-size: 8pt">Arizona<br/> $</span></td><td style="text-align: center; padding-bottom: 1.5pt"></td><td style="padding-bottom: 1.5pt; text-align: center"></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><span style="font-size: 8pt">Colorado<br/> $</span></td><td style="text-align: center; padding-bottom: 1.5pt"></td><td style="padding-bottom: 1.5pt; text-align: center"></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><span style="font-size: 8pt">New Mexico<br/> $</span></td><td style="text-align: center; padding-bottom: 1.5pt"></td><td style="padding-bottom: 1.5pt; text-align: center"></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><span style="font-size: 8pt">South Dakota<br/> $</span></td><td style="text-align: center; padding-bottom: 1.5pt"></td><td style="padding-bottom: 1.5pt; text-align: center"></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><span style="font-size: 8pt">Texas<br/> $</span></td><td style="text-align: center; padding-bottom: 1.5pt"></td><td style="padding-bottom: 1.5pt; text-align: center"></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><span style="font-size: 8pt">Utah<br/> $</span></td><td style="text-align: center; padding-bottom: 1.5pt"></td><td style="padding-bottom: 1.5pt; text-align: center"></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><span style="font-size: 8pt">Wyoming<br/> $</span></td><td style="text-align: center; padding-bottom: 1.5pt"></td><td style="padding-bottom: 1.5pt; text-align: center"></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><span style="font-size: 8pt">Canada<br/> $</span></td><td style="text-align: center; padding-bottom: 1.5pt"></td><td style="padding-bottom: 1.5pt; text-align: center"></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><span style="font-size: 8pt">Total<br/> $</span></td><td style="text-align: center; padding-bottom: 1.5pt"></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; width: 23%"><span style="font-size: 8pt">Balance, December 31, 2020</span></td><td style="width: 1%"></td>
    <td style="width: 0.5%; text-align: left"></td><td style="width: 7%; text-align: right"><span style="font-size: 8pt"><ix:nonFraction contextRef="c173" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:MiningAssets" scale="0" unitRef="usd">771,388</ix:nonFraction></span></td><td style="width: 0.5%; text-align: left"></td><td style="width: 0.5%"></td>
    <td style="width: 0.5%; text-align: left"></td><td style="width: 7%; text-align: right"><span style="-sec-ix-hidden: hidden-fact-196; font-size: 8pt">-</span></td><td style="width: 0.5%; text-align: left"></td><td style="width: 0.5%"></td>
    <td style="width: 0.5%; text-align: left"></td><td style="width: 7%; text-align: right"><span style="font-size: 8pt"><ix:nonFraction contextRef="c175" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:MiningAssets" scale="0" unitRef="usd">5,477,162</ix:nonFraction></span></td><td style="width: 0.5%; text-align: left"></td><td style="width: 0.5%"></td>
    <td style="width: 0.5%; text-align: left"></td><td style="width: 7%; text-align: right"><span style="-sec-ix-hidden: hidden-fact-197; font-size: 8pt">-</span></td><td style="width: 0.5%; text-align: left"></td><td style="width: 0.5%"></td>
    <td style="width: 0.5%; text-align: left"></td><td style="width: 7%; text-align: right"><span style="-sec-ix-hidden: hidden-fact-198; font-size: 8pt">-</span></td><td style="width: 0.5%; text-align: left"></td><td style="width: 0.5%"></td>
    <td style="width: 0.5%; text-align: left"></td><td style="width: 7%; text-align: right"><span style="font-size: 8pt"><ix:nonFraction contextRef="c178" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:MiningAssets" scale="0" unitRef="usd">300,460</ix:nonFraction></span></td><td style="width: 0.5%; text-align: left"></td><td style="width: 0.5%"></td>
    <td style="width: 0.5%; text-align: left"></td><td style="width: 7%; text-align: right"><span style="font-size: 8pt"><ix:nonFraction contextRef="c179" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:MiningAssets" scale="0" unitRef="usd">59,050</ix:nonFraction></span></td><td style="width: 0.5%; text-align: left"></td><td style="width: 0.5%"></td>
    <td style="width: 0.5%; text-align: left"></td><td style="width: 7%; text-align: right"><span style="-sec-ix-hidden: hidden-fact-199; font-size: 8pt">-</span></td><td style="width: 0.5%; text-align: left"></td><td style="width: 0.5%; font-weight: bold"></td>
    <td style="width: 0.5%; font-weight: bold; text-align: left"></td><td style="width: 7%; font-weight: bold; text-align: right"><span style="font-size: 8pt"><ix:nonFraction contextRef="c6" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:MiningAssets" scale="0" unitRef="usd">6,608,060</ix:nonFraction></span></td><td style="width: 0.5%; font-weight: bold; text-align: left"></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left"><span style="font-size: 8pt">Acquisition costs:</span></td><td></td>
    <td style="text-align: left"></td><td style="text-align: right"></td><td style="text-align: left"></td><td></td>
    <td style="text-align: left"></td><td style="text-align: right"></td><td style="text-align: left"></td><td></td>
    <td style="text-align: left"></td><td style="text-align: right"></td><td style="text-align: left"></td><td></td>
    <td style="text-align: left"></td><td style="text-align: right"></td><td style="text-align: left"></td><td></td>
    <td style="text-align: left"></td><td style="text-align: right"></td><td style="text-align: left"></td><td></td>
    <td style="text-align: left"></td><td style="text-align: right"></td><td style="text-align: left"></td><td></td>
    <td style="text-align: left"></td><td style="text-align: right"></td><td style="text-align: left"></td><td></td>
    <td style="text-align: left"></td><td style="text-align: right"></td><td style="text-align: left"></td><td></td>
    <td style="text-align: left"></td><td style="text-align: right"></td><td style="text-align: left"></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.25in; text-indent: -0.125in; text-align: left"><span style="font-size: 8pt">Asset acquisition (Note 10)</span></td><td></td>
    <td style="text-align: left"></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-200; font-size: 8pt">-</span></td><td style="text-align: left"></td><td></td>
    <td style="text-align: left"></td><td style="text-align: right"><span style="font-size: 8pt"><ix:nonFraction contextRef="c182" decimals="0" format="ixt:num-dot-decimal" name="cve:AssetAcquistion" scale="0" unitRef="usd">619,902</ix:nonFraction></span></td><td style="text-align: left"></td><td></td>
    <td style="text-align: left"></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-201; font-size: 8pt">-</span></td><td style="text-align: left"></td><td></td>
    <td style="text-align: left"></td><td style="text-align: right"><span style="font-size: 8pt"><ix:nonFraction contextRef="c184" decimals="0" format="ixt:num-dot-decimal" name="cve:AssetAcquistion" scale="0" unitRef="usd">85,667,919</ix:nonFraction></span></td><td style="text-align: left"></td><td></td>
    <td style="text-align: left"></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-202; font-size: 8pt">-</span></td><td style="text-align: left"></td><td></td>
    <td style="text-align: left"></td><td style="text-align: right"><span style="font-size: 8pt"><ix:nonFraction contextRef="c186" decimals="0" format="ixt:num-dot-decimal" name="cve:AssetAcquistion" scale="0" unitRef="usd">1,676,674</ix:nonFraction></span></td><td style="text-align: left"></td><td></td>
    <td style="text-align: left"></td><td style="text-align: right"><span style="font-size: 8pt"><ix:nonFraction contextRef="c187" decimals="0" format="ixt:num-dot-decimal" name="cve:AssetAcquistion" scale="0" unitRef="usd">41,164,807</ix:nonFraction></span></td><td style="text-align: left"></td><td></td>
    <td style="text-align: left"></td><td style="text-align: right"></td><td style="text-align: left"></td><td></td>
    <td style="text-align: left"></td><td style="text-align: right"><span style="font-size: 8pt"><ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="cve:AssetAcquistion" scale="0" unitRef="usd">129,129,302</ix:nonFraction></span></td><td style="text-align: left"></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left"><span style="font-size: 8pt">Exploration costs:</span></td><td></td>
    <td style="text-align: left"></td><td style="text-align: right"></td><td style="text-align: left"></td><td></td>
    <td style="text-align: left"></td><td style="text-align: right"></td><td style="text-align: left"></td><td></td>
    <td style="text-align: left"></td><td style="text-align: right"></td><td style="text-align: left"></td><td></td>
    <td style="text-align: left"></td><td style="text-align: right"></td><td style="text-align: left"></td><td></td>
    <td style="text-align: left"></td><td style="text-align: right"></td><td style="text-align: left"></td><td></td>
    <td style="text-align: left"></td><td style="text-align: right"></td><td style="text-align: left"></td><td></td>
    <td style="text-align: left"></td><td style="text-align: right"></td><td style="text-align: left"></td><td></td>
    <td style="text-align: left"></td><td style="text-align: right"></td><td style="text-align: left"></td><td></td>
    <td style="text-align: left"></td><td style="text-align: right"></td><td style="text-align: left"></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.25in; text-indent: -0.125in; text-align: left"><span style="font-size: 8pt">Maintenance and lease fees</span></td><td></td>
    <td style="text-align: left"></td><td style="text-align: right"><span style="font-size: 8pt"><ix:nonFraction contextRef="c181" decimals="0" format="ixt:num-dot-decimal" name="cve:MaintenancesAndLeaseFees" scale="0" unitRef="usd">86,364</ix:nonFraction></span></td><td style="text-align: left"></td><td></td>
    <td style="text-align: left"></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-203; font-size: 8pt">-</span></td><td style="text-align: left"></td><td></td>
    <td style="text-align: left"></td><td style="text-align: right"><span style="font-size: 8pt"><ix:nonFraction contextRef="c183" decimals="0" format="ixt:num-dot-decimal" name="cve:MaintenancesAndLeaseFees" scale="0" unitRef="usd">529,604</ix:nonFraction></span></td><td style="text-align: left"></td><td></td>
    <td style="text-align: left"></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-204; font-size: 8pt">-</span></td><td style="text-align: left"></td><td></td>
    <td style="text-align: left"></td><td style="text-align: right"><span style="font-size: 8pt"><ix:nonFraction contextRef="c185" decimals="0" format="ixt:num-dot-decimal" name="cve:MaintenancesAndLeaseFees" scale="0" unitRef="usd">1,455,206</ix:nonFraction></span></td><td style="text-align: left"></td><td></td>
    <td style="text-align: left"></td><td style="text-align: right"><span style="font-size: 8pt"><ix:nonFraction contextRef="c186" decimals="0" format="ixt:num-dot-decimal" name="cve:MaintenancesAndLeaseFees" scale="0" unitRef="usd">22,663</ix:nonFraction></span></td><td style="text-align: left"></td><td></td>
    <td style="text-align: left"></td><td style="text-align: right"><span style="font-size: 8pt"><ix:nonFraction contextRef="c187" decimals="0" format="ixt:num-dot-decimal" name="cve:MaintenancesAndLeaseFees" scale="0" unitRef="usd">11,870</ix:nonFraction></span></td><td style="text-align: left"></td><td></td>
    <td style="text-align: left"></td><td style="text-align: right"><span style="font-size: 8pt"><ix:nonFraction contextRef="c188" decimals="0" format="ixt:num-dot-decimal" name="cve:MaintenancesAndLeaseFees" scale="0" unitRef="usd">78,456</ix:nonFraction></span></td><td style="text-align: left"></td><td></td>
    <td style="text-align: left"></td><td style="text-align: right"><span style="font-size: 8pt"><ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="cve:MaintenancesAndLeaseFees" scale="0" unitRef="usd">2,184,163</ix:nonFraction></span></td><td style="text-align: left"></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.25in; text-indent: -0.125in; text-align: left"><span style="font-size: 8pt">Resource review</span></td><td></td>
    <td style="text-align: left"></td><td style="text-align: right"><span style="font-size: 8pt"><ix:nonFraction contextRef="c181" decimals="0" format="ixt:num-dot-decimal" name="cve:ResourceReview" scale="0" unitRef="usd">42,967</ix:nonFraction></span></td><td style="text-align: left"></td><td></td>
    <td style="text-align: left"></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-205; font-size: 8pt">-</span></td><td style="text-align: left"></td><td></td>
    <td style="text-align: left"></td><td style="text-align: right"><span style="font-size: 8pt"><ix:nonFraction contextRef="c183" decimals="0" format="ixt:num-dot-decimal" name="cve:ResourceReview" scale="0" unitRef="usd">130,120</ix:nonFraction></span></td><td style="text-align: left"></td><td></td>
    <td style="text-align: left"></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-206; font-size: 8pt">-</span></td><td style="text-align: left"></td><td></td>
    <td style="text-align: left"></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-207; font-size: 8pt">-</span></td><td style="text-align: left"></td><td></td>
    <td style="text-align: left"></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-208; font-size: 8pt">-</span></td><td style="text-align: left"></td><td></td>
    <td style="text-align: left"></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-209; font-size: 8pt">-</span></td><td style="text-align: left"></td><td></td>
    <td style="text-align: left"></td><td style="text-align: right"></td><td style="text-align: left"></td><td></td>
    <td style="text-align: left"></td><td style="text-align: right"><span style="font-size: 8pt"><ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="cve:ResourceReview" scale="0" unitRef="usd">173,087</ix:nonFraction></span></td><td style="text-align: left"></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.25in; text-indent: -0.125in; text-align: left"><span style="font-size: 8pt">Impairment charged</span></td><td></td>
    <td style="text-align: left"></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-210; font-size: 8pt">-</span></td><td style="text-align: left"></td><td></td>
    <td style="text-align: left"></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-211; font-size: 8pt">-</span></td><td style="text-align: left"></td><td></td>
    <td style="text-align: left"></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-212; font-size: 8pt">-</span></td><td style="text-align: left"></td><td></td>
    <td style="text-align: left"></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-213; font-size: 8pt">-</span></td><td style="text-align: left"></td><td></td>
    <td style="text-align: left"></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-214; font-size: 8pt">-</span></td><td style="text-align: left"></td><td></td>
    <td style="text-align: left"></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-215; font-size: 8pt">-</span></td><td style="text-align: left"></td><td></td>
    <td style="text-align: left"></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-216; font-size: 8pt">-</span></td><td style="text-align: left"></td><td></td>
    <td style="text-align: left"></td><td style="text-align: right"><span style="font-size: 8pt">(<ix:nonFraction contextRef="c188" decimals="0" format="ixt:num-dot-decimal" name="cve:ImpairmentCharged" scale="0" unitRef="usd">78,456</ix:nonFraction></span></td><td style="text-align: left"><span style="font-size: 8pt">)</span></td><td></td>
    <td style="text-align: left"></td><td style="text-align: right"><span style="font-size: 8pt">(<ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="cve:ImpairmentCharged" scale="0" unitRef="usd">78,456</ix:nonFraction></span></td><td style="text-align: left"><span style="font-size: 8pt">)</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-indent: -0.125in"><span style="font-size: 8pt">Divestment:</span></td><td></td>
    <td style="text-align: left"></td><td style="text-align: right"></td><td style="text-align: left"></td><td></td>
    <td style="text-align: left"></td><td style="text-align: right"></td><td style="text-align: left"></td><td></td>
    <td style="text-align: left"></td><td style="text-align: right"></td><td style="text-align: left"></td><td></td>
    <td style="text-align: left"></td><td style="text-align: right"></td><td style="text-align: left"></td><td></td>
    <td style="text-align: left"></td><td style="text-align: right"></td><td style="text-align: left"></td><td></td>
    <td style="text-align: left"></td><td style="text-align: right"></td><td style="text-align: left"></td><td></td>
    <td style="text-align: left"></td><td style="text-align: right"></td><td style="text-align: left"></td><td></td>
    <td style="text-align: left"></td><td style="text-align: right"></td><td style="text-align: left"></td><td></td>
    <td style="text-align: left"></td><td style="text-align: right"></td><td style="text-align: left"></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.375in; text-indent: -0.125in; text-align: left"><span style="font-size: 8pt">Divest - Mineral interest</span></td><td></td>
    <td style="text-align: left"></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-217; font-size: 8pt">-</span></td><td style="text-align: left"></td><td></td>
    <td style="text-align: left"></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-218; font-size: 8pt">-</span></td><td style="text-align: left"></td><td></td>
    <td style="text-align: left"></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-219; font-size: 8pt">-</span></td><td style="text-align: left"></td><td></td>
    <td style="text-align: left"></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-220; font-size: 8pt">-</span></td><td style="text-align: left"></td><td></td>
    <td style="text-align: left"></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-221; font-size: 8pt">-</span></td><td style="text-align: left"></td><td></td>
    <td style="text-align: left"></td><td style="text-align: right"><span style="font-size: 8pt">(<ix:nonFraction contextRef="c186" decimals="0" format="ixt:num-dot-decimal" name="cve:DivestMineralInterest" scale="0" unitRef="usd">195,514</ix:nonFraction></span></td><td style="text-align: left"><span style="font-size: 8pt">)</span></td><td></td>
    <td style="text-align: left"></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-222; font-size: 8pt">-</span></td><td style="text-align: left"></td><td></td>
    <td style="text-align: left"></td><td style="text-align: right"></td><td style="text-align: left"></td><td></td>
    <td style="text-align: left"></td><td style="text-align: right"><span style="font-size: 8pt">(<ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="cve:DivestMineralInterest" scale="0" unitRef="usd">195,514</ix:nonFraction></span></td><td style="text-align: left"><span style="font-size: 8pt">)</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.25in; text-indent: -0.125in; text-align: left; padding-bottom: 1.5pt"><span style="font-size: 8pt">Assets
    held for sale</span></td><td></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-223; font-size: 8pt">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"></td><td></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-224; font-size: 8pt">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"></td><td></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-size: 8pt">(<ix:nonFraction contextRef="c183" decimals="0" format="ixt:num-dot-decimal" name="cve:AssetsHeldForSale" scale="0" unitRef="usd">1,741,064</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-size: 8pt">)</span></td><td></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-225; font-size: 8pt">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"></td><td></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-226; font-size: 8pt">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"></td><td></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-227; font-size: 8pt">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"></td><td></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-228; font-size: 8pt">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"></td><td></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"></td><td style="border-bottom: Black 1.5pt solid; text-align: right"></td><td style="padding-bottom: 1.5pt; text-align: left"></td><td></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-size: 8pt">(<ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="cve:AssetsHeldForSale" scale="0" unitRef="usd">1,741,064</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-size: 8pt">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 1.5pt"><span style="font-size: 8pt">Balance, December 31,
    2021</span></td><td></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-size: 8pt"><ix:nonFraction contextRef="c189" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:MiningAssets" scale="0" unitRef="usd">900,719</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"></td><td></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-size: 8pt"><ix:nonFraction contextRef="c190" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:MiningAssets" scale="0" unitRef="usd">619,902</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"></td><td></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-size: 8pt"><ix:nonFraction contextRef="c191" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:MiningAssets" scale="0" unitRef="usd">4,395,822</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"></td><td></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-size: 8pt"><ix:nonFraction contextRef="c192" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:MiningAssets" scale="0" unitRef="usd">85,667,919</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"></td><td></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-size: 8pt"><ix:nonFraction contextRef="c193" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:MiningAssets" scale="0" unitRef="usd">1,455,206</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"></td><td></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-size: 8pt"><ix:nonFraction contextRef="c194" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:MiningAssets" scale="0" unitRef="usd">1,804,283</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"></td><td></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-size: 8pt"><ix:nonFraction contextRef="c195" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:MiningAssets" scale="0" unitRef="usd">41,235,727</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"></td><td></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-229; font-size: 8pt">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"></td><td style="font-weight: bold"></td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"></td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-size: 8pt"><ix:nonFraction contextRef="c3" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:MiningAssets" scale="0" unitRef="usd">136,079,578</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left"><span style="font-size: 8pt">Exploration costs:</span></td><td></td>
    <td style="text-align: left"></td><td style="text-align: right"></td><td style="text-align: left"></td><td></td>
    <td style="text-align: left"></td><td style="text-align: right"></td><td style="text-align: left"></td><td></td>
    <td style="text-align: left"></td><td style="text-align: right"></td><td style="text-align: left"></td><td></td>
    <td style="text-align: left"></td><td style="text-align: right"></td><td style="text-align: left"></td><td></td>
    <td style="text-align: left"></td><td style="text-align: right"></td><td style="text-align: left"></td><td></td>
    <td style="text-align: left"></td><td style="text-align: right"></td><td style="text-align: left"></td><td></td>
    <td style="text-align: left"></td><td style="text-align: right"></td><td style="text-align: left"></td><td></td>
    <td style="text-align: left"></td><td style="text-align: right"></td><td style="text-align: left"></td><td></td>
    <td style="text-align: left"></td><td style="text-align: right"></td><td style="text-align: left"></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.25in; text-indent: -0.125in"><span style="font-size: 8pt">Drilling</span></td><td></td>
    <td style="text-align: left"></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-230; font-size: 8pt">-</span></td><td style="text-align: left"></td><td></td>
    <td style="text-align: left"></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-231; font-size: 8pt">-</span></td><td style="text-align: left"></td><td></td>
    <td style="text-align: left"></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-232; font-size: 8pt">-</span></td><td style="text-align: left"></td><td></td>
    <td style="text-align: left"></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-233; font-size: 8pt">-</span></td><td style="text-align: left"></td><td></td>
    <td style="text-align: left"></td><td style="text-align: right"><span style="font-size: 8pt"><ix:nonFraction contextRef="c201" decimals="0" format="ixt:num-dot-decimal" name="cve:Drilling" scale="0" unitRef="usd">197,422</ix:nonFraction></span></td><td style="text-align: left"></td><td></td>
    <td style="text-align: left"></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-234; font-size: 8pt">-</span></td><td style="text-align: left"></td><td></td>
    <td style="text-align: left"></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-235; font-size: 8pt">-</span></td><td style="text-align: left"></td><td></td>
    <td style="text-align: left"></td><td style="text-align: right"></td><td style="text-align: left"></td><td></td>
    <td style="text-align: left"></td><td style="text-align: right"><span style="font-size: 8pt"><ix:nonFraction contextRef="c204" decimals="0" format="ixt:num-dot-decimal" name="cve:Drilling" scale="0" unitRef="usd">197,422</ix:nonFraction></span></td><td style="text-align: left"></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.25in; text-indent: -0.125in; text-align: left"><span style="font-size: 8pt">Maintenance and lease fees</span></td><td></td>
    <td style="text-align: left"></td><td style="text-align: right"><span style="font-size: 8pt"><ix:nonFraction contextRef="c197" decimals="0" format="ixt:num-dot-decimal" name="cve:MaintenancesAndLeaseFees" scale="0" unitRef="usd">111,004</ix:nonFraction></span></td><td style="text-align: left"></td><td></td>
    <td style="text-align: left"></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-236; font-size: 8pt">-</span></td><td style="text-align: left"></td><td></td>
    <td style="text-align: left"></td><td style="text-align: right"><span style="font-size: 8pt"><ix:nonFraction contextRef="c199" decimals="0" format="ixt:num-dot-decimal" name="cve:MaintenancesAndLeaseFees" scale="0" unitRef="usd">472,401</ix:nonFraction></span></td><td style="text-align: left"></td><td></td>
    <td style="text-align: left"></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-237; font-size: 8pt">-</span></td><td style="text-align: left"></td><td></td>
    <td style="text-align: left"></td><td style="text-align: right"><span style="font-size: 8pt"><ix:nonFraction contextRef="c201" decimals="0" format="ixt:num-dot-decimal" name="cve:MaintenancesAndLeaseFees" scale="0" unitRef="usd">2,523,123</ix:nonFraction></span></td><td style="text-align: left"></td><td></td>
    <td style="text-align: left"></td><td style="text-align: right"><span style="font-size: 8pt"><ix:nonFraction contextRef="c202" decimals="0" format="ixt:num-dot-decimal" name="cve:MaintenancesAndLeaseFees" scale="0" unitRef="usd">39,566</ix:nonFraction></span></td><td style="text-align: left"></td><td></td>
    <td style="text-align: left"></td><td style="text-align: right"><span style="font-size: 8pt"><ix:nonFraction contextRef="c203" decimals="0" format="ixt:num-dot-decimal" name="cve:MaintenancesAndLeaseFees" scale="0" unitRef="usd">397,324</ix:nonFraction></span></td><td style="text-align: left"></td><td></td>
    <td style="text-align: left"></td><td style="text-align: right"></td><td style="text-align: left"></td><td></td>
    <td style="text-align: left"></td><td style="text-align: right"><span style="font-size: 8pt"><ix:nonFraction contextRef="c204" decimals="0" format="ixt:num-dot-decimal" name="cve:MaintenancesAndLeaseFees" scale="0" unitRef="usd">3,543,418</ix:nonFraction></span></td><td style="text-align: left"></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.25in; text-indent: -0.125in; text-align: left"><span style="font-size: 8pt">Permitting &amp; Licensing</span></td><td></td>
    <td style="text-align: left"></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-238; font-size: 8pt">-</span></td><td style="text-align: left"></td><td></td>
    <td style="text-align: left"></td><td style="text-align: right"><span style="font-size: 8pt">(<ix:nonFraction contextRef="c198" decimals="0" format="ixt:num-dot-decimal" name="cve:PermittingLicensing" scale="0" sign="-" unitRef="usd">30,280</ix:nonFraction></span></td><td style="text-align: left"><span style="font-size: 8pt">)</span></td><td></td>
    <td style="text-align: left"></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-239; font-size: 8pt">-</span></td><td style="text-align: left"></td><td></td>
    <td style="text-align: left"></td><td style="text-align: right"><span style="font-size: 8pt"><ix:nonFraction contextRef="c200" decimals="0" format="ixt:num-dot-decimal" name="cve:PermittingLicensing" scale="0" unitRef="usd">251,863</ix:nonFraction></span></td><td style="text-align: left"></td><td></td>
    <td style="text-align: left"></td><td style="text-align: right"><span style="font-size: 8pt"><ix:nonFraction contextRef="c201" decimals="0" format="ixt:num-dot-decimal" name="cve:PermittingLicensing" scale="0" unitRef="usd">339,225</ix:nonFraction></span></td><td style="text-align: left"></td><td></td>
    <td style="text-align: left"></td><td style="text-align: right"><span style="font-size: 8pt"><ix:nonFraction contextRef="c202" decimals="0" format="ixt:num-dot-decimal" name="cve:PermittingLicensing" scale="0" unitRef="usd">5,698</ix:nonFraction></span></td><td style="text-align: left"></td><td></td>
    <td style="text-align: left"></td><td style="text-align: right"><span style="font-size: 8pt"><ix:nonFraction contextRef="c203" decimals="0" format="ixt:num-dot-decimal" name="cve:PermittingLicensing" scale="0" unitRef="usd">273,726</ix:nonFraction></span></td><td style="text-align: left"></td><td></td>
    <td style="text-align: left"></td><td style="text-align: right"></td><td style="text-align: left"></td><td></td>
    <td style="text-align: left"></td><td style="text-align: right"><span style="font-size: 8pt"><ix:nonFraction contextRef="c204" decimals="0" format="ixt:num-dot-decimal" name="cve:PermittingLicensing" scale="0" unitRef="usd">840,232</ix:nonFraction></span></td><td style="text-align: left"></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.25in; text-indent: -0.125in"><span style="font-size: 8pt">Personnel</span></td><td></td>
    <td style="text-align: left"></td><td style="text-align: right"><span style="font-size: 8pt"><ix:nonFraction contextRef="c197" decimals="0" format="ixt:num-dot-decimal" name="cve:Personnel" scale="0" unitRef="usd">4,500</ix:nonFraction></span></td><td style="text-align: left"></td><td></td>
    <td style="text-align: left"></td><td style="text-align: right"><span style="font-size: 8pt"><ix:nonFraction contextRef="c198" decimals="0" format="ixt:num-dot-decimal" name="cve:Personnel" scale="0" unitRef="usd">8,621</ix:nonFraction></span></td><td style="text-align: left"></td><td></td>
    <td style="text-align: left"></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-240; font-size: 8pt">-</span></td><td style="text-align: left"></td><td></td>
    <td style="text-align: left"></td><td style="text-align: right"><span style="font-size: 8pt"><ix:nonFraction contextRef="c200" decimals="0" format="ixt:num-dot-decimal" name="cve:Personnel" scale="0" unitRef="usd">301,066</ix:nonFraction></span></td><td style="text-align: left"></td><td></td>
    <td style="text-align: left"></td><td style="text-align: right"><span style="font-size: 8pt"><ix:nonFraction contextRef="c201" decimals="0" format="ixt:num-dot-decimal" name="cve:Personnel" scale="0" unitRef="usd">280,341</ix:nonFraction></span></td><td style="text-align: left"></td><td></td>
    <td style="text-align: left"></td><td style="text-align: right"><span style="font-size: 8pt"><ix:nonFraction contextRef="c202" decimals="0" format="ixt:num-dot-decimal" name="cve:Personnel" scale="0" unitRef="usd">19,620</ix:nonFraction></span></td><td style="text-align: left"></td><td></td>
    <td style="text-align: left"></td><td style="text-align: right"><span style="font-size: 8pt"><ix:nonFraction contextRef="c203" decimals="0" format="ixt:num-dot-decimal" name="cve:Personnel" scale="0" unitRef="usd">207,518</ix:nonFraction></span></td><td style="text-align: left"></td><td></td>
    <td style="text-align: left"></td><td style="text-align: right"></td><td style="text-align: left"></td><td></td>
    <td style="text-align: left"></td><td style="text-align: right"><span style="font-size: 8pt"><ix:nonFraction contextRef="c204" decimals="0" format="ixt:num-dot-decimal" name="cve:Personnel" scale="0" unitRef="usd">821,666</ix:nonFraction></span></td><td style="text-align: left"></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.25in; text-indent: -0.125in"><span style="font-size: 8pt">Recoveries</span></td><td></td>
    <td style="text-align: left"></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-241; font-size: 8pt">-</span></td><td style="text-align: left"></td><td></td>
    <td style="text-align: left"></td><td style="text-align: right"><span style="font-size: 8pt">(<ix:nonFraction contextRef="c198" decimals="0" format="ixt:num-dot-decimal" name="cve:Recoveries" scale="0" sign="-" unitRef="usd">20,000</ix:nonFraction></span></td><td style="text-align: left"><span style="font-size: 8pt">)</span></td><td></td>
    <td style="text-align: left"></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-242; font-size: 8pt">-</span></td><td style="text-align: left"></td><td></td>
    <td style="text-align: left"></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-243; font-size: 8pt">-</span></td><td style="text-align: left"></td><td></td>
    <td style="text-align: left"></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-244; font-size: 8pt">-</span></td><td style="text-align: left"></td><td></td>
    <td style="text-align: left"></td><td style="text-align: right"><span style="font-size: 8pt">(<ix:nonFraction contextRef="c202" decimals="0" format="ixt:num-dot-decimal" name="cve:Recoveries" scale="0" sign="-" unitRef="usd">2,000</ix:nonFraction></span></td><td style="text-align: left"><span style="font-size: 8pt">)</span></td><td></td>
    <td style="text-align: left"></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-245; font-size: 8pt">-</span></td><td style="text-align: left"></td><td></td>
    <td style="text-align: left"></td><td style="text-align: right"></td><td style="text-align: left"></td><td></td>
    <td style="text-align: left"></td><td style="text-align: right"><span style="font-size: 8pt">(<ix:nonFraction contextRef="c204" decimals="0" format="ixt:num-dot-decimal" name="cve:Recoveries" scale="0" sign="-" unitRef="usd">22,000</ix:nonFraction></span></td><td style="text-align: left"><span style="font-size: 8pt">)</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.25in; text-indent: -0.125in; text-align: left"><span style="font-size: 8pt">Resource review</span></td><td></td>
    <td style="text-align: left"></td><td style="text-align: right"><span style="font-size: 8pt"><ix:nonFraction contextRef="c197" decimals="0" format="ixt:num-dot-decimal" name="cve:ResourceReview" scale="0" unitRef="usd">118,500</ix:nonFraction></span></td><td style="text-align: left"></td><td></td>
    <td style="text-align: left"></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-246; font-size: 8pt">-</span></td><td style="text-align: left"></td><td></td>
    <td style="text-align: left"></td><td style="text-align: right"><span style="font-size: 8pt"><ix:nonFraction contextRef="c199" decimals="0" format="ixt:num-dot-decimal" name="cve:ResourceReview" scale="0" unitRef="usd">37,125</ix:nonFraction></span></td><td style="text-align: left"></td><td></td>
    <td style="text-align: left"></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-247; font-size: 8pt">-</span></td><td style="text-align: left"></td><td></td>
    <td style="text-align: left"></td><td style="text-align: right"><span style="font-size: 8pt"><ix:nonFraction contextRef="c201" decimals="0" format="ixt:num-dot-decimal" name="cve:ResourceReview" scale="0" unitRef="usd">47,104</ix:nonFraction></span></td><td style="text-align: left"></td><td></td>
    <td style="text-align: left"></td><td style="text-align: right"><span style="font-size: 8pt"><ix:nonFraction contextRef="c202" decimals="0" format="ixt:num-dot-decimal" name="cve:ResourceReview" scale="0" unitRef="usd">1,680</ix:nonFraction></span></td><td style="text-align: left"></td><td></td>
    <td style="text-align: left"></td><td style="text-align: right"><span style="font-size: 8pt"><ix:nonFraction contextRef="c203" decimals="0" format="ixt:num-dot-decimal" name="cve:ResourceReview" scale="0" unitRef="usd">10,080</ix:nonFraction></span></td><td style="text-align: left"></td><td></td>
    <td style="text-align: left"></td><td style="text-align: right"></td><td style="text-align: left"></td><td></td>
    <td style="text-align: left"></td><td style="text-align: right"><span style="font-size: 8pt"><ix:nonFraction contextRef="c204" decimals="0" format="ixt:num-dot-decimal" name="cve:ResourceReview" scale="0" unitRef="usd">214,489</ix:nonFraction></span></td><td style="text-align: left"></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-size: 8pt">Divestment:</span></td><td></td>
    <td style="text-align: left"></td><td style="text-align: right"></td><td style="text-align: left"></td><td></td>
    <td style="text-align: left"></td><td style="text-align: right"></td><td style="text-align: left"></td><td></td>
    <td style="text-align: left"></td><td style="text-align: right"></td><td style="text-align: left"></td><td></td>
    <td style="text-align: left"></td><td style="text-align: right"></td><td style="text-align: left"></td><td></td>
    <td style="text-align: left"></td><td style="text-align: right"></td><td style="text-align: left"></td><td></td>
    <td style="text-align: left"></td><td style="text-align: right"></td><td style="text-align: left"></td><td></td>
    <td style="text-align: left"></td><td style="text-align: right"></td><td style="text-align: left"></td><td></td>
    <td style="text-align: left"></td><td style="text-align: right"></td><td style="text-align: left"></td><td></td>
    <td style="text-align: left"></td><td style="text-align: right"></td><td style="text-align: left"></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.25in; text-indent: -0.125in; text-align: left"><span style="font-size: 8pt">Divestment of Mineral Interest</span></td><td></td>
    <td style="text-align: left"></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-248; font-size: 8pt">-</span></td><td style="text-align: left"></td><td></td>
    <td style="text-align: left"></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-249; font-size: 8pt">-</span></td><td style="text-align: left"></td><td></td>
    <td style="text-align: left"></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-250; font-size: 8pt">-</span></td><td style="text-align: left"></td><td></td>
    <td style="text-align: left"></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-251; font-size: 8pt">-</span></td><td style="text-align: left"></td><td></td>
    <td style="text-align: left"></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-252; font-size: 8pt">-</span></td><td style="text-align: left"></td><td></td>
    <td style="text-align: left"></td><td style="text-align: right"><span style="font-size: 8pt">(<ix:nonFraction contextRef="c210" decimals="0" format="ixt:num-dot-decimal" name="cve:DivestMineralInterest" scale="0" unitRef="usd">28,485</ix:nonFraction></span></td><td style="text-align: left"><span style="font-size: 8pt">)</span></td><td></td>
    <td style="text-align: left"></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-253; font-size: 8pt">-</span></td><td style="text-align: left"></td><td></td>
    <td style="text-align: left"></td><td style="text-align: right"></td><td style="text-align: left"></td><td></td>
    <td style="text-align: left"></td><td style="text-align: right"><span style="font-size: 8pt">(<ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="cve:DivestMineralInterest" scale="0" unitRef="usd">28,485</ix:nonFraction></span></td><td style="text-align: left"><span style="font-size: 8pt">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.25in; text-indent: -0.125in; text-align: left"><span style="font-size: 8pt">Assets held for sale</span></td><td></td>
    <td style="text-align: left"></td><td style="text-align: right"><span style="font-size: 8pt">(<ix:nonFraction contextRef="c205" decimals="0" format="ixt:num-dot-decimal" name="cve:AssetsHeldForSale" scale="0" unitRef="usd">358,969</ix:nonFraction></span></td><td style="text-align: left"><span style="font-size: 8pt">)</span></td><td></td>
    <td style="text-align: left"></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-254; font-size: 8pt">-</span></td><td style="text-align: left"></td><td></td>
    <td style="text-align: left"></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-255; font-size: 8pt">-</span></td><td style="text-align: left"></td><td></td>
    <td style="text-align: left"></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-256; font-size: 8pt">-</span></td><td style="text-align: left"></td><td></td>
    <td style="text-align: left"></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-257; font-size: 8pt">-</span></td><td style="text-align: left"></td><td></td>
    <td style="text-align: left"></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-258; font-size: 8pt">-</span></td><td style="text-align: left"></td><td></td>
    <td style="text-align: left"></td><td style="text-align: right"><span style="font-size: 8pt">(<ix:nonFraction contextRef="c211" decimals="0" format="ixt:num-dot-decimal" name="cve:AssetsHeldForSale" scale="0" unitRef="usd">369,913</ix:nonFraction></span></td><td style="text-align: left"><span style="font-size: 8pt">)</span></td><td></td>
    <td style="text-align: left"></td><td style="text-align: right"></td><td style="text-align: left"></td><td></td>
    <td style="text-align: left"></td><td style="text-align: right"><span style="font-size: 8pt">(<ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="cve:AssetsHeldForSale" scale="0" unitRef="usd">728,882</ix:nonFraction></span></td><td style="text-align: left"><span style="font-size: 8pt">)</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left"><span style="font-size: 8pt">Project Development costs:</span></td><td></td>
    <td style="text-align: left"></td><td style="text-align: right"></td><td style="text-align: left"></td><td></td>
    <td style="text-align: left"></td><td style="text-align: right"></td><td style="text-align: left"></td><td></td>
    <td style="text-align: left"></td><td style="text-align: right"></td><td style="text-align: left"></td><td></td>
    <td style="text-align: left"></td><td style="text-align: right"></td><td style="text-align: left"></td><td></td>
    <td style="text-align: left"></td><td style="text-align: right"></td><td style="text-align: left"></td><td></td>
    <td style="text-align: left"></td><td style="text-align: right"></td><td style="text-align: left"></td><td></td>
    <td style="text-align: left"></td><td style="text-align: right"></td><td style="text-align: left"></td><td></td>
    <td style="text-align: left"></td><td style="text-align: right"></td><td style="text-align: left"></td><td></td>
    <td style="text-align: left"></td><td style="text-align: right"></td><td style="text-align: left"></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.375in; text-indent: -0.125in"><span style="font-size: 8pt">Construction of wellfields</span></td><td></td>
    <td style="text-align: left"></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-259; font-size: 8pt">-</span></td><td style="text-align: left"></td><td></td>
    <td style="text-align: left"></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-260; font-size: 8pt">-</span></td><td style="text-align: left"></td><td></td>
    <td style="text-align: left"></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-261; font-size: 8pt">-</span></td><td style="text-align: left"></td><td></td>
    <td style="text-align: left"></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-262; font-size: 8pt">-</span></td><td style="text-align: left"></td><td></td>
    <td style="text-align: left"></td><td style="text-align: right"><span style="font-size: 8pt"><ix:nonFraction contextRef="c209" decimals="0" format="ixt:num-dot-decimal" name="cve:ConstructionOfWellfields" scale="0" unitRef="usd">1,670,151</ix:nonFraction></span></td><td style="text-align: left"></td><td></td>
    <td style="text-align: left"></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-263; font-size: 8pt">-</span></td><td style="text-align: left"></td><td></td>
    <td style="text-align: left"></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-264; font-size: 8pt">-</span></td><td style="text-align: left"></td><td></td>
    <td style="text-align: left"></td><td style="text-align: right"></td><td style="text-align: left"></td><td></td>
    <td style="text-align: left"></td><td style="text-align: right"><span style="font-size: 8pt"><ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="cve:ConstructionOfWellfields" scale="0" unitRef="usd">1,670,151</ix:nonFraction></span></td><td style="text-align: left"></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.25in; text-indent: -0.125in"><span style="font-size: 8pt">Drilling</span></td><td></td>
    <td style="text-align: left"></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-265; font-size: 8pt">-</span></td><td style="text-align: left"></td><td></td>
    <td style="text-align: left"></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-266; font-size: 8pt">-</span></td><td style="text-align: left"></td><td></td>
    <td style="text-align: left"></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-267; font-size: 8pt">-</span></td><td style="text-align: left"></td><td></td>
    <td style="text-align: left"></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-268; font-size: 8pt">-</span></td><td style="text-align: left"></td><td></td>
    <td style="text-align: left"></td><td style="text-align: right"><span style="font-size: 8pt"><ix:nonFraction contextRef="c209" decimals="0" format="ixt:num-dot-decimal" name="cve:Drilling" scale="0" unitRef="usd">2,109,835</ix:nonFraction></span></td><td style="text-align: left"></td><td></td>
    <td style="text-align: left"></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-269; font-size: 8pt">-</span></td><td style="text-align: left"></td><td></td>
    <td style="text-align: left"></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-270; font-size: 8pt">-</span></td><td style="text-align: left"></td><td></td>
    <td style="text-align: left"></td><td style="text-align: right"></td><td style="text-align: left"></td><td></td>
    <td style="text-align: left"></td><td style="text-align: right"><span style="font-size: 8pt"><ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="cve:Drilling" scale="0" unitRef="usd">2,109,835</ix:nonFraction></span></td><td style="text-align: left"></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.25in; text-indent: -0.125in; padding-bottom: 1.5pt"><span style="font-size: 8pt">Personnel</span></td><td></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-271; font-size: 8pt">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"></td><td></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-272; font-size: 8pt">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"></td><td></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-273; font-size: 8pt">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"></td><td></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-274; font-size: 8pt">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"></td><td></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-size: 8pt"><ix:nonFraction contextRef="c209" decimals="0" format="ixt:num-dot-decimal" name="cve:Personnel" scale="0" unitRef="usd">521,662</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"></td><td></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-275; font-size: 8pt">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"></td><td></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-276; font-size: 8pt">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"></td><td></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"></td><td style="border-bottom: Black 1.5pt solid; text-align: right"></td><td style="padding-bottom: 1.5pt; text-align: left"></td><td></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-size: 8pt"><ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="cve:Personnel" scale="0" unitRef="usd">521,662</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-indent: -0.125in; font-weight: bold; padding-bottom: 1.5pt"><span style="font-size: 8pt">Balance,
    December 31, 2022</span></td><td style="font-weight: bold"></td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"></td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-size: 8pt"><ix:nonFraction contextRef="c212" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:MiningAssets" scale="0" unitRef="usd">775,754</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"></td><td style="font-weight: bold"></td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"></td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-size: 8pt"><ix:nonFraction contextRef="c213" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:MiningAssets" scale="0" unitRef="usd">578,243</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"></td><td style="font-weight: bold"></td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"></td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-size: 8pt"><ix:nonFraction contextRef="c214" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:MiningAssets" scale="0" unitRef="usd">4,905,348</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"></td><td style="font-weight: bold"></td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"></td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-size: 8pt"><ix:nonFraction contextRef="c215" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:MiningAssets" scale="0" unitRef="usd">86,220,848</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"></td><td style="font-weight: bold"></td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"></td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-size: 8pt"><ix:nonFraction contextRef="c216" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:MiningAssets" scale="0" unitRef="usd">9,144,069</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"></td><td style="font-weight: bold"></td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"></td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-size: 8pt"><ix:nonFraction contextRef="c217" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:MiningAssets" scale="0" unitRef="usd">1,840,362</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"></td><td style="font-weight: bold"></td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"></td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-size: 8pt"><ix:nonFraction contextRef="c218" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:MiningAssets" scale="0" unitRef="usd">41,754,462</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"></td><td></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-277; font-size: 8pt">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"></td><td style="font-weight: bold"></td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"></td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-size: 8pt"><ix:nonFraction contextRef="c2" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:MiningAssets" scale="0" unitRef="usd">145,219,086</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"></td></tr>
  </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 18pt; text-align: justify; text-indent: -18pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p></ix:nonNumeric></ix:continuation><div>
</div><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 18pt; text-align: justify; text-indent: -18pt"></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 18pt; text-align: justify; text-indent: -18pt"></p><div>

</div><ix:continuation continuedAt="cve_DisclosureOfMineralProperties-c0_cont_3" id="cve_DisclosureOfMineralProperties-c0_cont_2"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b><i>Assets
Held for Sale</i></b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b><i>&#160;</i></b></span></p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="cve_DisclosureOfMineralProperties-c0_cont_4" id="cve_DisclosureOfMineralProperties-c0_cont_3"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Pursuant
to an agreement dated August 27, 2021, the Company completed the sale of its subsidiary, Cibola Resources, LLC (Note 2), including its
holding of the Cebolletta project to an arm&#8217;s length private company.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="cve_DisclosureOfMineralProperties-c0_cont_5" id="cve_DisclosureOfMineralProperties-c0_cont_4"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Pursuant
to an agreement dated November 3, 2022 the Company completed the sale of its subsidiaries Beltline Resources, Inc and Hydro Restoration
Corporation subsequent to the year ended December 31, 2022 (Note 22(k)).</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p></ix:continuation><div>

</div><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><!-- Field: Page; Sequence: 25; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="border-top: Black 1.5pt solid; width: 100%; padding-top: 2pt; padding-bottom: 2pt; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif"><b>enCore Energy Corp.</b></span></td></tr>
  <tr style="vertical-align: top">
    <td style="border-bottom: Black 1.5pt solid; padding-top: 2pt; padding-bottom: 2pt; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif"><b>Notes
    to the Consolidated Financial Statements</b></span></td></tr>
  <tr style="vertical-align: top">
    <td style="border-bottom: Black 1.5pt solid; padding-top: 2pt; padding-bottom: 2pt; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif"><b>For the years ended December 31, 2022 and December 31, 2021</b></span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif"><b>&#160;</b></span></p><div>

</div><table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif"><b>11.</b></span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b>Mineral
                                            properties</b> (continued)</span></td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -18pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><ix:continuation continuedAt="cve_DisclosureOfMineralProperties-c0_cont_6" id="cve_DisclosureOfMineralProperties-c0_cont_5"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt"><span style="font-family: Times New Roman, Times, Serif"><b><i><span style="text-decoration:underline">Arizona</span></i></b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b><i>&#160;</i></b></span></p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="cve_DisclosureOfMineralProperties-c0_cont_7" id="cve_DisclosureOfMineralProperties-c0_cont_6"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt"><span style="font-family: Times New Roman, Times, Serif"><b><i>Moonshine
Springs</i></b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b><i>&#160;</i></b></span></p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="cve_DisclosureOfMineralProperties-c0_cont_8" id="cve_DisclosureOfMineralProperties-c0_cont_7"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">The
Moonshine Springs project is located in Mohave County, Arizona.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="cve_DisclosureOfMineralProperties-c0_cont_9" id="cve_DisclosureOfMineralProperties-c0_cont_8"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">On
November 3, 2022, the Company entered into an agreement to sell the Moonshine Springs project to Nuclear Fuels, Inc, an arm&#8217;s length
private company (Note 22(k)).</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="cve_DisclosureOfMineralProperties-c0_cont_10" id="cve_DisclosureOfMineralProperties-c0_cont_9"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif"><b><i>Other
Arizona Properties</i></b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b><i>&#160;</i></b></span></p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="cve_DisclosureOfMineralProperties-c0_cont_11" id="cve_DisclosureOfMineralProperties-c0_cont_10"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">The
Company owns or controls three Arizona State mineral leases and 467 unpatented federal lode mining claims covering more than 10,000 acres
in the northern Arizona strip district. The Company holds cash bonds for $<ix:nonFraction contextRef="c2" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:LongtermDeposits" scale="0" unitRef="usd">88,500</ix:nonFraction> (December 31, 2021 - $<ix:nonFraction contextRef="c3" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:LongtermDeposits" scale="0" unitRef="usd">88,500</ix:nonFraction>) with the Bureau of Land
Management.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="cve_DisclosureOfMineralProperties-c0_cont_12" id="cve_DisclosureOfMineralProperties-c0_cont_11"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b><i><span style="text-decoration:underline">Colorado</span></i></b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b><i>&#160;</i></b></span></p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="cve_DisclosureOfMineralProperties-c0_cont_13" id="cve_DisclosureOfMineralProperties-c0_cont_12"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b><i>Centennial</i></b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b><i>&#160;</i></b></span></p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="cve_DisclosureOfMineralProperties-c0_cont_14" id="cve_DisclosureOfMineralProperties-c0_cont_13"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">The
Centennial Uranium Project is located in Colorado. In 2006, the Company entered into an option agreement to purchase uranium rights on
certain areas of the Centennial Project for consideration of $<ix:nonFraction contextRef="c158" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:ConsiderationPaidReceived" scale="0" unitRef="usd">1,895,000</ix:nonFraction> plus contingent payments of $<ix:nonFraction contextRef="c2" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:ContingentConsiderationRecognisedAsOfAcquisitionDate" scale="0" unitRef="usd">3,165,000</ix:nonFraction>. Pursuant to the agreement,
the contingent payments are payable upon receipt of regulatory permits and licenses allowing uranium production. If the Company does
not obtain such permits and licenses by September 27, 2019, the uranium rights, at the option of the seller, can be transferred back
to the seller. To date, the Company has neither obtained the required permits and licenses, nor has it been able to renegotiate the option
agreement. The Company is attempting to renegotiate the option agreement and the seller has not exercised its option to have the uranium
rights transferred back.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="cve_DisclosureOfMineralProperties-c0_cont_15" id="cve_DisclosureOfMineralProperties-c0_cont_14"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif"><b><i><span style="text-decoration:underline">New
Mexico</span></i></b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b><i>&#160;</i></b></span></p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="cve_DisclosureOfMineralProperties-c0_cont_16" id="cve_DisclosureOfMineralProperties-c0_cont_15"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt"><span style="font-family: Times New Roman, Times, Serif"><b><i>Marquez,
Nose Rock, &amp; Treeline</i></b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt"><span style="font-family: Times New Roman, Times, Serif"><b><i>&#160;</i></b></span></p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="cve_DisclosureOfMineralProperties-c0_cont_17" id="cve_DisclosureOfMineralProperties-c0_cont_16"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">The
Marquez project is located in McKinley and Sandoval counties of New Mexico adjacent to the Company&#8217;s Juan Tafoya property.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="cve_DisclosureOfMineralProperties-c0_cont_18" id="cve_DisclosureOfMineralProperties-c0_cont_17"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">The
Nose Rock Project is located in McKinley County, New Mexico, on the northern edge of the Grants Uranium District.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="cve_DisclosureOfMineralProperties-c0_cont_19" id="cve_DisclosureOfMineralProperties-c0_cont_18"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">The
Treeline project is located west-northwest of Albuquerque, in McKinley and Cibola Counties, Grants Uranium District, New Mexico.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="cve_DisclosureOfMineralProperties-c0_cont_20" id="cve_DisclosureOfMineralProperties-c0_cont_19"><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt"><span style="font-family: Times New Roman, Times, Serif">In
March 2021, the Company divested 2,240 acres of fee mineral interests to Tri State Generation and Transmission Association; $<ix:nonFraction contextRef="c159" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:ConsiderationPaidReceived" scale="0" unitRef="usd">89,600</ix:nonFraction> was
received in consideration. The assets having no net book value resulted in a gain on disposal of the mineral interests of $<ix:nonFraction contextRef="c159" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:GainsOnDisposalsOfInvestments" scale="0" unitRef="usd">89,600</ix:nonFraction> recorded
on the Company&#8217;s consolidated statement of loss and comprehensive loss.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="cve_DisclosureOfMineralProperties-c0_cont_21" id="cve_DisclosureOfMineralProperties-c0_cont_20"><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt"><span style="font-family: Times New Roman, Times, Serif">In
May 2021, the Company divested one section of 640 acres of fee mineral interests to Wildcat Solar Power Plant, LLC; $<ix:nonFraction contextRef="c160" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:ConsiderationPaidReceived" scale="0" unitRef="usd">16,000</ix:nonFraction> was received
in consideration. The assets having no net book value resulted in a gain on disposal of the mineral interests of $<ix:nonFraction contextRef="c160" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:GainsOnDisposalsOfInvestments" scale="0" unitRef="usd">16,000</ix:nonFraction> recorded on
the Company&#8217;s consolidated statement of loss and comprehensive loss.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="cve_DisclosureOfMineralProperties-c0_cont_22" id="cve_DisclosureOfMineralProperties-c0_cont_21"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt"><span style="font-family: Times New Roman, Times, Serif"><b>McKinley,
Crownpoint and Hosta Butte</b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt"><span style="font-family: Times New Roman, Times, Serif"><b>&#160;</b></span></p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="cve_DisclosureOfMineralProperties-c0_cont_23" id="cve_DisclosureOfMineralProperties-c0_cont_22"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">The
Company owns a <ix:nonFraction contextRef="c161" decimals="2" format="ixt:num-dot-decimal" name="cve:InvestmentInterestRates" scale="-2" unitRef="pure">100</ix:nonFraction>% interest in the McKinley properties and a <ix:nonFraction contextRef="c162" decimals="2" format="ixt:num-dot-decimal" name="cve:InvestmentInterestRates" scale="-2" unitRef="pure">60</ix:nonFraction>% - <ix:nonFraction contextRef="c163" decimals="2" format="ixt:num-dot-decimal" name="cve:InvestmentInterestRates" scale="-2" unitRef="pure">100</ix:nonFraction>% interest in the adjacent Crownpoint and Hosta Butte properties,
all of which are located in McKinley County, New Mexico. The Company holds a <ix:nonFraction contextRef="c164" decimals="2" format="ixt:num-dot-decimal" name="cve:InterestRateHold" scale="-2" unitRef="pure">60</ix:nonFraction>% interest in a portion of a certain section at Crownpoint.
The Company owns a <ix:nonFraction contextRef="c0" decimals="2" format="ixt:num-dot-decimal" name="cve:InvestmentInterestRates" scale="-2" unitRef="pure">100</ix:nonFraction>% interest in the rest of the Crownpoint and Hosta Butte project area, subject to a <ix:nonFraction contextRef="c0" decimals="2" format="ixt:num-dot-decimal" name="cve:RoyaltyIncomeRate" scale="-2" unitRef="pure">3</ix:nonFraction>% gross profit royalty on
uranium produced.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p></ix:continuation><div>

</div><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt"></p><div>

</div><!-- Field: Page; Sequence: 26; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->25<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt"></p><div>

</div><table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="border-top: Black 1.5pt solid; width: 100%; padding-top: 2pt; padding-bottom: 2pt; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif"><b>enCore Energy Corp.</b></span></td></tr>
  <tr style="vertical-align: top">
    <td style="border-bottom: Black 1.5pt solid; padding-top: 2pt; padding-bottom: 2pt; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif"><b>Notes
    to the Consolidated Financial Statements</b></span></td></tr>
  <tr style="vertical-align: top">
    <td style="border-bottom: Black 1.5pt solid; padding-top: 2pt; padding-bottom: 2pt; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif"><b>For the years ended December 31, 2022 and December 31, 2021</b></span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif"><b>11.</b></span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b>Mineral
                                            properties</b> (continued)</span></td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -18pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><ix:continuation continuedAt="cve_DisclosureOfMineralProperties-c0_cont_24" id="cve_DisclosureOfMineralProperties-c0_cont_23"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt"><span style="font-family: Times New Roman, Times, Serif"><b><i>Juan
Tafoya</i></b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="cve_DisclosureOfMineralProperties-c0_cont_25" id="cve_DisclosureOfMineralProperties-c0_cont_24"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">The
Juan Tafoya property, located in Cibola County in west-central New Mexico near the Company&#8217;s Marquez project is leased from the
Juan Tafoya Land Corporation (&#8220;JTLC&#8221;).</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="cve_DisclosureOfMineralProperties-c0_cont_26" id="cve_DisclosureOfMineralProperties-c0_cont_25"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt"><span style="font-family: Times New Roman, Times, Serif"><b><i>Cebolletta</i></b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="cve_DisclosureOfMineralProperties-c0_cont_27" id="cve_DisclosureOfMineralProperties-c0_cont_26"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">The
Cebolletta project is situated in the eastern portion of Cibola County, New Mexico. The lands that comprise the Cebolleta uranium project
are owned in fee by La Merced del Pueblo de Cebolleta [the &#8220;Cebolleta Land Grant&#8221; (CLG)].</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="cve_DisclosureOfMineralProperties-c0_cont_28" id="cve_DisclosureOfMineralProperties-c0_cont_27"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">On
May 24, 2022, the Company divested of the Cebolletta mineral property via its sale of Cibola Resources, LLC to Elephant (Note 6) pursuant
to a Share Purchase Agreement dated August 27, 2021. Consideration received in the transaction included $<ix:nonFraction contextRef="c165" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:ConsiderationPaidReceived" scale="0" unitRef="usd">250,000</ix:nonFraction> and <ix:nonFraction contextRef="c166" decimals="0" format="ixt:num-dot-decimal" name="cve:ConsiderationReceived" scale="0" unitRef="shares">11,308,250</ix:nonFraction> shares
of Elephant with a fair value of $<ix:nonFraction contextRef="c166" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:LongTermDebtFairValue" scale="0" unitRef="usd">3,085,965</ix:nonFraction>. The asset had a book value of $<ix:nonFraction contextRef="c166" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:NoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSaleOrAsHeldForDistributionToOwners" scale="0" unitRef="usd">1,741,064</ix:nonFraction> at the transaction date, resulting in a gain on
disposal of subsidiary of $<ix:nonFraction contextRef="c165" decimals="0" format="ixt:num-dot-decimal" name="cve:GainOnDisposalOfSubsidiary" scale="0" unitRef="usd">1,594,901</ix:nonFraction> recorded on the Company&#8217;s consolidated statement of loss and comprehensive loss.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="cve_DisclosureOfMineralProperties-c0_cont_29" id="cve_DisclosureOfMineralProperties-c0_cont_28"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt"><span style="font-family: Times New Roman, Times, Serif"><b><i>West
Largo</i></b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b><i>&#160;</i></b></span></p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="cve_DisclosureOfMineralProperties-c0_cont_30" id="cve_DisclosureOfMineralProperties-c0_cont_29"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">The
West Largo Project is near the north-central edge of the Grants Mineral Belt in McKinley County, New Mexico.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="cve_DisclosureOfMineralProperties-c0_cont_31" id="cve_DisclosureOfMineralProperties-c0_cont_30"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt"><span style="font-family: Times New Roman, Times, Serif"><b><i>Other
New Mexico Properties</i></b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b><i>&#160;</i></b></span></p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="cve_DisclosureOfMineralProperties-c0_cont_32" id="cve_DisclosureOfMineralProperties-c0_cont_31"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">The
Company holds mineral properties in the &#8220;checkerboard&#8221; area located primarily in McKinley County in northwestern New Mexico.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="cve_DisclosureOfMineralProperties-c0_cont_33" id="cve_DisclosureOfMineralProperties-c0_cont_32"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">In
January 2022, the Company divested approximately 808 acres of fee mineral interest to Ambrosia Solar, LLC. The assets, having no net
book value at the transaction date, resulted in a gain on disposal of the mineral interests of $<ix:nonFraction contextRef="c167" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:ProceedsFromSalesOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities" scale="0" unitRef="usd">48,480</ix:nonFraction> recorded on the Company&#8217;s
consolidated statement of loss and comprehensive loss. Under the agreement, Ambrosia Solar, LLC retains the right to acquire the uranium
mineral rights associated with the property by quit claim deed to be furnished by the Company. Subsequent to the period ended December
31, 2022, Ambrosia Solar, LLC has elected to exercise its right to extend the option through January 14, 2024 for an additional payment
of $<ix:nonFraction contextRef="c167" decimals="0" format="ixt:num-dot-decimal" name="cve:AdditionalPayment" scale="0" unitRef="usd">24,240</ix:nonFraction>.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="cve_DisclosureOfMineralProperties-c0_cont_34" id="cve_DisclosureOfMineralProperties-c0_cont_33"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt"><span style="font-family: Times New Roman, Times, Serif"><b><i><span style="text-decoration:underline">South
Dakota</span></i></b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b><i>&#160;</i></b></span></p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="cve_DisclosureOfMineralProperties-c0_cont_35" id="cve_DisclosureOfMineralProperties-c0_cont_34"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt"><span style="font-family: Times New Roman, Times, Serif"><b><i>Dewey-Burdock</i></b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b><i>&#160;</i></b></span></p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="cve_DisclosureOfMineralProperties-c0_cont_36" id="cve_DisclosureOfMineralProperties-c0_cont_35"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">The
Dewey-Burdock Project is an in-situ recovery uranium project located in the Edgemont uranium district in South Dakota.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="cve_DisclosureOfMineralProperties-c0_cont_37" id="cve_DisclosureOfMineralProperties-c0_cont_36"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt"><span style="font-family: Times New Roman, Times, Serif"><b><i><span style="text-decoration:underline">Texas</span></i></b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b><i>&#160;</i></b></span></p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="cve_DisclosureOfMineralProperties-c0_cont_38" id="cve_DisclosureOfMineralProperties-c0_cont_37"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt"><span style="font-family: Times New Roman, Times, Serif"><b><i>Kingsville
Dome</i></b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b><i>&#160;</i></b></span></p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="cve_DisclosureOfMineralProperties-c0_cont_39" id="cve_DisclosureOfMineralProperties-c0_cont_38"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">The
Kingsville Dome project is located in Kleberg County, Texas on land owned by the Company. A Central Processing Plant at the site has
been on standby since 2009.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="cve_DisclosureOfMineralProperties-c0_cont_40" id="cve_DisclosureOfMineralProperties-c0_cont_39"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt"><span style="font-family: Times New Roman, Times, Serif"><b><i>Rosita</i></b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b><i>&#160;</i></b></span></p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="cve_DisclosureOfMineralProperties-c0_cont_41" id="cve_DisclosureOfMineralProperties-c0_cont_40"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt"><span style="font-family: Times New Roman, Times, Serif">The
Rosita Project is located in Duval County, Texas on land owned by the Company.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="cve_DisclosureOfMineralProperties-c0_cont_42" id="cve_DisclosureOfMineralProperties-c0_cont_41"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt"><span style="font-family: Times New Roman, Times, Serif"><b><i>Upper
Spring Creek</i></b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b><i>&#160;</i></b></span></p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="cve_DisclosureOfMineralProperties-c0_cont_43" id="cve_DisclosureOfMineralProperties-c0_cont_42"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt"><span style="font-family: Times New Roman, Times, Serif">The
Upper Spring Creek Project is located in Live Oak and Bee counties in Texas.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="cve_DisclosureOfMineralProperties-c0_cont_44" id="cve_DisclosureOfMineralProperties-c0_cont_43"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt"><span style="font-family: Times New Roman, Times, Serif"><b><i>Butler
Ranch</i></b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b><i>&#160;</i></b></span></p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="cve_DisclosureOfMineralProperties-c0_cont_45" id="cve_DisclosureOfMineralProperties-c0_cont_44"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt"><span style="font-family: Times New Roman, Times, Serif">The
Butler Ranch Exploration project is located in Karnes County, Texas.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p></ix:continuation><div>

</div><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><!-- Field: Page; Sequence: 27; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->26<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="border-top: Black 1.5pt solid; width: 100%; padding-top: 2pt; padding-bottom: 2pt; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif"><b>enCore Energy Corp.</b></span></td></tr>
  <tr style="vertical-align: top">
    <td style="border-bottom: Black 1.5pt solid; padding-top: 2pt; padding-bottom: 2pt; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif"><b>Notes
    to the Consolidated Financial Statements</b></span></td></tr>
  <tr style="vertical-align: top">
    <td style="border-bottom: Black 1.5pt solid; padding-top: 2pt; padding-bottom: 2pt; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif"><b>For the years ended December 31, 2022 and December 31, 2021</b></span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif"><b>11.</b></span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b>Mineral
                                            properties</b> (continued)</span></td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 18pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><ix:continuation continuedAt="cve_DisclosureOfMineralProperties-c0_cont_46" id="cve_DisclosureOfMineralProperties-c0_cont_45"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt"><span style="font-family: Times New Roman, Times, Serif"><b><i><span style="text-decoration:underline">Utah</span></i></b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b><i>&#160;</i></b></span></p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="cve_DisclosureOfMineralProperties-c0_cont_47" id="cve_DisclosureOfMineralProperties-c0_cont_46"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt"><span style="font-family: Times New Roman, Times, Serif"><b><i>Ticaboo</i></b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b><i>&#160;</i></b></span></p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="cve_DisclosureOfMineralProperties-c0_cont_48" id="cve_DisclosureOfMineralProperties-c0_cont_47"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">The
Company owns three portions of a claim block located in Shootaring Canyon, Utah. The Company has a federal Plan of Operation and State
of Utah approval for processing of the assets.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="cve_DisclosureOfMineralProperties-c0_cont_49" id="cve_DisclosureOfMineralProperties-c0_cont_48"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt"><span style="font-family: Times New Roman, Times, Serif"><b><i>Other
Utah Properties</i></b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b><i>&#160;</i></b></span></p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="cve_DisclosureOfMineralProperties-c0_cont_50" id="cve_DisclosureOfMineralProperties-c0_cont_49"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">The
Company owns various mining claims throughout Utah, as well as its Cedar Mountain project located northwest of the White Mesa Mill in
Blanding County, Utah.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="cve_DisclosureOfMineralProperties-c0_cont_51" id="cve_DisclosureOfMineralProperties-c0_cont_50"><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt"><span style="font-family: Times New Roman, Times, Serif">In
March 2021, the Geitus, Blue Jay and Marcy Look properties were transferred to Kimmerle Mining LLC. $Nil consideration was received in
the transaction and a loss on the disposal of these mineral rights was recorded on the Company&#8217;s consolidated statement of loss
and comprehensive loss as a component of &#8220;Other Income (Expense)&#8221; for the net book value of the assets at the transaction
date, $<ix:nonFraction contextRef="c168" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:RecognisedAssetsDefinedBenefitPlan" scale="0" unitRef="usd">195,514</ix:nonFraction>.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="cve_DisclosureOfMineralProperties-c0_cont_52" id="cve_DisclosureOfMineralProperties-c0_cont_51"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">In
June 2022, the Company divested of its mineral interests in the Lisbon Valley to Prime Fuels Corp (&#8220;PFC&#8221;). In consideration
of the transaction the Company was granted a <ix:nonFraction contextRef="c169" decimals="3" format="ixt:num-dot-decimal" name="cve:GrantedPercentage" scale="-2" unitRef="pure">2.0</ix:nonFraction>% Net Smelter Royalty (&#8220;NSR&#8221;). Additionally, pursuant to the purchase agreement
dated June 20, 2022, should PFC sell, transfer or exchange the property or all of its shares to a third party, the Company shall receive
<ix:nonFraction contextRef="c169" decimals="2" format="ixt:num-dot-decimal" name="cve:ConsiderationPercentage" scale="-2" unitRef="pure">5</ix:nonFraction>% of the consideration that PFC receives for the lease, license, loan or sale of the property or the shares of PFC to any third party.
In October 2022, PFC and these mineral interests were acquired by Uravan Minerals, Inc resulting in the Company&#8217;s receipt of <ix:nonFraction contextRef="c80" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:NumberOfSharesIssuedAndFullyPaid" scale="0" unitRef="shares">80,000</ix:nonFraction>
shares of Uravan Minerals, Inc with a fair value of $<ix:nonFraction contextRef="c170" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:PlanAssetsAtFairValue" scale="0" unitRef="usd">9,153</ix:nonFraction>. The asset had a net book value of $<ix:nonFraction contextRef="c170" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:NoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSaleOrAsHeldForDistributionToOwners" scale="0" unitRef="usd">28,485</ix:nonFraction> at the transaction date, resulting
in a loss on disposal of the mineral interests of $<ix:nonFraction contextRef="c171" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:LossesOnDisposalsOfInvestments" scale="0" unitRef="usd">19,332</ix:nonFraction> recorded on the Company&#8217;s consolidated statement of loss and comprehensive
loss.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="cve_DisclosureOfMineralProperties-c0_cont_53" id="cve_DisclosureOfMineralProperties-c0_cont_52"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Also
in June 2022, the Company divested of a portion of its mineral interests, in the JB Claims, to PFC. As consideration for the transaction,
the Company was granted a <ix:nonFraction contextRef="c172" decimals="3" format="ixt:num-dot-decimal" name="cve:GrantedPercentage" scale="-2" unitRef="pure">2.0</ix:nonFraction>% NSR. Additionally, pursuant to the purchase agreement dated June 20, 2022, should PFC sell, transfer or
exchange the property or all of its shares to a third party, the Company shall receive <ix:nonFraction contextRef="c172" decimals="2" format="ixt:num-dot-decimal" name="cve:ConsiderationPercentage" scale="-2" unitRef="pure">5</ix:nonFraction>% of the consideration that PFC receives for
the lease, license, loan or sale of the property or the shares of PFC to any third party. The asset had no net book value at the transaction
date, resulting in no recognition of a gain or loss on disposal.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="cve_DisclosureOfMineralProperties-c0_cont_54" id="cve_DisclosureOfMineralProperties-c0_cont_53"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt"><span style="font-family: Times New Roman, Times, Serif"><b><i><span style="text-decoration:underline">Wyoming</span></i></b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b><i>&#160;</i></b></span></p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="cve_DisclosureOfMineralProperties-c0_cont_55" id="cve_DisclosureOfMineralProperties-c0_cont_54"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt"><span style="font-family: Times New Roman, Times, Serif"><b><i>Gas
Hills</i></b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b><i>&#160;</i></b></span></p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="cve_DisclosureOfMineralProperties-c0_cont_56" id="cve_DisclosureOfMineralProperties-c0_cont_55"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt"><span style="font-family: Times New Roman, Times, Serif">The
Gas Hills Project is located in the historic Gas Hills uranium district 45 miles east of Riverton, Wyoming.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="cve_DisclosureOfMineralProperties-c0_cont_57" id="cve_DisclosureOfMineralProperties-c0_cont_56"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt"><span style="font-family: Times New Roman, Times, Serif"><b><i>Bootheel</i></b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b><i>&#160;</i></b></span></p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="cve_DisclosureOfMineralProperties-c0_cont_58" id="cve_DisclosureOfMineralProperties-c0_cont_57"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">The
Bootheel uranium project is located in Albany County, Wyoming. On November 3, 2022, the Company entered into an agreement to sell the
Bootheel Uranium project to Nuclear Fuels, Inc, an arm&#8217;s length private company (Note 22(k)).</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="cve_DisclosureOfMineralProperties-c0_cont_59" id="cve_DisclosureOfMineralProperties-c0_cont_58"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt"><span style="font-family: Times New Roman, Times, Serif"><b><i>Dewey
Terrace</i></b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b><i>&#160;</i></b></span></p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="cve_DisclosureOfMineralProperties-c0_cont_60" id="cve_DisclosureOfMineralProperties-c0_cont_59"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">The
Dewey Terrace Project is located in Weston and Niobrara Counties of Wyoming. The project is located immediately adjacent to the Company&#8217;s
NRC licensed Dewey-Burdock Project along the Wyoming-South Dakota state line.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b><i>&#160;</i></b></span></p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="cve_DisclosureOfMineralProperties-c0_cont_61" id="cve_DisclosureOfMineralProperties-c0_cont_60"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt"><span style="font-family: Times New Roman, Times, Serif"><b><i>Juniper
Ridge</i></b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b><i>&#160;</i></b></span></p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="cve_DisclosureOfMineralProperties-c0_cont_62" id="cve_DisclosureOfMineralProperties-c0_cont_61"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">The
Juniper Ridge Project is located in the southwest portion of Wyoming, approximately 10 miles west of the town of Baggs.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p></ix:continuation><div>

</div><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><!-- Field: Page; Sequence: 28; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->27<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif"><b><i>&#160;</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="border-top: Black 1.5pt solid; width: 100%; padding-top: 2pt; padding-bottom: 2pt; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif"><b>enCore Energy Corp.</b></span></td></tr>
  <tr style="vertical-align: top">
    <td style="border-bottom: Black 1.5pt solid; padding-top: 2pt; padding-bottom: 2pt; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif"><b>Notes
    to the Consolidated Financial Statements</b></span></td></tr>
  <tr style="vertical-align: top">
    <td style="border-bottom: Black 1.5pt solid; padding-top: 2pt; padding-bottom: 2pt; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif"><b>For the years ended December 31, 2022 and December 31, 2021</b></span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif"><b><i>&#160;</i></b></span></p><div>

</div><table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif"><b>11.</b></span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b>Mineral
                                            properties</b> (continued)</span></td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><ix:continuation continuedAt="cve_DisclosureOfMineralProperties-c0_cont_63" id="cve_DisclosureOfMineralProperties-c0_cont_62"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt"><span style="font-family: Times New Roman, Times, Serif"><b><i><span style="text-decoration:underline">Utah
</span></i></b><i>(continued)</i></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><i>&#160;</i></span></p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="cve_DisclosureOfMineralProperties-c0_cont_64" id="cve_DisclosureOfMineralProperties-c0_cont_63"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt"><span style="font-family: Times New Roman, Times, Serif"><b><i>Kaycee</i></b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b><i>&#160;</i></b></span></p></ix:continuation><div>

</div><div>

</div><ix:continuation id="cve_DisclosureOfMineralProperties-c0_cont_64"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">The
Kaycee uranium project is located in Johnson County, Wyoming. On November 3, 2022, the Company entered into an agreement to sell the
Kaycee Uranium project to Nuclear Fuels, Inc, a private arm&#8217;s length company (Note 22(k)).</span></p></ix:continuation><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><ix:nonNumeric contextRef="c0" continuedAt="cve_AssetRetirementObligationsTextBlock-c0_cont_1" escape="true" name="cve:AssetRetirementObligationsTextBlock"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%"><tr style="vertical-align: top">
<td style="width: 18pt"></td><td style="width: 18pt"><span style="font-family: Times New Roman, Times, Serif"><b>12.</b></span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b>Asset
                                            retirement obligations</b></span></td></tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -18pt"><span style="font-family: Times New Roman, Times, Serif"><b>&#160;</b></span></p></ix:nonNumeric><div>

</div><div>

</div><ix:continuation continuedAt="cve_AssetRetirementObligationsTextBlock-c0_cont_2" id="cve_AssetRetirementObligationsTextBlock-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">The
Company is obligated by various federal and state mining laws and regulations which require the Company to reclaim surface areas and
restore underground water quality for certain assets in Texas, Wyoming, Utah and Colorado. These projects must be returned to the pre-existing
or background average quality after completion of mining.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="cve_AssetRetirementObligationsTextBlock-c0_cont_3" id="cve_AssetRetirementObligationsTextBlock-c0_cont_2"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Annually,
the Company updates these reclamation provisions based on cash flow estimates, and changes in regulatory requirements and settlements.
This review may result in an adjustment to the asset retirement obligations in addition to the outstanding liability balance. The Company
used an inflation factor of <ix:nonFraction contextRef="c0" decimals="3" format="ixt:num-dot-decimal" name="cve:InflationFactorPercentage" scale="-2" unitRef="pure">2.5</ix:nonFraction>% per year and a discount rate of <ix:nonFraction contextRef="c2" decimals="2" format="ixt:num-dot-decimal" name="ifrs-full:DescriptionOfDiscountRatesAppliedToCashFlowProjections" scale="-2" unitRef="pure">11</ix:nonFraction>% in estimating the present value of its future cash flows.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="cve_AssetRetirementObligationsTextBlock-c0_cont_4" id="cve_AssetRetirementObligationsTextBlock-c0_cont_3"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt"><span style="font-family: Times New Roman, Times, Serif">The
asset retirement obligations balance consists of:</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p></ix:continuation><div>

</div><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><ix:continuation continuedAt="cve_AssetRetirementObligationsTextBlock-c0_cont_5" id="cve_AssetRetirementObligationsTextBlock-c0_cont_4"><ix:nonNumeric contextRef="c0" escape="true" name="cve:DisclosureOfAssetRetirementObligationsBalanceTableTextBlock"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td style="text-align: center; padding-bottom: 1.5pt; padding-left: 0.125in">&#160;</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">December 31, <br/> 2022<br/> $</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="text-align: center; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">December 31, <br/> 2021<br/> $</td><td style="text-align: center; padding-bottom: 1.5pt">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; width: 76%">Kingsville</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c220" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:FinancialAssets" scale="0" unitRef="usd">3,151,875</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c221" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:FinancialAssets" scale="0" unitRef="usd">2,671,295</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-indent: -0.125in">Rosita</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c222" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:FinancialAssets" scale="0" unitRef="usd">1,298,397</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c223" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:FinancialAssets" scale="0" unitRef="usd">1,198,255</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in">Vasquez</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c224" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:FinancialAssets" scale="0" unitRef="usd">34,274</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c225" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:FinancialAssets" scale="0" unitRef="usd">39,137</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-indent: -0.125in">Centennial</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c226" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:FinancialAssets" scale="0" unitRef="usd">168,806</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c227" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:FinancialAssets" scale="0" unitRef="usd">168,806</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left">Gas Hills</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c228" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:FinancialAssets" scale="0" unitRef="usd">63,000</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c229" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:FinancialAssets" scale="0" unitRef="usd">63,000</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 1.5pt">Ticaboo</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c230" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:FinancialAssets" scale="0" unitRef="usd">36,000</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c231" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:FinancialAssets" scale="0" unitRef="usd">36,000</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; font-weight: bold; text-align: left; padding-bottom: 1.5pt">Asset retirement obligations</td><td style="font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><ix:nonFraction contextRef="c2" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:FinancialAssets" scale="0" unitRef="usd">4,752,352</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c3" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:FinancialAssets" scale="0" unitRef="usd">4,176,493</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p></ix:nonNumeric></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="cve_AssetRetirementObligationsTextBlock-c0_cont_6" id="cve_AssetRetirementObligationsTextBlock-c0_cont_5"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt"><span style="font-family: Times New Roman, Times, Serif">The
asset retirement obligations continuity summary is as follows:</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p></ix:continuation><div>

</div><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt"></p><div>

</div><ix:continuation id="cve_AssetRetirementObligationsTextBlock-c0_cont_6"><ix:nonNumeric contextRef="c0" escape="true" name="cve:DisclosureOfAssetRetirementObligationsContinuityTableTextBlock"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom; ">
    <td style="border-bottom: Black 1.5pt solid; width: 88%; font-weight: bold; text-align: left; padding-bottom: 1.5pt">Asset retirement obligation</td><td style="width: 1%; font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; width: 1%; font-weight: bold; text-align: left"></td><td style="border-bottom: Black 1.5pt solid; width: 9%; font-weight: bold; text-align: center">$</td><td style="width: 1%; padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Balance, December 31, 2020</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right"><ix:nonFraction contextRef="c6" decimals="0" format="ixt:num-dot-decimal" name="cve:AssetRetirementObligationsBalance" scale="0" unitRef="usd">5,239,108</ix:nonFraction></td><td style="font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Accretion</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="cve:AssetRetirementObligationsAccretion" scale="0" unitRef="usd">400,710</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td>Adjustments</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="cve:AssetRetirementObligationsAdjustments" scale="0" sign="-" unitRef="usd">1,719,943</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Settlement</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="cve:AssetRetirementObligationsSettlement" scale="0" sign="-" unitRef="usd">11,189</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt">Additions from Azarga asset acquisition (Note 10)</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="cve:AssetRetirementObligationsAdditionsFromAzargaAssetAcquisitionNote10" scale="0" unitRef="usd">267,807</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1.5pt">Balance, December 31, 2021</td><td style="font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><ix:nonFraction contextRef="c3" decimals="0" format="ixt:num-dot-decimal" name="cve:AssetRetirementObligationsBalance" scale="0" unitRef="usd">4,176,493</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Accretion</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="cve:AssetRetirementObligationsAccretion" scale="0" unitRef="usd">429,956</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td>Settlement</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="cve:AssetRetirementObligationsSettlement" scale="0" sign="-" unitRef="usd">11,324</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1.5pt">Adjustments</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="cve:AssetRetirementObligationsAdjustments" scale="0" unitRef="usd">157,227</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font-weight: bold; padding-bottom: 1.5pt">Balance, December 31, 2022</td><td style="font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><ix:nonFraction contextRef="c2" decimals="0" format="ixt:num-dot-decimal" name="cve:AssetRetirementObligationsBalance" scale="0" unitRef="usd">4,752,352</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  </table></ix:nonNumeric></ix:continuation><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><!-- Field: Page; Sequence: 29; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->28<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="border-top: Black 1.5pt solid; width: 100%; padding-top: 2pt; padding-bottom: 2pt; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif"><b>enCore Energy Corp.</b></span></td></tr>
  <tr style="vertical-align: top">
    <td style="border-bottom: Black 1.5pt solid; padding-top: 2pt; padding-bottom: 2pt; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif"><b>Notes
    to the Consolidated Financial Statements</b></span></td></tr>
  <tr style="vertical-align: top">
    <td style="border-bottom: Black 1.5pt solid; padding-top: 2pt; padding-bottom: 2pt; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif"><b>For the years ended December 31, 2022 and December 31, 2021</b></span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><ix:nonNumeric contextRef="c0" continuedAt="cve_DisclosueOfSalesContractsTextBlock-c0_cont_1" escape="true" name="cve:DisclosueOfSalesContractsTextBlock"><table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif"><b>13.</b></span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b>Sales
                                            contracts</b></span></td></tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -18pt"><span style="font-family: Times New Roman, Times, Serif"><b>&#160;</b></span></p></ix:nonNumeric><div>

</div><div>

</div><ix:continuation continuedAt="cve_DisclosueOfSalesContractsTextBlock-c0_cont_2" id="cve_DisclosueOfSalesContractsTextBlock-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">On
December 31, 2020, through an asset acquisition from Westwater Resources, Inc. the Company acquired an agreement with UG USA,&#160;Inc.
(&#8220;UG&#8221;). The contract provided for delivery of one-half of the Company&#8217;s actual production, for a total of <ix:nonFraction contextRef="c90" decimals="0" format="ixt:num-dot-decimal" name="cve:TotalDiscountedMarketPrices" scale="0" unitRef="usd">3,000,000</ix:nonFraction>
pounds U<sub>3</sub>O<sub>8</sub>, from its properties in Texas at discounted spot market prices. In August 2021, the Company and UG
agreed to terminate this agreement for a cancellation fee of $<ix:nonFraction contextRef="c90" decimals="0" format="ixt:num-dot-decimal" name="cve:CancellationFee" scale="0" unitRef="usd">2,750,000</ix:nonFraction>, which was paid by the Company to UG on January 15, 2022.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="cve_DisclosueOfSalesContractsTextBlock-c0_cont_3" id="cve_DisclosueOfSalesContractsTextBlock-c0_cont_2"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">In
July 2021, the Company entered into a new uranium supply contract with UG. Pursuant to the agreement, UG will purchase U<sub>3</sub>O<sub>8
</sub>from the Company for up to <ix:nonFraction contextRef="c232" decimals="0" format="ixt:num-dot-decimal" name="cve:PursuantToAgreement" scale="0" unitRef="usd">2,000,000</ix:nonFraction> pounds U<sub>3</sub>O<sub>8 </sub>from 2023 through 2027. The sales price under the new agreement
will continue to be tied to spot market pricing.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="cve_DisclosueOfSalesContractsTextBlock-c0_cont_4" id="cve_DisclosueOfSalesContractsTextBlock-c0_cont_3"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">In
December 2021, the Company entered into a new uranium supply contract. Pursuant to the agreement, a large utility will purchase U<sub>3</sub>O<sub>8
</sub>from the Company for up to <ix:nonFraction contextRef="c91" decimals="0" format="ixt:num-dot-decimal" name="cve:PursuantToAgreement" scale="0" unitRef="usd">1,300,000</ix:nonFraction> pounds from 2024 through 2030. The sales price under the agreement will be tied to spot market
pricing with a ceiling price significantly higher than spot market price at the time of the agreement.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="cve_DisclosueOfSalesContractsTextBlock-c0_cont_5" id="cve_DisclosueOfSalesContractsTextBlock-c0_cont_4"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">In
June 2022, the Company entered into a new uranium supply contract. Pursuant to the agreement, a domestic utility will purchase U<sub>3</sub>O<sub>8
</sub>from the Company for up to <ix:nonFraction contextRef="c171" decimals="0" format="ixt:num-dot-decimal" name="cve:PursuantToAgreement" scale="0" unitRef="usd">600,000</ix:nonFraction> pounds commencing in 2025. The sales price will be market based with a floor price and an inflation
adjusted ceiling price.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="cve_DisclosueOfSalesContractsTextBlock-c0_cont_6" id="cve_DisclosueOfSalesContractsTextBlock-c0_cont_5"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">In
December 2022, the Company was awarded a contract to sell <ix:nonFraction contextRef="c92" decimals="0" format="ixt:num-dot-decimal" name="cve:ContractPoundsOfUranium" scale="0" unitRef="usd">100,000</ix:nonFraction> pounds of uranium concentrates to the United States Government at a
price of $<ix:nonFraction contextRef="c92" decimals="2" format="ixt:num-dot-decimal" name="cve:PricePerPound" scale="0" unitRef="usdPershares">70.50</ix:nonFraction> per pound.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="cve_DisclosueOfSalesContractsTextBlock-c0_cont_7" id="cve_DisclosueOfSalesContractsTextBlock-c0_cont_6"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">As
of December 31, 2022, uranium sales contracts over the next <ix:nonNumeric contextRef="c0" format="ixt-sec:durwordsen" name="cve:SalesContractsTrem">five years</ix:nonNumeric> are as follows:</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p></ix:continuation><div>

</div><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"></p><div>

</div><ix:continuation id="cve_DisclosueOfSalesContractsTextBlock-c0_cont_7"><ix:nonNumeric contextRef="c0" escape="true" name="ifrs-full:DisclosureOfMaturityAnalysisForFinancialAssetsHeldForManagingLiquidityRiskExplanatory"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Sales Commitments in Pounds</td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 88%">Fiscal 2023</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="cve:SalesContractsFiscalTwoZeroTwoThree" scale="0" unitRef="usd">500,000</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td>Fiscal 2024</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="cve:SalesContractsFiscalTwoZeroTwoFour" scale="0" unitRef="usd">600,000</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Fiscal 2025</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="cve:SalesContractsFiscalTwoZeroTwoFive" scale="0" unitRef="usd">700,000</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td>Fiscal 2026</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="cve:SalesContractsFiscalTwoZeroTwoSix" scale="0" unitRef="usd">700,000</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Fiscal 2027</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="cve:SalesContractsFiscalTwoZeroTwoSeven" scale="0" unitRef="usd">650,000</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  </table></ix:nonNumeric></ix:continuation><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><ix:nonNumeric contextRef="c0" continuedAt="_DisclosureOfClassesOfShareCapitalExplanatory-c0_cont_1" escape="true" name="ifrs-full:DisclosureOfClassesOfShareCapitalExplanatory"><table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif"><b>14.</b></span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b>Share
                                            capital</b></span></td></tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -18pt"><span style="font-family: Times New Roman, Times, Serif"><b>&#160;</b></span></p></ix:nonNumeric><div>

</div><div>

</div><ix:continuation continuedAt="_DisclosureOfClassesOfShareCapitalExplanatory-c0_cont_2" id="_DisclosureOfClassesOfShareCapitalExplanatory-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">The
authorized share capital of the Company consists of an unlimited number of common and preferred shares without par value.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_DisclosureOfClassesOfShareCapitalExplanatory-c0_cont_3" id="_DisclosureOfClassesOfShareCapitalExplanatory-c0_cont_2"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt"><span style="font-family: Times New Roman, Times, Serif">During
the year ended December 31, 2022 the Company issued:</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_DisclosureOfClassesOfShareCapitalExplanatory-c0_cont_4" id="_DisclosureOfClassesOfShareCapitalExplanatory-c0_cont_3"><table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.75in"></td><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif">i)</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="cve:SharesUnit" scale="0" unitRef="shares">6,535,947</ix:nonFraction> units through a &#8220;bought deal&#8221; prospectus offering at a price of CAD $<ix:nonFraction contextRef="c0" decimals="2" format="ixt:num-dot-decimal" name="ifrs-full:WeightedAverageExercisePriceOfShareOptionsInSharebasedPaymentArrangementExercisedDuringPeriodAtDateOfExercise2019" scale="0" unitRef="cadPershares">4.59</ix:nonFraction> per unit, for gross proceeds of CAD $<ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="cve:GrossProceed" scale="0" unitRef="cad">30,000,000</ix:nonFraction> ($<ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="cve:GrossProceed" scale="0" unitRef="usd">23,057,411</ix:nonFraction>). Each unit consisted of <ix:nonFraction contextRef="c0" decimals="0" format="ixt-sec:numwordsen" name="cve:CommonShare" scale="0" unitRef="shares">one</ix:nonFraction> common share and <span style="-sec-ix-hidden: hidden-fact-280">one-half</span> share purchase warrant. Each whole warrant entitles the holder to purchase <ix:nonFraction contextRef="c0" decimals="0" format="ixt-sec:numwordsen" name="cve:PurchaseAdditionalShareWarrants" scale="0" unitRef="shares">one</ix:nonFraction> additional share at a price of CAD $<ix:nonFraction contextRef="c0" decimals="2" format="ixt:num-dot-decimal" name="cve:PurchaseAdditionalSharePricePerWarrant" scale="0" unitRef="cadPershares">6.00</ix:nonFraction> for a period of two years. The Company paid commissions of CAD $<ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:ReceiptsFromRoyaltiesFeesCommissionsAndOtherRevenue" scale="0" unitRef="cad">1,612,500</ix:nonFraction> <span style="-sec-ix-hidden: hidden-fact-278">($1,239,336)</span>, other cash issuance costs of CAD $<ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="cve:CashIssuanceCosts" scale="0" unitRef="cad">305,159</ix:nonFraction> ($<ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="cve:CashIssuanceCosts" scale="0" sign="-" unitRef="usd">234,539</ix:nonFraction>) and issued <ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="cve:ShareIssued" scale="0" unitRef="shares">351,307</ix:nonFraction> finders&#8217; warrants with a fair value of CAD $<ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="cve:WarrantsOfFairValue" scale="0" unitRef="cad">874,785</ix:nonFraction> ($<ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="cve:WarrantsOfFairValue" scale="0" sign="-" unitRef="usd">672,343</ix:nonFraction>). The finder&#8217;s warrants are exercisable into <ix:nonFraction contextRef="c0" decimals="0" format="ixt-sec:numwordsen" name="cve:WarrantsExercisableOfCommonShare" scale="0" unitRef="shares">one</ix:nonFraction> common share of the Company at a price of CAD $<ix:nonFraction contextRef="c0" decimals="2" format="ixt:num-dot-decimal" name="cve:WarrantsExercisablePricePerShare" scale="0" unitRef="cadPershares">4.59</ix:nonFraction> for two years from closing;</span></td></tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 72.3pt; text-align: justify; text-indent: -18pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_DisclosureOfClassesOfShareCapitalExplanatory-c0_cont_5" id="_DisclosureOfClassesOfShareCapitalExplanatory-c0_cont_4"><table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.75in"></td><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif">ii)</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c233" decimals="0" format="ixt:num-dot-decimal" name="cve:CommonShareIssued" scale="0" unitRef="shares">2,291,642</ix:nonFraction> common shares were issued on the exercise of warrants, for gross proceeds of $<ix:nonFraction contextRef="c233" decimals="0" format="ixt:num-dot-decimal" name="cve:GrossProceed" scale="0" unitRef="usd">2,452,227</ix:nonFraction>. In connection with certain of the warrants exercised, the Company reclassified $<ix:nonFraction contextRef="c233" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:EquityReclassifiedIntoFinancialLiabilities" scale="0" unitRef="usd">147,772</ix:nonFraction> from contributed surplus and credited share capital;</span></td></tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 72.3pt; text-align: justify; text-indent: -18pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_DisclosureOfClassesOfShareCapitalExplanatory-c0_cont_6" id="_DisclosureOfClassesOfShareCapitalExplanatory-c0_cont_5"><table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.75in"></td><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif">iii)</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c234" decimals="0" format="ixt:num-dot-decimal" name="cve:CommonShareIssued" scale="0" unitRef="shares">1,016,436</ix:nonFraction> common shares were issued on the exercised of stock options, for gross proceeds of $<ix:nonFraction contextRef="c234" decimals="0" format="ixt:num-dot-decimal" name="cve:GrossProceed" scale="0" unitRef="usd">1,177,093</ix:nonFraction>. In connection with the stock options exercised, the Company reclassified $<ix:nonFraction contextRef="c234" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:FinancialLiabilitiesReclassifiedIntoEquity" scale="0" unitRef="usd">2,728,487</ix:nonFraction> from contributed surplus and credited share capital; and</span></td></tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 72.3pt; text-align: justify; text-indent: -18pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_DisclosureOfClassesOfShareCapitalExplanatory-c0_cont_7" id="_DisclosureOfClassesOfShareCapitalExplanatory-c0_cont_6"><table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.75in"></td><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif">iv)</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="cve:CommonSharesOfSettlementAndCompensation" scale="0" unitRef="shares">193,348</ix:nonFraction> common shares for the settlement and compensation for services received in relation to the Company&#8217;s asset acquisition on December 31, 2021 (Note 10).</span></td></tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 72.3pt; text-align: justify; text-indent: -18pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p></ix:continuation><div>

</div><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 72.3pt; text-align: justify; text-indent: -18pt"></p><div>

</div><!-- Field: Page; Sequence: 30; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->29<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 72.3pt; text-align: justify; text-indent: -18pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 72.3pt; text-align: justify; text-indent: -18pt"></p><div>

</div><table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="border-top: Black 1.5pt solid; width: 100%; padding-top: 2pt; padding-bottom: 2pt; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif"><b>enCore
    Energy Corp.</b></span></td></tr>
  <tr style="vertical-align: top">
    <td style="border-bottom: Black 1.5pt solid; padding-top: 2pt; padding-bottom: 2pt; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif"><b>Notes
    to the Consolidated Financial Statements</b></span></td></tr>
  <tr style="vertical-align: top">
    <td style="border-bottom: Black 1.5pt solid; padding-top: 2pt; padding-bottom: 2pt; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif"><b>For
    the years ended December 31, 2022 and December 31, 2021</b></span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 72.3pt; text-align: justify; text-indent: -18pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif"><b>14.</b></span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b>Share
                                            capital</b> (continued)</span></td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -18pt"><span style="font-family: Times New Roman, Times, Serif"><b>&#160;</b></span></p><div>

</div><ix:continuation continuedAt="_DisclosureOfClassesOfShareCapitalExplanatory-c0_cont_8" id="_DisclosureOfClassesOfShareCapitalExplanatory-c0_cont_7"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt"><span style="font-family: Times New Roman, Times, Serif">During
the year ended December 31, 2021, the Company issued:</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_DisclosureOfClassesOfShareCapitalExplanatory-c0_cont_9" id="_DisclosureOfClassesOfShareCapitalExplanatory-c0_cont_8"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%"><tr style="vertical-align: top">
<td style="width: 54.3pt"></td><td style="width: 18pt"><span style="font-family: Times New Roman, Times, Serif">i)</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="cve:SharesUnit" scale="0" unitRef="shares">5,000,000</ix:nonFraction> units through a private placement at a price of CAD $<ix:nonFraction contextRef="c5" decimals="2" format="ixt:num-dot-decimal" name="ifrs-full:WeightedAverageExercisePriceOfShareOptionsInSharebasedPaymentArrangementExercisedDuringPeriodAtDateOfExercise2019" scale="0" unitRef="cadPershares">3.00</ix:nonFraction> per unit, for gross proceeds of CAD $<ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="cve:GrossProceed" scale="0" unitRef="cad">15,000,000</ix:nonFraction> ($<ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="cve:GrossProceed" scale="0" unitRef="usd">11,966,494</ix:nonFraction>). Each unit consisted of <ix:nonFraction contextRef="c5" decimals="0" format="ixt-sec:numwordsen" name="cve:CommonShare" scale="0" unitRef="shares">one</ix:nonFraction> common share and <span style="-sec-ix-hidden: hidden-fact-281">one-half</span> share purchase warrant. Each whole warrant entitles the holder to purchase <ix:nonFraction contextRef="c5" decimals="0" format="ixt-sec:numwordsen" name="cve:PurchaseAdditionalShareWarrants" scale="0" unitRef="shares">one</ix:nonFraction> additional share at a price of CAD $<ix:nonFraction contextRef="c5" decimals="2" format="ixt:num-dot-decimal" name="cve:PurchaseAdditionalSharePricePerWarrant" scale="0" unitRef="cadPershares">3.90</ix:nonFraction> for a period of three years. The Company paid commissions of CAD $<ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:ReceiptsFromRoyaltiesFeesCommissionsAndOtherRevenue" scale="0" unitRef="cad">758,001</ix:nonFraction> <span style="-sec-ix-hidden: hidden-fact-279">($604,708)</span>, other cash issuance costs of CAD $<ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="cve:CashIssuanceCosts" scale="0" unitRef="cad">198,298</ix:nonFraction> ($<ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="cve:CashIssuanceCosts" scale="0" sign="-" unitRef="usd">158,194</ix:nonFraction>) and issued <ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="cve:ShareIssued" scale="0" unitRef="shares">252,667</ix:nonFraction> finders&#8217; warrants with a fair value of CAD $<ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="cve:WarrantsOfFairValue" scale="0" unitRef="cad">536,673</ix:nonFraction> ($<ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="cve:WarrantsOfFairValue" scale="0" sign="-" unitRef="usd">428,140</ix:nonFraction>). The finder&#8217;s warrants are exercisable into <ix:nonFraction contextRef="c5" decimals="0" format="ixt-sec:numwordsen" name="cve:WarrantsExercisableOfCommonShare" scale="0" unitRef="shares">one</ix:nonFraction> common share of the Company at a price of CAD $<ix:nonFraction contextRef="c5" decimals="2" format="ixt:num-dot-decimal" name="cve:WarrantsExercisablePricePerShare" scale="0" unitRef="cadPershares">3.00</ix:nonFraction> for two years from closing;</span></td></tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 72.3pt; text-align: justify; text-indent: -18pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_DisclosureOfClassesOfShareCapitalExplanatory-c0_cont_10" id="_DisclosureOfClassesOfShareCapitalExplanatory-c0_cont_9"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%"><tr style="vertical-align: top">
<td style="width: 54.3pt"></td><td style="width: 18pt"><span style="font-family: Times New Roman, Times, Serif">ii)</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c235" decimals="0" format="ixt:num-dot-decimal" name="cve:CommonShareIssued" scale="0" unitRef="shares">2,052,843</ix:nonFraction> common shares were issued on the exercise of warrants, for gross proceeds of $<ix:nonFraction contextRef="c235" decimals="0" format="ixt:num-dot-decimal" name="cve:GrossProceed" scale="0" unitRef="usd">2,633,029</ix:nonFraction>. In connection with certain of the warrants exercised, the Company reclassified $<ix:nonFraction contextRef="c235" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:EquityReclassifiedIntoFinancialLiabilities" scale="0" unitRef="usd">166,751</ix:nonFraction> from contributed surplus and credited share capital;</span></td></tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 72.3pt; text-align: justify; text-indent: -18pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_DisclosureOfClassesOfShareCapitalExplanatory-c0_cont_11" id="_DisclosureOfClassesOfShareCapitalExplanatory-c0_cont_10"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%"><tr style="vertical-align: top">
<td style="width: 54.3pt"></td><td style="width: 18pt"><span style="font-family: Times New Roman, Times, Serif">iii)</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c236" decimals="0" format="ixt:num-dot-decimal" name="cve:CommonShareIssued" scale="0" unitRef="shares">590,000</ix:nonFraction> common shares were issued on the exercised of stock options, for gross proceeds of $<ix:nonFraction contextRef="c236" decimals="0" format="ixt:num-dot-decimal" name="cve:GrossProceed" scale="0" unitRef="usd">288,572</ix:nonFraction>. In connection with the stock options exercised, the Company reclassified $<ix:nonFraction contextRef="c236" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:FinancialLiabilitiesReclassifiedIntoEquity" scale="0" unitRef="usd">269,039</ix:nonFraction> from contributed surplus and credited share capital; and</span></td></tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 72.3pt; text-align: justify; text-indent: -18pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_DisclosureOfClassesOfShareCapitalExplanatory-c0_cont_12" id="_DisclosureOfClassesOfShareCapitalExplanatory-c0_cont_11"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%"><tr style="vertical-align: top">
<td style="width: 54.3pt"></td><td style="width: 18pt"><span style="font-family: Times New Roman, Times, Serif">iv)</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="cve:CommonShareIssued" scale="0" unitRef="shares">31,806,617</ix:nonFraction> common shares were issued in connection with the Azarga asset acquisition (Note 10).</span></td></tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 72.3pt; text-align: justify; text-indent: -18pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_DisclosureOfClassesOfShareCapitalExplanatory-c0_cont_13" id="_DisclosureOfClassesOfShareCapitalExplanatory-c0_cont_12"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b>Stock
options</b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_DisclosureOfClassesOfShareCapitalExplanatory-c0_cont_14" id="_DisclosureOfClassesOfShareCapitalExplanatory-c0_cont_13"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">The
Company has adopted a Stock Option Plan (the &#8220;Plan&#8221;) under which it is authorized to grant options to Officers, Directors,
employees and consultants enabling them to acquire common shares of the Company. The number of shares reserved for issuance under the
Plan cannot exceed <ix:nonFraction contextRef="c0" decimals="2" format="ixt:num-dot-decimal" name="cve:NumberOfSharesReservedInsurancePercentage" scale="-2" unitRef="pure">10</ix:nonFraction>% of the outstanding common shares at the time of the grant. The options can be granted for a maximum of <ix:nonNumeric contextRef="c0" format="ixt-sec:durwordsen" name="cve:OptionsGrantedForMaximumYear">five years</ix:nonNumeric>
and vest as determined by the Board of Directors.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_DisclosureOfClassesOfShareCapitalExplanatory-c0_cont_15" id="_DisclosureOfClassesOfShareCapitalExplanatory-c0_cont_14"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">The
Company&#8217;s stock options outstanding at December 31, 2022 and December 31, 2021, and the changes for the years then ended, are as
follows:</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p></ix:continuation><div>

</div><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"></p><div>

</div><ix:continuation continuedAt="_DisclosureOfClassesOfShareCapitalExplanatory-c0_cont_16" id="_DisclosureOfClassesOfShareCapitalExplanatory-c0_cont_15"><ix:nonNumeric contextRef="c0" escape="true" name="cve:ScheduleOfTheCompanysStockOptionsOutstandingTableTextBlock"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">Year
    ended <br/>
December 31, 2022</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="6" style="text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">Year
    ended <br/>
December 31, 2021</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">Weighted average</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">Weighted average</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">Options</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">exercise price</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">Options</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">exercise price</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">#</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">CAD
    $</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">#</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">CAD
    $</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 52%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Options outstanding, beginning
    of year</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c3" decimals="INF" format="ixt:num-dot-decimal" name="cve:SharesBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" scale="0" unitRef="shares">5,272,294</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c3" decimals="2" format="ixt:num-dot-decimal" name="ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019" scale="0" unitRef="cadPershares">1.42</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c6" decimals="INF" format="ixt:num-dot-decimal" name="cve:SharesBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" scale="0" unitRef="shares">3,572,084</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c6" decimals="2" format="ixt:num-dot-decimal" name="ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019" scale="0" unitRef="cadPershares">0.66</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td><span style="font-family: Times New Roman, Times, Serif">Granted</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c0" decimals="INF" format="ixt:num-dot-decimal" name="cve:SharesBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" scale="0" unitRef="shares">3,107,501</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c0" decimals="2" format="ixt:num-dot-decimal" name="ifrs-full:WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019" scale="0" unitRef="cadPershares">4.10</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c5" decimals="INF" format="ixt:num-dot-decimal" name="cve:SharesBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" scale="0" unitRef="shares">2,390,627</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c5" decimals="2" format="ixt:num-dot-decimal" name="ifrs-full:WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019" scale="0" unitRef="cadPershares">2.31</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif">Exercised</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction contextRef="c0" decimals="INF" format="ixt:num-dot-decimal" name="cve:StockIssuedDuringPeriodShareStockOptionsExercised" scale="0" sign="-" unitRef="shares">1,016,439</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c0" decimals="2" format="ixt:num-dot-decimal" name="ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019" scale="0" unitRef="cadPershares">1.51</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction contextRef="c5" decimals="INF" format="ixt:num-dot-decimal" name="cve:StockIssuedDuringPeriodShareStockOptionsExercised" scale="0" sign="-" unitRef="shares">590,000</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c5" decimals="2" format="ixt:num-dot-decimal" name="ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019" scale="0" unitRef="cadPershares">0.60</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Forfeited/expired</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction contextRef="c0" decimals="INF" format="ixt:num-dot-decimal" name="cve:StockIssuedDuringPeriodShareSharesBasedCompensationForfeited" scale="0" sign="-" unitRef="shares">127,708</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c0" decimals="2" format="ixt:num-dot-decimal" name="ifrs-full:WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019" scale="0" unitRef="cadPershares">3.60</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction contextRef="c5" decimals="INF" format="ixt:num-dot-decimal" name="cve:StockIssuedDuringPeriodShareSharesBasedCompensationForfeited" scale="0" sign="-" unitRef="shares">100,417</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c5" decimals="2" format="ixt:num-dot-decimal" name="ifrs-full:WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019" scale="0" unitRef="cadPershares">0.54</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Options
    outstanding, end of year</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c2" decimals="INF" format="ixt:num-dot-decimal" name="cve:SharesBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" scale="0" unitRef="shares">7,235,648</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c2" decimals="2" format="ixt:num-dot-decimal" name="ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019" scale="0" unitRef="cadPershares">2.53</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c3" decimals="INF" format="ixt:num-dot-decimal" name="cve:SharesBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" scale="0" unitRef="shares">5,272,294</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c3" decimals="2" format="ixt:num-dot-decimal" name="ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019" scale="0" unitRef="cadPershares">1.42</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Options
    exercisable, end of year</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c2" decimals="INF" format="ixt:num-dot-decimal" name="cve:SharesBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions" scale="0" unitRef="shares">4,928,147</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c2" decimals="2" format="ixt:num-dot-decimal" name="ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019" scale="0" unitRef="cadPershares">1.79</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c3" decimals="INF" format="ixt:num-dot-decimal" name="cve:SharesBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions" scale="0" unitRef="shares">4,515,210</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c3" decimals="2" format="ixt:num-dot-decimal" name="ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019" scale="0" unitRef="cadPershares">1.23</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p></ix:nonNumeric></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_DisclosureOfClassesOfShareCapitalExplanatory-c0_cont_17" id="_DisclosureOfClassesOfShareCapitalExplanatory-c0_cont_16"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">As
of December 31, 2022, stock options outstanding were as follows:</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p></ix:continuation><div>

</div><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"></p><div>

</div><ix:continuation continuedAt="_DisclosureOfClassesOfShareCapitalExplanatory-c0_cont_18" id="_DisclosureOfClassesOfShareCapitalExplanatory-c0_cont_17"><ix:nonNumeric contextRef="c0" escape="true" name="cve:ScheduleOfStockOptionsOutstandingTableTextBlock"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">Options
    Outstanding<br/> December 31, 2022</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">Options
    Exercisable<br/> December 31, 2022</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">Weighted average</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">Weighted average</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">Weighted average</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif">Option price</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">Options</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">Remaining</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">exercise price</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">Options</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">exercise price</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td colspan="2" style="border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">per share</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">#</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">Life</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">CAD
    $</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">#</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">CAD
    $</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 14%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.18
- 1.92</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 14%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c237" decimals="INF" format="ixt:num-dot-decimal" name="cve:SharesBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" scale="0" unitRef="shares">3,381,771</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 14%; text-align: right"><ix:nonNumeric contextRef="c237" format="ixt-sec:duryear" name="ifrs-full:WeightedAverageDurationOfDefinedBenefitObligation2019"><span style="font-family: Times New Roman, Times, Serif">0.88</span></ix:nonNumeric></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 14%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c238" decimals="2" format="ixt:num-dot-decimal" name="ifrs-full:ExercisePriceOfOutstandingShareOptions2019" scale="0" unitRef="cadPershares">0.85</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 14%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c237" decimals="INF" format="ixt:num-dot-decimal" name="cve:SharesBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber" scale="0" unitRef="shares">3,381,771</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 13%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c237" decimals="2" format="ixt:num-dot-decimal" name="ifrs-full:ExercisePriceShareOptionsGranted2019" scale="0" unitRef="cadPershares">0.85</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">$</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.40
- 3.78</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c239" decimals="INF" format="ixt:num-dot-decimal" name="cve:SharesBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" scale="0" unitRef="shares">1,034,710</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><ix:nonNumeric contextRef="c239" format="ixt-sec:duryear" name="ifrs-full:WeightedAverageDurationOfDefinedBenefitObligation2019"><span style="font-family: Times New Roman, Times, Serif">0.57</span></ix:nonNumeric></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c240" decimals="2" format="ixt:num-dot-decimal" name="ifrs-full:ExercisePriceOfOutstandingShareOptions2019" scale="0" unitRef="cadPershares">3.12</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c239" decimals="INF" format="ixt:num-dot-decimal" name="cve:SharesBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber" scale="0" unitRef="shares">594,710</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c239" decimals="2" format="ixt:num-dot-decimal" name="ifrs-full:ExercisePriceShareOptionsGranted2019" scale="0" unitRef="cadPershares">2.83</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.20
- 5.76</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c241" decimals="INF" format="ixt:num-dot-decimal" name="cve:SharesBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" scale="0" unitRef="shares">2,819,166</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonNumeric contextRef="c241" format="ixt-sec:duryear" name="ifrs-full:WeightedAverageDurationOfDefinedBenefitObligation2019"><span style="font-family: Times New Roman, Times, Serif">1.53</span></ix:nonNumeric></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c242" decimals="2" format="ixt:num-dot-decimal" name="ifrs-full:ExercisePriceOfOutstandingShareOptions2019" scale="0" unitRef="cadPershares">4.29</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c241" decimals="INF" format="ixt:num-dot-decimal" name="cve:SharesBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber" scale="0" unitRef="shares">951,666</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c241" decimals="2" format="ixt:num-dot-decimal" name="ifrs-full:ExercisePriceShareOptionsGranted2019" scale="0" unitRef="cadPershares">4.42</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c0" decimals="INF" format="ixt:num-dot-decimal" name="cve:SharesBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" scale="0" unitRef="shares">7,235,647</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><ix:nonNumeric contextRef="c0" format="ixt-sec:duryear" name="ifrs-full:WeightedAverageDurationOfDefinedBenefitObligation2019"><span style="font-family: Times New Roman, Times, Serif">2.99</span></ix:nonNumeric></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c2" decimals="2" format="ixt:num-dot-decimal" name="ifrs-full:ExercisePriceOfOutstandingShareOptions2019" scale="0" unitRef="cadPershares">2.52</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c0" decimals="INF" format="ixt:num-dot-decimal" name="cve:SharesBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber" scale="0" unitRef="shares">4,928,147</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c0" decimals="2" format="ixt:num-dot-decimal" name="ifrs-full:ExercisePriceShareOptionsGranted2019" scale="0" unitRef="cadPershares">1.78</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p></ix:nonNumeric></ix:continuation><div>

</div><div>

</div><p style="margin: 0pt 0; text-indent: 0.5in"></p><div>

</div><!-- Field: Page; Sequence: 31; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->30<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="margin: 0pt 0; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><p style="margin: 0pt 0; text-indent: 0.5in"></p><div>

</div><table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="border-top: Black 1.5pt solid; width: 100%; padding-top: 2pt; padding-bottom: 2pt; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif"><b>enCore
    Energy Corp.</b></span></td></tr>
  <tr style="vertical-align: top">
    <td style="border-bottom: Black 1.5pt solid; padding-top: 2pt; padding-bottom: 2pt; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif"><b>Notes
    to the Consolidated Financial Statements</b></span></td></tr>
  <tr style="vertical-align: top">
    <td style="border-bottom: Black 1.5pt solid; padding-top: 2pt; padding-bottom: 2pt; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif"><b>For
    the years ended December 31, 2022 and December 31, 2021</b></span></td></tr>
  </table><div>
</div><p style="margin: 0pt 0; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif"><b>14.</b></span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b>Share
                                            capital</b> (continued)</span></td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 18pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b>Stock
options</b> (continued)</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><ix:continuation continuedAt="_DisclosureOfClassesOfShareCapitalExplanatory-c0_cont_19" id="_DisclosureOfClassesOfShareCapitalExplanatory-c0_cont_18"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">During
the year ended December 31, 2022, the Company granted an aggregate of <ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="cve:AggregateOfGrantedShares" scale="0" unitRef="shares">3,107,501</ix:nonFraction> stock options to Directors, Officers, and consultants
of the Company. A fair value of $<ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="cve:FairValueOfGrantedOption" scale="0" unitRef="usd">7,665,042</ix:nonFraction> was calculated for these options as measured at the grant date using the Black-Scholes option
pricing model.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_DisclosureOfClassesOfShareCapitalExplanatory-c0_cont_20" id="_DisclosureOfClassesOfShareCapitalExplanatory-c0_cont_19"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">During
the year ended December 31, 2021, the Company granted an aggregate of <ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="cve:AggregateOfGrantedShares" scale="0" unitRef="shares">2,390,627</ix:nonFraction> stock options to Directors, Officers, and consultants
of the Company. A fair value of $<ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="cve:FairValueOfGrantedOption" scale="0" unitRef="usd">1,484,302</ix:nonFraction> was calculated for these options as measured at the grant date using the Black-Scholes option
pricing model.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_DisclosureOfClassesOfShareCapitalExplanatory-c0_cont_21" id="_DisclosureOfClassesOfShareCapitalExplanatory-c0_cont_20"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Further,
pursuant to the Company&#8217;s acquisition of Azarga during the year ended December 31, 2021 (Note 10), the Company issued replacement
stock options at the acquisition date vested immediately and retained their original expiration date, except for terminated Directors,
Officers, employees, and consultants. For these terminated positions, the stock options had a revised term that was <ix:nonNumeric contextRef="c0" format="ixt-sec:durmonth" name="cve:StockOptionsRevisedTerm">12</ix:nonNumeric> months from the
date of their resignation.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_DisclosureOfClassesOfShareCapitalExplanatory-c0_cont_22" id="_DisclosureOfClassesOfShareCapitalExplanatory-c0_cont_21"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">The
Company&#8217;s standard stock option vesting schedule calls for <ix:nonFraction contextRef="c0" decimals="2" format="ixt:num-dot-decimal" name="cve:StandardStockOptionVestingPercentage" scale="-2" unitRef="pure">25</ix:nonFraction>% every six months commencing six months after the grant date.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_DisclosureOfClassesOfShareCapitalExplanatory-c0_cont_23" id="_DisclosureOfClassesOfShareCapitalExplanatory-c0_cont_22"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">During
the year ended December 31, 2022, the Company recognized stock option expense of $<ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="cve:RecognizedStockOptionExpense" scale="0" unitRef="usd">5,744,655</ix:nonFraction> (2021 - $<ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="cve:RecognizedStockOptionExpense" scale="0" unitRef="usd">1,425,645</ix:nonFraction>) for the vested portion
of the stock options.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_DisclosureOfClassesOfShareCapitalExplanatory-c0_cont_24" id="_DisclosureOfClassesOfShareCapitalExplanatory-c0_cont_23"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">The
fair value of all compensatory options granted is estimated on the grant date using the Black-Scholes option pricing model. The weighted
average assumptions used in calculating the fair values are as follows:</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p></ix:continuation><div>

</div><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"></p><div>

</div><ix:continuation continuedAt="_DisclosureOfClassesOfShareCapitalExplanatory-c0_cont_25" id="_DisclosureOfClassesOfShareCapitalExplanatory-c0_cont_24"><ix:nonNumeric contextRef="c0" escape="true" name="cve:ScheduleOfWeightedAverageAssumptionsUsedInCalculatingTheFairValuesTableTextBlock"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">December
    31, <br/> 2022</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">December
    31, <br/> 2021</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Risk-free interest rate</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c0" decimals="4" format="ixt:num-dot-decimal" name="ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted" scale="-2" unitRef="pure">2.06</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c5" decimals="4" format="ixt:num-dot-decimal" name="ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted" scale="-2" unitRef="pure">0.88</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Expected life of option</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonNumeric contextRef="c0" format="ixt-sec:duryear" name="ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019">4.9</ix:nonNumeric> years</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonNumeric contextRef="c5" format="ixt-sec:duryear" name="ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019">5</ix:nonNumeric> years</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Expected dividend yield</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c0" decimals="2" format="ixt:num-dot-decimal" name="ifrs-full:ExpectedDividendAsPercentageShareOptionsGranted" scale="-2" unitRef="pure">0</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c5" decimals="2" format="ixt:num-dot-decimal" name="ifrs-full:ExpectedDividendAsPercentageShareOptionsGranted" scale="-2" unitRef="pure">0</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Expected stock price volatility</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c0" decimals="4" format="ixt:num-dot-decimal" name="ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted" scale="-2" unitRef="pure">116.48</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c5" decimals="4" format="ixt:num-dot-decimal" name="ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted" scale="-2" unitRef="pure">128.79</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif">Fair value per option</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">CAD
                                            $3.21</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">CAD
                                            $1.10</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p></ix:nonNumeric></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_DisclosureOfClassesOfShareCapitalExplanatory-c0_cont_26" id="_DisclosureOfClassesOfShareCapitalExplanatory-c0_cont_25"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt"><span style="font-family: Times New Roman, Times, Serif"><b>Share
purchase warrants</b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b>&#160;</b></span></p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_DisclosureOfClassesOfShareCapitalExplanatory-c0_cont_27" id="_DisclosureOfClassesOfShareCapitalExplanatory-c0_cont_26"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">A
summary of the status of the Company&#8217;s warrants as of December 31, 2022, and December 31, 2021, and changes during the years then
ended is as follows:</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p></ix:continuation><div>

</div><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"></p><div>

</div><ix:continuation continuedAt="_DisclosureOfClassesOfShareCapitalExplanatory-c0_cont_28" id="_DisclosureOfClassesOfShareCapitalExplanatory-c0_cont_27"><ix:nonNumeric contextRef="c0" escape="true" name="cve:ScheduleOfTheStatusOfTheCompanysWarrantsTableTextBlock"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Year
    ended <br/> December 31, 2022</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Year
    ended <br/> December 31, 2021</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">Warrants</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">Weighted average exercise price</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">Warrants</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">Weighted average exercise price</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif">#</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif">CAD
    $</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif">#</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif">CAD
    $</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 52%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Warrants outstanding, beginning
    of year</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c3" decimals="INF" format="ixt:num-dot-decimal" name="cve:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptionsWarrantsOutstanding" scale="0" unitRef="shares">6,298,839</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c3" decimals="2" format="ixt:num-dot-decimal" name="cve:SharesBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingPeriodIncreaseDecreaseWeightedAverageExercisePrice" scale="0" unitRef="cadPershares">2.43</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c6" decimals="INF" format="ixt:num-dot-decimal" name="cve:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptionsWarrantsOutstanding" scale="0" unitRef="shares">4,143,247</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c6" decimals="2" format="ixt:num-dot-decimal" name="cve:SharesBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingPeriodIncreaseDecreaseWeightedAverageExercisePrice" scale="0" unitRef="cadPershares">1.23</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: 0.125in"><span style="font-family: Times New Roman, Times, Serif">Granted</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c0" decimals="INF" format="ixt:num-dot-decimal" name="cve:ShareBasedCompensationArrangementBySharesBasedPaymentAwardOptionsGrantsInPeriodWarrantsGranted" scale="0" unitRef="shares">3,670,919</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c0" decimals="2" format="ixt:num-dot-decimal" name="cve:SharesbasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue" scale="0" unitRef="cadPershares">5.81</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c5" decimals="INF" format="ixt:num-dot-decimal" name="cve:ShareBasedCompensationArrangementBySharesBasedPaymentAwardOptionsGrantsInPeriodWarrantsGranted" scale="0" unitRef="shares">4,208,435</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c5" decimals="2" format="ixt:num-dot-decimal" name="cve:SharesbasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue" scale="0" unitRef="cadPershares">3.24</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: 0.125in"><span style="font-family: Times New Roman, Times, Serif">Exercised</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction contextRef="c0" decimals="INF" format="ixt:num-dot-decimal" name="cve:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisedWarrantsExercised" scale="0" sign="-" unitRef="shares">2,291,642</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c0" decimals="2" format="ixt:num-dot-decimal" name="cve:SharesBasedCompensationArrangementBySharesBasedPaymentAwardOptionsOutstandingPeriodIncreaseDecreaseWeightedAverageExercisePrice" scale="0" unitRef="cadPershares">1.39</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction contextRef="c5" decimals="INF" format="ixt:num-dot-decimal" name="cve:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisedWarrantsExercised" scale="0" sign="-" unitRef="shares">2,052,843</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c5" decimals="2" format="ixt:num-dot-decimal" name="cve:SharesBasedCompensationArrangementBySharesBasedPaymentAwardOptionsOutstandingPeriodIncreaseDecreaseWeightedAverageExercisePrice" scale="0" unitRef="cadPershares">1.62</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: 0.125in; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Expired</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction contextRef="c0" decimals="INF" format="ixt:num-dot-decimal" name="cve:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWarrantsExpired" scale="0" sign="-" unitRef="shares">183,610</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c0" decimals="2" format="ixt:num-dot-decimal" name="cve:ShareBasedCompensationArrangementsBySharesBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" scale="0" unitRef="cadPershares">1.67</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Warrants
    outstanding, end of year</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c2" decimals="INF" format="ixt:num-dot-decimal" name="cve:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptionsWarrantsOutstanding" scale="0" unitRef="shares">7,494,506</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c2" decimals="2" format="ixt:num-dot-decimal" name="cve:SharesBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingPeriodIncreaseDecreaseWeightedAverageExercisePrice" scale="0" unitRef="cadPershares">4.43</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c3" decimals="INF" format="ixt:num-dot-decimal" name="cve:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptionsWarrantsOutstanding" scale="0" unitRef="shares">6,298,839</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c3" decimals="2" format="ixt:num-dot-decimal" name="cve:SharesBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingPeriodIncreaseDecreaseWeightedAverageExercisePrice" scale="0" unitRef="cadPershares">2.43</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p></ix:nonNumeric></ix:continuation><div>

</div><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><!-- Field: Page; Sequence: 32; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->31<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="border-top: Black 1.5pt solid; width: 100%; padding-top: 2pt; padding-bottom: 2pt; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif"><b>enCore
    Energy Corp.</b></span></td></tr>
  <tr style="vertical-align: top">
    <td style="border-bottom: Black 1.5pt solid; padding-top: 2pt; padding-bottom: 2pt; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif"><b>Notes
    to the Consolidated Financial Statements</b></span></td></tr>
  <tr style="vertical-align: top">
    <td style="border-bottom: Black 1.5pt solid; padding-top: 2pt; padding-bottom: 2pt; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif"><b>For
    the years ended December 31, 2022 and December 31, 2021</b></span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif"><b>14.</b></span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b>Share
                                            capital</b> (continued)</span></td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -18pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b>Share
purchase warrants </b>(continued)</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><ix:continuation continuedAt="_DisclosureOfClassesOfShareCapitalExplanatory-c0_cont_29" id="_DisclosureOfClassesOfShareCapitalExplanatory-c0_cont_28"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt"><span style="font-family: Times New Roman, Times, Serif">As
of December 31, 2022, share purchase warrants outstanding were as follows:</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_DisclosureOfClassesOfShareCapitalExplanatory-c0_cont_30" id="_DisclosureOfClassesOfShareCapitalExplanatory-c0_cont_29"><ix:nonNumeric contextRef="c0" continuedAt="cve_ScheduleOfSharePurchaseWarrantsOutstandingTableTextBlock-c0_cont_1" escape="true" name="cve:ScheduleOfSharePurchaseWarrantsOutstandingTableTextBlock"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: center; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: center; padding-bottom: 1.5pt">&#160;</td>
                                                                                                                          <td style="text-align: center; padding-bottom: 1.5pt">&#160;</td>
                                                                                                                          <td colspan="6" style="border-bottom: Black 1.5pt solid; text-align: center; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"><b>Warrants Outstanding<br/> December 31, 2022</b></span></td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">Weighted average</span></td><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">Weighted average</span></td><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Warrant price</span></td><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">Warrants</span></td><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">Remaining</span></td><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">exercise price</span></td><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">per share</span></td><td style="padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif">#</span></td><td style="text-align: center; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Life</span></td><td style="text-align: center; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif">CAD
    $</span></td><td style="text-align: center; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; width: 46%"><span style="font-family: Times New Roman, Times, Serif">$1.59 - 1.80</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 15%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c243" decimals="INF" format="ixt:num-dot-decimal" name="cve:Warrants" scale="0" unitRef="shares">1,360,028</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 15%; text-align: right"><ix:nonNumeric contextRef="c243" format="ixt-sec:duryear" name="cve:WarrantsOutstandingWeightedAverageReimainingLife"><span style="font-family: Times New Roman, Times, Serif">0.14</span></ix:nonNumeric></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 15%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c243" decimals="2" format="ixt:num-dot-decimal" name="cve:WarrantsOutstandingWeightedAverageExercisePrice" scale="0" unitRef="cadPershares">1.81</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$2.22 - 3.90 <sup>1</sup></span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c244" decimals="INF" format="ixt:num-dot-decimal" id="ix_5_fact" name="cve:Warrants" scale="0" unitRef="shares">2,515,197</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><ix:nonNumeric contextRef="c244" format="ixt-sec:duryear" id="ix_6_fact" name="cve:WarrantsOutstandingWeightedAverageReimainingLife"><span style="font-family: Times New Roman, Times, Serif">0.39</span></ix:nonNumeric></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c244" decimals="2" format="ixt:num-dot-decimal" id="ix_7_fact" name="cve:WarrantsOutstandingWeightedAverageExercisePrice" scale="0" unitRef="cadPershares">3.84</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">$4.59 - 6.00</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c245" decimals="INF" format="ixt:num-dot-decimal" name="cve:Warrants" scale="0" unitRef="shares">3,619,281</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonNumeric contextRef="c245" format="ixt-sec:duryear" name="cve:WarrantsOutstandingWeightedAverageReimainingLife"><span style="font-family: Times New Roman, Times, Serif">0.59</span></ix:nonNumeric></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c245" decimals="2" format="ixt:num-dot-decimal" name="cve:WarrantsOutstandingWeightedAverageExercisePrice" scale="0" unitRef="cadPershares">5.86</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c0" decimals="INF" format="ixt:num-dot-decimal" name="cve:Warrants" scale="0" unitRef="shares">7,494,506</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><ix:nonNumeric contextRef="c0" format="ixt-sec:duryear" name="cve:WarrantsOutstandingWeightedAverageReimainingLife"><span style="font-family: Times New Roman, Times, Serif">1.12</span></ix:nonNumeric></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c0" decimals="2" format="ixt:num-dot-decimal" name="cve:WarrantsOutstandingWeightedAverageExercisePrice" scale="0" unitRef="cadPershares">4.43</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p></ix:nonNumeric></ix:continuation><div>


</div><div>

</div><ix:continuation continuedAt="_DisclosureOfClassesOfShareCapitalExplanatory-c0_cont_31" id="_DisclosureOfClassesOfShareCapitalExplanatory-c0_cont_30"><ix:continuation id="cve_ScheduleOfSharePurchaseWarrantsOutstandingTableTextBlock-c0_cont_1"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif"><sup>1</sup></span></td><td style="text-align: justify"><ix:footnote id="ix_2_footnote" xml:lang="en-US"><span style="font-family: Times New Roman, Times, Serif">Includes power warrants exercisable into <ix:nonFraction contextRef="c0" decimals="0" format="ixt-sec:numwordsen" name="cve:WarrantsExercisableShare" scale="0" unitRef="shares">one</ix:nonFraction> share and <span style="-sec-ix-hidden: hidden-fact-282">one-half</span> warrant. Each whole warrant is exercisable at $<ix:nonFraction contextRef="c0" decimals="2" format="ixt:num-dot-decimal" name="cve:WarrantsExercisablePrice" scale="0" unitRef="usdPershares">3.90</ix:nonFraction> for <ix:nonNumeric contextRef="c0" format="ixt-sec:durmonth" name="cve:WarrantIsExercisableTerm">36</ix:nonNumeric> months.</span></ix:footnote></td>
</tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b>&#160;</b></span></p></ix:continuation></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_DisclosureOfClassesOfShareCapitalExplanatory-c0_cont_32" id="_DisclosureOfClassesOfShareCapitalExplanatory-c0_cont_31"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b>Share
subscriptions received</b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p></ix:continuation><div>

</div><div>

</div><ix:continuation id="_DisclosureOfClassesOfShareCapitalExplanatory-c0_cont_32"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">As
of December 31, 2022, the Company has received CAD $<ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:DividendsReceived" scale="0" unitRef="cad">69,831,000</ix:nonFraction> ($<ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:DividendsReceived" scale="0" unitRef="usd">50,051,595</ix:nonFraction>) in share subscriptions pertaining to a financing that closed
subsequently (Note 22(b)).</span></p></ix:continuation><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><ix:nonNumeric contextRef="c0" continuedAt="_DisclosureOfRelatedPartyExplanatory-c0_cont_1" escape="true" name="ifrs-full:DisclosureOfRelatedPartyExplanatory"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%"><tr style="vertical-align: top">
<td style="width: 18pt"></td><td style="width: 18pt"><span style="font-family: Times New Roman, Times, Serif"><b>15.</b></span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b>Related
                                            party transactions and balances</b></span></td></tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -18pt"><span style="font-family: Times New Roman, Times, Serif"><b>&#160;</b></span></p></ix:nonNumeric><div>

</div><div>

</div><ix:continuation continuedAt="_DisclosureOfRelatedPartyExplanatory-c0_cont_2" id="_DisclosureOfRelatedPartyExplanatory-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Related
parties include key management of the Company and any entities controlled by these individuals as well as other entities providing key
management services to the Company. Key management personnel consist of Directors and senior management including the Executive Chairman,
Chief Executive Officer, Chief Financial Officer, Chief Operating Officer, and Chief Administrative Officer.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_DisclosureOfRelatedPartyExplanatory-c0_cont_3" id="_DisclosureOfRelatedPartyExplanatory-c0_cont_2"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt"><span style="font-family: Times New Roman, Times, Serif">The
amounts paid to key management or entities providing similar services are as follows:</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p></ix:continuation><div>

</div><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><ix:continuation continuedAt="_DisclosureOfRelatedPartyExplanatory-c0_cont_4" id="_DisclosureOfRelatedPartyExplanatory-c0_cont_3"><ix:nonNumeric contextRef="c0" continuedAt="_DisclosureOfGeneralAndAdministrativeExpenseExplanatory-c0_cont_1" escape="true" name="ifrs-full:DisclosureOfGeneralAndAdministrativeExpenseExplanatory"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">December
    31, <br/> 2022<br/> $</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif">December
    31, <br/> 2021<br/> $</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%"><span style="font-family: Times New Roman, Times, Serif">Consulting</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 9%; text-align: center"><span style="font-family: Times New Roman, Times, Serif">(1</span>)</td><td style="width: 1%; text-align: left"></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" id="ix_8_fact" name="ifrs-full:RevenueFromRenderingOfInformationTechnologyConsultingServices" scale="0" unitRef="usd">103,514</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" id="ix_9_fact" name="ifrs-full:RevenueFromRenderingOfInformationTechnologyConsultingServices" scale="0" unitRef="usd">61,899</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Data acquisition</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">(2</span>)</td><td style="text-align: left"></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" id="ix_10_fact" name="ifrs-full:AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill" scale="0" unitRef="usd">55,150</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-283; font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Directors&#8217; fees</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">(3</span>)</td><td style="text-align: left"></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" id="ix_11_fact" name="ifrs-full:DirectorsRemunerationExpense" scale="0" unitRef="usd">192,604</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-284; font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Office and administration</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-285; font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="cve:OfficeAndAdministration" scale="0" unitRef="usd">13,402</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Staff costs</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="cve:StaffCosts" scale="0" unitRef="usd">1,607,211</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="cve:StaffCosts" scale="0" unitRef="usd">1,151,731</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Stock option expense</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:StockOptionPlanExpense" scale="0" unitRef="usd">4,729,503</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:StockOptionPlanExpense" scale="0" unitRef="usd">749,255</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Total
    key management compensation</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:KeyManagementPersonnelCompensation" scale="0" unitRef="usd">6,687,982</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:KeyManagementPersonnelCompensation" scale="0" unitRef="usd">1,976,287</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p></ix:nonNumeric></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_DisclosureOfRelatedPartyExplanatory-c0_cont_5" id="_DisclosureOfRelatedPartyExplanatory-c0_cont_4"><ix:continuation continuedAt="_DisclosureOfGeneralAndAdministrativeExpenseExplanatory-c0_cont_2" id="_DisclosureOfGeneralAndAdministrativeExpenseExplanatory-c0_cont_1"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">(1)</span></td><td style="text-align: justify"><ix:footnote id="ix_3_footnote" xml:lang="en-US"><span style="font-family: Times New Roman, Times, Serif">- During the year ended December 31, 2022, the Company incurred communications &amp; community engagement consulting fees of $<ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="cve:ConsultingFees" scale="0" unitRef="usd">103,514</ix:nonFraction> (2021 - $<ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="cve:ConsultingFees" scale="0" unitRef="usd">61,899</ix:nonFraction>) according to a contract with Tintina Holdings, Ltd., a company owned and operated by the spouse of the Company&#8217;s Executive Chairman.</span></ix:footnote></td>
</tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p></ix:continuation></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_DisclosureOfRelatedPartyExplanatory-c0_cont_6" id="_DisclosureOfRelatedPartyExplanatory-c0_cont_5"><ix:continuation continuedAt="_DisclosureOfGeneralAndAdministrativeExpenseExplanatory-c0_cont_3" id="_DisclosureOfGeneralAndAdministrativeExpenseExplanatory-c0_cont_2"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">(2)</span></td><td style="text-align: justify"><ix:footnote id="ix_4_footnote" xml:lang="en-US"><span style="font-family: Times New Roman, Times, Serif">- In June 2022, the Company acquired access to the Getty Minerals database pursuant to a purchase agreement with Platoro West Inc., a company owned and operated by the Company&#8217;s Executive Chairman (Note 7).</span></ix:footnote></td>
</tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p></ix:continuation></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_DisclosureOfRelatedPartyExplanatory-c0_cont_7" id="_DisclosureOfRelatedPartyExplanatory-c0_cont_6"><ix:continuation id="_DisclosureOfGeneralAndAdministrativeExpenseExplanatory-c0_cont_3"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">(3)</span></td><td style="text-align: justify"><ix:footnote id="ix_5_footnote" xml:lang="en-US"><span style="font-family: Times New Roman, Times, Serif">&#8211; Directors&#8217; Fees are included in staff costs on the consolidated statement of loss and other comprehensive income (loss).</span></ix:footnote></td>
</tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p></ix:continuation></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_DisclosureOfRelatedPartyExplanatory-c0_cont_8" id="_DisclosureOfRelatedPartyExplanatory-c0_cont_7"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">During
the year ended December 31, 2022, the Company granted <ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="cve:GrantedOptionsShares" scale="0" unitRef="shares">2,566,667</ix:nonFraction> options to key management, with a fair value of $<ix:nonFraction contextRef="c246" decimals="0" format="ixt:num-dot-decimal" name="cve:FairValueAmount" scale="0" unitRef="usd">6,496,785</ix:nonFraction> (2021 &#8211;
<ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="cve:FairValueAmount" scale="0" unitRef="usd">150,000</ix:nonFraction> with a fair value of $<ix:nonFraction contextRef="c247" decimals="0" format="ixt:num-dot-decimal" name="cve:FairValueAmount" scale="0" unitRef="usd">384,881</ix:nonFraction>).</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p></ix:continuation><div>




</div><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><!-- Field: Page; Sequence: 33; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->32<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="border-top: Black 1.5pt solid; width: 100%; padding-top: 2pt; padding-bottom: 2pt; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif"><b>enCore
    Energy Corp.</b></span></td></tr>
  <tr style="vertical-align: top">
    <td style="border-bottom: Black 1.5pt solid; padding-top: 2pt; padding-bottom: 2pt; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif"><b>Notes
    to the Consolidated Financial Statements</b></span></td></tr>
  <tr style="vertical-align: top">
    <td style="border-bottom: Black 1.5pt solid; padding-top: 2pt; padding-bottom: 2pt; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif"><b>For
    the years ended December 31, 2022 and December 31, 2021</b></span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif"><b>15.</b></span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b>Related
                                            party transactions and balances </b>(continued)</span></td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -18pt"><span style="font-family: Times New Roman, Times, Serif"><b>&#160;</b></span></p><div>

</div><ix:continuation continuedAt="_DisclosureOfRelatedPartyExplanatory-c0_cont_9" id="_DisclosureOfRelatedPartyExplanatory-c0_cont_8"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">As
of December 31, 2022 and December 31, 2021, the following amounts were owing to related parties:</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: 18pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p></ix:continuation><div>

</div><div>

</div><ix:continuation id="_DisclosureOfRelatedPartyExplanatory-c0_cont_9"><ix:nonNumeric contextRef="c0" escape="true" name="ifrs-full:DisclosureOfTransactionsBetweenRelatedPartiesExplanatory"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">December
    31, <br/> 2022<br/> $</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif">December
    31, <br/> 2021<br/> $</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif">January
    1, <br/> 2021<br/> $</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 32%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Tintina Holdings, Ltd</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 31%; text-align: left; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif">Consulting
    services</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c248" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:AmountsPayableRelatedPartyTransactions" scale="0" unitRef="usd">12,744</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c249" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:AmountsPayableRelatedPartyTransactions" scale="0" unitRef="usd">6,893</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c250" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:AmountsPayableRelatedPartyTransactions" scale="0" unitRef="usd">0</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Officers and Board members</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left; padding-bottom: 1.5pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif">Accrued
    compensation</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c251" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:AmountsPayableRelatedPartyTransactions" scale="0" unitRef="usd">428,630</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-286; font-family: Times New Roman, Times, Serif">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c253" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:AmountsPayableRelatedPartyTransactions" scale="0" unitRef="usd">2,319</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="padding-bottom: 1.5pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c2" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:AmountsPayableRelatedPartyTransactions" scale="0" unitRef="usd">441,374</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c3" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:AmountsPayableRelatedPartyTransactions" scale="0" unitRef="usd">6,893</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c254" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:AmountsPayableRelatedPartyTransactions" scale="0" unitRef="usd">2,319</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table></ix:nonNumeric></ix:continuation><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: 18pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><ix:nonNumeric contextRef="c0" continuedAt="_DescriptionOfManagingLiquidityRisk-c0_cont_1" escape="true" name="ifrs-full:DescriptionOfManagingLiquidityRisk"><table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif"><b>16.</b></span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b>Management
                                            of capital</b></span></td></tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -18pt"><span style="font-family: Times New Roman, Times, Serif"><b>&#160;</b></span></p></ix:nonNumeric><div>

</div><div>

</div><ix:continuation continuedAt="_DescriptionOfManagingLiquidityRisk-c0_cont_2" id="_DescriptionOfManagingLiquidityRisk-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">The
Company&#8217;s objectives when managing capital are to safeguard its ability to continue as a going concern in order to support the
exploration, evaluation, and development of its mineral properties and to maintain a flexible capital structure that optimizes the cost
of capital within a framework of acceptable risk. The Company manages the capital structure and makes adjustments to it in light of changes
in economic conditions and the risk characteristics of the underlying assets. To maintain or adjust its capital structure, the Company
may issue new shares, issue debt, and acquire or dispose of assets.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_DescriptionOfManagingLiquidityRisk-c0_cont_3" id="_DescriptionOfManagingLiquidityRisk-c0_cont_2"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">The
Company is dependent on the capital markets as its primary source of operating capital and the Company&#8217;s capital resources are
largely determined by the strength of the junior resource markets, the status of the Company&#8217;s projects in relation to these markets,
and its ability to compete for investor support of its projects.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_DescriptionOfManagingLiquidityRisk-c0_cont_4" id="_DescriptionOfManagingLiquidityRisk-c0_cont_3"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt"><span style="font-family: Times New Roman, Times, Serif">The
Company considers the components of shareholders&#8217; equity as capital.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b>&#160;</b></span></p></ix:continuation><div>

</div><div>

</div><ix:continuation id="_DescriptionOfManagingLiquidityRisk-c0_cont_4"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">There
were no changes in the Company&#8217;s approach to capital management during the year ended December 31, 2022, and the Company is not
subject to any externally imposed capital requirements.</span></p></ix:continuation><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><ix:nonNumeric contextRef="c0" continuedAt="_DisclosureOfFinancialInstrumentsExplanatory-c0_cont_1" escape="true" name="ifrs-full:DisclosureOfFinancialInstrumentsExplanatory"><table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif"><b>17.</b></span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b>Financial
                                            instruments</b></span></td>
</tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 18pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b>&#160;</b></span></p></ix:nonNumeric><div>

</div><div>

</div><ix:continuation continuedAt="_DisclosureOfFinancialInstrumentsExplanatory-c0_cont_2" id="_DisclosureOfFinancialInstrumentsExplanatory-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Financial
instruments include cash, receivables and marketable securities and any contract that gives rise to a financial asset to one party and
a financial liability or equity instrument to another party. Financial assets and liabilities measured at fair value are classified in
the fair value hierarchy according to the lowest level of input that is significant to the fair value measurement. Assessment of the
significance of a particular input to the fair value measurement requires judgement and may affect placement within the fair value hierarchy
levels. The hierarchy is as follows:</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_DisclosureOfFinancialInstrumentsExplanatory-c0_cont_3" id="_DisclosureOfFinancialInstrumentsExplanatory-c0_cont_2"><table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.75in"></td><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Level
                                            1 fair value measurements are those derived from quoted prices in active markets for identical
                                            assets or liabilities. </span></td></tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 72pt; text-align: justify; text-indent: -18pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_DisclosureOfFinancialInstrumentsExplanatory-c0_cont_4" id="_DisclosureOfFinancialInstrumentsExplanatory-c0_cont_3"><table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.75in"></td><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Level
                                            2 fair value measurements are those derived from inputs other than quoted prices included
                                            within Level 1, that are observable either directly or indirectly. </span></td></tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 72pt; text-align: justify; text-indent: -18pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_DisclosureOfFinancialInstrumentsExplanatory-c0_cont_5" id="_DisclosureOfFinancialInstrumentsExplanatory-c0_cont_4"><table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.75in"></td><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Level
                                            3 fair value measurements are those derived from valuation techniques that include inputs
                                            that are not based on observable market data. </span></td></tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 72pt; text-align: justify; text-indent: -18pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_DisclosureOfFinancialInstrumentsExplanatory-c0_cont_6" id="_DisclosureOfFinancialInstrumentsExplanatory-c0_cont_5"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Cash,
restricted cash, and marketable securities are measured at Level 1 of the fair value hierarchy. The Company classifies its receivables
as financial assets measured at amortized cost. Accounts payable and accrued liabilities, lease liability and due to related parties
and notes payable are classified as financial liabilities measured at amortized cost. The carrying amounts of receivables, accounts payable
and accrued liabilities, and amounts due to related parties approximate their fair values due to the short-term nature of the financial
instruments.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_DisclosureOfFinancialInstrumentsExplanatory-c0_cont_7" id="_DisclosureOfFinancialInstrumentsExplanatory-c0_cont_6"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Investments
in uranium are measured at Level 2 of the fair value hierarchy. The Company classifies these investments as financial assets measured
at fair value as determined based on the most recent month-end spot prices for uranium published by UxC and converted to Canadian dollars
at the date of the consolidated statement of financial position.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_DisclosureOfFinancialInstrumentsExplanatory-c0_cont_8" id="_DisclosureOfFinancialInstrumentsExplanatory-c0_cont_7"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Marketable
securities are measured at Level 1 of the fair value hierarchy. The Company classifies these investments as financial assets whose value
is derived from quoted prices in active markets and carries them at FVTPL.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p></ix:continuation><div>

</div><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"></p><div>

</div><!-- Field: Page; Sequence: 34; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->33<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"></p><div>

</div><table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="border-top: Black 1.5pt solid; width: 100%; padding-top: 2pt; padding-bottom: 2pt; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif"><b>enCore
    Energy Corp.</b></span></td></tr>
  <tr style="vertical-align: top">
    <td style="border-bottom: Black 1.5pt solid; text-align: left; padding-top: 2pt; padding-bottom: 2pt; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif"><b>Notes
    to the Consolidated Financial Statements</b></span></td></tr>
  <tr style="vertical-align: top">
    <td style="border-bottom: Black 1.5pt solid; padding-top: 2pt; padding-bottom: 2pt; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif"><b>For
    the years ended December 31, 2022 and December 31, 2021</b></span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif"><b>17.</b></span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b>Financial
                                            instruments</b> (continued)</span></td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -18pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><ix:continuation continuedAt="_DisclosureOfFinancialInstrumentsExplanatory-c0_cont_9" id="_DisclosureOfFinancialInstrumentsExplanatory-c0_cont_8"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt"><span style="font-family: Times New Roman, Times, Serif">Discussions
of risks associated with financial assets and liabilities are detailed below:</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_DisclosureOfFinancialInstrumentsExplanatory-c0_cont_10" id="_DisclosureOfFinancialInstrumentsExplanatory-c0_cont_9"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt"><span style="font-family: Times New Roman, Times, Serif"><b>Currency
risk</b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b>&#160;</b></span></p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_DisclosureOfFinancialInstrumentsExplanatory-c0_cont_11" id="_DisclosureOfFinancialInstrumentsExplanatory-c0_cont_10"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Foreign
currency exchange risk is the risk that future cash flows, net income and comprehensive income will fluctuate as a result of changes
in foreign exchange rates. As the Company&#8217;s operations are conducted internationally, operations and capital activity may be transacted
in currencies other than the functional currency of the entity party to the transaction.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_DisclosureOfFinancialInstrumentsExplanatory-c0_cont_12" id="_DisclosureOfFinancialInstrumentsExplanatory-c0_cont_11"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">The
Company&#8217;s objective in managing its foreign currency risk is to minimize its net exposures to foreign currency cash flows by obtaining
most of its estimated annual U.S. cash requirements and holding the remaining currency in Canadian dollars. The Company monitors and
forecasts the values of net foreign currency cash flow and consolidated statement of financial position exposures and from time to time
could authorize the use of derivative financial instruments such as forward foreign exchange contracts to economically hedge a portion
of foreign currency fluctuations.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_DisclosureOfFinancialInstrumentsExplanatory-c0_cont_13" id="_DisclosureOfFinancialInstrumentsExplanatory-c0_cont_12"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">The
following table provides an indication of the Company&#8217;s foreign currency exposures during the years ended December 31, 2022 and
2021:</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p></ix:continuation><div>

</div><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"></p><div>

</div><ix:continuation continuedAt="_DisclosureOfFinancialInstrumentsExplanatory-c0_cont_14" id="_DisclosureOfFinancialInstrumentsExplanatory-c0_cont_13"><ix:nonNumeric contextRef="c0" escape="true" name="cve:ScheduleOfFinancialInstrumentTableTextBlock"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">December
    31, <br/> 2022<br/> CAD $</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif">December
    31, <br/> 2021<br/> CAD $</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%"><span style="font-family: Times New Roman, Times, Serif">Cash</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c2" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:Cash" scale="0" unitRef="cad">216,871</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c3" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:Cash" scale="0" unitRef="cad">5,689,671</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Marketable Securities - Current</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c2" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:MarketableSecurities" scale="0" unitRef="cad">3,162,362</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-287; font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Accounts payable and
    accrued liabilities</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction contextRef="c2" decimals="0" format="ixt:num-dot-decimal" name="cve:AccountPayablesAndAccruedLiabilities" scale="0" unitRef="cad">2,890,582</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction contextRef="c3" decimals="0" format="ixt:num-dot-decimal" name="cve:AccountPayablesAndAccruedLiabilities" scale="0" unitRef="cad">2,557,849</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c2" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:AssetsLessCurrentLiabilities" scale="0" unitRef="cad">488,651</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c3" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:AssetsLessCurrentLiabilities" scale="0" unitRef="cad">3,131,822</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p></ix:nonNumeric></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_DisclosureOfFinancialInstrumentsExplanatory-c0_cont_15" id="_DisclosureOfFinancialInstrumentsExplanatory-c0_cont_14"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">A
<ix:nonFraction contextRef="c0" decimals="2" format="ixt:num-dot-decimal" name="cve:ForeignExchangeRate" scale="-2" unitRef="pure">10</ix:nonFraction>% change in Canadian/US foreign exchange rate at year end would have changed the net loss of the Company, assuming that all other variables
remained constant, by approximately $<ix:nonFraction contextRef="c2" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:NotionalAmount" scale="0" unitRef="usd">352,315</ix:nonFraction> for the year ended December 31, 2022 (2021 - $<ix:nonFraction contextRef="c3" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:NotionalAmount" scale="0" unitRef="usd">247,028</ix:nonFraction>).</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_DisclosureOfFinancialInstrumentsExplanatory-c0_cont_16" id="_DisclosureOfFinancialInstrumentsExplanatory-c0_cont_15"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">The
Company has not, to the date of these financial statements, entered into derivative instruments to offset the impact of foreign currency
fluctuations.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_DisclosureOfFinancialInstrumentsExplanatory-c0_cont_17" id="_DisclosureOfFinancialInstrumentsExplanatory-c0_cont_16"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt"><span style="font-family: Times New Roman, Times, Serif"><b>Credit
risk</b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b>&#160;</b></span></p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_DisclosureOfFinancialInstrumentsExplanatory-c0_cont_18" id="_DisclosureOfFinancialInstrumentsExplanatory-c0_cont_17"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Credit
risk arises from cash held with banks and financial institutions and receivables. The maximum exposure to credit risk is equal to the
carrying value of these financial assets. The Company&#8217;s cash is primarily held with a major Canadian bank.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b>&#160;</b></span></p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_DisclosureOfFinancialInstrumentsExplanatory-c0_cont_19" id="_DisclosureOfFinancialInstrumentsExplanatory-c0_cont_18"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt"><span style="font-family: Times New Roman, Times, Serif"><b>Market
risk</b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b>&#160;</b></span></p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_DisclosureOfFinancialInstrumentsExplanatory-c0_cont_20" id="_DisclosureOfFinancialInstrumentsExplanatory-c0_cont_19"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">The
Company is exposed to market risk because of the fluctuating values of its publicly traded marketable securities (Note 6). The Company
has no control over these fluctuations and does not hedge its investments. Based on the December 31, 2022 value of marketable securities
every <ix:nonFraction contextRef="c0" decimals="2" format="ixt:num-dot-decimal" name="ifrs-full:TaxRateEffectFromChangeInTaxRate" scale="-2" unitRef="pure">10</ix:nonFraction>% increase or decrease in the share prices of their holdings would have impacted loss for the period, up or down, by approximately
$<ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="cve:ImpactedLoss" scale="0" unitRef="usd">394,719</ix:nonFraction> (2021 - $<span style="-sec-ix-hidden: hidden-fact-288">nil</span>) before income taxes.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_DisclosureOfFinancialInstrumentsExplanatory-c0_cont_21" id="_DisclosureOfFinancialInstrumentsExplanatory-c0_cont_20"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Further,
the Company is in the exploration stage and commodity prices are not reflected in operating financial results. However, fluctuations
in commodity prices may influence financial markets and may indirectly affect the Company&#8217;s ability to raise capital to fund exploration.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_DisclosureOfFinancialInstrumentsExplanatory-c0_cont_22" id="_DisclosureOfFinancialInstrumentsExplanatory-c0_cont_21"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt"><span style="font-family: Times New Roman, Times, Serif"><b>Interest
rate risk</b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b>&#160;</b></span></p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_DisclosureOfFinancialInstrumentsExplanatory-c0_cont_23" id="_DisclosureOfFinancialInstrumentsExplanatory-c0_cont_22"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Interest
rate risk mainly arises from the Company&#8217;s cash, which receives interest based on market interest rates. Fluctuations in interest
cash flows due to changes in market interest rates are not significant.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p></ix:continuation><div>

</div><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"></p><div>

</div><!-- Field: Page; Sequence: 35; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->34<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"></p><div>

</div><table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="border-top: Black 1.5pt solid; width: 100%; padding-top: 2pt; padding-bottom: 2pt; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif"><b>enCore
    Energy Corp.</b></span></td></tr>
  <tr style="vertical-align: top">
    <td style="border-bottom: Black 1.5pt solid; padding-top: 2pt; padding-bottom: 2pt; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif"><b>Notes
    to the Consolidated Financial Statements</b></span></td></tr>
  <tr style="vertical-align: top">
    <td style="border-bottom: Black 1.5pt solid; padding-top: 2pt; padding-bottom: 2pt; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif"><b>For
    the years ended December 31, 2022 and December 31, 2021</b></span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif"><b>17.</b></span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b>Financial
                                            instruments</b> (continued)</span></td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -18pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><ix:continuation continuedAt="_DisclosureOfFinancialInstrumentsExplanatory-c0_cont_24" id="_DisclosureOfFinancialInstrumentsExplanatory-c0_cont_23"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt"><span style="font-family: Times New Roman, Times, Serif"><b>Liquidity
risk</b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b>&#160;</b></span></p></ix:continuation><div>

</div><div>

</div><ix:continuation id="_DisclosureOfFinancialInstrumentsExplanatory-c0_cont_24"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Liquidity
risk is the risk that the Company will not be able to meet its current obligations as they become due. The majority of the Company&#8217;s
accounts payable and accrued liabilities are payable in less than 90 days. The Company prepares annual exploration and administrative
budgets and monitors expenditures to manage short-term liquidity. Due to the nature of the Company&#8217;s activities, funding for long-term
liquidity needs is dependent on the Company&#8217;s ability to obtain additional financing through various means, including equity financing.</span></p></ix:continuation><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><ix:nonNumeric contextRef="c0" continuedAt="_DisclosureOfEntitysReportableSegmentsExplanatory-c0_cont_1" escape="true" name="ifrs-full:DisclosureOfEntitysReportableSegmentsExplanatory"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%"><tr style="vertical-align: top">
<td style="width: 18pt"></td><td style="width: 18pt"><span style="font-family: Times New Roman, Times, Serif"><b>18.</b></span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b>Segmented
                                            information</b></span></td></tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -18pt"><span style="font-family: Times New Roman, Times, Serif"><b>&#160;</b></span></p></ix:nonNumeric><div>

</div><div>

</div><ix:continuation continuedAt="_DisclosureOfEntitysReportableSegmentsExplanatory-c0_cont_2" id="_DisclosureOfEntitysReportableSegmentsExplanatory-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">The
Company operates in a single segment: the acquisition, exploration, and development of mineral properties in the United States.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_DisclosureOfEntitysReportableSegmentsExplanatory-c0_cont_3" id="_DisclosureOfEntitysReportableSegmentsExplanatory-c0_cont_2"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">The
table below provides a breakdown of the Company&#8217;s long-term assets by geographic segment:</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p></ix:continuation><div>

</div><div>

</div><ix:continuation id="_DisclosureOfEntitysReportableSegmentsExplanatory-c0_cont_3"><ix:nonNumeric contextRef="c0" escape="true" name="cve:DisclosureOfLongtermAssetsByGeographicSegmentTableTextBlock"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; text-align: left; padding-left: 0.125in; text-indent: -0.125in"><span style="font-family: Times New Roman, Times, Serif">Balance
    Sheet Items</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif">South
    Dakota<br/> $</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Texas<br/>
    $</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif">New
    Mexico<br/> $</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Wyoming<br/>
    $</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Other
    States <br/> $</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Canada<br/>
    $</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Total<br/>
    $</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-left: 0.125in; text-indent: -0.125in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; width: 16%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Intangible
    assets</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 9%; text-align: right"><span style="-sec-ix-hidden: hidden-fact-289; font-family: Times New Roman, Times, Serif">-</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c193" decimals="0" format="ixt:num-dot-decimal" name="cve:IntangibleAssets" scale="0" unitRef="usd">67,251</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c191" decimals="0" format="ixt:num-dot-decimal" name="cve:IntangibleAssets" scale="0" unitRef="usd">217,241</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 9%; text-align: right"><span style="-sec-ix-hidden: hidden-fact-290; font-family: Times New Roman, Times, Serif">-</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c255" decimals="0" format="ixt:num-dot-decimal" name="cve:IntangibleAssets" scale="0" unitRef="usd">207,504</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 9%; text-align: right"><span style="-sec-ix-hidden: hidden-fact-291; font-family: Times New Roman, Times, Serif">-</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c3" decimals="0" format="ixt:num-dot-decimal" name="cve:IntangibleAssets" scale="0" unitRef="usd">491,996</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Property,
    plant and equipment</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c192" decimals="0" format="ixt:num-dot-decimal" name="cve:PropertyPlantAndEquipments" scale="0" unitRef="usd">62,946</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c193" decimals="0" format="ixt:num-dot-decimal" name="cve:PropertyPlantAndEquipments" scale="0" unitRef="usd">1,540,733</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-292; font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-293; font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-294; font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-295; font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c3" decimals="0" format="ixt:num-dot-decimal" name="cve:PropertyPlantAndEquipments" scale="0" unitRef="usd">1,603,679</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Mineral
    properties</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c192" decimals="0" format="ixt:num-dot-decimal" name="cve:MineralProperties" scale="0" unitRef="usd">85,667,919</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c193" decimals="0" format="ixt:num-dot-decimal" name="cve:MineralProperties" scale="0" unitRef="usd">1,455,206</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c191" decimals="0" format="ixt:num-dot-decimal" name="cve:MineralProperties" scale="0" unitRef="usd">4,395,822</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c195" decimals="0" format="ixt:num-dot-decimal" name="cve:MineralProperties" scale="0" unitRef="usd">41,235,727</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c255" decimals="0" format="ixt:num-dot-decimal" name="cve:MineralProperties" scale="0" unitRef="usd">3,324,904</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-296; font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c3" decimals="0" format="ixt:num-dot-decimal" name="cve:MineralProperties" scale="0" unitRef="usd">136,079,578</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Right-of-use
    assets</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-297; font-family: Times New Roman, Times, Serif">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c193" decimals="0" format="ixt:num-dot-decimal" name="cve:RightofuseAssets1" scale="0" unitRef="usd">199,120</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-298; font-family: Times New Roman, Times, Serif">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-299; font-family: Times New Roman, Times, Serif">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-300; font-family: Times New Roman, Times, Serif">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c196" decimals="0" format="ixt:num-dot-decimal" name="cve:RightofuseAssets1" scale="0" unitRef="usd">45,444</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c3" decimals="0" format="ixt:num-dot-decimal" name="cve:RightofuseAssets1" scale="0" unitRef="usd">244,564</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Balance,
    December 31, 2021</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c192" decimals="0" format="ixt:num-dot-decimal" name="cve:SegmentedInformationBalance" scale="0" unitRef="usd">85,730,865</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c193" decimals="0" format="ixt:num-dot-decimal" name="cve:SegmentedInformationBalance" scale="0" unitRef="usd">3,262,310</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c191" decimals="0" format="ixt:num-dot-decimal" name="cve:SegmentedInformationBalance" scale="0" unitRef="usd">4,613,063</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c195" decimals="0" format="ixt:num-dot-decimal" name="cve:SegmentedInformationBalance" scale="0" unitRef="usd">41,235,727</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c255" decimals="0" format="ixt:num-dot-decimal" name="cve:SegmentedInformationBalance" scale="0" unitRef="usd">3,532,408</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c196" decimals="0" format="ixt:num-dot-decimal" name="cve:SegmentedInformationBalance" scale="0" unitRef="usd">45,444</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c3" decimals="0" format="ixt:num-dot-decimal" name="cve:SegmentedInformationBalance" scale="0" unitRef="usd">138,419,817</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-indent: -0.125in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Intangible
    assets</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-301; font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c216" decimals="0" format="ixt:num-dot-decimal" name="cve:IntangibleAssets" scale="0" unitRef="usd">122,401</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c214" decimals="0" format="ixt:num-dot-decimal" name="cve:IntangibleAssets" scale="0" unitRef="usd">217,241</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-302; font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c256" decimals="0" format="ixt:num-dot-decimal" name="cve:IntangibleAssets" scale="0" unitRef="usd">188,640</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-303; font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c2" decimals="0" format="ixt:num-dot-decimal" name="cve:IntangibleAssets" scale="0" unitRef="usd">528,282</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Property,
    plant and equipment</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c215" decimals="0" format="ixt:num-dot-decimal" name="cve:PropertyPlantAndEquipments" scale="0" unitRef="usd">60,630</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c216" decimals="0" format="ixt:num-dot-decimal" name="cve:PropertyPlantAndEquipments" scale="0" unitRef="usd">2,273,791</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-304; font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-305; font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-306; font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-307; font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c2" decimals="0" format="ixt:num-dot-decimal" name="cve:PropertyPlantAndEquipments" scale="0" unitRef="usd">2,334,421</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Mineral
    properties</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c215" decimals="0" format="ixt:num-dot-decimal" name="cve:MineralProperties" scale="0" unitRef="usd">86,220,848</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c216" decimals="0" format="ixt:num-dot-decimal" name="cve:MineralProperties" scale="0" unitRef="usd">9,144,069</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c214" decimals="0" format="ixt:num-dot-decimal" name="cve:MineralProperties" scale="0" unitRef="usd">4,905,348</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c218" decimals="0" format="ixt:num-dot-decimal" name="cve:MineralProperties" scale="0" unitRef="usd">41,754,462</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c256" decimals="0" format="ixt:num-dot-decimal" name="cve:MineralProperties" scale="0" unitRef="usd">3,194,359</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-308; font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c2" decimals="0" format="ixt:num-dot-decimal" name="cve:MineralProperties" scale="0" unitRef="usd">145,219,086</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Right-of-use
    assets</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-309; font-family: Times New Roman, Times, Serif">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c216" decimals="0" format="ixt:num-dot-decimal" name="cve:RightofuseAssets1" scale="0" unitRef="usd">168,871</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-310; font-family: Times New Roman, Times, Serif">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-311; font-family: Times New Roman, Times, Serif">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-312; font-family: Times New Roman, Times, Serif">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c219" decimals="0" format="ixt:num-dot-decimal" name="cve:RightofuseAssets1" scale="0" unitRef="usd">16,743</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c2" decimals="0" format="ixt:num-dot-decimal" name="cve:RightofuseAssets1" scale="0" unitRef="usd">185,614</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Balance,
    December 31, 2022</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c215" decimals="0" format="ixt:num-dot-decimal" name="cve:SegmentedInformationBalance" scale="0" unitRef="usd">86,281,478</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c216" decimals="0" format="ixt:num-dot-decimal" name="cve:SegmentedInformationBalance" scale="0" unitRef="usd">11,709,132</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c214" decimals="0" format="ixt:num-dot-decimal" name="cve:SegmentedInformationBalance" scale="0" unitRef="usd">5,122,589</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c218" decimals="0" format="ixt:num-dot-decimal" name="cve:SegmentedInformationBalance" scale="0" unitRef="usd">41,754,462</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c256" decimals="0" format="ixt:num-dot-decimal" name="cve:SegmentedInformationBalance" scale="0" unitRef="usd">3,382,999</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c219" decimals="0" format="ixt:num-dot-decimal" name="cve:SegmentedInformationBalance" scale="0" unitRef="usd">16,743</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c2" decimals="0" format="ixt:num-dot-decimal" name="cve:SegmentedInformationBalance" scale="0" unitRef="usd">148,267,403</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table></ix:nonNumeric></ix:continuation><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><ix:nonNumeric contextRef="c0" continuedAt="cve_SupplementalDisclosureWithRespectToCashflowsTextBlock-c0_cont_1" escape="true" name="cve:SupplementalDisclosureWithRespectToCashflowsTextBlock"><table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif"><b>19.</b></span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b>Supplemental
                                            disclosure with respect to cash flows</b></span></td></tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p></ix:nonNumeric><div>

</div><div>

</div><ix:continuation continuedAt="cve_SupplementalDisclosureWithRespectToCashflowsTextBlock-c0_cont_2" id="cve_SupplementalDisclosureWithRespectToCashflowsTextBlock-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">The
Company incurred non-cash financing and investing activities during the years ended December 31, 2022, and December 31, 2021 as follows:</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"></p></ix:continuation><div>

</div><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><ix:continuation continuedAt="cve_SupplementalDisclosureWithRespectToCashflowsTextBlock-c0_cont_3" id="cve_SupplementalDisclosureWithRespectToCashflowsTextBlock-c0_cont_2"><ix:nonNumeric contextRef="c0" escape="true" name="cve:ScheduleOfIncurredNoncashFinancingAndInvestingActivitiesTableTextBlock"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">December 31,</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">December 31,</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2022</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">2021</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">Non-cash financing activities:</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: 0.125in; width: 76%; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Deferred
    financing costs remaining in accounts payable and accrued liabilities</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c2" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:CurrentAccruedExpensesAndOtherCurrentLiabilities" scale="0" unitRef="usd">1,513,220</ix:nonFraction></span></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-313; font-family: Times New Roman, Times, Serif">-</span></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c2" decimals="0" format="ixt:num-dot-decimal" name="cve:TotalNoncashFinancingActivities" scale="0" unitRef="usd">1,513,220</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-314; font-family: Times New Roman, Times, Serif">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Non-cash investing activities:</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: 0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Marketable securities
    received on disposition of mineral properties</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c2" decimals="0" format="ixt:num-dot-decimal" name="cve:MarketableSecuritieReceivedOnDispositionOfMineralProperties" scale="0" unitRef="usd">3,051,564</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-315; font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: 0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Mineral property costs
    included in accounts payable and accrued liabilities</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c2" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:LiabilitiesArisingFromExplorationForAndEvaluationOfMineralResources" scale="0" unitRef="usd">27,040</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-316; font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: 0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Property, plant, and
    equipment additions included in accounts payable and accrued liabilities</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c2" decimals="0" format="ixt:num-dot-decimal" name="cve:PropertyPlantAndEquipmentAdditionIncludedInAccountsPayableAndAccruedLiabilities" scale="0" unitRef="usd">20,090</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-317; font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: 0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Fair value of common
    shares issued for Azarga asset acquisition</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-318; font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c3" decimals="0" format="ixt:num-dot-decimal" name="cve:FairValueOfCommonSharesIssuedForAzargaAssetAcquisition" scale="0" unitRef="usd">121,796,381</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: 0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Fair value of replacement
    options issued for Azarga asset acquisition</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-319; font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c3" decimals="0" format="ixt:num-dot-decimal" name="cve:FairValueOfReplacementOptionsIssuedForAzargaAssetsAcquisition" scale="0" unitRef="usd">5,496,037</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: 0.125in; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Fair
    value of replacement warrants issued for Azarga asset acquisition</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-320; font-family: Times New Roman, Times, Serif">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c3" decimals="0" format="ixt:num-dot-decimal" name="cve:FairValueOfReplacementWarrantsIssuedForAzargaAssetAcquisition" scale="0" unitRef="usd">3,259,306</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c2" decimals="0" format="ixt:num-dot-decimal" name="cve:TotalNoncashInvestingActivities" scale="0" unitRef="usd">3,098,694</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c3" decimals="0" format="ixt:num-dot-decimal" name="cve:TotalNoncashInvestingActivities" scale="0" unitRef="usd">130,551,724</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p></ix:nonNumeric></ix:continuation><div>

</div><div>

</div><ix:continuation id="cve_SupplementalDisclosureWithRespectToCashflowsTextBlock-c0_cont_3"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">There
were no amounts paid for income taxes or interest during the years ended December 31, 2022, and December 31, 2021.</span></p></ix:continuation><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"></p><div>

</div><!-- Field: Page; Sequence: 36; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->35<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"></p><div>

</div><table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="border-top: Black 1.5pt solid; width: 100%; padding-top: 2pt; padding-bottom: 2pt; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif"><b>enCore
    Energy Corp.</b></span></td></tr>
  <tr style="vertical-align: top">
    <td style="border-bottom: Black 1.5pt solid; padding-top: 2pt; padding-bottom: 2pt; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif"><b>Notes
    to the Consolidated Financial Statements</b></span></td></tr>
  <tr style="vertical-align: top">
    <td style="border-bottom: Black 1.5pt solid; padding-top: 2pt; padding-bottom: 2pt; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif"><b>For
    the years ended December 31, 2022 and December 31, 2021</b></span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><ix:nonNumeric contextRef="c0" continuedAt="_DisclosureOfIncomeTaxExplanatory-c0_cont_1" escape="true" name="ifrs-full:DisclosureOfIncomeTaxExplanatory"><table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif"><b>20.</b></span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b>Income
                                            taxes</b></span></td></tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -18pt"><span style="font-family: Times New Roman, Times, Serif"><b>&#160;</b></span></p></ix:nonNumeric><div>

</div><div>

</div><ix:continuation continuedAt="_DisclosureOfIncomeTaxExplanatory-c0_cont_2" id="_DisclosureOfIncomeTaxExplanatory-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">The
actual income tax provision differs from the expected amount calculated by applying the Canadian combined federal and provincial corporate
tax rates to income before tax. These differences result from the following:</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_DisclosureOfIncomeTaxExplanatory-c0_cont_3" id="_DisclosureOfIncomeTaxExplanatory-c0_cont_2"><ix:nonNumeric contextRef="c0" escape="true" name="ifrs-full:DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsExplanatory"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">December 31,</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-style: normal; text-align: center; font-weight: normal"><span style="font-family: Times New Roman, Times, Serif">December
    31,</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2022</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">2021</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Loss before income tax</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:IncomeLossAttributableToParent" scale="0" sign="-" unitRef="usd">16,515,389</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:IncomeLossAttributableToParent" scale="0" sign="-" unitRef="usd">8,563,473</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Statutory income tax
    rate</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c0" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" scale="-2" unitRef="pure">27</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c5" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" scale="-2" unitRef="pure">27</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Expected income tax expense (recovery)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="cve:ExpectedIncomeTaxExpenserecovery" scale="0" sign="-" unitRef="usd">4,459,155</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="cve:ExpectedIncomeTaxExpenserecovery" scale="0" sign="-" unitRef="usd">2,312,138</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Increase (decrease) resulting from:</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: 0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Change in unrecognized
    temporary differences</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="cve:ChangeInUnrecognizedTemporaryDifferences" scale="0" unitRef="usd">2,949,101</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="cve:ChangeInUnrecognizedTemporaryDifferences" scale="0" unitRef="usd">1,800,688</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: 0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Permanent differences</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:TaxEffectOfExpenseNotDeductibleInDeterminingTaxableProfitTaxLoss" scale="0" unitRef="usd">1,159,884</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:TaxEffectOfExpenseNotDeductibleInDeterminingTaxableProfitTaxLoss" scale="0" unitRef="usd">433,595</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: 0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Effect of tax rates in
    foreign jurisdictions</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:TaxEffectOfForeignTaxRates" scale="0" unitRef="usd">146,727</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:TaxEffectOfForeignTaxRates" scale="0" unitRef="usd">77,855</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: 0.125in"><span style="font-family: Times New Roman, Times, Serif">Share issue costs</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="cve:ShareIssueCosts" scale="0" unitRef="usd">201,740</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-321; font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: 0.125in; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Prior period adjustments</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:AdjustmentsForCurrentTaxOfPriorPeriod" scale="0" unitRef="usd">1,703</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-322; font-family: Times New Roman, Times, Serif">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Income
    tax expense (recovery)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-323; font-family: Times New Roman, Times, Serif">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-324; font-family: Times New Roman, Times, Serif">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p></ix:nonNumeric></ix:continuation><div>


</div><div>

</div><ix:continuation continuedAt="_DisclosureOfIncomeTaxExplanatory-c0_cont_4" id="_DisclosureOfIncomeTaxExplanatory-c0_cont_3"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b><span style="text-decoration:underline">Recognized
deferred tax assets and liabilities</span></b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_DisclosureOfIncomeTaxExplanatory-c0_cont_5" id="_DisclosureOfIncomeTaxExplanatory-c0_cont_4"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt"><span style="font-family: Times New Roman, Times, Serif">Deferred
tax assets are attributable to the following:</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b>&#160;</b></span></p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_DisclosureOfIncomeTaxExplanatory-c0_cont_6" id="_DisclosureOfIncomeTaxExplanatory-c0_cont_5"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b><span style="text-decoration:underline">Income
tax expense (recovery)</span></b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_DisclosureOfIncomeTaxExplanatory-c0_cont_7" id="_DisclosureOfIncomeTaxExplanatory-c0_cont_6"><ix:nonNumeric contextRef="c0" continuedAt="_DisclosureOfInterestIncomeExplanatory-c0_cont_1" escape="true" name="ifrs-full:DisclosureOfInterestIncomeExplanatory"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">December 31,</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">December 31,</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2022</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">2021</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">Deferred tax expense (recovery)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Organization and reversal of temporary
    differences</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="cve:OrginationAndReversalOfTemporaryDifferences" scale="0" sign="-" unitRef="usd">2,949,101</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="cve:OrginationAndReversalOfTemporaryDifferences" scale="0" sign="-" unitRef="usd">1,800,688</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Change in unrecognized
    temporary differences</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="cve:ChangeInUnrecognizedTemporaryDifferences" scale="0" unitRef="usd">2,949,101</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="cve:ChangeInUnrecognizedTemporaryDifferences" scale="0" unitRef="usd">1,800,688</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Income
    tax expense (recovery)</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="-sec-ix-hidden: hidden-fact-325; font-family: Times New Roman, Times, Serif">-</span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="-sec-ix-hidden: hidden-fact-326; font-family: Times New Roman, Times, Serif">-</span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p></ix:nonNumeric></ix:continuation><div>


</div><div>

</div><ix:continuation continuedAt="_DisclosureOfIncomeTaxExplanatory-c0_cont_8" id="_DisclosureOfIncomeTaxExplanatory-c0_cont_7"><ix:continuation id="_DisclosureOfInterestIncomeExplanatory-c0_cont_1"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif"><b>&#160;</b></span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"><b>&#160;</b></span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><b>2022</b></span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"><b>&#160;</b></span></td><td><span style="font-family: Times New Roman, Times, Serif"><b>&#160;</b></span></td>
    <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">2021</span></td><td><span style="font-family: Times New Roman, Times, Serif"><b>&#160;</b></span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif"><b>&#160;</b></span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"><b>&#160;</b></span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif"><b>$</b></span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"><b>&#160;</b></span></td><td><span style="font-family: Times New Roman, Times, Serif"><b>&#160;</b></span></td>
    <td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"><b>&#160;</b></span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Loss carryforwards</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c2" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:DeferredTaxAssetsOtherLossCarryforwards" scale="0" unitRef="usd">488,823</ix:nonFraction></span></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c3" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:DeferredTaxAssetsOtherLossCarryforwards" scale="0" unitRef="usd">52,244</ix:nonFraction></span></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Deferred tax assets</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c2" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:DeferredTaxAssetsOther" scale="0" unitRef="usd">488,823</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c3" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:DeferredTaxAssetsOther" scale="0" unitRef="usd">52,244</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Set-off of tax</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="cve:SetoffOfTax" scale="0" unitRef="usd">488,823</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="cve:SetoffOfTax" scale="0" unitRef="usd">52,244</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Net
    deferred tax assets</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-327; font-family: Times New Roman, Times, Serif">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-328; font-family: Times New Roman, Times, Serif">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p></ix:continuation></ix:continuation><div>


</div><div>

</div><ix:continuation continuedAt="_DisclosureOfIncomeTaxExplanatory-c0_cont_9" id="_DisclosureOfIncomeTaxExplanatory-c0_cont_8"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Deferred
tax liabilities are attributable to the following:</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_DisclosureOfIncomeTaxExplanatory-c0_cont_10" id="_DisclosureOfIncomeTaxExplanatory-c0_cont_9"><ix:nonNumeric contextRef="c0" escape="true" name="us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">December 31,</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">December 31,</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2022</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">2021</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Intangible assets</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction contextRef="c2" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:OtherIntangibleAssets" scale="0" unitRef="usd">39,481</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 9%; text-align: right"><span style="-sec-ix-hidden: hidden-fact-329; font-family: Times New Roman, Times, Serif">-</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Right-of-use assets</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction contextRef="c2" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:RightofuseAssetsRevaluedAssetsAtCost" scale="0" unitRef="usd">42,472</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction contextRef="c3" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:RightofuseAssetsRevaluedAssetsAtCost" scale="0" unitRef="usd">52,244</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Fixed assets</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="cve:FixedAssets" scale="0" sign="-" unitRef="usd">276,699</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Right-of-use assets</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction contextRef="c2" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:RightofuseAssetsRevaluationSurplus" scale="0" unitRef="usd">130,171</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-330; font-family: Times New Roman, Times, Serif">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Marketable securities</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction contextRef="c2" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:MarketableSecuritiesCurrent" scale="0" sign="-" unitRef="usd">488,823</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction contextRef="c3" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:MarketableSecuritiesCurrent" scale="0" sign="-" unitRef="usd">52,244</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Set-off of tax</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="cve:SetoffOfTax" scale="0" unitRef="usd">488,823</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="cve:SetoffOfTax" scale="0" unitRef="usd">52,244</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Net
    deferred tax liability</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-331; font-family: Times New Roman, Times, Serif">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-332; font-family: Times New Roman, Times, Serif">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p></ix:nonNumeric></ix:continuation><div>


</div><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"></p><div>

</div><!-- Field: Page; Sequence: 37; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->36<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"></p><div>

</div><table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="border-top: Black 1.5pt solid; width: 100%; padding-top: 2pt; padding-bottom: 2pt; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif"><b>enCore
    Energy Corp.</b></span></td></tr>
  <tr style="vertical-align: top">
    <td style="border-bottom: Black 1.5pt solid; padding-top: 2pt; padding-bottom: 2pt; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif"><b>Notes
    to the Consolidated Financial Statements</b></span></td></tr>
  <tr style="vertical-align: top">
    <td style="border-bottom: Black 1.5pt solid; padding-top: 2pt; padding-bottom: 2pt; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif"><b>For
    the years ended December 31, 2022 and December 31, 2021</b></span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"></p><div>

</div><table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif"><b>20.</b></span></td><td style="text-align: justify"><p style="margin: 0pt 0; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"><b>Income
                                            taxes (continued)</b></span></p></td></tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"></p><div>

</div><ix:continuation continuedAt="_DisclosureOfIncomeTaxExplanatory-c0_cont_11" id="_DisclosureOfIncomeTaxExplanatory-c0_cont_10"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b><span style="text-decoration:underline">Unrecognized
deferred tax assets</span></b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p></ix:continuation><div>

</div><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"></p><div>

</div><ix:continuation continuedAt="_DisclosureOfIncomeTaxExplanatory-c0_cont_12" id="_DisclosureOfIncomeTaxExplanatory-c0_cont_11"><ix:nonNumeric contextRef="c0" escape="true" name="ifrs-full:DisclosureOfDeferredTaxesExplanatory"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">December 31,</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">December 31,</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2022</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">2021</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Deductible temporary differences</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="cve:DeductibleTemporaryDifferences" scale="0" sign="-" unitRef="usd">3,920,076</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="cve:DeductibleTemporaryDifferences" scale="0" sign="-" unitRef="usd">2,576,276</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Tax losses</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:TaxEffectOfTaxLosses" scale="0" sign="-" unitRef="usd">26,069,552</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:TaxEffectOfTaxLosses" scale="0" sign="-" unitRef="usd">12,754,678</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:ProfitLossBeforeTax" scale="0" unitRef="usd">29,989,628</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:ProfitLossBeforeTax" scale="0" unitRef="usd">15,330,954</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p></ix:nonNumeric></ix:continuation><div>

</div><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"></p><div>

</div><ix:continuation continuedAt="_DisclosureOfIncomeTaxExplanatory-c0_cont_13" id="_DisclosureOfIncomeTaxExplanatory-c0_cont_12"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Deferred tax assets have not been recognized
in respect of the above items, because it is not probable that future taxable profit will be available against which the Company can use
the benefits therefrom.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p></ix:continuation><div>

</div><div>

</div><ix:continuation id="_DisclosureOfIncomeTaxExplanatory-c0_cont_13"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The Company has Canadian non-capital
loss carryforwards of $<ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="cve:NoncapitalLoss" scale="0" unitRef="usd">28,628,469</ix:nonFraction> (December 31, 2021 - $<ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="cve:NoncapitalLoss" scale="0" unitRef="usd">22,107,188</ix:nonFraction>), that will start expiring in 2028 and US federal net operating loss
carryforwards of $<ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="cve:FederalNetOperatingLossCarryforwards" scale="0" unitRef="usd">21,099,321</ix:nonFraction> (December 31, 2021 - $<ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="cve:FederalNetOperatingLossCarryforwards" scale="0" unitRef="usd">11,232,201</ix:nonFraction>), of which $<ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="cve:CarriedForward" scale="0" unitRef="usd">15,223,100</ix:nonFraction> can be carried forward indefinitely and $<ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="cve:ExpiringAmount" scale="0" unitRef="usd">5,876,221</ix:nonFraction>
that will start expiring in 2027.</p></ix:continuation><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"></p><div>

</div><ix:nonNumeric contextRef="c0" continuedAt="_DisclosureOfReclassificationsOrChangesInPresentationExplanatory-c0_cont_1" escape="true" name="ifrs-full:DisclosureOfReclassificationsOrChangesInPresentationExplanatory"><table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif"><b>21.</b></span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b>Change
                                            in presentation currency </b></span></td></tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p></ix:nonNumeric><div>
</div><div>

</div><ix:continuation continuedAt="_DisclosureOfReclassificationsOrChangesInPresentationExplanatory-c0_cont_2" id="_DisclosureOfReclassificationsOrChangesInPresentationExplanatory-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">For
comparative purposes, the consolidated statements of financial position as of December 31, 2021 and January 1, 2021 includes adjustments
to reflect the change in accounting policy resulting from the change in presentation currency to the U.S. Dollar. The amounts previously
reported in Canadian Dollars as shown below have been translated into U.S. Dollars at the December 31, 2021 and January 1, 2021 exchange
rates (Note 2). The effect of the translation is as follows:</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_DisclosureOfReclassificationsOrChangesInPresentationExplanatory-c0_cont_3" id="_DisclosureOfReclassificationsOrChangesInPresentationExplanatory-c0_cont_2"><ix:nonNumeric contextRef="c0" continuedAt="_DescriptionOfAccountingPolicyForForeignCurrencyTranslationExplanatory-c0_cont_1" escape="true" name="ifrs-full:DescriptionOfAccountingPolicyForForeignCurrencyTranslationExplanatory"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"><span style="text-decoration:underline">As at January 1, 2021</span></span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">Previously
    reported (CAD$)</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">Translated
    (USD$)</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Current assets</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c257" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:CurrentAssets" scale="0" unitRef="cad">6,926,844</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c258" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:CurrentAssets" scale="0" unitRef="usd">5,436,341</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Non-current
    assets</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c257" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:NoncurrentAssets" scale="0" unitRef="cad">16,516,119</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c258" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:NoncurrentAssets" scale="0" unitRef="usd">12,918,903</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Total
    assets</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c257" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:Assets" scale="0" unitRef="cad">23,442,963</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c258" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:Assets" scale="0" unitRef="usd">18,355,244</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Current liabilities</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c257" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:CurrentLiabilities" scale="0" unitRef="cad">900,300</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c258" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:CurrentLiabilities" scale="0" unitRef="usd">707,056</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Non-current
    liabilities</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c257" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:NoncurrentLiabilities" scale="0" unitRef="cad">6,674,405</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c258" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:NoncurrentLiabilities" scale="0" unitRef="usd">5,242,229</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Total
    liabilities</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c257" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:Liabilities" scale="0" unitRef="cad">7,574,705</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c258" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:Liabilities" scale="0" unitRef="usd">5,949,285</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
</table><p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p></ix:nonNumeric></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_DisclosureOfReclassificationsOrChangesInPresentationExplanatory-c0_cont_4" id="_DisclosureOfReclassificationsOrChangesInPresentationExplanatory-c0_cont_3"><ix:continuation id="_DescriptionOfAccountingPolicyForForeignCurrencyTranslationExplanatory-c0_cont_1"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"><span style="text-decoration:underline">As at December 31, 2021</span></span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Previously
    reported (CAD$)</span></td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Translated
    (USD$)</span></td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Current assets</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c259" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:CurrentAssets" scale="0" unitRef="cad">14,651,619</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c260" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:CurrentAssets" scale="0" unitRef="usd">11,556,728</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Non-current
    assets</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c259" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:NoncurrentAssets" scale="0" unitRef="cad">187,434,040</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c260" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:NoncurrentAssets" scale="0" unitRef="usd">147,799,796</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Total
    assets</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c259" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:Assets" scale="0" unitRef="cad">202,085,659</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c260" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:Assets" scale="0" unitRef="usd">159,356,524</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Current liabilities</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c259" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:CurrentLiabilities" scale="0" unitRef="cad">7,510,606</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c260" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:CurrentLiabilities" scale="0" unitRef="usd">5,924,125</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Non-current
    liabilities</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c259" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:NoncurrentLiabilities" scale="0" unitRef="cad">5,507,178</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c260" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:NoncurrentLiabilities" scale="0" unitRef="usd">4,343,886</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Total
    liabilities</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c259" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:Liabilities" scale="0" unitRef="cad">13,017,784</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c260" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:Liabilities" scale="0" unitRef="usd">10,268,011</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p></ix:continuation></ix:continuation><div>



</div><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"></p><div>

</div><!-- Field: Page; Sequence: 38; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->37<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"></p><div>

</div><table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="border-top: Black 1.5pt solid; width: 100%; padding-top: 2pt; padding-bottom: 2pt; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif"><b>enCore
    Energy Corp.</b></span></td></tr>
  <tr style="vertical-align: top">
    <td style="border-bottom: Black 1.5pt solid; padding-top: 2pt; padding-bottom: 2pt; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif"><b>Notes
    to the Consolidated Financial Statements</b></span></td></tr>
  <tr style="vertical-align: top">
    <td style="border-bottom: Black 1.5pt solid; padding-top: 2pt; padding-bottom: 2pt; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif"><b>For
    the years ended December 31, 2022 and December 31, 2021</b></span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif"><b>21.</b></span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b>Change
                                            in presentation currency (continued)</b></span></td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -18pt"><span style="font-family: Times New Roman, Times, Serif"><b>&#160;</b></span></p><div>

</div><ix:continuation continuedAt="_DisclosureOfReclassificationsOrChangesInPresentationExplanatory-c0_cont_5" id="_DisclosureOfReclassificationsOrChangesInPresentationExplanatory-c0_cont_4"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">For comparative purposes, the consolidated
statements of loss and comprehensive loss for the year ended December 31, 2021 includes adjustments to reflect the change in accounting
policy resulting from the change in presentation currency to the U.S. Dollar. The amounts previously reported in Canadian Dollars as shown
below have been translated into U.S. Dollars at the average 2021 exchange rate (Note 2). The effect of the translation is as follows:</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"></p></ix:continuation><div>
</div><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><ix:continuation id="_DisclosureOfReclassificationsOrChangesInPresentationExplanatory-c0_cont_5"><ix:nonNumeric contextRef="c0" escape="true" name="ifrs-full:DisclosureOfFinancialInstrumentsAtFairValueThroughProfitOrLossExplanatory"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">Previously
    reported (CAD$)</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">Translated
    (USD$)</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">Expenses</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: 0.125in; width: 76%"><span style="font-family: Times New Roman, Times, Serif">Accretion</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c261" decimals="0" format="ixt:num-dot-decimal" name="cve:Accretion" scale="0" unitRef="cad">502,291</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c262" decimals="0" format="ixt:num-dot-decimal" name="cve:Accretion" scale="0" unitRef="usd">408,181</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: 0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Amortization and depreciation</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c261" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:AdjustmentsForDepreciationAndAmortisationExpense" scale="0" unitRef="cad">374,455</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c262" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:AdjustmentsForDepreciationAndAmortisationExpense" scale="0" unitRef="usd">298,666</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: 0.125in"><span style="font-family: Times New Roman, Times, Serif">Consulting</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c261" decimals="0" format="ixt:num-dot-decimal" name="cve:Consulting" scale="0" unitRef="cad">91,161</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c262" decimals="0" format="ixt:num-dot-decimal" name="cve:Consulting" scale="0" unitRef="usd">72,726</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: 0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">General administrative costs</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c261" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:AdministrativeExpense" scale="0" unitRef="cad">4,429,209</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c262" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:AdministrativeExpense" scale="0" unitRef="usd">3,533,474</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: 0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Impairment charges</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c261" decimals="0" format="ixt:num-dot-decimal" name="cve:ImpairmentCharges" scale="0" unitRef="cad">98,345</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c262" decimals="0" format="ixt:num-dot-decimal" name="cve:ImpairmentCharges" scale="0" unitRef="usd">78,456</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: 0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Interest expense</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c261" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:InterestExpense" scale="0" unitRef="cad">9,365</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-333; font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: 0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Office and administrative</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c261" decimals="0" format="ixt:num-dot-decimal" name="cve:OfficeAndAdministrative" scale="0" unitRef="cad">247,433</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c262" decimals="0" format="ixt:num-dot-decimal" name="cve:OfficeAndAdministrative" scale="0" unitRef="usd">197,391</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: 0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Professional fees</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c261" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:ProfessionalFeesExpense" scale="0" unitRef="cad">728,793</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c262" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:ProfessionalFeesExpense" scale="0" unitRef="usd">581,408</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: 0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Promotion and shareholder communication</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c261" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:OtherExpenseByNature" scale="0" unitRef="cad">208,201</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c262" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:OtherExpenseByNature" scale="0" unitRef="usd">166,096</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: 0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Reclamation costs</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c261" decimals="0" format="ixt:num-dot-decimal" name="cve:ReclamationCosts" scale="0" unitRef="cad">889,154</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c262" decimals="0" format="ixt:num-dot-decimal" name="cve:ReclamationCosts" scale="0" unitRef="usd">709,399</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: 0.125in"><span style="font-family: Times New Roman, Times, Serif">Travel</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c261" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:TravelExpense" scale="0" unitRef="cad">33,355</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c262" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:TravelExpense" scale="0" unitRef="usd">26,609</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: 0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Transfer agent and filing fees</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c261" decimals="0" format="ixt:num-dot-decimal" name="cve:TransferAgentAndFilingFees" scale="0" unitRef="cad">167,612</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c262" decimals="0" format="ixt:num-dot-decimal" name="cve:TransferAgentAndFilingFees" scale="0" unitRef="usd">133,717</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: 0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Staff costs</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c261" decimals="0" format="ixt:num-dot-decimal" name="cve:StaffCosts" scale="0" unitRef="cad">1,983,446</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c262" decimals="0" format="ixt:num-dot-decimal" name="cve:StaffCosts" scale="0" unitRef="usd">1,582,326</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: 0.125in; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Stock option expense</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c261" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:StockOptionPlanExpense" scale="0" unitRef="cad">1,787,046</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c262" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:StockOptionPlanExpense" scale="0" unitRef="usd">1,425,645</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Loss from operating expenses</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction contextRef="c261" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:OtherOperatingIncomeExpense" scale="0" sign="-" unitRef="cad">11,549,866</ix:nonFraction></span></td><td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction contextRef="c262" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:OtherOperatingIncomeExpense" scale="0" sign="-" unitRef="usd">9,214,094</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: 0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Interest income</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c261" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:InterestRevenueExpense" scale="0" unitRef="cad">26,307</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c262" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:InterestRevenueExpense" scale="0" unitRef="usd">20,987</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: 0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Foreign exchange gain</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c261" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:ForeignExchangeGain" scale="0" unitRef="cad">34,174</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c262" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:ForeignExchangeGain" scale="0" unitRef="usd">27,263</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: 0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Loss on divestment of mineral properties</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction contextRef="c261" decimals="0" format="ixt:num-dot-decimal" name="cve:LossesOnDivestmentOfMineralProperties" scale="0" unitRef="cad">112,708</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction contextRef="c262" decimals="0" format="ixt:num-dot-decimal" name="cve:LossesOnDivestmentOfMineralProperties" scale="0" unitRef="usd">89,914</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: 0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Gain on change in asset retirement obligation
    estimate</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c261" decimals="0" format="ixt:num-dot-decimal" name="cve:GainOnChangeInAssetRetirementObligationEstimate" scale="0" unitRef="cad">2,155,949</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c262" decimals="0" format="ixt:num-dot-decimal" name="cve:GainOnChangeInAssetRetirementObligationEstimate" scale="0" unitRef="usd">1,719,943</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: 0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Loss on contract termination</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction contextRef="c261" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:LossOnContractTermination" scale="0" unitRef="cad">3,447,125</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction contextRef="c262" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:LossOnContractTermination" scale="0" unitRef="usd">2,750,000</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: 0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Unrealized gain on uranium investment</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c261" decimals="0" format="ixt:num-dot-decimal" name="cve:UnrealizedGainOnUraniumInvestment" scale="0" unitRef="cad">1,947,939</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c262" decimals="0" format="ixt:num-dot-decimal" name="cve:UnrealizedGainOnUraniumInvestment" scale="0" unitRef="usd">1,554,000</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: 0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Gain on sale of uranium investment</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c261" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:GainsOnDisposalsOfInvestmentProperties" scale="0" unitRef="cad">656,928</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c262" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:GainsOnDisposalsOfInvestmentProperties" scale="0" unitRef="usd">524,075</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: 0.125in; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Loss on investment in
    associate</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction contextRef="c261" decimals="0" format="ixt:num-dot-decimal" name="cve:LossOnInvestmentInAssociate" scale="0" unitRef="cad">445,914</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction contextRef="c262" decimals="0" format="ixt:num-dot-decimal" name="cve:LossOnInvestmentInAssociate" scale="0" unitRef="usd">355,735</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: 0.125in; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Net loss for the year</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction contextRef="c261" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:NetForeignExchangeLoss" scale="0" unitRef="cad">10,734,316</ix:nonFraction></span></td><td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction contextRef="c262" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:NetForeignExchangeLoss" scale="0" unitRef="usd">8,563,475</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: 0.125in; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Exchange differences
    on translation foreign operations</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c261" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:OtherComprehensiveIncomeBeforeTaxExchangeDifferencesOnTranslation" scale="0" unitRef="cad">206,082</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction contextRef="c262" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:OtherComprehensiveIncomeBeforeTaxExchangeDifferencesOnTranslation" scale="0" sign="-" unitRef="usd">1,325,855</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Other
    comprehensive loss for the year</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction contextRef="c261" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:ReversalOfImpairmentLossRecognisedInOtherComprehensiveIncome" scale="0" unitRef="cad">10,528,234</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction contextRef="c262" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:ReversalOfImpairmentLossRecognisedInOtherComprehensiveIncome" scale="0" unitRef="usd">9,889,330</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt"><span style="-sec-ix-hidden: hidden-fact-335; -sec-ix-hidden: hidden-fact-334; font-family: Times New Roman, Times, Serif">Loss per share - basic and diluted</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction contextRef="c261" decimals="2" format="ixt:num-dot-decimal" name="ifrs-full:BasicEarningsLossPerShare" scale="0" sign="-" unitRef="cadPershares">0.05</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction contextRef="c262" decimals="2" format="ixt:num-dot-decimal" name="ifrs-full:BasicEarningsLossPerShare" scale="0" sign="-" unitRef="usdPershares">0.13</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  </table></ix:nonNumeric></ix:continuation><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"></p><div>

</div><!-- Field: Page; Sequence: 39; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->38<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"></p><div>

</div><table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="border-top: Black 1.5pt solid; width: 100%; padding-top: 2pt; padding-bottom: 2pt; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif"><b>enCore
    Energy Corp.</b></span></td></tr>
  <tr style="vertical-align: top">
    <td style="border-bottom: Black 1.5pt solid; padding-top: 2pt; padding-bottom: 2pt; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif"><b>Notes
    to the Consolidated Financial Statements</b></span></td></tr>
  <tr style="vertical-align: top">
    <td style="border-bottom: Black 1.5pt solid; padding-top: 2pt; padding-bottom: 2pt; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif"><b>For
    the years ended December 31, 2022 and December 31, 2021</b></span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><ix:nonNumeric contextRef="c0" continuedAt="_DisclosureOfEventsAfterReportingPeriodExplanatory-c0_cont_1" escape="true" name="ifrs-full:DisclosureOfEventsAfterReportingPeriodExplanatory"><table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif"><b>22.</b></span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b>Events
                                            after the reporting period</b></span></td>
</tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b>&#160;</b></span></p></ix:nonNumeric><div>

</div><div>

</div><ix:continuation continuedAt="_DisclosureOfEventsAfterReportingPeriodExplanatory-c0_cont_2" id="_DisclosureOfEventsAfterReportingPeriodExplanatory-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Subsequent
to December 31, 2022, the following reportable events were completed:</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_DisclosureOfEventsAfterReportingPeriodExplanatory-c0_cont_3" id="_DisclosureOfEventsAfterReportingPeriodExplanatory-c0_cont_2"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%"><tr style="vertical-align: top">
<td style="width: 36pt"></td><td style="width: 18pt"><span style="font-family: Times New Roman, Times, Serif"><b>(a)</b></span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">On February 14<sup>th</sup>, the Company completed its acquisition of the Alta Mesa project, a fully-licensed and constructed ISR processing facility, from Energy Fuels, Inc. Consideration paid to Energy Fuels, Inc in the transaction consisted of $<ix:nonFraction contextRef="c263" decimals="0" format="ixt:num-dot-decimal" name="cve:TransactionCosts" scale="0" unitRef="usd">60,000,000</ix:nonFraction> in cash and a $<ix:nonFraction contextRef="c263" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:Cash" scale="0" unitRef="usd">60,000,000</ix:nonFraction> secured vendor take-back convertible promissory note. The note has a two year term and bears interest at a rate of <ix:nonFraction contextRef="c264" decimals="2" format="ixt:num-dot-decimal" name="ifrs-full:BorrowingsInterestRate" scale="-2" unitRef="pure">8</ix:nonFraction>% per annum payable on June 30<sup>th</sup> and December 31<sup>st </sup>of each year during the term. The note is convertible at the election of the holder, to acquire common shares of enCore at a price of US$<ix:nonFraction contextRef="c265" decimals="4" format="ixt:num-dot-decimal" name="cve:AcquireCommonShare" scale="0" unitRef="usd">2.9103</ix:nonFraction> per share.</span></td></tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54pt; text-align: justify; text-indent: -18pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_DisclosureOfEventsAfterReportingPeriodExplanatory-c0_cont_4" id="_DisclosureOfEventsAfterReportingPeriodExplanatory-c0_cont_3"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%"><tr style="vertical-align: top">
<td style="width: 36pt"></td><td style="width: 18pt"><span style="font-family: Times New Roman, Times, Serif"><b>(b)</b></span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">In connection with the closing of the Alta Mesa Acquisition, <ix:nonFraction contextRef="c266" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:SubscriptionCirculationRevenue" scale="0" unitRef="usd">23,277,000</ix:nonFraction> subscription receipts issued December 6, 2022 at a price of C$<ix:nonFraction contextRef="c267" decimals="2" format="ixt:num-dot-decimal" name="cve:Saleofstockpershare" scale="0" unitRef="cadPershares">3.00</ix:nonFraction> were automatically converted into units comprised of one common share of the Company and one common share purchase warrant, with each warrant entitling the holder to acquire one common share of enCore at a price of C$<ix:nonFraction contextRef="c267" decimals="2" format="ixt:num-dot-decimal" name="cve:PricePerShare" scale="0" unitRef="cadPershares">3.75</ix:nonFraction> for a period of three years. The net proceeds from the Subscription Receipt Offering of $<ix:nonFraction contextRef="c267" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:ProceedsFromDebtNetOfIssuanceCosts" scale="0" unitRef="usd">49,392,680</ix:nonFraction> (CAD $<ix:nonFraction contextRef="c267" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:ProceedsFromDebtNetOfIssuanceCosts" scale="0" unitRef="cad">66,072,588</ix:nonFraction>), have been released from escrow to the Company.</span></td></tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54pt; text-align: justify; text-indent: -18pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_DisclosureOfEventsAfterReportingPeriodExplanatory-c0_cont_5" id="_DisclosureOfEventsAfterReportingPeriodExplanatory-c0_cont_4"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">On
February 8, 2023, the Company issued <ix:nonFraction contextRef="c268" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:NumberOfSharesIssued" scale="0" unitRef="shares">10,615,650</ix:nonFraction> units for a public offering at a price of C$<ix:nonFraction contextRef="c269" decimals="2" format="ixt:num-dot-decimal" name="cve:PublicOfferingPricePerShare" scale="0" unitRef="cadPershares">3.25</ix:nonFraction> per unit for gross proceeds of C$<ix:nonFraction contextRef="c269" decimals="0" format="ixt:num-dot-decimal" name="cve:GrossProceed" scale="0" unitRef="cad">34,500,863</ix:nonFraction>.
Each unit consisted of one common share and one-half share purchase warrant. Each whole warrant entitles the holder to purchase one additional
share at a price of C$<ix:nonFraction contextRef="c270" decimals="2" format="ixt:num-dot-decimal" name="cve:PurchasePricePerShare" scale="0" unitRef="cadPershares">4.05</ix:nonFraction> for a period of three years.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_DisclosureOfEventsAfterReportingPeriodExplanatory-c0_cont_6" id="_DisclosureOfEventsAfterReportingPeriodExplanatory-c0_cont_5"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%"><tr style="vertical-align: top">
<td style="width: 36pt"></td><td style="width: 18pt"><span style="font-family: Times New Roman, Times, Serif"><b>(c)</b></span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Subsequent to the year ended December 31, 2022 the Company issued <ix:nonFraction contextRef="c271" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:NumberOfSharesIssued" scale="0" unitRef="shares">229,946</ix:nonFraction> shares pursuant to the exercise of stock options for gross proceeds of $<ix:nonFraction contextRef="c272" decimals="0" format="ixt:num-dot-decimal" name="cve:GrossProceed" scale="0" unitRef="cad">391,958</ix:nonFraction> CAD.</span></td></tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54pt; text-align: justify; text-indent: -18pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_DisclosureOfEventsAfterReportingPeriodExplanatory-c0_cont_7" id="_DisclosureOfEventsAfterReportingPeriodExplanatory-c0_cont_6"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Subsequent
to the year ended December 31, 2022 <ix:nonFraction contextRef="c273" decimals="0" format="ixt:num-dot-decimal" name="cve:StockOptionsSharesOutstanding" scale="0" unitRef="shares">75,312</ix:nonFraction> stock options outstanding at December 31, 2022 have expired.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_DisclosureOfEventsAfterReportingPeriodExplanatory-c0_cont_8" id="_DisclosureOfEventsAfterReportingPeriodExplanatory-c0_cont_7"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%"><tr style="vertical-align: top">
<td style="width: 36pt"></td><td style="width: 18pt"><span style="font-family: Times New Roman, Times, Serif"><b>(d)</b></span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Subsequent to the year ended December 31, 2022 the Company issued <ix:nonFraction contextRef="c274" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:NumberOfSharesIssued" scale="0" unitRef="shares">162,707</ix:nonFraction> shares pursuant to the exercise of warrants for gross proceeds of $<ix:nonFraction contextRef="c275" decimals="0" format="ixt:num-dot-decimal" name="cve:GrossProceed" scale="0" unitRef="cad">312,985</ix:nonFraction> CAD.</span></td></tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54pt; text-align: justify; text-indent: -18pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_DisclosureOfEventsAfterReportingPeriodExplanatory-c0_cont_9" id="_DisclosureOfEventsAfterReportingPeriodExplanatory-c0_cont_8"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%"><tr style="vertical-align: top">
<td style="width: 36pt"></td><td style="width: 18pt"><span style="font-family: Times New Roman, Times, Serif"><b>(e)</b></span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Subsequent to year ended December 31, 2022 the Company granted <ix:nonFraction contextRef="c276" decimals="0" format="ixt:num-dot-decimal" name="cve:GrantedStockOptions" scale="0" unitRef="shares">121,681</ix:nonFraction> stock options to employees at a weighted average exercise price of C$<ix:nonFraction contextRef="c276" decimals="2" format="ixt:num-dot-decimal" name="cve:WeightedAverageExercisePrice" scale="0" unitRef="cadPershares">2.91</ix:nonFraction></span></td></tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54pt; text-align: justify; text-indent: -18pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_DisclosureOfEventsAfterReportingPeriodExplanatory-c0_cont_10" id="_DisclosureOfEventsAfterReportingPeriodExplanatory-c0_cont_9"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%"><tr style="vertical-align: top">
<td style="width: 36pt"></td><td style="width: 18pt"><span style="font-family: Times New Roman, Times, Serif"><b>(f)</b></span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">On January 13<sup>th</sup>, 2023, the Company purchased <ix:nonFraction contextRef="c277" decimals="0" format="ixt:num-dot-decimal" name="cve:PurchasedShares" scale="0" unitRef="shares">100,000</ix:nonFraction> lbs of uranium for $<ix:nonFraction contextRef="c277" decimals="0" format="ixt:num-dot-decimal" name="cve:TransactionCost" scale="0" unitRef="usd">5,922,500</ix:nonFraction> in an arm&#8217;s length transaction.</span></td></tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54pt; text-align: justify; text-indent: -18pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_DisclosureOfEventsAfterReportingPeriodExplanatory-c0_cont_11" id="_DisclosureOfEventsAfterReportingPeriodExplanatory-c0_cont_10"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%"><tr style="vertical-align: top">
<td style="width: 36pt"></td><td style="width: 18pt"><span style="font-family: Times New Roman, Times, Serif"><b>(g)</b></span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">On January 16<sup>th</sup>, 2023, the Company completed the sale of <ix:nonFraction contextRef="c278" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:NumberOfSharesIssued" scale="0" unitRef="shares">100,000</ix:nonFraction> lbs of uranium for $<ix:nonFraction contextRef="c279" decimals="0" format="ixt:num-dot-decimal" name="cve:TransactionCost" scale="0" unitRef="usd">7,050,000</ix:nonFraction> to the United States Department of Energy, National Nuclear Security Administration.</span></td></tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54pt; text-align: justify; text-indent: -18pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_DisclosureOfEventsAfterReportingPeriodExplanatory-c0_cont_12" id="_DisclosureOfEventsAfterReportingPeriodExplanatory-c0_cont_11"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%"><tr style="vertical-align: top">
<td style="width: 36pt"></td><td style="width: 18pt"><span style="font-family: Times New Roman, Times, Serif"><b>(h)</b></span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">In February of 2023, the Company secured an additional sales contract with a Fortune 500 listed United States Utility. The agreement commences in 2027 and covers firm deliveries of <ix:nonFraction contextRef="c280" decimals="0" format="ixt:num-dot-decimal" name="cve:PurchaseAgreementsAmount" scale="0" unitRef="usd">650,000</ix:nonFraction> pounds of uranium with an option to acquire up to <ix:nonFraction contextRef="c280" decimals="0" format="ixt:num-dot-decimal" name="cve:OptionToAcquireShares" scale="0" unitRef="shares">400,000</ix:nonFraction> additional pounds under a two-year extended term. The agreement is based on market pricing with a floor price and an inflation adjusted ceiling price.</span></td></tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54pt; text-align: justify; text-indent: -18pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_DisclosureOfEventsAfterReportingPeriodExplanatory-c0_cont_13" id="_DisclosureOfEventsAfterReportingPeriodExplanatory-c0_cont_12"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%"><tr style="vertical-align: top">
<td style="width: 36pt"></td><td style="width: 18pt"><span style="font-family: Times New Roman, Times, Serif"><b>(i)</b></span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">In March of 2023, the Company completed its purchase of <ix:nonFraction contextRef="c281" decimals="0" format="ixt:num-dot-decimal" name="cve:PurchasedShares" scale="0" unitRef="shares">200,000</ix:nonFraction> pounds of uranium concentrate from an arm&#8217;s length party for total consideration of $<ix:nonFraction contextRef="c281" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:ConsiderationPaidReceived" scale="0" unitRef="usd">8,750,000</ix:nonFraction> ($<ix:nonFraction contextRef="c281" decimals="2" format="ixt:num-dot-decimal" name="cve:TotalConsiderationPerPounds" scale="0" unitRef="usdPershares">43.75</ix:nonFraction>/pound). The contract required an initial payment of $<ix:nonFraction contextRef="c65" decimals="0" format="ixt:num-dot-decimal" name="cve:InitialPayment" scale="0" unitRef="usd">2,000,000</ix:nonFraction>, which was paid in March 2022, and final payment of $<ix:nonFraction contextRef="c65" decimals="0" format="ixt:num-dot-decimal" name="cve:PaymentAmount" scale="0" unitRef="usd">6,750,000</ix:nonFraction> paid in March 2023.</span></td></tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54pt; text-align: justify; text-indent: -18pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_DisclosureOfEventsAfterReportingPeriodExplanatory-c0_cont_14" id="_DisclosureOfEventsAfterReportingPeriodExplanatory-c0_cont_13"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%"><tr style="vertical-align: top">
<td style="width: 36pt"></td><td style="width: 18pt"><span style="font-family: Times New Roman, Times, Serif"><b>(j)</b></span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">In April of 2023, the Company completed the sale of <ix:nonFraction contextRef="c282" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:NumberOfSharesIssued" scale="0" unitRef="shares">200,000</ix:nonFraction> lbs of uranium pursuant to a sales contract with UG USA,&#160;Inc. (Note 13) for gross proceeds of $<ix:nonFraction contextRef="c283" decimals="0" format="ixt:num-dot-decimal" name="cve:GrossProceed" scale="0" unitRef="usd">9,660,000</ix:nonFraction>.</span></td></tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54pt; text-align: justify; text-indent: -18pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p></ix:continuation><div>

</div><div>

</div><ix:continuation id="_DisclosureOfEventsAfterReportingPeriodExplanatory-c0_cont_14"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%"><tr style="vertical-align: top">
<td style="width: 36pt"></td><td style="width: 18pt"><span style="font-family: Times New Roman, Times, Serif"><b>(k)</b></span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">In March of 2023, the Company completed its divestment of Belt Line Resources, Inc and Hydro Restoration Corporation, which held the Company&#8217;s Moonshine, Bootheel, and Kaycee projects (Note 11). In return for these assets the Company received <ix:nonFraction contextRef="c281" decimals="3" format="ixt:num-dot-decimal" name="cve:AssetsReceivedPercentage" scale="-2" unitRef="pure">19.9</ix:nonFraction>% of Nuclear Fuels, Inc.</span></td></tr></table></ix:continuation><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54pt; text-align: justify; text-indent: -18pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif">F-39&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"></p><div>

</div><!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><div style="font-size: 1pt; border-top: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></div></div><!-- Field: /Rule-Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><div style="display: none"><ix:header>
<ix:hidden>
<ix:nonFraction contextRef="c3" id="hidden-fact-0" name="cve:MarketableSecuritiecurrent" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c4" id="hidden-fact-1" name="cve:MarketableSecuritiecurrent" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c3" id="hidden-fact-2" name="cve:DepositUraniumInvestment" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c4" id="hidden-fact-3" name="cve:DepositUraniumInvestment" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c4" id="hidden-fact-4" name="ifrs-full:NoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSaleOrAsHeldForDistributionToOwners" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c2" id="hidden-fact-5" name="ifrs-full:InvestmentsInAssociates" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c2" id="hidden-fact-6" name="ifrs-full:InvestmentsInSubsidiariesJointVenturesAndAssociates" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c4" id="hidden-fact-7" name="ifrs-full:InvestmentsInSubsidiariesJointVenturesAndAssociates" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c3" id="hidden-fact-8" name="cve:MarketablesSecuritiesNoncurrent" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c4" id="hidden-fact-9" name="cve:MarketablesSecuritiesNoncurrent" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c3" id="hidden-fact-10" name="ifrs-full:DeferredTaxAssets" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c4" id="hidden-fact-11" name="ifrs-full:DeferredTaxAssets" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c3" id="hidden-fact-12" name="ifrs-full:NoncurrentFinancialAssets" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c4" id="hidden-fact-13" name="ifrs-full:NoncurrentFinancialAssets" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c2" id="hidden-fact-14" name="ifrs-full:OtherCurrentPayables" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c3" id="hidden-fact-15" name="ifrs-full:OtherCurrentPayables" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c3" id="hidden-fact-16" name="ifrs-full:SharePremium" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c4" id="hidden-fact-17" name="ifrs-full:SharePremium" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c5" id="hidden-fact-18" name="cve:CommunityEngagement" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c0" id="hidden-fact-19" name="ifrs-full:ImpairmentLossImpairmentGainAndReversalOfImpairmentLossDeterminedInAccordanceWithIFRS9" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c5" id="hidden-fact-20" name="ifrs-full:InterestExpense" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c5" id="hidden-fact-21" name="cve:ProjectInvestigationFess" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c0" id="hidden-fact-22" name="ifrs-full:ReclassificationAdjustmentsOnChangeInValueOfForwardElementsOfForwardContractsNetOfTax" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c5" decimals="2" id="hidden-fact-23" name="ifrs-full:DilutedEarningsLossPerShare" sign="-" unitRef="usdPershares">0.13</ix:nonFraction>
<ix:nonFraction contextRef="c0" decimals="2" id="hidden-fact-24" name="ifrs-full:DilutedEarningsLossPerShare" sign="-" unitRef="usdPershares">0.16</ix:nonFraction>
<ix:nonFraction contextRef="c8" id="hidden-fact-25" name="ifrs-full:Equity" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c13" id="hidden-fact-26" name="cve:PrivatePlacement" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c14" id="hidden-fact-27" name="cve:PrivatePlacement" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c15" id="hidden-fact-28" name="cve:PrivatePlacement" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c16" id="hidden-fact-29" name="cve:PrivatePlacement" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c13" id="hidden-fact-30" name="ifrs-full:ShareIssueRelatedCost" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c15" id="hidden-fact-31" name="ifrs-full:ShareIssueRelatedCost" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c16" id="hidden-fact-32" name="ifrs-full:ShareIssueRelatedCost" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c13" id="hidden-fact-33" name="ifrs-full:IncreaseDecreaseThroughExerciseOfWarrantsEquity" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c15" id="hidden-fact-34" name="ifrs-full:IncreaseDecreaseThroughExerciseOfWarrantsEquity" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c16" id="hidden-fact-35" name="ifrs-full:IncreaseDecreaseThroughExerciseOfWarrantsEquity" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c13" id="hidden-fact-36" name="ifrs-full:IncreaseDecreaseThroughExerciseOfOptions" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c15" id="hidden-fact-37" name="ifrs-full:IncreaseDecreaseThroughExerciseOfOptions" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c16" id="hidden-fact-38" name="ifrs-full:IncreaseDecreaseThroughExerciseOfOptions" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c12" id="hidden-fact-39" name="cve:StockOptionExpense" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c13" id="hidden-fact-40" name="cve:StockOptionExpense" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c15" id="hidden-fact-41" name="cve:StockOptionExpense" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c16" id="hidden-fact-42" name="cve:StockOptionExpense" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c13" id="hidden-fact-43" name="cve:SharesIssuedForAzargaAssetAcquisition" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c14" id="hidden-fact-44" name="cve:SharesIssuedForAzargaAssetAcquisition" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c15" id="hidden-fact-45" name="cve:SharesIssuedForAzargaAssetAcquisition" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c16" id="hidden-fact-46" name="cve:SharesIssuedForAzargaAssetAcquisition" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c12" id="hidden-fact-47" name="cve:ReplacementOptionsForAzargaAssetAcquisition" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c13" id="hidden-fact-48" name="cve:ReplacementOptionsForAzargaAssetAcquisition" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c15" id="hidden-fact-49" name="cve:ReplacementOptionsForAzargaAssetAcquisition" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c16" id="hidden-fact-50" name="cve:ReplacementOptionsForAzargaAssetAcquisition" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c12" id="hidden-fact-51" name="cve:ReplacementWarrantsForAzargaAssetAcquisition" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c13" id="hidden-fact-52" name="cve:ReplacementWarrantsForAzargaAssetAcquisition" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c15" id="hidden-fact-53" name="cve:ReplacementWarrantsForAzargaAssetAcquisition" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c16" id="hidden-fact-54" name="cve:ReplacementWarrantsForAzargaAssetAcquisition" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c12" id="hidden-fact-55" name="cve:AdjustmentToInvestmentInAssociate" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c13" id="hidden-fact-56" name="cve:AdjustmentToInvestmentInAssociate" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c15" id="hidden-fact-57" name="cve:AdjustmentToInvestmentInAssociate" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c16" id="hidden-fact-58" name="cve:AdjustmentToInvestmentInAssociate" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c12" id="hidden-fact-59" name="ifrs-full:GainsLossesOnExchangeDifferencesOnTranslationNetOfTax" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c13" id="hidden-fact-60" name="ifrs-full:GainsLossesOnExchangeDifferencesOnTranslationNetOfTax" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c14" id="hidden-fact-61" name="ifrs-full:GainsLossesOnExchangeDifferencesOnTranslationNetOfTax" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c16" id="hidden-fact-62" name="ifrs-full:GainsLossesOnExchangeDifferencesOnTranslationNetOfTax" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c12" id="hidden-fact-63" name="ifrs-full:ProfitLoss" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c13" id="hidden-fact-64" name="ifrs-full:ProfitLoss" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c14" id="hidden-fact-65" name="ifrs-full:ProfitLoss" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c15" id="hidden-fact-66" name="ifrs-full:ProfitLoss" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c18" id="hidden-fact-67" name="ifrs-full:Equity" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c18" id="hidden-fact-68" name="ifrs-full:Equity" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c23" id="hidden-fact-69" name="cve:PrivatePlacement" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c24" id="hidden-fact-70" name="cve:PrivatePlacement" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c25" id="hidden-fact-71" name="cve:PrivatePlacement" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c26" id="hidden-fact-72" name="cve:PrivatePlacement" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c23" id="hidden-fact-73" name="ifrs-full:ShareIssueRelatedCost" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c25" id="hidden-fact-74" name="ifrs-full:ShareIssueRelatedCost" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c26" id="hidden-fact-75" name="ifrs-full:ShareIssueRelatedCost" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c23" id="hidden-fact-76" name="ifrs-full:IncreaseDecreaseThroughExerciseOfWarrantsEquity" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c25" id="hidden-fact-77" name="ifrs-full:IncreaseDecreaseThroughExerciseOfWarrantsEquity" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c26" id="hidden-fact-78" name="ifrs-full:IncreaseDecreaseThroughExerciseOfWarrantsEquity" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c23" id="hidden-fact-79" name="ifrs-full:IncreaseDecreaseThroughExerciseOfOptions" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c25" id="hidden-fact-80" name="ifrs-full:IncreaseDecreaseThroughExerciseOfOptions" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c26" id="hidden-fact-81" name="ifrs-full:IncreaseDecreaseThroughExerciseOfOptions" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c22" id="hidden-fact-82" name="cve:StockOptionExpense" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c23" id="hidden-fact-83" name="cve:StockOptionExpense" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c25" id="hidden-fact-84" name="cve:StockOptionExpense" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c26" id="hidden-fact-85" name="cve:StockOptionExpense" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c23" id="hidden-fact-86" name="ifrs-full:IssueOfEquity" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c24" id="hidden-fact-87" name="ifrs-full:IssueOfEquity" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c25" id="hidden-fact-88" name="ifrs-full:IssueOfEquity" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c26" id="hidden-fact-89" name="ifrs-full:IssueOfEquity" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c22" id="hidden-fact-90" name="cve:ShareSubscriptionsReceived" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c24" id="hidden-fact-91" name="cve:ShareSubscriptionsReceived" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c25" id="hidden-fact-92" name="cve:ShareSubscriptionsReceived" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c26" id="hidden-fact-93" name="cve:ShareSubscriptionsReceived" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c22" id="hidden-fact-94" name="cve:AdjustmentToInvestmentInAssociate" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c23" id="hidden-fact-95" name="cve:AdjustmentToInvestmentInAssociate" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c25" id="hidden-fact-96" name="cve:AdjustmentToInvestmentInAssociate" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c26" id="hidden-fact-97" name="cve:AdjustmentToInvestmentInAssociate" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c22" id="hidden-fact-98" name="ifrs-full:GainsLossesOnExchangeDifferencesOnTranslationNetOfTax" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c23" id="hidden-fact-99" name="ifrs-full:GainsLossesOnExchangeDifferencesOnTranslationNetOfTax" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c24" id="hidden-fact-100" name="ifrs-full:GainsLossesOnExchangeDifferencesOnTranslationNetOfTax" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c26" id="hidden-fact-101" name="ifrs-full:GainsLossesOnExchangeDifferencesOnTranslationNetOfTax" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c22" id="hidden-fact-102" name="ifrs-full:ProfitLoss" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c23" id="hidden-fact-103" name="ifrs-full:ProfitLoss" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c24" id="hidden-fact-104" name="ifrs-full:ProfitLoss" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c25" id="hidden-fact-105" name="ifrs-full:ProfitLoss" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c5" id="hidden-fact-106" name="cve:OtherRevenuesCurrent" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c5" id="hidden-fact-107" name="cve:ExpensesCurrent" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c3" id="hidden-fact-108" name="ifrs-full:OtherNoncurrentLiabilities" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c5" id="hidden-fact-109" name="cve:OtherRevenuesNoncurrent" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c5" id="hidden-fact-110" name="cve:ExpensesNoncurrent" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c3" id="hidden-fact-111" name="cve:AssetsLossFromOperatingExpenses" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c5" id="hidden-fact-112" name="cve:LiabilitiesLossFromOperatingExpenses" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c5" id="hidden-fact-113" name="cve:RevenuesLossFromOperatingExpenses" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c5" id="hidden-fact-114" name="ifrs-full:OtherRevenue" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c0" id="hidden-fact-115" name="cve:OtherRevenuesCurrent" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c0" id="hidden-fact-116" name="cve:ExpensesCurrent" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c2" id="hidden-fact-117" name="ifrs-full:OtherNoncurrentLiabilities" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c0" id="hidden-fact-118" name="cve:OtherRevenuesNoncurrent" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c0" id="hidden-fact-119" name="cve:ExpensesNoncurrent" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c2" id="hidden-fact-120" name="cve:AssetsLossFromOperatingExpenses" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c0" id="hidden-fact-121" name="cve:LiabilitiesLossFromOperatingExpenses" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c0" id="hidden-fact-122" name="cve:RevenuesLossFromOperatingExpenses" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c0" id="hidden-fact-123" name="ifrs-full:OtherRevenue" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c6" id="hidden-fact-124" name="ifrs-full:CurrentInvestments" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c0" id="hidden-fact-125" name="ifrs-full:OtherComprehensiveIncomeNetOfTaxChangeInValueOfForeignCurrencyBasisSpreads" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c2" id="hidden-fact-126" name="ifrs-full:CurrentInvestments" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c72" id="hidden-fact-127" name="cve:PurchaseCommitments" unitRef="gbp" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c72" id="hidden-fact-128" name="cve:TotalPurchasePrice" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c73" id="hidden-fact-129" name="cve:PurchaseCommitments" unitRef="gbp" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c73" id="hidden-fact-130" name="cve:TotalPurchasePrice" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c74" id="hidden-fact-131" name="cve:PurchaseCommitments" unitRef="gbp" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c74" id="hidden-fact-132" name="cve:TotalPurchasePrice" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c75" id="hidden-fact-133" name="cve:PurchaseCommitments" unitRef="gbp" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c75" id="hidden-fact-134" name="cve:TotalPurchasePrice" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c82" id="hidden-fact-135" name="cve:MarketablesSecurities" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c83" id="hidden-fact-136" name="cve:MarketablesSecurities" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c3" id="hidden-fact-137" name="cve:MarketablesSecurities" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c109" id="hidden-fact-138" name="ifrs-full:PropertyPlantAndEquipmentCarryingAmountAtCostOfRevaluedAssets" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c110" id="hidden-fact-139" name="ifrs-full:PropertyPlantAndEquipmentCarryingAmountAtCostOfRevaluedAssets" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c111" id="hidden-fact-140" name="ifrs-full:PropertyPlantAndEquipmentCarryingAmountAtCostOfRevaluedAssets" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c113" id="hidden-fact-141" name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c116" id="hidden-fact-142" name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c112" id="hidden-fact-143" name="ifrs-full:DisposalsInvestmentProperty" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c113" id="hidden-fact-144" name="ifrs-full:DisposalsInvestmentProperty" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c114" id="hidden-fact-145" name="ifrs-full:DisposalsInvestmentProperty" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c115" id="hidden-fact-146" name="ifrs-full:DisposalsInvestmentProperty" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c116" id="hidden-fact-147" name="ifrs-full:DisposalsInvestmentProperty" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c5" id="hidden-fact-148" name="ifrs-full:DisposalsInvestmentProperty" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c115" id="hidden-fact-149" name="ifrs-full:DepreciationExpense" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c116" id="hidden-fact-150" name="ifrs-full:DepreciationExpense" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c112" id="hidden-fact-151" name="ifrs-full:ImpairmentLoss" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c113" id="hidden-fact-152" name="ifrs-full:ImpairmentLoss" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c114" id="hidden-fact-153" name="ifrs-full:ImpairmentLoss" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c115" id="hidden-fact-154" name="ifrs-full:ImpairmentLoss" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c116" id="hidden-fact-155" name="ifrs-full:ImpairmentLoss" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c5" id="hidden-fact-156" name="ifrs-full:ImpairmentLoss" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c112" id="hidden-fact-157" name="ifrs-full:OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c113" id="hidden-fact-158" name="ifrs-full:OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c115" id="hidden-fact-159" name="ifrs-full:OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c116" id="hidden-fact-160" name="ifrs-full:OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c121" id="hidden-fact-161" name="ifrs-full:PropertyPlantAndEquipmentCarryingAmountAtCostOfRevaluedAssets" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c125" id="hidden-fact-162" name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c122" id="hidden-fact-163" name="ifrs-full:DisposalsInvestmentProperty" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c123" id="hidden-fact-164" name="ifrs-full:DisposalsInvestmentProperty" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c124" id="hidden-fact-165" name="ifrs-full:DisposalsInvestmentProperty" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c125" id="hidden-fact-166" name="ifrs-full:DisposalsInvestmentProperty" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c126" id="hidden-fact-167" name="ifrs-full:DisposalsInvestmentProperty" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c0" id="hidden-fact-168" name="ifrs-full:DisposalsInvestmentProperty" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c122" id="hidden-fact-169" name="ifrs-full:ImpairmentLoss" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c123" id="hidden-fact-170" name="ifrs-full:ImpairmentLoss" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c124" id="hidden-fact-171" name="ifrs-full:ImpairmentLoss" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c125" id="hidden-fact-172" name="ifrs-full:ImpairmentLoss" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c126" id="hidden-fact-173" name="ifrs-full:ImpairmentLoss" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c0" id="hidden-fact-174" name="ifrs-full:ImpairmentLoss" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c122" id="hidden-fact-175" name="ifrs-full:OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c123" id="hidden-fact-176" name="ifrs-full:OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c124" id="hidden-fact-177" name="ifrs-full:OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c125" id="hidden-fact-178" name="ifrs-full:OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c126" id="hidden-fact-179" name="ifrs-full:OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c0" id="hidden-fact-180" name="ifrs-full:OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c135" id="hidden-fact-181" name="cve:Right-of-UseAssetsBalance" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c136" id="hidden-fact-182" name="cve:Right-of-UseAssetsAdditions" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c136" id="hidden-fact-183" name="cve:Right-of-UseAssetsCurrencyTranslationAdjustment" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c140" id="hidden-fact-184" name="cve:Right-of-UseAssetsAdditions" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c140" id="hidden-fact-185" name="cve:Right-of-UseAssetsCurrencyTranslationAdjustment" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c142" id="hidden-fact-186" name="cve:Right-of-UseAssetsBalance" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c135" id="hidden-fact-187" name="cve:Long-TermLeaseLiabilityBalance" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c136" id="hidden-fact-188" name="cve:Long-TermLeaseLiabilityAdditions" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c136" id="hidden-fact-189" name="cve:Long-TermLeaseLiabilityAccretion" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c136" id="hidden-fact-190" name="cve:Long-TermLeaseLiabilityCurrencyTranslationAdjustment" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c140" id="hidden-fact-191" name="cve:Long-TermLeaseLiabilityAdditions" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c140" id="hidden-fact-192" name="cve:Long-TermLeaseLiabilityCurrencyTranslationAdjustment" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c142" id="hidden-fact-193" name="cve:Long-TermLeaseLiabilityBalance" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c140" id="hidden-fact-194" name="cve:Long-TermLeaseLiabilityLessCurrentLeaseLiability" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c142" id="hidden-fact-195" name="ifrs-full:LongtermProvisionForDecommissioningRestorationAndRehabilitationCosts" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c174" id="hidden-fact-196" name="ifrs-full:MiningAssets" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c176" id="hidden-fact-197" name="ifrs-full:MiningAssets" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c177" id="hidden-fact-198" name="ifrs-full:MiningAssets" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c180" id="hidden-fact-199" name="ifrs-full:MiningAssets" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c181" id="hidden-fact-200" name="cve:AssetAcquistion" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c183" id="hidden-fact-201" name="cve:AssetAcquistion" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c185" id="hidden-fact-202" name="cve:AssetAcquistion" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c182" id="hidden-fact-203" name="cve:MaintenancesAndLeaseFees" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c184" id="hidden-fact-204" name="cve:MaintenancesAndLeaseFees" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c182" id="hidden-fact-205" name="cve:ResourceReview" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c184" id="hidden-fact-206" name="cve:ResourceReview" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c185" id="hidden-fact-207" name="cve:ResourceReview" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c186" id="hidden-fact-208" name="cve:ResourceReview" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c187" id="hidden-fact-209" name="cve:ResourceReview" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c181" id="hidden-fact-210" name="cve:ImpairmentCharged" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c182" id="hidden-fact-211" name="cve:ImpairmentCharged" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c183" id="hidden-fact-212" name="cve:ImpairmentCharged" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c184" id="hidden-fact-213" name="cve:ImpairmentCharged" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c185" id="hidden-fact-214" name="cve:ImpairmentCharged" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c186" id="hidden-fact-215" name="cve:ImpairmentCharged" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c187" id="hidden-fact-216" name="cve:ImpairmentCharged" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c181" id="hidden-fact-217" name="cve:DivestMineralInterest" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c182" id="hidden-fact-218" name="cve:DivestMineralInterest" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c183" id="hidden-fact-219" name="cve:DivestMineralInterest" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c184" id="hidden-fact-220" name="cve:DivestMineralInterest" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c185" id="hidden-fact-221" name="cve:DivestMineralInterest" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c187" id="hidden-fact-222" name="cve:DivestMineralInterest" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c181" id="hidden-fact-223" name="cve:AssetsHeldForSale" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c182" id="hidden-fact-224" name="cve:AssetsHeldForSale" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c184" id="hidden-fact-225" name="cve:AssetsHeldForSale" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c185" id="hidden-fact-226" name="cve:AssetsHeldForSale" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c186" id="hidden-fact-227" name="cve:AssetsHeldForSale" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c187" id="hidden-fact-228" name="cve:AssetsHeldForSale" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c196" id="hidden-fact-229" name="ifrs-full:MiningAssets" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c197" id="hidden-fact-230" name="cve:Drilling" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c198" id="hidden-fact-231" name="cve:Drilling" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c199" id="hidden-fact-232" name="cve:Drilling" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c200" id="hidden-fact-233" name="cve:Drilling" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c202" id="hidden-fact-234" name="cve:Drilling" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c203" id="hidden-fact-235" name="cve:Drilling" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c198" id="hidden-fact-236" name="cve:MaintenancesAndLeaseFees" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c200" id="hidden-fact-237" name="cve:MaintenancesAndLeaseFees" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c197" id="hidden-fact-238" name="cve:PermittingLicensing" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c199" id="hidden-fact-239" name="cve:PermittingLicensing" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c199" id="hidden-fact-240" name="cve:Personnel" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c197" id="hidden-fact-241" name="cve:Recoveries" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c199" id="hidden-fact-242" name="cve:Recoveries" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c200" id="hidden-fact-243" name="cve:Recoveries" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c201" id="hidden-fact-244" name="cve:Recoveries" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c203" id="hidden-fact-245" name="cve:Recoveries" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c198" id="hidden-fact-246" name="cve:ResourceReview" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c200" id="hidden-fact-247" name="cve:ResourceReview" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c205" id="hidden-fact-248" name="cve:DivestMineralInterest" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c206" id="hidden-fact-249" name="cve:DivestMineralInterest" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c207" id="hidden-fact-250" name="cve:DivestMineralInterest" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c208" id="hidden-fact-251" name="cve:DivestMineralInterest" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c209" id="hidden-fact-252" name="cve:DivestMineralInterest" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c211" id="hidden-fact-253" name="cve:DivestMineralInterest" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c206" id="hidden-fact-254" name="cve:AssetsHeldForSale" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c207" id="hidden-fact-255" name="cve:AssetsHeldForSale" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c208" id="hidden-fact-256" name="cve:AssetsHeldForSale" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c209" id="hidden-fact-257" name="cve:AssetsHeldForSale" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c210" id="hidden-fact-258" name="cve:AssetsHeldForSale" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c205" id="hidden-fact-259" name="cve:ConstructionOfWellfields" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c206" id="hidden-fact-260" name="cve:ConstructionOfWellfields" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c207" id="hidden-fact-261" name="cve:ConstructionOfWellfields" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c208" id="hidden-fact-262" name="cve:ConstructionOfWellfields" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c210" id="hidden-fact-263" name="cve:ConstructionOfWellfields" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c211" id="hidden-fact-264" name="cve:ConstructionOfWellfields" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c205" id="hidden-fact-265" name="cve:Drilling" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c206" id="hidden-fact-266" name="cve:Drilling" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c207" id="hidden-fact-267" name="cve:Drilling" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c208" id="hidden-fact-268" name="cve:Drilling" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c210" id="hidden-fact-269" name="cve:Drilling" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c211" id="hidden-fact-270" name="cve:Drilling" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c205" id="hidden-fact-271" name="cve:Personnel" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c206" id="hidden-fact-272" name="cve:Personnel" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c207" id="hidden-fact-273" name="cve:Personnel" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c208" id="hidden-fact-274" name="cve:Personnel" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c210" id="hidden-fact-275" name="cve:Personnel" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c211" id="hidden-fact-276" name="cve:Personnel" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c219" id="hidden-fact-277" name="ifrs-full:MiningAssets" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c0" id="hidden-fact-278" name="ifrs-full:ReceiptsFromRoyaltiesFeesCommissionsAndOtherRevenue" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c5" id="hidden-fact-279" name="ifrs-full:ReceiptsFromRoyaltiesFeesCommissionsAndOtherRevenue" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c0" decimals="1" id="hidden-fact-280" name="cve:PurchaseWarrantShares" unitRef="shares">0.5</ix:nonFraction>
<ix:nonFraction contextRef="c5" decimals="1" id="hidden-fact-281" name="cve:PurchaseWarrantShares" unitRef="shares">0.5</ix:nonFraction>
<ix:nonFraction contextRef="c0" decimals="1" id="hidden-fact-282" name="cve:WarrantShare" unitRef="shares">0.5</ix:nonFraction>
<ix:nonFraction contextRef="c5" id="hidden-fact-283" name="ifrs-full:AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c5" id="hidden-fact-284" name="ifrs-full:DirectorsRemunerationExpense" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c0" id="hidden-fact-285" name="cve:OfficeAndAdministration" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c252" id="hidden-fact-286" name="ifrs-full:AmountsPayableRelatedPartyTransactions" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c3" id="hidden-fact-287" name="us-gaap:MarketableSecurities" unitRef="cad" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c5" id="hidden-fact-288" name="cve:ImpactedLoss" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c192" id="hidden-fact-289" name="cve:IntangibleAssets" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c195" id="hidden-fact-290" name="cve:IntangibleAssets" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c196" id="hidden-fact-291" name="cve:IntangibleAssets" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c191" id="hidden-fact-292" name="cve:PropertyPlantAndEquipments" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c195" id="hidden-fact-293" name="cve:PropertyPlantAndEquipments" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c255" id="hidden-fact-294" name="cve:PropertyPlantAndEquipments" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c196" id="hidden-fact-295" name="cve:PropertyPlantAndEquipments" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c196" id="hidden-fact-296" name="cve:MineralProperties" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c192" id="hidden-fact-297" name="cve:RightofuseAssets1" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c191" id="hidden-fact-298" name="cve:RightofuseAssets1" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c195" id="hidden-fact-299" name="cve:RightofuseAssets1" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c255" id="hidden-fact-300" name="cve:RightofuseAssets1" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c215" id="hidden-fact-301" name="cve:IntangibleAssets" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c218" id="hidden-fact-302" name="cve:IntangibleAssets" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c219" id="hidden-fact-303" name="cve:IntangibleAssets" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c214" id="hidden-fact-304" name="cve:PropertyPlantAndEquipments" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c218" id="hidden-fact-305" name="cve:PropertyPlantAndEquipments" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c256" id="hidden-fact-306" name="cve:PropertyPlantAndEquipments" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c219" id="hidden-fact-307" name="cve:PropertyPlantAndEquipments" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c219" id="hidden-fact-308" name="cve:MineralProperties" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c215" id="hidden-fact-309" name="cve:RightofuseAssets1" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c214" id="hidden-fact-310" name="cve:RightofuseAssets1" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c218" id="hidden-fact-311" name="cve:RightofuseAssets1" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c256" id="hidden-fact-312" name="cve:RightofuseAssets1" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c3" id="hidden-fact-313" name="ifrs-full:CurrentAccruedExpensesAndOtherCurrentLiabilities" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c3" id="hidden-fact-314" name="cve:TotalNoncashFinancingActivities" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c3" id="hidden-fact-315" name="cve:MarketableSecuritieReceivedOnDispositionOfMineralProperties" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c3" id="hidden-fact-316" name="ifrs-full:LiabilitiesArisingFromExplorationForAndEvaluationOfMineralResources" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c3" id="hidden-fact-317" name="cve:PropertyPlantAndEquipmentAdditionIncludedInAccountsPayableAndAccruedLiabilities" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c2" id="hidden-fact-318" name="cve:FairValueOfCommonSharesIssuedForAzargaAssetAcquisition" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c2" id="hidden-fact-319" name="cve:FairValueOfReplacementOptionsIssuedForAzargaAssetsAcquisition" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c2" id="hidden-fact-320" name="cve:FairValueOfReplacementWarrantsIssuedForAzargaAssetAcquisition" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c5" id="hidden-fact-321" name="cve:ShareIssueCosts" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c5" id="hidden-fact-322" name="ifrs-full:AdjustmentsForCurrentTaxOfPriorPeriod" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c0" id="hidden-fact-323" name="ifrs-full:IncomeTaxExpenseContinuingOperations" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c5" id="hidden-fact-324" name="ifrs-full:IncomeTaxExpenseContinuingOperations" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c0" id="hidden-fact-325" name="ifrs-full:IncomeTaxExpenseContinuingOperations" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c5" id="hidden-fact-326" name="ifrs-full:IncomeTaxExpenseContinuingOperations" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c2" id="hidden-fact-327" name="ifrs-full:NetDeferredTaxAssets" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c3" id="hidden-fact-328" name="ifrs-full:NetDeferredTaxAssets" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c3" id="hidden-fact-329" name="ifrs-full:OtherIntangibleAssets" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c3" id="hidden-fact-330" name="ifrs-full:RightofuseAssetsRevaluationSurplus" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c2" id="hidden-fact-331" name="ifrs-full:NetDeferredTaxAssets" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c3" id="hidden-fact-332" name="ifrs-full:NetDeferredTaxAssets" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c262" id="hidden-fact-333" name="ifrs-full:InterestExpense" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c261" decimals="2" id="hidden-fact-334" name="ifrs-full:DilutedEarningsLossPerShare" sign="-" unitRef="cadPershares">0.05</ix:nonFraction>
<ix:nonFraction contextRef="c262" decimals="2" id="hidden-fact-335" name="ifrs-full:DilutedEarningsLossPerShare" sign="-" unitRef="usdPershares">0.13</ix:nonFraction>
<ix:nonNumeric contextRef="c0" name="dei:AmendmentFlag">false</ix:nonNumeric>
<ix:nonNumeric contextRef="c0" name="dei:DocumentFiscalPeriodFocus">FY</ix:nonNumeric>
<ix:nonNumeric contextRef="c0" name="dei:EntityCentralIndexKey">0001500881</ix:nonNumeric>
</ix:hidden>
<ix:references><link:schemaRef xlink:href="cve-20221231.xsd" xlink:type="simple"></link:schemaRef></ix:references>
<ix:resources><ix:relationship fromRefs="ix_0_fact ix_1_fact ix_2_fact ix_3_fact" toRefs="ix_0_footnote"></ix:relationship>
<ix:relationship fromRefs="ix_4_fact" toRefs="ix_1_footnote"></ix:relationship>
<ix:relationship fromRefs="ix_5_fact ix_6_fact ix_7_fact" toRefs="ix_2_footnote"></ix:relationship>
<ix:relationship fromRefs="ix_8_fact ix_9_fact" toRefs="ix_3_footnote"></ix:relationship>
<ix:relationship fromRefs="ix_10_fact hidden-fact-283" toRefs="ix_4_footnote"></ix:relationship>
<ix:relationship fromRefs="ix_11_fact hidden-fact-284" toRefs="ix_5_footnote"></ix:relationship>
<xbrli:context id="c0">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001500881</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-01-01</xbrli:startDate>
    <xbrli:endDate>2022-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c1">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001500881</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="dei:EntityAddressesAddressTypeAxis">dei:BusinessContactMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-01-01</xbrli:startDate>
    <xbrli:endDate>2022-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c2">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001500881</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c3">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001500881</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2021-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c4">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001500881</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2021-01-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c5">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001500881</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2021-01-01</xbrli:startDate>
    <xbrli:endDate>2021-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c6">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001500881</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2020-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c7">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001500881</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ClassesOfShareCapitalMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2020-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c8">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001500881</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:IssuedCapitalMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2020-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c9">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001500881</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">cve:ContributedSurplusMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2020-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c10">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001500881</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2020-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c11">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001500881</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RetainedEarningsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2020-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c12">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001500881</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ClassesOfShareCapitalMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2021-01-01</xbrli:startDate>
    <xbrli:endDate>2021-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c13">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001500881</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:IssuedCapitalMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2021-01-01</xbrli:startDate>
    <xbrli:endDate>2021-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c14">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001500881</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">cve:ContributedSurplusMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2021-01-01</xbrli:startDate>
    <xbrli:endDate>2021-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c15">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001500881</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2021-01-01</xbrli:startDate>
    <xbrli:endDate>2021-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c16">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001500881</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RetainedEarningsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2021-01-01</xbrli:startDate>
    <xbrli:endDate>2021-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c17">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001500881</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ClassesOfShareCapitalMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2021-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c18">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001500881</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:IssuedCapitalMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2021-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c19">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001500881</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">cve:ContributedSurplusMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2021-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c20">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001500881</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2021-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c21">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001500881</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RetainedEarningsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2021-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c22">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001500881</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ClassesOfShareCapitalMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-01-01</xbrli:startDate>
    <xbrli:endDate>2022-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c23">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001500881</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:IssuedCapitalMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-01-01</xbrli:startDate>
    <xbrli:endDate>2022-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c24">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001500881</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">cve:ContributedSurplusMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-01-01</xbrli:startDate>
    <xbrli:endDate>2022-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c25">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001500881</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-01-01</xbrli:startDate>
    <xbrli:endDate>2022-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c26">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001500881</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RetainedEarningsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-01-01</xbrli:startDate>
    <xbrli:endDate>2022-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c27">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001500881</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ClassesOfShareCapitalMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c28">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001500881</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:IssuedCapitalMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c29">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001500881</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">cve:ContributedSurplusMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c30">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001500881</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c31">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001500881</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RetainedEarningsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c32">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001500881</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">cve:TigrisUraniumUSCorpMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-01-01</xbrli:startDate>
    <xbrli:endDate>2022-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c33">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001500881</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">cve:MetaminEnterprisesUSIncMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-01-01</xbrli:startDate>
    <xbrli:endDate>2022-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c34">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001500881</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">cve:URIIncMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-01-01</xbrli:startDate>
    <xbrli:endDate>2022-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c35">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001500881</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">cve:NeutronEnergyIncMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-01-01</xbrli:startDate>
    <xbrli:endDate>2022-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c36">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001500881</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">cve:UrancoIncMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-01-01</xbrli:startDate>
    <xbrli:endDate>2022-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c37">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001500881</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">cve:UraniumResourcesIncMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-01-01</xbrli:startDate>
    <xbrli:endDate>2022-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c38">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001500881</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">cve:HRIChurchrockIncMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-01-01</xbrli:startDate>
    <xbrli:endDate>2022-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c39">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001500881</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">cve:HydroRestorationCorpMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-01-01</xbrli:startDate>
    <xbrli:endDate>2022-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c40">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001500881</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">cve:BeltLineResourcesIncMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-01-01</xbrli:startDate>
    <xbrli:endDate>2022-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c41">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001500881</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">cve:CibolaResourcesLLCMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-01-01</xbrli:startDate>
    <xbrli:endDate>2022-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c42">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001500881</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">cve:enCoreEnergyUSCorpMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-01-01</xbrli:startDate>
    <xbrli:endDate>2022-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c43">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001500881</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">cve:AzargaUraniumCorpMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-01-01</xbrli:startDate>
    <xbrli:endDate>2022-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c44">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001500881</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">cve:PowertechUSAIncMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-01-01</xbrli:startDate>
    <xbrli:endDate>2022-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c45">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001500881</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">cve:URZEnergyCorpMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-01-01</xbrli:startDate>
    <xbrli:endDate>2022-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c46">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001500881</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">cve:UcoloExplorationCorpMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-01-01</xbrli:startDate>
    <xbrli:endDate>2022-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c47">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001500881</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">cve:AzargaResourcesLimitedMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-01-01</xbrli:startDate>
    <xbrli:endDate>2022-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c48">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001500881</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">cve:AzargaResourcesHongKongLtdMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-01-01</xbrli:startDate>
    <xbrli:endDate>2022-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c49">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001500881</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">cve:AzargaResourcesUSACompanyMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-01-01</xbrli:startDate>
    <xbrli:endDate>2022-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c50">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001500881</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">cve:AzargaResourcesCanadaLtdMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-01-01</xbrli:startDate>
    <xbrli:endDate>2022-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c51">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001500881</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:IntangibleAssetsWithIndefiniteUsefulLifeAxis">cve:UraniumPlantsMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-01-01</xbrli:startDate>
    <xbrli:endDate>2022-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c52">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001500881</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:IntangibleAssetsWithIndefiniteUsefulLifeAxis">cve:UraniumPlantsMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-01-01</xbrli:startDate>
    <xbrli:endDate>2022-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c53">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001500881</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:IntangibleAssetsWithIndefiniteUsefulLifeAxis">ifrs-full:OtherPropertyPlantAndEquipmentMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-01-01</xbrli:startDate>
    <xbrli:endDate>2022-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c54">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001500881</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:IntangibleAssetsWithIndefiniteUsefulLifeAxis">ifrs-full:OtherPropertyPlantAndEquipmentMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-01-01</xbrli:startDate>
    <xbrli:endDate>2022-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c55">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001500881</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:IntangibleAssetsWithIndefiniteUsefulLifeAxis">cve:SoftwareMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-01-01</xbrli:startDate>
    <xbrli:endDate>2022-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c56">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001500881</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:IntangibleAssetsWithIndefiniteUsefulLifeAxis">cve:SoftwareMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-01-01</xbrli:startDate>
    <xbrli:endDate>2022-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c57">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001500881</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:IntangibleAssetsWithIndefiniteUsefulLifeAxis">cve:FurnitureMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-01-01</xbrli:startDate>
    <xbrli:endDate>2022-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c58">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001500881</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:IntangibleAssetsWithIndefiniteUsefulLifeAxis">cve:FurnitureMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-01-01</xbrli:startDate>
    <xbrli:endDate>2022-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c59">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001500881</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:IntangibleAssetsWithIndefiniteUsefulLifeAxis">ifrs-full:BuildingsMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-01-01</xbrli:startDate>
    <xbrli:endDate>2022-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c60">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001500881</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:IntangibleAssetsWithIndefiniteUsefulLifeAxis">ifrs-full:BuildingsMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-01-01</xbrli:startDate>
    <xbrli:endDate>2022-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c61">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001500881</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">cve:DataAccessAgreementMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-01-01</xbrli:startDate>
    <xbrli:endDate>2022-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c62">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001500881</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">cve:DataPurchasesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-01-01</xbrli:startDate>
    <xbrli:endDate>2022-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c63">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001500881</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2020-01-01</xbrli:startDate>
    <xbrli:endDate>2020-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c64">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001500881</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-02-15</xbrli:startDate>
    <xbrli:endDate>2022-02-15</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c65">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001500881</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-03-31</xbrli:startDate>
    <xbrli:endDate>2022-03-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c66">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001500881</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ScenarioForecastMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-03-31</xbrli:startDate>
    <xbrli:endDate>2023-03-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c67">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001500881</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-08-04</xbrli:startDate>
    <xbrli:endDate>2022-08-04</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c68">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001500881</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-08-31</xbrli:startDate>
    <xbrli:endDate>2022-08-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c69">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001500881</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-08-31</xbrli:startDate>
    <xbrli:endDate>2023-08-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c70">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001500881</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-12-15</xbrli:startDate>
    <xbrli:endDate>2022-12-15</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c71">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001500881</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:UnconsolidatedStructuredEntitiesAxis">cve:Fiscal2023Member</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-01-01</xbrli:startDate>
    <xbrli:endDate>2022-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c72">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001500881</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:UnconsolidatedStructuredEntitiesAxis">cve:Fiscal2024Member</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-01-01</xbrli:startDate>
    <xbrli:endDate>2022-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c73">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001500881</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:UnconsolidatedStructuredEntitiesAxis">cve:Fiscal2025Member</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-01-01</xbrli:startDate>
    <xbrli:endDate>2022-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c74">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001500881</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:UnconsolidatedStructuredEntitiesAxis">cve:Fiscal2026Member</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-01-01</xbrli:startDate>
    <xbrli:endDate>2022-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c75">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001500881</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:UnconsolidatedStructuredEntitiesAxis">cve:Fiscal2027Member</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-01-01</xbrli:startDate>
    <xbrli:endDate>2022-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c76">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001500881</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-05-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c77">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001500881</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-05-31</xbrli:startDate>
    <xbrli:endDate>2022-05-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c78">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001500881</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">cve:MarketableSecuritiesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-01-01</xbrli:startDate>
    <xbrli:endDate>2022-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c79">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001500881</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfOrdinarySharesAxis">cve:TradingSharesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c80">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001500881</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-10-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c81">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001500881</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-10-31</xbrli:startDate>
    <xbrli:endDate>2022-10-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c82">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001500881</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">cve:MarketableSecuritiescurrentMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2021-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c83">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001500881</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">cve:MarketableSecuritiesnoncurrentMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2021-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c84">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001500881</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">cve:MarketableSecuritiescurrentMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-01-01</xbrli:startDate>
    <xbrli:endDate>2022-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c85">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001500881</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">cve:MarketableSecuritiesnoncurrentMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-01-01</xbrli:startDate>
    <xbrli:endDate>2022-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c86">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001500881</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">cve:MarketableSecuritiescurrentMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c87">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001500881</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">cve:MarketableSecuritiesnoncurrentMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c88">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001500881</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2018-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c89">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001500881</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2018-12-01</xbrli:startDate>
    <xbrli:endDate>2018-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c90">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001500881</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2020-12-01</xbrli:startDate>
    <xbrli:endDate>2020-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c91">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001500881</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2021-12-01</xbrli:startDate>
    <xbrli:endDate>2021-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c92">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001500881</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-12-01</xbrli:startDate>
    <xbrli:endDate>2022-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c93">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001500881</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">cve:VANEAgreementMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2020-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c94">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001500881</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">cve:SignalEquitiesDatabaseMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2020-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c95">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001500881</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">cve:GrantsMineralBeltDatabaseMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2020-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c96">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001500881</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">cve:GrantsMineralBeltDatabaseMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2021-01-01</xbrli:startDate>
    <xbrli:endDate>2021-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c97">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001500881</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">cve:VANEAgreementMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2021-01-01</xbrli:startDate>
    <xbrli:endDate>2021-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c98">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001500881</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">cve:VANEAgreementMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2021-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c99">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001500881</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">cve:SignalEquitiesDatabaseMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2021-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c100">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001500881</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">cve:GrantsMineralBeltDatabaseMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2021-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c101">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001500881</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">cve:GettyDatabaseMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-01-01</xbrli:startDate>
    <xbrli:endDate>2022-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c102">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001500881</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">cve:VANEAgreementMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-01-01</xbrli:startDate>
    <xbrli:endDate>2022-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c103">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001500881</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">cve:VANEAgreementMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c104">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001500881</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">cve:GettyDatabaseMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c105">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001500881</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">cve:SignalEquitiesDatabaseMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c106">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001500881</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">cve:GrantsMineralBeltDatabaseMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c107">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001500881</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">cve:UraniumPlantsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2020-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c108">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001500881</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:OtherPropertyPlantAndEquipmentMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2020-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c109">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001500881</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">cve:FurnitureMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2020-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c110">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001500881</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:BuildingsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2020-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c111">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001500881</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">cve:SoftwareMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2020-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c112">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001500881</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">cve:UraniumPlantsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2021-01-01</xbrli:startDate>
    <xbrli:endDate>2021-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c113">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001500881</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:OtherPropertyPlantAndEquipmentMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2021-01-01</xbrli:startDate>
    <xbrli:endDate>2021-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c114">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001500881</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">cve:FurnitureMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2021-01-01</xbrli:startDate>
    <xbrli:endDate>2021-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c115">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001500881</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:BuildingsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2021-01-01</xbrli:startDate>
    <xbrli:endDate>2021-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c116">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001500881</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">cve:SoftwareMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2021-01-01</xbrli:startDate>
    <xbrli:endDate>2021-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c117">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001500881</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">cve:UraniumPlantsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2021-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c118">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001500881</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:OtherPropertyPlantAndEquipmentMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2021-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c119">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001500881</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">cve:FurnitureMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2021-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c120">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001500881</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:BuildingsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2021-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c121">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001500881</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">cve:SoftwareMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2021-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c122">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001500881</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">cve:UraniumPlantsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-01-01</xbrli:startDate>
    <xbrli:endDate>2022-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c123">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001500881</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:OtherPropertyPlantAndEquipmentMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-01-01</xbrli:startDate>
    <xbrli:endDate>2022-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c124">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001500881</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">cve:FurnitureMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-01-01</xbrli:startDate>
    <xbrli:endDate>2022-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c125">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001500881</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:BuildingsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-01-01</xbrli:startDate>
    <xbrli:endDate>2022-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c126">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001500881</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">cve:SoftwareMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
<!-- [WMV5][XcpuxYn59dz7vgYynUDuwG7r97K2jUTysl7vcz0lJt/tSeJz73kx1cLt0ZFF2SK/vxBCY0vdSrapBeolBQDhlou4Plg3ZACHgOGjaxwoV9s22fcKeqdlVg/8vXE8BEQPw2gSl8Pfy/SjqfZKUO0G5mehrda5xVrvtHGkgNXPOUg3vb7VF4CMNIMcgg6F7hiC/dgsHya46cPL6td1bLnSV35L5jAlrEDBDi0RC0EWIRx+TpXQjl5L5FZgRjEoUSEZLqVS4mt32wABDoRgPuZLDw==] CSR-->
  <xbrli:period>
    <xbrli:startDate>2022-01-01</xbrli:startDate>
    <xbrli:endDate>2022-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c127">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001500881</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">cve:UraniumPlantsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c128">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001500881</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:OtherPropertyPlantAndEquipmentMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c129">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001500881</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">cve:FurnitureMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c130">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001500881</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:BuildingsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c131">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001500881</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">cve:SoftwareMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c132">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001500881</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2021-07-01</xbrli:startDate>
    <xbrli:endDate>2021-07-01</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c133">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001500881</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">ifrs-full:RightofuseAssetsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2021-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c134">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001500881</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">cve:LeasedCopierMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2020-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c135">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001500881</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">cve:LeasedOfficesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2020-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c136">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001500881</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">cve:LeasedCopierMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2021-01-01</xbrli:startDate>
    <xbrli:endDate>2021-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c137">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001500881</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">cve:LeasedOfficesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2021-01-01</xbrli:startDate>
    <xbrli:endDate>2021-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c138">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001500881</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">cve:LeasedCopierMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2021-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c139">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001500881</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">cve:LeasedOfficesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2021-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c140">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001500881</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">cve:LeasedCopierMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-01-01</xbrli:startDate>
    <xbrli:endDate>2022-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c141">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001500881</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">cve:LeasedOfficesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-01-01</xbrli:startDate>
    <xbrli:endDate>2022-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c142">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001500881</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">cve:LeasedCopierMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c143">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001500881</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">cve:LeasedOfficesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c144">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001500881</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">cve:ReplacementOptionsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c145">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001500881</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">cve:ReplacementOptionsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-01-01</xbrli:startDate>
    <xbrli:endDate>2022-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c146">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001500881</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">cve:ReplacementOptionsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-09-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c147">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001500881</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">cve:ReplacementOptionsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-09-30</xbrli:startDate>
    <xbrli:endDate>2022-09-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c148">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001500881</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">cve:ReplacementOptionsMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-09-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c149">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001500881</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">cve:ReplacementOptionsMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-09-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c150">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001500881</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">cve:ReplacementWarrantsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-09-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c151">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001500881</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">cve:ReplacementWarrantsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-09-30</xbrli:startDate>
    <xbrli:endDate>2022-09-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c152">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001500881</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">cve:ReplacementWarrantsMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-09-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c153">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001500881</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">cve:ReplacementWarrantsMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-09-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c154">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001500881</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">cve:OptionsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-01-01</xbrli:startDate>
    <xbrli:endDate>2022-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c155">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001500881</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">cve:OptionsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c156">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001500881</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:WarrantReserveMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-01-01</xbrli:startDate>
    <xbrli:endDate>2022-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c157">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001500881</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:WarrantReserveMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c158">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001500881</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">ifrs-full:ContingentConsiderationMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-01-01</xbrli:startDate>
    <xbrli:endDate>2022-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c159">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001500881</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">cve:TriStateGenerationAndTransmissionAssociationMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2021-03-01</xbrli:startDate>
    <xbrli:endDate>2021-03-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c160">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001500881</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">cve:WildcatSolarPowerPlantLLCMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2021-05-01</xbrli:startDate>
    <xbrli:endDate>2021-05-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c161">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001500881</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">cve:McKinleyMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-01-01</xbrli:startDate>
    <xbrli:endDate>2022-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c162">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001500881</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">cve:CrownpointMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-01-01</xbrli:startDate>
    <xbrli:endDate>2022-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c163">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001500881</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">cve:HostaButteMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-01-01</xbrli:startDate>
    <xbrli:endDate>2022-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c164">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001500881</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">cve:CrownpointMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-01-01</xbrli:startDate>
    <xbrli:endDate>2022-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c165">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001500881</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-05-01</xbrli:startDate>
    <xbrli:endDate>2022-05-24</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c166">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001500881</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-05-24</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c167">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001500881</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-01-01</xbrli:startDate>
    <xbrli:endDate>2022-01-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c168">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001500881</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-03-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c169">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001500881</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">cve:PrimeFuelsCorpMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-06-20</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c170">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001500881</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c171">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001500881</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-06-01</xbrli:startDate>
    <xbrli:endDate>2022-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c172">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001500881</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-06-20</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c173">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001500881</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">stpr:AZ</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2020-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c174">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001500881</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">stpr:CO</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2020-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c175">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001500881</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">stpr:NM</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2020-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c176">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001500881</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">stpr:SD</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2020-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c177">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001500881</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">stpr:TX</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2020-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c178">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001500881</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">stpr:UT</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2020-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c179">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001500881</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">stpr:WY</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2020-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c180">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001500881</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:CA</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2020-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c181">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001500881</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">stpr:AZ</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2021-01-01</xbrli:startDate>
    <xbrli:endDate>2021-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c182">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001500881</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">stpr:CO</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2021-01-01</xbrli:startDate>
    <xbrli:endDate>2021-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c183">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001500881</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">stpr:NM</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2021-01-01</xbrli:startDate>
    <xbrli:endDate>2021-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c184">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001500881</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">stpr:SD</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2021-01-01</xbrli:startDate>
    <xbrli:endDate>2021-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c185">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001500881</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">stpr:TX</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2021-01-01</xbrli:startDate>
    <xbrli:endDate>2021-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c186">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001500881</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">stpr:UT</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2021-01-01</xbrli:startDate>
    <xbrli:endDate>2021-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c187">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001500881</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">stpr:WY</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2021-01-01</xbrli:startDate>
    <xbrli:endDate>2021-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c188">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001500881</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:CA</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2021-01-01</xbrli:startDate>
    <xbrli:endDate>2021-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c189">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001500881</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">stpr:AZ</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2021-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c190">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001500881</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">stpr:CO</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2021-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c191">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001500881</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">stpr:NM</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2021-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c192">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001500881</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">stpr:SD</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2021-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c193">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001500881</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">stpr:TX</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2021-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c194">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001500881</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">stpr:UT</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2021-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c195">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001500881</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">stpr:WY</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2021-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c196">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001500881</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:CA</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2021-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c197">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001500881</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">cve:ExplorationCostMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">stpr:AZ</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-01-01</xbrli:startDate>
    <xbrli:endDate>2022-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c198">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001500881</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">cve:ExplorationCostMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">stpr:CO</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-01-01</xbrli:startDate>
    <xbrli:endDate>2022-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c199">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001500881</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">cve:ExplorationCostMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">stpr:NM</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-01-01</xbrli:startDate>
    <xbrli:endDate>2022-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c200">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001500881</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">cve:ExplorationCostMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">stpr:SD</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-01-01</xbrli:startDate>
    <xbrli:endDate>2022-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c201">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001500881</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">cve:ExplorationCostMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">stpr:TX</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-01-01</xbrli:startDate>
    <xbrli:endDate>2022-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c202">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001500881</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">cve:ExplorationCostMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">stpr:UT</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-01-01</xbrli:startDate>
    <xbrli:endDate>2022-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c203">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001500881</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">cve:ExplorationCostMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">stpr:WY</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-01-01</xbrli:startDate>
    <xbrli:endDate>2022-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c204">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001500881</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">cve:ExplorationCostMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-01-01</xbrli:startDate>
    <xbrli:endDate>2022-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c205">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001500881</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">stpr:AZ</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-01-01</xbrli:startDate>
    <xbrli:endDate>2022-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c206">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001500881</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">stpr:CO</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-01-01</xbrli:startDate>
    <xbrli:endDate>2022-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c207">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001500881</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">stpr:NM</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-01-01</xbrli:startDate>
    <xbrli:endDate>2022-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c208">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001500881</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">stpr:SD</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-01-01</xbrli:startDate>
    <xbrli:endDate>2022-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c209">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001500881</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">stpr:TX</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-01-01</xbrli:startDate>
    <xbrli:endDate>2022-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c210">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001500881</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">stpr:UT</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-01-01</xbrli:startDate>
    <xbrli:endDate>2022-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c211">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001500881</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">stpr:WY</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-01-01</xbrli:startDate>
    <xbrli:endDate>2022-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c212">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001500881</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">stpr:AZ</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c213">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001500881</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">stpr:CO</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c214">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001500881</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">stpr:NM</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c215">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001500881</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">stpr:SD</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c216">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001500881</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">stpr:TX</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c217">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001500881</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">stpr:UT</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c218">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001500881</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">stpr:WY</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c219">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001500881</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:CA</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c220">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001500881</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">cve:KingsvilleMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c221">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001500881</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">cve:KingsvilleMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2021-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c222">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001500881</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">cve:RositaMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c223">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001500881</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">cve:RositaMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2021-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c224">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001500881</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">cve:VasquezMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c225">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001500881</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">cve:VasquezMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2021-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c226">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001500881</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">cve:CentennialMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c227">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001500881</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">cve:CentennialMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2021-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c228">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001500881</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">cve:GasHillsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c229">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001500881</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">cve:GasHillsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2021-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c230">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001500881</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">cve:TicabooMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c231">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001500881</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">cve:TicabooMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2021-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c232">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001500881</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2021-07-01</xbrli:startDate>
    <xbrli:endDate>2021-07-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c233">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001500881</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">cve:WarrantsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-01-01</xbrli:startDate>
    <xbrli:endDate>2022-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c234">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001500881</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">cve:StockOptionsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-01-01</xbrli:startDate>
    <xbrli:endDate>2022-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c235">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001500881</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">cve:WarrantsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2021-01-01</xbrli:startDate>
    <xbrli:endDate>2021-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c236">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001500881</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">cve:StockOptionsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2021-01-01</xbrli:startDate>
    <xbrli:endDate>2021-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c237">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001500881</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:RangesOfExercisePricesForOutstandingShareOptionsAxis">cve:ZeroOneEightOneNineTwoMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-01-01</xbrli:startDate>
    <xbrli:endDate>2022-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c238">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001500881</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:RangesOfExercisePricesForOutstandingShareOptionsAxis">cve:ZeroOneEightOneNineTwoMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c239">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001500881</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:RangesOfExercisePricesForOutstandingShareOptionsAxis">cve:TwoFourZeroThreeSevenEightMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-01-01</xbrli:startDate>
    <xbrli:endDate>2022-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c240">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001500881</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:RangesOfExercisePricesForOutstandingShareOptionsAxis">cve:TwoFourZeroThreeSevenEightMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c241">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001500881</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:RangesOfExercisePricesForOutstandingShareOptionsAxis">cve:FourTwoZeroFiveSevenSixMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-01-01</xbrli:startDate>
    <xbrli:endDate>2022-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c242">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001500881</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:RangesOfExercisePricesForOutstandingShareOptionsAxis">cve:FourTwoZeroFiveSevenSixMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c243">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001500881</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:RangesOfExercisePricesForOutstandingShareOptionsAxis">cve:OneFiveNineOneEightZeroMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-01-01</xbrli:startDate>
    <xbrli:endDate>2022-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c244">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001500881</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:RangesOfExercisePricesForOutstandingShareOptionsAxis">cve:TwoTwoTwoThreeNineZeroOneMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-01-01</xbrli:startDate>
    <xbrli:endDate>2022-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c245">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001500881</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:RangesOfExercisePricesForOutstandingShareOptionsAxis">cve:FourFiveNineSixZeroZeroMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-01-01</xbrli:startDate>
    <xbrli:endDate>2022-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c246">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001500881</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">cve:PlatoroWestIncMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-01-01</xbrli:startDate>
    <xbrli:endDate>2022-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c247">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001500881</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">cve:PlatoroWestIncMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2021-01-01</xbrli:startDate>
    <xbrli:endDate>2021-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c248">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001500881</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">cve:TintinaHoldingsLtdMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c249">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001500881</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">cve:TintinaHoldingsLtdMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2021-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c250">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001500881</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">cve:TintinaHoldingsLtdMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2021-01-01</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c251">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001500881</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">cve:OfficersAndBoardMembersMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c252">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001500881</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">cve:OfficersAndBoardMembersMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2021-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c253">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001500881</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">cve:OfficersAndBoardMembersMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2021-01-01</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c254">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001500881</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2021-01-01</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c255">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001500881</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">cve:OtherStatesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2021-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c256">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001500881</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">cve:OtherStatesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c257">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001500881</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:RetrospectiveApplicationAndRetrospectiveRestatementAxis">ifrs-full:PreviouslyStatedMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2021-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c258">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001500881</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:RetrospectiveApplicationAndRetrospectiveRestatementAxis">cve:TranslatedMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2021-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c259">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001500881</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:RetrospectiveApplicationAndRetrospectiveRestatementAxis">ifrs-full:PreviouslyStatedMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c260">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001500881</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:RetrospectiveApplicationAndRetrospectiveRestatementAxis">cve:TranslatedMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c261">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001500881</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2021-01-01</xbrli:startDate>
    <xbrli:endDate>2021-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c262">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001500881</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:RestatementAxis">cve:TranslatedMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2021-01-01</xbrli:startDate>
    <xbrli:endDate>2021-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c263">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001500881</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">cve:EnergyFuelsIncMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-02-14</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c264">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001500881</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-02-14</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c265">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001500881</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-01-01</xbrli:startDate>
    <xbrli:endDate>2022-02-14</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c266">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001500881</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">cve:AltaMesaAcquisitionMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-12-01</xbrli:startDate>
    <xbrli:endDate>2022-12-06</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c267">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001500881</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-12-01</xbrli:startDate>
    <xbrli:endDate>2022-12-06</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c268">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001500881</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-02-08</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c269">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001500881</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-02-01</xbrli:startDate>
    <xbrli:endDate>2023-02-08</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c270">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001500881</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:NonadjustingEventsAfterReportingPeriodAxis">cve:SubsequentEventOneMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-02-01</xbrli:startDate>
    <xbrli:endDate>2023-02-08</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c271">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001500881</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">cve:SubsequentEventOneMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c272">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001500881</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">cve:SubsequentEventOneMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-01-01</xbrli:startDate>
    <xbrli:endDate>2022-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c273">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001500881</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">cve:SubsequentEventTwoMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-01-01</xbrli:startDate>
    <xbrli:endDate>2022-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c274">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001500881</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">cve:SubsequentEventThreeMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c275">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001500881</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">cve:SubsequentEventThreeMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-01-01</xbrli:startDate>
    <xbrli:endDate>2022-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c276">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001500881</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">cve:SubsequentEventFourMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-01-01</xbrli:startDate>
    <xbrli:endDate>2022-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c277">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001500881</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:NonadjustingEventsAfterReportingPeriodAxis">cve:SubsequentEventOneMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-01-01</xbrli:startDate>
    <xbrli:endDate>2023-01-13</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c278">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001500881</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:NonadjustingEventsAfterReportingPeriodAxis">cve:SubsequentEventOneMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-01-16</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c279">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001500881</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:NonadjustingEventsAfterReportingPeriodAxis">cve:SubsequentEventOneMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-01-01</xbrli:startDate>
    <xbrli:endDate>2023-01-16</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c280">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001500881</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:NonadjustingEventsAfterReportingPeriodAxis">cve:SubsequentEventOneMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-02-01</xbrli:startDate>
    <xbrli:endDate>2023-02-28</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c281">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001500881</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:NonadjustingEventsAfterReportingPeriodAxis">cve:SubsequentEventOneMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-03-01</xbrli:startDate>
    <xbrli:endDate>2023-03-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c282">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001500881</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:NonadjustingEventsAfterReportingPeriodAxis">cve:SubsequentEventOneMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-04-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c283">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001500881</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:NonadjustingEventsAfterReportingPeriodAxis">cve:SubsequentEventOneMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-04-01</xbrli:startDate>
    <xbrli:endDate>2023-04-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:unit id="shares">
  <xbrli:measure>xbrli:shares</xbrli:measure>
</xbrli:unit><xbrli:unit id="usd">
  <xbrli:measure>iso4217:USD</xbrli:measure>
</xbrli:unit><xbrli:unit id="usdPershares">
  <xbrli:divide>
    <xbrli:unitNumerator>
      <xbrli:measure>iso4217:USD</xbrli:measure>
    </xbrli:unitNumerator>
    <xbrli:unitDenominator>
      <xbrli:measure>xbrli:shares</xbrli:measure>
    </xbrli:unitDenominator>
  </xbrli:divide>
</xbrli:unit><xbrli:unit id="pure">
  <xbrli:measure>xbrli:pure</xbrli:measure>
</xbrli:unit><xbrli:unit id="cad">
  <xbrli:measure>iso4217:CAD</xbrli:measure>
</xbrli:unit><xbrli:unit id="gbp">
  <xbrli:measure>iso4217:GBP</xbrli:measure>
</xbrli:unit><xbrli:unit id="cadPershares">
  <xbrli:divide>
    <xbrli:unitNumerator>
      <xbrli:measure>iso4217:CAD</xbrli:measure>
    </xbrli:unitNumerator>
    <xbrli:unitDenominator>
      <xbrli:measure>xbrli:shares</xbrli:measure>
    </xbrli:unitDenominator>
  </xbrli:divide>
</xbrli:unit></ix:resources></ix:header>

</div></div></body>
</html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.4
<SEQUENCE>5
<FILENAME>ea177383ex99-4_encoreenergy.htm
<DESCRIPTION>CERTIFICATION
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="text-align: right; margin: 0"><B>Exhibit 99.4</B></P>

<P STYLE="margin: 0; text-align: right">&nbsp;</P>

<P STYLE="margin-top: 0; margin-bottom: 0; text-align: center"><B>CERTIFICATION<BR>
PURSUANT TO RULE 13a-14(a) OR RULE 15d-14(a)<BR>
OF THE U.S. SECURITIES EXCHANGE ACT OF 1934</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">I, W. Paul Goranson, certify that:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">1.&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">I have reviewed this annual report on Form 40-F of enCore Energy Corp.</FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: top; width: 0.25in">&nbsp;</TD>
    <TD STYLE="vertical-align: top; width: 0.25in">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">2.&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report; </FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">3.&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the issuer as of, and for, the periods presented in this report; </FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">4.&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">The issuer&#8217;s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the issuer and have: </FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: justify"><FONT STYLE="font-size: 10pt">a) </FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the issuer, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this annual report is being prepared;</FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">b)</P></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Evaluated the effectiveness of the issuer&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and </FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: justify"><FONT STYLE="font-size: 10pt">c) </FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Disclosed in this report any change in the issuer&#8217;s internal control over financial reporting that occurred during the &nbsp;period covered by the annual report that has materially affected, or is reasonably likely to materially affect, the issuer&#8217;s internal control over financial reporting; and</FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">5.&nbsp;</FONT></TD>
    <TD COLSPAN="2">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The issuer&#8217;s other certifying officer and
    I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the issuer&#8217;s auditors and
    the audit committee of issuer&#8217;s board of directors (or persons performing the equivalent function):</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P></TD></TR>
</TABLE>

<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">(a)</TD><TD STYLE="text-align: justify">All significant deficiencies and material weaknesses in the
design or operation of internal control over financial reporting which are reasonably likely to adversely affect the issuer&#8217;s ability
to record, process, summarize and report financial information; and</TD>
</TR><TR STYLE="vertical-align: top; text-align: justify">
<TD>&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: justify">&nbsp;</TD></TR>
     </TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">(b)</TD><TD STYLE="text-align: justify">Any fraud, whether or not material, that involves management
or other employees who have a significant role in the issuer&#8217;s internal control over financial reporting.</TD>
</TR></TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR>
    <TD STYLE="width: 60%"><FONT STYLE="font-size: 10pt">Date: April 28, 2023</FONT></TD>
    <TD STYLE="width: 4%"><FONT STYLE="font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; width: 36%"><FONT STYLE="font-size: 10pt">/s/ W. Paul Goranson</FONT></TD></TR>
  <TR>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">W. Paul Goranson</FONT></TD></TR>
  <TR>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">Chief Executive Officer</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.5
<SEQUENCE>6
<FILENAME>ea177383ex99-5_encoreenergy.htm
<DESCRIPTION>CERTIFICATION
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="text-align: right; margin: 0"><B>Exhibit 99.5</B></P>

<P STYLE="margin: 0; text-align: right"><B>&nbsp;</B></P>

<P STYLE="text-align: center; margin-top: 0; margin-bottom: 0"><B>CERTIFICATION </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>PURSUANT TO RULE 13a-14(a) OR RULE 15d-14(a)<BR>
OF THE U.S. SECURITIES EXCHANGE ACT OF 1934</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">I, Carrie Mierkey, certify that:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">1.&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">I have reviewed this annual report on Form 40-F of enCore Energy Corp.</FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: top; width: 0.25in">&nbsp;</TD>
    <TD STYLE="vertical-align: top; width: 0.25in">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">2.&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report; </FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">3.&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the issuer as of, and for, the periods presented in this report; </FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">4.&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">The issuer&rsquo;s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the issuer and have: </FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: justify"><FONT STYLE="font-size: 10pt">a) </FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the issuer, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this annual report is being prepared;</FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">b)</P></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Evaluated the effectiveness of the issuer&rsquo;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and </FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: justify"><FONT STYLE="font-size: 10pt">c) </FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Disclosed in this report any change in the issuer&rsquo;s internal control over financial reporting that occurred during the &nbsp;period covered by the annual report that has materially affected, or is reasonably likely to materially affect, the issuer&rsquo;s internal control over financial reporting; and</FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">5.&nbsp;</FONT></TD>
    <TD COLSPAN="2">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The issuer&rsquo;s other certifying officer
and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the issuer&rsquo;s auditors
and the audit committee of issuer&rsquo;s board of directors (or persons performing the equivalent function):</P></TD></TR>
</TABLE>

<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">(a)</TD><TD STYLE="text-align: justify">All significant deficiencies and material weaknesses in the
design or operation of internal control over financial reporting which are reasonably likely to adversely affect the issuer's ability
to record, process, summarize and report financial information; and</TD>
</TR><TR STYLE="vertical-align: top; text-align: justify">
<TD>&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: justify">&nbsp;</TD></TR>
     </TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">(b)</TD><TD STYLE="text-align: justify">Any fraud, whether or not material, that involves management
or other employees who have a significant role in the issuer&rsquo;s internal control over financial reporting.</TD>
</TR></TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR>
    <TD STYLE="width: 60%"><FONT STYLE="font-size: 10pt">Date: April 28, 2023</FONT></TD>
    <TD STYLE="width: 4%"><FONT STYLE="font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; width: 36%"><FONT STYLE="font-size: 10pt">/s/ Carrie Mierkey</FONT></TD></TR>
  <TR>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">Carrie Mierkey</FONT></TD></TR>
  <TR>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">Chief Financial Officer</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.6
<SEQUENCE>7
<FILENAME>ea177383ex99-6_encoreenergy.htm
<DESCRIPTION>CERTIFICATION
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>Exhibit 99.6</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>CERTIFICATION </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>PURSUANT TO 18 U.S.C. SECTION 1350 </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>AND RULE 13a-14(b) OR RULE 15d-14(b)</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>OF THE U.S. SECURITIES EXCHANGE ACT OF 1934</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In connection with the Annual Report of enCore
Energy Corp. (the &#8220;Company&#8221;) on Form 40-F for the year ended December 31, 2022 (the &#8220;Report&#8221;), the undersigned, in
the capacity and on the date indicated below, hereby certifies pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906
of the Sarbanes-Oxley Act of 2002, that to his knowledge:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">1.</TD><TD STYLE="text-align: justify">The Report fully complies with the requirements of Section
13(a) or 15(d) of the Securities Exchange Act of 1934; and</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-size: 10pt">2.</FONT></TD><TD STYLE="text-align: justify">The information contained in the Report fairly presents, in all material respects, the financial condition
and results of operations of the Company.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 60%; text-align: justify">Dated: April 28, 2023</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; width: 40%; text-align: justify">/s/ W. Paul Goranson</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">W. Paul Goranson</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify">Chief Executive Officer</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 2in; text-align: justify; text-indent: -2in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.7
<SEQUENCE>8
<FILENAME>ea177383ex99-7_encoreenergy.htm
<DESCRIPTION>CERTIFICATION
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="text-align: right; margin: 0"><B>Exhibit 99.7</B></P>

<P STYLE="margin: 0; text-align: right"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>CERTIFICATION </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>PURSUANT TO 18 U.S.C. SECTION 1350 </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>AND RULE 13a-14(b) OR RULE 15d-14(b)</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>OF THE U.S. SECURITIES EXCHANGE ACT OF 1934</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In connection with the Annual Report of enCore
Energy Corp. (the &#8220;Company&#8221;) on Form 40-F for the year ended December 31, 2022 (the &#8220;Report&#8221;), the undersigned, in
the capacity and on the date indicated below, hereby certifies pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906
of the Sarbanes-Oxley Act of 2002, that to his knowledge:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">1.</TD><TD STYLE="text-align: justify">The Report fully complies with the requirements of Section
13(a) or 15(d) of the Securities Exchange Act of 1934; and</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-size: 10pt">2.</FONT></TD><TD STYLE="text-align: justify">The information contained in the Report fairly presents,
in all material respects, the financial condition and results of operations of the Company.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 60%; text-align: justify">Dated: April 28, 2023</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; width: 40%; text-align: justify">/s/ Carrie Mierkey</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">Carrie Mierkey</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify">Chief Financial Officer</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.8
<SEQUENCE>9
<FILENAME>ea177383ex99-8_encoreenergy.htm
<DESCRIPTION>CONSENT OF DAVIDSON & COMPANY LLP
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="text-align: right; margin: 0"><B>Exhibit 99.8</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: -0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><IMG SRC="ex99-8_001.jpg" ALT="">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B>CONSENT
OF Independent Registered Public Accounting Firm</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">We hereby consent to the incorporation
by reference in the Annual Report on Form 40-F No. 001-41489 for the year ended December 31, 2022 of enCore Energy Corp. of our report
dated April 28, 2023, relating to the consolidated financial statements of enCore Energy Corp, for the year ended December 31, 2022 which
is incorporated by reference in this Annual Report on Form 40-F.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">We also consent to the incorporation
by reference in the Registration Statements on Form F-10 (No. 333-269428 and 333-269387) of enCore Energy Corp. of our report referred
to above and references to our name under the heading &ldquo;Interests of Experts&rdquo; in the Annual Information Form forming a part
of the Annual Report on Form 40-F, which is incorporated by reference in such Form F-10.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>/s/ DAVIDSON &amp; COMPANY LLP</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 46%; text-align: justify">Vancouver, Canada </TD>
    <TD STYLE="width: 54%; text-align: right">Chartered Professional Accountants</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">April 28, 2023</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt; text-transform: uppercase"><IMG SRC="ex99-8_002.jpg" ALT="">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="margin: 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.9
<SEQUENCE>10
<FILENAME>ea177383ex99-9_encoreenergy.htm
<DESCRIPTION>CONSENT OF W. PAUL GORANSON, P.E
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="text-align: right; margin: 0"><B>Exhibit 99.9</B></P>

<P STYLE="margin-top: 0; margin-bottom: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>CONSENT OF EXPERT</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">I, W. Paul Goranson, P.E., am one of the authors
of the technical report titled &ldquo;Crownpoint and Hosta Butte Uranium Project, McKinley County, New Mexico, USA Mineral Resource Technical
Report, National Instrument 43-101&rdquo; dated and with an effective date of February 25, 2022 and a revision date of March 16, 2022
(the &ldquo;<B>Technical Report</B>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">I hereby consent to being named in the Annual
Report of enCore Energy Corp. on Form 40-F (the &ldquo;40-F&rdquo;) for the fiscal year ended December 31, 2022, to be filed with the
U.S. Securities and Exchange Commission pursuant to the Securities Exchange Act of 1934, as amended, as having prepared the Technical
Reports and to the use of the Technical Reports, or any portion thereof, and to the inclusion or incorporation by reference of information
derived from the Technical Reports in the 40-F and the Registration Statement (No. 333-269428) on Form F-10 of enCore Energy Corp (the
&ldquo;F-10&rdquo;). This consent extends to any amendments to the 40-F or to the F-10.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Dated: April 28, 2023</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 5%; text-align: justify; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; width: 35%; text-align: justify; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">/s/ W. Paul Goranson</FONT></TD>
    <TD STYLE="width: 60%">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Name:&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">W. Paul Goranson, P.E.</FONT></TD>
    <TD>&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="margin: 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.10
<SEQUENCE>11
<FILENAME>ea177383ex99-10_encoreenergy.htm
<DESCRIPTION>CONSENT OF TERENCE P. MCNULTY, P.E., PHD
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="text-align: right; margin: 0"><B>Exhibit 99.10</B></P>

<P STYLE="margin-top: 0; margin-bottom: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>CONSENT OF EXPERT</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">I, Terence P. McNulty, P.E., PhD of T.P. McNulty
and Associates, Inc., am one of the authors of the technical report entitled &ldquo;MARQUEZ-JUAN TAFOYA URANIUM PROJECT 43-101 Technical
Report Preliminary Economic Assessment&rdquo; dated and with an effective date of June 9, 2021 (the &ldquo;<B>Technical Report</B>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">I hereby consent to being named in the Annual
Report of enCore Energy Corp. on Form 40-F (the &ldquo;40-F&rdquo;) for the fiscal year ended December 31, 2022, to be filed with the
U.S. Securities and Exchange Commission pursuant to the Securities Exchange Act of 1934, as amended, as having prepared the Technical
Reports and to the use of the Technical Reports, or any portion thereof, and to the inclusion or incorporation by reference of information
derived from the Technical Reports in the 40-F and the Registration Statement (No. 333-269428) on Form F-10 of enCore Energy Corp (the
&ldquo;F-10&rdquo;). This consent extends to any amendments to the 40-F or to the F-10.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Dated: April 28, 2023</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 5%; text-align: justify; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; width: 35%; text-align: justify; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">/s/ Terence P. McNulty</FONT></TD>
    <TD STYLE="width: 60%">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Name:&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Terence P. McNulty, P.E., PhD</FONT></TD>
    <TD>&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="margin: 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.11
<SEQUENCE>12
<FILENAME>ea177383ex99-11_encoreenergy.htm
<DESCRIPTION>CONSENT OF CARL WARREN, P.E., P.G
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="text-align: right; margin: 0"><B>Exhibit 99.11</B></P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>CONSENT OF EXPERT</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">I, Carl Warren, P.E., P.G., am one of the authors
of the technical report titled &ldquo;Crownpoint and Hosta Butte Uranium Project, McKinley County, New Mexico, USA Mineral Resource Technical
Report, National Instrument 43-101&rdquo; dated and with an effective date of February 25, 2022 and a revision date of March 16, 2022
(the &ldquo;<B>Technical Report</B>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">I hereby consent to being named in the Annual
Report of enCore Energy Corp. on Form 40-F (the &ldquo;40-F&rdquo;) for the fiscal year ended December 31, 2022, to be filed with the
U.S. Securities and Exchange Commission pursuant to the Securities Exchange Act of 1934, as amended, as having prepared the Technical
Reports and to the use of the Technical Reports, or any portion thereof, and to the inclusion or incorporation by reference of information
derived from the Technical Reports in the 40-F and the Registration Statement (No. 333-269428) on Form F-10 of enCore Energy Corp (the
&ldquo;F-10&rdquo;). This consent extends to any amendments to the 40-F or to the F-10.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Dated: April 28, 2023</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 5%; text-align: justify; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; width: 35%; text-align: justify; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">/s/ Carl Warren</FONT></TD>
    <TD STYLE="width: 60%">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Name:&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Carl Warren, P.E., P.G.</FONT></TD>
    <TD>&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="margin: 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.12
<SEQUENCE>13
<FILENAME>ea177383ex99-12_encoreenergy.htm
<DESCRIPTION>CONSENT OF DOUGLAS L. BEAHM, P.E, P.G.
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="text-align: right; margin: 0"><B>Exhibit 99.12</B></P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>CONSENT OF EXPERT</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">I, Douglas L. Beahm, P.E., P.G., am an author
of:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.5in">(i)</TD><TD STYLE="text-align: justify">the technical report entitled &ldquo;MARQUEZ-JUAN TAFOYA URANIUM PROJECT 43-101 Technical Report Preliminary
Economic Assessment&rdquo; dated and with an effective date of June 9, 2021,</TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.5in">(ii)</TD><TD STYLE="text-align: justify">the amended technical report titled &ldquo;Crownpoint and Hosta Butte Uranium Project, McKinley County,
New Mexico, USA, Mineral Resource Technical Report, National Instrument 43-101&rdquo; dated February 25, 2022 with an effective date of
February 25, 2022 and a revision date of March 16, 2022, and</TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.5in">(iii)</TD><TD STYLE="text-align: justify">(iii) the technical report entitled &ldquo;Technical Report Summary for the Alta Mesa Uranium Project,
Brooks and Jim Hogg Counties, Texas, USA&rdquo; with an effective date of January 19, 2023</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.25in">(together, the
&ldquo;<B>Technical Reports</B>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">I hereby consent to being named in the Annual
Report of enCore Energy Corp. on Form 40-F (the &ldquo;40-F&rdquo;) for the fiscal year ended December 31, 2022, to be filed with the
U.S. Securities and Exchange Commission pursuant to the Securities Exchange Act of 1934, as amended, as having prepared the Technical
Reports and to the use of the Technical Reports, or any portion thereof, and to the inclusion or incorporation by reference of information
derived from the Technical Reports in the 40-F and the Registration Statement (No. 333-269428) on Form F-10 of enCore Energy Corp (the
&ldquo;F-10&rdquo;). This consent extends to any amendments to the 40-F or to the F-10.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Dated April 28, 2023</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse; font-size: 10pt">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 5%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; width: 35%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">/s/ Douglas L. Beahm</FONT></TD>
    <TD STYLE="padding-bottom: 1pt; width: 60%; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Name:&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Douglas L. Beahm, P.E., P.G.</FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.13
<SEQUENCE>14
<FILENAME>ea177383ex99-13_encoreenergy.htm
<DESCRIPTION>CONSENT OF STEVE CUTLER, P.G.
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>Exhibit 99.13</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>CONSENT OF EXPERT</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">I, Steve Cutler, P.G., am an author of:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.5in">(i)</TD><TD STYLE="text-align: justify">the technical report entitled &ldquo;NI 43-101 Technical Report Preliminary Economic Assessment Dewey-Burdock
Uranium ISR Project South Dakota, USA&rdquo; dated December 23, 2020 and effective as of December 3, 2019, and</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.5in">(ii)</TD><TD STYLE="text-align: justify">the technical report entitled &ldquo;NI 43-101 Technical Report, Preliminary Economic Assessment, Gas
Hills Uranium Project, Fremont and Natrona Counties, Wyoming, USA&rdquo; dated August 10, 2021 with an effective date of June 28, 2021</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.25in">(together, the
&ldquo;<B>Technical Reports</B>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">I hereby consent to being named in the Annual
Report of enCore Energy Corp. on Form 40-F (the &ldquo;40-F&rdquo;) for the fiscal year ended December 31, 2022, to be filed with the
U.S. Securities and Exchange Commission pursuant to the Securities Exchange Act of 1934, as amended, as having prepared the Technical
Reports and to the use of the Technical Reports, or any portion thereof, and to the inclusion or incorporation by reference of information
derived from the Technical Reports in the 40-F and the Registration Statement (No. 333-269428) on Form F-10 of enCore Energy Corp (the
&ldquo;F-10&rdquo;). This consent extends to any amendments to the 40-F or to the F-10.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Dated April 28, 2023</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse; font-size: 10pt">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 5%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; width: 35%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">/s/ Steve Cutler</FONT></TD>
    <TD STYLE="padding-bottom: 1pt; width: 60%; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Name:&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Steve Cutler, P.G.</FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.14
<SEQUENCE>15
<FILENAME>ea177383ex99-14_encoreenergy.htm
<DESCRIPTION>CONSENT OF RAY MOORES, P.E.
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="text-align: right; margin: 0"><B>Exhibit 99.14</B></P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>CONSENT OF EXPERT</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">I, Ray Moores, P.E. of Western Water Consultants
Inc., dba, WWC Engineering, am one of the authors of the technical report entitled &ldquo;NI 43-101 Technical Report, Preliminary Economic
Assessment, Gas Hills Uranium Project, Fremont and Natrona Counties, Wyoming, USA&rdquo; dated August 10, 2021 with an effective date
of June 28, 2021 (the &ldquo;<B>Technical Report</B>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">I hereby consent to being named in the Annual
Report of enCore Energy Corp. on Form 40-F (the &ldquo;40-F&rdquo;) for the fiscal year ended December 31, 2022, to be filed with the
U.S. Securities and Exchange Commission pursuant to the Securities Exchange Act of 1934, as amended, as having prepared the Technical
Reports and to the use of the Technical Reports, or any portion thereof, and to the inclusion or incorporation by reference of information
derived from the Technical Reports in the 40-F and the Registration Statement (No. 333-269428) on Form F-10 of enCore Energy Corp (the
&ldquo;F-10&rdquo;). This consent extends to any amendments to the 40-F or to the F-10.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Dated April 28, 2023</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse; font-size: 10pt">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 5%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; width: 35%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">/s/ Ray Moores</FONT></TD>
    <TD STYLE="padding-bottom: 1pt; width: 60%; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Name:&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Ray Moores, P.E.</FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.15
<SEQUENCE>16
<FILENAME>ea177383ex99-15_encoreenergy.htm
<DESCRIPTION>CONSENT OF MATTHEW YOVICH
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="text-align: right; margin: 0"><B>Exhibit 99.15</B></P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>CONSENT OF EXPERT</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">I, Matthew Yovich, am one of the authors of the
technical report entitled &ldquo;NI 43-101 Technical Report Preliminary Economic Assessment Dewey-Burdock Uranium ISR Project South Dakota,
USA&rdquo; dated December 23, 2020 and effective as of December 3, 2019 (the &ldquo;<B>Technical Report</B>&rdquo;). At the time of preparing
the Technical Report, I was a P.E. with Woodard &amp; Curran and a &ldquo;qualified person&rdquo; within the meaning of National Instrument
43-101 <I>Standards of Disclosure for Mineral Projects</I>. I have since retired.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">I hereby consent to being named in the Annual
Report of enCore Energy Corp. on Form 40-F (the &ldquo;40-F&rdquo;) for the fiscal year ended December 31, 2022, to be filed with the
U.S. Securities and Exchange Commission pursuant to the Securities Exchange Act of 1934, as amended, as having prepared the Technical
Reports and to the use of the Technical Reports, or any portion thereof, and to the inclusion or incorporation by reference of information
derived from the Technical Reports in the 40-F and the Registration Statement (No. 333-269428) on Form F-10 of enCore Energy Corp (the
&ldquo;F-10&rdquo;). This consent extends to any amendments to the 40-F or to the F-10.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Dated April 28, 2023</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse; font-size: 10pt">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 5%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; width: 35%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">/s/ Matthew Yovich</FONT></TD>
    <TD STYLE="padding-bottom: 1pt; width: 60%; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Name:&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Matthew Yovich</FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>17
<FILENAME>ex99-1_001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 ex99-1_001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" !K .\# 2(  A$! Q$!_\0
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MM[.DE4JQ7LZ?[QG]]$@3RY@56(+&4#K\CQCG:5D'*[#\Z%<;2 RX(S7X>_\
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M_*DD[W<IOE275NT5UT(<8R3C)2<9)QDH2Y9-/1J,GI&5MGT>IFN3MD63R]P
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MY!KNM^&_ GAG3%TBS:SL+'1]$U*R.IZG-&B7>HZS<JT]\ZLTI9%)D\(_:/\
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M?A/5OB?;RVVG>-?#VBW$SF1#XC\.:DPT^6**&1TEGTB\7[7%+.Z*A\J1]C2
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M1V'COPA801>!/"^H^*-=.B7_ (C\-I8^(KK14TV>?6[XZY::5::'::I>6_\
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+6Z3=K7>K;>I__]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>18
<FILENAME>ex99-1_002.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 ex99-1_002.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" '( 6(# 2(  A$! Q$!_\0
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M'OF>/$LANT+8A8NC  9Z_*V/K0!Z31110 4444 %%%% !1110 4444 %%%%
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MC68?#6@LW&BZ?C_KV3_"G?\ "-: !_R!-._\!D_PHYPL:/\ ;NC_ /05L?\
MP(3_ !H_MW1_^@K8_P#@0G^-9D?AO00<'1=.8_\ 7LG^%/\ ^$:T$]-$T[_P
M&3_"CF06-#^W='_Z"MC_ .!"?XT?V[H__05L?_ A/\:S_P#A&- R3_8NG>@_
MT9/\*5O#.@@$_P!B:=_X#)_A3Y@L7_[=TC_H*V/_ ($)_C1_;NC_ /05L?\
MP(3_ !KF=6\-:-:Q33KH]AY3H0P%NOR'U'%7D\.Z"8UQHNGGY1S]F0_TJ/:>
M13A97-C^W='_ .@K8_\ @0G^-']NZ1_T%;'_ ,"$_P :H1^%]!"@'1=.S[VR
M?X5!-X:T$MA=&T_(/:V3_"JYR;&M_;NC_P#05L?_  (3_&C^W='_ .@K8_\
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MQ9/U/-=/;^"K&.PN+*6[O[BVF0((YI]WE@'(V^A%0GX>:3Y0(DO?/\WS?/\
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MA*\$/_=]:[V+]W=C802RD?3WI;^0II\L2#DC);/6G)Z78H+HNYR7A>TO-/\
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M_IMIJ, 6ZA5S_">C+]#61_9NM:7@6%REW /^65QPP]@:F\EN:<M.?PNS[/\
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M3M0N7L[5YE7=@@'()"@]2<<X%0V#?Z3>J.TQ./P%6;R*>XMU%O.(7#!MQ7/
MZC'O4IW1F]S-;69H-/>Y>.*51*JQM"V1(AQEO;'/'M3;S59K?49+8QQX,8>"
M0DX)[J?PY%9VH2V=KJ/]GWUPD;2PO<L$C(09PG&#[UG)JEGJEZFEO<2--O\
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M7IWA?0M.DCEM-+MX7C<R(Z+C#'J169XR\,:;>:+JMW;Z9 ^K36YCCE"@,2>
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M_)*\CA5!VDXP*S_%Z[X='7.,ZI!_,UK(B1C:HP*SF- %6,;1DGO2@48%&<#
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M)29+VWP<C<QSZ<5;>EB4M2\D2X7<?N]#61XBECCMHKI0"UK*)/7Y>AK89DC
MWG@]ZSV2.:5@%_=G@ANAI3>ED..]V84Y:PBL/+#*82+B8+T&XX.?S/Y58<01
M)JB/L_>2L/\ >.P$5L&R@N9BSP1L"NUR1]X#L:A^P6!F?_18VR<DE:AQ*YD8
M1LUDTM$)6&\81X,?0+N^5OK3K9H;R>);J(1QO<N)D/ ,JJ.#^.37'W]VD'CN
M\MTN)HI8[N!(8=I^SB/&6W'H#Z5?U[QI:ZCI6J6<=O'''-%)]FF64%W=#R2H
MY7IP:I0=Q<RV.DA^S6&I.T$F^,6;&$DY).\\9^M6=.\QM,>W8MYUK(5_>=3_
M !#/X&N;F\4:;%J5I9S6=O)'!'%%/,\@#AF48 7J0#5G1?%3ZG<+&^D"Q%]'
M*8)0X8RF,[3GT[8JI1=KDP=W8T=+W3:+N^Z;N[8_4;O_ *U=6!L0 #'%>=^#
M?$]AK.-,MC-YNGS[9?,3 W'.0#WYKT8]1Z4TK02'5ES59,!C.:JZ8/\ 1I!T
M(FD_]"-6\57LON3?]=W_ )T=22WT%4)H7D<@)@#G)/6KQ&%ZU7DN5C(RI.:)
M)6U!7(%AEP>"#3EA8$@ID^M2K=(>Q%/,RD<"I2B5=G ?$&Y6VOM#BNKN_MK2
M:202?8=V]B%XX'-7$\0/:RPZ1IMK-=M%9"<2W,FQV!SCKR3QS5[Q)INJ7^H:
M7?Z1+:I/9,Y(N02K!ACM574-$U?5K_3IKMK&,6XW231*PDS@@JO^R:O2Q&IC
MS^(KJY\#Q3:[I44]O<HPN UPJ;ESV'<^WM5B#Q%:^&XVTK1]#<Z78PQ2R.KX
MV))['DFLW4/!FLI;QF2>QE6*&6W3<A;RT/S!QG^+M5T:1>.NIH%0R7=E$N,X
MVK'CYO?.>/I2NMBK,T+[Q+/?Z7JEQ;V,PTJW1U-VLH5RP'.T?UJQ!XK:#6--
MTR:W7RKM%6*3SPTF=N<LO;ZUB'3=0MM(U/2[>\MVTN>,2*)!B1?-[#UP14>G
M^'+NUUVUFDN;5HH[_!(7,S,$QC/]WBBZ"S/2A@'!XKG_ !+_ ,A;PS_V$?\
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MP*R_%PS%HX)Q_P 32#^9K3:?RR4/WNU9R=F4AOV=%9A''&">HV@"D> +M<A
MF.5V=ZD4L_(X%/D7>F"< ]:FXBDI\J,+.8=[OA2%P"*FP6_=JH"].E1R".>/
MR77<O0U(JM$B1KD\8W'J:&XM7!)IVZ#T0 D # I^T9Z"FHJJA8G/TI0^<4BB
M114?_+;/X4\<#IG-(1Q3"X,Z[AGH.<UCZBHGG2<L2 Z!5_&M&>3^!1R>IJC=
M8%N!G_EHG/XU$I=@23W+10E1GCFFR0RGS,.F",CVHZD=".N:BFNHXOE,HWMP
M%!R?RH2;V5Q2:2WL5XY+M602Q*ZCHT3?T-:!E! )(!]">13;:$F/<Q9?;OBG
MM;121R H,2#YL5=D]U8E76SOZCKDJ(!D9;L11&244L>:QXUO[2X%N^ZXLL\.
M/O)['UK5X8E01Q^>*)QL]'=!3GSJS5FB7.6']W'6G1X0@#)'K5*[G:&-0D,L
MI/\ "@_G38)[Z28;[-88>Y=\G\A5*#:N)U(J7+U+#<RL?4U(9&$8"D <TUBI
M;CD=L4\*691T5:RM;0UN1P(0NYC4P%2; 5([4PY2( CFFE85Q"*I3V2/(98V
M:&;^^G?ZCO4XE#,>H(J3.<'%*Z'L9LCWRF-#'!+EN=C%2P'L>*S-?O8[LV-J
M T;M+O>.5<$!>:WI\JHE'WD.?PKGK]4U77IPX#Q6\(10>Q/)/Y4Y:Q27<NB^
M6<IOHKG1:9"([",D89OF;-7<>M4([!3;Q&*>:-@HP0Y/;T-'FWML<2Q"X0?Q
MQ<-^*G^E7)ZF,5H$L;6S2,BLT,@.5'\)]14-O>RV]FB^5%(L:@$K)@XZ="*N
M0WD%UQ%("PZH?E8?4'FH-2BB>RE+! V.N<&I95BW=E3#DXZ=ZIQ)N'%1SL8&
M5&E9HG'RD\C=]:M1IE.",#J0>E1)792>@^WR59?X>QJM>W L8@[ N6.U57J3
M3)-6MK93$C>=-G CCY/_ -:G6MG<7%TEW>[59!^[A7D+GN3W-6E=#M;5E?['
M?Z@ ;ES;0G_EG&?F(]SVJ_;6<%DGEP0A1W;N?QJR74%@>W6FLX<#GJ:+)$N3
M8;<CU%-;B14'4C)IY<J6( Z<5'MW'/0T,DEQCTI<9R!WJ*X.-I'\-2 \Y-%]
M;#&.=HVUSGB+C6/#0_ZB(_\ 0#72E0QS7.>)/^0SX:_["(_] -4MQ'7T445J
M2<YXP_U&D?\ 84@_F:OHFZ;<_7''O6;XT?R[32GV%R-3@^4=^34VZ^DP?-B1
MF/RIMSC\:RF_>2+2TO<TI9& "KC/?%-8DLH+9P.:HM+=VC[KE!,G=XA]WZBE
M34[68$K<)C/..U0WJ5REH#<X';.32\%\K^=0+?6KD*)TP*LK/!P%=#Z#<*2L
M#3[$J8"@8XJ%>9&"C@'K4C.N._X4B] !@ ]:IDDPZ"H9-W\/7/6IE'RX/:HQ
M@N.>O&,TV)%68,BEF+9/0+U)JG-;LL.^5BS-*F<] ,] *TKAE&.<#IGTJ"\4
M?9(\]Y4_G2VND%KNY(L2,Z )M5>@Z4U;6VM&DG2)0[?Q=R:LJC?,P(&>E03,
M96"J/D'ZT^9Q6@G%-ZD<)D*GG[W3VJ8%L$+CTIVU8]H!R33900@88 -2E9%,
M18]@'\3&G>4I!8JN[N::K$#YB/:IA@1D_E0K QL8"950?K4?S2OG' _6I$&8
M_J.:<!MVJH^7!S3M<-B!XQPRG:>G%0F[CA?-Q(L9)PH8XS4OF \'K1+!%*F)
M(U8>XS1&W43O;0F67D\\&JMU,Y 49 H:.2'8(E!3.#D\@4DT@=A@9QW%*5[%
M1:ZD<6<  <Y[U;5O6JRL.,,*GP%!YZGO4)/J.Z8D\JPP22/]Q%);Z5RGAVVN
M;K[1*LK*\[ER,9VJ>GZ5K>))W6P%M$?WERPC'X]3^57M$MTM].CVC&X#\JN.
MK=^GYEN\::M]K\E_P2=;*94"B]FP!CH*/L4O\5W,1^ J[2>M59,S4V9\FB6D
MQ#2!V<=&WG(_&JM[H\$5E.?/F;:A.UB#_2MP, ,^E9>I2;X+C:/^61Z4FHI;
M I2?4KQ"Z*20PVZ^6QRC%A@ CTJ:+1K4J%(D/]XAR Q^E6K89"X& 5%6U 48
M I15]1SF^A!!9P6JXAB1/<"IZ25U0>_85%YW'3D=:NZ1%FQLD;*2W)6B/KN-
M31N)%Q363:>.:FW5#]2/.Z7BG$[2<8-,7'F-SG)IS#YJ5]  C(Y'4TP/B3;G
M(J8\BHEP9,#K0 _W[5S_ (D_Y"_AG_L(C_T UT3YP% KG?$O_(7\-?\ 81'_
M * :N.XF==1116I)SGB\A8=()&0-4@X_$U?MQOE&Y,D9(/I5#QA_J-(_["D'
M\S6G:8"DDDY-9R^)%=!75@Q_/-4FTRVEE$^PJY/S;3@-]:OR,01@=>*9N\M0
MIZ]ZE-IZ"<5):C3!'(FPQKM/M3&L(GW#RHP.QQBK,9!J3%"5RKM;,R/[,C1F
M(W2 =(RQP/I4OV()(K6CO"Y'S+U'XYJRQ!<QJ, CJ*53Y:!%)) Y8]3196&I
M213EN+R%"'B65>[1GG\J=#=VWRMY@#_PJ_!%6HD/+8X'3-(T22N?,16&.XJ+
M.]QWB]T1$^:1\P(W9.#4&J2EHE"?=#ICW^85&P6POM@^6";&!Z-_]>FWF]U)
M"$[65MJC)&"*ERZ=2N6S78TMY92N3NZ8%13R!3L7(;.#2F;$ >/[L@!![FH"
MK$^YZYIM]"4B12608Y([U*&5(\NI-(@P.G&:D=-Z@8&/6A)@[$)?<0?NJ>3D
MTZ.4.O). <5)(,@(%!/O4/S1@C&<=:-4"L68W&PG&%'%2(<A3BJTARJISD<D
M4[>VQ0./6K3L18AN<+<?+]>*>K,ZCVJ"0^9/Q]*G!*G9Z#M6:>NA?07^+H<X
MZTY$&PNP'%&, DT]>(AWXYK1$L@R5A7"YSG%)LC4%S_K&ZG-*V\H..<\5$[J
MB,[] ,U/,QJ-V8][-%)XC@CF?$5K$6=R.%9N!FM?1W#6+!3NC1RJ/_>'K7/Z
M+:'5KF\N+G=Y4[[Q'G[R=%S76+&EO$L<:JL:C"J.U:024+]6.LW[116T5;Y]
M1W+\C!%/4$<$Y(IJ\ <<8ZT;@H7 Y)S2($G88V[L<9(K.N0/[/N#W9"3]*T&
MC#,3QS5>YC::TEB0JH9"H..E*7F-$UKCR@0.P%.GF\E0 ,LWZ52MTU )M$]M
MP/\ GF?\:C:#4!*6,]O[?NS_ (TKM1T';74G0,Q8LYR>I/I4N,Q],#T[U25+
M\,?WUO\ C&?\:>8]1/"RVY)[^6?\:E7*9=B.!D=JE?E,YQ6>D>H*/EGMCD\_
MNS_C3Y(K_P OYKJ'GMY/_P!>K6Q#6I+&<[B*D'"Y8U2BBOMAQ<Q'V\G_ .O4
M4QOHY($-Q#^\;;_J>G&?6DGH.QI8&#QD&G1(%YVXJJL5[P/M</\ WY_^O3O)
MO^UY%_WY_P#KU0BU)DQGC!KFO$8/]K^&L]?[1'_H!K>$=TJDR7:9_P!F(5S&
MN-(==\.AI=X_M$'[H&/E-/JA6T.XHHHK4DYSQ=DQ:. ,_P#$T@_F:NAS#,0<
MA'.!QT-5/%APNC'_ *BL'\S5]69YV#<X/ITK.3LQVNAD[2.Z@= >*9*Y9]P!
M&."31$@$S,$)#$EB3TQ4ERS,F.BFLFM+W+CV);;D]:F+@-M'IR:KVZNI!( 7
M'%6'  YJXWL2UJ,DV1KO JN901[DU'.WF,0&R <8IJ*0/1JS<KO0M))%EG/D
MKP1SUIR%BP7:!GH/:F2Y&%'4 "I"RVXR3EB*OJ38KW4*7&Z-E^7IDU3BF:S<
M13$,C A9>^<=#5EI"9"7RP_A'O3'@2>VD60<,IR#63U=T:)VT>PRT5GM8&8D
M_(,"K049K.M$NXK. (Z3+L'RG@X^M6A?H@_?12Q$==R\#\::MU&XOH7%&.M2
M*>:K1WD$GW)4.?>K"D$]:T5C-JVX/(J2*O7/2HKD$R 9]\5(5!.>]0*FXMU.
M:3["09.[&1[FG+[&D?*-C I4!)R3Q4E#3A,8QDFE^42;01TYYJEJ$,-S?:;!
M*@>-ICE#T.$-7_["TK_GPA_[YJU"Z$Y#RV[ [#O3P0RL>/SJ+^PM+_Y\8?RI
M1H>EC_EQA_*KY2;B.5&U&88"UGWCF>TGCCQDHP&/I6@="TL];&'\J3^P=*[6
M$/\ WS4RIM]2HSL[F)H,Z&"T9.<Q[#[$<$?I6^X&1\W?N:A3P_I"?=TZW7OP
MF*>=#TOO90_E5<NB1,I7FY=R5OF/S<*/?K3N!@@CTZU"=#TL];&'\J/[#TO_
M )\8ORHY17)"3QT_.HGR<@.H Z\TO]AZ7_SXQ?E2?V#I?_/C#_WS0XW!,2!@
MK'D=/6K+!6ZD<>]5_P"P=+_Y\8?^^:/[#TS_ )\8?RH4;#N.$1\W)((^M2E"
M01N'T%0_V'IG_/C%^5']B:9_SY1?E0H"N3*JH,9'YU#<.3\@-']AZ9_SY0_E
M2'0M+/\ RXP_E3<=+ F.&V-1E\>PJI<,OVFT/7]Z>I_V35DZ%I9ZV,/Y4?V#
MI1()L(<CI\M+D'<<#G'(^F:>,=SC\:C_ +"TO_GQA_*C^PM+'_+C#^5'**XZ
M3!&-W'7K7.^(]HUCPR%7'_$P'/\ P UT']A:7G/V&'\JY[Q%I]I9ZUX;:WMT
MC8ZB 2HZC8:%'4+G8T445H(YWQ:P6/1V/0:I!_,UH*^W=G[[G(K.\7X\G2-W
M3^U(/YFKPPCM(6SV'%93>I<4"#8S;@S!L'@5)-@H"<Y//TIJ32JO( SR,FHY
M#)@AW7/7 J7)6L@2=R\& 13CC&:IF<ON4\Y/!]*4.WV<*/O$8JO\X(Z8'0U,
MI=BDB0#G"\FGJK!FQV_2EA;[K+R2<&IA&$R6.>YHM<&[:#54,X)//4U&S"60
MD<BE+AI/E'RXYI57L*+=A$+H6;G\ *DQ^[?)^4(:?LHD4>6W^Z:5AW*MF4%E
M;[02=@JWCUJO9*HL8#_L"K2\C--(39"]I#+G=$I/KCFHQIL:_P"KDEB_W7XJ
MZ!@$TX@8%5RH.=KJ9YAO44A;A7'^VN/Y4PSWL2[?LH/NC9)_"M G/3FD&%RQ
MZ"ER^8^;NC/-S<%0?LDN[U; H"WTH(+QPJ?3YC5KS"[%F''84^/!YQCGO4<M
MWN/G\C.DL5@U/3)2SO(9V&YCG^ UT(Z5DWW.H:7CM<-_Z U:U=,59&3;;NPH
MHHJA!1110 5A>)[U[&'3&20Q^;J$,)([AB<C\:W:X?XCSM&WAB)7QYFLPDK_
M '@H8_X4 =QTHHHH ***Q#XHTL1F0W/R@2DG:>/+.'_(_G0!MT5AMXKTE;M[
M5KDB5$#8V$YR 0!ZD@CBI(O$>GRK*RSD>4P2160AD8@G!!Z' - &Q16/;^([
M*Z>V$7GD7+%(F\DX)'/)[<59M]7L[N*Z>"7>+9BDIP>".OUH OT5CMXETU+1
M+IKD"%T+JVT\@$*?U(J:UUJRO+LVT$X>4,Z,H!X*XS_,4 :5)FJ6KZK;:+ID
MVH7C,MO" 7*KN(YQTKE?^%K>%R/]?=?^ [5I&E.:O%7)<DMSN,TF17$?\+5\
M+_\ />Z_\!VH_P"%J^%_^>]U_P" [5?U>K_*PYX]SN*Y?Q5_R%_#7_82'_H!
MJ]X>\2Z=XFAFGTV21XX7V/YD94@XSWJCXJ_Y"_AK_L)#_P! -8N+B[26I2UV
M.HHHHI <WXQ_X]])_P"PI!_,U?"J2#FJ'C'_ (]](_["D'\S5F2Y"L(HP7D/
M11U-8S5Y%)I+4L%<G)[]!3658P2<#TSR::(;HA7>8(?[H3I2,JJXW,7.>I%3
M)6'&5V-#-Y9P:=Y)2 .QX/:I%167(]:2=U+A.RU%K*[+OJ,B (SR".E/FG^4
M)MSGK@TY<'&!QZT](AG+#)JM;60G:Y5B1WR<8%7%7:!2A .@Q0::5D)NX"D=
M@L3D_P!TTX#C/:D;!@8@ _*:8D4[$,]G 2,#8,"KRCCBJ=@2;2$8X$8JZI%)
M!+<=CCFAON4IQMY(IK99,BK)(TZ9HDY7':E4 (Q[ <5'/*$BSGGTJ7L,:1Q3
MD'RCOS557).2>3VJ<-@?45$66T0W17^T=- .6^T-G_OAJV:Y]T(U'3"01^_;
M&?\ <-=!6\'H9M6844458@HHHH *\T^+$I6Z\+(#Q_:#.?4;4SD5Z77%>/\
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M9_UW;_T UNUU0V,9;A1115B"BBB@ KA_'OAZRUN+3DO;G[-B\4Q3";:RL>N
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M=%KY"\9P,* 2#NYXP1^M=+7&6TG@.TNDGMVT^*:+#HX8C';(_.NR5@X!'0T
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C:/X@U+5-+GOYM,2"RN//(@63<WRD8YX[T44 =31110!__]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>19
<FILENAME>ex99-1_003.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 ex99-1_003.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" '9 34# 2(  A$! Q$!_\0
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M:VP<4PMA7<(6*C  ZF@1B^3XF'75M+'_ '#W_P#CM.6V\3,,C5]*(]1I[_\
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MC.F5=N"H)E8_UI(K>"Q=OL\&UB,$[F.10M1-V,MG\3KJT=C_ &GI1#Q-)O\
ML#Y&#C&/-JVUIXH R-6TH_\ </?_ ..U)-C_ (2"T9N-UNXSZ<BM579"%<AE
M)P&_QJ(MMN_<$8RVOB9O^8OI?_@O?_X[2_8_%'_06TK_ ,%[_P#QVMET .0#
MGT'>B%V=59D9,C[K=15C,6.U\3N@/]K:6/\ N'O_ /':'M?$Z[?^)MI?)Q_R
M#W_^.UKQ2A0R9+$,>@]ZIPF9'N?,5_FN-T7?Y<?ISF@"HEKXG<9_M;2\9X_X
ME[__ !VFO;^)T./[6TLD]!_9[_\ QVMP2HB 8; &,[3Q422H7>4L" #CF@#(
M>W\4(A;^UM*] /[/?D_]_:9#;^+G@1Y-2TB.1A\R?87.T^F?,K8AE,X$I1D
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M=IDR>*(N?[4TH@*2W^@/Q_Y%K=!WJ,]Q56YE0(\8#9 ))QQ^?K38D9+?\).
M-NJ:62>O_$O?C_R+4UO!XHFA60ZKI2[NPT]__CM6K<-,/+4@ KRQ["M,8C"1
M(,D#@9Z"DM094T6XGO-)AFNC&TYW*YC4JI*L5R 2<=/6BF>'<_V)#GKOE_\
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M1]S;8SQ_$1Z4'++N'#J/\BE7) "#MG'2M"A,)]U@/+Q@#M3%2*,JL:JJ[P%
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MD!7)VY4>]01*KSG'' R?\*ENYLE5!SW-0Q@JC-@GV R?RJ>I1)Y^)9 N2H&
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M[5+&2JLI.3CC I%=E(5-K#&<'K0 J.P4<J<="#S4L3LV#O0X/IS4:JVPCRV
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M=HE &3(PP<CH/:H(8P'4.CG(SN XH ,]T23\H.!]*NJ#&1GO4;ZE;#&4["0
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M-(+C"5:1UY(4#GUR.*I7G%SIP'070Z?[IK255)P#QV..M9U\O^E:>.A^T?\
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M5E5^'[OS1,MOZ[F1XN+#PU<\$C<ASV'S"M^!V"G=C#!<<]>.163XP ;PG=L
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MR8!Z^U &;X@ 'AG4N<G[,_\ *I='&?#^G?\ 7M'_ .@BF:^H/AS4B>?]'?\
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M43D!EE !C<<GT-)]QH>Z9/7 /(JN7"'!;D]*=.^4"AB![50-U!!,49)2<\$
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MMFA4V@\X7.1GM3 9Y*8&<,1P..!^%*=RN,C([8]:>WRKGW YI,;3DG.._84
M1/#"\RRR0@R+T<C)%8%IM7QWJL1&5EM89#^'%:PU-)+[[)Y,JL"06RO^.?TK
M(=RGQ 4* /-TX@_\!:KCU]#:E]I>3_0Z*1E";-@*D8V@=15(6=I'(&M[>%&
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M -&+6@58,Q7&"<\]C6?XA_Y TG_72+_T8M:.2,X&>: &J K<G+8Y)I6;=P*
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M]4K9^/*.00*G9CW)58+(4DXSS[4IB?>75U*A>!CG\Z<Z"3H<GW[?2HR3$X#
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M3B?;MRDB XW;O[OJ!SWQSU- $WQ"T*X\1:78QV=Z(FM[V&<*(1)D[MNX\C
M8D_2NNB9D@C\^2,R;1N*<*3Z@$]*X/4/AQX9LTBN;B]N;6-3''G>N'?(P3E3
MR3C/;MTK:U7P+I6L7-C/</,#90B&)%";"H]5*X/ICI0!TI= <%E!^M.KS2[\
M-^%=,O/]-\27:&&\69HIF0@2C+@'Y.G[PG'^U[5Z%8:A:ZG9I=V<OFV[YV/M
M(#8.,C/:@"S16+<>+O#]J0)M7M5W9Q\^<X)4]/<$5L1R+-$DJ'*.H93C'!H
M=1110!F>'O\ D#1?]=)?_1C44>'O^0-%_P!=)?\ T8U% #?$1 T24GH)(O\
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MWC^SA_W32K!ED[YP>&].W'-21/\ $""!&:U6:=I5\U08%79M&Y@<Y+Y_# %
MRAX6?3_$%MJ,US:ZE:BSC63;%J]W(6!4D]2.1C'&><TMO)IEWX)'B"*PUR.=
MG6);*74[K<7+!<<,3CGJ16]J,OC-_"NFMI]ND6LB1!>)(T1!4*=Q'.WE@" #
MW[5C62_%!DF>ZD@0H 0A2$E\M@A,' 8#!^;C/% C)?5K&&*)9=*U?[7*K%(U
MU>ZV[E*C86)&&)+@>Z^]:=_##::1HNHI8:@T=^ZK.DNM72-;@J6Z9R3@-P<<
MCWJ[ID?Q$DU: ZC/%#9BX7S%2.%@8MI+<YR/F  QV;/:N^H \8BUV&ZD9[7P
M_K3VB^6K2-K-TKK(P),97/WN"!VR5YYK;T1]-U/5;?3;JTU:VGG$V&35[ET5
MHVVE2=PY)#D>R^]>F44 9'AB)8/#UM"A8K&TBJ68L<!V')/)/N:*?X>_Y L7
M_727_P!&-10!)K7_ ""W_P"ND?\ Z&M:%9^M?\@M_P#KI'_Z&M:% !1110 5
MGZA9WES*K6UUY2A2",D<YZ\?E[=16A6=J%W?V\Z+:68G3;D^_7(SV..F>N:
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MYXK0IK1QN<LBL?4C- &*_BO3HQEUN%(*@@Q\C(R._I4MMXFTNZGCABG/F/P
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M] 9O_ E*TZ* ,S[=J?\ T!F_\"4H^W:G_P! 9O\ P)2M.B@#,^W:G_T!F_\
M E*/MVI_] 9O_ E*TZ* ,S[=J?\ T!F_\"4H^W:G_P! 9O\ P)2M.B@#,^W:
MG_T!F_\  E*/MVI_] 9O_ E*TZ* ,S[=J?\ T!F_\"4H^W:G_P! 9O\ P)2M
M.B@#,^W:G_T!F_\  E*/MVI_] 9O_ E*TZ* ,S[=J?\ T!F_\"4H^W:G_P!
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"_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>20
<FILENAME>ex99-1_004.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 ex99-1_004.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" %: <X# 2(  A$! Q$!_\0
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MEKT>O./B/_R.WP^_["C_ ,EKT>@ HHHH **** "BBB@ HHHH Y_3?MVLV_\
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MY"G:787EA'';RWJ36T*>7&HBVL0.FXYYP.. *BDTR^35[B^L[V&-;A8U>.2
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M+#%8M>*VG13"58O*^<X;<%+9Z ^V:FDT+?I]U:_:,>?=_:=VS[OSAL=?;&:
M-BBBBD 4444 %%%% !1110 5Y1\+_P#DHOQ _P"OT?\ H<E>KUY1\+_^2B_$
M#_K]'_H<E 'J]%%% !1110!YQ\1_^1V^'W_84?\ DM>CUYQ\1_\ D=OA]_V%
M'_DM>CT %%%% !137=8XVD=@J*"6)Z "LO2]6DU&.]<1(/*?]TJMDLI4%2?0
MG- &M16#!K-W.L,"K +V5\,CHZB+";OF!Y/H".*;:>()[HP3""-;=I8X'!)W
MAV7.1VP"0* .@HHIGG1GI(OYT /HIGFQ_P!]?SH\V/\ OK^= #Z*9YL?]]?S
MH\Z/^^OYT /HIGFQ_P!]?SH\V/\ OK^= #Z*9YL?]]?SH\V/^^OYT /HIGG1
M_P!]?SH\V/\ OK^= #Z*9YL?]]?SH\V/^^OYT /HIGG1_P!]?SH\V/\ OK^=
M #Z*9YL?]]?SH\V/^^OYT /HIGFQ_P!]?SH\Z/\ OK^= #Z*9YL?]]?SH\V/
M^^OYT /HIGFQ_P!]?SH\Z/\ OK^= #Z*9YL?]]?SH\V/^^OYT /HIGFQ_P!]
M?SH\V/\ OK^= #Z*9YT?]]?SH\V/^^OYT /HIGFQ_P!]?SH\V/\ OK^= #Z*
M9YT?]]?SH\V/^^OYT /HIGFQ_P!]?SH\V/\ OK^= #Z*9YL?]]?SH\Z/^^OY
MT /HIGFQ_P!]?SH\V/\ OK^= #Z*9YL?]]?SH\V/^^OYT /HH!!&1THH *\H
M^%__ "47X@?]?H_]#DKU>O*/A?\ \E%^('_7Z/\ T.2@#U>BBB@ HHHH \X^
M(_\ R.WP^_["C_R6O1Z\X^(__([?#[_L*/\ R6O1Z "BBB@!&4,I5@"I&"".
M#5./2;*!W:" 0EW#MY1*9(&.W;';\:N]*SK36(+J"\G".D5JQ!9A]]0N[</;
M%  =$LRA!\XR%M_G&9O,SC'WLYZ$C'O3DT>QBN(YHXBICQM0,=N0, [>F0.,
MU577BSK"+&7[4^#'"77YE(+9ST' /XTL'B"&XDA,<$A@D9(S*2/E=AD*1U].
M?>F!L'H:CM_^/:+_ '!_*I#T-1V__'M%_N#^5("2BBB@ IC_ 'X_J?Y&GTQ_
MOQ_4_P C0 ^BBB@ HHHH 9']T_[Q_G3Z9']T_P"\?YT^@ HHHH 9)_!_O"GT
MR3^#_>%/H **** "F1]9/][^@I],CZR?[W]!0 ^BBB@ IDOW/^!#^8I],E^Y
M_P "'\Q0 ^BBB@ HHHH 8G^MD_#^5/IB?ZV3\/Y4^@ HHHH 9-_JF^E/IDW^
MJ;Z4^@ HHHH *9_RW'^[_6GTS_EN/]W^M #ZXN]^($5GXA;3OL3-!'+Y3R[^
M<YP2!CH*[2L:?PMH]SJPU.6T#7(8,3N.UF'0D=":VI.FF_:*YG44VER,V:**
M*Q-!D7^I3_=%/ID7^I3_ '13Z "O*/A?_P E%^('_7Z/_0Y*]7KRCX7_ /)1
M?B!_U^C_ -#DH ]7HHHH **** /./B/_ ,CM\/O^PH_\EKT>O./B/_R.WP^_
M["C_ ,EKT>@ HHKF]=G>'5$$LTZPO$!&L5XL'S9.<@D$]N>U '0RQI-$\4@R
MCJ589QD&LV#0;>V2XCAEF6*X($B,Y;*[-NT$YQ_.M)#M@4MN&%&<G)Z?K4%M
MJ-O=+,4+J83^\61"K+QGH?:@"@N@%6287TOVN/ 28HO"A2NW'0\$_C3H/#\-
MM+%Y<\@@1DD\DX^9U& Q/7TX]:G_ +8M?LR3[9]LAQ&ODMN?C/ QDC'-*FLV
M,D\422EO-V[7"G;DC(&>@)'.*8%\]#4$$49MXCL7[@[>U3GH:CM_^/:+_<'\
MJ0"^5'_<7\J/*C_N+^5/HH 9Y4?]Q?RICQ1[X_D7J>WM4U,?[\?U/\C0 >5'
M_<7\J/*C_N+^5/HH 9Y4?]Q?RH\J/^XOY4^B@"&.*,J?D7[Q[>]/\J/^XOY4
M1_=/^\?YT^@!GE1_W%_*CRH_[B_E3Z* (9(H_D^1?O#M3_*C_N+^5$G\'^\*
M?0 SRH_[B_E1Y4?]Q?RI]% #/*C_ +B_E3$BCR_R+][T]A4U,CZR?[W]!0 >
M5'_<7\J/*C_N+^5/HH 9Y4?]Q?RIDD4>S[B]1V]ZFIDOW/\ @0_F* #RH_[B
M_E1Y4?\ <7\J?10 SRH_[B_E1Y4?]Q?RI]% $*Q1^9)\B]NWM3_*C_N+^5"?
MZV3\/Y4^@!GE1_W%_*CRH_[B_E3Z* (98HQ$WR+T]*?Y4?\ <7\J)O\ 5-]*
M?0 SRH_[B_E1Y4?]Q?RI]% #/*C_ +B_E3/*C\\#8OW?3WJ:F?\ +<?[O]:
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M_4^M &] R-I\3(6FC,0(+<LXQW]S6'8VUU%;:FD=M*ANCMA;RQ'M.PC)4'
M( SWS711@") $V *,+_=]J=0P1R,=A(MQ#<'3)19($62VV EG",-VWH>2!G\
M:6QTR\AEM8YK9S<+-%(+C@A(U3!3=^8QWS76T4[@!Z&H(%?[/%^\'W!_#[5.
M>AJ.W_X]HO\ <'\J0"[9/^>@_P"^:-LG_/0?]\T^B@!FV3_GH/\ OFF.K[X_
MWG?^[[&IJ8_WX_J?Y&@ VR?\]!_WS1MD_P">@_[YI]% #-LG_/0?]\T;9/\
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M "47X@?]?H_]#DKU>O*/A?\ \E%^('_7Z/\ T.2@#U>BBB@ HHHH \X^(_\
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MGZU/9K8O+# YC=_.PQ8>@Z8K2G2E4=HHB=2,%>1WE<=K/C^QTZ^GM(K:6>:
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MC_Z]'ES_ //<?]\?_7K,LFHJ'RY_^>X_[X_^O1Y<_P#SW'_?'_UZ 'Q_=/\
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M["C_ ,EKT>@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH *J)J=H\<#K(2L[LD?RGYF7.1_XZ:MUS5MX>F@%E)DF6.:9Y 9F*@,'
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MK_H9=/\ ^_E'_"R_!7_0RZ?_ -_* .KHKE/^%E^"O^AET_\ [^4?\++\%?\
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MCD0\.I>3!'M0!Z[1110 4444 9>M>'-'\1PQ1:QIT%ZD+%HQ*N=I(P<5C_\
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M=910!R?_  K'P3_T+=C_ -\G_&C_ (5CX)_Z%NQ_[Y/^-=910!R?_"L?!/\
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M#R/-JLQ,C3.=L2#YI"A)_ QK^M:VDZP^J/=0/;_9YX C?>WJ5==RD'C\1_\
MKI-$O+S4/#,-S-+']K>-\R"/"[@2 =N?;IFAZ:B6I0_X0ZW6X6:*XV,MXMT'
M\A"YP^\H6QDJ6.?:J5CX3NKNW22_FEM9H;R26",*C!$,_F]1G.[:OTYIK>(]
M2%KHLS7,*^=:1SW.(L@%F5=S#JJ<M@CG.,\5N:7?74FN:G8W+2%8?+>+S(@N
M5;=RI!(*Y&.>>#GM3M9@]2L?"%H'G>.7RWDN%N$D$2^8A$@D*EL992PZ&HH/
M!RP7(N5U*<S"19 [(IR561>>.>)#^0KIZ*0'*1>!X(K%;3[?,R!$R2B\R(FQ
M']L#''0D?6M'1= ?1I9&6^>99!&&5HU'"1A!R/8 UM44[@%%%%( HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ (!!!
MZ&LM]!T1;58GTVR$$3,ZJT2[5+?>/MGO6FV-IR,C'(QFN"M+B[TSPC-:Z=IE
M_#?&>:08L3C:9B1G(P<J0/4#TQ0!U;>'=%<DMI=F2>_DKZ[O3UY^O-5;#PM9
M6D4D<ZQW*/V:%5SSD%@."V>]8']I>)_,G\M+Z0.9L&6TV!$$RA"N%^]Y98XY
MS@<9J*^O?%MLA$4EY,Z6SCS(K'*NWELR,%*DYW!0<X^@H&=S<6-G<I&EQ;0R
M+$=R!T!"GVIBZ78(MTJV<"K=$FX 0?O2>I;UKG/$5C<W.DZ-$(WO+H72.9+B
MT,@4%6SYBJ!A>0#T_2J>GG7+6WTNQMOM-G!;)B9[J$R9D#_.N0,;-OW6R!C'
M/&*!'3Q^'-%A9&CTJS4H5*D0KP5^[CCMDX],TZ+0=(@FCFATRTCEB;<CI"H*
MG&,@X].*X^QU'Q%>W-DC7=[$DTR>8HM%)"%')?<4P$+! .O4YJU#<^*4@6YG
M:65O.7S+2.W*,#T8*Y4@KG!';@_-3 ZE]*TLM#OL;7,9<1 QK\I?._'UYSZ\
MTP>']'$8C&E66P$G;Y"XY&#V] !^%<W-?>)HY4CB@GFD%Q( Y@_=R Q.4SE0
M4 ;8#R0<]>N*EW>^*(PY@DU%H/*E>(_8P9#((@0K?+P/,X''(SU&#2 Z]M T
M=WW-IEH6W!\^2OW@<@]/7GZT7>C:1>77G7=C:37#J%WR1@LP'('/4#K5>]22
M^\.W<;?;1)-%AA$NR1"5&0F0.GO[BN3%MK%O):26VFAKNW>Y$$\=LT2/F$!6
M*-_J\D8QT)&1P:.M@W.U70M)2-T73;0*X8,/*7D,=QSQW//UIW]BZ7MF7^S[
M;$^WS1Y0^?;]W/KCMZ5R%WJ&OPWB6\=U?&*99S: VJ^<Y58RN\%> '9AT''7
MUK8T1_$$]Y>-J,BQC8RK (3M1\_*ROT(([<_ATHZ 7=6\.V>IZ?=6T:1VTMQ
M$(6G2)2VP'ISU]*NV^FV5MY+16L"/"I5&2, KN^]CTR1S7,Z%9WD,$\<D=W:
MB6RC@E?RV+&ZP^^4>O;YNAXK).A:J;$L( P<^7!9^2ZI(WE[?.;G]TV?FY]#
MW- '=)H^FQP3P)8VZQ7#;YD$8Q(WJ1W/O1'I&FQ.KQV%LC*K*I6,# 8DD?0D
MG\ZYR"#5=/\ $UO>:BIEM8=/>)[A)6=>&3!V;?O'!)Z]^>*9XL6Y36(KW3[.
MX>[BTVX$-Q#:F7;*2FP=",G#=?4^M +4Z0Z)I3+M.G6I7RO)QY0QLZ;?ICM4
M@TNP!4BS@!5/+4[!PO P/;@?E7&--XC;4);B%=1D,$=REN)8MB/GRBI88&>#
M)C_= ^KUG\5)+-BZNYTCMEEC"V80-F0AERR@EPG..,D#BF!VD]G;7,D4D]O%
M*\+;HV=02A]1Z4Y+:!"A6) 4W;3CD;N3CZUQ>IW7B2WCG>VOYDM[>U>:.::S
M^:4!7)## "L/EZXSCH<T^P;6KS5=)N9I-0:Q$S-EHPA(:$9WC ^7?D ^_P!#
M0@.MN-/LKJVDM;BUAE@D;<\;H"K'.<D=^:=+:6TRQ"6")Q"=T>]0=AQC(]."
M17,6MM?6_B9[F6"?*W$[S3!"1) 5 B08ZX..!TP?7FO%:7,%]--=V%Q,%-Q]
MKQ&S"YW2*80 ,[@%_P"^1D&D!UUO96MG T-O;Q0Q,22J* #FF0Z586UNMO!9
MPQPJK*(T0!0&^\,>]<='I^HPW>FK;Q7$UM L?D13P-Y>XRMYI;=RA52-A/88
M%=Y0!131M,1+9%T^V"VW^H B'[O_ '?2I[:SMK-66V@CB#G<VQ<9/J:GHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ I" P((!!X(-+10!7M+"TL$*6EO' A.
M2(UP*L444 %%%% !1110!!)96LMY%>26\;7,(*QRE?F0'J >V:GHHH ****
M$90PPP!'H:6BB@ HHHH BN+>&[MY+>XB26&12KQN,A@>H(IT44<$*0Q(J1HH
M5548"@= *?10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
+ 4444 %%%% '_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>21
<FILENAME>ex99-1_005.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 ex99-1_005.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" %[ BP# 2(  A$! Q$!_\0
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MW_?*!Y@4 ,=W-5<1&N$MDV;Y"H"[Y7W%SW)X%*JY38BXSZ]_I2E<W#QJJXZ
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MC<L$*C:0&["D5<8LAV 9!]^F!4;9'&3G/7UJ0QG:<8W#KGG\*9\RDXR,\Y%
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M0#(W$'!KD/%+#^THE=?F6!1T!SR:$#'Z=)MTVVP%'[E>,=>!5H!UVE?JH_\
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M+NC&".,'I3N!%PH+%AM&![TS>".,=>_>B0-Y65!P._8?6A2@4,Q)!X([@^]
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MPR<;<#ZU2MFWNL8B7:6^8#KC&:ELR&L)G4*27 ((Z =Z3$.AC(E$B=2,X/\
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M9*[C]Y3S^ I Q5MK9C<C@?RI%'.V?E3_ !#O&0J@M+%(G"="7<MV] *Z@O\
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M5)V))&U60@YYX%(# &2&)Z]O6K5HY2-LC<6&,^](\,K2D^6Q(Z<<5-;K]G4
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MFD0,L$L@RA/\+%>/RJ*":[G$MOJ=KIOV1D8>7'(Y;)/3[HX(Z\U NGV&GO\
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MD94#GD 8R?I0S/:R(19RW+$[$5""<D]1D]!2*)I+?S(?,90N/051EB9'>-L
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MGFEVFRK.01C;@C&!U'O5ZSA.GPND]Q=WHDPRO.R@XQA@ H YZ^U/E#1LJE0
MG) SS5;[(U]<IF\NXT4#;%#*54$'.>.>>E)ZH$[;EG4[6:XDADT^_,, 15,*
MPAG##W;L<^G451U&QO FF?Z1-+!!(#>VI1,W0'1CG &#@X[TW[)JCI%;V^MF
M$(#Y8^R)*R_-GEF.2<<5HZC8W\EVAM[Y[<8 ;,*29.<D@GH"/RJ;:&B?<SDL
M=.UF.5I])DL8U&X$+%&69LJ>%R<]_6K-O!#IX=HUEG992XDGD,CC( (!/0<=
M*1[ R6L41O;[[0@8/-"XC\PG(R0!QC/;TJU:VXMK::$M-*Y?>TKR%VZ 8Y[<
M4.22U"R>QSVJ>(]*OM,GU/[-]L"L8(D: N!+GH5(R!WS5.S\2WEY<06,&G1J
MC2"*)ELW\L(>_P!_@$G^=6]9N+6.[_T2QN)K@';=K!+)!@*-P;Y!\QK-BM->
M6"X"FW%O<$O96ZZG_J]QRQ<CYG W=R,9[5:M8AH]!-W=6%E*;:"1KF"(X@P0
M'<+P <\ GM7)ZIIDC65IJ>O3PF[G\F**WDMX\^8QSMR3CKD_3-<YKGVK1+2P
MECM&><2A/-AO9W''S$[6R/7KG\:M-K.H236S:M+<FS2X,B[9;=F3 .QL%<#G
MU]:$A:G8:/XG@TH6VDZI9V&F/:H3\]Y%N9ASC8@XR#GTK:N?%&CZWIM];65]
M!=3?9'D,<;@X3')-< MYJ5_J\\FAZC/=I>R1N#/8)(Z/LV_.V-BC('ID#VKH
M;/1_$*BZ@U[48+*UN8/*V100;Y"RD,%*\K@D&DTF4G8P]*CU;7M%AU.".7)8
MQ_Z7?SQ*P#9RJIT   ]^:[-+W4H)+:369])M[&7=&ODRNCEL950&X/&2:\\T
MZ>_2V%F;C4K2W@"QQB>[DV>6F<L#&A ^[^%:D^I1W&C)#!'!K&H33?N(KJ62
M>-!DKYBLZ#ELD8]QDT68)G37>EZ%<ZDUVVL7<CR?O52UU$Q\@8V[%/.<<#UK
M'TZ2SMQ)/:^&M=D:7:3+?VYN).@'#,>/?^M0Z1;7[:7+J-M/;PZA:%@]D-(A
M\Z)E!Q&,MCW![YZUK7GBZ\L]#LT-I-<:G/*%N$GM6C\A3R6.S<#@8Z'F@+ZD
M=P]S:6%C]CC2TFO;@1K'/;#,8VLQR@/M^M4KJ7Q!ICVP?4K>Y>3>QAM]-#22
M*O+8!D&..*=#;2^+KB&\LM96Y6PD$UO+_9SHJ-G:2"7PW3W[=*Z"Y72[6>QO
M-3\B?6(4,,+(G[Z16/S;4!)QS_/FDW8J]S/6YAUE8K.XT+4_L9.[,X"1C<#D
M,5?)'8BK-O8Z%H-G+>*+3389@%?<QYV@X!+'L :J2^+M&LIG$D>I0+(3L66T
M*?7@GH3WKH(KBPNA]DWVEP77<%W+(R$=R.W7%2[CTZ#="U73-32Z.GWT%R8P
M"ZQ2!]H/3\*TA.BE#M/'.%P:KVL0B@EC@BC5BV7*H%R.W2K$$42*[.V%&2:A
MB)A<!URC'>@Y&.Y]JH7L#.ZNJ.>,8/J:L0+&)3)%)MR"-O7\?KBK+"(QC)"J
M,-D]C0!SDD8A?<%(/4@CT[5?B8/RRD*#DG-/N$%PTJ @$-65>ZQIVA!$U/4X
M[=VRRAT)4@$#KCWXI[CV-N4+<VC12$ONSM('0BLBQ7?.B$YS\K>XJQ8>(=(U
M>]-K97L;W<8+[$5@,#KU';-66M1!=).Q/F.?F5>F13VW$5+JV:W;:<E">/:J
MC NN<8QZ5N2Q>="V "3DMCM6%&<<=CUR*2'<DQE,D<CL12%R58#ICD,*%P5&
M6YI""R,!D_+CTS[TQEN*)&C3WX^AJ*^LI]0M5MK?4)K-O,#B>'[PQVQTQ4&D
MZ1+:7B7,FL:E=C;@0RR#RNF.5 _'ZUO"&6,AED4*1\PVYJ7OH%^YR\>AWMKJ
M<;-K^IS[(PS*X3$@W=#A> >G%;;#>"6YR.#Z#Z5)YP;5"S,!FVP5!''/K3I;
M*2)0T,JN#R,C/ZBHBV[W[D0>_J-69&X;<HVX/H./SI6B6>3E@<# V,!]:C">
M8W/R\XYXR3VI)8 R#G;MYPH[U98&WD4;E=G4<GY<<>@J7_6#! 5AV'!SFHH9
MY(W*R#)4<'V]:LQO'YH. "QP%]30"&XZY^9C\IXS41C*E@V".Y7U%6SM=1(-
MP)R#CGO56XC:5MP)&#_#_/WI#!XD1E96 &WGW/TJ"!A/AA)(CJ<^Y%3)'YFY
MXF!.<$D>E3")&Q\@W=L#\Z5P*YM9VE1]ZL-N,US7B92FH0J"1B =LY^9J[0*
M%8*"=O57 _05YIXT\1:7#KYMUE>=X8PDIAC9PK9/RDCC."/SJHW;$SJ]/0C3
M+$KLV"!,^OW11.OS!MY(!P!CK3;217TNT"GY5MT!.>IVBGDX.#GWJ[@&]+?+
M$J,<@=36?+<RR.TJ*L9;( (R,XZXJ64CS0=V3TP:;(-XZXP.!BFC-F3%%J:W
M,3SWEJT0;YTAMB&*XYP2WK5]9(E#[%);HI8]*,8;&=O'/_UJC9"/;\*LDE4A
M0J@#G'..<TH(8,""'ST &*8C<8(R,\''-.<AC@X7UQVH&2)Y9#?, >2 3@ U
M$Q7<IW-GOFD1@#\RJ2#0&+/G;C'4CM0 Y1@G)S]>U.VE@6SD#L!Q498JW][-
M6(GQZC..!Q28P+I(5!P,C))IWDC>2V!T((' HD3;(0#SP3D4\<'!Q]<\XI 2
M6[M%)E7RO/'],5.BS7<BQQ'9SDJ0,9/H:JPJS2 #[Q.!D9/M6AY+6Y5&41R9
MR#Z^]'4;V,XQ.EPZO&X8$ABP//XU5F4M"R-+)&IP<QN5;@YX/\Z6]\.V=S,T
MDYNY6D9F.V\D .3G@ XZ_P"%,U1+JX"(L\FGCYB&MU7)SQU(/3^IJDR6K$5I
M:V]A<F6")FF\HQ[[B=Y HZ@X)QP<5(^FZC*D=Q=:W),JE7DABM$5& '(&>0.
M_K2:;:F*"XAEN[BYWG>LD[ E,?PC '%6&N'7;& "5!'!R#0P5MQ0[NS*JD1$
M ;1U]JG>61LQLJ\=W88JO'<A<*\0#*WWE.&QZ"E)C^>55=ESD!N])C'%Y#E7
MC(XXV]*FDLKR[MHWM+J"TNE5C(;B R;QC"E<$8QW]:RVM+Z>=O*OU6+)"K';
MH2,XQRV?<?C6W:W(#+"N[#Y5=YR8SC';M4O;0"%+6XCMIH;J\2YF+^8C1H(U
M"XP0>2>M4XII(L,A*2+D#'45=E<1*T3<XX(SU-5I!$;@3;E="/F&<8H6NXFC
M,@L-0EFC:76+G:I4E4AC4-CJ,XSS_P#JJ]?Z=#J<P(O+^U&T I#=,BG&0.GU
M_2IE?S8P N #@*?3UJO>P7LDJQVUU!;)@'+0&1B0>1U P1^55<-A;O3FGM[>
MV>ZO8%A39F&=D9^G);J3QU]S4DCQ:+81Q1K?7;,7<(J-<2^N,Y_(?6I+Z/5X
M;6T2,V<UPB$2S74;(K''R[54G SUIUL-0\L-<R6XN=^U1;*0FWMDL<YZU(["
MI-]NMCJ ANK9@YB=+B+RV;'&0I_A/ZUC7FA644!$=K9PL 5#BWB)0]>,BK^L
M^)K/35CB^UZ8UR%83-=7'E%,$<8 .>#U^E01^&-/NR;S5=,TUFN78PA"TBO&
MP!#;B!C)]J+==BK]#'DT"WM[RQN[6P:\NXI26$TPBCC.,JV%49P<50U"XM;N
M*>WDL](@NI5"-<&!Y=IR1VC&?F ZFM"73)-0UI[BZM)(9F9 YCU-PB@+@X1%
MP<8Q3KF&+2(4@MM0NX"7)QYIE>0 8XWG@#-7JMR7:Y!%/#X7N7LYH+J.X*R>
M<+;58X8@=G5D"YSSE0<X)IECI6CRV:2:OK$FGMM62$74D$TCJX&UBS+D\@@
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M5L=8CM-.%P5GO)(+B1/,P?ERY4#I@$ _A5M&=SI=/^(.E&:-6LGMHW WR--
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M-'!L0$.A7'0GO37RTP8+@DYR#U_^O5C8@9E4LJX.<F@5AEK'YTQ42*'!W#G
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M!X23;6ZLS$DF!6W$\\Y%=!+"\QE5U7RP.".<UB30^02K!QN/!(XIIB:$?SF
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MM.F;2O[:DTFZA#7)L8W8!\\C#[P"3SQVJE:66F6UP91X=N+Q\M@W>IVLID+
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M/:E<92D8(X5LG;QP./PI)4XR?F4]ZM^4FYB4&2<_C32%4'/<T@*2#R!N0Y)
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MS=>O-37FC374X=;Z[@AV@>5;LH)//S9*GKGI[58>[N+&2*-+.YO')W%(BN
MP')8X!P2?PJM#/XF&DRW^HW]I80I+@QC3UEDV[\!OD8\$$#V(/:D)D=S%.BO
MIT.ESW8:(Q)<3WJQ&0E>&RH!!SP>G2JVE7FAZ6XNDTO5I+HKB9EAGG57+!6
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M?#WC3PKHL>EVEQI,T*,SAI]Y/)SC@@ 5L;O'O][0O^^9/\:77M0T"#5WAO\
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M'T!+9Q^(J7"+U:+4Y+9D^B^*_">I7J6VDW=LUS*S(JI$5+%1D\X].:R?&_\
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M;&2=K98#![8IHRW/''?TIL1:6.W<E=Q1B <-T'K4EQ'&@C,;YV_)ZFJJL=I
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MF*QH$&8(^@&/2G'PG,3SK$__ 'YC_P *Z:BERH.9G-#PI,%*_P!KS8]X(_\
M"FMX1D8'_B;S#)SQ#'_A73T4<J#F9S2>%)D&!K$^WT\F/'\J#X4FSG^V)O\
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73ZM<K/-K,RLJ! %@CZ9)]/>NGHH _]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>22
<FILENAME>ex99-1_006.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 ex99-1_006.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" )6 8H# 2(  A$! Q$!_\0
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M[;U'_H6]0_[^0_\ Q=;=% &)_;>H_P#0MZA_W\A_^+H_MO4?^A;U#_OY#_\
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M%3^T(NT5P?I"W^%)_:"_\^UU_P!^&JY119]PNNQDV]Z!?WA^S7)R4/\ JO\
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MHHH **** "BBB@ HHHH J0_\A.Z_W4/\ZJ:T66;3&7<=EUO8*,G:$?-6XO\
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MT./:MO59(M4MM+G7+6$EP#,'!"E<'&X>F[;UXJ[8R-!?W,%R"L\\C2HW&UU
M  'N !D5EW-K>VLL^F64D'V%X7F*RJ6:,'JJ\CC)R,]*J,%%61$I.3NRII=O
M;7EQ?1SP+ [!9UD@)&UB0",?[RY /3-5[JU\J>" 6)@>Y,<3SLC;8&R0Q';Y
MN,'-3:!Y6FR&\NIH[4219^SF-MSY YW'[Q/7CN:T9H;K4+)7UPF&VEF799P@
M[^2-@=L^N#QC]*22DKL;;6B(/%D(M+"VDCN'B*JUONP#N#+T)(]5'YUJ+I4\
M]MMNM0N7R@"@ +MX_B X8_7CVK.U[2(9XHK.'[5-<.=R[I"^Q!P3\QQWIUIK
M^I")?M6E!4+&))5G&-X)!W9^[R*::38--I#-/T^]/V@"6*6T29E6T?,:J5]0
M,\'KCI7&:UXM2/Q+:V8M(88X;X/Y"B1S)LZG<IV)SDCCG SUKK9;>Y$]Q<:Q
M82O#.04BLYG8!L 8(&/O<<]*SEMDU#Q%=0MIU_!IX2*6XL(54)+-GY6;IC 4
M9 (R0,YQ0Y1ZE0C._-'I_P -^IW]8GB5[F.SB:WSM$JF3 XP"#_,53N)G-O>
M"UCU,26Z'>'N0-AVY!Y8G'TIUQ:75UI<A^Q3,6BRN^]+$\9Z=Z4I)Q=B8Q::
MN=+7/V[Z<LMX]U(D["X<1PD[^#@_*OJ<U4+V4FLQPO83I$BJ)#(&Y9SA<Y/
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MED.$4'T !)-;*Q/($$D" #Y2/1<=N:JS;;9E>>VA2 ,!O/)!)X^G.*E4J?\
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ML@)YH6 D^:)L$\#CFJ]W;/9S6[R:E>BV)*RL7'R\<$\<#/\ ,5H7'_(1L_\
M@?\ *B?4K>)_*4M--_SSA7<P^OI^-0HIMEN321"EG%-")$O[IXR,AEGX/Y5C
MV\2N%:_EU".&X?,$HNFVX/W58@\'_.:?>6%Q+=1B#&G?:V971#N,@VDDL.@Z
M <<\]:TWM;][4V[_ &%XBNPIY;*,>G4T^2(N9D2:/;*6W2794-C)NI#^?-)<
MV-O%:[U,H_>JN3.YXW#CKWJ2V;4;"W\N>W%TJDXDBDRQ7MD-C)QQU.:;J4D=
MUX?:>S*LAV2*5.. P)_'&:F48I-V&I-NUR&\T[3898$FLMQG<HK%V(#8) //
M?%2C1=)3!CL(2@&6R,XJYJ-D;NS9(9##.I#Q.,?*XZ9]JCL;^.5#%<(+>Z0#
MSHGP.2.H]0?6GR1["YI=QR:;8,<+8VVP=S$#FN::ULKCQ7</9J\;6:K%BV0'
MYC][(/&.@-=9)=6\$;$R( BDX!'05D^$HHSH45^ IGOBUS*X&"Q=BV#] 0/P
MI65[(U2:IN3\E^OZ&8L>HV\'V-[::YLP=\,@Q')"P.0."1@>^/2KEY;W.I6"
MW%V&'E)YL,,#D[L=V_O9!^[_ #KH9(EDBDC^[O!!(]ZS(['4H;6&".[M0(D"
M!FMRQ( Q_>I[/8SW1.T=O>V4;HXV##1/&=I7CL1T^E-2:ZML+('N(NF_: Z^
MFX=_J*R+J'5](19([ZV=9IN4%KC!*GI\W^R/SJ^D-[<:?%=R:M)"&B$C;(4P
MH(R>H-'-TL+E\R74WDF@@M(DW2W!'SYP(P.2_P"';WQ5:R%OI.I7D \YBXCD
MR$:1G.""20.N152TMKV';?WUY=2QSQKAXU4&%>H!&.G.<C\:T+6YTRS:62.^
M>XDDP""V]CCH  />AW=AJRN4+C4UL#/MM;P6DN[S-L!VQL>,@GL>_O22A8O#
MEI.EM&9UCB7<$;<N>",J<UKR7)GC=6TRY:-P0V0H)'?C.:S_  GJT=YIPLV)
M6XMLH5;JR X#?T/O2:=]P35MB&.02Z/=7LFG.MS$VU1=YE)Z=,].M9DMS'J=
MS']HT^-/LX#<0DANAVX'(R0>O:NNOI9,Q6T#;)IB?FQG8H^\?Y#ZFIH+>*TB
MV1C ZLQ.2Q]2>YI.$OYAJ4>QS;6%I+HEI>II\,,[30F5?+^[\X# 9Z#K5R^T
M^R-W:2VUE8RHA<2Q_(N1C]<&DOM6%_ILL=C:W<LC8,9\A@K8(/4\8XK/@\.)
M>27!6Y:-A(2ZR0892?F'?IS^(XK-R=[1U-%%;RT*<.I65O$ML=*TPRJQC(D;
M!)S@<[,8]\UFM9YOQ:QV5MY\<D> P\P1QJ <\8!R<CU.:TDT03R6:Q21RW$@
M#R(8_EC0]=W/U '?CTJXGA\)?RA+N%&AV#,L8;=\O7KWR:=ZG;\16I]_P-#P
M_$([V^<111^:L;8BB"+QN' R:WZP-$6UM[W[):7,4RQV^'$0&T-O//'?G]*W
MZVC>VIE*U]!" <>U)Y8P!R<=.:=15$C=B]N#ZBE  I:* "BBB@ HHHH ****
M ,/_ )GS_N&?^U:W*P_^9\_[AG_M6MR@##U;_D9O#_\ OS_^BS6Y6'JW_(S>
M'_\ ?G_]%FMR@ HHHH **** "BBB@ HHHH **** ,[4;>.YO+&.7<4W.2 Q&
M?E/I5V&"&WC\N&)(T]%&*I:G=06=Q937$@CC$C#<?4J:NLQEMRT#J2R9C;J.
MG!J5U&^AF+#)JMT+U9Y+>.!BEOLQ\W9BP(/!Q@#VS6O7'6R:M.OD6CW*6\>%
M9UD7[^[+X..1R?RIPM/$VW;Y\P/\+F12 .^1Z]/R-9^U?\K-/9KNCJ;FYBM8
MO,E;J<*H&2Q] .YK#NK":+2+^[::6WDE5I6AC*[%XX&,=<=2.IK3T^Q:-(KB
M[+R7>P EVW;/4+_C3/$$@C\/WQ)P6A95XSEB, ?G6CUB0M)$<$FI23SI'/!(
MD6U<R1E221D\@^X[55O+&XU'5+:&YN538C2.+=2I"\#;N///X=*TM&$ TBU:
MV_U;QJV[NQ(Y)]Z9,PMM85W8*EQ#Y8). &4Y _$$_E5"*TD!TR15%K+>6K#"
MD+YCQ$=CW*_F14/@P2IX>$$ZJLD$\L94')7YR<'T(S6/>Q7VD8FOKQE@8%B3
M.V"!R8\CNW4$>F*9IVGZEJ%G]ILY'CB=W/SRE3(?[V?T_"N?G=[\IT\ON:RT
MN=W17.Z7I.J03-]JNW";,;EE+$\C'!&!C!_.M(VEU:R"6VN))^SQ3R<-[@XX
M/Z5M%MJ[5CGDDG9.X[5K1[S3W2%PDZ$/$QZ!ATS[=OQJFD@N=%TZT4?-<QQ@
MKGH@ +?IQ^(IE[K<D4UO 4%J\F_S/M$;,%P!T*\$<]<TZQM#:L+9)?-9+%52
M0<9R3R/3M^5*_O!;0VZ,5R36&O%0[3?9PBA6S<Y#84#/L<\U 9+N&\"QWRN-
MV!%)>YSE>%SZ@G\>*CVC_E9?LU_,CM*YV#16N+.U>WNFM)[:68!XT!SESP<_
M05:TJX%E:BVU&^A:Z#$G=*"<9XZU-HV\)>JYSB\EV^P)S_6JW:NA;)V,W38=
M0N-4O([Z]E6>W1(PT:H X;)W#CH<#\C6E_9#;]S:GJ#>WF@#]!3#MB\5K\AW
M3V9!;M\C]/\ Q\UIR2)#&TDCJB*,LS'  JN5$\S&P0I;6\<,8(1%"KDYXK!N
M=332]4U(,Z?:)S%]GC8XW-MQGZ CDU>;49K\^5I8RO1[J13L3_='\1_3WJ.\
MT9!H][% IENYHB#-(<N[8XR?Z=!2DM+KH$7K9]0T_1)+"W,::A+N8[I&5$!8
MGW(-49-,#:S=;TNKMBD9W%T&.O';T[5H2:M/;B(/IER$)5/,9D !/ S\WK5=
M=3==4E8VI5F@7<&F0 88]\TU),'%HCT87$6IO!*J1I&9$2/.7 .UN3T/6NBK
M @U&UN]<MBD4<=P5<.0Z,QX''RDYZ5OT1=[V!H****HD**** "BBB@ HHHH
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M^/<>QXK,N+R5M!U+[2R.]HY0R*,!]N&!QV/-5=/U#4M6G-G)=) 3$7<QQXD
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M !#J" BP\IFD#13!L\</G_V7]:ER4=64DWHB/Q'<W5[H-Y'!87,850_FRE4
MVD,>,Y[>E3W.I*J6/VV.2WVS(2SC*GY3@[AQU]:%\065\@M9(6WRC:\3$<*2
M!R?HV:RX!I=WJ=K;);W0B!R=UPS Y'R'[WU/Y5G[1<UTR^1VLSH=%"K8,$8%
M!/+M(.1C>:6\TBWOK@32O,&  PCX'&<?S/YUF6>E7$#7*V#QVX2=PI#-TZX*
M\@]>M64T[5(_FCU#;(>69B7#'_=/ _#%4K.-FA.ZE=,EC\/6,5TEPGFB1'WC
MY^,__JXJQK"[M&O!_P!,6_E4,%KJR2&2:_AD)&-HBPH_#/6I)K6]N()(7NH@
MLBE3B'L1C^]19)-)!=MIMER(YB0_[(I]4EMKU5"_;4P!CB$?XT[[-='K?-^$
M:U5WV)LNYS'BC1DU/Q7HH=I(58/NEB?:V4^90#V/6ME/#%@@D&^Y;S&+N6F)
M+,1@DGU(XJ:]T<:A;^3<WMPR[@P*[%*L.A!"Y!IZ/-IJ*EP[SVZC G/+K_O^
MOU'XTK+=HKF=DD]B0:;;@ ;I\#H//<#^=!TNT)!:-FQ_>D8_UJVK*ZAE(*D9
M!!X-+3Y41S,J?V78][:,_49IPT^S7I:P_P#? JS13Y5V#F?<A%I;*<BWB!]D
M%2+&B_=11]!3J*=A7"BFL"6!Y_.F /M'WL]\F@"6BH\/SG//IVIR9V\T .HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH P_P#F?/\ N&?^U:W*P_\ F?/^
MX9_[5K<H P]6_P"1F\/_ ._/_P"BS6Y6'JW_ ",WA_\ WY__ $6:W* "BBB@
M HHI&8(A9C@ 9- "T53_ +4M/^>C?A&W^%+_ &G:GHTG_?I_\*GF7<?*^Q;H
MJI_:-OV$I_[8M_A1_:,7:.<_]L6_PHYD'*RW153^T$[07)_[8M2?V@/^?6[_
M ._)HYD'*Q=2_P"/%O\ ?3_T(52U"SANM=LDEC4KY<COD??VX"@_3<34E[=M
M/:/''9W18E2/W>.A!HD82ZA!=FWO,PJRJFP 9;&2?RJ;IO4JS2T'RZ5I<4#.
M]G"$C!8_+T IFE:9;16\5P;2))V)D&%&4W=OP&!1?33W=C/#'97 9A@;@H!_
M7H:L+=W!4?\ $OF!QTW)Q^M/W>WX![W<6R_UEX/^FY_]!6K=5+02)]IEFB,7
MF2[@I()QM4=O<&K+2*IP3S3CL2]QU%-WK1O'OCUQ5"'5S9\;:=]IEMA;7[7,
M,TD,D(@^=-B!RQ&?N$$8;H<BM#5-&AU<'?>:C;.$*!K2[DAQGOA3@GW(-<NW
MPJTY[F:Y?Q!XE,\\7DRRG4CNDCY^4G'(Y/'O0!K1>.--G6,V]IJ4Y-O'<R+#
M:EC"CC*;\="1SCDXYI'\>:/#(HN4N[>,W<EF9I82$61!EMQ[+_M'BL(?!S0@
M4(U?Q"#&BQH1J)&U%^ZO3H.P[5P$OA'Q+%JKQVOAKQ 8C=2A+E]?P&W;E:1A
MMR-P SZC([T >H0^,M.CFA:SL]5=;B W*V\5IOW+YFS( /R_,>>V.?>I8OB)
MH[VMO=RVVI6UG<?ZNZGM2L1.W<HW=/FZ#U/'6O/V^'VJV/AG1]1T^RUO^U70
M6TUBFMM']E@8D[%;;P.F1T!]:B_X0G53\.(G;2/$INDG")H8UO$:*&RKCCC!
MP<>O-)*PV[GM5A>#4+"&[$$]N)5W"*X39(O^\O8U@CQ]H;2K ))_M3:B=-^S
M>7^\$P]1_=QSNZ5Y>UMXSCAD\S1/&_G!V""/Q"'7:",9..3][IQT]:N>$_AE
M%KEU?WFLZ?XBT:6*<-;22:INDF!);<2!PP//U)IB/2[GQIHEO#K+K<-.VCC-
MY'"NYE'<@=P.<XZ8-2^'_%.G>)6NUL/.#VC*LHECQ@L,C!&0?SKD?^%)>&PK
M :AKH#HT;XOB-RDY*GCD$\D&MW3O -IIIPNN^(IH]NU8I-3D"K[C;CF@#K**
M9%&(8DC4L0BA078L3CU)Y)]Z?0 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% &'_ ,SY_P!PS_VK6Y6'_P SY_W#/_:M;E '+>*I=2AUG0'TJUM[
MFY\V;$=Q,8EQY9R<@'G\*IWNO^,[!K19?#^DG[3.($VZD_#$$\_NNGRFKOBB
MSFOM;T"&#4+BQ<RS'S8-N[_5GCY@1^E8&N6-PMYIEN?$&J7"-?QQ&23R\!CE
M?EVJ.1DC)XSQ2;?8TC&+5W*WR9I1^(?&,HB$>@:0\DO(0:D^0O\ >/[O@5;^
MW^./^@#HW_@R?_XU5V'PQ%! (8]4U15]5G )^I S4;^$89#\VLZY^&H./Y4K
MOL5R4_Y_P9DW_B+QEITMC'-X?TDF\N!;QE=2?ABK-S^[Z84U/%K/C::YG@7P
M_I&82H9CJ3X)(S@?NO3^=9'BGPW8V+Z43K&J-)]M5ML^I2'"[6RP/\)'K^'>
MMG0O#%HUA')-?ZC)<N!)*!?R#ENF0&ZXQ^5%Y=@Y:7\WX?\ !)/M_CC_ * .
MC?\ @R?_ .-55O=?\9V+VBR>'])/VF<0+MU)^&()Y_==.#6[)X9TN90LL=S(
M!_>NYC_[-7.^(O"/AZSALI?L!.^^AB;=/(>&;:>K>]3)R2O8UI4Z,IJ+D_N\
MGYFA]O\ ''_0!T;_ ,&3_P#QJD;4/'"J3_8.C<#_ *";_P#QJIAX!\,*<C2E
M_&60_P#LU68O!_AZ'[FE6_\ P(%OYFJ]XRM1[O[E_F<N?''B59((I-%T>.66
M<VYC?5&!1@"<G]WC;QU&15T^)O$JG#6/AL'WUD__ !NF^+_#6ED:*(-/M8=^
MIQ1R-' N2I##!XY&<<&KUKH6@17"VFH>'])BNC_JY%M$"3#U7C@^JG]11[P+
MV75O\#(3QKXC<-_Q+/#^0X0#^V/O9/4?)TI+[QOXCLGM5.F:!*;B80KY6L9V
MG:6RW[O@?+U^E;6F>&]%N;RZO1IEL;=GVPQO;J%X !8#'0]OQ/>J?B?1-+M+
MC0)+;3+.(G58E?RX%7<"KC!P.1TH]X/W/G^!4E\9>(X+B.*33_#H$F<2?VS\
MHP._[OBF2>/=3B.)&\)J??6S_P#&Z[H6-HHPMK !Z",4[[';#I;0_P#? H]X
M/W/G^!YO<_$S4(7MHUB\-S^?,(OW.KLVS()W-^[X''ZBK<GC76XD#_V?HCKV
M,5_,_P#*&MKQ=!$DOAUDB1<:S!T4#JKC^M=31[P7H]G]Z_R/,)/B/K"'/]C6
M+$D#B:Y_^,5#<?$_5[=K9&T.T/G3")?WUP.2"1UA&>G09->CZB_RVRJ>MS&#
M@^^?Z5SWCO=YGA5T/ U^VS]"L@_K1:7<.:E_*_O_ . 947C?Q+*?W?AZU8G_
M *:7/_QBI)O&'C.(97P>DW_7.:;^L0KT"D#!LX(.#@X-%I=PYJ7\OX_\ \PF
M^(GC2"6&-_ 4H:9_+3,[#<VTM@93T4G\*O0>+O'MP<+X"5/^NE\$_FM=#XHE
M,5UX=8=]61?SBE']:Z&BS[AST_Y/Q9P9\1_$,=/ ML?^XJG^%5YO&'CNWN[.
MVF\%6D<MV[)$#JBG)"ECT7C@&O0DD23=L=6VMM;!S@^E9&M0AM5T*8D#R[QA
M^<,@I.Z6Y5/DG*W+WZOLS'BU;Q](/F\+:5%_OZJ?Z1FGG4?'_;P]H?XZI)_\
M:KKJBM[F&[C,D$@D0,5R/4=:LPN<1=>*O&%AJFFZ;<^'])%SJ#ND.S4G*Y5"
MYS^[]%-:7V_QQ_T -&_\&3__ !JH?%=L7\9>"KH9Q%?3H?\ @5O)_A7007 M
M[^2WE;(G<O"^<@\<K[8QF@1B_;_''_0!T;_P9/\ _&JIW7B+QC::A864F@:3
MYEZSI$1J3XRJECG]WZ UU]K=Q7D;/"V55RASZBN.UR>X_M;PS?O,?GO)@B^7
MN$8,3@<#DY''7J: +%QK'C:W"[O#^CLSL%1!J;Y8^W[K\:?+JGC>&)Y7T#1@
MB*6)_M-^W_;*MZPM[AL7=_L-VRX"K]V)?0>_J:FMKN"^6<1Y98I#$X9>XQG^
M= ''MXG\7K<:=#_8&DDWY80D:D^/E0L<_N_0&M#[?XX_Z .C?^#)_P#XU3_$
M;;/$OA1AT-[*GYP2?X5TU '(W&K^-;6WDGDT#2"B#)VZBY./^_54D\4^,&GL
MX&\.Z6DMT[QJC:BV495+$-^[]!71&4:W<26A$D=O;O\ O@#@NP/RC([<9_*L
MO5;.#3?$_AUX/,'VB^DWAG+<_9W'?Z"@!BZSXV-R;=_#^D))C<N[4GPX[X_=
M]JG^W^./^@#HW_@R?_XU6[J4;-:>=&/WL!\U/?'4?B,C\:=97,ET9F:+9&KX
MB;^^N <_K0!RMSK_ (SMKZRM'\/Z27NV=8R-1? *J6.?W7H*M_;_ !Q_T =&
M_P#!D_\ \:JQKTGE^(_#!_O7<J?G!)70GIQUH Y;[?XX_P"@#HW_ (,G_P#C
M54[CQ!XSMM1LK%_#^DF2[W["-2? V#)S^ZKL;=I6MXVG4+*5^=1T!K+U14&N
MZ'*Q^832HOXQ,?Z5,G9&E**E*S[/\F8LFN>,H)O+GT+1HLC*N^IN%;V!\KK[
M&K U#QN1D:#HQ'_82?\ ^-5U+*KJ5=0RGJ",@UD65O>+ TL*?9'WL/LTGS1D
M9X(QRN?;\JHS,"Y\1^,;75;'3I/#^D^=>B0QD:B^!L )S^[]ZN_;_''_ $ =
M&_\ !D__ ,:IFJ7/F^,?#+31M!)$]RLBOT ,7!!Z$<5TDNHV</#W,>>RALD_
M@.: .9T>?6I_'$AUFQL[5QIO[L6UR9=P\SG.57%=?7*Z;=7-WXU=[FV:!A8,
M$R,;D\[Y3CKT]:ZJ@#F?$MJ;W7= @#!0TLV7[J/+/*^A]^U9.L(L>GZ?(DPE
M$>N6L*OQ]Q9, <=\D\]\YK5\3^=_;6@K"KG=),KE!EE7RSD@=SBLOQ9):_9[
M&6S*+;PWEH]P1P%"S *,==W!% '=UG3ZH8[R6T2!GG 7RQR Y/X=!W/-6+N^
MBM(5=B&9^(T! +G_ #W[53@NK*U#W-W?6[3N/G?S!M4?W5]!_.@# \9VCV^C
MV<F?-O)=0A#/ZDY  ]!STKH-'@(5[S_1P+E$(6!< 8!Z^_/Z5S_C#6+&?3K&
M2"0RK!J=K*[*C;=HD&<'&#Q6AX6N8XTN;$!]ZSNX'ED!4/*YH WT>4W$JN@$
M8"[&!Z^M<_XWS_9%D1VU.T/_ )&6NEK%\50K+HF6.!'<V\GY2H:F?PLVP_\
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M\\5MVEO:*BSP6\<;,O55 (]J\^\8WOBQ1H#W&FZ7%_Q.K94\N\=\L2P /R#
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M2S<_@#4WC2/S?!6LK_TZ.WY#/]*75AGQ-X?X_CG_ /11I?&/_(E:X?2PF/\
MXX: -NLC6YIHUCV6Q**5<7 (Q"0>I'<8[#J,UHVC^99P/_>C4_I4K(KKM=0P
M]",T <+X^EOKKP3<W+1&U1 K>6W+DYY)] /S^E=V ,8QQ7-?$!=_@?5$ RS0
MG;]1S_(&NC9=\97<RY&,KP10!3F:ZANXTM[6-H6*AF'!&2<_TJ/5_P#2(/L
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M_L<=H?)3:#(. H*D],>V.#WKFO" B2UT:*W*>4;))F"_PR&-0P_'KCMS79T
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M]VW^]?SG_P!GH TO$$(_X135(47"_8944#_<(I_AXY\,Z4?6SA_] %8M_P"
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M298@98GGVP/I6SX&E$O@70V# XLH@<'N% IE_%J(\2VYM(8Q$V6)<\'"XW$
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MWO"=.QL@D#B%?,X7([UV]<W$$3XB/%$B(BZ4"0J@<F7_ .M724 <?XTLTO\
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M@"^!M4#DX&.37,Z$[1:1JC:;B1QJ=R6#<\^8=V!W/7 K=NKH+:3- ZM*(RR
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MDC:6886+()6,=,CWR3^-8WAJSO+?39WLKA3LOKI&MY?]60LS@;2.5X ]1[4
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M?=_P3D-$N_&6MZ997R:AI\,=S$)"39$JN1V/F9;\A6I_9WC'_H8=-'_<-/\
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MJU\7>$X;EY8]3:YG"8%Q('D//\(XX_  4 7_ .SI-5L=7^W$F2X(BQ$3\BJ
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M$I^T+&B&2-D& 6+8)'H<UM50OW$=Y9/*=L"NQ9^P;& #Z#D\_2K]48G/^$Y
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M2XAFB$CI;-ALQ*05&[(P..IKU..1)HDDC8,C@,I'<&N=TYX[/Q1XGFD8!/\
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MZGG\*PM \/Q7'BKQ)')?ZPJQ26Y0?VA*&.Z$<L0<D\8YZ"@#T%5"*%484#
M[4M<\W@W3W^_>:NWUU2?_P"+J"7P1H:;3+-J?S,%&[4[CDGH/OT /\)J4O\
MQ,I! _M=R/QBB/\ 6NEKS_1O VA-K&OPNMZWE7B8'V^8<-#&>?GYY)Y-;B^
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M\AYBQ("H>> 3_2L>V!7XF:AZ/I4!_*60?UKI6944LQPH&2: *KO]I%NFTJ)
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MUH Y3P]H6EOXA\0P76E:>[1RP.$-LA$>Z(?*O'3C^==,/#NB+TT;3Q]+5/\
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M[BDNG&U/+<-L/J?0#WKD(/!/A^W\;V]O+I5HV_3I)=JH0H82(.F>?O=ZZ%?
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M J?X5Y.(H>QJ.%[V]?UL_P #1.ZN7OM5O_S\1?\ ?8H^U6__ #\1?]]BJ/\
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M2O CB(#5W4(FUL2#YSZGW_PIW_"-:#_T!--_\!4_PH_X1K0?^@)IO_@*G^%
M$$MBDBX&M2H<#E9!_C6K]JM_^?B+_OL5DVOAS0R]SG1=..)CC-JG'RCVK!U2
M]\.Z;_:+_P#"+6,L%BPB>00PJ6DPIVA2,XPZ\XH [3[5;_\ /Q%_WV*/M5O_
M ,_$7_?8KS\:YX::V^T)X2M7B4)YA6"'(9RP0*,?,#M/(Z?GBLGB[P6^''AJ
MW\C=\TOV./"H<['Z?=;!/T!H ])^U6__ #\1?]]BC[5;_P#/Q%_WV*\\M?$'
MAF\G:&#PC;.[/'%$?L\05G< A6;&%Z^_0U3M/&O@VYFN8V\*V\?DSO;[C:Q$
M&10F02!QDO@'H<>] 'I_VJW_ .?B+_OL4?:K?_GXB_[[%<G9#0[FWFEF\+6$
M!2^^PJODQ-O?=M)X' J@^L^%3?\ ]GV_AFTEO#*\*(;6-%9UDV8W$8P<$Y_#
MK0!W?VJW_P"?B+_OL4?:K?\ Y^(O^^Q7GJZ]X:E$Q@\)6C>7:-<C?#"N_:,N
MJ\8) ST_ES6GI]SX6O=<;1GT#3X;U+5;AE-O$P!(!*9 Y(!4_P# J .O^U6_
M_/Q%_P!]BC[5;_\ /Q%_WV*\\L?$?A2\LS<-X6M8L0/<;#;Q9V*@?T[@_I5K
M[7I?G>7_ ,(58_\ '_\ 8,[8?O[=V?N],4 =S]JM_P#GXB_[[%'VJW_Y[Q?]
M]BN8\-1:!XDTTWR>&K&WC+80/;(2P]?NU/K.C:!8QVDS:%:NOV@ K!8"1C\K
M?PJN2* .@^U6_P#S\1?]]BC[5;_\_$7_ 'V*Y)E\/"-POAF3?MPI.AOC/_?%
M4;**P6:U-YX>#QBS59PFAMEKC(RP_=_=QG_"@#4LM!L[7XC:EXB4HHNK**(R
M?: 0[AFW?+VPH3GZUT_VJW_Y^(O^^Q7&62:.OVG[9X;+YG8P;-#88BXV@_N^
MO6K&WPWW\,RGGMH;C_V2@#J_M5O_ ,_$7_?8I&N+5U*O-"RG@@L"#7+M_P (
MUMX\+R@_]@-__B*:?^$<W CPO+CN/[";_P"(H WFL-"=BSVFG,QZDQH2:;_9
MV@?\^6F_]^H_\*Q/^*;&/^*8E///_$B;_P"(I_\ Q3'_ $*TO_@C?_XB@#8_
MLW0#_P N6F_]^H_\*/[.T#_GSTW_ +]1_P"%<]=V^@7<MG!:^'DMY7N4&^XT
M@H@'.<DJ!^&:UO\ A%;#_GPTC_P6I_C0!;.F^'SULM,_[]1_X4?V=H'_ #YZ
M;_WZC_PJI_PBM@/^7'1\?]@U/\:BB\/:5.6$5KHKE>#MTY#C]: -);#0D8,M
MIIP8<@B-./TJXD]I&@2.6!5'158 "L;_ (16Q_Y\-'_\%J?XT?\ "*V/_/AH
M_P#X+4_QH VOM5O_ ,_$7_?8H^U6_P#S\1?]]BL7_A%;'_GPTC_P6I_C1_PB
MMA_SX:1_X+4_QH V(Y8Y;MO+D1\(,[6![FK%9>F:5:Z;<R^1;6<3.@R;>W6+
M(R>N.M:E ''_ !,_Y$C4!ZP2?^@-7FMQXCT#6/#OA_1M'MO)UNW:W!O&C6)8
M"@&]C)GD<'ZU[!XFL6U'3?($'GJQ(>/8&!!4CD'@]:Y!O!-@=N/#D( *D@V<
M?(XR,[N_/YU]'EF+P]*ARU;W4FU9VZ6U75>6QC.+;T.:OM/TKQ#K?C&6._L8
M=0@O(+C3;B250"ZIG&3P5)X/X5WWAOQKHGB3PW!/J$]E;SX\NYM;AU 61>N
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MZ0?R;_&@#HJ*Y[_A&- _Z!!_)O\ &C_A&- _Z!!_)O\ &@"_K'2Q_P"OR/\
MK5EG>W5B^7C!)+#DC\*PV\/:9:W-I<6.FO'+%.K%U#9"\YZFM_[0/^>4O_?%
M &%=:E=:DQMK&%MO\1SU']!6/:^(;+3[A[5[S;(DA5HO*92S D'YL<@8/Y5U
M"V=K'/YT<-PC_P"R#C\JK3:'I%QGS]-63+;CN@'7).>GJ2?Q-,#/@\=:;=2(
MD,T<CO+Y0 #_ 'LXZ[<8XK8_M.7)&+?A=QR[=/\ OFJRZ!HR.KKIBJR,&4B
M#!'0].U7?(@_YY3>G^K'^%(",ZG*#C;!UQ]]NO\ WS4]I>M<NRD1_*,G82<?
MF!3/(A_YY3?]^Q_A4D02%B4CFYZ_N^M $X_X^S_N#^9J6H(V+W#-L=1L ^88
M[FIZ "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
0B@ HHHH **** "BBB@#_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>23
<FILENAME>ex99-1_007.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 ex99-1_007.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" &" <0# 2(  A$! Q$!_\0
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M@B5[EW58V;<5P3CKS70455Q6,[2]$L=&@EM[)'2"1V?R6D9D3<<D*"<*,DG
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M&Q&2I!ZT </]G^-W_/YX;_(__$T?9_C=_P _GAO\C_\ $UZ!_P (WIOI=_\
M@=-_\72_\(WIOI=_^!TW_P 70!Y]]G^-W_/YX;_(_P#Q-'V?XW?\_GAO\C_\
M37H/_"-Z;Z7?_@=-_P#%T?\ "-Z;Z7?_ ('3?_%T >??9_C=_P _GAO\C_\
M$T?9_C=_S^>&_P C_P#$UZ#_ ,(WIOI=_P#@=-_\71_PC>F^EW_X'3?_ !=
M'GWV?XW?\_GAO\C_ /$T?9_C=_S^>&_R/_Q->@_\(WIOI=_^!TW_ ,71_P (
MWIOI=_\ @=-_\70!Y]]G^-W_ #^>&_R/_P 31]G^-W_/YX;_ "/_ ,37H/\
MPC>F^EW_ .!TW_Q='_"-Z;Z7?_@=-_\ %T >??9_C=_S^>&_R/\ \31]G^-W
M_/YX;_(__$UZ#_PC>F^EW_X'3?\ Q='_  C>F^EW_P"!TW_Q= 'GWV?XW?\
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MZ?D'H?OT <#]G^-W_/YX;_(__$T?9_C=_P _GAO\C_\ $UZ#_P (WIOI=_\
M@=-_\71_PC>F^EW_ .!TW_Q= 'GWV?XW?\_GAO\ (_\ Q-'V?XW?\_GAO\C_
M /$UZ#_PC>F^EW_X'3?_ !='_"-Z;Z7?_@=-_P#%T >??9_C=_S^>&_R/_Q-
M'V?XW?\ /YX;_(__ !->@_\ "-Z;Z7?_ ('3?_%T?\(WIOI=_P#@=-_\70!Y
M]]G^-W_/YX;_ "/_ ,31]G^-W_/YX;_(_P#Q->@_\(WIOI=_^!TW_P 72?\
M"-Z;Z7?_ ('3_P#Q= 'G_P!G^-W_ #^>&_R/_P 31]G^-W_/YX;_ "/_ ,37
M<C1]%-Z;,27/VD1^:8OMTV0F<9^_TS5C_A&]-]+O_P #IO\ XN@#S[[/\;O^
M?SPW^1_^)H^S_&[_ )_/#?Y'_P")KT'_ (1O3?2[_P# Z;_XNC_A&]-]+O\
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MW%U<0(1+=/OE=F+$GL.>@]NE6P,5#9W"W5E!<(<K+&K@CT(S4] "8H Q2T4
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M3#Q%_P!>;?TI :7@K_D1/#W_ &#+;_T4M;E8?@K_ )$3P]_V#+;_ -%+6Y0
M4444 >:_&'_CU\+_ /8=MO\ T*O2J\U^,/\ QZ^%_P#L.VW_ *%7I5 !6%K7
M_(P>'_\ KXE_]%-6[6%K7_(P>'_^OB7_ -%-0!NT5B:CXGL].U9=,-O>W%V8
M?/\ +MK=I,)G&3CWJ:PU^QU**)[8RMOE:%D:,JT4B]5<'E3]: -6BH(KNWG=
MTAFCD=#AU1P2OU]*([VVFW>3<12;<EMC@XQ0!/15=;ZU>$3)<1-$3@2!P5S]
M:47MLUN;A9XC .3*'&W\^E $]%9MYKNGV-Y9VD]P%FO%=H .=X49//TZ>M6(
M[^W:.!VD$9G&8UD(5F]L>OM0!:HJO<WL-K+;1R$AKB3RH\#.6P3_ "!JJNNV
M+>(GT(._VY+<7)7:=OEDXSGZT :517,*W-M+ XRDJ%&!]",5+10!S?@21SX/
MLH)3F:UWVLG^]&Q7^E=)7/>&XFM-1U^U(PHOS,@_V9$5OY[JZ&@ HHJ-YXHY
M8XG<"23.Q3U;'6@#D[CQ]9V^B:AJ/V*Y>2RNC;-; C<YYPP/3! )_"M)/%FF
MR3" &;S",;O*;9OV[MF_&-V.U95SX#\]KAEOP@GM9877R\@NS,5DZ]5#$58&
MA75M)!92:I;"R>;S8XC#B5Y N<!MV",Y/3..* +FG>*]/U'11J$;E#\JM$WW
ME=AE5^IR*KZ7XZT;5--%VDLB-Y*S>24)<ACM&W^_\WR\=ZY^#PY_9_B'3[66
MZ,-E#9;99) $2YN%5@A4$Y.U"Q/T'I5[3_ ]S#!92MJT4T]C:I!92+;[4 #A
M]S@'YLX X(X]Z -*V\<:7.)N+@,DSPB(0LTC;0"S; ,@#/.:M77BW1K6YCMY
M+ILNL;[TC9D59#A"S 8 )X&:YV^^'=QJ-X=0NM0MY+UI)"P\EEBVN , *X.1
MMZYY[UI/X+'V*YM8KL*DL%I"N8_NB!L^O?\ 2@">+QOI)D<2O)$B0>>92I*$
M%]@4'NQ/:MRPOX-1M1/!O"Y*E9$*,I'4$'D&N/N?AV;K2EL7U$!1$%W"/^-9
M3(IZ].<$?J*V] T>7P_;1V:>4\<CR33N@( 8D8"Y)..O4F@"4^*=)&JR:;Y[
MFXB<128C8JCD9"EL8!(Z#O3;KQ;HUI%"\MT?W\8EC58V9F4G:. .I/&/6L:T
M\/ZC<Z_J[W+K#ISZE%=(AC^>78JD%6SP-P&<CM3=+\*SSS7E]<2/&\E^LEND
MB\QV\;EE3';+%C^5 &A-XWTRVU6WL9Q<(9ED<R&,A8PBACO[@X;IVK8TS6+3
M5D=K?S5:,C='+&8W (R#M/.".AK U?P9)J=^UPM\L:R>>LB&+/R2HJ\'(P04
M!_&C1/#=UX9622U^SSW%S-$DVU651$O!(W,3NY)ZX]!0!UU%9^J:YI>B1(^I
MW\%JKG">:X!<^@'4GZ5Q>M?$PI(D6@V/VD,/GN;K=&D9_P!P@,WZ4 >AE@!D
M]!U-<CJ'Q'T"UD:*TF?49E)#+: ,%(Z@L<*/SKS;4]2U/6N-5U&:X3=N$2'R
MXU_!>H^N:J,T5M"68QQ1+U)PJBG8#<UOQCK^MNT*7']F66X,@M'(G8>C/TQ[
M#\ZQ7199A-(#),.DDAW-^9IJI>7<:MI]G)/N/$C_ +N/'J&/7\*UH/#2NN=1
MNGGW#YH8_DC'MZG\Z8F8T4_VJX,-I')=2@X81#(4_P"TW05I6_ARYN9A)J%Q
MY,*ME;>W;EO9V_H*Z&"WAM8!%!$D42#A5& *QKWQ+$7>UT>(ZG? XV0\I&?5
MVZ 4 :7V?3].C:Z\BWMD0?-+M Q^-8YUZ_U@,/#MJLB E7N[H;8P?8=2:6V\
M-7.IE+KQ)<&>0=+.)L1)]<=372QQ1PQK'%&J(HP%48 H Q--\-+#&7U6\GU2
MX<?/]H;,:G_97L*VH8(;:(101)%&.BHH _2I*IZAJMCI,4<E_<I DK^6A;^)
MO04 7**S-3\1:1HQVW]_%%(>D7WG/T4<UAR:IXGUJX$.EZ?_ &98L?\ C^NA
ME\>H0XZT!8Z34=5L=(M3<ZA=1V\0Z%SU^@[USY\3ZAK4!_X1K3))$;Y?MMV/
M+B'T'4U8M/!M@MR+S4YIM4O<[O-N3E0?9.@KHE544*JJJCH%& * ,3PWI.J:
M9%</JVJO?W$S XR=D>/[N:W***!&7XE_Y%G4/^N7]17J]G_QY0?]<U_E7E'B
M7_D6=0_ZY?U%>KV?_'E!_P!<U_E291-7(_%'_DF'B+_KS;^E==7(_%'_ ))A
MXB_Z\V_I2 TO!7_(B>'O^P9;?^BEK<K#\%?\B)X>_P"P9;?^BEK<H **** /
M-?C#_P >OA?_ +#MM_Z%7I5>:_&'_CU\+_\ 8=MO_0J]*H *PM:_Y&#P_P#]
M?$O_ **:MVL+6O\ D8/#_P#U\2_^BFH Q=5N+C2?B(NJ'2M1O+1],\C?9P>9
MA_,S@\CM61::1K$+R:NFGS&:]U.XOEM&.UHT\DHBOC[I) _,5Z!JVIPZ/ITE
M]/%-)%&1N$*;VY.,XK.O/&&DVD\$/F-*\\'VA"F-NS(&2Q( ZCB@#Q8Z'XAM
M6^V"VN[9&TR6.Z<P?9(PV01'NW?,>HWGJ:W_ +,^HZCKUIX7TZXT=SI-N&@D
MCPS#S#O 7)R2O&<\_K7JMW=Z-J-I=6=U/:3P%"L\+2 C:3M((SZ\?6L_2HO"
M7ADR0:=)IUDTQ7<JS#+8''4YX!_*@#@]/\.ZC+HEU T=U/:SZE:-Y36?V9=J
ML/,8(#D#'4\9Q5/7_"FL)JFH0V%K<P:&FJ+-Y44/FH5,(^98LC<H?.1V/:O5
M$\2V#WIMB61A))&6<J!\BABPYR5P1R*G.O:3Y2R_VC:E&0NI$H.Y1G)'KT/Y
M4 >5Z9H.IV::-+?Z=?7L$<MVL*O;#?;JZ80E03L7=R!GBK[Z9/; _P!M:#>Z
MLLNG6T5A#"#F%U4^8I;CRR6P=WM[5Z%'X@TUVG#W4,0BE\K<\J@,=H8XY]".
MN*M6NHV5ZS+:W4,Q7[WER!L<X[>_% &'KYO;?3=)O;:QGG:SN(Y)K:'$DFS:
M58+DC<1G]*R] BO-7^(5YXD_L^YLM/\ L"V<8NTV22.&W$A>RCIFM_4]9%KK
MMAIJ'YI(I;J4 <^6@_JS#\JPK+XG:1<P0W-S9:A96D\$D\%Q<1 )*J=0,'KS
MQZT =Q17!ZG\0Q'HU])!I6H6>H1VOVFVBOH HF3< 2.><9R1UKM;.9KBSAF>
M-HW= Q1^JDCH: ,V"18O%UY!T,UI%*/?:S*3^JULUS6IM]D\;Z)<$X2YAGM&
M/;. Z_JIKI: "LJ]P?$&E ]DG;]%_P :U:Q)I0_C"TA_BCLY)/P+ ?TH Y6]
MU/4[6/4&WZY-?&XF3R((_DCAW?(P)& ,8Y&3UXK'FN_%-QIMS);0W,VH6MW(
MUD2ID 4V_&UF W<YZ@<UZ[10!Y'XD74]0\/S6UG_ &Q=@PR@O<0X;<;<Y5#C
M=][CMSP,UHVE[K:ZEI\%L;HVH-JD9=W&8]J^9E-F#_%DDC%>ET4 8&J67B-]
M02YTG5[6*V &^TN;;>&^C@@C/XTAUS5+-@-0\/W!4\>98RB<#W(.TC\C7044
M 8\'BG1I[D6PODCN",^5.#&WY,!6LI5P&&"#T(J"]L+34+<P7MO%/"W5)4#"
MN9NM)T3PVJ"VUN714<DI +@%&/LCYS^% '7TTD*I/  [UY9J7Q'U:SN6MM'C
M@U4)D//=1&V3/;;C.[\A7*ZGXHU;Q!NMM8DND@;[UM%'MA/XKDM^- 'K&K>/
M="TLRQ"X:\N8^#!:#>P/H3T'XFN&U3QUX@U*ZS:2)IEEMP8E DF8^N_HOT K
MEH)[*,"WADA0*.(P0I'X=:7[;"[F.#?<RXR(X%WDCIGT IV FF4W-S]INI)+
MF?\ YZSL78?3/3\*9-<PP%1+( S<*O4GZ 5?LM#U&Y1FOI$LU/W4A(=R/<GA
M3],ULZ?I%EI;.]M#B63[\KMN=OJ3_2F*YSL6FZK?J1#&+)<_ZVY7+$>R#^IK
M;@\/:?'L:>-KN1>=T[;AGU"]!6J3W/XU2DN[NY1$T6S^W3R$A7)*P+CJ6DZ8
M^F: W+,TT-K 99I$BA0<LQPJBL.Z\41_9&N+"!Y;?[HO9?D@W>QZN?912W^E
M17I@$TR:]=%MWD/E+"W(ZG*\N1VYYK1BT. ZA%J-ZYNKR%=L)*[8X%](T'"_
M7DT <U#I6O>)#"=0OIK?3"?WJ &*2X^B#[@^I)-=9IFDV&C6OV;3[9((^IQU
M8^I/>KM% @HHHH 9,YBA>18VD95)"+U8^@KR/4;'QIK&LB_FTZZ38Q,,9*@0
MCVSQGWKU^B@9SF@>'-/@MX;^YTH)J;#,C7$GG2 _[Q_R*Z.BB@04444 %%%%
M &7XE_Y%K4/^N7]17J]G_P >4'_7-?Y5Y1XE_P"1:U#_ *Y?U%>KV?\ QY0?
M]<U_E291-7(_%'_DF'B+_KS;^E==7(_%'_DF'B+_ *\V_I2 TO!7_(B>'O\
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M3#Q%_P!>;?TI :7@K_D1/#W_ &#+;_T4M;E8?@K_ )$3P]_V#+;_ -%+6Y0
M4444 >:_&'_CU\+_ /8=MO\ T*O2J\U^,/\ QZ^%_P#L.VW_ *%7I5 !6%K7
M_(P>'_\ KXE_]%-6[6%K7_(P>'_^OB7_ -%-0!9U&RT6_GABU%+264',:3$;
MC^'4CVK+UR7PWIFG7>MO9VEU)IT>]UA"%QC@#'MVSTK-U/PO<:EX[U/4#:Q[
M'T86]I<R 'RY]S<CN" 1S7*ZKX2U74=&2#3M ^P3V6FR6=RYPIO7(4 +C[RY
M!;<U 'H.B+I&HW5YJ%KIL<-Q#.87D*#);:&)'_?55M*O=#N=4U6*#3[&"VA?
MR7NC)&!,V/F4+U 'Y&LZR\,:](ESY&LW&CC[:TI6*)7\Y2D8R<]/ND5FWW@R
M>?Q%I4G]DPM9QZS/<3X10IB*84D=QGM0!WTL6D37#02_9'FDB\IHV*EFCZ[<
M>G>J,MEX8>WE0Q:=(J 3.H*DC:.#QSP!BN)7PQJ*0OI3:)OU3[>;M-:!&Q4W
MY&'^]NV_+MZ?A3-+\$75GIOA(#28X[B"2Z-^VT9PZ.!N/<9(XH [SPXVC:EI
M=MJ^EVL,,5PAD0H@4KGKG'0\#--:]T>^U]K0Q6\\RV9D:X^5U\O=M*$_7G!K
M!T?1=2D^%)T)+0Z=J2VIM\.0H9^[97L?7K6%JOA;4M<M+N+2=%;1MUC'!(&V
MQ^>4E!91MSD%0<$]>] 'HVGIHUE:EM/-E#!NP6A*@$^A([TV>VT.YT^=IULI
M+.9]TK,5V,_3)/K[UY(WA>YTZ WUQ9WLUO<W]G$+&[6*(S%7_N(,#T!SS72M
MHM]Y[ZQ_8LG]E&\$[:)L7>0(MF[9]TMN^;&??K0!VT<.AVEM:S1_88H(<_9Y
M 5"J3P=I]3WK/N[_ $;1)X/,LX(4$J16LJ%/F:8G.T Y [D]\UR.I^&;FXTN
M&Z32+RV_TZ6>WMK5(W:W1U VO$WRD,020#QFF1^%M8%F)KK1+;S87L)!;VX!
M7$;/O";N^",CZT =OI\UKJ%IJ^C06@M#:N]LT0 P0RY#C'8AL_G2^"[@W/A#
M3&;[Z0B)OJAVG^51Z1<1W?BO79H5 CA6WMG8?Q2*&9A]0'45!X6E2P?7[*5E
MCAL]0=PS'"JD@$@Y_P"!&@#J:YKPF/,N?$%SWEU.1<?[JJO]*S;OXG:0ETT&
MGPS7^WK/'A8<^@<]?P%>;VNO:U>6LH%\]I:RW4TWDVIVEBSGAFZG\,4 >RZ[
MXJT?P[$'U"["LQVK%&I>1C_NCFN)U+XD:E=1E=+L4L@3@37)WOCU"C@'ZDUQ
MBQ1I*TBJ/,?[SGEF^I/)IDUS% 55FS(QPD:C<[GT"CDFG8"2=9+R]EO+ZXEN
M[F4Y=YFROX+]U?P%*2%7)(51W/ %=!IW@G7]5LH[A88K!9.0+S/F*/4H._L3
M78:)\.M(TV,-?AM4N=V[S;H#"^P4<8^N:+@>::;:7VMSM#I%C)>%" \@(2-?
M^!G@_AFNSL/A>]P6&M:B3$?^6%EE 1Z,YY_+%>BPP101K'#&L<:C"H@  _ 5
M)THN!2T_2;#2H%AL;6*!%7:-B@$CW/4_C5WI5:^U"STRU:YOKJ&V@7K),X51
M^)KC9O%&O:]9E_#MG#90,Q5;S4,DNO9XT'4=P2:0';7%S#:P--<31PQ*.7D8
M*H_$UY-=ZUK7C?7F>PT_&D64K"UFG.R)W''F,.K]]H P*WK3PU;A%?5KF?6;
MO.XS7IW*#Z*GW0/3BML !0H "@8  P *=@.9B\)+=>5)K-[+=.C;A#"3%"#[
M@<M^)KI(HXK=-D$4<2?W8U"C]*=534]0CTO3I;R5=P3"H@/+N3A5'U-,#+\2
M7LY\O2+5/WEVA,TI./*AS@D?[1Z#\35:&"*VA6&"-8XE&%11@"J]A;3PB6>]
ME\Z^G<O,X.5'HB_[(' JY0)A1110(*Q;W6OL>HW*F+-K9P*]PZKERSG"*H_6
MMJL>?1GDUJ:[$N(+F)$F3N&0Y5A^'!H&,_M^W1\W&GW,*QR&$N8PVR0#=M &
M3G'I2+XCM-@5K:43NZQPP;5+2%@6&,' X!)!Q4][H-O?03Q23S()[@W#-&V&
M5BNW@_C68_A$V\< L[MWFCF203.51XPJE?E(&,G/.0: +$/BFSN8#=0V-PX"
M&21O+ ,:*Q4DY/J.G6G-XDTW>\4*!\[EA8!=LDBC=M Z@^YIND^&A9:-+97%
MPSO/$T4CIVRQ;(]^:(?"%A!??:8Y91&"Q$&U=H9EP3G&??&:!E&77#<WD=C/
MIJO%.T32Q;0&CRADR3G#=,_3-7SXA6\MYFL(P9$A-Q%YH!6:('G&#D'CO[4@
M\)P^:LK:A=F8&/,AVY8(I3!XZ%3@TV+PO_9UM=+IUP3)) 8(EE"JL2GJ<J,D
MX]?04"-*75+=+*TGCB>9KL P1( 6;*Y/7CI5:V\06=S*#%;3^6C+$\[1;1$[
M#(4YY[]N*EFT2*33[*VBN);62S $,\(&Y,+M/7CD5!;^&H[:<LNH7CPLZRRP
M2,&61U&-Q.,\X!/TH"Q7_P"$MT_[.LOV6?:P=U!11\BGYF&3T!_$]JWH9(+J
MWCGBV/#*HD1L#D'H:P9_!ME+:6T*W,\;VZ.BR@*696.2""".O2M^WA2VMHH(
MQB.- BCV% $E%%% C+\2_P#(LZA_UR_J*]7L_P#CR@_ZYK_*O*/$O_(LZA_U
MR_J*]7L_^/*#_KFO\J3*)JY'XH_\DP\1?]>;?TKKJY'XH_\ ),/$7_7FW]*0
M&EX*_P"1$\/?]@RV_P#12UN5A^"O^1$\/?\ 8,MO_12UN4 %%%% 'FOQA_X]
M?"__ &';;_T*O2J\U^,/_'KX7_[#MM_Z%7I5 !6%K7_(P>'_ /KXE_\ 135N
MUA:U_P C!X?_ .OB7_T4U &YBEQ110 8HQ110 F*Q_#NI7&J6EU+<[-T5Y-"
MNT8^56P/QK9KF_!G_(.U#_L)7/\ Z'0!T>,TN*** (I[6"Y"">)9 CB1=PSM
M8="/<5)BAF"@EC@ 9)/:N2U#XBZ#:^;'9SOJ$\9*E+9<J&]"W04 =;P.:QM:
M\5:+X?DCBU&_2*>7_5P@%G;Z 5YO<^._$NH!LR0::C<"*W42.!_OGC]*YY(E
M6664EGFE;=)([%F8^I)IV ['5/'TJ":W\-Z?':>8YD>[N4'S,>I"#J?<FN)9
M[BXO[O[9>7%T]PJ22F5^'/(^Z.,8 I\]Q#;*K32*@8X7/4GT [U9&@:_<ZWI
M\5O8?9S>(Z*]Z=@(7#9 &2>,G'% $0 50J@* . . *A\.VMSJUMY&EVLMY)$
M"9!&,*I))Y8X%>E+\--'BL)&U6:?4"J%F5V\N/@?W5Y_,UU/AZ&.+P[IB)&J
M*+6+"J,#[HHN!P.D_#34+UUEUR[%M;D9^RVC?O,_[4GI[ 5WFG>&=&TLQO:Z
M;;I+&,+,R!I!_P "/-:U%( HS5+4M5L=)M#=7]RD$(8+N;N3T  Y)]A6+/J>
MN:E=Q1Z=:K9:>1F2[NE_>Y[;(NX/J3^% &QJFLZ?HUL+C4+I((RP5=V268]
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M!%_)17$^-_%^FOX*N(;60WL]W$L86W^<)NQRQZ <XJI-JNO:A;[+V^%HF?\
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M*]7L_P#CR@_ZYK_*O*?$@)\,ZC@=(OZBO5K/_CRM_P#KFO\ *DRB:N1^*/\
MR3#Q%_UYM_2NNKD?BC_R3#Q%_P!>;?TI :7@K_D1/#W_ &#+;_T4M;E8?@K_
M )$3P]_V#+;_ -%+6Y0 4444 >:_&'_CU\+_ /8=MO\ T*O2J\U^,/\ QZ^%
M_P#L.VW_ *%7I5 !6%K7_(P>'_\ KXE_]%-6[7'>.]:&@7&A7_V5[DK=.BQ(
MP4DF-AU/04 =C5*^U?3]-A:6\O(($7J7<?RKRK6_&FNZS"(()AI46[<3:MND
M8?W2Q&/Q KG(K>*')C3#,<LQ.6)]233L!Z!J'Q01KHQ:1IKW$&/^/N=C&GX)
MC<?TKCM:U75/$3_\32^=H%.4MH,QQCZ@<M^-4WD2)"\CJB+U9C@"KFCZ3JNO
M3A=,L':#O=S92$#V./F_#\Z *B(L:[4540=E& *H:0^=.B54DD<L^$B0NQ^8
M] *]*L_A="95N-8U%[J- 2UG"NR%_P#>_B/YUT'@""*#P98>5&D:N'?:HP!E
MVX_#I1<#AM&\"Z]JBN][&NE1\>7YN)7<>NT'"_C79Z'\/M'T>87<BM?7NW!F
MN?F"_P"ZG1?PKK**0!BBBB@ HHHH BN+B*V@>::18XD!9G8X 'K7G&L:_<^*
M4EM;0S6>CEMK2#Y9+M?;NB_J:O>,;Q]1U:'2HI +6T9+BZ"G)D?DI&?0#[Q_
M"L[J<FG83,?78XTTJWM8D5$>Z@C5%& !N';\*M:W<-:Z/=R)]\H43_>;Y1^I
MJ+58WEN])54+*MV'8@9V@*W)K3_+\:8CL]+M([#2;*SB8-'! D:L#D$  5;K
MS_2I[[099ELG6>RE.Y;.8[1"W<H1T![@_A6H?%&IX_Y!MK_X$'_"E8HZRBN?
MT/Q9::M</8W"&QU)#@VLS#Y_]J-OXQ]*Z"D 44WS$\T1;U\PKN"9^;'KCTI(
MY8YE+12)(H)&48$9'44 .95D1D=59&&UE89# ]01Z5S,7A.:TG62TN[1?*!2
M&26R5Y8T[+OZG'0>U=/[4SS8S*8A(AD4!BF?F /0D>E &-_9>M?]!F#_ , Q
M_C4?]BZZ<Y\1@>FRQC%;OG1>=Y'FQ^=MW>66&['KCKBGT 8;6>MV]L2MQ9WT
MHYVM&86?VR"0/RJC;ZU.DZ6VL:=-I<TAQ&7<21R?1UX!]CBNJIDD:31/%(H:
M-P5=&&0P/4&@#.P.V/P[T=:S+?0KS1I&M=*U*V:U?+PV5\&)@4=5C93G:/?.
M,U.RZ^IP-)M9 /XEO@H/X%<T[@7*" 5*D J>H(R#5$G7E!)T:V '))U%>/\
MQRHX[G69H1-;Z3:W$9. 8=21@?QVXIW JWGA+1[N?[0D#V=QG/FV<AB/X@<&
MHTT#48B0NJQSH/NB>#!'_ E(S5YKC7U0L?#F0.RWZ$_@-M1G4M9 S_PC%U@=
M<7"9HN!7_LG5?^>EC_X]4,NG:S&P"1V4H/<2,N/T-6_[9U#_ *%G5?\ QS_&
MH_\ A(Y^_AO7<CK_ **/_BJ+@538ZZ%)%I9D^GV@\_I5-=2D@98]4L9["8]
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M\B7IG_7-O_0C6[<_\>LV/[C?RK$\#@#P3I&/^?<?UH Z"BBB@ HHHH ****
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MCDP7EIJJD])5^SNH^HR#^E-_L/Q#_P! E/\ P*2O1:*+A8\Z_L/Q!_T"4_\
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M10!YK\8?^/7PO_V';;_T*O2J\U^,/_'KX7_[#MM_Z%7I5 !6%K7_ ",'A_\
MZ^)?_135NUA:U_R,'A__ *^)?_134 ;M%%% !1110!3U5MFCWK8SBWD/_CIJ
MKX6C\KPEH\9.=ME#S_P 59UC_D"7_P#U[R?^@FLK3=;TO2?"VDMJ.HVMJ/L4
M)Q-*JD_(.@/)H Z*BN.N/BIX)MOO^(+=CZ(K-_(5YSKOQ]N#,T6@Z6BQ*2//
MNSDM[A1T_&@#W.2:.&,R2R*B+U9C@#\:YO4?B+X1TL-]HUZS++_#"_FGZ87-
M?,VL^,/$GBB8IJ&IW-P';Y;>,[4^@5>OZUM^%?A/XD\1SH\MJ^F6)&3<7*8)
M]@G7\Z!V/8+7XT>&[Z^CL[.#4+B>5]L:1P9+_05Z(C;E#8(R,X/:N0\'?#C1
M/!J>9;Q_:;XYW7DP!?'HO91]*[&@044A-51JE@9I81>VYEA4M+&)5+(!U)&<
MB@"W36D1&568!F^Z">37GOB7QT;G1+]M!>Z@O[)$O8UF@*?:H%8!]NX<KCO6
M+XA\3^(;&\TJ[UBSMHA;3PWD4]HQ*-;R'9*K \Y4,ISTH ]=S2UXM8:AX@_X
M3=KQ;EF==3:WEMEF>1YX2W!$1^5(PN#O_6O:10 4444 %%%(30 M%4;W6=,T
MW_C^O[:W)&0LDH!/T'4UQ.K_ !01)C!H>GO>8_Y>ISY<0^@^\?RH ]$S69J'
MB+1]+?R[[4[:"7_GFT@WGZ+U_2O*-1\5^(M4C"2ZD;5#]Y+-=F?^!'+?RK"\
MFW@<W#A?,_BGE;+'ZL>?UIV ]&U;XH00S^3H^FS7P(_X^)#Y4:GZ$;C^5<Y?
M^-/$>HHR->0V<3KM9+2/G\';D&L2&.ZO>+"QNKUV^[Y$1*M_P,_+^M=3I'P\
MUB] EU2XAT^-A_J(AYDJ_5ONT <=Y,,&9YY'D8<F>YD,C#_@3=*LVL%WJ*;M
M.LKJ]]#!&2I_X%]W]:]0TWX<:!8NLMQ#)J,RG(>\;>!_P'A?TKJXH8H(Q'%&
MD:+T5!@#\!1<#RG2?A]KE^BRZA)!IJ'_ )98\V0?7!VC]:Z2Q^&6B6]PEQ>-
M<ZA*O:>3]V?^ #BNUP**0'#VFJZ]>V]_-X<TW2H=.M)9(8(Y0RM<%."5VX"@
MD$#-7-+\?Z-=:/:WE]/]AGFM_.:WD5B1AMK*I ^<AN,#)JJ-'\4Z'))9:!+I
MLNG7$LDH>[#"2V+DL>!PPR3C]:SIO 6H_9=.LX;B IHZ?:+.:5<M/=EBQWCM
M'[#U]J .J_X2:QMY)A>7D0_T@011QQ2&0L5#;2N"2V.>!P*SM%\8KJ=PQDD@
M6,),XACBE:9E278& QT]1C.:SY?#6N/.-9BCM!JD-]]KCMG<F-MT0C=2W;N0
M:HP>$_%5D;B]MI;)-2DL9X49&(1)))M^1[ 9_&@#KD\9:%(LI2]8M%.+9H_(
MDW^:1G8%VY)QS@#BE_X2_0R41;UFF=V00+!(90RX+ QA=PQD=1WKAH_ &LS>
M&K6SFMK*"YT^Z^TP^7<R9NV92',D@PP<]B*M6'@C6-"EM=;TN*Q;5@TGVBVE
MED9&63:/]8Q+%AL'/0\T =-X3\4-KOA0ZY>I%;HKS!MF2H1'8;N>>@S5B'QC
MH=Q#%+!=2RB93)&J6LI9T_O!0N=O/WL8K+\.^&M0TOX?7.B730F]F%SS&?DS
M(S$?A\U5SX>US2(]'OM&BLY]0MM.33IX9W*QA1@[E(_VL\=Q0!N2>,_#\:(W
M]HJP:'S_ -W&[E8\XW, #M&0>6QT-5])\7V=]>7=M-/ KK=M#;+$2S2QA5;>
M1V'/7I7/V_@S7]"F:YTB>PGN;^W6WO3<(=L1W,V]!W4;C\I]JEL? ][IOB*7
M7[>9&OY+HK,,X2>V95!!7H"""1CZ4 =)#XJTW48WCTR=KBY>%Y+=?*=5FV_W
M&8 -SZ&I?"NG2:5X:L;69<3B/?,._F,=S?J37+^%_"FN:5XE-U,UK9:=&KJU
MK:2,T=PS'APC9\K'H.M>@ 4 %%&:* .=\=?\B7J/^ZG_ *&M="OW1]*Y[QU_
MR)>H_P"ZG_H:UT*_='TH 6N1^*/_ "3#Q%_UYM_2NNKD?BC_ ,DP\1?]>;?T
MH TO!7_(B>'O^P9;?^BEK<K#\%?\B)X>_P"P9;?^BEK<H **** /-?C#_P >
MOA?_ +#MM_Z%7I5>:_&'_CU\+_\ 8=MO_0J]*H *PM:_Y&#P_P#]?$O_ **:
MMVL#7I$AUO0I9&"1I-*S,QP !$V2: -^D)P*\QU_XW^'-+G,&GI+JKCK) P$
M8_X$>OX"O,M;^)/B[QW>?V3I<4D"2$[+2QSYDB_[3=Q^0H ^@-:\7Z%X?LY+
MG4=2@18^"B.'<GV4<UY=K/Q_ACN631-'-Q".DUTYCR?]T"N1TKX*>+-4"RW*
MV]@&Y)NG)?\ (9KK-(_9_59PVL:T9(P<^7:)M)_X$W^% '$ZY\6O%VO)) MT
MEI;R*4:&UC'(/;<<FN-6POKAE"6=W,Q. !$['^5?7VC^%-#T&T6VT_3+:)!S
MN\L%F/J2>2:UUC1/NHJ_08H'<^<?#/P1US5<3:Q*NE6Q4%  ))&^J]OQKT'3
M?@5X6M#NO)+R_/I))L7\E_QKT^B@1C:/X3T+0% TO2[>V(&-RKEOS/-7[B_L
M[0_Z3=00GK^]E"_SJU7GGC2W_LSQMHNNII,FJ?:()M/DM8@I9B1O4_-QT#?A
M0!J^(/B+H?AZ\6UG^TW#B(3RM;1>8L49. S,./PK,U#Q5K\T%U<V*64-A'?Q
M6J7 S([1R;?WN. .'7BL/3?A5>1"*^S8>=+;-"UM?1M*+?YF*%<$ LH;'/'%
M=YI/A.UT_1FTV>:6]BDCC27S^=Q0=>/7C\A0!QMU;ZVM_JES=:U>37NB2P^2
M8T"+-!(/F+(!@GEN?]D5@:)X3\36^M:;9+#-;3:;>2.]R(T$+0L3F0OR968'
M[IX%>W+$BN7V+N( +8Y('2I* /.-&^&;6NI0WMW=Q"2/SDE,89S=K(,$N6/R
M\8P%X&*W],\":98JXN9KG4BUJMF/MC[@L(_@ &!C@>]=110!''!'$%"1JH50
MHP.@'05)6-J_BK1-".S4=0ABF(RL.[,C?11S7)S?%'SED^Q:-,N.$>[<)N]]
MHR<4 >BGI69J'B#2M*MI9[R^@C6-=S*'!;\%')KQ[5==US77S?:G+#!T-K9$
MQ1L/1NI;\ZS"MI8PF1A%!&O)8\ ?B:=@.\O_ (JM,Z'0]):> _>GO&,/Y+C)
M_2L+5?%>OZJ"C:D;6 C#1VJ!-P]V.3^6*S-.L=3UN1/[+TRXN86./M6-D(_X
M$>OX5UL'PRU*9\7>JP01'J+9"S_@S8 _*@#A8K:ULP0JHA8\EVR2?J>:MV=K
MJ.JW3VNE:=/=3H,EF4QQ ?[YX/X5ZSHO@;0M#56AM%N+@=;FZ_>2G\3_ $KH
MU4*H4  #L!0!YGI_PTO[BU5]2U)+64_>CM4#[?\ @3?X5TFD?#_P_I$Z72VA
MNKU1@W%RY=C^'W1^ KJ:*0"*JJNU5 'H!2XHHH **** "BBB@#SO2[^[-U-J
MT21G4-6U5[!7F8E(8(MP "CJ?E)[9)JBM_-::LYN5BGG_P"$AE5':9HT0BW)
M!ZX XY!R!FNBA\%+)!K.GWTHETR]NS>VQC8K-;R-RV#VP>01ZFK%OX"T6WM8
MK9DGG1+AKDF>3>9'9"C%CWR#0!QI^*FH17R6?V6SN96L9)V9 Z1)*#@*KGB1
M>>6%=!K/C&[\-V=R^HB&613;K&UM"S -(3NRH))  .,=:H3>$_#.D:I::+:*
MTFL3VL_V/[:6EC\K&&C;_8'8"FZ!HNF:<^JZ-<QM(;F>&UD6W:27RGV%PQ=@
M"N.Q[8% #[;X@WVHJD>GVZ.TFIQ622W-O)!E70L6V-SD8/UJO>_$N[TS5AI=
M_;1I(EW/!)<6\$D^4C"E2(UYR=XSSQBNML?!FF65M:1![J>2WNA=^?/*7DDE
M (!=N_!Q3+_P/I&H)<EQ<17$]P;G[3!)LEB<@ [&'(! '% '-6?BJY\3:5#J
M9C\B(65^L]JR,OF&/: 0>",@_ADTGACQ3JVI>'I3H]EI\<.F0V\0ANIV'F,R
M@M\Y^Z #P3G-=3-X*T>:UL;98Y88[(.(Q"^W=O&'W?WL]3[UC+X9\*S7=A"U
MK.CVTOV-(G!5;HQ+D;QT=5'()H M^+&N6U[PB()1%(]X^3RR_P"J;J 1FL*^
M^)L]A<:;:7,"H]S'<-++#;R3X,<A1=J+S@XR3GBNZU/3[:=K34)H99)=-+3P
M)%U)VD$8[\5AP^&O#_B?P]936QGCB)::"YADV3IO8LZ[AR 22"* ,%/B+JES
MHT^I6UC;QK;:2VH/'-N!9ED9=@Z$ [<Y[5JQ^+]1VW0E2Q5TTZWOXW=BB+YA
M(*GUP!QW)XK8E\%:-):W%LL#1PSV/V!TC; $62>/?)/-+<>#=)NH9HI8Y"LM
MI%9GY^52,Y0CT8'G- '#ZGXTO=9MIX;*X:**VU2RB\XVSPO*KOR"K'(''7N*
ML>'M4<7%K/$!;6L,VI/+""TF_8PR<DYR?3H.U=*/A[H@TZYLV-U)]I,;S323
MEI7>,Y5]Q_BJ1? FD1_8?+-RC6=U)=1E9<$NYRP;U4^E '$7GQ 7Q'HMS8"*
M4^?:><S&SDB6)A(GRAFX<$$\CT]Z]=7[H^E<#XA\)Z;H?AS6+VU,[/*J+&DL
MI9+=#(I*1@_=4GM7?+]T?2@!:Y'XH_\ ),/$7_7FW]*ZZN1^*/\ R3#Q%_UY
MM_2@#2\%?\B)X>_[!EM_Z*6MRL/P5_R(GA[_ +!EM_Z*6MR@ HHHH \U^,/_
M !Z^%_\ L.VW_H5>E5YK\8?^/7PO_P!AVV_]"KTJ@ K!UQ5?7M 5@&4SR@@C
M@CRFK>K"UK_D8/#_ /U\2_\ HIJ ,2]^$?@R^U"2\DTK8\G+)%*R)GUV@X%=
M%HWAG1O#T(BTK3K>U4=61/F/U;J:UJ* #%%%% !1110 4444 %5[FRM[QH6N
M(ED,$@EBW#[CC.&'OR:L4F: #%+6'KWB[1?#6P:G=^5(_P!R,(S,Q]!@?SKC
M]8^)=](PCT33DC1A@SWIPR^X1<Y_$T >F9XS6%J_C'0M$^6\U"+SB,K!$=\C
M?117DUWJVL:BY>_U>ZFR,%(SY4>/]U:S6^R:; \I"01]68+C/^-.P'?W?Q0E
MGA/]FZ.\;$?*]ZX4CWV+G/YBN4N-=\07^?M^LW#AO^6=O^Y3'IA>3^)I=*T/
M6->M!<Z78AX6^[+/((T/\V_2NJTSX7O*BR:YJ;L<<V]E^[4'_?\ O']* .!<
MVMKF20QHW=G.6/XGFM/2M'UC6Y0+'2[CR&&5NK@>7$P]B>3^ KUK3O"FAZ6R
M/:Z; )D&!*Z[W_[Z/-;/2BX'F=A\,;V6Y635=61;?O;6:$$_]M#S^0%=;8>"
MO#^G,KQ:;%)*O_+6?,C?FV:Z"C-(!J(L:!$554= !@"G49I,T +1110 449H
MH **,T4 %%%% !0:** /'+/5"WC>R='>!O[5D2XC<2O,$(8#S'/RA"<8 '<5
M&UAJEOX9T"\T=KN/6[J>ZC:5G<ELK)M# Y&,A<>G%>S8Z\T8H \:\-26=U\0
M_#$ME;Z@LD6GS)?&Z5R5FP,ABW\6<_I5GQ"+V/Q3=M;BX57UF/<8PP#+]D?K
MCJ,X_&O7:* /'-$TDS7WA:"X%\\%UHTTUXLDTF))5*[2_/49.!45EJH_L6";
MQ2+Z6:?34732BR9\P%PPXZ/G9R>P%>SXHQ0!Y-JEA>W2>)KB\>]%_9Z=:20/
M'(Z[)A'EBH'!)(YIEI.RW=A>ZH)FV:[<!))58A&:%=A]AN_"O7,4M 'C7A"?
M6#XOTV&XN]]\'E_M".."3>!S_K6)VXSC&!Z5Z+X0*G2;DQ$?9S?7/D@# ">:
MW3VSFMN>!9X)(F9E$BE24." ?0U%IVGVVEV$-E:1^7;PJ$1<YP/ZF@"U1110
M 4444 <[XZ_Y$O4?]U/_ $-:Z%?NCZ5SWCK_ )$O4?\ =3_T-:Z%?NCZ4 +7
M(_%'_DF'B+_KS;^E==7(_%'_ ))AXB_Z\V_I0!I>"O\ D1/#W_8,MO\ T4M;
ME8?@K_D1/#W_ &#+;_T4M;E !1110!YK\8?^/7PO_P!AVV_]"KTJO-?C#_QZ
M^%_^P[;?^A5Z50 5A:U_R,'A_P#Z^)?_ $4U;M86M?\ (P>'_P#KXE_]%-0!
MNT444 %%%% !16;?:]I>G1R/=W]M$$&2ID!;\%')KB-2^*GFE!H&EO<+G$DU
M[F%0/]D8RWZ4 >D9K,U'Q'H^DR+'?ZC;P2-T1G^8_@.:\LU7Q;KVJ+Y7]H?9
M(2,,EJ@4M]6.3^6*YZ&WM;,;8PB,W)+-EF/U/)IV ](U?XG6\,A@TC3I[U^@
MG<^7$/?GD_E7*7'BSQ+?!OM.J"!23^[LD$8 ],G)/Z5FV=GJ>JW#6VEZ9<W$
MP&0TB&*+_OMAC\J[#3OAK>SV:/JFI"UN&^]%:('V_P# F_PHV X6<0(YN[I@
MTG>:=R[?]]-DU=M[#5+^&.73M*N[Q7.%9%VK]2S8&*]2T;P!H&C7(O$MC<WP
M'_'S<MO;\!T'X"NG  &!THN!Y?I?PUU.XE675]0CMH"/^/>U7+CV+GC\A766
M?@'PW9LKG3DN95_CNB9?T/'Z5TM%(!J(D:!$554# "C %<#XJN67QQ:V\EIJ
ME[;?V<TAM["9DVMYF-Q 89XXKT"L:ZM["V\2V>H2O)]MGA:SB1>05SO)(]L=
M: .%TWQ-JUGX>@>VD*G4M0E6Q^W[YFMH$'(?;EB<@\=1GFM2+Q?K%^^FZ/8Q
M6HUF=9I)I98W6$1QMC<JG#?/D8].]6M1T/1;"YN =0O+6Z>:35(S"<M"P&V1
MD&#D'/(.:MKX-TZXLM/>&[O(KFW9Y8[Q9/WK^;]_=D8.[/3'';% '*^%?%^J
MII4EM<;9I+?1IM0,DK%F,JRLNTGNO%:UMXE\1ZG:VUWIUM9O'#96]S>1N2&E
M:1=VR,DX7"]S4\OPQT5[*WM([J]A6*U>S=HY1NEA<[BK''J>O6KLO@33I(X(
M4NKN.!+>*VGB5QMN8X_NA^/U&.* .>7XB7\^JO/;VD<FE1WOV)X%C=I^" 9=
MP&S:">G7 JK)KOB/5]7\(ZLTD5OHU]J+*D,#,'V;6"B4YPV<9XZ5U;^ M(DU
M#SO,N5M?M(O#8K)B$SC&'P.>PXSCVJHG@'1-)O(-2-]=I;6%PUW!#)-F*!B#
MNQD=#GIF@"3QCKVKZ1*HT\VMO MNTKW%U"\B,P/"93[O'.3Q6!??$35+6ZCN
MEALGL$N8+>:!"S2GS ,N''RC!;A3S73WVFV/B/5+DV^HWMI=6\/V6Y: ;0\;
M_,%^8$'ZCUJC/\,-%GQ']IO4M1.ERELLH"+,H #],DX'TH JZ?XKUUYH=0OO
ML$>CR:C)8A$5O-^7?A\]/X>E4CXB\1W6I:+J7EPR6%VMU-:VUNQ5WVH=B29.
M&S@'VKL8O"NGPV5O:J\OEP7QOERPR9"2<'V^8\5F?\*\THW*O+=7DD$2S)!;
M-*-D2R@[PO&>_&3Q0!SD_BOQ'=:'J<#SV=MJ*6\%PA2-T>#=(%:-E;DGD?,.
M#S6M-XD\0P27-Z4L'TO3;A+2\ 5A+(WRAW3G  +< ^E,M?#OAW$EC-JMY/<7
MD)TR$W$F)5CC.2J<#(! .[GIUK3;P#I\EU'))?Z@\0>*2:W,WR3R1@!7?C.>
M!GUH P3XYUU;VXNC:6ATBSU9M-N.OFMSPZ]@!D#%/\,^/]4U?4+":ZLXET_4
MF988X8I#);]=K2,1M(..W2NE3P9ID=O=0;IBESJ']HR M_RTR#CZ<=*KZ5X!
MTG2+ZVFMY;DV]HSO9VCR[HK=W^\5[GZ$G% '5"EI.!QFC(]10 M%)D>HHS0
MM%4CJEJL\<+2JLLDK0HC<%F R0/7 J[F@ HHHH **** "BBB@ HHHH ****
M.=\=?\B7J/\ NI_Z&M="OW1]*Y[QU_R)>H_[J?\ H:UT*_='TH 6N1^*/_),
M/$7_ %YM_2NNKD?BC_R3#Q%_UYM_2@#2\%?\B)X>_P"P9;?^BEK<K#\%?\B)
MX>_[!EM_Z*6MR@ HHHH \U^,/_'KX7_[#MM_Z%7I5>:_&'_CU\+_ /8=MO\
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MKCU^0_G3+CPGJ<&IVFK:7=VJW\ N(BMPC&-HY7W]N=RG'L:Z'^T[K_H$7?\
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M7@_4/[ U#189XWEUN\@ < XBC1%WEOPC./J*](A010I&#D*H4'Z5G'4KH_\
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MWJVZ1K,TVP;1$6V^9UZ9_&I[SP/IE]<7+R27*PW<D4MU;HXV3M'C:6XR.@R
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MS20F>1K:9#&54Y#1;LRYXRRD#/6NC_X3/XB?]$W?_P &,5)_PF?Q#_Z)N_\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
=10 4444 %%%% !1110 4444 %%%% !1110!__]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>24
<FILENAME>ex99-1_008.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 ex99-1_008.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" &2 6 # 2(  A$! Q$!_\0
M'P   04! 0$! 0$           $" P0%!@<("0H+_\0 M1   @$# P($ P4%
M! 0   %] 0(#  01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$!
M 0$! 0        $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%! 0  0)W  $"
M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#VRZOI(+^*
MUAM6GEDC>3_6!0 I []?O"DDO]0BC9VTHX4$G_2%JIJ43R^([-4@BE(LYCB1
MB /GC]N:KSZ/<R[$CBAVL-LK$<@<].W3% &G'?ZA+&DBZ4<,,_\ 'PN>E9D_
MBN>"SBN'T6<B1BNQ95W*1GJ.W2MF+2K*.%(_L\9"J%!VTIL+2/E;>,?\!H Q
M?^$IN"\*_P!BS_O&*D^:N$PVWYO0'J*+/Q;)=W?V;^RIHG(RAEE50W? /KCF
MMHV5GAOW$0R.?DHCL+;>7:"+GA05'2@"#^T;S_H'K_X%)4*:S=232P_V<%>,
MC(:Y3E3T8>W6M#[/;[R!#"3Z;1FJT^D0SL)E589U!"LBC SV([CI0 S^T;L?
M\P]/_ I*4ZC=G_EP3_P*2ELC%,3#/:11W$8&]=@P?=3W%7/LEN.D,?/J@H H
MC4[L?\N"?^!24?VC=Y_Y!Z?^!25=-I 1@0Q?78*KSBSM4:26.%57J60?YS2;
M2&E?8SI?$DT6JP:=_9C---!).I6X0C:A .?^^A5R#4;ZYMXIH]+^610P_P!(
M7O7,3V*W/C?0GNX@1-:73>4%VJ@^3' [XQ7:IM0*J+M11@#'2DFV#26A5^U:
M@.NE_P#DRM(+W4#D#2^G_3PM:!PPQG-"@*.!Q5"*'VO4.O\ 9?\ Y,K0;S4#
M_P PO_R86K3L2^ V3Z#BFO*PX*\>U %?[;J '_(+_P#)A::VH7ZGG3/;_CX6
MJYM[@W=Q(L^(YXU7#$YCP""1[G^E4X=%NQ<132:B[E5"NJYVO@8)Z\$C:?KG
MUH U?MU^1QIG_DPM)]MO\D?V7_Y,K659Z'J$!M_-U%IC%)O;=N^<%0-N/08S
M^-6(]&N;>XC/VR26 ,6,,A.,%<8W=3@Y(S0!>^UZ@?\ F&#_ ,"5ILE_J4<;
M,-(9\?PK<+D_2FZ9975FLXGN!)O=F5CG(!.<<_6M'#YSC(/J:3OT S+?5[NY
M4M'IC<':RM.H93Z$=JG^VW__ $#!_P"!"U'>*UI<+?Q1L0HVSJ.K)Z^Y7K]*
MLK,)(Q(C!XW^8$#J*E2[CMV(OMNH?] O_P F%I/M]]N*_P!F<C_IX6K&0?F(
M*[?X<T%A*O8#(&:L13@U.^N$9H]*.%8J?](7J*D%_J!;!TK'_;PM)92H!,OF
M8Q<..>,\U<#IRQ8>G)H J?;K_./[+/U^T+6%>^.8=-U V>H6(M) I;,MPF#S
M[<UTOFQELF1<#MD"N?\ $>BV>K1/=(T0OHERN2"),<A6]L^F*:2;U&FKZFM'
M?WLL:21Z:&1P&5A<K@@]#3_M6H_] O\ \F5JAX>URTU'2(95FACV#8R!@ ".
M.GITK6%];,.;F 8Z_O!_C0U8E.ZNBG-JMU;,BS6"1F0D+NN5&<#)_2HH]<DF
M5G2UB954.Q%VO"XSD^V*L7?]FW^V.>6"15.X9D'!]14$&G:-;HZQRH$D14=?
M.R&50% /X 4AB/KKQNZ/:PJR+N8&[7@8SG\N:L1WU]*@=--#*>A%RO-46TG0
MC&49MZ[ F=Y; "[1^G%0:G?V^D-!>Q>9.D:&$;F;;&21AB/3MP.] &O]JU'_
M *!?_DRM'VK4?^@7_P"3*_X4EGK,%U;+*QV,200 2,@XX..G%6/[0MO^>A_[
MX;_"@"#[5J/_ $"__)E?\*/M6H_] O\ \F5_PJQ]O@/3S#](V_PH^W1]HYS]
M(6_PH K_ &K4?^@7_P"3*_X4U=1G6^M[:YL6A,^X(PE##*C../:K7VU/^>-S
M_P!^6_PK-N[@2Z[I($4JX:8Y="O_ "S/K0!/+_R--I_UY3?^AQUJ8'I69+_R
M-%K_ ->4W_H<=:= !WIC??7\:?3'/3'6@"-A(R]MI]*<R#&<GCFE#KG;@T[C
M'')H AB3<'(0QYZ'O4B@HO\ >],TWS-I/WL?G0KEQNP0>V>PH P[Z[N[>],_
MV7&W]V)2V 5/X<G('YUM6K/+;H95*N1D@]JDDB66-DD565A@@C(-9L,T>E7$
ML$\FR!OGA9F.%]5R>GK0!+JMU+:0HT.W>SJ@WY(Y.,X'6DCL)))UGO725T_U
M:(N$0^N#U/\ *HYIH[K5K!D=9(MDC*5.1NP.?RS6J.E1:[*O9:'*ZLF[X@>'
MP2R!K6[ VM@D_NZWS:$M_K[C_OZ:P=7)_P"%@>'./^7>\ ^NU*Z7))QMXJR2
M$67K/<_A,:0V:\YGN1C_ *;-5ER%7O4?F8'0Y- %86F5+">XQT'[YJ0Z?EMS
MSS@=,"9N:N1X*Y]#390791SUZT@*S62EB!/<A0,;1,V*%TZ(C):7'?,K'/ZU
M-$B@DARQSS4@E'W2"/PH JO80CGYNN,;VY_6H_L,(*EXCM!/)D;_ !JZ\BC:
M#BFY25L[@<8P/>A@5EL[1P?W>>>[M_C3A96I_P"6?'^^W^-3.%+ <>N<4PN%
M*[>1UVBD4-6RLV)Q%TZ?,W^-9LNFIIY>>VB5X<[I+;!X'<H<\>N*T5EV[V93
MGL *F5FQGR^<<TFK@G8JI;VDT*R111LC<Y )S4PL[8C/DQ+_ +RY%8]^TVF;
M)+5UB@EDQ(KCB,X)W#/TZ5'%JUW)>1VZRV32MNVX8MG'K@_+T//--":L;/V&
M#)_T:V;G)/EC_"G_ &*V0C%O$3W_ '8_PJO!J0\U8+Q/(E;Y4')1_=6Q@U=
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MCD=3,Q"MGC8>:O\ ]D0 .(Y9XPY+$"0D9/IG.*SY;!;/6](Q-+(?WJ9D(/\
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M%5K\9(RS_9U!_G6B>/[N#U':HV1?<>V:9)B7=MY]PCWMM)<%$95GMF*LH/\
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MY4P?R/4>]5YO#X+Q26MV]LT3F18U4&-F/=E/]"* -G"DYX-*  .E9!U"]T\
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MKITW'@C ]S0!)VIOO1CMVIPX'% #,D'!_05$?G!YQQSD58JNZ@EE/*XS@<4
M/0!E&3D#\*4'FF1A=@'(!'3-/&,C'(]Z $D91CG%5[WSWTZX6R;;<F,^4Q/
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MOO4O<M+1FBQ B.Y0,'O0G! "87KP,"G%5# @DDC//(I7QL(((R?7K5V(',V
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M.9U_GQ?X5R-W[^X_]$M74(&^\QQZ"N8\1#'B7PH2<_Z;+V_Z8/Q73JJ<$ T
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M?RGYR.H'O0FO6$B*ZS$*RJV2AZ,VU3^)! ^E &C+GRGQG.#C%<)+-.9X[6\
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MG>3W/M[=ZEOL-+N9MU)<RW8U!6?R0K+"%X!&5RWXC./:K^@W<]S%+]I8^8I
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M% X% $E)@=ZCBGCEZ.,^F:ER/4?G0 A%(SB-"QZ"G5%/)'%#))*0(U7+9]*
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M71QW^PP?^@"IM; .@:D#T-K+_P"@FJWA0D^#]$)ZFP@_]%K0!L4444 %%%%
M$-S:PW4>R>%)5!R%=<C/K69'X:LH)/,@\U.00OF$J""3G!^M;-% &$=,EM[A
MY9((9[8XRH!#* ,9 [G@5.]E;7-K'-8)$L@971B".AZ&M4C(Q5.>U>)S<6A
MF(P4<_(WU]#[T .LKB24SQS(JR1/M.TY!R ?ZU'K&/[+FR,@[0?IN%5],O(Y
M=2U*/(6570M&W##Y!^GO3KQKB^:XLH4C"(4W.S'/.&Z8H U<"BBB@ HHHH *
M6BB@ I*6B@#/N=*M;N?S9HB7P!D,1C&?\348T*Q QY38*E2-YY!&#6I24 <=
MX@T&PBO-+O?)^>RE,D$C2$;&^4?^@@UUZX*@^U8?C! WAJZ+'[NP@XSCYQS6
MW& (UQTVC%2MQO9#^:.:**H0A4,,$9'I1@ 8P*6B@"AJXQILASC#*<YQ_$.]
M9QY/8  G(X&/YX_4UI:N,Z7,.3]T\?[PK-)R<@@<D@@_F0?_ &;\!2V-(:H"
M#C;@]N,9R>WU/MT'>JZ ?V]I7)^8S8PW7Y/U^M3D#DC[N,=. /IZ>W4U$&+:
M_IG7K-GIUV=_?V'2D.6QIR_\C3:_]>4W_H<=:=9<W_(TVG_7E-_Z''6F%"]*
MHR%IA4EN^*?10!7O+A;:TDE(SM' ]3T _.H=.MFM[,+(?WS9>1O5CR:CU;FV
MA7NUQ&,>O-7\;@?>DM65T"-<+SR?6GX'I2 ;1BEIDB!1Z"EP/2BB@ Q1110!
M5U,9TF]&,Y@<?^.FL[P<<^"="/?[!#_Z *U+\;].N5]8G'Z&LCP2V[P/H9Q_
MRXQ#\E H WJ*** "BBB@ HHI: $H(SVI<44 9M_I<5U*ES'F&\C!$<Z#Y@/0
M^H/<52TFYN&U6]M;^-8[M4C<F/.QUY&X?B.E;QK&C;_BKKE2Y)%E'A=O'WW[
M_E0!M4444 %%%% !1110 4E+1B@ I"0*,U1U&=E6.WB95GG;8F[TQR?RH S=
M:9[ZWE"[EMH'4Y!XE;<./H/YUO#I^%9=_!':Z#)#"H6.-5"CT 85J+RH^E3U
M&]AU%%%4(**** *6K '2YP1D8';/<=JR\$GGJ6S_ )]<?D*UM2YTRX]D)Y]N
M:R021@C';&/TQ_[+^=)FD1<@C/&".#D]^_M]>_:JX_Y&#3"!_P ]>W3Y/T^E
M6,9/4[CSP><]SGU]^@[573GQ!I8X'^NQCL-G;V]SUI#>Q?NQ<'Q-9^08PWV.
M;.\$_P <?I5QAJ7K:_\ CPJ&7_D:+7_KRF_]#CK2ZU1D8LMSJBR./+Y7LHX(
M]5JS%?721(;JSE0[1EH\,,^X'(J^2 <=Z<.E &-<W:7%Y8JL<OE>>"SLN!G!
MP.?>ME>E9^J'$5O)_<N8S^N/ZUH TEN-[ 3BE!S2,H8<T@7;TIB'44QR4]Z5
M,[1GK0 ZBBB@"*Z4M9SJ.IC8#\JP_ K;O VB$=/L<?\ *MZ;_42?[I_E7+>!
M;^SA\"Z*DEU C"V4$-( 0?SH ZRBJ3:QIB?>U&T'UG7_ !IO]N:0?^8I9?\
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M)H/C/3OX;35&'^S8R?X4 =#6;>+C5]/EV,V2\?;"Y7.3^55!XLM&Z6&J\_\
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MELSJY\2:=_:.F16R8EVNMP)"3LZ8 X]J!MZ&_+_R-%K_ ->4W_H<=:=9DO\
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M.P]:Z8#:N.N!U-<[HNL6EOH\<;^>-K29(@<C[[=\59S$.K6&B6D$D4"VR7P
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MPES/()(U3[.$0;A\VX#[QQQFMXR3LH!TVZX(/WU[?C3C<7).1IMR#SSO3O\
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/0 =J0444 +2$444 ?__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>25
<FILENAME>ex99-1_009.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 ex99-1_009.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" &E 5H# 2(  A$! Q$!_\0
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M)K$W37MT?*C<^@)SM%0WK9#-^VD)B!7)#=,G[M.=+="7D(8]?6DB7[/9A2K
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MYVJX_.B]N[:T@^U/,J^5W)ZCTK(L?#NC7LDDK:=;LJG:/W8'/KQ5MO"&A%6
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M<5FV\CR6]S)$NYO.=AR<''3_ /51%2ALQ<B;5RA+I,\"M-+K^H*5&<D(<?\
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M!W%" ,^^>]-TGBU<-Q)YC%UW9VG/2I[:$Q08<DNQRQSGFHA^X;SP/E;_ %@
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MF-%&R%_[P"KS_P"/5VFH7UO$\*%V\Y7!VJI.!WSBN5T"-1\0]9V *L:;% '
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M \-@]N0#GWK7M8H?+$L07,BC<_=P!@$GO39F10.\TTKA7&1@9Z"FM:!(&C#
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MC8 <$4\YV\=<4 &T>E5+D&*XBD7G>P5U]163J$.J6LD]T-=$$+MD1O &V\C
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MF1]*Y*W\J^\4NMG]LN+..8M=>7=LEG')GI@C+-ZJO&:Z^?\ Y&VV'_4/F_\
M1D=<1::I]IU6UM8]2TZ13=;?*6P:-Q\^<;NF?>H*$T]F_L77Y]]RL,FO7#2R
MVL0DD0 XRJD'D$#G!Q73>$IIIK:;;>ZC>6JL/)FU*$QR$]QR 2/<BN5T![R/
MP=+<6-KY]PNLW4J#S-NPB1OF)[CMBNE\&"^"7\^KF;^T)9D,N^0,,@<!0/NC
MVHN!UV6/  ]S2[<G+8/<4WS5!ZC%'FJ,?,*8#=KQY._Y<]_2I P8<'M2>8I_
MB%1LPC;>H#9XZT 8/CG_ )%IUS]Z>)?S85O6Z@ DG/)Y/6N?\;2QC1H%=U53
M=PDDGH XZUHP:WIFQB+^U'S' \T5":YF=#C)THV75FKD 5"96\P@QL!T!JB^
MKV4D)7[5!D^DH_QIJWMJO[S[9'O(P ) >/SHYDS+DEV9H1J?G!4@9[G.:RM,
MTIK>]DG8L,,=HZ<>GTK0@NH5C :XB)/7YQ4HFB(.V1/^^A5J6EB'!WO8G[<U
M7,2O.QRP) S@XS2F90GWEX]ZC$S;V/EG;@=Q0!#JQ$>C79' 6!S_ ..FHO#J
M[= L%'W1;1@?]\C-'B"0#PYJ+Y_Y=9/_ $$U-I2^5H]HO985'Z"EU-?^7/S_
M $(;X&VN[>X$N%R86&.S=,GV('YU8L PM8B<'Y*6YMA>64T)8IO'WCS@]C_*
MH-'NC- \$I'GP,4D7T(H,C3R<U7DQ/<>7U1?F;W]!39G:)R0PW/A5![$U+''
MY,>!][J?<T;!T,3PHZKI$CY&'O)S_P"1#6O.R.2F2V?E*@9K$\(HIT&&1P&9
MY96QV&9&KH57"\]<UK5TJ2]3.'PHY76-+75/#<UE*S##M;A@<':.!S^ JMI>
MHVVH6ME/?V874(XVM;F*4 LC(<$X].AR/6MRY"I-<PR$K!<?,KD<!NA'MTKD
MKJ+^Q[^]@M6WKJ=LDBR$Y4,IVO\ 3Y2#^%8L[(+FLO,Z^VD,+P&!W>&<E1&[
M9V$ G@^G'2M0))][*EL<<5FP1)'?00J/DM[?<@]2>,_D/UJ[]NLTX-U;C'7]
MX/\ &FC*2U'3,PA^=0.1G!X'-1?VOI^,F[B Y^\P'3ZU!<ZUIRH ;^URQVK^
M\!W'CC]:X%=5L8VPLHD9G90##OR#V!'0<FE)M;&E&DIWN['6>(]2AFLUM8X8
M[Z*=O+9$.YBQ^ZH_ND]0QX&*YW3M2CT36DBBE)T_;NE:-"5@3./G ^X,\\XV
M_-U7I8CN(9+=XQ,Y$V$D1-/;[V._';U]JK?VI/HM^98=-NKL:E<&W>S%N(UD
MPGRL,X . 00>H^E";ZDSA&.SN=Y$SQR,R#= PW#'K[>HJ/4M6LM.LQ)>2E"_
MRQQA2SR-Z*HY8_2N<T%];@T>/3H+&2)QN99;M<1VRD_*@&=SXZ#ITK;T_0;>
MQFFO97:YU"90)KF3J0.RC^$>PJC)&&)-6U-FD:&XL=-CD(:*!@99T'')_A'7
MA>?>M;3K2*UMUBTR.W6SD^9 F5 X[CN?<\TX,]O =K'?9RX<?WT//\C^E+ %
MM-2F1,;#B4#..'Z_J#6,TQR@K:$A9UC+R*OFQN 0O?GIGTP:Q=:TVXO="-M:
ML$U*PF$T#-V*DE#QV/'ZBNC1/-*@+LC!W'/5C27=FEQ(6W/'(JD!T.#CTI03
M5Q4Y)&#HVK1ZG;>?:R+%>,2MW9R_*/-4 ,,=00>]:-C*\D!6-IH[M"=\/ "'
MMQW%<SJD#V>HR3X5UDE2*9U&WRY2,1S9'3(PI^@-;JNRPV^JG_6(OEW('0H>
M_P"'7\ZN[-W%6N:$5_<0,4NXT50/]8IX'N:LEMQC/#;S@D>E,CMU(5AL*L,@
MMZ5!,$LY/-B)5=XWQDX&?6FNQ@]#B[*.0^%]>N-T9B>YG!0+E@WF8SG\*])/
M4\UYYIX)\!:@X_Y:F:3('7]\:]"(.36]9I5)>I*U1CW8?_A++;RW"_Z!-R?]
M^.N0T6XCN/$>Z[U5[FXR0%$1A@(YSM&,,0.<YKKKS_D9HN,_\2R?C.,_/'WK
MG=.GBDO_ +%<^(5N_LP=H]/,:[U(4X!8=<"LRC \-C3_ /A7RF[>_#7%U,RK
M9Y,CDR,> .HQUKK?"@@M-);[!9$6[2'>Q5DD##KO#<[JY;PY_9 \!>'SK-]/
M9*8WDADA=HRS%LGYA]:[KPU]@337?3+N>\MWF9C-,Y9B< 8R>:0&FEQ$P $I
M!ST88_G5E<$YXQV/K49$,^5*@\<@BH_L29RC/$?16XI@6N">@IAC!(! QBH
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M?R;4HGS;G&%)."!Z>X[5S<S6X/#N#OOZ&QJ,$3^&M8@$ZL3!)YI*9W$J3_\
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M'PXX#7,G ]%7_&F!TSM@* 1@<8J1,=<,>#T%6@J;ONC-.R/7I4V'<K@R%?\
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M=%\[ /<X-76\;:;%J5UI\EO>I-:QF63]P2-H. 1CKD]/6DV:>SEV-#[#JO\
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M+:J'B.5'/OR3^%$-]XA%C'*LMP6.\M$\"94+M_GD_E5LQI;/<3O)?-M@2(A
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M(RDZVXQV%NM-_L:^ Q_:BX_Z]$K8\^+;NWKMQG.>WK1Y\7]]?SH Q9=#OY5
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MU'9WNEVL*Q0SQ+CAMHQDXSG'TYJ<Z;9M(93&OFD@EP>>.E-71]- _P"/>/\
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M^9_QHHH /^$;T?\ Y\8_S/\ C1_PC>C_ //C'^9_QHHH /\ A&]'_P"?&/\
M,_XTR7PSHKH8WT^)E?@@DD$?G110!'_PBN@R.2^DVI8\Y*9I!X2\/D\Z1:]_
MX*** %_X1+P_G_D$6O\ WQ3O^$0\/?\ 0(M?^^*** $_X1'P_P#] FU_[XH_
MX1'P_P#] FU_[XHHH 0^$_#ZC<-)MLC_ &*E_P"$<T@'/V&/)XZG_&BB@!P\
M.:1_SXQ_F?\ &E_X1S2/^?)/S/\ C110 ?\ ".:1_P ^2?F?\:3_ (1S2/\
MGQC_ #/^-%% "_\ ".:1_P ^2?F?\:3_ (1O1_\ GQC_ #/^-%% !_PC>C_\
M^,?YG_&C_A&]'_Y\8_S/^-%% $;^&M&D!1]/B93U!)/]:D_X1O2/^?&/\S_C
:110 UO#FCC_EPB/?!)(_G6D1R>3110!__]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>26
<FILENAME>ex99-1_010.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 ex99-1_010.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" %4 I$# 2(  A$! Q$!_\0
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MV.2Q_G?W(\*6TF^T.-MUG:I_U9]_:F!-DTJO+,C CA@0>@]J]XCGOO[8N/\
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M/O?WO840M+\_[D<.?XJ ;W^75$,31^0/](;OW]Z"8_L(_P!(;_5>OM4L1D,
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M?3J:T'B[6D:;;K%T-TA8X[G ]JS!>-.))9;J9G=V9B<\DDDFF1--ND^1?O\
M][V%)"9O)^XOWF_B]ZN-:I#6,K$5:M2::D[VMN_^ -$X^P_\?$O^K]_2GS3Y
MMV_?R]/>F9F^P#Y%_P!7_>]J=*TPMW^1>G]ZJ^LUOYW]Y"7O?-]O\A;B8,BJ
M9Y2"Z\<^M1R&+S(OWLGWCZ^AJ28S87Y%^^O\7O1(9A+%\B_>/\7L:SG4E/63
MN3!Z+Y]O\AC>5]H3][)T/K[5L:#:6%W=7 NS*VV-=O+#&2?2LIC-]H3Y%Z'^
M+Z5T?A-[D7=YLBC/[M.KD=S[5YN8RE'#3<79_=U[GKY+"-3&PC45U9Z:=BS%
MI&B?:[@'SL#81\S]P:(=(T0S7((FX<8^9_[HK9A>\-[=8AAZ)_RT/H?:D@DO
M!<W7[F'_ %B_\M#_ '![5\O/%5E?WWLOM>GD?H:P.&?_ "[7W(R+71]$;S,B
M7B9Q]Y_6N,D\A8Y52:7 W <GIS7I=E)>?O/W$1_?O_RT/]X^U>=RM/LF'EIU
M?^,^I]J]O*ZTYU:BE)O;K<N&!PSWIK[D55,7V)3Y\N?*'<^E$AB%M_K9<X7N
M?;VJ96G^P#]VF/)_OG^[]*)6G^S?ZM.B_P 9]O:O=N:_4,+O[*/W(N:5!9W.
MM64%Q),\+S .NYN1SZ"NZN/#?AH7%K^[FP7(/S/_ '37(:"UQ_PD>G;8D)\\
M8RY]#[5Z?<O??:K/]Q#]]O\ EJ?[I]J^5SFO4IXB*A)I-/9V/.Q>"PZGI3C]
MR.?E\.>&UO;=!'-A@Y/S/VQ2CPYX;_M'9Y<N/)S]Y_7Z5T$LE]_:-K_H\.=K
M\><?0>U&^]_M/)MX1^XZ><?[WTKPUC*]E^\>S^U_P#C^IX?^1?<>2>-H;/2M
M?6'3I)8H3 K,,L<G)]:YE+R3=)_I,OWO4^@]J[#XEM<'Q1%YD: _94X#YXR?
M:N,0R[I/D7[W][V'M7Z_D<(5,NHSFKMK5[]^I:PF'LER+[D>L^!M!\/:GX7M
M[O45G>Z>1]S!GYPWM6M9^%O";Z67:*8OB3G=)ZG':K'PQDOQX(M1';PLGF2<
MM*0?O'_9K?L9-1_L8XMK?&).?./]YO\ 9KGJ1BIO3J<,L-1N_<7W(Y23PMX4
M'A_SA'.)?LX;.Z3K@>U3:AX4\)QV99(IPWF1C):3NZ@]O>NAEDU'_A%\&VM]
MOV5>?./]T?[-6-5DU+[ <VUN!YL728_\]%_V:CE78GZO1_E7W'+WGA3PG'):
M!(I\-<!6^>3IM8^GM23>%?":ZA9HL4^QA)N&Z3L!74ZA)J)FL,VUN/\ 21C]
M\?[C_P"S27$FH_VK8DVUOG;+C]\?0?[-'*NP?5Z/\J^XY@^%/"?]JB/RI_+^
MSEL;I.NX4+X4\)G5)8S%/L\E& WR=2S9[>PKJ#)J/]MK_HUON^S'CSS_ 'A_
MLT1RZE_;,W^BV^?L\?\ RW/]Y_\ 9HY5V#ZM1_D7W(Y>W\*>$VO;U6CGVJR!
M?FD[J#Z46/A;PD[7.^*<XN'5?GDZ<5U%K)J/]H:ABVM\[TR///\ <'^S1I\F
MH[KO%M;_ /'R_P#RW/H/]FCECV#ZM2_E7W'+Z=X6\)R6*L\<Y.]QG=)V=@.W
MM44'A;PH="$C1SF3R&;.^3K@UUNDR:C_ &>NVVMR/,DZSG^^W^S4%K)J(\-@
M?9K?;]G;GSCZ'_9HY8]@^KT?Y5]R.8NO"WA1=#,R1SB3R5;.Z3VJ:_\ "GA2
M,0;(9P6N8U/S2=">:Z&\DU'_ (1O_CVM]OD)SYQ]O]FI]3DU'9;9MK<#[5%_
MRV/][_=HLNP?5Z/\J^XY:Y\*>$UO+)4BGVN[AOFDYPA/I2S>%?"8U&T18I]C
M"3<-TG. ,=JZ>[DU'[?I^;:W!\Q\?OS_ ,\V_P!FEN9-1_M:P)MK?.V7 $Q]
M!_LT<L>P?5Z/\J^XY?\ X17PG_:VP13[/L^[&Z3KNHA\*>$VU&Z0QS;%6/:-
MTG<'VKIQ)J/]N$_9;?/V7IYQ_O\ ^[2V\FI?VM>D6MOG9%_RW/HW^S19=@^K
MT?Y5]QR]KX5\)M/>!HIR%FPN&DZ;5]J+'PIX3D%QOCG)%PZCYI.@-=192:E]
MHO\ %M;']_\ \]S_ '%_V:-.DU+%UBUM\?:9/^6Y]?\ =HY8]@^KT?Y5]QRM
MCX5\)R:8KO%.6^?^*3LQ]O:H7\+^%1X=:813>;]DWYW2==F?2NMTZ34?[(&+
M:WQ^\_Y;G^\?]FH9)-1_X11O]&M]GV'KYQSC9_NT678/J]'^1?<<_J7A7PG'
MITLD<<X< 8.Z3U%.O_"GA2-8=D,X+7$:GYI.A;!KI=6DU+^R)\VUL!M'_+8^
MH_V:=J<FH[+?-M;X^U1=)C_>'^S1RQ[!]7H_RK[D<O<^%?":WEDJQ3;6D8-\
MTG0(Q_I0WA/PF-4BC\F<(8'8C=)UW+[>YKJ+R343?Z<3;6X(E?'[X\_NV_V:
M5Y-2_MF'_1K?=]FDP/../O)_LT678/J]'^5?<<LGA3PE_:<Z>5/L6%& W2=2
M6SV]A1#X3\)MJ%VC1S[5$>T;I.X/M74QR:E_;%Q_HMMGR(^///J_^S3;:34O
M[5OR+:WSB+(\X^A_V:?*NP?5Z/\ *ON.8M/"GA)Y+L/%/A9RJ_-)TVK[4:?X
M6\)O;,7CG)\V0<-)T#$#M74:?)J7G7V+6W_X^3_RV/\ =7_9I=+DU(6C8M;?
M_72_\MC_ 'S_ +-+ECV#ZO1_D7W')VGA;PF^C1RM'/YAA+$AY.N*8_A?PJN@
M><L<XE%N'!W2==N?2NJL9-1_X1^(?9K?'D'_ );'T_W:9*^HGPN0;>WQ]D'/
MGG^[_NT<L>P?5Z7\J^Y&9<Z?HGVFP FNL-*V[YI/^>;>U+%IVB_VG=J9;K8(
MXB/FDSU?VK8NY-2^UZ=FUM\^<V/WQY_=M_LTL,FI?VS>$6UOGRHL_OCZO_LU
MC]5H?R+[D=?M9]V<ZVGZ*='U(F6Z)!N /F?W]JK3^$_":G3\13X>4!OGDZ>6
MQ]/:NA\S41HNJ?Z/;E=UQD^<?]K_ &:L7$FI;M,S;6_^N&/WQ_YYO_LU<*-.
M'PQ2^0>UJ?S,YE/"GA(ZI.GES[1#&1\TG4E_;VJNOA;PK]@U-_+GWQO-M.Z3
MC XKL(Y-2_MBY_T:VW>1%G]^?[TG^S559+_^S-6_T:WQYD^?WQ]/]VKY5V'[
M:I_,RG/'IOEZ;_I5WS*F[E_[C>U2+'IG]KR#[5=[?LZ_Q/\ WF]JNSRZCY6E
MYMK?_7)M_?'^XW^S4RR:C_;4G^C6^?LR_P#+8_WF_P!FN?ZGAWO!?<O\C/F9
MCPIIWV?4B;N[XEEV_,_]T>U83^"_!IL;"06TNZ22(,=TG.>M=;%)J'V75,6U
MO_K9<_OC_='^S1))J)TW3/\ 1K?_ %D/_+8^G^[6]*G&C?V:Y;[VT'S/N8VE
MZ%X<T37&?33<V_F6I#E&DR?G'J*TK:2Q\S4,WU[_ *\_Q/S\B^U7C)J7]MK_
M *-;[OLQ_P"6YQ]X?[-):R:COU'%M;_ZX_\ +<_W%_V:T;;=V)N^YP>X>K?E
M11N/HM%(1T^N8_M,&VVR$1R"3S&?Y7[ <=/7'%4[,2^7"+DVXQ<*SJCR?NT
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M -?S\S_W%]J-..IXN=JVG_'S)U9_7Z4 9^G/I7]DC-S<9_>='D_O&H'?2O\
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MFJ(/LA^5_N'LU30B;#?,GWV['UIJ";[)]Z/[IZ@T%.2N]>J_K8C A^Q@X?\
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M[T 4[--+^T7V8+DCS^/W<O\ <6DTX:61=9ANO^/J3I'+ZU=LDU/[1?XEM/\
M7\YC;^XOO1IR:GBYQ+:?\?,F<QMZ_6@"AIRZ6=)&8+K/[SHDO]YJ@==+_P"$
M6($%UN-EQ\DN,[*TM-34O[(&);3&).L;?WF]ZA=-2_X1-LRVI7[#T\MLXV?6
M@"+51I?]DSXANL[1_P LY?44_4AIFVWQ#<Y%U%DF.7^\*MZLFJ?V3/NEM,;1
MTC;U'O1J:ZGLMR9;7'VJ+ $;?WA[T 5+I=+-]88@NL>8^<QR_P#/-J1UTO\
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M5! -OT&/]ZI/)U'_ )_K?_P'/_Q5,92V:?\ ] V]_P"_3_XT;-/_ .@;>_\
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M1M#_ .$6:3^PW\XV6X/]G;[VSK^=</<^%M0CLG=]%NPJKR2O_P!>O46AOO\
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MF0;MLN#Y'3A?]JN8R*7EV']M9_L^\Q]FZ>6^?O\ UI8([ :I>?\ $NO"-L7
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M &J ,HQV/]D:E_H%YG=<8/EO@?>]ZFN([#.FXT^\_P!<,_NWY_=O[U+Y5_\
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M[7WIMMM_M2__ .)R1Q%SNCY^4^U%IM^VZA_Q.B/WR\YCY_=K[4 /TQP(Y_\
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M+_H./_W_ $_PI?,L?^@X_P#X$)_A0 _:_P#T T_[ZCHVO_T T_[ZCIGF6/\
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MV*N?LPXW1_WS4<LEG_:UI_Q.W(\J3GSTX^[[4"2S_MMO^)V^/LPY\]/[Y]J
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MY\S_ &S[4 6;:2[_ +5OL:=">(\CSAQP?]FEM);S[;J&-.ASYRY'GCC]VO\
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MAEU+_A&T_P!'MMOV3KYS9^Y_NTRZDU'_ (1O_46VW[.G_+9L]!_LU5@?3_\
MA'4_TR^S]D QNEQ]SZ4RY>P_X1PC[7>Y\A,C=)CH/:@#5U1]2\B(?9[7'VB+
M_ELW]X?[-%[)J?GV.;>US]HX_?-_<;_9JEJ<FGF&+%Y?$_:(OXI/[P]J+V33
M_/L?],O3^_\ [TO]QO:@"Y=2:E_:5A_H]KUDQ^^;^[_NTK2:G_;,?^CVN?LS
M_P#+9O[R_P"S5*YDL/[1L1]LO<9DYW2Y^[]*&DT_^V(S]LOL"W?G=+_>7VH
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MFGC6!_IE]C[/UW2Y^]]* +T$FI_VM=_Z/;?<CS^^;_:_V:2SDU(W-]BWM?\
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M^LAS\TGI]* -,RZG_;:_Z/:[OLQX\YL8W#_9HM9-2WZC_H]MCSCG]\W]Q?\
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M]J;IJZ2--^:WGSOE_P"6<O\ ?:@"U"-2_P"$;3_CUV_8_P#:S]RF7/\ :/\
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MF?LY_O?WJI3II/\ :EGB"?&V3_EE+Z"@KI)U@?Z//C[.?^64O]Z@"[!_:?\
M:UWC[)G9'G[W^U19#4_M-_C[)GSQG[W]Q:I0KI']JW>;>?&R/'[J7WHLUTG[
M3?9MY\>=QB*7^XM %W3O[3_TK'V3_CY?.=WM3+'^TO[&/_'IC$G][^\U5=/&
MD_Z5FWG_ ./E\?NI?;VJ.Q72?['.8)MV)/\ EG+_ 'FH LR?VG_PB_/V7'V5
M?[V?NBI]5_M/^SSG[)_K(O[W_/1:RY%TG_A&<?9Y@WV9?^64OH/:K&J)I'V
MXMYL^9%_RSE_YZ+0!<U'^TO-L,_9,_:AC&[^ZU%S_:?]JV/_ !ZY*RX^]Z"J
M=^ND^98[8)O^/D9S%+_=;VI+A=)_M6QQ;SXQ+G]U+Z"@"EXAT#4->U:V1KBW
MA,,#-D*QSEA7 ^(_#]QHVL+;O<Q2EX%?<%(_B(Q^E>F%=)_M@'[/-M^S'_EE
M+UW#VJO+9:!<ZQ*UQIYEVVZ8WP2$CYG]JZ(5_=5.IK#L>7C,MIUTYI6F^IXX
M4GBN)5S&>0>_I38O.S)_J\;SZUV7B'0HIM?N#I>DS&W5(QB.!@ V.:Y.6R$%
MU/#);21R+(0496!'2L*V#NO:4M4_LK='S->A*C*49+:VMM"&'S_*',?4^OJ:
M;&9_L@_U?W?>DB6 )@QOU/8^M,06_P!C^XWW?0UYKTT(Y=7IU71?YDDGGBT_
MY9_='K3IO/\ D_U?WQZ^M0R"W^R_<;[H[-3YA!\G[MOOCL?6D"BKK3KV7^8^
M0S>9%_J^I]?0T.9S-'S'T;U]JCD%OYD7[MNI[-Z4,+?SHOD;HW8^U!,8JRTZ
M/HO\R0><+G_EG]SW]:ZCPE]I"7NP0XWIUSZ5R>(/M'W&^YZ'UI\,RPS2B-Y8
MP0I^7<,]:Y<90>(HNFG:YZ66XI8/$*O*-TEY>AZ+;"]\VZX@_P!;_M?W119B
M]_?8$'^O;^]ZUY['=MOE_?7'W_[S>@I8;QOGQ-<#YSW:O&>2SU]Y:VZ'T_\
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M_EF?[S^]55%__9FK?Z1;8\R?(V'T^M$::;_:UQ_Q*YL>1%Q]F;^])54+I_\
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M(M '&\^_YT444 =9XCA9[L><'G0PR82*(DA?3@\G_&L6VLXY-.:-;*>&%YU
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MC19@?M,?/DK_ 'A[T7<-E]KT_&BS ><W'DK_ '&]Z +<T-^-7M ;Z+/E2_\
M+#_=]Z!#??VXW^G19^S#GR/]L^]4Y8;+^U;7_B2RX\N3(\E?]GWH\FR_MIO^
M)+-C[,./)7^^?>@"W;0WQU:_Q?1@XBR?(Z\'WI;.&^-[J ^W19$JY_<?],U]
MZI6T-E_:=[G19B,187R5XX/O3K2&R^V7^=%F(\U<#REX_=K[T 6],BOC'<8O
M8@/M4O'D=?F/O5:UAO?^$6)^VQX^S/QY/L?>FZ=#9;)\Z-,Q^TRX/DKQ\Q]Z
MK6\-I_PC1SH\N[[._P WE+Z'WH O0PWW_",1XOH\?8AQY/\ L?6EO8;X:$#]
MNCQMCX\CW7WJG%!9?\(VG_$EFW?8Q\WE+UV=>M+>0V8T7C1I@=L?S>4OJ/>@
M#2U&&_ MLWT1_P!)3_EC[_6DNX;[[;8_Z=%GS&_Y8?[)]ZIZC#98M\:),/\
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MN/[5 _>2\;$_YZ-3+".+S+W.A[O])/&V+CY5]Z33DB_L[G0]WSR\[8O[[>]
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MA/X8N>?K1=1Q?;+'_B18_>-QLBY^4^] $MPD_P#:MG_Q-E/R2<[$XX%!2?\
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M_P 2+/[\_P ,7'R+[T <=D?WOUHIG/M^1HH ZGQ UM]M(F=[K]U)^Z5D./\
M9P1_/GFLB)K273F5[0PQ-*%6$LGS\<DX'2MK7VE2]) 2U'EN1(77YO\ :]/S
MYXK#25SI=RR:CYA$BA[DNN$&. ,?_JH).MM/*2UB3^V1'M0#8)(R%XZ=*GWQ
M?]!W_P ?C_PJ"Q,IL+=AI<<^8U/F^8GS\=?QZU8_??\ 0%C_ ._B4%";XO\
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M_$[)_?'G?'Q\C>U.U+S?+@SI$8_TF+G>G]X47GF_:]/_ .)/&/WS<>8G]QJ
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MX!\5ZIXA\17:ZIJR(L5GE&543DN/:NYM6BWZC_Q.R/WQ_CCY^1?:O+OA)O\
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MG]J+:>U%YJ!.NL 95YWIS^[7VJW%/=_VQ<_\2[_EA'QYJ_WGI+2XN_MVH_\
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MF#H3GT]JI)H&I"4N_B2^93P$"* !_/\ &K&G:1>65P9;G5[J]RI79*  .1R
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M 'Y/^-'_  JJZ_Z"=O\ ]^3_ (UES3_E.WV&%_Y^_@==&=+A#[/$##>Q=O\
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MCOO.T?[1Y_\ PD8\S9LW?;$Z9S5JTL[6Z:6XM-7N)MV%=XIU8<=!P/>O-_\
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MHL48H YR67Q4$7R[33F8A@?WK  YX(]>,Y%3H_B%64-#9LHA)9@Q!:3L ,X
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AB@!/)B_YYI_WR*/)B_YYI_WR*** #RX_[B_E1110!__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>27
<FILENAME>ex99-1_011.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 ex99-1_011.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" $F CT# 2(  A$! Q$!_\0
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M,:%BO)*]:E^S0_\ /)/^^11:_P#'K%_NBIJ (?LT/_/)/^^11]FA_P">2?\
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M)_WR*S8]>M/]!B:=)9;P-Y3PHQ1L=33-$U^#4K6V$TL*7LR,_D(W8$@XS]*
M-7[-#_SR3_OD4?9H?^>2?]\BH[S4;33U1KNXCA#G:N\XW'T%,;5;)$1WN$5'
MQM8\#GIGTS[T 3_9H?\ GDG_ 'R*/LT/_/)/^^14;:C:K(\9G0,F=PSTP,G]
M*AMM:TV\F6&"]ADD==ZJK?>7U'K0!:^S0_\ /)/^^11]FA_YY)_WR*B74K1I
M#&MQ&7"%\$X^4=2,]1[U4N_$>FVEK-<-/O6+;O5 2PW'"\>A]>E &A]FA_YY
M)_WR*/LT/_/)/^^12B=#&9.=N,]#_*J-GKUA>V2W<4I$3N47>I!)!(X'?H:
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M_/)/^^11]FA_YY)_WR*FHH A^S0_\\D_[Y%'V:'_ )Y)_P!\BIJ* (?LT/\
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M 'U0!-14/D#_ )Z2_P#?5'D#_GI+_P!]4 345#Y _P">DO\ WU1Y _YZ2_\
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M0/\ GI+_ -]4>0/^>DO_ 'U0!-14/D#_ )Z2_P#?5'D#_GI+_P!]4 345#Y
M_P">DO\ WU1Y _YZ2_\ ?5 $U%0^0/\ GI+_ -]4>0/^>DO_ 'U0!-14/D#_
M )Z2_P#?5'D#_GI+_P!]4 345#Y _P">DO\ WU1Y _YZ2_\ ?5 $U%0^0/\
MGI+_ -]4>0/^>DO_ 'U0!-14/D#_ )Z2_P#?5'D#_GI+_P!]4 345#Y _P">
MDO\ WU0(0#_K)/\ OJ@":LO5?OQ?0UICI69JOWXOH: +UK_QZQ?[HJ:H;7_C
MUB_W14U !1110 444AZ4 %%<]?7EQ;^(88VN6^SNN!&@'RGJ2P(R1[CI446I
MB>%WM]0::V-RJ-+CYHDP<\XQU'X T =-0*Y>UO\ 499[82[UD9HP8@HPT9!+
M.>X/\NG>NHSQ0 M074+3VTD2.8V=2H8=CZTNZ;_GD/\ ONC=-_SR7_ONDU=6
M Y:ST+5-.G\^UN(FD"X=78D,?\^M:/\ ;EW9\:AIDJ#O)#\ZUJ1F3+_NQG<?
MXOI4FZ7_ )Y+_P!]_P#UJP5'E^!V%8J6NMZ==G$5RF[NKG:1^!J^"#TY'K6=
M=:5;7F3-81,?[P.#^8JA_85W;9.GWLT/^P[[UIWJQW5_0-3H:*Y>[U#7[%8X
MGB@D=R0LJC@X]>PJ:Q\40O$BWB^1,>[Y"GZ<4HXB#=GIZA<Z.BJL5V)UW1>7
M(OJL@-2;Y?\ GD/^^ZW33U0R:BH=\W_/(?\ ?=&^;_GD/^^Z8$U%0[IO^>0_
M[[HW3?\ /(?]]T 345#NF_YY#_ONC=-_SR'_ 'W0!-14.Z;_ )Y#_ONC=-_S
MR'_?= $U%0[IO^>0_P"^Z-TW_/(?]]T 345#NF_YY#_ONC=-_P \A_WW0!-1
M4.Z;_GD/^^Z-TW_/(?\ ?= $U%0[IO\ GD/^^Z-TW_/(?]]T 345#NF_YY#_
M +[HW3?\\A_WW0!-14.Z;_GD/^^Z-TW_ #R'_?= $U%0[IO^>0_[[HW3?\\A
M_P!]T 345#NF_P">0_[[HW3?\\A_WW0!-14.Z;_GD/\ ONC=-_SR'_?= $U%
M0[IO^>0_[[HW3?\ /(?]]T 345#NF_YY#_ONC=-_SR'_ 'W0!-14.Z;_ )Y#
M_ONC=-_SR'_?= $U%0[IO^>0_P"^Z-TW_/(?]]T 345#NF_YY#_ONC=-_P \
MA_WW0!-14.Z;_GD/^^Z-TW_/(?\ ?= $U%0[IO\ GD/^^Z-TW_/(?]]T 345
M#NF_YY#_ +[HW3?\\A_WW0!-14.Z;_GD/^^Z-TW_ #R'_?= $U%0[IO^>0_[
M[HW3?\\A_P!]T 345#NF_P">0_[[HW3?\\A_WW0!-14.Z;_GD/\ ONC=-_SR
M'_?5 $U9>J_?B^AK3%9FJ_?B^AH O6O_ !ZQ?[HJ:H;7_CUB_P!T5-0 4444
M %%%(> : #:#U%&T>E9SZLHUC^SEAD9]H9F&. >X'<>I[4P:RC0"00R;VN&M
MTC) )<9[],<&@#4V+Z"EK(@UZWN7B$:OLD*KYAQA78$A2/P_E6L#Q0 N*:2!
M2>;'_P ]%_.JNH(;JQG@AN5ADDC95D##*DCK0")8I%)DP0?G/0U,"#7GECX4
MUNWG26WUF&UDBA$)()<2$$GD'MR*TOM'C.PZC3=10?W6\MC4<S['0Z*^S-/\
M#LOPH'-<7_PG5Q:'&IZ#>08ZM&=XK1LO'.@7>%%Z(6/\,Z[#0IQ9+H55JT;T
MX_<M^'\Z);:&=-LL2.OHPS5.?5].:W!6^MR'^[B0'/>K4-[;7$"S0SQR1.,J
MRL"#3:3W,G%K=&;+X:L6;?;^9:R?WH7(_2H_L6N6?-O?172#^"=<'\Q6UYT?
M]]?SH\V,_P :_G63HPOIIZ$V1B?VY<VAQJ&F31CO)%\ZU,GB?2WFCB$S9?@$
MH0!]:U?,B_OK^=8\^AZ9<7+NZC]X=S8; R/Y5,HUE\+OZA9FUN&,]J6L Z(U
MN<Z?JLL'^P[AU_6FG4=8L?\ CXMX;M!_' V#^55[5KXU8+G145BVGB6PN&V2
M2&!_[LHQ^M:J7$3KN25&![AA6D9QELPN2T5'YT?_ #T7\Z7S8_[Z_G5C'T4S
MSH_^>B_G1YT?_/1?SH ?13/.C_YZ+^='G1_\]%_.@!]%,\Z/_GHOYT>='_ST
M7\Z 'T4SSH_^>B_G1YT?_/1?SH ?13/.C_YZ+^='G1_\]%_.@!]%,\Z/_GHO
MYT>='_ST7\Z 'T4SSH_^>B_G1YT?_/1?SH ?13/.C_YZ+^='G1_\]%_.@!]%
M,\Z/_GHOYT>='_ST7\Z 'T4SSH_^>B_G1YT?_/1?SH ?13/.C_YZ+^='G1_\
M]%_.@!]%,\Z/_GHOYT>='_ST7\Z 'T4SSH_^>B_G1YT?_/1?SH ?13/.C_YZ
M+^='G1_\]%_.@!]%,\Z/_GHOYT>='_ST7\Z 'T4SSH_^>B_G1YT?_/1?SH ?
M13/.C_YZ+^='G1_\]%_.@!]%,\Z/_GHOYT>='_ST7\Z 'T4SSH_^>B_G1YT?
M_/1?SH ?13/.C_YZ+^='G1_\]%_.@!]%,\Z/_GHOYT>;'_ST7\Z 'UEZK]^+
MZ&M2LO5?OQ?0T 7K7_CUB_W14U0VO_'K%_NBIJ *=SJ=I:,%FF <]%52Q_("
MI;:\M[M-\$H<=\<$?4=JR];>>U2,66])IF()CCW'IRWX#UJ;16,MIYLHE\W>
MR$S#Y\ \9]: -6D(R*6@\"@#/N-+CN-0@NW>3="<JH(QG^=-&D1?99+=GD9)
M)3*V[&<DY...*OF5 X0NN\C(7/)'TH\U-I;<,#J<\"@"@NC6J31NB%%C*L(P
M?EW*,*<>H%:.*3S$SC<,GG&:6@!OEI_<7\J/*C/\"_E3Z2@"M;HA:;*J<2$#
MCV%3^6G]Q?RJ&V^_-_UU/\A5F@"/RDZ;%Q]*IW6CZ=>9%Q8V\F?[T8K0I*32
M8TVMF<?J'@;3%FBN[%/LCQ,2RH,JV1C\.M0VO@C4-,MTCT[7YXMH^X\8*9]A
MVKK[SBU?\/YU.*GDCV-OK%6UF[^NIQYMO&EF/E?3+]1V9-A-'_"1ZQ:<:AX7
MEP.KVS!Q78TTCFCE:V8O:I_%%?D<G%X[T0MLNH[BT?TF@(Q5M/%6@R3*4O(F
MCW",OM^4,W3)Q[5N2VT,PVRQ)(OHZ@US5SX)TB>\D!21(IW$KQ(<+E>./0<T
M>\5%T);IK\3I4\EUR C#U !IX2/^XOY5RK> [&,YL;Z_LV_Z9S$@?@:;_8/B
MBS_X\O$(F4?PW46?UHN^J%[.F_AG]Z.FGLK2Y4K-;QN/=:Q[SPY$L;R::\D$
M^.%#G::I?;O&=G_K]+LKQ?6&3::CE\;R6",^I:%?VVT=<!ES]:RE&G+XD'U:
M;^&S]&B6QL=9TXN\<:7,9QE)&Y)[XJ^FOVR.$O;26U?I\Z9'YU3LO&^ER7;V
MMT_V210K!I3\K!AGK[9K?BN+*_C_ '<T$Z'^ZP85,:;BO<E]^IE.C4ANF+;W
M-E=+F"2&3_=P:GV1G^!?RK*G\.Z=,=R1-!)V>)MIJ$:?K%G_ ,>FH"=!_!<+
M_6KYZD?BC]Q%S<\N/^XOY4>7'_<7\JY:\U_5[23RWL8D9%WN<Y!&<<5KV>NV
M%VB_Z0B2D<HYP0?3FB%>$M-O4+FEY:?W%_*CRT_N+^5*"",CI2@UN,;Y:?W%
M_*CRT_N+^5/HS0 SRT_N+^5'EI_<7\J?10 SRT_N+^5'EI_<7\J?10 SRT_N
M+^5'EI_<7\J?10 SRT_N+^5'EI_<7\J?10 SRT_N+^5'EI_<7\J?10 SRT_N
M+^5'EI_<7\J?10 SRT_N+^5'EI_<7\J?10 SRT_N+^5'EI_<7\J?10 SRT_N
M+^5'EI_<7\J?10 SRT_N+^5'EI_<7\J?10 SRT_N+^5'EI_<7\J?10 SRT_N
M+^5'EI_<7\J?10 SRT_N+^5'EI_<7\J?10 SRT_N+^5'EI_<7\J?10 SRT_N
M+^5'EI_<7\J?10 SRT_N+^5'EI_<7\J?10 SRT_N+^5'EI_<7\J?10 "LO5?
MOQ?0UJ5EZK]^+Z&@"]:_\>L7^Z*EJ*U_X]8O]T5*W2@##\0QB>*WRH9%D)9U
M02,G'92>_P"E6-!4+IJ[8EB!D8[0 ._4@$X/M65J,$D]Y*CP/)"DFY%_LX2
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MJ3NQR >QHFLK6Y7$]O%*/1T!I.%]]0=2C)6<+>C.;M(;!U!TCQ %/9#*&!_
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M )[-^0J6B@"+RY/^>S?D*/+D_P">S?D*EHH B\N3_GLWY"CRY.\K'\!4M%
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MC1YQ_P">,GZ?XU+FC- $7G'_ )XR?I_C1YQ_YXR?I_C4N:* (O./_/&3]/\
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MO-]ON%CT^P<;A\\LH5VX'4;35W2R(X3"98VD#%F6(Y5 3PH- &C0>!0*#TH
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MJ+[5_74XW4+?QM;6I1+^"X5F"^9'%B1 3UQ46E>(?$6G67EZGH]Y>!6.VXC
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M3]/\:/.;_GA)^G^- $M(:C\YO^>$GZ?XTGG-_P \9/T_QH JZ1SIX_ZZ2?\
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MF7_4MW]J?;2)]DA^9?\ 5KW]J.@%C%-9%<88 CT(H\U/[R_F*/-3^\OYBE9
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MK5H 9Y4?]Q/RI/*C_N+^524AH R?$2(NA7!"*/N=O]L5I^5&3]Q?RK-\2?\
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M<8]WK2\J/^XGY5F6Y_XJB^'_ $ZP_P#H3UK4V SRH_[B?E1Y4?\ <3\J?12
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MT 63TK,NM4^R7$L<D1VQVS7&\'J%/(Q6GVJH^GVSW)N&CW2E2A8L?NGJ,>E
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M\<+ND9D8#(0'&3Z5C?VQJN/^0'+_ -_!_A6]1BLY1;V=@./M]?UA]0:,V9D
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M_NBIJ "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH :XSWQ7,Q6%YIEK<+$SW W(&
M&TC=SRV,Y/!R<=<8%=128'I0!@7S7UWI%G(8)4S,INH8\AC&"<X'7T..N*AU
M"V@;[)-:02IF[BRR1$!0-W(4CCW.*Z7 ]*,"@#DX=2UA_L9:.<#*K/N@Z@LP
M)Z=0 I_&HQK&JQ6VZ83$F"-SFW(;>9"&51CKMP<<UV.*CE@CG39+&KKG.&4$
M?K0!RT6H:M*EK\\B[QS(+1F^8-]QAQM^7OP,UU:9QS2)&J*%50% P !@"GT
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9 !_:L/\ <D_(53OKI9S&RJ0 #UHHH __V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>28
<FILENAME>ex99-1_012.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 ex99-1_012.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" %B CH# 2(  A$! Q$!_\0
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M17-W:M)>O;7$<Z+O7Y"<9Z$\#!'K3+?5]0BN/[,GNE<?;9;=+R0[#(%56"Y
MP&RQ'3M6MJ6AO<3Z<+:*W2VM;@S21N#\^5(XQWYK3;3+&:S^R2VD+V^?]4R
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MO$/VE_"FHK9LSW!MFV%.IX[>^*-.%C/X=M8TV/9FW52!TQCD?7^M:ZH%4*H
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M3_>/\ZZ*N=F_U\G^\?YT ;EK_P >L7^Z*FJ&U_X]8O\ =%34 %%%% !1110
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MH?,E_P">'_CXH\R7_GA_X^* )J*A\R7_ )X?^/BCS)?^>'_CXH FHJ'S)?\
MGA_X^*/,E_YX?^/B@":BH?,E_P">'_CXH\R7_GA_X^* )J*A\R7_ )X?^/BC
MS)?^>'_CXH FHJ'S)?\ GA_X^*/,E_YX?^/B@":BH?,E_P">'_CXH\R7_GA_
MX^* )J*A\R7_ )X?^/BCS)?^>'_CXH FHJ'S)?\ GA_X^*/,E_YX?^/B@":B
MH?,E_P">'_CXH\R7_GA_X^* )J*A\R7_ )X?^/BCS)?^>'_CXH FHJ'S)?\
MGA_X^*/,E_YX?^/B@":BH?,E_P">'_CXH\R7_GA_X^* )J*A\R7_ )X?^/BC
MS)?^>'_CXH FHJ'S)?\ GA_X^*/,E_YX?^/B@":BH?,E_P">'_CXH\R7_GA_
MX^* )J*A\R7_ )X?^/BCS)?^>'_CXH FHJ'S)?\ GA_X^*/,E_YX?^/B@":B
MH?,E_P">'_CXH\R7_GA_X^* )J*A\R7_ )X?^/BCS)?^>'_CXH FHJ'S)?\
MGA_X^*/,E_YX?^/B@":BH?,E_P">'_CXH\R7_GA_X^* )J*A\R7_ )X?^/BE
M1W+8:+:/7<#0!+7.S?Z^3_>/\ZZ*N=F_U\G^\?YT ;EK_P >L7^Z*FJ&U_X]
M8O\ =%34 %%%% !1110!')#',I66-74]0PR*/(B#A_+7>!M#8Y ]*?GG%&[V
MH 8]O%(I5XT93R0R@BG@>U)N&,FG#I0 4E+0: (0/](<?[(_K5?4-+MM1BV3
MQY/9AP5^AJRO_'T_^Z/ZU*:F48R5F@.6$NI>'3MGW7=@.CC[R"M^SOK>]@$L
M$@=3^8^M3L@8$$9!ZBL&]T"2&<W>DR>1/U,?\#?X5S\LZ7PZKL3J;^12\5@6
M7B*(,8-20VMR@^;</E;Z5L6]W!=Q++;R+(AZ%36L*L9[,JZ+%%%%:@%%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !7.S?Z^3_ 'C_ #KHJYV;_7R?[Q_G0!N6O_'K%_NBIJAM?^/6+_=%
M34 %%%% !1110!0U:U@N["1+B-I%4;@@8C)'3IS63'IC1:O8F&=F%O"(F@<$
M^6"#\X;N<^N:Z,C-&.<YH Y,)?Z39D9-RJS#<0&QG;U(ZGD?FWI74Q.TD$;L
MA1F4$J>HXZ4_:,TH% $12?)Q*H'IL_\ KTFRX_Y[+_WQ_P#7J>DH JJLWVAQ
MYJYVCG9]?>I-D_\ SV7_ +]__7H4_P"F2#_87^M3XH @V3_\]E_[]_\ UZ/+
MG_Y[+_WQ_P#7J?%&* ,76-'?4H$W2)OC;.=N,CN,UDQ0ZEX=WND2S6<C;FV\
ME?\ (KK9!F-OH:;&-T2Y[J,USRH)OF3LQ6*%AJ4>HQ[H+M"P^\A3#+^&:NA)
M\?ZY?^^/_KUEW_AV&:3[19N;:Z'1TX!/TJM%K=WIL@M]7A.WM<(,J?K255P=
MJGW] N^IN[)_^>R_]^__ *]&R?\ Y[+_ -^__KTZ&>.XB$D3JZ'HRG.:DKH3
MN,AV3_\ /9?^_?\ ]>C9/_SV7_OW_P#7J?%&*8$&R?\ Y[+_ -^__KT;)_\
MGLO_ '[_ /KU/BC% $&R?_GLO_?O_P"O1LG_ .>R_P#?O_Z]3XHQ0!!LG_Y[
M+_W[_P#KT;)_^>R_]^__ *]3XHQ0!!LG_P">R_\ ?O\ ^O1LG_Y[+_W[_P#K
MU/BC% $&R?\ Y[+_ -^__KT;)_\ GLO_ '[_ /KU/BC% $&R?_GLO_?O_P"O
M1LG_ .>R_P#?O_Z]3XHQ0!!LG_Y[+_W[_P#KT;)_^>R_]^__ *]3XHQ0!!LG
M_P">R_\ ?O\ ^O1LG_Y[+_W[_P#KU/BC% $&R?\ Y[+_ -^__KT;)_\ GLO_
M '[_ /KU/BC% $&R?_GLO_?O_P"O1LG_ .>R_P#?O_Z]3XHQ0!!LG_Y[+_W[
M_P#KT;)_^>R_]^__ *]3XHQ0!!LG_P">R_\ ?O\ ^O1LG_Y[+_W[_P#KU/BC
M% $&R?\ Y[+_ -^__KT;)_\ GLO_ '[_ /KU/BC% $&R?_GLO_?O_P"O1LG_
M .>R_P#?O_Z]3XHQ0!!LG_Y[+_W[_P#KT;)_^>R_]^__ *]3XHQ0!!LG_P">
MR_\ ?O\ ^O1LG_Y[+_W[_P#KU/BC% $&R?\ Y[+_ -^__KT;)_\ GLO_ '[_
M /KU/BC% $&R?_GLO_?O_P"O1LG_ .>R_P#?O_Z]3XHQ0!!LG_Y[+_W[_P#K
MT;)_^>R_]^__ *]3XHQ0!!LG_P">R_\ ?O\ ^O1LG_Y[+_W[_P#KU/BC% $&
MR?\ Y[+_ -^__KT;)_\ GLO_ '[_ /KU/BC% $&R?_GLO_?O_P"O1LG_ .>R
M_P#?O_Z]3XHQ0!!LG_Y[+_W[_P#KT^-9 WSN&'LN*DQ10 5SLW^OD_WC_.NB
MKG9O]?)_O'^= &Y:_P#'K%_NBIJAM?\ CUB_W14U !1110 4444 5KR^MM/A
M,UU,L,0(&]CQDTR+4[.<Q"*X1S*NY,'[PJ2Z1WMY!&H,A'RY]:QSI,XOBJJ/
MLQEBDWYY 1-I7'7G^IH UH]0M9XO,BF21=VS*G/S>E617-2:)=6D!&G,P991
MM#.-VP+MX)&!T7\ ?6NBB$@A02D&3:-Q' )QS0 _-%1&%B<^=(/8&D\@_P#/
M:7_OK_ZU "(?].E_W%_K5C-4EB)O)%\V7A%YS]:F\AO^>TO_ 'U_]:@"?-&:
M@\AO^>TO_?7_ -:CR&_Y[2_]]?\ UJ ))#^[;Z&DB_U,?^Z*AD@81L?/E. 3
MC/\ ]:B&%C"A\Z7[H_B]OI0!9J*:".XC:.5%=&ZAN12>0W_/:7_OK_ZU'D-_
MSVE_[Z_^M2:35F!@S:)=:=(;C2)MHZM;L<JWTI(?%D22K!>6[Q2YVMSP#6\8
M#_SVE_[Z_P#K5E7/AZRN;AVD,F92&;D9X]#[YKEE2E%WI.WD39]#:5PPR.GK
M3LUR[V6KZ.<VLSW=J.L9/S >U7=.U>UOR(S<2PSCK%(0#5QK=)Z,=S<S1FH/
M(/\ SWE_/_ZU'D-_SVE_[Z_^M70,GS1FH/(/_/:7_OH?X4>0W_/:7_OK_P"M
M0!/FC-0>0W_/:7_OK_ZU'D-_SVE_[Z_^M0!/FC-0>0W_ #VE_P"^O_K4>0W_
M #VE_P"^O_K4 3YHS4'D-_SVE_[Z_P#K4>0W_/:7_OK_ .M0!/FC-0>0W_/:
M7_OK_P"M1Y#?\]I?^^O_ *U $^:,U!Y#?\]I?^^O_K4>0W_/:7_OK_ZU $^:
M,U!Y#?\ /:7_ +Z_^M1Y#?\ /:7_ +Z_^M0!/FC-0>0W_/:7_OK_ .M1Y#?\
M]I?^^O\ ZU $^:,U!Y#?\]I?^^O_ *U'D-_SVE_[Z_\ K4 3YHS4'D-_SVE_
M[Z_^M1Y#?\]I?^^O_K4 3YHS4'D-_P ]I?\ OK_ZU'D-_P ]I?\ OK_ZU $^
M:,U!Y#?\]I?^^O\ ZU'D-_SVE_[Z_P#K4 3YHS4'D-_SVE_[Z_\ K4>0W_/:
M7_OK_P"M0!/FC-0>0W_/:7_OK_ZU'D-_SVE_[Z_^M0!/FC-0>0W_ #VE_P"^
MO_K4>0W_ #VE_P"^O_K4 3YHS4'D-_SVE_[Z_P#K4>0W_/:7_OK_ .M0!/FC
M-0>0W_/:7_OK_P"M1Y#?\]I?^^O_ *U $^:,U!Y#?\]I?^^O_K4>0W_/:7_O
MK_ZU $^:,U!Y#?\ /:7_ +Z_^M1Y#?\ /:7_ +Z_^M0!/FC-0>0W_/:7_OK_
M .M1Y#?\]I?^^O\ ZU $^:,U!Y#?\]I?^^O_ *U'D-_SVE_[Z_\ K4 3YHS4
M'D-_SVE_[Z_^M3HXRC9,CM[,: ):YV;_ %\G^\?YUT5<[-_KY/\ >/\ .@#<
MM?\ CUB_W14U0VO_ !ZQ?[HJ:@ HHHS0 4444 %%5;V]AL(3-.^U,A0!U)/0
M >M5?[:@%_#9%)//DB\U@ "(U]3S_+- &I169::U;7L:O$7RS!0K#!Y&0?I@
M@UI T +249'J*,CU% %:/_D(S?\ 7-?YFK55(R/[2FY_Y9I_6K61ZB@!:*3(
M]11D>HH 9-_J7_W3_*BW_P"/:+_<'\J28CR).?X3_*BV(^S1<C[@_E0!+129
M'J*,CU% "FHF_P"/B/Z&I,CU%0LW^E1<]F_I0!-67J&B6>H L\827J)4X8&M
M3(]12<>HJ904E9BL<P;C5=!($P^VV8XW#[RBMNPU2UU!-T$F3W4\$?A5PA2,
M'!%<_J^@Q&-[JP4QW2\XC; :N?DG35XNZ[!L= "#R*<*XK3KN\T.1C=QSR6S
MX^;^Z>_6NIL]1M;Z/?;S*WJ.A'X55.M&?DP3+E%-!]Z7(]170,6BDR/449'J
M* %HI,CU%&1ZB@!:*3(]11D>HH 6BDR/449'J* %HI,CU%&1ZB@!:*3(]11D
M>HH 6BDR/449'J* %HI,CU%&1ZB@!:*3(]11D>HH 6BDR/449'J* %HI,CU%
M&1ZB@!:*3(]11D>HH 6BDR/449'J* %HI,CU%&1ZB@!:*3(]11D>HH 6BDR/
M449'J* %HI,CU%&1ZB@!:*3(]11D>HH 6BDR/449'J* %HI,CU%&1ZT +7.S
M?Z^3_>/\ZZ*N=F_U\G^\?YT ;EK_ ,>L7^Z*FJ&U_P"/6+_=%2GO0!BW^N/9
M7CHUE));J50R(X+%VZ +Z>]6]+GN9[7S+M8TE,C?NT;=L&>%)]0.M8>L?V?%
MJLLUUHPND^1'E!W/O(^50OIVS[UJ^'[?[-I[)Y,4&Z9W\F-MPCR?ND^OK0!K
MT444 9^IZ>;Y8&5D$D$HD02+N4G!!!'T-06VC+"]J&,3):J!$^WY\X(()].>
ME:]'% &%=^'DEMREM(L#>9N&U?EQ@\8_'/U K8BC,<2(6+E5"[CU..]2T4 0
MFWC8Y* DT?9H?^>8J:FDXH HI!'_ &E,NP8\M/YFK7V:+^X*YFW\7Z7+KIB$
MC*LK>0LC#"EESGGMUKJ%GB<925&'LV:5TRY0E'XD-^S1?W!1]FB_N"I,CUHW
M#UID7()K>(02$(,[3_*FV]O$;:(E!DH/Y5)<,/L\N#SL/\J2U8?9(>?X%_E0
M [[-%_<%'V:+^X*ESFC- $7V:'_GF*A>WB%U$ @P5;/Z5;)%5G/^GP_[K?TH
M D^S0_\ /,4?9H?^>8J7(I: (?LT/_/,4AMHO[@J>D- %6.VBDA(=%8$D$$5
MFWOAFUF/F6K-:S]F3I^5:]MS /\ >;^9J6HG3C/XD*QRPNM0TE@NHVGVB <>
M='U_&MBRN].OUS;LC'NN<$?A5\J""" 0:Q[WPY:W$OG09MYQR'C..?I6/+.G
M\.J#5&I]GA_N+2_9HO[@KD;G5M9TF<VLC+.47?O*]5]ZZ'3=9M-0A4K*JR_Q
M1D\@T0Q$9/EV87+OV:+^X*/LT7]P5)D4O6ND9%]FB_N"C[-%_<%2TM $/V:+
M^X*/LT7]P5-10!#]FB_N"C[-%_<%344 0_9HO[@H^S1?W!4U% $/V:+^X*/L
MT7]P5-10!#]FB_N"C[-%_<%344 0_9HO[@H^S1?W!4U% $/V:+^X*/LT7]P5
M-10!#]FB_N"C[-%_<%344 0_9HO[@H^S1?W!4U% $/V:+^X*/LT7]P5-10!#
M]FB_N"C[-%_<%344 0_9HO[@H^S1?W!4U% $/V:+^X*/LT7]P5-10!#]FB_N
M"C[-%_<%344 0_9HO[@H^S1?W!4U% $/V:+^X*/LT7]P5-10!#]FB_N"G)"D
M;950#[5)10 5SLW^OD_WC_.NBKG9O]?)_O'^= &Y:_\ 'K%_NBIC4-K_ ,>L
M7^Z*FH YR]T.>ZU2XN/L]@ZN5*F=6+<#V-7]$L9=/LV@E2%"9G<+#G: 3VS6
MI10 4444 4-3U V$:%8FEEE<1QH.[8)_( $U0AU]II$*)')#N2)G4D$NRYX!
M[#CKZUJ7EE'>HBN64HX=60X92.X/XFH(]%M(IHY(T*[-N%!^4D# )'J!0!0M
M/$1E@WW,2P'S .<X"XS^8Y'X'M6ZKJZAE(((R".XJG=:3;WD924/R_F;@<'.
M,=?H2/QJY'$L4:1H,(BA5'H!0 PW$:D@MR/8TQ[F(C!8_D:L8HQ0!PO_  A>
MCS:E*CR3&W7]Z(QQRYY&>O&*>_@325.;:_O[<]MLA(%=7%_R%[C_ *Y)_-JN
M8J'"+Z'0L356G,SA#X7U.WXL_$UR!Z2*32"W\96P_=:K:7 ])$/^%=YBC%+V
M:&L3/JD_D><:CK_BNPMP+NUMECD<1F>,$XR?2G:9XWOX()([K2[BZBCD9%FA
M7L#T-=]>(CV4RLH8;"<$9'2F6,:+8P;%55,:G"C Z4<C6S'[:FXV=-',Q?$/
M2/NW,5U;GOOC/%:%OXST"? 348A_O9'\ZVI+6WF&)((G_P!Y :S+GPMH=UGS
M=,M\GNJX/Z57O$J5#LT68M9TZ?'E7L#Y_NN*@FU>PCU*)'NX@X4@@MT)QC^5
M9,_P]T*1LQQ30GU24C%8-UX N$O'M;:\'DS.LB22$EU"]?J>1BE>:Z%PIT)?
M;:]4>B_:8O[WZ&C[3%_>_0UQXT'Q;;#_ $;Q$L@':9*7?X[M>L5C=#V.*7/Y
M,ET(OX9IG7_:8O[WZ&C[3$>-WZ&N//B;Q-:@_:O#3L >L39J.7XA"UB9KG1;
MV%P. PXS]:?/$/JM5[*_HT=?;7,8@ +?Q-V/J:E^U1?WOT-<?I_CW3DE>VU#
M-LR@,KX+*0PW?AUK?@\2Z+<X\G4[9CZ%\?SI\R[D2H5(NSBS1^U1?WOT-'VJ
M+^]^AI(KF&89CFC?_=8&I>U5H8M-;E.X%K.59U5CG&2O;TJC>Z1IEXV_!AE_
MOQ @UIS-CRN?^6@_K4XP142A&2LQ:',"?5M)/!%];#V(85HV7B*QN1M9S#)W
M23@UL8K.O]&L]0SYT(#XX=>"*Q=.</@?R8%O[3%_>_0T?:HO[WZ&N?>TU;1E
M:2VN/M-LO)CDZ@>U-TWQ49[Q8KN-(8G&4?G%'UA)I35F%SHOM47][]#1]JB_
MO?H:>LBR*&1@P/0@T_M70G<9#]JB_O?H:/M47][]#4U%,"'[5%_>_0T?:HO[
MWZ&IL48H A^U1?WOT-'VJ+^]^AJ;%&* (?M47][]#1]JB_O?H:FQ1B@"'[5%
M_>_0T?:HO[WZ&IL48H A^U1?WOT-'VJ+^]^AJ;%&* (?M47][]#1]JB_O?H:
MFQ1B@"'[5%_>_0T?:HO[WZ&IL48H A^U1?WOT-'VJ+^]^AJ;%&* (?M47][]
M#1]JB_O?H:FQ1B@"'[5%_>_0T?:HO[WZ&IL48H A^U1?WOT-'VJ+^]^AJ;%&
M* (?M47][]#1]JB_O?H:FQ1B@"'[5%_>_0T?:HO[WZ&IL48H A^U1?WOT-'V
MJ+^]^AJ;%&* (?M47][]#3HYDD;"G)^E28HQ0 M<[-_KY/\ >/\ .NBKG9O]
M?)_O'^= &Y:_\>L7^Z*FJ&U_X]8O]T5-0 4444 %%%% !16;K7VPZ9*+"5(K
MDC"LYQ]<'U]*SDEU)K_3W$C?97APT98;Q(03F08Y'';% '1T5RJ:I?Z?;?\
M$QW,RS!2RD'G;DC/3'!_2NFBE66))%SAU##([&@"2@U"TDH) A)'KD4GFR_\
M\3_WT* ((C_Q.;D?],8_YM5ZLN*23^V;D^2<^3'QN'JU7?-E_P">)_[Z% $]
M%0>;+_SQ/_?0H\V7_GB?^^A0 MU_QZ3?[C?RIME_QX6__7)?Y5'<R2&TF!A(
M_=MSN'I3;*63[!;_ +D_ZI?XAZ"@"]BDQ4/FR_\ /$_]]"CS9?\ GB?^^A0!
M*1R*JRC_ (F=L/\ 8?\ I4GFR_\ /$_]]"JLLDG]IVW[D@^7)QN'/W:$"-#8
M*7:*A\V7_GB?^^A1YLO_ #Q/_?0H E*#.:@O+*WO[62VN8Q)%(-K*:=YLO\
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MX#_Q4%V/^G>+^;5I4 0_Z1Z1_F:/](](_P S4U% %*\,XL;@D1_ZINY]#3;
MS_V=:X$>/*7N?2IK[C3[G_KD_P#(TFG<Z9:'_IBG\A0!)_I'I'^9H_TCTC_,
MU-10!!_I'I'^9JC.9_[:L\A,^7+CD_[-:IK.N#_Q/+'_ *Y2_P#LM" M9N/2
M/\S2_P"D>D?YFIA10!#_ *1Z1_F:0FXXXC_,U/24 9FDF?[ ,"/'F2=2?[YJ
M]_I'I'^9JKHW_(.7_KI)_P"AM6A0!#_I'I'^9I,W'I'^9J>@T 9E^9]UID1C
M_2%[GK@U<!N/2/\ ,U6U(X>R_P"OI/Y&KX[_ %H B_TCTC_,T?Z1Z1_F:FHH
M @S<>D?YFJEH9S<WF F1-SR?[JUHU1L3_I5__P!?'_LBT 6?](](_P S1_I'
MI'^9J:B@"#-QZ1_F:KWYF%E(6" <="?45>-4]5.--E/^[_Z$* )LW'81_F:7
M_2/2/\S4HZ?C2T@(/](](_UH_P!(](OS-3TE,"DIF-](,1Y\M>Y]34DL,DR[
M98H'4]F!-)'SJLWM$G\S5NAJ^X'/7'AJ*1_,@Q;2>L;$#\JC$/B'3A\DB7L8
M['AJZ6DK!T([QT%8YD>)BNZ*ZM7@EQ@ @\UH:=J7VV'$!3,9V,K$@Y%3:KI\
M-]9,LF04^=6'4$5EP^&('MHYHKF:*=@'WJ?7MBH_?1?="U6QO?Z1Z1_K1_I!
M[1_F:PMFOZ>?E>.]B'8\-4D/B>%&$=[;2VK?[0XJE7BOBNAW1LXG_NQ?F:A8
MS_:(Q\F<' R<4^WOK>Z4-!,C@^AH=O\ 3H!ZAOZ5NI*6J&AVV?\ NQ?F: MP
M.T7YFI\T9I@5S'*PPT<#?6LW4M M=2M)+>>TME$@VF1%PR^X.*VZ:1D4K)E*
M4D[IG'6_@32VWO<0K.S )\Q(V[1CC'KBFR?#O33S \\![>7,<"NLM/F@R?[[
M?S-6,"ER1[&KQ-5N_,SA?^$%U*#FS\0W4?LQ)I_]C>,[48AUV*8#H)%_^M7;
MXI"HI<B*^LU'O9_)'ENLZAXSM;A8KBX\LQQF8- OROCM[GVK9A\5^)(+>,W7
MAV:0;1F1"<GWQ797 &8L@']X!4P'%+D?1E/$1E%)P1Q(^(2(<7>E7EO[E":M
M0_$#1I#@W0C/_31&%=5Y*D88!AZ$54FT73K@DS6-N^?6,4[3[D\]%[Q:]'_F
M48?%&F3_ .KU*S/L7Q2Z?XELM4NGMK.ZADE7JO(S[CU%0W7@G0;E&']GQQL1
MPR<8/K69X?\ !":3J\-X;@.;=63"C[[$D@G\"!1[]^@<M!Q;3=SK_P#2/2/\
MS3H_-W?.$ ]B:DI:LY@KG9O]?)_O'^==%7.S?Z^3_>/\Z -RU_X]8O\ =%35
M#:_\>L7^Z*FH **** "BBB@!KR)&I9V"JHR2>@%0'4+03PP&XC\V9=T29Y<>
MH]JKZS:SWFG2P0,@9E((8?>&#Q[<XK/MM+=;NSE>%XYX;=(IG#_NY%VX*XSU
M![T ;,5]:SQ^9%.CINVY![^E6,UR\NC7-G:D:>S$K(-JLPW%0N..W8#Z ^M=
M%"'\F,2X,@4;L=,XYH ES29%,,+$D^<X]A2&%O\ GM)^E %* _\ %17G_7O%
M_-JT\BL:")O^$CO!YK_\>T7/XM6GY#?\]Y* )LBC(J'R&_Y[R4>0W_/>2@".
M_(_LZY_ZY/\ R-)IA']E6G_7%/Y"F7\3#3KH^<Y_<OZ>AIFFQ,=*LSYSC]RG
M3'H* -'(HR*A\AO^>\E'D-_SWDH E)%9MP?^)]8?]<IO_9:N^2W_ #WD_2LV
MXB8>(+$>:_,4W/I]VFAHUP1ZTN14/DM_SWD_2CR&_P">\E(1+D4F034?DM_S
MWD_2CR6_Y[2?I0!3T0YTQ>?^6LO_ *&U:6161HD3-I:GS7'[V7H?]MJT?(;_
M )[R4 39%)FHO(;_ )[R4GD-_P ]Y/TH J:H1OL/^OM/Y-6@IXK)U2-EDT_]
MZYS>)_)JT1"V/]?)0!/D4F147D-_SWDH\EO^>\GZ4 29'K5#3C_IFI?]?(_]
M 6K9A;_GM)^E9VG1L;S4QYKC%SC/_ %H U\BC(J'R&_Y[R4>0W_/>2@"4D>M
M4=8.-*F/^[_Z$*L^2W_/>3]*H:W&4TB=C*YQMZ_[PH U,TN14/DL?^6T@_*C
MR&_Y[R4 2Y%%0^0W_/>3]*/);_GO)0!!&1_;,XS_ ,L8_P";5>R*RXXF.N7
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M8G2/81(27$ZF1>G89XH I_VMIX'G_9V$385IMG&XKN"GOG!_.K%E?6=\ZI'
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MKSTH =9W=I>.$C@(;:2X('R'.,$^O!_*K_V:''^J3\JR;;0S:WL,ZSX"C,@
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M+*]BECE CQF503R<'@#TZ>_%;HZ4 %9PUBW\F:8K(L,)8-(5^4D'!Q^-:!K
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M8[%4NEVN#@#C(7MG'% %^HIKB.WC,DKJB#JS'%2UF:U:2W<$'E!F,4ZR,JL
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M%VMA ".GX>^:U* "N=F_U\G^\?YUT5<[-_KY/]X_SH W+7_CUB_W14U0VO\
MQZQ?[HJ:@ Q1BBB@ HQ110 4444 &**** #%)BEHH 3 HQ2T4 %%%% !BDP*
M6B@ HHHH *,444 )BEHHH *3%+10 F!2T44 %&*** #%)M%+10 4444 )BC
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00 >;)_?;\Z;DGN:** /_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>29
<FILENAME>ex99-1_013.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 ex99-1_013.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" %( E<# 2(  A$! Q$!_\0
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M\U-10!#]EA_YY1_]\T?98?\ GE'_ -\U-2&@"+[+#_SRC_[YH^RP_P#/*/\
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M_P!\T?98?^>4?_?-344 0_98?^>4?_?-'V6'_GE'_P!\U-10!#]EA_YY1_\
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MT>\+:-/_ &@B!7;:,38<-\O.#ZUV(48HP* ,K6HC/HYV6K2[7CD\D*"Q 8'
M'KBLZUL[HZA$9HG6XBO))?/VX5H6SA<_0J,>HKIL48% '->(+![RY+Q6]U#>
M01AK2]MNNXYRC#NO3@\<U T-VFK^>UA*,!UE>),^83$/FR3TW#&!Z5UN*3%
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M#4M% $7VF'^_^AH^TP_W_P!#4M% $7VF'^_^AH^TP_W_ -#4M% $7VF'^_\
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M_7/T]Z>N@V:%2/.^4DC,S<9.2.O0GJ/:I_[+MA=I="("9=WS9/.>I/J>3^=
M%X44@Z4M %:]_P"/5_P_F**+W_CU?\/YBB@"6#_4Q_[H_E4E1P?ZF/\ W1_*
MI* "BBHYRRP2%6"MM.">@..M #\BC(KE8]7NQ]DA$TKN;M(YI @9#D<@,.QZ
M^HZ4^#5+M]2$!N=UMA627:!YCG&8_P ,GWH ZBBHR6"G R1V]:;OF_YX?^/B
M@":BH=\W_/#_ ,?%&^;_ )X?^/B@":BH=\W_ #P_\?%&^;_GA_X^* )J*AWS
M?\\/_'Q1OF_YX?\ CXH FHJ'?-_SP_\ 'Q1OF_YX?^/B@":BH=\W_/#_ ,?%
M&^;_ )X?^/B@":BH=\W_ #P_\?%&^;_GA_X^* )J*AWS?\\/_'Q1OF_YX?\
MCXH FHJ'?-_SP_\ 'Q1OF_YX?^/B@":BH=\W_/#_ ,?%&^;_ )X?^/B@":BH
M=\W_ #P_\?%&^;_GA_X^* )J*AWS?\\/_'Q1OF_YX?\ CXH FHJ'?-_SP_\
M'Q1OF_YX?^/B@":BH=\W_/#_ ,?%&^;_ )X?^/B@":BH=\W_ #P_\?%&^;_G
MA_X^* )J*AWS?\\/_'Q1OF_YX?\ CXH FHJ'?-_SP_\ 'Q1OF_YX?^/B@":B
MH=\W_/#_ ,?%&^;_ )X?^/B@":BH=\W_ #P_\?%&^;_GA_X^* )J*AWS?\\/
M_'Q1OF_YX?\ CXH FHJ'?-_SP_\ 'Q1OF_YX?^/B@":BH=\W_/#_ ,?%&^;_
M )X?^/B@":BH=\W_ #P_\?%&^;_GA_X^* )J*AWS?\\/_'Q1OF_YX?\ CXH
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M #W?\A_A4U% $/E2?\]W_(?X4>5)_P ]W_(?X5-10!#Y4G_/=_R'^%'E2?\
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M#P?Y=.])%KL4MTMN(9!)D%E(&54XPQ]N?\XIT>A1QR;S<2,#*)BI50"XQ@C
MXZ=NN:(]!@CN1<>=*9> S''S*,84\=.!^M &IN !)( H\R/^^OYTFP$$-R#Z
MT>5'_<7\A0 OF1_WU_.CS(_[Z_G2>5'_ '%_(4>5'_<7\A0 OF1_WU_.CS(_
M[Z_G2>5'_<7\A1Y4?]Q?R% "^9'_ 'U_.CS(_P"^OYTGE1_W%_(4>5'_ '%_
M(4 +YD?]]?SH\R/^^OYTGE1_W%_(4>5'_<7\A0 OF1_WU_.CS(_[Z_G2>5'_
M '%_(4>5'_<7\A0 OF1_WU_.CS(_[Z_G2>5'_<7\A1Y4?]Q?R% "^9'_ 'U_
M.CS(_P"^OYTGE1_W%_(4>5'_ '%_(4 +YD?]]?SH\R/^^OYTGE1_W%_(4>5'
M_<7\A0 OF1_WU_.CS(_[Z_G2>5'_ '%_(4>5'_<7\A0 OF1_WU_.CS(_[Z_G
M2>5'_<7\A1Y4?]Q?R% "^9'_ 'U_.CS(_P"^OYTGE1_W%_(4>5'_ '%_(4 +
MYD?]]?SH\R/^^OYTGE1_W%_(4>5'_<7\A0 OF1_WU_.CS(_[Z_G2>5'_ '%_
M(4>5'_<7\A0 OF1_WU_.CS(_[Z_G2>5'_<7\A1Y4?]Q?R% "^9'_ 'U_.CS(
M_P"^OYTGE1_W%_(4>5'_ '%_(4 +YD?]]?SH\R/^^OYTGE1_W%_(4>5'_<7\
MA0 OF1_WU_.CS(_[Z_G2>5'_ '%_(4>5'_<7\A0 OF1_WU_.CS(_[Z_G2>5'
M_<7\A1Y4?]Q?R% "^9'_ 'U_.CS(_P"^OYTGE1_W%_(4>5'_ '%_(4 +YD?]
M]?SH\R/^^OYTGE1_W%_(4AC3_GFOY4 .\R/^^OYT>9'_ 'U_.F;$[QI^5-D,
M,2%W$:J.2S8 % $OF1_WU_.F^:F?OK^=<9J/Q#TBQOI;<6K3Q1CF:,KM)]!G
MM[US4WC[6M?E-OX>THGG!:*/>1]7.%%).^QT?5YI7G[J\SU2>[@MH_,FGBCC
M'5G8 5RFJ?$C1M/RL+M=N.!Y8POYG^E<_:?#W7-9E%QXAU/R%//E0MYC_P#?
M1^4?@#7::1X-T+1@&MK)'F_Y[3?O'_,]/PHLQ/V,>\OP1RBZWXR\2_\ (.M(
M]/M&/$\GR<>Q/)_ 4I^'<UQ<1SW^MFXE+ R$ID'!R1DGH1D5Z)Y*<_*O_?(J
M-HT$L8VKR3GCVI<JZA]9J1^#3T(K*RT^PA$5G##;H.-L8 JUNC!SO7\Z!%&1
M]Q?R%+Y4?]Q?R%48;ZL-\?\ ?7\Z#)'_ 'U_.CRH_P"XOY"CRH_[B_E0!%/(
MGEG#J3D=_>I1)'_?7\ZAN(T$60B@[AV'K4HBC_N+^0H$.\R/^^OYT>9'_?7\
MZ3RH_P"XOY"CRH_[B_D*!B^9'_?7\ZAN)$^SR8=?NGO4OE1_W%_(5%<QHMO*
M0BYVGL* 8])$VCYUZ>M/\R/^^OYTR..,J/D7H.PIWE1_W%_(4 AP=6^ZP/T-
M+30BI]U0/H*SK[5A8W=O T8/G' 8MCG/0>_.>W0T :=%8$GB-X+W[//9E%\L
M2>8'RN"2 .G7(/\ ]>MJ"7SH4D^7YE!^4Y'Y]Z ):*** *U[_P >K_A_,447
MO_'J_P"'\Q10!+!_J8_]T?RI9=OE/N^[@Y^E-A_U,?\ NBJVHW#V\ D43MAP
M"L$7F,1Z8]/>@"CH(EQ(9=PRJE%8Q_=YP<(!CZ&MRL'P] (FN2(I8R[!CYEF
ML&3SZ?>K;F9EB=D +!20"< F@!]%85KJ5Y/%%N:(2^<(YHMI#)QE@>>W4'D'
MBHK75]0:[^SW4<<,HD8LF,X3*A0#GDD-G/X8H Z*BF,Q520"3Z#O4?G/_P \
M)/T_QH GHJ#SG_YX2?I_C1YS_P#/"3]/\: )Z*@\Y_\ GA)^G^-'G/\ \\)/
MT_QH GHJ#SG_ .>$GZ?XT><__/"3]/\ &@">BH/.?_GA)^G^-'G/_P \)/T_
MQH GHJ#SG_YX2?I_C1YS_P#/"3]/\: )Z*@\Y_\ GA)^G^-'G/\ \\)/T_QH
M GHJ#SG_ .>$GZ?XT><__/"3]/\ &@">BH/.?_GA)^G^-'G/_P \)/T_QH G
MHJ#SG_YX2?I_C1YS_P#/"3]/\: )Z*@\Y_\ GA)^G^-'G/\ \\)/T_QH GHJ
M#SG_ .>$GZ?XT><__/"3]/\ &@">BH/.?_GA)^G^-'G/_P \)/T_QH GHJ#S
MG_YX2?I_C1YS_P#/"3]/\: )Z*@\Y_\ GA)^G^-'G/\ \\)/T_QH GHJ#SG_
M .>$GZ?XT><__/"3]/\ &@">BH/.?_GA)^G^-'G/_P \)/T_QH GHJ#SG_YX
M2?I_C1YS_P#/&3]/\: )Z*@\]O\ GC)^G^-)Y[?\\)/T_P : +%(363J7B'3
M]*C+7LPB/9-P+'\ <UP5_P#%6>"2=H;.$0 XB:0DM[$@>OI4N:3MU-X8>I-.
M26BZ['J.\<^U8>J>,-%THLL]XCRK_P LHOG;\<=*\Q-SXY\8X%M:W*VS'[\I
M\B+ZXZG]:V=,^$\>5DUR\N;I@<F"W CCS]<Y/Z5?)+J[$_NH]>;TV^]_HAFJ
M?%>2:;[-I%IF1CA05,CGZ**I)X=\<>*Y!)J#-96[?Q7;9./:->A^M>EZ5HNF
MZ)&(]-TE+8=RB+N/U.<FM+S6_P">#_I_C3M!;+[Q>VDE[JY?3?[SA-.^%]A:
M2PB\OIK[:PD=94 1^ORD?W<X/X5W5M:0VD*PV\4<42C 2-0JC\!3/-;SA^Z?
M.WIQZ_6I/.?_ )X2?I_C4F;DY.\G<F Q1BH?.?\ YX2?I_C1YS_\\)/T_P :
M )JAD_U\7U/\J/.?_GA)^G^-122MYT1\I^IXX]/K0)EL4M0><_\ SQD_3_&C
MSG_YX2?I_C0,GH-0><__ #PD_3_&CSG_ .>$GZ?XT )=?ZG_ ($O\Q4X[U3N
M96,7^ID'S+Z>H]ZF\Y_^>$GZ?XT^@B>BH/.?_GA)^G^-'G/_ ,\)/T_QI#)Z
M@N_^/27_ '31YS_\\)/T_P :ANIF^RRYAD V'DX_QH$]BU']Q?H*?59)6\M?
MW,G0>G^-.\Y_^>$GZ?XT MB>J5UI=O>3++*&W!=IPV RYS@^HR!5E)&8G,;+
MCUQ4E S.31H(RQ5Y2QZEG)[$ ?09.*N0P^3$D89F"C&6.2?J:EHH **** *U
M[_QZO^'\Q11>_P#'J_X?S%% $D/^IC_W16?KAMQ8DW6!;K(AD)9EVC/7*\UH
MP?ZF/_='\JKZE--!9R/!;?:9> D60 Q)QR3VH R_#@B4W C2W7[O^IED?UQG
M>!^E;SH'4J>AX(]:RM%@NH1+]K,@9B"L6 (XQZ)R3]<_I6O0!0&C:<)8Y19Q
M>9&VY'V\J?45,+"U41@0IB-MR<?=/J*LYHS0 F!2XHHH ,48HHH ,48HHH ,
M48HHH ,48HHH ,48HHH ,48HHH ,48HHH ,48HHH ,48HHH ,48HHH ,48HH
MH ,48HHH ,48HHH ,48HHH ,48HI,CU% !Q1Q378*,D@ =<G%<YJWC72-+5X
M_M*W%P ?W</S<^Y' I-I%0A*;M%'29'K4-U>6UG 9KB:.&,?Q2-@5X[-\2=:
M0.K7,0,Q_=".'<PSV0#K^-1VWAWQ?XJE$\L+VT3<BXU%B6(_V8^U.*<E=:+S
M-JE*-)VJ2^2U9W.J_$?2+(.+4-=NO5A\B#\3_2N'N?'/B/Q-*;;1H)Y,G&RS
M0@#ZN:ZO2?A5I%NZS:M+-JDX_P">K;8Q]%%=S:6=M90B"UAC@A4<1QJ%4?@*
M=H+?7\#/VMO@C;S>K_R/*-.^&&MZFWG:W?BS1N6BM_GD/U8UUNB?#_2M'OX9
MHFFE%MO,:38;[X'4XYQCCZUV51)_KY/H*?-I9+0ARE)WDVQ^T8Z4H%.HJ1!B
MDQ2T4 0'_C[4?[!_G4PJ _\ 'XO^X?YU.*!(7%&***!B5!+Q<P>Y;^53U7E/
M^E6X_P!IOY4"98 I<4@Z4M PQ24M(: *U[Q;Y_VE_P#0A5D56O\ _CV_X&O\
MQ5D=*8NHN*,444AABJ][Q9S?[AJQ5:^/^@S_ .X?Y4">Q+%_JU^@I^*9%_JE
M_P!T5)0"V#%%%(6 ZD"@8M%)N'J*7(/>@ SBBLK4=6DL+A$^Q2S1N,*T;#)<
MYPN/PZ]!5RRE>:TADE*%V0%C&<KGO@]Q0 7O_'J_X?S%%%[_ ,>K_A_,44 2
MP_ZF/_=%5=2GGM[1Y((S(RX.%&3C/.!W.*M0?ZF/_='\JIZMO%D_EAMY90NU
M-W.X8R!U'K[9H KZ1/?2RSB^>/=PPCC'^JSG"Y[\8S[UISC-NXRPRI&5Z_A[
MUE:%:+9"6)0>@+&2,K([$DLS'OR>/05M4 <G9(T;6]NUM=AEG!6X$3E6  R6
M'1<\@YX.":6WM[T:D',-P+7Y=BMG*RC&YC[=?8\UU=&* &<E3C@]LTS$_P#?
MC_[X/^-344 0XG_OQ_\ ?!_QHQ/_ 'X_^^#_ (U-10!#B?\ OQ_]\'_&C$_]
M^/\ [X/^-344 0XG_OQ_]\'_ !HQ/_?C_P"^#_C4U% $.)_[\?\ WP?\:,3_
M -^/_O@_XU-10!#B?^_'_P!\'_&C$_\ ?C_[X/\ C4U% $.)_P"_'_WP?\:,
M3_WX_P#O@_XU-10!#B?^_'_WP?\ &C$_]^/_ +X/^-344 0XG_OQ_P#?!_QH
MQ/\ WX_^^#_C4U% $.)_[\?_ 'P?\:,3_P!^/_O@_P"-344 0XG_ +\?_?!_
MQHQ/_?C_ .^#_C4U% $.)_[\?_?!_P :,3_WX_\ O@_XU-10!#B?^_'_ -\'
M_&C$_P#?C_[X/^-34E $6)_[\?\ WP?\:,3_ -^/_O@_XU+FJUU>6]E&9;F>
M.&,#[TC 4!9O8DQ/_?C_ .^#_C1B?^_'_P!\G_&N)U[XA64%C.-+9Y)0-HN"
MN(T/KD]:X9/%OB+44%A;7%_?2'G9:J-W/]Y\<"IBW)VBKG3]7:@YU&HKSW^X
M];U+Q!9:4#]MO[>-O[@!+'\ <UQ^J_$T0HWV2WCC3M-='8#]%ZUD:?\ #KQ%
MJ;>9J%S!I43<E8SYLQ^K'I^==EI'PW\.:4R3-:&]N1UGNV\PD_0\#\JMP7VG
M]W^9ESPC\,;^NWW'G4FJ^*/%[[+*WO+V(GER/(MQ^/?\:W]-^%E[<JK:SJXC
M3O:V*[5(]"W4UZDD:QH%10JCH , 4[&*:<8_ K?BR)SG-6D].RT1S.B>#M-T
M.Y$]D@\R*+R$:0;BJ[BW'OD]?0"NAQ/_ ,]$_P"^#_C1$<O+_O\ ]*FI-MZL
ME*Q#B?\ YZ1_]\'_ !HQ/_?C_P"^#_C4U%(9#B?^_'_WP?\ &H4$OGR8=,X7
MDJ?\:MFH(_\ CZE_W5_K0)CL3_WX_P#O@_XT8G_OQ_\ ?!_QJ:B@9#B?^_'_
M -\'_&C$_P#?C_[X/^-344 4OWPO5&],^6?X3ZCWJ<"?'WX_^^#_ (U%_P Q
M!/\ KD?YBK0H$B+$_P#?C_[X/^-&)_[\?_?!_P :FHH&0XG_ +\?_?!_QJO,
M)?M5OEDSN;^'VJ[568_Z9:^[-_Z#0)DH$^/OQ_\ ?)_QHQ/_ 'X_^^#_ (U*
M.E+0,AQ/_?C_ .^#_C1B?^_'_P!\'_&IJ#0!0OQ,+;ET^^O\)_O#WJSB?^_'
M_P!\G_&H=0XM#_OI_P"A"K8[T^A/4BQ/_?C_ .^#_C1B?^_'_P!\'_&IJ*11
M#B?^_'_WP?\ &J]ZLOV&?<Z$;#T4^GUJ]574#C3[G_KFW\J$)["Q";REP\>-
MH_A/^-/Q/_?C_P"^#_C2P_ZI/]T5+0P6PQ _.]E/T&*QM4ANVU*"6! Z(I 4
MJ" ^X<G/3C/(YK<HP*!G(?V3+)?&YB@FMOW83& 02,EFQGJ> #GGO7360(M(
M@R[6"#*[<8_#M5G ]** .6\1W%I;ZA&;FQTVY+H$3[1(%<,<X//1!W/7FMS2
M51-*M%C=)(Q"H5T&%(QV'I3+S36N[@2B\EB&W;M1$/XY92:GL;7['906Y<OY
M483>1C=@8S0 7O\ QZO^'\Q11>_\>K_A_,44 2P?ZF/_ '1_*JNIB<V;?9G=
M) RMN1=Q !!. >O':K,/^IC_ -T5#?RF&W+_ &B* !ER\OW<9Y'X]* ,_2+J
M2>1PT]U<]B\EMY*ICT! R3GWK8D<11,[G"J"2?850TO4QJ/G$1-L0A5E .Q_
M]TGK_+W-7Y%+(0#C(ZXH I0:M!<>1M65?/.(]R8SQN!SZ8J*VURUNB#"975I
M&16V\'!P6_W<\9J*#1&AEAD%P<1SF8((\*,KMPHSQZ_4T]-&"W(N1(%D8GS0
MD8"N..W;[HYH ULT9'K2;0RD$9!J/[-#_P \E_*@"7(]:,CUJ+[-#_SR7\J/
MLT/_ #R7\J )<CUHR/6HOLT/_/)?RH^S0_\ /)?RH ER/6C(]:B^S0_\\E_*
MC[-#_P \E_*@"7(]:,CUJ+[-#_SR7\J/LT/_ #R7\J )<CUHR/6HOLT/_/)?
MRH^S0_\ /)?RH ER/6C(]:B^S0_\\E_*C[-#_P \E_*@"7(]:,CUJ+[-#_SR
M7\J/LT/_ #R7\J )<CUHR/6HOLT/_/)?RH^S0_\ /)?RH ER/6C(]:B^S0_\
M\E_*C[-#_P \E_*@"7(]:,CUJ+[-#_SR7\J3[/!VC3\J )LCUI,\\5A:IKVB
M:0"+F>'S>T48W.?P%<%XJ\837,$4-O;2:?%(^%8MB63C/W1R!4\W1:F].A*>
MKT7=Z'JT]Q'!&7ED6-!U9VP!^)KF+[QYIL+F*Q674)1_SP'RCZL>*\VLEUOQ
M0J_8=.N-1(.W[3>R[;9<>@_B_P \5U=A\+WN@K^(-4EG'7[)9CR81[<<FK49
M;RT_,F3I0DTO>?W+[]RCJGQ+O)'^S6QCAF;@0VR_:)B?P^455LO#'BGQ"ZW-
M[#]D#<F;4)#))^$8X'XUZ9I?AC1M&B":?IT$''WE7YC]6ZUH_98?^>:_E3]Q
M;*_J3[6?V?=]/\]S@;/X5::V7UF^NM2E(P 6\N-?HHKJ]#T.RT9)C:(RF=@T
MA8YR0-H_05I_9X1_RR7\JC@AB>$%HU).>U.524E9LRY5>Y8XI>*B^S0_\\E_
M*C[-#_SR7\J@HER/6@D8ZU%]FA_YY+^5'V>$?\LE_*@!L!^>;G_EI_05/D>M
M4[>&)I)P44XDP./85/\ 9H?^>2_E0)$N1ZT9'K47V:'_ )Y+^5'V:'_GDOY4
M#)"1ZU7C/^F3\_PK_6I#;0X_U2_E5:.&(W\X,:X")V^M F7LCUHR/6HOLT/_
M #R7\J/LT/\ SR7\J!DN1ZT9'K47V:'_ )Y+^5'V:'_GDOY4 1$_\3%.?^61
M_F*L@CUJB88O[31=BX\D\8]Q5K[-#_SR7\J!+=DN1ZT9'K47V:'_ )Y+^5'V
M:'_GDOY4#)<CUJI<'_3;3_>;_P!!J;[-#_SR7\JJ7$,2WMH!&N&9L\?[--"9
M?!&.M+D>M1?9H?\ GDOY4?9H?^>2_E2&2Y'K1D>M1?9H?^>2_E1]FA_YY+^5
M $&I$?9.O\:?^A"K@(]:SM3@B6SXC4?.@Z?[0JX+:'/^J7\J">I+D>M&1ZU%
M]FA_YY+^5'V:'_GDOY4%$N1ZU5U$C^SKGG_EFW\JE^S0_P#/)?RJKJ,$2Z=<
MD1J"(V[>U"$]BW"1Y2<_PBI,CUJO#;P^2G[I?NCM3_LT/_/)?RH!;$N0:6F)
M$D>=B!?I3Z!A1110 4444 5KW_CU?\/YBBB]_P"/5_P_F** )(?]3'_NBL_7
MB%TJ0XR2Z 'R_,P=PP=G\1!YQ6A#_J8_]T53U@H-.DWP2SX*E8XFPSMN&T ]
MN<4 ,T6^>\M@LJ2B:,8=G@:(-R0" ?85J5D:)9R6RRO.\[3RD,RNS%$]%3<3
MT[GO6G,6$+L@!8*2H8X!/;- $E%8%MJES+):QRK&)'F:*= I#1D(6Q_@>XP:
M9#K-RVH_8W$)*(LK.,X96Q\H]^: .BHIA?:I."<=@.:9]H'_ #RE_P"^: )J
M*A^T#_GE+_WS1]H'_/*7_OF@":BH?M _YY2_]\T?:!_SRE_[YH FHJ'[0/\
MGE+_ -\T?:!_SRE_[YH FHJ'[0/^>4O_ 'S1]H'_ #RE_P"^: )J*A^T#_GE
M+_WS1]H'_/*7_OF@":BH?M _YY2_]\T?:!_SRE_[YH FHJ'[0/\ GE+_ -\T
M&<?\\Y/^^: )J3-0^?\ ],I/^^:S=2\3Z7I*9O9_+?M&!EC^ I-I;E1BY/EB
MKLURQR>E0SW<-K"9;B6.*,=6=L#]:\I\1_$"XU&XCBTJ66SCC!D;##>X'))
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M/X?K0A,T:*A^T#_GE+_WS1]H'_/*7_OF@9-14/V@?\\I?^^:/M _YY2_]\T
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MCDL>!7+ZSX_T32E<+-]JE7^&$C:/JW2N8/AOQGXH8/JMVMC;,<^6YW,![(O
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MDQYL?8_WQ6AB?/#1X_W35+6_^0:?^NL?_H8K2% NI%B?^]'_ -\FC$_]Z/\
M[Y-344#(<3_WH_\ ODU2U<3#1[S+)CR6SA3Z5IU1UG_D#7O_ %Q;^5"$]B2
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MN:,U%Y _OR?]]FCR!_?D_P"^S0!1?_D8HO\ KU?_ -"%:59#Q#_A)(EW2?\
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M4Y5'D+$ X'R4(3V-@=*6H!=0X_UBTOVJ'_GH*!DU!J'[5#_ST%!NH?\ GHM
M%#Q!_P @IO\ KM%_Z&M:@ZFL?7)5ETQDC.YO-C. "> ZYK2%S",_O%I]">I/
M14/VJ'_GHM'VJ'_GH*11-6?KG_(#OO\ K@_\JM?:H?\ GHM4=9F271;Y(VW,
MT#@!>23BA;@7;7_CVA_ZYK_*IZJ6\\26\0+@$( 1^%2_:H?^>@H8D344Q)4D
MSM;.*S-1U=K*X,:Q!A''YLA.<[=P7 ]^:!FM165::J9[LVLH5)1GY2""Q![
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MX)B04&T@*$SNX^8?-QSQS6H;6V*JIAC*J<@;1@'UQZT](84<LB*&(P2 ,D4
M2CI1110!#<EEMI"KA&"G#'H#ZUS$FJWS:9I<\5Z@EN(MKD[-I8J<$C&1SCGH
M/2NK=5=2K %3U![U$+6V'2&(?+MX0=/3Z4 945_(^FHXO CH^)'E*,6P<$9&
M!CW%;2L&&0<BH3;6K((S%$RCHI4$#\*F50HPHP/04 .H/0T4'I0!S,5[>7%H
M474 MR;UH4957! /0C!Z#-7+6\>6UO1+>(TL<SHCJ57 &,#GC\ZTUM;=.%B1
M><_*H'- MK95*K#$%;J HY^M %?1KF2[TN&:5]\A!#-C&2#C_.*OTU$5!A0
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MF4-O^143#8 89QD@<^_:NII-H- ',V-Y>V^JQP73231W!)C91P,@'&3SQ73
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% %:]_P"/5_P_F**+W_CU?\/YBB@ BN(5B0&5 0HXW4_[5!_SU3\Z** #
M[5!_SU3\Z/M4'_/5/SHHH /M4'_/5/SH^U0?\]4_.BB@ ^U0?\]4_.C[5!_S
MU3\Z** #[5!_SU3\Z/M4'_/5/SHHH /M4'_/5/SH^U0?\]4_.BB@ ^U0?\]4
M_.C[5!_SU3\Z** #[5!_SU3\Z/M4'_/5/SHHH /M4'_/5/SH^U0?\]4_.BB@
M ^U0?\]4_.C[5!_SU3\Z** #[5!_SU3\Z/M4'_/5/SHHH /M4'_/5/SH^U0?
M\]4_.BB@ ^U0?\]4_.C[5!_SU3\Z** #[5!_SU3\Z/M4'_/5/SHHH /M4'_/
M5/SH^U0?\]4_.BB@ ^U0?\]4_.C[5!_SU3\Z** #[5!_SU3\Z/M4'_/5/SHH
MH /M4'_/5/SH^U0?\]4_.BB@ ^U0?\]4_.C[5!_SU3\Z** #[5!_SU3\Z/M4
M'_/5/SHHH /M4'_/5/SH^U0?\]4_.BB@ ^U0?\]4_.C[5!_SU3\Z** #[5!_
MSU3\Z/M4'_/5/SHHH /M4'_/5/SH^U0?\]4_.BB@ ^U0?\]4_.C[5!_SU3\Z
M** #[5!_SU3\Z/M4'_/5/SHHH /M4'_/5/SH^U0?\]4_.BB@ ^U0?\]4_.C[
M5!_SU3\Z** #[5!_SU3\Z/M4'_/5/SHHH /M4'_/5/SH^U0?\]4_.BB@ ^U0
M?\]4_.C[5!_SU3\Z** #[5!_SU3\Z/M4'_/5/SHHH /M4'_/5/SH^U0?\]4_
M.BB@ ^U0?\]4_.C[5!_SU3\Z** #[5!_SU3\Z/M4'_/5/SHHH /M4'_/5/SH
L^U0?\]4_.BB@ ^U0?\]4_.C[5!_SU3\Z** (;F:&2!U$J<XZ'WHHHH __]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>30
<FILENAME>ex99-1_014.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 ex99-1_014.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" &9 A$# 2(  A$! Q$!_\0
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M?_%5N\"[Y_B3C\#_ /7IQ'EG<O"]P/YT^:'\OXL7+/\ F_!& ?%%XHR?"VL
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M1\I)^9@<5I%M.Z,Y+2S*]G9-:L5<!RPSP>*NY?\ N?\ CU1?;(FE^02O\O\
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MES,4&^5%>RT/3+!_,M[*(2GK*PWN?JQR?UK1J "=>C(_U&#2[Y_^> _[[_\
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MJ^]!IJY;KD^9ZUV K@Q/Q_)'7AO@?JQ:***YCH'T444 %%%% !1110 4444
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MR=O)]ZEJG&9+49D4>4S9R#DIGU_QJY1):BB] HHHJ2@I.I]A03V'4TH&!B@
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M2PXD/X]ZU[>^-M"JS*Q@&0DJC=QZ-Z&DZ;<=!J:3U-%F0GRRX#,#@9YI 70
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M7+;<****0!0:*#0 AIAIYIAH BT+_D>[K_L&K_Z,KM!7%Z%_R/=U_P!@U?\
MT97:"O/Q7\3Y([,-\#]6+1117*=(^BBB@ HHHH *#THH/2@#-O\ [AKE8_\
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M=BTB%6#C"D'(.:I-RM$327O'.W,S,TDN<LQX]SVK1LXH[>R1'8*9?F8D_P
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M3<T9H =FDS3<T9H ":3-&:2@9'H7_(]W7_8-7_T97:"N+T'_ )'NZ_[!J_\
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M$<-_:EQ_T M8_P# 4_XT?VI<?] +6/\ P%/^->@<^M'/K5?6_P"[^+)^K/\
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ME &3+IZMVJL=,&>E;C5&: ,>VT6VAE\P1 D?=#<A?]T'I^%;,4>T4+4JT7N
M^BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
)HH **** /__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>31
<FILENAME>ex99-1_015.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 ex99-1_015.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" &! A # 2(  A$! Q$!_\0
M'P   04! 0$! 0$           $" P0%!@<("0H+_\0 M1   @$# P($ P4%
M! 0   %] 0(#  01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$!
M 0$! 0        $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%! 0  0)W  $"
M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#=^%?@'PIK
M?PXTK4-2T.TN;N42>9+(I+-B1@,\^@%=E_PJSP-_T+-A_P!\'_&J/P6_Y)/H
MOTE_]&O7?4 <?_PJSP-_T+-A_P!\'_&C_A5G@;_H6;#_ +X/^-=A10!Q_P#P
MJSP-_P!"S8?]\'_&C_A5G@;_ *%FP_[X/^-=A10!Q_\ PJSP-_T+-A_WP?\
M&C_A5G@;_H6;#_O@_P"-=A10!Q__  JSP-_T+-A_WP?\:/\ A5G@;_H6;#_O
M@_XUV%0W-S%:HKR%OF;:H52Q8^@ H Y7_A5G@;_H6;#_ +X/^-'_  JSP-_T
M+-A_WP?\:ZY'WQJX##<,X88(^HIU ''_ /"K/ W_ $+-A_WP?\:/^%6>!O\
MH6;#_O@_XUV%% ''_P#"K/ W_0LV'_?!_P :/^%6>!O^A9L/^^#_ (UV%% '
M'_\ "K/ W_0LV'_?!_QH_P"%6>!O^A9L/^^#_C7844 <?_PJSP-_T+-A_P!\
M'_&C_A5G@;_H6;#_ +X/^-=A10!Q%U\*/!K('MO#FGB5.0K*=K^QY_7M5?\
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MQ@X&.,]/\:WK'P+X0AN8)!H]C=:?>,45YX"&CDQ\H4]U8=/?'K0!ZI]KMO\
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MB,;<D"!2<=L[F/-7]:TF'42ENL[6BI#\L1.P9Z#<&/8;AGI\U0& 6_C'PD%
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M"F@1D',EA#@CVC4\U9\0?\BUJW_7E/\ ^BVJAX2^;P_H>?X-)@(^I49_]!%
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M ++2#4FF7-K9S3*?N2'"(WODG./?'TS4UE;M;PMYC!I9',DA48&3Z>P&!^%
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MW_))]%^DO_HUZ[Z@ J"YN5MU7Y2\CG"1KU8_Y[]JGIGE1^<9=@\PKMW=\>E
M%9+21_WL\\@F/_/)R%3V Z'ZD<T?Z;!UVW2>V$?_  /Z5<HH Y^;1]*U"_\
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MEE4D8O9$X5V.3#Z!O5??MW]: -&J=O\ \A"\_P" '_QVKE4X/^0E=_2/^1H
MN5ROQ*_Y)SKO_7J?YBNJKE?B5_R3G7?^O4_S% &7\%O^23Z+])?_ $:]=]7
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M\\+VX)YZ=/4-U!]HMGC!PQ&5;T8<@_GBEMI3/;QR%=K,/F7T/<?G0!+1110
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MQ!Z#^,^U(EF?B->@R#_BD[67(/?4Y5..#VA!R/\ ;/M7H:(L:*B*%11A548
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M,\+^)&?H/>K$\R6\#RO]U1GCJ?8>]164+11%Y<>=*=\GL?3Z 8'X4 6:***
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ML63K%KVGW&EN3@3-^]MV/M(O _X$!70I(DJ!XW5U/1E.0: '4444 (RAU*L
M5(P01D$5YK!X2\10W%QX5MIOLGA;>98[])/](6%SDVJ#^'!R-_92 .:]$O))
M8;222%0TBC(!]._UXS4*QW4R*_VU C#(,40Y'U)- $FGZ?::5I\%A8VZ6]K
M@2.*,8"@58)"C)( '<U5^P[CF2ZN7_[:;?\ T'%*--LP<F!7/K)ES^N: &2Z
ME'Y\<%L8YII">!( !@9Y(S3PEZZG?+#&>VQ"Q'XG_"F7R+#;1R(H40R*^%&.
M,X/Z$U=H J"R9I$::YEE1&W!&"@;NQX Z5;HHH **** "JG35_\ >@_DW_UZ
MMU5NXY R7,(W219RG]]3U'UX!'N* +5%,AE2>)98VW(PR#3Z "BBB@ HHHH
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MW-1W[0&V,,ZF02_*(U&68^W\\]NM '"ZUHMUI=U)X@TJ(WLSILU2PQ@7\/\
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M@T =E;W4=R&V$AUX=&&&7ZBIJ@N+6.X*ODI*OW9$.&7_ .M['BHA=/:X2\
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MY'GC_>;T4?\ UJ+NZ,)6*%!)<R9V)G ]R?11ZTMI:"V#.[^9<2<R2D?>]AZ
M=A0 MI:_9D8LYDF<[I)#U8_T [#M4=ZA22"Y2-F:-L/L&24(Y&._.#^%7**
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M:HZD9,VJ1('8S!MI;&0H+=?P% %ZBJGVFY[6$OXNG^-'VFZ_Y\7_ ._B?XT
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MJH_J:MU44;M6D/\ <@4?FQ_PH MTC,%4LQP ,DTM5-3)&G3@'&Y=I^A./ZT
M+IRG[()&&&F)E(]-QR!^ P*M4@    P!TI: ();RWAN(H))0LDOW >_X]*GI
MDL,<\9CE171NJL,@U4^R7-N<VEQE/^>,^6 ^C=1^M %ZBJUK=^>7BD3R[B/[
MZ9SUZ$'N#ZU9H *K7=U]G151#)/(=L<8.-Q]3Z =S52[N6L]64K&TKW$.V*,
M=V4YZ]AALD^U6K2T,3-/.PENG'S/C@#^ZOH/Y]30 6=H8-\LK"2YDYDDQCZ
M>@'8?UJU110!1N/W>J6<H'#AX2?J-P_]!/YU>J*>W2?R]V08W#J0>X_R:EH
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MLIM20RG(/(H S?@M_P DGT7Z2_\ HUZ[ZN!^"W_))]%^DO\ Z->N^H ****
M"BBJT^H6ENVR2X0/_<!RWY#F@"S15'[=/)_Q[V$S#^]*1&/UY_2CR=0F_P!;
M<QP+_=@7<?\ OIO\* +U%4?[,7'_ !]7F[^]Y[?RZ?I1#+-:W(MKJ0R))_J9
MFP"Q[JV._<>H^E %ZBBB@ HHJ&YNHK2+?(3R=JJHRSGL .YH ?++'!$TDKA$
M49+$\"J(BDU-MUPC1V8/RPL,&7W?T'^S^?I3H;66XE6YO<;E.Z. '*Q^Y]6]
M^W;U-^@#.<#2[@RKQ9RG]X,<1-_>]E/?T//K6C2,H92K $$8(/>LZ(G3)DMW
M)-FYVPN?^69_N$^GH?P]* -*BBB@ I" RD$ @\$&EHH Q=.\+Z;HL+0Z-&VG
M1,YD:.W/RECU)4Y%7/\ B90?\\+I?QC;^H/Z5>HH I+J* [;B&:W.0,R)\N3
MQ]X9'ZU=J*YMTNK=X9,[7')4X(JKI]PPM95N9LRP.XD,A *KDE2>@^[@YH O
MUYM'-%\.]=NC;0^;X;OI/FE'"Z=<$XV,_:)B?^ $^]=.]WJ6OB4:5,EG8J2@
MNI(RSS,#@A!D;5ZC<>?0=ZKC3I=8M)=,F+&PVF*5U9?*=3P50!03Z$G@>YH
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M,GJ0>@[?7IJ44 4)M+62=V2:2**7F:)#@2'USU'OCK4\TGV6!%A@9SPB1H,
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M %%%% !1110 4449H **,T9H **,T9H **,T9H **,T9H **,T9H **,T9H
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MVYO.<=)& Z-Z 59_X1;1_P#GU?\ [_R?_%59T?\ X\7_ .OB?_T:]7Z ,?\
MX1;1_P#GU?\ [_R?_%4?\(MH_P#SZM_W_D_^*K8KFO%.LZMIU[HUAH\=DUSJ
M-P\6Z\W[$"QL^?EY_AQ0!=_X1;1_^?5_^_\ )_\ %4?\(MH__/J__?\ D_\
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M6+>*.6:TA\Q$DSM8Y YQSWH D_X1;1_^?5_^_P#)_P#%4?\ "+:/_P ^K_\
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M5)H]2>>UEMS9H\OEN&#R1J6&\ @#!V\8)ZU5/B_R[AK>:Q*R0A'GVRY"HQC
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M;@*8E\P?,&.%Q]3T]>U36FM:9?WLUG:7T$UQ#G?&C@L,'!/T!X/O0!?HHHH
M*Y7XE?\ ).==_P"O4_S%=57*_$K_ ))SKO\ UZG^8H R_@M_R2?1?I+_ .C7
MKOJ\Z^#5[:P_"K1DDN848"7*M( 1^]:N[_M*Q_Y_+?\ [^K_ (T 6'W;&V8W
M8XSTS7-^$D\2H+W_ (2!U;,@\GE2>^>G;IBMS^TK'_G\M_\ OZO^-']HV/\
MS^6__?U?\: (]7-VNES&R#^?\N-@!;;N&[;GC=MSCWQ6"M_XB2X%O:V4CVI4
M;)[Q<R'+8RP4@<#L<$CDUT7]I6/_ #^6_P#W]7_&C^T;'_G\M_\ OZO^- ',
M_P!I^+$MKF0V"/(I_=IY/<XP!\W08/OS[599?$5Y%8;6:VD:29IR2 $&?D!X
M.?IQGN:W?[1L?^?RW_[^K_C1_:-C_P _EO\ ]_5_QH YF'4O%F\P'3EPJ?ZV
M6/J1D]F .>![5T.CR7LM@6U!2MQYL@(V;<+N.WZ_+CGO4O\ :-C_ ,_EO_W]
M7_&C^TK'_G\M_P#OZO\ C0!:HJK_ &E8_P#/Y;_]_5_QH_M*Q_Y_+?\ [^K_
M (T 6J*J_P!I6/\ S^6__?U?\:/[2L?^?RW_ ._J_P"- %JBJO\ :5C_ ,_E
MO_W]7_&C^TK'_G\M_P#OZO\ C0!:HJK_ &E8_P#/Y;_]_5_QH_M*Q_Y_+?\
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M?_OZO^- %JL;Q-I5WJVF1164D*7$-U#<IY^=A,;AL''/.*O_ -I6/_/Y;_\
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MXC7UI)\/-<1+J%F-L<!9 2>1[T ?)5U_Q\R_[YJ&BB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
F* "BBB@ HHHH **** "BBB@ HHHH *EMO^/J'_KHG_H0HHH _]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>32
<FILENAME>ex99-1_016.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 ex99-1_016.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" +' F4# 2(  A$! Q$!_\0
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M$5[_ /&:/^$RTO\ Y]=<_P#!%>__ !F@#H**Y_\ X3+2_P#GUUS_ ,$5[_\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M53CGCKK'3K33EG6TB\L3S-/)\Q.YVY)Y/'TZ4=-0>^A:HI&944LS!5 R23@
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M Z"BN?\ ^$-TO_GZUS_P>WO_ ,>H_P"$-TO_ )^M<_\ ![>__'J .@HKG_\
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M/^A,US_O]9?_ "10!T%%<_\ \)#JG_0F:Y_W^LO_ )(H_P"$AU3_ *$S7/\
MO]9?_)% '045S_\ PD.J?]"9KG_?ZR_^2*/^$AU3_H3-<_[_ %E_\D4 =!17
M/_\ "0ZI_P!"9KG_ '^LO_DBC_A(=4_Z$S7/^_UE_P#)% '045S_ /PD.J?]
M"9KG_?ZR_P#DBC_A(=4_Z$S7/^_UE_\ )% !X$_Y)YX:_P"P5:_^BEKH*XOP
MUJ&M:-X5TC2[CP?K+3V5E#;R-'/9%2R(%)&;@'&1Z"M3_A(=4_Z$S7/^_P!9
M?_)% '045S__  D.J?\ 0F:Y_P!_K+_Y(H_X2'5/^A,US_O]9?\ R10!T%%<
M_P#\)#JG_0F:Y_W^LO\ Y(H_X2'5/^A,US_O]9?_ "10!T%%<_\ \)#JG_0F
M:Y_W^LO_ )(H_P"$AU3_ *$S7/\ O]9?_)% '045S_\ PD.J?]"9KG_?ZR_^
M2*/^$AU3_H3-<_[_ %E_\D4 =!17/_\ "0ZI_P!"9KG_ '^LO_DBC_A(=4_Z
M$S7/^_UE_P#)% '045S_ /PD.J?]"9KG_?ZR_P#DBC_A(=4_Z$S7/^_UE_\
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M0 4444 %%%% !1110 445S9UO7KK5M4M-+T?39H-/N%MVENM2>%G8PQRY"K
MX Q*!U[&@#I**Y_[9XP_Z 6A_P#@YF_^1:CAU#QE*A9_#FC0D.R[7UJ0D@,0
M&^6V(P0,CO@C(!R  =)17/\ VSQA_P! +0__  <S?_(M'VSQA_T M#_\',W_
M ,BT =!17-PZAXRE0L_AS1H2'9=KZU(20&(#?+;$8(&1WP1D Y D^V>,/^@%
MH?\ X.9O_D6@#H**Y_[9XP_Z 6A_^#F;_P"1:/MGC#_H!:'_ .#F;_Y%H Z"
MBN?^V>,/^@%H?_@YF_\ D6C[9XP_Z 6A_P#@YF_^1: #QE_R [;_ +"NF_\
MI;#3_&<"7'@K6D<R "SE<&.1D(*J2.5(/4#ZUD:^GC+4M.B@30M&RM[:3_)J
M\A.([B.0_>MU&,)SSG&<!CA3=O!XEU&TDM+[PSX<NK:08>&?59'1N<\J;7!I
M-75BHNTDS(\1QVMP]NFI,!:P:)-<P;FP%F79^\7T=01@CD;CBJ-EYD]]!?71
M*:^^J16K,#AUA-NK,@_V<;GQTW<]:WVLM<>VMK9O"'A=K>T96MXCJ3E82O0H
M/LF%([8J7R_$?]H?VA_PB_AO[;L\O[1_:LGF;.NW=]ESCVJM+_U_7EZ&:5DE
M?^OZU]3%M+*+P;I\]M-))?VXN8WE2UA6/S92%5(P&?&XX\QV+#).?XL5W5A?
M0:GIUM?VS%H+F)98R1@E6&1Q]#7/7,7B*\M);2Z\+>&I[:4YDAEU21D<YSRI
MM<'GFITN/%L4:QQZ!H*(H 55UB4 #T ^RT7ON5U.BHKG_MGC#_H!:'_X.9O_
M )%H^V>,/^@%H?\ X.9O_D6D!T%%<_\ ;/&'_0"T/_P<S?\ R+1]L\8?] +0
M_P#P<S?_ "+0!T%%<_\ ;/&'_0"T/_P<S?\ R+1]L\8?] +0_P#P<S?_ "+0
M!T%%<O=ZYXDTQ;>>_P!$TI;62[M[9V@U621U\V5(@P4VZ@X+@XR.E=10 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%<V=;UZZ
MU;5+32]'TV:#3[A;=I;K4GA9V,,<N0JP. ,2@=>QH Z2BN;@U#QE-;Q2OX<T
M:!W0,T4FM2%D)'W3MMB,CIP2/0FI/MGC#_H!:'_X.9O_ )%H Z"BN?\ MGC#
M_H!:'_X.9O\ Y%H^V>,/^@%H?_@YF_\ D6@#H**Y_P"V>,/^@%H?_@YF_P#D
M6HYM0\91(&3PYHTQ+JNU-:D! + %OFM@, ')[X!P"< @'245S_VSQA_T M#_
M /!S-_\ (M'VSQA_T M#_P#!S-_\BT =!17/_;/&'_0"T/\ \',W_P BT?;/
M&'_0"T/_ ,',W_R+0!T%%<_]L\8?] +0_P#P<S?_ "+1]L\8?] +0_\ P<S?
M_(M '05S]G_R4/6?^P58?^C;NC[9XP_Z 6A_^#F;_P"1:RX$\91^*M0U$Z%H
MVR>RMH!G5Y-N8WG8X/V?.?W@SE0.F"<D* 7[^!%^(>BS@R;WLKI&'F-MP#&1
M\N< _,><9KBKR5[73FOK21DU2[CU#^T94;$FQ),9)_Z9\!?[H/'6NNFM->N-
M1AU&?PEX8EOH!MBN7U-VEC'/"L;3(ZGIZT^.'Q%#=7%U%X6\-)<7( GE75)
M\H'3<?LN6Q[T+3^O._\ PXWK_7]?(P+GPS9ZI'K&EV-U!8Z193QRJ/*\R%&:
M$[\+N !&Y9 1T<[L$UO6&O6T7B*+3KJ&Z%]=(H1W4;(EVLR1GG.XJC,3C&>,
M]!1;0>(;*S%G:^%?#4%JIW"&+5)%0'.<[1:XZ\_6E:+Q$^H)J#>%O#;7J(8U
MN#JDAD53U4-]ER![4T_Z_K^K$V.IHKG_ +9XP_Z 6A_^#F;_ .1:/MGC#_H!
M:'_X.9O_ )%I#.@HKG_MGC#_ * 6A_\ @YF_^1:/MGC#_H!:'_X.9O\ Y%H
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MA1110!S_ (R_Y =M_P!A73?_ $MAKH*Y_P 9?\@.V_["NF_^EL-=!0 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %<_X>_Y#GBS_
M +"L?_I%:UT%<_X>_P"0YXL_["L?_I%:T =!1110 4C$JI(4L0,[1U/YTM%
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MJ9R 21DXKT>B@#R*X\)ZO_836?\ PBK2RKHXL R36_SR)*"C9+C  ^93U'/
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M <W!XYT6ZMXKBWBUF:"5 \<D>B7K*ZD9!!$6"".<U)_PF6E_\^NN?^"*]_\
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M]G:DPW0;D"Q;EBF.(I3^\QL8^^X=P*=@>CL:/_"9:7_SZZY_X(KW_P",T?\
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M_P $5[_\9J2V\6Z5=7]M9*NI0SW3E(?M6EW,"NP1G(#21JN=J,<9[&MRN?\
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MD"R(' *\[L'N/6DTUI_6C_IB3OKY?FOZ12NOAU;7FHO?7&NZN]P\EM*S?Z.
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MOUJ>@WN9O_"&Z7_S]:Y_X/;W_P"/4?\ "&Z7_P _6N?^#V]_^/5T%%(#G_\
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MA_>?*N[@@X<9&5YJ_=^-+6QGMTNM-U"))[K[*LS"+8&\SRU.=^2"W906 Y(
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MV/QA_P!!W0__  33?_)5 '045S_V/QA_T'=#_P#!--_\E4?8_&'_ $'=#_\
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M^<&P';)49*C!.T<@<FA7T2_JPV[:O^KG(>*_!>HZC=>(;N/P^E[<WMG9K:S
MP;TD1LR#+L"IZ'(X..M7)/#&MR>(;F[DT]I5DFGFEF8PDW%LT&Q+0Y;)PYS@
M_)WSDUWFNW%W9Z#?75B\*7,$+2H9XS(GRC."H92<XQU%9RWVLM'H3B>Q;[3&
M6NE%J^7.S>!&?,^3ICG=UJ;Z-?UJG_P1VM9_UI8Y7X:^'=9T#4 M_H\UE =)
MMX'<S1,K3QL^[(1R3PPP<=!CCBMK3=/U7PUXAUMH-,EU"RU:Z%W'-%-&I@<H
MJLL@=@=OR@@J&..W%6O"GB"\UJ(R7<UB656-Q;Q(T<MF_P N(I%9B20-WS84
M'' QUM>'=<GU:2^BNHHXI(I%DA"9^:WD7=&QR>OW@?<&J;;?R_46R^9SMYX<
MUN;QLNH"('==P3)?*4Q!;HF)+?D[_F;G &TYR2"*YC5/#/\ 9OP\O9=0T46U
MZFL P!VC;]U)=JR[=C$#@X[$<]CS[-534-,T_5K;[-J5C;7L&X-Y5S"LBY'0
MX8$9J5I_7FF5OO\ UHU^IS7A.QU711-#_9'D6-[J,TJ0>=&OV"$H-HVJ2IRX
M/"GC=GUKL*155$5$4*JC  & !2TVR0KG_$/_ "'/"?\ V%9/_2*ZKH*Y_P 0
M_P#(<\)_]A63_P!(KJD,Z"BBB@ HHHH *Y_P)_R3SPU_V"K7_P!%+705S_@3
M_DGGAK_L%6O_ **6@#H**** .?\  G_)//#7_8*M?_12UT%<_P"!/^2>>&O^
MP5:_^BEKH*  YQQUKB-)\"Q/HNM6VL:9I<%[J;W(DN[(^9(T<K,V"[1H<KNQ
MCD?*/I7;T4#NT<E'H>NWTVE1ZNVG_9])D6>-[:1RUU*J%5+*5 B'.< OSW];
MGA6QUC2]-^RZC;V*LUU/,S6]T\F%D=I!C=&N3EL=N!GO@=#13NR;'*7-CXFB
M\67^I:?:Z2UO<6L-M&\][(KIL9V+E!$0?]8?EW#[O7GC%;X;2136(\Q;^%;<
M17"RWT]J!)YK2F4+%P^68G8V!P,&O1:*$[#>NYYO?^#/$=_IUS:L-+B\Z:\<
M%+F3=B5Q(F6\H'&1AE'!X)W8VU?U;P;JE[J%Q=6EY!;YN([N!=[?)*4$4V>.
M1L!QZECG%=S10G8'J[G%:IX7UB;Q)!J-D+ V]I*LL$3S-%N_</$0X6,Y.6!#
M$GCC ZG+/P_U"?3-$@OHK2X^RV'V"ZMTU.Y@C*A@=ZM&H+YP,HP Z<\9/I-%
M";0-Z6*5C+<7$$Z7-N(-DC1(5=FWH.C?,H(SZ<]."1S6'HFBZS86^FZ9<_8?
M[/TS AGCE=I9PJE5W(5 3KSAFSCM74T4@Z6..BT+6XM;N-8ALM(M;PVK1M]G
MN9 M[*<;6E'E_*%P<'YVYQGU33?"M]HNKZ5?6"JY^SF#4A=:I/*,':<Q*RD<
M,&/&P<].>.RHIK3^OZ[@]0HHHI <_P",O^0';?\ 85TW_P!+8:Z"N?\ &7_(
M#MO^PKIO_I;#704 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110!S]G_R4/6?^P58?^C;NN@KG[/_ )*'K/\ V"K#_P!&W==!
M0 4444 %<_X[_P"2>>)?^P5=?^BFKH*Y_P =_P#)//$O_8*NO_134 =!1110
M 4444 %4M7LYM1T>\LK>>."6XB:(2R1F0+N&"=H9<\'U%7:*35U9C3L[HPKG
MPZ=0\,VVE7UWFXM_*>.ZMX_+VR1D%'526Q@@<$G/-9U[X1U+4XKV:^UBVDU*
M>S>QAF2Q*PP1.1O(C\PDL<#DOC@<=0>NHJF[W%'W;6Z%+3K>]M;>**[N;>?9
M"B9B@:/+#.3R[<'C [8/)SQD3>&[TWM^+;5(XM-U&3S+JW>UWR$E0K;)-X"@
MA1U5N^".W2447UN)*RL<EJ/@ZXOKG4"FJ)':WUREQ+;M;%@P$0B9&(<;@0%8
M<<$<AAQ5!/ >K1Q)&NO66U/L(&=-;I;'*_\ +;^(]:[RBA-K8;UW,^*WN;W3
M+FUU3RSYQDC_ '2[,QG('&YL''?/O@=!0TO1-2M6@%]JT5U':1F.U$=IY17C
M:&D)=M[ <<!1R>/3?HI <E=>%-6O+BYO)-9LUOGM#9Q3)I[+B-BI8R 2Y=OE
MX(*A<GBK%AX1AT77X;_14TS3K,V_DW=K;6 0SG.0VY7 !';*G@GGD8Z6BG<
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M2Q2RSLJDA?E&W<K2-P(T!"\[:[.SN[>_LX;NUE$MO,@>-UZ,IZ&ETN'4QO\
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MBDLP*]78  9R>>@[U@S^#4CTC3KS2K&6+4[:Z@O'BO;MI9)-@*^4TA=^BLV
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M>A_^#&'_ .*H Z"BN?\ ^$[\'_\ 0UZ'_P"#&'_XJC_A._!__0UZ'_X,8?\
MXJ@#H*Y_Q#_R'/"?_85D_P#2*ZH_X3OP?_T->A_^#&'_ .*K+U#Q+H.L^)/"
MMOI>MZ;?3KJ<CM':W22L%^QW(R0I)QD@9]Q0!VE%%% !1110 5S_ ($_Y)YX
M:_[!5K_Z*6N@KG_ G_)//#7_ &"K7_T4M '04444 %%<GI7Q"TK5=+M[]=.\
M00).F]$?1;ESM/0[HT9"",$$,>"*N?\ "9:7_P ^NN?^"*]_^,T =!17/_\
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M>&O^P5:_^BEKH*Y_P)_R3SPU_P!@JU_]%+6IJVI0Z-HU]JEPLC065O)<2+&
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M';OQ71/X6T:;PNGA[R)?[($8C6%+J4$IV7>&W%?;.,<=*G>'GH5=*1Q/A[Q
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M@@A.R=V>7S':0NS<$EF))XP.O   X%9-OX+TR.73I9VNII=,!2Q874L?DQ]
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M"NF_^EL-=!7/^,O^0';?]A73?_2V&N@H **** "BBB@ HHHH **** "BBB@
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M/$O_ &"KK_T4U=!5>_L;?4].N;"\C\RUNHGAF3<1N1@0PR.1D$]* +%%<_\
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MJVOE26\4TD\<8$1G'[O< Y;K\IXR#UXYI)/;^OZU!OK_ %_6A?\ ^$[\'_\
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MPK=7$5O;^)=&FGE<)'''?Q,SL3@  -DDGC%;E<_XR_Y =M_V%=-_]+8:Z"@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "N?\0_\ASPG_V%9/\ TBNJZ"N?\0_\ASPG_P!A63_TBNJ
M.@K/U/7='T3RO[6U6QL/.SY?VNX2+?C&<;B,XR.GJ*T*Y^\_Y*'HW_8*O_\
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MAY#]"IX/YXJ0+?\ PG?@_P#Z&O0__!C#_P#%4?\ "=^#_P#H:]#_ /!C#_\
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M_P"P5:_^BEKH*X/P7XT\*VO@7P];W'B71H9XM,MDDCDOXE9&$2@@@MD$'C%
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M"O< R1E5R,K&<;7)  ^5<Y(=M4@.W,NDV&KV=H((X;VXA:. I;$ QIR4WA<
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M@_TO<<&<)P 1M.)/EZYYJI*U\GB6[NOL^L*L>J0&X-O!.J2Q&V\MB  !(HD
MY&=O7@<T+^OZ_KH5;?\ K^O^'.ZM-&TK3S$;+3+.V,081^3 J; Q!;&!QD@$
M^N*=<ZI:6=_9V4[NL]ZS+ !$Q5BJEB"P&U3@$\D9P<=*\E>ZU=+"<(/&"WEO
M9 1@PWK@SK.=N3@JYV$9ZJPZYQQJ.D]W-^^A\1OIMCK+N)#%=B<0O;%<H<>:
MP\UF'RYP#V&*:UU)N>G^:IG,.'W!0V=AVXSC[V,9XZ9S3Z\O\[6[;[3;7:>(
M)9&T^VWM$)\ ^<P;#HI <1LF[R_F.#@Y&1U/@^]N(M$L=/U0WIU#,R[KB"4;
M@DA R[Y_AVD98DCG)P30EH-Z'3US_B'_ )#GA/\ ["LG_I%=5T%<_P"(?^0Y
MX3_["LG_ *175(#H**** "BBB@ KG_ G_)//#7_8*M?_ $4M=!7/^!/^2>>&
MO^P5:_\ HI: .@HHHH Y_P "?\D\\-?]@JU_]%+705S_ ($_Y)YX:_[!5K_Z
M*6N@H **** "BBB@ HHHH **** "FM'&SH[(I=,[6(Y7/7'I3J* "BBB@ HH
MHH **** .?\ &7_(#MO^PKIO_I;#705S_C+_ ) =M_V%=-_]+8:Z"@ HHHH
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M:7_SZZY_X(KW_P",T?\ "9:7_P ^NN?^"*]_^,T '_"">#_^A4T/_P %T/\
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MT^*8PKI&K22_:+BV5$2'+R0\N!F0#[N6!/8'O@5:\2Z[)-\,[WQ#HE[+;/\
M8/MEM,L:$_=W %7##GH>/QJO_P *WL/M:W/]K:IYBW-S=+S#@/.NU_\ EGT
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M^;*A)S$_0'M0!N45S_\ PD.J?]"9KG_?ZR_^2*/^$AU3_H3-<_[_ %E_\D4
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MZ=:7J1MO1;F!9 K>HW X-)>:+I6H^5]NTRRNO*QY?GP*^S'(QD<5-M/Z\_\
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MV  ':N\KG_ G_)//#7_8*M?_ $4M !_PANE_\_6N?^#V]_\ CU'_  ANE_\
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MGAK_ +!5K_Z*6N@KG_ G_)//#7_8*M?_ $4M '04444 %%%% !1110 4444
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M;F&::='G>.031E=\9C(9-N01@$9P01R<YS5K2].@TC2K73K8N8+:,1H7.6(
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MQXJA-X4UQ=#@M)]!?4)(;&."U/GP@VLD<C%B,L -Z%<%?[N"%%>LT47_ $_
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M+[BW/^B[<9/9?;UKT&B@#GQXQTP  VVNGW.@WO/_ )!H_P"$RTO_ )]=<_\
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MM^[#%@N"2.I/YURNLZWJ]IXUCTVSU#3=,L%V2B.XF"-=(Y)E9%,3%V')&UU
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH *Y_P)_R3SPU_P!@JU_]%+705S_@3_DGGAK_ +!5K_Z*6@#H**** .+\
M-Z)XVTKPUINFSZQX?B>SMTMPJ:;-,-J#:IWF=,DJ 3\HY)K4^Q^,/^@[H?\
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M1UE%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MZ$5V%<_XR_Y =M_V%=-_]+8:Z"@ HHHH **** "BBB@ HHHH **** "BBB@
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MH_\ A._!_P#T->A_^#&'_P"*H=N@'045S_\ PG?@_P#Z&O0__!C#_P#%4?\
M"=^#_P#H:]#_ /!C#_\ %4AAXR_Y =M_V%=-_P#2V&N@KA_$GBSPWJ>GV=G8
M>(-*N[J35=.V0P7L<CMB\A)PH.3@ G\*[B@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MR,@X["M#1O$6F:3HUGIY37[@VT*Q>:^@WH+X&,_ZJIZ#>YUU%<__ ,)EI?\
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MD0*2,W .,CT% ':45S__  D.J?\ 0F:Y_P!_K+_Y(H_X2'5/^A,US_O]9?\
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M<5E:?XBM= AOH?[3TS4+:QLDCM=0218RISM2"8YV[\X((QQG*COU'VSQA_T
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
+"BBB@ HHHH __]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>33
<FILENAME>ex99-2_001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 ex99-2_001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" #' :X# 2(  A$! Q$!_\0
M'P   04! 0$! 0$           $" P0%!@<("0H+_\0 M1   @$# P($ P4%
M! 0   %] 0(#  01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$!
M 0$! 0        $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%! 0  0)W  $"
M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#W^BBB@ HH
MHH **** "BBB@ HHHH ***@NKN"R@,UQ*L<8ZEC2;25V!-44]U!:QEYYDC4=
MV.*XK5?'$DA:+3(]J]/.<<_@*Y2XN;B\D,ES,\K'^\:\^KCX1TAJ<L\3&.BU
M/0+WQMIEOE8 ]PP_NC _.L.Y\=W\F1;V\40]6Y-<M17GSQM:76QS2Q$WU-:;
MQ-K,[$F]9 >R# JB]_>R??NYFSZM5:EKFE4G+=F+G)[L<99&^](Q^IIRW$Z<
MI-(N/0U%4]G:O?7L-K&,M*X'X4E=NR$KMZ'H'@R*Z_LIKFZGDD\YLH'.< 5T
MM16T"6UM'!&,)&H45+7T]*')!1['L0CRQ2"BBBM"@HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH ***I:IJ46E6$EU*>%X5?[Q["E*2BKL3=E=D&M:
MW;:-:^9+\TC?ZN,=6/\ A7FFIZK=ZM<&6ZDR/X8P?E6FW][/J5X]U<-EV/ [
M*/055KY_$XJ55V6QYM:LYNRV$HHI:XSG$HH) ZFG(DDI CC=R>FU2:+ -HJ_
M%HNJ3G$=C,3[KBK \,:T?^7%_P Q6BI5'M%EJ$GT,BNO\"Z=YES-J#K\L8V1
M_7O6,WAC6@/^/%\_45Z-HFGC3-)@ML88+E_J>M=N#P\O:<TEL=%"D^>[6QH4
M445[AZ 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M:O:>,;Z"VU*XAA7;M1&P!Q7IW@76FUSPK:W$K9GC'E2GW%>0_$'_ )'C4/\
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M-3/E\PS8/[B;_OV?\*]S\!AE^'4(964A).&&#WK<L=6T34KZXLK.6VEGM_\
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M32O$=_9R+@K*67W4\@U>!>K1&.6B93M;F\MG9K.6>-R,,8<Y(]\5:_M77/\
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MO W9E/\ A7I7PQ\1)?:3_9,[_P"DVOW 3]Y/_K5T?B?PS:>)M--O/\DR<PS
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MP%9TFO:[J&J7.GZ+:VC&RVK<SSN0I<C.% K+\"::9-7OYKNY:Y.EN;.T#?\
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M<Y'O2]G&U[C]I)Z6.ATN:\?5]32XU"VGA1U\J&-<-"".C4__ (2;1?MWV/\
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FRK>Q6?P[I,DWG-8Q%\YZ<5I*BH@1%"J!@ #@444U",=D-)+8_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>34
<FILENAME>ex99-2_002.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 ex99-2_002.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" $X G # 2(  A$! Q$!_\0
M'P   04! 0$! 0$           $" P0%!@<("0H+_\0 M1   @$# P($ P4%
M! 0   %] 0(#  01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$!
M 0$! 0        $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%! 0  0)W  $"
M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#V=OO'ZTE*
MW4TE;G,%%%% !1110 4444 %%%% !1110 4455OKY+%(\H\LDK;(XTQEC^/0
M>]-)MV1,I**NRU162^O116\KRV\R312)')#P6!;H1C@@TRXUTP6MX9+22&Z@
M166*0@AMQPIR/>K5*;Z&3Q%)=?ZU_P F;-%9'V#5$B2:/5'EN>&:*10(F]0
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MSRR(\IB(D0*00,]C3Y/^16M_^OQ__0!6GOV<9ZZ777MU%IHT58-0N;:+RXG
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M%R#QD$ _J*H:.1_9VL<_\NP_]"JE9ZA=:>7-M+L\P -E0<X^M6QXCU4 @7(
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M_P"6*G_T*MC4[WR(_*C/[QAR?05[&%A#"47C,1\OZ[O_ ()QU7*M-4:?]?\
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M663TY2<N9Z^AVK&22M8\[_LN_P#^?.;_ +YH_LN__P"?.;_OFO1**G^QJ?\
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M]$HH_L:G_._P#Z[+L>=_V7?_ //G-_WS1_9=_P#\^<W_ 'S7HE%']C4_YW^
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M@XBAV@^['_ZQK2H[09A05ZD4>L4445YI[H4444 %%%% !1110 4444 %%%%
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MW]LZG_S_ -S_ -_6_P :/[9U/_G_ +G_ +^M_C5&BCDCV#VD^[^\O?VSJ?\
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M6=11RKL+GEW9H_V_J_\ T$[O_O\ -_C1_;^K_P#03N_^_P W^-9U*590"58
M]"1UHY5V#GEW9H?V_J__ $$[O_O\W^-']OZO_P!!.[_[_-_C6=11RKL'/+NS
M1_M_5_\ H)W?_?YO\:/[?U?_ *"=W_W^;_&LZBCE78.>7=FC_;^K_P#03N_^
M_P W^-']OZO_ -!.[_[_ #?XUG8.,XZ44<J[!SR[LT?[?U?_ *"=W_W^;_&C
M^W]7_P"@G=_]_F_QK.HHY5V#GEW9H_V_J_\ T$[O_O\ -_C1_;^K_P#03N_^
M_P W^-9U)D#N*.5=@YY=V:7]OZO_ -!.[_[_ #?XT?V_K!_YB=Y_W^;_ !K-
MW#U%:WAG:WB;3P<']Z.#]#2:25[#C*4FE<8=>U@'!U*\!';SF_QI/[?U?_H)
MW?\ W^;_ !JZ2GB,,&*IJZ9P>@N@.WL_\ZPF5D=D=2K*<$$8(-"2?0<G):IN
MQH?V_J__ $$[O_O\W^-']OZO_P!!.[_[_-_C6=13Y5V)YY=V:/\ ;^K_ /03
MN_\ O\W^-;/APZYKVI+ -3O5@7YI9!,WRK^?4USEG9S7]W':VZ%Y9&VJ*]=M
M8+#P7X;>29AB-=TKCK(_H/Y"L:LE%62U9U8:$JCO)^ZO,A\6^)(_#.CA8FW7
MDB[(%8Y(Q_$?I^IKQZ77]8GSYFIWC ]C,W^-&N:S<Z[JDM[<GECA4'1%[ 5G
M44Z:BM=QUZ[J2TV',[N<NQ8^I--J6VM9[R=8+:%YI6SA$&2<5?\ ^$:US_H$
MW?\ WZ-:-I&"C)[(RZ*T(="U:X#F'3KE]CE&VQD[6'4'WI+G1-4LX&GN=/N(
M8EZNZ$ 477<.65KV*%36EW<6-RMQ:S/#,O1T.#4-%,E.QO/XS\0.A5M0)!!!
M_=IWZ]JP>E%%))+8J4I2W85[/\-]--EX8%PXP]VYD_X".!_4_C7DVCZ9+J^K
M6]C%G=*X!/\ ='<_E7T);P1VMM%;Q+MCB0(H'8 8%<^(EIRG;@H7DY]B6BBB
MN(]0**** "BBB@ HHHH **** "BBB@ HHHH **** $) !). .I-<3XA\6LY>
MTTY\)T>8=3]/;WIOBOQ$97?3[-_W:\2N/XCZ#VKD*]##X?[4CQ\7C'?V=-^K
M)[:WEOKN.",CS)#@%CQ3[BQ\B,,MU;3$G&V%]Q_*I-&FCM]8MI97"1J^2QZ#
MBK]O<"*_M9IIM/5(Y,DVX (X/7':NJ4FGH<$(1<==[F)Y<FX+Y;[B,@;3FG&
M%PRJ%+,PSM4$D?45KVNI8LPTMR?M AG4,3\P)Q@9_.B.\22U\M+M8;EHD'FL
MQ'0G*Y_(_A1S/L"IQ[F6]I,EM%/M)23=C SC!P<^E1".0@$1N03@$*:WSJ:+
M+9*M[O022F8@;0V>Y'O4/]I[()4CN2H%D$0 ]'W=O?&>:2G+L-TX=S&$<A8J
M(W+#J IR* CE2P1BHY) .!72#4;9L^7-$)B8G>1Y&3=A #R.I!SQWJ*/5(A+
M9!9UCB\^9ID7(7:QXR/0^E'/+L'LH_S&'/;RVZQ-*A42IO3/<5<ET>>(.!-;
MR21KO:)),N!C)XIFHSBXM;#$V\I;B-ESDJPS4^HZH3=W/V98 KKL\U(QN(P
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M$4*JC  Z 4M>9.3D[L]VG35.*B@HHHJ30**** "BBB@ HHHH **** "BBB@
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MM1)['16]O%:P+#!&$C48"BI:**\<^D2MH@HHHH&%%%% !1110 4444 %%%%
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MHHKB/>"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MB+[-<JB3L,%&^Z_T_P *\YI02I!!((Y!%%2E&>^XL)C:F&>FJZH]+U'5M/\
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M C>"&7_61(_^\H-5I-(TZ48>Q@/_   5=HIIM;$2IPEND_D9W]@Z5_T#[?\
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MD>QD?\(UI7_/N?\ OMO\:/\ A&M*_P"?<_\ ?;?XUKT4?5J/\B^X.2/8R?\
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*BBB@ HHHH __V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>35
<FILENAME>ex99-2_003.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 ex99-2_003.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" *C!*8# 2(  A$! Q$!_\0
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MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#W^BLKQ/\
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MO^&7J>-F7QQ]/U"BBBO2/+"BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH *U_"O\ R-FD?]?D7_H0K(K7
M\*_\C9I'_7Y%_P"A"HG\+]"Z?QKU7YGT51117SA]2%%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !2C[P^M)2C[P^M $M%%%0,RO$_
M_(IZS_UXS_\ H!KYMKZ2\3_\BGK/_7C/_P"@&OFVO7R_X9>IXV9?''T_4***
M*](\L**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ K7\*_P#(V:1_U^1?^A"LBM?PK_R-FD?]?D7_ *$*
MB?POT+I_&O5?F?15%%%?.'U(4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %*/O#ZTE*/O#ZT 2T445 S*\3_\BGK/_7C/_P"@&OFV
MOI+Q/_R*>L_]>,__ * :^;:]?+_AEZGC9E\<?3]0HHHKTCRPHHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "M?PK_ ,C9I'_7Y%_Z$*R*U_"O_(V:1_U^1?\ H0J)_"_0NG\:]5^9]%44
M45\X?4A1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4H^\/K24H^\/K0!+1114#,KQ/_R*>L_]>,__ * :^;:^DO$__(IZS_UXS_\
MH!KYMKU\O^&7J>-F7QQ]/U"BBBO2/+"BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *U_"O\ R-FD?]?D
M7_H0K(K7\*_\C9I'_7Y%_P"A"HG\+]"Z?QKU7YGT51117SA]2%%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 54;5+-=173S-_I3=$"DXXS@G& <<X)JW69?Q2/K&DNL;
M,B22%V R%S&0,^G- $C:Q:"_>R N7F1UC<QVDK(K$ @%PNT<,#UXSS1#K-C<
M78MHI7,A9D5C"X1V7.X*Y&UB,'@$]#Z&L2\B9-7E>U@U*'4)+V%]T;S-;RQ_
MNU9F_P"68_=J00><KQSBBR28QZ1IIMKE9[.Y9YI&A8(%"R#<'(VMNR.A)^;G
MH: .JHHHH **** "BBB@ I1]X?6DI1]X?6@"6BBBH&97B?\ Y%/6?^O&?_T
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M\DG SRA% G4J6V2<=O+.:EHH B\]0@;9)@G&/+.:&G5<920Y&>$)J6B@",S
M2;-KY]=AQ^= G4L5V2<>J'%244 1"=2K'9)QZH://79NV28SC&PY_*I:* (C
M.H53LDY]$-*9E#A=DF3W"'%244 1B93)LVR9YYV''YTBSJP)V2<#/*$5+10!
M%YZ["VR3&<8V'/Y4&=0JMLDY[!#FI:* (FG52!LD.1GA":7SAYFS:^?78<?G
M4E% !1110 4444 %%%% !1110 4H^\/K24H^\/K0!+1114#,KQ/_ ,BGK/\
MUXS_ /H!KYMKZ2\3_P#(IZS_ ->,_P#Z :^;:]?+_AEZGC9E\<?3]0HHHKTC
MRPHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "M?PK_R-FD?]?D7_ *$*R*U_"O\ R-FD?]?D7_H0J)_"
M_0NG\:]5^9]%4445\X?4A1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4H^\/K24H^\/K0!+1114#,KQ/_ ,BGK/\ UXS_ /H!KYMK
MZ2\3_P#(IZS_ ->,_P#Z :^;:]?+_AEZGC9E\<?3]0HHHKTCRPHHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "M?PK_R-FD?]?D7_ *$*R*U_"O\ R-FD?]?D7_H0J)_"_0NG\:]5^9]%
M4445\X?4A1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 45E>(=5.CZ/)<1IYERY$5O'_?D;A1_7\*P[2"^
M\.ZWI8NM0N+N/45:*Y,KY59\;@5],_=QZ"M8TG*-[_\ !L8SJJ,N6WKY7V.Q
MHHHK(V"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ I1]X?6DI1]X?6@"6BBBH&97B
M?_D4]9_Z\9__ $ U\VU])>)_^13UG_KQG_\ 0#7S;7KY?\,O4\;,OCCZ?J%%
M%%>D>6%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 5K^%?\ D;-(_P"OR+_T(5D5K^%?^1LTC_K\B_\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M/K0!+1114#,KQ/\ \BGK/_7C/_Z :^;:^DO$_P#R*>L_]>,__H!KYMKU\O\
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M_K\B_P#0A43^%^A=/XUZK\SZ*HHHKYP^I"BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** //;IFFTS4-,0G?J&OO
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M7_#+U/&S+XX^GZA1117I'EA1110 4444 %%%% !1110 4444 %%%% !1110
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M "BBB@ HHHH **** "BBB@ HHHH **** "M?PK_R-FD?]?D7_H0K(K7\*_\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HJ*>X@M83-<31PQ+U
M>1@H'XFJ]IK.F:A(8[/4;2X<?PQ3*Q_(&G9VN+F2=KEVBBBD,YOQ;_I;Z3I
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M>4*='DZLY\/&=2NJEM$=31117D'M!1110 4444 %%%% !1110 4444 %%%%
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M];/NPG#2Z[+\3"IZ1M(>.GK6];:=;6_A"6^NH@US>SB*TSU1$Y=Q]3A?SK-
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MDXKF_"MY!']KLWDQ<3:E?R1I@\JDY#'/3C>OYU4>RA\7>*+U;M3+I>FK]G1
M2 \[#YSQW4<?E44X*5V]D74FXV45=L[&BN<\,W$]I<7>@7LK23V1#02OUE@/
MW3[D=#^%='2G'E=BJ<^>-PHHHJ"PHHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** $9@BEF("@9)/0"N7\-J=:U6\\2S F-R;:P
M!_AA4\M]6.:?XIN9;Z6W\-V3E;B^&;AU_P"6-N/O'ZG[H_&NAMK>*TMHK:!
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MZ^E:P@FG*6R,JDVFHQW?]7-G3O%.E:O=>187L$K=E)9&(]@RC/X5K R[CE$
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M@*!P!3Z**Q-PHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MN&'L.B_CS6AI?A?3=,F^TB-KF]/+7=RWF2$^N3T_"M.6,?B?W&?/*7PKYO\
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M&OI,@,"" 0>H-<[X9M+9+S6Y4MHD8:DZJP0 @!$&!Z#.>*]"&-LDI*[1YD\
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MLU%NOT)&2:M6/@_0;!O,CTZ*27.3+/\ O6)]<MFGRP6[OZ?\$.:H]E;U_P"
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MLQA:&49;^]MP<YZYK2>'A=M/3_@%2I1W3T.-JYJ6G3:7<B"=D9R@?*$D8/U
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MGP=T<8..,2$Y_P#':EHH BW3["?+CW9Z>8<8^NV@M/M7$<9;N#(<#_QVI:*
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MN9,%]V-H<[L;<\ 9J.U\/RP36BM=0M:VDS31*MOME+,&'S/N(/WCG"@GCWR
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M=+NK.[U+1TT^6-Q;6,B3+&1^Y!\L!&'\)R.AY^4UT]% !1110 4444 %%%%
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M(****HD**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"M?PK_R-FD?]?D7_ *$*R*U_"O\ R-FD?]?D7_H0J)_"_0NG\:]5^9]%4445
M\X?4A1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M4<[R1V\KPQ"654)2,MMWMC@9[9]:DHH YS^U_$__ $*L?_@S3_XFC^U_$_\
MT*L?_@S3_P")KHZ*TYU_*OQ_S,N27\S_  _R.<_M?Q/_ -"K'_X,T_\ B:/[
M7\3_ /0JQ_\ @S3_ .)KHZ*.=?RK\?\ ,.27\S_#_(YS^U_$_P#T*L?_ (,T
M_P#B:/[7\3_]"K'_ .#-/_B:Z.BCG7\J_'_,.27\S_#_ ".<_M?Q/_T*L?\
MX,T_^)JUIVH:Y<7BQWV@I9P$',PO5DP>WRA16S10YK^5?C_F-0:?Q/\ #_(J
M:HI?2+U5!+&!P .YVFL/P[-$/AU:R&1=B61W-G@8!SFNGK!D\&>'Y9WE;3ER
M[;F19'5"?= =OZ4XRC:TA3C+FYH]K'+6%A'?:5X)L[I"89?.+ITW+L9L'V.!
M5^^T_39M9N;*VT*;4S:11QM'),L<%J",@)GG)!R3S77R:?:RW%I.\(\RT+&
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ME*X[@_2DIB"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *U_"O\
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M+1]:DFU/Q-XFM+BWU2=(;&-+F,HXBB106P1_$P!^JFO4Z*8'S8G@O6+"*_\
M#-YIOC6[EEO&$26%VL6F3Q,00[N48*>YR#T&<'IZ&=!OK7XW>'ITLKN2PL]
M%LUVR,Z*X,@PTF -V"/3KTYKU"BE8#Q.;PWK%UI7Q6@73+L/>W0EM T++]H"
MLS?N\CYNG;.<^]-U.'^U_"'A:2^\$^* VFQ+:F]L<PZA9RQHGS1PD?.C%1AB
M>,,< XS[=118#@_A?+XEETW4?[<74A8+<;=,.K(%O#",Y\T#J>G)Y//;%=Y1
M13 **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M1110 4444 %%%% !1110 4H^\/K24H^\/K0!+1114#,KQ/\ \BGK/_7C/_Z
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MW*O-HZ1Z<+F.VDG6[W2*[VPG!$>P @9VGY@>^#TH [NBN-E\::A9^'TU.^T
MQ&Y, LHXKAIQ+YN2 VR,NK*!\P5''(VEN<96L^/M8D\.ZB=-T:6TU"UTR>\G
M>Y+1FW"EE1XTDB!D!*LWS*G Y&3B@#T>BF0L6AC9CDE03^5/H **** "N?\
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MA8,C2YNI6EC!R<,[\'&P@#&I)I?B>PL[@V\6JW=U?6T\;$:B"MO+YA\M_GD
M4;" /+';G'6NBU'Q;;:??S62V%]=W$(9Y$MU0[8U5&9_F89 \Q!@?,2> :AE
M\<Z;%I U(V]V82\B!=J Y12Q))8 # ZD@#J<#)I <L=&\9W.OW.\ZG%I\TX$
MI^W;,I]JB.499S@>2)1\B0G! PS8(Z/PD;N?4M3W7TESI^GN;&U<SM()3N+N
MS,2=S*&2+)R<QOSR:DTGQ@-;U>P@M+%_L=U9S7!G$\$H1DD5-NZ.1E/4YVEO
MO+T(8"MK?B+6=)U.:.-M-N8R#MM8XI#);*1B.663=C#/@;=@."<%MC&@#/O-
M/U?4KUY'\-W%NEA<B6RA1K812QK.DC\B0DR2;-PRJJ#P3GYC'_8>LM<ZI)_8
MTH76@BJ/.A_T K,[%I/FY)#A_P!WN^8'V-7)_$GB*&XU*P5M+>ZTJ*2XGF-O
M(J7"!(W5%7S"8R=Y!8E\;0=IS@6]!\47NJ>(Y;246WV-_/\ )VQ,I7RW"KB0
ML4F)!)8(/W9&UN: -O3+6<7E_?7B;9YIBD0)!V0)P@!'8G<_KE\'H,:=%%,
MHHHH **** ,#Q-I5[JMSH7V*XGM?LVH--+<P>7OB3[/.F0)%93EG5?NG[V>,
M9'%ZEH7C*"*.*Q&H2W<<DTLEY'<1HEU*6!60HDT(7*A5VLLB@@@J?OOWVM7U
MW;M96EAY"W=[,8DEN$+I& C.6*@J6X7 &1USGBLH^)+[2[PV&J1QWM]@"*+3
M8MIG);Y<>9)A#MR2K$C"YW<A: .<U>TU70;"#4;Z[U,6DAD&I@ZHR];B/R@C
M-(%ARA;Y@4&.&()%4]'M_%FH2:9J-M<:D^FM.[0MYPF9(_M4A_>$W,:R Q[
M&VR_+RO8GJF^(VD1W=C;36]W!)=S&$"8Q(5?SFAQM+[G^=3G8&V@@MC-6CXI
M>Z\+6.N6=E+!'>75G'$MX%R\4\T2;P$<X^60D9.<CD>J S)?"][>_#73]&OT
MN;J^F>P?45N+HRL2LT+3_,S$8 5SA3CC@<\THM"\3R75AJ=Q$ZZCM@@N9$G4
M$1QW-L6&0W*ND=Q)CGB0J>3BNDUOQEIN@:S9Z9>)+YMT4"N&C51O?8,!G#.<
M]0@8J,$@ C.-8_$S3SX4M=8ODYD\J%WCDBCB:Y9"[QJTD@"[0"27('0 L>*
M,V[\/>+8='M?L=QJ+SRP1'4(WOWE=W5CD1YGCV'D$[)$!"G)/0[CZ1K5[X/T
MBSFGNX[^&ZA>68B,31(LF<_,\JDA<<EG)ZG))IVM^,7B\'V>OZ)'%<I<2I\D
MGS93G>HVM@M\I ()&?45'-XSDCUZYA"QG3(_)$,J1EWF+;]Y!W@!>  ><%6X
M.1@ BU?0]:2^66&74-1A6WBCN)(YX[>YN%$KL45D,84C<O(VY4$9R:HPZ7XL
M$MN634Q/YD9M9FU &*U@$S%H[A/,_?2>5A=VV3)Q\P(W5HW'Q+TJS@1[RRO+
M2258Y(8KF6WB,L<@8JX9I0@'R-PS!N.E3Z]XJDCT;0=0T::/R=5N%59FL9;L
MB,P22@B*)@Y.4 X/ ))Z4 1^$-+U*SU:\N;ZTU"$/9V\+/>WJW!EF5I#(R$.
MQ5#N4@';WPJ]^QKC[3Q;>071L[R!]0N72$V\=G9FUDE9Q,YS'/)\@5(OXF'.
M>Y J5O'^EI#+=-:WRV$ Q<7AC7RX9-F_RV&[?NP1T4KD@9I@=717/6'B"[O?
M[8,NG36+642ND-R%WY*EOF*.RD<#H?8\],[PWXLO]8UFWL[B&V6.2WGE)C5@
M<HMH1U)X_P!(?\E]\@'94444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4H^\/K24H^\/K0!+1114
M#,KQ/_R*>L_]>,__ * :^;:^DO$__(IZS_UXS_\ H!KYMKU\O^&7J>-F7QQ]
M/U"BBBO2/+"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH *U_"O\ R-FD?]?D7_H0K(K7\*_\C9I'_7Y%
M_P"A"HG\+]"Z?QKU7YGT51117SA]2%%%% !1110 5SFO6'AM]7LY]7U)[*_G
M3[-;!=6EM&E&X':JI(NXY8= 3ROM71UQ?Q 4RZ;-:VUAJ$E_/"/(:VL_.CN2
MI)6WE< F-"Q!))3CHW!% '4SVMH+"[CN6;[-*K&<RS,0%*X;DGY1CTP!UK&T
MS0?#%F;9[9UN1=VQBM?M5_)=!X" 66(2.PV%=N=O! &>,5?U9GN_#>JQ1Q2-
M/]FEBV"-AN?8>%R/F'/!'6O--0TGQ'I=IHUGI-C>^7%ITTT$L"?-;.T2B2+G
M[K9R4SCEMH^[2 [Z+P/H$-HUNEK<8+QN)3>SF93&"$VRE]ZA0S  ,  S>IR^
M7P5X?F%HK6!"6L20HB3R*KQHVY5D 8"50V3A]W)/J<\@_P#PD-K%=7VAKK<U
MH;A[2S@OFF+A985'FE9?WFU)U!R_(4N1\N*](M+<6EE!;"6640QK'YDKEW;
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ML-XLHA:WB*XW,TX7S >-V<@Y 7<  >MPZ;9VUT+B"!8Y! MNNSA5C4DJH7H
M,GH/Y52U3POHVM-<G4;%;C[5#%!,&=@'2-RZ# /9F8^^<'(XK@[(>*S=Z?\
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M17!C20!SEHW%TS(""?E2.+@C@%0!O^#K+6[/4=3_ +1COA:N087OIR[L=S=
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M=2\^XBM\([S;@S%2NR10=[$&9/F&516!Z)1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %*/O#ZTE*/O#
MZT 2T445 S*\3_\ (IZS_P!>,_\ Z :^;:^DO$__ "*>L_\ 7C/_ .@&OFVO
M7R_X9>IXV9?''T_4****](\L**** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ K7\*_\C9I'_7Y%_Z$*R*U
M_"O_ "-FD?\ 7Y%_Z$*B?POT+I_&O5?F?15%%%?.'U(4444 %%%% !65K_B&
MQ\.6,=U?&0B29(8XXEW.[,0.!D<#.2>P!K5KDO&7@^X\2)YUIJMQ:W*QI$D?
M[LQ;?-5V/S1LP)VCH1G:N>,T =;6)8^*])OH[Z0S_98K.Y-L\ET5C5SG:&4D
M\JS @'O@U=N1J7]EW:6HMQ>A&6U>60[6;;\K/A>.>H ->>:YX)U72(=*.E7<
MVKQ++96TUO>H@PD5PC1M^ZB!*KF7<6R0&)SP<@'=3^*="ALH[L:OI\D<R,]O
MMNXAY^W@A"6"GGCK@'J126?B.VOM.OKRWMKJ06<K1-%&@=Y&"JV$"D@YW 9S
MC\.:Y:+P-JC75_>SO8)->V6HQF*-V9(9;AHRH4E02H$9W-@$ECQS6OHFAZSH
M'A[5(;5K"749IFEMO-=_)!,:*-Y"YQE2<#J.XSP ./C:!2]NVC:J-36X%O\
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M HWD$ACN"KP.W2^&])U&RU+6-0U*"P@DU"2)Q%9RM(%V1A.69%R3C/0>G;)
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M:C=>6\3H;I49MZLK$!<+E6Y4@=B ?7F@"W1110 4444 %%%% !1110 4444
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MM?27B?\ Y%/6?^O&?_T U\VUZ^7_  R]3QLR^./I^H4445Z1Y84444 %%%%
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M Z+^.37;>+=/N-4\*ZC96G^OEBP@_O8(./QQC\:Y;2]:U*6T@TSPAHL?V&V
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
5BB@ HHHH **** "BBB@ HHHH __9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>36
<FILENAME>ex99-2_004.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 ex99-2_004.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" &1 GD# 2(  A$! Q$!_\0
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MR-:DC-S;WS1".+[D8V@[5.,D#/4UUM,$[A1112&%%%% !1110 4444 %%%%
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MOHIW%8Q/#^B3:/<ZO++,D@OKUKE H(V@@#!]^*VZ**0PHHHH **** "BBB@
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M/X50-SSUJP?#5BT(B+S[1&T?WAT+;CV]:E.@632F1_,;,CR%2W!++M(Z=,4
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M>4UQ:RA&>%"JL&17& 2?[V.O:M6JFGZ=;Z9;F&W\PAFW,\CEV8].6/)X 'T
MJW38AAD .-K?]\T>8/[K_P#?-/HI ,\P?W7_ .^:/,']U_\ OFGT4 ,\P?W7
M_P"^:/,']U_^^:?10 SS!_=?_OFCS!_=?_OFGT4 ,\P?W7_[YH\P?W7_ .^:
M?10 SS!_=?\ [YH\P?W7_P"^:?10 SS!_=?_ +YH\P?W7_[YI]% #/,']U_^
M^:/,']U_^^:?10 SS!_=?_OFCS!_=?\ [YI]% #/,']U_P#OFCS!_=?_ +YI
M]% #/,']U_\ OFCS!_=?_OFGT4 ,\P?W7_[YH\P?W7_[YI]% #/,']U_^^:/
M,']U_P#OFGT4 ,\P?W7_ .^:/,']U_\ OFGT4 ,\P?W7_P"^:/,']U_^^:?1
M0 SS!_=?_OFCS!_=?_OFGT4 ,\P?W7_[YH\P?W7_ .^:?10 SS!_=?\ [YH\
MP?W7_P"^:?10 SS!_=?_ +YH\P?W7_[YI]% #/,']U_^^:/,']U_^^:?10 S
MS!_=?_OFCS!_=?\ [YI]% #/,']U_P#OFCS!_=?_ +YI]% #/,']U_\ OFCS
M!_=?_OFGT4 ,\P?W7_[YH\P?W7_[YI]% #/,']U_^^:/,']U_P#OFGT4 ,\P
M?W7_ .^:ANKM;:TFG96Q'&SG(]!FK-8OBN5H_#UQ&A_>3E84]RQ _P :BI+E
M@Y%PCS22#PNAM_#MF'5B\BF5CMZECG/ZUK^8/[K_ /?-)!$L%O'"@PJ*%'T
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MZ??MI$G!]-K#/Z9K*M_#;[:_<:4OC2[Z?>;E%-C<2Q)(O1E##\:=6QD%%%%
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MS]PWVCQI9KM;%K:/+TZ%CMK=\S_8?\JQIZRD_/\ )&L](Q7E^8^BF>9_L/\
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M!%<>1(?]B3C^>*Z"JIW3<7T''J@HHHK4H**** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH *3(SC/-+7#ZG%;76LWW]G6\T%_'#,#(L,BO<N4Q
MC>1C:.W/7IC% TCN 01D'-%<_P"%(ECM[PV\+0V+S@VT9C,>!L4-\I (^8-^
MIKH*;$%%,(?/##'THQ)_?'_?-(!]%,Q)_?'_ 'S1B3^^/^^: 'T4S$G]\?\
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MI97S0K;R;OOE5PW'48/K6W%J=E-J$EC'<QM=1KN>('D"@"A_;5__ -"_??\
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M%)*RL!D:%:W4*WES=Q&"2ZF$@@+AO+ 15QD<<[<_C6O113$E8****!A1110
M5A:PE[<W\-JNEO-I[;6FECDC!8ALA2&(.T8SQG/3Z[M% '$)X=U3R)8V@53;
M+MBPXQ<XG\WCGCCCG')/:B70-5D,D@MR&OUD21?-7-KND#9)SSQ_=SS7;T4
M]1 , "EHHH **** "BBB@!DV1!)MB\T[3B/(&[CISQS7)_8=3N1_:,ND2)?1
MW$4K0M+%B1%# (A#8&-Q.6QDDUU]% '*VWAVX@70,HC2V@D6>7(RH9&  ]1E
MNU3^&]+O;*=I+N$0B*UBM%4.&$FPL=XQT!W< \]:Z.BG<'J%%%%( HHHH **
M** ,?7C?-%'#9Z?)<K*&2:2-XU=$/4#>1U_I6-'HU_:WC>5IVZWBD>ZC7S4
M?,000\GMZ].*[&BE8#CFT_5)0NH'2Y/MID?SHGEC!?='L!4AB %Z<\XS73Z;
M:M8Z7:6COYC00I&7_O$ #/Z5:HIBL%%%% PHHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** *]PS"10&(&,\5%N?_GHWYU)<?ZU
M?]VL?4-:CT^Y\AK*]F.T-NAAW+SVSZU482D[1(G.,%>3LC4W/_ST;\Z-S_\
M/1OSK!_X2F'_ *!FJ?\ @.:FUG66T[PY)JD4.7VILCF^7!8@#=Z8SS53ISAK
M)$TZU.H[0=_Z]#8W/_ST;\Z-S_\ /1OSKBK77-7AU*[L)9H)KR?4EM8G8-Y,
M(\D.<+G/KQGJ>M12^,]3:UD>"WLP]O:3SS;]Q5FBDV$+@C@\X)Z>]9]+FIW6
MY_\ GHWYT;G_ .>C?G7#R^,=2AF-DUM UT\\21R10R2*%>+S.4!W$CIP13YO
M&&I02:9)<6$=I:3HAN)9D=E1V?;M)7[F>H+ @YQQ3MK8#M=S_P#/1OSHW/\
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MG_YZ-^=&Y_\ GHWYUP3^-=5M]+COI;>Q<7-I/-"D8;*-&V,-SR"/3&#6A?\
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M .>C?G24=J +D9)B0GJ0*=3(?]2G^Z*?0 4444 %%%% !1110 4444 %%%%
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M1_M#[##]L#;Q-CG=C&?3..,U'!X?T>V>5X=-MT:5&20A<[E8Y9<'L3VK2HH
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M]0: %HHSSCO10 4444 %%%% !129'J*"R@@%@">@)ZT +102 ,DX%-5U?[K
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MNS-% (Q*Q*= N1MZ=3P:MZW:1WEE&WV=9G$D>"8]Q"[AG\,5/<ZG:VT[PW+
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M.GUK/U&6]EOY)[:WGCDMX64D(3GYU^[Q@Y /2M6+5;:XU,6D0WN$8F3!P,$
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** ./^('_'IIO_ %]#_P!!-2>!/^//4/\ KZ/\A117I_\ ,'_7<\5?\C'Y
M?^VG64445YA[04444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
9%% !1110 4444 %%%% !1110 4444 ?_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>37
<FILENAME>ex99-2_005.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 ex99-2_005.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" #@ H,# 2(  A$! Q$!_\0
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M'T[_ )\H/^^!5?\ MP?\^%U_WU'_ /%T?VX/^?"Z_P"^H_\ XN@"Q_8^G?\
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M$XNW2RVM'&D,$85@NWY2'RJD=5]J -O2]*L)+%6>SA8[Y!DKG^,U<_L?3O\
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M#_GPNO\ OJ/_ .+H L?V/IW_ #Y0?]\"JU]9Z=96WFC2OM#%@JQP1!F))Q]
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MMY4UV(HIFN&MS;P&)I6(.X+O&W&.!S@DGK0!G>)\VOB*ZAMV:*)=FU$8@#Y
M>E%5_$]UY_B*ZD\F1-VSY6*Y'R+Z$BB@#J-+_P"018_]>\?_ *"*MT_2=,F;
M1K ADYMX^_\ LCVJY_94W]Y/S/\ A0!0HJ__ &5-_>3\S_A1_94W]Y/S/^%
M%"BK_P#94W]Y/S/^%']E3?WD_,_X4 4**O\ ]E3?WD_,_P"%']E3?WD_,_X4
M 4**O_V5-_>3\S_A1_94W]Y/S/\ A0!0KGK_ ,5Q67B5-$6S>68K&Q;SD0D.
M2,HK$%\8^;'2NP_LJ;^\GYG_  K UCP NMWJSW5]-Y(:-S;@J5W(<@J2NY,G
MKM(S0!77Q7H3RS1+J46Z)MK?*P!.[9\IQAOF(&1G!JCJOCO1]+EEAS+<2Q0S
M2LL2\#RR RY/&<G]*N/\+K*2-HVNKKRU4K;+YPQ:@R"0^7\O]X#KGCBFO\++
M62%D>_NV:03K*YD&9!,P9\_+ZJ",8H MV>LV^J:?+=:4#>M&QC,0/EMO&/E.
MX#!Y'6LC3?'.FWEO;RWR'3#=,5MTGD#F0!MA)VY"C=QDXSFNJTWPO_9<]Y+#
M)N:[G^T2;VSAMJKQQTPHK#'PMT\&Q/FRYM 5&7!\Q3)YF&RO]X]L'% #CXJT
M39<.+]6^SD"8)&[-&2Q7! &0<@\=:=9^*-%OKZWM+6_2:>=%EC5%8Y4@D$G&
M!G!X-1M\,(&-VW]I7JO>3+<7!$P_>2J20Q!7'0[<8Q@"EL?AA96%[IEU%<W!
M;3U"Q*9!SC.-Q"Y(^8\9P>* +NE_\@Z/_?D_]#:KE5;)?(M1$W++)(#CI_K&
MJQY@]ZODEV)YX]QU%-\P>]'F#WH]G+L+GCW'44WS![T>8/>CV<NP<\>XZBF^
M8/>CS![T>SEV#GCW'44WS![T>8/>CV<NP<\>XZBI+:%KIRJ8! SS5O\ LJ;^
M\GYG_"I::T92:>Q0HJ__ &5-_>3\S_A1_94W]Y/S/^%(90HJ_P#V5-_>3\S_
M (4?V5-_>3\S_A0!0HJ__94W]Y/S/^%']E3?WD_,_P"% %"BK_\ 94W]Y/S/
M^%']E3?WD_,_X4 4**O_ -E3?WD_,_X4?V5-_>3\S_A0!0HJ_P#V5-_>3\S_
M (4?V5-_>3\S_A0!0HJ__94W]Y/S/^%']E3?WD_,_P"% %"BK_\ 94W]Y/S/
M^%']E3?WD_,_X4 4**O_ -E3?WD_,_X4?V5-_>3\S_A0!0HJ_P#V5-_>3\S_
M (4?V5-_>3\S_A0!0HJ__94W]Y/S/^%']E3?WD_,_P"% %"BK_\ 94W]Y/S/
M^%']E3?WD_,_X4 4**O_ -E3?WD_,_X4?V5-_>3\S_A0!0HJ_P#V5-_>3\S_
M (4?V5-_>3\S_A0!0HJ__94W]Y/S/^%']E3?WD_,_P"% %"BK_\ 94W]Y/S/
M^%']E3?WD_,_X4 4**O_ -E3?WD_,_X4?V5-_>3\S_A0!0HJ_P#V5-_>3\S_
M (4?V5-_>3\S_A0!0HJ__94W]Y/S/^%']E3?WD_,_P"% %"BK_\ 94W]Y/S/
M^%']E3?WD_,_X4 4**O_ -E3?WD_,_X4?V5-_>3\S_A0!0HJ_P#V5-_>3\S_
M (4?V5-_>3\S_A0!0HJ__94W]Y/S/^%']E3?WD_,_P"% %"BK_\ 94W]Y/S/
M^%']E3?WD_,_X4 4**O_ -E3?WD_,_X4?V5-_>3\S_A0!YOXC_Y#MS]$_P#0
M!14WB>W:+Q#=(2,C9T_W%HH ]+T;_D!:?_U[1_\ H(J]5'1O^0%I_P#U[1_^
M@BKU !1110 4444 %%%% !63K>NQ:*;1&B,LUU(4C3S%C'"EB2S$ #C]16M6
M9J.@V.K7L4]_$EQ'%#)$(9%#)\^,GGOA<4 5K#Q;I-\MLK7 @N)R0L,AY!#%
M>HR.2IP<\]JCN?&>B0:>;Y;L36ZD@M&#GID8!Y.<C&/6H(_!D,9C4ZE>&)5C
MW(-HW/&NU'SC/ P<=,@&F0>!K:%%'V^X9E?>/E4*"71CA0,#/EC./4F@#<M-
M9T^^NY;2WN5>XB7<\>""!G&>>O/'%9=CXNMKZ25Q ([*-G#7+SQX 5MI)4'<
M!D=Q2Z-X2M]&U*ZODNYYIIXS'F3&5!8MUQDG)ZGT%5K3P4EMIDNG/?E[>6+R
M9"EM''(R$_,"X&?F&03[T 7F\7:(EY+;&\4F.,.SJI*G+%0!C[Q)4\#/2IQX
MDT8S11#48"\J"1,-P5(+ YZ#(4GGT-9%QX$M+BVCA>\F/E"(1$HIV>6K(.,8
M/#'\>:M1^#K&" 0P330HLGF)LV@J1%Y2CIT )/U)H L#Q7HS0I<)>QM P8[^
M1TV] >3G<N,#G(J5?$NC/);1KJ$1>YQY2C.6R2H^G((YQR,5D0^!;>!(VCU"
MX6>)M\+A5VQ-NW':F, 'TZ5;M/"-G:,&%Q.Y\^.=V<@EV3<>>.[,6/N: **=
M'_Z[2_\ HQJ=5FUT^:X@,J;=K2RD9/\ TT:IO[(N?]C_ +ZKLC.-EJ<CA*^Q
M0HJ__9%S_L?]]4?V1<_['_?5/GCW)Y)=BA12*P8$CLS+^()!_44M62%%%% !
M1110!IZ-_P ?#_[I_F*VJY_3KF.VE9I,X*XXK2_M:V_V_P JYJD6Y:(Z:<DH
MZLO451_M:V_V_P J/[6MO]O\JSY)=B^>/<O451_M:V_V_P J/[6MO]O\J.27
M8.>/<O451_M:V_V_RH_M:V_V_P J.278.>/<O451_M:V_P!O\J/[6MO]O\J.
M278.>/<O451_M:V_V_RH_M:V_P!O\J.278.>/<O451_M:V_V_P J/[6MO]O\
MJ.278.>/<O451_M:V_V_RH_M:V_V_P J.278.>/<O451_M:V_P!O\J/[6MO]
MO\J.278.>/<O451_M:V_V_RH_M:V_P!O\J.278.>/<O451_M:V_V_P J/[6M
MO]O\J.278.>/<O451_M:V_V_RH_M:V_V_P J.278.>/<O451_M:V_P!O\J/[
M6MO]O\J.278.>/<O451_M:V_V_RH_M:V_P!O\J.278.>/<O451_M:V_V_P J
M/[6MO]O\J.278.>/<O451_M:V_V_RH_M:V_V_P J.278.>/<O451_M:V_P!O
M\J/[6MO]O\J.278.>/<O451_M:V_V_RH_M:V_P!O\J.278.>/<O451_M:V_V
M_P J/[6MO]O\J.278.>/<O451_M:V_V_RH_M:V_V_P J.278.>/<O451_M:V
M_P!O\J/[6MO]O\J.278.>/<O451_M:V_V_RH_M:V_P!O\J.278.>/<O451_M
M:V_V_P J/[6MO]O\J.278.>/<O451_M:V_V_RH_M:V_V_P J.278.>/<O451
M_M:V_P!O\J/[6MO]O\J.278.>/<O451_M:V_V_RH_M:V_P!O\J.278.>/<\\
M\7?\C1>?\ _] 6BHO%5PDOB2[=<X.SK_ +BT5-F5='I&C?\ ("T__KVC_P#0
M15ZJ.C?\@+3_ /KVC_\ 015ZD,**** "BBB@ HHHH **** "BBB@!'=8T9W8
M*JC))/ %<';>/9;Q=0E@$#)YD!LT((8QL[!BV>^U"P^HKN9X(KJWD@GC62*1
M2KHPR&!Z@U!/I=A<R))/:0R/&NQ"R [5Z8'YF@#FM*\;275[IEA=Z>8[F\ #
MF)]RQ.4,@4\8^Z!GG/S#BH-4\:W6GZAKL*PQ2+:Q*MBO(,DP&7!/H,@_0&NF
M@T'2;:[CNX=/@2XC4*D@3E0%V\?AQ]*?)HVF3,S26,#LV_<2@).\@M^9 S]*
M .8L_'AECEC.F74\T,+'?&A432H0K*N1CEB0.3G!J>+QY;R76FP"T+&\=(V,
M<FX1,Q(4'C_9)P<'VK=?0-)D-R7TZW8W7,Q*#Y^<_P ^?KS2)X>T>.Y@N$TV
MV6:  1.(QE<9QCWY//O0 _1O^0:O_723_P!#:K]4-&_Y!B?]=)/_ $-JOT %
M%%% '&P?<?\ Z[2_^AM4M:.GZ7'-:>89&!:60]!_?:K7]C1?\]'_ "%=2JQ2
M.5TY7,2BMO\ L:+_ )Z/^0H_L:+_ )Z/^0I^UB+V4C$HK;_L:+_GH_Y"C^QH
MO^>C_D*/:Q#V4C$HJSJ5NME<6T:$L)0Y)/;&/\:K5I&2DKHAQ:=F%%%%,044
M44 %%%% !1110 4444 %%%% !1110 4444 %%%&* "LC7[F2WAM/](>VM9+@
M)=7$?!C3![_P@G SVK7Q10P1R3>(9+,+%:7!O( "T<ETIWW7SA?+B(P&(_O$
M'/ZT1^(M7;8\D%IY3*CX5'W;6E,>,YQG^+/X8[UUW-)4V?<JZ.$MO%&HKI]L
M28;N1(M[21[@-WER'RY/5LJ#VZ]*LWWBO5+%S ]K:M(K',N&6-OD5@@R<[CN
M(ZGIT-=ES2\T6?<+KL<QIFM7>H>)8H)7BBC$<^^T4'S(RK*%+D\<C)&,<'O5
M:#6/)5[J[U*Z_M)&F,VGJNY$5=V 4 R%P%.[OGWKKZ.:+!<X>/QI>NI!^P(R
MM)AW5L2[41@J@,>26(ZGIT[5*_C*[%_- EM#M"M]]6!@*LH)?GD#<2>!TXSU
MKL&@C:XCN&C!EC4JC]P#U_E3\T6?<+KL<<VN:I-J426EQ:2!I5CW!'\J<F.4
MJ%R?ERRCGGGN>^_HFIOK%@;[RO+A=R(000Q X).?]K</PK1=1)&T;C*L"",X
MXID$$5M!'!"@CBC4*B+T %-)B;1)1113$%%%% !1110 4444 %%%% !1110
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M .@:_P#W^2J=% %S^W9_^@:__?Y*/[=G_P"@:_\ W^2J=% %S^W9_P#H&O\
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MC^W9_P#H&O\ ]_DJG10!<_MV?_H&O_W^2C^W9_\ H&O_ -_DJG10!<_MV?\
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MPW-W;W$"R)DR!-T8DV;_ "P>I;'MC/&<U.OB^ ZQ::=)974$]Q&S""9,2Y#
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MSU3_ +Z% %/1O^08G_723_T-JOUFZ/-$--4&1/\ 62?Q#^^U7_.B_P">J?\
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M"1Y!';B1R"["$9;!R,GZ@42>&X)H&@E6!XF;>R-%D%LYSCUSS6UYT7_/5/\
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M^A2]C#L'MY]S$A\,6UL08([>(CH4A"^W:G1:<9;F>$2*#$5!..N1FMGSHO\
MGJG_ 'T*HVLT7]IZ@?-3K'_$/[M'L8=@]O/N1?V,W_/9?^^?_KT?V,W_ #V7
M_OG_ .O6GYT7_/5/^^A1YT7_ #U3_OH4>PAV'[>IW,S^QF_Y[+_WS_\ 7H_L
M9O\ GLO_ 'S_ /7K3\Z+_GJG_?0H\Z+_ )ZI_P!]"CV$.P>WJ=S,_L9O^>R_
M]\__ %ZANM/-K!YID4C>BXQ_>8+_ %K9\Z+_ )ZI_P!]"J.KS1&PXE3_ %T7
M\0_YZ+1["'8/;U.Y%_8S?\]E_P"^?_KT?V,W_/9?^^?_ *]:?G1?\]4_[Z%'
MG1?\]4_[Z%'L(=@]O4[F9_8S?\]E_P"^?_KT?V,W_/9?^^?_ *]:?G1?\]4_
M[Z%'G1?\]4_[Z%'L(=@]O4[F9_8S?\]E_P"^?_KT?V,W_/9?^^?_ *]:?G1?
M\]4_[Z%'G1?\]4_[Z%'L(=@]O4[GE/B>V,/B*ZC+@XV<X_V%HJ?Q:RMXGO"&
M!'R<@_["T5HHI*QDY-N[-W2[:W_LBQS;0'_1X^L2_P!T>U6OLUM_SZV__?I?
M\*CTM&_L>QX_Y=X^_P#LBK?EMZ?K5$D'V:V_Y];?_OTO^%'V:V_Y];?_ +]+
M_A4_EMZ?K1Y;>GZT 0?9K;_GUM_^_2_X4?9K;_GUM_\ OTO^%3^6WI^M'EMZ
M?K0!!]FMO^?6W_[]+_A1]FMO^?6W_P"_2_X5/Y;>GZT>6WI^M $'V:V_Y];?
M_OTO^%'V:V_Y];?_ +]+_A4_EMZ?K1Y;>GZT 0?9K;_GUM_^_2_X4?9K;_GU
MM_\ OTO^%3^6WI^M'EMZ?K0!5>.QC8*\5HK$%@&1 2!U/T%)&MA,0(DLY"R[
MQL5#E?[W';WK \<>'M1UFUL&TP*+F*9HI&+ ?N)5*2?H<_A7*R:!KOA2WN+F
MS<FYBNDL=*A5BPFM3NPK8Z8,F[G^Y0!Z=]EM_P#GU@_[]+_A2&VME4LUM;@
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M7_"C[-;?\^MO_P!^E_PJ6B@"+[-;?\^MO_WZ7_"C[+;9_P"/6W_[]+_A4M%
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MWR8.U8PNWJ3@X)_&FT@L:#W-O& 7GA0'&"T@&<]/S[4-=6ZNZ-<0JT8RZF0
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MR_\ \70!T%%<_P#VEJG_ #TLO^_+_P#Q=']I:I_STLO^_+__ != '045S_\
M:6J?\]++_OR__P 71_:6J?\ /2R_[\O_ /%T =!17/\ ]I:I_P ]++_OR_\
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MKG_[2U3_ )Z67_?E_P#XNC^TM4_YZ67_ 'Y?_P"+H Z"BN?_ +2U3_GI9?\
M?E__ (NC^TM4_P">EE_WY?\ ^+H Z"J.K_\ (/\ ^VT7_HQ:S?[2U3_GI9?]
M^7_^+J&YNM2NH?*:6S W*W$+_P +!O[_ +4 =-17/_VEJG_/2R_[\O\ _%T?
MVEJG_/2R_P"_+_\ Q= '045S_P#:6J?\]++_ +\O_P#%T?VEJG_/2R_[\O\
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MF9%A4 N#D,1CJ#T-2CPSI@LVLQ;1"U=BS0B-=A).XDC&.3S]: /);7XF7?\
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M1O\ D!:?_P!>T?\ Z"*O5F6^G7MK;16\>I?NXD"+F!2< 8%2?9-0_P"@F/\
MP'7_ !K01?HJA]DU#_H)C_P'7_&C[)J'_03'_@.O^- %^BJ'V34/^@F/_ =?
M\:/LFH?]!,?^ Z_XT <RGB&Z6R.N3ZK"D7F3[=+V+ETCW#:#][S/E!SG'.,4
MZ;QK=VCRBXTZW!B=XGC2ZS('6,R$XQ]P#@MZ^U;"^'PMQ+<*]J)Y?]9)]B3<
M_P!3WJ0Z-(T\D[7%N9I%V/(;--S+Z$]Q[4 8T/CK[;*T5EIS2N9TA3?*%!#X
M*-TXRNY\>BU77X@G9'*]C'Y2+&9]D^7R^X_(N,L %W$G'!]JZ)=(F1MR7,"G
M(.1:(.0-H/X+Q].*KVWAH6ES-<Q3PB:5MQ<VJ$K\H7:#V7"CCZT 8S^.I41A
M)9IYJ8DVV\XD5E*;@I;'#9**<?W@:OZ9XAU+4?$*6#6EM#'")_M167<<J55=
MO XR6!]U-7X]",**D4MJB*20JV2  D@G]0/R%2KI=PDOFI=Q++@C>+5 <$Y/
M/N>: .4G\::E;VJ7+V;_ &66^F\N<%,-;Q[B0!G.2$ZGUS5J?QS<6W[J2RM#
M.EP(YBEUNC52JG.<9/+!3@8!Z\5T']DS[$3[5#M0$*OV1,*#P0/3-1#0 J1(
MKV@2%MT2BR3$9]5]#0!ST?CRZCEMTGM;>4W%WL18922L3RF.+MC<<$]>QIWB
MKQ)J5CK%Q#83-'!:6\3R$+$1YCN0 ^X[L;1T7GFM_P#L >9')OM-\1S&WV),
MH<YR#VYY^M$N@^==B[EDM9+D8Q,UDA<8Z<]>* ,:]\:RR10P:7%;O=S2[!YD
MORHOG"-6(_V@'(^E5]+\>7ES>V5G/IRN]PZEGA<E524DQ[>,'" %LD5T2Z#L
M9F62U5G8.Q%DF2P.03[YYI4T-HI8Y8YK9)(EVQNMF@*#T!["@"SH_P#R#5_Z
MZ2?^AM5^LNWTV]MH1%'J7R@D\P+W))_G4OV34/\ H)C_ ,!U_P : +]%4/LF
MH?\ 03'_ (#K_C1]EU#_ *"8_P# =?\ &@!=)_Y!Z_\ 723_ -#:KU9D&G7M
MO$(X]2^7)/,"]R2?YU)]DU#_ *"8_P# =?\ &@"_15#[)J'_ $$Q_P" Z_XT
M?9-0_P"@F/\ P'7_ !H OT50^R:A_P!!,?\ @.O^-'V34/\ H)C_ ,!U_P :
M %G_ .0S9?\ 7*7_ -DJ]68VG7KW$<YU+YXU95_<+C!QG^0J3[)J'_03'_@.
MO^- %^BJ'V34/^@F/_ =?\:/LFH?]!,?^ Z_XT 7Z*H?9-0_Z"8_\!U_QH^R
M:A_T$Q_X#K_C0!?JCHW_ "!;+_K@G\J3[)J'_03'_@.O^-1V^G7MM;QP1ZE\
MD:A5S N<"@#3HJA]DU#_ *"8_P# =?\ &C[)J'_03'_@.O\ C0!?HJA]DU#_
M *"8_P# =?\ &C[)J'_03'_@.O\ C0!?K'U+_D+VW_7O)_Z$E6?LFH?]!,?^
M Z_XU#)I5U-<)-)J)+HA08A4<$@G^0K&O!U*;BMV7!\LKLBHJ;^RKC_H(-_W
MY3_"C^RKC_H(-_WY3_"O(^H5?(Z?;Q(:*F_LJX_Z"#?]^4_PH_LJX_Z"#?\
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*Y1@DSF<DW<__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>38
<FILENAME>ex99-2_006.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 ex99-2_006.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" -3 I(# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M/^@_9_\ ?1_PKI\#THP/2@#F/^%B^$/^@_9_]]'_  H_X6+X0_Z#]G_WT?\
M"NGP/2C ]* .8_X6+X0_Z#]G_P!]'_"C_A8OA#_H/V?_ 'T?\*Z? ]*,#TH
MYC_A8OA#_H/V?_?1_P */^%B^$/^@_9_]]'_  KI\#THP/2@#F/^%B^$/^@_
M9_\ ?1_PH_X6+X0_Z#]G_P!]'_"NGP/2C ]* .8_X6+X0_Z#]G_WT?\ "C_A
M8OA#_H/V?_?1_P *Z? ]*,#TH YC_A8OA#_H/V?_ 'T?\*/^%B^$/^@_9_\
M?1_PKI\#THP/2@#F/^%B^$/^@_9_]]'_  H_X6+X0_Z#]G_WT?\ "NGP/2C
M]* .8_X6+X0_Z#]G_P!]'_"C_A8OA#_H/V?_ 'T?\*Z? ]*,#TH YC_A8OA#
M_H/V?_?1_P */^%B^$/^@_9_]]'_  KI\#THP/2@#F/^%B^$/^@_9_\ ?1_P
MH_X6+X0_Z#]G_P!]'_"NGP/2C ]* .8_X6+X0_Z#]G_WT?\ "C_A8OA#_H/V
M?_?1_P *Z? ]*,#TH YC_A8OA#_H/V?_ 'T?\*/^%B^$/^@_9_\ ?1_PKI\#
MTHP/2@#F/^%B^$/^@_9_]]'_  H_X6+X0_Z#]G_WT?\ "NGP/2C ]* .8_X6
M+X0_Z#]G_P!]'_"C_A8OA#_H/V?_ 'T?\*Z? ]*,#TH YC_A8OA#_H/V?_?1
M_P */^%B^$/^@_9_]]'_  KI\#THP/2@#.TC7M*UZ"2;2K^"[CC;8YB;.TXS
M@CM6C7)^'?\ D>_&7_7:T_\ 2=:ZR@ HHHH **** "BBB@ KE_B+_P B'J?_
M &R_]&I745R_Q%_Y$/4_^V7_ *-2@#3\1ZE<:5HSW-HL37!EBA3S02H+R*F2
M!R<;LU6\GQ;_ ,_VB_\ @'+_ /'*;XS_ .1?7_K]M/\ THCKH* ,'R?%O_/]
MHO\ X!R__'*0Q>+1S]NT7'_7G+_\<K?HH P!%XL(R+[1<?\ 7G+_ /'*7R?%
MO_/]HO\ X!R__'*W(SE>?4C]:=0!@^3XM_Y_M%_\ Y?_ (Y3)5\5Q1/(^H:&
MJHI8LUK*  /4^9Q70UQ>LB7Q?XDF\-*X31[%8Y=29<[IV;E8,]A@ M[$"@ \
M.ZMXJ\0Z'::FEQHL(N QV?9I6QAB.#Y@R..#6MY/BW_G^T7_ , Y?_CE;$<*
MVZHD$2+$BA$1/E"@=@*?N8<E./8\T["N8GD^+?\ G^T7_P  Y?\ XY1Y/BW_
M )_M%_\  .7_ ..5M^8.-OS$]A2A^=K#![>AHL%SGYSXHMH))YM2T..*-2SN
MUI* H'))_>5B>%_$GB3Q4-0FLKK1?LEK<^1%.+:8B<;0=P^<8'.._2IOBO>0
M6_@>6UF,:F^GCMD>5RJ1DMG>Y /RC;D^U='/JFG:)HOVR]N[6&WBA$CR*0JL
M,=5'?..,4AE7R?%O_/\ :+_X!R__ !RCR?%O_/\ :+_X!R__ !RJ_A+QE;^*
MA=Q&SGT^]M6'F6ER0) C %'QZ$'\*Z1BP'RC)]Z ,/R?%O\ S_:+_P" <O\
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MUGQ9XF\.6NK"31[4S%PT#6TK%"KE2,^8,]/2NWKD/AQ+(WAZ]MI8RDEIJEY
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MR1(\[(W<MC:,]AS@56M/A9K/]I&[U'7K:\?[-=6OF30/(767HS*[%>#_  J
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M_7[:?^E$==!7/^,_^1?7_K]M/_2B.M]F"#)H 6BD7)4;A@TM !1@9SCFBB@
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MXX^"%MV+:?XFU^S#)C'VSSE&/:0-0-#\:VD4/V/Q?;787[POM.7YQ_O(P.:
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M)P,9HT#4XQ;WXCOA#H_A^,C@N;R0@^X 7/X>XIL^M>,=!,5YJ^DV=_I[?\?
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M KE_B+_R(>I_]LO_ $:E=17+_$7_ )$/4_\ ME_Z-2@"QXS_ .1?7_K]M/\
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M12&E8=7)>.U$B^'83_'KEJ?R)/\ 2NMKC?',H&K^#X<?-)K2$?18W)JAG9$
MC!&:9L*_</'H:?11<+%"YMMQ+J-K=QV/TJET.#UK<(R.:A>W1LX53[$5$J:>
MQ#B9T$#3N  =O<^E:RJ$4*HP!TIJ%5 4+M]L4^G&/*-*Q%<6T-U'Y<\:R)D-
MAO4=*AETNQF:9I+6-C-CS"1]['3-4M<UUM*DM+2ULVO=1O2XM[82",$*N69F
M/W5'&3@\D<<U#;>)5AT^6?7[4Z-+%*(F6:0,CL1D>6X^^,>V>#QQ5%%[^P],
M$'DBRB\O=OVXXSC&:E33+*)8ECM8E$+;XPJXVMZ_6J-SXM\/6<$,UQK5C'%-
M'YL;&889,XW?3/?H*9_PENC)<ZC#/>Q0_8'C25I' !+J"N/7.<?6@#0BTJPA
MD$D=I$K#.#CIGK3&T7371$:SBVH25&.F3D_A[56G\5^'[:U@N9M8LTAG#-$Q
ME'SA3AB/H>OIWI\WB71(+F&VEU6T6:8J(U\T?-NP5_/(QZYXH MG3K-O-S;1
MGS4$;\?>4=!35TJP6.1!:Q[9%"L",Y & *SCXLTJUM_,U*_LK4M++&H%R'!"
M.5))'3'?^Z>#5VPU5-0O]1M43 LY$3S V1)NC5P1_P!]4 7HXUBC6-%VHH"J
M!V IU%(S!1R: %HIF7/W5 ]VI5+9^8#ZBG85QU1JQ0!6!],]C4E(RAE(-"!G
M$?$.3R;WPG-(R);IK,?FR..%^5L?-V!/%=M'(DL:O&P9&&0P.0:HZII5CKNE
M7&FZK;QW%M*"KHX_(CT/O7,_#:[*Z'>Z.SW#RZ3?368\X$E8PW[L;NX";>:0
MSMJ0D#J131$@ R 3ZFG;%_NC\J #<O\ >'YTGF)ZY^G-+M7T'Y4M $32/G"Q
M$^Y-,2-TR7 89Z#M4LI*QL1U I].XK$8=,@8VD= 1BI*" 1@C-1X9.5Y']T_
MTH DHI%8.,@YI:0PJGJ-W'96%W>2NJQ6L32L6Z# )R?:KE07=I#>VTMO/&LD
M4J%'1AD,I&"#[$4T)G$:/X>U+Q3H-EJ6N>)=4(O($G%M9L+5(]PW8RHW$<XY
M-7/"6F6>C>*?$>GV$"PVT*6@1!_N,22>Y)Y)-1^%4N] \5WOA,W$UQI<-C%=
M6+3G+1*69#&&[J,#&>16AHO_ "/?BG_=L_\ T6U(9#X=_P"1[\9?]=K3_P!)
MUKK*Y/P[_P CWXR_Z[6G_I.M=90 4444 %%%% !1110 5R_Q%_Y$/4_^V7_H
MU*ZBN7^(O_(AZG_VR_\ 1J4 6/&?_(OK_P!?MI_Z41UT%<_XS_Y%]?\ K]M/
M_2B.N@H **** "BBB@ HHHH **** .2^)4I'@FZM4)#WTL-FN.O[R15/Z$UU
M<:+%&L:#"J H'H!7)>,C]IUWPEIN?];J?VA@.ZPQLW\]M=?0 4444 %9&NZX
MNB/IV^(/'=77D.Q;'EKY;N6Z<_<Z>]:]<M>>%;W4=7#WNKM-I:7#W,5N8L2(
M[1F/;OS]P;F(&,Y/6@"Y=^)](MX(;R:[VP?91>[O+8YB;"AL 9ZL..M)#XLT
MRZD58I2C),T4\4\3QR1D1&3[I&1\HSSP1TK(M? ][Y"17VLI,(;..R@\NUV8
MC217#-\QRQV 'H*GN_")?4]4UB.Z9Y;I_.6W"#J+5H N[/?.<_A0(NP>-] N
M+:6X%W(D20K.#+ Z&2-CA60$9<$D#C/) [T__A,=($*/ON?,:X^R_9_LLGG"
M7:7VF/;N'RC.2,8KFE^'UWK>@VT6NZBIGBL(;>W1+?:(2K(YWC=\YW(H.,#
M]ZUO#W@E-$ECN/-MDE%T;AX[6 I&?W1C"C+%N,YR2?PH&6/$OB671-3TNQB^
MP1F]69C-?7!AC3RPO&<').[]*J:5XYAN8U:_-I;*);E#*DCO'*D*AC)&VT97
M!YSCH<9K9U+0(-3UO3=0N"CI91S)Y#Q!ED\P+SSTQM].]<_+\.HI8H[3^TI%
ML+<726L B&8(YD V!L\A""5XZ8':@:\RW#X\TR:^OH9(YXK>VCMR#)!(LLCS
M,P5!&5W$G:,8ZY]JLQ^,="EMEFA>YD9II(!#':2&;?'C>-@7<-N1DX[UC:KX
M>UR*)]6FOGO]31[;RQ9VB*(A&SY;8S_/D2-E=P]L5FVW@*_UNP2^U1XEOQ>W
M4ZQWEOE6CEV#YD1QM8>6" &..AS0KB=B_P"%M8LI/$GB?4;J_LTMKJY@%J99
M54O&L*X8 ]CN/Y'TK9U34/"0B:YN+C27FZ*P"22,?0 98GV%9G@O3-.O=&9K
MG2[.<6T\EE$[6Z$E8F*;CD<9(8X' R!74V^G:78R&6TT^TMY<8W1P*A_,"FU
M<G3J<(]H-1E(TWPM!;)(3F[U%3#GW$2_.?QVUB7?PUOC=1^1?P21O_K9'4H5
M/?"C.1Z#/UKUXJCY>1-_^T1TI#90,,@$?0UIAZ]?"3YZ+LVK'/6P\*\>6:NC
MD8?#AMK2.WM]8U*,1J%4^:#C'L14ATS55BVQZ]*6'1I+=&_/I73_ &&$G =L
M_6G+80]RQ_&N-PDW=FJB<REAXEDB98-1L'E"\-+;,!GWP:2W/Q MUV2P>&YF
M[,DDT8P/;!KL%544*H  ["EK6,>4M*QQ\6K^.XI'6Y\*Z=,@/RM;:GC/X,@H
M_P"$K\1PSA+KP+J 3O);W<,H_+(KL**HHXT^.GMI0ESX4\2P@]Q9B11^*L:<
M_P 0=,3#RV6N1+T^;2Y>#[X6NLEFC@C>25PB1J79CT '4URNG_$;P[>WIMA<
MR09W$2W"A(SC_:)X_'%:PHU)Q<HQ;2W\C.52$6E)V;V(8_B=X7W;'NK^-B?^
M6NGSC;_XY6)K_C+PWJ'B'PW.-51[>RNY)IG:-E\O]TRJ>G/)Q77'QEI4QQIJ
M7>J/D#%C;M(O_??"#\6I#=>)[\ 6^DV.GH?X[Z;S6_[XCX_\>K(T*]O\0?!M
MP2L?B:Q;V:<+_A5L^+O"R0M*?$6FJBCEC>+Q^9JF?!C7N?[6U66X4]8K6".V
M3] 7_P#'JM6?@3PI8JRP>'M.R_WF>W5V;ZLV2?SH S_^%DZ#/,8-*G.JR\@&
MV*A,^F]RJ_D34AUG7[T?NFT73$)(+2W'VJ11CKM7:N<_[1JU)X,\*.Y \.::
M[=\6R<?I41^'WA67[_AW3%'H(!G\Z8AJ:%#>@MJGB>]OUSEHX[A;>+[N,8BP
M<=3RQJRGA+PTD:K%HMNP50 ?*SQ]3UK!\4_#[PI;>%-5N(=%MHYH;662-TRI
M5@IP>#VKK?#N?^$8TG<23]CAR3W^04 8M]X9,-[IM_H%M:6EW8/)MCEC(CDC
MD $BDK]T_*I!P?N],&JFH^&-?U>:VO[R\MFNK:[,T5M'-)%#'&8RFT2)A]W)
M;=T[8Q7;T4AG"6'@VXMIYG=K6/S=)FL62-9&4222M(6W/DE?FYR<D]J??>#]
M2N7#1SVK+%<6]S$#-+&69(?*92R<KQDA@2<]17<4TH,Y4[3[4 <=8>#;FW(D
M=K2-VM+R)UC:1QOG=6#;G)8\+R>,GM5>Q\!W-KH5U8O<6K2SV^GPAPAQFV5
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M4G^E8P::.B+=B6HI')/EI]X]3_=%!68\;E ]0.:>B+&,#\3ZU>P]P1%10JC
M%.HHI#.=\?2+%\/_ ! [' %A-_Z":U-%!70M.!&"+:,8_P" BL3XDG_BW.NC
M^]:E?S(']:Z.TC$5E!&O1(U4?@* )J**"0!DG% !13?,0_Q#\Z3S%/0Y^@IV
M8KH?3#&#T++]#1O;_GFWZ4JN"<<@^AHL%P"D# =OJ>:/+!ZDGZFG44AB  #
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M $HCKH*Y_P 9_P#(OK_U^VG_ *41UT% !1110 4444 %%%% !115#7+W^SM
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M5R_Q%_Y$/4_^V7_HU* +'C/_ )%]?^OVT_\ 2B.N@KG_ !G_ ,B^O_7[:?\
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M+J6TCWK);LHW$D##8S@C\:S_ .QM1EMM/C\C;M:9@LH#B-3]U6H [,NJ@%F
M!Z$FFK(@PK.H8] 3S7&2:;J-QI5A8+8W&R)'>0/(%Q)DA<'T'7'I3KJTN[N5
M)[O2IYG-AY6 !\LV3SU_'\: .S>1$(#NJ[C@9.,T..C#J/Y5QEU93QN5U"T>
M^<V:1Q,F#Y<@'.>>.>]=-H[.-,MX9G+3QQJLA)SSBE=;"N7@P(R"*7(]::44
MG)4$^XH\M/[B_E3&.R/6C--\M/[B_E0(T'10/H* ..^*8+^ KJ-069[BV4 #
M)_UR5V(=  -Z_G7)_$91_P (LBJ,,^H6@'U\]*ZW ]!0 %@!DGBD$BL< \TN
M .PH9=RX_(T +1358GJ"#WHWJ6*YY% #J*** "BBB@!#G'!P:9ND7JH8?[/6
MI**=Q6&@I(.F<=B*1HE*\  XX(XI'^217[=":DHVV#?<8C[A@\,.H-!YE ;I
MCY:'7HX^\OZTF])5."3CN.QI^8O(DHIJMN'1A]1BC<><J0!^M24.JGJNEV>M
M:9/IVH0K-:SKM=#_ #!['WJT'!.,'WXI!*K'"Y)^AH XSPS>W^DZ_=^%M7O'
MN7B'G:5/.OSW%OCY@S=&92<>N,&NS8[BJCOR?I69K/A_3/$$,2:O9Q3K"V^,
MY(9#_LL"",]#CK6)\.1)%H-Y:;Y62TU*YMT\^0NZHK\#)[ =/:@#L:*:2V>%
M&/K2L6'0 _C0 M  '2HV>4'"Q!AZ[L4T&XSRL>/K3L*Y-13 9".0JGZYI0&[
MMG\*0QU%-*L3GS&'L *,/S\P]N* '5S.B_\ (]^*?]VS_P#1;5TAW\;2OOFN
M:T7_ )'OQ3_NV?\ Z+:@"+P[_P CWXR_Z[6G_I.M=97)^'?^1[\9?]=K3_TG
M6NLH **** "BBB@ HHHH *Y?XB_\B'J?_;+_ -&I745R_P 1?^1#U/\ [9?^
MC4H L>,_^1?7_K]M/_2B.N@KG_&?_(OK_P!?MI_Z41UT% !1110 4444 %%%
M% !7(7CB]^+&F6_F-C3]+FN2@'&Z1U0$GZ*U=?7(: WVWXB>*KOS%9;9+:R0
M*.A"%VR?JXH Z^BBB@ IHYD)'0#%)EG'R\#^]3@ HP* !EW8]CFEHHH ****
M "FHQ.01@CK3JC(Q,I'<$&FA,DK*U-BUPL8_NY)STYK5K(NO^/ISG)Z9K.;L
MB9[$( 48 P*Q_P#6>++@_P#/"R0#ZEB?Z5LUD6 +>)-8<G[HA0#_ ("3_6N>
MY!K@Y&10!N(![F@  8%20+NG0#UI]0-5XP8]H I5<-G@@CJ#3J:R!CGD'U!K
MK-1U%,\L?WF_.G  # Z4ABT444 %-=UC0LQP!3JH:@3E%_AZ_C4R=E<3=D-6
M_DW LJE>X%6XIED1MAR1S632J[1RJR'!Z?6LHS:W(4A"2223DGK5FQS]IXZ8
M.:)K202DHA*GD5:M;8P@LV-Y].U$8OF!)W+-%%%;F@4444 <G\0QGP]:#UU.
MS_\ 1RUUE<A\1&(T;3%!X;5[,$>H\P'^E=?0 4444 %! (P1D444 ,\I!T!!
M]C2[6!X;CT(S3J* &Y<=5!^AHW-_</YBG44 -#'^X?S%!9NR?F:=10 PE\'Y
M%Z>M1B.4-\C*JXZ8S^53'H:2,DQJ3U(%-,30SR-QS(Q?V[5( %& ,"EHHN%@
MIK$\ =3^E*2 "3T%1HZ'+EER>.O2D,D "C Z4$@#)/%)Y@_A^;Z4!26#-U'0
M>E "#+G)&%'0>M<GX%)2?Q1;$Y,6MS'\&5&'\ZZ^N/\ !H">(O&46>1J@?'I
MNA2@#L***;O ;:>#[]Z '44F1G&1FC(]10 M%&<5'(^1M0Y8^G:FE<3=AV[Y
M]OMFFDDSJH/ &2* HAB.#T'6EB V \Y/4GK3T$/KF=%_Y'OQ3_NV?_HMJZ5F
MVCU/8>M<SH@(\=>*,G)VV>?^_;5)1%X=_P"1[\9?]=K3_P!)UKK*Y/P[_P C
MWXR_Z[6G_I.M=90 4444 %%%% !1110 5R_Q%_Y$/4_^V7_HU*ZBN7^(O_(A
MZG_VR_\ 1J4 6/&?_(OK_P!?MI_Z41UT%<O\0K07_@ZXLS*\0N)[>+S(SADW
M3(,CW%.\)ZW<W+76AZP5&MZ:0LQ' N(S]R91Z,.OH<B@#IJ*** "BBB@ HHH
MH *Y#X?AI[+6M1=$4WNKW,B[><JK>6N?P2NGO[@6FG7-R>D,32'G'0$UR/PV
MU+28O VDVD>HV1N%BW31+<*S)(Q+,",]<M0!VU,8;FV]L9-&_<<)S[]A3E7:
M/4GJ: %Z4444 %%%% !1110 4F 6![BEHH 9+(L49=N@K'9BS%CU)S5B\E+S
M%/X5XQ[U6KGG*[,Y.X5D:-\^H:S-U#700'_=4"M<=:R/#F6L+B8G)FNYG_\
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MK.M]?T:[ -OJUC-D9'EW"-_(U?21)%W(ZL/4'-4E;8L=1113 **** "BBB@
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MZ3K765R?AW_D>_&7_7:T_P#2=:ZR@ HHHH **** "BBB@ KE_B+_ ,B'J?\
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M;)_JV^AKF?\ A -%_P">VJ_^#.?_ .+JC)\*O"3R-/+:7<KYW$R7\YR??YZ
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M4AFB$X@,J><5+B/<-Q4<9QZ<BM"Q]%!( R>!3)9HH(FEFD2.-1EG=@ ![DT
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M\1:>!_M2X_G71-!"_P!Z)#]5%1/I]E(<O9V['_:B4_TH Q1\0/![=/$VE?\
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M%QH;;EN(;-;R1F $8C9F7KGKE3FITU72WL6NTO[-K.,[6F693&IXX+9P.HH
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ME_UVM/\ TG6NLI#"BBB@ HHHH **** "N7^(O_(AZG_VR_\ 1J5U%<O\1?\
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MBAE7]V7(4*[JWS$J!SC'K4W@/P-KNB^,5UK4X;.!#826TJ6[( TAD5MR*B*
MA )^8ELDUZD %& *6@#R+Q;\-]5UGQ-XAOH]'TJ^CU)(EMKBXOI(9+8K$%R
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MJRWEX7@DCF>UCV1M$'"_N^0P(D;(/KVXPT>!)(DL?(UQH6M9GN-BV,0B,K8
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M1EB3^0]!70U#%$T$*0Q[0D:A5!))P.!3]SC[RY]UH ?12!U/0\^E+0 4444
M(QVJ3Z#-(@P@%$APA-.H **** "BBB@ HHHH :R*W)'-13E;:WDFW;%C0LWI
M@#-3UC^++Q-/\'ZS=R9V164S''7[AIW%8R_ADD2?#K1FACV)+$TV,8)+NS$G
MZYS765C^$H%MO!VB0J@0)8PC:!C'R"MBD,*Y_1O^1K\2?]=+?_T4*Z"N?T;_
M )&OQ)_UTM__ $4* "$&T\>W28?R[^P24$XV[XF*M^.UT_*N@KG?$86UUGP]
MJ9"_N[PVK,0<A9E*CG_?"5T5 &?=7UI;75M8SW,<<UVY6"-SAI2!N8+ZX'-:
M%><>(]*U[7];U'4=.C@C_LH1QV/VB-][2H1*[1]L,<1YYR :K-9ZCKE[<ZH9
MM>M0^JVJ01++)$$MY(XO-&SIU+ GL1U%#8)'I#7UJE_'8-,@NI(VE2+/S,BD
M GZ L/SJQ7D=YIJVNK6<>ICQ"UA:I?P0S6K3/*!YL1B4NOS$8!VY.#CG-6S9
M^)WTS4;^>75#J<-M91B.-V&U2J&X,:CY3)@-R,D$<4 >HU!'=V\MW/:QRJT\
M 4RH.JAL[<_7!KR;4(KI[.2/3+K7H]!2Y4PB[2Y(E;RV+*77]^J;MA!Y&[(Q
MBK-S>:ZVCSF[M=659TL(W4RR@Q@I)YA=HUWD<+NV@-DC..: /4;J>"UM)KFY
M=8X(4,DCMT50,DGZ"EMIH;FUBGMW5X94#QNO1E(R"/PKA]*CU";X7:W:SQW;
MSB*\B@CF60R%-K>6!ORY&",9R:K3Z[O^'EG965OJ9NH;>VBN%6&> QC"JQ+!
M-VT<@[/F],=: /0)+NWBNH;6255GG#&)">7"XW8^F14U>-6UMXKFLX4T\70>
MVN;U8))EE#_9C'"0L;298,WS!6?.#]*MWSZO/XB26RGU2!,6W]E*T%PW[HJF
M\, P3.0X?S>0.G:F(]:KE_$?_(W>$O\ KZG_ /1#5U%<9XDN)#\2/!EFB@H?
MMD[G'(VQ #\/F-(9V=%%% #9,;"3T'-.HZTV/[N/3B@!U%%% !1110!Q]ES\
M7=5]M(M__1DE=A7 7FK6_A_XJW-UJ,<\-E>:?;VZ7?E$PK)YCX#/T7.0/QKO
MP01D'(- #6D5/O9_*G4V3&PYS@^G6B/=L&_[U/H+J.I H!R !2T4AC'3=@@X
M8=#2"0XP4;<.N!4E%.XK%>'E=J28*G!4CI4FV0<A\GTQQ39,+/&V.#P?Z5-3
M;$D1[)",,XQWP*<$53D#%.HI7'8****0PH(!ZCI110!P^LDK\8_"_HVG7J_7
ME#7<5RFNQ _$'PE-W47B=/6,'^E=70 4444 %(2%&2<"EI@^<[B.!T_QH "&
M?C[J_J:> !T%%% !7,Z+_P CWXI_W;/_ -%M735S.B_\CWXI_P!VS_\ 1;4
M0^'?^1[\9?\ 7:T_])UKK*Y/P[_R/?C+_KM:?^DZUUE !1110 4444 %%%%
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MB<?TKKA*IX)VGT-%@N/HHI"V.!R?2D,:_P Q"=NI^E/I%7;GN3U- ;+,OI0
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MRIBT&Z-@PSL;C(I#$\._\CWXR_Z[6G_I.M=97)^'?^1[\9?]=K3_ -)UKK*
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M3<8ESZC&:B$\:W1MVF7S2N]4)&['0G'I5%CU_P!<Y^E25"942X56D0&3A06
M)(]/6G^:IX&2?3%-B0UG"SKD\D8 KDOB#'&]MH<OE(UU%J]N8%? +$MR >HX
MYX]*Z\J C%QGN<"O%-%UVVU3XBSZ[J=P+:TL9Y7?[7*$2!=GEPJJL<EC\S'
MX)QU%-"/:V#[2=W.#P*2.)%&X9);J<]:Y)_B?X7(7[)<W-\6.%%I9RR9_$+C
M]:2+XD:-%Q?VNJ:=%_#-=V3*C#UR,X_'%*SL/J=>VQ#D*-S>@Y-*BX0!N3WJ
MCI^K:=K"B:POK>YC'(,,BM^>#Q6A0 5S.B_\CWXI_P!VS_\ 1;5G^//%6O\
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M?'Y5IP1F*WVR ASSN X]JKVD)DF!(^5>34NJZUIFAV;7>IWL-K"IQND;&3V
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M110 4444 %<O\1?^1#U/_ME_Z-2NHKE_B+_R(>I_]LO_ $:E #_'G_(J2?\
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MUX4^V:]2    & . !117J4Z:@K(Y92<F%%%%:$A1110 4444 %%%% !1110
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ME;<FHIJ.''':G5R--.S-D[A1112 **** "BBB@ HHHH **** "BBB@ HHHH
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MLPHHHK<S"BBB@"W'_JU^E.JJDFPU.),G.,+ZFN&I3:9T1DFA]%%%8EA1110
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MH_X0>T_Z"^N_^#*3_&CF"Q-14/\ P@]I_P!!?7?_  92?XT?\(/:?]!?7?\
MP92?XT<P6)J*A_X0>T_Z"^N_^#*3_&C_ (0>T_Z"^N_^#*3_ !HY@L345#_P
M@]I_T%]=_P#!E)_C1_P@]I_T%]=_\&4G^-',%B:BH?\ A![3_H+Z[_X,I/\
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MKKG_ (,9/\:ZOK4>QC[)]R*BI?\ A ['_H*ZY_X,9/\ &C_A ['_ *"NN?\
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M_P# V?\ ^+H Z2BN;_X0+PY_SYS_ /@;/_\ %T?\(%X<_P"?.?\ \#9__BZ
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MAV_T^&Z.FW$7FKN"->S$@=OXZRA6IS=HNY$:D9.R9UU%<W_P@7AS_GSG_P#
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M9/=P+=N-RP&0!V'J%ZU9KCK?3[NSU.]BDT$7TUQJ/VF*_=DV)&2""23O!3&
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M[0_]^Q7J_P!KK^3\?^ </]F_WOP/D;(]11D>HKZY^QVO_/M#_P!^Q1]CM?\
MGVA_[]BC^UU_)^/_   _LW^]^!\C9'J*,CU%?7/V.U_Y]H?^_8H^QVO_ #[0
M_P#?L4?VNOY/Q_X ?V;_ 'OP/D;*^U&5]17US]CM?^?:'_OV*/L=K_S[0_\
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MO7^@![)17*?#SQ@?&WA9=2DACAN8Y6@G6)MR;UQRI]""#75T %%%% !1110
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M5BSD=^IH ;9?:KJ.1I+QB@<JC(B@,/4<55M+6]1X;51&T5E*Q$CMR^0=O ]
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M<-5E5I*<X\K[,RHU'4AS25GV):*\[DT/5+J^U?48RL MK^6:.0>89I56,8C
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M/_2=:ZRN3\._\CWXR_Z[6G_I.M=90 4444 %%%% !1110 5R_P 1?^1#U/\
M[9?^C4KJ*Y?XB_\ (AZG_P!LO_1J4 6/&?\ R+Z_]?MI_P"E$==!7/\ C/\
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M0P]JI/;030M!+!&\+\.C*"K#W%9/@^&%M(EM5EE1K2XE@:%7*B,!B0,?0@T
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M]_9UC_SYV_\ WZ7_  H_LZQ_Y\[?_OTO^% %'_A*_#O_ $'M,_\  M/\:/\
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M-TF^0+%*]R"JEHBB(XX!YR)!]._>@"E%XB\1W:!U$$2!8X\"U?,ADW@2#)X
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M_P".4 5]OQ(_YZ>%/^_=Q_C1M^)'_/3PI_W[N/\ &K'E>//^?SPY_P" L_\
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M$811CH<5:N?#_C.\O/M=Q;>$)+C=$^]DN>L9)0_>[%C^=;/E>//^?SPY_P"
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MK7\KQY_S^>'/_ 6?_P".4>5X\_Y_/#G_ ("S_P#QR@"OM^)'_/3PI_W[N/\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
1HH **** "BBB@ HHHH __]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>39
<FILENAME>ex99-2_007.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 ex99-2_007.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" (4 JP# 2(  A$! Q$!_\0
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M]"/,R#4XB\6%MIU'1PWI]BD_^.4AEO\ X1?P_P#] +3/_ 2/_"C_ (1?P_\
M] +3/_ 2/_"JWV?Q;_T$='_\ I/_ (Y3)8O%T<3.-0T=MHSC[')_\<H N?\
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M66+KQ%SG6=#R#C:MI(Q_(24Y?^$QD.4O-'6/'#26DBDGZ>9Q0!I?\(OX?_Z
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MH+&O_P (OX?_ .@%IG_@)'_A1_PB_A__ * 6F?\ @)'_ (54,/BP==2T8?\
M;G)_\<H\KQ82 -1T?D9_X\I/_CE,"W_PB_A__H!:9_X"1_X4?\(OX?\ ^@%I
MG_@)'_A5;[/XM_Z".C_^ 4G_ ,<IIA\6A@#J.C\]/]"D_P#CE %O_A%_#_\
MT M,_P# 2/\ PH_X1?P__P! +3/_  $C_P *K?9_%O\ T$='_P# *3_XY3#'
MXK =FU/1E5.I-G)@?^1* +G_  B_A_\ Z 6F?^ D?^%'_"+^'_\ H!:9_P"
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MM]G\6_\ 01T?_P  I/\ XY3?)\6[]O\ :.CYQG_CRD_^.4 6_P#A%_#_ /T
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M]5.<[L='&./Q _2JNJV^VXA,<AC:27<<#(/3G'^%6KE))+^",N J#>0!P3D
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M>=\O3K_E_73U&E=EA55%"J % P .@%+1176:B'J/K0RAE*GH:#U'UH+!1DG
MH ;&Q(*M]Y>#2%RQ*QX/JW857F\QFWHI53QR<$U:0 (H7H!4K708PQA!GJ21
MN)ZFE'R28_A?I[&GD C!Z4P@L"AZ]5:G;300Z21(HR\C!5'4FD7;*BOAAD9&
M>#5.TQ>.9IB&DC<KY7:,C^9]ZOTP&99/O<CUHE& ''5>?P[TYAE2/44U7#
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M?\B[JG_7I+_Z :WY5&-D9WN]3L]+_P"019?]<$_]!%>1?%W_ )&NU_Z\4_\
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MX8H#!NAI:8AH;G:W#?SJO>2O% YC7<S81>?XCTJ<_O.!]WN?\*@>V67*2*&
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M %XP?^BUK)U;_D>K/_L&2_\ HR.FMQ,MT445J2%%%% !1110 5/H;8N;Z/\
MA$@(]B5!-056BU$:5J4AG1ELY0)#-M)"O]W!(Z C'6HFM!K<ZJHTYED/T%.5
MU= ZD%2,YI(N5+?WCFLRRN2?[7 VG A/.?>K=5(3YU]-,/N*HB4^I!R?\/PJ
MW3$%%&<4UW"#)Y)Z =Z '45'F4]D'MFE_>_['ZTKCL/J(J#,P]5!_&G?O?\
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MKC4;*T@EGGNX4CB5V<[QP%&6_$#M5&R\3:/J-S'!:7J2F2S^VJX^YY6<9+=
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MOJ#)*OV>(K)&X15*#MLRI(Y[UK""BVRE&QV-5V.2\28)ZCVJ3#R=<HOIW/\
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M_P!!%>1?%W_D:[7_ *\4_P#0Y*\8[3U+PO\ \BEHW_7C!_Z+6LG5O^1ZL_\
ML&2_^C(ZUO"__(I:-_UXP?\ HM:R=6_Y'JS_ .P9+_Z,CIK<3+=%%%:DA111
M0 4444 %,FB2>"2&09212I^AI]% "Z'=HUG]A:51<6V8G1>"Z+P& /MBMYBJ
MQEB<*!DGT%<S<.L,MK.S^6%F56?. %;@Y]NE;,C_ &NX6T.X1JN9<=_1<_K6
M+5I%K8ETY&2QCW$DL-_/;)S_ %J=G.=J#+?H/K2%BQVQ\ <%O3Z4]5"# _\
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M(8@[_6EJ/>=Q5%W$=>>!1M=^'8 >B]_QI7 4R<X4%B.N.U-:5Q@"/DG R:D
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M'D_B<_E6L7,AVQGZMZ?_ %ZKZ?:M;Z?!"TA^5!G Q5@ 1M@<*?YT;@.10JX
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MH-$F]5D.6 R/6CS0?N*6]QTI3$A PJ@CH<4!F'WE/X<U6H@WO_SR;\Q2;W/
MCP?5CQ3MY_N-2@@C(.:5@N-$8SN8[F]3VI]%%,"&ZN8K.SFNIFVQ0QM(Y]%
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MLDAO[ZXO;VY$^KQ;@YWG9!G. @/&!Z^N:V+F6.VM9KR6)I([=?-?8N3@=_\
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MZ&FI-:BYWW,=N%:7RP"YQDM@X JE;?$+2@NEQ:DOV:;42%B:+,T!9F(4>:
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MO:R)!?(\-P AF$8,B0[VVKN<= 3TITWAZRF=Y!]HCF:X-RLT<A#HY4*2I]"
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M*\B^+O\ R-=K_P!>*?\ H<E>NZ7_ ,@BR_ZX)_Z"*\B^+O\ R-=K_P!>*?\
MH<E>,=IZEX7_ .12T;_KQ@_]%K63JW_(]6?_ &#)?_1D=:WA?_D4M&_Z\8/_
M $6M9.K?\CU9_P#8,E_]&1TUN)ENBBBM20HHHH **** "BBB@ HHHH ****
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M;PO_ ,BEHW_7C!_Z+6LG5O\ D>K/_L&2_P#HR.FMQ,MT445J2%%%% !1110
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M44 %%%% !1110 4444 %%%% !6?KW_(NZI_UZ2_^@&M"L_7O^1=U3_KTE_\
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M,%A922<#D'OZ5!X>?S/#UBV<_NL?D2*[XZ32\CG>WS-.BBBMB HHHH ****
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M/3%5M)LL@'_1TZC_ &17D?Q< 'BJT & +%./^!R5XQVGJ7A?_D4M&_Z\8/\
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M;)"X5&+%1D@= ?04U*2=[A9$JL'17'1@"*6HX/\ CWB_W%_E4E>PCB"BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH *S]>_Y%W5/^O27_ - -:%9^O?\ (NZI_P!>DO\ Z :3V8UN=GI?
M_((LO^N"?^@BO(OB[_R-=K_UXI_Z')7KNE_\@BR_ZX)_Z"*\B^+O_(UVO_7B
MG_H<E>,=IZEX7_Y%+1O^O&#_ -%K63JW_(]6?_8,E_\ 1D=:WA?_ )%+1O\
MKQ@_]%K63JW_ "/5G_V#)?\ T9'36XF6Z***U)"BBB@ HHHH **** "BL#Q-
M)<H;)+69XG9G/R-C=A<X/Y5DC4[NX>^NA<2I'+:/+$@8@)A@ 1^1I7'8[6BN
M2TB1I8)GN]18(;8L6%YO9??;V(IFEW]U<BX:[NI5EBLR;=#E?,&#\_N:+A8[
M"BN/ANY;A-(@N[^6WMI;=G>42;2[@G@M^52S7F]=,MQJDYL97<271^1F(Z+G
M^M%PL=716+X=N99EO8VG:X@AGV0S,<EE^O>MJF(**** "BBB@ HHHH ****
M(YXUF@DC<$JRG@=?P]Z1Y3/I6EW;.&?S4W$=RRE3^.34M9UV%@-R$&U=B7!4
M="RR#)'X'FL*Z_=L3V-(L!(,'DG!%25"#P#@YW9)J:N5JSL2&2>IHH%% #4^
M[CT.*=D*"2< #))]*;']W/J2:5E5T9& *L""#W!I(&>?:.;ZTM_#US<:E;%Y
MI%@LK9$&]K23[V[CDC:IW#^M=_$$1=BJJ8_A Q5'3M"TS2I3+96HBD,8BW%V
M8A!R%&XG ]A5]P,9)QCG-5)C%9MON3T%-(9B,\#T!I%1C\S,0?Y"G8<=&!^H
MJ0%50O3O619C/B#7AZI;_P#HMJUU;.>,$=163/IFHIJ5W>6%];1BZ5 \<]N7
MP54@8(8>OI30#O#)W>%M)/\ TZQ_RJ[?+NLIO7RV _$4S2K(Z;I%G8F02&WA
M6,N!C=@=<=JGF&Y-GJ#_ "I3U3$:^GN7T^U;'!A0Y_ 59JEH[;M%LC_TP3^0
MJ[733=X)^2_(U6Q4U10VDW@8 CR'X/\ NFO*_$5UXLN_&D&E>'+N]1TTBVGC
M2.5%@C8R89Y0P^9=HQ@<]*]5U/\ Y!5Y_P!<'_\ 032:>B?8+5]J[_(0;L<X
MP.*L9YL_Q \1K9/<RKI-M;2:S)I:74B2;+<(6S))SC!P .1R>M,TGXF:QJES
M9I/'IVF@VBW&VX#YOV,C)M@Y&,A01U/S#M71^*/&MIX?UVUT%M+BN'O(3/F2
MXBACQOVX^? +9[5<;QIX5\^ZCN;N*&738S-(+B!D,: [=R[EY&<#Y?:@#@;;
MXK^(Y]$NKTVFDJY6-XT,ZJ\.7(=&0ORP XR4R<\5(WQ0U6ZN;>WQ;+;7=@9(
MWBB82O)Y3,<KOW18P,'##OFNAUCX@:)8PW4T&EK=Q_9#=R*Z>3(Y$JQX*.N>
MK Y-2R?$+1K;7H[&YT\B:2[FL1+ GF[1&@8[L+D9R!M&<=>E '-Z9\0_$,;:
M9$(+26R4:9%/YOF-/(;E"20V<9!'<<U:\.>/]5\2WM_IU\EBB-I=S<M#%&ZR
MVS+)L$;[CR<<\ 5W6D^(?#^M3Q0Z;<0W$DELMVH2,_ZO<55CD<<@C!YXJJWA
M71]%MM7U"RM66[N+:19)I)7D;;@G:"Q.!GG H IP?\>\7^XO\JDJ*U97M('4
MY5HU(/J,5+7LK8X0HHHI@%%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !6?KW_ "+NJ?\ 7I+_ .@&M"L_7O\
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M(OB[_P C7:_]>*?^AR5XQVGJ7A?_ )%+1O\ KQ@_]%K63JW_ "/5G_V#)?\
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M;PO_ ,BEHW_7C!_Z+6LG5O\ D>K/_L&2_P#HR.FMQ,MT445J2%%%% !1110
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ME_\ ((LO^N"?^@BO(OB[_P C7:_]>*?^AR5Z[I?_ ""++_K@G_H(KR+XN_\
M(UVO_7BG_H<E>,=IZEX7_P"12T;_ *\8/_1:UDZM_P CU9_]@R7_ -&1UK>%
M_P#D4M&_Z\8/_1:UA>()+N/QO9&STZ6^<Z;,&2.1$*CS(^<L0*:W$S2HK/\
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MNBZ"QH45G_:=;_Z%>\_\"H/_ (NC[3K?_0KWG_@5!_\ %T706-"BL_[3K?\
MT*]Y_P"!4'_Q='VG6_\ H5[S_P "H/\ XNBZ"QH45G_:=;_Z%>\_\"H/_BZ/
MM.M_]"O>?^!4'_Q=%T%C0HK/^TZW_P!"O>?^!4'_ ,71]IUO_H5[S_P*@_\
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M[.'W;0 #DGY'XZC%2Q^+-<FOWM()-,F:.,2.T5E=,%RF\ ^Y4@XZ\XJ*_P#
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M\(GJ'VF31O*V+N\M)=WWATR:W-OC#_GIH7_?N;_&J?BBZ^U> =1WL#/&JQS
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MN%S@E,8/6O6?^%.^%?2^_P# C_ZU'_"G?"OI??\ @1_]:NOZ]A;WU_KYG/\
M5,1:UT>96GC]K9_MITW=JWV<6[W"W++'* NT,\8X9@/>J5UXFL;[2;6TNM)F
M:>VLQ:I,E\R*0,X8H!@\FO6O^%.^%?2^_P# C_ZU'_"G?"OI??\ @1_]:DL;
MA$[I/^OF/ZMB;6NCRT>/;L)J</V5#;WUBEJ8R_\ JV6,1^8#CJ1U%)/XUB96
MGM](2+4FL5L3=M<,P$80(2J8 !('6O4_^%.^%?2^_P# C_ZU'_"G?"OI??\
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M,S0(&91F8G@$GHWUJQIBP:5#H<$\ED;BVT>]$@WI(HDW @'L37)_\*M\7_\
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M?S^E75LVVA6N9=H& J80 ?@*@E:2[OT^S,H%LQ#NPR"2,;:H&ZU1Q-,94:"
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M]G'W03A021D\@#.?H:F2C]DJ+G]I&INO/^>,'_?T_P#Q-&Z\_P">,'_?T_\
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M@[L?I7<5S5MHPU#6CJ\__'JZ@PP,#D8(PQ],]<?2NEH Y[QS_P B9J7^XO\
MZ&M=#7/>.?\ D3-2_P!Q?_0UKH: *]Y>1V<6]^6/"H.K&L^RU=S*4NRH5S\K
M@8"^Q]O>KM]8I>1CG;*OW'_H?:LRSTJ264FZ0I&IP5/\9_P_G7/-U.=6,I<W
M-H;U9NJZW;Z2]O'+'/++/N\N.%06(49)Y(]1QU/85I 8&!63KNAC6X4B-P(U
M4,&1X5E1@>^UNC#L1TYKH-2S'K&G2SM M[!YZ[=T1<!UW8P"#R#R./>J4WBW
M0X+LVTFH0JX<(S%OE4E2PR>G0&L__A"8T,?E:E< 6[^;:[T5C&Y969F)Y?)4
M=?4^U.@\%6\(VM>S2+Y94Y1<EC&R%NGH_3VH T]2UV+3;JU@>TNYOM)Q')"@
M9,X).22,< GZ"IX=9TRX17BU"V=7.%(E')R!_,@?B*K7_A^VU&PM+.:2016Z
M,GRD L#&T9_1B:RK7P+;6QM7%Y();64S1ND:KARH0DCG/R#'/KGTP ;:Z_H[
M*K+J=H5:3R@1*.7]*+K6K.S:\64OFT2-Y<+GAR0N/7H:YU/A]$B@G5+@R^8C
MF7:-_P JA>#U!( SV]JV-2\.C4+V287DD,5PL:7,2H#YH1BRX)Y7J0?:@"VN
MO:2TJQ+J5J7=F55$HY(ZC\*(-;TRZ:/[/>P3*[%0Z2*1N&..O7YA^=8EUX&@
MNFM%.H7"PVZ@", 8)#LV?_'CGCL.E2R>#+?S4FAO)8IHUC\MMJD*R! IQW_U
M8X]Z -2;Q#HUN^R;5+.-L;L-,H./SJ'4_$MEI5VEO.D[EHA,SQ)N5$+;<GGU
M],U1@\%VD,'EM=32,2Q9RJY),;QD]/1R:75/!]OJ<]O(UP4$-L+8YA1VV@@Y
M4D?*W'44 7[WQ+I%@DK37L9$+[)=AW&,[2WS =.%-:<,T=Q!'/$P:.10Z,.X
M(R#7)I\/[%&GQ<R[9&8K\HW*&WY!8]>7)_"NJMHF@M886?>T:!2^,;L#&<=J
M ):*** "BBB@"K?%@D)50Q\U?E)QFJ*3V5PK*EM8R!QE@)$.X+W/'(%7[OD0
M#_IJO]:HKX<L8WA:$RQ&*+RAL8?,ISG.1WS514>I,G+HA5N[5K:)1#9&!@1&
M/-7:1T.!CW_6G6_V>9O-MK*T<HWWXW4[6QCJ!UQ44OAC3Y[*VM9A(\=MGRCN
M"D=/0#TQ^)JY8:7#IQ8PO*VX '>P/  "CIV Q5-0MHR4YWU0BQ% P73H &8L
MP##DG@GIUIK6JLJAM+MR$;<HRO!]1Q6A169H9XM5"A1I=L%!R!\N ?RJ1UDD
MSOL(FW=<N#G]*N44 54:>,$)9HH)).V0#)/4]*=YMU_SZK_W]_\ K58HH K^
M;=?\^J_]_?\ ZU0E;EKDR-:(RE0 #(#R"3GI[U>HH SC:(RQJ=*MBL?W!\N%
M^G'%22(\K!I-/A=@<@LP//Y>YJ[10!1AB-NQ:'3H(R0%)1@./3@5-YMU_P ^
MJ_\ ?W_ZU6** *_FW7_/JO\ W]_^M3;$L8Y2Z[6\ULC.<<U:JO9_=F_Z[-_.
M@"Q1110 5FZ_JZ:!X?O]7EB:9+.!IFC4X+!1G K2K)\3Z0^O^%]3TB.987O+
M9X5D89"EAC.* ,+1?B!'?ZI]@U/33ICFQ-^DANHYH_*! )9E/RD9'6M5/&GA
MM](EU5=7MC912")Y,D8<]%QC.3D8&.:YA_A9;PIJ5KIMQ#96&JZ:+2]ACA_Y
M;*,+*GI[KT/UK-O_  5J>BZ.FHJHN]5BU*VNE^Q0/,,1J4!=7DW.,$]"",C'
M2@#N(?%VEWEYIT6GW-O=0WDDT?G), %:-=S#!^][XZ56D\1^#-=M+J6>\TR]
M@T\>;*9E#B(9QO&X=,C[PXKE/#/@?4=1L+:[U5GM";W4II(FB\N1TN5* A03
ML/?!S4[_  TU.\TN>UOM5LR\>CG1[-H+<H/+W*=\@SRWRC@<#GUH Z23Q'X,
MO[%M0EN]-N+?3Y5C$CQAC"Y^Z%!&<GMCKVIG]M^']3\1:/';V5K?-J=O--#?
MA%;:L)7C)&>I_ BLW5? >IW%WJ=SI^K1VS7DMFY3:RADA0HR,RD, <YRI!XQ
M3O#/@"XT&YT&22_BE72TO48+&1YGGR!QC).,8QWS0!LV=[IESXRU/24TJ%+J
MTCANY+GRU_>,^X ],Y !Y]ZGB\0^';76!H,-]9Q7Q8_Z*F%^8_-CCC<>N.O>
MLB]\.>(8/&-_KNBZAIL2WMO##)%=V[N1Y>[D%6'7=5-_ %[)JKJVHV_]D2:L
M-8=!"?/\X ?('SC9D9SC..* -R#Q)X3NCJ5G#?Z<ZP*\M['QMP.'9N,,,\$\
M^]9<OC+P3IVG6%S;&T>W:[%A#Y%N!Y+N,MD8!48Y/'(]:JV/@;7K'0;C18=<
MM(;6*UEM[&:.T_?+O?<&=B>W3"XSUZU4M/AMJEI:RNNI6AO&U6VU-=RR.FZ)
M=I4EF+'/7.: -K^V?"<5@]_J=MI=I';7,EA"65)"=C=%P,CIG:.E6;KQ)X+T
MJZCU*>^TN"XNX!,MRJKOEB)P&W 9*Y[UDKX#U*RG@U#3]1M/[1MM1O+N(7$+
M-$R7'52 <Y'&"/?UJM#\+WMM/EM(]1C?S-#FTPN\7_+264R%P,\+DD;: .E\
M8^+(?"/AHZTUK)>Q^8B+'"P!;<< @UGV_P 1M,N?%BZ(L3+%_9XOWO6<"-%V
MAL'Z*P.?>KNL^%GU;PWI>DFX119SVLDC%<AUB()&.V<5RFE_"B\TA"UKK82Y
M^S7D"S^42R^;L$9&3T14 Q0!V$?C?PS+ISWZZS;?94E6%Y&)7:[#*J01GD=/
M6M/2]6L-;L%O=-NH[FV8E0\9[@X(/<$>AKRZZ^'VN:5:(\$\5Y>76L6%PQ5'
MD6'R@0SOO8LR]">:[_PIH%QH5I?&\N(I[R_O9+V<PH4C5GQ\J@DG  ')Y- &
M_1110 5E^)?^15U?_KRF_P#0#6I67XE_Y%75_P#KRF_] - %G2O^019?]<(_
M_017D7Q=_P"1KM?^O%/_ $.2O7=*_P"019?]<(__ $$5Y%\7?^1KM?\ KQ3_
M -#DH ]2\+_\BEHW_7C!_P"BUJM+_P E!MO^P7+_ .C8ZL^%_P#D4M&_Z\8/
M_1:U6E_Y*#;?]@N7_P!&QT ;Q (((!!Z@UF7%F_]IQM!=2V^Z'8!&%*_*<@8
M(/J:TF<JR+L8[CC([?6H+P$>5,H)\I]S8Z[<8- &7%<366I3R7,OVN/:$WQH
M \8'7<HZCGJ/RK9AGBN(EEAD62-NC*<@UG,T9@D&0)4<S)@\E<YR#Z8J>33(
M7E,\$LMM(_+- V _N0<@_7% $K?-J:#^Y$3^9'^%6:RFTJZ>;<^J3[#C=M15
M8@9P-PQCK7%^+M&N]&U,:\=5UV3260)>);7;A[;'24*."G]X8R.OK0!O?$#]
MYHMC:YXN=3M8S]/,#']%I=2ALM4TRZLKBX06]RC1.R2J#AAV/K66GAPS7%C<
MS>(-5O;>WF6YBAN)$D1C@@$G;DC#>M)<>&RCVC6MO9XCGN)'1-D>1(P*_>C8
M' &.G'8T 1H/'.A0HFGWUAKEJF=L5^ODS[?3S%^4XZ<J*)_$WCHP>6_A332Y
M7YXTU0%Y1W\L%1R >YJQ-H=Y++J;)/:Q)J(V,HRWV=-PW!!T;>N2W3FDMM%O
MK>\L)'>UF-MLC-P3RT:,2,H5)#;3@%6'/7(H Z#P]XDLM:T&UOUW6WF*089R
M Z%25(./<&K=@$NIKFZ8*Y,AC0X!PJ]/ZFN:^'ET\(UOP_-&!)I5\^QQT>*4
MF1#]?F((]A70V5PD DDF257GFR1Y9 7)P!G\J +=H );K  _>_\ LHHC(COY
MHB<>8!(H_0_T_.J,FKV6G3W*SSH&:0,!N'0@#)R?7BA-0CN[N*YA198XE96*
M2(Q7/? /'2@"U=1O;,;NVQGK)&>CC^A]ZIVEP^O3QW"QE-.A<E/,',[C(SC^
MZ.ON:LW-W//9/]EM'=I%*HQ9=O/&>IXJ31UC31[-(P J1*N!V(&"/SS0!=HH
MHH Y[QS_ ,B9J7^XO_H:UT-<]XY_Y$S4O]Q?_0UKH: *U[>PV%LT\[8 Z =6
M/H*R=)\1K>7+072K$SM^Z(/'T/O5[6-)35+<#.V9,F-NWT/M6!I/AR::Y+WT
M9CBC;&WNY']/>O%Q=7'QQ=.-&*<'O^M^UNG?\#OHPP[HR=1^]_6W?S.PJ"[N
MX+&V-Q</LB#*I.">6(4=/<BIQP,5DZWI$^L11VXO3!:EAY\8CR7 96&UL_*<
MKC//7I7M' 7#J=@J%S?6P4/Y98RK@/\ W>O7VI7U"RC\[S+RW7R<"7=(!Y>>
MF[GC\:YA/ <3 ?:+N-]D#6Z!;8*-NQD#$9.7^8DMW]J@;X>1XN=MZK-(VZ-Y
M(V+*2^\Y.\=^F,>^: .EU#7+/37B2;SI&EC:51!"TGR+C+':#@?,/SJ:/5M.
ME3>E];E?+67_ %@!"'D,1V!R*R;_ ,(6FJV]I#?3/,+:S>V#;=K$ML_>#'0C
M9TZ<UGMX$>?4UO+O4UE *GRQ;!5.#&<8SC'[L=N_?% '27.LZ;:V_GRWL C\
MLRC#@ED'\0 ZCW%/?4K-(8)OM"/%/*(HW0[@S$X R*YN3P,K"YB2\C%O<Y,B
MM:JS+RQ 0Y^5<-R,=NV36D_AP+8O!;7(BD%]]MA;R\JC;L[2H(R.HZCK0!?3
M6-.?S?\ 3(4,3NCB1@N"APW7L#WZ4]M3L5 Q=PL3&9%5) 690,Y [BN?;P86
MBNG^WK]LN0"\OD# /FF0X&<@'..#GC.<U7@^'T$6GFV-\6D)_P!=Y(W ;'3'
M7./WF>O:@#K)+ZTAC\R6ZAC3&=SR #KC^=12ZI8PV<EV;F-H(V".\9W@,2!C
MCODBN?3P4#=I)/?++#"S&*(VXX!9W^8D\G+^@Z"IT\(QP:)=:=;W0C\]8 '\
MD84Q*H!V@C.=F3]: .@>ZMXYEA>>)96!949P&('4@>E1)J5C((C'>VS"5BL>
MV53O(Z@<\FN<O?!LVHZI_:-QJ*?:&C"LR0$!64,%*J7('WN00<X[9JK!\/FB
M>)SJA\P2F1W6$AL$*"JDL>/E[YZ\8Q0!UKZE91V<UX;J$V\&?,D5PP7'4''?
MVJM;:_IUPLF^8VSQD!X[I3"PW?=X;'7M63IG@N&PT6^TUKDL+D(HE12"NP?*
M3N9LG@'L/:H-2\)ZAJ%_;W<U[:S7!S')(]M\B1>6Z@*A8Y;+DYS^E '0IK6F
MOYQ%Y#LA9DE<N J,I ()/0Y(JREW;23F!+B)I@NXQJX+ >N.N*Y5? PAECE@
MO8]T#LT*S6X=3NQG>,C<>O/';TJYI'A"WTBXMIH[@N\+NQ8Q@%PT:I@GT&W/
M_P"J@#:OF*I"0I8B5?E'4T[[1+_SZ2_]]+_C1=_\L/\ KLM6* *_VB7_ )])
M?^^E_P :/M$O_/I+_P!]+_C5BB@"O]HE_P"?27_OI?\ &C[1+_SZ2_\ ?2_X
MU8HH K_:)?\ GTE_[Z7_ !H^T2_\^DO_ 'TO^-5=:UF#1;/SY5+NQVQQCJQ_
MPKFTU7Q;J+J]M9BWA<C!,8P!Z_-7/4Q$82Y=6_(SE447;=G7?:)?^?27_OI?
M\:/M$O\ SZ2_]]+_ (U.H(10S;F Y.,9I:Z#0K_:)?\ GTE_[Z7_ !H^T2_\
M^DO_ 'TO^-$&H6=U-)%;W<$TD?#I'(&*_4#I5BBU@O<K_:)?^?27_OI?\:/M
M$O\ SZ2_]]+_ (U8HH K_:)?^?27_OI?\:/M$O\ SZ2_]]+_ (U8HH K_:)?
M^?27_OI?\:K6]T\:3%K=P/.;DLH[_6M&L/48;&>P9=0D9(!=YP 26.3A>.>:
M:M?43O;0T?MI/_+!NNW_ %B=?3KUI3>$-M,#!L9P73/\ZYRWT+298KF:VO)3
M$A;S3Y><=<[<CJ.Q'(Y]:=;:5IVI74LD6I--/-'O?,>&P3D''& <CJ.>:TY8
M?S?@9\U3^7\3H!>EC@0,2!G D3I^=.%TY;:+9RV,X#IG'YU1?P];2V]Q$[?\
M?$212,B*IPI)XQTSFH[#PY'I\\4L=U*[1\Y=068XP<GKC';UYI<L+;CYIWV-
M/[1+_P ^DO\ WTO^--DNWB3<UI+C('5>YQZU:JO><6^?]M?_ $(5F:!]HE_Y
M])?^^E_QILEX\4;2/:2[5&3@K_C7,:GH5I#/BYU:6W>5GD0QQ'! );+$9&02
M#GCA15ZRTF&RM+J[MKZ2X@GC^13RHY)RI]#Q^6>]:.,+74OP,E*;=G'\3;^T
M2_\ /I+_ -]+_C37NWCC9VM9=J@DX93_ %K#UK2;16DFO-4-K'/,I5L8;=C
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M21>*=&N#MMKZ*9\@;5.#RP7OCNPX]QZB@"MXY_Y$S4O]Q?\ T-:Z&N>\<_\
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MF0;5RR.7!P% ZD@\=*MZ!HZZ+IIMMRL[RO-(5SM!8YP,\X PH]@* -2BBB@
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M8_.IJR-2O]J;_GUN/R'^-5[RY8VY'V6<?,O8?WA[UH57O/\ CW_X&O\ Z$*
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M]=OM7NM% 'S;_P *=\(_]#-K'_@GE_\ B:/^%.^$?^AFUC_P3R__ !-?25%
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M4?\ "::+_?O?_!?/_P#$5T%% '/_ /"::+_?O?\ P7S_ /Q%'_"::+_?O?\
MP7S_ /Q%=!10!S__  FFB_W[W_P7S_\ Q%4G\2Z!=VL]O=B\>*24MM^P7 SS
MD=$KK:* .&^T^#?,ED\F^WROYC-]CN<[O4?+Q0;KP:V<PWQ!R"/LESR#_P !
M[9./3-=S10!Q]AK'A32YWFLXKN)WSDBPN.A()'W/:M#_ (331?[][_X+Y_\
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M_/CI/_?F3_XY110 ?\+Q\3?\^.D_]^9/_CE'_"\?$W_/CI/_ 'YD_P#CE%%
M!_PO'Q-_SXZ3_P!^9/\ XY1_PO'Q-_SXZ3_WYD_^.444 '_"\?$W_/CI/_?F
M3_XY1_PO'Q-_SXZ3_P!^9/\ XY110 ?\+Q\3?\^.D_\ ?F3_ ..4?\+Q\3?\
M^.D_]^9/_CE%% !_PO'Q-_SXZ3_WYD_^.4?\+Q\3?\^.D_\ ?F3_ ..444 '
M_"\?$W_/CI/_ 'YD_P#CE'_"\?$W_/CI/_?F3_XY110 ?\+Q\3?\^.D_]^9/
M_CE'_"\?$W_/CI/_ 'YD_P#CE%% !_PO'Q-_SXZ3_P!^9/\ XY1_PO'Q-_SX
MZ3_WYD_^.444 '_"\?$W_/CI/_?F3_XY1_PO'Q-_SXZ3_P!^9/\ XY110 ?\
M+Q\3?\^.D_\ ?F3_ ..4?\+Q\3?\^.D_]^9/_CE%% !_PO'Q-_SXZ3_WYD_^
M.4?\+Q\3?\^.D_\ ?F3_ ..444 '_"\?$W_/CI/_ 'YD_P#CE'_"\?$W_/CI
M/_?F3_XY110 ?\+Q\3?\^.D_]^9/_CE'_"\?$W_/CI/_ 'YD_P#CE%% !_PO
M'Q-_SXZ3_P!^9/\ XY1_PO'Q-_SXZ3_WYD_^.444 '_"\?$W_/CI/_?F3_XY
M1_PO'Q-_SXZ3_P!^9/\ XY110 ?\+Q\3?\^.D_\ ?F3_ ..4?\+Q\3?\^.D_
M]^9/_CE%% !_PO'Q-_SXZ3_WYD_^.4?\+Q\3?\^.D_\ ?F3_ ..444 '_"\?
M$W_/CI/_ 'YD_P#CE'_"\?$W_/CI/_?F3_XY110 ?\+Q\3?\^.D_]^9/_CE'
M_"\?$W_/CI/_ 'YD_P#CE%% !_PO'Q-_SXZ3_P!^9/\ XY1_PO'Q-_SXZ3_W
MYD_^.444 '_"\?$W_/CI/_?F3_XY1_PO'Q-_SXZ3_P!^9/\ XY110 ?\+Q\3
M?\^.D_\ ?F3_ ..4?\+Q\3?\^.D_]^9/_CE%% !_PO'Q-_SXZ3_WYD_^.4?\
M+Q\3?\^.D_\ ?F3_ ..444 '_"\?$W_/CI/_ 'YD_P#CE'_"\?$W_/CI/_?F
M3_XY110 ?\+Q\3?\^.D_]^9/_CE'_"\?$W_/CI/_ 'YD_P#CE%% !_PO'Q-_
MSXZ3_P!^9/\ XY1_PO'Q-_SXZ3_WYD_^.444 '_"\?$W_/CI/_?F3_XY1_PO
M'Q-_SXZ3_P!^9/\ XY110 ?\+Q\3?\^.D_\ ?F3_ ..4?\+Q\3?\^.D_]^9/
M_CE%% !_PO'Q-_SXZ3_WYD_^.4?\+Q\3?\^.D_\ ?F3_ ..444 '_"\?$W_/
MCI/_ 'YD_P#CE'_"\?$W_/CI/_?F3_XY110 ?\+Q\3?\^.D_]^9/_CE'_"\?
M$W_/CI/_ 'YD_P#CE%% !_PO'Q-_SXZ3_P!^9/\ XY7)>*?'FJ>(]3BO+R"S
221(1$!"C 8#,>['GDT44 ?_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>40
<FILENAME>ex99-2_008.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 ex99-2_008.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" $6 G # 2(  A$! Q$!_\0
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MN1Z5@K?W<0V0W5Q'$/NH)3P/2F)=W,<[3I<3+,W617(8_4TE6@DHV?G\^O\
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M=BQ"C &3GBF45A*I*2LS-R;T84445!(4444 %7]#_P"0]8?]=U_G5"K^A_\
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MG_Y_8/\ OEO\*Z>BCZA0[?B'U6GV.8_X1.?_ )_8/^^6_P */^$3G_Y_8/\
MOEO\*Z>BCZA0[?B'U6GV.8_X1.?_ )_8/^^6_P */^$3G_Y_8/\ OEO\*Z>B
MCZA0[?B'U6GV.8_X1.?_ )_8/^^6_P */^$3G_Y_8/\ OEO\*Z>BCZA0[?B'
MU6GV.8_X1.?_ )_8/^^6_P */^$3G_Y_8/\ OEO\*Z>BCZA0[?B'U6GV.8_X
M1.?_ )_8/^^6_P */^$3G_Y_8/\ OEO\*Z>BCZA0[?B'U6GV.8_X1.?_ )_8
M/^^6_P */^$3G_Y_8/\ OEO\*Z>BCZA0[?B'U6GV.8_X1.?_ )_8/^^6_P *
M/^$3G_Y_8/\ OEO\*Z>BCZA0[?B'U6GV.8_X1.?_ )_8/^^6_P */^$3G_Y_
M8/\ OEO\*Z>BCZA0[?B'U6GV.8_X1.?_ )_8/^^6_P */^$3G_Y_8/\ OEO\
M*Z>BCZA0[?B'U6GV.8_X1.?_ )_8/^^6_P */^$3G_Y_8/\ OEO\*Z>BCZA0
M[?B'U6GV.8_X1.?_ )_8/^^6_P */^$3G_Y_8/\ OEO\*Z>BCZA0[?B'U6GV
M.8_X1.?_ )_8/^^6_P */^$3G_Y_8/\ OEO\*Z>BCZA0[?B'U6GV.8_X1.?_
M )_8/^^6_P */^$3G_Y_8/\ OEO\*Z>BCZA0[?B'U6GV.8_X1.?_ )_8/^^6
M_P */^$3G_Y_8/\ OEO\*Z>BCZA0[?B'U6GV.8_X1.?_ )_8/^^6_P */^$3
MG_Y_8/\ OEO\*Z>BCZA0[?B'U6GV.8_X1.?_ )_8/^^6_P */^$3G_Y_8/\
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MZ^SW=VL4H@>Y<$$B.)>KL1T'89ZGI277B'1K&2VCO-5L[:2Y4/"DTP1G!Z$
M\US&AZ=:>)+[QL-3B,L<^HBR==Q!\J)5*J".0,DFLU+"SO\ 4/B4][;Q3/$J
MPH95!,<:PDJ 3TY /'I0!WNI:WI>CK&^IZE:V8E.(S/*$W?3/6G7NL:;IMDE
MY?:A:VUJ^-DLLH56STP>]>:> H4UGQ# =5B2Z:/PU:K&)U#X5B0Q /KZU0\
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M6-X6\)OX=N))GNX)-UM';!+>W\I7"$GS'Y.Z0YP30!T]%%(K*Z[E8,/4'(H
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MVJ2M/;-:R,>IB8Y*@]N>:O44 96BZ!;:']H>*>ZN9[C9YD]W+YCL$&U5S@<
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M/(R,]\5I6N@WX\831R(%\*V^EQ6=O9.P>.63=DML/3:H"\]: /)_!FN6]_\
M&C3-<O\ 6+6:[U6RD9HDE#+;,Q*QVX/]X*!D>I-=3+H-OHGQZ\/O%<WEQ)>6
MMW/*]U.9""0V N>%4= !7:?\(#HB^,K3Q)#;QPS6MN8$MXH46,DDG?@#.X9Z
MU<O?"UK>^,=-\2O/,MS8020QQ+C8P?J3QG/- 'EE[I%AXH\6_$Z;6;=;J33;
M1([,R?\ +N!$S93T.0#FO1OAK>7%_P##?0+FZD:29K10SL<EL< G\ *I>(OA
MG8:]K%UJ,6JZEIKW\2P7\=G(%6Z0< ,"#SCC/I76Z;IUKI.F6VG640BM;:-8
MHD'90,"@"U1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%<GX\O]16PLM&T6Y-MJ^K7 @@F R844%Y)/P5<?\"% '645YOK
M?B*ZU3X01:HDLEK?>?;0W/EL5:.5;E$E7CIR&'T-:6E^*=:F\;>(]/O=+<:=
MI\,<D9B=7=058_='+%\9 [8QWH [:BN3TKQI-=Z[::5J6AW&F27T3RVAEF1R
MP0 LKJIS&V"#@^_I6+\3-?UC0=8\.SZ9/(((S/<WENO2>&,*SCZA2Q'TH ]&
MHKS/XI^++^RT:S@\/7ABGE07\MQ&>5ME91Q_O,Z@?C71:QXRDL=4N=.TW1Y]
M4GLH5GO?+F2,0JP)4#<?F<@$[1VQSS0!U5%<?<>/HII-,@T+3)=5N-0LOM\<
M?G) !#D#JYY;)QM'O5JX\5W7]EZ?<V/A[49[B\5G,$P$ MPO7S7;A3G@#G/:
M@#IJJ,!N/(ZU2\->(8/$ND"^AAD@997@FAD()CD1MK+D<'D=1UJXWWS]: #
M_O"C _O"DHH 7 ]11@?WA7!-XLFT6_\ '5]?&>[L]+N+40VZ$957100OXMFM
M6S\67<VKS:5<^'KFTOS:->6<,EQ&1<H" 06'"-DC(/K0!U&W SGK[48']X5Y
M=X,\03:;X137=3L[VYU76+OR8$-X)#=R%VPJ*3MB50"#TX&:WKCX@1V.D:I<
MWND7,5]IDL$<]BDJ2,PF8!&1QPP.3^((H [/ _O"C _O"N1G\8ZC#J5AI?\
MPBUVVIWD#W'V<74>(D5PI+MTZ$'CZ4R]\?PVDU[/'I5Q<:/87'V:[U%)4 C<
M$!BL9.YU4D D>_7% '8X'J*,>XKCM>\6W ?6M/TG1[J_%A;'[7=PS(@A9HRR
MA0QR[ 8)QTK3\%32W'@30)II6EEDT^%GD<Y+$H,DD]30!O8']X48']X4E% %
MJ+_5BGTR'_5"GT %%%<-\0KC7].@MM0L=8%K9+=VL+6T< +REY0K;G)X&#T
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M4L5P]K,TDUR6CV[RQ49&1G!)/)YKJM;\/SZIXMT#41Y+6=BETEPCGEA+&%
M[^]=)10!Y6GPSU5/"FO:?)>P7%Y<+%9:<[L0(K.*0-&C''7EL_05?U_P+/+X
MKO\ 6;?1M+UB/4(XP\5]*T;6\B+M#*0#E",9'7(XKT6B@#@=9\)W\EGIMK'H
M>A:A8V]J(C9DM;_9YN[PR %@O;'!X'-4[KP7XA&G^&UN7M-?.G0R1W5I?3NL
M<CL1MDR0=Y0?+\PY'/6O2J* .6\ ^'KWPUH=S97R6:227TUPJ6>?*57.0%!
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MAAY46['"8&"N1@G.:Z&X\.:L_A+X@62VA-QJEW<R6:;U_>JT**IZ\9((Y]*
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M00"/<5Z" !T &>:6@#PK53JWB3PIK&KZM:31W.DV\&D(C(3OG$\9N)5'H<(
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M <=*6@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH *3:/2BB@ VCTHVCTHHH -H]*-H]*
M** #:/2C:/2BB@ VCTHVCTHHH -H]*-H]*** #:/2C:/2BB@!0,4444 %%%%
M !1110 4444 %)M'I110 ;1Z4;1Z444 &T>E&T>E%% !M'I1M'I110 ;1Z4;
F1Z444 &T>E+110 4444 %%%% !1110 4444 %%%% !1110!__]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>41
<FILENAME>ex99-3_001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 ex99-3_001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" #' :X# 2(  A$! Q$!_\0
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M445[AZ 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M:O:>,;Z"VU*XAA7;M1&P!Q7IW@76FUSPK:W$K9GC'E2GW%>0_$'_ )'C4/\
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M-3/E\PS8/[B;_OV?\*]S\!AE^'4(964A).&&#WK<L=6T34KZXLK.6VEGM_\
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M32O$=_9R+@K*67W4\@U>!>K1&.6B93M;F\MG9K.6>-R,,8<Y(]\5:_M77/\
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MO W9E/\ A7I7PQ\1)?:3_9,[_P"DVOW 3]Y/_K5T?B?PS:>)M--O/\DR<PS
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MP%9TFO:[J&J7.GZ+:VC&RVK<SSN0I<C.% K+\"::9-7OYKNY:Y.EN;.T#?\
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M<Y'O2]G&U[C]I)Z6.ATN:\?5]32XU"VGA1U\J&-<-"".C4__ (2;1?MWV/\
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FRK>Q6?P[I,DWG-8Q%\YZ<5I*BH@1%"J!@ #@444U",=D-)+8_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>42
<FILENAME>ex99-3_002.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 ex99-3_002.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1"  L R # 2(  A$! Q$!_\0
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M?]@/1O@#^QEX6GMOCW\7--\!?L)_L*?#WPO>06%_H?C3Q9X7N/"'AO6-&O\
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M[7M8L_%<=II !^W'[(WB[]L[_@JS\,-/_:ZUO]H;XG_L!_LM?%JZUN^_9>^
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M=X[_ &9V\6?&?]OW]N7XI>%?AMX,^*GQA\2^$-6^-W[3_P"V_P#&_4;KX>_
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M O!.E11V5UX[U75_"L^@6[P>)M(:?]-V4L!M*JRON! W<@D'^[RPRK]\%E#
MX8?QT?LM?LD^%_ '_!P/^T_^P#X6\7ZK:?L.>!(/"7_!8+0OV9+:"SB\$Z=^
MUG?2>"/ ?A^VN##MN(_ /@WQ3X^'QB\,^"[1+/1+3Q?X"^"TL]A=0?#K2WN
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M"!(;6TBM=1TBR@MXUBL[&RMXX[<?2GAS_@BI\4_C%JFBZC_P4W_X*:?M1_\
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MACX;^'_'6N>+O&WAG1[S2?A^\FI>(M;T^VT30_#)UWQ->:II-MIU\_B>XO\
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MU/P/\?\ P%IOA_X2?$;2O%=[;V\FD6.M:K+H^L:=XCC\'Z%^H%% 'XH>'O\
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M=?%7_A/=+\6^$?BA\&O#_P 2_"VHZEXKO[&YT_7?$7PTU2+[,VG>.+3]/J*
M/RS\+?\ !-Z3P]\3O!NH7?Q035_A!X"_;=^+7_!0;0O"DGAUK3Q9<?';XQ_#
M+QSX0\0>'=1UF#43I9\!Z3\2?BS\5?C?H\MOIT>K#6M?\*>!_(MM!\$S:KXK
M^/?!_P#P1<^+FD_#?X?_  ]UK]J+X<&'X9_L]_L#?LX:#>:7\ _$4IU3PO\
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M (:7]N__ .FAU_4-10!_+S_Q"Y_L1?\ 1#?V*?\ PTO[=_\ ]-#H_P"(7/\
M8B_Z(;^Q3_X:7]N__P"FAU_4-10!_+S_ ,0N?[$7_1#?V*?_  TO[=__ --#
MH_XA<_V(O^B&_L4_^&E_;O\ _IH=?U#44 ?R\G_@US_8BP<? W]BDG!Q_P 6
MF_;O'.#M.?\ AZ$3C=C.,$C(!!YK^@K]ESX!^%?V6_V?/A/^SYX)TKPMH?A3
MX4>$[3PIHFD^"=.\7:3X4LK2VFN+@Q:'IWCWQ]\4O&5I9&:YED6/Q'\0O%NI
..EW=Y]8GW*J>^44 ?_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>43
<FILENAME>ex99-3_003.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 ex99-3_003.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" !; 9 # 2(  A$! Q$!_\0
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MR*[AACO;>2"594@N8X;RWM+V.XM8>ZJ.-0H8A]X9V?/!QN_A!&<@=LDX&%'
M $E !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% %"X"M+L?&PE=VX@*0#&"
M,GU5FP.A(VGKBOXVO^":WPFT#]H#_@K9^W[XD^-$\UI\6+.]_:;O?A_JUPVW
M6/!OC.Z^)P^&P\6^&(/.ADMO$'P]\!ZI%IGA2:"6*;2+9OM]A)!>:>MW;?V3
MS1>8[AMY5]H VY4?+@X)R#DX/3 8<YK^:S_@IK^RGXL_9F_:7\,_\%'/V;"N
MB:M<>*=/NOBA:Q1/+::1X]N].70XO$UY80?9VN/!OQ.T<Q^%/'-DL\)NM>N%
M1YII_&!:Q^KX5Y*^)QN60KPPN-S3!+"Y;BY.:C3Q=.I]9=";A[T7BU!X=-IP
M<I1C).,Y(_GKZ1%>>1<-Y!QSB<KJY]PQP-Q"LWXWR6C[1U<5PKC<%7R7,<QH
MT85\/[6>1QS26+J0G-1C&G0KQE3M];P.A^P'K^B_#_QA\=?^"=G[3_A2Q2T^
M)OB+4WGTK4I[B6SU'QY+H^FV&H:2MZ$$CGQ1HFE>'_$/P_\ $ELT%V;_ $JP
MO+:X74-2TH6];X"^+/$W_!,G]K+Q!\ ?B1?SW/P'^)NH:7+I_B6^4&PN[+6+
MB32_!?Q*-K:HL=O/9+877A#XAP"WAB9--N;N0:C;Z/X>CN?5_P!K#X8:5^WW
M\"?!/[9_[+^F7<_QG\):?%9^)? NA:C%#XSG_L*X-]+X<MY+ P27'Q'\!Z@C
M:CX,N#)IL_B3PW>++I$EQ=2>%K1?RG_:@_X*C?#SX\?#GP)X/_:N^%OQ"TSX
MN?!S4M5L=6U_X<2^$O#TGC!;[2[?3=7L-?TOQTD6H> -1O[W3-/NM0:UT7Q?
MI]OJFFS7]OX8MX)[72[#]"I..:U<2JF&4*.<0>7\59"G1IXG*,^P=.5#!YO@
M,/.I"-.-:MAJ$E*C%TZ<$XU:FL9K^#<?A,TX$P7#N!R7-GBN(?#3,,)Q9]&#
MQ3Q2Q,^&O%/PEXOS!8G/?"SC+-X4:E#$5\LH9KF%*IALSE0JMT\QH4L%A<=4
MR]T/=/%.G2_\$V/^"U7P;\%?"F^%E\)/VDKWP1I5QX)CF+VMAX#^-WB76_ U
MUX2NXPRB:T\#?$O0(_$O@J<E9[#2K/3=%FDNE&IRZCZO_P %=_@5H_[3G_!3
M?]B+]G[Q#JUYX?TWXL? [QMX7DUS3K>WN[C1K\O\3M6T34?L5R/L^H6=IKFF
MZ;)J>G.\ U+2Q>V275K)<).GSQ_P3N^"/[2O_!2[_@H)X7_X**_M ^$-0\'?
ML_\ P8DT&\^&<=Y'JD&G>+M3\ :5<:3\*?!G@";5XEU3Q3X<\%ZW=W7Q(\=>
M/R8=*UOQRMQI^G0[-9U32/#G['_M._LC_'+XF_\ !3S]AS]I_P 'Z%H5Y\'?
M@;X8UO2/B/KE]XGTS3M6TR]O%\>I;Q:=X?NG74=7#C7].+/:!PIED#8-O('_
M #[BK$>TQ&6TZM>GB\QPN4X7#YGBJ<E4=;$PEB/9JI54I>TK4<.Z=*N^>5ZL
M9<S4N9']_P#@+E%/+\CXKQ>69=6R7A'B#C/-,^X-R?$4JM"6!RG'4,)+&RPV
M&JJFL'E^-S7ZQB\%AJ>&PM-4*L)TZ4:;A&'Y4?$;]JWXA>+/^"6?[;_[#_[4
M GTS]KC]D;3_ (5>%O$/VZ5KVX^(/PPTCXX?"+3= \?6^J+%$NMG3%U/2]/U
M+61'&=;T34O"'BUGN+SQ+J M?:/&/[?_ ,3/@Q\#/^"<O[(/P'\>_!GX(^/O
MB5^R;\*?B%X]_:%^/=YIL/@'X4>"/^$1N[328;2'5UDTB7Q1KM]X2UN. ZOI
MNK0EX]*TJTTJ:ZUX:OHOTY_P5_\ ^"8'B3]LBR\*_&;]GVQT2#]H3PY%:>!_
M%&FZEK5OX6TSXF?#"YNI+B.VU'5;F,V?]O\ @G5[D:GI!U*2W@U#0+G6-*GD
MNKJQ\-P6_C/QQ_X)H?M&+X5_83^//PD\ _ _XJ_'S]FO]G#P-\"OB[^SK\;8
M_#_B#X;_ !%T+P_H>H(MMIE_J2CPU?ZKHVK^)_$,4-W?ZQHL.Q](US1=9BNM
M"?1=<^6D[I>;;:NG9M+\/^"C]UCN_N6F^K_$O?LE?M[?M%:[^U'JO[#7Q+_:
MI_9]_:,UCXK?"SQ9XH^ 7[5_P)T;PEK%MX5\<Z9HFLZE#X9\=>$=$&G>%-0N
M-.T[PIKNN7GAV>SMM72VBT;&N7FG^)H9M#\G7_@J3_P4 G$/[!Z_"[PU'_P4
MR/Q]_P"%<7/BN;PK%)\(8_AC'9+XO_X6*--2\>W$7]C22,U^MB-(E^',$GC6
M,1^)+F+1(OLW]E'X=?M8:5\0_%?Q4^(__!,K]B#X!Z'X/^'>OW7PI\._#.3X
M<V7QZUCXIM;M'IT5C\1/#YU7PCH/A#Q!IEUJ^@>(+C5)?#=]I$=U'=V<GB.V
MFNK"Z^+(_P#@F)_P4/26'_@H!'\1/#<W_!2Z7X\2?$"3X?OXOMA\([GX3_V:
M/"*_#==8C3RC&NBJ;==*'B1_#\7POE7PBLX\61_VM(DD[W=NWK_EW8VVK65S
M[7^(GQ>^(W@?_@K3^PU^SOKB_##QS%XK_9IU;7?'/Q.U?X.^#K/XG:KXKT72
M?C<EWJ7A3Q9'#+K'@+0-4O= 6Y7PIHUZUA96NI:G9&:X_M.^GF^*OVL_VW?V
MPO@_\3/C-8/_ ,%0?V%_A_XE\#^(_%9\!?LW^&/AI/XHO-?T/19[MM&\,>-_
M$NI>$_&-QX0^)&HV%M#9WWAJY\5S06^M2Q6U[K7AZSF>YLOT!\>_LT?M"?$[
M_@I_^QE^V3-X!TOPK\-?AS^SMK/A'XIV-WXY\-:GKW@OQWKFD?&#SO#^GVUA
M-,OBRWT^]\:Z+!'KNE1G3[J$S71CB,,UJGYN?"#]@W_@H=^S_P#"GX_?LF>$
M?V3OV3_B4WQ.UKQ]>:;^VA\0O&'AB>_?1O$N@OIR"?0KJTU+X@3>)5CMYY/"
MT%YH=AI/AGQ=K5]J&JQZS81W_B'5TDFGK9K9::_?V\M0;::LM_7]#]\?V"/V
MD-4_:Z_9'^#7[1&O>'K'PKXA^(>CZ[_PD>A:5)>/I%GXB\(>,/$/@/79-'&H
M7%W?PZ3?ZKX7N]1TRUOKN\O;2QNX+:[N[JXBDN)/K^O@G_@F)\"/B3^S+^P[
M\$O@?\7=+LM&^(7@?_A9"Z_INGZU8^(;.W3Q)\7/'OB_1C%K.G22V=ZTV@Z_
MI<]PT4CF&YDFMI&:2%F/WM2*"BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MA05/.MK?8D1*%"L2Q[   B@ ;%P/E554*B*=J@ **^%_C%X=^+^J?M):7%X
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M?B&W\1/K'Q%\5?$31]$UB_B^'7A#^Q_"&M:!XE\4ZAJ]I87-A^O9MXSR2Q(
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MXHT33OBMX:UW0(_$_C+4[GP;9R^+?&5MINJ:;X;U/5@#^F=75\[<\'!R".<
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M]'T[7X_A[HFAWL4OA34O$FB:U]4^'OVCM<_:*_:8_9:T!/CS\=OV?=&_:O\
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M^$L_[0?B/XI?\))X?\-^&/$GB+P-X)\/_"+X!W?Q#T'Q%'9^);CQ1JOB[2?
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M)82?$GP_\<M2=;3_ (EG@K1O&NCR227^AZ3?^) #]HZ8[JF-V>>F 3W [>Y
MK\EM4_X*C6NG>-?&OA&S^"/B;Q5<_#J^A\.^,;?P=XB;5]2TWQ;K7[/GQ0_:
M?\,0F*Y\)Z?IFG^"+CX4^#?AJ_B+X@^*-7\.Z+X9\5_'?PIX8N1=2^']3O\
M4/L']DGXZ>.OVF/@KX9^,OC+X/WGP8TWXAV>A^+?AUHES\0-"\>7?B/X5>,_
M!_A?QCX.\<3W_AW3M%F\-:GJMGXDNM'U+PEJ=L-5\/ZOH5_(E_J6GRZ7J-Z
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M+0?<OBC^R7:_%KXLW_C[Q3\0O%%SX&\1>'?V>M)\7_!.XL] OO >IZY^R_\
M'3Q1^T!\*O&6@7EYI\VL^%?$%UXS\4R:=\1GC.JVWC/PMX<\&:?8Q^&=4T'^
MU[C[%HH _(_X>_\ !(SX,^%/A'\0_@OXJ^*OQE^)G@OXD_L1^%OV M:35V^&
MOA^^TWX&?#KQ/\9O$'PRU+PS?>$/AYHUWIOQ,\$V_P </$^F)XMU*]URSUQM
M(\,ZY?Z#'K-C?WFL>IWG[(NMZ%\1/A+^T=XR_:Z^(MM\9OAYX%\3?!?XF_%.
M\\-_"#PKX>^,/PA\=>)O >N#P7KWA+_A&(/"O@'7=*\;>"?#^I>!_&7A:2TU
M72M5\8?$O3[>SN;;QSHUCX<\6_X*T?##PU?>&_V8_BM?0ZA/XLT_]M+]A/X,
M6J_VQJ$&C-\/?BY^V[\ %^)^A7>EVDL,%[;^.]+T6P\,^)1?>?'J/A8ZAH,D
M8TW5]5M[S\\_CC\2OBQ\0OV(?$'PTTCX-'3_ -C/X2_&OP!\ OA[\0?$EWX6
MOM<\/>)?V+?^"J_[*G[+_P (]/U&:]^).M_$#QIXO^*>D>#?B_\ $?Q;XFOO
MA;X-T3P7=>#?#.CVFK7FM:W<:IKH!^T/[+_[,7C;]EO5]*^'_A?XN>-/%?[/
M/A[P1\4'T[P1XQT3X>0QZ;X\^(GQ_P#%7Q8T:XT+6O#.@:/XPN3X/\)^*=6\
M!:Q_PDEQ=Z?K.EV_@K5K5Y/%#>+)GS_A_P#L<> /AYI_Q ^$%I\9/&?BGP[\
M9_CS\?OVE_C9\+?&-O\ "75!\4?#7[26C^.O#GQ'^%NKZ58>!])UC3?@BOC+
MQM9^)]'OM*6U\:0Z[X3T?P[K'C_5] OM>TC5OB.S_P""@W[8GB[X?GXV>#?@
M]X)T3X)^-/VA=$^$'A'XE^.]'TW5O#WAQ]8_X*D^"/V#=+\,77A#PQ^T%I'Q
M0\4^,O$?P@U[Q)\:+^^U?PMX&\*^"?&_AYO!EQ>:Q;:U#:6'R;X2_:X_: N/
MVG_A]^T??:+\"K3XKMX!^#'['/[0)LO OBX^'O'NC:-_P6^\:?\ !/\ \2ZW
M\, /B/;:Q\/!?RZSK_Q@\&0^,=8^+%EX/O+J/PI<Z?XCCO\ 5M=< _7SX??\
M$_K;X<0V^L:%\??BP?B?X,_9E\,_L@?!+XNW=CX U+QE\(_@=X4\16'B=5M]
M/UWPOK7A+QE\3/'%_H?A&U^*'COQ%H?V'Q;8_#_P&]AX5\-ZKI6LZKXB[S]I
M7]C#3OVD/B/\.OBC+\:?B]\(_%/PQ^&'QZ^%'AJZ^%L?PJ?;H?[1VF>$-%\?
M:S</\1_AE\0'C\3Z5I_@?P_+X)U"Q^S:=HNIPW-WK&C>)K:8V#?E?=_\%:/V
M@Y?A_P"&/'>B>$?A/$/C[\&?$W[0'P-L-?T?QG<Q^ /"/@S_ (*$_!']DG4O
M"WQ/M]/\9Z1J7B;7->^$O[0OPW\:V@LI?!]UX<^+.A_$/2[XZAX5GTK0M [W
MX=?\%#OVS_B1XST[X._#SX-^%/C-\6OAO9?%C7OBR_@ZRT;X<>&/'?AOP%_P
M4V^*?[#>F7^@VOQ2^-]K%\/XQ\'?@'\8/B]XKMM/\4_$C6;/Q]_P@MGHMC=Z
M$E[X.\> 'TMX3_X)A_ ;X*WG@FU^&7BWQ1\+?A]\-_B#X6^*7PD\"V/_  BF
MJZ=X#^/OA_\ 8XLOV /A_P"/M&U+QAI>K2ZU/HWP)M=-&E^!/$-KK>CZU\7P
MGQ%U?^UK^_ET*3Z4_9Q^ W@/]GB'XR_#GX7?$;7=2A\6?$?5_BU<^";Z?PQ?
MZ=\&O$GQ*T?3IO$,/@_1-'TFPGT70O'OBNQU7XPZEH_BJXU6;5/B'XU\<^*;
M:Y@T7Q%!I6F^ ?M&_&#7/"O[8&@VTFAW?BOPM\!/V"/VJ?VM/#/@^V\^0^.O
MBYX>\5_#CP'X>N[(B14FUOPAX$U+QWX4TV)W2!4^-E]<F&>ZCT^ZTS\L_@Q^
MT%XPUV[_ ."7/[$WQ(T6SU6S^/6L?LF?M2_&KXGZ?X@O/$VD?M0^&/VC?V,_
MV_\ X\>*+?XNZ=J7A[0TTWQ-K'[5_P"RY9^*-4\+17?BGP=KG@*\\)>'[>:+
M3K'4?#T !^E-I_P2\^"WAC]GKX6_ %?BY\6%M/AQX7_:3^$/ACXF^(]1^'=I
M\3M5^''[8:ZI_P +M^'-[+X>\#^%O!SWNMWUWI^N>#=:T;P;:ZQX=\0>"O!M
M_)9^(;'3-<T_Q-]&:)^SO>^*/B/\'/'_ (VU7X9:C\.?V9O%OBGQ;^R/X9^%
MOAK6-!BT'P_XO^",/P8\-W/C/5=7\4^*['Q#K/A3P/XP^,'A[3=2\'CP]X8\
M0Z)XY\.7LF@Z5>^%3/JOX[?LS?MW_$*W^&/_  2.T+Q[<^,_&&I>,OB9X7^!
M^M>,/&7PE^.GCL>.K36?AW^T_I.A?%JR^*V@Z-/X-UWXA#PK\)OA]9_VY>^*
M_%431_%'XO\ B/QOX=AN?#5MXI\-?I[\ ?B=JO@+1O\ @I'H]OH]]XE\,_LF
M?M-?$*T^&OA;2@@N]2\.Z[^R7^SK^UOJ/@G0FE*P)9VGQ&^.7C?PAX?L42*R
MTBQM--T6TCL[/3(+>, [+XB_LSVWQ3\ >"O@GX/_ &J/C'\$?&?P?\6#XDZ]
MXV^ <7P+D^(&L>*?&&E>-UN]0\8:9\8_A#\;?#>DV7B?5?&OB/QI''9^'=+U
MY=9_LW5=-UQ!9Q7-SZ)\'?A'\1_AE#XZ\!2?%'QGK_PMT_P#\(/AU\%D\5:5
MX'U#Q/X+E\#?#"#P=XM\30ZIH^AVR>([;Q1?0:#XBN(O'=I<7J^/+3QL+2QM
M_!-YX;T]?Y\/#W[1WQTG_9M_9+^!?A;P1X(^,/[3?C3P/^PK^W_X4\!:O\0=
M1TSPO_P4SUG]I+P5^T+\0OV@/@U\3?%&L>&]-T?X1>-?#]S\'_B;\?O!VO>*
M9O&OPFTBW\!_!KPSJ45[IFB7/A6\^IO@!^R/^Q7^U+\+_P#@G5^TKJWP\\:^
M//CN;GX?>']-\;_%76?B9X1^*'PWL?V5_&WC_P"(OB/X<>-OAK8^/;KPQ#'\
M&_BKX6U+X#:C:^);;QLL4=YI6@ZIXG\4RRZ1JUP ?7_C[_@EQ\//&_['W[-'
M[%,/QS^._AKX0_LS>#;SX8V.JZ//\-YO&GQ)^%MY^SE\3?V9H?#/Q!FN_A_+
MX3;5=-\!?$F;4]*\7:'X2TJ^TKQ;HFG>*-)MM+\06UIJ&GU9/^"7MAJOP[_:
M=^$6K?M._'%OA;^V)X FT3X]^&=(\.?!70;O7?B?XC^!'A7]G'XE_&+PKJJ?
M#.Z3PMJ'Q"^'G@S0-;U#P)'IFI>!]'^)D5YXYTO3I1?7NB7?YP?M[_MC>(?&
M_B?]J+XL_"1OBKI&C_LN?\$Y?A?^TC^SUI?CWX6?&7]G[Q;>_'O4?VS?%^E^
M,+\?#3XU^$OAWX]CEO-*^!GPY\ 6^LW?A2"RUKP?\1_&?ABQU74/#OC+7;2\
M[SX=?$[XV_L]_M4>#H_%V@_$ZS^*NM_"'_@I^/V@=.N_!/Q0\:Z%\1V\.?MY
M?L_VO[''QXL_#?@:Q\0:U\2/!GACP'^T%!'HFM>#+/7;[X>?![Q3XN^&-RFC
M:M\.M1\*>% #[<\?_P#!*KX!?'/Q/\9_$OQ ^)?Q1\9:=\;]=_:2F^)GAC3;
MSX?6&A3:A^TC^S)\+/V0OB3H.F7.F^"'UKP];>%/ /P1\%ZKX,+:Y/XC\/?$
M2/Q#J7B'6]<LKFPT#1_I+6_V2(OBY^RGXZ_9=_:9^+OQ _:!MOB5X=?0?%/Q
M.U+3? _P]\=VMS90Z0GA?Q7X0L? _AO3_#'A?Q9X2UOP[H7Q"TC5DT>_BA^)
M45YXD2QMM)EL_"NF_D_HGP,_94_X*A_L5^'?%?Q_^$H\<^.O!/Q__:I_8^^$
MVOS)^T1\&-;L;"Y_:M\6?">/QW>:7>^)O!FL>*?'.L?#[POH7Q@^*.MZA:7>
MG3?$6P\96K:?X7U#3=?\'Z/^D'_!6.QMK;_@EI_P4/%M#':_V-^Q%^TQJ^B-
M9@V3Z/JOACX.>*]9\-ZCI;VAADL+W0-6TS3=1TBZM&BFL+VPM;FV>*2"(H 9
MMG^P#KT/Q[MOVHU_:?\ BG:?'?49?&'AGX@>(=*\*?#ZP\+>*?@MXU\)_ GP
MY?\ PBT'PCJ6B:V? \6EZU^SIX&^)'A_QSI^LZMXDT7QYXN^,=Q9,OAGQY8>
M$O"?FGBK_@DI\.-:TW5[?3OCS\;]!\07ESXKUSP_K]OI_P '-0?PQXO\6_\
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M4+K4_AW\4_BEX?O)3KVL^&O&7A+C-1_X).?";7]6_:)N?%'Q4^+FM^&_C_\
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M+0]-A\$1>&?%8UKQ7XA]&\(?L#S?#/4;.V^$7[0/Q-^%?@+PSXI^,_C+X=>
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M !%<:CXX\0^)=7N&\1ZM\2?&WB.[TW^T8]+C\2^(;_7(+1+^1II.X^,WP?\
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MP1<^)7O$\,>*KZXFT:"RTYETY/L"B@#X'3_@F=^QS'HB>'5^%>K-I,7@_2/
M<5N?C+\>%<>%] ^.<G[2VC6+7O\ PLQ]0>[L/CC/<>/8=<FO)_$!N)/[#?5&
M\+JFAI][KD* QRP !/J>YZ#KUZ"EHH **** "BBB@ HHHH **** "BBB@ HH
%HH __]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>44
<FILENAME>ex99-8_001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 ex99-8_001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1"  J R # 2(  A$! Q$!_\0
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ME>.])UKPKX[T.Q\5^%M9TI]-\2KX7M?#-]?ZY;WE]XANM0UFXO+Z7\/?C?\
M"O\ X*'>'E_X+7?\$:]=_:I^-G[>7PO\/_\ !/+0_P!KOX)_$3XJ0W'BSXU^
M$?$6@>// /B^#X%:CKULVO\ B'7=8^*?A+1/%>@:5H$^J-IVN7/AC3M4\&^%
M_"DOB7Q#8S '[F?L7_!W]H/_ (*D? SP7^VY^VG\<_V@OA'X$_:#TZ+XC?L^
M?L;_ +-'Q@\6?L_>"?A5\#]::ZF^&>L?$'XF?"NY\,_%SXL_$CQSX5DTGQS?
M:O+XT\.^#K'3]:TS2]/\%6TUO>32?,/_  4?TC]K'_@B!X TG]OC]E#]HO\
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M5ZSIOA[PWX<T#2+2?4-7UO6M:U:YM+#3=+TO3[:>_O[R\GA@MK2&6:215C;
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M#\7OVDOV_/\ @L'^SY\6/VZ_V]]9^%G[&OQH^%/@7X(Z+I/[1-UX=N=,\/\
MQ1T/XB>(-3AU[6M.\.+K>O7V@G0M+L/#MY-?PB*QM'.JPZE>W+W5>X?\$^/C
M1^UI\$/^"U'[8/\ P2[\=?'SXG_M:?LR?#O]FSPI^T/\-_B)\:4TC6_BG\']
M6\2:AX!32_AIXE\>Z'HFCCQ-'K&G>,];:SN?$2?VK?VOAJQU*TBA:360?-_^
M"<'PNN/C-_P4M_X.,/ =C\5OBY\&+Y_VK_V3-;MO'?P3\1Z5X4\<V;:;X(^+
M+R6,.I:]X;\7:)<:5J*,UKJ6G:GX?OX;J!Q)&L-S'#<P?H5\</!'P8_X(_\
M[(7[2'QD_9G\!ZQXZ_:S^.VN>%/!7@?Q+\3_ !AK?Q>^.7[67[9/Q<U6Q^%'
M[.^@^._&?Q \567B/QC9CQ]XCT:\U#PCHVNZ'H/A7P%I_BZ_\,Z+HMC9W)0
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MPZ+^*RBOX2]A'?ZC<Z9<07-S'<1?.7[#'[%OP1_X*#?\$+_ W[,OQZT:#7/
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MG_YIZ/\ AY7_ ,$\O^CYOV1?_$B?A3_\T] 'VY17Q'_P\K_X)Y?]'S?LB_\
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MZ[??!K3?!EUH]A8>-X+35_BI\/\ 4&U6XN[R[TV  _=RC(_G^AP:_#7XQ_\
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M\&Z]:>)]"\$:G/;: VCZ?81ZYH_AN^OM7TK3K;5]1&AI:W$YMK_4(KC].:*
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M5TRPB \C3+CQ%812P^(=)A=4,&F^);'5K>TB1H;'[(D\XD_4^B@#^6[X6_\
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MXR\7:MK<_P#;,=PVFB2.PTYXK**.%/(/^"H7_!)3]FW_ (*I?#WP/X4^,O\
M;7@GQU\*/%%EXL^$_P 9_ L.D_\ "<^#+G[5;R:WX?:+5K2YT_6_"/B**UMF
MU70=00PKJ%GIVJV,EK?69>;]3J* (E1@) >0SEE 8]R&(W8R 6R/8=,9P/QM
M^(W_  2&F^(W[:'AK]OFZ_;2_:+T3]HKP!X8USX>?#?5=(TSX9)X2\'?"[Q
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M .(1_"K_ .:"OWRHH _ W_B'Z_9$_P"B;?LE_P#B$?PJ_P#F@H_XA^OV1/\
MHFW[)?\ XA'\*O\ YH*_?*B@#\#?^(?K]D3_ *)M^R7_ .(1_"K_ .:"C_B'
MZ_9$_P"B;?LE_P#B$?PJ_P#F@K]\J* /P-_XA^OV1/\ HFW[)?\ XA'\*O\
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"_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>45
<FILENAME>ex99-8_002.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 ex99-8_002.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" !: 9 # 2(  A$! Q$!_\0
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M&VE^%-6M?$/P^\(236^M^-/#WB:RU_Q3X>T76_"NG7EK9+K_ .TQAC*[2IP
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MUC0_&_Q]\*_#+2OAM;-_PG?C/QCI7B%/"6D:KI%G:ZI> '[#T5^0MW_P5O\
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M^+=%\%:E;VFAS7OC#3P#]3J*_G$_:J_X*!>)K#_A+]'U&\_:JD^%'@OXA_\
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M*-,\=1:U-JEEXOO+GXH>*K!9H=)33K/3DT-K.SAU73+C5=1_0>B@#\D?#O\
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M/&>J6/A[6] \":M<_I]10!\+>&?^"<?[*?@C3="LO!/A+Q9X4O?"&D_!+1?
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<% !1110 4444 %%%% !1110 4444 %%%% '_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>46
<FILENAME>cve-20221231.xsd
<DESCRIPTION>XBRL SCHEMA FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!-- Generated by CompSci Transform (tm) - http://www.compsciresources.com -->
<!-- Created: Fri Apr 28 19:14:45 UTC 2023 -->
<xs:schema elementFormDefault="qualified" xmlns:srt-types="http://fasb.org/srt-types/2022" targetNamespace="http://encoreuranium.com/20221231" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:us-types="http://fasb.org/us-types/2022" xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:cve="http://encoreuranium.com/20221231" xmlns:dtr="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:xbrli="http://www.xbrl.org/2003/instance">
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xlink:type="simple" xlink:href="cve-20221231_lab.xml" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef"/>
      <link:linkbaseRef xlink:type="simple" xlink:href="cve-20221231_pre.xml" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef"/>
      <link:linkbaseRef xlink:type="simple" xlink:href="cve-20221231_def.xml" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef"/>
      <link:linkbaseRef xlink:type="simple" xlink:href="cve-20221231_cal.xml" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef"/>
      <link:roleType roleURI="http://encoreuranium.com/role/ConsolidatedBalanceSheet" id="cve_r_ConsolidatedBalanceSheet">
        <link:definition>001 - Statement - Consolidated Statements of Financial Position</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://encoreuranium.com/role/ConsolidatedComprehensiveIncome" id="cve_r_ConsolidatedComprehensiveIncome">
        <link:definition>002 - Statement - Consolidated Statements of Loss and Comprehensive Loss</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://encoreuranium.com/role/ConsolidatedComprehensiveIncome_Parentheticals" id="cve_r_ConsolidatedComprehensiveIncome_Parentheticals">
        <link:definition>003 - Statement - Consolidated Statements of Loss and Comprehensive Loss (Parentheticals)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://encoreuranium.com/role/ConsolidatedCashFlow" id="cve_r_ConsolidatedCashFlow">
        <link:definition>004 - Statement - Consolidated Statements of Cash Flows</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://encoreuranium.com/role/ShareholdersEquityType2or3" id="cve_r_ShareholdersEquityType2or3">
        <link:definition>005 - Statement - Consolidated Statements of Changes in Shareholder&#8217;s Equity</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://encoreuranium.com/role/NatureofOperationsandGoingConcern" id="cve_r_NatureofOperationsandGoingConcern">
        <link:definition>006 - Disclosure - Nature of Operations and Going Concern</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://encoreuranium.com/role/Significantaccountingpolicies" id="cve_r_Significantaccountingpolicies">
        <link:definition>007 - Disclosure - Significant accounting policies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://encoreuranium.com/role/CriticalAccountingEstimatesAndJudgements" id="cve_r_CriticalAccountingEstimatesAndJudgements">
        <link:definition>008 - Disclosure - Critical Accounting Estimates And Judgements</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://encoreuranium.com/role/InvestmentInAssociate" id="cve_r_InvestmentInAssociate">
        <link:definition>009 - Disclosure - Investment In Associate</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://encoreuranium.com/role/Investmentinuranium" id="cve_r_Investmentinuranium">
        <link:definition>010 - Disclosure - Investment in uranium</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://encoreuranium.com/role/MarketableSecurities" id="cve_r_MarketableSecurities">
        <link:definition>011 - Disclosure - Marketable Securities</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://encoreuranium.com/role/Intangibleassets" id="cve_r_Intangibleassets">
        <link:definition>012 - Disclosure - Intangible assets</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://encoreuranium.com/role/Propertyplantandequipment" id="cve_r_Propertyplantandequipment">
        <link:definition>013 - Disclosure - Property, plant, and equipment</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://encoreuranium.com/role/Rightofuseassets" id="cve_r_Rightofuseassets">
        <link:definition>014 - Disclosure - Right-of-use assets</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://encoreuranium.com/role/Assetacquisition" id="cve_r_Assetacquisition">
        <link:definition>015 - Disclosure - Asset acquisition</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://encoreuranium.com/role/MineralProperties" id="cve_r_MineralProperties">
        <link:definition>016 - Disclosure - Mineral Properties</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://encoreuranium.com/role/Assetretirementobligations" id="cve_r_Assetretirementobligations">
        <link:definition>017 - Disclosure - Asset retirement obligations</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://encoreuranium.com/role/Salescontracts" id="cve_r_Salescontracts">
        <link:definition>018 - Disclosure - Sales contracts</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://encoreuranium.com/role/ShareCapital" id="cve_r_ShareCapital">
        <link:definition>019 - Disclosure - Share Capital</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://encoreuranium.com/role/Relatedpartytransactionsandbalances" id="cve_r_Relatedpartytransactionsandbalances">
        <link:definition>020 - Disclosure - Related party transactions and balances</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://encoreuranium.com/role/Managementofcapital" id="cve_r_Managementofcapital">
        <link:definition>021 - Disclosure - Management of capital</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://encoreuranium.com/role/FinancialInstruments" id="cve_r_FinancialInstruments">
        <link:definition>022 - Disclosure - Financial Instruments</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://encoreuranium.com/role/Segmentedinformation" id="cve_r_Segmentedinformation">
        <link:definition>023 - Disclosure - Segmented information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://encoreuranium.com/role/Supplementaldisclosurewithrespecttocashflows" id="cve_r_Supplementaldisclosurewithrespecttocashflows">
        <link:definition>024 - Disclosure - Supplemental disclosure with respect to cash flows</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://encoreuranium.com/role/Incometaxes" id="cve_r_Incometaxes">
        <link:definition>025 - Disclosure - Income taxes</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://encoreuranium.com/role/ChangeinPresentationCurrency" id="cve_r_ChangeinPresentationCurrency">
        <link:definition>026 - Disclosure - Change in Presentation Currency</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://encoreuranium.com/role/Eventsafterthereportingperiod" id="cve_r_Eventsafterthereportingperiod">
        <link:definition>027 - Disclosure - Events after the reporting period</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://encoreuranium.com/role/AccountingPoliciesByPolicy" id="cve_r_AccountingPoliciesByPolicy">
        <link:definition>028 - Disclosure - Accounting Policies, by Policy (Policies)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://encoreuranium.com/role/SignificantaccountingpoliciesTables" id="cve_r_SignificantaccountingpoliciesTables">
        <link:definition>029 - Disclosure - Significant accounting policies (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://encoreuranium.com/role/InvestmentInAssociateTables" id="cve_r_InvestmentInAssociateTables">
        <link:definition>030 - Disclosure - Investment In Associate (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://encoreuranium.com/role/InvestmentinuraniumTables" id="cve_r_InvestmentinuraniumTables">
        <link:definition>031 - Disclosure - Investment in uranium (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://encoreuranium.com/role/MarketableSecuritiesTables" id="cve_r_MarketableSecuritiesTables">
        <link:definition>032 - Disclosure - Marketable Securities (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://encoreuranium.com/role/IntangibleassetsTables" id="cve_r_IntangibleassetsTables">
        <link:definition>033 - Disclosure - Intangible assets (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://encoreuranium.com/role/PropertyplantandequipmentTables" id="cve_r_PropertyplantandequipmentTables">
        <link:definition>034 - Disclosure - Property, plant, and equipment (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://encoreuranium.com/role/RightofuseassetsTables" id="cve_r_RightofuseassetsTables">
        <link:definition>035 - Disclosure - Right-of-use assets (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://encoreuranium.com/role/AssetacquisitionTables" id="cve_r_AssetacquisitionTables">
        <link:definition>036 - Disclosure - Asset acquisition (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://encoreuranium.com/role/MineralPropertiesTables" id="cve_r_MineralPropertiesTables">
        <link:definition>037 - Disclosure - Mineral Properties (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://encoreuranium.com/role/AssetretirementobligationsTables" id="cve_r_AssetretirementobligationsTables">
        <link:definition>038 - Disclosure - Asset retirement obligations (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://encoreuranium.com/role/SalescontractsTables" id="cve_r_SalescontractsTables">
        <link:definition>039 - Disclosure - Sales contracts (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://encoreuranium.com/role/ShareCapitalTables" id="cve_r_ShareCapitalTables">
        <link:definition>040 - Disclosure - Share Capital (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://encoreuranium.com/role/RelatedpartytransactionsandbalancesTables" id="cve_r_RelatedpartytransactionsandbalancesTables">
        <link:definition>041 - Disclosure - Related party transactions and balances (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://encoreuranium.com/role/FinancialInstrumentsTables" id="cve_r_FinancialInstrumentsTables">
        <link:definition>042 - Disclosure - Financial Instruments (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://encoreuranium.com/role/SegmentedinformationTables" id="cve_r_SegmentedinformationTables">
        <link:definition>043 - Disclosure - Segmented information (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://encoreuranium.com/role/SupplementaldisclosurewithrespecttocashflowsTables" id="cve_r_SupplementaldisclosurewithrespecttocashflowsTables">
        <link:definition>044 - Disclosure - Supplemental disclosure with respect to cash flows (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://encoreuranium.com/role/IncometaxesTables" id="cve_r_IncometaxesTables">
        <link:definition>045 - Disclosure - Income taxes (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://encoreuranium.com/role/ChangeinPresentationCurrencyTables" id="cve_r_ChangeinPresentationCurrencyTables">
        <link:definition>046 - Disclosure - Change in Presentation Currency (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://encoreuranium.com/role/NatureofOperationsandGoingConcernDetails" id="cve_r_NatureofOperationsandGoingConcernDetails">
        <link:definition>047 - Disclosure - Nature of Operations and Going Concern (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://encoreuranium.com/role/SignificantaccountingpoliciesDetails" id="cve_r_SignificantaccountingpoliciesDetails">
        <link:definition>048 - Disclosure - Significant accounting policies (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://encoreuranium.com/role/ScheduleofexchangeratesTable" id="cve_r_ScheduleofexchangeratesTable">
        <link:definition>049 - Disclosure - Significant accounting policies (Details) - Schedule of exchange rates</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://encoreuranium.com/role/ScheduleofsignificantsubsidiariesTable" id="cve_r_ScheduleofsignificantsubsidiariesTable">
        <link:definition>050 - Disclosure - Significant accounting policies (Details) - Schedule of significant subsidiaries</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://encoreuranium.com/role/ScheduleofusefullivesofpropertyplantandequipementTable" id="cve_r_ScheduleofusefullivesofpropertyplantandequipementTable">
        <link:definition>051 - Disclosure - Significant accounting policies (Details) - Schedule of useful lives of property, plant and equipement</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://encoreuranium.com/role/ScheduleofusefullivesofintangibleassetsTable" id="cve_r_ScheduleofusefullivesofintangibleassetsTable">
        <link:definition>052 - Disclosure - Significant accounting policies (Details) - Schedule of useful lives of intangible assets</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://encoreuranium.com/role/InvestmentInAssociateDetails" id="cve_r_InvestmentInAssociateDetails">
        <link:definition>053 - Disclosure - Investment In Associate (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://encoreuranium.com/role/ScheduleofproportionalshareintheassociateTable" id="cve_r_ScheduleofproportionalshareintheassociateTable">
        <link:definition>054 - Disclosure - Investment In Associate (Details) - Schedule of proportional share in the associate</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://encoreuranium.com/role/ScheduleofinvestmentinassociatecontinuityTable" id="cve_r_ScheduleofinvestmentinassociatecontinuityTable">
        <link:definition>055 - Disclosure - Investment In Associate (Details) - Schedule of investment in associate continuity</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://encoreuranium.com/role/InvestmentinuraniumDetails" id="cve_r_InvestmentinuraniumDetails">
        <link:definition>056 - Disclosure - Investment in uranium (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://encoreuranium.com/role/ScheduleofthefairvalueofthephysicaluraniuminvestmentTable" id="cve_r_ScheduleofthefairvalueofthephysicaluraniuminvestmentTable">
        <link:definition>057 - Disclosure - Investment in uranium (Details) - Schedule of the fair value of the physical uranium investment</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://encoreuranium.com/role/ScheduleofuraniumconcentratespurchaseagreementTable" id="cve_r_ScheduleofuraniumconcentratespurchaseagreementTable">
        <link:definition>058 - Disclosure - Investment in uranium (Details) - Schedule of uranium concentrates purchase agreement</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://encoreuranium.com/role/MarketableSecuritiesDetails" id="cve_r_MarketableSecuritiesDetails">
        <link:definition>059 - Disclosure - Marketable Securities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://encoreuranium.com/role/ScheduleofmarketablesecuritiesTable" id="cve_r_ScheduleofmarketablesecuritiesTable">
        <link:definition>060 - Disclosure - Marketable Securities (Details) - Schedule of marketable securities</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://encoreuranium.com/role/IntangibleassetsDetails" id="cve_r_IntangibleassetsDetails">
        <link:definition>061 - Disclosure - Intangible assets (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://encoreuranium.com/role/ScheduleofintangibleassetwasdeterminedTable" id="cve_r_ScheduleofintangibleassetwasdeterminedTable">
        <link:definition>062 - Disclosure - Intangible assets (Details) - Schedule of intangible asset was determined</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://encoreuranium.com/role/ScheduleofpropertyplantandequipmentTable" id="cve_r_ScheduleofpropertyplantandequipmentTable">
        <link:definition>063 - Disclosure - Property, plant, and equipment (Details) - Schedule of property, plant, and equipment</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://encoreuranium.com/role/RightofuseassetsDetails" id="cve_r_RightofuseassetsDetails">
        <link:definition>064 - Disclosure - Right-of-use assets (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://encoreuranium.com/role/ScheduleofchangeintheROUassetsTable" id="cve_r_ScheduleofchangeintheROUassetsTable">
        <link:definition>065 - Disclosure - Right-of-use assets (Details) - Schedule of change in the ROU assets</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://encoreuranium.com/role/ScheduleofchangeinthelongTermleaseliabilityTable" id="cve_r_ScheduleofchangeinthelongTermleaseliabilityTable">
        <link:definition>066 - Disclosure - Right-of-use assets (Details) - Schedule of change in the long-Term lease liability</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://encoreuranium.com/role/ScheduleofundiscountedfutureleasepaymentsTable" id="cve_r_ScheduleofundiscountedfutureleasepaymentsTable">
        <link:definition>067 - Disclosure - Right-of-use assets (Details) - Schedule of undiscounted future lease payments</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://encoreuranium.com/role/AssetacquisitionDetails" id="cve_r_AssetacquisitionDetails">
        <link:definition>068 - Disclosure - Asset acquisition (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://encoreuranium.com/role/ScheduleofestimatedfairvalueofassetsandliabilitiesTable" id="cve_r_ScheduleofestimatedfairvalueofassetsandliabilitiesTable">
        <link:definition>069 - Disclosure - Asset acquisition (Details) - Schedule of estimated fair value of assets and liabilities</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://encoreuranium.com/role/ScheduleofnetassetsacquiredTable" id="cve_r_ScheduleofnetassetsacquiredTable">
        <link:definition>070 - Disclosure - Asset acquisition (Details) - Schedule of net assets acquired</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://encoreuranium.com/role/ScheduleofweightedaverageassumptionsusedintheblackscholesoptionTable" id="cve_r_ScheduleofweightedaverageassumptionsusedintheblackscholesoptionTable">
        <link:definition>071 - Disclosure - Asset acquisition (Details) - Schedule of weighted average assumptions used in the black-scholes option</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://encoreuranium.com/role/MineralPropertiesDetails" id="cve_r_MineralPropertiesDetails">
        <link:definition>072 - Disclosure - Mineral Properties (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://encoreuranium.com/role/ScheduleofmineralpropertiesTable" id="cve_r_ScheduleofmineralpropertiesTable">
        <link:definition>073 - Disclosure - Mineral Properties (Details) - Schedule of mineral properties</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://encoreuranium.com/role/AssetretirementobligationsDetails" id="cve_r_AssetretirementobligationsDetails">
        <link:definition>074 - Disclosure - Asset retirement obligations (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://encoreuranium.com/role/ScheduleofassetretirementobligationsbalanceTable" id="cve_r_ScheduleofassetretirementobligationsbalanceTable">
        <link:definition>075 - Disclosure - Asset retirement obligations (Details) - Schedule of asset retirement obligations balance</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://encoreuranium.com/role/ScheduleofassetretirementobligationscontinuityTable" id="cve_r_ScheduleofassetretirementobligationscontinuityTable">
        <link:definition>076 - Disclosure - Asset retirement obligations (Details) - Schedule of asset retirement obligations continuity</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://encoreuranium.com/role/SalescontractsDetails" id="cve_r_SalescontractsDetails">
        <link:definition>077 - Disclosure - Sales contracts (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://encoreuranium.com/role/ScheduleofuraniumsalescontractsoverthenextfiveyearsTable" id="cve_r_ScheduleofuraniumsalescontractsoverthenextfiveyearsTable">
        <link:definition>078 - Disclosure - Sales contracts (Details) - Schedule of uranium sales contracts over the next five years</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://encoreuranium.com/role/ShareCapitalDetails" id="cve_r_ShareCapitalDetails">
        <link:definition>079 - Disclosure - Share Capital (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://encoreuranium.com/role/ScheduleofthecompanysstockoptionsoutstandingTable" id="cve_r_ScheduleofthecompanysstockoptionsoutstandingTable">
        <link:definition>080 - Disclosure - Share Capital (Details) - Schedule of the company&#8217;s stock options outstanding</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://encoreuranium.com/role/ScheduleofstockoptionsoutstandingTable" id="cve_r_ScheduleofstockoptionsoutstandingTable">
        <link:definition>081 - Disclosure - Share Capital (Details) - Schedule of stock options outstanding</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://encoreuranium.com/role/ScheduleofweightedaverageassumptionsusedincalculatingthefairvaluesTable" id="cve_r_ScheduleofweightedaverageassumptionsusedincalculatingthefairvaluesTable">
        <link:definition>082 - Disclosure - Share Capital (Details) - Schedule of weighted average assumptions used in calculating the fair values</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://encoreuranium.com/role/ScheduleofthestatusofthecompanyswarrantsTable" id="cve_r_ScheduleofthestatusofthecompanyswarrantsTable">
        <link:definition>083 - Disclosure - Share Capital (Details) - Schedule of the status of the company&#8217;s warrants</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://encoreuranium.com/role/ScheduleofsharepurchasewarrantsoutstandingTable" id="cve_r_ScheduleofsharepurchasewarrantsoutstandingTable">
        <link:definition>084 - Disclosure - Share Capital (Details) - Schedule of share purchase warrants outstanding</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://encoreuranium.com/role/RelatedpartytransactionsandbalancesDetails" id="cve_r_RelatedpartytransactionsandbalancesDetails">
        <link:definition>085 - Disclosure - Related party transactions and balances (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://encoreuranium.com/role/ScheduleofamountspaidtokeymanagementorentitiesprovidingsimilarservicesTable" id="cve_r_ScheduleofamountspaidtokeymanagementorentitiesprovidingsimilarservicesTable">
        <link:definition>086 - Disclosure - Related party transactions and balances (Details) - Schedule of amounts paid to key management or entities providing similar services</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://encoreuranium.com/role/ScheduleofowingtorelatedpartiesTable" id="cve_r_ScheduleofowingtorelatedpartiesTable">
        <link:definition>087 - Disclosure - Related party transactions and balances (Details) - Schedule of owing to related parties</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://encoreuranium.com/role/FinancialInstrumentsDetails" id="cve_r_FinancialInstrumentsDetails">
        <link:definition>088 - Disclosure - Financial Instruments (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://encoreuranium.com/role/ScheduleofforeigncurrencyexposuresTable" id="cve_r_ScheduleofforeigncurrencyexposuresTable">
        <link:definition>089 - Disclosure - Financial Instruments (Details) - Schedule of foreign currency exposures</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://encoreuranium.com/role/ScheduleoflongtermassetsbygeographicsegmentTable" id="cve_r_ScheduleoflongtermassetsbygeographicsegmentTable">
        <link:definition>090 - Disclosure - Segmented information (Details) - Schedule of long-term assets by geographic segment</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://encoreuranium.com/role/ScheduleofincurrednoncashfinancingandinvestingactivitiesTable" id="cve_r_ScheduleofincurrednoncashfinancingandinvestingactivitiesTable">
        <link:definition>091 - Disclosure - Supplemental disclosure with respect to cash flows (Details) - Schedule of incurred non-cash financing and investing activities</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://encoreuranium.com/role/IncometaxesDetails" id="cve_r_IncometaxesDetails">
        <link:definition>092 - Disclosure - Income taxes (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://encoreuranium.com/role/ScheduleoffederalandprovincialcorporatetaxratestoincomebeforetaxTable" id="cve_r_ScheduleoffederalandprovincialcorporatetaxratestoincomebeforetaxTable">
        <link:definition>093 - Disclosure - Income taxes (Details) - Schedule of federal and provincial corporate tax rates to income before tax</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://encoreuranium.com/role/ScheduleofincometaxexpenserecoveryTable" id="cve_r_ScheduleofincometaxexpenserecoveryTable">
        <link:definition>094 - Disclosure - Income taxes (Details) - Schedule of income tax expense (recovery)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://encoreuranium.com/role/ScheduleofdeferredtaxliabilitiesTable" id="cve_r_ScheduleofdeferredtaxliabilitiesTable">
        <link:definition>095 - Disclosure - Income taxes (Details) - Schedule of deferred tax liabilities</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://encoreuranium.com/role/ScheduleofunrecognizeddeferredtaxassetsTable" id="cve_r_ScheduleofunrecognizeddeferredtaxassetsTable">
        <link:definition>096 - Disclosure - Income taxes (Details) - Schedule of unrecognized deferred tax assets</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://encoreuranium.com/role/ScheduleofeffectoftranslationTable" id="cve_r_ScheduleofeffectoftranslationTable">
        <link:definition>097 - Disclosure - Change in Presentation Currency (Details) - Schedule of effect of translation</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://encoreuranium.com/role/ScheduleofconsolidatedstatementsoflossandcomprehensivelossTable" id="cve_r_ScheduleofconsolidatedstatementsoflossandcomprehensivelossTable">
        <link:definition>098 - Disclosure - Change in Presentation Currency (Details) - Schedule of consolidated statements of loss and comprehensive loss</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
<!-- [WMV5][XcpuxYn59dz7vgYynUDuwG7r97K2jUTysl7vcz0lJt/tSeJz73kx1cLt0ZFF2SK/vxBCY0vdSrapBeolBQDhlou4Plg3ZACHgOGjaxwoV9s22fcKeqdlVg/8vXE8BEQPw2gSl8Pfy/SjqfZKUO0G5mehrda5xVrvtHGkgNXPOUg3vb7VF4CMNIMcgg6F7hiC/dgsHya46cPL6td1bLnSV35L5jAlrEDBDi0RC0EWIRx+TpXQjl5L5FZgRjEoUSEZhryyHyKdqq5iJBws95AwJg==] CSR-->
      <link:roleType roleURI="http://encoreuranium.com/role/ScheduleofconsolidatedstatementsoflossandcomprehensivelossTable_Parentheticals" id="cve_r_ScheduleofconsolidatedstatementsoflossandcomprehensivelossTable_Parentheticals">
        <link:definition>099 - Disclosure - Change in Presentation Currency (Details) - Schedule of consolidated statements of loss and comprehensive loss (Parentheticals)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://encoreuranium.com/role/EventsafterthereportingperiodDetails" id="cve_r_EventsafterthereportingperiodDetails">
        <link:definition>100 - Disclosure - Events after the reporting period (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://encoreuranium.com/role/DocumentAndEntityInformation" id="DocumentAndEntityInformation">
        <link:definition>000 - Document - Document And Entity Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://fasb.org/us-types/2022" schemaLocation="https://xbrl.fasb.org/us-gaap/2022/elts/us-types-2022.xsd"/>
  <xs:import namespace="http://www.xbrl.org/dtr/type/2020-01-21" schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd"/>
  <xs:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd"/>
  <xs:import namespace="http://fasb.org/srt-types/2022" schemaLocation="https://xbrl.fasb.org/srt/2022/elts/srt-types-2022.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/sic/2022" schemaLocation="https://xbrl.sec.gov/sic/2022/sic-2022.xsd"/>
  <xs:element name="ConsolidatedStatementsOfLossAndComprehensiveLossAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cve_ConsolidatedStatementsOfLossAndComprehensiveLossAbstract"/>
  <xs:element name="ConsolidatedStatementsOfChangesInShareholderSEquityAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cve_ConsolidatedStatementsOfChangesInShareholderSEquityAbstract"/>
  <xs:element name="NatureOfOperationAndGoingConcernAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cve_NatureOfOperationAndGoingConcernAbstract"/>
  <xs:element name="DisclosureOfSignificantAccountingPoliciesTextBlockAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cve_DisclosureOfSignificantAccountingPoliciesTextBlockAbstract"/>
  <xs:element name="ScheduleOfExchangeRatesAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cve_ScheduleOfExchangeRatesAbstract"/>
  <xs:element name="ScheduleOfSignificantSubsidiariesAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cve_ScheduleOfSignificantSubsidiariesAbstract"/>
  <xs:element name="ScheduleOfUsefulLivesOfPropertyPlantAndEquipementAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cve_ScheduleOfUsefulLivesOfPropertyPlantAndEquipementAbstract"/>
  <xs:element name="ScheduleOfUsefulLivesOfIntangibleAssetsAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cve_ScheduleOfUsefulLivesOfIntangibleAssetsAbstract"/>
  <xs:element name="DisclosureOfAccountingJudgementsAndEstimatesTextBlockAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cve_DisclosureOfAccountingJudgementsAndEstimatesTextBlockAbstract"/>
  <xs:element name="DisclosureOfAssociatesTextBlockAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cve_DisclosureOfAssociatesTextBlockAbstract"/>
  <xs:element name="ScheduleOfProportionalShareInTheAssociateAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cve_ScheduleOfProportionalShareInTheAssociateAbstract"/>
  <xs:element name="ScheduleOfInvestmentInAssociateContinuityAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cve_ScheduleOfInvestmentInAssociateContinuityAbstract"/>
  <xs:element name="DisclosureOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethodTextBlockAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cve_DisclosureOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethodTextBlockAbstract"/>
  <xs:element name="ScheduleOfTheFairValueOfThePhysicalUraniumInvestmentAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cve_ScheduleOfTheFairValueOfThePhysicalUraniumInvestmentAbstract"/>
  <xs:element name="ScheduleOfUraniumConcentratesPurchaseAgreementAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cve_ScheduleOfUraniumConcentratesPurchaseAgreementAbstract"/>
  <xs:element name="DisclosureOfMarketRiskTextBlockAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cve_DisclosureOfMarketRiskTextBlockAbstract"/>
  <xs:element name="ScheduleOfMarketableSecuritiesAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cve_ScheduleOfMarketableSecuritiesAbstract"/>
  <xs:element name="DisclosureOfIntangibleAssetsTextBlockAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cve_DisclosureOfIntangibleAssetsTextBlockAbstract"/>
  <xs:element name="ScheduleOfIntangibleAssetWasDeterminedAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cve_ScheduleOfIntangibleAssetWasDeterminedAbstract"/>
  <xs:element name="DisclosureOfPropertyPlantAndEquipmentTextBlockAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cve_DisclosureOfPropertyPlantAndEquipmentTextBlockAbstract"/>
  <xs:element name="ScheduleOfPropertyPlantAndEquipmentAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cve_ScheduleOfPropertyPlantAndEquipmentAbstract"/>
  <xs:element name="ScheduleOfChangeInTheRouAssetsAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cve_ScheduleOfChangeInTheRouAssetsAbstract"/>
  <xs:element name="ScheduleOfChangeInTheLongTermLeaseLiabilityAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cve_ScheduleOfChangeInTheLongTermLeaseLiabilityAbstract"/>
  <xs:element name="ScheduleOfUndiscountedFutureLeasePaymentsAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cve_ScheduleOfUndiscountedFutureLeasePaymentsAbstract"/>
  <xs:element name="DisclosureOfTransactionsRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombinationTextBlockAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cve_DisclosureOfTransactionsRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombinationTextBlockAbstract"/>
  <xs:element name="ScheduleOfEstimatedFairValueOfAssetsAndLiabilitiesAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cve_ScheduleOfEstimatedFairValueOfAssetsAndLiabilitiesAbstract"/>
  <xs:element name="ScheduleOfNetAssetsAcquiredAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cve_ScheduleOfNetAssetsAcquiredAbstract"/>
  <xs:element name="ScheduleOfWeightedAverageAssumptionsUsedInTheBlackScholesOptionAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cve_ScheduleOfWeightedAverageAssumptionsUsedInTheBlackScholesOptionAbstract"/>
  <xs:element name="DisclosureOfMineralPropertiesAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cve_DisclosureOfMineralPropertiesAbstract"/>
  <xs:element name="ScheduleOfMineralPropertiesAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cve_ScheduleOfMineralPropertiesAbstract"/>
  <xs:element name="AssetRetirementObligationsAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cve_AssetRetirementObligationsAbstract"/>
  <xs:element name="ScheduleOfAssetRetirementObligationsBalanceAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cve_ScheduleOfAssetRetirementObligationsBalanceAbstract"/>
  <xs:element name="ScheduleOfAssetRetirementObligationsContinuityAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cve_ScheduleOfAssetRetirementObligationsContinuityAbstract"/>
  <xs:element name="DisclosueOfSalesContractsAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cve_DisclosueOfSalesContractsAbstract"/>
  <xs:element name="ScheduleOfUraniumSalesContractsOverTheNextFiveYearsAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cve_ScheduleOfUraniumSalesContractsOverTheNextFiveYearsAbstract"/>
  <xs:element name="DisclosureOfClassesOfShareCapitalTextBlockAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cve_DisclosureOfClassesOfShareCapitalTextBlockAbstract"/>
  <xs:element name="ScheduleOfTheCompanySStockOptionsOutstandingAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cve_ScheduleOfTheCompanySStockOptionsOutstandingAbstract"/>
  <xs:element name="ScheduleOfStockOptionsOutstandingAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cve_ScheduleOfStockOptionsOutstandingAbstract"/>
  <xs:element name="ScheduleOfWeightedAverageAssumptionsUsedInCalculatingTheFairValuesAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cve_ScheduleOfWeightedAverageAssumptionsUsedInCalculatingTheFairValuesAbstract"/>
  <xs:element name="ScheduleOfTheStatusOfTheCompanySWarrantsAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cve_ScheduleOfTheStatusOfTheCompanySWarrantsAbstract"/>
  <xs:element name="ScheduleOfSharePurchaseWarrantsOutstandingAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cve_ScheduleOfSharePurchaseWarrantsOutstandingAbstract"/>
  <xs:element name="DisclosureOfRelatedPartyTextBlockAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cve_DisclosureOfRelatedPartyTextBlockAbstract"/>
  <xs:element name="ScheduleOfAmountsPaidToKeyManagementOrEntitiesProvidingSimilarServicesAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cve_ScheduleOfAmountsPaidToKeyManagementOrEntitiesProvidingSimilarServicesAbstract"/>
  <xs:element name="ScheduleOfOwingToRelatedPartiesAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cve_ScheduleOfOwingToRelatedPartiesAbstract"/>
  <xs:element name="DisclosureOfHowEntityManagesLiquidityRiskTextBlockAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cve_DisclosureOfHowEntityManagesLiquidityRiskTextBlockAbstract"/>
  <xs:element name="DisclosureOfFinancialInstrumentsTextBlockAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cve_DisclosureOfFinancialInstrumentsTextBlockAbstract"/>
  <xs:element name="ScheduleOfForeignCurrencyExposuresAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cve_ScheduleOfForeignCurrencyExposuresAbstract"/>
  <xs:element name="DisclosureOfEntitysOperatingSegmentsTextBlockAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cve_DisclosureOfEntitysOperatingSegmentsTextBlockAbstract"/>
  <xs:element name="ScheduleOfLongTermAssetsByGeographicSegmentAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cve_ScheduleOfLongTermAssetsByGeographicSegmentAbstract"/>
  <xs:element name="SupplementalDisclosureWithRespectToCashflowsAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cve_SupplementalDisclosureWithRespectToCashflowsAbstract"/>
  <xs:element name="ScheduleOfIncurredNonCashFinancingAndInvestingActivitiesAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cve_ScheduleOfIncurredNonCashFinancingAndInvestingActivitiesAbstract"/>
  <xs:element name="DisclosureOfIncomeTaxTextBlockAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cve_DisclosureOfIncomeTaxTextBlockAbstract"/>
  <xs:element name="ScheduleOfFederalAndProvincialCorporateTaxRatesToIncomeBeforeTaxAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cve_ScheduleOfFederalAndProvincialCorporateTaxRatesToIncomeBeforeTaxAbstract"/>
  <xs:element name="ScheduleOfIncomeTaxExpenseRecoveryAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cve_ScheduleOfIncomeTaxExpenseRecoveryAbstract"/>
  <xs:element name="ScheduleOfDeferredTaxLiabilitiesAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cve_ScheduleOfDeferredTaxLiabilitiesAbstract"/>
  <xs:element name="ScheduleOfUnrecognizedDeferredTaxAssetsAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cve_ScheduleOfUnrecognizedDeferredTaxAssetsAbstract"/>
  <xs:element name="DisclosureOfReclassificationsOrChangesInPresentationTextBlockAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cve_DisclosureOfReclassificationsOrChangesInPresentationTextBlockAbstract"/>
  <xs:element name="ScheduleOfEffectOfTranslationAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cve_ScheduleOfEffectOfTranslationAbstract"/>
  <xs:element name="ScheduleOfConsolidatedStatementsOfLossAndComprehensiveLossAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cve_ScheduleOfConsolidatedStatementsOfLossAndComprehensiveLossAbstract"/>
  <xs:element name="DisclosureOfEventsAfterReportingPeriodTextBlockAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cve_DisclosureOfEventsAfterReportingPeriodTextBlockAbstract"/>
  <xs:element name="NonCurrentAssetsAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cve_NonCurrentAssetsAbstract"/>
  <xs:element name="UnlabeledAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cve_UnlabeledAbstract"/>
  <xs:element name="NonCurrentLiabilitiesAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cve_NonCurrentLiabilitiesAbstract"/>
  <xs:element name="UnlabeledAbstract0" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cve_UnlabeledAbstract0"/>
  <xs:element name="UnlabeledAbstract1" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cve_UnlabeledAbstract1"/>
  <xs:element name="ExpensesAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cve_ExpensesAbstract"/>
  <xs:element name="UnlabeledAbstract2" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cve_UnlabeledAbstract2"/>
  <xs:element name="UnlabeledAbstract3" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cve_UnlabeledAbstract3"/>
  <xs:element name="WeightedAverageNumberOfCommonSharesOutstandingAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cve_WeightedAverageNumberOfCommonSharesOutstandingAbstract"/>
  <xs:element name="UnlabeledAbstract4" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cve_UnlabeledAbstract4"/>
  <xs:element name="OperatingActivitiesAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cve_OperatingActivitiesAbstract"/>
  <xs:element name="UnlabeledAbstract5" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cve_UnlabeledAbstract5"/>
  <xs:element name="ItemsNotAffectingCashAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cve_ItemsNotAffectingCashAbstract"/>
  <xs:element name="UnlabeledAbstract6" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cve_UnlabeledAbstract6"/>
  <xs:element name="ChangesInNonCashWorkingCapitalItemsAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cve_ChangesInNonCashWorkingCapitalItemsAbstract"/>
  <xs:element name="UnlabeledAbstract7" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cve_UnlabeledAbstract7"/>
  <xs:element name="InvestingActivitiesAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cve_InvestingActivitiesAbstract"/>
  <xs:element name="UnlabeledAbstract8" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cve_UnlabeledAbstract8"/>
  <xs:element name="FinancingActivitiesAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cve_FinancingActivitiesAbstract"/>
  <xs:element name="UnlabeledAbstract9" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cve_UnlabeledAbstract9"/>
  <xs:element name="UnlabeledAbstract10" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cve_UnlabeledAbstract10"/>
  <xs:element name="UnlabeledAbstract11" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cve_UnlabeledAbstract11"/>
  <xs:element name="YearEndedDecember312022Abstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cve_YearEndedDecember312022Abstract"/>
  <xs:element name="UnlabeledAbstract12" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cve_UnlabeledAbstract12"/>
  <xs:element name="InvestmentInAssociateAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cve_InvestmentInAssociateAbstract"/>
  <xs:element name="UnlabeledAbstract13" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cve_UnlabeledAbstract13"/>
  <xs:element name="UnlabeledAbstract14" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cve_UnlabeledAbstract14"/>
  <xs:element name="AdjustmentsToCarryingValueAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cve_AdjustmentsToCarryingValueAbstract"/>
  <xs:element name="UnlabeledAbstract15" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cve_UnlabeledAbstract15"/>
  <xs:element name="AdjustmentsToCarryingValueAbstract0" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cve_AdjustmentsToCarryingValueAbstract0"/>
  <xs:element name="InvestmentInUraniumAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cve_InvestmentInUraniumAbstract"/>
  <xs:element name="UnlabeledAbstract16" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cve_UnlabeledAbstract16"/>
  <xs:element name="UnlabeledAbstract17" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cve_UnlabeledAbstract17"/>
  <xs:element name="UnlabeledAbstract18" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cve_UnlabeledAbstract18"/>
  <xs:element name="UnlabeledAbstract19" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cve_UnlabeledAbstract19"/>
  <xs:element name="AcquisitionCostsAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cve_AcquisitionCostsAbstract"/>
  <xs:element name="ExplorationCostsAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cve_ExplorationCostsAbstract"/>
  <xs:element name="DivestmentAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cve_DivestmentAbstract"/>
  <xs:element name="ExplorationCostsAbstract0" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cve_ExplorationCostsAbstract0"/>
  <xs:element name="DivestmentAbstract0" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cve_DivestmentAbstract0"/>
  <xs:element name="ProjectDevelopmentCostsAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cve_ProjectDevelopmentCostsAbstract"/>
  <xs:element name="UnlabeledAbstract20" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cve_UnlabeledAbstract20"/>
  <xs:element name="UnlabeledAbstract21" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cve_UnlabeledAbstract21"/>
  <xs:element name="SalesCommitmentsInPoundsAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cve_SalesCommitmentsInPoundsAbstract"/>
  <xs:element name="UnlabeledAbstract22" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cve_UnlabeledAbstract22"/>
  <xs:element name="NonCashFinancingActivitiesAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cve_NonCashFinancingActivitiesAbstract"/>
  <xs:element name="UnlabeledAbstract23" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cve_UnlabeledAbstract23"/>
  <xs:element name="NonCashInvestingActivitiesAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cve_NonCashInvestingActivitiesAbstract"/>
  <xs:element name="IncreaseDecreaseResultingFromAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cve_IncreaseDecreaseResultingFromAbstract"/>
  <xs:element name="DeferredTaxExpenseRecoveryAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cve_DeferredTaxExpenseRecoveryAbstract"/>
  <xs:element name="UnlabeledAbstract24" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cve_UnlabeledAbstract24"/>
  <xs:element name="UnlabeledAbstract25" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cve_UnlabeledAbstract25"/>
  <xs:element name="ExpensesAbstract0" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cve_ExpensesAbstract0"/>
  <xs:element name="UnlabeledAbstract26" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cve_UnlabeledAbstract26"/>
  <xs:element name="MarketableSecuritiecurrent" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="cve_MarketableSecuritiecurrent"/>
  <xs:element name="DepositUraniumInvestment" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="cve_DepositUraniumInvestment"/>
  <xs:element name="MarketablesSecuritiesNoncurrent" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="cve_MarketablesSecuritiesNoncurrent"/>
  <xs:element name="ContributedSurplus" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="cve_ContributedSurplus"/>
  <xs:element name="AccretionExpenses" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="cve_AccretionExpenses"/>
  <xs:element name="CommunityEngagement" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="cve_CommunityEngagement"/>
  <xs:element name="Consulting" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="cve_Consulting"/>
  <xs:element name="ProjectInvestigationFess" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="cve_ProjectInvestigationFess"/>
  <xs:element name="TransferAgentAndFilingFees" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="cve_TransferAgentAndFilingFees"/>
  <xs:element name="LossOnWriteoffOfSalesTaxRecoverable" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="cve_LossOnWriteoffOfSalesTaxRecoverable"/>
  <xs:element name="GainOnDisposalOfSubsidiary" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="cve_GainOnDisposalOfSubsidiary"/>
  <xs:element name="LossOnContractTerminations" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="cve_LossOnContractTerminations"/>
  <xs:element name="UnrealizedGainOnUraniumInvestment" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="cve_UnrealizedGainOnUraniumInvestment"/>
  <xs:element name="GainOnSaleOfUraniumInvestment" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="cve_GainOnSaleOfUraniumInvestment"/>
  <xs:element name="UnrealizedGainOnMarketableSecurities" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="cve_UnrealizedGainOnMarketableSecurities"/>
  <xs:element name="Accretion" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="cve_Accretion"/>
  <xs:element name="CashAcquiredFromAzargaAssetAcquisition" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="cve_CashAcquiredFromAzargaAssetAcquisition"/>
  <xs:element name="TransactionCostsOnAzargaAssetAcquisition" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="cve_TransactionCostsOnAzargaAssetAcquisition"/>
  <xs:element name="PaymentsofInvestmentInUranium" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="cve_PaymentsofInvestmentInUranium"/>
  <xs:element name="ProceedsReceivedFromSaleOfUraniumInvestment" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="cve_ProceedsReceivedFromSaleOfUraniumInvestment"/>
  <xs:element name="PrivatePlacementProceeds" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="cve_PrivatePlacementProceeds"/>
  <xs:element name="PrivatePlacement" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="cve_PrivatePlacement"/>
  <xs:element name="PrivatePlacementinShares" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cve_PrivatePlacementinShares"/>
  <xs:element name="SharesIssuedForExerciseOfWarrantsShares" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cve_SharesIssuedForExerciseOfWarrantsShares"/>
  <xs:element name="SharesIssuedForExerciseOfStockOptionsShares" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cve_SharesIssuedForExerciseOfStockOptionsShares"/>
  <xs:element name="StockOptionExpense" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="cve_StockOptionExpense"/>
  <xs:element name="SharesIssuedForAzargaAssetAcquisition" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="cve_SharesIssuedForAzargaAssetAcquisition"/>
  <xs:element name="SharesIssuedForAzargaAssetAcquisitionNote10Shares" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cve_SharesIssuedForAzargaAssetAcquisitionNote10Shares"/>
  <xs:element name="ReplacementOptionsForAzargaAssetAcquisition" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="cve_ReplacementOptionsForAzargaAssetAcquisition"/>
  <xs:element name="ReplacementWarrantsForAzargaAssetAcquisition" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="cve_ReplacementWarrantsForAzargaAssetAcquisition"/>
  <xs:element name="AdjustmentToInvestmentInAssociate" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="cve_AdjustmentToInvestmentInAssociate"/>
  <xs:element name="SharesIssuedForServicesShares" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cve_SharesIssuedForServicesShares"/>
  <xs:element name="ShareSubscriptionsReceived" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="cve_ShareSubscriptionsReceived"/>
  <xs:element name="NatureOfOperationAndGoingConcern" type="dtr:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cve_NatureOfOperationAndGoingConcern"/>
  <xs:element name="NatureofOperationsandGoingConcernTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="cve_NatureofOperationsandGoingConcernTable"/>
  <xs:element name="NatureofOperationsandGoingConcernLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cve_NatureofOperationsandGoingConcernLineItems"/>
  <xs:element name="SignificantaccountingpoliciesTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="cve_SignificantaccountingpoliciesTable"/>
  <xs:element name="SignificantaccountingpoliciesLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cve_SignificantaccountingpoliciesLineItems"/>
  <xs:element name="CriticalAccountingEstimatesAndJudgementsTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="cve_CriticalAccountingEstimatesAndJudgementsTable"/>
  <xs:element name="CriticalAccountingEstimatesAndJudgementsLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cve_CriticalAccountingEstimatesAndJudgementsLineItems"/>
  <xs:element name="InvestmentInAssociateTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="cve_InvestmentInAssociateTable"/>
  <xs:element name="InvestmentInAssociateLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cve_InvestmentInAssociateLineItems"/>
  <xs:element name="IntangibleassetsTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="cve_IntangibleassetsTable"/>
  <xs:element name="IntangibleassetsLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cve_IntangibleassetsLineItems"/>
  <xs:element name="RightofuseassetsTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="cve_RightofuseassetsTable"/>
  <xs:element name="RightofuseassetsLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cve_RightofuseassetsLineItems"/>
  <xs:element name="DisclosureOfMineralProperties" type="dtr:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cve_DisclosureOfMineralProperties"/>
  <xs:element name="AssetRetirementObligationsTextBlock" type="dtr:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cve_AssetRetirementObligationsTextBlock"/>
  <xs:element name="AssetretirementobligationsTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="cve_AssetretirementobligationsTable"/>
  <xs:element name="AssetretirementobligationsLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cve_AssetretirementobligationsLineItems"/>
  <xs:element name="DisclosueOfSalesContractsTextBlock" type="dtr:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cve_DisclosueOfSalesContractsTextBlock"/>
  <xs:element name="SalescontractsTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="cve_SalescontractsTable"/>
  <xs:element name="SalescontractsLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cve_SalescontractsLineItems"/>
  <xs:element name="ShareCapitalTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="cve_ShareCapitalTable"/>
  <xs:element name="ShareCapitalLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cve_ShareCapitalLineItems"/>
  <xs:element name="SegmentedinformationTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="cve_SegmentedinformationTable"/>
  <xs:element name="SegmentedinformationLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cve_SegmentedinformationLineItems"/>
  <xs:element name="SupplementalDisclosureWithRespectToCashflowsTextBlock" type="dtr:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cve_SupplementalDisclosureWithRespectToCashflowsTextBlock"/>
  <xs:element name="DescriptionOfAccountingPolicyForBasisOfPresentationtextBlock" type="dtr:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cve_DescriptionOfAccountingPolicyForBasisOfPresentationtextBlock"/>
  <xs:element name="DescriptionOfAccountingPolicyForChangeInPresentationCurrencytextBlock" type="dtr:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cve_DescriptionOfAccountingPolicyForChangeInPresentationCurrencytextBlock"/>
  <xs:element name="DescriptionOfAccountingPolicyForBasisOfConsolidationtextBlock" type="dtr:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cve_DescriptionOfAccountingPolicyForBasisOfConsolidationtextBlock"/>
  <xs:element name="DescriptionOfAccountingPolicyForCashtextBlock" type="dtr:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cve_DescriptionOfAccountingPolicyForCashtextBlock"/>
  <xs:element name="DescriptionOfAccountingPolicyForAssetRetirementObligationstextBlock" type="dtr:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cve_DescriptionOfAccountingPolicyForAssetRetirementObligationstextBlock"/>
  <xs:element name="DescriptionOfAccountingPolicyForMineralPropertiestextBlock" type="dtr:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cve_DescriptionOfAccountingPolicyForMineralPropertiestextBlock"/>
  <xs:element name="DescriptionOfAccountingPolicyForInvestmentsInUraniumtextBlock" type="dtr:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cve_DescriptionOfAccountingPolicyForInvestmentsInUraniumtextBlock"/>
  <xs:element name="DescriptionOfAccountingPolicyForUraniumPlantstextBlock" type="dtr:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cve_DescriptionOfAccountingPolicyForUraniumPlantstextBlock"/>
  <xs:element name="DescriptionOfAccountingPolicyForOtherPropertyPlantAndEquipmenttextBlock" type="dtr:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cve_DescriptionOfAccountingPolicyForOtherPropertyPlantAndEquipmenttextBlock"/>
  <xs:element name="DescriptionOfAccountingPolicyForBuildingtextBlock" type="dtr:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cve_DescriptionOfAccountingPolicyForBuildingtextBlock"/>
  <xs:element name="DescriptionOfAccountingPolicyForSoftwaretextBlock" type="dtr:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cve_DescriptionOfAccountingPolicyForSoftwaretextBlock"/>
  <xs:element name="DescriptionOfAccountingPolicyForNewStandardsAndInterpretationsNotYetAdoptedtextBlock" type="dtr:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cve_DescriptionOfAccountingPolicyForNewStandardsAndInterpretationsNotYetAdoptedtextBlock"/>
  <xs:element name="DisclosureOfUsefulLivesOfPropertyPlantAndEquipementTextBlock" type="dtr:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cve_DisclosureOfUsefulLivesOfPropertyPlantAndEquipementTextBlock"/>
  <xs:element name="DisclosureOfUsefulLivesOfIntangibleAssetsTextBllock" type="dtr:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cve_DisclosureOfUsefulLivesOfIntangibleAssetsTextBllock"/>
  <xs:element name="SignificantaccountingpoliciesTablesTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="cve_SignificantaccountingpoliciesTablesTable"/>
  <xs:element name="SignificantaccountingpoliciesTablesLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cve_SignificantaccountingpoliciesTablesLineItems"/>
  <xs:element name="DisclosureOfProportionalShareAssociatesExplanatory" type="dtr:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cve_DisclosureOfProportionalShareAssociatesExplanatory"/>
  <xs:element name="InvestmentInAssociateTablesTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="cve_InvestmentInAssociateTablesTable"/>
  <xs:element name="InvestmentInAssociateTablesLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cve_InvestmentInAssociateTablesLineItems"/>
  <xs:element name="ScheduleOfTheFairValueOfThePhysicalUraniumInvestmentTableTextBlck" type="dtr:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cve_ScheduleOfTheFairValueOfThePhysicalUraniumInvestmentTableTextBlck"/>
  <xs:element name="ScheduleOfUraniumConcentratesPurchaseAgreementTableTextBlock" type="dtr:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cve_ScheduleOfUraniumConcentratesPurchaseAgreementTableTextBlock"/>
  <xs:element name="ScheduleOfMarketableSecuritiesTableTextBlock" type="dtr:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cve_ScheduleOfMarketableSecuritiesTableTextBlock"/>
  <xs:element name="MarketableSecuritiesTablesTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="cve_MarketableSecuritiesTablesTable"/>
  <xs:element name="MarketableSecuritiesTablesLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cve_MarketableSecuritiesTablesLineItems"/>
  <xs:element name="IntangibleassetsTablesTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="cve_IntangibleassetsTablesTable"/>
  <xs:element name="IntangibleassetsTablesLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cve_IntangibleassetsTablesLineItems"/>
  <xs:element name="PropertyplantandequipmentTablesTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="cve_PropertyplantandequipmentTablesTable"/>
  <xs:element name="PropertyplantandequipmentTablesLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cve_PropertyplantandequipmentTablesLineItems"/>
  <xs:element name="DisclosureOfChangeInTheROUAssetsTableTextBlock" type="dtr:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cve_DisclosureOfChangeInTheROUAssetsTableTextBlock"/>
  <xs:element name="DisclosureOfChangeInTheLongTermLeaseLiabilityTableTextBlock" type="dtr:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cve_DisclosureOfChangeInTheLongTermLeaseLiabilityTableTextBlock"/>
  <xs:element name="RightofuseassetsTablesTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="cve_RightofuseassetsTablesTable"/>
  <xs:element name="RightofuseassetsTablesLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cve_RightofuseassetsTablesLineItems"/>
  <xs:element name="ScheduleOfMineralProperties" type="dtr:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cve_ScheduleOfMineralProperties"/>
  <xs:element name="DisclosureOfAssetRetirementObligationsBalanceTableTextBlock" type="dtr:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cve_DisclosureOfAssetRetirementObligationsBalanceTableTextBlock"/>
  <xs:element name="DisclosureOfAssetRetirementObligationsContinuityTableTextBlock" type="dtr:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cve_DisclosureOfAssetRetirementObligationsContinuityTableTextBlock"/>
  <xs:element name="AssetretirementobligationsTablesTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="cve_AssetretirementobligationsTablesTable"/>
  <xs:element name="AssetretirementobligationsTablesLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cve_AssetretirementobligationsTablesLineItems"/>
  <xs:element name="SalescontractsTablesTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="cve_SalescontractsTablesTable"/>
  <xs:element name="SalescontractsTablesLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cve_SalescontractsTablesLineItems"/>
  <xs:element name="ScheduleOfTheCompanysStockOptionsOutstandingTableTextBlock" type="dtr:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cve_ScheduleOfTheCompanysStockOptionsOutstandingTableTextBlock"/>
  <xs:element name="ScheduleOfStockOptionsOutstandingTableTextBlock" type="dtr:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cve_ScheduleOfStockOptionsOutstandingTableTextBlock"/>
  <xs:element name="ScheduleOfWeightedAverageAssumptionsUsedInCalculatingTheFairValuesTableTextBlock" type="dtr:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cve_ScheduleOfWeightedAverageAssumptionsUsedInCalculatingTheFairValuesTableTextBlock"/>
  <xs:element name="ScheduleOfTheStatusOfTheCompanysWarrantsTableTextBlock" type="dtr:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cve_ScheduleOfTheStatusOfTheCompanysWarrantsTableTextBlock"/>
  <xs:element name="ScheduleOfSharePurchaseWarrantsOutstandingTableTextBlock" type="dtr:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cve_ScheduleOfSharePurchaseWarrantsOutstandingTableTextBlock"/>
  <xs:element name="ShareCapitalTablesTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="cve_ShareCapitalTablesTable"/>
  <xs:element name="ShareCapitalTablesLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cve_ShareCapitalTablesLineItems"/>
  <xs:element name="ScheduleOfFinancialInstrumentTableTextBlock" type="dtr:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cve_ScheduleOfFinancialInstrumentTableTextBlock"/>
  <xs:element name="DisclosureOfLongtermAssetsByGeographicSegmentTableTextBlock" type="dtr:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cve_DisclosureOfLongtermAssetsByGeographicSegmentTableTextBlock"/>
  <xs:element name="SegmentedinformationTablesTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="cve_SegmentedinformationTablesTable"/>
  <xs:element name="SegmentedinformationTablesLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cve_SegmentedinformationTablesLineItems"/>
  <xs:element name="ScheduleOfIncurredNoncashFinancingAndInvestingActivitiesTableTextBlock" type="dtr:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cve_ScheduleOfIncurredNoncashFinancingAndInvestingActivitiesTableTextBlock"/>
  <xs:element name="SignificantaccountingpoliciesDetailsScheduleofexchangeratesTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="cve_SignificantaccountingpoliciesDetailsScheduleofexchangeratesTable"/>
  <xs:element name="SignificantaccountingpoliciesDetailsScheduleofexchangeratesLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cve_SignificantaccountingpoliciesDetailsScheduleofexchangeratesLineItems"/>
  <xs:element name="SignificantaccountingpoliciesDetailsScheduleofsignificantsubsidiariesTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="cve_SignificantaccountingpoliciesDetailsScheduleofsignificantsubsidiariesTable"/>
  <xs:element name="SignificantaccountingpoliciesDetailsScheduleofsignificantsubsidiariesLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cve_SignificantaccountingpoliciesDetailsScheduleofsignificantsubsidiariesLineItems"/>
  <xs:element name="NameofSubsidaryPlaceOfIncorporation" type="xbrli:stringItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cve_NameofSubsidaryPlaceOfIncorporation"/>
  <xs:element name="NameofSubsidaryPrincipalActivity" type="xbrli:stringItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cve_NameofSubsidaryPrincipalActivity"/>
  <xs:element name="NameofSubsidaryFunctionalCurrency" type="xbrli:stringItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cve_NameofSubsidaryFunctionalCurrency"/>
  <xs:element name="SignificantaccountingpoliciesDetailsScheduleofusefullivesofpropertyplantandequipementTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="cve_SignificantaccountingpoliciesDetailsScheduleofusefullivesofpropertyplantandequipementTable"/>
  <xs:element name="SignificantaccountingpoliciesDetailsScheduleofusefullivesofpropertyplantandequipementLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cve_SignificantaccountingpoliciesDetailsScheduleofusefullivesofpropertyplantandequipementLineItems"/>
  <xs:element name="PropertyPlantAndEquipmentRange" type="xbrli:durationItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cve_PropertyPlantAndEquipmentRange"/>
  <xs:element name="SignificantaccountingpoliciesDetailsScheduleofusefullivesofintangibleassetsTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="cve_SignificantaccountingpoliciesDetailsScheduleofusefullivesofintangibleassetsTable"/>
  <xs:element name="SignificantaccountingpoliciesDetailsScheduleofusefullivesofintangibleassetsLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cve_SignificantaccountingpoliciesDetailsScheduleofusefullivesofintangibleassetsLineItems"/>
  <xs:element name="CategoryRange" type="xbrli:stringItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cve_CategoryRange"/>
  <xs:element name="InvestmentInAssociateDetailsScheduleofproportionalshareintheassociateTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="cve_InvestmentInAssociateDetailsScheduleofproportionalshareintheassociateTable"/>
  <xs:element name="InvestmentInAssociateDetailsScheduleofproportionalshareintheassociateLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cve_InvestmentInAssociateDetailsScheduleofproportionalshareintheassociateLineItems"/>
  <xs:element name="OtherRevenuesCurrent" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="cve_OtherRevenuesCurrent"/>
  <xs:element name="ExpensesCurrent" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="cve_ExpensesCurrent"/>
  <xs:element name="OtherRevenuesNoncurrent" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cve_OtherRevenuesNoncurrent"/>
  <xs:element name="ExpensesNoncurrent" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="cve_ExpensesNoncurrent"/>
  <xs:element name="AssetsLossFromOperatingExpenses" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="cve_AssetsLossFromOperatingExpenses"/>
  <xs:element name="LiabilitiesLossFromOperatingExpenses" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="cve_LiabilitiesLossFromOperatingExpenses"/>
  <xs:element name="RevenuesLossFromOperatingExpenses" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="cve_RevenuesLossFromOperatingExpenses"/>
  <xs:element name="ExpensesLossFromOperatingExpenses" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="cve_ExpensesLossFromOperatingExpenses"/>
  <xs:element name="InvestmentInAssociateDetailsScheduleofinvestmentinassociatecontinuityTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="cve_InvestmentInAssociateDetailsScheduleofinvestmentinassociatecontinuityTable"/>
  <xs:element name="InvestmentInAssociateDetailsScheduleofinvestmentinassociatecontinuityLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cve_InvestmentInAssociateDetailsScheduleofinvestmentinassociatecontinuityLineItems"/>
  <xs:element name="InvestmentBalance1" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="cve_InvestmentBalance1"/>
  <xs:element name="ProportionateShareOfNetLoss" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="cve_ProportionateShareOfNetLoss"/>
  <xs:element name="AdjustmentToInvestmentInGroup11" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="cve_AdjustmentToInvestmentInGroup11"/>
  <xs:element name="DilutionLoss" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="cve_DilutionLoss"/>
  <xs:element name="CurrencyTranslationAdjustment" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="cve_CurrencyTranslationAdjustment"/>
  <xs:element name="WriteoffOfInvestment" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="cve_WriteoffOfInvestment"/>
  <xs:element name="PhysicalUranium" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="cve_PhysicalUranium"/>
  <xs:element name="GainOnSaleOfUranium" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="cve_GainOnSaleOfUranium"/>
  <xs:element name="SaleOfUraniumInvestment" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="cve_SaleOfUraniumInvestment"/>
  <xs:element name="InvestmentinuraniumDetailsScheduleofuraniumconcentratespurchaseagreementTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="cve_InvestmentinuraniumDetailsScheduleofuraniumconcentratespurchaseagreementTable"/>
  <xs:element name="InvestmentinuraniumDetailsScheduleofuraniumconcentratespurchaseagreementLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cve_InvestmentinuraniumDetailsScheduleofuraniumconcentratespurchaseagreementLineItems"/>
  <xs:element name="PurchaseCommitments" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="cve_PurchaseCommitments"/>
  <xs:element name="TotalPurchasePrice" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="cve_TotalPurchasePrice"/>
  <xs:element name="MarketableSecuritiesDetailsScheduleofmarketablesecuritiesTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="cve_MarketableSecuritiesDetailsScheduleofmarketablesecuritiesTable"/>
  <xs:element name="MarketableSecuritiesDetailsScheduleofmarketablesecuritiesLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cve_MarketableSecuritiesDetailsScheduleofmarketablesecuritiesLineItems"/>
  <xs:element name="MarketablesSecurities" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="cve_MarketablesSecurities"/>
  <xs:element name="IntangibleassetsDetailsScheduleofintangibleassetwasdeterminedTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="cve_IntangibleassetsDetailsScheduleofintangibleassetwasdeterminedTable"/>
  <xs:element name="IntangibleassetsDetailsScheduleofintangibleassetwasdeterminedLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cve_IntangibleassetsDetailsScheduleofintangibleassetwasdeterminedLineItems"/>
  <xs:element name="IntangibleAssetsBalance" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="cve_IntangibleAssetsBalance"/>
  <xs:element name="Additions" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="cve_Additions"/>
  <xs:element name="CurrencyTranslationAdjustment1" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="cve_CurrencyTranslationAdjustment1"/>
  <xs:element name="PropertyplantandequipmentDetailsScheduleofpropertyplantandequipmentTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="cve_PropertyplantandequipmentDetailsScheduleofpropertyplantandequipmentTable"/>
  <xs:element name="PropertyplantandequipmentDetailsScheduleofpropertyplantandequipmentLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cve_PropertyplantandequipmentDetailsScheduleofpropertyplantandequipmentLineItems"/>
  <xs:element name="RightofuseassetsDetailsScheduleofchangeintheROUassetsTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="cve_RightofuseassetsDetailsScheduleofchangeintheROUassetsTable"/>
  <xs:element name="RightofuseassetsDetailsScheduleofchangeintheROUassetsLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cve_RightofuseassetsDetailsScheduleofchangeintheROUassetsLineItems"/>
  <xs:element name="Right-of-UseAssetsBalance" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="cve_Right-of-UseAssetsBalance"/>
  <xs:element name="Right-of-UseAssetsAdditions" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="cve_Right-of-UseAssetsAdditions"/>
  <xs:element name="Right-of-UseAssetsDepreciation" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="cve_Right-of-UseAssetsDepreciation"/>
  <xs:element name="Right-of-UseAssetsCurrencyTranslationAdjustment" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="cve_Right-of-UseAssetsCurrencyTranslationAdjustment"/>
  <xs:element name="RightofuseassetsDetailsScheduleofchangeinthelongTermleaseliabilityTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="cve_RightofuseassetsDetailsScheduleofchangeinthelongTermleaseliabilityTable"/>
  <xs:element name="RightofuseassetsDetailsScheduleofchangeinthelongTermleaseliabilityLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cve_RightofuseassetsDetailsScheduleofchangeinthelongTermleaseliabilityLineItems"/>
  <xs:element name="Long-TermLeaseLiabilityBalance" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="cve_Long-TermLeaseLiabilityBalance"/>
  <xs:element name="Long-TermLeaseLiabilityAdditions" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="cve_Long-TermLeaseLiabilityAdditions"/>
  <xs:element name="Long-TermLeaseLiabilityAccretion" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="cve_Long-TermLeaseLiabilityAccretion"/>
  <xs:element name="Long-TermLeaseLiabilityLeasePaymentsMade" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="cve_Long-TermLeaseLiabilityLeasePaymentsMade"/>
  <xs:element name="Long-TermLeaseLiabilityCurrencyTranslationAdjustment" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cve_Long-TermLeaseLiabilityCurrencyTranslationAdjustment"/>
  <xs:element name="Long-TermLeaseLiabilityLessCurrentLeaseLiability" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="cve_Long-TermLeaseLiabilityLessCurrentLeaseLiability"/>
  <xs:element name="RightofuseassetsDetailsScheduleofundiscountedfutureleasepaymentsTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="cve_RightofuseassetsDetailsScheduleofundiscountedfutureleasepaymentsTable"/>
  <xs:element name="RightofuseassetsDetailsScheduleofundiscountedfutureleasepaymentsLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cve_RightofuseassetsDetailsScheduleofundiscountedfutureleasepaymentsLineItems"/>
  <xs:element name="Right-of-UseAssetsTwoZeroTwoThree" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="cve_Right-of-UseAssetsTwoZeroTwoThree"/>
  <xs:element name="Right-of-UseAssetsTwoZeroTwoFour" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cve_Right-of-UseAssetsTwoZeroTwoFour"/>
  <xs:element name="Right-of-UseAssetsTwoZeroTwoFive" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cve_Right-of-UseAssetsTwoZeroTwoFive"/>
  <xs:element name="FairValueOfReplacementOptions" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="cve_FairValueOfReplacementOptions"/>
  <xs:element name="FairValueOfReplacementWarrants" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="cve_FairValueOfReplacementWarrants"/>
  <xs:element name="TransactionCosts" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="cve_TransactionCosts"/>
  <xs:element name="TotalConsiderationValue" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="cve_TotalConsiderationValue"/>
  <xs:element name="AssetRetirementObligations" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="cve_AssetRetirementObligations"/>
  <xs:element name="AccountsPayableAndAccruedLiability" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="cve_AccountsPayableAndAccruedLiability"/>
  <xs:element name="AssetacquisitionDetailsScheduleofweightedaverageassumptionsusedintheblackscholesoptionTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="cve_AssetacquisitionDetailsScheduleofweightedaverageassumptionsusedintheblackscholesoptionTable"/>
  <xs:element name="AssetacquisitionDetailsScheduleofweightedaverageassumptionsusedintheblackscholesoptionLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cve_AssetacquisitionDetailsScheduleofweightedaverageassumptionsusedintheblackscholesoptionLineItems"/>
  <xs:element name="FairValueOfReplacement" type="dtr:perShareItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cve_FairValueOfReplacement"/>
  <xs:element name="MineralPropertiesDetailsScheduleofmineralpropertiesTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="cve_MineralPropertiesDetailsScheduleofmineralpropertiesTable"/>
  <xs:element name="MineralPropertiesDetailsScheduleofmineralpropertiesLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cve_MineralPropertiesDetailsScheduleofmineralpropertiesLineItems"/>
  <xs:element name="AssetAcquistion" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="cve_AssetAcquistion"/>
  <xs:element name="MaintenancesAndLeaseFees" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="cve_MaintenancesAndLeaseFees"/>
  <xs:element name="ResourceReview" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="cve_ResourceReview"/>
  <xs:element name="ImpairmentCharged" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="cve_ImpairmentCharged"/>
  <xs:element name="Drilling" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="cve_Drilling"/>
  <xs:element name="PermittingLicensing" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="cve_PermittingLicensing"/>
  <xs:element name="Personnel" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="cve_Personnel"/>
  <xs:element name="Recoveries" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="cve_Recoveries"/>
  <xs:element name="DivestMineralInterest" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="cve_DivestMineralInterest"/>
  <xs:element name="AssetsHeldForSale" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="cve_AssetsHeldForSale"/>
  <xs:element name="ConstructionOfWellfields" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="cve_ConstructionOfWellfields"/>
  <xs:element name="AssetretirementobligationsDetailsScheduleofassetretirementobligationsbalanceTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="cve_AssetretirementobligationsDetailsScheduleofassetretirementobligationsbalanceTable"/>
  <xs:element name="AssetretirementobligationsDetailsScheduleofassetretirementobligationsbalanceLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cve_AssetretirementobligationsDetailsScheduleofassetretirementobligationsbalanceLineItems"/>
  <xs:element name="AssetretirementobligationsDetailsScheduleofassetretirementobligationscontinuityTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="cve_AssetretirementobligationsDetailsScheduleofassetretirementobligationscontinuityTable"/>
  <xs:element name="AssetretirementobligationsDetailsScheduleofassetretirementobligationscontinuityLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cve_AssetretirementobligationsDetailsScheduleofassetretirementobligationscontinuityLineItems"/>
  <xs:element name="AssetRetirementObligationsBalance" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="cve_AssetRetirementObligationsBalance"/>
  <xs:element name="AssetRetirementObligationsAccretion" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="cve_AssetRetirementObligationsAccretion"/>
  <xs:element name="AssetRetirementObligationsAdjustments" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="cve_AssetRetirementObligationsAdjustments"/>
  <xs:element name="AssetRetirementObligationsSettlement" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="cve_AssetRetirementObligationsSettlement"/>
  <xs:element name="AssetRetirementObligationsAdditionsFromAzargaAssetAcquisitionNote10" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="cve_AssetRetirementObligationsAdditionsFromAzargaAssetAcquisitionNote10"/>
  <xs:element name="SalescontractsDetailsScheduleofuraniumsalescontractsoverthenextfiveyearsTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="cve_SalescontractsDetailsScheduleofuraniumsalescontractsoverthenextfiveyearsTable"/>
  <xs:element name="SalescontractsDetailsScheduleofuraniumsalescontractsoverthenextfiveyearsLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cve_SalescontractsDetailsScheduleofuraniumsalescontractsoverthenextfiveyearsLineItems"/>
  <xs:element name="SalesContractsFiscalTwoZeroTwoThree" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="cve_SalesContractsFiscalTwoZeroTwoThree"/>
  <xs:element name="SalesContractsFiscalTwoZeroTwoFour" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="cve_SalesContractsFiscalTwoZeroTwoFour"/>
  <xs:element name="SalesContractsFiscalTwoZeroTwoFive" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="cve_SalesContractsFiscalTwoZeroTwoFive"/>
  <xs:element name="SalesContractsFiscalTwoZeroTwoSix" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cve_SalesContractsFiscalTwoZeroTwoSix"/>
  <xs:element name="SalesContractsFiscalTwoZeroTwoSeven" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="cve_SalesContractsFiscalTwoZeroTwoSeven"/>
  <xs:element name="SharesBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="instant" nillable="true" substitutionGroup="xbrli:item" id="cve_SharesBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber"/>
  <xs:element name="SharesBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cve_SharesBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
  <xs:element name="StockIssuedDuringPeriodShareStockOptionsExercised" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cve_StockIssuedDuringPeriodShareStockOptionsExercised"/>
  <xs:element name="StockIssuedDuringPeriodShareSharesBasedCompensationForfeited" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cve_StockIssuedDuringPeriodShareSharesBasedCompensationForfeited"/>
  <xs:element name="SharesBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="instant" nillable="true" substitutionGroup="xbrli:item" id="cve_SharesBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions"/>
  <xs:element name="ShareCapitalDetailsScheduleofstockoptionsoutstandingTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="cve_ShareCapitalDetailsScheduleofstockoptionsoutstandingTable"/>
  <xs:element name="ShareCapitalDetailsScheduleofstockoptionsoutstandingLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cve_ShareCapitalDetailsScheduleofstockoptionsoutstandingLineItems"/>
  <xs:element name="SharesBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cve_SharesBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
  <xs:element name="SharesBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cve_SharesBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber"/>
  <xs:element name="ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptionsWarrantsOutstanding" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="instant" nillable="true" substitutionGroup="xbrli:item" id="cve_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptionsWarrantsOutstanding"/>
  <xs:element name="SharesBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingPeriodIncreaseDecreaseWeightedAverageExercisePrice" type="dtr:perShareItemType" abstract="false" xbrli:periodType="instant" nillable="true" substitutionGroup="xbrli:item" id="cve_SharesBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingPeriodIncreaseDecreaseWeightedAverageExercisePrice"/>
  <xs:element name="ShareBasedCompensationArrangementBySharesBasedPaymentAwardOptionsGrantsInPeriodWarrantsGranted" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cve_ShareBasedCompensationArrangementBySharesBasedPaymentAwardOptionsGrantsInPeriodWarrantsGranted"/>
  <xs:element name="SharesbasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue" type="dtr:perShareItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cve_SharesbasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue"/>
  <xs:element name="ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisedWarrantsExercised" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cve_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisedWarrantsExercised"/>
  <xs:element name="SharesBasedCompensationArrangementBySharesBasedPaymentAwardOptionsOutstandingPeriodIncreaseDecreaseWeightedAverageExercisePrice" type="dtr:perShareItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cve_SharesBasedCompensationArrangementBySharesBasedPaymentAwardOptionsOutstandingPeriodIncreaseDecreaseWeightedAverageExercisePrice"/>
  <xs:element name="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWarrantsExpired" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cve_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWarrantsExpired"/>
  <xs:element name="ShareBasedCompensationArrangementsBySharesBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" type="dtr:perShareItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cve_ShareBasedCompensationArrangementsBySharesBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice"/>
  <xs:element name="ShareCapitalDetailsScheduleofsharepurchasewarrantsoutstandingTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="cve_ShareCapitalDetailsScheduleofsharepurchasewarrantsoutstandingTable"/>
  <xs:element name="ShareCapitalDetailsScheduleofsharepurchasewarrantsoutstandingLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cve_ShareCapitalDetailsScheduleofsharepurchasewarrantsoutstandingLineItems"/>
  <xs:element name="Warrants" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cve_Warrants"/>
  <xs:element name="WarrantsOutstandingWeightedAverageReimainingLife" type="xbrli:durationItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cve_WarrantsOutstandingWeightedAverageReimainingLife"/>
  <xs:element name="WarrantsOutstandingWeightedAverageExercisePrice" type="dtr:perShareItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cve_WarrantsOutstandingWeightedAverageExercisePrice"/>
  <xs:element name="OfficeAndAdministration" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="cve_OfficeAndAdministration"/>
  <xs:element name="StaffCosts" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="cve_StaffCosts"/>
  <xs:element name="RelatedpartytransactionsandbalancesDetailsScheduleofowingtorelatedpartiesTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="cve_RelatedpartytransactionsandbalancesDetailsScheduleofowingtorelatedpartiesTable"/>
  <xs:element name="RelatedpartytransactionsandbalancesDetailsScheduleofowingtorelatedpartiesLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cve_RelatedpartytransactionsandbalancesDetailsScheduleofowingtorelatedpartiesLineItems"/>
  <xs:element name="AccountPayablesAndAccruedLiabilities" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="cve_AccountPayablesAndAccruedLiabilities"/>
  <xs:element name="SegmentedinformationDetailsScheduleoflongtermassetsbygeographicsegmentTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="cve_SegmentedinformationDetailsScheduleoflongtermassetsbygeographicsegmentTable"/>
  <xs:element name="SegmentedinformationDetailsScheduleoflongtermassetsbygeographicsegmentLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cve_SegmentedinformationDetailsScheduleoflongtermassetsbygeographicsegmentLineItems"/>
  <xs:element name="IntangibleAssets" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="cve_IntangibleAssets"/>
  <xs:element name="PropertyPlantAndEquipments" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="cve_PropertyPlantAndEquipments"/>
  <xs:element name="MineralProperties" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="cve_MineralProperties"/>
  <xs:element name="RightofuseAssets1" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="cve_RightofuseAssets1"/>
  <xs:element name="SegmentedInformationBalance" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="cve_SegmentedInformationBalance"/>
  <xs:element name="TotalNoncashFinancingActivities" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="cve_TotalNoncashFinancingActivities"/>
  <xs:element name="MarketableSecuritieReceivedOnDispositionOfMineralProperties" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="cve_MarketableSecuritieReceivedOnDispositionOfMineralProperties"/>
  <xs:element name="PropertyPlantAndEquipmentAdditionIncludedInAccountsPayableAndAccruedLiabilities" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="cve_PropertyPlantAndEquipmentAdditionIncludedInAccountsPayableAndAccruedLiabilities"/>
  <xs:element name="FairValueOfCommonSharesIssuedForAzargaAssetAcquisition" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="cve_FairValueOfCommonSharesIssuedForAzargaAssetAcquisition"/>
  <xs:element name="FairValueOfReplacementOptionsIssuedForAzargaAssetsAcquisition" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="cve_FairValueOfReplacementOptionsIssuedForAzargaAssetsAcquisition"/>
  <xs:element name="FairValueOfReplacementWarrantsIssuedForAzargaAssetAcquisition" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="cve_FairValueOfReplacementWarrantsIssuedForAzargaAssetAcquisition"/>
  <xs:element name="TotalNoncashInvestingActivities" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="cve_TotalNoncashInvestingActivities"/>
  <xs:element name="ExpectedIncomeTaxExpenserecovery" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="cve_ExpectedIncomeTaxExpenserecovery"/>
  <xs:element name="ChangeInUnrecognizedTemporaryDifferences" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="cve_ChangeInUnrecognizedTemporaryDifferences"/>
  <xs:element name="ShareIssueCosts" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="cve_ShareIssueCosts"/>
  <xs:element name="OrginationAndReversalOfTemporaryDifferences" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="cve_OrginationAndReversalOfTemporaryDifferences"/>
  <xs:element name="SetoffOfTax" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="cve_SetoffOfTax"/>
  <xs:element name="FixedAssets" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="cve_FixedAssets"/>
  <xs:element name="DeductibleTemporaryDifferences" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="cve_DeductibleTemporaryDifferences"/>
  <xs:element name="ChangeinPresentationCurrencyDetailsScheduleofeffectoftranslationTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="cve_ChangeinPresentationCurrencyDetailsScheduleofeffectoftranslationTable"/>
  <xs:element name="ChangeinPresentationCurrencyDetailsScheduleofeffectoftranslationLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cve_ChangeinPresentationCurrencyDetailsScheduleofeffectoftranslationLineItems"/>
  <xs:element name="ChangeinPresentationCurrencyDetailsScheduleofconsolidatedstatementsoflossandcomprehensivelossTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="cve_ChangeinPresentationCurrencyDetailsScheduleofconsolidatedstatementsoflossandcomprehensivelossTable"/>
  <xs:element name="ChangeinPresentationCurrencyDetailsScheduleofconsolidatedstatementsoflossandcomprehensivelossLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cve_ChangeinPresentationCurrencyDetailsScheduleofconsolidatedstatementsoflossandcomprehensivelossLineItems"/>
  <xs:element name="ImpairmentCharges" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="cve_ImpairmentCharges"/>
  <xs:element name="OfficeAndAdministrative" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="cve_OfficeAndAdministrative"/>
  <xs:element name="ReclamationCosts" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="cve_ReclamationCosts"/>
  <xs:element name="LossesOnDivestmentOfMineralProperties" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="cve_LossesOnDivestmentOfMineralProperties"/>
  <xs:element name="GainOnChangeInAssetRetirementObligationEstimate" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="cve_GainOnChangeInAssetRetirementObligationEstimate"/>
  <xs:element name="LossOnInvestmentInAssociate" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="cve_LossOnInvestmentInAssociate"/>
  <xs:element name="ChangeinPresentationCurrencyDetailsScheduleofconsolidatedstatementsoflossandcomprehensivelossParentheticalsTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="cve_ChangeinPresentationCurrencyDetailsScheduleofconsolidatedstatementsoflossandcomprehensivelossParentheticalsTable"/>
  <xs:element name="ChangeinPresentationCurrencyDetailsScheduleofconsolidatedstatementsoflossandcomprehensivelossParentheticalsLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cve_ChangeinPresentationCurrencyDetailsScheduleofconsolidatedstatementsoflossandcomprehensivelossParentheticalsLineItems"/>
  <xs:element name="WorkingCapital" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="cve_WorkingCapital"/>
  <xs:element name="AccumulatedDeficit" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="cve_AccumulatedDeficit"/>
  <xs:element name="ShareSubscriptionsValue" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="cve_ShareSubscriptionsValue"/>
  <xs:element name="AcquiredShares" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cve_AcquiredShares"/>
  <xs:element name="IssuedAndOutstandingSharesPercentage" type="dtr:percentItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cve_IssuedAndOutstandingSharesPercentage"/>
  <xs:element name="AdvancedAmount" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="cve_AdvancedAmount"/>
  <xs:element name="InvestmentinuraniumDetailsTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="cve_InvestmentinuraniumDetailsTable"/>
  <xs:element name="InvestmentinuraniumDetailsLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cve_InvestmentinuraniumDetailsLineItems"/>
  <xs:element name="PurchaseAgreementsAmount" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="cve_PurchaseAgreementsAmount"/>
  <xs:element name="SaleOfPhysicalUranium" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="cve_SaleOfPhysicalUranium"/>
  <xs:element name="GrossProceeds" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="cve_GrossProceeds"/>
  <xs:element name="TotalConsideration" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="cve_TotalConsideration"/>
  <xs:element name="TotalConsiderationPerShare" type="dtr:perShareItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cve_TotalConsiderationPerShare"/>
  <xs:element name="InitialPayment" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="cve_InitialPayment"/>
  <xs:element name="InvestmentAmount" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="cve_InvestmentAmount"/>
  <xs:element name="MarketableSecuritiesDetailsTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="cve_MarketableSecuritiesDetailsTable"/>
  <xs:element name="MarketableSecuritiesDetailsLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cve_MarketableSecuritiesDetailsLineItems"/>
  <xs:element name="CommonShares" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="instant" nillable="true" substitutionGroup="xbrli:item" id="cve_CommonShares"/>
  <xs:element name="MarketValuePerShare" type="dtr:perShareItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cve_MarketValuePerShare"/>
  <xs:element name="ConvertedShares" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cve_ConvertedShares"/>
  <xs:element name="TradingShares" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cve_TradingShares"/>
  <xs:element name="ReleasedShares" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cve_ReleasedShares"/>
  <xs:element name="PrimeFuelsConsiderationPercentage" type="dtr:percentItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cve_PrimeFuelsConsiderationPercentage"/>
  <xs:element name="CommonSharesIssued" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="instant" nillable="true" substitutionGroup="xbrli:item" id="cve_CommonSharesIssued"/>
  <xs:element name="PrimaryTerm" type="xbrli:durationItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cve_PrimaryTerm"/>
  <xs:element name="RenewalPeriods" type="xbrli:durationItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cve_RenewalPeriods"/>
  <xs:element name="IntangibleAssetDeterminedLife" type="xbrli:durationItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cve_IntangibleAssetDeterminedLife"/>
  <xs:element name="AcquiredAmonut" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="cve_AcquiredAmonut"/>
  <xs:element name="RightofuseassetsDetailsTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="cve_RightofuseassetsDetailsTable"/>
  <xs:element name="RightofuseassetsDetailsLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cve_RightofuseassetsDetailsLineItems"/>
  <xs:element name="CorrespondingLeaseObligation" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="cve_CorrespondingLeaseObligation"/>
  <xs:element name="AssetacquisitionDetailsTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="cve_AssetacquisitionDetailsTable"/>
  <xs:element name="AssetacquisitionDetailsLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cve_AssetacquisitionDetailsLineItems"/>
  <xs:element name="ShareConsiderationAmount" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="cve_ShareConsiderationAmount"/>
  <xs:element name="StockOptions" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cve_StockOptions"/>
  <xs:element name="SharePurchaseWarrants" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cve_SharePurchaseWarrants"/>
  <xs:element name="ExchangeRatio" type="dtr:perShareItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cve_ExchangeRatio"/>
  <xs:element name="ShareConsolidation" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="instant" nillable="true" substitutionGroup="xbrli:item" id="cve_ShareConsolidation"/>
  <xs:element name="MineralPropertiesDetailsTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="cve_MineralPropertiesDetailsTable"/>
  <xs:element name="MineralPropertiesDetailsLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cve_MineralPropertiesDetailsLineItems"/>
  <xs:element name="InvestmentInterestRates" type="dtr:percentItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cve_InvestmentInterestRates"/>
  <xs:element name="InterestRateHold" type="dtr:percentItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cve_InterestRateHold"/>
  <xs:element name="RoyaltyIncomeRate" type="dtr:percentItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cve_RoyaltyIncomeRate"/>
  <xs:element name="ConsiderationReceived" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="instant" nillable="true" substitutionGroup="xbrli:item" id="cve_ConsiderationReceived"/>
  <xs:element name="AdditionalPayment" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="cve_AdditionalPayment"/>
  <xs:element name="GrantedPercentage" type="dtr:percentItemType" abstract="false" xbrli:periodType="instant" nillable="true" substitutionGroup="xbrli:item" id="cve_GrantedPercentage"/>
  <xs:element name="ConsiderationPercentage" type="dtr:percentItemType" abstract="false" xbrli:periodType="instant" nillable="true" substitutionGroup="xbrli:item" id="cve_ConsiderationPercentage"/>
  <xs:element name="InflationFactorPercentage" type="dtr:percentItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cve_InflationFactorPercentage"/>
  <xs:element name="TotalDiscountedMarketPrices" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="cve_TotalDiscountedMarketPrices"/>
  <xs:element name="CancellationFee" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="cve_CancellationFee"/>
  <xs:element name="PursuantToAgreement" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="cve_PursuantToAgreement"/>
  <xs:element name="ContractPoundsOfUranium" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="cve_ContractPoundsOfUranium"/>
  <xs:element name="PricePerPound" type="dtr:perShareItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cve_PricePerPound"/>
  <xs:element name="SalesContractsTrem" type="xbrli:durationItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cve_SalesContractsTrem"/>
  <xs:element name="ShareCapitalDetailsTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="cve_ShareCapitalDetailsTable"/>
  <xs:element name="ShareCapitalDetailsLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cve_ShareCapitalDetailsLineItems"/>
  <xs:element name="SharesUnit" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cve_SharesUnit"/>
  <xs:element name="GrossProceed" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="cve_GrossProceed"/>
  <xs:element name="CommonShare" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cve_CommonShare"/>
  <xs:element name="PurchaseWarrantShares" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cve_PurchaseWarrantShares"/>
  <xs:element name="PurchaseAdditionalShareWarrants" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cve_PurchaseAdditionalShareWarrants"/>
  <xs:element name="PurchaseAdditionalSharePricePerWarrant" type="dtr:perShareItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cve_PurchaseAdditionalSharePricePerWarrant"/>
  <xs:element name="CashIssuanceCosts" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="cve_CashIssuanceCosts"/>
  <xs:element name="ShareIssued" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cve_ShareIssued"/>
  <xs:element name="WarrantsOfFairValue" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="cve_WarrantsOfFairValue"/>
  <xs:element name="WarrantsExercisableOfCommonShare" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cve_WarrantsExercisableOfCommonShare"/>
  <xs:element name="WarrantsExercisablePricePerShare" type="dtr:perShareItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cve_WarrantsExercisablePricePerShare"/>
  <xs:element name="CommonShareIssued" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cve_CommonShareIssued"/>
  <xs:element name="CommonSharesOfSettlementAndCompensation" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cve_CommonSharesOfSettlementAndCompensation"/>
  <xs:element name="NumberOfSharesReservedInsurancePercentage" type="dtr:percentItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cve_NumberOfSharesReservedInsurancePercentage"/>
  <xs:element name="OptionsGrantedForMaximumYear" type="xbrli:durationItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cve_OptionsGrantedForMaximumYear"/>
  <xs:element name="AggregateOfGrantedShares" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cve_AggregateOfGrantedShares"/>
  <xs:element name="FairValueOfGrantedOption" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="cve_FairValueOfGrantedOption"/>
  <xs:element name="StockOptionsRevisedTerm" type="xbrli:durationItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cve_StockOptionsRevisedTerm"/>
  <xs:element name="StandardStockOptionVestingPercentage" type="dtr:percentItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cve_StandardStockOptionVestingPercentage"/>
  <xs:element name="RecognizedStockOptionExpense" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="cve_RecognizedStockOptionExpense"/>
  <xs:element name="WarrantsExercisableShare" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cve_WarrantsExercisableShare"/>
  <xs:element name="WarrantShare" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cve_WarrantShare"/>
  <xs:element name="WarrantsExercisablePrice" type="dtr:perShareItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cve_WarrantsExercisablePrice"/>
  <xs:element name="WarrantIsExercisableTerm" type="xbrli:durationItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cve_WarrantIsExercisableTerm"/>
  <xs:element name="RelatedpartytransactionsandbalancesDetailsTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="cve_RelatedpartytransactionsandbalancesDetailsTable"/>
  <xs:element name="RelatedpartytransactionsandbalancesDetailsLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cve_RelatedpartytransactionsandbalancesDetailsLineItems"/>
  <xs:element name="ConsultingFees" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="cve_ConsultingFees"/>
  <xs:element name="GrantedOptionsShares" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cve_GrantedOptionsShares"/>
  <xs:element name="FairValueAmount" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="cve_FairValueAmount"/>
  <xs:element name="ForeignExchangeRate" type="dtr:percentItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cve_ForeignExchangeRate"/>
  <xs:element name="ImpactedLoss" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="cve_ImpactedLoss"/>
  <xs:element name="NoncapitalLoss" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="cve_NoncapitalLoss"/>
  <xs:element name="FederalNetOperatingLossCarryforwards" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="cve_FederalNetOperatingLossCarryforwards"/>
  <xs:element name="CarriedForward" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="cve_CarriedForward"/>
  <xs:element name="ExpiringAmount" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="cve_ExpiringAmount"/>
  <xs:element name="EventsafterthereportingperiodDetailsTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="cve_EventsafterthereportingperiodDetailsTable"/>
  <xs:element name="EventsafterthereportingperiodDetailsLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cve_EventsafterthereportingperiodDetailsLineItems"/>
  <xs:element name="AcquireCommonShare" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="cve_AcquireCommonShare"/>
  <xs:element name="Saleofstockpershare" type="dtr:perShareItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cve_Saleofstockpershare"/>
  <xs:element name="PricePerShare" type="dtr:perShareItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cve_PricePerShare"/>
  <xs:element name="PublicOfferingPricePerShare" type="dtr:perShareItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cve_PublicOfferingPricePerShare"/>
  <xs:element name="PurchasePricePerShare" type="dtr:perShareItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cve_PurchasePricePerShare"/>
  <xs:element name="StockOptionsSharesOutstanding" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cve_StockOptionsSharesOutstanding"/>
  <xs:element name="GrantedStockOptions" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cve_GrantedStockOptions"/>
  <xs:element name="WeightedAverageExercisePrice" type="dtr:perShareItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cve_WeightedAverageExercisePrice"/>
  <xs:element name="PurchasedShares" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cve_PurchasedShares"/>
  <xs:element name="TransactionCost" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="cve_TransactionCost"/>
  <xs:element name="OptionToAcquireShares" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cve_OptionToAcquireShares"/>
  <xs:element name="TotalConsiderationPerPounds" type="dtr:perShareItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cve_TotalConsiderationPerPounds"/>
  <xs:element name="PaymentAmount" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="cve_PaymentAmount"/>
  <xs:element name="AssetsReceivedPercentage" type="dtr:percentItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cve_AssetsReceivedPercentage"/>
  <xs:element name="AltaMesaAcquisitionMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cve_AltaMesaAcquisitionMember"/>
  <xs:element name="AzargaResourcesCanadaLtdMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cve_AzargaResourcesCanadaLtdMember"/>
  <xs:element name="AzargaResourcesHongKongLtdMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cve_AzargaResourcesHongKongLtdMember"/>
  <xs:element name="AzargaResourcesLimitedMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cve_AzargaResourcesLimitedMember"/>
  <xs:element name="AzargaResourcesUSACompanyMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cve_AzargaResourcesUSACompanyMember"/>
  <xs:element name="AzargaUraniumCorpMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cve_AzargaUraniumCorpMember"/>
  <xs:element name="BeltLineResourcesIncMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cve_BeltLineResourcesIncMember"/>
  <xs:element name="CentennialMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cve_CentennialMember"/>
  <xs:element name="CibolaResourcesLLCMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cve_CibolaResourcesLLCMember"/>
  <xs:element name="ContributedSurplusMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cve_ContributedSurplusMember"/>
  <xs:element name="CrownpointMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cve_CrownpointMember"/>
  <xs:element name="DataAccessAgreementMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cve_DataAccessAgreementMember"/>
  <xs:element name="DataPurchasesMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cve_DataPurchasesMember"/>
  <xs:element name="EnergyFuelsIncMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cve_EnergyFuelsIncMember"/>
  <xs:element name="ExplorationCostMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cve_ExplorationCostMember"/>
  <xs:element name="Fiscal2023Member" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cve_Fiscal2023Member"/>
  <xs:element name="Fiscal2024Member" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cve_Fiscal2024Member"/>
  <xs:element name="Fiscal2025Member" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cve_Fiscal2025Member"/>
  <xs:element name="Fiscal2026Member" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cve_Fiscal2026Member"/>
  <xs:element name="Fiscal2027Member" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cve_Fiscal2027Member"/>
  <xs:element name="FourFiveNineSixZeroZeroMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cve_FourFiveNineSixZeroZeroMember"/>
  <xs:element name="FourTwoZeroFiveSevenSixMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cve_FourTwoZeroFiveSevenSixMember"/>
  <xs:element name="FurnitureMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cve_FurnitureMember"/>
  <xs:element name="GasHillsMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cve_GasHillsMember"/>
  <xs:element name="GettyDatabaseMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cve_GettyDatabaseMember"/>
  <xs:element name="GrantsMineralBeltDatabaseMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cve_GrantsMineralBeltDatabaseMember"/>
  <xs:element name="HRIChurchrockIncMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cve_HRIChurchrockIncMember"/>
  <xs:element name="HostaButteMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cve_HostaButteMember"/>
  <xs:element name="HydroRestorationCorpMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cve_HydroRestorationCorpMember"/>
  <xs:element name="KingsvilleMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cve_KingsvilleMember"/>
  <xs:element name="LeasedCopierMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cve_LeasedCopierMember"/>
  <xs:element name="LeasedOfficesMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cve_LeasedOfficesMember"/>
  <xs:element name="MarketableSecuritiesMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cve_MarketableSecuritiesMember"/>
  <xs:element name="MarketableSecuritiescurrentMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cve_MarketableSecuritiescurrentMember"/>
  <xs:element name="MarketableSecuritiesnoncurrentMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cve_MarketableSecuritiesnoncurrentMember"/>
  <xs:element name="McKinleyMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cve_McKinleyMember"/>
  <xs:element name="MetaminEnterprisesUSIncMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cve_MetaminEnterprisesUSIncMember"/>
  <xs:element name="NeutronEnergyIncMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cve_NeutronEnergyIncMember"/>
  <xs:element name="OfficersAndBoardMembersMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cve_OfficersAndBoardMembersMember"/>
  <xs:element name="OneFiveNineOneEightZeroMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cve_OneFiveNineOneEightZeroMember"/>
  <xs:element name="OptionsMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cve_OptionsMember"/>
  <xs:element name="OtherStatesMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cve_OtherStatesMember"/>
  <xs:element name="PlatoroWestIncMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cve_PlatoroWestIncMember"/>
  <xs:element name="PowertechUSAIncMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cve_PowertechUSAIncMember"/>
  <xs:element name="PrimeFuelsCorpMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cve_PrimeFuelsCorpMember"/>
  <xs:element name="ReplacementOptionsMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cve_ReplacementOptionsMember"/>
  <xs:element name="ReplacementWarrantsMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cve_ReplacementWarrantsMember"/>
  <xs:element name="RositaMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cve_RositaMember"/>
  <xs:element name="SignalEquitiesDatabaseMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cve_SignalEquitiesDatabaseMember"/>
  <xs:element name="SoftwareMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cve_SoftwareMember"/>
  <xs:element name="StockOptionsMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cve_StockOptionsMember"/>
  <xs:element name="SubsequentEventFourMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cve_SubsequentEventFourMember"/>
  <xs:element name="SubsequentEventOneMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cve_SubsequentEventOneMember"/>
  <xs:element name="SubsequentEventThreeMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cve_SubsequentEventThreeMember"/>
  <xs:element name="SubsequentEventTwoMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cve_SubsequentEventTwoMember"/>
  <xs:element name="TicabooMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cve_TicabooMember"/>
  <xs:element name="TigrisUraniumUSCorpMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cve_TigrisUraniumUSCorpMember"/>
  <xs:element name="TintinaHoldingsLtdMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cve_TintinaHoldingsLtdMember"/>
  <xs:element name="TradingSharesMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cve_TradingSharesMember"/>
  <xs:element name="TranslatedMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cve_TranslatedMember"/>
  <xs:element name="TriStateGenerationAndTransmissionAssociationMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cve_TriStateGenerationAndTransmissionAssociationMember"/>
  <xs:element name="TwoFourZeroThreeSevenEightMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cve_TwoFourZeroThreeSevenEightMember"/>
  <xs:element name="TwoTwoTwoThreeNineZeroOneMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cve_TwoTwoTwoThreeNineZeroOneMember"/>
  <xs:element name="URIIncMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cve_URIIncMember"/>
  <xs:element name="URZEnergyCorpMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cve_URZEnergyCorpMember"/>
  <xs:element name="UcoloExplorationCorpMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cve_UcoloExplorationCorpMember"/>
  <xs:element name="UrancoIncMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cve_UrancoIncMember"/>
  <xs:element name="UraniumPlantsMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cve_UraniumPlantsMember"/>
  <xs:element name="UraniumResourcesIncMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cve_UraniumResourcesIncMember"/>
  <xs:element name="VANEAgreementMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cve_VANEAgreementMember"/>
  <xs:element name="VasquezMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cve_VasquezMember"/>
  <xs:element name="WarrantsMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cve_WarrantsMember"/>
  <xs:element name="WildcatSolarPowerPlantLLCMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cve_WildcatSolarPowerPlantLLCMember"/>
  <xs:element name="ZeroOneEightOneNineTwoMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cve_ZeroOneEightOneNineTwoMember"/>
  <xs:element name="enCoreEnergyUSCorpMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cve_enCoreEnergyUSCorpMember"/>
  <xs:element name="DocumentAndEntityInformationAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cve_DocumentAndEntityInformationAbstract"/>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>47
<FILENAME>cve-20221231_cal.xml
<DESCRIPTION>XBRL CALCULATION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!-- Generated by CompSci Transform (tm) - http://www.compsciresources.com -->
<!-- Created: Fri Apr 28 19:14:45 UTC 2023 -->
<linkbase xmlns="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <roleRef xlink:type="simple" xlink:href="cve-20221231.xsd#cve_r_ConsolidatedBalanceSheet" roleURI="http://encoreuranium.com/role/ConsolidatedBalanceSheet"/>
  <roleRef xlink:type="simple" xlink:href="cve-20221231.xsd#cve_r_ConsolidatedComprehensiveIncome" roleURI="http://encoreuranium.com/role/ConsolidatedComprehensiveIncome"/>
  <roleRef xlink:type="simple" xlink:href="cve-20221231.xsd#cve_r_ConsolidatedCashFlow" roleURI="http://encoreuranium.com/role/ConsolidatedCashFlow"/>
  <roleRef xlink:type="simple" xlink:href="cve-20221231.xsd#cve_r_ScheduleofforeigncurrencyexposuresTable" roleURI="http://encoreuranium.com/role/ScheduleofforeigncurrencyexposuresTable"/>
  <roleRef xlink:type="simple" xlink:href="cve-20221231.xsd#cve_r_ScheduleofincurrednoncashfinancingandinvestingactivitiesTable" roleURI="http://encoreuranium.com/role/ScheduleofincurrednoncashfinancingandinvestingactivitiesTable"/>
  <roleRef xlink:type="simple" xlink:href="cve-20221231.xsd#cve_r_ScheduleofunrecognizeddeferredtaxassetsTable" roleURI="http://encoreuranium.com/role/ScheduleofunrecognizeddeferredtaxassetsTable"/>
  <roleRef xlink:type="simple" xlink:href="cve-20221231.xsd#cve_r_ScheduleofeffectoftranslationTable" roleURI="http://encoreuranium.com/role/ScheduleofeffectoftranslationTable"/>
  <roleRef xlink:type="simple" xlink:href="cve-20221231.xsd#cve_r_ScheduleofconsolidatedstatementsoflossandcomprehensivelossTable" roleURI="http://encoreuranium.com/role/ScheduleofconsolidatedstatementsoflossandcomprehensivelossTable"/>
  <calculationLink xlink:type="extended" xlink:role="http://encoreuranium.com/role/ConsolidatedBalanceSheet">
    <loc xlink:type="locator" xlink:label="ifrs-full_CurrentAssets" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_CurrentAssets"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CashAndCashEquivalents" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_CashAndCashEquivalents"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_CurrentAssets" xlink:to="ifrs-full_CashAndCashEquivalents" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_TradeAndOtherReceivables" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_TradeAndOtherReceivables"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_CurrentAssets" xlink:to="ifrs-full_TradeAndOtherReceivables" order="2" weight="1"/>
    <loc xlink:type="locator" xlink:label="cve_MarketableSecuritiecurrent" xlink:href="cve-20221231.xsd#cve_MarketableSecuritiecurrent"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_CurrentAssets" xlink:to="cve_MarketableSecuritiecurrent" order="3" weight="1"/>
    <loc xlink:type="locator" xlink:label="cve_DepositUraniumInvestment" xlink:href="cve-20221231.xsd#cve_DepositUraniumInvestment"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_CurrentAssets" xlink:to="cve_DepositUraniumInvestment" order="4" weight="1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_NoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSaleOrAsHeldForDistributionToOwners" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_NoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSaleOrAsHeldForDistributionToOwners"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_CurrentAssets" xlink:to="ifrs-full_NoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSaleOrAsHeldForDistributionToOwners" order="5" weight="1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_Assets" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_Assets"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_Assets" xlink:to="ifrs-full_CurrentAssets" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_IntangibleAssetsOtherThanGoodwill" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_IntangibleAssetsOtherThanGoodwill"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_Assets" xlink:to="ifrs-full_IntangibleAssetsOtherThanGoodwill" order="2" weight="1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_PropertyPlantAndEquipment" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_PropertyPlantAndEquipment"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_Assets" xlink:to="ifrs-full_PropertyPlantAndEquipment" order="3" weight="1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_InvestmentsInAssociates" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_InvestmentsInAssociates"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_Assets" xlink:to="ifrs-full_InvestmentsInAssociates" order="4" weight="1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_InvestmentsInSubsidiariesJointVenturesAndAssociates" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_InvestmentsInSubsidiariesJointVenturesAndAssociates"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_Assets" xlink:to="ifrs-full_InvestmentsInSubsidiariesJointVenturesAndAssociates" order="5" weight="1"/>
    <loc xlink:type="locator" xlink:label="cve_MarketablesSecuritiesNoncurrent" xlink:href="cve-20221231.xsd#cve_MarketablesSecuritiesNoncurrent"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_Assets" xlink:to="cve_MarketablesSecuritiesNoncurrent" order="6" weight="1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_MiningAssets" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_MiningAssets"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_Assets" xlink:to="ifrs-full_MiningAssets" order="7" weight="1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_LongtermDeposits" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_LongtermDeposits"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_Assets" xlink:to="ifrs-full_LongtermDeposits" order="8" weight="1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_RightofuseAssets" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_RightofuseAssets"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_Assets" xlink:to="ifrs-full_RightofuseAssets" order="9" weight="1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DeferredTaxAssets" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_DeferredTaxAssets"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_Assets" xlink:to="ifrs-full_DeferredTaxAssets" order="10" weight="1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_NoncurrentFinancialAssets" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_NoncurrentFinancialAssets"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_Assets" xlink:to="ifrs-full_NoncurrentFinancialAssets" order="11" weight="1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_RestrictedCashAndCashEquivalents" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_RestrictedCashAndCashEquivalents"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_Assets" xlink:to="ifrs-full_RestrictedCashAndCashEquivalents" order="12" weight="1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CurrentLiabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_CurrentLiabilities"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_TradeAndOtherCurrentPayables" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_TradeAndOtherCurrentPayables"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_CurrentLiabilities" xlink:to="ifrs-full_TradeAndOtherCurrentPayables" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_TradeAndOtherCurrentPayablesToRelatedParties" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_TradeAndOtherCurrentPayablesToRelatedParties"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_CurrentLiabilities" xlink:to="ifrs-full_TradeAndOtherCurrentPayablesToRelatedParties" order="2" weight="1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_OtherCurrentPayables" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_OtherCurrentPayables"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_CurrentLiabilities" xlink:to="ifrs-full_OtherCurrentPayables" order="3" weight="1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CurrentLeaseLiabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_CurrentLeaseLiabilities"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_CurrentLiabilities" xlink:to="ifrs-full_CurrentLeaseLiabilities" order="4" weight="1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_Liabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_Liabilities"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_Liabilities" xlink:to="ifrs-full_CurrentLiabilities" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DefinedBenefitObligationAtPresentValue" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_DefinedBenefitObligationAtPresentValue"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_Liabilities" xlink:to="ifrs-full_DefinedBenefitObligationAtPresentValue" order="2" weight="1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_NoncurrentLeaseLiabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_NoncurrentLeaseLiabilities"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_Liabilities" xlink:to="ifrs-full_NoncurrentLeaseLiabilities" order="3" weight="1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_Equity" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_Equity"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_IssuedCapital" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_IssuedCapital"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_Equity" xlink:to="ifrs-full_IssuedCapital" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_SharePremium" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_SharePremium"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_Equity" xlink:to="ifrs-full_SharePremium" order="2" weight="1"/>
    <loc xlink:type="locator" xlink:label="cve_ContributedSurplus" xlink:href="cve-20221231.xsd#cve_ContributedSurplus"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_Equity" xlink:to="cve_ContributedSurplus" order="3" weight="1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AccumulatedOtherComprehensiveIncome" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_AccumulatedOtherComprehensiveIncome"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_Equity" xlink:to="ifrs-full_AccumulatedOtherComprehensiveIncome" order="4" weight="1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_RetainedEarnings" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_RetainedEarnings"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_Equity" xlink:to="ifrs-full_RetainedEarnings" order="5" weight="1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_EquityAndLiabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_EquityAndLiabilities"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_EquityAndLiabilities" xlink:to="ifrs-full_Liabilities" order="1" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_EquityAndLiabilities" xlink:to="ifrs-full_Equity" order="2" weight="1"/>
  </calculationLink>
  <calculationLink xlink:type="extended" xlink:role="http://encoreuranium.com/role/ConsolidatedComprehensiveIncome">
    <loc xlink:type="locator" xlink:label="ifrs-full_ProfitLossFromOperatingActivities" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_ProfitLossFromOperatingActivities"/>
    <loc xlink:type="locator" xlink:label="cve_AccretionExpenses" xlink:href="cve-20221231.xsd#cve_AccretionExpenses"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_ProfitLossFromOperatingActivities" xlink:to="cve_AccretionExpenses" order="1" weight="-1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DepreciationAndAmortisationExpense" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_DepreciationAndAmortisationExpense"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_ProfitLossFromOperatingActivities" xlink:to="ifrs-full_DepreciationAndAmortisationExpense" order="2" weight="-1"/>
    <loc xlink:type="locator" xlink:label="cve_CommunityEngagement" xlink:href="cve-20221231.xsd#cve_CommunityEngagement"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_ProfitLossFromOperatingActivities" xlink:to="cve_CommunityEngagement" order="3" weight="-1"/>
    <loc xlink:type="locator" xlink:label="cve_Consulting" xlink:href="cve-20221231.xsd#cve_Consulting"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_ProfitLossFromOperatingActivities" xlink:to="cve_Consulting" order="4" weight="-1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_GeneralAndAdministrativeExpense" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_GeneralAndAdministrativeExpense"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_ProfitLossFromOperatingActivities" xlink:to="ifrs-full_GeneralAndAdministrativeExpense" order="5" weight="-1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ImpairmentLossImpairmentGainAndReversalOfImpairmentLossDeterminedInAccordanceWithIFRS9" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_ImpairmentLossImpairmentGainAndReversalOfImpairmentLossDeterminedInAccordanceWithIFRS9"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_ProfitLossFromOperatingActivities" xlink:to="ifrs-full_ImpairmentLossImpairmentGainAndReversalOfImpairmentLossDeterminedInAccordanceWithIFRS9" order="6" weight="-1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_InterestExpense" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_InterestExpense"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_ProfitLossFromOperatingActivities" xlink:to="ifrs-full_InterestExpense" order="7" weight="-1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AdministrativeExpense" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_AdministrativeExpense"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_ProfitLossFromOperatingActivities" xlink:to="ifrs-full_AdministrativeExpense" order="8" weight="-1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ProfessionalFeesExpense" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_ProfessionalFeesExpense"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_ProfitLossFromOperatingActivities" xlink:to="ifrs-full_ProfessionalFeesExpense" order="9" weight="-1"/>
    <loc xlink:type="locator" xlink:label="cve_ProjectInvestigationFess" xlink:href="cve-20221231.xsd#cve_ProjectInvestigationFess"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_ProfitLossFromOperatingActivities" xlink:to="cve_ProjectInvestigationFess" order="10" weight="-1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CommunicationExpense" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_CommunicationExpense"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_ProfitLossFromOperatingActivities" xlink:to="ifrs-full_CommunicationExpense" order="11" weight="-1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ReclassificationAdjustmentsOnChangeInValueOfForwardElementsOfForwardContractsNetOfTax" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_ReclassificationAdjustmentsOnChangeInValueOfForwardElementsOfForwardContractsNetOfTax"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_ProfitLossFromOperatingActivities" xlink:to="ifrs-full_ReclassificationAdjustmentsOnChangeInValueOfForwardElementsOfForwardContractsNetOfTax" order="12" weight="-1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_TravelExpense" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_TravelExpense"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_ProfitLossFromOperatingActivities" xlink:to="ifrs-full_TravelExpense" order="13" weight="-1"/>
    <loc xlink:type="locator" xlink:label="cve_TransferAgentAndFilingFees" xlink:href="cve-20221231.xsd#cve_TransferAgentAndFilingFees"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_ProfitLossFromOperatingActivities" xlink:to="cve_TransferAgentAndFilingFees" order="14" weight="-1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_WagesAndSalaries" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_WagesAndSalaries"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_ProfitLossFromOperatingActivities" xlink:to="ifrs-full_WagesAndSalaries" order="15" weight="-1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ExpenseFromSharebasedPaymentTransactionsWithEmployees" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_ExpenseFromSharebasedPaymentTransactionsWithEmployees"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_ProfitLossFromOperatingActivities" xlink:to="ifrs-full_ExpenseFromSharebasedPaymentTransactionsWithEmployees" order="16" weight="-1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ProfitLoss" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_ProfitLoss"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_ProfitLoss" xlink:to="ifrs-full_ProfitLossFromOperatingActivities" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_RevenueFromInterest" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_RevenueFromInterest"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_ProfitLoss" xlink:to="ifrs-full_RevenueFromInterest" order="2" weight="1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_ProfitLoss" xlink:to="ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss" order="3" weight="1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_GainsLossesOnDisposalsOfPropertyPlantAndEquipment" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_GainsLossesOnDisposalsOfPropertyPlantAndEquipment"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_ProfitLoss" xlink:to="ifrs-full_GainsLossesOnDisposalsOfPropertyPlantAndEquipment" order="4" weight="1"/>
    <loc xlink:type="locator" xlink:label="cve_GainOnDisposalOfSubsidiary" xlink:href="cve-20221231.xsd#cve_GainOnDisposalOfSubsidiary"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_ProfitLoss" xlink:to="cve_GainOnDisposalOfSubsidiary" order="5" weight="1"/>
    <loc xlink:type="locator" xlink:label="cve_UnrealizedGainOnUraniumInvestment" xlink:href="cve-20221231.xsd#cve_UnrealizedGainOnUraniumInvestment"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_ProfitLoss" xlink:to="cve_UnrealizedGainOnUraniumInvestment" order="6" weight="1"/>
    <loc xlink:type="locator" xlink:label="cve_GainOnSaleOfUraniumInvestment" xlink:href="cve-20221231.xsd#cve_GainOnSaleOfUraniumInvestment"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_ProfitLoss" xlink:to="cve_GainOnSaleOfUraniumInvestment" order="7" weight="1"/>
    <loc xlink:type="locator" xlink:label="cve_UnrealizedGainOnMarketableSecurities" xlink:href="cve-20221231.xsd#cve_UnrealizedGainOnMarketableSecurities"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_ProfitLoss" xlink:to="cve_UnrealizedGainOnMarketableSecurities" order="8" weight="1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_GainsLossesOnFairValueAdjustmentInvestmentProperty" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_GainsLossesOnFairValueAdjustmentInvestmentProperty"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_ProfitLoss" xlink:to="ifrs-full_GainsLossesOnFairValueAdjustmentInvestmentProperty" order="9" weight="1"/>
    <loc xlink:type="locator" xlink:label="cve_LossOnWriteoffOfSalesTaxRecoverable" xlink:href="cve-20221231.xsd#cve_LossOnWriteoffOfSalesTaxRecoverable"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_ProfitLoss" xlink:to="cve_LossOnWriteoffOfSalesTaxRecoverable" order="10" weight="-1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_GainLossOnRemeasurementOfReimbursementRights" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_GainLossOnRemeasurementOfReimbursementRights"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_ProfitLoss" xlink:to="ifrs-full_GainLossOnRemeasurementOfReimbursementRights" order="11" weight="-1"/>
    <loc xlink:type="locator" xlink:label="cve_LossOnContractTerminations" xlink:href="cve-20221231.xsd#cve_LossOnContractTerminations"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_ProfitLoss" xlink:to="cve_LossOnContractTerminations" order="12" weight="-1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ComprehensiveIncome" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_ComprehensiveIncome"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_ComprehensiveIncome" xlink:to="ifrs-full_ProfitLoss" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_OtherComprehensiveIncomeNetOfTaxHedgesOfNetInvestmentsInForeignOperations" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_OtherComprehensiveIncomeNetOfTaxHedgesOfNetInvestmentsInForeignOperations"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_ComprehensiveIncome" xlink:to="ifrs-full_OtherComprehensiveIncomeNetOfTaxHedgesOfNetInvestmentsInForeignOperations" order="2" weight="1"/>
  </calculationLink>
  <calculationLink xlink:type="extended" xlink:role="http://encoreuranium.com/role/ConsolidatedCashFlow">
    <loc xlink:type="locator" xlink:label="ifrs-full_CashFlowsFromUsedInOperatingActivities" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_CashFlowsFromUsedInOperatingActivities"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ProfitLoss" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_ProfitLoss"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_CashFlowsFromUsedInOperatingActivities" xlink:to="ifrs-full_ProfitLoss" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="cve_Accretion" xlink:href="cve-20221231.xsd#cve_Accretion"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_CashFlowsFromUsedInOperatingActivities" xlink:to="cve_Accretion" order="2" weight="1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AdjustmentsForDepreciationAndAmortisationExpense" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_AdjustmentsForDepreciationAndAmortisationExpense"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_CashFlowsFromUsedInOperatingActivities" xlink:to="ifrs-full_AdjustmentsForDepreciationAndAmortisationExpense" order="3" weight="1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AdjustmentsForImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLoss" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_AdjustmentsForImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLoss"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_CashFlowsFromUsedInOperatingActivities" xlink:to="ifrs-full_AdjustmentsForImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLoss" order="4" weight="1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AdjustmentsForUnrealisedForeignExchangeLossesGains" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_AdjustmentsForUnrealisedForeignExchangeLossesGains"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_CashFlowsFromUsedInOperatingActivities" xlink:to="ifrs-full_AdjustmentsForUnrealisedForeignExchangeLossesGains" order="5" weight="1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AdjustmentsForSharebasedPayments" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_AdjustmentsForSharebasedPayments"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_CashFlowsFromUsedInOperatingActivities" xlink:to="ifrs-full_AdjustmentsForSharebasedPayments" order="6" weight="1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AdjustmentsForDeferredTaxExpense" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_AdjustmentsForDeferredTaxExpense"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_CashFlowsFromUsedInOperatingActivities" xlink:to="ifrs-full_AdjustmentsForDeferredTaxExpense" order="7" weight="1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AdjustmentsForIncreaseDecreaseInEmployeeBenefitLiabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_AdjustmentsForIncreaseDecreaseInEmployeeBenefitLiabilities"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_CashFlowsFromUsedInOperatingActivities" xlink:to="ifrs-full_AdjustmentsForIncreaseDecreaseInEmployeeBenefitLiabilities" order="8" weight="1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AdjustmentsForFairValueGainsLosses" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_AdjustmentsForFairValueGainsLosses"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_CashFlowsFromUsedInOperatingActivities" xlink:to="ifrs-full_AdjustmentsForFairValueGainsLosses" order="9" weight="1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AdjustmentsForDecreaseIncreaseInOtherOperatingReceivables" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_AdjustmentsForDecreaseIncreaseInOtherOperatingReceivables"/>
<!-- [WMV5][XcpuxYn59dz7vgYynUDuwG7r97K2jUTysl7vcz0lJt/tSeJz73kx1cLt0ZFF2SK/vxBCY0vdSrapBeolBQDhlou4Plg3ZACHgOGjaxwoV9s22fcKeqdlVg/8vXE8BEQPw2gSl8Pfy/SjqfZKUO0G5mehrda5xVrvtHGkgNXPOUg3vb7VF4CMNIMcgg6F7hiC/dgsHya46cPL6td1bLnSV35L5jAlrEDBDi0RC0EWIRx+TpXQjl5L5FZgRjEoUSEZzVn9VnLE4rp0W8LdJDWyfpwtW7MsfWEg] CSR-->
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_CashFlowsFromUsedInOperatingActivities" xlink:to="ifrs-full_AdjustmentsForDecreaseIncreaseInOtherOperatingReceivables" order="10" weight="1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AdjustmentsForIncreaseDecreaseInDepositsFromCustomers" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_AdjustmentsForIncreaseDecreaseInDepositsFromCustomers"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_CashFlowsFromUsedInOperatingActivities" xlink:to="ifrs-full_AdjustmentsForIncreaseDecreaseInDepositsFromCustomers" order="11" weight="1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_OtherInflowsOutflowsOfCashClassifiedAsOperatingActivities" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_OtherInflowsOutflowsOfCashClassifiedAsOperatingActivities"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_CashFlowsFromUsedInOperatingActivities" xlink:to="ifrs-full_OtherInflowsOutflowsOfCashClassifiedAsOperatingActivities" order="12" weight="1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAccountPayable" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAccountPayable"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_CashFlowsFromUsedInOperatingActivities" xlink:to="ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAccountPayable" order="13" weight="1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CashReceiptsFromRepaymentOfAdvancesAndLoansMadeToRelatedParties" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_CashReceiptsFromRepaymentOfAdvancesAndLoansMadeToRelatedParties"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_CashFlowsFromUsedInOperatingActivities" xlink:to="ifrs-full_CashReceiptsFromRepaymentOfAdvancesAndLoansMadeToRelatedParties" order="14" weight="1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AdjustmentsForInterestIncome" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_AdjustmentsForInterestIncome"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_CashFlowsFromUsedInOperatingActivities" xlink:to="ifrs-full_AdjustmentsForInterestIncome" order="15" weight="-1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AdjustmentsForGainLossOnDisposalsPropertyPlantAndEquipment" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_AdjustmentsForGainLossOnDisposalsPropertyPlantAndEquipment"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_CashFlowsFromUsedInOperatingActivities" xlink:to="ifrs-full_AdjustmentsForGainLossOnDisposalsPropertyPlantAndEquipment" order="16" weight="-1"/>
    <loc xlink:type="locator" xlink:label="cve_GainOnDisposalOfSubsidiary" xlink:href="cve-20221231.xsd#cve_GainOnDisposalOfSubsidiary"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_CashFlowsFromUsedInOperatingActivities" xlink:to="cve_GainOnDisposalOfSubsidiary" order="17" weight="-1"/>
    <loc xlink:type="locator" xlink:label="cve_UnrealizedGainOnUraniumInvestment" xlink:href="cve-20221231.xsd#cve_UnrealizedGainOnUraniumInvestment"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_CashFlowsFromUsedInOperatingActivities" xlink:to="cve_UnrealizedGainOnUraniumInvestment" order="18" weight="-1"/>
    <loc xlink:type="locator" xlink:label="cve_GainOnSaleOfUraniumInvestment" xlink:href="cve-20221231.xsd#cve_GainOnSaleOfUraniumInvestment"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_CashFlowsFromUsedInOperatingActivities" xlink:to="cve_GainOnSaleOfUraniumInvestment" order="19" weight="-1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AdjustmentsForUndistributedProfitsOfAssociates" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_AdjustmentsForUndistributedProfitsOfAssociates"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_CashFlowsFromUsedInOperatingActivities" xlink:to="ifrs-full_AdjustmentsForUndistributedProfitsOfAssociates" order="20" weight="-1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CashFlowsFromUsedInInvestingActivities" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_CashFlowsFromUsedInInvestingActivities"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ProceedsFromSalesOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_ProceedsFromSalesOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_CashFlowsFromUsedInInvestingActivities" xlink:to="ifrs-full_ProceedsFromSalesOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="cve_TransactionCostsOnAzargaAssetAcquisition" xlink:href="cve-20221231.xsd#cve_TransactionCostsOnAzargaAssetAcquisition"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_CashFlowsFromUsedInInvestingActivities" xlink:to="cve_TransactionCostsOnAzargaAssetAcquisition" order="2" weight="1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_InterestReceivedClassifiedAsInvestingActivities" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_InterestReceivedClassifiedAsInvestingActivities"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_CashFlowsFromUsedInInvestingActivities" xlink:to="ifrs-full_InterestReceivedClassifiedAsInvestingActivities" order="3" weight="1"/>
    <loc xlink:type="locator" xlink:label="cve_ProceedsReceivedFromSaleOfUraniumInvestment" xlink:href="cve-20221231.xsd#cve_ProceedsReceivedFromSaleOfUraniumInvestment"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_CashFlowsFromUsedInInvestingActivities" xlink:to="cve_ProceedsReceivedFromSaleOfUraniumInvestment" order="4" weight="1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_CashFlowsFromUsedInInvestingActivities" xlink:to="ifrs-full_PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities" order="5" weight="-1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_CashFlowsFromUsedInInvestingActivities" xlink:to="ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities" order="6" weight="-1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_PurchaseOfInvestmentProperty" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_PurchaseOfInvestmentProperty"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_CashFlowsFromUsedInInvestingActivities" xlink:to="ifrs-full_PurchaseOfInvestmentProperty" order="7" weight="-1"/>
    <loc xlink:type="locator" xlink:label="cve_CashAcquiredFromAzargaAssetAcquisition" xlink:href="cve-20221231.xsd#cve_CashAcquiredFromAzargaAssetAcquisition"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_CashFlowsFromUsedInInvestingActivities" xlink:to="cve_CashAcquiredFromAzargaAssetAcquisition" order="8" weight="-1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CashFlowsUsedInObtainingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_CashFlowsUsedInObtainingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_CashFlowsFromUsedInInvestingActivities" xlink:to="ifrs-full_CashFlowsUsedInObtainingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities" order="9" weight="-1"/>
    <loc xlink:type="locator" xlink:label="cve_PaymentsofInvestmentInUranium" xlink:href="cve-20221231.xsd#cve_PaymentsofInvestmentInUranium"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_CashFlowsFromUsedInInvestingActivities" xlink:to="cve_PaymentsofInvestmentInUranium" order="10" weight="-1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_GainsLossesOnFinancialAssetsAtFairValueThroughProfitOrLoss" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_GainsLossesOnFinancialAssetsAtFairValueThroughProfitOrLoss"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_CashFlowsFromUsedInInvestingActivities" xlink:to="ifrs-full_GainsLossesOnFinancialAssetsAtFairValueThroughProfitOrLoss" order="11" weight="-1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CashFlowsFromUsedInFinancingActivities" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_CashFlowsFromUsedInFinancingActivities"/>
    <loc xlink:type="locator" xlink:label="cve_PrivatePlacementProceeds" xlink:href="cve-20221231.xsd#cve_PrivatePlacementProceeds"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_CashFlowsFromUsedInFinancingActivities" xlink:to="cve_PrivatePlacementProceeds" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ProceedsFromExerciseOfWarrants" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_ProceedsFromExerciseOfWarrants"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_CashFlowsFromUsedInFinancingActivities" xlink:to="ifrs-full_ProceedsFromExerciseOfWarrants" order="2" weight="1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ProceedsFromExerciseOfOptions" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_ProceedsFromExerciseOfOptions"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_CashFlowsFromUsedInFinancingActivities" xlink:to="ifrs-full_ProceedsFromExerciseOfOptions" order="3" weight="1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ProceedsFromIssuingShares" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_ProceedsFromIssuingShares"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_CashFlowsFromUsedInFinancingActivities" xlink:to="ifrs-full_ProceedsFromIssuingShares" order="4" weight="1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_PaymentsForShareIssueCosts" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_PaymentsForShareIssueCosts"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_CashFlowsFromUsedInFinancingActivities" xlink:to="ifrs-full_PaymentsForShareIssueCosts" order="5" weight="-1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_RepaymentsOfBorrowingsClassifiedAsFinancingActivities" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_RepaymentsOfBorrowingsClassifiedAsFinancingActivities"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_CashFlowsFromUsedInFinancingActivities" xlink:to="ifrs-full_RepaymentsOfBorrowingsClassifiedAsFinancingActivities" order="6" weight="-1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_CashFlowsFromUsedInFinancingActivities" xlink:to="ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities" order="7" weight="-1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CashFlowsFromUsedInOperationsBeforeChangesInWorkingCapital" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_CashFlowsFromUsedInOperationsBeforeChangesInWorkingCapital"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_CashFlowsFromUsedInOperationsBeforeChangesInWorkingCapital" xlink:to="ifrs-full_CashFlowsFromUsedInOperatingActivities" order="1" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_CashFlowsFromUsedInOperationsBeforeChangesInWorkingCapital" xlink:to="ifrs-full_CashFlowsFromUsedInInvestingActivities" order="2" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_CashFlowsFromUsedInOperationsBeforeChangesInWorkingCapital" xlink:to="ifrs-full_CashFlowsFromUsedInFinancingActivities" order="3" weight="1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_CashFlowsFromUsedInOperationsBeforeChangesInWorkingCapital" xlink:to="ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents" order="4" weight="1"/>
  </calculationLink>
  <calculationLink xlink:type="extended" xlink:role="http://encoreuranium.com/role/ScheduleofforeigncurrencyexposuresTable">
    <loc xlink:type="locator" xlink:label="ifrs-full_AssetsLessCurrentLiabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_AssetsLessCurrentLiabilities"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_Cash" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_Cash"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_AssetsLessCurrentLiabilities" xlink:to="ifrs-full_Cash" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_MarketableSecurities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MarketableSecurities"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_AssetsLessCurrentLiabilities" xlink:to="us-gaap_MarketableSecurities" order="2" weight="1"/>
    <loc xlink:type="locator" xlink:label="cve_AccountPayablesAndAccruedLiabilities" xlink:href="cve-20221231.xsd#cve_AccountPayablesAndAccruedLiabilities"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_AssetsLessCurrentLiabilities" xlink:to="cve_AccountPayablesAndAccruedLiabilities" order="3" weight="-1"/>
  </calculationLink>
  <calculationLink xlink:type="extended" xlink:role="http://encoreuranium.com/role/ScheduleofincurrednoncashfinancingandinvestingactivitiesTable">
    <loc xlink:type="locator" xlink:label="cve_TotalNoncashFinancingActivities" xlink:href="cve-20221231.xsd#cve_TotalNoncashFinancingActivities"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CurrentAccruedExpensesAndOtherCurrentLiabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_CurrentAccruedExpensesAndOtherCurrentLiabilities"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="cve_TotalNoncashFinancingActivities" xlink:to="ifrs-full_CurrentAccruedExpensesAndOtherCurrentLiabilities" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="cve_TotalNoncashInvestingActivities" xlink:href="cve-20221231.xsd#cve_TotalNoncashInvestingActivities"/>
    <loc xlink:type="locator" xlink:label="cve_MarketableSecuritieReceivedOnDispositionOfMineralProperties" xlink:href="cve-20221231.xsd#cve_MarketableSecuritieReceivedOnDispositionOfMineralProperties"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="cve_TotalNoncashInvestingActivities" xlink:to="cve_MarketableSecuritieReceivedOnDispositionOfMineralProperties" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_LiabilitiesArisingFromExplorationForAndEvaluationOfMineralResources" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_LiabilitiesArisingFromExplorationForAndEvaluationOfMineralResources"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="cve_TotalNoncashInvestingActivities" xlink:to="ifrs-full_LiabilitiesArisingFromExplorationForAndEvaluationOfMineralResources" order="2" weight="1"/>
    <loc xlink:type="locator" xlink:label="cve_PropertyPlantAndEquipmentAdditionIncludedInAccountsPayableAndAccruedLiabilities" xlink:href="cve-20221231.xsd#cve_PropertyPlantAndEquipmentAdditionIncludedInAccountsPayableAndAccruedLiabilities"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="cve_TotalNoncashInvestingActivities" xlink:to="cve_PropertyPlantAndEquipmentAdditionIncludedInAccountsPayableAndAccruedLiabilities" order="3" weight="1"/>
    <loc xlink:type="locator" xlink:label="cve_FairValueOfCommonSharesIssuedForAzargaAssetAcquisition" xlink:href="cve-20221231.xsd#cve_FairValueOfCommonSharesIssuedForAzargaAssetAcquisition"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="cve_TotalNoncashInvestingActivities" xlink:to="cve_FairValueOfCommonSharesIssuedForAzargaAssetAcquisition" order="4" weight="1"/>
    <loc xlink:type="locator" xlink:label="cve_FairValueOfReplacementOptionsIssuedForAzargaAssetsAcquisition" xlink:href="cve-20221231.xsd#cve_FairValueOfReplacementOptionsIssuedForAzargaAssetsAcquisition"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="cve_TotalNoncashInvestingActivities" xlink:to="cve_FairValueOfReplacementOptionsIssuedForAzargaAssetsAcquisition" order="5" weight="1"/>
    <loc xlink:type="locator" xlink:label="cve_FairValueOfReplacementWarrantsIssuedForAzargaAssetAcquisition" xlink:href="cve-20221231.xsd#cve_FairValueOfReplacementWarrantsIssuedForAzargaAssetAcquisition"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="cve_TotalNoncashInvestingActivities" xlink:to="cve_FairValueOfReplacementWarrantsIssuedForAzargaAssetAcquisition" order="6" weight="1"/>
  </calculationLink>
  <calculationLink xlink:type="extended" xlink:role="http://encoreuranium.com/role/ScheduleofunrecognizeddeferredtaxassetsTable">
    <loc xlink:type="locator" xlink:label="ifrs-full_ProfitLossBeforeTax" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_ProfitLossBeforeTax"/>
    <loc xlink:type="locator" xlink:label="cve_DeductibleTemporaryDifferences" xlink:href="cve-20221231.xsd#cve_DeductibleTemporaryDifferences"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_ProfitLossBeforeTax" xlink:to="cve_DeductibleTemporaryDifferences" order="1" weight="-1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_TaxEffectOfTaxLosses" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_TaxEffectOfTaxLosses"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_ProfitLossBeforeTax" xlink:to="ifrs-full_TaxEffectOfTaxLosses" order="2" weight="-1"/>
  </calculationLink>
  <calculationLink xlink:type="extended" xlink:role="http://encoreuranium.com/role/ScheduleofeffectoftranslationTable">
    <loc xlink:type="locator" xlink:label="ifrs-full_Assets" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_Assets"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CurrentAssets" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_CurrentAssets"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_Assets" xlink:to="ifrs-full_CurrentAssets" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_NoncurrentAssets" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_NoncurrentAssets"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_Assets" xlink:to="ifrs-full_NoncurrentAssets" order="2" weight="1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_Liabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_Liabilities"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CurrentLiabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_CurrentLiabilities"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_Liabilities" xlink:to="ifrs-full_CurrentLiabilities" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_NoncurrentLiabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_NoncurrentLiabilities"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_Liabilities" xlink:to="ifrs-full_NoncurrentLiabilities" order="2" weight="1"/>
  </calculationLink>
  <calculationLink xlink:type="extended" xlink:role="http://encoreuranium.com/role/ScheduleofconsolidatedstatementsoflossandcomprehensivelossTable">
    <loc xlink:type="locator" xlink:label="ifrs-full_OtherOperatingIncomeExpense" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_OtherOperatingIncomeExpense"/>
    <loc xlink:type="locator" xlink:label="cve_Accretion" xlink:href="cve-20221231.xsd#cve_Accretion"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_OtherOperatingIncomeExpense" xlink:to="cve_Accretion" order="1" weight="-1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AdjustmentsForDepreciationAndAmortisationExpense" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_AdjustmentsForDepreciationAndAmortisationExpense"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_OtherOperatingIncomeExpense" xlink:to="ifrs-full_AdjustmentsForDepreciationAndAmortisationExpense" order="2" weight="-1"/>
    <loc xlink:type="locator" xlink:label="cve_Consulting" xlink:href="cve-20221231.xsd#cve_Consulting"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_OtherOperatingIncomeExpense" xlink:to="cve_Consulting" order="3" weight="-1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AdministrativeExpense" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_AdministrativeExpense"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_OtherOperatingIncomeExpense" xlink:to="ifrs-full_AdministrativeExpense" order="4" weight="-1"/>
    <loc xlink:type="locator" xlink:label="cve_ImpairmentCharges" xlink:href="cve-20221231.xsd#cve_ImpairmentCharges"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_OtherOperatingIncomeExpense" xlink:to="cve_ImpairmentCharges" order="5" weight="-1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_InterestExpense" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_InterestExpense"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_OtherOperatingIncomeExpense" xlink:to="ifrs-full_InterestExpense" order="6" weight="-1"/>
    <loc xlink:type="locator" xlink:label="cve_OfficeAndAdministrative" xlink:href="cve-20221231.xsd#cve_OfficeAndAdministrative"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_OtherOperatingIncomeExpense" xlink:to="cve_OfficeAndAdministrative" order="7" weight="-1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ProfessionalFeesExpense" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_ProfessionalFeesExpense"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_OtherOperatingIncomeExpense" xlink:to="ifrs-full_ProfessionalFeesExpense" order="8" weight="-1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_OtherExpenseByNature" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_OtherExpenseByNature"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_OtherOperatingIncomeExpense" xlink:to="ifrs-full_OtherExpenseByNature" order="9" weight="-1"/>
    <loc xlink:type="locator" xlink:label="cve_ReclamationCosts" xlink:href="cve-20221231.xsd#cve_ReclamationCosts"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_OtherOperatingIncomeExpense" xlink:to="cve_ReclamationCosts" order="10" weight="-1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_TravelExpense" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_TravelExpense"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_OtherOperatingIncomeExpense" xlink:to="ifrs-full_TravelExpense" order="11" weight="-1"/>
    <loc xlink:type="locator" xlink:label="cve_TransferAgentAndFilingFees" xlink:href="cve-20221231.xsd#cve_TransferAgentAndFilingFees"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_OtherOperatingIncomeExpense" xlink:to="cve_TransferAgentAndFilingFees" order="12" weight="-1"/>
    <loc xlink:type="locator" xlink:label="cve_StaffCosts" xlink:href="cve-20221231.xsd#cve_StaffCosts"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_OtherOperatingIncomeExpense" xlink:to="cve_StaffCosts" order="13" weight="-1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockOptionPlanExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockOptionPlanExpense"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_OtherOperatingIncomeExpense" xlink:to="us-gaap_StockOptionPlanExpense" order="14" weight="-1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_NetForeignExchangeLoss" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_NetForeignExchangeLoss"/>
    <loc xlink:type="locator" xlink:label="cve_LossesOnDivestmentOfMineralProperties" xlink:href="cve-20221231.xsd#cve_LossesOnDivestmentOfMineralProperties"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_NetForeignExchangeLoss" xlink:to="cve_LossesOnDivestmentOfMineralProperties" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LossOnContractTermination" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossOnContractTermination"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_NetForeignExchangeLoss" xlink:to="us-gaap_LossOnContractTermination" order="2" weight="1"/>
    <loc xlink:type="locator" xlink:label="cve_LossOnInvestmentInAssociate" xlink:href="cve-20221231.xsd#cve_LossOnInvestmentInAssociate"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_NetForeignExchangeLoss" xlink:to="cve_LossOnInvestmentInAssociate" order="3" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_NetForeignExchangeLoss" xlink:to="ifrs-full_OtherOperatingIncomeExpense" order="4" weight="-1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_InterestRevenueExpense" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_InterestRevenueExpense"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_NetForeignExchangeLoss" xlink:to="ifrs-full_InterestRevenueExpense" order="5" weight="-1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ForeignExchangeGain" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_ForeignExchangeGain"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_NetForeignExchangeLoss" xlink:to="ifrs-full_ForeignExchangeGain" order="6" weight="-1"/>
    <loc xlink:type="locator" xlink:label="cve_GainOnChangeInAssetRetirementObligationEstimate" xlink:href="cve-20221231.xsd#cve_GainOnChangeInAssetRetirementObligationEstimate"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_NetForeignExchangeLoss" xlink:to="cve_GainOnChangeInAssetRetirementObligationEstimate" order="7" weight="-1"/>
    <loc xlink:type="locator" xlink:label="cve_UnrealizedGainOnUraniumInvestment" xlink:href="cve-20221231.xsd#cve_UnrealizedGainOnUraniumInvestment"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_NetForeignExchangeLoss" xlink:to="cve_UnrealizedGainOnUraniumInvestment" order="8" weight="-1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_GainsOnDisposalsOfInvestmentProperties" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_GainsOnDisposalsOfInvestmentProperties"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_NetForeignExchangeLoss" xlink:to="ifrs-full_GainsOnDisposalsOfInvestmentProperties" order="9" weight="-1"/>
  </calculationLink>
</linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>48
<FILENAME>cve-20221231_def.xml
<DESCRIPTION>XBRL DEFINITION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!-- Generated by CompSci Transform (tm) - http://www.compsciresources.com -->
<!-- Created: Fri Apr 28 19:14:45 UTC 2023 -->
<linkbase xmlns="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:xbrldt="http://xbrl.org/2005/xbrldt">
  <roleRef xlink:type="simple" xlink:href="cve-20221231.xsd#cve_r_ConsolidatedBalanceSheet" roleURI="http://encoreuranium.com/role/ConsolidatedBalanceSheet"/>
  <roleRef xlink:type="simple" xlink:href="cve-20221231.xsd#cve_r_ConsolidatedComprehensiveIncome" roleURI="http://encoreuranium.com/role/ConsolidatedComprehensiveIncome"/>
  <roleRef xlink:type="simple" xlink:href="cve-20221231.xsd#cve_r_ConsolidatedComprehensiveIncome_Parentheticals" roleURI="http://encoreuranium.com/role/ConsolidatedComprehensiveIncome_Parentheticals"/>
  <roleRef xlink:type="simple" xlink:href="cve-20221231.xsd#cve_r_ConsolidatedCashFlow" roleURI="http://encoreuranium.com/role/ConsolidatedCashFlow"/>
  <roleRef xlink:type="simple" xlink:href="cve-20221231.xsd#cve_r_ShareholdersEquityType2or3" roleURI="http://encoreuranium.com/role/ShareholdersEquityType2or3"/>
  <roleRef xlink:type="simple" xlink:href="cve-20221231.xsd#cve_r_NatureofOperationsandGoingConcern" roleURI="http://encoreuranium.com/role/NatureofOperationsandGoingConcern"/>
  <roleRef xlink:type="simple" xlink:href="cve-20221231.xsd#cve_r_Significantaccountingpolicies" roleURI="http://encoreuranium.com/role/Significantaccountingpolicies"/>
  <roleRef xlink:type="simple" xlink:href="cve-20221231.xsd#cve_r_CriticalAccountingEstimatesAndJudgements" roleURI="http://encoreuranium.com/role/CriticalAccountingEstimatesAndJudgements"/>
  <roleRef xlink:type="simple" xlink:href="cve-20221231.xsd#cve_r_InvestmentInAssociate" roleURI="http://encoreuranium.com/role/InvestmentInAssociate"/>
  <roleRef xlink:type="simple" xlink:href="cve-20221231.xsd#cve_r_Investmentinuranium" roleURI="http://encoreuranium.com/role/Investmentinuranium"/>
  <roleRef xlink:type="simple" xlink:href="cve-20221231.xsd#cve_r_MarketableSecurities" roleURI="http://encoreuranium.com/role/MarketableSecurities"/>
  <roleRef xlink:type="simple" xlink:href="cve-20221231.xsd#cve_r_Intangibleassets" roleURI="http://encoreuranium.com/role/Intangibleassets"/>
  <roleRef xlink:type="simple" xlink:href="cve-20221231.xsd#cve_r_Propertyplantandequipment" roleURI="http://encoreuranium.com/role/Propertyplantandequipment"/>
  <roleRef xlink:type="simple" xlink:href="cve-20221231.xsd#cve_r_Rightofuseassets" roleURI="http://encoreuranium.com/role/Rightofuseassets"/>
  <roleRef xlink:type="simple" xlink:href="cve-20221231.xsd#cve_r_Assetacquisition" roleURI="http://encoreuranium.com/role/Assetacquisition"/>
  <roleRef xlink:type="simple" xlink:href="cve-20221231.xsd#cve_r_MineralProperties" roleURI="http://encoreuranium.com/role/MineralProperties"/>
  <roleRef xlink:type="simple" xlink:href="cve-20221231.xsd#cve_r_Assetretirementobligations" roleURI="http://encoreuranium.com/role/Assetretirementobligations"/>
  <roleRef xlink:type="simple" xlink:href="cve-20221231.xsd#cve_r_Salescontracts" roleURI="http://encoreuranium.com/role/Salescontracts"/>
  <roleRef xlink:type="simple" xlink:href="cve-20221231.xsd#cve_r_ShareCapital" roleURI="http://encoreuranium.com/role/ShareCapital"/>
  <roleRef xlink:type="simple" xlink:href="cve-20221231.xsd#cve_r_Relatedpartytransactionsandbalances" roleURI="http://encoreuranium.com/role/Relatedpartytransactionsandbalances"/>
  <roleRef xlink:type="simple" xlink:href="cve-20221231.xsd#cve_r_Managementofcapital" roleURI="http://encoreuranium.com/role/Managementofcapital"/>
  <roleRef xlink:type="simple" xlink:href="cve-20221231.xsd#cve_r_FinancialInstruments" roleURI="http://encoreuranium.com/role/FinancialInstruments"/>
  <roleRef xlink:type="simple" xlink:href="cve-20221231.xsd#cve_r_Segmentedinformation" roleURI="http://encoreuranium.com/role/Segmentedinformation"/>
  <roleRef xlink:type="simple" xlink:href="cve-20221231.xsd#cve_r_Supplementaldisclosurewithrespecttocashflows" roleURI="http://encoreuranium.com/role/Supplementaldisclosurewithrespecttocashflows"/>
  <roleRef xlink:type="simple" xlink:href="cve-20221231.xsd#cve_r_Incometaxes" roleURI="http://encoreuranium.com/role/Incometaxes"/>
  <roleRef xlink:type="simple" xlink:href="cve-20221231.xsd#cve_r_ChangeinPresentationCurrency" roleURI="http://encoreuranium.com/role/ChangeinPresentationCurrency"/>
  <roleRef xlink:type="simple" xlink:href="cve-20221231.xsd#cve_r_Eventsafterthereportingperiod" roleURI="http://encoreuranium.com/role/Eventsafterthereportingperiod"/>
  <roleRef xlink:type="simple" xlink:href="cve-20221231.xsd#cve_r_AccountingPoliciesByPolicy" roleURI="http://encoreuranium.com/role/AccountingPoliciesByPolicy"/>
  <roleRef xlink:type="simple" xlink:href="cve-20221231.xsd#cve_r_SignificantaccountingpoliciesTables" roleURI="http://encoreuranium.com/role/SignificantaccountingpoliciesTables"/>
  <roleRef xlink:type="simple" xlink:href="cve-20221231.xsd#cve_r_InvestmentInAssociateTables" roleURI="http://encoreuranium.com/role/InvestmentInAssociateTables"/>
  <roleRef xlink:type="simple" xlink:href="cve-20221231.xsd#cve_r_InvestmentinuraniumTables" roleURI="http://encoreuranium.com/role/InvestmentinuraniumTables"/>
  <roleRef xlink:type="simple" xlink:href="cve-20221231.xsd#cve_r_MarketableSecuritiesTables" roleURI="http://encoreuranium.com/role/MarketableSecuritiesTables"/>
  <roleRef xlink:type="simple" xlink:href="cve-20221231.xsd#cve_r_IntangibleassetsTables" roleURI="http://encoreuranium.com/role/IntangibleassetsTables"/>
  <roleRef xlink:type="simple" xlink:href="cve-20221231.xsd#cve_r_PropertyplantandequipmentTables" roleURI="http://encoreuranium.com/role/PropertyplantandequipmentTables"/>
  <roleRef xlink:type="simple" xlink:href="cve-20221231.xsd#cve_r_RightofuseassetsTables" roleURI="http://encoreuranium.com/role/RightofuseassetsTables"/>
  <roleRef xlink:type="simple" xlink:href="cve-20221231.xsd#cve_r_AssetacquisitionTables" roleURI="http://encoreuranium.com/role/AssetacquisitionTables"/>
  <roleRef xlink:type="simple" xlink:href="cve-20221231.xsd#cve_r_MineralPropertiesTables" roleURI="http://encoreuranium.com/role/MineralPropertiesTables"/>
  <roleRef xlink:type="simple" xlink:href="cve-20221231.xsd#cve_r_AssetretirementobligationsTables" roleURI="http://encoreuranium.com/role/AssetretirementobligationsTables"/>
  <roleRef xlink:type="simple" xlink:href="cve-20221231.xsd#cve_r_SalescontractsTables" roleURI="http://encoreuranium.com/role/SalescontractsTables"/>
  <roleRef xlink:type="simple" xlink:href="cve-20221231.xsd#cve_r_ShareCapitalTables" roleURI="http://encoreuranium.com/role/ShareCapitalTables"/>
  <roleRef xlink:type="simple" xlink:href="cve-20221231.xsd#cve_r_RelatedpartytransactionsandbalancesTables" roleURI="http://encoreuranium.com/role/RelatedpartytransactionsandbalancesTables"/>
  <roleRef xlink:type="simple" xlink:href="cve-20221231.xsd#cve_r_FinancialInstrumentsTables" roleURI="http://encoreuranium.com/role/FinancialInstrumentsTables"/>
  <roleRef xlink:type="simple" xlink:href="cve-20221231.xsd#cve_r_SegmentedinformationTables" roleURI="http://encoreuranium.com/role/SegmentedinformationTables"/>
  <roleRef xlink:type="simple" xlink:href="cve-20221231.xsd#cve_r_SupplementaldisclosurewithrespecttocashflowsTables" roleURI="http://encoreuranium.com/role/SupplementaldisclosurewithrespecttocashflowsTables"/>
  <roleRef xlink:type="simple" xlink:href="cve-20221231.xsd#cve_r_IncometaxesTables" roleURI="http://encoreuranium.com/role/IncometaxesTables"/>
  <roleRef xlink:type="simple" xlink:href="cve-20221231.xsd#cve_r_ChangeinPresentationCurrencyTables" roleURI="http://encoreuranium.com/role/ChangeinPresentationCurrencyTables"/>
  <roleRef xlink:type="simple" xlink:href="cve-20221231.xsd#cve_r_ScheduleofexchangeratesTable" roleURI="http://encoreuranium.com/role/ScheduleofexchangeratesTable"/>
  <roleRef xlink:type="simple" xlink:href="cve-20221231.xsd#cve_r_ScheduleofsignificantsubsidiariesTable" roleURI="http://encoreuranium.com/role/ScheduleofsignificantsubsidiariesTable"/>
  <roleRef xlink:type="simple" xlink:href="cve-20221231.xsd#cve_r_ScheduleofusefullivesofpropertyplantandequipementTable" roleURI="http://encoreuranium.com/role/ScheduleofusefullivesofpropertyplantandequipementTable"/>
  <roleRef xlink:type="simple" xlink:href="cve-20221231.xsd#cve_r_ScheduleofusefullivesofintangibleassetsTable" roleURI="http://encoreuranium.com/role/ScheduleofusefullivesofintangibleassetsTable"/>
  <roleRef xlink:type="simple" xlink:href="cve-20221231.xsd#cve_r_ScheduleofproportionalshareintheassociateTable" roleURI="http://encoreuranium.com/role/ScheduleofproportionalshareintheassociateTable"/>
  <roleRef xlink:type="simple" xlink:href="cve-20221231.xsd#cve_r_ScheduleofinvestmentinassociatecontinuityTable" roleURI="http://encoreuranium.com/role/ScheduleofinvestmentinassociatecontinuityTable"/>
  <roleRef xlink:type="simple" xlink:href="cve-20221231.xsd#cve_r_ScheduleofthefairvalueofthephysicaluraniuminvestmentTable" roleURI="http://encoreuranium.com/role/ScheduleofthefairvalueofthephysicaluraniuminvestmentTable"/>
  <roleRef xlink:type="simple" xlink:href="cve-20221231.xsd#cve_r_ScheduleofuraniumconcentratespurchaseagreementTable" roleURI="http://encoreuranium.com/role/ScheduleofuraniumconcentratespurchaseagreementTable"/>
  <roleRef xlink:type="simple" xlink:href="cve-20221231.xsd#cve_r_ScheduleofmarketablesecuritiesTable" roleURI="http://encoreuranium.com/role/ScheduleofmarketablesecuritiesTable"/>
  <roleRef xlink:type="simple" xlink:href="cve-20221231.xsd#cve_r_ScheduleofintangibleassetwasdeterminedTable" roleURI="http://encoreuranium.com/role/ScheduleofintangibleassetwasdeterminedTable"/>
  <roleRef xlink:type="simple" xlink:href="cve-20221231.xsd#cve_r_ScheduleofpropertyplantandequipmentTable" roleURI="http://encoreuranium.com/role/ScheduleofpropertyplantandequipmentTable"/>
  <roleRef xlink:type="simple" xlink:href="cve-20221231.xsd#cve_r_ScheduleofchangeintheROUassetsTable" roleURI="http://encoreuranium.com/role/ScheduleofchangeintheROUassetsTable"/>
  <roleRef xlink:type="simple" xlink:href="cve-20221231.xsd#cve_r_ScheduleofchangeinthelongTermleaseliabilityTable" roleURI="http://encoreuranium.com/role/ScheduleofchangeinthelongTermleaseliabilityTable"/>
  <roleRef xlink:type="simple" xlink:href="cve-20221231.xsd#cve_r_ScheduleofundiscountedfutureleasepaymentsTable" roleURI="http://encoreuranium.com/role/ScheduleofundiscountedfutureleasepaymentsTable"/>
  <roleRef xlink:type="simple" xlink:href="cve-20221231.xsd#cve_r_ScheduleofestimatedfairvalueofassetsandliabilitiesTable" roleURI="http://encoreuranium.com/role/ScheduleofestimatedfairvalueofassetsandliabilitiesTable"/>
  <roleRef xlink:type="simple" xlink:href="cve-20221231.xsd#cve_r_ScheduleofnetassetsacquiredTable" roleURI="http://encoreuranium.com/role/ScheduleofnetassetsacquiredTable"/>
  <roleRef xlink:type="simple" xlink:href="cve-20221231.xsd#cve_r_ScheduleofweightedaverageassumptionsusedintheblackscholesoptionTable" roleURI="http://encoreuranium.com/role/ScheduleofweightedaverageassumptionsusedintheblackscholesoptionTable"/>
  <roleRef xlink:type="simple" xlink:href="cve-20221231.xsd#cve_r_ScheduleofmineralpropertiesTable" roleURI="http://encoreuranium.com/role/ScheduleofmineralpropertiesTable"/>
  <roleRef xlink:type="simple" xlink:href="cve-20221231.xsd#cve_r_ScheduleofassetretirementobligationsbalanceTable" roleURI="http://encoreuranium.com/role/ScheduleofassetretirementobligationsbalanceTable"/>
  <roleRef xlink:type="simple" xlink:href="cve-20221231.xsd#cve_r_ScheduleofassetretirementobligationscontinuityTable" roleURI="http://encoreuranium.com/role/ScheduleofassetretirementobligationscontinuityTable"/>
  <roleRef xlink:type="simple" xlink:href="cve-20221231.xsd#cve_r_ScheduleofuraniumsalescontractsoverthenextfiveyearsTable" roleURI="http://encoreuranium.com/role/ScheduleofuraniumsalescontractsoverthenextfiveyearsTable"/>
  <roleRef xlink:type="simple" xlink:href="cve-20221231.xsd#cve_r_ScheduleofthecompanysstockoptionsoutstandingTable" roleURI="http://encoreuranium.com/role/ScheduleofthecompanysstockoptionsoutstandingTable"/>
  <roleRef xlink:type="simple" xlink:href="cve-20221231.xsd#cve_r_ScheduleofstockoptionsoutstandingTable" roleURI="http://encoreuranium.com/role/ScheduleofstockoptionsoutstandingTable"/>
  <roleRef xlink:type="simple" xlink:href="cve-20221231.xsd#cve_r_ScheduleofweightedaverageassumptionsusedincalculatingthefairvaluesTable" roleURI="http://encoreuranium.com/role/ScheduleofweightedaverageassumptionsusedincalculatingthefairvaluesTable"/>
  <roleRef xlink:type="simple" xlink:href="cve-20221231.xsd#cve_r_ScheduleofthestatusofthecompanyswarrantsTable" roleURI="http://encoreuranium.com/role/ScheduleofthestatusofthecompanyswarrantsTable"/>
  <roleRef xlink:type="simple" xlink:href="cve-20221231.xsd#cve_r_ScheduleofsharepurchasewarrantsoutstandingTable" roleURI="http://encoreuranium.com/role/ScheduleofsharepurchasewarrantsoutstandingTable"/>
  <roleRef xlink:type="simple" xlink:href="cve-20221231.xsd#cve_r_ScheduleofamountspaidtokeymanagementorentitiesprovidingsimilarservicesTable" roleURI="http://encoreuranium.com/role/ScheduleofamountspaidtokeymanagementorentitiesprovidingsimilarservicesTable"/>
  <roleRef xlink:type="simple" xlink:href="cve-20221231.xsd#cve_r_ScheduleofowingtorelatedpartiesTable" roleURI="http://encoreuranium.com/role/ScheduleofowingtorelatedpartiesTable"/>
  <roleRef xlink:type="simple" xlink:href="cve-20221231.xsd#cve_r_ScheduleofforeigncurrencyexposuresTable" roleURI="http://encoreuranium.com/role/ScheduleofforeigncurrencyexposuresTable"/>
  <roleRef xlink:type="simple" xlink:href="cve-20221231.xsd#cve_r_ScheduleoflongtermassetsbygeographicsegmentTable" roleURI="http://encoreuranium.com/role/ScheduleoflongtermassetsbygeographicsegmentTable"/>
  <roleRef xlink:type="simple" xlink:href="cve-20221231.xsd#cve_r_ScheduleofincurrednoncashfinancingandinvestingactivitiesTable" roleURI="http://encoreuranium.com/role/ScheduleofincurrednoncashfinancingandinvestingactivitiesTable"/>
  <roleRef xlink:type="simple" xlink:href="cve-20221231.xsd#cve_r_ScheduleoffederalandprovincialcorporatetaxratestoincomebeforetaxTable" roleURI="http://encoreuranium.com/role/ScheduleoffederalandprovincialcorporatetaxratestoincomebeforetaxTable"/>
  <roleRef xlink:type="simple" xlink:href="cve-20221231.xsd#cve_r_ScheduleofincometaxexpenserecoveryTable" roleURI="http://encoreuranium.com/role/ScheduleofincometaxexpenserecoveryTable"/>
  <roleRef xlink:type="simple" xlink:href="cve-20221231.xsd#cve_r_ScheduleofdeferredtaxliabilitiesTable" roleURI="http://encoreuranium.com/role/ScheduleofdeferredtaxliabilitiesTable"/>
  <roleRef xlink:type="simple" xlink:href="cve-20221231.xsd#cve_r_ScheduleofunrecognizeddeferredtaxassetsTable" roleURI="http://encoreuranium.com/role/ScheduleofunrecognizeddeferredtaxassetsTable"/>
  <roleRef xlink:type="simple" xlink:href="cve-20221231.xsd#cve_r_ScheduleofeffectoftranslationTable" roleURI="http://encoreuranium.com/role/ScheduleofeffectoftranslationTable"/>
  <roleRef xlink:type="simple" xlink:href="cve-20221231.xsd#cve_r_ScheduleofconsolidatedstatementsoflossandcomprehensivelossTable" roleURI="http://encoreuranium.com/role/ScheduleofconsolidatedstatementsoflossandcomprehensivelossTable"/>
  <roleRef xlink:type="simple" xlink:href="cve-20221231.xsd#cve_r_ScheduleofconsolidatedstatementsoflossandcomprehensivelossTable_Parentheticals" roleURI="http://encoreuranium.com/role/ScheduleofconsolidatedstatementsoflossandcomprehensivelossTable_Parentheticals"/>
  <roleRef xlink:type="simple" xlink:href="cve-20221231.xsd#cve_r_NatureofOperationsandGoingConcernDetails" roleURI="http://encoreuranium.com/role/NatureofOperationsandGoingConcernDetails"/>
  <roleRef xlink:type="simple" xlink:href="cve-20221231.xsd#cve_r_SignificantaccountingpoliciesDetails" roleURI="http://encoreuranium.com/role/SignificantaccountingpoliciesDetails"/>
  <roleRef xlink:type="simple" xlink:href="cve-20221231.xsd#cve_r_InvestmentInAssociateDetails" roleURI="http://encoreuranium.com/role/InvestmentInAssociateDetails"/>
  <roleRef xlink:type="simple" xlink:href="cve-20221231.xsd#cve_r_InvestmentinuraniumDetails" roleURI="http://encoreuranium.com/role/InvestmentinuraniumDetails"/>
  <roleRef xlink:type="simple" xlink:href="cve-20221231.xsd#cve_r_MarketableSecuritiesDetails" roleURI="http://encoreuranium.com/role/MarketableSecuritiesDetails"/>
  <roleRef xlink:type="simple" xlink:href="cve-20221231.xsd#cve_r_IntangibleassetsDetails" roleURI="http://encoreuranium.com/role/IntangibleassetsDetails"/>
  <roleRef xlink:type="simple" xlink:href="cve-20221231.xsd#cve_r_RightofuseassetsDetails" roleURI="http://encoreuranium.com/role/RightofuseassetsDetails"/>
  <roleRef xlink:type="simple" xlink:href="cve-20221231.xsd#cve_r_AssetacquisitionDetails" roleURI="http://encoreuranium.com/role/AssetacquisitionDetails"/>
  <roleRef xlink:type="simple" xlink:href="cve-20221231.xsd#cve_r_MineralPropertiesDetails" roleURI="http://encoreuranium.com/role/MineralPropertiesDetails"/>
  <roleRef xlink:type="simple" xlink:href="cve-20221231.xsd#cve_r_AssetretirementobligationsDetails" roleURI="http://encoreuranium.com/role/AssetretirementobligationsDetails"/>
  <roleRef xlink:type="simple" xlink:href="cve-20221231.xsd#cve_r_SalescontractsDetails" roleURI="http://encoreuranium.com/role/SalescontractsDetails"/>
  <roleRef xlink:type="simple" xlink:href="cve-20221231.xsd#cve_r_ShareCapitalDetails" roleURI="http://encoreuranium.com/role/ShareCapitalDetails"/>
  <roleRef xlink:type="simple" xlink:href="cve-20221231.xsd#cve_r_RelatedpartytransactionsandbalancesDetails" roleURI="http://encoreuranium.com/role/RelatedpartytransactionsandbalancesDetails"/>
  <roleRef xlink:type="simple" xlink:href="cve-20221231.xsd#cve_r_FinancialInstrumentsDetails" roleURI="http://encoreuranium.com/role/FinancialInstrumentsDetails"/>
  <roleRef xlink:type="simple" xlink:href="cve-20221231.xsd#cve_r_IncometaxesDetails" roleURI="http://encoreuranium.com/role/IncometaxesDetails"/>
  <roleRef xlink:type="simple" xlink:href="cve-20221231.xsd#cve_r_EventsafterthereportingperiodDetails" roleURI="http://encoreuranium.com/role/EventsafterthereportingperiodDetails"/>
  <roleRef xlink:type="simple" xlink:href="cve-20221231.xsd#DocumentAndEntityInformation" roleURI="http://encoreuranium.com/role/DocumentAndEntityInformation"/>
  <arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default"/>
  <arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain"/>
  <arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension" arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension"/>
  <arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member" arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member"/>
  <arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all" arcroleURI="http://xbrl.org/int/dim/arcrole/all"/>
  <definitionLink xlink:type="extended" xlink:role="http://encoreuranium.com/role/ConsolidatedBalanceSheet">
    <loc xlink:type="locator" xlink:label="ifrs-full_StatementOfFinancialPositionAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_StatementOfFinancialPositionAbstract"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CurrentAssetsAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_CurrentAssetsAbstract"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_StatementOfFinancialPositionAbstract" xlink:to="ifrs-full_CurrentAssetsAbstract" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CashAndCashEquivalents" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_CashAndCashEquivalents"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_CurrentAssetsAbstract" xlink:to="ifrs-full_CashAndCashEquivalents" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_TradeAndOtherReceivables" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_TradeAndOtherReceivables"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_CurrentAssetsAbstract" xlink:to="ifrs-full_TradeAndOtherReceivables" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cve_MarketableSecuritiecurrent" xlink:href="cve-20221231.xsd#cve_MarketableSecuritiecurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_CurrentAssetsAbstract" xlink:to="cve_MarketableSecuritiecurrent" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cve_DepositUraniumInvestment" xlink:href="cve-20221231.xsd#cve_DepositUraniumInvestment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_CurrentAssetsAbstract" xlink:to="cve_DepositUraniumInvestment" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_NoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSaleOrAsHeldForDistributionToOwners" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_NoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSaleOrAsHeldForDistributionToOwners"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_CurrentAssetsAbstract" xlink:to="ifrs-full_NoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSaleOrAsHeldForDistributionToOwners" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CurrentAssets" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_CurrentAssets"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_CurrentAssetsAbstract" xlink:to="ifrs-full_CurrentAssets" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cve_NonCurrentAssetsAbstract" xlink:href="cve-20221231.xsd#cve_NonCurrentAssetsAbstract"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_StatementOfFinancialPositionAbstract" xlink:to="cve_NonCurrentAssetsAbstract" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_IntangibleAssetsOtherThanGoodwill" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_IntangibleAssetsOtherThanGoodwill"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_NonCurrentAssetsAbstract" xlink:to="ifrs-full_IntangibleAssetsOtherThanGoodwill" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_PropertyPlantAndEquipment" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_PropertyPlantAndEquipment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_NonCurrentAssetsAbstract" xlink:to="ifrs-full_PropertyPlantAndEquipment" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_InvestmentsInAssociates" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_InvestmentsInAssociates"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_NonCurrentAssetsAbstract" xlink:to="ifrs-full_InvestmentsInAssociates" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_InvestmentsInSubsidiariesJointVenturesAndAssociates" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_InvestmentsInSubsidiariesJointVenturesAndAssociates"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_NonCurrentAssetsAbstract" xlink:to="ifrs-full_InvestmentsInSubsidiariesJointVenturesAndAssociates" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cve_MarketablesSecuritiesNoncurrent" xlink:href="cve-20221231.xsd#cve_MarketablesSecuritiesNoncurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_NonCurrentAssetsAbstract" xlink:to="cve_MarketablesSecuritiesNoncurrent" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_MiningAssets" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_MiningAssets"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_NonCurrentAssetsAbstract" xlink:to="ifrs-full_MiningAssets" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_LongtermDeposits" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_LongtermDeposits"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_NonCurrentAssetsAbstract" xlink:to="ifrs-full_LongtermDeposits" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_RightofuseAssets" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_RightofuseAssets"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_NonCurrentAssetsAbstract" xlink:to="ifrs-full_RightofuseAssets" order="7" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DeferredTaxAssets" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_DeferredTaxAssets"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_NonCurrentAssetsAbstract" xlink:to="ifrs-full_DeferredTaxAssets" order="8" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_NoncurrentFinancialAssets" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_NoncurrentFinancialAssets"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_NonCurrentAssetsAbstract" xlink:to="ifrs-full_NoncurrentFinancialAssets" order="9" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_RestrictedCashAndCashEquivalents" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_RestrictedCashAndCashEquivalents"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_NonCurrentAssetsAbstract" xlink:to="ifrs-full_RestrictedCashAndCashEquivalents" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_Assets" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_Assets"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_StatementOfFinancialPositionAbstract" xlink:to="ifrs-full_Assets" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CurrentLiabilitiesAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_CurrentLiabilitiesAbstract"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_StatementOfFinancialPositionAbstract" xlink:to="ifrs-full_CurrentLiabilitiesAbstract" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_TradeAndOtherCurrentPayables" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_TradeAndOtherCurrentPayables"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_CurrentLiabilitiesAbstract" xlink:to="ifrs-full_TradeAndOtherCurrentPayables" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_TradeAndOtherCurrentPayablesToRelatedParties" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_TradeAndOtherCurrentPayablesToRelatedParties"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_CurrentLiabilitiesAbstract" xlink:to="ifrs-full_TradeAndOtherCurrentPayablesToRelatedParties" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_OtherCurrentPayables" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_OtherCurrentPayables"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_CurrentLiabilitiesAbstract" xlink:to="ifrs-full_OtherCurrentPayables" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CurrentLeaseLiabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_CurrentLeaseLiabilities"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_CurrentLiabilitiesAbstract" xlink:to="ifrs-full_CurrentLeaseLiabilities" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CurrentLiabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_CurrentLiabilities"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_CurrentLiabilitiesAbstract" xlink:to="ifrs-full_CurrentLiabilities" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cve_NonCurrentLiabilitiesAbstract" xlink:href="cve-20221231.xsd#cve_NonCurrentLiabilitiesAbstract"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_StatementOfFinancialPositionAbstract" xlink:to="cve_NonCurrentLiabilitiesAbstract" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DefinedBenefitObligationAtPresentValue" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_DefinedBenefitObligationAtPresentValue"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_NonCurrentLiabilitiesAbstract" xlink:to="ifrs-full_DefinedBenefitObligationAtPresentValue" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_NoncurrentLeaseLiabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_NoncurrentLeaseLiabilities"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_NonCurrentLiabilitiesAbstract" xlink:to="ifrs-full_NoncurrentLeaseLiabilities" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_Liabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_Liabilities"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_StatementOfFinancialPositionAbstract" xlink:to="ifrs-full_Liabilities" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityAbstract"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_StockholdersEquityAbstract" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_IssuedCapital" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_IssuedCapital"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="ifrs-full_IssuedCapital" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_SharePremium" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_SharePremium"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="ifrs-full_SharePremium" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cve_ContributedSurplus" xlink:href="cve-20221231.xsd#cve_ContributedSurplus"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="cve_ContributedSurplus" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AccumulatedOtherComprehensiveIncome" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_AccumulatedOtherComprehensiveIncome"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="ifrs-full_AccumulatedOtherComprehensiveIncome" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_RetainedEarnings" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_RetainedEarnings"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="ifrs-full_RetainedEarnings" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_Equity" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_Equity"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_StatementOfFinancialPositionAbstract" xlink:to="ifrs-full_Equity" order="7" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_EquityAndLiabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_EquityAndLiabilities"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_StatementOfFinancialPositionAbstract" xlink:to="ifrs-full_EquityAndLiabilities" order="8" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://encoreuranium.com/role/ConsolidatedComprehensiveIncome">
    <loc xlink:type="locator" xlink:label="cve_ConsolidatedStatementsOfLossAndComprehensiveLossAbstract" xlink:href="cve-20221231.xsd#cve_ConsolidatedStatementsOfLossAndComprehensiveLossAbstract"/>
    <loc xlink:type="locator" xlink:label="cve_ExpensesAbstract" xlink:href="cve-20221231.xsd#cve_ExpensesAbstract"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_ConsolidatedStatementsOfLossAndComprehensiveLossAbstract" xlink:to="cve_ExpensesAbstract" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cve_AccretionExpenses" xlink:href="cve-20221231.xsd#cve_AccretionExpenses"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_ExpensesAbstract" xlink:to="cve_AccretionExpenses" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DepreciationAndAmortisationExpense" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_DepreciationAndAmortisationExpense"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_ExpensesAbstract" xlink:to="ifrs-full_DepreciationAndAmortisationExpense" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cve_CommunityEngagement" xlink:href="cve-20221231.xsd#cve_CommunityEngagement"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_ExpensesAbstract" xlink:to="cve_CommunityEngagement" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cve_Consulting" xlink:href="cve-20221231.xsd#cve_Consulting"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_ExpensesAbstract" xlink:to="cve_Consulting" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_GeneralAndAdministrativeExpense" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_GeneralAndAdministrativeExpense"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_ExpensesAbstract" xlink:to="ifrs-full_GeneralAndAdministrativeExpense" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ImpairmentLossImpairmentGainAndReversalOfImpairmentLossDeterminedInAccordanceWithIFRS9" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_ImpairmentLossImpairmentGainAndReversalOfImpairmentLossDeterminedInAccordanceWithIFRS9"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_ExpensesAbstract" xlink:to="ifrs-full_ImpairmentLossImpairmentGainAndReversalOfImpairmentLossDeterminedInAccordanceWithIFRS9" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_InterestExpense" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_InterestExpense"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_ExpensesAbstract" xlink:to="ifrs-full_InterestExpense" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AdministrativeExpense" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_AdministrativeExpense"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_ExpensesAbstract" xlink:to="ifrs-full_AdministrativeExpense" order="7" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ProfessionalFeesExpense" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_ProfessionalFeesExpense"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_ExpensesAbstract" xlink:to="ifrs-full_ProfessionalFeesExpense" order="8" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cve_ProjectInvestigationFess" xlink:href="cve-20221231.xsd#cve_ProjectInvestigationFess"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_ExpensesAbstract" xlink:to="cve_ProjectInvestigationFess" order="9" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CommunicationExpense" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_CommunicationExpense"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_ExpensesAbstract" xlink:to="ifrs-full_CommunicationExpense" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ReclassificationAdjustmentsOnChangeInValueOfForwardElementsOfForwardContractsNetOfTax" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_ReclassificationAdjustmentsOnChangeInValueOfForwardElementsOfForwardContractsNetOfTax"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_ExpensesAbstract" xlink:to="ifrs-full_ReclassificationAdjustmentsOnChangeInValueOfForwardElementsOfForwardContractsNetOfTax" order="11" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_TravelExpense" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_TravelExpense"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_ExpensesAbstract" xlink:to="ifrs-full_TravelExpense" order="12" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cve_TransferAgentAndFilingFees" xlink:href="cve-20221231.xsd#cve_TransferAgentAndFilingFees"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_ExpensesAbstract" xlink:to="cve_TransferAgentAndFilingFees" order="13" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_WagesAndSalaries" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_WagesAndSalaries"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_ExpensesAbstract" xlink:to="ifrs-full_WagesAndSalaries" order="14" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ExpenseFromSharebasedPaymentTransactionsWithEmployees" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_ExpenseFromSharebasedPaymentTransactionsWithEmployees"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_ExpensesAbstract" xlink:to="ifrs-full_ExpenseFromSharebasedPaymentTransactionsWithEmployees" order="15" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ProfitLossFromOperatingActivities" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_ProfitLossFromOperatingActivities"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_ExpensesAbstract" xlink:to="ifrs-full_ProfitLossFromOperatingActivities" order="16" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_RevenueFromInterest" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_RevenueFromInterest"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_ExpensesAbstract" xlink:to="ifrs-full_RevenueFromInterest" order="17" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cve_LossOnWriteoffOfSalesTaxRecoverable" xlink:href="cve-20221231.xsd#cve_LossOnWriteoffOfSalesTaxRecoverable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_ExpensesAbstract" xlink:to="cve_LossOnWriteoffOfSalesTaxRecoverable" order="18" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_ExpensesAbstract" xlink:to="ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss" order="19" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_GainsLossesOnDisposalsOfPropertyPlantAndEquipment" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_GainsLossesOnDisposalsOfPropertyPlantAndEquipment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_ExpensesAbstract" xlink:to="ifrs-full_GainsLossesOnDisposalsOfPropertyPlantAndEquipment" order="20" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_GainLossOnRemeasurementOfReimbursementRights" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_GainLossOnRemeasurementOfReimbursementRights"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_ExpensesAbstract" xlink:to="ifrs-full_GainLossOnRemeasurementOfReimbursementRights" order="21" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cve_GainOnDisposalOfSubsidiary" xlink:href="cve-20221231.xsd#cve_GainOnDisposalOfSubsidiary"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_ExpensesAbstract" xlink:to="cve_GainOnDisposalOfSubsidiary" order="22" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cve_LossOnContractTerminations" xlink:href="cve-20221231.xsd#cve_LossOnContractTerminations"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_ExpensesAbstract" xlink:to="cve_LossOnContractTerminations" order="23" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cve_UnrealizedGainOnUraniumInvestment" xlink:href="cve-20221231.xsd#cve_UnrealizedGainOnUraniumInvestment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_ExpensesAbstract" xlink:to="cve_UnrealizedGainOnUraniumInvestment" order="24" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cve_GainOnSaleOfUraniumInvestment" xlink:href="cve-20221231.xsd#cve_GainOnSaleOfUraniumInvestment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_ExpensesAbstract" xlink:to="cve_GainOnSaleOfUraniumInvestment" order="25" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cve_UnrealizedGainOnMarketableSecurities" xlink:href="cve-20221231.xsd#cve_UnrealizedGainOnMarketableSecurities"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_ExpensesAbstract" xlink:to="cve_UnrealizedGainOnMarketableSecurities" order="26" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_GainsLossesOnFairValueAdjustmentInvestmentProperty" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_GainsLossesOnFairValueAdjustmentInvestmentProperty"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_ExpensesAbstract" xlink:to="ifrs-full_GainsLossesOnFairValueAdjustmentInvestmentProperty" order="27" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ProfitLoss" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_ProfitLoss"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_ExpensesAbstract" xlink:to="ifrs-full_ProfitLoss" order="28" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_OtherComprehensiveIncomeNetOfTaxHedgesOfNetInvestmentsInForeignOperations" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_OtherComprehensiveIncomeNetOfTaxHedgesOfNetInvestmentsInForeignOperations"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_ProfitLoss" xlink:to="ifrs-full_OtherComprehensiveIncomeNetOfTaxHedgesOfNetInvestmentsInForeignOperations" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ComprehensiveIncome" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_ComprehensiveIncome"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_ExpensesAbstract" xlink:to="ifrs-full_ComprehensiveIncome" order="29" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_WeightedAverageShares" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_WeightedAverageShares"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_ExpensesAbstract" xlink:to="ifrs-full_WeightedAverageShares" order="30" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AdjustedWeightedAverageShares" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_AdjustedWeightedAverageShares"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_ExpensesAbstract" xlink:to="ifrs-full_AdjustedWeightedAverageShares" order="31" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_BasicEarningsLossPerShare" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_BasicEarningsLossPerShare"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_ExpensesAbstract" xlink:to="ifrs-full_BasicEarningsLossPerShare" order="32" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://encoreuranium.com/role/ConsolidatedComprehensiveIncome_Parentheticals">
    <loc xlink:type="locator" xlink:label="cve_ConsolidatedStatementsOfLossAndComprehensiveLossAbstract" xlink:href="cve-20221231.xsd#cve_ConsolidatedStatementsOfLossAndComprehensiveLossAbstract"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DilutedEarningsLossPerShare" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_DilutedEarningsLossPerShare"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_ConsolidatedStatementsOfLossAndComprehensiveLossAbstract" xlink:to="ifrs-full_DilutedEarningsLossPerShare" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://encoreuranium.com/role/ConsolidatedCashFlow">
    <loc xlink:type="locator" xlink:label="ifrs-full_StatementOfCashFlowsAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_StatementOfCashFlowsAbstract"/>
    <loc xlink:type="locator" xlink:label="cve_OperatingActivitiesAbstract" xlink:href="cve-20221231.xsd#cve_OperatingActivitiesAbstract"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_StatementOfCashFlowsAbstract" xlink:to="cve_OperatingActivitiesAbstract" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ProfitLoss" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_ProfitLoss"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_OperatingActivitiesAbstract" xlink:to="ifrs-full_ProfitLoss" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cve_ItemsNotAffectingCashAbstract" xlink:href="cve-20221231.xsd#cve_ItemsNotAffectingCashAbstract"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_OperatingActivitiesAbstract" xlink:to="cve_ItemsNotAffectingCashAbstract" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cve_Accretion" xlink:href="cve-20221231.xsd#cve_Accretion"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_ItemsNotAffectingCashAbstract" xlink:to="cve_Accretion" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AdjustmentsForDepreciationAndAmortisationExpense" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_AdjustmentsForDepreciationAndAmortisationExpense"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_ItemsNotAffectingCashAbstract" xlink:to="ifrs-full_AdjustmentsForDepreciationAndAmortisationExpense" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AdjustmentsForImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLoss" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_AdjustmentsForImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLoss"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_ItemsNotAffectingCashAbstract" xlink:to="ifrs-full_AdjustmentsForImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLoss" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AdjustmentsForUnrealisedForeignExchangeLossesGains" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_AdjustmentsForUnrealisedForeignExchangeLossesGains"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_ItemsNotAffectingCashAbstract" xlink:to="ifrs-full_AdjustmentsForUnrealisedForeignExchangeLossesGains" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AdjustmentsForSharebasedPayments" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_AdjustmentsForSharebasedPayments"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_ItemsNotAffectingCashAbstract" xlink:to="ifrs-full_AdjustmentsForSharebasedPayments" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AdjustmentsForInterestIncome" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_AdjustmentsForInterestIncome"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_ItemsNotAffectingCashAbstract" xlink:to="ifrs-full_AdjustmentsForInterestIncome" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AdjustmentsForDeferredTaxExpense" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_AdjustmentsForDeferredTaxExpense"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_ItemsNotAffectingCashAbstract" xlink:to="ifrs-full_AdjustmentsForDeferredTaxExpense" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AdjustmentsForGainLossOnDisposalsPropertyPlantAndEquipment" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_AdjustmentsForGainLossOnDisposalsPropertyPlantAndEquipment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_ItemsNotAffectingCashAbstract" xlink:to="ifrs-full_AdjustmentsForGainLossOnDisposalsPropertyPlantAndEquipment" order="7" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cve_GainOnDisposalOfSubsidiary" xlink:href="cve-20221231.xsd#cve_GainOnDisposalOfSubsidiary"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_ItemsNotAffectingCashAbstract" xlink:to="cve_GainOnDisposalOfSubsidiary" order="8" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AdjustmentsForIncreaseDecreaseInEmployeeBenefitLiabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_AdjustmentsForIncreaseDecreaseInEmployeeBenefitLiabilities"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_ItemsNotAffectingCashAbstract" xlink:to="ifrs-full_AdjustmentsForIncreaseDecreaseInEmployeeBenefitLiabilities" order="9" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cve_UnrealizedGainOnUraniumInvestment" xlink:href="cve-20221231.xsd#cve_UnrealizedGainOnUraniumInvestment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_ItemsNotAffectingCashAbstract" xlink:to="cve_UnrealizedGainOnUraniumInvestment" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cve_GainOnSaleOfUraniumInvestment" xlink:href="cve-20221231.xsd#cve_GainOnSaleOfUraniumInvestment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_ItemsNotAffectingCashAbstract" xlink:to="cve_GainOnSaleOfUraniumInvestment" order="11" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AdjustmentsForFairValueGainsLosses" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_AdjustmentsForFairValueGainsLosses"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_ItemsNotAffectingCashAbstract" xlink:to="ifrs-full_AdjustmentsForFairValueGainsLosses" order="12" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AdjustmentsForUndistributedProfitsOfAssociates" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_AdjustmentsForUndistributedProfitsOfAssociates"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_ItemsNotAffectingCashAbstract" xlink:to="ifrs-full_AdjustmentsForUndistributedProfitsOfAssociates" order="13" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cve_ChangesInNonCashWorkingCapitalItemsAbstract" xlink:href="cve-20221231.xsd#cve_ChangesInNonCashWorkingCapitalItemsAbstract"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_OperatingActivitiesAbstract" xlink:to="cve_ChangesInNonCashWorkingCapitalItemsAbstract" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AdjustmentsForDecreaseIncreaseInOtherOperatingReceivables" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_AdjustmentsForDecreaseIncreaseInOtherOperatingReceivables"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_ChangesInNonCashWorkingCapitalItemsAbstract" xlink:to="ifrs-full_AdjustmentsForDecreaseIncreaseInOtherOperatingReceivables" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AdjustmentsForIncreaseDecreaseInDepositsFromCustomers" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_AdjustmentsForIncreaseDecreaseInDepositsFromCustomers"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_OperatingActivitiesAbstract" xlink:to="ifrs-full_AdjustmentsForIncreaseDecreaseInDepositsFromCustomers" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_OtherInflowsOutflowsOfCashClassifiedAsOperatingActivities" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_OtherInflowsOutflowsOfCashClassifiedAsOperatingActivities"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_AdjustmentsForIncreaseDecreaseInDepositsFromCustomers" xlink:to="ifrs-full_OtherInflowsOutflowsOfCashClassifiedAsOperatingActivities" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAccountPayable" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAccountPayable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_AdjustmentsForIncreaseDecreaseInDepositsFromCustomers" xlink:to="ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAccountPayable" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CashReceiptsFromRepaymentOfAdvancesAndLoansMadeToRelatedParties" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_CashReceiptsFromRepaymentOfAdvancesAndLoansMadeToRelatedParties"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_AdjustmentsForIncreaseDecreaseInDepositsFromCustomers" xlink:to="ifrs-full_CashReceiptsFromRepaymentOfAdvancesAndLoansMadeToRelatedParties" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CashFlowsFromUsedInOperatingActivities" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_CashFlowsFromUsedInOperatingActivities"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_AdjustmentsForIncreaseDecreaseInDepositsFromCustomers" xlink:to="ifrs-full_CashFlowsFromUsedInOperatingActivities" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cve_InvestingActivitiesAbstract" xlink:href="cve-20221231.xsd#cve_InvestingActivitiesAbstract"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_OperatingActivitiesAbstract" xlink:to="cve_InvestingActivitiesAbstract" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_InvestingActivitiesAbstract" xlink:to="ifrs-full_PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_InvestingActivitiesAbstract" xlink:to="ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_PurchaseOfInvestmentProperty" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_PurchaseOfInvestmentProperty"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_InvestingActivitiesAbstract" xlink:to="ifrs-full_PurchaseOfInvestmentProperty" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ProceedsFromSalesOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_ProceedsFromSalesOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_InvestingActivitiesAbstract" xlink:to="ifrs-full_ProceedsFromSalesOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cve_CashAcquiredFromAzargaAssetAcquisition" xlink:href="cve-20221231.xsd#cve_CashAcquiredFromAzargaAssetAcquisition"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_InvestingActivitiesAbstract" xlink:to="cve_CashAcquiredFromAzargaAssetAcquisition" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cve_TransactionCostsOnAzargaAssetAcquisition" xlink:href="cve-20221231.xsd#cve_TransactionCostsOnAzargaAssetAcquisition"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_InvestingActivitiesAbstract" xlink:to="cve_TransactionCostsOnAzargaAssetAcquisition" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CashFlowsUsedInObtainingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_CashFlowsUsedInObtainingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_InvestingActivitiesAbstract" xlink:to="ifrs-full_CashFlowsUsedInObtainingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_InterestReceivedClassifiedAsInvestingActivities" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_InterestReceivedClassifiedAsInvestingActivities"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_InvestingActivitiesAbstract" xlink:to="ifrs-full_InterestReceivedClassifiedAsInvestingActivities" order="7" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cve_PaymentsofInvestmentInUranium" xlink:href="cve-20221231.xsd#cve_PaymentsofInvestmentInUranium"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_InvestingActivitiesAbstract" xlink:to="cve_PaymentsofInvestmentInUranium" order="8" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cve_ProceedsReceivedFromSaleOfUraniumInvestment" xlink:href="cve-20221231.xsd#cve_ProceedsReceivedFromSaleOfUraniumInvestment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_InvestingActivitiesAbstract" xlink:to="cve_ProceedsReceivedFromSaleOfUraniumInvestment" order="9" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_GainsLossesOnFinancialAssetsAtFairValueThroughProfitOrLoss" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_GainsLossesOnFinancialAssetsAtFairValueThroughProfitOrLoss"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_InvestingActivitiesAbstract" xlink:to="ifrs-full_GainsLossesOnFinancialAssetsAtFairValueThroughProfitOrLoss" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CashFlowsFromUsedInInvestingActivities" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_CashFlowsFromUsedInInvestingActivities"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_InvestingActivitiesAbstract" xlink:to="ifrs-full_CashFlowsFromUsedInInvestingActivities" order="11" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cve_FinancingActivitiesAbstract" xlink:href="cve-20221231.xsd#cve_FinancingActivitiesAbstract"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_OperatingActivitiesAbstract" xlink:to="cve_FinancingActivitiesAbstract" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cve_PrivatePlacementProceeds" xlink:href="cve-20221231.xsd#cve_PrivatePlacementProceeds"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_FinancingActivitiesAbstract" xlink:to="cve_PrivatePlacementProceeds" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_PaymentsForShareIssueCosts" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_PaymentsForShareIssueCosts"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_FinancingActivitiesAbstract" xlink:to="ifrs-full_PaymentsForShareIssueCosts" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ProceedsFromExerciseOfWarrants" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_ProceedsFromExerciseOfWarrants"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_FinancingActivitiesAbstract" xlink:to="ifrs-full_ProceedsFromExerciseOfWarrants" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ProceedsFromExerciseOfOptions" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_ProceedsFromExerciseOfOptions"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_FinancingActivitiesAbstract" xlink:to="ifrs-full_ProceedsFromExerciseOfOptions" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ProceedsFromIssuingShares" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_ProceedsFromIssuingShares"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_FinancingActivitiesAbstract" xlink:to="ifrs-full_ProceedsFromIssuingShares" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_RepaymentsOfBorrowingsClassifiedAsFinancingActivities" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_RepaymentsOfBorrowingsClassifiedAsFinancingActivities"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_FinancingActivitiesAbstract" xlink:to="ifrs-full_RepaymentsOfBorrowingsClassifiedAsFinancingActivities" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_FinancingActivitiesAbstract" xlink:to="ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CashFlowsFromUsedInFinancingActivities" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_CashFlowsFromUsedInFinancingActivities"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_FinancingActivitiesAbstract" xlink:to="ifrs-full_CashFlowsFromUsedInFinancingActivities" order="7" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_OperatingActivitiesAbstract" xlink:to="ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CashFlowsFromUsedInOperationsBeforeChangesInWorkingCapital" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_CashFlowsFromUsedInOperationsBeforeChangesInWorkingCapital"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_OperatingActivitiesAbstract" xlink:to="ifrs-full_CashFlowsFromUsedInOperationsBeforeChangesInWorkingCapital" order="7" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CashAndCashEquivalents" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_CashAndCashEquivalents"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_OperatingActivitiesAbstract" xlink:to="ifrs-full_CashAndCashEquivalents" order="8" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://encoreuranium.com/role/ShareholdersEquityType2or3">
    <loc xlink:type="locator" xlink:label="ifrs-full_StatementOfChangesInEquityLineItems" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_StatementOfChangesInEquityLineItems"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_StatementOfChangesInEquityTable" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_StatementOfChangesInEquityTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="ifrs-full_StatementOfChangesInEquityLineItems" xlink:to="ifrs-full_StatementOfChangesInEquityTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ComponentsOfEquityAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_ComponentsOfEquityAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="ifrs-full_StatementOfChangesInEquityTable" xlink:to="ifrs-full_ComponentsOfEquityAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_EquityMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_EquityMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="ifrs-full_ComponentsOfEquityAxis" xlink:to="ifrs-full_EquityMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_EquityMember_0" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_EquityMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="ifrs-full_ComponentsOfEquityAxis" xlink:to="ifrs-full_EquityMember_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ClassesOfShareCapitalMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_ClassesOfShareCapitalMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_EquityMember" xlink:to="ifrs-full_ClassesOfShareCapitalMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_IssuedCapitalMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_IssuedCapitalMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_EquityMember" xlink:to="ifrs-full_IssuedCapitalMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cve_ContributedSurplusMember" xlink:href="cve-20221231.xsd#cve_ContributedSurplusMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_EquityMember" xlink:to="cve_ContributedSurplusMember" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AccumulatedOtherComprehensiveIncomeMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_AccumulatedOtherComprehensiveIncomeMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_EquityMember" xlink:to="ifrs-full_AccumulatedOtherComprehensiveIncomeMember" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_RetainedEarningsMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_RetainedEarningsMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_EquityMember" xlink:to="ifrs-full_RetainedEarningsMember" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_Equity" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_Equity"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_StatementOfChangesInEquityLineItems" xlink:to="ifrs-full_Equity" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_NumberOfSharesOutstanding" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_NumberOfSharesOutstanding"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_StatementOfChangesInEquityLineItems" xlink:to="ifrs-full_NumberOfSharesOutstanding" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cve_PrivatePlacement" xlink:href="cve-20221231.xsd#cve_PrivatePlacement"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_StatementOfChangesInEquityLineItems" xlink:to="cve_PrivatePlacement" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cve_PrivatePlacementinShares" xlink:href="cve-20221231.xsd#cve_PrivatePlacementinShares"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_StatementOfChangesInEquityLineItems" xlink:to="cve_PrivatePlacementinShares" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ShareIssueRelatedCost" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_ShareIssueRelatedCost"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_StatementOfChangesInEquityLineItems" xlink:to="ifrs-full_ShareIssueRelatedCost" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_IncreaseDecreaseThroughExerciseOfWarrantsEquity" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_IncreaseDecreaseThroughExerciseOfWarrantsEquity"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_StatementOfChangesInEquityLineItems" xlink:to="ifrs-full_IncreaseDecreaseThroughExerciseOfWarrantsEquity" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cve_SharesIssuedForExerciseOfWarrantsShares" xlink:href="cve-20221231.xsd#cve_SharesIssuedForExerciseOfWarrantsShares"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_StatementOfChangesInEquityLineItems" xlink:to="cve_SharesIssuedForExerciseOfWarrantsShares" order="7" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_IncreaseDecreaseThroughExerciseOfOptions" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_IncreaseDecreaseThroughExerciseOfOptions"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_StatementOfChangesInEquityLineItems" xlink:to="ifrs-full_IncreaseDecreaseThroughExerciseOfOptions" order="8" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cve_SharesIssuedForExerciseOfStockOptionsShares" xlink:href="cve-20221231.xsd#cve_SharesIssuedForExerciseOfStockOptionsShares"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_StatementOfChangesInEquityLineItems" xlink:to="cve_SharesIssuedForExerciseOfStockOptionsShares" order="9" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cve_StockOptionExpense" xlink:href="cve-20221231.xsd#cve_StockOptionExpense"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_StatementOfChangesInEquityLineItems" xlink:to="cve_StockOptionExpense" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_IssueOfEquity" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_IssueOfEquity"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_StatementOfChangesInEquityLineItems" xlink:to="ifrs-full_IssueOfEquity" order="11" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cve_SharesIssuedForServicesShares" xlink:href="cve-20221231.xsd#cve_SharesIssuedForServicesShares"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_StatementOfChangesInEquityLineItems" xlink:to="cve_SharesIssuedForServicesShares" order="12" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cve_ShareSubscriptionsReceived" xlink:href="cve-20221231.xsd#cve_ShareSubscriptionsReceived"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_StatementOfChangesInEquityLineItems" xlink:to="cve_ShareSubscriptionsReceived" order="13" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cve_SharesIssuedForAzargaAssetAcquisition" xlink:href="cve-20221231.xsd#cve_SharesIssuedForAzargaAssetAcquisition"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_StatementOfChangesInEquityLineItems" xlink:to="cve_SharesIssuedForAzargaAssetAcquisition" order="14" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cve_SharesIssuedForAzargaAssetAcquisitionNote10Shares" xlink:href="cve-20221231.xsd#cve_SharesIssuedForAzargaAssetAcquisitionNote10Shares"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_StatementOfChangesInEquityLineItems" xlink:to="cve_SharesIssuedForAzargaAssetAcquisitionNote10Shares" order="15" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cve_ReplacementOptionsForAzargaAssetAcquisition" xlink:href="cve-20221231.xsd#cve_ReplacementOptionsForAzargaAssetAcquisition"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_StatementOfChangesInEquityLineItems" xlink:to="cve_ReplacementOptionsForAzargaAssetAcquisition" order="16" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cve_ReplacementWarrantsForAzargaAssetAcquisition" xlink:href="cve-20221231.xsd#cve_ReplacementWarrantsForAzargaAssetAcquisition"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_StatementOfChangesInEquityLineItems" xlink:to="cve_ReplacementWarrantsForAzargaAssetAcquisition" order="17" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cve_AdjustmentToInvestmentInAssociate" xlink:href="cve-20221231.xsd#cve_AdjustmentToInvestmentInAssociate"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_StatementOfChangesInEquityLineItems" xlink:to="cve_AdjustmentToInvestmentInAssociate" order="18" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationNetOfTax" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationNetOfTax"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_StatementOfChangesInEquityLineItems" xlink:to="ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationNetOfTax" order="19" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ProfitLoss" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_ProfitLoss"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_StatementOfChangesInEquityLineItems" xlink:to="ifrs-full_ProfitLoss" order="20" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://encoreuranium.com/role/NatureofOperationsandGoingConcern">
    <loc xlink:type="locator" xlink:label="cve_NatureofOperationsandGoingConcernLineItems" xlink:href="cve-20221231.xsd#cve_NatureofOperationsandGoingConcernLineItems"/>
    <loc xlink:type="locator" xlink:label="cve_NatureofOperationsandGoingConcernTable" xlink:href="cve-20221231.xsd#cve_NatureofOperationsandGoingConcernTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="cve_NatureofOperationsandGoingConcernLineItems" xlink:to="cve_NatureofOperationsandGoingConcernTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cve_NatureOfOperationAndGoingConcern" xlink:href="cve-20221231.xsd#cve_NatureOfOperationAndGoingConcern"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_NatureofOperationsandGoingConcernLineItems" xlink:to="cve_NatureOfOperationAndGoingConcern" order="1" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://encoreuranium.com/role/Significantaccountingpolicies">
    <loc xlink:type="locator" xlink:label="cve_SignificantaccountingpoliciesLineItems" xlink:href="cve-20221231.xsd#cve_SignificantaccountingpoliciesLineItems"/>
    <loc xlink:type="locator" xlink:label="cve_SignificantaccountingpoliciesTable" xlink:href="cve-20221231.xsd#cve_SignificantaccountingpoliciesTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="cve_SignificantaccountingpoliciesLineItems" xlink:to="cve_SignificantaccountingpoliciesTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_SignificantaccountingpoliciesLineItems" xlink:to="ifrs-full_DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory" order="1" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://encoreuranium.com/role/CriticalAccountingEstimatesAndJudgements">
    <loc xlink:type="locator" xlink:label="cve_CriticalAccountingEstimatesAndJudgementsLineItems" xlink:href="cve-20221231.xsd#cve_CriticalAccountingEstimatesAndJudgementsLineItems"/>
    <loc xlink:type="locator" xlink:label="cve_CriticalAccountingEstimatesAndJudgementsTable" xlink:href="cve-20221231.xsd#cve_CriticalAccountingEstimatesAndJudgementsTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="cve_CriticalAccountingEstimatesAndJudgementsLineItems" xlink:to="cve_CriticalAccountingEstimatesAndJudgementsTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfAccountingJudgementsAndEstimatesExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_DisclosureOfAccountingJudgementsAndEstimatesExplanatory"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_CriticalAccountingEstimatesAndJudgementsLineItems" xlink:to="ifrs-full_DisclosureOfAccountingJudgementsAndEstimatesExplanatory" order="1" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://encoreuranium.com/role/InvestmentInAssociate">
    <loc xlink:type="locator" xlink:label="cve_InvestmentInAssociateLineItems" xlink:href="cve-20221231.xsd#cve_InvestmentInAssociateLineItems"/>
    <loc xlink:type="locator" xlink:label="cve_InvestmentInAssociateTable" xlink:href="cve-20221231.xsd#cve_InvestmentInAssociateTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="cve_InvestmentInAssociateLineItems" xlink:to="cve_InvestmentInAssociateTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesExplanatory"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_InvestmentInAssociateLineItems" xlink:to="ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesExplanatory" order="1" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://encoreuranium.com/role/Investmentinuranium">
    <loc xlink:type="locator" xlink:label="cve_DisclosureOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethodTextBlockAbstract" xlink:href="cve-20221231.xsd#cve_DisclosureOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethodTextBlockAbstract"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethodExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_DisclosureOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethodExplanatory"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_DisclosureOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethodTextBlockAbstract" xlink:to="ifrs-full_DisclosureOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethodExplanatory" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://encoreuranium.com/role/MarketableSecurities">
    <loc xlink:type="locator" xlink:label="us-gaap_MarketableSecuritiesLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MarketableSecuritiesLineItems"/>
    <loc xlink:type="locator" xlink:label="us-gaap_MarketableSecuritiesTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MarketableSecuritiesTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_MarketableSecuritiesLineItems" xlink:to="us-gaap_MarketableSecuritiesTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfMarketRiskExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_DisclosureOfMarketRiskExplanatory"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_MarketableSecuritiesLineItems" xlink:to="ifrs-full_DisclosureOfMarketRiskExplanatory" order="1" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://encoreuranium.com/role/Intangibleassets">
    <loc xlink:type="locator" xlink:label="cve_IntangibleassetsLineItems" xlink:href="cve-20221231.xsd#cve_IntangibleassetsLineItems"/>
    <loc xlink:type="locator" xlink:label="cve_IntangibleassetsTable" xlink:href="cve-20221231.xsd#cve_IntangibleassetsTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="cve_IntangibleassetsLineItems" xlink:to="cve_IntangibleassetsTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfIntangibleAssetsExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_DisclosureOfIntangibleAssetsExplanatory"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_IntangibleassetsLineItems" xlink:to="ifrs-full_DisclosureOfIntangibleAssetsExplanatory" order="1" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://encoreuranium.com/role/Propertyplantandequipment">
    <loc xlink:type="locator" xlink:label="cve_DisclosureOfPropertyPlantAndEquipmentTextBlockAbstract" xlink:href="cve-20221231.xsd#cve_DisclosureOfPropertyPlantAndEquipmentTextBlockAbstract"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfPropertyPlantAndEquipmentExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_DisclosureOfPropertyPlantAndEquipmentExplanatory"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_DisclosureOfPropertyPlantAndEquipmentTextBlockAbstract" xlink:to="ifrs-full_DisclosureOfPropertyPlantAndEquipmentExplanatory" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://encoreuranium.com/role/Rightofuseassets">
    <loc xlink:type="locator" xlink:label="cve_RightofuseassetsLineItems" xlink:href="cve-20221231.xsd#cve_RightofuseassetsLineItems"/>
    <loc xlink:type="locator" xlink:label="cve_RightofuseassetsTable" xlink:href="cve-20221231.xsd#cve_RightofuseassetsTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="cve_RightofuseassetsLineItems" xlink:to="cve_RightofuseassetsTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsExplanatory"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_RightofuseassetsLineItems" xlink:to="ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsExplanatory" order="1" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://encoreuranium.com/role/Assetacquisition">
    <loc xlink:type="locator" xlink:label="cve_DisclosureOfTransactionsRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombinationTextBlockAbstract" xlink:href="cve-20221231.xsd#cve_DisclosureOfTransactionsRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombinationTextBlockAbstract"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfTransactionsRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombinationExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_DisclosureOfTransactionsRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombinationExplanatory"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_DisclosureOfTransactionsRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombinationTextBlockAbstract" xlink:to="ifrs-full_DisclosureOfTransactionsRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombinationExplanatory" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://encoreuranium.com/role/MineralProperties">
    <loc xlink:type="locator" xlink:label="cve_DisclosureOfMineralPropertiesAbstract" xlink:href="cve-20221231.xsd#cve_DisclosureOfMineralPropertiesAbstract"/>
    <loc xlink:type="locator" xlink:label="cve_DisclosureOfMineralProperties" xlink:href="cve-20221231.xsd#cve_DisclosureOfMineralProperties"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_DisclosureOfMineralPropertiesAbstract" xlink:to="cve_DisclosureOfMineralProperties" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://encoreuranium.com/role/Assetretirementobligations">
    <loc xlink:type="locator" xlink:label="cve_AssetretirementobligationsLineItems" xlink:href="cve-20221231.xsd#cve_AssetretirementobligationsLineItems"/>
    <loc xlink:type="locator" xlink:label="cve_AssetretirementobligationsTable" xlink:href="cve-20221231.xsd#cve_AssetretirementobligationsTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="cve_AssetretirementobligationsLineItems" xlink:to="cve_AssetretirementobligationsTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cve_AssetRetirementObligationsTextBlock" xlink:href="cve-20221231.xsd#cve_AssetRetirementObligationsTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_AssetretirementobligationsLineItems" xlink:to="cve_AssetRetirementObligationsTextBlock" order="1" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://encoreuranium.com/role/Salescontracts">
    <loc xlink:type="locator" xlink:label="cve_SalescontractsLineItems" xlink:href="cve-20221231.xsd#cve_SalescontractsLineItems"/>
    <loc xlink:type="locator" xlink:label="cve_SalescontractsTable" xlink:href="cve-20221231.xsd#cve_SalescontractsTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="cve_SalescontractsLineItems" xlink:to="cve_SalescontractsTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cve_DisclosueOfSalesContractsTextBlock" xlink:href="cve-20221231.xsd#cve_DisclosueOfSalesContractsTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_SalescontractsLineItems" xlink:to="cve_DisclosueOfSalesContractsTextBlock" order="1" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://encoreuranium.com/role/ShareCapital">
    <loc xlink:type="locator" xlink:label="cve_ShareCapitalLineItems" xlink:href="cve-20221231.xsd#cve_ShareCapitalLineItems"/>
    <loc xlink:type="locator" xlink:label="cve_ShareCapitalTable" xlink:href="cve-20221231.xsd#cve_ShareCapitalTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="cve_ShareCapitalLineItems" xlink:to="cve_ShareCapitalTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfClassesOfShareCapitalExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_DisclosureOfClassesOfShareCapitalExplanatory"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_ShareCapitalLineItems" xlink:to="ifrs-full_DisclosureOfClassesOfShareCapitalExplanatory" order="1" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://encoreuranium.com/role/Relatedpartytransactionsandbalances">
    <loc xlink:type="locator" xlink:label="cve_DisclosureOfRelatedPartyTextBlockAbstract" xlink:href="cve-20221231.xsd#cve_DisclosureOfRelatedPartyTextBlockAbstract"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfRelatedPartyExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_DisclosureOfRelatedPartyExplanatory"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_DisclosureOfRelatedPartyTextBlockAbstract" xlink:to="ifrs-full_DisclosureOfRelatedPartyExplanatory" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://encoreuranium.com/role/Managementofcapital">
    <loc xlink:type="locator" xlink:label="cve_DisclosureOfHowEntityManagesLiquidityRiskTextBlockAbstract" xlink:href="cve-20221231.xsd#cve_DisclosureOfHowEntityManagesLiquidityRiskTextBlockAbstract"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DescriptionOfManagingLiquidityRisk" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_DescriptionOfManagingLiquidityRisk"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_DisclosureOfHowEntityManagesLiquidityRiskTextBlockAbstract" xlink:to="ifrs-full_DescriptionOfManagingLiquidityRisk" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://encoreuranium.com/role/FinancialInstruments">
    <loc xlink:type="locator" xlink:label="cve_DisclosureOfFinancialInstrumentsTextBlockAbstract" xlink:href="cve-20221231.xsd#cve_DisclosureOfFinancialInstrumentsTextBlockAbstract"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfFinancialInstrumentsExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_DisclosureOfFinancialInstrumentsExplanatory"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_DisclosureOfFinancialInstrumentsTextBlockAbstract" xlink:to="ifrs-full_DisclosureOfFinancialInstrumentsExplanatory" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://encoreuranium.com/role/Segmentedinformation">
    <loc xlink:type="locator" xlink:label="cve_SegmentedinformationLineItems" xlink:href="cve-20221231.xsd#cve_SegmentedinformationLineItems"/>
    <loc xlink:type="locator" xlink:label="cve_SegmentedinformationTable" xlink:href="cve-20221231.xsd#cve_SegmentedinformationTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="cve_SegmentedinformationLineItems" xlink:to="cve_SegmentedinformationTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfEntitysReportableSegmentsExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_DisclosureOfEntitysReportableSegmentsExplanatory"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_SegmentedinformationLineItems" xlink:to="ifrs-full_DisclosureOfEntitysReportableSegmentsExplanatory" order="1" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://encoreuranium.com/role/Supplementaldisclosurewithrespecttocashflows">
    <loc xlink:type="locator" xlink:label="cve_SupplementalDisclosureWithRespectToCashflowsAbstract" xlink:href="cve-20221231.xsd#cve_SupplementalDisclosureWithRespectToCashflowsAbstract"/>
    <loc xlink:type="locator" xlink:label="cve_SupplementalDisclosureWithRespectToCashflowsTextBlock" xlink:href="cve-20221231.xsd#cve_SupplementalDisclosureWithRespectToCashflowsTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_SupplementalDisclosureWithRespectToCashflowsAbstract" xlink:to="cve_SupplementalDisclosureWithRespectToCashflowsTextBlock" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://encoreuranium.com/role/Incometaxes">
    <loc xlink:type="locator" xlink:label="cve_DisclosureOfIncomeTaxTextBlockAbstract" xlink:href="cve-20221231.xsd#cve_DisclosureOfIncomeTaxTextBlockAbstract"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfIncomeTaxExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_DisclosureOfIncomeTaxExplanatory"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_DisclosureOfIncomeTaxTextBlockAbstract" xlink:to="ifrs-full_DisclosureOfIncomeTaxExplanatory" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://encoreuranium.com/role/ChangeinPresentationCurrency">
    <loc xlink:type="locator" xlink:label="cve_DisclosureOfReclassificationsOrChangesInPresentationTextBlockAbstract" xlink:href="cve-20221231.xsd#cve_DisclosureOfReclassificationsOrChangesInPresentationTextBlockAbstract"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfReclassificationsOrChangesInPresentationExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_DisclosureOfReclassificationsOrChangesInPresentationExplanatory"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_DisclosureOfReclassificationsOrChangesInPresentationTextBlockAbstract" xlink:to="ifrs-full_DisclosureOfReclassificationsOrChangesInPresentationExplanatory" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://encoreuranium.com/role/Eventsafterthereportingperiod">
    <loc xlink:type="locator" xlink:label="cve_DisclosureOfEventsAfterReportingPeriodTextBlockAbstract" xlink:href="cve-20221231.xsd#cve_DisclosureOfEventsAfterReportingPeriodTextBlockAbstract"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfEventsAfterReportingPeriodExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_DisclosureOfEventsAfterReportingPeriodExplanatory"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_DisclosureOfEventsAfterReportingPeriodTextBlockAbstract" xlink:to="ifrs-full_DisclosureOfEventsAfterReportingPeriodExplanatory" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://encoreuranium.com/role/AccountingPoliciesByPolicy">
    <loc xlink:type="locator" xlink:label="us-gaap_AccountingPoliciesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <loc xlink:type="locator" xlink:label="cve_DescriptionOfAccountingPolicyForBasisOfPresentationtextBlock" xlink:href="cve-20221231.xsd#cve_DescriptionOfAccountingPolicyForBasisOfPresentationtextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="cve_DescriptionOfAccountingPolicyForBasisOfPresentationtextBlock" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cve_DescriptionOfAccountingPolicyForChangeInPresentationCurrencytextBlock" xlink:href="cve-20221231.xsd#cve_DescriptionOfAccountingPolicyForChangeInPresentationCurrencytextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="cve_DescriptionOfAccountingPolicyForChangeInPresentationCurrencytextBlock" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cve_DescriptionOfAccountingPolicyForBasisOfConsolidationtextBlock" xlink:href="cve-20221231.xsd#cve_DescriptionOfAccountingPolicyForBasisOfConsolidationtextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="cve_DescriptionOfAccountingPolicyForBasisOfConsolidationtextBlock" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cve_DescriptionOfAccountingPolicyForCashtextBlock" xlink:href="cve-20221231.xsd#cve_DescriptionOfAccountingPolicyForCashtextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="cve_DescriptionOfAccountingPolicyForCashtextBlock" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DescriptionOfAccountingPolicyToDetermineComponentsOfCashAndCashEquivalents" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_DescriptionOfAccountingPolicyToDetermineComponentsOfCashAndCashEquivalents"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="ifrs-full_DescriptionOfAccountingPolicyToDetermineComponentsOfCashAndCashEquivalents" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cve_DescriptionOfAccountingPolicyForAssetRetirementObligationstextBlock" xlink:href="cve-20221231.xsd#cve_DescriptionOfAccountingPolicyForAssetRetirementObligationstextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="cve_DescriptionOfAccountingPolicyForAssetRetirementObligationstextBlock" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForAvailableforsaleFinancialAssetsExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_DescriptionOfAccountingPolicyForAvailableforsaleFinancialAssetsExplanatory"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="ifrs-full_DescriptionOfAccountingPolicyForAvailableforsaleFinancialAssetsExplanatory" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cve_DescriptionOfAccountingPolicyForMineralPropertiestextBlock" xlink:href="cve-20221231.xsd#cve_DescriptionOfAccountingPolicyForMineralPropertiestextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="cve_DescriptionOfAccountingPolicyForMineralPropertiestextBlock" order="7" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cve_DescriptionOfAccountingPolicyForInvestmentsInUraniumtextBlock" xlink:href="cve-20221231.xsd#cve_DescriptionOfAccountingPolicyForInvestmentsInUraniumtextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="cve_DescriptionOfAccountingPolicyForInvestmentsInUraniumtextBlock" order="8" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForInvestmentInAssociates" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_DescriptionOfAccountingPolicyForInvestmentInAssociates"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="ifrs-full_DescriptionOfAccountingPolicyForInvestmentInAssociates" order="9" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="ifrs-full_DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cve_DescriptionOfAccountingPolicyForUraniumPlantstextBlock" xlink:href="cve-20221231.xsd#cve_DescriptionOfAccountingPolicyForUraniumPlantstextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="cve_DescriptionOfAccountingPolicyForUraniumPlantstextBlock" order="11" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cve_DescriptionOfAccountingPolicyForOtherPropertyPlantAndEquipmenttextBlock" xlink:href="cve-20221231.xsd#cve_DescriptionOfAccountingPolicyForOtherPropertyPlantAndEquipmenttextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="cve_DescriptionOfAccountingPolicyForOtherPropertyPlantAndEquipmenttextBlock" order="12" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cve_DescriptionOfAccountingPolicyForBuildingtextBlock" xlink:href="cve-20221231.xsd#cve_DescriptionOfAccountingPolicyForBuildingtextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="cve_DescriptionOfAccountingPolicyForBuildingtextBlock" order="13" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cve_DescriptionOfAccountingPolicyForSoftwaretextBlock" xlink:href="cve-20221231.xsd#cve_DescriptionOfAccountingPolicyForSoftwaretextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="cve_DescriptionOfAccountingPolicyForSoftwaretextBlock" order="14" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForIntangibleAssetsAndGoodwillExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_DescriptionOfAccountingPolicyForIntangibleAssetsAndGoodwillExplanatory"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="ifrs-full_DescriptionOfAccountingPolicyForIntangibleAssetsAndGoodwillExplanatory" order="15" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForImpairmentOfNonfinancialAssetsExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_DescriptionOfAccountingPolicyForImpairmentOfNonfinancialAssetsExplanatory"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="ifrs-full_DescriptionOfAccountingPolicyForImpairmentOfNonfinancialAssetsExplanatory" order="16" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForLeasesExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_DescriptionOfAccountingPolicyForLeasesExplanatory"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="ifrs-full_DescriptionOfAccountingPolicyForLeasesExplanatory" order="17" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForIncomeTaxExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_DescriptionOfAccountingPolicyForIncomeTaxExplanatory"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="ifrs-full_DescriptionOfAccountingPolicyForIncomeTaxExplanatory" order="18" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" order="19" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForEarningsPerShareExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_DescriptionOfAccountingPolicyForEarningsPerShareExplanatory"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="ifrs-full_DescriptionOfAccountingPolicyForEarningsPerShareExplanatory" order="20" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_DescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="ifrs-full_DescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory" order="21" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForWarrantsExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_DescriptionOfAccountingPolicyForWarrantsExplanatory"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="ifrs-full_DescriptionOfAccountingPolicyForWarrantsExplanatory" order="22" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForFinancialInstrumentsExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_DescriptionOfAccountingPolicyForFinancialInstrumentsExplanatory"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="ifrs-full_DescriptionOfAccountingPolicyForFinancialInstrumentsExplanatory" order="23" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForImpairmentOfFinancialAssetsExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_DescriptionOfAccountingPolicyForImpairmentOfFinancialAssetsExplanatory"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="ifrs-full_DescriptionOfAccountingPolicyForImpairmentOfFinancialAssetsExplanatory" order="24" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForDerecognitionOfFinancialInstrumentsExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_DescriptionOfAccountingPolicyForDerecognitionOfFinancialInstrumentsExplanatory"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="ifrs-full_DescriptionOfAccountingPolicyForDerecognitionOfFinancialInstrumentsExplanatory" order="25" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cve_DescriptionOfAccountingPolicyForNewStandardsAndInterpretationsNotYetAdoptedtextBlock" xlink:href="cve-20221231.xsd#cve_DescriptionOfAccountingPolicyForNewStandardsAndInterpretationsNotYetAdoptedtextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="cve_DescriptionOfAccountingPolicyForNewStandardsAndInterpretationsNotYetAdoptedtextBlock" order="26" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://encoreuranium.com/role/SignificantaccountingpoliciesTables">
    <loc xlink:type="locator" xlink:label="cve_SignificantaccountingpoliciesTablesLineItems" xlink:href="cve-20221231.xsd#cve_SignificantaccountingpoliciesTablesLineItems"/>
    <loc xlink:type="locator" xlink:label="cve_SignificantaccountingpoliciesTablesTable" xlink:href="cve-20221231.xsd#cve_SignificantaccountingpoliciesTablesTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="cve_SignificantaccountingpoliciesTablesLineItems" xlink:to="cve_SignificantaccountingpoliciesTablesTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfEffectOfChangesInForeignExchangeRatesExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_DisclosureOfEffectOfChangesInForeignExchangeRatesExplanatory"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_SignificantaccountingpoliciesTablesLineItems" xlink:to="ifrs-full_DisclosureOfEffectOfChangesInForeignExchangeRatesExplanatory" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesExplanatory"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_SignificantaccountingpoliciesTablesLineItems" xlink:to="ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesExplanatory" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cve_DisclosureOfUsefulLivesOfPropertyPlantAndEquipementTextBlock" xlink:href="cve-20221231.xsd#cve_DisclosureOfUsefulLivesOfPropertyPlantAndEquipementTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_SignificantaccountingpoliciesTablesLineItems" xlink:to="cve_DisclosureOfUsefulLivesOfPropertyPlantAndEquipementTextBlock" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cve_DisclosureOfUsefulLivesOfIntangibleAssetsTextBllock" xlink:href="cve-20221231.xsd#cve_DisclosureOfUsefulLivesOfIntangibleAssetsTextBllock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_SignificantaccountingpoliciesTablesLineItems" xlink:to="cve_DisclosureOfUsefulLivesOfIntangibleAssetsTextBllock" order="4" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://encoreuranium.com/role/InvestmentInAssociateTables">
    <loc xlink:type="locator" xlink:label="cve_InvestmentInAssociateTablesLineItems" xlink:href="cve-20221231.xsd#cve_InvestmentInAssociateTablesLineItems"/>
    <loc xlink:type="locator" xlink:label="cve_InvestmentInAssociateTablesTable" xlink:href="cve-20221231.xsd#cve_InvestmentInAssociateTablesTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="cve_InvestmentInAssociateTablesLineItems" xlink:to="cve_InvestmentInAssociateTablesTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cve_DisclosureOfProportionalShareAssociatesExplanatory" xlink:href="cve-20221231.xsd#cve_DisclosureOfProportionalShareAssociatesExplanatory"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_InvestmentInAssociateTablesLineItems" xlink:to="cve_DisclosureOfProportionalShareAssociatesExplanatory" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfInterestsInAssociatesExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_DisclosureOfInterestsInAssociatesExplanatory"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_InvestmentInAssociateTablesLineItems" xlink:to="ifrs-full_DisclosureOfInterestsInAssociatesExplanatory" order="2" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://encoreuranium.com/role/InvestmentinuraniumTables">
    <loc xlink:type="locator" xlink:label="cve_DisclosureOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethodTextBlockAbstract" xlink:href="cve-20221231.xsd#cve_DisclosureOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethodTextBlockAbstract"/>
    <loc xlink:type="locator" xlink:label="cve_ScheduleOfTheFairValueOfThePhysicalUraniumInvestmentTableTextBlck" xlink:href="cve-20221231.xsd#cve_ScheduleOfTheFairValueOfThePhysicalUraniumInvestmentTableTextBlck"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_DisclosureOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethodTextBlockAbstract" xlink:to="cve_ScheduleOfTheFairValueOfThePhysicalUraniumInvestmentTableTextBlck" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cve_ScheduleOfUraniumConcentratesPurchaseAgreementTableTextBlock" xlink:href="cve-20221231.xsd#cve_ScheduleOfUraniumConcentratesPurchaseAgreementTableTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_DisclosureOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethodTextBlockAbstract" xlink:to="cve_ScheduleOfUraniumConcentratesPurchaseAgreementTableTextBlock" order="1" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://encoreuranium.com/role/MarketableSecuritiesTables">
    <loc xlink:type="locator" xlink:label="cve_MarketableSecuritiesTablesLineItems" xlink:href="cve-20221231.xsd#cve_MarketableSecuritiesTablesLineItems"/>
    <loc xlink:type="locator" xlink:label="cve_MarketableSecuritiesTablesTable" xlink:href="cve-20221231.xsd#cve_MarketableSecuritiesTablesTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="cve_MarketableSecuritiesTablesLineItems" xlink:to="cve_MarketableSecuritiesTablesTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cve_ScheduleOfMarketableSecuritiesTableTextBlock" xlink:href="cve-20221231.xsd#cve_ScheduleOfMarketableSecuritiesTableTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_MarketableSecuritiesTablesLineItems" xlink:to="cve_ScheduleOfMarketableSecuritiesTableTextBlock" order="1" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://encoreuranium.com/role/IntangibleassetsTables">
    <loc xlink:type="locator" xlink:label="cve_IntangibleassetsTablesLineItems" xlink:href="cve-20221231.xsd#cve_IntangibleassetsTablesLineItems"/>
    <loc xlink:type="locator" xlink:label="cve_IntangibleassetsTablesTable" xlink:href="cve-20221231.xsd#cve_IntangibleassetsTablesTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="cve_IntangibleassetsTablesLineItems" xlink:to="cve_IntangibleassetsTablesTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfDetailedInformationAboutIntangibleAssetsExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_DisclosureOfDetailedInformationAboutIntangibleAssetsExplanatory"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_IntangibleassetsTablesLineItems" xlink:to="ifrs-full_DisclosureOfDetailedInformationAboutIntangibleAssetsExplanatory" order="1" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://encoreuranium.com/role/PropertyplantandequipmentTables">
    <loc xlink:type="locator" xlink:label="cve_PropertyplantandequipmentTablesLineItems" xlink:href="cve-20221231.xsd#cve_PropertyplantandequipmentTablesLineItems"/>
    <loc xlink:type="locator" xlink:label="cve_PropertyplantandequipmentTablesTable" xlink:href="cve-20221231.xsd#cve_PropertyplantandequipmentTablesTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="cve_PropertyplantandequipmentTablesLineItems" xlink:to="cve_PropertyplantandequipmentTablesTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_PropertyplantandequipmentTablesLineItems" xlink:to="ifrs-full_DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory" order="1" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://encoreuranium.com/role/RightofuseassetsTables">
    <loc xlink:type="locator" xlink:label="cve_RightofuseassetsTablesLineItems" xlink:href="cve-20221231.xsd#cve_RightofuseassetsTablesLineItems"/>
    <loc xlink:type="locator" xlink:label="cve_RightofuseassetsTablesTable" xlink:href="cve-20221231.xsd#cve_RightofuseassetsTablesTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="cve_RightofuseassetsTablesLineItems" xlink:to="cve_RightofuseassetsTablesTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cve_DisclosureOfChangeInTheROUAssetsTableTextBlock" xlink:href="cve-20221231.xsd#cve_DisclosureOfChangeInTheROUAssetsTableTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_RightofuseassetsTablesLineItems" xlink:to="cve_DisclosureOfChangeInTheROUAssetsTableTextBlock" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cve_DisclosureOfChangeInTheLongTermLeaseLiabilityTableTextBlock" xlink:href="cve-20221231.xsd#cve_DisclosureOfChangeInTheLongTermLeaseLiabilityTableTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_RightofuseassetsTablesLineItems" xlink:to="cve_DisclosureOfChangeInTheLongTermLeaseLiabilityTableTextBlock" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_MaturityAnalysisForDerivativeFinancialLiabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_MaturityAnalysisForDerivativeFinancialLiabilities"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_RightofuseassetsTablesLineItems" xlink:to="ifrs-full_MaturityAnalysisForDerivativeFinancialLiabilities" order="3" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://encoreuranium.com/role/AssetacquisitionTables">
    <loc xlink:type="locator" xlink:label="cve_DisclosureOfTransactionsRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombinationTextBlockAbstract" xlink:href="cve-20221231.xsd#cve_DisclosureOfTransactionsRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombinationTextBlockAbstract"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfFairValueMeasurementOfAssetsExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_DisclosureOfFairValueMeasurementOfAssetsExplanatory"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_DisclosureOfTransactionsRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombinationTextBlockAbstract" xlink:to="ifrs-full_DisclosureOfFairValueMeasurementOfAssetsExplanatory" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfRedesignatedFinancialAssetsAndLiabilitiesExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_DisclosureOfRedesignatedFinancialAssetsAndLiabilitiesExplanatory"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_DisclosureOfTransactionsRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombinationTextBlockAbstract" xlink:to="ifrs-full_DisclosureOfRedesignatedFinancialAssetsAndLiabilitiesExplanatory" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfIndirectMeasurementOfFairValueOfGoodsOrServicesReceivedShareOptionsGrantedDuringPeriodExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_DisclosureOfIndirectMeasurementOfFairValueOfGoodsOrServicesReceivedShareOptionsGrantedDuringPeriodExplanatory"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_DisclosureOfTransactionsRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombinationTextBlockAbstract" xlink:to="ifrs-full_DisclosureOfIndirectMeasurementOfFairValueOfGoodsOrServicesReceivedShareOptionsGrantedDuringPeriodExplanatory" order="2" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://encoreuranium.com/role/MineralPropertiesTables">
    <loc xlink:type="locator" xlink:label="cve_DisclosureOfMineralPropertiesAbstract" xlink:href="cve-20221231.xsd#cve_DisclosureOfMineralPropertiesAbstract"/>
    <loc xlink:type="locator" xlink:label="cve_ScheduleOfMineralProperties" xlink:href="cve-20221231.xsd#cve_ScheduleOfMineralProperties"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_DisclosureOfMineralPropertiesAbstract" xlink:to="cve_ScheduleOfMineralProperties" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://encoreuranium.com/role/AssetretirementobligationsTables">
    <loc xlink:type="locator" xlink:label="cve_AssetretirementobligationsTablesLineItems" xlink:href="cve-20221231.xsd#cve_AssetretirementobligationsTablesLineItems"/>
    <loc xlink:type="locator" xlink:label="cve_AssetretirementobligationsTablesTable" xlink:href="cve-20221231.xsd#cve_AssetretirementobligationsTablesTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="cve_AssetretirementobligationsTablesLineItems" xlink:to="cve_AssetretirementobligationsTablesTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cve_DisclosureOfAssetRetirementObligationsBalanceTableTextBlock" xlink:href="cve-20221231.xsd#cve_DisclosureOfAssetRetirementObligationsBalanceTableTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_AssetretirementobligationsTablesLineItems" xlink:to="cve_DisclosureOfAssetRetirementObligationsBalanceTableTextBlock" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cve_DisclosureOfAssetRetirementObligationsContinuityTableTextBlock" xlink:href="cve-20221231.xsd#cve_DisclosureOfAssetRetirementObligationsContinuityTableTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_AssetretirementobligationsTablesLineItems" xlink:to="cve_DisclosureOfAssetRetirementObligationsContinuityTableTextBlock" order="2" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://encoreuranium.com/role/SalescontractsTables">
    <loc xlink:type="locator" xlink:label="cve_SalescontractsTablesLineItems" xlink:href="cve-20221231.xsd#cve_SalescontractsTablesLineItems"/>
    <loc xlink:type="locator" xlink:label="cve_SalescontractsTablesTable" xlink:href="cve-20221231.xsd#cve_SalescontractsTablesTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="cve_SalescontractsTablesLineItems" xlink:to="cve_SalescontractsTablesTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfMaturityAnalysisForFinancialAssetsHeldForManagingLiquidityRiskExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_DisclosureOfMaturityAnalysisForFinancialAssetsHeldForManagingLiquidityRiskExplanatory"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_SalescontractsTablesLineItems" xlink:to="ifrs-full_DisclosureOfMaturityAnalysisForFinancialAssetsHeldForManagingLiquidityRiskExplanatory" order="1" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://encoreuranium.com/role/ShareCapitalTables">
    <loc xlink:type="locator" xlink:label="cve_ShareCapitalTablesLineItems" xlink:href="cve-20221231.xsd#cve_ShareCapitalTablesLineItems"/>
    <loc xlink:type="locator" xlink:label="cve_ShareCapitalTablesTable" xlink:href="cve-20221231.xsd#cve_ShareCapitalTablesTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="cve_ShareCapitalTablesLineItems" xlink:to="cve_ShareCapitalTablesTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cve_ScheduleOfTheCompanysStockOptionsOutstandingTableTextBlock" xlink:href="cve-20221231.xsd#cve_ScheduleOfTheCompanysStockOptionsOutstandingTableTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_ShareCapitalTablesLineItems" xlink:to="cve_ScheduleOfTheCompanysStockOptionsOutstandingTableTextBlock" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cve_ScheduleOfStockOptionsOutstandingTableTextBlock" xlink:href="cve-20221231.xsd#cve_ScheduleOfStockOptionsOutstandingTableTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_ShareCapitalTablesLineItems" xlink:to="cve_ScheduleOfStockOptionsOutstandingTableTextBlock" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cve_ScheduleOfWeightedAverageAssumptionsUsedInCalculatingTheFairValuesTableTextBlock" xlink:href="cve-20221231.xsd#cve_ScheduleOfWeightedAverageAssumptionsUsedInCalculatingTheFairValuesTableTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_ShareCapitalTablesLineItems" xlink:to="cve_ScheduleOfWeightedAverageAssumptionsUsedInCalculatingTheFairValuesTableTextBlock" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cve_ScheduleOfTheStatusOfTheCompanysWarrantsTableTextBlock" xlink:href="cve-20221231.xsd#cve_ScheduleOfTheStatusOfTheCompanysWarrantsTableTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_ShareCapitalTablesLineItems" xlink:to="cve_ScheduleOfTheStatusOfTheCompanysWarrantsTableTextBlock" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cve_ScheduleOfSharePurchaseWarrantsOutstandingTableTextBlock" xlink:href="cve-20221231.xsd#cve_ScheduleOfSharePurchaseWarrantsOutstandingTableTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_ShareCapitalTablesLineItems" xlink:to="cve_ScheduleOfSharePurchaseWarrantsOutstandingTableTextBlock" order="5" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://encoreuranium.com/role/RelatedpartytransactionsandbalancesTables">
    <loc xlink:type="locator" xlink:label="cve_DisclosureOfRelatedPartyTextBlockAbstract" xlink:href="cve-20221231.xsd#cve_DisclosureOfRelatedPartyTextBlockAbstract"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfGeneralAndAdministrativeExpenseExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_DisclosureOfGeneralAndAdministrativeExpenseExplanatory"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_DisclosureOfRelatedPartyTextBlockAbstract" xlink:to="ifrs-full_DisclosureOfGeneralAndAdministrativeExpenseExplanatory" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesExplanatory"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_DisclosureOfRelatedPartyTextBlockAbstract" xlink:to="ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesExplanatory" order="1" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://encoreuranium.com/role/FinancialInstrumentsTables">
    <loc xlink:type="locator" xlink:label="cve_DisclosureOfFinancialInstrumentsTextBlockAbstract" xlink:href="cve-20221231.xsd#cve_DisclosureOfFinancialInstrumentsTextBlockAbstract"/>
    <loc xlink:type="locator" xlink:label="cve_ScheduleOfFinancialInstrumentTableTextBlock" xlink:href="cve-20221231.xsd#cve_ScheduleOfFinancialInstrumentTableTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_DisclosureOfFinancialInstrumentsTextBlockAbstract" xlink:to="cve_ScheduleOfFinancialInstrumentTableTextBlock" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://encoreuranium.com/role/SegmentedinformationTables">
    <loc xlink:type="locator" xlink:label="cve_SegmentedinformationTablesLineItems" xlink:href="cve-20221231.xsd#cve_SegmentedinformationTablesLineItems"/>
    <loc xlink:type="locator" xlink:label="cve_SegmentedinformationTablesTable" xlink:href="cve-20221231.xsd#cve_SegmentedinformationTablesTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="cve_SegmentedinformationTablesLineItems" xlink:to="cve_SegmentedinformationTablesTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cve_DisclosureOfLongtermAssetsByGeographicSegmentTableTextBlock" xlink:href="cve-20221231.xsd#cve_DisclosureOfLongtermAssetsByGeographicSegmentTableTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_SegmentedinformationTablesLineItems" xlink:to="cve_DisclosureOfLongtermAssetsByGeographicSegmentTableTextBlock" order="1" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://encoreuranium.com/role/SupplementaldisclosurewithrespecttocashflowsTables">
    <loc xlink:type="locator" xlink:label="cve_SupplementalDisclosureWithRespectToCashflowsAbstract" xlink:href="cve-20221231.xsd#cve_SupplementalDisclosureWithRespectToCashflowsAbstract"/>
    <loc xlink:type="locator" xlink:label="cve_ScheduleOfIncurredNoncashFinancingAndInvestingActivitiesTableTextBlock" xlink:href="cve-20221231.xsd#cve_ScheduleOfIncurredNoncashFinancingAndInvestingActivitiesTableTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_SupplementalDisclosureWithRespectToCashflowsAbstract" xlink:to="cve_ScheduleOfIncurredNoncashFinancingAndInvestingActivitiesTableTextBlock" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://encoreuranium.com/role/IncometaxesTables">
    <loc xlink:type="locator" xlink:label="cve_DisclosureOfIncomeTaxTextBlockAbstract" xlink:href="cve-20221231.xsd#cve_DisclosureOfIncomeTaxTextBlockAbstract"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsExplanatory"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_DisclosureOfIncomeTaxTextBlockAbstract" xlink:to="ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsExplanatory" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfInterestIncomeExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_DisclosureOfInterestIncomeExplanatory"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_DisclosureOfIncomeTaxTextBlockAbstract" xlink:to="ifrs-full_DisclosureOfInterestIncomeExplanatory" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_DisclosureOfIncomeTaxTextBlockAbstract" xlink:to="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfDeferredTaxesExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_DisclosureOfDeferredTaxesExplanatory"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_DisclosureOfIncomeTaxTextBlockAbstract" xlink:to="ifrs-full_DisclosureOfDeferredTaxesExplanatory" order="3" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://encoreuranium.com/role/ChangeinPresentationCurrencyTables">
    <loc xlink:type="locator" xlink:label="cve_DisclosureOfReclassificationsOrChangesInPresentationTextBlockAbstract" xlink:href="cve-20221231.xsd#cve_DisclosureOfReclassificationsOrChangesInPresentationTextBlockAbstract"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForForeignCurrencyTranslationExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_DescriptionOfAccountingPolicyForForeignCurrencyTranslationExplanatory"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_DisclosureOfReclassificationsOrChangesInPresentationTextBlockAbstract" xlink:to="ifrs-full_DescriptionOfAccountingPolicyForForeignCurrencyTranslationExplanatory" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfFinancialInstrumentsAtFairValueThroughProfitOrLossExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_DisclosureOfFinancialInstrumentsAtFairValueThroughProfitOrLossExplanatory"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_DisclosureOfReclassificationsOrChangesInPresentationTextBlockAbstract" xlink:to="ifrs-full_DisclosureOfFinancialInstrumentsAtFairValueThroughProfitOrLossExplanatory" order="1" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://encoreuranium.com/role/ScheduleofexchangeratesTable">
    <loc xlink:type="locator" xlink:label="cve_SignificantaccountingpoliciesDetailsScheduleofexchangeratesLineItems" xlink:href="cve-20221231.xsd#cve_SignificantaccountingpoliciesDetailsScheduleofexchangeratesLineItems"/>
    <loc xlink:type="locator" xlink:label="cve_SignificantaccountingpoliciesDetailsScheduleofexchangeratesTable" xlink:href="cve-20221231.xsd#cve_SignificantaccountingpoliciesDetailsScheduleofexchangeratesTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="cve_SignificantaccountingpoliciesDetailsScheduleofexchangeratesLineItems" xlink:to="cve_SignificantaccountingpoliciesDetailsScheduleofexchangeratesTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_SegmentsAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_SegmentsAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="cve_SignificantaccountingpoliciesDetailsScheduleofexchangeratesTable" xlink:to="ifrs-full_SegmentsAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_SegmentsMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_SegmentsMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="ifrs-full_SegmentsAxis" xlink:to="ifrs-full_SegmentsMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_SegmentsMember_0" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_SegmentsMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="ifrs-full_SegmentsAxis" xlink:to="ifrs-full_SegmentsMember_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ClosingForeignExchangeRate" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_ClosingForeignExchangeRate"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_SignificantaccountingpoliciesDetailsScheduleofexchangeratesLineItems" xlink:to="ifrs-full_ClosingForeignExchangeRate" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AverageForeignExchangeRate" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_AverageForeignExchangeRate"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_SignificantaccountingpoliciesDetailsScheduleofexchangeratesLineItems" xlink:to="ifrs-full_AverageForeignExchangeRate" order="2" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://encoreuranium.com/role/ScheduleofsignificantsubsidiariesTable">
    <loc xlink:type="locator" xlink:label="cve_SignificantaccountingpoliciesDetailsScheduleofsignificantsubsidiariesLineItems" xlink:href="cve-20221231.xsd#cve_SignificantaccountingpoliciesDetailsScheduleofsignificantsubsidiariesLineItems"/>
    <loc xlink:type="locator" xlink:label="cve_SignificantaccountingpoliciesDetailsScheduleofsignificantsubsidiariesTable" xlink:href="cve-20221231.xsd#cve_SignificantaccountingpoliciesDetailsScheduleofsignificantsubsidiariesTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="cve_SignificantaccountingpoliciesDetailsScheduleofsignificantsubsidiariesLineItems" xlink:to="cve_SignificantaccountingpoliciesDetailsScheduleofsignificantsubsidiariesTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CategoriesOfRelatedPartiesAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_CategoriesOfRelatedPartiesAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="cve_SignificantaccountingpoliciesDetailsScheduleofsignificantsubsidiariesTable" xlink:to="ifrs-full_CategoriesOfRelatedPartiesAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_EntitysTotalForRelatedPartiesMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_EntitysTotalForRelatedPartiesMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="ifrs-full_CategoriesOfRelatedPartiesAxis" xlink:to="ifrs-full_EntitysTotalForRelatedPartiesMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_EntitysTotalForRelatedPartiesMember_0" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_EntitysTotalForRelatedPartiesMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="ifrs-full_CategoriesOfRelatedPartiesAxis" xlink:to="ifrs-full_EntitysTotalForRelatedPartiesMember_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cve_TigrisUraniumUSCorpMember" xlink:href="cve-20221231.xsd#cve_TigrisUraniumUSCorpMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_EntitysTotalForRelatedPartiesMember" xlink:to="cve_TigrisUraniumUSCorpMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cve_MetaminEnterprisesUSIncMember" xlink:href="cve-20221231.xsd#cve_MetaminEnterprisesUSIncMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_EntitysTotalForRelatedPartiesMember" xlink:to="cve_MetaminEnterprisesUSIncMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cve_URIIncMember" xlink:href="cve-20221231.xsd#cve_URIIncMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_EntitysTotalForRelatedPartiesMember" xlink:to="cve_URIIncMember" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cve_NeutronEnergyIncMember" xlink:href="cve-20221231.xsd#cve_NeutronEnergyIncMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_EntitysTotalForRelatedPartiesMember" xlink:to="cve_NeutronEnergyIncMember" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cve_UrancoIncMember" xlink:href="cve-20221231.xsd#cve_UrancoIncMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_EntitysTotalForRelatedPartiesMember" xlink:to="cve_UrancoIncMember" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cve_UraniumResourcesIncMember" xlink:href="cve-20221231.xsd#cve_UraniumResourcesIncMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_EntitysTotalForRelatedPartiesMember" xlink:to="cve_UraniumResourcesIncMember" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cve_HRIChurchrockIncMember" xlink:href="cve-20221231.xsd#cve_HRIChurchrockIncMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_EntitysTotalForRelatedPartiesMember" xlink:to="cve_HRIChurchrockIncMember" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cve_HydroRestorationCorpMember" xlink:href="cve-20221231.xsd#cve_HydroRestorationCorpMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_EntitysTotalForRelatedPartiesMember" xlink:to="cve_HydroRestorationCorpMember" order="7" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cve_BeltLineResourcesIncMember" xlink:href="cve-20221231.xsd#cve_BeltLineResourcesIncMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_EntitysTotalForRelatedPartiesMember" xlink:to="cve_BeltLineResourcesIncMember" order="8" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cve_CibolaResourcesLLCMember" xlink:href="cve-20221231.xsd#cve_CibolaResourcesLLCMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_EntitysTotalForRelatedPartiesMember" xlink:to="cve_CibolaResourcesLLCMember" order="9" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cve_enCoreEnergyUSCorpMember" xlink:href="cve-20221231.xsd#cve_enCoreEnergyUSCorpMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_EntitysTotalForRelatedPartiesMember" xlink:to="cve_enCoreEnergyUSCorpMember" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cve_AzargaUraniumCorpMember" xlink:href="cve-20221231.xsd#cve_AzargaUraniumCorpMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_EntitysTotalForRelatedPartiesMember" xlink:to="cve_AzargaUraniumCorpMember" order="11" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cve_PowertechUSAIncMember" xlink:href="cve-20221231.xsd#cve_PowertechUSAIncMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_EntitysTotalForRelatedPartiesMember" xlink:to="cve_PowertechUSAIncMember" order="12" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cve_URZEnergyCorpMember" xlink:href="cve-20221231.xsd#cve_URZEnergyCorpMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_EntitysTotalForRelatedPartiesMember" xlink:to="cve_URZEnergyCorpMember" order="13" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cve_UcoloExplorationCorpMember" xlink:href="cve-20221231.xsd#cve_UcoloExplorationCorpMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_EntitysTotalForRelatedPartiesMember" xlink:to="cve_UcoloExplorationCorpMember" order="14" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cve_AzargaResourcesLimitedMember" xlink:href="cve-20221231.xsd#cve_AzargaResourcesLimitedMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_EntitysTotalForRelatedPartiesMember" xlink:to="cve_AzargaResourcesLimitedMember" order="15" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cve_AzargaResourcesHongKongLtdMember" xlink:href="cve-20221231.xsd#cve_AzargaResourcesHongKongLtdMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_EntitysTotalForRelatedPartiesMember" xlink:to="cve_AzargaResourcesHongKongLtdMember" order="16" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cve_AzargaResourcesUSACompanyMember" xlink:href="cve-20221231.xsd#cve_AzargaResourcesUSACompanyMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_EntitysTotalForRelatedPartiesMember" xlink:to="cve_AzargaResourcesUSACompanyMember" order="17" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cve_AzargaResourcesCanadaLtdMember" xlink:href="cve-20221231.xsd#cve_AzargaResourcesCanadaLtdMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_EntitysTotalForRelatedPartiesMember" xlink:to="cve_AzargaResourcesCanadaLtdMember" order="18" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cve_NameofSubsidaryPlaceOfIncorporation" xlink:href="cve-20221231.xsd#cve_NameofSubsidaryPlaceOfIncorporation"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_SignificantaccountingpoliciesDetailsScheduleofsignificantsubsidiariesLineItems" xlink:to="cve_NameofSubsidaryPlaceOfIncorporation" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ProportionOfOwnershipInterestInSubsidiary" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_ProportionOfOwnershipInterestInSubsidiary"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_SignificantaccountingpoliciesDetailsScheduleofsignificantsubsidiariesLineItems" xlink:to="ifrs-full_ProportionOfOwnershipInterestInSubsidiary" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cve_NameofSubsidaryPrincipalActivity" xlink:href="cve-20221231.xsd#cve_NameofSubsidaryPrincipalActivity"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_SignificantaccountingpoliciesDetailsScheduleofsignificantsubsidiariesLineItems" xlink:to="cve_NameofSubsidaryPrincipalActivity" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cve_NameofSubsidaryFunctionalCurrency" xlink:href="cve-20221231.xsd#cve_NameofSubsidaryFunctionalCurrency"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_SignificantaccountingpoliciesDetailsScheduleofsignificantsubsidiariesLineItems" xlink:to="cve_NameofSubsidaryFunctionalCurrency" order="4" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://encoreuranium.com/role/ScheduleofusefullivesofpropertyplantandequipementTable">
    <loc xlink:type="locator" xlink:label="cve_SignificantaccountingpoliciesDetailsScheduleofusefullivesofpropertyplantandequipementLineItems" xlink:href="cve-20221231.xsd#cve_SignificantaccountingpoliciesDetailsScheduleofusefullivesofpropertyplantandequipementLineItems"/>
    <loc xlink:type="locator" xlink:label="cve_SignificantaccountingpoliciesDetailsScheduleofusefullivesofpropertyplantandequipementTable" xlink:href="cve-20221231.xsd#cve_SignificantaccountingpoliciesDetailsScheduleofusefullivesofpropertyplantandequipementTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="cve_SignificantaccountingpoliciesDetailsScheduleofusefullivesofpropertyplantandequipementLineItems" xlink:to="cve_SignificantaccountingpoliciesDetailsScheduleofusefullivesofpropertyplantandequipementTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_RangeAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_RangeAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="cve_SignificantaccountingpoliciesDetailsScheduleofusefullivesofpropertyplantandequipementTable" xlink:to="ifrs-full_RangeAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_RangesMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_RangesMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="ifrs-full_RangeAxis" xlink:to="ifrs-full_RangesMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_RangesMember_0" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_RangesMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="ifrs-full_RangeAxis" xlink:to="ifrs-full_RangesMember_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_IntangibleAssetsWithIndefiniteUsefulLifeAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_IntangibleAssetsWithIndefiniteUsefulLifeAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="cve_SignificantaccountingpoliciesDetailsScheduleofusefullivesofpropertyplantandequipementTable" xlink:to="ifrs-full_IntangibleAssetsWithIndefiniteUsefulLifeAxis" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_IntangibleAssetsWithIndefiniteUsefulLifeMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_IntangibleAssetsWithIndefiniteUsefulLifeMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="ifrs-full_IntangibleAssetsWithIndefiniteUsefulLifeAxis" xlink:to="ifrs-full_IntangibleAssetsWithIndefiniteUsefulLifeMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_IntangibleAssetsWithIndefiniteUsefulLifeMember_0" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_IntangibleAssetsWithIndefiniteUsefulLifeMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="ifrs-full_IntangibleAssetsWithIndefiniteUsefulLifeAxis" xlink:to="ifrs-full_IntangibleAssetsWithIndefiniteUsefulLifeMember_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cve_UraniumPlantsMember" xlink:href="cve-20221231.xsd#cve_UraniumPlantsMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_IntangibleAssetsWithIndefiniteUsefulLifeMember" xlink:to="cve_UraniumPlantsMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_OtherPropertyPlantAndEquipmentMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_OtherPropertyPlantAndEquipmentMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_IntangibleAssetsWithIndefiniteUsefulLifeMember" xlink:to="ifrs-full_OtherPropertyPlantAndEquipmentMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cve_SoftwareMember" xlink:href="cve-20221231.xsd#cve_SoftwareMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_IntangibleAssetsWithIndefiniteUsefulLifeMember" xlink:to="cve_SoftwareMember" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cve_FurnitureMember" xlink:href="cve-20221231.xsd#cve_FurnitureMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_IntangibleAssetsWithIndefiniteUsefulLifeMember" xlink:to="cve_FurnitureMember" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_BuildingsMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_BuildingsMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_IntangibleAssetsWithIndefiniteUsefulLifeMember" xlink:to="ifrs-full_BuildingsMember" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_BottomOfRangeMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_BottomOfRangeMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_RangesMember" xlink:to="ifrs-full_BottomOfRangeMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_TopOfRangeMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_TopOfRangeMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_RangesMember" xlink:to="ifrs-full_TopOfRangeMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cve_PropertyPlantAndEquipmentRange" xlink:href="cve-20221231.xsd#cve_PropertyPlantAndEquipmentRange"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_SignificantaccountingpoliciesDetailsScheduleofusefullivesofpropertyplantandequipementLineItems" xlink:to="cve_PropertyPlantAndEquipmentRange" order="1" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://encoreuranium.com/role/ScheduleofusefullivesofintangibleassetsTable">
    <loc xlink:type="locator" xlink:label="cve_SignificantaccountingpoliciesDetailsScheduleofusefullivesofintangibleassetsLineItems" xlink:href="cve-20221231.xsd#cve_SignificantaccountingpoliciesDetailsScheduleofusefullivesofintangibleassetsLineItems"/>
    <loc xlink:type="locator" xlink:label="cve_SignificantaccountingpoliciesDetailsScheduleofusefullivesofintangibleassetsTable" xlink:href="cve-20221231.xsd#cve_SignificantaccountingpoliciesDetailsScheduleofusefullivesofintangibleassetsTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="cve_SignificantaccountingpoliciesDetailsScheduleofusefullivesofintangibleassetsLineItems" xlink:to="cve_SignificantaccountingpoliciesDetailsScheduleofusefullivesofintangibleassetsTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CategoriesOfRelatedPartiesAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_CategoriesOfRelatedPartiesAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="cve_SignificantaccountingpoliciesDetailsScheduleofusefullivesofintangibleassetsTable" xlink:to="ifrs-full_CategoriesOfRelatedPartiesAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_EntitysTotalForRelatedPartiesMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_EntitysTotalForRelatedPartiesMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="ifrs-full_CategoriesOfRelatedPartiesAxis" xlink:to="ifrs-full_EntitysTotalForRelatedPartiesMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_EntitysTotalForRelatedPartiesMember_0" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_EntitysTotalForRelatedPartiesMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="ifrs-full_CategoriesOfRelatedPartiesAxis" xlink:to="ifrs-full_EntitysTotalForRelatedPartiesMember_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cve_DataAccessAgreementMember" xlink:href="cve-20221231.xsd#cve_DataAccessAgreementMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_EntitysTotalForRelatedPartiesMember" xlink:to="cve_DataAccessAgreementMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cve_DataPurchasesMember" xlink:href="cve-20221231.xsd#cve_DataPurchasesMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_EntitysTotalForRelatedPartiesMember" xlink:to="cve_DataPurchasesMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cve_CategoryRange" xlink:href="cve-20221231.xsd#cve_CategoryRange"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_SignificantaccountingpoliciesDetailsScheduleofusefullivesofintangibleassetsLineItems" xlink:to="cve_CategoryRange" order="1" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://encoreuranium.com/role/ScheduleofproportionalshareintheassociateTable">
    <loc xlink:type="locator" xlink:label="cve_InvestmentInAssociateDetailsScheduleofproportionalshareintheassociateLineItems" xlink:href="cve-20221231.xsd#cve_InvestmentInAssociateDetailsScheduleofproportionalshareintheassociateLineItems"/>
    <loc xlink:type="locator" xlink:label="cve_InvestmentInAssociateDetailsScheduleofproportionalshareintheassociateTable" xlink:href="cve-20221231.xsd#cve_InvestmentInAssociateDetailsScheduleofproportionalshareintheassociateTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="cve_InvestmentInAssociateDetailsScheduleofproportionalshareintheassociateLineItems" xlink:to="cve_InvestmentInAssociateDetailsScheduleofproportionalshareintheassociateTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_SegmentsAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_SegmentsAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="cve_InvestmentInAssociateDetailsScheduleofproportionalshareintheassociateTable" xlink:to="ifrs-full_SegmentsAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_SegmentsMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_SegmentsMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="ifrs-full_SegmentsAxis" xlink:to="ifrs-full_SegmentsMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_SegmentsMember_0" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_SegmentsMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="ifrs-full_SegmentsAxis" xlink:to="ifrs-full_SegmentsMember_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_OtherCurrentAssets" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_OtherCurrentAssets"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_InvestmentInAssociateDetailsScheduleofproportionalshareintheassociateLineItems" xlink:to="ifrs-full_OtherCurrentAssets" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_OtherCurrentLiabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_OtherCurrentLiabilities"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_InvestmentInAssociateDetailsScheduleofproportionalshareintheassociateLineItems" xlink:to="ifrs-full_OtherCurrentLiabilities" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cve_OtherRevenuesCurrent" xlink:href="cve-20221231.xsd#cve_OtherRevenuesCurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_InvestmentInAssociateDetailsScheduleofproportionalshareintheassociateLineItems" xlink:to="cve_OtherRevenuesCurrent" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cve_ExpensesCurrent" xlink:href="cve-20221231.xsd#cve_ExpensesCurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_InvestmentInAssociateDetailsScheduleofproportionalshareintheassociateLineItems" xlink:to="cve_ExpensesCurrent" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_OtherNoncurrentAssets" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_OtherNoncurrentAssets"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_InvestmentInAssociateDetailsScheduleofproportionalshareintheassociateLineItems" xlink:to="ifrs-full_OtherNoncurrentAssets" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_OtherNoncurrentLiabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_OtherNoncurrentLiabilities"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_InvestmentInAssociateDetailsScheduleofproportionalshareintheassociateLineItems" xlink:to="ifrs-full_OtherNoncurrentLiabilities" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cve_OtherRevenuesNoncurrent" xlink:href="cve-20221231.xsd#cve_OtherRevenuesNoncurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_InvestmentInAssociateDetailsScheduleofproportionalshareintheassociateLineItems" xlink:to="cve_OtherRevenuesNoncurrent" order="7" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cve_ExpensesNoncurrent" xlink:href="cve-20221231.xsd#cve_ExpensesNoncurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_InvestmentInAssociateDetailsScheduleofproportionalshareintheassociateLineItems" xlink:to="cve_ExpensesNoncurrent" order="8" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cve_AssetsLossFromOperatingExpenses" xlink:href="cve-20221231.xsd#cve_AssetsLossFromOperatingExpenses"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_InvestmentInAssociateDetailsScheduleofproportionalshareintheassociateLineItems" xlink:to="cve_AssetsLossFromOperatingExpenses" order="9" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cve_LiabilitiesLossFromOperatingExpenses" xlink:href="cve-20221231.xsd#cve_LiabilitiesLossFromOperatingExpenses"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_InvestmentInAssociateDetailsScheduleofproportionalshareintheassociateLineItems" xlink:to="cve_LiabilitiesLossFromOperatingExpenses" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cve_RevenuesLossFromOperatingExpenses" xlink:href="cve-20221231.xsd#cve_RevenuesLossFromOperatingExpenses"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_InvestmentInAssociateDetailsScheduleofproportionalshareintheassociateLineItems" xlink:to="cve_RevenuesLossFromOperatingExpenses" order="11" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cve_ExpensesLossFromOperatingExpenses" xlink:href="cve-20221231.xsd#cve_ExpensesLossFromOperatingExpenses"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_InvestmentInAssociateDetailsScheduleofproportionalshareintheassociateLineItems" xlink:to="cve_ExpensesLossFromOperatingExpenses" order="12" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_OtherAssets" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_OtherAssets"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_InvestmentInAssociateDetailsScheduleofproportionalshareintheassociateLineItems" xlink:to="ifrs-full_OtherAssets" order="13" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_OtherLiabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_OtherLiabilities"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_InvestmentInAssociateDetailsScheduleofproportionalshareintheassociateLineItems" xlink:to="ifrs-full_OtherLiabilities" order="14" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_OtherRevenue" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_OtherRevenue"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_InvestmentInAssociateDetailsScheduleofproportionalshareintheassociateLineItems" xlink:to="ifrs-full_OtherRevenue" order="15" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_OtherOperatingIncomeExpense" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_OtherOperatingIncomeExpense"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_InvestmentInAssociateDetailsScheduleofproportionalshareintheassociateLineItems" xlink:to="ifrs-full_OtherOperatingIncomeExpense" order="16" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cve_YearEndedDecember312022Abstract" xlink:href="cve-20221231.xsd#cve_YearEndedDecember312022Abstract"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_InvestmentInAssociateDetailsScheduleofproportionalshareintheassociateLineItems" xlink:to="cve_YearEndedDecember312022Abstract" order="17" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_TaxRateEffectOfForeignTaxRates" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_TaxRateEffectOfForeignTaxRates"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_InvestmentInAssociateDetailsScheduleofproportionalshareintheassociateLineItems" xlink:to="ifrs-full_TaxRateEffectOfForeignTaxRates" order="18" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://encoreuranium.com/role/ScheduleofinvestmentinassociatecontinuityTable">
    <loc xlink:type="locator" xlink:label="cve_InvestmentInAssociateDetailsScheduleofinvestmentinassociatecontinuityLineItems" xlink:href="cve-20221231.xsd#cve_InvestmentInAssociateDetailsScheduleofinvestmentinassociatecontinuityLineItems"/>
    <loc xlink:type="locator" xlink:label="cve_InvestmentInAssociateDetailsScheduleofinvestmentinassociatecontinuityTable" xlink:href="cve-20221231.xsd#cve_InvestmentInAssociateDetailsScheduleofinvestmentinassociatecontinuityTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="cve_InvestmentInAssociateDetailsScheduleofinvestmentinassociatecontinuityLineItems" xlink:to="cve_InvestmentInAssociateDetailsScheduleofinvestmentinassociatecontinuityTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_SegmentsAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_SegmentsAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="cve_InvestmentInAssociateDetailsScheduleofinvestmentinassociatecontinuityTable" xlink:to="ifrs-full_SegmentsAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_SegmentsMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_SegmentsMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="ifrs-full_SegmentsAxis" xlink:to="ifrs-full_SegmentsMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_SegmentsMember_0" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_SegmentsMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="ifrs-full_SegmentsAxis" xlink:to="ifrs-full_SegmentsMember_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cve_InvestmentBalance1" xlink:href="cve-20221231.xsd#cve_InvestmentBalance1"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_InvestmentInAssociateDetailsScheduleofinvestmentinassociatecontinuityLineItems" xlink:to="cve_InvestmentBalance1" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cve_AdjustmentsToCarryingValueAbstract" xlink:href="cve-20221231.xsd#cve_AdjustmentsToCarryingValueAbstract"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_InvestmentInAssociateDetailsScheduleofinvestmentinassociatecontinuityLineItems" xlink:to="cve_AdjustmentsToCarryingValueAbstract" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cve_ProportionateShareOfNetLoss" xlink:href="cve-20221231.xsd#cve_ProportionateShareOfNetLoss"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_AdjustmentsToCarryingValueAbstract" xlink:to="cve_ProportionateShareOfNetLoss" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cve_AdjustmentToInvestmentInGroup11" xlink:href="cve-20221231.xsd#cve_AdjustmentToInvestmentInGroup11"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_AdjustmentsToCarryingValueAbstract" xlink:to="cve_AdjustmentToInvestmentInGroup11" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cve_WriteoffOfInvestment" xlink:href="cve-20221231.xsd#cve_WriteoffOfInvestment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_AdjustmentsToCarryingValueAbstract" xlink:to="cve_WriteoffOfInvestment" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cve_DilutionLoss" xlink:href="cve-20221231.xsd#cve_DilutionLoss"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_AdjustmentsToCarryingValueAbstract" xlink:to="cve_DilutionLoss" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cve_CurrencyTranslationAdjustment" xlink:href="cve-20221231.xsd#cve_CurrencyTranslationAdjustment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_AdjustmentsToCarryingValueAbstract" xlink:to="cve_CurrencyTranslationAdjustment" order="4" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://encoreuranium.com/role/ScheduleofthefairvalueofthephysicaluraniuminvestmentTable">
    <loc xlink:type="locator" xlink:label="cve_ScheduleOfTheFairValueOfThePhysicalUraniumInvestmentAbstract" xlink:href="cve-20221231.xsd#cve_ScheduleOfTheFairValueOfThePhysicalUraniumInvestmentAbstract"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CurrentInvestments" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_CurrentInvestments"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_ScheduleOfTheFairValueOfThePhysicalUraniumInvestmentAbstract" xlink:to="ifrs-full_CurrentInvestments" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cve_PhysicalUranium" xlink:href="cve-20221231.xsd#cve_PhysicalUranium"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_ScheduleOfTheFairValueOfThePhysicalUraniumInvestmentAbstract" xlink:to="cve_PhysicalUranium" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AdjustmentsForGainsLossesOnChangeInFairValueOfDerivatives" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_AdjustmentsForGainsLossesOnChangeInFairValueOfDerivatives"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_ScheduleOfTheFairValueOfThePhysicalUraniumInvestmentAbstract" xlink:to="ifrs-full_AdjustmentsForGainsLossesOnChangeInFairValueOfDerivatives" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cve_GainOnSaleOfUranium" xlink:href="cve-20221231.xsd#cve_GainOnSaleOfUranium"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_ScheduleOfTheFairValueOfThePhysicalUraniumInvestmentAbstract" xlink:to="cve_GainOnSaleOfUranium" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cve_SaleOfUraniumInvestment" xlink:href="cve-20221231.xsd#cve_SaleOfUraniumInvestment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_ScheduleOfTheFairValueOfThePhysicalUraniumInvestmentAbstract" xlink:to="cve_SaleOfUraniumInvestment" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_OtherComprehensiveIncomeNetOfTaxChangeInValueOfForeignCurrencyBasisSpreads" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_OtherComprehensiveIncomeNetOfTaxChangeInValueOfForeignCurrencyBasisSpreads"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_ScheduleOfTheFairValueOfThePhysicalUraniumInvestmentAbstract" xlink:to="ifrs-full_OtherComprehensiveIncomeNetOfTaxChangeInValueOfForeignCurrencyBasisSpreads" order="5" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://encoreuranium.com/role/ScheduleofuraniumconcentratespurchaseagreementTable">
    <loc xlink:type="locator" xlink:label="cve_InvestmentinuraniumDetailsScheduleofuraniumconcentratespurchaseagreementLineItems" xlink:href="cve-20221231.xsd#cve_InvestmentinuraniumDetailsScheduleofuraniumconcentratespurchaseagreementLineItems"/>
    <loc xlink:type="locator" xlink:label="cve_InvestmentinuraniumDetailsScheduleofuraniumconcentratespurchaseagreementTable" xlink:href="cve-20221231.xsd#cve_InvestmentinuraniumDetailsScheduleofuraniumconcentratespurchaseagreementTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="cve_InvestmentinuraniumDetailsScheduleofuraniumconcentratespurchaseagreementLineItems" xlink:to="cve_InvestmentinuraniumDetailsScheduleofuraniumconcentratespurchaseagreementTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_UnconsolidatedStructuredEntitiesAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_UnconsolidatedStructuredEntitiesAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="cve_InvestmentinuraniumDetailsScheduleofuraniumconcentratespurchaseagreementTable" xlink:to="ifrs-full_UnconsolidatedStructuredEntitiesAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_EntitysTotalForUnconsolidatedStructuredEntitiesMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_EntitysTotalForUnconsolidatedStructuredEntitiesMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="ifrs-full_UnconsolidatedStructuredEntitiesAxis" xlink:to="ifrs-full_EntitysTotalForUnconsolidatedStructuredEntitiesMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_EntitysTotalForUnconsolidatedStructuredEntitiesMember_0" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_EntitysTotalForUnconsolidatedStructuredEntitiesMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="ifrs-full_UnconsolidatedStructuredEntitiesAxis" xlink:to="ifrs-full_EntitysTotalForUnconsolidatedStructuredEntitiesMember_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cve_Fiscal2023Member" xlink:href="cve-20221231.xsd#cve_Fiscal2023Member"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_EntitysTotalForUnconsolidatedStructuredEntitiesMember" xlink:to="cve_Fiscal2023Member" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cve_Fiscal2024Member" xlink:href="cve-20221231.xsd#cve_Fiscal2024Member"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_EntitysTotalForUnconsolidatedStructuredEntitiesMember" xlink:to="cve_Fiscal2024Member" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cve_Fiscal2025Member" xlink:href="cve-20221231.xsd#cve_Fiscal2025Member"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_EntitysTotalForUnconsolidatedStructuredEntitiesMember" xlink:to="cve_Fiscal2025Member" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cve_Fiscal2026Member" xlink:href="cve-20221231.xsd#cve_Fiscal2026Member"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_EntitysTotalForUnconsolidatedStructuredEntitiesMember" xlink:to="cve_Fiscal2026Member" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cve_Fiscal2027Member" xlink:href="cve-20221231.xsd#cve_Fiscal2027Member"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_EntitysTotalForUnconsolidatedStructuredEntitiesMember" xlink:to="cve_Fiscal2027Member" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cve_PurchaseCommitments" xlink:href="cve-20221231.xsd#cve_PurchaseCommitments"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_InvestmentinuraniumDetailsScheduleofuraniumconcentratespurchaseagreementLineItems" xlink:to="cve_PurchaseCommitments" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cve_TotalPurchasePrice" xlink:href="cve-20221231.xsd#cve_TotalPurchasePrice"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_InvestmentinuraniumDetailsScheduleofuraniumconcentratespurchaseagreementLineItems" xlink:to="cve_TotalPurchasePrice" order="2" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://encoreuranium.com/role/ScheduleofmarketablesecuritiesTable">
    <loc xlink:type="locator" xlink:label="cve_MarketableSecuritiesDetailsScheduleofmarketablesecuritiesLineItems" xlink:href="cve-20221231.xsd#cve_MarketableSecuritiesDetailsScheduleofmarketablesecuritiesLineItems"/>
    <loc xlink:type="locator" xlink:label="cve_MarketableSecuritiesDetailsScheduleofmarketablesecuritiesTable" xlink:href="cve-20221231.xsd#cve_MarketableSecuritiesDetailsScheduleofmarketablesecuritiesTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="cve_MarketableSecuritiesDetailsScheduleofmarketablesecuritiesLineItems" xlink:to="cve_MarketableSecuritiesDetailsScheduleofmarketablesecuritiesTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ClassesOfAssetsAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_ClassesOfAssetsAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="cve_MarketableSecuritiesDetailsScheduleofmarketablesecuritiesTable" xlink:to="ifrs-full_ClassesOfAssetsAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ClassesOfAssetsMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_ClassesOfAssetsMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="ifrs-full_ClassesOfAssetsAxis" xlink:to="ifrs-full_ClassesOfAssetsMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ClassesOfAssetsMember_0" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_ClassesOfAssetsMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="ifrs-full_ClassesOfAssetsAxis" xlink:to="ifrs-full_ClassesOfAssetsMember_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cve_MarketableSecuritiescurrentMember" xlink:href="cve-20221231.xsd#cve_MarketableSecuritiescurrentMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_ClassesOfAssetsMember" xlink:to="cve_MarketableSecuritiescurrentMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cve_MarketableSecuritiesnoncurrentMember" xlink:href="cve-20221231.xsd#cve_MarketableSecuritiesnoncurrentMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_ClassesOfAssetsMember" xlink:to="cve_MarketableSecuritiesnoncurrentMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cve_MarketablesSecurities" xlink:href="cve-20221231.xsd#cve_MarketablesSecurities"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_MarketableSecuritiesDetailsScheduleofmarketablesecuritiesLineItems" xlink:to="cve_MarketablesSecurities" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AdditionalProvisionsOtherProvisions" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_AdditionalProvisionsOtherProvisions"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_MarketableSecuritiesDetailsScheduleofmarketablesecuritiesLineItems" xlink:to="ifrs-full_AdditionalProvisionsOtherProvisions" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AdjustmentsForGainsLossesOnFairValueAdjustmentInvestmentProperty" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_AdjustmentsForGainsLossesOnFairValueAdjustmentInvestmentProperty"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_MarketableSecuritiesDetailsScheduleofmarketablesecuritiesLineItems" xlink:to="ifrs-full_AdjustmentsForGainsLossesOnFairValueAdjustmentInvestmentProperty" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RestructuringReserveTranslationAdjustment" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringReserveTranslationAdjustment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_MarketableSecuritiesDetailsScheduleofmarketablesecuritiesLineItems" xlink:to="us-gaap_RestructuringReserveTranslationAdjustment" order="4" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://encoreuranium.com/role/ScheduleofintangibleassetwasdeterminedTable">
    <loc xlink:type="locator" xlink:label="cve_IntangibleassetsDetailsScheduleofintangibleassetwasdeterminedLineItems" xlink:href="cve-20221231.xsd#cve_IntangibleassetsDetailsScheduleofintangibleassetwasdeterminedLineItems"/>
    <loc xlink:type="locator" xlink:label="cve_IntangibleassetsDetailsScheduleofintangibleassetwasdeterminedTable" xlink:href="cve-20221231.xsd#cve_IntangibleassetsDetailsScheduleofintangibleassetwasdeterminedTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="cve_IntangibleassetsDetailsScheduleofintangibleassetwasdeterminedLineItems" xlink:to="cve_IntangibleassetsDetailsScheduleofintangibleassetwasdeterminedTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="cve_IntangibleassetsDetailsScheduleofintangibleassetwasdeterminedTable" xlink:to="ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_IntangibleAssetsOtherThanGoodwillMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_IntangibleAssetsOtherThanGoodwillMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis" xlink:to="ifrs-full_IntangibleAssetsOtherThanGoodwillMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_IntangibleAssetsOtherThanGoodwillMember_0" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_IntangibleAssetsOtherThanGoodwillMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis" xlink:to="ifrs-full_IntangibleAssetsOtherThanGoodwillMember_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cve_VANEAgreementMember" xlink:href="cve-20221231.xsd#cve_VANEAgreementMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_IntangibleAssetsOtherThanGoodwillMember" xlink:to="cve_VANEAgreementMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cve_SignalEquitiesDatabaseMember" xlink:href="cve-20221231.xsd#cve_SignalEquitiesDatabaseMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_IntangibleAssetsOtherThanGoodwillMember" xlink:to="cve_SignalEquitiesDatabaseMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cve_GrantsMineralBeltDatabaseMember" xlink:href="cve-20221231.xsd#cve_GrantsMineralBeltDatabaseMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_IntangibleAssetsOtherThanGoodwillMember" xlink:to="cve_GrantsMineralBeltDatabaseMember" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cve_GettyDatabaseMember" xlink:href="cve-20221231.xsd#cve_GettyDatabaseMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_IntangibleAssetsOtherThanGoodwillMember" xlink:to="cve_GettyDatabaseMember" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cve_IntangibleAssetsBalance" xlink:href="cve-20221231.xsd#cve_IntangibleAssetsBalance"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_IntangibleassetsDetailsScheduleofintangibleassetwasdeterminedLineItems" xlink:to="cve_IntangibleAssetsBalance" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cve_Additions" xlink:href="cve-20221231.xsd#cve_Additions"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_IntangibleassetsDetailsScheduleofintangibleassetwasdeterminedLineItems" xlink:to="cve_Additions" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AmortisationIntangibleAssetsOtherThanGoodwill" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_AmortisationIntangibleAssetsOtherThanGoodwill"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_IntangibleassetsDetailsScheduleofintangibleassetwasdeterminedLineItems" xlink:to="ifrs-full_AmortisationIntangibleAssetsOtherThanGoodwill" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cve_CurrencyTranslationAdjustment1" xlink:href="cve-20221231.xsd#cve_CurrencyTranslationAdjustment1"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_IntangibleassetsDetailsScheduleofintangibleassetwasdeterminedLineItems" xlink:to="cve_CurrencyTranslationAdjustment1" order="4" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://encoreuranium.com/role/ScheduleofpropertyplantandequipmentTable">
    <loc xlink:type="locator" xlink:label="cve_PropertyplantandequipmentDetailsScheduleofpropertyplantandequipmentLineItems" xlink:href="cve-20221231.xsd#cve_PropertyplantandequipmentDetailsScheduleofpropertyplantandequipmentLineItems"/>
    <loc xlink:type="locator" xlink:label="cve_PropertyplantandequipmentDetailsScheduleofpropertyplantandequipmentTable" xlink:href="cve-20221231.xsd#cve_PropertyplantandequipmentDetailsScheduleofpropertyplantandequipmentTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="cve_PropertyplantandequipmentDetailsScheduleofpropertyplantandequipmentLineItems" xlink:to="cve_PropertyplantandequipmentDetailsScheduleofpropertyplantandequipmentTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="cve_PropertyplantandequipmentDetailsScheduleofpropertyplantandequipmentTable" xlink:to="ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_PropertyPlantAndEquipmentMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_PropertyPlantAndEquipmentMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis" xlink:to="ifrs-full_PropertyPlantAndEquipmentMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_PropertyPlantAndEquipmentMember_0" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_PropertyPlantAndEquipmentMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis" xlink:to="ifrs-full_PropertyPlantAndEquipmentMember_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cve_UraniumPlantsMember" xlink:href="cve-20221231.xsd#cve_UraniumPlantsMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_PropertyPlantAndEquipmentMember" xlink:to="cve_UraniumPlantsMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_OtherPropertyPlantAndEquipmentMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_OtherPropertyPlantAndEquipmentMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_PropertyPlantAndEquipmentMember" xlink:to="ifrs-full_OtherPropertyPlantAndEquipmentMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cve_FurnitureMember" xlink:href="cve-20221231.xsd#cve_FurnitureMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_PropertyPlantAndEquipmentMember" xlink:to="cve_FurnitureMember" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_BuildingsMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_BuildingsMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_PropertyPlantAndEquipmentMember" xlink:to="ifrs-full_BuildingsMember" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cve_SoftwareMember" xlink:href="cve-20221231.xsd#cve_SoftwareMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_PropertyPlantAndEquipmentMember" xlink:to="cve_SoftwareMember" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_PropertyPlantAndEquipmentCarryingAmountAtCostOfRevaluedAssets" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_PropertyPlantAndEquipmentCarryingAmountAtCostOfRevaluedAssets"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_PropertyplantandequipmentDetailsScheduleofpropertyplantandequipmentLineItems" xlink:to="ifrs-full_PropertyPlantAndEquipmentCarryingAmountAtCostOfRevaluedAssets" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_PropertyplantandequipmentDetailsScheduleofpropertyplantandequipmentLineItems" xlink:to="ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisposalsInvestmentProperty" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_DisposalsInvestmentProperty"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_PropertyplantandequipmentDetailsScheduleofpropertyplantandequipmentLineItems" xlink:to="ifrs-full_DisposalsInvestmentProperty" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DepreciationExpense" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_DepreciationExpense"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_PropertyplantandequipmentDetailsScheduleofpropertyplantandequipmentLineItems" xlink:to="ifrs-full_DepreciationExpense" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ImpairmentLoss" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_ImpairmentLoss"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_PropertyplantandequipmentDetailsScheduleofpropertyplantandequipmentLineItems" xlink:to="ifrs-full_ImpairmentLoss" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_PropertyplantandequipmentDetailsScheduleofpropertyplantandequipmentLineItems" xlink:to="ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation" order="6" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://encoreuranium.com/role/ScheduleofchangeintheROUassetsTable">
    <loc xlink:type="locator" xlink:label="cve_RightofuseassetsDetailsScheduleofchangeintheROUassetsLineItems" xlink:href="cve-20221231.xsd#cve_RightofuseassetsDetailsScheduleofchangeintheROUassetsLineItems"/>
    <loc xlink:type="locator" xlink:label="cve_RightofuseassetsDetailsScheduleofchangeintheROUassetsTable" xlink:href="cve-20221231.xsd#cve_RightofuseassetsDetailsScheduleofchangeintheROUassetsTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="cve_RightofuseassetsDetailsScheduleofchangeintheROUassetsLineItems" xlink:to="cve_RightofuseassetsDetailsScheduleofchangeintheROUassetsTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CategoriesOfRelatedPartiesAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_CategoriesOfRelatedPartiesAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="cve_RightofuseassetsDetailsScheduleofchangeintheROUassetsTable" xlink:to="ifrs-full_CategoriesOfRelatedPartiesAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_EntitysTotalForRelatedPartiesMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_EntitysTotalForRelatedPartiesMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="ifrs-full_CategoriesOfRelatedPartiesAxis" xlink:to="ifrs-full_EntitysTotalForRelatedPartiesMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_EntitysTotalForRelatedPartiesMember_0" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_EntitysTotalForRelatedPartiesMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="ifrs-full_CategoriesOfRelatedPartiesAxis" xlink:to="ifrs-full_EntitysTotalForRelatedPartiesMember_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cve_LeasedCopierMember" xlink:href="cve-20221231.xsd#cve_LeasedCopierMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_EntitysTotalForRelatedPartiesMember" xlink:to="cve_LeasedCopierMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cve_LeasedOfficesMember" xlink:href="cve-20221231.xsd#cve_LeasedOfficesMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_EntitysTotalForRelatedPartiesMember" xlink:to="cve_LeasedOfficesMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cve_Right-of-UseAssetsBalance" xlink:href="cve-20221231.xsd#cve_Right-of-UseAssetsBalance"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_RightofuseassetsDetailsScheduleofchangeintheROUassetsLineItems" xlink:to="cve_Right-of-UseAssetsBalance" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cve_Right-of-UseAssetsAdditions" xlink:href="cve-20221231.xsd#cve_Right-of-UseAssetsAdditions"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_RightofuseassetsDetailsScheduleofchangeintheROUassetsLineItems" xlink:to="cve_Right-of-UseAssetsAdditions" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cve_Right-of-UseAssetsDepreciation" xlink:href="cve-20221231.xsd#cve_Right-of-UseAssetsDepreciation"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_RightofuseassetsDetailsScheduleofchangeintheROUassetsLineItems" xlink:to="cve_Right-of-UseAssetsDepreciation" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cve_Right-of-UseAssetsCurrencyTranslationAdjustment" xlink:href="cve-20221231.xsd#cve_Right-of-UseAssetsCurrencyTranslationAdjustment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_RightofuseassetsDetailsScheduleofchangeintheROUassetsLineItems" xlink:to="cve_Right-of-UseAssetsCurrencyTranslationAdjustment" order="4" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://encoreuranium.com/role/ScheduleofchangeinthelongTermleaseliabilityTable">
    <loc xlink:type="locator" xlink:label="cve_RightofuseassetsDetailsScheduleofchangeinthelongTermleaseliabilityLineItems" xlink:href="cve-20221231.xsd#cve_RightofuseassetsDetailsScheduleofchangeinthelongTermleaseliabilityLineItems"/>
    <loc xlink:type="locator" xlink:label="cve_RightofuseassetsDetailsScheduleofchangeinthelongTermleaseliabilityTable" xlink:href="cve-20221231.xsd#cve_RightofuseassetsDetailsScheduleofchangeinthelongTermleaseliabilityTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="cve_RightofuseassetsDetailsScheduleofchangeinthelongTermleaseliabilityLineItems" xlink:to="cve_RightofuseassetsDetailsScheduleofchangeinthelongTermleaseliabilityTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CategoriesOfRelatedPartiesAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_CategoriesOfRelatedPartiesAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="cve_RightofuseassetsDetailsScheduleofchangeinthelongTermleaseliabilityTable" xlink:to="ifrs-full_CategoriesOfRelatedPartiesAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_EntitysTotalForRelatedPartiesMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_EntitysTotalForRelatedPartiesMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="ifrs-full_CategoriesOfRelatedPartiesAxis" xlink:to="ifrs-full_EntitysTotalForRelatedPartiesMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_EntitysTotalForRelatedPartiesMember_0" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_EntitysTotalForRelatedPartiesMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="ifrs-full_CategoriesOfRelatedPartiesAxis" xlink:to="ifrs-full_EntitysTotalForRelatedPartiesMember_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cve_LeasedCopierMember" xlink:href="cve-20221231.xsd#cve_LeasedCopierMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_EntitysTotalForRelatedPartiesMember" xlink:to="cve_LeasedCopierMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cve_LeasedOfficesMember" xlink:href="cve-20221231.xsd#cve_LeasedOfficesMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_EntitysTotalForRelatedPartiesMember" xlink:to="cve_LeasedOfficesMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cve_Long-TermLeaseLiabilityBalance" xlink:href="cve-20221231.xsd#cve_Long-TermLeaseLiabilityBalance"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_RightofuseassetsDetailsScheduleofchangeinthelongTermleaseliabilityLineItems" xlink:to="cve_Long-TermLeaseLiabilityBalance" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cve_Long-TermLeaseLiabilityAdditions" xlink:href="cve-20221231.xsd#cve_Long-TermLeaseLiabilityAdditions"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_RightofuseassetsDetailsScheduleofchangeinthelongTermleaseliabilityLineItems" xlink:to="cve_Long-TermLeaseLiabilityAdditions" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cve_Long-TermLeaseLiabilityAccretion" xlink:href="cve-20221231.xsd#cve_Long-TermLeaseLiabilityAccretion"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_RightofuseassetsDetailsScheduleofchangeinthelongTermleaseliabilityLineItems" xlink:to="cve_Long-TermLeaseLiabilityAccretion" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cve_Long-TermLeaseLiabilityLeasePaymentsMade" xlink:href="cve-20221231.xsd#cve_Long-TermLeaseLiabilityLeasePaymentsMade"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_RightofuseassetsDetailsScheduleofchangeinthelongTermleaseliabilityLineItems" xlink:to="cve_Long-TermLeaseLiabilityLeasePaymentsMade" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cve_Long-TermLeaseLiabilityCurrencyTranslationAdjustment" xlink:href="cve-20221231.xsd#cve_Long-TermLeaseLiabilityCurrencyTranslationAdjustment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_RightofuseassetsDetailsScheduleofchangeinthelongTermleaseliabilityLineItems" xlink:to="cve_Long-TermLeaseLiabilityCurrencyTranslationAdjustment" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_LongtermProvisionForDecommissioningRestorationAndRehabilitationCosts" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_LongtermProvisionForDecommissioningRestorationAndRehabilitationCosts"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_RightofuseassetsDetailsScheduleofchangeinthelongTermleaseliabilityLineItems" xlink:to="ifrs-full_LongtermProvisionForDecommissioningRestorationAndRehabilitationCosts" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cve_Long-TermLeaseLiabilityLessCurrentLeaseLiability" xlink:href="cve-20221231.xsd#cve_Long-TermLeaseLiabilityLessCurrentLeaseLiability"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_RightofuseassetsDetailsScheduleofchangeinthelongTermleaseliabilityLineItems" xlink:to="cve_Long-TermLeaseLiabilityLessCurrentLeaseLiability" order="7" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://encoreuranium.com/role/ScheduleofundiscountedfutureleasepaymentsTable">
    <loc xlink:type="locator" xlink:label="cve_RightofuseassetsDetailsScheduleofundiscountedfutureleasepaymentsLineItems" xlink:href="cve-20221231.xsd#cve_RightofuseassetsDetailsScheduleofundiscountedfutureleasepaymentsLineItems"/>
    <loc xlink:type="locator" xlink:label="cve_RightofuseassetsDetailsScheduleofundiscountedfutureleasepaymentsTable" xlink:href="cve-20221231.xsd#cve_RightofuseassetsDetailsScheduleofundiscountedfutureleasepaymentsTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="cve_RightofuseassetsDetailsScheduleofundiscountedfutureleasepaymentsLineItems" xlink:to="cve_RightofuseassetsDetailsScheduleofundiscountedfutureleasepaymentsTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_SegmentsAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_SegmentsAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="cve_RightofuseassetsDetailsScheduleofundiscountedfutureleasepaymentsTable" xlink:to="ifrs-full_SegmentsAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_SegmentsMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_SegmentsMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="ifrs-full_SegmentsAxis" xlink:to="ifrs-full_SegmentsMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_SegmentsMember_0" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_SegmentsMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="ifrs-full_SegmentsAxis" xlink:to="ifrs-full_SegmentsMember_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cve_Right-of-UseAssetsTwoZeroTwoThree" xlink:href="cve-20221231.xsd#cve_Right-of-UseAssetsTwoZeroTwoThree"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_RightofuseassetsDetailsScheduleofundiscountedfutureleasepaymentsLineItems" xlink:to="cve_Right-of-UseAssetsTwoZeroTwoThree" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cve_Right-of-UseAssetsTwoZeroTwoFour" xlink:href="cve-20221231.xsd#cve_Right-of-UseAssetsTwoZeroTwoFour"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_RightofuseassetsDetailsScheduleofundiscountedfutureleasepaymentsLineItems" xlink:to="cve_Right-of-UseAssetsTwoZeroTwoFour" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cve_Right-of-UseAssetsTwoZeroTwoFive" xlink:href="cve-20221231.xsd#cve_Right-of-UseAssetsTwoZeroTwoFive"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_RightofuseassetsDetailsScheduleofundiscountedfutureleasepaymentsLineItems" xlink:to="cve_Right-of-UseAssetsTwoZeroTwoFive" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_NetInvestmentInFinanceLease" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_NetInvestmentInFinanceLease"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_RightofuseassetsDetailsScheduleofundiscountedfutureleasepaymentsLineItems" xlink:to="ifrs-full_NetInvestmentInFinanceLease" order="4" xbrldt:closed="true"/>
  </definitionLink>
<!-- [WMV5][XcpuxYn59dz7vgYynUDuwG7r97K2jUTysl7vcz0lJt/tSeJz73kx1cLt0ZFF2SK/vxBCY0vdSrapBeolBQDhlou4Plg3ZACHgOGjaxwoV9s22fcKeqdlVg/8vXE8BEQPw2gSl8Pfy/SjqfZKUO0G5mehrda5xVrvtHGkgNXPOUg3vb7VF4CMNIMcgg6F7hiC/dgsHya46cPL6td1bLnSV35L5jAlrEDBDi0RC0EWIRx+TpXQjl5L5FZgRjEoUSEZANpBp7XUkVrm7577F5R2Qg==] CSR-->
  <definitionLink xlink:type="extended" xlink:role="http://encoreuranium.com/role/ScheduleofestimatedfairvalueofassetsandliabilitiesTable">
    <loc xlink:type="locator" xlink:label="cve_ScheduleOfEstimatedFairValueOfAssetsAndLiabilitiesAbstract" xlink:href="cve-20221231.xsd#cve_ScheduleOfEstimatedFairValueOfAssetsAndLiabilitiesAbstract"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_ScheduleOfEstimatedFairValueOfAssetsAndLiabilitiesAbstract" xlink:to="ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cve_FairValueOfReplacementOptions" xlink:href="cve-20221231.xsd#cve_FairValueOfReplacementOptions"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_ScheduleOfEstimatedFairValueOfAssetsAndLiabilitiesAbstract" xlink:to="cve_FairValueOfReplacementOptions" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cve_FairValueOfReplacementWarrants" xlink:href="cve-20221231.xsd#cve_FairValueOfReplacementWarrants"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_ScheduleOfEstimatedFairValueOfAssetsAndLiabilitiesAbstract" xlink:to="cve_FairValueOfReplacementWarrants" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cve_TransactionCosts" xlink:href="cve-20221231.xsd#cve_TransactionCosts"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_ScheduleOfEstimatedFairValueOfAssetsAndLiabilitiesAbstract" xlink:to="cve_TransactionCosts" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cve_TotalConsiderationValue" xlink:href="cve-20221231.xsd#cve_TotalConsiderationValue"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_ScheduleOfEstimatedFairValueOfAssetsAndLiabilitiesAbstract" xlink:to="cve_TotalConsiderationValue" order="4" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://encoreuranium.com/role/ScheduleofnetassetsacquiredTable">
    <loc xlink:type="locator" xlink:label="cve_ScheduleOfNetAssetsAcquiredAbstract" xlink:href="cve-20221231.xsd#cve_ScheduleOfNetAssetsAcquiredAbstract"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_OtherCashAndCashEquivalents" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_OtherCashAndCashEquivalents"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_ScheduleOfNetAssetsAcquiredAbstract" xlink:to="ifrs-full_OtherCashAndCashEquivalents" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_NoncurrentRestrictedCashAndCashEquivalents" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_NoncurrentRestrictedCashAndCashEquivalents"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_ScheduleOfNetAssetsAcquiredAbstract" xlink:to="ifrs-full_NoncurrentRestrictedCashAndCashEquivalents" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_Prepayments" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_Prepayments"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_ScheduleOfNetAssetsAcquiredAbstract" xlink:to="ifrs-full_Prepayments" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_ScheduleOfNetAssetsAcquiredAbstract" xlink:to="ifrs-full_PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_RightofuseAssetsThatDoNotMeetDefinitionOfInvestmentProperty" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_RightofuseAssetsThatDoNotMeetDefinitionOfInvestmentProperty"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_ScheduleOfNetAssetsAcquiredAbstract" xlink:to="ifrs-full_RightofuseAssetsThatDoNotMeetDefinitionOfInvestmentProperty" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AssetsArisingFromExplorationForAndEvaluationOfMineralResources" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_AssetsArisingFromExplorationForAndEvaluationOfMineralResources"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_ScheduleOfNetAssetsAcquiredAbstract" xlink:to="ifrs-full_AssetsArisingFromExplorationForAndEvaluationOfMineralResources" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cve_AssetRetirementObligations" xlink:href="cve-20221231.xsd#cve_AssetRetirementObligations"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_ScheduleOfNetAssetsAcquiredAbstract" xlink:to="cve_AssetRetirementObligations" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_LeaseLiabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_LeaseLiabilities"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_ScheduleOfNetAssetsAcquiredAbstract" xlink:to="ifrs-full_LeaseLiabilities" order="7" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_LoansAndReceivables" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_LoansAndReceivables"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_ScheduleOfNetAssetsAcquiredAbstract" xlink:to="ifrs-full_LoansAndReceivables" order="8" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cve_AccountsPayableAndAccruedLiability" xlink:href="cve-20221231.xsd#cve_AccountsPayableAndAccruedLiability"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_ScheduleOfNetAssetsAcquiredAbstract" xlink:to="cve_AccountsPayableAndAccruedLiability" order="9" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_IdentifiableAssetsAcquiredLiabilitiesAssumed" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_IdentifiableAssetsAcquiredLiabilitiesAssumed"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_ScheduleOfNetAssetsAcquiredAbstract" xlink:to="ifrs-full_IdentifiableAssetsAcquiredLiabilitiesAssumed" order="10" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://encoreuranium.com/role/ScheduleofweightedaverageassumptionsusedintheblackscholesoptionTable">
    <loc xlink:type="locator" xlink:label="cve_AssetacquisitionDetailsScheduleofweightedaverageassumptionsusedintheblackscholesoptionLineItems" xlink:href="cve-20221231.xsd#cve_AssetacquisitionDetailsScheduleofweightedaverageassumptionsusedintheblackscholesoptionLineItems"/>
    <loc xlink:type="locator" xlink:label="cve_AssetacquisitionDetailsScheduleofweightedaverageassumptionsusedintheblackscholesoptionTable" xlink:href="cve-20221231.xsd#cve_AssetacquisitionDetailsScheduleofweightedaverageassumptionsusedintheblackscholesoptionTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="cve_AssetacquisitionDetailsScheduleofweightedaverageassumptionsusedintheblackscholesoptionLineItems" xlink:to="cve_AssetacquisitionDetailsScheduleofweightedaverageassumptionsusedintheblackscholesoptionTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ComponentsOfEquityAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_ComponentsOfEquityAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="cve_AssetacquisitionDetailsScheduleofweightedaverageassumptionsusedintheblackscholesoptionTable" xlink:to="ifrs-full_ComponentsOfEquityAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_EquityMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_EquityMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="ifrs-full_ComponentsOfEquityAxis" xlink:to="ifrs-full_EquityMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_EquityMember_0" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_EquityMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="ifrs-full_ComponentsOfEquityAxis" xlink:to="ifrs-full_EquityMember_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cve_OptionsMember" xlink:href="cve-20221231.xsd#cve_OptionsMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_EquityMember" xlink:to="cve_OptionsMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_WarrantReserveMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_WarrantReserveMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_EquityMember" xlink:to="ifrs-full_WarrantReserveMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ExercisePriceShareOptionsGranted2019" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_ExercisePriceShareOptionsGranted2019"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_AssetacquisitionDetailsScheduleofweightedaverageassumptionsusedintheblackscholesoptionLineItems" xlink:to="ifrs-full_ExercisePriceShareOptionsGranted2019" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_WeightedAverageSharePriceShareOptionsGranted2019" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_WeightedAverageSharePriceShareOptionsGranted2019"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_AssetacquisitionDetailsScheduleofweightedaverageassumptionsusedintheblackscholesoptionLineItems" xlink:to="ifrs-full_WeightedAverageSharePriceShareOptionsGranted2019" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ActuarialAssumptionOfDiscountRates" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_ActuarialAssumptionOfDiscountRates"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_AssetacquisitionDetailsScheduleofweightedaverageassumptionsusedintheblackscholesoptionLineItems" xlink:to="ifrs-full_ActuarialAssumptionOfDiscountRates" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_AssetacquisitionDetailsScheduleofweightedaverageassumptionsusedintheblackscholesoptionLineItems" xlink:to="ifrs-full_WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DescriptionOfExpectedVolatilityShareOptionsGranted" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_DescriptionOfExpectedVolatilityShareOptionsGranted"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_AssetacquisitionDetailsScheduleofweightedaverageassumptionsusedintheblackscholesoptionLineItems" xlink:to="ifrs-full_DescriptionOfExpectedVolatilityShareOptionsGranted" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cve_FairValueOfReplacement" xlink:href="cve-20221231.xsd#cve_FairValueOfReplacement"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_AssetacquisitionDetailsScheduleofweightedaverageassumptionsusedintheblackscholesoptionLineItems" xlink:to="cve_FairValueOfReplacement" order="6" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://encoreuranium.com/role/ScheduleofmineralpropertiesTable">
    <loc xlink:type="locator" xlink:label="cve_MineralPropertiesDetailsScheduleofmineralpropertiesLineItems" xlink:href="cve-20221231.xsd#cve_MineralPropertiesDetailsScheduleofmineralpropertiesLineItems"/>
    <loc xlink:type="locator" xlink:label="cve_MineralPropertiesDetailsScheduleofmineralpropertiesTable" xlink:href="cve-20221231.xsd#cve_MineralPropertiesDetailsScheduleofmineralpropertiesTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="cve_MineralPropertiesDetailsScheduleofmineralpropertiesLineItems" xlink:to="cve_MineralPropertiesDetailsScheduleofmineralpropertiesTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_GeographicalAreasAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_GeographicalAreasAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="cve_MineralPropertiesDetailsScheduleofmineralpropertiesTable" xlink:to="ifrs-full_GeographicalAreasAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_GeographicalAreasMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_GeographicalAreasMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="ifrs-full_GeographicalAreasAxis" xlink:to="ifrs-full_GeographicalAreasMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_GeographicalAreasMember_0" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_GeographicalAreasMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="ifrs-full_GeographicalAreasAxis" xlink:to="ifrs-full_GeographicalAreasMember_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ClassesOfLiabilitiesAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_ClassesOfLiabilitiesAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="cve_MineralPropertiesDetailsScheduleofmineralpropertiesTable" xlink:to="ifrs-full_ClassesOfLiabilitiesAxis" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_LiabilitiesMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_LiabilitiesMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="ifrs-full_ClassesOfLiabilitiesAxis" xlink:to="ifrs-full_LiabilitiesMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_LiabilitiesMember_0" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_LiabilitiesMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="ifrs-full_ClassesOfLiabilitiesAxis" xlink:to="ifrs-full_LiabilitiesMember_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cve_ExplorationCostMember" xlink:href="cve-20221231.xsd#cve_ExplorationCostMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_LiabilitiesMember" xlink:to="cve_ExplorationCostMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="stpr_AZ" xlink:href="https://xbrl.sec.gov/stpr/2022/stpr-2022.xsd#stpr_AZ"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_GeographicalAreasMember" xlink:to="stpr_AZ" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="stpr_CO" xlink:href="https://xbrl.sec.gov/stpr/2022/stpr-2022.xsd#stpr_CO"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_GeographicalAreasMember" xlink:to="stpr_CO" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="stpr_NM" xlink:href="https://xbrl.sec.gov/stpr/2022/stpr-2022.xsd#stpr_NM"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_GeographicalAreasMember" xlink:to="stpr_NM" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="stpr_SD" xlink:href="https://xbrl.sec.gov/stpr/2022/stpr-2022.xsd#stpr_SD"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_GeographicalAreasMember" xlink:to="stpr_SD" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="stpr_TX" xlink:href="https://xbrl.sec.gov/stpr/2022/stpr-2022.xsd#stpr_TX"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_GeographicalAreasMember" xlink:to="stpr_TX" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="stpr_UT" xlink:href="https://xbrl.sec.gov/stpr/2022/stpr-2022.xsd#stpr_UT"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_GeographicalAreasMember" xlink:to="stpr_UT" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="stpr_WY" xlink:href="https://xbrl.sec.gov/stpr/2022/stpr-2022.xsd#stpr_WY"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_GeographicalAreasMember" xlink:to="stpr_WY" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="country_CA" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_CA"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_GeographicalAreasMember" xlink:to="country_CA" order="7" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_MiningAssets" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_MiningAssets"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_MineralPropertiesDetailsScheduleofmineralpropertiesLineItems" xlink:to="ifrs-full_MiningAssets" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cve_ExplorationCostsAbstract" xlink:href="cve-20221231.xsd#cve_ExplorationCostsAbstract"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_MineralPropertiesDetailsScheduleofmineralpropertiesLineItems" xlink:to="cve_ExplorationCostsAbstract" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cve_Drilling" xlink:href="cve-20221231.xsd#cve_Drilling"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_ExplorationCostsAbstract" xlink:to="cve_Drilling" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cve_MaintenancesAndLeaseFees" xlink:href="cve-20221231.xsd#cve_MaintenancesAndLeaseFees"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_ExplorationCostsAbstract" xlink:to="cve_MaintenancesAndLeaseFees" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cve_PermittingLicensing" xlink:href="cve-20221231.xsd#cve_PermittingLicensing"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_ExplorationCostsAbstract" xlink:to="cve_PermittingLicensing" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cve_Personnel" xlink:href="cve-20221231.xsd#cve_Personnel"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_ExplorationCostsAbstract" xlink:to="cve_Personnel" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cve_Recoveries" xlink:href="cve-20221231.xsd#cve_Recoveries"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_ExplorationCostsAbstract" xlink:to="cve_Recoveries" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cve_ResourceReview" xlink:href="cve-20221231.xsd#cve_ResourceReview"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_ExplorationCostsAbstract" xlink:to="cve_ResourceReview" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cve_ImpairmentCharged" xlink:href="cve-20221231.xsd#cve_ImpairmentCharged"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_ExplorationCostsAbstract" xlink:to="cve_ImpairmentCharged" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cve_DivestmentAbstract" xlink:href="cve-20221231.xsd#cve_DivestmentAbstract"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_MineralPropertiesDetailsScheduleofmineralpropertiesLineItems" xlink:to="cve_DivestmentAbstract" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cve_DivestMineralInterest" xlink:href="cve-20221231.xsd#cve_DivestMineralInterest"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_DivestmentAbstract" xlink:to="cve_DivestMineralInterest" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cve_AssetsHeldForSale" xlink:href="cve-20221231.xsd#cve_AssetsHeldForSale"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_DivestmentAbstract" xlink:to="cve_AssetsHeldForSale" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cve_ProjectDevelopmentCostsAbstract" xlink:href="cve-20221231.xsd#cve_ProjectDevelopmentCostsAbstract"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_MineralPropertiesDetailsScheduleofmineralpropertiesLineItems" xlink:to="cve_ProjectDevelopmentCostsAbstract" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cve_ConstructionOfWellfields" xlink:href="cve-20221231.xsd#cve_ConstructionOfWellfields"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_ProjectDevelopmentCostsAbstract" xlink:to="cve_ConstructionOfWellfields" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cve_AssetAcquistion" xlink:href="cve-20221231.xsd#cve_AssetAcquistion"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_MineralPropertiesDetailsScheduleofmineralpropertiesLineItems" xlink:to="cve_AssetAcquistion" order="5" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://encoreuranium.com/role/ScheduleofassetretirementobligationsbalanceTable">
    <loc xlink:type="locator" xlink:label="cve_AssetretirementobligationsDetailsScheduleofassetretirementobligationsbalanceLineItems" xlink:href="cve-20221231.xsd#cve_AssetretirementobligationsDetailsScheduleofassetretirementobligationsbalanceLineItems"/>
    <loc xlink:type="locator" xlink:label="cve_AssetretirementobligationsDetailsScheduleofassetretirementobligationsbalanceTable" xlink:href="cve-20221231.xsd#cve_AssetretirementobligationsDetailsScheduleofassetretirementobligationsbalanceTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="cve_AssetretirementobligationsDetailsScheduleofassetretirementobligationsbalanceLineItems" xlink:to="cve_AssetretirementobligationsDetailsScheduleofassetretirementobligationsbalanceTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ClassesOfAssetsAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_ClassesOfAssetsAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="cve_AssetretirementobligationsDetailsScheduleofassetretirementobligationsbalanceTable" xlink:to="ifrs-full_ClassesOfAssetsAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ClassesOfAssetsMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_ClassesOfAssetsMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="ifrs-full_ClassesOfAssetsAxis" xlink:to="ifrs-full_ClassesOfAssetsMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ClassesOfAssetsMember_0" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_ClassesOfAssetsMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="ifrs-full_ClassesOfAssetsAxis" xlink:to="ifrs-full_ClassesOfAssetsMember_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cve_KingsvilleMember" xlink:href="cve-20221231.xsd#cve_KingsvilleMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_ClassesOfAssetsMember" xlink:to="cve_KingsvilleMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cve_RositaMember" xlink:href="cve-20221231.xsd#cve_RositaMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_ClassesOfAssetsMember" xlink:to="cve_RositaMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cve_VasquezMember" xlink:href="cve-20221231.xsd#cve_VasquezMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_ClassesOfAssetsMember" xlink:to="cve_VasquezMember" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cve_CentennialMember" xlink:href="cve-20221231.xsd#cve_CentennialMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_ClassesOfAssetsMember" xlink:to="cve_CentennialMember" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cve_GasHillsMember" xlink:href="cve-20221231.xsd#cve_GasHillsMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_ClassesOfAssetsMember" xlink:to="cve_GasHillsMember" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cve_TicabooMember" xlink:href="cve-20221231.xsd#cve_TicabooMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_ClassesOfAssetsMember" xlink:to="cve_TicabooMember" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_FinancialAssets" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_FinancialAssets"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_AssetretirementobligationsDetailsScheduleofassetretirementobligationsbalanceLineItems" xlink:to="ifrs-full_FinancialAssets" order="1" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://encoreuranium.com/role/ScheduleofassetretirementobligationscontinuityTable">
    <loc xlink:type="locator" xlink:label="cve_AssetretirementobligationsDetailsScheduleofassetretirementobligationscontinuityLineItems" xlink:href="cve-20221231.xsd#cve_AssetretirementobligationsDetailsScheduleofassetretirementobligationscontinuityLineItems"/>
    <loc xlink:type="locator" xlink:label="cve_AssetretirementobligationsDetailsScheduleofassetretirementobligationscontinuityTable" xlink:href="cve-20221231.xsd#cve_AssetretirementobligationsDetailsScheduleofassetretirementobligationscontinuityTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="cve_AssetretirementobligationsDetailsScheduleofassetretirementobligationscontinuityLineItems" xlink:to="cve_AssetretirementobligationsDetailsScheduleofassetretirementobligationscontinuityTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_SegmentsAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_SegmentsAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="cve_AssetretirementobligationsDetailsScheduleofassetretirementobligationscontinuityTable" xlink:to="ifrs-full_SegmentsAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_SegmentsMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_SegmentsMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="ifrs-full_SegmentsAxis" xlink:to="ifrs-full_SegmentsMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_SegmentsMember_0" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_SegmentsMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="ifrs-full_SegmentsAxis" xlink:to="ifrs-full_SegmentsMember_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cve_AssetRetirementObligationsBalance" xlink:href="cve-20221231.xsd#cve_AssetRetirementObligationsBalance"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_AssetretirementobligationsDetailsScheduleofassetretirementobligationscontinuityLineItems" xlink:to="cve_AssetRetirementObligationsBalance" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cve_AssetRetirementObligationsAccretion" xlink:href="cve-20221231.xsd#cve_AssetRetirementObligationsAccretion"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_AssetretirementobligationsDetailsScheduleofassetretirementobligationscontinuityLineItems" xlink:to="cve_AssetRetirementObligationsAccretion" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cve_AssetRetirementObligationsAdjustments" xlink:href="cve-20221231.xsd#cve_AssetRetirementObligationsAdjustments"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_AssetretirementobligationsDetailsScheduleofassetretirementobligationscontinuityLineItems" xlink:to="cve_AssetRetirementObligationsAdjustments" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cve_AssetRetirementObligationsSettlement" xlink:href="cve-20221231.xsd#cve_AssetRetirementObligationsSettlement"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_AssetretirementobligationsDetailsScheduleofassetretirementobligationscontinuityLineItems" xlink:to="cve_AssetRetirementObligationsSettlement" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cve_AssetRetirementObligationsAdditionsFromAzargaAssetAcquisitionNote10" xlink:href="cve-20221231.xsd#cve_AssetRetirementObligationsAdditionsFromAzargaAssetAcquisitionNote10"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_AssetretirementobligationsDetailsScheduleofassetretirementobligationscontinuityLineItems" xlink:to="cve_AssetRetirementObligationsAdditionsFromAzargaAssetAcquisitionNote10" order="5" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://encoreuranium.com/role/ScheduleofuraniumsalescontractsoverthenextfiveyearsTable">
    <loc xlink:type="locator" xlink:label="cve_SalescontractsDetailsScheduleofuraniumsalescontractsoverthenextfiveyearsLineItems" xlink:href="cve-20221231.xsd#cve_SalescontractsDetailsScheduleofuraniumsalescontractsoverthenextfiveyearsLineItems"/>
    <loc xlink:type="locator" xlink:label="cve_SalescontractsDetailsScheduleofuraniumsalescontractsoverthenextfiveyearsTable" xlink:href="cve-20221231.xsd#cve_SalescontractsDetailsScheduleofuraniumsalescontractsoverthenextfiveyearsTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="cve_SalescontractsDetailsScheduleofuraniumsalescontractsoverthenextfiveyearsLineItems" xlink:to="cve_SalescontractsDetailsScheduleofuraniumsalescontractsoverthenextfiveyearsTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_SegmentsAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_SegmentsAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="cve_SalescontractsDetailsScheduleofuraniumsalescontractsoverthenextfiveyearsTable" xlink:to="ifrs-full_SegmentsAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_SegmentsMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_SegmentsMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="ifrs-full_SegmentsAxis" xlink:to="ifrs-full_SegmentsMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_SegmentsMember_0" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_SegmentsMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="ifrs-full_SegmentsAxis" xlink:to="ifrs-full_SegmentsMember_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cve_SalesContractsFiscalTwoZeroTwoThree" xlink:href="cve-20221231.xsd#cve_SalesContractsFiscalTwoZeroTwoThree"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_SalescontractsDetailsScheduleofuraniumsalescontractsoverthenextfiveyearsLineItems" xlink:to="cve_SalesContractsFiscalTwoZeroTwoThree" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cve_SalesContractsFiscalTwoZeroTwoFour" xlink:href="cve-20221231.xsd#cve_SalesContractsFiscalTwoZeroTwoFour"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_SalescontractsDetailsScheduleofuraniumsalescontractsoverthenextfiveyearsLineItems" xlink:to="cve_SalesContractsFiscalTwoZeroTwoFour" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cve_SalesContractsFiscalTwoZeroTwoFive" xlink:href="cve-20221231.xsd#cve_SalesContractsFiscalTwoZeroTwoFive"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_SalescontractsDetailsScheduleofuraniumsalescontractsoverthenextfiveyearsLineItems" xlink:to="cve_SalesContractsFiscalTwoZeroTwoFive" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cve_SalesContractsFiscalTwoZeroTwoSix" xlink:href="cve-20221231.xsd#cve_SalesContractsFiscalTwoZeroTwoSix"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_SalescontractsDetailsScheduleofuraniumsalescontractsoverthenextfiveyearsLineItems" xlink:to="cve_SalesContractsFiscalTwoZeroTwoSix" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cve_SalesContractsFiscalTwoZeroTwoSeven" xlink:href="cve-20221231.xsd#cve_SalesContractsFiscalTwoZeroTwoSeven"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_SalescontractsDetailsScheduleofuraniumsalescontractsoverthenextfiveyearsLineItems" xlink:to="cve_SalesContractsFiscalTwoZeroTwoSeven" order="5" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://encoreuranium.com/role/ScheduleofthecompanysstockoptionsoutstandingTable">
    <loc xlink:type="locator" xlink:label="cve_ScheduleOfTheCompanySStockOptionsOutstandingAbstract" xlink:href="cve-20221231.xsd#cve_ScheduleOfTheCompanySStockOptionsOutstandingAbstract"/>
    <loc xlink:type="locator" xlink:label="cve_SharesBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:href="cve-20221231.xsd#cve_SharesBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_ScheduleOfTheCompanySStockOptionsOutstandingAbstract" xlink:to="cve_SharesBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_ScheduleOfTheCompanySStockOptionsOutstandingAbstract" xlink:to="ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cve_SharesBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:href="cve-20221231.xsd#cve_SharesBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_ScheduleOfTheCompanySStockOptionsOutstandingAbstract" xlink:to="cve_SharesBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_ScheduleOfTheCompanySStockOptionsOutstandingAbstract" xlink:to="ifrs-full_WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cve_StockIssuedDuringPeriodShareStockOptionsExercised" xlink:href="cve-20221231.xsd#cve_StockIssuedDuringPeriodShareStockOptionsExercised"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_ScheduleOfTheCompanySStockOptionsOutstandingAbstract" xlink:to="cve_StockIssuedDuringPeriodShareStockOptionsExercised" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_ScheduleOfTheCompanySStockOptionsOutstandingAbstract" xlink:to="ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cve_StockIssuedDuringPeriodShareSharesBasedCompensationForfeited" xlink:href="cve-20221231.xsd#cve_StockIssuedDuringPeriodShareSharesBasedCompensationForfeited"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_ScheduleOfTheCompanySStockOptionsOutstandingAbstract" xlink:to="cve_StockIssuedDuringPeriodShareSharesBasedCompensationForfeited" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_ScheduleOfTheCompanySStockOptionsOutstandingAbstract" xlink:to="ifrs-full_WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019" order="7" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cve_SharesBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions" xlink:href="cve-20221231.xsd#cve_SharesBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_ScheduleOfTheCompanySStockOptionsOutstandingAbstract" xlink:to="cve_SharesBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions" order="8" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_ScheduleOfTheCompanySStockOptionsOutstandingAbstract" xlink:to="ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019" order="9" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://encoreuranium.com/role/ScheduleofstockoptionsoutstandingTable">
    <loc xlink:type="locator" xlink:label="cve_ShareCapitalDetailsScheduleofstockoptionsoutstandingLineItems" xlink:href="cve-20221231.xsd#cve_ShareCapitalDetailsScheduleofstockoptionsoutstandingLineItems"/>
    <loc xlink:type="locator" xlink:label="cve_ShareCapitalDetailsScheduleofstockoptionsoutstandingTable" xlink:href="cve-20221231.xsd#cve_ShareCapitalDetailsScheduleofstockoptionsoutstandingTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="cve_ShareCapitalDetailsScheduleofstockoptionsoutstandingLineItems" xlink:to="cve_ShareCapitalDetailsScheduleofstockoptionsoutstandingTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="cve_ShareCapitalDetailsScheduleofstockoptionsoutstandingTable" xlink:to="ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis" xlink:to="ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsMember_0" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis" xlink:to="ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsMember_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cve_ZeroOneEightOneNineTwoMember" xlink:href="cve-20221231.xsd#cve_ZeroOneEightOneNineTwoMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsMember" xlink:to="cve_ZeroOneEightOneNineTwoMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cve_TwoFourZeroThreeSevenEightMember" xlink:href="cve-20221231.xsd#cve_TwoFourZeroThreeSevenEightMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsMember" xlink:to="cve_TwoFourZeroThreeSevenEightMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cve_FourTwoZeroFiveSevenSixMember" xlink:href="cve-20221231.xsd#cve_FourTwoZeroFiveSevenSixMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsMember" xlink:to="cve_FourTwoZeroFiveSevenSixMember" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cve_SharesBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:href="cve-20221231.xsd#cve_SharesBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_ShareCapitalDetailsScheduleofstockoptionsoutstandingLineItems" xlink:to="cve_SharesBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_WeightedAverageDurationOfDefinedBenefitObligation2019" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_WeightedAverageDurationOfDefinedBenefitObligation2019"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_ShareCapitalDetailsScheduleofstockoptionsoutstandingLineItems" xlink:to="ifrs-full_WeightedAverageDurationOfDefinedBenefitObligation2019" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ExercisePriceOfOutstandingShareOptions2019" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_ExercisePriceOfOutstandingShareOptions2019"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_ShareCapitalDetailsScheduleofstockoptionsoutstandingLineItems" xlink:to="ifrs-full_ExercisePriceOfOutstandingShareOptions2019" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cve_SharesBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber" xlink:href="cve-20221231.xsd#cve_SharesBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_ShareCapitalDetailsScheduleofstockoptionsoutstandingLineItems" xlink:to="cve_SharesBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ExercisePriceShareOptionsGranted2019" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_ExercisePriceShareOptionsGranted2019"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_ShareCapitalDetailsScheduleofstockoptionsoutstandingLineItems" xlink:to="ifrs-full_ExercisePriceShareOptionsGranted2019" order="5" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://encoreuranium.com/role/ScheduleofweightedaverageassumptionsusedincalculatingthefairvaluesTable">
    <loc xlink:type="locator" xlink:label="cve_ScheduleOfWeightedAverageAssumptionsUsedInCalculatingTheFairValuesAbstract" xlink:href="cve-20221231.xsd#cve_ScheduleOfWeightedAverageAssumptionsUsedInCalculatingTheFairValuesAbstract"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DescriptionOfRiskFreeInterestRateShareOptionsGranted" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_DescriptionOfRiskFreeInterestRateShareOptionsGranted"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_ScheduleOfWeightedAverageAssumptionsUsedInCalculatingTheFairValuesAbstract" xlink:to="ifrs-full_DescriptionOfRiskFreeInterestRateShareOptionsGranted" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_ScheduleOfWeightedAverageAssumptionsUsedInCalculatingTheFairValuesAbstract" xlink:to="ifrs-full_WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ExpectedDividendAsPercentageShareOptionsGranted" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_ExpectedDividendAsPercentageShareOptionsGranted"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_ScheduleOfWeightedAverageAssumptionsUsedInCalculatingTheFairValuesAbstract" xlink:to="ifrs-full_ExpectedDividendAsPercentageShareOptionsGranted" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DescriptionOfExpectedVolatilityShareOptionsGranted" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_DescriptionOfExpectedVolatilityShareOptionsGranted"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_ScheduleOfWeightedAverageAssumptionsUsedInCalculatingTheFairValuesAbstract" xlink:to="ifrs-full_DescriptionOfExpectedVolatilityShareOptionsGranted" order="3" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://encoreuranium.com/role/ScheduleofthestatusofthecompanyswarrantsTable">
    <loc xlink:type="locator" xlink:label="cve_ScheduleOfTheStatusOfTheCompanySWarrantsAbstract" xlink:href="cve-20221231.xsd#cve_ScheduleOfTheStatusOfTheCompanySWarrantsAbstract"/>
    <loc xlink:type="locator" xlink:label="cve_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptionsWarrantsOutstanding" xlink:href="cve-20221231.xsd#cve_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptionsWarrantsOutstanding"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_ScheduleOfTheStatusOfTheCompanySWarrantsAbstract" xlink:to="cve_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptionsWarrantsOutstanding" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cve_SharesBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingPeriodIncreaseDecreaseWeightedAverageExercisePrice" xlink:href="cve-20221231.xsd#cve_SharesBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingPeriodIncreaseDecreaseWeightedAverageExercisePrice"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_ScheduleOfTheStatusOfTheCompanySWarrantsAbstract" xlink:to="cve_SharesBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingPeriodIncreaseDecreaseWeightedAverageExercisePrice" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cve_ShareBasedCompensationArrangementBySharesBasedPaymentAwardOptionsGrantsInPeriodWarrantsGranted" xlink:href="cve-20221231.xsd#cve_ShareBasedCompensationArrangementBySharesBasedPaymentAwardOptionsGrantsInPeriodWarrantsGranted"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_ScheduleOfTheStatusOfTheCompanySWarrantsAbstract" xlink:to="cve_ShareBasedCompensationArrangementBySharesBasedPaymentAwardOptionsGrantsInPeriodWarrantsGranted" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cve_SharesbasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue" xlink:href="cve-20221231.xsd#cve_SharesbasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_ScheduleOfTheStatusOfTheCompanySWarrantsAbstract" xlink:to="cve_SharesbasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cve_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisedWarrantsExercised" xlink:href="cve-20221231.xsd#cve_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisedWarrantsExercised"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_ScheduleOfTheStatusOfTheCompanySWarrantsAbstract" xlink:to="cve_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisedWarrantsExercised" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cve_SharesBasedCompensationArrangementBySharesBasedPaymentAwardOptionsOutstandingPeriodIncreaseDecreaseWeightedAverageExercisePrice" xlink:href="cve-20221231.xsd#cve_SharesBasedCompensationArrangementBySharesBasedPaymentAwardOptionsOutstandingPeriodIncreaseDecreaseWeightedAverageExercisePrice"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_ScheduleOfTheStatusOfTheCompanySWarrantsAbstract" xlink:to="cve_SharesBasedCompensationArrangementBySharesBasedPaymentAwardOptionsOutstandingPeriodIncreaseDecreaseWeightedAverageExercisePrice" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cve_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWarrantsExpired" xlink:href="cve-20221231.xsd#cve_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWarrantsExpired"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_ScheduleOfTheStatusOfTheCompanySWarrantsAbstract" xlink:to="cve_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWarrantsExpired" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cve_ShareBasedCompensationArrangementsBySharesBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" xlink:href="cve-20221231.xsd#cve_ShareBasedCompensationArrangementsBySharesBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_ScheduleOfTheStatusOfTheCompanySWarrantsAbstract" xlink:to="cve_ShareBasedCompensationArrangementsBySharesBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" order="7" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://encoreuranium.com/role/ScheduleofsharepurchasewarrantsoutstandingTable">
    <loc xlink:type="locator" xlink:label="cve_ShareCapitalDetailsScheduleofsharepurchasewarrantsoutstandingLineItems" xlink:href="cve-20221231.xsd#cve_ShareCapitalDetailsScheduleofsharepurchasewarrantsoutstandingLineItems"/>
    <loc xlink:type="locator" xlink:label="cve_ShareCapitalDetailsScheduleofsharepurchasewarrantsoutstandingTable" xlink:href="cve-20221231.xsd#cve_ShareCapitalDetailsScheduleofsharepurchasewarrantsoutstandingTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="cve_ShareCapitalDetailsScheduleofsharepurchasewarrantsoutstandingLineItems" xlink:to="cve_ShareCapitalDetailsScheduleofsharepurchasewarrantsoutstandingTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="cve_ShareCapitalDetailsScheduleofsharepurchasewarrantsoutstandingTable" xlink:to="ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis" xlink:to="ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsMember_0" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis" xlink:to="ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsMember_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cve_OneFiveNineOneEightZeroMember" xlink:href="cve-20221231.xsd#cve_OneFiveNineOneEightZeroMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsMember" xlink:to="cve_OneFiveNineOneEightZeroMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cve_TwoTwoTwoThreeNineZeroOneMember" xlink:href="cve-20221231.xsd#cve_TwoTwoTwoThreeNineZeroOneMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsMember" xlink:to="cve_TwoTwoTwoThreeNineZeroOneMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cve_FourFiveNineSixZeroZeroMember" xlink:href="cve-20221231.xsd#cve_FourFiveNineSixZeroZeroMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsMember" xlink:to="cve_FourFiveNineSixZeroZeroMember" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cve_Warrants" xlink:href="cve-20221231.xsd#cve_Warrants"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_ShareCapitalDetailsScheduleofsharepurchasewarrantsoutstandingLineItems" xlink:to="cve_Warrants" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cve_WarrantsOutstandingWeightedAverageReimainingLife" xlink:href="cve-20221231.xsd#cve_WarrantsOutstandingWeightedAverageReimainingLife"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_ShareCapitalDetailsScheduleofsharepurchasewarrantsoutstandingLineItems" xlink:to="cve_WarrantsOutstandingWeightedAverageReimainingLife" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cve_WarrantsOutstandingWeightedAverageExercisePrice" xlink:href="cve-20221231.xsd#cve_WarrantsOutstandingWeightedAverageExercisePrice"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_ShareCapitalDetailsScheduleofsharepurchasewarrantsoutstandingLineItems" xlink:to="cve_WarrantsOutstandingWeightedAverageExercisePrice" order="3" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://encoreuranium.com/role/ScheduleofamountspaidtokeymanagementorentitiesprovidingsimilarservicesTable">
    <loc xlink:type="locator" xlink:label="cve_ScheduleOfAmountsPaidToKeyManagementOrEntitiesProvidingSimilarServicesAbstract" xlink:href="cve-20221231.xsd#cve_ScheduleOfAmountsPaidToKeyManagementOrEntitiesProvidingSimilarServicesAbstract"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_RevenueFromRenderingOfInformationTechnologyConsultingServices" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_RevenueFromRenderingOfInformationTechnologyConsultingServices"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_ScheduleOfAmountsPaidToKeyManagementOrEntitiesProvidingSimilarServicesAbstract" xlink:to="ifrs-full_RevenueFromRenderingOfInformationTechnologyConsultingServices" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_ScheduleOfAmountsPaidToKeyManagementOrEntitiesProvidingSimilarServicesAbstract" xlink:to="ifrs-full_AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DirectorsRemunerationExpense" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_DirectorsRemunerationExpense"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_ScheduleOfAmountsPaidToKeyManagementOrEntitiesProvidingSimilarServicesAbstract" xlink:to="ifrs-full_DirectorsRemunerationExpense" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cve_OfficeAndAdministration" xlink:href="cve-20221231.xsd#cve_OfficeAndAdministration"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_ScheduleOfAmountsPaidToKeyManagementOrEntitiesProvidingSimilarServicesAbstract" xlink:to="cve_OfficeAndAdministration" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cve_StaffCosts" xlink:href="cve-20221231.xsd#cve_StaffCosts"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_ScheduleOfAmountsPaidToKeyManagementOrEntitiesProvidingSimilarServicesAbstract" xlink:to="cve_StaffCosts" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockOptionPlanExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockOptionPlanExpense"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_ScheduleOfAmountsPaidToKeyManagementOrEntitiesProvidingSimilarServicesAbstract" xlink:to="us-gaap_StockOptionPlanExpense" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_KeyManagementPersonnelCompensation" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_KeyManagementPersonnelCompensation"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_ScheduleOfAmountsPaidToKeyManagementOrEntitiesProvidingSimilarServicesAbstract" xlink:to="ifrs-full_KeyManagementPersonnelCompensation" order="6" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://encoreuranium.com/role/ScheduleofowingtorelatedpartiesTable">
    <loc xlink:type="locator" xlink:label="cve_RelatedpartytransactionsandbalancesDetailsScheduleofowingtorelatedpartiesLineItems" xlink:href="cve-20221231.xsd#cve_RelatedpartytransactionsandbalancesDetailsScheduleofowingtorelatedpartiesLineItems"/>
    <loc xlink:type="locator" xlink:label="cve_RelatedpartytransactionsandbalancesDetailsScheduleofowingtorelatedpartiesTable" xlink:href="cve-20221231.xsd#cve_RelatedpartytransactionsandbalancesDetailsScheduleofowingtorelatedpartiesTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="cve_RelatedpartytransactionsandbalancesDetailsScheduleofowingtorelatedpartiesLineItems" xlink:to="cve_RelatedpartytransactionsandbalancesDetailsScheduleofowingtorelatedpartiesTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CategoriesOfRelatedPartiesAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_CategoriesOfRelatedPartiesAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="cve_RelatedpartytransactionsandbalancesDetailsScheduleofowingtorelatedpartiesTable" xlink:to="ifrs-full_CategoriesOfRelatedPartiesAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_EntitysTotalForRelatedPartiesMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_EntitysTotalForRelatedPartiesMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="ifrs-full_CategoriesOfRelatedPartiesAxis" xlink:to="ifrs-full_EntitysTotalForRelatedPartiesMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_EntitysTotalForRelatedPartiesMember_0" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_EntitysTotalForRelatedPartiesMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="ifrs-full_CategoriesOfRelatedPartiesAxis" xlink:to="ifrs-full_EntitysTotalForRelatedPartiesMember_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cve_TintinaHoldingsLtdMember" xlink:href="cve-20221231.xsd#cve_TintinaHoldingsLtdMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_EntitysTotalForRelatedPartiesMember" xlink:to="cve_TintinaHoldingsLtdMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cve_OfficersAndBoardMembersMember" xlink:href="cve-20221231.xsd#cve_OfficersAndBoardMembersMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_EntitysTotalForRelatedPartiesMember" xlink:to="cve_OfficersAndBoardMembersMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AmountsPayableRelatedPartyTransactions" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_AmountsPayableRelatedPartyTransactions"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_RelatedpartytransactionsandbalancesDetailsScheduleofowingtorelatedpartiesLineItems" xlink:to="ifrs-full_AmountsPayableRelatedPartyTransactions" order="1" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://encoreuranium.com/role/ScheduleofforeigncurrencyexposuresTable">
    <loc xlink:type="locator" xlink:label="cve_ScheduleOfForeignCurrencyExposuresAbstract" xlink:href="cve-20221231.xsd#cve_ScheduleOfForeignCurrencyExposuresAbstract"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_Cash" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_Cash"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_ScheduleOfForeignCurrencyExposuresAbstract" xlink:to="ifrs-full_Cash" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_MarketableSecurities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MarketableSecurities"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_ScheduleOfForeignCurrencyExposuresAbstract" xlink:to="us-gaap_MarketableSecurities" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cve_AccountPayablesAndAccruedLiabilities" xlink:href="cve-20221231.xsd#cve_AccountPayablesAndAccruedLiabilities"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_ScheduleOfForeignCurrencyExposuresAbstract" xlink:to="cve_AccountPayablesAndAccruedLiabilities" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AssetsLessCurrentLiabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_AssetsLessCurrentLiabilities"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_ScheduleOfForeignCurrencyExposuresAbstract" xlink:to="ifrs-full_AssetsLessCurrentLiabilities" order="3" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://encoreuranium.com/role/ScheduleoflongtermassetsbygeographicsegmentTable">
    <loc xlink:type="locator" xlink:label="cve_SegmentedinformationDetailsScheduleoflongtermassetsbygeographicsegmentLineItems" xlink:href="cve-20221231.xsd#cve_SegmentedinformationDetailsScheduleoflongtermassetsbygeographicsegmentLineItems"/>
    <loc xlink:type="locator" xlink:label="cve_SegmentedinformationDetailsScheduleoflongtermassetsbygeographicsegmentTable" xlink:href="cve-20221231.xsd#cve_SegmentedinformationDetailsScheduleoflongtermassetsbygeographicsegmentTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="cve_SegmentedinformationDetailsScheduleoflongtermassetsbygeographicsegmentLineItems" xlink:to="cve_SegmentedinformationDetailsScheduleoflongtermassetsbygeographicsegmentTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_GeographicalAreasAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_GeographicalAreasAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="cve_SegmentedinformationDetailsScheduleoflongtermassetsbygeographicsegmentTable" xlink:to="ifrs-full_GeographicalAreasAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_GeographicalAreasMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_GeographicalAreasMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="ifrs-full_GeographicalAreasAxis" xlink:to="ifrs-full_GeographicalAreasMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_GeographicalAreasMember_0" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_GeographicalAreasMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="ifrs-full_GeographicalAreasAxis" xlink:to="ifrs-full_GeographicalAreasMember_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="stpr_SD" xlink:href="https://xbrl.sec.gov/stpr/2022/stpr-2022.xsd#stpr_SD"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_GeographicalAreasMember" xlink:to="stpr_SD" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="stpr_TX" xlink:href="https://xbrl.sec.gov/stpr/2022/stpr-2022.xsd#stpr_TX"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_GeographicalAreasMember" xlink:to="stpr_TX" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="stpr_NM" xlink:href="https://xbrl.sec.gov/stpr/2022/stpr-2022.xsd#stpr_NM"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_GeographicalAreasMember" xlink:to="stpr_NM" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="stpr_WY" xlink:href="https://xbrl.sec.gov/stpr/2022/stpr-2022.xsd#stpr_WY"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_GeographicalAreasMember" xlink:to="stpr_WY" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cve_OtherStatesMember" xlink:href="cve-20221231.xsd#cve_OtherStatesMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_GeographicalAreasMember" xlink:to="cve_OtherStatesMember" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="country_CA" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_CA"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_GeographicalAreasMember" xlink:to="country_CA" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cve_IntangibleAssets" xlink:href="cve-20221231.xsd#cve_IntangibleAssets"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_SegmentedinformationDetailsScheduleoflongtermassetsbygeographicsegmentLineItems" xlink:to="cve_IntangibleAssets" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cve_PropertyPlantAndEquipments" xlink:href="cve-20221231.xsd#cve_PropertyPlantAndEquipments"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_SegmentedinformationDetailsScheduleoflongtermassetsbygeographicsegmentLineItems" xlink:to="cve_PropertyPlantAndEquipments" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cve_MineralProperties" xlink:href="cve-20221231.xsd#cve_MineralProperties"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_SegmentedinformationDetailsScheduleoflongtermassetsbygeographicsegmentLineItems" xlink:to="cve_MineralProperties" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cve_RightofuseAssets1" xlink:href="cve-20221231.xsd#cve_RightofuseAssets1"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_SegmentedinformationDetailsScheduleoflongtermassetsbygeographicsegmentLineItems" xlink:to="cve_RightofuseAssets1" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cve_SegmentedInformationBalance" xlink:href="cve-20221231.xsd#cve_SegmentedInformationBalance"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_SegmentedinformationDetailsScheduleoflongtermassetsbygeographicsegmentLineItems" xlink:to="cve_SegmentedInformationBalance" order="5" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://encoreuranium.com/role/ScheduleofincurrednoncashfinancingandinvestingactivitiesTable">
    <loc xlink:type="locator" xlink:label="cve_ScheduleOfIncurredNonCashFinancingAndInvestingActivitiesAbstract" xlink:href="cve-20221231.xsd#cve_ScheduleOfIncurredNonCashFinancingAndInvestingActivitiesAbstract"/>
    <loc xlink:type="locator" xlink:label="cve_NonCashFinancingActivitiesAbstract" xlink:href="cve-20221231.xsd#cve_NonCashFinancingActivitiesAbstract"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_ScheduleOfIncurredNonCashFinancingAndInvestingActivitiesAbstract" xlink:to="cve_NonCashFinancingActivitiesAbstract" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CurrentAccruedExpensesAndOtherCurrentLiabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_CurrentAccruedExpensesAndOtherCurrentLiabilities"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_NonCashFinancingActivitiesAbstract" xlink:to="ifrs-full_CurrentAccruedExpensesAndOtherCurrentLiabilities" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cve_TotalNoncashFinancingActivities" xlink:href="cve-20221231.xsd#cve_TotalNoncashFinancingActivities"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_NonCashFinancingActivitiesAbstract" xlink:to="cve_TotalNoncashFinancingActivities" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cve_NonCashInvestingActivitiesAbstract" xlink:href="cve-20221231.xsd#cve_NonCashInvestingActivitiesAbstract"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_ScheduleOfIncurredNonCashFinancingAndInvestingActivitiesAbstract" xlink:to="cve_NonCashInvestingActivitiesAbstract" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cve_MarketableSecuritieReceivedOnDispositionOfMineralProperties" xlink:href="cve-20221231.xsd#cve_MarketableSecuritieReceivedOnDispositionOfMineralProperties"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_NonCashInvestingActivitiesAbstract" xlink:to="cve_MarketableSecuritieReceivedOnDispositionOfMineralProperties" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_LiabilitiesArisingFromExplorationForAndEvaluationOfMineralResources" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_LiabilitiesArisingFromExplorationForAndEvaluationOfMineralResources"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_NonCashInvestingActivitiesAbstract" xlink:to="ifrs-full_LiabilitiesArisingFromExplorationForAndEvaluationOfMineralResources" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cve_PropertyPlantAndEquipmentAdditionIncludedInAccountsPayableAndAccruedLiabilities" xlink:href="cve-20221231.xsd#cve_PropertyPlantAndEquipmentAdditionIncludedInAccountsPayableAndAccruedLiabilities"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_NonCashInvestingActivitiesAbstract" xlink:to="cve_PropertyPlantAndEquipmentAdditionIncludedInAccountsPayableAndAccruedLiabilities" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cve_FairValueOfCommonSharesIssuedForAzargaAssetAcquisition" xlink:href="cve-20221231.xsd#cve_FairValueOfCommonSharesIssuedForAzargaAssetAcquisition"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_NonCashInvestingActivitiesAbstract" xlink:to="cve_FairValueOfCommonSharesIssuedForAzargaAssetAcquisition" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cve_FairValueOfReplacementOptionsIssuedForAzargaAssetsAcquisition" xlink:href="cve-20221231.xsd#cve_FairValueOfReplacementOptionsIssuedForAzargaAssetsAcquisition"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_NonCashInvestingActivitiesAbstract" xlink:to="cve_FairValueOfReplacementOptionsIssuedForAzargaAssetsAcquisition" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cve_FairValueOfReplacementWarrantsIssuedForAzargaAssetAcquisition" xlink:href="cve-20221231.xsd#cve_FairValueOfReplacementWarrantsIssuedForAzargaAssetAcquisition"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_NonCashInvestingActivitiesAbstract" xlink:to="cve_FairValueOfReplacementWarrantsIssuedForAzargaAssetAcquisition" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cve_TotalNoncashInvestingActivities" xlink:href="cve-20221231.xsd#cve_TotalNoncashInvestingActivities"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_NonCashInvestingActivitiesAbstract" xlink:to="cve_TotalNoncashInvestingActivities" order="6" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://encoreuranium.com/role/ScheduleoffederalandprovincialcorporatetaxratestoincomebeforetaxTable">
    <loc xlink:type="locator" xlink:label="cve_ScheduleOfFederalAndProvincialCorporateTaxRatesToIncomeBeforeTaxAbstract" xlink:href="cve-20221231.xsd#cve_ScheduleOfFederalAndProvincialCorporateTaxRatesToIncomeBeforeTaxAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeLossAttributableToParent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossAttributableToParent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_ScheduleOfFederalAndProvincialCorporateTaxRatesToIncomeBeforeTaxAbstract" xlink:to="us-gaap_IncomeLossAttributableToParent" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_ScheduleOfFederalAndProvincialCorporateTaxRatesToIncomeBeforeTaxAbstract" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cve_ExpectedIncomeTaxExpenserecovery" xlink:href="cve-20221231.xsd#cve_ExpectedIncomeTaxExpenserecovery"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_ScheduleOfFederalAndProvincialCorporateTaxRatesToIncomeBeforeTaxAbstract" xlink:to="cve_ExpectedIncomeTaxExpenserecovery" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cve_IncreaseDecreaseResultingFromAbstract" xlink:href="cve-20221231.xsd#cve_IncreaseDecreaseResultingFromAbstract"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_ScheduleOfFederalAndProvincialCorporateTaxRatesToIncomeBeforeTaxAbstract" xlink:to="cve_IncreaseDecreaseResultingFromAbstract" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cve_ChangeInUnrecognizedTemporaryDifferences" xlink:href="cve-20221231.xsd#cve_ChangeInUnrecognizedTemporaryDifferences"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_IncreaseDecreaseResultingFromAbstract" xlink:to="cve_ChangeInUnrecognizedTemporaryDifferences" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_TaxEffectOfExpenseNotDeductibleInDeterminingTaxableProfitTaxLoss" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_TaxEffectOfExpenseNotDeductibleInDeterminingTaxableProfitTaxLoss"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_IncreaseDecreaseResultingFromAbstract" xlink:to="ifrs-full_TaxEffectOfExpenseNotDeductibleInDeterminingTaxableProfitTaxLoss" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_TaxEffectOfForeignTaxRates" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_TaxEffectOfForeignTaxRates"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_IncreaseDecreaseResultingFromAbstract" xlink:to="ifrs-full_TaxEffectOfForeignTaxRates" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cve_ShareIssueCosts" xlink:href="cve-20221231.xsd#cve_ShareIssueCosts"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_IncreaseDecreaseResultingFromAbstract" xlink:to="cve_ShareIssueCosts" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AdjustmentsForCurrentTaxOfPriorPeriod" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_AdjustmentsForCurrentTaxOfPriorPeriod"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_IncreaseDecreaseResultingFromAbstract" xlink:to="ifrs-full_AdjustmentsForCurrentTaxOfPriorPeriod" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_IncomeTaxExpenseContinuingOperations" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_IncomeTaxExpenseContinuingOperations"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_ScheduleOfFederalAndProvincialCorporateTaxRatesToIncomeBeforeTaxAbstract" xlink:to="ifrs-full_IncomeTaxExpenseContinuingOperations" order="4" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://encoreuranium.com/role/ScheduleofincometaxexpenserecoveryTable">
    <loc xlink:type="locator" xlink:label="cve_ScheduleOfIncomeTaxExpenseRecoveryAbstract" xlink:href="cve-20221231.xsd#cve_ScheduleOfIncomeTaxExpenseRecoveryAbstract"/>
    <loc xlink:type="locator" xlink:label="cve_DeferredTaxExpenseRecoveryAbstract" xlink:href="cve-20221231.xsd#cve_DeferredTaxExpenseRecoveryAbstract"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_ScheduleOfIncomeTaxExpenseRecoveryAbstract" xlink:to="cve_DeferredTaxExpenseRecoveryAbstract" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cve_OrginationAndReversalOfTemporaryDifferences" xlink:href="cve-20221231.xsd#cve_OrginationAndReversalOfTemporaryDifferences"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_DeferredTaxExpenseRecoveryAbstract" xlink:to="cve_OrginationAndReversalOfTemporaryDifferences" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cve_ChangeInUnrecognizedTemporaryDifferences" xlink:href="cve-20221231.xsd#cve_ChangeInUnrecognizedTemporaryDifferences"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_DeferredTaxExpenseRecoveryAbstract" xlink:to="cve_ChangeInUnrecognizedTemporaryDifferences" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_IncomeTaxExpenseContinuingOperations" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_IncomeTaxExpenseContinuingOperations"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_ScheduleOfIncomeTaxExpenseRecoveryAbstract" xlink:to="ifrs-full_IncomeTaxExpenseContinuingOperations" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsOtherLossCarryforwards" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsOtherLossCarryforwards"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_ScheduleOfIncomeTaxExpenseRecoveryAbstract" xlink:to="us-gaap_DeferredTaxAssetsOtherLossCarryforwards" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsOther" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsOther"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_ScheduleOfIncomeTaxExpenseRecoveryAbstract" xlink:to="us-gaap_DeferredTaxAssetsOther" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cve_SetoffOfTax" xlink:href="cve-20221231.xsd#cve_SetoffOfTax"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_ScheduleOfIncomeTaxExpenseRecoveryAbstract" xlink:to="cve_SetoffOfTax" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_NetDeferredTaxAssets" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_NetDeferredTaxAssets"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_ScheduleOfIncomeTaxExpenseRecoveryAbstract" xlink:to="ifrs-full_NetDeferredTaxAssets" order="5" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://encoreuranium.com/role/ScheduleofdeferredtaxliabilitiesTable">
    <loc xlink:type="locator" xlink:label="cve_ScheduleOfDeferredTaxLiabilitiesAbstract" xlink:href="cve-20221231.xsd#cve_ScheduleOfDeferredTaxLiabilitiesAbstract"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_OtherIntangibleAssets" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_OtherIntangibleAssets"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_ScheduleOfDeferredTaxLiabilitiesAbstract" xlink:to="ifrs-full_OtherIntangibleAssets" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_RightofuseAssetsRevaluedAssetsAtCost" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_RightofuseAssetsRevaluedAssetsAtCost"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_ScheduleOfDeferredTaxLiabilitiesAbstract" xlink:to="ifrs-full_RightofuseAssetsRevaluedAssetsAtCost" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cve_FixedAssets" xlink:href="cve-20221231.xsd#cve_FixedAssets"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_ScheduleOfDeferredTaxLiabilitiesAbstract" xlink:to="cve_FixedAssets" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_RightofuseAssetsRevaluationSurplus" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_RightofuseAssetsRevaluationSurplus"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_ScheduleOfDeferredTaxLiabilitiesAbstract" xlink:to="ifrs-full_RightofuseAssetsRevaluationSurplus" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_MarketableSecuritiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MarketableSecuritiesCurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_ScheduleOfDeferredTaxLiabilitiesAbstract" xlink:to="us-gaap_MarketableSecuritiesCurrent" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cve_SetoffOfTax" xlink:href="cve-20221231.xsd#cve_SetoffOfTax"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_ScheduleOfDeferredTaxLiabilitiesAbstract" xlink:to="cve_SetoffOfTax" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_NetDeferredTaxAssets" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_NetDeferredTaxAssets"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_ScheduleOfDeferredTaxLiabilitiesAbstract" xlink:to="ifrs-full_NetDeferredTaxAssets" order="6" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://encoreuranium.com/role/ScheduleofunrecognizeddeferredtaxassetsTable">
    <loc xlink:type="locator" xlink:label="cve_ScheduleOfUnrecognizedDeferredTaxAssetsAbstract" xlink:href="cve-20221231.xsd#cve_ScheduleOfUnrecognizedDeferredTaxAssetsAbstract"/>
    <loc xlink:type="locator" xlink:label="cve_DeductibleTemporaryDifferences" xlink:href="cve-20221231.xsd#cve_DeductibleTemporaryDifferences"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_ScheduleOfUnrecognizedDeferredTaxAssetsAbstract" xlink:to="cve_DeductibleTemporaryDifferences" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_TaxEffectOfTaxLosses" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_TaxEffectOfTaxLosses"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_ScheduleOfUnrecognizedDeferredTaxAssetsAbstract" xlink:to="ifrs-full_TaxEffectOfTaxLosses" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ProfitLossBeforeTax" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_ProfitLossBeforeTax"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_ScheduleOfUnrecognizedDeferredTaxAssetsAbstract" xlink:to="ifrs-full_ProfitLossBeforeTax" order="2" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://encoreuranium.com/role/ScheduleofeffectoftranslationTable">
    <loc xlink:type="locator" xlink:label="cve_ChangeinPresentationCurrencyDetailsScheduleofeffectoftranslationLineItems" xlink:href="cve-20221231.xsd#cve_ChangeinPresentationCurrencyDetailsScheduleofeffectoftranslationLineItems"/>
    <loc xlink:type="locator" xlink:label="cve_ChangeinPresentationCurrencyDetailsScheduleofeffectoftranslationTable" xlink:href="cve-20221231.xsd#cve_ChangeinPresentationCurrencyDetailsScheduleofeffectoftranslationTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="cve_ChangeinPresentationCurrencyDetailsScheduleofeffectoftranslationLineItems" xlink:to="cve_ChangeinPresentationCurrencyDetailsScheduleofeffectoftranslationTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_RetrospectiveApplicationAndRetrospectiveRestatementAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_RetrospectiveApplicationAndRetrospectiveRestatementAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="cve_ChangeinPresentationCurrencyDetailsScheduleofeffectoftranslationTable" xlink:to="ifrs-full_RetrospectiveApplicationAndRetrospectiveRestatementAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_RestatedMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_RestatedMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="ifrs-full_RetrospectiveApplicationAndRetrospectiveRestatementAxis" xlink:to="ifrs-full_RestatedMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_RestatedMember_0" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_RestatedMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="ifrs-full_RetrospectiveApplicationAndRetrospectiveRestatementAxis" xlink:to="ifrs-full_RestatedMember_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_PreviouslyStatedMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_PreviouslyStatedMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_RestatedMember" xlink:to="ifrs-full_PreviouslyStatedMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cve_TranslatedMember" xlink:href="cve-20221231.xsd#cve_TranslatedMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_RestatedMember" xlink:to="cve_TranslatedMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CurrentAssets" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_CurrentAssets"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_ChangeinPresentationCurrencyDetailsScheduleofeffectoftranslationLineItems" xlink:to="ifrs-full_CurrentAssets" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_NoncurrentAssets" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_NoncurrentAssets"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_ChangeinPresentationCurrencyDetailsScheduleofeffectoftranslationLineItems" xlink:to="ifrs-full_NoncurrentAssets" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_Assets" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_Assets"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_ChangeinPresentationCurrencyDetailsScheduleofeffectoftranslationLineItems" xlink:to="ifrs-full_Assets" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CurrentLiabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_CurrentLiabilities"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_ChangeinPresentationCurrencyDetailsScheduleofeffectoftranslationLineItems" xlink:to="ifrs-full_CurrentLiabilities" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_NoncurrentLiabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_NoncurrentLiabilities"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_ChangeinPresentationCurrencyDetailsScheduleofeffectoftranslationLineItems" xlink:to="ifrs-full_NoncurrentLiabilities" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_Liabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_Liabilities"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_ChangeinPresentationCurrencyDetailsScheduleofeffectoftranslationLineItems" xlink:to="ifrs-full_Liabilities" order="6" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://encoreuranium.com/role/ScheduleofconsolidatedstatementsoflossandcomprehensivelossTable">
    <loc xlink:type="locator" xlink:label="cve_ChangeinPresentationCurrencyDetailsScheduleofconsolidatedstatementsoflossandcomprehensivelossLineItems" xlink:href="cve-20221231.xsd#cve_ChangeinPresentationCurrencyDetailsScheduleofconsolidatedstatementsoflossandcomprehensivelossLineItems"/>
    <loc xlink:type="locator" xlink:label="cve_ChangeinPresentationCurrencyDetailsScheduleofconsolidatedstatementsoflossandcomprehensivelossTable" xlink:href="cve-20221231.xsd#cve_ChangeinPresentationCurrencyDetailsScheduleofconsolidatedstatementsoflossandcomprehensivelossTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="cve_ChangeinPresentationCurrencyDetailsScheduleofconsolidatedstatementsoflossandcomprehensivelossLineItems" xlink:to="cve_ChangeinPresentationCurrencyDetailsScheduleofconsolidatedstatementsoflossandcomprehensivelossTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_RestatementAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RestatementAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="cve_ChangeinPresentationCurrencyDetailsScheduleofconsolidatedstatementsoflossandcomprehensivelossTable" xlink:to="srt_RestatementAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_RestatementDomain" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RestatementDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_RestatementAxis" xlink:to="srt_RestatementDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_RestatementDomain_0" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RestatementDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="srt_RestatementAxis" xlink:to="srt_RestatementDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_ScenarioPreviouslyReportedMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioPreviouslyReportedMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RestatementDomain" xlink:to="srt_ScenarioPreviouslyReportedMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cve_TranslatedMember" xlink:href="cve-20221231.xsd#cve_TranslatedMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RestatementDomain" xlink:to="cve_TranslatedMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cve_ExpensesAbstract0" xlink:href="cve-20221231.xsd#cve_ExpensesAbstract0"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_ChangeinPresentationCurrencyDetailsScheduleofconsolidatedstatementsoflossandcomprehensivelossLineItems" xlink:to="cve_ExpensesAbstract0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cve_Accretion" xlink:href="cve-20221231.xsd#cve_Accretion"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_ExpensesAbstract0" xlink:to="cve_Accretion" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AdjustmentsForDepreciationAndAmortisationExpense" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_AdjustmentsForDepreciationAndAmortisationExpense"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_ExpensesAbstract0" xlink:to="ifrs-full_AdjustmentsForDepreciationAndAmortisationExpense" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cve_Consulting" xlink:href="cve-20221231.xsd#cve_Consulting"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_ExpensesAbstract0" xlink:to="cve_Consulting" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AdministrativeExpense" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_AdministrativeExpense"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_ExpensesAbstract0" xlink:to="ifrs-full_AdministrativeExpense" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cve_ImpairmentCharges" xlink:href="cve-20221231.xsd#cve_ImpairmentCharges"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_ExpensesAbstract0" xlink:to="cve_ImpairmentCharges" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_InterestExpense" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_InterestExpense"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_ExpensesAbstract0" xlink:to="ifrs-full_InterestExpense" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cve_OfficeAndAdministrative" xlink:href="cve-20221231.xsd#cve_OfficeAndAdministrative"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_ExpensesAbstract0" xlink:to="cve_OfficeAndAdministrative" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ProfessionalFeesExpense" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_ProfessionalFeesExpense"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_ExpensesAbstract0" xlink:to="ifrs-full_ProfessionalFeesExpense" order="7" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_OtherExpenseByNature" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_OtherExpenseByNature"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_ExpensesAbstract0" xlink:to="ifrs-full_OtherExpenseByNature" order="8" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cve_ReclamationCosts" xlink:href="cve-20221231.xsd#cve_ReclamationCosts"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_ExpensesAbstract0" xlink:to="cve_ReclamationCosts" order="9" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_TravelExpense" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_TravelExpense"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_ExpensesAbstract0" xlink:to="ifrs-full_TravelExpense" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cve_TransferAgentAndFilingFees" xlink:href="cve-20221231.xsd#cve_TransferAgentAndFilingFees"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_ExpensesAbstract0" xlink:to="cve_TransferAgentAndFilingFees" order="11" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cve_StaffCosts" xlink:href="cve-20221231.xsd#cve_StaffCosts"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_ExpensesAbstract0" xlink:to="cve_StaffCosts" order="12" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockOptionPlanExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockOptionPlanExpense"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_ExpensesAbstract0" xlink:to="us-gaap_StockOptionPlanExpense" order="13" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_OtherOperatingIncomeExpense" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_OtherOperatingIncomeExpense"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_ChangeinPresentationCurrencyDetailsScheduleofconsolidatedstatementsoflossandcomprehensivelossLineItems" xlink:to="ifrs-full_OtherOperatingIncomeExpense" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_InterestRevenueExpense" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_InterestRevenueExpense"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_OtherOperatingIncomeExpense" xlink:to="ifrs-full_InterestRevenueExpense" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ForeignExchangeGain" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_ForeignExchangeGain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_OtherOperatingIncomeExpense" xlink:to="ifrs-full_ForeignExchangeGain" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cve_LossesOnDivestmentOfMineralProperties" xlink:href="cve-20221231.xsd#cve_LossesOnDivestmentOfMineralProperties"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_OtherOperatingIncomeExpense" xlink:to="cve_LossesOnDivestmentOfMineralProperties" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cve_GainOnChangeInAssetRetirementObligationEstimate" xlink:href="cve-20221231.xsd#cve_GainOnChangeInAssetRetirementObligationEstimate"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_OtherOperatingIncomeExpense" xlink:to="cve_GainOnChangeInAssetRetirementObligationEstimate" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LossOnContractTermination" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossOnContractTermination"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_OtherOperatingIncomeExpense" xlink:to="us-gaap_LossOnContractTermination" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cve_UnrealizedGainOnUraniumInvestment" xlink:href="cve-20221231.xsd#cve_UnrealizedGainOnUraniumInvestment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_OtherOperatingIncomeExpense" xlink:to="cve_UnrealizedGainOnUraniumInvestment" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_GainsOnDisposalsOfInvestmentProperties" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_GainsOnDisposalsOfInvestmentProperties"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_OtherOperatingIncomeExpense" xlink:to="ifrs-full_GainsOnDisposalsOfInvestmentProperties" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cve_LossOnInvestmentInAssociate" xlink:href="cve-20221231.xsd#cve_LossOnInvestmentInAssociate"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_OtherOperatingIncomeExpense" xlink:to="cve_LossOnInvestmentInAssociate" order="7" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_NetForeignExchangeLoss" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_NetForeignExchangeLoss"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_OtherOperatingIncomeExpense" xlink:to="ifrs-full_NetForeignExchangeLoss" order="8" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_OtherComprehensiveIncomeBeforeTaxExchangeDifferencesOnTranslation" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_OtherComprehensiveIncomeBeforeTaxExchangeDifferencesOnTranslation"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_NetForeignExchangeLoss" xlink:to="ifrs-full_OtherComprehensiveIncomeBeforeTaxExchangeDifferencesOnTranslation" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ReversalOfImpairmentLossRecognisedInOtherComprehensiveIncome" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_ReversalOfImpairmentLossRecognisedInOtherComprehensiveIncome"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_ChangeinPresentationCurrencyDetailsScheduleofconsolidatedstatementsoflossandcomprehensivelossLineItems" xlink:to="ifrs-full_ReversalOfImpairmentLossRecognisedInOtherComprehensiveIncome" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_BasicEarningsLossPerShare" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_BasicEarningsLossPerShare"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_ChangeinPresentationCurrencyDetailsScheduleofconsolidatedstatementsoflossandcomprehensivelossLineItems" xlink:to="ifrs-full_BasicEarningsLossPerShare" order="4" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://encoreuranium.com/role/ScheduleofconsolidatedstatementsoflossandcomprehensivelossTable_Parentheticals">
    <loc xlink:type="locator" xlink:label="cve_ChangeinPresentationCurrencyDetailsScheduleofconsolidatedstatementsoflossandcomprehensivelossParentheticalsLineItems" xlink:href="cve-20221231.xsd#cve_ChangeinPresentationCurrencyDetailsScheduleofconsolidatedstatementsoflossandcomprehensivelossParentheticalsLineItems"/>
    <loc xlink:type="locator" xlink:label="cve_ChangeinPresentationCurrencyDetailsScheduleofconsolidatedstatementsoflossandcomprehensivelossParentheticalsTable" xlink:href="cve-20221231.xsd#cve_ChangeinPresentationCurrencyDetailsScheduleofconsolidatedstatementsoflossandcomprehensivelossParentheticalsTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="cve_ChangeinPresentationCurrencyDetailsScheduleofconsolidatedstatementsoflossandcomprehensivelossParentheticalsLineItems" xlink:to="cve_ChangeinPresentationCurrencyDetailsScheduleofconsolidatedstatementsoflossandcomprehensivelossParentheticalsTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_RestatementAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RestatementAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="cve_ChangeinPresentationCurrencyDetailsScheduleofconsolidatedstatementsoflossandcomprehensivelossParentheticalsTable" xlink:to="srt_RestatementAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_RestatementDomain" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RestatementDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_RestatementAxis" xlink:to="srt_RestatementDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_RestatementDomain_0" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RestatementDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="srt_RestatementAxis" xlink:to="srt_RestatementDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_ScenarioPreviouslyReportedMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioPreviouslyReportedMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RestatementDomain" xlink:to="srt_ScenarioPreviouslyReportedMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cve_TranslatedMember" xlink:href="cve-20221231.xsd#cve_TranslatedMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RestatementDomain" xlink:to="cve_TranslatedMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DilutedEarningsLossPerShare" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_DilutedEarningsLossPerShare"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_ChangeinPresentationCurrencyDetailsScheduleofconsolidatedstatementsoflossandcomprehensivelossParentheticalsLineItems" xlink:to="ifrs-full_DilutedEarningsLossPerShare" order="1" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://encoreuranium.com/role/NatureofOperationsandGoingConcernDetails">
    <loc xlink:type="locator" xlink:label="cve_NatureOfOperationAndGoingConcernAbstract" xlink:href="cve-20221231.xsd#cve_NatureOfOperationAndGoingConcernAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProfitLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_NatureOfOperationAndGoingConcernAbstract" xlink:to="us-gaap_ProfitLoss" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cve_WorkingCapital" xlink:href="cve-20221231.xsd#cve_WorkingCapital"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_NatureOfOperationAndGoingConcernAbstract" xlink:to="cve_WorkingCapital" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cve_AccumulatedDeficit" xlink:href="cve-20221231.xsd#cve_AccumulatedDeficit"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_NatureOfOperationAndGoingConcernAbstract" xlink:to="cve_AccumulatedDeficit" order="2" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://encoreuranium.com/role/SignificantaccountingpoliciesDetails">
    <loc xlink:type="locator" xlink:label="cve_DisclosureOfSignificantAccountingPoliciesTextBlockAbstract" xlink:href="cve-20221231.xsd#cve_DisclosureOfSignificantAccountingPoliciesTextBlockAbstract"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_PercentageOfVotingEquityInterestsAcquired" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_PercentageOfVotingEquityInterestsAcquired"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_DisclosureOfSignificantAccountingPoliciesTextBlockAbstract" xlink:to="ifrs-full_PercentageOfVotingEquityInterestsAcquired" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DepositsFromBanks" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_DepositsFromBanks"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_DisclosureOfSignificantAccountingPoliciesTextBlockAbstract" xlink:to="ifrs-full_DepositsFromBanks" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cve_ShareSubscriptionsValue" xlink:href="cve-20221231.xsd#cve_ShareSubscriptionsValue"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_DisclosureOfSignificantAccountingPoliciesTextBlockAbstract" xlink:to="cve_ShareSubscriptionsValue" order="2" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://encoreuranium.com/role/InvestmentInAssociateDetails">
    <loc xlink:type="locator" xlink:label="cve_DisclosureOfAssociatesTextBlockAbstract" xlink:href="cve-20221231.xsd#cve_DisclosureOfAssociatesTextBlockAbstract"/>
    <loc xlink:type="locator" xlink:label="cve_AcquiredShares" xlink:href="cve-20221231.xsd#cve_AcquiredShares"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_DisclosureOfAssociatesTextBlockAbstract" xlink:to="cve_AcquiredShares" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cve_IssuedAndOutstandingSharesPercentage" xlink:href="cve-20221231.xsd#cve_IssuedAndOutstandingSharesPercentage"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_DisclosureOfAssociatesTextBlockAbstract" xlink:to="cve_IssuedAndOutstandingSharesPercentage" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cve_AdvancedAmount" xlink:href="cve-20221231.xsd#cve_AdvancedAmount"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_DisclosureOfAssociatesTextBlockAbstract" xlink:to="cve_AdvancedAmount" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ProportionOfOwnershipInterestInAssociate" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_ProportionOfOwnershipInterestInAssociate"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_DisclosureOfAssociatesTextBlockAbstract" xlink:to="ifrs-full_ProportionOfOwnershipInterestInAssociate" order="3" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://encoreuranium.com/role/InvestmentinuraniumDetails">
    <loc xlink:type="locator" xlink:label="cve_InvestmentinuraniumDetailsLineItems" xlink:href="cve-20221231.xsd#cve_InvestmentinuraniumDetailsLineItems"/>
    <loc xlink:type="locator" xlink:label="cve_InvestmentinuraniumDetailsTable" xlink:href="cve-20221231.xsd#cve_InvestmentinuraniumDetailsTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="cve_InvestmentinuraniumDetailsLineItems" xlink:to="cve_InvestmentinuraniumDetailsTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_StatementScenarioAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementScenarioAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="cve_InvestmentinuraniumDetailsTable" xlink:to="srt_StatementScenarioAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_ScenarioUnspecifiedDomain" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioUnspecifiedDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_StatementScenarioAxis" xlink:to="srt_ScenarioUnspecifiedDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_ScenarioUnspecifiedDomain_0" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioUnspecifiedDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="srt_StatementScenarioAxis" xlink:to="srt_ScenarioUnspecifiedDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_ScenarioForecastMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioForecastMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_ScenarioUnspecifiedDomain" xlink:to="srt_ScenarioForecastMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cve_PurchaseAgreementsAmount" xlink:href="cve-20221231.xsd#cve_PurchaseAgreementsAmount"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_InvestmentinuraniumDetailsLineItems" xlink:to="cve_PurchaseAgreementsAmount" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherLongTermInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLongTermInvestments"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_InvestmentinuraniumDetailsLineItems" xlink:to="us-gaap_OtherLongTermInvestments" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cve_SaleOfPhysicalUranium" xlink:href="cve-20221231.xsd#cve_SaleOfPhysicalUranium"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_InvestmentinuraniumDetailsLineItems" xlink:to="cve_SaleOfPhysicalUranium" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cve_GrossProceeds" xlink:href="cve-20221231.xsd#cve_GrossProceeds"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_InvestmentinuraniumDetailsLineItems" xlink:to="cve_GrossProceeds" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_GainsOnDisposalsOfInvestments" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_GainsOnDisposalsOfInvestments"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_InvestmentinuraniumDetailsLineItems" xlink:to="ifrs-full_GainsOnDisposalsOfInvestments" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cve_TotalConsideration" xlink:href="cve-20221231.xsd#cve_TotalConsideration"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_InvestmentinuraniumDetailsLineItems" xlink:to="cve_TotalConsideration" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cve_TotalConsiderationPerShare" xlink:href="cve-20221231.xsd#cve_TotalConsiderationPerShare"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_InvestmentinuraniumDetailsLineItems" xlink:to="cve_TotalConsiderationPerShare" order="7" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cve_InitialPayment" xlink:href="cve-20221231.xsd#cve_InitialPayment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_InvestmentinuraniumDetailsLineItems" xlink:to="cve_InitialPayment" order="8" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cve_InvestmentAmount" xlink:href="cve-20221231.xsd#cve_InvestmentAmount"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_InvestmentinuraniumDetailsLineItems" xlink:to="cve_InvestmentAmount" order="9" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://encoreuranium.com/role/MarketableSecuritiesDetails">
    <loc xlink:type="locator" xlink:label="cve_MarketableSecuritiesDetailsLineItems" xlink:href="cve-20221231.xsd#cve_MarketableSecuritiesDetailsLineItems"/>
    <loc xlink:type="locator" xlink:label="cve_MarketableSecuritiesDetailsTable" xlink:href="cve-20221231.xsd#cve_MarketableSecuritiesDetailsTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="cve_MarketableSecuritiesDetailsLineItems" xlink:to="cve_MarketableSecuritiesDetailsTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ClassesOfOrdinarySharesAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_ClassesOfOrdinarySharesAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="cve_MarketableSecuritiesDetailsTable" xlink:to="ifrs-full_ClassesOfOrdinarySharesAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_OrdinarySharesMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_OrdinarySharesMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="ifrs-full_ClassesOfOrdinarySharesAxis" xlink:to="ifrs-full_OrdinarySharesMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_OrdinarySharesMember_0" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_OrdinarySharesMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="ifrs-full_ClassesOfOrdinarySharesAxis" xlink:to="ifrs-full_OrdinarySharesMember_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="cve_MarketableSecuritiesDetailsTable" xlink:to="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="us-gaap_RelatedPartyDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="us-gaap_RelatedPartyDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cve_MarketableSecuritiesMember" xlink:href="cve-20221231.xsd#cve_MarketableSecuritiesMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyDomain" xlink:to="cve_MarketableSecuritiesMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cve_TradingSharesMember" xlink:href="cve-20221231.xsd#cve_TradingSharesMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_OrdinarySharesMember" xlink:to="cve_TradingSharesMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cve_CommonShares" xlink:href="cve-20221231.xsd#cve_CommonShares"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_MarketableSecuritiesDetailsLineItems" xlink:to="cve_CommonShares" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cve_MarketValuePerShare" xlink:href="cve-20221231.xsd#cve_MarketValuePerShare"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_MarketableSecuritiesDetailsLineItems" xlink:to="cve_MarketValuePerShare" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_NumberOfSharesIssuedAndFullyPaid" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_NumberOfSharesIssuedAndFullyPaid"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_MarketableSecuritiesDetailsLineItems" xlink:to="ifrs-full_NumberOfSharesIssuedAndFullyPaid" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cve_ConvertedShares" xlink:href="cve-20221231.xsd#cve_ConvertedShares"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_MarketableSecuritiesDetailsLineItems" xlink:to="cve_ConvertedShares" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DescriptionOfKeyAssumptionsOnWhichManagementHasBasedDeterminationOfFairValueLessCostsOfDisposal" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_DescriptionOfKeyAssumptionsOnWhichManagementHasBasedDeterminationOfFairValueLessCostsOfDisposal"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_MarketableSecuritiesDetailsLineItems" xlink:to="ifrs-full_DescriptionOfKeyAssumptionsOnWhichManagementHasBasedDeterminationOfFairValueLessCostsOfDisposal" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cve_TradingShares" xlink:href="cve-20221231.xsd#cve_TradingShares"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_MarketableSecuritiesDetailsLineItems" xlink:to="cve_TradingShares" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_FinancialLiabilitiesAtFairValue" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_FinancialLiabilitiesAtFairValue"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_MarketableSecuritiesDetailsLineItems" xlink:to="ifrs-full_FinancialLiabilitiesAtFairValue" order="7" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ParValuePerShare" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_ParValuePerShare"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_MarketableSecuritiesDetailsLineItems" xlink:to="ifrs-full_ParValuePerShare" order="8" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cve_ReleasedShares" xlink:href="cve-20221231.xsd#cve_ReleasedShares"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_MarketableSecuritiesDetailsLineItems" xlink:to="cve_ReleasedShares" order="9" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cve_PrimeFuelsConsiderationPercentage" xlink:href="cve-20221231.xsd#cve_PrimeFuelsConsiderationPercentage"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_MarketableSecuritiesDetailsLineItems" xlink:to="cve_PrimeFuelsConsiderationPercentage" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_Assets" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_Assets"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_MarketableSecuritiesDetailsLineItems" xlink:to="ifrs-full_Assets" order="11" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://encoreuranium.com/role/IntangibleassetsDetails">
    <loc xlink:type="locator" xlink:label="cve_DisclosureOfIntangibleAssetsTextBlockAbstract" xlink:href="cve-20221231.xsd#cve_DisclosureOfIntangibleAssetsTextBlockAbstract"/>
    <loc xlink:type="locator" xlink:label="cve_CommonSharesIssued" xlink:href="cve-20221231.xsd#cve_CommonSharesIssued"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_DisclosureOfIntangibleAssetsTextBlockAbstract" xlink:to="cve_CommonSharesIssued" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_PlanAssetsAtFairValue" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_PlanAssetsAtFairValue"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_DisclosureOfIntangibleAssetsTextBlockAbstract" xlink:to="ifrs-full_PlanAssetsAtFairValue" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cve_PrimaryTerm" xlink:href="cve-20221231.xsd#cve_PrimaryTerm"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_DisclosureOfIntangibleAssetsTextBlockAbstract" xlink:to="cve_PrimaryTerm" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cve_RenewalPeriods" xlink:href="cve-20221231.xsd#cve_RenewalPeriods"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_DisclosureOfIntangibleAssetsTextBlockAbstract" xlink:to="cve_RenewalPeriods" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cve_IntangibleAssetDeterminedLife" xlink:href="cve-20221231.xsd#cve_IntangibleAssetDeterminedLife"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_DisclosureOfIntangibleAssetsTextBlockAbstract" xlink:to="cve_IntangibleAssetDeterminedLife" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cve_AcquiredAmonut" xlink:href="cve-20221231.xsd#cve_AcquiredAmonut"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_DisclosureOfIntangibleAssetsTextBlockAbstract" xlink:to="cve_AcquiredAmonut" order="5" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://encoreuranium.com/role/RightofuseassetsDetails">
    <loc xlink:type="locator" xlink:label="cve_RightofuseassetsDetailsLineItems" xlink:href="cve-20221231.xsd#cve_RightofuseassetsDetailsLineItems"/>
    <loc xlink:type="locator" xlink:label="cve_RightofuseassetsDetailsTable" xlink:href="cve-20221231.xsd#cve_RightofuseassetsDetailsTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="cve_RightofuseassetsDetailsLineItems" xlink:to="cve_RightofuseassetsDetailsTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ClassesOfAssetsAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_ClassesOfAssetsAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="cve_RightofuseassetsDetailsTable" xlink:to="ifrs-full_ClassesOfAssetsAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ClassesOfAssetsMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_ClassesOfAssetsMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="ifrs-full_ClassesOfAssetsAxis" xlink:to="ifrs-full_ClassesOfAssetsMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ClassesOfAssetsMember_0" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_ClassesOfAssetsMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="ifrs-full_ClassesOfAssetsAxis" xlink:to="ifrs-full_ClassesOfAssetsMember_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_RightofuseAssetsMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_RightofuseAssetsMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_ClassesOfAssetsMember" xlink:to="ifrs-full_RightofuseAssetsMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLeasePayments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeasePayments"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_RightofuseassetsDetailsLineItems" xlink:to="us-gaap_OperatingLeasePayments" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cve_CorrespondingLeaseObligation" xlink:href="cve-20221231.xsd#cve_CorrespondingLeaseObligation"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_RightofuseassetsDetailsLineItems" xlink:to="cve_CorrespondingLeaseObligation" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_BorrowingsInterestRate" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_BorrowingsInterestRate"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_RightofuseassetsDetailsLineItems" xlink:to="ifrs-full_BorrowingsInterestRate" order="3" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://encoreuranium.com/role/AssetacquisitionDetails">
    <loc xlink:type="locator" xlink:label="cve_AssetacquisitionDetailsLineItems" xlink:href="cve-20221231.xsd#cve_AssetacquisitionDetailsLineItems"/>
    <loc xlink:type="locator" xlink:label="cve_AssetacquisitionDetailsTable" xlink:href="cve-20221231.xsd#cve_AssetacquisitionDetailsTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="cve_AssetacquisitionDetailsLineItems" xlink:to="cve_AssetacquisitionDetailsTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_RangeAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_RangeAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="cve_AssetacquisitionDetailsTable" xlink:to="ifrs-full_RangeAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_RangesMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_RangesMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="ifrs-full_RangeAxis" xlink:to="ifrs-full_RangesMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_RangesMember_0" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_RangesMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="ifrs-full_RangeAxis" xlink:to="ifrs-full_RangesMember_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ClassesOfAssetsAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_ClassesOfAssetsAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="cve_AssetacquisitionDetailsTable" xlink:to="ifrs-full_ClassesOfAssetsAxis" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ClassesOfAssetsMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_ClassesOfAssetsMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="ifrs-full_ClassesOfAssetsAxis" xlink:to="ifrs-full_ClassesOfAssetsMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ClassesOfAssetsMember_0" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_ClassesOfAssetsMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="ifrs-full_ClassesOfAssetsAxis" xlink:to="ifrs-full_ClassesOfAssetsMember_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cve_ReplacementOptionsMember" xlink:href="cve-20221231.xsd#cve_ReplacementOptionsMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_ClassesOfAssetsMember" xlink:to="cve_ReplacementOptionsMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cve_ReplacementWarrantsMember" xlink:href="cve-20221231.xsd#cve_ReplacementWarrantsMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_ClassesOfAssetsMember" xlink:to="cve_ReplacementWarrantsMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_TopOfRangeMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_TopOfRangeMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_RangesMember" xlink:to="ifrs-full_TopOfRangeMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_BottomOfRangeMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_BottomOfRangeMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_RangesMember" xlink:to="ifrs-full_BottomOfRangeMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cve_MarketValuePerShare" xlink:href="cve-20221231.xsd#cve_MarketValuePerShare"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_AssetacquisitionDetailsLineItems" xlink:to="cve_MarketValuePerShare" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_AssetacquisitionDetailsLineItems" xlink:to="ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_NumberOfSharesIssued" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_NumberOfSharesIssued"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_AssetacquisitionDetailsLineItems" xlink:to="ifrs-full_NumberOfSharesIssued" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cve_ShareConsiderationAmount" xlink:href="cve-20221231.xsd#cve_ShareConsiderationAmount"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_AssetacquisitionDetailsLineItems" xlink:to="cve_ShareConsiderationAmount" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cve_StockOptions" xlink:href="cve-20221231.xsd#cve_StockOptions"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_AssetacquisitionDetailsLineItems" xlink:to="cve_StockOptions" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ProceedsFromExerciseOfOptions" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_ProceedsFromExerciseOfOptions"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_AssetacquisitionDetailsLineItems" xlink:to="ifrs-full_ProceedsFromExerciseOfOptions" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cve_SharePurchaseWarrants" xlink:href="cve-20221231.xsd#cve_SharePurchaseWarrants"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_AssetacquisitionDetailsLineItems" xlink:to="cve_SharePurchaseWarrants" order="7" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ProceedsFromExerciseOfWarrants" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_ProceedsFromExerciseOfWarrants"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_AssetacquisitionDetailsLineItems" xlink:to="ifrs-full_ProceedsFromExerciseOfWarrants" order="8" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AcquisitionrelatedCostsRecognisedAsExpenseForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_AcquisitionrelatedCostsRecognisedAsExpenseForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_AssetacquisitionDetailsLineItems" xlink:to="ifrs-full_AcquisitionrelatedCostsRecognisedAsExpenseForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination" order="9" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_WeightedAverageSharePrice2019" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_WeightedAverageSharePrice2019"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_AssetacquisitionDetailsLineItems" xlink:to="ifrs-full_WeightedAverageSharePrice2019" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_NumberOfSharesOutstanding" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_NumberOfSharesOutstanding"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_AssetacquisitionDetailsLineItems" xlink:to="ifrs-full_NumberOfSharesOutstanding" order="11" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cve_ExchangeRatio" xlink:href="cve-20221231.xsd#cve_ExchangeRatio"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_AssetacquisitionDetailsLineItems" xlink:to="cve_ExchangeRatio" order="12" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cve_ShareConsolidation" xlink:href="cve-20221231.xsd#cve_ShareConsolidation"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_AssetacquisitionDetailsLineItems" xlink:to="cve_ShareConsolidation" order="13" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://encoreuranium.com/role/MineralPropertiesDetails">
    <loc xlink:type="locator" xlink:label="cve_MineralPropertiesDetailsLineItems" xlink:href="cve-20221231.xsd#cve_MineralPropertiesDetailsLineItems"/>
    <loc xlink:type="locator" xlink:label="cve_MineralPropertiesDetailsTable" xlink:href="cve-20221231.xsd#cve_MineralPropertiesDetailsTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="cve_MineralPropertiesDetailsLineItems" xlink:to="cve_MineralPropertiesDetailsTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_RangeAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_RangeAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="cve_MineralPropertiesDetailsTable" xlink:to="ifrs-full_RangeAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_RangesMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_RangesMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="ifrs-full_RangeAxis" xlink:to="ifrs-full_RangesMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_RangesMember_0" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_RangesMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="ifrs-full_RangeAxis" xlink:to="ifrs-full_RangesMember_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ClassesOfLiabilitiesAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_ClassesOfLiabilitiesAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="cve_MineralPropertiesDetailsTable" xlink:to="ifrs-full_ClassesOfLiabilitiesAxis" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_LiabilitiesMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_LiabilitiesMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="ifrs-full_ClassesOfLiabilitiesAxis" xlink:to="ifrs-full_LiabilitiesMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_LiabilitiesMember_0" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_LiabilitiesMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="ifrs-full_ClassesOfLiabilitiesAxis" xlink:to="ifrs-full_LiabilitiesMember_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CategoriesOfRelatedPartiesAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_CategoriesOfRelatedPartiesAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="cve_MineralPropertiesDetailsTable" xlink:to="ifrs-full_CategoriesOfRelatedPartiesAxis" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_EntitysTotalForRelatedPartiesMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_EntitysTotalForRelatedPartiesMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="ifrs-full_CategoriesOfRelatedPartiesAxis" xlink:to="ifrs-full_EntitysTotalForRelatedPartiesMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_EntitysTotalForRelatedPartiesMember_0" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_EntitysTotalForRelatedPartiesMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="ifrs-full_CategoriesOfRelatedPartiesAxis" xlink:to="ifrs-full_EntitysTotalForRelatedPartiesMember_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ContingentConsiderationMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_ContingentConsiderationMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_LiabilitiesMember" xlink:to="ifrs-full_ContingentConsiderationMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cve_TriStateGenerationAndTransmissionAssociationMember" xlink:href="cve-20221231.xsd#cve_TriStateGenerationAndTransmissionAssociationMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_LiabilitiesMember" xlink:to="cve_TriStateGenerationAndTransmissionAssociationMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cve_WildcatSolarPowerPlantLLCMember" xlink:href="cve-20221231.xsd#cve_WildcatSolarPowerPlantLLCMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_LiabilitiesMember" xlink:to="cve_WildcatSolarPowerPlantLLCMember" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cve_McKinleyMember" xlink:href="cve-20221231.xsd#cve_McKinleyMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_LiabilitiesMember" xlink:to="cve_McKinleyMember" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cve_CrownpointMember" xlink:href="cve-20221231.xsd#cve_CrownpointMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_LiabilitiesMember" xlink:to="cve_CrownpointMember" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cve_HostaButteMember" xlink:href="cve-20221231.xsd#cve_HostaButteMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_LiabilitiesMember" xlink:to="cve_HostaButteMember" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_BottomOfRangeMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_BottomOfRangeMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_RangesMember" xlink:to="ifrs-full_BottomOfRangeMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_TopOfRangeMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_TopOfRangeMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_RangesMember" xlink:to="ifrs-full_TopOfRangeMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cve_PrimeFuelsCorpMember" xlink:href="cve-20221231.xsd#cve_PrimeFuelsCorpMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_EntitysTotalForRelatedPartiesMember" xlink:to="cve_PrimeFuelsCorpMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_LongtermDeposits" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_LongtermDeposits"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_MineralPropertiesDetailsLineItems" xlink:to="ifrs-full_LongtermDeposits" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ConsiderationPaidReceived" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_ConsiderationPaidReceived"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_MineralPropertiesDetailsLineItems" xlink:to="ifrs-full_ConsiderationPaidReceived" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ContingentConsiderationRecognisedAsOfAcquisitionDate" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_ContingentConsiderationRecognisedAsOfAcquisitionDate"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_MineralPropertiesDetailsLineItems" xlink:to="ifrs-full_ContingentConsiderationRecognisedAsOfAcquisitionDate" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_GainsOnDisposalsOfInvestments" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_GainsOnDisposalsOfInvestments"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_MineralPropertiesDetailsLineItems" xlink:to="ifrs-full_GainsOnDisposalsOfInvestments" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cve_InvestmentInterestRates" xlink:href="cve-20221231.xsd#cve_InvestmentInterestRates"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_MineralPropertiesDetailsLineItems" xlink:to="cve_InvestmentInterestRates" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cve_InterestRateHold" xlink:href="cve-20221231.xsd#cve_InterestRateHold"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_MineralPropertiesDetailsLineItems" xlink:to="cve_InterestRateHold" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cve_RoyaltyIncomeRate" xlink:href="cve-20221231.xsd#cve_RoyaltyIncomeRate"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_MineralPropertiesDetailsLineItems" xlink:to="cve_RoyaltyIncomeRate" order="7" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cve_ConsiderationReceived" xlink:href="cve-20221231.xsd#cve_ConsiderationReceived"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_MineralPropertiesDetailsLineItems" xlink:to="cve_ConsiderationReceived" order="8" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LongTermDebtFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtFairValue"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_MineralPropertiesDetailsLineItems" xlink:to="us-gaap_LongTermDebtFairValue" order="9" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_NoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSaleOrAsHeldForDistributionToOwners" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_NoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSaleOrAsHeldForDistributionToOwners"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_MineralPropertiesDetailsLineItems" xlink:to="ifrs-full_NoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSaleOrAsHeldForDistributionToOwners" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cve_GainOnDisposalOfSubsidiary" xlink:href="cve-20221231.xsd#cve_GainOnDisposalOfSubsidiary"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_MineralPropertiesDetailsLineItems" xlink:to="cve_GainOnDisposalOfSubsidiary" order="11" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ProceedsFromSalesOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_ProceedsFromSalesOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_MineralPropertiesDetailsLineItems" xlink:to="ifrs-full_ProceedsFromSalesOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities" order="12" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cve_AdditionalPayment" xlink:href="cve-20221231.xsd#cve_AdditionalPayment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_MineralPropertiesDetailsLineItems" xlink:to="cve_AdditionalPayment" order="13" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_RecognisedAssetsDefinedBenefitPlan" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_RecognisedAssetsDefinedBenefitPlan"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_MineralPropertiesDetailsLineItems" xlink:to="ifrs-full_RecognisedAssetsDefinedBenefitPlan" order="14" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cve_GrantedPercentage" xlink:href="cve-20221231.xsd#cve_GrantedPercentage"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_MineralPropertiesDetailsLineItems" xlink:to="cve_GrantedPercentage" order="15" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cve_ConsiderationPercentage" xlink:href="cve-20221231.xsd#cve_ConsiderationPercentage"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_MineralPropertiesDetailsLineItems" xlink:to="cve_ConsiderationPercentage" order="16" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_NumberOfSharesIssuedAndFullyPaid" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_NumberOfSharesIssuedAndFullyPaid"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_MineralPropertiesDetailsLineItems" xlink:to="ifrs-full_NumberOfSharesIssuedAndFullyPaid" order="17" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_PlanAssetsAtFairValue" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_PlanAssetsAtFairValue"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_MineralPropertiesDetailsLineItems" xlink:to="ifrs-full_PlanAssetsAtFairValue" order="18" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_LossesOnDisposalsOfInvestments" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_LossesOnDisposalsOfInvestments"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_MineralPropertiesDetailsLineItems" xlink:to="ifrs-full_LossesOnDisposalsOfInvestments" order="19" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://encoreuranium.com/role/AssetretirementobligationsDetails">
    <loc xlink:type="locator" xlink:label="cve_AssetRetirementObligationsAbstract" xlink:href="cve-20221231.xsd#cve_AssetRetirementObligationsAbstract"/>
    <loc xlink:type="locator" xlink:label="cve_InflationFactorPercentage" xlink:href="cve-20221231.xsd#cve_InflationFactorPercentage"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_AssetRetirementObligationsAbstract" xlink:to="cve_InflationFactorPercentage" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DescriptionOfDiscountRatesAppliedToCashFlowProjections" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_DescriptionOfDiscountRatesAppliedToCashFlowProjections"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_AssetRetirementObligationsAbstract" xlink:to="ifrs-full_DescriptionOfDiscountRatesAppliedToCashFlowProjections" order="1" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://encoreuranium.com/role/SalescontractsDetails">
    <loc xlink:type="locator" xlink:label="cve_DisclosueOfSalesContractsAbstract" xlink:href="cve-20221231.xsd#cve_DisclosueOfSalesContractsAbstract"/>
    <loc xlink:type="locator" xlink:label="cve_TotalDiscountedMarketPrices" xlink:href="cve-20221231.xsd#cve_TotalDiscountedMarketPrices"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_DisclosueOfSalesContractsAbstract" xlink:to="cve_TotalDiscountedMarketPrices" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cve_CancellationFee" xlink:href="cve-20221231.xsd#cve_CancellationFee"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_DisclosueOfSalesContractsAbstract" xlink:to="cve_CancellationFee" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cve_PursuantToAgreement" xlink:href="cve-20221231.xsd#cve_PursuantToAgreement"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_DisclosueOfSalesContractsAbstract" xlink:to="cve_PursuantToAgreement" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cve_ContractPoundsOfUranium" xlink:href="cve-20221231.xsd#cve_ContractPoundsOfUranium"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_DisclosueOfSalesContractsAbstract" xlink:to="cve_ContractPoundsOfUranium" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cve_PricePerPound" xlink:href="cve-20221231.xsd#cve_PricePerPound"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_DisclosueOfSalesContractsAbstract" xlink:to="cve_PricePerPound" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cve_SalesContractsTrem" xlink:href="cve-20221231.xsd#cve_SalesContractsTrem"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_DisclosueOfSalesContractsAbstract" xlink:to="cve_SalesContractsTrem" order="5" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://encoreuranium.com/role/ShareCapitalDetails">
    <loc xlink:type="locator" xlink:label="cve_ShareCapitalDetailsLineItems" xlink:href="cve-20221231.xsd#cve_ShareCapitalDetailsLineItems"/>
    <loc xlink:type="locator" xlink:label="cve_ShareCapitalDetailsTable" xlink:href="cve-20221231.xsd#cve_ShareCapitalDetailsTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="cve_ShareCapitalDetailsLineItems" xlink:to="cve_ShareCapitalDetailsTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ComponentsOfEquityAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_ComponentsOfEquityAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="cve_ShareCapitalDetailsTable" xlink:to="ifrs-full_ComponentsOfEquityAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_EquityMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_EquityMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="ifrs-full_ComponentsOfEquityAxis" xlink:to="ifrs-full_EquityMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_EquityMember_0" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_EquityMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="ifrs-full_ComponentsOfEquityAxis" xlink:to="ifrs-full_EquityMember_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cve_WarrantsMember" xlink:href="cve-20221231.xsd#cve_WarrantsMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_EquityMember" xlink:to="cve_WarrantsMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cve_StockOptionsMember" xlink:href="cve-20221231.xsd#cve_StockOptionsMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_EquityMember" xlink:to="cve_StockOptionsMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cve_SharesUnit" xlink:href="cve-20221231.xsd#cve_SharesUnit"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_ShareCapitalDetailsLineItems" xlink:to="cve_SharesUnit" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_WeightedAverageExercisePriceOfShareOptionsInSharebasedPaymentArrangementExercisedDuringPeriodAtDateOfExercise2019" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_WeightedAverageExercisePriceOfShareOptionsInSharebasedPaymentArrangementExercisedDuringPeriodAtDateOfExercise2019"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_ShareCapitalDetailsLineItems" xlink:to="ifrs-full_WeightedAverageExercisePriceOfShareOptionsInSharebasedPaymentArrangementExercisedDuringPeriodAtDateOfExercise2019" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cve_GrossProceed" xlink:href="cve-20221231.xsd#cve_GrossProceed"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_ShareCapitalDetailsLineItems" xlink:to="cve_GrossProceed" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cve_CommonShare" xlink:href="cve-20221231.xsd#cve_CommonShare"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_ShareCapitalDetailsLineItems" xlink:to="cve_CommonShare" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cve_PurchaseWarrantShares" xlink:href="cve-20221231.xsd#cve_PurchaseWarrantShares"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_ShareCapitalDetailsLineItems" xlink:to="cve_PurchaseWarrantShares" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cve_PurchaseAdditionalShareWarrants" xlink:href="cve-20221231.xsd#cve_PurchaseAdditionalShareWarrants"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_ShareCapitalDetailsLineItems" xlink:to="cve_PurchaseAdditionalShareWarrants" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cve_PurchaseAdditionalSharePricePerWarrant" xlink:href="cve-20221231.xsd#cve_PurchaseAdditionalSharePricePerWarrant"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_ShareCapitalDetailsLineItems" xlink:to="cve_PurchaseAdditionalSharePricePerWarrant" order="7" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ReceiptsFromRoyaltiesFeesCommissionsAndOtherRevenue" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_ReceiptsFromRoyaltiesFeesCommissionsAndOtherRevenue"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_ShareCapitalDetailsLineItems" xlink:to="ifrs-full_ReceiptsFromRoyaltiesFeesCommissionsAndOtherRevenue" order="8" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cve_CashIssuanceCosts" xlink:href="cve-20221231.xsd#cve_CashIssuanceCosts"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_ShareCapitalDetailsLineItems" xlink:to="cve_CashIssuanceCosts" order="9" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cve_ShareIssued" xlink:href="cve-20221231.xsd#cve_ShareIssued"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_ShareCapitalDetailsLineItems" xlink:to="cve_ShareIssued" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cve_WarrantsOfFairValue" xlink:href="cve-20221231.xsd#cve_WarrantsOfFairValue"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_ShareCapitalDetailsLineItems" xlink:to="cve_WarrantsOfFairValue" order="11" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cve_WarrantsExercisableOfCommonShare" xlink:href="cve-20221231.xsd#cve_WarrantsExercisableOfCommonShare"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_ShareCapitalDetailsLineItems" xlink:to="cve_WarrantsExercisableOfCommonShare" order="12" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cve_WarrantsExercisablePricePerShare" xlink:href="cve-20221231.xsd#cve_WarrantsExercisablePricePerShare"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_ShareCapitalDetailsLineItems" xlink:to="cve_WarrantsExercisablePricePerShare" order="13" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cve_CommonShareIssued" xlink:href="cve-20221231.xsd#cve_CommonShareIssued"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_ShareCapitalDetailsLineItems" xlink:to="cve_CommonShareIssued" order="14" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_EquityReclassifiedIntoFinancialLiabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_EquityReclassifiedIntoFinancialLiabilities"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_ShareCapitalDetailsLineItems" xlink:to="ifrs-full_EquityReclassifiedIntoFinancialLiabilities" order="15" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_FinancialLiabilitiesReclassifiedIntoEquity" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_FinancialLiabilitiesReclassifiedIntoEquity"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_ShareCapitalDetailsLineItems" xlink:to="ifrs-full_FinancialLiabilitiesReclassifiedIntoEquity" order="16" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cve_CommonSharesOfSettlementAndCompensation" xlink:href="cve-20221231.xsd#cve_CommonSharesOfSettlementAndCompensation"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_ShareCapitalDetailsLineItems" xlink:to="cve_CommonSharesOfSettlementAndCompensation" order="17" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cve_NumberOfSharesReservedInsurancePercentage" xlink:href="cve-20221231.xsd#cve_NumberOfSharesReservedInsurancePercentage"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_ShareCapitalDetailsLineItems" xlink:to="cve_NumberOfSharesReservedInsurancePercentage" order="18" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cve_OptionsGrantedForMaximumYear" xlink:href="cve-20221231.xsd#cve_OptionsGrantedForMaximumYear"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_ShareCapitalDetailsLineItems" xlink:to="cve_OptionsGrantedForMaximumYear" order="19" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cve_AggregateOfGrantedShares" xlink:href="cve-20221231.xsd#cve_AggregateOfGrantedShares"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_ShareCapitalDetailsLineItems" xlink:to="cve_AggregateOfGrantedShares" order="20" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cve_FairValueOfGrantedOption" xlink:href="cve-20221231.xsd#cve_FairValueOfGrantedOption"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_ShareCapitalDetailsLineItems" xlink:to="cve_FairValueOfGrantedOption" order="21" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cve_StockOptionsRevisedTerm" xlink:href="cve-20221231.xsd#cve_StockOptionsRevisedTerm"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_ShareCapitalDetailsLineItems" xlink:to="cve_StockOptionsRevisedTerm" order="22" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cve_StandardStockOptionVestingPercentage" xlink:href="cve-20221231.xsd#cve_StandardStockOptionVestingPercentage"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_ShareCapitalDetailsLineItems" xlink:to="cve_StandardStockOptionVestingPercentage" order="23" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cve_RecognizedStockOptionExpense" xlink:href="cve-20221231.xsd#cve_RecognizedStockOptionExpense"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_ShareCapitalDetailsLineItems" xlink:to="cve_RecognizedStockOptionExpense" order="24" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cve_WarrantsExercisableShare" xlink:href="cve-20221231.xsd#cve_WarrantsExercisableShare"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_ShareCapitalDetailsLineItems" xlink:to="cve_WarrantsExercisableShare" order="25" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cve_WarrantShare" xlink:href="cve-20221231.xsd#cve_WarrantShare"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_ShareCapitalDetailsLineItems" xlink:to="cve_WarrantShare" order="26" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cve_WarrantsExercisablePrice" xlink:href="cve-20221231.xsd#cve_WarrantsExercisablePrice"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_ShareCapitalDetailsLineItems" xlink:to="cve_WarrantsExercisablePrice" order="27" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cve_WarrantIsExercisableTerm" xlink:href="cve-20221231.xsd#cve_WarrantIsExercisableTerm"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_ShareCapitalDetailsLineItems" xlink:to="cve_WarrantIsExercisableTerm" order="28" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DividendsReceived" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_DividendsReceived"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_ShareCapitalDetailsLineItems" xlink:to="ifrs-full_DividendsReceived" order="29" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://encoreuranium.com/role/RelatedpartytransactionsandbalancesDetails">
    <loc xlink:type="locator" xlink:label="cve_RelatedpartytransactionsandbalancesDetailsLineItems" xlink:href="cve-20221231.xsd#cve_RelatedpartytransactionsandbalancesDetailsLineItems"/>
    <loc xlink:type="locator" xlink:label="cve_RelatedpartytransactionsandbalancesDetailsTable" xlink:href="cve-20221231.xsd#cve_RelatedpartytransactionsandbalancesDetailsTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="cve_RelatedpartytransactionsandbalancesDetailsLineItems" xlink:to="cve_RelatedpartytransactionsandbalancesDetailsTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="cve_RelatedpartytransactionsandbalancesDetailsTable" xlink:to="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="us-gaap_RelatedPartyDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="us-gaap_RelatedPartyDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cve_PlatoroWestIncMember" xlink:href="cve-20221231.xsd#cve_PlatoroWestIncMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyDomain" xlink:to="cve_PlatoroWestIncMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cve_ConsultingFees" xlink:href="cve-20221231.xsd#cve_ConsultingFees"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_RelatedpartytransactionsandbalancesDetailsLineItems" xlink:to="cve_ConsultingFees" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cve_GrantedOptionsShares" xlink:href="cve-20221231.xsd#cve_GrantedOptionsShares"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_RelatedpartytransactionsandbalancesDetailsLineItems" xlink:to="cve_GrantedOptionsShares" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cve_FairValueAmount" xlink:href="cve-20221231.xsd#cve_FairValueAmount"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_RelatedpartytransactionsandbalancesDetailsLineItems" xlink:to="cve_FairValueAmount" order="3" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://encoreuranium.com/role/FinancialInstrumentsDetails">
    <loc xlink:type="locator" xlink:label="cve_DisclosureOfFinancialInstrumentsTextBlockAbstract" xlink:href="cve-20221231.xsd#cve_DisclosureOfFinancialInstrumentsTextBlockAbstract"/>
    <loc xlink:type="locator" xlink:label="cve_ForeignExchangeRate" xlink:href="cve-20221231.xsd#cve_ForeignExchangeRate"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_DisclosureOfFinancialInstrumentsTextBlockAbstract" xlink:to="cve_ForeignExchangeRate" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_NotionalAmount" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_NotionalAmount"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_DisclosureOfFinancialInstrumentsTextBlockAbstract" xlink:to="ifrs-full_NotionalAmount" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_TaxRateEffectFromChangeInTaxRate" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_TaxRateEffectFromChangeInTaxRate"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_DisclosureOfFinancialInstrumentsTextBlockAbstract" xlink:to="ifrs-full_TaxRateEffectFromChangeInTaxRate" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cve_ImpactedLoss" xlink:href="cve-20221231.xsd#cve_ImpactedLoss"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_DisclosureOfFinancialInstrumentsTextBlockAbstract" xlink:to="cve_ImpactedLoss" order="3" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://encoreuranium.com/role/IncometaxesDetails">
    <loc xlink:type="locator" xlink:label="cve_DisclosureOfIncomeTaxTextBlockAbstract" xlink:href="cve-20221231.xsd#cve_DisclosureOfIncomeTaxTextBlockAbstract"/>
    <loc xlink:type="locator" xlink:label="cve_NoncapitalLoss" xlink:href="cve-20221231.xsd#cve_NoncapitalLoss"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_DisclosureOfIncomeTaxTextBlockAbstract" xlink:to="cve_NoncapitalLoss" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cve_FederalNetOperatingLossCarryforwards" xlink:href="cve-20221231.xsd#cve_FederalNetOperatingLossCarryforwards"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_DisclosureOfIncomeTaxTextBlockAbstract" xlink:to="cve_FederalNetOperatingLossCarryforwards" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cve_CarriedForward" xlink:href="cve-20221231.xsd#cve_CarriedForward"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_DisclosureOfIncomeTaxTextBlockAbstract" xlink:to="cve_CarriedForward" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cve_ExpiringAmount" xlink:href="cve-20221231.xsd#cve_ExpiringAmount"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_DisclosureOfIncomeTaxTextBlockAbstract" xlink:to="cve_ExpiringAmount" order="3" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://encoreuranium.com/role/EventsafterthereportingperiodDetails">
    <loc xlink:type="locator" xlink:label="cve_EventsafterthereportingperiodDetailsLineItems" xlink:href="cve-20221231.xsd#cve_EventsafterthereportingperiodDetailsLineItems"/>
    <loc xlink:type="locator" xlink:label="cve_EventsafterthereportingperiodDetailsTable" xlink:href="cve-20221231.xsd#cve_EventsafterthereportingperiodDetailsTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="cve_EventsafterthereportingperiodDetailsLineItems" xlink:to="cve_EventsafterthereportingperiodDetailsTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ClassesOfLiabilitiesAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_ClassesOfLiabilitiesAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="cve_EventsafterthereportingperiodDetailsTable" xlink:to="ifrs-full_ClassesOfLiabilitiesAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_LiabilitiesMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_LiabilitiesMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="ifrs-full_ClassesOfLiabilitiesAxis" xlink:to="ifrs-full_LiabilitiesMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_LiabilitiesMember_0" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_LiabilitiesMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="ifrs-full_ClassesOfLiabilitiesAxis" xlink:to="ifrs-full_LiabilitiesMember_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsequentEventTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="cve_EventsafterthereportingperiodDetailsTable" xlink:to="us-gaap_SubsequentEventTypeAxis" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsequentEventTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_SubsequentEventTypeAxis" xlink:to="us-gaap_SubsequentEventTypeDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsequentEventTypeDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_SubsequentEventTypeAxis" xlink:to="us-gaap_SubsequentEventTypeDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_NonadjustingEventsAfterReportingPeriodAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_NonadjustingEventsAfterReportingPeriodAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="cve_EventsafterthereportingperiodDetailsTable" xlink:to="ifrs-full_NonadjustingEventsAfterReportingPeriodAxis" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_NonadjustingEventsMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_NonadjustingEventsMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="ifrs-full_NonadjustingEventsAfterReportingPeriodAxis" xlink:to="ifrs-full_NonadjustingEventsMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_NonadjustingEventsMember_0" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_NonadjustingEventsMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="ifrs-full_NonadjustingEventsAfterReportingPeriodAxis" xlink:to="ifrs-full_NonadjustingEventsMember_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cve_SubsequentEventOneMember" xlink:href="cve-20221231.xsd#cve_SubsequentEventOneMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_NonadjustingEventsMember" xlink:to="cve_SubsequentEventOneMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cve_EnergyFuelsIncMember" xlink:href="cve-20221231.xsd#cve_EnergyFuelsIncMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_LiabilitiesMember" xlink:to="cve_EnergyFuelsIncMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cve_AltaMesaAcquisitionMember" xlink:href="cve-20221231.xsd#cve_AltaMesaAcquisitionMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_LiabilitiesMember" xlink:to="cve_AltaMesaAcquisitionMember" order="1" xbrldt:closed="true"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsequentEventTypeDomain" xlink:to="cve_SubsequentEventOneMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cve_SubsequentEventTwoMember" xlink:href="cve-20221231.xsd#cve_SubsequentEventTwoMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsequentEventTypeDomain" xlink:to="cve_SubsequentEventTwoMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cve_SubsequentEventThreeMember" xlink:href="cve-20221231.xsd#cve_SubsequentEventThreeMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsequentEventTypeDomain" xlink:to="cve_SubsequentEventThreeMember" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cve_SubsequentEventFourMember" xlink:href="cve-20221231.xsd#cve_SubsequentEventFourMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsequentEventTypeDomain" xlink:to="cve_SubsequentEventFourMember" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cve_TransactionCosts" xlink:href="cve-20221231.xsd#cve_TransactionCosts"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_EventsafterthereportingperiodDetailsLineItems" xlink:to="cve_TransactionCosts" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_Cash" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_Cash"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_EventsafterthereportingperiodDetailsLineItems" xlink:to="ifrs-full_Cash" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_BorrowingsInterestRate" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_BorrowingsInterestRate"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_EventsafterthereportingperiodDetailsLineItems" xlink:to="ifrs-full_BorrowingsInterestRate" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cve_AcquireCommonShare" xlink:href="cve-20221231.xsd#cve_AcquireCommonShare"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_EventsafterthereportingperiodDetailsLineItems" xlink:to="cve_AcquireCommonShare" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_SubscriptionCirculationRevenue" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_SubscriptionCirculationRevenue"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_EventsafterthereportingperiodDetailsLineItems" xlink:to="ifrs-full_SubscriptionCirculationRevenue" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cve_Saleofstockpershare" xlink:href="cve-20221231.xsd#cve_Saleofstockpershare"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_EventsafterthereportingperiodDetailsLineItems" xlink:to="cve_Saleofstockpershare" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cve_PricePerShare" xlink:href="cve-20221231.xsd#cve_PricePerShare"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_EventsafterthereportingperiodDetailsLineItems" xlink:to="cve_PricePerShare" order="7" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromDebtNetOfIssuanceCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromDebtNetOfIssuanceCosts"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_EventsafterthereportingperiodDetailsLineItems" xlink:to="us-gaap_ProceedsFromDebtNetOfIssuanceCosts" order="8" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_NumberOfSharesIssued" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_NumberOfSharesIssued"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_EventsafterthereportingperiodDetailsLineItems" xlink:to="ifrs-full_NumberOfSharesIssued" order="9" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cve_PublicOfferingPricePerShare" xlink:href="cve-20221231.xsd#cve_PublicOfferingPricePerShare"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_EventsafterthereportingperiodDetailsLineItems" xlink:to="cve_PublicOfferingPricePerShare" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cve_GrossProceed" xlink:href="cve-20221231.xsd#cve_GrossProceed"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_EventsafterthereportingperiodDetailsLineItems" xlink:to="cve_GrossProceed" order="11" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cve_PurchasePricePerShare" xlink:href="cve-20221231.xsd#cve_PurchasePricePerShare"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_EventsafterthereportingperiodDetailsLineItems" xlink:to="cve_PurchasePricePerShare" order="12" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cve_StockOptionsSharesOutstanding" xlink:href="cve-20221231.xsd#cve_StockOptionsSharesOutstanding"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_EventsafterthereportingperiodDetailsLineItems" xlink:to="cve_StockOptionsSharesOutstanding" order="13" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cve_GrantedStockOptions" xlink:href="cve-20221231.xsd#cve_GrantedStockOptions"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_EventsafterthereportingperiodDetailsLineItems" xlink:to="cve_GrantedStockOptions" order="14" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cve_WeightedAverageExercisePrice" xlink:href="cve-20221231.xsd#cve_WeightedAverageExercisePrice"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_EventsafterthereportingperiodDetailsLineItems" xlink:to="cve_WeightedAverageExercisePrice" order="15" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cve_PurchasedShares" xlink:href="cve-20221231.xsd#cve_PurchasedShares"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_EventsafterthereportingperiodDetailsLineItems" xlink:to="cve_PurchasedShares" order="16" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cve_TransactionCost" xlink:href="cve-20221231.xsd#cve_TransactionCost"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_EventsafterthereportingperiodDetailsLineItems" xlink:to="cve_TransactionCost" order="17" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cve_PurchaseAgreementsAmount" xlink:href="cve-20221231.xsd#cve_PurchaseAgreementsAmount"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_EventsafterthereportingperiodDetailsLineItems" xlink:to="cve_PurchaseAgreementsAmount" order="18" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cve_OptionToAcquireShares" xlink:href="cve-20221231.xsd#cve_OptionToAcquireShares"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_EventsafterthereportingperiodDetailsLineItems" xlink:to="cve_OptionToAcquireShares" order="19" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ConsiderationPaidReceived" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_ConsiderationPaidReceived"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_EventsafterthereportingperiodDetailsLineItems" xlink:to="ifrs-full_ConsiderationPaidReceived" order="20" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cve_TotalConsiderationPerPounds" xlink:href="cve-20221231.xsd#cve_TotalConsiderationPerPounds"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_EventsafterthereportingperiodDetailsLineItems" xlink:to="cve_TotalConsiderationPerPounds" order="21" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cve_InitialPayment" xlink:href="cve-20221231.xsd#cve_InitialPayment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_EventsafterthereportingperiodDetailsLineItems" xlink:to="cve_InitialPayment" order="22" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cve_PaymentAmount" xlink:href="cve-20221231.xsd#cve_PaymentAmount"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_EventsafterthereportingperiodDetailsLineItems" xlink:to="cve_PaymentAmount" order="23" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cve_AssetsReceivedPercentage" xlink:href="cve-20221231.xsd#cve_AssetsReceivedPercentage"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cve_EventsafterthereportingperiodDetailsLineItems" xlink:to="cve_AssetsReceivedPercentage" order="24" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://encoreuranium.com/role/DocumentAndEntityInformation">
    <loc xlink:type="locator" xlink:label="dei_DocumentInformationLineItems" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentInformationLineItems"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentInformationTable" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentInformationTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentInformationTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityAddressesAddressTypeAxis" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressesAddressTypeAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="dei_DocumentInformationTable" xlink:to="dei_EntityAddressesAddressTypeAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_AddressTypeDomain" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AddressTypeDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="dei_EntityAddressesAddressTypeAxis" xlink:to="dei_AddressTypeDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_AddressTypeDomain_0" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AddressTypeDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="dei_EntityAddressesAddressTypeAxis" xlink:to="dei_AddressTypeDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_BusinessContactMember" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_BusinessContactMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_AddressTypeDomain" xlink:to="dei_BusinessContactMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityRegistrantName" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_TradingSymbol" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentType" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_CurrentFiscalYearEndDate" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CurrentFiscalYearEndDate"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_CurrentFiscalYearEndDate" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityCommonStockSharesOutstanding" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityCommonStockSharesOutstanding" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_AmendmentFlag" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityCentralIndexKey" order="7" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityCurrentReportingStatus" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCurrentReportingStatus"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityCurrentReportingStatus" order="8" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentPeriodEndDate" order="9" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentFiscalYearFocus" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalYearFocus"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentFiscalYearFocus" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentFiscalPeriodFocus" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalPeriodFocus"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentFiscalPeriodFocus" order="11" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityEmergingGrowthCompany" order="12" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityExTransitionPeriod" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityExTransitionPeriod"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityExTransitionPeriod" order="13" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_IcfrAuditorAttestationFlag" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_IcfrAuditorAttestationFlag"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_IcfrAuditorAttestationFlag" order="14" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentRegistrationStatement" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentRegistrationStatement"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentRegistrationStatement" order="15" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentAnnualReport" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentAnnualReport"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentAnnualReport" order="16" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityFileNumber" order="17" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityIncorporationStateCountryCode" order="18" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressAddressLine1" order="19" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityAddressAddressLine2" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine2"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressAddressLine2" order="20" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressCityOrTown" order="21" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityAddressStateOrProvince" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressStateOrProvince"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressStateOrProvince" order="22" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressPostalZipCode" order="23" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_CityAreaCode" order="24" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_LocalPhoneNumber" order="25" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_ContactPersonnelName" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_ContactPersonnelName"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_ContactPersonnelName" order="26" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_Security12bTitle" order="27" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_SecurityExchangeName" order="28" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_AnnualInformationForm" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AnnualInformationForm"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_AnnualInformationForm" order="29" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_AuditedAnnualFinancialStatements" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AuditedAnnualFinancialStatements"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_AuditedAnnualFinancialStatements" order="30" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityInteractiveDataCurrent" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityInteractiveDataCurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityInteractiveDataCurrent" order="31" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_AuditorName" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AuditorName"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_AuditorName" order="32" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_AuditorLocation" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AuditorLocation"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_AuditorLocation" order="33" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_AuditorFirmId" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AuditorFirmId"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_AuditorFirmId" order="34" xbrldt:closed="true"/>
  </definitionLink>
</linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>49
<FILENAME>cve-20221231_lab.xml
<DESCRIPTION>XBRL LABEL FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!-- Generated by CompSci Transform (tm) - http://www.compsciresources.com -->
<!-- Created: Fri Apr 28 19:14:45 UTC 2023 -->
<linkbase xmlns="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel"/>
  <roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
  <labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
    <loc xlink:type="locator" xlink:label="dei_EntityAddressesAddressTypeAxis" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressesAddressTypeAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressesAddressTypeAxis_lbl" xml:lang="en-US">Entity Addresses, Address Type [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressesAddressTypeAxis" xlink:to="dei_EntityAddressesAddressTypeAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CurrentAssets" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_CurrentAssets"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="ifrs-full_CurrentAssets_lbl" xml:lang="en-US">Total current assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CurrentAssets" xlink:to="ifrs-full_CurrentAssets_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_CurrentAssets_lbl0" xml:lang="en-US">Current assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CurrentAssets" xlink:to="ifrs-full_CurrentAssets_lbl0"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_Assets" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_Assets"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="ifrs-full_Assets_lbl" xml:lang="en-US">Total assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_Assets" xlink:to="ifrs-full_Assets_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_Assets_lbl0" xml:lang="en-US">Assets (in Dollars)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_Assets" xlink:to="ifrs-full_Assets_lbl0"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CurrentLiabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_CurrentLiabilities"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="ifrs-full_CurrentLiabilities_lbl" xml:lang="en-US">Total current liabilities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CurrentLiabilities" xlink:to="ifrs-full_CurrentLiabilities_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_CurrentLiabilities_lbl0" xml:lang="en-US">Current liabilities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CurrentLiabilities" xlink:to="ifrs-full_CurrentLiabilities_lbl0"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_Liabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_Liabilities"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="ifrs-full_Liabilities_lbl" xml:lang="en-US">Total liabilities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_Liabilities" xlink:to="ifrs-full_Liabilities_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_Equity" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_Equity"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="ifrs-full_Equity_lbl" xml:lang="en-US">Total shareholders&#8217; equity</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_Equity" xlink:to="ifrs-full_Equity_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="ifrs-full_Equity_lbl0" xml:lang="en-US">Balance as of beginning</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_Equity" xlink:to="ifrs-full_Equity_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="ifrs-full_Equity_lbl1" xml:lang="en-US">Balance as of ending</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_Equity" xlink:to="ifrs-full_Equity_lbl1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_EquityAndLiabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_EquityAndLiabilities"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="ifrs-full_EquityAndLiabilities_lbl" xml:lang="en-US">Total liabilities and shareholders&#8217; equity</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_EquityAndLiabilities" xlink:to="ifrs-full_EquityAndLiabilities_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ProfitLossFromOperatingActivities" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_ProfitLossFromOperatingActivities"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="ifrs-full_ProfitLossFromOperatingActivities_lbl" xml:lang="en-US">Loss from operating expenses</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ProfitLossFromOperatingActivities" xlink:to="ifrs-full_ProfitLossFromOperatingActivities_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ProfitLoss" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_ProfitLoss"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="ifrs-full_ProfitLoss_lbl" xml:lang="en-US">Net loss for the year</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ProfitLoss" xlink:to="ifrs-full_ProfitLoss_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_ProfitLoss_lbl0" xml:lang="en-US">Net loss for the year</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ProfitLoss" xlink:to="ifrs-full_ProfitLoss_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_ProfitLoss_lbl1" xml:lang="en-US">Loss for the year</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ProfitLoss" xlink:to="ifrs-full_ProfitLoss_lbl1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ComprehensiveIncome" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_ComprehensiveIncome"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="ifrs-full_ComprehensiveIncome_lbl" xml:lang="en-US">Comprehensive loss for the year</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ComprehensiveIncome" xlink:to="ifrs-full_ComprehensiveIncome_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CashFlowsFromUsedInOperatingActivities" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_CashFlowsFromUsedInOperatingActivities"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="ifrs-full_CashFlowsFromUsedInOperatingActivities_lbl" xml:lang="en-US">Net cash operating activities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CashFlowsFromUsedInOperatingActivities" xlink:to="ifrs-full_CashFlowsFromUsedInOperatingActivities_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CashFlowsFromUsedInInvestingActivities" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_CashFlowsFromUsedInInvestingActivities"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="ifrs-full_CashFlowsFromUsedInInvestingActivities_lbl" xml:lang="en-US">Net cash investing activities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CashFlowsFromUsedInInvestingActivities" xlink:to="ifrs-full_CashFlowsFromUsedInInvestingActivities_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CashFlowsFromUsedInFinancingActivities" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_CashFlowsFromUsedInFinancingActivities"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="ifrs-full_CashFlowsFromUsedInFinancingActivities_lbl" xml:lang="en-US">Net cash financing activities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CashFlowsFromUsedInFinancingActivities" xlink:to="ifrs-full_CashFlowsFromUsedInFinancingActivities_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CashFlowsFromUsedInOperationsBeforeChangesInWorkingCapital" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_CashFlowsFromUsedInOperationsBeforeChangesInWorkingCapital"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="ifrs-full_CashFlowsFromUsedInOperationsBeforeChangesInWorkingCapital_lbl" xml:lang="en-US">Change in cash</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CashFlowsFromUsedInOperationsBeforeChangesInWorkingCapital" xlink:to="ifrs-full_CashFlowsFromUsedInOperationsBeforeChangesInWorkingCapital_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CashAndCashEquivalents" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_CashAndCashEquivalents"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="ifrs-full_CashAndCashEquivalents_lbl" xml:lang="en-US">Cash, beginning of year</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CashAndCashEquivalents" xlink:to="ifrs-full_CashAndCashEquivalents_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="ifrs-full_CashAndCashEquivalents_lbl0" xml:lang="en-US">Cash, end of year</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CashAndCashEquivalents" xlink:to="ifrs-full_CashAndCashEquivalents_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_CashAndCashEquivalents_lbl1" xml:lang="en-US">Cash</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CashAndCashEquivalents" xlink:to="ifrs-full_CashAndCashEquivalents_lbl1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_NumberOfSharesOutstanding" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_NumberOfSharesOutstanding"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="ifrs-full_NumberOfSharesOutstanding_lbl" xml:lang="en-US">Balance as of beginning (in Shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NumberOfSharesOutstanding" xlink:to="ifrs-full_NumberOfSharesOutstanding_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="ifrs-full_NumberOfSharesOutstanding_lbl0" xml:lang="en-US">Balance as of ending (in Shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NumberOfSharesOutstanding" xlink:to="ifrs-full_NumberOfSharesOutstanding_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_NumberOfSharesOutstanding_lbl1" xml:lang="en-US">Shares Outstanding</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NumberOfSharesOutstanding" xlink:to="ifrs-full_NumberOfSharesOutstanding_lbl1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ComponentsOfEquityAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_ComponentsOfEquityAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ComponentsOfEquityAxis_lbl" xml:lang="en-US">Components of equity [axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ComponentsOfEquityAxis" xlink:to="ifrs-full_ComponentsOfEquityAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_NatureOfOperationAndGoingConcernAbstract" xlink:href="cve-20221231.xsd#cve_NatureOfOperationAndGoingConcernAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_NatureOfOperationAndGoingConcernAbstract_lbl" xml:lang="en-US">Nature of Operation and Going Concern [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_NatureOfOperationAndGoingConcernAbstract" xlink:to="cve_NatureOfOperationAndGoingConcernAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_DisclosureOfSignificantAccountingPoliciesTextBlockAbstract" xlink:href="cve-20221231.xsd#cve_DisclosureOfSignificantAccountingPoliciesTextBlockAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_DisclosureOfSignificantAccountingPoliciesTextBlockAbstract_lbl" xml:lang="en-US">Significant accounting policies [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_DisclosureOfSignificantAccountingPoliciesTextBlockAbstract" xlink:to="cve_DisclosureOfSignificantAccountingPoliciesTextBlockAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CategoriesOfRelatedPartiesAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_CategoriesOfRelatedPartiesAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_CategoriesOfRelatedPartiesAxis_lbl" xml:lang="en-US">Categories of related parties [axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CategoriesOfRelatedPartiesAxis" xlink:to="ifrs-full_CategoriesOfRelatedPartiesAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_IntangibleAssetsWithIndefiniteUsefulLifeAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_IntangibleAssetsWithIndefiniteUsefulLifeAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_IntangibleAssetsWithIndefiniteUsefulLifeAxis_lbl" xml:lang="en-US">Intangible assets with indefinite useful life [axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_IntangibleAssetsWithIndefiniteUsefulLifeAxis" xlink:to="ifrs-full_IntangibleAssetsWithIndefiniteUsefulLifeAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_RangeAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_RangeAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_RangeAxis_lbl" xml:lang="en-US">Range [axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_RangeAxis" xlink:to="ifrs-full_RangeAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_DisclosureOfAccountingJudgementsAndEstimatesTextBlockAbstract" xlink:href="cve-20221231.xsd#cve_DisclosureOfAccountingJudgementsAndEstimatesTextBlockAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_DisclosureOfAccountingJudgementsAndEstimatesTextBlockAbstract_lbl" xml:lang="en-US">Critical accounting estimates and judgements [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_DisclosureOfAccountingJudgementsAndEstimatesTextBlockAbstract" xlink:to="cve_DisclosureOfAccountingJudgementsAndEstimatesTextBlockAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_DisclosureOfAssociatesTextBlockAbstract" xlink:href="cve-20221231.xsd#cve_DisclosureOfAssociatesTextBlockAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_DisclosureOfAssociatesTextBlockAbstract_lbl" xml:lang="en-US">Investment in Associate [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_DisclosureOfAssociatesTextBlockAbstract" xlink:to="cve_DisclosureOfAssociatesTextBlockAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_InvestmentBalance1" xlink:href="cve-20221231.xsd#cve_InvestmentBalance1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="cve_InvestmentBalance1_lbl" xml:lang="en-US">Balance</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_InvestmentBalance1" xlink:to="cve_InvestmentBalance1_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="cve_InvestmentBalance1_lbl0" xml:lang="en-US">Balance</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_InvestmentBalance1" xlink:to="cve_InvestmentBalance1_lbl0"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CurrentInvestments" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_CurrentInvestments"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="ifrs-full_CurrentInvestments_lbl" xml:lang="en-US">Balance as of beginning</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CurrentInvestments" xlink:to="ifrs-full_CurrentInvestments_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="ifrs-full_CurrentInvestments_lbl0" xml:lang="en-US">Balance as of ending</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CurrentInvestments" xlink:to="ifrs-full_CurrentInvestments_lbl0"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_UnconsolidatedStructuredEntitiesAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_UnconsolidatedStructuredEntitiesAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_UnconsolidatedStructuredEntitiesAxis_lbl" xml:lang="en-US">Unconsolidated structured entities [axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_UnconsolidatedStructuredEntitiesAxis" xlink:to="ifrs-full_UnconsolidatedStructuredEntitiesAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_MarketablesSecurities" xlink:href="cve-20221231.xsd#cve_MarketablesSecurities"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="cve_MarketablesSecurities_lbl" xml:lang="en-US">Balance beginning</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_MarketablesSecurities" xlink:to="cve_MarketablesSecurities_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="cve_MarketablesSecurities_lbl0" xml:lang="en-US">Balance ending</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_MarketablesSecurities" xlink:to="cve_MarketablesSecurities_lbl0"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ClassesOfAssetsAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_ClassesOfAssetsAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ClassesOfAssetsAxis_lbl" xml:lang="en-US">Classes of assets [axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ClassesOfAssetsAxis" xlink:to="ifrs-full_ClassesOfAssetsAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_IntangibleAssetsBalance" xlink:href="cve-20221231.xsd#cve_IntangibleAssetsBalance"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="cve_IntangibleAssetsBalance_lbl" xml:lang="en-US">Balance beginning</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_IntangibleAssetsBalance" xlink:to="cve_IntangibleAssetsBalance_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="cve_IntangibleAssetsBalance_lbl0" xml:lang="en-US">Balance ending</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_IntangibleAssetsBalance" xlink:to="cve_IntangibleAssetsBalance_lbl0"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_lbl" xml:lang="en-US">Classes of intangible assets other than goodwill [axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis" xlink:to="ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_DisclosureOfPropertyPlantAndEquipmentTextBlockAbstract" xlink:href="cve-20221231.xsd#cve_DisclosureOfPropertyPlantAndEquipmentTextBlockAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_DisclosureOfPropertyPlantAndEquipmentTextBlockAbstract_lbl" xml:lang="en-US">Schedule of property, plant, and equipment [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_DisclosureOfPropertyPlantAndEquipmentTextBlockAbstract" xlink:to="cve_DisclosureOfPropertyPlantAndEquipmentTextBlockAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_PropertyPlantAndEquipmentCarryingAmountAtCostOfRevaluedAssets" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_PropertyPlantAndEquipmentCarryingAmountAtCostOfRevaluedAssets"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="ifrs-full_PropertyPlantAndEquipmentCarryingAmountAtCostOfRevaluedAssets_lbl" xml:lang="en-US">Balance as of beginning</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_PropertyPlantAndEquipmentCarryingAmountAtCostOfRevaluedAssets" xlink:to="ifrs-full_PropertyPlantAndEquipmentCarryingAmountAtCostOfRevaluedAssets_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="ifrs-full_PropertyPlantAndEquipmentCarryingAmountAtCostOfRevaluedAssets_lbl0" xml:lang="en-US">Balance as of ending</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_PropertyPlantAndEquipmentCarryingAmountAtCostOfRevaluedAssets" xlink:to="ifrs-full_PropertyPlantAndEquipmentCarryingAmountAtCostOfRevaluedAssets_lbl0"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_lbl" xml:lang="en-US">Classes of property, plant and equipment [axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis" xlink:to="ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_Right-of-UseAssetsBalance" xlink:href="cve-20221231.xsd#cve_Right-of-UseAssetsBalance"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="cve_Right-of-UseAssetsBalance_lbl" xml:lang="en-US">Balance, beginning</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_Right-of-UseAssetsBalance" xlink:to="cve_Right-of-UseAssetsBalance_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="cve_Right-of-UseAssetsBalance_lbl0" xml:lang="en-US">Balance, ending</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_Right-of-UseAssetsBalance" xlink:to="cve_Right-of-UseAssetsBalance_lbl0"/>
    <loc xlink:type="locator" xlink:label="cve_Long-TermLeaseLiabilityBalance" xlink:href="cve-20221231.xsd#cve_Long-TermLeaseLiabilityBalance"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="cve_Long-TermLeaseLiabilityBalance_lbl" xml:lang="en-US">Balance, beginning</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_Long-TermLeaseLiabilityBalance" xlink:to="cve_Long-TermLeaseLiabilityBalance_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="cve_Long-TermLeaseLiabilityBalance_lbl0" xml:lang="en-US">Balance, ending</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_Long-TermLeaseLiabilityBalance" xlink:to="cve_Long-TermLeaseLiabilityBalance_lbl0"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_MiningAssets" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_MiningAssets"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="ifrs-full_MiningAssets_lbl" xml:lang="en-US">Balance, December 31, 2020</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_MiningAssets" xlink:to="ifrs-full_MiningAssets_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="ifrs-full_MiningAssets_lbl0" xml:lang="en-US">Balance</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_MiningAssets" xlink:to="ifrs-full_MiningAssets_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_MiningAssets_lbl1" xml:lang="en-US">Mineral properties</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_MiningAssets" xlink:to="ifrs-full_MiningAssets_lbl1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ClassesOfLiabilitiesAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_ClassesOfLiabilitiesAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ClassesOfLiabilitiesAxis_lbl" xml:lang="en-US">Classes of liabilities [axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ClassesOfLiabilitiesAxis" xlink:to="ifrs-full_ClassesOfLiabilitiesAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_GeographicalAreasAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_GeographicalAreasAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_GeographicalAreasAxis_lbl" xml:lang="en-US">Geographical areas [axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_GeographicalAreasAxis" xlink:to="ifrs-full_GeographicalAreasAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_AssetRetirementObligationsBalance" xlink:href="cve-20221231.xsd#cve_AssetRetirementObligationsBalance"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="cve_AssetRetirementObligationsBalance_lbl" xml:lang="en-US">Balance, beginning</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_AssetRetirementObligationsBalance" xlink:to="cve_AssetRetirementObligationsBalance_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="cve_AssetRetirementObligationsBalance_lbl0" xml:lang="en-US">Balance, ending</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_AssetRetirementObligationsBalance" xlink:to="cve_AssetRetirementObligationsBalance_lbl0"/>
    <loc xlink:type="locator" xlink:label="cve_SharesBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:href="cve-20221231.xsd#cve_SharesBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="cve_SharesBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_lbl" xml:lang="en-US">Options, Options outstanding, beginning of year</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_SharesBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:to="cve_SharesBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="cve_SharesBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_lbl0" xml:lang="en-US">Options, Options outstanding, end of year</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_SharesBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:to="cve_SharesBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_lbl0"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_lbl" xml:lang="en-US">Weighted average exercise price, Options outstanding, beginning of year</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019" xlink:to="ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_lbl0" xml:lang="en-US">Weighted average exercise price, Options outstanding, end of year</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019" xlink:to="ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_lbl0"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis_lbl" xml:lang="en-US">Ranges of exercise prices for outstanding share options [axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis" xlink:to="ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptionsWarrantsOutstanding" xlink:href="cve-20221231.xsd#cve_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptionsWarrantsOutstanding"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="cve_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptionsWarrantsOutstanding_lbl" xml:lang="en-US">Warrants, Warrants outstanding, beginning of year</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptionsWarrantsOutstanding" xlink:to="cve_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptionsWarrantsOutstanding_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="cve_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptionsWarrantsOutstanding_lbl0" xml:lang="en-US">Warrants, Warrants outstanding, end of year</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptionsWarrantsOutstanding" xlink:to="cve_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptionsWarrantsOutstanding_lbl0"/>
    <loc xlink:type="locator" xlink:label="cve_SharesBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingPeriodIncreaseDecreaseWeightedAverageExercisePrice" xlink:href="cve-20221231.xsd#cve_SharesBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingPeriodIncreaseDecreaseWeightedAverageExercisePrice"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="cve_SharesBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingPeriodIncreaseDecreaseWeightedAverageExercisePrice_lbl" xml:lang="en-US">Weighted average exercise price, Warrants outstanding, beginning of year</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_SharesBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingPeriodIncreaseDecreaseWeightedAverageExercisePrice" xlink:to="cve_SharesBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingPeriodIncreaseDecreaseWeightedAverageExercisePrice_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="cve_SharesBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingPeriodIncreaseDecreaseWeightedAverageExercisePrice_lbl0" xml:lang="en-US">Weighted average exercise price, Warrants outstanding, end of year</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_SharesBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingPeriodIncreaseDecreaseWeightedAverageExercisePrice" xlink:to="cve_SharesBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingPeriodIncreaseDecreaseWeightedAverageExercisePrice_lbl0"/>
    <loc xlink:type="locator" xlink:label="cve_DisclosureOfRelatedPartyTextBlockAbstract" xlink:href="cve-20221231.xsd#cve_DisclosureOfRelatedPartyTextBlockAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_DisclosureOfRelatedPartyTextBlockAbstract_lbl" xml:lang="en-US">Related party transactions and balances [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_DisclosureOfRelatedPartyTextBlockAbstract" xlink:to="cve_DisclosureOfRelatedPartyTextBlockAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AssetsLessCurrentLiabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_AssetsLessCurrentLiabilities"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="ifrs-full_AssetsLessCurrentLiabilities_lbl" xml:lang="en-US">Total</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AssetsLessCurrentLiabilities" xlink:to="ifrs-full_AssetsLessCurrentLiabilities_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_TotalNoncashFinancingActivities" xlink:href="cve-20221231.xsd#cve_TotalNoncashFinancingActivities"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="cve_TotalNoncashFinancingActivities_lbl" xml:lang="en-US">Total non-cash financing activities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_TotalNoncashFinancingActivities" xlink:to="cve_TotalNoncashFinancingActivities_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_TotalNoncashInvestingActivities" xlink:href="cve-20221231.xsd#cve_TotalNoncashInvestingActivities"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="cve_TotalNoncashInvestingActivities_lbl" xml:lang="en-US">Total non-cash investing activities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_TotalNoncashInvestingActivities" xlink:to="cve_TotalNoncashInvestingActivities_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ProfitLossBeforeTax" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_ProfitLossBeforeTax"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="ifrs-full_ProfitLossBeforeTax_lbl" xml:lang="en-US">Total</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ProfitLossBeforeTax" xlink:to="ifrs-full_ProfitLossBeforeTax_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_RetrospectiveApplicationAndRetrospectiveRestatementAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_RetrospectiveApplicationAndRetrospectiveRestatementAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_RetrospectiveApplicationAndRetrospectiveRestatementAxis_lbl" xml:lang="en-US">Retrospective application and retrospective restatement [axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_RetrospectiveApplicationAndRetrospectiveRestatementAxis" xlink:to="ifrs-full_RetrospectiveApplicationAndRetrospectiveRestatementAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_OtherOperatingIncomeExpense" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_OtherOperatingIncomeExpense"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="ifrs-full_OtherOperatingIncomeExpense_lbl" xml:lang="en-US">Loss from operating expenses</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_OtherOperatingIncomeExpense" xlink:to="ifrs-full_OtherOperatingIncomeExpense_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_OtherOperatingIncomeExpense_lbl0" xml:lang="en-US">Expenses Total</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_OtherOperatingIncomeExpense" xlink:to="ifrs-full_OtherOperatingIncomeExpense_lbl0"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_NetForeignExchangeLoss" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_NetForeignExchangeLoss"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:label="ifrs-full_NetForeignExchangeLoss_lbl" xml:lang="en-US">Net loss for the year</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NetForeignExchangeLoss" xlink:to="ifrs-full_NetForeignExchangeLoss_lbl"/>
    <loc xlink:type="locator" xlink:label="srt_RestatementAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RestatementAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_RestatementAxis_lbl" xml:lang="en-US">Revision of Prior Period [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_RestatementAxis" xlink:to="srt_RestatementAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_DisclosureOfEventsAfterReportingPeriodTextBlockAbstract" xlink:href="cve-20221231.xsd#cve_DisclosureOfEventsAfterReportingPeriodTextBlockAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_DisclosureOfEventsAfterReportingPeriodTextBlockAbstract_lbl" xml:lang="en-US">Events after the reporting period [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_DisclosureOfEventsAfterReportingPeriodTextBlockAbstract" xlink:to="cve_DisclosureOfEventsAfterReportingPeriodTextBlockAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_DocumentType_lbl" xml:lang="en-US">Document Type</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentRegistrationStatement" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentRegistrationStatement"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_DocumentRegistrationStatement_lbl" xml:lang="en-US">Document Registration Statement</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentRegistrationStatement" xlink:to="dei_DocumentRegistrationStatement_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentAnnualReport" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentAnnualReport"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_DocumentAnnualReport_lbl" xml:lang="en-US">Document Annual Report</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAnnualReport" xlink:to="dei_DocumentAnnualReport_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_CurrentFiscalYearEndDate" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CurrentFiscalYearEndDate"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_CurrentFiscalYearEndDate_lbl" xml:lang="en-US">Current Fiscal Year End Date</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CurrentFiscalYearEndDate" xlink:to="dei_CurrentFiscalYearEndDate_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_DocumentPeriodEndDate_lbl" xml:lang="en-US">Document Period End Date</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentFiscalYearFocus" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalYearFocus"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_DocumentFiscalYearFocus_lbl" xml:lang="en-US">Document Fiscal Year Focus</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_EntityFileNumber_lbl" xml:lang="en-US">Entity File Number</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_EntityRegistrantName_lbl" xml:lang="en-US">Entity Registrant Name</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xml:lang="en-US">Entity Incorporation, State or Country Code</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_EntityAddressAddressLine1_lbl" xml:lang="en-US">Entity Address, Address Line One</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_EntityAddressAddressLine2" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine2"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_EntityAddressAddressLine2_lbl" xml:lang="en-US">Entity Address, Address Line Two</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_EntityAddressCityOrTown_lbl" xml:lang="en-US">Entity Address, City or Town</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_EntityAddressStateOrProvince" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressStateOrProvince"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_EntityAddressStateOrProvince_lbl" xml:lang="en-US">Entity Address, State or Province</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_EntityAddressPostalZipCode_lbl" xml:lang="en-US">Entity Address, Postal Zip Code</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_CityAreaCode_lbl" xml:lang="en-US">City Area Code</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_LocalPhoneNumber_lbl" xml:lang="en-US">Local Phone Number</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_ContactPersonnelName" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_ContactPersonnelName"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_ContactPersonnelName_lbl" xml:lang="en-US">Contact Personnel Name</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_ContactPersonnelName" xlink:to="dei_ContactPersonnelName_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_Security12bTitle_lbl" xml:lang="en-US">Title of 12(b) Security</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_TradingSymbol_lbl" xml:lang="en-US">Trading Symbol</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_SecurityExchangeName_lbl" xml:lang="en-US">Security Exchange Name</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_AnnualInformationForm" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AnnualInformationForm"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_AnnualInformationForm_lbl" xml:lang="en-US">Annual Information Form</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AnnualInformationForm" xlink:to="dei_AnnualInformationForm_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_AuditedAnnualFinancialStatements" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AuditedAnnualFinancialStatements"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_AuditedAnnualFinancialStatements_lbl" xml:lang="en-US">Audited Annual Financial Statements</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditedAnnualFinancialStatements" xlink:to="dei_AuditedAnnualFinancialStatements_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_EntityCommonStockSharesOutstanding" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_EntityCommonStockSharesOutstanding_lbl" xml:lang="en-US">Entity Common Stock, Shares Outstanding</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCommonStockSharesOutstanding" xlink:to="dei_EntityCommonStockSharesOutstanding_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_EntityCurrentReportingStatus" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCurrentReportingStatus"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_EntityCurrentReportingStatus_lbl" xml:lang="en-US">Entity Current Reporting Status</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCurrentReportingStatus" xlink:to="dei_EntityCurrentReportingStatus_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_EntityInteractiveDataCurrent" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityInteractiveDataCurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_EntityInteractiveDataCurrent_lbl" xml:lang="en-US">Entity Interactive Data Current</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityInteractiveDataCurrent" xlink:to="dei_EntityInteractiveDataCurrent_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xml:lang="en-US">Entity Emerging Growth Company</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_EntityExTransitionPeriod" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityExTransitionPeriod"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_EntityExTransitionPeriod_lbl" xml:lang="en-US">Entity Ex Transition Period</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityExTransitionPeriod" xlink:to="dei_EntityExTransitionPeriod_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_IcfrAuditorAttestationFlag" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_IcfrAuditorAttestationFlag"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_IcfrAuditorAttestationFlag_lbl" xml:lang="en-US">ICFR Auditor Attestation Flag</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_IcfrAuditorAttestationFlag" xlink:to="dei_IcfrAuditorAttestationFlag_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_AuditorName" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AuditorName"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_AuditorName_lbl" xml:lang="en-US">Auditor Name</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditorName" xlink:to="dei_AuditorName_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_AuditorLocation" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AuditorLocation"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_AuditorLocation_lbl" xml:lang="en-US">Auditor Location</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditorLocation" xlink:to="dei_AuditorLocation_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_AuditorFirmId" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AuditorFirmId"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_AuditorFirmId_lbl" xml:lang="en-US">Auditor Firm ID</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditorFirmId" xlink:to="dei_AuditorFirmId_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_AmendmentFlag_lbl" xml:lang="en-US">Amendment Flag</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentFiscalPeriodFocus" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalPeriodFocus"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xml:lang="en-US">Document Fiscal Period Focus</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_EntityCentralIndexKey_lbl" xml:lang="en-US">Entity Central Index Key</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AssetsAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_AssetsAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_AssetsAbstract_lbl" xml:lang="en-US">Assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AssetsAbstract" xlink:to="ifrs-full_AssetsAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CurrentAssetsAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_CurrentAssetsAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_CurrentAssetsAbstract_lbl" xml:lang="en-US">Current assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CurrentAssetsAbstract" xlink:to="ifrs-full_CurrentAssetsAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_TradeAndOtherReceivables" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_TradeAndOtherReceivables"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_TradeAndOtherReceivables_lbl" xml:lang="en-US">Receivables and prepaid expenses</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_TradeAndOtherReceivables" xlink:to="ifrs-full_TradeAndOtherReceivables_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_MarketableSecuritiecurrent" xlink:href="cve-20221231.xsd#cve_MarketableSecuritiecurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cve_MarketableSecuritiecurrent_lbl" xml:lang="en-US">Marketable securities - current</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_MarketableSecuritiecurrent" xlink:to="cve_MarketableSecuritiecurrent_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_DepositUraniumInvestment" xlink:href="cve-20221231.xsd#cve_DepositUraniumInvestment"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cve_DepositUraniumInvestment_lbl" xml:lang="en-US">Deposit - uranium investment</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_DepositUraniumInvestment" xlink:to="cve_DepositUraniumInvestment_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_NoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSaleOrAsHeldForDistributionToOwners" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_NoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSaleOrAsHeldForDistributionToOwners"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_NoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSaleOrAsHeldForDistributionToOwners_lbl" xml:lang="en-US">Assets held for sale</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSaleOrAsHeldForDistributionToOwners" xlink:to="ifrs-full_NoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSaleOrAsHeldForDistributionToOwners_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_NoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSaleOrAsHeldForDistributionToOwners_lbl0" xml:lang="en-US">Non-current assets or disposal groups classified as held for sale or as held for distribution to owners</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSaleOrAsHeldForDistributionToOwners" xlink:to="ifrs-full_NoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSaleOrAsHeldForDistributionToOwners_lbl0"/>
    <loc xlink:type="locator" xlink:label="cve_NonCurrentAssetsAbstract" xlink:href="cve-20221231.xsd#cve_NonCurrentAssetsAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cve_NonCurrentAssetsAbstract_lbl" xml:lang="en-US">Non-current assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_NonCurrentAssetsAbstract" xlink:to="cve_NonCurrentAssetsAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_IntangibleAssetsOtherThanGoodwill" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_IntangibleAssetsOtherThanGoodwill"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_IntangibleAssetsOtherThanGoodwill_lbl" xml:lang="en-US">Intangible assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_IntangibleAssetsOtherThanGoodwill" xlink:to="ifrs-full_IntangibleAssetsOtherThanGoodwill_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_PropertyPlantAndEquipment" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_PropertyPlantAndEquipment"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_PropertyPlantAndEquipment_lbl" xml:lang="en-US">Property, plant, and equipment</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_PropertyPlantAndEquipment" xlink:to="ifrs-full_PropertyPlantAndEquipment_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_InvestmentsInAssociates" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_InvestmentsInAssociates"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_InvestmentsInAssociates_lbl" xml:lang="en-US">Investment in associate</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_InvestmentsInAssociates" xlink:to="ifrs-full_InvestmentsInAssociates_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_InvestmentsInSubsidiariesJointVenturesAndAssociates" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_InvestmentsInSubsidiariesJointVenturesAndAssociates"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_InvestmentsInSubsidiariesJointVenturesAndAssociates_lbl" xml:lang="en-US">Investment in uranium</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_InvestmentsInSubsidiariesJointVenturesAndAssociates" xlink:to="ifrs-full_InvestmentsInSubsidiariesJointVenturesAndAssociates_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_MarketablesSecuritiesNoncurrent" xlink:href="cve-20221231.xsd#cve_MarketablesSecuritiesNoncurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cve_MarketablesSecuritiesNoncurrent_lbl" xml:lang="en-US">Marketable securities - non-current</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_MarketablesSecuritiesNoncurrent" xlink:to="cve_MarketablesSecuritiesNoncurrent_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_LongtermDeposits" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_LongtermDeposits"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_LongtermDeposits_lbl" xml:lang="en-US">Reclamation deposits</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_LongtermDeposits" xlink:to="ifrs-full_LongtermDeposits_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_LongtermDeposits_lbl0" xml:lang="en-US">Cash bonds</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_LongtermDeposits" xlink:to="ifrs-full_LongtermDeposits_lbl0"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_RightofuseAssets" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_RightofuseAssets"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_RightofuseAssets_lbl" xml:lang="en-US">Right-of-use asset</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_RightofuseAssets" xlink:to="ifrs-full_RightofuseAssets_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DeferredTaxAssets" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_DeferredTaxAssets"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DeferredTaxAssets_lbl" xml:lang="en-US">Deferred acquisition costs</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DeferredTaxAssets" xlink:to="ifrs-full_DeferredTaxAssets_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_NoncurrentFinancialAssets" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_NoncurrentFinancialAssets"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_NoncurrentFinancialAssets_lbl" xml:lang="en-US">Deferred financing costs</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NoncurrentFinancialAssets" xlink:to="ifrs-full_NoncurrentFinancialAssets_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_RestrictedCashAndCashEquivalents" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_RestrictedCashAndCashEquivalents"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_RestrictedCashAndCashEquivalents_lbl" xml:lang="en-US">Restricted cash</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_RestrictedCashAndCashEquivalents" xlink:to="ifrs-full_RestrictedCashAndCashEquivalents_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_UnlabeledAbstract" xlink:href="cve-20221231.xsd#cve_UnlabeledAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cve_UnlabeledAbstract_lbl" xml:lang="en-US"></label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_UnlabeledAbstract" xlink:to="cve_UnlabeledAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_LiabilitiesAndStockholdersEquityAbstract_lbl" xml:lang="en-US">Liabilities and shareholders&#8217; equity</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_LiabilitiesAndStockholdersEquityAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CurrentLiabilitiesAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_CurrentLiabilitiesAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_CurrentLiabilitiesAbstract_lbl" xml:lang="en-US">Current liabilities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CurrentLiabilitiesAbstract" xlink:to="ifrs-full_CurrentLiabilitiesAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_TradeAndOtherCurrentPayables" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_TradeAndOtherCurrentPayables"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_TradeAndOtherCurrentPayables_lbl" xml:lang="en-US">Accounts payable and accrued liabilities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_TradeAndOtherCurrentPayables" xlink:to="ifrs-full_TradeAndOtherCurrentPayables_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_TradeAndOtherCurrentPayablesToRelatedParties" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_TradeAndOtherCurrentPayablesToRelatedParties"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_TradeAndOtherCurrentPayablesToRelatedParties_lbl" xml:lang="en-US">Due to related parties</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_TradeAndOtherCurrentPayablesToRelatedParties" xlink:to="ifrs-full_TradeAndOtherCurrentPayablesToRelatedParties_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_OtherCurrentPayables" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_OtherCurrentPayables"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_OtherCurrentPayables_lbl" xml:lang="en-US">Note payable</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_OtherCurrentPayables" xlink:to="ifrs-full_OtherCurrentPayables_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CurrentLeaseLiabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_CurrentLeaseLiabilities"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_CurrentLeaseLiabilities_lbl" xml:lang="en-US">Lease liability - current</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CurrentLeaseLiabilities" xlink:to="ifrs-full_CurrentLeaseLiabilities_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_NonCurrentLiabilitiesAbstract" xlink:href="cve-20221231.xsd#cve_NonCurrentLiabilitiesAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cve_NonCurrentLiabilitiesAbstract_lbl" xml:lang="en-US">Non-current liabilities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_NonCurrentLiabilitiesAbstract" xlink:to="cve_NonCurrentLiabilitiesAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DefinedBenefitObligationAtPresentValue" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_DefinedBenefitObligationAtPresentValue"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DefinedBenefitObligationAtPresentValue_lbl" xml:lang="en-US">Asset retirement obligations</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DefinedBenefitObligationAtPresentValue" xlink:to="ifrs-full_DefinedBenefitObligationAtPresentValue_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_NoncurrentLeaseLiabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_NoncurrentLeaseLiabilities"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_NoncurrentLeaseLiabilities_lbl" xml:lang="en-US">Lease liability - non-current</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NoncurrentLeaseLiabilities" xlink:to="ifrs-full_NoncurrentLeaseLiabilities_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_UnlabeledAbstract0" xlink:href="cve-20221231.xsd#cve_UnlabeledAbstract0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cve_UnlabeledAbstract0_lbl" xml:lang="en-US"></label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_UnlabeledAbstract0" xlink:to="cve_UnlabeledAbstract0_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_StockholdersEquityAbstract_lbl" xml:lang="en-US">Shareholders&#8217; equity</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_StockholdersEquityAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_IssuedCapital" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_IssuedCapital"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_IssuedCapital_lbl" xml:lang="en-US">Share capital</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_IssuedCapital" xlink:to="ifrs-full_IssuedCapital_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_SharePremium" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_SharePremium"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_SharePremium_lbl" xml:lang="en-US">Share subscriptions received</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_SharePremium" xlink:to="ifrs-full_SharePremium_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_ContributedSurplus" xlink:href="cve-20221231.xsd#cve_ContributedSurplus"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cve_ContributedSurplus_lbl" xml:lang="en-US">Contributed surplus</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_ContributedSurplus" xlink:to="cve_ContributedSurplus_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AccumulatedOtherComprehensiveIncome" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_AccumulatedOtherComprehensiveIncome"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_AccumulatedOtherComprehensiveIncome_lbl" xml:lang="en-US">Accumulated other comprehensive income</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AccumulatedOtherComprehensiveIncome" xlink:to="ifrs-full_AccumulatedOtherComprehensiveIncome_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_RetainedEarnings" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_RetainedEarnings"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_RetainedEarnings_lbl" xml:lang="en-US">Deficit</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_RetainedEarnings" xlink:to="ifrs-full_RetainedEarnings_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_UnlabeledAbstract1" xlink:href="cve-20221231.xsd#cve_UnlabeledAbstract1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cve_UnlabeledAbstract1_lbl" xml:lang="en-US"></label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_UnlabeledAbstract1" xlink:to="cve_UnlabeledAbstract1_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_ExpensesAbstract" xlink:href="cve-20221231.xsd#cve_ExpensesAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cve_ExpensesAbstract_lbl" xml:lang="en-US">Expenses</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_ExpensesAbstract" xlink:to="cve_ExpensesAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_AccretionExpenses" xlink:href="cve-20221231.xsd#cve_AccretionExpenses"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cve_AccretionExpenses_lbl" xml:lang="en-US">Accretion</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_AccretionExpenses" xlink:to="cve_AccretionExpenses_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DepreciationAndAmortisationExpense" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_DepreciationAndAmortisationExpense"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DepreciationAndAmortisationExpense_lbl" xml:lang="en-US">Amortization and depreciation</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DepreciationAndAmortisationExpense" xlink:to="ifrs-full_DepreciationAndAmortisationExpense_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_CommunityEngagement" xlink:href="cve-20221231.xsd#cve_CommunityEngagement"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cve_CommunityEngagement_lbl" xml:lang="en-US">Community engagement</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_CommunityEngagement" xlink:to="cve_CommunityEngagement_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_Consulting" xlink:href="cve-20221231.xsd#cve_Consulting"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cve_Consulting_lbl" xml:lang="en-US">Consulting</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_Consulting" xlink:to="cve_Consulting_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_GeneralAndAdministrativeExpense" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_GeneralAndAdministrativeExpense"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_GeneralAndAdministrativeExpense_lbl" xml:lang="en-US">General administrative costs</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_GeneralAndAdministrativeExpense" xlink:to="ifrs-full_GeneralAndAdministrativeExpense_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ImpairmentLossImpairmentGainAndReversalOfImpairmentLossDeterminedInAccordanceWithIFRS9" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_ImpairmentLossImpairmentGainAndReversalOfImpairmentLossDeterminedInAccordanceWithIFRS9"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_ImpairmentLossImpairmentGainAndReversalOfImpairmentLossDeterminedInAccordanceWithIFRS9_lbl" xml:lang="en-US">Impairment charges</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ImpairmentLossImpairmentGainAndReversalOfImpairmentLossDeterminedInAccordanceWithIFRS9" xlink:to="ifrs-full_ImpairmentLossImpairmentGainAndReversalOfImpairmentLossDeterminedInAccordanceWithIFRS9_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_InterestExpense" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_InterestExpense"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_InterestExpense_lbl" xml:lang="en-US">Interest expense</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_InterestExpense" xlink:to="ifrs-full_InterestExpense_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AdministrativeExpense" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_AdministrativeExpense"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_AdministrativeExpense_lbl" xml:lang="en-US">Office and administrative</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AdministrativeExpense" xlink:to="ifrs-full_AdministrativeExpense_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_AdministrativeExpense_lbl0" xml:lang="en-US">General administrative costs</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AdministrativeExpense" xlink:to="ifrs-full_AdministrativeExpense_lbl0"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ProfessionalFeesExpense" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_ProfessionalFeesExpense"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_ProfessionalFeesExpense_lbl" xml:lang="en-US">Professional fees</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ProfessionalFeesExpense" xlink:to="ifrs-full_ProfessionalFeesExpense_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_ProjectInvestigationFess" xlink:href="cve-20221231.xsd#cve_ProjectInvestigationFess"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cve_ProjectInvestigationFess_lbl" xml:lang="en-US">Project investigation</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_ProjectInvestigationFess" xlink:to="cve_ProjectInvestigationFess_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CommunicationExpense" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_CommunicationExpense"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_CommunicationExpense_lbl" xml:lang="en-US">Promotion and shareholder communication</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CommunicationExpense" xlink:to="ifrs-full_CommunicationExpense_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ReclassificationAdjustmentsOnChangeInValueOfForwardElementsOfForwardContractsNetOfTax" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_ReclassificationAdjustmentsOnChangeInValueOfForwardElementsOfForwardContractsNetOfTax"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_ReclassificationAdjustmentsOnChangeInValueOfForwardElementsOfForwardContractsNetOfTax_lbl" xml:lang="en-US">Reclamation costs</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ReclassificationAdjustmentsOnChangeInValueOfForwardElementsOfForwardContractsNetOfTax" xlink:to="ifrs-full_ReclassificationAdjustmentsOnChangeInValueOfForwardElementsOfForwardContractsNetOfTax_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_TravelExpense" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_TravelExpense"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_TravelExpense_lbl" xml:lang="en-US">Travel</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_TravelExpense" xlink:to="ifrs-full_TravelExpense_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_TransferAgentAndFilingFees" xlink:href="cve-20221231.xsd#cve_TransferAgentAndFilingFees"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cve_TransferAgentAndFilingFees_lbl" xml:lang="en-US">Transfer agent and filing fees</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_TransferAgentAndFilingFees" xlink:to="cve_TransferAgentAndFilingFees_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_WagesAndSalaries" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_WagesAndSalaries"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_WagesAndSalaries_lbl" xml:lang="en-US">Staff costs</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_WagesAndSalaries" xlink:to="ifrs-full_WagesAndSalaries_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ExpenseFromSharebasedPaymentTransactionsWithEmployees" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_ExpenseFromSharebasedPaymentTransactionsWithEmployees"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_ExpenseFromSharebasedPaymentTransactionsWithEmployees_lbl" xml:lang="en-US">Stock option expense</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ExpenseFromSharebasedPaymentTransactionsWithEmployees" xlink:to="ifrs-full_ExpenseFromSharebasedPaymentTransactionsWithEmployees_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_UnlabeledAbstract2" xlink:href="cve-20221231.xsd#cve_UnlabeledAbstract2"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cve_UnlabeledAbstract2_lbl" xml:lang="en-US"></label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_UnlabeledAbstract2" xlink:to="cve_UnlabeledAbstract2_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_RevenueFromInterest" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_RevenueFromInterest"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_RevenueFromInterest_lbl" xml:lang="en-US">Interest income</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_RevenueFromInterest" xlink:to="ifrs-full_RevenueFromInterest_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss_lbl" xml:lang="en-US">Foreign exchange (loss) gain</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss" xlink:to="ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_GainsLossesOnDisposalsOfPropertyPlantAndEquipment" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_GainsLossesOnDisposalsOfPropertyPlantAndEquipment"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_GainsLossesOnDisposalsOfPropertyPlantAndEquipment_lbl" xml:lang="en-US">Gain (loss) on divestment of mineral properties</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_GainsLossesOnDisposalsOfPropertyPlantAndEquipment" xlink:to="ifrs-full_GainsLossesOnDisposalsOfPropertyPlantAndEquipment_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_GainOnDisposalOfSubsidiary" xlink:href="cve-20221231.xsd#cve_GainOnDisposalOfSubsidiary"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cve_GainOnDisposalOfSubsidiary_lbl" xml:lang="en-US">Gain on disposal of subsidiary</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_GainOnDisposalOfSubsidiary" xlink:to="cve_GainOnDisposalOfSubsidiary_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="cve_GainOnDisposalOfSubsidiary_lbl0" xml:lang="en-US">(Gain) loss on divestment of subsidiary</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_GainOnDisposalOfSubsidiary" xlink:to="cve_GainOnDisposalOfSubsidiary_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="cve_GainOnDisposalOfSubsidiary_lbl1" xml:lang="en-US"></label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_GainOnDisposalOfSubsidiary" xlink:to="cve_GainOnDisposalOfSubsidiary_lbl1"/>
    <loc xlink:type="locator" xlink:label="cve_UnrealizedGainOnUraniumInvestment" xlink:href="cve-20221231.xsd#cve_UnrealizedGainOnUraniumInvestment"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cve_UnrealizedGainOnUraniumInvestment_lbl" xml:lang="en-US">Unrealized gain on uranium investment</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_UnrealizedGainOnUraniumInvestment" xlink:to="cve_UnrealizedGainOnUraniumInvestment_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="cve_UnrealizedGainOnUraniumInvestment_lbl0" xml:lang="en-US">Unrealized gain on uranium investment</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_UnrealizedGainOnUraniumInvestment" xlink:to="cve_UnrealizedGainOnUraniumInvestment_lbl0"/>
    <loc xlink:type="locator" xlink:label="cve_GainOnSaleOfUraniumInvestment" xlink:href="cve-20221231.xsd#cve_GainOnSaleOfUraniumInvestment"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cve_GainOnSaleOfUraniumInvestment_lbl" xml:lang="en-US">Gain on sale of uranium investment</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_GainOnSaleOfUraniumInvestment" xlink:to="cve_GainOnSaleOfUraniumInvestment_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="cve_GainOnSaleOfUraniumInvestment_lbl0" xml:lang="en-US">Gain on sale of uranium investment</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_GainOnSaleOfUraniumInvestment" xlink:to="cve_GainOnSaleOfUraniumInvestment_lbl0"/>
    <loc xlink:type="locator" xlink:label="cve_UnrealizedGainOnMarketableSecurities" xlink:href="cve-20221231.xsd#cve_UnrealizedGainOnMarketableSecurities"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cve_UnrealizedGainOnMarketableSecurities_lbl" xml:lang="en-US">Unrealized gain on marketable securities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_UnrealizedGainOnMarketableSecurities" xlink:to="cve_UnrealizedGainOnMarketableSecurities_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_GainsLossesOnFairValueAdjustmentInvestmentProperty" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_GainsLossesOnFairValueAdjustmentInvestmentProperty"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_GainsLossesOnFairValueAdjustmentInvestmentProperty_lbl" xml:lang="en-US">Loss on investment in associate</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_GainsLossesOnFairValueAdjustmentInvestmentProperty" xlink:to="ifrs-full_GainsLossesOnFairValueAdjustmentInvestmentProperty_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_OtherComprehensiveIncomeNetOfTaxHedgesOfNetInvestmentsInForeignOperations" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_OtherComprehensiveIncomeNetOfTaxHedgesOfNetInvestmentsInForeignOperations"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_OtherComprehensiveIncomeNetOfTaxHedgesOfNetInvestmentsInForeignOperations_lbl" xml:lang="en-US">Foreign currency translation adjustment</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_OtherComprehensiveIncomeNetOfTaxHedgesOfNetInvestmentsInForeignOperations" xlink:to="ifrs-full_OtherComprehensiveIncomeNetOfTaxHedgesOfNetInvestmentsInForeignOperations_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_UnlabeledAbstract3" xlink:href="cve-20221231.xsd#cve_UnlabeledAbstract3"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cve_UnlabeledAbstract3_lbl" xml:lang="en-US"></label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_UnlabeledAbstract3" xlink:to="cve_UnlabeledAbstract3_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_EarningsPerShareAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_EarningsPerShareAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_EarningsPerShareAbstract_lbl" xml:lang="en-US">Loss per share</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_EarningsPerShareAbstract" xlink:to="ifrs-full_EarningsPerShareAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_WeightedAverageNumberOfCommonSharesOutstandingAbstract" xlink:href="cve-20221231.xsd#cve_WeightedAverageNumberOfCommonSharesOutstandingAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cve_WeightedAverageNumberOfCommonSharesOutstandingAbstract_lbl" xml:lang="en-US">Weighted average number of common shares outstanding</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_WeightedAverageNumberOfCommonSharesOutstandingAbstract" xlink:to="cve_WeightedAverageNumberOfCommonSharesOutstandingAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_WeightedAverageShares" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_WeightedAverageShares"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_WeightedAverageShares_lbl" xml:lang="en-US">- basic # (in Shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_WeightedAverageShares" xlink:to="ifrs-full_WeightedAverageShares_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AdjustedWeightedAverageShares" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_AdjustedWeightedAverageShares"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_AdjustedWeightedAverageShares_lbl" xml:lang="en-US">- diluted # (in Shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AdjustedWeightedAverageShares" xlink:to="ifrs-full_AdjustedWeightedAverageShares_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_UnlabeledAbstract4" xlink:href="cve-20221231.xsd#cve_UnlabeledAbstract4"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cve_UnlabeledAbstract4_lbl" xml:lang="en-US"></label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_UnlabeledAbstract4" xlink:to="cve_UnlabeledAbstract4_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_BasicEarningsLossPerShare" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_BasicEarningsLossPerShare"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_BasicEarningsLossPerShare_lbl" xml:lang="en-US">Basic and diluted loss per share $ (in Dollars per share)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_BasicEarningsLossPerShare" xlink:to="ifrs-full_BasicEarningsLossPerShare_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_BasicEarningsLossPerShare_lbl0" xml:lang="en-US">Loss per share - basic and diluted</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_BasicEarningsLossPerShare" xlink:to="ifrs-full_BasicEarningsLossPerShare_lbl0"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DilutedEarningsLossPerShare" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_DilutedEarningsLossPerShare"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DilutedEarningsLossPerShare_lbl" xml:lang="en-US">Diluted loss per share</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DilutedEarningsLossPerShare" xlink:to="ifrs-full_DilutedEarningsLossPerShare_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_DilutedEarningsLossPerShare_lbl0" xml:lang="en-US">Loss per share - diluted</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DilutedEarningsLossPerShare" xlink:to="ifrs-full_DilutedEarningsLossPerShare_lbl0"/>
    <loc xlink:type="locator" xlink:label="cve_OperatingActivitiesAbstract" xlink:href="cve-20221231.xsd#cve_OperatingActivitiesAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cve_OperatingActivitiesAbstract_lbl" xml:lang="en-US">Operating activities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_OperatingActivitiesAbstract" xlink:to="cve_OperatingActivitiesAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_UnlabeledAbstract5" xlink:href="cve-20221231.xsd#cve_UnlabeledAbstract5"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cve_UnlabeledAbstract5_lbl" xml:lang="en-US"></label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_UnlabeledAbstract5" xlink:to="cve_UnlabeledAbstract5_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_ItemsNotAffectingCashAbstract" xlink:href="cve-20221231.xsd#cve_ItemsNotAffectingCashAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cve_ItemsNotAffectingCashAbstract_lbl" xml:lang="en-US">Items not affecting cash:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_ItemsNotAffectingCashAbstract" xlink:to="cve_ItemsNotAffectingCashAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_Accretion" xlink:href="cve-20221231.xsd#cve_Accretion"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cve_Accretion_lbl" xml:lang="en-US">Accretion</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_Accretion" xlink:to="cve_Accretion_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AdjustmentsForDepreciationAndAmortisationExpense" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_AdjustmentsForDepreciationAndAmortisationExpense"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_AdjustmentsForDepreciationAndAmortisationExpense_lbl" xml:lang="en-US">Amortization and depreciation</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AdjustmentsForDepreciationAndAmortisationExpense" xlink:to="ifrs-full_AdjustmentsForDepreciationAndAmortisationExpense_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AdjustmentsForImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLoss" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_AdjustmentsForImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLoss"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_AdjustmentsForImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLoss_lbl" xml:lang="en-US">Impairment charges</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AdjustmentsForImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLoss" xlink:to="ifrs-full_AdjustmentsForImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLoss_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AdjustmentsForUnrealisedForeignExchangeLossesGains" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_AdjustmentsForUnrealisedForeignExchangeLossesGains"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_AdjustmentsForUnrealisedForeignExchangeLossesGains_lbl" xml:lang="en-US">Foreign exchange loss</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AdjustmentsForUnrealisedForeignExchangeLossesGains" xlink:to="ifrs-full_AdjustmentsForUnrealisedForeignExchangeLossesGains_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AdjustmentsForSharebasedPayments" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_AdjustmentsForSharebasedPayments"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_AdjustmentsForSharebasedPayments_lbl" xml:lang="en-US">Stock option expense</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AdjustmentsForSharebasedPayments" xlink:to="ifrs-full_AdjustmentsForSharebasedPayments_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AdjustmentsForDeferredTaxExpense" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_AdjustmentsForDeferredTaxExpense"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_AdjustmentsForDeferredTaxExpense_lbl" xml:lang="en-US">Loss on write-off of sales tax recoverable</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AdjustmentsForDeferredTaxExpense" xlink:to="ifrs-full_AdjustmentsForDeferredTaxExpense_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AdjustmentsForIncreaseDecreaseInEmployeeBenefitLiabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_AdjustmentsForIncreaseDecreaseInEmployeeBenefitLiabilities"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_AdjustmentsForIncreaseDecreaseInEmployeeBenefitLiabilities_lbl" xml:lang="en-US">Loss (gain) on change in asset retirement obligation estimate</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AdjustmentsForIncreaseDecreaseInEmployeeBenefitLiabilities" xlink:to="ifrs-full_AdjustmentsForIncreaseDecreaseInEmployeeBenefitLiabilities_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AdjustmentsForFairValueGainsLosses" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_AdjustmentsForFairValueGainsLosses"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_AdjustmentsForFairValueGainsLosses_lbl" xml:lang="en-US">Unrealized gain on marketable securities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AdjustmentsForFairValueGainsLosses" xlink:to="ifrs-full_AdjustmentsForFairValueGainsLosses_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_UnlabeledAbstract6" xlink:href="cve-20221231.xsd#cve_UnlabeledAbstract6"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cve_UnlabeledAbstract6_lbl" xml:lang="en-US"></label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_UnlabeledAbstract6" xlink:to="cve_UnlabeledAbstract6_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_ChangesInNonCashWorkingCapitalItemsAbstract" xlink:href="cve-20221231.xsd#cve_ChangesInNonCashWorkingCapitalItemsAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cve_ChangesInNonCashWorkingCapitalItemsAbstract_lbl" xml:lang="en-US">Changes in non-cash working capital items:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_ChangesInNonCashWorkingCapitalItemsAbstract" xlink:to="cve_ChangesInNonCashWorkingCapitalItemsAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AdjustmentsForDecreaseIncreaseInOtherOperatingReceivables" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_AdjustmentsForDecreaseIncreaseInOtherOperatingReceivables"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_AdjustmentsForDecreaseIncreaseInOtherOperatingReceivables_lbl" xml:lang="en-US">Receivables and prepaid expenses</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AdjustmentsForDecreaseIncreaseInOtherOperatingReceivables" xlink:to="ifrs-full_AdjustmentsForDecreaseIncreaseInOtherOperatingReceivables_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AdjustmentsForIncreaseDecreaseInDepositsFromCustomers" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_AdjustmentsForIncreaseDecreaseInDepositsFromCustomers"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_AdjustmentsForIncreaseDecreaseInDepositsFromCustomers_lbl" xml:lang="en-US">Deposit - uranium investment</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AdjustmentsForIncreaseDecreaseInDepositsFromCustomers" xlink:to="ifrs-full_AdjustmentsForIncreaseDecreaseInDepositsFromCustomers_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_OtherInflowsOutflowsOfCashClassifiedAsOperatingActivities" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_OtherInflowsOutflowsOfCashClassifiedAsOperatingActivities"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_OtherInflowsOutflowsOfCashClassifiedAsOperatingActivities_lbl" xml:lang="en-US">Restricted cash</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_OtherInflowsOutflowsOfCashClassifiedAsOperatingActivities" xlink:to="ifrs-full_OtherInflowsOutflowsOfCashClassifiedAsOperatingActivities_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAccountPayable" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAccountPayable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAccountPayable_lbl" xml:lang="en-US">Accounts payable and accrued liabilities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAccountPayable" xlink:to="ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAccountPayable_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CashReceiptsFromRepaymentOfAdvancesAndLoansMadeToRelatedParties" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_CashReceiptsFromRepaymentOfAdvancesAndLoansMadeToRelatedParties"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_CashReceiptsFromRepaymentOfAdvancesAndLoansMadeToRelatedParties_lbl" xml:lang="en-US">Due to related parties</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CashReceiptsFromRepaymentOfAdvancesAndLoansMadeToRelatedParties" xlink:to="ifrs-full_CashReceiptsFromRepaymentOfAdvancesAndLoansMadeToRelatedParties_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_UnlabeledAbstract7" xlink:href="cve-20221231.xsd#cve_UnlabeledAbstract7"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cve_UnlabeledAbstract7_lbl" xml:lang="en-US"></label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_UnlabeledAbstract7" xlink:to="cve_UnlabeledAbstract7_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_InvestingActivitiesAbstract" xlink:href="cve-20221231.xsd#cve_InvestingActivitiesAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cve_InvestingActivitiesAbstract_lbl" xml:lang="en-US">Investing activities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_InvestingActivitiesAbstract" xlink:to="cve_InvestingActivitiesAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ProceedsFromSalesOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_ProceedsFromSalesOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_ProceedsFromSalesOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities_lbl" xml:lang="en-US">Proceeds from divestment of mineral properties</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ProceedsFromSalesOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities" xlink:to="ifrs-full_ProceedsFromSalesOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_ProceedsFromSalesOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities_lbl0" xml:lang="en-US">Disposal of the mineral interests</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ProceedsFromSalesOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities" xlink:to="ifrs-full_ProceedsFromSalesOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities_lbl0"/>
    <loc xlink:type="locator" xlink:label="cve_TransactionCostsOnAzargaAssetAcquisition" xlink:href="cve-20221231.xsd#cve_TransactionCostsOnAzargaAssetAcquisition"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cve_TransactionCostsOnAzargaAssetAcquisition_lbl" xml:lang="en-US">Transaction costs on Azarga asset acquisition</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_TransactionCostsOnAzargaAssetAcquisition" xlink:to="cve_TransactionCostsOnAzargaAssetAcquisition_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_InterestReceivedClassifiedAsInvestingActivities" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_InterestReceivedClassifiedAsInvestingActivities"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_InterestReceivedClassifiedAsInvestingActivities_lbl" xml:lang="en-US">Interest income received</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_InterestReceivedClassifiedAsInvestingActivities" xlink:to="ifrs-full_InterestReceivedClassifiedAsInvestingActivities_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_ProceedsReceivedFromSaleOfUraniumInvestment" xlink:href="cve-20221231.xsd#cve_ProceedsReceivedFromSaleOfUraniumInvestment"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cve_ProceedsReceivedFromSaleOfUraniumInvestment_lbl" xml:lang="en-US">Proceeds received from sale of uranium investment</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_ProceedsReceivedFromSaleOfUraniumInvestment" xlink:to="cve_ProceedsReceivedFromSaleOfUraniumInvestment_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_UnlabeledAbstract8" xlink:href="cve-20221231.xsd#cve_UnlabeledAbstract8"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cve_UnlabeledAbstract8_lbl" xml:lang="en-US"></label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_UnlabeledAbstract8" xlink:to="cve_UnlabeledAbstract8_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_FinancingActivitiesAbstract" xlink:href="cve-20221231.xsd#cve_FinancingActivitiesAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cve_FinancingActivitiesAbstract_lbl" xml:lang="en-US">Financing activities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_FinancingActivitiesAbstract" xlink:to="cve_FinancingActivitiesAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_PrivatePlacementProceeds" xlink:href="cve-20221231.xsd#cve_PrivatePlacementProceeds"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cve_PrivatePlacementProceeds_lbl" xml:lang="en-US">Private placement proceeds</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_PrivatePlacementProceeds" xlink:to="cve_PrivatePlacementProceeds_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ProceedsFromExerciseOfWarrants" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_ProceedsFromExerciseOfWarrants"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_ProceedsFromExerciseOfWarrants_lbl" xml:lang="en-US">Proceeds from exercise of warrants</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ProceedsFromExerciseOfWarrants" xlink:to="ifrs-full_ProceedsFromExerciseOfWarrants_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_ProceedsFromExerciseOfWarrants_lbl0" xml:lang="en-US">Replacement of warrants held (in Dollars)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ProceedsFromExerciseOfWarrants" xlink:to="ifrs-full_ProceedsFromExerciseOfWarrants_lbl0"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ProceedsFromExerciseOfOptions" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_ProceedsFromExerciseOfOptions"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_ProceedsFromExerciseOfOptions_lbl" xml:lang="en-US">Proceeds from exercise of stock options</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ProceedsFromExerciseOfOptions" xlink:to="ifrs-full_ProceedsFromExerciseOfOptions_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_ProceedsFromExerciseOfOptions_lbl0" xml:lang="en-US">Replacement of options held (in Dollars)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ProceedsFromExerciseOfOptions" xlink:to="ifrs-full_ProceedsFromExerciseOfOptions_lbl0"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ProceedsFromIssuingShares" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_ProceedsFromIssuingShares"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_ProceedsFromIssuingShares_lbl" xml:lang="en-US">Share subscriptions received</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ProceedsFromIssuingShares" xlink:to="ifrs-full_ProceedsFromIssuingShares_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_UnlabeledAbstract9" xlink:href="cve-20221231.xsd#cve_UnlabeledAbstract9"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cve_UnlabeledAbstract9_lbl" xml:lang="en-US"></label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_UnlabeledAbstract9" xlink:to="cve_UnlabeledAbstract9_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents_lbl" xml:lang="en-US">Effect of foreign exchange on cash</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents" xlink:to="ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_PrivatePlacement" xlink:href="cve-20221231.xsd#cve_PrivatePlacement"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cve_PrivatePlacement_lbl" xml:lang="en-US">Private placements</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_PrivatePlacement" xlink:to="cve_PrivatePlacement_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_PrivatePlacementinShares" xlink:href="cve-20221231.xsd#cve_PrivatePlacementinShares"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cve_PrivatePlacementinShares_lbl" xml:lang="en-US">Private placements (in Shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_PrivatePlacementinShares" xlink:to="cve_PrivatePlacementinShares_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_IncreaseDecreaseThroughExerciseOfWarrantsEquity" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_IncreaseDecreaseThroughExerciseOfWarrantsEquity"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_IncreaseDecreaseThroughExerciseOfWarrantsEquity_lbl" xml:lang="en-US">Shares issued for exercise of warrants</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_IncreaseDecreaseThroughExerciseOfWarrantsEquity" xlink:to="ifrs-full_IncreaseDecreaseThroughExerciseOfWarrantsEquity_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_SharesIssuedForExerciseOfWarrantsShares" xlink:href="cve-20221231.xsd#cve_SharesIssuedForExerciseOfWarrantsShares"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cve_SharesIssuedForExerciseOfWarrantsShares_lbl" xml:lang="en-US">Shares issued for exercise of warrants (in Shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_SharesIssuedForExerciseOfWarrantsShares" xlink:to="cve_SharesIssuedForExerciseOfWarrantsShares_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_IncreaseDecreaseThroughExerciseOfOptions" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_IncreaseDecreaseThroughExerciseOfOptions"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_IncreaseDecreaseThroughExerciseOfOptions_lbl" xml:lang="en-US">Shares issued for exercise of stock options</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_IncreaseDecreaseThroughExerciseOfOptions" xlink:to="ifrs-full_IncreaseDecreaseThroughExerciseOfOptions_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_SharesIssuedForExerciseOfStockOptionsShares" xlink:href="cve-20221231.xsd#cve_SharesIssuedForExerciseOfStockOptionsShares"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cve_SharesIssuedForExerciseOfStockOptionsShares_lbl" xml:lang="en-US">Shares issued for exercise of stock options (in Shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_SharesIssuedForExerciseOfStockOptionsShares" xlink:to="cve_SharesIssuedForExerciseOfStockOptionsShares_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_StockOptionExpense" xlink:href="cve-20221231.xsd#cve_StockOptionExpense"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cve_StockOptionExpense_lbl" xml:lang="en-US">Stock option expense</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_StockOptionExpense" xlink:to="cve_StockOptionExpense_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_SharesIssuedForAzargaAssetAcquisition" xlink:href="cve-20221231.xsd#cve_SharesIssuedForAzargaAssetAcquisition"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cve_SharesIssuedForAzargaAssetAcquisition_lbl" xml:lang="en-US">Shares issued for Azarga asset acquisition (Note 10)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_SharesIssuedForAzargaAssetAcquisition" xlink:to="cve_SharesIssuedForAzargaAssetAcquisition_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_SharesIssuedForAzargaAssetAcquisitionNote10Shares" xlink:href="cve-20221231.xsd#cve_SharesIssuedForAzargaAssetAcquisitionNote10Shares"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cve_SharesIssuedForAzargaAssetAcquisitionNote10Shares_lbl" xml:lang="en-US">Shares issued for Azarga asset acquisition (Note 10) (in Shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_SharesIssuedForAzargaAssetAcquisitionNote10Shares" xlink:to="cve_SharesIssuedForAzargaAssetAcquisitionNote10Shares_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_ReplacementOptionsForAzargaAssetAcquisition" xlink:href="cve-20221231.xsd#cve_ReplacementOptionsForAzargaAssetAcquisition"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cve_ReplacementOptionsForAzargaAssetAcquisition_lbl" xml:lang="en-US">Replacement options for Azarga asset acquisition (Note 10)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_ReplacementOptionsForAzargaAssetAcquisition" xlink:to="cve_ReplacementOptionsForAzargaAssetAcquisition_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_ReplacementWarrantsForAzargaAssetAcquisition" xlink:href="cve-20221231.xsd#cve_ReplacementWarrantsForAzargaAssetAcquisition"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cve_ReplacementWarrantsForAzargaAssetAcquisition_lbl" xml:lang="en-US">Replacement warrants for Azarga asset acquisition (Note 10)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_ReplacementWarrantsForAzargaAssetAcquisition" xlink:to="cve_ReplacementWarrantsForAzargaAssetAcquisition_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_AdjustmentToInvestmentInAssociate" xlink:href="cve-20221231.xsd#cve_AdjustmentToInvestmentInAssociate"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cve_AdjustmentToInvestmentInAssociate_lbl" xml:lang="en-US">Adjustment to investment in associate</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_AdjustmentToInvestmentInAssociate" xlink:to="cve_AdjustmentToInvestmentInAssociate_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationNetOfTax" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationNetOfTax"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationNetOfTax_lbl" xml:lang="en-US">Cumulative translation adjustment</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationNetOfTax" xlink:to="ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationNetOfTax_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_UnlabeledAbstract10" xlink:href="cve-20221231.xsd#cve_UnlabeledAbstract10"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cve_UnlabeledAbstract10_lbl" xml:lang="en-US"></label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_UnlabeledAbstract10" xlink:to="cve_UnlabeledAbstract10_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_IssueOfEquity" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_IssueOfEquity"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_IssueOfEquity_lbl" xml:lang="en-US">Shares issued for services</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_IssueOfEquity" xlink:to="ifrs-full_IssueOfEquity_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_SharesIssuedForServicesShares" xlink:href="cve-20221231.xsd#cve_SharesIssuedForServicesShares"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cve_SharesIssuedForServicesShares_lbl" xml:lang="en-US">Shares issued for services (in Shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_SharesIssuedForServicesShares" xlink:to="cve_SharesIssuedForServicesShares_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_ShareSubscriptionsReceived" xlink:href="cve-20221231.xsd#cve_ShareSubscriptionsReceived"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cve_ShareSubscriptionsReceived_lbl" xml:lang="en-US">Share subscriptions received</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_ShareSubscriptionsReceived" xlink:to="cve_ShareSubscriptionsReceived_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_LossOnWriteoffOfSalesTaxRecoverable" xlink:href="cve-20221231.xsd#cve_LossOnWriteoffOfSalesTaxRecoverable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="cve_LossOnWriteoffOfSalesTaxRecoverable_lbl" xml:lang="en-US">Loss on write-off of sales tax recoverable</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_LossOnWriteoffOfSalesTaxRecoverable" xlink:to="cve_LossOnWriteoffOfSalesTaxRecoverable_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_GainLossOnRemeasurementOfReimbursementRights" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_GainLossOnRemeasurementOfReimbursementRights"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="ifrs-full_GainLossOnRemeasurementOfReimbursementRights_lbl" xml:lang="en-US">(Loss) gain on change in asset retirement obligation estimate</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_GainLossOnRemeasurementOfReimbursementRights" xlink:to="ifrs-full_GainLossOnRemeasurementOfReimbursementRights_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_LossOnContractTerminations" xlink:href="cve-20221231.xsd#cve_LossOnContractTerminations"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="cve_LossOnContractTerminations_lbl" xml:lang="en-US">Loss on contract termination</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_LossOnContractTerminations" xlink:to="cve_LossOnContractTerminations_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AdjustmentsForInterestIncome" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_AdjustmentsForInterestIncome"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="ifrs-full_AdjustmentsForInterestIncome_lbl" xml:lang="en-US">Interest income</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AdjustmentsForInterestIncome" xlink:to="ifrs-full_AdjustmentsForInterestIncome_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AdjustmentsForGainLossOnDisposalsPropertyPlantAndEquipment" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_AdjustmentsForGainLossOnDisposalsPropertyPlantAndEquipment"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="ifrs-full_AdjustmentsForGainLossOnDisposalsPropertyPlantAndEquipment_lbl" xml:lang="en-US">(Gain) loss on divestment of mineral properties</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AdjustmentsForGainLossOnDisposalsPropertyPlantAndEquipment" xlink:to="ifrs-full_AdjustmentsForGainLossOnDisposalsPropertyPlantAndEquipment_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AdjustmentsForUndistributedProfitsOfAssociates" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_AdjustmentsForUndistributedProfitsOfAssociates"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="ifrs-full_AdjustmentsForUndistributedProfitsOfAssociates_lbl" xml:lang="en-US">Loss on investment in associate</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AdjustmentsForUndistributedProfitsOfAssociates" xlink:to="ifrs-full_AdjustmentsForUndistributedProfitsOfAssociates_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="ifrs-full_PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities_lbl" xml:lang="en-US">Acquisition of intangible assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities" xlink:to="ifrs-full_PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities_lbl" xml:lang="en-US">Acquisition of property, plant, and equipment</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities" xlink:to="ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_PurchaseOfInvestmentProperty" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_PurchaseOfInvestmentProperty"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="ifrs-full_PurchaseOfInvestmentProperty_lbl" xml:lang="en-US">Mineral property expenditures</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_PurchaseOfInvestmentProperty" xlink:to="ifrs-full_PurchaseOfInvestmentProperty_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_CashAcquiredFromAzargaAssetAcquisition" xlink:href="cve-20221231.xsd#cve_CashAcquiredFromAzargaAssetAcquisition"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="cve_CashAcquiredFromAzargaAssetAcquisition_lbl" xml:lang="en-US">Cash acquired from Azarga asset acquisition</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_CashAcquiredFromAzargaAssetAcquisition" xlink:to="cve_CashAcquiredFromAzargaAssetAcquisition_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CashFlowsUsedInObtainingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_CashFlowsUsedInObtainingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="ifrs-full_CashFlowsUsedInObtainingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities_lbl" xml:lang="en-US">Deferred acquisition costs</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CashFlowsUsedInObtainingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities" xlink:to="ifrs-full_CashFlowsUsedInObtainingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_PaymentsofInvestmentInUranium" xlink:href="cve-20221231.xsd#cve_PaymentsofInvestmentInUranium"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="cve_PaymentsofInvestmentInUranium_lbl" xml:lang="en-US">Investment in uranium</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_PaymentsofInvestmentInUranium" xlink:to="cve_PaymentsofInvestmentInUranium_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_GainsLossesOnFinancialAssetsAtFairValueThroughProfitOrLoss" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_GainsLossesOnFinancialAssetsAtFairValueThroughProfitOrLoss"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="ifrs-full_GainsLossesOnFinancialAssetsAtFairValueThroughProfitOrLoss_lbl" xml:lang="en-US">Settlement of asset retirement obligation</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_GainsLossesOnFinancialAssetsAtFairValueThroughProfitOrLoss" xlink:to="ifrs-full_GainsLossesOnFinancialAssetsAtFairValueThroughProfitOrLoss_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_PaymentsForShareIssueCosts" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_PaymentsForShareIssueCosts"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="ifrs-full_PaymentsForShareIssueCosts_lbl" xml:lang="en-US">Share issue costs</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_PaymentsForShareIssueCosts" xlink:to="ifrs-full_PaymentsForShareIssueCosts_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_RepaymentsOfBorrowingsClassifiedAsFinancingActivities" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_RepaymentsOfBorrowingsClassifiedAsFinancingActivities"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="ifrs-full_RepaymentsOfBorrowingsClassifiedAsFinancingActivities_lbl" xml:lang="en-US">Deferred financing costs</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_RepaymentsOfBorrowingsClassifiedAsFinancingActivities" xlink:to="ifrs-full_RepaymentsOfBorrowingsClassifiedAsFinancingActivities_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities_lbl" xml:lang="en-US">Lease payments</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities" xlink:to="ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ShareIssueRelatedCost" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_ShareIssueRelatedCost"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="ifrs-full_ShareIssueRelatedCost_lbl" xml:lang="en-US">Share issuance costs</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ShareIssueRelatedCost" xlink:to="ifrs-full_ShareIssueRelatedCost_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_BusinessContactMember" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_BusinessContactMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_BusinessContactMember_lbl" xml:lang="en-US">Business Contact [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_BusinessContactMember" xlink:to="dei_BusinessContactMember_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ClassesOfShareCapitalMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_ClassesOfShareCapitalMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_ClassesOfShareCapitalMember_lbl" xml:lang="en-US">Share capital</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ClassesOfShareCapitalMember" xlink:to="ifrs-full_ClassesOfShareCapitalMember_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_IssuedCapitalMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_IssuedCapitalMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_IssuedCapitalMember_lbl" xml:lang="en-US">Share subscriptions received</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_IssuedCapitalMember" xlink:to="ifrs-full_IssuedCapitalMember_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_ContributedSurplusMember" xlink:href="cve-20221231.xsd#cve_ContributedSurplusMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cve_ContributedSurplusMember_lbl" xml:lang="en-US">Contributed surplus</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_ContributedSurplusMember" xlink:to="cve_ContributedSurplusMember_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AccumulatedOtherComprehensiveIncomeMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_AccumulatedOtherComprehensiveIncomeMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_AccumulatedOtherComprehensiveIncomeMember_lbl" xml:lang="en-US">Accumulated other comprehensive income (loss)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AccumulatedOtherComprehensiveIncomeMember" xlink:to="ifrs-full_AccumulatedOtherComprehensiveIncomeMember_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_RetainedEarningsMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_RetainedEarningsMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_RetainedEarningsMember_lbl" xml:lang="en-US">Deficit</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_RetainedEarningsMember" xlink:to="ifrs-full_RetainedEarningsMember_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_NatureOfOperationAndGoingConcern" xlink:href="cve-20221231.xsd#cve_NatureOfOperationAndGoingConcern"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cve_NatureOfOperationAndGoingConcern_lbl" xml:lang="en-US">Nature of operations and going concern</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_NatureOfOperationAndGoingConcern" xlink:to="cve_NatureOfOperationAndGoingConcern_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory_lbl" xml:lang="en-US">Significant Accounting Policies</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory" xlink:to="ifrs-full_DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfEffectOfChangesInForeignExchangeRatesExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_DisclosureOfEffectOfChangesInForeignExchangeRatesExplanatory"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DisclosureOfEffectOfChangesInForeignExchangeRatesExplanatory_lbl" xml:lang="en-US">Schedule of exchange rates</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfEffectOfChangesInForeignExchangeRatesExplanatory" xlink:to="ifrs-full_DisclosureOfEffectOfChangesInForeignExchangeRatesExplanatory_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ClosingForeignExchangeRate" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_ClosingForeignExchangeRate"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_ClosingForeignExchangeRate_lbl" xml:lang="en-US">Closing rate at the reporting date</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ClosingForeignExchangeRate" xlink:to="ifrs-full_ClosingForeignExchangeRate_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AverageForeignExchangeRate" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_AverageForeignExchangeRate"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_AverageForeignExchangeRate_lbl" xml:lang="en-US">Average rate for the year</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AverageForeignExchangeRate" xlink:to="ifrs-full_AverageForeignExchangeRate_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesExplanatory"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesExplanatory_lbl" xml:lang="en-US">Schedule of significant subsidiaries</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesExplanatory" xlink:to="ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesExplanatory_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_NameofSubsidaryPlaceOfIncorporation" xlink:href="cve-20221231.xsd#cve_NameofSubsidaryPlaceOfIncorporation"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cve_NameofSubsidaryPlaceOfIncorporation_lbl" xml:lang="en-US">Place of Incorporation</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_NameofSubsidaryPlaceOfIncorporation" xlink:to="cve_NameofSubsidaryPlaceOfIncorporation_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ProportionOfOwnershipInterestInSubsidiary" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_ProportionOfOwnershipInterestInSubsidiary"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_ProportionOfOwnershipInterestInSubsidiary_lbl" xml:lang="en-US">Ownership Interest</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ProportionOfOwnershipInterestInSubsidiary" xlink:to="ifrs-full_ProportionOfOwnershipInterestInSubsidiary_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_NameofSubsidaryPrincipalActivity" xlink:href="cve-20221231.xsd#cve_NameofSubsidaryPrincipalActivity"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cve_NameofSubsidaryPrincipalActivity_lbl" xml:lang="en-US">Principal Activity</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_NameofSubsidaryPrincipalActivity" xlink:to="cve_NameofSubsidaryPrincipalActivity_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_NameofSubsidaryFunctionalCurrency" xlink:href="cve-20221231.xsd#cve_NameofSubsidaryFunctionalCurrency"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cve_NameofSubsidaryFunctionalCurrency_lbl" xml:lang="en-US">Functional Currency</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_NameofSubsidaryFunctionalCurrency" xlink:to="cve_NameofSubsidaryFunctionalCurrency_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_DisclosureOfUsefulLivesOfPropertyPlantAndEquipementTextBlock" xlink:href="cve-20221231.xsd#cve_DisclosureOfUsefulLivesOfPropertyPlantAndEquipementTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cve_DisclosureOfUsefulLivesOfPropertyPlantAndEquipementTextBlock_lbl" xml:lang="en-US">Schedule of useful lives of property, plant and equipement</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_DisclosureOfUsefulLivesOfPropertyPlantAndEquipementTextBlock" xlink:to="cve_DisclosureOfUsefulLivesOfPropertyPlantAndEquipementTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_PropertyPlantAndEquipmentRange" xlink:href="cve-20221231.xsd#cve_PropertyPlantAndEquipmentRange"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cve_PropertyPlantAndEquipmentRange_lbl" xml:lang="en-US">Range</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_PropertyPlantAndEquipmentRange" xlink:to="cve_PropertyPlantAndEquipmentRange_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_DisclosureOfUsefulLivesOfIntangibleAssetsTextBllock" xlink:href="cve-20221231.xsd#cve_DisclosureOfUsefulLivesOfIntangibleAssetsTextBllock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cve_DisclosureOfUsefulLivesOfIntangibleAssetsTextBllock_lbl" xml:lang="en-US">Schedule of useful lives of intangible assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_DisclosureOfUsefulLivesOfIntangibleAssetsTextBllock" xlink:to="cve_DisclosureOfUsefulLivesOfIntangibleAssetsTextBllock_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_CategoryRange" xlink:href="cve-20221231.xsd#cve_CategoryRange"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cve_CategoryRange_lbl" xml:lang="en-US">Range</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_CategoryRange" xlink:to="cve_CategoryRange_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfAccountingJudgementsAndEstimatesExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_DisclosureOfAccountingJudgementsAndEstimatesExplanatory"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DisclosureOfAccountingJudgementsAndEstimatesExplanatory_lbl" xml:lang="en-US">Critical accounting estimates and judgements</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfAccountingJudgementsAndEstimatesExplanatory" xlink:to="ifrs-full_DisclosureOfAccountingJudgementsAndEstimatesExplanatory_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesExplanatory"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesExplanatory_lbl" xml:lang="en-US">Investment in associate</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesExplanatory" xlink:to="ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesExplanatory_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_DisclosureOfProportionalShareAssociatesExplanatory" xlink:href="cve-20221231.xsd#cve_DisclosureOfProportionalShareAssociatesExplanatory"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cve_DisclosureOfProportionalShareAssociatesExplanatory_lbl" xml:lang="en-US">Schedule of proportional share in the associate</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_DisclosureOfProportionalShareAssociatesExplanatory" xlink:to="cve_DisclosureOfProportionalShareAssociatesExplanatory_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_OtherCurrentAssets" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_OtherCurrentAssets"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_OtherCurrentAssets_lbl" xml:lang="en-US">Assets, Current</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_OtherCurrentAssets" xlink:to="ifrs-full_OtherCurrentAssets_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_OtherCurrentLiabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_OtherCurrentLiabilities"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_OtherCurrentLiabilities_lbl" xml:lang="en-US">Liabilities, Current</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_OtherCurrentLiabilities" xlink:to="ifrs-full_OtherCurrentLiabilities_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_OtherRevenuesCurrent" xlink:href="cve-20221231.xsd#cve_OtherRevenuesCurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cve_OtherRevenuesCurrent_lbl" xml:lang="en-US">Revenues, Current</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_OtherRevenuesCurrent" xlink:to="cve_OtherRevenuesCurrent_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_ExpensesCurrent" xlink:href="cve-20221231.xsd#cve_ExpensesCurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cve_ExpensesCurrent_lbl" xml:lang="en-US">Expenses, Current</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_ExpensesCurrent" xlink:to="cve_ExpensesCurrent_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_OtherNoncurrentAssets" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_OtherNoncurrentAssets"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_OtherNoncurrentAssets_lbl" xml:lang="en-US">Assets, Non-current</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_OtherNoncurrentAssets" xlink:to="ifrs-full_OtherNoncurrentAssets_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_OtherNoncurrentLiabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_OtherNoncurrentLiabilities"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_OtherNoncurrentLiabilities_lbl" xml:lang="en-US">Liabilities Non-current</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_OtherNoncurrentLiabilities" xlink:to="ifrs-full_OtherNoncurrentLiabilities_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_OtherRevenuesNoncurrent" xlink:href="cve-20221231.xsd#cve_OtherRevenuesNoncurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cve_OtherRevenuesNoncurrent_lbl" xml:lang="en-US">Revenues, Non-current</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_OtherRevenuesNoncurrent" xlink:to="cve_OtherRevenuesNoncurrent_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_ExpensesNoncurrent" xlink:href="cve-20221231.xsd#cve_ExpensesNoncurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cve_ExpensesNoncurrent_lbl" xml:lang="en-US">Expenses, Non-current</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_ExpensesNoncurrent" xlink:to="cve_ExpensesNoncurrent_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_AssetsLossFromOperatingExpenses" xlink:href="cve-20221231.xsd#cve_AssetsLossFromOperatingExpenses"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cve_AssetsLossFromOperatingExpenses_lbl" xml:lang="en-US">Assets, Loss from operating expenses</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_AssetsLossFromOperatingExpenses" xlink:to="cve_AssetsLossFromOperatingExpenses_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_LiabilitiesLossFromOperatingExpenses" xlink:href="cve-20221231.xsd#cve_LiabilitiesLossFromOperatingExpenses"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cve_LiabilitiesLossFromOperatingExpenses_lbl" xml:lang="en-US">Liabilities Loss from operating expenses</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_LiabilitiesLossFromOperatingExpenses" xlink:to="cve_LiabilitiesLossFromOperatingExpenses_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_RevenuesLossFromOperatingExpenses" xlink:href="cve-20221231.xsd#cve_RevenuesLossFromOperatingExpenses"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cve_RevenuesLossFromOperatingExpenses_lbl" xml:lang="en-US">Revenues, Loss from operating expenses</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_RevenuesLossFromOperatingExpenses" xlink:to="cve_RevenuesLossFromOperatingExpenses_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_ExpensesLossFromOperatingExpenses" xlink:href="cve-20221231.xsd#cve_ExpensesLossFromOperatingExpenses"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cve_ExpensesLossFromOperatingExpenses_lbl" xml:lang="en-US">Expenses, Loss from operating expenses</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_ExpensesLossFromOperatingExpenses" xlink:to="cve_ExpensesLossFromOperatingExpenses_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_OtherAssets" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_OtherAssets"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_OtherAssets_lbl" xml:lang="en-US">Assets, Total</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_OtherAssets" xlink:to="ifrs-full_OtherAssets_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_OtherLiabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_OtherLiabilities"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_OtherLiabilities_lbl" xml:lang="en-US">Liabilities, Total</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_OtherLiabilities" xlink:to="ifrs-full_OtherLiabilities_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_OtherRevenue" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_OtherRevenue"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_OtherRevenue_lbl" xml:lang="en-US">Revenues, Total</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_OtherRevenue" xlink:to="ifrs-full_OtherRevenue_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_UnlabeledAbstract11" xlink:href="cve-20221231.xsd#cve_UnlabeledAbstract11"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cve_UnlabeledAbstract11_lbl" xml:lang="en-US"></label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_UnlabeledAbstract11" xlink:to="cve_UnlabeledAbstract11_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_YearEndedDecember312022Abstract" xlink:href="cve-20221231.xsd#cve_YearEndedDecember312022Abstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cve_YearEndedDecember312022Abstract_lbl" xml:lang="en-US">Year ended December 31, 2022</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_YearEndedDecember312022Abstract" xlink:to="cve_YearEndedDecember312022Abstract_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_UnlabeledAbstract12" xlink:href="cve-20221231.xsd#cve_UnlabeledAbstract12"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cve_UnlabeledAbstract12_lbl" xml:lang="en-US"></label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_UnlabeledAbstract12" xlink:to="cve_UnlabeledAbstract12_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_TaxRateEffectOfForeignTaxRates" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_TaxRateEffectOfForeignTaxRates"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_TaxRateEffectOfForeignTaxRates_lbl" xml:lang="en-US">The Company&#8217;s percentage ownership</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_TaxRateEffectOfForeignTaxRates" xlink:to="ifrs-full_TaxRateEffectOfForeignTaxRates_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfInterestsInAssociatesExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_DisclosureOfInterestsInAssociatesExplanatory"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DisclosureOfInterestsInAssociatesExplanatory_lbl" xml:lang="en-US">Schedule of investment in associate continuity summary</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfInterestsInAssociatesExplanatory" xlink:to="ifrs-full_DisclosureOfInterestsInAssociatesExplanatory_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_InvestmentInAssociateAbstract" xlink:href="cve-20221231.xsd#cve_InvestmentInAssociateAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cve_InvestmentInAssociateAbstract_lbl" xml:lang="en-US">Investment in associate</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_InvestmentInAssociateAbstract" xlink:to="cve_InvestmentInAssociateAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_UnlabeledAbstract13" xlink:href="cve-20221231.xsd#cve_UnlabeledAbstract13"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cve_UnlabeledAbstract13_lbl" xml:lang="en-US">$</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_UnlabeledAbstract13" xlink:to="cve_UnlabeledAbstract13_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_UnlabeledAbstract14" xlink:href="cve-20221231.xsd#cve_UnlabeledAbstract14"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cve_UnlabeledAbstract14_lbl" xml:lang="en-US"></label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_UnlabeledAbstract14" xlink:to="cve_UnlabeledAbstract14_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_AdjustmentsToCarryingValueAbstract" xlink:href="cve-20221231.xsd#cve_AdjustmentsToCarryingValueAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cve_AdjustmentsToCarryingValueAbstract_lbl" xml:lang="en-US">Adjustments to carrying value:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_AdjustmentsToCarryingValueAbstract" xlink:to="cve_AdjustmentsToCarryingValueAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_ProportionateShareOfNetLoss" xlink:href="cve-20221231.xsd#cve_ProportionateShareOfNetLoss"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cve_ProportionateShareOfNetLoss_lbl" xml:lang="en-US">Proportionate share of net loss</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_ProportionateShareOfNetLoss" xlink:to="cve_ProportionateShareOfNetLoss_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_AdjustmentToInvestmentInGroup11" xlink:href="cve-20221231.xsd#cve_AdjustmentToInvestmentInGroup11"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cve_AdjustmentToInvestmentInGroup11_lbl" xml:lang="en-US">Adjustment to investment in Group 11</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_AdjustmentToInvestmentInGroup11" xlink:to="cve_AdjustmentToInvestmentInGroup11_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_DilutionLoss" xlink:href="cve-20221231.xsd#cve_DilutionLoss"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cve_DilutionLoss_lbl" xml:lang="en-US">Dilution loss</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_DilutionLoss" xlink:to="cve_DilutionLoss_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_CurrencyTranslationAdjustment" xlink:href="cve-20221231.xsd#cve_CurrencyTranslationAdjustment"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cve_CurrencyTranslationAdjustment_lbl" xml:lang="en-US">Currency translation adjustment</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_CurrencyTranslationAdjustment" xlink:to="cve_CurrencyTranslationAdjustment_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_UnlabeledAbstract15" xlink:href="cve-20221231.xsd#cve_UnlabeledAbstract15"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cve_UnlabeledAbstract15_lbl" xml:lang="en-US"></label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_UnlabeledAbstract15" xlink:to="cve_UnlabeledAbstract15_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_AdjustmentsToCarryingValueAbstract0" xlink:href="cve-20221231.xsd#cve_AdjustmentsToCarryingValueAbstract0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cve_AdjustmentsToCarryingValueAbstract0_lbl" xml:lang="en-US">Adjustments to carrying value:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_AdjustmentsToCarryingValueAbstract0" xlink:to="cve_AdjustmentsToCarryingValueAbstract0_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_WriteoffOfInvestment" xlink:href="cve-20221231.xsd#cve_WriteoffOfInvestment"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cve_WriteoffOfInvestment_lbl" xml:lang="en-US">Write-off of investment</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_WriteoffOfInvestment" xlink:to="cve_WriteoffOfInvestment_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethodExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_DisclosureOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethodExplanatory"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DisclosureOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethodExplanatory_lbl" xml:lang="en-US">Investment in uranium</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethodExplanatory" xlink:to="ifrs-full_DisclosureOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethodExplanatory_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_ScheduleOfTheFairValueOfThePhysicalUraniumInvestmentTableTextBlck" xlink:href="cve-20221231.xsd#cve_ScheduleOfTheFairValueOfThePhysicalUraniumInvestmentTableTextBlck"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cve_ScheduleOfTheFairValueOfThePhysicalUraniumInvestmentTableTextBlck_lbl" xml:lang="en-US">Schedule of the fair value of the physical uranium investment</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_ScheduleOfTheFairValueOfThePhysicalUraniumInvestmentTableTextBlck" xlink:to="cve_ScheduleOfTheFairValueOfThePhysicalUraniumInvestmentTableTextBlck_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_InvestmentInUraniumAbstract" xlink:href="cve-20221231.xsd#cve_InvestmentInUraniumAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cve_InvestmentInUraniumAbstract_lbl" xml:lang="en-US">Investment in uranium</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_InvestmentInUraniumAbstract" xlink:to="cve_InvestmentInUraniumAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_UnlabeledAbstract16" xlink:href="cve-20221231.xsd#cve_UnlabeledAbstract16"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cve_UnlabeledAbstract16_lbl" xml:lang="en-US">$</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_UnlabeledAbstract16" xlink:to="cve_UnlabeledAbstract16_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_UnlabeledAbstract17" xlink:href="cve-20221231.xsd#cve_UnlabeledAbstract17"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cve_UnlabeledAbstract17_lbl" xml:lang="en-US"></label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_UnlabeledAbstract17" xlink:to="cve_UnlabeledAbstract17_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_PhysicalUranium" xlink:href="cve-20221231.xsd#cve_PhysicalUranium"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cve_PhysicalUranium_lbl" xml:lang="en-US">Physical uranium</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_PhysicalUranium" xlink:to="cve_PhysicalUranium_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AdjustmentsForGainsLossesOnChangeInFairValueOfDerivatives" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_AdjustmentsForGainsLossesOnChangeInFairValueOfDerivatives"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_AdjustmentsForGainsLossesOnChangeInFairValueOfDerivatives_lbl" xml:lang="en-US">Fair value adjustment</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AdjustmentsForGainsLossesOnChangeInFairValueOfDerivatives" xlink:to="ifrs-full_AdjustmentsForGainsLossesOnChangeInFairValueOfDerivatives_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_GainOnSaleOfUranium" xlink:href="cve-20221231.xsd#cve_GainOnSaleOfUranium"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cve_GainOnSaleOfUranium_lbl" xml:lang="en-US">Gain on sale of uranium</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_GainOnSaleOfUranium" xlink:to="cve_GainOnSaleOfUranium_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_SaleOfUraniumInvestment" xlink:href="cve-20221231.xsd#cve_SaleOfUraniumInvestment"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cve_SaleOfUraniumInvestment_lbl" xml:lang="en-US">Sale of uranium investment</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_SaleOfUraniumInvestment" xlink:to="cve_SaleOfUraniumInvestment_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_OtherComprehensiveIncomeNetOfTaxChangeInValueOfForeignCurrencyBasisSpreads" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_OtherComprehensiveIncomeNetOfTaxChangeInValueOfForeignCurrencyBasisSpreads"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_OtherComprehensiveIncomeNetOfTaxChangeInValueOfForeignCurrencyBasisSpreads_lbl" xml:lang="en-US">Currency translation adjustment</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_OtherComprehensiveIncomeNetOfTaxChangeInValueOfForeignCurrencyBasisSpreads" xlink:to="ifrs-full_OtherComprehensiveIncomeNetOfTaxChangeInValueOfForeignCurrencyBasisSpreads_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_UnlabeledAbstract18" xlink:href="cve-20221231.xsd#cve_UnlabeledAbstract18"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cve_UnlabeledAbstract18_lbl" xml:lang="en-US"></label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_UnlabeledAbstract18" xlink:to="cve_UnlabeledAbstract18_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_ScheduleOfUraniumConcentratesPurchaseAgreementTableTextBlock" xlink:href="cve-20221231.xsd#cve_ScheduleOfUraniumConcentratesPurchaseAgreementTableTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cve_ScheduleOfUraniumConcentratesPurchaseAgreementTableTextBlock_lbl" xml:lang="en-US">Schedule of uranium concentrates purchase agreement</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_ScheduleOfUraniumConcentratesPurchaseAgreementTableTextBlock" xlink:to="cve_ScheduleOfUraniumConcentratesPurchaseAgreementTableTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_PurchaseCommitments" xlink:href="cve-20221231.xsd#cve_PurchaseCommitments"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cve_PurchaseCommitments_lbl" xml:lang="en-US">Purchase Commitments</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_PurchaseCommitments" xlink:to="cve_PurchaseCommitments_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_TotalPurchasePrice" xlink:href="cve-20221231.xsd#cve_TotalPurchasePrice"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cve_TotalPurchasePrice_lbl" xml:lang="en-US">Total Purchase Price</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_TotalPurchasePrice" xlink:to="cve_TotalPurchasePrice_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfMarketRiskExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_DisclosureOfMarketRiskExplanatory"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DisclosureOfMarketRiskExplanatory_lbl" xml:lang="en-US">Marketable securities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfMarketRiskExplanatory" xlink:to="ifrs-full_DisclosureOfMarketRiskExplanatory_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_ScheduleOfMarketableSecuritiesTableTextBlock" xlink:href="cve-20221231.xsd#cve_ScheduleOfMarketableSecuritiesTableTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cve_ScheduleOfMarketableSecuritiesTableTextBlock_lbl" xml:lang="en-US">Schedule of marketable securities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_ScheduleOfMarketableSecuritiesTableTextBlock" xlink:to="cve_ScheduleOfMarketableSecuritiesTableTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_UnlabeledAbstract19" xlink:href="cve-20221231.xsd#cve_UnlabeledAbstract19"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cve_UnlabeledAbstract19_lbl" xml:lang="en-US"></label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_UnlabeledAbstract19" xlink:to="cve_UnlabeledAbstract19_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AdditionalProvisionsOtherProvisions" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_AdditionalProvisionsOtherProvisions"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_AdditionalProvisionsOtherProvisions_lbl" xml:lang="en-US">Additions</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AdditionalProvisionsOtherProvisions" xlink:to="ifrs-full_AdditionalProvisionsOtherProvisions_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AdjustmentsForGainsLossesOnFairValueAdjustmentInvestmentProperty" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_AdjustmentsForGainsLossesOnFairValueAdjustmentInvestmentProperty"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_AdjustmentsForGainsLossesOnFairValueAdjustmentInvestmentProperty_lbl" xml:lang="en-US">Fair value adjustments</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AdjustmentsForGainsLossesOnFairValueAdjustmentInvestmentProperty" xlink:to="ifrs-full_AdjustmentsForGainsLossesOnFairValueAdjustmentInvestmentProperty_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RestructuringReserveTranslationAdjustment" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringReserveTranslationAdjustment"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_RestructuringReserveTranslationAdjustment_lbl" xml:lang="en-US">Currency translation adjustment</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RestructuringReserveTranslationAdjustment" xlink:to="us-gaap_RestructuringReserveTranslationAdjustment_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfIntangibleAssetsExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_DisclosureOfIntangibleAssetsExplanatory"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DisclosureOfIntangibleAssetsExplanatory_lbl" xml:lang="en-US">Intangible assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfIntangibleAssetsExplanatory" xlink:to="ifrs-full_DisclosureOfIntangibleAssetsExplanatory_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfDetailedInformationAboutIntangibleAssetsExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_DisclosureOfDetailedInformationAboutIntangibleAssetsExplanatory"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DisclosureOfDetailedInformationAboutIntangibleAssetsExplanatory_lbl" xml:lang="en-US">Schedule of intangible asset was determined</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfDetailedInformationAboutIntangibleAssetsExplanatory" xlink:to="ifrs-full_DisclosureOfDetailedInformationAboutIntangibleAssetsExplanatory_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_Additions" xlink:href="cve-20221231.xsd#cve_Additions"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cve_Additions_lbl" xml:lang="en-US">Additions</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_Additions" xlink:to="cve_Additions_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_CurrencyTranslationAdjustment1" xlink:href="cve-20221231.xsd#cve_CurrencyTranslationAdjustment1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cve_CurrencyTranslationAdjustment1_lbl" xml:lang="en-US">Currency Translation Adjustment</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_CurrencyTranslationAdjustment1" xlink:to="cve_CurrencyTranslationAdjustment1_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfPropertyPlantAndEquipmentExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_DisclosureOfPropertyPlantAndEquipmentExplanatory"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DisclosureOfPropertyPlantAndEquipmentExplanatory_lbl" xml:lang="en-US">Property, plant, and equipment</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfPropertyPlantAndEquipmentExplanatory" xlink:to="ifrs-full_DisclosureOfPropertyPlantAndEquipmentExplanatory_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory_lbl" xml:lang="en-US">Schedule of property, plant, and equipment</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory" xlink:to="ifrs-full_DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment_lbl" xml:lang="en-US">Additions</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment" xlink:to="ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisposalsInvestmentProperty" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_DisposalsInvestmentProperty"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DisposalsInvestmentProperty_lbl" xml:lang="en-US">Disposals</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisposalsInvestmentProperty" xlink:to="ifrs-full_DisposalsInvestmentProperty_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ImpairmentLoss" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_ImpairmentLoss"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_ImpairmentLoss_lbl" xml:lang="en-US">Impairment</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ImpairmentLoss" xlink:to="ifrs-full_ImpairmentLoss_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation_lbl" xml:lang="en-US">Currency translation adjustment</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation" xlink:to="ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsExplanatory"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsExplanatory_lbl" xml:lang="en-US">Right-of-use assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsExplanatory" xlink:to="ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsExplanatory_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_DisclosureOfChangeInTheROUAssetsTableTextBlock" xlink:href="cve-20221231.xsd#cve_DisclosureOfChangeInTheROUAssetsTableTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cve_DisclosureOfChangeInTheROUAssetsTableTextBlock_lbl" xml:lang="en-US">Schedule of change in the ROU assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_DisclosureOfChangeInTheROUAssetsTableTextBlock" xlink:to="cve_DisclosureOfChangeInTheROUAssetsTableTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_Right-of-UseAssetsAdditions" xlink:href="cve-20221231.xsd#cve_Right-of-UseAssetsAdditions"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cve_Right-of-UseAssetsAdditions_lbl" xml:lang="en-US">Additions</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_Right-of-UseAssetsAdditions" xlink:to="cve_Right-of-UseAssetsAdditions_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_Right-of-UseAssetsDepreciation" xlink:href="cve-20221231.xsd#cve_Right-of-UseAssetsDepreciation"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cve_Right-of-UseAssetsDepreciation_lbl" xml:lang="en-US">Depreciation</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_Right-of-UseAssetsDepreciation" xlink:to="cve_Right-of-UseAssetsDepreciation_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_Right-of-UseAssetsCurrencyTranslationAdjustment" xlink:href="cve-20221231.xsd#cve_Right-of-UseAssetsCurrencyTranslationAdjustment"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cve_Right-of-UseAssetsCurrencyTranslationAdjustment_lbl" xml:lang="en-US">Currency translation adjustment</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_Right-of-UseAssetsCurrencyTranslationAdjustment" xlink:to="cve_Right-of-UseAssetsCurrencyTranslationAdjustment_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_DisclosureOfChangeInTheLongTermLeaseLiabilityTableTextBlock" xlink:href="cve-20221231.xsd#cve_DisclosureOfChangeInTheLongTermLeaseLiabilityTableTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cve_DisclosureOfChangeInTheLongTermLeaseLiabilityTableTextBlock_lbl" xml:lang="en-US">Schedule of change in the long-Term lease liability</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_DisclosureOfChangeInTheLongTermLeaseLiabilityTableTextBlock" xlink:to="cve_DisclosureOfChangeInTheLongTermLeaseLiabilityTableTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_Long-TermLeaseLiabilityAdditions" xlink:href="cve-20221231.xsd#cve_Long-TermLeaseLiabilityAdditions"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cve_Long-TermLeaseLiabilityAdditions_lbl" xml:lang="en-US">Additions</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_Long-TermLeaseLiabilityAdditions" xlink:to="cve_Long-TermLeaseLiabilityAdditions_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_Long-TermLeaseLiabilityAccretion" xlink:href="cve-20221231.xsd#cve_Long-TermLeaseLiabilityAccretion"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cve_Long-TermLeaseLiabilityAccretion_lbl" xml:lang="en-US">Accretion</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_Long-TermLeaseLiabilityAccretion" xlink:to="cve_Long-TermLeaseLiabilityAccretion_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_Long-TermLeaseLiabilityLeasePaymentsMade" xlink:href="cve-20221231.xsd#cve_Long-TermLeaseLiabilityLeasePaymentsMade"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cve_Long-TermLeaseLiabilityLeasePaymentsMade_lbl" xml:lang="en-US">Lease payments made</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_Long-TermLeaseLiabilityLeasePaymentsMade" xlink:to="cve_Long-TermLeaseLiabilityLeasePaymentsMade_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_Long-TermLeaseLiabilityCurrencyTranslationAdjustment" xlink:href="cve-20221231.xsd#cve_Long-TermLeaseLiabilityCurrencyTranslationAdjustment"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cve_Long-TermLeaseLiabilityCurrencyTranslationAdjustment_lbl" xml:lang="en-US">Currency translation adjustment</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_Long-TermLeaseLiabilityCurrencyTranslationAdjustment" xlink:to="cve_Long-TermLeaseLiabilityCurrencyTranslationAdjustment_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_Long-TermLeaseLiabilityLessCurrentLeaseLiability" xlink:href="cve-20221231.xsd#cve_Long-TermLeaseLiabilityLessCurrentLeaseLiability"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cve_Long-TermLeaseLiabilityLessCurrentLeaseLiability_lbl" xml:lang="en-US">Less: current lease liability</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_Long-TermLeaseLiabilityLessCurrentLeaseLiability" xlink:to="cve_Long-TermLeaseLiabilityLessCurrentLeaseLiability_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_LongtermProvisionForDecommissioningRestorationAndRehabilitationCosts" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_LongtermProvisionForDecommissioningRestorationAndRehabilitationCosts"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_LongtermProvisionForDecommissioningRestorationAndRehabilitationCosts_lbl" xml:lang="en-US">Balance (Long Term), December 31, 2022</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_LongtermProvisionForDecommissioningRestorationAndRehabilitationCosts" xlink:to="ifrs-full_LongtermProvisionForDecommissioningRestorationAndRehabilitationCosts_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_MaturityAnalysisForDerivativeFinancialLiabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_MaturityAnalysisForDerivativeFinancialLiabilities"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_MaturityAnalysisForDerivativeFinancialLiabilities_lbl" xml:lang="en-US">Schedule of undiscounted future lease payments</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_MaturityAnalysisForDerivativeFinancialLiabilities" xlink:to="ifrs-full_MaturityAnalysisForDerivativeFinancialLiabilities_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_Right-of-UseAssetsTwoZeroTwoThree" xlink:href="cve-20221231.xsd#cve_Right-of-UseAssetsTwoZeroTwoThree"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cve_Right-of-UseAssetsTwoZeroTwoThree_lbl" xml:lang="en-US">2023</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_Right-of-UseAssetsTwoZeroTwoThree" xlink:to="cve_Right-of-UseAssetsTwoZeroTwoThree_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_Right-of-UseAssetsTwoZeroTwoFive" xlink:href="cve-20221231.xsd#cve_Right-of-UseAssetsTwoZeroTwoFive"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cve_Right-of-UseAssetsTwoZeroTwoFive_lbl" xml:lang="en-US">2025</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_Right-of-UseAssetsTwoZeroTwoFive" xlink:to="cve_Right-of-UseAssetsTwoZeroTwoFive_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_NetInvestmentInFinanceLease" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_NetInvestmentInFinanceLease"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_NetInvestmentInFinanceLease_lbl" xml:lang="en-US">Total</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NetInvestmentInFinanceLease" xlink:to="ifrs-full_NetInvestmentInFinanceLease_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfTransactionsRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombinationExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_DisclosureOfTransactionsRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombinationExplanatory"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DisclosureOfTransactionsRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombinationExplanatory_lbl" xml:lang="en-US">Asset acquisition</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfTransactionsRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombinationExplanatory" xlink:to="ifrs-full_DisclosureOfTransactionsRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombinationExplanatory_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfFairValueMeasurementOfAssetsExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_DisclosureOfFairValueMeasurementOfAssetsExplanatory"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DisclosureOfFairValueMeasurementOfAssetsExplanatory_lbl" xml:lang="en-US">Schedule of estimated fair value of assets and liabilities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfFairValueMeasurementOfAssetsExplanatory" xlink:to="ifrs-full_DisclosureOfFairValueMeasurementOfAssetsExplanatory_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred_lbl" xml:lang="en-US">Fair value of share consideration</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred" xlink:to="ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred_lbl0" xml:lang="en-US">Total consideration (in Dollars)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred" xlink:to="ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred_lbl0"/>
    <loc xlink:type="locator" xlink:label="cve_FairValueOfReplacementOptions" xlink:href="cve-20221231.xsd#cve_FairValueOfReplacementOptions"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cve_FairValueOfReplacementOptions_lbl" xml:lang="en-US">Fair value of replacement options</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_FairValueOfReplacementOptions" xlink:to="cve_FairValueOfReplacementOptions_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_FairValueOfReplacementWarrants" xlink:href="cve-20221231.xsd#cve_FairValueOfReplacementWarrants"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cve_FairValueOfReplacementWarrants_lbl" xml:lang="en-US">Fair value of replacement warrants</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_FairValueOfReplacementWarrants" xlink:to="cve_FairValueOfReplacementWarrants_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_TransactionCosts" xlink:href="cve-20221231.xsd#cve_TransactionCosts"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cve_TransactionCosts_lbl" xml:lang="en-US">Transaction costs</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_TransactionCosts" xlink:to="cve_TransactionCosts_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="cve_TransactionCosts_lbl0" xml:lang="en-US">Transaction cost</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_TransactionCosts" xlink:to="cve_TransactionCosts_lbl0"/>
    <loc xlink:type="locator" xlink:label="cve_TotalConsiderationValue" xlink:href="cve-20221231.xsd#cve_TotalConsiderationValue"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cve_TotalConsiderationValue_lbl" xml:lang="en-US">Total consideration value</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_TotalConsiderationValue" xlink:to="cve_TotalConsiderationValue_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfRedesignatedFinancialAssetsAndLiabilitiesExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_DisclosureOfRedesignatedFinancialAssetsAndLiabilitiesExplanatory"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DisclosureOfRedesignatedFinancialAssetsAndLiabilitiesExplanatory_lbl" xml:lang="en-US">Schedule of net assets acquired</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfRedesignatedFinancialAssetsAndLiabilitiesExplanatory" xlink:to="ifrs-full_DisclosureOfRedesignatedFinancialAssetsAndLiabilitiesExplanatory_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_OtherCashAndCashEquivalents" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_OtherCashAndCashEquivalents"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_OtherCashAndCashEquivalents_lbl" xml:lang="en-US">Cash</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_OtherCashAndCashEquivalents" xlink:to="ifrs-full_OtherCashAndCashEquivalents_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_NoncurrentRestrictedCashAndCashEquivalents" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_NoncurrentRestrictedCashAndCashEquivalents"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_NoncurrentRestrictedCashAndCashEquivalents_lbl" xml:lang="en-US">Restricted cash</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NoncurrentRestrictedCashAndCashEquivalents" xlink:to="ifrs-full_NoncurrentRestrictedCashAndCashEquivalents_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_Prepayments" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_Prepayments"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_Prepayments_lbl" xml:lang="en-US">Prepaids</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_Prepayments" xlink:to="ifrs-full_Prepayments_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate_lbl" xml:lang="en-US">Property, plant, and equipment</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate" xlink:to="ifrs-full_PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_RightofuseAssetsThatDoNotMeetDefinitionOfInvestmentProperty" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_RightofuseAssetsThatDoNotMeetDefinitionOfInvestmentProperty"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_RightofuseAssetsThatDoNotMeetDefinitionOfInvestmentProperty_lbl" xml:lang="en-US">Right-of-use asset</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_RightofuseAssetsThatDoNotMeetDefinitionOfInvestmentProperty" xlink:to="ifrs-full_RightofuseAssetsThatDoNotMeetDefinitionOfInvestmentProperty_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AssetsArisingFromExplorationForAndEvaluationOfMineralResources" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_AssetsArisingFromExplorationForAndEvaluationOfMineralResources"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_AssetsArisingFromExplorationForAndEvaluationOfMineralResources_lbl" xml:lang="en-US">Mineral properties</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AssetsArisingFromExplorationForAndEvaluationOfMineralResources" xlink:to="ifrs-full_AssetsArisingFromExplorationForAndEvaluationOfMineralResources_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_AssetRetirementObligations" xlink:href="cve-20221231.xsd#cve_AssetRetirementObligations"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cve_AssetRetirementObligations_lbl" xml:lang="en-US">Asset retirement obligations</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_AssetRetirementObligations" xlink:to="cve_AssetRetirementObligations_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_LoansAndReceivables" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_LoansAndReceivables"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_LoansAndReceivables_lbl" xml:lang="en-US">Loan receivable</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_LoansAndReceivables" xlink:to="ifrs-full_LoansAndReceivables_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_AccountsPayableAndAccruedLiability" xlink:href="cve-20221231.xsd#cve_AccountsPayableAndAccruedLiability"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cve_AccountsPayableAndAccruedLiability_lbl" xml:lang="en-US">Accounts payable and accrued liabilities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_AccountsPayableAndAccruedLiability" xlink:to="cve_AccountsPayableAndAccruedLiability_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_IdentifiableAssetsAcquiredLiabilitiesAssumed" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_IdentifiableAssetsAcquiredLiabilitiesAssumed"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_IdentifiableAssetsAcquiredLiabilitiesAssumed_lbl" xml:lang="en-US">Total net assets acquired</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_IdentifiableAssetsAcquiredLiabilitiesAssumed" xlink:to="ifrs-full_IdentifiableAssetsAcquiredLiabilitiesAssumed_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfIndirectMeasurementOfFairValueOfGoodsOrServicesReceivedShareOptionsGrantedDuringPeriodExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_DisclosureOfIndirectMeasurementOfFairValueOfGoodsOrServicesReceivedShareOptionsGrantedDuringPeriodExplanatory"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DisclosureOfIndirectMeasurementOfFairValueOfGoodsOrServicesReceivedShareOptionsGrantedDuringPeriodExplanatory_lbl" xml:lang="en-US">Schedule of weighted average assumptions used in the black-scholes option</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfIndirectMeasurementOfFairValueOfGoodsOrServicesReceivedShareOptionsGrantedDuringPeriodExplanatory" xlink:to="ifrs-full_DisclosureOfIndirectMeasurementOfFairValueOfGoodsOrServicesReceivedShareOptionsGrantedDuringPeriodExplanatory_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ExercisePriceShareOptionsGranted2019" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_ExercisePriceShareOptionsGranted2019"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_ExercisePriceShareOptionsGranted2019_lbl" xml:lang="en-US">Exercise price</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ExercisePriceShareOptionsGranted2019" xlink:to="ifrs-full_ExercisePriceShareOptionsGranted2019_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_ExercisePriceShareOptionsGranted2019_lbl0" xml:lang="en-US">Options Exercisable, Weighted average exercise price</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ExercisePriceShareOptionsGranted2019" xlink:to="ifrs-full_ExercisePriceShareOptionsGranted2019_lbl0"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_WeightedAverageSharePriceShareOptionsGranted2019" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_WeightedAverageSharePriceShareOptionsGranted2019"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_WeightedAverageSharePriceShareOptionsGranted2019_lbl" xml:lang="en-US">Share price</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_WeightedAverageSharePriceShareOptionsGranted2019" xlink:to="ifrs-full_WeightedAverageSharePriceShareOptionsGranted2019_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ActuarialAssumptionOfDiscountRates" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_ActuarialAssumptionOfDiscountRates"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_ActuarialAssumptionOfDiscountRates_lbl" xml:lang="en-US">Discount rate</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ActuarialAssumptionOfDiscountRates" xlink:to="ifrs-full_ActuarialAssumptionOfDiscountRates_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019_lbl" xml:lang="en-US">Expected life (years)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019" xlink:to="ifrs-full_WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019_lbl0" xml:lang="en-US">Expected life of option</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019" xlink:to="ifrs-full_WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019_lbl0"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DescriptionOfExpectedVolatilityShareOptionsGranted" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_DescriptionOfExpectedVolatilityShareOptionsGranted"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DescriptionOfExpectedVolatilityShareOptionsGranted_lbl" xml:lang="en-US">Volatility</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DescriptionOfExpectedVolatilityShareOptionsGranted" xlink:to="ifrs-full_DescriptionOfExpectedVolatilityShareOptionsGranted_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_DescriptionOfExpectedVolatilityShareOptionsGranted_lbl0" xml:lang="en-US">Expected stock price volatility</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DescriptionOfExpectedVolatilityShareOptionsGranted" xlink:to="ifrs-full_DescriptionOfExpectedVolatilityShareOptionsGranted_lbl0"/>
    <loc xlink:type="locator" xlink:label="cve_FairValueOfReplacement" xlink:href="cve-20221231.xsd#cve_FairValueOfReplacement"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cve_FairValueOfReplacement_lbl" xml:lang="en-US">Fair value of replacement</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_FairValueOfReplacement" xlink:to="cve_FairValueOfReplacement_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_DisclosureOfMineralProperties" xlink:href="cve-20221231.xsd#cve_DisclosureOfMineralProperties"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cve_DisclosureOfMineralProperties_lbl" xml:lang="en-US">Mineral properties</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_DisclosureOfMineralProperties" xlink:to="cve_DisclosureOfMineralProperties_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_ScheduleOfMineralProperties" xlink:href="cve-20221231.xsd#cve_ScheduleOfMineralProperties"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cve_ScheduleOfMineralProperties_lbl" xml:lang="en-US">Schedule of mineral properties</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_ScheduleOfMineralProperties" xlink:to="cve_ScheduleOfMineralProperties_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_AcquisitionCostsAbstract" xlink:href="cve-20221231.xsd#cve_AcquisitionCostsAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cve_AcquisitionCostsAbstract_lbl" xml:lang="en-US">Acquisition costs:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_AcquisitionCostsAbstract" xlink:to="cve_AcquisitionCostsAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_AssetAcquistion" xlink:href="cve-20221231.xsd#cve_AssetAcquistion"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cve_AssetAcquistion_lbl" xml:lang="en-US">Asset acquisition (Note 10)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_AssetAcquistion" xlink:to="cve_AssetAcquistion_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_ExplorationCostsAbstract" xlink:href="cve-20221231.xsd#cve_ExplorationCostsAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cve_ExplorationCostsAbstract_lbl" xml:lang="en-US">Exploration costs:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_ExplorationCostsAbstract" xlink:to="cve_ExplorationCostsAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_MaintenancesAndLeaseFees" xlink:href="cve-20221231.xsd#cve_MaintenancesAndLeaseFees"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cve_MaintenancesAndLeaseFees_lbl" xml:lang="en-US">Maintenance and lease fees</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_MaintenancesAndLeaseFees" xlink:to="cve_MaintenancesAndLeaseFees_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_ResourceReview" xlink:href="cve-20221231.xsd#cve_ResourceReview"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cve_ResourceReview_lbl" xml:lang="en-US">Resource review</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_ResourceReview" xlink:to="cve_ResourceReview_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_DivestmentAbstract" xlink:href="cve-20221231.xsd#cve_DivestmentAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cve_DivestmentAbstract_lbl" xml:lang="en-US">Divestment:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_DivestmentAbstract" xlink:to="cve_DivestmentAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_ExplorationCostsAbstract0" xlink:href="cve-20221231.xsd#cve_ExplorationCostsAbstract0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cve_ExplorationCostsAbstract0_lbl" xml:lang="en-US">Exploration costs:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_ExplorationCostsAbstract0" xlink:to="cve_ExplorationCostsAbstract0_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_Drilling" xlink:href="cve-20221231.xsd#cve_Drilling"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cve_Drilling_lbl" xml:lang="en-US">Drilling</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_Drilling" xlink:to="cve_Drilling_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_PermittingLicensing" xlink:href="cve-20221231.xsd#cve_PermittingLicensing"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cve_PermittingLicensing_lbl" xml:lang="en-US">Permitting &amp; Licensing</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_PermittingLicensing" xlink:to="cve_PermittingLicensing_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_Personnel" xlink:href="cve-20221231.xsd#cve_Personnel"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cve_Personnel_lbl" xml:lang="en-US">Personnel</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_Personnel" xlink:to="cve_Personnel_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_Recoveries" xlink:href="cve-20221231.xsd#cve_Recoveries"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cve_Recoveries_lbl" xml:lang="en-US">Recoveries</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_Recoveries" xlink:to="cve_Recoveries_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_DivestmentAbstract0" xlink:href="cve-20221231.xsd#cve_DivestmentAbstract0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cve_DivestmentAbstract0_lbl" xml:lang="en-US">Divestment:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_DivestmentAbstract0" xlink:to="cve_DivestmentAbstract0_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_ProjectDevelopmentCostsAbstract" xlink:href="cve-20221231.xsd#cve_ProjectDevelopmentCostsAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cve_ProjectDevelopmentCostsAbstract_lbl" xml:lang="en-US">Project Development costs:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_ProjectDevelopmentCostsAbstract" xlink:to="cve_ProjectDevelopmentCostsAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_ConstructionOfWellfields" xlink:href="cve-20221231.xsd#cve_ConstructionOfWellfields"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cve_ConstructionOfWellfields_lbl" xml:lang="en-US">Construction of wellfields</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_ConstructionOfWellfields" xlink:to="cve_ConstructionOfWellfields_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_AssetRetirementObligationsTextBlock" xlink:href="cve-20221231.xsd#cve_AssetRetirementObligationsTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cve_AssetRetirementObligationsTextBlock_lbl" xml:lang="en-US">Asset retirement obligations</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_AssetRetirementObligationsTextBlock" xlink:to="cve_AssetRetirementObligationsTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_DisclosureOfAssetRetirementObligationsBalanceTableTextBlock" xlink:href="cve-20221231.xsd#cve_DisclosureOfAssetRetirementObligationsBalanceTableTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cve_DisclosureOfAssetRetirementObligationsBalanceTableTextBlock_lbl" xml:lang="en-US">Schedule of asset retirement obligations balance</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_DisclosureOfAssetRetirementObligationsBalanceTableTextBlock" xlink:to="cve_DisclosureOfAssetRetirementObligationsBalanceTableTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_FinancialAssets" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_FinancialAssets"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_FinancialAssets_lbl" xml:lang="en-US">Asset retirement obligations</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_FinancialAssets" xlink:to="ifrs-full_FinancialAssets_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_DisclosureOfAssetRetirementObligationsContinuityTableTextBlock" xlink:href="cve-20221231.xsd#cve_DisclosureOfAssetRetirementObligationsContinuityTableTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cve_DisclosureOfAssetRetirementObligationsContinuityTableTextBlock_lbl" xml:lang="en-US">Schedule of asset retirement obligations continuity</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_DisclosureOfAssetRetirementObligationsContinuityTableTextBlock" xlink:to="cve_DisclosureOfAssetRetirementObligationsContinuityTableTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_UnlabeledAbstract20" xlink:href="cve-20221231.xsd#cve_UnlabeledAbstract20"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cve_UnlabeledAbstract20_lbl" xml:lang="en-US"></label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_UnlabeledAbstract20" xlink:to="cve_UnlabeledAbstract20_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_AssetRetirementObligationsAccretion" xlink:href="cve-20221231.xsd#cve_AssetRetirementObligationsAccretion"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cve_AssetRetirementObligationsAccretion_lbl" xml:lang="en-US">Accretion</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_AssetRetirementObligationsAccretion" xlink:to="cve_AssetRetirementObligationsAccretion_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_AssetRetirementObligationsAdjustments" xlink:href="cve-20221231.xsd#cve_AssetRetirementObligationsAdjustments"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cve_AssetRetirementObligationsAdjustments_lbl" xml:lang="en-US">Adjustments</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_AssetRetirementObligationsAdjustments" xlink:to="cve_AssetRetirementObligationsAdjustments_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_AssetRetirementObligationsSettlement" xlink:href="cve-20221231.xsd#cve_AssetRetirementObligationsSettlement"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cve_AssetRetirementObligationsSettlement_lbl" xml:lang="en-US">Settlement</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_AssetRetirementObligationsSettlement" xlink:to="cve_AssetRetirementObligationsSettlement_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_AssetRetirementObligationsAdditionsFromAzargaAssetAcquisitionNote10" xlink:href="cve-20221231.xsd#cve_AssetRetirementObligationsAdditionsFromAzargaAssetAcquisitionNote10"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cve_AssetRetirementObligationsAdditionsFromAzargaAssetAcquisitionNote10_lbl" xml:lang="en-US">Additions from Azarga asset acquisition (Note 10)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_AssetRetirementObligationsAdditionsFromAzargaAssetAcquisitionNote10" xlink:to="cve_AssetRetirementObligationsAdditionsFromAzargaAssetAcquisitionNote10_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_UnlabeledAbstract21" xlink:href="cve-20221231.xsd#cve_UnlabeledAbstract21"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cve_UnlabeledAbstract21_lbl" xml:lang="en-US"></label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_UnlabeledAbstract21" xlink:to="cve_UnlabeledAbstract21_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_DisclosueOfSalesContractsTextBlock" xlink:href="cve-20221231.xsd#cve_DisclosueOfSalesContractsTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cve_DisclosueOfSalesContractsTextBlock_lbl" xml:lang="en-US">Sales contracts</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_DisclosueOfSalesContractsTextBlock" xlink:to="cve_DisclosueOfSalesContractsTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfMaturityAnalysisForFinancialAssetsHeldForManagingLiquidityRiskExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_DisclosureOfMaturityAnalysisForFinancialAssetsHeldForManagingLiquidityRiskExplanatory"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DisclosureOfMaturityAnalysisForFinancialAssetsHeldForManagingLiquidityRiskExplanatory_lbl" xml:lang="en-US">Schedule of uranium sales contracts over the next five years</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfMaturityAnalysisForFinancialAssetsHeldForManagingLiquidityRiskExplanatory" xlink:to="ifrs-full_DisclosureOfMaturityAnalysisForFinancialAssetsHeldForManagingLiquidityRiskExplanatory_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_SalesCommitmentsInPoundsAbstract" xlink:href="cve-20221231.xsd#cve_SalesCommitmentsInPoundsAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cve_SalesCommitmentsInPoundsAbstract_lbl" xml:lang="en-US">Sales Commitments in Pounds</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_SalesCommitmentsInPoundsAbstract" xlink:to="cve_SalesCommitmentsInPoundsAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_SalesContractsFiscalTwoZeroTwoThree" xlink:href="cve-20221231.xsd#cve_SalesContractsFiscalTwoZeroTwoThree"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cve_SalesContractsFiscalTwoZeroTwoThree_lbl" xml:lang="en-US">Fiscal 2023</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_SalesContractsFiscalTwoZeroTwoThree" xlink:to="cve_SalesContractsFiscalTwoZeroTwoThree_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_SalesContractsFiscalTwoZeroTwoFour" xlink:href="cve-20221231.xsd#cve_SalesContractsFiscalTwoZeroTwoFour"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cve_SalesContractsFiscalTwoZeroTwoFour_lbl" xml:lang="en-US">Fiscal 2024</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_SalesContractsFiscalTwoZeroTwoFour" xlink:to="cve_SalesContractsFiscalTwoZeroTwoFour_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_SalesContractsFiscalTwoZeroTwoFive" xlink:href="cve-20221231.xsd#cve_SalesContractsFiscalTwoZeroTwoFive"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cve_SalesContractsFiscalTwoZeroTwoFive_lbl" xml:lang="en-US">Fiscal 2025</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_SalesContractsFiscalTwoZeroTwoFive" xlink:to="cve_SalesContractsFiscalTwoZeroTwoFive_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_SalesContractsFiscalTwoZeroTwoSix" xlink:href="cve-20221231.xsd#cve_SalesContractsFiscalTwoZeroTwoSix"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cve_SalesContractsFiscalTwoZeroTwoSix_lbl" xml:lang="en-US">Fiscal 2026</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_SalesContractsFiscalTwoZeroTwoSix" xlink:to="cve_SalesContractsFiscalTwoZeroTwoSix_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_SalesContractsFiscalTwoZeroTwoSeven" xlink:href="cve-20221231.xsd#cve_SalesContractsFiscalTwoZeroTwoSeven"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cve_SalesContractsFiscalTwoZeroTwoSeven_lbl" xml:lang="en-US">Fiscal 2027</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_SalesContractsFiscalTwoZeroTwoSeven" xlink:to="cve_SalesContractsFiscalTwoZeroTwoSeven_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfClassesOfShareCapitalExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_DisclosureOfClassesOfShareCapitalExplanatory"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DisclosureOfClassesOfShareCapitalExplanatory_lbl" xml:lang="en-US">Share capital</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfClassesOfShareCapitalExplanatory" xlink:to="ifrs-full_DisclosureOfClassesOfShareCapitalExplanatory_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_ScheduleOfTheCompanysStockOptionsOutstandingTableTextBlock" xlink:href="cve-20221231.xsd#cve_ScheduleOfTheCompanysStockOptionsOutstandingTableTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cve_ScheduleOfTheCompanysStockOptionsOutstandingTableTextBlock_lbl" xml:lang="en-US">Schedule of the company&#8217;s stock options outstanding</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_ScheduleOfTheCompanysStockOptionsOutstandingTableTextBlock" xlink:to="cve_ScheduleOfTheCompanysStockOptionsOutstandingTableTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_SharesBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:href="cve-20221231.xsd#cve_SharesBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cve_SharesBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_lbl" xml:lang="en-US">Options, Granted</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_SharesBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:to="cve_SharesBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019_lbl" xml:lang="en-US">Weighted average exercise price, Granted</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019" xlink:to="ifrs-full_WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_StockIssuedDuringPeriodShareStockOptionsExercised" xlink:href="cve-20221231.xsd#cve_StockIssuedDuringPeriodShareStockOptionsExercised"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cve_StockIssuedDuringPeriodShareStockOptionsExercised_lbl" xml:lang="en-US">Options, Exercised</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_StockIssuedDuringPeriodShareStockOptionsExercised" xlink:to="cve_StockIssuedDuringPeriodShareStockOptionsExercised_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019_lbl" xml:lang="en-US">Weighted average exercise price, Exercised</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019" xlink:to="ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_StockIssuedDuringPeriodShareSharesBasedCompensationForfeited" xlink:href="cve-20221231.xsd#cve_StockIssuedDuringPeriodShareSharesBasedCompensationForfeited"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cve_StockIssuedDuringPeriodShareSharesBasedCompensationForfeited_lbl" xml:lang="en-US">Options, Forfeited/expired</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_StockIssuedDuringPeriodShareSharesBasedCompensationForfeited" xlink:to="cve_StockIssuedDuringPeriodShareSharesBasedCompensationForfeited_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019_lbl" xml:lang="en-US">Weighted average exercise price, Forfeited/expired</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019" xlink:to="ifrs-full_WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_SharesBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions" xlink:href="cve-20221231.xsd#cve_SharesBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cve_SharesBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions_lbl" xml:lang="en-US">Options, Options exercisable, end of year</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_SharesBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions" xlink:to="cve_SharesBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019_lbl" xml:lang="en-US">Weighted average exercise price, Options exercisable, end of year</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019" xlink:to="ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_ScheduleOfStockOptionsOutstandingTableTextBlock" xlink:href="cve-20221231.xsd#cve_ScheduleOfStockOptionsOutstandingTableTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cve_ScheduleOfStockOptionsOutstandingTableTextBlock_lbl" xml:lang="en-US">Schedule of stock options outstanding</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_ScheduleOfStockOptionsOutstandingTableTextBlock" xlink:to="cve_ScheduleOfStockOptionsOutstandingTableTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_SharesBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:href="cve-20221231.xsd#cve_SharesBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cve_SharesBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_lbl" xml:lang="en-US">Options</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_SharesBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:to="cve_SharesBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_WeightedAverageDurationOfDefinedBenefitObligation2019" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_WeightedAverageDurationOfDefinedBenefitObligation2019"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_WeightedAverageDurationOfDefinedBenefitObligation2019_lbl" xml:lang="en-US">Options Outstanding, Weighted average Reimaining Life</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_WeightedAverageDurationOfDefinedBenefitObligation2019" xlink:to="ifrs-full_WeightedAverageDurationOfDefinedBenefitObligation2019_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ExercisePriceOfOutstandingShareOptions2019" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_ExercisePriceOfOutstandingShareOptions2019"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_ExercisePriceOfOutstandingShareOptions2019_lbl" xml:lang="en-US">Options Outstanding, Weighted average exercise price</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ExercisePriceOfOutstandingShareOptions2019" xlink:to="ifrs-full_ExercisePriceOfOutstandingShareOptions2019_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_SharesBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber" xlink:href="cve-20221231.xsd#cve_SharesBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cve_SharesBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber_lbl" xml:lang="en-US">Options Exercisable, Options</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_SharesBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber" xlink:to="cve_SharesBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_ScheduleOfWeightedAverageAssumptionsUsedInCalculatingTheFairValuesTableTextBlock" xlink:href="cve-20221231.xsd#cve_ScheduleOfWeightedAverageAssumptionsUsedInCalculatingTheFairValuesTableTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cve_ScheduleOfWeightedAverageAssumptionsUsedInCalculatingTheFairValuesTableTextBlock_lbl" xml:lang="en-US">Schedule of weighted average assumptions used in calculating the fair values</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_ScheduleOfWeightedAverageAssumptionsUsedInCalculatingTheFairValuesTableTextBlock" xlink:to="cve_ScheduleOfWeightedAverageAssumptionsUsedInCalculatingTheFairValuesTableTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DescriptionOfRiskFreeInterestRateShareOptionsGranted" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_DescriptionOfRiskFreeInterestRateShareOptionsGranted"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DescriptionOfRiskFreeInterestRateShareOptionsGranted_lbl" xml:lang="en-US">Risk-free interest rate</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DescriptionOfRiskFreeInterestRateShareOptionsGranted" xlink:to="ifrs-full_DescriptionOfRiskFreeInterestRateShareOptionsGranted_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ExpectedDividendAsPercentageShareOptionsGranted" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_ExpectedDividendAsPercentageShareOptionsGranted"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_ExpectedDividendAsPercentageShareOptionsGranted_lbl" xml:lang="en-US">Expected dividend yield</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ExpectedDividendAsPercentageShareOptionsGranted" xlink:to="ifrs-full_ExpectedDividendAsPercentageShareOptionsGranted_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_ScheduleOfTheStatusOfTheCompanysWarrantsTableTextBlock" xlink:href="cve-20221231.xsd#cve_ScheduleOfTheStatusOfTheCompanysWarrantsTableTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cve_ScheduleOfTheStatusOfTheCompanysWarrantsTableTextBlock_lbl" xml:lang="en-US">Schedule of the status of the company&#8217;s warrants</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_ScheduleOfTheStatusOfTheCompanysWarrantsTableTextBlock" xlink:to="cve_ScheduleOfTheStatusOfTheCompanysWarrantsTableTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_ShareBasedCompensationArrangementBySharesBasedPaymentAwardOptionsGrantsInPeriodWarrantsGranted" xlink:href="cve-20221231.xsd#cve_ShareBasedCompensationArrangementBySharesBasedPaymentAwardOptionsGrantsInPeriodWarrantsGranted"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cve_ShareBasedCompensationArrangementBySharesBasedPaymentAwardOptionsGrantsInPeriodWarrantsGranted_lbl" xml:lang="en-US">Warrants, Granted</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_ShareBasedCompensationArrangementBySharesBasedPaymentAwardOptionsGrantsInPeriodWarrantsGranted" xlink:to="cve_ShareBasedCompensationArrangementBySharesBasedPaymentAwardOptionsGrantsInPeriodWarrantsGranted_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_SharesbasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue" xlink:href="cve-20221231.xsd#cve_SharesbasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cve_SharesbasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue_lbl" xml:lang="en-US">Weighted average exercise price, Granted</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_SharesbasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue" xlink:to="cve_SharesbasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisedWarrantsExercised" xlink:href="cve-20221231.xsd#cve_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisedWarrantsExercised"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cve_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisedWarrantsExercised_lbl" xml:lang="en-US">Warrants, Exercised</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisedWarrantsExercised" xlink:to="cve_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisedWarrantsExercised_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_SharesBasedCompensationArrangementBySharesBasedPaymentAwardOptionsOutstandingPeriodIncreaseDecreaseWeightedAverageExercisePrice" xlink:href="cve-20221231.xsd#cve_SharesBasedCompensationArrangementBySharesBasedPaymentAwardOptionsOutstandingPeriodIncreaseDecreaseWeightedAverageExercisePrice"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cve_SharesBasedCompensationArrangementBySharesBasedPaymentAwardOptionsOutstandingPeriodIncreaseDecreaseWeightedAverageExercisePrice_lbl" xml:lang="en-US">Weighted average exercise price, Exercised</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_SharesBasedCompensationArrangementBySharesBasedPaymentAwardOptionsOutstandingPeriodIncreaseDecreaseWeightedAverageExercisePrice" xlink:to="cve_SharesBasedCompensationArrangementBySharesBasedPaymentAwardOptionsOutstandingPeriodIncreaseDecreaseWeightedAverageExercisePrice_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWarrantsExpired" xlink:href="cve-20221231.xsd#cve_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWarrantsExpired"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cve_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWarrantsExpired_lbl" xml:lang="en-US">Warrants, Expired</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWarrantsExpired" xlink:to="cve_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWarrantsExpired_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_ShareBasedCompensationArrangementsBySharesBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" xlink:href="cve-20221231.xsd#cve_ShareBasedCompensationArrangementsBySharesBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cve_ShareBasedCompensationArrangementsBySharesBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_lbl" xml:lang="en-US">Weighted average exercise price, Expired</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_ShareBasedCompensationArrangementsBySharesBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" xlink:to="cve_ShareBasedCompensationArrangementsBySharesBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_ScheduleOfSharePurchaseWarrantsOutstandingTableTextBlock" xlink:href="cve-20221231.xsd#cve_ScheduleOfSharePurchaseWarrantsOutstandingTableTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cve_ScheduleOfSharePurchaseWarrantsOutstandingTableTextBlock_lbl" xml:lang="en-US">Schedule of share purchase warrants outstanding</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_ScheduleOfSharePurchaseWarrantsOutstandingTableTextBlock" xlink:to="cve_ScheduleOfSharePurchaseWarrantsOutstandingTableTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_Warrants" xlink:href="cve-20221231.xsd#cve_Warrants"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cve_Warrants_lbl" xml:lang="en-US">Warrants</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_Warrants" xlink:to="cve_Warrants_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_WarrantsOutstandingWeightedAverageReimainingLife" xlink:href="cve-20221231.xsd#cve_WarrantsOutstandingWeightedAverageReimainingLife"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cve_WarrantsOutstandingWeightedAverageReimainingLife_lbl" xml:lang="en-US">Warrants Outstanding, Weighted average Reimaining Life</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_WarrantsOutstandingWeightedAverageReimainingLife" xlink:to="cve_WarrantsOutstandingWeightedAverageReimainingLife_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_WarrantsOutstandingWeightedAverageExercisePrice" xlink:href="cve-20221231.xsd#cve_WarrantsOutstandingWeightedAverageExercisePrice"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cve_WarrantsOutstandingWeightedAverageExercisePrice_lbl" xml:lang="en-US">Warrants Outstanding, Weighted average exercise price</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_WarrantsOutstandingWeightedAverageExercisePrice" xlink:to="cve_WarrantsOutstandingWeightedAverageExercisePrice_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfRelatedPartyExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_DisclosureOfRelatedPartyExplanatory"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DisclosureOfRelatedPartyExplanatory_lbl" xml:lang="en-US">Related party transactions and balances</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfRelatedPartyExplanatory" xlink:to="ifrs-full_DisclosureOfRelatedPartyExplanatory_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfGeneralAndAdministrativeExpenseExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_DisclosureOfGeneralAndAdministrativeExpenseExplanatory"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DisclosureOfGeneralAndAdministrativeExpenseExplanatory_lbl" xml:lang="en-US">Schedule of amounts paid to key management or entities providing similar services</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfGeneralAndAdministrativeExpenseExplanatory" xlink:to="ifrs-full_DisclosureOfGeneralAndAdministrativeExpenseExplanatory_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_RevenueFromRenderingOfInformationTechnologyConsultingServices" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_RevenueFromRenderingOfInformationTechnologyConsultingServices"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_RevenueFromRenderingOfInformationTechnologyConsultingServices_lbl" xml:lang="en-US">Consulting</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_RevenueFromRenderingOfInformationTechnologyConsultingServices" xlink:to="ifrs-full_RevenueFromRenderingOfInformationTechnologyConsultingServices_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill_lbl" xml:lang="en-US">Data acquisition</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill" xlink:to="ifrs-full_AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DirectorsRemunerationExpense" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_DirectorsRemunerationExpense"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DirectorsRemunerationExpense_lbl" xml:lang="en-US">Directors&#8217; fees</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DirectorsRemunerationExpense" xlink:to="ifrs-full_DirectorsRemunerationExpense_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_OfficeAndAdministration" xlink:href="cve-20221231.xsd#cve_OfficeAndAdministration"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cve_OfficeAndAdministration_lbl" xml:lang="en-US">Office and administration</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_OfficeAndAdministration" xlink:to="cve_OfficeAndAdministration_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_StaffCosts" xlink:href="cve-20221231.xsd#cve_StaffCosts"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cve_StaffCosts_lbl" xml:lang="en-US">Staff costs</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_StaffCosts" xlink:to="cve_StaffCosts_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockOptionPlanExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockOptionPlanExpense"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_StockOptionPlanExpense_lbl" xml:lang="en-US">Stock option expense</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockOptionPlanExpense" xlink:to="us-gaap_StockOptionPlanExpense_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_KeyManagementPersonnelCompensation" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_KeyManagementPersonnelCompensation"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_KeyManagementPersonnelCompensation_lbl" xml:lang="en-US">Total key management compensation</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_KeyManagementPersonnelCompensation" xlink:to="ifrs-full_KeyManagementPersonnelCompensation_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesExplanatory"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesExplanatory_lbl" xml:lang="en-US">Schedule of owing to related parties</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesExplanatory" xlink:to="ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesExplanatory_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AmountsPayableRelatedPartyTransactions" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_AmountsPayableRelatedPartyTransactions"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_AmountsPayableRelatedPartyTransactions_lbl" xml:lang="en-US">Total related party transactions</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AmountsPayableRelatedPartyTransactions" xlink:to="ifrs-full_AmountsPayableRelatedPartyTransactions_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DescriptionOfManagingLiquidityRisk" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_DescriptionOfManagingLiquidityRisk"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DescriptionOfManagingLiquidityRisk_lbl" xml:lang="en-US">Management of capital</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DescriptionOfManagingLiquidityRisk" xlink:to="ifrs-full_DescriptionOfManagingLiquidityRisk_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfFinancialInstrumentsExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_DisclosureOfFinancialInstrumentsExplanatory"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DisclosureOfFinancialInstrumentsExplanatory_lbl" xml:lang="en-US">Schedule of financial instrument</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfFinancialInstrumentsExplanatory" xlink:to="ifrs-full_DisclosureOfFinancialInstrumentsExplanatory_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_ScheduleOfFinancialInstrumentTableTextBlock" xlink:href="cve-20221231.xsd#cve_ScheduleOfFinancialInstrumentTableTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cve_ScheduleOfFinancialInstrumentTableTextBlock_lbl" xml:lang="en-US">Schedule of foreign currency exposures</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_ScheduleOfFinancialInstrumentTableTextBlock" xlink:to="cve_ScheduleOfFinancialInstrumentTableTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_Cash" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_Cash"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_Cash_lbl" xml:lang="en-US">Cash</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_Cash" xlink:to="ifrs-full_Cash_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_MarketableSecurities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MarketableSecurities"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_MarketableSecurities_lbl" xml:lang="en-US">Marketable Securities - Current</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MarketableSecurities" xlink:to="us-gaap_MarketableSecurities_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfEntitysReportableSegmentsExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_DisclosureOfEntitysReportableSegmentsExplanatory"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DisclosureOfEntitysReportableSegmentsExplanatory_lbl" xml:lang="en-US">Segmented information</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfEntitysReportableSegmentsExplanatory" xlink:to="ifrs-full_DisclosureOfEntitysReportableSegmentsExplanatory_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_DisclosureOfLongtermAssetsByGeographicSegmentTableTextBlock" xlink:href="cve-20221231.xsd#cve_DisclosureOfLongtermAssetsByGeographicSegmentTableTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cve_DisclosureOfLongtermAssetsByGeographicSegmentTableTextBlock_lbl" xml:lang="en-US">Schedule of long-term assets by geographic segment</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_DisclosureOfLongtermAssetsByGeographicSegmentTableTextBlock" xlink:to="cve_DisclosureOfLongtermAssetsByGeographicSegmentTableTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_IntangibleAssets" xlink:href="cve-20221231.xsd#cve_IntangibleAssets"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cve_IntangibleAssets_lbl" xml:lang="en-US">Intangible assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_IntangibleAssets" xlink:to="cve_IntangibleAssets_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_PropertyPlantAndEquipments" xlink:href="cve-20221231.xsd#cve_PropertyPlantAndEquipments"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cve_PropertyPlantAndEquipments_lbl" xml:lang="en-US">Property, plant and equipment</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_PropertyPlantAndEquipments" xlink:to="cve_PropertyPlantAndEquipments_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_MineralProperties" xlink:href="cve-20221231.xsd#cve_MineralProperties"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cve_MineralProperties_lbl" xml:lang="en-US">Mineral properties</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_MineralProperties" xlink:to="cve_MineralProperties_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_RightofuseAssets1" xlink:href="cve-20221231.xsd#cve_RightofuseAssets1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cve_RightofuseAssets1_lbl" xml:lang="en-US">Right-of-use assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_RightofuseAssets1" xlink:to="cve_RightofuseAssets1_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_SegmentedInformationBalance" xlink:href="cve-20221231.xsd#cve_SegmentedInformationBalance"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cve_SegmentedInformationBalance_lbl" xml:lang="en-US">Balance</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_SegmentedInformationBalance" xlink:to="cve_SegmentedInformationBalance_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_UnlabeledAbstract22" xlink:href="cve-20221231.xsd#cve_UnlabeledAbstract22"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cve_UnlabeledAbstract22_lbl" xml:lang="en-US"></label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_UnlabeledAbstract22" xlink:to="cve_UnlabeledAbstract22_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_SupplementalDisclosureWithRespectToCashflowsTextBlock" xlink:href="cve-20221231.xsd#cve_SupplementalDisclosureWithRespectToCashflowsTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cve_SupplementalDisclosureWithRespectToCashflowsTextBlock_lbl" xml:lang="en-US">Supplemental disclosure with respect to cash flows</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_SupplementalDisclosureWithRespectToCashflowsTextBlock" xlink:to="cve_SupplementalDisclosureWithRespectToCashflowsTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_ScheduleOfIncurredNoncashFinancingAndInvestingActivitiesTableTextBlock" xlink:href="cve-20221231.xsd#cve_ScheduleOfIncurredNoncashFinancingAndInvestingActivitiesTableTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cve_ScheduleOfIncurredNoncashFinancingAndInvestingActivitiesTableTextBlock_lbl" xml:lang="en-US">Schedule of incurred non-cash financing and investing activities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_ScheduleOfIncurredNoncashFinancingAndInvestingActivitiesTableTextBlock" xlink:to="cve_ScheduleOfIncurredNoncashFinancingAndInvestingActivitiesTableTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_NonCashFinancingActivitiesAbstract" xlink:href="cve-20221231.xsd#cve_NonCashFinancingActivitiesAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cve_NonCashFinancingActivitiesAbstract_lbl" xml:lang="en-US">Non-cash financing activities:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_NonCashFinancingActivitiesAbstract" xlink:to="cve_NonCashFinancingActivitiesAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CurrentAccruedExpensesAndOtherCurrentLiabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_CurrentAccruedExpensesAndOtherCurrentLiabilities"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_CurrentAccruedExpensesAndOtherCurrentLiabilities_lbl" xml:lang="en-US">Deferred financing costs remaining in accounts payable and accrued liabilities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CurrentAccruedExpensesAndOtherCurrentLiabilities" xlink:to="ifrs-full_CurrentAccruedExpensesAndOtherCurrentLiabilities_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_UnlabeledAbstract23" xlink:href="cve-20221231.xsd#cve_UnlabeledAbstract23"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cve_UnlabeledAbstract23_lbl" xml:lang="en-US"></label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_UnlabeledAbstract23" xlink:to="cve_UnlabeledAbstract23_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_NonCashInvestingActivitiesAbstract" xlink:href="cve-20221231.xsd#cve_NonCashInvestingActivitiesAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cve_NonCashInvestingActivitiesAbstract_lbl" xml:lang="en-US">Non-cash investing activities:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_NonCashInvestingActivitiesAbstract" xlink:to="cve_NonCashInvestingActivitiesAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_MarketableSecuritieReceivedOnDispositionOfMineralProperties" xlink:href="cve-20221231.xsd#cve_MarketableSecuritieReceivedOnDispositionOfMineralProperties"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cve_MarketableSecuritieReceivedOnDispositionOfMineralProperties_lbl" xml:lang="en-US">Marketable securities received on disposition of mineral properties</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_MarketableSecuritieReceivedOnDispositionOfMineralProperties" xlink:to="cve_MarketableSecuritieReceivedOnDispositionOfMineralProperties_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_LiabilitiesArisingFromExplorationForAndEvaluationOfMineralResources" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_LiabilitiesArisingFromExplorationForAndEvaluationOfMineralResources"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_LiabilitiesArisingFromExplorationForAndEvaluationOfMineralResources_lbl" xml:lang="en-US">Mineral property costs included in accounts payable and accrued liabilities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_LiabilitiesArisingFromExplorationForAndEvaluationOfMineralResources" xlink:to="ifrs-full_LiabilitiesArisingFromExplorationForAndEvaluationOfMineralResources_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_PropertyPlantAndEquipmentAdditionIncludedInAccountsPayableAndAccruedLiabilities" xlink:href="cve-20221231.xsd#cve_PropertyPlantAndEquipmentAdditionIncludedInAccountsPayableAndAccruedLiabilities"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cve_PropertyPlantAndEquipmentAdditionIncludedInAccountsPayableAndAccruedLiabilities_lbl" xml:lang="en-US">Property, plant, and equipment additions included in accounts payable and accrued liabilities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_PropertyPlantAndEquipmentAdditionIncludedInAccountsPayableAndAccruedLiabilities" xlink:to="cve_PropertyPlantAndEquipmentAdditionIncludedInAccountsPayableAndAccruedLiabilities_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_FairValueOfCommonSharesIssuedForAzargaAssetAcquisition" xlink:href="cve-20221231.xsd#cve_FairValueOfCommonSharesIssuedForAzargaAssetAcquisition"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cve_FairValueOfCommonSharesIssuedForAzargaAssetAcquisition_lbl" xml:lang="en-US">Fair value of common shares issued for Azarga asset acquisition</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_FairValueOfCommonSharesIssuedForAzargaAssetAcquisition" xlink:to="cve_FairValueOfCommonSharesIssuedForAzargaAssetAcquisition_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_FairValueOfReplacementOptionsIssuedForAzargaAssetsAcquisition" xlink:href="cve-20221231.xsd#cve_FairValueOfReplacementOptionsIssuedForAzargaAssetsAcquisition"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cve_FairValueOfReplacementOptionsIssuedForAzargaAssetsAcquisition_lbl" xml:lang="en-US">Fair value of replacement options issued for Azarga asset acquisition</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_FairValueOfReplacementOptionsIssuedForAzargaAssetsAcquisition" xlink:to="cve_FairValueOfReplacementOptionsIssuedForAzargaAssetsAcquisition_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_FairValueOfReplacementWarrantsIssuedForAzargaAssetAcquisition" xlink:href="cve-20221231.xsd#cve_FairValueOfReplacementWarrantsIssuedForAzargaAssetAcquisition"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cve_FairValueOfReplacementWarrantsIssuedForAzargaAssetAcquisition_lbl" xml:lang="en-US">Fair value of replacement warrants issued for Azarga asset acquisition</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_FairValueOfReplacementWarrantsIssuedForAzargaAssetAcquisition" xlink:to="cve_FairValueOfReplacementWarrantsIssuedForAzargaAssetAcquisition_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfIncomeTaxExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_DisclosureOfIncomeTaxExplanatory"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DisclosureOfIncomeTaxExplanatory_lbl" xml:lang="en-US">Income taxes</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfIncomeTaxExplanatory" xlink:to="ifrs-full_DisclosureOfIncomeTaxExplanatory_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsExplanatory"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsExplanatory_lbl" xml:lang="en-US">Schedule of federal and provincial corporate tax rates to income before tax</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsExplanatory" xlink:to="ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsExplanatory_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeLossAttributableToParent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossAttributableToParent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_IncomeLossAttributableToParent_lbl" xml:lang="en-US">Loss before income tax</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeLossAttributableToParent" xlink:to="us-gaap_IncomeLossAttributableToParent_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_lbl" xml:lang="en-US">Statutory income tax rate</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_ExpectedIncomeTaxExpenserecovery" xlink:href="cve-20221231.xsd#cve_ExpectedIncomeTaxExpenserecovery"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cve_ExpectedIncomeTaxExpenserecovery_lbl" xml:lang="en-US">Expected income tax expense (recovery)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_ExpectedIncomeTaxExpenserecovery" xlink:to="cve_ExpectedIncomeTaxExpenserecovery_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_IncreaseDecreaseResultingFromAbstract" xlink:href="cve-20221231.xsd#cve_IncreaseDecreaseResultingFromAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cve_IncreaseDecreaseResultingFromAbstract_lbl" xml:lang="en-US">Increase (decrease) resulting from:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_IncreaseDecreaseResultingFromAbstract" xlink:to="cve_IncreaseDecreaseResultingFromAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_ChangeInUnrecognizedTemporaryDifferences" xlink:href="cve-20221231.xsd#cve_ChangeInUnrecognizedTemporaryDifferences"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cve_ChangeInUnrecognizedTemporaryDifferences_lbl" xml:lang="en-US">Change in unrecognized temporary differences</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_ChangeInUnrecognizedTemporaryDifferences" xlink:to="cve_ChangeInUnrecognizedTemporaryDifferences_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_TaxEffectOfExpenseNotDeductibleInDeterminingTaxableProfitTaxLoss" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_TaxEffectOfExpenseNotDeductibleInDeterminingTaxableProfitTaxLoss"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_TaxEffectOfExpenseNotDeductibleInDeterminingTaxableProfitTaxLoss_lbl" xml:lang="en-US">Permanent differences</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_TaxEffectOfExpenseNotDeductibleInDeterminingTaxableProfitTaxLoss" xlink:to="ifrs-full_TaxEffectOfExpenseNotDeductibleInDeterminingTaxableProfitTaxLoss_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_TaxEffectOfForeignTaxRates" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_TaxEffectOfForeignTaxRates"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_TaxEffectOfForeignTaxRates_lbl" xml:lang="en-US">Effect of tax rates in foreign jurisdictions</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_TaxEffectOfForeignTaxRates" xlink:to="ifrs-full_TaxEffectOfForeignTaxRates_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_ShareIssueCosts" xlink:href="cve-20221231.xsd#cve_ShareIssueCosts"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cve_ShareIssueCosts_lbl" xml:lang="en-US">Share issue costs</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_ShareIssueCosts" xlink:to="cve_ShareIssueCosts_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AdjustmentsForCurrentTaxOfPriorPeriod" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_AdjustmentsForCurrentTaxOfPriorPeriod"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_AdjustmentsForCurrentTaxOfPriorPeriod_lbl" xml:lang="en-US">Prior period adjustments</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AdjustmentsForCurrentTaxOfPriorPeriod" xlink:to="ifrs-full_AdjustmentsForCurrentTaxOfPriorPeriod_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_IncomeTaxExpenseContinuingOperations" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_IncomeTaxExpenseContinuingOperations"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_IncomeTaxExpenseContinuingOperations_lbl" xml:lang="en-US">Income tax expense (recovery)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_IncomeTaxExpenseContinuingOperations" xlink:to="ifrs-full_IncomeTaxExpenseContinuingOperations_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfInterestIncomeExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_DisclosureOfInterestIncomeExplanatory"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DisclosureOfInterestIncomeExplanatory_lbl" xml:lang="en-US">Schedule of income tax expense (recovery)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfInterestIncomeExplanatory" xlink:to="ifrs-full_DisclosureOfInterestIncomeExplanatory_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_DeferredTaxExpenseRecoveryAbstract" xlink:href="cve-20221231.xsd#cve_DeferredTaxExpenseRecoveryAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cve_DeferredTaxExpenseRecoveryAbstract_lbl" xml:lang="en-US">Deferred tax expense (recovery)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_DeferredTaxExpenseRecoveryAbstract" xlink:to="cve_DeferredTaxExpenseRecoveryAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_OrginationAndReversalOfTemporaryDifferences" xlink:href="cve-20221231.xsd#cve_OrginationAndReversalOfTemporaryDifferences"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cve_OrginationAndReversalOfTemporaryDifferences_lbl" xml:lang="en-US">Organization and reversal of temporary differences</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_OrginationAndReversalOfTemporaryDifferences" xlink:to="cve_OrginationAndReversalOfTemporaryDifferences_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsOtherLossCarryforwards" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsOtherLossCarryforwards"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DeferredTaxAssetsOtherLossCarryforwards_lbl" xml:lang="en-US">Loss carryforwards</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsOtherLossCarryforwards" xlink:to="us-gaap_DeferredTaxAssetsOtherLossCarryforwards_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsOther" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsOther"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DeferredTaxAssetsOther_lbl" xml:lang="en-US">Deferred tax assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsOther" xlink:to="us-gaap_DeferredTaxAssetsOther_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_NetDeferredTaxAssets" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_NetDeferredTaxAssets"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_NetDeferredTaxAssets_lbl" xml:lang="en-US">Net deferred tax assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NetDeferredTaxAssets" xlink:to="ifrs-full_NetDeferredTaxAssets_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_NetDeferredTaxAssets_lbl0" xml:lang="en-US">Net deferred tax liability</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NetDeferredTaxAssets" xlink:to="ifrs-full_NetDeferredTaxAssets_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_lbl" xml:lang="en-US">Schedule of deferred tax liabilities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:to="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_FixedAssets" xlink:href="cve-20221231.xsd#cve_FixedAssets"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cve_FixedAssets_lbl" xml:lang="en-US">Fixed assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_FixedAssets" xlink:to="cve_FixedAssets_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_MarketableSecuritiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MarketableSecuritiesCurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_MarketableSecuritiesCurrent_lbl" xml:lang="en-US">Marketable securities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MarketableSecuritiesCurrent" xlink:to="us-gaap_MarketableSecuritiesCurrent_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_SetoffOfTax" xlink:href="cve-20221231.xsd#cve_SetoffOfTax"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cve_SetoffOfTax_lbl" xml:lang="en-US">Set-off of tax</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_SetoffOfTax" xlink:to="cve_SetoffOfTax_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="cve_SetoffOfTax_lbl0" xml:lang="en-US">Set-off of tax</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_SetoffOfTax" xlink:to="cve_SetoffOfTax_lbl0"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfDeferredTaxesExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_DisclosureOfDeferredTaxesExplanatory"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DisclosureOfDeferredTaxesExplanatory_lbl" xml:lang="en-US">Schedule of unrecognized deferred tax assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfDeferredTaxesExplanatory" xlink:to="ifrs-full_DisclosureOfDeferredTaxesExplanatory_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfReclassificationsOrChangesInPresentationExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_DisclosureOfReclassificationsOrChangesInPresentationExplanatory"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DisclosureOfReclassificationsOrChangesInPresentationExplanatory_lbl" xml:lang="en-US">Change in presentation currency</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfReclassificationsOrChangesInPresentationExplanatory" xlink:to="ifrs-full_DisclosureOfReclassificationsOrChangesInPresentationExplanatory_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForForeignCurrencyTranslationExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_DescriptionOfAccountingPolicyForForeignCurrencyTranslationExplanatory"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForForeignCurrencyTranslationExplanatory_lbl" xml:lang="en-US">Schedule of effect of translation</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DescriptionOfAccountingPolicyForForeignCurrencyTranslationExplanatory" xlink:to="ifrs-full_DescriptionOfAccountingPolicyForForeignCurrencyTranslationExplanatory_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_NoncurrentAssets" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_NoncurrentAssets"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_NoncurrentAssets_lbl" xml:lang="en-US">Non-current assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NoncurrentAssets" xlink:to="ifrs-full_NoncurrentAssets_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_UnlabeledAbstract24" xlink:href="cve-20221231.xsd#cve_UnlabeledAbstract24"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cve_UnlabeledAbstract24_lbl" xml:lang="en-US"></label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_UnlabeledAbstract24" xlink:to="cve_UnlabeledAbstract24_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_NoncurrentLiabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_NoncurrentLiabilities"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_NoncurrentLiabilities_lbl" xml:lang="en-US">Non-current liabilities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NoncurrentLiabilities" xlink:to="ifrs-full_NoncurrentLiabilities_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_UnlabeledAbstract25" xlink:href="cve-20221231.xsd#cve_UnlabeledAbstract25"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cve_UnlabeledAbstract25_lbl" xml:lang="en-US"></label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_UnlabeledAbstract25" xlink:to="cve_UnlabeledAbstract25_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfFinancialInstrumentsAtFairValueThroughProfitOrLossExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_DisclosureOfFinancialInstrumentsAtFairValueThroughProfitOrLossExplanatory"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DisclosureOfFinancialInstrumentsAtFairValueThroughProfitOrLossExplanatory_lbl" xml:lang="en-US">Schedule of consolidated statements of loss and comprehensive loss</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfFinancialInstrumentsAtFairValueThroughProfitOrLossExplanatory" xlink:to="ifrs-full_DisclosureOfFinancialInstrumentsAtFairValueThroughProfitOrLossExplanatory_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_ExpensesAbstract0" xlink:href="cve-20221231.xsd#cve_ExpensesAbstract0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cve_ExpensesAbstract0_lbl" xml:lang="en-US">Expenses</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_ExpensesAbstract0" xlink:to="cve_ExpensesAbstract0_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_ImpairmentCharges" xlink:href="cve-20221231.xsd#cve_ImpairmentCharges"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cve_ImpairmentCharges_lbl" xml:lang="en-US">Impairment charges</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_ImpairmentCharges" xlink:to="cve_ImpairmentCharges_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_OfficeAndAdministrative" xlink:href="cve-20221231.xsd#cve_OfficeAndAdministrative"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cve_OfficeAndAdministrative_lbl" xml:lang="en-US">Office and administrative</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_OfficeAndAdministrative" xlink:to="cve_OfficeAndAdministrative_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_OtherExpenseByNature" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_OtherExpenseByNature"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_OtherExpenseByNature_lbl" xml:lang="en-US">Promotion and shareholder communication</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_OtherExpenseByNature" xlink:to="ifrs-full_OtherExpenseByNature_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_ReclamationCosts" xlink:href="cve-20221231.xsd#cve_ReclamationCosts"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cve_ReclamationCosts_lbl" xml:lang="en-US">Reclamation costs</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_ReclamationCosts" xlink:to="cve_ReclamationCosts_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_InterestRevenueExpense" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_InterestRevenueExpense"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_InterestRevenueExpense_lbl" xml:lang="en-US">Interest income</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_InterestRevenueExpense" xlink:to="ifrs-full_InterestRevenueExpense_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ForeignExchangeGain" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_ForeignExchangeGain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_ForeignExchangeGain_lbl" xml:lang="en-US">Foreign exchange gain</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ForeignExchangeGain" xlink:to="ifrs-full_ForeignExchangeGain_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_GainOnChangeInAssetRetirementObligationEstimate" xlink:href="cve-20221231.xsd#cve_GainOnChangeInAssetRetirementObligationEstimate"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cve_GainOnChangeInAssetRetirementObligationEstimate_lbl" xml:lang="en-US">Gain on change in asset retirement obligation estimate</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_GainOnChangeInAssetRetirementObligationEstimate" xlink:to="cve_GainOnChangeInAssetRetirementObligationEstimate_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_GainsOnDisposalsOfInvestmentProperties" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_GainsOnDisposalsOfInvestmentProperties"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_GainsOnDisposalsOfInvestmentProperties_lbl" xml:lang="en-US">Gain on sale of uranium investment</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_GainsOnDisposalsOfInvestmentProperties" xlink:to="ifrs-full_GainsOnDisposalsOfInvestmentProperties_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_OtherComprehensiveIncomeBeforeTaxExchangeDifferencesOnTranslation" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_OtherComprehensiveIncomeBeforeTaxExchangeDifferencesOnTranslation"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_OtherComprehensiveIncomeBeforeTaxExchangeDifferencesOnTranslation_lbl" xml:lang="en-US">Exchange differences on translation foreign operations</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_OtherComprehensiveIncomeBeforeTaxExchangeDifferencesOnTranslation" xlink:to="ifrs-full_OtherComprehensiveIncomeBeforeTaxExchangeDifferencesOnTranslation_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_UnlabeledAbstract26" xlink:href="cve-20221231.xsd#cve_UnlabeledAbstract26"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cve_UnlabeledAbstract26_lbl" xml:lang="en-US"></label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_UnlabeledAbstract26" xlink:to="cve_UnlabeledAbstract26_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfEventsAfterReportingPeriodExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_DisclosureOfEventsAfterReportingPeriodExplanatory"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DisclosureOfEventsAfterReportingPeriodExplanatory_lbl" xml:lang="en-US">Events after the reporting period</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfEventsAfterReportingPeriodExplanatory" xlink:to="ifrs-full_DisclosureOfEventsAfterReportingPeriodExplanatory_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AmortisationIntangibleAssetsOtherThanGoodwill" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_AmortisationIntangibleAssetsOtherThanGoodwill"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="ifrs-full_AmortisationIntangibleAssetsOtherThanGoodwill_lbl" xml:lang="en-US">Amortization</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AmortisationIntangibleAssetsOtherThanGoodwill" xlink:to="ifrs-full_AmortisationIntangibleAssetsOtherThanGoodwill_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DepreciationExpense" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_DepreciationExpense"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="ifrs-full_DepreciationExpense_lbl" xml:lang="en-US">Depreciation</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DepreciationExpense" xlink:to="ifrs-full_DepreciationExpense_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_Right-of-UseAssetsTwoZeroTwoFour" xlink:href="cve-20221231.xsd#cve_Right-of-UseAssetsTwoZeroTwoFour"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="cve_Right-of-UseAssetsTwoZeroTwoFour_lbl" xml:lang="en-US">2024</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_Right-of-UseAssetsTwoZeroTwoFour" xlink:to="cve_Right-of-UseAssetsTwoZeroTwoFour_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_LeaseLiabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_LeaseLiabilities"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="ifrs-full_LeaseLiabilities_lbl" xml:lang="en-US">Lease liability</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_LeaseLiabilities" xlink:to="ifrs-full_LeaseLiabilities_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_ImpairmentCharged" xlink:href="cve-20221231.xsd#cve_ImpairmentCharged"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="cve_ImpairmentCharged_lbl" xml:lang="en-US">Impairment charged</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_ImpairmentCharged" xlink:to="cve_ImpairmentCharged_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_DivestMineralInterest" xlink:href="cve-20221231.xsd#cve_DivestMineralInterest"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="cve_DivestMineralInterest_lbl" xml:lang="en-US">Divest - Mineral interest</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_DivestMineralInterest" xlink:to="cve_DivestMineralInterest_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_AssetsHeldForSale" xlink:href="cve-20221231.xsd#cve_AssetsHeldForSale"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="cve_AssetsHeldForSale_lbl" xml:lang="en-US">Assets held for sale</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_AssetsHeldForSale" xlink:to="cve_AssetsHeldForSale_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_AccountPayablesAndAccruedLiabilities" xlink:href="cve-20221231.xsd#cve_AccountPayablesAndAccruedLiabilities"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="cve_AccountPayablesAndAccruedLiabilities_lbl" xml:lang="en-US">Accounts payable and accrued liabilities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_AccountPayablesAndAccruedLiabilities" xlink:to="cve_AccountPayablesAndAccruedLiabilities_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_OtherIntangibleAssets" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_OtherIntangibleAssets"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="ifrs-full_OtherIntangibleAssets_lbl" xml:lang="en-US">Intangible assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_OtherIntangibleAssets" xlink:to="ifrs-full_OtherIntangibleAssets_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_RightofuseAssetsRevaluedAssetsAtCost" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_RightofuseAssetsRevaluedAssetsAtCost"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="ifrs-full_RightofuseAssetsRevaluedAssetsAtCost_lbl" xml:lang="en-US">Right-of-use assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_RightofuseAssetsRevaluedAssetsAtCost" xlink:to="ifrs-full_RightofuseAssetsRevaluedAssetsAtCost_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_RightofuseAssetsRevaluationSurplus" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_RightofuseAssetsRevaluationSurplus"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="ifrs-full_RightofuseAssetsRevaluationSurplus_lbl" xml:lang="en-US">Right-of-use assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_RightofuseAssetsRevaluationSurplus" xlink:to="ifrs-full_RightofuseAssetsRevaluationSurplus_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_DeductibleTemporaryDifferences" xlink:href="cve-20221231.xsd#cve_DeductibleTemporaryDifferences"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="cve_DeductibleTemporaryDifferences_lbl" xml:lang="en-US">Deductible temporary differences</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_DeductibleTemporaryDifferences" xlink:to="cve_DeductibleTemporaryDifferences_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_TaxEffectOfTaxLosses" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_TaxEffectOfTaxLosses"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="ifrs-full_TaxEffectOfTaxLosses_lbl" xml:lang="en-US">Tax losses</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_TaxEffectOfTaxLosses" xlink:to="ifrs-full_TaxEffectOfTaxLosses_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_LossesOnDivestmentOfMineralProperties" xlink:href="cve-20221231.xsd#cve_LossesOnDivestmentOfMineralProperties"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="cve_LossesOnDivestmentOfMineralProperties_lbl" xml:lang="en-US">Loss on divestment of mineral properties</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_LossesOnDivestmentOfMineralProperties" xlink:to="cve_LossesOnDivestmentOfMineralProperties_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LossOnContractTermination" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossOnContractTermination"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_LossOnContractTermination_lbl" xml:lang="en-US">Loss on contract termination</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LossOnContractTermination" xlink:to="us-gaap_LossOnContractTermination_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_LossOnInvestmentInAssociate" xlink:href="cve-20221231.xsd#cve_LossOnInvestmentInAssociate"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="cve_LossOnInvestmentInAssociate_lbl" xml:lang="en-US">Loss on investment in associate</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_LossOnInvestmentInAssociate" xlink:to="cve_LossOnInvestmentInAssociate_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ReversalOfImpairmentLossRecognisedInOtherComprehensiveIncome" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_ReversalOfImpairmentLossRecognisedInOtherComprehensiveIncome"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="ifrs-full_ReversalOfImpairmentLossRecognisedInOtherComprehensiveIncome_lbl" xml:lang="en-US">Other comprehensive loss for the year</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ReversalOfImpairmentLossRecognisedInOtherComprehensiveIncome" xlink:to="ifrs-full_ReversalOfImpairmentLossRecognisedInOtherComprehensiveIncome_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_TigrisUraniumUSCorpMember" xlink:href="cve-20221231.xsd#cve_TigrisUraniumUSCorpMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cve_TigrisUraniumUSCorpMember_lbl" xml:lang="en-US">Tigris Uranium US Corp. [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_TigrisUraniumUSCorpMember" xlink:to="cve_TigrisUraniumUSCorpMember_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_MetaminEnterprisesUSIncMember" xlink:href="cve-20221231.xsd#cve_MetaminEnterprisesUSIncMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cve_MetaminEnterprisesUSIncMember_lbl" xml:lang="en-US">Metamin Enterprises US Inc. [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_MetaminEnterprisesUSIncMember" xlink:to="cve_MetaminEnterprisesUSIncMember_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_URIIncMember" xlink:href="cve-20221231.xsd#cve_URIIncMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cve_URIIncMember_lbl" xml:lang="en-US">URI, Inc. [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_URIIncMember" xlink:to="cve_URIIncMember_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_NeutronEnergyIncMember" xlink:href="cve-20221231.xsd#cve_NeutronEnergyIncMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cve_NeutronEnergyIncMember_lbl" xml:lang="en-US">Neutron Energy, Inc. [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_NeutronEnergyIncMember" xlink:to="cve_NeutronEnergyIncMember_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_UrancoIncMember" xlink:href="cve-20221231.xsd#cve_UrancoIncMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cve_UrancoIncMember_lbl" xml:lang="en-US">Uranco, Inc. [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_UrancoIncMember" xlink:to="cve_UrancoIncMember_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_UraniumResourcesIncMember" xlink:href="cve-20221231.xsd#cve_UraniumResourcesIncMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cve_UraniumResourcesIncMember_lbl" xml:lang="en-US">Uranium Resources, Inc. [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_UraniumResourcesIncMember" xlink:to="cve_UraniumResourcesIncMember_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_HRIChurchrockIncMember" xlink:href="cve-20221231.xsd#cve_HRIChurchrockIncMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cve_HRIChurchrockIncMember_lbl" xml:lang="en-US">HRI-Churchrock, Inc. [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_HRIChurchrockIncMember" xlink:to="cve_HRIChurchrockIncMember_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_HydroRestorationCorpMember" xlink:href="cve-20221231.xsd#cve_HydroRestorationCorpMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cve_HydroRestorationCorpMember_lbl" xml:lang="en-US">Hydro Restoration Corp.[Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_HydroRestorationCorpMember" xlink:to="cve_HydroRestorationCorpMember_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_BeltLineResourcesIncMember" xlink:href="cve-20221231.xsd#cve_BeltLineResourcesIncMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cve_BeltLineResourcesIncMember_lbl" xml:lang="en-US">Belt Line Resources, Inc. [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_BeltLineResourcesIncMember" xlink:to="cve_BeltLineResourcesIncMember_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_CibolaResourcesLLCMember" xlink:href="cve-20221231.xsd#cve_CibolaResourcesLLCMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cve_CibolaResourcesLLCMember_lbl" xml:lang="en-US">Cibola Resources, LLC [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_CibolaResourcesLLCMember" xlink:to="cve_CibolaResourcesLLCMember_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_enCoreEnergyUSCorpMember" xlink:href="cve-20221231.xsd#cve_enCoreEnergyUSCorpMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cve_enCoreEnergyUSCorpMember_lbl" xml:lang="en-US">enCore Energy US Corp. [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_enCoreEnergyUSCorpMember" xlink:to="cve_enCoreEnergyUSCorpMember_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_AzargaUraniumCorpMember" xlink:href="cve-20221231.xsd#cve_AzargaUraniumCorpMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cve_AzargaUraniumCorpMember_lbl" xml:lang="en-US">Azarga Uranium Corp. [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_AzargaUraniumCorpMember" xlink:to="cve_AzargaUraniumCorpMember_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_PowertechUSAIncMember" xlink:href="cve-20221231.xsd#cve_PowertechUSAIncMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cve_PowertechUSAIncMember_lbl" xml:lang="en-US">Powertech (USA) Inc. [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_PowertechUSAIncMember" xlink:to="cve_PowertechUSAIncMember_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_URZEnergyCorpMember" xlink:href="cve-20221231.xsd#cve_URZEnergyCorpMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cve_URZEnergyCorpMember_lbl" xml:lang="en-US">URZ Energy Corp. [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_URZEnergyCorpMember" xlink:to="cve_URZEnergyCorpMember_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_UcoloExplorationCorpMember" xlink:href="cve-20221231.xsd#cve_UcoloExplorationCorpMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cve_UcoloExplorationCorpMember_lbl" xml:lang="en-US">Ucolo Exploration Corp. [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_UcoloExplorationCorpMember" xlink:to="cve_UcoloExplorationCorpMember_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_AzargaResourcesLimitedMember" xlink:href="cve-20221231.xsd#cve_AzargaResourcesLimitedMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cve_AzargaResourcesLimitedMember_lbl" xml:lang="en-US">Azarga Resources Limited [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_AzargaResourcesLimitedMember" xlink:to="cve_AzargaResourcesLimitedMember_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_AzargaResourcesHongKongLtdMember" xlink:href="cve-20221231.xsd#cve_AzargaResourcesHongKongLtdMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cve_AzargaResourcesHongKongLtdMember_lbl" xml:lang="en-US">Azarga Resources (Hong Kong) Ltd. [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_AzargaResourcesHongKongLtdMember" xlink:to="cve_AzargaResourcesHongKongLtdMember_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_AzargaResourcesUSACompanyMember" xlink:href="cve-20221231.xsd#cve_AzargaResourcesUSACompanyMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cve_AzargaResourcesUSACompanyMember_lbl" xml:lang="en-US">Azarga Resources USA Company [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_AzargaResourcesUSACompanyMember" xlink:to="cve_AzargaResourcesUSACompanyMember_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_AzargaResourcesCanadaLtdMember" xlink:href="cve-20221231.xsd#cve_AzargaResourcesCanadaLtdMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cve_AzargaResourcesCanadaLtdMember_lbl" xml:lang="en-US">Azarga Resources Canada Ltd. [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_AzargaResourcesCanadaLtdMember" xlink:to="cve_AzargaResourcesCanadaLtdMember_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_UraniumPlantsMember" xlink:href="cve-20221231.xsd#cve_UraniumPlantsMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cve_UraniumPlantsMember_lbl" xml:lang="en-US">Uranium Plants [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_UraniumPlantsMember" xlink:to="cve_UraniumPlantsMember_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_OtherPropertyPlantAndEquipmentMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_OtherPropertyPlantAndEquipmentMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_OtherPropertyPlantAndEquipmentMember_lbl" xml:lang="en-US">Other property, plant and equipment [member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_OtherPropertyPlantAndEquipmentMember" xlink:to="ifrs-full_OtherPropertyPlantAndEquipmentMember_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_SoftwareMember" xlink:href="cve-20221231.xsd#cve_SoftwareMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cve_SoftwareMember_lbl" xml:lang="en-US">Software [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_SoftwareMember" xlink:to="cve_SoftwareMember_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_FurnitureMember" xlink:href="cve-20221231.xsd#cve_FurnitureMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cve_FurnitureMember_lbl" xml:lang="en-US">Furniture [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_FurnitureMember" xlink:to="cve_FurnitureMember_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_BuildingsMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_BuildingsMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_BuildingsMember_lbl" xml:lang="en-US">Buildings [member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_BuildingsMember" xlink:to="ifrs-full_BuildingsMember_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_BottomOfRangeMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_BottomOfRangeMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_BottomOfRangeMember_lbl" xml:lang="en-US">Bottom of range [member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_BottomOfRangeMember" xlink:to="ifrs-full_BottomOfRangeMember_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_TopOfRangeMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_TopOfRangeMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_TopOfRangeMember_lbl" xml:lang="en-US">Top of range [member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_TopOfRangeMember" xlink:to="ifrs-full_TopOfRangeMember_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_DataAccessAgreementMember" xlink:href="cve-20221231.xsd#cve_DataAccessAgreementMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cve_DataAccessAgreementMember_lbl" xml:lang="en-US">Data Access Agreement	[Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_DataAccessAgreementMember" xlink:to="cve_DataAccessAgreementMember_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_DataPurchasesMember" xlink:href="cve-20221231.xsd#cve_DataPurchasesMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cve_DataPurchasesMember_lbl" xml:lang="en-US">Data Purchases [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_DataPurchasesMember" xlink:to="cve_DataPurchasesMember_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_Fiscal2023Member" xlink:href="cve-20221231.xsd#cve_Fiscal2023Member"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cve_Fiscal2023Member_lbl" xml:lang="en-US">Fiscal 2023 [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_Fiscal2023Member" xlink:to="cve_Fiscal2023Member_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_Fiscal2024Member" xlink:href="cve-20221231.xsd#cve_Fiscal2024Member"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cve_Fiscal2024Member_lbl" xml:lang="en-US">Fiscal 2024 [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_Fiscal2024Member" xlink:to="cve_Fiscal2024Member_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_Fiscal2025Member" xlink:href="cve-20221231.xsd#cve_Fiscal2025Member"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cve_Fiscal2025Member_lbl" xml:lang="en-US">Fiscal 2025 [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_Fiscal2025Member" xlink:to="cve_Fiscal2025Member_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_Fiscal2026Member" xlink:href="cve-20221231.xsd#cve_Fiscal2026Member"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cve_Fiscal2026Member_lbl" xml:lang="en-US">Fiscal 2026 [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_Fiscal2026Member" xlink:to="cve_Fiscal2026Member_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_Fiscal2027Member" xlink:href="cve-20221231.xsd#cve_Fiscal2027Member"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cve_Fiscal2027Member_lbl" xml:lang="en-US">Fiscal 2027 [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_Fiscal2027Member" xlink:to="cve_Fiscal2027Member_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_MarketableSecuritiescurrentMember" xlink:href="cve-20221231.xsd#cve_MarketableSecuritiescurrentMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cve_MarketableSecuritiescurrentMember_lbl" xml:lang="en-US">Marketable securities (current) [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_MarketableSecuritiescurrentMember" xlink:to="cve_MarketableSecuritiescurrentMember_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_MarketableSecuritiesnoncurrentMember" xlink:href="cve-20221231.xsd#cve_MarketableSecuritiesnoncurrentMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cve_MarketableSecuritiesnoncurrentMember_lbl" xml:lang="en-US">Marketable securities (non-current) [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_MarketableSecuritiesnoncurrentMember" xlink:to="cve_MarketableSecuritiesnoncurrentMember_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_VANEAgreementMember" xlink:href="cve-20221231.xsd#cve_VANEAgreementMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cve_VANEAgreementMember_lbl" xml:lang="en-US">VANE Agreement [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_VANEAgreementMember" xlink:to="cve_VANEAgreementMember_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_GettyDatabaseMember" xlink:href="cve-20221231.xsd#cve_GettyDatabaseMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cve_GettyDatabaseMember_lbl" xml:lang="en-US">Getty Database [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_GettyDatabaseMember" xlink:to="cve_GettyDatabaseMember_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_SignalEquitiesDatabaseMember" xlink:href="cve-20221231.xsd#cve_SignalEquitiesDatabaseMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cve_SignalEquitiesDatabaseMember_lbl" xml:lang="en-US">Signal Equities Database [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_SignalEquitiesDatabaseMember" xlink:to="cve_SignalEquitiesDatabaseMember_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_GrantsMineralBeltDatabaseMember" xlink:href="cve-20221231.xsd#cve_GrantsMineralBeltDatabaseMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cve_GrantsMineralBeltDatabaseMember_lbl" xml:lang="en-US">Grants Mineral Belt Database [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_GrantsMineralBeltDatabaseMember" xlink:to="cve_GrantsMineralBeltDatabaseMember_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_LeasedCopierMember" xlink:href="cve-20221231.xsd#cve_LeasedCopierMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cve_LeasedCopierMember_lbl" xml:lang="en-US">Leased copier [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_LeasedCopierMember" xlink:to="cve_LeasedCopierMember_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_LeasedOfficesMember" xlink:href="cve-20221231.xsd#cve_LeasedOfficesMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cve_LeasedOfficesMember_lbl" xml:lang="en-US">Leased offices [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_LeasedOfficesMember" xlink:to="cve_LeasedOfficesMember_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_OptionsMember" xlink:href="cve-20221231.xsd#cve_OptionsMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cve_OptionsMember_lbl" xml:lang="en-US">Options [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_OptionsMember" xlink:to="cve_OptionsMember_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_WarrantReserveMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_WarrantReserveMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_WarrantReserveMember_lbl" xml:lang="en-US">Warrants [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_WarrantReserveMember" xlink:to="ifrs-full_WarrantReserveMember_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_ExplorationCostMember" xlink:href="cve-20221231.xsd#cve_ExplorationCostMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cve_ExplorationCostMember_lbl" xml:lang="en-US">Exploration Cost [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_ExplorationCostMember" xlink:to="cve_ExplorationCostMember_lbl"/>
    <loc xlink:type="locator" xlink:label="stpr_AZ" xlink:href="https://xbrl.sec.gov/stpr/2022/stpr-2022.xsd#stpr_AZ"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="stpr_AZ_lbl" xml:lang="en-US">Arizona [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="stpr_AZ" xlink:to="stpr_AZ_lbl"/>
    <loc xlink:type="locator" xlink:label="stpr_CO" xlink:href="https://xbrl.sec.gov/stpr/2022/stpr-2022.xsd#stpr_CO"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="stpr_CO_lbl" xml:lang="en-US">Colorado [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="stpr_CO" xlink:to="stpr_CO_lbl"/>
    <loc xlink:type="locator" xlink:label="stpr_NM" xlink:href="https://xbrl.sec.gov/stpr/2022/stpr-2022.xsd#stpr_NM"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="stpr_NM_lbl" xml:lang="en-US">New Mexico [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="stpr_NM" xlink:to="stpr_NM_lbl"/>
    <loc xlink:type="locator" xlink:label="stpr_SD" xlink:href="https://xbrl.sec.gov/stpr/2022/stpr-2022.xsd#stpr_SD"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="stpr_SD_lbl" xml:lang="en-US">South Dakota [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="stpr_SD" xlink:to="stpr_SD_lbl"/>
    <loc xlink:type="locator" xlink:label="stpr_TX" xlink:href="https://xbrl.sec.gov/stpr/2022/stpr-2022.xsd#stpr_TX"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="stpr_TX_lbl" xml:lang="en-US">Texas [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="stpr_TX" xlink:to="stpr_TX_lbl"/>
    <loc xlink:type="locator" xlink:label="stpr_UT" xlink:href="https://xbrl.sec.gov/stpr/2022/stpr-2022.xsd#stpr_UT"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="stpr_UT_lbl" xml:lang="en-US">Utah [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="stpr_UT" xlink:to="stpr_UT_lbl"/>
    <loc xlink:type="locator" xlink:label="stpr_WY" xlink:href="https://xbrl.sec.gov/stpr/2022/stpr-2022.xsd#stpr_WY"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="stpr_WY_lbl" xml:lang="en-US">Wyoming [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="stpr_WY" xlink:to="stpr_WY_lbl"/>
    <loc xlink:type="locator" xlink:label="country_CA" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_CA"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="country_CA_lbl" xml:lang="en-US">Canada [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="country_CA" xlink:to="country_CA_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_KingsvilleMember" xlink:href="cve-20221231.xsd#cve_KingsvilleMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cve_KingsvilleMember_lbl" xml:lang="en-US">Kingsville [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_KingsvilleMember" xlink:to="cve_KingsvilleMember_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_RositaMember" xlink:href="cve-20221231.xsd#cve_RositaMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cve_RositaMember_lbl" xml:lang="en-US">Rosita [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_RositaMember" xlink:to="cve_RositaMember_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_VasquezMember" xlink:href="cve-20221231.xsd#cve_VasquezMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cve_VasquezMember_lbl" xml:lang="en-US">Vasquez [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_VasquezMember" xlink:to="cve_VasquezMember_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_CentennialMember" xlink:href="cve-20221231.xsd#cve_CentennialMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cve_CentennialMember_lbl" xml:lang="en-US">Centennial [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_CentennialMember" xlink:to="cve_CentennialMember_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_GasHillsMember" xlink:href="cve-20221231.xsd#cve_GasHillsMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cve_GasHillsMember_lbl" xml:lang="en-US">Gas Hills [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_GasHillsMember" xlink:to="cve_GasHillsMember_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_TicabooMember" xlink:href="cve-20221231.xsd#cve_TicabooMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cve_TicabooMember_lbl" xml:lang="en-US">Ticaboo [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_TicabooMember" xlink:to="cve_TicabooMember_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_ZeroOneEightOneNineTwoMember" xlink:href="cve-20221231.xsd#cve_ZeroOneEightOneNineTwoMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cve_ZeroOneEightOneNineTwoMember_lbl" xml:lang="en-US">0.18 - 1.92 [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_ZeroOneEightOneNineTwoMember" xlink:to="cve_ZeroOneEightOneNineTwoMember_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_TwoFourZeroThreeSevenEightMember" xlink:href="cve-20221231.xsd#cve_TwoFourZeroThreeSevenEightMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cve_TwoFourZeroThreeSevenEightMember_lbl" xml:lang="en-US">2.40 - 3.78 [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_TwoFourZeroThreeSevenEightMember" xlink:to="cve_TwoFourZeroThreeSevenEightMember_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_FourTwoZeroFiveSevenSixMember" xlink:href="cve-20221231.xsd#cve_FourTwoZeroFiveSevenSixMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cve_FourTwoZeroFiveSevenSixMember_lbl" xml:lang="en-US">4.20 - 5.76 [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_FourTwoZeroFiveSevenSixMember" xlink:to="cve_FourTwoZeroFiveSevenSixMember_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_OneFiveNineOneEightZeroMember" xlink:href="cve-20221231.xsd#cve_OneFiveNineOneEightZeroMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cve_OneFiveNineOneEightZeroMember_lbl" xml:lang="en-US">$1.59 - 1.80 [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_OneFiveNineOneEightZeroMember" xlink:to="cve_OneFiveNineOneEightZeroMember_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_TwoTwoTwoThreeNineZeroOneMember" xlink:href="cve-20221231.xsd#cve_TwoTwoTwoThreeNineZeroOneMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cve_TwoTwoTwoThreeNineZeroOneMember_lbl" xml:lang="en-US">$2.22 - 3.90 1 [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_TwoTwoTwoThreeNineZeroOneMember" xlink:to="cve_TwoTwoTwoThreeNineZeroOneMember_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_FourFiveNineSixZeroZeroMember" xlink:href="cve-20221231.xsd#cve_FourFiveNineSixZeroZeroMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cve_FourFiveNineSixZeroZeroMember_lbl" xml:lang="en-US">$4.59 - 6.00 [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_FourFiveNineSixZeroZeroMember" xlink:to="cve_FourFiveNineSixZeroZeroMember_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_TintinaHoldingsLtdMember" xlink:href="cve-20221231.xsd#cve_TintinaHoldingsLtdMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cve_TintinaHoldingsLtdMember_lbl" xml:lang="en-US">Tintina Holdings, Ltd [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_TintinaHoldingsLtdMember" xlink:to="cve_TintinaHoldingsLtdMember_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_OfficersAndBoardMembersMember" xlink:href="cve-20221231.xsd#cve_OfficersAndBoardMembersMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cve_OfficersAndBoardMembersMember_lbl" xml:lang="en-US">Officers and Board members [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_OfficersAndBoardMembersMember" xlink:to="cve_OfficersAndBoardMembersMember_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_OtherStatesMember" xlink:href="cve-20221231.xsd#cve_OtherStatesMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cve_OtherStatesMember_lbl" xml:lang="en-US">Other States [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_OtherStatesMember" xlink:to="cve_OtherStatesMember_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_PreviouslyStatedMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_PreviouslyStatedMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_PreviouslyStatedMember_lbl" xml:lang="en-US">Previously stated [member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_PreviouslyStatedMember" xlink:to="ifrs-full_PreviouslyStatedMember_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_TranslatedMember" xlink:href="cve-20221231.xsd#cve_TranslatedMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cve_TranslatedMember_lbl" xml:lang="en-US">Translated [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_TranslatedMember" xlink:to="cve_TranslatedMember_lbl"/>
    <loc xlink:type="locator" xlink:label="srt_ScenarioPreviouslyReportedMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioPreviouslyReportedMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="srt_ScenarioPreviouslyReportedMember_lbl" xml:lang="en-US">Previously Reported [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_ScenarioPreviouslyReportedMember" xlink:to="srt_ScenarioPreviouslyReportedMember_lbl"/>
    <loc xlink:type="locator" xlink:label="srt_StatementScenarioAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementScenarioAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_StatementScenarioAxis_lbl" xml:lang="en-US">Scenario [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_StatementScenarioAxis" xlink:to="srt_StatementScenarioAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_lbl" xml:lang="en-US">Related Party [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ClassesOfOrdinarySharesAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_ClassesOfOrdinarySharesAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ClassesOfOrdinarySharesAxis_lbl" xml:lang="en-US">Classes of ordinary shares [axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ClassesOfOrdinarySharesAxis" xlink:to="ifrs-full_ClassesOfOrdinarySharesAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_NonadjustingEventsAfterReportingPeriodAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_NonadjustingEventsAfterReportingPeriodAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_lbl" xml:lang="en-US">Non-adjusting events after reporting period [axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NonadjustingEventsAfterReportingPeriodAxis" xlink:to="ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsequentEventTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsequentEventTypeAxis_lbl" xml:lang="en-US">Subsequent Event Type [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventTypeAxis" xlink:to="us-gaap_SubsequentEventTypeAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccountingPoliciesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountingPoliciesAbstract_lbl" xml:lang="en-US">Accounting Policies [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_AccountingPoliciesAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProfitLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ProfitLoss_lbl" xml:lang="en-US">Net loss</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProfitLoss" xlink:to="us-gaap_ProfitLoss_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_WorkingCapital" xlink:href="cve-20221231.xsd#cve_WorkingCapital"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cve_WorkingCapital_lbl" xml:lang="en-US">Working capital</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_WorkingCapital" xlink:to="cve_WorkingCapital_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_AccumulatedDeficit" xlink:href="cve-20221231.xsd#cve_AccumulatedDeficit"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cve_AccumulatedDeficit_lbl" xml:lang="en-US">Accumulated deficit</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_AccumulatedDeficit" xlink:to="cve_AccumulatedDeficit_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_PercentageOfVotingEquityInterestsAcquired" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_PercentageOfVotingEquityInterestsAcquired"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_PercentageOfVotingEquityInterestsAcquired_lbl" xml:lang="en-US">Voting rights</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_PercentageOfVotingEquityInterestsAcquired" xlink:to="ifrs-full_PercentageOfVotingEquityInterestsAcquired_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DepositsFromBanks" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_DepositsFromBanks"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DepositsFromBanks_lbl" xml:lang="en-US">Deposit</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DepositsFromBanks" xlink:to="ifrs-full_DepositsFromBanks_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_ShareSubscriptionsValue" xlink:href="cve-20221231.xsd#cve_ShareSubscriptionsValue"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cve_ShareSubscriptionsValue_lbl" xml:lang="en-US">Share subscriptions value</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_ShareSubscriptionsValue" xlink:to="cve_ShareSubscriptionsValue_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_AcquiredShares" xlink:href="cve-20221231.xsd#cve_AcquiredShares"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cve_AcquiredShares_lbl" xml:lang="en-US">Acquired shares (in Shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_AcquiredShares" xlink:to="cve_AcquiredShares_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_IssuedAndOutstandingSharesPercentage" xlink:href="cve-20221231.xsd#cve_IssuedAndOutstandingSharesPercentage"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cve_IssuedAndOutstandingSharesPercentage_lbl" xml:lang="en-US">Issued and outstanding shares percentage</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_IssuedAndOutstandingSharesPercentage" xlink:to="cve_IssuedAndOutstandingSharesPercentage_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_AdvancedAmount" xlink:href="cve-20221231.xsd#cve_AdvancedAmount"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cve_AdvancedAmount_lbl" xml:lang="en-US">Advanced amount (in Dollars)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_AdvancedAmount" xlink:to="cve_AdvancedAmount_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ProportionOfOwnershipInterestInAssociate" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_ProportionOfOwnershipInterestInAssociate"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_ProportionOfOwnershipInterestInAssociate_lbl" xml:lang="en-US">Ownership percentage</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ProportionOfOwnershipInterestInAssociate" xlink:to="ifrs-full_ProportionOfOwnershipInterestInAssociate_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_PurchaseAgreementsAmount" xlink:href="cve-20221231.xsd#cve_PurchaseAgreementsAmount"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cve_PurchaseAgreementsAmount_lbl" xml:lang="en-US">Purchase agreements amount (in Pounds)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_PurchaseAgreementsAmount" xlink:to="cve_PurchaseAgreementsAmount_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="cve_PurchaseAgreementsAmount_lbl0" xml:lang="en-US">Agreement amount</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_PurchaseAgreementsAmount" xlink:to="cve_PurchaseAgreementsAmount_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherLongTermInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLongTermInvestments"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_OtherLongTermInvestments_lbl" xml:lang="en-US">Long-term investment</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherLongTermInvestments" xlink:to="us-gaap_OtherLongTermInvestments_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_SaleOfPhysicalUranium" xlink:href="cve-20221231.xsd#cve_SaleOfPhysicalUranium"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cve_SaleOfPhysicalUranium_lbl" xml:lang="en-US">Sale of physical uranium (in Pounds)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_SaleOfPhysicalUranium" xlink:to="cve_SaleOfPhysicalUranium_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_GrossProceeds" xlink:href="cve-20221231.xsd#cve_GrossProceeds"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cve_GrossProceeds_lbl" xml:lang="en-US">Gross proceeds</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_GrossProceeds" xlink:to="cve_GrossProceeds_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_GainsOnDisposalsOfInvestments" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_GainsOnDisposalsOfInvestments"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_GainsOnDisposalsOfInvestments_lbl" xml:lang="en-US">Gain on investment</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_GainsOnDisposalsOfInvestments" xlink:to="ifrs-full_GainsOnDisposalsOfInvestments_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_GainsOnDisposalsOfInvestments_lbl0" xml:lang="en-US">Gain on disposal of the mineral interests</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_GainsOnDisposalsOfInvestments" xlink:to="ifrs-full_GainsOnDisposalsOfInvestments_lbl0"/>
    <loc xlink:type="locator" xlink:label="cve_TotalConsideration" xlink:href="cve-20221231.xsd#cve_TotalConsideration"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cve_TotalConsideration_lbl" xml:lang="en-US">Total consideration</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_TotalConsideration" xlink:to="cve_TotalConsideration_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_TotalConsiderationPerShare" xlink:href="cve-20221231.xsd#cve_TotalConsiderationPerShare"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cve_TotalConsiderationPerShare_lbl" xml:lang="en-US">Total consideration per share (in Dollars per share)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_TotalConsiderationPerShare" xlink:to="cve_TotalConsiderationPerShare_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_InitialPayment" xlink:href="cve-20221231.xsd#cve_InitialPayment"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cve_InitialPayment_lbl" xml:lang="en-US">Initial payment</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_InitialPayment" xlink:to="cve_InitialPayment_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_InvestmentAmount" xlink:href="cve-20221231.xsd#cve_InvestmentAmount"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cve_InvestmentAmount_lbl" xml:lang="en-US">Final payment of investment</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_InvestmentAmount" xlink:to="cve_InvestmentAmount_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_CommonShares" xlink:href="cve-20221231.xsd#cve_CommonShares"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cve_CommonShares_lbl" xml:lang="en-US">Common shares</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_CommonShares" xlink:to="cve_CommonShares_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_MarketValuePerShare" xlink:href="cve-20221231.xsd#cve_MarketValuePerShare"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cve_MarketValuePerShare_lbl" xml:lang="en-US">Market value per share (in Dollars per share)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_MarketValuePerShare" xlink:to="cve_MarketValuePerShare_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="cve_MarketValuePerShare_lbl0" xml:lang="en-US">Common Shares (in Dollars per share)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_MarketValuePerShare" xlink:to="cve_MarketValuePerShare_lbl0"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_NumberOfSharesIssuedAndFullyPaid" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_NumberOfSharesIssuedAndFullyPaid"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_NumberOfSharesIssuedAndFullyPaid_lbl" xml:lang="en-US">Shares issued</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NumberOfSharesIssuedAndFullyPaid" xlink:to="ifrs-full_NumberOfSharesIssuedAndFullyPaid_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_NumberOfSharesIssuedAndFullyPaid_lbl0" xml:lang="en-US">Shares (in Shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NumberOfSharesIssuedAndFullyPaid" xlink:to="ifrs-full_NumberOfSharesIssuedAndFullyPaid_lbl0"/>
    <loc xlink:type="locator" xlink:label="cve_ConvertedShares" xlink:href="cve-20221231.xsd#cve_ConvertedShares"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cve_ConvertedShares_lbl" xml:lang="en-US">Converted shares</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_ConvertedShares" xlink:to="cve_ConvertedShares_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DescriptionOfKeyAssumptionsOnWhichManagementHasBasedDeterminationOfFairValueLessCostsOfDisposal" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_DescriptionOfKeyAssumptionsOnWhichManagementHasBasedDeterminationOfFairValueLessCostsOfDisposal"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DescriptionOfKeyAssumptionsOnWhichManagementHasBasedDeterminationOfFairValueLessCostsOfDisposal_lbl" xml:lang="en-US">Cost base shareholdings amount</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DescriptionOfKeyAssumptionsOnWhichManagementHasBasedDeterminationOfFairValueLessCostsOfDisposal" xlink:to="ifrs-full_DescriptionOfKeyAssumptionsOnWhichManagementHasBasedDeterminationOfFairValueLessCostsOfDisposal_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_TradingShares" xlink:href="cve-20221231.xsd#cve_TradingShares"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cve_TradingShares_lbl" xml:lang="en-US">Trading shares</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_TradingShares" xlink:to="cve_TradingShares_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_FinancialLiabilitiesAtFairValue" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_FinancialLiabilitiesAtFairValue"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_FinancialLiabilitiesAtFairValue_lbl" xml:lang="en-US">Fair value (in Dollars)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_FinancialLiabilitiesAtFairValue" xlink:to="ifrs-full_FinancialLiabilitiesAtFairValue_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ParValuePerShare" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_ParValuePerShare"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_ParValuePerShare_lbl" xml:lang="en-US">Price per share (in Dollars per share)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ParValuePerShare" xlink:to="ifrs-full_ParValuePerShare_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_ReleasedShares" xlink:href="cve-20221231.xsd#cve_ReleasedShares"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cve_ReleasedShares_lbl" xml:lang="en-US">Released shares</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_ReleasedShares" xlink:to="cve_ReleasedShares_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_PrimeFuelsConsiderationPercentage" xlink:href="cve-20221231.xsd#cve_PrimeFuelsConsiderationPercentage"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cve_PrimeFuelsConsiderationPercentage_lbl" xml:lang="en-US">Prime fuels consideration percentage</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_PrimeFuelsConsiderationPercentage" xlink:to="cve_PrimeFuelsConsiderationPercentage_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_CommonSharesIssued" xlink:href="cve-20221231.xsd#cve_CommonSharesIssued"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cve_CommonSharesIssued_lbl" xml:lang="en-US">Common shares issued (in Shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_CommonSharesIssued" xlink:to="cve_CommonSharesIssued_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_PlanAssetsAtFairValue" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_PlanAssetsAtFairValue"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_PlanAssetsAtFairValue_lbl" xml:lang="en-US">Fair value</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_PlanAssetsAtFairValue" xlink:to="ifrs-full_PlanAssetsAtFairValue_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_PlanAssetsAtFairValue_lbl0" xml:lang="en-US">Fair value of uravan minerals</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_PlanAssetsAtFairValue" xlink:to="ifrs-full_PlanAssetsAtFairValue_lbl0"/>
    <loc xlink:type="locator" xlink:label="cve_PrimaryTerm" xlink:href="cve-20221231.xsd#cve_PrimaryTerm"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cve_PrimaryTerm_lbl" xml:lang="en-US">Primary term</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_PrimaryTerm" xlink:to="cve_PrimaryTerm_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_RenewalPeriods" xlink:href="cve-20221231.xsd#cve_RenewalPeriods"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cve_RenewalPeriods_lbl" xml:lang="en-US">Renewal periods</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_RenewalPeriods" xlink:to="cve_RenewalPeriods_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_IntangibleAssetDeterminedLife" xlink:href="cve-20221231.xsd#cve_IntangibleAssetDeterminedLife"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cve_IntangibleAssetDeterminedLife_lbl" xml:lang="en-US">Intangible asset determined life</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_IntangibleAssetDeterminedLife" xlink:to="cve_IntangibleAssetDeterminedLife_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_AcquiredAmonut" xlink:href="cve-20221231.xsd#cve_AcquiredAmonut"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cve_AcquiredAmonut_lbl" xml:lang="en-US">Acquired amount</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_AcquiredAmonut" xlink:to="cve_AcquiredAmonut_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLeasePayments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeasePayments"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_OperatingLeasePayments_lbl" xml:lang="en-US">Lease payment</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeasePayments" xlink:to="us-gaap_OperatingLeasePayments_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_CorrespondingLeaseObligation" xlink:href="cve-20221231.xsd#cve_CorrespondingLeaseObligation"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cve_CorrespondingLeaseObligation_lbl" xml:lang="en-US">Corresponding lease obligation</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_CorrespondingLeaseObligation" xlink:to="cve_CorrespondingLeaseObligation_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_BorrowingsInterestRate" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_BorrowingsInterestRate"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_BorrowingsInterestRate_lbl" xml:lang="en-US">Estimated borrowing rate</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_BorrowingsInterestRate" xlink:to="ifrs-full_BorrowingsInterestRate_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_BorrowingsInterestRate_lbl0" xml:lang="en-US">Interest rate</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_BorrowingsInterestRate" xlink:to="ifrs-full_BorrowingsInterestRate_lbl0"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_NumberOfSharesIssued" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_NumberOfSharesIssued"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_NumberOfSharesIssued_lbl" xml:lang="en-US">Issuance shares</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NumberOfSharesIssued" xlink:to="ifrs-full_NumberOfSharesIssued_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_NumberOfSharesIssued_lbl0" xml:lang="en-US">Shares issued (in Shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NumberOfSharesIssued" xlink:to="ifrs-full_NumberOfSharesIssued_lbl0"/>
    <loc xlink:type="locator" xlink:label="cve_ShareConsiderationAmount" xlink:href="cve-20221231.xsd#cve_ShareConsiderationAmount"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cve_ShareConsiderationAmount_lbl" xml:lang="en-US">Share Consideration (in Dollars)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_ShareConsiderationAmount" xlink:to="cve_ShareConsiderationAmount_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_StockOptions" xlink:href="cve-20221231.xsd#cve_StockOptions"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cve_StockOptions_lbl" xml:lang="en-US">Stock Options</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_StockOptions" xlink:to="cve_StockOptions_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_SharePurchaseWarrants" xlink:href="cve-20221231.xsd#cve_SharePurchaseWarrants"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cve_SharePurchaseWarrants_lbl" xml:lang="en-US">Share purchase warrants</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_SharePurchaseWarrants" xlink:to="cve_SharePurchaseWarrants_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AcquisitionrelatedCostsRecognisedAsExpenseForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_AcquisitionrelatedCostsRecognisedAsExpenseForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_AcquisitionrelatedCostsRecognisedAsExpenseForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination_lbl" xml:lang="en-US">Transaction costs (in Dollars)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AcquisitionrelatedCostsRecognisedAsExpenseForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination" xlink:to="ifrs-full_AcquisitionrelatedCostsRecognisedAsExpenseForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_WeightedAverageSharePrice2019" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_WeightedAverageSharePrice2019"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_WeightedAverageSharePrice2019_lbl" xml:lang="en-US">Price per share</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_WeightedAverageSharePrice2019" xlink:to="ifrs-full_WeightedAverageSharePrice2019_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_ExchangeRatio" xlink:href="cve-20221231.xsd#cve_ExchangeRatio"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cve_ExchangeRatio_lbl" xml:lang="en-US">Exchange Ratio (in Dollars per share)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_ExchangeRatio" xlink:to="cve_ExchangeRatio_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_ShareConsolidation" xlink:href="cve-20221231.xsd#cve_ShareConsolidation"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cve_ShareConsolidation_lbl" xml:lang="en-US">Share consolidation</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_ShareConsolidation" xlink:to="cve_ShareConsolidation_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ConsiderationPaidReceived" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_ConsiderationPaidReceived"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_ConsiderationPaidReceived_lbl" xml:lang="en-US">Consideration received</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ConsiderationPaidReceived" xlink:to="ifrs-full_ConsiderationPaidReceived_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_ConsiderationPaidReceived_lbl0" xml:lang="en-US">Total consideration</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ConsiderationPaidReceived" xlink:to="ifrs-full_ConsiderationPaidReceived_lbl0"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ContingentConsiderationRecognisedAsOfAcquisitionDate" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_ContingentConsiderationRecognisedAsOfAcquisitionDate"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_ContingentConsiderationRecognisedAsOfAcquisitionDate_lbl" xml:lang="en-US">Contingent payments</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ContingentConsiderationRecognisedAsOfAcquisitionDate" xlink:to="ifrs-full_ContingentConsiderationRecognisedAsOfAcquisitionDate_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_InvestmentInterestRates" xlink:href="cve-20221231.xsd#cve_InvestmentInterestRates"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cve_InvestmentInterestRates_lbl" xml:lang="en-US">Interest rate</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_InvestmentInterestRates" xlink:to="cve_InvestmentInterestRates_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_InterestRateHold" xlink:href="cve-20221231.xsd#cve_InterestRateHold"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cve_InterestRateHold_lbl" xml:lang="en-US">Company holds a interest</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_InterestRateHold" xlink:to="cve_InterestRateHold_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_RoyaltyIncomeRate" xlink:href="cve-20221231.xsd#cve_RoyaltyIncomeRate"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cve_RoyaltyIncomeRate_lbl" xml:lang="en-US">Gross profit royalty</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_RoyaltyIncomeRate" xlink:to="cve_RoyaltyIncomeRate_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_ConsiderationReceived" xlink:href="cve-20221231.xsd#cve_ConsiderationReceived"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cve_ConsiderationReceived_lbl" xml:lang="en-US">Consideration received (in Shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_ConsiderationReceived" xlink:to="cve_ConsiderationReceived_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LongTermDebtFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtFairValue"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_LongTermDebtFairValue_lbl" xml:lang="en-US">Fair value</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermDebtFairValue" xlink:to="us-gaap_LongTermDebtFairValue_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_AdditionalPayment" xlink:href="cve-20221231.xsd#cve_AdditionalPayment"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cve_AdditionalPayment_lbl" xml:lang="en-US">Additional payment</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_AdditionalPayment" xlink:to="cve_AdditionalPayment_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_RecognisedAssetsDefinedBenefitPlan" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_RecognisedAssetsDefinedBenefitPlan"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_RecognisedAssetsDefinedBenefitPlan_lbl" xml:lang="en-US">Net book value of asset</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_RecognisedAssetsDefinedBenefitPlan" xlink:to="ifrs-full_RecognisedAssetsDefinedBenefitPlan_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_GrantedPercentage" xlink:href="cve-20221231.xsd#cve_GrantedPercentage"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cve_GrantedPercentage_lbl" xml:lang="en-US">Granted percentage</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_GrantedPercentage" xlink:to="cve_GrantedPercentage_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_ConsiderationPercentage" xlink:href="cve-20221231.xsd#cve_ConsiderationPercentage"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cve_ConsiderationPercentage_lbl" xml:lang="en-US">Consideration percentage</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_ConsiderationPercentage" xlink:to="cve_ConsiderationPercentage_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_LossesOnDisposalsOfInvestments" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_LossesOnDisposalsOfInvestments"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_LossesOnDisposalsOfInvestments_lbl" xml:lang="en-US">Losses on disposals of investments</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_LossesOnDisposalsOfInvestments" xlink:to="ifrs-full_LossesOnDisposalsOfInvestments_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_InflationFactorPercentage" xlink:href="cve-20221231.xsd#cve_InflationFactorPercentage"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cve_InflationFactorPercentage_lbl" xml:lang="en-US">Inflation factor, percentage</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_InflationFactorPercentage" xlink:to="cve_InflationFactorPercentage_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DescriptionOfDiscountRatesAppliedToCashFlowProjections" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_DescriptionOfDiscountRatesAppliedToCashFlowProjections"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DescriptionOfDiscountRatesAppliedToCashFlowProjections_lbl" xml:lang="en-US">Discount rate</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DescriptionOfDiscountRatesAppliedToCashFlowProjections" xlink:to="ifrs-full_DescriptionOfDiscountRatesAppliedToCashFlowProjections_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_TotalDiscountedMarketPrices" xlink:href="cve-20221231.xsd#cve_TotalDiscountedMarketPrices"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cve_TotalDiscountedMarketPrices_lbl" xml:lang="en-US">Total discounted market prices</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_TotalDiscountedMarketPrices" xlink:to="cve_TotalDiscountedMarketPrices_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_CancellationFee" xlink:href="cve-20221231.xsd#cve_CancellationFee"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cve_CancellationFee_lbl" xml:lang="en-US">Cancellation fee</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_CancellationFee" xlink:to="cve_CancellationFee_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_PursuantToAgreement" xlink:href="cve-20221231.xsd#cve_PursuantToAgreement"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cve_PursuantToAgreement_lbl" xml:lang="en-US">Pursuant to agreement</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_PursuantToAgreement" xlink:to="cve_PursuantToAgreement_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_ContractPoundsOfUranium" xlink:href="cve-20221231.xsd#cve_ContractPoundsOfUranium"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cve_ContractPoundsOfUranium_lbl" xml:lang="en-US">Contract pounds of uranium</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_ContractPoundsOfUranium" xlink:to="cve_ContractPoundsOfUranium_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_PricePerPound" xlink:href="cve-20221231.xsd#cve_PricePerPound"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cve_PricePerPound_lbl" xml:lang="en-US">Price per pound (in Dollars per share)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_PricePerPound" xlink:to="cve_PricePerPound_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_SalesContractsTrem" xlink:href="cve-20221231.xsd#cve_SalesContractsTrem"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cve_SalesContractsTrem_lbl" xml:lang="en-US">Sales contracts term</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_SalesContractsTrem" xlink:to="cve_SalesContractsTrem_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_SharesUnit" xlink:href="cve-20221231.xsd#cve_SharesUnit"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cve_SharesUnit_lbl" xml:lang="en-US">Shares unit</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_SharesUnit" xlink:to="cve_SharesUnit_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_WeightedAverageExercisePriceOfShareOptionsInSharebasedPaymentArrangementExercisedDuringPeriodAtDateOfExercise2019" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_WeightedAverageExercisePriceOfShareOptionsInSharebasedPaymentArrangementExercisedDuringPeriodAtDateOfExercise2019"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_WeightedAverageExercisePriceOfShareOptionsInSharebasedPaymentArrangementExercisedDuringPeriodAtDateOfExercise2019_lbl" xml:lang="en-US">Offering price per unit (in Dollars per share)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_WeightedAverageExercisePriceOfShareOptionsInSharebasedPaymentArrangementExercisedDuringPeriodAtDateOfExercise2019" xlink:to="ifrs-full_WeightedAverageExercisePriceOfShareOptionsInSharebasedPaymentArrangementExercisedDuringPeriodAtDateOfExercise2019_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_GrossProceed" xlink:href="cve-20221231.xsd#cve_GrossProceed"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cve_GrossProceed_lbl" xml:lang="en-US">Gross proceeds</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_GrossProceed" xlink:to="cve_GrossProceed_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_CommonShare" xlink:href="cve-20221231.xsd#cve_CommonShare"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cve_CommonShare_lbl" xml:lang="en-US">Common share</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_CommonShare" xlink:to="cve_CommonShare_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_PurchaseWarrantShares" xlink:href="cve-20221231.xsd#cve_PurchaseWarrantShares"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cve_PurchaseWarrantShares_lbl" xml:lang="en-US">Purchase warrant shares</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_PurchaseWarrantShares" xlink:to="cve_PurchaseWarrantShares_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_PurchaseAdditionalShareWarrants" xlink:href="cve-20221231.xsd#cve_PurchaseAdditionalShareWarrants"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cve_PurchaseAdditionalShareWarrants_lbl" xml:lang="en-US">Purchase additional share warrants</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_PurchaseAdditionalShareWarrants" xlink:to="cve_PurchaseAdditionalShareWarrants_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_PurchaseAdditionalSharePricePerWarrant" xlink:href="cve-20221231.xsd#cve_PurchaseAdditionalSharePricePerWarrant"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cve_PurchaseAdditionalSharePricePerWarrant_lbl" xml:lang="en-US">Purchase additional share price per warrant (in Dollars per share)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_PurchaseAdditionalSharePricePerWarrant" xlink:to="cve_PurchaseAdditionalSharePricePerWarrant_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ReceiptsFromRoyaltiesFeesCommissionsAndOtherRevenue" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_ReceiptsFromRoyaltiesFeesCommissionsAndOtherRevenue"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_ReceiptsFromRoyaltiesFeesCommissionsAndOtherRevenue_lbl" xml:lang="en-US">Paid commissions</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ReceiptsFromRoyaltiesFeesCommissionsAndOtherRevenue" xlink:to="ifrs-full_ReceiptsFromRoyaltiesFeesCommissionsAndOtherRevenue_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_CashIssuanceCosts" xlink:href="cve-20221231.xsd#cve_CashIssuanceCosts"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cve_CashIssuanceCosts_lbl" xml:lang="en-US">Other cash issuance costs</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_CashIssuanceCosts" xlink:to="cve_CashIssuanceCosts_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_ShareIssued" xlink:href="cve-20221231.xsd#cve_ShareIssued"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cve_ShareIssued_lbl" xml:lang="en-US">Shares issued</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_ShareIssued" xlink:to="cve_ShareIssued_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_WarrantsOfFairValue" xlink:href="cve-20221231.xsd#cve_WarrantsOfFairValue"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cve_WarrantsOfFairValue_lbl" xml:lang="en-US">Warrants of fair value</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_WarrantsOfFairValue" xlink:to="cve_WarrantsOfFairValue_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_WarrantsExercisableOfCommonShare" xlink:href="cve-20221231.xsd#cve_WarrantsExercisableOfCommonShare"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cve_WarrantsExercisableOfCommonShare_lbl" xml:lang="en-US">Warrants exercisable of common share</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_WarrantsExercisableOfCommonShare" xlink:to="cve_WarrantsExercisableOfCommonShare_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_WarrantsExercisablePricePerShare" xlink:href="cve-20221231.xsd#cve_WarrantsExercisablePricePerShare"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cve_WarrantsExercisablePricePerShare_lbl" xml:lang="en-US">Warrants exercisable price per share (in Dollars per share)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_WarrantsExercisablePricePerShare" xlink:to="cve_WarrantsExercisablePricePerShare_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_CommonShareIssued" xlink:href="cve-20221231.xsd#cve_CommonShareIssued"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cve_CommonShareIssued_lbl" xml:lang="en-US">Common shares issued</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_CommonShareIssued" xlink:to="cve_CommonShareIssued_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_EquityReclassifiedIntoFinancialLiabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_EquityReclassifiedIntoFinancialLiabilities"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_EquityReclassifiedIntoFinancialLiabilities_lbl" xml:lang="en-US">Warrants exercise reclassified amount (in Dollars)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_EquityReclassifiedIntoFinancialLiabilities" xlink:to="ifrs-full_EquityReclassifiedIntoFinancialLiabilities_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_FinancialLiabilitiesReclassifiedIntoEquity" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_FinancialLiabilitiesReclassifiedIntoEquity"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_FinancialLiabilitiesReclassifiedIntoEquity_lbl" xml:lang="en-US">Stock options exercise reclassified amount (in Dollars)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_FinancialLiabilitiesReclassifiedIntoEquity" xlink:to="ifrs-full_FinancialLiabilitiesReclassifiedIntoEquity_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_CommonSharesOfSettlementAndCompensation" xlink:href="cve-20221231.xsd#cve_CommonSharesOfSettlementAndCompensation"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cve_CommonSharesOfSettlementAndCompensation_lbl" xml:lang="en-US">Common shares of settlement and compensation</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_CommonSharesOfSettlementAndCompensation" xlink:to="cve_CommonSharesOfSettlementAndCompensation_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_NumberOfSharesReservedInsurancePercentage" xlink:href="cve-20221231.xsd#cve_NumberOfSharesReservedInsurancePercentage"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cve_NumberOfSharesReservedInsurancePercentage_lbl" xml:lang="en-US">Number of shares reserved insurance percentage</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_NumberOfSharesReservedInsurancePercentage" xlink:to="cve_NumberOfSharesReservedInsurancePercentage_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_OptionsGrantedForMaximumYear" xlink:href="cve-20221231.xsd#cve_OptionsGrantedForMaximumYear"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cve_OptionsGrantedForMaximumYear_lbl" xml:lang="en-US">Options granted for maximum year</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_OptionsGrantedForMaximumYear" xlink:to="cve_OptionsGrantedForMaximumYear_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_AggregateOfGrantedShares" xlink:href="cve-20221231.xsd#cve_AggregateOfGrantedShares"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cve_AggregateOfGrantedShares_lbl" xml:lang="en-US">Aggregate of granted shares</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_AggregateOfGrantedShares" xlink:to="cve_AggregateOfGrantedShares_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_FairValueOfGrantedOption" xlink:href="cve-20221231.xsd#cve_FairValueOfGrantedOption"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cve_FairValueOfGrantedOption_lbl" xml:lang="en-US">Fair value of granted option (in Dollars)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_FairValueOfGrantedOption" xlink:to="cve_FairValueOfGrantedOption_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_StockOptionsRevisedTerm" xlink:href="cve-20221231.xsd#cve_StockOptionsRevisedTerm"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cve_StockOptionsRevisedTerm_lbl" xml:lang="en-US">Stock options revised term</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_StockOptionsRevisedTerm" xlink:to="cve_StockOptionsRevisedTerm_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_StandardStockOptionVestingPercentage" xlink:href="cve-20221231.xsd#cve_StandardStockOptionVestingPercentage"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cve_StandardStockOptionVestingPercentage_lbl" xml:lang="en-US">Standard stock option vesting percentage</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_StandardStockOptionVestingPercentage" xlink:to="cve_StandardStockOptionVestingPercentage_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_RecognizedStockOptionExpense" xlink:href="cve-20221231.xsd#cve_RecognizedStockOptionExpense"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cve_RecognizedStockOptionExpense_lbl" xml:lang="en-US">Recognized stock option expense (in Dollars)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_RecognizedStockOptionExpense" xlink:to="cve_RecognizedStockOptionExpense_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_WarrantsExercisableShare" xlink:href="cve-20221231.xsd#cve_WarrantsExercisableShare"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cve_WarrantsExercisableShare_lbl" xml:lang="en-US">Warrants exercisable share</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_WarrantsExercisableShare" xlink:to="cve_WarrantsExercisableShare_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_WarrantShare" xlink:href="cve-20221231.xsd#cve_WarrantShare"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cve_WarrantShare_lbl" xml:lang="en-US">Warrant share</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_WarrantShare" xlink:to="cve_WarrantShare_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_WarrantsExercisablePrice" xlink:href="cve-20221231.xsd#cve_WarrantsExercisablePrice"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cve_WarrantsExercisablePrice_lbl" xml:lang="en-US">Warrants exercisable (in Dollars per share)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_WarrantsExercisablePrice" xlink:to="cve_WarrantsExercisablePrice_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_WarrantIsExercisableTerm" xlink:href="cve-20221231.xsd#cve_WarrantIsExercisableTerm"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cve_WarrantIsExercisableTerm_lbl" xml:lang="en-US">Warrant is exercisable term</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_WarrantIsExercisableTerm" xlink:to="cve_WarrantIsExercisableTerm_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DividendsReceived" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_DividendsReceived"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DividendsReceived_lbl" xml:lang="en-US">Company has received amount</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DividendsReceived" xlink:to="ifrs-full_DividendsReceived_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_ConsultingFees" xlink:href="cve-20221231.xsd#cve_ConsultingFees"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cve_ConsultingFees_lbl" xml:lang="en-US">Consulting fees</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_ConsultingFees" xlink:to="cve_ConsultingFees_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_GrantedOptionsShares" xlink:href="cve-20221231.xsd#cve_GrantedOptionsShares"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cve_GrantedOptionsShares_lbl" xml:lang="en-US">Granted options shares (in Shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_GrantedOptionsShares" xlink:to="cve_GrantedOptionsShares_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_FairValueAmount" xlink:href="cve-20221231.xsd#cve_FairValueAmount"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cve_FairValueAmount_lbl" xml:lang="en-US">Fair value amount</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_FairValueAmount" xlink:to="cve_FairValueAmount_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_ForeignExchangeRate" xlink:href="cve-20221231.xsd#cve_ForeignExchangeRate"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cve_ForeignExchangeRate_lbl" xml:lang="en-US">Foreign exchange rate</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_ForeignExchangeRate" xlink:to="cve_ForeignExchangeRate_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_NotionalAmount" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_NotionalAmount"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_NotionalAmount_lbl" xml:lang="en-US">Financial instrument</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NotionalAmount" xlink:to="ifrs-full_NotionalAmount_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_TaxRateEffectFromChangeInTaxRate" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_TaxRateEffectFromChangeInTaxRate"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_TaxRateEffectFromChangeInTaxRate_lbl" xml:lang="en-US">Marketable securities increase or decrease in the share prices</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_TaxRateEffectFromChangeInTaxRate" xlink:to="ifrs-full_TaxRateEffectFromChangeInTaxRate_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_ImpactedLoss" xlink:href="cve-20221231.xsd#cve_ImpactedLoss"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cve_ImpactedLoss_lbl" xml:lang="en-US">Impacted loss</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_ImpactedLoss" xlink:to="cve_ImpactedLoss_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_NoncapitalLoss" xlink:href="cve-20221231.xsd#cve_NoncapitalLoss"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cve_NoncapitalLoss_lbl" xml:lang="en-US">Non-capital loss</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_NoncapitalLoss" xlink:to="cve_NoncapitalLoss_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_FederalNetOperatingLossCarryforwards" xlink:href="cve-20221231.xsd#cve_FederalNetOperatingLossCarryforwards"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cve_FederalNetOperatingLossCarryforwards_lbl" xml:lang="en-US">Federal net operating loss carryforwards</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_FederalNetOperatingLossCarryforwards" xlink:to="cve_FederalNetOperatingLossCarryforwards_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_CarriedForward" xlink:href="cve-20221231.xsd#cve_CarriedForward"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cve_CarriedForward_lbl" xml:lang="en-US">Carried forward</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_CarriedForward" xlink:to="cve_CarriedForward_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_ExpiringAmount" xlink:href="cve-20221231.xsd#cve_ExpiringAmount"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cve_ExpiringAmount_lbl" xml:lang="en-US">Expiring amount</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_ExpiringAmount" xlink:to="cve_ExpiringAmount_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_AcquireCommonShare" xlink:href="cve-20221231.xsd#cve_AcquireCommonShare"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cve_AcquireCommonShare_lbl" xml:lang="en-US">Acquire common shares</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_AcquireCommonShare" xlink:to="cve_AcquireCommonShare_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_SubscriptionCirculationRevenue" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_SubscriptionCirculationRevenue"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_SubscriptionCirculationRevenue_lbl" xml:lang="en-US">Subscription receipts issued</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_SubscriptionCirculationRevenue" xlink:to="ifrs-full_SubscriptionCirculationRevenue_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_Saleofstockpershare" xlink:href="cve-20221231.xsd#cve_Saleofstockpershare"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cve_Saleofstockpershare_lbl" xml:lang="en-US">Sale of stock per share (in Dollars per share)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_Saleofstockpershare" xlink:to="cve_Saleofstockpershare_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_PricePerShare" xlink:href="cve-20221231.xsd#cve_PricePerShare"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cve_PricePerShare_lbl" xml:lang="en-US">Price per share (in Dollars per share)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_PricePerShare" xlink:to="cve_PricePerShare_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromDebtNetOfIssuanceCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromDebtNetOfIssuanceCosts"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ProceedsFromDebtNetOfIssuanceCosts_lbl" xml:lang="en-US">Net proceeds</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromDebtNetOfIssuanceCosts" xlink:to="us-gaap_ProceedsFromDebtNetOfIssuanceCosts_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_PublicOfferingPricePerShare" xlink:href="cve-20221231.xsd#cve_PublicOfferingPricePerShare"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cve_PublicOfferingPricePerShare_lbl" xml:lang="en-US">Public offering price per share (in Dollars per share)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_PublicOfferingPricePerShare" xlink:to="cve_PublicOfferingPricePerShare_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_PurchasePricePerShare" xlink:href="cve-20221231.xsd#cve_PurchasePricePerShare"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cve_PurchasePricePerShare_lbl" xml:lang="en-US">Purchase price per share (in Dollars per share)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_PurchasePricePerShare" xlink:to="cve_PurchasePricePerShare_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_StockOptionsSharesOutstanding" xlink:href="cve-20221231.xsd#cve_StockOptionsSharesOutstanding"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cve_StockOptionsSharesOutstanding_lbl" xml:lang="en-US">Stock options shares outstanding (in Shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_StockOptionsSharesOutstanding" xlink:to="cve_StockOptionsSharesOutstanding_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_GrantedStockOptions" xlink:href="cve-20221231.xsd#cve_GrantedStockOptions"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cve_GrantedStockOptions_lbl" xml:lang="en-US">Granted stock options shares (in Shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_GrantedStockOptions" xlink:to="cve_GrantedStockOptions_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_WeightedAverageExercisePrice" xlink:href="cve-20221231.xsd#cve_WeightedAverageExercisePrice"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cve_WeightedAverageExercisePrice_lbl" xml:lang="en-US">Weighted average exercise price (in Dollars per share)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_WeightedAverageExercisePrice" xlink:to="cve_WeightedAverageExercisePrice_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_PurchasedShares" xlink:href="cve-20221231.xsd#cve_PurchasedShares"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cve_PurchasedShares_lbl" xml:lang="en-US">Purchased shares (in Shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_PurchasedShares" xlink:to="cve_PurchasedShares_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_TransactionCost" xlink:href="cve-20221231.xsd#cve_TransactionCost"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cve_TransactionCost_lbl" xml:lang="en-US">Transaction cost</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_TransactionCost" xlink:to="cve_TransactionCost_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_OptionToAcquireShares" xlink:href="cve-20221231.xsd#cve_OptionToAcquireShares"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cve_OptionToAcquireShares_lbl" xml:lang="en-US">Option to acquire shares (in Shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_OptionToAcquireShares" xlink:to="cve_OptionToAcquireShares_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_TotalConsiderationPerPounds" xlink:href="cve-20221231.xsd#cve_TotalConsiderationPerPounds"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cve_TotalConsiderationPerPounds_lbl" xml:lang="en-US">Total consideration per pound (in Dollars per share)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_TotalConsiderationPerPounds" xlink:to="cve_TotalConsiderationPerPounds_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_PaymentAmount" xlink:href="cve-20221231.xsd#cve_PaymentAmount"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cve_PaymentAmount_lbl" xml:lang="en-US">Payment amount</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_PaymentAmount" xlink:to="cve_PaymentAmount_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_AssetsReceivedPercentage" xlink:href="cve-20221231.xsd#cve_AssetsReceivedPercentage"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cve_AssetsReceivedPercentage_lbl" xml:lang="en-US">Assets received percentage</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_AssetsReceivedPercentage" xlink:to="cve_AssetsReceivedPercentage_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_DescriptionOfAccountingPolicyForBasisOfPresentationtextBlock" xlink:href="cve-20221231.xsd#cve_DescriptionOfAccountingPolicyForBasisOfPresentationtextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cve_DescriptionOfAccountingPolicyForBasisOfPresentationtextBlock_lbl" xml:lang="en-US">Basis of presentation</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_DescriptionOfAccountingPolicyForBasisOfPresentationtextBlock" xlink:to="cve_DescriptionOfAccountingPolicyForBasisOfPresentationtextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_DescriptionOfAccountingPolicyForChangeInPresentationCurrencytextBlock" xlink:href="cve-20221231.xsd#cve_DescriptionOfAccountingPolicyForChangeInPresentationCurrencytextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cve_DescriptionOfAccountingPolicyForChangeInPresentationCurrencytextBlock_lbl" xml:lang="en-US">Change in presentation currency</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_DescriptionOfAccountingPolicyForChangeInPresentationCurrencytextBlock" xlink:to="cve_DescriptionOfAccountingPolicyForChangeInPresentationCurrencytextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_DescriptionOfAccountingPolicyForBasisOfConsolidationtextBlock" xlink:href="cve-20221231.xsd#cve_DescriptionOfAccountingPolicyForBasisOfConsolidationtextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cve_DescriptionOfAccountingPolicyForBasisOfConsolidationtextBlock_lbl" xml:lang="en-US">Basis of consolidation</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_DescriptionOfAccountingPolicyForBasisOfConsolidationtextBlock" xlink:to="cve_DescriptionOfAccountingPolicyForBasisOfConsolidationtextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_DescriptionOfAccountingPolicyForCashtextBlock" xlink:href="cve-20221231.xsd#cve_DescriptionOfAccountingPolicyForCashtextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cve_DescriptionOfAccountingPolicyForCashtextBlock_lbl" xml:lang="en-US">Cash</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_DescriptionOfAccountingPolicyForCashtextBlock" xlink:to="cve_DescriptionOfAccountingPolicyForCashtextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DescriptionOfAccountingPolicyToDetermineComponentsOfCashAndCashEquivalents" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_DescriptionOfAccountingPolicyToDetermineComponentsOfCashAndCashEquivalents"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DescriptionOfAccountingPolicyToDetermineComponentsOfCashAndCashEquivalents_lbl" xml:lang="en-US">Restricted cash</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DescriptionOfAccountingPolicyToDetermineComponentsOfCashAndCashEquivalents" xlink:to="ifrs-full_DescriptionOfAccountingPolicyToDetermineComponentsOfCashAndCashEquivalents_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_DescriptionOfAccountingPolicyForAssetRetirementObligationstextBlock" xlink:href="cve-20221231.xsd#cve_DescriptionOfAccountingPolicyForAssetRetirementObligationstextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cve_DescriptionOfAccountingPolicyForAssetRetirementObligationstextBlock_lbl" xml:lang="en-US">Asset retirement obligations</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_DescriptionOfAccountingPolicyForAssetRetirementObligationstextBlock" xlink:to="cve_DescriptionOfAccountingPolicyForAssetRetirementObligationstextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForAvailableforsaleFinancialAssetsExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_DescriptionOfAccountingPolicyForAvailableforsaleFinancialAssetsExplanatory"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForAvailableforsaleFinancialAssetsExplanatory_lbl" xml:lang="en-US">Assets held for sale</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DescriptionOfAccountingPolicyForAvailableforsaleFinancialAssetsExplanatory" xlink:to="ifrs-full_DescriptionOfAccountingPolicyForAvailableforsaleFinancialAssetsExplanatory_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_DescriptionOfAccountingPolicyForMineralPropertiestextBlock" xlink:href="cve-20221231.xsd#cve_DescriptionOfAccountingPolicyForMineralPropertiestextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cve_DescriptionOfAccountingPolicyForMineralPropertiestextBlock_lbl" xml:lang="en-US">Mineral properties</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_DescriptionOfAccountingPolicyForMineralPropertiestextBlock" xlink:to="cve_DescriptionOfAccountingPolicyForMineralPropertiestextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_DescriptionOfAccountingPolicyForInvestmentsInUraniumtextBlock" xlink:href="cve-20221231.xsd#cve_DescriptionOfAccountingPolicyForInvestmentsInUraniumtextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cve_DescriptionOfAccountingPolicyForInvestmentsInUraniumtextBlock_lbl" xml:lang="en-US">Investments in uranium</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_DescriptionOfAccountingPolicyForInvestmentsInUraniumtextBlock" xlink:to="cve_DescriptionOfAccountingPolicyForInvestmentsInUraniumtextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForInvestmentInAssociates" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_DescriptionOfAccountingPolicyForInvestmentInAssociates"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForInvestmentInAssociates_lbl" xml:lang="en-US">Investments in associates</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DescriptionOfAccountingPolicyForInvestmentInAssociates" xlink:to="ifrs-full_DescriptionOfAccountingPolicyForInvestmentInAssociates_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory_lbl" xml:lang="en-US">Property, plant and equipment</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory" xlink:to="ifrs-full_DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_DescriptionOfAccountingPolicyForUraniumPlantstextBlock" xlink:href="cve-20221231.xsd#cve_DescriptionOfAccountingPolicyForUraniumPlantstextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cve_DescriptionOfAccountingPolicyForUraniumPlantstextBlock_lbl" xml:lang="en-US">Uranium plants</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_DescriptionOfAccountingPolicyForUraniumPlantstextBlock" xlink:to="cve_DescriptionOfAccountingPolicyForUraniumPlantstextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_DescriptionOfAccountingPolicyForOtherPropertyPlantAndEquipmenttextBlock" xlink:href="cve-20221231.xsd#cve_DescriptionOfAccountingPolicyForOtherPropertyPlantAndEquipmenttextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cve_DescriptionOfAccountingPolicyForOtherPropertyPlantAndEquipmenttextBlock_lbl" xml:lang="en-US">Other property, plant and equipment</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_DescriptionOfAccountingPolicyForOtherPropertyPlantAndEquipmenttextBlock" xlink:to="cve_DescriptionOfAccountingPolicyForOtherPropertyPlantAndEquipmenttextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_DescriptionOfAccountingPolicyForBuildingtextBlock" xlink:href="cve-20221231.xsd#cve_DescriptionOfAccountingPolicyForBuildingtextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cve_DescriptionOfAccountingPolicyForBuildingtextBlock_lbl" xml:lang="en-US">Buildings</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_DescriptionOfAccountingPolicyForBuildingtextBlock" xlink:to="cve_DescriptionOfAccountingPolicyForBuildingtextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_DescriptionOfAccountingPolicyForSoftwaretextBlock" xlink:href="cve-20221231.xsd#cve_DescriptionOfAccountingPolicyForSoftwaretextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cve_DescriptionOfAccountingPolicyForSoftwaretextBlock_lbl" xml:lang="en-US">Software</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_DescriptionOfAccountingPolicyForSoftwaretextBlock" xlink:to="cve_DescriptionOfAccountingPolicyForSoftwaretextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForIntangibleAssetsAndGoodwillExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_DescriptionOfAccountingPolicyForIntangibleAssetsAndGoodwillExplanatory"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForIntangibleAssetsAndGoodwillExplanatory_lbl" xml:lang="en-US">Intangible assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DescriptionOfAccountingPolicyForIntangibleAssetsAndGoodwillExplanatory" xlink:to="ifrs-full_DescriptionOfAccountingPolicyForIntangibleAssetsAndGoodwillExplanatory_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForImpairmentOfNonfinancialAssetsExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_DescriptionOfAccountingPolicyForImpairmentOfNonfinancialAssetsExplanatory"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForImpairmentOfNonfinancialAssetsExplanatory_lbl" xml:lang="en-US">Impairment of non-financial assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DescriptionOfAccountingPolicyForImpairmentOfNonfinancialAssetsExplanatory" xlink:to="ifrs-full_DescriptionOfAccountingPolicyForImpairmentOfNonfinancialAssetsExplanatory_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForLeasesExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_DescriptionOfAccountingPolicyForLeasesExplanatory"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForLeasesExplanatory_lbl" xml:lang="en-US">Leases</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DescriptionOfAccountingPolicyForLeasesExplanatory" xlink:to="ifrs-full_DescriptionOfAccountingPolicyForLeasesExplanatory_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForIncomeTaxExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_DescriptionOfAccountingPolicyForIncomeTaxExplanatory"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForIncomeTaxExplanatory_lbl" xml:lang="en-US">Income Tax</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DescriptionOfAccountingPolicyForIncomeTaxExplanatory" xlink:to="ifrs-full_DescriptionOfAccountingPolicyForIncomeTaxExplanatory_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_lbl" xml:lang="en-US">Foreign currency translation</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:to="us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForEarningsPerShareExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_DescriptionOfAccountingPolicyForEarningsPerShareExplanatory"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForEarningsPerShareExplanatory_lbl" xml:lang="en-US">Earnings (loss) per share</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DescriptionOfAccountingPolicyForEarningsPerShareExplanatory" xlink:to="ifrs-full_DescriptionOfAccountingPolicyForEarningsPerShareExplanatory_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_DescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory_lbl" xml:lang="en-US">Share-based payments</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory" xlink:to="ifrs-full_DescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForWarrantsExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_DescriptionOfAccountingPolicyForWarrantsExplanatory"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForWarrantsExplanatory_lbl" xml:lang="en-US">Warrants issued in equity financing transactions</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DescriptionOfAccountingPolicyForWarrantsExplanatory" xlink:to="ifrs-full_DescriptionOfAccountingPolicyForWarrantsExplanatory_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForFinancialInstrumentsExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_DescriptionOfAccountingPolicyForFinancialInstrumentsExplanatory"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForFinancialInstrumentsExplanatory_lbl" xml:lang="en-US">Financial instruments</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DescriptionOfAccountingPolicyForFinancialInstrumentsExplanatory" xlink:to="ifrs-full_DescriptionOfAccountingPolicyForFinancialInstrumentsExplanatory_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForImpairmentOfFinancialAssetsExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_DescriptionOfAccountingPolicyForImpairmentOfFinancialAssetsExplanatory"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForImpairmentOfFinancialAssetsExplanatory_lbl" xml:lang="en-US">Impairment of financial assets at amortized cost</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DescriptionOfAccountingPolicyForImpairmentOfFinancialAssetsExplanatory" xlink:to="ifrs-full_DescriptionOfAccountingPolicyForImpairmentOfFinancialAssetsExplanatory_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForDerecognitionOfFinancialInstrumentsExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_DescriptionOfAccountingPolicyForDerecognitionOfFinancialInstrumentsExplanatory"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForDerecognitionOfFinancialInstrumentsExplanatory_lbl" xml:lang="en-US">Derecognition of financial assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DescriptionOfAccountingPolicyForDerecognitionOfFinancialInstrumentsExplanatory" xlink:to="ifrs-full_DescriptionOfAccountingPolicyForDerecognitionOfFinancialInstrumentsExplanatory_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_DescriptionOfAccountingPolicyForNewStandardsAndInterpretationsNotYetAdoptedtextBlock" xlink:href="cve-20221231.xsd#cve_DescriptionOfAccountingPolicyForNewStandardsAndInterpretationsNotYetAdoptedtextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cve_DescriptionOfAccountingPolicyForNewStandardsAndInterpretationsNotYetAdoptedtextBlock_lbl" xml:lang="en-US">New standards and interpretations not yet adopted</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_DescriptionOfAccountingPolicyForNewStandardsAndInterpretationsNotYetAdoptedtextBlock" xlink:to="cve_DescriptionOfAccountingPolicyForNewStandardsAndInterpretationsNotYetAdoptedtextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="srt_ScenarioForecastMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioForecastMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="srt_ScenarioForecastMember_lbl" xml:lang="en-US">Forecast [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_ScenarioForecastMember" xlink:to="srt_ScenarioForecastMember_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_MarketableSecuritiesMember" xlink:href="cve-20221231.xsd#cve_MarketableSecuritiesMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cve_MarketableSecuritiesMember_lbl" xml:lang="en-US">Marketable securities [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_MarketableSecuritiesMember" xlink:to="cve_MarketableSecuritiesMember_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_TradingSharesMember" xlink:href="cve-20221231.xsd#cve_TradingSharesMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cve_TradingSharesMember_lbl" xml:lang="en-US">Trading Shares [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_TradingSharesMember" xlink:to="cve_TradingSharesMember_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_RightofuseAssetsMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_RightofuseAssetsMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_RightofuseAssetsMember_lbl" xml:lang="en-US">Right-of-use assets [member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_RightofuseAssetsMember" xlink:to="ifrs-full_RightofuseAssetsMember_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_ReplacementOptionsMember" xlink:href="cve-20221231.xsd#cve_ReplacementOptionsMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cve_ReplacementOptionsMember_lbl" xml:lang="en-US">Replacement Options [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_ReplacementOptionsMember" xlink:to="cve_ReplacementOptionsMember_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_ReplacementWarrantsMember" xlink:href="cve-20221231.xsd#cve_ReplacementWarrantsMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cve_ReplacementWarrantsMember_lbl" xml:lang="en-US">Replacement Warrants [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_ReplacementWarrantsMember" xlink:to="cve_ReplacementWarrantsMember_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ContingentConsiderationMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_ContingentConsiderationMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_ContingentConsiderationMember_lbl" xml:lang="en-US">Contingent consideration [member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ContingentConsiderationMember" xlink:to="ifrs-full_ContingentConsiderationMember_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_TriStateGenerationAndTransmissionAssociationMember" xlink:href="cve-20221231.xsd#cve_TriStateGenerationAndTransmissionAssociationMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cve_TriStateGenerationAndTransmissionAssociationMember_lbl" xml:lang="en-US">Tri State Generation and Transmission Association [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_TriStateGenerationAndTransmissionAssociationMember" xlink:to="cve_TriStateGenerationAndTransmissionAssociationMember_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="cve_TriStateGenerationAndTransmissionAssociationMember_lbl0" xml:lang="en-US">Tri State Generation and Transmission Association [Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_TriStateGenerationAndTransmissionAssociationMember" xlink:to="cve_TriStateGenerationAndTransmissionAssociationMember_lbl0"/>
    <loc xlink:type="locator" xlink:label="cve_WildcatSolarPowerPlantLLCMember" xlink:href="cve-20221231.xsd#cve_WildcatSolarPowerPlantLLCMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cve_WildcatSolarPowerPlantLLCMember_lbl" xml:lang="en-US">Wildcat Solar Power Plant, LLC [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_WildcatSolarPowerPlantLLCMember" xlink:to="cve_WildcatSolarPowerPlantLLCMember_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_McKinleyMember" xlink:href="cve-20221231.xsd#cve_McKinleyMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cve_McKinleyMember_lbl" xml:lang="en-US">McKinley [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_McKinleyMember" xlink:to="cve_McKinleyMember_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_CrownpointMember" xlink:href="cve-20221231.xsd#cve_CrownpointMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cve_CrownpointMember_lbl" xml:lang="en-US">Crownpoint [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_CrownpointMember" xlink:to="cve_CrownpointMember_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_HostaButteMember" xlink:href="cve-20221231.xsd#cve_HostaButteMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cve_HostaButteMember_lbl" xml:lang="en-US">Hosta butte [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_HostaButteMember" xlink:to="cve_HostaButteMember_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_PrimeFuelsCorpMember" xlink:href="cve-20221231.xsd#cve_PrimeFuelsCorpMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cve_PrimeFuelsCorpMember_lbl" xml:lang="en-US">Prime Fuels Corp [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_PrimeFuelsCorpMember" xlink:to="cve_PrimeFuelsCorpMember_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_WarrantsMember" xlink:href="cve-20221231.xsd#cve_WarrantsMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cve_WarrantsMember_lbl" xml:lang="en-US">Warrants [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_WarrantsMember" xlink:to="cve_WarrantsMember_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_StockOptionsMember" xlink:href="cve-20221231.xsd#cve_StockOptionsMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cve_StockOptionsMember_lbl" xml:lang="en-US">Stock Options [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_StockOptionsMember" xlink:to="cve_StockOptionsMember_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_PlatoroWestIncMember" xlink:href="cve-20221231.xsd#cve_PlatoroWestIncMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cve_PlatoroWestIncMember_lbl" xml:lang="en-US">Platoro West Inc. [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_PlatoroWestIncMember" xlink:to="cve_PlatoroWestIncMember_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_EnergyFuelsIncMember" xlink:href="cve-20221231.xsd#cve_EnergyFuelsIncMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cve_EnergyFuelsIncMember_lbl" xml:lang="en-US">Energy Fuels, Inc [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_EnergyFuelsIncMember" xlink:to="cve_EnergyFuelsIncMember_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_AltaMesaAcquisitionMember" xlink:href="cve-20221231.xsd#cve_AltaMesaAcquisitionMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cve_AltaMesaAcquisitionMember_lbl" xml:lang="en-US">Alta Mesa Acquisition [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_AltaMesaAcquisitionMember" xlink:to="cve_AltaMesaAcquisitionMember_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_SubsequentEventOneMember" xlink:href="cve-20221231.xsd#cve_SubsequentEventOneMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cve_SubsequentEventOneMember_lbl" xml:lang="en-US">Subsequent [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_SubsequentEventOneMember" xlink:to="cve_SubsequentEventOneMember_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="cve_SubsequentEventOneMember_lbl0" xml:lang="en-US">Subsequent Event [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_SubsequentEventOneMember" xlink:to="cve_SubsequentEventOneMember_lbl0"/>
    <loc xlink:type="locator" xlink:label="cve_SubsequentEventTwoMember" xlink:href="cve-20221231.xsd#cve_SubsequentEventTwoMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cve_SubsequentEventTwoMember_lbl" xml:lang="en-US">Subsequent Event [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_SubsequentEventTwoMember" xlink:to="cve_SubsequentEventTwoMember_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_SubsequentEventThreeMember" xlink:href="cve-20221231.xsd#cve_SubsequentEventThreeMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cve_SubsequentEventThreeMember_lbl" xml:lang="en-US">Subsequent Event [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_SubsequentEventThreeMember" xlink:to="cve_SubsequentEventThreeMember_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_SubsequentEventFourMember" xlink:href="cve-20221231.xsd#cve_SubsequentEventFourMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cve_SubsequentEventFourMember_lbl" xml:lang="en-US">Subsequent Event [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_SubsequentEventFourMember" xlink:to="cve_SubsequentEventFourMember_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_EquityMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_EquityMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_EquityMember_lbl" xml:lang="en-US">Equity [member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_EquityMember" xlink:to="ifrs-full_EquityMember_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_StatementOfChangesInEquityTable" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_StatementOfChangesInEquityTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_StatementOfChangesInEquityTable_lbl" xml:lang="en-US">Statement of changes in equity [table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_StatementOfChangesInEquityTable" xlink:to="ifrs-full_StatementOfChangesInEquityTable_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_StatementOfChangesInEquityLineItems" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_StatementOfChangesInEquityLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_StatementOfChangesInEquityLineItems_lbl" xml:lang="en-US">Statement of changes in equity [line items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_StatementOfChangesInEquityLineItems" xlink:to="ifrs-full_StatementOfChangesInEquityLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_NatureofOperationsandGoingConcernTable" xlink:href="cve-20221231.xsd#cve_NatureofOperationsandGoingConcernTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_NatureofOperationsandGoingConcernTable_lbl" xml:lang="en-US">Nature of Operations and Going Concern [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_NatureofOperationsandGoingConcernTable" xlink:to="cve_NatureofOperationsandGoingConcernTable_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_NatureofOperationsandGoingConcernLineItems" xlink:href="cve-20221231.xsd#cve_NatureofOperationsandGoingConcernLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cve_NatureofOperationsandGoingConcernLineItems_lbl" xml:lang="en-US">Nature of Operation and Going Concern [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_NatureofOperationsandGoingConcernLineItems" xlink:to="cve_NatureofOperationsandGoingConcernLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_SignificantaccountingpoliciesTable" xlink:href="cve-20221231.xsd#cve_SignificantaccountingpoliciesTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_SignificantaccountingpoliciesTable_lbl" xml:lang="en-US">Significant accounting policies [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_SignificantaccountingpoliciesTable" xlink:to="cve_SignificantaccountingpoliciesTable_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_SignificantaccountingpoliciesLineItems" xlink:href="cve-20221231.xsd#cve_SignificantaccountingpoliciesLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cve_SignificantaccountingpoliciesLineItems_lbl" xml:lang="en-US">Significant accounting policies [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_SignificantaccountingpoliciesLineItems" xlink:to="cve_SignificantaccountingpoliciesLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_CriticalAccountingEstimatesAndJudgementsTable" xlink:href="cve-20221231.xsd#cve_CriticalAccountingEstimatesAndJudgementsTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_CriticalAccountingEstimatesAndJudgementsTable_lbl" xml:lang="en-US">Critical Accounting Estimates And Judgements [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_CriticalAccountingEstimatesAndJudgementsTable" xlink:to="cve_CriticalAccountingEstimatesAndJudgementsTable_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_CriticalAccountingEstimatesAndJudgementsLineItems" xlink:href="cve-20221231.xsd#cve_CriticalAccountingEstimatesAndJudgementsLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cve_CriticalAccountingEstimatesAndJudgementsLineItems_lbl" xml:lang="en-US">Critical accounting estimates and judgements [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_CriticalAccountingEstimatesAndJudgementsLineItems" xlink:to="cve_CriticalAccountingEstimatesAndJudgementsLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_InvestmentInAssociateTable" xlink:href="cve-20221231.xsd#cve_InvestmentInAssociateTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_InvestmentInAssociateTable_lbl" xml:lang="en-US">Investment In Associate [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_InvestmentInAssociateTable" xlink:to="cve_InvestmentInAssociateTable_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_InvestmentInAssociateLineItems" xlink:href="cve-20221231.xsd#cve_InvestmentInAssociateLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_InvestmentInAssociateLineItems_lbl" xml:lang="en-US">Investment In Associate [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_InvestmentInAssociateLineItems" xlink:to="cve_InvestmentInAssociateLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_MarketableSecuritiesTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MarketableSecuritiesTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_MarketableSecuritiesTable_lbl" xml:lang="en-US">Marketable Securities [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MarketableSecuritiesTable" xlink:to="us-gaap_MarketableSecuritiesTable_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_MarketableSecuritiesLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MarketableSecuritiesLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_MarketableSecuritiesLineItems_lbl" xml:lang="en-US">Marketable Securities [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MarketableSecuritiesLineItems" xlink:to="us-gaap_MarketableSecuritiesLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_IntangibleassetsTable" xlink:href="cve-20221231.xsd#cve_IntangibleassetsTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_IntangibleassetsTable_lbl" xml:lang="en-US">Intangible assets [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_IntangibleassetsTable" xlink:to="cve_IntangibleassetsTable_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_IntangibleassetsLineItems" xlink:href="cve-20221231.xsd#cve_IntangibleassetsLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_IntangibleassetsLineItems_lbl" xml:lang="en-US">Intangible assets [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_IntangibleassetsLineItems" xlink:to="cve_IntangibleassetsLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_RightofuseassetsTable" xlink:href="cve-20221231.xsd#cve_RightofuseassetsTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_RightofuseassetsTable_lbl" xml:lang="en-US">Right-of-use assets [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_RightofuseassetsTable" xlink:to="cve_RightofuseassetsTable_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_RightofuseassetsLineItems" xlink:href="cve-20221231.xsd#cve_RightofuseassetsLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_RightofuseassetsLineItems_lbl" xml:lang="en-US">Right-of-use assets [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_RightofuseassetsLineItems" xlink:to="cve_RightofuseassetsLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_AssetretirementobligationsTable" xlink:href="cve-20221231.xsd#cve_AssetretirementobligationsTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_AssetretirementobligationsTable_lbl" xml:lang="en-US">Asset retirement obligations [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_AssetretirementobligationsTable" xlink:to="cve_AssetretirementobligationsTable_lbl"/>
<!-- [WMV5][XcpuxYn59dz7vgYynUDuwG7r97K2jUTysl7vcz0lJt/tSeJz73kx1cLt0ZFF2SK/vxBCY0vdSrapBeolBQDhlou4Plg3ZACHgOGjaxwoV9s22fcKeqdlVg/8vXE8BEQPw2gSl8Pfy/SjqfZKUO0G5mehrda5xVrvtHGkgNXPOUg3vb7VF4CMNIMcgg6F7hiC/dgsHya46cPL6td1bLnSV35L5jAlrEDBDi0RC0EWIRx+TpXQjl5L5FZgRjEoUSEZnPyEl4EzUNPtNlIjOphFGvJ66a/UEiIC] CSR-->
    <loc xlink:type="locator" xlink:label="cve_AssetretirementobligationsLineItems" xlink:href="cve-20221231.xsd#cve_AssetretirementobligationsLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_AssetretirementobligationsLineItems_lbl" xml:lang="en-US">Asset retirement obligations [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_AssetretirementobligationsLineItems" xlink:to="cve_AssetretirementobligationsLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_SalescontractsTable" xlink:href="cve-20221231.xsd#cve_SalescontractsTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_SalescontractsTable_lbl" xml:lang="en-US">Sales contracts [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_SalescontractsTable" xlink:to="cve_SalescontractsTable_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_SalescontractsLineItems" xlink:href="cve-20221231.xsd#cve_SalescontractsLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_SalescontractsLineItems_lbl" xml:lang="en-US">Sales contracts [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_SalescontractsLineItems" xlink:to="cve_SalescontractsLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_ShareCapitalTable" xlink:href="cve-20221231.xsd#cve_ShareCapitalTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_ShareCapitalTable_lbl" xml:lang="en-US">Share Capital [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_ShareCapitalTable" xlink:to="cve_ShareCapitalTable_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_ShareCapitalLineItems" xlink:href="cve-20221231.xsd#cve_ShareCapitalLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_ShareCapitalLineItems_lbl" xml:lang="en-US">Share Capital [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_ShareCapitalLineItems" xlink:to="cve_ShareCapitalLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_SegmentedinformationTable" xlink:href="cve-20221231.xsd#cve_SegmentedinformationTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_SegmentedinformationTable_lbl" xml:lang="en-US">Segmented information [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_SegmentedinformationTable" xlink:to="cve_SegmentedinformationTable_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_SegmentedinformationLineItems" xlink:href="cve-20221231.xsd#cve_SegmentedinformationLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_SegmentedinformationLineItems_lbl" xml:lang="en-US">Segmented information [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_SegmentedinformationLineItems" xlink:to="cve_SegmentedinformationLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_SignificantaccountingpoliciesTablesTable" xlink:href="cve-20221231.xsd#cve_SignificantaccountingpoliciesTablesTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_SignificantaccountingpoliciesTablesTable_lbl" xml:lang="en-US">Significant accounting policies (Tables) [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_SignificantaccountingpoliciesTablesTable" xlink:to="cve_SignificantaccountingpoliciesTablesTable_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_SignificantaccountingpoliciesTablesLineItems" xlink:href="cve-20221231.xsd#cve_SignificantaccountingpoliciesTablesLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cve_SignificantaccountingpoliciesTablesLineItems_lbl" xml:lang="en-US">Significant accounting policies [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_SignificantaccountingpoliciesTablesLineItems" xlink:to="cve_SignificantaccountingpoliciesTablesLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_InvestmentInAssociateTablesTable" xlink:href="cve-20221231.xsd#cve_InvestmentInAssociateTablesTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_InvestmentInAssociateTablesTable_lbl" xml:lang="en-US">Investment In Associate (Tables) [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_InvestmentInAssociateTablesTable" xlink:to="cve_InvestmentInAssociateTablesTable_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_InvestmentInAssociateTablesLineItems" xlink:href="cve-20221231.xsd#cve_InvestmentInAssociateTablesLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cve_InvestmentInAssociateTablesLineItems_lbl" xml:lang="en-US">Investment in Associate [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_InvestmentInAssociateTablesLineItems" xlink:to="cve_InvestmentInAssociateTablesLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_MarketableSecuritiesTablesTable" xlink:href="cve-20221231.xsd#cve_MarketableSecuritiesTablesTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_MarketableSecuritiesTablesTable_lbl" xml:lang="en-US">Marketable Securities (Tables) [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_MarketableSecuritiesTablesTable" xlink:to="cve_MarketableSecuritiesTablesTable_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_MarketableSecuritiesTablesLineItems" xlink:href="cve-20221231.xsd#cve_MarketableSecuritiesTablesLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cve_MarketableSecuritiesTablesLineItems_lbl" xml:lang="en-US">Marketable Securities [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_MarketableSecuritiesTablesLineItems" xlink:to="cve_MarketableSecuritiesTablesLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_IntangibleassetsTablesTable" xlink:href="cve-20221231.xsd#cve_IntangibleassetsTablesTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_IntangibleassetsTablesTable_lbl" xml:lang="en-US">Intangible assets (Tables) [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_IntangibleassetsTablesTable" xlink:to="cve_IntangibleassetsTablesTable_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_IntangibleassetsTablesLineItems" xlink:href="cve-20221231.xsd#cve_IntangibleassetsTablesLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cve_IntangibleassetsTablesLineItems_lbl" xml:lang="en-US">Intangible assets [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_IntangibleassetsTablesLineItems" xlink:to="cve_IntangibleassetsTablesLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_PropertyplantandequipmentTablesTable" xlink:href="cve-20221231.xsd#cve_PropertyplantandequipmentTablesTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cve_PropertyplantandequipmentTablesTable_lbl" xml:lang="en-US">Schedule of property, plant, and equipment [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_PropertyplantandequipmentTablesTable" xlink:to="cve_PropertyplantandequipmentTablesTable_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_PropertyplantandequipmentTablesLineItems" xlink:href="cve-20221231.xsd#cve_PropertyplantandequipmentTablesLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cve_PropertyplantandequipmentTablesLineItems_lbl" xml:lang="en-US">Schedule of property, plant, and equipment [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_PropertyplantandequipmentTablesLineItems" xlink:to="cve_PropertyplantandequipmentTablesLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_RightofuseassetsTablesTable" xlink:href="cve-20221231.xsd#cve_RightofuseassetsTablesTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_RightofuseassetsTablesTable_lbl" xml:lang="en-US">Right-of-use assets (Tables) [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_RightofuseassetsTablesTable" xlink:to="cve_RightofuseassetsTablesTable_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_RightofuseassetsTablesLineItems" xlink:href="cve-20221231.xsd#cve_RightofuseassetsTablesLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cve_RightofuseassetsTablesLineItems_lbl" xml:lang="en-US">Right-of-use assets [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_RightofuseassetsTablesLineItems" xlink:to="cve_RightofuseassetsTablesLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_AssetretirementobligationsTablesTable" xlink:href="cve-20221231.xsd#cve_AssetretirementobligationsTablesTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_AssetretirementobligationsTablesTable_lbl" xml:lang="en-US">Asset retirement obligations (Tables) [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_AssetretirementobligationsTablesTable" xlink:to="cve_AssetretirementobligationsTablesTable_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_AssetretirementobligationsTablesLineItems" xlink:href="cve-20221231.xsd#cve_AssetretirementobligationsTablesLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cve_AssetretirementobligationsTablesLineItems_lbl" xml:lang="en-US">Asset retirement obligations [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_AssetretirementobligationsTablesLineItems" xlink:to="cve_AssetretirementobligationsTablesLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_SalescontractsTablesTable" xlink:href="cve-20221231.xsd#cve_SalescontractsTablesTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_SalescontractsTablesTable_lbl" xml:lang="en-US">Sales contracts (Tables) [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_SalescontractsTablesTable" xlink:to="cve_SalescontractsTablesTable_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_SalescontractsTablesLineItems" xlink:href="cve-20221231.xsd#cve_SalescontractsTablesLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cve_SalescontractsTablesLineItems_lbl" xml:lang="en-US">Sales contracts [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_SalescontractsTablesLineItems" xlink:to="cve_SalescontractsTablesLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_ShareCapitalTablesTable" xlink:href="cve-20221231.xsd#cve_ShareCapitalTablesTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_ShareCapitalTablesTable_lbl" xml:lang="en-US">Share Capital (Tables) [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_ShareCapitalTablesTable" xlink:to="cve_ShareCapitalTablesTable_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_ShareCapitalTablesLineItems" xlink:href="cve-20221231.xsd#cve_ShareCapitalTablesLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cve_ShareCapitalTablesLineItems_lbl" xml:lang="en-US">Share Capital [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_ShareCapitalTablesLineItems" xlink:to="cve_ShareCapitalTablesLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_SegmentedinformationTablesTable" xlink:href="cve-20221231.xsd#cve_SegmentedinformationTablesTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_SegmentedinformationTablesTable_lbl" xml:lang="en-US">Segmented information (Tables) [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_SegmentedinformationTablesTable" xlink:to="cve_SegmentedinformationTablesTable_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_SegmentedinformationTablesLineItems" xlink:href="cve-20221231.xsd#cve_SegmentedinformationTablesLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cve_SegmentedinformationTablesLineItems_lbl" xml:lang="en-US">Segmented information [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_SegmentedinformationTablesLineItems" xlink:to="cve_SegmentedinformationTablesLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_SignificantaccountingpoliciesDetailsScheduleofexchangeratesTable" xlink:href="cve-20221231.xsd#cve_SignificantaccountingpoliciesDetailsScheduleofexchangeratesTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_SignificantaccountingpoliciesDetailsScheduleofexchangeratesTable_lbl" xml:lang="en-US">Significant accounting policies (Details) - Schedule of exchange rates [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_SignificantaccountingpoliciesDetailsScheduleofexchangeratesTable" xlink:to="cve_SignificantaccountingpoliciesDetailsScheduleofexchangeratesTable_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_SignificantaccountingpoliciesDetailsScheduleofexchangeratesLineItems" xlink:href="cve-20221231.xsd#cve_SignificantaccountingpoliciesDetailsScheduleofexchangeratesLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_SignificantaccountingpoliciesDetailsScheduleofexchangeratesLineItems_lbl" xml:lang="en-US">Schedule of exchange rates [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_SignificantaccountingpoliciesDetailsScheduleofexchangeratesLineItems" xlink:to="cve_SignificantaccountingpoliciesDetailsScheduleofexchangeratesLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_EntitysTotalForRelatedPartiesMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_EntitysTotalForRelatedPartiesMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_EntitysTotalForRelatedPartiesMember_lbl" xml:lang="en-US">Entity&apos;s total for related parties [member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_EntitysTotalForRelatedPartiesMember" xlink:to="ifrs-full_EntitysTotalForRelatedPartiesMember_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_SignificantaccountingpoliciesDetailsScheduleofsignificantsubsidiariesTable" xlink:href="cve-20221231.xsd#cve_SignificantaccountingpoliciesDetailsScheduleofsignificantsubsidiariesTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_SignificantaccountingpoliciesDetailsScheduleofsignificantsubsidiariesTable_lbl" xml:lang="en-US">Significant accounting policies (Details) - Schedule of significant subsidiaries [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_SignificantaccountingpoliciesDetailsScheduleofsignificantsubsidiariesTable" xlink:to="cve_SignificantaccountingpoliciesDetailsScheduleofsignificantsubsidiariesTable_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_SignificantaccountingpoliciesDetailsScheduleofsignificantsubsidiariesLineItems" xlink:href="cve-20221231.xsd#cve_SignificantaccountingpoliciesDetailsScheduleofsignificantsubsidiariesLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_SignificantaccountingpoliciesDetailsScheduleofsignificantsubsidiariesLineItems_lbl" xml:lang="en-US">Schedule of significant subsidiaries [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_SignificantaccountingpoliciesDetailsScheduleofsignificantsubsidiariesLineItems" xlink:to="cve_SignificantaccountingpoliciesDetailsScheduleofsignificantsubsidiariesLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_RangesMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_RangesMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_RangesMember_lbl" xml:lang="en-US">Ranges [member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_RangesMember" xlink:to="ifrs-full_RangesMember_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_IntangibleAssetsWithIndefiniteUsefulLifeMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_IntangibleAssetsWithIndefiniteUsefulLifeMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_IntangibleAssetsWithIndefiniteUsefulLifeMember_lbl" xml:lang="en-US">Intangible assets with indefinite useful life [member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_IntangibleAssetsWithIndefiniteUsefulLifeMember" xlink:to="ifrs-full_IntangibleAssetsWithIndefiniteUsefulLifeMember_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_SignificantaccountingpoliciesDetailsScheduleofusefullivesofpropertyplantandequipementTable" xlink:href="cve-20221231.xsd#cve_SignificantaccountingpoliciesDetailsScheduleofusefullivesofpropertyplantandequipementTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_SignificantaccountingpoliciesDetailsScheduleofusefullivesofpropertyplantandequipementTable_lbl" xml:lang="en-US">Significant accounting policies (Details) - Schedule of useful lives of property, plant and equipement [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_SignificantaccountingpoliciesDetailsScheduleofusefullivesofpropertyplantandequipementTable" xlink:to="cve_SignificantaccountingpoliciesDetailsScheduleofusefullivesofpropertyplantandequipementTable_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_SignificantaccountingpoliciesDetailsScheduleofusefullivesofpropertyplantandequipementLineItems" xlink:href="cve-20221231.xsd#cve_SignificantaccountingpoliciesDetailsScheduleofusefullivesofpropertyplantandequipementLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_SignificantaccountingpoliciesDetailsScheduleofusefullivesofpropertyplantandequipementLineItems_lbl" xml:lang="en-US">Schedule of useful lives of property, plant and equipement [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_SignificantaccountingpoliciesDetailsScheduleofusefullivesofpropertyplantandequipementLineItems" xlink:to="cve_SignificantaccountingpoliciesDetailsScheduleofusefullivesofpropertyplantandequipementLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_SignificantaccountingpoliciesDetailsScheduleofusefullivesofintangibleassetsTable" xlink:href="cve-20221231.xsd#cve_SignificantaccountingpoliciesDetailsScheduleofusefullivesofintangibleassetsTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_SignificantaccountingpoliciesDetailsScheduleofusefullivesofintangibleassetsTable_lbl" xml:lang="en-US">Significant accounting policies (Details) - Schedule of useful lives of intangible assets [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_SignificantaccountingpoliciesDetailsScheduleofusefullivesofintangibleassetsTable" xlink:to="cve_SignificantaccountingpoliciesDetailsScheduleofusefullivesofintangibleassetsTable_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_SignificantaccountingpoliciesDetailsScheduleofusefullivesofintangibleassetsLineItems" xlink:href="cve-20221231.xsd#cve_SignificantaccountingpoliciesDetailsScheduleofusefullivesofintangibleassetsLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_SignificantaccountingpoliciesDetailsScheduleofusefullivesofintangibleassetsLineItems_lbl" xml:lang="en-US">Schedule of useful lives of intangible assets [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_SignificantaccountingpoliciesDetailsScheduleofusefullivesofintangibleassetsLineItems" xlink:to="cve_SignificantaccountingpoliciesDetailsScheduleofusefullivesofintangibleassetsLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_InvestmentInAssociateDetailsScheduleofproportionalshareintheassociateTable" xlink:href="cve-20221231.xsd#cve_InvestmentInAssociateDetailsScheduleofproportionalshareintheassociateTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_InvestmentInAssociateDetailsScheduleofproportionalshareintheassociateTable_lbl" xml:lang="en-US">Investment In Associate (Details) - Schedule of proportional share in the associate [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_InvestmentInAssociateDetailsScheduleofproportionalshareintheassociateTable" xlink:to="cve_InvestmentInAssociateDetailsScheduleofproportionalshareintheassociateTable_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_InvestmentInAssociateDetailsScheduleofproportionalshareintheassociateLineItems" xlink:href="cve-20221231.xsd#cve_InvestmentInAssociateDetailsScheduleofproportionalshareintheassociateLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_InvestmentInAssociateDetailsScheduleofproportionalshareintheassociateLineItems_lbl" xml:lang="en-US">Schedule of proportional share in the associate [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_InvestmentInAssociateDetailsScheduleofproportionalshareintheassociateLineItems" xlink:to="cve_InvestmentInAssociateDetailsScheduleofproportionalshareintheassociateLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_InvestmentInAssociateDetailsScheduleofinvestmentinassociatecontinuityTable" xlink:href="cve-20221231.xsd#cve_InvestmentInAssociateDetailsScheduleofinvestmentinassociatecontinuityTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_InvestmentInAssociateDetailsScheduleofinvestmentinassociatecontinuityTable_lbl" xml:lang="en-US">Investment In Associate (Details) - Schedule of investment in associate continuity [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_InvestmentInAssociateDetailsScheduleofinvestmentinassociatecontinuityTable" xlink:to="cve_InvestmentInAssociateDetailsScheduleofinvestmentinassociatecontinuityTable_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_InvestmentInAssociateDetailsScheduleofinvestmentinassociatecontinuityLineItems" xlink:href="cve-20221231.xsd#cve_InvestmentInAssociateDetailsScheduleofinvestmentinassociatecontinuityLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_InvestmentInAssociateDetailsScheduleofinvestmentinassociatecontinuityLineItems_lbl" xml:lang="en-US">Schedule of investment in associate continuity [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_InvestmentInAssociateDetailsScheduleofinvestmentinassociatecontinuityLineItems" xlink:to="cve_InvestmentInAssociateDetailsScheduleofinvestmentinassociatecontinuityLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_EntitysTotalForUnconsolidatedStructuredEntitiesMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_EntitysTotalForUnconsolidatedStructuredEntitiesMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_EntitysTotalForUnconsolidatedStructuredEntitiesMember_lbl" xml:lang="en-US">Entity&apos;s total for unconsolidated structured entities [member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_EntitysTotalForUnconsolidatedStructuredEntitiesMember" xlink:to="ifrs-full_EntitysTotalForUnconsolidatedStructuredEntitiesMember_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_InvestmentinuraniumDetailsScheduleofuraniumconcentratespurchaseagreementTable" xlink:href="cve-20221231.xsd#cve_InvestmentinuraniumDetailsScheduleofuraniumconcentratespurchaseagreementTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_InvestmentinuraniumDetailsScheduleofuraniumconcentratespurchaseagreementTable_lbl" xml:lang="en-US">Investment in uranium (Details) - Schedule of uranium concentrates purchase agreement [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_InvestmentinuraniumDetailsScheduleofuraniumconcentratespurchaseagreementTable" xlink:to="cve_InvestmentinuraniumDetailsScheduleofuraniumconcentratespurchaseagreementTable_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_InvestmentinuraniumDetailsScheduleofuraniumconcentratespurchaseagreementLineItems" xlink:href="cve-20221231.xsd#cve_InvestmentinuraniumDetailsScheduleofuraniumconcentratespurchaseagreementLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_InvestmentinuraniumDetailsScheduleofuraniumconcentratespurchaseagreementLineItems_lbl" xml:lang="en-US">Investment in uranium (Details) - Schedule of uranium concentrates purchase agreement [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_InvestmentinuraniumDetailsScheduleofuraniumconcentratespurchaseagreementLineItems" xlink:to="cve_InvestmentinuraniumDetailsScheduleofuraniumconcentratespurchaseagreementLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ClassesOfAssetsMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_ClassesOfAssetsMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ClassesOfAssetsMember_lbl" xml:lang="en-US">Assets [member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ClassesOfAssetsMember" xlink:to="ifrs-full_ClassesOfAssetsMember_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_MarketableSecuritiesDetailsScheduleofmarketablesecuritiesTable" xlink:href="cve-20221231.xsd#cve_MarketableSecuritiesDetailsScheduleofmarketablesecuritiesTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_MarketableSecuritiesDetailsScheduleofmarketablesecuritiesTable_lbl" xml:lang="en-US">Marketable Securities (Details) - Schedule of marketable securities [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_MarketableSecuritiesDetailsScheduleofmarketablesecuritiesTable" xlink:to="cve_MarketableSecuritiesDetailsScheduleofmarketablesecuritiesTable_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_MarketableSecuritiesDetailsScheduleofmarketablesecuritiesLineItems" xlink:href="cve-20221231.xsd#cve_MarketableSecuritiesDetailsScheduleofmarketablesecuritiesLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_MarketableSecuritiesDetailsScheduleofmarketablesecuritiesLineItems_lbl" xml:lang="en-US">Schedule of Marketable Securities [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_MarketableSecuritiesDetailsScheduleofmarketablesecuritiesLineItems" xlink:to="cve_MarketableSecuritiesDetailsScheduleofmarketablesecuritiesLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_IntangibleAssetsOtherThanGoodwillMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_IntangibleAssetsOtherThanGoodwillMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_IntangibleAssetsOtherThanGoodwillMember_lbl" xml:lang="en-US">Intangible assets other than goodwill [member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_IntangibleAssetsOtherThanGoodwillMember" xlink:to="ifrs-full_IntangibleAssetsOtherThanGoodwillMember_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_IntangibleassetsDetailsScheduleofintangibleassetwasdeterminedTable" xlink:href="cve-20221231.xsd#cve_IntangibleassetsDetailsScheduleofintangibleassetwasdeterminedTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_IntangibleassetsDetailsScheduleofintangibleassetwasdeterminedTable_lbl" xml:lang="en-US">Intangible assets (Details) - Schedule of intangible asset was determined [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_IntangibleassetsDetailsScheduleofintangibleassetwasdeterminedTable" xlink:to="cve_IntangibleassetsDetailsScheduleofintangibleassetwasdeterminedTable_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_IntangibleassetsDetailsScheduleofintangibleassetwasdeterminedLineItems" xlink:href="cve-20221231.xsd#cve_IntangibleassetsDetailsScheduleofintangibleassetwasdeterminedLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_IntangibleassetsDetailsScheduleofintangibleassetwasdeterminedLineItems_lbl" xml:lang="en-US">Schedule of intangible asset was determined [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_IntangibleassetsDetailsScheduleofintangibleassetwasdeterminedLineItems" xlink:to="cve_IntangibleassetsDetailsScheduleofintangibleassetwasdeterminedLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_PropertyPlantAndEquipmentMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_PropertyPlantAndEquipmentMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_PropertyPlantAndEquipmentMember_lbl" xml:lang="en-US">Property, plant and equipment [member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_PropertyPlantAndEquipmentMember" xlink:to="ifrs-full_PropertyPlantAndEquipmentMember_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_PropertyplantandequipmentDetailsScheduleofpropertyplantandequipmentTable" xlink:href="cve-20221231.xsd#cve_PropertyplantandequipmentDetailsScheduleofpropertyplantandequipmentTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_PropertyplantandequipmentDetailsScheduleofpropertyplantandequipmentTable_lbl" xml:lang="en-US">Property, plant, and equipment (Details) - Schedule of property, plant, and equipment [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_PropertyplantandequipmentDetailsScheduleofpropertyplantandequipmentTable" xlink:to="cve_PropertyplantandequipmentDetailsScheduleofpropertyplantandequipmentTable_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_PropertyplantandequipmentDetailsScheduleofpropertyplantandequipmentLineItems" xlink:href="cve-20221231.xsd#cve_PropertyplantandequipmentDetailsScheduleofpropertyplantandequipmentLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_PropertyplantandequipmentDetailsScheduleofpropertyplantandequipmentLineItems_lbl" xml:lang="en-US">Property, plant, and equipment (Details) - Schedule of property, plant, and equipment [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_PropertyplantandequipmentDetailsScheduleofpropertyplantandequipmentLineItems" xlink:to="cve_PropertyplantandequipmentDetailsScheduleofpropertyplantandequipmentLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_RightofuseassetsDetailsScheduleofchangeintheROUassetsTable" xlink:href="cve-20221231.xsd#cve_RightofuseassetsDetailsScheduleofchangeintheROUassetsTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_RightofuseassetsDetailsScheduleofchangeintheROUassetsTable_lbl" xml:lang="en-US">Right-of-use assets (Details) - Schedule of change in the ROU assets [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_RightofuseassetsDetailsScheduleofchangeintheROUassetsTable" xlink:to="cve_RightofuseassetsDetailsScheduleofchangeintheROUassetsTable_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_RightofuseassetsDetailsScheduleofchangeintheROUassetsLineItems" xlink:href="cve-20221231.xsd#cve_RightofuseassetsDetailsScheduleofchangeintheROUassetsLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_RightofuseassetsDetailsScheduleofchangeintheROUassetsLineItems_lbl" xml:lang="en-US">Schedue of change in the ROU assets [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_RightofuseassetsDetailsScheduleofchangeintheROUassetsLineItems" xlink:to="cve_RightofuseassetsDetailsScheduleofchangeintheROUassetsLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_RightofuseassetsDetailsScheduleofchangeinthelongTermleaseliabilityTable" xlink:href="cve-20221231.xsd#cve_RightofuseassetsDetailsScheduleofchangeinthelongTermleaseliabilityTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_RightofuseassetsDetailsScheduleofchangeinthelongTermleaseliabilityTable_lbl" xml:lang="en-US">Right-of-use assets (Details) - Schedule of change in the long-Term lease liability [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_RightofuseassetsDetailsScheduleofchangeinthelongTermleaseliabilityTable" xlink:to="cve_RightofuseassetsDetailsScheduleofchangeinthelongTermleaseliabilityTable_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_RightofuseassetsDetailsScheduleofchangeinthelongTermleaseliabilityLineItems" xlink:href="cve-20221231.xsd#cve_RightofuseassetsDetailsScheduleofchangeinthelongTermleaseliabilityLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_RightofuseassetsDetailsScheduleofchangeinthelongTermleaseliabilityLineItems_lbl" xml:lang="en-US">Shedule of change in the long-Term lease liability [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_RightofuseassetsDetailsScheduleofchangeinthelongTermleaseliabilityLineItems" xlink:to="cve_RightofuseassetsDetailsScheduleofchangeinthelongTermleaseliabilityLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_RightofuseassetsDetailsScheduleofundiscountedfutureleasepaymentsTable" xlink:href="cve-20221231.xsd#cve_RightofuseassetsDetailsScheduleofundiscountedfutureleasepaymentsTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_RightofuseassetsDetailsScheduleofundiscountedfutureleasepaymentsTable_lbl" xml:lang="en-US">Right-of-use assets (Details) - Schedule of undiscounted future lease payments [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_RightofuseassetsDetailsScheduleofundiscountedfutureleasepaymentsTable" xlink:to="cve_RightofuseassetsDetailsScheduleofundiscountedfutureleasepaymentsTable_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_RightofuseassetsDetailsScheduleofundiscountedfutureleasepaymentsLineItems" xlink:href="cve-20221231.xsd#cve_RightofuseassetsDetailsScheduleofundiscountedfutureleasepaymentsLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_RightofuseassetsDetailsScheduleofundiscountedfutureleasepaymentsLineItems_lbl" xml:lang="en-US">Shedule of undiscounted future lease payments [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_RightofuseassetsDetailsScheduleofundiscountedfutureleasepaymentsLineItems" xlink:to="cve_RightofuseassetsDetailsScheduleofundiscountedfutureleasepaymentsLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_AssetacquisitionDetailsScheduleofweightedaverageassumptionsusedintheblackscholesoptionTable" xlink:href="cve-20221231.xsd#cve_AssetacquisitionDetailsScheduleofweightedaverageassumptionsusedintheblackscholesoptionTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_AssetacquisitionDetailsScheduleofweightedaverageassumptionsusedintheblackscholesoptionTable_lbl" xml:lang="en-US">Asset acquisition (Details) - Schedule of weighted average assumptions used in the black-scholes option [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_AssetacquisitionDetailsScheduleofweightedaverageassumptionsusedintheblackscholesoptionTable" xlink:to="cve_AssetacquisitionDetailsScheduleofweightedaverageassumptionsusedintheblackscholesoptionTable_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_AssetacquisitionDetailsScheduleofweightedaverageassumptionsusedintheblackscholesoptionLineItems" xlink:href="cve-20221231.xsd#cve_AssetacquisitionDetailsScheduleofweightedaverageassumptionsusedintheblackscholesoptionLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_AssetacquisitionDetailsScheduleofweightedaverageassumptionsusedintheblackscholesoptionLineItems_lbl" xml:lang="en-US">Asset acquisition (Details) - Schedule of weighted average assumptions used in the black-scholes option [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_AssetacquisitionDetailsScheduleofweightedaverageassumptionsusedintheblackscholesoptionLineItems" xlink:to="cve_AssetacquisitionDetailsScheduleofweightedaverageassumptionsusedintheblackscholesoptionLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_GeographicalAreasMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_GeographicalAreasMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_GeographicalAreasMember_lbl" xml:lang="en-US">Geographical areas [member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_GeographicalAreasMember" xlink:to="ifrs-full_GeographicalAreasMember_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_LiabilitiesMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_LiabilitiesMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_LiabilitiesMember_lbl" xml:lang="en-US">Liabilities [member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_LiabilitiesMember" xlink:to="ifrs-full_LiabilitiesMember_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_MineralPropertiesDetailsScheduleofmineralpropertiesTable" xlink:href="cve-20221231.xsd#cve_MineralPropertiesDetailsScheduleofmineralpropertiesTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_MineralPropertiesDetailsScheduleofmineralpropertiesTable_lbl" xml:lang="en-US">Mineral Properties (Details) - Schedule of mineral properties [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_MineralPropertiesDetailsScheduleofmineralpropertiesTable" xlink:to="cve_MineralPropertiesDetailsScheduleofmineralpropertiesTable_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_MineralPropertiesDetailsScheduleofmineralpropertiesLineItems" xlink:href="cve-20221231.xsd#cve_MineralPropertiesDetailsScheduleofmineralpropertiesLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_MineralPropertiesDetailsScheduleofmineralpropertiesLineItems_lbl" xml:lang="en-US">Mineral Properties (Details) - Schedule of mineral properties [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_MineralPropertiesDetailsScheduleofmineralpropertiesLineItems" xlink:to="cve_MineralPropertiesDetailsScheduleofmineralpropertiesLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_AssetretirementobligationsDetailsScheduleofassetretirementobligationsbalanceTable" xlink:href="cve-20221231.xsd#cve_AssetretirementobligationsDetailsScheduleofassetretirementobligationsbalanceTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_AssetretirementobligationsDetailsScheduleofassetretirementobligationsbalanceTable_lbl" xml:lang="en-US">Asset retirement obligations (Details) - Schedule of asset retirement obligations balance [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_AssetretirementobligationsDetailsScheduleofassetretirementobligationsbalanceTable" xlink:to="cve_AssetretirementobligationsDetailsScheduleofassetretirementobligationsbalanceTable_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_AssetretirementobligationsDetailsScheduleofassetretirementobligationsbalanceLineItems" xlink:href="cve-20221231.xsd#cve_AssetretirementobligationsDetailsScheduleofassetretirementobligationsbalanceLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_AssetretirementobligationsDetailsScheduleofassetretirementobligationsbalanceLineItems_lbl" xml:lang="en-US">Schedule of asset retirement obligations balance [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_AssetretirementobligationsDetailsScheduleofassetretirementobligationsbalanceLineItems" xlink:to="cve_AssetretirementobligationsDetailsScheduleofassetretirementobligationsbalanceLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_AssetretirementobligationsDetailsScheduleofassetretirementobligationscontinuityTable" xlink:href="cve-20221231.xsd#cve_AssetretirementobligationsDetailsScheduleofassetretirementobligationscontinuityTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_AssetretirementobligationsDetailsScheduleofassetretirementobligationscontinuityTable_lbl" xml:lang="en-US">Asset retirement obligations (Details) - Schedule of asset retirement obligations continuity [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_AssetretirementobligationsDetailsScheduleofassetretirementobligationscontinuityTable" xlink:to="cve_AssetretirementobligationsDetailsScheduleofassetretirementobligationscontinuityTable_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_AssetretirementobligationsDetailsScheduleofassetretirementobligationscontinuityLineItems" xlink:href="cve-20221231.xsd#cve_AssetretirementobligationsDetailsScheduleofassetretirementobligationscontinuityLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_AssetretirementobligationsDetailsScheduleofassetretirementobligationscontinuityLineItems_lbl" xml:lang="en-US">Schedule of asset retirement obligations continuity [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_AssetretirementobligationsDetailsScheduleofassetretirementobligationscontinuityLineItems" xlink:to="cve_AssetretirementobligationsDetailsScheduleofassetretirementobligationscontinuityLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_SalescontractsDetailsScheduleofuraniumsalescontractsoverthenextfiveyearsTable" xlink:href="cve-20221231.xsd#cve_SalescontractsDetailsScheduleofuraniumsalescontractsoverthenextfiveyearsTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_SalescontractsDetailsScheduleofuraniumsalescontractsoverthenextfiveyearsTable_lbl" xml:lang="en-US">Sales contracts (Details) - Schedule of uranium sales contracts over the next five years [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_SalescontractsDetailsScheduleofuraniumsalescontractsoverthenextfiveyearsTable" xlink:to="cve_SalescontractsDetailsScheduleofuraniumsalescontractsoverthenextfiveyearsTable_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_SalescontractsDetailsScheduleofuraniumsalescontractsoverthenextfiveyearsLineItems" xlink:href="cve-20221231.xsd#cve_SalescontractsDetailsScheduleofuraniumsalescontractsoverthenextfiveyearsLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_SalescontractsDetailsScheduleofuraniumsalescontractsoverthenextfiveyearsLineItems_lbl" xml:lang="en-US">Schedule of uranium sales contracts over the next five years [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_SalescontractsDetailsScheduleofuraniumsalescontractsoverthenextfiveyearsLineItems" xlink:to="cve_SalescontractsDetailsScheduleofuraniumsalescontractsoverthenextfiveyearsLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsMember_lbl" xml:lang="en-US">Ranges of exercise prices for outstanding share options [member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsMember" xlink:to="ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsMember_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_ShareCapitalDetailsScheduleofstockoptionsoutstandingTable" xlink:href="cve-20221231.xsd#cve_ShareCapitalDetailsScheduleofstockoptionsoutstandingTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_ShareCapitalDetailsScheduleofstockoptionsoutstandingTable_lbl" xml:lang="en-US">Share Capital (Details) - Schedule of stock options outstanding [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_ShareCapitalDetailsScheduleofstockoptionsoutstandingTable" xlink:to="cve_ShareCapitalDetailsScheduleofstockoptionsoutstandingTable_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_ShareCapitalDetailsScheduleofstockoptionsoutstandingLineItems" xlink:href="cve-20221231.xsd#cve_ShareCapitalDetailsScheduleofstockoptionsoutstandingLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_ShareCapitalDetailsScheduleofstockoptionsoutstandingLineItems_lbl" xml:lang="en-US">Share Capital (Details) - Schedule of stock options outstanding [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_ShareCapitalDetailsScheduleofstockoptionsoutstandingLineItems" xlink:to="cve_ShareCapitalDetailsScheduleofstockoptionsoutstandingLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_ShareCapitalDetailsScheduleofsharepurchasewarrantsoutstandingTable" xlink:href="cve-20221231.xsd#cve_ShareCapitalDetailsScheduleofsharepurchasewarrantsoutstandingTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_ShareCapitalDetailsScheduleofsharepurchasewarrantsoutstandingTable_lbl" xml:lang="en-US">Share Capital (Details) - Schedule of share purchase warrants outstanding [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_ShareCapitalDetailsScheduleofsharepurchasewarrantsoutstandingTable" xlink:to="cve_ShareCapitalDetailsScheduleofsharepurchasewarrantsoutstandingTable_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_ShareCapitalDetailsScheduleofsharepurchasewarrantsoutstandingLineItems" xlink:href="cve-20221231.xsd#cve_ShareCapitalDetailsScheduleofsharepurchasewarrantsoutstandingLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_ShareCapitalDetailsScheduleofsharepurchasewarrantsoutstandingLineItems_lbl" xml:lang="en-US">Share Capital (Details) - Schedule of share purchase warrants outstanding [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_ShareCapitalDetailsScheduleofsharepurchasewarrantsoutstandingLineItems" xlink:to="cve_ShareCapitalDetailsScheduleofsharepurchasewarrantsoutstandingLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_RelatedpartytransactionsandbalancesDetailsScheduleofowingtorelatedpartiesTable" xlink:href="cve-20221231.xsd#cve_RelatedpartytransactionsandbalancesDetailsScheduleofowingtorelatedpartiesTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_RelatedpartytransactionsandbalancesDetailsScheduleofowingtorelatedpartiesTable_lbl" xml:lang="en-US">Related party transactions and balances (Details) - Schedule of owing to related parties [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_RelatedpartytransactionsandbalancesDetailsScheduleofowingtorelatedpartiesTable" xlink:to="cve_RelatedpartytransactionsandbalancesDetailsScheduleofowingtorelatedpartiesTable_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_RelatedpartytransactionsandbalancesDetailsScheduleofowingtorelatedpartiesLineItems" xlink:href="cve-20221231.xsd#cve_RelatedpartytransactionsandbalancesDetailsScheduleofowingtorelatedpartiesLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_RelatedpartytransactionsandbalancesDetailsScheduleofowingtorelatedpartiesLineItems_lbl" xml:lang="en-US">Related party transactions and balances (Details) - Schedule of owing to related parties [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_RelatedpartytransactionsandbalancesDetailsScheduleofowingtorelatedpartiesLineItems" xlink:to="cve_RelatedpartytransactionsandbalancesDetailsScheduleofowingtorelatedpartiesLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_SegmentedinformationDetailsScheduleoflongtermassetsbygeographicsegmentTable" xlink:href="cve-20221231.xsd#cve_SegmentedinformationDetailsScheduleoflongtermassetsbygeographicsegmentTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_SegmentedinformationDetailsScheduleoflongtermassetsbygeographicsegmentTable_lbl" xml:lang="en-US">Segmented information (Details) - Schedule of long-term assets by geographic segment [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_SegmentedinformationDetailsScheduleoflongtermassetsbygeographicsegmentTable" xlink:to="cve_SegmentedinformationDetailsScheduleoflongtermassetsbygeographicsegmentTable_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_SegmentedinformationDetailsScheduleoflongtermassetsbygeographicsegmentLineItems" xlink:href="cve-20221231.xsd#cve_SegmentedinformationDetailsScheduleoflongtermassetsbygeographicsegmentLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_SegmentedinformationDetailsScheduleoflongtermassetsbygeographicsegmentLineItems_lbl" xml:lang="en-US">Schedule of long-term assets by geographic segment [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_SegmentedinformationDetailsScheduleoflongtermassetsbygeographicsegmentLineItems" xlink:to="cve_SegmentedinformationDetailsScheduleoflongtermassetsbygeographicsegmentLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_RestatedMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_RestatedMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_RestatedMember_lbl" xml:lang="en-US">Currently stated [member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_RestatedMember" xlink:to="ifrs-full_RestatedMember_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_ChangeinPresentationCurrencyDetailsScheduleofeffectoftranslationTable" xlink:href="cve-20221231.xsd#cve_ChangeinPresentationCurrencyDetailsScheduleofeffectoftranslationTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_ChangeinPresentationCurrencyDetailsScheduleofeffectoftranslationTable_lbl" xml:lang="en-US">Change in Presentation Currency (Details) - Schedule of effect of translation [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_ChangeinPresentationCurrencyDetailsScheduleofeffectoftranslationTable" xlink:to="cve_ChangeinPresentationCurrencyDetailsScheduleofeffectoftranslationTable_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_ChangeinPresentationCurrencyDetailsScheduleofeffectoftranslationLineItems" xlink:href="cve-20221231.xsd#cve_ChangeinPresentationCurrencyDetailsScheduleofeffectoftranslationLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_ChangeinPresentationCurrencyDetailsScheduleofeffectoftranslationLineItems_lbl" xml:lang="en-US">Change in Presentation Currency (Details) - Schedule of effect of translation [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_ChangeinPresentationCurrencyDetailsScheduleofeffectoftranslationLineItems" xlink:to="cve_ChangeinPresentationCurrencyDetailsScheduleofeffectoftranslationLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="srt_RestatementDomain" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RestatementDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_RestatementDomain_lbl" xml:lang="en-US">Revision of Prior Period [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_RestatementDomain" xlink:to="srt_RestatementDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_ChangeinPresentationCurrencyDetailsScheduleofconsolidatedstatementsoflossandcomprehensivelossTable" xlink:href="cve-20221231.xsd#cve_ChangeinPresentationCurrencyDetailsScheduleofconsolidatedstatementsoflossandcomprehensivelossTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_ChangeinPresentationCurrencyDetailsScheduleofconsolidatedstatementsoflossandcomprehensivelossTable_lbl" xml:lang="en-US">Change in Presentation Currency (Details) - Schedule of consolidated statements of loss and comprehensive loss [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_ChangeinPresentationCurrencyDetailsScheduleofconsolidatedstatementsoflossandcomprehensivelossTable" xlink:to="cve_ChangeinPresentationCurrencyDetailsScheduleofconsolidatedstatementsoflossandcomprehensivelossTable_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_ChangeinPresentationCurrencyDetailsScheduleofconsolidatedstatementsoflossandcomprehensivelossLineItems" xlink:href="cve-20221231.xsd#cve_ChangeinPresentationCurrencyDetailsScheduleofconsolidatedstatementsoflossandcomprehensivelossLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_ChangeinPresentationCurrencyDetailsScheduleofconsolidatedstatementsoflossandcomprehensivelossLineItems_lbl" xml:lang="en-US">Change in Presentation Currency (Details) - Schedule of consolidated statements of loss and comprehensive loss [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_ChangeinPresentationCurrencyDetailsScheduleofconsolidatedstatementsoflossandcomprehensivelossLineItems" xlink:to="cve_ChangeinPresentationCurrencyDetailsScheduleofconsolidatedstatementsoflossandcomprehensivelossLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_ChangeinPresentationCurrencyDetailsScheduleofconsolidatedstatementsoflossandcomprehensivelossParentheticalsTable" xlink:href="cve-20221231.xsd#cve_ChangeinPresentationCurrencyDetailsScheduleofconsolidatedstatementsoflossandcomprehensivelossParentheticalsTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_ChangeinPresentationCurrencyDetailsScheduleofconsolidatedstatementsoflossandcomprehensivelossParentheticalsTable_lbl" xml:lang="en-US">Change in Presentation Currency (Details) - Schedule of consolidated statements of loss and comprehensive loss (Parentheticals) [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_ChangeinPresentationCurrencyDetailsScheduleofconsolidatedstatementsoflossandcomprehensivelossParentheticalsTable" xlink:to="cve_ChangeinPresentationCurrencyDetailsScheduleofconsolidatedstatementsoflossandcomprehensivelossParentheticalsTable_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_ChangeinPresentationCurrencyDetailsScheduleofconsolidatedstatementsoflossandcomprehensivelossParentheticalsLineItems" xlink:href="cve-20221231.xsd#cve_ChangeinPresentationCurrencyDetailsScheduleofconsolidatedstatementsoflossandcomprehensivelossParentheticalsLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_ChangeinPresentationCurrencyDetailsScheduleofconsolidatedstatementsoflossandcomprehensivelossParentheticalsLineItems_lbl" xml:lang="en-US">Change in Presentation Currency (Details) - Schedule of consolidated statements of loss and comprehensive loss (Parentheticals) [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_ChangeinPresentationCurrencyDetailsScheduleofconsolidatedstatementsoflossandcomprehensivelossParentheticalsLineItems" xlink:to="cve_ChangeinPresentationCurrencyDetailsScheduleofconsolidatedstatementsoflossandcomprehensivelossParentheticalsLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="srt_ScenarioUnspecifiedDomain" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioUnspecifiedDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_ScenarioUnspecifiedDomain_lbl" xml:lang="en-US">Scenario [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_ScenarioUnspecifiedDomain" xlink:to="srt_ScenarioUnspecifiedDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_InvestmentinuraniumDetailsTable" xlink:href="cve-20221231.xsd#cve_InvestmentinuraniumDetailsTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_InvestmentinuraniumDetailsTable_lbl" xml:lang="en-US">Investment in uranium (Details) [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_InvestmentinuraniumDetailsTable" xlink:to="cve_InvestmentinuraniumDetailsTable_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_InvestmentinuraniumDetailsLineItems" xlink:href="cve-20221231.xsd#cve_InvestmentinuraniumDetailsLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_InvestmentinuraniumDetailsLineItems_lbl" xml:lang="en-US">Investment in uranium (Details) [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_InvestmentinuraniumDetailsLineItems" xlink:to="cve_InvestmentinuraniumDetailsLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_OrdinarySharesMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_OrdinarySharesMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_OrdinarySharesMember_lbl" xml:lang="en-US">Ordinary shares [member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_OrdinarySharesMember" xlink:to="ifrs-full_OrdinarySharesMember_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RelatedPartyDomain_lbl" xml:lang="en-US">Related Party [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyDomain" xlink:to="us-gaap_RelatedPartyDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_MarketableSecuritiesDetailsTable" xlink:href="cve-20221231.xsd#cve_MarketableSecuritiesDetailsTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_MarketableSecuritiesDetailsTable_lbl" xml:lang="en-US">Marketable Securities (Details) [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_MarketableSecuritiesDetailsTable" xlink:to="cve_MarketableSecuritiesDetailsTable_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_MarketableSecuritiesDetailsLineItems" xlink:href="cve-20221231.xsd#cve_MarketableSecuritiesDetailsLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cve_MarketableSecuritiesDetailsLineItems_lbl" xml:lang="en-US">Marketable Securities [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_MarketableSecuritiesDetailsLineItems" xlink:to="cve_MarketableSecuritiesDetailsLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_RightofuseassetsDetailsTable" xlink:href="cve-20221231.xsd#cve_RightofuseassetsDetailsTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_RightofuseassetsDetailsTable_lbl" xml:lang="en-US">Right-of-use assets (Details) [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_RightofuseassetsDetailsTable" xlink:to="cve_RightofuseassetsDetailsTable_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_RightofuseassetsDetailsLineItems" xlink:href="cve-20221231.xsd#cve_RightofuseassetsDetailsLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_RightofuseassetsDetailsLineItems_lbl" xml:lang="en-US">Right-of-use assets (Details) [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_RightofuseassetsDetailsLineItems" xlink:to="cve_RightofuseassetsDetailsLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_AssetacquisitionDetailsTable" xlink:href="cve-20221231.xsd#cve_AssetacquisitionDetailsTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_AssetacquisitionDetailsTable_lbl" xml:lang="en-US">Asset acquisition (Details) [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_AssetacquisitionDetailsTable" xlink:to="cve_AssetacquisitionDetailsTable_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_AssetacquisitionDetailsLineItems" xlink:href="cve-20221231.xsd#cve_AssetacquisitionDetailsLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_AssetacquisitionDetailsLineItems_lbl" xml:lang="en-US">Asset acquisition (Details) [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_AssetacquisitionDetailsLineItems" xlink:to="cve_AssetacquisitionDetailsLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_MineralPropertiesDetailsTable" xlink:href="cve-20221231.xsd#cve_MineralPropertiesDetailsTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_MineralPropertiesDetailsTable_lbl" xml:lang="en-US">Mineral Properties (Details) [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_MineralPropertiesDetailsTable" xlink:to="cve_MineralPropertiesDetailsTable_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_MineralPropertiesDetailsLineItems" xlink:href="cve-20221231.xsd#cve_MineralPropertiesDetailsLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_MineralPropertiesDetailsLineItems_lbl" xml:lang="en-US">Mineral Properties (Details) [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_MineralPropertiesDetailsLineItems" xlink:to="cve_MineralPropertiesDetailsLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_ShareCapitalDetailsTable" xlink:href="cve-20221231.xsd#cve_ShareCapitalDetailsTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_ShareCapitalDetailsTable_lbl" xml:lang="en-US">Share Capital (Details) [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_ShareCapitalDetailsTable" xlink:to="cve_ShareCapitalDetailsTable_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_ShareCapitalDetailsLineItems" xlink:href="cve-20221231.xsd#cve_ShareCapitalDetailsLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_ShareCapitalDetailsLineItems_lbl" xml:lang="en-US">Share Capital (Details) [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_ShareCapitalDetailsLineItems" xlink:to="cve_ShareCapitalDetailsLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_RelatedpartytransactionsandbalancesDetailsTable" xlink:href="cve-20221231.xsd#cve_RelatedpartytransactionsandbalancesDetailsTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_RelatedpartytransactionsandbalancesDetailsTable_lbl" xml:lang="en-US">Related party transactions and balances (Details) [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_RelatedpartytransactionsandbalancesDetailsTable" xlink:to="cve_RelatedpartytransactionsandbalancesDetailsTable_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_RelatedpartytransactionsandbalancesDetailsLineItems" xlink:href="cve-20221231.xsd#cve_RelatedpartytransactionsandbalancesDetailsLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_RelatedpartytransactionsandbalancesDetailsLineItems_lbl" xml:lang="en-US">Related party transactions and balances (Details) [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_RelatedpartytransactionsandbalancesDetailsLineItems" xlink:to="cve_RelatedpartytransactionsandbalancesDetailsLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsequentEventTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsequentEventTypeDomain_lbl" xml:lang="en-US">Subsequent Event Type [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventTypeDomain" xlink:to="us-gaap_SubsequentEventTypeDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_NonadjustingEventsMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_NonadjustingEventsMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_NonadjustingEventsMember_lbl" xml:lang="en-US">Non-adjusting events after reporting period [member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NonadjustingEventsMember" xlink:to="ifrs-full_NonadjustingEventsMember_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_EventsafterthereportingperiodDetailsTable" xlink:href="cve-20221231.xsd#cve_EventsafterthereportingperiodDetailsTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_EventsafterthereportingperiodDetailsTable_lbl" xml:lang="en-US">Events after the reporting period (Details) [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_EventsafterthereportingperiodDetailsTable" xlink:to="cve_EventsafterthereportingperiodDetailsTable_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_EventsafterthereportingperiodDetailsLineItems" xlink:href="cve-20221231.xsd#cve_EventsafterthereportingperiodDetailsLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_EventsafterthereportingperiodDetailsLineItems_lbl" xml:lang="en-US">Events after the reporting period (Details) [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_EventsafterthereportingperiodDetailsLineItems" xlink:to="cve_EventsafterthereportingperiodDetailsLineItems_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cve_AccountsPayableAndAccruedLiability_lbl0" xml:lang="en-US">Accounts payable and accrued liabilities.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_AccountsPayableAndAccruedLiability" xlink:to="cve_AccountsPayableAndAccruedLiability_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cve_Accretion_lbl0" xml:lang="en-US">Accretion Expense</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_Accretion" xlink:to="cve_Accretion_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cve_AccretionExpenses_lbl0" xml:lang="en-US">Amount recognized for the passage of time, typically for liabilities, that have been discounted to their net present values. Excludes accretion associated with asset retirement obligations.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_AccretionExpenses" xlink:to="cve_AccretionExpenses_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cve_AccumulatedDeficit_lbl0" xml:lang="en-US">Accumulated deficit.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_AccumulatedDeficit" xlink:to="cve_AccumulatedDeficit_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cve_AcquireCommonShare_lbl0" xml:lang="en-US">Acquire common shares.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_AcquireCommonShare" xlink:to="cve_AcquireCommonShare_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cve_AcquiredAmonut_lbl0" xml:lang="en-US">Acquired amonut.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_AcquiredAmonut" xlink:to="cve_AcquiredAmonut_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cve_AcquiredShares_lbl0" xml:lang="en-US">Acquired shares.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_AcquiredShares" xlink:to="cve_AcquiredShares_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cve_Additions_lbl0" xml:lang="en-US">Additions.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_Additions" xlink:to="cve_Additions_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cve_AdjustmentToInvestmentInAssociate_lbl0" xml:lang="en-US">Adjustment to investment in associate.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_AdjustmentToInvestmentInAssociate" xlink:to="cve_AdjustmentToInvestmentInAssociate_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cve_AdjustmentToInvestmentInGroup11_lbl0" xml:lang="en-US">Adjustment to investment in Group 11.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_AdjustmentToInvestmentInGroup11" xlink:to="cve_AdjustmentToInvestmentInGroup11_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cve_AdvancedAmount_lbl0" xml:lang="en-US">Advanced amount.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_AdvancedAmount" xlink:to="cve_AdvancedAmount_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cve_AggregateOfGrantedShares_lbl0" xml:lang="en-US">Aggregate of granted shares.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_AggregateOfGrantedShares" xlink:to="cve_AggregateOfGrantedShares_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cve_AssetRetirementObligations_lbl0" xml:lang="en-US">Asset retirement obligations.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_AssetRetirementObligations" xlink:to="cve_AssetRetirementObligations_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cve_AssetRetirementObligationsAccretion_lbl0" xml:lang="en-US">Asset Retirement Obligations Accretion.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_AssetRetirementObligationsAccretion" xlink:to="cve_AssetRetirementObligationsAccretion_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cve_AssetRetirementObligationsAdditionsFromAzargaAssetAcquisitionNote10_lbl0" xml:lang="en-US">Asset Retirement Obligations Additions From Azarga Asset Acquisition Note 10.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_AssetRetirementObligationsAdditionsFromAzargaAssetAcquisitionNote10" xlink:to="cve_AssetRetirementObligationsAdditionsFromAzargaAssetAcquisitionNote10_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cve_AssetRetirementObligationsAdjustments_lbl0" xml:lang="en-US">Asset Retirement Obligations Adjustments.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_AssetRetirementObligationsAdjustments" xlink:to="cve_AssetRetirementObligationsAdjustments_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cve_AssetRetirementObligationsBalance_lbl1" xml:lang="en-US">Asset Retirement Obligations Balance.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_AssetRetirementObligationsBalance" xlink:to="cve_AssetRetirementObligationsBalance_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cve_AssetRetirementObligationsSettlement_lbl0" xml:lang="en-US">Asset Retirement Obligations Settlement.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_AssetRetirementObligationsSettlement" xlink:to="cve_AssetRetirementObligationsSettlement_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cve_AssetsLossFromOperatingExpenses_lbl0" xml:lang="en-US">Assets, Loss from operating expenses</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_AssetsLossFromOperatingExpenses" xlink:to="cve_AssetsLossFromOperatingExpenses_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cve_AssetsReceivedPercentage_lbl0" xml:lang="en-US">Assets received percentage</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_AssetsReceivedPercentage" xlink:to="cve_AssetsReceivedPercentage_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cve_CancellationFee_lbl0" xml:lang="en-US">Cancellation fee.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_CancellationFee" xlink:to="cve_CancellationFee_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cve_CarriedForward_lbl0" xml:lang="en-US">Carried forward.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_CarriedForward" xlink:to="cve_CarriedForward_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cve_CashAcquiredFromAzargaAssetAcquisition_lbl0" xml:lang="en-US">Cash acquired from azarga asset acquisition.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_CashAcquiredFromAzargaAssetAcquisition" xlink:to="cve_CashAcquiredFromAzargaAssetAcquisition_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cve_CashIssuanceCosts_lbl0" xml:lang="en-US">Flotation costs are incurred by a publicly-traded company when it issues new securities and the cost makes the company&apos;s new equity more expensive.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_CashIssuanceCosts" xlink:to="cve_CashIssuanceCosts_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cve_CategoryRange_lbl0" xml:lang="en-US">Range.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_CategoryRange" xlink:to="cve_CategoryRange_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cve_ChangeInUnrecognizedTemporaryDifferences_lbl0" xml:lang="en-US">Change in unrecognized temporary differences.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_ChangeInUnrecognizedTemporaryDifferences" xlink:to="cve_ChangeInUnrecognizedTemporaryDifferences_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cve_CommonShare_lbl0" xml:lang="en-US">A common shareholder is an individual, business, or institution that holds common shares in a company, giving the holder an ownership stake in the company. This will also give the holder the right to vote on corporate issues such as board elections and corporate policy, along with the right to any common dividend payments.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_CommonShare" xlink:to="cve_CommonShare_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cve_CommonShareIssued_lbl0" xml:lang="en-US">Issued shares are the subset of authorized shares that have been sold to and held by the shareholders of a company, regardless of whether they are insiders, institutional investors, or the general public (as shown in the company&#8217;s annual report). Issued shares include the stock a company sells publicly to generate capital and the stock given to insiders as part of their compensation packages.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_CommonShareIssued" xlink:to="cve_CommonShareIssued_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cve_CommonShares_lbl0" xml:lang="en-US">Number of shares common.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_CommonShares" xlink:to="cve_CommonShares_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cve_CommonSharesOfSettlementAndCompensation_lbl0" xml:lang="en-US">Common shares of settlement and compensation.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_CommonSharesOfSettlementAndCompensation" xlink:to="cve_CommonSharesOfSettlementAndCompensation_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cve_CommunityEngagement_lbl0" xml:lang="en-US">Community engagement expenses.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_CommunityEngagement" xlink:to="cve_CommunityEngagement_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cve_Consulting_lbl0" xml:lang="en-US">Consulting Expenses.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_Consulting" xlink:to="cve_Consulting_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cve_ConsultingFees_lbl0" xml:lang="en-US">The amount of consulting fees.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_ConsultingFees" xlink:to="cve_ConsultingFees_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cve_ContractPoundsOfUranium_lbl0" xml:lang="en-US">Contract pounds of uranium.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_ContractPoundsOfUranium" xlink:to="cve_ContractPoundsOfUranium_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cve_ContributedSurplus_lbl0" xml:lang="en-US">Contributed surplus.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_ContributedSurplus" xlink:to="cve_ContributedSurplus_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cve_ConvertedShares_lbl0" xml:lang="en-US">Number of shares converted.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_ConvertedShares" xlink:to="cve_ConvertedShares_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cve_CorrespondingLeaseObligation_lbl0" xml:lang="en-US">Corresponding lease obligation.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_CorrespondingLeaseObligation" xlink:to="cve_CorrespondingLeaseObligation_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cve_CurrencyTranslationAdjustment_lbl0" xml:lang="en-US">Amount of currency translation adjustment.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_CurrencyTranslationAdjustment" xlink:to="cve_CurrencyTranslationAdjustment_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cve_CurrencyTranslationAdjustment1_lbl0" xml:lang="en-US">Currency Translation Adjustment.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_CurrencyTranslationAdjustment1" xlink:to="cve_CurrencyTranslationAdjustment1_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cve_DeductibleTemporaryDifferences_lbl0" xml:lang="en-US">Deductible temporary differences.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_DeductibleTemporaryDifferences" xlink:to="cve_DeductibleTemporaryDifferences_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cve_DepositUraniumInvestment_lbl0" xml:lang="en-US">Deposit uranium investment.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_DepositUraniumInvestment" xlink:to="cve_DepositUraniumInvestment_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cve_DescriptionOfAccountingPolicyForAssetRetirementObligationstextBlock_lbl0" xml:lang="en-US">The description of the entity&apos;s accounting policy for asset retirement obligations.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_DescriptionOfAccountingPolicyForAssetRetirementObligationstextBlock" xlink:to="cve_DescriptionOfAccountingPolicyForAssetRetirementObligationstextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cve_DescriptionOfAccountingPolicyForBasisOfConsolidationtextBlock_lbl0" xml:lang="en-US">The description of the entity&apos;s accounting policy for basis of consolidation.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_DescriptionOfAccountingPolicyForBasisOfConsolidationtextBlock" xlink:to="cve_DescriptionOfAccountingPolicyForBasisOfConsolidationtextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cve_DescriptionOfAccountingPolicyForBasisOfPresentationtextBlock_lbl0" xml:lang="en-US">The description of the entity&apos;s accounting policy for basis of presentation.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_DescriptionOfAccountingPolicyForBasisOfPresentationtextBlock" xlink:to="cve_DescriptionOfAccountingPolicyForBasisOfPresentationtextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cve_DescriptionOfAccountingPolicyForBuildingtextBlock_lbl0" xml:lang="en-US">The description of the entity&apos;s accounting policy for buildings.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_DescriptionOfAccountingPolicyForBuildingtextBlock" xlink:to="cve_DescriptionOfAccountingPolicyForBuildingtextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cve_DescriptionOfAccountingPolicyForCashtextBlock_lbl0" xml:lang="en-US">The description of the entity&apos;s accounting policy for cash.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_DescriptionOfAccountingPolicyForCashtextBlock" xlink:to="cve_DescriptionOfAccountingPolicyForCashtextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cve_DescriptionOfAccountingPolicyForChangeInPresentationCurrencytextBlock_lbl0" xml:lang="en-US">The description of the entity&apos;s accounting policy for change in presentation currency.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_DescriptionOfAccountingPolicyForChangeInPresentationCurrencytextBlock" xlink:to="cve_DescriptionOfAccountingPolicyForChangeInPresentationCurrencytextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cve_DescriptionOfAccountingPolicyForInvestmentsInUraniumtextBlock_lbl0" xml:lang="en-US">The description of the entity&apos;s accounting policy for investments in uranium.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_DescriptionOfAccountingPolicyForInvestmentsInUraniumtextBlock" xlink:to="cve_DescriptionOfAccountingPolicyForInvestmentsInUraniumtextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cve_DescriptionOfAccountingPolicyForMineralPropertiestextBlock_lbl0" xml:lang="en-US">The description of the entity&apos;s accounting policy for mineral properties.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_DescriptionOfAccountingPolicyForMineralPropertiestextBlock" xlink:to="cve_DescriptionOfAccountingPolicyForMineralPropertiestextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cve_DescriptionOfAccountingPolicyForNewStandardsAndInterpretationsNotYetAdoptedtextBlock_lbl0" xml:lang="en-US">The description of the entity&apos;s accounting policy for new standards and interpretations not yet adopted.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_DescriptionOfAccountingPolicyForNewStandardsAndInterpretationsNotYetAdoptedtextBlock" xlink:to="cve_DescriptionOfAccountingPolicyForNewStandardsAndInterpretationsNotYetAdoptedtextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cve_DescriptionOfAccountingPolicyForOtherPropertyPlantAndEquipmenttextBlock_lbl0" xml:lang="en-US">The description of the entity&apos;s accounting policy for other property, plant and equipment. [Refer: Property, plant and equipment] Effective 2023-01-01: The description of the entity&apos;s material accounting policy information for property, plant and equipment. [Refer: Property, plant and equipment]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_DescriptionOfAccountingPolicyForOtherPropertyPlantAndEquipmenttextBlock" xlink:to="cve_DescriptionOfAccountingPolicyForOtherPropertyPlantAndEquipmenttextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cve_DescriptionOfAccountingPolicyForSoftwaretextBlock_lbl0" xml:lang="en-US">The description of the entity&apos;s accounting policy for software.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_DescriptionOfAccountingPolicyForSoftwaretextBlock" xlink:to="cve_DescriptionOfAccountingPolicyForSoftwaretextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cve_DescriptionOfAccountingPolicyForUraniumPlantstextBlock_lbl0" xml:lang="en-US">The description of the entity&apos;s accounting policy for uranium plants.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_DescriptionOfAccountingPolicyForUraniumPlantstextBlock" xlink:to="cve_DescriptionOfAccountingPolicyForUraniumPlantstextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cve_DilutionLoss_lbl0" xml:lang="en-US">Amount of dilution loss.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_DilutionLoss" xlink:to="cve_DilutionLoss_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cve_DisclosueOfSalesContractsTextBlock_lbl0" xml:lang="en-US">Disclosue of Sales contracts.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_DisclosueOfSalesContractsTextBlock" xlink:to="cve_DisclosueOfSalesContractsTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cve_DisclosureOfAssetRetirementObligationsBalanceTableTextBlock_lbl0" xml:lang="en-US">Disclosure of asset retirement obligations balance.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_DisclosureOfAssetRetirementObligationsBalanceTableTextBlock" xlink:to="cve_DisclosureOfAssetRetirementObligationsBalanceTableTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cve_DisclosureOfAssetRetirementObligationsContinuityTableTextBlock_lbl0" xml:lang="en-US">Disclosure of asset retirement obligations continuity.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_DisclosureOfAssetRetirementObligationsContinuityTableTextBlock" xlink:to="cve_DisclosureOfAssetRetirementObligationsContinuityTableTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cve_DisclosureOfChangeInTheLongTermLeaseLiabilityTableTextBlock_lbl0" xml:lang="en-US">Disclosure of change in the long-Term lease liability.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_DisclosureOfChangeInTheLongTermLeaseLiabilityTableTextBlock" xlink:to="cve_DisclosureOfChangeInTheLongTermLeaseLiabilityTableTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cve_DisclosureOfChangeInTheROUAssetsTableTextBlock_lbl0" xml:lang="en-US">Disclosure of change in the ROU assets.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_DisclosureOfChangeInTheROUAssetsTableTextBlock" xlink:to="cve_DisclosureOfChangeInTheROUAssetsTableTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cve_DisclosureOfLongtermAssetsByGeographicSegmentTableTextBlock_lbl0" xml:lang="en-US">Disclosure of long-term assets by geographic segment.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_DisclosureOfLongtermAssetsByGeographicSegmentTableTextBlock" xlink:to="cve_DisclosureOfLongtermAssetsByGeographicSegmentTableTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cve_DisclosureOfProportionalShareAssociatesExplanatory_lbl0" xml:lang="en-US">Disclosure Of Proportional Share Associates Explanatory.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_DisclosureOfProportionalShareAssociatesExplanatory" xlink:to="cve_DisclosureOfProportionalShareAssociatesExplanatory_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cve_DisclosureOfUsefulLivesOfIntangibleAssetsTextBllock_lbl0" xml:lang="en-US">Disclosure of useful lives of intangible assets.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_DisclosureOfUsefulLivesOfIntangibleAssetsTextBllock" xlink:to="cve_DisclosureOfUsefulLivesOfIntangibleAssetsTextBllock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cve_DisclosureOfUsefulLivesOfPropertyPlantAndEquipementTextBlock_lbl0" xml:lang="en-US">Disclosure of useful lives of property, plant and equipement.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_DisclosureOfUsefulLivesOfPropertyPlantAndEquipementTextBlock" xlink:to="cve_DisclosureOfUsefulLivesOfPropertyPlantAndEquipementTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cve_ExchangeRatio_lbl0" xml:lang="en-US">The amount of exchange ratio.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_ExchangeRatio" xlink:to="cve_ExchangeRatio_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cve_ExpectedIncomeTaxExpenserecovery_lbl0" xml:lang="en-US">expected income tax expense (recovery).</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_ExpectedIncomeTaxExpenserecovery" xlink:to="cve_ExpectedIncomeTaxExpenserecovery_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cve_ExpiringAmount_lbl0" xml:lang="en-US">Expiring amount.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_ExpiringAmount" xlink:to="cve_ExpiringAmount_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cve_FairValueAmount_lbl0" xml:lang="en-US">Fair Value Amount.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_FairValueAmount" xlink:to="cve_FairValueAmount_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cve_FairValueOfCommonSharesIssuedForAzargaAssetAcquisition_lbl0" xml:lang="en-US">The amount of fair value of common shares issued for Azarga asset acquisition.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_FairValueOfCommonSharesIssuedForAzargaAssetAcquisition" xlink:to="cve_FairValueOfCommonSharesIssuedForAzargaAssetAcquisition_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cve_FairValueOfGrantedOption_lbl0" xml:lang="en-US">Fair value of granted option.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_FairValueOfGrantedOption" xlink:to="cve_FairValueOfGrantedOption_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cve_FairValueOfReplacement_lbl0" xml:lang="en-US">Fair value of replacement.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_FairValueOfReplacement" xlink:to="cve_FairValueOfReplacement_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cve_FairValueOfReplacementOptions_lbl0" xml:lang="en-US">Fair value of replacement options.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_FairValueOfReplacementOptions" xlink:to="cve_FairValueOfReplacementOptions_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cve_FairValueOfReplacementOptionsIssuedForAzargaAssetsAcquisition_lbl0" xml:lang="en-US">Fair value of replacement options issued for Azarga asset acquisition.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_FairValueOfReplacementOptionsIssuedForAzargaAssetsAcquisition" xlink:to="cve_FairValueOfReplacementOptionsIssuedForAzargaAssetsAcquisition_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cve_FairValueOfReplacementWarrants_lbl0" xml:lang="en-US">Fair value of replacement warrants.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_FairValueOfReplacementWarrants" xlink:to="cve_FairValueOfReplacementWarrants_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cve_FairValueOfReplacementWarrantsIssuedForAzargaAssetAcquisition_lbl0" xml:lang="en-US">The amount of fair value of replacement warrants issued for Azarga asset acquisition.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_FairValueOfReplacementWarrantsIssuedForAzargaAssetAcquisition" xlink:to="cve_FairValueOfReplacementWarrantsIssuedForAzargaAssetAcquisition_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cve_FederalNetOperatingLossCarryforwards_lbl0" xml:lang="en-US">Federal net operating loss carryforwards.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_FederalNetOperatingLossCarryforwards" xlink:to="cve_FederalNetOperatingLossCarryforwards_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cve_FixedAssets_lbl0" xml:lang="en-US">Fixed assets.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_FixedAssets" xlink:to="cve_FixedAssets_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cve_GainOnDisposalOfSubsidiary_lbl2" xml:lang="en-US">Gain on disposal of subsidiary</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_GainOnDisposalOfSubsidiary" xlink:to="cve_GainOnDisposalOfSubsidiary_lbl2"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cve_GainOnSaleOfUranium_lbl0" xml:lang="en-US">The net realized gain (loss) on investments sold during the period, not including gains (losses) on securities separately or otherwise categorized as trading, available-for-sale, or held-to-maturity, which, for cash flow reporting, is a component of proceeds from investing activities.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_GainOnSaleOfUranium" xlink:to="cve_GainOnSaleOfUranium_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cve_GrantedOptionsShares_lbl0" xml:lang="en-US">Granted options shares.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_GrantedOptionsShares" xlink:to="cve_GrantedOptionsShares_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cve_GrantedStockOptions_lbl0" xml:lang="en-US">Granted  stock options.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_GrantedStockOptions" xlink:to="cve_GrantedStockOptions_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cve_GrossProceed_lbl0" xml:lang="en-US">Net proceeds are the amount the seller receives following the sale of an asset after all costs and expenses are deducted from the gross proceeds.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_GrossProceed" xlink:to="cve_GrossProceed_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cve_GrossProceeds_lbl0" xml:lang="en-US">The amount of gross proseeds.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_GrossProceeds" xlink:to="cve_GrossProceeds_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cve_ImpactedLoss_lbl0" xml:lang="en-US">Impacted loss.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_ImpactedLoss" xlink:to="cve_ImpactedLoss_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cve_InflationFactorPercentage_lbl0" xml:lang="en-US">Inflation factor, percentage.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_InflationFactorPercentage" xlink:to="cve_InflationFactorPercentage_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cve_InitialPayment_lbl0" xml:lang="en-US">initial payment.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_InitialPayment" xlink:to="cve_InitialPayment_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cve_IntangibleAssetDeterminedLife_lbl0" xml:lang="en-US">Intangible asset determined life.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_IntangibleAssetDeterminedLife" xlink:to="cve_IntangibleAssetDeterminedLife_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cve_IntangibleAssets_lbl0" xml:lang="en-US">Intangible assets.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_IntangibleAssets" xlink:to="cve_IntangibleAssets_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cve_IntangibleAssetsBalance_lbl1" xml:lang="en-US">Intangible Assets Balance.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_IntangibleAssetsBalance" xlink:to="cve_IntangibleAssetsBalance_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cve_InvestmentAmount_lbl0" xml:lang="en-US">Investment amount.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_InvestmentAmount" xlink:to="cve_InvestmentAmount_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cve_IssuedAndOutstandingSharesPercentage_lbl0" xml:lang="en-US">percentage of issued and outstanding shares.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_IssuedAndOutstandingSharesPercentage" xlink:to="cve_IssuedAndOutstandingSharesPercentage_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cve_Long-TermLeaseLiabilityAccretion_lbl0" xml:lang="en-US">Long-Term Lease Liability Accretion.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_Long-TermLeaseLiabilityAccretion" xlink:to="cve_Long-TermLeaseLiabilityAccretion_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cve_Long-TermLeaseLiabilityAdditions_lbl0" xml:lang="en-US">Additions.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_Long-TermLeaseLiabilityAdditions" xlink:to="cve_Long-TermLeaseLiabilityAdditions_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cve_Long-TermLeaseLiabilityBalance_lbl1" xml:lang="en-US">Long-Term Lease Liability Balance.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_Long-TermLeaseLiabilityBalance" xlink:to="cve_Long-TermLeaseLiabilityBalance_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cve_Long-TermLeaseLiabilityCurrencyTranslationAdjustment_lbl0" xml:lang="en-US">Long-Term Lease Liability Currency Translation Adjustment.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_Long-TermLeaseLiabilityCurrencyTranslationAdjustment" xlink:to="cve_Long-TermLeaseLiabilityCurrencyTranslationAdjustment_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cve_Long-TermLeaseLiabilityLeasePaymentsMade_lbl0" xml:lang="en-US">Long-Term Lease Liability Lease Payments Made.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_Long-TermLeaseLiabilityLeasePaymentsMade" xlink:to="cve_Long-TermLeaseLiabilityLeasePaymentsMade_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cve_Long-TermLeaseLiabilityLessCurrentLeaseLiability_lbl0" xml:lang="en-US">Long-Term Lease Liability Less Current Lease Liability.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_Long-TermLeaseLiabilityLessCurrentLeaseLiability" xlink:to="cve_Long-TermLeaseLiabilityLessCurrentLeaseLiability_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cve_LossOnContractTerminations_lbl0" xml:lang="en-US">The loss recognized on termination of a contract.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_LossOnContractTerminations" xlink:to="cve_LossOnContractTerminations_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cve_MaintenancesAndLeaseFees_lbl0" xml:lang="en-US">Maintenance and lease fees.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_MaintenancesAndLeaseFees" xlink:to="cve_MaintenancesAndLeaseFees_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cve_MarketValuePerShare_lbl1" xml:lang="en-US">Market value per share.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_MarketValuePerShare" xlink:to="cve_MarketValuePerShare_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cve_MarketableSecuritieReceivedOnDispositionOfMineralProperties_lbl0" xml:lang="en-US">Marketable securities received on disposition of mineral properties.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_MarketableSecuritieReceivedOnDispositionOfMineralProperties" xlink:to="cve_MarketableSecuritieReceivedOnDispositionOfMineralProperties_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cve_MarketableSecuritiecurrent_lbl0" xml:lang="en-US">The amount of marketable securities as current.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_MarketableSecuritiecurrent" xlink:to="cve_MarketableSecuritiecurrent_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cve_MarketablesSecurities_lbl1" xml:lang="en-US">Amount of marketable securities.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_MarketablesSecurities" xlink:to="cve_MarketablesSecurities_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cve_MarketablesSecuritiesNoncurrent_lbl0" xml:lang="en-US">The amount of marketable securities non current.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_MarketablesSecuritiesNoncurrent" xlink:to="cve_MarketablesSecuritiesNoncurrent_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cve_MineralProperties_lbl0" xml:lang="en-US">Mineral properties.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_MineralProperties" xlink:to="cve_MineralProperties_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cve_NameofSubsidaryFunctionalCurrency_lbl0" xml:lang="en-US">Functional Currency.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_NameofSubsidaryFunctionalCurrency" xlink:to="cve_NameofSubsidaryFunctionalCurrency_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cve_NameofSubsidaryPlaceOfIncorporation_lbl0" xml:lang="en-US">Place of Incorporation.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_NameofSubsidaryPlaceOfIncorporation" xlink:to="cve_NameofSubsidaryPlaceOfIncorporation_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cve_NameofSubsidaryPrincipalActivity_lbl0" xml:lang="en-US">Principal Activity.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_NameofSubsidaryPrincipalActivity" xlink:to="cve_NameofSubsidaryPrincipalActivity_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cve_NatureOfOperationAndGoingConcern_lbl0" xml:lang="en-US">Nature of operations and going concern.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_NatureOfOperationAndGoingConcern" xlink:to="cve_NatureOfOperationAndGoingConcern_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cve_NoncapitalLoss_lbl0" xml:lang="en-US">Non-capital loss.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_NoncapitalLoss" xlink:to="cve_NoncapitalLoss_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cve_NumberOfSharesReservedInsurancePercentage_lbl0" xml:lang="en-US">Number of shares reserved insurance percentage.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_NumberOfSharesReservedInsurancePercentage" xlink:to="cve_NumberOfSharesReservedInsurancePercentage_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cve_OfficeAndAdministration_lbl0" xml:lang="en-US">The amount of office and administration.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_OfficeAndAdministration" xlink:to="cve_OfficeAndAdministration_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cve_OfficeAndAdministrative_lbl0" xml:lang="en-US">Office and administrative.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_OfficeAndAdministrative" xlink:to="cve_OfficeAndAdministrative_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cve_OptionToAcquireShares_lbl0" xml:lang="en-US">Option to acquire shares.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_OptionToAcquireShares" xlink:to="cve_OptionToAcquireShares_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cve_OptionsGrantedForMaximumYear_lbl0" xml:lang="en-US">Options granted for maximum year.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_OptionsGrantedForMaximumYear" xlink:to="cve_OptionsGrantedForMaximumYear_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cve_OrginationAndReversalOfTemporaryDifferences_lbl0" xml:lang="en-US">Orgination and reversal of temporary differences.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_OrginationAndReversalOfTemporaryDifferences" xlink:to="cve_OrginationAndReversalOfTemporaryDifferences_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cve_OtherRevenuesCurrent_lbl0" xml:lang="en-US">Revenues, Current</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_OtherRevenuesCurrent" xlink:to="cve_OtherRevenuesCurrent_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cve_OtherRevenuesNoncurrent_lbl0" xml:lang="en-US">Revenues, Non-current</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_OtherRevenuesNoncurrent" xlink:to="cve_OtherRevenuesNoncurrent_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cve_PaymentAmount_lbl0" xml:lang="en-US">Payment amount.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_PaymentAmount" xlink:to="cve_PaymentAmount_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cve_PaymentsofInvestmentInUranium_lbl0" xml:lang="en-US">Investment in uranium</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_PaymentsofInvestmentInUranium" xlink:to="cve_PaymentsofInvestmentInUranium_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cve_PhysicalUranium_lbl0" xml:lang="en-US">Physical uranium.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_PhysicalUranium" xlink:to="cve_PhysicalUranium_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cve_PricePerPound_lbl0" xml:lang="en-US">Price per pound.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_PricePerPound" xlink:to="cve_PricePerPound_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cve_PricePerShare_lbl0" xml:lang="en-US">Price per share value.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_PricePerShare" xlink:to="cve_PricePerShare_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cve_PrimaryTerm_lbl0" xml:lang="en-US">Primary term.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_PrimaryTerm" xlink:to="cve_PrimaryTerm_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cve_PrimeFuelsConsiderationPercentage_lbl0" xml:lang="en-US">Percentage of prime fuels consideration.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_PrimeFuelsConsiderationPercentage" xlink:to="cve_PrimeFuelsConsiderationPercentage_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cve_PrivatePlacement_lbl0" xml:lang="en-US">Private placement.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_PrivatePlacement" xlink:to="cve_PrivatePlacement_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cve_PrivatePlacementProceeds_lbl0" xml:lang="en-US">The cash inflow from the private placement proceeds.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_PrivatePlacementProceeds" xlink:to="cve_PrivatePlacementProceeds_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cve_PrivatePlacementinShares_lbl0" xml:lang="en-US">Private placement in shares.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_PrivatePlacementinShares" xlink:to="cve_PrivatePlacementinShares_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cve_ProceedsReceivedFromSaleOfUraniumInvestment_lbl0" xml:lang="en-US">Proceeds received from sale of uranium investment</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_ProceedsReceivedFromSaleOfUraniumInvestment" xlink:to="cve_ProceedsReceivedFromSaleOfUraniumInvestment_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cve_ProjectInvestigationFess_lbl0" xml:lang="en-US">Project investigation expenses.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_ProjectInvestigationFess" xlink:to="cve_ProjectInvestigationFess_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cve_PropertyPlantAndEquipmentAdditionIncludedInAccountsPayableAndAccruedLiabilities_lbl0" xml:lang="en-US">Property, plant, and equipment additions included in accounts payable and accrued liabilities.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_PropertyPlantAndEquipmentAdditionIncludedInAccountsPayableAndAccruedLiabilities" xlink:to="cve_PropertyPlantAndEquipmentAdditionIncludedInAccountsPayableAndAccruedLiabilities_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cve_PropertyPlantAndEquipments_lbl0" xml:lang="en-US">Property, plant and equipment.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_PropertyPlantAndEquipments" xlink:to="cve_PropertyPlantAndEquipments_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cve_ProportionateShareOfNetLoss_lbl0" xml:lang="en-US">Amount of proportionate share of net loss.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_ProportionateShareOfNetLoss" xlink:to="cve_ProportionateShareOfNetLoss_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cve_PublicOfferingPricePerShare_lbl0" xml:lang="en-US">Public offering price per share.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_PublicOfferingPricePerShare" xlink:to="cve_PublicOfferingPricePerShare_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cve_PurchaseAdditionalSharePricePerWarrant_lbl0" xml:lang="en-US">Purchase additional share price per warrant.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_PurchaseAdditionalSharePricePerWarrant" xlink:to="cve_PurchaseAdditionalSharePricePerWarrant_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cve_PurchaseAdditionalShareWarrants_lbl0" xml:lang="en-US">A stock warrant gives the holder the right to purchase a company&apos;s stock at a specific price and at a specific date. A stock warrant is issued directly by the company concerned; when an investor exercises a stock warrant, the shares that fulfill the obligation are not received from another investor but directly from the company.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_PurchaseAdditionalShareWarrants" xlink:to="cve_PurchaseAdditionalShareWarrants_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cve_PurchaseAgreementsAmount_lbl1" xml:lang="en-US">The amount of purchase agreements amount.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_PurchaseAgreementsAmount" xlink:to="cve_PurchaseAgreementsAmount_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cve_PurchaseCommitments_lbl0" xml:lang="en-US">Amount of Purchase Commitments.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_PurchaseCommitments" xlink:to="cve_PurchaseCommitments_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cve_PurchasePricePerShare_lbl0" xml:lang="en-US">Purchase price per share.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_PurchasePricePerShare" xlink:to="cve_PurchasePricePerShare_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cve_PurchaseWarrantShares_lbl0" xml:lang="en-US">hen an investor exercises a warrant, they purchase stock, and the proceeds are a source of capital for the company. A warrant certificate is issued to the investor when they exercise a warrant. The certificate includes the terms of the warrant, such as the expiry date and the final day it can be exercised.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_PurchaseWarrantShares" xlink:to="cve_PurchaseWarrantShares_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cve_PurchasedShares_lbl0" xml:lang="en-US">Purchased shares.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_PurchasedShares" xlink:to="cve_PurchasedShares_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cve_PursuantToAgreement_lbl0" xml:lang="en-US">Pursuant to agreement.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_PursuantToAgreement" xlink:to="cve_PursuantToAgreement_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cve_RecognizedStockOptionExpense_lbl0" xml:lang="en-US">Recognized stock option expense.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_RecognizedStockOptionExpense" xlink:to="cve_RecognizedStockOptionExpense_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cve_ReleasedShares_lbl0" xml:lang="en-US">Released shares.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_ReleasedShares" xlink:to="cve_ReleasedShares_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cve_RenewalPeriods_lbl0" xml:lang="en-US">Renewal periods.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_RenewalPeriods" xlink:to="cve_RenewalPeriods_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cve_ReplacementOptionsForAzargaAssetAcquisition_lbl0" xml:lang="en-US">Replacement options for azarga asset acquisition.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_ReplacementOptionsForAzargaAssetAcquisition" xlink:to="cve_ReplacementOptionsForAzargaAssetAcquisition_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cve_ReplacementWarrantsForAzargaAssetAcquisition_lbl0" xml:lang="en-US">Replacement warrants for azarga asset acquisition.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_ReplacementWarrantsForAzargaAssetAcquisition" xlink:to="cve_ReplacementWarrantsForAzargaAssetAcquisition_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cve_Right-of-UseAssetsAdditions_lbl0" xml:lang="en-US">Additions.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_Right-of-UseAssetsAdditions" xlink:to="cve_Right-of-UseAssetsAdditions_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cve_Right-of-UseAssetsCurrencyTranslationAdjustment_lbl0" xml:lang="en-US">Currency translation adjustment.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_Right-of-UseAssetsCurrencyTranslationAdjustment" xlink:to="cve_Right-of-UseAssetsCurrencyTranslationAdjustment_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cve_Right-of-UseAssetsDepreciation_lbl0" xml:lang="en-US">Depreciation.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_Right-of-UseAssetsDepreciation" xlink:to="cve_Right-of-UseAssetsDepreciation_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cve_Right-of-UseAssetsTwoZeroTwoFive_lbl0" xml:lang="en-US">Right-of-use assets two zero two five.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_Right-of-UseAssetsTwoZeroTwoFive" xlink:to="cve_Right-of-UseAssetsTwoZeroTwoFive_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cve_Right-of-UseAssetsTwoZeroTwoFour_lbl0" xml:lang="en-US">Right-of-use assets two zero two four.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_Right-of-UseAssetsTwoZeroTwoFour" xlink:to="cve_Right-of-UseAssetsTwoZeroTwoFour_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cve_Right-of-UseAssetsTwoZeroTwoThree_lbl0" xml:lang="en-US">Right-of-use assets two zero two three.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_Right-of-UseAssetsTwoZeroTwoThree" xlink:to="cve_Right-of-UseAssetsTwoZeroTwoThree_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cve_RightofuseAssets1_lbl0" xml:lang="en-US">Right-of-use assets.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_RightofuseAssets1" xlink:to="cve_RightofuseAssets1_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cve_SaleOfPhysicalUranium_lbl0" xml:lang="en-US">The amount of sale of physical uranium.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_SaleOfPhysicalUranium" xlink:to="cve_SaleOfPhysicalUranium_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cve_SaleOfUraniumInvestment_lbl0" xml:lang="en-US">The net realized gain (loss) on investments sold during the period, not including gains (losses) on securities separately or otherwise categorized as trading, available-for-sale, or held-to-maturity, which, for cash flow reporting, is a component of proceeds from investing activities.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_SaleOfUraniumInvestment" xlink:to="cve_SaleOfUraniumInvestment_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cve_Saleofstockpershare_lbl0" xml:lang="en-US">Sale of stock per share.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_Saleofstockpershare" xlink:to="cve_Saleofstockpershare_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cve_SalesContractsFiscalTwoZeroTwoFive_lbl0" xml:lang="en-US">Sales contracts fiscal two zero two five.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_SalesContractsFiscalTwoZeroTwoFive" xlink:to="cve_SalesContractsFiscalTwoZeroTwoFive_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cve_SalesContractsFiscalTwoZeroTwoFour_lbl0" xml:lang="en-US">Sales contracts fiscal two zero two four.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_SalesContractsFiscalTwoZeroTwoFour" xlink:to="cve_SalesContractsFiscalTwoZeroTwoFour_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cve_SalesContractsFiscalTwoZeroTwoSeven_lbl0" xml:lang="en-US">Sales contracts fiscal two zero two seven.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_SalesContractsFiscalTwoZeroTwoSeven" xlink:to="cve_SalesContractsFiscalTwoZeroTwoSeven_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cve_SalesContractsFiscalTwoZeroTwoSix_lbl0" xml:lang="en-US">Sales contracts fiscal two zero two six.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_SalesContractsFiscalTwoZeroTwoSix" xlink:to="cve_SalesContractsFiscalTwoZeroTwoSix_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cve_SalesContractsFiscalTwoZeroTwoThree_lbl0" xml:lang="en-US">Sales contracts fiscal two zero two three.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_SalesContractsFiscalTwoZeroTwoThree" xlink:to="cve_SalesContractsFiscalTwoZeroTwoThree_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cve_SalesContractsTrem_lbl0" xml:lang="en-US">Sales contracts trem.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_SalesContractsTrem" xlink:to="cve_SalesContractsTrem_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cve_ScheduleOfMarketableSecuritiesTableTextBlock_lbl0" xml:lang="en-US">The entire disclosure for marketable securities.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_ScheduleOfMarketableSecuritiesTableTextBlock" xlink:to="cve_ScheduleOfMarketableSecuritiesTableTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cve_SegmentedInformationBalance_lbl0" xml:lang="en-US">Segmented information balance.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_SegmentedInformationBalance" xlink:to="cve_SegmentedInformationBalance_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cve_SetoffOfTax_lbl1" xml:lang="en-US">Set-off of tax.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_SetoffOfTax" xlink:to="cve_SetoffOfTax_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cve_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisedWarrantsExercised_lbl0" xml:lang="en-US">Number of non-option equity instruments exercised by participants.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisedWarrantsExercised" xlink:to="cve_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisedWarrantsExercised_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cve_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWarrantsExpired_lbl0" xml:lang="en-US">For presentations that combine terminations, the number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan or that expired.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWarrantsExpired" xlink:to="cve_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWarrantsExpired_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cve_ShareBasedCompensationArrangementBySharesBasedPaymentAwardOptionsGrantsInPeriodWarrantsGranted_lbl0" xml:lang="en-US">Net number of share options (or share units) granted during the period.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_ShareBasedCompensationArrangementBySharesBasedPaymentAwardOptionsGrantsInPeriodWarrantsGranted" xlink:to="cve_ShareBasedCompensationArrangementBySharesBasedPaymentAwardOptionsGrantsInPeriodWarrantsGranted_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cve_ShareBasedCompensationArrangementsBySharesBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_lbl0" xml:lang="en-US">Weighted average price at which grantees could have acquired the underlying shares with respect to stock options of the plan that expired.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_ShareBasedCompensationArrangementsBySharesBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" xlink:to="cve_ShareBasedCompensationArrangementsBySharesBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cve_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptionsWarrantsOutstanding_lbl1" xml:lang="en-US">The number of shares reserved for issuance pertaining to the outstanding stock options as of the balance sheet date for all option plans in the customized range of exercise prices.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptionsWarrantsOutstanding" xlink:to="cve_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptionsWarrantsOutstanding_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cve_ShareConsiderationAmount_lbl0" xml:lang="en-US">The amount of share consideration.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_ShareConsiderationAmount" xlink:to="cve_ShareConsiderationAmount_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cve_ShareConsolidation_lbl0" xml:lang="en-US">Share consolidation.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_ShareConsolidation" xlink:to="cve_ShareConsolidation_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cve_ShareIssueCosts_lbl0" xml:lang="en-US">Share issue costs.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_ShareIssueCosts" xlink:to="cve_ShareIssueCosts_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cve_ShareIssued_lbl0" xml:lang="en-US">Shares issued.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_ShareIssued" xlink:to="cve_ShareIssued_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cve_SharePurchaseWarrants_lbl0" xml:lang="en-US">Share purchase warrants.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_SharePurchaseWarrants" xlink:to="cve_SharePurchaseWarrants_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cve_ShareSubscriptionsReceived_lbl0" xml:lang="en-US">Share subscriptions received.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_ShareSubscriptionsReceived" xlink:to="cve_ShareSubscriptionsReceived_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cve_ShareSubscriptionsValue_lbl0" xml:lang="en-US">Amount of share subscriptions value.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_ShareSubscriptionsValue" xlink:to="cve_ShareSubscriptionsValue_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cve_SharesBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_lbl1" xml:lang="en-US">The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_SharesBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:to="cve_SharesBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cve_SharesBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_lbl0" xml:lang="en-US">Gross number of share options (or share units) granted during the period.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_SharesBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:to="cve_SharesBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cve_SharesBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingPeriodIncreaseDecreaseWeightedAverageExercisePrice_lbl1" xml:lang="en-US">Change in the weighted average exercise price of options outstanding.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_SharesBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingPeriodIncreaseDecreaseWeightedAverageExercisePrice" xlink:to="cve_SharesBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingPeriodIncreaseDecreaseWeightedAverageExercisePrice_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cve_SharesBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_lbl0" xml:lang="en-US">Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_SharesBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:to="cve_SharesBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cve_SharesBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber_lbl0" xml:lang="en-US">Number of fully vested and expected to vest exercisable options that may be converted into shares under option plan. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_SharesBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber" xlink:to="cve_SharesBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cve_SharesBasedCompensationArrangementBySharesBasedPaymentAwardOptionsOutstandingPeriodIncreaseDecreaseWeightedAverageExercisePrice_lbl0" xml:lang="en-US">Change in the weighted average exercise price of options outstanding.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_SharesBasedCompensationArrangementBySharesBasedPaymentAwardOptionsOutstandingPeriodIncreaseDecreaseWeightedAverageExercisePrice" xlink:to="cve_SharesBasedCompensationArrangementBySharesBasedPaymentAwardOptionsOutstandingPeriodIncreaseDecreaseWeightedAverageExercisePrice_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cve_SharesBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions_lbl0" xml:lang="en-US">The number of shares reserved for issuance pertaining to the outstanding exercisable stock options as of the balance sheet date in the customized range of exercise prices for which the market and performance vesting condition has been satisfied.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_SharesBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions" xlink:to="cve_SharesBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cve_SharesIssuedForAzargaAssetAcquisition_lbl0" xml:lang="en-US">Shares issued for azarga asset acquisition.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_SharesIssuedForAzargaAssetAcquisition" xlink:to="cve_SharesIssuedForAzargaAssetAcquisition_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cve_SharesIssuedForAzargaAssetAcquisitionNote10Shares_lbl0" xml:lang="en-US">Shares issued for Azarga asset acquisition(Shares).</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_SharesIssuedForAzargaAssetAcquisitionNote10Shares" xlink:to="cve_SharesIssuedForAzargaAssetAcquisitionNote10Shares_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cve_SharesIssuedForExerciseOfStockOptionsShares_lbl0" xml:lang="en-US">Shares issued for exercise of stock options(Shares).</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_SharesIssuedForExerciseOfStockOptionsShares" xlink:to="cve_SharesIssuedForExerciseOfStockOptionsShares_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cve_SharesIssuedForExerciseOfWarrantsShares_lbl0" xml:lang="en-US">Shares issued for exercise of warrants(Shares).</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_SharesIssuedForExerciseOfWarrantsShares" xlink:to="cve_SharesIssuedForExerciseOfWarrantsShares_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cve_SharesIssuedForServicesShares_lbl0" xml:lang="en-US">Shares issued for services(Shares).</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_SharesIssuedForServicesShares" xlink:to="cve_SharesIssuedForServicesShares_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cve_SharesUnit_lbl0" xml:lang="en-US">Shares are units of equity ownership in a corporation. For some companies, shares exist as a financial asset providing for an equal distribution of any residual profits, if any are declared, in the form of dividends. Shareholders of a stock that pays no dividends do not participate in a distribution of profits. Instead, they anticipate participating in the growth of the stock price as company profits increase.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_SharesUnit" xlink:to="cve_SharesUnit_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cve_SharesbasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue_lbl0" xml:lang="en-US">Tabular disclosure of the weighted-average grant-date fair value of equity options or other equity instruments granted during the year.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_SharesbasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue" xlink:to="cve_SharesbasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cve_StaffCosts_lbl0" xml:lang="en-US">Staff costs.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_StaffCosts" xlink:to="cve_StaffCosts_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cve_StandardStockOptionVestingPercentage_lbl0" xml:lang="en-US">Standard stock option vesting percentage.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_StandardStockOptionVestingPercentage" xlink:to="cve_StandardStockOptionVestingPercentage_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cve_StockIssuedDuringPeriodShareSharesBasedCompensationForfeited_lbl0" xml:lang="en-US">Number of shares (or other type of equity) forfeited during the period.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_StockIssuedDuringPeriodShareSharesBasedCompensationForfeited" xlink:to="cve_StockIssuedDuringPeriodShareSharesBasedCompensationForfeited_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cve_StockIssuedDuringPeriodShareStockOptionsExercised_lbl0" xml:lang="en-US">Number of share options (or share units) exercised during the current period.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_StockIssuedDuringPeriodShareStockOptionsExercised" xlink:to="cve_StockIssuedDuringPeriodShareStockOptionsExercised_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cve_StockOptionExpense_lbl0" xml:lang="en-US">Stock option expense.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_StockOptionExpense" xlink:to="cve_StockOptionExpense_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cve_StockOptionsRevisedTerm_lbl0" xml:lang="en-US">Stock options revised term</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_StockOptionsRevisedTerm" xlink:to="cve_StockOptionsRevisedTerm_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cve_StockOptionsSharesOutstanding_lbl0" xml:lang="en-US">Stock options shares outstanding.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_StockOptionsSharesOutstanding" xlink:to="cve_StockOptionsSharesOutstanding_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cve_TotalConsideration_lbl0" xml:lang="en-US">Amount of Total Consideration.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_TotalConsideration" xlink:to="cve_TotalConsideration_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cve_TotalConsiderationPerPounds_lbl0" xml:lang="en-US">Total consideration per pound.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_TotalConsiderationPerPounds" xlink:to="cve_TotalConsiderationPerPounds_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cve_TotalConsiderationPerShare_lbl0" xml:lang="en-US">Amount of total consideration per share.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_TotalConsiderationPerShare" xlink:to="cve_TotalConsiderationPerShare_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cve_TotalConsiderationValue_lbl0" xml:lang="en-US">Total consideration value.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_TotalConsiderationValue" xlink:to="cve_TotalConsiderationValue_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cve_TotalDiscountedMarketPrices_lbl0" xml:lang="en-US">Total discounted market prices.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_TotalDiscountedMarketPrices" xlink:to="cve_TotalDiscountedMarketPrices_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cve_TotalNoncashFinancingActivities_lbl0" xml:lang="en-US">The amount of non cash financing activities.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_TotalNoncashFinancingActivities" xlink:to="cve_TotalNoncashFinancingActivities_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cve_TotalPurchasePrice_lbl0" xml:lang="en-US">Amount of Purchase Price.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_TotalPurchasePrice" xlink:to="cve_TotalPurchasePrice_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cve_TradingShares_lbl0" xml:lang="en-US">Trading shares.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_TradingShares" xlink:to="cve_TradingShares_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cve_TransactionCost_lbl0" xml:lang="en-US">Transaction cost.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_TransactionCost" xlink:to="cve_TransactionCost_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cve_TransactionCosts_lbl1" xml:lang="en-US">Transaction costs.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_TransactionCosts" xlink:to="cve_TransactionCosts_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cve_TransferAgentAndFilingFees_lbl0" xml:lang="en-US">Transfer agent and filing fees</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_TransferAgentAndFilingFees" xlink:to="cve_TransferAgentAndFilingFees_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cve_UnrealizedGainOnMarketableSecurities_lbl0" xml:lang="en-US">Amount of unrealized gain (loss) on investment in marketable security.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_UnrealizedGainOnMarketableSecurities" xlink:to="cve_UnrealizedGainOnMarketableSecurities_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cve_UnrealizedGainOnUraniumInvestment_lbl1" xml:lang="en-US">Unrealized gain on uranium investment</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_UnrealizedGainOnUraniumInvestment" xlink:to="cve_UnrealizedGainOnUraniumInvestment_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cve_WarrantIsExercisableTerm_lbl0" xml:lang="en-US">Warrant is exercisable term.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_WarrantIsExercisableTerm" xlink:to="cve_WarrantIsExercisableTerm_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cve_WarrantShare_lbl0" xml:lang="en-US">When an investor exercises a warrant, they purchase stock, and the proceeds are a source of capital for the company. A warrant certificate is issued to the investor when they exercise a warrant. The certificate includes the terms of the warrant, such as the expiry date and the final day it can be exercised.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_WarrantShare" xlink:to="cve_WarrantShare_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cve_Warrants_lbl0" xml:lang="en-US">A stock warrant gives the holder the right to purchase a company&apos;s stock at a specific price and at a specific date. A stock warrant is issued directly by the company concerned; when an investor exercises a stock warrant, the shares that fulfill the obligation are not received from another investor but directly from the company.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_Warrants" xlink:to="cve_Warrants_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cve_WarrantsExercisableOfCommonShare_lbl0" xml:lang="en-US">Warrants exercisable of common share.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_WarrantsExercisableOfCommonShare" xlink:to="cve_WarrantsExercisableOfCommonShare_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cve_WarrantsExercisablePrice_lbl0" xml:lang="en-US">Warrants exercisable price per share.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_WarrantsExercisablePrice" xlink:to="cve_WarrantsExercisablePrice_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cve_WarrantsExercisablePricePerShare_lbl0" xml:lang="en-US">Warrants exercisable price per share.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_WarrantsExercisablePricePerShare" xlink:to="cve_WarrantsExercisablePricePerShare_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cve_WarrantsExercisableShare_lbl0" xml:lang="en-US">When an investor exercises a warrant, they purchase stock, and the proceeds are a source of capital for the company. A warrant certificate is issued to the investor when they exercise a warrant. The certificate includes the terms of the warrant, such as the expiry date and the final day it can be exercised.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_WarrantsExercisableShare" xlink:to="cve_WarrantsExercisableShare_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cve_WarrantsOfFairValue_lbl0" xml:lang="en-US">A warrant premium represents the cost of purchasing a share through exercising a warrant, compared to buying the share directly through the open market.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_WarrantsOfFairValue" xlink:to="cve_WarrantsOfFairValue_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cve_WarrantsOutstandingWeightedAverageExercisePrice_lbl0" xml:lang="en-US">Warrants Outstanding, Weighted average exercise price.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_WarrantsOutstandingWeightedAverageExercisePrice" xlink:to="cve_WarrantsOutstandingWeightedAverageExercisePrice_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cve_WarrantsOutstandingWeightedAverageReimainingLife_lbl0" xml:lang="en-US">Warrants Outstanding, Weighted average Reimaining Life.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_WarrantsOutstandingWeightedAverageReimainingLife" xlink:to="cve_WarrantsOutstandingWeightedAverageReimainingLife_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cve_WeightedAverageExercisePrice_lbl0" xml:lang="en-US">Weighted average exercise price.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_WeightedAverageExercisePrice" xlink:to="cve_WeightedAverageExercisePrice_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cve_WorkingCapital_lbl0" xml:lang="en-US">Working capital.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_WorkingCapital" xlink:to="cve_WorkingCapital_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cve_WriteoffOfInvestment_lbl0" xml:lang="en-US">Write-off of investment.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_WriteoffOfInvestment" xlink:to="cve_WriteoffOfInvestment_lbl0"/>
    <loc xlink:type="locator" xlink:label="dei_AddressTypeDomain" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AddressTypeDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AddressTypeDomain_lbl" xml:lang="en-US">Address Type [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AddressTypeDomain" xlink:to="dei_AddressTypeDomain_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="stpr_NM_lbl0" xml:lang="en-US">NEW MEXICO</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="stpr_NM" xlink:to="stpr_NM_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DirectorsRemunerationExpense_lbl0" xml:lang="en-US">Directors&apos; remuneration expense</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DirectorsRemunerationExpense" xlink:to="ifrs-full_DirectorsRemunerationExpense_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfFairValueMeasurementOfAssetsExplanatory_lbl0" xml:lang="en-US">Disclosure of fair value measurement of assets [text block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfFairValueMeasurementOfAssetsExplanatory" xlink:to="ifrs-full_DisclosureOfFairValueMeasurementOfAssetsExplanatory_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_ScheduleOfMarketableSecuritiesTableTextBlock_lbl1" xml:lang="en-US">Schedule Of Marketable Securities Table Text Block</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_ScheduleOfMarketableSecuritiesTableTextBlock" xlink:to="cve_ScheduleOfMarketableSecuritiesTableTextBlock_lbl1"/>
    <loc xlink:type="locator" xlink:label="cve_DisclosureOfMarketRiskTextBlockAbstract" xlink:href="cve-20221231.xsd#cve_DisclosureOfMarketRiskTextBlockAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_DisclosureOfMarketRiskTextBlockAbstract_lbl" xml:lang="en-US">Disclosure Of Market Risk Text Block Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_DisclosureOfMarketRiskTextBlockAbstract" xlink:to="cve_DisclosureOfMarketRiskTextBlockAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_WildcatSolarPowerPlantLLCMember_lbl0" xml:lang="en-US">Wildcat Solar Power Plant LLCMember</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_WildcatSolarPowerPlantLLCMember" xlink:to="cve_WildcatSolarPowerPlantLLCMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_DescriptionOfAccountingPolicyForCashtextBlock_lbl1" xml:lang="en-US">Description Of Accounting Policy For Cashtext Block</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_DescriptionOfAccountingPolicyForCashtextBlock" xlink:to="cve_DescriptionOfAccountingPolicyForCashtextBlock_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_RestrictedCashAndCashEquivalents_lbl0" xml:lang="en-US">Restricted cash and cash equivalents</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_RestrictedCashAndCashEquivalents" xlink:to="ifrs-full_RestrictedCashAndCashEquivalents_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_RevenuesLossFromOperatingExpenses_lbl0" xml:lang="en-US">Revenues Loss From Operating Expenses</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_RevenuesLossFromOperatingExpenses" xlink:to="cve_RevenuesLossFromOperatingExpenses_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_NatureofOperationsandGoingConcernLineItems_lbl0" xml:lang="en-US">Natureof Operationsand Going Concern Line Items</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_NatureofOperationsandGoingConcernLineItems" xlink:to="cve_NatureofOperationsandGoingConcernLineItems_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_TransactionCost_lbl1" xml:lang="en-US">Transaction Cost</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_TransactionCost" xlink:to="cve_TransactionCost_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_ScheduleOfTheFairValueOfThePhysicalUraniumInvestmentTableTextBlck_lbl0" xml:lang="en-US">Schedule Of The Fair Value Of The Physical Uranium Investment Table Text Blck</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_ScheduleOfTheFairValueOfThePhysicalUraniumInvestmentTableTextBlck" xlink:to="cve_ScheduleOfTheFairValueOfThePhysicalUraniumInvestmentTableTextBlck_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_FairValueAmount_lbl1" xml:lang="en-US">Fair Value Amount</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_FairValueAmount" xlink:to="cve_FairValueAmount_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_AssetsArisingFromExplorationForAndEvaluationOfMineralResources_lbl0" xml:lang="en-US">Assets arising from exploration for and evaluation of mineral resources</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AssetsArisingFromExplorationForAndEvaluationOfMineralResources" xlink:to="ifrs-full_AssetsArisingFromExplorationForAndEvaluationOfMineralResources_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_WeightedAverageDurationOfDefinedBenefitObligation2019_lbl0" xml:lang="en-US">Weighted average duration of defined benefit obligation</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_WeightedAverageDurationOfDefinedBenefitObligation2019" xlink:to="ifrs-full_WeightedAverageDurationOfDefinedBenefitObligation2019_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AuditorName_lbl0" xml:lang="en-US">Auditor Name</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditorName" xlink:to="dei_AuditorName_lbl0"/>
    <loc xlink:type="locator" xlink:label="cve_ScheduleOfSharePurchaseWarrantsOutstandingAbstract" xlink:href="cve-20221231.xsd#cve_ScheduleOfSharePurchaseWarrantsOutstandingAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_ScheduleOfSharePurchaseWarrantsOutstandingAbstract_lbl" xml:lang="en-US">Schedule Of Share Purchase Warrants Outstanding Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_ScheduleOfSharePurchaseWarrantsOutstandingAbstract" xlink:to="cve_ScheduleOfSharePurchaseWarrantsOutstandingAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_CurrentLiabilitiesAbstract_lbl0" xml:lang="en-US">Current liabilities [abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CurrentLiabilitiesAbstract" xlink:to="ifrs-full_CurrentLiabilitiesAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_IssuedAndOutstandingSharesPercentage_lbl1" xml:lang="en-US">Issued And Outstanding Shares Percentage</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_IssuedAndOutstandingSharesPercentage" xlink:to="cve_IssuedAndOutstandingSharesPercentage_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_CancellationFee_lbl1" xml:lang="en-US">Cancellation Fee</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_CancellationFee" xlink:to="cve_CancellationFee_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_HRIChurchrockIncMember_lbl0" xml:lang="en-US">HRIChurchrock Inc Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_HRIChurchrockIncMember" xlink:to="cve_HRIChurchrockIncMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_ShareCapitalTablesLineItems_lbl0" xml:lang="en-US">Share Capital Tables Line Items</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_ShareCapitalTablesLineItems" xlink:to="cve_ShareCapitalTablesLineItems_lbl0"/>
    <loc xlink:type="locator" xlink:label="cve_DisclosureOfIntangibleAssetsTextBlockAbstract" xlink:href="cve-20221231.xsd#cve_DisclosureOfIntangibleAssetsTextBlockAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_DisclosureOfIntangibleAssetsTextBlockAbstract_lbl" xml:lang="en-US">Disclosure Of Intangible Assets Text Block Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_DisclosureOfIntangibleAssetsTextBlockAbstract" xlink:to="cve_DisclosureOfIntangibleAssetsTextBlockAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_LossOnWriteoffOfSalesTaxRecoverable_lbl0" xml:lang="en-US">Loss On Writeoff Of Sales Tax Recoverable</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_LossOnWriteoffOfSalesTaxRecoverable" xlink:to="cve_LossOnWriteoffOfSalesTaxRecoverable_lbl0"/>
    <loc xlink:type="locator" xlink:label="cve_ScheduleOfMineralPropertiesAbstract" xlink:href="cve-20221231.xsd#cve_ScheduleOfMineralPropertiesAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_ScheduleOfMineralPropertiesAbstract_lbl" xml:lang="en-US">Schedule Of Mineral Properties Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_ScheduleOfMineralPropertiesAbstract" xlink:to="cve_ScheduleOfMineralPropertiesAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_DilutionLoss_lbl1" xml:lang="en-US">Dilution Loss</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_DilutionLoss" xlink:to="cve_DilutionLoss_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_Fiscal2024Member_lbl0" xml:lang="en-US">Fiscal2024 Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_Fiscal2024Member" xlink:to="cve_Fiscal2024Member_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ProceedsFromExerciseOfOptions_lbl1" xml:lang="en-US">Proceeds from exercise of options</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ProceedsFromExerciseOfOptions" xlink:to="ifrs-full_ProceedsFromExerciseOfOptions_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ContingentConsiderationRecognisedAsOfAcquisitionDate_lbl0" xml:lang="en-US">Contingent consideration recognised as of acquisition date</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ContingentConsiderationRecognisedAsOfAcquisitionDate" xlink:to="ifrs-full_ContingentConsiderationRecognisedAsOfAcquisitionDate_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_IncreaseDecreaseThroughExerciseOfOptions_lbl0" xml:lang="en-US">Increase (decrease) through exercise of options, equity</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_IncreaseDecreaseThroughExerciseOfOptions" xlink:to="ifrs-full_IncreaseDecreaseThroughExerciseOfOptions_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019_lbl0" xml:lang="en-US">Weighted average exercise price of share options granted in share-based payment arrangement</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019" xlink:to="ifrs-full_WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_OptionToAcquireShares_lbl1" xml:lang="en-US">Option To Acquire Shares</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_OptionToAcquireShares" xlink:to="cve_OptionToAcquireShares_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_ScheduleOfFinancialInstrumentTableTextBlock_lbl0" xml:lang="en-US">Schedule Of Financial Instrument Table Text Block</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_ScheduleOfFinancialInstrumentTableTextBlock" xlink:to="cve_ScheduleOfFinancialInstrumentTableTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_KeyManagementPersonnelCompensation_lbl0" xml:lang="en-US">Key management personnel compensation</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_KeyManagementPersonnelCompensation" xlink:to="ifrs-full_KeyManagementPersonnelCompensation_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_FairValueOfReplacementWarrants_lbl1" xml:lang="en-US">Fair Value Of Replacement Warrants</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_FairValueOfReplacementWarrants" xlink:to="cve_FairValueOfReplacementWarrants_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_CibolaResourcesLLCMember_lbl0" xml:lang="en-US">Cibola Resources LLCMember</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_CibolaResourcesLLCMember" xlink:to="cve_CibolaResourcesLLCMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_NotionalAmount_lbl0" xml:lang="en-US">Notional amount</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NotionalAmount" xlink:to="ifrs-full_NotionalAmount_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_ReplacementOptionsMember_lbl0" xml:lang="en-US">Replacement Options Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_ReplacementOptionsMember" xlink:to="cve_ReplacementOptionsMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_DisclosureOfUsefulLivesOfIntangibleAssetsTextBllock_lbl1" xml:lang="en-US">Disclosure Of Useful Lives Of Intangible Assets Text Bllock</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_DisclosureOfUsefulLivesOfIntangibleAssetsTextBllock" xlink:to="cve_DisclosureOfUsefulLivesOfIntangibleAssetsTextBllock_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockholdersEquityAbstract_lbl0" xml:lang="en-US">Stockholders&apos; Equity Attributable to Parent [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_StockholdersEquityAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationNetOfTax_lbl0" xml:lang="en-US">Gains (losses) on exchange differences on translation of foreign operations, net of tax</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationNetOfTax" xlink:to="ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationNetOfTax_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_AdjustmentsForGainsLossesOnChangeInFairValueOfDerivatives_lbl0" xml:lang="en-US">Adjustments for gains (losses) on change in fair value of derivatives</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AdjustmentsForGainsLossesOnChangeInFairValueOfDerivatives" xlink:to="ifrs-full_AdjustmentsForGainsLossesOnChangeInFairValueOfDerivatives_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_NeutronEnergyIncMember_lbl0" xml:lang="en-US">Neutron Energy Inc Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_NeutronEnergyIncMember" xlink:to="cve_NeutronEnergyIncMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_NonCurrentLiabilitiesAbstract_lbl0" xml:lang="en-US">Non Current Liabilities Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_NonCurrentLiabilitiesAbstract" xlink:to="cve_NonCurrentLiabilitiesAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_TaxEffectOfExpenseNotDeductibleInDeterminingTaxableProfitTaxLoss_lbl0" xml:lang="en-US">Tax effect of expense not deductible in determining taxable profit (tax loss)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_TaxEffectOfExpenseNotDeductibleInDeterminingTaxableProfitTaxLoss" xlink:to="ifrs-full_TaxEffectOfExpenseNotDeductibleInDeterminingTaxableProfitTaxLoss_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_Personnel_lbl0" xml:lang="en-US">Personnel</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_Personnel" xlink:to="cve_Personnel_lbl0"/>
    <loc xlink:type="locator" xlink:label="cve_ConsolidatedStatementsOfChangesInShareholderSEquityAbstract" xlink:href="cve-20221231.xsd#cve_ConsolidatedStatementsOfChangesInShareholderSEquityAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_ConsolidatedStatementsOfChangesInShareholderSEquityAbstract_lbl" xml:lang="en-US">Consolidated Statements Of Changes In Shareholder SEquity Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_ConsolidatedStatementsOfChangesInShareholderSEquityAbstract" xlink:to="cve_ConsolidatedStatementsOfChangesInShareholderSEquityAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_ScheduleOfTheStatusOfTheCompanySWarrantsAbstract" xlink:href="cve-20221231.xsd#cve_ScheduleOfTheStatusOfTheCompanySWarrantsAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_ScheduleOfTheStatusOfTheCompanySWarrantsAbstract_lbl" xml:lang="en-US">Schedule Of The Status Of The Company SWarrants Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_ScheduleOfTheStatusOfTheCompanySWarrantsAbstract" xlink:to="cve_ScheduleOfTheStatusOfTheCompanySWarrantsAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_ItemsNotAffectingCashAbstract_lbl0" xml:lang="en-US">Items Not Affecting Cash Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_ItemsNotAffectingCashAbstract" xlink:to="cve_ItemsNotAffectingCashAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_CashFlowsFromUsedInOperatingActivities_lbl0" xml:lang="en-US">Cash flows from (used in) operating activities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CashFlowsFromUsedInOperatingActivities" xlink:to="ifrs-full_CashFlowsFromUsedInOperatingActivities_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_PaymentsofInvestmentInUranium_lbl1" xml:lang="en-US">Paymentsof Investment In Uranium</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_PaymentsofInvestmentInUranium" xlink:to="cve_PaymentsofInvestmentInUranium_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019_lbl1" xml:lang="en-US">Weighted average remaining contractual life of outstanding share options</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019" xlink:to="ifrs-full_WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentRegistrationStatement_lbl0" xml:lang="en-US">Document Registration Statement</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentRegistrationStatement" xlink:to="dei_DocumentRegistrationStatement_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_GainsLossesOnFinancialAssetsAtFairValueThroughProfitOrLoss_lbl0" xml:lang="en-US">Gains (losses) on financial assets at fair value through profit or loss</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_GainsLossesOnFinancialAssetsAtFairValueThroughProfitOrLoss" xlink:to="ifrs-full_GainsLossesOnFinancialAssetsAtFairValueThroughProfitOrLoss_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForEarningsPerShareExplanatory_lbl0" xml:lang="en-US">Description of accounting policy for earnings per share [text block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DescriptionOfAccountingPolicyForEarningsPerShareExplanatory" xlink:to="ifrs-full_DescriptionOfAccountingPolicyForEarningsPerShareExplanatory_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCommonStockSharesOutstanding_lbl0" xml:lang="en-US">Entity Common Stock, Shares Outstanding</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCommonStockSharesOutstanding" xlink:to="dei_EntityCommonStockSharesOutstanding_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfPropertyPlantAndEquipmentExplanatory_lbl0" xml:lang="en-US">Disclosure of property, plant and equipment [text block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfPropertyPlantAndEquipmentExplanatory" xlink:to="ifrs-full_DisclosureOfPropertyPlantAndEquipmentExplanatory_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_CashReceiptsFromRepaymentOfAdvancesAndLoansMadeToRelatedParties_lbl0" xml:lang="en-US">Cash receipts from repayment of advances and loans made to related parties</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CashReceiptsFromRepaymentOfAdvancesAndLoansMadeToRelatedParties" xlink:to="ifrs-full_CashReceiptsFromRepaymentOfAdvancesAndLoansMadeToRelatedParties_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_LeaseLiabilities_lbl0" xml:lang="en-US">Lease liabilities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_LeaseLiabilities" xlink:to="ifrs-full_LeaseLiabilities_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_RositaMember_lbl0" xml:lang="en-US">Rosita Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_RositaMember" xlink:to="cve_RositaMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_OfficeAndAdministrative_lbl1" xml:lang="en-US">Office And Administrative</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_OfficeAndAdministrative" xlink:to="cve_OfficeAndAdministrative_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_OtherCurrentAssets_lbl0" xml:lang="en-US">Other current assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_OtherCurrentAssets" xlink:to="ifrs-full_OtherCurrentAssets_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_TaxEffectOfForeignTaxRates_lbl0" xml:lang="en-US">Tax effect of foreign tax rates</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_TaxEffectOfForeignTaxRates" xlink:to="ifrs-full_TaxEffectOfForeignTaxRates_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfInterestsInAssociatesExplanatory_lbl0" xml:lang="en-US">Disclosure of interests in associates [text block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfInterestsInAssociatesExplanatory" xlink:to="ifrs-full_DisclosureOfInterestsInAssociatesExplanatory_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_WeightedAverageNumberOfCommonSharesOutstandingAbstract_lbl0" xml:lang="en-US">Weighted Average Number Of Common Shares Outstanding Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_WeightedAverageNumberOfCommonSharesOutstandingAbstract" xlink:to="cve_WeightedAverageNumberOfCommonSharesOutstandingAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_MarketableSecurities_lbl0" xml:lang="en-US">Marketable Securities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MarketableSecurities" xlink:to="us-gaap_MarketableSecurities_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_FurnitureMember_lbl0" xml:lang="en-US">Furniture Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_FurnitureMember" xlink:to="cve_FurnitureMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_DisclosueOfSalesContractsTextBlock_lbl1" xml:lang="en-US">Disclosue Of Sales Contracts Text Block</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_DisclosueOfSalesContractsTextBlock" xlink:to="cve_DisclosueOfSalesContractsTextBlock_lbl1"/>
    <loc xlink:type="locator" xlink:label="cve_DisclosureOfIncomeTaxTextBlockAbstract" xlink:href="cve-20221231.xsd#cve_DisclosureOfIncomeTaxTextBlockAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_DisclosureOfIncomeTaxTextBlockAbstract_lbl" xml:lang="en-US">Disclosure Of Income Tax Text Block Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_DisclosureOfIncomeTaxTextBlockAbstract" xlink:to="cve_DisclosureOfIncomeTaxTextBlockAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ShareIssueRelatedCost_lbl0" xml:lang="en-US">Share issue related cost</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ShareIssueRelatedCost" xlink:to="ifrs-full_ShareIssueRelatedCost_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_MarketableSecuritiecurrent_lbl1" xml:lang="en-US">Marketable Securitiecurrent</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_MarketableSecuritiecurrent" xlink:to="cve_MarketableSecuritiecurrent_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_ProjectInvestigationFess_lbl1" xml:lang="en-US">Project Investigation Fess</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_ProjectInvestigationFess" xlink:to="cve_ProjectInvestigationFess_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_TotalNoncashFinancingActivities_lbl1" xml:lang="en-US">Total Noncash Financing Activities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_TotalNoncashFinancingActivities" xlink:to="cve_TotalNoncashFinancingActivities_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityIncorporationStateCountryCode_lbl0" xml:lang="en-US">Entity Incorporation, State or Country Code</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityExchangeName_lbl0" xml:lang="en-US">Security Exchange Name</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_TradingSharesMember_lbl0" xml:lang="en-US">Trading Shares Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_TradingSharesMember" xlink:to="cve_TradingSharesMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine2_lbl0" xml:lang="en-US">Entity Address, Address Line Two</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl0"/>
    <loc xlink:type="locator" xlink:label="cve_DisclosueOfSalesContractsAbstract" xlink:href="cve-20221231.xsd#cve_DisclosueOfSalesContractsAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_DisclosueOfSalesContractsAbstract_lbl" xml:lang="en-US">Disclosue Of Sales Contracts Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_DisclosueOfSalesContractsAbstract" xlink:to="cve_DisclosueOfSalesContractsAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine1_lbl0" xml:lang="en-US">Entity Address, Address Line One</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_SharesIssuedForExerciseOfStockOptionsShares_lbl1" xml:lang="en-US">Shares Issued For Exercise Of Stock Options Shares</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_SharesIssuedForExerciseOfStockOptionsShares" xlink:to="cve_SharesIssuedForExerciseOfStockOptionsShares_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_AccumulatedOtherComprehensiveIncomeMember_lbl0" xml:lang="en-US">Accumulated other comprehensive income [member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AccumulatedOtherComprehensiveIncomeMember" xlink:to="ifrs-full_AccumulatedOtherComprehensiveIncomeMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_ConstructionOfWellfields_lbl0" xml:lang="en-US">Construction Of Wellfields</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_ConstructionOfWellfields" xlink:to="cve_ConstructionOfWellfields_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_ShareIssueCosts_lbl1" xml:lang="en-US">Share Issue Costs</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_ShareIssueCosts" xlink:to="cve_ShareIssueCosts_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_ProceedsReceivedFromSaleOfUraniumInvestment_lbl1" xml:lang="en-US">Proceeds Received From Sale Of Uranium Investment</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_ProceedsReceivedFromSaleOfUraniumInvestment" xlink:to="cve_ProceedsReceivedFromSaleOfUraniumInvestment_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_NoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSaleOrAsHeldForDistributionToOwners_lbl1" xml:lang="en-US">Non-current assets or disposal groups classified as held for sale or as held for distribution to owners</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSaleOrAsHeldForDistributionToOwners" xlink:to="ifrs-full_NoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSaleOrAsHeldForDistributionToOwners_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_CommonShare_lbl1" xml:lang="en-US">Common Share</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_CommonShare" xlink:to="cve_CommonShare_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12bTitle_lbl0" xml:lang="en-US">Title of 12(b) Security</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockOptionPlanExpense_lbl0" xml:lang="en-US">Stock or Unit Option Plan Expense</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockOptionPlanExpense" xlink:to="us-gaap_StockOptionPlanExpense_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_PurchaseAdditionalShareWarrants_lbl1" xml:lang="en-US">Purchase Additional Share Warrants</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_PurchaseAdditionalShareWarrants" xlink:to="cve_PurchaseAdditionalShareWarrants_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss_lbl0" xml:lang="en-US">Foreign exchange gain (loss)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss" xlink:to="ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_TranslatedMember_lbl0" xml:lang="en-US">Translated Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_TranslatedMember" xlink:to="cve_TranslatedMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ExercisePriceOfOutstandingShareOptions2019_lbl0" xml:lang="en-US">Exercise price of outstanding share options</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ExercisePriceOfOutstandingShareOptions2019" xlink:to="ifrs-full_ExercisePriceOfOutstandingShareOptions2019_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_FairValueOfGrantedOption_lbl1" xml:lang="en-US">Fair Value Of Granted Option</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_FairValueOfGrantedOption" xlink:to="cve_FairValueOfGrantedOption_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DeferredTaxAssets_lbl0" xml:lang="en-US">Deferred tax assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DeferredTaxAssets" xlink:to="ifrs-full_DeferredTaxAssets_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_RightofuseAssets1_lbl1" xml:lang="en-US">Rightofuse Assets1</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_RightofuseAssets1" xlink:to="cve_RightofuseAssets1_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_AcquisitionrelatedCostsRecognisedAsExpenseForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination_lbl0" xml:lang="en-US">Acquisition-related costs recognised as expense for transaction recognised separately from acquisition of assets and assumption of liabilities in business combination</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AcquisitionrelatedCostsRecognisedAsExpenseForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination" xlink:to="ifrs-full_AcquisitionrelatedCostsRecognisedAsExpenseForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_DescriptionOfAccountingPolicyForInvestmentsInUraniumtextBlock_lbl1" xml:lang="en-US">Description Of Accounting Policy For Investments In Uraniumtext Block</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_DescriptionOfAccountingPolicyForInvestmentsInUraniumtextBlock" xlink:to="cve_DescriptionOfAccountingPolicyForInvestmentsInUraniumtextBlock_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_TotalConsiderationValue_lbl1" xml:lang="en-US">Total Consideration Value</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_TotalConsiderationValue" xlink:to="cve_TotalConsiderationValue_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_ContactPersonnelName_lbl0" xml:lang="en-US">Contact Personnel Name</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_ContactPersonnelName" xlink:to="dei_ContactPersonnelName_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_AssetAcquistion_lbl0" xml:lang="en-US">Asset Acquistion</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_AssetAcquistion" xlink:to="cve_AssetAcquistion_lbl0"/>
    <loc xlink:type="locator" xlink:label="cve_ScheduleOfExchangeRatesAbstract" xlink:href="cve-20221231.xsd#cve_ScheduleOfExchangeRatesAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_ScheduleOfExchangeRatesAbstract_lbl" xml:lang="en-US">Schedule Of Exchange Rates Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_ScheduleOfExchangeRatesAbstract" xlink:to="cve_ScheduleOfExchangeRatesAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_RightofuseAssetsThatDoNotMeetDefinitionOfInvestmentProperty_lbl0" xml:lang="en-US">Right-of-use assets that do not meet definition of investment property</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_RightofuseAssetsThatDoNotMeetDefinitionOfInvestmentProperty" xlink:to="ifrs-full_RightofuseAssetsThatDoNotMeetDefinitionOfInvestmentProperty_lbl0"/>
    <loc xlink:type="locator" xlink:label="cve_ScheduleOfTheCompanySStockOptionsOutstandingAbstract" xlink:href="cve-20221231.xsd#cve_ScheduleOfTheCompanySStockOptionsOutstandingAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_ScheduleOfTheCompanySStockOptionsOutstandingAbstract_lbl" xml:lang="en-US">Schedule Of The Company SStock Options Outstanding Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_ScheduleOfTheCompanySStockOptionsOutstandingAbstract" xlink:to="cve_ScheduleOfTheCompanySStockOptionsOutstandingAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_ChangesInNonCashWorkingCapitalItemsAbstract_lbl0" xml:lang="en-US">Changes In Non Cash Working Capital Items Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_ChangesInNonCashWorkingCapitalItemsAbstract" xlink:to="cve_ChangesInNonCashWorkingCapitalItemsAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_ShareBasedCompensationArrangementBySharesBasedPaymentAwardOptionsGrantsInPeriodWarrantsGranted_lbl1" xml:lang="en-US">Share Based Compensation Arrangement By Shares Based Payment Award Options Grants In Period Warrants Granted</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_ShareBasedCompensationArrangementBySharesBasedPaymentAwardOptionsGrantsInPeriodWarrantsGranted" xlink:to="cve_ShareBasedCompensationArrangementBySharesBasedPaymentAwardOptionsGrantsInPeriodWarrantsGranted_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_SalesContractsFiscalTwoZeroTwoThree_lbl1" xml:lang="en-US">Sales Contracts Fiscal Two Zero Two Three</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_SalesContractsFiscalTwoZeroTwoThree" xlink:to="cve_SalesContractsFiscalTwoZeroTwoThree_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfFinancialInstrumentsAtFairValueThroughProfitOrLossExplanatory_lbl0" xml:lang="en-US">Disclosure of financial instruments at fair value through profit or loss [text block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfFinancialInstrumentsAtFairValueThroughProfitOrLossExplanatory" xlink:to="ifrs-full_DisclosureOfFinancialInstrumentsAtFairValueThroughProfitOrLossExplanatory_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_InterestReceivedClassifiedAsInvestingActivities_lbl0" xml:lang="en-US">Interest received, classified as investing activities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_InterestReceivedClassifiedAsInvestingActivities" xlink:to="ifrs-full_InterestReceivedClassifiedAsInvestingActivities_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_GasHillsMember_lbl0" xml:lang="en-US">Gas Hills Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_GasHillsMember" xlink:to="cve_GasHillsMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_TradeAndOtherReceivables_lbl0" xml:lang="en-US">Trade and other receivables</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_TradeAndOtherReceivables" xlink:to="ifrs-full_TradeAndOtherReceivables_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_FairValueOfReplacementOptionsIssuedForAzargaAssetsAcquisition_lbl1" xml:lang="en-US">Fair Value Of Replacement Options Issued For Azarga Assets Acquisition</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_FairValueOfReplacementOptionsIssuedForAzargaAssetsAcquisition" xlink:to="cve_FairValueOfReplacementOptionsIssuedForAzargaAssetsAcquisition_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_OtherAssets_lbl0" xml:lang="en-US">Other assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_OtherAssets" xlink:to="ifrs-full_OtherAssets_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfEntitysReportableSegmentsExplanatory_lbl0" xml:lang="en-US">Disclosure of entity&apos;s operating segments [text block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfEntitysReportableSegmentsExplanatory" xlink:to="ifrs-full_DisclosureOfEntitysReportableSegmentsExplanatory_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_FinancialLiabilitiesReclassifiedIntoEquity_lbl0" xml:lang="en-US">Financial liabilities reclassified into equity</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_FinancialLiabilitiesReclassifiedIntoEquity" xlink:to="ifrs-full_FinancialLiabilitiesReclassifiedIntoEquity_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_EnergyFuelsIncMember_lbl0" xml:lang="en-US">Energy Fuels Inc Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_EnergyFuelsIncMember" xlink:to="cve_EnergyFuelsIncMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities_lbl0" xml:lang="en-US">Purchase of intangible assets, classified as investing activities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities" xlink:to="ifrs-full_PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DescriptionOfDiscountRatesAppliedToCashFlowProjections_lbl0" xml:lang="en-US">Discount rate applied to cash flow projections</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DescriptionOfDiscountRatesAppliedToCashFlowProjections" xlink:to="ifrs-full_DescriptionOfDiscountRatesAppliedToCashFlowProjections_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_LossesOnDisposalsOfInvestments_lbl0" xml:lang="en-US">Losses on disposals of investments</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_LossesOnDisposalsOfInvestments" xlink:to="ifrs-full_LossesOnDisposalsOfInvestments_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_NumberOfSharesIssued_lbl1" xml:lang="en-US">Number of shares issued</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NumberOfSharesIssued" xlink:to="ifrs-full_NumberOfSharesIssued_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_InitialPayment_lbl1" xml:lang="en-US">Initial Payment</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_InitialPayment" xlink:to="cve_InitialPayment_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_SharesIssuedForServicesShares_lbl1" xml:lang="en-US">Shares Issued For Services Shares</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_SharesIssuedForServicesShares" xlink:to="cve_SharesIssuedForServicesShares_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_TotalPurchasePrice_lbl1" xml:lang="en-US">Total Purchase Price</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_TotalPurchasePrice" xlink:to="cve_TotalPurchasePrice_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_MarketableSecuritiesnoncurrentMember_lbl0" xml:lang="en-US">Marketable Securitiesnoncurrent Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_MarketableSecuritiesnoncurrentMember" xlink:to="cve_MarketableSecuritiesnoncurrentMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ParValuePerShare_lbl0" xml:lang="en-US">Par value per share</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ParValuePerShare" xlink:to="ifrs-full_ParValuePerShare_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_PrivatePlacementProceeds_lbl1" xml:lang="en-US">Private Placement Proceeds</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_PrivatePlacementProceeds" xlink:to="cve_PrivatePlacementProceeds_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_SharesUnit_lbl1" xml:lang="en-US">Shares Unit</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_SharesUnit" xlink:to="cve_SharesUnit_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_AssetRetirementObligationsAccretion_lbl1" xml:lang="en-US">Asset Retirement Obligations Accretion</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_AssetRetirementObligationsAccretion" xlink:to="cve_AssetRetirementObligationsAccretion_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_NetDeferredTaxAssets_lbl1" xml:lang="en-US">Net deferred tax assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NetDeferredTaxAssets" xlink:to="ifrs-full_NetDeferredTaxAssets_lbl1"/>
    <loc xlink:type="locator" xlink:label="cve_ScheduleOfChangeInTheRouAssetsAbstract" xlink:href="cve-20221231.xsd#cve_ScheduleOfChangeInTheRouAssetsAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_ScheduleOfChangeInTheRouAssetsAbstract_lbl" xml:lang="en-US">Schedule Of Change In The Rou Assets Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_ScheduleOfChangeInTheRouAssetsAbstract" xlink:to="cve_ScheduleOfChangeInTheRouAssetsAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_IntangibleassetsTablesLineItems_lbl0" xml:lang="en-US">Intangibleassets Tables Line Items</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_IntangibleassetsTablesLineItems" xlink:to="cve_IntangibleassetsTablesLineItems_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ExpenseFromSharebasedPaymentTransactionsWithEmployees_lbl0" xml:lang="en-US">Expense from share-based payment transactions with employees</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ExpenseFromSharebasedPaymentTransactionsWithEmployees" xlink:to="ifrs-full_ExpenseFromSharebasedPaymentTransactionsWithEmployees_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_SaleOfPhysicalUranium_lbl1" xml:lang="en-US">Sale Of Physical Uranium</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_SaleOfPhysicalUranium" xlink:to="cve_SaleOfPhysicalUranium_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherLongTermInvestments_lbl0" xml:lang="en-US">Other Long-Term Investments</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherLongTermInvestments" xlink:to="us-gaap_OtherLongTermInvestments_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_AdditionalProvisionsOtherProvisions_lbl0" xml:lang="en-US">Additional provisions, other provisions</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AdditionalProvisionsOtherProvisions" xlink:to="ifrs-full_AdditionalProvisionsOtherProvisions_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_Right-of-UseAssetsTwoZeroTwoFive_lbl1" xml:lang="en-US">Right-of- Use Assets Two Zero Two Five</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_Right-of-UseAssetsTwoZeroTwoFive" xlink:to="cve_Right-of-UseAssetsTwoZeroTwoFive_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_MarketableSecuritiesDetailsLineItems_lbl0" xml:lang="en-US">Marketable Securities Details Line Items</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_MarketableSecuritiesDetailsLineItems" xlink:to="cve_MarketableSecuritiesDetailsLineItems_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_SharesIssuedForAzargaAssetAcquisitionNote10Shares_lbl1" xml:lang="en-US">Shares Issued For Azarga Asset Acquisition Note10 Shares</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_SharesIssuedForAzargaAssetAcquisitionNote10Shares" xlink:to="cve_SharesIssuedForAzargaAssetAcquisitionNote10Shares_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_SharesBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_lbl1" xml:lang="en-US">Shares Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_SharesBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:to="cve_SharesBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_OfficeAndAdministration_lbl1" xml:lang="en-US">Office And Administration</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_OfficeAndAdministration" xlink:to="cve_OfficeAndAdministration_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_FourFiveNineSixZeroZeroMember_lbl0" xml:lang="en-US">Four Five Nine Six Zero Zero Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_FourFiveNineSixZeroZeroMember" xlink:to="cve_FourFiveNineSixZeroZeroMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_AzargaResourcesLimitedMember_lbl0" xml:lang="en-US">Azarga Resources Limited Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_AzargaResourcesLimitedMember" xlink:to="cve_AzargaResourcesLimitedMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_OtherRevenue_lbl0" xml:lang="en-US">Other revenue</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_OtherRevenue" xlink:to="ifrs-full_OtherRevenue_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_DeductibleTemporaryDifferences_lbl1" xml:lang="en-US">Deductible Temporary Differences</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_DeductibleTemporaryDifferences" xlink:to="cve_DeductibleTemporaryDifferences_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_AdjustmentsForIncreaseDecreaseInEmployeeBenefitLiabilities_lbl0" xml:lang="en-US">Adjustments for increase (decrease) in employee benefit liabilities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AdjustmentsForIncreaseDecreaseInEmployeeBenefitLiabilities" xlink:to="ifrs-full_AdjustmentsForIncreaseDecreaseInEmployeeBenefitLiabilities_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfClassesOfShareCapitalExplanatory_lbl0" xml:lang="en-US">Disclosure of classes of share capital [text block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfClassesOfShareCapitalExplanatory" xlink:to="ifrs-full_DisclosureOfClassesOfShareCapitalExplanatory_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForLeasesExplanatory_lbl0" xml:lang="en-US">Description of accounting policy for leases [text block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DescriptionOfAccountingPolicyForLeasesExplanatory" xlink:to="ifrs-full_DescriptionOfAccountingPolicyForLeasesExplanatory_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_WarrantReserveMember_lbl0" xml:lang="en-US">Warrant reserve [member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_WarrantReserveMember" xlink:to="ifrs-full_WarrantReserveMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_lbl0" xml:lang="en-US">Schedule of Deferred Tax Assets and Liabilities [Table Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:to="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_SharesBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions_lbl1" xml:lang="en-US">Shares Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Exercisable Options</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_SharesBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions" xlink:to="cve_SharesBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_RecognisedAssetsDefinedBenefitPlan_lbl0" xml:lang="en-US">Net defined benefit asset</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_RecognisedAssetsDefinedBenefitPlan" xlink:to="ifrs-full_RecognisedAssetsDefinedBenefitPlan_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_RenewalPeriods_lbl1" xml:lang="en-US">Renewal Periods</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_RenewalPeriods" xlink:to="cve_RenewalPeriods_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_BottomOfRangeMember_lbl0" xml:lang="en-US">Bottom of range [member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_BottomOfRangeMember" xlink:to="ifrs-full_BottomOfRangeMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_CorrespondingLeaseObligation_lbl1" xml:lang="en-US">Corresponding Lease Obligation</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_CorrespondingLeaseObligation" xlink:to="cve_CorrespondingLeaseObligation_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_PublicOfferingPricePerShare_lbl1" xml:lang="en-US">Public Offering Price Per Share</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_PublicOfferingPricePerShare" xlink:to="cve_PublicOfferingPricePerShare_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_MarketValuePerShare_lbl2" xml:lang="en-US">Market Value Per Share</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_MarketValuePerShare" xlink:to="cve_MarketValuePerShare_lbl2"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisedWarrantsExercised_lbl1" xml:lang="en-US">Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercised Warrants Exercised</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisedWarrantsExercised" xlink:to="cve_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisedWarrantsExercised_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_SharePremium_lbl0" xml:lang="en-US">Share premium</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_SharePremium" xlink:to="ifrs-full_SharePremium_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_TravelExpense_lbl0" xml:lang="en-US">Travel expense</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_TravelExpense" xlink:to="ifrs-full_TravelExpense_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_ShareBasedCompensationArrangementsBySharesBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_lbl1" xml:lang="en-US">Share Based Compensation Arrangements By Shares Based Payment Award Options Expirations In Period Weighted Average Exercise Price</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_ShareBasedCompensationArrangementsBySharesBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" xlink:to="cve_ShareBasedCompensationArrangementsBySharesBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_lbl1"/>
    <loc xlink:type="locator" xlink:label="cve_ScheduleOfForeignCurrencyExposuresAbstract" xlink:href="cve-20221231.xsd#cve_ScheduleOfForeignCurrencyExposuresAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_ScheduleOfForeignCurrencyExposuresAbstract_lbl" xml:lang="en-US">Schedule Of Foreign Currency Exposures Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_ScheduleOfForeignCurrencyExposuresAbstract" xlink:to="cve_ScheduleOfForeignCurrencyExposuresAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_ProportionateShareOfNetLoss_lbl1" xml:lang="en-US">Proportionate Share Of Net Loss</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_ProportionateShareOfNetLoss" xlink:to="cve_ProportionateShareOfNetLoss_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_CurrencyTranslationAdjustment_lbl1" xml:lang="en-US">Currency Translation Adjustment</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_CurrencyTranslationAdjustment" xlink:to="cve_CurrencyTranslationAdjustment_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_MarketableSecuritiesMember_lbl0" xml:lang="en-US">Marketable Securities Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_MarketableSecuritiesMember" xlink:to="cve_MarketableSecuritiesMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_ScheduleOfIncurredNoncashFinancingAndInvestingActivitiesTableTextBlock_lbl0" xml:lang="en-US">Schedule Of Incurred Noncash Financing And Investing Activities Table Text Block</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_ScheduleOfIncurredNoncashFinancingAndInvestingActivitiesTableTextBlock" xlink:to="cve_ScheduleOfIncurredNoncashFinancingAndInvestingActivitiesTableTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_MarketableSecuritiesCurrent_lbl0" xml:lang="en-US">Marketable Securities, Current</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MarketableSecuritiesCurrent" xlink:to="us-gaap_MarketableSecuritiesCurrent_lbl0"/>
    <loc xlink:type="locator" xlink:label="cve_ScheduleOfOwingToRelatedPartiesAbstract" xlink:href="cve-20221231.xsd#cve_ScheduleOfOwingToRelatedPartiesAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_ScheduleOfOwingToRelatedPartiesAbstract_lbl" xml:lang="en-US">Schedule Of Owing To Related Parties Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_ScheduleOfOwingToRelatedPartiesAbstract" xlink:to="cve_ScheduleOfOwingToRelatedPartiesAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_VasquezMember_lbl0" xml:lang="en-US">Vasquez Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_VasquezMember" xlink:to="cve_VasquezMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_PropertyPlantAndEquipmentRange_lbl0" xml:lang="en-US">Property Plant And Equipment Range</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_PropertyPlantAndEquipmentRange" xlink:to="cve_PropertyPlantAndEquipmentRange_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_McKinleyMember_lbl0" xml:lang="en-US">Mc Kinley Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_McKinleyMember" xlink:to="cve_McKinleyMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="stpr_AZ_lbl0" xml:lang="en-US">ARIZONA</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="stpr_AZ" xlink:to="stpr_AZ_lbl0"/>
    <loc xlink:type="locator" xlink:label="cve_ScheduleOfTheFairValueOfThePhysicalUraniumInvestmentAbstract" xlink:href="cve-20221231.xsd#cve_ScheduleOfTheFairValueOfThePhysicalUraniumInvestmentAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_ScheduleOfTheFairValueOfThePhysicalUraniumInvestmentAbstract_lbl" xml:lang="en-US">Schedule Of The Fair Value Of The Physical Uranium Investment Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_ScheduleOfTheFairValueOfThePhysicalUraniumInvestmentAbstract" xlink:to="cve_ScheduleOfTheFairValueOfThePhysicalUraniumInvestmentAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_DescriptionOfAccountingPolicyForBasisOfConsolidationtextBlock_lbl1" xml:lang="en-US">Description Of Accounting Policy For Basis Of Consolidationtext Block</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_DescriptionOfAccountingPolicyForBasisOfConsolidationtextBlock" xlink:to="cve_DescriptionOfAccountingPolicyForBasisOfConsolidationtextBlock_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_WeightedAverageSharePrice2019_lbl0" xml:lang="en-US">Weighted average share price</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_WeightedAverageSharePrice2019" xlink:to="ifrs-full_WeightedAverageSharePrice2019_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_GrantsMineralBeltDatabaseMember_lbl0" xml:lang="en-US">Grants Mineral Belt Database Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_GrantsMineralBeltDatabaseMember" xlink:to="cve_GrantsMineralBeltDatabaseMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_DescriptionOfAccountingPolicyForChangeInPresentationCurrencytextBlock_lbl1" xml:lang="en-US">Description Of Accounting Policy For Change In Presentation Currencytext Block</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_DescriptionOfAccountingPolicyForChangeInPresentationCurrencytextBlock" xlink:to="cve_DescriptionOfAccountingPolicyForChangeInPresentationCurrencytextBlock_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_RetainedEarnings_lbl0" xml:lang="en-US">Retained earnings</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_RetainedEarnings" xlink:to="ifrs-full_RetainedEarnings_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentType_lbl0" xml:lang="en-US">Document Type</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ComprehensiveIncome_lbl0" xml:lang="en-US">Comprehensive income</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ComprehensiveIncome" xlink:to="ifrs-full_ComprehensiveIncome_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalPeriodFocus_lbl0" xml:lang="en-US">Document Fiscal Period Focus</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_OtherIntangibleAssets_lbl0" xml:lang="en-US">Other intangible assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_OtherIntangibleAssets" xlink:to="ifrs-full_OtherIntangibleAssets_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityInteractiveDataCurrent_lbl0" xml:lang="en-US">Entity Interactive Data Current</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityInteractiveDataCurrent" xlink:to="dei_EntityInteractiveDataCurrent_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_ExplorationCostMember_lbl0" xml:lang="en-US">Exploration Cost Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_ExplorationCostMember" xlink:to="cve_ExplorationCostMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_RecognizedStockOptionExpense_lbl1" xml:lang="en-US">Recognized Stock Option Expense</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_RecognizedStockOptionExpense" xlink:to="cve_RecognizedStockOptionExpense_lbl1"/>
    <loc xlink:type="locator" xlink:label="cve_ScheduleOfLongTermAssetsByGeographicSegmentAbstract" xlink:href="cve-20221231.xsd#cve_ScheduleOfLongTermAssetsByGeographicSegmentAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_ScheduleOfLongTermAssetsByGeographicSegmentAbstract_lbl" xml:lang="en-US">Schedule Of Long Term Assets By Geographic Segment Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_ScheduleOfLongTermAssetsByGeographicSegmentAbstract" xlink:to="cve_ScheduleOfLongTermAssetsByGeographicSegmentAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_LossesOnDivestmentOfMineralProperties_lbl0" xml:lang="en-US">Losses On Divestment Of Mineral Properties</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_LossesOnDivestmentOfMineralProperties" xlink:to="cve_LossesOnDivestmentOfMineralProperties_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_GainsLossesOnFairValueAdjustmentInvestmentProperty_lbl0" xml:lang="en-US">Gains (losses) on fair value adjustment, investment property</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_GainsLossesOnFairValueAdjustmentInvestmentProperty" xlink:to="ifrs-full_GainsLossesOnFairValueAdjustmentInvestmentProperty_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_AccountsPayableAndAccruedLiability_lbl1" xml:lang="en-US">Accounts Payable And Accrued Liability</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_AccountsPayableAndAccruedLiability" xlink:to="cve_AccountsPayableAndAccruedLiability_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_CategoryRange_lbl1" xml:lang="en-US">Category Range</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_CategoryRange" xlink:to="cve_CategoryRange_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesExplanatory_lbl0" xml:lang="en-US">Disclosure of subsidiaries [text block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesExplanatory" xlink:to="ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesExplanatory_lbl0"/>
    <loc xlink:type="locator" xlink:label="cve_DisclosureOfReclassificationsOrChangesInPresentationTextBlockAbstract" xlink:href="cve-20221231.xsd#cve_DisclosureOfReclassificationsOrChangesInPresentationTextBlockAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_DisclosureOfReclassificationsOrChangesInPresentationTextBlockAbstract_lbl" xml:lang="en-US">Disclosure Of Reclassifications Or Changes In Presentation Text Block Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_DisclosureOfReclassificationsOrChangesInPresentationTextBlockAbstract" xlink:to="cve_DisclosureOfReclassificationsOrChangesInPresentationTextBlockAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_CommonSharesOfSettlementAndCompensation_lbl1" xml:lang="en-US">Common Shares Of Settlement And Compensation</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_CommonSharesOfSettlementAndCompensation" xlink:to="cve_CommonSharesOfSettlementAndCompensation_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_EquityReclassifiedIntoFinancialLiabilities_lbl0" xml:lang="en-US">Equity reclassified into financial liabilities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_EquityReclassifiedIntoFinancialLiabilities" xlink:to="ifrs-full_EquityReclassifiedIntoFinancialLiabilities_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="stpr_CO_lbl0" xml:lang="en-US">COLORADO</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="stpr_CO" xlink:to="stpr_CO_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_OtherOperatingIncomeExpense_lbl1" xml:lang="en-US">Other operating income (expense)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_OtherOperatingIncomeExpense" xlink:to="ifrs-full_OtherOperatingIncomeExpense_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_LongtermProvisionForDecommissioningRestorationAndRehabilitationCosts_lbl0" xml:lang="en-US">Non-current provision for decommissioning, restoration and rehabilitation costs</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_LongtermProvisionForDecommissioningRestorationAndRehabilitationCosts" xlink:to="ifrs-full_LongtermProvisionForDecommissioningRestorationAndRehabilitationCosts_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_TotalConsideration_lbl1" xml:lang="en-US">Total Consideration</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_TotalConsideration" xlink:to="cve_TotalConsideration_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_Additions_lbl1" xml:lang="en-US">Additions</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_Additions" xlink:to="cve_Additions_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_Right-of-UseAssetsDepreciation_lbl1" xml:lang="en-US">Right-of- Use Assets Depreciation</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_Right-of-UseAssetsDepreciation" xlink:to="cve_Right-of-UseAssetsDepreciation_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForForeignCurrencyTranslationExplanatory_lbl0" xml:lang="en-US">Description of accounting policy for foreign currency translation [text block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DescriptionOfAccountingPolicyForForeignCurrencyTranslationExplanatory" xlink:to="ifrs-full_DescriptionOfAccountingPolicyForForeignCurrencyTranslationExplanatory_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_WeightedAverageSharePriceShareOptionsGranted2019_lbl0" xml:lang="en-US">Weighted average share price, share options granted</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_WeightedAverageSharePriceShareOptionsGranted2019" xlink:to="ifrs-full_WeightedAverageSharePriceShareOptionsGranted2019_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_WeightedAverageExercisePrice_lbl1" xml:lang="en-US">Weighted Average Exercise Price</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_WeightedAverageExercisePrice" xlink:to="cve_WeightedAverageExercisePrice_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeasePayments_lbl0" xml:lang="en-US">Operating Lease, Payments</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeasePayments" xlink:to="us-gaap_OperatingLeasePayments_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_GeneralAndAdministrativeExpense_lbl0" xml:lang="en-US">General and administrative expense</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_GeneralAndAdministrativeExpense" xlink:to="ifrs-full_GeneralAndAdministrativeExpense_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_SegmentedInformationBalance_lbl1" xml:lang="en-US">Segmented Information Balance</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_SegmentedInformationBalance" xlink:to="cve_SegmentedInformationBalance_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_AccumulatedDeficit_lbl1" xml:lang="en-US">Accumulated Deficit</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_AccumulatedDeficit" xlink:to="cve_AccumulatedDeficit_lbl1"/>
    <loc xlink:type="locator" xlink:label="cve_ConsolidatedStatementsOfLossAndComprehensiveLossAbstract" xlink:href="cve-20221231.xsd#cve_ConsolidatedStatementsOfLossAndComprehensiveLossAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_ConsolidatedStatementsOfLossAndComprehensiveLossAbstract_lbl" xml:lang="en-US">Consolidated Statements Of Loss And Comprehensive Loss Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_ConsolidatedStatementsOfLossAndComprehensiveLossAbstract" xlink:to="cve_ConsolidatedStatementsOfLossAndComprehensiveLossAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_NoncurrentLeaseLiabilities_lbl0" xml:lang="en-US">Non-current lease liabilities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NoncurrentLeaseLiabilities" xlink:to="ifrs-full_NoncurrentLeaseLiabilities_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_DescriptionOfAccountingPolicyForBuildingtextBlock_lbl1" xml:lang="en-US">Description Of Accounting Policy For Buildingtext Block</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_DescriptionOfAccountingPolicyForBuildingtextBlock" xlink:to="cve_DescriptionOfAccountingPolicyForBuildingtextBlock_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_AdjustmentsForGainLossOnDisposalsPropertyPlantAndEquipment_lbl0" xml:lang="en-US">Adjustments for gain (loss) on disposals, property, plant and equipment</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AdjustmentsForGainLossOnDisposalsPropertyPlantAndEquipment" xlink:to="ifrs-full_AdjustmentsForGainLossOnDisposalsPropertyPlantAndEquipment_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_PurchasedShares_lbl1" xml:lang="en-US">Purchased Shares</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_PurchasedShares" xlink:to="cve_PurchasedShares_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_IncreaseDecreaseThroughExerciseOfWarrantsEquity_lbl0" xml:lang="en-US">Increase (decrease) through exercise of warrants, equity</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_IncreaseDecreaseThroughExerciseOfWarrantsEquity" xlink:to="ifrs-full_IncreaseDecreaseThroughExerciseOfWarrantsEquity_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_UrancoIncMember_lbl0" xml:lang="en-US">Uranco Inc Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_UrancoIncMember" xlink:to="cve_UrancoIncMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_CurrentAccruedExpensesAndOtherCurrentLiabilities_lbl0" xml:lang="en-US">Current accrued expenses and other current liabilities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CurrentAccruedExpensesAndOtherCurrentLiabilities" xlink:to="ifrs-full_CurrentAccruedExpensesAndOtherCurrentLiabilities_lbl0"/>
    <loc xlink:type="locator" xlink:label="cve_ScheduleOfUnrecognizedDeferredTaxAssetsAbstract" xlink:href="cve-20221231.xsd#cve_ScheduleOfUnrecognizedDeferredTaxAssetsAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_ScheduleOfUnrecognizedDeferredTaxAssetsAbstract_lbl" xml:lang="en-US">Schedule Of Unrecognized Deferred Tax Assets Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_ScheduleOfUnrecognizedDeferredTaxAssetsAbstract" xlink:to="cve_ScheduleOfUnrecognizedDeferredTaxAssetsAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_CashFlowsFromUsedInOperationsBeforeChangesInWorkingCapital_lbl0" xml:lang="en-US">Cash flows from (used in) operations before changes in working capital</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CashFlowsFromUsedInOperationsBeforeChangesInWorkingCapital" xlink:to="ifrs-full_CashFlowsFromUsedInOperationsBeforeChangesInWorkingCapital_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_AdjustmentsForSharebasedPayments_lbl0" xml:lang="en-US">Adjustments for share-based payments</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AdjustmentsForSharebasedPayments" xlink:to="ifrs-full_AdjustmentsForSharebasedPayments_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_BuildingsMember_lbl0" xml:lang="en-US">Buildings [member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_BuildingsMember" xlink:to="ifrs-full_BuildingsMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_InvestmentInUraniumAbstract_lbl0" xml:lang="en-US">Investment In Uranium Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_InvestmentInUraniumAbstract" xlink:to="cve_InvestmentInUraniumAbstract_lbl0"/>
    <loc xlink:type="locator" xlink:label="cve_ScheduleOfAmountsPaidToKeyManagementOrEntitiesProvidingSimilarServicesAbstract" xlink:href="cve-20221231.xsd#cve_ScheduleOfAmountsPaidToKeyManagementOrEntitiesProvidingSimilarServicesAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_ScheduleOfAmountsPaidToKeyManagementOrEntitiesProvidingSimilarServicesAbstract_lbl" xml:lang="en-US">Schedule Of Amounts Paid To Key Management Or Entities Providing Similar Services Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_ScheduleOfAmountsPaidToKeyManagementOrEntitiesProvidingSimilarServicesAbstract" xlink:to="cve_ScheduleOfAmountsPaidToKeyManagementOrEntitiesProvidingSimilarServicesAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_SharesbasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue_lbl1" xml:lang="en-US">Sharesbased Compensation Arrangement By Sharebased Payment Award Options Vested Weighted Average Grant Date Fair Value</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_SharesbasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue" xlink:to="cve_SharesbasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_WarrantShare_lbl1" xml:lang="en-US">Warrant Share</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_WarrantShare" xlink:to="cve_WarrantShare_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_Prepayments_lbl0" xml:lang="en-US">Prepayments</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_Prepayments" xlink:to="ifrs-full_Prepayments_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_ScheduleOfTheStatusOfTheCompanysWarrantsTableTextBlock_lbl0" xml:lang="en-US">Schedule Of The Status Of The Companys Warrants Table Text Block</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_ScheduleOfTheStatusOfTheCompanysWarrantsTableTextBlock" xlink:to="cve_ScheduleOfTheStatusOfTheCompanysWarrantsTableTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_TicabooMember_lbl0" xml:lang="en-US">Ticaboo Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_TicabooMember" xlink:to="cve_TicabooMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_GainOnChangeInAssetRetirementObligationEstimate_lbl0" xml:lang="en-US">Gain On Change In Asset Retirement Obligation Estimate</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_GainOnChangeInAssetRetirementObligationEstimate" xlink:to="cve_GainOnChangeInAssetRetirementObligationEstimate_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_CommunicationExpense_lbl0" xml:lang="en-US">Communication expense</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CommunicationExpense" xlink:to="ifrs-full_CommunicationExpense_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_PrimaryTerm_lbl1" xml:lang="en-US">Primary Term</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_PrimaryTerm" xlink:to="cve_PrimaryTerm_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory_lbl0" xml:lang="en-US">Description of accounting policy for property, plant and equipment [text block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory" xlink:to="ifrs-full_DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory_lbl0"/>
    <loc xlink:type="locator" xlink:label="cve_ScheduleOfPropertyPlantAndEquipmentAbstract" xlink:href="cve-20221231.xsd#cve_ScheduleOfPropertyPlantAndEquipmentAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_ScheduleOfPropertyPlantAndEquipmentAbstract_lbl" xml:lang="en-US">Schedule Of Property Plant And Equipment Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_ScheduleOfPropertyPlantAndEquipmentAbstract" xlink:to="cve_ScheduleOfPropertyPlantAndEquipmentAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProfitLoss_lbl0" xml:lang="en-US">Net Income (Loss), Including Portion Attributable to Noncontrolling Interest</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProfitLoss" xlink:to="us-gaap_ProfitLoss_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_Long-TermLeaseLiabilityBalance_lbl2" xml:lang="en-US">Long- Term Lease Liability Balance</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_Long-TermLeaseLiabilityBalance" xlink:to="cve_Long-TermLeaseLiabilityBalance_lbl2"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_PropertyPlantAndEquipments_lbl1" xml:lang="en-US">Property Plant And Equipments</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_PropertyPlantAndEquipments" xlink:to="cve_PropertyPlantAndEquipments_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_MarketablesSecurities_lbl2" xml:lang="en-US">Marketables Securities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_MarketablesSecurities" xlink:to="cve_MarketablesSecurities_lbl2"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_ShareSubscriptionsReceived_lbl1" xml:lang="en-US">Share Subscriptions Received</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_ShareSubscriptionsReceived" xlink:to="cve_ShareSubscriptionsReceived_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_ShareSubscriptionsValue_lbl1" xml:lang="en-US">Share Subscriptions Value</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_ShareSubscriptionsValue" xlink:to="cve_ShareSubscriptionsValue_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForIncomeTaxExplanatory_lbl0" xml:lang="en-US">Description of accounting policy for income tax [text block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DescriptionOfAccountingPolicyForIncomeTaxExplanatory" xlink:to="ifrs-full_DescriptionOfAccountingPolicyForIncomeTaxExplanatory_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_CommonShares_lbl1" xml:lang="en-US">Common Shares</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_CommonShares" xlink:to="cve_CommonShares_lbl1"/>
    <loc xlink:type="locator" xlink:label="cve_ScheduleOfEstimatedFairValueOfAssetsAndLiabilitiesAbstract" xlink:href="cve-20221231.xsd#cve_ScheduleOfEstimatedFairValueOfAssetsAndLiabilitiesAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_ScheduleOfEstimatedFairValueOfAssetsAndLiabilitiesAbstract_lbl" xml:lang="en-US">Schedule Of Estimated Fair Value Of Assets And Liabilities Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_ScheduleOfEstimatedFairValueOfAssetsAndLiabilitiesAbstract" xlink:to="cve_ScheduleOfEstimatedFairValueOfAssetsAndLiabilitiesAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ImpairmentLoss_lbl0" xml:lang="en-US">Impairment loss</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ImpairmentLoss" xlink:to="ifrs-full_ImpairmentLoss_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_Cash_lbl0" xml:lang="en-US">Cash</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_Cash" xlink:to="ifrs-full_Cash_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ProfitLossFromOperatingActivities_lbl0" xml:lang="en-US">Profit (loss) from operating activities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ProfitLossFromOperatingActivities" xlink:to="ifrs-full_ProfitLossFromOperatingActivities_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_SalesContractsFiscalTwoZeroTwoSeven_lbl1" xml:lang="en-US">Sales Contracts Fiscal Two Zero Two Seven</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_SalesContractsFiscalTwoZeroTwoSeven" xlink:to="cve_SalesContractsFiscalTwoZeroTwoSeven_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_ContributedSurplusMember_lbl0" xml:lang="en-US">Contributed Surplus Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_ContributedSurplusMember" xlink:to="cve_ContributedSurplusMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_NameofSubsidaryFunctionalCurrency_lbl1" xml:lang="en-US">Nameof Subsidary Functional Currency</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_NameofSubsidaryFunctionalCurrency" xlink:to="cve_NameofSubsidaryFunctionalCurrency_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_WarrantIsExercisableTerm_lbl1" xml:lang="en-US">Warrant Is Exercisable Term</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_WarrantIsExercisableTerm" xlink:to="cve_WarrantIsExercisableTerm_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_CashFlowsFromUsedInFinancingActivities_lbl0" xml:lang="en-US">Cash flows from (used in) financing activities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CashFlowsFromUsedInFinancingActivities" xlink:to="ifrs-full_CashFlowsFromUsedInFinancingActivities_lbl0"/>
    <loc xlink:type="locator" xlink:label="cve_ScheduleOfWeightedAverageAssumptionsUsedInCalculatingTheFairValuesAbstract" xlink:href="cve-20221231.xsd#cve_ScheduleOfWeightedAverageAssumptionsUsedInCalculatingTheFairValuesAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_ScheduleOfWeightedAverageAssumptionsUsedInCalculatingTheFairValuesAbstract_lbl" xml:lang="en-US">Schedule Of Weighted Average Assumptions Used In Calculating The Fair Values Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_ScheduleOfWeightedAverageAssumptionsUsedInCalculatingTheFairValuesAbstract" xlink:to="cve_ScheduleOfWeightedAverageAssumptionsUsedInCalculatingTheFairValuesAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ReversalOfImpairmentLossRecognisedInOtherComprehensiveIncome_lbl0" xml:lang="en-US">Reversal of impairment loss recognised in other comprehensive income</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ReversalOfImpairmentLossRecognisedInOtherComprehensiveIncome" xlink:to="ifrs-full_ReversalOfImpairmentLossRecognisedInOtherComprehensiveIncome_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_Saleofstockpershare_lbl1" xml:lang="en-US">Saleofstockpershare</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_Saleofstockpershare" xlink:to="cve_Saleofstockpershare_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_ChangeInUnrecognizedTemporaryDifferences_lbl1" xml:lang="en-US">Change In Unrecognized Temporary Differences</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_ChangeInUnrecognizedTemporaryDifferences" xlink:to="cve_ChangeInUnrecognizedTemporaryDifferences_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_SubscriptionCirculationRevenue_lbl0" xml:lang="en-US">Subscription circulation revenue</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_SubscriptionCirculationRevenue" xlink:to="ifrs-full_SubscriptionCirculationRevenue_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfTransactionsRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombinationExplanatory_lbl0" xml:lang="en-US">Disclosure of transactions recognised separately from acquisition of assets and assumption of liabilities in business combination [text block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfTransactionsRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombinationExplanatory" xlink:to="ifrs-full_DisclosureOfTransactionsRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombinationExplanatory_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_IssuedCapital_lbl0" xml:lang="en-US">Issued capital</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_IssuedCapital" xlink:to="ifrs-full_IssuedCapital_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_StockOptions_lbl0" xml:lang="en-US">Stock Options</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_StockOptions" xlink:to="cve_StockOptions_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_AdjustedWeightedAverageShares_lbl0" xml:lang="en-US">Weighted average number of ordinary shares used in calculating diluted earnings per share</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AdjustedWeightedAverageShares" xlink:to="ifrs-full_AdjustedWeightedAverageShares_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_ContractPoundsOfUranium_lbl1" xml:lang="en-US">Contract Pounds Of Uranium</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_ContractPoundsOfUranium" xlink:to="cve_ContractPoundsOfUranium_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_EquityAndLiabilities_lbl0" xml:lang="en-US">Equity and liabilities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_EquityAndLiabilities" xlink:to="ifrs-full_EquityAndLiabilities_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_OrginationAndReversalOfTemporaryDifferences_lbl1" xml:lang="en-US">Orgination And Reversal Of Temporary Differences</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_OrginationAndReversalOfTemporaryDifferences" xlink:to="cve_OrginationAndReversalOfTemporaryDifferences_lbl1"/>
    <loc xlink:type="locator" xlink:label="cve_DisclosureOfEntitysOperatingSegmentsTextBlockAbstract" xlink:href="cve-20221231.xsd#cve_DisclosureOfEntitysOperatingSegmentsTextBlockAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_DisclosureOfEntitysOperatingSegmentsTextBlockAbstract_lbl" xml:lang="en-US">Disclosure Of Entitys Operating Segments Text Block Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_DisclosureOfEntitysOperatingSegmentsTextBlockAbstract" xlink:to="cve_DisclosureOfEntitysOperatingSegmentsTextBlockAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_TransactionCostsOnAzargaAssetAcquisition_lbl0" xml:lang="en-US">Transaction Costs On Azarga Asset Acquisition</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_TransactionCostsOnAzargaAssetAcquisition" xlink:to="cve_TransactionCostsOnAzargaAssetAcquisition_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_BorrowingsInterestRate_lbl1" xml:lang="en-US">Borrowings, interest rate</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_BorrowingsInterestRate" xlink:to="ifrs-full_BorrowingsInterestRate_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_InvestmentInAssociateAbstract_lbl0" xml:lang="en-US">Investment In Associate Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_InvestmentInAssociateAbstract" xlink:to="cve_InvestmentInAssociateAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ClosingForeignExchangeRate_lbl0" xml:lang="en-US">Closing foreign exchange rate</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ClosingForeignExchangeRate" xlink:to="ifrs-full_ClosingForeignExchangeRate_lbl0"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_StatementOfCashFlowsAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_StatementOfCashFlowsAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_StatementOfCashFlowsAbstract_lbl" xml:lang="en-US">Statement of cash flows [abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_StatementOfCashFlowsAbstract" xlink:to="ifrs-full_StatementOfCashFlowsAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_InterestExpense_lbl0" xml:lang="en-US">Interest expense</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_InterestExpense" xlink:to="ifrs-full_InterestExpense_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_Recoveries_lbl0" xml:lang="en-US">Recoveries</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_Recoveries" xlink:to="cve_Recoveries_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_WeightedAverageExercisePriceOfShareOptionsInSharebasedPaymentArrangementExercisedDuringPeriodAtDateOfExercise2019_lbl0" xml:lang="en-US">Weighted average share price for share options in share-based payment arrangement exercised during period at date of exercise</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_WeightedAverageExercisePriceOfShareOptionsInSharebasedPaymentArrangementExercisedDuringPeriodAtDateOfExercise2019" xlink:to="ifrs-full_WeightedAverageExercisePriceOfShareOptionsInSharebasedPaymentArrangementExercisedDuringPeriodAtDateOfExercise2019_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_Right-of-UseAssetsBalance_lbl1" xml:lang="en-US">Right-of- Use Assets Balance</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_Right-of-UseAssetsBalance" xlink:to="cve_Right-of-UseAssetsBalance_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AuditorLocation_lbl0" xml:lang="en-US">Auditor Location</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditorLocation" xlink:to="dei_AuditorLocation_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_MineralProperties_lbl1" xml:lang="en-US">Mineral Properties</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_MineralProperties" xlink:to="cve_MineralProperties_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_OneFiveNineOneEightZeroMember_lbl0" xml:lang="en-US">One Five Nine One Eight Zero Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_OneFiveNineOneEightZeroMember" xlink:to="cve_OneFiveNineOneEightZeroMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_NonCurrentAssetsAbstract_lbl0" xml:lang="en-US">Non Current Assets Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_NonCurrentAssetsAbstract" xlink:to="cve_NonCurrentAssetsAbstract_lbl0"/>
    <loc xlink:type="locator" xlink:label="cve_ScheduleOfUndiscountedFutureLeasePaymentsAbstract" xlink:href="cve-20221231.xsd#cve_ScheduleOfUndiscountedFutureLeasePaymentsAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_ScheduleOfUndiscountedFutureLeasePaymentsAbstract_lbl" xml:lang="en-US">Schedule Of Undiscounted Future Lease Payments Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_ScheduleOfUndiscountedFutureLeasePaymentsAbstract" xlink:to="cve_ScheduleOfUndiscountedFutureLeasePaymentsAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ImpairmentLossImpairmentGainAndReversalOfImpairmentLossDeterminedInAccordanceWithIFRS9_lbl0" xml:lang="en-US">Impairment loss (impairment gain and reversal of impairment loss) determined in accordance with IFRS 9</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ImpairmentLossImpairmentGainAndReversalOfImpairmentLossDeterminedInAccordanceWithIFRS9" xlink:to="ifrs-full_ImpairmentLossImpairmentGainAndReversalOfImpairmentLossDeterminedInAccordanceWithIFRS9_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityRegistrantName_lbl0" xml:lang="en-US">Entity Registrant Name</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_TwoFourZeroThreeSevenEightMember_lbl0" xml:lang="en-US">Two Four Zero Three Seven Eight Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_TwoFourZeroThreeSevenEightMember" xlink:to="cve_TwoFourZeroThreeSevenEightMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_CurrentLiabilities_lbl1" xml:lang="en-US">Current liabilities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CurrentLiabilities" xlink:to="ifrs-full_CurrentLiabilities_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_AssetsHeldForSale_lbl0" xml:lang="en-US">Assets Held For Sale</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_AssetsHeldForSale" xlink:to="cve_AssetsHeldForSale_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CityAreaCode_lbl0" xml:lang="en-US">City Area Code</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_SalesContractsFiscalTwoZeroTwoFive_lbl1" xml:lang="en-US">Sales Contracts Fiscal Two Zero Two Five</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_SalesContractsFiscalTwoZeroTwoFive" xlink:to="cve_SalesContractsFiscalTwoZeroTwoFive_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_PursuantToAgreement_lbl1" xml:lang="en-US">Pursuant To Agreement</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_PursuantToAgreement" xlink:to="cve_PursuantToAgreement_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_AcquireCommonShare_lbl1" xml:lang="en-US">Acquire Common Share</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_AcquireCommonShare" xlink:to="cve_AcquireCommonShare_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_StockIssuedDuringPeriodShareSharesBasedCompensationForfeited_lbl1" xml:lang="en-US">Stock Issued During Period Share Shares Based Compensation Forfeited</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_StockIssuedDuringPeriodShareSharesBasedCompensationForfeited" xlink:to="cve_StockIssuedDuringPeriodShareSharesBasedCompensationForfeited_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_InvestmentAmount_lbl1" xml:lang="en-US">Investment Amount</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_InvestmentAmount" xlink:to="cve_InvestmentAmount_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethodExplanatory_lbl0" xml:lang="en-US">Disclosure of investments other than investments accounted for using equity method [text block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethodExplanatory" xlink:to="ifrs-full_DisclosureOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethodExplanatory_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AnnualInformationForm_lbl0" xml:lang="en-US">Annual Information Form</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AnnualInformationForm" xlink:to="dei_AnnualInformationForm_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsExplanatory_lbl0" xml:lang="en-US">Disclosure of temporary difference, unused tax losses and unused tax credits [text block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsExplanatory" xlink:to="ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsExplanatory_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_Right-of-UseAssetsCurrencyTranslationAdjustment_lbl1" xml:lang="en-US">Right-of- Use Assets Currency Translation Adjustment</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_Right-of-UseAssetsCurrencyTranslationAdjustment" xlink:to="cve_Right-of-UseAssetsCurrencyTranslationAdjustment_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_ExpensesAbstract0_lbl0" xml:lang="en-US">Expenses Abstract0</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_ExpensesAbstract0" xlink:to="cve_ExpensesAbstract0_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_NameofSubsidaryPlaceOfIncorporation_lbl1" xml:lang="en-US">Nameof Subsidary Place Of Incorporation</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_NameofSubsidaryPlaceOfIncorporation" xlink:to="cve_NameofSubsidaryPlaceOfIncorporation_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory_lbl0" xml:lang="en-US">Description of accounting policy for share-based payment transactions [text block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory" xlink:to="ifrs-full_DescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_LeasedOfficesMember_lbl0" xml:lang="en-US">Leased Offices Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_LeasedOfficesMember" xlink:to="cve_LeasedOfficesMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_AssetRetirementObligations_lbl1" xml:lang="en-US">Asset Retirement Obligations</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_AssetRetirementObligations" xlink:to="cve_AssetRetirementObligations_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_PreviouslyStatedMember_lbl0" xml:lang="en-US">Previously stated [member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_PreviouslyStatedMember" xlink:to="ifrs-full_PreviouslyStatedMember_lbl0"/>
    <loc xlink:type="locator" xlink:label="cve_ScheduleOfProportionalShareInTheAssociateAbstract" xlink:href="cve-20221231.xsd#cve_ScheduleOfProportionalShareInTheAssociateAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_ScheduleOfProportionalShareInTheAssociateAbstract_lbl" xml:lang="en-US">Schedule Of Proportional Share In The Associate Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_ScheduleOfProportionalShareInTheAssociateAbstract" xlink:to="cve_ScheduleOfProportionalShareInTheAssociateAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_DivestMineralInterest_lbl0" xml:lang="en-US">Divest Mineral Interest</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_DivestMineralInterest" xlink:to="cve_DivestMineralInterest_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_AdditionalPayment_lbl0" xml:lang="en-US">Additional Payment</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_AdditionalPayment" xlink:to="cve_AdditionalPayment_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_HydroRestorationCorpMember_lbl0" xml:lang="en-US">Hydro Restoration Corp Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_HydroRestorationCorpMember" xlink:to="cve_HydroRestorationCorpMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_AssetsReceivedPercentage_lbl1" xml:lang="en-US">Assets Received Percentage</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_AssetsReceivedPercentage" xlink:to="cve_AssetsReceivedPercentage_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="stpr_UT_lbl0" xml:lang="en-US">UTAH</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="stpr_UT" xlink:to="stpr_UT_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_RoyaltyIncomeRate_lbl0" xml:lang="en-US">Royalty Income Rate</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_RoyaltyIncomeRate" xlink:to="cve_RoyaltyIncomeRate_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_OtherNoncurrentLiabilities_lbl0" xml:lang="en-US">Other non-current liabilities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_OtherNoncurrentLiabilities" xlink:to="ifrs-full_OtherNoncurrentLiabilities_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_Long-TermLeaseLiabilityCurrencyTranslationAdjustment_lbl1" xml:lang="en-US">Long- Term Lease Liability Currency Translation Adjustment</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_Long-TermLeaseLiabilityCurrencyTranslationAdjustment" xlink:to="cve_Long-TermLeaseLiabilityCurrencyTranslationAdjustment_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_CarriedForward_lbl1" xml:lang="en-US">Carried Forward</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_CarriedForward" xlink:to="cve_CarriedForward_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_Right-of-UseAssetsAdditions_lbl1" xml:lang="en-US">Right-of- Use Assets Additions</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_Right-of-UseAssetsAdditions" xlink:to="cve_Right-of-UseAssetsAdditions_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_StockOptionsSharesOutstanding_lbl1" xml:lang="en-US">Stock Options Shares Outstanding</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_StockOptionsSharesOutstanding" xlink:to="cve_StockOptionsSharesOutstanding_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_RightofuseAssetsMember_lbl0" xml:lang="en-US">Right-of-use assets [member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_RightofuseAssetsMember" xlink:to="ifrs-full_RightofuseAssetsMember_lbl0"/>
    <loc xlink:type="locator" xlink:label="cve_ScheduleOfUraniumSalesContractsOverTheNextFiveYearsAbstract" xlink:href="cve-20221231.xsd#cve_ScheduleOfUraniumSalesContractsOverTheNextFiveYearsAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_ScheduleOfUraniumSalesContractsOverTheNextFiveYearsAbstract_lbl" xml:lang="en-US">Schedule Of Uranium Sales Contracts Over The Next Five Years Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_ScheduleOfUraniumSalesContractsOverTheNextFiveYearsAbstract" xlink:to="cve_ScheduleOfUraniumSalesContractsOverTheNextFiveYearsAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="stpr_TX_lbl0" xml:lang="en-US">TEXAS</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="stpr_TX" xlink:to="stpr_TX_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_WriteoffOfInvestment_lbl1" xml:lang="en-US">Writeoff Of Investment</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_WriteoffOfInvestment" xlink:to="cve_WriteoffOfInvestment_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_CashAndCashEquivalents_lbl2" xml:lang="en-US">Cash and cash equivalents</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CashAndCashEquivalents" xlink:to="ifrs-full_CashAndCashEquivalents_lbl2"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_ScheduleOfWeightedAverageAssumptionsUsedInCalculatingTheFairValuesTableTextBlock_lbl0" xml:lang="en-US">Schedule Of Weighted Average Assumptions Used In Calculating The Fair Values Table Text Block</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_ScheduleOfWeightedAverageAssumptionsUsedInCalculatingTheFairValuesTableTextBlock" xlink:to="cve_ScheduleOfWeightedAverageAssumptionsUsedInCalculatingTheFairValuesTableTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesAndStockholdersEquityAbstract_lbl0" xml:lang="en-US">Liabilities and Equity [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_LiabilitiesAndStockholdersEquityAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_FairValueOfReplacementOptions_lbl1" xml:lang="en-US">Fair Value Of Replacement Options</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_FairValueOfReplacementOptions" xlink:to="cve_FairValueOfReplacementOptions_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_RightofuseassetsTablesLineItems_lbl0" xml:lang="en-US">Rightofuseassets Tables Line Items</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_RightofuseassetsTablesLineItems" xlink:to="cve_RightofuseassetsTablesLineItems_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_PurchaseAdditionalSharePricePerWarrant_lbl1" xml:lang="en-US">Purchase Additional Share Price Per Warrant</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_PurchaseAdditionalSharePricePerWarrant" xlink:to="cve_PurchaseAdditionalSharePricePerWarrant_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_AzargaUraniumCorpMember_lbl0" xml:lang="en-US">Azarga Uranium Corp Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_AzargaUraniumCorpMember" xlink:to="cve_AzargaUraniumCorpMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_SubsequentEventThreeMember_lbl0" xml:lang="en-US">Subsequent Event Three Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_SubsequentEventThreeMember" xlink:to="cve_SubsequentEventThreeMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_GainLossOnRemeasurementOfReimbursementRights_lbl0" xml:lang="en-US">Increase (decrease) in reimbursement rights related to defined benefit obligation, resulting from gain (loss) on remeasurement</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_GainLossOnRemeasurementOfReimbursementRights" xlink:to="ifrs-full_GainLossOnRemeasurementOfReimbursementRights_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_OtherComprehensiveIncomeNetOfTaxHedgesOfNetInvestmentsInForeignOperations_lbl0" xml:lang="en-US">Other comprehensive income, net of tax, hedges of net investments in foreign operations</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_OtherComprehensiveIncomeNetOfTaxHedgesOfNetInvestmentsInForeignOperations" xlink:to="ifrs-full_OtherComprehensiveIncomeNetOfTaxHedgesOfNetInvestmentsInForeignOperations_lbl0"/>
    <loc xlink:type="locator" xlink:label="cve_ScheduleOfAssetRetirementObligationsContinuityAbstract" xlink:href="cve-20221231.xsd#cve_ScheduleOfAssetRetirementObligationsContinuityAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_ScheduleOfAssetRetirementObligationsContinuityAbstract_lbl" xml:lang="en-US">Schedule Of Asset Retirement Obligations Continuity Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_ScheduleOfAssetRetirementObligationsContinuityAbstract" xlink:to="cve_ScheduleOfAssetRetirementObligationsContinuityAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="stpr_WY_lbl0" xml:lang="en-US">WYOMING</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="stpr_WY" xlink:to="stpr_WY_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_StaffCosts_lbl1" xml:lang="en-US">Staff Costs</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_StaffCosts" xlink:to="cve_StaffCosts_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_ExpensesLossFromOperatingExpenses_lbl0" xml:lang="en-US">Expenses Loss From Operating Expenses</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_ExpensesLossFromOperatingExpenses" xlink:to="cve_ExpensesLossFromOperatingExpenses_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_AdjustmentsForImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLoss_lbl0" xml:lang="en-US">Adjustments for impairment loss (reversal of impairment loss) recognised in profit or loss</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AdjustmentsForImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLoss" xlink:to="ifrs-full_AdjustmentsForImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLoss_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_SharesBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber_lbl1" xml:lang="en-US">Shares Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Number</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_SharesBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber" xlink:to="cve_SharesBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_lbl1" xml:lang="en-US">Weighted average exercise price of share options outstanding in share-based payment arrangement</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019" xlink:to="ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_DataPurchasesMember_lbl0" xml:lang="en-US">Data Purchases Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_DataPurchasesMember" xlink:to="cve_DataPurchasesMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_PropertyPlantAndEquipment_lbl0" xml:lang="en-US">Property, plant and equipment</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_PropertyPlantAndEquipment" xlink:to="ifrs-full_PropertyPlantAndEquipment_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_TotalNoncashInvestingActivities_lbl0" xml:lang="en-US">Total Noncash Investing Activities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_TotalNoncashInvestingActivities" xlink:to="cve_TotalNoncashInvestingActivities_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityExTransitionPeriod_lbl0" xml:lang="en-US">Entity Ex Transition Period</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityExTransitionPeriod" xlink:to="dei_EntityExTransitionPeriod_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_TransferAgentAndFilingFees_lbl1" xml:lang="en-US">Transfer Agent And Filing Fees</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_TransferAgentAndFilingFees" xlink:to="cve_TransferAgentAndFilingFees_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DilutedEarningsLossPerShare_lbl1" xml:lang="en-US">Diluted earnings (loss) per share</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DilutedEarningsLossPerShare" xlink:to="ifrs-full_DilutedEarningsLossPerShare_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_DisclosureOfLongtermAssetsByGeographicSegmentTableTextBlock_lbl1" xml:lang="en-US">Disclosure Of Longterm Assets By Geographic Segment Table Text Block</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_DisclosureOfLongtermAssetsByGeographicSegmentTableTextBlock" xlink:to="cve_DisclosureOfLongtermAssetsByGeographicSegmentTableTextBlock_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForInvestmentInAssociates_lbl0" xml:lang="en-US">Description of accounting policy for investment in associates [text block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DescriptionOfAccountingPolicyForInvestmentInAssociates" xlink:to="ifrs-full_DescriptionOfAccountingPolicyForInvestmentInAssociates_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_StockOptionExpense_lbl1" xml:lang="en-US">Stock Option Expense</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_StockOptionExpense" xlink:to="cve_StockOptionExpense_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_DisclosureOfMineralProperties_lbl0" xml:lang="en-US">Disclosure Of Mineral Properties</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_DisclosureOfMineralProperties" xlink:to="cve_DisclosureOfMineralProperties_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_OfficersAndBoardMembersMember_lbl0" xml:lang="en-US">Officers And Board Members Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_OfficersAndBoardMembersMember" xlink:to="cve_OfficersAndBoardMembersMember_lbl0"/>
    <loc xlink:type="locator" xlink:label="cve_ScheduleOfSignificantSubsidiariesAbstract" xlink:href="cve-20221231.xsd#cve_ScheduleOfSignificantSubsidiariesAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_ScheduleOfSignificantSubsidiariesAbstract_lbl" xml:lang="en-US">Schedule Of Significant Subsidiaries Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_ScheduleOfSignificantSubsidiariesAbstract" xlink:to="cve_ScheduleOfSignificantSubsidiariesAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_DisclosureOfTransactionsRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombinationTextBlockAbstract" xlink:href="cve-20221231.xsd#cve_DisclosureOfTransactionsRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombinationTextBlockAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_DisclosureOfTransactionsRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombinationTextBlockAbstract_lbl" xml:lang="en-US">Disclosure Of Transactions Recognised Separately From Acquisition Of Assets And Assumption Of Liabilities In Business Combination Text Block Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_DisclosureOfTransactionsRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombinationTextBlockAbstract" xlink:to="cve_DisclosureOfTransactionsRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombinationTextBlockAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_PurchasePricePerShare_lbl1" xml:lang="en-US">Purchase Price Per Share</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_PurchasePricePerShare" xlink:to="cve_PurchasePricePerShare_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_MaturityAnalysisForDerivativeFinancialLiabilities_lbl0" xml:lang="en-US">Disclosure of maturity analysis for derivative financial liabilities [text block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_MaturityAnalysisForDerivativeFinancialLiabilities" xlink:to="ifrs-full_MaturityAnalysisForDerivativeFinancialLiabilities_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred_lbl1" xml:lang="en-US">Consideration transferred, acquisition-date fair value</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred" xlink:to="ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_AdjustmentsForFairValueGainsLosses_lbl0" xml:lang="en-US">Adjustments for fair value losses (gains)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AdjustmentsForFairValueGainsLosses" xlink:to="ifrs-full_AdjustmentsForFairValueGainsLosses_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_LoansAndReceivables_lbl0" xml:lang="en-US">Loans and receivables</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_LoansAndReceivables" xlink:to="ifrs-full_LoansAndReceivables_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromDebtNetOfIssuanceCosts_lbl0" xml:lang="en-US">Proceeds from Debt, Net of Issuance Costs</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromDebtNetOfIssuanceCosts" xlink:to="us-gaap_ProceedsFromDebtNetOfIssuanceCosts_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalYearFocus_lbl0" xml:lang="en-US">Document Fiscal Year Focus</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_TintinaHoldingsLtdMember_lbl0" xml:lang="en-US">Tintina Holdings Ltd Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_TintinaHoldingsLtdMember" xlink:to="cve_TintinaHoldingsLtdMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityEmergingGrowthCompany_lbl0" xml:lang="en-US">Entity Emerging Growth Company</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_LiabilitiesLossFromOperatingExpenses_lbl0" xml:lang="en-US">Liabilities Loss From Operating Expenses</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_LiabilitiesLossFromOperatingExpenses" xlink:to="cve_LiabilitiesLossFromOperatingExpenses_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_PrivatePlacementinShares_lbl1" xml:lang="en-US">Private Placementin Shares</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_PrivatePlacementinShares" xlink:to="cve_PrivatePlacementinShares_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfGeneralAndAdministrativeExpenseExplanatory_lbl0" xml:lang="en-US">Disclosure of general and administrative expense [text block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfGeneralAndAdministrativeExpenseExplanatory" xlink:to="ifrs-full_DisclosureOfGeneralAndAdministrativeExpenseExplanatory_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RestructuringReserveTranslationAdjustment_lbl0" xml:lang="en-US">Restructuring Reserve, Foreign Currency Translation Gain (Loss)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RestructuringReserveTranslationAdjustment" xlink:to="us-gaap_RestructuringReserveTranslationAdjustment_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_DescriptionOfAccountingPolicyForAssetRetirementObligationstextBlock_lbl1" xml:lang="en-US">Description Of Accounting Policy For Asset Retirement Obligationstext Block</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_DescriptionOfAccountingPolicyForAssetRetirementObligationstextBlock" xlink:to="cve_DescriptionOfAccountingPolicyForAssetRetirementObligationstextBlock_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_DisclosureOfChangeInTheROUAssetsTableTextBlock_lbl1" xml:lang="en-US">Disclosure Of Change In The ROUAssets Table Text Block</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_DisclosureOfChangeInTheROUAssetsTableTextBlock" xlink:to="cve_DisclosureOfChangeInTheROUAssetsTableTextBlock_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_OtherRevenuesCurrent_lbl1" xml:lang="en-US">Other Revenues Current</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_OtherRevenuesCurrent" xlink:to="cve_OtherRevenuesCurrent_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_lbl0" xml:lang="en-US">Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_lbl0"/>
    <loc xlink:type="locator" xlink:label="cve_ScheduleOfMarketableSecuritiesAbstract" xlink:href="cve-20221231.xsd#cve_ScheduleOfMarketableSecuritiesAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_ScheduleOfMarketableSecuritiesAbstract_lbl" xml:lang="en-US">Schedule Of Marketable Securities Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_ScheduleOfMarketableSecuritiesAbstract" xlink:to="cve_ScheduleOfMarketableSecuritiesAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_NetInvestmentInFinanceLease_lbl0" xml:lang="en-US">Net investment in finance lease</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NetInvestmentInFinanceLease" xlink:to="ifrs-full_NetInvestmentInFinanceLease_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AuditorFirmId_lbl0" xml:lang="en-US">Auditor Firm ID</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditorFirmId" xlink:to="dei_AuditorFirmId_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_WarrantsMember_lbl0" xml:lang="en-US">Warrants Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_WarrantsMember" xlink:to="cve_WarrantsMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_AssetRetirementObligationsTextBlock_lbl0" xml:lang="en-US">Asset Retirement Obligations Text Block</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_AssetRetirementObligationsTextBlock" xlink:to="cve_AssetRetirementObligationsTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_NoncapitalLoss_lbl1" xml:lang="en-US">Noncapital Loss</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_NoncapitalLoss" xlink:to="cve_NoncapitalLoss_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ProfitLoss_lbl2" xml:lang="en-US">Profit (loss)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ProfitLoss" xlink:to="ifrs-full_ProfitLoss_lbl2"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_PowertechUSAIncMember_lbl0" xml:lang="en-US">Powertech USAInc Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_PowertechUSAIncMember" xlink:to="cve_PowertechUSAIncMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_ProjectDevelopmentCostsAbstract_lbl0" xml:lang="en-US">Project Development Costs Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_ProjectDevelopmentCostsAbstract" xlink:to="cve_ProjectDevelopmentCostsAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_ScheduleOfUraniumConcentratesPurchaseAgreementTableTextBlock_lbl0" xml:lang="en-US">Schedule Of Uranium Concentrates Purchase Agreement Table Text Block</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_ScheduleOfUraniumConcentratesPurchaseAgreementTableTextBlock" xlink:to="cve_ScheduleOfUraniumConcentratesPurchaseAgreementTableTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_OtherComprehensiveIncomeBeforeTaxExchangeDifferencesOnTranslation_lbl0" xml:lang="en-US">Other comprehensive income, before tax, exchange differences on translation of foreign operations</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_OtherComprehensiveIncomeBeforeTaxExchangeDifferencesOnTranslation" xlink:to="ifrs-full_OtherComprehensiveIncomeBeforeTaxExchangeDifferencesOnTranslation_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_Equity_lbl2" xml:lang="en-US">Equity</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_Equity" xlink:to="ifrs-full_Equity_lbl2"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfDetailedInformationAboutIntangibleAssetsExplanatory_lbl0" xml:lang="en-US">Disclosure of detailed information about intangible assets [text block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfDetailedInformationAboutIntangibleAssetsExplanatory" xlink:to="ifrs-full_DisclosureOfDetailedInformationAboutIntangibleAssetsExplanatory_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ProfitLossBeforeTax_lbl0" xml:lang="en-US">Profit (loss) before tax</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ProfitLossBeforeTax" xlink:to="ifrs-full_ProfitLossBeforeTax_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_FixedAssets_lbl1" xml:lang="en-US">Fixed Assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_FixedAssets" xlink:to="cve_FixedAssets_lbl1"/>
    <loc xlink:type="locator" xlink:label="cve_ScheduleOfNetAssetsAcquiredAbstract" xlink:href="cve-20221231.xsd#cve_ScheduleOfNetAssetsAcquiredAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_ScheduleOfNetAssetsAcquiredAbstract_lbl" xml:lang="en-US">Schedule Of Net Assets Acquired Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_ScheduleOfNetAssetsAcquiredAbstract" xlink:to="cve_ScheduleOfNetAssetsAcquiredAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_ReplacementWarrantsMember_lbl0" xml:lang="en-US">Replacement Warrants Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_ReplacementWarrantsMember" xlink:to="cve_ReplacementWarrantsMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="stpr_SD_lbl0" xml:lang="en-US">SOUTH DAKOTA</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="stpr_SD" xlink:to="stpr_SD_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_AdjustmentsForDecreaseIncreaseInOtherOperatingReceivables_lbl0" xml:lang="en-US">Adjustments for decrease (increase) in other operating receivables</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AdjustmentsForDecreaseIncreaseInOtherOperatingReceivables" xlink:to="ifrs-full_AdjustmentsForDecreaseIncreaseInOtherOperatingReceivables_lbl0"/>
    <loc xlink:type="locator" xlink:label="cve_ScheduleOfAssetRetirementObligationsBalanceAbstract" xlink:href="cve-20221231.xsd#cve_ScheduleOfAssetRetirementObligationsBalanceAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_ScheduleOfAssetRetirementObligationsBalanceAbstract_lbl" xml:lang="en-US">Schedule Of Asset Retirement Obligations Balance Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_ScheduleOfAssetRetirementObligationsBalanceAbstract" xlink:to="cve_ScheduleOfAssetRetirementObligationsBalanceAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_InvestmentsInSubsidiariesJointVenturesAndAssociates_lbl0" xml:lang="en-US">Investments in subsidiaries, joint ventures and associates reported in separate financial statements</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_InvestmentsInSubsidiariesJointVenturesAndAssociates" xlink:to="ifrs-full_InvestmentsInSubsidiariesJointVenturesAndAssociates_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_TradeAndOtherCurrentPayablesToRelatedParties_lbl0" xml:lang="en-US">Current payables to related parties</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_TradeAndOtherCurrentPayablesToRelatedParties" xlink:to="ifrs-full_TradeAndOtherCurrentPayablesToRelatedParties_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_PrimeFuelsCorpMember_lbl0" xml:lang="en-US">Prime Fuels Corp Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_PrimeFuelsCorpMember" xlink:to="cve_PrimeFuelsCorpMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill_lbl0" xml:lang="en-US">Acquisitions through business combinations, intangible assets and goodwill</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill" xlink:to="ifrs-full_AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_DisclosureOfAssetRetirementObligationsContinuityTableTextBlock_lbl1" xml:lang="en-US">Disclosure Of Asset Retirement Obligations Continuity Table Text Block</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_DisclosureOfAssetRetirementObligationsContinuityTableTextBlock" xlink:to="cve_DisclosureOfAssetRetirementObligationsContinuityTableTextBlock_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_OtherExpenseByNature_lbl0" xml:lang="en-US">Other expenses, by nature</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_OtherExpenseByNature" xlink:to="ifrs-full_OtherExpenseByNature_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_AzargaResourcesUSACompanyMember_lbl0" xml:lang="en-US">Azarga Resources USACompany Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_AzargaResourcesUSACompanyMember" xlink:to="cve_AzargaResourcesUSACompanyMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_LossOnInvestmentInAssociate_lbl0" xml:lang="en-US">Loss On Investment In Associate</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_LossOnInvestmentInAssociate" xlink:to="cve_LossOnInvestmentInAssociate_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LongTermDebtFairValue_lbl0" xml:lang="en-US">Long-Term Debt, Fair Value</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermDebtFairValue" xlink:to="us-gaap_LongTermDebtFairValue_lbl0"/>
    <loc xlink:type="locator" xlink:label="cve_ScheduleOfStockOptionsOutstandingAbstract" xlink:href="cve-20221231.xsd#cve_ScheduleOfStockOptionsOutstandingAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_ScheduleOfStockOptionsOutstandingAbstract_lbl" xml:lang="en-US">Schedule Of Stock Options Outstanding Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_ScheduleOfStockOptionsOutstandingAbstract" xlink:to="cve_ScheduleOfStockOptionsOutstandingAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_GainOnSaleOfUranium_lbl1" xml:lang="en-US">Gain On Sale Of Uranium</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_GainOnSaleOfUranium" xlink:to="cve_GainOnSaleOfUranium_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_AssetRetirementObligationsAdditionsFromAzargaAssetAcquisitionNote10_lbl1" xml:lang="en-US">Asset Retirement Obligations Additions From Azarga Asset Acquisition Note10</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_AssetRetirementObligationsAdditionsFromAzargaAssetAcquisitionNote10" xlink:to="cve_AssetRetirementObligationsAdditionsFromAzargaAssetAcquisitionNote10_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_PercentageOfVotingEquityInterestsAcquired_lbl0" xml:lang="en-US">Percentage of voting equity interests acquired</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_PercentageOfVotingEquityInterestsAcquired" xlink:to="ifrs-full_PercentageOfVotingEquityInterestsAcquired_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_ForeignExchangeRate_lbl0" xml:lang="en-US">Foreign Exchange Rate</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_ForeignExchangeRate" xlink:to="cve_ForeignExchangeRate_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfMarketRiskExplanatory_lbl0" xml:lang="en-US">Disclosure of market risk [text block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfMarketRiskExplanatory" xlink:to="ifrs-full_DisclosureOfMarketRiskExplanatory_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_SignalEquitiesDatabaseMember_lbl0" xml:lang="en-US">Signal Equities Database Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_SignalEquitiesDatabaseMember" xlink:to="cve_SignalEquitiesDatabaseMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_WorkingCapital_lbl1" xml:lang="en-US">Working Capital</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_WorkingCapital" xlink:to="cve_WorkingCapital_lbl1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_StatementOfFinancialPositionAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_StatementOfFinancialPositionAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_StatementOfFinancialPositionAbstract_lbl" xml:lang="en-US">Statement of financial position [abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_StatementOfFinancialPositionAbstract" xlink:to="ifrs-full_StatementOfFinancialPositionAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_OtherInflowsOutflowsOfCashClassifiedAsOperatingActivities_lbl0" xml:lang="en-US">Other inflows (outflows) of cash, classified as operating activities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_OtherInflowsOutflowsOfCashClassifiedAsOperatingActivities" xlink:to="ifrs-full_OtherInflowsOutflowsOfCashClassifiedAsOperatingActivities_lbl0"/>
    <loc xlink:type="locator" xlink:label="cve_ScheduleOfIncurredNonCashFinancingAndInvestingActivitiesAbstract" xlink:href="cve-20221231.xsd#cve_ScheduleOfIncurredNonCashFinancingAndInvestingActivitiesAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_ScheduleOfIncurredNonCashFinancingAndInvestingActivitiesAbstract_lbl" xml:lang="en-US">Schedule Of Incurred Non Cash Financing And Investing Activities Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_ScheduleOfIncurredNonCashFinancingAndInvestingActivitiesAbstract" xlink:to="cve_ScheduleOfIncurredNonCashFinancingAndInvestingActivitiesAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_CashFlowsFromUsedInInvestingActivities_lbl0" xml:lang="en-US">Cash flows from (used in) investing activities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CashFlowsFromUsedInInvestingActivities" xlink:to="ifrs-full_CashFlowsFromUsedInInvestingActivities_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_ScenarioForecastMember_lbl0" xml:lang="en-US">Forecast [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_ScenarioForecastMember" xlink:to="srt_ScenarioForecastMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFileNumber_lbl0" xml:lang="en-US">Entity File Number</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_UraniumPlantsMember_lbl0" xml:lang="en-US">Uranium Plants Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_UraniumPlantsMember" xlink:to="cve_UraniumPlantsMember_lbl0"/>
    <loc xlink:type="locator" xlink:label="cve_SupplementalDisclosureWithRespectToCashflowsAbstract" xlink:href="cve-20221231.xsd#cve_SupplementalDisclosureWithRespectToCashflowsAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_SupplementalDisclosureWithRespectToCashflowsAbstract_lbl" xml:lang="en-US">Supplemental Disclosure With Respect To Cashflows Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_SupplementalDisclosureWithRespectToCashflowsAbstract" xlink:to="cve_SupplementalDisclosureWithRespectToCashflowsAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_PaymentAmount_lbl1" xml:lang="en-US">Payment Amount</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_PaymentAmount" xlink:to="cve_PaymentAmount_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_DescriptionOfAccountingPolicyForSoftwaretextBlock_lbl1" xml:lang="en-US">Description Of Accounting Policy For Softwaretext Block</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_DescriptionOfAccountingPolicyForSoftwaretextBlock" xlink:to="cve_DescriptionOfAccountingPolicyForSoftwaretextBlock_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_SignificantaccountingpoliciesTablesLineItems_lbl0" xml:lang="en-US">Significantaccountingpolicies Tables Line Items</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_SignificantaccountingpoliciesTablesLineItems" xlink:to="cve_SignificantaccountingpoliciesTablesLineItems_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_DescriptionOfAccountingPolicyForNewStandardsAndInterpretationsNotYetAdoptedtextBlock_lbl1" xml:lang="en-US">Description Of Accounting Policy For New Standards And Interpretations Not Yet Adoptedtext Block</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_DescriptionOfAccountingPolicyForNewStandardsAndInterpretationsNotYetAdoptedtextBlock" xlink:to="cve_DescriptionOfAccountingPolicyForNewStandardsAndInterpretationsNotYetAdoptedtextBlock_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_OtherRevenuesNoncurrent_lbl1" xml:lang="en-US">Other Revenues Noncurrent</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_OtherRevenuesNoncurrent" xlink:to="cve_OtherRevenuesNoncurrent_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_PurchaseWarrantShares_lbl1" xml:lang="en-US">Purchase Warrant Shares</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_PurchaseWarrantShares" xlink:to="cve_PurchaseWarrantShares_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_ReclamationCosts_lbl0" xml:lang="en-US">Reclamation Costs</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_ReclamationCosts" xlink:to="cve_ReclamationCosts_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_CurrentAssetsAbstract_lbl0" xml:lang="en-US">Current assets [abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CurrentAssetsAbstract" xlink:to="ifrs-full_CurrentAssetsAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_OptionsMember_lbl0" xml:lang="en-US">Options Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_OptionsMember" xlink:to="cve_OptionsMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_InvestmentInAssociateTablesLineItems_lbl0" xml:lang="en-US">Investment In Associate Tables Line Items</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_InvestmentInAssociateTablesLineItems" xlink:to="cve_InvestmentInAssociateTablesLineItems_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_AdjustmentsForIncreaseDecreaseInDepositsFromCustomers_lbl0" xml:lang="en-US">Adjustments for increase (decrease) in deposits from customers</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AdjustmentsForIncreaseDecreaseInDepositsFromCustomers" xlink:to="ifrs-full_AdjustmentsForIncreaseDecreaseInDepositsFromCustomers_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_PricePerPound_lbl1" xml:lang="en-US">Price Per Pound</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_PricePerPound" xlink:to="cve_PricePerPound_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_ConsiderationPercentage_lbl0" xml:lang="en-US">Consideration Percentage</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_ConsiderationPercentage" xlink:to="cve_ConsiderationPercentage_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_Consulting_lbl1" xml:lang="en-US">Consulting</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_Consulting" xlink:to="cve_Consulting_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_GettyDatabaseMember_lbl0" xml:lang="en-US">Getty Database Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_GettyDatabaseMember" xlink:to="cve_GettyDatabaseMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ClassesOfShareCapitalMember_lbl0" xml:lang="en-US">Share capital [member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ClassesOfShareCapitalMember" xlink:to="ifrs-full_ClassesOfShareCapitalMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_LocalPhoneNumber_lbl0" xml:lang="en-US">Local Phone Number</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_DisclosureOfUsefulLivesOfPropertyPlantAndEquipementTextBlock_lbl1" xml:lang="en-US">Disclosure Of Useful Lives Of Property Plant And Equipement Text Block</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_DisclosureOfUsefulLivesOfPropertyPlantAndEquipementTextBlock" xlink:to="cve_DisclosureOfUsefulLivesOfPropertyPlantAndEquipementTextBlock_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_WarrantsExercisablePricePerShare_lbl1" xml:lang="en-US">Warrants Exercisable Price Per Share</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_WarrantsExercisablePricePerShare" xlink:to="cve_WarrantsExercisablePricePerShare_lbl1"/>
    <loc xlink:type="locator" xlink:label="cve_ScheduleOfIntangibleAssetWasDeterminedAbstract" xlink:href="cve-20221231.xsd#cve_ScheduleOfIntangibleAssetWasDeterminedAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_ScheduleOfIntangibleAssetWasDeterminedAbstract_lbl" xml:lang="en-US">Schedule Of Intangible Asset Was Determined Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_ScheduleOfIntangibleAssetWasDeterminedAbstract" xlink:to="cve_ScheduleOfIntangibleAssetWasDeterminedAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_InflationFactorPercentage_lbl1" xml:lang="en-US">Inflation Factor Percentage</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_InflationFactorPercentage" xlink:to="cve_InflationFactorPercentage_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_AdjustmentToInvestmentInGroup11_lbl1" xml:lang="en-US">Adjustment To Investment In Group11</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_AdjustmentToInvestmentInGroup11" xlink:to="cve_AdjustmentToInvestmentInGroup11_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_ExpectedIncomeTaxExpenserecovery_lbl1" xml:lang="en-US">Expected Income Tax Expenserecovery</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_ExpectedIncomeTaxExpenserecovery" xlink:to="cve_ExpectedIncomeTaxExpenserecovery_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_GrantedOptionsShares_lbl1" xml:lang="en-US">Granted Options Shares</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_GrantedOptionsShares" xlink:to="cve_GrantedOptionsShares_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_TaxEffectOfTaxLosses_lbl0" xml:lang="en-US">Tax effect of tax losses</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_TaxEffectOfTaxLosses" xlink:to="ifrs-full_TaxEffectOfTaxLosses_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_AdministrativeExpense_lbl1" xml:lang="en-US">Administrative expenses</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AdministrativeExpense" xlink:to="ifrs-full_AdministrativeExpense_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_AcquiredAmonut_lbl1" xml:lang="en-US">Acquired Amonut</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_AcquiredAmonut" xlink:to="cve_AcquiredAmonut_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_AggregateOfGrantedShares_lbl1" xml:lang="en-US">Aggregate Of Granted Shares</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_AggregateOfGrantedShares" xlink:to="cve_AggregateOfGrantedShares_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_UnlabeledAbstract18_lbl0" xml:lang="en-US">Unlabeled Abstract18</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_UnlabeledAbstract18" xlink:to="cve_UnlabeledAbstract18_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_UnlabeledAbstract19_lbl0" xml:lang="en-US">Unlabeled Abstract19</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_UnlabeledAbstract19" xlink:to="cve_UnlabeledAbstract19_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_UnlabeledAbstract16_lbl0" xml:lang="en-US">Unlabeled Abstract16</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_UnlabeledAbstract16" xlink:to="cve_UnlabeledAbstract16_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_LeasedCopierMember_lbl0" xml:lang="en-US">Leased Copier Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_LeasedCopierMember" xlink:to="cve_LeasedCopierMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_UnlabeledAbstract17_lbl0" xml:lang="en-US">Unlabeled Abstract17</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_UnlabeledAbstract17" xlink:to="cve_UnlabeledAbstract17_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_ScheduleOfTheCompanysStockOptionsOutstandingTableTextBlock_lbl0" xml:lang="en-US">Schedule Of The Companys Stock Options Outstanding Table Text Block</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_ScheduleOfTheCompanysStockOptionsOutstandingTableTextBlock" xlink:to="cve_ScheduleOfTheCompanysStockOptionsOutstandingTableTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_IntangibleAssets_lbl1" xml:lang="en-US">Intangible Assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_IntangibleAssets" xlink:to="cve_IntangibleAssets_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForAvailableforsaleFinancialAssetsExplanatory_lbl0" xml:lang="en-US">Description of accounting policy for available-for-sale financial assets [text block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DescriptionOfAccountingPolicyForAvailableforsaleFinancialAssetsExplanatory" xlink:to="ifrs-full_DescriptionOfAccountingPolicyForAvailableforsaleFinancialAssetsExplanatory_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_DivestmentAbstract0_lbl0" xml:lang="en-US">Divestment Abstract0</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_DivestmentAbstract0" xlink:to="cve_DivestmentAbstract0_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_SalesContractsFiscalTwoZeroTwoSix_lbl1" xml:lang="en-US">Sales Contracts Fiscal Two Zero Two Six</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_SalesContractsFiscalTwoZeroTwoSix" xlink:to="cve_SalesContractsFiscalTwoZeroTwoSix_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_Warrants_lbl1" xml:lang="en-US">Warrants</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_Warrants" xlink:to="cve_Warrants_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_ExpensesCurrent_lbl0" xml:lang="en-US">Expenses Current</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_ExpensesCurrent" xlink:to="cve_ExpensesCurrent_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_AcquisitionCostsAbstract_lbl0" xml:lang="en-US">Acquisition Costs Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_AcquisitionCostsAbstract" xlink:to="cve_AcquisitionCostsAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_AverageForeignExchangeRate_lbl0" xml:lang="en-US">Average foreign exchange rate</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AverageForeignExchangeRate" xlink:to="ifrs-full_AverageForeignExchangeRate_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_RevenueFromInterest_lbl0" xml:lang="en-US">Interest income</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_RevenueFromInterest" xlink:to="ifrs-full_RevenueFromInterest_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_DisclosureOfAssetRetirementObligationsBalanceTableTextBlock_lbl1" xml:lang="en-US">Disclosure Of Asset Retirement Obligations Balance Table Text Block</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_DisclosureOfAssetRetirementObligationsBalanceTableTextBlock" xlink:to="cve_DisclosureOfAssetRetirementObligationsBalanceTableTextBlock_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_UnlabeledAbstract21_lbl0" xml:lang="en-US">Unlabeled Abstract21</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_UnlabeledAbstract21" xlink:to="cve_UnlabeledAbstract21_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_InvestmentInterestRates_lbl0" xml:lang="en-US">Investment Interest Rates</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_InvestmentInterestRates" xlink:to="cve_InvestmentInterestRates_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_UnlabeledAbstract22_lbl0" xml:lang="en-US">Unlabeled Abstract22</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_UnlabeledAbstract22" xlink:to="cve_UnlabeledAbstract22_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_GainsOnDisposalsOfInvestmentProperties_lbl0" xml:lang="en-US">Gains on disposals of investment properties</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_GainsOnDisposalsOfInvestmentProperties" xlink:to="ifrs-full_GainsOnDisposalsOfInvestmentProperties_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_UnlabeledAbstract20_lbl0" xml:lang="en-US">Unlabeled Abstract20</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_UnlabeledAbstract20" xlink:to="cve_UnlabeledAbstract20_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_YearEndedDecember312022Abstract_lbl0" xml:lang="en-US">Year Ended December312022 Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_YearEndedDecember312022Abstract" xlink:to="cve_YearEndedDecember312022Abstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_UnlabeledAbstract25_lbl0" xml:lang="en-US">Unlabeled Abstract25</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_UnlabeledAbstract25" xlink:to="cve_UnlabeledAbstract25_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_UnlabeledAbstract26_lbl0" xml:lang="en-US">Unlabeled Abstract26</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_UnlabeledAbstract26" xlink:to="cve_UnlabeledAbstract26_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_WarrantsOfFairValue_lbl1" xml:lang="en-US">Warrants Of Fair Value</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_WarrantsOfFairValue" xlink:to="cve_WarrantsOfFairValue_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_UnlabeledAbstract23_lbl0" xml:lang="en-US">Unlabeled Abstract23</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_UnlabeledAbstract23" xlink:to="cve_UnlabeledAbstract23_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_UnlabeledAbstract24_lbl0" xml:lang="en-US">Unlabeled Abstract24</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_UnlabeledAbstract24" xlink:to="cve_UnlabeledAbstract24_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_FinancialLiabilitiesAtFairValue_lbl0" xml:lang="en-US">Financial liabilities, at fair value</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_FinancialLiabilitiesAtFairValue" xlink:to="ifrs-full_FinancialLiabilitiesAtFairValue_lbl0"/>
    <loc xlink:type="locator" xlink:label="cve_AssetRetirementObligationsAbstract" xlink:href="cve-20221231.xsd#cve_AssetRetirementObligationsAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_AssetRetirementObligationsAbstract_lbl" xml:lang="en-US">Asset Retirement Obligations Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_AssetRetirementObligationsAbstract" xlink:to="cve_AssetRetirementObligationsAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_OtherComprehensiveIncomeNetOfTaxChangeInValueOfForeignCurrencyBasisSpreads_lbl0" xml:lang="en-US">Other comprehensive income, net of tax, change in value of foreign currency basis spreads</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_OtherComprehensiveIncomeNetOfTaxChangeInValueOfForeignCurrencyBasisSpreads" xlink:to="ifrs-full_OtherComprehensiveIncomeNetOfTaxChangeInValueOfForeignCurrencyBasisSpreads_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_AdvancedAmount_lbl1" xml:lang="en-US">Advanced Amount</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_AdvancedAmount" xlink:to="cve_AdvancedAmount_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_NumberOfSharesOutstanding_lbl2" xml:lang="en-US">Number of shares outstanding</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NumberOfSharesOutstanding" xlink:to="ifrs-full_NumberOfSharesOutstanding_lbl2"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_LossOnContractTerminations_lbl1" xml:lang="en-US">Loss On Contract Terminations</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_LossOnContractTerminations" xlink:to="cve_LossOnContractTerminations_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_ReplacementWarrantsForAzargaAssetAcquisition_lbl1" xml:lang="en-US">Replacement Warrants For Azarga Asset Acquisition</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_ReplacementWarrantsForAzargaAssetAcquisition" xlink:to="cve_ReplacementWarrantsForAzargaAssetAcquisition_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_TigrisUraniumUSCorpMember_lbl0" xml:lang="en-US">Tigris Uranium USCorp Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_TigrisUraniumUSCorpMember" xlink:to="cve_TigrisUraniumUSCorpMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_AzargaResourcesHongKongLtdMember_lbl0" xml:lang="en-US">Azarga Resources Hong Kong Ltd Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_AzargaResourcesHongKongLtdMember" xlink:to="cve_AzargaResourcesHongKongLtdMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_UnrealizedGainOnMarketableSecurities_lbl1" xml:lang="en-US">Unrealized Gain On Marketable Securities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_UnrealizedGainOnMarketableSecurities" xlink:to="cve_UnrealizedGainOnMarketableSecurities_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfReclassificationsOrChangesInPresentationExplanatory_lbl0" xml:lang="en-US">Disclosure of reclassifications or changes in presentation [text block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfReclassificationsOrChangesInPresentationExplanatory" xlink:to="ifrs-full_DisclosureOfReclassificationsOrChangesInPresentationExplanatory_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_TransactionCosts_lbl2" xml:lang="en-US">Transaction Costs</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_TransactionCosts" xlink:to="cve_TransactionCosts_lbl2"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_MetaminEnterprisesUSIncMember_lbl0" xml:lang="en-US">Metamin Enterprises USInc Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_MetaminEnterprisesUSIncMember" xlink:to="cve_MetaminEnterprisesUSIncMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_FinancingActivitiesAbstract_lbl0" xml:lang="en-US">Financing Activities Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_FinancingActivitiesAbstract" xlink:to="cve_FinancingActivitiesAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForImpairmentOfFinancialAssetsExplanatory_lbl0" xml:lang="en-US">Description of accounting policy for impairment of financial assets [text block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DescriptionOfAccountingPolicyForImpairmentOfFinancialAssetsExplanatory" xlink:to="ifrs-full_DescriptionOfAccountingPolicyForImpairmentOfFinancialAssetsExplanatory_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_CurrentLeaseLiabilities_lbl0" xml:lang="en-US">Current lease liabilities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CurrentLeaseLiabilities" xlink:to="ifrs-full_CurrentLeaseLiabilities_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_CashIssuanceCosts_lbl1" xml:lang="en-US">Cash Issuance Costs</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_CashIssuanceCosts" xlink:to="cve_CashIssuanceCosts_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_URIIncMember_lbl0" xml:lang="en-US">URIInc Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_URIIncMember" xlink:to="cve_URIIncMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DescriptionOfAccountingPolicyToDetermineComponentsOfCashAndCashEquivalents_lbl0" xml:lang="en-US">Description of accounting policy for determining components of cash and cash equivalents [text block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DescriptionOfAccountingPolicyToDetermineComponentsOfCashAndCashEquivalents" xlink:to="ifrs-full_DescriptionOfAccountingPolicyToDetermineComponentsOfCashAndCashEquivalents_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_SharesIssuedForAzargaAssetAcquisition_lbl1" xml:lang="en-US">Shares Issued For Azarga Asset Acquisition</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_SharesIssuedForAzargaAssetAcquisition" xlink:to="cve_SharesIssuedForAzargaAssetAcquisition_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptionsWarrantsOutstanding_lbl2" xml:lang="en-US">Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Outstanding Options Warrants Outstanding</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptionsWarrantsOutstanding" xlink:to="cve_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptionsWarrantsOutstanding_lbl2"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_DeferredTaxExpenseRecoveryAbstract_lbl0" xml:lang="en-US">Deferred Tax Expense Recovery Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_DeferredTaxExpenseRecoveryAbstract" xlink:to="cve_DeferredTaxExpenseRecoveryAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_InvestmentBalance1_lbl1" xml:lang="en-US">Investment Balance1</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_InvestmentBalance1" xlink:to="cve_InvestmentBalance1_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_ReplacementOptionsForAzargaAssetAcquisition_lbl1" xml:lang="en-US">Replacement Options For Azarga Asset Acquisition</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_ReplacementOptionsForAzargaAssetAcquisition" xlink:to="cve_ReplacementOptionsForAzargaAssetAcquisition_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_UnlabeledAbstract10_lbl0" xml:lang="en-US">Unlabeled Abstract10</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_UnlabeledAbstract10" xlink:to="cve_UnlabeledAbstract10_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_UnlabeledAbstract11_lbl0" xml:lang="en-US">Unlabeled Abstract11</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_UnlabeledAbstract11" xlink:to="cve_UnlabeledAbstract11_lbl0"/>
    <loc xlink:type="locator" xlink:label="cve_ScheduleOfUsefulLivesOfIntangibleAssetsAbstract" xlink:href="cve-20221231.xsd#cve_ScheduleOfUsefulLivesOfIntangibleAssetsAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_ScheduleOfUsefulLivesOfIntangibleAssetsAbstract_lbl" xml:lang="en-US">Schedule Of Useful Lives Of Intangible Assets Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_ScheduleOfUsefulLivesOfIntangibleAssetsAbstract" xlink:to="cve_ScheduleOfUsefulLivesOfIntangibleAssetsAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_UnlabeledAbstract14_lbl0" xml:lang="en-US">Unlabeled Abstract14</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_UnlabeledAbstract14" xlink:to="cve_UnlabeledAbstract14_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_UnlabeledAbstract15_lbl0" xml:lang="en-US">Unlabeled Abstract15</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_UnlabeledAbstract15" xlink:to="cve_UnlabeledAbstract15_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_UnlabeledAbstract12_lbl0" xml:lang="en-US">Unlabeled Abstract12</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_UnlabeledAbstract12" xlink:to="cve_UnlabeledAbstract12_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_UnlabeledAbstract13_lbl0" xml:lang="en-US">Unlabeled Abstract13</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_UnlabeledAbstract13" xlink:to="cve_UnlabeledAbstract13_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_AdjustmentsForDeferredTaxExpense_lbl0" xml:lang="en-US">Adjustments for deferred tax expense</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AdjustmentsForDeferredTaxExpense" xlink:to="ifrs-full_AdjustmentsForDeferredTaxExpense_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_PropertyplantandequipmentTablesLineItems_lbl0" xml:lang="en-US">Propertyplantandequipment Tables Line Items</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_PropertyplantandequipmentTablesLineItems" xlink:to="cve_PropertyplantandequipmentTablesLineItems_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_FairValueOfReplacementWarrantsIssuedForAzargaAssetAcquisition_lbl1" xml:lang="en-US">Fair Value Of Replacement Warrants Issued For Azarga Asset Acquisition</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_FairValueOfReplacementWarrantsIssuedForAzargaAssetAcquisition" xlink:to="cve_FairValueOfReplacementWarrantsIssuedForAzargaAssetAcquisition_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory_lbl0" xml:lang="en-US">Disclosure of significant accounting policies [text block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory" xlink:to="ifrs-full_DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ExpectedDividendAsPercentageShareOptionsGranted_lbl0" xml:lang="en-US">Expected dividend as percentage, share options granted</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ExpectedDividendAsPercentageShareOptionsGranted" xlink:to="ifrs-full_ExpectedDividendAsPercentageShareOptionsGranted_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_DepositUraniumInvestment_lbl1" xml:lang="en-US">Deposit Uranium Investment</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_DepositUraniumInvestment" xlink:to="cve_DepositUraniumInvestment_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_NoncurrentAssets_lbl0" xml:lang="en-US">Non-current assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NoncurrentAssets" xlink:to="ifrs-full_NoncurrentAssets_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_AdjustmentsToCarryingValueAbstract_lbl0" xml:lang="en-US">Adjustments To Carrying Value Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_AdjustmentsToCarryingValueAbstract" xlink:to="cve_AdjustmentsToCarryingValueAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeLossAttributableToParent_lbl0" xml:lang="en-US">Income (Loss) Attributable to Parent, before Tax</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeLossAttributableToParent" xlink:to="us-gaap_IncomeLossAttributableToParent_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_MarketablesSecuritiesNoncurrent_lbl1" xml:lang="en-US">Marketables Securities Noncurrent</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_MarketablesSecuritiesNoncurrent" xlink:to="cve_MarketablesSecuritiesNoncurrent_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_TaxRateEffectOfForeignTaxRates_lbl0" xml:lang="en-US">Tax rate effect of foreign tax rates</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_TaxRateEffectOfForeignTaxRates" xlink:to="ifrs-full_TaxRateEffectOfForeignTaxRates_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForDerecognitionOfFinancialInstrumentsExplanatory_lbl0" xml:lang="en-US">Description of accounting policy for derecognition of financial instruments [text block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DescriptionOfAccountingPolicyForDerecognitionOfFinancialInstrumentsExplanatory" xlink:to="ifrs-full_DescriptionOfAccountingPolicyForDerecognitionOfFinancialInstrumentsExplanatory_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_UnlabeledAbstract2_lbl0" xml:lang="en-US">Unlabeled Abstract2</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_UnlabeledAbstract2" xlink:to="cve_UnlabeledAbstract2_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DescriptionOfExpectedVolatilityShareOptionsGranted_lbl1" xml:lang="en-US">Expected volatility, share options granted</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DescriptionOfExpectedVolatilityShareOptionsGranted" xlink:to="ifrs-full_DescriptionOfExpectedVolatilityShareOptionsGranted_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_UnlabeledAbstract1_lbl0" xml:lang="en-US">Unlabeled Abstract1</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_UnlabeledAbstract1" xlink:to="cve_UnlabeledAbstract1_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ProceedsFromExerciseOfWarrants_lbl1" xml:lang="en-US">Proceeds from exercise of warrants</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ProceedsFromExerciseOfWarrants" xlink:to="ifrs-full_ProceedsFromExerciseOfWarrants_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_FairValueOfCommonSharesIssuedForAzargaAssetAcquisition_lbl1" xml:lang="en-US">Fair Value Of Common Shares Issued For Azarga Asset Acquisition</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_FairValueOfCommonSharesIssuedForAzargaAssetAcquisition" xlink:to="cve_FairValueOfCommonSharesIssuedForAzargaAssetAcquisition_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_UnlabeledAbstract4_lbl0" xml:lang="en-US">Unlabeled Abstract4</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_UnlabeledAbstract4" xlink:to="cve_UnlabeledAbstract4_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_UnlabeledAbstract3_lbl0" xml:lang="en-US">Unlabeled Abstract3</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_UnlabeledAbstract3" xlink:to="cve_UnlabeledAbstract3_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_UnlabeledAbstract0_lbl0" xml:lang="en-US">Unlabeled Abstract0</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_UnlabeledAbstract0" xlink:to="cve_UnlabeledAbstract0_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_UnlabeledAbstract9_lbl0" xml:lang="en-US">Unlabeled Abstract9</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_UnlabeledAbstract9" xlink:to="cve_UnlabeledAbstract9_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_UnlabeledAbstract6_lbl0" xml:lang="en-US">Unlabeled Abstract6</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_UnlabeledAbstract6" xlink:to="cve_UnlabeledAbstract6_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DepreciationExpense_lbl0" xml:lang="en-US">Depreciation expense</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DepreciationExpense" xlink:to="ifrs-full_DepreciationExpense_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_UnlabeledAbstract5_lbl0" xml:lang="en-US">Unlabeled Abstract5</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_UnlabeledAbstract5" xlink:to="cve_UnlabeledAbstract5_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_UnlabeledAbstract8_lbl0" xml:lang="en-US">Unlabeled Abstract8</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_UnlabeledAbstract8" xlink:to="cve_UnlabeledAbstract8_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_OtherCurrentPayables_lbl0" xml:lang="en-US">Other current payables</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_OtherCurrentPayables" xlink:to="ifrs-full_OtherCurrentPayables_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_UnlabeledAbstract7_lbl0" xml:lang="en-US">Unlabeled Abstract7</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_UnlabeledAbstract7" xlink:to="cve_UnlabeledAbstract7_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_PurchaseOfInvestmentProperty_lbl0" xml:lang="en-US">Purchase of investment property</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_PurchaseOfInvestmentProperty" xlink:to="ifrs-full_PurchaseOfInvestmentProperty_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ProceedsFromSalesOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities_lbl1" xml:lang="en-US">Proceeds from sales of property, plant and equipment, classified as investing activities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ProceedsFromSalesOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities" xlink:to="ifrs-full_ProceedsFromSalesOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities_lbl1"/>
    <loc xlink:type="locator" xlink:label="cve_ScheduleOfUsefulLivesOfPropertyPlantAndEquipementAbstract" xlink:href="cve-20221231.xsd#cve_ScheduleOfUsefulLivesOfPropertyPlantAndEquipementAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_ScheduleOfUsefulLivesOfPropertyPlantAndEquipementAbstract_lbl" xml:lang="en-US">Schedule Of Useful Lives Of Property Plant And Equipement Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_ScheduleOfUsefulLivesOfPropertyPlantAndEquipementAbstract" xlink:to="cve_ScheduleOfUsefulLivesOfPropertyPlantAndEquipementAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_DisclosureOfClassesOfShareCapitalTextBlockAbstract" xlink:href="cve-20221231.xsd#cve_DisclosureOfClassesOfShareCapitalTextBlockAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_DisclosureOfClassesOfShareCapitalTextBlockAbstract_lbl" xml:lang="en-US">Disclosure Of Classes Of Share Capital Text Block Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_DisclosureOfClassesOfShareCapitalTextBlockAbstract" xlink:to="cve_DisclosureOfClassesOfShareCapitalTextBlockAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_DescriptionOfAccountingPolicyForUraniumPlantstextBlock_lbl1" xml:lang="en-US">Description Of Accounting Policy For Uranium Plantstext Block</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_DescriptionOfAccountingPolicyForUraniumPlantstextBlock" xlink:to="cve_DescriptionOfAccountingPolicyForUraniumPlantstextBlock_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_AssetRetirementObligationsSettlement_lbl1" xml:lang="en-US">Asset Retirement Obligations Settlement</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_AssetRetirementObligationsSettlement" xlink:to="cve_AssetRetirementObligationsSettlement_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_ShareIssued_lbl1" xml:lang="en-US">Share Issued</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_ShareIssued" xlink:to="cve_ShareIssued_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_RepaymentsOfBorrowingsClassifiedAsFinancingActivities_lbl0" xml:lang="en-US">Repayments of borrowings, classified as financing activities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_RepaymentsOfBorrowingsClassifiedAsFinancingActivities" xlink:to="ifrs-full_RepaymentsOfBorrowingsClassifiedAsFinancingActivities_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_BusinessContactMember_lbl0" xml:lang="en-US">Business Contact [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_BusinessContactMember" xlink:to="dei_BusinessContactMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_OperatingActivitiesAbstract_lbl0" xml:lang="en-US">Operating Activities Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_OperatingActivitiesAbstract" xlink:to="cve_OperatingActivitiesAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_Accretion_lbl1" xml:lang="en-US">Accretion</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_Accretion" xlink:to="cve_Accretion_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_DisclosureOfProportionalShareAssociatesExplanatory_lbl1" xml:lang="en-US">Disclosure Of Proportional Share Associates Explanatory</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_DisclosureOfProportionalShareAssociatesExplanatory" xlink:to="cve_DisclosureOfProportionalShareAssociatesExplanatory_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_ExpensesAbstract_lbl0" xml:lang="en-US">Expenses Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_ExpensesAbstract" xlink:to="cve_ExpensesAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_DescriptionOfAccountingPolicyForMineralPropertiestextBlock_lbl1" xml:lang="en-US">Description Of Accounting Policy For Mineral Propertiestext Block</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_DescriptionOfAccountingPolicyForMineralPropertiestextBlock" xlink:to="cve_DescriptionOfAccountingPolicyForMineralPropertiestextBlock_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CurrentFiscalYearEndDate_lbl0" xml:lang="en-US">Current Fiscal Year End Date</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CurrentFiscalYearEndDate" xlink:to="dei_CurrentFiscalYearEndDate_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_BeltLineResourcesIncMember_lbl0" xml:lang="en-US">Belt Line Resources Inc Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_BeltLineResourcesIncMember" xlink:to="cve_BeltLineResourcesIncMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_OtherCashAndCashEquivalents_lbl0" xml:lang="en-US">Other cash and cash equivalents</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_OtherCashAndCashEquivalents" xlink:to="ifrs-full_OtherCashAndCashEquivalents_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019_lbl0" xml:lang="en-US">Weighted average exercise price of share options exercisable in share-based payment arrangement</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019" xlink:to="ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_FederalNetOperatingLossCarryforwards_lbl1" xml:lang="en-US">Federal Net Operating Loss Carryforwards</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_FederalNetOperatingLossCarryforwards" xlink:to="cve_FederalNetOperatingLossCarryforwards_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_UnlabeledAbstract_lbl0" xml:lang="en-US">Unlabeled Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_UnlabeledAbstract" xlink:to="cve_UnlabeledAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForWarrantsExplanatory_lbl0" xml:lang="en-US">Description of accounting policy for warrants [text block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DescriptionOfAccountingPolicyForWarrantsExplanatory" xlink:to="ifrs-full_DescriptionOfAccountingPolicyForWarrantsExplanatory_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_PurchaseCommitments_lbl1" xml:lang="en-US">Purchase Commitments</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_PurchaseCommitments" xlink:to="cve_PurchaseCommitments_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_ScheduleOfSharePurchaseWarrantsOutstandingTableTextBlock_lbl0" xml:lang="en-US">Schedule Of Share Purchase Warrants Outstanding Table Text Block</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_ScheduleOfSharePurchaseWarrantsOutstandingTableTextBlock" xlink:to="cve_ScheduleOfSharePurchaseWarrantsOutstandingTableTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_ShareConsolidation_lbl1" xml:lang="en-US">Share Consolidation</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_ShareConsolidation" xlink:to="cve_ShareConsolidation_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_Right-of-UseAssetsTwoZeroTwoThree_lbl1" xml:lang="en-US">Right-of- Use Assets Two Zero Two Three</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_Right-of-UseAssetsTwoZeroTwoThree" xlink:to="cve_Right-of-UseAssetsTwoZeroTwoThree_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_OtherNoncurrentAssets_lbl0" xml:lang="en-US">Other non-current assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_OtherNoncurrentAssets" xlink:to="ifrs-full_OtherNoncurrentAssets_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_SalesContractsFiscalTwoZeroTwoFour_lbl1" xml:lang="en-US">Sales Contracts Fiscal Two Zero Two Four</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_SalesContractsFiscalTwoZeroTwoFour" xlink:to="cve_SalesContractsFiscalTwoZeroTwoFour_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_AcquiredShares_lbl1" xml:lang="en-US">Acquired Shares</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_AcquiredShares" xlink:to="cve_AcquiredShares_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_NoncurrentRestrictedCashAndCashEquivalents_lbl0" xml:lang="en-US">Non-current restricted cash and cash equivalents</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NoncurrentRestrictedCashAndCashEquivalents" xlink:to="ifrs-full_NoncurrentRestrictedCashAndCashEquivalents_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_GainOnDisposalOfSubsidiary_lbl3" xml:lang="en-US">Gain On Disposal Of Subsidiary</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_GainOnDisposalOfSubsidiary" xlink:to="cve_GainOnDisposalOfSubsidiary_lbl3"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AuditedAnnualFinancialStatements_lbl0" xml:lang="en-US">Audited Annual Financial Statements</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditedAnnualFinancialStatements" xlink:to="dei_AuditedAnnualFinancialStatements_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_OtherLiabilities_lbl0" xml:lang="en-US">Other liabilities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_OtherLiabilities" xlink:to="ifrs-full_OtherLiabilities_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019_lbl0" xml:lang="en-US">Weighted average exercise price of share options forfeited in share-based payment arrangement</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019" xlink:to="ifrs-full_WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsOtherLossCarryforwards_lbl0" xml:lang="en-US">Deferred Tax Assets, Other Loss Carryforwards</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsOtherLossCarryforwards" xlink:to="us-gaap_DeferredTaxAssetsOtherLossCarryforwards_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_SegmentedinformationTablesLineItems_lbl0" xml:lang="en-US">Segmentedinformation Tables Line Items</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_SegmentedinformationTablesLineItems" xlink:to="cve_SegmentedinformationTablesLineItems_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_TotalDiscountedMarketPrices_lbl1" xml:lang="en-US">Total Discounted Market Prices</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_TotalDiscountedMarketPrices" xlink:to="cve_TotalDiscountedMarketPrices_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_GainsOnDisposalsOfInvestments_lbl1" xml:lang="en-US">Gains on disposals of investments</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_GainsOnDisposalsOfInvestments" xlink:to="ifrs-full_GainsOnDisposalsOfInvestments_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_DisclosureOfChangeInTheLongTermLeaseLiabilityTableTextBlock_lbl1" xml:lang="en-US">Disclosure Of Change In The Long Term Lease Liability Table Text Block</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_DisclosureOfChangeInTheLongTermLeaseLiabilityTableTextBlock" xlink:to="cve_DisclosureOfChangeInTheLongTermLeaseLiabilityTableTextBlock_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_TaxRateEffectFromChangeInTaxRate_lbl0" xml:lang="en-US">Tax rate effect from change in tax rate</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_TaxRateEffectFromChangeInTaxRate" xlink:to="ifrs-full_TaxRateEffectFromChangeInTaxRate_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_ExpensesNoncurrent_lbl0" xml:lang="en-US">Expenses Noncurrent</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_ExpensesNoncurrent" xlink:to="cve_ExpensesNoncurrent_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_OtherStatesMember_lbl0" xml:lang="en-US">Other States Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_OtherStatesMember" xlink:to="cve_OtherStatesMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate_lbl0" xml:lang="en-US">Property, plant and equipment recognised as of acquisition date</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate" xlink:to="ifrs-full_PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_MaintenancesAndLeaseFees_lbl1" xml:lang="en-US">Maintenances And Lease Fees</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_MaintenancesAndLeaseFees" xlink:to="cve_MaintenancesAndLeaseFees_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_AmortisationIntangibleAssetsOtherThanGoodwill_lbl0" xml:lang="en-US">Amortisation, intangible assets other than goodwill</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AmortisationIntangibleAssetsOtherThanGoodwill" xlink:to="ifrs-full_AmortisationIntangibleAssetsOtherThanGoodwill_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_GrossProceeds_lbl1" xml:lang="en-US">Gross Proceeds</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_GrossProceeds" xlink:to="cve_GrossProceeds_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressPostalZipCode_lbl0" xml:lang="en-US">Entity Address, Postal Zip Code</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment_lbl0" xml:lang="en-US">Additions other than through business combinations, property, plant and equipment</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment" xlink:to="ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_BasicEarningsLossPerShare_lbl1" xml:lang="en-US">Basic earnings (loss) per share</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_BasicEarningsLossPerShare" xlink:to="ifrs-full_BasicEarningsLossPerShare_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_IdentifiableAssetsAcquiredLiabilitiesAssumed_lbl0" xml:lang="en-US">Identifiable assets acquired (liabilities assumed)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_IdentifiableAssetsAcquiredLiabilitiesAssumed" xlink:to="ifrs-full_IdentifiableAssetsAcquiredLiabilitiesAssumed_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_AssetsAbstract_lbl0" xml:lang="en-US">Assets [abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AssetsAbstract" xlink:to="ifrs-full_AssetsAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_LongtermDeposits_lbl1" xml:lang="en-US">Long-term deposits</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_LongtermDeposits" xlink:to="ifrs-full_LongtermDeposits_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_SupplementalDisclosureWithRespectToCashflowsTextBlock_lbl0" xml:lang="en-US">Supplemental Disclosure With Respect To Cashflows Text Block</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_SupplementalDisclosureWithRespectToCashflowsTextBlock" xlink:to="cve_SupplementalDisclosureWithRespectToCashflowsTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_HostaButteMember_lbl0" xml:lang="en-US">Hosta Butte Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_HostaButteMember" xlink:to="cve_HostaButteMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_SharesIssuedForExerciseOfWarrantsShares_lbl1" xml:lang="en-US">Shares Issued For Exercise Of Warrants Shares</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_SharesIssuedForExerciseOfWarrantsShares" xlink:to="cve_SharesIssuedForExerciseOfWarrantsShares_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_WarrantsExercisableOfCommonShare_lbl1" xml:lang="en-US">Warrants Exercisable Of Common Share</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_WarrantsExercisableOfCommonShare" xlink:to="cve_WarrantsExercisableOfCommonShare_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019_lbl0" xml:lang="en-US">Weighted average exercise price of share options exercised in share-based payment arrangement</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019" xlink:to="ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_CurrentAssets_lbl1" xml:lang="en-US">Current assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CurrentAssets" xlink:to="ifrs-full_CurrentAssets_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_SharesBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_lbl1" xml:lang="en-US">Shares Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_SharesBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:to="cve_SharesBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_TotalConsiderationPerShare_lbl1" xml:lang="en-US">Total Consideration Per Share</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_TotalConsiderationPerShare" xlink:to="cve_TotalConsiderationPerShare_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_TradingSymbol_lbl0" xml:lang="en-US">Trading Symbol</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl0"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfQuantitativeInformationAboutLeasesForLesseeAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_DisclosureOfQuantitativeInformationAboutLeasesForLesseeAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfQuantitativeInformationAboutLeasesForLesseeAbstract_lbl" xml:lang="en-US">Disclosure of quantitative information about leases for lessee [abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfQuantitativeInformationAboutLeasesForLesseeAbstract" xlink:to="ifrs-full_DisclosureOfQuantitativeInformationAboutLeasesForLesseeAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfIncomeTaxExplanatory_lbl0" xml:lang="en-US">Disclosure of income tax [text block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfIncomeTaxExplanatory" xlink:to="ifrs-full_DisclosureOfIncomeTaxExplanatory_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ConsiderationPaidReceived_lbl1" xml:lang="en-US">Consideration paid (received)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ConsiderationPaidReceived" xlink:to="ifrs-full_ConsiderationPaidReceived_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisposalsInvestmentProperty_lbl0" xml:lang="en-US">Disposals, investment property</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisposalsInvestmentProperty" xlink:to="ifrs-full_DisposalsInvestmentProperty_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_TriStateGenerationAndTransmissionAssociationMember_lbl1" xml:lang="en-US">Tri State Generation And Transmission Association Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_TriStateGenerationAndTransmissionAssociationMember" xlink:to="cve_TriStateGenerationAndTransmissionAssociationMember_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_SharesBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_lbl2" xml:lang="en-US">Shares Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_SharesBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:to="cve_SharesBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_lbl2"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_AccountPayablesAndAccruedLiabilities_lbl0" xml:lang="en-US">Account Payables And Accrued Liabilities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_AccountPayablesAndAccruedLiabilities" xlink:to="cve_AccountPayablesAndAccruedLiabilities_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_DescriptionOfAccountingPolicyForBasisOfPresentationtextBlock_lbl1" xml:lang="en-US">Description Of Accounting Policy For Basis Of Presentationtext Block</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_DescriptionOfAccountingPolicyForBasisOfPresentationtextBlock" xlink:to="cve_DescriptionOfAccountingPolicyForBasisOfPresentationtextBlock_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodEndDate_lbl0" xml:lang="en-US">Document Period End Date</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_TopOfRangeMember_lbl0" xml:lang="en-US">Top of range [member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_TopOfRangeMember" xlink:to="ifrs-full_TopOfRangeMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_SaleOfUraniumInvestment_lbl1" xml:lang="en-US">Sale Of Uranium Investment</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_SaleOfUraniumInvestment" xlink:to="cve_SaleOfUraniumInvestment_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_ShareConsiderationAmount_lbl1" xml:lang="en-US">Share Consideration Amount</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_ShareConsiderationAmount" xlink:to="cve_ShareConsiderationAmount_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_NetForeignExchangeLoss_lbl0" xml:lang="en-US">Net foreign exchange loss</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NetForeignExchangeLoss" xlink:to="ifrs-full_NetForeignExchangeLoss_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_SubsequentEventTwoMember_lbl0" xml:lang="en-US">Subsequent Event Two Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_SubsequentEventTwoMember" xlink:to="cve_SubsequentEventTwoMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_NatureOfOperationAndGoingConcern_lbl1" xml:lang="en-US">Nature Of Operation And Going Concern</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_NatureOfOperationAndGoingConcern" xlink:to="cve_NatureOfOperationAndGoingConcern_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_RetainedEarningsMember_lbl0" xml:lang="en-US">Retained earnings [member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_RetainedEarningsMember" xlink:to="ifrs-full_RetainedEarningsMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_PrivatePlacement_lbl1" xml:lang="en-US">Private Placement</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_PrivatePlacement" xlink:to="cve_PrivatePlacement_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_CrownpointMember_lbl0" xml:lang="en-US">Crownpoint Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_CrownpointMember" xlink:to="cve_CrownpointMember_lbl0"/>
    <loc xlink:type="locator" xlink:label="cve_DisclosureOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethodTextBlockAbstract" xlink:href="cve-20221231.xsd#cve_DisclosureOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethodTextBlockAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_DisclosureOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethodTextBlockAbstract_lbl" xml:lang="en-US">Disclosure Of Investments Other Than Investments Accounted For Using Equity Method Text Block Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_DisclosureOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethodTextBlockAbstract" xlink:to="cve_DisclosureOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethodTextBlockAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_MarketableSecuritieReceivedOnDispositionOfMineralProperties_lbl1" xml:lang="en-US">Marketable Securitie Received On Disposition Of Mineral Properties</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_MarketableSecuritieReceivedOnDispositionOfMineralProperties" xlink:to="cve_MarketableSecuritieReceivedOnDispositionOfMineralProperties_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_VANEAgreementMember_lbl0" xml:lang="en-US">VANEAgreement Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_VANEAgreementMember" xlink:to="cve_VANEAgreementMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAnnualReport_lbl0" xml:lang="en-US">Document Annual Report</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAnnualReport" xlink:to="dei_DocumentAnnualReport_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_ImpactedLoss_lbl1" xml:lang="en-US">Impacted Loss</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_ImpactedLoss" xlink:to="cve_ImpactedLoss_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_ResourceReview_lbl0" xml:lang="en-US">Resource Review</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_ResourceReview" xlink:to="cve_ResourceReview_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_StandardStockOptionVestingPercentage_lbl1" xml:lang="en-US">Standard Stock Option Vesting Percentage</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_StandardStockOptionVestingPercentage" xlink:to="cve_StandardStockOptionVestingPercentage_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_SubsequentEventOneMember_lbl1" xml:lang="en-US">Subsequent Event One Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_SubsequentEventOneMember" xlink:to="cve_SubsequentEventOneMember_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCityOrTown_lbl0" xml:lang="en-US">Entity Address, City or Town</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfInterestIncomeExplanatory_lbl0" xml:lang="en-US">Disclosure of interest income [text block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfInterestIncomeExplanatory" xlink:to="ifrs-full_DisclosureOfInterestIncomeExplanatory_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_AccretionExpenses_lbl1" xml:lang="en-US">Accretion Expenses</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_AccretionExpenses" xlink:to="cve_AccretionExpenses_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_AdjustmentsForUnrealisedForeignExchangeLossesGains_lbl0" xml:lang="en-US">Adjustments for unrealised foreign exchange losses (gains)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AdjustmentsForUnrealisedForeignExchangeLossesGains" xlink:to="ifrs-full_AdjustmentsForUnrealisedForeignExchangeLossesGains_lbl0"/>
    <loc xlink:type="locator" xlink:label="cve_ScheduleOfConsolidatedStatementsOfLossAndComprehensiveLossAbstract" xlink:href="cve-20221231.xsd#cve_ScheduleOfConsolidatedStatementsOfLossAndComprehensiveLossAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_ScheduleOfConsolidatedStatementsOfLossAndComprehensiveLossAbstract_lbl" xml:lang="en-US">Schedule Of Consolidated Statements Of Loss And Comprehensive Loss Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_ScheduleOfConsolidatedStatementsOfLossAndComprehensiveLossAbstract" xlink:to="cve_ScheduleOfConsolidatedStatementsOfLossAndComprehensiveLossAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DepositsFromBanks_lbl0" xml:lang="en-US">Deposits from banks</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DepositsFromBanks" xlink:to="ifrs-full_DepositsFromBanks_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_PurchaseAgreementsAmount_lbl2" xml:lang="en-US">Purchase Agreements Amount</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_PurchaseAgreementsAmount" xlink:to="cve_PurchaseAgreementsAmount_lbl2"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_NameofSubsidaryPrincipalActivity_lbl1" xml:lang="en-US">Nameof Subsidary Principal Activity</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_NameofSubsidaryPrincipalActivity" xlink:to="cve_NameofSubsidaryPrincipalActivity_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_AssetsLessCurrentLiabilities_lbl0" xml:lang="en-US">Assets less current liabilities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AssetsLessCurrentLiabilities" xlink:to="ifrs-full_AssetsLessCurrentLiabilities_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_StockIssuedDuringPeriodShareStockOptionsExercised_lbl1" xml:lang="en-US">Stock Issued During Period Share Stock Options Exercised</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_StockIssuedDuringPeriodShareStockOptionsExercised" xlink:to="cve_StockIssuedDuringPeriodShareStockOptionsExercised_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_InterestRateHold_lbl0" xml:lang="en-US">Interest Rate Hold</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_InterestRateHold" xlink:to="cve_InterestRateHold_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_AccumulatedOtherComprehensiveIncome_lbl0" xml:lang="en-US">Accumulated other comprehensive income</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AccumulatedOtherComprehensiveIncome" xlink:to="ifrs-full_AccumulatedOtherComprehensiveIncome_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_SharesBasedCompensationArrangementBySharesBasedPaymentAwardOptionsOutstandingPeriodIncreaseDecreaseWeightedAverageExercisePrice_lbl1" xml:lang="en-US">Shares Based Compensation Arrangement By Shares Based Payment Award Options Outstanding Period Increase Decrease Weighted Average Exercise Price</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_SharesBasedCompensationArrangementBySharesBasedPaymentAwardOptionsOutstandingPeriodIncreaseDecreaseWeightedAverageExercisePrice" xlink:to="cve_SharesBasedCompensationArrangementBySharesBasedPaymentAwardOptionsOutstandingPeriodIncreaseDecreaseWeightedAverageExercisePrice_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_OtherCurrentLiabilities_lbl0" xml:lang="en-US">Other current liabilities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_OtherCurrentLiabilities" xlink:to="ifrs-full_OtherCurrentLiabilities_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_URZEnergyCorpMember_lbl0" xml:lang="en-US">URZEnergy Corp Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_URZEnergyCorpMember" xlink:to="cve_URZEnergyCorpMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_ImpairmentCharges_lbl0" xml:lang="en-US">Impairment Charges</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_ImpairmentCharges" xlink:to="cve_ImpairmentCharges_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_Drilling_lbl0" xml:lang="en-US">Drilling</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_Drilling" xlink:to="cve_Drilling_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_InvestmentsInAssociates_lbl0" xml:lang="en-US">Investments in associates reported in separate financial statements</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_InvestmentsInAssociates" xlink:to="ifrs-full_InvestmentsInAssociates_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_WagesAndSalaries_lbl0" xml:lang="en-US">Wages and salaries</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_WagesAndSalaries" xlink:to="ifrs-full_WagesAndSalaries_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_CashFlowsUsedInObtainingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities_lbl0" xml:lang="en-US">Cash flows used in obtaining control of subsidiaries or other businesses, classified as investing activities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CashFlowsUsedInObtainingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities" xlink:to="ifrs-full_CashFlowsUsedInObtainingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_IncomeTaxExpenseContinuingOperations_lbl0" xml:lang="en-US">Tax expense (income)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_IncomeTaxExpenseContinuingOperations" xlink:to="ifrs-full_IncomeTaxExpenseContinuingOperations_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory_lbl0" xml:lang="en-US">Disclosure of detailed information about property, plant and equipment [text block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory" xlink:to="ifrs-full_DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory_lbl0"/>
    <loc xlink:type="locator" xlink:label="cve_ScheduleOfChangeInTheLongTermLeaseLiabilityAbstract" xlink:href="cve-20221231.xsd#cve_ScheduleOfChangeInTheLongTermLeaseLiabilityAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_ScheduleOfChangeInTheLongTermLeaseLiabilityAbstract_lbl" xml:lang="en-US">Schedule Of Change In The Long Term Lease Liability Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_ScheduleOfChangeInTheLongTermLeaseLiabilityAbstract" xlink:to="cve_ScheduleOfChangeInTheLongTermLeaseLiabilityAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_ImpairmentCharged_lbl0" xml:lang="en-US">Impairment Charged</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_ImpairmentCharged" xlink:to="cve_ImpairmentCharged_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_CentennialMember_lbl0" xml:lang="en-US">Centennial Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_CentennialMember" xlink:to="cve_CentennialMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_PrimeFuelsConsiderationPercentage_lbl1" xml:lang="en-US">Prime Fuels Consideration Percentage</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_PrimeFuelsConsiderationPercentage" xlink:to="cve_PrimeFuelsConsiderationPercentage_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressStateOrProvince_lbl0" xml:lang="en-US">Entity Address, State or Province</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_NoncurrentLiabilities_lbl0" xml:lang="en-US">Non-current liabilities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NoncurrentLiabilities" xlink:to="ifrs-full_NoncurrentLiabilities_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_AdjustmentsToCarryingValueAbstract0_lbl0" xml:lang="en-US">Adjustments To Carrying Value Abstract0</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_AdjustmentsToCarryingValueAbstract0" xlink:to="cve_AdjustmentsToCarryingValueAbstract0_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_WeightedAverageShares_lbl0" xml:lang="en-US">Weighted average number of ordinary shares used in calculating basic earnings per share</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_WeightedAverageShares" xlink:to="ifrs-full_WeightedAverageShares_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_PermittingLicensing_lbl0" xml:lang="en-US">Permitting Licensing</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_PermittingLicensing" xlink:to="cve_PermittingLicensing_lbl0"/>
    <loc xlink:type="locator" xlink:label="cve_ScheduleOfInvestmentInAssociateContinuityAbstract" xlink:href="cve-20221231.xsd#cve_ScheduleOfInvestmentInAssociateContinuityAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_ScheduleOfInvestmentInAssociateContinuityAbstract_lbl" xml:lang="en-US">Schedule Of Investment In Associate Continuity Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_ScheduleOfInvestmentInAssociateContinuityAbstract" xlink:to="cve_ScheduleOfInvestmentInAssociateContinuityAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_PropertyplantandequipmentTablesTable_lbl0" xml:lang="en-US">Propertyplantandequipment Tables Table</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_PropertyplantandequipmentTablesTable" xlink:to="cve_PropertyplantandequipmentTablesTable_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_FinancialAssets_lbl0" xml:lang="en-US">Financial assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_FinancialAssets" xlink:to="ifrs-full_FinancialAssets_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfFinancialInstrumentsExplanatory_lbl0" xml:lang="en-US">Disclosure of financial instruments [text block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfFinancialInstrumentsExplanatory" xlink:to="ifrs-full_DisclosureOfFinancialInstrumentsExplanatory_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_TotalConsiderationPerPounds_lbl1" xml:lang="en-US">Total Consideration Per Pounds</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_TotalConsiderationPerPounds" xlink:to="cve_TotalConsiderationPerPounds_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_RevenueFromRenderingOfInformationTechnologyConsultingServices_lbl0" xml:lang="en-US">Revenue from rendering of information technology consulting services</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_RevenueFromRenderingOfInformationTechnologyConsultingServices" xlink:to="ifrs-full_RevenueFromRenderingOfInformationTechnologyConsultingServices_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWarrantsExpired_lbl1" xml:lang="en-US">Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Warrants Expired</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWarrantsExpired" xlink:to="cve_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWarrantsExpired_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_UraniumResourcesIncMember_lbl0" xml:lang="en-US">Uranium Resources Inc Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_UraniumResourcesIncMember" xlink:to="cve_UraniumResourcesIncMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DescriptionOfManagingLiquidityRisk_lbl0" xml:lang="en-US">Disclosure of how entity manages liquidity risk [text block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DescriptionOfManagingLiquidityRisk" xlink:to="ifrs-full_DescriptionOfManagingLiquidityRisk_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_NumberOfSharesReservedInsurancePercentage_lbl1" xml:lang="en-US">Number Of Shares Reserved Insurance Percentage</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_NumberOfSharesReservedInsurancePercentage" xlink:to="cve_NumberOfSharesReservedInsurancePercentage_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ContingentConsiderationMember_lbl0" xml:lang="en-US">Contingent consideration [member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ContingentConsiderationMember" xlink:to="ifrs-full_ContingentConsiderationMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_PropertyPlantAndEquipmentAdditionIncludedInAccountsPayableAndAccruedLiabilities_lbl1" xml:lang="en-US">Property Plant And Equipment Addition Included In Accounts Payable And Accrued Liabilities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_PropertyPlantAndEquipmentAdditionIncludedInAccountsPayableAndAccruedLiabilities" xlink:to="cve_PropertyPlantAndEquipmentAdditionIncludedInAccountsPayableAndAccruedLiabilities_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_DivestmentAbstract_lbl0" xml:lang="en-US">Divestment Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_DivestmentAbstract" xlink:to="cve_DivestmentAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_ScenarioPreviouslyReportedMember_lbl0" xml:lang="en-US">Previously Reported [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_ScenarioPreviouslyReportedMember" xlink:to="srt_ScenarioPreviouslyReportedMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_WarrantsExercisablePrice_lbl1" xml:lang="en-US">Warrants Exercisable Price</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_WarrantsExercisablePrice" xlink:to="cve_WarrantsExercisablePrice_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_Long-TermLeaseLiabilityAccretion_lbl1" xml:lang="en-US">Long- Term Lease Liability Accretion</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_Long-TermLeaseLiabilityAccretion" xlink:to="cve_Long-TermLeaseLiabilityAccretion_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_Long-TermLeaseLiabilityLeasePaymentsMade_lbl1" xml:lang="en-US">Long- Term Lease Liability Lease Payments Made</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_Long-TermLeaseLiabilityLeasePaymentsMade" xlink:to="cve_Long-TermLeaseLiabilityLeasePaymentsMade_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_PlanAssetsAtFairValue_lbl1" xml:lang="en-US">Plan assets, at fair value</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_PlanAssetsAtFairValue" xlink:to="ifrs-full_PlanAssetsAtFairValue_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_SalesCommitmentsInPoundsAbstract_lbl0" xml:lang="en-US">Sales Commitments In Pounds Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_SalesCommitmentsInPoundsAbstract" xlink:to="cve_SalesCommitmentsInPoundsAbstract_lbl0"/>
    <loc xlink:type="locator" xlink:label="cve_ScheduleOfWeightedAverageAssumptionsUsedInTheBlackScholesOptionAbstract" xlink:href="cve-20221231.xsd#cve_ScheduleOfWeightedAverageAssumptionsUsedInTheBlackScholesOptionAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_ScheduleOfWeightedAverageAssumptionsUsedInTheBlackScholesOptionAbstract_lbl" xml:lang="en-US">Schedule Of Weighted Average Assumptions Used In The Black Scholes Option Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_ScheduleOfWeightedAverageAssumptionsUsedInTheBlackScholesOptionAbstract" xlink:to="cve_ScheduleOfWeightedAverageAssumptionsUsedInTheBlackScholesOptionAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_CurrentInvestments_lbl1" xml:lang="en-US">Current investments</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CurrentInvestments" xlink:to="ifrs-full_CurrentInvestments_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ForeignExchangeGain_lbl0" xml:lang="en-US">Foreign exchange gain</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ForeignExchangeGain" xlink:to="ifrs-full_ForeignExchangeGain_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_AdjustmentsForGainsLossesOnFairValueAdjustmentInvestmentProperty_lbl0" xml:lang="en-US">Adjustments for gains (losses) on fair value adjustment, investment property</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AdjustmentsForGainsLossesOnFairValueAdjustmentInvestmentProperty" xlink:to="ifrs-full_AdjustmentsForGainsLossesOnFairValueAdjustmentInvestmentProperty_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_FairValueOfReplacement_lbl1" xml:lang="en-US">Fair Value Of Replacement</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_FairValueOfReplacement" xlink:to="cve_FairValueOfReplacement_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation_lbl0" xml:lang="en-US">Other comprehensive income, net of tax, exchange differences on translation of foreign operations</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation" xlink:to="ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_PricePerShare_lbl1" xml:lang="en-US">Price Per Share</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_PricePerShare" xlink:to="cve_PricePerShare_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesExplanatory_lbl0" xml:lang="en-US">Disclosure of transactions between related parties [text block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesExplanatory" xlink:to="ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesExplanatory_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_GrantedPercentage_lbl0" xml:lang="en-US">Granted Percentage</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_GrantedPercentage" xlink:to="cve_GrantedPercentage_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="country_CA_lbl0" xml:lang="en-US">CANADA</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="country_CA" xlink:to="country_CA_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_TradingShares_lbl1" xml:lang="en-US">Trading Shares</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_TradingShares" xlink:to="cve_TradingShares_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_ExchangeRatio_lbl1" xml:lang="en-US">Exchange Ratio</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_ExchangeRatio" xlink:to="cve_ExchangeRatio_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForFinancialInstrumentsExplanatory_lbl0" xml:lang="en-US">Description of accounting policy for financial instruments [text block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DescriptionOfAccountingPolicyForFinancialInstrumentsExplanatory" xlink:to="ifrs-full_DescriptionOfAccountingPolicyForFinancialInstrumentsExplanatory_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_SignificantaccountingpoliciesLineItems_lbl0" xml:lang="en-US">Significantaccountingpolicies Line Items</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_SignificantaccountingpoliciesLineItems" xlink:to="cve_SignificantaccountingpoliciesLineItems_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_AssetRetirementObligationsAdjustments_lbl1" xml:lang="en-US">Asset Retirement Obligations Adjustments</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_AssetRetirementObligationsAdjustments" xlink:to="cve_AssetRetirementObligationsAdjustments_lbl1"/>
    <loc xlink:type="locator" xlink:label="cve_ScheduleOfIncomeTaxExpenseRecoveryAbstract" xlink:href="cve-20221231.xsd#cve_ScheduleOfIncomeTaxExpenseRecoveryAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_ScheduleOfIncomeTaxExpenseRecoveryAbstract_lbl" xml:lang="en-US">Schedule Of Income Tax Expense Recovery Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_ScheduleOfIncomeTaxExpenseRecoveryAbstract" xlink:to="cve_ScheduleOfIncomeTaxExpenseRecoveryAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_SharePurchaseWarrants_lbl1" xml:lang="en-US">Share Purchase Warrants</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_SharePurchaseWarrants" xlink:to="cve_SharePurchaseWarrants_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_NonCashFinancingActivitiesAbstract_lbl0" xml:lang="en-US">Non Cash Financing Activities Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_NonCashFinancingActivitiesAbstract" xlink:to="cve_NonCashFinancingActivitiesAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ProfessionalFeesExpense_lbl0" xml:lang="en-US">Professional fees expense</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ProfessionalFeesExpense" xlink:to="ifrs-full_ProfessionalFeesExpense_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfEffectOfChangesInForeignExchangeRatesExplanatory_lbl0" xml:lang="en-US">Disclosure of effect of changes in foreign exchange rates [text block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfEffectOfChangesInForeignExchangeRatesExplanatory" xlink:to="ifrs-full_DisclosureOfEffectOfChangesInForeignExchangeRatesExplanatory_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_AdjustmentsForCurrentTaxOfPriorPeriod_lbl0" xml:lang="en-US">Adjustments for current tax of prior periods</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AdjustmentsForCurrentTaxOfPriorPeriod" xlink:to="ifrs-full_AdjustmentsForCurrentTaxOfPriorPeriod_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_AltaMesaAcquisitionMember_lbl0" xml:lang="en-US">Alta Mesa Acquisition Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_AltaMesaAcquisitionMember" xlink:to="cve_AltaMesaAcquisitionMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_RightofuseAssets_lbl0" xml:lang="en-US">Right-of-use assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_RightofuseAssets" xlink:to="ifrs-full_RightofuseAssets_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ActuarialAssumptionOfDiscountRates_lbl0" xml:lang="en-US">Actuarial assumption of discount rates</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ActuarialAssumptionOfDiscountRates" xlink:to="ifrs-full_ActuarialAssumptionOfDiscountRates_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_GrantedStockOptions_lbl1" xml:lang="en-US">Granted Stock Options</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_GrantedStockOptions" xlink:to="cve_GrantedStockOptions_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForImpairmentOfNonfinancialAssetsExplanatory_lbl0" xml:lang="en-US">Description of accounting policy for impairment of non-financial assets [text block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DescriptionOfAccountingPolicyForImpairmentOfNonfinancialAssetsExplanatory" xlink:to="ifrs-full_DescriptionOfAccountingPolicyForImpairmentOfNonfinancialAssetsExplanatory_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfRelatedPartyExplanatory_lbl0" xml:lang="en-US">Disclosure of related party [text block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfRelatedPartyExplanatory" xlink:to="ifrs-full_DisclosureOfRelatedPartyExplanatory_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities_lbl0" xml:lang="en-US">Purchase of property, plant and equipment, classified as investing activities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities" xlink:to="ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DepreciationAndAmortisationExpense_lbl0" xml:lang="en-US">Depreciation and amortisation expense</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DepreciationAndAmortisationExpense" xlink:to="ifrs-full_DepreciationAndAmortisationExpense_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DescriptionOfRiskFreeInterestRateShareOptionsGranted_lbl0" xml:lang="en-US">Risk free interest rate, share options granted</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DescriptionOfRiskFreeInterestRateShareOptionsGranted" xlink:to="ifrs-full_DescriptionOfRiskFreeInterestRateShareOptionsGranted_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_CashAcquiredFromAzargaAssetAcquisition_lbl1" xml:lang="en-US">Cash Acquired From Azarga Asset Acquisition</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_CashAcquiredFromAzargaAssetAcquisition" xlink:to="cve_CashAcquiredFromAzargaAssetAcquisition_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_CriticalAccountingEstimatesAndJudgementsLineItems_lbl0" xml:lang="en-US">Critical Accounting Estimates And Judgements Line Items</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_CriticalAccountingEstimatesAndJudgementsLineItems" xlink:to="cve_CriticalAccountingEstimatesAndJudgementsLineItems_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_AssetretirementobligationsTablesLineItems_lbl0" xml:lang="en-US">Assetretirementobligations Tables Line Items</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_AssetretirementobligationsTablesLineItems" xlink:to="cve_AssetretirementobligationsTablesLineItems_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_ExpiringAmount_lbl1" xml:lang="en-US">Expiring Amount</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_ExpiringAmount" xlink:to="cve_ExpiringAmount_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_DataAccessAgreementMember_lbl0" xml:lang="en-US">Data Access Agreement Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_DataAccessAgreementMember" xlink:to="cve_DataAccessAgreementMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_ConsultingFees_lbl1" xml:lang="en-US">Consulting Fees</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_ConsultingFees" xlink:to="cve_ConsultingFees_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_EarningsPerShareAbstract_lbl0" xml:lang="en-US">Earnings per share [abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_EarningsPerShareAbstract" xlink:to="ifrs-full_EarningsPerShareAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_PlatoroWestIncMember_lbl0" xml:lang="en-US">Platoro West Inc Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_PlatoroWestIncMember" xlink:to="cve_PlatoroWestIncMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_TradeAndOtherCurrentPayables_lbl0" xml:lang="en-US">Trade and other current payables</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_TradeAndOtherCurrentPayables" xlink:to="ifrs-full_TradeAndOtherCurrentPayables_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentFlag_lbl0" xml:lang="en-US">Amendment Flag</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl0"/>
    <loc xlink:type="locator" xlink:label="cve_ScheduleOfEffectOfTranslationAbstract" xlink:href="cve-20221231.xsd#cve_ScheduleOfEffectOfTranslationAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_ScheduleOfEffectOfTranslationAbstract_lbl" xml:lang="en-US">Schedule Of Effect Of Translation Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_ScheduleOfEffectOfTranslationAbstract" xlink:to="cve_ScheduleOfEffectOfTranslationAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_AssetsLossFromOperatingExpenses_lbl1" xml:lang="en-US">Assets Loss From Operating Expenses</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_AssetsLossFromOperatingExpenses" xlink:to="cve_AssetsLossFromOperatingExpenses_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCentralIndexKey_lbl0" xml:lang="en-US">Entity Central Index Key</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_RightofuseAssetsRevaluationSurplus_lbl0" xml:lang="en-US">Right-of-use assets, revaluation surplus</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_RightofuseAssetsRevaluationSurplus" xlink:to="ifrs-full_RightofuseAssetsRevaluationSurplus_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_TwoTwoTwoThreeNineZeroOneMember_lbl0" xml:lang="en-US">Two Two Two Three Nine Zero One Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_TwoTwoTwoThreeNineZeroOneMember" xlink:to="cve_TwoTwoTwoThreeNineZeroOneMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ReclassificationAdjustmentsOnChangeInValueOfForwardElementsOfForwardContractsNetOfTax_lbl0" xml:lang="en-US">Reclassification adjustments on change in value of forward elements of forward contracts, net of tax</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ReclassificationAdjustmentsOnChangeInValueOfForwardElementsOfForwardContractsNetOfTax" xlink:to="ifrs-full_ReclassificationAdjustmentsOnChangeInValueOfForwardElementsOfForwardContractsNetOfTax_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities_lbl0" xml:lang="en-US">Payments of lease liabilities, classified as financing activities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities" xlink:to="ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_lbl0" xml:lang="en-US">Foreign Currency Transactions and Translations Policy [Policy Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:to="us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_SubsequentEventFourMember_lbl0" xml:lang="en-US">Subsequent Event Four Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_SubsequentEventFourMember" xlink:to="cve_SubsequentEventFourMember_lbl0"/>
    <loc xlink:type="locator" xlink:label="cve_DisclosureOfMineralPropertiesAbstract" xlink:href="cve-20221231.xsd#cve_DisclosureOfMineralPropertiesAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_DisclosureOfMineralPropertiesAbstract_lbl" xml:lang="en-US">Disclosure Of Mineral Properties Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_DisclosureOfMineralPropertiesAbstract" xlink:to="cve_DisclosureOfMineralPropertiesAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DefinedBenefitObligationAtPresentValue_lbl0" xml:lang="en-US">Defined benefit obligation, at present value</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DefinedBenefitObligationAtPresentValue" xlink:to="ifrs-full_DefinedBenefitObligationAtPresentValue_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_SalesContractsTrem_lbl1" xml:lang="en-US">Sales Contracts Trem</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_SalesContractsTrem" xlink:to="cve_SalesContractsTrem_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_CommonSharesIssued_lbl0" xml:lang="en-US">Common Shares Issued</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_CommonSharesIssued" xlink:to="cve_CommonSharesIssued_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfDeferredTaxesExplanatory_lbl0" xml:lang="en-US">Disclosure of deferred taxes [text block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfDeferredTaxesExplanatory" xlink:to="ifrs-full_DisclosureOfDeferredTaxesExplanatory_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ProceedsFromIssuingShares_lbl0" xml:lang="en-US">Proceeds from issuing shares</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ProceedsFromIssuingShares" xlink:to="ifrs-full_ProceedsFromIssuingShares_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_PhysicalUranium_lbl1" xml:lang="en-US">Physical Uranium</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_PhysicalUranium" xlink:to="cve_PhysicalUranium_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_AdjustmentToInvestmentInAssociate_lbl1" xml:lang="en-US">Adjustment To Investment In Associate</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_AdjustmentToInvestmentInAssociate" xlink:to="cve_AdjustmentToInvestmentInAssociate_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_ScheduleOfMineralProperties_lbl0" xml:lang="en-US">Schedule Of Mineral Properties</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_ScheduleOfMineralProperties" xlink:to="cve_ScheduleOfMineralProperties_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_SoftwareMember_lbl0" xml:lang="en-US">Software Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_SoftwareMember" xlink:to="cve_SoftwareMember_lbl0"/>
    <loc xlink:type="locator" xlink:label="cve_ScheduleOfDeferredTaxLiabilitiesAbstract" xlink:href="cve-20221231.xsd#cve_ScheduleOfDeferredTaxLiabilitiesAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_ScheduleOfDeferredTaxLiabilitiesAbstract_lbl" xml:lang="en-US">Schedule Of Deferred Tax Liabilities Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_ScheduleOfDeferredTaxLiabilitiesAbstract" xlink:to="cve_ScheduleOfDeferredTaxLiabilitiesAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="cve_ScheduleOfUraniumConcentratesPurchaseAgreementAbstract" xlink:href="cve-20221231.xsd#cve_ScheduleOfUraniumConcentratesPurchaseAgreementAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_ScheduleOfUraniumConcentratesPurchaseAgreementAbstract_lbl" xml:lang="en-US">Schedule Of Uranium Concentrates Purchase Agreement Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_ScheduleOfUraniumConcentratesPurchaseAgreementAbstract" xlink:to="cve_ScheduleOfUraniumConcentratesPurchaseAgreementAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_ConsiderationReceived_lbl0" xml:lang="en-US">Consideration Received</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_ConsiderationReceived" xlink:to="cve_ConsiderationReceived_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_ExplorationCostsAbstract_lbl0" xml:lang="en-US">Exploration Costs Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_ExplorationCostsAbstract" xlink:to="cve_ExplorationCostsAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_CurrencyTranslationAdjustment1_lbl1" xml:lang="en-US">Currency Translation Adjustment1</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_CurrencyTranslationAdjustment1" xlink:to="cve_CurrencyTranslationAdjustment1_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_StockOptionsRevisedTerm_lbl1" xml:lang="en-US">Stock Options Revised Term</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_StockOptionsRevisedTerm" xlink:to="cve_StockOptionsRevisedTerm_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_WarrantsOutstandingWeightedAverageExercisePrice_lbl1" xml:lang="en-US">Warrants Outstanding Weighted Average Exercise Price</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_WarrantsOutstandingWeightedAverageExercisePrice" xlink:to="cve_WarrantsOutstandingWeightedAverageExercisePrice_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LossOnContractTermination_lbl0" xml:lang="en-US">Loss on Contract Termination</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LossOnContractTermination" xlink:to="us-gaap_LossOnContractTermination_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfIntangibleAssetsExplanatory_lbl0" xml:lang="en-US">Disclosure of intangible assets [text block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfIntangibleAssetsExplanatory" xlink:to="ifrs-full_DisclosureOfIntangibleAssetsExplanatory_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_PaymentsForShareIssueCosts_lbl0" xml:lang="en-US">Payments for share issue costs</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_PaymentsForShareIssueCosts" xlink:to="ifrs-full_PaymentsForShareIssueCosts_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DescriptionOfKeyAssumptionsOnWhichManagementHasBasedDeterminationOfFairValueLessCostsOfDisposal_lbl0" xml:lang="en-US">Description of key assumptions on which management has based determination of fair value less costs of disposal</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DescriptionOfKeyAssumptionsOnWhichManagementHasBasedDeterminationOfFairValueLessCostsOfDisposal" xlink:to="ifrs-full_DescriptionOfKeyAssumptionsOnWhichManagementHasBasedDeterminationOfFairValueLessCostsOfDisposal_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ProportionOfOwnershipInterestInAssociate_lbl0" xml:lang="en-US">Proportion of ownership interest in associate</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ProportionOfOwnershipInterestInAssociate" xlink:to="ifrs-full_ProportionOfOwnershipInterestInAssociate_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_Fiscal2027Member_lbl0" xml:lang="en-US">Fiscal2027 Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_Fiscal2027Member" xlink:to="cve_Fiscal2027Member_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_Long-TermLeaseLiabilityAdditions_lbl1" xml:lang="en-US">Long- Term Lease Liability Additions</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_Long-TermLeaseLiabilityAdditions" xlink:to="cve_Long-TermLeaseLiabilityAdditions_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_AssetRetirementObligationsBalance_lbl2" xml:lang="en-US">Asset Retirement Obligations Balance</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_AssetRetirementObligationsBalance" xlink:to="cve_AssetRetirementObligationsBalance_lbl2"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_OtherPropertyPlantAndEquipmentMember_lbl0" xml:lang="en-US">Other property, plant and equipment [member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_OtherPropertyPlantAndEquipmentMember" xlink:to="ifrs-full_OtherPropertyPlantAndEquipmentMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesExplanatory_lbl0" xml:lang="en-US">Disclosure of associates [text block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesExplanatory" xlink:to="ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesExplanatory_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_StockOptionsMember_lbl0" xml:lang="en-US">Stock Options Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_StockOptionsMember" xlink:to="cve_StockOptionsMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_IcfrAuditorAttestationFlag_lbl0" xml:lang="en-US">ICFR Auditor Attestation Flag</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_IcfrAuditorAttestationFlag" xlink:to="dei_IcfrAuditorAttestationFlag_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfIndirectMeasurementOfFairValueOfGoodsOrServicesReceivedShareOptionsGrantedDuringPeriodExplanatory_lbl0" xml:lang="en-US">Disclosure of indirect measurement of fair value of goods or services received, share options granted during period [text block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfIndirectMeasurementOfFairValueOfGoodsOrServicesReceivedShareOptionsGrantedDuringPeriodExplanatory" xlink:to="ifrs-full_DisclosureOfIndirectMeasurementOfFairValueOfGoodsOrServicesReceivedShareOptionsGrantedDuringPeriodExplanatory_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_Fiscal2026Member_lbl0" xml:lang="en-US">Fiscal2026 Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_Fiscal2026Member" xlink:to="cve_Fiscal2026Member_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_ExplorationCostsAbstract0_lbl0" xml:lang="en-US">Exploration Costs Abstract0</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_ExplorationCostsAbstract0" xlink:to="cve_ExplorationCostsAbstract0_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_MarketableSecuritiesTablesLineItems_lbl0" xml:lang="en-US">Marketable Securities Tables Line Items</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_MarketableSecuritiesTablesLineItems" xlink:to="cve_MarketableSecuritiesTablesLineItems_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_WarrantsOutstandingWeightedAverageReimainingLife_lbl1" xml:lang="en-US">Warrants Outstanding Weighted Average Reimaining Life</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_WarrantsOutstandingWeightedAverageReimainingLife" xlink:to="cve_WarrantsOutstandingWeightedAverageReimainingLife_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_ContributedSurplus_lbl1" xml:lang="en-US">Contributed Surplus</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_ContributedSurplus" xlink:to="cve_ContributedSurplus_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents_lbl0" xml:lang="en-US">Effect of exchange rate changes on cash and cash equivalents</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents" xlink:to="ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_OptionsGrantedForMaximumYear_lbl1" xml:lang="en-US">Options Granted For Maximum Year</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_OptionsGrantedForMaximumYear" xlink:to="cve_OptionsGrantedForMaximumYear_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfMaturityAnalysisForFinancialAssetsHeldForManagingLiquidityRiskExplanatory_lbl0" xml:lang="en-US">Disclosure of maturity analysis for financial assets held for managing liquidity risk [text block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfMaturityAnalysisForFinancialAssetsHeldForManagingLiquidityRiskExplanatory" xlink:to="ifrs-full_DisclosureOfMaturityAnalysisForFinancialAssetsHeldForManagingLiquidityRiskExplanatory_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_SharesBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingPeriodIncreaseDecreaseWeightedAverageExercisePrice_lbl2" xml:lang="en-US">Shares Based Compensation Arrangement By Share Based Payment Award Options Outstanding Period Increase Decrease Weighted Average Exercise Price</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_SharesBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingPeriodIncreaseDecreaseWeightedAverageExercisePrice" xlink:to="cve_SharesBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingPeriodIncreaseDecreaseWeightedAverageExercisePrice_lbl2"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_NonCashInvestingActivitiesAbstract_lbl0" xml:lang="en-US">Non Cash Investing Activities Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_NonCashInvestingActivitiesAbstract" xlink:to="cve_NonCashInvestingActivitiesAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_KingsvilleMember_lbl0" xml:lang="en-US">Kingsville Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_KingsvilleMember" xlink:to="cve_KingsvilleMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_FourTwoZeroFiveSevenSixMember_lbl0" xml:lang="en-US">Four Two Zero Five Seven Six Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_FourTwoZeroFiveSevenSixMember" xlink:to="cve_FourTwoZeroFiveSevenSixMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfRedesignatedFinancialAssetsAndLiabilitiesExplanatory_lbl0" xml:lang="en-US">Disclosure of redesignated financial assets and liabilities [text block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfRedesignatedFinancialAssetsAndLiabilitiesExplanatory" xlink:to="ifrs-full_DisclosureOfRedesignatedFinancialAssetsAndLiabilitiesExplanatory_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_AzargaResourcesCanadaLtdMember_lbl0" xml:lang="en-US">Azarga Resources Canada Ltd Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_AzargaResourcesCanadaLtdMember" xlink:to="cve_AzargaResourcesCanadaLtdMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_Liabilities_lbl0" xml:lang="en-US">Liabilities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_Liabilities" xlink:to="ifrs-full_Liabilities_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ProportionOfOwnershipInterestInSubsidiary_lbl0" xml:lang="en-US">Proportion of ownership interest in subsidiary</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ProportionOfOwnershipInterestInSubsidiary" xlink:to="ifrs-full_ProportionOfOwnershipInterestInSubsidiary_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_Fiscal2025Member_lbl0" xml:lang="en-US">Fiscal2025 Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_Fiscal2025Member" xlink:to="cve_Fiscal2025Member_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAccountPayable_lbl0" xml:lang="en-US">Adjustments for increase (decrease) in trade accounts payable</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAccountPayable" xlink:to="ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAccountPayable_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_ZeroOneEightOneNineTwoMember_lbl0" xml:lang="en-US">Zero One Eight One Nine Two Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_ZeroOneEightOneNineTwoMember" xlink:to="cve_ZeroOneEightOneNineTwoMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_SetoffOfTax_lbl2" xml:lang="en-US">Setoff Of Tax</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_SetoffOfTax" xlink:to="cve_SetoffOfTax_lbl2"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_NoncurrentFinancialAssets_lbl0" xml:lang="en-US">Non-current financial assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NoncurrentFinancialAssets" xlink:to="ifrs-full_NoncurrentFinancialAssets_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_LiabilitiesArisingFromExplorationForAndEvaluationOfMineralResources_lbl0" xml:lang="en-US">Liabilities arising from exploration for and evaluation of mineral resources</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_LiabilitiesArisingFromExplorationForAndEvaluationOfMineralResources" xlink:to="ifrs-full_LiabilitiesArisingFromExplorationForAndEvaluationOfMineralResources_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_GrossProceed_lbl1" xml:lang="en-US">Gross Proceed</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_GrossProceed" xlink:to="cve_GrossProceed_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_AdjustmentsForInterestIncome_lbl0" xml:lang="en-US">Adjustments for interest income</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AdjustmentsForInterestIncome" xlink:to="ifrs-full_AdjustmentsForInterestIncome_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_ReleasedShares_lbl1" xml:lang="en-US">Released Shares</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_ReleasedShares" xlink:to="cve_ReleasedShares_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_IssueOfEquity_lbl0" xml:lang="en-US">Issue of equity</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_IssueOfEquity" xlink:to="ifrs-full_IssueOfEquity_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfEventsAfterReportingPeriodExplanatory_lbl0" xml:lang="en-US">Disclosure of events after reporting period [text block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfEventsAfterReportingPeriodExplanatory" xlink:to="ifrs-full_DisclosureOfEventsAfterReportingPeriodExplanatory_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_NumberOfSharesIssuedAndFullyPaid_lbl1" xml:lang="en-US">Number of shares issued and fully paid</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NumberOfSharesIssuedAndFullyPaid" xlink:to="ifrs-full_NumberOfSharesIssuedAndFullyPaid_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_InterestRevenueExpense_lbl0" xml:lang="en-US">Interest income (expense)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_InterestRevenueExpense" xlink:to="ifrs-full_InterestRevenueExpense_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ExercisePriceShareOptionsGranted2019_lbl1" xml:lang="en-US">Exercise price, share options granted</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ExercisePriceShareOptionsGranted2019" xlink:to="ifrs-full_ExercisePriceShareOptionsGranted2019_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_enCoreEnergyUSCorpMember_lbl0" xml:lang="en-US">en Core Energy USCorp Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_enCoreEnergyUSCorpMember" xlink:to="cve_enCoreEnergyUSCorpMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_ConvertedShares_lbl1" xml:lang="en-US">Converted Shares</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_ConvertedShares" xlink:to="cve_ConvertedShares_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_WarrantsExercisableShare_lbl1" xml:lang="en-US">Warrants Exercisable Share</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_WarrantsExercisableShare" xlink:to="cve_WarrantsExercisableShare_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_AmountsPayableRelatedPartyTransactions_lbl0" xml:lang="en-US">Amounts payable, related party transactions</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AmountsPayableRelatedPartyTransactions" xlink:to="ifrs-full_AmountsPayableRelatedPartyTransactions_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCurrentReportingStatus_lbl0" xml:lang="en-US">Entity Current Reporting Status</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCurrentReportingStatus" xlink:to="dei_EntityCurrentReportingStatus_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_IssuedCapitalMember_lbl0" xml:lang="en-US">Issued capital [member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_IssuedCapitalMember" xlink:to="ifrs-full_IssuedCapitalMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_CommonShareIssued_lbl1" xml:lang="en-US">Common Share Issued</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_CommonShareIssued" xlink:to="cve_CommonShareIssued_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_MarketableSecuritiescurrentMember_lbl0" xml:lang="en-US">Marketable Securitiescurrent Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_MarketableSecuritiescurrentMember" xlink:to="cve_MarketableSecuritiescurrentMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfAccountingJudgementsAndEstimatesExplanatory_lbl0" xml:lang="en-US">Disclosure of accounting judgements and estimates [text block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfAccountingJudgementsAndEstimatesExplanatory" xlink:to="ifrs-full_DisclosureOfAccountingJudgementsAndEstimatesExplanatory_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_MiningAssets_lbl2" xml:lang="en-US">Mining assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_MiningAssets" xlink:to="ifrs-full_MiningAssets_lbl2"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_RightofuseAssetsRevaluedAssetsAtCost_lbl0" xml:lang="en-US">Right-of-use assets, revalued assets, at cost</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_RightofuseAssetsRevaluedAssetsAtCost" xlink:to="ifrs-full_RightofuseAssetsRevaluedAssetsAtCost_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_UnrealizedGainOnUraniumInvestment_lbl2" xml:lang="en-US">Unrealized Gain On Uranium Investment</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_UnrealizedGainOnUraniumInvestment" xlink:to="cve_UnrealizedGainOnUraniumInvestment_lbl2"/>
    <loc xlink:type="locator" xlink:label="cve_ScheduleOfFederalAndProvincialCorporateTaxRatesToIncomeBeforeTaxAbstract" xlink:href="cve-20221231.xsd#cve_ScheduleOfFederalAndProvincialCorporateTaxRatesToIncomeBeforeTaxAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_ScheduleOfFederalAndProvincialCorporateTaxRatesToIncomeBeforeTaxAbstract_lbl" xml:lang="en-US">Schedule Of Federal And Provincial Corporate Tax Rates To Income Before Tax Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_ScheduleOfFederalAndProvincialCorporateTaxRatesToIncomeBeforeTaxAbstract" xlink:to="cve_ScheduleOfFederalAndProvincialCorporateTaxRatesToIncomeBeforeTaxAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_CommunityEngagement_lbl1" xml:lang="en-US">Community Engagement</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_CommunityEngagement" xlink:to="cve_CommunityEngagement_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_Right-of-UseAssetsTwoZeroTwoFour_lbl1" xml:lang="en-US">Right-of- Use Assets Two Zero Two Four</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_Right-of-UseAssetsTwoZeroTwoFour" xlink:to="cve_Right-of-UseAssetsTwoZeroTwoFour_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsExplanatory_lbl0" xml:lang="en-US">Disclosure of quantitative information about right-of-use assets [text block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsExplanatory" xlink:to="ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsExplanatory_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_SalescontractsTablesLineItems_lbl0" xml:lang="en-US">Salescontracts Tables Line Items</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_SalescontractsTablesLineItems" xlink:to="cve_SalescontractsTablesLineItems_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_Assets_lbl1" xml:lang="en-US">Assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_Assets" xlink:to="ifrs-full_Assets_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_IntangibleAssetsOtherThanGoodwill_lbl0" xml:lang="en-US">Intangible assets other than goodwill</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_IntangibleAssetsOtherThanGoodwill" xlink:to="ifrs-full_IntangibleAssetsOtherThanGoodwill_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_Long-TermLeaseLiabilityLessCurrentLeaseLiability_lbl1" xml:lang="en-US">Long- Term Lease Liability Less Current Lease Liability</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_Long-TermLeaseLiabilityLessCurrentLeaseLiability" xlink:to="cve_Long-TermLeaseLiabilityLessCurrentLeaseLiability_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_UcoloExplorationCorpMember_lbl0" xml:lang="en-US">Ucolo Exploration Corp Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_UcoloExplorationCorpMember" xlink:to="cve_UcoloExplorationCorpMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_IntangibleAssetsBalance_lbl2" xml:lang="en-US">Intangible Assets Balance</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_IntangibleAssetsBalance" xlink:to="cve_IntangibleAssetsBalance_lbl2"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_Fiscal2023Member_lbl0" xml:lang="en-US">Fiscal2023 Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_Fiscal2023Member" xlink:to="cve_Fiscal2023Member_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_ScheduleOfStockOptionsOutstandingTableTextBlock_lbl0" xml:lang="en-US">Schedule Of Stock Options Outstanding Table Text Block</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_ScheduleOfStockOptionsOutstandingTableTextBlock" xlink:to="cve_ScheduleOfStockOptionsOutstandingTableTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_AdjustmentsForUndistributedProfitsOfAssociates_lbl0" xml:lang="en-US">Adjustments for undistributed profits of associates</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AdjustmentsForUndistributedProfitsOfAssociates" xlink:to="ifrs-full_AdjustmentsForUndistributedProfitsOfAssociates_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForIntangibleAssetsAndGoodwillExplanatory_lbl0" xml:lang="en-US">Description of accounting policy for intangible assets and goodwill [text block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DescriptionOfAccountingPolicyForIntangibleAssetsAndGoodwillExplanatory" xlink:to="ifrs-full_DescriptionOfAccountingPolicyForIntangibleAssetsAndGoodwillExplanatory_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_InvestingActivitiesAbstract_lbl0" xml:lang="en-US">Investing Activities Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_InvestingActivitiesAbstract" xlink:to="cve_InvestingActivitiesAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_DescriptionOfAccountingPolicyForOtherPropertyPlantAndEquipmenttextBlock_lbl1" xml:lang="en-US">Description Of Accounting Policy For Other Property Plant And Equipmenttext Block</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_DescriptionOfAccountingPolicyForOtherPropertyPlantAndEquipmenttextBlock" xlink:to="cve_DescriptionOfAccountingPolicyForOtherPropertyPlantAndEquipmenttextBlock_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ReceiptsFromRoyaltiesFeesCommissionsAndOtherRevenue_lbl0" xml:lang="en-US">Receipts from royalties, fees, commissions and other revenue</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ReceiptsFromRoyaltiesFeesCommissionsAndOtherRevenue" xlink:to="ifrs-full_ReceiptsFromRoyaltiesFeesCommissionsAndOtherRevenue_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_GainOnSaleOfUraniumInvestment_lbl1" xml:lang="en-US">Gain On Sale Of Uranium Investment</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_GainOnSaleOfUraniumInvestment" xlink:to="cve_GainOnSaleOfUraniumInvestment_lbl1"/>
    <loc xlink:type="locator" xlink:label="cve_DisclosureOfFinancialInstrumentsTextBlockAbstract" xlink:href="cve-20221231.xsd#cve_DisclosureOfFinancialInstrumentsTextBlockAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_DisclosureOfFinancialInstrumentsTextBlockAbstract_lbl" xml:lang="en-US">Disclosure Of Financial Instruments Text Block Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_DisclosureOfFinancialInstrumentsTextBlockAbstract" xlink:to="cve_DisclosureOfFinancialInstrumentsTextBlockAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_IncreaseDecreaseResultingFromAbstract_lbl0" xml:lang="en-US">Increase Decrease Resulting From Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_IncreaseDecreaseResultingFromAbstract" xlink:to="cve_IncreaseDecreaseResultingFromAbstract_lbl0"/>
    <loc xlink:type="locator" xlink:label="cve_DisclosureOfHowEntityManagesLiquidityRiskTextBlockAbstract" xlink:href="cve-20221231.xsd#cve_DisclosureOfHowEntityManagesLiquidityRiskTextBlockAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_DisclosureOfHowEntityManagesLiquidityRiskTextBlockAbstract_lbl" xml:lang="en-US">Disclosure Of How Entity Manages Liquidity Risk Text Block Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_DisclosureOfHowEntityManagesLiquidityRiskTextBlockAbstract" xlink:to="cve_DisclosureOfHowEntityManagesLiquidityRiskTextBlockAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_PropertyPlantAndEquipmentCarryingAmountAtCostOfRevaluedAssets_lbl1" xml:lang="en-US">Property, plant and equipment, revalued assets, at cost</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_PropertyPlantAndEquipmentCarryingAmountAtCostOfRevaluedAssets" xlink:to="ifrs-full_PropertyPlantAndEquipmentCarryingAmountAtCostOfRevaluedAssets_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_AdjustmentsForDepreciationAndAmortisationExpense_lbl0" xml:lang="en-US">Adjustments for depreciation and amortisation expense</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AdjustmentsForDepreciationAndAmortisationExpense" xlink:to="ifrs-full_AdjustmentsForDepreciationAndAmortisationExpense_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_GainsLossesOnDisposalsOfPropertyPlantAndEquipment_lbl0" xml:lang="en-US">Gains (losses) on disposals of property, plant and equipment</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_GainsLossesOnDisposalsOfPropertyPlantAndEquipment" xlink:to="ifrs-full_GainsLossesOnDisposalsOfPropertyPlantAndEquipment_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DividendsReceived_lbl0" xml:lang="en-US">Dividends received</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DividendsReceived" xlink:to="ifrs-full_DividendsReceived_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsOther_lbl0" xml:lang="en-US">Deferred Tax Assets, Other</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsOther" xlink:to="us-gaap_DeferredTaxAssetsOther_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cve_IntangibleAssetDeterminedLife_lbl1" xml:lang="en-US">Intangible Asset Determined Life</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cve_IntangibleAssetDeterminedLife" xlink:to="cve_IntangibleAssetDeterminedLife_lbl1"/>
  </labelLink>
</linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>50
<FILENAME>cve-20221231_pre.xml
<DESCRIPTION>XBRL PRESENTATION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!-- Generated by CompSci Transform (tm) - http://www.compsciresources.com -->
<!-- Created: Fri Apr 28 19:14:45 UTC 2023 -->
<linkbase xmlns="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <roleRef xlink:type="simple" xlink:href="cve-20221231.xsd#cve_r_ConsolidatedBalanceSheet" roleURI="http://encoreuranium.com/role/ConsolidatedBalanceSheet"/>
  <roleRef xlink:type="simple" xlink:href="cve-20221231.xsd#cve_r_ConsolidatedComprehensiveIncome" roleURI="http://encoreuranium.com/role/ConsolidatedComprehensiveIncome"/>
  <roleRef xlink:type="simple" xlink:href="cve-20221231.xsd#cve_r_ConsolidatedComprehensiveIncome_Parentheticals" roleURI="http://encoreuranium.com/role/ConsolidatedComprehensiveIncome_Parentheticals"/>
  <roleRef xlink:type="simple" xlink:href="cve-20221231.xsd#cve_r_ConsolidatedCashFlow" roleURI="http://encoreuranium.com/role/ConsolidatedCashFlow"/>
  <roleRef xlink:type="simple" xlink:href="cve-20221231.xsd#cve_r_ShareholdersEquityType2or3" roleURI="http://encoreuranium.com/role/ShareholdersEquityType2or3"/>
  <roleRef xlink:type="simple" xlink:href="cve-20221231.xsd#cve_r_NatureofOperationsandGoingConcern" roleURI="http://encoreuranium.com/role/NatureofOperationsandGoingConcern"/>
  <roleRef xlink:type="simple" xlink:href="cve-20221231.xsd#cve_r_Significantaccountingpolicies" roleURI="http://encoreuranium.com/role/Significantaccountingpolicies"/>
  <roleRef xlink:type="simple" xlink:href="cve-20221231.xsd#cve_r_CriticalAccountingEstimatesAndJudgements" roleURI="http://encoreuranium.com/role/CriticalAccountingEstimatesAndJudgements"/>
  <roleRef xlink:type="simple" xlink:href="cve-20221231.xsd#cve_r_InvestmentInAssociate" roleURI="http://encoreuranium.com/role/InvestmentInAssociate"/>
  <roleRef xlink:type="simple" xlink:href="cve-20221231.xsd#cve_r_Investmentinuranium" roleURI="http://encoreuranium.com/role/Investmentinuranium"/>
  <roleRef xlink:type="simple" xlink:href="cve-20221231.xsd#cve_r_MarketableSecurities" roleURI="http://encoreuranium.com/role/MarketableSecurities"/>
  <roleRef xlink:type="simple" xlink:href="cve-20221231.xsd#cve_r_Intangibleassets" roleURI="http://encoreuranium.com/role/Intangibleassets"/>
  <roleRef xlink:type="simple" xlink:href="cve-20221231.xsd#cve_r_Propertyplantandequipment" roleURI="http://encoreuranium.com/role/Propertyplantandequipment"/>
  <roleRef xlink:type="simple" xlink:href="cve-20221231.xsd#cve_r_Rightofuseassets" roleURI="http://encoreuranium.com/role/Rightofuseassets"/>
  <roleRef xlink:type="simple" xlink:href="cve-20221231.xsd#cve_r_Assetacquisition" roleURI="http://encoreuranium.com/role/Assetacquisition"/>
  <roleRef xlink:type="simple" xlink:href="cve-20221231.xsd#cve_r_MineralProperties" roleURI="http://encoreuranium.com/role/MineralProperties"/>
  <roleRef xlink:type="simple" xlink:href="cve-20221231.xsd#cve_r_Assetretirementobligations" roleURI="http://encoreuranium.com/role/Assetretirementobligations"/>
  <roleRef xlink:type="simple" xlink:href="cve-20221231.xsd#cve_r_Salescontracts" roleURI="http://encoreuranium.com/role/Salescontracts"/>
  <roleRef xlink:type="simple" xlink:href="cve-20221231.xsd#cve_r_ShareCapital" roleURI="http://encoreuranium.com/role/ShareCapital"/>
  <roleRef xlink:type="simple" xlink:href="cve-20221231.xsd#cve_r_Relatedpartytransactionsandbalances" roleURI="http://encoreuranium.com/role/Relatedpartytransactionsandbalances"/>
  <roleRef xlink:type="simple" xlink:href="cve-20221231.xsd#cve_r_Managementofcapital" roleURI="http://encoreuranium.com/role/Managementofcapital"/>
  <roleRef xlink:type="simple" xlink:href="cve-20221231.xsd#cve_r_FinancialInstruments" roleURI="http://encoreuranium.com/role/FinancialInstruments"/>
  <roleRef xlink:type="simple" xlink:href="cve-20221231.xsd#cve_r_Segmentedinformation" roleURI="http://encoreuranium.com/role/Segmentedinformation"/>
  <roleRef xlink:type="simple" xlink:href="cve-20221231.xsd#cve_r_Supplementaldisclosurewithrespecttocashflows" roleURI="http://encoreuranium.com/role/Supplementaldisclosurewithrespecttocashflows"/>
  <roleRef xlink:type="simple" xlink:href="cve-20221231.xsd#cve_r_Incometaxes" roleURI="http://encoreuranium.com/role/Incometaxes"/>
  <roleRef xlink:type="simple" xlink:href="cve-20221231.xsd#cve_r_ChangeinPresentationCurrency" roleURI="http://encoreuranium.com/role/ChangeinPresentationCurrency"/>
  <roleRef xlink:type="simple" xlink:href="cve-20221231.xsd#cve_r_Eventsafterthereportingperiod" roleURI="http://encoreuranium.com/role/Eventsafterthereportingperiod"/>
  <roleRef xlink:type="simple" xlink:href="cve-20221231.xsd#cve_r_AccountingPoliciesByPolicy" roleURI="http://encoreuranium.com/role/AccountingPoliciesByPolicy"/>
  <roleRef xlink:type="simple" xlink:href="cve-20221231.xsd#cve_r_SignificantaccountingpoliciesTables" roleURI="http://encoreuranium.com/role/SignificantaccountingpoliciesTables"/>
  <roleRef xlink:type="simple" xlink:href="cve-20221231.xsd#cve_r_InvestmentInAssociateTables" roleURI="http://encoreuranium.com/role/InvestmentInAssociateTables"/>
  <roleRef xlink:type="simple" xlink:href="cve-20221231.xsd#cve_r_InvestmentinuraniumTables" roleURI="http://encoreuranium.com/role/InvestmentinuraniumTables"/>
  <roleRef xlink:type="simple" xlink:href="cve-20221231.xsd#cve_r_MarketableSecuritiesTables" roleURI="http://encoreuranium.com/role/MarketableSecuritiesTables"/>
  <roleRef xlink:type="simple" xlink:href="cve-20221231.xsd#cve_r_IntangibleassetsTables" roleURI="http://encoreuranium.com/role/IntangibleassetsTables"/>
  <roleRef xlink:type="simple" xlink:href="cve-20221231.xsd#cve_r_PropertyplantandequipmentTables" roleURI="http://encoreuranium.com/role/PropertyplantandequipmentTables"/>
  <roleRef xlink:type="simple" xlink:href="cve-20221231.xsd#cve_r_RightofuseassetsTables" roleURI="http://encoreuranium.com/role/RightofuseassetsTables"/>
  <roleRef xlink:type="simple" xlink:href="cve-20221231.xsd#cve_r_AssetacquisitionTables" roleURI="http://encoreuranium.com/role/AssetacquisitionTables"/>
  <roleRef xlink:type="simple" xlink:href="cve-20221231.xsd#cve_r_MineralPropertiesTables" roleURI="http://encoreuranium.com/role/MineralPropertiesTables"/>
  <roleRef xlink:type="simple" xlink:href="cve-20221231.xsd#cve_r_AssetretirementobligationsTables" roleURI="http://encoreuranium.com/role/AssetretirementobligationsTables"/>
  <roleRef xlink:type="simple" xlink:href="cve-20221231.xsd#cve_r_SalescontractsTables" roleURI="http://encoreuranium.com/role/SalescontractsTables"/>
  <roleRef xlink:type="simple" xlink:href="cve-20221231.xsd#cve_r_ShareCapitalTables" roleURI="http://encoreuranium.com/role/ShareCapitalTables"/>
  <roleRef xlink:type="simple" xlink:href="cve-20221231.xsd#cve_r_RelatedpartytransactionsandbalancesTables" roleURI="http://encoreuranium.com/role/RelatedpartytransactionsandbalancesTables"/>
  <roleRef xlink:type="simple" xlink:href="cve-20221231.xsd#cve_r_FinancialInstrumentsTables" roleURI="http://encoreuranium.com/role/FinancialInstrumentsTables"/>
  <roleRef xlink:type="simple" xlink:href="cve-20221231.xsd#cve_r_SegmentedinformationTables" roleURI="http://encoreuranium.com/role/SegmentedinformationTables"/>
  <roleRef xlink:type="simple" xlink:href="cve-20221231.xsd#cve_r_SupplementaldisclosurewithrespecttocashflowsTables" roleURI="http://encoreuranium.com/role/SupplementaldisclosurewithrespecttocashflowsTables"/>
  <roleRef xlink:type="simple" xlink:href="cve-20221231.xsd#cve_r_IncometaxesTables" roleURI="http://encoreuranium.com/role/IncometaxesTables"/>
  <roleRef xlink:type="simple" xlink:href="cve-20221231.xsd#cve_r_ChangeinPresentationCurrencyTables" roleURI="http://encoreuranium.com/role/ChangeinPresentationCurrencyTables"/>
  <roleRef xlink:type="simple" xlink:href="cve-20221231.xsd#cve_r_ScheduleofexchangeratesTable" roleURI="http://encoreuranium.com/role/ScheduleofexchangeratesTable"/>
  <roleRef xlink:type="simple" xlink:href="cve-20221231.xsd#cve_r_ScheduleofsignificantsubsidiariesTable" roleURI="http://encoreuranium.com/role/ScheduleofsignificantsubsidiariesTable"/>
  <roleRef xlink:type="simple" xlink:href="cve-20221231.xsd#cve_r_ScheduleofusefullivesofpropertyplantandequipementTable" roleURI="http://encoreuranium.com/role/ScheduleofusefullivesofpropertyplantandequipementTable"/>
  <roleRef xlink:type="simple" xlink:href="cve-20221231.xsd#cve_r_ScheduleofusefullivesofintangibleassetsTable" roleURI="http://encoreuranium.com/role/ScheduleofusefullivesofintangibleassetsTable"/>
  <roleRef xlink:type="simple" xlink:href="cve-20221231.xsd#cve_r_ScheduleofproportionalshareintheassociateTable" roleURI="http://encoreuranium.com/role/ScheduleofproportionalshareintheassociateTable"/>
  <roleRef xlink:type="simple" xlink:href="cve-20221231.xsd#cve_r_ScheduleofinvestmentinassociatecontinuityTable" roleURI="http://encoreuranium.com/role/ScheduleofinvestmentinassociatecontinuityTable"/>
  <roleRef xlink:type="simple" xlink:href="cve-20221231.xsd#cve_r_ScheduleofthefairvalueofthephysicaluraniuminvestmentTable" roleURI="http://encoreuranium.com/role/ScheduleofthefairvalueofthephysicaluraniuminvestmentTable"/>
  <roleRef xlink:type="simple" xlink:href="cve-20221231.xsd#cve_r_ScheduleofuraniumconcentratespurchaseagreementTable" roleURI="http://encoreuranium.com/role/ScheduleofuraniumconcentratespurchaseagreementTable"/>
  <roleRef xlink:type="simple" xlink:href="cve-20221231.xsd#cve_r_ScheduleofmarketablesecuritiesTable" roleURI="http://encoreuranium.com/role/ScheduleofmarketablesecuritiesTable"/>
  <roleRef xlink:type="simple" xlink:href="cve-20221231.xsd#cve_r_ScheduleofintangibleassetwasdeterminedTable" roleURI="http://encoreuranium.com/role/ScheduleofintangibleassetwasdeterminedTable"/>
  <roleRef xlink:type="simple" xlink:href="cve-20221231.xsd#cve_r_ScheduleofpropertyplantandequipmentTable" roleURI="http://encoreuranium.com/role/ScheduleofpropertyplantandequipmentTable"/>
  <roleRef xlink:type="simple" xlink:href="cve-20221231.xsd#cve_r_ScheduleofchangeintheROUassetsTable" roleURI="http://encoreuranium.com/role/ScheduleofchangeintheROUassetsTable"/>
  <roleRef xlink:type="simple" xlink:href="cve-20221231.xsd#cve_r_ScheduleofchangeinthelongTermleaseliabilityTable" roleURI="http://encoreuranium.com/role/ScheduleofchangeinthelongTermleaseliabilityTable"/>
  <roleRef xlink:type="simple" xlink:href="cve-20221231.xsd#cve_r_ScheduleofundiscountedfutureleasepaymentsTable" roleURI="http://encoreuranium.com/role/ScheduleofundiscountedfutureleasepaymentsTable"/>
  <roleRef xlink:type="simple" xlink:href="cve-20221231.xsd#cve_r_ScheduleofestimatedfairvalueofassetsandliabilitiesTable" roleURI="http://encoreuranium.com/role/ScheduleofestimatedfairvalueofassetsandliabilitiesTable"/>
  <roleRef xlink:type="simple" xlink:href="cve-20221231.xsd#cve_r_ScheduleofnetassetsacquiredTable" roleURI="http://encoreuranium.com/role/ScheduleofnetassetsacquiredTable"/>
  <roleRef xlink:type="simple" xlink:href="cve-20221231.xsd#cve_r_ScheduleofweightedaverageassumptionsusedintheblackscholesoptionTable" roleURI="http://encoreuranium.com/role/ScheduleofweightedaverageassumptionsusedintheblackscholesoptionTable"/>
  <roleRef xlink:type="simple" xlink:href="cve-20221231.xsd#cve_r_ScheduleofmineralpropertiesTable" roleURI="http://encoreuranium.com/role/ScheduleofmineralpropertiesTable"/>
  <roleRef xlink:type="simple" xlink:href="cve-20221231.xsd#cve_r_ScheduleofassetretirementobligationsbalanceTable" roleURI="http://encoreuranium.com/role/ScheduleofassetretirementobligationsbalanceTable"/>
  <roleRef xlink:type="simple" xlink:href="cve-20221231.xsd#cve_r_ScheduleofassetretirementobligationscontinuityTable" roleURI="http://encoreuranium.com/role/ScheduleofassetretirementobligationscontinuityTable"/>
  <roleRef xlink:type="simple" xlink:href="cve-20221231.xsd#cve_r_ScheduleofuraniumsalescontractsoverthenextfiveyearsTable" roleURI="http://encoreuranium.com/role/ScheduleofuraniumsalescontractsoverthenextfiveyearsTable"/>
  <roleRef xlink:type="simple" xlink:href="cve-20221231.xsd#cve_r_ScheduleofthecompanysstockoptionsoutstandingTable" roleURI="http://encoreuranium.com/role/ScheduleofthecompanysstockoptionsoutstandingTable"/>
  <roleRef xlink:type="simple" xlink:href="cve-20221231.xsd#cve_r_ScheduleofstockoptionsoutstandingTable" roleURI="http://encoreuranium.com/role/ScheduleofstockoptionsoutstandingTable"/>
  <roleRef xlink:type="simple" xlink:href="cve-20221231.xsd#cve_r_ScheduleofweightedaverageassumptionsusedincalculatingthefairvaluesTable" roleURI="http://encoreuranium.com/role/ScheduleofweightedaverageassumptionsusedincalculatingthefairvaluesTable"/>
  <roleRef xlink:type="simple" xlink:href="cve-20221231.xsd#cve_r_ScheduleofthestatusofthecompanyswarrantsTable" roleURI="http://encoreuranium.com/role/ScheduleofthestatusofthecompanyswarrantsTable"/>
  <roleRef xlink:type="simple" xlink:href="cve-20221231.xsd#cve_r_ScheduleofsharepurchasewarrantsoutstandingTable" roleURI="http://encoreuranium.com/role/ScheduleofsharepurchasewarrantsoutstandingTable"/>
  <roleRef xlink:type="simple" xlink:href="cve-20221231.xsd#cve_r_ScheduleofamountspaidtokeymanagementorentitiesprovidingsimilarservicesTable" roleURI="http://encoreuranium.com/role/ScheduleofamountspaidtokeymanagementorentitiesprovidingsimilarservicesTable"/>
  <roleRef xlink:type="simple" xlink:href="cve-20221231.xsd#cve_r_ScheduleofowingtorelatedpartiesTable" roleURI="http://encoreuranium.com/role/ScheduleofowingtorelatedpartiesTable"/>
  <roleRef xlink:type="simple" xlink:href="cve-20221231.xsd#cve_r_ScheduleofforeigncurrencyexposuresTable" roleURI="http://encoreuranium.com/role/ScheduleofforeigncurrencyexposuresTable"/>
  <roleRef xlink:type="simple" xlink:href="cve-20221231.xsd#cve_r_ScheduleoflongtermassetsbygeographicsegmentTable" roleURI="http://encoreuranium.com/role/ScheduleoflongtermassetsbygeographicsegmentTable"/>
  <roleRef xlink:type="simple" xlink:href="cve-20221231.xsd#cve_r_ScheduleofincurrednoncashfinancingandinvestingactivitiesTable" roleURI="http://encoreuranium.com/role/ScheduleofincurrednoncashfinancingandinvestingactivitiesTable"/>
  <roleRef xlink:type="simple" xlink:href="cve-20221231.xsd#cve_r_ScheduleoffederalandprovincialcorporatetaxratestoincomebeforetaxTable" roleURI="http://encoreuranium.com/role/ScheduleoffederalandprovincialcorporatetaxratestoincomebeforetaxTable"/>
  <roleRef xlink:type="simple" xlink:href="cve-20221231.xsd#cve_r_ScheduleofincometaxexpenserecoveryTable" roleURI="http://encoreuranium.com/role/ScheduleofincometaxexpenserecoveryTable"/>
  <roleRef xlink:type="simple" xlink:href="cve-20221231.xsd#cve_r_ScheduleofdeferredtaxliabilitiesTable" roleURI="http://encoreuranium.com/role/ScheduleofdeferredtaxliabilitiesTable"/>
  <roleRef xlink:type="simple" xlink:href="cve-20221231.xsd#cve_r_ScheduleofunrecognizeddeferredtaxassetsTable" roleURI="http://encoreuranium.com/role/ScheduleofunrecognizeddeferredtaxassetsTable"/>
  <roleRef xlink:type="simple" xlink:href="cve-20221231.xsd#cve_r_ScheduleofeffectoftranslationTable" roleURI="http://encoreuranium.com/role/ScheduleofeffectoftranslationTable"/>
  <roleRef xlink:type="simple" xlink:href="cve-20221231.xsd#cve_r_ScheduleofconsolidatedstatementsoflossandcomprehensivelossTable" roleURI="http://encoreuranium.com/role/ScheduleofconsolidatedstatementsoflossandcomprehensivelossTable"/>
  <roleRef xlink:type="simple" xlink:href="cve-20221231.xsd#cve_r_ScheduleofconsolidatedstatementsoflossandcomprehensivelossTable_Parentheticals" roleURI="http://encoreuranium.com/role/ScheduleofconsolidatedstatementsoflossandcomprehensivelossTable_Parentheticals"/>
  <roleRef xlink:type="simple" xlink:href="cve-20221231.xsd#cve_r_NatureofOperationsandGoingConcernDetails" roleURI="http://encoreuranium.com/role/NatureofOperationsandGoingConcernDetails"/>
  <roleRef xlink:type="simple" xlink:href="cve-20221231.xsd#cve_r_SignificantaccountingpoliciesDetails" roleURI="http://encoreuranium.com/role/SignificantaccountingpoliciesDetails"/>
  <roleRef xlink:type="simple" xlink:href="cve-20221231.xsd#cve_r_InvestmentInAssociateDetails" roleURI="http://encoreuranium.com/role/InvestmentInAssociateDetails"/>
  <roleRef xlink:type="simple" xlink:href="cve-20221231.xsd#cve_r_InvestmentinuraniumDetails" roleURI="http://encoreuranium.com/role/InvestmentinuraniumDetails"/>
  <roleRef xlink:type="simple" xlink:href="cve-20221231.xsd#cve_r_MarketableSecuritiesDetails" roleURI="http://encoreuranium.com/role/MarketableSecuritiesDetails"/>
  <roleRef xlink:type="simple" xlink:href="cve-20221231.xsd#cve_r_IntangibleassetsDetails" roleURI="http://encoreuranium.com/role/IntangibleassetsDetails"/>
  <roleRef xlink:type="simple" xlink:href="cve-20221231.xsd#cve_r_RightofuseassetsDetails" roleURI="http://encoreuranium.com/role/RightofuseassetsDetails"/>
  <roleRef xlink:type="simple" xlink:href="cve-20221231.xsd#cve_r_AssetacquisitionDetails" roleURI="http://encoreuranium.com/role/AssetacquisitionDetails"/>
  <roleRef xlink:type="simple" xlink:href="cve-20221231.xsd#cve_r_MineralPropertiesDetails" roleURI="http://encoreuranium.com/role/MineralPropertiesDetails"/>
  <roleRef xlink:type="simple" xlink:href="cve-20221231.xsd#cve_r_AssetretirementobligationsDetails" roleURI="http://encoreuranium.com/role/AssetretirementobligationsDetails"/>
  <roleRef xlink:type="simple" xlink:href="cve-20221231.xsd#cve_r_SalescontractsDetails" roleURI="http://encoreuranium.com/role/SalescontractsDetails"/>
  <roleRef xlink:type="simple" xlink:href="cve-20221231.xsd#cve_r_ShareCapitalDetails" roleURI="http://encoreuranium.com/role/ShareCapitalDetails"/>
  <roleRef xlink:type="simple" xlink:href="cve-20221231.xsd#cve_r_RelatedpartytransactionsandbalancesDetails" roleURI="http://encoreuranium.com/role/RelatedpartytransactionsandbalancesDetails"/>
  <roleRef xlink:type="simple" xlink:href="cve-20221231.xsd#cve_r_FinancialInstrumentsDetails" roleURI="http://encoreuranium.com/role/FinancialInstrumentsDetails"/>
  <roleRef xlink:type="simple" xlink:href="cve-20221231.xsd#cve_r_IncometaxesDetails" roleURI="http://encoreuranium.com/role/IncometaxesDetails"/>
  <roleRef xlink:type="simple" xlink:href="cve-20221231.xsd#cve_r_EventsafterthereportingperiodDetails" roleURI="http://encoreuranium.com/role/EventsafterthereportingperiodDetails"/>
  <roleRef xlink:type="simple" xlink:href="cve-20221231.xsd#DocumentAndEntityInformation" roleURI="http://encoreuranium.com/role/DocumentAndEntityInformation"/>
  <presentationLink xlink:type="extended" xlink:role="http://encoreuranium.com/role/ConsolidatedBalanceSheet">
    <loc xlink:type="locator" xlink:label="ifrs-full_StatementOfFinancialPositionAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_StatementOfFinancialPositionAbstract"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CurrentAssetsAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_CurrentAssetsAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_StatementOfFinancialPositionAbstract" xlink:to="ifrs-full_CurrentAssetsAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CashAndCashEquivalents" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_CashAndCashEquivalents"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CurrentAssetsAbstract" xlink:to="ifrs-full_CashAndCashEquivalents" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_TradeAndOtherReceivables" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_TradeAndOtherReceivables"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CurrentAssetsAbstract" xlink:to="ifrs-full_TradeAndOtherReceivables" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="MarketableSecuritiecurrent" xlink:href="cve-20221231.xsd#cve_MarketableSecuritiecurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CurrentAssetsAbstract" xlink:to="MarketableSecuritiecurrent" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="DepositUraniumInvestment" xlink:href="cve-20221231.xsd#cve_DepositUraniumInvestment"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CurrentAssetsAbstract" xlink:to="DepositUraniumInvestment" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_NoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSaleOrAsHeldForDistributionToOwners" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_NoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSaleOrAsHeldForDistributionToOwners"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CurrentAssetsAbstract" xlink:to="ifrs-full_NoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSaleOrAsHeldForDistributionToOwners" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CurrentAssets" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_CurrentAssets"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CurrentAssetsAbstract" xlink:to="ifrs-full_CurrentAssets" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="NonCurrentAssetsAbstract" xlink:href="cve-20221231.xsd#cve_NonCurrentAssetsAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_StatementOfFinancialPositionAbstract" xlink:to="NonCurrentAssetsAbstract" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_IntangibleAssetsOtherThanGoodwill" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_IntangibleAssetsOtherThanGoodwill"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="NonCurrentAssetsAbstract" xlink:to="ifrs-full_IntangibleAssetsOtherThanGoodwill" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_PropertyPlantAndEquipment" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_PropertyPlantAndEquipment"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="NonCurrentAssetsAbstract" xlink:to="ifrs-full_PropertyPlantAndEquipment" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_InvestmentsInAssociates" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_InvestmentsInAssociates"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="NonCurrentAssetsAbstract" xlink:to="ifrs-full_InvestmentsInAssociates" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_InvestmentsInSubsidiariesJointVenturesAndAssociates" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_InvestmentsInSubsidiariesJointVenturesAndAssociates"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="NonCurrentAssetsAbstract" xlink:to="ifrs-full_InvestmentsInSubsidiariesJointVenturesAndAssociates" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="MarketablesSecuritiesNoncurrent" xlink:href="cve-20221231.xsd#cve_MarketablesSecuritiesNoncurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="NonCurrentAssetsAbstract" xlink:to="MarketablesSecuritiesNoncurrent" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_MiningAssets" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_MiningAssets"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="NonCurrentAssetsAbstract" xlink:to="ifrs-full_MiningAssets" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_LongtermDeposits" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_LongtermDeposits"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="NonCurrentAssetsAbstract" xlink:to="ifrs-full_LongtermDeposits" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_RightofuseAssets" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_RightofuseAssets"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="NonCurrentAssetsAbstract" xlink:to="ifrs-full_RightofuseAssets" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DeferredTaxAssets" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_DeferredTaxAssets"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="NonCurrentAssetsAbstract" xlink:to="ifrs-full_DeferredTaxAssets" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_NoncurrentFinancialAssets" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_NoncurrentFinancialAssets"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="NonCurrentAssetsAbstract" xlink:to="ifrs-full_NoncurrentFinancialAssets" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_RestrictedCashAndCashEquivalents" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_RestrictedCashAndCashEquivalents"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="NonCurrentAssetsAbstract" xlink:to="ifrs-full_RestrictedCashAndCashEquivalents" order="10.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_Assets" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_Assets"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_StatementOfFinancialPositionAbstract" xlink:to="ifrs-full_Assets" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CurrentLiabilitiesAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_CurrentLiabilitiesAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_StatementOfFinancialPositionAbstract" xlink:to="ifrs-full_CurrentLiabilitiesAbstract" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_TradeAndOtherCurrentPayables" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_TradeAndOtherCurrentPayables"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CurrentLiabilitiesAbstract" xlink:to="ifrs-full_TradeAndOtherCurrentPayables" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_TradeAndOtherCurrentPayablesToRelatedParties" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_TradeAndOtherCurrentPayablesToRelatedParties"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CurrentLiabilitiesAbstract" xlink:to="ifrs-full_TradeAndOtherCurrentPayablesToRelatedParties" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_OtherCurrentPayables" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_OtherCurrentPayables"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CurrentLiabilitiesAbstract" xlink:to="ifrs-full_OtherCurrentPayables" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CurrentLeaseLiabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_CurrentLeaseLiabilities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CurrentLiabilitiesAbstract" xlink:to="ifrs-full_CurrentLeaseLiabilities" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CurrentLiabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_CurrentLiabilities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CurrentLiabilitiesAbstract" xlink:to="ifrs-full_CurrentLiabilities" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="NonCurrentLiabilitiesAbstract" xlink:href="cve-20221231.xsd#cve_NonCurrentLiabilitiesAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_StatementOfFinancialPositionAbstract" xlink:to="NonCurrentLiabilitiesAbstract" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DefinedBenefitObligationAtPresentValue" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_DefinedBenefitObligationAtPresentValue"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="NonCurrentLiabilitiesAbstract" xlink:to="ifrs-full_DefinedBenefitObligationAtPresentValue" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_NoncurrentLeaseLiabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_NoncurrentLeaseLiabilities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="NonCurrentLiabilitiesAbstract" xlink:to="ifrs-full_NoncurrentLeaseLiabilities" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_Liabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_Liabilities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_StatementOfFinancialPositionAbstract" xlink:to="ifrs-full_Liabilities" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_StockholdersEquityAbstract" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_IssuedCapital" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_IssuedCapital"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="ifrs-full_IssuedCapital" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_SharePremium" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_SharePremium"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="ifrs-full_SharePremium" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ContributedSurplus" xlink:href="cve-20221231.xsd#cve_ContributedSurplus"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="ContributedSurplus" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AccumulatedOtherComprehensiveIncome" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_AccumulatedOtherComprehensiveIncome"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="ifrs-full_AccumulatedOtherComprehensiveIncome" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_RetainedEarnings" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_RetainedEarnings"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="ifrs-full_RetainedEarnings" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_Equity" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_Equity"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_StatementOfFinancialPositionAbstract" xlink:to="ifrs-full_Equity" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_EquityAndLiabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_EquityAndLiabilities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_StatementOfFinancialPositionAbstract" xlink:to="ifrs-full_EquityAndLiabilities" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://encoreuranium.com/role/ConsolidatedComprehensiveIncome">
    <loc xlink:type="locator" xlink:label="ConsolidatedStatementsOfLossAndComprehensiveLossAbstract" xlink:href="cve-20221231.xsd#cve_ConsolidatedStatementsOfLossAndComprehensiveLossAbstract"/>
    <loc xlink:type="locator" xlink:label="ExpensesAbstract" xlink:href="cve-20221231.xsd#cve_ExpensesAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ConsolidatedStatementsOfLossAndComprehensiveLossAbstract" xlink:to="ExpensesAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="AccretionExpenses" xlink:href="cve-20221231.xsd#cve_AccretionExpenses"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ExpensesAbstract" xlink:to="AccretionExpenses" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DepreciationAndAmortisationExpense" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_DepreciationAndAmortisationExpense"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ExpensesAbstract" xlink:to="ifrs-full_DepreciationAndAmortisationExpense" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="CommunityEngagement" xlink:href="cve-20221231.xsd#cve_CommunityEngagement"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ExpensesAbstract" xlink:to="CommunityEngagement" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="Consulting" xlink:href="cve-20221231.xsd#cve_Consulting"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ExpensesAbstract" xlink:to="Consulting" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_GeneralAndAdministrativeExpense" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_GeneralAndAdministrativeExpense"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ExpensesAbstract" xlink:to="ifrs-full_GeneralAndAdministrativeExpense" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ImpairmentLossImpairmentGainAndReversalOfImpairmentLossDeterminedInAccordanceWithIFRS9" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_ImpairmentLossImpairmentGainAndReversalOfImpairmentLossDeterminedInAccordanceWithIFRS9"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ExpensesAbstract" xlink:to="ifrs-full_ImpairmentLossImpairmentGainAndReversalOfImpairmentLossDeterminedInAccordanceWithIFRS9" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_InterestExpense" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_InterestExpense"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ExpensesAbstract" xlink:to="ifrs-full_InterestExpense" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AdministrativeExpense" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_AdministrativeExpense"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ExpensesAbstract" xlink:to="ifrs-full_AdministrativeExpense" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ProfessionalFeesExpense" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_ProfessionalFeesExpense"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ExpensesAbstract" xlink:to="ifrs-full_ProfessionalFeesExpense" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ProjectInvestigationFess" xlink:href="cve-20221231.xsd#cve_ProjectInvestigationFess"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ExpensesAbstract" xlink:to="ProjectInvestigationFess" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CommunicationExpense" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_CommunicationExpense"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ExpensesAbstract" xlink:to="ifrs-full_CommunicationExpense" order="10.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ReclassificationAdjustmentsOnChangeInValueOfForwardElementsOfForwardContractsNetOfTax" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_ReclassificationAdjustmentsOnChangeInValueOfForwardElementsOfForwardContractsNetOfTax"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ExpensesAbstract" xlink:to="ifrs-full_ReclassificationAdjustmentsOnChangeInValueOfForwardElementsOfForwardContractsNetOfTax" order="11.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_TravelExpense" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_TravelExpense"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ExpensesAbstract" xlink:to="ifrs-full_TravelExpense" order="12.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="TransferAgentAndFilingFees" xlink:href="cve-20221231.xsd#cve_TransferAgentAndFilingFees"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ExpensesAbstract" xlink:to="TransferAgentAndFilingFees" order="13.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_WagesAndSalaries" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_WagesAndSalaries"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ExpensesAbstract" xlink:to="ifrs-full_WagesAndSalaries" order="14.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ExpenseFromSharebasedPaymentTransactionsWithEmployees" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_ExpenseFromSharebasedPaymentTransactionsWithEmployees"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ExpensesAbstract" xlink:to="ifrs-full_ExpenseFromSharebasedPaymentTransactionsWithEmployees" order="15.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ProfitLossFromOperatingActivities" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_ProfitLossFromOperatingActivities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ExpensesAbstract" xlink:to="ifrs-full_ProfitLossFromOperatingActivities" order="16.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_RevenueFromInterest" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_RevenueFromInterest"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ExpensesAbstract" xlink:to="ifrs-full_RevenueFromInterest" order="17.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="LossOnWriteoffOfSalesTaxRecoverable" xlink:href="cve-20221231.xsd#cve_LossOnWriteoffOfSalesTaxRecoverable"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ExpensesAbstract" xlink:to="LossOnWriteoffOfSalesTaxRecoverable" order="18.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ExpensesAbstract" xlink:to="ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss" order="19.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_GainsLossesOnDisposalsOfPropertyPlantAndEquipment" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_GainsLossesOnDisposalsOfPropertyPlantAndEquipment"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ExpensesAbstract" xlink:to="ifrs-full_GainsLossesOnDisposalsOfPropertyPlantAndEquipment" order="20.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_GainLossOnRemeasurementOfReimbursementRights" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_GainLossOnRemeasurementOfReimbursementRights"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ExpensesAbstract" xlink:to="ifrs-full_GainLossOnRemeasurementOfReimbursementRights" order="21.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="GainOnDisposalOfSubsidiary" xlink:href="cve-20221231.xsd#cve_GainOnDisposalOfSubsidiary"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ExpensesAbstract" xlink:to="GainOnDisposalOfSubsidiary" order="22.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="LossOnContractTerminations" xlink:href="cve-20221231.xsd#cve_LossOnContractTerminations"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ExpensesAbstract" xlink:to="LossOnContractTerminations" order="23.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="UnrealizedGainOnUraniumInvestment" xlink:href="cve-20221231.xsd#cve_UnrealizedGainOnUraniumInvestment"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ExpensesAbstract" xlink:to="UnrealizedGainOnUraniumInvestment" order="24.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="GainOnSaleOfUraniumInvestment" xlink:href="cve-20221231.xsd#cve_GainOnSaleOfUraniumInvestment"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ExpensesAbstract" xlink:to="GainOnSaleOfUraniumInvestment" order="25.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="UnrealizedGainOnMarketableSecurities" xlink:href="cve-20221231.xsd#cve_UnrealizedGainOnMarketableSecurities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ExpensesAbstract" xlink:to="UnrealizedGainOnMarketableSecurities" order="26.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_GainsLossesOnFairValueAdjustmentInvestmentProperty" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_GainsLossesOnFairValueAdjustmentInvestmentProperty"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ExpensesAbstract" xlink:to="ifrs-full_GainsLossesOnFairValueAdjustmentInvestmentProperty" order="27.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ProfitLoss" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_ProfitLoss"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ExpensesAbstract" xlink:to="ifrs-full_ProfitLoss" order="28.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_OtherComprehensiveIncomeNetOfTaxHedgesOfNetInvestmentsInForeignOperations" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_OtherComprehensiveIncomeNetOfTaxHedgesOfNetInvestmentsInForeignOperations"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ProfitLoss" xlink:to="ifrs-full_OtherComprehensiveIncomeNetOfTaxHedgesOfNetInvestmentsInForeignOperations" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ComprehensiveIncome" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_ComprehensiveIncome"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ExpensesAbstract" xlink:to="ifrs-full_ComprehensiveIncome" order="29.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_WeightedAverageShares" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_WeightedAverageShares"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ExpensesAbstract" xlink:to="ifrs-full_WeightedAverageShares" order="30.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AdjustedWeightedAverageShares" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_AdjustedWeightedAverageShares"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ExpensesAbstract" xlink:to="ifrs-full_AdjustedWeightedAverageShares" order="31.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_BasicEarningsLossPerShare" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_BasicEarningsLossPerShare"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ExpensesAbstract" xlink:to="ifrs-full_BasicEarningsLossPerShare" order="32.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://encoreuranium.com/role/ConsolidatedComprehensiveIncome_Parentheticals">
    <loc xlink:type="locator" xlink:label="ConsolidatedStatementsOfLossAndComprehensiveLossAbstract" xlink:href="cve-20221231.xsd#cve_ConsolidatedStatementsOfLossAndComprehensiveLossAbstract"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DilutedEarningsLossPerShare" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_DilutedEarningsLossPerShare"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ConsolidatedStatementsOfLossAndComprehensiveLossAbstract" xlink:to="ifrs-full_DilutedEarningsLossPerShare" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://encoreuranium.com/role/ConsolidatedCashFlow">
    <loc xlink:type="locator" xlink:label="ifrs-full_StatementOfCashFlowsAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_StatementOfCashFlowsAbstract"/>
    <loc xlink:type="locator" xlink:label="OperatingActivitiesAbstract" xlink:href="cve-20221231.xsd#cve_OperatingActivitiesAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_StatementOfCashFlowsAbstract" xlink:to="OperatingActivitiesAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ProfitLoss" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_ProfitLoss"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OperatingActivitiesAbstract" xlink:to="ifrs-full_ProfitLoss" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ItemsNotAffectingCashAbstract" xlink:href="cve-20221231.xsd#cve_ItemsNotAffectingCashAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OperatingActivitiesAbstract" xlink:to="ItemsNotAffectingCashAbstract" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="Accretion" xlink:href="cve-20221231.xsd#cve_Accretion"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ItemsNotAffectingCashAbstract" xlink:to="Accretion" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AdjustmentsForDepreciationAndAmortisationExpense" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_AdjustmentsForDepreciationAndAmortisationExpense"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ItemsNotAffectingCashAbstract" xlink:to="ifrs-full_AdjustmentsForDepreciationAndAmortisationExpense" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AdjustmentsForImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLoss" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_AdjustmentsForImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLoss"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ItemsNotAffectingCashAbstract" xlink:to="ifrs-full_AdjustmentsForImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLoss" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AdjustmentsForUnrealisedForeignExchangeLossesGains" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_AdjustmentsForUnrealisedForeignExchangeLossesGains"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ItemsNotAffectingCashAbstract" xlink:to="ifrs-full_AdjustmentsForUnrealisedForeignExchangeLossesGains" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AdjustmentsForSharebasedPayments" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_AdjustmentsForSharebasedPayments"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ItemsNotAffectingCashAbstract" xlink:to="ifrs-full_AdjustmentsForSharebasedPayments" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AdjustmentsForInterestIncome" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_AdjustmentsForInterestIncome"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ItemsNotAffectingCashAbstract" xlink:to="ifrs-full_AdjustmentsForInterestIncome" order="5.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AdjustmentsForDeferredTaxExpense" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_AdjustmentsForDeferredTaxExpense"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ItemsNotAffectingCashAbstract" xlink:to="ifrs-full_AdjustmentsForDeferredTaxExpense" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AdjustmentsForGainLossOnDisposalsPropertyPlantAndEquipment" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_AdjustmentsForGainLossOnDisposalsPropertyPlantAndEquipment"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ItemsNotAffectingCashAbstract" xlink:to="ifrs-full_AdjustmentsForGainLossOnDisposalsPropertyPlantAndEquipment" order="7.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="GainOnDisposalOfSubsidiary" xlink:href="cve-20221231.xsd#cve_GainOnDisposalOfSubsidiary"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ItemsNotAffectingCashAbstract" xlink:to="GainOnDisposalOfSubsidiary" order="8.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AdjustmentsForIncreaseDecreaseInEmployeeBenefitLiabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_AdjustmentsForIncreaseDecreaseInEmployeeBenefitLiabilities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ItemsNotAffectingCashAbstract" xlink:to="ifrs-full_AdjustmentsForIncreaseDecreaseInEmployeeBenefitLiabilities" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="UnrealizedGainOnUraniumInvestment" xlink:href="cve-20221231.xsd#cve_UnrealizedGainOnUraniumInvestment"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ItemsNotAffectingCashAbstract" xlink:to="UnrealizedGainOnUraniumInvestment" order="10.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="GainOnSaleOfUraniumInvestment" xlink:href="cve-20221231.xsd#cve_GainOnSaleOfUraniumInvestment"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ItemsNotAffectingCashAbstract" xlink:to="GainOnSaleOfUraniumInvestment" order="11.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AdjustmentsForFairValueGainsLosses" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_AdjustmentsForFairValueGainsLosses"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ItemsNotAffectingCashAbstract" xlink:to="ifrs-full_AdjustmentsForFairValueGainsLosses" order="12.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AdjustmentsForUndistributedProfitsOfAssociates" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_AdjustmentsForUndistributedProfitsOfAssociates"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ItemsNotAffectingCashAbstract" xlink:to="ifrs-full_AdjustmentsForUndistributedProfitsOfAssociates" order="13.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="ChangesInNonCashWorkingCapitalItemsAbstract" xlink:href="cve-20221231.xsd#cve_ChangesInNonCashWorkingCapitalItemsAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OperatingActivitiesAbstract" xlink:to="ChangesInNonCashWorkingCapitalItemsAbstract" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AdjustmentsForDecreaseIncreaseInOtherOperatingReceivables" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_AdjustmentsForDecreaseIncreaseInOtherOperatingReceivables"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ChangesInNonCashWorkingCapitalItemsAbstract" xlink:to="ifrs-full_AdjustmentsForDecreaseIncreaseInOtherOperatingReceivables" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AdjustmentsForIncreaseDecreaseInDepositsFromCustomers" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_AdjustmentsForIncreaseDecreaseInDepositsFromCustomers"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OperatingActivitiesAbstract" xlink:to="ifrs-full_AdjustmentsForIncreaseDecreaseInDepositsFromCustomers" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_OtherInflowsOutflowsOfCashClassifiedAsOperatingActivities" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_OtherInflowsOutflowsOfCashClassifiedAsOperatingActivities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_AdjustmentsForIncreaseDecreaseInDepositsFromCustomers" xlink:to="ifrs-full_OtherInflowsOutflowsOfCashClassifiedAsOperatingActivities" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAccountPayable" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAccountPayable"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_AdjustmentsForIncreaseDecreaseInDepositsFromCustomers" xlink:to="ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAccountPayable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CashReceiptsFromRepaymentOfAdvancesAndLoansMadeToRelatedParties" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_CashReceiptsFromRepaymentOfAdvancesAndLoansMadeToRelatedParties"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_AdjustmentsForIncreaseDecreaseInDepositsFromCustomers" xlink:to="ifrs-full_CashReceiptsFromRepaymentOfAdvancesAndLoansMadeToRelatedParties" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CashFlowsFromUsedInOperatingActivities" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_CashFlowsFromUsedInOperatingActivities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_AdjustmentsForIncreaseDecreaseInDepositsFromCustomers" xlink:to="ifrs-full_CashFlowsFromUsedInOperatingActivities" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="InvestingActivitiesAbstract" xlink:href="cve-20221231.xsd#cve_InvestingActivitiesAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OperatingActivitiesAbstract" xlink:to="InvestingActivitiesAbstract" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="InvestingActivitiesAbstract" xlink:to="ifrs-full_PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities" order="0.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="InvestingActivitiesAbstract" xlink:to="ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities" order="1.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_PurchaseOfInvestmentProperty" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_PurchaseOfInvestmentProperty"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="InvestingActivitiesAbstract" xlink:to="ifrs-full_PurchaseOfInvestmentProperty" order="2.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ProceedsFromSalesOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_ProceedsFromSalesOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="InvestingActivitiesAbstract" xlink:to="ifrs-full_ProceedsFromSalesOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="CashAcquiredFromAzargaAssetAcquisition" xlink:href="cve-20221231.xsd#cve_CashAcquiredFromAzargaAssetAcquisition"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="InvestingActivitiesAbstract" xlink:to="CashAcquiredFromAzargaAssetAcquisition" order="4.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="TransactionCostsOnAzargaAssetAcquisition" xlink:href="cve-20221231.xsd#cve_TransactionCostsOnAzargaAssetAcquisition"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="InvestingActivitiesAbstract" xlink:to="TransactionCostsOnAzargaAssetAcquisition" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CashFlowsUsedInObtainingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_CashFlowsUsedInObtainingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="InvestingActivitiesAbstract" xlink:to="ifrs-full_CashFlowsUsedInObtainingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities" order="6.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_InterestReceivedClassifiedAsInvestingActivities" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_InterestReceivedClassifiedAsInvestingActivities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="InvestingActivitiesAbstract" xlink:to="ifrs-full_InterestReceivedClassifiedAsInvestingActivities" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="PaymentsofInvestmentInUranium" xlink:href="cve-20221231.xsd#cve_PaymentsofInvestmentInUranium"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="InvestingActivitiesAbstract" xlink:to="PaymentsofInvestmentInUranium" order="8.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="ProceedsReceivedFromSaleOfUraniumInvestment" xlink:href="cve-20221231.xsd#cve_ProceedsReceivedFromSaleOfUraniumInvestment"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="InvestingActivitiesAbstract" xlink:to="ProceedsReceivedFromSaleOfUraniumInvestment" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_GainsLossesOnFinancialAssetsAtFairValueThroughProfitOrLoss" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_GainsLossesOnFinancialAssetsAtFairValueThroughProfitOrLoss"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="InvestingActivitiesAbstract" xlink:to="ifrs-full_GainsLossesOnFinancialAssetsAtFairValueThroughProfitOrLoss" order="10.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CashFlowsFromUsedInInvestingActivities" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_CashFlowsFromUsedInInvestingActivities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="InvestingActivitiesAbstract" xlink:to="ifrs-full_CashFlowsFromUsedInInvestingActivities" order="11.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="FinancingActivitiesAbstract" xlink:href="cve-20221231.xsd#cve_FinancingActivitiesAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OperatingActivitiesAbstract" xlink:to="FinancingActivitiesAbstract" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="PrivatePlacementProceeds" xlink:href="cve-20221231.xsd#cve_PrivatePlacementProceeds"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FinancingActivitiesAbstract" xlink:to="PrivatePlacementProceeds" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_PaymentsForShareIssueCosts" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_PaymentsForShareIssueCosts"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FinancingActivitiesAbstract" xlink:to="ifrs-full_PaymentsForShareIssueCosts" order="1.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ProceedsFromExerciseOfWarrants" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_ProceedsFromExerciseOfWarrants"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FinancingActivitiesAbstract" xlink:to="ifrs-full_ProceedsFromExerciseOfWarrants" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ProceedsFromExerciseOfOptions" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_ProceedsFromExerciseOfOptions"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FinancingActivitiesAbstract" xlink:to="ifrs-full_ProceedsFromExerciseOfOptions" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ProceedsFromIssuingShares" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_ProceedsFromIssuingShares"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FinancingActivitiesAbstract" xlink:to="ifrs-full_ProceedsFromIssuingShares" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_RepaymentsOfBorrowingsClassifiedAsFinancingActivities" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_RepaymentsOfBorrowingsClassifiedAsFinancingActivities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FinancingActivitiesAbstract" xlink:to="ifrs-full_RepaymentsOfBorrowingsClassifiedAsFinancingActivities" order="5.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FinancingActivitiesAbstract" xlink:to="ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities" order="6.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CashFlowsFromUsedInFinancingActivities" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_CashFlowsFromUsedInFinancingActivities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FinancingActivitiesAbstract" xlink:to="ifrs-full_CashFlowsFromUsedInFinancingActivities" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OperatingActivitiesAbstract" xlink:to="ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CashFlowsFromUsedInOperationsBeforeChangesInWorkingCapital" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_CashFlowsFromUsedInOperationsBeforeChangesInWorkingCapital"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OperatingActivitiesAbstract" xlink:to="ifrs-full_CashFlowsFromUsedInOperationsBeforeChangesInWorkingCapital" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CashAndCashEquivalents" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_CashAndCashEquivalents"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OperatingActivitiesAbstract" xlink:to="ifrs-full_CashAndCashEquivalents" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CashAndCashEquivalents_0" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_CashAndCashEquivalents"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OperatingActivitiesAbstract" xlink:to="ifrs-full_CashAndCashEquivalents_0" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://encoreuranium.com/role/ShareholdersEquityType2or3">
    <loc xlink:type="locator" xlink:label="ConsolidatedStatementsOfChangesInShareholderSEquityAbstract" xlink:href="cve-20221231.xsd#cve_ConsolidatedStatementsOfChangesInShareholderSEquityAbstract"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_StatementOfChangesInEquityTable" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_StatementOfChangesInEquityTable"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_StatementOfChangesInEquityLineItems" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_StatementOfChangesInEquityLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ConsolidatedStatementsOfChangesInShareholderSEquityAbstract" xlink:to="ifrs-full_StatementOfChangesInEquityTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ComponentsOfEquityAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_ComponentsOfEquityAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_StatementOfChangesInEquityTable" xlink:to="ifrs-full_ComponentsOfEquityAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ClassesOfShareCapitalMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_ClassesOfShareCapitalMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ComponentsOfEquityAxis" xlink:to="ifrs-full_ClassesOfShareCapitalMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_IssuedCapitalMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_IssuedCapitalMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ComponentsOfEquityAxis" xlink:to="ifrs-full_IssuedCapitalMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ContributedSurplusMember" xlink:href="cve-20221231.xsd#cve_ContributedSurplusMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ComponentsOfEquityAxis" xlink:to="ContributedSurplusMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AccumulatedOtherComprehensiveIncomeMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_AccumulatedOtherComprehensiveIncomeMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ComponentsOfEquityAxis" xlink:to="ifrs-full_AccumulatedOtherComprehensiveIncomeMember" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_RetainedEarningsMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_RetainedEarningsMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ComponentsOfEquityAxis" xlink:to="ifrs-full_RetainedEarningsMember" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_EquityMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_EquityMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ComponentsOfEquityAxis" xlink:to="ifrs-full_EquityMember" order="5.0"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_StatementOfChangesInEquityTable" xlink:to="ifrs-full_StatementOfChangesInEquityLineItems" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_Equity" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_Equity"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_StatementOfChangesInEquityLineItems" xlink:to="ifrs-full_Equity" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_NumberOfSharesOutstanding" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_NumberOfSharesOutstanding"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_StatementOfChangesInEquityLineItems" xlink:to="ifrs-full_NumberOfSharesOutstanding" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <loc xlink:type="locator" xlink:label="PrivatePlacement" xlink:href="cve-20221231.xsd#cve_PrivatePlacement"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_StatementOfChangesInEquityLineItems" xlink:to="PrivatePlacement" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="PrivatePlacementinShares" xlink:href="cve-20221231.xsd#cve_PrivatePlacementinShares"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_StatementOfChangesInEquityLineItems" xlink:to="PrivatePlacementinShares" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ShareIssueRelatedCost" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_ShareIssueRelatedCost"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_StatementOfChangesInEquityLineItems" xlink:to="ifrs-full_ShareIssueRelatedCost" order="4.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_IncreaseDecreaseThroughExerciseOfWarrantsEquity" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_IncreaseDecreaseThroughExerciseOfWarrantsEquity"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_StatementOfChangesInEquityLineItems" xlink:to="ifrs-full_IncreaseDecreaseThroughExerciseOfWarrantsEquity" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="SharesIssuedForExerciseOfWarrantsShares" xlink:href="cve-20221231.xsd#cve_SharesIssuedForExerciseOfWarrantsShares"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_StatementOfChangesInEquityLineItems" xlink:to="SharesIssuedForExerciseOfWarrantsShares" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_IncreaseDecreaseThroughExerciseOfOptions" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_IncreaseDecreaseThroughExerciseOfOptions"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_StatementOfChangesInEquityLineItems" xlink:to="ifrs-full_IncreaseDecreaseThroughExerciseOfOptions" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="SharesIssuedForExerciseOfStockOptionsShares" xlink:href="cve-20221231.xsd#cve_SharesIssuedForExerciseOfStockOptionsShares"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_StatementOfChangesInEquityLineItems" xlink:to="SharesIssuedForExerciseOfStockOptionsShares" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="StockOptionExpense" xlink:href="cve-20221231.xsd#cve_StockOptionExpense"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_StatementOfChangesInEquityLineItems" xlink:to="StockOptionExpense" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_IssueOfEquity" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_IssueOfEquity"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_StatementOfChangesInEquityLineItems" xlink:to="ifrs-full_IssueOfEquity" order="10.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="SharesIssuedForServicesShares" xlink:href="cve-20221231.xsd#cve_SharesIssuedForServicesShares"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_StatementOfChangesInEquityLineItems" xlink:to="SharesIssuedForServicesShares" order="11.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ShareSubscriptionsReceived" xlink:href="cve-20221231.xsd#cve_ShareSubscriptionsReceived"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_StatementOfChangesInEquityLineItems" xlink:to="ShareSubscriptionsReceived" order="12.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="SharesIssuedForAzargaAssetAcquisition" xlink:href="cve-20221231.xsd#cve_SharesIssuedForAzargaAssetAcquisition"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_StatementOfChangesInEquityLineItems" xlink:to="SharesIssuedForAzargaAssetAcquisition" order="13.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="SharesIssuedForAzargaAssetAcquisitionNote10Shares" xlink:href="cve-20221231.xsd#cve_SharesIssuedForAzargaAssetAcquisitionNote10Shares"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_StatementOfChangesInEquityLineItems" xlink:to="SharesIssuedForAzargaAssetAcquisitionNote10Shares" order="14.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ReplacementOptionsForAzargaAssetAcquisition" xlink:href="cve-20221231.xsd#cve_ReplacementOptionsForAzargaAssetAcquisition"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_StatementOfChangesInEquityLineItems" xlink:to="ReplacementOptionsForAzargaAssetAcquisition" order="15.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ReplacementWarrantsForAzargaAssetAcquisition" xlink:href="cve-20221231.xsd#cve_ReplacementWarrantsForAzargaAssetAcquisition"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_StatementOfChangesInEquityLineItems" xlink:to="ReplacementWarrantsForAzargaAssetAcquisition" order="16.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="AdjustmentToInvestmentInAssociate" xlink:href="cve-20221231.xsd#cve_AdjustmentToInvestmentInAssociate"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_StatementOfChangesInEquityLineItems" xlink:to="AdjustmentToInvestmentInAssociate" order="17.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationNetOfTax" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationNetOfTax"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_StatementOfChangesInEquityLineItems" xlink:to="ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationNetOfTax" order="18.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ProfitLoss" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_ProfitLoss"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_StatementOfChangesInEquityLineItems" xlink:to="ifrs-full_ProfitLoss" order="19.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_Equity_0" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_Equity"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_StatementOfChangesInEquityLineItems" xlink:to="ifrs-full_Equity_0" order="20.0" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_NumberOfSharesOutstanding_0" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_NumberOfSharesOutstanding"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_StatementOfChangesInEquityLineItems" xlink:to="ifrs-full_NumberOfSharesOutstanding_0" order="21.0" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://encoreuranium.com/role/NatureofOperationsandGoingConcern">
    <loc xlink:type="locator" xlink:label="NatureOfOperationAndGoingConcernAbstract" xlink:href="cve-20221231.xsd#cve_NatureOfOperationAndGoingConcernAbstract"/>
    <loc xlink:type="locator" xlink:label="NatureofOperationsandGoingConcernTable" xlink:href="cve-20221231.xsd#cve_NatureofOperationsandGoingConcernTable"/>
    <loc xlink:type="locator" xlink:label="NatureofOperationsandGoingConcernLineItems" xlink:href="cve-20221231.xsd#cve_NatureofOperationsandGoingConcernLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="NatureOfOperationAndGoingConcernAbstract" xlink:to="NatureofOperationsandGoingConcernTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="NatureofOperationsandGoingConcernTable" xlink:to="NatureofOperationsandGoingConcernLineItems" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="NatureOfOperationAndGoingConcern" xlink:href="cve-20221231.xsd#cve_NatureOfOperationAndGoingConcern"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="NatureofOperationsandGoingConcernLineItems" xlink:to="NatureOfOperationAndGoingConcern" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://encoreuranium.com/role/Significantaccountingpolicies">
    <loc xlink:type="locator" xlink:label="DisclosureOfSignificantAccountingPoliciesTextBlockAbstract" xlink:href="cve-20221231.xsd#cve_DisclosureOfSignificantAccountingPoliciesTextBlockAbstract"/>
    <loc xlink:type="locator" xlink:label="SignificantaccountingpoliciesTable" xlink:href="cve-20221231.xsd#cve_SignificantaccountingpoliciesTable"/>
    <loc xlink:type="locator" xlink:label="SignificantaccountingpoliciesLineItems" xlink:href="cve-20221231.xsd#cve_SignificantaccountingpoliciesLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisclosureOfSignificantAccountingPoliciesTextBlockAbstract" xlink:to="SignificantaccountingpoliciesTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SignificantaccountingpoliciesTable" xlink:to="SignificantaccountingpoliciesLineItems" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SignificantaccountingpoliciesLineItems" xlink:to="ifrs-full_DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://encoreuranium.com/role/CriticalAccountingEstimatesAndJudgements">
    <loc xlink:type="locator" xlink:label="DisclosureOfAccountingJudgementsAndEstimatesTextBlockAbstract" xlink:href="cve-20221231.xsd#cve_DisclosureOfAccountingJudgementsAndEstimatesTextBlockAbstract"/>
    <loc xlink:type="locator" xlink:label="CriticalAccountingEstimatesAndJudgementsTable" xlink:href="cve-20221231.xsd#cve_CriticalAccountingEstimatesAndJudgementsTable"/>
    <loc xlink:type="locator" xlink:label="CriticalAccountingEstimatesAndJudgementsLineItems" xlink:href="cve-20221231.xsd#cve_CriticalAccountingEstimatesAndJudgementsLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisclosureOfAccountingJudgementsAndEstimatesTextBlockAbstract" xlink:to="CriticalAccountingEstimatesAndJudgementsTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CriticalAccountingEstimatesAndJudgementsTable" xlink:to="CriticalAccountingEstimatesAndJudgementsLineItems" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfAccountingJudgementsAndEstimatesExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_DisclosureOfAccountingJudgementsAndEstimatesExplanatory"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CriticalAccountingEstimatesAndJudgementsLineItems" xlink:to="ifrs-full_DisclosureOfAccountingJudgementsAndEstimatesExplanatory" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://encoreuranium.com/role/InvestmentInAssociate">
    <loc xlink:type="locator" xlink:label="DisclosureOfAssociatesTextBlockAbstract" xlink:href="cve-20221231.xsd#cve_DisclosureOfAssociatesTextBlockAbstract"/>
    <loc xlink:type="locator" xlink:label="InvestmentInAssociateTable" xlink:href="cve-20221231.xsd#cve_InvestmentInAssociateTable"/>
    <loc xlink:type="locator" xlink:label="InvestmentInAssociateLineItems" xlink:href="cve-20221231.xsd#cve_InvestmentInAssociateLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisclosureOfAssociatesTextBlockAbstract" xlink:to="InvestmentInAssociateTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="InvestmentInAssociateTable" xlink:to="InvestmentInAssociateLineItems" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesExplanatory"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="InvestmentInAssociateLineItems" xlink:to="ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesExplanatory" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://encoreuranium.com/role/Investmentinuranium">
    <loc xlink:type="locator" xlink:label="DisclosureOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethodTextBlockAbstract" xlink:href="cve-20221231.xsd#cve_DisclosureOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethodTextBlockAbstract"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethodExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_DisclosureOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethodExplanatory"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisclosureOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethodTextBlockAbstract" xlink:to="ifrs-full_DisclosureOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethodExplanatory" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://encoreuranium.com/role/MarketableSecurities">
    <loc xlink:type="locator" xlink:label="DisclosureOfMarketRiskTextBlockAbstract" xlink:href="cve-20221231.xsd#cve_DisclosureOfMarketRiskTextBlockAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_MarketableSecuritiesTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MarketableSecuritiesTable"/>
    <loc xlink:type="locator" xlink:label="us-gaap_MarketableSecuritiesLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MarketableSecuritiesLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisclosureOfMarketRiskTextBlockAbstract" xlink:to="us-gaap_MarketableSecuritiesTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_MarketableSecuritiesTable" xlink:to="us-gaap_MarketableSecuritiesLineItems" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfMarketRiskExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_DisclosureOfMarketRiskExplanatory"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_MarketableSecuritiesLineItems" xlink:to="ifrs-full_DisclosureOfMarketRiskExplanatory" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://encoreuranium.com/role/Intangibleassets">
    <loc xlink:type="locator" xlink:label="DisclosureOfIntangibleAssetsTextBlockAbstract" xlink:href="cve-20221231.xsd#cve_DisclosureOfIntangibleAssetsTextBlockAbstract"/>
    <loc xlink:type="locator" xlink:label="IntangibleassetsTable" xlink:href="cve-20221231.xsd#cve_IntangibleassetsTable"/>
    <loc xlink:type="locator" xlink:label="IntangibleassetsLineItems" xlink:href="cve-20221231.xsd#cve_IntangibleassetsLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisclosureOfIntangibleAssetsTextBlockAbstract" xlink:to="IntangibleassetsTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IntangibleassetsTable" xlink:to="IntangibleassetsLineItems" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfIntangibleAssetsExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_DisclosureOfIntangibleAssetsExplanatory"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IntangibleassetsLineItems" xlink:to="ifrs-full_DisclosureOfIntangibleAssetsExplanatory" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://encoreuranium.com/role/Propertyplantandequipment">
    <loc xlink:type="locator" xlink:label="DisclosureOfPropertyPlantAndEquipmentTextBlockAbstract" xlink:href="cve-20221231.xsd#cve_DisclosureOfPropertyPlantAndEquipmentTextBlockAbstract"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfPropertyPlantAndEquipmentExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_DisclosureOfPropertyPlantAndEquipmentExplanatory"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisclosureOfPropertyPlantAndEquipmentTextBlockAbstract" xlink:to="ifrs-full_DisclosureOfPropertyPlantAndEquipmentExplanatory" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://encoreuranium.com/role/Rightofuseassets">
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfQuantitativeInformationAboutLeasesForLesseeAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_DisclosureOfQuantitativeInformationAboutLeasesForLesseeAbstract"/>
    <loc xlink:type="locator" xlink:label="RightofuseassetsTable" xlink:href="cve-20221231.xsd#cve_RightofuseassetsTable"/>
    <loc xlink:type="locator" xlink:label="RightofuseassetsLineItems" xlink:href="cve-20221231.xsd#cve_RightofuseassetsLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfQuantitativeInformationAboutLeasesForLesseeAbstract" xlink:to="RightofuseassetsTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RightofuseassetsTable" xlink:to="RightofuseassetsLineItems" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsExplanatory"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RightofuseassetsLineItems" xlink:to="ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsExplanatory" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://encoreuranium.com/role/Assetacquisition">
    <loc xlink:type="locator" xlink:label="DisclosureOfTransactionsRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombinationTextBlockAbstract" xlink:href="cve-20221231.xsd#cve_DisclosureOfTransactionsRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombinationTextBlockAbstract"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfTransactionsRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombinationExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_DisclosureOfTransactionsRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombinationExplanatory"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisclosureOfTransactionsRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombinationTextBlockAbstract" xlink:to="ifrs-full_DisclosureOfTransactionsRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombinationExplanatory" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://encoreuranium.com/role/MineralProperties">
    <loc xlink:type="locator" xlink:label="DisclosureOfMineralPropertiesAbstract" xlink:href="cve-20221231.xsd#cve_DisclosureOfMineralPropertiesAbstract"/>
    <loc xlink:type="locator" xlink:label="DisclosureOfMineralProperties" xlink:href="cve-20221231.xsd#cve_DisclosureOfMineralProperties"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisclosureOfMineralPropertiesAbstract" xlink:to="DisclosureOfMineralProperties" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://encoreuranium.com/role/Assetretirementobligations">
    <loc xlink:type="locator" xlink:label="AssetRetirementObligationsAbstract" xlink:href="cve-20221231.xsd#cve_AssetRetirementObligationsAbstract"/>
    <loc xlink:type="locator" xlink:label="AssetretirementobligationsTable" xlink:href="cve-20221231.xsd#cve_AssetretirementobligationsTable"/>
    <loc xlink:type="locator" xlink:label="AssetretirementobligationsLineItems" xlink:href="cve-20221231.xsd#cve_AssetretirementobligationsLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AssetRetirementObligationsAbstract" xlink:to="AssetretirementobligationsTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AssetretirementobligationsTable" xlink:to="AssetretirementobligationsLineItems" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="AssetRetirementObligationsTextBlock" xlink:href="cve-20221231.xsd#cve_AssetRetirementObligationsTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AssetretirementobligationsLineItems" xlink:to="AssetRetirementObligationsTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://encoreuranium.com/role/Salescontracts">
    <loc xlink:type="locator" xlink:label="DisclosueOfSalesContractsAbstract" xlink:href="cve-20221231.xsd#cve_DisclosueOfSalesContractsAbstract"/>
    <loc xlink:type="locator" xlink:label="SalescontractsTable" xlink:href="cve-20221231.xsd#cve_SalescontractsTable"/>
    <loc xlink:type="locator" xlink:label="SalescontractsLineItems" xlink:href="cve-20221231.xsd#cve_SalescontractsLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisclosueOfSalesContractsAbstract" xlink:to="SalescontractsTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SalescontractsTable" xlink:to="SalescontractsLineItems" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="DisclosueOfSalesContractsTextBlock" xlink:href="cve-20221231.xsd#cve_DisclosueOfSalesContractsTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SalescontractsLineItems" xlink:to="DisclosueOfSalesContractsTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://encoreuranium.com/role/ShareCapital">
    <loc xlink:type="locator" xlink:label="DisclosureOfClassesOfShareCapitalTextBlockAbstract" xlink:href="cve-20221231.xsd#cve_DisclosureOfClassesOfShareCapitalTextBlockAbstract"/>
    <loc xlink:type="locator" xlink:label="ShareCapitalTable" xlink:href="cve-20221231.xsd#cve_ShareCapitalTable"/>
    <loc xlink:type="locator" xlink:label="ShareCapitalLineItems" xlink:href="cve-20221231.xsd#cve_ShareCapitalLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisclosureOfClassesOfShareCapitalTextBlockAbstract" xlink:to="ShareCapitalTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareCapitalTable" xlink:to="ShareCapitalLineItems" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfClassesOfShareCapitalExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_DisclosureOfClassesOfShareCapitalExplanatory"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareCapitalLineItems" xlink:to="ifrs-full_DisclosureOfClassesOfShareCapitalExplanatory" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://encoreuranium.com/role/Relatedpartytransactionsandbalances">
    <loc xlink:type="locator" xlink:label="DisclosureOfRelatedPartyTextBlockAbstract" xlink:href="cve-20221231.xsd#cve_DisclosureOfRelatedPartyTextBlockAbstract"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfRelatedPartyExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_DisclosureOfRelatedPartyExplanatory"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisclosureOfRelatedPartyTextBlockAbstract" xlink:to="ifrs-full_DisclosureOfRelatedPartyExplanatory" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://encoreuranium.com/role/Managementofcapital">
    <loc xlink:type="locator" xlink:label="DisclosureOfHowEntityManagesLiquidityRiskTextBlockAbstract" xlink:href="cve-20221231.xsd#cve_DisclosureOfHowEntityManagesLiquidityRiskTextBlockAbstract"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DescriptionOfManagingLiquidityRisk" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_DescriptionOfManagingLiquidityRisk"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisclosureOfHowEntityManagesLiquidityRiskTextBlockAbstract" xlink:to="ifrs-full_DescriptionOfManagingLiquidityRisk" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://encoreuranium.com/role/FinancialInstruments">
    <loc xlink:type="locator" xlink:label="DisclosureOfFinancialInstrumentsTextBlockAbstract" xlink:href="cve-20221231.xsd#cve_DisclosureOfFinancialInstrumentsTextBlockAbstract"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfFinancialInstrumentsExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_DisclosureOfFinancialInstrumentsExplanatory"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisclosureOfFinancialInstrumentsTextBlockAbstract" xlink:to="ifrs-full_DisclosureOfFinancialInstrumentsExplanatory" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://encoreuranium.com/role/Segmentedinformation">
    <loc xlink:type="locator" xlink:label="DisclosureOfEntitysOperatingSegmentsTextBlockAbstract" xlink:href="cve-20221231.xsd#cve_DisclosureOfEntitysOperatingSegmentsTextBlockAbstract"/>
    <loc xlink:type="locator" xlink:label="SegmentedinformationTable" xlink:href="cve-20221231.xsd#cve_SegmentedinformationTable"/>
    <loc xlink:type="locator" xlink:label="SegmentedinformationLineItems" xlink:href="cve-20221231.xsd#cve_SegmentedinformationLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisclosureOfEntitysOperatingSegmentsTextBlockAbstract" xlink:to="SegmentedinformationTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SegmentedinformationTable" xlink:to="SegmentedinformationLineItems" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfEntitysReportableSegmentsExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_DisclosureOfEntitysReportableSegmentsExplanatory"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SegmentedinformationLineItems" xlink:to="ifrs-full_DisclosureOfEntitysReportableSegmentsExplanatory" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://encoreuranium.com/role/Supplementaldisclosurewithrespecttocashflows">
    <loc xlink:type="locator" xlink:label="SupplementalDisclosureWithRespectToCashflowsAbstract" xlink:href="cve-20221231.xsd#cve_SupplementalDisclosureWithRespectToCashflowsAbstract"/>
    <loc xlink:type="locator" xlink:label="SupplementalDisclosureWithRespectToCashflowsTextBlock" xlink:href="cve-20221231.xsd#cve_SupplementalDisclosureWithRespectToCashflowsTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SupplementalDisclosureWithRespectToCashflowsAbstract" xlink:to="SupplementalDisclosureWithRespectToCashflowsTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://encoreuranium.com/role/Incometaxes">
    <loc xlink:type="locator" xlink:label="DisclosureOfIncomeTaxTextBlockAbstract" xlink:href="cve-20221231.xsd#cve_DisclosureOfIncomeTaxTextBlockAbstract"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfIncomeTaxExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_DisclosureOfIncomeTaxExplanatory"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisclosureOfIncomeTaxTextBlockAbstract" xlink:to="ifrs-full_DisclosureOfIncomeTaxExplanatory" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://encoreuranium.com/role/ChangeinPresentationCurrency">
    <loc xlink:type="locator" xlink:label="DisclosureOfReclassificationsOrChangesInPresentationTextBlockAbstract" xlink:href="cve-20221231.xsd#cve_DisclosureOfReclassificationsOrChangesInPresentationTextBlockAbstract"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfReclassificationsOrChangesInPresentationExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_DisclosureOfReclassificationsOrChangesInPresentationExplanatory"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisclosureOfReclassificationsOrChangesInPresentationTextBlockAbstract" xlink:to="ifrs-full_DisclosureOfReclassificationsOrChangesInPresentationExplanatory" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://encoreuranium.com/role/Eventsafterthereportingperiod">
    <loc xlink:type="locator" xlink:label="DisclosureOfEventsAfterReportingPeriodTextBlockAbstract" xlink:href="cve-20221231.xsd#cve_DisclosureOfEventsAfterReportingPeriodTextBlockAbstract"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfEventsAfterReportingPeriodExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_DisclosureOfEventsAfterReportingPeriodExplanatory"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisclosureOfEventsAfterReportingPeriodTextBlockAbstract" xlink:to="ifrs-full_DisclosureOfEventsAfterReportingPeriodExplanatory" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://encoreuranium.com/role/AccountingPoliciesByPolicy">
    <loc xlink:type="locator" xlink:label="us-gaap_AccountingPoliciesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <loc xlink:type="locator" xlink:label="DescriptionOfAccountingPolicyForBasisOfPresentationtextBlock" xlink:href="cve-20221231.xsd#cve_DescriptionOfAccountingPolicyForBasisOfPresentationtextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="DescriptionOfAccountingPolicyForBasisOfPresentationtextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="DescriptionOfAccountingPolicyForChangeInPresentationCurrencytextBlock" xlink:href="cve-20221231.xsd#cve_DescriptionOfAccountingPolicyForChangeInPresentationCurrencytextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="DescriptionOfAccountingPolicyForChangeInPresentationCurrencytextBlock" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="DescriptionOfAccountingPolicyForBasisOfConsolidationtextBlock" xlink:href="cve-20221231.xsd#cve_DescriptionOfAccountingPolicyForBasisOfConsolidationtextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="DescriptionOfAccountingPolicyForBasisOfConsolidationtextBlock" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="DescriptionOfAccountingPolicyForCashtextBlock" xlink:href="cve-20221231.xsd#cve_DescriptionOfAccountingPolicyForCashtextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="DescriptionOfAccountingPolicyForCashtextBlock" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DescriptionOfAccountingPolicyToDetermineComponentsOfCashAndCashEquivalents" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_DescriptionOfAccountingPolicyToDetermineComponentsOfCashAndCashEquivalents"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="ifrs-full_DescriptionOfAccountingPolicyToDetermineComponentsOfCashAndCashEquivalents" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="DescriptionOfAccountingPolicyForAssetRetirementObligationstextBlock" xlink:href="cve-20221231.xsd#cve_DescriptionOfAccountingPolicyForAssetRetirementObligationstextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="DescriptionOfAccountingPolicyForAssetRetirementObligationstextBlock" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForAvailableforsaleFinancialAssetsExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_DescriptionOfAccountingPolicyForAvailableforsaleFinancialAssetsExplanatory"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="ifrs-full_DescriptionOfAccountingPolicyForAvailableforsaleFinancialAssetsExplanatory" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="DescriptionOfAccountingPolicyForMineralPropertiestextBlock" xlink:href="cve-20221231.xsd#cve_DescriptionOfAccountingPolicyForMineralPropertiestextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="DescriptionOfAccountingPolicyForMineralPropertiestextBlock" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="DescriptionOfAccountingPolicyForInvestmentsInUraniumtextBlock" xlink:href="cve-20221231.xsd#cve_DescriptionOfAccountingPolicyForInvestmentsInUraniumtextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="DescriptionOfAccountingPolicyForInvestmentsInUraniumtextBlock" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForInvestmentInAssociates" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_DescriptionOfAccountingPolicyForInvestmentInAssociates"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="ifrs-full_DescriptionOfAccountingPolicyForInvestmentInAssociates" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="ifrs-full_DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory" order="10.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="DescriptionOfAccountingPolicyForUraniumPlantstextBlock" xlink:href="cve-20221231.xsd#cve_DescriptionOfAccountingPolicyForUraniumPlantstextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="DescriptionOfAccountingPolicyForUraniumPlantstextBlock" order="11.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="DescriptionOfAccountingPolicyForOtherPropertyPlantAndEquipmenttextBlock" xlink:href="cve-20221231.xsd#cve_DescriptionOfAccountingPolicyForOtherPropertyPlantAndEquipmenttextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="DescriptionOfAccountingPolicyForOtherPropertyPlantAndEquipmenttextBlock" order="12.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="DescriptionOfAccountingPolicyForBuildingtextBlock" xlink:href="cve-20221231.xsd#cve_DescriptionOfAccountingPolicyForBuildingtextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="DescriptionOfAccountingPolicyForBuildingtextBlock" order="13.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="DescriptionOfAccountingPolicyForSoftwaretextBlock" xlink:href="cve-20221231.xsd#cve_DescriptionOfAccountingPolicyForSoftwaretextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="DescriptionOfAccountingPolicyForSoftwaretextBlock" order="14.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForIntangibleAssetsAndGoodwillExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_DescriptionOfAccountingPolicyForIntangibleAssetsAndGoodwillExplanatory"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="ifrs-full_DescriptionOfAccountingPolicyForIntangibleAssetsAndGoodwillExplanatory" order="15.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForImpairmentOfNonfinancialAssetsExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_DescriptionOfAccountingPolicyForImpairmentOfNonfinancialAssetsExplanatory"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="ifrs-full_DescriptionOfAccountingPolicyForImpairmentOfNonfinancialAssetsExplanatory" order="16.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForLeasesExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_DescriptionOfAccountingPolicyForLeasesExplanatory"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="ifrs-full_DescriptionOfAccountingPolicyForLeasesExplanatory" order="17.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForIncomeTaxExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_DescriptionOfAccountingPolicyForIncomeTaxExplanatory"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="ifrs-full_DescriptionOfAccountingPolicyForIncomeTaxExplanatory" order="18.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" order="19.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForEarningsPerShareExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_DescriptionOfAccountingPolicyForEarningsPerShareExplanatory"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="ifrs-full_DescriptionOfAccountingPolicyForEarningsPerShareExplanatory" order="20.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_DescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="ifrs-full_DescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory" order="21.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForWarrantsExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_DescriptionOfAccountingPolicyForWarrantsExplanatory"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="ifrs-full_DescriptionOfAccountingPolicyForWarrantsExplanatory" order="22.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForFinancialInstrumentsExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_DescriptionOfAccountingPolicyForFinancialInstrumentsExplanatory"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="ifrs-full_DescriptionOfAccountingPolicyForFinancialInstrumentsExplanatory" order="23.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForImpairmentOfFinancialAssetsExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_DescriptionOfAccountingPolicyForImpairmentOfFinancialAssetsExplanatory"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="ifrs-full_DescriptionOfAccountingPolicyForImpairmentOfFinancialAssetsExplanatory" order="24.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForDerecognitionOfFinancialInstrumentsExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_DescriptionOfAccountingPolicyForDerecognitionOfFinancialInstrumentsExplanatory"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="ifrs-full_DescriptionOfAccountingPolicyForDerecognitionOfFinancialInstrumentsExplanatory" order="25.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="DescriptionOfAccountingPolicyForNewStandardsAndInterpretationsNotYetAdoptedtextBlock" xlink:href="cve-20221231.xsd#cve_DescriptionOfAccountingPolicyForNewStandardsAndInterpretationsNotYetAdoptedtextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="DescriptionOfAccountingPolicyForNewStandardsAndInterpretationsNotYetAdoptedtextBlock" order="26.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://encoreuranium.com/role/SignificantaccountingpoliciesTables">
    <loc xlink:type="locator" xlink:label="DisclosureOfSignificantAccountingPoliciesTextBlockAbstract" xlink:href="cve-20221231.xsd#cve_DisclosureOfSignificantAccountingPoliciesTextBlockAbstract"/>
    <loc xlink:type="locator" xlink:label="SignificantaccountingpoliciesTablesTable" xlink:href="cve-20221231.xsd#cve_SignificantaccountingpoliciesTablesTable"/>
    <loc xlink:type="locator" xlink:label="SignificantaccountingpoliciesTablesLineItems" xlink:href="cve-20221231.xsd#cve_SignificantaccountingpoliciesTablesLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisclosureOfSignificantAccountingPoliciesTextBlockAbstract" xlink:to="SignificantaccountingpoliciesTablesTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SignificantaccountingpoliciesTablesTable" xlink:to="SignificantaccountingpoliciesTablesLineItems" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfEffectOfChangesInForeignExchangeRatesExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_DisclosureOfEffectOfChangesInForeignExchangeRatesExplanatory"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SignificantaccountingpoliciesTablesLineItems" xlink:to="ifrs-full_DisclosureOfEffectOfChangesInForeignExchangeRatesExplanatory" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesExplanatory"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SignificantaccountingpoliciesTablesLineItems" xlink:to="ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesExplanatory" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="DisclosureOfUsefulLivesOfPropertyPlantAndEquipementTextBlock" xlink:href="cve-20221231.xsd#cve_DisclosureOfUsefulLivesOfPropertyPlantAndEquipementTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SignificantaccountingpoliciesTablesLineItems" xlink:to="DisclosureOfUsefulLivesOfPropertyPlantAndEquipementTextBlock" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="DisclosureOfUsefulLivesOfIntangibleAssetsTextBllock" xlink:href="cve-20221231.xsd#cve_DisclosureOfUsefulLivesOfIntangibleAssetsTextBllock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SignificantaccountingpoliciesTablesLineItems" xlink:to="DisclosureOfUsefulLivesOfIntangibleAssetsTextBllock" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://encoreuranium.com/role/InvestmentInAssociateTables">
    <loc xlink:type="locator" xlink:label="DisclosureOfAssociatesTextBlockAbstract" xlink:href="cve-20221231.xsd#cve_DisclosureOfAssociatesTextBlockAbstract"/>
    <loc xlink:type="locator" xlink:label="InvestmentInAssociateTablesTable" xlink:href="cve-20221231.xsd#cve_InvestmentInAssociateTablesTable"/>
    <loc xlink:type="locator" xlink:label="InvestmentInAssociateTablesLineItems" xlink:href="cve-20221231.xsd#cve_InvestmentInAssociateTablesLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisclosureOfAssociatesTextBlockAbstract" xlink:to="InvestmentInAssociateTablesTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="InvestmentInAssociateTablesTable" xlink:to="InvestmentInAssociateTablesLineItems" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="DisclosureOfProportionalShareAssociatesExplanatory" xlink:href="cve-20221231.xsd#cve_DisclosureOfProportionalShareAssociatesExplanatory"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="InvestmentInAssociateTablesLineItems" xlink:to="DisclosureOfProportionalShareAssociatesExplanatory" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfInterestsInAssociatesExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_DisclosureOfInterestsInAssociatesExplanatory"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="InvestmentInAssociateTablesLineItems" xlink:to="ifrs-full_DisclosureOfInterestsInAssociatesExplanatory" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://encoreuranium.com/role/InvestmentinuraniumTables">
    <loc xlink:type="locator" xlink:label="DisclosureOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethodTextBlockAbstract" xlink:href="cve-20221231.xsd#cve_DisclosureOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethodTextBlockAbstract"/>
    <loc xlink:type="locator" xlink:label="ScheduleOfTheFairValueOfThePhysicalUraniumInvestmentTableTextBlck" xlink:href="cve-20221231.xsd#cve_ScheduleOfTheFairValueOfThePhysicalUraniumInvestmentTableTextBlck"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisclosureOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethodTextBlockAbstract" xlink:to="ScheduleOfTheFairValueOfThePhysicalUraniumInvestmentTableTextBlck" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ScheduleOfUraniumConcentratesPurchaseAgreementTableTextBlock" xlink:href="cve-20221231.xsd#cve_ScheduleOfUraniumConcentratesPurchaseAgreementTableTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisclosureOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethodTextBlockAbstract" xlink:to="ScheduleOfUraniumConcentratesPurchaseAgreementTableTextBlock" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://encoreuranium.com/role/MarketableSecuritiesTables">
    <loc xlink:type="locator" xlink:label="DisclosureOfMarketRiskTextBlockAbstract" xlink:href="cve-20221231.xsd#cve_DisclosureOfMarketRiskTextBlockAbstract"/>
    <loc xlink:type="locator" xlink:label="MarketableSecuritiesTablesTable" xlink:href="cve-20221231.xsd#cve_MarketableSecuritiesTablesTable"/>
    <loc xlink:type="locator" xlink:label="MarketableSecuritiesTablesLineItems" xlink:href="cve-20221231.xsd#cve_MarketableSecuritiesTablesLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisclosureOfMarketRiskTextBlockAbstract" xlink:to="MarketableSecuritiesTablesTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="MarketableSecuritiesTablesTable" xlink:to="MarketableSecuritiesTablesLineItems" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ScheduleOfMarketableSecuritiesTableTextBlock" xlink:href="cve-20221231.xsd#cve_ScheduleOfMarketableSecuritiesTableTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="MarketableSecuritiesTablesLineItems" xlink:to="ScheduleOfMarketableSecuritiesTableTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://encoreuranium.com/role/IntangibleassetsTables">
    <loc xlink:type="locator" xlink:label="DisclosureOfIntangibleAssetsTextBlockAbstract" xlink:href="cve-20221231.xsd#cve_DisclosureOfIntangibleAssetsTextBlockAbstract"/>
    <loc xlink:type="locator" xlink:label="IntangibleassetsTablesTable" xlink:href="cve-20221231.xsd#cve_IntangibleassetsTablesTable"/>
    <loc xlink:type="locator" xlink:label="IntangibleassetsTablesLineItems" xlink:href="cve-20221231.xsd#cve_IntangibleassetsTablesLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisclosureOfIntangibleAssetsTextBlockAbstract" xlink:to="IntangibleassetsTablesTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IntangibleassetsTablesTable" xlink:to="IntangibleassetsTablesLineItems" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfDetailedInformationAboutIntangibleAssetsExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_DisclosureOfDetailedInformationAboutIntangibleAssetsExplanatory"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IntangibleassetsTablesLineItems" xlink:to="ifrs-full_DisclosureOfDetailedInformationAboutIntangibleAssetsExplanatory" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://encoreuranium.com/role/PropertyplantandequipmentTables">
    <loc xlink:type="locator" xlink:label="DisclosureOfPropertyPlantAndEquipmentTextBlockAbstract" xlink:href="cve-20221231.xsd#cve_DisclosureOfPropertyPlantAndEquipmentTextBlockAbstract"/>
    <loc xlink:type="locator" xlink:label="PropertyplantandequipmentTablesTable" xlink:href="cve-20221231.xsd#cve_PropertyplantandequipmentTablesTable"/>
    <loc xlink:type="locator" xlink:label="PropertyplantandequipmentTablesLineItems" xlink:href="cve-20221231.xsd#cve_PropertyplantandequipmentTablesLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisclosureOfPropertyPlantAndEquipmentTextBlockAbstract" xlink:to="PropertyplantandequipmentTablesTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="PropertyplantandequipmentTablesTable" xlink:to="PropertyplantandequipmentTablesLineItems" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="PropertyplantandequipmentTablesLineItems" xlink:to="ifrs-full_DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://encoreuranium.com/role/RightofuseassetsTables">
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfQuantitativeInformationAboutLeasesForLesseeAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_DisclosureOfQuantitativeInformationAboutLeasesForLesseeAbstract"/>
    <loc xlink:type="locator" xlink:label="RightofuseassetsTablesTable" xlink:href="cve-20221231.xsd#cve_RightofuseassetsTablesTable"/>
    <loc xlink:type="locator" xlink:label="RightofuseassetsTablesLineItems" xlink:href="cve-20221231.xsd#cve_RightofuseassetsTablesLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfQuantitativeInformationAboutLeasesForLesseeAbstract" xlink:to="RightofuseassetsTablesTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RightofuseassetsTablesTable" xlink:to="RightofuseassetsTablesLineItems" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="DisclosureOfChangeInTheROUAssetsTableTextBlock" xlink:href="cve-20221231.xsd#cve_DisclosureOfChangeInTheROUAssetsTableTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RightofuseassetsTablesLineItems" xlink:to="DisclosureOfChangeInTheROUAssetsTableTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="DisclosureOfChangeInTheLongTermLeaseLiabilityTableTextBlock" xlink:href="cve-20221231.xsd#cve_DisclosureOfChangeInTheLongTermLeaseLiabilityTableTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RightofuseassetsTablesLineItems" xlink:to="DisclosureOfChangeInTheLongTermLeaseLiabilityTableTextBlock" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_MaturityAnalysisForDerivativeFinancialLiabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_MaturityAnalysisForDerivativeFinancialLiabilities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RightofuseassetsTablesLineItems" xlink:to="ifrs-full_MaturityAnalysisForDerivativeFinancialLiabilities" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://encoreuranium.com/role/AssetacquisitionTables">
    <loc xlink:type="locator" xlink:label="DisclosureOfTransactionsRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombinationTextBlockAbstract" xlink:href="cve-20221231.xsd#cve_DisclosureOfTransactionsRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombinationTextBlockAbstract"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfFairValueMeasurementOfAssetsExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_DisclosureOfFairValueMeasurementOfAssetsExplanatory"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisclosureOfTransactionsRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombinationTextBlockAbstract" xlink:to="ifrs-full_DisclosureOfFairValueMeasurementOfAssetsExplanatory" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfRedesignatedFinancialAssetsAndLiabilitiesExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_DisclosureOfRedesignatedFinancialAssetsAndLiabilitiesExplanatory"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisclosureOfTransactionsRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombinationTextBlockAbstract" xlink:to="ifrs-full_DisclosureOfRedesignatedFinancialAssetsAndLiabilitiesExplanatory" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfIndirectMeasurementOfFairValueOfGoodsOrServicesReceivedShareOptionsGrantedDuringPeriodExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_DisclosureOfIndirectMeasurementOfFairValueOfGoodsOrServicesReceivedShareOptionsGrantedDuringPeriodExplanatory"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisclosureOfTransactionsRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombinationTextBlockAbstract" xlink:to="ifrs-full_DisclosureOfIndirectMeasurementOfFairValueOfGoodsOrServicesReceivedShareOptionsGrantedDuringPeriodExplanatory" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://encoreuranium.com/role/MineralPropertiesTables">
    <loc xlink:type="locator" xlink:label="DisclosureOfMineralPropertiesAbstract" xlink:href="cve-20221231.xsd#cve_DisclosureOfMineralPropertiesAbstract"/>
    <loc xlink:type="locator" xlink:label="ScheduleOfMineralProperties" xlink:href="cve-20221231.xsd#cve_ScheduleOfMineralProperties"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisclosureOfMineralPropertiesAbstract" xlink:to="ScheduleOfMineralProperties" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://encoreuranium.com/role/AssetretirementobligationsTables">
    <loc xlink:type="locator" xlink:label="AssetRetirementObligationsAbstract" xlink:href="cve-20221231.xsd#cve_AssetRetirementObligationsAbstract"/>
    <loc xlink:type="locator" xlink:label="AssetretirementobligationsTablesTable" xlink:href="cve-20221231.xsd#cve_AssetretirementobligationsTablesTable"/>
    <loc xlink:type="locator" xlink:label="AssetretirementobligationsTablesLineItems" xlink:href="cve-20221231.xsd#cve_AssetretirementobligationsTablesLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AssetRetirementObligationsAbstract" xlink:to="AssetretirementobligationsTablesTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AssetretirementobligationsTablesTable" xlink:to="AssetretirementobligationsTablesLineItems" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="DisclosureOfAssetRetirementObligationsBalanceTableTextBlock" xlink:href="cve-20221231.xsd#cve_DisclosureOfAssetRetirementObligationsBalanceTableTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AssetretirementobligationsTablesLineItems" xlink:to="DisclosureOfAssetRetirementObligationsBalanceTableTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="DisclosureOfAssetRetirementObligationsContinuityTableTextBlock" xlink:href="cve-20221231.xsd#cve_DisclosureOfAssetRetirementObligationsContinuityTableTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AssetretirementobligationsTablesLineItems" xlink:to="DisclosureOfAssetRetirementObligationsContinuityTableTextBlock" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://encoreuranium.com/role/SalescontractsTables">
    <loc xlink:type="locator" xlink:label="DisclosueOfSalesContractsAbstract" xlink:href="cve-20221231.xsd#cve_DisclosueOfSalesContractsAbstract"/>
    <loc xlink:type="locator" xlink:label="SalescontractsTablesTable" xlink:href="cve-20221231.xsd#cve_SalescontractsTablesTable"/>
    <loc xlink:type="locator" xlink:label="SalescontractsTablesLineItems" xlink:href="cve-20221231.xsd#cve_SalescontractsTablesLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisclosueOfSalesContractsAbstract" xlink:to="SalescontractsTablesTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SalescontractsTablesTable" xlink:to="SalescontractsTablesLineItems" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfMaturityAnalysisForFinancialAssetsHeldForManagingLiquidityRiskExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_DisclosureOfMaturityAnalysisForFinancialAssetsHeldForManagingLiquidityRiskExplanatory"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SalescontractsTablesLineItems" xlink:to="ifrs-full_DisclosureOfMaturityAnalysisForFinancialAssetsHeldForManagingLiquidityRiskExplanatory" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://encoreuranium.com/role/ShareCapitalTables">
    <loc xlink:type="locator" xlink:label="DisclosureOfClassesOfShareCapitalTextBlockAbstract" xlink:href="cve-20221231.xsd#cve_DisclosureOfClassesOfShareCapitalTextBlockAbstract"/>
    <loc xlink:type="locator" xlink:label="ShareCapitalTablesTable" xlink:href="cve-20221231.xsd#cve_ShareCapitalTablesTable"/>
    <loc xlink:type="locator" xlink:label="ShareCapitalTablesLineItems" xlink:href="cve-20221231.xsd#cve_ShareCapitalTablesLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisclosureOfClassesOfShareCapitalTextBlockAbstract" xlink:to="ShareCapitalTablesTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareCapitalTablesTable" xlink:to="ShareCapitalTablesLineItems" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ScheduleOfTheCompanysStockOptionsOutstandingTableTextBlock" xlink:href="cve-20221231.xsd#cve_ScheduleOfTheCompanysStockOptionsOutstandingTableTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareCapitalTablesLineItems" xlink:to="ScheduleOfTheCompanysStockOptionsOutstandingTableTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ScheduleOfStockOptionsOutstandingTableTextBlock" xlink:href="cve-20221231.xsd#cve_ScheduleOfStockOptionsOutstandingTableTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareCapitalTablesLineItems" xlink:to="ScheduleOfStockOptionsOutstandingTableTextBlock" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ScheduleOfWeightedAverageAssumptionsUsedInCalculatingTheFairValuesTableTextBlock" xlink:href="cve-20221231.xsd#cve_ScheduleOfWeightedAverageAssumptionsUsedInCalculatingTheFairValuesTableTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareCapitalTablesLineItems" xlink:to="ScheduleOfWeightedAverageAssumptionsUsedInCalculatingTheFairValuesTableTextBlock" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ScheduleOfTheStatusOfTheCompanysWarrantsTableTextBlock" xlink:href="cve-20221231.xsd#cve_ScheduleOfTheStatusOfTheCompanysWarrantsTableTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareCapitalTablesLineItems" xlink:to="ScheduleOfTheStatusOfTheCompanysWarrantsTableTextBlock" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ScheduleOfSharePurchaseWarrantsOutstandingTableTextBlock" xlink:href="cve-20221231.xsd#cve_ScheduleOfSharePurchaseWarrantsOutstandingTableTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareCapitalTablesLineItems" xlink:to="ScheduleOfSharePurchaseWarrantsOutstandingTableTextBlock" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://encoreuranium.com/role/RelatedpartytransactionsandbalancesTables">
    <loc xlink:type="locator" xlink:label="DisclosureOfRelatedPartyTextBlockAbstract" xlink:href="cve-20221231.xsd#cve_DisclosureOfRelatedPartyTextBlockAbstract"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfGeneralAndAdministrativeExpenseExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_DisclosureOfGeneralAndAdministrativeExpenseExplanatory"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisclosureOfRelatedPartyTextBlockAbstract" xlink:to="ifrs-full_DisclosureOfGeneralAndAdministrativeExpenseExplanatory" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesExplanatory"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisclosureOfRelatedPartyTextBlockAbstract" xlink:to="ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesExplanatory" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://encoreuranium.com/role/FinancialInstrumentsTables">
    <loc xlink:type="locator" xlink:label="DisclosureOfFinancialInstrumentsTextBlockAbstract" xlink:href="cve-20221231.xsd#cve_DisclosureOfFinancialInstrumentsTextBlockAbstract"/>
    <loc xlink:type="locator" xlink:label="ScheduleOfFinancialInstrumentTableTextBlock" xlink:href="cve-20221231.xsd#cve_ScheduleOfFinancialInstrumentTableTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisclosureOfFinancialInstrumentsTextBlockAbstract" xlink:to="ScheduleOfFinancialInstrumentTableTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://encoreuranium.com/role/SegmentedinformationTables">
    <loc xlink:type="locator" xlink:label="DisclosureOfEntitysOperatingSegmentsTextBlockAbstract" xlink:href="cve-20221231.xsd#cve_DisclosureOfEntitysOperatingSegmentsTextBlockAbstract"/>
    <loc xlink:type="locator" xlink:label="SegmentedinformationTablesTable" xlink:href="cve-20221231.xsd#cve_SegmentedinformationTablesTable"/>
    <loc xlink:type="locator" xlink:label="SegmentedinformationTablesLineItems" xlink:href="cve-20221231.xsd#cve_SegmentedinformationTablesLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisclosureOfEntitysOperatingSegmentsTextBlockAbstract" xlink:to="SegmentedinformationTablesTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SegmentedinformationTablesTable" xlink:to="SegmentedinformationTablesLineItems" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="DisclosureOfLongtermAssetsByGeographicSegmentTableTextBlock" xlink:href="cve-20221231.xsd#cve_DisclosureOfLongtermAssetsByGeographicSegmentTableTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SegmentedinformationTablesLineItems" xlink:to="DisclosureOfLongtermAssetsByGeographicSegmentTableTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://encoreuranium.com/role/SupplementaldisclosurewithrespecttocashflowsTables">
    <loc xlink:type="locator" xlink:label="SupplementalDisclosureWithRespectToCashflowsAbstract" xlink:href="cve-20221231.xsd#cve_SupplementalDisclosureWithRespectToCashflowsAbstract"/>
    <loc xlink:type="locator" xlink:label="ScheduleOfIncurredNoncashFinancingAndInvestingActivitiesTableTextBlock" xlink:href="cve-20221231.xsd#cve_ScheduleOfIncurredNoncashFinancingAndInvestingActivitiesTableTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SupplementalDisclosureWithRespectToCashflowsAbstract" xlink:to="ScheduleOfIncurredNoncashFinancingAndInvestingActivitiesTableTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://encoreuranium.com/role/IncometaxesTables">
    <loc xlink:type="locator" xlink:label="DisclosureOfIncomeTaxTextBlockAbstract" xlink:href="cve-20221231.xsd#cve_DisclosureOfIncomeTaxTextBlockAbstract"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsExplanatory"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisclosureOfIncomeTaxTextBlockAbstract" xlink:to="ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsExplanatory" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfInterestIncomeExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_DisclosureOfInterestIncomeExplanatory"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisclosureOfIncomeTaxTextBlockAbstract" xlink:to="ifrs-full_DisclosureOfInterestIncomeExplanatory" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisclosureOfIncomeTaxTextBlockAbstract" xlink:to="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfDeferredTaxesExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_DisclosureOfDeferredTaxesExplanatory"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisclosureOfIncomeTaxTextBlockAbstract" xlink:to="ifrs-full_DisclosureOfDeferredTaxesExplanatory" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://encoreuranium.com/role/ChangeinPresentationCurrencyTables">
    <loc xlink:type="locator" xlink:label="DisclosureOfReclassificationsOrChangesInPresentationTextBlockAbstract" xlink:href="cve-20221231.xsd#cve_DisclosureOfReclassificationsOrChangesInPresentationTextBlockAbstract"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForForeignCurrencyTranslationExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_DescriptionOfAccountingPolicyForForeignCurrencyTranslationExplanatory"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisclosureOfReclassificationsOrChangesInPresentationTextBlockAbstract" xlink:to="ifrs-full_DescriptionOfAccountingPolicyForForeignCurrencyTranslationExplanatory" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfFinancialInstrumentsAtFairValueThroughProfitOrLossExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_DisclosureOfFinancialInstrumentsAtFairValueThroughProfitOrLossExplanatory"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisclosureOfReclassificationsOrChangesInPresentationTextBlockAbstract" xlink:to="ifrs-full_DisclosureOfFinancialInstrumentsAtFairValueThroughProfitOrLossExplanatory" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://encoreuranium.com/role/ScheduleofexchangeratesTable">
    <loc xlink:type="locator" xlink:label="ScheduleOfExchangeRatesAbstract" xlink:href="cve-20221231.xsd#cve_ScheduleOfExchangeRatesAbstract"/>
    <loc xlink:type="locator" xlink:label="SignificantaccountingpoliciesDetailsScheduleofexchangeratesTable" xlink:href="cve-20221231.xsd#cve_SignificantaccountingpoliciesDetailsScheduleofexchangeratesTable"/>
    <loc xlink:type="locator" xlink:label="SignificantaccountingpoliciesDetailsScheduleofexchangeratesLineItems" xlink:href="cve-20221231.xsd#cve_SignificantaccountingpoliciesDetailsScheduleofexchangeratesLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfExchangeRatesAbstract" xlink:to="SignificantaccountingpoliciesDetailsScheduleofexchangeratesTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_SegmentsAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_SegmentsAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SignificantaccountingpoliciesDetailsScheduleofexchangeratesTable" xlink:to="ifrs-full_SegmentsAxis" order="1.0"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_SegmentsMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_SegmentsMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_SegmentsAxis" xlink:to="ifrs-full_SegmentsMember" order="0.0"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SignificantaccountingpoliciesDetailsScheduleofexchangeratesTable" xlink:to="SignificantaccountingpoliciesDetailsScheduleofexchangeratesLineItems" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ClosingForeignExchangeRate" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_ClosingForeignExchangeRate"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SignificantaccountingpoliciesDetailsScheduleofexchangeratesLineItems" xlink:to="ifrs-full_ClosingForeignExchangeRate" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AverageForeignExchangeRate" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_AverageForeignExchangeRate"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SignificantaccountingpoliciesDetailsScheduleofexchangeratesLineItems" xlink:to="ifrs-full_AverageForeignExchangeRate" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://encoreuranium.com/role/ScheduleofsignificantsubsidiariesTable">
    <loc xlink:type="locator" xlink:label="ScheduleOfSignificantSubsidiariesAbstract" xlink:href="cve-20221231.xsd#cve_ScheduleOfSignificantSubsidiariesAbstract"/>
    <loc xlink:type="locator" xlink:label="SignificantaccountingpoliciesDetailsScheduleofsignificantsubsidiariesTable" xlink:href="cve-20221231.xsd#cve_SignificantaccountingpoliciesDetailsScheduleofsignificantsubsidiariesTable"/>
    <loc xlink:type="locator" xlink:label="SignificantaccountingpoliciesDetailsScheduleofsignificantsubsidiariesLineItems" xlink:href="cve-20221231.xsd#cve_SignificantaccountingpoliciesDetailsScheduleofsignificantsubsidiariesLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfSignificantSubsidiariesAbstract" xlink:to="SignificantaccountingpoliciesDetailsScheduleofsignificantsubsidiariesTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CategoriesOfRelatedPartiesAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_CategoriesOfRelatedPartiesAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SignificantaccountingpoliciesDetailsScheduleofsignificantsubsidiariesTable" xlink:to="ifrs-full_CategoriesOfRelatedPartiesAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="TigrisUraniumUSCorpMember" xlink:href="cve-20221231.xsd#cve_TigrisUraniumUSCorpMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CategoriesOfRelatedPartiesAxis" xlink:to="TigrisUraniumUSCorpMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="MetaminEnterprisesUSIncMember" xlink:href="cve-20221231.xsd#cve_MetaminEnterprisesUSIncMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CategoriesOfRelatedPartiesAxis" xlink:to="MetaminEnterprisesUSIncMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="URIIncMember" xlink:href="cve-20221231.xsd#cve_URIIncMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CategoriesOfRelatedPartiesAxis" xlink:to="URIIncMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="NeutronEnergyIncMember" xlink:href="cve-20221231.xsd#cve_NeutronEnergyIncMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CategoriesOfRelatedPartiesAxis" xlink:to="NeutronEnergyIncMember" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="UrancoIncMember" xlink:href="cve-20221231.xsd#cve_UrancoIncMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CategoriesOfRelatedPartiesAxis" xlink:to="UrancoIncMember" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="UraniumResourcesIncMember" xlink:href="cve-20221231.xsd#cve_UraniumResourcesIncMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CategoriesOfRelatedPartiesAxis" xlink:to="UraniumResourcesIncMember" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="HRIChurchrockIncMember" xlink:href="cve-20221231.xsd#cve_HRIChurchrockIncMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CategoriesOfRelatedPartiesAxis" xlink:to="HRIChurchrockIncMember" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="HydroRestorationCorpMember" xlink:href="cve-20221231.xsd#cve_HydroRestorationCorpMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CategoriesOfRelatedPartiesAxis" xlink:to="HydroRestorationCorpMember" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="BeltLineResourcesIncMember" xlink:href="cve-20221231.xsd#cve_BeltLineResourcesIncMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CategoriesOfRelatedPartiesAxis" xlink:to="BeltLineResourcesIncMember" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="CibolaResourcesLLCMember" xlink:href="cve-20221231.xsd#cve_CibolaResourcesLLCMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CategoriesOfRelatedPartiesAxis" xlink:to="CibolaResourcesLLCMember" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="enCoreEnergyUSCorpMember" xlink:href="cve-20221231.xsd#cve_enCoreEnergyUSCorpMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CategoriesOfRelatedPartiesAxis" xlink:to="enCoreEnergyUSCorpMember" order="10.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="AzargaUraniumCorpMember" xlink:href="cve-20221231.xsd#cve_AzargaUraniumCorpMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CategoriesOfRelatedPartiesAxis" xlink:to="AzargaUraniumCorpMember" order="11.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="PowertechUSAIncMember" xlink:href="cve-20221231.xsd#cve_PowertechUSAIncMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CategoriesOfRelatedPartiesAxis" xlink:to="PowertechUSAIncMember" order="12.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="URZEnergyCorpMember" xlink:href="cve-20221231.xsd#cve_URZEnergyCorpMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CategoriesOfRelatedPartiesAxis" xlink:to="URZEnergyCorpMember" order="13.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="UcoloExplorationCorpMember" xlink:href="cve-20221231.xsd#cve_UcoloExplorationCorpMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CategoriesOfRelatedPartiesAxis" xlink:to="UcoloExplorationCorpMember" order="14.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="AzargaResourcesLimitedMember" xlink:href="cve-20221231.xsd#cve_AzargaResourcesLimitedMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CategoriesOfRelatedPartiesAxis" xlink:to="AzargaResourcesLimitedMember" order="15.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="AzargaResourcesHongKongLtdMember" xlink:href="cve-20221231.xsd#cve_AzargaResourcesHongKongLtdMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CategoriesOfRelatedPartiesAxis" xlink:to="AzargaResourcesHongKongLtdMember" order="16.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="AzargaResourcesUSACompanyMember" xlink:href="cve-20221231.xsd#cve_AzargaResourcesUSACompanyMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CategoriesOfRelatedPartiesAxis" xlink:to="AzargaResourcesUSACompanyMember" order="17.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="AzargaResourcesCanadaLtdMember" xlink:href="cve-20221231.xsd#cve_AzargaResourcesCanadaLtdMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CategoriesOfRelatedPartiesAxis" xlink:to="AzargaResourcesCanadaLtdMember" order="18.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SignificantaccountingpoliciesDetailsScheduleofsignificantsubsidiariesTable" xlink:to="SignificantaccountingpoliciesDetailsScheduleofsignificantsubsidiariesLineItems" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="NameofSubsidaryPlaceOfIncorporation" xlink:href="cve-20221231.xsd#cve_NameofSubsidaryPlaceOfIncorporation"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SignificantaccountingpoliciesDetailsScheduleofsignificantsubsidiariesLineItems" xlink:to="NameofSubsidaryPlaceOfIncorporation" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ProportionOfOwnershipInterestInSubsidiary" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_ProportionOfOwnershipInterestInSubsidiary"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SignificantaccountingpoliciesDetailsScheduleofsignificantsubsidiariesLineItems" xlink:to="ifrs-full_ProportionOfOwnershipInterestInSubsidiary" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="NameofSubsidaryPrincipalActivity" xlink:href="cve-20221231.xsd#cve_NameofSubsidaryPrincipalActivity"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SignificantaccountingpoliciesDetailsScheduleofsignificantsubsidiariesLineItems" xlink:to="NameofSubsidaryPrincipalActivity" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="NameofSubsidaryFunctionalCurrency" xlink:href="cve-20221231.xsd#cve_NameofSubsidaryFunctionalCurrency"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SignificantaccountingpoliciesDetailsScheduleofsignificantsubsidiariesLineItems" xlink:to="NameofSubsidaryFunctionalCurrency" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://encoreuranium.com/role/ScheduleofusefullivesofpropertyplantandequipementTable">
    <loc xlink:type="locator" xlink:label="ScheduleOfUsefulLivesOfPropertyPlantAndEquipementAbstract" xlink:href="cve-20221231.xsd#cve_ScheduleOfUsefulLivesOfPropertyPlantAndEquipementAbstract"/>
    <loc xlink:type="locator" xlink:label="SignificantaccountingpoliciesDetailsScheduleofusefullivesofpropertyplantandequipementTable" xlink:href="cve-20221231.xsd#cve_SignificantaccountingpoliciesDetailsScheduleofusefullivesofpropertyplantandequipementTable"/>
    <loc xlink:type="locator" xlink:label="SignificantaccountingpoliciesDetailsScheduleofusefullivesofpropertyplantandequipementLineItems" xlink:href="cve-20221231.xsd#cve_SignificantaccountingpoliciesDetailsScheduleofusefullivesofpropertyplantandequipementLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfUsefulLivesOfPropertyPlantAndEquipementAbstract" xlink:to="SignificantaccountingpoliciesDetailsScheduleofusefullivesofpropertyplantandequipementTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_RangeAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_RangeAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SignificantaccountingpoliciesDetailsScheduleofusefullivesofpropertyplantandequipementTable" xlink:to="ifrs-full_RangeAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_BottomOfRangeMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_BottomOfRangeMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_RangeAxis" xlink:to="ifrs-full_BottomOfRangeMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_TopOfRangeMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_TopOfRangeMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_RangeAxis" xlink:to="ifrs-full_TopOfRangeMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_IntangibleAssetsWithIndefiniteUsefulLifeAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_IntangibleAssetsWithIndefiniteUsefulLifeAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SignificantaccountingpoliciesDetailsScheduleofusefullivesofpropertyplantandequipementTable" xlink:to="ifrs-full_IntangibleAssetsWithIndefiniteUsefulLifeAxis" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="UraniumPlantsMember" xlink:href="cve-20221231.xsd#cve_UraniumPlantsMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_IntangibleAssetsWithIndefiniteUsefulLifeAxis" xlink:to="UraniumPlantsMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_OtherPropertyPlantAndEquipmentMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_OtherPropertyPlantAndEquipmentMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_IntangibleAssetsWithIndefiniteUsefulLifeAxis" xlink:to="ifrs-full_OtherPropertyPlantAndEquipmentMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="SoftwareMember" xlink:href="cve-20221231.xsd#cve_SoftwareMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_IntangibleAssetsWithIndefiniteUsefulLifeAxis" xlink:to="SoftwareMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="FurnitureMember" xlink:href="cve-20221231.xsd#cve_FurnitureMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_IntangibleAssetsWithIndefiniteUsefulLifeAxis" xlink:to="FurnitureMember" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_BuildingsMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_BuildingsMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_IntangibleAssetsWithIndefiniteUsefulLifeAxis" xlink:to="ifrs-full_BuildingsMember" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SignificantaccountingpoliciesDetailsScheduleofusefullivesofpropertyplantandequipementTable" xlink:to="SignificantaccountingpoliciesDetailsScheduleofusefullivesofpropertyplantandequipementLineItems" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="PropertyPlantAndEquipmentRange" xlink:href="cve-20221231.xsd#cve_PropertyPlantAndEquipmentRange"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SignificantaccountingpoliciesDetailsScheduleofusefullivesofpropertyplantandequipementLineItems" xlink:to="PropertyPlantAndEquipmentRange" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://encoreuranium.com/role/ScheduleofusefullivesofintangibleassetsTable">
    <loc xlink:type="locator" xlink:label="ScheduleOfUsefulLivesOfIntangibleAssetsAbstract" xlink:href="cve-20221231.xsd#cve_ScheduleOfUsefulLivesOfIntangibleAssetsAbstract"/>
    <loc xlink:type="locator" xlink:label="SignificantaccountingpoliciesDetailsScheduleofusefullivesofintangibleassetsTable" xlink:href="cve-20221231.xsd#cve_SignificantaccountingpoliciesDetailsScheduleofusefullivesofintangibleassetsTable"/>
    <loc xlink:type="locator" xlink:label="SignificantaccountingpoliciesDetailsScheduleofusefullivesofintangibleassetsLineItems" xlink:href="cve-20221231.xsd#cve_SignificantaccountingpoliciesDetailsScheduleofusefullivesofintangibleassetsLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfUsefulLivesOfIntangibleAssetsAbstract" xlink:to="SignificantaccountingpoliciesDetailsScheduleofusefullivesofintangibleassetsTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CategoriesOfRelatedPartiesAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_CategoriesOfRelatedPartiesAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SignificantaccountingpoliciesDetailsScheduleofusefullivesofintangibleassetsTable" xlink:to="ifrs-full_CategoriesOfRelatedPartiesAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="DataAccessAgreementMember" xlink:href="cve-20221231.xsd#cve_DataAccessAgreementMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CategoriesOfRelatedPartiesAxis" xlink:to="DataAccessAgreementMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="DataPurchasesMember" xlink:href="cve-20221231.xsd#cve_DataPurchasesMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CategoriesOfRelatedPartiesAxis" xlink:to="DataPurchasesMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SignificantaccountingpoliciesDetailsScheduleofusefullivesofintangibleassetsTable" xlink:to="SignificantaccountingpoliciesDetailsScheduleofusefullivesofintangibleassetsLineItems" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="CategoryRange" xlink:href="cve-20221231.xsd#cve_CategoryRange"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SignificantaccountingpoliciesDetailsScheduleofusefullivesofintangibleassetsLineItems" xlink:to="CategoryRange" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://encoreuranium.com/role/ScheduleofproportionalshareintheassociateTable">
    <loc xlink:type="locator" xlink:label="ScheduleOfProportionalShareInTheAssociateAbstract" xlink:href="cve-20221231.xsd#cve_ScheduleOfProportionalShareInTheAssociateAbstract"/>
    <loc xlink:type="locator" xlink:label="InvestmentInAssociateDetailsScheduleofproportionalshareintheassociateTable" xlink:href="cve-20221231.xsd#cve_InvestmentInAssociateDetailsScheduleofproportionalshareintheassociateTable"/>
    <loc xlink:type="locator" xlink:label="InvestmentInAssociateDetailsScheduleofproportionalshareintheassociateLineItems" xlink:href="cve-20221231.xsd#cve_InvestmentInAssociateDetailsScheduleofproportionalshareintheassociateLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfProportionalShareInTheAssociateAbstract" xlink:to="InvestmentInAssociateDetailsScheduleofproportionalshareintheassociateTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_SegmentsAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_SegmentsAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="InvestmentInAssociateDetailsScheduleofproportionalshareintheassociateTable" xlink:to="ifrs-full_SegmentsAxis" order="1.0"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_SegmentsMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_SegmentsMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_SegmentsAxis" xlink:to="ifrs-full_SegmentsMember" order="0.0"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="InvestmentInAssociateDetailsScheduleofproportionalshareintheassociateTable" xlink:to="InvestmentInAssociateDetailsScheduleofproportionalshareintheassociateLineItems" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_OtherCurrentAssets" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_OtherCurrentAssets"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="InvestmentInAssociateDetailsScheduleofproportionalshareintheassociateLineItems" xlink:to="ifrs-full_OtherCurrentAssets" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_OtherCurrentLiabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_OtherCurrentLiabilities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="InvestmentInAssociateDetailsScheduleofproportionalshareintheassociateLineItems" xlink:to="ifrs-full_OtherCurrentLiabilities" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="OtherRevenuesCurrent" xlink:href="cve-20221231.xsd#cve_OtherRevenuesCurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="InvestmentInAssociateDetailsScheduleofproportionalshareintheassociateLineItems" xlink:to="OtherRevenuesCurrent" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ExpensesCurrent" xlink:href="cve-20221231.xsd#cve_ExpensesCurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="InvestmentInAssociateDetailsScheduleofproportionalshareintheassociateLineItems" xlink:to="ExpensesCurrent" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_OtherNoncurrentAssets" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_OtherNoncurrentAssets"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="InvestmentInAssociateDetailsScheduleofproportionalshareintheassociateLineItems" xlink:to="ifrs-full_OtherNoncurrentAssets" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_OtherNoncurrentLiabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_OtherNoncurrentLiabilities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="InvestmentInAssociateDetailsScheduleofproportionalshareintheassociateLineItems" xlink:to="ifrs-full_OtherNoncurrentLiabilities" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="OtherRevenuesNoncurrent" xlink:href="cve-20221231.xsd#cve_OtherRevenuesNoncurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="InvestmentInAssociateDetailsScheduleofproportionalshareintheassociateLineItems" xlink:to="OtherRevenuesNoncurrent" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ExpensesNoncurrent" xlink:href="cve-20221231.xsd#cve_ExpensesNoncurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="InvestmentInAssociateDetailsScheduleofproportionalshareintheassociateLineItems" xlink:to="ExpensesNoncurrent" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="AssetsLossFromOperatingExpenses" xlink:href="cve-20221231.xsd#cve_AssetsLossFromOperatingExpenses"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="InvestmentInAssociateDetailsScheduleofproportionalshareintheassociateLineItems" xlink:to="AssetsLossFromOperatingExpenses" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="LiabilitiesLossFromOperatingExpenses" xlink:href="cve-20221231.xsd#cve_LiabilitiesLossFromOperatingExpenses"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="InvestmentInAssociateDetailsScheduleofproportionalshareintheassociateLineItems" xlink:to="LiabilitiesLossFromOperatingExpenses" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="RevenuesLossFromOperatingExpenses" xlink:href="cve-20221231.xsd#cve_RevenuesLossFromOperatingExpenses"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="InvestmentInAssociateDetailsScheduleofproportionalshareintheassociateLineItems" xlink:to="RevenuesLossFromOperatingExpenses" order="10.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ExpensesLossFromOperatingExpenses" xlink:href="cve-20221231.xsd#cve_ExpensesLossFromOperatingExpenses"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="InvestmentInAssociateDetailsScheduleofproportionalshareintheassociateLineItems" xlink:to="ExpensesLossFromOperatingExpenses" order="11.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_OtherAssets" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_OtherAssets"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="InvestmentInAssociateDetailsScheduleofproportionalshareintheassociateLineItems" xlink:to="ifrs-full_OtherAssets" order="12.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_OtherLiabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_OtherLiabilities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="InvestmentInAssociateDetailsScheduleofproportionalshareintheassociateLineItems" xlink:to="ifrs-full_OtherLiabilities" order="13.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_OtherRevenue" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_OtherRevenue"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="InvestmentInAssociateDetailsScheduleofproportionalshareintheassociateLineItems" xlink:to="ifrs-full_OtherRevenue" order="14.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_OtherOperatingIncomeExpense" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_OtherOperatingIncomeExpense"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="InvestmentInAssociateDetailsScheduleofproportionalshareintheassociateLineItems" xlink:to="ifrs-full_OtherOperatingIncomeExpense" order="15.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="YearEndedDecember312022Abstract" xlink:href="cve-20221231.xsd#cve_YearEndedDecember312022Abstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="InvestmentInAssociateDetailsScheduleofproportionalshareintheassociateLineItems" xlink:to="YearEndedDecember312022Abstract" order="16.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_TaxRateEffectOfForeignTaxRates" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_TaxRateEffectOfForeignTaxRates"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="InvestmentInAssociateDetailsScheduleofproportionalshareintheassociateLineItems" xlink:to="ifrs-full_TaxRateEffectOfForeignTaxRates" order="17.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://encoreuranium.com/role/ScheduleofinvestmentinassociatecontinuityTable">
    <loc xlink:type="locator" xlink:label="ScheduleOfInvestmentInAssociateContinuityAbstract" xlink:href="cve-20221231.xsd#cve_ScheduleOfInvestmentInAssociateContinuityAbstract"/>
    <loc xlink:type="locator" xlink:label="InvestmentInAssociateDetailsScheduleofinvestmentinassociatecontinuityTable" xlink:href="cve-20221231.xsd#cve_InvestmentInAssociateDetailsScheduleofinvestmentinassociatecontinuityTable"/>
    <loc xlink:type="locator" xlink:label="InvestmentInAssociateDetailsScheduleofinvestmentinassociatecontinuityLineItems" xlink:href="cve-20221231.xsd#cve_InvestmentInAssociateDetailsScheduleofinvestmentinassociatecontinuityLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfInvestmentInAssociateContinuityAbstract" xlink:to="InvestmentInAssociateDetailsScheduleofinvestmentinassociatecontinuityTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_SegmentsAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_SegmentsAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="InvestmentInAssociateDetailsScheduleofinvestmentinassociatecontinuityTable" xlink:to="ifrs-full_SegmentsAxis" order="1.0"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_SegmentsMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_SegmentsMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_SegmentsAxis" xlink:to="ifrs-full_SegmentsMember" order="0.0"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="InvestmentInAssociateDetailsScheduleofinvestmentinassociatecontinuityTable" xlink:to="InvestmentInAssociateDetailsScheduleofinvestmentinassociatecontinuityLineItems" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="InvestmentBalance1" xlink:href="cve-20221231.xsd#cve_InvestmentBalance1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="InvestmentInAssociateDetailsScheduleofinvestmentinassociatecontinuityLineItems" xlink:to="InvestmentBalance1" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <loc xlink:type="locator" xlink:label="AdjustmentsToCarryingValueAbstract" xlink:href="cve-20221231.xsd#cve_AdjustmentsToCarryingValueAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="InvestmentInAssociateDetailsScheduleofinvestmentinassociatecontinuityLineItems" xlink:to="AdjustmentsToCarryingValueAbstract" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ProportionateShareOfNetLoss" xlink:href="cve-20221231.xsd#cve_ProportionateShareOfNetLoss"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AdjustmentsToCarryingValueAbstract" xlink:to="ProportionateShareOfNetLoss" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="AdjustmentToInvestmentInGroup11" xlink:href="cve-20221231.xsd#cve_AdjustmentToInvestmentInGroup11"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AdjustmentsToCarryingValueAbstract" xlink:to="AdjustmentToInvestmentInGroup11" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="WriteoffOfInvestment" xlink:href="cve-20221231.xsd#cve_WriteoffOfInvestment"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AdjustmentsToCarryingValueAbstract" xlink:to="WriteoffOfInvestment" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="DilutionLoss" xlink:href="cve-20221231.xsd#cve_DilutionLoss"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AdjustmentsToCarryingValueAbstract" xlink:to="DilutionLoss" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="CurrencyTranslationAdjustment" xlink:href="cve-20221231.xsd#cve_CurrencyTranslationAdjustment"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AdjustmentsToCarryingValueAbstract" xlink:to="CurrencyTranslationAdjustment" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="InvestmentBalance1_0" xlink:href="cve-20221231.xsd#cve_InvestmentBalance1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="InvestmentInAssociateDetailsScheduleofinvestmentinassociatecontinuityLineItems" xlink:to="InvestmentBalance1_0" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://encoreuranium.com/role/ScheduleofthefairvalueofthephysicaluraniuminvestmentTable">
    <loc xlink:type="locator" xlink:label="ScheduleOfTheFairValueOfThePhysicalUraniumInvestmentAbstract" xlink:href="cve-20221231.xsd#cve_ScheduleOfTheFairValueOfThePhysicalUraniumInvestmentAbstract"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CurrentInvestments" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_CurrentInvestments"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfTheFairValueOfThePhysicalUraniumInvestmentAbstract" xlink:to="ifrs-full_CurrentInvestments" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <loc xlink:type="locator" xlink:label="PhysicalUranium" xlink:href="cve-20221231.xsd#cve_PhysicalUranium"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfTheFairValueOfThePhysicalUraniumInvestmentAbstract" xlink:to="PhysicalUranium" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AdjustmentsForGainsLossesOnChangeInFairValueOfDerivatives" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_AdjustmentsForGainsLossesOnChangeInFairValueOfDerivatives"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfTheFairValueOfThePhysicalUraniumInvestmentAbstract" xlink:to="ifrs-full_AdjustmentsForGainsLossesOnChangeInFairValueOfDerivatives" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="GainOnSaleOfUranium" xlink:href="cve-20221231.xsd#cve_GainOnSaleOfUranium"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfTheFairValueOfThePhysicalUraniumInvestmentAbstract" xlink:to="GainOnSaleOfUranium" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="SaleOfUraniumInvestment" xlink:href="cve-20221231.xsd#cve_SaleOfUraniumInvestment"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfTheFairValueOfThePhysicalUraniumInvestmentAbstract" xlink:to="SaleOfUraniumInvestment" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_OtherComprehensiveIncomeNetOfTaxChangeInValueOfForeignCurrencyBasisSpreads" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_OtherComprehensiveIncomeNetOfTaxChangeInValueOfForeignCurrencyBasisSpreads"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfTheFairValueOfThePhysicalUraniumInvestmentAbstract" xlink:to="ifrs-full_OtherComprehensiveIncomeNetOfTaxChangeInValueOfForeignCurrencyBasisSpreads" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CurrentInvestments_0" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_CurrentInvestments"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfTheFairValueOfThePhysicalUraniumInvestmentAbstract" xlink:to="ifrs-full_CurrentInvestments_0" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://encoreuranium.com/role/ScheduleofuraniumconcentratespurchaseagreementTable">
    <loc xlink:type="locator" xlink:label="ScheduleOfUraniumConcentratesPurchaseAgreementAbstract" xlink:href="cve-20221231.xsd#cve_ScheduleOfUraniumConcentratesPurchaseAgreementAbstract"/>
    <loc xlink:type="locator" xlink:label="InvestmentinuraniumDetailsScheduleofuraniumconcentratespurchaseagreementTable" xlink:href="cve-20221231.xsd#cve_InvestmentinuraniumDetailsScheduleofuraniumconcentratespurchaseagreementTable"/>
    <loc xlink:type="locator" xlink:label="InvestmentinuraniumDetailsScheduleofuraniumconcentratespurchaseagreementLineItems" xlink:href="cve-20221231.xsd#cve_InvestmentinuraniumDetailsScheduleofuraniumconcentratespurchaseagreementLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfUraniumConcentratesPurchaseAgreementAbstract" xlink:to="InvestmentinuraniumDetailsScheduleofuraniumconcentratespurchaseagreementTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_UnconsolidatedStructuredEntitiesAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_UnconsolidatedStructuredEntitiesAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="InvestmentinuraniumDetailsScheduleofuraniumconcentratespurchaseagreementTable" xlink:to="ifrs-full_UnconsolidatedStructuredEntitiesAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="Fiscal2023Member" xlink:href="cve-20221231.xsd#cve_Fiscal2023Member"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_UnconsolidatedStructuredEntitiesAxis" xlink:to="Fiscal2023Member" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="Fiscal2024Member" xlink:href="cve-20221231.xsd#cve_Fiscal2024Member"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_UnconsolidatedStructuredEntitiesAxis" xlink:to="Fiscal2024Member" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="Fiscal2025Member" xlink:href="cve-20221231.xsd#cve_Fiscal2025Member"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_UnconsolidatedStructuredEntitiesAxis" xlink:to="Fiscal2025Member" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="Fiscal2026Member" xlink:href="cve-20221231.xsd#cve_Fiscal2026Member"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_UnconsolidatedStructuredEntitiesAxis" xlink:to="Fiscal2026Member" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="Fiscal2027Member" xlink:href="cve-20221231.xsd#cve_Fiscal2027Member"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_UnconsolidatedStructuredEntitiesAxis" xlink:to="Fiscal2027Member" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="InvestmentinuraniumDetailsScheduleofuraniumconcentratespurchaseagreementTable" xlink:to="InvestmentinuraniumDetailsScheduleofuraniumconcentratespurchaseagreementLineItems" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="PurchaseCommitments" xlink:href="cve-20221231.xsd#cve_PurchaseCommitments"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="InvestmentinuraniumDetailsScheduleofuraniumconcentratespurchaseagreementLineItems" xlink:to="PurchaseCommitments" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="TotalPurchasePrice" xlink:href="cve-20221231.xsd#cve_TotalPurchasePrice"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="InvestmentinuraniumDetailsScheduleofuraniumconcentratespurchaseagreementLineItems" xlink:to="TotalPurchasePrice" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://encoreuranium.com/role/ScheduleofmarketablesecuritiesTable">
    <loc xlink:type="locator" xlink:label="ScheduleOfMarketableSecuritiesAbstract" xlink:href="cve-20221231.xsd#cve_ScheduleOfMarketableSecuritiesAbstract"/>
    <loc xlink:type="locator" xlink:label="MarketableSecuritiesDetailsScheduleofmarketablesecuritiesTable" xlink:href="cve-20221231.xsd#cve_MarketableSecuritiesDetailsScheduleofmarketablesecuritiesTable"/>
    <loc xlink:type="locator" xlink:label="MarketableSecuritiesDetailsScheduleofmarketablesecuritiesLineItems" xlink:href="cve-20221231.xsd#cve_MarketableSecuritiesDetailsScheduleofmarketablesecuritiesLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfMarketableSecuritiesAbstract" xlink:to="MarketableSecuritiesDetailsScheduleofmarketablesecuritiesTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ClassesOfAssetsAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_ClassesOfAssetsAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="MarketableSecuritiesDetailsScheduleofmarketablesecuritiesTable" xlink:to="ifrs-full_ClassesOfAssetsAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ClassesOfAssetsMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_ClassesOfAssetsMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ClassesOfAssetsAxis" xlink:to="ifrs-full_ClassesOfAssetsMember" order="0.0"/>
    <loc xlink:type="locator" xlink:label="MarketableSecuritiescurrentMember" xlink:href="cve-20221231.xsd#cve_MarketableSecuritiescurrentMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ClassesOfAssetsAxis" xlink:to="MarketableSecuritiescurrentMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="MarketableSecuritiesnoncurrentMember" xlink:href="cve-20221231.xsd#cve_MarketableSecuritiesnoncurrentMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ClassesOfAssetsAxis" xlink:to="MarketableSecuritiesnoncurrentMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="MarketableSecuritiesDetailsScheduleofmarketablesecuritiesTable" xlink:to="MarketableSecuritiesDetailsScheduleofmarketablesecuritiesLineItems" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="MarketablesSecurities" xlink:href="cve-20221231.xsd#cve_MarketablesSecurities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="MarketableSecuritiesDetailsScheduleofmarketablesecuritiesLineItems" xlink:to="MarketablesSecurities" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AdditionalProvisionsOtherProvisions" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_AdditionalProvisionsOtherProvisions"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="MarketableSecuritiesDetailsScheduleofmarketablesecuritiesLineItems" xlink:to="ifrs-full_AdditionalProvisionsOtherProvisions" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AdjustmentsForGainsLossesOnFairValueAdjustmentInvestmentProperty" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_AdjustmentsForGainsLossesOnFairValueAdjustmentInvestmentProperty"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="MarketableSecuritiesDetailsScheduleofmarketablesecuritiesLineItems" xlink:to="ifrs-full_AdjustmentsForGainsLossesOnFairValueAdjustmentInvestmentProperty" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RestructuringReserveTranslationAdjustment" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringReserveTranslationAdjustment"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="MarketableSecuritiesDetailsScheduleofmarketablesecuritiesLineItems" xlink:to="us-gaap_RestructuringReserveTranslationAdjustment" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="MarketablesSecurities_0" xlink:href="cve-20221231.xsd#cve_MarketablesSecurities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="MarketableSecuritiesDetailsScheduleofmarketablesecuritiesLineItems" xlink:to="MarketablesSecurities_0" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://encoreuranium.com/role/ScheduleofintangibleassetwasdeterminedTable">
    <loc xlink:type="locator" xlink:label="ScheduleOfIntangibleAssetWasDeterminedAbstract" xlink:href="cve-20221231.xsd#cve_ScheduleOfIntangibleAssetWasDeterminedAbstract"/>
    <loc xlink:type="locator" xlink:label="IntangibleassetsDetailsScheduleofintangibleassetwasdeterminedTable" xlink:href="cve-20221231.xsd#cve_IntangibleassetsDetailsScheduleofintangibleassetwasdeterminedTable"/>
    <loc xlink:type="locator" xlink:label="IntangibleassetsDetailsScheduleofintangibleassetwasdeterminedLineItems" xlink:href="cve-20221231.xsd#cve_IntangibleassetsDetailsScheduleofintangibleassetwasdeterminedLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfIntangibleAssetWasDeterminedAbstract" xlink:to="IntangibleassetsDetailsScheduleofintangibleassetwasdeterminedTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IntangibleassetsDetailsScheduleofintangibleassetwasdeterminedTable" xlink:to="ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_IntangibleAssetsOtherThanGoodwillMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_IntangibleAssetsOtherThanGoodwillMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis" xlink:to="ifrs-full_IntangibleAssetsOtherThanGoodwillMember" order="0.0"/>
    <loc xlink:type="locator" xlink:label="VANEAgreementMember" xlink:href="cve-20221231.xsd#cve_VANEAgreementMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis" xlink:to="VANEAgreementMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="SignalEquitiesDatabaseMember" xlink:href="cve-20221231.xsd#cve_SignalEquitiesDatabaseMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis" xlink:to="SignalEquitiesDatabaseMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="GrantsMineralBeltDatabaseMember" xlink:href="cve-20221231.xsd#cve_GrantsMineralBeltDatabaseMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis" xlink:to="GrantsMineralBeltDatabaseMember" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="GettyDatabaseMember" xlink:href="cve-20221231.xsd#cve_GettyDatabaseMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis" xlink:to="GettyDatabaseMember" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IntangibleassetsDetailsScheduleofintangibleassetwasdeterminedTable" xlink:to="IntangibleassetsDetailsScheduleofintangibleassetwasdeterminedLineItems" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="IntangibleAssetsBalance" xlink:href="cve-20221231.xsd#cve_IntangibleAssetsBalance"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IntangibleassetsDetailsScheduleofintangibleassetwasdeterminedLineItems" xlink:to="IntangibleAssetsBalance" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <loc xlink:type="locator" xlink:label="Additions" xlink:href="cve-20221231.xsd#cve_Additions"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IntangibleassetsDetailsScheduleofintangibleassetwasdeterminedLineItems" xlink:to="Additions" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AmortisationIntangibleAssetsOtherThanGoodwill" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_AmortisationIntangibleAssetsOtherThanGoodwill"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IntangibleassetsDetailsScheduleofintangibleassetwasdeterminedLineItems" xlink:to="ifrs-full_AmortisationIntangibleAssetsOtherThanGoodwill" order="2.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="CurrencyTranslationAdjustment1" xlink:href="cve-20221231.xsd#cve_CurrencyTranslationAdjustment1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IntangibleassetsDetailsScheduleofintangibleassetwasdeterminedLineItems" xlink:to="CurrencyTranslationAdjustment1" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="IntangibleAssetsBalance_0" xlink:href="cve-20221231.xsd#cve_IntangibleAssetsBalance"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IntangibleassetsDetailsScheduleofintangibleassetwasdeterminedLineItems" xlink:to="IntangibleAssetsBalance_0" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://encoreuranium.com/role/ScheduleofpropertyplantandequipmentTable">
    <loc xlink:type="locator" xlink:label="ScheduleOfPropertyPlantAndEquipmentAbstract" xlink:href="cve-20221231.xsd#cve_ScheduleOfPropertyPlantAndEquipmentAbstract"/>
    <loc xlink:type="locator" xlink:label="PropertyplantandequipmentDetailsScheduleofpropertyplantandequipmentTable" xlink:href="cve-20221231.xsd#cve_PropertyplantandequipmentDetailsScheduleofpropertyplantandequipmentTable"/>
    <loc xlink:type="locator" xlink:label="PropertyplantandequipmentDetailsScheduleofpropertyplantandequipmentLineItems" xlink:href="cve-20221231.xsd#cve_PropertyplantandequipmentDetailsScheduleofpropertyplantandequipmentLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfPropertyPlantAndEquipmentAbstract" xlink:to="PropertyplantandequipmentDetailsScheduleofpropertyplantandequipmentTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="PropertyplantandequipmentDetailsScheduleofpropertyplantandequipmentTable" xlink:to="ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_PropertyPlantAndEquipmentMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_PropertyPlantAndEquipmentMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis" xlink:to="ifrs-full_PropertyPlantAndEquipmentMember" order="0.0"/>
    <loc xlink:type="locator" xlink:label="UraniumPlantsMember" xlink:href="cve-20221231.xsd#cve_UraniumPlantsMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis" xlink:to="UraniumPlantsMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_OtherPropertyPlantAndEquipmentMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_OtherPropertyPlantAndEquipmentMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis" xlink:to="ifrs-full_OtherPropertyPlantAndEquipmentMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="FurnitureMember" xlink:href="cve-20221231.xsd#cve_FurnitureMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis" xlink:to="FurnitureMember" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_BuildingsMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_BuildingsMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis" xlink:to="ifrs-full_BuildingsMember" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="SoftwareMember" xlink:href="cve-20221231.xsd#cve_SoftwareMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis" xlink:to="SoftwareMember" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="PropertyplantandequipmentDetailsScheduleofpropertyplantandequipmentTable" xlink:to="PropertyplantandequipmentDetailsScheduleofpropertyplantandequipmentLineItems" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_PropertyPlantAndEquipmentCarryingAmountAtCostOfRevaluedAssets" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_PropertyPlantAndEquipmentCarryingAmountAtCostOfRevaluedAssets"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="PropertyplantandequipmentDetailsScheduleofpropertyplantandequipmentLineItems" xlink:to="ifrs-full_PropertyPlantAndEquipmentCarryingAmountAtCostOfRevaluedAssets" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="PropertyplantandequipmentDetailsScheduleofpropertyplantandequipmentLineItems" xlink:to="ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisposalsInvestmentProperty" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_DisposalsInvestmentProperty"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="PropertyplantandequipmentDetailsScheduleofpropertyplantandequipmentLineItems" xlink:to="ifrs-full_DisposalsInvestmentProperty" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DepreciationExpense" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_DepreciationExpense"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="PropertyplantandequipmentDetailsScheduleofpropertyplantandequipmentLineItems" xlink:to="ifrs-full_DepreciationExpense" order="3.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ImpairmentLoss" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_ImpairmentLoss"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="PropertyplantandequipmentDetailsScheduleofpropertyplantandequipmentLineItems" xlink:to="ifrs-full_ImpairmentLoss" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="PropertyplantandequipmentDetailsScheduleofpropertyplantandequipmentLineItems" xlink:to="ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_PropertyPlantAndEquipmentCarryingAmountAtCostOfRevaluedAssets_0" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_PropertyPlantAndEquipmentCarryingAmountAtCostOfRevaluedAssets"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="PropertyplantandequipmentDetailsScheduleofpropertyplantandequipmentLineItems" xlink:to="ifrs-full_PropertyPlantAndEquipmentCarryingAmountAtCostOfRevaluedAssets_0" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://encoreuranium.com/role/ScheduleofchangeintheROUassetsTable">
    <loc xlink:type="locator" xlink:label="ScheduleOfChangeInTheRouAssetsAbstract" xlink:href="cve-20221231.xsd#cve_ScheduleOfChangeInTheRouAssetsAbstract"/>
    <loc xlink:type="locator" xlink:label="RightofuseassetsDetailsScheduleofchangeintheROUassetsTable" xlink:href="cve-20221231.xsd#cve_RightofuseassetsDetailsScheduleofchangeintheROUassetsTable"/>
    <loc xlink:type="locator" xlink:label="RightofuseassetsDetailsScheduleofchangeintheROUassetsLineItems" xlink:href="cve-20221231.xsd#cve_RightofuseassetsDetailsScheduleofchangeintheROUassetsLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfChangeInTheRouAssetsAbstract" xlink:to="RightofuseassetsDetailsScheduleofchangeintheROUassetsTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CategoriesOfRelatedPartiesAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_CategoriesOfRelatedPartiesAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RightofuseassetsDetailsScheduleofchangeintheROUassetsTable" xlink:to="ifrs-full_CategoriesOfRelatedPartiesAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_EntitysTotalForRelatedPartiesMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_EntitysTotalForRelatedPartiesMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CategoriesOfRelatedPartiesAxis" xlink:to="ifrs-full_EntitysTotalForRelatedPartiesMember" order="0.0"/>
    <loc xlink:type="locator" xlink:label="LeasedCopierMember" xlink:href="cve-20221231.xsd#cve_LeasedCopierMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CategoriesOfRelatedPartiesAxis" xlink:to="LeasedCopierMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="LeasedOfficesMember" xlink:href="cve-20221231.xsd#cve_LeasedOfficesMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CategoriesOfRelatedPartiesAxis" xlink:to="LeasedOfficesMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RightofuseassetsDetailsScheduleofchangeintheROUassetsTable" xlink:to="RightofuseassetsDetailsScheduleofchangeintheROUassetsLineItems" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="Right-of-UseAssetsBalance" xlink:href="cve-20221231.xsd#cve_Right-of-UseAssetsBalance"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RightofuseassetsDetailsScheduleofchangeintheROUassetsLineItems" xlink:to="Right-of-UseAssetsBalance" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <loc xlink:type="locator" xlink:label="Right-of-UseAssetsAdditions" xlink:href="cve-20221231.xsd#cve_Right-of-UseAssetsAdditions"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RightofuseassetsDetailsScheduleofchangeintheROUassetsLineItems" xlink:to="Right-of-UseAssetsAdditions" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="Right-of-UseAssetsDepreciation" xlink:href="cve-20221231.xsd#cve_Right-of-UseAssetsDepreciation"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RightofuseassetsDetailsScheduleofchangeintheROUassetsLineItems" xlink:to="Right-of-UseAssetsDepreciation" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="Right-of-UseAssetsCurrencyTranslationAdjustment" xlink:href="cve-20221231.xsd#cve_Right-of-UseAssetsCurrencyTranslationAdjustment"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RightofuseassetsDetailsScheduleofchangeintheROUassetsLineItems" xlink:to="Right-of-UseAssetsCurrencyTranslationAdjustment" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="Right-of-UseAssetsBalance_0" xlink:href="cve-20221231.xsd#cve_Right-of-UseAssetsBalance"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RightofuseassetsDetailsScheduleofchangeintheROUassetsLineItems" xlink:to="Right-of-UseAssetsBalance_0" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://encoreuranium.com/role/ScheduleofchangeinthelongTermleaseliabilityTable">
    <loc xlink:type="locator" xlink:label="ScheduleOfChangeInTheLongTermLeaseLiabilityAbstract" xlink:href="cve-20221231.xsd#cve_ScheduleOfChangeInTheLongTermLeaseLiabilityAbstract"/>
    <loc xlink:type="locator" xlink:label="RightofuseassetsDetailsScheduleofchangeinthelongTermleaseliabilityTable" xlink:href="cve-20221231.xsd#cve_RightofuseassetsDetailsScheduleofchangeinthelongTermleaseliabilityTable"/>
    <loc xlink:type="locator" xlink:label="RightofuseassetsDetailsScheduleofchangeinthelongTermleaseliabilityLineItems" xlink:href="cve-20221231.xsd#cve_RightofuseassetsDetailsScheduleofchangeinthelongTermleaseliabilityLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfChangeInTheLongTermLeaseLiabilityAbstract" xlink:to="RightofuseassetsDetailsScheduleofchangeinthelongTermleaseliabilityTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CategoriesOfRelatedPartiesAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_CategoriesOfRelatedPartiesAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RightofuseassetsDetailsScheduleofchangeinthelongTermleaseliabilityTable" xlink:to="ifrs-full_CategoriesOfRelatedPartiesAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_EntitysTotalForRelatedPartiesMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_EntitysTotalForRelatedPartiesMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CategoriesOfRelatedPartiesAxis" xlink:to="ifrs-full_EntitysTotalForRelatedPartiesMember" order="0.0"/>
    <loc xlink:type="locator" xlink:label="LeasedCopierMember" xlink:href="cve-20221231.xsd#cve_LeasedCopierMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CategoriesOfRelatedPartiesAxis" xlink:to="LeasedCopierMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="LeasedOfficesMember" xlink:href="cve-20221231.xsd#cve_LeasedOfficesMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CategoriesOfRelatedPartiesAxis" xlink:to="LeasedOfficesMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RightofuseassetsDetailsScheduleofchangeinthelongTermleaseliabilityTable" xlink:to="RightofuseassetsDetailsScheduleofchangeinthelongTermleaseliabilityLineItems" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="Long-TermLeaseLiabilityBalance" xlink:href="cve-20221231.xsd#cve_Long-TermLeaseLiabilityBalance"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RightofuseassetsDetailsScheduleofchangeinthelongTermleaseliabilityLineItems" xlink:to="Long-TermLeaseLiabilityBalance" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <loc xlink:type="locator" xlink:label="Long-TermLeaseLiabilityAdditions" xlink:href="cve-20221231.xsd#cve_Long-TermLeaseLiabilityAdditions"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RightofuseassetsDetailsScheduleofchangeinthelongTermleaseliabilityLineItems" xlink:to="Long-TermLeaseLiabilityAdditions" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="Long-TermLeaseLiabilityAccretion" xlink:href="cve-20221231.xsd#cve_Long-TermLeaseLiabilityAccretion"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RightofuseassetsDetailsScheduleofchangeinthelongTermleaseliabilityLineItems" xlink:to="Long-TermLeaseLiabilityAccretion" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="Long-TermLeaseLiabilityLeasePaymentsMade" xlink:href="cve-20221231.xsd#cve_Long-TermLeaseLiabilityLeasePaymentsMade"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RightofuseassetsDetailsScheduleofchangeinthelongTermleaseliabilityLineItems" xlink:to="Long-TermLeaseLiabilityLeasePaymentsMade" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="Long-TermLeaseLiabilityCurrencyTranslationAdjustment" xlink:href="cve-20221231.xsd#cve_Long-TermLeaseLiabilityCurrencyTranslationAdjustment"/>
<!-- [WMV5][XcpuxYn59dz7vgYynUDuwG7r97K2jUTysl7vcz0lJt/tSeJz73kx1cLt0ZFF2SK/vxBCY0vdSrapBeolBQDhlou4Plg3ZACHgOGjaxwoV9s22fcKeqdlVg/8vXE8BEQPw2gSl8Pfy/SjqfZKUO0G5mehrda5xVrvtHGkgNXPOUg3vb7VF4CMNIMcgg6F7hiC/dgsHya46cPL6td1bLnSV35L5jAlrEDBDi0RC0EWIRx+TpXQjl5L5FZgRjEoUSEZ2JqlBbJxzYoijAKQW3xCyA==] CSR-->
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RightofuseassetsDetailsScheduleofchangeinthelongTermleaseliabilityLineItems" xlink:to="Long-TermLeaseLiabilityCurrencyTranslationAdjustment" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="Long-TermLeaseLiabilityBalance_0" xlink:href="cve-20221231.xsd#cve_Long-TermLeaseLiabilityBalance"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RightofuseassetsDetailsScheduleofchangeinthelongTermleaseliabilityLineItems" xlink:to="Long-TermLeaseLiabilityBalance_0" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_LongtermProvisionForDecommissioningRestorationAndRehabilitationCosts" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_LongtermProvisionForDecommissioningRestorationAndRehabilitationCosts"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RightofuseassetsDetailsScheduleofchangeinthelongTermleaseliabilityLineItems" xlink:to="ifrs-full_LongtermProvisionForDecommissioningRestorationAndRehabilitationCosts" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="Long-TermLeaseLiabilityLessCurrentLeaseLiability" xlink:href="cve-20221231.xsd#cve_Long-TermLeaseLiabilityLessCurrentLeaseLiability"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RightofuseassetsDetailsScheduleofchangeinthelongTermleaseliabilityLineItems" xlink:to="Long-TermLeaseLiabilityLessCurrentLeaseLiability" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://encoreuranium.com/role/ScheduleofundiscountedfutureleasepaymentsTable">
    <loc xlink:type="locator" xlink:label="ScheduleOfUndiscountedFutureLeasePaymentsAbstract" xlink:href="cve-20221231.xsd#cve_ScheduleOfUndiscountedFutureLeasePaymentsAbstract"/>
    <loc xlink:type="locator" xlink:label="RightofuseassetsDetailsScheduleofundiscountedfutureleasepaymentsTable" xlink:href="cve-20221231.xsd#cve_RightofuseassetsDetailsScheduleofundiscountedfutureleasepaymentsTable"/>
    <loc xlink:type="locator" xlink:label="RightofuseassetsDetailsScheduleofundiscountedfutureleasepaymentsLineItems" xlink:href="cve-20221231.xsd#cve_RightofuseassetsDetailsScheduleofundiscountedfutureleasepaymentsLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfUndiscountedFutureLeasePaymentsAbstract" xlink:to="RightofuseassetsDetailsScheduleofundiscountedfutureleasepaymentsTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_SegmentsAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_SegmentsAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RightofuseassetsDetailsScheduleofundiscountedfutureleasepaymentsTable" xlink:to="ifrs-full_SegmentsAxis" order="1.0"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_SegmentsMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_SegmentsMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_SegmentsAxis" xlink:to="ifrs-full_SegmentsMember" order="0.0"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RightofuseassetsDetailsScheduleofundiscountedfutureleasepaymentsTable" xlink:to="RightofuseassetsDetailsScheduleofundiscountedfutureleasepaymentsLineItems" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="Right-of-UseAssetsTwoZeroTwoThree" xlink:href="cve-20221231.xsd#cve_Right-of-UseAssetsTwoZeroTwoThree"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RightofuseassetsDetailsScheduleofundiscountedfutureleasepaymentsLineItems" xlink:to="Right-of-UseAssetsTwoZeroTwoThree" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="Right-of-UseAssetsTwoZeroTwoFour" xlink:href="cve-20221231.xsd#cve_Right-of-UseAssetsTwoZeroTwoFour"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RightofuseassetsDetailsScheduleofundiscountedfutureleasepaymentsLineItems" xlink:to="Right-of-UseAssetsTwoZeroTwoFour" order="1.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="Right-of-UseAssetsTwoZeroTwoFive" xlink:href="cve-20221231.xsd#cve_Right-of-UseAssetsTwoZeroTwoFive"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RightofuseassetsDetailsScheduleofundiscountedfutureleasepaymentsLineItems" xlink:to="Right-of-UseAssetsTwoZeroTwoFive" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_NetInvestmentInFinanceLease" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_NetInvestmentInFinanceLease"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RightofuseassetsDetailsScheduleofundiscountedfutureleasepaymentsLineItems" xlink:to="ifrs-full_NetInvestmentInFinanceLease" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://encoreuranium.com/role/ScheduleofestimatedfairvalueofassetsandliabilitiesTable">
    <loc xlink:type="locator" xlink:label="ScheduleOfEstimatedFairValueOfAssetsAndLiabilitiesAbstract" xlink:href="cve-20221231.xsd#cve_ScheduleOfEstimatedFairValueOfAssetsAndLiabilitiesAbstract"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfEstimatedFairValueOfAssetsAndLiabilitiesAbstract" xlink:to="ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="FairValueOfReplacementOptions" xlink:href="cve-20221231.xsd#cve_FairValueOfReplacementOptions"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfEstimatedFairValueOfAssetsAndLiabilitiesAbstract" xlink:to="FairValueOfReplacementOptions" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="FairValueOfReplacementWarrants" xlink:href="cve-20221231.xsd#cve_FairValueOfReplacementWarrants"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfEstimatedFairValueOfAssetsAndLiabilitiesAbstract" xlink:to="FairValueOfReplacementWarrants" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="TransactionCosts" xlink:href="cve-20221231.xsd#cve_TransactionCosts"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfEstimatedFairValueOfAssetsAndLiabilitiesAbstract" xlink:to="TransactionCosts" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="TotalConsiderationValue" xlink:href="cve-20221231.xsd#cve_TotalConsiderationValue"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfEstimatedFairValueOfAssetsAndLiabilitiesAbstract" xlink:to="TotalConsiderationValue" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://encoreuranium.com/role/ScheduleofnetassetsacquiredTable">
    <loc xlink:type="locator" xlink:label="ScheduleOfNetAssetsAcquiredAbstract" xlink:href="cve-20221231.xsd#cve_ScheduleOfNetAssetsAcquiredAbstract"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_OtherCashAndCashEquivalents" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_OtherCashAndCashEquivalents"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfNetAssetsAcquiredAbstract" xlink:to="ifrs-full_OtherCashAndCashEquivalents" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_NoncurrentRestrictedCashAndCashEquivalents" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_NoncurrentRestrictedCashAndCashEquivalents"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfNetAssetsAcquiredAbstract" xlink:to="ifrs-full_NoncurrentRestrictedCashAndCashEquivalents" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_Prepayments" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_Prepayments"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfNetAssetsAcquiredAbstract" xlink:to="ifrs-full_Prepayments" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfNetAssetsAcquiredAbstract" xlink:to="ifrs-full_PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_RightofuseAssetsThatDoNotMeetDefinitionOfInvestmentProperty" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_RightofuseAssetsThatDoNotMeetDefinitionOfInvestmentProperty"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfNetAssetsAcquiredAbstract" xlink:to="ifrs-full_RightofuseAssetsThatDoNotMeetDefinitionOfInvestmentProperty" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AssetsArisingFromExplorationForAndEvaluationOfMineralResources" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_AssetsArisingFromExplorationForAndEvaluationOfMineralResources"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfNetAssetsAcquiredAbstract" xlink:to="ifrs-full_AssetsArisingFromExplorationForAndEvaluationOfMineralResources" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="AssetRetirementObligations" xlink:href="cve-20221231.xsd#cve_AssetRetirementObligations"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfNetAssetsAcquiredAbstract" xlink:to="AssetRetirementObligations" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_LeaseLiabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_LeaseLiabilities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfNetAssetsAcquiredAbstract" xlink:to="ifrs-full_LeaseLiabilities" order="7.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_LoansAndReceivables" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_LoansAndReceivables"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfNetAssetsAcquiredAbstract" xlink:to="ifrs-full_LoansAndReceivables" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="AccountsPayableAndAccruedLiability" xlink:href="cve-20221231.xsd#cve_AccountsPayableAndAccruedLiability"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfNetAssetsAcquiredAbstract" xlink:to="AccountsPayableAndAccruedLiability" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_IdentifiableAssetsAcquiredLiabilitiesAssumed" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_IdentifiableAssetsAcquiredLiabilitiesAssumed"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfNetAssetsAcquiredAbstract" xlink:to="ifrs-full_IdentifiableAssetsAcquiredLiabilitiesAssumed" order="10.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://encoreuranium.com/role/ScheduleofweightedaverageassumptionsusedintheblackscholesoptionTable">
    <loc xlink:type="locator" xlink:label="ScheduleOfWeightedAverageAssumptionsUsedInTheBlackScholesOptionAbstract" xlink:href="cve-20221231.xsd#cve_ScheduleOfWeightedAverageAssumptionsUsedInTheBlackScholesOptionAbstract"/>
    <loc xlink:type="locator" xlink:label="AssetacquisitionDetailsScheduleofweightedaverageassumptionsusedintheblackscholesoptionTable" xlink:href="cve-20221231.xsd#cve_AssetacquisitionDetailsScheduleofweightedaverageassumptionsusedintheblackscholesoptionTable"/>
    <loc xlink:type="locator" xlink:label="AssetacquisitionDetailsScheduleofweightedaverageassumptionsusedintheblackscholesoptionLineItems" xlink:href="cve-20221231.xsd#cve_AssetacquisitionDetailsScheduleofweightedaverageassumptionsusedintheblackscholesoptionLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfWeightedAverageAssumptionsUsedInTheBlackScholesOptionAbstract" xlink:to="AssetacquisitionDetailsScheduleofweightedaverageassumptionsusedintheblackscholesoptionTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ComponentsOfEquityAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_ComponentsOfEquityAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AssetacquisitionDetailsScheduleofweightedaverageassumptionsusedintheblackscholesoptionTable" xlink:to="ifrs-full_ComponentsOfEquityAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="OptionsMember" xlink:href="cve-20221231.xsd#cve_OptionsMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ComponentsOfEquityAxis" xlink:to="OptionsMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_WarrantReserveMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_WarrantReserveMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ComponentsOfEquityAxis" xlink:to="ifrs-full_WarrantReserveMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AssetacquisitionDetailsScheduleofweightedaverageassumptionsusedintheblackscholesoptionTable" xlink:to="AssetacquisitionDetailsScheduleofweightedaverageassumptionsusedintheblackscholesoptionLineItems" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ExercisePriceShareOptionsGranted2019" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_ExercisePriceShareOptionsGranted2019"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AssetacquisitionDetailsScheduleofweightedaverageassumptionsusedintheblackscholesoptionLineItems" xlink:to="ifrs-full_ExercisePriceShareOptionsGranted2019" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_WeightedAverageSharePriceShareOptionsGranted2019" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_WeightedAverageSharePriceShareOptionsGranted2019"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AssetacquisitionDetailsScheduleofweightedaverageassumptionsusedintheblackscholesoptionLineItems" xlink:to="ifrs-full_WeightedAverageSharePriceShareOptionsGranted2019" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ActuarialAssumptionOfDiscountRates" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_ActuarialAssumptionOfDiscountRates"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AssetacquisitionDetailsScheduleofweightedaverageassumptionsusedintheblackscholesoptionLineItems" xlink:to="ifrs-full_ActuarialAssumptionOfDiscountRates" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AssetacquisitionDetailsScheduleofweightedaverageassumptionsusedintheblackscholesoptionLineItems" xlink:to="ifrs-full_WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DescriptionOfExpectedVolatilityShareOptionsGranted" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_DescriptionOfExpectedVolatilityShareOptionsGranted"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AssetacquisitionDetailsScheduleofweightedaverageassumptionsusedintheblackscholesoptionLineItems" xlink:to="ifrs-full_DescriptionOfExpectedVolatilityShareOptionsGranted" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="FairValueOfReplacement" xlink:href="cve-20221231.xsd#cve_FairValueOfReplacement"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AssetacquisitionDetailsScheduleofweightedaverageassumptionsusedintheblackscholesoptionLineItems" xlink:to="FairValueOfReplacement" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://encoreuranium.com/role/ScheduleofmineralpropertiesTable">
    <loc xlink:type="locator" xlink:label="ScheduleOfMineralPropertiesAbstract" xlink:href="cve-20221231.xsd#cve_ScheduleOfMineralPropertiesAbstract"/>
    <loc xlink:type="locator" xlink:label="MineralPropertiesDetailsScheduleofmineralpropertiesTable" xlink:href="cve-20221231.xsd#cve_MineralPropertiesDetailsScheduleofmineralpropertiesTable"/>
    <loc xlink:type="locator" xlink:label="MineralPropertiesDetailsScheduleofmineralpropertiesLineItems" xlink:href="cve-20221231.xsd#cve_MineralPropertiesDetailsScheduleofmineralpropertiesLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfMineralPropertiesAbstract" xlink:to="MineralPropertiesDetailsScheduleofmineralpropertiesTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_GeographicalAreasAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_GeographicalAreasAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="MineralPropertiesDetailsScheduleofmineralpropertiesTable" xlink:to="ifrs-full_GeographicalAreasAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_GeographicalAreasMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_GeographicalAreasMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_GeographicalAreasAxis" xlink:to="ifrs-full_GeographicalAreasMember" order="0.0"/>
    <loc xlink:type="locator" xlink:label="stpr_AZ" xlink:href="https://xbrl.sec.gov/stpr/2022/stpr-2022.xsd#stpr_AZ"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_GeographicalAreasAxis" xlink:to="stpr_AZ" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="stpr_CO" xlink:href="https://xbrl.sec.gov/stpr/2022/stpr-2022.xsd#stpr_CO"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_GeographicalAreasAxis" xlink:to="stpr_CO" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="stpr_NM" xlink:href="https://xbrl.sec.gov/stpr/2022/stpr-2022.xsd#stpr_NM"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_GeographicalAreasAxis" xlink:to="stpr_NM" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="stpr_SD" xlink:href="https://xbrl.sec.gov/stpr/2022/stpr-2022.xsd#stpr_SD"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_GeographicalAreasAxis" xlink:to="stpr_SD" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="stpr_TX" xlink:href="https://xbrl.sec.gov/stpr/2022/stpr-2022.xsd#stpr_TX"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_GeographicalAreasAxis" xlink:to="stpr_TX" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="stpr_UT" xlink:href="https://xbrl.sec.gov/stpr/2022/stpr-2022.xsd#stpr_UT"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_GeographicalAreasAxis" xlink:to="stpr_UT" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="stpr_WY" xlink:href="https://xbrl.sec.gov/stpr/2022/stpr-2022.xsd#stpr_WY"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_GeographicalAreasAxis" xlink:to="stpr_WY" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="country_CA" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_CA"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_GeographicalAreasAxis" xlink:to="country_CA" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ClassesOfLiabilitiesAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_ClassesOfLiabilitiesAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="MineralPropertiesDetailsScheduleofmineralpropertiesTable" xlink:to="ifrs-full_ClassesOfLiabilitiesAxis" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_LiabilitiesMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_LiabilitiesMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ClassesOfLiabilitiesAxis" xlink:to="ifrs-full_LiabilitiesMember" order="0.0"/>
    <loc xlink:type="locator" xlink:label="ExplorationCostMember" xlink:href="cve-20221231.xsd#cve_ExplorationCostMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ClassesOfLiabilitiesAxis" xlink:to="ExplorationCostMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="MineralPropertiesDetailsScheduleofmineralpropertiesTable" xlink:to="MineralPropertiesDetailsScheduleofmineralpropertiesLineItems" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_MiningAssets" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_MiningAssets"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="MineralPropertiesDetailsScheduleofmineralpropertiesLineItems" xlink:to="ifrs-full_MiningAssets" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <loc xlink:type="locator" xlink:label="ExplorationCostsAbstract" xlink:href="cve-20221231.xsd#cve_ExplorationCostsAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="MineralPropertiesDetailsScheduleofmineralpropertiesLineItems" xlink:to="ExplorationCostsAbstract" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="Drilling" xlink:href="cve-20221231.xsd#cve_Drilling"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ExplorationCostsAbstract" xlink:to="Drilling" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="MaintenancesAndLeaseFees" xlink:href="cve-20221231.xsd#cve_MaintenancesAndLeaseFees"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ExplorationCostsAbstract" xlink:to="MaintenancesAndLeaseFees" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="PermittingLicensing" xlink:href="cve-20221231.xsd#cve_PermittingLicensing"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ExplorationCostsAbstract" xlink:to="PermittingLicensing" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="Personnel" xlink:href="cve-20221231.xsd#cve_Personnel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ExplorationCostsAbstract" xlink:to="Personnel" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="Recoveries" xlink:href="cve-20221231.xsd#cve_Recoveries"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ExplorationCostsAbstract" xlink:to="Recoveries" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ResourceReview" xlink:href="cve-20221231.xsd#cve_ResourceReview"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ExplorationCostsAbstract" xlink:to="ResourceReview" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ImpairmentCharged" xlink:href="cve-20221231.xsd#cve_ImpairmentCharged"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ExplorationCostsAbstract" xlink:to="ImpairmentCharged" order="6.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="DivestmentAbstract" xlink:href="cve-20221231.xsd#cve_DivestmentAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="MineralPropertiesDetailsScheduleofmineralpropertiesLineItems" xlink:to="DivestmentAbstract" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="DivestMineralInterest" xlink:href="cve-20221231.xsd#cve_DivestMineralInterest"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DivestmentAbstract" xlink:to="DivestMineralInterest" order="0.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="AssetsHeldForSale" xlink:href="cve-20221231.xsd#cve_AssetsHeldForSale"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DivestmentAbstract" xlink:to="AssetsHeldForSale" order="1.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_MiningAssets_0" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_MiningAssets"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DivestmentAbstract" xlink:to="ifrs-full_MiningAssets_0" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <loc xlink:type="locator" xlink:label="ProjectDevelopmentCostsAbstract" xlink:href="cve-20221231.xsd#cve_ProjectDevelopmentCostsAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="MineralPropertiesDetailsScheduleofmineralpropertiesLineItems" xlink:to="ProjectDevelopmentCostsAbstract" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ConstructionOfWellfields" xlink:href="cve-20221231.xsd#cve_ConstructionOfWellfields"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ProjectDevelopmentCostsAbstract" xlink:to="ConstructionOfWellfields" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="AssetAcquistion" xlink:href="cve-20221231.xsd#cve_AssetAcquistion"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="MineralPropertiesDetailsScheduleofmineralpropertiesLineItems" xlink:to="AssetAcquistion" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://encoreuranium.com/role/ScheduleofassetretirementobligationsbalanceTable">
    <loc xlink:type="locator" xlink:label="ScheduleOfAssetRetirementObligationsBalanceAbstract" xlink:href="cve-20221231.xsd#cve_ScheduleOfAssetRetirementObligationsBalanceAbstract"/>
    <loc xlink:type="locator" xlink:label="AssetretirementobligationsDetailsScheduleofassetretirementobligationsbalanceTable" xlink:href="cve-20221231.xsd#cve_AssetretirementobligationsDetailsScheduleofassetretirementobligationsbalanceTable"/>
    <loc xlink:type="locator" xlink:label="AssetretirementobligationsDetailsScheduleofassetretirementobligationsbalanceLineItems" xlink:href="cve-20221231.xsd#cve_AssetretirementobligationsDetailsScheduleofassetretirementobligationsbalanceLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfAssetRetirementObligationsBalanceAbstract" xlink:to="AssetretirementobligationsDetailsScheduleofassetretirementobligationsbalanceTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ClassesOfAssetsAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_ClassesOfAssetsAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AssetretirementobligationsDetailsScheduleofassetretirementobligationsbalanceTable" xlink:to="ifrs-full_ClassesOfAssetsAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ClassesOfAssetsMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_ClassesOfAssetsMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ClassesOfAssetsAxis" xlink:to="ifrs-full_ClassesOfAssetsMember" order="0.0"/>
    <loc xlink:type="locator" xlink:label="KingsvilleMember" xlink:href="cve-20221231.xsd#cve_KingsvilleMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ClassesOfAssetsAxis" xlink:to="KingsvilleMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="RositaMember" xlink:href="cve-20221231.xsd#cve_RositaMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ClassesOfAssetsAxis" xlink:to="RositaMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="VasquezMember" xlink:href="cve-20221231.xsd#cve_VasquezMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ClassesOfAssetsAxis" xlink:to="VasquezMember" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="CentennialMember" xlink:href="cve-20221231.xsd#cve_CentennialMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ClassesOfAssetsAxis" xlink:to="CentennialMember" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="GasHillsMember" xlink:href="cve-20221231.xsd#cve_GasHillsMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ClassesOfAssetsAxis" xlink:to="GasHillsMember" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="TicabooMember" xlink:href="cve-20221231.xsd#cve_TicabooMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ClassesOfAssetsAxis" xlink:to="TicabooMember" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AssetretirementobligationsDetailsScheduleofassetretirementobligationsbalanceTable" xlink:to="AssetretirementobligationsDetailsScheduleofassetretirementobligationsbalanceLineItems" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_FinancialAssets" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_FinancialAssets"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AssetretirementobligationsDetailsScheduleofassetretirementobligationsbalanceLineItems" xlink:to="ifrs-full_FinancialAssets" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://encoreuranium.com/role/ScheduleofassetretirementobligationscontinuityTable">
    <loc xlink:type="locator" xlink:label="ScheduleOfAssetRetirementObligationsContinuityAbstract" xlink:href="cve-20221231.xsd#cve_ScheduleOfAssetRetirementObligationsContinuityAbstract"/>
    <loc xlink:type="locator" xlink:label="AssetretirementobligationsDetailsScheduleofassetretirementobligationscontinuityTable" xlink:href="cve-20221231.xsd#cve_AssetretirementobligationsDetailsScheduleofassetretirementobligationscontinuityTable"/>
    <loc xlink:type="locator" xlink:label="AssetretirementobligationsDetailsScheduleofassetretirementobligationscontinuityLineItems" xlink:href="cve-20221231.xsd#cve_AssetretirementobligationsDetailsScheduleofassetretirementobligationscontinuityLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfAssetRetirementObligationsContinuityAbstract" xlink:to="AssetretirementobligationsDetailsScheduleofassetretirementobligationscontinuityTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_SegmentsAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_SegmentsAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AssetretirementobligationsDetailsScheduleofassetretirementobligationscontinuityTable" xlink:to="ifrs-full_SegmentsAxis" order="1.0"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_SegmentsMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_SegmentsMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_SegmentsAxis" xlink:to="ifrs-full_SegmentsMember" order="0.0"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AssetretirementobligationsDetailsScheduleofassetretirementobligationscontinuityTable" xlink:to="AssetretirementobligationsDetailsScheduleofassetretirementobligationscontinuityLineItems" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="AssetRetirementObligationsBalance" xlink:href="cve-20221231.xsd#cve_AssetRetirementObligationsBalance"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AssetretirementobligationsDetailsScheduleofassetretirementobligationscontinuityLineItems" xlink:to="AssetRetirementObligationsBalance" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <loc xlink:type="locator" xlink:label="AssetRetirementObligationsAccretion" xlink:href="cve-20221231.xsd#cve_AssetRetirementObligationsAccretion"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AssetretirementobligationsDetailsScheduleofassetretirementobligationscontinuityLineItems" xlink:to="AssetRetirementObligationsAccretion" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="AssetRetirementObligationsAdjustments" xlink:href="cve-20221231.xsd#cve_AssetRetirementObligationsAdjustments"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AssetretirementobligationsDetailsScheduleofassetretirementobligationscontinuityLineItems" xlink:to="AssetRetirementObligationsAdjustments" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="AssetRetirementObligationsSettlement" xlink:href="cve-20221231.xsd#cve_AssetRetirementObligationsSettlement"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AssetretirementobligationsDetailsScheduleofassetretirementobligationscontinuityLineItems" xlink:to="AssetRetirementObligationsSettlement" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="AssetRetirementObligationsAdditionsFromAzargaAssetAcquisitionNote10" xlink:href="cve-20221231.xsd#cve_AssetRetirementObligationsAdditionsFromAzargaAssetAcquisitionNote10"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AssetretirementobligationsDetailsScheduleofassetretirementobligationscontinuityLineItems" xlink:to="AssetRetirementObligationsAdditionsFromAzargaAssetAcquisitionNote10" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="AssetRetirementObligationsBalance_0" xlink:href="cve-20221231.xsd#cve_AssetRetirementObligationsBalance"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AssetretirementobligationsDetailsScheduleofassetretirementobligationscontinuityLineItems" xlink:to="AssetRetirementObligationsBalance_0" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://encoreuranium.com/role/ScheduleofuraniumsalescontractsoverthenextfiveyearsTable">
    <loc xlink:type="locator" xlink:label="ScheduleOfUraniumSalesContractsOverTheNextFiveYearsAbstract" xlink:href="cve-20221231.xsd#cve_ScheduleOfUraniumSalesContractsOverTheNextFiveYearsAbstract"/>
    <loc xlink:type="locator" xlink:label="SalescontractsDetailsScheduleofuraniumsalescontractsoverthenextfiveyearsTable" xlink:href="cve-20221231.xsd#cve_SalescontractsDetailsScheduleofuraniumsalescontractsoverthenextfiveyearsTable"/>
    <loc xlink:type="locator" xlink:label="SalescontractsDetailsScheduleofuraniumsalescontractsoverthenextfiveyearsLineItems" xlink:href="cve-20221231.xsd#cve_SalescontractsDetailsScheduleofuraniumsalescontractsoverthenextfiveyearsLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfUraniumSalesContractsOverTheNextFiveYearsAbstract" xlink:to="SalescontractsDetailsScheduleofuraniumsalescontractsoverthenextfiveyearsTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_SegmentsAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_SegmentsAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SalescontractsDetailsScheduleofuraniumsalescontractsoverthenextfiveyearsTable" xlink:to="ifrs-full_SegmentsAxis" order="1.0"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_SegmentsMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_SegmentsMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_SegmentsAxis" xlink:to="ifrs-full_SegmentsMember" order="0.0"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SalescontractsDetailsScheduleofuraniumsalescontractsoverthenextfiveyearsTable" xlink:to="SalescontractsDetailsScheduleofuraniumsalescontractsoverthenextfiveyearsLineItems" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="SalesContractsFiscalTwoZeroTwoThree" xlink:href="cve-20221231.xsd#cve_SalesContractsFiscalTwoZeroTwoThree"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SalescontractsDetailsScheduleofuraniumsalescontractsoverthenextfiveyearsLineItems" xlink:to="SalesContractsFiscalTwoZeroTwoThree" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="SalesContractsFiscalTwoZeroTwoFour" xlink:href="cve-20221231.xsd#cve_SalesContractsFiscalTwoZeroTwoFour"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SalescontractsDetailsScheduleofuraniumsalescontractsoverthenextfiveyearsLineItems" xlink:to="SalesContractsFiscalTwoZeroTwoFour" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="SalesContractsFiscalTwoZeroTwoFive" xlink:href="cve-20221231.xsd#cve_SalesContractsFiscalTwoZeroTwoFive"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SalescontractsDetailsScheduleofuraniumsalescontractsoverthenextfiveyearsLineItems" xlink:to="SalesContractsFiscalTwoZeroTwoFive" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="SalesContractsFiscalTwoZeroTwoSix" xlink:href="cve-20221231.xsd#cve_SalesContractsFiscalTwoZeroTwoSix"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SalescontractsDetailsScheduleofuraniumsalescontractsoverthenextfiveyearsLineItems" xlink:to="SalesContractsFiscalTwoZeroTwoSix" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="SalesContractsFiscalTwoZeroTwoSeven" xlink:href="cve-20221231.xsd#cve_SalesContractsFiscalTwoZeroTwoSeven"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SalescontractsDetailsScheduleofuraniumsalescontractsoverthenextfiveyearsLineItems" xlink:to="SalesContractsFiscalTwoZeroTwoSeven" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://encoreuranium.com/role/ScheduleofthecompanysstockoptionsoutstandingTable">
    <loc xlink:type="locator" xlink:label="ScheduleOfTheCompanySStockOptionsOutstandingAbstract" xlink:href="cve-20221231.xsd#cve_ScheduleOfTheCompanySStockOptionsOutstandingAbstract"/>
    <loc xlink:type="locator" xlink:label="SharesBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:href="cve-20221231.xsd#cve_SharesBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfTheCompanySStockOptionsOutstandingAbstract" xlink:to="SharesBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfTheCompanySStockOptionsOutstandingAbstract" xlink:to="ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <loc xlink:type="locator" xlink:label="SharesBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:href="cve-20221231.xsd#cve_SharesBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfTheCompanySStockOptionsOutstandingAbstract" xlink:to="SharesBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfTheCompanySStockOptionsOutstandingAbstract" xlink:to="ifrs-full_WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="StockIssuedDuringPeriodShareStockOptionsExercised" xlink:href="cve-20221231.xsd#cve_StockIssuedDuringPeriodShareStockOptionsExercised"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfTheCompanySStockOptionsOutstandingAbstract" xlink:to="StockIssuedDuringPeriodShareStockOptionsExercised" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfTheCompanySStockOptionsOutstandingAbstract" xlink:to="ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="StockIssuedDuringPeriodShareSharesBasedCompensationForfeited" xlink:href="cve-20221231.xsd#cve_StockIssuedDuringPeriodShareSharesBasedCompensationForfeited"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfTheCompanySStockOptionsOutstandingAbstract" xlink:to="StockIssuedDuringPeriodShareSharesBasedCompensationForfeited" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfTheCompanySStockOptionsOutstandingAbstract" xlink:to="ifrs-full_WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="SharesBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_0" xlink:href="cve-20221231.xsd#cve_SharesBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfTheCompanySStockOptionsOutstandingAbstract" xlink:to="SharesBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_0" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_0" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfTheCompanySStockOptionsOutstandingAbstract" xlink:to="ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_0" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <loc xlink:type="locator" xlink:label="SharesBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions" xlink:href="cve-20221231.xsd#cve_SharesBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfTheCompanySStockOptionsOutstandingAbstract" xlink:to="SharesBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions" order="10.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfTheCompanySStockOptionsOutstandingAbstract" xlink:to="ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019" order="11.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://encoreuranium.com/role/ScheduleofstockoptionsoutstandingTable">
    <loc xlink:type="locator" xlink:label="ScheduleOfStockOptionsOutstandingAbstract" xlink:href="cve-20221231.xsd#cve_ScheduleOfStockOptionsOutstandingAbstract"/>
    <loc xlink:type="locator" xlink:label="ShareCapitalDetailsScheduleofstockoptionsoutstandingTable" xlink:href="cve-20221231.xsd#cve_ShareCapitalDetailsScheduleofstockoptionsoutstandingTable"/>
    <loc xlink:type="locator" xlink:label="ShareCapitalDetailsScheduleofstockoptionsoutstandingLineItems" xlink:href="cve-20221231.xsd#cve_ShareCapitalDetailsScheduleofstockoptionsoutstandingLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfStockOptionsOutstandingAbstract" xlink:to="ShareCapitalDetailsScheduleofstockoptionsoutstandingTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareCapitalDetailsScheduleofstockoptionsoutstandingTable" xlink:to="ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis" xlink:to="ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsMember" order="0.0"/>
    <loc xlink:type="locator" xlink:label="ZeroOneEightOneNineTwoMember" xlink:href="cve-20221231.xsd#cve_ZeroOneEightOneNineTwoMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis" xlink:to="ZeroOneEightOneNineTwoMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="TwoFourZeroThreeSevenEightMember" xlink:href="cve-20221231.xsd#cve_TwoFourZeroThreeSevenEightMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis" xlink:to="TwoFourZeroThreeSevenEightMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="FourTwoZeroFiveSevenSixMember" xlink:href="cve-20221231.xsd#cve_FourTwoZeroFiveSevenSixMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis" xlink:to="FourTwoZeroFiveSevenSixMember" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareCapitalDetailsScheduleofstockoptionsoutstandingTable" xlink:to="ShareCapitalDetailsScheduleofstockoptionsoutstandingLineItems" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="SharesBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:href="cve-20221231.xsd#cve_SharesBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareCapitalDetailsScheduleofstockoptionsoutstandingLineItems" xlink:to="SharesBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_WeightedAverageDurationOfDefinedBenefitObligation2019" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_WeightedAverageDurationOfDefinedBenefitObligation2019"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareCapitalDetailsScheduleofstockoptionsoutstandingLineItems" xlink:to="ifrs-full_WeightedAverageDurationOfDefinedBenefitObligation2019" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ExercisePriceOfOutstandingShareOptions2019" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_ExercisePriceOfOutstandingShareOptions2019"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareCapitalDetailsScheduleofstockoptionsoutstandingLineItems" xlink:to="ifrs-full_ExercisePriceOfOutstandingShareOptions2019" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="SharesBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber" xlink:href="cve-20221231.xsd#cve_SharesBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareCapitalDetailsScheduleofstockoptionsoutstandingLineItems" xlink:to="SharesBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ExercisePriceShareOptionsGranted2019" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_ExercisePriceShareOptionsGranted2019"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareCapitalDetailsScheduleofstockoptionsoutstandingLineItems" xlink:to="ifrs-full_ExercisePriceShareOptionsGranted2019" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://encoreuranium.com/role/ScheduleofweightedaverageassumptionsusedincalculatingthefairvaluesTable">
    <loc xlink:type="locator" xlink:label="ScheduleOfWeightedAverageAssumptionsUsedInCalculatingTheFairValuesAbstract" xlink:href="cve-20221231.xsd#cve_ScheduleOfWeightedAverageAssumptionsUsedInCalculatingTheFairValuesAbstract"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DescriptionOfRiskFreeInterestRateShareOptionsGranted" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_DescriptionOfRiskFreeInterestRateShareOptionsGranted"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfWeightedAverageAssumptionsUsedInCalculatingTheFairValuesAbstract" xlink:to="ifrs-full_DescriptionOfRiskFreeInterestRateShareOptionsGranted" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfWeightedAverageAssumptionsUsedInCalculatingTheFairValuesAbstract" xlink:to="ifrs-full_WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ExpectedDividendAsPercentageShareOptionsGranted" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_ExpectedDividendAsPercentageShareOptionsGranted"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfWeightedAverageAssumptionsUsedInCalculatingTheFairValuesAbstract" xlink:to="ifrs-full_ExpectedDividendAsPercentageShareOptionsGranted" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DescriptionOfExpectedVolatilityShareOptionsGranted" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_DescriptionOfExpectedVolatilityShareOptionsGranted"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfWeightedAverageAssumptionsUsedInCalculatingTheFairValuesAbstract" xlink:to="ifrs-full_DescriptionOfExpectedVolatilityShareOptionsGranted" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://encoreuranium.com/role/ScheduleofthestatusofthecompanyswarrantsTable">
    <loc xlink:type="locator" xlink:label="ScheduleOfTheStatusOfTheCompanySWarrantsAbstract" xlink:href="cve-20221231.xsd#cve_ScheduleOfTheStatusOfTheCompanySWarrantsAbstract"/>
    <loc xlink:type="locator" xlink:label="ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptionsWarrantsOutstanding" xlink:href="cve-20221231.xsd#cve_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptionsWarrantsOutstanding"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfTheStatusOfTheCompanySWarrantsAbstract" xlink:to="ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptionsWarrantsOutstanding" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <loc xlink:type="locator" xlink:label="SharesBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingPeriodIncreaseDecreaseWeightedAverageExercisePrice" xlink:href="cve-20221231.xsd#cve_SharesBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingPeriodIncreaseDecreaseWeightedAverageExercisePrice"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfTheStatusOfTheCompanySWarrantsAbstract" xlink:to="SharesBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingPeriodIncreaseDecreaseWeightedAverageExercisePrice" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <loc xlink:type="locator" xlink:label="ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptionsWarrantsOutstanding_0" xlink:href="cve-20221231.xsd#cve_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptionsWarrantsOutstanding"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfTheStatusOfTheCompanySWarrantsAbstract" xlink:to="ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptionsWarrantsOutstanding_0" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <loc xlink:type="locator" xlink:label="SharesBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingPeriodIncreaseDecreaseWeightedAverageExercisePrice_0" xlink:href="cve-20221231.xsd#cve_SharesBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingPeriodIncreaseDecreaseWeightedAverageExercisePrice"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfTheStatusOfTheCompanySWarrantsAbstract" xlink:to="SharesBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingPeriodIncreaseDecreaseWeightedAverageExercisePrice_0" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <loc xlink:type="locator" xlink:label="ShareBasedCompensationArrangementBySharesBasedPaymentAwardOptionsGrantsInPeriodWarrantsGranted" xlink:href="cve-20221231.xsd#cve_ShareBasedCompensationArrangementBySharesBasedPaymentAwardOptionsGrantsInPeriodWarrantsGranted"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfTheStatusOfTheCompanySWarrantsAbstract" xlink:to="ShareBasedCompensationArrangementBySharesBasedPaymentAwardOptionsGrantsInPeriodWarrantsGranted" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="SharesbasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue" xlink:href="cve-20221231.xsd#cve_SharesbasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfTheStatusOfTheCompanySWarrantsAbstract" xlink:to="SharesbasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisedWarrantsExercised" xlink:href="cve-20221231.xsd#cve_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisedWarrantsExercised"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfTheStatusOfTheCompanySWarrantsAbstract" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisedWarrantsExercised" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="SharesBasedCompensationArrangementBySharesBasedPaymentAwardOptionsOutstandingPeriodIncreaseDecreaseWeightedAverageExercisePrice" xlink:href="cve-20221231.xsd#cve_SharesBasedCompensationArrangementBySharesBasedPaymentAwardOptionsOutstandingPeriodIncreaseDecreaseWeightedAverageExercisePrice"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfTheStatusOfTheCompanySWarrantsAbstract" xlink:to="SharesBasedCompensationArrangementBySharesBasedPaymentAwardOptionsOutstandingPeriodIncreaseDecreaseWeightedAverageExercisePrice" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWarrantsExpired" xlink:href="cve-20221231.xsd#cve_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWarrantsExpired"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfTheStatusOfTheCompanySWarrantsAbstract" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWarrantsExpired" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ShareBasedCompensationArrangementsBySharesBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" xlink:href="cve-20221231.xsd#cve_ShareBasedCompensationArrangementsBySharesBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfTheStatusOfTheCompanySWarrantsAbstract" xlink:to="ShareBasedCompensationArrangementsBySharesBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://encoreuranium.com/role/ScheduleofsharepurchasewarrantsoutstandingTable">
    <loc xlink:type="locator" xlink:label="ScheduleOfSharePurchaseWarrantsOutstandingAbstract" xlink:href="cve-20221231.xsd#cve_ScheduleOfSharePurchaseWarrantsOutstandingAbstract"/>
    <loc xlink:type="locator" xlink:label="ShareCapitalDetailsScheduleofsharepurchasewarrantsoutstandingTable" xlink:href="cve-20221231.xsd#cve_ShareCapitalDetailsScheduleofsharepurchasewarrantsoutstandingTable"/>
    <loc xlink:type="locator" xlink:label="ShareCapitalDetailsScheduleofsharepurchasewarrantsoutstandingLineItems" xlink:href="cve-20221231.xsd#cve_ShareCapitalDetailsScheduleofsharepurchasewarrantsoutstandingLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfSharePurchaseWarrantsOutstandingAbstract" xlink:to="ShareCapitalDetailsScheduleofsharepurchasewarrantsoutstandingTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareCapitalDetailsScheduleofsharepurchasewarrantsoutstandingTable" xlink:to="ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis" xlink:to="ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsMember" order="0.0"/>
    <loc xlink:type="locator" xlink:label="OneFiveNineOneEightZeroMember" xlink:href="cve-20221231.xsd#cve_OneFiveNineOneEightZeroMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis" xlink:to="OneFiveNineOneEightZeroMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="TwoTwoTwoThreeNineZeroOneMember" xlink:href="cve-20221231.xsd#cve_TwoTwoTwoThreeNineZeroOneMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis" xlink:to="TwoTwoTwoThreeNineZeroOneMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="FourFiveNineSixZeroZeroMember" xlink:href="cve-20221231.xsd#cve_FourFiveNineSixZeroZeroMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis" xlink:to="FourFiveNineSixZeroZeroMember" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareCapitalDetailsScheduleofsharepurchasewarrantsoutstandingTable" xlink:to="ShareCapitalDetailsScheduleofsharepurchasewarrantsoutstandingLineItems" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="Warrants" xlink:href="cve-20221231.xsd#cve_Warrants"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareCapitalDetailsScheduleofsharepurchasewarrantsoutstandingLineItems" xlink:to="Warrants" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="WarrantsOutstandingWeightedAverageReimainingLife" xlink:href="cve-20221231.xsd#cve_WarrantsOutstandingWeightedAverageReimainingLife"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareCapitalDetailsScheduleofsharepurchasewarrantsoutstandingLineItems" xlink:to="WarrantsOutstandingWeightedAverageReimainingLife" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="WarrantsOutstandingWeightedAverageExercisePrice" xlink:href="cve-20221231.xsd#cve_WarrantsOutstandingWeightedAverageExercisePrice"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareCapitalDetailsScheduleofsharepurchasewarrantsoutstandingLineItems" xlink:to="WarrantsOutstandingWeightedAverageExercisePrice" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://encoreuranium.com/role/ScheduleofamountspaidtokeymanagementorentitiesprovidingsimilarservicesTable">
    <loc xlink:type="locator" xlink:label="ScheduleOfAmountsPaidToKeyManagementOrEntitiesProvidingSimilarServicesAbstract" xlink:href="cve-20221231.xsd#cve_ScheduleOfAmountsPaidToKeyManagementOrEntitiesProvidingSimilarServicesAbstract"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_RevenueFromRenderingOfInformationTechnologyConsultingServices" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_RevenueFromRenderingOfInformationTechnologyConsultingServices"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfAmountsPaidToKeyManagementOrEntitiesProvidingSimilarServicesAbstract" xlink:to="ifrs-full_RevenueFromRenderingOfInformationTechnologyConsultingServices" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfAmountsPaidToKeyManagementOrEntitiesProvidingSimilarServicesAbstract" xlink:to="ifrs-full_AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DirectorsRemunerationExpense" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_DirectorsRemunerationExpense"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfAmountsPaidToKeyManagementOrEntitiesProvidingSimilarServicesAbstract" xlink:to="ifrs-full_DirectorsRemunerationExpense" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="OfficeAndAdministration" xlink:href="cve-20221231.xsd#cve_OfficeAndAdministration"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfAmountsPaidToKeyManagementOrEntitiesProvidingSimilarServicesAbstract" xlink:to="OfficeAndAdministration" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="StaffCosts" xlink:href="cve-20221231.xsd#cve_StaffCosts"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfAmountsPaidToKeyManagementOrEntitiesProvidingSimilarServicesAbstract" xlink:to="StaffCosts" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockOptionPlanExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockOptionPlanExpense"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfAmountsPaidToKeyManagementOrEntitiesProvidingSimilarServicesAbstract" xlink:to="us-gaap_StockOptionPlanExpense" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_KeyManagementPersonnelCompensation" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_KeyManagementPersonnelCompensation"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfAmountsPaidToKeyManagementOrEntitiesProvidingSimilarServicesAbstract" xlink:to="ifrs-full_KeyManagementPersonnelCompensation" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://encoreuranium.com/role/ScheduleofowingtorelatedpartiesTable">
    <loc xlink:type="locator" xlink:label="ScheduleOfOwingToRelatedPartiesAbstract" xlink:href="cve-20221231.xsd#cve_ScheduleOfOwingToRelatedPartiesAbstract"/>
    <loc xlink:type="locator" xlink:label="RelatedpartytransactionsandbalancesDetailsScheduleofowingtorelatedpartiesTable" xlink:href="cve-20221231.xsd#cve_RelatedpartytransactionsandbalancesDetailsScheduleofowingtorelatedpartiesTable"/>
    <loc xlink:type="locator" xlink:label="RelatedpartytransactionsandbalancesDetailsScheduleofowingtorelatedpartiesLineItems" xlink:href="cve-20221231.xsd#cve_RelatedpartytransactionsandbalancesDetailsScheduleofowingtorelatedpartiesLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfOwingToRelatedPartiesAbstract" xlink:to="RelatedpartytransactionsandbalancesDetailsScheduleofowingtorelatedpartiesTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CategoriesOfRelatedPartiesAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_CategoriesOfRelatedPartiesAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RelatedpartytransactionsandbalancesDetailsScheduleofowingtorelatedpartiesTable" xlink:to="ifrs-full_CategoriesOfRelatedPartiesAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_EntitysTotalForRelatedPartiesMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_EntitysTotalForRelatedPartiesMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CategoriesOfRelatedPartiesAxis" xlink:to="ifrs-full_EntitysTotalForRelatedPartiesMember" order="0.0"/>
    <loc xlink:type="locator" xlink:label="TintinaHoldingsLtdMember" xlink:href="cve-20221231.xsd#cve_TintinaHoldingsLtdMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CategoriesOfRelatedPartiesAxis" xlink:to="TintinaHoldingsLtdMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="OfficersAndBoardMembersMember" xlink:href="cve-20221231.xsd#cve_OfficersAndBoardMembersMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CategoriesOfRelatedPartiesAxis" xlink:to="OfficersAndBoardMembersMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RelatedpartytransactionsandbalancesDetailsScheduleofowingtorelatedpartiesTable" xlink:to="RelatedpartytransactionsandbalancesDetailsScheduleofowingtorelatedpartiesLineItems" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AmountsPayableRelatedPartyTransactions" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_AmountsPayableRelatedPartyTransactions"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RelatedpartytransactionsandbalancesDetailsScheduleofowingtorelatedpartiesLineItems" xlink:to="ifrs-full_AmountsPayableRelatedPartyTransactions" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://encoreuranium.com/role/ScheduleofforeigncurrencyexposuresTable">
    <loc xlink:type="locator" xlink:label="ScheduleOfForeignCurrencyExposuresAbstract" xlink:href="cve-20221231.xsd#cve_ScheduleOfForeignCurrencyExposuresAbstract"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_Cash" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_Cash"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfForeignCurrencyExposuresAbstract" xlink:to="ifrs-full_Cash" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_MarketableSecurities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MarketableSecurities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfForeignCurrencyExposuresAbstract" xlink:to="us-gaap_MarketableSecurities" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="AccountPayablesAndAccruedLiabilities" xlink:href="cve-20221231.xsd#cve_AccountPayablesAndAccruedLiabilities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfForeignCurrencyExposuresAbstract" xlink:to="AccountPayablesAndAccruedLiabilities" order="2.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AssetsLessCurrentLiabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_AssetsLessCurrentLiabilities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfForeignCurrencyExposuresAbstract" xlink:to="ifrs-full_AssetsLessCurrentLiabilities" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://encoreuranium.com/role/ScheduleoflongtermassetsbygeographicsegmentTable">
    <loc xlink:type="locator" xlink:label="ScheduleOfLongTermAssetsByGeographicSegmentAbstract" xlink:href="cve-20221231.xsd#cve_ScheduleOfLongTermAssetsByGeographicSegmentAbstract"/>
    <loc xlink:type="locator" xlink:label="SegmentedinformationDetailsScheduleoflongtermassetsbygeographicsegmentTable" xlink:href="cve-20221231.xsd#cve_SegmentedinformationDetailsScheduleoflongtermassetsbygeographicsegmentTable"/>
    <loc xlink:type="locator" xlink:label="SegmentedinformationDetailsScheduleoflongtermassetsbygeographicsegmentLineItems" xlink:href="cve-20221231.xsd#cve_SegmentedinformationDetailsScheduleoflongtermassetsbygeographicsegmentLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfLongTermAssetsByGeographicSegmentAbstract" xlink:to="SegmentedinformationDetailsScheduleoflongtermassetsbygeographicsegmentTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_GeographicalAreasAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_GeographicalAreasAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SegmentedinformationDetailsScheduleoflongtermassetsbygeographicsegmentTable" xlink:to="ifrs-full_GeographicalAreasAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_GeographicalAreasMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_GeographicalAreasMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_GeographicalAreasAxis" xlink:to="ifrs-full_GeographicalAreasMember" order="0.0"/>
    <loc xlink:type="locator" xlink:label="stpr_SD" xlink:href="https://xbrl.sec.gov/stpr/2022/stpr-2022.xsd#stpr_SD"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_GeographicalAreasAxis" xlink:to="stpr_SD" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="stpr_TX" xlink:href="https://xbrl.sec.gov/stpr/2022/stpr-2022.xsd#stpr_TX"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_GeographicalAreasAxis" xlink:to="stpr_TX" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="stpr_NM" xlink:href="https://xbrl.sec.gov/stpr/2022/stpr-2022.xsd#stpr_NM"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_GeographicalAreasAxis" xlink:to="stpr_NM" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="stpr_WY" xlink:href="https://xbrl.sec.gov/stpr/2022/stpr-2022.xsd#stpr_WY"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_GeographicalAreasAxis" xlink:to="stpr_WY" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="OtherStatesMember" xlink:href="cve-20221231.xsd#cve_OtherStatesMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_GeographicalAreasAxis" xlink:to="OtherStatesMember" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="country_CA" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_CA"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_GeographicalAreasAxis" xlink:to="country_CA" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SegmentedinformationDetailsScheduleoflongtermassetsbygeographicsegmentTable" xlink:to="SegmentedinformationDetailsScheduleoflongtermassetsbygeographicsegmentLineItems" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="IntangibleAssets" xlink:href="cve-20221231.xsd#cve_IntangibleAssets"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SegmentedinformationDetailsScheduleoflongtermassetsbygeographicsegmentLineItems" xlink:to="IntangibleAssets" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="PropertyPlantAndEquipments" xlink:href="cve-20221231.xsd#cve_PropertyPlantAndEquipments"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SegmentedinformationDetailsScheduleoflongtermassetsbygeographicsegmentLineItems" xlink:to="PropertyPlantAndEquipments" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="MineralProperties" xlink:href="cve-20221231.xsd#cve_MineralProperties"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SegmentedinformationDetailsScheduleoflongtermassetsbygeographicsegmentLineItems" xlink:to="MineralProperties" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="RightofuseAssets1" xlink:href="cve-20221231.xsd#cve_RightofuseAssets1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SegmentedinformationDetailsScheduleoflongtermassetsbygeographicsegmentLineItems" xlink:to="RightofuseAssets1" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="SegmentedInformationBalance" xlink:href="cve-20221231.xsd#cve_SegmentedInformationBalance"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SegmentedinformationDetailsScheduleoflongtermassetsbygeographicsegmentLineItems" xlink:to="SegmentedInformationBalance" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://encoreuranium.com/role/ScheduleofincurrednoncashfinancingandinvestingactivitiesTable">
    <loc xlink:type="locator" xlink:label="ScheduleOfIncurredNonCashFinancingAndInvestingActivitiesAbstract" xlink:href="cve-20221231.xsd#cve_ScheduleOfIncurredNonCashFinancingAndInvestingActivitiesAbstract"/>
    <loc xlink:type="locator" xlink:label="NonCashFinancingActivitiesAbstract" xlink:href="cve-20221231.xsd#cve_NonCashFinancingActivitiesAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfIncurredNonCashFinancingAndInvestingActivitiesAbstract" xlink:to="NonCashFinancingActivitiesAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CurrentAccruedExpensesAndOtherCurrentLiabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_CurrentAccruedExpensesAndOtherCurrentLiabilities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="NonCashFinancingActivitiesAbstract" xlink:to="ifrs-full_CurrentAccruedExpensesAndOtherCurrentLiabilities" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="TotalNoncashFinancingActivities" xlink:href="cve-20221231.xsd#cve_TotalNoncashFinancingActivities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="NonCashFinancingActivitiesAbstract" xlink:to="TotalNoncashFinancingActivities" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="NonCashInvestingActivitiesAbstract" xlink:href="cve-20221231.xsd#cve_NonCashInvestingActivitiesAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfIncurredNonCashFinancingAndInvestingActivitiesAbstract" xlink:to="NonCashInvestingActivitiesAbstract" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="MarketableSecuritieReceivedOnDispositionOfMineralProperties" xlink:href="cve-20221231.xsd#cve_MarketableSecuritieReceivedOnDispositionOfMineralProperties"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="NonCashInvestingActivitiesAbstract" xlink:to="MarketableSecuritieReceivedOnDispositionOfMineralProperties" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_LiabilitiesArisingFromExplorationForAndEvaluationOfMineralResources" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_LiabilitiesArisingFromExplorationForAndEvaluationOfMineralResources"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="NonCashInvestingActivitiesAbstract" xlink:to="ifrs-full_LiabilitiesArisingFromExplorationForAndEvaluationOfMineralResources" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="PropertyPlantAndEquipmentAdditionIncludedInAccountsPayableAndAccruedLiabilities" xlink:href="cve-20221231.xsd#cve_PropertyPlantAndEquipmentAdditionIncludedInAccountsPayableAndAccruedLiabilities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="NonCashInvestingActivitiesAbstract" xlink:to="PropertyPlantAndEquipmentAdditionIncludedInAccountsPayableAndAccruedLiabilities" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="FairValueOfCommonSharesIssuedForAzargaAssetAcquisition" xlink:href="cve-20221231.xsd#cve_FairValueOfCommonSharesIssuedForAzargaAssetAcquisition"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="NonCashInvestingActivitiesAbstract" xlink:to="FairValueOfCommonSharesIssuedForAzargaAssetAcquisition" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="FairValueOfReplacementOptionsIssuedForAzargaAssetsAcquisition" xlink:href="cve-20221231.xsd#cve_FairValueOfReplacementOptionsIssuedForAzargaAssetsAcquisition"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="NonCashInvestingActivitiesAbstract" xlink:to="FairValueOfReplacementOptionsIssuedForAzargaAssetsAcquisition" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="FairValueOfReplacementWarrantsIssuedForAzargaAssetAcquisition" xlink:href="cve-20221231.xsd#cve_FairValueOfReplacementWarrantsIssuedForAzargaAssetAcquisition"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="NonCashInvestingActivitiesAbstract" xlink:to="FairValueOfReplacementWarrantsIssuedForAzargaAssetAcquisition" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="TotalNoncashInvestingActivities" xlink:href="cve-20221231.xsd#cve_TotalNoncashInvestingActivities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="NonCashInvestingActivitiesAbstract" xlink:to="TotalNoncashInvestingActivities" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://encoreuranium.com/role/ScheduleoffederalandprovincialcorporatetaxratestoincomebeforetaxTable">
    <loc xlink:type="locator" xlink:label="ScheduleOfFederalAndProvincialCorporateTaxRatesToIncomeBeforeTaxAbstract" xlink:href="cve-20221231.xsd#cve_ScheduleOfFederalAndProvincialCorporateTaxRatesToIncomeBeforeTaxAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeLossAttributableToParent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossAttributableToParent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfFederalAndProvincialCorporateTaxRatesToIncomeBeforeTaxAbstract" xlink:to="us-gaap_IncomeLossAttributableToParent" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfFederalAndProvincialCorporateTaxRatesToIncomeBeforeTaxAbstract" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ExpectedIncomeTaxExpenserecovery" xlink:href="cve-20221231.xsd#cve_ExpectedIncomeTaxExpenserecovery"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfFederalAndProvincialCorporateTaxRatesToIncomeBeforeTaxAbstract" xlink:to="ExpectedIncomeTaxExpenserecovery" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="IncreaseDecreaseResultingFromAbstract" xlink:href="cve-20221231.xsd#cve_IncreaseDecreaseResultingFromAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfFederalAndProvincialCorporateTaxRatesToIncomeBeforeTaxAbstract" xlink:to="IncreaseDecreaseResultingFromAbstract" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ChangeInUnrecognizedTemporaryDifferences" xlink:href="cve-20221231.xsd#cve_ChangeInUnrecognizedTemporaryDifferences"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncreaseDecreaseResultingFromAbstract" xlink:to="ChangeInUnrecognizedTemporaryDifferences" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_TaxEffectOfExpenseNotDeductibleInDeterminingTaxableProfitTaxLoss" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_TaxEffectOfExpenseNotDeductibleInDeterminingTaxableProfitTaxLoss"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncreaseDecreaseResultingFromAbstract" xlink:to="ifrs-full_TaxEffectOfExpenseNotDeductibleInDeterminingTaxableProfitTaxLoss" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_TaxEffectOfForeignTaxRates" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_TaxEffectOfForeignTaxRates"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncreaseDecreaseResultingFromAbstract" xlink:to="ifrs-full_TaxEffectOfForeignTaxRates" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ShareIssueCosts" xlink:href="cve-20221231.xsd#cve_ShareIssueCosts"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncreaseDecreaseResultingFromAbstract" xlink:to="ShareIssueCosts" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AdjustmentsForCurrentTaxOfPriorPeriod" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_AdjustmentsForCurrentTaxOfPriorPeriod"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncreaseDecreaseResultingFromAbstract" xlink:to="ifrs-full_AdjustmentsForCurrentTaxOfPriorPeriod" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_IncomeTaxExpenseContinuingOperations" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_IncomeTaxExpenseContinuingOperations"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfFederalAndProvincialCorporateTaxRatesToIncomeBeforeTaxAbstract" xlink:to="ifrs-full_IncomeTaxExpenseContinuingOperations" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://encoreuranium.com/role/ScheduleofincometaxexpenserecoveryTable">
    <loc xlink:type="locator" xlink:label="ScheduleOfIncomeTaxExpenseRecoveryAbstract" xlink:href="cve-20221231.xsd#cve_ScheduleOfIncomeTaxExpenseRecoveryAbstract"/>
    <loc xlink:type="locator" xlink:label="DeferredTaxExpenseRecoveryAbstract" xlink:href="cve-20221231.xsd#cve_DeferredTaxExpenseRecoveryAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfIncomeTaxExpenseRecoveryAbstract" xlink:to="DeferredTaxExpenseRecoveryAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="OrginationAndReversalOfTemporaryDifferences" xlink:href="cve-20221231.xsd#cve_OrginationAndReversalOfTemporaryDifferences"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DeferredTaxExpenseRecoveryAbstract" xlink:to="OrginationAndReversalOfTemporaryDifferences" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ChangeInUnrecognizedTemporaryDifferences" xlink:href="cve-20221231.xsd#cve_ChangeInUnrecognizedTemporaryDifferences"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DeferredTaxExpenseRecoveryAbstract" xlink:to="ChangeInUnrecognizedTemporaryDifferences" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_IncomeTaxExpenseContinuingOperations" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_IncomeTaxExpenseContinuingOperations"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfIncomeTaxExpenseRecoveryAbstract" xlink:to="ifrs-full_IncomeTaxExpenseContinuingOperations" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsOtherLossCarryforwards" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsOtherLossCarryforwards"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfIncomeTaxExpenseRecoveryAbstract" xlink:to="us-gaap_DeferredTaxAssetsOtherLossCarryforwards" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsOther" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsOther"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfIncomeTaxExpenseRecoveryAbstract" xlink:to="us-gaap_DeferredTaxAssetsOther" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="SetoffOfTax" xlink:href="cve-20221231.xsd#cve_SetoffOfTax"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfIncomeTaxExpenseRecoveryAbstract" xlink:to="SetoffOfTax" order="4.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_NetDeferredTaxAssets" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_NetDeferredTaxAssets"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfIncomeTaxExpenseRecoveryAbstract" xlink:to="ifrs-full_NetDeferredTaxAssets" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://encoreuranium.com/role/ScheduleofdeferredtaxliabilitiesTable">
    <loc xlink:type="locator" xlink:label="ScheduleOfDeferredTaxLiabilitiesAbstract" xlink:href="cve-20221231.xsd#cve_ScheduleOfDeferredTaxLiabilitiesAbstract"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_OtherIntangibleAssets" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_OtherIntangibleAssets"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfDeferredTaxLiabilitiesAbstract" xlink:to="ifrs-full_OtherIntangibleAssets" order="0.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_RightofuseAssetsRevaluedAssetsAtCost" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_RightofuseAssetsRevaluedAssetsAtCost"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfDeferredTaxLiabilitiesAbstract" xlink:to="ifrs-full_RightofuseAssetsRevaluedAssetsAtCost" order="1.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="FixedAssets" xlink:href="cve-20221231.xsd#cve_FixedAssets"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfDeferredTaxLiabilitiesAbstract" xlink:to="FixedAssets" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_RightofuseAssetsRevaluationSurplus" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_RightofuseAssetsRevaluationSurplus"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfDeferredTaxLiabilitiesAbstract" xlink:to="ifrs-full_RightofuseAssetsRevaluationSurplus" order="3.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_MarketableSecuritiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MarketableSecuritiesCurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfDeferredTaxLiabilitiesAbstract" xlink:to="us-gaap_MarketableSecuritiesCurrent" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="SetoffOfTax" xlink:href="cve-20221231.xsd#cve_SetoffOfTax"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfDeferredTaxLiabilitiesAbstract" xlink:to="SetoffOfTax" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_NetDeferredTaxAssets" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_NetDeferredTaxAssets"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfDeferredTaxLiabilitiesAbstract" xlink:to="ifrs-full_NetDeferredTaxAssets" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://encoreuranium.com/role/ScheduleofunrecognizeddeferredtaxassetsTable">
    <loc xlink:type="locator" xlink:label="ScheduleOfUnrecognizedDeferredTaxAssetsAbstract" xlink:href="cve-20221231.xsd#cve_ScheduleOfUnrecognizedDeferredTaxAssetsAbstract"/>
    <loc xlink:type="locator" xlink:label="DeductibleTemporaryDifferences" xlink:href="cve-20221231.xsd#cve_DeductibleTemporaryDifferences"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfUnrecognizedDeferredTaxAssetsAbstract" xlink:to="DeductibleTemporaryDifferences" order="0.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_TaxEffectOfTaxLosses" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_TaxEffectOfTaxLosses"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfUnrecognizedDeferredTaxAssetsAbstract" xlink:to="ifrs-full_TaxEffectOfTaxLosses" order="1.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ProfitLossBeforeTax" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_ProfitLossBeforeTax"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfUnrecognizedDeferredTaxAssetsAbstract" xlink:to="ifrs-full_ProfitLossBeforeTax" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://encoreuranium.com/role/ScheduleofeffectoftranslationTable">
    <loc xlink:type="locator" xlink:label="ScheduleOfEffectOfTranslationAbstract" xlink:href="cve-20221231.xsd#cve_ScheduleOfEffectOfTranslationAbstract"/>
    <loc xlink:type="locator" xlink:label="ChangeinPresentationCurrencyDetailsScheduleofeffectoftranslationTable" xlink:href="cve-20221231.xsd#cve_ChangeinPresentationCurrencyDetailsScheduleofeffectoftranslationTable"/>
    <loc xlink:type="locator" xlink:label="ChangeinPresentationCurrencyDetailsScheduleofeffectoftranslationLineItems" xlink:href="cve-20221231.xsd#cve_ChangeinPresentationCurrencyDetailsScheduleofeffectoftranslationLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfEffectOfTranslationAbstract" xlink:to="ChangeinPresentationCurrencyDetailsScheduleofeffectoftranslationTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_RetrospectiveApplicationAndRetrospectiveRestatementAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_RetrospectiveApplicationAndRetrospectiveRestatementAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ChangeinPresentationCurrencyDetailsScheduleofeffectoftranslationTable" xlink:to="ifrs-full_RetrospectiveApplicationAndRetrospectiveRestatementAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_PreviouslyStatedMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_PreviouslyStatedMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_RetrospectiveApplicationAndRetrospectiveRestatementAxis" xlink:to="ifrs-full_PreviouslyStatedMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="TranslatedMember" xlink:href="cve-20221231.xsd#cve_TranslatedMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_RetrospectiveApplicationAndRetrospectiveRestatementAxis" xlink:to="TranslatedMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ChangeinPresentationCurrencyDetailsScheduleofeffectoftranslationTable" xlink:to="ChangeinPresentationCurrencyDetailsScheduleofeffectoftranslationLineItems" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CurrentAssets" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_CurrentAssets"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ChangeinPresentationCurrencyDetailsScheduleofeffectoftranslationLineItems" xlink:to="ifrs-full_CurrentAssets" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_NoncurrentAssets" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_NoncurrentAssets"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ChangeinPresentationCurrencyDetailsScheduleofeffectoftranslationLineItems" xlink:to="ifrs-full_NoncurrentAssets" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_Assets" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_Assets"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ChangeinPresentationCurrencyDetailsScheduleofeffectoftranslationLineItems" xlink:to="ifrs-full_Assets" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CurrentLiabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_CurrentLiabilities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ChangeinPresentationCurrencyDetailsScheduleofeffectoftranslationLineItems" xlink:to="ifrs-full_CurrentLiabilities" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_NoncurrentLiabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_NoncurrentLiabilities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ChangeinPresentationCurrencyDetailsScheduleofeffectoftranslationLineItems" xlink:to="ifrs-full_NoncurrentLiabilities" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_Liabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_Liabilities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ChangeinPresentationCurrencyDetailsScheduleofeffectoftranslationLineItems" xlink:to="ifrs-full_Liabilities" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://encoreuranium.com/role/ScheduleofconsolidatedstatementsoflossandcomprehensivelossTable">
    <loc xlink:type="locator" xlink:label="ScheduleOfConsolidatedStatementsOfLossAndComprehensiveLossAbstract" xlink:href="cve-20221231.xsd#cve_ScheduleOfConsolidatedStatementsOfLossAndComprehensiveLossAbstract"/>
    <loc xlink:type="locator" xlink:label="ChangeinPresentationCurrencyDetailsScheduleofconsolidatedstatementsoflossandcomprehensivelossTable" xlink:href="cve-20221231.xsd#cve_ChangeinPresentationCurrencyDetailsScheduleofconsolidatedstatementsoflossandcomprehensivelossTable"/>
    <loc xlink:type="locator" xlink:label="ChangeinPresentationCurrencyDetailsScheduleofconsolidatedstatementsoflossandcomprehensivelossLineItems" xlink:href="cve-20221231.xsd#cve_ChangeinPresentationCurrencyDetailsScheduleofconsolidatedstatementsoflossandcomprehensivelossLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfConsolidatedStatementsOfLossAndComprehensiveLossAbstract" xlink:to="ChangeinPresentationCurrencyDetailsScheduleofconsolidatedstatementsoflossandcomprehensivelossTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="srt_RestatementAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RestatementAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ChangeinPresentationCurrencyDetailsScheduleofconsolidatedstatementsoflossandcomprehensivelossTable" xlink:to="srt_RestatementAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="srt_ScenarioPreviouslyReportedMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioPreviouslyReportedMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RestatementAxis" xlink:to="srt_ScenarioPreviouslyReportedMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="TranslatedMember" xlink:href="cve-20221231.xsd#cve_TranslatedMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RestatementAxis" xlink:to="TranslatedMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ChangeinPresentationCurrencyDetailsScheduleofconsolidatedstatementsoflossandcomprehensivelossTable" xlink:to="ChangeinPresentationCurrencyDetailsScheduleofconsolidatedstatementsoflossandcomprehensivelossLineItems" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ExpensesAbstract0" xlink:href="cve-20221231.xsd#cve_ExpensesAbstract0"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ChangeinPresentationCurrencyDetailsScheduleofconsolidatedstatementsoflossandcomprehensivelossLineItems" xlink:to="ExpensesAbstract0" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="Accretion" xlink:href="cve-20221231.xsd#cve_Accretion"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ExpensesAbstract0" xlink:to="Accretion" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AdjustmentsForDepreciationAndAmortisationExpense" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_AdjustmentsForDepreciationAndAmortisationExpense"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ExpensesAbstract0" xlink:to="ifrs-full_AdjustmentsForDepreciationAndAmortisationExpense" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="Consulting" xlink:href="cve-20221231.xsd#cve_Consulting"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ExpensesAbstract0" xlink:to="Consulting" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AdministrativeExpense" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_AdministrativeExpense"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ExpensesAbstract0" xlink:to="ifrs-full_AdministrativeExpense" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="ImpairmentCharges" xlink:href="cve-20221231.xsd#cve_ImpairmentCharges"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ExpensesAbstract0" xlink:to="ImpairmentCharges" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_InterestExpense" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_InterestExpense"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ExpensesAbstract0" xlink:to="ifrs-full_InterestExpense" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="OfficeAndAdministrative" xlink:href="cve-20221231.xsd#cve_OfficeAndAdministrative"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ExpensesAbstract0" xlink:to="OfficeAndAdministrative" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ProfessionalFeesExpense" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_ProfessionalFeesExpense"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ExpensesAbstract0" xlink:to="ifrs-full_ProfessionalFeesExpense" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_OtherExpenseByNature" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_OtherExpenseByNature"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ExpensesAbstract0" xlink:to="ifrs-full_OtherExpenseByNature" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ReclamationCosts" xlink:href="cve-20221231.xsd#cve_ReclamationCosts"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ExpensesAbstract0" xlink:to="ReclamationCosts" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_TravelExpense" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_TravelExpense"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ExpensesAbstract0" xlink:to="ifrs-full_TravelExpense" order="10.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="TransferAgentAndFilingFees" xlink:href="cve-20221231.xsd#cve_TransferAgentAndFilingFees"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ExpensesAbstract0" xlink:to="TransferAgentAndFilingFees" order="11.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="StaffCosts" xlink:href="cve-20221231.xsd#cve_StaffCosts"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ExpensesAbstract0" xlink:to="StaffCosts" order="12.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockOptionPlanExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockOptionPlanExpense"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ExpensesAbstract0" xlink:to="us-gaap_StockOptionPlanExpense" order="13.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_OtherOperatingIncomeExpense" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_OtherOperatingIncomeExpense"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ChangeinPresentationCurrencyDetailsScheduleofconsolidatedstatementsoflossandcomprehensivelossLineItems" xlink:to="ifrs-full_OtherOperatingIncomeExpense" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_InterestRevenueExpense" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_InterestRevenueExpense"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_OtherOperatingIncomeExpense" xlink:to="ifrs-full_InterestRevenueExpense" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ForeignExchangeGain" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_ForeignExchangeGain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_OtherOperatingIncomeExpense" xlink:to="ifrs-full_ForeignExchangeGain" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="LossesOnDivestmentOfMineralProperties" xlink:href="cve-20221231.xsd#cve_LossesOnDivestmentOfMineralProperties"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_OtherOperatingIncomeExpense" xlink:to="LossesOnDivestmentOfMineralProperties" order="2.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="GainOnChangeInAssetRetirementObligationEstimate" xlink:href="cve-20221231.xsd#cve_GainOnChangeInAssetRetirementObligationEstimate"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_OtherOperatingIncomeExpense" xlink:to="GainOnChangeInAssetRetirementObligationEstimate" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LossOnContractTermination" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossOnContractTermination"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_OtherOperatingIncomeExpense" xlink:to="us-gaap_LossOnContractTermination" order="4.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="UnrealizedGainOnUraniumInvestment" xlink:href="cve-20221231.xsd#cve_UnrealizedGainOnUraniumInvestment"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_OtherOperatingIncomeExpense" xlink:to="UnrealizedGainOnUraniumInvestment" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_GainsOnDisposalsOfInvestmentProperties" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_GainsOnDisposalsOfInvestmentProperties"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_OtherOperatingIncomeExpense" xlink:to="ifrs-full_GainsOnDisposalsOfInvestmentProperties" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="LossOnInvestmentInAssociate" xlink:href="cve-20221231.xsd#cve_LossOnInvestmentInAssociate"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_OtherOperatingIncomeExpense" xlink:to="LossOnInvestmentInAssociate" order="7.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_NetForeignExchangeLoss" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_NetForeignExchangeLoss"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_OtherOperatingIncomeExpense" xlink:to="ifrs-full_NetForeignExchangeLoss" order="8.0" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_OtherComprehensiveIncomeBeforeTaxExchangeDifferencesOnTranslation" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_OtherComprehensiveIncomeBeforeTaxExchangeDifferencesOnTranslation"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_NetForeignExchangeLoss" xlink:to="ifrs-full_OtherComprehensiveIncomeBeforeTaxExchangeDifferencesOnTranslation" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ReversalOfImpairmentLossRecognisedInOtherComprehensiveIncome" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_ReversalOfImpairmentLossRecognisedInOtherComprehensiveIncome"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ChangeinPresentationCurrencyDetailsScheduleofconsolidatedstatementsoflossandcomprehensivelossLineItems" xlink:to="ifrs-full_ReversalOfImpairmentLossRecognisedInOtherComprehensiveIncome" order="2.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_BasicEarningsLossPerShare" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_BasicEarningsLossPerShare"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ChangeinPresentationCurrencyDetailsScheduleofconsolidatedstatementsoflossandcomprehensivelossLineItems" xlink:to="ifrs-full_BasicEarningsLossPerShare" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://encoreuranium.com/role/ScheduleofconsolidatedstatementsoflossandcomprehensivelossTable_Parentheticals">
    <loc xlink:type="locator" xlink:label="ScheduleOfConsolidatedStatementsOfLossAndComprehensiveLossAbstract" xlink:href="cve-20221231.xsd#cve_ScheduleOfConsolidatedStatementsOfLossAndComprehensiveLossAbstract"/>
    <loc xlink:type="locator" xlink:label="ChangeinPresentationCurrencyDetailsScheduleofconsolidatedstatementsoflossandcomprehensivelossParentheticalsTable" xlink:href="cve-20221231.xsd#cve_ChangeinPresentationCurrencyDetailsScheduleofconsolidatedstatementsoflossandcomprehensivelossParentheticalsTable"/>
    <loc xlink:type="locator" xlink:label="ChangeinPresentationCurrencyDetailsScheduleofconsolidatedstatementsoflossandcomprehensivelossParentheticalsLineItems" xlink:href="cve-20221231.xsd#cve_ChangeinPresentationCurrencyDetailsScheduleofconsolidatedstatementsoflossandcomprehensivelossParentheticalsLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfConsolidatedStatementsOfLossAndComprehensiveLossAbstract" xlink:to="ChangeinPresentationCurrencyDetailsScheduleofconsolidatedstatementsoflossandcomprehensivelossParentheticalsTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="srt_RestatementAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RestatementAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ChangeinPresentationCurrencyDetailsScheduleofconsolidatedstatementsoflossandcomprehensivelossParentheticalsTable" xlink:to="srt_RestatementAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="srt_ScenarioPreviouslyReportedMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioPreviouslyReportedMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RestatementAxis" xlink:to="srt_ScenarioPreviouslyReportedMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="TranslatedMember" xlink:href="cve-20221231.xsd#cve_TranslatedMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RestatementAxis" xlink:to="TranslatedMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ChangeinPresentationCurrencyDetailsScheduleofconsolidatedstatementsoflossandcomprehensivelossParentheticalsTable" xlink:to="ChangeinPresentationCurrencyDetailsScheduleofconsolidatedstatementsoflossandcomprehensivelossParentheticalsLineItems" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DilutedEarningsLossPerShare" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_DilutedEarningsLossPerShare"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ChangeinPresentationCurrencyDetailsScheduleofconsolidatedstatementsoflossandcomprehensivelossParentheticalsLineItems" xlink:to="ifrs-full_DilutedEarningsLossPerShare" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://encoreuranium.com/role/NatureofOperationsandGoingConcernDetails">
    <loc xlink:type="locator" xlink:label="NatureOfOperationAndGoingConcernAbstract" xlink:href="cve-20221231.xsd#cve_NatureOfOperationAndGoingConcernAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProfitLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="NatureOfOperationAndGoingConcernAbstract" xlink:to="us-gaap_ProfitLoss" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="WorkingCapital" xlink:href="cve-20221231.xsd#cve_WorkingCapital"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="NatureOfOperationAndGoingConcernAbstract" xlink:to="WorkingCapital" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="AccumulatedDeficit" xlink:href="cve-20221231.xsd#cve_AccumulatedDeficit"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="NatureOfOperationAndGoingConcernAbstract" xlink:to="AccumulatedDeficit" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://encoreuranium.com/role/SignificantaccountingpoliciesDetails">
    <loc xlink:type="locator" xlink:label="DisclosureOfSignificantAccountingPoliciesTextBlockAbstract" xlink:href="cve-20221231.xsd#cve_DisclosureOfSignificantAccountingPoliciesTextBlockAbstract"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_PercentageOfVotingEquityInterestsAcquired" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_PercentageOfVotingEquityInterestsAcquired"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisclosureOfSignificantAccountingPoliciesTextBlockAbstract" xlink:to="ifrs-full_PercentageOfVotingEquityInterestsAcquired" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DepositsFromBanks" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_DepositsFromBanks"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisclosureOfSignificantAccountingPoliciesTextBlockAbstract" xlink:to="ifrs-full_DepositsFromBanks" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ShareSubscriptionsValue" xlink:href="cve-20221231.xsd#cve_ShareSubscriptionsValue"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisclosureOfSignificantAccountingPoliciesTextBlockAbstract" xlink:to="ShareSubscriptionsValue" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://encoreuranium.com/role/InvestmentInAssociateDetails">
    <loc xlink:type="locator" xlink:label="DisclosureOfAssociatesTextBlockAbstract" xlink:href="cve-20221231.xsd#cve_DisclosureOfAssociatesTextBlockAbstract"/>
    <loc xlink:type="locator" xlink:label="AcquiredShares" xlink:href="cve-20221231.xsd#cve_AcquiredShares"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisclosureOfAssociatesTextBlockAbstract" xlink:to="AcquiredShares" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="IssuedAndOutstandingSharesPercentage" xlink:href="cve-20221231.xsd#cve_IssuedAndOutstandingSharesPercentage"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisclosureOfAssociatesTextBlockAbstract" xlink:to="IssuedAndOutstandingSharesPercentage" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="AdvancedAmount" xlink:href="cve-20221231.xsd#cve_AdvancedAmount"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisclosureOfAssociatesTextBlockAbstract" xlink:to="AdvancedAmount" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ProportionOfOwnershipInterestInAssociate" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_ProportionOfOwnershipInterestInAssociate"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisclosureOfAssociatesTextBlockAbstract" xlink:to="ifrs-full_ProportionOfOwnershipInterestInAssociate" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://encoreuranium.com/role/InvestmentinuraniumDetails">
    <loc xlink:type="locator" xlink:label="DisclosureOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethodTextBlockAbstract" xlink:href="cve-20221231.xsd#cve_DisclosureOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethodTextBlockAbstract"/>
    <loc xlink:type="locator" xlink:label="InvestmentinuraniumDetailsTable" xlink:href="cve-20221231.xsd#cve_InvestmentinuraniumDetailsTable"/>
    <loc xlink:type="locator" xlink:label="InvestmentinuraniumDetailsLineItems" xlink:href="cve-20221231.xsd#cve_InvestmentinuraniumDetailsLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisclosureOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethodTextBlockAbstract" xlink:to="InvestmentinuraniumDetailsTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="srt_StatementScenarioAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementScenarioAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="InvestmentinuraniumDetailsTable" xlink:to="srt_StatementScenarioAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="srt_ScenarioUnspecifiedDomain" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioUnspecifiedDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_StatementScenarioAxis" xlink:to="srt_ScenarioUnspecifiedDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="srt_ScenarioForecastMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioForecastMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_StatementScenarioAxis" xlink:to="srt_ScenarioForecastMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="InvestmentinuraniumDetailsTable" xlink:to="InvestmentinuraniumDetailsLineItems" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="PurchaseAgreementsAmount" xlink:href="cve-20221231.xsd#cve_PurchaseAgreementsAmount"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="InvestmentinuraniumDetailsLineItems" xlink:to="PurchaseAgreementsAmount" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherLongTermInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLongTermInvestments"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="InvestmentinuraniumDetailsLineItems" xlink:to="us-gaap_OtherLongTermInvestments" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="SaleOfPhysicalUranium" xlink:href="cve-20221231.xsd#cve_SaleOfPhysicalUranium"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="InvestmentinuraniumDetailsLineItems" xlink:to="SaleOfPhysicalUranium" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="GrossProceeds" xlink:href="cve-20221231.xsd#cve_GrossProceeds"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="InvestmentinuraniumDetailsLineItems" xlink:to="GrossProceeds" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_GainsOnDisposalsOfInvestments" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_GainsOnDisposalsOfInvestments"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="InvestmentinuraniumDetailsLineItems" xlink:to="ifrs-full_GainsOnDisposalsOfInvestments" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="TotalConsideration" xlink:href="cve-20221231.xsd#cve_TotalConsideration"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="InvestmentinuraniumDetailsLineItems" xlink:to="TotalConsideration" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="TotalConsiderationPerShare" xlink:href="cve-20221231.xsd#cve_TotalConsiderationPerShare"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="InvestmentinuraniumDetailsLineItems" xlink:to="TotalConsiderationPerShare" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="InitialPayment" xlink:href="cve-20221231.xsd#cve_InitialPayment"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="InvestmentinuraniumDetailsLineItems" xlink:to="InitialPayment" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="InvestmentAmount" xlink:href="cve-20221231.xsd#cve_InvestmentAmount"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="InvestmentinuraniumDetailsLineItems" xlink:to="InvestmentAmount" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://encoreuranium.com/role/MarketableSecuritiesDetails">
    <loc xlink:type="locator" xlink:label="DisclosureOfMarketRiskTextBlockAbstract" xlink:href="cve-20221231.xsd#cve_DisclosureOfMarketRiskTextBlockAbstract"/>
    <loc xlink:type="locator" xlink:label="MarketableSecuritiesDetailsTable" xlink:href="cve-20221231.xsd#cve_MarketableSecuritiesDetailsTable"/>
    <loc xlink:type="locator" xlink:label="MarketableSecuritiesDetailsLineItems" xlink:href="cve-20221231.xsd#cve_MarketableSecuritiesDetailsLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisclosureOfMarketRiskTextBlockAbstract" xlink:to="MarketableSecuritiesDetailsTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ClassesOfOrdinarySharesAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_ClassesOfOrdinarySharesAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="MarketableSecuritiesDetailsTable" xlink:to="ifrs-full_ClassesOfOrdinarySharesAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_OrdinarySharesMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_OrdinarySharesMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ClassesOfOrdinarySharesAxis" xlink:to="ifrs-full_OrdinarySharesMember" order="0.0"/>
    <loc xlink:type="locator" xlink:label="TradingSharesMember" xlink:href="cve-20221231.xsd#cve_TradingSharesMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ClassesOfOrdinarySharesAxis" xlink:to="TradingSharesMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="MarketableSecuritiesDetailsTable" xlink:to="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="us-gaap_RelatedPartyDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="MarketableSecuritiesMember" xlink:href="cve-20221231.xsd#cve_MarketableSecuritiesMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="MarketableSecuritiesMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="MarketableSecuritiesDetailsTable" xlink:to="MarketableSecuritiesDetailsLineItems" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="CommonShares" xlink:href="cve-20221231.xsd#cve_CommonShares"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="MarketableSecuritiesDetailsLineItems" xlink:to="CommonShares" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="MarketValuePerShare" xlink:href="cve-20221231.xsd#cve_MarketValuePerShare"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="MarketableSecuritiesDetailsLineItems" xlink:to="MarketValuePerShare" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_NumberOfSharesIssuedAndFullyPaid" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_NumberOfSharesIssuedAndFullyPaid"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="MarketableSecuritiesDetailsLineItems" xlink:to="ifrs-full_NumberOfSharesIssuedAndFullyPaid" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ConvertedShares" xlink:href="cve-20221231.xsd#cve_ConvertedShares"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="MarketableSecuritiesDetailsLineItems" xlink:to="ConvertedShares" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DescriptionOfKeyAssumptionsOnWhichManagementHasBasedDeterminationOfFairValueLessCostsOfDisposal" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_DescriptionOfKeyAssumptionsOnWhichManagementHasBasedDeterminationOfFairValueLessCostsOfDisposal"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="MarketableSecuritiesDetailsLineItems" xlink:to="ifrs-full_DescriptionOfKeyAssumptionsOnWhichManagementHasBasedDeterminationOfFairValueLessCostsOfDisposal" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="TradingShares" xlink:href="cve-20221231.xsd#cve_TradingShares"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="MarketableSecuritiesDetailsLineItems" xlink:to="TradingShares" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_FinancialLiabilitiesAtFairValue" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_FinancialLiabilitiesAtFairValue"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="MarketableSecuritiesDetailsLineItems" xlink:to="ifrs-full_FinancialLiabilitiesAtFairValue" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ParValuePerShare" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_ParValuePerShare"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="MarketableSecuritiesDetailsLineItems" xlink:to="ifrs-full_ParValuePerShare" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ReleasedShares" xlink:href="cve-20221231.xsd#cve_ReleasedShares"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="MarketableSecuritiesDetailsLineItems" xlink:to="ReleasedShares" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="PrimeFuelsConsiderationPercentage" xlink:href="cve-20221231.xsd#cve_PrimeFuelsConsiderationPercentage"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="MarketableSecuritiesDetailsLineItems" xlink:to="PrimeFuelsConsiderationPercentage" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_Assets" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_Assets"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="MarketableSecuritiesDetailsLineItems" xlink:to="ifrs-full_Assets" order="10.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://encoreuranium.com/role/IntangibleassetsDetails">
    <loc xlink:type="locator" xlink:label="DisclosureOfIntangibleAssetsTextBlockAbstract" xlink:href="cve-20221231.xsd#cve_DisclosureOfIntangibleAssetsTextBlockAbstract"/>
    <loc xlink:type="locator" xlink:label="CommonSharesIssued" xlink:href="cve-20221231.xsd#cve_CommonSharesIssued"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisclosureOfIntangibleAssetsTextBlockAbstract" xlink:to="CommonSharesIssued" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_PlanAssetsAtFairValue" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_PlanAssetsAtFairValue"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisclosureOfIntangibleAssetsTextBlockAbstract" xlink:to="ifrs-full_PlanAssetsAtFairValue" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="PrimaryTerm" xlink:href="cve-20221231.xsd#cve_PrimaryTerm"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisclosureOfIntangibleAssetsTextBlockAbstract" xlink:to="PrimaryTerm" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="RenewalPeriods" xlink:href="cve-20221231.xsd#cve_RenewalPeriods"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisclosureOfIntangibleAssetsTextBlockAbstract" xlink:to="RenewalPeriods" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="IntangibleAssetDeterminedLife" xlink:href="cve-20221231.xsd#cve_IntangibleAssetDeterminedLife"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisclosureOfIntangibleAssetsTextBlockAbstract" xlink:to="IntangibleAssetDeterminedLife" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="AcquiredAmonut" xlink:href="cve-20221231.xsd#cve_AcquiredAmonut"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisclosureOfIntangibleAssetsTextBlockAbstract" xlink:to="AcquiredAmonut" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://encoreuranium.com/role/RightofuseassetsDetails">
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfQuantitativeInformationAboutLeasesForLesseeAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_DisclosureOfQuantitativeInformationAboutLeasesForLesseeAbstract"/>
    <loc xlink:type="locator" xlink:label="RightofuseassetsDetailsTable" xlink:href="cve-20221231.xsd#cve_RightofuseassetsDetailsTable"/>
    <loc xlink:type="locator" xlink:label="RightofuseassetsDetailsLineItems" xlink:href="cve-20221231.xsd#cve_RightofuseassetsDetailsLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfQuantitativeInformationAboutLeasesForLesseeAbstract" xlink:to="RightofuseassetsDetailsTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ClassesOfAssetsAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_ClassesOfAssetsAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RightofuseassetsDetailsTable" xlink:to="ifrs-full_ClassesOfAssetsAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ClassesOfAssetsMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_ClassesOfAssetsMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ClassesOfAssetsAxis" xlink:to="ifrs-full_ClassesOfAssetsMember" order="0.0"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_RightofuseAssetsMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_RightofuseAssetsMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ClassesOfAssetsAxis" xlink:to="ifrs-full_RightofuseAssetsMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RightofuseassetsDetailsTable" xlink:to="RightofuseassetsDetailsLineItems" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLeasePayments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeasePayments"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RightofuseassetsDetailsLineItems" xlink:to="us-gaap_OperatingLeasePayments" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="CorrespondingLeaseObligation" xlink:href="cve-20221231.xsd#cve_CorrespondingLeaseObligation"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RightofuseassetsDetailsLineItems" xlink:to="CorrespondingLeaseObligation" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_BorrowingsInterestRate" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_BorrowingsInterestRate"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RightofuseassetsDetailsLineItems" xlink:to="ifrs-full_BorrowingsInterestRate" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://encoreuranium.com/role/AssetacquisitionDetails">
    <loc xlink:type="locator" xlink:label="DisclosureOfTransactionsRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombinationTextBlockAbstract" xlink:href="cve-20221231.xsd#cve_DisclosureOfTransactionsRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombinationTextBlockAbstract"/>
    <loc xlink:type="locator" xlink:label="AssetacquisitionDetailsTable" xlink:href="cve-20221231.xsd#cve_AssetacquisitionDetailsTable"/>
    <loc xlink:type="locator" xlink:label="AssetacquisitionDetailsLineItems" xlink:href="cve-20221231.xsd#cve_AssetacquisitionDetailsLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisclosureOfTransactionsRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombinationTextBlockAbstract" xlink:to="AssetacquisitionDetailsTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_RangeAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_RangeAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AssetacquisitionDetailsTable" xlink:to="ifrs-full_RangeAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_RangesMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_RangesMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_RangeAxis" xlink:to="ifrs-full_RangesMember" order="0.0"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_TopOfRangeMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_TopOfRangeMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_RangeAxis" xlink:to="ifrs-full_TopOfRangeMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_BottomOfRangeMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_BottomOfRangeMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_RangeAxis" xlink:to="ifrs-full_BottomOfRangeMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ClassesOfAssetsAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_ClassesOfAssetsAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AssetacquisitionDetailsTable" xlink:to="ifrs-full_ClassesOfAssetsAxis" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ClassesOfAssetsMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_ClassesOfAssetsMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ClassesOfAssetsAxis" xlink:to="ifrs-full_ClassesOfAssetsMember" order="0.0"/>
    <loc xlink:type="locator" xlink:label="ReplacementOptionsMember" xlink:href="cve-20221231.xsd#cve_ReplacementOptionsMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ClassesOfAssetsAxis" xlink:to="ReplacementOptionsMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ReplacementWarrantsMember" xlink:href="cve-20221231.xsd#cve_ReplacementWarrantsMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ClassesOfAssetsAxis" xlink:to="ReplacementWarrantsMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AssetacquisitionDetailsTable" xlink:to="AssetacquisitionDetailsLineItems" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="MarketValuePerShare" xlink:href="cve-20221231.xsd#cve_MarketValuePerShare"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AssetacquisitionDetailsLineItems" xlink:to="MarketValuePerShare" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AssetacquisitionDetailsLineItems" xlink:to="ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_NumberOfSharesIssued" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_NumberOfSharesIssued"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AssetacquisitionDetailsLineItems" xlink:to="ifrs-full_NumberOfSharesIssued" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ShareConsiderationAmount" xlink:href="cve-20221231.xsd#cve_ShareConsiderationAmount"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AssetacquisitionDetailsLineItems" xlink:to="ShareConsiderationAmount" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="StockOptions" xlink:href="cve-20221231.xsd#cve_StockOptions"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AssetacquisitionDetailsLineItems" xlink:to="StockOptions" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ProceedsFromExerciseOfOptions" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_ProceedsFromExerciseOfOptions"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AssetacquisitionDetailsLineItems" xlink:to="ifrs-full_ProceedsFromExerciseOfOptions" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="SharePurchaseWarrants" xlink:href="cve-20221231.xsd#cve_SharePurchaseWarrants"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AssetacquisitionDetailsLineItems" xlink:to="SharePurchaseWarrants" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ProceedsFromExerciseOfWarrants" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_ProceedsFromExerciseOfWarrants"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AssetacquisitionDetailsLineItems" xlink:to="ifrs-full_ProceedsFromExerciseOfWarrants" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AcquisitionrelatedCostsRecognisedAsExpenseForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_AcquisitionrelatedCostsRecognisedAsExpenseForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AssetacquisitionDetailsLineItems" xlink:to="ifrs-full_AcquisitionrelatedCostsRecognisedAsExpenseForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_WeightedAverageSharePrice2019" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_WeightedAverageSharePrice2019"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AssetacquisitionDetailsLineItems" xlink:to="ifrs-full_WeightedAverageSharePrice2019" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_NumberOfSharesOutstanding" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_NumberOfSharesOutstanding"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AssetacquisitionDetailsLineItems" xlink:to="ifrs-full_NumberOfSharesOutstanding" order="10.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ExchangeRatio" xlink:href="cve-20221231.xsd#cve_ExchangeRatio"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AssetacquisitionDetailsLineItems" xlink:to="ExchangeRatio" order="11.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ShareConsolidation" xlink:href="cve-20221231.xsd#cve_ShareConsolidation"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AssetacquisitionDetailsLineItems" xlink:to="ShareConsolidation" order="12.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://encoreuranium.com/role/MineralPropertiesDetails">
    <loc xlink:type="locator" xlink:label="DisclosureOfMineralPropertiesAbstract" xlink:href="cve-20221231.xsd#cve_DisclosureOfMineralPropertiesAbstract"/>
    <loc xlink:type="locator" xlink:label="MineralPropertiesDetailsTable" xlink:href="cve-20221231.xsd#cve_MineralPropertiesDetailsTable"/>
    <loc xlink:type="locator" xlink:label="MineralPropertiesDetailsLineItems" xlink:href="cve-20221231.xsd#cve_MineralPropertiesDetailsLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisclosureOfMineralPropertiesAbstract" xlink:to="MineralPropertiesDetailsTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_RangeAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_RangeAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="MineralPropertiesDetailsTable" xlink:to="ifrs-full_RangeAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_RangesMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_RangesMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_RangeAxis" xlink:to="ifrs-full_RangesMember" order="0.0"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_BottomOfRangeMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_BottomOfRangeMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_RangeAxis" xlink:to="ifrs-full_BottomOfRangeMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_TopOfRangeMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_TopOfRangeMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_RangeAxis" xlink:to="ifrs-full_TopOfRangeMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ClassesOfLiabilitiesAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_ClassesOfLiabilitiesAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="MineralPropertiesDetailsTable" xlink:to="ifrs-full_ClassesOfLiabilitiesAxis" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_LiabilitiesMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_LiabilitiesMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ClassesOfLiabilitiesAxis" xlink:to="ifrs-full_LiabilitiesMember" order="0.0"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ContingentConsiderationMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_ContingentConsiderationMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ClassesOfLiabilitiesAxis" xlink:to="ifrs-full_ContingentConsiderationMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="TriStateGenerationAndTransmissionAssociationMember" xlink:href="cve-20221231.xsd#cve_TriStateGenerationAndTransmissionAssociationMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ClassesOfLiabilitiesAxis" xlink:to="TriStateGenerationAndTransmissionAssociationMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="WildcatSolarPowerPlantLLCMember" xlink:href="cve-20221231.xsd#cve_WildcatSolarPowerPlantLLCMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ClassesOfLiabilitiesAxis" xlink:to="WildcatSolarPowerPlantLLCMember" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="McKinleyMember" xlink:href="cve-20221231.xsd#cve_McKinleyMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ClassesOfLiabilitiesAxis" xlink:to="McKinleyMember" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="CrownpointMember" xlink:href="cve-20221231.xsd#cve_CrownpointMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ClassesOfLiabilitiesAxis" xlink:to="CrownpointMember" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="HostaButteMember" xlink:href="cve-20221231.xsd#cve_HostaButteMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ClassesOfLiabilitiesAxis" xlink:to="HostaButteMember" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CategoriesOfRelatedPartiesAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_CategoriesOfRelatedPartiesAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="MineralPropertiesDetailsTable" xlink:to="ifrs-full_CategoriesOfRelatedPartiesAxis" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_EntitysTotalForRelatedPartiesMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_EntitysTotalForRelatedPartiesMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CategoriesOfRelatedPartiesAxis" xlink:to="ifrs-full_EntitysTotalForRelatedPartiesMember" order="0.0"/>
    <loc xlink:type="locator" xlink:label="PrimeFuelsCorpMember" xlink:href="cve-20221231.xsd#cve_PrimeFuelsCorpMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CategoriesOfRelatedPartiesAxis" xlink:to="PrimeFuelsCorpMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="MineralPropertiesDetailsTable" xlink:to="MineralPropertiesDetailsLineItems" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_LongtermDeposits" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_LongtermDeposits"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="MineralPropertiesDetailsLineItems" xlink:to="ifrs-full_LongtermDeposits" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ConsiderationPaidReceived" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_ConsiderationPaidReceived"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="MineralPropertiesDetailsLineItems" xlink:to="ifrs-full_ConsiderationPaidReceived" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ContingentConsiderationRecognisedAsOfAcquisitionDate" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_ContingentConsiderationRecognisedAsOfAcquisitionDate"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="MineralPropertiesDetailsLineItems" xlink:to="ifrs-full_ContingentConsiderationRecognisedAsOfAcquisitionDate" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_GainsOnDisposalsOfInvestments" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_GainsOnDisposalsOfInvestments"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="MineralPropertiesDetailsLineItems" xlink:to="ifrs-full_GainsOnDisposalsOfInvestments" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="InvestmentInterestRates" xlink:href="cve-20221231.xsd#cve_InvestmentInterestRates"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="MineralPropertiesDetailsLineItems" xlink:to="InvestmentInterestRates" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="InterestRateHold" xlink:href="cve-20221231.xsd#cve_InterestRateHold"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="MineralPropertiesDetailsLineItems" xlink:to="InterestRateHold" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="RoyaltyIncomeRate" xlink:href="cve-20221231.xsd#cve_RoyaltyIncomeRate"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="MineralPropertiesDetailsLineItems" xlink:to="RoyaltyIncomeRate" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ConsiderationReceived" xlink:href="cve-20221231.xsd#cve_ConsiderationReceived"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="MineralPropertiesDetailsLineItems" xlink:to="ConsiderationReceived" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LongTermDebtFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtFairValue"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="MineralPropertiesDetailsLineItems" xlink:to="us-gaap_LongTermDebtFairValue" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_NoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSaleOrAsHeldForDistributionToOwners" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_NoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSaleOrAsHeldForDistributionToOwners"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="MineralPropertiesDetailsLineItems" xlink:to="ifrs-full_NoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSaleOrAsHeldForDistributionToOwners" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="GainOnDisposalOfSubsidiary" xlink:href="cve-20221231.xsd#cve_GainOnDisposalOfSubsidiary"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="MineralPropertiesDetailsLineItems" xlink:to="GainOnDisposalOfSubsidiary" order="10.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ProceedsFromSalesOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_ProceedsFromSalesOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="MineralPropertiesDetailsLineItems" xlink:to="ifrs-full_ProceedsFromSalesOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities" order="11.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="AdditionalPayment" xlink:href="cve-20221231.xsd#cve_AdditionalPayment"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="MineralPropertiesDetailsLineItems" xlink:to="AdditionalPayment" order="12.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_RecognisedAssetsDefinedBenefitPlan" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_RecognisedAssetsDefinedBenefitPlan"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="MineralPropertiesDetailsLineItems" xlink:to="ifrs-full_RecognisedAssetsDefinedBenefitPlan" order="13.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="GrantedPercentage" xlink:href="cve-20221231.xsd#cve_GrantedPercentage"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="MineralPropertiesDetailsLineItems" xlink:to="GrantedPercentage" order="14.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ConsiderationPercentage" xlink:href="cve-20221231.xsd#cve_ConsiderationPercentage"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="MineralPropertiesDetailsLineItems" xlink:to="ConsiderationPercentage" order="15.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_NumberOfSharesIssuedAndFullyPaid" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_NumberOfSharesIssuedAndFullyPaid"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="MineralPropertiesDetailsLineItems" xlink:to="ifrs-full_NumberOfSharesIssuedAndFullyPaid" order="16.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_PlanAssetsAtFairValue" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_PlanAssetsAtFairValue"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="MineralPropertiesDetailsLineItems" xlink:to="ifrs-full_PlanAssetsAtFairValue" order="17.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_LossesOnDisposalsOfInvestments" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_LossesOnDisposalsOfInvestments"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="MineralPropertiesDetailsLineItems" xlink:to="ifrs-full_LossesOnDisposalsOfInvestments" order="18.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://encoreuranium.com/role/AssetretirementobligationsDetails">
    <loc xlink:type="locator" xlink:label="AssetRetirementObligationsAbstract" xlink:href="cve-20221231.xsd#cve_AssetRetirementObligationsAbstract"/>
    <loc xlink:type="locator" xlink:label="InflationFactorPercentage" xlink:href="cve-20221231.xsd#cve_InflationFactorPercentage"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AssetRetirementObligationsAbstract" xlink:to="InflationFactorPercentage" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DescriptionOfDiscountRatesAppliedToCashFlowProjections" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_DescriptionOfDiscountRatesAppliedToCashFlowProjections"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AssetRetirementObligationsAbstract" xlink:to="ifrs-full_DescriptionOfDiscountRatesAppliedToCashFlowProjections" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://encoreuranium.com/role/SalescontractsDetails">
    <loc xlink:type="locator" xlink:label="DisclosueOfSalesContractsAbstract" xlink:href="cve-20221231.xsd#cve_DisclosueOfSalesContractsAbstract"/>
    <loc xlink:type="locator" xlink:label="TotalDiscountedMarketPrices" xlink:href="cve-20221231.xsd#cve_TotalDiscountedMarketPrices"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisclosueOfSalesContractsAbstract" xlink:to="TotalDiscountedMarketPrices" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="CancellationFee" xlink:href="cve-20221231.xsd#cve_CancellationFee"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisclosueOfSalesContractsAbstract" xlink:to="CancellationFee" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="PursuantToAgreement" xlink:href="cve-20221231.xsd#cve_PursuantToAgreement"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisclosueOfSalesContractsAbstract" xlink:to="PursuantToAgreement" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ContractPoundsOfUranium" xlink:href="cve-20221231.xsd#cve_ContractPoundsOfUranium"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisclosueOfSalesContractsAbstract" xlink:to="ContractPoundsOfUranium" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="PricePerPound" xlink:href="cve-20221231.xsd#cve_PricePerPound"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisclosueOfSalesContractsAbstract" xlink:to="PricePerPound" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="SalesContractsTrem" xlink:href="cve-20221231.xsd#cve_SalesContractsTrem"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisclosueOfSalesContractsAbstract" xlink:to="SalesContractsTrem" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://encoreuranium.com/role/ShareCapitalDetails">
    <loc xlink:type="locator" xlink:label="DisclosureOfClassesOfShareCapitalTextBlockAbstract" xlink:href="cve-20221231.xsd#cve_DisclosureOfClassesOfShareCapitalTextBlockAbstract"/>
    <loc xlink:type="locator" xlink:label="ShareCapitalDetailsTable" xlink:href="cve-20221231.xsd#cve_ShareCapitalDetailsTable"/>
    <loc xlink:type="locator" xlink:label="ShareCapitalDetailsLineItems" xlink:href="cve-20221231.xsd#cve_ShareCapitalDetailsLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisclosureOfClassesOfShareCapitalTextBlockAbstract" xlink:to="ShareCapitalDetailsTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ComponentsOfEquityAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_ComponentsOfEquityAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareCapitalDetailsTable" xlink:to="ifrs-full_ComponentsOfEquityAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_EquityMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_EquityMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ComponentsOfEquityAxis" xlink:to="ifrs-full_EquityMember" order="0.0"/>
    <loc xlink:type="locator" xlink:label="WarrantsMember" xlink:href="cve-20221231.xsd#cve_WarrantsMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ComponentsOfEquityAxis" xlink:to="WarrantsMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="StockOptionsMember" xlink:href="cve-20221231.xsd#cve_StockOptionsMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ComponentsOfEquityAxis" xlink:to="StockOptionsMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareCapitalDetailsTable" xlink:to="ShareCapitalDetailsLineItems" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="SharesUnit" xlink:href="cve-20221231.xsd#cve_SharesUnit"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareCapitalDetailsLineItems" xlink:to="SharesUnit" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_WeightedAverageExercisePriceOfShareOptionsInSharebasedPaymentArrangementExercisedDuringPeriodAtDateOfExercise2019" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_WeightedAverageExercisePriceOfShareOptionsInSharebasedPaymentArrangementExercisedDuringPeriodAtDateOfExercise2019"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareCapitalDetailsLineItems" xlink:to="ifrs-full_WeightedAverageExercisePriceOfShareOptionsInSharebasedPaymentArrangementExercisedDuringPeriodAtDateOfExercise2019" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="GrossProceed" xlink:href="cve-20221231.xsd#cve_GrossProceed"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareCapitalDetailsLineItems" xlink:to="GrossProceed" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="CommonShare" xlink:href="cve-20221231.xsd#cve_CommonShare"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareCapitalDetailsLineItems" xlink:to="CommonShare" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="PurchaseWarrantShares" xlink:href="cve-20221231.xsd#cve_PurchaseWarrantShares"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareCapitalDetailsLineItems" xlink:to="PurchaseWarrantShares" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="PurchaseAdditionalShareWarrants" xlink:href="cve-20221231.xsd#cve_PurchaseAdditionalShareWarrants"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareCapitalDetailsLineItems" xlink:to="PurchaseAdditionalShareWarrants" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="PurchaseAdditionalSharePricePerWarrant" xlink:href="cve-20221231.xsd#cve_PurchaseAdditionalSharePricePerWarrant"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareCapitalDetailsLineItems" xlink:to="PurchaseAdditionalSharePricePerWarrant" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ReceiptsFromRoyaltiesFeesCommissionsAndOtherRevenue" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_ReceiptsFromRoyaltiesFeesCommissionsAndOtherRevenue"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareCapitalDetailsLineItems" xlink:to="ifrs-full_ReceiptsFromRoyaltiesFeesCommissionsAndOtherRevenue" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="CashIssuanceCosts" xlink:href="cve-20221231.xsd#cve_CashIssuanceCosts"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareCapitalDetailsLineItems" xlink:to="CashIssuanceCosts" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ShareIssued" xlink:href="cve-20221231.xsd#cve_ShareIssued"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareCapitalDetailsLineItems" xlink:to="ShareIssued" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="WarrantsOfFairValue" xlink:href="cve-20221231.xsd#cve_WarrantsOfFairValue"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareCapitalDetailsLineItems" xlink:to="WarrantsOfFairValue" order="10.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="WarrantsExercisableOfCommonShare" xlink:href="cve-20221231.xsd#cve_WarrantsExercisableOfCommonShare"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareCapitalDetailsLineItems" xlink:to="WarrantsExercisableOfCommonShare" order="11.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="WarrantsExercisablePricePerShare" xlink:href="cve-20221231.xsd#cve_WarrantsExercisablePricePerShare"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareCapitalDetailsLineItems" xlink:to="WarrantsExercisablePricePerShare" order="12.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="CommonShareIssued" xlink:href="cve-20221231.xsd#cve_CommonShareIssued"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareCapitalDetailsLineItems" xlink:to="CommonShareIssued" order="13.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_EquityReclassifiedIntoFinancialLiabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_EquityReclassifiedIntoFinancialLiabilities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareCapitalDetailsLineItems" xlink:to="ifrs-full_EquityReclassifiedIntoFinancialLiabilities" order="14.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_FinancialLiabilitiesReclassifiedIntoEquity" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_FinancialLiabilitiesReclassifiedIntoEquity"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareCapitalDetailsLineItems" xlink:to="ifrs-full_FinancialLiabilitiesReclassifiedIntoEquity" order="15.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="CommonSharesOfSettlementAndCompensation" xlink:href="cve-20221231.xsd#cve_CommonSharesOfSettlementAndCompensation"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareCapitalDetailsLineItems" xlink:to="CommonSharesOfSettlementAndCompensation" order="16.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="NumberOfSharesReservedInsurancePercentage" xlink:href="cve-20221231.xsd#cve_NumberOfSharesReservedInsurancePercentage"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareCapitalDetailsLineItems" xlink:to="NumberOfSharesReservedInsurancePercentage" order="17.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="OptionsGrantedForMaximumYear" xlink:href="cve-20221231.xsd#cve_OptionsGrantedForMaximumYear"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareCapitalDetailsLineItems" xlink:to="OptionsGrantedForMaximumYear" order="18.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="AggregateOfGrantedShares" xlink:href="cve-20221231.xsd#cve_AggregateOfGrantedShares"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareCapitalDetailsLineItems" xlink:to="AggregateOfGrantedShares" order="19.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="FairValueOfGrantedOption" xlink:href="cve-20221231.xsd#cve_FairValueOfGrantedOption"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareCapitalDetailsLineItems" xlink:to="FairValueOfGrantedOption" order="20.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="StockOptionsRevisedTerm" xlink:href="cve-20221231.xsd#cve_StockOptionsRevisedTerm"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareCapitalDetailsLineItems" xlink:to="StockOptionsRevisedTerm" order="21.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="StandardStockOptionVestingPercentage" xlink:href="cve-20221231.xsd#cve_StandardStockOptionVestingPercentage"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareCapitalDetailsLineItems" xlink:to="StandardStockOptionVestingPercentage" order="22.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="RecognizedStockOptionExpense" xlink:href="cve-20221231.xsd#cve_RecognizedStockOptionExpense"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareCapitalDetailsLineItems" xlink:to="RecognizedStockOptionExpense" order="23.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="WarrantsExercisableShare" xlink:href="cve-20221231.xsd#cve_WarrantsExercisableShare"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareCapitalDetailsLineItems" xlink:to="WarrantsExercisableShare" order="24.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="WarrantShare" xlink:href="cve-20221231.xsd#cve_WarrantShare"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareCapitalDetailsLineItems" xlink:to="WarrantShare" order="25.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="WarrantsExercisablePrice" xlink:href="cve-20221231.xsd#cve_WarrantsExercisablePrice"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareCapitalDetailsLineItems" xlink:to="WarrantsExercisablePrice" order="26.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="WarrantIsExercisableTerm" xlink:href="cve-20221231.xsd#cve_WarrantIsExercisableTerm"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareCapitalDetailsLineItems" xlink:to="WarrantIsExercisableTerm" order="27.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DividendsReceived" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_DividendsReceived"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareCapitalDetailsLineItems" xlink:to="ifrs-full_DividendsReceived" order="28.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://encoreuranium.com/role/RelatedpartytransactionsandbalancesDetails">
    <loc xlink:type="locator" xlink:label="DisclosureOfRelatedPartyTextBlockAbstract" xlink:href="cve-20221231.xsd#cve_DisclosureOfRelatedPartyTextBlockAbstract"/>
    <loc xlink:type="locator" xlink:label="RelatedpartytransactionsandbalancesDetailsTable" xlink:href="cve-20221231.xsd#cve_RelatedpartytransactionsandbalancesDetailsTable"/>
    <loc xlink:type="locator" xlink:label="RelatedpartytransactionsandbalancesDetailsLineItems" xlink:href="cve-20221231.xsd#cve_RelatedpartytransactionsandbalancesDetailsLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisclosureOfRelatedPartyTextBlockAbstract" xlink:to="RelatedpartytransactionsandbalancesDetailsTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RelatedpartytransactionsandbalancesDetailsTable" xlink:to="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="us-gaap_RelatedPartyDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="PlatoroWestIncMember" xlink:href="cve-20221231.xsd#cve_PlatoroWestIncMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="PlatoroWestIncMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RelatedpartytransactionsandbalancesDetailsTable" xlink:to="RelatedpartytransactionsandbalancesDetailsLineItems" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ConsultingFees" xlink:href="cve-20221231.xsd#cve_ConsultingFees"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RelatedpartytransactionsandbalancesDetailsLineItems" xlink:to="ConsultingFees" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="GrantedOptionsShares" xlink:href="cve-20221231.xsd#cve_GrantedOptionsShares"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RelatedpartytransactionsandbalancesDetailsLineItems" xlink:to="GrantedOptionsShares" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="FairValueAmount" xlink:href="cve-20221231.xsd#cve_FairValueAmount"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RelatedpartytransactionsandbalancesDetailsLineItems" xlink:to="FairValueAmount" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://encoreuranium.com/role/FinancialInstrumentsDetails">
    <loc xlink:type="locator" xlink:label="DisclosureOfFinancialInstrumentsTextBlockAbstract" xlink:href="cve-20221231.xsd#cve_DisclosureOfFinancialInstrumentsTextBlockAbstract"/>
    <loc xlink:type="locator" xlink:label="ForeignExchangeRate" xlink:href="cve-20221231.xsd#cve_ForeignExchangeRate"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisclosureOfFinancialInstrumentsTextBlockAbstract" xlink:to="ForeignExchangeRate" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_NotionalAmount" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_NotionalAmount"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisclosureOfFinancialInstrumentsTextBlockAbstract" xlink:to="ifrs-full_NotionalAmount" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_TaxRateEffectFromChangeInTaxRate" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_TaxRateEffectFromChangeInTaxRate"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisclosureOfFinancialInstrumentsTextBlockAbstract" xlink:to="ifrs-full_TaxRateEffectFromChangeInTaxRate" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ImpactedLoss" xlink:href="cve-20221231.xsd#cve_ImpactedLoss"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisclosureOfFinancialInstrumentsTextBlockAbstract" xlink:to="ImpactedLoss" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://encoreuranium.com/role/IncometaxesDetails">
    <loc xlink:type="locator" xlink:label="DisclosureOfIncomeTaxTextBlockAbstract" xlink:href="cve-20221231.xsd#cve_DisclosureOfIncomeTaxTextBlockAbstract"/>
    <loc xlink:type="locator" xlink:label="NoncapitalLoss" xlink:href="cve-20221231.xsd#cve_NoncapitalLoss"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisclosureOfIncomeTaxTextBlockAbstract" xlink:to="NoncapitalLoss" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="FederalNetOperatingLossCarryforwards" xlink:href="cve-20221231.xsd#cve_FederalNetOperatingLossCarryforwards"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisclosureOfIncomeTaxTextBlockAbstract" xlink:to="FederalNetOperatingLossCarryforwards" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="CarriedForward" xlink:href="cve-20221231.xsd#cve_CarriedForward"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisclosureOfIncomeTaxTextBlockAbstract" xlink:to="CarriedForward" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ExpiringAmount" xlink:href="cve-20221231.xsd#cve_ExpiringAmount"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisclosureOfIncomeTaxTextBlockAbstract" xlink:to="ExpiringAmount" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://encoreuranium.com/role/EventsafterthereportingperiodDetails">
    <loc xlink:type="locator" xlink:label="DisclosureOfEventsAfterReportingPeriodTextBlockAbstract" xlink:href="cve-20221231.xsd#cve_DisclosureOfEventsAfterReportingPeriodTextBlockAbstract"/>
    <loc xlink:type="locator" xlink:label="EventsafterthereportingperiodDetailsTable" xlink:href="cve-20221231.xsd#cve_EventsafterthereportingperiodDetailsTable"/>
    <loc xlink:type="locator" xlink:label="EventsafterthereportingperiodDetailsLineItems" xlink:href="cve-20221231.xsd#cve_EventsafterthereportingperiodDetailsLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisclosureOfEventsAfterReportingPeriodTextBlockAbstract" xlink:to="EventsafterthereportingperiodDetailsTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ClassesOfLiabilitiesAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_ClassesOfLiabilitiesAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EventsafterthereportingperiodDetailsTable" xlink:to="ifrs-full_ClassesOfLiabilitiesAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_LiabilitiesMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_LiabilitiesMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ClassesOfLiabilitiesAxis" xlink:to="ifrs-full_LiabilitiesMember" order="0.0"/>
    <loc xlink:type="locator" xlink:label="EnergyFuelsIncMember" xlink:href="cve-20221231.xsd#cve_EnergyFuelsIncMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ClassesOfLiabilitiesAxis" xlink:to="EnergyFuelsIncMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="AltaMesaAcquisitionMember" xlink:href="cve-20221231.xsd#cve_AltaMesaAcquisitionMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ClassesOfLiabilitiesAxis" xlink:to="AltaMesaAcquisitionMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsequentEventTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EventsafterthereportingperiodDetailsTable" xlink:to="us-gaap_SubsequentEventTypeAxis" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsequentEventTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventTypeAxis" xlink:to="us-gaap_SubsequentEventTypeDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="SubsequentEventOneMember" xlink:href="cve-20221231.xsd#cve_SubsequentEventOneMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventTypeAxis" xlink:to="SubsequentEventOneMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="SubsequentEventTwoMember" xlink:href="cve-20221231.xsd#cve_SubsequentEventTwoMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventTypeAxis" xlink:to="SubsequentEventTwoMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="SubsequentEventThreeMember" xlink:href="cve-20221231.xsd#cve_SubsequentEventThreeMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventTypeAxis" xlink:to="SubsequentEventThreeMember" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="SubsequentEventFourMember" xlink:href="cve-20221231.xsd#cve_SubsequentEventFourMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventTypeAxis" xlink:to="SubsequentEventFourMember" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_NonadjustingEventsAfterReportingPeriodAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_NonadjustingEventsAfterReportingPeriodAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EventsafterthereportingperiodDetailsTable" xlink:to="ifrs-full_NonadjustingEventsAfterReportingPeriodAxis" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_NonadjustingEventsMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_NonadjustingEventsMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_NonadjustingEventsAfterReportingPeriodAxis" xlink:to="ifrs-full_NonadjustingEventsMember" order="0.0"/>
    <loc xlink:type="locator" xlink:label="SubsequentEventOneMember_0" xlink:href="cve-20221231.xsd#cve_SubsequentEventOneMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_NonadjustingEventsAfterReportingPeriodAxis" xlink:to="SubsequentEventOneMember_0" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EventsafterthereportingperiodDetailsTable" xlink:to="EventsafterthereportingperiodDetailsLineItems" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="TransactionCosts" xlink:href="cve-20221231.xsd#cve_TransactionCosts"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EventsafterthereportingperiodDetailsLineItems" xlink:to="TransactionCosts" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_Cash" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_Cash"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EventsafterthereportingperiodDetailsLineItems" xlink:to="ifrs-full_Cash" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_BorrowingsInterestRate" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_BorrowingsInterestRate"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EventsafterthereportingperiodDetailsLineItems" xlink:to="ifrs-full_BorrowingsInterestRate" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="AcquireCommonShare" xlink:href="cve-20221231.xsd#cve_AcquireCommonShare"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EventsafterthereportingperiodDetailsLineItems" xlink:to="AcquireCommonShare" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_SubscriptionCirculationRevenue" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_SubscriptionCirculationRevenue"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EventsafterthereportingperiodDetailsLineItems" xlink:to="ifrs-full_SubscriptionCirculationRevenue" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="Saleofstockpershare" xlink:href="cve-20221231.xsd#cve_Saleofstockpershare"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EventsafterthereportingperiodDetailsLineItems" xlink:to="Saleofstockpershare" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="PricePerShare" xlink:href="cve-20221231.xsd#cve_PricePerShare"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EventsafterthereportingperiodDetailsLineItems" xlink:to="PricePerShare" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromDebtNetOfIssuanceCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromDebtNetOfIssuanceCosts"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EventsafterthereportingperiodDetailsLineItems" xlink:to="us-gaap_ProceedsFromDebtNetOfIssuanceCosts" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_NumberOfSharesIssued" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_NumberOfSharesIssued"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EventsafterthereportingperiodDetailsLineItems" xlink:to="ifrs-full_NumberOfSharesIssued" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="PublicOfferingPricePerShare" xlink:href="cve-20221231.xsd#cve_PublicOfferingPricePerShare"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EventsafterthereportingperiodDetailsLineItems" xlink:to="PublicOfferingPricePerShare" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="GrossProceed" xlink:href="cve-20221231.xsd#cve_GrossProceed"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EventsafterthereportingperiodDetailsLineItems" xlink:to="GrossProceed" order="10.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="PurchasePricePerShare" xlink:href="cve-20221231.xsd#cve_PurchasePricePerShare"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EventsafterthereportingperiodDetailsLineItems" xlink:to="PurchasePricePerShare" order="11.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="StockOptionsSharesOutstanding" xlink:href="cve-20221231.xsd#cve_StockOptionsSharesOutstanding"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EventsafterthereportingperiodDetailsLineItems" xlink:to="StockOptionsSharesOutstanding" order="12.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="GrantedStockOptions" xlink:href="cve-20221231.xsd#cve_GrantedStockOptions"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EventsafterthereportingperiodDetailsLineItems" xlink:to="GrantedStockOptions" order="13.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="WeightedAverageExercisePrice" xlink:href="cve-20221231.xsd#cve_WeightedAverageExercisePrice"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EventsafterthereportingperiodDetailsLineItems" xlink:to="WeightedAverageExercisePrice" order="14.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="PurchasedShares" xlink:href="cve-20221231.xsd#cve_PurchasedShares"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EventsafterthereportingperiodDetailsLineItems" xlink:to="PurchasedShares" order="15.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="TransactionCost" xlink:href="cve-20221231.xsd#cve_TransactionCost"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EventsafterthereportingperiodDetailsLineItems" xlink:to="TransactionCost" order="16.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="PurchaseAgreementsAmount" xlink:href="cve-20221231.xsd#cve_PurchaseAgreementsAmount"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EventsafterthereportingperiodDetailsLineItems" xlink:to="PurchaseAgreementsAmount" order="17.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="OptionToAcquireShares" xlink:href="cve-20221231.xsd#cve_OptionToAcquireShares"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EventsafterthereportingperiodDetailsLineItems" xlink:to="OptionToAcquireShares" order="18.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ConsiderationPaidReceived" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_ConsiderationPaidReceived"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EventsafterthereportingperiodDetailsLineItems" xlink:to="ifrs-full_ConsiderationPaidReceived" order="19.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="TotalConsiderationPerPounds" xlink:href="cve-20221231.xsd#cve_TotalConsiderationPerPounds"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EventsafterthereportingperiodDetailsLineItems" xlink:to="TotalConsiderationPerPounds" order="20.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="InitialPayment" xlink:href="cve-20221231.xsd#cve_InitialPayment"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EventsafterthereportingperiodDetailsLineItems" xlink:to="InitialPayment" order="21.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="PaymentAmount" xlink:href="cve-20221231.xsd#cve_PaymentAmount"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EventsafterthereportingperiodDetailsLineItems" xlink:to="PaymentAmount" order="22.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="AssetsReceivedPercentage" xlink:href="cve-20221231.xsd#cve_AssetsReceivedPercentage"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EventsafterthereportingperiodDetailsLineItems" xlink:to="AssetsReceivedPercentage" order="23.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://encoreuranium.com/role/DocumentAndEntityInformation">
    <loc xlink:type="locator" xlink:label="DocumentAndEntityInformationAbstract" xlink:href="cve-20221231.xsd#cve_DocumentAndEntityInformationAbstract"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentInformationTable" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentInformationTable"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentInformationLineItems" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentInformationLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DocumentAndEntityInformationAbstract" xlink:to="dei_DocumentInformationTable" order="1.0"/>
    <loc xlink:type="locator" xlink:label="dei_EntityAddressesAddressTypeAxis" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressesAddressTypeAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationTable" xlink:to="dei_EntityAddressesAddressTypeAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="dei_AddressTypeDomain" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AddressTypeDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_EntityAddressesAddressTypeAxis" xlink:to="dei_AddressTypeDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="dei_BusinessContactMember" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_BusinessContactMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_EntityAddressesAddressTypeAxis" xlink:to="dei_BusinessContactMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationTable" xlink:to="dei_DocumentInformationLineItems" order="2.0"/>
    <loc xlink:type="locator" xlink:label="dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityRegistrantName" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_TradingSymbol" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentType" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_CurrentFiscalYearEndDate" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CurrentFiscalYearEndDate"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_CurrentFiscalYearEndDate" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_EntityCommonStockSharesOutstanding" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityCommonStockSharesOutstanding" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_AmendmentFlag" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityCentralIndexKey" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_EntityCurrentReportingStatus" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCurrentReportingStatus"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityCurrentReportingStatus" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentPeriodEndDate" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentFiscalYearFocus" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalYearFocus"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentFiscalYearFocus" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentFiscalPeriodFocus" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalPeriodFocus"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentFiscalPeriodFocus" order="10.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityEmergingGrowthCompany" order="11.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_EntityExTransitionPeriod" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityExTransitionPeriod"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityExTransitionPeriod" order="12.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_IcfrAuditorAttestationFlag" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_IcfrAuditorAttestationFlag"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_IcfrAuditorAttestationFlag" order="13.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentRegistrationStatement" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentRegistrationStatement"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentRegistrationStatement" order="14.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentAnnualReport" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentAnnualReport"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentAnnualReport" order="15.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityFileNumber" order="16.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityIncorporationStateCountryCode" order="17.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressAddressLine1" order="18.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_EntityAddressAddressLine2" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine2"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressAddressLine2" order="19.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressCityOrTown" order="20.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_EntityAddressStateOrProvince" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressStateOrProvince"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressStateOrProvince" order="21.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressPostalZipCode" order="22.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_CityAreaCode" order="23.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_LocalPhoneNumber" order="24.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_ContactPersonnelName" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_ContactPersonnelName"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_ContactPersonnelName" order="25.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_Security12bTitle" order="26.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_SecurityExchangeName" order="27.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_AnnualInformationForm" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AnnualInformationForm"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_AnnualInformationForm" order="28.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_AuditedAnnualFinancialStatements" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AuditedAnnualFinancialStatements"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_AuditedAnnualFinancialStatements" order="29.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_EntityInteractiveDataCurrent" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityInteractiveDataCurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityInteractiveDataCurrent" order="30.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_AuditorName" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AuditorName"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_AuditorName" order="31.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_AuditorLocation" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AuditorLocation"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_AuditorLocation" order="32.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_AuditorFirmId" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AuditorFirmId"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_AuditorFirmId" order="33.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
</linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>51
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139782927430672">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Document And Entity Information<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Dec. 31, 2022 </div>
<div>shares</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentInformationLineItems', window );"><strong>Document Information Line Items</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">enCore Energy Corp.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">EU<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">40-F<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--12-31<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
<td class="nump">108,940,051<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001500881<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCurrentReportingStatus', window );">Entity Current Reporting Status</a></td>
<td class="text">Yes<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Dec. 31,  2022<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="text">2022<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
<td class="text">FY<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityExTransitionPeriod', window );">Entity Ex Transition Period</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_IcfrAuditorAttestationFlag', window );">ICFR Auditor Attestation Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentRegistrationStatement', window );">Document Registration Statement</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentAnnualReport', window );">Document Annual Report</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-41489<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">Z4<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">101 N. Shoreline Blvd.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">Suite 450<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Corpus Christi<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">TX<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">78401<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">361<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">239-5449<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Shares<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSEAMER<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AnnualInformationForm', window );">Annual Information Form</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AuditedAnnualFinancialStatements', window );">Audited Annual Financial Statements</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityInteractiveDataCurrent', window );">Entity Interactive Data Current</a></td>
<td class="text">Yes<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AuditorName', window );">Auditor Name</a></td>
<td class="text">Davidson &
Company LLP<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AuditorLocation', window );">Auditor Location</a></td>
<td class="text">Vancouver, British Columbia, Canada<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AuditorFirmId', window );">Auditor Firm ID</a></td>
<td class="text">731<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressesAddressTypeAxis=dei_BusinessContactMember', window );">Business Contact [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentInformationLineItems', window );"><strong>Document Information Line Items</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">122 E. 42nd Street<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">18th
Floor<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">New York<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">NY<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">10168<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">800<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">221-0102<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_ContactPersonnelName', window );">Contact Personnel Name</a></td>
<td class="text">Cogency Global Inc.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AnnualInformationForm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag with value true on a form if it is an annual report containing an annual information form.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AnnualInformationForm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditedAnnualFinancialStatements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag with value true on a form if it is an annual report containing audited financial statements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditedAnnualFinancialStatements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorFirmId">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>PCAOB issued Audit Firm Identifier</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorFirmId</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:nonemptySequenceNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorLocation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorLocation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:internationalNameItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:internationalNameItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_ContactPersonnelName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of contact personnel</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_ContactPersonnelName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentAnnualReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as an annual report.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentAnnualReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fiscalPeriodItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentRegistrationStatement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as a registration statement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentRegistrationStatement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCurrentReportingStatus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCurrentReportingStatus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityExTransitionPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 7A<br> -Section B<br> -Subsection 2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityExTransitionPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInteractiveDataCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-T<br> -Number 232<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInteractiveDataCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_IcfrAuditorAttestationFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_IcfrAuditorAttestationFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressesAddressTypeAxis=dei_BusinessContactMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressesAddressTypeAxis=dei_BusinessContactMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>52
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139782927826080">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Consolidated Statements of Financial Position - USD ($)<br></strong></div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Jan. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CurrentAssetsAbstract', window );"><strong>Current assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CashAndCashEquivalents', window );">Cash</a></td>
<td class="nump">$ 2,512,012<span></span>
</td>
<td class="nump">$ 9,188,483<span></span>
</td>
<td class="nump">$ 5,182,249<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TradeAndOtherReceivables', window );">Receivables and prepaid expenses</a></td>
<td class="nump">1,244,561<span></span>
</td>
<td class="nump">627,181<span></span>
</td>
<td class="nump">254,092<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_MarketableSecuritiecurrent', window );">Marketable securities - current</a></td>
<td class="nump">3,162,361<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_DepositUraniumInvestment', window );">Deposit - uranium investment</a></td>
<td class="nump">3,000,000<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSaleOrAsHeldForDistributionToOwners', window );">Assets held for sale</a></td>
<td class="nump">728,882<span></span>
</td>
<td class="nump">1,741,064<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CurrentAssets', window );">Total current assets</a></td>
<td class="nump">10,647,816<span></span>
</td>
<td class="nump">11,556,728<span></span>
</td>
<td class="nump">5,436,341<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_NonCurrentAssetsAbstract', window );"><strong>Non-current assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsOtherThanGoodwill', window );">Intangible assets</a></td>
<td class="nump">528,282<span></span>
</td>
<td class="nump">491,996<span></span>
</td>
<td class="nump">483,631<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Property, plant, and equipment</a></td>
<td class="nump">2,334,421<span></span>
</td>
<td class="nump">1,603,679<span></span>
</td>
<td class="nump">1,484,836<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_InvestmentsInAssociates', window );">Investment in associate</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">564,340<span></span>
</td>
<td class="nump">451,221<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_InvestmentsInSubsidiariesJointVenturesAndAssociates', window );">Investment in uranium</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">4,210,000<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_MarketablesSecuritiesNoncurrent', window );">Marketable securities - non-current</a></td>
<td class="nump">784,832<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MiningAssets', window );">Mineral properties</a></td>
<td class="nump">145,219,086<span></span>
</td>
<td class="nump">136,079,578<span></span>
</td>
<td class="nump">6,608,060<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_LongtermDeposits', window );">Reclamation deposits</a></td>
<td class="nump">88,500<span></span>
</td>
<td class="nump">88,500<span></span>
</td>
<td class="nump">85,500<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RightofuseAssets', window );">Right-of-use asset</a></td>
<td class="nump">185,614<span></span>
</td>
<td class="nump">244,564<span></span>
</td>
<td class="nump">8,867<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DeferredTaxAssets', window );">Deferred acquisition costs</a></td>
<td class="nump">6,009,303<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NoncurrentFinancialAssets', window );">Deferred financing costs</a></td>
<td class="nump">3,162,936<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RestrictedCashAndCashEquivalents', window );">Restricted cash</a></td>
<td class="nump">54,568,668<span></span>
</td>
<td class="nump">4,517,139<span></span>
</td>
<td class="nump">3,796,788<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Assets', window );">Total assets</a></td>
<td class="nump">223,529,458<span></span>
</td>
<td class="nump">159,356,524<span></span>
</td>
<td class="nump">18,355,244<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CurrentLiabilitiesAbstract', window );"><strong>Current liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TradeAndOtherCurrentPayables', window );">Accounts payable and accrued liabilities</a></td>
<td class="nump">3,105,065<span></span>
</td>
<td class="nump">5,835,116<span></span>
</td>
<td class="nump">368,056<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TradeAndOtherCurrentPayablesToRelatedParties', window );">Due to related parties</a></td>
<td class="nump">441,374<span></span>
</td>
<td class="nump">6,893<span></span>
</td>
<td class="nump">2,319<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherCurrentPayables', window );">Note payable</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">330,935<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CurrentLeaseLiabilities', window );">Lease liability - current</a></td>
<td class="nump">84,262<span></span>
</td>
<td class="nump">82,116<span></span>
</td>
<td class="nump">5,746<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CurrentLiabilities', window );">Total current liabilities</a></td>
<td class="nump">3,630,701<span></span>
</td>
<td class="nump">5,924,125<span></span>
</td>
<td class="nump">707,056<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_NonCurrentLiabilitiesAbstract', window );"><strong>Non-current liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DefinedBenefitObligationAtPresentValue', window );">Asset retirement obligations</a></td>
<td class="nump">4,752,352<span></span>
</td>
<td class="nump">4,176,493<span></span>
</td>
<td class="nump">5,239,108<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NoncurrentLeaseLiabilities', window );">Lease liability - non-current</a></td>
<td class="nump">96,166<span></span>
</td>
<td class="nump">167,393<span></span>
</td>
<td class="nump">3,121<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Liabilities', window );">Total liabilities</a></td>
<td class="nump">8,479,219<span></span>
</td>
<td class="nump">10,268,011<span></span>
</td>
<td class="nump">5,949,285<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Shareholders&#8217; equity</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IssuedCapital', window );">Share capital</a></td>
<td class="nump">190,610,250<span></span>
</td>
<td class="nump">162,582,365<span></span>
</td>
<td class="nump">26,653,141<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SharePremium', window );">Share subscriptions received</a></td>
<td class="nump">51,558,624<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_ContributedSurplus', window );">Contributed surplus</a></td>
<td class="nump">16,218,518<span></span>
</td>
<td class="nump">12,662,103<span></span>
</td>
<td class="nump">2,019,445<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AccumulatedOtherComprehensiveIncome', window );">Accumulated other comprehensive income</a></td>
<td class="nump">5,530,224<span></span>
</td>
<td class="nump">6,196,033<span></span>
</td>
<td class="nump">7,521,888<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RetainedEarnings', window );">Deficit</a></td>
<td class="num">(48,867,377)<span></span>
</td>
<td class="num">(32,351,988)<span></span>
</td>
<td class="num">(23,788,515)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Equity', window );">Total shareholders&#8217; equity</a></td>
<td class="nump">215,050,239<span></span>
</td>
<td class="nump">149,088,513<span></span>
</td>
<td class="nump">12,405,959<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_EquityAndLiabilities', window );">Total liabilities and shareholders&#8217; equity</a></td>
<td class="nump">$ 223,529,458<span></span>
</td>
<td class="nump">$ 159,356,524<span></span>
</td>
<td class="nump">$ 18,355,244<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cve_ContributedSurplus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Contributed surplus.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cve_ContributedSurplus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cve_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cve_DepositUraniumInvestment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Deposit uranium investment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cve_DepositUraniumInvestment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cve_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cve_MarketableSecuritiecurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of marketable securities as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cve_MarketableSecuritiecurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cve_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cve_MarketablesSecuritiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of marketable securities non current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cve_MarketablesSecuritiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cve_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cve_NonCurrentAssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cve_NonCurrentAssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cve_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cve_NonCurrentLiabilitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cve_NonCurrentLiabilitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cve_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AccumulatedOtherComprehensiveIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of accumulated items of income and expense (including reclassification adjustments) that are not recognised in profit or loss as required or permitted by other IFRSs. [Refer: IFRSs [member]; Other comprehensive income]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2022-03-24<br> -Paragraph 55<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AccumulatedOtherComprehensiveIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of a present economic resource controlled by the entity as a result of past events. Economic resource is a right that has the potential to produce economic benefits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2022-03-24<br> -Paragraph 93<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_93_a&amp;doctype=Standard<br> -URIDate 2022-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2022-03-24<br> -Paragraph 28<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_28_c&amp;doctype=Standard<br> -URIDate 2022-03-24<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2022-03-24<br> -Paragraph 93<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_93_b&amp;doctype=Standard<br> -URIDate 2022-03-24<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2022-03-24<br> -Paragraph 93<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_93_e&amp;doctype=Standard<br> -URIDate 2022-03-24<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2022-03-24<br> -Paragraph 23<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_23&amp;doctype=Standard<br> -URIDate 2022-03-24<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2022-03-24<br> -Paragraph 55<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CashAndCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of cash on hand and demand deposits, along with short-term, highly liquid investments that are readily convertible to known amounts of cash and that are subject to an insignificant risk of changes in value. [Refer: Cash; Cash equivalents]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2022-03-24<br> -Paragraph 45<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_45&amp;doctype=Standard<br> -URIDate 2022-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2022-03-24<br> -Paragraph B13<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_B13_a&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2022-03-24<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2022-03-24<br> -Paragraph 54<br> -Subparagraph i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_54_i&amp;doctype=Standard<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CashAndCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrentAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of assets that the entity (a) expects to realise or intends to sell or consume in its normal operating cycle; (b) holds primarily for the purpose of trading; (c) expects to realise within twelve months after the reporting period; or (d) classifies as cash or cash equivalents (as defined in IAS 7) unless the asset is restricted from being exchanged or used to settle a liability for at least twelve months after the reporting period. [Refer: Assets]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2022-03-24<br> -Paragraph B12<br> -Subparagraph b<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_B12_b_i&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2022-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2022-03-24<br> -Paragraph B10<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_B10_b&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2022-03-24<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2022-03-24<br> -Paragraph 66<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_66&amp;doctype=Standard<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrentAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrentAssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrentAssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrentLeaseLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of current lease liabilities. [Refer: Lease liabilities]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 16<br> -IssueDate 2022-03-24<br> -Paragraph 47<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=16&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_47_b&amp;doctype=Standard<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrentLeaseLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrentLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Expiry date 2023-01-01: The amount of liabilities that: (a) the entity expects to settle in its normal operating cycle; (b) the entity holds primarily for the purpose of trading; (c) are due to be settled within twelve months after the reporting period; or (d) the entity does not have an unconditional right to defer settlement for at least twelve months after the reporting period.
Effective 2023-01-01: The amount of liabilities that: (a) the entity expects to settle in its normal operating cycle; (b) the entity holds primarily for the purpose of trading; (c) are due to be settled within twelve months after the reporting period; or (d) the entity does not have the right at the end of the reporting period to defer settlement for at least twelve months after the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2022-03-24<br> -Paragraph B12<br> -Subparagraph b<br> -Clause iii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_B12_b_iii&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2022-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2022-03-24<br> -Paragraph B10<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_B10_b&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2022-03-24<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2022-03-24<br> -Paragraph 69<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_69&amp;doctype=Standard<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrentLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrentLiabilitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrentLiabilitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DeferredTaxAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amounts of income taxes recoverable in future periods in respect of: (a) deductible temporary differences; (b) the carryforward of unused tax losses; and (c) the carryforward of unused tax credits. [Refer: Temporary differences [member]; Unused tax credits [member]; Unused tax losses [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2022-03-24<br> -Paragraph 81<br> -Subparagraph g<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_81_g_i&amp;doctype=Standard<br> -URIDate 2022-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2022-03-24<br> -Paragraph 54<br> -Subparagraph o<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_54_o&amp;doctype=Standard<br> -URIDate 2022-03-24<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2022-03-24<br> -Paragraph 56<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_56&amp;doctype=Standard<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DeferredTaxAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DefinedBenefitObligationAtPresentValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The present value, without deducting any plan assets, of expected future payments required to settle the obligation resulting from employee service in the current and prior periods. [Refer: Plan assets, at fair value]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 19<br> -IssueDate 2022-03-24<br> -Paragraph 57<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=19&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_57_a&amp;doctype=Standard<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DefinedBenefitObligationAtPresentValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_Equity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of residual interest in the assets of the entity after deducting all its liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 1<br> -IssueDate 2022-03-24<br> -Paragraph 24<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=1&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_24_a&amp;doctype=Standard<br> -URIDate 2022-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 1<br> -IssueDate 2022-03-24<br> -Paragraph 32<br> -Subparagraph a<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=1&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_32_a_i&amp;doctype=Standard<br> -URIDate 2022-03-24<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2022-03-24<br> -Paragraph 93<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_93_a&amp;doctype=Standard<br> -URIDate 2022-03-24<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2022-03-24<br> -Paragraph 93<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_93_b&amp;doctype=Standard<br> -URIDate 2022-03-24<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2022-03-24<br> -Paragraph 93<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_93_e&amp;doctype=Standard<br> -URIDate 2022-03-24<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2022-03-24<br> -Paragraph 55<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2022-03-24<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2022-03-24<br> -Paragraph 78<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_78_e&amp;doctype=Standard<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_Equity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_EquityAndLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of the entity's equity and liabilities. [Refer: Equity; Liabilities]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2022-03-24<br> -Paragraph 55<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_EquityAndLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IntangibleAssetsOtherThanGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of identifiable non-monetary assets without physical substance. This amount does not include goodwill. [Refer: Goodwill]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 38<br> -IssueDate 2022-03-24<br> -Paragraph 118<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=38&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_118_e&amp;doctype=Standard<br> -URIDate 2022-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2022-03-24<br> -Paragraph 54<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_54_c&amp;doctype=Standard<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IntangibleAssetsOtherThanGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_InvestmentsInAssociates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of investments in associates in an entity's separate financial statements. [Refer: Associates [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 27<br> -IssueDate 2022-03-24<br> -Paragraph 10<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=27&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_10&amp;doctype=Standard<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_InvestmentsInAssociates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_InvestmentsInSubsidiariesJointVenturesAndAssociates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of investments in subsidiaries, joint ventures and associates in an entity's separate financial statements. [Refer: Associates [member]; Joint ventures [member]; Subsidiaries [member]; Investments in subsidiaries reported in separate financial statements]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 27<br> -IssueDate 2022-03-24<br> -Paragraph 10<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=27&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_10&amp;doctype=Standard<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_InvestmentsInSubsidiariesJointVenturesAndAssociates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IssuedCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The nominal value of capital issued.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2022-03-24<br> -Paragraph 78<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_78_e&amp;doctype=Standard<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IssuedCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of a present obligation of the entity to transfer an economic resource as a result of past events. Economic resource is a right that has the potential to produce economic benefits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2022-03-24<br> -Paragraph 93<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_93_a&amp;doctype=Standard<br> -URIDate 2022-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2022-03-24<br> -Paragraph 93<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_93_b&amp;doctype=Standard<br> -URIDate 2022-03-24<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2022-03-24<br> -Paragraph 93<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_93_e&amp;doctype=Standard<br> -URIDate 2022-03-24<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2022-03-24<br> -Paragraph 28<br> -Subparagraph d<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_28_d&amp;doctype=Standard<br> -URIDate 2022-03-24<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2022-03-24<br> -Paragraph 23<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_23&amp;doctype=Standard<br> -URIDate 2022-03-24<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2022-03-24<br> -Paragraph 55<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_LongtermDeposits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of long-term deposits held by the entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2022-03-24<br> -Paragraph 55<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_LongtermDeposits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_MiningAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of assets related to mining activities of the entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 16<br> -IssueDate 2022-03-24<br> -Paragraph 37<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=16&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_37&amp;doctype=Standard<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_MiningAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSaleOrAsHeldForDistributionToOwners">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of non-current assets or disposal groups classified as held for sale or as held for distribution to owners. [Refer: Non-current assets or disposal groups classified as held for distribution to owners; Non-current assets or disposal groups classified as held for sale]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2022-03-24<br> -Paragraph 54<br> -Subparagraph j<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_54_j&amp;doctype=Standard<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSaleOrAsHeldForDistributionToOwners</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NoncurrentFinancialAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of non-current financial assets. [Refer: Financial assets]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 7<br> -IssueDate 2022-03-24<br> -Paragraph 25<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_25&amp;doctype=Standard<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NoncurrentFinancialAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NoncurrentLeaseLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of non-current lease liabilities. [Refer: Lease liabilities]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 16<br> -IssueDate 2022-03-24<br> -Paragraph 47<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=16&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_47_b&amp;doctype=Standard<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NoncurrentLeaseLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_OtherCurrentPayables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of current payables that the entity does not separately disclose in the same statement or note.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2022-03-24<br> -Paragraph 55<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_OtherCurrentPayables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_PropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of tangible assets that: (a) are held for use in the production or supply of goods or services, for rental to others, or for administrative purposes; and (b) are expected to be used during more than one period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 16<br> -IssueDate 2022-03-24<br> -Paragraph 73<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=16&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_73_e&amp;doctype=Standard<br> -URIDate 2022-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2022-03-24<br> -Paragraph 54<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_54_a&amp;doctype=Standard<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_PropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RestrictedCashAndCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of cash and cash equivalents whose use or withdrawal is restricted. [Refer: Cash and cash equivalents]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2022-03-24<br> -Paragraph 55<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RestrictedCashAndCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RetainedEarnings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A component of equity representing the entity's cumulative undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2022-03-24<br> -Paragraph IG6<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_IG6&amp;doctype=Implementation%20Guidance<br> -URIDate 2022-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2022-03-24<br> -Paragraph 78<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_78_e&amp;doctype=Standard<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RetainedEarnings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RightofuseAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of assets that represent a lessee's right to use an underlying asset for the lease term. Underlying asset is an asset that is the subject of a lease, for which the right to use that asset has been provided by a lessor to a lessee.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 16<br> -IssueDate 2022-03-24<br> -Paragraph 53<br> -Subparagraph j<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=16&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_53_j&amp;doctype=Standard<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RightofuseAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SharePremium">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount received or receivable from the issuance of the entity's shares in excess of nominal value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2022-03-24<br> -Paragraph 78<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_78_e&amp;doctype=Standard<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SharePremium</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TradeAndOtherCurrentPayables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of current trade payables and current other payables. [Refer: Current trade payables; Other current payables]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2022-03-24<br> -Paragraph 54<br> -Subparagraph k<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_54_k&amp;doctype=Standard<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TradeAndOtherCurrentPayables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TradeAndOtherCurrentPayablesToRelatedParties">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of current payables due to related parties. [Refer: Related parties [member]; Payables to related parties]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2022-03-24<br> -Paragraph 78<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_78&amp;doctype=Standard<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TradeAndOtherCurrentPayablesToRelatedParties</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TradeAndOtherReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of trade receivables and other receivables. [Refer: Trade receivables; Other receivables]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2022-03-24<br> -Paragraph 54<br> -Subparagraph h<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_54_h&amp;doctype=Standard<br> -URIDate 2022-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2022-03-24<br> -Paragraph 78<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_78_b&amp;doctype=Standard<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TradeAndOtherReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>53
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139782922864688">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated Statements of Loss and Comprehensive Loss - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_ExpensesAbstract', window );"><strong>Expenses</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_AccretionExpenses', window );">Accretion</a></td>
<td class="nump">$ 445,190<span></span>
</td>
<td class="nump">$ 408,181<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DepreciationAndAmortisationExpense', window );">Amortization and depreciation</a></td>
<td class="nump">380,336<span></span>
</td>
<td class="nump">298,666<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_CommunityEngagement', window );">Community engagement</a></td>
<td class="nump">44,110<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_Consulting', window );">Consulting</a></td>
<td class="nump">258,495<span></span>
</td>
<td class="nump">72,726<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GeneralAndAdministrativeExpense', window );">General administrative costs</a></td>
<td class="nump">4,731,367<span></span>
</td>
<td class="nump">3,533,474<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ImpairmentLossImpairmentGainAndReversalOfImpairmentLossDeterminedInAccordanceWithIFRS9', window );">Impairment charges</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">78,456<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_InterestExpense', window );">Interest expense</a></td>
<td class="nump">2,556<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdministrativeExpense', window );">Office and administrative</a></td>
<td class="nump">137,551<span></span>
</td>
<td class="nump">197,391<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProfessionalFeesExpense', window );">Professional fees</a></td>
<td class="nump">1,944,668<span></span>
</td>
<td class="nump">581,408<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_ProjectInvestigationFess', window );">Project investigation</a></td>
<td class="nump">1,519<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CommunicationExpense', window );">Promotion and shareholder communication</a></td>
<td class="nump">287,887<span></span>
</td>
<td class="nump">166,096<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ReclassificationAdjustmentsOnChangeInValueOfForwardElementsOfForwardContractsNetOfTax', window );">Reclamation costs</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">709,399<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TravelExpense', window );">Travel</a></td>
<td class="nump">312,236<span></span>
</td>
<td class="nump">26,609<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_TransferAgentAndFilingFees', window );">Transfer agent and filing fees</a></td>
<td class="nump">322,792<span></span>
</td>
<td class="nump">133,717<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_WagesAndSalaries', window );">Staff costs</a></td>
<td class="nump">4,130,741<span></span>
</td>
<td class="nump">1,582,326<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ExpenseFromSharebasedPaymentTransactionsWithEmployees', window );">Stock option expense</a></td>
<td class="nump">5,744,655<span></span>
</td>
<td class="nump">1,425,645<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProfitLossFromOperatingActivities', window );">Loss from operating expenses</a></td>
<td class="num">(18,744,103)<span></span>
</td>
<td class="num">(9,214,094)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RevenueFromInterest', window );">Interest income</a></td>
<td class="nump">406,132<span></span>
</td>
<td class="nump">20,987<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_LossOnWriteoffOfSalesTaxRecoverable', window );">Loss on write-off of sales tax recoverable</a></td>
<td class="num">(91,289)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss', window );">Foreign exchange (loss) gain</a></td>
<td class="num">(58,456)<span></span>
</td>
<td class="nump">27,265<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GainsLossesOnDisposalsOfPropertyPlantAndEquipment', window );">Gain (loss) on divestment of mineral properties</a></td>
<td class="nump">29,148<span></span>
</td>
<td class="num">(89,914)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GainLossOnRemeasurementOfReimbursementRights', window );">(Loss) gain on change in asset retirement obligation estimate</a></td>
<td class="num">(157,227)<span></span>
</td>
<td class="nump">1,719,943<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_GainOnDisposalOfSubsidiary', window );">Gain on disposal of subsidiary</a></td>
<td class="nump">1,594,901<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_LossOnContractTerminations', window );">Loss on contract termination</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2,750,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_UnrealizedGainOnUraniumInvestment', window );">Unrealized gain on uranium investment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,554,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_GainOnSaleOfUraniumInvestment', window );">Gain on sale of uranium investment</a></td>
<td class="nump">35,000<span></span>
</td>
<td class="nump">524,075<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_UnrealizedGainOnMarketableSecurities', window );">Unrealized gain on marketable securities</a></td>
<td class="nump">1,057,405<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GainsLossesOnFairValueAdjustmentInvestmentProperty', window );">Loss on investment in associate</a></td>
<td class="num">(586,900)<span></span>
</td>
<td class="num">(355,735)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProfitLoss', window );">Net loss for the year</a></td>
<td class="num">(16,515,389)<span></span>
</td>
<td class="num">(8,563,473)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherComprehensiveIncomeNetOfTaxHedgesOfNetInvestmentsInForeignOperations', window );">Foreign currency translation adjustment</a></td>
<td class="num">(665,809)<span></span>
</td>
<td class="num">(1,325,855)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ComprehensiveIncome', window );">Comprehensive loss for the year</a></td>
<td class="num">$ (17,181,198)<span></span>
</td>
<td class="num">$ (9,889,328)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_WeightedAverageShares', window );">- basic # (in Shares)</a></td>
<td class="nump">105,529,292<span></span>
</td>
<td class="nump">65,325,525<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdjustedWeightedAverageShares', window );">- diluted # (in Shares)</a></td>
<td class="nump">105,529,292<span></span>
</td>
<td class="nump">65,325,525<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BasicEarningsLossPerShare', window );">Basic and diluted loss per share $ (in Dollars per share)</a></td>
<td class="num">$ (0.16)<span></span>
</td>
<td class="num">$ (0.13)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cve_AccretionExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount recognized for the passage of time, typically for liabilities, that have been discounted to their net present values. Excludes accretion associated with asset retirement obligations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cve_AccretionExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cve_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cve_CommunityEngagement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Community engagement expenses.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cve_CommunityEngagement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cve_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cve_Consulting">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Consulting Expenses.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cve_Consulting</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cve_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cve_ExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cve_ExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cve_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cve_GainOnDisposalOfSubsidiary">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Gain on disposal of subsidiary</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cve_GainOnDisposalOfSubsidiary</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cve_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cve_GainOnSaleOfUraniumInvestment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cve_GainOnSaleOfUraniumInvestment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cve_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cve_LossOnContractTerminations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The loss recognized on termination of a contract.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cve_LossOnContractTerminations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cve_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cve_LossOnWriteoffOfSalesTaxRecoverable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cve_LossOnWriteoffOfSalesTaxRecoverable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cve_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cve_ProjectInvestigationFess">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Project investigation expenses.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cve_ProjectInvestigationFess</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cve_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cve_TransferAgentAndFilingFees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Transfer agent and filing fees</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cve_TransferAgentAndFilingFees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cve_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cve_UnrealizedGainOnMarketableSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of unrealized gain (loss) on investment in marketable security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cve_UnrealizedGainOnMarketableSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cve_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cve_UnrealizedGainOnUraniumInvestment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Unrealized gain on uranium investment</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cve_UnrealizedGainOnUraniumInvestment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cve_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AdjustedWeightedAverageShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average number of ordinary shares outstanding plus the weighted average number of ordinary shares that would be issued on the conversion of all the dilutive potential ordinary shares into ordinary shares. [Refer: Ordinary shares [member]; Weighted average [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 33<br> -IssueDate 2022-03-24<br> -Paragraph 70<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=33&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_70_b&amp;doctype=Standard<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AdjustedWeightedAverageShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of expenses that the entity classifies as being administrative.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 26<br> -IssueDate 2022-03-24<br> -Paragraph 35<br> -Subparagraph b<br> -Clause vi<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=26&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_35_b_vi&amp;doctype=Standard<br> -URIDate 2022-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2022-03-24<br> -Paragraph 103<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_103&amp;doctype=Standard<br> -URIDate 2022-03-24<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2022-03-24<br> -Paragraph 99<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_99&amp;doctype=Standard<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BasicEarningsLossPerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of profit (loss) attributable to ordinary equity holders of the parent entity (the numerator) divided by the weighted average number of ordinary shares outstanding during the period (the denominator).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 33<br> -IssueDate 2022-03-24<br> -Paragraph 66<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=33&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_66&amp;doctype=Standard<br> -URIDate 2022-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 33<br> -IssueDate 2022-03-24<br> -Paragraph 67<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=33&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_67&amp;doctype=Standard<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BasicEarningsLossPerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CommunicationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of expense arising from communication.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2022-03-24<br> -Paragraph 112<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_112_c&amp;doctype=Standard<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CommunicationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ComprehensiveIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of change in equity resulting from transactions and other events, other than those changes resulting from transactions with owners in their capacity as owners.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 1<br> -IssueDate 2022-03-24<br> -Paragraph 32<br> -Subparagraph a<br> -Clause ii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=1&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_32_a_ii&amp;doctype=Standard<br> -URIDate 2022-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 1<br> -IssueDate 2022-03-24<br> -Paragraph 24<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=1&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_24_b&amp;doctype=Standard<br> -URIDate 2022-03-24<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2022-03-24<br> -Paragraph B12<br> -Subparagraph b<br> -Clause ix<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_B12_b_ix&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2022-03-24<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2022-03-24<br> -Paragraph B10<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_B10_b&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2022-03-24<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2022-03-24<br> -Paragraph 81A<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_81A_c&amp;doctype=Standard<br> -URIDate 2022-03-24<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2022-03-24<br> -Paragraph 106<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_106_a&amp;doctype=Standard<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ComprehensiveIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DepreciationAndAmortisationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of depreciation and amortisation expense. Depreciation and amortisation are the systematic allocations of depreciable amounts of assets over their useful lives.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2022-03-24<br> -Paragraph 28<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_28_e&amp;doctype=Standard<br> -URIDate 2022-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2022-03-24<br> -Paragraph B13<br> -Subparagraph d<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_B13_d&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2022-03-24<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2022-03-24<br> -Paragraph 23<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_23_e&amp;doctype=Standard<br> -URIDate 2022-03-24<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2022-03-24<br> -Paragraph 102<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_102&amp;doctype=Standard<br> -URIDate 2022-03-24<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2022-03-24<br> -Paragraph 99<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_99&amp;doctype=Standard<br> -URIDate 2022-03-24<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2022-03-24<br> -Paragraph 104<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_104&amp;doctype=Standard<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DepreciationAndAmortisationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ExpenseFromSharebasedPaymentTransactionsWithEmployees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of expense from share-based payment transactions with employees. [Refer: Expense from share-based payment transactions]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2022-03-24<br> -Paragraph 112<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_112_c&amp;doctype=Standard<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ExpenseFromSharebasedPaymentTransactionsWithEmployees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_GainLossOnRemeasurementOfReimbursementRights">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) in reimbursement rights related to defined benefit obligation, resulting from the remeasurement of reimbursement rights. [Refer: Reimbursement rights related to defined benefit obligation, at fair value]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 19<br> -IssueDate 2022-03-24<br> -Paragraph 141<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=19&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_141_c&amp;doctype=Standard<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_GainLossOnRemeasurementOfReimbursementRights</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_GainsLossesOnDisposalsOfPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The gains (losses) on disposals of property, plant and equipment. [Refer: Property, plant and equipment]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2022-03-24<br> -Paragraph 98<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_98_c&amp;doctype=Standard<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_GainsLossesOnDisposalsOfPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of exchange differences recognised in profit or loss that arise from foreign currency transactions, excluding those arising on financial instruments measured at fair value through profit or loss in accordance with IFRS 9. [Refer: At fair value [member]; Financial instruments, class [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 21<br> -IssueDate 2022-03-24<br> -Paragraph 52<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=21&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_52_a&amp;doctype=Standard<br> -URIDate 2022-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2022-03-24<br> -Paragraph 35<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_35&amp;doctype=Standard<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_GainsLossesOnFairValueAdjustmentInvestmentProperty">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The gains (losses) from changes in the fair value of investment property. [Refer: Investment property]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 40<br> -IssueDate 2022-03-24<br> -Paragraph 76<br> -Subparagraph d<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=40&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_76_d&amp;doctype=Standard<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_GainsLossesOnFairValueAdjustmentInvestmentProperty</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_GeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of expense relating to general and administrative activities of the entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2022-03-24<br> -Paragraph 112<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_112_c&amp;doctype=Standard<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_GeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ImpairmentLossImpairmentGainAndReversalOfImpairmentLossDeterminedInAccordanceWithIFRS9">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of impairment loss, impairment gain or reversal of impairment loss that is recognised in profit or loss in accordance with paragraph 5.5.8 of IFRS 9 and that arises from applying the impairment requirements in Section 5.5 of IFRS 9.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2022-03-24<br> -Paragraph 82<br> -Subparagraph ba<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_82_ba&amp;doctype=Standard<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ImpairmentLossImpairmentGainAndReversalOfImpairmentLossDeterminedInAccordanceWithIFRS9</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_InterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of expense arising from interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2022-03-24<br> -Paragraph 28<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_28_e&amp;doctype=Standard<br> -URIDate 2022-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2022-03-24<br> -Paragraph 23<br> -Subparagraph d<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_23_d&amp;doctype=Standard<br> -URIDate 2022-03-24<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2022-03-24<br> -Paragraph B13<br> -Subparagraph f<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_B13_f&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_InterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_OtherComprehensiveIncomeNetOfTaxHedgesOfNetInvestmentsInForeignOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of other comprehensive income, net of tax, after reclassification adjustments, related to hedges of net investments in foreign operations. [Refer: Other comprehensive income]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 39<br> -IssueDate 2022-03-24<br> -Paragraph 102<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=39&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_102_a&amp;doctype=Standard<br> -URIDate 2022-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2022-03-24<br> -Paragraph 91<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_91_a&amp;doctype=Standard<br> -URIDate 2022-03-24<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 9<br> -IssueDate 2022-03-24<br> -Paragraph 6.5.13<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=9&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_6.5.13_a&amp;doctype=Standard<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_OtherComprehensiveIncomeNetOfTaxHedgesOfNetInvestmentsInForeignOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProfessionalFeesExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of fees paid or payable for professional services.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2022-03-24<br> -Paragraph 112<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_112_c&amp;doctype=Standard<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProfessionalFeesExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The total of income less expenses from continuing and discontinued operations, excluding the components of other comprehensive income. [Refer: Other comprehensive income]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2022-03-24<br> -Paragraph 18<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_18_b&amp;doctype=Standard<br> -URIDate 2022-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 1<br> -IssueDate 2022-03-24<br> -Paragraph 32<br> -Subparagraph a<br> -Clause ii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=1&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_32_a_ii&amp;doctype=Standard<br> -URIDate 2022-03-24<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 1<br> -IssueDate 2022-03-24<br> -Paragraph 24<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=1&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_24_b&amp;doctype=Standard<br> -URIDate 2022-03-24<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2022-03-24<br> -Paragraph 28<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_28_b&amp;doctype=Standard<br> -URIDate 2022-03-24<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Note Effective on first application of IFRS 9<br> -Name IFRS<br> -Number 4<br> -IssueDate 2022-03-24<br> -Paragraph 39L<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=4&amp;code=ifrs-tx-2022-en-b&amp;anchor=para_39L_e&amp;doctype=Standard<br> -URIDate 2022-03-24<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2022-03-24<br> -Paragraph 23<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_23&amp;doctype=Standard<br> -URIDate 2022-03-24<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2022-03-24<br> -Paragraph B10<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_B10_b&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2022-03-24<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Note Effective 2023-01-01<br> -Name IFRS<br> -Number 17<br> -IssueDate 2022-03-24<br> -Paragraph 113<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=17&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_113_b&amp;doctype=Standard<br> -URIDate 2022-03-24<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2022-03-24<br> -Paragraph 81A<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_81A_a&amp;doctype=Standard<br> -URIDate 2022-03-24<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2022-03-24<br> -Paragraph 106<br> -Subparagraph d<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_106_d_i&amp;doctype=Standard<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProfitLossFromOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The profit (loss) from operating activities of the entity. [Refer: Profit (loss)]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 32<br> -IssueDate 2022-03-24<br> -Paragraph IE33<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=32&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_IE33&amp;doctype=Illustrative%20Examples<br> -URIDate 2022-03-24<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2022-03-24<br> -Paragraph 85<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_85&amp;doctype=Standard<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProfitLossFromOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ReclassificationAdjustmentsOnChangeInValueOfForwardElementsOfForwardContractsNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of reclassification adjustments related to change in value of forward elements of forward contracts, net of tax. Reclassification adjustments are amounts reclassified to profit (loss) in the current period that were recognised in other comprehensive income in the current or previous periods. [Refer: Other comprehensive income]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2022-03-24<br> -Paragraph 92<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_92&amp;doctype=Standard<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ReclassificationAdjustmentsOnChangeInValueOfForwardElementsOfForwardContractsNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RevenueFromInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of income arising from interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2022-03-24<br> -Paragraph 23<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_23_c&amp;doctype=Standard<br> -URIDate 2022-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2022-03-24<br> -Paragraph 28<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_28_e&amp;doctype=Standard<br> -URIDate 2022-03-24<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2022-03-24<br> -Paragraph B13<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_B13_e&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2022-03-24<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2022-03-24<br> -Paragraph 112<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_112_c&amp;doctype=Standard<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RevenueFromInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TravelExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of expense arising from travel.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2022-03-24<br> -Paragraph 112<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_112_c&amp;doctype=Standard<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TravelExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_WagesAndSalaries">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A class of employee benefits expense that represents wages and salaries. [Refer: Employee benefits expense]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 19<br> -IssueDate 2022-03-24<br> -Paragraph 9<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=19&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_9&amp;doctype=Standard<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_WagesAndSalaries</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_WeightedAverageShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of ordinary shares outstanding at the beginning of the period, adjusted by the number of ordinary shares bought back or issued during the period multiplied by a time-weighting factor.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 33<br> -IssueDate 2022-03-24<br> -Paragraph 70<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=33&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_70_b&amp;doctype=Standard<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_WeightedAverageShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>54
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139782924835184">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated Statements of Loss and Comprehensive Loss (Parentheticals) - $ / shares<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_ConsolidatedStatementsOfLossAndComprehensiveLossAbstract', window );"><strong>Consolidated Statements Of Loss And Comprehensive Loss Abstract</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DilutedEarningsLossPerShare', window );">Diluted loss per share</a></td>
<td class="num">$ (0.16)<span></span>
</td>
<td class="num">$ (0.13)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cve_ConsolidatedStatementsOfLossAndComprehensiveLossAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cve_ConsolidatedStatementsOfLossAndComprehensiveLossAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cve_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DilutedEarningsLossPerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of profit (loss) attributable to ordinary equity holders of the parent entity (the numerator), divided by the weighted average number of ordinary shares outstanding during the period (the denominator), both adjusted for the effects of all dilutive potential ordinary shares. [Refer: Ordinary shares [member]; Weighted average [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 33<br> -IssueDate 2022-03-24<br> -Paragraph 66<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=33&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_66&amp;doctype=Standard<br> -URIDate 2022-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 33<br> -IssueDate 2022-03-24<br> -Paragraph 67<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=33&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_67&amp;doctype=Standard<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DilutedEarningsLossPerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>55
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139782921954384">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated Statements of Cash Flows - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_OperatingActivitiesAbstract', window );"><strong>Operating activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProfitLoss', window );">Net loss for the year</a></td>
<td class="num">$ (16,515,389)<span></span>
</td>
<td class="num">$ (8,563,473)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_ItemsNotAffectingCashAbstract', window );"><strong>Items not affecting cash:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_Accretion', window );">Accretion</a></td>
<td class="nump">445,190<span></span>
</td>
<td class="nump">408,181<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdjustmentsForDepreciationAndAmortisationExpense', window );">Amortization and depreciation</a></td>
<td class="nump">380,338<span></span>
</td>
<td class="nump">298,666<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdjustmentsForImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLoss', window );">Impairment charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">78,456<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdjustmentsForUnrealisedForeignExchangeLossesGains', window );">Foreign exchange loss</a></td>
<td class="nump">20,904<span></span>
</td>
<td class="nump">36,530<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdjustmentsForSharebasedPayments', window );">Stock option expense</a></td>
<td class="nump">5,744,656<span></span>
</td>
<td class="nump">1,425,645<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdjustmentsForInterestIncome', window );">Interest income</a></td>
<td class="num">(406,132)<span></span>
</td>
<td class="num">(20,987)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdjustmentsForDeferredTaxExpense', window );">Loss on write-off of sales tax recoverable</a></td>
<td class="nump">91,289<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdjustmentsForGainLossOnDisposalsPropertyPlantAndEquipment', window );">(Gain) loss on divestment of mineral properties</a></td>
<td class="num">(29,148)<span></span>
</td>
<td class="nump">89,914<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_GainOnDisposalOfSubsidiary', window );">(Gain) loss on divestment of subsidiary</a></td>
<td class="num">(1,594,901)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdjustmentsForIncreaseDecreaseInEmployeeBenefitLiabilities', window );">Loss (gain) on change in asset retirement obligation estimate</a></td>
<td class="nump">157,226<span></span>
</td>
<td class="num">(1,719,943)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_UnrealizedGainOnUraniumInvestment', window );">Unrealized gain on uranium investment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,554,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_GainOnSaleOfUraniumInvestment', window );">Gain on sale of uranium investment</a></td>
<td class="num">(35,000)<span></span>
</td>
<td class="num">(524,075)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdjustmentsForFairValueGainsLosses', window );">Unrealized gain on marketable securities</a></td>
<td class="num">(1,057,405)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdjustmentsForUndistributedProfitsOfAssociates', window );">Loss on investment in associate</a></td>
<td class="nump">586,900<span></span>
</td>
<td class="nump">355,735<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_ChangesInNonCashWorkingCapitalItemsAbstract', window );"><strong>Changes in non-cash working capital items:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdjustmentsForDecreaseIncreaseInOtherOperatingReceivables', window );">Receivables and prepaid expenses</a></td>
<td class="num">(715,928)<span></span>
</td>
<td class="num">(203,160)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdjustmentsForIncreaseDecreaseInDepositsFromCustomers', window );">Deposit - uranium investment</a></td>
<td class="num">(3,000,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherInflowsOutflowsOfCashClassifiedAsOperatingActivities', window );">Restricted cash</a></td>
<td class="num">(50,049,202)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAccountPayable', window );">Accounts payable and accrued liabilities</a></td>
<td class="num">(3,656,511)<span></span>
</td>
<td class="nump">5,921,147<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CashReceiptsFromRepaymentOfAdvancesAndLoansMadeToRelatedParties', window );">Due to related parties</a></td>
<td class="nump">434,902<span></span>
</td>
<td class="nump">4,562<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CashFlowsFromUsedInOperatingActivities', window );">Net cash operating activities</a></td>
<td class="num">(69,198,211)<span></span>
</td>
<td class="num">(3,966,802)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_InvestingActivitiesAbstract', window );"><strong>Investing activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities', window );">Acquisition of intangible assets</a></td>
<td class="num">(55,150)<span></span>
</td>
<td class="num">(17,241)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities', window );">Acquisition of property, plant, and equipment</a></td>
<td class="num">(979,501)<span></span>
</td>
<td class="num">(300,737)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PurchaseOfInvestmentProperty', window );">Mineral property expenditures</a></td>
<td class="num">(9,860,682)<span></span>
</td>
<td class="num">(2,357,254)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProceedsFromSalesOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities', window );">Proceeds from divestment of mineral properties</a></td>
<td class="nump">48,480<span></span>
</td>
<td class="nump">105,600<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_CashAcquiredFromAzargaAssetAcquisition', window );">Cash acquired from Azarga asset acquisition</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,860,360<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_TransactionCostsOnAzargaAssetAcquisition', window );">Transaction costs on Azarga asset acquisition</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(3,252,264)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CashFlowsUsedInObtainingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities', window );">Deferred acquisition costs</a></td>
<td class="num">(6,009,303)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_InterestReceivedClassifiedAsInvestingActivities', window );">Interest income received</a></td>
<td class="nump">406,132<span></span>
</td>
<td class="nump">20,987<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_PaymentsofInvestmentInUranium', window );">Investment in uranium</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(9,076,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_ProceedsReceivedFromSaleOfUraniumInvestment', window );">Proceeds received from sale of uranium investment</a></td>
<td class="nump">4,245,000<span></span>
</td>
<td class="nump">6,975,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GainsLossesOnFinancialAssetsAtFairValueThroughProfitOrLoss', window );">Settlement of asset retirement obligation</a></td>
<td class="num">(11,324)<span></span>
</td>
<td class="num">(11,189)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CashFlowsFromUsedInInvestingActivities', window );">Net cash investing activities</a></td>
<td class="num">(12,216,348)<span></span>
</td>
<td class="num">(6,052,738)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_FinancingActivitiesAbstract', window );"><strong>Financing activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_PrivatePlacementProceeds', window );">Private placement proceeds</a></td>
<td class="nump">23,057,411<span></span>
</td>
<td class="nump">11,966,494<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PaymentsForShareIssueCosts', window );">Share issue costs</a></td>
<td class="num">(1,473,875)<span></span>
</td>
<td class="num">(762,902)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProceedsFromExerciseOfWarrants', window );">Proceeds from exercise of warrants</a></td>
<td class="nump">2,452,227<span></span>
</td>
<td class="nump">2,633,029<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProceedsFromExerciseOfOptions', window );">Proceeds from exercise of stock options</a></td>
<td class="nump">1,177,093<span></span>
</td>
<td class="nump">288,572<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProceedsFromIssuingShares', window );">Share subscriptions received</a></td>
<td class="nump">51,558,624<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RepaymentsOfBorrowingsClassifiedAsFinancingActivities', window );">Deferred financing costs</a></td>
<td class="num">(1,717,268)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities', window );">Lease payments</a></td>
<td class="num">(104,815)<span></span>
</td>
<td class="num">(37,588)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CashFlowsFromUsedInFinancingActivities', window );">Net cash financing activities</a></td>
<td class="nump">74,949,397<span></span>
</td>
<td class="nump">14,087,605<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents', window );">Effect of foreign exchange on cash</a></td>
<td class="num">(211,309)<span></span>
</td>
<td class="num">(61,831)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CashFlowsFromUsedInOperationsBeforeChangesInWorkingCapital', window );">Change in cash</a></td>
<td class="num">(6,676,471)<span></span>
</td>
<td class="nump">4,006,234<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CashAndCashEquivalents', window );">Cash, beginning of year</a></td>
<td class="nump">9,188,483<span></span>
</td>
<td class="nump">5,182,249<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CashAndCashEquivalents', window );">Cash, end of year</a></td>
<td class="nump">$ 2,512,012<span></span>
</td>
<td class="nump">$ 9,188,483<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cve_Accretion">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accretion Expense</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cve_Accretion</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cve_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cve_CashAcquiredFromAzargaAssetAcquisition">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cash acquired from azarga asset acquisition.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cve_CashAcquiredFromAzargaAssetAcquisition</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cve_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cve_ChangesInNonCashWorkingCapitalItemsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cve_ChangesInNonCashWorkingCapitalItemsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cve_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cve_FinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cve_FinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cve_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cve_GainOnDisposalOfSubsidiary">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Gain on disposal of subsidiary</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cve_GainOnDisposalOfSubsidiary</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cve_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cve_GainOnSaleOfUraniumInvestment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cve_GainOnSaleOfUraniumInvestment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cve_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cve_InvestingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cve_InvestingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cve_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cve_ItemsNotAffectingCashAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cve_ItemsNotAffectingCashAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cve_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cve_OperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cve_OperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cve_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cve_PaymentsofInvestmentInUranium">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Investment in uranium</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cve_PaymentsofInvestmentInUranium</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cve_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cve_PrivatePlacementProceeds">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the private placement proceeds.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cve_PrivatePlacementProceeds</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cve_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cve_ProceedsReceivedFromSaleOfUraniumInvestment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Proceeds received from sale of uranium investment</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cve_ProceedsReceivedFromSaleOfUraniumInvestment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cve_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cve_TransactionCostsOnAzargaAssetAcquisition">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cve_TransactionCostsOnAzargaAssetAcquisition</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cve_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cve_UnrealizedGainOnUraniumInvestment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Unrealized gain on uranium investment</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cve_UnrealizedGainOnUraniumInvestment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cve_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AdjustmentsForDecreaseIncreaseInOtherOperatingReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Adjustments for decrease (increase) in other operating receivables to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Profit (loss)]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2022-03-24<br> -Paragraph 20<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_20_a&amp;doctype=Standard<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AdjustmentsForDecreaseIncreaseInOtherOperatingReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AdjustmentsForDeferredTaxExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Adjustments for deferred tax expense to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Deferred tax expense (income); Profit (loss)]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2022-03-24<br> -Paragraph 20<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_20&amp;doctype=Standard<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AdjustmentsForDeferredTaxExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AdjustmentsForDepreciationAndAmortisationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Adjustments for depreciation and amortisation expense to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Depreciation and amortisation expense; Profit (loss)]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2022-03-24<br> -Paragraph 20<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_20_b&amp;doctype=Standard<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AdjustmentsForDepreciationAndAmortisationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AdjustmentsForFairValueGainsLosses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Adjustments for fair value losses (gains) to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Profit (loss)]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2022-03-24<br> -Paragraph 20<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_20_b&amp;doctype=Standard<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AdjustmentsForFairValueGainsLosses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AdjustmentsForGainLossOnDisposalsPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Adjustments for gain (loss) on disposals of property, plant and equipment to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Profit (loss); Property, plant and equipment; Disposals, property, plant and equipment]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2022-03-24<br> -Paragraph 20<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_20&amp;doctype=Standard<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AdjustmentsForGainLossOnDisposalsPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AdjustmentsForImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Adjustments for impairment loss (reversal of impairment loss) recognised in profit or loss to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Impairment loss (reversal of impairment loss) recognised in profit or loss]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2022-03-24<br> -Paragraph 20<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_20_b&amp;doctype=Standard<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AdjustmentsForImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AdjustmentsForIncreaseDecreaseInDepositsFromCustomers">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Adjustments for increase (decrease) in deposits from customers to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Deposits from customers; Profit (loss)]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2022-03-24<br> -Paragraph 20<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_20&amp;doctype=Standard<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AdjustmentsForIncreaseDecreaseInDepositsFromCustomers</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AdjustmentsForIncreaseDecreaseInEmployeeBenefitLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Adjustments for increase (decrease) in employee benefit liabilities to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Profit (loss)]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2022-03-24<br> -Paragraph 20<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_20&amp;doctype=Standard<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AdjustmentsForIncreaseDecreaseInEmployeeBenefitLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAccountPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Adjustments for increase (decrease) in trade accounts payable to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Profit (loss)]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2022-03-24<br> -Paragraph 20<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_20_a&amp;doctype=Standard<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAccountPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AdjustmentsForInterestIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Adjustments for interest income expense to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Interest income; Profit (loss)]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2022-03-24<br> -Paragraph 20<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_20&amp;doctype=Standard<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AdjustmentsForInterestIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AdjustmentsForSharebasedPayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Adjustments for share-based payments to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Profit (loss)]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2022-03-24<br> -Paragraph 20<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_20_b&amp;doctype=Standard<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AdjustmentsForSharebasedPayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AdjustmentsForUndistributedProfitsOfAssociates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Adjustments for undistributed profits of associates to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Associates [member]; Profit (loss)]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2022-03-24<br> -Paragraph 20<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_20_b&amp;doctype=Standard<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AdjustmentsForUndistributedProfitsOfAssociates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AdjustmentsForUnrealisedForeignExchangeLossesGains">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Adjustments for unrealised foreign exchange losses (gains) to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Profit (loss)]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2022-03-24<br> -Paragraph 20<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_20_b&amp;doctype=Standard<br> -URIDate 2022-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2022-03-24<br> -Section A Statement of cash flows for an entity other than a financial institution<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2022-en-r&amp;doctype=Illustrative%20Examples&amp;dita_xref=IAS07_IE_A__IAS07_IE_A_TI<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AdjustmentsForUnrealisedForeignExchangeLossesGains</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CashAndCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of cash on hand and demand deposits, along with short-term, highly liquid investments that are readily convertible to known amounts of cash and that are subject to an insignificant risk of changes in value. [Refer: Cash; Cash equivalents]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2022-03-24<br> -Paragraph 45<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_45&amp;doctype=Standard<br> -URIDate 2022-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2022-03-24<br> -Paragraph B13<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_B13_a&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2022-03-24<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2022-03-24<br> -Paragraph 54<br> -Subparagraph i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_54_i&amp;doctype=Standard<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CashAndCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CashFlowsFromUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash flows from (used in) financing activities, which are activities that result in changes in the size and composition of the contributed equity and borrowings of the entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2022-03-24<br> -Paragraph 10<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_10&amp;doctype=Standard<br> -URIDate 2022-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2022-03-24<br> -Paragraph 50<br> -Subparagraph d<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_50_d&amp;doctype=Standard<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CashFlowsFromUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CashFlowsFromUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash flows from (used in) investing activities, which are the acquisition and disposal of long-term assets and other investments not included in cash equivalents.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2022-03-24<br> -Paragraph 10<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_10&amp;doctype=Standard<br> -URIDate 2022-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2022-03-24<br> -Paragraph 50<br> -Subparagraph d<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_50_d&amp;doctype=Standard<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CashFlowsFromUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CashFlowsFromUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash flows from (used in) operating activities, which are the principal revenue-producing activities of the entity and other activities that are not investing or financing activities. [Refer: Revenue]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2022-03-24<br> -Paragraph 10<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_10&amp;doctype=Standard<br> -URIDate 2022-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2022-03-24<br> -Paragraph 50<br> -Subparagraph d<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_50_d&amp;doctype=Standard<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CashFlowsFromUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CashFlowsFromUsedInOperationsBeforeChangesInWorkingCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow (outflow) from the entity's operations before changes in working capital.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2022-03-24<br> -Section A Statement of cash flows for an entity other than a financial institution<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2022-en-r&amp;doctype=Illustrative%20Examples&amp;dita_xref=IAS07_IE_A__IAS07_IE_A_TI<br> -URIDate 2022-03-24<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2022-03-24<br> -Paragraph 20<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_20&amp;doctype=Standard<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CashFlowsFromUsedInOperationsBeforeChangesInWorkingCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CashFlowsUsedInObtainingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate cash flows used in obtaining control of subsidiaries or other businesses, classified as investing activities. [Refer: Subsidiaries [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2022-03-24<br> -Paragraph 39<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_39&amp;doctype=Standard<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CashFlowsUsedInObtainingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CashReceiptsFromRepaymentOfAdvancesAndLoansMadeToRelatedParties">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from repayment to the entity of loans and advances made to related parties. [Refer: Related parties [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2022-03-24<br> -Paragraph 16<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_16&amp;doctype=Standard<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CashReceiptsFromRepaymentOfAdvancesAndLoansMadeToRelatedParties</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The effect of exchange rate changes on cash and cash equivalents held or due in a foreign currency. [Refer: Cash and cash equivalents]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2022-03-24<br> -Paragraph 25<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_25&amp;doctype=Standard<br> -URIDate 2022-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2022-03-24<br> -Paragraph 28<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_28&amp;doctype=Standard<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_GainsLossesOnFinancialAssetsAtFairValueThroughProfitOrLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The gains (losses) on financial assets at fair value through profit or loss. [Refer: Financial assets at fair value through profit or loss]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 7<br> -IssueDate 2022-03-24<br> -Paragraph 20<br> -Subparagraph a<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_20_a_i&amp;doctype=Standard<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_GainsLossesOnFinancialAssetsAtFairValueThroughProfitOrLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_InterestReceivedClassifiedAsInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from interest received, classified as investing activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2022-03-24<br> -Paragraph 31<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_31&amp;doctype=Standard<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_InterestReceivedClassifiedAsInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_OtherInflowsOutflowsOfCashClassifiedAsOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Inflows (outflows) of cash, classified as operating activities, that the entity does not separately disclose in the same statement or note.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2022-03-24<br> -Paragraph 14<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_14&amp;doctype=Standard<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_OtherInflowsOutflowsOfCashClassifiedAsOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_PaymentsForShareIssueCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for share issue costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2022-03-24<br> -Paragraph 17<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_17&amp;doctype=Standard<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_PaymentsForShareIssueCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for payment of lease liabilities, classified as financing activities. [Refer: Lease liabilities]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2022-03-24<br> -Paragraph 17<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_17_e&amp;doctype=Standard<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProceedsFromExerciseOfOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the exercise of options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2022-03-24<br> -Paragraph 17<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_17&amp;doctype=Standard<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProceedsFromExerciseOfOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProceedsFromExerciseOfWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the exercise of share purchase warrants.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2022-03-24<br> -Paragraph 17<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_17&amp;doctype=Standard<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProceedsFromExerciseOfWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProceedsFromIssuingShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from issuing shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2022-03-24<br> -Paragraph 17<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_17_a&amp;doctype=Standard<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProceedsFromIssuingShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProceedsFromSalesOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from sales of property, plant and equipment, classified as investing activities. [Refer: Property, plant and equipment]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2022-03-24<br> -Paragraph 16<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_16_b&amp;doctype=Standard<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProceedsFromSalesOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The total of income less expenses from continuing and discontinued operations, excluding the components of other comprehensive income. [Refer: Other comprehensive income]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2022-03-24<br> -Paragraph 18<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_18_b&amp;doctype=Standard<br> -URIDate 2022-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 1<br> -IssueDate 2022-03-24<br> -Paragraph 32<br> -Subparagraph a<br> -Clause ii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=1&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_32_a_ii&amp;doctype=Standard<br> -URIDate 2022-03-24<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 1<br> -IssueDate 2022-03-24<br> -Paragraph 24<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=1&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_24_b&amp;doctype=Standard<br> -URIDate 2022-03-24<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2022-03-24<br> -Paragraph 28<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_28_b&amp;doctype=Standard<br> -URIDate 2022-03-24<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Note Effective on first application of IFRS 9<br> -Name IFRS<br> -Number 4<br> -IssueDate 2022-03-24<br> -Paragraph 39L<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=4&amp;code=ifrs-tx-2022-en-b&amp;anchor=para_39L_e&amp;doctype=Standard<br> -URIDate 2022-03-24<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2022-03-24<br> -Paragraph 23<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_23&amp;doctype=Standard<br> -URIDate 2022-03-24<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2022-03-24<br> -Paragraph B10<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_B10_b&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2022-03-24<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Note Effective 2023-01-01<br> -Name IFRS<br> -Number 17<br> -IssueDate 2022-03-24<br> -Paragraph 113<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=17&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_113_b&amp;doctype=Standard<br> -URIDate 2022-03-24<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2022-03-24<br> -Paragraph 81A<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_81A_a&amp;doctype=Standard<br> -URIDate 2022-03-24<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2022-03-24<br> -Paragraph 106<br> -Subparagraph d<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_106_d_i&amp;doctype=Standard<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for the purchases of intangible assets, classified as investing activities. [Refer: Intangible assets other than goodwill]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2022-03-24<br> -Paragraph 16<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_16_a&amp;doctype=Standard<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_PurchaseOfInvestmentProperty">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for the purchase of investment property. [Refer: Investment property]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2022-03-24<br> -Paragraph 16<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_16&amp;doctype=Standard<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_PurchaseOfInvestmentProperty</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for the purchases of property, plant and equipment, classified as investing activities. [Refer: Property, plant and equipment]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2022-03-24<br> -Paragraph 16<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_16_a&amp;doctype=Standard<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RepaymentsOfBorrowingsClassifiedAsFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow to settle borrowings, classified as financing activities. [Refer: Borrowings]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2022-03-24<br> -Paragraph 17<br> -Subparagraph d<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_17_d&amp;doctype=Standard<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RepaymentsOfBorrowingsClassifiedAsFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>56
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139782928154544">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Consolidated Statements of Changes in Shareholder&#8217;s Equity - USD ($)<br></strong></div></th>
<th class="th"><div>Share capital</div></th>
<th class="th"><div>Share subscriptions received</div></th>
<th class="th"><div>Contributed surplus</div></th>
<th class="th"><div>Accumulated other comprehensive income (loss)</div></th>
<th class="th"><div>Deficit</div></th>
<th class="th"><div>Total</div></th>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Equity', window );">Balance as of beginning at Dec. 31, 2020</a></td>
<td class="nump">$ 26,653,141<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 2,019,445<span></span>
</td>
<td class="nump">$ 7,521,888<span></span>
</td>
<td class="num">$ (23,788,515)<span></span>
</td>
<td class="nump">$ 12,405,959<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfSharesOutstanding', window );">Balance as of beginning (in Shares) at Dec. 31, 2020</a></td>
<td class="nump">59,453,218<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_PrivatePlacement', window );">Private placements</a></td>
<td class="nump">$ 11,966,494<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">11,966,494<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_PrivatePlacementinShares', window );">Private placements (in Shares)</a></td>
<td class="nump">5,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ShareIssueRelatedCost', window );">Share issuance costs</a></td>
<td class="num">$ (1,191,042)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">428,140<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(762,902)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughExerciseOfWarrantsEquity', window );">Shares issued for exercise of warrants</a></td>
<td class="nump">$ 2,799,780<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(166,751)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">2,633,029<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_SharesIssuedForExerciseOfWarrantsShares', window );">Shares issued for exercise of warrants (in Shares)</a></td>
<td class="nump">2,052,843<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughExerciseOfOptions', window );">Shares issued for exercise of stock options</a></td>
<td class="nump">$ 557,611<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(269,039)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">288,572<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_SharesIssuedForExerciseOfStockOptionsShares', window );">Shares issued for exercise of stock options (in Shares)</a></td>
<td class="nump">590,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_StockOptionExpense', window );">Stock option expense</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">1,425,645<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">1,425,645<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_SharesIssuedForAzargaAssetAcquisition', window );">Shares issued for Azarga asset acquisition (Note 10)</a></td>
<td class="nump">$ 121,796,381<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">121,796,381<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_SharesIssuedForAzargaAssetAcquisitionNote10Shares', window );">Shares issued for Azarga asset acquisition (Note 10) (in Shares)</a></td>
<td class="nump">31,806,617<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_ReplacementOptionsForAzargaAssetAcquisition', window );">Replacement options for Azarga asset acquisition (Note 10)</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">5,496,037<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">5,496,037<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_ReplacementWarrantsForAzargaAssetAcquisition', window );">Replacement warrants for Azarga asset acquisition (Note 10)</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">3,259,306<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">3,259,306<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_AdjustmentToInvestmentInAssociate', window );">Adjustment to investment in associate</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">469,320<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">469,320<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationNetOfTax', window );">Cumulative translation adjustment</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(1,325,855)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(1,325,855)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProfitLoss', window );">Loss for the year</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(8,563,473)<span></span>
</td>
<td class="num">(8,563,473)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Equity', window );">Balance as of ending at Dec. 31, 2021</a></td>
<td class="nump">$ 162,582,365<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">12,662,103<span></span>
</td>
<td class="nump">6,196,033<span></span>
</td>
<td class="num">(32,351,988)<span></span>
</td>
<td class="nump">149,088,513<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfSharesOutstanding', window );">Balance as of ending (in Shares) at Dec. 31, 2021</a></td>
<td class="nump">98,902,678<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_PrivatePlacement', window );">Private placements</a></td>
<td class="nump">$ 23,057,411<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">23,057,411<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_PrivatePlacementinShares', window );">Private placements (in Shares)</a></td>
<td class="nump">6,535,947<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ShareIssueRelatedCost', window );">Share issuance costs</a></td>
<td class="num">$ (2,146,218)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">672,343<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(1,473,875)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughExerciseOfWarrantsEquity', window );">Shares issued for exercise of warrants</a></td>
<td class="nump">$ 2,599,999<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(147,772)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">2,452,227<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_SharesIssuedForExerciseOfWarrantsShares', window );">Shares issued for exercise of warrants (in Shares)</a></td>
<td class="nump">2,291,642<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughExerciseOfOptions', window );">Shares issued for exercise of stock options</a></td>
<td class="nump">$ 3,905,580<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(2,728,487)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">1,177,093<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_SharesIssuedForExerciseOfStockOptionsShares', window );">Shares issued for exercise of stock options (in Shares)</a></td>
<td class="nump">1,016,436<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_StockOptionExpense', window );">Stock option expense</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">5,744,656<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">5,744,656<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IssueOfEquity', window );">Shares issued for services</a></td>
<td class="nump">$ 611,113<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">611,113<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_SharesIssuedForServicesShares', window );">Shares issued for services (in Shares)</a></td>
<td class="nump">193,348<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_ShareSubscriptionsReceived', window );">Share subscriptions received</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">51,558,624<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">51,558,624<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_AdjustmentToInvestmentInAssociate', window );">Adjustment to investment in associate</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">15,675<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">15,675<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationNetOfTax', window );">Cumulative translation adjustment</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(665,809)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(665,809)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProfitLoss', window );">Loss for the year</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(16,515,389)<span></span>
</td>
<td class="num">(16,515,389)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Equity', window );">Balance as of ending at Dec. 31, 2022</a></td>
<td class="nump">$ 190,610,250<span></span>
</td>
<td class="nump">$ 51,558,624<span></span>
</td>
<td class="nump">$ 16,218,518<span></span>
</td>
<td class="nump">$ 5,530,224<span></span>
</td>
<td class="num">$ (48,867,377)<span></span>
</td>
<td class="nump">$ 215,050,239<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfSharesOutstanding', window );">Balance as of ending (in Shares) at Dec. 31, 2022</a></td>
<td class="nump">108,940,051<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cve_AdjustmentToInvestmentInAssociate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Adjustment to investment in associate.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cve_AdjustmentToInvestmentInAssociate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cve_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cve_PrivatePlacement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Private placement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cve_PrivatePlacement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cve_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cve_PrivatePlacementinShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Private placement in shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cve_PrivatePlacementinShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cve_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cve_ReplacementOptionsForAzargaAssetAcquisition">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Replacement options for azarga asset acquisition.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cve_ReplacementOptionsForAzargaAssetAcquisition</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cve_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cve_ReplacementWarrantsForAzargaAssetAcquisition">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Replacement warrants for azarga asset acquisition.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cve_ReplacementWarrantsForAzargaAssetAcquisition</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cve_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cve_ShareSubscriptionsReceived">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Share subscriptions received.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cve_ShareSubscriptionsReceived</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cve_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cve_SharesIssuedForAzargaAssetAcquisition">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Shares issued for azarga asset acquisition.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cve_SharesIssuedForAzargaAssetAcquisition</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cve_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cve_SharesIssuedForAzargaAssetAcquisitionNote10Shares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Shares issued for Azarga asset acquisition(Shares).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cve_SharesIssuedForAzargaAssetAcquisitionNote10Shares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cve_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cve_SharesIssuedForExerciseOfStockOptionsShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Shares issued for exercise of stock options(Shares).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cve_SharesIssuedForExerciseOfStockOptionsShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cve_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cve_SharesIssuedForExerciseOfWarrantsShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Shares issued for exercise of warrants(Shares).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cve_SharesIssuedForExerciseOfWarrantsShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cve_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cve_SharesIssuedForServicesShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Shares issued for services(Shares).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cve_SharesIssuedForServicesShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cve_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cve_StockOptionExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Stock option expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cve_StockOptionExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cve_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_Equity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of residual interest in the assets of the entity after deducting all its liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 1<br> -IssueDate 2022-03-24<br> -Paragraph 24<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=1&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_24_a&amp;doctype=Standard<br> -URIDate 2022-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 1<br> -IssueDate 2022-03-24<br> -Paragraph 32<br> -Subparagraph a<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=1&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_32_a_i&amp;doctype=Standard<br> -URIDate 2022-03-24<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2022-03-24<br> -Paragraph 93<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_93_a&amp;doctype=Standard<br> -URIDate 2022-03-24<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2022-03-24<br> -Paragraph 93<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_93_b&amp;doctype=Standard<br> -URIDate 2022-03-24<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2022-03-24<br> -Paragraph 93<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_93_e&amp;doctype=Standard<br> -URIDate 2022-03-24<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2022-03-24<br> -Paragraph 55<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2022-03-24<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2022-03-24<br> -Paragraph 78<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_78_e&amp;doctype=Standard<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_Equity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The gains (losses) recognised in other comprehensive income on exchange differences on the translation of financial statements of foreign operations, net of tax, before reclassification adjustments. [Refer: Other comprehensive income]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2022-03-24<br> -Paragraph 91<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_91_a&amp;doctype=Standard<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IncreaseDecreaseThroughExerciseOfOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) in equity resulting from the exercise of options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2022-03-24<br> -Paragraph 106<br> -Subparagraph d<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_106_d&amp;doctype=Standard<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IncreaseDecreaseThroughExerciseOfOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IncreaseDecreaseThroughExerciseOfWarrantsEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) in equity resulting from the exercise of warrants.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2022-03-24<br> -Paragraph 106<br> -Subparagraph d<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_106_d&amp;doctype=Standard<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IncreaseDecreaseThroughExerciseOfWarrantsEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IssueOfEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase in equity through the issue of equity instruments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2022-03-24<br> -Paragraph 106<br> -Subparagraph d<br> -Clause iii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_106_d_iii&amp;doctype=Standard<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IssueOfEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NumberOfSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares that have been authorised and issued, reduced by treasury shares held. [Refer: Treasury shares]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2022-03-24<br> -Paragraph 79<br> -Subparagraph a<br> -Clause iv<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_79_a_iv&amp;doctype=Standard<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NumberOfSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The total of income less expenses from continuing and discontinued operations, excluding the components of other comprehensive income. [Refer: Other comprehensive income]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2022-03-24<br> -Paragraph 18<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_18_b&amp;doctype=Standard<br> -URIDate 2022-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 1<br> -IssueDate 2022-03-24<br> -Paragraph 32<br> -Subparagraph a<br> -Clause ii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=1&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_32_a_ii&amp;doctype=Standard<br> -URIDate 2022-03-24<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 1<br> -IssueDate 2022-03-24<br> -Paragraph 24<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=1&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_24_b&amp;doctype=Standard<br> -URIDate 2022-03-24<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2022-03-24<br> -Paragraph 28<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_28_b&amp;doctype=Standard<br> -URIDate 2022-03-24<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Note Effective on first application of IFRS 9<br> -Name IFRS<br> -Number 4<br> -IssueDate 2022-03-24<br> -Paragraph 39L<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=4&amp;code=ifrs-tx-2022-en-b&amp;anchor=para_39L_e&amp;doctype=Standard<br> -URIDate 2022-03-24<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2022-03-24<br> -Paragraph 23<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_23&amp;doctype=Standard<br> -URIDate 2022-03-24<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2022-03-24<br> -Paragraph B10<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_B10_b&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2022-03-24<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Note Effective 2023-01-01<br> -Name IFRS<br> -Number 17<br> -IssueDate 2022-03-24<br> -Paragraph 113<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=17&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_113_b&amp;doctype=Standard<br> -URIDate 2022-03-24<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2022-03-24<br> -Paragraph 81A<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_81A_a&amp;doctype=Standard<br> -URIDate 2022-03-24<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2022-03-24<br> -Paragraph 106<br> -Subparagraph d<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_106_d_i&amp;doctype=Standard<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ShareIssueRelatedCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of cost related to the issuance of shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2022-03-24<br> -Paragraph 106<br> -Subparagraph d<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_106_d&amp;doctype=Standard<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ShareIssueRelatedCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>57
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139782928889168">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Nature of Operations and Going Concern<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_NatureofOperationsandGoingConcernLineItems', window );"><strong>Nature of Operation and Going Concern [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_NatureOfOperationAndGoingConcern', window );">Nature of operations and going concern</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif"><b>1.</b></span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b>Nature
                                            of operations and going concern</b></span></td></tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">enCore
Energy Corp. was incorporated on October 30, 2009 under the Laws of British Columbia, Canada. enCore Energy Corp., together with its
subsidiaries (collectively referred to as the &#8220;Company&#8221; or &#8220;enCore&#8221;), is principally engaged in the acquisition,
exploration, and development of uranium resource properties in the United States. The Company&#8217;s common shares trade on the TSX
Venture Exchange and the NYSE American Market under the symbol &#8220;EU&#8221;. The Company&#8217;s corporate headquarters is located
at 101 N Shoreline, Suite 450, Corpus Christi, TX 78401.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">On
September 14, 2022, the Company consolidated its issued and outstanding shares on a ratio of three old common shares for every one new
post-consolidated common share (the &#8220;Share Consolidation&#8221;). All current and comparative references to the number of common
shares, weighted average number of common shares, loss per share, stock options and warrants have been restated to give effect to this
Share Consolidation.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">These
consolidated financial statements (the &#8220;financial statements&#8221;) have been prepared assuming the Company will continue on a
going-concern basis, which assumes that the Company will be able to continue in operation for the foreseeable future and will be able
to realize its assets and discharge its liabilities and commitments in the normal course of operations. The Company has no source of
operating cash flow and operations to date have been funded primarily from the issue of share capital. For the year ended December 31,
2022, the Company reported a net loss of $16,515,389 (2021 - $8,563,475), had working capital of $7,017,115 (December 31, 2021 - $5,632,603),
and an accumulated deficit of $48,867,377 (December 31, 2021 - $32,351,988). These financial statements do not reflect the adjustments
to the carrying values of assets and liabilities and the reported expenses and statement of financial position classifications that would
be necessary were the going concern assumption not appropriate. Such adjustments could be material.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">In
March 2020, the World Health Organization declared the COVID-19 outbreak a global pandemic and the Company continues to evaluate the
COVID-19 situation and monitor any impacts or any potential impacts to the business. enCore Energy Corp has implemented health and safety
measures in accordance with the health officials and guidance from local government authorities. While the pandemic has had limited impact
on the Company&#8217;s operations to date, future activities could be impacted as a result of the pandemic. As the COVID-19 health crisis
continues, the Company will continue to rely on guidance and recommendations from local health authorities, Health Canada and the Centers
for Disease Control and Prevention to update the Company&#8217;s policies.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Geopolitical
uncertainty driven by the Russian invasion of Ukraine has led many governments and utility providers to re-examine supply chains and
procurement strategies reliant on nuclear fuel supplies coming out of or through Russia. Sanctions, restrictions, and an inability to
obtain insurance on cargo have contributed to transportation and other supply chain disruptions between producers and suppliers. As a
result of this and coupled with multiple years of declining uranium production globally, uranium market fundamentals are shifting from
an inventory driven market to one more driven by production.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Management
estimates that it has adequate working capital to fund all of its planned activities for the next year. However, the Company&#8217;s
long-term continued operations are dependent on its abilities to monetize assets or raise additional funding from loans or equity financings,
or through other arrangements. There is no assurance that future financing activities will be successful.</span></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cve_NatureOfOperationAndGoingConcern">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Nature of operations and going concern.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cve_NatureOfOperationAndGoingConcern</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cve_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cve_NatureofOperationsandGoingConcernLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cve_NatureofOperationsandGoingConcernLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cve_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>58
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139782921253216">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Significant accounting policies<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_SignificantaccountingpoliciesLineItems', window );"><strong>Significant accounting policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory', window );">Significant Accounting Policies</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif"><b>2.</b></span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b>Significant
                                            accounting policies</b></span></td></tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif"><b>&#160;</b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif"><b>Basis
of presentation</b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">These
financial statements, including comparatives, have been prepared using accounting policies consistent with International Financial Reporting
Standards (&#8220;IFRS&#8221;) as issued by the International Accounting Standards Board (&#8220;IASB&#8221;) and interpretations of
the International Financial Reporting Interpretations Committee (&#8220;IFRIC&#8221;).</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">The
policies applied in these financial statements are based on IFRS issued and effective as of December 31, 2022.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">These
financial statements have been prepared on a historical cost basis except for certain financial instruments which are measured at fair
value. All dollar amounts presented are in United States Dollars (&#8220;U.S. Dollars&#8221;) unless otherwise specified. In addition,
these financial statements have been prepared using the accrual basis of accounting, except for cash flow information.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">These
financial statements were approved for issuance by the audit committee of the Board of Directors on April 26, 2023.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b>Change
in presentation currency</b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">These
financial statements are presented in U.S. Dollars, unless otherwise specified. The functional currency of enCore Energy Corp. is the
Canadian Dollar. The functional currency of the Company&#8217;s subsidiaries is the U.S. Dollar. During the year ended December 31, 2022,
the Company changed its presentation currency from Canadian Dollars to U.S. Dollars to better reflect the Company&#8217;s business activities.
Accordingly, these financial statements are presented in U.S. Dollars. The change in presentation currency is to better reflect the Company&#8217;s
business activities and to improve investors&#8217; ability to compare the Company&#8217;s financial results with other publicly traded
businesses in the exploration industry.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">In
making this change to the U.S. Dollar presentation currency, the Company followed the guidance in IAS 21 <i>The Effects of Changes in
Foreign Exchange Rates</i> and has applied the change retrospectively as if the new presentation currency had always been the Company&#8217;s
presentation currency. In accordance with IAS 21, the financial statements for all years presented have been translated to the new U.S.
Dollar presentation currency. For 2021 and 2020 comparative balances, assets and liabilities have been translated into the U.S. Dollar
presentation currency at the rate of exchange prevailing at the reporting date. The consolidated statements of loss and comprehensive
loss were translated at the average exchange rates for the reporting period. Share capital and reserves were translated at the historical
rates prevailing at the dates of the transactions. Exchange differences arising on translation were taken to the foreign currency translation
reserve in shareholders&#8217; equity.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">The
exchange rates used were as follows:</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify">&#160;</p><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; text-align: left; font-weight: bold">U.S. Dollar/CDN Dollar exchange rate</td><td style="text-align: center; font-weight: bold">&#160;</td>
    <td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid; font-weight: bold">December 31, 2022</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="text-align: center; border-bottom: Black 1.5pt solid; font-weight: bold">&#160;</td>
    <td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid; font-weight: bold">December 31, 2021</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%; text-align: left">Closing rate at the reporting date</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">0.738</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">0.789</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Average rate for the year</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">0.769</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">0.798</td><td style="text-align: left">&#160;</td></tr>
  </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b>Basis
of consolidation</b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">These
financial statements incorporate the financial statements of the Company and its controlled subsidiaries. Control is defined as the exposure,
or rights, to variable returns from involvement with an investee and the ability to affect those returns through power over the investee.
Power over an investee exists when an investor has existing rights that give it the ability to direct the activities that significantly
affect the investee&#8217;s returns. This control is generally evidenced through owning more than 50% of the voting rights or currently
exercisable potential voting rights of a Company&#8217;s share capital. All significant intercompany transactions and balances have been
eliminated.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">These
consolidated financial statements include the financial statements of the Company and its significant subsidiaries listed in the following
table:</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify">&#160;</p><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Name of <br/> Subsidiary</td><td style="font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Place of <br/> Incorporation</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Ownership<br/> Interest</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Principal<br/> Activity</td><td style="font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Functional<br/> Currency</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 30%; text-align: center">Tigris Uranium US Corp.</td><td style="width: 1%">&#160;</td>
    <td style="width: 25%; text-align: center">Nevada, USA</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">100</td><td style="width: 1%; text-align: left">%</td><td style="width: 1%">&#160;</td>
    <td style="width: 19%; text-align: center">Mineral Exploration</td><td style="width: 1%">&#160;</td>
    <td style="width: 11%; text-align: center">USD</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: center">Metamin Enterprises US Inc.</td><td>&#160;</td>
    <td style="text-align: center">Nevada, USA</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">100</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: center">Mineral Exploration</td><td>&#160;</td>
    <td style="text-align: center">USD</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: center">URI, Inc.</td><td>&#160;</td>
    <td style="text-align: center">Delaware, USA</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">100</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: center">Mineral Exploration</td><td>&#160;</td>
    <td style="text-align: center">USD</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: center">Neutron Energy, Inc.</td><td>&#160;</td>
    <td style="text-align: center">Nevada, USA</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">100</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: center">Mineral Exploration</td><td>&#160;</td>
    <td style="text-align: center">USD</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: center">Uranco, Inc.</td><td>&#160;</td>
    <td style="text-align: center">Delaware, USA</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">100</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: center">Mineral Exploration</td><td>&#160;</td>
    <td style="text-align: center">USD</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: center">Uranium Resources, Inc.</td><td>&#160;</td>
    <td style="text-align: center">Delaware, USA</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">100</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: center">Mineral Exploration</td><td>&#160;</td>
    <td style="text-align: center">USD</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: center">HRI-Churchrock, Inc.</td><td>&#160;</td>
    <td style="text-align: center">Delaware, USA</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">100</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: center">Mineral Exploration</td><td>&#160;</td>
    <td style="text-align: center">USD</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: center">Hydro Restoration Corp.</td><td>&#160;</td>
    <td style="text-align: center">Delaware, USA</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">100</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: center">Mineral Exploration</td><td>&#160;</td>
    <td style="text-align: center">USD</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: center">Belt Line Resources, Inc.</td><td>&#160;</td>
    <td style="text-align: center">Texas, USA</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">100</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: center">Mineral Exploration</td><td>&#160;</td>
    <td style="text-align: center">USD</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: center">Cibola Resources, LLC (*)</td><td>&#160;</td>
    <td style="text-align: center">Delaware, USA</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">100</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: center">Mineral Exploration</td><td>&#160;</td>
    <td style="text-align: center">USD</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: center">enCore Energy US Corp.</td><td>&#160;</td>
    <td style="text-align: center">Nevada, USA</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">100</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: center">Holding Company</td><td>&#160;</td>
    <td style="text-align: center">USD</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: center">Azarga Uranium Corp.</td><td>&#160;</td>
    <td style="text-align: center">British Columbia, CA</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">100</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: center">Mineral Exploration</td><td>&#160;</td>
    <td style="text-align: center">USD</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: center">Powertech (USA) Inc.</td><td>&#160;</td>
    <td style="text-align: center">South Dakota, USA</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">100</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: center">Mineral Exploration</td><td>&#160;</td>
    <td style="text-align: center">USD</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: center">URZ Energy Corp.</td><td>&#160;</td>
    <td style="text-align: center">British Columbia, CA</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">100</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: center">Mineral Exploration</td><td>&#160;</td>
    <td style="text-align: center">USD</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: center">Ucolo Exploration Corp.</td><td>&#160;</td>
    <td style="text-align: center">Utah, USA</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">100</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: center">Mineral Exploration</td><td>&#160;</td>
    <td style="text-align: center">USD</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: center">Azarga Resources Limited</td><td>&#160;</td>
    <td style="text-align: center">British Virgin Islands</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">100</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: center">Mineral Exploration</td><td>&#160;</td>
    <td style="text-align: center">USD</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: center">Azarga Resources (Hong Kong) Ltd.</td><td>&#160;</td>
    <td style="text-align: center">Hong Kong</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">100</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: center">Mineral Exploration</td><td>&#160;</td>
    <td style="text-align: center">USD</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: center">Azarga Resources USA Company</td><td>&#160;</td>
    <td style="text-align: center">Colorado, USA</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">100</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: center">Mineral Exploration</td><td>&#160;</td>
    <td style="text-align: center">USD</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: center; padding-bottom: 1.5pt">Azarga Resources Canada Ltd.</td><td>&#160;</td>
    <td style="text-align: center; padding-bottom: 1.5pt">British Columbia, CA</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">100</td><td style="padding-bottom: 1.5pt; text-align: left">%</td><td>&#160;</td>
    <td style="text-align: center; padding-bottom: 1.5pt">Mineral Exploration</td><td>&#160;</td>
    <td style="text-align: center; padding-bottom: 1.5pt">USD</td></tr>
  </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">*
Cibola Resources, LLC was divested in May 2022 (Note 11).</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b>Cash</b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Cash
is comprised of cash held at banks and demand deposits.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b>Restricted
cash</b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">As
of December 31, 2022, the Company deposited $4,517,073 for collateralization of performance obligations. These funds are not available
for the payment of general corporate obligations. The bonds are collateralized performance bonds required for future restoration and
reclamation obligations related to the Company&#8217;s operations. (Note 11).</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">As
of December 31, 2022, the Company held in escrow CAD $67,789,880 ($50,051,595) in share subscriptions pertaining to a financing that
closed subsequent to year end (Note 22(b)).</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b>Asset
retirement obligations </b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Various
federal and state mining laws and regulations require the Company to reclaim the surface areas and restore underground water quality
for its ISR projects to the pre-existing or background average quality after the completion of mining. Asset retirement obligations,
consisting primarily of estimated restoration and reclamation costs at the Company&#8217;s ISR projects, are recognized in the period
incurred and recorded as liabilities at fair value. Such obligations, which are initially estimated based on discounted cash flow estimates,
are accreted to full value over time through charges to accretion expense. In addition, the asset retirement cost is capitalized as part
of the asset&#8217;s carrying value and amortized over the life of the related asset. Asset retirement obligations are periodically adjusted
to reflect changes in the estimated present value resulting from revisions to the estimated timing or amount of restoration and reclamation
costs. As the Company completes its restoration and reclamation work at its properties, the liability is reduced by the carrying value
of the related asset retirement liability which is based upon the percentage of completion of each restoration and reclamation activity.
Any gain or loss upon settlement is charged to income or expense for the period. The Company reviews and evaluates its asset retirement
obligations annually or more frequently at interim periods if deemed necessary.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b>Assets
held for sale</b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">The
Company classifies long-lived assets or disposal groups to be sold as held for sale in the period in which all of the following criteria
are met: management commits to a plan to sell the asset or disposal group; the asset or disposal group is available for immediate sale;
an active program to locate a buyer is initiated; the sale of the asset or disposal group is highly probable, within 12 months.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif"><b>Mineral
properties</b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">The
Company is in the exploration stage, and records exploration and evaluation assets, which consists of the costs of acquiring licenses
for the right to explore and costs associated with exploration and evaluation activity, at cost. All direct and indirect costs related
to the acquisition, exploration and development of exploration and evaluation assets are capitalized by property.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">The
exploration and evaluation assets are capitalized until the technical feasibility and commercial viability of the extraction of mineral
resources in an area of interest are demonstrable. Exploration and evaluation assets are then assessed for impairment and reclassified
to mining property and development assets within property and equipment. If an exploration and evaluation property interest is abandoned,
both the acquisition costs and the exploration and evaluation cost will be written off to net income or loss in the period of abandonment.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">On
an ongoing basis, exploration and evaluation assets are reviewed on a property-by-property basis to consider if there are any indicators
of impairment, including the following:</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.5in"><span style="font-family: Times New Roman, Times, Serif">(i)</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Whether
                                            the period during which the Company has the right to explore in the specific area has expired
                                            during the year or will expire in the near future;</span></td></tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.5in"><span style="font-family: Times New Roman, Times, Serif">(ii)</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Whether
                                            substantive expenditure on further exploration for and evaluation of mineral resources in
                                            the specific area is neither budgeted nor planned;</span></td></tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.5in"><span style="font-family: Times New Roman, Times, Serif">(iii)</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Whether
                                            the Company has decided to discontinue activities in an area as the exploration and evaluation
                                            activities in the area have not led to the discovery of commercially viable quantities of
                                            mineral resources; and</span></td></tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.5in"><span style="font-family: Times New Roman, Times, Serif">(iv)</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Whether
                                            sufficient data exists to indicate that the carrying amount exceeds the recoverable amount.</span></td></tr></table><p style="margin: 0"/><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-9</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">If
any indication of impairment exists, an estimate of the exploration and evaluation asset&#8217;s recoverable amount is calculated. The
recoverable amount is determined as the higher of the fair value less costs of disposal for the exploration and evaluation property interest
and its value in use. The fair value less costs of disposal and the value in use is determined for an individual exploration and evaluation
property interest, unless the exploration and evaluation property interest does not generate cash inflows that are largely independent
of other exploration and evaluation property interests. If this is the case, the exploration and evaluation property interests are grouped
together into cash generating units (&#8220;CGUs&#8221;) for impairment purposes. If the recoverable amount of an asset is estimated
to be less than its carrying amount, the carrying amount of the asset is reduced to its recoverable amount and the impairment loss is
recognized in net income or loss for the period. Where an impairment subsequently reverses, the carrying amount of the asset (or CGU)
is increased to the revised estimate of its recoverable amount, but to an amount that does not exceed the carrying amount that would
have been determined had no impairment loss been recognized for the asset (or CGU) in prior periods. A reversal of an impairment loss
is recognized in the period in which that determination was made in net income or loss.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b>Investments
</b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt"><span style="font-family: Times New Roman, Times, Serif"><b>&#160;</b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b>Investments
in uranium</b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt"><span style="font-family: Times New Roman, Times, Serif"><b>&#160;</b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Investments
in uranium are initially recorded at cost, on the date that control of the uranium passes to the Company. Cost is calculated as the purchase
price and any directly attributable expenditure. Subsequent to initial recognition, investments in uranium are measured at fair value
at each reporting period end. Fair value is determined based on the most recent month-end spot prices for uranium published by UxC LLC
(&#8220;UxC&#8221;). Related fair value gains and losses subsequent to initial recognition are recorded in the consolidated statement
of loss and comprehensive loss as a component of &#8220;Other Income (Expense)&#8221; in the period in which they arise.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Due
to the lack of specific IFRS guidance on accounting for investments in uranium, the Company considered IAS 1 Presentation of Financial
Statements and IAS 8, Accounting Policies, Changes in Accounting Estimates and Errors, to develop and apply an accounting policy that
would result in information that is most relevant to the economic decision-making needs of users within the overall IFRS accounting framework.
Consequently, the uranium investments are presented at fair value based on the application of IAS 40, Investment Property, which allows
the use of a fair value model for assets held for long-term capital appreciation.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">In
2022, the Company entered into fixed price agreements for future purchases of uranium. These agreements required the company to make
a deposit at the time of contract execution toward its future purchase. These deposits are recorded on the Company&#8217;s statement
of financial position in accordance with IFRS 9.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt"><span style="font-family: Times New Roman, Times, Serif"><b>Investments
in associates</b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt"><span style="font-family: Times New Roman, Times, Serif"><b>&#160;</b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Investments
in associates are accounted for using the equity method. The equity method involves the recording of the initial investment at cost and
the subsequent adjusting of the carrying value of the investment for the Company&#8217;s proportionate share of the earnings or loss.
The cost of the investment includes transaction costs.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Adjustments
are made to align the accounting policies of the associate with those of the Company before applying the equity method. When the Company&#8217;s
share of losses exceeds its interest in an equity-accounted investee, the carrying amount of that interest is reduced to zero, and the
recognition of further losses is discontinued except to the extent that the Company has incurred legal or constructive obligations or
made payments on behalf of the associate. If the associate subsequently reports profits, the Company resumes recognizing its share of
those profits only after its share of the profits equals the share of losses not recognized.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif"><b>&#160;</b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b>Property,
plant and equipment </b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b>&#160;</b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Useful
lives are based on the Company&#8217;s estimate at the date of acquisition and are as follows for each class of assets:</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom; ">
    <td style="border-bottom: Black 1.5pt solid; text-align: center; width: 49%"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><b>Category</b></span></p></td><td style="width: 2%; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; width: 49%; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Range</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Uranium Plants</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Straight-line over 15-25 years</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Other Property Plant and Equipment</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Straight-line over 3-5 years</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif">Software</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Straight-line over 2-3 years</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td><span style="font-family: Times New Roman, Times, Serif">Furniture</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Straight-line over 3-5 years</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif">Buildings</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Straight-line over 10-40 years</span></td></tr>
  </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b>&#160;</b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b>Uranium
plants</b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b>&#160;</b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Uranium
plant expenditures for new facilities or equipment and expenditures that extend the useful lives of existing facilities or equipment
are capitalized and recorded at cost. Depreciation on other property is computed based upon the estimated useful lives of the assets.
Repair and maintenance costs are expensed as incurred. Gain or loss on disposal of such assets is recorded as other income or expense
as such assets are disposed.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b>Other
property, plant and equipment </b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b>&#160;</b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Other
property, plant and equipment consists of office equipment, furniture and fixtures and transportation equipment. Depreciation on other
property is computed based upon the estimated useful lives of the assets. Repairs and maintenance costs are expensed as incurred. Gain
or loss on disposal of such assets is recorded as other income or expense as such assets are disposed.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b>Buildings</b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b>&#160;</b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Depreciation
on buildings is computed based upon the estimated useful lives of the asset. Repairs and maintenance costs are expensed as incurred.
Gain or loss on disposal of such assets is recorded as other income or expense as such assets are disposed.&#8195;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b>Software</b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b>&#160;</b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Software
acquired in the normal course of business through a perpetual license is capitalized and depreciated over the estimated useful life of
the asset. Support and maintenance costs are expensed as incurred. Gain or loss on disposal of such assets is recorded as other income
or expense as such assets are disposed</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif"><b>Intangible
assets</b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b>&#160;</b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Intangible
assets are recognized and measured at cost. Intangible assets with indefinite useful lives are assessed for impairment annually and whenever
there is an indication that the intangible asset may be impaired. Intangible assets that have finite useful lives are amortized over
their estimated remaining useful lives. Amortization methods and useful lives are reviewed at each reporting period and are adjusted
if appropriate.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Useful
lives are based on the Company&#8217;s estimate at the date of acquisition and are as follows for each class of assets:</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom; ">
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center; width: 49%"><span style="font-family: Times New Roman, Times, Serif">Category</span></td><td style="width: 2%; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; width: 49%; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Range</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Data Access Agreement</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Straight-line over 14 years</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Data Purchases</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Indefinite life intangible asset</span></td></tr>
  </table><p style="margin-top: 0; margin-bottom: 0"/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt"><span style="font-family: Times New Roman, Times, Serif"><b>Impairment
of non-financial assets</b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt"><span style="font-family: Times New Roman, Times, Serif"><b>&#160;</b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">At
the end of each reporting period, the Company&#8217;s assets are reviewed to determine whether there is any indication that those assets
may be impaired. If such indication exists, the recoverable amount of the asset is estimated in order to determine the extent of the
impairment, if any. The recoverable amount is the higher of fair value less costs of disposal and the value in use. Fair value is the
price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at
the measurement date. In assessing value in use, the estimated future cash flows are discounted to their present value using a pre-tax
discount rate that reflects a current market assessment of the time value of money and the risks specific to the asset. If the recoverable
amount of an asset is estimated to be less than its carrying amount, the carrying amount of the asset is reduced to its recoverable amount
and the impairment loss is recognized in profit or loss for the period. For an asset that does not generate largely independent cash
flows, the recoverable amount is determined for the cash generating unit to which the asset belongs.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">When
an impairment loss subsequently reverses, the carrying amount of the asset (or cash-generating unit) is increased to the revised estimate
of its recoverable amount, but to an amount that does not exceed the carrying amount that would have been determined had no impairment
loss been recognized for the asset (or cash generating unit) in prior years. A reversal of an impairment loss is recognized immediately
in profit or loss.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt"><span style="font-family: Times New Roman, Times, Serif"><b>Leases</b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt"><span style="font-family: Times New Roman, Times, Serif"><b>&#160;</b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">In
accordance with IFRS 16, the Company recognizes a right-of-use asset and a lease liability at the lease commencement date. The right-of-use
asset represents the Company&#8217;s right to use an underlying asset for the lease term and lease liabilities represent our obligation
to make lease payments arising from the lease. Right-of-use assets and lease liabilities are recognized at the commencement date of the
lease based on the present value of lease payments over the lease term.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b>Income
Tax</b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b>&#160;</b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Income
tax expense comprises current and deferred tax. Income tax is recognized in profit or loss except to the extent that it relates to items
recognized directly in equity. Current tax expense is the expected tax payable on taxable income for the year, using tax rates enacted
or substantively enacted at period end, adjusted for amendments to tax payable with regards to previous years.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Deferred
tax is recorded using the liability method, providing for temporary differences between the carrying amounts of assets and liabilities
for financial reporting purposes and the amounts used for taxation purposes.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Temporary
differences are not provided for the initial recognition of assets or liabilities that do not affect either accounting or taxable loss
or those differences relating to investments in subsidiaries to the extent that they are not probable to reverse in the foreseeable future.
The amount of deferred tax provided is based on the expected manner of realization or settlement of the carrying amount of assets and
liabilities, using tax rates enacted or substantively enacted at the date of the statement of financial position.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">A
deferred tax asset is recognized only to the extent that it is probable that future taxable profits will be available against which the
asset can be utilized. To the extent that the Company does not consider it probable that a deferred tax asset will be recovered, it is
not recorded.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-12</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif"><b>Foreign
currency translation</b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b>&#160;</b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">The
financial statements for the Company and each of its subsidiaries are prepared using their functional currencies. Functional currency
is the currency of the primary economic environment in which an entity operates.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Foreign
currency transactions are translated into the functional currency using the exchange rates prevailing at the date of the transaction.
Foreign currency monetary items are translated at the period-end exchange rate. Non-monetary items measured at historical cost continue
to be carried at the exchange rate at the date of the transaction. Non-monetary items measured at fair value are reported at the exchange
rate at the date when fair values were determined.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Exchange
differences arising on the translation of monetary items or on settlement of monetary items are recognized in profit or loss in the period
in which they arise, except where deferred in equity as a qualifying cash flow or net investment hedge. Exchange differences arising
on the translation of non-monetary items are recognized in other comprehensive income (loss) in the consolidated statement of loss and
comprehensive loss to the extent that gains and losses arising on those non-monetary items are also recognized in other comprehensive
income (loss). Where the non-monetary gain or loss is recognized in profit or loss, the exchange component is also recognized in profit
or loss.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">On
consolidation, the parent Company&#8217;s financial statements are translated into the presentation currency, being the U.S. Dollar.
Assets and liabilities are translated at the period-end exchange rate. Income and expenses are translated at the average exchange rate
for the period in which they arise. Exchange differences are recognized in other comprehensive income (loss) as a separate component
of equity.	</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b>Earnings
(loss) per share</b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">The
Company presents basic and diluted earnings (loss) per share (&#8220;EPS&#8221;) data for its common shares. Basic EPS is calculated
by dividing the profit or loss of the Company by the weighted average number of common shares outstanding during the year, adjusted for
own shares held. Diluted EPS is determined by dividing the profit or loss attributable to common shareholders by the weighted average
number of common shares outstanding, adjusted for own shares held and for the effects of all potential dilutive common shares related
to outstanding stock options and warrants issued by the Company for the years presented, except if their inclusion proves to be anti-dilutive.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif"><b>Share-based
payments</b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">The
fair value of all stock options granted to directors, officers, and employees is recorded as a charge to operations and a credit to contributed
surplus. The fair value of these stock options is measured at the grant date using the Black-Scholes option pricing model. The fair value
of stock options which vest immediately is recorded at the grant date. For stock options which vest in the future, the fair value of
stock options, as adjusted for the expected level of vesting of the stock options and the number of stock options which ultimately vest,
is recognized over the vesting period. Stock options granted to non-employees are measured at the fair value of goods or services rendered
or at the fair value of the instruments issued if it is determined that the fair value of the goods or services received cannot be reliably
measured. The number of shares and options expected to vest is reviewed and adjusted at the end of each reporting period such that the
amount recognized for services received as consideration for the equity instruments granted shall be based on the number of equity instruments
that eventually vest.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Warrants
issued to brokers are measured at their fair value on the vesting date and are recognized as a deduction from equity and credited to
contributed surplus. The fair value of stock options and warrants issued to brokers are estimated using the Black-Scholes option pricing
model. Any consideration received on the exercise of stock options and/or warrants, together with the related portion of contributed
surplus, is credited to share capital.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif"><b>&#160;</b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt"><span style="font-family: Times New Roman, Times, Serif"><b>Warrants
issued in equity financing transactions</b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">The
Company engages in equity financing transactions to obtain the funds necessary to continue operations and explore its exploration and
evaluation assets. These equity financing transactions may involve the issuance of common shares or units. Each unit comprises a certain
number of common shares and a certain number of share purchase warrants.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Depending
on the terms and conditions of each equity financing agreement, the Warrants are exercisable into additional common shares at a price
prior to expiry as stipulated by the agreement. Warrants that are part of units are valued based on the residual value method. Warrants
that are issued as payment for agency fees or other transactions costs are accounted for as share-based payments.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif"><b>Financial
instruments </b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b>&#160;</b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">The
Company classifies its financial instruments in the following categories: at fair value through profit and loss (&#8220;FVTPL&#8221;),
at fair value through other comprehensive income (loss) (&#8220;FVTOCI&#8221;), or at amortized cost. The Company determines the classification
of financial assets at initial recognition. The classification of debt instruments is driven by the Company&#8217;s business model for
managing the financial assets and their contractual cash flow characteristics. Equity instruments that are held for trading are classified
as FVTPL. For other equity instruments, on the day of acquisition the Company can make an irrevocable election (on an instrument-by instrument
basis) to designate them as at FVTOCI. Financial liabilities are measured at amortized cost, unless they are required to be measured
at FVTPL (such as instruments held for trading or derivatives) or the Company has opted to measure them at FVTPL.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Financial
assets and liabilities carried at FVTPL are initially recorded at fair value and transaction costs are expensed in profit or loss. Realized
and unrealized gains and losses arising from changes in the fair value of the financial assets and liabilities held at FVTPL are included
in the consolidated statements of loss and comprehensive loss in the period in which they arise.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif"><b>Impairment
of financial assets at amortized cost</b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b>&#160;</b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">An
&#8216;expected credit loss&#8217; impairment model applies which requires a loss allowance to be recognized based on expected credit
losses. The estimated present value of future cash flows associated with the asset is determined and an impairment loss is recognized
for the difference between this amount and the carrying amount as follows: the carrying amount of the asset is reduced to estimated present
value of the future cash flows associated with the asset, discounted at the financial asset&#8217;s original effective interest rate,
either directly or through the use of an allowance account and the resulting loss is recognized in profit or loss for the period.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">In
a subsequent period, if the amount of the impairment loss related to financial assets measured at amortized cost decreases, the previously
recognized impairment loss is reversed through profit or loss to the extent that the carrying amount of the investment at the date the
impairment is reversed does not exceed what the amortized cost would have been had the impairment not been recognized.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 36pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 36pt"><span style="font-family: Times New Roman, Times, Serif">The
Company&#8217;s mineral property interest impairment policy is more specifically discussed above.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 36pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt"><span style="font-family: Times New Roman, Times, Serif"><b>Derecognition
of financial assets</b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt"><span style="font-family: Times New Roman, Times, Serif"><b>&#160;</b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">The
Company derecognizes financial assets only when the contractual rights to cash flows from the financial assets expire, or when it transfers
the financial assets and substantially all of the associated risks and rewards of ownership to another entity. Gains and losses on derecognition
are generally recognized in profit or loss</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-14</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b>New
standards and interpretations not yet adopted</b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">The
following new standards, amendments to standards and interpretations have been issued but are not effective during the year ended
December 31, 2022:</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">The
following amendments will be in effect for annual reporting periods beginning on or after January 1, 2023:</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Disclosure
of Accounting Policies (Amendments to IAS 1 and IFRS Practice Statement 2) &#8211; the amendments </span>require that an entity
discloses its material accounting policies, instead of its significant accounting policies. <span style="font-family: Times New Roman, Times, Serif">Further
amendments explain how an entity can identify a material accounting policy.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Definition
of Accounting Estimates (Amendments to IAS 8) &#8211; the amendments replace the definition of a change in accounting estimates with
a definition of accounting estimates. Under the new definition, accounting estimates are &#8220;monetary amounts in financial
statements that are subject to measurement uncertainty&#8221;. Entities develop accounting estimates if accounting policies require
items in financial statements to be measured in a way that involves measurement uncertainty. The amendments clarify that a change in
accounting estimate that results from new information or new developments is not the correction of an error.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">The
Company does not anticipate that these amendments will have a material impact on the results of operations and financial position of
the Company.</span></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cve_SignificantaccountingpoliciesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cve_SignificantaccountingpoliciesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cve_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for significant accounting policies applied by the entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2023-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2022-03-24<br> -Paragraph 117<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_117&amp;doctype=Standard<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>59
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139782928298400">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Critical Accounting Estimates And Judgements<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_CriticalAccountingEstimatesAndJudgementsLineItems', window );"><strong>Critical accounting estimates and judgements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfAccountingJudgementsAndEstimatesExplanatory', window );">Critical accounting estimates and judgements</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%"><tr style="vertical-align: top">
<td style="width: 18pt"/><td style="width: 18pt"><span style="font-family: Times New Roman, Times, Serif"><b>3.</b></span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b>Critical
                                            accounting estimates and judgements</b></span></td></tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">The
preparation of financial statements in conformity with IFRS requires management to use judgment in applying its accounting policies and
estimates and assumptions about the future. Estimates and other judgments are continuously evaluated and are based on management&#8217;s
experience and other factors, including expectations about future events that are believed to be reasonable under the circumstances.
Although management uses historical experience and its best knowledge of the expected amounts, events or actions to form the basis for
estimates, actual results may differ from these estimates.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b>&#160;</b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b>Critical
accounting estimates:</b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b>&#160;</b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b>The
assessment of the recoverable amount of mineral properties as a result of impairment indicators - </b>When indicators of impairment are
identified, recoverable amount calculations are based either on discounted estimated future cash flows or on comparable recent transactions.
The assumptions used are based on management&#8217;s best estimates of what an independent market participant would consider appropriate.
Changes in these assumptions may alter the results of impairment testing, the amount of the impairment charges recorded in the statement
of loss and comprehensive loss and the resulting carrying values of assets.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b>&#160;</b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b>Share-based
payments -</b> The fair value of stock options issued is subject to the limitation of the Black-Scholes option pricing model that incorporates
market data and involves uncertainty in estimates used by management in the assumptions. Because the Black-Scholes option pricing model
requires the input of highly subjective assumptions, including the volatility of share prices, changes in subjective input assumptions
can materially affect the fair value estimate.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b>&#160;</b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b>Asset
retirement obligations -</b> Significant estimates were utilized in determining future costs to complete groundwater restoration, plugging
and abandonment of wellfields and surface reclamation at the Company&#8217;s uranium in-situ recovery (ISR) sites. Estimating future
costs can be difficult and unpredictable as they are based principally on current legal and regulatory requirements and ISR site closure
plans that may change materially. The laws and regulations governing ISR site closure and remediation in a particular jurisdiction are
subject to review at any time and may be amended to impose additional requirements and conditions which may cause our provisions for
environmental liabilities to be underestimated and could materially affect our financial position or results of operations. Estimates
of future asset retirement obligation costs are also subject to operational risks such as acceptability of treatment techniques or other
operational changes.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b>Recovery
of deferred tax assets -</b> Judgment is required in determining whether deferred tax assets are recognized in the statement of financial
position. Deferred tax assets, including those arising from unutilized tax losses, require management to assess the likelihood that the
Company will generate taxable earnings in future periods in order to utilize recognized deferred tax assets. Estimates of future taxable
income are based on forecast cash flows from operations and the application of existing tax laws in each jurisdiction. To the extent
that future cash flows and taxable income differ significantly from estimates, the ability of the Company to realize the net deferred
tax assets recorded at the date of the statement of financial position could be impacted. Additionally, future changes in tax laws in
the jurisdictions in which the Company operates could limit the ability of the Company to obtain tax deductions in future periods. The
Company has not recorded any deferred tax assets.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b>&#160;</b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b>Amortization
and impairment of intangible assets - </b>Amortization of intangible assets is dependent upon the estimated useful lives, which are determined
through the exercise of judgement. The assessment of any impairment of these assets is dependent upon estimates of recoverable amounts
that take into account factors such as economic and market conditions and the useful lives of assets.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 36pt"><span style="font-family: Times New Roman, Times, Serif"><b>Critical
accounting judgments:</b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 36pt"><span style="font-family: Times New Roman, Times, Serif"><b>&#160;</b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b>The
assessment of indicators of impairment for mineral properties - </b>The Company follows the guidance of IFRS 6 to determine when a mineral
property asset is impaired. This determination requires significant judgment. In making this judgment, the Company evaluates, among other
factors, the results of exploration and evaluation activities to date and the Company&#8217;s future plans to explore and evaluate a
mineral property.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b>Valuation
of acquired mineral properties &#8211;</b> The valuation of mineral properties acquired by the Company requires significant judgement.
Acquired mineral properties are valued at their fair market value which can require significant estimates in future cash flows, production,
and timing.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b>&#160;</b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b>Business
combinations -</b> The determination of whether a set of assets acquired and liabilities assumed constitute a business may require the
Company to make certain judgments, taking into account all facts and circumstances. A business is presumed to be an integrated set of
activities and assets capable of being conducted and managed for the purpose of providing a return in the form of dividends, lower costs
or economic benefits. The acquisition of Azarga Uranium Corporation and its subsidiary entities on December 31, 2021 (Note 10) was determined
to constitute an acquisition of assets.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b>&#160;</b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b>Determination
of functional currency -</b> In accordance with IAS 21, The Effects of Changes in Foreign Exchange Rates, management determined that
the functional currency of the Company is the Canadian dollar and the functional currency of its subsidiaries is the U.S. Dollar.</span></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cve_CriticalAccountingEstimatesAndJudgementsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cve_CriticalAccountingEstimatesAndJudgementsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cve_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfAccountingJudgementsAndEstimatesExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of judgements that management has made in the process of applying the entity's accounting policies that have the most significant effect on amounts recognised in the financial statements along with information about the assumptions that the entity makes about the future, and other major sources of estimation uncertainty at the end of the reporting period, that have a significant risk of resulting in a material adjustment to the carrying amounts of assets and liabilities within the next year. [Refer: Carrying amount [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2022-03-24<br> -Paragraph 10<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_10_e&amp;doctype=Standard<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfAccountingJudgementsAndEstimatesExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>60
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139782931112752">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Investment In Associate<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_InvestmentInAssociateLineItems', window );"><strong>Investment In Associate [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesExplanatory', window );">Investment in associate</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif"><b>4.</b></span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b>Investment
                                            in associate</b></span></td></tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b>&#160;</b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">During
the year ended December 31, 2020, the Company acquired 12,000,000 shares of Group 11 Technologies Inc. (&#8220;Group 11&#8221;), a US-based
technology firm, representing 40% of the issued and outstanding shares of Group 11. The Company advanced $750,000 in accordance with
the Letter of Intent with EnviroLeach Technologies Inc. and Golden Predator Mining Corp. to establish Group 11. The Company has determined
that it exercises significant influence over Group 11 and accounts for this investment using the equity method of accounting. During
the year ended December 31, 2021, Group 11 completed a private placement financing, resulting in the issuance of additional shares and
a dilution of the Company&#8217;s ownership in the associate to 34.46%. During the year ended December 31, 2022, Group 11 issued additional
shares resulting in the dilution of the Company&#8217;s ownership in the associate to 33.71%.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">As
of December 31, 2022, Group 11 has severely constrained its activities as financing is unavailable in its market. The Company, determined
its investment to be unrecoverable and wrote off the balance of its investment.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 18pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 18pt; text-indent: 18pt"><span style="font-family: Times New Roman, Times, Serif">The
Company&#8217;s proportional share in the associate at the last available date, June 30<sup>th</sup>, 2022, is as follows:</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 18pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td style="padding-left: 0.125in; text-align: center">&#160;</td><td style="text-align: center">&#160;</td>
    <td colspan="2" style="text-align: center">Assets</td><td style="text-align: center">&#160;</td><td style="text-align: center">&#160;</td>
    <td colspan="2" style="text-align: center">Liabilities</td><td style="text-align: center">&#160;</td><td style="text-align: center">&#160;</td>
    <td colspan="2" style="text-align: center">Revenues</td><td style="text-align: center">&#160;</td><td style="text-align: center">&#160;</td>
    <td colspan="2" style="text-align: center">Expenses</td><td style="text-align: center">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center; padding-left: 0.125in">&#160;</td><td style="text-align: center">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">$</td><td style="text-align: center; padding-bottom: 1.5pt">&#160;</td><td style="text-align: center">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">$</td><td style="text-align: center; padding-bottom: 1.5pt">&#160;</td><td style="text-align: center">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">$</td><td style="text-align: center; padding-bottom: 1.5pt">&#160;</td><td style="text-align: center">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">$</td><td style="text-align: center; padding-bottom: 1.5pt">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-indent: -0.125in">Year ended December 31, 2021</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.25in; text-indent: -0.125in; width: 52%">Current</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">1,078,019</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">120,569</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-106">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;-</div></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-107">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;-</div></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.25in; text-indent: -0.125in">Non-current</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">751,065</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-108">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-109">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-110">-</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.25in; text-indent: -0.125in; text-align: left; padding-bottom: 1.5pt">Loss from operating expenses</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-111">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-112">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-113">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(755,943</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 1.5pt">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">1,829,084</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">120,569</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-114">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(755,943</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-indent: -0.125in; font-weight: bold">Year ended December 31, 2022</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.25in; text-indent: -0.125in">Current</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">609,704</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">39,259</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-115">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-116">-</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.25in; text-indent: -0.125in">Non-current</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">729,261</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-117">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-118">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-119">-</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.25in; text-indent: -0.125in; text-align: left; padding-bottom: 1.5pt">Loss from operating expenses</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-120">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-121">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-122">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(415,769</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 1.5pt">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">1,338,965</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">39,259</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-123">-</div></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">(415,769</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-indent: -0.125in; font-weight: bold; text-align: left; padding-bottom: 1.5pt">The Company&#8217;s percentage ownership</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">33.71</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">%</td></tr>
  </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 18pt"/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt"><span style="font-family: Times New Roman, Times, Serif">The
investment in associate continuity summary is as follows:</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 18pt; text-align: center; text-indent: 18pt"/><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="text-align: center">&#160;</td>
    <td colspan="2" style="text-align: center">Investment in <br/> associate</td><td style="text-align: center">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="text-align: center">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">$</td><td style="text-align: center; padding-bottom: 1.5pt">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 88%; padding-bottom: 1.5pt">Balance, December 31, 2020</td><td style="width: 1%">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; width: 9%; text-align: right">451,221</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Adjustments to carrying value:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in">Proportionate share of net loss</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(260,055</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-align: left">Adjustment to investment in Group 11</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">469,320</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-align: left">Dilution loss</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(95,680</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-align: left; padding-bottom: 1.5pt">Currency translation adjustment</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(466</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-bottom: 1.5pt">Balance, December 31, 2021</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">564,340</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Adjustments to carrying value:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in">Proportionate share of net loss through June 30</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(143,286</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-align: left">Adjustment to investment in Group 11 through June 30</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">15,675</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in">Write-off of investment</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(443,614</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-align: left; padding-bottom: 1.5pt">Currency translation adjustment</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">6,885</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; padding-bottom: 1.5pt">Balance, December 31, 2022</td><td style="font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">-</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cve_InvestmentInAssociateLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cve_InvestmentInAssociateLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cve_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of associates. [Refer: Associates [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 27<br> -IssueDate 2022-03-24<br> -Paragraph 17<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=27&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_17_b&amp;doctype=Standard<br> -URIDate 2022-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 27<br> -IssueDate 2022-03-24<br> -Paragraph 16<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=27&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_16_b&amp;doctype=Standard<br> -URIDate 2022-03-24<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2022-03-24<br> -Paragraph B4<br> -Subparagraph d<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_B4_d&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>61
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139782929200512">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Investment in uranium<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_DisclosureOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethodTextBlockAbstract', window );"><strong>Disclosure Of Investments Other Than Investments Accounted For Using Equity Method Text Block Abstract</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethodExplanatory', window );">Investment in uranium</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif"><b>5.</b></span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b>Investment
                                            in uranium</b></span></td></tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -18pt"><span style="font-family: Times New Roman, Times, Serif"><b>&#160;</b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">During
the year ended December 31, 2021, the Company entered into purchase agreements to acquire a total of 300,000 pounds of physical uranium
as U<sub>3</sub>O<sub>8</sub> for a total of $9,076,000 including associated expenses to be held as a long-term investment. </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">During
the year ended December 31, 2021, the Company sold 200,000 pounds of physical uranium as U<sub>3</sub>O<sub>8</sub> for gross proceeds
of $6,975,000 and a gain of $524,075.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">During
the year ended December 31, 2022, the Company sold 100,000 pounds of physical uranium as U<sub>3</sub>O<sub>8</sub> for gross proceeds
of $4,245,000 and a gain of $35,000.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Investments
in uranium are categorized in Level 2 of the fair value hierarchy (Note 17).</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">The
following table summarizes the fair value of the physical uranium investment:</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify">&#160;</p><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">Investment in<br/> uranium</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="text-align: center">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">$</td><td style="text-align: center; padding-bottom: 1.5pt">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1.5pt">Balance, December 31, 2020</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-124">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 88%; text-align: left">Physical uranium</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">9,076,000</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td>Fair value adjustment</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,554,000</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Gain on sale of uranium</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">524,075</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Sale of uranium investment</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(6,975,000</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">Currency translation adjustment</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">30,925</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-bottom: 1.5pt">Balance, December 31, 2021</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">4,210,000</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Sale of uranium investment</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(4,245,000</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Gain on sale of uranium</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">35,000</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt">Currency translation adjustment</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-125">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; padding-bottom: 1.5pt">Balance, December 31, 2022</td><td style="font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-126">-</div></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b>Deposits
on uranium investment:</b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b>&#160;</b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">On
February 15, 2022, the Company entered into a Uranium Concentrates purchase Agreement with an arm&#8217;s length party whereby the Company
will purchase 200,000 pounds of uranium concentrate from the seller for total consideration of $8,750,000 ($43.75/pound). The contract
required an initial payment of $2,000,000, which was paid in March 2022, and will require a final payment of $6,750,000 on March 31,
2023.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">On
August 4, 2022, the Company entered into a Uranium Concentrates purchase Agreement with an arm&#8217;s length party whereby the Company
will purchase 100,000 pounds of uranium concentrate from the seller for total consideration of $4,900,000 ($49.00/pound). The contract
required an initial payment of $1,000,000, which was paid in August 2022, and will require a final payment of $3,900,000 two days prior
to the delivery date, which shall occur between May 1, 2023 and August 31, 2023.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">On
December 15, 2022, the Company entered into a Uranium concentrates purchase agreement with an arm&#8217;s length party whereby the Company
will purchase 100,000 pounds of uranium concentrate from the seller for total consideration of $5,922,500 ($59.225/pound) in January
2023.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td style="padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 1.5pt; text-align: center">&#160;</td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Purchase Commitments in Pounds</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Total Purchase Price</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; width: 76%">Fiscal 2023</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">400,000</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">19,572,500</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-indent: -0.125in">Fiscal 2024</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-127">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-128">-</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in">Fiscal 2025</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-129">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-130">-</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-indent: -0.125in">Fiscal 2026</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-131">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-132">-</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in">Fiscal 2027</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-133">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-134">-</div></td><td style="text-align: left">&#160;</td></tr>
  </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cve_DisclosureOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethodTextBlockAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cve_DisclosureOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethodTextBlockAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cve_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethodExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of investments other than investments accounted for using the equity method. [Refer: Investments other than investments accounted for using equity method]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2022-03-24<br> -Paragraph 10<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_10_e&amp;doctype=Standard<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethodExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>62
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139782921380736">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Marketable Securities<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesLineItems', window );"><strong>Marketable Securities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfMarketRiskExplanatory', window );">Marketable securities</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif"><b>6.</b></span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b>Marketable
                                            securities</b></span></td></tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -18pt"><span style="font-family: Times New Roman, Times, Serif"><b>&#160;</b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">In
May 2022, the Company divested of Cibola Resources, LLC to Elephant Capital (&#8220;Elephant&#8221;) pursuant to a Share Purchase Agreement
whereby the Company received consideration in the form of 11,308,250 common shares with a market value of $0.27 per share. Elephant was
subsequently acquired by Evolving Gold, who renamed themselves American Future Fuel Corp (&#8220;AFFC&#8221;). Accordingly, the 11,308,250
shares of Elephant were converted to 11,308,250 shares of AFFC (CSE: AMPS).</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">The
cost base of the Company&#8217;s shareholdings is $3,085,965. In accordance with the Company&#8217;s significant accounting policy, the
common shares are classified as FVTPL, with gains/losses being recognized to the consolidated statements of loss and comprehensive loss.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">As
of December 31, 2022, 9,046,600 of the shares held are free trading (the &#8220;Trading Shares&#8221;) or will become free trading within
the next 12 months. These shares have been classified as a current asset on the consolidated statements of financial position, due to
the Company&#8217;s ability to liquidate those shareholdings within the next 12 months. These shares are carried at a fair value of $3,139,325
($0.35 per share).</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">The
Final 2,261,650 Released Shares are presented as a non-current asset due to the fact that the escrow provisions restrict the Company&#8217;s
ability to dispose of the securities within the next 12 months and are carried at a fair value of $784,832 ($0.35 per share).</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">In
October 2022, the Company received 80,000 common shares of Uravan Minerals, Inc with a market value of $0.12 per share pursuant to its
previous agreement with Prime Fuels, Inc to divest of the Company&#8217;s LS mining claims. The agreement required that Prime Fuels,
Inc pay to the Company 10% of any consideration Prime Fuels, Inc received upon sale, transfer, or exchange to a third party. Uravan Minerals,
Inc acquired Prime Fuels, Inc and all of the mineral claims on October 28, 2022. The cost base of the Company&#8217;s shareholdings is
$9,530. The shares have been classified as a current asset on the consolidated statements of financial position, due to the Company&#8217;s
ability to liquidate those shareholdings within the next 12 months. These shares are carried at a fair value of $23,036 ($0.30 per share).</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">The
following table summarizes the fair value of the Company&#8217;s marketable securities at December 31, 2022:</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="text-align: center; font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Marketable<br/> securities (current)</td><td style="text-align: center; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Marketable<br/> securities (non-current)</td><td style="text-align: center; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Total</td><td style="text-align: center; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">$</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">$</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">$</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%; padding-bottom: 1.5pt">Balance, December 31, 2020, and 2021</td><td style="border-bottom: Black 1.5pt solid; width: 1%">&#160;</td>
    <td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-135">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;-</div></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-136">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;-</div></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-137">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;-</div></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Additions</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,443,094</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">608,391</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3,051,485</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td>Fair value adjustments</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">848,814</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">208,592</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,057,406</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">Currency translation adjustment</td><td style="border-bottom: Black 1.5pt solid">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(129,547</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(32,151</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(161,698</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font-weight: bold; padding-bottom: 1.5pt">Balance, December 31, 2022</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">3,162,361</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">784,832</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">3,947,193</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfMarketRiskExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of market risk. [Refer: Market risk [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2022-03-24<br> -Paragraph 10<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_10_e&amp;doctype=Standard<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfMarketRiskExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MarketableSecuritiesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MarketableSecuritiesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>63
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139782924623808">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Intangible assets<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_IntangibleassetsLineItems', window );"><strong>Intangible assets [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfIntangibleAssetsExplanatory', window );">Intangible assets</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif"><b>7.</b></span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b>Intangible
                                            assets</b></span></td></tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -18pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">In
2018, the Company acquired access to certain uranium exploration data from VANE Minerals (US) LLC (&#8220;VANE&#8221;). In exchange the
Company issued 3,000,000 common shares at a fair value of $264,096 and granted VANE certain back-in rights for any projects developed
from the use of the data. The primary term of the agreement is five years, and it may be renewed by the Company by written notice for
three successive renewal periods of three years each. Thus, the intangible asset has been determined to have a life of 14 years.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">In
2020, for $67,251 the Company permanently acquired certain electronic data pertaining to properties and geology in South Texas from Signal
Equities, LLC. The intangible asset was determined to have an indefinite life and therefore is not being amortized but reviewed for impairment
annually and more frequently if required.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">In
2020, the Company permanently acquired the Grants Mineral Belt database through its asset acquisition with Westwater Resources, Inc.
The intangible asset was determined to have an indefinite life and therefore is not being amortized but reviewed for impairment annually
and more frequently if required.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">In
2021, the Company permanently acquired additional borehole logs for the Grants Mineral Belt property for $17,500. The intangible asset
was determined to have an indefinite life and therefore is not being amortized but reviewed for impairment annually or more frequently
if required.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">In
2022, the Company acquired access to the Getty Minerals Database from Platoro West Incorporated for $55,500 (Note 15). The intangible
asset was determined to have an indefinite life and therefore is not being amortized but reviewed for impairment annually and more frequently
if required.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td style="padding-left: 0.125in; text-align: center">&#160;</td><td style="text-align: center; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">VANE<br/> Agreement<br/> $</td><td style="text-align: center; padding-bottom: 1.5pt">&#160;</td><td style="text-align: center; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">Getty<br/> Database<br/> $</td><td style="text-align: center; padding-bottom: 1.5pt">&#160;</td><td style="text-align: center; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">Signal<br/> Equities<br/> Database<br/> $</td><td style="text-align: center; padding-bottom: 1.5pt">&#160;</td><td style="text-align: center; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">Grants<br/> Mineral Belt<br/> Database<br/> $</td><td style="text-align: center; padding-bottom: 1.5pt">&#160;</td><td style="text-align: center; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">Total<br/> $</td><td style="text-align: center; padding-bottom: 1.5pt">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; width: 40%">Balance, December 31, 2020</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">226,368</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">-</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">67,251</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">190,012</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">483,631</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-indent: -0.125in">Additions</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">17,500</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">17,500</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in">Amortization</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(20,515</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(20,515</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left; padding-bottom: 1.5pt">Currency Translation Adjustment</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">1,651</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">9,729</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">11,380</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 1.5pt">Balance, December 31, 2021</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">207,504</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">67,251</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">217,241</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">491,996</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-indent: -0.125in">Additions</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">55,500</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">55,500</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in">Amortization</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(19,764</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(19,764</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left; padding-bottom: 1.5pt">Currency Translation Adjustment</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">900</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(350</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">550</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; font-weight: bold; padding-bottom: 1.5pt">Balance, December 31, 2022</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">188,640</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">55,150</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">67,251</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">217,241</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">528,282</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cve_IntangibleassetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cve_IntangibleassetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cve_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfIntangibleAssetsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for intangible assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 38<br> -IssueDate 2022-03-24<br> -Section Disclosure<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=38&amp;code=ifrs-tx-2022-en-r&amp;doctype=Standard&amp;dita_xref=IAS38_g118-128__IAS38_g118-128_TI<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfIntangibleAssetsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>64
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139782928988608">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Property, plant, and equipment<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_DisclosureOfPropertyPlantAndEquipmentTextBlockAbstract', window );"><strong>Schedule of property, plant, and equipment [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfPropertyPlantAndEquipmentExplanatory', window );">Property, plant, and equipment</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif"><b>8.</b></span></td><td><span style="font-family: Times New Roman, Times, Serif"><b>Property,
                                            plant, and equipment</b></span></td></tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-indent: -18pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="text-align: center; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">Uranium<br/> plants<br/> $</td><td style="text-align: center; padding-bottom: 1.5pt">&#160;</td><td style="text-align: center; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">Other property,<br/> plant, and equipment<br/> $</td><td style="text-align: center; padding-bottom: 1.5pt">&#160;</td><td style="text-align: center; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">Furniture<br/> $</td><td style="text-align: center; padding-bottom: 1.5pt">&#160;</td><td style="text-align: center; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">Buildings<br/> $</td><td style="text-align: center; padding-bottom: 1.5pt">&#160;</td><td style="text-align: center; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">Software<br/> $</td><td style="text-align: center; padding-bottom: 1.5pt">&#160;</td><td style="text-align: center; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">Total<br/> $</td><td style="text-align: center; padding-bottom: 1.5pt">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 28%">Balance, December 31, 2020</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">1,196,108</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">288,728</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-138">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;-</div></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-139">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;-</div></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-140">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;-</div></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">1,484,836</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td>Additions</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">282,339</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-141">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">16,471</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">62,946</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-142">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">361,756</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Disposals</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-143">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-144">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-145">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-146">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-147">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-148">-</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in">Depreciation</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(168,932</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(73,980</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(2,146</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-149">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-150">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(245,058</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in">Impairment</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-151">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-152">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-153">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-154">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-155">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-156">-</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Currency translation adjustment</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-157">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-158">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,145</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-159">&#160;</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-160">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,145</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1.5pt">Balance, December 31, 2021</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">1,309,515</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">214,748</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">16,470</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">62,946</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-161">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">1,603,679</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-bottom: 1.5pt">Additions</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">758,747</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">172,198</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">8,507</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-162">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">60,135</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">999,587</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Disposals</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-163">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-164">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-165">&#160;</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-166">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-167">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-168">-</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in">Depreciation</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(162,208</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(78,646</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(4,377</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(2,316</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(21,298</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(268,845</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in">Impairment</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-169">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-170">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-171">&#160;</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-172">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-173">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-174">-</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt">Currency translation adjustment</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-175">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-176">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-177">&#160;</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-178">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-179">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-180">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; padding-bottom: 1.5pt">Balance, December 31, 2022</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">1,906,054</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">308,300</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">20,600</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">60,630</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">38,837</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">2,334,421</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cve_DisclosureOfPropertyPlantAndEquipmentTextBlockAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cve_DisclosureOfPropertyPlantAndEquipmentTextBlockAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cve_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfPropertyPlantAndEquipmentExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for property, plant and equipment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 16<br> -IssueDate 2022-03-24<br> -Section Disclosure<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=16&amp;code=ifrs-tx-2022-en-r&amp;doctype=Standard&amp;dita_xref=IAS16_g73-79__IAS16_g73-79_TI<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfPropertyPlantAndEquipmentExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>65
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139782929045168">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Right-of-use assets<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_RightofuseassetsLineItems', window );"><strong>Right-of-use assets [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsExplanatory', window );">Right-of-use assets</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%"><tr style="vertical-align: top">
<td style="width: 18pt"/><td style="width: 18pt"><span style="font-family: Times New Roman, Times, Serif"><b>9.</b></span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b>Right-of-use
                                            assets</b></span></td></tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -18pt"><span style="font-family: Times New Roman, Times, Serif"><b>&#160;</b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif">The
Company had a contractual arrangement to lease a copier through August 8, 2022.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">In
2021, the Company entered a contractual agreement to lease office space in Corpus Christi, Texas through June 30, 2025. The terms of
the lease call for a monthly lease payment of $5,417. The Company recorded a right-of use (&#8220;ROU&#8221;) asset based on the corresponding
lease obligation of $221,139 on July 1, 2021.When measuring the present value of lease obligations, the remaining lease payments were
discounted using the estimated borrowing rate of 7%.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">In
2021, the Company acquired a contractual agreement to lease additional office space in Vancouver, B.C. through July 10, 2023. The terms
of the lease call for a monthly payment of $4,068 CAD. The Company recorded an ROU asset based on that corresponding lease obligation
of $45,444. When measuring the present value of lease obligations, the Company discounted the remaining lease payments using the estimated
borrowing rate of 7%.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">In
2022, the Company entered a contractual agreement to lease office space in Corpus Christi, Texas through August 31, 2024. The terms of
the lease call for a monthly lease payment of $1,640. The Company recorded an ROU asset based on the corresponding lease obligation of
$34,898 on September 1, 2022. When measuring the present value of lease obligations, the remaining lease payments were discounted using
the Company&#8217;s estimated borrowing rate of 7%.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
change in the ROU assets during the years ended December 31, 2021 and December 31, 2022 was as follows:</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td style="text-align: center; padding-bottom: 1.5pt">&#160;</td><td style="text-align: center; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">Leased copier<br/> $</td><td style="text-align: center; padding-bottom: 1.5pt">&#160;</td><td style="text-align: center; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">Leased offices<br/> $</td><td style="text-align: center; padding-bottom: 1.5pt">&#160;</td><td style="text-align: center; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">Total<br/> $</td><td style="text-align: center; padding-bottom: 1.5pt">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%">Balance, December 31, 2020</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">8,867</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-181">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;-</div></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">8,867</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td>Additions</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-182">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">266,583</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">266,583</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Depreciation</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(5,451</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(27,642</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(33,093</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt">Currency translation adjustment</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-183">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">2,207</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">2,207</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1.5pt">Balance, December 31, 2021</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">3,416</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">241,148</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">244,564</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td>Additions</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-184">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">34,898</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">34,898</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Depreciation</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(3,416</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(88,311</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(91,727</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt">Currency translation adjustment</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-185">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(2,121</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(2,121</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; padding-bottom: 1.5pt">Balance, December 31, 2022</td><td style="font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-186">-</div></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">185,614</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">185,614</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">The
change in the Long-Term lease liability during the years ended December 31, 2021 and December 31, 2022 was as follows:</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td style="text-align: center; padding-bottom: 1.5pt">&#160;</td><td style="text-align: center; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">Leased copier<br/> $</td><td style="text-align: center; padding-bottom: 1.5pt">&#160;</td><td style="text-align: center; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">Leased offices<br/> $</td><td style="text-align: center; padding-bottom: 1.5pt">&#160;</td><td style="text-align: center; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">Total<br/> $</td><td style="text-align: center; padding-bottom: 1.5pt">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%">Balance, December 31, 2020</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">8,867</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-187">&#160;&#160;&#160;&#160;&#160;&#160;-</div></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">8,867</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td>Additions</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-188">&#160;</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">273,001</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">273,001</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Accretion</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-189">&#160;</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">7,471</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">7,471</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Lease payments made</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(5,451</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(32,137</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(37,588</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">Currency translation adjustment</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-190">&#160;</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(2,242</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(2,242</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-bottom: 1.5pt">Balance, December 31, 2021</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">3,416</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">246,093</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">249,509</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Additions</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-191">&#160;</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">34,898</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">34,898</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td>Accretion</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">77</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">15,157</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">15,234</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Lease payments made</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(3,493</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(103,953</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(107,446</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt">Currency translation adjustment</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-192">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(11,767</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(11,767</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; padding-bottom: 1.5pt">Balance, December 31, 2022</td><td style="font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-193">-</div></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">180,428</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">180,428</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt">Less: current lease liability</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-194">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(84,262</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(84,262</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; padding-bottom: 1.5pt">Balance (Long Term), December 31, 2022</td><td style="font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-195">-</div></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">96,166</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">96,166</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt"><span style="font-family: Times New Roman, Times, Serif">As
of December 31, 2022, the undiscounted future lease payments are as follows:</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom; ">
    <td style="border-bottom: Black 1.5pt solid; width: 88%; font-weight: bold; text-align: left">Year</td><td style="width: 1%; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; width: 1%; padding-bottom: 1.5pt; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; width: 9%; font-weight: bold; text-align: right">&#160;&#160;&#160;&#160;&#160;&#160;&#160;</td><td style="width: 1%; padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">2023</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">127,967</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">2024</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">81,267</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">2025</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">32,502</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt">Total</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">241,736</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cve_RightofuseassetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cve_RightofuseassetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cve_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of quantitative information about right-of-use assets. [Refer: Right-of-use assets]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 16<br> -IssueDate 2022-03-24<br> -Paragraph 53<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=16&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_53&amp;doctype=Standard<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>66
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139782928985184">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Asset acquisition<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_DisclosureOfTransactionsRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombinationTextBlockAbstract', window );"><strong>Disclosure Of Transactions Recognised Separately From Acquisition Of Assets And Assumption Of Liabilities In Business Combination Text Block Abstract</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTransactionsRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombinationExplanatory', window );">Asset acquisition</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif"><b>10.</b></span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b>Asset
                                            acquisition</b></span></td></tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -18pt"><span style="font-family: Times New Roman, Times, Serif"><b>&#160;</b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">During
the year ended December 31, 2021, the Company, and Azarga Uranium Corporation (&#8220;Azarga&#8221;) entered into an Arrangement Agreement
pursuant to which the Company acquired all of the issued and outstanding common shares of Azarga by way of a statutory Plan of Arrangement
under the Canada Business Corporations Act (the &#8220;Arrangement&#8221;). Pursuant to the terms of the Arrangement, securityholders
of Azarga received 0.375 common shares of enCore for each Azarga common share (the &#8220;Exchange Ratio&#8221;).</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">In
connection with the Arrangement, all outstanding vested and unvested stock options and share purchase warrants of Azarga were exchanged
for replacement options and warrants of enCore, adjusted for the Exchange Ratio.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">The
aggregate amount of the total consideration was $132,294,625 calculated by taking into account: the issuance of 31,806,617 enCore common
shares (the &#8220;Share Consideration&#8221;) valued at $120,422,593, the issuance of 1,828,960 enCore stock options (the &#8220;Replacement
Options&#8221;) in replacement of options held by Azarga option holders, valued at $5,434,045 using the Black-Scholes option pricing
model, the issuance of 1,403,156 enCore share purchase warrants (the &#8220;Replacement Warrants&#8221;) in replacement of warrants held
by Azarga warrant holders, valued at $3,222,543 using the Black-Scholes option pricing model, and total transaction costs of $3,215,444
associated with the Arrangement.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">As
Azarga did not qualify as a business according to the definition in IFRS 3 <i>Business Combinations</i>, the Arrangement had been accounted
for as an asset acquisition with the purchase price being allocated based on the estimated fair value of Azarga&#8217;s assets and liabilities
summarized as follows:</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom; ">
    <td style="border-bottom: Black 1.5pt solid; width: 88%; font-weight: bold; padding-bottom: 1.5pt">Consideration</td><td style="width: 1%; font-weight: bold">&#160;</td>
    <td style="width: 1%; border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"/><td style="border-bottom: Black 1.5pt solid; width: 9%; font-weight: bold; text-align: center">&#160;</td><td style="width: 1%; padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: 9pt">Fair value of share consideration</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">120,422,593</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: 9pt">Fair value of replacement options</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">5,434,045</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: 9pt">Fair value of replacement warrants</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3,222,543</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt; text-indent: 9pt">Transaction costs</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">3,215,444</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; padding-bottom: 1.5pt">Total consideration value</td><td style="font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">132,294,625</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
</table><p style="margin: 0">&#160;</p><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom; ">
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left; padding-bottom: 1.5pt; width: 88%">Net assets acquired</td><td style="font-weight: bold; width: 1%">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left; width: 1%"/><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center; width: 9%">$</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left; width: 1%">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: 9pt">Cash</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,860,360</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; text-indent: 9pt">Restricted cash</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">720,039</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: 9pt">Prepaids</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">169,688</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; text-indent: 9pt">Property, plant, and equipment</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">62,946</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; text-indent: 9pt">Right-of-use asset</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">45,444</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; text-indent: 9pt">Mineral properties</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">129,129,302</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; text-indent: 9pt">Asset retirement obligations</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(267,807</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; text-indent: 9pt">Lease liability</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(49,339</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; text-indent: 9pt">Loan receivable (1)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,845,941</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt; text-indent: 9pt">Accounts payable and accrued liabilities</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(1,221,949</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt">Total net assets acquired</td><td style="font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">132,294,625</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  </table><p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt"><span style="font-family: Times New Roman, Times, Serif">(1)
- Transaction costs incurred by Azarga which were subsequently paid by the Company.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">The
value of the Consideration Shares was calculated based on the issuance of 31,806,617 enCore common shares at a price per share of $3.79
($4.80 CAD) on December 31, 2021.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">The
value of the Replacement Options was derived using the Black-Scholes option pricing model. The weighted average assumptions used in the
Black-Scholes option pricing model were as follows:</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">Weighted
    average</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 88%"><span style="font-family: Times New Roman, Times, Serif">Exercise price</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">1.40</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td><span style="font-family: Times New Roman, Times, Serif">Share price</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">3.79</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Discount rate</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">1.04</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Expected life (years)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">3.43</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Volatility</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">104.40</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Fair value of replacement
    options (per option):</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">2.97</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">The
fair value of the Replacement Options is based on the outstanding 14,631,709 Azarga options adjusted for the Exchange Ratio (0.375) to
5,489,881; 1,828,960 enCore options after the September 2022 share consolidation.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">The
value of the Replacement Warrants was derived using the Black-Scholes option pricing model. The weighted average assumptions used in
the Black-Scholes option pricing model were as follows:</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">Weighted
    average</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 88%"><span style="font-family: Times New Roman, Times, Serif">Exercise price</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">1.66</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td><span style="font-family: Times New Roman, Times, Serif">Share price</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">3.79</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Discount rate</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">0.91</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Expected life (years)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">0.98</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Volatility</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">77.10</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Fair
    value of replacement warrants (per warrant):</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">2.30</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">The
fair value of the Replacement Warrants is based on the outstanding 11,225,255 Azarga warrants adjusted for the Exchange Ratio (0.375)
to 4,209,471; 1,403,156 enCore warrants after the September 2022 share consolidation.</span></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cve_DisclosureOfTransactionsRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombinationTextBlockAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cve_DisclosureOfTransactionsRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombinationTextBlockAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cve_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfTransactionsRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombinationExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of transactions recognised separately from acquisition of assets and assumption of liabilities in a business combination. [Refer: Business combinations [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 3<br> -IssueDate 2022-03-24<br> -Paragraph B64<br> -Subparagraph l<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=3&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_B64_l&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfTransactionsRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombinationExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>67
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139782928979024">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Mineral Properties<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_DisclosureOfMineralPropertiesAbstract', window );"><strong>Disclosure Of Mineral Properties Abstract</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_DisclosureOfMineralProperties', window );">Mineral properties</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif"><b>11.</b></span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b>Mineral
                                            properties</b></span></td></tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 18pt; text-align: justify; text-indent: -18pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td style="padding-left: 0.125in; padding-bottom: 1.5pt; text-align: center"/><td style="padding-bottom: 1.5pt; text-align: center"/>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><span style="font-size: 8pt">Arizona<br/> $</span></td><td style="text-align: center; padding-bottom: 1.5pt"/><td style="padding-bottom: 1.5pt; text-align: center"/>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><span style="font-size: 8pt">Colorado<br/> $</span></td><td style="text-align: center; padding-bottom: 1.5pt"/><td style="padding-bottom: 1.5pt; text-align: center"/>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><span style="font-size: 8pt">New Mexico<br/> $</span></td><td style="text-align: center; padding-bottom: 1.5pt"/><td style="padding-bottom: 1.5pt; text-align: center"/>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><span style="font-size: 8pt">South Dakota<br/> $</span></td><td style="text-align: center; padding-bottom: 1.5pt"/><td style="padding-bottom: 1.5pt; text-align: center"/>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><span style="font-size: 8pt">Texas<br/> $</span></td><td style="text-align: center; padding-bottom: 1.5pt"/><td style="padding-bottom: 1.5pt; text-align: center"/>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><span style="font-size: 8pt">Utah<br/> $</span></td><td style="text-align: center; padding-bottom: 1.5pt"/><td style="padding-bottom: 1.5pt; text-align: center"/>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><span style="font-size: 8pt">Wyoming<br/> $</span></td><td style="text-align: center; padding-bottom: 1.5pt"/><td style="padding-bottom: 1.5pt; text-align: center"/>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><span style="font-size: 8pt">Canada<br/> $</span></td><td style="text-align: center; padding-bottom: 1.5pt"/><td style="padding-bottom: 1.5pt; text-align: center"/>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><span style="font-size: 8pt">Total<br/> $</span></td><td style="text-align: center; padding-bottom: 1.5pt"/></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; width: 23%"><span style="font-size: 8pt">Balance, December 31, 2020</span></td><td style="width: 1%"/>
    <td style="width: 0.5%; text-align: left"/><td style="width: 7%; text-align: right"><span style="font-size: 8pt">771,388</span></td><td style="width: 0.5%; text-align: left"/><td style="width: 0.5%"/>
    <td style="width: 0.5%; text-align: left"/><td style="width: 7%; text-align: right"><span style="-sec-ix-hidden: hidden-fact-196; font-size: 8pt">-</span></td><td style="width: 0.5%; text-align: left"/><td style="width: 0.5%"/>
    <td style="width: 0.5%; text-align: left"/><td style="width: 7%; text-align: right"><span style="font-size: 8pt">5,477,162</span></td><td style="width: 0.5%; text-align: left"/><td style="width: 0.5%"/>
    <td style="width: 0.5%; text-align: left"/><td style="width: 7%; text-align: right"><span style="-sec-ix-hidden: hidden-fact-197; font-size: 8pt">-</span></td><td style="width: 0.5%; text-align: left"/><td style="width: 0.5%"/>
    <td style="width: 0.5%; text-align: left"/><td style="width: 7%; text-align: right"><span style="-sec-ix-hidden: hidden-fact-198; font-size: 8pt">-</span></td><td style="width: 0.5%; text-align: left"/><td style="width: 0.5%"/>
    <td style="width: 0.5%; text-align: left"/><td style="width: 7%; text-align: right"><span style="font-size: 8pt">300,460</span></td><td style="width: 0.5%; text-align: left"/><td style="width: 0.5%"/>
    <td style="width: 0.5%; text-align: left"/><td style="width: 7%; text-align: right"><span style="font-size: 8pt">59,050</span></td><td style="width: 0.5%; text-align: left"/><td style="width: 0.5%"/>
    <td style="width: 0.5%; text-align: left"/><td style="width: 7%; text-align: right"><span style="-sec-ix-hidden: hidden-fact-199; font-size: 8pt">-</span></td><td style="width: 0.5%; text-align: left"/><td style="width: 0.5%; font-weight: bold"/>
    <td style="width: 0.5%; font-weight: bold; text-align: left"/><td style="width: 7%; font-weight: bold; text-align: right"><span style="font-size: 8pt">6,608,060</span></td><td style="width: 0.5%; font-weight: bold; text-align: left"/></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left"><span style="font-size: 8pt">Acquisition costs:</span></td><td/>
    <td style="text-align: left"/><td style="text-align: right"/><td style="text-align: left"/><td/>
    <td style="text-align: left"/><td style="text-align: right"/><td style="text-align: left"/><td/>
    <td style="text-align: left"/><td style="text-align: right"/><td style="text-align: left"/><td/>
    <td style="text-align: left"/><td style="text-align: right"/><td style="text-align: left"/><td/>
    <td style="text-align: left"/><td style="text-align: right"/><td style="text-align: left"/><td/>
    <td style="text-align: left"/><td style="text-align: right"/><td style="text-align: left"/><td/>
    <td style="text-align: left"/><td style="text-align: right"/><td style="text-align: left"/><td/>
    <td style="text-align: left"/><td style="text-align: right"/><td style="text-align: left"/><td/>
    <td style="text-align: left"/><td style="text-align: right"/><td style="text-align: left"/></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.25in; text-indent: -0.125in; text-align: left"><span style="font-size: 8pt">Asset acquisition (Note 10)</span></td><td/>
    <td style="text-align: left"/><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-200; font-size: 8pt">-</span></td><td style="text-align: left"/><td/>
    <td style="text-align: left"/><td style="text-align: right"><span style="font-size: 8pt">619,902</span></td><td style="text-align: left"/><td/>
    <td style="text-align: left"/><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-201; font-size: 8pt">-</span></td><td style="text-align: left"/><td/>
    <td style="text-align: left"/><td style="text-align: right"><span style="font-size: 8pt">85,667,919</span></td><td style="text-align: left"/><td/>
    <td style="text-align: left"/><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-202; font-size: 8pt">-</span></td><td style="text-align: left"/><td/>
    <td style="text-align: left"/><td style="text-align: right"><span style="font-size: 8pt">1,676,674</span></td><td style="text-align: left"/><td/>
    <td style="text-align: left"/><td style="text-align: right"><span style="font-size: 8pt">41,164,807</span></td><td style="text-align: left"/><td/>
    <td style="text-align: left"/><td style="text-align: right"/><td style="text-align: left"/><td/>
    <td style="text-align: left"/><td style="text-align: right"><span style="font-size: 8pt">129,129,302</span></td><td style="text-align: left"/></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left"><span style="font-size: 8pt">Exploration costs:</span></td><td/>
    <td style="text-align: left"/><td style="text-align: right"/><td style="text-align: left"/><td/>
    <td style="text-align: left"/><td style="text-align: right"/><td style="text-align: left"/><td/>
    <td style="text-align: left"/><td style="text-align: right"/><td style="text-align: left"/><td/>
    <td style="text-align: left"/><td style="text-align: right"/><td style="text-align: left"/><td/>
    <td style="text-align: left"/><td style="text-align: right"/><td style="text-align: left"/><td/>
    <td style="text-align: left"/><td style="text-align: right"/><td style="text-align: left"/><td/>
    <td style="text-align: left"/><td style="text-align: right"/><td style="text-align: left"/><td/>
    <td style="text-align: left"/><td style="text-align: right"/><td style="text-align: left"/><td/>
    <td style="text-align: left"/><td style="text-align: right"/><td style="text-align: left"/></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.25in; text-indent: -0.125in; text-align: left"><span style="font-size: 8pt">Maintenance and lease fees</span></td><td/>
    <td style="text-align: left"/><td style="text-align: right"><span style="font-size: 8pt">86,364</span></td><td style="text-align: left"/><td/>
    <td style="text-align: left"/><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-203; font-size: 8pt">-</span></td><td style="text-align: left"/><td/>
    <td style="text-align: left"/><td style="text-align: right"><span style="font-size: 8pt">529,604</span></td><td style="text-align: left"/><td/>
    <td style="text-align: left"/><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-204; font-size: 8pt">-</span></td><td style="text-align: left"/><td/>
    <td style="text-align: left"/><td style="text-align: right"><span style="font-size: 8pt">1,455,206</span></td><td style="text-align: left"/><td/>
    <td style="text-align: left"/><td style="text-align: right"><span style="font-size: 8pt">22,663</span></td><td style="text-align: left"/><td/>
    <td style="text-align: left"/><td style="text-align: right"><span style="font-size: 8pt">11,870</span></td><td style="text-align: left"/><td/>
    <td style="text-align: left"/><td style="text-align: right"><span style="font-size: 8pt">78,456</span></td><td style="text-align: left"/><td/>
    <td style="text-align: left"/><td style="text-align: right"><span style="font-size: 8pt">2,184,163</span></td><td style="text-align: left"/></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.25in; text-indent: -0.125in; text-align: left"><span style="font-size: 8pt">Resource review</span></td><td/>
    <td style="text-align: left"/><td style="text-align: right"><span style="font-size: 8pt">42,967</span></td><td style="text-align: left"/><td/>
    <td style="text-align: left"/><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-205; font-size: 8pt">-</span></td><td style="text-align: left"/><td/>
    <td style="text-align: left"/><td style="text-align: right"><span style="font-size: 8pt">130,120</span></td><td style="text-align: left"/><td/>
    <td style="text-align: left"/><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-206; font-size: 8pt">-</span></td><td style="text-align: left"/><td/>
    <td style="text-align: left"/><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-207; font-size: 8pt">-</span></td><td style="text-align: left"/><td/>
    <td style="text-align: left"/><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-208; font-size: 8pt">-</span></td><td style="text-align: left"/><td/>
    <td style="text-align: left"/><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-209; font-size: 8pt">-</span></td><td style="text-align: left"/><td/>
    <td style="text-align: left"/><td style="text-align: right"/><td style="text-align: left"/><td/>
    <td style="text-align: left"/><td style="text-align: right"><span style="font-size: 8pt">173,087</span></td><td style="text-align: left"/></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.25in; text-indent: -0.125in; text-align: left"><span style="font-size: 8pt">Impairment charged</span></td><td/>
    <td style="text-align: left"/><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-210; font-size: 8pt">-</span></td><td style="text-align: left"/><td/>
    <td style="text-align: left"/><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-211; font-size: 8pt">-</span></td><td style="text-align: left"/><td/>
    <td style="text-align: left"/><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-212; font-size: 8pt">-</span></td><td style="text-align: left"/><td/>
    <td style="text-align: left"/><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-213; font-size: 8pt">-</span></td><td style="text-align: left"/><td/>
    <td style="text-align: left"/><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-214; font-size: 8pt">-</span></td><td style="text-align: left"/><td/>
    <td style="text-align: left"/><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-215; font-size: 8pt">-</span></td><td style="text-align: left"/><td/>
    <td style="text-align: left"/><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-216; font-size: 8pt">-</span></td><td style="text-align: left"/><td/>
    <td style="text-align: left"/><td style="text-align: right"><span style="font-size: 8pt">(78,456</span></td><td style="text-align: left"><span style="font-size: 8pt">)</span></td><td/>
    <td style="text-align: left"/><td style="text-align: right"><span style="font-size: 8pt">(78,456</span></td><td style="text-align: left"><span style="font-size: 8pt">)</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-indent: -0.125in"><span style="font-size: 8pt">Divestment:</span></td><td/>
    <td style="text-align: left"/><td style="text-align: right"/><td style="text-align: left"/><td/>
    <td style="text-align: left"/><td style="text-align: right"/><td style="text-align: left"/><td/>
    <td style="text-align: left"/><td style="text-align: right"/><td style="text-align: left"/><td/>
    <td style="text-align: left"/><td style="text-align: right"/><td style="text-align: left"/><td/>
    <td style="text-align: left"/><td style="text-align: right"/><td style="text-align: left"/><td/>
    <td style="text-align: left"/><td style="text-align: right"/><td style="text-align: left"/><td/>
    <td style="text-align: left"/><td style="text-align: right"/><td style="text-align: left"/><td/>
    <td style="text-align: left"/><td style="text-align: right"/><td style="text-align: left"/><td/>
    <td style="text-align: left"/><td style="text-align: right"/><td style="text-align: left"/></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.375in; text-indent: -0.125in; text-align: left"><span style="font-size: 8pt">Divest - Mineral interest</span></td><td/>
    <td style="text-align: left"/><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-217; font-size: 8pt">-</span></td><td style="text-align: left"/><td/>
    <td style="text-align: left"/><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-218; font-size: 8pt">-</span></td><td style="text-align: left"/><td/>
    <td style="text-align: left"/><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-219; font-size: 8pt">-</span></td><td style="text-align: left"/><td/>
    <td style="text-align: left"/><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-220; font-size: 8pt">-</span></td><td style="text-align: left"/><td/>
    <td style="text-align: left"/><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-221; font-size: 8pt">-</span></td><td style="text-align: left"/><td/>
    <td style="text-align: left"/><td style="text-align: right"><span style="font-size: 8pt">(195,514</span></td><td style="text-align: left"><span style="font-size: 8pt">)</span></td><td/>
    <td style="text-align: left"/><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-222; font-size: 8pt">-</span></td><td style="text-align: left"/><td/>
    <td style="text-align: left"/><td style="text-align: right"/><td style="text-align: left"/><td/>
    <td style="text-align: left"/><td style="text-align: right"><span style="font-size: 8pt">(195,514</span></td><td style="text-align: left"><span style="font-size: 8pt">)</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.25in; text-indent: -0.125in; text-align: left; padding-bottom: 1.5pt"><span style="font-size: 8pt">Assets
    held for sale</span></td><td/>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"/><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-223; font-size: 8pt">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"/><td/>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"/><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-224; font-size: 8pt">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"/><td/>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"/><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-size: 8pt">(1,741,064</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-size: 8pt">)</span></td><td/>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"/><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-225; font-size: 8pt">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"/><td/>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"/><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-226; font-size: 8pt">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"/><td/>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"/><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-227; font-size: 8pt">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"/><td/>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"/><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-228; font-size: 8pt">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"/><td/>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"/><td style="border-bottom: Black 1.5pt solid; text-align: right"/><td style="padding-bottom: 1.5pt; text-align: left"/><td/>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"/><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-size: 8pt">(1,741,064</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-size: 8pt">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 1.5pt"><span style="font-size: 8pt">Balance, December 31,
    2021</span></td><td/>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"/><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-size: 8pt">900,719</span></td><td style="padding-bottom: 1.5pt; text-align: left"/><td/>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"/><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-size: 8pt">619,902</span></td><td style="padding-bottom: 1.5pt; text-align: left"/><td/>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"/><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-size: 8pt">4,395,822</span></td><td style="padding-bottom: 1.5pt; text-align: left"/><td/>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"/><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-size: 8pt">85,667,919</span></td><td style="padding-bottom: 1.5pt; text-align: left"/><td/>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"/><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-size: 8pt">1,455,206</span></td><td style="padding-bottom: 1.5pt; text-align: left"/><td/>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"/><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-size: 8pt">1,804,283</span></td><td style="padding-bottom: 1.5pt; text-align: left"/><td/>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"/><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-size: 8pt">41,235,727</span></td><td style="padding-bottom: 1.5pt; text-align: left"/><td/>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"/><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-229; font-size: 8pt">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"/><td style="font-weight: bold"/>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"/><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-size: 8pt">136,079,578</span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"/></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left"><span style="font-size: 8pt">Exploration costs:</span></td><td/>
    <td style="text-align: left"/><td style="text-align: right"/><td style="text-align: left"/><td/>
    <td style="text-align: left"/><td style="text-align: right"/><td style="text-align: left"/><td/>
    <td style="text-align: left"/><td style="text-align: right"/><td style="text-align: left"/><td/>
    <td style="text-align: left"/><td style="text-align: right"/><td style="text-align: left"/><td/>
    <td style="text-align: left"/><td style="text-align: right"/><td style="text-align: left"/><td/>
    <td style="text-align: left"/><td style="text-align: right"/><td style="text-align: left"/><td/>
    <td style="text-align: left"/><td style="text-align: right"/><td style="text-align: left"/><td/>
    <td style="text-align: left"/><td style="text-align: right"/><td style="text-align: left"/><td/>
    <td style="text-align: left"/><td style="text-align: right"/><td style="text-align: left"/></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.25in; text-indent: -0.125in"><span style="font-size: 8pt">Drilling</span></td><td/>
    <td style="text-align: left"/><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-230; font-size: 8pt">-</span></td><td style="text-align: left"/><td/>
    <td style="text-align: left"/><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-231; font-size: 8pt">-</span></td><td style="text-align: left"/><td/>
    <td style="text-align: left"/><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-232; font-size: 8pt">-</span></td><td style="text-align: left"/><td/>
    <td style="text-align: left"/><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-233; font-size: 8pt">-</span></td><td style="text-align: left"/><td/>
    <td style="text-align: left"/><td style="text-align: right"><span style="font-size: 8pt">197,422</span></td><td style="text-align: left"/><td/>
    <td style="text-align: left"/><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-234; font-size: 8pt">-</span></td><td style="text-align: left"/><td/>
    <td style="text-align: left"/><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-235; font-size: 8pt">-</span></td><td style="text-align: left"/><td/>
    <td style="text-align: left"/><td style="text-align: right"/><td style="text-align: left"/><td/>
    <td style="text-align: left"/><td style="text-align: right"><span style="font-size: 8pt">197,422</span></td><td style="text-align: left"/></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.25in; text-indent: -0.125in; text-align: left"><span style="font-size: 8pt">Maintenance and lease fees</span></td><td/>
    <td style="text-align: left"/><td style="text-align: right"><span style="font-size: 8pt">111,004</span></td><td style="text-align: left"/><td/>
    <td style="text-align: left"/><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-236; font-size: 8pt">-</span></td><td style="text-align: left"/><td/>
    <td style="text-align: left"/><td style="text-align: right"><span style="font-size: 8pt">472,401</span></td><td style="text-align: left"/><td/>
    <td style="text-align: left"/><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-237; font-size: 8pt">-</span></td><td style="text-align: left"/><td/>
    <td style="text-align: left"/><td style="text-align: right"><span style="font-size: 8pt">2,523,123</span></td><td style="text-align: left"/><td/>
    <td style="text-align: left"/><td style="text-align: right"><span style="font-size: 8pt">39,566</span></td><td style="text-align: left"/><td/>
    <td style="text-align: left"/><td style="text-align: right"><span style="font-size: 8pt">397,324</span></td><td style="text-align: left"/><td/>
    <td style="text-align: left"/><td style="text-align: right"/><td style="text-align: left"/><td/>
    <td style="text-align: left"/><td style="text-align: right"><span style="font-size: 8pt">3,543,418</span></td><td style="text-align: left"/></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.25in; text-indent: -0.125in; text-align: left"><span style="font-size: 8pt">Permitting &amp; Licensing</span></td><td/>
    <td style="text-align: left"/><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-238; font-size: 8pt">-</span></td><td style="text-align: left"/><td/>
    <td style="text-align: left"/><td style="text-align: right"><span style="font-size: 8pt">(30,280</span></td><td style="text-align: left"><span style="font-size: 8pt">)</span></td><td/>
    <td style="text-align: left"/><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-239; font-size: 8pt">-</span></td><td style="text-align: left"/><td/>
    <td style="text-align: left"/><td style="text-align: right"><span style="font-size: 8pt">251,863</span></td><td style="text-align: left"/><td/>
    <td style="text-align: left"/><td style="text-align: right"><span style="font-size: 8pt">339,225</span></td><td style="text-align: left"/><td/>
    <td style="text-align: left"/><td style="text-align: right"><span style="font-size: 8pt">5,698</span></td><td style="text-align: left"/><td/>
    <td style="text-align: left"/><td style="text-align: right"><span style="font-size: 8pt">273,726</span></td><td style="text-align: left"/><td/>
    <td style="text-align: left"/><td style="text-align: right"/><td style="text-align: left"/><td/>
    <td style="text-align: left"/><td style="text-align: right"><span style="font-size: 8pt">840,232</span></td><td style="text-align: left"/></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.25in; text-indent: -0.125in"><span style="font-size: 8pt">Personnel</span></td><td/>
    <td style="text-align: left"/><td style="text-align: right"><span style="font-size: 8pt">4,500</span></td><td style="text-align: left"/><td/>
    <td style="text-align: left"/><td style="text-align: right"><span style="font-size: 8pt">8,621</span></td><td style="text-align: left"/><td/>
    <td style="text-align: left"/><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-240; font-size: 8pt">-</span></td><td style="text-align: left"/><td/>
    <td style="text-align: left"/><td style="text-align: right"><span style="font-size: 8pt">301,066</span></td><td style="text-align: left"/><td/>
    <td style="text-align: left"/><td style="text-align: right"><span style="font-size: 8pt">280,341</span></td><td style="text-align: left"/><td/>
    <td style="text-align: left"/><td style="text-align: right"><span style="font-size: 8pt">19,620</span></td><td style="text-align: left"/><td/>
    <td style="text-align: left"/><td style="text-align: right"><span style="font-size: 8pt">207,518</span></td><td style="text-align: left"/><td/>
    <td style="text-align: left"/><td style="text-align: right"/><td style="text-align: left"/><td/>
    <td style="text-align: left"/><td style="text-align: right"><span style="font-size: 8pt">821,666</span></td><td style="text-align: left"/></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.25in; text-indent: -0.125in"><span style="font-size: 8pt">Recoveries</span></td><td/>
    <td style="text-align: left"/><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-241; font-size: 8pt">-</span></td><td style="text-align: left"/><td/>
    <td style="text-align: left"/><td style="text-align: right"><span style="font-size: 8pt">(20,000</span></td><td style="text-align: left"><span style="font-size: 8pt">)</span></td><td/>
    <td style="text-align: left"/><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-242; font-size: 8pt">-</span></td><td style="text-align: left"/><td/>
    <td style="text-align: left"/><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-243; font-size: 8pt">-</span></td><td style="text-align: left"/><td/>
    <td style="text-align: left"/><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-244; font-size: 8pt">-</span></td><td style="text-align: left"/><td/>
    <td style="text-align: left"/><td style="text-align: right"><span style="font-size: 8pt">(2,000</span></td><td style="text-align: left"><span style="font-size: 8pt">)</span></td><td/>
    <td style="text-align: left"/><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-245; font-size: 8pt">-</span></td><td style="text-align: left"/><td/>
    <td style="text-align: left"/><td style="text-align: right"/><td style="text-align: left"/><td/>
    <td style="text-align: left"/><td style="text-align: right"><span style="font-size: 8pt">(22,000</span></td><td style="text-align: left"><span style="font-size: 8pt">)</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.25in; text-indent: -0.125in; text-align: left"><span style="font-size: 8pt">Resource review</span></td><td/>
    <td style="text-align: left"/><td style="text-align: right"><span style="font-size: 8pt">118,500</span></td><td style="text-align: left"/><td/>
    <td style="text-align: left"/><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-246; font-size: 8pt">-</span></td><td style="text-align: left"/><td/>
    <td style="text-align: left"/><td style="text-align: right"><span style="font-size: 8pt">37,125</span></td><td style="text-align: left"/><td/>
    <td style="text-align: left"/><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-247; font-size: 8pt">-</span></td><td style="text-align: left"/><td/>
    <td style="text-align: left"/><td style="text-align: right"><span style="font-size: 8pt">47,104</span></td><td style="text-align: left"/><td/>
    <td style="text-align: left"/><td style="text-align: right"><span style="font-size: 8pt">1,680</span></td><td style="text-align: left"/><td/>
    <td style="text-align: left"/><td style="text-align: right"><span style="font-size: 8pt">10,080</span></td><td style="text-align: left"/><td/>
    <td style="text-align: left"/><td style="text-align: right"/><td style="text-align: left"/><td/>
    <td style="text-align: left"/><td style="text-align: right"><span style="font-size: 8pt">214,489</span></td><td style="text-align: left"/></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-size: 8pt">Divestment:</span></td><td/>
    <td style="text-align: left"/><td style="text-align: right"/><td style="text-align: left"/><td/>
    <td style="text-align: left"/><td style="text-align: right"/><td style="text-align: left"/><td/>
    <td style="text-align: left"/><td style="text-align: right"/><td style="text-align: left"/><td/>
    <td style="text-align: left"/><td style="text-align: right"/><td style="text-align: left"/><td/>
    <td style="text-align: left"/><td style="text-align: right"/><td style="text-align: left"/><td/>
    <td style="text-align: left"/><td style="text-align: right"/><td style="text-align: left"/><td/>
    <td style="text-align: left"/><td style="text-align: right"/><td style="text-align: left"/><td/>
    <td style="text-align: left"/><td style="text-align: right"/><td style="text-align: left"/><td/>
    <td style="text-align: left"/><td style="text-align: right"/><td style="text-align: left"/></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.25in; text-indent: -0.125in; text-align: left"><span style="font-size: 8pt">Divestment of Mineral Interest</span></td><td/>
    <td style="text-align: left"/><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-248; font-size: 8pt">-</span></td><td style="text-align: left"/><td/>
    <td style="text-align: left"/><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-249; font-size: 8pt">-</span></td><td style="text-align: left"/><td/>
    <td style="text-align: left"/><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-250; font-size: 8pt">-</span></td><td style="text-align: left"/><td/>
    <td style="text-align: left"/><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-251; font-size: 8pt">-</span></td><td style="text-align: left"/><td/>
    <td style="text-align: left"/><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-252; font-size: 8pt">-</span></td><td style="text-align: left"/><td/>
    <td style="text-align: left"/><td style="text-align: right"><span style="font-size: 8pt">(28,485</span></td><td style="text-align: left"><span style="font-size: 8pt">)</span></td><td/>
    <td style="text-align: left"/><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-253; font-size: 8pt">-</span></td><td style="text-align: left"/><td/>
    <td style="text-align: left"/><td style="text-align: right"/><td style="text-align: left"/><td/>
    <td style="text-align: left"/><td style="text-align: right"><span style="font-size: 8pt">(28,485</span></td><td style="text-align: left"><span style="font-size: 8pt">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.25in; text-indent: -0.125in; text-align: left"><span style="font-size: 8pt">Assets held for sale</span></td><td/>
    <td style="text-align: left"/><td style="text-align: right"><span style="font-size: 8pt">(358,969</span></td><td style="text-align: left"><span style="font-size: 8pt">)</span></td><td/>
    <td style="text-align: left"/><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-254; font-size: 8pt">-</span></td><td style="text-align: left"/><td/>
    <td style="text-align: left"/><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-255; font-size: 8pt">-</span></td><td style="text-align: left"/><td/>
    <td style="text-align: left"/><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-256; font-size: 8pt">-</span></td><td style="text-align: left"/><td/>
    <td style="text-align: left"/><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-257; font-size: 8pt">-</span></td><td style="text-align: left"/><td/>
    <td style="text-align: left"/><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-258; font-size: 8pt">-</span></td><td style="text-align: left"/><td/>
    <td style="text-align: left"/><td style="text-align: right"><span style="font-size: 8pt">(369,913</span></td><td style="text-align: left"><span style="font-size: 8pt">)</span></td><td/>
    <td style="text-align: left"/><td style="text-align: right"/><td style="text-align: left"/><td/>
    <td style="text-align: left"/><td style="text-align: right"><span style="font-size: 8pt">(728,882</span></td><td style="text-align: left"><span style="font-size: 8pt">)</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left"><span style="font-size: 8pt">Project Development costs:</span></td><td/>
    <td style="text-align: left"/><td style="text-align: right"/><td style="text-align: left"/><td/>
    <td style="text-align: left"/><td style="text-align: right"/><td style="text-align: left"/><td/>
    <td style="text-align: left"/><td style="text-align: right"/><td style="text-align: left"/><td/>
    <td style="text-align: left"/><td style="text-align: right"/><td style="text-align: left"/><td/>
    <td style="text-align: left"/><td style="text-align: right"/><td style="text-align: left"/><td/>
    <td style="text-align: left"/><td style="text-align: right"/><td style="text-align: left"/><td/>
    <td style="text-align: left"/><td style="text-align: right"/><td style="text-align: left"/><td/>
    <td style="text-align: left"/><td style="text-align: right"/><td style="text-align: left"/><td/>
    <td style="text-align: left"/><td style="text-align: right"/><td style="text-align: left"/></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.375in; text-indent: -0.125in"><span style="font-size: 8pt">Construction of wellfields</span></td><td/>
    <td style="text-align: left"/><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-259; font-size: 8pt">-</span></td><td style="text-align: left"/><td/>
    <td style="text-align: left"/><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-260; font-size: 8pt">-</span></td><td style="text-align: left"/><td/>
    <td style="text-align: left"/><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-261; font-size: 8pt">-</span></td><td style="text-align: left"/><td/>
    <td style="text-align: left"/><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-262; font-size: 8pt">-</span></td><td style="text-align: left"/><td/>
    <td style="text-align: left"/><td style="text-align: right"><span style="font-size: 8pt">1,670,151</span></td><td style="text-align: left"/><td/>
    <td style="text-align: left"/><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-263; font-size: 8pt">-</span></td><td style="text-align: left"/><td/>
    <td style="text-align: left"/><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-264; font-size: 8pt">-</span></td><td style="text-align: left"/><td/>
    <td style="text-align: left"/><td style="text-align: right"/><td style="text-align: left"/><td/>
    <td style="text-align: left"/><td style="text-align: right"><span style="font-size: 8pt">1,670,151</span></td><td style="text-align: left"/></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.25in; text-indent: -0.125in"><span style="font-size: 8pt">Drilling</span></td><td/>
    <td style="text-align: left"/><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-265; font-size: 8pt">-</span></td><td style="text-align: left"/><td/>
    <td style="text-align: left"/><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-266; font-size: 8pt">-</span></td><td style="text-align: left"/><td/>
    <td style="text-align: left"/><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-267; font-size: 8pt">-</span></td><td style="text-align: left"/><td/>
    <td style="text-align: left"/><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-268; font-size: 8pt">-</span></td><td style="text-align: left"/><td/>
    <td style="text-align: left"/><td style="text-align: right"><span style="font-size: 8pt">2,109,835</span></td><td style="text-align: left"/><td/>
    <td style="text-align: left"/><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-269; font-size: 8pt">-</span></td><td style="text-align: left"/><td/>
    <td style="text-align: left"/><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-270; font-size: 8pt">-</span></td><td style="text-align: left"/><td/>
    <td style="text-align: left"/><td style="text-align: right"/><td style="text-align: left"/><td/>
    <td style="text-align: left"/><td style="text-align: right"><span style="font-size: 8pt">2,109,835</span></td><td style="text-align: left"/></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.25in; text-indent: -0.125in; padding-bottom: 1.5pt"><span style="font-size: 8pt">Personnel</span></td><td/>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"/><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-271; font-size: 8pt">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"/><td/>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"/><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-272; font-size: 8pt">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"/><td/>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"/><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-273; font-size: 8pt">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"/><td/>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"/><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-274; font-size: 8pt">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"/><td/>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"/><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-size: 8pt">521,662</span></td><td style="padding-bottom: 1.5pt; text-align: left"/><td/>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"/><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-275; font-size: 8pt">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"/><td/>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"/><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-276; font-size: 8pt">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"/><td/>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"/><td style="border-bottom: Black 1.5pt solid; text-align: right"/><td style="padding-bottom: 1.5pt; text-align: left"/><td/>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"/><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-size: 8pt">521,662</span></td><td style="padding-bottom: 1.5pt; text-align: left"/></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-indent: -0.125in; font-weight: bold; padding-bottom: 1.5pt"><span style="font-size: 8pt">Balance,
    December 31, 2022</span></td><td style="font-weight: bold"/>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"/><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-size: 8pt">775,754</span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"/><td style="font-weight: bold"/>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"/><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-size: 8pt">578,243</span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"/><td style="font-weight: bold"/>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"/><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-size: 8pt">4,905,348</span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"/><td style="font-weight: bold"/>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"/><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-size: 8pt">86,220,848</span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"/><td style="font-weight: bold"/>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"/><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-size: 8pt">9,144,069</span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"/><td style="font-weight: bold"/>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"/><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-size: 8pt">1,840,362</span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"/><td style="font-weight: bold"/>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"/><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-size: 8pt">41,754,462</span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"/><td/>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"/><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-277; font-size: 8pt">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"/><td style="font-weight: bold"/>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"/><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-size: 8pt">145,219,086</span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"/></tr>
  </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 18pt; text-align: justify; text-indent: -18pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b><i>Assets
Held for Sale</i></b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b><i>&#160;</i></b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Pursuant
to an agreement dated August 27, 2021, the Company completed the sale of its subsidiary, Cibola Resources, LLC (Note 2), including its
holding of the Cebolletta project to an arm&#8217;s length private company.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Pursuant
to an agreement dated November 3, 2022 the Company completed the sale of its subsidiaries Beltline Resources, Inc and Hydro Restoration
Corporation subsequent to the year ended December 31, 2022 (Note 22(k)).</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt"><span style="font-family: Times New Roman, Times, Serif"><b><i><span style="text-decoration:underline">Arizona</span></i></b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b><i>&#160;</i></b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt"><span style="font-family: Times New Roman, Times, Serif"><b><i>Moonshine
Springs</i></b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b><i>&#160;</i></b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">The
Moonshine Springs project is located in Mohave County, Arizona.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">On
November 3, 2022, the Company entered into an agreement to sell the Moonshine Springs project to Nuclear Fuels, Inc, an arm&#8217;s length
private company (Note 22(k)).</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif"><b><i>Other
Arizona Properties</i></b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b><i>&#160;</i></b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">The
Company owns or controls three Arizona State mineral leases and 467 unpatented federal lode mining claims covering more than 10,000 acres
in the northern Arizona strip district. The Company holds cash bonds for $88,500 (December 31, 2021 - $88,500) with the Bureau of Land
Management.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b><i><span style="text-decoration:underline">Colorado</span></i></b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b><i>&#160;</i></b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b><i>Centennial</i></b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b><i>&#160;</i></b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">The
Centennial Uranium Project is located in Colorado. In 2006, the Company entered into an option agreement to purchase uranium rights on
certain areas of the Centennial Project for consideration of $1,895,000 plus contingent payments of $3,165,000. Pursuant to the agreement,
the contingent payments are payable upon receipt of regulatory permits and licenses allowing uranium production. If the Company does
not obtain such permits and licenses by September 27, 2019, the uranium rights, at the option of the seller, can be transferred back
to the seller. To date, the Company has neither obtained the required permits and licenses, nor has it been able to renegotiate the option
agreement. The Company is attempting to renegotiate the option agreement and the seller has not exercised its option to have the uranium
rights transferred back.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif"><b><i><span style="text-decoration:underline">New
Mexico</span></i></b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b><i>&#160;</i></b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt"><span style="font-family: Times New Roman, Times, Serif"><b><i>Marquez,
Nose Rock, &amp; Treeline</i></b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt"><span style="font-family: Times New Roman, Times, Serif"><b><i>&#160;</i></b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">The
Marquez project is located in McKinley and Sandoval counties of New Mexico adjacent to the Company&#8217;s Juan Tafoya property.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">The
Nose Rock Project is located in McKinley County, New Mexico, on the northern edge of the Grants Uranium District.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">The
Treeline project is located west-northwest of Albuquerque, in McKinley and Cibola Counties, Grants Uranium District, New Mexico.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt"><span style="font-family: Times New Roman, Times, Serif">In
March 2021, the Company divested 2,240 acres of fee mineral interests to Tri State Generation and Transmission Association; $89,600 was
received in consideration. The assets having no net book value resulted in a gain on disposal of the mineral interests of $89,600 recorded
on the Company&#8217;s consolidated statement of loss and comprehensive loss.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt"><span style="font-family: Times New Roman, Times, Serif">In
May 2021, the Company divested one section of 640 acres of fee mineral interests to Wildcat Solar Power Plant, LLC; $16,000 was received
in consideration. The assets having no net book value resulted in a gain on disposal of the mineral interests of $16,000 recorded on
the Company&#8217;s consolidated statement of loss and comprehensive loss.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt"><span style="font-family: Times New Roman, Times, Serif"><b>McKinley,
Crownpoint and Hosta Butte</b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt"><span style="font-family: Times New Roman, Times, Serif"><b>&#160;</b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">The
Company owns a 100% interest in the McKinley properties and a 60% - 100% interest in the adjacent Crownpoint and Hosta Butte properties,
all of which are located in McKinley County, New Mexico. The Company holds a 60% interest in a portion of a certain section at Crownpoint.
The Company owns a 100% interest in the rest of the Crownpoint and Hosta Butte project area, subject to a 3% gross profit royalty on
uranium produced.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt"><span style="font-family: Times New Roman, Times, Serif"><b><i>Juan
Tafoya</i></b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">The
Juan Tafoya property, located in Cibola County in west-central New Mexico near the Company&#8217;s Marquez project is leased from the
Juan Tafoya Land Corporation (&#8220;JTLC&#8221;).</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt"><span style="font-family: Times New Roman, Times, Serif"><b><i>Cebolletta</i></b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">The
Cebolletta project is situated in the eastern portion of Cibola County, New Mexico. The lands that comprise the Cebolleta uranium project
are owned in fee by La Merced del Pueblo de Cebolleta [the &#8220;Cebolleta Land Grant&#8221; (CLG)].</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">On
May 24, 2022, the Company divested of the Cebolletta mineral property via its sale of Cibola Resources, LLC to Elephant (Note 6) pursuant
to a Share Purchase Agreement dated August 27, 2021. Consideration received in the transaction included $250,000 and 11,308,250 shares
of Elephant with a fair value of $3,085,965. The asset had a book value of $1,741,064 at the transaction date, resulting in a gain on
disposal of subsidiary of $1,594,901 recorded on the Company&#8217;s consolidated statement of loss and comprehensive loss.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt"><span style="font-family: Times New Roman, Times, Serif"><b><i>West
Largo</i></b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b><i>&#160;</i></b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">The
West Largo Project is near the north-central edge of the Grants Mineral Belt in McKinley County, New Mexico.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt"><span style="font-family: Times New Roman, Times, Serif"><b><i>Other
New Mexico Properties</i></b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b><i>&#160;</i></b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">The
Company holds mineral properties in the &#8220;checkerboard&#8221; area located primarily in McKinley County in northwestern New Mexico.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">In
January 2022, the Company divested approximately 808 acres of fee mineral interest to Ambrosia Solar, LLC. The assets, having no net
book value at the transaction date, resulted in a gain on disposal of the mineral interests of $48,480 recorded on the Company&#8217;s
consolidated statement of loss and comprehensive loss. Under the agreement, Ambrosia Solar, LLC retains the right to acquire the uranium
mineral rights associated with the property by quit claim deed to be furnished by the Company. Subsequent to the period ended December
31, 2022, Ambrosia Solar, LLC has elected to exercise its right to extend the option through January 14, 2024 for an additional payment
of $24,240.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt"><span style="font-family: Times New Roman, Times, Serif"><b><i><span style="text-decoration:underline">South
Dakota</span></i></b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b><i>&#160;</i></b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt"><span style="font-family: Times New Roman, Times, Serif"><b><i>Dewey-Burdock</i></b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b><i>&#160;</i></b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">The
Dewey-Burdock Project is an in-situ recovery uranium project located in the Edgemont uranium district in South Dakota.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt"><span style="font-family: Times New Roman, Times, Serif"><b><i><span style="text-decoration:underline">Texas</span></i></b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b><i>&#160;</i></b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt"><span style="font-family: Times New Roman, Times, Serif"><b><i>Kingsville
Dome</i></b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b><i>&#160;</i></b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">The
Kingsville Dome project is located in Kleberg County, Texas on land owned by the Company. A Central Processing Plant at the site has
been on standby since 2009.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt"><span style="font-family: Times New Roman, Times, Serif"><b><i>Rosita</i></b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b><i>&#160;</i></b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt"><span style="font-family: Times New Roman, Times, Serif">The
Rosita Project is located in Duval County, Texas on land owned by the Company.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt"><span style="font-family: Times New Roman, Times, Serif"><b><i>Upper
Spring Creek</i></b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b><i>&#160;</i></b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt"><span style="font-family: Times New Roman, Times, Serif">The
Upper Spring Creek Project is located in Live Oak and Bee counties in Texas.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt"><span style="font-family: Times New Roman, Times, Serif"><b><i>Butler
Ranch</i></b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b><i>&#160;</i></b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt"><span style="font-family: Times New Roman, Times, Serif">The
Butler Ranch Exploration project is located in Karnes County, Texas.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt"><span style="font-family: Times New Roman, Times, Serif"><b><i><span style="text-decoration:underline">Utah</span></i></b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b><i>&#160;</i></b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt"><span style="font-family: Times New Roman, Times, Serif"><b><i>Ticaboo</i></b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b><i>&#160;</i></b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">The
Company owns three portions of a claim block located in Shootaring Canyon, Utah. The Company has a federal Plan of Operation and State
of Utah approval for processing of the assets.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt"><span style="font-family: Times New Roman, Times, Serif"><b><i>Other
Utah Properties</i></b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b><i>&#160;</i></b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">The
Company owns various mining claims throughout Utah, as well as its Cedar Mountain project located northwest of the White Mesa Mill in
Blanding County, Utah.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt"><span style="font-family: Times New Roman, Times, Serif">In
March 2021, the Geitus, Blue Jay and Marcy Look properties were transferred to Kimmerle Mining LLC. $Nil consideration was received in
the transaction and a loss on the disposal of these mineral rights was recorded on the Company&#8217;s consolidated statement of loss
and comprehensive loss as a component of &#8220;Other Income (Expense)&#8221; for the net book value of the assets at the transaction
date, $195,514.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">In
June 2022, the Company divested of its mineral interests in the Lisbon Valley to Prime Fuels Corp (&#8220;PFC&#8221;). In consideration
of the transaction the Company was granted a 2.0% Net Smelter Royalty (&#8220;NSR&#8221;). Additionally, pursuant to the purchase agreement
dated June 20, 2022, should PFC sell, transfer or exchange the property or all of its shares to a third party, the Company shall receive
5% of the consideration that PFC receives for the lease, license, loan or sale of the property or the shares of PFC to any third party.
In October 2022, PFC and these mineral interests were acquired by Uravan Minerals, Inc resulting in the Company&#8217;s receipt of 80,000
shares of Uravan Minerals, Inc with a fair value of $9,153. The asset had a net book value of $28,485 at the transaction date, resulting
in a loss on disposal of the mineral interests of $19,332 recorded on the Company&#8217;s consolidated statement of loss and comprehensive
loss.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Also
in June 2022, the Company divested of a portion of its mineral interests, in the JB Claims, to PFC. As consideration for the transaction,
the Company was granted a 2.0% NSR. Additionally, pursuant to the purchase agreement dated June 20, 2022, should PFC sell, transfer or
exchange the property or all of its shares to a third party, the Company shall receive 5% of the consideration that PFC receives for
the lease, license, loan or sale of the property or the shares of PFC to any third party. The asset had no net book value at the transaction
date, resulting in no recognition of a gain or loss on disposal.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt"><span style="font-family: Times New Roman, Times, Serif"><b><i><span style="text-decoration:underline">Wyoming</span></i></b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b><i>&#160;</i></b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt"><span style="font-family: Times New Roman, Times, Serif"><b><i>Gas
Hills</i></b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b><i>&#160;</i></b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt"><span style="font-family: Times New Roman, Times, Serif">The
Gas Hills Project is located in the historic Gas Hills uranium district 45 miles east of Riverton, Wyoming.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt"><span style="font-family: Times New Roman, Times, Serif"><b><i>Bootheel</i></b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b><i>&#160;</i></b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">The
Bootheel uranium project is located in Albany County, Wyoming. On November 3, 2022, the Company entered into an agreement to sell the
Bootheel Uranium project to Nuclear Fuels, Inc, an arm&#8217;s length private company (Note 22(k)).</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt"><span style="font-family: Times New Roman, Times, Serif"><b><i>Dewey
Terrace</i></b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b><i>&#160;</i></b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">The
Dewey Terrace Project is located in Weston and Niobrara Counties of Wyoming. The project is located immediately adjacent to the Company&#8217;s
NRC licensed Dewey-Burdock Project along the Wyoming-South Dakota state line.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b><i>&#160;</i></b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt"><span style="font-family: Times New Roman, Times, Serif"><b><i>Juniper
Ridge</i></b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b><i>&#160;</i></b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">The
Juniper Ridge Project is located in the southwest portion of Wyoming, approximately 10 miles west of the town of Baggs.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt"><span style="font-family: Times New Roman, Times, Serif"><b><i><span style="text-decoration:underline">Utah
</span></i></b><i>(continued)</i></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><i>&#160;</i></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt"><span style="font-family: Times New Roman, Times, Serif"><b><i>Kaycee</i></b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b><i>&#160;</i></b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">The
Kaycee uranium project is located in Johnson County, Wyoming. On November 3, 2022, the Company entered into an agreement to sell the
Kaycee Uranium project to Nuclear Fuels, Inc, a private arm&#8217;s length company (Note 22(k)).</span></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cve_DisclosureOfMineralProperties">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cve_DisclosureOfMineralProperties</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cve_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cve_DisclosureOfMineralPropertiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cve_DisclosureOfMineralPropertiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cve_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>68
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139782927376304">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Asset retirement obligations<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_AssetretirementobligationsLineItems', window );"><strong>Asset retirement obligations [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_AssetRetirementObligationsTextBlock', window );">Asset retirement obligations</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%"><tr style="vertical-align: top">
<td style="width: 18pt"/><td style="width: 18pt"><span style="font-family: Times New Roman, Times, Serif"><b>12.</b></span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b>Asset
                                            retirement obligations</b></span></td></tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -18pt"><span style="font-family: Times New Roman, Times, Serif"><b>&#160;</b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">The
Company is obligated by various federal and state mining laws and regulations which require the Company to reclaim surface areas and
restore underground water quality for certain assets in Texas, Wyoming, Utah and Colorado. These projects must be returned to the pre-existing
or background average quality after completion of mining.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Annually,
the Company updates these reclamation provisions based on cash flow estimates, and changes in regulatory requirements and settlements.
This review may result in an adjustment to the asset retirement obligations in addition to the outstanding liability balance. The Company
used an inflation factor of 2.5% per year and a discount rate of 11% in estimating the present value of its future cash flows.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt"><span style="font-family: Times New Roman, Times, Serif">The
asset retirement obligations balance consists of:</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td style="text-align: center; padding-bottom: 1.5pt; padding-left: 0.125in">&#160;</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">December 31, <br/> 2022<br/> $</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="text-align: center; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">December 31, <br/> 2021<br/> $</td><td style="text-align: center; padding-bottom: 1.5pt">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; width: 76%">Kingsville</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">3,151,875</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">2,671,295</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-indent: -0.125in">Rosita</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,298,397</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,198,255</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in">Vasquez</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">34,274</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">39,137</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-indent: -0.125in">Centennial</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">168,806</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">168,806</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left">Gas Hills</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">63,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">63,000</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 1.5pt">Ticaboo</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">36,000</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">36,000</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; font-weight: bold; text-align: left; padding-bottom: 1.5pt">Asset retirement obligations</td><td style="font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">4,752,352</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">4,176,493</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt"><span style="font-family: Times New Roman, Times, Serif">The
asset retirement obligations continuity summary is as follows:</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom; ">
    <td style="border-bottom: Black 1.5pt solid; width: 88%; font-weight: bold; text-align: left; padding-bottom: 1.5pt">Asset retirement obligation</td><td style="width: 1%; font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; width: 1%; font-weight: bold; text-align: left"/><td style="border-bottom: Black 1.5pt solid; width: 9%; font-weight: bold; text-align: center">$</td><td style="width: 1%; padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Balance, December 31, 2020</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">5,239,108</td><td style="font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Accretion</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">400,710</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td>Adjustments</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(1,719,943</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Settlement</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(11,189</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt">Additions from Azarga asset acquisition (Note 10)</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">267,807</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1.5pt">Balance, December 31, 2021</td><td style="font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">4,176,493</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Accretion</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">429,956</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td>Settlement</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(11,324</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1.5pt">Adjustments</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">157,227</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font-weight: bold; padding-bottom: 1.5pt">Balance, December 31, 2022</td><td style="font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">4,752,352</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cve_AssetRetirementObligationsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cve_AssetRetirementObligationsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cve_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cve_AssetretirementobligationsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cve_AssetretirementobligationsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cve_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>69
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139782928979024">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Sales contracts<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_SalescontractsLineItems', window );"><strong>Sales contracts [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_DisclosueOfSalesContractsTextBlock', window );">Sales contracts</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif"><b>13.</b></span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b>Sales
                                            contracts</b></span></td></tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -18pt"><span style="font-family: Times New Roman, Times, Serif"><b>&#160;</b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">On
December 31, 2020, through an asset acquisition from Westwater Resources, Inc. the Company acquired an agreement with UG USA,&#160;Inc.
(&#8220;UG&#8221;). The contract provided for delivery of one-half of the Company&#8217;s actual production, for a total of 3,000,000
pounds U<sub>3</sub>O<sub>8</sub>, from its properties in Texas at discounted spot market prices. In August 2021, the Company and UG
agreed to terminate this agreement for a cancellation fee of $2,750,000, which was paid by the Company to UG on January 15, 2022.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">In
July 2021, the Company entered into a new uranium supply contract with UG. Pursuant to the agreement, UG will purchase U<sub>3</sub>O<sub>8
</sub>from the Company for up to 2,000,000 pounds U<sub>3</sub>O<sub>8 </sub>from 2023 through 2027. The sales price under the new agreement
will continue to be tied to spot market pricing.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">In
December 2021, the Company entered into a new uranium supply contract. Pursuant to the agreement, a large utility will purchase U<sub>3</sub>O<sub>8
</sub>from the Company for up to 1,300,000 pounds from 2024 through 2030. The sales price under the agreement will be tied to spot market
pricing with a ceiling price significantly higher than spot market price at the time of the agreement.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">In
June 2022, the Company entered into a new uranium supply contract. Pursuant to the agreement, a domestic utility will purchase U<sub>3</sub>O<sub>8
</sub>from the Company for up to 600,000 pounds commencing in 2025. The sales price will be market based with a floor price and an inflation
adjusted ceiling price.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">In
December 2022, the Company was awarded a contract to sell 100,000 pounds of uranium concentrates to the United States Government at a
price of $70.50 per pound.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">As
of December 31, 2022, uranium sales contracts over the next five years are as follows:</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Sales Commitments in Pounds</td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 88%">Fiscal 2023</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">500,000</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td>Fiscal 2024</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">600,000</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Fiscal 2025</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">700,000</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td>Fiscal 2026</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">700,000</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Fiscal 2027</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">650,000</td><td style="text-align: left">&#160;</td></tr>
  </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cve_DisclosueOfSalesContractsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosue of Sales contracts.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cve_DisclosueOfSalesContractsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cve_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cve_SalescontractsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cve_SalescontractsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cve_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>70
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139782929071248">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share Capital<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_ShareCapitalLineItems', window );"><strong>Share Capital [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfClassesOfShareCapitalExplanatory', window );">Share capital</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif"><b>14.</b></span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b>Share
                                            capital</b></span></td></tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -18pt"><span style="font-family: Times New Roman, Times, Serif"><b>&#160;</b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">The
authorized share capital of the Company consists of an unlimited number of common and preferred shares without par value.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt"><span style="font-family: Times New Roman, Times, Serif">During
the year ended December 31, 2022 the Company issued:</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.75in"/><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif">i)</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">6,535,947 units through a &#8220;bought deal&#8221; prospectus offering at a price of CAD $4.59 per unit, for gross proceeds of CAD $30,000,000 ($23,057,411). Each unit consisted of one common share and <span style="-sec-ix-hidden: hidden-fact-280">one-half</span> share purchase warrant. Each whole warrant entitles the holder to purchase one additional share at a price of CAD $6.00 for a period of two years. The Company paid commissions of CAD $1,612,500 <span style="-sec-ix-hidden: hidden-fact-278">($1,239,336)</span>, other cash issuance costs of CAD $305,159 ($234,539) and issued 351,307 finders&#8217; warrants with a fair value of CAD $874,785 ($672,343). The finder&#8217;s warrants are exercisable into one common share of the Company at a price of CAD $4.59 for two years from closing;</span></td></tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 72.3pt; text-align: justify; text-indent: -18pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.75in"/><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif">ii)</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">2,291,642 common shares were issued on the exercise of warrants, for gross proceeds of $2,452,227. In connection with certain of the warrants exercised, the Company reclassified $147,772 from contributed surplus and credited share capital;</span></td></tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 72.3pt; text-align: justify; text-indent: -18pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.75in"/><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif">iii)</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">1,016,436 common shares were issued on the exercised of stock options, for gross proceeds of $1,177,093. In connection with the stock options exercised, the Company reclassified $2,728,487 from contributed surplus and credited share capital; and</span></td></tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 72.3pt; text-align: justify; text-indent: -18pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.75in"/><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif">iv)</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">193,348 common shares for the settlement and compensation for services received in relation to the Company&#8217;s asset acquisition on December 31, 2021 (Note 10).</span></td></tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 72.3pt; text-align: justify; text-indent: -18pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt"><span style="font-family: Times New Roman, Times, Serif">During
the year ended December 31, 2021, the Company issued:</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%"><tr style="vertical-align: top">
<td style="width: 54.3pt"/><td style="width: 18pt"><span style="font-family: Times New Roman, Times, Serif">i)</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">5,000,000 units through a private placement at a price of CAD $3.00 per unit, for gross proceeds of CAD $15,000,000 ($11,966,494). Each unit consisted of one common share and <span style="-sec-ix-hidden: hidden-fact-281">one-half</span> share purchase warrant. Each whole warrant entitles the holder to purchase one additional share at a price of CAD $3.90 for a period of three years. The Company paid commissions of CAD $758,001 <span style="-sec-ix-hidden: hidden-fact-279">($604,708)</span>, other cash issuance costs of CAD $198,298 ($158,194) and issued 252,667 finders&#8217; warrants with a fair value of CAD $536,673 ($428,140). The finder&#8217;s warrants are exercisable into one common share of the Company at a price of CAD $3.00 for two years from closing;</span></td></tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 72.3pt; text-align: justify; text-indent: -18pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%"><tr style="vertical-align: top">
<td style="width: 54.3pt"/><td style="width: 18pt"><span style="font-family: Times New Roman, Times, Serif">ii)</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">2,052,843 common shares were issued on the exercise of warrants, for gross proceeds of $2,633,029. In connection with certain of the warrants exercised, the Company reclassified $166,751 from contributed surplus and credited share capital;</span></td></tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 72.3pt; text-align: justify; text-indent: -18pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%"><tr style="vertical-align: top">
<td style="width: 54.3pt"/><td style="width: 18pt"><span style="font-family: Times New Roman, Times, Serif">iii)</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">590,000 common shares were issued on the exercised of stock options, for gross proceeds of $288,572. In connection with the stock options exercised, the Company reclassified $269,039 from contributed surplus and credited share capital; and</span></td></tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 72.3pt; text-align: justify; text-indent: -18pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%"><tr style="vertical-align: top">
<td style="width: 54.3pt"/><td style="width: 18pt"><span style="font-family: Times New Roman, Times, Serif">iv)</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">31,806,617 common shares were issued in connection with the Azarga asset acquisition (Note 10).</span></td></tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 72.3pt; text-align: justify; text-indent: -18pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b>Stock
options</b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">The
Company has adopted a Stock Option Plan (the &#8220;Plan&#8221;) under which it is authorized to grant options to Officers, Directors,
employees and consultants enabling them to acquire common shares of the Company. The number of shares reserved for issuance under the
Plan cannot exceed 10% of the outstanding common shares at the time of the grant. The options can be granted for a maximum of five years
and vest as determined by the Board of Directors.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">The
Company&#8217;s stock options outstanding at December 31, 2022 and December 31, 2021, and the changes for the years then ended, are as
follows:</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">Year
    ended <br/>
December 31, 2022</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="6" style="text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">Year
    ended <br/>
December 31, 2021</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">Weighted average</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">Weighted average</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">Options</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">exercise price</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">Options</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">exercise price</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">#</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">CAD
    $</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">#</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">CAD
    $</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 52%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Options outstanding, beginning
    of year</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">5,272,294</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">1.42</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">3,572,084</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">0.66</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td><span style="font-family: Times New Roman, Times, Serif">Granted</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">3,107,501</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">4.10</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">2,390,627</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">2.31</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif">Exercised</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(1,016,439</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">1.51</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(590,000</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">0.60</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Forfeited/expired</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(127,708</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">3.60</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(100,417</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">0.54</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Options
    outstanding, end of year</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">7,235,648</span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">2.53</span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">5,272,294</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">1.42</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Options
    exercisable, end of year</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">4,928,147</span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">1.79</span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">4,515,210</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">1.23</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">As
of December 31, 2022, stock options outstanding were as follows:</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">Options
    Outstanding<br/> December 31, 2022</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">Options
    Exercisable<br/> December 31, 2022</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">Weighted average</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">Weighted average</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">Weighted average</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif">Option price</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">Options</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">Remaining</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">exercise price</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">Options</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">exercise price</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td colspan="2" style="border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">per share</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">#</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">Life</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">CAD
    $</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">#</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">CAD
    $</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 14%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.18
- 1.92</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 14%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">3,381,771</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 14%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">0.88</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 14%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">0.85</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 14%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">3,381,771</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 13%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">0.85</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">$</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.40
- 3.78</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">1,034,710</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">0.57</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">3.12</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">594,710</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">2.83</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.20
- 5.76</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">2,819,166</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">1.53</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">4.29</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">951,666</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">4.42</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">7,235,647</span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">2.99</span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">2.52</span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">4,928,147</span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">1.78</span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">During
the year ended December 31, 2022, the Company granted an aggregate of 3,107,501 stock options to Directors, Officers, and consultants
of the Company. A fair value of $7,665,042 was calculated for these options as measured at the grant date using the Black-Scholes option
pricing model.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">During
the year ended December 31, 2021, the Company granted an aggregate of 2,390,627 stock options to Directors, Officers, and consultants
of the Company. A fair value of $1,484,302 was calculated for these options as measured at the grant date using the Black-Scholes option
pricing model.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Further,
pursuant to the Company&#8217;s acquisition of Azarga during the year ended December 31, 2021 (Note 10), the Company issued replacement
stock options at the acquisition date vested immediately and retained their original expiration date, except for terminated Directors,
Officers, employees, and consultants. For these terminated positions, the stock options had a revised term that was 12 months from the
date of their resignation.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">The
Company&#8217;s standard stock option vesting schedule calls for 25% every six months commencing six months after the grant date.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">During
the year ended December 31, 2022, the Company recognized stock option expense of $5,744,655 (2021 - $1,425,645) for the vested portion
of the stock options.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">The
fair value of all compensatory options granted is estimated on the grant date using the Black-Scholes option pricing model. The weighted
average assumptions used in calculating the fair values are as follows:</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">December
    31, <br/> 2022</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">December
    31, <br/> 2021</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Risk-free interest rate</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">2.06</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">0.88</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Expected life of option</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.9 years</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5 years</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Expected dividend yield</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">0</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">0</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Expected stock price volatility</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">116.48</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">128.79</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif">Fair value per option</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">CAD
                                            $3.21</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">CAD
                                            $1.10</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt"><span style="font-family: Times New Roman, Times, Serif"><b>Share
purchase warrants</b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b>&#160;</b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">A
summary of the status of the Company&#8217;s warrants as of December 31, 2022, and December 31, 2021, and changes during the years then
ended is as follows:</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Year
    ended <br/> December 31, 2022</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Year
    ended <br/> December 31, 2021</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">Warrants</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">Weighted average exercise price</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">Warrants</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">Weighted average exercise price</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif">#</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif">CAD
    $</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif">#</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif">CAD
    $</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 52%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Warrants outstanding, beginning
    of year</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">6,298,839</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">2.43</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">4,143,247</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">1.23</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: 0.125in"><span style="font-family: Times New Roman, Times, Serif">Granted</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">3,670,919</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">5.81</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">4,208,435</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">3.24</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: 0.125in"><span style="font-family: Times New Roman, Times, Serif">Exercised</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(2,291,642</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">1.39</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(2,052,843</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">1.62</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: 0.125in; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Expired</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(183,610</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">1.67</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Warrants
    outstanding, end of year</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">7,494,506</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">4.43</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">6,298,839</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">2.43</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt"><span style="font-family: Times New Roman, Times, Serif">As
of December 31, 2022, share purchase warrants outstanding were as follows:</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: center; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: center; padding-bottom: 1.5pt">&#160;</td>
                                                                                                                          <td style="text-align: center; padding-bottom: 1.5pt">&#160;</td>
                                                                                                                          <td colspan="6" style="border-bottom: Black 1.5pt solid; text-align: center; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"><b>Warrants Outstanding<br/> December 31, 2022</b></span></td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">Weighted average</span></td><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">Weighted average</span></td><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Warrant price</span></td><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">Warrants</span></td><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">Remaining</span></td><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">exercise price</span></td><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">per share</span></td><td style="padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif">#</span></td><td style="text-align: center; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Life</span></td><td style="text-align: center; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif">CAD
    $</span></td><td style="text-align: center; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; width: 46%"><span style="font-family: Times New Roman, Times, Serif">$1.59 - 1.80</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 15%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">1,360,028</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 15%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">0.14</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 15%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">1.81</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$2.22 - 3.90 <sup>1</sup></span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">2,515,197</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">0.39</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">3.84</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">$4.59 - 6.00</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">3,619,281</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">0.59</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">5.86</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">7,494,506</span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">1.12</span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">4.43</span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif"><sup>1</sup></span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Includes power warrants exercisable into one share and <span style="-sec-ix-hidden: hidden-fact-282">one-half</span> warrant. Each whole warrant is exercisable at $3.90 for 36 months.</span></td>
</tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b>&#160;</b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b>Share
subscriptions received</b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">As
of December 31, 2022, the Company has received CAD $69,831,000 ($50,051,595) in share subscriptions pertaining to a financing that closed
subsequently (Note 22(b)).</span></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cve_ShareCapitalLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cve_ShareCapitalLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cve_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfClassesOfShareCapitalExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of classes of share capital. [Refer: Share capital [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2022-03-24<br> -Paragraph 79<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_79_a&amp;doctype=Standard<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfClassesOfShareCapitalExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>71
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139782929146912">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Related party transactions and balances<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_DisclosureOfRelatedPartyTextBlockAbstract', window );"><strong>Related party transactions and balances [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfRelatedPartyExplanatory', window );">Related party transactions and balances</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%"><tr style="vertical-align: top">
<td style="width: 18pt"/><td style="width: 18pt"><span style="font-family: Times New Roman, Times, Serif"><b>15.</b></span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b>Related
                                            party transactions and balances</b></span></td></tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -18pt"><span style="font-family: Times New Roman, Times, Serif"><b>&#160;</b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Related
parties include key management of the Company and any entities controlled by these individuals as well as other entities providing key
management services to the Company. Key management personnel consist of Directors and senior management including the Executive Chairman,
Chief Executive Officer, Chief Financial Officer, Chief Operating Officer, and Chief Administrative Officer.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt"><span style="font-family: Times New Roman, Times, Serif">The
amounts paid to key management or entities providing similar services are as follows:</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">December
    31, <br/> 2022<br/> $</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif">December
    31, <br/> 2021<br/> $</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%"><span style="font-family: Times New Roman, Times, Serif">Consulting</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 9%; text-align: center"><span style="font-family: Times New Roman, Times, Serif">(1</span>)</td><td style="width: 1%; text-align: left"/><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">103,514</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">61,899</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Data acquisition</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">(2</span>)</td><td style="text-align: left"/><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">55,150</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-283; font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Directors&#8217; fees</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">(3</span>)</td><td style="text-align: left"/><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">192,604</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-284; font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Office and administration</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-285; font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">13,402</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Staff costs</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">1,607,211</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">1,151,731</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Stock option expense</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">4,729,503</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">749,255</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Total
    key management compensation</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">6,687,982</span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">1,976,287</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">(1)</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">- During the year ended December 31, 2022, the Company incurred communications &amp; community engagement consulting fees of $103,514 (2021 - $61,899) according to a contract with Tintina Holdings, Ltd., a company owned and operated by the spouse of the Company&#8217;s Executive Chairman.</span></td>
</tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">(2)</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">- In June 2022, the Company acquired access to the Getty Minerals database pursuant to a purchase agreement with Platoro West Inc., a company owned and operated by the Company&#8217;s Executive Chairman (Note 7).</span></td>
</tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">(3)</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#8211; Directors&#8217; Fees are included in staff costs on the consolidated statement of loss and other comprehensive income (loss).</span></td>
</tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">During
the year ended December 31, 2022, the Company granted 2,566,667 options to key management, with a fair value of $6,496,785 (2021 &#8211;
150,000 with a fair value of $384,881).</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">As
of December 31, 2022 and December 31, 2021, the following amounts were owing to related parties:</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: 18pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">December
    31, <br/> 2022<br/> $</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif">December
    31, <br/> 2021<br/> $</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif">January
    1, <br/> 2021<br/> $</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 32%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Tintina Holdings, Ltd</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 31%; text-align: left; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif">Consulting
    services</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">12,744</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">6,893</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">0</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Officers and Board members</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left; padding-bottom: 1.5pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif">Accrued
    compensation</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">428,630</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-286; font-family: Times New Roman, Times, Serif">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">2,319</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="padding-bottom: 1.5pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">441,374</span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">6,893</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">2,319</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cve_DisclosureOfRelatedPartyTextBlockAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cve_DisclosureOfRelatedPartyTextBlockAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cve_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfRelatedPartyExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for related parties.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 24<br> -IssueDate 2022-03-24<br> -Section Disclosures<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=24&amp;code=ifrs-tx-2022-en-r&amp;doctype=Standard&amp;dita_xref=IAS24_g13-24__IAS24_g13-24_TI<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfRelatedPartyExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>72
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139782929134960">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Management of capital<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_DisclosureOfHowEntityManagesLiquidityRiskTextBlockAbstract', window );"><strong>Disclosure Of How Entity Manages Liquidity Risk Text Block Abstract</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfManagingLiquidityRisk', window );">Management of capital</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif"><b>16.</b></span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b>Management
                                            of capital</b></span></td></tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -18pt"><span style="font-family: Times New Roman, Times, Serif"><b>&#160;</b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">The
Company&#8217;s objectives when managing capital are to safeguard its ability to continue as a going concern in order to support the
exploration, evaluation, and development of its mineral properties and to maintain a flexible capital structure that optimizes the cost
of capital within a framework of acceptable risk. The Company manages the capital structure and makes adjustments to it in light of changes
in economic conditions and the risk characteristics of the underlying assets. To maintain or adjust its capital structure, the Company
may issue new shares, issue debt, and acquire or dispose of assets.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">The
Company is dependent on the capital markets as its primary source of operating capital and the Company&#8217;s capital resources are
largely determined by the strength of the junior resource markets, the status of the Company&#8217;s projects in relation to these markets,
and its ability to compete for investor support of its projects.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt"><span style="font-family: Times New Roman, Times, Serif">The
Company considers the components of shareholders&#8217; equity as capital.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b>&#160;</b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">There
were no changes in the Company&#8217;s approach to capital management during the year ended December 31, 2022, and the Company is not
subject to any externally imposed capital requirements.</span></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cve_DisclosureOfHowEntityManagesLiquidityRiskTextBlockAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cve_DisclosureOfHowEntityManagesLiquidityRiskTextBlockAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cve_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfManagingLiquidityRisk">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of how the entity manages its liquidity risk. [Refer: Liquidity risk [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 7<br> -IssueDate 2022-03-24<br> -Paragraph 39<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_39_c&amp;doctype=Standard<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfManagingLiquidityRisk</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>73
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139782929081824">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Financial Instruments<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_DisclosureOfFinancialInstrumentsTextBlockAbstract', window );"><strong>Disclosure Of Financial Instruments Text Block Abstract</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialInstrumentsExplanatory', window );">Schedule of financial instrument</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif"><b>17.</b></span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b>Financial
                                            instruments</b></span></td>
</tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 18pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b>&#160;</b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Financial
instruments include cash, receivables and marketable securities and any contract that gives rise to a financial asset to one party and
a financial liability or equity instrument to another party. Financial assets and liabilities measured at fair value are classified in
the fair value hierarchy according to the lowest level of input that is significant to the fair value measurement. Assessment of the
significance of a particular input to the fair value measurement requires judgement and may affect placement within the fair value hierarchy
levels. The hierarchy is as follows:</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.75in"/><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Level
                                            1 fair value measurements are those derived from quoted prices in active markets for identical
                                            assets or liabilities. </span></td></tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 72pt; text-align: justify; text-indent: -18pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.75in"/><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Level
                                            2 fair value measurements are those derived from inputs other than quoted prices included
                                            within Level 1, that are observable either directly or indirectly. </span></td></tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 72pt; text-align: justify; text-indent: -18pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.75in"/><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Level
                                            3 fair value measurements are those derived from valuation techniques that include inputs
                                            that are not based on observable market data. </span></td></tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 72pt; text-align: justify; text-indent: -18pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Cash,
restricted cash, and marketable securities are measured at Level 1 of the fair value hierarchy. The Company classifies its receivables
as financial assets measured at amortized cost. Accounts payable and accrued liabilities, lease liability and due to related parties
and notes payable are classified as financial liabilities measured at amortized cost. The carrying amounts of receivables, accounts payable
and accrued liabilities, and amounts due to related parties approximate their fair values due to the short-term nature of the financial
instruments.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Investments
in uranium are measured at Level 2 of the fair value hierarchy. The Company classifies these investments as financial assets measured
at fair value as determined based on the most recent month-end spot prices for uranium published by UxC and converted to Canadian dollars
at the date of the consolidated statement of financial position.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Marketable
securities are measured at Level 1 of the fair value hierarchy. The Company classifies these investments as financial assets whose value
is derived from quoted prices in active markets and carries them at FVTPL.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt"><span style="font-family: Times New Roman, Times, Serif">Discussions
of risks associated with financial assets and liabilities are detailed below:</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt"><span style="font-family: Times New Roman, Times, Serif"><b>Currency
risk</b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b>&#160;</b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Foreign
currency exchange risk is the risk that future cash flows, net income and comprehensive income will fluctuate as a result of changes
in foreign exchange rates. As the Company&#8217;s operations are conducted internationally, operations and capital activity may be transacted
in currencies other than the functional currency of the entity party to the transaction.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">The
Company&#8217;s objective in managing its foreign currency risk is to minimize its net exposures to foreign currency cash flows by obtaining
most of its estimated annual U.S. cash requirements and holding the remaining currency in Canadian dollars. The Company monitors and
forecasts the values of net foreign currency cash flow and consolidated statement of financial position exposures and from time to time
could authorize the use of derivative financial instruments such as forward foreign exchange contracts to economically hedge a portion
of foreign currency fluctuations.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">The
following table provides an indication of the Company&#8217;s foreign currency exposures during the years ended December 31, 2022 and
2021:</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">December
    31, <br/> 2022<br/> CAD $</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif">December
    31, <br/> 2021<br/> CAD $</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%"><span style="font-family: Times New Roman, Times, Serif">Cash</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">216,871</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">5,689,671</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Marketable Securities - Current</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">3,162,362</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-287; font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Accounts payable and
    accrued liabilities</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(2,890,582</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(2,557,849</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">488,651</span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">3,131,822</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">A
10% change in Canadian/US foreign exchange rate at year end would have changed the net loss of the Company, assuming that all other variables
remained constant, by approximately $352,315 for the year ended December 31, 2022 (2021 - $247,028).</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">The
Company has not, to the date of these financial statements, entered into derivative instruments to offset the impact of foreign currency
fluctuations.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt"><span style="font-family: Times New Roman, Times, Serif"><b>Credit
risk</b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b>&#160;</b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Credit
risk arises from cash held with banks and financial institutions and receivables. The maximum exposure to credit risk is equal to the
carrying value of these financial assets. The Company&#8217;s cash is primarily held with a major Canadian bank.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b>&#160;</b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt"><span style="font-family: Times New Roman, Times, Serif"><b>Market
risk</b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b>&#160;</b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">The
Company is exposed to market risk because of the fluctuating values of its publicly traded marketable securities (Note 6). The Company
has no control over these fluctuations and does not hedge its investments. Based on the December 31, 2022 value of marketable securities
every 10% increase or decrease in the share prices of their holdings would have impacted loss for the period, up or down, by approximately
$394,719 (2021 - $<span style="-sec-ix-hidden: hidden-fact-288">nil</span>) before income taxes.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Further,
the Company is in the exploration stage and commodity prices are not reflected in operating financial results. However, fluctuations
in commodity prices may influence financial markets and may indirectly affect the Company&#8217;s ability to raise capital to fund exploration.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt"><span style="font-family: Times New Roman, Times, Serif"><b>Interest
rate risk</b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b>&#160;</b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Interest
rate risk mainly arises from the Company&#8217;s cash, which receives interest based on market interest rates. Fluctuations in interest
cash flows due to changes in market interest rates are not significant.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt"><span style="font-family: Times New Roman, Times, Serif"><b>Liquidity
risk</b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b>&#160;</b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Liquidity
risk is the risk that the Company will not be able to meet its current obligations as they become due. The majority of the Company&#8217;s
accounts payable and accrued liabilities are payable in less than 90 days. The Company prepares annual exploration and administrative
budgets and monitors expenditures to manage short-term liquidity. Due to the nature of the Company&#8217;s activities, funding for long-term
liquidity needs is dependent on the Company&#8217;s ability to obtain additional financing through various means, including equity financing.</span></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cve_DisclosureOfFinancialInstrumentsTextBlockAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cve_DisclosureOfFinancialInstrumentsTextBlockAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cve_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfFinancialInstrumentsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for financial instruments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 7<br> -IssueDate 2022-03-24<br> -Section Scope<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2022-en-r&amp;doctype=Standard&amp;dita_xref=IFRS07_g3-5A__IFRS07_g3-5A_TI<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfFinancialInstrumentsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>74
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139782928911984">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segmented information<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_SegmentedinformationLineItems', window );"><strong>Segmented information [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfEntitysReportableSegmentsExplanatory', window );">Segmented information</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%"><tr style="vertical-align: top">
<td style="width: 18pt"/><td style="width: 18pt"><span style="font-family: Times New Roman, Times, Serif"><b>18.</b></span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b>Segmented
                                            information</b></span></td></tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -18pt"><span style="font-family: Times New Roman, Times, Serif"><b>&#160;</b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">The
Company operates in a single segment: the acquisition, exploration, and development of mineral properties in the United States.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">The
table below provides a breakdown of the Company&#8217;s long-term assets by geographic segment:</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; text-align: left; padding-left: 0.125in; text-indent: -0.125in"><span style="font-family: Times New Roman, Times, Serif">Balance
    Sheet Items</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif">South
    Dakota<br/> $</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Texas<br/>
    $</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif">New
    Mexico<br/> $</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Wyoming<br/>
    $</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Other
    States <br/> $</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Canada<br/>
    $</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Total<br/>
    $</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-left: 0.125in; text-indent: -0.125in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; width: 16%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Intangible
    assets</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 9%; text-align: right"><span style="-sec-ix-hidden: hidden-fact-289; font-family: Times New Roman, Times, Serif">-</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">67,251</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">217,241</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 9%; text-align: right"><span style="-sec-ix-hidden: hidden-fact-290; font-family: Times New Roman, Times, Serif">-</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">207,504</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 9%; text-align: right"><span style="-sec-ix-hidden: hidden-fact-291; font-family: Times New Roman, Times, Serif">-</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">491,996</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Property,
    plant and equipment</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">62,946</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">1,540,733</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-292; font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-293; font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-294; font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-295; font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">1,603,679</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Mineral
    properties</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">85,667,919</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">1,455,206</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">4,395,822</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">41,235,727</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">3,324,904</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-296; font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">136,079,578</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Right-of-use
    assets</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-297; font-family: Times New Roman, Times, Serif">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">199,120</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-298; font-family: Times New Roman, Times, Serif">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-299; font-family: Times New Roman, Times, Serif">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-300; font-family: Times New Roman, Times, Serif">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">45,444</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">244,564</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Balance,
    December 31, 2021</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">85,730,865</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">3,262,310</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">4,613,063</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">41,235,727</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">3,532,408</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">45,444</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">138,419,817</span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-indent: -0.125in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Intangible
    assets</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-301; font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">122,401</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">217,241</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-302; font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">188,640</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-303; font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">528,282</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Property,
    plant and equipment</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">60,630</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">2,273,791</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-304; font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-305; font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-306; font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-307; font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">2,334,421</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Mineral
    properties</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">86,220,848</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">9,144,069</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">4,905,348</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">41,754,462</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">3,194,359</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-308; font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">145,219,086</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Right-of-use
    assets</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-309; font-family: Times New Roman, Times, Serif">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">168,871</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-310; font-family: Times New Roman, Times, Serif">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-311; font-family: Times New Roman, Times, Serif">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-312; font-family: Times New Roman, Times, Serif">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">16,743</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">185,614</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Balance,
    December 31, 2022</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">86,281,478</span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">11,709,132</span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">5,122,589</span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">41,754,462</span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">3,382,999</span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">16,743</span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">148,267,403</span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cve_SegmentedinformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cve_SegmentedinformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cve_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfEntitysReportableSegmentsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for operating segments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2022-03-24<br> -Section Disclosure<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2022-en-r&amp;doctype=Standard&amp;dita_xref=IFRS08_g20-24__IFRS08_g20-24_TI<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfEntitysReportableSegmentsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>75
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139782928952064">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Supplemental disclosure with respect to cash flows<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_SupplementalDisclosureWithRespectToCashflowsAbstract', window );"><strong>Supplemental Disclosure With Respect To Cashflows Abstract</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_SupplementalDisclosureWithRespectToCashflowsTextBlock', window );">Supplemental disclosure with respect to cash flows</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif"><b>19.</b></span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b>Supplemental
                                            disclosure with respect to cash flows</b></span></td></tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">The
Company incurred non-cash financing and investing activities during the years ended December 31, 2022, and December 31, 2021 as follows:</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"/><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">December 31,</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">December 31,</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2022</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">2021</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">Non-cash financing activities:</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: 0.125in; width: 76%; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Deferred
    financing costs remaining in accounts payable and accrued liabilities</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">1,513,220</span></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-313; font-family: Times New Roman, Times, Serif">-</span></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">1,513,220</span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-314; font-family: Times New Roman, Times, Serif">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Non-cash investing activities:</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: 0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Marketable securities
    received on disposition of mineral properties</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">3,051,564</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-315; font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: 0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Mineral property costs
    included in accounts payable and accrued liabilities</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">27,040</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-316; font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: 0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Property, plant, and
    equipment additions included in accounts payable and accrued liabilities</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">20,090</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-317; font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: 0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Fair value of common
    shares issued for Azarga asset acquisition</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-318; font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">121,796,381</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: 0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Fair value of replacement
    options issued for Azarga asset acquisition</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-319; font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">5,496,037</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: 0.125in; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Fair
    value of replacement warrants issued for Azarga asset acquisition</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-320; font-family: Times New Roman, Times, Serif">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">3,259,306</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">3,098,694</span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">130,551,724</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">There
were no amounts paid for income taxes or interest during the years ended December 31, 2022, and December 31, 2021.</span></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cve_SupplementalDisclosureWithRespectToCashflowsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cve_SupplementalDisclosureWithRespectToCashflowsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cve_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cve_SupplementalDisclosureWithRespectToCashflowsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cve_SupplementalDisclosureWithRespectToCashflowsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cve_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>76
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139782928991040">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income taxes<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_DisclosureOfIncomeTaxTextBlockAbstract', window );"><strong>Disclosure Of Income Tax Text Block Abstract</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfIncomeTaxExplanatory', window );">Income taxes</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif"><b>20.</b></span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b>Income
                                            taxes</b></span></td></tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -18pt"><span style="font-family: Times New Roman, Times, Serif"><b>&#160;</b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">The
actual income tax provision differs from the expected amount calculated by applying the Canadian combined federal and provincial corporate
tax rates to income before tax. These differences result from the following:</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">December 31,</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-style: normal; text-align: center; font-weight: normal"><span style="font-family: Times New Roman, Times, Serif">December
    31,</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2022</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">2021</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Loss before income tax</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(16,515,389</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(8,563,473</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Statutory income tax
    rate</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">27</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">27</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Expected income tax expense (recovery)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(4,459,155</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(2,312,138</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Increase (decrease) resulting from:</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: 0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Change in unrecognized
    temporary differences</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">2,949,101</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">1,800,688</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: 0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Permanent differences</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">1,159,884</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">433,595</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: 0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Effect of tax rates in
    foreign jurisdictions</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">146,727</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">77,855</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: 0.125in"><span style="font-family: Times New Roman, Times, Serif">Share issue costs</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">201,740</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-321; font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: 0.125in; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Prior period adjustments</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">1,703</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-322; font-family: Times New Roman, Times, Serif">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Income
    tax expense (recovery)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-323; font-family: Times New Roman, Times, Serif">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-324; font-family: Times New Roman, Times, Serif">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b><span style="text-decoration:underline">Recognized
deferred tax assets and liabilities</span></b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt"><span style="font-family: Times New Roman, Times, Serif">Deferred
tax assets are attributable to the following:</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b>&#160;</b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b><span style="text-decoration:underline">Income
tax expense (recovery)</span></b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">December 31,</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">December 31,</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2022</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">2021</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">Deferred tax expense (recovery)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Organization and reversal of temporary
    differences</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(2,949,101</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(1,800,688</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Change in unrecognized
    temporary differences</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">2,949,101</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">1,800,688</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Income
    tax expense (recovery)</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="-sec-ix-hidden: hidden-fact-325; font-family: Times New Roman, Times, Serif">-</span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="-sec-ix-hidden: hidden-fact-326; font-family: Times New Roman, Times, Serif">-</span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif"><b>&#160;</b></span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"><b>&#160;</b></span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><b>2022</b></span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"><b>&#160;</b></span></td><td><span style="font-family: Times New Roman, Times, Serif"><b>&#160;</b></span></td>
    <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">2021</span></td><td><span style="font-family: Times New Roman, Times, Serif"><b>&#160;</b></span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif"><b>&#160;</b></span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"><b>&#160;</b></span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif"><b>$</b></span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"><b>&#160;</b></span></td><td><span style="font-family: Times New Roman, Times, Serif"><b>&#160;</b></span></td>
    <td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"><b>&#160;</b></span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Loss carryforwards</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">488,823</span></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">52,244</span></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Deferred tax assets</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">488,823</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">52,244</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Set-off of tax</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(488,823</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(52,244</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Net
    deferred tax assets</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-327; font-family: Times New Roman, Times, Serif">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-328; font-family: Times New Roman, Times, Serif">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Deferred
tax liabilities are attributable to the following:</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">December 31,</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">December 31,</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2022</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">2021</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Intangible assets</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(39,481</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 9%; text-align: right"><span style="-sec-ix-hidden: hidden-fact-329; font-family: Times New Roman, Times, Serif">-</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Right-of-use assets</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(42,472</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(52,244</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Fixed assets</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(276,699</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Right-of-use assets</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(130,171</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-330; font-family: Times New Roman, Times, Serif">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Marketable securities</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(488,823</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(52,244</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Set-off of tax</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">488,823</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">52,244</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Net
    deferred tax liability</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-331; font-family: Times New Roman, Times, Serif">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-332; font-family: Times New Roman, Times, Serif">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b><span style="text-decoration:underline">Unrecognized
deferred tax assets</span></b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">December 31,</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">December 31,</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2022</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">2021</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Deductible temporary differences</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">3,920,076</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">2,576,276</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Tax losses</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">26,069,552</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">12,754,678</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">29,989,628</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">15,330,954</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Deferred tax assets have not been recognized
in respect of the above items, because it is not probable that future taxable profit will be available against which the Company can use
the benefits therefrom.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The Company has Canadian non-capital
loss carryforwards of $28,628,469 (December 31, 2021 - $22,107,188), that will start expiring in 2028 and US federal net operating loss
carryforwards of $21,099,321 (December 31, 2021 - $11,232,201), of which $15,223,100 can be carried forward indefinitely and $5,876,221
that will start expiring in 2027.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cve_DisclosureOfIncomeTaxTextBlockAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cve_DisclosureOfIncomeTaxTextBlockAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cve_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfIncomeTaxExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for income taxes.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2022-03-24<br> -Section Disclosure<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2022-en-r&amp;doctype=Standard&amp;dita_xref=IAS12_g79-88__IAS12_g79-88_TI<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfIncomeTaxExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>77
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139782921311904">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Change in Presentation Currency<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_DisclosureOfReclassificationsOrChangesInPresentationTextBlockAbstract', window );"><strong>Disclosure Of Reclassifications Or Changes In Presentation Text Block Abstract</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfReclassificationsOrChangesInPresentationExplanatory', window );">Change in presentation currency</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif"><b>21.</b></span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b>Change
                                            in presentation currency </b></span></td></tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">For
comparative purposes, the consolidated statements of financial position as of December 31, 2021 and January 1, 2021 includes adjustments
to reflect the change in accounting policy resulting from the change in presentation currency to the U.S. Dollar. The amounts previously
reported in Canadian Dollars as shown below have been translated into U.S. Dollars at the December 31, 2021 and January 1, 2021 exchange
rates (Note 2). The effect of the translation is as follows:</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"><span style="text-decoration:underline">As at January 1, 2021</span></span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">Previously
    reported (CAD$)</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">Translated
    (USD$)</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Current assets</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">6,926,844</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">5,436,341</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Non-current
    assets</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">16,516,119</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">12,918,903</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Total
    assets</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">23,442,963</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">18,355,244</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Current liabilities</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">900,300</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">707,056</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Non-current
    liabilities</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">6,674,405</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">5,242,229</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Total
    liabilities</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">7,574,705</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">5,949,285</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
</table><p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"><span style="text-decoration:underline">As at December 31, 2021</span></span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Previously
    reported (CAD$)</span></td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Translated
    (USD$)</span></td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Current assets</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">14,651,619</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">11,556,728</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Non-current
    assets</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">187,434,040</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">147,799,796</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Total
    assets</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">202,085,659</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">159,356,524</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Current liabilities</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">7,510,606</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">5,924,125</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Non-current
    liabilities</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">5,507,178</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">4,343,886</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Total
    liabilities</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">13,017,784</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">10,268,011</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">For comparative purposes, the consolidated
statements of loss and comprehensive loss for the year ended December 31, 2021 includes adjustments to reflect the change in accounting
policy resulting from the change in presentation currency to the U.S. Dollar. The amounts previously reported in Canadian Dollars as shown
below have been translated into U.S. Dollars at the average 2021 exchange rate (Note 2). The effect of the translation is as follows:</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"/><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">Previously
    reported (CAD$)</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">Translated
    (USD$)</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">Expenses</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: 0.125in; width: 76%"><span style="font-family: Times New Roman, Times, Serif">Accretion</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">502,291</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">408,181</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: 0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Amortization and depreciation</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">374,455</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">298,666</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: 0.125in"><span style="font-family: Times New Roman, Times, Serif">Consulting</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">91,161</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">72,726</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: 0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">General administrative costs</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">4,429,209</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">3,533,474</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: 0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Impairment charges</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">98,345</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">78,456</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: 0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Interest expense</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">9,365</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-333; font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: 0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Office and administrative</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">247,433</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">197,391</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: 0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Professional fees</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">728,793</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">581,408</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: 0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Promotion and shareholder communication</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">208,201</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">166,096</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: 0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Reclamation costs</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">889,154</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">709,399</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: 0.125in"><span style="font-family: Times New Roman, Times, Serif">Travel</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">33,355</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">26,609</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: 0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Transfer agent and filing fees</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">167,612</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">133,717</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: 0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Staff costs</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">1,983,446</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">1,582,326</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: 0.125in; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Stock option expense</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">1,787,046</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">1,425,645</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Loss from operating expenses</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(11,549,866</span></td><td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(9,214,094</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: 0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Interest income</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">26,307</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">20,987</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: 0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Foreign exchange gain</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">34,174</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">27,263</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: 0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Loss on divestment of mineral properties</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(112,708</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(89,914</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: 0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Gain on change in asset retirement obligation
    estimate</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">2,155,949</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">1,719,943</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: 0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Loss on contract termination</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(3,447,125</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(2,750,000</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: 0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Unrealized gain on uranium investment</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">1,947,939</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">1,554,000</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: 0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Gain on sale of uranium investment</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">656,928</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">524,075</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: 0.125in; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Loss on investment in
    associate</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(445,914</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(355,735</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: 0.125in; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Net loss for the year</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(10,734,316</span></td><td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(8,563,475</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: 0.125in; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Exchange differences
    on translation foreign operations</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">206,082</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(1,325,855</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Other
    comprehensive loss for the year</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(10,528,234</span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(9,889,330</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt"><span style="-sec-ix-hidden: hidden-fact-335; -sec-ix-hidden: hidden-fact-334; font-family: Times New Roman, Times, Serif">Loss per share - basic and diluted</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(0.05</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(0.13</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cve_DisclosureOfReclassificationsOrChangesInPresentationTextBlockAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cve_DisclosureOfReclassificationsOrChangesInPresentationTextBlockAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cve_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfReclassificationsOrChangesInPresentationExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of reclassifications or changes in the presentation of items in the financial statements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2022-03-24<br> -Paragraph 41<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_41&amp;doctype=Standard<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfReclassificationsOrChangesInPresentationExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>78
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139782928982752">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Events after the reporting period<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_DisclosureOfEventsAfterReportingPeriodTextBlockAbstract', window );"><strong>Events after the reporting period [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfEventsAfterReportingPeriodExplanatory', window );">Events after the reporting period</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif"><b>22.</b></span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b>Events
                                            after the reporting period</b></span></td>
</tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b>&#160;</b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Subsequent
to December 31, 2022, the following reportable events were completed:</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%"><tr style="vertical-align: top">
<td style="width: 36pt"/><td style="width: 18pt"><span style="font-family: Times New Roman, Times, Serif"><b>(a)</b></span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">On February 14<sup>th</sup>, the Company completed its acquisition of the Alta Mesa project, a fully-licensed and constructed ISR processing facility, from Energy Fuels, Inc. Consideration paid to Energy Fuels, Inc in the transaction consisted of $60,000,000 in cash and a $60,000,000 secured vendor take-back convertible promissory note. The note has a two year term and bears interest at a rate of 8% per annum payable on June 30<sup>th</sup> and December 31<sup>st </sup>of each year during the term. The note is convertible at the election of the holder, to acquire common shares of enCore at a price of US$2.9103 per share.</span></td></tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54pt; text-align: justify; text-indent: -18pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%"><tr style="vertical-align: top">
<td style="width: 36pt"/><td style="width: 18pt"><span style="font-family: Times New Roman, Times, Serif"><b>(b)</b></span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">In connection with the closing of the Alta Mesa Acquisition, 23,277,000 subscription receipts issued December 6, 2022 at a price of C$3.00 were automatically converted into units comprised of one common share of the Company and one common share purchase warrant, with each warrant entitling the holder to acquire one common share of enCore at a price of C$3.75 for a period of three years. The net proceeds from the Subscription Receipt Offering of $49,392,680 (CAD $66,072,588), have been released from escrow to the Company.</span></td></tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54pt; text-align: justify; text-indent: -18pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">On
February 8, 2023, the Company issued 10,615,650 units for a public offering at a price of C$3.25 per unit for gross proceeds of C$34,500,863.
Each unit consisted of one common share and one-half share purchase warrant. Each whole warrant entitles the holder to purchase one additional
share at a price of C$4.05 for a period of three years.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%"><tr style="vertical-align: top">
<td style="width: 36pt"/><td style="width: 18pt"><span style="font-family: Times New Roman, Times, Serif"><b>(c)</b></span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Subsequent to the year ended December 31, 2022 the Company issued 229,946 shares pursuant to the exercise of stock options for gross proceeds of $391,958 CAD.</span></td></tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54pt; text-align: justify; text-indent: -18pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Subsequent
to the year ended December 31, 2022 75,312 stock options outstanding at December 31, 2022 have expired.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%"><tr style="vertical-align: top">
<td style="width: 36pt"/><td style="width: 18pt"><span style="font-family: Times New Roman, Times, Serif"><b>(d)</b></span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Subsequent to the year ended December 31, 2022 the Company issued 162,707 shares pursuant to the exercise of warrants for gross proceeds of $312,985 CAD.</span></td></tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54pt; text-align: justify; text-indent: -18pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%"><tr style="vertical-align: top">
<td style="width: 36pt"/><td style="width: 18pt"><span style="font-family: Times New Roman, Times, Serif"><b>(e)</b></span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Subsequent to year ended December 31, 2022 the Company granted 121,681 stock options to employees at a weighted average exercise price of C$2.91</span></td></tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54pt; text-align: justify; text-indent: -18pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%"><tr style="vertical-align: top">
<td style="width: 36pt"/><td style="width: 18pt"><span style="font-family: Times New Roman, Times, Serif"><b>(f)</b></span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">On January 13<sup>th</sup>, 2023, the Company purchased 100,000 lbs of uranium for $5,922,500 in an arm&#8217;s length transaction.</span></td></tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54pt; text-align: justify; text-indent: -18pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%"><tr style="vertical-align: top">
<td style="width: 36pt"/><td style="width: 18pt"><span style="font-family: Times New Roman, Times, Serif"><b>(g)</b></span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">On January 16<sup>th</sup>, 2023, the Company completed the sale of 100,000 lbs of uranium for $7,050,000 to the United States Department of Energy, National Nuclear Security Administration.</span></td></tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54pt; text-align: justify; text-indent: -18pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%"><tr style="vertical-align: top">
<td style="width: 36pt"/><td style="width: 18pt"><span style="font-family: Times New Roman, Times, Serif"><b>(h)</b></span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">In February of 2023, the Company secured an additional sales contract with a Fortune 500 listed United States Utility. The agreement commences in 2027 and covers firm deliveries of 650,000 pounds of uranium with an option to acquire up to 400,000 additional pounds under a two-year extended term. The agreement is based on market pricing with a floor price and an inflation adjusted ceiling price.</span></td></tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54pt; text-align: justify; text-indent: -18pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%"><tr style="vertical-align: top">
<td style="width: 36pt"/><td style="width: 18pt"><span style="font-family: Times New Roman, Times, Serif"><b>(i)</b></span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">In March of 2023, the Company completed its purchase of 200,000 pounds of uranium concentrate from an arm&#8217;s length party for total consideration of $8,750,000 ($43.75/pound). The contract required an initial payment of $2,000,000, which was paid in March 2022, and final payment of $6,750,000 paid in March 2023.</span></td></tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54pt; text-align: justify; text-indent: -18pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%"><tr style="vertical-align: top">
<td style="width: 36pt"/><td style="width: 18pt"><span style="font-family: Times New Roman, Times, Serif"><b>(j)</b></span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">In April of 2023, the Company completed the sale of 200,000 lbs of uranium pursuant to a sales contract with UG USA,&#160;Inc. (Note 13) for gross proceeds of $9,660,000.</span></td></tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54pt; text-align: justify; text-indent: -18pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%"><tr style="vertical-align: top">
<td style="width: 36pt"/><td style="width: 18pt"><span style="font-family: Times New Roman, Times, Serif"><b>(k)</b></span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">In March of 2023, the Company completed its divestment of Belt Line Resources, Inc and Hydro Restoration Corporation, which held the Company&#8217;s Moonshine, Bootheel, and Kaycee projects (Note 11). In return for these assets the Company received 19.9% of Nuclear Fuels, Inc.</span></td></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cve_DisclosureOfEventsAfterReportingPeriodTextBlockAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cve_DisclosureOfEventsAfterReportingPeriodTextBlockAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cve_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfEventsAfterReportingPeriodExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for events after the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 10<br> -IssueDate 2022-03-24<br> -Section Disclosure<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=10&amp;code=ifrs-tx-2022-en-r&amp;doctype=Standard&amp;dita_xref=IAS10_g17-22_IAS10_g17-22_TI<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfEventsAfterReportingPeriodExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>79
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139782921685776">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Accounting Policies, by Policy (Policies)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_DescriptionOfAccountingPolicyForBasisOfPresentationtextBlock', window );">Basis of presentation</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif"><b>Basis
of presentation</b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">These
financial statements, including comparatives, have been prepared using accounting policies consistent with International Financial Reporting
Standards (&#8220;IFRS&#8221;) as issued by the International Accounting Standards Board (&#8220;IASB&#8221;) and interpretations of
the International Financial Reporting Interpretations Committee (&#8220;IFRIC&#8221;).</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">The
policies applied in these financial statements are based on IFRS issued and effective as of December 31, 2022.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">These
financial statements have been prepared on a historical cost basis except for certain financial instruments which are measured at fair
value. All dollar amounts presented are in United States Dollars (&#8220;U.S. Dollars&#8221;) unless otherwise specified. In addition,
these financial statements have been prepared using the accrual basis of accounting, except for cash flow information.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">These
financial statements were approved for issuance by the audit committee of the Board of Directors on April 26, 2023.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_DescriptionOfAccountingPolicyForChangeInPresentationCurrencytextBlock', window );">Change in presentation currency</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b>Change
in presentation currency</b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">These
financial statements are presented in U.S. Dollars, unless otherwise specified. The functional currency of enCore Energy Corp. is the
Canadian Dollar. The functional currency of the Company&#8217;s subsidiaries is the U.S. Dollar. During the year ended December 31, 2022,
the Company changed its presentation currency from Canadian Dollars to U.S. Dollars to better reflect the Company&#8217;s business activities.
Accordingly, these financial statements are presented in U.S. Dollars. The change in presentation currency is to better reflect the Company&#8217;s
business activities and to improve investors&#8217; ability to compare the Company&#8217;s financial results with other publicly traded
businesses in the exploration industry.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">In
making this change to the U.S. Dollar presentation currency, the Company followed the guidance in IAS 21 <i>The Effects of Changes in
Foreign Exchange Rates</i> and has applied the change retrospectively as if the new presentation currency had always been the Company&#8217;s
presentation currency. In accordance with IAS 21, the financial statements for all years presented have been translated to the new U.S.
Dollar presentation currency. For 2021 and 2020 comparative balances, assets and liabilities have been translated into the U.S. Dollar
presentation currency at the rate of exchange prevailing at the reporting date. The consolidated statements of loss and comprehensive
loss were translated at the average exchange rates for the reporting period. Share capital and reserves were translated at the historical
rates prevailing at the dates of the transactions. Exchange differences arising on translation were taken to the foreign currency translation
reserve in shareholders&#8217; equity.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">The
exchange rates used were as follows:</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify">&#160;</p><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; text-align: left; font-weight: bold">U.S. Dollar/CDN Dollar exchange rate</td><td style="text-align: center; font-weight: bold">&#160;</td>
    <td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid; font-weight: bold">December 31, 2022</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="text-align: center; border-bottom: Black 1.5pt solid; font-weight: bold">&#160;</td>
    <td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid; font-weight: bold">December 31, 2021</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%; text-align: left">Closing rate at the reporting date</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">0.738</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">0.789</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Average rate for the year</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">0.769</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">0.798</td><td style="text-align: left">&#160;</td></tr>
  </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_DescriptionOfAccountingPolicyForBasisOfConsolidationtextBlock', window );">Basis of consolidation</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b>Basis
of consolidation</b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">These
financial statements incorporate the financial statements of the Company and its controlled subsidiaries. Control is defined as the exposure,
or rights, to variable returns from involvement with an investee and the ability to affect those returns through power over the investee.
Power over an investee exists when an investor has existing rights that give it the ability to direct the activities that significantly
affect the investee&#8217;s returns. This control is generally evidenced through owning more than 50% of the voting rights or currently
exercisable potential voting rights of a Company&#8217;s share capital. All significant intercompany transactions and balances have been
eliminated.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">These
consolidated financial statements include the financial statements of the Company and its significant subsidiaries listed in the following
table:</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify">&#160;</p><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Name of <br/> Subsidiary</td><td style="font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Place of <br/> Incorporation</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Ownership<br/> Interest</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Principal<br/> Activity</td><td style="font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Functional<br/> Currency</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 30%; text-align: center">Tigris Uranium US Corp.</td><td style="width: 1%">&#160;</td>
    <td style="width: 25%; text-align: center">Nevada, USA</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">100</td><td style="width: 1%; text-align: left">%</td><td style="width: 1%">&#160;</td>
    <td style="width: 19%; text-align: center">Mineral Exploration</td><td style="width: 1%">&#160;</td>
    <td style="width: 11%; text-align: center">USD</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: center">Metamin Enterprises US Inc.</td><td>&#160;</td>
    <td style="text-align: center">Nevada, USA</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">100</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: center">Mineral Exploration</td><td>&#160;</td>
    <td style="text-align: center">USD</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: center">URI, Inc.</td><td>&#160;</td>
    <td style="text-align: center">Delaware, USA</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">100</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: center">Mineral Exploration</td><td>&#160;</td>
    <td style="text-align: center">USD</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: center">Neutron Energy, Inc.</td><td>&#160;</td>
    <td style="text-align: center">Nevada, USA</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">100</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: center">Mineral Exploration</td><td>&#160;</td>
    <td style="text-align: center">USD</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: center">Uranco, Inc.</td><td>&#160;</td>
    <td style="text-align: center">Delaware, USA</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">100</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: center">Mineral Exploration</td><td>&#160;</td>
    <td style="text-align: center">USD</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: center">Uranium Resources, Inc.</td><td>&#160;</td>
    <td style="text-align: center">Delaware, USA</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">100</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: center">Mineral Exploration</td><td>&#160;</td>
    <td style="text-align: center">USD</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: center">HRI-Churchrock, Inc.</td><td>&#160;</td>
    <td style="text-align: center">Delaware, USA</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">100</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: center">Mineral Exploration</td><td>&#160;</td>
    <td style="text-align: center">USD</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: center">Hydro Restoration Corp.</td><td>&#160;</td>
    <td style="text-align: center">Delaware, USA</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">100</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: center">Mineral Exploration</td><td>&#160;</td>
    <td style="text-align: center">USD</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: center">Belt Line Resources, Inc.</td><td>&#160;</td>
    <td style="text-align: center">Texas, USA</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">100</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: center">Mineral Exploration</td><td>&#160;</td>
    <td style="text-align: center">USD</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: center">Cibola Resources, LLC (*)</td><td>&#160;</td>
    <td style="text-align: center">Delaware, USA</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">100</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: center">Mineral Exploration</td><td>&#160;</td>
    <td style="text-align: center">USD</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: center">enCore Energy US Corp.</td><td>&#160;</td>
    <td style="text-align: center">Nevada, USA</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">100</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: center">Holding Company</td><td>&#160;</td>
    <td style="text-align: center">USD</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: center">Azarga Uranium Corp.</td><td>&#160;</td>
    <td style="text-align: center">British Columbia, CA</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">100</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: center">Mineral Exploration</td><td>&#160;</td>
    <td style="text-align: center">USD</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: center">Powertech (USA) Inc.</td><td>&#160;</td>
    <td style="text-align: center">South Dakota, USA</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">100</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: center">Mineral Exploration</td><td>&#160;</td>
    <td style="text-align: center">USD</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: center">URZ Energy Corp.</td><td>&#160;</td>
    <td style="text-align: center">British Columbia, CA</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">100</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: center">Mineral Exploration</td><td>&#160;</td>
    <td style="text-align: center">USD</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: center">Ucolo Exploration Corp.</td><td>&#160;</td>
    <td style="text-align: center">Utah, USA</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">100</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: center">Mineral Exploration</td><td>&#160;</td>
    <td style="text-align: center">USD</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: center">Azarga Resources Limited</td><td>&#160;</td>
    <td style="text-align: center">British Virgin Islands</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">100</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: center">Mineral Exploration</td><td>&#160;</td>
    <td style="text-align: center">USD</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: center">Azarga Resources (Hong Kong) Ltd.</td><td>&#160;</td>
    <td style="text-align: center">Hong Kong</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">100</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: center">Mineral Exploration</td><td>&#160;</td>
    <td style="text-align: center">USD</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: center">Azarga Resources USA Company</td><td>&#160;</td>
    <td style="text-align: center">Colorado, USA</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">100</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: center">Mineral Exploration</td><td>&#160;</td>
    <td style="text-align: center">USD</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: center; padding-bottom: 1.5pt">Azarga Resources Canada Ltd.</td><td>&#160;</td>
    <td style="text-align: center; padding-bottom: 1.5pt">British Columbia, CA</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">100</td><td style="padding-bottom: 1.5pt; text-align: left">%</td><td>&#160;</td>
    <td style="text-align: center; padding-bottom: 1.5pt">Mineral Exploration</td><td>&#160;</td>
    <td style="text-align: center; padding-bottom: 1.5pt">USD</td></tr>
  </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">*
Cibola Resources, LLC was divested in May 2022 (Note 11).</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_DescriptionOfAccountingPolicyForCashtextBlock', window );">Cash</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b>Cash</b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Cash
is comprised of cash held at banks and demand deposits.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfAccountingPolicyToDetermineComponentsOfCashAndCashEquivalents', window );">Restricted cash</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b>Restricted
cash</b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">As
of December 31, 2022, the Company deposited $4,517,073 for collateralization of performance obligations. These funds are not available
for the payment of general corporate obligations. The bonds are collateralized performance bonds required for future restoration and
reclamation obligations related to the Company&#8217;s operations. (Note 11).</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">As
of December 31, 2022, the Company held in escrow CAD $67,789,880 ($50,051,595) in share subscriptions pertaining to a financing that
closed subsequent to year end (Note 22(b)).</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_DescriptionOfAccountingPolicyForAssetRetirementObligationstextBlock', window );">Asset retirement obligations</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b>Asset
retirement obligations </b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Various
federal and state mining laws and regulations require the Company to reclaim the surface areas and restore underground water quality
for its ISR projects to the pre-existing or background average quality after the completion of mining. Asset retirement obligations,
consisting primarily of estimated restoration and reclamation costs at the Company&#8217;s ISR projects, are recognized in the period
incurred and recorded as liabilities at fair value. Such obligations, which are initially estimated based on discounted cash flow estimates,
are accreted to full value over time through charges to accretion expense. In addition, the asset retirement cost is capitalized as part
of the asset&#8217;s carrying value and amortized over the life of the related asset. Asset retirement obligations are periodically adjusted
to reflect changes in the estimated present value resulting from revisions to the estimated timing or amount of restoration and reclamation
costs. As the Company completes its restoration and reclamation work at its properties, the liability is reduced by the carrying value
of the related asset retirement liability which is based upon the percentage of completion of each restoration and reclamation activity.
Any gain or loss upon settlement is charged to income or expense for the period. The Company reviews and evaluates its asset retirement
obligations annually or more frequently at interim periods if deemed necessary.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfAccountingPolicyForAvailableforsaleFinancialAssetsExplanatory', window );">Assets held for sale</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b>Assets
held for sale</b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">The
Company classifies long-lived assets or disposal groups to be sold as held for sale in the period in which all of the following criteria
are met: management commits to a plan to sell the asset or disposal group; the asset or disposal group is available for immediate sale;
an active program to locate a buyer is initiated; the sale of the asset or disposal group is highly probable, within 12 months.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_DescriptionOfAccountingPolicyForMineralPropertiestextBlock', window );">Mineral properties</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif"><b>Mineral
properties</b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">The
Company is in the exploration stage, and records exploration and evaluation assets, which consists of the costs of acquiring licenses
for the right to explore and costs associated with exploration and evaluation activity, at cost. All direct and indirect costs related
to the acquisition, exploration and development of exploration and evaluation assets are capitalized by property.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">The
exploration and evaluation assets are capitalized until the technical feasibility and commercial viability of the extraction of mineral
resources in an area of interest are demonstrable. Exploration and evaluation assets are then assessed for impairment and reclassified
to mining property and development assets within property and equipment. If an exploration and evaluation property interest is abandoned,
both the acquisition costs and the exploration and evaluation cost will be written off to net income or loss in the period of abandonment.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">On
an ongoing basis, exploration and evaluation assets are reviewed on a property-by-property basis to consider if there are any indicators
of impairment, including the following:</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.5in"><span style="font-family: Times New Roman, Times, Serif">(i)</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Whether
                                            the period during which the Company has the right to explore in the specific area has expired
                                            during the year or will expire in the near future;</span></td></tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.5in"><span style="font-family: Times New Roman, Times, Serif">(ii)</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Whether
                                            substantive expenditure on further exploration for and evaluation of mineral resources in
                                            the specific area is neither budgeted nor planned;</span></td></tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.5in"><span style="font-family: Times New Roman, Times, Serif">(iii)</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Whether
                                            the Company has decided to discontinue activities in an area as the exploration and evaluation
                                            activities in the area have not led to the discovery of commercially viable quantities of
                                            mineral resources; and</span></td></tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.5in"><span style="font-family: Times New Roman, Times, Serif">(iv)</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Whether
                                            sufficient data exists to indicate that the carrying amount exceeds the recoverable amount.</span></td></tr></table><p style="margin: 0"/><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-9</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">If
any indication of impairment exists, an estimate of the exploration and evaluation asset&#8217;s recoverable amount is calculated. The
recoverable amount is determined as the higher of the fair value less costs of disposal for the exploration and evaluation property interest
and its value in use. The fair value less costs of disposal and the value in use is determined for an individual exploration and evaluation
property interest, unless the exploration and evaluation property interest does not generate cash inflows that are largely independent
of other exploration and evaluation property interests. If this is the case, the exploration and evaluation property interests are grouped
together into cash generating units (&#8220;CGUs&#8221;) for impairment purposes. If the recoverable amount of an asset is estimated
to be less than its carrying amount, the carrying amount of the asset is reduced to its recoverable amount and the impairment loss is
recognized in net income or loss for the period. Where an impairment subsequently reverses, the carrying amount of the asset (or CGU)
is increased to the revised estimate of its recoverable amount, but to an amount that does not exceed the carrying amount that would
have been determined had no impairment loss been recognized for the asset (or CGU) in prior periods. A reversal of an impairment loss
is recognized in the period in which that determination was made in net income or loss.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_DescriptionOfAccountingPolicyForInvestmentsInUraniumtextBlock', window );">Investments in uranium</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b>Investments
</b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt"><span style="font-family: Times New Roman, Times, Serif"><b>&#160;</b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b>Investments
in uranium</b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt"><span style="font-family: Times New Roman, Times, Serif"><b>&#160;</b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Investments
in uranium are initially recorded at cost, on the date that control of the uranium passes to the Company. Cost is calculated as the purchase
price and any directly attributable expenditure. Subsequent to initial recognition, investments in uranium are measured at fair value
at each reporting period end. Fair value is determined based on the most recent month-end spot prices for uranium published by UxC LLC
(&#8220;UxC&#8221;). Related fair value gains and losses subsequent to initial recognition are recorded in the consolidated statement
of loss and comprehensive loss as a component of &#8220;Other Income (Expense)&#8221; in the period in which they arise.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Due
to the lack of specific IFRS guidance on accounting for investments in uranium, the Company considered IAS 1 Presentation of Financial
Statements and IAS 8, Accounting Policies, Changes in Accounting Estimates and Errors, to develop and apply an accounting policy that
would result in information that is most relevant to the economic decision-making needs of users within the overall IFRS accounting framework.
Consequently, the uranium investments are presented at fair value based on the application of IAS 40, Investment Property, which allows
the use of a fair value model for assets held for long-term capital appreciation.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">In
2022, the Company entered into fixed price agreements for future purchases of uranium. These agreements required the company to make
a deposit at the time of contract execution toward its future purchase. These deposits are recorded on the Company&#8217;s statement
of financial position in accordance with IFRS 9.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfAccountingPolicyForInvestmentInAssociates', window );">Investments in associates</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt"><span style="font-family: Times New Roman, Times, Serif"><b>Investments
in associates</b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt"><span style="font-family: Times New Roman, Times, Serif"><b>&#160;</b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Investments
in associates are accounted for using the equity method. The equity method involves the recording of the initial investment at cost and
the subsequent adjusting of the carrying value of the investment for the Company&#8217;s proportionate share of the earnings or loss.
The cost of the investment includes transaction costs.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Adjustments
are made to align the accounting policies of the associate with those of the Company before applying the equity method. When the Company&#8217;s
share of losses exceeds its interest in an equity-accounted investee, the carrying amount of that interest is reduced to zero, and the
recognition of further losses is discontinued except to the extent that the Company has incurred legal or constructive obligations or
made payments on behalf of the associate. If the associate subsequently reports profits, the Company resumes recognizing its share of
those profits only after its share of the profits equals the share of losses not recognized.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif"><b>&#160;</b></span></p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory', window );">Property, plant and equipment</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b>Property,
plant and equipment </b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b>&#160;</b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Useful
lives are based on the Company&#8217;s estimate at the date of acquisition and are as follows for each class of assets:</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom; ">
    <td style="border-bottom: Black 1.5pt solid; text-align: center; width: 49%"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><b>Category</b></span></p></td><td style="width: 2%; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; width: 49%; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Range</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Uranium Plants</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Straight-line over 15-25 years</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Other Property Plant and Equipment</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Straight-line over 3-5 years</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif">Software</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Straight-line over 2-3 years</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td><span style="font-family: Times New Roman, Times, Serif">Furniture</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Straight-line over 3-5 years</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif">Buildings</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Straight-line over 10-40 years</span></td></tr>
  </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b>&#160;</b></span></p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_DescriptionOfAccountingPolicyForUraniumPlantstextBlock', window );">Uranium plants</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b>Uranium
plants</b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b>&#160;</b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Uranium
plant expenditures for new facilities or equipment and expenditures that extend the useful lives of existing facilities or equipment
are capitalized and recorded at cost. Depreciation on other property is computed based upon the estimated useful lives of the assets.
Repair and maintenance costs are expensed as incurred. Gain or loss on disposal of such assets is recorded as other income or expense
as such assets are disposed.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_DescriptionOfAccountingPolicyForOtherPropertyPlantAndEquipmenttextBlock', window );">Other property, plant and equipment</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b>Other
property, plant and equipment </b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b>&#160;</b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Other
property, plant and equipment consists of office equipment, furniture and fixtures and transportation equipment. Depreciation on other
property is computed based upon the estimated useful lives of the assets. Repairs and maintenance costs are expensed as incurred. Gain
or loss on disposal of such assets is recorded as other income or expense as such assets are disposed.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_DescriptionOfAccountingPolicyForBuildingtextBlock', window );">Buildings</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b>Buildings</b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b>&#160;</b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Depreciation
on buildings is computed based upon the estimated useful lives of the asset. Repairs and maintenance costs are expensed as incurred.
Gain or loss on disposal of such assets is recorded as other income or expense as such assets are disposed.&#8195;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_DescriptionOfAccountingPolicyForSoftwaretextBlock', window );">Software</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b>Software</b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b>&#160;</b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Software
acquired in the normal course of business through a perpetual license is capitalized and depreciated over the estimated useful life of
the asset. Support and maintenance costs are expensed as incurred. Gain or loss on disposal of such assets is recorded as other income
or expense as such assets are disposed</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfAccountingPolicyForIntangibleAssetsAndGoodwillExplanatory', window );">Intangible assets</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif"><b>Intangible
assets</b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b>&#160;</b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Intangible
assets are recognized and measured at cost. Intangible assets with indefinite useful lives are assessed for impairment annually and whenever
there is an indication that the intangible asset may be impaired. Intangible assets that have finite useful lives are amortized over
their estimated remaining useful lives. Amortization methods and useful lives are reviewed at each reporting period and are adjusted
if appropriate.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Useful
lives are based on the Company&#8217;s estimate at the date of acquisition and are as follows for each class of assets:</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom; ">
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center; width: 49%"><span style="font-family: Times New Roman, Times, Serif">Category</span></td><td style="width: 2%; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; width: 49%; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Range</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Data Access Agreement</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Straight-line over 14 years</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Data Purchases</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Indefinite life intangible asset</span></td></tr>
  </table><p style="margin-top: 0; margin-bottom: 0"/><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfAccountingPolicyForImpairmentOfNonfinancialAssetsExplanatory', window );">Impairment of non-financial assets</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt"><span style="font-family: Times New Roman, Times, Serif"><b>Impairment
of non-financial assets</b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt"><span style="font-family: Times New Roman, Times, Serif"><b>&#160;</b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">At
the end of each reporting period, the Company&#8217;s assets are reviewed to determine whether there is any indication that those assets
may be impaired. If such indication exists, the recoverable amount of the asset is estimated in order to determine the extent of the
impairment, if any. The recoverable amount is the higher of fair value less costs of disposal and the value in use. Fair value is the
price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at
the measurement date. In assessing value in use, the estimated future cash flows are discounted to their present value using a pre-tax
discount rate that reflects a current market assessment of the time value of money and the risks specific to the asset. If the recoverable
amount of an asset is estimated to be less than its carrying amount, the carrying amount of the asset is reduced to its recoverable amount
and the impairment loss is recognized in profit or loss for the period. For an asset that does not generate largely independent cash
flows, the recoverable amount is determined for the cash generating unit to which the asset belongs.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">When
an impairment loss subsequently reverses, the carrying amount of the asset (or cash-generating unit) is increased to the revised estimate
of its recoverable amount, but to an amount that does not exceed the carrying amount that would have been determined had no impairment
loss been recognized for the asset (or cash generating unit) in prior years. A reversal of an impairment loss is recognized immediately
in profit or loss.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfAccountingPolicyForLeasesExplanatory', window );">Leases</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt"><span style="font-family: Times New Roman, Times, Serif"><b>Leases</b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt"><span style="font-family: Times New Roman, Times, Serif"><b>&#160;</b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">In
accordance with IFRS 16, the Company recognizes a right-of-use asset and a lease liability at the lease commencement date. The right-of-use
asset represents the Company&#8217;s right to use an underlying asset for the lease term and lease liabilities represent our obligation
to make lease payments arising from the lease. Right-of-use assets and lease liabilities are recognized at the commencement date of the
lease based on the present value of lease payments over the lease term.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfAccountingPolicyForIncomeTaxExplanatory', window );">Income Tax</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b>Income
Tax</b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b>&#160;</b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Income
tax expense comprises current and deferred tax. Income tax is recognized in profit or loss except to the extent that it relates to items
recognized directly in equity. Current tax expense is the expected tax payable on taxable income for the year, using tax rates enacted
or substantively enacted at period end, adjusted for amendments to tax payable with regards to previous years.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Deferred
tax is recorded using the liability method, providing for temporary differences between the carrying amounts of assets and liabilities
for financial reporting purposes and the amounts used for taxation purposes.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Temporary
differences are not provided for the initial recognition of assets or liabilities that do not affect either accounting or taxable loss
or those differences relating to investments in subsidiaries to the extent that they are not probable to reverse in the foreseeable future.
The amount of deferred tax provided is based on the expected manner of realization or settlement of the carrying amount of assets and
liabilities, using tax rates enacted or substantively enacted at the date of the statement of financial position.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">A
deferred tax asset is recognized only to the extent that it is probable that future taxable profits will be available against which the
asset can be utilized. To the extent that the Company does not consider it probable that a deferred tax asset will be recovered, it is
not recorded.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock', window );">Foreign currency translation</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif"><b>Foreign
currency translation</b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b>&#160;</b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">The
financial statements for the Company and each of its subsidiaries are prepared using their functional currencies. Functional currency
is the currency of the primary economic environment in which an entity operates.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Foreign
currency transactions are translated into the functional currency using the exchange rates prevailing at the date of the transaction.
Foreign currency monetary items are translated at the period-end exchange rate. Non-monetary items measured at historical cost continue
to be carried at the exchange rate at the date of the transaction. Non-monetary items measured at fair value are reported at the exchange
rate at the date when fair values were determined.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Exchange
differences arising on the translation of monetary items or on settlement of monetary items are recognized in profit or loss in the period
in which they arise, except where deferred in equity as a qualifying cash flow or net investment hedge. Exchange differences arising
on the translation of non-monetary items are recognized in other comprehensive income (loss) in the consolidated statement of loss and
comprehensive loss to the extent that gains and losses arising on those non-monetary items are also recognized in other comprehensive
income (loss). Where the non-monetary gain or loss is recognized in profit or loss, the exchange component is also recognized in profit
or loss.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">On
consolidation, the parent Company&#8217;s financial statements are translated into the presentation currency, being the U.S. Dollar.
Assets and liabilities are translated at the period-end exchange rate. Income and expenses are translated at the average exchange rate
for the period in which they arise. Exchange differences are recognized in other comprehensive income (loss) as a separate component
of equity.	</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfAccountingPolicyForEarningsPerShareExplanatory', window );">Earnings (loss) per share</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b>Earnings
(loss) per share</b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">The
Company presents basic and diluted earnings (loss) per share (&#8220;EPS&#8221;) data for its common shares. Basic EPS is calculated
by dividing the profit or loss of the Company by the weighted average number of common shares outstanding during the year, adjusted for
own shares held. Diluted EPS is determined by dividing the profit or loss attributable to common shareholders by the weighted average
number of common shares outstanding, adjusted for own shares held and for the effects of all potential dilutive common shares related
to outstanding stock options and warrants issued by the Company for the years presented, except if their inclusion proves to be anti-dilutive.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory', window );">Share-based payments</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif"><b>Share-based
payments</b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">The
fair value of all stock options granted to directors, officers, and employees is recorded as a charge to operations and a credit to contributed
surplus. The fair value of these stock options is measured at the grant date using the Black-Scholes option pricing model. The fair value
of stock options which vest immediately is recorded at the grant date. For stock options which vest in the future, the fair value of
stock options, as adjusted for the expected level of vesting of the stock options and the number of stock options which ultimately vest,
is recognized over the vesting period. Stock options granted to non-employees are measured at the fair value of goods or services rendered
or at the fair value of the instruments issued if it is determined that the fair value of the goods or services received cannot be reliably
measured. The number of shares and options expected to vest is reviewed and adjusted at the end of each reporting period such that the
amount recognized for services received as consideration for the equity instruments granted shall be based on the number of equity instruments
that eventually vest.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Warrants
issued to brokers are measured at their fair value on the vesting date and are recognized as a deduction from equity and credited to
contributed surplus. The fair value of stock options and warrants issued to brokers are estimated using the Black-Scholes option pricing
model. Any consideration received on the exercise of stock options and/or warrants, together with the related portion of contributed
surplus, is credited to share capital.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif"><b>&#160;</b></span></p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfAccountingPolicyForWarrantsExplanatory', window );">Warrants issued in equity financing transactions</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt"><span style="font-family: Times New Roman, Times, Serif"><b>Warrants
issued in equity financing transactions</b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">The
Company engages in equity financing transactions to obtain the funds necessary to continue operations and explore its exploration and
evaluation assets. These equity financing transactions may involve the issuance of common shares or units. Each unit comprises a certain
number of common shares and a certain number of share purchase warrants.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Depending
on the terms and conditions of each equity financing agreement, the Warrants are exercisable into additional common shares at a price
prior to expiry as stipulated by the agreement. Warrants that are part of units are valued based on the residual value method. Warrants
that are issued as payment for agency fees or other transactions costs are accounted for as share-based payments.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfAccountingPolicyForFinancialInstrumentsExplanatory', window );">Financial instruments</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif"><b>Financial
instruments </b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b>&#160;</b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">The
Company classifies its financial instruments in the following categories: at fair value through profit and loss (&#8220;FVTPL&#8221;),
at fair value through other comprehensive income (loss) (&#8220;FVTOCI&#8221;), or at amortized cost. The Company determines the classification
of financial assets at initial recognition. The classification of debt instruments is driven by the Company&#8217;s business model for
managing the financial assets and their contractual cash flow characteristics. Equity instruments that are held for trading are classified
as FVTPL. For other equity instruments, on the day of acquisition the Company can make an irrevocable election (on an instrument-by instrument
basis) to designate them as at FVTOCI. Financial liabilities are measured at amortized cost, unless they are required to be measured
at FVTPL (such as instruments held for trading or derivatives) or the Company has opted to measure them at FVTPL.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Financial
assets and liabilities carried at FVTPL are initially recorded at fair value and transaction costs are expensed in profit or loss. Realized
and unrealized gains and losses arising from changes in the fair value of the financial assets and liabilities held at FVTPL are included
in the consolidated statements of loss and comprehensive loss in the period in which they arise.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfAccountingPolicyForImpairmentOfFinancialAssetsExplanatory', window );">Impairment of financial assets at amortized cost</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif"><b>Impairment
of financial assets at amortized cost</b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b>&#160;</b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">An
&#8216;expected credit loss&#8217; impairment model applies which requires a loss allowance to be recognized based on expected credit
losses. The estimated present value of future cash flows associated with the asset is determined and an impairment loss is recognized
for the difference between this amount and the carrying amount as follows: the carrying amount of the asset is reduced to estimated present
value of the future cash flows associated with the asset, discounted at the financial asset&#8217;s original effective interest rate,
either directly or through the use of an allowance account and the resulting loss is recognized in profit or loss for the period.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">In
a subsequent period, if the amount of the impairment loss related to financial assets measured at amortized cost decreases, the previously
recognized impairment loss is reversed through profit or loss to the extent that the carrying amount of the investment at the date the
impairment is reversed does not exceed what the amortized cost would have been had the impairment not been recognized.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 36pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 36pt"><span style="font-family: Times New Roman, Times, Serif">The
Company&#8217;s mineral property interest impairment policy is more specifically discussed above.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 36pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfAccountingPolicyForDerecognitionOfFinancialInstrumentsExplanatory', window );">Derecognition of financial assets</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt"><span style="font-family: Times New Roman, Times, Serif"><b>Derecognition
of financial assets</b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt"><span style="font-family: Times New Roman, Times, Serif"><b>&#160;</b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">The
Company derecognizes financial assets only when the contractual rights to cash flows from the financial assets expire, or when it transfers
the financial assets and substantially all of the associated risks and rewards of ownership to another entity. Gains and losses on derecognition
are generally recognized in profit or loss</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_DescriptionOfAccountingPolicyForNewStandardsAndInterpretationsNotYetAdoptedtextBlock', window );">New standards and interpretations not yet adopted</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b>New
standards and interpretations not yet adopted</b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">The
following new standards, amendments to standards and interpretations have been issued but are not effective during the year ended
December 31, 2022:</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">The
following amendments will be in effect for annual reporting periods beginning on or after January 1, 2023:</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Disclosure
of Accounting Policies (Amendments to IAS 1 and IFRS Practice Statement 2) &#8211; the amendments </span>require that an entity
discloses its material accounting policies, instead of its significant accounting policies. <span style="font-family: Times New Roman, Times, Serif">Further
amendments explain how an entity can identify a material accounting policy.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Definition
of Accounting Estimates (Amendments to IAS 8) &#8211; the amendments replace the definition of a change in accounting estimates with
a definition of accounting estimates. Under the new definition, accounting estimates are &#8220;monetary amounts in financial
statements that are subject to measurement uncertainty&#8221;. Entities develop accounting estimates if accounting policies require
items in financial statements to be measured in a way that involves measurement uncertainty. The amendments clarify that a change in
accounting estimate that results from new information or new developments is not the correction of an error.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">The
Company does not anticipate that these amendments will have a material impact on the results of operations and financial position of
the Company.</span></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cve_DescriptionOfAccountingPolicyForAssetRetirementObligationstextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The description of the entity's accounting policy for asset retirement obligations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cve_DescriptionOfAccountingPolicyForAssetRetirementObligationstextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cve_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cve_DescriptionOfAccountingPolicyForBasisOfConsolidationtextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The description of the entity's accounting policy for basis of consolidation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cve_DescriptionOfAccountingPolicyForBasisOfConsolidationtextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cve_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cve_DescriptionOfAccountingPolicyForBasisOfPresentationtextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The description of the entity's accounting policy for basis of presentation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cve_DescriptionOfAccountingPolicyForBasisOfPresentationtextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cve_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cve_DescriptionOfAccountingPolicyForBuildingtextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The description of the entity's accounting policy for buildings.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cve_DescriptionOfAccountingPolicyForBuildingtextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cve_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cve_DescriptionOfAccountingPolicyForCashtextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The description of the entity's accounting policy for cash.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cve_DescriptionOfAccountingPolicyForCashtextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cve_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cve_DescriptionOfAccountingPolicyForChangeInPresentationCurrencytextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The description of the entity's accounting policy for change in presentation currency.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cve_DescriptionOfAccountingPolicyForChangeInPresentationCurrencytextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cve_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cve_DescriptionOfAccountingPolicyForInvestmentsInUraniumtextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The description of the entity's accounting policy for investments in uranium.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cve_DescriptionOfAccountingPolicyForInvestmentsInUraniumtextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cve_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cve_DescriptionOfAccountingPolicyForMineralPropertiestextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The description of the entity's accounting policy for mineral properties.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cve_DescriptionOfAccountingPolicyForMineralPropertiestextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cve_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cve_DescriptionOfAccountingPolicyForNewStandardsAndInterpretationsNotYetAdoptedtextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The description of the entity's accounting policy for new standards and interpretations not yet adopted.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cve_DescriptionOfAccountingPolicyForNewStandardsAndInterpretationsNotYetAdoptedtextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cve_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cve_DescriptionOfAccountingPolicyForOtherPropertyPlantAndEquipmenttextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The description of the entity's accounting policy for other property, plant and equipment. [Refer: Property, plant and equipment] Effective 2023-01-01: The description of the entity's material accounting policy information for property, plant and equipment. [Refer: Property, plant and equipment]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cve_DescriptionOfAccountingPolicyForOtherPropertyPlantAndEquipmenttextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cve_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cve_DescriptionOfAccountingPolicyForSoftwaretextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The description of the entity's accounting policy for software.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cve_DescriptionOfAccountingPolicyForSoftwaretextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cve_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cve_DescriptionOfAccountingPolicyForUraniumPlantstextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The description of the entity's accounting policy for uranium plants.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cve_DescriptionOfAccountingPolicyForUraniumPlantstextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cve_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfAccountingPolicyForAvailableforsaleFinancialAssetsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The description of the entity's accounting policy for available-for-sale financial assets. [Refer: Financial assets available-for-sale]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Note Expiry date 2023-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2022-03-24<br> -Paragraph 117<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2017-en-b&amp;anchor=para_117_b&amp;doctype=Standard&amp;forcepdf=true<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfAccountingPolicyForAvailableforsaleFinancialAssetsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfAccountingPolicyForDerecognitionOfFinancialInstrumentsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Expiry date 2023-01-01: The description of the entity's accounting policy for the derecognition of financial instruments. [Refer: Financial instruments, class [member]]
Effective 2023-01-01: The description of the entity's material accounting policy information for the derecognition of financial instruments. [Refer: Financial instruments, class [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Note Effective 2023-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2022-03-24<br> -Paragraph 117<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_117&amp;doctype=Standard<br> -URIDate 2022-03-24<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Note Expiry date 2023-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2022-03-24<br> -Paragraph 117<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2022-en-b&amp;anchor=para_117_b&amp;doctype=Standard&amp;forcepdf=true<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfAccountingPolicyForDerecognitionOfFinancialInstrumentsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfAccountingPolicyForEarningsPerShareExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Expiry date 2023-01-01: The description of the entity's accounting policy for earnings per share.
Effective 2023-01-01: The description of the entity's material accounting policy information for earnings per share.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Note Effective 2023-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2022-03-24<br> -Paragraph 117<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_117&amp;doctype=Standard<br> -URIDate 2022-03-24<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Note Expiry date 2023-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2022-03-24<br> -Paragraph 117<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2022-en-b&amp;anchor=para_117_b&amp;doctype=Standard&amp;forcepdf=true<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfAccountingPolicyForEarningsPerShareExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfAccountingPolicyForFinancialInstrumentsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Expiry date 2023-01-01: The description of the entity's accounting policy for financial instruments. [Refer: Financial instruments, class [member]]
Effective 2023-01-01: The description of the entity's material accounting policy information for financial instruments. [Refer: Financial instruments, class [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Note Effective 2023-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2022-03-24<br> -Paragraph 117<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_117&amp;doctype=Standard<br> -URIDate 2022-03-24<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Note Expiry date 2023-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2022-03-24<br> -Paragraph 117<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2022-en-b&amp;anchor=para_117_b&amp;doctype=Standard&amp;forcepdf=true<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfAccountingPolicyForFinancialInstrumentsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfAccountingPolicyForImpairmentOfFinancialAssetsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Expiry date 2023-01-01: The description of the entity's accounting policy for the impairment of financial assets. [Refer: Financial assets]
Effective 2023-01-01: The description of the entity's material accounting policy information for the impairment of financial assets. [Refer: Financial assets]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Note Effective 2023-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2022-03-24<br> -Paragraph 117<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_117&amp;doctype=Standard<br> -URIDate 2022-03-24<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Note Expiry date 2023-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2022-03-24<br> -Paragraph 117<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2022-en-b&amp;anchor=para_117_b&amp;doctype=Standard&amp;forcepdf=true<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfAccountingPolicyForImpairmentOfFinancialAssetsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfAccountingPolicyForImpairmentOfNonfinancialAssetsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Expiry date 2023-01-01: The description of the entity's accounting policy for the impairment of non-financial assets. [Refer: Financial assets]
Effective 2023-01-01: The description of the entity's material accounting policy information for the impairment of non-financial assets. [Refer: Financial assets]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Note Effective 2023-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2022-03-24<br> -Paragraph 117<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_117&amp;doctype=Standard<br> -URIDate 2022-03-24<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Note Expiry date 2023-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2022-03-24<br> -Paragraph 117<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2022-en-b&amp;anchor=para_117_b&amp;doctype=Standard&amp;forcepdf=true<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfAccountingPolicyForImpairmentOfNonfinancialAssetsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfAccountingPolicyForIncomeTaxExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Expiry date 2023-01-01: The description of the entity's accounting policy for income tax.
Effective 2023-01-01: The description of the entity's material accounting policy information for income tax.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Note Effective 2023-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2022-03-24<br> -Paragraph 117<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_117&amp;doctype=Standard<br> -URIDate 2022-03-24<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Note Expiry date 2023-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2022-03-24<br> -Paragraph 117<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2022-en-b&amp;anchor=para_117_b&amp;doctype=Standard&amp;forcepdf=true<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfAccountingPolicyForIncomeTaxExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfAccountingPolicyForIntangibleAssetsAndGoodwillExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Expiry date 2023-01-01: The description of the entity's accounting policy for intangible assets and goodwill. [Refer: Intangible assets and goodwill]
Effective 2023-01-01: The description of the entity's material accounting policy information for intangible assets and goodwill. [Refer: Intangible assets and goodwill]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Note Effective 2023-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2022-03-24<br> -Paragraph 117<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_117&amp;doctype=Standard<br> -URIDate 2022-03-24<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Note Expiry date 2023-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2022-03-24<br> -Paragraph 117<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2022-en-b&amp;anchor=para_117_b&amp;doctype=Standard&amp;forcepdf=true<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfAccountingPolicyForIntangibleAssetsAndGoodwillExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfAccountingPolicyForInvestmentInAssociates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Expiry date 2023-01-01: The description of the entity's accounting policy for investments in associates. [Refer: Associates [member]]
Effective 2023-01-01: The description of the entity's material accounting policy information for investments in associates. [Refer: Associates [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Note Effective 2023-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2022-03-24<br> -Paragraph 117<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_117&amp;doctype=Standard<br> -URIDate 2022-03-24<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Note Expiry date 2023-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2022-03-24<br> -Paragraph 117<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2022-en-b&amp;anchor=para_117_b&amp;doctype=Standard&amp;forcepdf=true<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfAccountingPolicyForInvestmentInAssociates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfAccountingPolicyForLeasesExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Expiry date 2023-01-01: The description of the entity's accounting policy for leases. A lease is an agreement whereby the lessor conveys to the lessee in return for a payment or series of payments the right to use an asset for an agreed period of time.
Effective 2023-01-01: The description of the entity's material accounting policy information for leases. A lease is an agreement whereby the lessor conveys to the lessee in return for a payment or series of payments the right to use an asset for an agreed period of time.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Note Effective 2023-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2022-03-24<br> -Paragraph 117<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_117&amp;doctype=Standard<br> -URIDate 2022-03-24<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Note Expiry date 2023-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2022-03-24<br> -Paragraph 117<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2022-en-b&amp;anchor=para_117_b&amp;doctype=Standard&amp;forcepdf=true<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfAccountingPolicyForLeasesExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Expiry date 2023-01-01: The description of the entity's accounting policy for property, plant and equipment. [Refer: Property, plant and equipment]
Effective 2023-01-01: The description of the entity's material accounting policy information for property, plant and equipment. [Refer: Property, plant and equipment]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Note Effective 2023-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2022-03-24<br> -Paragraph 117<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_117&amp;doctype=Standard<br> -URIDate 2022-03-24<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Note Expiry date 2023-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2022-03-24<br> -Paragraph 117<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2022-en-b&amp;anchor=para_117_b&amp;doctype=Standard&amp;forcepdf=true<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Expiry date 2023-01-01: The description of the entity's accounting policy for transactions in which the entity: (a) receives goods or services from the supplier of those goods or services (including an employee) in a share-based payment arrangement; or (b) incurs an obligation to settle the transaction with the supplier in a share-based payment arrangement when another group entity receives those goods or services. [Refer: Share-based payment arrangements [member]]
Effective 2023-01-01: The description of the entity's material accounting policy information for transactions in which the entity: (a) receives goods or services from the supplier of those goods or services (including an employee) in a share-based payment arrangement; or (b) incurs an obligation to settle the transaction with the supplier in a share-based payment arrangement when another group entity receives those goods or services. [Refer: Share-based payment arrangements [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Note Effective 2023-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2022-03-24<br> -Paragraph 117<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_117&amp;doctype=Standard<br> -URIDate 2022-03-24<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Note Expiry date 2023-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2022-03-24<br> -Paragraph 117<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2022-en-b&amp;anchor=para_117_b&amp;doctype=Standard&amp;forcepdf=true<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfAccountingPolicyForWarrantsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Expiry date 2023-01-01: The description of the entity's accounting policy for warrants. Warrants are financial instruments that give the holder the right to purchase ordinary shares.
Effective 2023-01-01: The description of the entity's material accounting policy information for warrants. Warrants are financial instruments that give the holder the right to purchase ordinary shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Note Effective 2023-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2022-03-24<br> -Paragraph 117<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_117&amp;doctype=Standard<br> -URIDate 2022-03-24<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Note Expiry date 2023-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2022-03-24<br> -Paragraph 117<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2022-en-b&amp;anchor=para_117_b&amp;doctype=Standard&amp;forcepdf=true<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfAccountingPolicyForWarrantsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfAccountingPolicyToDetermineComponentsOfCashAndCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The description of the entity's accounting policy used to determine the components of cash and cash equivalents. [Refer: Cash and cash equivalents]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2022-03-24<br> -Paragraph 46<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_46&amp;doctype=Standard<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfAccountingPolicyToDetermineComponentsOfCashAndCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for (1) transactions denominated in a currency other than the reporting enterprise's functional currency, (2) translating foreign currency financial statements that are incorporated into the financial statements of the reporting enterprise by consolidation, combination, or the equity method of accounting, and (3) remeasurement of the financial statements of a foreign reporting enterprise in a hyperinflationary economy.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -URI https://asc.fasb.org/topic&amp;trid=2175825<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>80
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139782922074352">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Significant accounting policies (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_SignificantaccountingpoliciesTablesLineItems', window );"><strong>Significant accounting policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfEffectOfChangesInForeignExchangeRatesExplanatory', window );">Schedule of exchange rates</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; text-align: left; font-weight: bold">U.S. Dollar/CDN Dollar exchange rate</td><td style="text-align: center; font-weight: bold">&#160;</td>
    <td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid; font-weight: bold">December 31, 2022</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="text-align: center; border-bottom: Black 1.5pt solid; font-weight: bold">&#160;</td>
    <td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid; font-weight: bold">December 31, 2021</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%; text-align: left">Closing rate at the reporting date</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">0.738</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">0.789</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Average rate for the year</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">0.769</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">0.798</td><td style="text-align: left">&#160;</td></tr>
  </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesExplanatory', window );">Schedule of significant subsidiaries</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Name of <br/> Subsidiary</td><td style="font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Place of <br/> Incorporation</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Ownership<br/> Interest</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Principal<br/> Activity</td><td style="font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Functional<br/> Currency</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 30%; text-align: center">Tigris Uranium US Corp.</td><td style="width: 1%">&#160;</td>
    <td style="width: 25%; text-align: center">Nevada, USA</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">100</td><td style="width: 1%; text-align: left">%</td><td style="width: 1%">&#160;</td>
    <td style="width: 19%; text-align: center">Mineral Exploration</td><td style="width: 1%">&#160;</td>
    <td style="width: 11%; text-align: center">USD</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: center">Metamin Enterprises US Inc.</td><td>&#160;</td>
    <td style="text-align: center">Nevada, USA</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">100</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: center">Mineral Exploration</td><td>&#160;</td>
    <td style="text-align: center">USD</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: center">URI, Inc.</td><td>&#160;</td>
    <td style="text-align: center">Delaware, USA</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">100</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: center">Mineral Exploration</td><td>&#160;</td>
    <td style="text-align: center">USD</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: center">Neutron Energy, Inc.</td><td>&#160;</td>
    <td style="text-align: center">Nevada, USA</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">100</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: center">Mineral Exploration</td><td>&#160;</td>
    <td style="text-align: center">USD</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: center">Uranco, Inc.</td><td>&#160;</td>
    <td style="text-align: center">Delaware, USA</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">100</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: center">Mineral Exploration</td><td>&#160;</td>
    <td style="text-align: center">USD</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: center">Uranium Resources, Inc.</td><td>&#160;</td>
    <td style="text-align: center">Delaware, USA</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">100</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: center">Mineral Exploration</td><td>&#160;</td>
    <td style="text-align: center">USD</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: center">HRI-Churchrock, Inc.</td><td>&#160;</td>
    <td style="text-align: center">Delaware, USA</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">100</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: center">Mineral Exploration</td><td>&#160;</td>
    <td style="text-align: center">USD</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: center">Hydro Restoration Corp.</td><td>&#160;</td>
    <td style="text-align: center">Delaware, USA</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">100</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: center">Mineral Exploration</td><td>&#160;</td>
    <td style="text-align: center">USD</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: center">Belt Line Resources, Inc.</td><td>&#160;</td>
    <td style="text-align: center">Texas, USA</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">100</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: center">Mineral Exploration</td><td>&#160;</td>
    <td style="text-align: center">USD</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: center">Cibola Resources, LLC (*)</td><td>&#160;</td>
    <td style="text-align: center">Delaware, USA</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">100</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: center">Mineral Exploration</td><td>&#160;</td>
    <td style="text-align: center">USD</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: center">enCore Energy US Corp.</td><td>&#160;</td>
    <td style="text-align: center">Nevada, USA</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">100</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: center">Holding Company</td><td>&#160;</td>
    <td style="text-align: center">USD</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: center">Azarga Uranium Corp.</td><td>&#160;</td>
    <td style="text-align: center">British Columbia, CA</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">100</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: center">Mineral Exploration</td><td>&#160;</td>
    <td style="text-align: center">USD</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: center">Powertech (USA) Inc.</td><td>&#160;</td>
    <td style="text-align: center">South Dakota, USA</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">100</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: center">Mineral Exploration</td><td>&#160;</td>
    <td style="text-align: center">USD</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: center">URZ Energy Corp.</td><td>&#160;</td>
    <td style="text-align: center">British Columbia, CA</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">100</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: center">Mineral Exploration</td><td>&#160;</td>
    <td style="text-align: center">USD</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: center">Ucolo Exploration Corp.</td><td>&#160;</td>
    <td style="text-align: center">Utah, USA</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">100</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: center">Mineral Exploration</td><td>&#160;</td>
    <td style="text-align: center">USD</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: center">Azarga Resources Limited</td><td>&#160;</td>
    <td style="text-align: center">British Virgin Islands</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">100</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: center">Mineral Exploration</td><td>&#160;</td>
    <td style="text-align: center">USD</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: center">Azarga Resources (Hong Kong) Ltd.</td><td>&#160;</td>
    <td style="text-align: center">Hong Kong</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">100</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: center">Mineral Exploration</td><td>&#160;</td>
    <td style="text-align: center">USD</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: center">Azarga Resources USA Company</td><td>&#160;</td>
    <td style="text-align: center">Colorado, USA</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">100</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: center">Mineral Exploration</td><td>&#160;</td>
    <td style="text-align: center">USD</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: center; padding-bottom: 1.5pt">Azarga Resources Canada Ltd.</td><td>&#160;</td>
    <td style="text-align: center; padding-bottom: 1.5pt">British Columbia, CA</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">100</td><td style="padding-bottom: 1.5pt; text-align: left">%</td><td>&#160;</td>
    <td style="text-align: center; padding-bottom: 1.5pt">Mineral Exploration</td><td>&#160;</td>
    <td style="text-align: center; padding-bottom: 1.5pt">USD</td></tr>
  </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">*
Cibola Resources, LLC was divested in May 2022 (Note 11).</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_DisclosureOfUsefulLivesOfPropertyPlantAndEquipementTextBlock', window );">Schedule of useful lives of property, plant and equipement</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom; ">
    <td style="border-bottom: Black 1.5pt solid; text-align: center; width: 49%"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><b>Category</b></span></p></td><td style="width: 2%; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; width: 49%; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Range</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Uranium Plants</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Straight-line over 15-25 years</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Other Property Plant and Equipment</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Straight-line over 3-5 years</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif">Software</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Straight-line over 2-3 years</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td><span style="font-family: Times New Roman, Times, Serif">Furniture</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Straight-line over 3-5 years</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif">Buildings</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Straight-line over 10-40 years</span></td></tr>
  </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b>&#160;</b></span></p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_DisclosureOfUsefulLivesOfIntangibleAssetsTextBllock', window );">Schedule of useful lives of intangible assets</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom; ">
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center; width: 49%"><span style="font-family: Times New Roman, Times, Serif">Category</span></td><td style="width: 2%; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; width: 49%; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Range</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Data Access Agreement</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Straight-line over 14 years</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Data Purchases</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Indefinite life intangible asset</span></td></tr>
  </table><p style="margin-top: 0; margin-bottom: 0"/><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cve_DisclosureOfUsefulLivesOfIntangibleAssetsTextBllock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of useful lives of intangible assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cve_DisclosureOfUsefulLivesOfIntangibleAssetsTextBllock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cve_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cve_DisclosureOfUsefulLivesOfPropertyPlantAndEquipementTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of useful lives of property, plant and equipement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cve_DisclosureOfUsefulLivesOfPropertyPlantAndEquipementTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cve_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cve_SignificantaccountingpoliciesTablesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cve_SignificantaccountingpoliciesTablesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cve_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfEffectOfChangesInForeignExchangeRatesExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the effect of changes in foreign exchange rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 21<br> -IssueDate 2022-03-24<br> -Section Disclosure<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=21&amp;code=ifrs-tx-2022-en-r&amp;doctype=Standard&amp;dita_xref=IAS21_g51-57__IAS21_g51-57_TI<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfEffectOfChangesInForeignExchangeRatesExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of subsidiaries. [Refer: Subsidiaries [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 27<br> -IssueDate 2022-03-24<br> -Paragraph 17<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=27&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_17_b&amp;doctype=Standard<br> -URIDate 2022-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 27<br> -IssueDate 2022-03-24<br> -Paragraph 16<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=27&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_16_b&amp;doctype=Standard<br> -URIDate 2022-03-24<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2022-03-24<br> -Paragraph B4<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_B4_a&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>81
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139782922705600">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Investment In Associate (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_InvestmentInAssociateTablesLineItems', window );"><strong>Investment in Associate [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_DisclosureOfProportionalShareAssociatesExplanatory', window );">Schedule of proportional share in the associate</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td style="padding-left: 0.125in; text-align: center">&#160;</td><td style="text-align: center">&#160;</td>
    <td colspan="2" style="text-align: center">Assets</td><td style="text-align: center">&#160;</td><td style="text-align: center">&#160;</td>
    <td colspan="2" style="text-align: center">Liabilities</td><td style="text-align: center">&#160;</td><td style="text-align: center">&#160;</td>
    <td colspan="2" style="text-align: center">Revenues</td><td style="text-align: center">&#160;</td><td style="text-align: center">&#160;</td>
    <td colspan="2" style="text-align: center">Expenses</td><td style="text-align: center">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center; padding-left: 0.125in">&#160;</td><td style="text-align: center">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">$</td><td style="text-align: center; padding-bottom: 1.5pt">&#160;</td><td style="text-align: center">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">$</td><td style="text-align: center; padding-bottom: 1.5pt">&#160;</td><td style="text-align: center">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">$</td><td style="text-align: center; padding-bottom: 1.5pt">&#160;</td><td style="text-align: center">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">$</td><td style="text-align: center; padding-bottom: 1.5pt">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-indent: -0.125in">Year ended December 31, 2021</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.25in; text-indent: -0.125in; width: 52%">Current</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">1,078,019</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">120,569</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-106">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;-</div></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-107">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;-</div></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.25in; text-indent: -0.125in">Non-current</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">751,065</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-108">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-109">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-110">-</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.25in; text-indent: -0.125in; text-align: left; padding-bottom: 1.5pt">Loss from operating expenses</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-111">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-112">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-113">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(755,943</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 1.5pt">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">1,829,084</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">120,569</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-114">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(755,943</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-indent: -0.125in; font-weight: bold">Year ended December 31, 2022</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.25in; text-indent: -0.125in">Current</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">609,704</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">39,259</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-115">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-116">-</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.25in; text-indent: -0.125in">Non-current</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">729,261</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-117">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-118">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-119">-</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.25in; text-indent: -0.125in; text-align: left; padding-bottom: 1.5pt">Loss from operating expenses</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-120">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-121">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-122">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(415,769</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 1.5pt">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">1,338,965</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">39,259</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-123">-</div></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">(415,769</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-indent: -0.125in; font-weight: bold; text-align: left; padding-bottom: 1.5pt">The Company&#8217;s percentage ownership</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">33.71</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">%</td></tr>
  </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 18pt"/><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfInterestsInAssociatesExplanatory', window );">Schedule of investment in associate continuity summary</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="text-align: center">&#160;</td>
    <td colspan="2" style="text-align: center">Investment in <br/> associate</td><td style="text-align: center">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="text-align: center">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">$</td><td style="text-align: center; padding-bottom: 1.5pt">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 88%; padding-bottom: 1.5pt">Balance, December 31, 2020</td><td style="width: 1%">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; width: 9%; text-align: right">451,221</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Adjustments to carrying value:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in">Proportionate share of net loss</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(260,055</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-align: left">Adjustment to investment in Group 11</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">469,320</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-align: left">Dilution loss</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(95,680</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-align: left; padding-bottom: 1.5pt">Currency translation adjustment</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(466</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-bottom: 1.5pt">Balance, December 31, 2021</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">564,340</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Adjustments to carrying value:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in">Proportionate share of net loss through June 30</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(143,286</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-align: left">Adjustment to investment in Group 11 through June 30</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">15,675</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in">Write-off of investment</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(443,614</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-align: left; padding-bottom: 1.5pt">Currency translation adjustment</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">6,885</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; padding-bottom: 1.5pt">Balance, December 31, 2022</td><td style="font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">-</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cve_DisclosureOfProportionalShareAssociatesExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure Of Proportional Share Associates Explanatory.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cve_DisclosureOfProportionalShareAssociatesExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cve_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cve_InvestmentInAssociateTablesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cve_InvestmentInAssociateTablesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cve_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfInterestsInAssociatesExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of interests in associates. [Refer: Associates [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2022-03-24<br> -Paragraph 2<br> -Subparagraph b<br> -Clause ii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_2_b_ii&amp;doctype=Standard<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfInterestsInAssociatesExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>82
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139782921938304">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Investment in uranium (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_DisclosureOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethodTextBlockAbstract', window );"><strong>Disclosure Of Investments Other Than Investments Accounted For Using Equity Method Text Block Abstract</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_ScheduleOfTheFairValueOfThePhysicalUraniumInvestmentTableTextBlck', window );">Schedule of the fair value of the physical uranium investment</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">Investment in<br/> uranium</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="text-align: center">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">$</td><td style="text-align: center; padding-bottom: 1.5pt">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1.5pt">Balance, December 31, 2020</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-124">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 88%; text-align: left">Physical uranium</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">9,076,000</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td>Fair value adjustment</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,554,000</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Gain on sale of uranium</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">524,075</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Sale of uranium investment</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(6,975,000</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">Currency translation adjustment</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">30,925</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-bottom: 1.5pt">Balance, December 31, 2021</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">4,210,000</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Sale of uranium investment</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(4,245,000</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Gain on sale of uranium</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">35,000</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt">Currency translation adjustment</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-125">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; padding-bottom: 1.5pt">Balance, December 31, 2022</td><td style="font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-126">-</div></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_ScheduleOfUraniumConcentratesPurchaseAgreementTableTextBlock', window );">Schedule of uranium concentrates purchase agreement</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td style="padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 1.5pt; text-align: center">&#160;</td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Purchase Commitments in Pounds</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Total Purchase Price</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; width: 76%">Fiscal 2023</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">400,000</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">19,572,500</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-indent: -0.125in">Fiscal 2024</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-127">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-128">-</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in">Fiscal 2025</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-129">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-130">-</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-indent: -0.125in">Fiscal 2026</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-131">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-132">-</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in">Fiscal 2027</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-133">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-134">-</div></td><td style="text-align: left">&#160;</td></tr>
  </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cve_DisclosureOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethodTextBlockAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cve_DisclosureOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethodTextBlockAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cve_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cve_ScheduleOfTheFairValueOfThePhysicalUraniumInvestmentTableTextBlck">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cve_ScheduleOfTheFairValueOfThePhysicalUraniumInvestmentTableTextBlck</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cve_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cve_ScheduleOfUraniumConcentratesPurchaseAgreementTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cve_ScheduleOfUraniumConcentratesPurchaseAgreementTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cve_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>83
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139782929032064">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Marketable Securities (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_MarketableSecuritiesTablesLineItems', window );"><strong>Marketable Securities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_ScheduleOfMarketableSecuritiesTableTextBlock', window );">Schedule of marketable securities</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="text-align: center; font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Marketable<br/> securities (current)</td><td style="text-align: center; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Marketable<br/> securities (non-current)</td><td style="text-align: center; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Total</td><td style="text-align: center; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">$</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">$</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">$</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%; padding-bottom: 1.5pt">Balance, December 31, 2020, and 2021</td><td style="border-bottom: Black 1.5pt solid; width: 1%">&#160;</td>
    <td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-135">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;-</div></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-136">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;-</div></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-137">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;-</div></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Additions</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,443,094</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">608,391</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3,051,485</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td>Fair value adjustments</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">848,814</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">208,592</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,057,406</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">Currency translation adjustment</td><td style="border-bottom: Black 1.5pt solid">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(129,547</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(32,151</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(161,698</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font-weight: bold; padding-bottom: 1.5pt">Balance, December 31, 2022</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">3,162,361</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">784,832</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">3,947,193</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cve_MarketableSecuritiesTablesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cve_MarketableSecuritiesTablesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cve_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cve_ScheduleOfMarketableSecuritiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for marketable securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cve_ScheduleOfMarketableSecuritiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cve_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>84
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139782928955296">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Intangible assets (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_IntangibleassetsTablesLineItems', window );"><strong>Intangible assets [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDetailedInformationAboutIntangibleAssetsExplanatory', window );">Schedule of intangible asset was determined</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td style="padding-left: 0.125in; text-align: center">&#160;</td><td style="text-align: center; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">VANE<br/> Agreement<br/> $</td><td style="text-align: center; padding-bottom: 1.5pt">&#160;</td><td style="text-align: center; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">Getty<br/> Database<br/> $</td><td style="text-align: center; padding-bottom: 1.5pt">&#160;</td><td style="text-align: center; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">Signal<br/> Equities<br/> Database<br/> $</td><td style="text-align: center; padding-bottom: 1.5pt">&#160;</td><td style="text-align: center; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">Grants<br/> Mineral Belt<br/> Database<br/> $</td><td style="text-align: center; padding-bottom: 1.5pt">&#160;</td><td style="text-align: center; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">Total<br/> $</td><td style="text-align: center; padding-bottom: 1.5pt">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; width: 40%">Balance, December 31, 2020</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">226,368</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">-</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">67,251</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">190,012</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">483,631</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-indent: -0.125in">Additions</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">17,500</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">17,500</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in">Amortization</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(20,515</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(20,515</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left; padding-bottom: 1.5pt">Currency Translation Adjustment</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">1,651</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">9,729</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">11,380</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 1.5pt">Balance, December 31, 2021</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">207,504</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">67,251</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">217,241</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">491,996</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-indent: -0.125in">Additions</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">55,500</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">55,500</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in">Amortization</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(19,764</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(19,764</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left; padding-bottom: 1.5pt">Currency Translation Adjustment</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">900</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(350</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">550</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; font-weight: bold; padding-bottom: 1.5pt">Balance, December 31, 2022</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">188,640</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">55,150</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">67,251</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">217,241</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">528,282</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cve_IntangibleassetsTablesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cve_IntangibleassetsTablesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cve_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfDetailedInformationAboutIntangibleAssetsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of detailed information about intangible assets. [Refer: Intangible assets other than goodwill]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 38<br> -IssueDate 2022-03-24<br> -Paragraph 118<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=38&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_118&amp;doctype=Standard<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfDetailedInformationAboutIntangibleAssetsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>85
<FILENAME>R35.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139782928911984">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Property, plant, and equipment (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_PropertyplantandequipmentTablesLineItems', window );"><strong>Schedule of property, plant, and equipment [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory', window );">Schedule of property, plant, and equipment</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="text-align: center; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">Uranium<br/> plants<br/> $</td><td style="text-align: center; padding-bottom: 1.5pt">&#160;</td><td style="text-align: center; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">Other property,<br/> plant, and equipment<br/> $</td><td style="text-align: center; padding-bottom: 1.5pt">&#160;</td><td style="text-align: center; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">Furniture<br/> $</td><td style="text-align: center; padding-bottom: 1.5pt">&#160;</td><td style="text-align: center; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">Buildings<br/> $</td><td style="text-align: center; padding-bottom: 1.5pt">&#160;</td><td style="text-align: center; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">Software<br/> $</td><td style="text-align: center; padding-bottom: 1.5pt">&#160;</td><td style="text-align: center; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">Total<br/> $</td><td style="text-align: center; padding-bottom: 1.5pt">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 28%">Balance, December 31, 2020</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">1,196,108</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">288,728</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-138">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;-</div></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-139">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;-</div></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-140">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;-</div></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">1,484,836</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td>Additions</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">282,339</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-141">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">16,471</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">62,946</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-142">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">361,756</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Disposals</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-143">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-144">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-145">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-146">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-147">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-148">-</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in">Depreciation</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(168,932</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(73,980</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(2,146</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-149">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-150">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(245,058</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in">Impairment</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-151">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-152">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-153">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-154">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-155">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-156">-</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Currency translation adjustment</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-157">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-158">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,145</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-159">&#160;</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-160">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,145</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1.5pt">Balance, December 31, 2021</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">1,309,515</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">214,748</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">16,470</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">62,946</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-161">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">1,603,679</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-bottom: 1.5pt">Additions</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">758,747</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">172,198</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">8,507</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-162">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">60,135</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">999,587</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Disposals</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-163">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-164">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-165">&#160;</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-166">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-167">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-168">-</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in">Depreciation</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(162,208</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(78,646</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(4,377</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(2,316</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(21,298</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(268,845</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in">Impairment</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-169">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-170">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-171">&#160;</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-172">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-173">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-174">-</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt">Currency translation adjustment</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-175">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-176">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-177">&#160;</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-178">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-179">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-180">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; padding-bottom: 1.5pt">Balance, December 31, 2022</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">1,906,054</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">308,300</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">20,600</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">60,630</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">38,837</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">2,334,421</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cve_PropertyplantandequipmentTablesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cve_PropertyplantandequipmentTablesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cve_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of detailed information about property, plant and equipment. [Refer: Property, plant and equipment]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 16<br> -IssueDate 2022-03-24<br> -Paragraph 73<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=16&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_73&amp;doctype=Standard<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>86
<FILENAME>R36.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139782928910000">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Right-of-use assets (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_RightofuseassetsTablesLineItems', window );"><strong>Right-of-use assets [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_DisclosureOfChangeInTheROUAssetsTableTextBlock', window );">Schedule of change in the ROU assets</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td style="text-align: center; padding-bottom: 1.5pt">&#160;</td><td style="text-align: center; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">Leased copier<br/> $</td><td style="text-align: center; padding-bottom: 1.5pt">&#160;</td><td style="text-align: center; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">Leased offices<br/> $</td><td style="text-align: center; padding-bottom: 1.5pt">&#160;</td><td style="text-align: center; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">Total<br/> $</td><td style="text-align: center; padding-bottom: 1.5pt">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%">Balance, December 31, 2020</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">8,867</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-181">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;-</div></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">8,867</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td>Additions</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-182">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">266,583</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">266,583</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Depreciation</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(5,451</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(27,642</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(33,093</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt">Currency translation adjustment</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-183">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">2,207</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">2,207</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1.5pt">Balance, December 31, 2021</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">3,416</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">241,148</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">244,564</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td>Additions</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-184">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">34,898</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">34,898</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Depreciation</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(3,416</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(88,311</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(91,727</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt">Currency translation adjustment</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-185">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(2,121</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(2,121</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; padding-bottom: 1.5pt">Balance, December 31, 2022</td><td style="font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-186">-</div></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">185,614</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">185,614</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_DisclosureOfChangeInTheLongTermLeaseLiabilityTableTextBlock', window );">Schedule of change in the long-Term lease liability</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td style="text-align: center; padding-bottom: 1.5pt">&#160;</td><td style="text-align: center; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">Leased copier<br/> $</td><td style="text-align: center; padding-bottom: 1.5pt">&#160;</td><td style="text-align: center; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">Leased offices<br/> $</td><td style="text-align: center; padding-bottom: 1.5pt">&#160;</td><td style="text-align: center; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">Total<br/> $</td><td style="text-align: center; padding-bottom: 1.5pt">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%">Balance, December 31, 2020</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">8,867</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-187">&#160;&#160;&#160;&#160;&#160;&#160;-</div></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">8,867</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td>Additions</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-188">&#160;</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">273,001</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">273,001</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Accretion</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-189">&#160;</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">7,471</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">7,471</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Lease payments made</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(5,451</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(32,137</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(37,588</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">Currency translation adjustment</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-190">&#160;</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(2,242</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(2,242</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-bottom: 1.5pt">Balance, December 31, 2021</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">3,416</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">246,093</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">249,509</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Additions</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-191">&#160;</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">34,898</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">34,898</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td>Accretion</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">77</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">15,157</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">15,234</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Lease payments made</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(3,493</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(103,953</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(107,446</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt">Currency translation adjustment</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-192">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(11,767</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(11,767</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; padding-bottom: 1.5pt">Balance, December 31, 2022</td><td style="font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-193">-</div></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">180,428</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">180,428</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt">Less: current lease liability</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-194">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(84,262</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(84,262</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; padding-bottom: 1.5pt">Balance (Long Term), December 31, 2022</td><td style="font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-195">-</div></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">96,166</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">96,166</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MaturityAnalysisForDerivativeFinancialLiabilities', window );">Schedule of undiscounted future lease payments</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom; ">
    <td style="border-bottom: Black 1.5pt solid; width: 88%; font-weight: bold; text-align: left">Year</td><td style="width: 1%; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; width: 1%; padding-bottom: 1.5pt; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; width: 9%; font-weight: bold; text-align: right">&#160;&#160;&#160;&#160;&#160;&#160;&#160;</td><td style="width: 1%; padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">2023</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">127,967</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">2024</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">81,267</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">2025</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">32,502</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt">Total</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">241,736</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cve_DisclosureOfChangeInTheLongTermLeaseLiabilityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of change in the long-Term lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cve_DisclosureOfChangeInTheLongTermLeaseLiabilityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cve_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cve_DisclosureOfChangeInTheROUAssetsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of change in the ROU assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cve_DisclosureOfChangeInTheROUAssetsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cve_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cve_RightofuseassetsTablesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cve_RightofuseassetsTablesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cve_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_MaturityAnalysisForDerivativeFinancialLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of a maturity analysis for derivative financial liabilities, including the remaining contractual maturities for those derivative financial liabilities for which contractual maturities are essential for an understanding of the timing of the cash flows. [Refer: Derivative financial liabilities]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 7<br> -IssueDate 2022-03-24<br> -Paragraph 39<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_39_b&amp;doctype=Standard<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_MaturityAnalysisForDerivativeFinancialLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>87
<FILENAME>R37.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139782923990320">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Asset acquisition (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_DisclosureOfTransactionsRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombinationTextBlockAbstract', window );"><strong>Disclosure Of Transactions Recognised Separately From Acquisition Of Assets And Assumption Of Liabilities In Business Combination Text Block Abstract</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfFairValueMeasurementOfAssetsExplanatory', window );">Schedule of estimated fair value of assets and liabilities</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom; ">
    <td style="border-bottom: Black 1.5pt solid; width: 88%; font-weight: bold; padding-bottom: 1.5pt">Consideration</td><td style="width: 1%; font-weight: bold">&#160;</td>
    <td style="width: 1%; border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"/><td style="border-bottom: Black 1.5pt solid; width: 9%; font-weight: bold; text-align: center">&#160;</td><td style="width: 1%; padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: 9pt">Fair value of share consideration</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">120,422,593</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: 9pt">Fair value of replacement options</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">5,434,045</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: 9pt">Fair value of replacement warrants</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3,222,543</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt; text-indent: 9pt">Transaction costs</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">3,215,444</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; padding-bottom: 1.5pt">Total consideration value</td><td style="font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">132,294,625</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
</table><p style="margin: 0">&#160;</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfRedesignatedFinancialAssetsAndLiabilitiesExplanatory', window );">Schedule of net assets acquired</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom; ">
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left; padding-bottom: 1.5pt; width: 88%">Net assets acquired</td><td style="font-weight: bold; width: 1%">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left; width: 1%"/><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center; width: 9%">$</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left; width: 1%">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: 9pt">Cash</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,860,360</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; text-indent: 9pt">Restricted cash</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">720,039</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: 9pt">Prepaids</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">169,688</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; text-indent: 9pt">Property, plant, and equipment</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">62,946</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; text-indent: 9pt">Right-of-use asset</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">45,444</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; text-indent: 9pt">Mineral properties</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">129,129,302</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; text-indent: 9pt">Asset retirement obligations</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(267,807</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; text-indent: 9pt">Lease liability</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(49,339</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; text-indent: 9pt">Loan receivable (1)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,845,941</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt; text-indent: 9pt">Accounts payable and accrued liabilities</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(1,221,949</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt">Total net assets acquired</td><td style="font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">132,294,625</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  </table><p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt"><span style="font-family: Times New Roman, Times, Serif">(1)
- Transaction costs incurred by Azarga which were subsequently paid by the Company.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfIndirectMeasurementOfFairValueOfGoodsOrServicesReceivedShareOptionsGrantedDuringPeriodExplanatory', window );">Schedule of weighted average assumptions used in the black-scholes option</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">Weighted
    average</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 88%"><span style="font-family: Times New Roman, Times, Serif">Exercise price</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">1.40</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td><span style="font-family: Times New Roman, Times, Serif">Share price</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">3.79</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Discount rate</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">1.04</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Expected life (years)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">3.43</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Volatility</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">104.40</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Fair value of replacement
    options (per option):</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">2.97</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">Weighted
    average</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 88%"><span style="font-family: Times New Roman, Times, Serif">Exercise price</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">1.66</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td><span style="font-family: Times New Roman, Times, Serif">Share price</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">3.79</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Discount rate</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">0.91</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Expected life (years)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">0.98</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Volatility</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">77.10</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Fair
    value of replacement warrants (per warrant):</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">2.30</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cve_DisclosureOfTransactionsRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombinationTextBlockAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cve_DisclosureOfTransactionsRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombinationTextBlockAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cve_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfFairValueMeasurementOfAssetsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of the fair value measurement of assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2022-03-24<br> -Paragraph 93<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_93&amp;doctype=Standard<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfFairValueMeasurementOfAssetsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfIndirectMeasurementOfFairValueOfGoodsOrServicesReceivedShareOptionsGrantedDuringPeriodExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of information about indirect, by reference to the fair value of the equity instruments granted, measurement of the fair value of goods or services received as consideration for the entity's share options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2022-03-24<br> -Paragraph 47<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_47_a&amp;doctype=Standard<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfIndirectMeasurementOfFairValueOfGoodsOrServicesReceivedShareOptionsGrantedDuringPeriodExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfRedesignatedFinancialAssetsAndLiabilitiesExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of financial assets and financial liabilities that have been redesignated during the transition to IFRSs. [Refer: Financial assets; Financial liabilities; IFRSs [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 1<br> -IssueDate 2022-03-24<br> -Paragraph 29<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=1&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_29&amp;doctype=Standard<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfRedesignatedFinancialAssetsAndLiabilitiesExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>88
<FILENAME>R38.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139782927402128">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Mineral Properties (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_DisclosureOfMineralPropertiesAbstract', window );"><strong>Disclosure Of Mineral Properties Abstract</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_ScheduleOfMineralProperties', window );">Schedule of mineral properties</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td style="padding-left: 0.125in; padding-bottom: 1.5pt; text-align: center"/><td style="padding-bottom: 1.5pt; text-align: center"/>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><span style="font-size: 8pt">Arizona<br/> $</span></td><td style="text-align: center; padding-bottom: 1.5pt"/><td style="padding-bottom: 1.5pt; text-align: center"/>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><span style="font-size: 8pt">Colorado<br/> $</span></td><td style="text-align: center; padding-bottom: 1.5pt"/><td style="padding-bottom: 1.5pt; text-align: center"/>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><span style="font-size: 8pt">New Mexico<br/> $</span></td><td style="text-align: center; padding-bottom: 1.5pt"/><td style="padding-bottom: 1.5pt; text-align: center"/>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><span style="font-size: 8pt">South Dakota<br/> $</span></td><td style="text-align: center; padding-bottom: 1.5pt"/><td style="padding-bottom: 1.5pt; text-align: center"/>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><span style="font-size: 8pt">Texas<br/> $</span></td><td style="text-align: center; padding-bottom: 1.5pt"/><td style="padding-bottom: 1.5pt; text-align: center"/>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><span style="font-size: 8pt">Utah<br/> $</span></td><td style="text-align: center; padding-bottom: 1.5pt"/><td style="padding-bottom: 1.5pt; text-align: center"/>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><span style="font-size: 8pt">Wyoming<br/> $</span></td><td style="text-align: center; padding-bottom: 1.5pt"/><td style="padding-bottom: 1.5pt; text-align: center"/>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><span style="font-size: 8pt">Canada<br/> $</span></td><td style="text-align: center; padding-bottom: 1.5pt"/><td style="padding-bottom: 1.5pt; text-align: center"/>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><span style="font-size: 8pt">Total<br/> $</span></td><td style="text-align: center; padding-bottom: 1.5pt"/></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; width: 23%"><span style="font-size: 8pt">Balance, December 31, 2020</span></td><td style="width: 1%"/>
    <td style="width: 0.5%; text-align: left"/><td style="width: 7%; text-align: right"><span style="font-size: 8pt">771,388</span></td><td style="width: 0.5%; text-align: left"/><td style="width: 0.5%"/>
    <td style="width: 0.5%; text-align: left"/><td style="width: 7%; text-align: right"><span style="-sec-ix-hidden: hidden-fact-196; font-size: 8pt">-</span></td><td style="width: 0.5%; text-align: left"/><td style="width: 0.5%"/>
    <td style="width: 0.5%; text-align: left"/><td style="width: 7%; text-align: right"><span style="font-size: 8pt">5,477,162</span></td><td style="width: 0.5%; text-align: left"/><td style="width: 0.5%"/>
    <td style="width: 0.5%; text-align: left"/><td style="width: 7%; text-align: right"><span style="-sec-ix-hidden: hidden-fact-197; font-size: 8pt">-</span></td><td style="width: 0.5%; text-align: left"/><td style="width: 0.5%"/>
    <td style="width: 0.5%; text-align: left"/><td style="width: 7%; text-align: right"><span style="-sec-ix-hidden: hidden-fact-198; font-size: 8pt">-</span></td><td style="width: 0.5%; text-align: left"/><td style="width: 0.5%"/>
    <td style="width: 0.5%; text-align: left"/><td style="width: 7%; text-align: right"><span style="font-size: 8pt">300,460</span></td><td style="width: 0.5%; text-align: left"/><td style="width: 0.5%"/>
    <td style="width: 0.5%; text-align: left"/><td style="width: 7%; text-align: right"><span style="font-size: 8pt">59,050</span></td><td style="width: 0.5%; text-align: left"/><td style="width: 0.5%"/>
    <td style="width: 0.5%; text-align: left"/><td style="width: 7%; text-align: right"><span style="-sec-ix-hidden: hidden-fact-199; font-size: 8pt">-</span></td><td style="width: 0.5%; text-align: left"/><td style="width: 0.5%; font-weight: bold"/>
    <td style="width: 0.5%; font-weight: bold; text-align: left"/><td style="width: 7%; font-weight: bold; text-align: right"><span style="font-size: 8pt">6,608,060</span></td><td style="width: 0.5%; font-weight: bold; text-align: left"/></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left"><span style="font-size: 8pt">Acquisition costs:</span></td><td/>
    <td style="text-align: left"/><td style="text-align: right"/><td style="text-align: left"/><td/>
    <td style="text-align: left"/><td style="text-align: right"/><td style="text-align: left"/><td/>
    <td style="text-align: left"/><td style="text-align: right"/><td style="text-align: left"/><td/>
    <td style="text-align: left"/><td style="text-align: right"/><td style="text-align: left"/><td/>
    <td style="text-align: left"/><td style="text-align: right"/><td style="text-align: left"/><td/>
    <td style="text-align: left"/><td style="text-align: right"/><td style="text-align: left"/><td/>
    <td style="text-align: left"/><td style="text-align: right"/><td style="text-align: left"/><td/>
    <td style="text-align: left"/><td style="text-align: right"/><td style="text-align: left"/><td/>
    <td style="text-align: left"/><td style="text-align: right"/><td style="text-align: left"/></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.25in; text-indent: -0.125in; text-align: left"><span style="font-size: 8pt">Asset acquisition (Note 10)</span></td><td/>
    <td style="text-align: left"/><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-200; font-size: 8pt">-</span></td><td style="text-align: left"/><td/>
    <td style="text-align: left"/><td style="text-align: right"><span style="font-size: 8pt">619,902</span></td><td style="text-align: left"/><td/>
    <td style="text-align: left"/><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-201; font-size: 8pt">-</span></td><td style="text-align: left"/><td/>
    <td style="text-align: left"/><td style="text-align: right"><span style="font-size: 8pt">85,667,919</span></td><td style="text-align: left"/><td/>
    <td style="text-align: left"/><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-202; font-size: 8pt">-</span></td><td style="text-align: left"/><td/>
    <td style="text-align: left"/><td style="text-align: right"><span style="font-size: 8pt">1,676,674</span></td><td style="text-align: left"/><td/>
    <td style="text-align: left"/><td style="text-align: right"><span style="font-size: 8pt">41,164,807</span></td><td style="text-align: left"/><td/>
    <td style="text-align: left"/><td style="text-align: right"/><td style="text-align: left"/><td/>
    <td style="text-align: left"/><td style="text-align: right"><span style="font-size: 8pt">129,129,302</span></td><td style="text-align: left"/></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left"><span style="font-size: 8pt">Exploration costs:</span></td><td/>
    <td style="text-align: left"/><td style="text-align: right"/><td style="text-align: left"/><td/>
    <td style="text-align: left"/><td style="text-align: right"/><td style="text-align: left"/><td/>
    <td style="text-align: left"/><td style="text-align: right"/><td style="text-align: left"/><td/>
    <td style="text-align: left"/><td style="text-align: right"/><td style="text-align: left"/><td/>
    <td style="text-align: left"/><td style="text-align: right"/><td style="text-align: left"/><td/>
    <td style="text-align: left"/><td style="text-align: right"/><td style="text-align: left"/><td/>
    <td style="text-align: left"/><td style="text-align: right"/><td style="text-align: left"/><td/>
    <td style="text-align: left"/><td style="text-align: right"/><td style="text-align: left"/><td/>
    <td style="text-align: left"/><td style="text-align: right"/><td style="text-align: left"/></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.25in; text-indent: -0.125in; text-align: left"><span style="font-size: 8pt">Maintenance and lease fees</span></td><td/>
    <td style="text-align: left"/><td style="text-align: right"><span style="font-size: 8pt">86,364</span></td><td style="text-align: left"/><td/>
    <td style="text-align: left"/><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-203; font-size: 8pt">-</span></td><td style="text-align: left"/><td/>
    <td style="text-align: left"/><td style="text-align: right"><span style="font-size: 8pt">529,604</span></td><td style="text-align: left"/><td/>
    <td style="text-align: left"/><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-204; font-size: 8pt">-</span></td><td style="text-align: left"/><td/>
    <td style="text-align: left"/><td style="text-align: right"><span style="font-size: 8pt">1,455,206</span></td><td style="text-align: left"/><td/>
    <td style="text-align: left"/><td style="text-align: right"><span style="font-size: 8pt">22,663</span></td><td style="text-align: left"/><td/>
    <td style="text-align: left"/><td style="text-align: right"><span style="font-size: 8pt">11,870</span></td><td style="text-align: left"/><td/>
    <td style="text-align: left"/><td style="text-align: right"><span style="font-size: 8pt">78,456</span></td><td style="text-align: left"/><td/>
    <td style="text-align: left"/><td style="text-align: right"><span style="font-size: 8pt">2,184,163</span></td><td style="text-align: left"/></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.25in; text-indent: -0.125in; text-align: left"><span style="font-size: 8pt">Resource review</span></td><td/>
    <td style="text-align: left"/><td style="text-align: right"><span style="font-size: 8pt">42,967</span></td><td style="text-align: left"/><td/>
    <td style="text-align: left"/><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-205; font-size: 8pt">-</span></td><td style="text-align: left"/><td/>
    <td style="text-align: left"/><td style="text-align: right"><span style="font-size: 8pt">130,120</span></td><td style="text-align: left"/><td/>
    <td style="text-align: left"/><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-206; font-size: 8pt">-</span></td><td style="text-align: left"/><td/>
    <td style="text-align: left"/><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-207; font-size: 8pt">-</span></td><td style="text-align: left"/><td/>
    <td style="text-align: left"/><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-208; font-size: 8pt">-</span></td><td style="text-align: left"/><td/>
    <td style="text-align: left"/><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-209; font-size: 8pt">-</span></td><td style="text-align: left"/><td/>
    <td style="text-align: left"/><td style="text-align: right"/><td style="text-align: left"/><td/>
    <td style="text-align: left"/><td style="text-align: right"><span style="font-size: 8pt">173,087</span></td><td style="text-align: left"/></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.25in; text-indent: -0.125in; text-align: left"><span style="font-size: 8pt">Impairment charged</span></td><td/>
    <td style="text-align: left"/><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-210; font-size: 8pt">-</span></td><td style="text-align: left"/><td/>
    <td style="text-align: left"/><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-211; font-size: 8pt">-</span></td><td style="text-align: left"/><td/>
    <td style="text-align: left"/><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-212; font-size: 8pt">-</span></td><td style="text-align: left"/><td/>
    <td style="text-align: left"/><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-213; font-size: 8pt">-</span></td><td style="text-align: left"/><td/>
    <td style="text-align: left"/><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-214; font-size: 8pt">-</span></td><td style="text-align: left"/><td/>
    <td style="text-align: left"/><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-215; font-size: 8pt">-</span></td><td style="text-align: left"/><td/>
    <td style="text-align: left"/><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-216; font-size: 8pt">-</span></td><td style="text-align: left"/><td/>
    <td style="text-align: left"/><td style="text-align: right"><span style="font-size: 8pt">(78,456</span></td><td style="text-align: left"><span style="font-size: 8pt">)</span></td><td/>
    <td style="text-align: left"/><td style="text-align: right"><span style="font-size: 8pt">(78,456</span></td><td style="text-align: left"><span style="font-size: 8pt">)</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-indent: -0.125in"><span style="font-size: 8pt">Divestment:</span></td><td/>
    <td style="text-align: left"/><td style="text-align: right"/><td style="text-align: left"/><td/>
    <td style="text-align: left"/><td style="text-align: right"/><td style="text-align: left"/><td/>
    <td style="text-align: left"/><td style="text-align: right"/><td style="text-align: left"/><td/>
    <td style="text-align: left"/><td style="text-align: right"/><td style="text-align: left"/><td/>
    <td style="text-align: left"/><td style="text-align: right"/><td style="text-align: left"/><td/>
    <td style="text-align: left"/><td style="text-align: right"/><td style="text-align: left"/><td/>
    <td style="text-align: left"/><td style="text-align: right"/><td style="text-align: left"/><td/>
    <td style="text-align: left"/><td style="text-align: right"/><td style="text-align: left"/><td/>
    <td style="text-align: left"/><td style="text-align: right"/><td style="text-align: left"/></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.375in; text-indent: -0.125in; text-align: left"><span style="font-size: 8pt">Divest - Mineral interest</span></td><td/>
    <td style="text-align: left"/><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-217; font-size: 8pt">-</span></td><td style="text-align: left"/><td/>
    <td style="text-align: left"/><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-218; font-size: 8pt">-</span></td><td style="text-align: left"/><td/>
    <td style="text-align: left"/><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-219; font-size: 8pt">-</span></td><td style="text-align: left"/><td/>
    <td style="text-align: left"/><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-220; font-size: 8pt">-</span></td><td style="text-align: left"/><td/>
    <td style="text-align: left"/><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-221; font-size: 8pt">-</span></td><td style="text-align: left"/><td/>
    <td style="text-align: left"/><td style="text-align: right"><span style="font-size: 8pt">(195,514</span></td><td style="text-align: left"><span style="font-size: 8pt">)</span></td><td/>
    <td style="text-align: left"/><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-222; font-size: 8pt">-</span></td><td style="text-align: left"/><td/>
    <td style="text-align: left"/><td style="text-align: right"/><td style="text-align: left"/><td/>
    <td style="text-align: left"/><td style="text-align: right"><span style="font-size: 8pt">(195,514</span></td><td style="text-align: left"><span style="font-size: 8pt">)</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.25in; text-indent: -0.125in; text-align: left; padding-bottom: 1.5pt"><span style="font-size: 8pt">Assets
    held for sale</span></td><td/>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"/><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-223; font-size: 8pt">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"/><td/>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"/><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-224; font-size: 8pt">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"/><td/>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"/><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-size: 8pt">(1,741,064</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-size: 8pt">)</span></td><td/>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"/><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-225; font-size: 8pt">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"/><td/>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"/><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-226; font-size: 8pt">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"/><td/>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"/><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-227; font-size: 8pt">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"/><td/>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"/><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-228; font-size: 8pt">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"/><td/>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"/><td style="border-bottom: Black 1.5pt solid; text-align: right"/><td style="padding-bottom: 1.5pt; text-align: left"/><td/>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"/><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-size: 8pt">(1,741,064</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-size: 8pt">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 1.5pt"><span style="font-size: 8pt">Balance, December 31,
    2021</span></td><td/>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"/><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-size: 8pt">900,719</span></td><td style="padding-bottom: 1.5pt; text-align: left"/><td/>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"/><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-size: 8pt">619,902</span></td><td style="padding-bottom: 1.5pt; text-align: left"/><td/>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"/><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-size: 8pt">4,395,822</span></td><td style="padding-bottom: 1.5pt; text-align: left"/><td/>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"/><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-size: 8pt">85,667,919</span></td><td style="padding-bottom: 1.5pt; text-align: left"/><td/>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"/><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-size: 8pt">1,455,206</span></td><td style="padding-bottom: 1.5pt; text-align: left"/><td/>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"/><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-size: 8pt">1,804,283</span></td><td style="padding-bottom: 1.5pt; text-align: left"/><td/>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"/><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-size: 8pt">41,235,727</span></td><td style="padding-bottom: 1.5pt; text-align: left"/><td/>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"/><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-229; font-size: 8pt">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"/><td style="font-weight: bold"/>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"/><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-size: 8pt">136,079,578</span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"/></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left"><span style="font-size: 8pt">Exploration costs:</span></td><td/>
    <td style="text-align: left"/><td style="text-align: right"/><td style="text-align: left"/><td/>
    <td style="text-align: left"/><td style="text-align: right"/><td style="text-align: left"/><td/>
    <td style="text-align: left"/><td style="text-align: right"/><td style="text-align: left"/><td/>
    <td style="text-align: left"/><td style="text-align: right"/><td style="text-align: left"/><td/>
    <td style="text-align: left"/><td style="text-align: right"/><td style="text-align: left"/><td/>
    <td style="text-align: left"/><td style="text-align: right"/><td style="text-align: left"/><td/>
    <td style="text-align: left"/><td style="text-align: right"/><td style="text-align: left"/><td/>
    <td style="text-align: left"/><td style="text-align: right"/><td style="text-align: left"/><td/>
    <td style="text-align: left"/><td style="text-align: right"/><td style="text-align: left"/></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.25in; text-indent: -0.125in"><span style="font-size: 8pt">Drilling</span></td><td/>
    <td style="text-align: left"/><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-230; font-size: 8pt">-</span></td><td style="text-align: left"/><td/>
    <td style="text-align: left"/><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-231; font-size: 8pt">-</span></td><td style="text-align: left"/><td/>
    <td style="text-align: left"/><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-232; font-size: 8pt">-</span></td><td style="text-align: left"/><td/>
    <td style="text-align: left"/><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-233; font-size: 8pt">-</span></td><td style="text-align: left"/><td/>
    <td style="text-align: left"/><td style="text-align: right"><span style="font-size: 8pt">197,422</span></td><td style="text-align: left"/><td/>
    <td style="text-align: left"/><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-234; font-size: 8pt">-</span></td><td style="text-align: left"/><td/>
    <td style="text-align: left"/><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-235; font-size: 8pt">-</span></td><td style="text-align: left"/><td/>
    <td style="text-align: left"/><td style="text-align: right"/><td style="text-align: left"/><td/>
    <td style="text-align: left"/><td style="text-align: right"><span style="font-size: 8pt">197,422</span></td><td style="text-align: left"/></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.25in; text-indent: -0.125in; text-align: left"><span style="font-size: 8pt">Maintenance and lease fees</span></td><td/>
    <td style="text-align: left"/><td style="text-align: right"><span style="font-size: 8pt">111,004</span></td><td style="text-align: left"/><td/>
    <td style="text-align: left"/><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-236; font-size: 8pt">-</span></td><td style="text-align: left"/><td/>
    <td style="text-align: left"/><td style="text-align: right"><span style="font-size: 8pt">472,401</span></td><td style="text-align: left"/><td/>
    <td style="text-align: left"/><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-237; font-size: 8pt">-</span></td><td style="text-align: left"/><td/>
    <td style="text-align: left"/><td style="text-align: right"><span style="font-size: 8pt">2,523,123</span></td><td style="text-align: left"/><td/>
    <td style="text-align: left"/><td style="text-align: right"><span style="font-size: 8pt">39,566</span></td><td style="text-align: left"/><td/>
    <td style="text-align: left"/><td style="text-align: right"><span style="font-size: 8pt">397,324</span></td><td style="text-align: left"/><td/>
    <td style="text-align: left"/><td style="text-align: right"/><td style="text-align: left"/><td/>
    <td style="text-align: left"/><td style="text-align: right"><span style="font-size: 8pt">3,543,418</span></td><td style="text-align: left"/></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.25in; text-indent: -0.125in; text-align: left"><span style="font-size: 8pt">Permitting &amp; Licensing</span></td><td/>
    <td style="text-align: left"/><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-238; font-size: 8pt">-</span></td><td style="text-align: left"/><td/>
    <td style="text-align: left"/><td style="text-align: right"><span style="font-size: 8pt">(30,280</span></td><td style="text-align: left"><span style="font-size: 8pt">)</span></td><td/>
    <td style="text-align: left"/><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-239; font-size: 8pt">-</span></td><td style="text-align: left"/><td/>
    <td style="text-align: left"/><td style="text-align: right"><span style="font-size: 8pt">251,863</span></td><td style="text-align: left"/><td/>
    <td style="text-align: left"/><td style="text-align: right"><span style="font-size: 8pt">339,225</span></td><td style="text-align: left"/><td/>
    <td style="text-align: left"/><td style="text-align: right"><span style="font-size: 8pt">5,698</span></td><td style="text-align: left"/><td/>
    <td style="text-align: left"/><td style="text-align: right"><span style="font-size: 8pt">273,726</span></td><td style="text-align: left"/><td/>
    <td style="text-align: left"/><td style="text-align: right"/><td style="text-align: left"/><td/>
    <td style="text-align: left"/><td style="text-align: right"><span style="font-size: 8pt">840,232</span></td><td style="text-align: left"/></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.25in; text-indent: -0.125in"><span style="font-size: 8pt">Personnel</span></td><td/>
    <td style="text-align: left"/><td style="text-align: right"><span style="font-size: 8pt">4,500</span></td><td style="text-align: left"/><td/>
    <td style="text-align: left"/><td style="text-align: right"><span style="font-size: 8pt">8,621</span></td><td style="text-align: left"/><td/>
    <td style="text-align: left"/><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-240; font-size: 8pt">-</span></td><td style="text-align: left"/><td/>
    <td style="text-align: left"/><td style="text-align: right"><span style="font-size: 8pt">301,066</span></td><td style="text-align: left"/><td/>
    <td style="text-align: left"/><td style="text-align: right"><span style="font-size: 8pt">280,341</span></td><td style="text-align: left"/><td/>
    <td style="text-align: left"/><td style="text-align: right"><span style="font-size: 8pt">19,620</span></td><td style="text-align: left"/><td/>
    <td style="text-align: left"/><td style="text-align: right"><span style="font-size: 8pt">207,518</span></td><td style="text-align: left"/><td/>
    <td style="text-align: left"/><td style="text-align: right"/><td style="text-align: left"/><td/>
    <td style="text-align: left"/><td style="text-align: right"><span style="font-size: 8pt">821,666</span></td><td style="text-align: left"/></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.25in; text-indent: -0.125in"><span style="font-size: 8pt">Recoveries</span></td><td/>
    <td style="text-align: left"/><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-241; font-size: 8pt">-</span></td><td style="text-align: left"/><td/>
    <td style="text-align: left"/><td style="text-align: right"><span style="font-size: 8pt">(20,000</span></td><td style="text-align: left"><span style="font-size: 8pt">)</span></td><td/>
    <td style="text-align: left"/><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-242; font-size: 8pt">-</span></td><td style="text-align: left"/><td/>
    <td style="text-align: left"/><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-243; font-size: 8pt">-</span></td><td style="text-align: left"/><td/>
    <td style="text-align: left"/><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-244; font-size: 8pt">-</span></td><td style="text-align: left"/><td/>
    <td style="text-align: left"/><td style="text-align: right"><span style="font-size: 8pt">(2,000</span></td><td style="text-align: left"><span style="font-size: 8pt">)</span></td><td/>
    <td style="text-align: left"/><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-245; font-size: 8pt">-</span></td><td style="text-align: left"/><td/>
    <td style="text-align: left"/><td style="text-align: right"/><td style="text-align: left"/><td/>
    <td style="text-align: left"/><td style="text-align: right"><span style="font-size: 8pt">(22,000</span></td><td style="text-align: left"><span style="font-size: 8pt">)</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.25in; text-indent: -0.125in; text-align: left"><span style="font-size: 8pt">Resource review</span></td><td/>
    <td style="text-align: left"/><td style="text-align: right"><span style="font-size: 8pt">118,500</span></td><td style="text-align: left"/><td/>
    <td style="text-align: left"/><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-246; font-size: 8pt">-</span></td><td style="text-align: left"/><td/>
    <td style="text-align: left"/><td style="text-align: right"><span style="font-size: 8pt">37,125</span></td><td style="text-align: left"/><td/>
    <td style="text-align: left"/><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-247; font-size: 8pt">-</span></td><td style="text-align: left"/><td/>
    <td style="text-align: left"/><td style="text-align: right"><span style="font-size: 8pt">47,104</span></td><td style="text-align: left"/><td/>
    <td style="text-align: left"/><td style="text-align: right"><span style="font-size: 8pt">1,680</span></td><td style="text-align: left"/><td/>
    <td style="text-align: left"/><td style="text-align: right"><span style="font-size: 8pt">10,080</span></td><td style="text-align: left"/><td/>
    <td style="text-align: left"/><td style="text-align: right"/><td style="text-align: left"/><td/>
    <td style="text-align: left"/><td style="text-align: right"><span style="font-size: 8pt">214,489</span></td><td style="text-align: left"/></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-size: 8pt">Divestment:</span></td><td/>
    <td style="text-align: left"/><td style="text-align: right"/><td style="text-align: left"/><td/>
    <td style="text-align: left"/><td style="text-align: right"/><td style="text-align: left"/><td/>
    <td style="text-align: left"/><td style="text-align: right"/><td style="text-align: left"/><td/>
    <td style="text-align: left"/><td style="text-align: right"/><td style="text-align: left"/><td/>
    <td style="text-align: left"/><td style="text-align: right"/><td style="text-align: left"/><td/>
    <td style="text-align: left"/><td style="text-align: right"/><td style="text-align: left"/><td/>
    <td style="text-align: left"/><td style="text-align: right"/><td style="text-align: left"/><td/>
    <td style="text-align: left"/><td style="text-align: right"/><td style="text-align: left"/><td/>
    <td style="text-align: left"/><td style="text-align: right"/><td style="text-align: left"/></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.25in; text-indent: -0.125in; text-align: left"><span style="font-size: 8pt">Divestment of Mineral Interest</span></td><td/>
    <td style="text-align: left"/><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-248; font-size: 8pt">-</span></td><td style="text-align: left"/><td/>
    <td style="text-align: left"/><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-249; font-size: 8pt">-</span></td><td style="text-align: left"/><td/>
    <td style="text-align: left"/><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-250; font-size: 8pt">-</span></td><td style="text-align: left"/><td/>
    <td style="text-align: left"/><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-251; font-size: 8pt">-</span></td><td style="text-align: left"/><td/>
    <td style="text-align: left"/><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-252; font-size: 8pt">-</span></td><td style="text-align: left"/><td/>
    <td style="text-align: left"/><td style="text-align: right"><span style="font-size: 8pt">(28,485</span></td><td style="text-align: left"><span style="font-size: 8pt">)</span></td><td/>
    <td style="text-align: left"/><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-253; font-size: 8pt">-</span></td><td style="text-align: left"/><td/>
    <td style="text-align: left"/><td style="text-align: right"/><td style="text-align: left"/><td/>
    <td style="text-align: left"/><td style="text-align: right"><span style="font-size: 8pt">(28,485</span></td><td style="text-align: left"><span style="font-size: 8pt">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.25in; text-indent: -0.125in; text-align: left"><span style="font-size: 8pt">Assets held for sale</span></td><td/>
    <td style="text-align: left"/><td style="text-align: right"><span style="font-size: 8pt">(358,969</span></td><td style="text-align: left"><span style="font-size: 8pt">)</span></td><td/>
    <td style="text-align: left"/><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-254; font-size: 8pt">-</span></td><td style="text-align: left"/><td/>
    <td style="text-align: left"/><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-255; font-size: 8pt">-</span></td><td style="text-align: left"/><td/>
    <td style="text-align: left"/><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-256; font-size: 8pt">-</span></td><td style="text-align: left"/><td/>
    <td style="text-align: left"/><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-257; font-size: 8pt">-</span></td><td style="text-align: left"/><td/>
    <td style="text-align: left"/><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-258; font-size: 8pt">-</span></td><td style="text-align: left"/><td/>
    <td style="text-align: left"/><td style="text-align: right"><span style="font-size: 8pt">(369,913</span></td><td style="text-align: left"><span style="font-size: 8pt">)</span></td><td/>
    <td style="text-align: left"/><td style="text-align: right"/><td style="text-align: left"/><td/>
    <td style="text-align: left"/><td style="text-align: right"><span style="font-size: 8pt">(728,882</span></td><td style="text-align: left"><span style="font-size: 8pt">)</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left"><span style="font-size: 8pt">Project Development costs:</span></td><td/>
    <td style="text-align: left"/><td style="text-align: right"/><td style="text-align: left"/><td/>
    <td style="text-align: left"/><td style="text-align: right"/><td style="text-align: left"/><td/>
    <td style="text-align: left"/><td style="text-align: right"/><td style="text-align: left"/><td/>
    <td style="text-align: left"/><td style="text-align: right"/><td style="text-align: left"/><td/>
    <td style="text-align: left"/><td style="text-align: right"/><td style="text-align: left"/><td/>
    <td style="text-align: left"/><td style="text-align: right"/><td style="text-align: left"/><td/>
    <td style="text-align: left"/><td style="text-align: right"/><td style="text-align: left"/><td/>
    <td style="text-align: left"/><td style="text-align: right"/><td style="text-align: left"/><td/>
    <td style="text-align: left"/><td style="text-align: right"/><td style="text-align: left"/></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.375in; text-indent: -0.125in"><span style="font-size: 8pt">Construction of wellfields</span></td><td/>
    <td style="text-align: left"/><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-259; font-size: 8pt">-</span></td><td style="text-align: left"/><td/>
    <td style="text-align: left"/><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-260; font-size: 8pt">-</span></td><td style="text-align: left"/><td/>
    <td style="text-align: left"/><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-261; font-size: 8pt">-</span></td><td style="text-align: left"/><td/>
    <td style="text-align: left"/><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-262; font-size: 8pt">-</span></td><td style="text-align: left"/><td/>
    <td style="text-align: left"/><td style="text-align: right"><span style="font-size: 8pt">1,670,151</span></td><td style="text-align: left"/><td/>
    <td style="text-align: left"/><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-263; font-size: 8pt">-</span></td><td style="text-align: left"/><td/>
    <td style="text-align: left"/><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-264; font-size: 8pt">-</span></td><td style="text-align: left"/><td/>
    <td style="text-align: left"/><td style="text-align: right"/><td style="text-align: left"/><td/>
    <td style="text-align: left"/><td style="text-align: right"><span style="font-size: 8pt">1,670,151</span></td><td style="text-align: left"/></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.25in; text-indent: -0.125in"><span style="font-size: 8pt">Drilling</span></td><td/>
    <td style="text-align: left"/><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-265; font-size: 8pt">-</span></td><td style="text-align: left"/><td/>
    <td style="text-align: left"/><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-266; font-size: 8pt">-</span></td><td style="text-align: left"/><td/>
    <td style="text-align: left"/><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-267; font-size: 8pt">-</span></td><td style="text-align: left"/><td/>
    <td style="text-align: left"/><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-268; font-size: 8pt">-</span></td><td style="text-align: left"/><td/>
    <td style="text-align: left"/><td style="text-align: right"><span style="font-size: 8pt">2,109,835</span></td><td style="text-align: left"/><td/>
    <td style="text-align: left"/><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-269; font-size: 8pt">-</span></td><td style="text-align: left"/><td/>
    <td style="text-align: left"/><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-270; font-size: 8pt">-</span></td><td style="text-align: left"/><td/>
    <td style="text-align: left"/><td style="text-align: right"/><td style="text-align: left"/><td/>
    <td style="text-align: left"/><td style="text-align: right"><span style="font-size: 8pt">2,109,835</span></td><td style="text-align: left"/></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.25in; text-indent: -0.125in; padding-bottom: 1.5pt"><span style="font-size: 8pt">Personnel</span></td><td/>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"/><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-271; font-size: 8pt">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"/><td/>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"/><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-272; font-size: 8pt">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"/><td/>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"/><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-273; font-size: 8pt">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"/><td/>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"/><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-274; font-size: 8pt">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"/><td/>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"/><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-size: 8pt">521,662</span></td><td style="padding-bottom: 1.5pt; text-align: left"/><td/>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"/><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-275; font-size: 8pt">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"/><td/>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"/><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-276; font-size: 8pt">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"/><td/>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"/><td style="border-bottom: Black 1.5pt solid; text-align: right"/><td style="padding-bottom: 1.5pt; text-align: left"/><td/>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"/><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-size: 8pt">521,662</span></td><td style="padding-bottom: 1.5pt; text-align: left"/></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-indent: -0.125in; font-weight: bold; padding-bottom: 1.5pt"><span style="font-size: 8pt">Balance,
    December 31, 2022</span></td><td style="font-weight: bold"/>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"/><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-size: 8pt">775,754</span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"/><td style="font-weight: bold"/>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"/><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-size: 8pt">578,243</span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"/><td style="font-weight: bold"/>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"/><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-size: 8pt">4,905,348</span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"/><td style="font-weight: bold"/>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"/><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-size: 8pt">86,220,848</span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"/><td style="font-weight: bold"/>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"/><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-size: 8pt">9,144,069</span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"/><td style="font-weight: bold"/>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"/><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-size: 8pt">1,840,362</span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"/><td style="font-weight: bold"/>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"/><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-size: 8pt">41,754,462</span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"/><td/>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"/><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-277; font-size: 8pt">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"/><td style="font-weight: bold"/>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"/><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-size: 8pt">145,219,086</span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"/></tr>
  </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 18pt; text-align: justify; text-indent: -18pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cve_DisclosureOfMineralPropertiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cve_DisclosureOfMineralPropertiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cve_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cve_ScheduleOfMineralProperties">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cve_ScheduleOfMineralProperties</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cve_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>89
<FILENAME>R39.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139782810462544">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Asset retirement obligations (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_AssetretirementobligationsTablesLineItems', window );"><strong>Asset retirement obligations [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_DisclosureOfAssetRetirementObligationsBalanceTableTextBlock', window );">Schedule of asset retirement obligations balance</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td style="text-align: center; padding-bottom: 1.5pt; padding-left: 0.125in">&#160;</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">December 31, <br/> 2022<br/> $</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="text-align: center; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">December 31, <br/> 2021<br/> $</td><td style="text-align: center; padding-bottom: 1.5pt">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; width: 76%">Kingsville</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">3,151,875</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">2,671,295</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-indent: -0.125in">Rosita</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,298,397</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,198,255</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in">Vasquez</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">34,274</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">39,137</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-indent: -0.125in">Centennial</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">168,806</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">168,806</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left">Gas Hills</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">63,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">63,000</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 1.5pt">Ticaboo</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">36,000</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">36,000</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; font-weight: bold; text-align: left; padding-bottom: 1.5pt">Asset retirement obligations</td><td style="font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">4,752,352</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">4,176,493</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_DisclosureOfAssetRetirementObligationsContinuityTableTextBlock', window );">Schedule of asset retirement obligations continuity</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom; ">
    <td style="border-bottom: Black 1.5pt solid; width: 88%; font-weight: bold; text-align: left; padding-bottom: 1.5pt">Asset retirement obligation</td><td style="width: 1%; font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; width: 1%; font-weight: bold; text-align: left"/><td style="border-bottom: Black 1.5pt solid; width: 9%; font-weight: bold; text-align: center">$</td><td style="width: 1%; padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Balance, December 31, 2020</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">5,239,108</td><td style="font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Accretion</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">400,710</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td>Adjustments</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(1,719,943</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Settlement</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(11,189</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt">Additions from Azarga asset acquisition (Note 10)</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">267,807</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1.5pt">Balance, December 31, 2021</td><td style="font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">4,176,493</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Accretion</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">429,956</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td>Settlement</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(11,324</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1.5pt">Adjustments</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">157,227</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font-weight: bold; padding-bottom: 1.5pt">Balance, December 31, 2022</td><td style="font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">4,752,352</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cve_AssetretirementobligationsTablesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cve_AssetretirementobligationsTablesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cve_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cve_DisclosureOfAssetRetirementObligationsBalanceTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of asset retirement obligations balance.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cve_DisclosureOfAssetRetirementObligationsBalanceTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cve_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cve_DisclosureOfAssetRetirementObligationsContinuityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of asset retirement obligations continuity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cve_DisclosureOfAssetRetirementObligationsContinuityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cve_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>90
<FILENAME>R40.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139782929183328">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Sales contracts (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_SalescontractsTablesLineItems', window );"><strong>Sales contracts [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfMaturityAnalysisForFinancialAssetsHeldForManagingLiquidityRiskExplanatory', window );">Schedule of uranium sales contracts over the next five years</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Sales Commitments in Pounds</td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 88%">Fiscal 2023</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">500,000</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td>Fiscal 2024</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">600,000</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Fiscal 2025</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">700,000</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td>Fiscal 2026</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">700,000</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Fiscal 2027</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">650,000</td><td style="text-align: left">&#160;</td></tr>
  </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cve_SalescontractsTablesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cve_SalescontractsTablesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cve_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfMaturityAnalysisForFinancialAssetsHeldForManagingLiquidityRiskExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of a maturity analysis for financial assets held for managing liquidity risk. [Refer: Financial assets; Liquidity risk [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 7<br> -IssueDate 2022-03-24<br> -Paragraph B11E<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_B11E&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfMaturityAnalysisForFinancialAssetsHeldForManagingLiquidityRiskExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>91
<FILENAME>R41.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139782921926080">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share Capital (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_ShareCapitalTablesLineItems', window );"><strong>Share Capital [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_ScheduleOfTheCompanysStockOptionsOutstandingTableTextBlock', window );">Schedule of the company&#8217;s stock options outstanding</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">Year
    ended <br/>
December 31, 2022</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="6" style="text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">Year
    ended <br/>
December 31, 2021</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">Weighted average</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">Weighted average</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">Options</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">exercise price</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">Options</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">exercise price</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">#</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">CAD
    $</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">#</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">CAD
    $</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 52%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Options outstanding, beginning
    of year</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">5,272,294</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">1.42</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">3,572,084</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">0.66</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td><span style="font-family: Times New Roman, Times, Serif">Granted</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">3,107,501</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">4.10</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">2,390,627</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">2.31</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif">Exercised</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(1,016,439</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">1.51</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(590,000</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">0.60</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Forfeited/expired</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(127,708</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">3.60</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(100,417</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">0.54</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Options
    outstanding, end of year</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">7,235,648</span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">2.53</span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">5,272,294</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">1.42</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Options
    exercisable, end of year</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">4,928,147</span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">1.79</span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">4,515,210</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">1.23</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_ScheduleOfStockOptionsOutstandingTableTextBlock', window );">Schedule of stock options outstanding</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">Options
    Outstanding<br/> December 31, 2022</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">Options
    Exercisable<br/> December 31, 2022</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">Weighted average</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">Weighted average</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">Weighted average</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif">Option price</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">Options</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">Remaining</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">exercise price</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">Options</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">exercise price</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td colspan="2" style="border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">per share</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">#</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">Life</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">CAD
    $</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">#</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">CAD
    $</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 14%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.18
- 1.92</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 14%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">3,381,771</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 14%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">0.88</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 14%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">0.85</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 14%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">3,381,771</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 13%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">0.85</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">$</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.40
- 3.78</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">1,034,710</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">0.57</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">3.12</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">594,710</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">2.83</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.20
- 5.76</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">2,819,166</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">1.53</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">4.29</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">951,666</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">4.42</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">7,235,647</span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">2.99</span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">2.52</span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">4,928,147</span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">1.78</span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_ScheduleOfWeightedAverageAssumptionsUsedInCalculatingTheFairValuesTableTextBlock', window );">Schedule of weighted average assumptions used in calculating the fair values</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">December
    31, <br/> 2022</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">December
    31, <br/> 2021</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Risk-free interest rate</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">2.06</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">0.88</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Expected life of option</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.9 years</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5 years</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Expected dividend yield</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">0</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">0</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Expected stock price volatility</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">116.48</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">128.79</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif">Fair value per option</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">CAD
                                            $3.21</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">CAD
                                            $1.10</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_ScheduleOfTheStatusOfTheCompanysWarrantsTableTextBlock', window );">Schedule of the status of the company&#8217;s warrants</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Year
    ended <br/> December 31, 2022</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Year
    ended <br/> December 31, 2021</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">Warrants</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">Weighted average exercise price</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">Warrants</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">Weighted average exercise price</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif">#</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif">CAD
    $</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif">#</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif">CAD
    $</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 52%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Warrants outstanding, beginning
    of year</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">6,298,839</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">2.43</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">4,143,247</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">1.23</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: 0.125in"><span style="font-family: Times New Roman, Times, Serif">Granted</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">3,670,919</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">5.81</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">4,208,435</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">3.24</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: 0.125in"><span style="font-family: Times New Roman, Times, Serif">Exercised</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(2,291,642</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">1.39</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(2,052,843</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">1.62</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: 0.125in; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Expired</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(183,610</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">1.67</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Warrants
    outstanding, end of year</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">7,494,506</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">4.43</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">6,298,839</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">2.43</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_ScheduleOfSharePurchaseWarrantsOutstandingTableTextBlock', window );">Schedule of share purchase warrants outstanding</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: center; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: center; padding-bottom: 1.5pt">&#160;</td>
                                                                                                                          <td style="text-align: center; padding-bottom: 1.5pt">&#160;</td>
                                                                                                                          <td colspan="6" style="border-bottom: Black 1.5pt solid; text-align: center; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"><b>Warrants Outstanding<br/> December 31, 2022</b></span></td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">Weighted average</span></td><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">Weighted average</span></td><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Warrant price</span></td><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">Warrants</span></td><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">Remaining</span></td><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">exercise price</span></td><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">per share</span></td><td style="padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif">#</span></td><td style="text-align: center; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Life</span></td><td style="text-align: center; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif">CAD
    $</span></td><td style="text-align: center; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; width: 46%"><span style="font-family: Times New Roman, Times, Serif">$1.59 - 1.80</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 15%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">1,360,028</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 15%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">0.14</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 15%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">1.81</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$2.22 - 3.90 <sup>1</sup></span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">2,515,197</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">0.39</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">3.84</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">$4.59 - 6.00</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">3,619,281</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">0.59</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">5.86</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">7,494,506</span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">1.12</span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">4.43</span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif"><sup>1</sup></span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Includes power warrants exercisable into one share and <span style="-sec-ix-hidden: hidden-fact-282">one-half</span> warrant. Each whole warrant is exercisable at $3.90 for 36 months.</span></td>
</tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b>&#160;</b></span></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cve_ScheduleOfSharePurchaseWarrantsOutstandingTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cve_ScheduleOfSharePurchaseWarrantsOutstandingTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cve_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cve_ScheduleOfStockOptionsOutstandingTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cve_ScheduleOfStockOptionsOutstandingTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cve_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cve_ScheduleOfTheCompanysStockOptionsOutstandingTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cve_ScheduleOfTheCompanysStockOptionsOutstandingTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cve_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cve_ScheduleOfTheStatusOfTheCompanysWarrantsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cve_ScheduleOfTheStatusOfTheCompanysWarrantsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cve_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cve_ScheduleOfWeightedAverageAssumptionsUsedInCalculatingTheFairValuesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cve_ScheduleOfWeightedAverageAssumptionsUsedInCalculatingTheFairValuesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cve_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cve_ShareCapitalTablesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cve_ShareCapitalTablesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cve_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>92
<FILENAME>R42.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139782927680032">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Related party transactions and balances (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_DisclosureOfRelatedPartyTextBlockAbstract', window );"><strong>Related party transactions and balances [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfGeneralAndAdministrativeExpenseExplanatory', window );">Schedule of amounts paid to key management or entities providing similar services</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">December
    31, <br/> 2022<br/> $</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif">December
    31, <br/> 2021<br/> $</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%"><span style="font-family: Times New Roman, Times, Serif">Consulting</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 9%; text-align: center"><span style="font-family: Times New Roman, Times, Serif">(1</span>)</td><td style="width: 1%; text-align: left"/><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">103,514</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">61,899</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Data acquisition</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">(2</span>)</td><td style="text-align: left"/><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">55,150</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-283; font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Directors&#8217; fees</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">(3</span>)</td><td style="text-align: left"/><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">192,604</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-284; font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Office and administration</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-285; font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">13,402</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Staff costs</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">1,607,211</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">1,151,731</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Stock option expense</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">4,729,503</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">749,255</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Total
    key management compensation</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">6,687,982</span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">1,976,287</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">(1)</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">- During the year ended December 31, 2022, the Company incurred communications &amp; community engagement consulting fees of $103,514 (2021 - $61,899) according to a contract with Tintina Holdings, Ltd., a company owned and operated by the spouse of the Company&#8217;s Executive Chairman.</span></td>
</tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">(2)</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">- In June 2022, the Company acquired access to the Getty Minerals database pursuant to a purchase agreement with Platoro West Inc., a company owned and operated by the Company&#8217;s Executive Chairman (Note 7).</span></td>
</tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">(3)</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#8211; Directors&#8217; Fees are included in staff costs on the consolidated statement of loss and other comprehensive income (loss).</span></td>
</tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesExplanatory', window );">Schedule of owing to related parties</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">December
    31, <br/> 2022<br/> $</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif">December
    31, <br/> 2021<br/> $</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif">January
    1, <br/> 2021<br/> $</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 32%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Tintina Holdings, Ltd</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 31%; text-align: left; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif">Consulting
    services</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">12,744</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">6,893</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">0</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Officers and Board members</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left; padding-bottom: 1.5pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif">Accrued
    compensation</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">428,630</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-286; font-family: Times New Roman, Times, Serif">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">2,319</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="padding-bottom: 1.5pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">441,374</span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">6,893</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">2,319</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cve_DisclosureOfRelatedPartyTextBlockAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cve_DisclosureOfRelatedPartyTextBlockAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cve_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfGeneralAndAdministrativeExpenseExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of general and administrative expenses. [Refer: Administrative expenses]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2022-03-24<br> -Paragraph 10<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_10_e&amp;doctype=Standard<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfGeneralAndAdministrativeExpenseExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of transactions between the entity and its related parties. [Refer: Related parties [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 24<br> -IssueDate 2022-03-24<br> -Paragraph 18<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=24&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_18&amp;doctype=Standard<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>93
<FILENAME>R43.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139782928291872">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Financial Instruments (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_DisclosureOfFinancialInstrumentsTextBlockAbstract', window );"><strong>Disclosure Of Financial Instruments Text Block Abstract</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_ScheduleOfFinancialInstrumentTableTextBlock', window );">Schedule of foreign currency exposures</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">December
    31, <br/> 2022<br/> CAD $</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif">December
    31, <br/> 2021<br/> CAD $</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%"><span style="font-family: Times New Roman, Times, Serif">Cash</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">216,871</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">5,689,671</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Marketable Securities - Current</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">3,162,362</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-287; font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Accounts payable and
    accrued liabilities</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(2,890,582</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(2,557,849</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">488,651</span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">3,131,822</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cve_DisclosureOfFinancialInstrumentsTextBlockAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cve_DisclosureOfFinancialInstrumentsTextBlockAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cve_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cve_ScheduleOfFinancialInstrumentTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cve_ScheduleOfFinancialInstrumentTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cve_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>94
<FILENAME>R44.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139782921942048">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segmented information (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_SegmentedinformationTablesLineItems', window );"><strong>Segmented information [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_DisclosureOfLongtermAssetsByGeographicSegmentTableTextBlock', window );">Schedule of long-term assets by geographic segment</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; text-align: left; padding-left: 0.125in; text-indent: -0.125in"><span style="font-family: Times New Roman, Times, Serif">Balance
    Sheet Items</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif">South
    Dakota<br/> $</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Texas<br/>
    $</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif">New
    Mexico<br/> $</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Wyoming<br/>
    $</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Other
    States <br/> $</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Canada<br/>
    $</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Total<br/>
    $</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-left: 0.125in; text-indent: -0.125in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; width: 16%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Intangible
    assets</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 9%; text-align: right"><span style="-sec-ix-hidden: hidden-fact-289; font-family: Times New Roman, Times, Serif">-</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">67,251</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">217,241</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 9%; text-align: right"><span style="-sec-ix-hidden: hidden-fact-290; font-family: Times New Roman, Times, Serif">-</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">207,504</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 9%; text-align: right"><span style="-sec-ix-hidden: hidden-fact-291; font-family: Times New Roman, Times, Serif">-</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">491,996</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Property,
    plant and equipment</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">62,946</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">1,540,733</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-292; font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-293; font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-294; font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-295; font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">1,603,679</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Mineral
    properties</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">85,667,919</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">1,455,206</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">4,395,822</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">41,235,727</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">3,324,904</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-296; font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">136,079,578</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Right-of-use
    assets</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-297; font-family: Times New Roman, Times, Serif">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">199,120</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-298; font-family: Times New Roman, Times, Serif">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-299; font-family: Times New Roman, Times, Serif">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-300; font-family: Times New Roman, Times, Serif">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">45,444</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">244,564</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Balance,
    December 31, 2021</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">85,730,865</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">3,262,310</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">4,613,063</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">41,235,727</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">3,532,408</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">45,444</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">138,419,817</span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-indent: -0.125in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Intangible
    assets</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-301; font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">122,401</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">217,241</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-302; font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">188,640</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-303; font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">528,282</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Property,
    plant and equipment</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">60,630</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">2,273,791</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-304; font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-305; font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-306; font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-307; font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">2,334,421</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Mineral
    properties</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">86,220,848</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">9,144,069</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">4,905,348</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">41,754,462</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">3,194,359</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-308; font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">145,219,086</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Right-of-use
    assets</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-309; font-family: Times New Roman, Times, Serif">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">168,871</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-310; font-family: Times New Roman, Times, Serif">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-311; font-family: Times New Roman, Times, Serif">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-312; font-family: Times New Roman, Times, Serif">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">16,743</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">185,614</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Balance,
    December 31, 2022</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">86,281,478</span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">11,709,132</span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">5,122,589</span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">41,754,462</span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">3,382,999</span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">16,743</span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">148,267,403</span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cve_DisclosureOfLongtermAssetsByGeographicSegmentTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of long-term assets by geographic segment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cve_DisclosureOfLongtermAssetsByGeographicSegmentTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cve_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cve_SegmentedinformationTablesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cve_SegmentedinformationTablesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cve_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>95
<FILENAME>R45.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139783058549344">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Supplemental disclosure with respect to cash flows (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_SupplementalDisclosureWithRespectToCashflowsAbstract', window );"><strong>Supplemental Disclosure With Respect To Cashflows Abstract</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_ScheduleOfIncurredNoncashFinancingAndInvestingActivitiesTableTextBlock', window );">Schedule of incurred non-cash financing and investing activities</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">December 31,</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">December 31,</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2022</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">2021</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">Non-cash financing activities:</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: 0.125in; width: 76%; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Deferred
    financing costs remaining in accounts payable and accrued liabilities</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">1,513,220</span></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-313; font-family: Times New Roman, Times, Serif">-</span></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">1,513,220</span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-314; font-family: Times New Roman, Times, Serif">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Non-cash investing activities:</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: 0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Marketable securities
    received on disposition of mineral properties</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">3,051,564</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-315; font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: 0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Mineral property costs
    included in accounts payable and accrued liabilities</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">27,040</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-316; font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: 0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Property, plant, and
    equipment additions included in accounts payable and accrued liabilities</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">20,090</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-317; font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: 0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Fair value of common
    shares issued for Azarga asset acquisition</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-318; font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">121,796,381</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: 0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Fair value of replacement
    options issued for Azarga asset acquisition</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-319; font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">5,496,037</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: 0.125in; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Fair
    value of replacement warrants issued for Azarga asset acquisition</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-320; font-family: Times New Roman, Times, Serif">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">3,259,306</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">3,098,694</span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">130,551,724</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cve_ScheduleOfIncurredNoncashFinancingAndInvestingActivitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cve_ScheduleOfIncurredNoncashFinancingAndInvestingActivitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cve_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cve_SupplementalDisclosureWithRespectToCashflowsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cve_SupplementalDisclosureWithRespectToCashflowsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cve_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>96
<FILENAME>R46.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139782922713248">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income taxes (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_DisclosureOfIncomeTaxTextBlockAbstract', window );"><strong>Disclosure Of Income Tax Text Block Abstract</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsExplanatory', window );">Schedule of federal and provincial corporate tax rates to income before tax</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">December 31,</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-style: normal; text-align: center; font-weight: normal"><span style="font-family: Times New Roman, Times, Serif">December
    31,</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2022</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">2021</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Loss before income tax</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(16,515,389</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(8,563,473</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Statutory income tax
    rate</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">27</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">27</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Expected income tax expense (recovery)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(4,459,155</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(2,312,138</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Increase (decrease) resulting from:</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: 0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Change in unrecognized
    temporary differences</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">2,949,101</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">1,800,688</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: 0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Permanent differences</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">1,159,884</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">433,595</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: 0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Effect of tax rates in
    foreign jurisdictions</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">146,727</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">77,855</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: 0.125in"><span style="font-family: Times New Roman, Times, Serif">Share issue costs</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">201,740</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-321; font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: 0.125in; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Prior period adjustments</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">1,703</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-322; font-family: Times New Roman, Times, Serif">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Income
    tax expense (recovery)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-323; font-family: Times New Roman, Times, Serif">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-324; font-family: Times New Roman, Times, Serif">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfInterestIncomeExplanatory', window );">Schedule of income tax expense (recovery)</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">December 31,</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">December 31,</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2022</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">2021</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">Deferred tax expense (recovery)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Organization and reversal of temporary
    differences</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(2,949,101</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(1,800,688</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Change in unrecognized
    temporary differences</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">2,949,101</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">1,800,688</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Income
    tax expense (recovery)</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="-sec-ix-hidden: hidden-fact-325; font-family: Times New Roman, Times, Serif">-</span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="-sec-ix-hidden: hidden-fact-326; font-family: Times New Roman, Times, Serif">-</span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif"><b>&#160;</b></span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"><b>&#160;</b></span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><b>2022</b></span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"><b>&#160;</b></span></td><td><span style="font-family: Times New Roman, Times, Serif"><b>&#160;</b></span></td>
    <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">2021</span></td><td><span style="font-family: Times New Roman, Times, Serif"><b>&#160;</b></span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif"><b>&#160;</b></span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"><b>&#160;</b></span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif"><b>$</b></span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"><b>&#160;</b></span></td><td><span style="font-family: Times New Roman, Times, Serif"><b>&#160;</b></span></td>
    <td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"><b>&#160;</b></span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Loss carryforwards</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">488,823</span></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">52,244</span></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Deferred tax assets</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">488,823</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">52,244</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Set-off of tax</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(488,823</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(52,244</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Net
    deferred tax assets</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-327; font-family: Times New Roman, Times, Serif">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-328; font-family: Times New Roman, Times, Serif">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock', window );">Schedule of deferred tax liabilities</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">December 31,</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">December 31,</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2022</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">2021</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Intangible assets</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(39,481</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 9%; text-align: right"><span style="-sec-ix-hidden: hidden-fact-329; font-family: Times New Roman, Times, Serif">-</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Right-of-use assets</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(42,472</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(52,244</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Fixed assets</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(276,699</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Right-of-use assets</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(130,171</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-330; font-family: Times New Roman, Times, Serif">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Marketable securities</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(488,823</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(52,244</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Set-off of tax</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">488,823</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">52,244</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Net
    deferred tax liability</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-331; font-family: Times New Roman, Times, Serif">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-332; font-family: Times New Roman, Times, Serif">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDeferredTaxesExplanatory', window );">Schedule of unrecognized deferred tax assets</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">December 31,</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">December 31,</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2022</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">2021</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Deductible temporary differences</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">3,920,076</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">2,576,276</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Tax losses</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">26,069,552</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">12,754,678</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">29,989,628</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">15,330,954</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cve_DisclosureOfIncomeTaxTextBlockAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cve_DisclosureOfIncomeTaxTextBlockAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cve_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfDeferredTaxesExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of deferred taxes. [Refer: Deferred tax liabilities; Deferred tax assets]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2022-03-24<br> -Paragraph 10<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_10_e&amp;doctype=Standard<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfDeferredTaxesExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfInterestIncomeExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of interest income. [Refer: Interest income]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2022-03-24<br> -Paragraph 10<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_10_e&amp;doctype=Standard<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfInterestIncomeExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of types of temporary differences, unused tax losses and unused tax credits. [Refer: Unused tax credits [member]; Unused tax losses [member]; Temporary differences [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2022-03-24<br> -Paragraph 81<br> -Subparagraph g<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_81_g&amp;doctype=Standard<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>97
<FILENAME>R47.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139782928328672">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Change in Presentation Currency (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_DisclosureOfReclassificationsOrChangesInPresentationTextBlockAbstract', window );"><strong>Disclosure Of Reclassifications Or Changes In Presentation Text Block Abstract</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfAccountingPolicyForForeignCurrencyTranslationExplanatory', window );">Schedule of effect of translation</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"><span style="text-decoration:underline">As at January 1, 2021</span></span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">Previously
    reported (CAD$)</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">Translated
    (USD$)</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Current assets</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">6,926,844</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">5,436,341</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Non-current
    assets</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">16,516,119</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">12,918,903</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Total
    assets</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">23,442,963</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">18,355,244</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Current liabilities</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">900,300</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">707,056</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Non-current
    liabilities</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">6,674,405</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">5,242,229</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Total
    liabilities</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">7,574,705</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">5,949,285</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
</table><p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"><span style="text-decoration:underline">As at December 31, 2021</span></span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Previously
    reported (CAD$)</span></td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Translated
    (USD$)</span></td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Current assets</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">14,651,619</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">11,556,728</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Non-current
    assets</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">187,434,040</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">147,799,796</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Total
    assets</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">202,085,659</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">159,356,524</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Current liabilities</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">7,510,606</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">5,924,125</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Non-current
    liabilities</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">5,507,178</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">4,343,886</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Total
    liabilities</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">13,017,784</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">10,268,011</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialInstrumentsAtFairValueThroughProfitOrLossExplanatory', window );">Schedule of consolidated statements of loss and comprehensive loss</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">Previously
    reported (CAD$)</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">Translated
    (USD$)</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">Expenses</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: 0.125in; width: 76%"><span style="font-family: Times New Roman, Times, Serif">Accretion</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">502,291</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">408,181</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: 0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Amortization and depreciation</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">374,455</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">298,666</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: 0.125in"><span style="font-family: Times New Roman, Times, Serif">Consulting</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">91,161</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">72,726</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: 0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">General administrative costs</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">4,429,209</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">3,533,474</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: 0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Impairment charges</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">98,345</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">78,456</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: 0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Interest expense</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">9,365</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-333; font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: 0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Office and administrative</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">247,433</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">197,391</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: 0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Professional fees</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">728,793</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">581,408</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: 0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Promotion and shareholder communication</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">208,201</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">166,096</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: 0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Reclamation costs</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">889,154</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">709,399</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: 0.125in"><span style="font-family: Times New Roman, Times, Serif">Travel</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">33,355</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">26,609</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: 0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Transfer agent and filing fees</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">167,612</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">133,717</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: 0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Staff costs</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">1,983,446</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">1,582,326</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: 0.125in; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Stock option expense</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">1,787,046</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">1,425,645</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Loss from operating expenses</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(11,549,866</span></td><td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(9,214,094</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: 0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Interest income</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">26,307</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">20,987</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: 0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Foreign exchange gain</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">34,174</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">27,263</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: 0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Loss on divestment of mineral properties</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(112,708</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(89,914</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: 0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Gain on change in asset retirement obligation
    estimate</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">2,155,949</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">1,719,943</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: 0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Loss on contract termination</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(3,447,125</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(2,750,000</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: 0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Unrealized gain on uranium investment</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">1,947,939</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">1,554,000</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: 0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Gain on sale of uranium investment</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">656,928</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">524,075</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: 0.125in; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Loss on investment in
    associate</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(445,914</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(355,735</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: 0.125in; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Net loss for the year</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(10,734,316</span></td><td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(8,563,475</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: 0.125in; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Exchange differences
    on translation foreign operations</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">206,082</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(1,325,855</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Other
    comprehensive loss for the year</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(10,528,234</span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(9,889,330</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt"><span style="-sec-ix-hidden: hidden-fact-335; -sec-ix-hidden: hidden-fact-334; font-family: Times New Roman, Times, Serif">Loss per share - basic and diluted</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(0.05</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(0.13</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cve_DisclosureOfReclassificationsOrChangesInPresentationTextBlockAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cve_DisclosureOfReclassificationsOrChangesInPresentationTextBlockAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cve_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfAccountingPolicyForForeignCurrencyTranslationExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Expiry date 2023-01-01: The description of the entity's accounting policy for foreign currency translation.
Effective 2023-01-01: The description of the entity's material accounting policy information for foreign currency translation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Note Effective 2023-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2022-03-24<br> -Paragraph 117<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_117&amp;doctype=Standard<br> -URIDate 2022-03-24<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Note Expiry date 2023-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2022-03-24<br> -Paragraph 117<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2022-en-b&amp;anchor=para_117_b&amp;doctype=Standard&amp;forcepdf=true<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfAccountingPolicyForForeignCurrencyTranslationExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfFinancialInstrumentsAtFairValueThroughProfitOrLossExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of financial instruments measured at fair value through profit or loss. [Refer: At fair value [member]; Financial instruments, class [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2022-03-24<br> -Paragraph 10<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_10_e&amp;doctype=Standard<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfFinancialInstrumentsAtFairValueThroughProfitOrLossExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>98
<FILENAME>R48.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139782927699776">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Nature of Operations and Going Concern (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_NatureOfOperationAndGoingConcernAbstract', window );"><strong>Nature of Operation and Going Concern [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net loss</a></td>
<td class="nump">$ 16,515,389<span></span>
</td>
<td class="nump">$ 8,563,475<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_WorkingCapital', window );">Working capital</a></td>
<td class="nump">7,017,115<span></span>
</td>
<td class="nump">5,632,603<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_AccumulatedDeficit', window );">Accumulated deficit</a></td>
<td class="nump">$ 48,867,377<span></span>
</td>
<td class="nump">$ 32,351,988<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cve_AccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accumulated deficit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cve_AccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cve_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cve_NatureOfOperationAndGoingConcernAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cve_NatureOfOperationAndGoingConcernAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cve_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cve_WorkingCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Working capital.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cve_WorkingCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cve_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3000-108585<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569616-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 23: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 29: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 31: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>99
<FILENAME>R49.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139782927325888">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Significant accounting policies (Details) - 12 months ended Dec. 31, 2022<br></strong></div></th>
<th class="th"><div>USD ($)</div></th>
<th class="th"><div>CAD ($)</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_DisclosureOfSignificantAccountingPoliciesTextBlockAbstract', window );"><strong>Significant accounting policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PercentageOfVotingEquityInterestsAcquired', window );">Voting rights</a></td>
<td class="nump">50.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DepositsFromBanks', window );">Deposit</a></td>
<td class="nump">$ 4,517,073<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_ShareSubscriptionsValue', window );">Share subscriptions value</a></td>
<td class="num">$ (50,051,595)<span></span>
</td>
<td class="nump">$ 67,789,880<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cve_DisclosureOfSignificantAccountingPoliciesTextBlockAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cve_DisclosureOfSignificantAccountingPoliciesTextBlockAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cve_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cve_ShareSubscriptionsValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of share subscriptions value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cve_ShareSubscriptionsValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cve_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DepositsFromBanks">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of deposit liabilities from banks held by the entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2022-03-24<br> -Paragraph 55<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DepositsFromBanks</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_PercentageOfVotingEquityInterestsAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The percentage of voting equity interests acquired in a business combination. [Refer: Business combinations [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 3<br> -IssueDate 2022-03-24<br> -Paragraph B64<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=3&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_B64_c&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_PercentageOfVotingEquityInterestsAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>100
<FILENAME>R50.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139782921339568">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Significant accounting policies (Details) - Schedule of exchange rates<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_SignificantaccountingpoliciesDetailsScheduleofexchangeratesLineItems', window );"><strong>Schedule of exchange rates [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClosingForeignExchangeRate', window );">Closing rate at the reporting date</a></td>
<td class="nump">0.738<span></span>
</td>
<td class="nump">0.789<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AverageForeignExchangeRate', window );">Average rate for the year</a></td>
<td class="nump">0.769<span></span>
</td>
<td class="nump">0.798<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cve_SignificantaccountingpoliciesDetailsScheduleofexchangeratesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cve_SignificantaccountingpoliciesDetailsScheduleofexchangeratesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cve_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AverageForeignExchangeRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The average exchange rate used by the entity. Exchange rate is the ratio of exchange for two currencies.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2022-03-24<br> -Paragraph 112<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_112_c&amp;doctype=Standard<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AverageForeignExchangeRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClosingForeignExchangeRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The spot exchange rate at the end of the reporting period. Exchange rate is the ratio of exchange for two currencies. Spot exchange rate is the exchange rate for immediate delivery.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2022-03-24<br> -Paragraph 112<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_112_c&amp;doctype=Standard<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClosingForeignExchangeRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>101
<FILENAME>R51.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139782922334752">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Significant accounting policies (Details) - Schedule of significant subsidiaries<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr><th class="th" colspan="2"><div>Dec. 31, 2022</div></th></tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CategoriesOfRelatedPartiesAxis=cve_TigrisUraniumUSCorpMember', window );">Tigris Uranium US Corp. [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_SignificantaccountingpoliciesDetailsScheduleofsignificantsubsidiariesLineItems', window );"><strong>Schedule of significant subsidiaries [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_NameofSubsidaryPlaceOfIncorporation', window );">Place of Incorporation</a></td>
<td class="text">Nevada, USA<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestInSubsidiary', window );">Ownership Interest</a></td>
<td class="nump">100.00%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_NameofSubsidaryPrincipalActivity', window );">Principal Activity</a></td>
<td class="text">Mineral Exploration<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_NameofSubsidaryFunctionalCurrency', window );">Functional Currency</a></td>
<td class="text">USD<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CategoriesOfRelatedPartiesAxis=cve_MetaminEnterprisesUSIncMember', window );">Metamin Enterprises US Inc. [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_SignificantaccountingpoliciesDetailsScheduleofsignificantsubsidiariesLineItems', window );"><strong>Schedule of significant subsidiaries [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_NameofSubsidaryPlaceOfIncorporation', window );">Place of Incorporation</a></td>
<td class="text">Nevada, USA<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestInSubsidiary', window );">Ownership Interest</a></td>
<td class="nump">100.00%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_NameofSubsidaryPrincipalActivity', window );">Principal Activity</a></td>
<td class="text">Mineral Exploration<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_NameofSubsidaryFunctionalCurrency', window );">Functional Currency</a></td>
<td class="text">USD<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CategoriesOfRelatedPartiesAxis=cve_URIIncMember', window );">URI, Inc. [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_SignificantaccountingpoliciesDetailsScheduleofsignificantsubsidiariesLineItems', window );"><strong>Schedule of significant subsidiaries [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_NameofSubsidaryPlaceOfIncorporation', window );">Place of Incorporation</a></td>
<td class="text">Delaware, USA<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestInSubsidiary', window );">Ownership Interest</a></td>
<td class="nump">100.00%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_NameofSubsidaryPrincipalActivity', window );">Principal Activity</a></td>
<td class="text">Mineral Exploration<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_NameofSubsidaryFunctionalCurrency', window );">Functional Currency</a></td>
<td class="text">USD<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CategoriesOfRelatedPartiesAxis=cve_NeutronEnergyIncMember', window );">Neutron Energy, Inc. [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_SignificantaccountingpoliciesDetailsScheduleofsignificantsubsidiariesLineItems', window );"><strong>Schedule of significant subsidiaries [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_NameofSubsidaryPlaceOfIncorporation', window );">Place of Incorporation</a></td>
<td class="text">Nevada, USA<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestInSubsidiary', window );">Ownership Interest</a></td>
<td class="nump">100.00%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_NameofSubsidaryPrincipalActivity', window );">Principal Activity</a></td>
<td class="text">Mineral Exploration<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_NameofSubsidaryFunctionalCurrency', window );">Functional Currency</a></td>
<td class="text">USD<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CategoriesOfRelatedPartiesAxis=cve_UrancoIncMember', window );">Uranco, Inc. [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_SignificantaccountingpoliciesDetailsScheduleofsignificantsubsidiariesLineItems', window );"><strong>Schedule of significant subsidiaries [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_NameofSubsidaryPlaceOfIncorporation', window );">Place of Incorporation</a></td>
<td class="text">Delaware, USA<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestInSubsidiary', window );">Ownership Interest</a></td>
<td class="nump">100.00%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_NameofSubsidaryPrincipalActivity', window );">Principal Activity</a></td>
<td class="text">Mineral Exploration<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_NameofSubsidaryFunctionalCurrency', window );">Functional Currency</a></td>
<td class="text">USD<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CategoriesOfRelatedPartiesAxis=cve_UraniumResourcesIncMember', window );">Uranium Resources, Inc. [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_SignificantaccountingpoliciesDetailsScheduleofsignificantsubsidiariesLineItems', window );"><strong>Schedule of significant subsidiaries [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_NameofSubsidaryPlaceOfIncorporation', window );">Place of Incorporation</a></td>
<td class="text">Delaware, USA<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestInSubsidiary', window );">Ownership Interest</a></td>
<td class="nump">100.00%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_NameofSubsidaryPrincipalActivity', window );">Principal Activity</a></td>
<td class="text">Mineral Exploration<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_NameofSubsidaryFunctionalCurrency', window );">Functional Currency</a></td>
<td class="text">USD<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CategoriesOfRelatedPartiesAxis=cve_HRIChurchrockIncMember', window );">HRI-Churchrock, Inc. [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_SignificantaccountingpoliciesDetailsScheduleofsignificantsubsidiariesLineItems', window );"><strong>Schedule of significant subsidiaries [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_NameofSubsidaryPlaceOfIncorporation', window );">Place of Incorporation</a></td>
<td class="text">Delaware, USA<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestInSubsidiary', window );">Ownership Interest</a></td>
<td class="nump">100.00%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_NameofSubsidaryPrincipalActivity', window );">Principal Activity</a></td>
<td class="text">Mineral Exploration<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_NameofSubsidaryFunctionalCurrency', window );">Functional Currency</a></td>
<td class="text">USD<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CategoriesOfRelatedPartiesAxis=cve_HydroRestorationCorpMember', window );">Hydro Restoration Corp.[Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_SignificantaccountingpoliciesDetailsScheduleofsignificantsubsidiariesLineItems', window );"><strong>Schedule of significant subsidiaries [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_NameofSubsidaryPlaceOfIncorporation', window );">Place of Incorporation</a></td>
<td class="text">Delaware, USA<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestInSubsidiary', window );">Ownership Interest</a></td>
<td class="nump">100.00%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_NameofSubsidaryPrincipalActivity', window );">Principal Activity</a></td>
<td class="text">Mineral Exploration<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_NameofSubsidaryFunctionalCurrency', window );">Functional Currency</a></td>
<td class="text">USD<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CategoriesOfRelatedPartiesAxis=cve_BeltLineResourcesIncMember', window );">Belt Line Resources, Inc. [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_SignificantaccountingpoliciesDetailsScheduleofsignificantsubsidiariesLineItems', window );"><strong>Schedule of significant subsidiaries [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_NameofSubsidaryPlaceOfIncorporation', window );">Place of Incorporation</a></td>
<td class="text">Texas, USA<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestInSubsidiary', window );">Ownership Interest</a></td>
<td class="nump">100.00%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_NameofSubsidaryPrincipalActivity', window );">Principal Activity</a></td>
<td class="text">Mineral Exploration<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_NameofSubsidaryFunctionalCurrency', window );">Functional Currency</a></td>
<td class="text">USD<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CategoriesOfRelatedPartiesAxis=cve_CibolaResourcesLLCMember', window );">Cibola Resources, LLC [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_SignificantaccountingpoliciesDetailsScheduleofsignificantsubsidiariesLineItems', window );"><strong>Schedule of significant subsidiaries [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_NameofSubsidaryPlaceOfIncorporation', window );">Place of Incorporation</a></td>
<td class="text">Delaware, USA<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestInSubsidiary', window );">Ownership Interest</a></td>
<td class="nump">100.00%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_NameofSubsidaryPrincipalActivity', window );">Principal Activity</a></td>
<td class="text">Mineral Exploration<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_NameofSubsidaryFunctionalCurrency', window );">Functional Currency</a></td>
<td class="text">USD<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CategoriesOfRelatedPartiesAxis=cve_enCoreEnergyUSCorpMember', window );">enCore Energy US Corp. [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_SignificantaccountingpoliciesDetailsScheduleofsignificantsubsidiariesLineItems', window );"><strong>Schedule of significant subsidiaries [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_NameofSubsidaryPlaceOfIncorporation', window );">Place of Incorporation</a></td>
<td class="text">Nevada, USA<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestInSubsidiary', window );">Ownership Interest</a></td>
<td class="nump">100.00%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_NameofSubsidaryPrincipalActivity', window );">Principal Activity</a></td>
<td class="text">Holding Company<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_NameofSubsidaryFunctionalCurrency', window );">Functional Currency</a></td>
<td class="text">USD<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CategoriesOfRelatedPartiesAxis=cve_AzargaUraniumCorpMember', window );">Azarga Uranium Corp. [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_SignificantaccountingpoliciesDetailsScheduleofsignificantsubsidiariesLineItems', window );"><strong>Schedule of significant subsidiaries [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_NameofSubsidaryPlaceOfIncorporation', window );">Place of Incorporation</a></td>
<td class="text">British Columbia, CA<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestInSubsidiary', window );">Ownership Interest</a></td>
<td class="nump">100.00%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_NameofSubsidaryPrincipalActivity', window );">Principal Activity</a></td>
<td class="text">Mineral Exploration<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_NameofSubsidaryFunctionalCurrency', window );">Functional Currency</a></td>
<td class="text">USD<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CategoriesOfRelatedPartiesAxis=cve_PowertechUSAIncMember', window );">Powertech (USA) Inc. [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_SignificantaccountingpoliciesDetailsScheduleofsignificantsubsidiariesLineItems', window );"><strong>Schedule of significant subsidiaries [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_NameofSubsidaryPlaceOfIncorporation', window );">Place of Incorporation</a></td>
<td class="text">South Dakota, USA<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestInSubsidiary', window );">Ownership Interest</a></td>
<td class="nump">100.00%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_NameofSubsidaryPrincipalActivity', window );">Principal Activity</a></td>
<td class="text">Mineral Exploration<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_NameofSubsidaryFunctionalCurrency', window );">Functional Currency</a></td>
<td class="text">USD<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CategoriesOfRelatedPartiesAxis=cve_URZEnergyCorpMember', window );">URZ Energy Corp. [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_SignificantaccountingpoliciesDetailsScheduleofsignificantsubsidiariesLineItems', window );"><strong>Schedule of significant subsidiaries [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_NameofSubsidaryPlaceOfIncorporation', window );">Place of Incorporation</a></td>
<td class="text">British Columbia, CA<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestInSubsidiary', window );">Ownership Interest</a></td>
<td class="nump">100.00%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_NameofSubsidaryPrincipalActivity', window );">Principal Activity</a></td>
<td class="text">Mineral Exploration<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_NameofSubsidaryFunctionalCurrency', window );">Functional Currency</a></td>
<td class="text">USD<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CategoriesOfRelatedPartiesAxis=cve_UcoloExplorationCorpMember', window );">Ucolo Exploration Corp. [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_SignificantaccountingpoliciesDetailsScheduleofsignificantsubsidiariesLineItems', window );"><strong>Schedule of significant subsidiaries [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_NameofSubsidaryPlaceOfIncorporation', window );">Place of Incorporation</a></td>
<td class="text">Utah, USA<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestInSubsidiary', window );">Ownership Interest</a></td>
<td class="nump">100.00%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_NameofSubsidaryPrincipalActivity', window );">Principal Activity</a></td>
<td class="text">Mineral Exploration<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_NameofSubsidaryFunctionalCurrency', window );">Functional Currency</a></td>
<td class="text">USD<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CategoriesOfRelatedPartiesAxis=cve_AzargaResourcesLimitedMember', window );">Azarga Resources Limited [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_SignificantaccountingpoliciesDetailsScheduleofsignificantsubsidiariesLineItems', window );"><strong>Schedule of significant subsidiaries [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_NameofSubsidaryPlaceOfIncorporation', window );">Place of Incorporation</a></td>
<td class="text">British Virgin Islands<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestInSubsidiary', window );">Ownership Interest</a></td>
<td class="nump">100.00%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_NameofSubsidaryPrincipalActivity', window );">Principal Activity</a></td>
<td class="text">Mineral Exploration<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_NameofSubsidaryFunctionalCurrency', window );">Functional Currency</a></td>
<td class="text">USD<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CategoriesOfRelatedPartiesAxis=cve_AzargaResourcesHongKongLtdMember', window );">Azarga Resources (Hong Kong) Ltd. [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_SignificantaccountingpoliciesDetailsScheduleofsignificantsubsidiariesLineItems', window );"><strong>Schedule of significant subsidiaries [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_NameofSubsidaryPlaceOfIncorporation', window );">Place of Incorporation</a></td>
<td class="text">Hong Kong<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestInSubsidiary', window );">Ownership Interest</a></td>
<td class="nump">100.00%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_NameofSubsidaryPrincipalActivity', window );">Principal Activity</a></td>
<td class="text">Mineral Exploration<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_NameofSubsidaryFunctionalCurrency', window );">Functional Currency</a></td>
<td class="text">USD<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CategoriesOfRelatedPartiesAxis=cve_AzargaResourcesUSACompanyMember', window );">Azarga Resources USA Company [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_SignificantaccountingpoliciesDetailsScheduleofsignificantsubsidiariesLineItems', window );"><strong>Schedule of significant subsidiaries [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_NameofSubsidaryPlaceOfIncorporation', window );">Place of Incorporation</a></td>
<td class="text">Colorado, USA<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestInSubsidiary', window );">Ownership Interest</a></td>
<td class="nump">100.00%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_NameofSubsidaryPrincipalActivity', window );">Principal Activity</a></td>
<td class="text">Mineral Exploration<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_NameofSubsidaryFunctionalCurrency', window );">Functional Currency</a></td>
<td class="text">USD<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CategoriesOfRelatedPartiesAxis=cve_AzargaResourcesCanadaLtdMember', window );">Azarga Resources Canada Ltd. [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_SignificantaccountingpoliciesDetailsScheduleofsignificantsubsidiariesLineItems', window );"><strong>Schedule of significant subsidiaries [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_NameofSubsidaryPlaceOfIncorporation', window );">Place of Incorporation</a></td>
<td class="text">British Columbia, CA<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestInSubsidiary', window );">Ownership Interest</a></td>
<td class="nump">100.00%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_NameofSubsidaryPrincipalActivity', window );">Principal Activity</a></td>
<td class="text">Mineral Exploration<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_NameofSubsidaryFunctionalCurrency', window );">Functional Currency</a></td>
<td class="text">USD<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr><td colspan="3"></td></tr>
<tr><td colspan="3"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">Cibola Resources, LLC was divested in May 2022 (Note 11).</td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cve_NameofSubsidaryFunctionalCurrency">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Functional Currency.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cve_NameofSubsidaryFunctionalCurrency</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cve_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cve_NameofSubsidaryPlaceOfIncorporation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Place of Incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cve_NameofSubsidaryPlaceOfIncorporation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cve_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cve_NameofSubsidaryPrincipalActivity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Principal Activity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cve_NameofSubsidaryPrincipalActivity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cve_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cve_SignificantaccountingpoliciesDetailsScheduleofsignificantsubsidiariesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cve_SignificantaccountingpoliciesDetailsScheduleofsignificantsubsidiariesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cve_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProportionOfOwnershipInterestInSubsidiary">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The proportion of ownership interest in a subsidiary attributable to the entity. [Refer: Subsidiaries [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 27<br> -IssueDate 2022-03-24<br> -Paragraph 17<br> -Subparagraph b<br> -Clause iii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=27&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_17_b_iii&amp;doctype=Standard<br> -URIDate 2022-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 27<br> -IssueDate 2022-03-24<br> -Paragraph 16<br> -Subparagraph b<br> -Clause iii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=27&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_16_b_iii&amp;doctype=Standard<br> -URIDate 2022-03-24<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2022-03-24<br> -Paragraph 19B<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_19B_c&amp;doctype=Standard<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProportionOfOwnershipInterestInSubsidiary</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CategoriesOfRelatedPartiesAxis=cve_TigrisUraniumUSCorpMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CategoriesOfRelatedPartiesAxis=cve_TigrisUraniumUSCorpMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CategoriesOfRelatedPartiesAxis=cve_MetaminEnterprisesUSIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CategoriesOfRelatedPartiesAxis=cve_MetaminEnterprisesUSIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CategoriesOfRelatedPartiesAxis=cve_URIIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CategoriesOfRelatedPartiesAxis=cve_URIIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CategoriesOfRelatedPartiesAxis=cve_NeutronEnergyIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CategoriesOfRelatedPartiesAxis=cve_NeutronEnergyIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CategoriesOfRelatedPartiesAxis=cve_UrancoIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CategoriesOfRelatedPartiesAxis=cve_UrancoIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CategoriesOfRelatedPartiesAxis=cve_UraniumResourcesIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CategoriesOfRelatedPartiesAxis=cve_UraniumResourcesIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CategoriesOfRelatedPartiesAxis=cve_HRIChurchrockIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CategoriesOfRelatedPartiesAxis=cve_HRIChurchrockIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CategoriesOfRelatedPartiesAxis=cve_HydroRestorationCorpMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CategoriesOfRelatedPartiesAxis=cve_HydroRestorationCorpMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CategoriesOfRelatedPartiesAxis=cve_BeltLineResourcesIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CategoriesOfRelatedPartiesAxis=cve_BeltLineResourcesIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CategoriesOfRelatedPartiesAxis=cve_CibolaResourcesLLCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CategoriesOfRelatedPartiesAxis=cve_CibolaResourcesLLCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CategoriesOfRelatedPartiesAxis=cve_enCoreEnergyUSCorpMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CategoriesOfRelatedPartiesAxis=cve_enCoreEnergyUSCorpMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CategoriesOfRelatedPartiesAxis=cve_AzargaUraniumCorpMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CategoriesOfRelatedPartiesAxis=cve_AzargaUraniumCorpMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CategoriesOfRelatedPartiesAxis=cve_PowertechUSAIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CategoriesOfRelatedPartiesAxis=cve_PowertechUSAIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CategoriesOfRelatedPartiesAxis=cve_URZEnergyCorpMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CategoriesOfRelatedPartiesAxis=cve_URZEnergyCorpMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CategoriesOfRelatedPartiesAxis=cve_UcoloExplorationCorpMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CategoriesOfRelatedPartiesAxis=cve_UcoloExplorationCorpMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CategoriesOfRelatedPartiesAxis=cve_AzargaResourcesLimitedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CategoriesOfRelatedPartiesAxis=cve_AzargaResourcesLimitedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CategoriesOfRelatedPartiesAxis=cve_AzargaResourcesHongKongLtdMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CategoriesOfRelatedPartiesAxis=cve_AzargaResourcesHongKongLtdMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CategoriesOfRelatedPartiesAxis=cve_AzargaResourcesUSACompanyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CategoriesOfRelatedPartiesAxis=cve_AzargaResourcesUSACompanyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CategoriesOfRelatedPartiesAxis=cve_AzargaResourcesCanadaLtdMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CategoriesOfRelatedPartiesAxis=cve_AzargaResourcesCanadaLtdMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>102
<FILENAME>R52.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139782922313584">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Significant accounting policies (Details) - Schedule of useful lives of property, plant and equipement<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RangeAxis=ifrs-full_BottomOfRangeMember', window );">Bottom of range [member] | Uranium Plants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_SignificantaccountingpoliciesDetailsScheduleofusefullivesofpropertyplantandequipementLineItems', window );"><strong>Schedule of useful lives of property, plant and equipement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_PropertyPlantAndEquipmentRange', window );">Range</a></td>
<td class="text">15 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RangeAxis=ifrs-full_BottomOfRangeMember', window );">Bottom of range [member] | Other property, plant and equipment [member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_SignificantaccountingpoliciesDetailsScheduleofusefullivesofpropertyplantandequipementLineItems', window );"><strong>Schedule of useful lives of property, plant and equipement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_PropertyPlantAndEquipmentRange', window );">Range</a></td>
<td class="text">3 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RangeAxis=ifrs-full_BottomOfRangeMember', window );">Bottom of range [member] | Software [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_SignificantaccountingpoliciesDetailsScheduleofusefullivesofpropertyplantandequipementLineItems', window );"><strong>Schedule of useful lives of property, plant and equipement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_PropertyPlantAndEquipmentRange', window );">Range</a></td>
<td class="text">2 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RangeAxis=ifrs-full_BottomOfRangeMember', window );">Bottom of range [member] | Furniture [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_SignificantaccountingpoliciesDetailsScheduleofusefullivesofpropertyplantandequipementLineItems', window );"><strong>Schedule of useful lives of property, plant and equipement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_PropertyPlantAndEquipmentRange', window );">Range</a></td>
<td class="text">3 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RangeAxis=ifrs-full_BottomOfRangeMember', window );">Bottom of range [member] | Buildings [member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_SignificantaccountingpoliciesDetailsScheduleofusefullivesofpropertyplantandequipementLineItems', window );"><strong>Schedule of useful lives of property, plant and equipement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_PropertyPlantAndEquipmentRange', window );">Range</a></td>
<td class="text">10 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RangeAxis=ifrs-full_TopOfRangeMember', window );">Top of range [member] | Uranium Plants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_SignificantaccountingpoliciesDetailsScheduleofusefullivesofpropertyplantandequipementLineItems', window );"><strong>Schedule of useful lives of property, plant and equipement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_PropertyPlantAndEquipmentRange', window );">Range</a></td>
<td class="text">25 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RangeAxis=ifrs-full_TopOfRangeMember', window );">Top of range [member] | Other property, plant and equipment [member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_SignificantaccountingpoliciesDetailsScheduleofusefullivesofpropertyplantandequipementLineItems', window );"><strong>Schedule of useful lives of property, plant and equipement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_PropertyPlantAndEquipmentRange', window );">Range</a></td>
<td class="text">5 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RangeAxis=ifrs-full_TopOfRangeMember', window );">Top of range [member] | Software [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_SignificantaccountingpoliciesDetailsScheduleofusefullivesofpropertyplantandequipementLineItems', window );"><strong>Schedule of useful lives of property, plant and equipement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_PropertyPlantAndEquipmentRange', window );">Range</a></td>
<td class="text">3 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RangeAxis=ifrs-full_TopOfRangeMember', window );">Top of range [member] | Furniture [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_SignificantaccountingpoliciesDetailsScheduleofusefullivesofpropertyplantandequipementLineItems', window );"><strong>Schedule of useful lives of property, plant and equipement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_PropertyPlantAndEquipmentRange', window );">Range</a></td>
<td class="text">5 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RangeAxis=ifrs-full_TopOfRangeMember', window );">Top of range [member] | Buildings [member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_SignificantaccountingpoliciesDetailsScheduleofusefullivesofpropertyplantandequipementLineItems', window );"><strong>Schedule of useful lives of property, plant and equipement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_PropertyPlantAndEquipmentRange', window );">Range</a></td>
<td class="text">40 years<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cve_PropertyPlantAndEquipmentRange">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cve_PropertyPlantAndEquipmentRange</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cve_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cve_SignificantaccountingpoliciesDetailsScheduleofusefullivesofpropertyplantandequipementLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cve_SignificantaccountingpoliciesDetailsScheduleofusefullivesofpropertyplantandequipementLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cve_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RangeAxis=ifrs-full_BottomOfRangeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RangeAxis=ifrs-full_BottomOfRangeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IntangibleAssetsWithIndefiniteUsefulLifeAxis=cve_UraniumPlantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IntangibleAssetsWithIndefiniteUsefulLifeAxis=cve_UraniumPlantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IntangibleAssetsWithIndefiniteUsefulLifeAxis=ifrs-full_OtherPropertyPlantAndEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IntangibleAssetsWithIndefiniteUsefulLifeAxis=ifrs-full_OtherPropertyPlantAndEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IntangibleAssetsWithIndefiniteUsefulLifeAxis=cve_SoftwareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IntangibleAssetsWithIndefiniteUsefulLifeAxis=cve_SoftwareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IntangibleAssetsWithIndefiniteUsefulLifeAxis=cve_FurnitureMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IntangibleAssetsWithIndefiniteUsefulLifeAxis=cve_FurnitureMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IntangibleAssetsWithIndefiniteUsefulLifeAxis=ifrs-full_BuildingsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IntangibleAssetsWithIndefiniteUsefulLifeAxis=ifrs-full_BuildingsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RangeAxis=ifrs-full_TopOfRangeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RangeAxis=ifrs-full_TopOfRangeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>103
<FILENAME>R53.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139782927240448">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Significant accounting policies (Details) - Schedule of useful lives of intangible assets<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CategoriesOfRelatedPartiesAxis=cve_DataAccessAgreementMember', window );">Data Access Agreement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_SignificantaccountingpoliciesDetailsScheduleofusefullivesofintangibleassetsLineItems', window );"><strong>Schedule of useful lives of intangible assets [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_CategoryRange', window );">Range</a></td>
<td class="text">Straight-line over 14 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CategoriesOfRelatedPartiesAxis=cve_DataPurchasesMember', window );">Data Purchases [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_SignificantaccountingpoliciesDetailsScheduleofusefullivesofintangibleassetsLineItems', window );"><strong>Schedule of useful lives of intangible assets [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_CategoryRange', window );">Range</a></td>
<td class="text">Indefinite life intangible asset<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cve_CategoryRange">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Range.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cve_CategoryRange</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cve_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cve_SignificantaccountingpoliciesDetailsScheduleofusefullivesofintangibleassetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cve_SignificantaccountingpoliciesDetailsScheduleofusefullivesofintangibleassetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cve_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CategoriesOfRelatedPartiesAxis=cve_DataAccessAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CategoriesOfRelatedPartiesAxis=cve_DataAccessAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CategoriesOfRelatedPartiesAxis=cve_DataPurchasesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CategoriesOfRelatedPartiesAxis=cve_DataPurchasesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>104
<FILENAME>R54.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139782921982944">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Investment In Associate (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_DisclosureOfAssociatesTextBlockAbstract', window );"><strong>Investment in Associate [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_AcquiredShares', window );">Acquired shares (in Shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_IssuedAndOutstandingSharesPercentage', window );">Issued and outstanding shares percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">40.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_AdvancedAmount', window );">Advanced amount (in Dollars)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 750,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestInAssociate', window );">Ownership percentage</a></td>
<td class="nump">33.71%<span></span>
</td>
<td class="nump">34.46%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cve_AcquiredShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Acquired shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cve_AcquiredShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cve_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cve_AdvancedAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Advanced amount.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cve_AdvancedAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cve_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cve_DisclosureOfAssociatesTextBlockAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cve_DisclosureOfAssociatesTextBlockAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cve_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cve_IssuedAndOutstandingSharesPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>percentage of issued and outstanding shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cve_IssuedAndOutstandingSharesPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cve_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProportionOfOwnershipInterestInAssociate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The proportion of ownership interest in an associate attributable to the entity. [Refer: Associates [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 27<br> -IssueDate 2022-03-24<br> -Paragraph 17<br> -Subparagraph b<br> -Clause iii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=27&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_17_b_iii&amp;doctype=Standard<br> -URIDate 2022-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 27<br> -IssueDate 2022-03-24<br> -Paragraph 16<br> -Subparagraph b<br> -Clause iii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=27&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_16_b_iii&amp;doctype=Standard<br> -URIDate 2022-03-24<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2022-03-24<br> -Paragraph 21<br> -Subparagraph a<br> -Clause iv<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_21_a_iv&amp;doctype=Standard<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProportionOfOwnershipInterestInAssociate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>105
<FILENAME>R55.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139782810244240">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Investment In Associate (Details) - Schedule of proportional share in the associate - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_InvestmentInAssociateDetailsScheduleofproportionalshareintheassociateLineItems', window );"><strong>Schedule of proportional share in the associate [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherCurrentAssets', window );">Assets, Current</a></td>
<td class="nump">$ 609,704<span></span>
</td>
<td class="nump">$ 1,078,019<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherCurrentLiabilities', window );">Liabilities, Current</a></td>
<td class="nump">39,259<span></span>
</td>
<td class="nump">120,569<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_OtherRevenuesCurrent', window );">Revenues, Current</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_ExpensesCurrent', window );">Expenses, Current</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherNoncurrentAssets', window );">Assets, Non-current</a></td>
<td class="nump">729,261<span></span>
</td>
<td class="nump">751,065<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherNoncurrentLiabilities', window );">Liabilities Non-current</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_OtherRevenuesNoncurrent', window );">Revenues, Non-current</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_ExpensesNoncurrent', window );">Expenses, Non-current</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_AssetsLossFromOperatingExpenses', window );">Assets, Loss from operating expenses</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_LiabilitiesLossFromOperatingExpenses', window );">Liabilities Loss from operating expenses</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_RevenuesLossFromOperatingExpenses', window );">Revenues, Loss from operating expenses</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_ExpensesLossFromOperatingExpenses', window );">Expenses, Loss from operating expenses</a></td>
<td class="num">(415,769)<span></span>
</td>
<td class="num">(755,943)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherAssets', window );">Assets, Total</a></td>
<td class="nump">1,338,965<span></span>
</td>
<td class="nump">1,829,084<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherLiabilities', window );">Liabilities, Total</a></td>
<td class="nump">39,259<span></span>
</td>
<td class="nump">120,569<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherRevenue', window );">Revenues, Total</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherOperatingIncomeExpense', window );">Expenses Total</a></td>
<td class="num">$ (415,769)<span></span>
</td>
<td class="num">$ (755,943)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_YearEndedDecember312022Abstract', window );"><strong>Year ended December 31, 2022</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TaxRateEffectOfForeignTaxRates', window );">The Company&#8217;s percentage ownership</a></td>
<td class="nump">33.71%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cve_AssetsLossFromOperatingExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Assets, Loss from operating expenses</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cve_AssetsLossFromOperatingExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cve_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cve_ExpensesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cve_ExpensesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cve_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cve_ExpensesLossFromOperatingExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cve_ExpensesLossFromOperatingExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cve_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cve_ExpensesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cve_ExpensesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cve_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cve_InvestmentInAssociateDetailsScheduleofproportionalshareintheassociateLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cve_InvestmentInAssociateDetailsScheduleofproportionalshareintheassociateLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cve_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cve_LiabilitiesLossFromOperatingExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cve_LiabilitiesLossFromOperatingExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cve_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cve_OtherRevenuesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Revenues, Current</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cve_OtherRevenuesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cve_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cve_OtherRevenuesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Revenues, Non-current</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cve_OtherRevenuesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cve_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cve_RevenuesLossFromOperatingExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cve_RevenuesLossFromOperatingExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cve_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cve_YearEndedDecember312022Abstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cve_YearEndedDecember312022Abstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cve_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_OtherAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of assets that the entity does not separately disclose in the same statement or note.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2022-03-24<br> -Paragraph 55<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_OtherAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_OtherCurrentAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of current assets that the entity does not separately disclose in the same statement or note. [Refer: Current assets]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2022-03-24<br> -Paragraph 55<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_OtherCurrentAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_OtherCurrentLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of current liabilities that the entity does not separately disclose in the same statement or note. [Refer: Current liabilities]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2022-03-24<br> -Paragraph 55<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_OtherCurrentLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_OtherLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of liabilities that the entity does not separately disclose in the same statement or note.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2022-03-24<br> -Paragraph 55<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_OtherLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_OtherNoncurrentAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of non-current assets that the entity does not separately disclose in the same statement or note. [Refer: Non-current assets]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2022-03-24<br> -Paragraph 55<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_OtherNoncurrentAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_OtherNoncurrentLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of non-current liabilities that the entity does not separately disclose in the same statement or note. [Refer: Non-current liabilities]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2022-03-24<br> -Paragraph 55<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_OtherNoncurrentLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_OtherOperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of operating income (expense) that the entity does not separately disclose in the same statement or note.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2022-03-24<br> -Paragraph 85<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_85&amp;doctype=Standard<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_OtherOperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_OtherRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of revenue arising from sources that the entity does not separately disclose in the same statement or note. [Refer: Revenue]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2022-03-24<br> -Paragraph 112<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_112_c&amp;doctype=Standard<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_OtherRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TaxRateEffectOfForeignTaxRates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The tax rate effect on the reconciliation between the average effective tax rate and the applicable tax rate resulting from the application of foreign tax rates. [Refer: Average effective tax rate; Applicable tax rate]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2022-03-24<br> -Paragraph 81<br> -Subparagraph c<br> -Clause ii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_81_c_ii&amp;doctype=Standard<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TaxRateEffectOfForeignTaxRates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>106
<FILENAME>R56.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139782922834368">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Investment In Associate (Details) - Schedule of investment in associate continuity - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_InvestmentInAssociateDetailsScheduleofinvestmentinassociatecontinuityLineItems', window );"><strong>Schedule of investment in associate continuity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_InvestmentBalance1', window );">Balance</a></td>
<td class="nump">$ 564,340<span></span>
</td>
<td class="nump">$ 451,221<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_AdjustmentsToCarryingValueAbstract', window );"><strong>Adjustments to carrying value:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_ProportionateShareOfNetLoss', window );">Proportionate share of net loss</a></td>
<td class="num">(143,286)<span></span>
</td>
<td class="num">(260,055)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_AdjustmentToInvestmentInGroup11', window );">Adjustment to investment in Group 11</a></td>
<td class="nump">15,675<span></span>
</td>
<td class="nump">469,320<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_WriteoffOfInvestment', window );">Write-off of investment</a></td>
<td class="num">(443,614)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_DilutionLoss', window );">Dilution loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(95,680)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_CurrencyTranslationAdjustment', window );">Currency translation adjustment</a></td>
<td class="nump">$ 6,885<span></span>
</td>
<td class="num">(466)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_InvestmentBalance1', window );">Balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 564,340<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cve_AdjustmentToInvestmentInGroup11">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Adjustment to investment in Group 11.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cve_AdjustmentToInvestmentInGroup11</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cve_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cve_AdjustmentsToCarryingValueAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cve_AdjustmentsToCarryingValueAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cve_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cve_CurrencyTranslationAdjustment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of currency translation adjustment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cve_CurrencyTranslationAdjustment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cve_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cve_DilutionLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of dilution loss.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cve_DilutionLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cve_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cve_InvestmentBalance1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cve_InvestmentBalance1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cve_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cve_InvestmentInAssociateDetailsScheduleofinvestmentinassociatecontinuityLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cve_InvestmentInAssociateDetailsScheduleofinvestmentinassociatecontinuityLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cve_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cve_ProportionateShareOfNetLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of proportionate share of net loss.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cve_ProportionateShareOfNetLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cve_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cve_WriteoffOfInvestment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Write-off of investment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cve_WriteoffOfInvestment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cve_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>107
<FILENAME>R57.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139782809574224">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Investment in uranium (Details)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2"></th>
<th class="th" colspan="4">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Aug. 31, 2023 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Mar. 31, 2023 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 15, 2022 </div>
<div>USD ($) </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Dec. 15, 2022 </div>
<div>GBP (&#163;)</div>
</th>
<th class="th">
<div>Aug. 31, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Aug. 04, 2022 </div>
<div>USD ($) </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Aug. 04, 2022 </div>
<div>GBP (&#163;)</div>
</th>
<th class="th">
<div>Mar. 31, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Feb. 15, 2022 </div>
<div>USD ($) </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Feb. 15, 2022 </div>
<div>GBP (&#163;)</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>GBP (&#163;)</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>GBP (&#163;)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_InvestmentinuraniumDetailsLineItems', window );"><strong>Investment in uranium (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_PurchaseAgreementsAmount', window );">Purchase agreements amount (in Pounds) | &#163;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#163; 100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#163; 100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#163; 200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#163; 300,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLongTermInvestments', window );">Long-term investment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 9,076,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_SaleOfPhysicalUranium', window );">Sale of physical uranium (in Pounds) | &#163;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#163; 100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#163; 200,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_GrossProceeds', window );">Gross proceeds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,245,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,975,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GainsOnDisposalsOfInvestments', window );">Gain on investment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 35,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 524,075<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_TotalConsideration', window );">Total consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,922,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 8,750,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_TotalConsiderationPerShare', window );">Total consideration per share (in Dollars per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 59.225<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 49<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 43.75<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_InitialPayment', window );">Initial payment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_InvestmentAmount', window );">Final payment of investment</a></td>
<td class="nump">$ 3,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementScenarioAxis=srt_ScenarioForecastMember', window );">Forecast [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_InvestmentinuraniumDetailsLineItems', window );"><strong>Investment in uranium (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_InvestmentAmount', window );">Final payment of investment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6,750,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cve_GrossProceeds">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of gross proseeds.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cve_GrossProceeds</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cve_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cve_InitialPayment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>initial payment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cve_InitialPayment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cve_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cve_InvestmentAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Investment amount.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cve_InvestmentAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cve_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cve_InvestmentinuraniumDetailsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cve_InvestmentinuraniumDetailsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cve_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cve_PurchaseAgreementsAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of purchase agreements amount.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cve_PurchaseAgreementsAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cve_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cve_SaleOfPhysicalUranium">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of sale of physical uranium.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cve_SaleOfPhysicalUranium</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cve_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cve_TotalConsideration">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of Total Consideration.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cve_TotalConsideration</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cve_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cve_TotalConsiderationPerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of total consideration per share.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cve_TotalConsiderationPerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cve_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_GainsOnDisposalsOfInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The gain on the disposal of investments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2022-03-24<br> -Paragraph 98<br> -Subparagraph d<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_98_d&amp;doctype=Standard<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_GainsOnDisposalsOfInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLongTermInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term investments classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.1(f))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(12))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLongTermInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementScenarioAxis=srt_ScenarioForecastMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementScenarioAxis=srt_ScenarioForecastMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>108
<FILENAME>R58.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139782923909712">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Investment in uranium (Details) - Schedule of the fair value of the physical uranium investment - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_ScheduleOfTheFairValueOfThePhysicalUraniumInvestmentAbstract', window );"><strong>Schedule Of The Fair Value Of The Physical Uranium Investment Abstract</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CurrentInvestments', window );">Balance as of beginning</a></td>
<td class="nump">$ 4,210,000<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_PhysicalUranium', window );">Physical uranium</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,076,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdjustmentsForGainsLossesOnChangeInFairValueOfDerivatives', window );">Fair value adjustment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,554,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_GainOnSaleOfUranium', window );">Gain on sale of uranium</a></td>
<td class="nump">35,000<span></span>
</td>
<td class="nump">524,075<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_SaleOfUraniumInvestment', window );">Sale of uranium investment</a></td>
<td class="num">(4,245,000)<span></span>
</td>
<td class="num">(6,975,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherComprehensiveIncomeNetOfTaxChangeInValueOfForeignCurrencyBasisSpreads', window );">Currency translation adjustment</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">30,925<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CurrentInvestments', window );">Balance as of ending</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 4,210,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cve_GainOnSaleOfUranium">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net realized gain (loss) on investments sold during the period, not including gains (losses) on securities separately or otherwise categorized as trading, available-for-sale, or held-to-maturity, which, for cash flow reporting, is a component of proceeds from investing activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cve_GainOnSaleOfUranium</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cve_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cve_PhysicalUranium">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Physical uranium.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cve_PhysicalUranium</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cve_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cve_SaleOfUraniumInvestment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net realized gain (loss) on investments sold during the period, not including gains (losses) on securities separately or otherwise categorized as trading, available-for-sale, or held-to-maturity, which, for cash flow reporting, is a component of proceeds from investing activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cve_SaleOfUraniumInvestment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cve_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cve_ScheduleOfTheFairValueOfThePhysicalUraniumInvestmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cve_ScheduleOfTheFairValueOfThePhysicalUraniumInvestmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cve_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AdjustmentsForGainsLossesOnChangeInFairValueOfDerivatives">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Adjustments for gains (losses) on changes in the fair value of derivatives to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: At fair value [member]; Derivatives [member]; Profit (loss)]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2022-03-24<br> -Paragraph 20<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_20&amp;doctype=Standard<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AdjustmentsForGainsLossesOnChangeInFairValueOfDerivatives</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrentInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of current investments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2022-03-24<br> -Paragraph 55<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrentInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_OtherComprehensiveIncomeNetOfTaxChangeInValueOfForeignCurrencyBasisSpreads">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of other comprehensive income, net of tax, after reclassification adjustments, related to change in value of foreign currency basis spreads. [Refer: Other comprehensive income]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2022-03-24<br> -Paragraph 91<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_91_a&amp;doctype=Standard<br> -URIDate 2022-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2022-03-24<br> -Paragraph 7<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_7&amp;doctype=Standard<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_OtherComprehensiveIncomeNetOfTaxChangeInValueOfForeignCurrencyBasisSpreads</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>109
<FILENAME>R59.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139782921974000">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Investment in uranium (Details) - Schedule of uranium concentrates purchase agreement - 12 months ended Dec. 31, 2022<br></strong></div></th>
<th class="th"><div>USD ($)</div></th>
<th class="th"><div>GBP (&#163;)</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_UnconsolidatedStructuredEntitiesAxis=cve_Fiscal2023Member', window );">Fiscal 2023 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_InvestmentinuraniumDetailsScheduleofuraniumconcentratespurchaseagreementLineItems', window );"><strong>Investment in uranium (Details) - Schedule of uranium concentrates purchase agreement [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_PurchaseCommitments', window );">Purchase Commitments | &#163;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#163; 400,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_TotalPurchasePrice', window );">Total Purchase Price | $</a></td>
<td class="nump">$ 19,572,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_UnconsolidatedStructuredEntitiesAxis=cve_Fiscal2024Member', window );">Fiscal 2024 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_InvestmentinuraniumDetailsScheduleofuraniumconcentratespurchaseagreementLineItems', window );"><strong>Investment in uranium (Details) - Schedule of uranium concentrates purchase agreement [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_PurchaseCommitments', window );">Purchase Commitments | &#163;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_TotalPurchasePrice', window );">Total Purchase Price | $</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_UnconsolidatedStructuredEntitiesAxis=cve_Fiscal2025Member', window );">Fiscal 2025 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_InvestmentinuraniumDetailsScheduleofuraniumconcentratespurchaseagreementLineItems', window );"><strong>Investment in uranium (Details) - Schedule of uranium concentrates purchase agreement [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_PurchaseCommitments', window );">Purchase Commitments | &#163;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_TotalPurchasePrice', window );">Total Purchase Price | $</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_UnconsolidatedStructuredEntitiesAxis=cve_Fiscal2026Member', window );">Fiscal 2026 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_InvestmentinuraniumDetailsScheduleofuraniumconcentratespurchaseagreementLineItems', window );"><strong>Investment in uranium (Details) - Schedule of uranium concentrates purchase agreement [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_PurchaseCommitments', window );">Purchase Commitments | &#163;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_TotalPurchasePrice', window );">Total Purchase Price | $</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_UnconsolidatedStructuredEntitiesAxis=cve_Fiscal2027Member', window );">Fiscal 2027 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_InvestmentinuraniumDetailsScheduleofuraniumconcentratespurchaseagreementLineItems', window );"><strong>Investment in uranium (Details) - Schedule of uranium concentrates purchase agreement [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_PurchaseCommitments', window );">Purchase Commitments | &#163;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_TotalPurchasePrice', window );">Total Purchase Price | $</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cve_InvestmentinuraniumDetailsScheduleofuraniumconcentratespurchaseagreementLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cve_InvestmentinuraniumDetailsScheduleofuraniumconcentratespurchaseagreementLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cve_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cve_PurchaseCommitments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of Purchase Commitments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cve_PurchaseCommitments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cve_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cve_TotalPurchasePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of Purchase Price.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cve_TotalPurchasePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cve_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_UnconsolidatedStructuredEntitiesAxis=cve_Fiscal2023Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_UnconsolidatedStructuredEntitiesAxis=cve_Fiscal2023Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_UnconsolidatedStructuredEntitiesAxis=cve_Fiscal2024Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_UnconsolidatedStructuredEntitiesAxis=cve_Fiscal2024Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_UnconsolidatedStructuredEntitiesAxis=cve_Fiscal2025Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_UnconsolidatedStructuredEntitiesAxis=cve_Fiscal2025Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_UnconsolidatedStructuredEntitiesAxis=cve_Fiscal2026Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_UnconsolidatedStructuredEntitiesAxis=cve_Fiscal2026Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_UnconsolidatedStructuredEntitiesAxis=cve_Fiscal2027Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_UnconsolidatedStructuredEntitiesAxis=cve_Fiscal2027Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>110
<FILENAME>R60.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139782927540176">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Marketable Securities (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Oct. 31, 2022</div></th>
<th class="th"><div>May 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Jan. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_MarketableSecuritiesDetailsLineItems', window );"><strong>Marketable Securities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_CommonShares', window );">Common shares</a></td>
<td class="nump">80,000<span></span>
</td>
<td class="nump">11,308,250<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_MarketValuePerShare', window );">Market value per share (in Dollars per share)</a></td>
<td class="nump">$ 0.12<span></span>
</td>
<td class="nump">$ 0.27<span></span>
</td>
<td class="nump">$ 0.375<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfSharesIssuedAndFullyPaid', window );">Shares issued</a></td>
<td class="nump">80,000<span></span>
</td>
<td class="nump">11,308,250<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_ConvertedShares', window );">Converted shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11,308,250<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_TradingShares', window );">Trading shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,046,600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FinancialLiabilitiesAtFairValue', window );">Fair value (in Dollars)</a></td>
<td class="nump">$ 23,036<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 784,832<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ParValuePerShare', window );">Price per share (in Dollars per share)</a></td>
<td class="nump">$ 0.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.35<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_ReleasedShares', window );">Released shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,261,650<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_PrimeFuelsConsiderationPercentage', window );">Prime fuels consideration percentage</a></td>
<td class="nump">10.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Assets', window );">Assets (in Dollars)</a></td>
<td class="nump">$ 9,530<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 223,529,458<span></span>
</td>
<td class="nump">$ 159,356,524<span></span>
</td>
<td class="nump">$ 18,355,244<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=cve_MarketableSecuritiesMember', window );">Marketable securities [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_MarketableSecuritiesDetailsLineItems', window );"><strong>Marketable Securities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfKeyAssumptionsOnWhichManagementHasBasedDeterminationOfFairValueLessCostsOfDisposal', window );">Cost base shareholdings amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">$3,085,965<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfOrdinarySharesAxis=cve_TradingSharesMember', window );">Trading Shares [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_MarketableSecuritiesDetailsLineItems', window );"><strong>Marketable Securities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FinancialLiabilitiesAtFairValue', window );">Fair value (in Dollars)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,139,325<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ParValuePerShare', window );">Price per share (in Dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.35<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cve_CommonShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares common.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cve_CommonShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cve_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cve_ConvertedShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares converted.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cve_ConvertedShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cve_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cve_MarketValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Market value per share.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cve_MarketValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cve_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cve_MarketableSecuritiesDetailsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cve_MarketableSecuritiesDetailsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cve_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cve_PrimeFuelsConsiderationPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of prime fuels consideration.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cve_PrimeFuelsConsiderationPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cve_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cve_ReleasedShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Released shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cve_ReleasedShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cve_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cve_TradingShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cve_TradingShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cve_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of a present economic resource controlled by the entity as a result of past events. Economic resource is a right that has the potential to produce economic benefits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2022-03-24<br> -Paragraph 93<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_93_a&amp;doctype=Standard<br> -URIDate 2022-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2022-03-24<br> -Paragraph 28<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_28_c&amp;doctype=Standard<br> -URIDate 2022-03-24<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2022-03-24<br> -Paragraph 93<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_93_b&amp;doctype=Standard<br> -URIDate 2022-03-24<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2022-03-24<br> -Paragraph 93<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_93_e&amp;doctype=Standard<br> -URIDate 2022-03-24<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2022-03-24<br> -Paragraph 23<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_23&amp;doctype=Standard<br> -URIDate 2022-03-24<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2022-03-24<br> -Paragraph 55<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfKeyAssumptionsOnWhichManagementHasBasedDeterminationOfFairValueLessCostsOfDisposal">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The description of key assumptions on which management has based its determination of fair value less costs of disposal for a cash-generating unit (group of units). Key assumptions are those to which the unit's (group of units') recoverable amount is most sensitive. [Refer: Cash-generating units [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 36<br> -IssueDate 2022-03-24<br> -Paragraph 134<br> -Subparagraph e<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=36&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_134_e_i&amp;doctype=Standard<br> -URIDate 2022-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 36<br> -IssueDate 2022-03-24<br> -Paragraph 130<br> -Subparagraph f<br> -Clause iii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=36&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_130_f_iii&amp;doctype=Standard<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfKeyAssumptionsOnWhichManagementHasBasedDeterminationOfFairValueLessCostsOfDisposal</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_FinancialLiabilitiesAtFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The fair value of financial liabilities. [Refer: At fair value [member]; Financial liabilities]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 7<br> -IssueDate 2022-03-24<br> -Paragraph 25<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_25&amp;doctype=Standard<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_FinancialLiabilitiesAtFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NumberOfSharesIssuedAndFullyPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares issued by the entity, for which full payment has been received.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2022-03-24<br> -Paragraph 79<br> -Subparagraph a<br> -Clause ii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_79_a_ii&amp;doctype=Standard<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NumberOfSharesIssuedAndFullyPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ParValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The nominal value per share.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2022-03-24<br> -Paragraph 79<br> -Subparagraph a<br> -Clause iii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_79_a_iii&amp;doctype=Standard<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ParValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=cve_MarketableSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=cve_MarketableSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfOrdinarySharesAxis=cve_TradingSharesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfOrdinarySharesAxis=cve_TradingSharesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>111
<FILENAME>R61.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139782927526272">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Marketable Securities (Details) - Schedule of marketable securities<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($)</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_MarketableSecuritiesDetailsScheduleofmarketablesecuritiesLineItems', window );"><strong>Schedule of Marketable Securities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_MarketablesSecurities', window );">Balance beginning</a></td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdditionalProvisionsOtherProvisions', window );">Additions</a></td>
<td class="nump">3,051,485<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdjustmentsForGainsLossesOnFairValueAdjustmentInvestmentProperty', window );">Fair value adjustments</a></td>
<td class="nump">1,057,406<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserveTranslationAdjustment', window );">Currency translation adjustment</a></td>
<td class="num">(161,698)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_MarketablesSecurities', window );">Balance ending</a></td>
<td class="nump">3,947,193<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfAssetsAxis=cve_MarketableSecuritiescurrentMember', window );">Marketable securities (current) [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_MarketableSecuritiesDetailsScheduleofmarketablesecuritiesLineItems', window );"><strong>Schedule of Marketable Securities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_MarketablesSecurities', window );">Balance beginning</a></td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdditionalProvisionsOtherProvisions', window );">Additions</a></td>
<td class="nump">2,443,094<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdjustmentsForGainsLossesOnFairValueAdjustmentInvestmentProperty', window );">Fair value adjustments</a></td>
<td class="nump">848,814<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserveTranslationAdjustment', window );">Currency translation adjustment</a></td>
<td class="num">(129,547)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_MarketablesSecurities', window );">Balance ending</a></td>
<td class="nump">3,162,361<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfAssetsAxis=cve_MarketableSecuritiesnoncurrentMember', window );">Marketable securities (non-current) [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_MarketableSecuritiesDetailsScheduleofmarketablesecuritiesLineItems', window );"><strong>Schedule of Marketable Securities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_MarketablesSecurities', window );">Balance beginning</a></td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdditionalProvisionsOtherProvisions', window );">Additions</a></td>
<td class="nump">608,391<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdjustmentsForGainsLossesOnFairValueAdjustmentInvestmentProperty', window );">Fair value adjustments</a></td>
<td class="nump">208,592<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserveTranslationAdjustment', window );">Currency translation adjustment</a></td>
<td class="num">(32,151)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_MarketablesSecurities', window );">Balance ending</a></td>
<td class="nump">$ 784,832<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cve_MarketableSecuritiesDetailsScheduleofmarketablesecuritiesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cve_MarketableSecuritiesDetailsScheduleofmarketablesecuritiesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cve_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cve_MarketablesSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of marketable securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cve_MarketablesSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cve_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AdditionalProvisionsOtherProvisions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of additional other provisions made. [Refer: Other provisions]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 37<br> -IssueDate 2022-03-24<br> -Paragraph 84<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=37&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_84_b&amp;doctype=Standard<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AdditionalProvisionsOtherProvisions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AdjustmentsForGainsLossesOnFairValueAdjustmentInvestmentProperty">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Adjustments for gains (losses) arising from a change in the fair value of investment property to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Investment property; Gains (losses) on fair value adjustment, investment property; Profit (loss)]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2022-03-24<br> -Paragraph 20<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_20&amp;doctype=Standard<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AdjustmentsForGainsLossesOnFairValueAdjustmentInvestmentProperty</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringReserveTranslationAdjustment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of foreign currency translation gain (loss) which decreases (increases) the restructuring reserve.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringReserveTranslationAdjustment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfAssetsAxis=cve_MarketableSecuritiescurrentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfAssetsAxis=cve_MarketableSecuritiescurrentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfAssetsAxis=cve_MarketableSecuritiesnoncurrentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfAssetsAxis=cve_MarketableSecuritiesnoncurrentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>112
<FILENAME>R62.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139782809571424">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Intangible assets (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="4">1 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_DisclosureOfIntangibleAssetsTextBlockAbstract', window );"><strong>Disclosure Of Intangible Assets Text Block Abstract</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_CommonSharesIssued', window );">Common shares issued (in Shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PlanAssetsAtFairValue', window );">Fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 264,096<span></span>
</td>
<td class="nump">$ 9,153<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_PrimaryTerm', window );">Primary term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_RenewalPeriods', window );">Renewal periods</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_IntangibleAssetDeterminedLife', window );">Intangible asset determined life</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">14 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_AcquiredAmonut', window );">Acquired amount</a></td>
<td class="nump">$ 55,500<span></span>
</td>
<td class="nump">$ 17,500<span></span>
</td>
<td class="nump">$ 67,251<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cve_AcquiredAmonut">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Acquired amonut.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cve_AcquiredAmonut</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cve_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cve_CommonSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cve_CommonSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cve_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cve_DisclosureOfIntangibleAssetsTextBlockAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cve_DisclosureOfIntangibleAssetsTextBlockAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cve_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cve_IntangibleAssetDeterminedLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Intangible asset determined life.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cve_IntangibleAssetDeterminedLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cve_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cve_PrimaryTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Primary term.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cve_PrimaryTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cve_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cve_RenewalPeriods">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Renewal periods.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cve_RenewalPeriods</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cve_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_PlanAssetsAtFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The fair value of defined benefit plan assets. Plan assets comprise assets held by a long-term employee benefit fund and qualifying insurance policies. [Refer: At fair value [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 19<br> -IssueDate 2022-03-24<br> -Paragraph 57<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=19&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_57_a&amp;doctype=Standard<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_PlanAssetsAtFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>113
<FILENAME>R63.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139782922323120">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Intangible assets (Details) - Schedule of intangible asset was determined - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_IntangibleassetsDetailsScheduleofintangibleassetwasdeterminedLineItems', window );"><strong>Schedule of intangible asset was determined [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_IntangibleAssetsBalance', window );">Balance beginning</a></td>
<td class="nump">$ 491,996<span></span>
</td>
<td class="nump">$ 483,631<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_Additions', window );">Additions</a></td>
<td class="nump">55,500<span></span>
</td>
<td class="nump">17,500<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AmortisationIntangibleAssetsOtherThanGoodwill', window );">Amortization</a></td>
<td class="num">(19,764)<span></span>
</td>
<td class="num">(20,515)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_CurrencyTranslationAdjustment1', window );">Currency Translation Adjustment</a></td>
<td class="nump">550<span></span>
</td>
<td class="nump">11,380<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_IntangibleAssetsBalance', window );">Balance ending</a></td>
<td class="nump">528,282<span></span>
</td>
<td class="nump">491,996<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=cve_VANEAgreementMember', window );">VANE Agreement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_IntangibleassetsDetailsScheduleofintangibleassetwasdeterminedLineItems', window );"><strong>Schedule of intangible asset was determined [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_IntangibleAssetsBalance', window );">Balance beginning</a></td>
<td class="nump">207,504<span></span>
</td>
<td class="nump">226,368<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AmortisationIntangibleAssetsOtherThanGoodwill', window );">Amortization</a></td>
<td class="num">(19,764)<span></span>
</td>
<td class="num">(20,515)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_CurrencyTranslationAdjustment1', window );">Currency Translation Adjustment</a></td>
<td class="nump">900<span></span>
</td>
<td class="nump">1,651<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_IntangibleAssetsBalance', window );">Balance ending</a></td>
<td class="nump">188,640<span></span>
</td>
<td class="nump">207,504<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=cve_SignalEquitiesDatabaseMember', window );">Signal Equities Database [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_IntangibleassetsDetailsScheduleofintangibleassetwasdeterminedLineItems', window );"><strong>Schedule of intangible asset was determined [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_IntangibleAssetsBalance', window );">Balance beginning</a></td>
<td class="nump">67,251<span></span>
</td>
<td class="nump">67,251<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_IntangibleAssetsBalance', window );">Balance ending</a></td>
<td class="nump">67,251<span></span>
</td>
<td class="nump">67,251<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=cve_GrantsMineralBeltDatabaseMember', window );">Grants Mineral Belt Database [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_IntangibleassetsDetailsScheduleofintangibleassetwasdeterminedLineItems', window );"><strong>Schedule of intangible asset was determined [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_IntangibleAssetsBalance', window );">Balance beginning</a></td>
<td class="nump">217,241<span></span>
</td>
<td class="nump">190,012<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_Additions', window );">Additions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">17,500<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_CurrencyTranslationAdjustment1', window );">Currency Translation Adjustment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,729<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_IntangibleAssetsBalance', window );">Balance ending</a></td>
<td class="nump">217,241<span></span>
</td>
<td class="nump">$ 217,241<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=cve_GettyDatabaseMember', window );">Getty Database [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_IntangibleassetsDetailsScheduleofintangibleassetwasdeterminedLineItems', window );"><strong>Schedule of intangible asset was determined [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_Additions', window );">Additions</a></td>
<td class="nump">55,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_CurrencyTranslationAdjustment1', window );">Currency Translation Adjustment</a></td>
<td class="num">(350)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_IntangibleAssetsBalance', window );">Balance ending</a></td>
<td class="nump">$ 55,150<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cve_Additions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Additions.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cve_Additions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cve_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cve_CurrencyTranslationAdjustment1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Currency Translation Adjustment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cve_CurrencyTranslationAdjustment1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cve_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cve_IntangibleAssetsBalance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Intangible Assets Balance.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cve_IntangibleAssetsBalance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cve_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cve_IntangibleassetsDetailsScheduleofintangibleassetwasdeterminedLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cve_IntangibleassetsDetailsScheduleofintangibleassetwasdeterminedLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cve_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AmortisationIntangibleAssetsOtherThanGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of amortisation of intangible assets other than goodwill. [Refer: Depreciation and amortisation expense; Intangible assets other than goodwill]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 38<br> -IssueDate 2022-03-24<br> -Paragraph 118<br> -Subparagraph e<br> -Clause vi<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=38&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_118_e_vi&amp;doctype=Standard<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AmortisationIntangibleAssetsOtherThanGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=cve_VANEAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=cve_VANEAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=cve_SignalEquitiesDatabaseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=cve_SignalEquitiesDatabaseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=cve_GrantsMineralBeltDatabaseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=cve_GrantsMineralBeltDatabaseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=cve_GettyDatabaseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=cve_GettyDatabaseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>114
<FILENAME>R64.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139782921493744">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Property, plant, and equipment (Details) - Schedule of property, plant, and equipment - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_PropertyplantandequipmentDetailsScheduleofpropertyplantandequipmentLineItems', window );"><strong>Property, plant, and equipment (Details) - Schedule of property, plant, and equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipmentCarryingAmountAtCostOfRevaluedAssets', window );">Balance as of beginning</a></td>
<td class="nump">$ 1,603,679<span></span>
</td>
<td class="nump">$ 1,484,836<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment', window );">Additions</a></td>
<td class="nump">999,587<span></span>
</td>
<td class="nump">361,756<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisposalsInvestmentProperty', window );">Disposals</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DepreciationExpense', window );">Depreciation</a></td>
<td class="num">(268,845)<span></span>
</td>
<td class="num">(245,058)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ImpairmentLoss', window );">Impairment</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation', window );">Currency translation adjustment</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">2,145<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipmentCarryingAmountAtCostOfRevaluedAssets', window );">Balance as of ending</a></td>
<td class="nump">2,334,421<span></span>
</td>
<td class="nump">1,603,679<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=cve_UraniumPlantsMember', window );">Uranium Plants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_PropertyplantandequipmentDetailsScheduleofpropertyplantandequipmentLineItems', window );"><strong>Property, plant, and equipment (Details) - Schedule of property, plant, and equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipmentCarryingAmountAtCostOfRevaluedAssets', window );">Balance as of beginning</a></td>
<td class="nump">1,309,515<span></span>
</td>
<td class="nump">1,196,108<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment', window );">Additions</a></td>
<td class="nump">758,747<span></span>
</td>
<td class="nump">282,339<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisposalsInvestmentProperty', window );">Disposals</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DepreciationExpense', window );">Depreciation</a></td>
<td class="num">(162,208)<span></span>
</td>
<td class="num">(168,932)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ImpairmentLoss', window );">Impairment</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation', window );">Currency translation adjustment</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipmentCarryingAmountAtCostOfRevaluedAssets', window );">Balance as of ending</a></td>
<td class="nump">1,906,054<span></span>
</td>
<td class="nump">1,309,515<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_OtherPropertyPlantAndEquipmentMember', window );">Other property, plant and equipment [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_PropertyplantandequipmentDetailsScheduleofpropertyplantandequipmentLineItems', window );"><strong>Property, plant, and equipment (Details) - Schedule of property, plant, and equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipmentCarryingAmountAtCostOfRevaluedAssets', window );">Balance as of beginning</a></td>
<td class="nump">214,748<span></span>
</td>
<td class="nump">288,728<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment', window );">Additions</a></td>
<td class="nump">172,198<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisposalsInvestmentProperty', window );">Disposals</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DepreciationExpense', window );">Depreciation</a></td>
<td class="num">(78,646)<span></span>
</td>
<td class="num">(73,980)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ImpairmentLoss', window );">Impairment</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation', window );">Currency translation adjustment</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipmentCarryingAmountAtCostOfRevaluedAssets', window );">Balance as of ending</a></td>
<td class="nump">308,300<span></span>
</td>
<td class="nump">214,748<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=cve_FurnitureMember', window );">Furniture [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_PropertyplantandequipmentDetailsScheduleofpropertyplantandequipmentLineItems', window );"><strong>Property, plant, and equipment (Details) - Schedule of property, plant, and equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipmentCarryingAmountAtCostOfRevaluedAssets', window );">Balance as of beginning</a></td>
<td class="nump">16,470<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment', window );">Additions</a></td>
<td class="nump">8,507<span></span>
</td>
<td class="nump">16,471<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisposalsInvestmentProperty', window );">Disposals</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DepreciationExpense', window );">Depreciation</a></td>
<td class="num">(4,377)<span></span>
</td>
<td class="num">(2,146)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ImpairmentLoss', window );">Impairment</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation', window );">Currency translation adjustment</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">2,145<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipmentCarryingAmountAtCostOfRevaluedAssets', window );">Balance as of ending</a></td>
<td class="nump">20,600<span></span>
</td>
<td class="nump">16,470<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_BuildingsMember', window );">Buildings [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_PropertyplantandequipmentDetailsScheduleofpropertyplantandequipmentLineItems', window );"><strong>Property, plant, and equipment (Details) - Schedule of property, plant, and equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipmentCarryingAmountAtCostOfRevaluedAssets', window );">Balance as of beginning</a></td>
<td class="nump">62,946<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment', window );">Additions</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">62,946<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisposalsInvestmentProperty', window );">Disposals</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DepreciationExpense', window );">Depreciation</a></td>
<td class="num">(2,316)<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ImpairmentLoss', window );">Impairment</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation', window );">Currency translation adjustment</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipmentCarryingAmountAtCostOfRevaluedAssets', window );">Balance as of ending</a></td>
<td class="nump">60,630<span></span>
</td>
<td class="nump">62,946<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=cve_SoftwareMember', window );">Software [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_PropertyplantandequipmentDetailsScheduleofpropertyplantandequipmentLineItems', window );"><strong>Property, plant, and equipment (Details) - Schedule of property, plant, and equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipmentCarryingAmountAtCostOfRevaluedAssets', window );">Balance as of beginning</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment', window );">Additions</a></td>
<td class="nump">60,135<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisposalsInvestmentProperty', window );">Disposals</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DepreciationExpense', window );">Depreciation</a></td>
<td class="num">(21,298)<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ImpairmentLoss', window );">Impairment</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation', window );">Currency translation adjustment</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipmentCarryingAmountAtCostOfRevaluedAssets', window );">Balance as of ending</a></td>
<td class="nump">$ 38,837<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cve_PropertyplantandequipmentDetailsScheduleofpropertyplantandequipmentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cve_PropertyplantandequipmentDetailsScheduleofpropertyplantandequipmentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cve_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of additions to property, plant and equipment other than those acquired through business combinations. [Refer: Business combinations [member]; Property, plant and equipment]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 16<br> -IssueDate 2022-03-24<br> -Paragraph 73<br> -Subparagraph e<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=16&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_73_e_i&amp;doctype=Standard<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DepreciationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of depreciation expense. Depreciation is the systematic allocation of depreciable amounts of tangible assets over their useful lives.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2022-03-24<br> -Paragraph 112<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_112_c&amp;doctype=Standard<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DepreciationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisposalsInvestmentProperty">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The decrease in investment property resulting from disposals. [Refer: Investment property]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 40<br> -IssueDate 2022-03-24<br> -Paragraph 76<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=40&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_76_c&amp;doctype=Standard<br> -URIDate 2022-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 40<br> -IssueDate 2022-03-24<br> -Paragraph 79<br> -Subparagraph d<br> -Clause iii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=40&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_79_d_iii&amp;doctype=Standard<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisposalsInvestmentProperty</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ImpairmentLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount recognised as a reduction of the carrying amount of an asset or cash-generating unit to its recoverable amount. [Refer: Carrying amount [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 36<br> -IssueDate 2022-03-24<br> -Paragraph 130<br> -Subparagraph d<br> -Clause ii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=36&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_130_d_ii&amp;doctype=Standard<br> -URIDate 2022-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 36<br> -IssueDate 2022-03-24<br> -Paragraph 130<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=36&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_130_b&amp;doctype=Standard<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ImpairmentLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of other comprehensive income, net of tax, after reclassification adjustments, related to exchange differences when financial statements of foreign operations are translated. [Refer: Other comprehensive income]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2022-03-24<br> -Paragraph 91<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_91_a&amp;doctype=Standard<br> -URIDate 2022-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2022-03-24<br> -Paragraph 7<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_7&amp;doctype=Standard<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_PropertyPlantAndEquipmentCarryingAmountAtCostOfRevaluedAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of property, plant and equipment that would have been recognised had the revalued assets been carried under the cost model. [Refer: Property, plant and equipment]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 16<br> -IssueDate 2022-03-24<br> -Paragraph 77<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=16&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_77_e&amp;doctype=Standard<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_PropertyPlantAndEquipmentCarryingAmountAtCostOfRevaluedAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=cve_UraniumPlantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=cve_UraniumPlantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_OtherPropertyPlantAndEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_OtherPropertyPlantAndEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=cve_FurnitureMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=cve_FurnitureMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_BuildingsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_BuildingsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=cve_SoftwareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=cve_SoftwareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>115
<FILENAME>R65.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139782927501648">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Right-of-use assets (Details)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="3">1 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Jul. 01, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>CAD ($)</div>
</th>
<th class="th"><div>Feb. 14, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_RightofuseassetsDetailsLineItems', window );"><strong>Right-of-use assets (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeasePayments', window );">Lease payment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,640<span></span>
</td>
<td class="nump">$ 5,417<span></span>
</td>
<td class="nump">$ 4,068<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_CorrespondingLeaseObligation', window );">Corresponding lease obligation</a></td>
<td class="nump">$ 221,139<span></span>
</td>
<td class="nump">$ 34,898<span></span>
</td>
<td class="nump">$ 45,444<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BorrowingsInterestRate', window );">Estimated borrowing rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7.00%<span></span>
</td>
<td class="nump">7.00%<span></span>
</td>
<td class="nump">7.00%<span></span>
</td>
<td class="nump">8.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfAssetsAxis=ifrs-full_RightofuseAssetsMember', window );">Right-of-use assets [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_RightofuseassetsDetailsLineItems', window );"><strong>Right-of-use assets (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BorrowingsInterestRate', window );">Estimated borrowing rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7.00%<span></span>
</td>
<td class="nump">7.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cve_CorrespondingLeaseObligation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Corresponding lease obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cve_CorrespondingLeaseObligation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cve_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cve_RightofuseassetsDetailsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cve_RightofuseassetsDetailsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cve_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BorrowingsInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The interest rate on borrowings. [Refer: Borrowings]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IFRS<br> -Number 7<br> -IssueDate 2022-03-24<br> -Paragraph 7<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_7&amp;doctype=Standard<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BorrowingsInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasePayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918643-209977<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasePayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfAssetsAxis=ifrs-full_RightofuseAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfAssetsAxis=ifrs-full_RightofuseAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>116
<FILENAME>R66.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139782921848832">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Right-of-use assets (Details) - Schedule of change in the ROU assets - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_RightofuseassetsDetailsScheduleofchangeintheROUassetsLineItems', window );"><strong>Schedue of change in the ROU assets [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_Right-of-UseAssetsBalance', window );">Balance, beginning</a></td>
<td class="nump">$ 244,564<span></span>
</td>
<td class="nump">$ 8,867<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_Right-of-UseAssetsAdditions', window );">Additions</a></td>
<td class="nump">34,898<span></span>
</td>
<td class="nump">266,583<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_Right-of-UseAssetsDepreciation', window );">Depreciation</a></td>
<td class="num">(91,727)<span></span>
</td>
<td class="num">(33,093)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_Right-of-UseAssetsCurrencyTranslationAdjustment', window );">Currency translation adjustment</a></td>
<td class="num">(2,121)<span></span>
</td>
<td class="nump">2,207<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_Right-of-UseAssetsBalance', window );">Balance, ending</a></td>
<td class="nump">185,614<span></span>
</td>
<td class="nump">244,564<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CategoriesOfRelatedPartiesAxis=cve_LeasedCopierMember', window );">Leased copier [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_RightofuseassetsDetailsScheduleofchangeintheROUassetsLineItems', window );"><strong>Schedue of change in the ROU assets [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_Right-of-UseAssetsBalance', window );">Balance, beginning</a></td>
<td class="nump">3,416<span></span>
</td>
<td class="nump">8,867<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_Right-of-UseAssetsAdditions', window );">Additions</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_Right-of-UseAssetsDepreciation', window );">Depreciation</a></td>
<td class="num">(3,416)<span></span>
</td>
<td class="num">(5,451)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_Right-of-UseAssetsCurrencyTranslationAdjustment', window );">Currency translation adjustment</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_Right-of-UseAssetsBalance', window );">Balance, ending</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">3,416<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CategoriesOfRelatedPartiesAxis=cve_LeasedOfficesMember', window );">Leased offices [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_RightofuseassetsDetailsScheduleofchangeintheROUassetsLineItems', window );"><strong>Schedue of change in the ROU assets [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_Right-of-UseAssetsBalance', window );">Balance, beginning</a></td>
<td class="nump">241,148<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_Right-of-UseAssetsAdditions', window );">Additions</a></td>
<td class="nump">34,898<span></span>
</td>
<td class="nump">266,583<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_Right-of-UseAssetsDepreciation', window );">Depreciation</a></td>
<td class="num">(88,311)<span></span>
</td>
<td class="num">(27,642)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_Right-of-UseAssetsCurrencyTranslationAdjustment', window );">Currency translation adjustment</a></td>
<td class="num">(2,121)<span></span>
</td>
<td class="nump">2,207<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_Right-of-UseAssetsBalance', window );">Balance, ending</a></td>
<td class="nump">$ 185,614<span></span>
</td>
<td class="nump">$ 241,148<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cve_Right-of-UseAssetsAdditions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Additions.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cve_Right-of-UseAssetsAdditions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cve_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cve_Right-of-UseAssetsBalance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cve_Right-of-UseAssetsBalance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cve_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cve_Right-of-UseAssetsCurrencyTranslationAdjustment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Currency translation adjustment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cve_Right-of-UseAssetsCurrencyTranslationAdjustment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cve_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cve_Right-of-UseAssetsDepreciation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Depreciation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cve_Right-of-UseAssetsDepreciation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cve_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cve_RightofuseassetsDetailsScheduleofchangeintheROUassetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cve_RightofuseassetsDetailsScheduleofchangeintheROUassetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cve_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CategoriesOfRelatedPartiesAxis=cve_LeasedCopierMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CategoriesOfRelatedPartiesAxis=cve_LeasedCopierMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CategoriesOfRelatedPartiesAxis=cve_LeasedOfficesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CategoriesOfRelatedPartiesAxis=cve_LeasedOfficesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>117
<FILENAME>R67.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139782923918096">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Right-of-use assets (Details) - Schedule of change in the long-Term lease liability - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_RightofuseassetsDetailsScheduleofchangeinthelongTermleaseliabilityLineItems', window );"><strong>Shedule of change in the long-Term lease liability [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_Long-TermLeaseLiabilityBalance', window );">Balance, beginning</a></td>
<td class="nump">$ 249,509<span></span>
</td>
<td class="nump">$ 8,867<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_Long-TermLeaseLiabilityAdditions', window );">Additions</a></td>
<td class="nump">34,898<span></span>
</td>
<td class="nump">273,001<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_Long-TermLeaseLiabilityAccretion', window );">Accretion</a></td>
<td class="nump">15,234<span></span>
</td>
<td class="nump">7,471<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_Long-TermLeaseLiabilityLeasePaymentsMade', window );">Lease payments made</a></td>
<td class="num">(107,446)<span></span>
</td>
<td class="num">(37,588)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_Long-TermLeaseLiabilityCurrencyTranslationAdjustment', window );">Currency translation adjustment</a></td>
<td class="num">(11,767)<span></span>
</td>
<td class="num">(2,242)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_Long-TermLeaseLiabilityBalance', window );">Balance, ending</a></td>
<td class="nump">180,428<span></span>
</td>
<td class="nump">249,509<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_LongtermProvisionForDecommissioningRestorationAndRehabilitationCosts', window );">Balance (Long Term), December 31, 2022</a></td>
<td class="nump">96,166<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_Long-TermLeaseLiabilityLessCurrentLeaseLiability', window );">Less: current lease liability</a></td>
<td class="num">(84,262)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CategoriesOfRelatedPartiesAxis=cve_LeasedCopierMember', window );">Leased copier [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_RightofuseassetsDetailsScheduleofchangeinthelongTermleaseliabilityLineItems', window );"><strong>Shedule of change in the long-Term lease liability [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_Long-TermLeaseLiabilityBalance', window );">Balance, beginning</a></td>
<td class="nump">3,416<span></span>
</td>
<td class="nump">8,867<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_Long-TermLeaseLiabilityAdditions', window );">Additions</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_Long-TermLeaseLiabilityAccretion', window );">Accretion</a></td>
<td class="nump">77<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_Long-TermLeaseLiabilityLeasePaymentsMade', window );">Lease payments made</a></td>
<td class="num">(3,493)<span></span>
</td>
<td class="num">(5,451)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_Long-TermLeaseLiabilityCurrencyTranslationAdjustment', window );">Currency translation adjustment</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_Long-TermLeaseLiabilityBalance', window );">Balance, ending</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">3,416<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_LongtermProvisionForDecommissioningRestorationAndRehabilitationCosts', window );">Balance (Long Term), December 31, 2022</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_Long-TermLeaseLiabilityLessCurrentLeaseLiability', window );">Less: current lease liability</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CategoriesOfRelatedPartiesAxis=cve_LeasedOfficesMember', window );">Leased offices [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_RightofuseassetsDetailsScheduleofchangeinthelongTermleaseliabilityLineItems', window );"><strong>Shedule of change in the long-Term lease liability [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_Long-TermLeaseLiabilityBalance', window );">Balance, beginning</a></td>
<td class="nump">246,093<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_Long-TermLeaseLiabilityAdditions', window );">Additions</a></td>
<td class="nump">34,898<span></span>
</td>
<td class="nump">273,001<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_Long-TermLeaseLiabilityAccretion', window );">Accretion</a></td>
<td class="nump">15,157<span></span>
</td>
<td class="nump">7,471<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_Long-TermLeaseLiabilityLeasePaymentsMade', window );">Lease payments made</a></td>
<td class="num">(103,953)<span></span>
</td>
<td class="num">(32,137)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_Long-TermLeaseLiabilityCurrencyTranslationAdjustment', window );">Currency translation adjustment</a></td>
<td class="num">(11,767)<span></span>
</td>
<td class="num">(2,242)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_Long-TermLeaseLiabilityBalance', window );">Balance, ending</a></td>
<td class="nump">180,428<span></span>
</td>
<td class="nump">$ 246,093<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_LongtermProvisionForDecommissioningRestorationAndRehabilitationCosts', window );">Balance (Long Term), December 31, 2022</a></td>
<td class="nump">96,166<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_Long-TermLeaseLiabilityLessCurrentLeaseLiability', window );">Less: current lease liability</a></td>
<td class="num">$ (84,262)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cve_Long-TermLeaseLiabilityAccretion">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Long-Term Lease Liability Accretion.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cve_Long-TermLeaseLiabilityAccretion</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cve_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cve_Long-TermLeaseLiabilityAdditions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Additions.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cve_Long-TermLeaseLiabilityAdditions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cve_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cve_Long-TermLeaseLiabilityBalance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Long-Term Lease Liability Balance.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cve_Long-TermLeaseLiabilityBalance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cve_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cve_Long-TermLeaseLiabilityCurrencyTranslationAdjustment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Long-Term Lease Liability Currency Translation Adjustment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cve_Long-TermLeaseLiabilityCurrencyTranslationAdjustment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cve_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cve_Long-TermLeaseLiabilityLeasePaymentsMade">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Long-Term Lease Liability Lease Payments Made.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cve_Long-TermLeaseLiabilityLeasePaymentsMade</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cve_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cve_Long-TermLeaseLiabilityLessCurrentLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Long-Term Lease Liability Less Current Lease Liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cve_Long-TermLeaseLiabilityLessCurrentLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cve_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cve_RightofuseassetsDetailsScheduleofchangeinthelongTermleaseliabilityLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cve_RightofuseassetsDetailsScheduleofchangeinthelongTermleaseliabilityLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cve_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_LongtermProvisionForDecommissioningRestorationAndRehabilitationCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of non-current provision for decommissioning, restoration and rehabilitation costs. [Refer: Provision for decommissioning, restoration and rehabilitation costs]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 37<br> -IssueDate 2022-03-24<br> -Section D Examples: disclosures<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=37&amp;code=ifrs-tx-2022-en-r&amp;doctype=Illustrative%20Examples&amp;dita_xref=IAS37_IE_D__IAS37_IE_D_TI<br> -URIDate 2022-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 37<br> -IssueDate 2022-03-24<br> -Paragraph 87<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=37&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_87&amp;doctype=Standard<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_LongtermProvisionForDecommissioningRestorationAndRehabilitationCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CategoriesOfRelatedPartiesAxis=cve_LeasedCopierMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CategoriesOfRelatedPartiesAxis=cve_LeasedCopierMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CategoriesOfRelatedPartiesAxis=cve_LeasedOfficesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CategoriesOfRelatedPartiesAxis=cve_LeasedOfficesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>118
<FILENAME>R68.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139782928021744">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Right-of-use assets (Details) - Schedule of undiscounted future lease payments<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($)</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_RightofuseassetsDetailsScheduleofundiscountedfutureleasepaymentsLineItems', window );"><strong>Shedule of undiscounted future lease payments [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_Right-of-UseAssetsTwoZeroTwoThree', window );">2023</a></td>
<td class="nump">$ 127,967<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_Right-of-UseAssetsTwoZeroTwoFour', window );">2024</a></td>
<td class="nump">81,267<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_Right-of-UseAssetsTwoZeroTwoFive', window );">2025</a></td>
<td class="nump">32,502<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NetInvestmentInFinanceLease', window );">Total</a></td>
<td class="nump">$ 241,736<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cve_Right-of-UseAssetsTwoZeroTwoFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Right-of-use assets two zero two five.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cve_Right-of-UseAssetsTwoZeroTwoFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cve_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cve_Right-of-UseAssetsTwoZeroTwoFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Right-of-use assets two zero two four.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cve_Right-of-UseAssetsTwoZeroTwoFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cve_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cve_Right-of-UseAssetsTwoZeroTwoThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Right-of-use assets two zero two three.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cve_Right-of-UseAssetsTwoZeroTwoThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cve_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cve_RightofuseassetsDetailsScheduleofundiscountedfutureleasepaymentsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cve_RightofuseassetsDetailsScheduleofundiscountedfutureleasepaymentsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cve_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NetInvestmentInFinanceLease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The gross investment in the finance lease discounted at the interest rate implicit in the lease. Finance lease is a lease that transfers substantially all the risks and rewards incidental to ownership of an underlying asset. Gross investment in the finance lease is the sum of: (a) the lease payments receivable by a lessor under a finance lease; and (b) any unguaranteed residual value accruing to the lessor. Interest rate implicit in the lease is the rate of interest that causes the present value of (a) the lease payments and (b) the unguaranteed residual value to equal to the sum of (i) the fair value of the underlying asset and (ii) the initial direct costs of the lessor.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 16<br> -IssueDate 2022-03-24<br> -Paragraph 94<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=16&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_94&amp;doctype=Standard<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NetInvestmentInFinanceLease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>119
<FILENAME>R69.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139782922364208">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Asset acquisition (Details)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Oct. 31, 2022 </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Sep. 30, 2022 </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>May 31, 2022 </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Feb. 08, 2023 </div>
<div>shares</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_AssetacquisitionDetailsLineItems', window );"><strong>Asset acquisition (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_MarketValuePerShare', window );">Common Shares (in Dollars per share) | $ / shares</a></td>
<td class="nump">$ 0.12<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.27<span></span>
</td>
<td class="nump">$ 0.375<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred', window );">Total consideration (in Dollars) | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 120,422,593<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfSharesIssued', window );">Issuance shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">31,806,617<span></span>
</td>
<td class="nump">31,806,617<span></span>
</td>
<td class="nump">31,806,617<span></span>
</td>
<td class="nump">10,615,650<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_ShareConsiderationAmount', window );">Share Consideration (in Dollars) | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 120,422,593<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_StockOptions', window );">Stock Options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,828,960<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProceedsFromExerciseOfOptions', window );">Replacement of options held (in Dollars) | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,177,093<span></span>
</td>
<td class="nump">$ 288,572<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_SharePurchaseWarrants', window );">Share purchase warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,403,156<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProceedsFromExerciseOfWarrants', window );">Replacement of warrants held (in Dollars) | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,452,227<span></span>
</td>
<td class="nump">$ 2,633,029<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AcquisitionrelatedCostsRecognisedAsExpenseForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination', window );">Transaction costs (in Dollars) | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,215,444<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_WeightedAverageSharePrice2019', window );">Price per share | (per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3.79<span></span>
</td>
<td class="nump">$ 4.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfAssetsAxis=cve_ReplacementOptionsMember', window );">Replacement Options [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_AssetacquisitionDetailsLineItems', window );"><strong>Asset acquisition (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred', window );">Total consideration (in Dollars) | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">132,294,625<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProceedsFromExerciseOfOptions', window );">Replacement of options held (in Dollars) | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,434,045<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProceedsFromExerciseOfWarrants', window );">Replacement of warrants held (in Dollars) | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,222,543<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfSharesOutstanding', window );">Shares Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">14,631,709<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_ExchangeRatio', window );">Exchange Ratio (in Dollars per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.375<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfAssetsAxis=cve_ReplacementWarrantsMember', window );">Replacement Warrants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_AssetacquisitionDetailsLineItems', window );"><strong>Asset acquisition (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfSharesOutstanding', window );">Shares Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11,225,255<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_ExchangeRatio', window );">Exchange Ratio (in Dollars per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.375<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RangeAxis=ifrs-full_TopOfRangeMember', window );">Top of range [member] | Replacement Options [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_AssetacquisitionDetailsLineItems', window );"><strong>Asset acquisition (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_ShareConsolidation', window );">Share consolidation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,489,881<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RangeAxis=ifrs-full_TopOfRangeMember', window );">Top of range [member] | Replacement Warrants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_AssetacquisitionDetailsLineItems', window );"><strong>Asset acquisition (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_ShareConsolidation', window );">Share consolidation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,209,471<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RangeAxis=ifrs-full_BottomOfRangeMember', window );">Bottom of range [member] | Replacement Options [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_AssetacquisitionDetailsLineItems', window );"><strong>Asset acquisition (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_ShareConsolidation', window );">Share consolidation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,828,960<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RangeAxis=ifrs-full_BottomOfRangeMember', window );">Bottom of range [member] | Replacement Warrants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_AssetacquisitionDetailsLineItems', window );"><strong>Asset acquisition (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_ShareConsolidation', window );">Share consolidation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,403,156<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cve_AssetacquisitionDetailsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cve_AssetacquisitionDetailsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cve_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cve_ExchangeRatio">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of exchange ratio.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cve_ExchangeRatio</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cve_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cve_MarketValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Market value per share.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cve_MarketValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cve_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cve_ShareConsiderationAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of share consideration.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cve_ShareConsiderationAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cve_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cve_ShareConsolidation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Share consolidation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cve_ShareConsolidation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cve_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cve_SharePurchaseWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Share purchase warrants.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cve_SharePurchaseWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cve_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cve_StockOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cve_StockOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cve_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The fair value, at acquisition date, of the consideration transferred in a business combination. [Refer: Business combinations [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 3<br> -IssueDate 2022-03-24<br> -Paragraph B64<br> -Subparagraph f<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=3&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_B64_f&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AcquisitionrelatedCostsRecognisedAsExpenseForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of acquisition-related costs recognised as an expense for transactions that are recognised separately from the acquisition of assets and the assumption of liabilities in business combinations. [Refer: Business combinations [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 3<br> -IssueDate 2022-03-24<br> -Paragraph B64<br> -Subparagraph m<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=3&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_B64_m&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AcquisitionrelatedCostsRecognisedAsExpenseForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NumberOfSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares issued by the entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2022-03-24<br> -Paragraph 106<br> -Subparagraph d<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_106_d&amp;doctype=Standard<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NumberOfSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NumberOfSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares that have been authorised and issued, reduced by treasury shares held. [Refer: Treasury shares]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2022-03-24<br> -Paragraph 79<br> -Subparagraph a<br> -Clause iv<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_79_a_iv&amp;doctype=Standard<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NumberOfSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProceedsFromExerciseOfOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the exercise of options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2022-03-24<br> -Paragraph 17<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_17&amp;doctype=Standard<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProceedsFromExerciseOfOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProceedsFromExerciseOfWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the exercise of share purchase warrants.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2022-03-24<br> -Paragraph 17<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_17&amp;doctype=Standard<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProceedsFromExerciseOfWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_WeightedAverageSharePrice2019">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average share price. [Refer: Weighted average [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2022-03-24<br> -Paragraph 45<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_45_c&amp;doctype=Standard<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_WeightedAverageSharePrice2019</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfAssetsAxis=cve_ReplacementOptionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfAssetsAxis=cve_ReplacementOptionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfAssetsAxis=cve_ReplacementWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfAssetsAxis=cve_ReplacementWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RangeAxis=ifrs-full_TopOfRangeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RangeAxis=ifrs-full_TopOfRangeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RangeAxis=ifrs-full_BottomOfRangeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RangeAxis=ifrs-full_BottomOfRangeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>120
<FILENAME>R70.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139782922713248">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Asset acquisition (Details) - Schedule of estimated fair value of assets and liabilities<br></strong></div></th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_ScheduleOfEstimatedFairValueOfAssetsAndLiabilitiesAbstract', window );"><strong>Schedule Of Estimated Fair Value Of Assets And Liabilities Abstract</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred', window );">Fair value of share consideration</a></td>
<td class="nump">$ 120,422,593<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_FairValueOfReplacementOptions', window );">Fair value of replacement options</a></td>
<td class="nump">5,434,045<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_FairValueOfReplacementWarrants', window );">Fair value of replacement warrants</a></td>
<td class="nump">3,222,543<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_TransactionCosts', window );">Transaction costs</a></td>
<td class="nump">3,215,444<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_TotalConsiderationValue', window );">Total consideration value</a></td>
<td class="nump">$ 132,294,625<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cve_FairValueOfReplacementOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of replacement options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cve_FairValueOfReplacementOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cve_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cve_FairValueOfReplacementWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of replacement warrants.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cve_FairValueOfReplacementWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cve_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cve_ScheduleOfEstimatedFairValueOfAssetsAndLiabilitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cve_ScheduleOfEstimatedFairValueOfAssetsAndLiabilitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cve_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cve_TotalConsiderationValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total consideration value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cve_TotalConsiderationValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cve_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cve_TransactionCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Transaction costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cve_TransactionCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cve_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The fair value, at acquisition date, of the consideration transferred in a business combination. [Refer: Business combinations [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 3<br> -IssueDate 2022-03-24<br> -Paragraph B64<br> -Subparagraph f<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=3&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_B64_f&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>121
<FILENAME>R71.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139782809572784">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Asset acquisition (Details) - Schedule of net assets acquired<br></strong></div></th>
<th class="th" colspan="2">
<div>Dec. 31, 2022 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_ScheduleOfNetAssetsAcquiredAbstract', window );"><strong>Schedule Of Net Assets Acquired Abstract</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherCashAndCashEquivalents', window );">Cash</a></td>
<td class="nump">$ 1,860,360<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NoncurrentRestrictedCashAndCashEquivalents', window );">Restricted cash</a></td>
<td class="nump">720,039<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Prepayments', window );">Prepaids</a></td>
<td class="nump">169,688<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate', window );">Property, plant, and equipment</a></td>
<td class="nump">62,946<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RightofuseAssetsThatDoNotMeetDefinitionOfInvestmentProperty', window );">Right-of-use asset</a></td>
<td class="nump">45,444<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AssetsArisingFromExplorationForAndEvaluationOfMineralResources', window );">Mineral properties</a></td>
<td class="nump">129,129,302<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_AssetRetirementObligations', window );">Asset retirement obligations</a></td>
<td class="num">(267,807)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_LeaseLiabilities', window );">Lease liability</a></td>
<td class="num">(49,339)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_LoansAndReceivables', window );">Loan receivable</a></td>
<td class="nump">1,845,941<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_AccountsPayableAndAccruedLiability', window );">Accounts payable and accrued liabilities</a></td>
<td class="num">(1,221,949)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IdentifiableAssetsAcquiredLiabilitiesAssumed', window );">Total net assets acquired</a></td>
<td class="nump">$ 132,294,625<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr><td colspan="3"></td></tr>
<tr><td colspan="3"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">Transaction costs incurred by Azarga which were subsequently paid by the Company.</td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cve_AccountsPayableAndAccruedLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accounts payable and accrued liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cve_AccountsPayableAndAccruedLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cve_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cve_AssetRetirementObligations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Asset retirement obligations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cve_AssetRetirementObligations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cve_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cve_ScheduleOfNetAssetsAcquiredAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cve_ScheduleOfNetAssetsAcquiredAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cve_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AssetsArisingFromExplorationForAndEvaluationOfMineralResources">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of assets arising from the search for mineral resources, including minerals, oil, natural gas and similar non-regenerative resources after the entity has obtained legal rights to explore in a specific area, as well as the determination of the technical feasibility and commercial viability of extracting the mineral resource.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 6<br> -IssueDate 2022-03-24<br> -Paragraph 24<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=6&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_24_b&amp;doctype=Standard<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AssetsArisingFromExplorationForAndEvaluationOfMineralResources</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IdentifiableAssetsAcquiredLiabilitiesAssumed">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount recognised as of the acquisition date for net identifiable assets acquired or liabilities assumed in a business combination. [Refer: Business combinations [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 3<br> -IssueDate 2022-03-24<br> -Paragraph B64<br> -Subparagraph i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=3&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_B64_i&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2022-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 3<br> -IssueDate 2022-03-24<br> -Paragraph IE72<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=3&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_IE72&amp;doctype=Illustrative%20Examples<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IdentifiableAssetsAcquiredLiabilitiesAssumed</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_LeaseLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of liabilities related to the entity's leases. Lease is a contract, or part of a contract, that conveys the right to use an underlying asset for a period of time in exchange for consideration.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 16<br> -IssueDate 2022-03-24<br> -Paragraph 47<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=16&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_47_b&amp;doctype=Standard<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_LeaseLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_LoansAndReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of non-derivative financial assets with fixed or determinable payments that are not quoted in an active market, other than: (a) those that the entity intends to sell immediately or in the near term, which shall be classified as held for trading, and those that the entity, upon initial recognition, designates as at fair value through profit or loss; (b) those that the entity, upon initial recognition, designates as available for sale; or (c) those for which the holder may not recover substantially all of its initial investment, other than because of credit deterioration, which shall be classified as available for sale. An interest acquired in a pool of assets that are not loans or receivables (for example, an interest in a mutual fund or a similar fund) is not a loan or receivable. [Refer: Derivative financial assets]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2023-01-01<br> -Name IFRS<br> -Number 7<br> -IssueDate 2022-03-24<br> -Paragraph 8<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2017-en-b&amp;anchor=para_8_c&amp;doctype=Standard&amp;book=b<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_LoansAndReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NoncurrentRestrictedCashAndCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of non-current restricted cash and cash equivalents. [Refer: Restricted cash and cash equivalents]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2022-03-24<br> -Paragraph 55<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NoncurrentRestrictedCashAndCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_OtherCashAndCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of cash and cash equivalents that the entity does not separately disclose in the same statement or note. [Refer: Cash and cash equivalents]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2022-03-24<br> -Paragraph 45<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_45&amp;doctype=Standard<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_OtherCashAndCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_Prepayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Receivables that represent amounts paid for goods and services before they have been delivered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2022-03-24<br> -Paragraph 78<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_78_b&amp;doctype=Standard<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_Prepayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount recognised as of the acquisition date for plant, property and equipment acquired in a business combination. [Refer: Property, plant and equipment; Business combinations [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 3<br> -IssueDate 2022-03-24<br> -Paragraph B64<br> -Subparagraph i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=3&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_B64_i&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2022-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 3<br> -IssueDate 2022-03-24<br> -Paragraph IE72<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=3&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_IE72&amp;doctype=Illustrative%20Examples<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RightofuseAssetsThatDoNotMeetDefinitionOfInvestmentProperty">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of right-of-use assets that do not meet the definition of investment property. [Refer: Right-of-use assets; Investment property]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 16<br> -IssueDate 2022-03-24<br> -Paragraph 47<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=16&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_47_a&amp;doctype=Standard<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RightofuseAssetsThatDoNotMeetDefinitionOfInvestmentProperty</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>122
<FILENAME>R72.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139782927768400">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Asset acquisition (Details) - Schedule of weighted average assumptions used in the black-scholes option<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Dec. 31, 2022 </div>
<div>$ / shares</div>
</th></tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ComponentsOfEquityAxis=cve_OptionsMember', window );">Options [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_AssetacquisitionDetailsScheduleofweightedaverageassumptionsusedintheblackscholesoptionLineItems', window );"><strong>Asset acquisition (Details) - Schedule of weighted average assumptions used in the black-scholes option [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ExercisePriceShareOptionsGranted2019', window );">Exercise price</a></td>
<td class="nump">$ 1.4<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_WeightedAverageSharePriceShareOptionsGranted2019', window );">Share price</a></td>
<td class="nump">$ 3.79<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ActuarialAssumptionOfDiscountRates', window );">Discount rate</a></td>
<td class="nump">1.04%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019', window );">Expected life (years)</a></td>
<td class="text">3 years 5 months 4 days<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfExpectedVolatilityShareOptionsGranted', window );">Volatility</a></td>
<td class="nump">104.40%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_FairValueOfReplacement', window );">Fair value of replacement</a></td>
<td class="nump">$ 2.97<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ComponentsOfEquityAxis=ifrs-full_WarrantReserveMember', window );">Warrants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_AssetacquisitionDetailsScheduleofweightedaverageassumptionsusedintheblackscholesoptionLineItems', window );"><strong>Asset acquisition (Details) - Schedule of weighted average assumptions used in the black-scholes option [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ExercisePriceShareOptionsGranted2019', window );">Exercise price</a></td>
<td class="nump">1.66<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_WeightedAverageSharePriceShareOptionsGranted2019', window );">Share price</a></td>
<td class="nump">$ 3.79<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ActuarialAssumptionOfDiscountRates', window );">Discount rate</a></td>
<td class="nump">0.91%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019', window );">Expected life (years)</a></td>
<td class="text">11 months 23 days<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfExpectedVolatilityShareOptionsGranted', window );">Volatility</a></td>
<td class="nump">77.10%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_FairValueOfReplacement', window );">Fair value of replacement</a></td>
<td class="nump">$ 2.3<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cve_AssetacquisitionDetailsScheduleofweightedaverageassumptionsusedintheblackscholesoptionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cve_AssetacquisitionDetailsScheduleofweightedaverageassumptionsusedintheblackscholesoptionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cve_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cve_FairValueOfReplacement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of replacement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cve_FairValueOfReplacement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cve_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ActuarialAssumptionOfDiscountRates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The discount rate used as the significant actuarial assumption to determine the present value of a defined benefit obligation. [Refer: Defined benefit obligation, at present value; Actuarial assumptions [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 19<br> -IssueDate 2022-03-24<br> -Paragraph 144<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=19&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_144&amp;doctype=Standard<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ActuarialAssumptionOfDiscountRates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfExpectedVolatilityShareOptionsGranted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The expected volatility of the share price used to calculate the fair value of the share options granted. Expected volatility is a measure of the amount by which a price is expected to fluctuate during a period. The measure of volatility used in option pricing models is the annualised standard deviation of the continuously compounded rates of return on the share over a period of time.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2022-03-24<br> -Paragraph 47<br> -Subparagraph a<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_47_a_i&amp;doctype=Standard<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfExpectedVolatilityShareOptionsGranted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ExercisePriceShareOptionsGranted2019">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exercise price of share options granted.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2022-03-24<br> -Paragraph 47<br> -Subparagraph a<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_47_a_i&amp;doctype=Standard<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ExercisePriceShareOptionsGranted2019</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average remaining contractual life of outstanding share options. [Refer: Weighted average [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2022-03-24<br> -Paragraph 45<br> -Subparagraph d<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_45_d&amp;doctype=Standard<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_WeightedAverageSharePriceShareOptionsGranted2019">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average share price used as input to the option pricing model to calculate the fair value of share options granted. [Refer: Option pricing model [member]; Weighted average [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2022-03-24<br> -Paragraph 47<br> -Subparagraph a<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_47_a_i&amp;doctype=Standard<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_WeightedAverageSharePriceShareOptionsGranted2019</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ComponentsOfEquityAxis=cve_OptionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ComponentsOfEquityAxis=cve_OptionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ComponentsOfEquityAxis=ifrs-full_WarrantReserveMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ComponentsOfEquityAxis=ifrs-full_WarrantReserveMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>123
<FILENAME>R73.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139782808708848">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Mineral Properties (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="5">1 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>May 24, 2022</div></th>
<th class="th"><div>Jan. 31, 2022</div></th>
<th class="th"><div>May 31, 2021</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Oct. 31, 2022</div></th>
<th class="th"><div>Jun. 20, 2022</div></th>
<th class="th"><div>May 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Jan. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_MineralPropertiesDetailsLineItems', window );"><strong>Mineral Properties (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_LongtermDeposits', window );">Cash bonds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 88,500<span></span>
</td>
<td class="nump">$ 88,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 85,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ConsiderationPaidReceived', window );">Consideration received</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 250,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ContingentConsiderationRecognisedAsOfAcquisitionDate', window );">Contingent payments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,165,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GainsOnDisposalsOfInvestments', window );">Gain on disposal of the mineral interests</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 35,000<span></span>
</td>
<td class="nump">524,075<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_InvestmentInterestRates', window );">Interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_RoyaltyIncomeRate', window );">Gross profit royalty</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_ConsiderationReceived', window );">Consideration received (in Shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11,308,250<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtFairValue', window );">Fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,085,965<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSaleOrAsHeldForDistributionToOwners', window );">Non-current assets or disposal groups classified as held for sale or as held for distribution to owners</a></td>
<td class="nump">$ 28,485<span></span>
</td>
<td class="nump">1,741,064<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 728,882<span></span>
</td>
<td class="nump">1,741,064<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_GainOnDisposalOfSubsidiary', window );"></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,594,901<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,594,901<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProceedsFromSalesOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities', window );">Disposal of the mineral interests</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 48,480<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">48,480<span></span>
</td>
<td class="nump">$ 105,600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_AdditionalPayment', window );">Additional payment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 24,240<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RecognisedAssetsDefinedBenefitPlan', window );">Net book value of asset</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 195,514<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_GrantedPercentage', window );">Granted percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_ConsiderationPercentage', window );">Consideration percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfSharesIssuedAndFullyPaid', window );">Shares (in Shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">80,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11,308,250<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PlanAssetsAtFairValue', window );">Fair value of uravan minerals</a></td>
<td class="nump">9,153<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 264,096<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_LossesOnDisposalsOfInvestments', window );">Losses on disposals of investments</a></td>
<td class="nump">$ 19,332<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CategoriesOfRelatedPartiesAxis=cve_PrimeFuelsCorpMember', window );">Prime Fuels Corp [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_MineralPropertiesDetailsLineItems', window );"><strong>Mineral Properties (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_GrantedPercentage', window );">Granted percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_ConsiderationPercentage', window );">Consideration percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfLiabilitiesAxis=ifrs-full_ContingentConsiderationMember', window );">Contingent consideration [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_MineralPropertiesDetailsLineItems', window );"><strong>Mineral Properties (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ConsiderationPaidReceived', window );">Consideration received</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,895,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfLiabilitiesAxis=cve_TriStateGenerationAndTransmissionAssociationMember', window );">Tri State Generation and Transmission Association [Member</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_MineralPropertiesDetailsLineItems', window );"><strong>Mineral Properties (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ConsiderationPaidReceived', window );">Consideration received</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 89,600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GainsOnDisposalsOfInvestments', window );">Gain on disposal of the mineral interests</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 89,600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfLiabilitiesAxis=cve_WildcatSolarPowerPlantLLCMember', window );">Wildcat Solar Power Plant, LLC [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_MineralPropertiesDetailsLineItems', window );"><strong>Mineral Properties (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ConsiderationPaidReceived', window );">Consideration received</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 16,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GainsOnDisposalsOfInvestments', window );">Gain on disposal of the mineral interests</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 16,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfLiabilitiesAxis=cve_McKinleyMember', window );">McKinley [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_MineralPropertiesDetailsLineItems', window );"><strong>Mineral Properties (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_InvestmentInterestRates', window );">Interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfLiabilitiesAxis=cve_CrownpointMember', window );">Crownpoint [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_MineralPropertiesDetailsLineItems', window );"><strong>Mineral Properties (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_InterestRateHold', window );">Company holds a interest</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">60.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RangeAxis=ifrs-full_BottomOfRangeMember', window );">Bottom of range [member] | Crownpoint [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_MineralPropertiesDetailsLineItems', window );"><strong>Mineral Properties (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_InvestmentInterestRates', window );">Interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">60.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RangeAxis=ifrs-full_TopOfRangeMember', window );">Top of range [member] | Hosta butte [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_MineralPropertiesDetailsLineItems', window );"><strong>Mineral Properties (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_InvestmentInterestRates', window );">Interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cve_AdditionalPayment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cve_AdditionalPayment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cve_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cve_ConsiderationPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cve_ConsiderationPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cve_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cve_ConsiderationReceived">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cve_ConsiderationReceived</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cve_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cve_GainOnDisposalOfSubsidiary">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Gain on disposal of subsidiary</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cve_GainOnDisposalOfSubsidiary</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cve_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cve_GrantedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cve_GrantedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cve_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cve_InterestRateHold">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cve_InterestRateHold</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cve_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cve_InvestmentInterestRates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cve_InvestmentInterestRates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cve_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cve_MineralPropertiesDetailsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cve_MineralPropertiesDetailsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cve_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cve_RoyaltyIncomeRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cve_RoyaltyIncomeRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cve_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ConsiderationPaidReceived">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of consideration paid or received in respect of both obtaining and losing control of subsidiaries or other businesses. [Refer: Subsidiaries [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2022-03-24<br> -Paragraph 40<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_40_a&amp;doctype=Standard<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ConsiderationPaidReceived</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ContingentConsiderationRecognisedAsOfAcquisitionDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount, at acquisition date, of contingent consideration arrangements recognised as consideration transferred in a business combination. [Refer: Business combinations [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 3<br> -IssueDate 2022-03-24<br> -Paragraph B64<br> -Subparagraph g<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=3&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_B64_g_i&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ContingentConsiderationRecognisedAsOfAcquisitionDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_GainsOnDisposalsOfInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The gain on the disposal of investments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2022-03-24<br> -Paragraph 98<br> -Subparagraph d<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_98_d&amp;doctype=Standard<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_GainsOnDisposalsOfInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_LongtermDeposits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of long-term deposits held by the entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2022-03-24<br> -Paragraph 55<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_LongtermDeposits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_LossesOnDisposalsOfInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The losses on the disposal of investments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2022-03-24<br> -Paragraph 98<br> -Subparagraph d<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_98_d&amp;doctype=Standard<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_LossesOnDisposalsOfInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSaleOrAsHeldForDistributionToOwners">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of non-current assets or disposal groups classified as held for sale or as held for distribution to owners. [Refer: Non-current assets or disposal groups classified as held for distribution to owners; Non-current assets or disposal groups classified as held for sale]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2022-03-24<br> -Paragraph 54<br> -Subparagraph j<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_54_j&amp;doctype=Standard<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSaleOrAsHeldForDistributionToOwners</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NumberOfSharesIssuedAndFullyPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares issued by the entity, for which full payment has been received.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2022-03-24<br> -Paragraph 79<br> -Subparagraph a<br> -Clause ii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_79_a_ii&amp;doctype=Standard<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NumberOfSharesIssuedAndFullyPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_PlanAssetsAtFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The fair value of defined benefit plan assets. Plan assets comprise assets held by a long-term employee benefit fund and qualifying insurance policies. [Refer: At fair value [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 19<br> -IssueDate 2022-03-24<br> -Paragraph 57<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=19&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_57_a&amp;doctype=Standard<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_PlanAssetsAtFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProceedsFromSalesOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from sales of property, plant and equipment, classified as investing activities. [Refer: Property, plant and equipment]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2022-03-24<br> -Paragraph 16<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_16_b&amp;doctype=Standard<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProceedsFromSalesOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RecognisedAssetsDefinedBenefitPlan">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of surplus in a defined benefit plan, adjusted for any effect of limiting a net defined benefit asset to the asset ceiling. [Refer: Defined benefit plans [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2022-03-24<br> -Paragraph 55<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RecognisedAssetsDefinedBenefitPlan</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The fair value amount of long-term debt whether such amount is presented as a separate caption or as a parenthetical disclosure. Additionally, this element may be used in connection with the fair value disclosures required in the footnote disclosures to the financial statements. The element may be used in both the balance sheet and disclosure in the same submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CategoriesOfRelatedPartiesAxis=cve_PrimeFuelsCorpMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CategoriesOfRelatedPartiesAxis=cve_PrimeFuelsCorpMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfLiabilitiesAxis=ifrs-full_ContingentConsiderationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfLiabilitiesAxis=ifrs-full_ContingentConsiderationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfLiabilitiesAxis=cve_TriStateGenerationAndTransmissionAssociationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfLiabilitiesAxis=cve_TriStateGenerationAndTransmissionAssociationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfLiabilitiesAxis=cve_WildcatSolarPowerPlantLLCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfLiabilitiesAxis=cve_WildcatSolarPowerPlantLLCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfLiabilitiesAxis=cve_McKinleyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfLiabilitiesAxis=cve_McKinleyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfLiabilitiesAxis=cve_CrownpointMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfLiabilitiesAxis=cve_CrownpointMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RangeAxis=ifrs-full_BottomOfRangeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RangeAxis=ifrs-full_BottomOfRangeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RangeAxis=ifrs-full_TopOfRangeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RangeAxis=ifrs-full_TopOfRangeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfLiabilitiesAxis=cve_HostaButteMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfLiabilitiesAxis=cve_HostaButteMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>124
<FILENAME>R74.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139782807403568">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Mineral Properties (Details) - Schedule of mineral properties - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_MineralPropertiesDetailsScheduleofmineralpropertiesLineItems', window );"><strong>Mineral Properties (Details) - Schedule of mineral properties [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MiningAssets', window );">Balance, December 31, 2020</a></td>
<td class="nump">$ 136,079,578<span></span>
</td>
<td class="nump">$ 6,608,060<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_ExplorationCostsAbstract', window );"><strong>Exploration costs:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_Drilling', window );">Drilling</a></td>
<td class="nump">2,109,835<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_MaintenancesAndLeaseFees', window );">Maintenance and lease fees</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,184,163<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_Personnel', window );">Personnel</a></td>
<td class="nump">521,662<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_ResourceReview', window );">Resource review</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">173,087<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_ImpairmentCharged', window );">Impairment charged</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(78,456)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_DivestmentAbstract', window );"><strong>Divestment:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_DivestMineralInterest', window );">Divest - Mineral interest</a></td>
<td class="num">(28,485)<span></span>
</td>
<td class="num">(195,514)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_AssetsHeldForSale', window );">Assets held for sale</a></td>
<td class="num">(728,882)<span></span>
</td>
<td class="num">(1,741,064)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MiningAssets', window );">Balance</a></td>
<td class="nump">145,219,086<span></span>
</td>
<td class="nump">136,079,578<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_ProjectDevelopmentCostsAbstract', window );"><strong>Project Development costs:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_ConstructionOfWellfields', window );">Construction of wellfields</a></td>
<td class="nump">1,670,151<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_AssetAcquistion', window );">Asset acquisition (Note 10)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">129,129,302<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfLiabilitiesAxis=cve_ExplorationCostMember', window );">Exploration Cost [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_ExplorationCostsAbstract', window );"><strong>Exploration costs:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_Drilling', window );">Drilling</a></td>
<td class="nump">197,422<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_MaintenancesAndLeaseFees', window );">Maintenance and lease fees</a></td>
<td class="nump">3,543,418<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_PermittingLicensing', window );">Permitting &amp; Licensing</a></td>
<td class="nump">840,232<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_Personnel', window );">Personnel</a></td>
<td class="nump">821,666<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_Recoveries', window );">Recoveries</a></td>
<td class="num">(22,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_ResourceReview', window );">Resource review</a></td>
<td class="nump">214,489<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GeographicalAreasAxis=stpr_AZ', window );">Arizona [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_MineralPropertiesDetailsScheduleofmineralpropertiesLineItems', window );"><strong>Mineral Properties (Details) - Schedule of mineral properties [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MiningAssets', window );">Balance, December 31, 2020</a></td>
<td class="nump">900,719<span></span>
</td>
<td class="nump">771,388<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_ExplorationCostsAbstract', window );"><strong>Exploration costs:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_Drilling', window );">Drilling</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_MaintenancesAndLeaseFees', window );">Maintenance and lease fees</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">86,364<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_Personnel', window );">Personnel</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_ResourceReview', window );">Resource review</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">42,967<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_ImpairmentCharged', window );">Impairment charged</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_DivestmentAbstract', window );"><strong>Divestment:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_DivestMineralInterest', window );">Divest - Mineral interest</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_AssetsHeldForSale', window );">Assets held for sale</a></td>
<td class="num">(358,969)<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MiningAssets', window );">Balance</a></td>
<td class="nump">775,754<span></span>
</td>
<td class="nump">900,719<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_ProjectDevelopmentCostsAbstract', window );"><strong>Project Development costs:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_ConstructionOfWellfields', window );">Construction of wellfields</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_AssetAcquistion', window );">Asset acquisition (Note 10)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GeographicalAreasAxis=stpr_AZ', window );">Arizona [Member] | Exploration Cost [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_ExplorationCostsAbstract', window );"><strong>Exploration costs:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_Drilling', window );">Drilling</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_MaintenancesAndLeaseFees', window );">Maintenance and lease fees</a></td>
<td class="nump">111,004<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_PermittingLicensing', window );">Permitting &amp; Licensing</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_Personnel', window );">Personnel</a></td>
<td class="nump">4,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_Recoveries', window );">Recoveries</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_ResourceReview', window );">Resource review</a></td>
<td class="nump">118,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GeographicalAreasAxis=stpr_CO', window );">Colorado [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_MineralPropertiesDetailsScheduleofmineralpropertiesLineItems', window );"><strong>Mineral Properties (Details) - Schedule of mineral properties [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MiningAssets', window );">Balance, December 31, 2020</a></td>
<td class="nump">619,902<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_ExplorationCostsAbstract', window );"><strong>Exploration costs:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_Drilling', window );">Drilling</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_MaintenancesAndLeaseFees', window );">Maintenance and lease fees</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_Personnel', window );">Personnel</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_ResourceReview', window );">Resource review</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_ImpairmentCharged', window );">Impairment charged</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_DivestmentAbstract', window );"><strong>Divestment:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_DivestMineralInterest', window );">Divest - Mineral interest</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_AssetsHeldForSale', window );">Assets held for sale</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MiningAssets', window );">Balance</a></td>
<td class="nump">578,243<span></span>
</td>
<td class="nump">619,902<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_ProjectDevelopmentCostsAbstract', window );"><strong>Project Development costs:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_ConstructionOfWellfields', window );">Construction of wellfields</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_AssetAcquistion', window );">Asset acquisition (Note 10)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">619,902<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GeographicalAreasAxis=stpr_CO', window );">Colorado [Member] | Exploration Cost [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_ExplorationCostsAbstract', window );"><strong>Exploration costs:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_Drilling', window );">Drilling</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_MaintenancesAndLeaseFees', window );">Maintenance and lease fees</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_PermittingLicensing', window );">Permitting &amp; Licensing</a></td>
<td class="num">(30,280)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_Personnel', window );">Personnel</a></td>
<td class="nump">8,621<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_Recoveries', window );">Recoveries</a></td>
<td class="num">(20,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_ResourceReview', window );">Resource review</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GeographicalAreasAxis=stpr_NM', window );">New Mexico [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_MineralPropertiesDetailsScheduleofmineralpropertiesLineItems', window );"><strong>Mineral Properties (Details) - Schedule of mineral properties [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MiningAssets', window );">Balance, December 31, 2020</a></td>
<td class="nump">4,395,822<span></span>
</td>
<td class="nump">5,477,162<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_ExplorationCostsAbstract', window );"><strong>Exploration costs:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_Drilling', window );">Drilling</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_MaintenancesAndLeaseFees', window );">Maintenance and lease fees</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">529,604<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_Personnel', window );">Personnel</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_ResourceReview', window );">Resource review</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">130,120<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_ImpairmentCharged', window );">Impairment charged</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_DivestmentAbstract', window );"><strong>Divestment:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_DivestMineralInterest', window );">Divest - Mineral interest</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_AssetsHeldForSale', window );">Assets held for sale</a></td>
<td class="text"> <span></span>
</td>
<td class="num">(1,741,064)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MiningAssets', window );">Balance</a></td>
<td class="nump">4,905,348<span></span>
</td>
<td class="nump">4,395,822<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_ProjectDevelopmentCostsAbstract', window );"><strong>Project Development costs:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_ConstructionOfWellfields', window );">Construction of wellfields</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_AssetAcquistion', window );">Asset acquisition (Note 10)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GeographicalAreasAxis=stpr_NM', window );">New Mexico [Member] | Exploration Cost [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_ExplorationCostsAbstract', window );"><strong>Exploration costs:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_Drilling', window );">Drilling</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_MaintenancesAndLeaseFees', window );">Maintenance and lease fees</a></td>
<td class="nump">472,401<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_PermittingLicensing', window );">Permitting &amp; Licensing</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_Personnel', window );">Personnel</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_Recoveries', window );">Recoveries</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_ResourceReview', window );">Resource review</a></td>
<td class="nump">37,125<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GeographicalAreasAxis=stpr_SD', window );">South Dakota [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_MineralPropertiesDetailsScheduleofmineralpropertiesLineItems', window );"><strong>Mineral Properties (Details) - Schedule of mineral properties [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MiningAssets', window );">Balance, December 31, 2020</a></td>
<td class="nump">85,667,919<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_ExplorationCostsAbstract', window );"><strong>Exploration costs:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_Drilling', window );">Drilling</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_MaintenancesAndLeaseFees', window );">Maintenance and lease fees</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_Personnel', window );">Personnel</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_ResourceReview', window );">Resource review</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_ImpairmentCharged', window );">Impairment charged</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_DivestmentAbstract', window );"><strong>Divestment:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_DivestMineralInterest', window );">Divest - Mineral interest</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_AssetsHeldForSale', window );">Assets held for sale</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MiningAssets', window );">Balance</a></td>
<td class="nump">86,220,848<span></span>
</td>
<td class="nump">85,667,919<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_ProjectDevelopmentCostsAbstract', window );"><strong>Project Development costs:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_ConstructionOfWellfields', window );">Construction of wellfields</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_AssetAcquistion', window );">Asset acquisition (Note 10)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">85,667,919<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GeographicalAreasAxis=stpr_SD', window );">South Dakota [Member] | Exploration Cost [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_ExplorationCostsAbstract', window );"><strong>Exploration costs:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_Drilling', window );">Drilling</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_MaintenancesAndLeaseFees', window );">Maintenance and lease fees</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_PermittingLicensing', window );">Permitting &amp; Licensing</a></td>
<td class="nump">251,863<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_Personnel', window );">Personnel</a></td>
<td class="nump">301,066<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_Recoveries', window );">Recoveries</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_ResourceReview', window );">Resource review</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GeographicalAreasAxis=stpr_TX', window );">Texas [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_MineralPropertiesDetailsScheduleofmineralpropertiesLineItems', window );"><strong>Mineral Properties (Details) - Schedule of mineral properties [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MiningAssets', window );">Balance, December 31, 2020</a></td>
<td class="nump">1,455,206<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_ExplorationCostsAbstract', window );"><strong>Exploration costs:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_Drilling', window );">Drilling</a></td>
<td class="nump">2,109,835<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_MaintenancesAndLeaseFees', window );">Maintenance and lease fees</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,455,206<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_Personnel', window );">Personnel</a></td>
<td class="nump">521,662<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_ResourceReview', window );">Resource review</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_ImpairmentCharged', window );">Impairment charged</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_DivestmentAbstract', window );"><strong>Divestment:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_DivestMineralInterest', window );">Divest - Mineral interest</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_AssetsHeldForSale', window );">Assets held for sale</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MiningAssets', window );">Balance</a></td>
<td class="nump">9,144,069<span></span>
</td>
<td class="nump">1,455,206<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_ProjectDevelopmentCostsAbstract', window );"><strong>Project Development costs:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_ConstructionOfWellfields', window );">Construction of wellfields</a></td>
<td class="nump">1,670,151<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_AssetAcquistion', window );">Asset acquisition (Note 10)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GeographicalAreasAxis=stpr_TX', window );">Texas [Member] | Exploration Cost [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_ExplorationCostsAbstract', window );"><strong>Exploration costs:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_Drilling', window );">Drilling</a></td>
<td class="nump">197,422<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_MaintenancesAndLeaseFees', window );">Maintenance and lease fees</a></td>
<td class="nump">2,523,123<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_PermittingLicensing', window );">Permitting &amp; Licensing</a></td>
<td class="nump">339,225<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_Personnel', window );">Personnel</a></td>
<td class="nump">280,341<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_Recoveries', window );">Recoveries</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_ResourceReview', window );">Resource review</a></td>
<td class="nump">47,104<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GeographicalAreasAxis=stpr_UT', window );">Utah [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_MineralPropertiesDetailsScheduleofmineralpropertiesLineItems', window );"><strong>Mineral Properties (Details) - Schedule of mineral properties [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MiningAssets', window );">Balance, December 31, 2020</a></td>
<td class="nump">1,804,283<span></span>
</td>
<td class="nump">300,460<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_ExplorationCostsAbstract', window );"><strong>Exploration costs:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_Drilling', window );">Drilling</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_MaintenancesAndLeaseFees', window );">Maintenance and lease fees</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">22,663<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_Personnel', window );">Personnel</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_ResourceReview', window );">Resource review</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_ImpairmentCharged', window );">Impairment charged</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_DivestmentAbstract', window );"><strong>Divestment:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_DivestMineralInterest', window );">Divest - Mineral interest</a></td>
<td class="num">(28,485)<span></span>
</td>
<td class="num">(195,514)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_AssetsHeldForSale', window );">Assets held for sale</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MiningAssets', window );">Balance</a></td>
<td class="nump">1,840,362<span></span>
</td>
<td class="nump">1,804,283<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_ProjectDevelopmentCostsAbstract', window );"><strong>Project Development costs:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_ConstructionOfWellfields', window );">Construction of wellfields</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_AssetAcquistion', window );">Asset acquisition (Note 10)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,676,674<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GeographicalAreasAxis=stpr_UT', window );">Utah [Member] | Exploration Cost [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_ExplorationCostsAbstract', window );"><strong>Exploration costs:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_Drilling', window );">Drilling</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_MaintenancesAndLeaseFees', window );">Maintenance and lease fees</a></td>
<td class="nump">39,566<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_PermittingLicensing', window );">Permitting &amp; Licensing</a></td>
<td class="nump">5,698<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_Personnel', window );">Personnel</a></td>
<td class="nump">19,620<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_Recoveries', window );">Recoveries</a></td>
<td class="num">(2,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_ResourceReview', window );">Resource review</a></td>
<td class="nump">1,680<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GeographicalAreasAxis=stpr_WY', window );">Wyoming [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_MineralPropertiesDetailsScheduleofmineralpropertiesLineItems', window );"><strong>Mineral Properties (Details) - Schedule of mineral properties [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MiningAssets', window );">Balance, December 31, 2020</a></td>
<td class="nump">41,235,727<span></span>
</td>
<td class="nump">59,050<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_ExplorationCostsAbstract', window );"><strong>Exploration costs:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_Drilling', window );">Drilling</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_MaintenancesAndLeaseFees', window );">Maintenance and lease fees</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11,870<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_Personnel', window );">Personnel</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_ResourceReview', window );">Resource review</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_ImpairmentCharged', window );">Impairment charged</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_DivestmentAbstract', window );"><strong>Divestment:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_DivestMineralInterest', window );">Divest - Mineral interest</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_AssetsHeldForSale', window );">Assets held for sale</a></td>
<td class="num">(369,913)<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MiningAssets', window );">Balance</a></td>
<td class="nump">41,754,462<span></span>
</td>
<td class="nump">41,235,727<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_ProjectDevelopmentCostsAbstract', window );"><strong>Project Development costs:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_ConstructionOfWellfields', window );">Construction of wellfields</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_AssetAcquistion', window );">Asset acquisition (Note 10)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">41,164,807<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GeographicalAreasAxis=stpr_WY', window );">Wyoming [Member] | Exploration Cost [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_ExplorationCostsAbstract', window );"><strong>Exploration costs:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_Drilling', window );">Drilling</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_MaintenancesAndLeaseFees', window );">Maintenance and lease fees</a></td>
<td class="nump">397,324<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_PermittingLicensing', window );">Permitting &amp; Licensing</a></td>
<td class="nump">273,726<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_Personnel', window );">Personnel</a></td>
<td class="nump">207,518<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_Recoveries', window );">Recoveries</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_ResourceReview', window );">Resource review</a></td>
<td class="nump">10,080<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GeographicalAreasAxis=country_CA', window );">Canada [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_MineralPropertiesDetailsScheduleofmineralpropertiesLineItems', window );"><strong>Mineral Properties (Details) - Schedule of mineral properties [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MiningAssets', window );">Balance, December 31, 2020</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_ExplorationCostsAbstract', window );"><strong>Exploration costs:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_MaintenancesAndLeaseFees', window );">Maintenance and lease fees</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">78,456<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_ImpairmentCharged', window );">Impairment charged</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(78,456)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_DivestmentAbstract', window );"><strong>Divestment:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MiningAssets', window );">Balance</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cve_AssetAcquistion">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cve_AssetAcquistion</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cve_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cve_AssetsHeldForSale">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cve_AssetsHeldForSale</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cve_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cve_ConstructionOfWellfields">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cve_ConstructionOfWellfields</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cve_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cve_DivestMineralInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cve_DivestMineralInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cve_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cve_DivestmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cve_DivestmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cve_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cve_Drilling">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cve_Drilling</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cve_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cve_ExplorationCostsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cve_ExplorationCostsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cve_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cve_ImpairmentCharged">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cve_ImpairmentCharged</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cve_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cve_MaintenancesAndLeaseFees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Maintenance and lease fees.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cve_MaintenancesAndLeaseFees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cve_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cve_MineralPropertiesDetailsScheduleofmineralpropertiesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cve_MineralPropertiesDetailsScheduleofmineralpropertiesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cve_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cve_PermittingLicensing">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cve_PermittingLicensing</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cve_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cve_Personnel">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cve_Personnel</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cve_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cve_ProjectDevelopmentCostsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cve_ProjectDevelopmentCostsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cve_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cve_Recoveries">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cve_Recoveries</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cve_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cve_ResourceReview">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cve_ResourceReview</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cve_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_MiningAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of assets related to mining activities of the entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 16<br> -IssueDate 2022-03-24<br> -Paragraph 37<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=16&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_37&amp;doctype=Standard<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_MiningAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfLiabilitiesAxis=cve_ExplorationCostMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfLiabilitiesAxis=cve_ExplorationCostMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_GeographicalAreasAxis=stpr_AZ">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_GeographicalAreasAxis=stpr_AZ</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_GeographicalAreasAxis=stpr_CO">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_GeographicalAreasAxis=stpr_CO</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_GeographicalAreasAxis=stpr_NM">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_GeographicalAreasAxis=stpr_NM</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_GeographicalAreasAxis=stpr_SD">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_GeographicalAreasAxis=stpr_SD</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_GeographicalAreasAxis=stpr_TX">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_GeographicalAreasAxis=stpr_TX</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_GeographicalAreasAxis=stpr_UT">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_GeographicalAreasAxis=stpr_UT</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_GeographicalAreasAxis=stpr_WY">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_GeographicalAreasAxis=stpr_WY</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_GeographicalAreasAxis=country_CA">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_GeographicalAreasAxis=country_CA</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>125
<FILENAME>R75.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139782929017568">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Asset retirement obligations (Details)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_AssetRetirementObligationsAbstract', window );"><strong>Asset Retirement Obligations Abstract</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_InflationFactorPercentage', window );">Inflation factor, percentage</a></td>
<td class="nump">2.50%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfDiscountRatesAppliedToCashFlowProjections', window );">Discount rate</a></td>
<td class="nump">11.00%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cve_AssetRetirementObligationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cve_AssetRetirementObligationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cve_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cve_InflationFactorPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Inflation factor, percentage.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cve_InflationFactorPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cve_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfDiscountRatesAppliedToCashFlowProjections">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The discount rate applied to cash flow projections for a cash-generating unit (group of units). [Refer: Cash-generating units [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 36<br> -IssueDate 2022-03-24<br> -Paragraph 134<br> -Subparagraph d<br> -Clause v<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=36&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_134_d_v&amp;doctype=Standard<br> -URIDate 2022-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 36<br> -IssueDate 2022-03-24<br> -Paragraph 134<br> -Subparagraph e<br> -Clause v<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=36&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_134_e_v&amp;doctype=Standard<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfDiscountRatesAppliedToCashFlowProjections</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>126
<FILENAME>R76.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139782810250624">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Asset retirement obligations (Details) - Schedule of asset retirement obligations balance - USD ($)<br></strong></div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_AssetretirementobligationsDetailsScheduleofassetretirementobligationsbalanceLineItems', window );"><strong>Schedule of asset retirement obligations balance [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FinancialAssets', window );">Asset retirement obligations</a></td>
<td class="nump">$ 4,752,352<span></span>
</td>
<td class="nump">$ 4,176,493<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfAssetsAxis=cve_KingsvilleMember', window );">Kingsville [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_AssetretirementobligationsDetailsScheduleofassetretirementobligationsbalanceLineItems', window );"><strong>Schedule of asset retirement obligations balance [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FinancialAssets', window );">Asset retirement obligations</a></td>
<td class="nump">3,151,875<span></span>
</td>
<td class="nump">2,671,295<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfAssetsAxis=cve_RositaMember', window );">Rosita [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_AssetretirementobligationsDetailsScheduleofassetretirementobligationsbalanceLineItems', window );"><strong>Schedule of asset retirement obligations balance [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FinancialAssets', window );">Asset retirement obligations</a></td>
<td class="nump">1,298,397<span></span>
</td>
<td class="nump">1,198,255<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfAssetsAxis=cve_VasquezMember', window );">Vasquez [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_AssetretirementobligationsDetailsScheduleofassetretirementobligationsbalanceLineItems', window );"><strong>Schedule of asset retirement obligations balance [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FinancialAssets', window );">Asset retirement obligations</a></td>
<td class="nump">34,274<span></span>
</td>
<td class="nump">39,137<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfAssetsAxis=cve_CentennialMember', window );">Centennial [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_AssetretirementobligationsDetailsScheduleofassetretirementobligationsbalanceLineItems', window );"><strong>Schedule of asset retirement obligations balance [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FinancialAssets', window );">Asset retirement obligations</a></td>
<td class="nump">168,806<span></span>
</td>
<td class="nump">168,806<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfAssetsAxis=cve_GasHillsMember', window );">Gas Hills [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_AssetretirementobligationsDetailsScheduleofassetretirementobligationsbalanceLineItems', window );"><strong>Schedule of asset retirement obligations balance [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FinancialAssets', window );">Asset retirement obligations</a></td>
<td class="nump">63,000<span></span>
</td>
<td class="nump">63,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfAssetsAxis=cve_TicabooMember', window );">Ticaboo [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_AssetretirementobligationsDetailsScheduleofassetretirementobligationsbalanceLineItems', window );"><strong>Schedule of asset retirement obligations balance [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FinancialAssets', window );">Asset retirement obligations</a></td>
<td class="nump">$ 36,000<span></span>
</td>
<td class="nump">$ 36,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cve_AssetretirementobligationsDetailsScheduleofassetretirementobligationsbalanceLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cve_AssetretirementobligationsDetailsScheduleofassetretirementobligationsbalanceLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cve_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_FinancialAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of assets that are: (a) cash; (b) an equity instrument of another entity; (c) a contractual right: (i) to receive cash or another financial asset from another entity; or (ii) to exchange financial assets or financial liabilities with another entity under conditions that are potentially favourable to the entity; or (d) a contract that will, or may be, settled in the entity&#8217;s own equity instruments and is: (i) a non-derivative for which the entity is, or may be, obliged to receive a variable number of the entity&#8217;s own equity instruments; or (ii) a derivative that will, or may be, settled other than by the exchange of a fixed amount of cash or another financial asset for a fixed number of the entity&#8217;s own equity instruments. For this purpose the entity&#8217;s own equity instruments do not include puttable financial instruments classified as equity instruments in accordance with paragraphs 16A-16B of IAS 32, instruments that impose on the entity an obligation to deliver to another party a pro rata share of the net assets of the entity only on liquidation and are classified as equity instruments in accordance with paragraphs 16C-16D of IAS 32, or instruments that are contracts for the future receipt or delivery of the entity&#8217;s own equity instruments. [Refer: Financial instruments, class [member]; Financial liabilities]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 7<br> -IssueDate 2022-03-24<br> -Paragraph 35H<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_35H&amp;doctype=Standard<br> -URIDate 2022-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 7<br> -IssueDate 2022-03-24<br> -Paragraph 35M<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_35M&amp;doctype=Standard<br> -URIDate 2022-03-24<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 7<br> -IssueDate 2022-03-24<br> -Paragraph 35N<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_35N&amp;doctype=Standard<br> -URIDate 2022-03-24<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 7<br> -IssueDate 2022-03-24<br> -Paragraph 35I<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_35I&amp;doctype=Standard<br> -URIDate 2022-03-24<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 7<br> -IssueDate 2022-03-24<br> -Paragraph 25<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_25&amp;doctype=Standard<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_FinancialAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfAssetsAxis=cve_KingsvilleMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfAssetsAxis=cve_KingsvilleMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfAssetsAxis=cve_RositaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfAssetsAxis=cve_RositaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfAssetsAxis=cve_VasquezMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfAssetsAxis=cve_VasquezMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfAssetsAxis=cve_CentennialMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfAssetsAxis=cve_CentennialMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfAssetsAxis=cve_GasHillsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfAssetsAxis=cve_GasHillsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfAssetsAxis=cve_TicabooMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfAssetsAxis=cve_TicabooMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>127
<FILENAME>R77.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139782923842432">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Asset retirement obligations (Details) - Schedule of asset retirement obligations continuity - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_AssetretirementobligationsDetailsScheduleofassetretirementobligationscontinuityLineItems', window );"><strong>Schedule of asset retirement obligations continuity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_AssetRetirementObligationsBalance', window );">Balance, beginning</a></td>
<td class="nump">$ 4,176,493<span></span>
</td>
<td class="nump">$ 5,239,108<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_AssetRetirementObligationsAccretion', window );">Accretion</a></td>
<td class="nump">429,956<span></span>
</td>
<td class="nump">400,710<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_AssetRetirementObligationsAdjustments', window );">Adjustments</a></td>
<td class="nump">157,227<span></span>
</td>
<td class="num">(1,719,943)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_AssetRetirementObligationsSettlement', window );">Settlement</a></td>
<td class="num">(11,324)<span></span>
</td>
<td class="num">(11,189)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_AssetRetirementObligationsAdditionsFromAzargaAssetAcquisitionNote10', window );">Additions from Azarga asset acquisition (Note 10)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">267,807<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_AssetRetirementObligationsBalance', window );">Balance, ending</a></td>
<td class="nump">$ 4,752,352<span></span>
</td>
<td class="nump">$ 4,176,493<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cve_AssetRetirementObligationsAccretion">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Asset Retirement Obligations Accretion.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cve_AssetRetirementObligationsAccretion</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cve_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cve_AssetRetirementObligationsAdditionsFromAzargaAssetAcquisitionNote10">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Asset Retirement Obligations Additions From Azarga Asset Acquisition Note 10.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cve_AssetRetirementObligationsAdditionsFromAzargaAssetAcquisitionNote10</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cve_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cve_AssetRetirementObligationsAdjustments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Asset Retirement Obligations Adjustments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cve_AssetRetirementObligationsAdjustments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cve_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cve_AssetRetirementObligationsBalance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Asset Retirement Obligations Balance.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cve_AssetRetirementObligationsBalance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cve_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cve_AssetRetirementObligationsSettlement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Asset Retirement Obligations Settlement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cve_AssetRetirementObligationsSettlement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cve_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cve_AssetretirementobligationsDetailsScheduleofassetretirementobligationscontinuityLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cve_AssetretirementobligationsDetailsScheduleofassetretirementobligationscontinuityLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cve_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>128
<FILENAME>R78.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139782921833536">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Sales contracts (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="5">1 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Jul. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_DisclosueOfSalesContractsAbstract', window );"><strong>Disclosue Of Sales Contracts Abstract</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_TotalDiscountedMarketPrices', window );">Total discounted market prices</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_CancellationFee', window );">Cancellation fee</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,750,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_PursuantToAgreement', window );">Pursuant to agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 600,000<span></span>
</td>
<td class="nump">$ 1,300,000<span></span>
</td>
<td class="nump">$ 2,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_ContractPoundsOfUranium', window );">Contract pounds of uranium</a></td>
<td class="nump">$ 100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_PricePerPound', window );">Price per pound (in Dollars per share)</a></td>
<td class="nump">$ 70.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_SalesContractsTrem', window );">Sales contracts term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cve_CancellationFee">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cancellation fee.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cve_CancellationFee</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cve_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cve_ContractPoundsOfUranium">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Contract pounds of uranium.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cve_ContractPoundsOfUranium</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cve_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cve_DisclosueOfSalesContractsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cve_DisclosueOfSalesContractsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cve_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cve_PricePerPound">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Price per pound.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cve_PricePerPound</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cve_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cve_PursuantToAgreement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Pursuant to agreement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cve_PursuantToAgreement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cve_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cve_SalesContractsTrem">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sales contracts trem.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cve_SalesContractsTrem</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cve_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cve_TotalDiscountedMarketPrices">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total discounted market prices.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cve_TotalDiscountedMarketPrices</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cve_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>129
<FILENAME>R79.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139782810161968">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Sales contracts (Details) - Schedule of uranium sales contracts over the next five years<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($)</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_SalescontractsDetailsScheduleofuraniumsalescontractsoverthenextfiveyearsLineItems', window );"><strong>Schedule of uranium sales contracts over the next five years [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_SalesContractsFiscalTwoZeroTwoThree', window );">Fiscal 2023</a></td>
<td class="nump">$ 500,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_SalesContractsFiscalTwoZeroTwoFour', window );">Fiscal 2024</a></td>
<td class="nump">600,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_SalesContractsFiscalTwoZeroTwoFive', window );">Fiscal 2025</a></td>
<td class="nump">700,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_SalesContractsFiscalTwoZeroTwoSix', window );">Fiscal 2026</a></td>
<td class="nump">700,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_SalesContractsFiscalTwoZeroTwoSeven', window );">Fiscal 2027</a></td>
<td class="nump">$ 650,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cve_SalesContractsFiscalTwoZeroTwoFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sales contracts fiscal two zero two five.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cve_SalesContractsFiscalTwoZeroTwoFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cve_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cve_SalesContractsFiscalTwoZeroTwoFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sales contracts fiscal two zero two four.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cve_SalesContractsFiscalTwoZeroTwoFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cve_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cve_SalesContractsFiscalTwoZeroTwoSeven">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sales contracts fiscal two zero two seven.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cve_SalesContractsFiscalTwoZeroTwoSeven</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cve_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cve_SalesContractsFiscalTwoZeroTwoSix">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sales contracts fiscal two zero two six.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cve_SalesContractsFiscalTwoZeroTwoSix</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cve_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cve_SalesContractsFiscalTwoZeroTwoThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sales contracts fiscal two zero two three.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cve_SalesContractsFiscalTwoZeroTwoThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cve_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cve_SalescontractsDetailsScheduleofuraniumsalescontractsoverthenextfiveyearsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cve_SalescontractsDetailsScheduleofuraniumsalescontractsoverthenextfiveyearsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cve_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>130
<FILENAME>R80.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139782922672464">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share Capital (Details)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="4">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Feb. 08, 2023 </div>
<div>CAD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>CAD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>CAD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_ShareCapitalDetailsLineItems', window );"><strong>Share Capital (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_SharesUnit', window );">Shares unit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,535,947<span></span>
</td>
<td class="nump">6,535,947<span></span>
</td>
<td class="nump">5,000,000<span></span>
</td>
<td class="nump">5,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsInSharebasedPaymentArrangementExercisedDuringPeriodAtDateOfExercise2019', window );">Offering price per unit (in Dollars per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4.59<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_GrossProceed', window );">Gross proceeds</a></td>
<td class="nump">$ 34,500,863<span></span>
</td>
<td class="nump">$ 23,057,411<span></span>
</td>
<td class="nump">$ 30,000,000<span></span>
</td>
<td class="nump">$ 11,966,494<span></span>
</td>
<td class="nump">$ 15,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_CommonShare', window );">Common share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_PurchaseWarrantShares', window );">Purchase warrant shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.5<span></span>
</td>
<td class="nump">0.5<span></span>
</td>
<td class="nump">0.5<span></span>
</td>
<td class="nump">0.5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_PurchaseAdditionalShareWarrants', window );">Purchase additional share warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_PurchaseAdditionalSharePricePerWarrant', window );">Purchase additional share price per warrant (in Dollars per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3.9<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ReceiptsFromRoyaltiesFeesCommissionsAndOtherRevenue', window );">Paid commissions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 1,612,500<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 758,001<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_CashIssuanceCosts', window );">Other cash issuance costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (234,539)<span></span>
</td>
<td class="nump">$ 305,159<span></span>
</td>
<td class="num">$ (158,194)<span></span>
</td>
<td class="nump">$ 198,298<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_ShareIssued', window );">Shares issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">351,307<span></span>
</td>
<td class="nump">351,307<span></span>
</td>
<td class="nump">252,667<span></span>
</td>
<td class="nump">252,667<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_WarrantsOfFairValue', window );">Warrants of fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (672,343)<span></span>
</td>
<td class="nump">$ 874,785<span></span>
</td>
<td class="num">$ (428,140)<span></span>
</td>
<td class="nump">$ 536,673<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_WarrantsExercisableOfCommonShare', window );">Warrants exercisable of common share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_WarrantsExercisablePricePerShare', window );">Warrants exercisable price per share (in Dollars per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4.59<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_CommonShareIssued', window );">Common shares issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">31,806,617<span></span>
</td>
<td class="nump">31,806,617<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_CommonSharesOfSettlementAndCompensation', window );">Common shares of settlement and compensation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">193,348<span></span>
</td>
<td class="nump">193,348<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_NumberOfSharesReservedInsurancePercentage', window );">Number of shares reserved insurance percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10.00%<span></span>
</td>
<td class="nump">10.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_OptionsGrantedForMaximumYear', window );">Options granted for maximum year</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_AggregateOfGrantedShares', window );">Aggregate of granted shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,107,501<span></span>
</td>
<td class="nump">3,107,501<span></span>
</td>
<td class="nump">2,390,627<span></span>
</td>
<td class="nump">2,390,627<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_FairValueOfGrantedOption', window );">Fair value of granted option (in Dollars) | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7,665,042<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,484,302<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_StockOptionsRevisedTerm', window );">Stock options revised term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">12 months<span></span>
</td>
<td class="text">12 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_StandardStockOptionVestingPercentage', window );">Standard stock option vesting percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">25.00%<span></span>
</td>
<td class="nump">25.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_RecognizedStockOptionExpense', window );">Recognized stock option expense (in Dollars) | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,744,655<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,425,645<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_WarrantsExercisableShare', window );">Warrants exercisable share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_WarrantShare', window );">Warrant share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.5<span></span>
</td>
<td class="nump">0.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_WarrantsExercisablePrice', window );">Warrants exercisable (in Dollars per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_WarrantIsExercisableTerm', window );">Warrant is exercisable term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">36 months<span></span>
</td>
<td class="text">36 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DividendsReceived', window );">Company has received amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 50,051,595<span></span>
</td>
<td class="nump">$ 69,831,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ComponentsOfEquityAxis=cve_WarrantsMember', window );">Warrants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_ShareCapitalDetailsLineItems', window );"><strong>Share Capital (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_GrossProceed', window );">Gross proceeds | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,452,227<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,633,029<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_CommonShareIssued', window );">Common shares issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,291,642<span></span>
</td>
<td class="nump">2,291,642<span></span>
</td>
<td class="nump">2,052,843<span></span>
</td>
<td class="nump">2,052,843<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_EquityReclassifiedIntoFinancialLiabilities', window );">Warrants exercise reclassified amount (in Dollars) | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 147,772<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 166,751<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ComponentsOfEquityAxis=cve_StockOptionsMember', window );">Stock Options [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_ShareCapitalDetailsLineItems', window );"><strong>Share Capital (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_GrossProceed', window );">Gross proceeds | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,177,093<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 288,572<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_CommonShareIssued', window );">Common shares issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,016,436<span></span>
</td>
<td class="nump">1,016,436<span></span>
</td>
<td class="nump">590,000<span></span>
</td>
<td class="nump">590,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FinancialLiabilitiesReclassifiedIntoEquity', window );">Stock options exercise reclassified amount (in Dollars) | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,728,487<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 269,039<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cve_AggregateOfGrantedShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate of granted shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cve_AggregateOfGrantedShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cve_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cve_CashIssuanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Flotation costs are incurred by a publicly-traded company when it issues new securities and the cost makes the company's new equity more expensive.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cve_CashIssuanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cve_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cve_CommonShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A common shareholder is an individual, business, or institution that holds common shares in a company, giving the holder an ownership stake in the company. This will also give the holder the right to vote on corporate issues such as board elections and corporate policy, along with the right to any common dividend payments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cve_CommonShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cve_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cve_CommonShareIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Issued shares are the subset of authorized shares that have been sold to and held by the shareholders of a company, regardless of whether they are insiders, institutional investors, or the general public (as shown in the company&#8217;s annual report). Issued shares include the stock a company sells publicly to generate capital and the stock given to insiders as part of their compensation packages.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cve_CommonShareIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cve_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cve_CommonSharesOfSettlementAndCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Common shares of settlement and compensation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cve_CommonSharesOfSettlementAndCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cve_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cve_FairValueOfGrantedOption">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of granted option.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cve_FairValueOfGrantedOption</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cve_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cve_GrossProceed">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Net proceeds are the amount the seller receives following the sale of an asset after all costs and expenses are deducted from the gross proceeds.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cve_GrossProceed</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cve_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cve_NumberOfSharesReservedInsurancePercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares reserved insurance percentage.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cve_NumberOfSharesReservedInsurancePercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cve_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cve_OptionsGrantedForMaximumYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Options granted for maximum year.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cve_OptionsGrantedForMaximumYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cve_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cve_PurchaseAdditionalSharePricePerWarrant">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Purchase additional share price per warrant.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cve_PurchaseAdditionalSharePricePerWarrant</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cve_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cve_PurchaseAdditionalShareWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A stock warrant gives the holder the right to purchase a company's stock at a specific price and at a specific date. A stock warrant is issued directly by the company concerned; when an investor exercises a stock warrant, the shares that fulfill the obligation are not received from another investor but directly from the company.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cve_PurchaseAdditionalShareWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cve_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cve_PurchaseWarrantShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>hen an investor exercises a warrant, they purchase stock, and the proceeds are a source of capital for the company. A warrant certificate is issued to the investor when they exercise a warrant. The certificate includes the terms of the warrant, such as the expiry date and the final day it can be exercised.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cve_PurchaseWarrantShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cve_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cve_RecognizedStockOptionExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Recognized stock option expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cve_RecognizedStockOptionExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cve_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cve_ShareCapitalDetailsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cve_ShareCapitalDetailsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cve_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cve_ShareIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Shares issued.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cve_ShareIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cve_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cve_SharesUnit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Shares are units of equity ownership in a corporation. For some companies, shares exist as a financial asset providing for an equal distribution of any residual profits, if any are declared, in the form of dividends. Shareholders of a stock that pays no dividends do not participate in a distribution of profits. Instead, they anticipate participating in the growth of the stock price as company profits increase.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cve_SharesUnit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cve_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cve_StandardStockOptionVestingPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Standard stock option vesting percentage.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cve_StandardStockOptionVestingPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cve_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cve_StockOptionsRevisedTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Stock options revised term</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cve_StockOptionsRevisedTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cve_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cve_WarrantIsExercisableTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Warrant is exercisable term.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cve_WarrantIsExercisableTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cve_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cve_WarrantShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>When an investor exercises a warrant, they purchase stock, and the proceeds are a source of capital for the company. A warrant certificate is issued to the investor when they exercise a warrant. The certificate includes the terms of the warrant, such as the expiry date and the final day it can be exercised.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cve_WarrantShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cve_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cve_WarrantsExercisableOfCommonShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Warrants exercisable of common share.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cve_WarrantsExercisableOfCommonShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cve_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cve_WarrantsExercisablePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Warrants exercisable price per share.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cve_WarrantsExercisablePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cve_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cve_WarrantsExercisablePricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Warrants exercisable price per share.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cve_WarrantsExercisablePricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cve_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cve_WarrantsExercisableShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>When an investor exercises a warrant, they purchase stock, and the proceeds are a source of capital for the company. A warrant certificate is issued to the investor when they exercise a warrant. The certificate includes the terms of the warrant, such as the expiry date and the final day it can be exercised.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cve_WarrantsExercisableShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cve_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cve_WarrantsOfFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A warrant premium represents the cost of purchasing a share through exercising a warrant, compared to buying the share directly through the open market.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cve_WarrantsOfFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cve_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DividendsReceived">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of dividends received.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2022-03-24<br> -Paragraph B12<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_B12_a&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DividendsReceived</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_EquityReclassifiedIntoFinancialLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of equity reclassified into financial liabilities. [Refer: Equity; Financial liabilities]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2022-03-24<br> -Paragraph 80A<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_80A&amp;doctype=Standard<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_EquityReclassifiedIntoFinancialLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_FinancialLiabilitiesReclassifiedIntoEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of financial liabilities reclassified into equity. [Refer: Equity; Financial liabilities]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2022-03-24<br> -Paragraph 80A<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_80A&amp;doctype=Standard<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_FinancialLiabilitiesReclassifiedIntoEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ReceiptsFromRoyaltiesFeesCommissionsAndOtherRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from royalties, fees, commissions and other revenue. [Refer: Other revenue]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2022-03-24<br> -Paragraph 14<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_14_b&amp;doctype=Standard<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ReceiptsFromRoyaltiesFeesCommissionsAndOtherRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsInSharebasedPaymentArrangementExercisedDuringPeriodAtDateOfExercise2019">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average share price at the date of exercise for share options that are exercised in a share-based payment arrangement. [Refer: Share-based payment arrangements [member]; Weighted average [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2022-03-24<br> -Paragraph 45<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_45_c&amp;doctype=Standard<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_WeightedAverageExercisePriceOfShareOptionsInSharebasedPaymentArrangementExercisedDuringPeriodAtDateOfExercise2019</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ComponentsOfEquityAxis=cve_WarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ComponentsOfEquityAxis=cve_WarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ComponentsOfEquityAxis=cve_StockOptionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ComponentsOfEquityAxis=cve_StockOptionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>131
<FILENAME>R81.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139782807383712">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share Capital (Details) - Schedule of the company&#8217;s stock options outstanding - $ / shares<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_ScheduleOfTheCompanySStockOptionsOutstandingAbstract', window );"><strong>Schedule Of The Company SStock Options Outstanding Abstract</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_SharesBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber', window );">Options, Options outstanding, beginning of year</a></td>
<td class="nump">5,272,294<span></span>
</td>
<td class="nump">3,572,084<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019', window );">Weighted average exercise price, Options outstanding, beginning of year</a></td>
<td class="nump">$ 1.42<span></span>
</td>
<td class="nump">$ 0.66<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_SharesBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Options, Granted</a></td>
<td class="nump">3,107,501<span></span>
</td>
<td class="nump">2,390,627<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019', window );">Weighted average exercise price, Granted</a></td>
<td class="nump">$ 4.1<span></span>
</td>
<td class="nump">$ 2.31<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_StockIssuedDuringPeriodShareStockOptionsExercised', window );">Options, Exercised</a></td>
<td class="num">(1,016,439)<span></span>
</td>
<td class="num">(590,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019', window );">Weighted average exercise price, Exercised</a></td>
<td class="nump">$ 1.51<span></span>
</td>
<td class="nump">$ 0.6<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_StockIssuedDuringPeriodShareSharesBasedCompensationForfeited', window );">Options, Forfeited/expired</a></td>
<td class="num">(127,708)<span></span>
</td>
<td class="num">(100,417)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019', window );">Weighted average exercise price, Forfeited/expired</a></td>
<td class="nump">$ 3.6<span></span>
</td>
<td class="nump">$ 0.54<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_SharesBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber', window );">Options, Options outstanding, end of year</a></td>
<td class="nump">7,235,648<span></span>
</td>
<td class="nump">5,272,294<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019', window );">Weighted average exercise price, Options outstanding, end of year</a></td>
<td class="nump">$ 2.53<span></span>
</td>
<td class="nump">$ 1.42<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_SharesBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions', window );">Options, Options exercisable, end of year</a></td>
<td class="nump">4,928,147<span></span>
</td>
<td class="nump">4,515,210<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019', window );">Weighted average exercise price, Options exercisable, end of year</a></td>
<td class="nump">$ 1.79<span></span>
</td>
<td class="nump">$ 1.23<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cve_ScheduleOfTheCompanySStockOptionsOutstandingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cve_ScheduleOfTheCompanySStockOptionsOutstandingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cve_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cve_SharesBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cve_SharesBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cve_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cve_SharesBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Gross number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cve_SharesBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cve_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cve_SharesBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares reserved for issuance pertaining to the outstanding exercisable stock options as of the balance sheet date in the customized range of exercise prices for which the market and performance vesting condition has been satisfied.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cve_SharesBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cve_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cve_StockIssuedDuringPeriodShareSharesBasedCompensationForfeited">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares (or other type of equity) forfeited during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cve_StockIssuedDuringPeriodShareSharesBasedCompensationForfeited</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cve_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cve_StockIssuedDuringPeriodShareStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cve_StockIssuedDuringPeriodShareStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cve_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average exercise price of share options exercisable in a share-based payment arrangement. [Refer: Weighted average [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2022-03-24<br> -Paragraph 45<br> -Subparagraph b<br> -Clause vii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_45_b_vii&amp;doctype=Standard<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average exercise price of share options exercised in a share-based payment arrangement. [Refer: Weighted average [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2022-03-24<br> -Paragraph 45<br> -Subparagraph b<br> -Clause iv<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_45_b_iv&amp;doctype=Standard<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average exercise price of share options forfeited in a share-based payment arrangement. [Refer: Weighted average [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2022-03-24<br> -Paragraph 45<br> -Subparagraph b<br> -Clause iii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_45_b_iii&amp;doctype=Standard<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average exercise price of share options granted in a share-based payment arrangement. [Refer: Weighted average [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2022-03-24<br> -Paragraph 45<br> -Subparagraph b<br> -Clause ii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_45_b_ii&amp;doctype=Standard<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average exercise price of share options outstanding in a share-based payment arrangement. [Refer: Weighted average [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2022-03-24<br> -Paragraph 45<br> -Subparagraph b<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_45_b_i&amp;doctype=Standard<br> -URIDate 2022-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2022-03-24<br> -Paragraph 45<br> -Subparagraph b<br> -Clause vi<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_45_b_vi&amp;doctype=Standard<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>132
<FILENAME>R82.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139782922341280">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share Capital (Details) - Schedule of stock options outstanding<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Dec. 31, 2022 </div>
<div>$ / shares </div>
<div>shares</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_ShareCapitalDetailsScheduleofstockoptionsoutstandingLineItems', window );"><strong>Share Capital (Details) - Schedule of stock options outstanding [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_SharesBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Options | shares</a></td>
<td class="nump">7,235,647<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_WeightedAverageDurationOfDefinedBenefitObligation2019', window );">Options Outstanding, Weighted average Reimaining Life</a></td>
<td class="text">2 years 11 months 26 days<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ExercisePriceOfOutstandingShareOptions2019', window );">Options Outstanding, Weighted average exercise price | $ / shares</a></td>
<td class="nump">$ 2.52<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_SharesBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber', window );">Options Exercisable, Options | shares</a></td>
<td class="nump">4,928,147<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ExercisePriceShareOptionsGranted2019', window );">Options Exercisable, Weighted average exercise price | $ / shares</a></td>
<td class="nump">$ 1.78<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis=cve_ZeroOneEightOneNineTwoMember', window );">0.18 - 1.92 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_ShareCapitalDetailsScheduleofstockoptionsoutstandingLineItems', window );"><strong>Share Capital (Details) - Schedule of stock options outstanding [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_SharesBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Options | shares</a></td>
<td class="nump">3,381,771<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_WeightedAverageDurationOfDefinedBenefitObligation2019', window );">Options Outstanding, Weighted average Reimaining Life</a></td>
<td class="text">10 months 17 days<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ExercisePriceOfOutstandingShareOptions2019', window );">Options Outstanding, Weighted average exercise price | $ / shares</a></td>
<td class="nump">$ 0.85<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_SharesBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber', window );">Options Exercisable, Options | shares</a></td>
<td class="nump">3,381,771<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ExercisePriceShareOptionsGranted2019', window );">Options Exercisable, Weighted average exercise price | $ / shares</a></td>
<td class="nump">$ 0.85<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis=cve_TwoFourZeroThreeSevenEightMember', window );">2.40 - 3.78 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_ShareCapitalDetailsScheduleofstockoptionsoutstandingLineItems', window );"><strong>Share Capital (Details) - Schedule of stock options outstanding [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_SharesBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Options | shares</a></td>
<td class="nump">1,034,710<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_WeightedAverageDurationOfDefinedBenefitObligation2019', window );">Options Outstanding, Weighted average Reimaining Life</a></td>
<td class="text">6 months 25 days<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ExercisePriceOfOutstandingShareOptions2019', window );">Options Outstanding, Weighted average exercise price | $ / shares</a></td>
<td class="nump">$ 3.12<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_SharesBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber', window );">Options Exercisable, Options | shares</a></td>
<td class="nump">594,710<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ExercisePriceShareOptionsGranted2019', window );">Options Exercisable, Weighted average exercise price | $ / shares</a></td>
<td class="nump">$ 2.83<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis=cve_FourTwoZeroFiveSevenSixMember', window );">4.20 - 5.76 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_ShareCapitalDetailsScheduleofstockoptionsoutstandingLineItems', window );"><strong>Share Capital (Details) - Schedule of stock options outstanding [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_SharesBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Options | shares</a></td>
<td class="nump">2,819,166<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_WeightedAverageDurationOfDefinedBenefitObligation2019', window );">Options Outstanding, Weighted average Reimaining Life</a></td>
<td class="text">1 year 6 months 10 days<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ExercisePriceOfOutstandingShareOptions2019', window );">Options Outstanding, Weighted average exercise price | $ / shares</a></td>
<td class="nump">$ 4.29<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_SharesBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber', window );">Options Exercisable, Options | shares</a></td>
<td class="nump">951,666<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ExercisePriceShareOptionsGranted2019', window );">Options Exercisable, Weighted average exercise price | $ / shares</a></td>
<td class="nump">$ 4.42<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cve_ShareCapitalDetailsScheduleofstockoptionsoutstandingLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cve_ShareCapitalDetailsScheduleofstockoptionsoutstandingLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cve_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cve_SharesBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cve_SharesBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cve_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cve_SharesBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of fully vested and expected to vest exercisable options that may be converted into shares under option plan. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cve_SharesBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cve_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ExercisePriceOfOutstandingShareOptions2019">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exercise price of outstanding share options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2022-03-24<br> -Paragraph 45<br> -Subparagraph d<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_45_d&amp;doctype=Standard<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ExercisePriceOfOutstandingShareOptions2019</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ExercisePriceShareOptionsGranted2019">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exercise price of share options granted.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2022-03-24<br> -Paragraph 47<br> -Subparagraph a<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_47_a_i&amp;doctype=Standard<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ExercisePriceShareOptionsGranted2019</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_WeightedAverageDurationOfDefinedBenefitObligation2019">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average duration of a defined benefit obligation. [Refer: Weighted average [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 19<br> -IssueDate 2022-03-24<br> -Paragraph 147<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=19&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_147_c&amp;doctype=Standard<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_WeightedAverageDurationOfDefinedBenefitObligation2019</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis=cve_ZeroOneEightOneNineTwoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis=cve_ZeroOneEightOneNineTwoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis=cve_TwoFourZeroThreeSevenEightMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis=cve_TwoFourZeroThreeSevenEightMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis=cve_FourTwoZeroFiveSevenSixMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis=cve_FourTwoZeroFiveSevenSixMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>133
<FILENAME>R83.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139782921274256">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share Capital (Details) - Schedule of weighted average assumptions used in calculating the fair values<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_ScheduleOfWeightedAverageAssumptionsUsedInCalculatingTheFairValuesAbstract', window );"><strong>Schedule Of Weighted Average Assumptions Used In Calculating The Fair Values Abstract</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfRiskFreeInterestRateShareOptionsGranted', window );">Risk-free interest rate</a></td>
<td class="nump">2.06%<span></span>
</td>
<td class="nump">0.88%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019', window );">Expected life of option</a></td>
<td class="text">4 years 10 months 24 days<span></span>
</td>
<td class="text">5 years<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ExpectedDividendAsPercentageShareOptionsGranted', window );">Expected dividend yield</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfExpectedVolatilityShareOptionsGranted', window );">Expected stock price volatility</a></td>
<td class="nump">116.48%<span></span>
</td>
<td class="nump">128.79%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cve_ScheduleOfWeightedAverageAssumptionsUsedInCalculatingTheFairValuesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cve_ScheduleOfWeightedAverageAssumptionsUsedInCalculatingTheFairValuesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cve_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfExpectedVolatilityShareOptionsGranted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The expected volatility of the share price used to calculate the fair value of the share options granted. Expected volatility is a measure of the amount by which a price is expected to fluctuate during a period. The measure of volatility used in option pricing models is the annualised standard deviation of the continuously compounded rates of return on the share over a period of time.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2022-03-24<br> -Paragraph 47<br> -Subparagraph a<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_47_a_i&amp;doctype=Standard<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfExpectedVolatilityShareOptionsGranted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfRiskFreeInterestRateShareOptionsGranted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The implied yield currently available on zero-coupon government issues of the country in whose currency the exercise price for share options granted is expressed, with a remaining term equal to the expected term of the option being valued (based on the option's remaining contractual life and taking into account the effects of expected early exercise). [Refer: Government [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2022-03-24<br> -Paragraph 47<br> -Subparagraph a<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_47_a_i&amp;doctype=Standard<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfRiskFreeInterestRateShareOptionsGranted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ExpectedDividendAsPercentageShareOptionsGranted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The percentage of an expected dividend used to calculate the fair value of share options granted.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2022-03-24<br> -Paragraph 47<br> -Subparagraph a<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_47_a_i&amp;doctype=Standard<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ExpectedDividendAsPercentageShareOptionsGranted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average remaining contractual life of outstanding share options. [Refer: Weighted average [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2022-03-24<br> -Paragraph 45<br> -Subparagraph d<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_45_d&amp;doctype=Standard<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>134
<FILENAME>R84.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139782927172944">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share Capital (Details) - Schedule of the status of the company&#8217;s warrants - $ / shares<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_ScheduleOfTheStatusOfTheCompanySWarrantsAbstract', window );"><strong>Schedule Of The Status Of The Company SWarrants Abstract</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptionsWarrantsOutstanding', window );">Warrants, Warrants outstanding, beginning of year</a></td>
<td class="nump">6,298,839<span></span>
</td>
<td class="nump">4,143,247<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_SharesBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingPeriodIncreaseDecreaseWeightedAverageExercisePrice', window );">Weighted average exercise price, Warrants outstanding, beginning of year</a></td>
<td class="nump">$ 2.43<span></span>
</td>
<td class="nump">$ 1.23<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptionsWarrantsOutstanding', window );">Warrants, Warrants outstanding, end of year</a></td>
<td class="nump">7,494,506<span></span>
</td>
<td class="nump">6,298,839<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_SharesBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingPeriodIncreaseDecreaseWeightedAverageExercisePrice', window );">Weighted average exercise price, Warrants outstanding, end of year</a></td>
<td class="nump">$ 4.43<span></span>
</td>
<td class="nump">$ 2.43<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_ShareBasedCompensationArrangementBySharesBasedPaymentAwardOptionsGrantsInPeriodWarrantsGranted', window );">Warrants, Granted</a></td>
<td class="nump">3,670,919<span></span>
</td>
<td class="nump">4,208,435<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_SharesbasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue', window );">Weighted average exercise price, Granted</a></td>
<td class="nump">$ 5.81<span></span>
</td>
<td class="nump">$ 3.24<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisedWarrantsExercised', window );">Warrants, Exercised</a></td>
<td class="num">(2,291,642)<span></span>
</td>
<td class="num">(2,052,843)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_SharesBasedCompensationArrangementBySharesBasedPaymentAwardOptionsOutstandingPeriodIncreaseDecreaseWeightedAverageExercisePrice', window );">Weighted average exercise price, Exercised</a></td>
<td class="nump">$ 1.39<span></span>
</td>
<td class="nump">$ 1.62<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWarrantsExpired', window );">Warrants, Expired</a></td>
<td class="num">(183,610)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_ShareBasedCompensationArrangementsBySharesBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice', window );">Weighted average exercise price, Expired</a></td>
<td class="nump">$ 1.67<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cve_ScheduleOfTheStatusOfTheCompanySWarrantsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cve_ScheduleOfTheStatusOfTheCompanySWarrantsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cve_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cve_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisedWarrantsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of non-option equity instruments exercised by participants.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cve_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisedWarrantsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cve_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cve_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWarrantsExpired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For presentations that combine terminations, the number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan or that expired.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cve_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWarrantsExpired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cve_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cve_ShareBasedCompensationArrangementBySharesBasedPaymentAwardOptionsGrantsInPeriodWarrantsGranted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Net number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cve_ShareBasedCompensationArrangementBySharesBasedPaymentAwardOptionsGrantsInPeriodWarrantsGranted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cve_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cve_ShareBasedCompensationArrangementsBySharesBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees could have acquired the underlying shares with respect to stock options of the plan that expired.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cve_ShareBasedCompensationArrangementsBySharesBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cve_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cve_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptionsWarrantsOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares reserved for issuance pertaining to the outstanding stock options as of the balance sheet date for all option plans in the customized range of exercise prices.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cve_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptionsWarrantsOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cve_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cve_SharesBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingPeriodIncreaseDecreaseWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Change in the weighted average exercise price of options outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cve_SharesBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingPeriodIncreaseDecreaseWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cve_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cve_SharesBasedCompensationArrangementBySharesBasedPaymentAwardOptionsOutstandingPeriodIncreaseDecreaseWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Change in the weighted average exercise price of options outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cve_SharesBasedCompensationArrangementBySharesBasedPaymentAwardOptionsOutstandingPeriodIncreaseDecreaseWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cve_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cve_SharesbasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the weighted-average grant-date fair value of equity options or other equity instruments granted during the year.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cve_SharesbasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cve_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>135
<FILENAME>R85.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139782810246576">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share Capital (Details) - Schedule of share purchase warrants outstanding<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr><th class="th" colspan="2">
<div>Dec. 31, 2022 </div>
<div>$ / shares </div>
<div>shares</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_ShareCapitalDetailsScheduleofsharepurchasewarrantsoutstandingLineItems', window );"><strong>Share Capital (Details) - Schedule of share purchase warrants outstanding [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_Warrants', window );">Warrants | shares</a></td>
<td class="nump">7,494,506<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_WarrantsOutstandingWeightedAverageReimainingLife', window );">Warrants Outstanding, Weighted average Reimaining Life</a></td>
<td class="text">1 year 1 month 13 days<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_WarrantsOutstandingWeightedAverageExercisePrice', window );">Warrants Outstanding, Weighted average exercise price | $ / shares</a></td>
<td class="nump">$ 4.43<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis=cve_OneFiveNineOneEightZeroMember', window );">$1.59 - 1.80 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_ShareCapitalDetailsScheduleofsharepurchasewarrantsoutstandingLineItems', window );"><strong>Share Capital (Details) - Schedule of share purchase warrants outstanding [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_Warrants', window );">Warrants | shares</a></td>
<td class="nump">1,360,028<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_WarrantsOutstandingWeightedAverageReimainingLife', window );">Warrants Outstanding, Weighted average Reimaining Life</a></td>
<td class="text">1 month 20 days<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_WarrantsOutstandingWeightedAverageExercisePrice', window );">Warrants Outstanding, Weighted average exercise price | $ / shares</a></td>
<td class="nump">$ 1.81<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis=cve_TwoTwoTwoThreeNineZeroOneMember', window );">$2.22 - 3.90 1 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_ShareCapitalDetailsScheduleofsharepurchasewarrantsoutstandingLineItems', window );"><strong>Share Capital (Details) - Schedule of share purchase warrants outstanding [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_Warrants', window );">Warrants | shares</a></td>
<td class="nump">2,515,197<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_WarrantsOutstandingWeightedAverageReimainingLife', window );">Warrants Outstanding, Weighted average Reimaining Life</a></td>
<td class="text">4 months 20 days<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_WarrantsOutstandingWeightedAverageExercisePrice', window );">Warrants Outstanding, Weighted average exercise price | $ / shares</a></td>
<td class="nump">$ 3.84<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis=cve_FourFiveNineSixZeroZeroMember', window );">$4.59 - 6.00 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_ShareCapitalDetailsScheduleofsharepurchasewarrantsoutstandingLineItems', window );"><strong>Share Capital (Details) - Schedule of share purchase warrants outstanding [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_Warrants', window );">Warrants | shares</a></td>
<td class="nump">3,619,281<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_WarrantsOutstandingWeightedAverageReimainingLife', window );">Warrants Outstanding, Weighted average Reimaining Life</a></td>
<td class="text">7 months 2 days<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_WarrantsOutstandingWeightedAverageExercisePrice', window );">Warrants Outstanding, Weighted average exercise price | $ / shares</a></td>
<td class="nump">$ 5.86<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr><td colspan="3"></td></tr>
<tr><td colspan="3"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top"><span style="font-family: Times New Roman, Times, Serif">Includes power warrants exercisable into one share and <span style="-sec-ix-hidden: hidden-fact-282">one-half</span> warrant. Each whole warrant is exercisable at $3.90 for 36 months.</span></td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cve_ShareCapitalDetailsScheduleofsharepurchasewarrantsoutstandingLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cve_ShareCapitalDetailsScheduleofsharepurchasewarrantsoutstandingLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cve_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cve_Warrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A stock warrant gives the holder the right to purchase a company's stock at a specific price and at a specific date. A stock warrant is issued directly by the company concerned; when an investor exercises a stock warrant, the shares that fulfill the obligation are not received from another investor but directly from the company.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cve_Warrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cve_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cve_WarrantsOutstandingWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Warrants Outstanding, Weighted average exercise price.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cve_WarrantsOutstandingWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cve_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cve_WarrantsOutstandingWeightedAverageReimainingLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Warrants Outstanding, Weighted average Reimaining Life.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cve_WarrantsOutstandingWeightedAverageReimainingLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cve_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis=cve_OneFiveNineOneEightZeroMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis=cve_OneFiveNineOneEightZeroMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis=cve_TwoTwoTwoThreeNineZeroOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis=cve_TwoTwoTwoThreeNineZeroOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis=cve_FourFiveNineSixZeroZeroMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis=cve_FourFiveNineSixZeroZeroMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>136
<FILENAME>R86.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139782810293680">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Related party transactions and balances (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_RelatedpartytransactionsandbalancesDetailsLineItems', window );"><strong>Related party transactions and balances (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_ConsultingFees', window );">Consulting fees</a></td>
<td class="nump">$ 103,514<span></span>
</td>
<td class="nump">$ 61,899<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_GrantedOptionsShares', window );">Granted options shares (in Shares)</a></td>
<td class="nump">2,566,667<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_FairValueAmount', window );">Fair value amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">150,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=cve_PlatoroWestIncMember', window );">Platoro West Inc. [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_RelatedpartytransactionsandbalancesDetailsLineItems', window );"><strong>Related party transactions and balances (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_FairValueAmount', window );">Fair value amount</a></td>
<td class="nump">$ 6,496,785<span></span>
</td>
<td class="nump">$ 384,881<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cve_ConsultingFees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of consulting fees.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cve_ConsultingFees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cve_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cve_FairValueAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair Value Amount.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cve_FairValueAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cve_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cve_GrantedOptionsShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Granted options shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cve_GrantedOptionsShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cve_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cve_RelatedpartytransactionsandbalancesDetailsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cve_RelatedpartytransactionsandbalancesDetailsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cve_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=cve_PlatoroWestIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=cve_PlatoroWestIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>137
<FILENAME>R87.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139782923844320">
<tr>
<th class="tl" colspan="2" rowspan="2"><div style="width: 200px;"><strong>Related party transactions and balances (Details) - Schedule of amounts paid to key management or entities providing similar services - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_ScheduleOfAmountsPaidToKeyManagementOrEntitiesProvidingSimilarServicesAbstract', window );"><strong>Schedule Of Amounts Paid To Key Management Or Entities Providing Similar Services Abstract</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RevenueFromRenderingOfInformationTechnologyConsultingServices', window );">Consulting</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">$ 103,514<span></span>
</td>
<td class="nump">$ 61,899<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill', window );">Data acquisition</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[2]</sup></td>
<td class="nump">55,150<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DirectorsRemunerationExpense', window );">Directors&#8217; fees</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[3]</sup></td>
<td class="nump">192,604<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_OfficeAndAdministration', window );">Office and administration</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="nump">13,402<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_StaffCosts', window );">Staff costs</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">1,607,211<span></span>
</td>
<td class="nump">1,151,731<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockOptionPlanExpense', window );">Stock option expense</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">4,729,503<span></span>
</td>
<td class="nump">749,255<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_KeyManagementPersonnelCompensation', window );">Total key management compensation</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 6,687,982<span></span>
</td>
<td class="nump">$ 1,976,287<span></span>
</td>
</tr>
<tr><td colspan="3"></td></tr>
<tr><td colspan="3"><table class="outerFootnotes" width="100%">
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top"><span style="font-family: Times New Roman, Times, Serif">- During the year ended December 31, 2022, the Company incurred communications &amp; community engagement consulting fees of $103,514 (2021 - $61,899) according to a contract with Tintina Holdings, Ltd., a company owned and operated by the spouse of the Company&#8217;s Executive Chairman.</span></td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[2]</td>
<td style="vertical-align: top;" valign="top"><span style="font-family: Times New Roman, Times, Serif">- In June 2022, the Company acquired access to the Getty Minerals database pursuant to a purchase agreement with Platoro West Inc., a company owned and operated by the Company&#8217;s Executive Chairman (Note 7).</span></td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[3]</td>
<td style="vertical-align: top;" valign="top"><span style="font-family: Times New Roman, Times, Serif">&#8211; Directors&#8217; Fees are included in staff costs on the consolidated statement of loss and other comprehensive income (loss).</span></td>
</tr>
</table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cve_OfficeAndAdministration">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of office and administration.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cve_OfficeAndAdministration</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cve_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cve_ScheduleOfAmountsPaidToKeyManagementOrEntitiesProvidingSimilarServicesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cve_ScheduleOfAmountsPaidToKeyManagementOrEntitiesProvidingSimilarServicesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cve_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cve_StaffCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Staff costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cve_StaffCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cve_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase in intangible assets and goodwill resulting from acquisitions through business combinations. [Refer: Business combinations [member]; Intangible assets and goodwill]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 38<br> -IssueDate 2022-03-24<br> -Paragraph 118<br> -Subparagraph e<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=38&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_118_e_i&amp;doctype=Standard<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DirectorsRemunerationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of remuneration paid or payable to the entity's directors.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2022-03-24<br> -Paragraph 112<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_112_c&amp;doctype=Standard<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DirectorsRemunerationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_KeyManagementPersonnelCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of compensation to key management personnel. [Refer: Key management personnel of entity or parent [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 24<br> -IssueDate 2022-03-24<br> -Paragraph 17<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=24&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_17&amp;doctype=Standard<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_KeyManagementPersonnelCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RevenueFromRenderingOfInformationTechnologyConsultingServices">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of revenue arising from the rendering of consulting services relating to information technology. [Refer: Revenue]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2022-03-24<br> -Paragraph 112<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_112_c&amp;doctype=Standard<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RevenueFromRenderingOfInformationTechnologyConsultingServices</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockOptionPlanExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for option under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockOptionPlanExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>138
<FILENAME>R88.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139782923837248">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Related party transactions and balances (Details) - Schedule of owing to related parties - USD ($)<br></strong></div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Jan. 01, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_RelatedpartytransactionsandbalancesDetailsScheduleofowingtorelatedpartiesLineItems', window );"><strong>Related party transactions and balances (Details) - Schedule of owing to related parties [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AmountsPayableRelatedPartyTransactions', window );">Total related party transactions</a></td>
<td class="nump">$ 441,374<span></span>
</td>
<td class="nump">$ 6,893<span></span>
</td>
<td class="nump">$ 2,319<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CategoriesOfRelatedPartiesAxis=cve_TintinaHoldingsLtdMember', window );">Tintina Holdings, Ltd [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_RelatedpartytransactionsandbalancesDetailsScheduleofowingtorelatedpartiesLineItems', window );"><strong>Related party transactions and balances (Details) - Schedule of owing to related parties [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AmountsPayableRelatedPartyTransactions', window );">Total related party transactions</a></td>
<td class="nump">12,744<span></span>
</td>
<td class="nump">6,893<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CategoriesOfRelatedPartiesAxis=cve_OfficersAndBoardMembersMember', window );">Officers and Board members [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_RelatedpartytransactionsandbalancesDetailsScheduleofowingtorelatedpartiesLineItems', window );"><strong>Related party transactions and balances (Details) - Schedule of owing to related parties [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AmountsPayableRelatedPartyTransactions', window );">Total related party transactions</a></td>
<td class="nump">$ 428,630<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 2,319<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cve_RelatedpartytransactionsandbalancesDetailsScheduleofowingtorelatedpartiesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cve_RelatedpartytransactionsandbalancesDetailsScheduleofowingtorelatedpartiesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cve_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AmountsPayableRelatedPartyTransactions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amounts payable resulting from related party transactions. [Refer: Related parties [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 24<br> -IssueDate 2022-03-24<br> -Paragraph 20<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=24&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_20&amp;doctype=Standard<br> -URIDate 2022-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 24<br> -IssueDate 2022-03-24<br> -Paragraph 18<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=24&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_18_b&amp;doctype=Standard<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AmountsPayableRelatedPartyTransactions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CategoriesOfRelatedPartiesAxis=cve_TintinaHoldingsLtdMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CategoriesOfRelatedPartiesAxis=cve_TintinaHoldingsLtdMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CategoriesOfRelatedPartiesAxis=cve_OfficersAndBoardMembersMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CategoriesOfRelatedPartiesAxis=cve_OfficersAndBoardMembersMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>139
<FILENAME>R89.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139782927311024">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Financial Instruments (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_DisclosureOfFinancialInstrumentsTextBlockAbstract', window );"><strong>Disclosure Of Financial Instruments Text Block Abstract</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_ForeignExchangeRate', window );">Foreign exchange rate</a></td>
<td class="nump">10.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NotionalAmount', window );">Financial instrument</a></td>
<td class="nump">$ 352,315<span></span>
</td>
<td class="nump">$ 247,028<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TaxRateEffectFromChangeInTaxRate', window );">Marketable securities increase or decrease in the share prices</a></td>
<td class="nump">10.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_ImpactedLoss', window );">Impacted loss</a></td>
<td class="nump">$ 394,719<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cve_DisclosureOfFinancialInstrumentsTextBlockAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cve_DisclosureOfFinancialInstrumentsTextBlockAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cve_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cve_ForeignExchangeRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cve_ForeignExchangeRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cve_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cve_ImpactedLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Impacted loss.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cve_ImpactedLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cve_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NotionalAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The nominal or face amount of a financial instrument, used to calculate payments made on that instrument.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2022-03-24<br> -Paragraph 112<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_112_c&amp;doctype=Standard<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NotionalAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TaxRateEffectFromChangeInTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The tax rate effect on the reconciliation between the average effective tax rate and the applicable tax rate resulting from a change in tax rate. [Refer: Average effective tax rate; Applicable tax rate]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2022-03-24<br> -Paragraph 81<br> -Subparagraph c<br> -Clause ii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_81_c_ii&amp;doctype=Standard<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TaxRateEffectFromChangeInTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>140
<FILENAME>R90.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139782921676736">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Financial Instruments (Details) - Schedule of foreign currency exposures - CAD ($)<br></strong></div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_ScheduleOfForeignCurrencyExposuresAbstract', window );"><strong>Schedule Of Foreign Currency Exposures Abstract</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Cash', window );">Cash</a></td>
<td class="nump">$ 216,871<span></span>
</td>
<td class="nump">$ 5,689,671<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MarketableSecurities', window );">Marketable Securities - Current</a></td>
<td class="nump">3,162,362<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_AccountPayablesAndAccruedLiabilities', window );">Accounts payable and accrued liabilities</a></td>
<td class="num">(2,890,582)<span></span>
</td>
<td class="num">(2,557,849)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AssetsLessCurrentLiabilities', window );">Total</a></td>
<td class="nump">$ 488,651<span></span>
</td>
<td class="nump">$ 3,131,822<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cve_AccountPayablesAndAccruedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cve_AccountPayablesAndAccruedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cve_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cve_ScheduleOfForeignCurrencyExposuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cve_ScheduleOfForeignCurrencyExposuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cve_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AssetsLessCurrentLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of assets less the amount of current liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2022-03-24<br> -Paragraph 55<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AssetsLessCurrentLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_Cash">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of cash on hand and demand deposits. [Refer: Cash on hand]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2022-03-24<br> -Paragraph 45<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_45&amp;doctype=Standard<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_Cash</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MarketableSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in marketable security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MarketableSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>141
<FILENAME>R91.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139782810362976">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Segmented information (Details) - Schedule of long-term assets by geographic segment - USD ($)<br></strong></div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_SegmentedinformationDetailsScheduleoflongtermassetsbygeographicsegmentLineItems', window );"><strong>Schedule of long-term assets by geographic segment [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_IntangibleAssets', window );">Intangible assets</a></td>
<td class="nump">$ 528,282<span></span>
</td>
<td class="nump">$ 491,996<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_PropertyPlantAndEquipments', window );">Property, plant and equipment</a></td>
<td class="nump">2,334,421<span></span>
</td>
<td class="nump">1,603,679<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_MineralProperties', window );">Mineral properties</a></td>
<td class="nump">145,219,086<span></span>
</td>
<td class="nump">136,079,578<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_RightofuseAssets1', window );">Right-of-use assets</a></td>
<td class="nump">185,614<span></span>
</td>
<td class="nump">244,564<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_SegmentedInformationBalance', window );">Balance</a></td>
<td class="nump">148,267,403<span></span>
</td>
<td class="nump">138,419,817<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GeographicalAreasAxis=stpr_SD', window );">South Dakota [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_SegmentedinformationDetailsScheduleoflongtermassetsbygeographicsegmentLineItems', window );"><strong>Schedule of long-term assets by geographic segment [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_IntangibleAssets', window );">Intangible assets</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_PropertyPlantAndEquipments', window );">Property, plant and equipment</a></td>
<td class="nump">60,630<span></span>
</td>
<td class="nump">62,946<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_MineralProperties', window );">Mineral properties</a></td>
<td class="nump">86,220,848<span></span>
</td>
<td class="nump">85,667,919<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_RightofuseAssets1', window );">Right-of-use assets</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_SegmentedInformationBalance', window );">Balance</a></td>
<td class="nump">86,281,478<span></span>
</td>
<td class="nump">85,730,865<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GeographicalAreasAxis=stpr_TX', window );">Texas [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_SegmentedinformationDetailsScheduleoflongtermassetsbygeographicsegmentLineItems', window );"><strong>Schedule of long-term assets by geographic segment [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_IntangibleAssets', window );">Intangible assets</a></td>
<td class="nump">122,401<span></span>
</td>
<td class="nump">67,251<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_PropertyPlantAndEquipments', window );">Property, plant and equipment</a></td>
<td class="nump">2,273,791<span></span>
</td>
<td class="nump">1,540,733<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_MineralProperties', window );">Mineral properties</a></td>
<td class="nump">9,144,069<span></span>
</td>
<td class="nump">1,455,206<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_RightofuseAssets1', window );">Right-of-use assets</a></td>
<td class="nump">168,871<span></span>
</td>
<td class="nump">199,120<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_SegmentedInformationBalance', window );">Balance</a></td>
<td class="nump">11,709,132<span></span>
</td>
<td class="nump">3,262,310<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GeographicalAreasAxis=stpr_NM', window );">New Mexico [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_SegmentedinformationDetailsScheduleoflongtermassetsbygeographicsegmentLineItems', window );"><strong>Schedule of long-term assets by geographic segment [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_IntangibleAssets', window );">Intangible assets</a></td>
<td class="nump">217,241<span></span>
</td>
<td class="nump">217,241<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_PropertyPlantAndEquipments', window );">Property, plant and equipment</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_MineralProperties', window );">Mineral properties</a></td>
<td class="nump">4,905,348<span></span>
</td>
<td class="nump">4,395,822<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_RightofuseAssets1', window );">Right-of-use assets</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_SegmentedInformationBalance', window );">Balance</a></td>
<td class="nump">5,122,589<span></span>
</td>
<td class="nump">4,613,063<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GeographicalAreasAxis=stpr_WY', window );">Wyoming [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_SegmentedinformationDetailsScheduleoflongtermassetsbygeographicsegmentLineItems', window );"><strong>Schedule of long-term assets by geographic segment [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_IntangibleAssets', window );">Intangible assets</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_PropertyPlantAndEquipments', window );">Property, plant and equipment</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_MineralProperties', window );">Mineral properties</a></td>
<td class="nump">41,754,462<span></span>
</td>
<td class="nump">41,235,727<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_RightofuseAssets1', window );">Right-of-use assets</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_SegmentedInformationBalance', window );">Balance</a></td>
<td class="nump">41,754,462<span></span>
</td>
<td class="nump">41,235,727<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GeographicalAreasAxis=cve_OtherStatesMember', window );">Other States [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_SegmentedinformationDetailsScheduleoflongtermassetsbygeographicsegmentLineItems', window );"><strong>Schedule of long-term assets by geographic segment [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_IntangibleAssets', window );">Intangible assets</a></td>
<td class="nump">188,640<span></span>
</td>
<td class="nump">207,504<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_PropertyPlantAndEquipments', window );">Property, plant and equipment</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_MineralProperties', window );">Mineral properties</a></td>
<td class="nump">3,194,359<span></span>
</td>
<td class="nump">3,324,904<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_RightofuseAssets1', window );">Right-of-use assets</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_SegmentedInformationBalance', window );">Balance</a></td>
<td class="nump">3,382,999<span></span>
</td>
<td class="nump">3,532,408<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GeographicalAreasAxis=country_CA', window );">Canada [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_SegmentedinformationDetailsScheduleoflongtermassetsbygeographicsegmentLineItems', window );"><strong>Schedule of long-term assets by geographic segment [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_IntangibleAssets', window );">Intangible assets</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_PropertyPlantAndEquipments', window );">Property, plant and equipment</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_MineralProperties', window );">Mineral properties</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_RightofuseAssets1', window );">Right-of-use assets</a></td>
<td class="nump">16,743<span></span>
</td>
<td class="nump">45,444<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_SegmentedInformationBalance', window );">Balance</a></td>
<td class="nump">$ 16,743<span></span>
</td>
<td class="nump">$ 45,444<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cve_IntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Intangible assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cve_IntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cve_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cve_MineralProperties">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Mineral properties.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cve_MineralProperties</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cve_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cve_PropertyPlantAndEquipments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Property, plant and equipment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cve_PropertyPlantAndEquipments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cve_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cve_RightofuseAssets1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Right-of-use assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cve_RightofuseAssets1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cve_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cve_SegmentedInformationBalance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Segmented information balance.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cve_SegmentedInformationBalance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cve_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cve_SegmentedinformationDetailsScheduleoflongtermassetsbygeographicsegmentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cve_SegmentedinformationDetailsScheduleoflongtermassetsbygeographicsegmentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cve_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_GeographicalAreasAxis=stpr_SD">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_GeographicalAreasAxis=stpr_SD</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_GeographicalAreasAxis=stpr_TX">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_GeographicalAreasAxis=stpr_TX</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_GeographicalAreasAxis=stpr_NM">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_GeographicalAreasAxis=stpr_NM</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_GeographicalAreasAxis=stpr_WY">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_GeographicalAreasAxis=stpr_WY</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_GeographicalAreasAxis=cve_OtherStatesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_GeographicalAreasAxis=cve_OtherStatesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_GeographicalAreasAxis=country_CA">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_GeographicalAreasAxis=country_CA</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>142
<FILENAME>R92.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139782924996176">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Supplemental disclosure with respect to cash flows (Details) - Schedule of incurred non-cash financing and investing activities - USD ($)<br></strong></div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_NonCashFinancingActivitiesAbstract', window );"><strong>Non-cash financing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CurrentAccruedExpensesAndOtherCurrentLiabilities', window );">Deferred financing costs remaining in accounts payable and accrued liabilities</a></td>
<td class="nump">$ 1,513,220<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_TotalNoncashFinancingActivities', window );">Total non-cash financing activities</a></td>
<td class="nump">1,513,220<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_NonCashInvestingActivitiesAbstract', window );"><strong>Non-cash investing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_MarketableSecuritieReceivedOnDispositionOfMineralProperties', window );">Marketable securities received on disposition of mineral properties</a></td>
<td class="nump">3,051,564<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_LiabilitiesArisingFromExplorationForAndEvaluationOfMineralResources', window );">Mineral property costs included in accounts payable and accrued liabilities</a></td>
<td class="nump">27,040<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_PropertyPlantAndEquipmentAdditionIncludedInAccountsPayableAndAccruedLiabilities', window );">Property, plant, and equipment additions included in accounts payable and accrued liabilities</a></td>
<td class="nump">20,090<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_FairValueOfCommonSharesIssuedForAzargaAssetAcquisition', window );">Fair value of common shares issued for Azarga asset acquisition</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">121,796,381<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_FairValueOfReplacementOptionsIssuedForAzargaAssetsAcquisition', window );">Fair value of replacement options issued for Azarga asset acquisition</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">5,496,037<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_FairValueOfReplacementWarrantsIssuedForAzargaAssetAcquisition', window );">Fair value of replacement warrants issued for Azarga asset acquisition</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">3,259,306<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_TotalNoncashInvestingActivities', window );">Total non-cash investing activities</a></td>
<td class="nump">$ 3,098,694<span></span>
</td>
<td class="nump">$ 130,551,724<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cve_FairValueOfCommonSharesIssuedForAzargaAssetAcquisition">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of fair value of common shares issued for Azarga asset acquisition.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cve_FairValueOfCommonSharesIssuedForAzargaAssetAcquisition</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cve_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cve_FairValueOfReplacementOptionsIssuedForAzargaAssetsAcquisition">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of replacement options issued for Azarga asset acquisition.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cve_FairValueOfReplacementOptionsIssuedForAzargaAssetsAcquisition</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cve_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cve_FairValueOfReplacementWarrantsIssuedForAzargaAssetAcquisition">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of fair value of replacement warrants issued for Azarga asset acquisition.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cve_FairValueOfReplacementWarrantsIssuedForAzargaAssetAcquisition</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cve_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cve_MarketableSecuritieReceivedOnDispositionOfMineralProperties">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Marketable securities received on disposition of mineral properties.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cve_MarketableSecuritieReceivedOnDispositionOfMineralProperties</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cve_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cve_NonCashFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cve_NonCashFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cve_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cve_NonCashInvestingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cve_NonCashInvestingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cve_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cve_PropertyPlantAndEquipmentAdditionIncludedInAccountsPayableAndAccruedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Property, plant, and equipment additions included in accounts payable and accrued liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cve_PropertyPlantAndEquipmentAdditionIncludedInAccountsPayableAndAccruedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cve_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cve_TotalNoncashFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of non cash financing activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cve_TotalNoncashFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cve_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cve_TotalNoncashInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cve_TotalNoncashInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cve_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrentAccruedExpensesAndOtherCurrentLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of current accrued expenses and other current liabilities. [Refer: Accruals; Other current liabilities]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2022-03-24<br> -Paragraph 55<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrentAccruedExpensesAndOtherCurrentLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_LiabilitiesArisingFromExplorationForAndEvaluationOfMineralResources">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of liabilities arising from the search for mineral resources, including minerals, oil, natural gas and similar non-regenerative resources after the entity has obtained legal rights to explore in a specific area, as well as the determination of the technical feasibility and commercial viability of extracting the mineral resource.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 6<br> -IssueDate 2022-03-24<br> -Paragraph 24<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=6&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_24_b&amp;doctype=Standard<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_LiabilitiesArisingFromExplorationForAndEvaluationOfMineralResources</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>143
<FILENAME>R93.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139782924657920">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income taxes (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_DisclosureOfIncomeTaxTextBlockAbstract', window );"><strong>Disclosure Of Income Tax Text Block Abstract</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_NoncapitalLoss', window );">Non-capital loss</a></td>
<td class="nump">$ 28,628,469<span></span>
</td>
<td class="nump">$ 22,107,188<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_FederalNetOperatingLossCarryforwards', window );">Federal net operating loss carryforwards</a></td>
<td class="nump">21,099,321<span></span>
</td>
<td class="nump">$ 11,232,201<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_CarriedForward', window );">Carried forward</a></td>
<td class="nump">15,223,100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_ExpiringAmount', window );">Expiring amount</a></td>
<td class="nump">$ 5,876,221<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cve_CarriedForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carried forward.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cve_CarriedForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cve_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cve_DisclosureOfIncomeTaxTextBlockAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cve_DisclosureOfIncomeTaxTextBlockAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cve_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cve_ExpiringAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Expiring amount.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cve_ExpiringAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cve_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cve_FederalNetOperatingLossCarryforwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Federal net operating loss carryforwards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cve_FederalNetOperatingLossCarryforwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cve_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cve_NoncapitalLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Non-capital loss.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cve_NoncapitalLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cve_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>144
<FILENAME>R94.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139782923801712">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income taxes (Details) - Schedule of federal and provincial corporate tax rates to income before tax - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_ScheduleOfFederalAndProvincialCorporateTaxRatesToIncomeBeforeTaxAbstract', window );"><strong>Schedule Of Federal And Provincial Corporate Tax Rates To Income Before Tax Abstract</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossAttributableToParent', window );">Loss before income tax</a></td>
<td class="num">$ (16,515,389)<span></span>
</td>
<td class="num">$ (8,563,473)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate', window );">Statutory income tax rate</a></td>
<td class="nump">27.00%<span></span>
</td>
<td class="nump">27.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_ExpectedIncomeTaxExpenserecovery', window );">Expected income tax expense (recovery)</a></td>
<td class="num">$ (4,459,155)<span></span>
</td>
<td class="num">$ (2,312,138)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_IncreaseDecreaseResultingFromAbstract', window );"><strong>Increase (decrease) resulting from:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_ChangeInUnrecognizedTemporaryDifferences', window );">Change in unrecognized temporary differences</a></td>
<td class="nump">2,949,101<span></span>
</td>
<td class="nump">1,800,688<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TaxEffectOfExpenseNotDeductibleInDeterminingTaxableProfitTaxLoss', window );">Permanent differences</a></td>
<td class="nump">1,159,884<span></span>
</td>
<td class="nump">433,595<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TaxEffectOfForeignTaxRates', window );">Effect of tax rates in foreign jurisdictions</a></td>
<td class="nump">146,727<span></span>
</td>
<td class="nump">77,855<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_ShareIssueCosts', window );">Share issue costs</a></td>
<td class="nump">201,740<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdjustmentsForCurrentTaxOfPriorPeriod', window );">Prior period adjustments</a></td>
<td class="nump">1,703<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncomeTaxExpenseContinuingOperations', window );">Income tax expense (recovery)</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cve_ChangeInUnrecognizedTemporaryDifferences">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Change in unrecognized temporary differences.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cve_ChangeInUnrecognizedTemporaryDifferences</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cve_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cve_ExpectedIncomeTaxExpenserecovery">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>expected income tax expense (recovery).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cve_ExpectedIncomeTaxExpenserecovery</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cve_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cve_IncreaseDecreaseResultingFromAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cve_IncreaseDecreaseResultingFromAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cve_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cve_ScheduleOfFederalAndProvincialCorporateTaxRatesToIncomeBeforeTaxAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cve_ScheduleOfFederalAndProvincialCorporateTaxRatesToIncomeBeforeTaxAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cve_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cve_ShareIssueCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Share issue costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cve_ShareIssueCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cve_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AdjustmentsForCurrentTaxOfPriorPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Adjustments of tax expense (income) recognised in the period for current tax of prior periods.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2022-03-24<br> -Paragraph 80<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_80_b&amp;doctype=Standard<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AdjustmentsForCurrentTaxOfPriorPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IncomeTaxExpenseContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount included in the determination of profit (loss) for the period in respect of current tax and deferred tax. [Refer: Current tax expense (income); Deferred tax expense (income)]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2022-03-24<br> -Paragraph 23<br> -Subparagraph h<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_23_h&amp;doctype=Standard<br> -URIDate 2022-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 26<br> -IssueDate 2022-03-24<br> -Paragraph 35<br> -Subparagraph b<br> -Clause viii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=26&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_35_b_viii&amp;doctype=Standard<br> -URIDate 2022-03-24<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2022-03-24<br> -Paragraph 79<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_79&amp;doctype=Standard<br> -URIDate 2022-03-24<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2022-03-24<br> -Paragraph 81<br> -Subparagraph c<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_81_c_i&amp;doctype=Standard<br> -URIDate 2022-03-24<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2022-03-24<br> -Paragraph 81<br> -Subparagraph c<br> -Clause ii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_81_c_ii&amp;doctype=Standard<br> -URIDate 2022-03-24<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2022-03-24<br> -Paragraph B13<br> -Subparagraph g<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_B13_g&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2022-03-24<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2022-03-24<br> -Paragraph 82<br> -Subparagraph d<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_82_d&amp;doctype=Standard<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IncomeTaxExpenseContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TaxEffectOfExpenseNotDeductibleInDeterminingTaxableProfitTaxLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount that represents the difference between the tax expense (income) and the product of the accounting profit multiplied by the applicable tax rate(s) that relates to expenses not deductible in determining taxable profit (tax loss). [Refer: Accounting profit]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2022-03-24<br> -Paragraph 81<br> -Subparagraph c<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_81_c_i&amp;doctype=Standard<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TaxEffectOfExpenseNotDeductibleInDeterminingTaxableProfitTaxLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TaxEffectOfForeignTaxRates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount that represents the difference between the tax expense (income) and the product of the accounting profit multiplied by the applicable tax rate(s) that relates to foreign tax rates. [Refer: Accounting profit]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2022-03-24<br> -Paragraph 81<br> -Subparagraph c<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_81_c_i&amp;doctype=Standard<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TaxEffectOfForeignTaxRates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of domestic federal statutory tax rate applicable to pretax income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of income (loss) attributable to parent. Includes, but is not limited to, income (loss) from continuing operations, discontinued operations and equity method investments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.20)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>145
<FILENAME>R95.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139782810248336">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income taxes (Details) - Schedule of income tax expense (recovery) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_DeferredTaxExpenseRecoveryAbstract', window );"><strong>Deferred tax expense (recovery)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_OrginationAndReversalOfTemporaryDifferences', window );">Organization and reversal of temporary differences</a></td>
<td class="num">$ (2,949,101)<span></span>
</td>
<td class="num">$ (1,800,688)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_ChangeInUnrecognizedTemporaryDifferences', window );">Change in unrecognized temporary differences</a></td>
<td class="nump">2,949,101<span></span>
</td>
<td class="nump">1,800,688<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncomeTaxExpenseContinuingOperations', window );">Income tax expense (recovery)</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOtherLossCarryforwards', window );">Loss carryforwards</a></td>
<td class="nump">488,823<span></span>
</td>
<td class="nump">52,244<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOther', window );">Deferred tax assets</a></td>
<td class="nump">488,823<span></span>
</td>
<td class="nump">52,244<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_SetoffOfTax', window );">Set-off of tax</a></td>
<td class="num">(488,823)<span></span>
</td>
<td class="num">(52,244)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NetDeferredTaxAssets', window );">Net deferred tax assets</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cve_ChangeInUnrecognizedTemporaryDifferences">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Change in unrecognized temporary differences.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cve_ChangeInUnrecognizedTemporaryDifferences</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cve_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cve_DeferredTaxExpenseRecoveryAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cve_DeferredTaxExpenseRecoveryAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cve_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cve_OrginationAndReversalOfTemporaryDifferences">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Orgination and reversal of temporary differences.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cve_OrginationAndReversalOfTemporaryDifferences</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cve_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cve_SetoffOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Set-off of tax.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cve_SetoffOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cve_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IncomeTaxExpenseContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount included in the determination of profit (loss) for the period in respect of current tax and deferred tax. [Refer: Current tax expense (income); Deferred tax expense (income)]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2022-03-24<br> -Paragraph 23<br> -Subparagraph h<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_23_h&amp;doctype=Standard<br> -URIDate 2022-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 26<br> -IssueDate 2022-03-24<br> -Paragraph 35<br> -Subparagraph b<br> -Clause viii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=26&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_35_b_viii&amp;doctype=Standard<br> -URIDate 2022-03-24<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2022-03-24<br> -Paragraph 79<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_79&amp;doctype=Standard<br> -URIDate 2022-03-24<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2022-03-24<br> -Paragraph 81<br> -Subparagraph c<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_81_c_i&amp;doctype=Standard<br> -URIDate 2022-03-24<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2022-03-24<br> -Paragraph 81<br> -Subparagraph c<br> -Clause ii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_81_c_ii&amp;doctype=Standard<br> -URIDate 2022-03-24<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2022-03-24<br> -Paragraph B13<br> -Subparagraph g<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_B13_g&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2022-03-24<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2022-03-24<br> -Paragraph 82<br> -Subparagraph d<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_82_d&amp;doctype=Standard<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IncomeTaxExpenseContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NetDeferredTaxAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of deferred tax assets net of deferred tax liabilities, when the absolute amount of deferred tax assets is greater than the absolute amount of deferred tax liabilities. [Refer: Deferred tax assets; Deferred tax liabilities]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2022-03-24<br> -Paragraph 81<br> -Subparagraph g<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_81_g_i&amp;doctype=Standard<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NetDeferredTaxAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary differences, classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsOtherLossCarryforwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible loss carryforwards, classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsOtherLossCarryforwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>146
<FILENAME>R96.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139782921822224">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income taxes (Details) - Schedule of deferred tax liabilities - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_ScheduleOfDeferredTaxLiabilitiesAbstract', window );"><strong>Schedule Of Deferred Tax Liabilities Abstract</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherIntangibleAssets', window );">Intangible assets</a></td>
<td class="num">$ (39,481)<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RightofuseAssetsRevaluedAssetsAtCost', window );">Right-of-use assets</a></td>
<td class="num">(42,472)<span></span>
</td>
<td class="num">(52,244)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_FixedAssets', window );">Fixed assets</a></td>
<td class="num">(276,699)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RightofuseAssetsRevaluationSurplus', window );">Right-of-use assets</a></td>
<td class="num">(130,171)<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesCurrent', window );">Marketable securities</a></td>
<td class="num">(488,823)<span></span>
</td>
<td class="num">(52,244)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_SetoffOfTax', window );">Set-off of tax</a></td>
<td class="nump">488,823<span></span>
</td>
<td class="nump">52,244<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NetDeferredTaxAssets', window );">Net deferred tax liability</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cve_FixedAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fixed assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cve_FixedAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cve_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cve_ScheduleOfDeferredTaxLiabilitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cve_ScheduleOfDeferredTaxLiabilitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cve_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cve_SetoffOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Set-off of tax.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cve_SetoffOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cve_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NetDeferredTaxAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of deferred tax assets net of deferred tax liabilities, when the absolute amount of deferred tax assets is greater than the absolute amount of deferred tax liabilities. [Refer: Deferred tax assets; Deferred tax liabilities]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2022-03-24<br> -Paragraph 81<br> -Subparagraph g<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_81_g_i&amp;doctype=Standard<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NetDeferredTaxAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_OtherIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of intangible assets that the entity does not separately disclose in the same statement or note. [Refer: Intangible assets other than goodwill]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 38<br> -IssueDate 2022-03-24<br> -Paragraph 119<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=38&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_119&amp;doctype=Standard<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_OtherIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RightofuseAssetsRevaluationSurplus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of the revaluation surplus that relates to right-of-use assets. [Refer: Revaluation surplus; Right-of-use assets]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 16<br> -IssueDate 2022-03-24<br> -Paragraph 57<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=16&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_57&amp;doctype=Standard<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RightofuseAssetsRevaluationSurplus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RightofuseAssetsRevaluedAssetsAtCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of right-of-use assets that would have been recognised had the revalued assets been carried under the cost model. [Refer: Right-of-use assets]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 16<br> -IssueDate 2022-03-24<br> -Paragraph 57<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=16&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_57&amp;doctype=Standard<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RightofuseAssetsRevaluedAssetsAtCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MarketableSecuritiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in marketable security, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MarketableSecuritiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>147
<FILENAME>R97.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139782929093504">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income taxes (Details) - Schedule of unrecognized deferred tax assets - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_ScheduleOfUnrecognizedDeferredTaxAssetsAbstract', window );"><strong>Schedule Of Unrecognized Deferred Tax Assets Abstract</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_DeductibleTemporaryDifferences', window );">Deductible temporary differences</a></td>
<td class="nump">$ 3,920,076<span></span>
</td>
<td class="nump">$ 2,576,276<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TaxEffectOfTaxLosses', window );">Tax losses</a></td>
<td class="nump">26,069,552<span></span>
</td>
<td class="nump">12,754,678<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProfitLossBeforeTax', window );">Total</a></td>
<td class="nump">$ 29,989,628<span></span>
</td>
<td class="nump">$ 15,330,954<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cve_DeductibleTemporaryDifferences">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Deductible temporary differences.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cve_DeductibleTemporaryDifferences</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cve_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cve_ScheduleOfUnrecognizedDeferredTaxAssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cve_ScheduleOfUnrecognizedDeferredTaxAssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cve_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProfitLossBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The profit (loss) before tax expense or income. [Refer: Profit (loss)]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2022-03-24<br> -Paragraph 28<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_28_b&amp;doctype=Standard<br> -URIDate 2022-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2022-03-24<br> -Paragraph 23<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_23&amp;doctype=Standard<br> -URIDate 2022-03-24<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 5<br> -IssueDate 2022-03-24<br> -Paragraph 33<br> -Subparagraph b<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=5&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_33_b_i&amp;doctype=Standard<br> -URIDate 2022-03-24<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2022-03-24<br> -Paragraph 103<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_103&amp;doctype=Standard<br> -URIDate 2022-03-24<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2022-03-24<br> -Paragraph 102<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_102&amp;doctype=Standard<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProfitLossBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TaxEffectOfTaxLosses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount that represents the difference between the tax expense (income) and the product of the accounting profit multiplied by the applicable tax rate(s) that relates to tax losses. [Refer: Accounting profit]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2022-03-24<br> -Paragraph 81<br> -Subparagraph c<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_81_c_i&amp;doctype=Standard<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TaxEffectOfTaxLosses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>148
<FILENAME>R98.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139782810281792">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Change in Presentation Currency (Details) - Schedule of effect of translation<br></strong></div></th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>CAD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>CAD ($)</div>
</th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RetrospectiveApplicationAndRetrospectiveRestatementAxis=ifrs-full_PreviouslyStatedMember', window );">Previously stated [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_ChangeinPresentationCurrencyDetailsScheduleofeffectoftranslationLineItems', window );"><strong>Change in Presentation Currency (Details) - Schedule of effect of translation [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CurrentAssets', window );">Current assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 14,651,619<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6,926,844<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NoncurrentAssets', window );">Non-current assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">187,434,040<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">16,516,119<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Assets', window );">Total assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">202,085,659<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">23,442,963<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CurrentLiabilities', window );">Current liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,510,606<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">900,300<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NoncurrentLiabilities', window );">Non-current liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,507,178<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,674,405<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Liabilities', window );">Total liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 13,017,784<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7,574,705<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RetrospectiveApplicationAndRetrospectiveRestatementAxis=cve_TranslatedMember', window );">Translated [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_ChangeinPresentationCurrencyDetailsScheduleofeffectoftranslationLineItems', window );"><strong>Change in Presentation Currency (Details) - Schedule of effect of translation [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CurrentAssets', window );">Current assets</a></td>
<td class="nump">$ 11,556,728<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,436,341<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NoncurrentAssets', window );">Non-current assets</a></td>
<td class="nump">147,799,796<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12,918,903<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Assets', window );">Total assets</a></td>
<td class="nump">159,356,524<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">18,355,244<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CurrentLiabilities', window );">Current liabilities</a></td>
<td class="nump">5,924,125<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">707,056<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NoncurrentLiabilities', window );">Non-current liabilities</a></td>
<td class="nump">4,343,886<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,242,229<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Liabilities', window );">Total liabilities</a></td>
<td class="nump">$ 10,268,011<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,949,285<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cve_ChangeinPresentationCurrencyDetailsScheduleofeffectoftranslationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cve_ChangeinPresentationCurrencyDetailsScheduleofeffectoftranslationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cve_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of a present economic resource controlled by the entity as a result of past events. Economic resource is a right that has the potential to produce economic benefits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2022-03-24<br> -Paragraph 93<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_93_a&amp;doctype=Standard<br> -URIDate 2022-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2022-03-24<br> -Paragraph 28<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_28_c&amp;doctype=Standard<br> -URIDate 2022-03-24<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2022-03-24<br> -Paragraph 93<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_93_b&amp;doctype=Standard<br> -URIDate 2022-03-24<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2022-03-24<br> -Paragraph 93<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_93_e&amp;doctype=Standard<br> -URIDate 2022-03-24<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2022-03-24<br> -Paragraph 23<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_23&amp;doctype=Standard<br> -URIDate 2022-03-24<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2022-03-24<br> -Paragraph 55<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrentAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of assets that the entity (a) expects to realise or intends to sell or consume in its normal operating cycle; (b) holds primarily for the purpose of trading; (c) expects to realise within twelve months after the reporting period; or (d) classifies as cash or cash equivalents (as defined in IAS 7) unless the asset is restricted from being exchanged or used to settle a liability for at least twelve months after the reporting period. [Refer: Assets]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2022-03-24<br> -Paragraph B12<br> -Subparagraph b<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_B12_b_i&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2022-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2022-03-24<br> -Paragraph B10<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_B10_b&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2022-03-24<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2022-03-24<br> -Paragraph 66<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_66&amp;doctype=Standard<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrentAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrentLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Expiry date 2023-01-01: The amount of liabilities that: (a) the entity expects to settle in its normal operating cycle; (b) the entity holds primarily for the purpose of trading; (c) are due to be settled within twelve months after the reporting period; or (d) the entity does not have an unconditional right to defer settlement for at least twelve months after the reporting period.
Effective 2023-01-01: The amount of liabilities that: (a) the entity expects to settle in its normal operating cycle; (b) the entity holds primarily for the purpose of trading; (c) are due to be settled within twelve months after the reporting period; or (d) the entity does not have the right at the end of the reporting period to defer settlement for at least twelve months after the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2022-03-24<br> -Paragraph B12<br> -Subparagraph b<br> -Clause iii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_B12_b_iii&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2022-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2022-03-24<br> -Paragraph B10<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_B10_b&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2022-03-24<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2022-03-24<br> -Paragraph 69<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_69&amp;doctype=Standard<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrentLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of a present obligation of the entity to transfer an economic resource as a result of past events. Economic resource is a right that has the potential to produce economic benefits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2022-03-24<br> -Paragraph 93<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_93_a&amp;doctype=Standard<br> -URIDate 2022-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2022-03-24<br> -Paragraph 93<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_93_b&amp;doctype=Standard<br> -URIDate 2022-03-24<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2022-03-24<br> -Paragraph 93<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_93_e&amp;doctype=Standard<br> -URIDate 2022-03-24<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2022-03-24<br> -Paragraph 28<br> -Subparagraph d<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_28_d&amp;doctype=Standard<br> -URIDate 2022-03-24<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2022-03-24<br> -Paragraph 23<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_23&amp;doctype=Standard<br> -URIDate 2022-03-24<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2022-03-24<br> -Paragraph 55<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NoncurrentAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of assets that do not meet the definition of current assets. [Refer: Current assets]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2022-03-24<br> -Paragraph B12<br> -Subparagraph b<br> -Clause ii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_B12_b_ii&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2022-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2022-03-24<br> -Paragraph B10<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_B10_b&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2022-03-24<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2022-03-24<br> -Paragraph 66<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_66&amp;doctype=Standard<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NoncurrentAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NoncurrentLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of liabilities that do not meet the definition of current liabilities. [Refer: Current liabilities]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2022-03-24<br> -Paragraph B12<br> -Subparagraph b<br> -Clause iv<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_B12_b_iv&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2022-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2022-03-24<br> -Paragraph B10<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_B10_b&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2022-03-24<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2022-03-24<br> -Paragraph 69<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_69&amp;doctype=Standard<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NoncurrentLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RetrospectiveApplicationAndRetrospectiveRestatementAxis=ifrs-full_PreviouslyStatedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RetrospectiveApplicationAndRetrospectiveRestatementAxis=ifrs-full_PreviouslyStatedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RetrospectiveApplicationAndRetrospectiveRestatementAxis=cve_TranslatedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RetrospectiveApplicationAndRetrospectiveRestatementAxis=cve_TranslatedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>149
<FILENAME>R99.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139782808523744">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Change in Presentation Currency (Details) - Schedule of consolidated statements of loss and comprehensive loss - 12 months ended Dec. 31, 2021<br></strong></div></th>
<th class="th">
<div>USD ($) </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>CAD ($) </div>
<div>$ / shares</div>
</th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RestatementAxis=srt_ScenarioPreviouslyReportedMember', window );">Previously Reported [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_ExpensesAbstract0', window );"><strong>Expenses</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_Accretion', window );">Accretion</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 502,291<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdjustmentsForDepreciationAndAmortisationExpense', window );">Amortization and depreciation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">374,455<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_Consulting', window );">Consulting</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">91,161<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdministrativeExpense', window );">General administrative costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,429,209<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_ImpairmentCharges', window );">Impairment charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">98,345<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_InterestExpense', window );">Interest expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,365<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_OfficeAndAdministrative', window );">Office and administrative</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">247,433<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProfessionalFeesExpense', window );">Professional fees</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">728,793<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherExpenseByNature', window );">Promotion and shareholder communication</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">208,201<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_ReclamationCosts', window );">Reclamation costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">889,154<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TravelExpense', window );">Travel</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">33,355<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_TransferAgentAndFilingFees', window );">Transfer agent and filing fees</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">167,612<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_StaffCosts', window );">Staff costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,983,446<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockOptionPlanExpense', window );">Stock option expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,787,046<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherOperatingIncomeExpense', window );">Loss from operating expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(11,549,866)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_InterestRevenueExpense', window );">Interest income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">26,307<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ForeignExchangeGain', window );">Foreign exchange gain</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">34,174<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_LossesOnDivestmentOfMineralProperties', window );">Loss on divestment of mineral properties</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(112,708)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_GainOnChangeInAssetRetirementObligationEstimate', window );">Gain on change in asset retirement obligation estimate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,155,949<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossOnContractTermination', window );">Loss on contract termination</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(3,447,125)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_UnrealizedGainOnUraniumInvestment', window );">Unrealized gain on uranium investment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,947,939<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GainsOnDisposalsOfInvestmentProperties', window );">Gain on sale of uranium investment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">656,928<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_LossOnInvestmentInAssociate', window );">Loss on investment in associate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(445,914)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NetForeignExchangeLoss', window );">Net loss for the year</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(10,734,316)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherComprehensiveIncomeBeforeTaxExchangeDifferencesOnTranslation', window );">Exchange differences on translation foreign operations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">206,082<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ReversalOfImpairmentLossRecognisedInOtherComprehensiveIncome', window );">Other comprehensive loss for the year</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (10,528,234)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BasicEarningsLossPerShare', window );">Loss per share - basic and diluted | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (0.05)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RestatementAxis=cve_TranslatedMember', window );">Translated [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_ExpensesAbstract0', window );"><strong>Expenses</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_Accretion', window );">Accretion</a></td>
<td class="nump">$ 408,181<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdjustmentsForDepreciationAndAmortisationExpense', window );">Amortization and depreciation</a></td>
<td class="nump">298,666<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_Consulting', window );">Consulting</a></td>
<td class="nump">72,726<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdministrativeExpense', window );">General administrative costs</a></td>
<td class="nump">3,533,474<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_ImpairmentCharges', window );">Impairment charges</a></td>
<td class="nump">78,456<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_InterestExpense', window );">Interest expense</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_OfficeAndAdministrative', window );">Office and administrative</a></td>
<td class="nump">197,391<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProfessionalFeesExpense', window );">Professional fees</a></td>
<td class="nump">581,408<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherExpenseByNature', window );">Promotion and shareholder communication</a></td>
<td class="nump">166,096<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_ReclamationCosts', window );">Reclamation costs</a></td>
<td class="nump">709,399<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TravelExpense', window );">Travel</a></td>
<td class="nump">26,609<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_TransferAgentAndFilingFees', window );">Transfer agent and filing fees</a></td>
<td class="nump">133,717<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_StaffCosts', window );">Staff costs</a></td>
<td class="nump">1,582,326<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockOptionPlanExpense', window );">Stock option expense</a></td>
<td class="nump">1,425,645<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherOperatingIncomeExpense', window );">Loss from operating expenses</a></td>
<td class="num">(9,214,094)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_InterestRevenueExpense', window );">Interest income</a></td>
<td class="nump">20,987<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ForeignExchangeGain', window );">Foreign exchange gain</a></td>
<td class="nump">27,263<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_LossesOnDivestmentOfMineralProperties', window );">Loss on divestment of mineral properties</a></td>
<td class="num">(89,914)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_GainOnChangeInAssetRetirementObligationEstimate', window );">Gain on change in asset retirement obligation estimate</a></td>
<td class="nump">1,719,943<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossOnContractTermination', window );">Loss on contract termination</a></td>
<td class="num">(2,750,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_UnrealizedGainOnUraniumInvestment', window );">Unrealized gain on uranium investment</a></td>
<td class="nump">1,554,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GainsOnDisposalsOfInvestmentProperties', window );">Gain on sale of uranium investment</a></td>
<td class="nump">524,075<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_LossOnInvestmentInAssociate', window );">Loss on investment in associate</a></td>
<td class="num">(355,735)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NetForeignExchangeLoss', window );">Net loss for the year</a></td>
<td class="num">(8,563,475)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherComprehensiveIncomeBeforeTaxExchangeDifferencesOnTranslation', window );">Exchange differences on translation foreign operations</a></td>
<td class="num">(1,325,855)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ReversalOfImpairmentLossRecognisedInOtherComprehensiveIncome', window );">Other comprehensive loss for the year</a></td>
<td class="num">$ (9,889,330)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BasicEarningsLossPerShare', window );">Loss per share - basic and diluted | $ / shares</a></td>
<td class="num">$ (0.13)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cve_Accretion">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accretion Expense</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cve_Accretion</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cve_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cve_Consulting">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Consulting Expenses.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cve_Consulting</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cve_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cve_ExpensesAbstract0">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cve_ExpensesAbstract0</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cve_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cve_GainOnChangeInAssetRetirementObligationEstimate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cve_GainOnChangeInAssetRetirementObligationEstimate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cve_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cve_ImpairmentCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cve_ImpairmentCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cve_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cve_LossOnInvestmentInAssociate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cve_LossOnInvestmentInAssociate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cve_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cve_LossesOnDivestmentOfMineralProperties">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cve_LossesOnDivestmentOfMineralProperties</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cve_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cve_OfficeAndAdministrative">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Office and administrative.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cve_OfficeAndAdministrative</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cve_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cve_ReclamationCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cve_ReclamationCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cve_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cve_StaffCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Staff costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cve_StaffCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cve_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cve_TransferAgentAndFilingFees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Transfer agent and filing fees</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cve_TransferAgentAndFilingFees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cve_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cve_UnrealizedGainOnUraniumInvestment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Unrealized gain on uranium investment</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cve_UnrealizedGainOnUraniumInvestment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cve_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AdjustmentsForDepreciationAndAmortisationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Adjustments for depreciation and amortisation expense to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Depreciation and amortisation expense; Profit (loss)]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2022-03-24<br> -Paragraph 20<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_20_b&amp;doctype=Standard<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AdjustmentsForDepreciationAndAmortisationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of expenses that the entity classifies as being administrative.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 26<br> -IssueDate 2022-03-24<br> -Paragraph 35<br> -Subparagraph b<br> -Clause vi<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=26&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_35_b_vi&amp;doctype=Standard<br> -URIDate 2022-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2022-03-24<br> -Paragraph 103<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_103&amp;doctype=Standard<br> -URIDate 2022-03-24<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2022-03-24<br> -Paragraph 99<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_99&amp;doctype=Standard<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BasicEarningsLossPerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of profit (loss) attributable to ordinary equity holders of the parent entity (the numerator) divided by the weighted average number of ordinary shares outstanding during the period (the denominator).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 33<br> -IssueDate 2022-03-24<br> -Paragraph 66<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=33&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_66&amp;doctype=Standard<br> -URIDate 2022-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 33<br> -IssueDate 2022-03-24<br> -Paragraph 67<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=33&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_67&amp;doctype=Standard<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BasicEarningsLossPerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ForeignExchangeGain">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The gross gain arising from exchange differences recognised in profit or loss, excluding those arising on financial instruments measured at fair value through profit or loss in accordance with IFRS 9. [Refer: Foreign exchange gain (loss)]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 21<br> -IssueDate 2022-03-24<br> -Paragraph 52<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=21&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_52_a&amp;doctype=Standard<br> -URIDate 2022-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2022-03-24<br> -Paragraph 35<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_35&amp;doctype=Standard<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ForeignExchangeGain</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_GainsOnDisposalsOfInvestmentProperties">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The gain on disposals of investment properties. [Refer: Investment property]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2022-03-24<br> -Paragraph 112<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_112_c&amp;doctype=Standard<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_GainsOnDisposalsOfInvestmentProperties</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_InterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of expense arising from interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2022-03-24<br> -Paragraph 28<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_28_e&amp;doctype=Standard<br> -URIDate 2022-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2022-03-24<br> -Paragraph 23<br> -Subparagraph d<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_23_d&amp;doctype=Standard<br> -URIDate 2022-03-24<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2022-03-24<br> -Paragraph B13<br> -Subparagraph f<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_B13_f&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_InterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_InterestRevenueExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of income or expense arising from interest. [Refer: Interest expense; Interest income]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2022-03-24<br> -Paragraph 28<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_28_e&amp;doctype=Standard<br> -URIDate 2022-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2022-03-24<br> -Paragraph 23<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_23&amp;doctype=Standard<br> -URIDate 2022-03-24<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2022-03-24<br> -Paragraph 85<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_85&amp;doctype=Standard<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_InterestRevenueExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NetForeignExchangeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net loss arising from exchange differences recognised in profit or loss, excluding those arising on financial instruments measured at fair value through profit or loss in accordance with IFRS 9. [Refer: Foreign exchange gain (loss)]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 21<br> -IssueDate 2022-03-24<br> -Paragraph 52<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=21&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_52_a&amp;doctype=Standard<br> -URIDate 2022-03-24<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2022-03-24<br> -Paragraph 35<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_35&amp;doctype=Standard<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NetForeignExchangeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_OtherComprehensiveIncomeBeforeTaxExchangeDifferencesOnTranslation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of other comprehensive income, before tax, after reclassification adjustments, related to exchange differences on translation of financial statements of foreign operations. [Refer: Other comprehensive income, before tax]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2022-03-24<br> -Paragraph 91<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_91_b&amp;doctype=Standard<br> -URIDate 2022-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2022-03-24<br> -Paragraph 7<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_7&amp;doctype=Standard<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_OtherComprehensiveIncomeBeforeTaxExchangeDifferencesOnTranslation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_OtherExpenseByNature">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of expenses that the entity does not separately disclose in the same statement or note when the entity uses the 'nature of expense' form for its analysis of expenses. [Refer: Expenses, by nature]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2022-03-24<br> -Paragraph 102<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_102&amp;doctype=Standard<br> -URIDate 2022-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2022-03-24<br> -Paragraph 99<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_99&amp;doctype=Standard<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_OtherExpenseByNature</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_OtherOperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of operating income (expense) that the entity does not separately disclose in the same statement or note.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2022-03-24<br> -Paragraph 85<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_85&amp;doctype=Standard<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_OtherOperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProfessionalFeesExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of fees paid or payable for professional services.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2022-03-24<br> -Paragraph 112<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_112_c&amp;doctype=Standard<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProfessionalFeesExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ReversalOfImpairmentLossRecognisedInOtherComprehensiveIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of reversal of impairment loss recognised in other comprehensive income. [Refer: Reversal of impairment loss; Impairment loss recognised in other comprehensive income]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 36<br> -IssueDate 2022-03-24<br> -Paragraph 129<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=36&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_129_b&amp;doctype=Standard<br> -URIDate 2022-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 36<br> -IssueDate 2022-03-24<br> -Paragraph 126<br> -Subparagraph d<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=36&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_126_d&amp;doctype=Standard<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ReversalOfImpairmentLossRecognisedInOtherComprehensiveIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TravelExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of expense arising from travel.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2022-03-24<br> -Paragraph 112<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_112_c&amp;doctype=Standard<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TravelExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossOnContractTermination">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The loss recognized on termination of a contract.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 912<br> -SubTopic 275<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126938061&amp;loc=d3e54681-109401<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossOnContractTermination</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockOptionPlanExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for option under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockOptionPlanExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RestatementAxis=srt_ScenarioPreviouslyReportedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RestatementAxis=srt_ScenarioPreviouslyReportedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RestatementAxis=cve_TranslatedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RestatementAxis=cve_TranslatedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>150
<FILENAME>R100.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139782923827280">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Change in Presentation Currency (Details) - Schedule of consolidated statements of loss and comprehensive loss (Parentheticals) - 12 months ended Dec. 31, 2021<br></strong></div></th>
<th class="th"><div>$ / shares</div></th>
<th class="th"><div>$ / shares</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RestatementAxis=srt_ScenarioPreviouslyReportedMember', window );">Previously Reported [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_ChangeinPresentationCurrencyDetailsScheduleofconsolidatedstatementsoflossandcomprehensivelossParentheticalsLineItems', window );"><strong>Change in Presentation Currency (Details) - Schedule of consolidated statements of loss and comprehensive loss (Parentheticals) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DilutedEarningsLossPerShare', window );">Loss per share - diluted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (0.05)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RestatementAxis=cve_TranslatedMember', window );">Translated [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_ChangeinPresentationCurrencyDetailsScheduleofconsolidatedstatementsoflossandcomprehensivelossParentheticalsLineItems', window );"><strong>Change in Presentation Currency (Details) - Schedule of consolidated statements of loss and comprehensive loss (Parentheticals) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DilutedEarningsLossPerShare', window );">Loss per share - diluted</a></td>
<td class="num">$ (0.13)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cve_ChangeinPresentationCurrencyDetailsScheduleofconsolidatedstatementsoflossandcomprehensivelossParentheticalsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cve_ChangeinPresentationCurrencyDetailsScheduleofconsolidatedstatementsoflossandcomprehensivelossParentheticalsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cve_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DilutedEarningsLossPerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of profit (loss) attributable to ordinary equity holders of the parent entity (the numerator), divided by the weighted average number of ordinary shares outstanding during the period (the denominator), both adjusted for the effects of all dilutive potential ordinary shares. [Refer: Ordinary shares [member]; Weighted average [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 33<br> -IssueDate 2022-03-24<br> -Paragraph 66<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=33&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_66&amp;doctype=Standard<br> -URIDate 2022-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 33<br> -IssueDate 2022-03-24<br> -Paragraph 67<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=33&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_67&amp;doctype=Standard<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DilutedEarningsLossPerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RestatementAxis=srt_ScenarioPreviouslyReportedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RestatementAxis=srt_ScenarioPreviouslyReportedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RestatementAxis=cve_TranslatedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RestatementAxis=cve_TranslatedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>151
<FILENAME>R101.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139782806526368">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Events after the reporting period (Details)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="5">1 Months Ended</th>
<th class="th" colspan="1">2 Months Ended</th>
<th class="th" colspan="5">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Feb. 08, 2023 </div>
<div>CAD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Jan. 13, 2023 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 15, 2022 </div>
<div>GBP (&#163;)</div>
</th>
<th class="th">
<div>Dec. 06, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 06, 2022 </div>
<div>CAD ($) </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Aug. 31, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Aug. 04, 2022 </div>
<div>GBP (&#163;)</div>
</th>
<th class="th">
<div>Mar. 31, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Feb. 15, 2022 </div>
<div>GBP (&#163;)</div>
</th>
<th class="th">
<div>Apr. 30, 2023 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
<th class="th">
<div>Mar. 31, 2023 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Feb. 28, 2023 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
<th class="th">
<div>Jan. 16, 2023 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
<th class="th">
<div>May 24, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Feb. 14, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>CAD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>CAD ($) </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>GBP (&#163;)</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>CAD ($) </div>
<div>shares</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_EventsafterthereportingperiodDetailsLineItems', window );"><strong>Events after the reporting period (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_TransactionCosts', window );">Transaction cost</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,215,444<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Cash', window );">Cash</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,689,671<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 216,871<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BorrowingsInterestRate', window );">Interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8.00%<span></span>
</td>
<td class="nump">7.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_AcquireCommonShare', window );">Acquire common shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2.9103<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_Saleofstockpershare', window );">Sale of stock per share (in Dollars per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_PricePerShare', window );">Price per share (in Dollars per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3.75<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromDebtNetOfIssuanceCosts', window );">Net proceeds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 49,392,680<span></span>
</td>
<td class="nump">$ 66,072,588<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfSharesIssued', window );">Shares issued (in Shares) | shares</a></td>
<td class="nump">10,615,650<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">31,806,617<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">31,806,617<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">31,806,617<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_PublicOfferingPricePerShare', window );">Public offering price per share (in Dollars per share) | $ / shares</a></td>
<td class="nump">$ 3.25<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_GrossProceed', window );">Gross proceeds</a></td>
<td class="nump">$ 34,500,863<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 23,057,411<span></span>
</td>
<td class="nump">$ 30,000,000<span></span>
</td>
<td class="nump">$ 11,966,494<span></span>
</td>
<td class="nump">$ 15,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_PurchaseAgreementsAmount', window );">Agreement amount | &#163;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#163; 100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#163; 100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#163; 200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#163; 300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ConsiderationPaidReceived', window );">Total consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 250,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_InitialPayment', window );">Initial payment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_PaymentAmount', window );">Payment amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6,750,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis=cve_SubsequentEventOneMember', window );">Subsequent [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_EventsafterthereportingperiodDetailsLineItems', window );"><strong>Events after the reporting period (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfSharesIssued', window );">Shares issued (in Shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_GrossProceed', window );">Gross proceeds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 9,660,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_PurchasePricePerShare', window );">Purchase price per share (in Dollars per share) | $ / shares</a></td>
<td class="nump">$ 4.05<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_PurchasedShares', window );">Purchased shares (in Shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_TransactionCost', window );">Transaction cost</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,922,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7,050,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_PurchaseAgreementsAmount', window );">Agreement amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 650,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_OptionToAcquireShares', window );">Option to acquire shares (in Shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ConsiderationPaidReceived', window );">Total consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 8,750,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_TotalConsiderationPerPounds', window );">Total consideration per pound (in Dollars per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 43.75<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_AssetsReceivedPercentage', window );">Assets received percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">19.90%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=cve_SubsequentEventOneMember', window );">Subsequent [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_EventsafterthereportingperiodDetailsLineItems', window );"><strong>Events after the reporting period (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfSharesIssued', window );">Shares issued (in Shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">229,946<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">229,946<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_GrossProceed', window );">Gross proceeds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 391,958<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=cve_SubsequentEventTwoMember', window );">Subsequent Event [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_EventsafterthereportingperiodDetailsLineItems', window );"><strong>Events after the reporting period (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_StockOptionsSharesOutstanding', window );">Stock options shares outstanding (in Shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">75,312<span></span>
</td>
<td class="nump">75,312<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=cve_SubsequentEventThreeMember', window );">Subsequent Event [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_EventsafterthereportingperiodDetailsLineItems', window );"><strong>Events after the reporting period (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfSharesIssued', window );">Shares issued (in Shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">162,707<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">162,707<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_GrossProceed', window );">Gross proceeds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 312,985<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=cve_SubsequentEventFourMember', window );">Subsequent Event [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_EventsafterthereportingperiodDetailsLineItems', window );"><strong>Events after the reporting period (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_GrantedStockOptions', window );">Granted stock options shares (in Shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">121,681<span></span>
</td>
<td class="nump">121,681<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_WeightedAverageExercisePrice', window );">Weighted average exercise price (in Dollars per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2.91<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfLiabilitiesAxis=cve_EnergyFuelsIncMember', window );">Energy Fuels, Inc [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_EventsafterthereportingperiodDetailsLineItems', window );"><strong>Events after the reporting period (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_TransactionCosts', window );">Transaction cost</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">60,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Cash', window );">Cash</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 60,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfLiabilitiesAxis=cve_AltaMesaAcquisitionMember', window );">Alta Mesa Acquisition [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cve_EventsafterthereportingperiodDetailsLineItems', window );"><strong>Events after the reporting period (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SubscriptionCirculationRevenue', window );">Subscription receipts issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 23,277,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cve_AcquireCommonShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Acquire common shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cve_AcquireCommonShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cve_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cve_AssetsReceivedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Assets received percentage</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cve_AssetsReceivedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cve_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cve_EventsafterthereportingperiodDetailsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cve_EventsafterthereportingperiodDetailsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cve_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cve_GrantedStockOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Granted  stock options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cve_GrantedStockOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cve_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cve_GrossProceed">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Net proceeds are the amount the seller receives following the sale of an asset after all costs and expenses are deducted from the gross proceeds.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cve_GrossProceed</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cve_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cve_InitialPayment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>initial payment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cve_InitialPayment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cve_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cve_OptionToAcquireShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Option to acquire shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cve_OptionToAcquireShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cve_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cve_PaymentAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Payment amount.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cve_PaymentAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cve_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cve_PricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Price per share value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cve_PricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cve_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cve_PublicOfferingPricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Public offering price per share.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cve_PublicOfferingPricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cve_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cve_PurchaseAgreementsAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of purchase agreements amount.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cve_PurchaseAgreementsAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cve_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cve_PurchasePricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Purchase price per share.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cve_PurchasePricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cve_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cve_PurchasedShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Purchased shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cve_PurchasedShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cve_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cve_Saleofstockpershare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sale of stock per share.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cve_Saleofstockpershare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cve_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cve_StockOptionsSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Stock options shares outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cve_StockOptionsSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cve_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cve_TotalConsiderationPerPounds">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total consideration per pound.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cve_TotalConsiderationPerPounds</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cve_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cve_TransactionCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Transaction cost.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cve_TransactionCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cve_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cve_TransactionCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Transaction costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cve_TransactionCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cve_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cve_WeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average exercise price.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cve_WeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cve_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BorrowingsInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The interest rate on borrowings. [Refer: Borrowings]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IFRS<br> -Number 7<br> -IssueDate 2022-03-24<br> -Paragraph 7<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_7&amp;doctype=Standard<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BorrowingsInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_Cash">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of cash on hand and demand deposits. [Refer: Cash on hand]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2022-03-24<br> -Paragraph 45<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_45&amp;doctype=Standard<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_Cash</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ConsiderationPaidReceived">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of consideration paid or received in respect of both obtaining and losing control of subsidiaries or other businesses. [Refer: Subsidiaries [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2022-03-24<br> -Paragraph 40<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_40_a&amp;doctype=Standard<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ConsiderationPaidReceived</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NumberOfSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares issued by the entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2022-03-24<br> -Paragraph 106<br> -Subparagraph d<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_106_d&amp;doctype=Standard<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NumberOfSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SubscriptionCirculationRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of circulation revenue derived from subscriptions. [Refer: Revenue; Circulation revenue]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2022-03-24<br> -Paragraph 112<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_112_c&amp;doctype=Standard<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SubscriptionCirculationRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromDebtNetOfIssuanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from additional borrowings, net of cash paid to third parties in connection with debt origination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromDebtNetOfIssuanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis=cve_SubsequentEventOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NonadjustingEventsAfterReportingPeriodAxis=cve_SubsequentEventOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=cve_SubsequentEventOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=cve_SubsequentEventOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=cve_SubsequentEventTwoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=cve_SubsequentEventTwoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=cve_SubsequentEventThreeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=cve_SubsequentEventThreeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=cve_SubsequentEventFourMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=cve_SubsequentEventFourMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfLiabilitiesAxis=cve_EnergyFuelsIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfLiabilitiesAxis=cve_EnergyFuelsIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfLiabilitiesAxis=cve_AltaMesaAcquisitionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfLiabilitiesAxis=cve_AltaMesaAcquisitionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>152
<FILENAME>ea177383-40f_encore_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:country="http://xbrl.sec.gov/country/2022"
  xmlns:cve="http://encoreuranium.com/20221231"
  xmlns:dei="http://xbrl.sec.gov/dei/2022"
  xmlns:ifrs-full="https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:srt="http://fasb.org/srt/2022"
  xmlns:stpr="http://xbrl.sec.gov/stpr/2022"
  xmlns:us-gaap="http://fasb.org/us-gaap/2022"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xhtml="http://www.w3.org/1999/xhtml"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <link:schemaRef xlink:href="cve-20221231.xsd" xlink:type="simple"/>
    <context id="c0">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001500881</identifier>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c1">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001500881</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:EntityAddressesAddressTypeAxis">dei:BusinessContactMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c2">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001500881</identifier>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c3">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001500881</identifier>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c4">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001500881</identifier>
        </entity>
        <period>
            <instant>2021-01-31</instant>
        </period>
    </context>
    <context id="c5">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001500881</identifier>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c6">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001500881</identifier>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="c7">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001500881</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ClassesOfShareCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="c8">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001500881</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:IssuedCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="c9">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001500881</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">cve:ContributedSurplusMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="c10">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001500881</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="c11">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001500881</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="c12">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001500881</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ClassesOfShareCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c13">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001500881</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:IssuedCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c14">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001500881</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">cve:ContributedSurplusMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c15">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001500881</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c16">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001500881</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c17">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001500881</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ClassesOfShareCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c18">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001500881</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:IssuedCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c19">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001500881</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">cve:ContributedSurplusMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c20">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001500881</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c21">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001500881</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c22">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001500881</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ClassesOfShareCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c23">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001500881</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:IssuedCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c24">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001500881</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">cve:ContributedSurplusMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c25">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001500881</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c26">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001500881</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c27">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001500881</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ClassesOfShareCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c28">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001500881</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:IssuedCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c29">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001500881</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">cve:ContributedSurplusMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001500881</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001500881</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c32">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001500881</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">cve:TigrisUraniumUSCorpMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c33">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001500881</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">cve:MetaminEnterprisesUSIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c34">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001500881</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">cve:URIIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c35">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001500881</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">cve:NeutronEnergyIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c36">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001500881</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">cve:UrancoIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c37">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001500881</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">cve:UraniumResourcesIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c38">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001500881</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">cve:HRIChurchrockIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c39">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001500881</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">cve:HydroRestorationCorpMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c40">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001500881</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">cve:BeltLineResourcesIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c41">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001500881</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">cve:CibolaResourcesLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c42">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001500881</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">cve:enCoreEnergyUSCorpMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c43">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001500881</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">cve:AzargaUraniumCorpMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c44">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001500881</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">cve:PowertechUSAIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c45">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001500881</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">cve:URZEnergyCorpMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c46">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001500881</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">cve:UcoloExplorationCorpMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c47">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001500881</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">cve:AzargaResourcesLimitedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c48">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001500881</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">cve:AzargaResourcesHongKongLtdMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c49">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001500881</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">cve:AzargaResourcesUSACompanyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c50">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001500881</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">cve:AzargaResourcesCanadaLtdMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c51">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001500881</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:IntangibleAssetsWithIndefiniteUsefulLifeAxis">cve:UraniumPlantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c52">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001500881</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:IntangibleAssetsWithIndefiniteUsefulLifeAxis">cve:UraniumPlantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c53">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001500881</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:IntangibleAssetsWithIndefiniteUsefulLifeAxis">ifrs-full:OtherPropertyPlantAndEquipmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c54">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001500881</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:IntangibleAssetsWithIndefiniteUsefulLifeAxis">ifrs-full:OtherPropertyPlantAndEquipmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c55">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001500881</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:IntangibleAssetsWithIndefiniteUsefulLifeAxis">cve:SoftwareMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c56">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001500881</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:IntangibleAssetsWithIndefiniteUsefulLifeAxis">cve:SoftwareMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c57">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001500881</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:IntangibleAssetsWithIndefiniteUsefulLifeAxis">cve:FurnitureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c58">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001500881</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:IntangibleAssetsWithIndefiniteUsefulLifeAxis">cve:FurnitureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c59">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001500881</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:IntangibleAssetsWithIndefiniteUsefulLifeAxis">ifrs-full:BuildingsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c60">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001500881</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:IntangibleAssetsWithIndefiniteUsefulLifeAxis">ifrs-full:BuildingsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c61">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001500881</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">cve:DataAccessAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c62">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001500881</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">cve:DataPurchasesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c63">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001500881</identifier>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="c64">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001500881</identifier>
        </entity>
        <period>
            <startDate>2022-02-15</startDate>
            <endDate>2022-02-15</endDate>
        </period>
    </context>
    <context id="c65">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001500881</identifier>
        </entity>
        <period>
            <startDate>2022-03-31</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="c66">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001500881</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ScenarioForecastMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-03-31</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="c67">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001500881</identifier>
        </entity>
        <period>
            <startDate>2022-08-04</startDate>
            <endDate>2022-08-04</endDate>
        </period>
    </context>
    <context id="c68">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001500881</identifier>
        </entity>
        <period>
            <startDate>2022-08-31</startDate>
            <endDate>2022-08-31</endDate>
        </period>
    </context>
    <context id="c69">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001500881</identifier>
        </entity>
        <period>
            <startDate>2023-08-31</startDate>
            <endDate>2023-08-31</endDate>
        </period>
    </context>
    <context id="c70">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001500881</identifier>
        </entity>
        <period>
            <startDate>2022-12-15</startDate>
            <endDate>2022-12-15</endDate>
        </period>
    </context>
    <context id="c71">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001500881</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:UnconsolidatedStructuredEntitiesAxis">cve:Fiscal2023Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c72">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001500881</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:UnconsolidatedStructuredEntitiesAxis">cve:Fiscal2024Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c73">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001500881</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:UnconsolidatedStructuredEntitiesAxis">cve:Fiscal2025Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c74">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001500881</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:UnconsolidatedStructuredEntitiesAxis">cve:Fiscal2026Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c75">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001500881</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:UnconsolidatedStructuredEntitiesAxis">cve:Fiscal2027Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c76">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001500881</identifier>
        </entity>
        <period>
            <instant>2022-05-31</instant>
        </period>
    </context>
    <context id="c77">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001500881</identifier>
        </entity>
        <period>
            <startDate>2022-05-31</startDate>
            <endDate>2022-05-31</endDate>
        </period>
    </context>
    <context id="c78">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001500881</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">cve:MarketableSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c79">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001500881</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfOrdinarySharesAxis">cve:TradingSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c80">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001500881</identifier>
        </entity>
        <period>
            <instant>2022-10-31</instant>
        </period>
    </context>
    <context id="c81">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001500881</identifier>
        </entity>
        <period>
            <startDate>2022-10-31</startDate>
            <endDate>2022-10-31</endDate>
        </period>
    </context>
    <context id="c82">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001500881</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">cve:MarketableSecuritiescurrentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c83">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001500881</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">cve:MarketableSecuritiesnoncurrentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c84">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001500881</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">cve:MarketableSecuritiescurrentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c85">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001500881</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">cve:MarketableSecuritiesnoncurrentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c86">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001500881</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">cve:MarketableSecuritiescurrentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c87">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001500881</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">cve:MarketableSecuritiesnoncurrentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c88">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001500881</identifier>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="c89">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001500881</identifier>
        </entity>
        <period>
            <startDate>2018-12-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="c90">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001500881</identifier>
        </entity>
        <period>
            <startDate>2020-12-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="c91">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001500881</identifier>
        </entity>
        <period>
            <startDate>2021-12-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c92">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001500881</identifier>
        </entity>
        <period>
            <startDate>2022-12-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c93">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001500881</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">cve:VANEAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="c94">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001500881</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">cve:SignalEquitiesDatabaseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="c95">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001500881</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">cve:GrantsMineralBeltDatabaseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="c96">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001500881</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">cve:GrantsMineralBeltDatabaseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c97">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001500881</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">cve:VANEAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c98">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001500881</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">cve:VANEAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c99">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001500881</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">cve:SignalEquitiesDatabaseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c100">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001500881</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">cve:GrantsMineralBeltDatabaseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c101">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001500881</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">cve:GettyDatabaseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c102">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001500881</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">cve:VANEAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c103">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001500881</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">cve:VANEAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c104">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001500881</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">cve:GettyDatabaseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c105">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001500881</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">cve:SignalEquitiesDatabaseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c106">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001500881</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">cve:GrantsMineralBeltDatabaseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c107">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001500881</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">cve:UraniumPlantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="c108">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001500881</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:OtherPropertyPlantAndEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="c109">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001500881</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">cve:FurnitureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="c110">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001500881</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:BuildingsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="c111">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001500881</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">cve:SoftwareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="c112">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001500881</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">cve:UraniumPlantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c113">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001500881</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:OtherPropertyPlantAndEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c114">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001500881</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">cve:FurnitureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c115">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001500881</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:BuildingsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c116">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001500881</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">cve:SoftwareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c117">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001500881</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">cve:UraniumPlantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c118">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001500881</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:OtherPropertyPlantAndEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c119">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001500881</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">cve:FurnitureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c120">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001500881</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:BuildingsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c121">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001500881</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">cve:SoftwareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c122">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001500881</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">cve:UraniumPlantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c123">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001500881</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:OtherPropertyPlantAndEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c124">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001500881</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">cve:FurnitureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c125">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001500881</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:BuildingsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c126">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001500881</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">cve:SoftwareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c127">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001500881</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">cve:UraniumPlantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c128">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001500881</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:OtherPropertyPlantAndEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c129">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001500881</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">cve:FurnitureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c130">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001500881</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:BuildingsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001500881</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">cve:SoftwareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c132">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001500881</identifier>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-07-01</endDate>
        </period>
    </context>
    <context id="c133">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001500881</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">ifrs-full:RightofuseAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c134">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001500881</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">cve:LeasedCopierMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="c135">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001500881</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">cve:LeasedOfficesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="c136">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001500881</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">cve:LeasedCopierMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c137">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001500881</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">cve:LeasedOfficesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c138">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001500881</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">cve:LeasedCopierMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c139">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001500881</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">cve:LeasedOfficesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c140">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001500881</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">cve:LeasedCopierMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c141">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001500881</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">cve:LeasedOfficesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c142">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001500881</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">cve:LeasedCopierMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c143">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001500881</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">cve:LeasedOfficesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c144">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001500881</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">cve:ReplacementOptionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c145">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001500881</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">cve:ReplacementOptionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c146">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001500881</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">cve:ReplacementOptionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="c147">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001500881</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">cve:ReplacementOptionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-09-30</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="c148">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001500881</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">cve:ReplacementOptionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="c149">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001500881</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">cve:ReplacementOptionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="c150">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001500881</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">cve:ReplacementWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="c151">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001500881</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">cve:ReplacementWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-09-30</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="c152">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001500881</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">cve:ReplacementWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="c153">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001500881</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">cve:ReplacementWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="c154">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001500881</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">cve:OptionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c155">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001500881</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">cve:OptionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c156">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001500881</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:WarrantReserveMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c157">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001500881</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:WarrantReserveMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c158">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001500881</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">ifrs-full:ContingentConsiderationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c159">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001500881</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">cve:TriStateGenerationAndTransmissionAssociationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-03-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="c160">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001500881</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">cve:WildcatSolarPowerPlantLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-05-01</startDate>
            <endDate>2021-05-31</endDate>
        </period>
    </context>
    <context id="c161">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001500881</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">cve:McKinleyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c162">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001500881</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">cve:CrownpointMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c163">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001500881</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">cve:HostaButteMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c164">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001500881</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">cve:CrownpointMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c165">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001500881</identifier>
        </entity>
        <period>
            <startDate>2022-05-01</startDate>
            <endDate>2022-05-24</endDate>
        </period>
    </context>
    <context id="c166">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001500881</identifier>
        </entity>
        <period>
            <instant>2022-05-24</instant>
        </period>
    </context>
    <context id="c167">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001500881</identifier>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-01-31</endDate>
        </period>
    </context>
    <context id="c168">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001500881</identifier>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="c169">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001500881</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">cve:PrimeFuelsCorpMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-20</instant>
        </period>
    </context>
    <context id="c170">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001500881</identifier>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="c171">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001500881</identifier>
        </entity>
        <period>
            <startDate>2022-06-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="c172">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001500881</identifier>
        </entity>
        <period>
            <instant>2022-06-20</instant>
        </period>
    </context>
    <context id="c173">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001500881</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">stpr:AZ</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="c174">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001500881</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">stpr:CO</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="c175">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001500881</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">stpr:NM</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="c176">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001500881</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">stpr:SD</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="c177">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001500881</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">stpr:TX</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="c178">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001500881</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">stpr:UT</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="c179">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001500881</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">stpr:WY</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="c180">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001500881</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:CA</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="c181">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001500881</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">stpr:AZ</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c182">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001500881</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">stpr:CO</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c183">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001500881</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">stpr:NM</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c184">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001500881</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">stpr:SD</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c185">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001500881</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">stpr:TX</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c186">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001500881</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">stpr:UT</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c187">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001500881</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">stpr:WY</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c188">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001500881</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:CA</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c189">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001500881</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">stpr:AZ</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c190">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001500881</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">stpr:CO</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c191">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001500881</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">stpr:NM</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c192">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001500881</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">stpr:SD</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c193">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001500881</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">stpr:TX</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c194">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001500881</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">stpr:UT</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c195">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001500881</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">stpr:WY</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c196">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001500881</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:CA</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c197">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001500881</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">cve:ExplorationCostMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">stpr:AZ</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c198">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001500881</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">cve:ExplorationCostMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">stpr:CO</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c199">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001500881</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">cve:ExplorationCostMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">stpr:NM</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c200">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001500881</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">cve:ExplorationCostMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">stpr:SD</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c201">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001500881</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">cve:ExplorationCostMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">stpr:TX</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c202">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001500881</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">cve:ExplorationCostMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">stpr:UT</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c203">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001500881</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">cve:ExplorationCostMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">stpr:WY</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c204">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001500881</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">cve:ExplorationCostMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c205">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001500881</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">stpr:AZ</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c206">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001500881</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">stpr:CO</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c207">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001500881</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">stpr:NM</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c208">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001500881</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">stpr:SD</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c209">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001500881</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">stpr:TX</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c210">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001500881</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">stpr:UT</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c211">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001500881</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">stpr:WY</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c212">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001500881</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">stpr:AZ</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c213">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001500881</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">stpr:CO</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c214">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001500881</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">stpr:NM</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c215">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001500881</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">stpr:SD</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c216">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001500881</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">stpr:TX</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c217">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001500881</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">stpr:UT</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c218">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001500881</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">stpr:WY</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c219">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001500881</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:CA</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c220">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001500881</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">cve:KingsvilleMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c221">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001500881</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">cve:KingsvilleMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c222">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001500881</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">cve:RositaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c223">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001500881</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">cve:RositaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c224">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001500881</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">cve:VasquezMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c225">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001500881</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">cve:VasquezMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c226">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001500881</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">cve:CentennialMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c227">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001500881</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">cve:CentennialMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c228">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001500881</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">cve:GasHillsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c229">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001500881</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">cve:GasHillsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c230">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001500881</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">cve:TicabooMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001500881</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">cve:TicabooMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c232">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001500881</identifier>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-07-31</endDate>
        </period>
    </context>
    <context id="c233">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001500881</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">cve:WarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c234">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001500881</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">cve:StockOptionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c235">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001500881</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">cve:WarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c236">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001500881</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">cve:StockOptionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c237">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001500881</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:RangesOfExercisePricesForOutstandingShareOptionsAxis">cve:ZeroOneEightOneNineTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c238">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001500881</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:RangesOfExercisePricesForOutstandingShareOptionsAxis">cve:ZeroOneEightOneNineTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c239">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001500881</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:RangesOfExercisePricesForOutstandingShareOptionsAxis">cve:TwoFourZeroThreeSevenEightMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c240">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001500881</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:RangesOfExercisePricesForOutstandingShareOptionsAxis">cve:TwoFourZeroThreeSevenEightMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c241">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001500881</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:RangesOfExercisePricesForOutstandingShareOptionsAxis">cve:FourTwoZeroFiveSevenSixMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c242">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001500881</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:RangesOfExercisePricesForOutstandingShareOptionsAxis">cve:FourTwoZeroFiveSevenSixMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c243">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001500881</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:RangesOfExercisePricesForOutstandingShareOptionsAxis">cve:OneFiveNineOneEightZeroMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c244">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001500881</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:RangesOfExercisePricesForOutstandingShareOptionsAxis">cve:TwoTwoTwoThreeNineZeroOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c245">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001500881</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:RangesOfExercisePricesForOutstandingShareOptionsAxis">cve:FourFiveNineSixZeroZeroMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c246">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001500881</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">cve:PlatoroWestIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c247">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001500881</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">cve:PlatoroWestIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c248">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001500881</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">cve:TintinaHoldingsLtdMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c249">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001500881</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">cve:TintinaHoldingsLtdMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c250">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001500881</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">cve:TintinaHoldingsLtdMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-01-01</instant>
        </period>
    </context>
    <context id="c251">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001500881</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">cve:OfficersAndBoardMembersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c252">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001500881</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">cve:OfficersAndBoardMembersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c253">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001500881</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">cve:OfficersAndBoardMembersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-01-01</instant>
        </period>
    </context>
    <context id="c254">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001500881</identifier>
        </entity>
        <period>
            <instant>2021-01-01</instant>
        </period>
    </context>
    <context id="c255">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001500881</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">cve:OtherStatesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c256">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001500881</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">cve:OtherStatesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c257">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001500881</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:RetrospectiveApplicationAndRetrospectiveRestatementAxis">ifrs-full:PreviouslyStatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c258">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001500881</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:RetrospectiveApplicationAndRetrospectiveRestatementAxis">cve:TranslatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c259">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001500881</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:RetrospectiveApplicationAndRetrospectiveRestatementAxis">ifrs-full:PreviouslyStatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c260">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001500881</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:RetrospectiveApplicationAndRetrospectiveRestatementAxis">cve:TranslatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c261">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001500881</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c262">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001500881</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">cve:TranslatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c263">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001500881</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">cve:EnergyFuelsIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-02-14</instant>
        </period>
    </context>
    <context id="c264">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001500881</identifier>
        </entity>
        <period>
            <instant>2022-02-14</instant>
        </period>
    </context>
    <context id="c265">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001500881</identifier>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-02-14</endDate>
        </period>
    </context>
    <context id="c266">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001500881</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">cve:AltaMesaAcquisitionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-12-01</startDate>
            <endDate>2022-12-06</endDate>
        </period>
    </context>
    <context id="c267">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001500881</identifier>
        </entity>
        <period>
            <startDate>2022-12-01</startDate>
            <endDate>2022-12-06</endDate>
        </period>
    </context>
    <context id="c268">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001500881</identifier>
        </entity>
        <period>
            <instant>2023-02-08</instant>
        </period>
    </context>
    <context id="c269">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001500881</identifier>
        </entity>
        <period>
            <startDate>2023-02-01</startDate>
            <endDate>2023-02-08</endDate>
        </period>
    </context>
    <context id="c270">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001500881</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:NonadjustingEventsAfterReportingPeriodAxis">cve:SubsequentEventOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-02-01</startDate>
            <endDate>2023-02-08</endDate>
        </period>
    </context>
    <context id="c271">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001500881</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">cve:SubsequentEventOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c272">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001500881</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">cve:SubsequentEventOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c273">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001500881</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">cve:SubsequentEventTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c274">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001500881</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">cve:SubsequentEventThreeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c275">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001500881</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">cve:SubsequentEventThreeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c276">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001500881</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">cve:SubsequentEventFourMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c277">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001500881</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:NonadjustingEventsAfterReportingPeriodAxis">cve:SubsequentEventOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-01-13</endDate>
        </period>
    </context>
    <context id="c278">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001500881</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:NonadjustingEventsAfterReportingPeriodAxis">cve:SubsequentEventOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-01-16</instant>
        </period>
    </context>
    <context id="c279">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001500881</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:NonadjustingEventsAfterReportingPeriodAxis">cve:SubsequentEventOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-01-16</endDate>
        </period>
    </context>
    <context id="c280">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001500881</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:NonadjustingEventsAfterReportingPeriodAxis">cve:SubsequentEventOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-02-01</startDate>
            <endDate>2023-02-28</endDate>
        </period>
    </context>
    <context id="c281">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001500881</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:NonadjustingEventsAfterReportingPeriodAxis">cve:SubsequentEventOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-03-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="c282">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001500881</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:NonadjustingEventsAfterReportingPeriodAxis">cve:SubsequentEventOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-30</instant>
        </period>
    </context>
    <context id="c283">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001500881</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:NonadjustingEventsAfterReportingPeriodAxis">cve:SubsequentEventOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-04-30</endDate>
        </period>
    </context>
    <unit id="shares">
        <measure>shares</measure>
    </unit>
    <unit id="usd">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="usdPershares">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="pure">
        <measure>pure</measure>
    </unit>
    <unit id="cad">
        <measure>iso4217:CAD</measure>
    </unit>
    <unit id="gbp">
        <measure>iso4217:GBP</measure>
    </unit>
    <unit id="cadPershares">
        <divide>
            <unitNumerator>
                <measure>iso4217:CAD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <dei:DocumentType contextRef="c0">40-F</dei:DocumentType>
    <dei:DocumentRegistrationStatement contextRef="c0">false</dei:DocumentRegistrationStatement>
    <dei:DocumentAnnualReport contextRef="c0">true</dei:DocumentAnnualReport>
    <dei:DocumentPeriodEndDate contextRef="c0">2022-12-31</dei:DocumentPeriodEndDate>
    <dei:CurrentFiscalYearEndDate contextRef="c0">--12-31</dei:CurrentFiscalYearEndDate>
    <dei:DocumentFiscalYearFocus contextRef="c0">2022</dei:DocumentFiscalYearFocus>
    <dei:EntityFileNumber contextRef="c0">001-41489</dei:EntityFileNumber>
    <dei:EntityRegistrantName contextRef="c0">enCore Energy Corp.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="c0">Z4</dei:EntityIncorporationStateCountryCode>
    <dei:EntityAddressAddressLine1 contextRef="c0">101 N. Shoreline Blvd.</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2 contextRef="c0">Suite 450</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown contextRef="c0">Corpus Christi</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="c0">TX</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="c0">78401</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="c0">361</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="c0">239-5449</dei:LocalPhoneNumber>
    <dei:ContactPersonnelName contextRef="c1">Cogency Global Inc.</dei:ContactPersonnelName>
    <dei:EntityAddressAddressLine1 contextRef="c1">122 E. 42nd Street</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2 contextRef="c1">18th Floor</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown contextRef="c1">New York</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="c1">NY</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="c1">10168</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="c1">800</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="c1">221-0102</dei:LocalPhoneNumber>
    <dei:Security12bTitle contextRef="c0">Common Shares</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="c0">EU</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="c0">NYSEAMER</dei:SecurityExchangeName>
    <dei:AnnualInformationForm contextRef="c0">true</dei:AnnualInformationForm>
    <dei:AuditedAnnualFinancialStatements contextRef="c0">true</dei:AuditedAnnualFinancialStatements>
    <dei:EntityCommonStockSharesOutstanding contextRef="c2" decimals="INF" unitRef="shares">108940051</dei:EntityCommonStockSharesOutstanding>
    <dei:EntityCurrentReportingStatus contextRef="c0">Yes</dei:EntityCurrentReportingStatus>
    <dei:EntityInteractiveDataCurrent contextRef="c0">Yes</dei:EntityInteractiveDataCurrent>
    <dei:EntityEmergingGrowthCompany contextRef="c0">true</dei:EntityEmergingGrowthCompany>
    <dei:EntityExTransitionPeriod contextRef="c0">false</dei:EntityExTransitionPeriod>
    <dei:IcfrAuditorAttestationFlag contextRef="c0">false</dei:IcfrAuditorAttestationFlag>
    <dei:AuditorName contextRef="c0">Davidson &amp; Company LLP</dei:AuditorName>
    <dei:AuditorLocation contextRef="c0">Vancouver, British Columbia, Canada</dei:AuditorLocation>
    <dei:AuditorFirmId contextRef="c0">731</dei:AuditorFirmId>
    <ifrs-full:CashAndCashEquivalents contextRef="c2" decimals="0" unitRef="usd">2512012</ifrs-full:CashAndCashEquivalents>
    <ifrs-full:CashAndCashEquivalents contextRef="c3" decimals="0" unitRef="usd">9188483</ifrs-full:CashAndCashEquivalents>
    <ifrs-full:CashAndCashEquivalents contextRef="c4" decimals="0" unitRef="usd">5182249</ifrs-full:CashAndCashEquivalents>
    <ifrs-full:TradeAndOtherReceivables contextRef="c2" decimals="0" unitRef="usd">1244561</ifrs-full:TradeAndOtherReceivables>
    <ifrs-full:TradeAndOtherReceivables contextRef="c3" decimals="0" unitRef="usd">627181</ifrs-full:TradeAndOtherReceivables>
    <ifrs-full:TradeAndOtherReceivables contextRef="c4" decimals="0" unitRef="usd">254092</ifrs-full:TradeAndOtherReceivables>
    <cve:MarketableSecuritiecurrent contextRef="c2" decimals="0" unitRef="usd">3162361</cve:MarketableSecuritiecurrent>
    <cve:DepositUraniumInvestment contextRef="c2" decimals="0" unitRef="usd">3000000</cve:DepositUraniumInvestment>
    <ifrs-full:NoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSaleOrAsHeldForDistributionToOwners contextRef="c2" decimals="0" unitRef="usd">728882</ifrs-full:NoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSaleOrAsHeldForDistributionToOwners>
    <ifrs-full:NoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSaleOrAsHeldForDistributionToOwners contextRef="c3" decimals="0" unitRef="usd">1741064</ifrs-full:NoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSaleOrAsHeldForDistributionToOwners>
    <ifrs-full:CurrentAssets contextRef="c2" decimals="0" unitRef="usd">10647816</ifrs-full:CurrentAssets>
    <ifrs-full:CurrentAssets contextRef="c3" decimals="0" unitRef="usd">11556728</ifrs-full:CurrentAssets>
    <ifrs-full:CurrentAssets contextRef="c4" decimals="0" unitRef="usd">5436341</ifrs-full:CurrentAssets>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill contextRef="c2" decimals="0" unitRef="usd">528282</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill contextRef="c3" decimals="0" unitRef="usd">491996</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill contextRef="c4" decimals="0" unitRef="usd">483631</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <ifrs-full:PropertyPlantAndEquipment contextRef="c2" decimals="0" unitRef="usd">2334421</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment contextRef="c3" decimals="0" unitRef="usd">1603679</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment contextRef="c4" decimals="0" unitRef="usd">1484836</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:InvestmentsInAssociates contextRef="c3" decimals="0" unitRef="usd">564340</ifrs-full:InvestmentsInAssociates>
    <ifrs-full:InvestmentsInAssociates contextRef="c4" decimals="0" unitRef="usd">451221</ifrs-full:InvestmentsInAssociates>
    <ifrs-full:InvestmentsInSubsidiariesJointVenturesAndAssociates contextRef="c3" decimals="0" unitRef="usd">4210000</ifrs-full:InvestmentsInSubsidiariesJointVenturesAndAssociates>
    <cve:MarketablesSecuritiesNoncurrent contextRef="c2" decimals="0" unitRef="usd">784832</cve:MarketablesSecuritiesNoncurrent>
    <ifrs-full:MiningAssets contextRef="c2" decimals="0" unitRef="usd">145219086</ifrs-full:MiningAssets>
    <ifrs-full:MiningAssets contextRef="c3" decimals="0" unitRef="usd">136079578</ifrs-full:MiningAssets>
    <ifrs-full:MiningAssets contextRef="c4" decimals="0" unitRef="usd">6608060</ifrs-full:MiningAssets>
    <ifrs-full:LongtermDeposits contextRef="c2" decimals="0" unitRef="usd">88500</ifrs-full:LongtermDeposits>
    <ifrs-full:LongtermDeposits contextRef="c3" decimals="0" unitRef="usd">88500</ifrs-full:LongtermDeposits>
    <ifrs-full:LongtermDeposits contextRef="c4" decimals="0" unitRef="usd">85500</ifrs-full:LongtermDeposits>
    <ifrs-full:RightofuseAssets contextRef="c2" decimals="0" unitRef="usd">185614</ifrs-full:RightofuseAssets>
    <ifrs-full:RightofuseAssets contextRef="c3" decimals="0" unitRef="usd">244564</ifrs-full:RightofuseAssets>
    <ifrs-full:RightofuseAssets contextRef="c4" decimals="0" unitRef="usd">8867</ifrs-full:RightofuseAssets>
    <ifrs-full:DeferredTaxAssets contextRef="c2" decimals="0" unitRef="usd">6009303</ifrs-full:DeferredTaxAssets>
    <ifrs-full:NoncurrentFinancialAssets contextRef="c2" decimals="0" unitRef="usd">3162936</ifrs-full:NoncurrentFinancialAssets>
    <ifrs-full:RestrictedCashAndCashEquivalents contextRef="c2" decimals="0" unitRef="usd">54568668</ifrs-full:RestrictedCashAndCashEquivalents>
    <ifrs-full:RestrictedCashAndCashEquivalents contextRef="c3" decimals="0" unitRef="usd">4517139</ifrs-full:RestrictedCashAndCashEquivalents>
    <ifrs-full:RestrictedCashAndCashEquivalents contextRef="c4" decimals="0" unitRef="usd">3796788</ifrs-full:RestrictedCashAndCashEquivalents>
    <ifrs-full:Assets contextRef="c2" decimals="0" unitRef="usd">223529458</ifrs-full:Assets>
    <ifrs-full:Assets contextRef="c3" decimals="0" unitRef="usd">159356524</ifrs-full:Assets>
    <ifrs-full:Assets contextRef="c4" decimals="0" unitRef="usd">18355244</ifrs-full:Assets>
    <ifrs-full:TradeAndOtherCurrentPayables contextRef="c2" decimals="0" unitRef="usd">3105065</ifrs-full:TradeAndOtherCurrentPayables>
    <ifrs-full:TradeAndOtherCurrentPayables contextRef="c3" decimals="0" unitRef="usd">5835116</ifrs-full:TradeAndOtherCurrentPayables>
    <ifrs-full:TradeAndOtherCurrentPayables contextRef="c4" decimals="0" unitRef="usd">368056</ifrs-full:TradeAndOtherCurrentPayables>
    <ifrs-full:TradeAndOtherCurrentPayablesToRelatedParties contextRef="c2" decimals="0" unitRef="usd">441374</ifrs-full:TradeAndOtherCurrentPayablesToRelatedParties>
    <ifrs-full:TradeAndOtherCurrentPayablesToRelatedParties contextRef="c3" decimals="0" unitRef="usd">6893</ifrs-full:TradeAndOtherCurrentPayablesToRelatedParties>
    <ifrs-full:TradeAndOtherCurrentPayablesToRelatedParties contextRef="c4" decimals="0" unitRef="usd">2319</ifrs-full:TradeAndOtherCurrentPayablesToRelatedParties>
    <ifrs-full:OtherCurrentPayables contextRef="c4" decimals="0" unitRef="usd">330935</ifrs-full:OtherCurrentPayables>
    <ifrs-full:CurrentLeaseLiabilities contextRef="c2" decimals="0" unitRef="usd">84262</ifrs-full:CurrentLeaseLiabilities>
    <ifrs-full:CurrentLeaseLiabilities contextRef="c3" decimals="0" unitRef="usd">82116</ifrs-full:CurrentLeaseLiabilities>
    <ifrs-full:CurrentLeaseLiabilities contextRef="c4" decimals="0" unitRef="usd">5746</ifrs-full:CurrentLeaseLiabilities>
    <ifrs-full:CurrentLiabilities contextRef="c2" decimals="0" unitRef="usd">3630701</ifrs-full:CurrentLiabilities>
    <ifrs-full:CurrentLiabilities contextRef="c3" decimals="0" unitRef="usd">5924125</ifrs-full:CurrentLiabilities>
    <ifrs-full:CurrentLiabilities contextRef="c4" decimals="0" unitRef="usd">707056</ifrs-full:CurrentLiabilities>
    <ifrs-full:DefinedBenefitObligationAtPresentValue contextRef="c2" decimals="0" unitRef="usd">4752352</ifrs-full:DefinedBenefitObligationAtPresentValue>
    <ifrs-full:DefinedBenefitObligationAtPresentValue contextRef="c3" decimals="0" unitRef="usd">4176493</ifrs-full:DefinedBenefitObligationAtPresentValue>
    <ifrs-full:DefinedBenefitObligationAtPresentValue contextRef="c4" decimals="0" unitRef="usd">5239108</ifrs-full:DefinedBenefitObligationAtPresentValue>
    <ifrs-full:NoncurrentLeaseLiabilities contextRef="c2" decimals="0" unitRef="usd">96166</ifrs-full:NoncurrentLeaseLiabilities>
    <ifrs-full:NoncurrentLeaseLiabilities contextRef="c3" decimals="0" unitRef="usd">167393</ifrs-full:NoncurrentLeaseLiabilities>
    <ifrs-full:NoncurrentLeaseLiabilities contextRef="c4" decimals="0" unitRef="usd">3121</ifrs-full:NoncurrentLeaseLiabilities>
    <ifrs-full:Liabilities contextRef="c2" decimals="0" unitRef="usd">8479219</ifrs-full:Liabilities>
    <ifrs-full:Liabilities contextRef="c3" decimals="0" unitRef="usd">10268011</ifrs-full:Liabilities>
    <ifrs-full:Liabilities contextRef="c4" decimals="0" unitRef="usd">5949285</ifrs-full:Liabilities>
    <ifrs-full:IssuedCapital contextRef="c2" decimals="0" unitRef="usd">190610250</ifrs-full:IssuedCapital>
    <ifrs-full:IssuedCapital contextRef="c3" decimals="0" unitRef="usd">162582365</ifrs-full:IssuedCapital>
    <ifrs-full:IssuedCapital contextRef="c4" decimals="0" unitRef="usd">26653141</ifrs-full:IssuedCapital>
    <ifrs-full:SharePremium contextRef="c2" decimals="0" unitRef="usd">51558624</ifrs-full:SharePremium>
    <cve:ContributedSurplus contextRef="c2" decimals="0" unitRef="usd">16218518</cve:ContributedSurplus>
    <cve:ContributedSurplus contextRef="c3" decimals="0" unitRef="usd">12662103</cve:ContributedSurplus>
    <cve:ContributedSurplus contextRef="c4" decimals="0" unitRef="usd">2019445</cve:ContributedSurplus>
    <ifrs-full:AccumulatedOtherComprehensiveIncome contextRef="c2" decimals="0" unitRef="usd">5530224</ifrs-full:AccumulatedOtherComprehensiveIncome>
    <ifrs-full:AccumulatedOtherComprehensiveIncome contextRef="c3" decimals="0" unitRef="usd">6196033</ifrs-full:AccumulatedOtherComprehensiveIncome>
    <ifrs-full:AccumulatedOtherComprehensiveIncome contextRef="c4" decimals="0" unitRef="usd">7521888</ifrs-full:AccumulatedOtherComprehensiveIncome>
    <ifrs-full:RetainedEarnings contextRef="c2" decimals="0" unitRef="usd">-48867377</ifrs-full:RetainedEarnings>
    <ifrs-full:RetainedEarnings contextRef="c3" decimals="0" unitRef="usd">-32351988</ifrs-full:RetainedEarnings>
    <ifrs-full:RetainedEarnings contextRef="c4" decimals="0" unitRef="usd">-23788515</ifrs-full:RetainedEarnings>
    <ifrs-full:Equity contextRef="c2" decimals="0" unitRef="usd">215050239</ifrs-full:Equity>
    <ifrs-full:Equity contextRef="c3" decimals="0" unitRef="usd">149088513</ifrs-full:Equity>
    <ifrs-full:Equity contextRef="c4" decimals="0" unitRef="usd">12405959</ifrs-full:Equity>
    <ifrs-full:EquityAndLiabilities contextRef="c2" decimals="0" unitRef="usd">223529458</ifrs-full:EquityAndLiabilities>
    <ifrs-full:EquityAndLiabilities contextRef="c3" decimals="0" unitRef="usd">159356524</ifrs-full:EquityAndLiabilities>
    <ifrs-full:EquityAndLiabilities contextRef="c4" decimals="0" unitRef="usd">18355244</ifrs-full:EquityAndLiabilities>
    <cve:AccretionExpenses contextRef="c0" decimals="0" unitRef="usd">445190</cve:AccretionExpenses>
    <cve:AccretionExpenses contextRef="c5" decimals="0" unitRef="usd">408181</cve:AccretionExpenses>
    <ifrs-full:DepreciationAndAmortisationExpense contextRef="c0" decimals="0" unitRef="usd">380336</ifrs-full:DepreciationAndAmortisationExpense>
    <ifrs-full:DepreciationAndAmortisationExpense contextRef="c5" decimals="0" unitRef="usd">298666</ifrs-full:DepreciationAndAmortisationExpense>
    <cve:CommunityEngagement contextRef="c0" decimals="0" unitRef="usd">44110</cve:CommunityEngagement>
    <cve:Consulting contextRef="c0" decimals="0" unitRef="usd">258495</cve:Consulting>
    <cve:Consulting contextRef="c5" decimals="0" unitRef="usd">72726</cve:Consulting>
    <ifrs-full:GeneralAndAdministrativeExpense contextRef="c0" decimals="0" unitRef="usd">4731367</ifrs-full:GeneralAndAdministrativeExpense>
    <ifrs-full:GeneralAndAdministrativeExpense contextRef="c5" decimals="0" unitRef="usd">3533474</ifrs-full:GeneralAndAdministrativeExpense>
    <ifrs-full:ImpairmentLossImpairmentGainAndReversalOfImpairmentLossDeterminedInAccordanceWithIFRS9 contextRef="c5" decimals="0" unitRef="usd">78456</ifrs-full:ImpairmentLossImpairmentGainAndReversalOfImpairmentLossDeterminedInAccordanceWithIFRS9>
    <ifrs-full:InterestExpense contextRef="c0" decimals="0" unitRef="usd">2556</ifrs-full:InterestExpense>
    <ifrs-full:AdministrativeExpense contextRef="c0" decimals="0" unitRef="usd">137551</ifrs-full:AdministrativeExpense>
    <ifrs-full:AdministrativeExpense contextRef="c5" decimals="0" unitRef="usd">197391</ifrs-full:AdministrativeExpense>
    <ifrs-full:ProfessionalFeesExpense contextRef="c0" decimals="0" unitRef="usd">1944668</ifrs-full:ProfessionalFeesExpense>
    <ifrs-full:ProfessionalFeesExpense contextRef="c5" decimals="0" unitRef="usd">581408</ifrs-full:ProfessionalFeesExpense>
    <cve:ProjectInvestigationFess contextRef="c0" decimals="0" unitRef="usd">1519</cve:ProjectInvestigationFess>
    <ifrs-full:CommunicationExpense contextRef="c0" decimals="0" unitRef="usd">287887</ifrs-full:CommunicationExpense>
    <ifrs-full:CommunicationExpense contextRef="c5" decimals="0" unitRef="usd">166096</ifrs-full:CommunicationExpense>
    <ifrs-full:ReclassificationAdjustmentsOnChangeInValueOfForwardElementsOfForwardContractsNetOfTax contextRef="c5" decimals="0" unitRef="usd">709399</ifrs-full:ReclassificationAdjustmentsOnChangeInValueOfForwardElementsOfForwardContractsNetOfTax>
    <ifrs-full:TravelExpense contextRef="c0" decimals="0" unitRef="usd">312236</ifrs-full:TravelExpense>
    <ifrs-full:TravelExpense contextRef="c5" decimals="0" unitRef="usd">26609</ifrs-full:TravelExpense>
    <cve:TransferAgentAndFilingFees contextRef="c0" decimals="0" unitRef="usd">322792</cve:TransferAgentAndFilingFees>
    <cve:TransferAgentAndFilingFees contextRef="c5" decimals="0" unitRef="usd">133717</cve:TransferAgentAndFilingFees>
    <ifrs-full:WagesAndSalaries contextRef="c0" decimals="0" unitRef="usd">4130741</ifrs-full:WagesAndSalaries>
    <ifrs-full:WagesAndSalaries contextRef="c5" decimals="0" unitRef="usd">1582326</ifrs-full:WagesAndSalaries>
    <ifrs-full:ExpenseFromSharebasedPaymentTransactionsWithEmployees contextRef="c0" decimals="0" unitRef="usd">5744655</ifrs-full:ExpenseFromSharebasedPaymentTransactionsWithEmployees>
    <ifrs-full:ExpenseFromSharebasedPaymentTransactionsWithEmployees contextRef="c5" decimals="0" unitRef="usd">1425645</ifrs-full:ExpenseFromSharebasedPaymentTransactionsWithEmployees>
    <ifrs-full:ProfitLossFromOperatingActivities contextRef="c0" decimals="0" unitRef="usd">-18744103</ifrs-full:ProfitLossFromOperatingActivities>
    <ifrs-full:ProfitLossFromOperatingActivities contextRef="c5" decimals="0" unitRef="usd">-9214094</ifrs-full:ProfitLossFromOperatingActivities>
    <ifrs-full:RevenueFromInterest contextRef="c0" decimals="0" unitRef="usd">406132</ifrs-full:RevenueFromInterest>
    <ifrs-full:RevenueFromInterest contextRef="c5" decimals="0" unitRef="usd">20987</ifrs-full:RevenueFromInterest>
    <cve:LossOnWriteoffOfSalesTaxRecoverable contextRef="c0" decimals="0" unitRef="usd">91289</cve:LossOnWriteoffOfSalesTaxRecoverable>
    <ifrs-full:GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss contextRef="c0" decimals="0" unitRef="usd">-58456</ifrs-full:GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss>
    <ifrs-full:GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss contextRef="c5" decimals="0" unitRef="usd">27265</ifrs-full:GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss>
    <ifrs-full:GainsLossesOnDisposalsOfPropertyPlantAndEquipment contextRef="c0" decimals="0" unitRef="usd">29148</ifrs-full:GainsLossesOnDisposalsOfPropertyPlantAndEquipment>
    <ifrs-full:GainsLossesOnDisposalsOfPropertyPlantAndEquipment contextRef="c5" decimals="0" unitRef="usd">-89914</ifrs-full:GainsLossesOnDisposalsOfPropertyPlantAndEquipment>
    <ifrs-full:GainLossOnRemeasurementOfReimbursementRights contextRef="c0" decimals="0" unitRef="usd">157227</ifrs-full:GainLossOnRemeasurementOfReimbursementRights>
    <ifrs-full:GainLossOnRemeasurementOfReimbursementRights contextRef="c5" decimals="0" unitRef="usd">-1719943</ifrs-full:GainLossOnRemeasurementOfReimbursementRights>
    <cve:GainOnDisposalOfSubsidiary contextRef="c0" decimals="0" unitRef="usd">1594901</cve:GainOnDisposalOfSubsidiary>
    <cve:LossOnContractTerminations contextRef="c5" decimals="0" unitRef="usd">2750000</cve:LossOnContractTerminations>
    <cve:UnrealizedGainOnUraniumInvestment contextRef="c5" decimals="0" unitRef="usd">1554000</cve:UnrealizedGainOnUraniumInvestment>
    <cve:GainOnSaleOfUraniumInvestment contextRef="c0" decimals="0" unitRef="usd">35000</cve:GainOnSaleOfUraniumInvestment>
    <cve:GainOnSaleOfUraniumInvestment contextRef="c5" decimals="0" unitRef="usd">524075</cve:GainOnSaleOfUraniumInvestment>
    <cve:UnrealizedGainOnMarketableSecurities contextRef="c0" decimals="0" unitRef="usd">1057405</cve:UnrealizedGainOnMarketableSecurities>
    <ifrs-full:GainsLossesOnFairValueAdjustmentInvestmentProperty contextRef="c0" decimals="0" unitRef="usd">-586900</ifrs-full:GainsLossesOnFairValueAdjustmentInvestmentProperty>
    <ifrs-full:GainsLossesOnFairValueAdjustmentInvestmentProperty contextRef="c5" decimals="0" unitRef="usd">-355735</ifrs-full:GainsLossesOnFairValueAdjustmentInvestmentProperty>
    <ifrs-full:ProfitLoss contextRef="c0" decimals="0" unitRef="usd">-16515389</ifrs-full:ProfitLoss>
    <ifrs-full:ProfitLoss contextRef="c5" decimals="0" unitRef="usd">-8563473</ifrs-full:ProfitLoss>
    <ifrs-full:OtherComprehensiveIncomeNetOfTaxHedgesOfNetInvestmentsInForeignOperations contextRef="c0" decimals="0" unitRef="usd">-665809</ifrs-full:OtherComprehensiveIncomeNetOfTaxHedgesOfNetInvestmentsInForeignOperations>
    <ifrs-full:OtherComprehensiveIncomeNetOfTaxHedgesOfNetInvestmentsInForeignOperations contextRef="c5" decimals="0" unitRef="usd">-1325855</ifrs-full:OtherComprehensiveIncomeNetOfTaxHedgesOfNetInvestmentsInForeignOperations>
    <ifrs-full:ComprehensiveIncome contextRef="c0" decimals="0" unitRef="usd">-17181198</ifrs-full:ComprehensiveIncome>
    <ifrs-full:ComprehensiveIncome contextRef="c5" decimals="0" unitRef="usd">-9889328</ifrs-full:ComprehensiveIncome>
    <ifrs-full:WeightedAverageShares contextRef="c0" decimals="INF" unitRef="shares">105529292</ifrs-full:WeightedAverageShares>
    <ifrs-full:WeightedAverageShares contextRef="c5" decimals="INF" unitRef="shares">65325525</ifrs-full:WeightedAverageShares>
    <ifrs-full:AdjustedWeightedAverageShares contextRef="c0" decimals="INF" unitRef="shares">105529292</ifrs-full:AdjustedWeightedAverageShares>
    <ifrs-full:AdjustedWeightedAverageShares contextRef="c5" decimals="INF" unitRef="shares">65325525</ifrs-full:AdjustedWeightedAverageShares>
    <ifrs-full:BasicEarningsLossPerShare contextRef="c0" decimals="2" unitRef="usdPershares">-0.16</ifrs-full:BasicEarningsLossPerShare>
    <ifrs-full:BasicEarningsLossPerShare contextRef="c5" decimals="2" unitRef="usdPershares">-0.13</ifrs-full:BasicEarningsLossPerShare>
    <ifrs-full:ProfitLoss contextRef="c0" decimals="0" unitRef="usd">-16515389</ifrs-full:ProfitLoss>
    <ifrs-full:ProfitLoss contextRef="c5" decimals="0" unitRef="usd">-8563473</ifrs-full:ProfitLoss>
    <cve:Accretion contextRef="c0" decimals="0" unitRef="usd">445190</cve:Accretion>
    <cve:Accretion contextRef="c5" decimals="0" unitRef="usd">408181</cve:Accretion>
    <ifrs-full:AdjustmentsForDepreciationAndAmortisationExpense contextRef="c0" decimals="0" unitRef="usd">380338</ifrs-full:AdjustmentsForDepreciationAndAmortisationExpense>
    <ifrs-full:AdjustmentsForDepreciationAndAmortisationExpense contextRef="c5" decimals="0" unitRef="usd">298666</ifrs-full:AdjustmentsForDepreciationAndAmortisationExpense>
    <ifrs-full:AdjustmentsForImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLoss contextRef="c5" decimals="0" unitRef="usd">78456</ifrs-full:AdjustmentsForImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLoss>
    <ifrs-full:AdjustmentsForUnrealisedForeignExchangeLossesGains contextRef="c0" decimals="0" unitRef="usd">20904</ifrs-full:AdjustmentsForUnrealisedForeignExchangeLossesGains>
    <ifrs-full:AdjustmentsForUnrealisedForeignExchangeLossesGains contextRef="c5" decimals="0" unitRef="usd">36530</ifrs-full:AdjustmentsForUnrealisedForeignExchangeLossesGains>
    <ifrs-full:AdjustmentsForSharebasedPayments contextRef="c0" decimals="0" unitRef="usd">5744656</ifrs-full:AdjustmentsForSharebasedPayments>
    <ifrs-full:AdjustmentsForSharebasedPayments contextRef="c5" decimals="0" unitRef="usd">1425645</ifrs-full:AdjustmentsForSharebasedPayments>
    <ifrs-full:AdjustmentsForInterestIncome contextRef="c0" decimals="0" unitRef="usd">406132</ifrs-full:AdjustmentsForInterestIncome>
    <ifrs-full:AdjustmentsForInterestIncome contextRef="c5" decimals="0" unitRef="usd">20987</ifrs-full:AdjustmentsForInterestIncome>
    <ifrs-full:AdjustmentsForDeferredTaxExpense contextRef="c0" decimals="0" unitRef="usd">91289</ifrs-full:AdjustmentsForDeferredTaxExpense>
    <ifrs-full:AdjustmentsForGainLossOnDisposalsPropertyPlantAndEquipment contextRef="c0" decimals="0" unitRef="usd">29148</ifrs-full:AdjustmentsForGainLossOnDisposalsPropertyPlantAndEquipment>
    <ifrs-full:AdjustmentsForGainLossOnDisposalsPropertyPlantAndEquipment contextRef="c5" decimals="0" unitRef="usd">-89914</ifrs-full:AdjustmentsForGainLossOnDisposalsPropertyPlantAndEquipment>
    <cve:GainOnDisposalOfSubsidiary contextRef="c0" decimals="0" unitRef="usd">1594901</cve:GainOnDisposalOfSubsidiary>
    <ifrs-full:AdjustmentsForIncreaseDecreaseInEmployeeBenefitLiabilities contextRef="c0" decimals="0" unitRef="usd">157226</ifrs-full:AdjustmentsForIncreaseDecreaseInEmployeeBenefitLiabilities>
    <ifrs-full:AdjustmentsForIncreaseDecreaseInEmployeeBenefitLiabilities contextRef="c5" decimals="0" unitRef="usd">-1719943</ifrs-full:AdjustmentsForIncreaseDecreaseInEmployeeBenefitLiabilities>
    <cve:UnrealizedGainOnUraniumInvestment contextRef="c5" decimals="0" unitRef="usd">1554000</cve:UnrealizedGainOnUraniumInvestment>
    <cve:GainOnSaleOfUraniumInvestment contextRef="c0" decimals="0" unitRef="usd">35000</cve:GainOnSaleOfUraniumInvestment>
    <cve:GainOnSaleOfUraniumInvestment contextRef="c5" decimals="0" unitRef="usd">524075</cve:GainOnSaleOfUraniumInvestment>
    <ifrs-full:AdjustmentsForFairValueGainsLosses contextRef="c0" decimals="0" unitRef="usd">-1057405</ifrs-full:AdjustmentsForFairValueGainsLosses>
    <ifrs-full:AdjustmentsForUndistributedProfitsOfAssociates contextRef="c0" decimals="0" unitRef="usd">-586900</ifrs-full:AdjustmentsForUndistributedProfitsOfAssociates>
    <ifrs-full:AdjustmentsForUndistributedProfitsOfAssociates contextRef="c5" decimals="0" unitRef="usd">-355735</ifrs-full:AdjustmentsForUndistributedProfitsOfAssociates>
    <ifrs-full:AdjustmentsForDecreaseIncreaseInOtherOperatingReceivables contextRef="c0" decimals="0" unitRef="usd">-715928</ifrs-full:AdjustmentsForDecreaseIncreaseInOtherOperatingReceivables>
    <ifrs-full:AdjustmentsForDecreaseIncreaseInOtherOperatingReceivables contextRef="c5" decimals="0" unitRef="usd">-203160</ifrs-full:AdjustmentsForDecreaseIncreaseInOtherOperatingReceivables>
    <ifrs-full:AdjustmentsForIncreaseDecreaseInDepositsFromCustomers contextRef="c0" decimals="0" unitRef="usd">-3000000</ifrs-full:AdjustmentsForIncreaseDecreaseInDepositsFromCustomers>
    <ifrs-full:OtherInflowsOutflowsOfCashClassifiedAsOperatingActivities contextRef="c0" decimals="0" unitRef="usd">-50049202</ifrs-full:OtherInflowsOutflowsOfCashClassifiedAsOperatingActivities>
    <ifrs-full:AdjustmentsForIncreaseDecreaseInTradeAccountPayable contextRef="c0" decimals="0" unitRef="usd">-3656511</ifrs-full:AdjustmentsForIncreaseDecreaseInTradeAccountPayable>
    <ifrs-full:AdjustmentsForIncreaseDecreaseInTradeAccountPayable contextRef="c5" decimals="0" unitRef="usd">5921147</ifrs-full:AdjustmentsForIncreaseDecreaseInTradeAccountPayable>
    <ifrs-full:CashReceiptsFromRepaymentOfAdvancesAndLoansMadeToRelatedParties contextRef="c0" decimals="0" unitRef="usd">434902</ifrs-full:CashReceiptsFromRepaymentOfAdvancesAndLoansMadeToRelatedParties>
    <ifrs-full:CashReceiptsFromRepaymentOfAdvancesAndLoansMadeToRelatedParties contextRef="c5" decimals="0" unitRef="usd">4562</ifrs-full:CashReceiptsFromRepaymentOfAdvancesAndLoansMadeToRelatedParties>
    <ifrs-full:CashFlowsFromUsedInOperatingActivities contextRef="c0" decimals="0" unitRef="usd">-69198211</ifrs-full:CashFlowsFromUsedInOperatingActivities>
    <ifrs-full:CashFlowsFromUsedInOperatingActivities contextRef="c5" decimals="0" unitRef="usd">-3966802</ifrs-full:CashFlowsFromUsedInOperatingActivities>
    <ifrs-full:PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities contextRef="c0" decimals="0" unitRef="usd">55150</ifrs-full:PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities>
    <ifrs-full:PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities contextRef="c5" decimals="0" unitRef="usd">17241</ifrs-full:PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities>
    <ifrs-full:PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities contextRef="c0" decimals="0" unitRef="usd">979501</ifrs-full:PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities>
    <ifrs-full:PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities contextRef="c5" decimals="0" unitRef="usd">300737</ifrs-full:PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities>
    <ifrs-full:PurchaseOfInvestmentProperty contextRef="c0" decimals="0" unitRef="usd">9860682</ifrs-full:PurchaseOfInvestmentProperty>
    <ifrs-full:PurchaseOfInvestmentProperty contextRef="c5" decimals="0" unitRef="usd">2357254</ifrs-full:PurchaseOfInvestmentProperty>
    <ifrs-full:ProceedsFromSalesOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities contextRef="c0" decimals="0" unitRef="usd">48480</ifrs-full:ProceedsFromSalesOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities>
    <ifrs-full:ProceedsFromSalesOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities contextRef="c5" decimals="0" unitRef="usd">105600</ifrs-full:ProceedsFromSalesOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities>
    <cve:CashAcquiredFromAzargaAssetAcquisition contextRef="c5" decimals="0" unitRef="usd">-1860360</cve:CashAcquiredFromAzargaAssetAcquisition>
    <cve:TransactionCostsOnAzargaAssetAcquisition contextRef="c5" decimals="0" unitRef="usd">-3252264</cve:TransactionCostsOnAzargaAssetAcquisition>
    <ifrs-full:CashFlowsUsedInObtainingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities contextRef="c0" decimals="0" unitRef="usd">6009303</ifrs-full:CashFlowsUsedInObtainingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities>
    <ifrs-full:InterestReceivedClassifiedAsInvestingActivities contextRef="c0" decimals="0" unitRef="usd">406132</ifrs-full:InterestReceivedClassifiedAsInvestingActivities>
    <ifrs-full:InterestReceivedClassifiedAsInvestingActivities contextRef="c5" decimals="0" unitRef="usd">20987</ifrs-full:InterestReceivedClassifiedAsInvestingActivities>
    <cve:PaymentsofInvestmentInUranium contextRef="c5" decimals="0" unitRef="usd">9076000</cve:PaymentsofInvestmentInUranium>
    <cve:ProceedsReceivedFromSaleOfUraniumInvestment contextRef="c0" decimals="0" unitRef="usd">4245000</cve:ProceedsReceivedFromSaleOfUraniumInvestment>
    <cve:ProceedsReceivedFromSaleOfUraniumInvestment contextRef="c5" decimals="0" unitRef="usd">6975000</cve:ProceedsReceivedFromSaleOfUraniumInvestment>
    <ifrs-full:GainsLossesOnFinancialAssetsAtFairValueThroughProfitOrLoss contextRef="c0" decimals="0" unitRef="usd">11324</ifrs-full:GainsLossesOnFinancialAssetsAtFairValueThroughProfitOrLoss>
    <ifrs-full:GainsLossesOnFinancialAssetsAtFairValueThroughProfitOrLoss contextRef="c5" decimals="0" unitRef="usd">11189</ifrs-full:GainsLossesOnFinancialAssetsAtFairValueThroughProfitOrLoss>
    <ifrs-full:CashFlowsFromUsedInInvestingActivities contextRef="c0" decimals="0" unitRef="usd">-12216348</ifrs-full:CashFlowsFromUsedInInvestingActivities>
    <ifrs-full:CashFlowsFromUsedInInvestingActivities contextRef="c5" decimals="0" unitRef="usd">-6052738</ifrs-full:CashFlowsFromUsedInInvestingActivities>
    <cve:PrivatePlacementProceeds contextRef="c0" decimals="0" unitRef="usd">23057411</cve:PrivatePlacementProceeds>
    <cve:PrivatePlacementProceeds contextRef="c5" decimals="0" unitRef="usd">11966494</cve:PrivatePlacementProceeds>
    <ifrs-full:PaymentsForShareIssueCosts contextRef="c0" decimals="0" unitRef="usd">1473875</ifrs-full:PaymentsForShareIssueCosts>
    <ifrs-full:PaymentsForShareIssueCosts contextRef="c5" decimals="0" unitRef="usd">762902</ifrs-full:PaymentsForShareIssueCosts>
    <ifrs-full:ProceedsFromExerciseOfWarrants contextRef="c0" decimals="0" unitRef="usd">2452227</ifrs-full:ProceedsFromExerciseOfWarrants>
    <ifrs-full:ProceedsFromExerciseOfWarrants contextRef="c5" decimals="0" unitRef="usd">2633029</ifrs-full:ProceedsFromExerciseOfWarrants>
    <ifrs-full:ProceedsFromExerciseOfOptions contextRef="c0" decimals="0" unitRef="usd">1177093</ifrs-full:ProceedsFromExerciseOfOptions>
    <ifrs-full:ProceedsFromExerciseOfOptions contextRef="c5" decimals="0" unitRef="usd">288572</ifrs-full:ProceedsFromExerciseOfOptions>
    <ifrs-full:ProceedsFromIssuingShares contextRef="c0" decimals="0" unitRef="usd">51558624</ifrs-full:ProceedsFromIssuingShares>
    <ifrs-full:RepaymentsOfBorrowingsClassifiedAsFinancingActivities contextRef="c0" decimals="0" unitRef="usd">1717268</ifrs-full:RepaymentsOfBorrowingsClassifiedAsFinancingActivities>
    <ifrs-full:PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities contextRef="c0" decimals="0" unitRef="usd">104815</ifrs-full:PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities>
    <ifrs-full:PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities contextRef="c5" decimals="0" unitRef="usd">37588</ifrs-full:PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities>
    <ifrs-full:CashFlowsFromUsedInFinancingActivities contextRef="c0" decimals="0" unitRef="usd">74949397</ifrs-full:CashFlowsFromUsedInFinancingActivities>
    <ifrs-full:CashFlowsFromUsedInFinancingActivities contextRef="c5" decimals="0" unitRef="usd">14087605</ifrs-full:CashFlowsFromUsedInFinancingActivities>
    <ifrs-full:EffectOfExchangeRateChangesOnCashAndCashEquivalents contextRef="c0" decimals="0" unitRef="usd">-211309</ifrs-full:EffectOfExchangeRateChangesOnCashAndCashEquivalents>
    <ifrs-full:EffectOfExchangeRateChangesOnCashAndCashEquivalents contextRef="c5" decimals="0" unitRef="usd">-61831</ifrs-full:EffectOfExchangeRateChangesOnCashAndCashEquivalents>
    <ifrs-full:CashFlowsFromUsedInOperationsBeforeChangesInWorkingCapital contextRef="c0" decimals="0" unitRef="usd">-6676471</ifrs-full:CashFlowsFromUsedInOperationsBeforeChangesInWorkingCapital>
    <ifrs-full:CashFlowsFromUsedInOperationsBeforeChangesInWorkingCapital contextRef="c5" decimals="0" unitRef="usd">4006234</ifrs-full:CashFlowsFromUsedInOperationsBeforeChangesInWorkingCapital>
    <ifrs-full:CashAndCashEquivalents contextRef="c3" decimals="0" unitRef="usd">9188483</ifrs-full:CashAndCashEquivalents>
    <ifrs-full:CashAndCashEquivalents contextRef="c6" decimals="0" unitRef="usd">5182249</ifrs-full:CashAndCashEquivalents>
    <ifrs-full:CashAndCashEquivalents contextRef="c2" decimals="0" unitRef="usd">2512012</ifrs-full:CashAndCashEquivalents>
    <ifrs-full:CashAndCashEquivalents contextRef="c3" decimals="0" unitRef="usd">9188483</ifrs-full:CashAndCashEquivalents>
    <ifrs-full:NumberOfSharesOutstanding contextRef="c7" decimals="INF" unitRef="shares">59453218</ifrs-full:NumberOfSharesOutstanding>
    <ifrs-full:Equity contextRef="c7" decimals="0" unitRef="usd">26653141</ifrs-full:Equity>
    <ifrs-full:Equity contextRef="c9" decimals="0" unitRef="usd">2019445</ifrs-full:Equity>
    <ifrs-full:Equity contextRef="c10" decimals="0" unitRef="usd">7521888</ifrs-full:Equity>
    <ifrs-full:Equity contextRef="c11" decimals="0" unitRef="usd">-23788515</ifrs-full:Equity>
    <ifrs-full:Equity contextRef="c6" decimals="0" unitRef="usd">12405959</ifrs-full:Equity>
    <cve:PrivatePlacementinShares contextRef="c12" decimals="INF" unitRef="shares">5000000</cve:PrivatePlacementinShares>
    <cve:PrivatePlacement contextRef="c12" decimals="0" unitRef="usd">11966494</cve:PrivatePlacement>
    <cve:PrivatePlacement contextRef="c5" decimals="0" unitRef="usd">11966494</cve:PrivatePlacement>
    <ifrs-full:ShareIssueRelatedCost contextRef="c12" decimals="0" unitRef="usd">1191042</ifrs-full:ShareIssueRelatedCost>
    <ifrs-full:ShareIssueRelatedCost contextRef="c14" decimals="0" unitRef="usd">-428140</ifrs-full:ShareIssueRelatedCost>
    <ifrs-full:ShareIssueRelatedCost contextRef="c5" decimals="0" unitRef="usd">762902</ifrs-full:ShareIssueRelatedCost>
    <cve:SharesIssuedForExerciseOfWarrantsShares contextRef="c12" decimals="INF" unitRef="shares">2052843</cve:SharesIssuedForExerciseOfWarrantsShares>
    <ifrs-full:IncreaseDecreaseThroughExerciseOfWarrantsEquity contextRef="c12" decimals="0" unitRef="usd">2799780</ifrs-full:IncreaseDecreaseThroughExerciseOfWarrantsEquity>
    <ifrs-full:IncreaseDecreaseThroughExerciseOfWarrantsEquity contextRef="c14" decimals="0" unitRef="usd">-166751</ifrs-full:IncreaseDecreaseThroughExerciseOfWarrantsEquity>
    <ifrs-full:IncreaseDecreaseThroughExerciseOfWarrantsEquity contextRef="c5" decimals="0" unitRef="usd">2633029</ifrs-full:IncreaseDecreaseThroughExerciseOfWarrantsEquity>
    <cve:SharesIssuedForExerciseOfStockOptionsShares contextRef="c12" decimals="INF" unitRef="shares">590000</cve:SharesIssuedForExerciseOfStockOptionsShares>
    <ifrs-full:IncreaseDecreaseThroughExerciseOfOptions contextRef="c12" decimals="0" unitRef="usd">557611</ifrs-full:IncreaseDecreaseThroughExerciseOfOptions>
    <ifrs-full:IncreaseDecreaseThroughExerciseOfOptions contextRef="c14" decimals="0" unitRef="usd">-269039</ifrs-full:IncreaseDecreaseThroughExerciseOfOptions>
    <ifrs-full:IncreaseDecreaseThroughExerciseOfOptions contextRef="c5" decimals="0" unitRef="usd">288572</ifrs-full:IncreaseDecreaseThroughExerciseOfOptions>
    <cve:StockOptionExpense contextRef="c14" decimals="0" unitRef="usd">1425645</cve:StockOptionExpense>
    <cve:StockOptionExpense contextRef="c5" decimals="0" unitRef="usd">1425645</cve:StockOptionExpense>
    <cve:SharesIssuedForAzargaAssetAcquisitionNote10Shares contextRef="c12" decimals="INF" unitRef="shares">31806617</cve:SharesIssuedForAzargaAssetAcquisitionNote10Shares>
    <cve:SharesIssuedForAzargaAssetAcquisition contextRef="c12" decimals="0" unitRef="usd">121796381</cve:SharesIssuedForAzargaAssetAcquisition>
    <cve:SharesIssuedForAzargaAssetAcquisition contextRef="c5" decimals="0" unitRef="usd">121796381</cve:SharesIssuedForAzargaAssetAcquisition>
    <cve:ReplacementOptionsForAzargaAssetAcquisition contextRef="c14" decimals="0" unitRef="usd">5496037</cve:ReplacementOptionsForAzargaAssetAcquisition>
    <cve:ReplacementOptionsForAzargaAssetAcquisition contextRef="c5" decimals="0" unitRef="usd">5496037</cve:ReplacementOptionsForAzargaAssetAcquisition>
    <cve:ReplacementWarrantsForAzargaAssetAcquisition contextRef="c14" decimals="0" unitRef="usd">3259306</cve:ReplacementWarrantsForAzargaAssetAcquisition>
    <cve:ReplacementWarrantsForAzargaAssetAcquisition contextRef="c5" decimals="0" unitRef="usd">3259306</cve:ReplacementWarrantsForAzargaAssetAcquisition>
    <cve:AdjustmentToInvestmentInAssociate contextRef="c14" decimals="0" unitRef="usd">469320</cve:AdjustmentToInvestmentInAssociate>
    <cve:AdjustmentToInvestmentInAssociate contextRef="c5" decimals="0" unitRef="usd">469320</cve:AdjustmentToInvestmentInAssociate>
    <ifrs-full:GainsLossesOnExchangeDifferencesOnTranslationNetOfTax contextRef="c15" decimals="0" unitRef="usd">-1325855</ifrs-full:GainsLossesOnExchangeDifferencesOnTranslationNetOfTax>
    <ifrs-full:GainsLossesOnExchangeDifferencesOnTranslationNetOfTax contextRef="c5" decimals="0" unitRef="usd">-1325855</ifrs-full:GainsLossesOnExchangeDifferencesOnTranslationNetOfTax>
    <ifrs-full:ProfitLoss contextRef="c16" decimals="0" unitRef="usd">-8563473</ifrs-full:ProfitLoss>
    <ifrs-full:ProfitLoss contextRef="c5" decimals="0" unitRef="usd">-8563473</ifrs-full:ProfitLoss>
    <ifrs-full:NumberOfSharesOutstanding contextRef="c17" decimals="INF" unitRef="shares">98902678</ifrs-full:NumberOfSharesOutstanding>
    <ifrs-full:Equity contextRef="c17" decimals="0" unitRef="usd">162582365</ifrs-full:Equity>
    <ifrs-full:Equity contextRef="c19" decimals="0" unitRef="usd">12662103</ifrs-full:Equity>
    <ifrs-full:Equity contextRef="c20" decimals="0" unitRef="usd">6196033</ifrs-full:Equity>
    <ifrs-full:Equity contextRef="c21" decimals="0" unitRef="usd">-32351988</ifrs-full:Equity>
    <ifrs-full:Equity contextRef="c3" decimals="0" unitRef="usd">149088513</ifrs-full:Equity>
    <ifrs-full:NumberOfSharesOutstanding contextRef="c17" decimals="INF" unitRef="shares">98902678</ifrs-full:NumberOfSharesOutstanding>
    <ifrs-full:Equity contextRef="c17" decimals="0" unitRef="usd">162582365</ifrs-full:Equity>
    <ifrs-full:Equity contextRef="c19" decimals="0" unitRef="usd">12662103</ifrs-full:Equity>
    <ifrs-full:Equity contextRef="c20" decimals="0" unitRef="usd">6196033</ifrs-full:Equity>
    <ifrs-full:Equity contextRef="c21" decimals="0" unitRef="usd">-32351988</ifrs-full:Equity>
    <ifrs-full:Equity contextRef="c3" decimals="0" unitRef="usd">149088513</ifrs-full:Equity>
    <cve:PrivatePlacementinShares contextRef="c22" decimals="INF" unitRef="shares">6535947</cve:PrivatePlacementinShares>
    <cve:PrivatePlacement contextRef="c22" decimals="0" unitRef="usd">23057411</cve:PrivatePlacement>
    <cve:PrivatePlacement contextRef="c0" decimals="0" unitRef="usd">23057411</cve:PrivatePlacement>
    <ifrs-full:ShareIssueRelatedCost contextRef="c22" decimals="0" unitRef="usd">2146218</ifrs-full:ShareIssueRelatedCost>
    <ifrs-full:ShareIssueRelatedCost contextRef="c24" decimals="0" unitRef="usd">-672343</ifrs-full:ShareIssueRelatedCost>
    <ifrs-full:ShareIssueRelatedCost contextRef="c0" decimals="0" unitRef="usd">1473875</ifrs-full:ShareIssueRelatedCost>
    <cve:SharesIssuedForExerciseOfWarrantsShares contextRef="c22" decimals="INF" unitRef="shares">2291642</cve:SharesIssuedForExerciseOfWarrantsShares>
    <ifrs-full:IncreaseDecreaseThroughExerciseOfWarrantsEquity contextRef="c22" decimals="0" unitRef="usd">2599999</ifrs-full:IncreaseDecreaseThroughExerciseOfWarrantsEquity>
    <ifrs-full:IncreaseDecreaseThroughExerciseOfWarrantsEquity contextRef="c24" decimals="0" unitRef="usd">-147772</ifrs-full:IncreaseDecreaseThroughExerciseOfWarrantsEquity>
    <ifrs-full:IncreaseDecreaseThroughExerciseOfWarrantsEquity contextRef="c0" decimals="0" unitRef="usd">2452227</ifrs-full:IncreaseDecreaseThroughExerciseOfWarrantsEquity>
    <cve:SharesIssuedForExerciseOfStockOptionsShares contextRef="c22" decimals="INF" unitRef="shares">1016436</cve:SharesIssuedForExerciseOfStockOptionsShares>
    <ifrs-full:IncreaseDecreaseThroughExerciseOfOptions contextRef="c22" decimals="0" unitRef="usd">3905580</ifrs-full:IncreaseDecreaseThroughExerciseOfOptions>
    <ifrs-full:IncreaseDecreaseThroughExerciseOfOptions contextRef="c24" decimals="0" unitRef="usd">-2728487</ifrs-full:IncreaseDecreaseThroughExerciseOfOptions>
    <ifrs-full:IncreaseDecreaseThroughExerciseOfOptions contextRef="c0" decimals="0" unitRef="usd">1177093</ifrs-full:IncreaseDecreaseThroughExerciseOfOptions>
    <cve:StockOptionExpense contextRef="c24" decimals="0" unitRef="usd">5744656</cve:StockOptionExpense>
    <cve:StockOptionExpense contextRef="c0" decimals="0" unitRef="usd">5744656</cve:StockOptionExpense>
    <cve:SharesIssuedForServicesShares contextRef="c22" decimals="INF" unitRef="shares">193348</cve:SharesIssuedForServicesShares>
    <ifrs-full:IssueOfEquity contextRef="c22" decimals="0" unitRef="usd">611113</ifrs-full:IssueOfEquity>
    <ifrs-full:IssueOfEquity contextRef="c0" decimals="0" unitRef="usd">611113</ifrs-full:IssueOfEquity>
    <cve:ShareSubscriptionsReceived contextRef="c23" decimals="0" unitRef="usd">51558624</cve:ShareSubscriptionsReceived>
    <cve:ShareSubscriptionsReceived contextRef="c0" decimals="0" unitRef="usd">51558624</cve:ShareSubscriptionsReceived>
    <cve:AdjustmentToInvestmentInAssociate contextRef="c24" decimals="0" unitRef="usd">15675</cve:AdjustmentToInvestmentInAssociate>
    <cve:AdjustmentToInvestmentInAssociate contextRef="c0" decimals="0" unitRef="usd">15675</cve:AdjustmentToInvestmentInAssociate>
    <ifrs-full:GainsLossesOnExchangeDifferencesOnTranslationNetOfTax contextRef="c25" decimals="0" unitRef="usd">-665809</ifrs-full:GainsLossesOnExchangeDifferencesOnTranslationNetOfTax>
    <ifrs-full:GainsLossesOnExchangeDifferencesOnTranslationNetOfTax contextRef="c0" decimals="0" unitRef="usd">-665809</ifrs-full:GainsLossesOnExchangeDifferencesOnTranslationNetOfTax>
    <ifrs-full:ProfitLoss contextRef="c26" decimals="0" unitRef="usd">-16515389</ifrs-full:ProfitLoss>
    <ifrs-full:ProfitLoss contextRef="c0" decimals="0" unitRef="usd">-16515389</ifrs-full:ProfitLoss>
    <ifrs-full:NumberOfSharesOutstanding contextRef="c27" decimals="INF" unitRef="shares">108940051</ifrs-full:NumberOfSharesOutstanding>
    <ifrs-full:Equity contextRef="c27" decimals="0" unitRef="usd">190610250</ifrs-full:Equity>
    <ifrs-full:Equity contextRef="c28" decimals="0" unitRef="usd">51558624</ifrs-full:Equity>
    <ifrs-full:Equity contextRef="c29" decimals="0" unitRef="usd">16218518</ifrs-full:Equity>
    <ifrs-full:Equity contextRef="c30" decimals="0" unitRef="usd">5530224</ifrs-full:Equity>
    <ifrs-full:Equity contextRef="c31" decimals="0" unitRef="usd">-48867377</ifrs-full:Equity>
    <ifrs-full:Equity contextRef="c2" decimals="0" unitRef="usd">215050239</ifrs-full:Equity>
    <cve:NatureOfOperationAndGoingConcern contextRef="c0">&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.25in"/&gt;&lt;td style="width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;1.&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Nature
                                            of operations and going concern&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;enCore
Energy Corp. was incorporated on October 30, 2009 under the Laws of British Columbia, Canada. enCore Energy Corp., together with its
subsidiaries (collectively referred to as the &#x201c;Company&#x201d; or &#x201c;enCore&#x201d;), is principally engaged in the acquisition,
exploration, and development of uranium resource properties in the United States. The Company&#x2019;s common shares trade on the TSX
Venture Exchange and the NYSE American Market under the symbol &#x201c;EU&#x201d;. The Company&#x2019;s corporate headquarters is located
at 101 N Shoreline, Suite 450, Corpus Christi, TX 78401.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;On
September 14, 2022, the Company consolidated its issued and outstanding shares on a ratio of three old common shares for every one new
post-consolidated common share (the &#x201c;Share Consolidation&#x201d;). All current and comparative references to the number of common
shares, weighted average number of common shares, loss per share, stock options and warrants have been restated to give effect to this
Share Consolidation.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;These
consolidated financial statements (the &#x201c;financial statements&#x201d;) have been prepared assuming the Company will continue on a
going-concern basis, which assumes that the Company will be able to continue in operation for the foreseeable future and will be able
to realize its assets and discharge its liabilities and commitments in the normal course of operations. The Company has no source of
operating cash flow and operations to date have been funded primarily from the issue of share capital. For the year ended December 31,
2022, the Company reported a net loss of $16,515,389 (2021 - $8,563,475), had working capital of $7,017,115 (December 31, 2021 - $5,632,603),
and an accumulated deficit of $48,867,377 (December 31, 2021 - $32,351,988). These financial statements do not reflect the adjustments
to the carrying values of assets and liabilities and the reported expenses and statement of financial position classifications that would
be necessary were the going concern assumption not appropriate. Such adjustments could be material.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;In
March 2020, the World Health Organization declared the COVID-19 outbreak a global pandemic and the Company continues to evaluate the
COVID-19 situation and monitor any impacts or any potential impacts to the business. enCore Energy Corp has implemented health and safety
measures in accordance with the health officials and guidance from local government authorities. While the pandemic has had limited impact
on the Company&#x2019;s operations to date, future activities could be impacted as a result of the pandemic. As the COVID-19 health crisis
continues, the Company will continue to rely on guidance and recommendations from local health authorities, Health Canada and the Centers
for Disease Control and Prevention to update the Company&#x2019;s policies.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Geopolitical
uncertainty driven by the Russian invasion of Ukraine has led many governments and utility providers to re-examine supply chains and
procurement strategies reliant on nuclear fuel supplies coming out of or through Russia. Sanctions, restrictions, and an inability to
obtain insurance on cargo have contributed to transportation and other supply chain disruptions between producers and suppliers. As a
result of this and coupled with multiple years of declining uranium production globally, uranium market fundamentals are shifting from
an inventory driven market to one more driven by production.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Management
estimates that it has adequate working capital to fund all of its planned activities for the next year. However, the Company&#x2019;s
long-term continued operations are dependent on its abilities to monetize assets or raise additional funding from loans or equity financings,
or through other arrangements. There is no assurance that future financing activities will be successful.&lt;/span&gt;&lt;/p&gt;</cve:NatureOfOperationAndGoingConcern>
    <us-gaap:ProfitLoss contextRef="c0" decimals="0" unitRef="usd">16515389</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss contextRef="c5" decimals="0" unitRef="usd">8563475</us-gaap:ProfitLoss>
    <cve:WorkingCapital contextRef="c2" decimals="0" unitRef="usd">7017115</cve:WorkingCapital>
    <cve:WorkingCapital contextRef="c3" decimals="0" unitRef="usd">5632603</cve:WorkingCapital>
    <cve:AccumulatedDeficit contextRef="c2" decimals="0" unitRef="usd">48867377</cve:AccumulatedDeficit>
    <cve:AccumulatedDeficit contextRef="c3" decimals="0" unitRef="usd">32351988</cve:AccumulatedDeficit>
    <ifrs-full:DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory contextRef="c0">&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.25in"/&gt;&lt;td style="width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;2.&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Significant
                                            accounting policies&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Basis
of presentation&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;These
financial statements, including comparatives, have been prepared using accounting policies consistent with International Financial Reporting
Standards (&#x201c;IFRS&#x201d;) as issued by the International Accounting Standards Board (&#x201c;IASB&#x201d;) and interpretations of
the International Financial Reporting Interpretations Committee (&#x201c;IFRIC&#x201d;).&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;The
policies applied in these financial statements are based on IFRS issued and effective as of December 31, 2022.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;These
financial statements have been prepared on a historical cost basis except for certain financial instruments which are measured at fair
value. All dollar amounts presented are in United States Dollars (&#x201c;U.S. Dollars&#x201d;) unless otherwise specified. In addition,
these financial statements have been prepared using the accrual basis of accounting, except for cash flow information.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;These
financial statements were approved for issuance by the audit committee of the Board of Directors on April 26, 2023.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Change
in presentation currency&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;These
financial statements are presented in U.S. Dollars, unless otherwise specified. The functional currency of enCore Energy Corp. is the
Canadian Dollar. The functional currency of the Company&#x2019;s subsidiaries is the U.S. Dollar. During the year ended December 31, 2022,
the Company changed its presentation currency from Canadian Dollars to U.S. Dollars to better reflect the Company&#x2019;s business activities.
Accordingly, these financial statements are presented in U.S. Dollars. The change in presentation currency is to better reflect the Company&#x2019;s
business activities and to improve investors&#x2019; ability to compare the Company&#x2019;s financial results with other publicly traded
businesses in the exploration industry.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;In
making this change to the U.S. Dollar presentation currency, the Company followed the guidance in IAS 21 &lt;i&gt;The Effects of Changes in
Foreign Exchange Rates&lt;/i&gt; and has applied the change retrospectively as if the new presentation currency had always been the Company&#x2019;s
presentation currency. In accordance with IAS 21, the financial statements for all years presented have been translated to the new U.S.
Dollar presentation currency. For 2021 and 2020 comparative balances, assets and liabilities have been translated into the U.S. Dollar
presentation currency at the rate of exchange prevailing at the reporting date. The consolidated statements of loss and comprehensive
loss were translated at the average exchange rates for the reporting period. Share capital and reserves were translated at the historical
rates prevailing at the dates of the transactions. Exchange differences arising on translation were taken to the foreign currency translation
reserve in shareholders&#x2019; equity.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;The
exchange rates used were as follows:&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left; font-weight: bold"&gt;U.S. Dollar/CDN Dollar exchange rate&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid; font-weight: bold"&gt;December 31, 2022&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; border-bottom: Black 1.5pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid; font-weight: bold"&gt;December 31, 2021&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 76%; text-align: left"&gt;Closing rate at the reporting date&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;0.738&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;0.789&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left"&gt;Average rate for the year&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;0.769&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;0.798&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Basis
of consolidation&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;These
financial statements incorporate the financial statements of the Company and its controlled subsidiaries. Control is defined as the exposure,
or rights, to variable returns from involvement with an investee and the ability to affect those returns through power over the investee.
Power over an investee exists when an investor has existing rights that give it the ability to direct the activities that significantly
affect the investee&#x2019;s returns. This control is generally evidenced through owning more than 50% of the voting rights or currently
exercisable potential voting rights of a Company&#x2019;s share capital. All significant intercompany transactions and balances have been
eliminated.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;These
consolidated financial statements include the financial statements of the Company and its significant subsidiaries listed in the following
table:&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Name of &lt;br/&gt; Subsidiary&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Place of &lt;br/&gt; Incorporation&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Ownership&lt;br/&gt; Interest&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Principal&lt;br/&gt; Activity&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Functional&lt;br/&gt; Currency&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 30%; text-align: center"&gt;Tigris Uranium US Corp.&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 25%; text-align: center"&gt;Nevada, USA&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;100&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;%&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 19%; text-align: center"&gt;Mineral Exploration&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 11%; text-align: center"&gt;USD&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: center"&gt;Metamin Enterprises US Inc.&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;Nevada, USA&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;100&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;Mineral Exploration&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;USD&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: center"&gt;URI, Inc.&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;Delaware, USA&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;100&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;Mineral Exploration&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;USD&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: center"&gt;Neutron Energy, Inc.&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;Nevada, USA&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;100&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;Mineral Exploration&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;USD&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: center"&gt;Uranco, Inc.&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;Delaware, USA&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;100&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;Mineral Exploration&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;USD&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: center"&gt;Uranium Resources, Inc.&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;Delaware, USA&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;100&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;Mineral Exploration&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;USD&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: center"&gt;HRI-Churchrock, Inc.&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;Delaware, USA&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;100&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;Mineral Exploration&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;USD&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: center"&gt;Hydro Restoration Corp.&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;Delaware, USA&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;100&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;Mineral Exploration&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;USD&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: center"&gt;Belt Line Resources, Inc.&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;Texas, USA&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;100&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;Mineral Exploration&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;USD&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: center"&gt;Cibola Resources, LLC (*)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;Delaware, USA&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;100&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;Mineral Exploration&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;USD&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: center"&gt;enCore Energy US Corp.&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;Nevada, USA&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;100&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;Holding Company&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;USD&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: center"&gt;Azarga Uranium Corp.&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;British Columbia, CA&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;100&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;Mineral Exploration&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;USD&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: center"&gt;Powertech (USA) Inc.&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;South Dakota, USA&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;100&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;Mineral Exploration&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;USD&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: center"&gt;URZ Energy Corp.&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;British Columbia, CA&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;100&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;Mineral Exploration&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;USD&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: center"&gt;Ucolo Exploration Corp.&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;Utah, USA&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;100&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;Mineral Exploration&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;USD&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: center"&gt;Azarga Resources Limited&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;British Virgin Islands&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;100&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;Mineral Exploration&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;USD&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: center"&gt;Azarga Resources (Hong Kong) Ltd.&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;Hong Kong&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;100&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;Mineral Exploration&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;USD&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: center"&gt;Azarga Resources USA Company&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;Colorado, USA&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;100&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;Mineral Exploration&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;USD&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: center; padding-bottom: 1.5pt"&gt;Azarga Resources Canada Ltd.&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center; padding-bottom: 1.5pt"&gt;British Columbia, CA&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;100&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center; padding-bottom: 1.5pt"&gt;Mineral Exploration&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center; padding-bottom: 1.5pt"&gt;USD&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;*
Cibola Resources, LLC was divested in May 2022 (Note 11).&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Cash&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Cash
is comprised of cash held at banks and demand deposits.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Restricted
cash&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;As
of December 31, 2022, the Company deposited $4,517,073 for collateralization of performance obligations. These funds are not available
for the payment of general corporate obligations. The bonds are collateralized performance bonds required for future restoration and
reclamation obligations related to the Company&#x2019;s operations. (Note 11).&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;As
of December 31, 2022, the Company held in escrow CAD $67,789,880 ($50,051,595) in share subscriptions pertaining to a financing that
closed subsequent to year end (Note 22(b)).&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Asset
retirement obligations &lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Various
federal and state mining laws and regulations require the Company to reclaim the surface areas and restore underground water quality
for its ISR projects to the pre-existing or background average quality after the completion of mining. Asset retirement obligations,
consisting primarily of estimated restoration and reclamation costs at the Company&#x2019;s ISR projects, are recognized in the period
incurred and recorded as liabilities at fair value. Such obligations, which are initially estimated based on discounted cash flow estimates,
are accreted to full value over time through charges to accretion expense. In addition, the asset retirement cost is capitalized as part
of the asset&#x2019;s carrying value and amortized over the life of the related asset. Asset retirement obligations are periodically adjusted
to reflect changes in the estimated present value resulting from revisions to the estimated timing or amount of restoration and reclamation
costs. As the Company completes its restoration and reclamation work at its properties, the liability is reduced by the carrying value
of the related asset retirement liability which is based upon the percentage of completion of each restoration and reclamation activity.
Any gain or loss upon settlement is charged to income or expense for the period. The Company reviews and evaluates its asset retirement
obligations annually or more frequently at interim periods if deemed necessary.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Assets
held for sale&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;The
Company classifies long-lived assets or disposal groups to be sold as held for sale in the period in which all of the following criteria
are met: management commits to a plan to sell the asset or disposal group; the asset or disposal group is available for immediate sale;
an active program to locate a buyer is initiated; the sale of the asset or disposal group is highly probable, within 12 months.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Mineral
properties&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;The
Company is in the exploration stage, and records exploration and evaluation assets, which consists of the costs of acquiring licenses
for the right to explore and costs associated with exploration and evaluation activity, at cost. All direct and indirect costs related
to the acquisition, exploration and development of exploration and evaluation assets are capitalized by property.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;The
exploration and evaluation assets are capitalized until the technical feasibility and commercial viability of the extraction of mineral
resources in an area of interest are demonstrable. Exploration and evaluation assets are then assessed for impairment and reclassified
to mining property and development assets within property and equipment. If an exploration and evaluation property interest is abandoned,
both the acquisition costs and the exploration and evaluation cost will be written off to net income or loss in the period of abandonment.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;On
an ongoing basis, exploration and evaluation assets are reviewed on a property-by-property basis to consider if there are any indicators
of impairment, including the following:&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.5in"/&gt;&lt;td style="width: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(i)&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Whether
                                            the period during which the Company has the right to explore in the specific area has expired
                                            during the year or will expire in the near future;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.5in"/&gt;&lt;td style="width: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(ii)&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Whether
                                            substantive expenditure on further exploration for and evaluation of mineral resources in
                                            the specific area is neither budgeted nor planned;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.5in"/&gt;&lt;td style="width: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(iii)&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Whether
                                            the Company has decided to discontinue activities in an area as the exploration and evaluation
                                            activities in the area have not led to the discovery of commercially viable quantities of
                                            mineral resources; and&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.5in"/&gt;&lt;td style="width: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(iv)&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Whether
                                            sufficient data exists to indicate that the carrying amount exceeds the recoverable amount.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="margin: 0"/&gt;&lt;p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"&gt;F-9&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;If
any indication of impairment exists, an estimate of the exploration and evaluation asset&#x2019;s recoverable amount is calculated. The
recoverable amount is determined as the higher of the fair value less costs of disposal for the exploration and evaluation property interest
and its value in use. The fair value less costs of disposal and the value in use is determined for an individual exploration and evaluation
property interest, unless the exploration and evaluation property interest does not generate cash inflows that are largely independent
of other exploration and evaluation property interests. If this is the case, the exploration and evaluation property interests are grouped
together into cash generating units (&#x201c;CGUs&#x201d;) for impairment purposes. If the recoverable amount of an asset is estimated
to be less than its carrying amount, the carrying amount of the asset is reduced to its recoverable amount and the impairment loss is
recognized in net income or loss for the period. Where an impairment subsequently reverses, the carrying amount of the asset (or CGU)
is increased to the revised estimate of its recoverable amount, but to an amount that does not exceed the carrying amount that would
have been determined had no impairment loss been recognized for the asset (or CGU) in prior periods. A reversal of an impairment loss
is recognized in the period in which that determination was made in net income or loss.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Investments
&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Investments
in uranium&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Investments
in uranium are initially recorded at cost, on the date that control of the uranium passes to the Company. Cost is calculated as the purchase
price and any directly attributable expenditure. Subsequent to initial recognition, investments in uranium are measured at fair value
at each reporting period end. Fair value is determined based on the most recent month-end spot prices for uranium published by UxC LLC
(&#x201c;UxC&#x201d;). Related fair value gains and losses subsequent to initial recognition are recorded in the consolidated statement
of loss and comprehensive loss as a component of &#x201c;Other Income (Expense)&#x201d; in the period in which they arise.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Due
to the lack of specific IFRS guidance on accounting for investments in uranium, the Company considered IAS 1 Presentation of Financial
Statements and IAS 8, Accounting Policies, Changes in Accounting Estimates and Errors, to develop and apply an accounting policy that
would result in information that is most relevant to the economic decision-making needs of users within the overall IFRS accounting framework.
Consequently, the uranium investments are presented at fair value based on the application of IAS 40, Investment Property, which allows
the use of a fair value model for assets held for long-term capital appreciation.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;In
2022, the Company entered into fixed price agreements for future purchases of uranium. These agreements required the company to make
a deposit at the time of contract execution toward its future purchase. These deposits are recorded on the Company&#x2019;s statement
of financial position in accordance with IFRS 9.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Investments
in associates&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Investments
in associates are accounted for using the equity method. The equity method involves the recording of the initial investment at cost and
the subsequent adjusting of the carrying value of the investment for the Company&#x2019;s proportionate share of the earnings or loss.
The cost of the investment includes transaction costs.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Adjustments
are made to align the accounting policies of the associate with those of the Company before applying the equity method. When the Company&#x2019;s
share of losses exceeds its interest in an equity-accounted investee, the carrying amount of that interest is reduced to zero, and the
recognition of further losses is discontinued except to the extent that the Company has incurred legal or constructive obligations or
made payments on behalf of the associate. If the associate subsequently reports profits, the Company resumes recognizing its share of
those profits only after its share of the profits equals the share of losses not recognized.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Property,
plant and equipment &lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Useful
lives are based on the Company&#x2019;s estimate at the date of acquisition and are as follows for each class of assets:&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: center; width: 49%"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"/&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Category&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="width: 2%; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; width: 49%; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Range&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Uranium Plants&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Straight-line over 15-25 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Other Property Plant and Equipment&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Straight-line over 3-5 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Software&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Straight-line over 2-3 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Furniture&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Straight-line over 3-5 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Buildings&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Straight-line over 10-40 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Uranium
plants&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Uranium
plant expenditures for new facilities or equipment and expenditures that extend the useful lives of existing facilities or equipment
are capitalized and recorded at cost. Depreciation on other property is computed based upon the estimated useful lives of the assets.
Repair and maintenance costs are expensed as incurred. Gain or loss on disposal of such assets is recorded as other income or expense
as such assets are disposed.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Other
property, plant and equipment &lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Other
property, plant and equipment consists of office equipment, furniture and fixtures and transportation equipment. Depreciation on other
property is computed based upon the estimated useful lives of the assets. Repairs and maintenance costs are expensed as incurred. Gain
or loss on disposal of such assets is recorded as other income or expense as such assets are disposed.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Buildings&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Depreciation
on buildings is computed based upon the estimated useful lives of the asset. Repairs and maintenance costs are expensed as incurred.
Gain or loss on disposal of such assets is recorded as other income or expense as such assets are disposed.&#x2003;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Software&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Software
acquired in the normal course of business through a perpetual license is capitalized and depreciated over the estimated useful life of
the asset. Support and maintenance costs are expensed as incurred. Gain or loss on disposal of such assets is recorded as other income
or expense as such assets are disposed&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Intangible
assets&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Intangible
assets are recognized and measured at cost. Intangible assets with indefinite useful lives are assessed for impairment annually and whenever
there is an indication that the intangible asset may be impaired. Intangible assets that have finite useful lives are amortized over
their estimated remaining useful lives. Amortization methods and useful lives are reviewed at each reporting period and are adjusted
if appropriate.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Useful
lives are based on the Company&#x2019;s estimate at the date of acquisition and are as follows for each class of assets:&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center; width: 49%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Category&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; width: 49%; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Range&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Data Access Agreement&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Straight-line over 14 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Data Purchases&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Indefinite life intangible asset&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;&lt;p style="margin-top: 0; margin-bottom: 0"/&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Impairment
of non-financial assets&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;At
the end of each reporting period, the Company&#x2019;s assets are reviewed to determine whether there is any indication that those assets
may be impaired. If such indication exists, the recoverable amount of the asset is estimated in order to determine the extent of the
impairment, if any. The recoverable amount is the higher of fair value less costs of disposal and the value in use. Fair value is the
price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at
the measurement date. In assessing value in use, the estimated future cash flows are discounted to their present value using a pre-tax
discount rate that reflects a current market assessment of the time value of money and the risks specific to the asset. If the recoverable
amount of an asset is estimated to be less than its carrying amount, the carrying amount of the asset is reduced to its recoverable amount
and the impairment loss is recognized in profit or loss for the period. For an asset that does not generate largely independent cash
flows, the recoverable amount is determined for the cash generating unit to which the asset belongs.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;When
an impairment loss subsequently reverses, the carrying amount of the asset (or cash-generating unit) is increased to the revised estimate
of its recoverable amount, but to an amount that does not exceed the carrying amount that would have been determined had no impairment
loss been recognized for the asset (or cash generating unit) in prior years. A reversal of an impairment loss is recognized immediately
in profit or loss.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Leases&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;In
accordance with IFRS 16, the Company recognizes a right-of-use asset and a lease liability at the lease commencement date. The right-of-use
asset represents the Company&#x2019;s right to use an underlying asset for the lease term and lease liabilities represent our obligation
to make lease payments arising from the lease. Right-of-use assets and lease liabilities are recognized at the commencement date of the
lease based on the present value of lease payments over the lease term.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Income
Tax&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Income
tax expense comprises current and deferred tax. Income tax is recognized in profit or loss except to the extent that it relates to items
recognized directly in equity. Current tax expense is the expected tax payable on taxable income for the year, using tax rates enacted
or substantively enacted at period end, adjusted for amendments to tax payable with regards to previous years.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Deferred
tax is recorded using the liability method, providing for temporary differences between the carrying amounts of assets and liabilities
for financial reporting purposes and the amounts used for taxation purposes.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Temporary
differences are not provided for the initial recognition of assets or liabilities that do not affect either accounting or taxable loss
or those differences relating to investments in subsidiaries to the extent that they are not probable to reverse in the foreseeable future.
The amount of deferred tax provided is based on the expected manner of realization or settlement of the carrying amount of assets and
liabilities, using tax rates enacted or substantively enacted at the date of the statement of financial position.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;A
deferred tax asset is recognized only to the extent that it is probable that future taxable profits will be available against which the
asset can be utilized. To the extent that the Company does not consider it probable that a deferred tax asset will be recovered, it is
not recorded.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"&gt;F-12&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Foreign
currency translation&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;The
financial statements for the Company and each of its subsidiaries are prepared using their functional currencies. Functional currency
is the currency of the primary economic environment in which an entity operates.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Foreign
currency transactions are translated into the functional currency using the exchange rates prevailing at the date of the transaction.
Foreign currency monetary items are translated at the period-end exchange rate. Non-monetary items measured at historical cost continue
to be carried at the exchange rate at the date of the transaction. Non-monetary items measured at fair value are reported at the exchange
rate at the date when fair values were determined.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Exchange
differences arising on the translation of monetary items or on settlement of monetary items are recognized in profit or loss in the period
in which they arise, except where deferred in equity as a qualifying cash flow or net investment hedge. Exchange differences arising
on the translation of non-monetary items are recognized in other comprehensive income (loss) in the consolidated statement of loss and
comprehensive loss to the extent that gains and losses arising on those non-monetary items are also recognized in other comprehensive
income (loss). Where the non-monetary gain or loss is recognized in profit or loss, the exchange component is also recognized in profit
or loss.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;On
consolidation, the parent Company&#x2019;s financial statements are translated into the presentation currency, being the U.S. Dollar.
Assets and liabilities are translated at the period-end exchange rate. Income and expenses are translated at the average exchange rate
for the period in which they arise. Exchange differences are recognized in other comprehensive income (loss) as a separate component
of equity.	&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Earnings
(loss) per share&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;The
Company presents basic and diluted earnings (loss) per share (&#x201c;EPS&#x201d;) data for its common shares. Basic EPS is calculated
by dividing the profit or loss of the Company by the weighted average number of common shares outstanding during the year, adjusted for
own shares held. Diluted EPS is determined by dividing the profit or loss attributable to common shareholders by the weighted average
number of common shares outstanding, adjusted for own shares held and for the effects of all potential dilutive common shares related
to outstanding stock options and warrants issued by the Company for the years presented, except if their inclusion proves to be anti-dilutive.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Share-based
payments&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;The
fair value of all stock options granted to directors, officers, and employees is recorded as a charge to operations and a credit to contributed
surplus. The fair value of these stock options is measured at the grant date using the Black-Scholes option pricing model. The fair value
of stock options which vest immediately is recorded at the grant date. For stock options which vest in the future, the fair value of
stock options, as adjusted for the expected level of vesting of the stock options and the number of stock options which ultimately vest,
is recognized over the vesting period. Stock options granted to non-employees are measured at the fair value of goods or services rendered
or at the fair value of the instruments issued if it is determined that the fair value of the goods or services received cannot be reliably
measured. The number of shares and options expected to vest is reviewed and adjusted at the end of each reporting period such that the
amount recognized for services received as consideration for the equity instruments granted shall be based on the number of equity instruments
that eventually vest.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Warrants
issued to brokers are measured at their fair value on the vesting date and are recognized as a deduction from equity and credited to
contributed surplus. The fair value of stock options and warrants issued to brokers are estimated using the Black-Scholes option pricing
model. Any consideration received on the exercise of stock options and/or warrants, together with the related portion of contributed
surplus, is credited to share capital.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Warrants
issued in equity financing transactions&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;The
Company engages in equity financing transactions to obtain the funds necessary to continue operations and explore its exploration and
evaluation assets. These equity financing transactions may involve the issuance of common shares or units. Each unit comprises a certain
number of common shares and a certain number of share purchase warrants.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Depending
on the terms and conditions of each equity financing agreement, the Warrants are exercisable into additional common shares at a price
prior to expiry as stipulated by the agreement. Warrants that are part of units are valued based on the residual value method. Warrants
that are issued as payment for agency fees or other transactions costs are accounted for as share-based payments.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Financial
instruments &lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;The
Company classifies its financial instruments in the following categories: at fair value through profit and loss (&#x201c;FVTPL&#x201d;),
at fair value through other comprehensive income (loss) (&#x201c;FVTOCI&#x201d;), or at amortized cost. The Company determines the classification
of financial assets at initial recognition. The classification of debt instruments is driven by the Company&#x2019;s business model for
managing the financial assets and their contractual cash flow characteristics. Equity instruments that are held for trading are classified
as FVTPL. For other equity instruments, on the day of acquisition the Company can make an irrevocable election (on an instrument-by instrument
basis) to designate them as at FVTOCI. Financial liabilities are measured at amortized cost, unless they are required to be measured
at FVTPL (such as instruments held for trading or derivatives) or the Company has opted to measure them at FVTPL.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Financial
assets and liabilities carried at FVTPL are initially recorded at fair value and transaction costs are expensed in profit or loss. Realized
and unrealized gains and losses arising from changes in the fair value of the financial assets and liabilities held at FVTPL are included
in the consolidated statements of loss and comprehensive loss in the period in which they arise.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Impairment
of financial assets at amortized cost&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;An
&#x2018;expected credit loss&#x2019; impairment model applies which requires a loss allowance to be recognized based on expected credit
losses. The estimated present value of future cash flows associated with the asset is determined and an impairment loss is recognized
for the difference between this amount and the carrying amount as follows: the carrying amount of the asset is reduced to estimated present
value of the future cash flows associated with the asset, discounted at the financial asset&#x2019;s original effective interest rate,
either directly or through the use of an allowance account and the resulting loss is recognized in profit or loss for the period.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;In
a subsequent period, if the amount of the impairment loss related to financial assets measured at amortized cost decreases, the previously
recognized impairment loss is reversed through profit or loss to the extent that the carrying amount of the investment at the date the
impairment is reversed does not exceed what the amortized cost would have been had the impairment not been recognized.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 36pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 36pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;The
Company&#x2019;s mineral property interest impairment policy is more specifically discussed above.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 36pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Derecognition
of financial assets&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;The
Company derecognizes financial assets only when the contractual rights to cash flows from the financial assets expire, or when it transfers
the financial assets and substantially all of the associated risks and rewards of ownership to another entity. Gains and losses on derecognition
are generally recognized in profit or loss&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"&gt;F-14&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;New
standards and interpretations not yet adopted&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;The
following new standards, amendments to standards and interpretations have been issued but are not effective during the year ended
December 31, 2022:&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;The
following amendments will be in effect for annual reporting periods beginning on or after January 1, 2023:&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Disclosure
of Accounting Policies (Amendments to IAS 1 and IFRS Practice Statement 2) &#x2013; the amendments &lt;/span&gt;require that an entity
discloses its material accounting policies, instead of its significant accounting policies. &lt;span style="font-family: Times New Roman, Times, Serif"&gt;Further
amendments explain how an entity can identify a material accounting policy.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Definition
of Accounting Estimates (Amendments to IAS 8) &#x2013; the amendments replace the definition of a change in accounting estimates with
a definition of accounting estimates. Under the new definition, accounting estimates are &#x201c;monetary amounts in financial
statements that are subject to measurement uncertainty&#x201d;. Entities develop accounting estimates if accounting policies require
items in financial statements to be measured in a way that involves measurement uncertainty. The amendments clarify that a change in
accounting estimate that results from new information or new developments is not the correction of an error.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;The
Company does not anticipate that these amendments will have a material impact on the results of operations and financial position of
the Company.&lt;/span&gt;&lt;/p&gt;</ifrs-full:DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory>
    <cve:DescriptionOfAccountingPolicyForBasisOfPresentationtextBlock contextRef="c0">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Basis
of presentation&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;These
financial statements, including comparatives, have been prepared using accounting policies consistent with International Financial Reporting
Standards (&#x201c;IFRS&#x201d;) as issued by the International Accounting Standards Board (&#x201c;IASB&#x201d;) and interpretations of
the International Financial Reporting Interpretations Committee (&#x201c;IFRIC&#x201d;).&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;The
policies applied in these financial statements are based on IFRS issued and effective as of December 31, 2022.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;These
financial statements have been prepared on a historical cost basis except for certain financial instruments which are measured at fair
value. All dollar amounts presented are in United States Dollars (&#x201c;U.S. Dollars&#x201d;) unless otherwise specified. In addition,
these financial statements have been prepared using the accrual basis of accounting, except for cash flow information.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;These
financial statements were approved for issuance by the audit committee of the Board of Directors on April 26, 2023.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;</cve:DescriptionOfAccountingPolicyForBasisOfPresentationtextBlock>
    <cve:DescriptionOfAccountingPolicyForChangeInPresentationCurrencytextBlock contextRef="c0">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Change
in presentation currency&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;These
financial statements are presented in U.S. Dollars, unless otherwise specified. The functional currency of enCore Energy Corp. is the
Canadian Dollar. The functional currency of the Company&#x2019;s subsidiaries is the U.S. Dollar. During the year ended December 31, 2022,
the Company changed its presentation currency from Canadian Dollars to U.S. Dollars to better reflect the Company&#x2019;s business activities.
Accordingly, these financial statements are presented in U.S. Dollars. The change in presentation currency is to better reflect the Company&#x2019;s
business activities and to improve investors&#x2019; ability to compare the Company&#x2019;s financial results with other publicly traded
businesses in the exploration industry.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;In
making this change to the U.S. Dollar presentation currency, the Company followed the guidance in IAS 21 &lt;i&gt;The Effects of Changes in
Foreign Exchange Rates&lt;/i&gt; and has applied the change retrospectively as if the new presentation currency had always been the Company&#x2019;s
presentation currency. In accordance with IAS 21, the financial statements for all years presented have been translated to the new U.S.
Dollar presentation currency. For 2021 and 2020 comparative balances, assets and liabilities have been translated into the U.S. Dollar
presentation currency at the rate of exchange prevailing at the reporting date. The consolidated statements of loss and comprehensive
loss were translated at the average exchange rates for the reporting period. Share capital and reserves were translated at the historical
rates prevailing at the dates of the transactions. Exchange differences arising on translation were taken to the foreign currency translation
reserve in shareholders&#x2019; equity.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;The
exchange rates used were as follows:&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left; font-weight: bold"&gt;U.S. Dollar/CDN Dollar exchange rate&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid; font-weight: bold"&gt;December 31, 2022&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; border-bottom: Black 1.5pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid; font-weight: bold"&gt;December 31, 2021&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 76%; text-align: left"&gt;Closing rate at the reporting date&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;0.738&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;0.789&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left"&gt;Average rate for the year&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;0.769&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;0.798&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;</cve:DescriptionOfAccountingPolicyForChangeInPresentationCurrencytextBlock>
    <ifrs-full:DisclosureOfEffectOfChangesInForeignExchangeRatesExplanatory contextRef="c0">&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left; font-weight: bold"&gt;U.S. Dollar/CDN Dollar exchange rate&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid; font-weight: bold"&gt;December 31, 2022&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; border-bottom: Black 1.5pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid; font-weight: bold"&gt;December 31, 2021&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 76%; text-align: left"&gt;Closing rate at the reporting date&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;0.738&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;0.789&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left"&gt;Average rate for the year&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;0.769&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;0.798&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;</ifrs-full:DisclosureOfEffectOfChangesInForeignExchangeRatesExplanatory>
    <ifrs-full:ClosingForeignExchangeRate contextRef="c2" decimals="3" unitRef="pure">0.738</ifrs-full:ClosingForeignExchangeRate>
    <ifrs-full:ClosingForeignExchangeRate contextRef="c3" decimals="3" unitRef="pure">0.789</ifrs-full:ClosingForeignExchangeRate>
    <ifrs-full:AverageForeignExchangeRate contextRef="c0" decimals="3" unitRef="pure">0.769</ifrs-full:AverageForeignExchangeRate>
    <ifrs-full:AverageForeignExchangeRate contextRef="c5" decimals="3" unitRef="pure">0.798</ifrs-full:AverageForeignExchangeRate>
    <cve:DescriptionOfAccountingPolicyForBasisOfConsolidationtextBlock contextRef="c0">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Basis
of consolidation&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;These
financial statements incorporate the financial statements of the Company and its controlled subsidiaries. Control is defined as the exposure,
or rights, to variable returns from involvement with an investee and the ability to affect those returns through power over the investee.
Power over an investee exists when an investor has existing rights that give it the ability to direct the activities that significantly
affect the investee&#x2019;s returns. This control is generally evidenced through owning more than 50% of the voting rights or currently
exercisable potential voting rights of a Company&#x2019;s share capital. All significant intercompany transactions and balances have been
eliminated.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;These
consolidated financial statements include the financial statements of the Company and its significant subsidiaries listed in the following
table:&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Name of &lt;br/&gt; Subsidiary&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Place of &lt;br/&gt; Incorporation&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Ownership&lt;br/&gt; Interest&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Principal&lt;br/&gt; Activity&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Functional&lt;br/&gt; Currency&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 30%; text-align: center"&gt;Tigris Uranium US Corp.&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 25%; text-align: center"&gt;Nevada, USA&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;100&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;%&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 19%; text-align: center"&gt;Mineral Exploration&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 11%; text-align: center"&gt;USD&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: center"&gt;Metamin Enterprises US Inc.&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;Nevada, USA&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;100&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;Mineral Exploration&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;USD&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: center"&gt;URI, Inc.&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;Delaware, USA&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;100&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;Mineral Exploration&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;USD&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: center"&gt;Neutron Energy, Inc.&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;Nevada, USA&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;100&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;Mineral Exploration&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;USD&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: center"&gt;Uranco, Inc.&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;Delaware, USA&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;100&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;Mineral Exploration&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;USD&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: center"&gt;Uranium Resources, Inc.&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;Delaware, USA&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;100&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;Mineral Exploration&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;USD&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: center"&gt;HRI-Churchrock, Inc.&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;Delaware, USA&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;100&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;Mineral Exploration&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;USD&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: center"&gt;Hydro Restoration Corp.&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;Delaware, USA&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;100&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;Mineral Exploration&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;USD&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: center"&gt;Belt Line Resources, Inc.&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;Texas, USA&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;100&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;Mineral Exploration&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;USD&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: center"&gt;Cibola Resources, LLC (*)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;Delaware, USA&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;100&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;Mineral Exploration&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;USD&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: center"&gt;enCore Energy US Corp.&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;Nevada, USA&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;100&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;Holding Company&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;USD&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: center"&gt;Azarga Uranium Corp.&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;British Columbia, CA&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;100&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;Mineral Exploration&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;USD&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: center"&gt;Powertech (USA) Inc.&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;South Dakota, USA&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;100&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;Mineral Exploration&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;USD&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: center"&gt;URZ Energy Corp.&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;British Columbia, CA&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;100&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;Mineral Exploration&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;USD&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: center"&gt;Ucolo Exploration Corp.&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;Utah, USA&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;100&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;Mineral Exploration&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;USD&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: center"&gt;Azarga Resources Limited&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;British Virgin Islands&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;100&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;Mineral Exploration&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;USD&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: center"&gt;Azarga Resources (Hong Kong) Ltd.&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;Hong Kong&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;100&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;Mineral Exploration&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;USD&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: center"&gt;Azarga Resources USA Company&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;Colorado, USA&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;100&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;Mineral Exploration&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;USD&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: center; padding-bottom: 1.5pt"&gt;Azarga Resources Canada Ltd.&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center; padding-bottom: 1.5pt"&gt;British Columbia, CA&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;100&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center; padding-bottom: 1.5pt"&gt;Mineral Exploration&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center; padding-bottom: 1.5pt"&gt;USD&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;*
Cibola Resources, LLC was divested in May 2022 (Note 11).&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;</cve:DescriptionOfAccountingPolicyForBasisOfConsolidationtextBlock>
    <ifrs-full:PercentageOfVotingEquityInterestsAcquired contextRef="c2" decimals="2" unitRef="pure">0.50</ifrs-full:PercentageOfVotingEquityInterestsAcquired>
    <ifrs-full:DisclosureOfSignificantInvestmentsInSubsidiariesExplanatory contextRef="c0">&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Name of &lt;br/&gt; Subsidiary&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Place of &lt;br/&gt; Incorporation&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Ownership&lt;br/&gt; Interest&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Principal&lt;br/&gt; Activity&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Functional&lt;br/&gt; Currency&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 30%; text-align: center"&gt;Tigris Uranium US Corp.&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 25%; text-align: center"&gt;Nevada, USA&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;100&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;%&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 19%; text-align: center"&gt;Mineral Exploration&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 11%; text-align: center"&gt;USD&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: center"&gt;Metamin Enterprises US Inc.&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;Nevada, USA&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;100&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;Mineral Exploration&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;USD&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: center"&gt;URI, Inc.&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;Delaware, USA&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;100&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;Mineral Exploration&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;USD&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: center"&gt;Neutron Energy, Inc.&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;Nevada, USA&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;100&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;Mineral Exploration&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;USD&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: center"&gt;Uranco, Inc.&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;Delaware, USA&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;100&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;Mineral Exploration&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;USD&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: center"&gt;Uranium Resources, Inc.&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;Delaware, USA&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;100&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;Mineral Exploration&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;USD&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: center"&gt;HRI-Churchrock, Inc.&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;Delaware, USA&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;100&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;Mineral Exploration&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;USD&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: center"&gt;Hydro Restoration Corp.&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;Delaware, USA&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;100&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;Mineral Exploration&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;USD&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: center"&gt;Belt Line Resources, Inc.&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;Texas, USA&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;100&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;Mineral Exploration&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;USD&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: center"&gt;Cibola Resources, LLC (*)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;Delaware, USA&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;100&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;Mineral Exploration&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;USD&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: center"&gt;enCore Energy US Corp.&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;Nevada, USA&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;100&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;Holding Company&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;USD&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: center"&gt;Azarga Uranium Corp.&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;British Columbia, CA&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;100&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;Mineral Exploration&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;USD&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: center"&gt;Powertech (USA) Inc.&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;South Dakota, USA&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;100&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;Mineral Exploration&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;USD&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: center"&gt;URZ Energy Corp.&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;British Columbia, CA&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;100&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;Mineral Exploration&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;USD&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: center"&gt;Ucolo Exploration Corp.&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;Utah, USA&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;100&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;Mineral Exploration&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;USD&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: center"&gt;Azarga Resources Limited&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;British Virgin Islands&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;100&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;Mineral Exploration&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;USD&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: center"&gt;Azarga Resources (Hong Kong) Ltd.&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;Hong Kong&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;100&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;Mineral Exploration&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;USD&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: center"&gt;Azarga Resources USA Company&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;Colorado, USA&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;100&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;Mineral Exploration&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;USD&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: center; padding-bottom: 1.5pt"&gt;Azarga Resources Canada Ltd.&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center; padding-bottom: 1.5pt"&gt;British Columbia, CA&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;100&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center; padding-bottom: 1.5pt"&gt;Mineral Exploration&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center; padding-bottom: 1.5pt"&gt;USD&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;*
Cibola Resources, LLC was divested in May 2022 (Note 11).&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;</ifrs-full:DisclosureOfSignificantInvestmentsInSubsidiariesExplanatory>
    <cve:NameofSubsidaryPlaceOfIncorporation contextRef="c32">Nevada, USA</cve:NameofSubsidaryPlaceOfIncorporation>
    <ifrs-full:ProportionOfOwnershipInterestInSubsidiary contextRef="c32" decimals="2" unitRef="pure">1</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
    <cve:NameofSubsidaryPrincipalActivity contextRef="c32">Mineral Exploration</cve:NameofSubsidaryPrincipalActivity>
    <cve:NameofSubsidaryFunctionalCurrency contextRef="c32">USD</cve:NameofSubsidaryFunctionalCurrency>
    <cve:NameofSubsidaryPlaceOfIncorporation contextRef="c33">Nevada, USA</cve:NameofSubsidaryPlaceOfIncorporation>
    <ifrs-full:ProportionOfOwnershipInterestInSubsidiary contextRef="c33" decimals="2" unitRef="pure">1</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
    <cve:NameofSubsidaryPrincipalActivity contextRef="c33">Mineral Exploration</cve:NameofSubsidaryPrincipalActivity>
    <cve:NameofSubsidaryFunctionalCurrency contextRef="c33">USD</cve:NameofSubsidaryFunctionalCurrency>
    <cve:NameofSubsidaryPlaceOfIncorporation contextRef="c34">Delaware, USA</cve:NameofSubsidaryPlaceOfIncorporation>
    <ifrs-full:ProportionOfOwnershipInterestInSubsidiary contextRef="c34" decimals="2" unitRef="pure">1</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
    <cve:NameofSubsidaryPrincipalActivity contextRef="c34">Mineral Exploration</cve:NameofSubsidaryPrincipalActivity>
    <cve:NameofSubsidaryFunctionalCurrency contextRef="c34">USD</cve:NameofSubsidaryFunctionalCurrency>
    <cve:NameofSubsidaryPlaceOfIncorporation contextRef="c35">Nevada, USA</cve:NameofSubsidaryPlaceOfIncorporation>
    <ifrs-full:ProportionOfOwnershipInterestInSubsidiary contextRef="c35" decimals="2" unitRef="pure">1</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
    <cve:NameofSubsidaryPrincipalActivity contextRef="c35">Mineral Exploration</cve:NameofSubsidaryPrincipalActivity>
    <cve:NameofSubsidaryFunctionalCurrency contextRef="c35">USD</cve:NameofSubsidaryFunctionalCurrency>
    <cve:NameofSubsidaryPlaceOfIncorporation contextRef="c36">Delaware, USA</cve:NameofSubsidaryPlaceOfIncorporation>
    <ifrs-full:ProportionOfOwnershipInterestInSubsidiary contextRef="c36" decimals="2" unitRef="pure">1</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
    <cve:NameofSubsidaryPrincipalActivity contextRef="c36">Mineral Exploration</cve:NameofSubsidaryPrincipalActivity>
    <cve:NameofSubsidaryFunctionalCurrency contextRef="c36">USD</cve:NameofSubsidaryFunctionalCurrency>
    <cve:NameofSubsidaryPlaceOfIncorporation contextRef="c37">Delaware, USA</cve:NameofSubsidaryPlaceOfIncorporation>
    <ifrs-full:ProportionOfOwnershipInterestInSubsidiary contextRef="c37" decimals="2" unitRef="pure">1</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
    <cve:NameofSubsidaryPrincipalActivity contextRef="c37">Mineral Exploration</cve:NameofSubsidaryPrincipalActivity>
    <cve:NameofSubsidaryFunctionalCurrency contextRef="c37">USD</cve:NameofSubsidaryFunctionalCurrency>
    <cve:NameofSubsidaryPlaceOfIncorporation contextRef="c38">Delaware, USA</cve:NameofSubsidaryPlaceOfIncorporation>
    <ifrs-full:ProportionOfOwnershipInterestInSubsidiary contextRef="c38" decimals="2" unitRef="pure">1</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
    <cve:NameofSubsidaryPrincipalActivity contextRef="c38">Mineral Exploration</cve:NameofSubsidaryPrincipalActivity>
    <cve:NameofSubsidaryFunctionalCurrency contextRef="c38">USD</cve:NameofSubsidaryFunctionalCurrency>
    <cve:NameofSubsidaryPlaceOfIncorporation contextRef="c39">Delaware, USA</cve:NameofSubsidaryPlaceOfIncorporation>
    <ifrs-full:ProportionOfOwnershipInterestInSubsidiary contextRef="c39" decimals="2" unitRef="pure">1</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
    <cve:NameofSubsidaryPrincipalActivity contextRef="c39">Mineral Exploration</cve:NameofSubsidaryPrincipalActivity>
    <cve:NameofSubsidaryFunctionalCurrency contextRef="c39">USD</cve:NameofSubsidaryFunctionalCurrency>
    <cve:NameofSubsidaryPlaceOfIncorporation contextRef="c40">Texas, USA</cve:NameofSubsidaryPlaceOfIncorporation>
    <ifrs-full:ProportionOfOwnershipInterestInSubsidiary contextRef="c40" decimals="2" unitRef="pure">1</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
    <cve:NameofSubsidaryPrincipalActivity contextRef="c40">Mineral Exploration</cve:NameofSubsidaryPrincipalActivity>
    <cve:NameofSubsidaryFunctionalCurrency contextRef="c40">USD</cve:NameofSubsidaryFunctionalCurrency>
    <cve:NameofSubsidaryPlaceOfIncorporation contextRef="c41" id="ix_0_fact">Delaware, USA</cve:NameofSubsidaryPlaceOfIncorporation>
    <ifrs-full:ProportionOfOwnershipInterestInSubsidiary contextRef="c41" decimals="2" id="ix_1_fact" unitRef="pure">1</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
    <cve:NameofSubsidaryPrincipalActivity contextRef="c41" id="ix_2_fact">Mineral Exploration</cve:NameofSubsidaryPrincipalActivity>
    <cve:NameofSubsidaryFunctionalCurrency contextRef="c41" id="ix_3_fact">USD</cve:NameofSubsidaryFunctionalCurrency>
    <cve:NameofSubsidaryPlaceOfIncorporation contextRef="c42">Nevada, USA</cve:NameofSubsidaryPlaceOfIncorporation>
    <ifrs-full:ProportionOfOwnershipInterestInSubsidiary contextRef="c42" decimals="2" unitRef="pure">1</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
    <cve:NameofSubsidaryPrincipalActivity contextRef="c42">Holding Company</cve:NameofSubsidaryPrincipalActivity>
    <cve:NameofSubsidaryFunctionalCurrency contextRef="c42">USD</cve:NameofSubsidaryFunctionalCurrency>
    <cve:NameofSubsidaryPlaceOfIncorporation contextRef="c43">British Columbia, CA</cve:NameofSubsidaryPlaceOfIncorporation>
    <ifrs-full:ProportionOfOwnershipInterestInSubsidiary contextRef="c43" decimals="2" unitRef="pure">1</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
    <cve:NameofSubsidaryPrincipalActivity contextRef="c43">Mineral Exploration</cve:NameofSubsidaryPrincipalActivity>
    <cve:NameofSubsidaryFunctionalCurrency contextRef="c43">USD</cve:NameofSubsidaryFunctionalCurrency>
    <cve:NameofSubsidaryPlaceOfIncorporation contextRef="c44">South Dakota, USA</cve:NameofSubsidaryPlaceOfIncorporation>
    <ifrs-full:ProportionOfOwnershipInterestInSubsidiary contextRef="c44" decimals="2" unitRef="pure">1</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
    <cve:NameofSubsidaryPrincipalActivity contextRef="c44">Mineral Exploration</cve:NameofSubsidaryPrincipalActivity>
    <cve:NameofSubsidaryFunctionalCurrency contextRef="c44">USD</cve:NameofSubsidaryFunctionalCurrency>
    <cve:NameofSubsidaryPlaceOfIncorporation contextRef="c45">British Columbia, CA</cve:NameofSubsidaryPlaceOfIncorporation>
    <ifrs-full:ProportionOfOwnershipInterestInSubsidiary contextRef="c45" decimals="2" unitRef="pure">1</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
    <cve:NameofSubsidaryPrincipalActivity contextRef="c45">Mineral Exploration</cve:NameofSubsidaryPrincipalActivity>
    <cve:NameofSubsidaryFunctionalCurrency contextRef="c45">USD</cve:NameofSubsidaryFunctionalCurrency>
    <cve:NameofSubsidaryPlaceOfIncorporation contextRef="c46">Utah, USA</cve:NameofSubsidaryPlaceOfIncorporation>
    <ifrs-full:ProportionOfOwnershipInterestInSubsidiary contextRef="c46" decimals="2" unitRef="pure">1</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
    <cve:NameofSubsidaryPrincipalActivity contextRef="c46">Mineral Exploration</cve:NameofSubsidaryPrincipalActivity>
    <cve:NameofSubsidaryFunctionalCurrency contextRef="c46">USD</cve:NameofSubsidaryFunctionalCurrency>
    <cve:NameofSubsidaryPlaceOfIncorporation contextRef="c47">British Virgin Islands</cve:NameofSubsidaryPlaceOfIncorporation>
    <ifrs-full:ProportionOfOwnershipInterestInSubsidiary contextRef="c47" decimals="2" unitRef="pure">1</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
    <cve:NameofSubsidaryPrincipalActivity contextRef="c47">Mineral Exploration</cve:NameofSubsidaryPrincipalActivity>
    <cve:NameofSubsidaryFunctionalCurrency contextRef="c47">USD</cve:NameofSubsidaryFunctionalCurrency>
    <cve:NameofSubsidaryPlaceOfIncorporation contextRef="c48">Hong Kong</cve:NameofSubsidaryPlaceOfIncorporation>
    <ifrs-full:ProportionOfOwnershipInterestInSubsidiary contextRef="c48" decimals="2" unitRef="pure">1</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
    <cve:NameofSubsidaryPrincipalActivity contextRef="c48">Mineral Exploration</cve:NameofSubsidaryPrincipalActivity>
    <cve:NameofSubsidaryFunctionalCurrency contextRef="c48">USD</cve:NameofSubsidaryFunctionalCurrency>
    <cve:NameofSubsidaryPlaceOfIncorporation contextRef="c49">Colorado, USA</cve:NameofSubsidaryPlaceOfIncorporation>
    <ifrs-full:ProportionOfOwnershipInterestInSubsidiary contextRef="c49" decimals="2" unitRef="pure">1</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
    <cve:NameofSubsidaryPrincipalActivity contextRef="c49">Mineral Exploration</cve:NameofSubsidaryPrincipalActivity>
    <cve:NameofSubsidaryFunctionalCurrency contextRef="c49">USD</cve:NameofSubsidaryFunctionalCurrency>
    <cve:NameofSubsidaryPlaceOfIncorporation contextRef="c50">British Columbia, CA</cve:NameofSubsidaryPlaceOfIncorporation>
    <ifrs-full:ProportionOfOwnershipInterestInSubsidiary contextRef="c50" decimals="2" unitRef="pure">1</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
    <cve:NameofSubsidaryPrincipalActivity contextRef="c50">Mineral Exploration</cve:NameofSubsidaryPrincipalActivity>
    <cve:NameofSubsidaryFunctionalCurrency contextRef="c50">USD</cve:NameofSubsidaryFunctionalCurrency>
    <cve:DescriptionOfAccountingPolicyForCashtextBlock contextRef="c0">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Cash&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Cash
is comprised of cash held at banks and demand deposits.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;</cve:DescriptionOfAccountingPolicyForCashtextBlock>
    <ifrs-full:DescriptionOfAccountingPolicyToDetermineComponentsOfCashAndCashEquivalents contextRef="c0">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Restricted
cash&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;As
of December 31, 2022, the Company deposited $4,517,073 for collateralization of performance obligations. These funds are not available
for the payment of general corporate obligations. The bonds are collateralized performance bonds required for future restoration and
reclamation obligations related to the Company&#x2019;s operations. (Note 11).&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;As
of December 31, 2022, the Company held in escrow CAD $67,789,880 ($50,051,595) in share subscriptions pertaining to a financing that
closed subsequent to year end (Note 22(b)).&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;</ifrs-full:DescriptionOfAccountingPolicyToDetermineComponentsOfCashAndCashEquivalents>
    <ifrs-full:DepositsFromBanks contextRef="c2" decimals="0" unitRef="usd">4517073</ifrs-full:DepositsFromBanks>
    <cve:ShareSubscriptionsValue contextRef="c0" decimals="0" unitRef="cad">67789880</cve:ShareSubscriptionsValue>
    <cve:ShareSubscriptionsValue contextRef="c0" decimals="0" unitRef="usd">-50051595</cve:ShareSubscriptionsValue>
    <cve:DescriptionOfAccountingPolicyForAssetRetirementObligationstextBlock contextRef="c0">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Asset
retirement obligations &lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Various
federal and state mining laws and regulations require the Company to reclaim the surface areas and restore underground water quality
for its ISR projects to the pre-existing or background average quality after the completion of mining. Asset retirement obligations,
consisting primarily of estimated restoration and reclamation costs at the Company&#x2019;s ISR projects, are recognized in the period
incurred and recorded as liabilities at fair value. Such obligations, which are initially estimated based on discounted cash flow estimates,
are accreted to full value over time through charges to accretion expense. In addition, the asset retirement cost is capitalized as part
of the asset&#x2019;s carrying value and amortized over the life of the related asset. Asset retirement obligations are periodically adjusted
to reflect changes in the estimated present value resulting from revisions to the estimated timing or amount of restoration and reclamation
costs. As the Company completes its restoration and reclamation work at its properties, the liability is reduced by the carrying value
of the related asset retirement liability which is based upon the percentage of completion of each restoration and reclamation activity.
Any gain or loss upon settlement is charged to income or expense for the period. The Company reviews and evaluates its asset retirement
obligations annually or more frequently at interim periods if deemed necessary.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;</cve:DescriptionOfAccountingPolicyForAssetRetirementObligationstextBlock>
    <ifrs-full:DescriptionOfAccountingPolicyForAvailableforsaleFinancialAssetsExplanatory contextRef="c0">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Assets
held for sale&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;The
Company classifies long-lived assets or disposal groups to be sold as held for sale in the period in which all of the following criteria
are met: management commits to a plan to sell the asset or disposal group; the asset or disposal group is available for immediate sale;
an active program to locate a buyer is initiated; the sale of the asset or disposal group is highly probable, within 12 months.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;</ifrs-full:DescriptionOfAccountingPolicyForAvailableforsaleFinancialAssetsExplanatory>
    <cve:DescriptionOfAccountingPolicyForMineralPropertiestextBlock contextRef="c0">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Mineral
properties&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;The
Company is in the exploration stage, and records exploration and evaluation assets, which consists of the costs of acquiring licenses
for the right to explore and costs associated with exploration and evaluation activity, at cost. All direct and indirect costs related
to the acquisition, exploration and development of exploration and evaluation assets are capitalized by property.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;The
exploration and evaluation assets are capitalized until the technical feasibility and commercial viability of the extraction of mineral
resources in an area of interest are demonstrable. Exploration and evaluation assets are then assessed for impairment and reclassified
to mining property and development assets within property and equipment. If an exploration and evaluation property interest is abandoned,
both the acquisition costs and the exploration and evaluation cost will be written off to net income or loss in the period of abandonment.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;On
an ongoing basis, exploration and evaluation assets are reviewed on a property-by-property basis to consider if there are any indicators
of impairment, including the following:&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.5in"/&gt;&lt;td style="width: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(i)&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Whether
                                            the period during which the Company has the right to explore in the specific area has expired
                                            during the year or will expire in the near future;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.5in"/&gt;&lt;td style="width: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(ii)&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Whether
                                            substantive expenditure on further exploration for and evaluation of mineral resources in
                                            the specific area is neither budgeted nor planned;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.5in"/&gt;&lt;td style="width: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(iii)&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Whether
                                            the Company has decided to discontinue activities in an area as the exploration and evaluation
                                            activities in the area have not led to the discovery of commercially viable quantities of
                                            mineral resources; and&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.5in"/&gt;&lt;td style="width: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(iv)&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Whether
                                            sufficient data exists to indicate that the carrying amount exceeds the recoverable amount.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="margin: 0"/&gt;&lt;p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"&gt;F-9&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;If
any indication of impairment exists, an estimate of the exploration and evaluation asset&#x2019;s recoverable amount is calculated. The
recoverable amount is determined as the higher of the fair value less costs of disposal for the exploration and evaluation property interest
and its value in use. The fair value less costs of disposal and the value in use is determined for an individual exploration and evaluation
property interest, unless the exploration and evaluation property interest does not generate cash inflows that are largely independent
of other exploration and evaluation property interests. If this is the case, the exploration and evaluation property interests are grouped
together into cash generating units (&#x201c;CGUs&#x201d;) for impairment purposes. If the recoverable amount of an asset is estimated
to be less than its carrying amount, the carrying amount of the asset is reduced to its recoverable amount and the impairment loss is
recognized in net income or loss for the period. Where an impairment subsequently reverses, the carrying amount of the asset (or CGU)
is increased to the revised estimate of its recoverable amount, but to an amount that does not exceed the carrying amount that would
have been determined had no impairment loss been recognized for the asset (or CGU) in prior periods. A reversal of an impairment loss
is recognized in the period in which that determination was made in net income or loss.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;</cve:DescriptionOfAccountingPolicyForMineralPropertiestextBlock>
    <cve:DescriptionOfAccountingPolicyForInvestmentsInUraniumtextBlock contextRef="c0">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Investments
&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Investments
in uranium&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Investments
in uranium are initially recorded at cost, on the date that control of the uranium passes to the Company. Cost is calculated as the purchase
price and any directly attributable expenditure. Subsequent to initial recognition, investments in uranium are measured at fair value
at each reporting period end. Fair value is determined based on the most recent month-end spot prices for uranium published by UxC LLC
(&#x201c;UxC&#x201d;). Related fair value gains and losses subsequent to initial recognition are recorded in the consolidated statement
of loss and comprehensive loss as a component of &#x201c;Other Income (Expense)&#x201d; in the period in which they arise.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Due
to the lack of specific IFRS guidance on accounting for investments in uranium, the Company considered IAS 1 Presentation of Financial
Statements and IAS 8, Accounting Policies, Changes in Accounting Estimates and Errors, to develop and apply an accounting policy that
would result in information that is most relevant to the economic decision-making needs of users within the overall IFRS accounting framework.
Consequently, the uranium investments are presented at fair value based on the application of IAS 40, Investment Property, which allows
the use of a fair value model for assets held for long-term capital appreciation.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;In
2022, the Company entered into fixed price agreements for future purchases of uranium. These agreements required the company to make
a deposit at the time of contract execution toward its future purchase. These deposits are recorded on the Company&#x2019;s statement
of financial position in accordance with IFRS 9.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;</cve:DescriptionOfAccountingPolicyForInvestmentsInUraniumtextBlock>
    <ifrs-full:DescriptionOfAccountingPolicyForInvestmentInAssociates contextRef="c0">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Investments
in associates&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Investments
in associates are accounted for using the equity method. The equity method involves the recording of the initial investment at cost and
the subsequent adjusting of the carrying value of the investment for the Company&#x2019;s proportionate share of the earnings or loss.
The cost of the investment includes transaction costs.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Adjustments
are made to align the accounting policies of the associate with those of the Company before applying the equity method. When the Company&#x2019;s
share of losses exceeds its interest in an equity-accounted investee, the carrying amount of that interest is reduced to zero, and the
recognition of further losses is discontinued except to the extent that the Company has incurred legal or constructive obligations or
made payments on behalf of the associate. If the associate subsequently reports profits, the Company resumes recognizing its share of
those profits only after its share of the profits equals the share of losses not recognized.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;</ifrs-full:DescriptionOfAccountingPolicyForInvestmentInAssociates>
    <ifrs-full:DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory contextRef="c0">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Property,
plant and equipment &lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Useful
lives are based on the Company&#x2019;s estimate at the date of acquisition and are as follows for each class of assets:&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: center; width: 49%"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"/&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Category&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="width: 2%; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; width: 49%; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Range&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Uranium Plants&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Straight-line over 15-25 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Other Property Plant and Equipment&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Straight-line over 3-5 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Software&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Straight-line over 2-3 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Furniture&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Straight-line over 3-5 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Buildings&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Straight-line over 10-40 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;</ifrs-full:DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory>
    <cve:DisclosureOfUsefulLivesOfPropertyPlantAndEquipementTextBlock contextRef="c0">&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: center; width: 49%"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"/&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Category&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="width: 2%; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; width: 49%; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Range&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Uranium Plants&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Straight-line over 15-25 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Other Property Plant and Equipment&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Straight-line over 3-5 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Software&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Straight-line over 2-3 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Furniture&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Straight-line over 3-5 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Buildings&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Straight-line over 10-40 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;</cve:DisclosureOfUsefulLivesOfPropertyPlantAndEquipementTextBlock>
    <cve:PropertyPlantAndEquipmentRange contextRef="c51">P15Y</cve:PropertyPlantAndEquipmentRange>
    <cve:PropertyPlantAndEquipmentRange contextRef="c52">P25Y</cve:PropertyPlantAndEquipmentRange>
    <cve:PropertyPlantAndEquipmentRange contextRef="c53">P3Y</cve:PropertyPlantAndEquipmentRange>
    <cve:PropertyPlantAndEquipmentRange contextRef="c54">P5Y</cve:PropertyPlantAndEquipmentRange>
    <cve:PropertyPlantAndEquipmentRange contextRef="c55">P2Y</cve:PropertyPlantAndEquipmentRange>
    <cve:PropertyPlantAndEquipmentRange contextRef="c56">P3Y</cve:PropertyPlantAndEquipmentRange>
    <cve:PropertyPlantAndEquipmentRange contextRef="c57">P3Y</cve:PropertyPlantAndEquipmentRange>
    <cve:PropertyPlantAndEquipmentRange contextRef="c58">P5Y</cve:PropertyPlantAndEquipmentRange>
    <cve:PropertyPlantAndEquipmentRange contextRef="c59">P10Y</cve:PropertyPlantAndEquipmentRange>
    <cve:PropertyPlantAndEquipmentRange contextRef="c60">P40Y</cve:PropertyPlantAndEquipmentRange>
    <cve:DescriptionOfAccountingPolicyForUraniumPlantstextBlock contextRef="c0">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Uranium
plants&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Uranium
plant expenditures for new facilities or equipment and expenditures that extend the useful lives of existing facilities or equipment
are capitalized and recorded at cost. Depreciation on other property is computed based upon the estimated useful lives of the assets.
Repair and maintenance costs are expensed as incurred. Gain or loss on disposal of such assets is recorded as other income or expense
as such assets are disposed.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;</cve:DescriptionOfAccountingPolicyForUraniumPlantstextBlock>
    <cve:DescriptionOfAccountingPolicyForOtherPropertyPlantAndEquipmenttextBlock contextRef="c0">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Other
property, plant and equipment &lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Other
property, plant and equipment consists of office equipment, furniture and fixtures and transportation equipment. Depreciation on other
property is computed based upon the estimated useful lives of the assets. Repairs and maintenance costs are expensed as incurred. Gain
or loss on disposal of such assets is recorded as other income or expense as such assets are disposed.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;</cve:DescriptionOfAccountingPolicyForOtherPropertyPlantAndEquipmenttextBlock>
    <cve:DescriptionOfAccountingPolicyForBuildingtextBlock contextRef="c0">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Buildings&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Depreciation
on buildings is computed based upon the estimated useful lives of the asset. Repairs and maintenance costs are expensed as incurred.
Gain or loss on disposal of such assets is recorded as other income or expense as such assets are disposed.&#x2003;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;</cve:DescriptionOfAccountingPolicyForBuildingtextBlock>
    <cve:DescriptionOfAccountingPolicyForSoftwaretextBlock contextRef="c0">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Software&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Software
acquired in the normal course of business through a perpetual license is capitalized and depreciated over the estimated useful life of
the asset. Support and maintenance costs are expensed as incurred. Gain or loss on disposal of such assets is recorded as other income
or expense as such assets are disposed&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;</cve:DescriptionOfAccountingPolicyForSoftwaretextBlock>
    <ifrs-full:DescriptionOfAccountingPolicyForIntangibleAssetsAndGoodwillExplanatory contextRef="c0">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Intangible
assets&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Intangible
assets are recognized and measured at cost. Intangible assets with indefinite useful lives are assessed for impairment annually and whenever
there is an indication that the intangible asset may be impaired. Intangible assets that have finite useful lives are amortized over
their estimated remaining useful lives. Amortization methods and useful lives are reviewed at each reporting period and are adjusted
if appropriate.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Useful
lives are based on the Company&#x2019;s estimate at the date of acquisition and are as follows for each class of assets:&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center; width: 49%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Category&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; width: 49%; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Range&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Data Access Agreement&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Straight-line over 14 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Data Purchases&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Indefinite life intangible asset&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;&lt;p style="margin-top: 0; margin-bottom: 0"/&gt;</ifrs-full:DescriptionOfAccountingPolicyForIntangibleAssetsAndGoodwillExplanatory>
    <cve:DisclosureOfUsefulLivesOfIntangibleAssetsTextBllock contextRef="c0">&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center; width: 49%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Category&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; width: 49%; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Range&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Data Access Agreement&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Straight-line over 14 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Data Purchases&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Indefinite life intangible asset&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;&lt;p style="margin-top: 0; margin-bottom: 0"/&gt;</cve:DisclosureOfUsefulLivesOfIntangibleAssetsTextBllock>
    <cve:CategoryRange contextRef="c61">Straight-line over 14 years</cve:CategoryRange>
    <cve:CategoryRange contextRef="c62">Indefinite life intangible asset</cve:CategoryRange>
    <ifrs-full:DescriptionOfAccountingPolicyForImpairmentOfNonfinancialAssetsExplanatory contextRef="c0">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Impairment
of non-financial assets&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;At
the end of each reporting period, the Company&#x2019;s assets are reviewed to determine whether there is any indication that those assets
may be impaired. If such indication exists, the recoverable amount of the asset is estimated in order to determine the extent of the
impairment, if any. The recoverable amount is the higher of fair value less costs of disposal and the value in use. Fair value is the
price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at
the measurement date. In assessing value in use, the estimated future cash flows are discounted to their present value using a pre-tax
discount rate that reflects a current market assessment of the time value of money and the risks specific to the asset. If the recoverable
amount of an asset is estimated to be less than its carrying amount, the carrying amount of the asset is reduced to its recoverable amount
and the impairment loss is recognized in profit or loss for the period. For an asset that does not generate largely independent cash
flows, the recoverable amount is determined for the cash generating unit to which the asset belongs.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;When
an impairment loss subsequently reverses, the carrying amount of the asset (or cash-generating unit) is increased to the revised estimate
of its recoverable amount, but to an amount that does not exceed the carrying amount that would have been determined had no impairment
loss been recognized for the asset (or cash generating unit) in prior years. A reversal of an impairment loss is recognized immediately
in profit or loss.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;</ifrs-full:DescriptionOfAccountingPolicyForImpairmentOfNonfinancialAssetsExplanatory>
    <ifrs-full:DescriptionOfAccountingPolicyForLeasesExplanatory contextRef="c0">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Leases&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;In
accordance with IFRS 16, the Company recognizes a right-of-use asset and a lease liability at the lease commencement date. The right-of-use
asset represents the Company&#x2019;s right to use an underlying asset for the lease term and lease liabilities represent our obligation
to make lease payments arising from the lease. Right-of-use assets and lease liabilities are recognized at the commencement date of the
lease based on the present value of lease payments over the lease term.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;</ifrs-full:DescriptionOfAccountingPolicyForLeasesExplanatory>
    <ifrs-full:DescriptionOfAccountingPolicyForIncomeTaxExplanatory contextRef="c0">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Income
Tax&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Income
tax expense comprises current and deferred tax. Income tax is recognized in profit or loss except to the extent that it relates to items
recognized directly in equity. Current tax expense is the expected tax payable on taxable income for the year, using tax rates enacted
or substantively enacted at period end, adjusted for amendments to tax payable with regards to previous years.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Deferred
tax is recorded using the liability method, providing for temporary differences between the carrying amounts of assets and liabilities
for financial reporting purposes and the amounts used for taxation purposes.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Temporary
differences are not provided for the initial recognition of assets or liabilities that do not affect either accounting or taxable loss
or those differences relating to investments in subsidiaries to the extent that they are not probable to reverse in the foreseeable future.
The amount of deferred tax provided is based on the expected manner of realization or settlement of the carrying amount of assets and
liabilities, using tax rates enacted or substantively enacted at the date of the statement of financial position.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;A
deferred tax asset is recognized only to the extent that it is probable that future taxable profits will be available against which the
asset can be utilized. To the extent that the Company does not consider it probable that a deferred tax asset will be recovered, it is
not recorded.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;</ifrs-full:DescriptionOfAccountingPolicyForIncomeTaxExplanatory>
    <us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock contextRef="c0">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Foreign
currency translation&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;The
financial statements for the Company and each of its subsidiaries are prepared using their functional currencies. Functional currency
is the currency of the primary economic environment in which an entity operates.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Foreign
currency transactions are translated into the functional currency using the exchange rates prevailing at the date of the transaction.
Foreign currency monetary items are translated at the period-end exchange rate. Non-monetary items measured at historical cost continue
to be carried at the exchange rate at the date of the transaction. Non-monetary items measured at fair value are reported at the exchange
rate at the date when fair values were determined.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Exchange
differences arising on the translation of monetary items or on settlement of monetary items are recognized in profit or loss in the period
in which they arise, except where deferred in equity as a qualifying cash flow or net investment hedge. Exchange differences arising
on the translation of non-monetary items are recognized in other comprehensive income (loss) in the consolidated statement of loss and
comprehensive loss to the extent that gains and losses arising on those non-monetary items are also recognized in other comprehensive
income (loss). Where the non-monetary gain or loss is recognized in profit or loss, the exchange component is also recognized in profit
or loss.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;On
consolidation, the parent Company&#x2019;s financial statements are translated into the presentation currency, being the U.S. Dollar.
Assets and liabilities are translated at the period-end exchange rate. Income and expenses are translated at the average exchange rate
for the period in which they arise. Exchange differences are recognized in other comprehensive income (loss) as a separate component
of equity.	&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;</us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock>
    <ifrs-full:DescriptionOfAccountingPolicyForEarningsPerShareExplanatory contextRef="c0">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Earnings
(loss) per share&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;The
Company presents basic and diluted earnings (loss) per share (&#x201c;EPS&#x201d;) data for its common shares. Basic EPS is calculated
by dividing the profit or loss of the Company by the weighted average number of common shares outstanding during the year, adjusted for
own shares held. Diluted EPS is determined by dividing the profit or loss attributable to common shareholders by the weighted average
number of common shares outstanding, adjusted for own shares held and for the effects of all potential dilutive common shares related
to outstanding stock options and warrants issued by the Company for the years presented, except if their inclusion proves to be anti-dilutive.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;</ifrs-full:DescriptionOfAccountingPolicyForEarningsPerShareExplanatory>
    <ifrs-full:DescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory contextRef="c0">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Share-based
payments&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;The
fair value of all stock options granted to directors, officers, and employees is recorded as a charge to operations and a credit to contributed
surplus. The fair value of these stock options is measured at the grant date using the Black-Scholes option pricing model. The fair value
of stock options which vest immediately is recorded at the grant date. For stock options which vest in the future, the fair value of
stock options, as adjusted for the expected level of vesting of the stock options and the number of stock options which ultimately vest,
is recognized over the vesting period. Stock options granted to non-employees are measured at the fair value of goods or services rendered
or at the fair value of the instruments issued if it is determined that the fair value of the goods or services received cannot be reliably
measured. The number of shares and options expected to vest is reviewed and adjusted at the end of each reporting period such that the
amount recognized for services received as consideration for the equity instruments granted shall be based on the number of equity instruments
that eventually vest.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Warrants
issued to brokers are measured at their fair value on the vesting date and are recognized as a deduction from equity and credited to
contributed surplus. The fair value of stock options and warrants issued to brokers are estimated using the Black-Scholes option pricing
model. Any consideration received on the exercise of stock options and/or warrants, together with the related portion of contributed
surplus, is credited to share capital.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;</ifrs-full:DescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory>
    <ifrs-full:DescriptionOfAccountingPolicyForWarrantsExplanatory contextRef="c0">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Warrants
issued in equity financing transactions&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;The
Company engages in equity financing transactions to obtain the funds necessary to continue operations and explore its exploration and
evaluation assets. These equity financing transactions may involve the issuance of common shares or units. Each unit comprises a certain
number of common shares and a certain number of share purchase warrants.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Depending
on the terms and conditions of each equity financing agreement, the Warrants are exercisable into additional common shares at a price
prior to expiry as stipulated by the agreement. Warrants that are part of units are valued based on the residual value method. Warrants
that are issued as payment for agency fees or other transactions costs are accounted for as share-based payments.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;</ifrs-full:DescriptionOfAccountingPolicyForWarrantsExplanatory>
    <ifrs-full:DescriptionOfAccountingPolicyForFinancialInstrumentsExplanatory contextRef="c0">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Financial
instruments &lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;The
Company classifies its financial instruments in the following categories: at fair value through profit and loss (&#x201c;FVTPL&#x201d;),
at fair value through other comprehensive income (loss) (&#x201c;FVTOCI&#x201d;), or at amortized cost. The Company determines the classification
of financial assets at initial recognition. The classification of debt instruments is driven by the Company&#x2019;s business model for
managing the financial assets and their contractual cash flow characteristics. Equity instruments that are held for trading are classified
as FVTPL. For other equity instruments, on the day of acquisition the Company can make an irrevocable election (on an instrument-by instrument
basis) to designate them as at FVTOCI. Financial liabilities are measured at amortized cost, unless they are required to be measured
at FVTPL (such as instruments held for trading or derivatives) or the Company has opted to measure them at FVTPL.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Financial
assets and liabilities carried at FVTPL are initially recorded at fair value and transaction costs are expensed in profit or loss. Realized
and unrealized gains and losses arising from changes in the fair value of the financial assets and liabilities held at FVTPL are included
in the consolidated statements of loss and comprehensive loss in the period in which they arise.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;</ifrs-full:DescriptionOfAccountingPolicyForFinancialInstrumentsExplanatory>
    <ifrs-full:DescriptionOfAccountingPolicyForImpairmentOfFinancialAssetsExplanatory contextRef="c0">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Impairment
of financial assets at amortized cost&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;An
&#x2018;expected credit loss&#x2019; impairment model applies which requires a loss allowance to be recognized based on expected credit
losses. The estimated present value of future cash flows associated with the asset is determined and an impairment loss is recognized
for the difference between this amount and the carrying amount as follows: the carrying amount of the asset is reduced to estimated present
value of the future cash flows associated with the asset, discounted at the financial asset&#x2019;s original effective interest rate,
either directly or through the use of an allowance account and the resulting loss is recognized in profit or loss for the period.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;In
a subsequent period, if the amount of the impairment loss related to financial assets measured at amortized cost decreases, the previously
recognized impairment loss is reversed through profit or loss to the extent that the carrying amount of the investment at the date the
impairment is reversed does not exceed what the amortized cost would have been had the impairment not been recognized.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 36pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 36pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;The
Company&#x2019;s mineral property interest impairment policy is more specifically discussed above.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 36pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;</ifrs-full:DescriptionOfAccountingPolicyForImpairmentOfFinancialAssetsExplanatory>
    <ifrs-full:DescriptionOfAccountingPolicyForDerecognitionOfFinancialInstrumentsExplanatory contextRef="c0">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Derecognition
of financial assets&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;The
Company derecognizes financial assets only when the contractual rights to cash flows from the financial assets expire, or when it transfers
the financial assets and substantially all of the associated risks and rewards of ownership to another entity. Gains and losses on derecognition
are generally recognized in profit or loss&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;</ifrs-full:DescriptionOfAccountingPolicyForDerecognitionOfFinancialInstrumentsExplanatory>
    <cve:DescriptionOfAccountingPolicyForNewStandardsAndInterpretationsNotYetAdoptedtextBlock contextRef="c0">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;New
standards and interpretations not yet adopted&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;The
following new standards, amendments to standards and interpretations have been issued but are not effective during the year ended
December 31, 2022:&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;The
following amendments will be in effect for annual reporting periods beginning on or after January 1, 2023:&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Disclosure
of Accounting Policies (Amendments to IAS 1 and IFRS Practice Statement 2) &#x2013; the amendments &lt;/span&gt;require that an entity
discloses its material accounting policies, instead of its significant accounting policies. &lt;span style="font-family: Times New Roman, Times, Serif"&gt;Further
amendments explain how an entity can identify a material accounting policy.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Definition
of Accounting Estimates (Amendments to IAS 8) &#x2013; the amendments replace the definition of a change in accounting estimates with
a definition of accounting estimates. Under the new definition, accounting estimates are &#x201c;monetary amounts in financial
statements that are subject to measurement uncertainty&#x201d;. Entities develop accounting estimates if accounting policies require
items in financial statements to be measured in a way that involves measurement uncertainty. The amendments clarify that a change in
accounting estimate that results from new information or new developments is not the correction of an error.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;The
Company does not anticipate that these amendments will have a material impact on the results of operations and financial position of
the Company.&lt;/span&gt;&lt;/p&gt;</cve:DescriptionOfAccountingPolicyForNewStandardsAndInterpretationsNotYetAdoptedtextBlock>
    <ifrs-full:DisclosureOfAccountingJudgementsAndEstimatesExplanatory contextRef="c0">&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 18pt"/&gt;&lt;td style="width: 18pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;3.&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Critical
                                            accounting estimates and judgements&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;The
preparation of financial statements in conformity with IFRS requires management to use judgment in applying its accounting policies and
estimates and assumptions about the future. Estimates and other judgments are continuously evaluated and are based on management&#x2019;s
experience and other factors, including expectations about future events that are believed to be reasonable under the circumstances.
Although management uses historical experience and its best knowledge of the expected amounts, events or actions to form the basis for
estimates, actual results may differ from these estimates.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Critical
accounting estimates:&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;The
assessment of the recoverable amount of mineral properties as a result of impairment indicators - &lt;/b&gt;When indicators of impairment are
identified, recoverable amount calculations are based either on discounted estimated future cash flows or on comparable recent transactions.
The assumptions used are based on management&#x2019;s best estimates of what an independent market participant would consider appropriate.
Changes in these assumptions may alter the results of impairment testing, the amount of the impairment charges recorded in the statement
of loss and comprehensive loss and the resulting carrying values of assets.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Share-based
payments -&lt;/b&gt; The fair value of stock options issued is subject to the limitation of the Black-Scholes option pricing model that incorporates
market data and involves uncertainty in estimates used by management in the assumptions. Because the Black-Scholes option pricing model
requires the input of highly subjective assumptions, including the volatility of share prices, changes in subjective input assumptions
can materially affect the fair value estimate.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Asset
retirement obligations -&lt;/b&gt; Significant estimates were utilized in determining future costs to complete groundwater restoration, plugging
and abandonment of wellfields and surface reclamation at the Company&#x2019;s uranium in-situ recovery (ISR) sites. Estimating future
costs can be difficult and unpredictable as they are based principally on current legal and regulatory requirements and ISR site closure
plans that may change materially. The laws and regulations governing ISR site closure and remediation in a particular jurisdiction are
subject to review at any time and may be amended to impose additional requirements and conditions which may cause our provisions for
environmental liabilities to be underestimated and could materially affect our financial position or results of operations. Estimates
of future asset retirement obligation costs are also subject to operational risks such as acceptability of treatment techniques or other
operational changes.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Recovery
of deferred tax assets -&lt;/b&gt; Judgment is required in determining whether deferred tax assets are recognized in the statement of financial
position. Deferred tax assets, including those arising from unutilized tax losses, require management to assess the likelihood that the
Company will generate taxable earnings in future periods in order to utilize recognized deferred tax assets. Estimates of future taxable
income are based on forecast cash flows from operations and the application of existing tax laws in each jurisdiction. To the extent
that future cash flows and taxable income differ significantly from estimates, the ability of the Company to realize the net deferred
tax assets recorded at the date of the statement of financial position could be impacted. Additionally, future changes in tax laws in
the jurisdictions in which the Company operates could limit the ability of the Company to obtain tax deductions in future periods. The
Company has not recorded any deferred tax assets.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Amortization
and impairment of intangible assets - &lt;/b&gt;Amortization of intangible assets is dependent upon the estimated useful lives, which are determined
through the exercise of judgement. The assessment of any impairment of these assets is dependent upon estimates of recoverable amounts
that take into account factors such as economic and market conditions and the useful lives of assets.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 36pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Critical
accounting judgments:&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 36pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;The
assessment of indicators of impairment for mineral properties - &lt;/b&gt;The Company follows the guidance of IFRS 6 to determine when a mineral
property asset is impaired. This determination requires significant judgment. In making this judgment, the Company evaluates, among other
factors, the results of exploration and evaluation activities to date and the Company&#x2019;s future plans to explore and evaluate a
mineral property.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Valuation
of acquired mineral properties &#x2013;&lt;/b&gt; The valuation of mineral properties acquired by the Company requires significant judgement.
Acquired mineral properties are valued at their fair market value which can require significant estimates in future cash flows, production,
and timing.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Business
combinations -&lt;/b&gt; The determination of whether a set of assets acquired and liabilities assumed constitute a business may require the
Company to make certain judgments, taking into account all facts and circumstances. A business is presumed to be an integrated set of
activities and assets capable of being conducted and managed for the purpose of providing a return in the form of dividends, lower costs
or economic benefits. The acquisition of Azarga Uranium Corporation and its subsidiary entities on December 31, 2021 (Note 10) was determined
to constitute an acquisition of assets.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Determination
of functional currency -&lt;/b&gt; In accordance with IAS 21, The Effects of Changes in Foreign Exchange Rates, management determined that
the functional currency of the Company is the Canadian dollar and the functional currency of its subsidiaries is the U.S. Dollar.&lt;/span&gt;&lt;/p&gt;</ifrs-full:DisclosureOfAccountingJudgementsAndEstimatesExplanatory>
    <ifrs-full:DisclosureOfSignificantInvestmentsInAssociatesExplanatory contextRef="c0">&lt;table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.25in"/&gt;&lt;td style="width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;4.&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Investment
                                            in associate&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;During
the year ended December 31, 2020, the Company acquired 12,000,000 shares of Group 11 Technologies Inc. (&#x201c;Group 11&#x201d;), a US-based
technology firm, representing 40% of the issued and outstanding shares of Group 11. The Company advanced $750,000 in accordance with
the Letter of Intent with EnviroLeach Technologies Inc. and Golden Predator Mining Corp. to establish Group 11. The Company has determined
that it exercises significant influence over Group 11 and accounts for this investment using the equity method of accounting. During
the year ended December 31, 2021, Group 11 completed a private placement financing, resulting in the issuance of additional shares and
a dilution of the Company&#x2019;s ownership in the associate to 34.46%. During the year ended December 31, 2022, Group 11 issued additional
shares resulting in the dilution of the Company&#x2019;s ownership in the associate to 33.71%.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;As
of December 31, 2022, Group 11 has severely constrained its activities as financing is unavailable in its market. The Company, determined
its investment to be unrecoverable and wrote off the balance of its investment.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 18pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 18pt; text-indent: 18pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;The
Company&#x2019;s proportional share in the associate at the last available date, June 30&lt;sup&gt;th&lt;/sup&gt;, 2022, is as follows:&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 18pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-left: 0.125in; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;Assets&lt;/td&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;Liabilities&lt;/td&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;Revenues&lt;/td&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;Expenses&lt;/td&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center; padding-left: 0.125in"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;$&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;$&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;$&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;$&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in"&gt;Year ended December 31, 2021&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.25in; text-indent: -0.125in; width: 52%"&gt;Current&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;1,078,019&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;120,569&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-106"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;-&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-107"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;-&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-left: 0.25in; text-indent: -0.125in"&gt;Non-current&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;751,065&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-108"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-109"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-110"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.25in; text-indent: -0.125in; text-align: left; padding-bottom: 1.5pt"&gt;Loss from operating expenses&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-111"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-112"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-113"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(755,943&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;1,829,084&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;120,569&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-114"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(755,943&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; font-weight: bold"&gt;Year ended December 31, 2022&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.25in; text-indent: -0.125in"&gt;Current&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;609,704&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;39,259&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-115"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-116"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-left: 0.25in; text-indent: -0.125in"&gt;Non-current&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;729,261&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-117"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-118"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-119"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.25in; text-indent: -0.125in; text-align: left; padding-bottom: 1.5pt"&gt;Loss from operating expenses&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-120"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-121"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-122"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(415,769&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;1,338,965&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;39,259&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-123"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;(415,769&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; font-weight: bold; text-align: left; padding-bottom: 1.5pt"&gt;The Company&#x2019;s percentage ownership&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;33.71&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 18pt"/&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;The
investment in associate continuity summary is as follows:&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 18pt; text-align: center; text-indent: 18pt"/&gt;&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;Investment in &lt;br/&gt; associate&lt;/td&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;$&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 88%; padding-bottom: 1.5pt"&gt;Balance, December 31, 2020&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; width: 9%; text-align: right"&gt;451,221&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Adjustments to carrying value:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-left: 0.125in"&gt;Proportionate share of net loss&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(260,055&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.125in; text-align: left"&gt;Adjustment to investment in Group 11&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;469,320&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-left: 0.125in; text-align: left"&gt;Dilution loss&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(95,680&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.125in; text-align: left; padding-bottom: 1.5pt"&gt;Currency translation adjustment&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(466&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;Balance, December 31, 2021&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;564,340&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left"&gt;Adjustments to carrying value:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.125in"&gt;Proportionate share of net loss through June 30&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(143,286&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-left: 0.125in; text-align: left"&gt;Adjustment to investment in Group 11 through June 30&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;15,675&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.125in"&gt;Write-off of investment&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(443,614&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-left: 0.125in; text-align: left; padding-bottom: 1.5pt"&gt;Currency translation adjustment&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;6,885&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;Balance, December 31, 2022&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;-&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</ifrs-full:DisclosureOfSignificantInvestmentsInAssociatesExplanatory>
    <cve:AcquiredShares contextRef="c63" decimals="0" unitRef="shares">12000000</cve:AcquiredShares>
    <cve:IssuedAndOutstandingSharesPercentage contextRef="c63" decimals="2" unitRef="pure">0.40</cve:IssuedAndOutstandingSharesPercentage>
    <cve:AdvancedAmount contextRef="c63" decimals="0" unitRef="usd">750000</cve:AdvancedAmount>
    <ifrs-full:ProportionOfOwnershipInterestInAssociate contextRef="c5" decimals="4" unitRef="pure">0.3446</ifrs-full:ProportionOfOwnershipInterestInAssociate>
    <ifrs-full:ProportionOfOwnershipInterestInAssociate contextRef="c0" decimals="4" unitRef="pure">0.3371</ifrs-full:ProportionOfOwnershipInterestInAssociate>
    <cve:DisclosureOfProportionalShareAssociatesExplanatory contextRef="c0">&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-left: 0.125in; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;Assets&lt;/td&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;Liabilities&lt;/td&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;Revenues&lt;/td&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;Expenses&lt;/td&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center; padding-left: 0.125in"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;$&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;$&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;$&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;$&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in"&gt;Year ended December 31, 2021&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.25in; text-indent: -0.125in; width: 52%"&gt;Current&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;1,078,019&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;120,569&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-106"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;-&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-107"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;-&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-left: 0.25in; text-indent: -0.125in"&gt;Non-current&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;751,065&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-108"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-109"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-110"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.25in; text-indent: -0.125in; text-align: left; padding-bottom: 1.5pt"&gt;Loss from operating expenses&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-111"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-112"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-113"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(755,943&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;1,829,084&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;120,569&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-114"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(755,943&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; font-weight: bold"&gt;Year ended December 31, 2022&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.25in; text-indent: -0.125in"&gt;Current&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;609,704&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;39,259&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-115"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-116"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-left: 0.25in; text-indent: -0.125in"&gt;Non-current&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;729,261&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-117"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-118"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-119"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.25in; text-indent: -0.125in; text-align: left; padding-bottom: 1.5pt"&gt;Loss from operating expenses&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-120"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-121"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-122"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(415,769&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;1,338,965&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;39,259&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-123"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;(415,769&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; font-weight: bold; text-align: left; padding-bottom: 1.5pt"&gt;The Company&#x2019;s percentage ownership&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;33.71&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 18pt"/&gt;</cve:DisclosureOfProportionalShareAssociatesExplanatory>
    <ifrs-full:OtherCurrentAssets contextRef="c3" decimals="0" unitRef="usd">1078019</ifrs-full:OtherCurrentAssets>
    <ifrs-full:OtherCurrentLiabilities contextRef="c3" decimals="0" unitRef="usd">120569</ifrs-full:OtherCurrentLiabilities>
    <ifrs-full:OtherNoncurrentAssets contextRef="c3" decimals="0" unitRef="usd">751065</ifrs-full:OtherNoncurrentAssets>
    <cve:ExpensesLossFromOperatingExpenses contextRef="c5" decimals="0" unitRef="usd">-755943</cve:ExpensesLossFromOperatingExpenses>
    <ifrs-full:OtherAssets contextRef="c3" decimals="0" unitRef="usd">1829084</ifrs-full:OtherAssets>
    <ifrs-full:OtherLiabilities contextRef="c3" decimals="0" unitRef="usd">120569</ifrs-full:OtherLiabilities>
    <ifrs-full:OtherOperatingIncomeExpense contextRef="c5" decimals="0" unitRef="usd">-755943</ifrs-full:OtherOperatingIncomeExpense>
    <ifrs-full:OtherCurrentAssets contextRef="c2" decimals="0" unitRef="usd">609704</ifrs-full:OtherCurrentAssets>
    <ifrs-full:OtherCurrentLiabilities contextRef="c2" decimals="0" unitRef="usd">39259</ifrs-full:OtherCurrentLiabilities>
    <ifrs-full:OtherNoncurrentAssets contextRef="c2" decimals="0" unitRef="usd">729261</ifrs-full:OtherNoncurrentAssets>
    <cve:ExpensesLossFromOperatingExpenses contextRef="c0" decimals="0" unitRef="usd">-415769</cve:ExpensesLossFromOperatingExpenses>
    <ifrs-full:OtherAssets contextRef="c2" decimals="0" unitRef="usd">1338965</ifrs-full:OtherAssets>
    <ifrs-full:OtherLiabilities contextRef="c2" decimals="0" unitRef="usd">39259</ifrs-full:OtherLiabilities>
    <ifrs-full:OtherOperatingIncomeExpense contextRef="c0" decimals="0" unitRef="usd">-415769</ifrs-full:OtherOperatingIncomeExpense>
    <ifrs-full:TaxRateEffectOfForeignTaxRates contextRef="c0" decimals="4" unitRef="pure">0.3371</ifrs-full:TaxRateEffectOfForeignTaxRates>
    <ifrs-full:DisclosureOfInterestsInAssociatesExplanatory contextRef="c0">&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;Investment in &lt;br/&gt; associate&lt;/td&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;$&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 88%; padding-bottom: 1.5pt"&gt;Balance, December 31, 2020&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; width: 9%; text-align: right"&gt;451,221&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Adjustments to carrying value:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-left: 0.125in"&gt;Proportionate share of net loss&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(260,055&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.125in; text-align: left"&gt;Adjustment to investment in Group 11&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;469,320&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-left: 0.125in; text-align: left"&gt;Dilution loss&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(95,680&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.125in; text-align: left; padding-bottom: 1.5pt"&gt;Currency translation adjustment&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(466&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;Balance, December 31, 2021&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;564,340&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left"&gt;Adjustments to carrying value:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.125in"&gt;Proportionate share of net loss through June 30&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(143,286&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-left: 0.125in; text-align: left"&gt;Adjustment to investment in Group 11 through June 30&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;15,675&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.125in"&gt;Write-off of investment&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(443,614&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-left: 0.125in; text-align: left; padding-bottom: 1.5pt"&gt;Currency translation adjustment&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;6,885&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;Balance, December 31, 2022&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;-&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</ifrs-full:DisclosureOfInterestsInAssociatesExplanatory>
    <cve:InvestmentBalance1 contextRef="c6" decimals="0" unitRef="usd">451221</cve:InvestmentBalance1>
    <cve:ProportionateShareOfNetLoss contextRef="c5" decimals="0" unitRef="usd">-260055</cve:ProportionateShareOfNetLoss>
    <cve:AdjustmentToInvestmentInGroup11 contextRef="c5" decimals="0" unitRef="usd">469320</cve:AdjustmentToInvestmentInGroup11>
    <cve:DilutionLoss contextRef="c5" decimals="0" unitRef="usd">-95680</cve:DilutionLoss>
    <cve:CurrencyTranslationAdjustment contextRef="c5" decimals="0" unitRef="usd">-466</cve:CurrencyTranslationAdjustment>
    <cve:InvestmentBalance1 contextRef="c3" decimals="0" unitRef="usd">564340</cve:InvestmentBalance1>
    <cve:ProportionateShareOfNetLoss contextRef="c0" decimals="0" unitRef="usd">-143286</cve:ProportionateShareOfNetLoss>
    <cve:AdjustmentToInvestmentInGroup11 contextRef="c0" decimals="0" unitRef="usd">15675</cve:AdjustmentToInvestmentInGroup11>
    <cve:WriteoffOfInvestment contextRef="c0" decimals="0" unitRef="usd">-443614</cve:WriteoffOfInvestment>
    <cve:CurrencyTranslationAdjustment contextRef="c0" decimals="0" unitRef="usd">6885</cve:CurrencyTranslationAdjustment>
    <ifrs-full:DisclosureOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethodExplanatory contextRef="c0">&lt;table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.25in"/&gt;&lt;td style="width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;5.&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Investment
                                            in uranium&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -18pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;During
the year ended December 31, 2021, the Company entered into purchase agreements to acquire a total of 300,000 pounds of physical uranium
as U&lt;sub&gt;3&lt;/sub&gt;O&lt;sub&gt;8&lt;/sub&gt; for a total of $9,076,000 including associated expenses to be held as a long-term investment. &lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;During
the year ended December 31, 2021, the Company sold 200,000 pounds of physical uranium as U&lt;sub&gt;3&lt;/sub&gt;O&lt;sub&gt;8&lt;/sub&gt; for gross proceeds
of $6,975,000 and a gain of $524,075.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;During
the year ended December 31, 2022, the Company sold 100,000 pounds of physical uranium as U&lt;sub&gt;3&lt;/sub&gt;O&lt;sub&gt;8&lt;/sub&gt; for gross proceeds
of $4,245,000 and a gain of $35,000.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Investments
in uranium are categorized in Level 2 of the fair value hierarchy (Note 17).&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;The
following table summarizes the fair value of the physical uranium investment:&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;Investment in&lt;br/&gt; uranium&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;$&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;Balance, December 31, 2020&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-124"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 88%; text-align: left"&gt;Physical uranium&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;9,076,000&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td&gt;Fair value adjustment&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,554,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Gain on sale of uranium&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;524,075&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left"&gt;Sale of uranium investment&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(6,975,000&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Currency translation adjustment&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;30,925&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;Balance, December 31, 2021&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;4,210,000&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left"&gt;Sale of uranium investment&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(4,245,000&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Gain on sale of uranium&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;35,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Currency translation adjustment&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-125"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;Balance, December 31, 2022&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-126"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Deposits
on uranium investment:&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;On
February 15, 2022, the Company entered into a Uranium Concentrates purchase Agreement with an arm&#x2019;s length party whereby the Company
will purchase 200,000 pounds of uranium concentrate from the seller for total consideration of $8,750,000 ($43.75/pound). The contract
required an initial payment of $2,000,000, which was paid in March 2022, and will require a final payment of $6,750,000 on March 31,
2023.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;On
August 4, 2022, the Company entered into a Uranium Concentrates purchase Agreement with an arm&#x2019;s length party whereby the Company
will purchase 100,000 pounds of uranium concentrate from the seller for total consideration of $4,900,000 ($49.00/pound). The contract
required an initial payment of $1,000,000, which was paid in August 2022, and will require a final payment of $3,900,000 two days prior
to the delivery date, which shall occur between May 1, 2023 and August 31, 2023.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;On
December 15, 2022, the Company entered into a Uranium concentrates purchase agreement with an arm&#x2019;s length party whereby the Company
will purchase 100,000 pounds of uranium concentrate from the seller for total consideration of $5,922,500 ($59.225/pound) in January
2023.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 1.5pt; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Purchase Commitments in Pounds&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Total Purchase Price&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; width: 76%"&gt;Fiscal 2023&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;400,000&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;19,572,500&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in"&gt;Fiscal 2024&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-127"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-128"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in"&gt;Fiscal 2025&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-129"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-130"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in"&gt;Fiscal 2026&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-131"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-132"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in"&gt;Fiscal 2027&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-133"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-134"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</ifrs-full:DisclosureOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethodExplanatory>
    <cve:PurchaseAgreementsAmount contextRef="c5" decimals="0" unitRef="gbp">300000</cve:PurchaseAgreementsAmount>
    <us-gaap:OtherLongTermInvestments contextRef="c3" decimals="0" unitRef="usd">9076000</us-gaap:OtherLongTermInvestments>
    <cve:SaleOfPhysicalUranium contextRef="c5" decimals="0" unitRef="gbp">200000</cve:SaleOfPhysicalUranium>
    <cve:GrossProceeds contextRef="c5" decimals="0" unitRef="usd">6975000</cve:GrossProceeds>
    <ifrs-full:GainsOnDisposalsOfInvestments contextRef="c5" decimals="0" unitRef="usd">524075</ifrs-full:GainsOnDisposalsOfInvestments>
    <cve:SaleOfPhysicalUranium contextRef="c0" decimals="0" unitRef="gbp">100000</cve:SaleOfPhysicalUranium>
    <cve:GrossProceeds contextRef="c0" decimals="0" unitRef="usd">4245000</cve:GrossProceeds>
    <ifrs-full:GainsOnDisposalsOfInvestments contextRef="c0" decimals="0" unitRef="usd">35000</ifrs-full:GainsOnDisposalsOfInvestments>
    <cve:ScheduleOfTheFairValueOfThePhysicalUraniumInvestmentTableTextBlck contextRef="c0">&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;Investment in&lt;br/&gt; uranium&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;$&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;Balance, December 31, 2020&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-124"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 88%; text-align: left"&gt;Physical uranium&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;9,076,000&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td&gt;Fair value adjustment&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,554,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Gain on sale of uranium&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;524,075&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left"&gt;Sale of uranium investment&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(6,975,000&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Currency translation adjustment&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;30,925&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;Balance, December 31, 2021&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;4,210,000&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left"&gt;Sale of uranium investment&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(4,245,000&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Gain on sale of uranium&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;35,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Currency translation adjustment&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-125"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;Balance, December 31, 2022&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-126"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;</cve:ScheduleOfTheFairValueOfThePhysicalUraniumInvestmentTableTextBlck>
    <cve:PhysicalUranium contextRef="c5" decimals="0" unitRef="usd">9076000</cve:PhysicalUranium>
    <ifrs-full:AdjustmentsForGainsLossesOnChangeInFairValueOfDerivatives contextRef="c5" decimals="0" unitRef="usd">1554000</ifrs-full:AdjustmentsForGainsLossesOnChangeInFairValueOfDerivatives>
    <cve:GainOnSaleOfUranium contextRef="c5" decimals="0" unitRef="usd">524075</cve:GainOnSaleOfUranium>
    <cve:SaleOfUraniumInvestment contextRef="c5" decimals="0" unitRef="usd">-6975000</cve:SaleOfUraniumInvestment>
    <ifrs-full:OtherComprehensiveIncomeNetOfTaxChangeInValueOfForeignCurrencyBasisSpreads contextRef="c5" decimals="0" unitRef="usd">30925</ifrs-full:OtherComprehensiveIncomeNetOfTaxChangeInValueOfForeignCurrencyBasisSpreads>
    <ifrs-full:CurrentInvestments contextRef="c3" decimals="0" unitRef="usd">4210000</ifrs-full:CurrentInvestments>
    <cve:SaleOfUraniumInvestment contextRef="c0" decimals="0" unitRef="usd">-4245000</cve:SaleOfUraniumInvestment>
    <cve:GainOnSaleOfUranium contextRef="c0" decimals="0" unitRef="usd">35000</cve:GainOnSaleOfUranium>
    <cve:PurchaseAgreementsAmount contextRef="c64" decimals="0" unitRef="gbp">200000</cve:PurchaseAgreementsAmount>
    <cve:TotalConsideration contextRef="c64" decimals="0" unitRef="usd">8750000</cve:TotalConsideration>
    <cve:TotalConsiderationPerShare contextRef="c64" decimals="2" unitRef="usdPershares">43.75</cve:TotalConsiderationPerShare>
    <cve:InitialPayment contextRef="c65" decimals="0" unitRef="usd">2000000</cve:InitialPayment>
    <cve:InvestmentAmount contextRef="c66" decimals="0" unitRef="usd">6750000</cve:InvestmentAmount>
    <cve:PurchaseAgreementsAmount contextRef="c67" decimals="0" unitRef="gbp">100000</cve:PurchaseAgreementsAmount>
    <cve:TotalConsideration contextRef="c67" decimals="0" unitRef="usd">4900000</cve:TotalConsideration>
    <cve:TotalConsiderationPerShare contextRef="c67" decimals="2" unitRef="usdPershares">49</cve:TotalConsiderationPerShare>
    <cve:InitialPayment contextRef="c68" decimals="0" unitRef="usd">1000000</cve:InitialPayment>
    <cve:InvestmentAmount contextRef="c69" decimals="0" unitRef="usd">3900000</cve:InvestmentAmount>
    <cve:PurchaseAgreementsAmount contextRef="c70" decimals="0" unitRef="gbp">100000</cve:PurchaseAgreementsAmount>
    <cve:TotalConsideration contextRef="c70" decimals="0" unitRef="usd">5922500</cve:TotalConsideration>
    <cve:TotalConsiderationPerShare contextRef="c70" decimals="3" unitRef="usdPershares">59.225</cve:TotalConsiderationPerShare>
    <cve:ScheduleOfUraniumConcentratesPurchaseAgreementTableTextBlock contextRef="c0">&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 1.5pt; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Purchase Commitments in Pounds&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Total Purchase Price&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; width: 76%"&gt;Fiscal 2023&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;400,000&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;19,572,500&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in"&gt;Fiscal 2024&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-127"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-128"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in"&gt;Fiscal 2025&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-129"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-130"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in"&gt;Fiscal 2026&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-131"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-132"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in"&gt;Fiscal 2027&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-133"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-134"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</cve:ScheduleOfUraniumConcentratesPurchaseAgreementTableTextBlock>
    <cve:PurchaseCommitments contextRef="c71" decimals="0" unitRef="gbp">400000</cve:PurchaseCommitments>
    <cve:TotalPurchasePrice contextRef="c71" decimals="0" unitRef="usd">19572500</cve:TotalPurchasePrice>
    <ifrs-full:DisclosureOfMarketRiskExplanatory contextRef="c0">&lt;table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.25in"/&gt;&lt;td style="width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;6.&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Marketable
                                            securities&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -18pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;In
May 2022, the Company divested of Cibola Resources, LLC to Elephant Capital (&#x201c;Elephant&#x201d;) pursuant to a Share Purchase Agreement
whereby the Company received consideration in the form of 11,308,250 common shares with a market value of $0.27 per share. Elephant was
subsequently acquired by Evolving Gold, who renamed themselves American Future Fuel Corp (&#x201c;AFFC&#x201d;). Accordingly, the 11,308,250
shares of Elephant were converted to 11,308,250 shares of AFFC (CSE: AMPS).&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;The
cost base of the Company&#x2019;s shareholdings is $3,085,965. In accordance with the Company&#x2019;s significant accounting policy, the
common shares are classified as FVTPL, with gains/losses being recognized to the consolidated statements of loss and comprehensive loss.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;As
of December 31, 2022, 9,046,600 of the shares held are free trading (the &#x201c;Trading Shares&#x201d;) or will become free trading within
the next 12 months. These shares have been classified as a current asset on the consolidated statements of financial position, due to
the Company&#x2019;s ability to liquidate those shareholdings within the next 12 months. These shares are carried at a fair value of $3,139,325
($0.35 per share).&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;The
Final 2,261,650 Released Shares are presented as a non-current asset due to the fact that the escrow provisions restrict the Company&#x2019;s
ability to dispose of the securities within the next 12 months and are carried at a fair value of $784,832 ($0.35 per share).&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;In
October 2022, the Company received 80,000 common shares of Uravan Minerals, Inc with a market value of $0.12 per share pursuant to its
previous agreement with Prime Fuels, Inc to divest of the Company&#x2019;s LS mining claims. The agreement required that Prime Fuels,
Inc pay to the Company 10% of any consideration Prime Fuels, Inc received upon sale, transfer, or exchange to a third party. Uravan Minerals,
Inc acquired Prime Fuels, Inc and all of the mineral claims on October 28, 2022. The cost base of the Company&#x2019;s shareholdings is
$9,530. The shares have been classified as a current asset on the consolidated statements of financial position, due to the Company&#x2019;s
ability to liquidate those shareholdings within the next 12 months. These shares are carried at a fair value of $23,036 ($0.30 per share).&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;The
following table summarizes the fair value of the Company&#x2019;s marketable securities at December 31, 2022:&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;Marketable&lt;br/&gt; securities (current)&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;Marketable&lt;br/&gt; securities (non-current)&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;Total&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;$&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;$&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;$&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 64%; padding-bottom: 1.5pt"&gt;Balance, December 31, 2020, and 2021&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-135"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;-&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-136"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;-&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-137"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;-&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Additions&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;2,443,094&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;608,391&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;3,051,485&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td&gt;Fair value adjustments&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;848,814&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;208,592&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,057,406&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Currency translation adjustment&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(129,547&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(32,151&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(161,698&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;Balance, December 31, 2022&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;3,162,361&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;784,832&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;3,947,193&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</ifrs-full:DisclosureOfMarketRiskExplanatory>
    <cve:CommonShares contextRef="c76" decimals="0" unitRef="shares">11308250</cve:CommonShares>
    <cve:MarketValuePerShare contextRef="c77" decimals="2" unitRef="usdPershares">0.27</cve:MarketValuePerShare>
    <ifrs-full:NumberOfSharesIssuedAndFullyPaid contextRef="c76" decimals="0" unitRef="shares">11308250</ifrs-full:NumberOfSharesIssuedAndFullyPaid>
    <cve:ConvertedShares contextRef="c77" decimals="0" unitRef="shares">11308250</cve:ConvertedShares>
    <ifrs-full:DescriptionOfKeyAssumptionsOnWhichManagementHasBasedDeterminationOfFairValueLessCostsOfDisposal contextRef="c78">$3,085,965</ifrs-full:DescriptionOfKeyAssumptionsOnWhichManagementHasBasedDeterminationOfFairValueLessCostsOfDisposal>
    <cve:TradingShares contextRef="c0" decimals="0" unitRef="shares">9046600</cve:TradingShares>
    <ifrs-full:FinancialLiabilitiesAtFairValue contextRef="c79" decimals="0" unitRef="usd">3139325</ifrs-full:FinancialLiabilitiesAtFairValue>
    <ifrs-full:ParValuePerShare contextRef="c79" decimals="2" unitRef="usdPershares">0.35</ifrs-full:ParValuePerShare>
    <cve:ReleasedShares contextRef="c0" decimals="0" unitRef="shares">2261650</cve:ReleasedShares>
    <ifrs-full:FinancialLiabilitiesAtFairValue contextRef="c2" decimals="0" unitRef="usd">784832</ifrs-full:FinancialLiabilitiesAtFairValue>
    <ifrs-full:ParValuePerShare contextRef="c2" decimals="2" unitRef="usdPershares">0.35</ifrs-full:ParValuePerShare>
    <cve:CommonShares contextRef="c80" decimals="0" unitRef="shares">80000</cve:CommonShares>
    <cve:MarketValuePerShare contextRef="c81" decimals="2" unitRef="usdPershares">0.12</cve:MarketValuePerShare>
    <cve:PrimeFuelsConsiderationPercentage contextRef="c81" decimals="2" unitRef="pure">0.10</cve:PrimeFuelsConsiderationPercentage>
    <ifrs-full:Assets contextRef="c80" decimals="0" unitRef="usd">9530</ifrs-full:Assets>
    <ifrs-full:FinancialLiabilitiesAtFairValue contextRef="c80" decimals="0" unitRef="usd">23036</ifrs-full:FinancialLiabilitiesAtFairValue>
    <ifrs-full:ParValuePerShare contextRef="c80" decimals="2" unitRef="usdPershares">0.3</ifrs-full:ParValuePerShare>
    <cve:ScheduleOfMarketableSecuritiesTableTextBlock contextRef="c0">&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;Marketable&lt;br/&gt; securities (current)&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;Marketable&lt;br/&gt; securities (non-current)&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;Total&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;$&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;$&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;$&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 64%; padding-bottom: 1.5pt"&gt;Balance, December 31, 2020, and 2021&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-135"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;-&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-136"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;-&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-137"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;-&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Additions&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;2,443,094&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;608,391&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;3,051,485&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td&gt;Fair value adjustments&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;848,814&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;208,592&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,057,406&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Currency translation adjustment&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(129,547&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(32,151&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(161,698&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;Balance, December 31, 2022&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;3,162,361&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;784,832&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;3,947,193&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</cve:ScheduleOfMarketableSecuritiesTableTextBlock>
    <ifrs-full:AdditionalProvisionsOtherProvisions contextRef="c84" decimals="0" unitRef="usd">2443094</ifrs-full:AdditionalProvisionsOtherProvisions>
    <ifrs-full:AdditionalProvisionsOtherProvisions contextRef="c85" decimals="0" unitRef="usd">608391</ifrs-full:AdditionalProvisionsOtherProvisions>
    <ifrs-full:AdditionalProvisionsOtherProvisions contextRef="c0" decimals="0" unitRef="usd">3051485</ifrs-full:AdditionalProvisionsOtherProvisions>
    <ifrs-full:AdjustmentsForGainsLossesOnFairValueAdjustmentInvestmentProperty contextRef="c84" decimals="0" unitRef="usd">848814</ifrs-full:AdjustmentsForGainsLossesOnFairValueAdjustmentInvestmentProperty>
    <ifrs-full:AdjustmentsForGainsLossesOnFairValueAdjustmentInvestmentProperty contextRef="c85" decimals="0" unitRef="usd">208592</ifrs-full:AdjustmentsForGainsLossesOnFairValueAdjustmentInvestmentProperty>
    <ifrs-full:AdjustmentsForGainsLossesOnFairValueAdjustmentInvestmentProperty contextRef="c0" decimals="0" unitRef="usd">1057406</ifrs-full:AdjustmentsForGainsLossesOnFairValueAdjustmentInvestmentProperty>
    <us-gaap:RestructuringReserveTranslationAdjustment contextRef="c84" decimals="0" unitRef="usd">-129547</us-gaap:RestructuringReserveTranslationAdjustment>
    <us-gaap:RestructuringReserveTranslationAdjustment contextRef="c85" decimals="0" unitRef="usd">-32151</us-gaap:RestructuringReserveTranslationAdjustment>
    <us-gaap:RestructuringReserveTranslationAdjustment contextRef="c0" decimals="0" unitRef="usd">-161698</us-gaap:RestructuringReserveTranslationAdjustment>
    <cve:MarketablesSecurities contextRef="c86" decimals="0" unitRef="usd">3162361</cve:MarketablesSecurities>
    <cve:MarketablesSecurities contextRef="c87" decimals="0" unitRef="usd">784832</cve:MarketablesSecurities>
    <cve:MarketablesSecurities contextRef="c2" decimals="0" unitRef="usd">3947193</cve:MarketablesSecurities>
    <ifrs-full:DisclosureOfIntangibleAssetsExplanatory contextRef="c0">&lt;table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.25in"/&gt;&lt;td style="width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;7.&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Intangible
                                            assets&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -18pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;In
2018, the Company acquired access to certain uranium exploration data from VANE Minerals (US) LLC (&#x201c;VANE&#x201d;). In exchange the
Company issued 3,000,000 common shares at a fair value of $264,096 and granted VANE certain back-in rights for any projects developed
from the use of the data. The primary term of the agreement is five years, and it may be renewed by the Company by written notice for
three successive renewal periods of three years each. Thus, the intangible asset has been determined to have a life of 14 years.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;In
2020, for $67,251 the Company permanently acquired certain electronic data pertaining to properties and geology in South Texas from Signal
Equities, LLC. The intangible asset was determined to have an indefinite life and therefore is not being amortized but reviewed for impairment
annually and more frequently if required.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;In
2020, the Company permanently acquired the Grants Mineral Belt database through its asset acquisition with Westwater Resources, Inc.
The intangible asset was determined to have an indefinite life and therefore is not being amortized but reviewed for impairment annually
and more frequently if required.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;In
2021, the Company permanently acquired additional borehole logs for the Grants Mineral Belt property for $17,500. The intangible asset
was determined to have an indefinite life and therefore is not being amortized but reviewed for impairment annually or more frequently
if required.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;In
2022, the Company acquired access to the Getty Minerals Database from Platoro West Incorporated for $55,500 (Note 15). The intangible
asset was determined to have an indefinite life and therefore is not being amortized but reviewed for impairment annually and more frequently
if required.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-left: 0.125in; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;VANE&lt;br/&gt; Agreement&lt;br/&gt; $&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;Getty&lt;br/&gt; Database&lt;br/&gt; $&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;Signal&lt;br/&gt; Equities&lt;br/&gt; Database&lt;br/&gt; $&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;Grants&lt;br/&gt; Mineral Belt&lt;br/&gt; Database&lt;br/&gt; $&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;Total&lt;br/&gt; $&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; width: 40%"&gt;Balance, December 31, 2020&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;226,368&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;-&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;67,251&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;190,012&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;483,631&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in"&gt;Additions&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;17,500&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;17,500&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in"&gt;Amortization&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(20,515&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(20,515&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left; padding-bottom: 1.5pt"&gt;Currency Translation Adjustment&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;1,651&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;-&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;-&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;9,729&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;11,380&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 1.5pt"&gt;Balance, December 31, 2021&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;207,504&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;-&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;67,251&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;217,241&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;491,996&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in"&gt;Additions&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;55,500&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;55,500&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in"&gt;Amortization&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(19,764&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(19,764&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left; padding-bottom: 1.5pt"&gt;Currency Translation Adjustment&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;900&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(350&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;-&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;-&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;550&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; font-weight: bold; padding-bottom: 1.5pt"&gt;Balance, December 31, 2022&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;188,640&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;55,150&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;67,251&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;217,241&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;528,282&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</ifrs-full:DisclosureOfIntangibleAssetsExplanatory>
    <cve:CommonSharesIssued contextRef="c88" decimals="0" unitRef="shares">3000000</cve:CommonSharesIssued>
    <ifrs-full:PlanAssetsAtFairValue contextRef="c88" decimals="0" unitRef="usd">264096</ifrs-full:PlanAssetsAtFairValue>
    <cve:PrimaryTerm contextRef="c89">P5Y</cve:PrimaryTerm>
    <cve:RenewalPeriods contextRef="c89">P3Y</cve:RenewalPeriods>
    <cve:IntangibleAssetDeterminedLife contextRef="c89">P14Y</cve:IntangibleAssetDeterminedLife>
    <cve:AcquiredAmonut contextRef="c90" decimals="0" unitRef="usd">67251</cve:AcquiredAmonut>
    <cve:AcquiredAmonut contextRef="c91" decimals="0" unitRef="usd">17500</cve:AcquiredAmonut>
    <cve:AcquiredAmonut contextRef="c92" decimals="0" unitRef="usd">55500</cve:AcquiredAmonut>
    <ifrs-full:DisclosureOfDetailedInformationAboutIntangibleAssetsExplanatory contextRef="c0">&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-left: 0.125in; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;VANE&lt;br/&gt; Agreement&lt;br/&gt; $&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;Getty&lt;br/&gt; Database&lt;br/&gt; $&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;Signal&lt;br/&gt; Equities&lt;br/&gt; Database&lt;br/&gt; $&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;Grants&lt;br/&gt; Mineral Belt&lt;br/&gt; Database&lt;br/&gt; $&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;Total&lt;br/&gt; $&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; width: 40%"&gt;Balance, December 31, 2020&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;226,368&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;-&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;67,251&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;190,012&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;483,631&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in"&gt;Additions&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;17,500&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;17,500&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in"&gt;Amortization&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(20,515&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(20,515&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left; padding-bottom: 1.5pt"&gt;Currency Translation Adjustment&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;1,651&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;-&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;-&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;9,729&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;11,380&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 1.5pt"&gt;Balance, December 31, 2021&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;207,504&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;-&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;67,251&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;217,241&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;491,996&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in"&gt;Additions&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;55,500&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;55,500&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in"&gt;Amortization&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(19,764&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(19,764&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left; padding-bottom: 1.5pt"&gt;Currency Translation Adjustment&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;900&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(350&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;-&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;-&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;550&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; font-weight: bold; padding-bottom: 1.5pt"&gt;Balance, December 31, 2022&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;188,640&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;55,150&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;67,251&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;217,241&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;528,282&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</ifrs-full:DisclosureOfDetailedInformationAboutIntangibleAssetsExplanatory>
    <cve:IntangibleAssetsBalance contextRef="c93" decimals="0" unitRef="usd">226368</cve:IntangibleAssetsBalance>
    <cve:IntangibleAssetsBalance contextRef="c94" decimals="0" unitRef="usd">67251</cve:IntangibleAssetsBalance>
    <cve:IntangibleAssetsBalance contextRef="c95" decimals="0" unitRef="usd">190012</cve:IntangibleAssetsBalance>
    <cve:IntangibleAssetsBalance contextRef="c6" decimals="0" unitRef="usd">483631</cve:IntangibleAssetsBalance>
    <cve:Additions contextRef="c96" decimals="0" unitRef="usd">17500</cve:Additions>
    <cve:Additions contextRef="c5" decimals="0" unitRef="usd">17500</cve:Additions>
    <ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill contextRef="c97" decimals="0" unitRef="usd">20515</ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill contextRef="c5" decimals="0" unitRef="usd">20515</ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill>
    <cve:CurrencyTranslationAdjustment1 contextRef="c97" decimals="0" unitRef="usd">1651</cve:CurrencyTranslationAdjustment1>
    <cve:CurrencyTranslationAdjustment1 contextRef="c96" decimals="0" unitRef="usd">9729</cve:CurrencyTranslationAdjustment1>
    <cve:CurrencyTranslationAdjustment1 contextRef="c5" decimals="0" unitRef="usd">11380</cve:CurrencyTranslationAdjustment1>
    <cve:IntangibleAssetsBalance contextRef="c98" decimals="0" unitRef="usd">207504</cve:IntangibleAssetsBalance>
    <cve:IntangibleAssetsBalance contextRef="c99" decimals="0" unitRef="usd">67251</cve:IntangibleAssetsBalance>
    <cve:IntangibleAssetsBalance contextRef="c100" decimals="0" unitRef="usd">217241</cve:IntangibleAssetsBalance>
    <cve:IntangibleAssetsBalance contextRef="c3" decimals="0" unitRef="usd">491996</cve:IntangibleAssetsBalance>
    <cve:Additions contextRef="c101" decimals="0" unitRef="usd">55500</cve:Additions>
    <cve:Additions contextRef="c0" decimals="0" unitRef="usd">55500</cve:Additions>
    <ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill contextRef="c102" decimals="0" unitRef="usd">19764</ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill contextRef="c0" decimals="0" unitRef="usd">19764</ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill>
    <cve:CurrencyTranslationAdjustment1 contextRef="c102" decimals="0" unitRef="usd">900</cve:CurrencyTranslationAdjustment1>
    <cve:CurrencyTranslationAdjustment1 contextRef="c101" decimals="0" unitRef="usd">-350</cve:CurrencyTranslationAdjustment1>
    <cve:CurrencyTranslationAdjustment1 contextRef="c0" decimals="0" unitRef="usd">550</cve:CurrencyTranslationAdjustment1>
    <cve:IntangibleAssetsBalance contextRef="c103" decimals="0" unitRef="usd">188640</cve:IntangibleAssetsBalance>
    <cve:IntangibleAssetsBalance contextRef="c104" decimals="0" unitRef="usd">55150</cve:IntangibleAssetsBalance>
    <cve:IntangibleAssetsBalance contextRef="c105" decimals="0" unitRef="usd">67251</cve:IntangibleAssetsBalance>
    <cve:IntangibleAssetsBalance contextRef="c106" decimals="0" unitRef="usd">217241</cve:IntangibleAssetsBalance>
    <cve:IntangibleAssetsBalance contextRef="c2" decimals="0" unitRef="usd">528282</cve:IntangibleAssetsBalance>
    <ifrs-full:DisclosureOfPropertyPlantAndEquipmentExplanatory contextRef="c0">&lt;table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.25in"/&gt;&lt;td style="width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;8.&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Property,
                                            plant, and equipment&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-indent: -18pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;Uranium&lt;br/&gt; plants&lt;br/&gt; $&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;Other property,&lt;br/&gt; plant, and equipment&lt;br/&gt; $&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;Furniture&lt;br/&gt; $&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;Buildings&lt;br/&gt; $&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;Software&lt;br/&gt; $&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;Total&lt;br/&gt; $&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 28%"&gt;Balance, December 31, 2020&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;1,196,108&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;288,728&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-138"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;-&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-139"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;-&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-140"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;-&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;1,484,836&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td&gt;Additions&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;282,339&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-141"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;16,471&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;62,946&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-142"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;361,756&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Disposals&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-143"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-144"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-145"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-146"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-147"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-148"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-left: 0.125in"&gt;Depreciation&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(168,932&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(73,980&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(2,146&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-149"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-150"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(245,058&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.125in"&gt;Impairment&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-151"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-152"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-153"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-154"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-155"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-156"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left"&gt;Currency translation adjustment&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-157"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-158"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;2,145&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-159"&gt;&#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-160"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;2,145&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;Balance, December 31, 2021&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;1,309,515&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;214,748&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;16,470&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;62,946&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-161"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;1,603,679&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;Additions&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;758,747&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;172,198&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;8,507&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-162"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;60,135&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;999,587&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Disposals&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-163"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-164"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-165"&gt;&#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-166"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-167"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-168"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-left: 0.125in"&gt;Depreciation&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(162,208&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(78,646&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(4,377&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(2,316&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(21,298&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(268,845&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.125in"&gt;Impairment&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-169"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-170"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-171"&gt;&#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-172"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-173"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-174"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Currency translation adjustment&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-175"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-176"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-177"&gt;&#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-178"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-179"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-180"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;Balance, December 31, 2022&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;1,906,054&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;308,300&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;20,600&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;60,630&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;38,837&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;2,334,421&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</ifrs-full:DisclosureOfPropertyPlantAndEquipmentExplanatory>
    <ifrs-full:DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory contextRef="c0">&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;Uranium&lt;br/&gt; plants&lt;br/&gt; $&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;Other property,&lt;br/&gt; plant, and equipment&lt;br/&gt; $&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;Furniture&lt;br/&gt; $&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;Buildings&lt;br/&gt; $&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;Software&lt;br/&gt; $&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;Total&lt;br/&gt; $&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 28%"&gt;Balance, December 31, 2020&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;1,196,108&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;288,728&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-138"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;-&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-139"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;-&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-140"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;-&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;1,484,836&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td&gt;Additions&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;282,339&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-141"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;16,471&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;62,946&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-142"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;361,756&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Disposals&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-143"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-144"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-145"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-146"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-147"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-148"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-left: 0.125in"&gt;Depreciation&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(168,932&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(73,980&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(2,146&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-149"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-150"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(245,058&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.125in"&gt;Impairment&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-151"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-152"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-153"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-154"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-155"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-156"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left"&gt;Currency translation adjustment&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-157"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-158"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;2,145&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-159"&gt;&#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-160"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;2,145&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;Balance, December 31, 2021&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;1,309,515&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;214,748&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;16,470&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;62,946&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-161"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;1,603,679&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;Additions&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;758,747&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;172,198&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;8,507&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-162"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;60,135&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;999,587&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Disposals&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-163"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-164"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-165"&gt;&#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-166"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-167"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-168"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-left: 0.125in"&gt;Depreciation&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(162,208&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(78,646&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(4,377&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(2,316&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(21,298&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(268,845&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.125in"&gt;Impairment&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-169"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-170"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-171"&gt;&#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-172"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-173"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-174"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Currency translation adjustment&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-175"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-176"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-177"&gt;&#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-178"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-179"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-180"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;Balance, December 31, 2022&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;1,906,054&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;308,300&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;20,600&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;60,630&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;38,837&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;2,334,421&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</ifrs-full:DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory>
    <ifrs-full:PropertyPlantAndEquipmentCarryingAmountAtCostOfRevaluedAssets contextRef="c107" decimals="0" unitRef="usd">1196108</ifrs-full:PropertyPlantAndEquipmentCarryingAmountAtCostOfRevaluedAssets>
    <ifrs-full:PropertyPlantAndEquipmentCarryingAmountAtCostOfRevaluedAssets contextRef="c108" decimals="0" unitRef="usd">288728</ifrs-full:PropertyPlantAndEquipmentCarryingAmountAtCostOfRevaluedAssets>
    <ifrs-full:PropertyPlantAndEquipmentCarryingAmountAtCostOfRevaluedAssets contextRef="c6" decimals="0" unitRef="usd">1484836</ifrs-full:PropertyPlantAndEquipmentCarryingAmountAtCostOfRevaluedAssets>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment contextRef="c112" decimals="0" unitRef="usd">282339</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment contextRef="c114" decimals="0" unitRef="usd">16471</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment contextRef="c115" decimals="0" unitRef="usd">62946</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment contextRef="c5" decimals="0" unitRef="usd">361756</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment>
    <ifrs-full:DepreciationExpense contextRef="c112" decimals="0" unitRef="usd">168932</ifrs-full:DepreciationExpense>
    <ifrs-full:DepreciationExpense contextRef="c113" decimals="0" unitRef="usd">73980</ifrs-full:DepreciationExpense>
    <ifrs-full:DepreciationExpense contextRef="c114" decimals="0" unitRef="usd">2146</ifrs-full:DepreciationExpense>
    <ifrs-full:DepreciationExpense contextRef="c5" decimals="0" unitRef="usd">245058</ifrs-full:DepreciationExpense>
    <ifrs-full:OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation contextRef="c114" decimals="0" unitRef="usd">2145</ifrs-full:OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation>
    <ifrs-full:OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation contextRef="c5" decimals="0" unitRef="usd">2145</ifrs-full:OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation>
    <ifrs-full:PropertyPlantAndEquipmentCarryingAmountAtCostOfRevaluedAssets contextRef="c117" decimals="0" unitRef="usd">1309515</ifrs-full:PropertyPlantAndEquipmentCarryingAmountAtCostOfRevaluedAssets>
    <ifrs-full:PropertyPlantAndEquipmentCarryingAmountAtCostOfRevaluedAssets contextRef="c118" decimals="0" unitRef="usd">214748</ifrs-full:PropertyPlantAndEquipmentCarryingAmountAtCostOfRevaluedAssets>
    <ifrs-full:PropertyPlantAndEquipmentCarryingAmountAtCostOfRevaluedAssets contextRef="c119" decimals="0" unitRef="usd">16470</ifrs-full:PropertyPlantAndEquipmentCarryingAmountAtCostOfRevaluedAssets>
    <ifrs-full:PropertyPlantAndEquipmentCarryingAmountAtCostOfRevaluedAssets contextRef="c120" decimals="0" unitRef="usd">62946</ifrs-full:PropertyPlantAndEquipmentCarryingAmountAtCostOfRevaluedAssets>
    <ifrs-full:PropertyPlantAndEquipmentCarryingAmountAtCostOfRevaluedAssets contextRef="c3" decimals="0" unitRef="usd">1603679</ifrs-full:PropertyPlantAndEquipmentCarryingAmountAtCostOfRevaluedAssets>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment contextRef="c122" decimals="0" unitRef="usd">758747</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment contextRef="c123" decimals="0" unitRef="usd">172198</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment contextRef="c124" decimals="0" unitRef="usd">8507</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment contextRef="c126" decimals="0" unitRef="usd">60135</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment contextRef="c0" decimals="0" unitRef="usd">999587</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment>
    <ifrs-full:DepreciationExpense contextRef="c122" decimals="0" unitRef="usd">162208</ifrs-full:DepreciationExpense>
    <ifrs-full:DepreciationExpense contextRef="c123" decimals="0" unitRef="usd">78646</ifrs-full:DepreciationExpense>
    <ifrs-full:DepreciationExpense contextRef="c124" decimals="0" unitRef="usd">4377</ifrs-full:DepreciationExpense>
    <ifrs-full:DepreciationExpense contextRef="c125" decimals="0" unitRef="usd">2316</ifrs-full:DepreciationExpense>
    <ifrs-full:DepreciationExpense contextRef="c126" decimals="0" unitRef="usd">21298</ifrs-full:DepreciationExpense>
    <ifrs-full:DepreciationExpense contextRef="c0" decimals="0" unitRef="usd">268845</ifrs-full:DepreciationExpense>
    <ifrs-full:PropertyPlantAndEquipmentCarryingAmountAtCostOfRevaluedAssets contextRef="c127" decimals="0" unitRef="usd">1906054</ifrs-full:PropertyPlantAndEquipmentCarryingAmountAtCostOfRevaluedAssets>
    <ifrs-full:PropertyPlantAndEquipmentCarryingAmountAtCostOfRevaluedAssets contextRef="c128" decimals="0" unitRef="usd">308300</ifrs-full:PropertyPlantAndEquipmentCarryingAmountAtCostOfRevaluedAssets>
    <ifrs-full:PropertyPlantAndEquipmentCarryingAmountAtCostOfRevaluedAssets contextRef="c129" decimals="0" unitRef="usd">20600</ifrs-full:PropertyPlantAndEquipmentCarryingAmountAtCostOfRevaluedAssets>
    <ifrs-full:PropertyPlantAndEquipmentCarryingAmountAtCostOfRevaluedAssets contextRef="c130" decimals="0" unitRef="usd">60630</ifrs-full:PropertyPlantAndEquipmentCarryingAmountAtCostOfRevaluedAssets>
    <ifrs-full:PropertyPlantAndEquipmentCarryingAmountAtCostOfRevaluedAssets contextRef="c131" decimals="0" unitRef="usd">38837</ifrs-full:PropertyPlantAndEquipmentCarryingAmountAtCostOfRevaluedAssets>
    <ifrs-full:PropertyPlantAndEquipmentCarryingAmountAtCostOfRevaluedAssets contextRef="c2" decimals="0" unitRef="usd">2334421</ifrs-full:PropertyPlantAndEquipmentCarryingAmountAtCostOfRevaluedAssets>
    <ifrs-full:DisclosureOfQuantitativeInformationAboutRightofuseAssetsExplanatory contextRef="c0">&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 18pt"/&gt;&lt;td style="width: 18pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;9.&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Right-of-use
                                            assets&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -18pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;The
Company had a contractual arrangement to lease a copier through August 8, 2022.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;In
2021, the Company entered a contractual agreement to lease office space in Corpus Christi, Texas through June 30, 2025. The terms of
the lease call for a monthly lease payment of $5,417. The Company recorded a right-of use (&#x201c;ROU&#x201d;) asset based on the corresponding
lease obligation of $221,139 on July 1, 2021.When measuring the present value of lease obligations, the remaining lease payments were
discounted using the estimated borrowing rate of 7%.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;In
2021, the Company acquired a contractual agreement to lease additional office space in Vancouver, B.C. through July 10, 2023. The terms
of the lease call for a monthly payment of $4,068 CAD. The Company recorded an ROU asset based on that corresponding lease obligation
of $45,444. When measuring the present value of lease obligations, the Company discounted the remaining lease payments using the estimated
borrowing rate of 7%.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;In
2022, the Company entered a contractual agreement to lease office space in Corpus Christi, Texas through August 31, 2024. The terms of
the lease call for a monthly lease payment of $1,640. The Company recorded an ROU asset based on the corresponding lease obligation of
$34,898 on September 1, 2022. When measuring the present value of lease obligations, the remaining lease payments were discounted using
the Company&#x2019;s estimated borrowing rate of 7%.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
change in the ROU assets during the years ended December 31, 2021 and December 31, 2022 was as follows:&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;Leased copier&lt;br/&gt; $&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;Leased offices&lt;br/&gt; $&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;Total&lt;br/&gt; $&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 64%"&gt;Balance, December 31, 2020&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;8,867&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-181"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;-&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;8,867&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td&gt;Additions&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-182"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;266,583&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;266,583&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Depreciation&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(5,451&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(27,642&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(33,093&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Currency translation adjustment&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-183"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;2,207&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;2,207&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;Balance, December 31, 2021&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;3,416&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;241,148&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;244,564&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td&gt;Additions&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-184"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;34,898&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;34,898&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Depreciation&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(3,416&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(88,311&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(91,727&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Currency translation adjustment&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-185"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(2,121&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(2,121&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;Balance, December 31, 2022&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-186"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;185,614&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;185,614&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;The
change in the Long-Term lease liability during the years ended December 31, 2021 and December 31, 2022 was as follows:&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;Leased copier&lt;br/&gt; $&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;Leased offices&lt;br/&gt; $&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;Total&lt;br/&gt; $&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 64%"&gt;Balance, December 31, 2020&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;8,867&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-187"&gt;&#160;&#160;&#160;&#160;&#160;&#160;-&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;8,867&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td&gt;Additions&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-188"&gt;&#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;273,001&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;273,001&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Accretion&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-189"&gt;&#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;7,471&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;7,471&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left"&gt;Lease payments made&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(5,451&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(32,137&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(37,588&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Currency translation adjustment&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-190"&gt;&#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(2,242&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(2,242&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;Balance, December 31, 2021&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;3,416&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;246,093&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;249,509&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Additions&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-191"&gt;&#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;34,898&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;34,898&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td&gt;Accretion&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;77&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;15,157&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;15,234&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Lease payments made&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(3,493&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(103,953&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(107,446&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Currency translation adjustment&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-192"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(11,767&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(11,767&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;Balance, December 31, 2022&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-193"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;180,428&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;180,428&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Less: current lease liability&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-194"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(84,262&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(84,262&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;Balance (Long Term), December 31, 2022&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-195"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;96,166&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;96,166&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;As
of December 31, 2022, the undiscounted future lease payments are as follows:&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; width: 88%; font-weight: bold; text-align: left"&gt;Year&lt;/td&gt;&lt;td style="width: 1%; font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; width: 1%; padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; width: 9%; font-weight: bold; text-align: right"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;2023&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;127,967&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left"&gt;2024&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;81,267&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;2025&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;32,502&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt"&gt;Total&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;241,736&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</ifrs-full:DisclosureOfQuantitativeInformationAboutRightofuseAssetsExplanatory>
    <us-gaap:OperatingLeasePayments contextRef="c91" decimals="0" unitRef="usd">5417</us-gaap:OperatingLeasePayments>
    <cve:CorrespondingLeaseObligation contextRef="c132" decimals="0" unitRef="usd">221139</cve:CorrespondingLeaseObligation>
    <ifrs-full:BorrowingsInterestRate contextRef="c133" decimals="2" unitRef="pure">0.07</ifrs-full:BorrowingsInterestRate>
    <us-gaap:OperatingLeasePayments contextRef="c91" decimals="0" unitRef="cad">4068</us-gaap:OperatingLeasePayments>
    <cve:CorrespondingLeaseObligation contextRef="c91" decimals="0" unitRef="usd">45444</cve:CorrespondingLeaseObligation>
    <ifrs-full:BorrowingsInterestRate contextRef="c3" decimals="2" unitRef="pure">0.07</ifrs-full:BorrowingsInterestRate>
    <us-gaap:OperatingLeasePayments contextRef="c92" decimals="0" unitRef="usd">1640</us-gaap:OperatingLeasePayments>
    <cve:CorrespondingLeaseObligation contextRef="c92" decimals="0" unitRef="usd">34898</cve:CorrespondingLeaseObligation>
    <ifrs-full:BorrowingsInterestRate contextRef="c2" decimals="2" unitRef="pure">0.07</ifrs-full:BorrowingsInterestRate>
    <cve:DisclosureOfChangeInTheROUAssetsTableTextBlock contextRef="c0">&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;Leased copier&lt;br/&gt; $&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;Leased offices&lt;br/&gt; $&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;Total&lt;br/&gt; $&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 64%"&gt;Balance, December 31, 2020&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;8,867&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-181"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;-&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;8,867&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td&gt;Additions&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-182"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;266,583&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;266,583&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Depreciation&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(5,451&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(27,642&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(33,093&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Currency translation adjustment&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-183"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;2,207&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;2,207&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;Balance, December 31, 2021&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;3,416&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;241,148&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;244,564&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td&gt;Additions&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-184"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;34,898&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;34,898&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Depreciation&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(3,416&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(88,311&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(91,727&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Currency translation adjustment&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-185"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(2,121&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(2,121&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;Balance, December 31, 2022&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-186"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;185,614&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;185,614&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;</cve:DisclosureOfChangeInTheROUAssetsTableTextBlock>
    <cve:Right-of-UseAssetsBalance contextRef="c134" decimals="0" unitRef="usd">8867</cve:Right-of-UseAssetsBalance>
    <cve:Right-of-UseAssetsBalance contextRef="c6" decimals="0" unitRef="usd">8867</cve:Right-of-UseAssetsBalance>
    <cve:Right-of-UseAssetsAdditions contextRef="c137" decimals="0" unitRef="usd">266583</cve:Right-of-UseAssetsAdditions>
    <cve:Right-of-UseAssetsAdditions contextRef="c5" decimals="0" unitRef="usd">266583</cve:Right-of-UseAssetsAdditions>
    <cve:Right-of-UseAssetsDepreciation contextRef="c136" decimals="0" unitRef="usd">-5451</cve:Right-of-UseAssetsDepreciation>
    <cve:Right-of-UseAssetsDepreciation contextRef="c137" decimals="0" unitRef="usd">-27642</cve:Right-of-UseAssetsDepreciation>
    <cve:Right-of-UseAssetsDepreciation contextRef="c5" decimals="0" unitRef="usd">-33093</cve:Right-of-UseAssetsDepreciation>
    <cve:Right-of-UseAssetsCurrencyTranslationAdjustment contextRef="c137" decimals="0" unitRef="usd">2207</cve:Right-of-UseAssetsCurrencyTranslationAdjustment>
    <cve:Right-of-UseAssetsCurrencyTranslationAdjustment contextRef="c5" decimals="0" unitRef="usd">2207</cve:Right-of-UseAssetsCurrencyTranslationAdjustment>
    <cve:Right-of-UseAssetsBalance contextRef="c138" decimals="0" unitRef="usd">3416</cve:Right-of-UseAssetsBalance>
    <cve:Right-of-UseAssetsBalance contextRef="c139" decimals="0" unitRef="usd">241148</cve:Right-of-UseAssetsBalance>
    <cve:Right-of-UseAssetsBalance contextRef="c3" decimals="0" unitRef="usd">244564</cve:Right-of-UseAssetsBalance>
    <cve:Right-of-UseAssetsAdditions contextRef="c141" decimals="0" unitRef="usd">34898</cve:Right-of-UseAssetsAdditions>
    <cve:Right-of-UseAssetsAdditions contextRef="c0" decimals="0" unitRef="usd">34898</cve:Right-of-UseAssetsAdditions>
    <cve:Right-of-UseAssetsDepreciation contextRef="c140" decimals="0" unitRef="usd">-3416</cve:Right-of-UseAssetsDepreciation>
    <cve:Right-of-UseAssetsDepreciation contextRef="c141" decimals="0" unitRef="usd">-88311</cve:Right-of-UseAssetsDepreciation>
    <cve:Right-of-UseAssetsDepreciation contextRef="c0" decimals="0" unitRef="usd">-91727</cve:Right-of-UseAssetsDepreciation>
    <cve:Right-of-UseAssetsCurrencyTranslationAdjustment contextRef="c141" decimals="0" unitRef="usd">-2121</cve:Right-of-UseAssetsCurrencyTranslationAdjustment>
    <cve:Right-of-UseAssetsCurrencyTranslationAdjustment contextRef="c0" decimals="0" unitRef="usd">-2121</cve:Right-of-UseAssetsCurrencyTranslationAdjustment>
    <cve:Right-of-UseAssetsBalance contextRef="c143" decimals="0" unitRef="usd">185614</cve:Right-of-UseAssetsBalance>
    <cve:Right-of-UseAssetsBalance contextRef="c2" decimals="0" unitRef="usd">185614</cve:Right-of-UseAssetsBalance>
    <cve:DisclosureOfChangeInTheLongTermLeaseLiabilityTableTextBlock contextRef="c0">&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;Leased copier&lt;br/&gt; $&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;Leased offices&lt;br/&gt; $&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;Total&lt;br/&gt; $&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 64%"&gt;Balance, December 31, 2020&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;8,867&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-187"&gt;&#160;&#160;&#160;&#160;&#160;&#160;-&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;8,867&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td&gt;Additions&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-188"&gt;&#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;273,001&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;273,001&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Accretion&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-189"&gt;&#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;7,471&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;7,471&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left"&gt;Lease payments made&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(5,451&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(32,137&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(37,588&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Currency translation adjustment&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-190"&gt;&#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(2,242&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(2,242&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;Balance, December 31, 2021&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;3,416&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;246,093&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;249,509&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Additions&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-191"&gt;&#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;34,898&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;34,898&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td&gt;Accretion&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;77&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;15,157&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;15,234&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Lease payments made&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(3,493&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(103,953&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(107,446&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Currency translation adjustment&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-192"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(11,767&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(11,767&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;Balance, December 31, 2022&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-193"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;180,428&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;180,428&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Less: current lease liability&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-194"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(84,262&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(84,262&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;Balance (Long Term), December 31, 2022&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-195"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;96,166&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;96,166&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;</cve:DisclosureOfChangeInTheLongTermLeaseLiabilityTableTextBlock>
    <cve:Long-TermLeaseLiabilityBalance contextRef="c134" decimals="0" unitRef="usd">8867</cve:Long-TermLeaseLiabilityBalance>
    <cve:Long-TermLeaseLiabilityBalance contextRef="c6" decimals="0" unitRef="usd">8867</cve:Long-TermLeaseLiabilityBalance>
    <cve:Long-TermLeaseLiabilityAdditions contextRef="c137" decimals="0" unitRef="usd">273001</cve:Long-TermLeaseLiabilityAdditions>
    <cve:Long-TermLeaseLiabilityAdditions contextRef="c5" decimals="0" unitRef="usd">273001</cve:Long-TermLeaseLiabilityAdditions>
    <cve:Long-TermLeaseLiabilityAccretion contextRef="c137" decimals="0" unitRef="usd">7471</cve:Long-TermLeaseLiabilityAccretion>
    <cve:Long-TermLeaseLiabilityAccretion contextRef="c5" decimals="0" unitRef="usd">7471</cve:Long-TermLeaseLiabilityAccretion>
    <cve:Long-TermLeaseLiabilityLeasePaymentsMade contextRef="c136" decimals="0" unitRef="usd">-5451</cve:Long-TermLeaseLiabilityLeasePaymentsMade>
    <cve:Long-TermLeaseLiabilityLeasePaymentsMade contextRef="c137" decimals="0" unitRef="usd">-32137</cve:Long-TermLeaseLiabilityLeasePaymentsMade>
    <cve:Long-TermLeaseLiabilityLeasePaymentsMade contextRef="c5" decimals="0" unitRef="usd">-37588</cve:Long-TermLeaseLiabilityLeasePaymentsMade>
    <cve:Long-TermLeaseLiabilityCurrencyTranslationAdjustment contextRef="c137" decimals="0" unitRef="usd">-2242</cve:Long-TermLeaseLiabilityCurrencyTranslationAdjustment>
    <cve:Long-TermLeaseLiabilityCurrencyTranslationAdjustment contextRef="c5" decimals="0" unitRef="usd">-2242</cve:Long-TermLeaseLiabilityCurrencyTranslationAdjustment>
    <cve:Long-TermLeaseLiabilityBalance contextRef="c138" decimals="0" unitRef="usd">3416</cve:Long-TermLeaseLiabilityBalance>
    <cve:Long-TermLeaseLiabilityBalance contextRef="c139" decimals="0" unitRef="usd">246093</cve:Long-TermLeaseLiabilityBalance>
    <cve:Long-TermLeaseLiabilityBalance contextRef="c3" decimals="0" unitRef="usd">249509</cve:Long-TermLeaseLiabilityBalance>
    <cve:Long-TermLeaseLiabilityAdditions contextRef="c141" decimals="0" unitRef="usd">34898</cve:Long-TermLeaseLiabilityAdditions>
    <cve:Long-TermLeaseLiabilityAdditions contextRef="c0" decimals="0" unitRef="usd">34898</cve:Long-TermLeaseLiabilityAdditions>
    <cve:Long-TermLeaseLiabilityAccretion contextRef="c140" decimals="0" unitRef="usd">77</cve:Long-TermLeaseLiabilityAccretion>
    <cve:Long-TermLeaseLiabilityAccretion contextRef="c141" decimals="0" unitRef="usd">15157</cve:Long-TermLeaseLiabilityAccretion>
    <cve:Long-TermLeaseLiabilityAccretion contextRef="c0" decimals="0" unitRef="usd">15234</cve:Long-TermLeaseLiabilityAccretion>
    <cve:Long-TermLeaseLiabilityLeasePaymentsMade contextRef="c140" decimals="0" unitRef="usd">-3493</cve:Long-TermLeaseLiabilityLeasePaymentsMade>
    <cve:Long-TermLeaseLiabilityLeasePaymentsMade contextRef="c141" decimals="0" unitRef="usd">-103953</cve:Long-TermLeaseLiabilityLeasePaymentsMade>
    <cve:Long-TermLeaseLiabilityLeasePaymentsMade contextRef="c0" decimals="0" unitRef="usd">-107446</cve:Long-TermLeaseLiabilityLeasePaymentsMade>
    <cve:Long-TermLeaseLiabilityCurrencyTranslationAdjustment contextRef="c141" decimals="0" unitRef="usd">-11767</cve:Long-TermLeaseLiabilityCurrencyTranslationAdjustment>
    <cve:Long-TermLeaseLiabilityCurrencyTranslationAdjustment contextRef="c0" decimals="0" unitRef="usd">-11767</cve:Long-TermLeaseLiabilityCurrencyTranslationAdjustment>
    <cve:Long-TermLeaseLiabilityBalance contextRef="c143" decimals="0" unitRef="usd">180428</cve:Long-TermLeaseLiabilityBalance>
    <cve:Long-TermLeaseLiabilityBalance contextRef="c2" decimals="0" unitRef="usd">180428</cve:Long-TermLeaseLiabilityBalance>
    <cve:Long-TermLeaseLiabilityLessCurrentLeaseLiability contextRef="c141" decimals="0" unitRef="usd">-84262</cve:Long-TermLeaseLiabilityLessCurrentLeaseLiability>
    <cve:Long-TermLeaseLiabilityLessCurrentLeaseLiability contextRef="c0" decimals="0" unitRef="usd">-84262</cve:Long-TermLeaseLiabilityLessCurrentLeaseLiability>
    <ifrs-full:LongtermProvisionForDecommissioningRestorationAndRehabilitationCosts contextRef="c143" decimals="0" unitRef="usd">96166</ifrs-full:LongtermProvisionForDecommissioningRestorationAndRehabilitationCosts>
    <ifrs-full:LongtermProvisionForDecommissioningRestorationAndRehabilitationCosts contextRef="c2" decimals="0" unitRef="usd">96166</ifrs-full:LongtermProvisionForDecommissioningRestorationAndRehabilitationCosts>
    <ifrs-full:MaturityAnalysisForDerivativeFinancialLiabilities contextRef="c0">&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; width: 88%; font-weight: bold; text-align: left"&gt;Year&lt;/td&gt;&lt;td style="width: 1%; font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; width: 1%; padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; width: 9%; font-weight: bold; text-align: right"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;2023&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;127,967&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left"&gt;2024&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;81,267&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;2025&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;32,502&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt"&gt;Total&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;241,736&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</ifrs-full:MaturityAnalysisForDerivativeFinancialLiabilities>
    <cve:Right-of-UseAssetsTwoZeroTwoThree contextRef="c0" decimals="0" unitRef="usd">127967</cve:Right-of-UseAssetsTwoZeroTwoThree>
    <cve:Right-of-UseAssetsTwoZeroTwoFour contextRef="c0" decimals="0" unitRef="usd">-81267</cve:Right-of-UseAssetsTwoZeroTwoFour>
    <cve:Right-of-UseAssetsTwoZeroTwoFive contextRef="c0" decimals="0" unitRef="usd">32502</cve:Right-of-UseAssetsTwoZeroTwoFive>
    <ifrs-full:NetInvestmentInFinanceLease contextRef="c2" decimals="0" unitRef="usd">241736</ifrs-full:NetInvestmentInFinanceLease>
    <ifrs-full:DisclosureOfTransactionsRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombinationExplanatory contextRef="c0">&lt;table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.25in"/&gt;&lt;td style="width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;10.&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Asset
                                            acquisition&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -18pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;During
the year ended December 31, 2021, the Company, and Azarga Uranium Corporation (&#x201c;Azarga&#x201d;) entered into an Arrangement Agreement
pursuant to which the Company acquired all of the issued and outstanding common shares of Azarga by way of a statutory Plan of Arrangement
under the Canada Business Corporations Act (the &#x201c;Arrangement&#x201d;). Pursuant to the terms of the Arrangement, securityholders
of Azarga received 0.375 common shares of enCore for each Azarga common share (the &#x201c;Exchange Ratio&#x201d;).&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;In
connection with the Arrangement, all outstanding vested and unvested stock options and share purchase warrants of Azarga were exchanged
for replacement options and warrants of enCore, adjusted for the Exchange Ratio.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;The
aggregate amount of the total consideration was $132,294,625 calculated by taking into account: the issuance of 31,806,617 enCore common
shares (the &#x201c;Share Consideration&#x201d;) valued at $120,422,593, the issuance of 1,828,960 enCore stock options (the &#x201c;Replacement
Options&#x201d;) in replacement of options held by Azarga option holders, valued at $5,434,045 using the Black-Scholes option pricing
model, the issuance of 1,403,156 enCore share purchase warrants (the &#x201c;Replacement Warrants&#x201d;) in replacement of warrants held
by Azarga warrant holders, valued at $3,222,543 using the Black-Scholes option pricing model, and total transaction costs of $3,215,444
associated with the Arrangement.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;As
Azarga did not qualify as a business according to the definition in IFRS 3 &lt;i&gt;Business Combinations&lt;/i&gt;, the Arrangement had been accounted
for as an asset acquisition with the purchase price being allocated based on the estimated fair value of Azarga&#x2019;s assets and liabilities
summarized as follows:&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; width: 88%; font-weight: bold; padding-bottom: 1.5pt"&gt;Consideration&lt;/td&gt;&lt;td style="width: 1%; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"/&gt;&lt;td style="border-bottom: Black 1.5pt solid; width: 9%; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: 9pt"&gt;Fair value of share consideration&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;120,422,593&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-indent: 9pt"&gt;Fair value of replacement options&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;5,434,045&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: 9pt"&gt;Fair value of replacement warrants&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;3,222,543&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt; text-indent: 9pt"&gt;Transaction costs&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;3,215,444&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;Total consideration value&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;132,294,625&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;&lt;p style="margin: 0"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left; padding-bottom: 1.5pt; width: 88%"&gt;Net assets acquired&lt;/td&gt;&lt;td style="font-weight: bold; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left; width: 1%"/&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center; width: 9%"&gt;$&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left; width: 1%"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: 9pt"&gt;Cash&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,860,360&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; text-indent: 9pt"&gt;Restricted cash&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;720,039&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: 9pt"&gt;Prepaids&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;169,688&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; text-indent: 9pt"&gt;Property, plant, and equipment&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;62,946&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; text-indent: 9pt"&gt;Right-of-use asset&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;45,444&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; text-indent: 9pt"&gt;Mineral properties&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;129,129,302&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; text-indent: 9pt"&gt;Asset retirement obligations&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(267,807&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; text-indent: 9pt"&gt;Lease liability&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(49,339&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; text-indent: 9pt"&gt;Loan receivable (1)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,845,941&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt; text-indent: 9pt"&gt;Accounts payable and accrued liabilities&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(1,221,949&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt"&gt;Total net assets acquired&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;132,294,625&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;&lt;p style="margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(1)
- Transaction costs incurred by Azarga which were subsequently paid by the Company.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;The
value of the Consideration Shares was calculated based on the issuance of 31,806,617 enCore common shares at a price per share of $3.79
($4.80 CAD) on December 31, 2021.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;The
value of the Replacement Options was derived using the Black-Scholes option pricing model. The weighted average assumptions used in the
Black-Scholes option pricing model were as follows:&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Weighted
    average&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 88%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Exercise price&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1.40&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Share price&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;3.79&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Discount rate&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1.04&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Expected life (years)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;3.43&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Volatility&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;104.40&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Fair value of replacement
    options (per option):&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2.97&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;The
fair value of the Replacement Options is based on the outstanding 14,631,709 Azarga options adjusted for the Exchange Ratio (0.375) to
5,489,881; 1,828,960 enCore options after the September 2022 share consolidation.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;The
value of the Replacement Warrants was derived using the Black-Scholes option pricing model. The weighted average assumptions used in
the Black-Scholes option pricing model were as follows:&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Weighted
    average&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 88%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Exercise price&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1.66&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Share price&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;3.79&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Discount rate&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;0.91&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Expected life (years)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;0.98&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Volatility&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;77.10&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Fair
    value of replacement warrants (per warrant):&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2.30&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;The
fair value of the Replacement Warrants is based on the outstanding 11,225,255 Azarga warrants adjusted for the Exchange Ratio (0.375)
to 4,209,471; 1,403,156 enCore warrants after the September 2022 share consolidation.&lt;/span&gt;&lt;/p&gt;</ifrs-full:DisclosureOfTransactionsRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombinationExplanatory>
    <cve:MarketValuePerShare contextRef="c0" decimals="3" unitRef="usdPershares">0.375</cve:MarketValuePerShare>
    <ifrs-full:AcquisitiondateFairValueOfTotalConsiderationTransferred contextRef="c144" decimals="0" unitRef="usd">132294625</ifrs-full:AcquisitiondateFairValueOfTotalConsiderationTransferred>
    <ifrs-full:NumberOfSharesIssued contextRef="c2" decimals="0" unitRef="shares">31806617</ifrs-full:NumberOfSharesIssued>
    <cve:ShareConsiderationAmount contextRef="c0" decimals="0" unitRef="usd">120422593</cve:ShareConsiderationAmount>
    <cve:StockOptions contextRef="c0" decimals="0" unitRef="shares">1828960</cve:StockOptions>
    <ifrs-full:ProceedsFromExerciseOfOptions contextRef="c145" decimals="0" unitRef="usd">5434045</ifrs-full:ProceedsFromExerciseOfOptions>
    <cve:SharePurchaseWarrants contextRef="c0" decimals="0" unitRef="shares">1403156</cve:SharePurchaseWarrants>
    <ifrs-full:ProceedsFromExerciseOfWarrants contextRef="c145" decimals="0" unitRef="usd">3222543</ifrs-full:ProceedsFromExerciseOfWarrants>
    <ifrs-full:AcquisitionrelatedCostsRecognisedAsExpenseForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination contextRef="c0" decimals="0" unitRef="usd">3215444</ifrs-full:AcquisitionrelatedCostsRecognisedAsExpenseForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination>
    <ifrs-full:DisclosureOfFairValueMeasurementOfAssetsExplanatory contextRef="c0">&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; width: 88%; font-weight: bold; padding-bottom: 1.5pt"&gt;Consideration&lt;/td&gt;&lt;td style="width: 1%; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"/&gt;&lt;td style="border-bottom: Black 1.5pt solid; width: 9%; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: 9pt"&gt;Fair value of share consideration&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;120,422,593&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-indent: 9pt"&gt;Fair value of replacement options&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;5,434,045&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: 9pt"&gt;Fair value of replacement warrants&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;3,222,543&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt; text-indent: 9pt"&gt;Transaction costs&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;3,215,444&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;Total consideration value&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;132,294,625&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;&lt;p style="margin: 0"&gt;&#160;&lt;/p&gt;</ifrs-full:DisclosureOfFairValueMeasurementOfAssetsExplanatory>
    <ifrs-full:AcquisitiondateFairValueOfTotalConsiderationTransferred contextRef="c2" decimals="0" unitRef="usd">120422593</ifrs-full:AcquisitiondateFairValueOfTotalConsiderationTransferred>
    <cve:FairValueOfReplacementOptions contextRef="c2" decimals="0" unitRef="usd">5434045</cve:FairValueOfReplacementOptions>
    <cve:FairValueOfReplacementWarrants contextRef="c2" decimals="0" unitRef="usd">3222543</cve:FairValueOfReplacementWarrants>
    <cve:TransactionCosts contextRef="c2" decimals="0" unitRef="usd">3215444</cve:TransactionCosts>
    <cve:TotalConsiderationValue contextRef="c2" decimals="0" unitRef="usd">132294625</cve:TotalConsiderationValue>
    <ifrs-full:DisclosureOfRedesignatedFinancialAssetsAndLiabilitiesExplanatory contextRef="c0">&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left; padding-bottom: 1.5pt; width: 88%"&gt;Net assets acquired&lt;/td&gt;&lt;td style="font-weight: bold; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left; width: 1%"/&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center; width: 9%"&gt;$&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left; width: 1%"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: 9pt"&gt;Cash&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,860,360&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; text-indent: 9pt"&gt;Restricted cash&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;720,039&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: 9pt"&gt;Prepaids&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;169,688&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; text-indent: 9pt"&gt;Property, plant, and equipment&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;62,946&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; text-indent: 9pt"&gt;Right-of-use asset&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;45,444&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; text-indent: 9pt"&gt;Mineral properties&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;129,129,302&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; text-indent: 9pt"&gt;Asset retirement obligations&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(267,807&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; text-indent: 9pt"&gt;Lease liability&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(49,339&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; text-indent: 9pt"&gt;Loan receivable (1)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,845,941&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt; text-indent: 9pt"&gt;Accounts payable and accrued liabilities&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(1,221,949&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt"&gt;Total net assets acquired&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;132,294,625&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;&lt;p style="margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(1)
- Transaction costs incurred by Azarga which were subsequently paid by the Company.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;</ifrs-full:DisclosureOfRedesignatedFinancialAssetsAndLiabilitiesExplanatory>
    <ifrs-full:OtherCashAndCashEquivalents contextRef="c2" decimals="0" unitRef="usd">1860360</ifrs-full:OtherCashAndCashEquivalents>
    <ifrs-full:NoncurrentRestrictedCashAndCashEquivalents contextRef="c2" decimals="0" unitRef="usd">720039</ifrs-full:NoncurrentRestrictedCashAndCashEquivalents>
    <ifrs-full:Prepayments contextRef="c2" decimals="0" unitRef="usd">169688</ifrs-full:Prepayments>
    <ifrs-full:PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate contextRef="c2" decimals="0" unitRef="usd">62946</ifrs-full:PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate>
    <ifrs-full:RightofuseAssetsThatDoNotMeetDefinitionOfInvestmentProperty contextRef="c2" decimals="0" unitRef="usd">45444</ifrs-full:RightofuseAssetsThatDoNotMeetDefinitionOfInvestmentProperty>
    <ifrs-full:AssetsArisingFromExplorationForAndEvaluationOfMineralResources contextRef="c2" decimals="0" unitRef="usd">129129302</ifrs-full:AssetsArisingFromExplorationForAndEvaluationOfMineralResources>
    <cve:AssetRetirementObligations contextRef="c2" decimals="0" unitRef="usd">-267807</cve:AssetRetirementObligations>
    <ifrs-full:LeaseLiabilities contextRef="c2" decimals="0" unitRef="usd">49339</ifrs-full:LeaseLiabilities>
    <ifrs-full:LoansAndReceivables contextRef="c2" decimals="0" id="ix_4_fact" unitRef="usd">1845941</ifrs-full:LoansAndReceivables>
    <cve:AccountsPayableAndAccruedLiability contextRef="c2" decimals="0" unitRef="usd">-1221949</cve:AccountsPayableAndAccruedLiability>
    <ifrs-full:IdentifiableAssetsAcquiredLiabilitiesAssumed contextRef="c2" decimals="0" unitRef="usd">132294625</ifrs-full:IdentifiableAssetsAcquiredLiabilitiesAssumed>
    <ifrs-full:NumberOfSharesIssued contextRef="c3" decimals="0" unitRef="shares">31806617</ifrs-full:NumberOfSharesIssued>
    <ifrs-full:WeightedAverageSharePrice2019 contextRef="c5" decimals="2" unitRef="usdPershares">3.79</ifrs-full:WeightedAverageSharePrice2019>
    <ifrs-full:WeightedAverageSharePrice2019 contextRef="c5" decimals="2" unitRef="cadPershares">4.8</ifrs-full:WeightedAverageSharePrice2019>
    <ifrs-full:DisclosureOfIndirectMeasurementOfFairValueOfGoodsOrServicesReceivedShareOptionsGrantedDuringPeriodExplanatory contextRef="c0">&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Weighted
    average&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 88%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Exercise price&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1.40&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Share price&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;3.79&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Discount rate&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1.04&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Expected life (years)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;3.43&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Volatility&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;104.40&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Fair value of replacement
    options (per option):&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2.97&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Weighted
    average&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 88%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Exercise price&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1.66&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Share price&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;3.79&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Discount rate&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;0.91&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Expected life (years)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;0.98&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Volatility&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;77.10&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Fair
    value of replacement warrants (per warrant):&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2.30&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;</ifrs-full:DisclosureOfIndirectMeasurementOfFairValueOfGoodsOrServicesReceivedShareOptionsGrantedDuringPeriodExplanatory>
    <ifrs-full:ExercisePriceShareOptionsGranted2019 contextRef="c154" decimals="2" unitRef="usdPershares">1.4</ifrs-full:ExercisePriceShareOptionsGranted2019>
    <ifrs-full:WeightedAverageSharePriceShareOptionsGranted2019 contextRef="c154" decimals="2" unitRef="usdPershares">3.79</ifrs-full:WeightedAverageSharePriceShareOptionsGranted2019>
    <ifrs-full:ActuarialAssumptionOfDiscountRates contextRef="c155" decimals="4" unitRef="pure">0.0104</ifrs-full:ActuarialAssumptionOfDiscountRates>
    <ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019 contextRef="c154">P3Y5M4D</ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019>
    <ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted contextRef="c154" decimals="4" unitRef="pure">1.044</ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted>
    <cve:FairValueOfReplacement contextRef="c154" decimals="2" unitRef="usdPershares">2.97</cve:FairValueOfReplacement>
    <ifrs-full:NumberOfSharesOutstanding contextRef="c146" decimals="0" unitRef="shares">14631709</ifrs-full:NumberOfSharesOutstanding>
    <cve:ExchangeRatio contextRef="c147" decimals="3" unitRef="usdPershares">0.375</cve:ExchangeRatio>
    <cve:ShareConsolidation contextRef="c148" decimals="0" unitRef="shares">5489881</cve:ShareConsolidation>
    <cve:ShareConsolidation contextRef="c149" decimals="0" unitRef="shares">1828960</cve:ShareConsolidation>
    <ifrs-full:ExercisePriceShareOptionsGranted2019 contextRef="c156" decimals="2" unitRef="usdPershares">1.66</ifrs-full:ExercisePriceShareOptionsGranted2019>
    <ifrs-full:WeightedAverageSharePriceShareOptionsGranted2019 contextRef="c156" decimals="2" unitRef="usdPershares">3.79</ifrs-full:WeightedAverageSharePriceShareOptionsGranted2019>
    <ifrs-full:ActuarialAssumptionOfDiscountRates contextRef="c157" decimals="4" unitRef="pure">0.0091</ifrs-full:ActuarialAssumptionOfDiscountRates>
    <ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019 contextRef="c156">P0Y11M23D</ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019>
    <ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted contextRef="c156" decimals="4" unitRef="pure">0.771</ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted>
    <cve:FairValueOfReplacement contextRef="c156" decimals="2" unitRef="usdPershares">2.3</cve:FairValueOfReplacement>
    <ifrs-full:NumberOfSharesOutstanding contextRef="c150" decimals="0" unitRef="shares">11225255</ifrs-full:NumberOfSharesOutstanding>
    <cve:ExchangeRatio contextRef="c151" decimals="3" unitRef="usdPershares">0.375</cve:ExchangeRatio>
    <cve:ShareConsolidation contextRef="c152" decimals="0" unitRef="shares">4209471</cve:ShareConsolidation>
    <cve:ShareConsolidation contextRef="c153" decimals="0" unitRef="shares">1403156</cve:ShareConsolidation>
    <cve:DisclosureOfMineralProperties contextRef="c0">&lt;table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.25in"/&gt;&lt;td style="width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;11.&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Mineral
                                            properties&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 18pt; text-align: justify; text-indent: -18pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-left: 0.125in; padding-bottom: 1.5pt; text-align: center"/&gt;&lt;td style="padding-bottom: 1.5pt; text-align: center"/&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;&lt;span style="font-size: 8pt"&gt;Arizona&lt;br/&gt; $&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt"/&gt;&lt;td style="padding-bottom: 1.5pt; text-align: center"/&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;&lt;span style="font-size: 8pt"&gt;Colorado&lt;br/&gt; $&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt"/&gt;&lt;td style="padding-bottom: 1.5pt; text-align: center"/&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;&lt;span style="font-size: 8pt"&gt;New Mexico&lt;br/&gt; $&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt"/&gt;&lt;td style="padding-bottom: 1.5pt; text-align: center"/&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;&lt;span style="font-size: 8pt"&gt;South Dakota&lt;br/&gt; $&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt"/&gt;&lt;td style="padding-bottom: 1.5pt; text-align: center"/&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;&lt;span style="font-size: 8pt"&gt;Texas&lt;br/&gt; $&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt"/&gt;&lt;td style="padding-bottom: 1.5pt; text-align: center"/&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;&lt;span style="font-size: 8pt"&gt;Utah&lt;br/&gt; $&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt"/&gt;&lt;td style="padding-bottom: 1.5pt; text-align: center"/&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;&lt;span style="font-size: 8pt"&gt;Wyoming&lt;br/&gt; $&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt"/&gt;&lt;td style="padding-bottom: 1.5pt; text-align: center"/&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;&lt;span style="font-size: 8pt"&gt;Canada&lt;br/&gt; $&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt"/&gt;&lt;td style="padding-bottom: 1.5pt; text-align: center"/&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;&lt;span style="font-size: 8pt"&gt;Total&lt;br/&gt; $&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt"/&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; width: 23%"&gt;&lt;span style="font-size: 8pt"&gt;Balance, December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"/&gt;
    &lt;td style="width: 0.5%; text-align: left"/&gt;&lt;td style="width: 7%; text-align: right"&gt;&lt;span style="font-size: 8pt"&gt;771,388&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 0.5%; text-align: left"/&gt;&lt;td style="width: 0.5%"/&gt;
    &lt;td style="width: 0.5%; text-align: left"/&gt;&lt;td style="width: 7%; text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-196; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 0.5%; text-align: left"/&gt;&lt;td style="width: 0.5%"/&gt;
    &lt;td style="width: 0.5%; text-align: left"/&gt;&lt;td style="width: 7%; text-align: right"&gt;&lt;span style="font-size: 8pt"&gt;5,477,162&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 0.5%; text-align: left"/&gt;&lt;td style="width: 0.5%"/&gt;
    &lt;td style="width: 0.5%; text-align: left"/&gt;&lt;td style="width: 7%; text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-197; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 0.5%; text-align: left"/&gt;&lt;td style="width: 0.5%"/&gt;
    &lt;td style="width: 0.5%; text-align: left"/&gt;&lt;td style="width: 7%; text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-198; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 0.5%; text-align: left"/&gt;&lt;td style="width: 0.5%"/&gt;
    &lt;td style="width: 0.5%; text-align: left"/&gt;&lt;td style="width: 7%; text-align: right"&gt;&lt;span style="font-size: 8pt"&gt;300,460&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 0.5%; text-align: left"/&gt;&lt;td style="width: 0.5%"/&gt;
    &lt;td style="width: 0.5%; text-align: left"/&gt;&lt;td style="width: 7%; text-align: right"&gt;&lt;span style="font-size: 8pt"&gt;59,050&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 0.5%; text-align: left"/&gt;&lt;td style="width: 0.5%"/&gt;
    &lt;td style="width: 0.5%; text-align: left"/&gt;&lt;td style="width: 7%; text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-199; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 0.5%; text-align: left"/&gt;&lt;td style="width: 0.5%; font-weight: bold"/&gt;
    &lt;td style="width: 0.5%; font-weight: bold; text-align: left"/&gt;&lt;td style="width: 7%; font-weight: bold; text-align: right"&gt;&lt;span style="font-size: 8pt"&gt;6,608,060&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 0.5%; font-weight: bold; text-align: left"/&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left"&gt;&lt;span style="font-size: 8pt"&gt;Acquisition costs:&lt;/span&gt;&lt;/td&gt;&lt;td/&gt;
    &lt;td style="text-align: left"/&gt;&lt;td style="text-align: right"/&gt;&lt;td style="text-align: left"/&gt;&lt;td/&gt;
    &lt;td style="text-align: left"/&gt;&lt;td style="text-align: right"/&gt;&lt;td style="text-align: left"/&gt;&lt;td/&gt;
    &lt;td style="text-align: left"/&gt;&lt;td style="text-align: right"/&gt;&lt;td style="text-align: left"/&gt;&lt;td/&gt;
    &lt;td style="text-align: left"/&gt;&lt;td style="text-align: right"/&gt;&lt;td style="text-align: left"/&gt;&lt;td/&gt;
    &lt;td style="text-align: left"/&gt;&lt;td style="text-align: right"/&gt;&lt;td style="text-align: left"/&gt;&lt;td/&gt;
    &lt;td style="text-align: left"/&gt;&lt;td style="text-align: right"/&gt;&lt;td style="text-align: left"/&gt;&lt;td/&gt;
    &lt;td style="text-align: left"/&gt;&lt;td style="text-align: right"/&gt;&lt;td style="text-align: left"/&gt;&lt;td/&gt;
    &lt;td style="text-align: left"/&gt;&lt;td style="text-align: right"/&gt;&lt;td style="text-align: left"/&gt;&lt;td/&gt;
    &lt;td style="text-align: left"/&gt;&lt;td style="text-align: right"/&gt;&lt;td style="text-align: left"/&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.25in; text-indent: -0.125in; text-align: left"&gt;&lt;span style="font-size: 8pt"&gt;Asset acquisition (Note 10)&lt;/span&gt;&lt;/td&gt;&lt;td/&gt;
    &lt;td style="text-align: left"/&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-200; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"/&gt;&lt;td/&gt;
    &lt;td style="text-align: left"/&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-size: 8pt"&gt;619,902&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"/&gt;&lt;td/&gt;
    &lt;td style="text-align: left"/&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-201; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"/&gt;&lt;td/&gt;
    &lt;td style="text-align: left"/&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-size: 8pt"&gt;85,667,919&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"/&gt;&lt;td/&gt;
    &lt;td style="text-align: left"/&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-202; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"/&gt;&lt;td/&gt;
    &lt;td style="text-align: left"/&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-size: 8pt"&gt;1,676,674&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"/&gt;&lt;td/&gt;
    &lt;td style="text-align: left"/&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-size: 8pt"&gt;41,164,807&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"/&gt;&lt;td/&gt;
    &lt;td style="text-align: left"/&gt;&lt;td style="text-align: right"/&gt;&lt;td style="text-align: left"/&gt;&lt;td/&gt;
    &lt;td style="text-align: left"/&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-size: 8pt"&gt;129,129,302&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"/&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left"&gt;&lt;span style="font-size: 8pt"&gt;Exploration costs:&lt;/span&gt;&lt;/td&gt;&lt;td/&gt;
    &lt;td style="text-align: left"/&gt;&lt;td style="text-align: right"/&gt;&lt;td style="text-align: left"/&gt;&lt;td/&gt;
    &lt;td style="text-align: left"/&gt;&lt;td style="text-align: right"/&gt;&lt;td style="text-align: left"/&gt;&lt;td/&gt;
    &lt;td style="text-align: left"/&gt;&lt;td style="text-align: right"/&gt;&lt;td style="text-align: left"/&gt;&lt;td/&gt;
    &lt;td style="text-align: left"/&gt;&lt;td style="text-align: right"/&gt;&lt;td style="text-align: left"/&gt;&lt;td/&gt;
    &lt;td style="text-align: left"/&gt;&lt;td style="text-align: right"/&gt;&lt;td style="text-align: left"/&gt;&lt;td/&gt;
    &lt;td style="text-align: left"/&gt;&lt;td style="text-align: right"/&gt;&lt;td style="text-align: left"/&gt;&lt;td/&gt;
    &lt;td style="text-align: left"/&gt;&lt;td style="text-align: right"/&gt;&lt;td style="text-align: left"/&gt;&lt;td/&gt;
    &lt;td style="text-align: left"/&gt;&lt;td style="text-align: right"/&gt;&lt;td style="text-align: left"/&gt;&lt;td/&gt;
    &lt;td style="text-align: left"/&gt;&lt;td style="text-align: right"/&gt;&lt;td style="text-align: left"/&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.25in; text-indent: -0.125in; text-align: left"&gt;&lt;span style="font-size: 8pt"&gt;Maintenance and lease fees&lt;/span&gt;&lt;/td&gt;&lt;td/&gt;
    &lt;td style="text-align: left"/&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-size: 8pt"&gt;86,364&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"/&gt;&lt;td/&gt;
    &lt;td style="text-align: left"/&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-203; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"/&gt;&lt;td/&gt;
    &lt;td style="text-align: left"/&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-size: 8pt"&gt;529,604&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"/&gt;&lt;td/&gt;
    &lt;td style="text-align: left"/&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-204; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"/&gt;&lt;td/&gt;
    &lt;td style="text-align: left"/&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-size: 8pt"&gt;1,455,206&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"/&gt;&lt;td/&gt;
    &lt;td style="text-align: left"/&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-size: 8pt"&gt;22,663&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"/&gt;&lt;td/&gt;
    &lt;td style="text-align: left"/&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-size: 8pt"&gt;11,870&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"/&gt;&lt;td/&gt;
    &lt;td style="text-align: left"/&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-size: 8pt"&gt;78,456&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"/&gt;&lt;td/&gt;
    &lt;td style="text-align: left"/&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-size: 8pt"&gt;2,184,163&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"/&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-left: 0.25in; text-indent: -0.125in; text-align: left"&gt;&lt;span style="font-size: 8pt"&gt;Resource review&lt;/span&gt;&lt;/td&gt;&lt;td/&gt;
    &lt;td style="text-align: left"/&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-size: 8pt"&gt;42,967&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"/&gt;&lt;td/&gt;
    &lt;td style="text-align: left"/&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-205; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"/&gt;&lt;td/&gt;
    &lt;td style="text-align: left"/&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-size: 8pt"&gt;130,120&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"/&gt;&lt;td/&gt;
    &lt;td style="text-align: left"/&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-206; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"/&gt;&lt;td/&gt;
    &lt;td style="text-align: left"/&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-207; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"/&gt;&lt;td/&gt;
    &lt;td style="text-align: left"/&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-208; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"/&gt;&lt;td/&gt;
    &lt;td style="text-align: left"/&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-209; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"/&gt;&lt;td/&gt;
    &lt;td style="text-align: left"/&gt;&lt;td style="text-align: right"/&gt;&lt;td style="text-align: left"/&gt;&lt;td/&gt;
    &lt;td style="text-align: left"/&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-size: 8pt"&gt;173,087&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"/&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.25in; text-indent: -0.125in; text-align: left"&gt;&lt;span style="font-size: 8pt"&gt;Impairment charged&lt;/span&gt;&lt;/td&gt;&lt;td/&gt;
    &lt;td style="text-align: left"/&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-210; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"/&gt;&lt;td/&gt;
    &lt;td style="text-align: left"/&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-211; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"/&gt;&lt;td/&gt;
    &lt;td style="text-align: left"/&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-212; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"/&gt;&lt;td/&gt;
    &lt;td style="text-align: left"/&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-213; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"/&gt;&lt;td/&gt;
    &lt;td style="text-align: left"/&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-214; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"/&gt;&lt;td/&gt;
    &lt;td style="text-align: left"/&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-215; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"/&gt;&lt;td/&gt;
    &lt;td style="text-align: left"/&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-216; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"/&gt;&lt;td/&gt;
    &lt;td style="text-align: left"/&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-size: 8pt"&gt;(78,456&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-size: 8pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td/&gt;
    &lt;td style="text-align: left"/&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-size: 8pt"&gt;(78,456&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-size: 8pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;span style="font-size: 8pt"&gt;Divestment:&lt;/span&gt;&lt;/td&gt;&lt;td/&gt;
    &lt;td style="text-align: left"/&gt;&lt;td style="text-align: right"/&gt;&lt;td style="text-align: left"/&gt;&lt;td/&gt;
    &lt;td style="text-align: left"/&gt;&lt;td style="text-align: right"/&gt;&lt;td style="text-align: left"/&gt;&lt;td/&gt;
    &lt;td style="text-align: left"/&gt;&lt;td style="text-align: right"/&gt;&lt;td style="text-align: left"/&gt;&lt;td/&gt;
    &lt;td style="text-align: left"/&gt;&lt;td style="text-align: right"/&gt;&lt;td style="text-align: left"/&gt;&lt;td/&gt;
    &lt;td style="text-align: left"/&gt;&lt;td style="text-align: right"/&gt;&lt;td style="text-align: left"/&gt;&lt;td/&gt;
    &lt;td style="text-align: left"/&gt;&lt;td style="text-align: right"/&gt;&lt;td style="text-align: left"/&gt;&lt;td/&gt;
    &lt;td style="text-align: left"/&gt;&lt;td style="text-align: right"/&gt;&lt;td style="text-align: left"/&gt;&lt;td/&gt;
    &lt;td style="text-align: left"/&gt;&lt;td style="text-align: right"/&gt;&lt;td style="text-align: left"/&gt;&lt;td/&gt;
    &lt;td style="text-align: left"/&gt;&lt;td style="text-align: right"/&gt;&lt;td style="text-align: left"/&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.375in; text-indent: -0.125in; text-align: left"&gt;&lt;span style="font-size: 8pt"&gt;Divest - Mineral interest&lt;/span&gt;&lt;/td&gt;&lt;td/&gt;
    &lt;td style="text-align: left"/&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-217; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"/&gt;&lt;td/&gt;
    &lt;td style="text-align: left"/&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-218; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"/&gt;&lt;td/&gt;
    &lt;td style="text-align: left"/&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-219; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"/&gt;&lt;td/&gt;
    &lt;td style="text-align: left"/&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-220; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"/&gt;&lt;td/&gt;
    &lt;td style="text-align: left"/&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-221; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"/&gt;&lt;td/&gt;
    &lt;td style="text-align: left"/&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-size: 8pt"&gt;(195,514&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-size: 8pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td/&gt;
    &lt;td style="text-align: left"/&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-222; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"/&gt;&lt;td/&gt;
    &lt;td style="text-align: left"/&gt;&lt;td style="text-align: right"/&gt;&lt;td style="text-align: left"/&gt;&lt;td/&gt;
    &lt;td style="text-align: left"/&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-size: 8pt"&gt;(195,514&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-size: 8pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-left: 0.25in; text-indent: -0.125in; text-align: left; padding-bottom: 1.5pt"&gt;&lt;span style="font-size: 8pt"&gt;Assets
    held for sale&lt;/span&gt;&lt;/td&gt;&lt;td/&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"/&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-223; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"/&gt;&lt;td/&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"/&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-224; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"/&gt;&lt;td/&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"/&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-size: 8pt"&gt;(1,741,064&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-size: 8pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td/&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"/&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-225; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"/&gt;&lt;td/&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"/&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-226; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"/&gt;&lt;td/&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"/&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-227; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"/&gt;&lt;td/&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"/&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-228; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"/&gt;&lt;td/&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"/&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"/&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"/&gt;&lt;td/&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"/&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-size: 8pt"&gt;(1,741,064&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-size: 8pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 1.5pt"&gt;&lt;span style="font-size: 8pt"&gt;Balance, December 31,
    2021&lt;/span&gt;&lt;/td&gt;&lt;td/&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"/&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-size: 8pt"&gt;900,719&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"/&gt;&lt;td/&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"/&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-size: 8pt"&gt;619,902&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"/&gt;&lt;td/&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"/&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-size: 8pt"&gt;4,395,822&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"/&gt;&lt;td/&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"/&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-size: 8pt"&gt;85,667,919&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"/&gt;&lt;td/&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"/&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-size: 8pt"&gt;1,455,206&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"/&gt;&lt;td/&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"/&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-size: 8pt"&gt;1,804,283&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"/&gt;&lt;td/&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"/&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-size: 8pt"&gt;41,235,727&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"/&gt;&lt;td/&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"/&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-229; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"/&gt;&lt;td style="font-weight: bold"/&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"/&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;&lt;span style="font-size: 8pt"&gt;136,079,578&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"/&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left"&gt;&lt;span style="font-size: 8pt"&gt;Exploration costs:&lt;/span&gt;&lt;/td&gt;&lt;td/&gt;
    &lt;td style="text-align: left"/&gt;&lt;td style="text-align: right"/&gt;&lt;td style="text-align: left"/&gt;&lt;td/&gt;
    &lt;td style="text-align: left"/&gt;&lt;td style="text-align: right"/&gt;&lt;td style="text-align: left"/&gt;&lt;td/&gt;
    &lt;td style="text-align: left"/&gt;&lt;td style="text-align: right"/&gt;&lt;td style="text-align: left"/&gt;&lt;td/&gt;
    &lt;td style="text-align: left"/&gt;&lt;td style="text-align: right"/&gt;&lt;td style="text-align: left"/&gt;&lt;td/&gt;
    &lt;td style="text-align: left"/&gt;&lt;td style="text-align: right"/&gt;&lt;td style="text-align: left"/&gt;&lt;td/&gt;
    &lt;td style="text-align: left"/&gt;&lt;td style="text-align: right"/&gt;&lt;td style="text-align: left"/&gt;&lt;td/&gt;
    &lt;td style="text-align: left"/&gt;&lt;td style="text-align: right"/&gt;&lt;td style="text-align: left"/&gt;&lt;td/&gt;
    &lt;td style="text-align: left"/&gt;&lt;td style="text-align: right"/&gt;&lt;td style="text-align: left"/&gt;&lt;td/&gt;
    &lt;td style="text-align: left"/&gt;&lt;td style="text-align: right"/&gt;&lt;td style="text-align: left"/&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.25in; text-indent: -0.125in"&gt;&lt;span style="font-size: 8pt"&gt;Drilling&lt;/span&gt;&lt;/td&gt;&lt;td/&gt;
    &lt;td style="text-align: left"/&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-230; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"/&gt;&lt;td/&gt;
    &lt;td style="text-align: left"/&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-231; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"/&gt;&lt;td/&gt;
    &lt;td style="text-align: left"/&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-232; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"/&gt;&lt;td/&gt;
    &lt;td style="text-align: left"/&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-233; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"/&gt;&lt;td/&gt;
    &lt;td style="text-align: left"/&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-size: 8pt"&gt;197,422&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"/&gt;&lt;td/&gt;
    &lt;td style="text-align: left"/&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-234; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"/&gt;&lt;td/&gt;
    &lt;td style="text-align: left"/&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-235; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"/&gt;&lt;td/&gt;
    &lt;td style="text-align: left"/&gt;&lt;td style="text-align: right"/&gt;&lt;td style="text-align: left"/&gt;&lt;td/&gt;
    &lt;td style="text-align: left"/&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-size: 8pt"&gt;197,422&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"/&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-left: 0.25in; text-indent: -0.125in; text-align: left"&gt;&lt;span style="font-size: 8pt"&gt;Maintenance and lease fees&lt;/span&gt;&lt;/td&gt;&lt;td/&gt;
    &lt;td style="text-align: left"/&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-size: 8pt"&gt;111,004&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"/&gt;&lt;td/&gt;
    &lt;td style="text-align: left"/&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-236; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"/&gt;&lt;td/&gt;
    &lt;td style="text-align: left"/&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-size: 8pt"&gt;472,401&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"/&gt;&lt;td/&gt;
    &lt;td style="text-align: left"/&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-237; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"/&gt;&lt;td/&gt;
    &lt;td style="text-align: left"/&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-size: 8pt"&gt;2,523,123&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"/&gt;&lt;td/&gt;
    &lt;td style="text-align: left"/&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-size: 8pt"&gt;39,566&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"/&gt;&lt;td/&gt;
    &lt;td style="text-align: left"/&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-size: 8pt"&gt;397,324&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"/&gt;&lt;td/&gt;
    &lt;td style="text-align: left"/&gt;&lt;td style="text-align: right"/&gt;&lt;td style="text-align: left"/&gt;&lt;td/&gt;
    &lt;td style="text-align: left"/&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-size: 8pt"&gt;3,543,418&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"/&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.25in; text-indent: -0.125in; text-align: left"&gt;&lt;span style="font-size: 8pt"&gt;Permitting &amp;amp; Licensing&lt;/span&gt;&lt;/td&gt;&lt;td/&gt;
    &lt;td style="text-align: left"/&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-238; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"/&gt;&lt;td/&gt;
    &lt;td style="text-align: left"/&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-size: 8pt"&gt;(30,280&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-size: 8pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td/&gt;
    &lt;td style="text-align: left"/&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-239; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"/&gt;&lt;td/&gt;
    &lt;td style="text-align: left"/&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-size: 8pt"&gt;251,863&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"/&gt;&lt;td/&gt;
    &lt;td style="text-align: left"/&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-size: 8pt"&gt;339,225&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"/&gt;&lt;td/&gt;
    &lt;td style="text-align: left"/&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-size: 8pt"&gt;5,698&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"/&gt;&lt;td/&gt;
    &lt;td style="text-align: left"/&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-size: 8pt"&gt;273,726&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"/&gt;&lt;td/&gt;
    &lt;td style="text-align: left"/&gt;&lt;td style="text-align: right"/&gt;&lt;td style="text-align: left"/&gt;&lt;td/&gt;
    &lt;td style="text-align: left"/&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-size: 8pt"&gt;840,232&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"/&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-left: 0.25in; text-indent: -0.125in"&gt;&lt;span style="font-size: 8pt"&gt;Personnel&lt;/span&gt;&lt;/td&gt;&lt;td/&gt;
    &lt;td style="text-align: left"/&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-size: 8pt"&gt;4,500&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"/&gt;&lt;td/&gt;
    &lt;td style="text-align: left"/&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-size: 8pt"&gt;8,621&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"/&gt;&lt;td/&gt;
    &lt;td style="text-align: left"/&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-240; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"/&gt;&lt;td/&gt;
    &lt;td style="text-align: left"/&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-size: 8pt"&gt;301,066&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"/&gt;&lt;td/&gt;
    &lt;td style="text-align: left"/&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-size: 8pt"&gt;280,341&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"/&gt;&lt;td/&gt;
    &lt;td style="text-align: left"/&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-size: 8pt"&gt;19,620&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"/&gt;&lt;td/&gt;
    &lt;td style="text-align: left"/&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-size: 8pt"&gt;207,518&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"/&gt;&lt;td/&gt;
    &lt;td style="text-align: left"/&gt;&lt;td style="text-align: right"/&gt;&lt;td style="text-align: left"/&gt;&lt;td/&gt;
    &lt;td style="text-align: left"/&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-size: 8pt"&gt;821,666&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"/&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.25in; text-indent: -0.125in"&gt;&lt;span style="font-size: 8pt"&gt;Recoveries&lt;/span&gt;&lt;/td&gt;&lt;td/&gt;
    &lt;td style="text-align: left"/&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-241; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"/&gt;&lt;td/&gt;
    &lt;td style="text-align: left"/&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-size: 8pt"&gt;(20,000&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-size: 8pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td/&gt;
    &lt;td style="text-align: left"/&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-242; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"/&gt;&lt;td/&gt;
    &lt;td style="text-align: left"/&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-243; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"/&gt;&lt;td/&gt;
    &lt;td style="text-align: left"/&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-244; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"/&gt;&lt;td/&gt;
    &lt;td style="text-align: left"/&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-size: 8pt"&gt;(2,000&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-size: 8pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td/&gt;
    &lt;td style="text-align: left"/&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-245; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"/&gt;&lt;td/&gt;
    &lt;td style="text-align: left"/&gt;&lt;td style="text-align: right"/&gt;&lt;td style="text-align: left"/&gt;&lt;td/&gt;
    &lt;td style="text-align: left"/&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-size: 8pt"&gt;(22,000&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-size: 8pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-left: 0.25in; text-indent: -0.125in; text-align: left"&gt;&lt;span style="font-size: 8pt"&gt;Resource review&lt;/span&gt;&lt;/td&gt;&lt;td/&gt;
    &lt;td style="text-align: left"/&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-size: 8pt"&gt;118,500&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"/&gt;&lt;td/&gt;
    &lt;td style="text-align: left"/&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-246; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"/&gt;&lt;td/&gt;
    &lt;td style="text-align: left"/&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-size: 8pt"&gt;37,125&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"/&gt;&lt;td/&gt;
    &lt;td style="text-align: left"/&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-247; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"/&gt;&lt;td/&gt;
    &lt;td style="text-align: left"/&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-size: 8pt"&gt;47,104&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"/&gt;&lt;td/&gt;
    &lt;td style="text-align: left"/&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-size: 8pt"&gt;1,680&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"/&gt;&lt;td/&gt;
    &lt;td style="text-align: left"/&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-size: 8pt"&gt;10,080&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"/&gt;&lt;td/&gt;
    &lt;td style="text-align: left"/&gt;&lt;td style="text-align: right"/&gt;&lt;td style="text-align: left"/&gt;&lt;td/&gt;
    &lt;td style="text-align: left"/&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-size: 8pt"&gt;214,489&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"/&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 8pt"&gt;Divestment:&lt;/span&gt;&lt;/td&gt;&lt;td/&gt;
    &lt;td style="text-align: left"/&gt;&lt;td style="text-align: right"/&gt;&lt;td style="text-align: left"/&gt;&lt;td/&gt;
    &lt;td style="text-align: left"/&gt;&lt;td style="text-align: right"/&gt;&lt;td style="text-align: left"/&gt;&lt;td/&gt;
    &lt;td style="text-align: left"/&gt;&lt;td style="text-align: right"/&gt;&lt;td style="text-align: left"/&gt;&lt;td/&gt;
    &lt;td style="text-align: left"/&gt;&lt;td style="text-align: right"/&gt;&lt;td style="text-align: left"/&gt;&lt;td/&gt;
    &lt;td style="text-align: left"/&gt;&lt;td style="text-align: right"/&gt;&lt;td style="text-align: left"/&gt;&lt;td/&gt;
    &lt;td style="text-align: left"/&gt;&lt;td style="text-align: right"/&gt;&lt;td style="text-align: left"/&gt;&lt;td/&gt;
    &lt;td style="text-align: left"/&gt;&lt;td style="text-align: right"/&gt;&lt;td style="text-align: left"/&gt;&lt;td/&gt;
    &lt;td style="text-align: left"/&gt;&lt;td style="text-align: right"/&gt;&lt;td style="text-align: left"/&gt;&lt;td/&gt;
    &lt;td style="text-align: left"/&gt;&lt;td style="text-align: right"/&gt;&lt;td style="text-align: left"/&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-left: 0.25in; text-indent: -0.125in; text-align: left"&gt;&lt;span style="font-size: 8pt"&gt;Divestment of Mineral Interest&lt;/span&gt;&lt;/td&gt;&lt;td/&gt;
    &lt;td style="text-align: left"/&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-248; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"/&gt;&lt;td/&gt;
    &lt;td style="text-align: left"/&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-249; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"/&gt;&lt;td/&gt;
    &lt;td style="text-align: left"/&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-250; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"/&gt;&lt;td/&gt;
    &lt;td style="text-align: left"/&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-251; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"/&gt;&lt;td/&gt;
    &lt;td style="text-align: left"/&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-252; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"/&gt;&lt;td/&gt;
    &lt;td style="text-align: left"/&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-size: 8pt"&gt;(28,485&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-size: 8pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td/&gt;
    &lt;td style="text-align: left"/&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-253; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"/&gt;&lt;td/&gt;
    &lt;td style="text-align: left"/&gt;&lt;td style="text-align: right"/&gt;&lt;td style="text-align: left"/&gt;&lt;td/&gt;
    &lt;td style="text-align: left"/&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-size: 8pt"&gt;(28,485&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-size: 8pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.25in; text-indent: -0.125in; text-align: left"&gt;&lt;span style="font-size: 8pt"&gt;Assets held for sale&lt;/span&gt;&lt;/td&gt;&lt;td/&gt;
    &lt;td style="text-align: left"/&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-size: 8pt"&gt;(358,969&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-size: 8pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td/&gt;
    &lt;td style="text-align: left"/&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-254; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"/&gt;&lt;td/&gt;
    &lt;td style="text-align: left"/&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-255; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"/&gt;&lt;td/&gt;
    &lt;td style="text-align: left"/&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-256; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"/&gt;&lt;td/&gt;
    &lt;td style="text-align: left"/&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-257; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"/&gt;&lt;td/&gt;
    &lt;td style="text-align: left"/&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-258; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"/&gt;&lt;td/&gt;
    &lt;td style="text-align: left"/&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-size: 8pt"&gt;(369,913&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-size: 8pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td/&gt;
    &lt;td style="text-align: left"/&gt;&lt;td style="text-align: right"/&gt;&lt;td style="text-align: left"/&gt;&lt;td/&gt;
    &lt;td style="text-align: left"/&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-size: 8pt"&gt;(728,882&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-size: 8pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left"&gt;&lt;span style="font-size: 8pt"&gt;Project Development costs:&lt;/span&gt;&lt;/td&gt;&lt;td/&gt;
    &lt;td style="text-align: left"/&gt;&lt;td style="text-align: right"/&gt;&lt;td style="text-align: left"/&gt;&lt;td/&gt;
    &lt;td style="text-align: left"/&gt;&lt;td style="text-align: right"/&gt;&lt;td style="text-align: left"/&gt;&lt;td/&gt;
    &lt;td style="text-align: left"/&gt;&lt;td style="text-align: right"/&gt;&lt;td style="text-align: left"/&gt;&lt;td/&gt;
    &lt;td style="text-align: left"/&gt;&lt;td style="text-align: right"/&gt;&lt;td style="text-align: left"/&gt;&lt;td/&gt;
    &lt;td style="text-align: left"/&gt;&lt;td style="text-align: right"/&gt;&lt;td style="text-align: left"/&gt;&lt;td/&gt;
    &lt;td style="text-align: left"/&gt;&lt;td style="text-align: right"/&gt;&lt;td style="text-align: left"/&gt;&lt;td/&gt;
    &lt;td style="text-align: left"/&gt;&lt;td style="text-align: right"/&gt;&lt;td style="text-align: left"/&gt;&lt;td/&gt;
    &lt;td style="text-align: left"/&gt;&lt;td style="text-align: right"/&gt;&lt;td style="text-align: left"/&gt;&lt;td/&gt;
    &lt;td style="text-align: left"/&gt;&lt;td style="text-align: right"/&gt;&lt;td style="text-align: left"/&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.375in; text-indent: -0.125in"&gt;&lt;span style="font-size: 8pt"&gt;Construction of wellfields&lt;/span&gt;&lt;/td&gt;&lt;td/&gt;
    &lt;td style="text-align: left"/&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-259; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"/&gt;&lt;td/&gt;
    &lt;td style="text-align: left"/&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-260; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"/&gt;&lt;td/&gt;
    &lt;td style="text-align: left"/&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-261; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"/&gt;&lt;td/&gt;
    &lt;td style="text-align: left"/&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-262; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"/&gt;&lt;td/&gt;
    &lt;td style="text-align: left"/&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-size: 8pt"&gt;1,670,151&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"/&gt;&lt;td/&gt;
    &lt;td style="text-align: left"/&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-263; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"/&gt;&lt;td/&gt;
    &lt;td style="text-align: left"/&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-264; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"/&gt;&lt;td/&gt;
    &lt;td style="text-align: left"/&gt;&lt;td style="text-align: right"/&gt;&lt;td style="text-align: left"/&gt;&lt;td/&gt;
    &lt;td style="text-align: left"/&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-size: 8pt"&gt;1,670,151&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"/&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-left: 0.25in; text-indent: -0.125in"&gt;&lt;span style="font-size: 8pt"&gt;Drilling&lt;/span&gt;&lt;/td&gt;&lt;td/&gt;
    &lt;td style="text-align: left"/&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-265; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"/&gt;&lt;td/&gt;
    &lt;td style="text-align: left"/&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-266; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"/&gt;&lt;td/&gt;
    &lt;td style="text-align: left"/&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-267; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"/&gt;&lt;td/&gt;
    &lt;td style="text-align: left"/&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-268; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"/&gt;&lt;td/&gt;
    &lt;td style="text-align: left"/&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-size: 8pt"&gt;2,109,835&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"/&gt;&lt;td/&gt;
    &lt;td style="text-align: left"/&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-269; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"/&gt;&lt;td/&gt;
    &lt;td style="text-align: left"/&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-270; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"/&gt;&lt;td/&gt;
    &lt;td style="text-align: left"/&gt;&lt;td style="text-align: right"/&gt;&lt;td style="text-align: left"/&gt;&lt;td/&gt;
    &lt;td style="text-align: left"/&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-size: 8pt"&gt;2,109,835&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"/&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.25in; text-indent: -0.125in; padding-bottom: 1.5pt"&gt;&lt;span style="font-size: 8pt"&gt;Personnel&lt;/span&gt;&lt;/td&gt;&lt;td/&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"/&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-271; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"/&gt;&lt;td/&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"/&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-272; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"/&gt;&lt;td/&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"/&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-273; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"/&gt;&lt;td/&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"/&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-274; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"/&gt;&lt;td/&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"/&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-size: 8pt"&gt;521,662&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"/&gt;&lt;td/&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"/&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-275; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"/&gt;&lt;td/&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"/&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-276; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"/&gt;&lt;td/&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"/&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"/&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"/&gt;&lt;td/&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"/&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-size: 8pt"&gt;521,662&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"/&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-size: 8pt"&gt;Balance,
    December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"/&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"/&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;&lt;span style="font-size: 8pt"&gt;775,754&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"/&gt;&lt;td style="font-weight: bold"/&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"/&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;&lt;span style="font-size: 8pt"&gt;578,243&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"/&gt;&lt;td style="font-weight: bold"/&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"/&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;&lt;span style="font-size: 8pt"&gt;4,905,348&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"/&gt;&lt;td style="font-weight: bold"/&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"/&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;&lt;span style="font-size: 8pt"&gt;86,220,848&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"/&gt;&lt;td style="font-weight: bold"/&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"/&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;&lt;span style="font-size: 8pt"&gt;9,144,069&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"/&gt;&lt;td style="font-weight: bold"/&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"/&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;&lt;span style="font-size: 8pt"&gt;1,840,362&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"/&gt;&lt;td style="font-weight: bold"/&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"/&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;&lt;span style="font-size: 8pt"&gt;41,754,462&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"/&gt;&lt;td/&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"/&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-277; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"/&gt;&lt;td style="font-weight: bold"/&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"/&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;&lt;span style="font-size: 8pt"&gt;145,219,086&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"/&gt;&lt;/tr&gt;
  &lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 18pt; text-align: justify; text-indent: -18pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;i&gt;Assets
Held for Sale&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Pursuant
to an agreement dated August 27, 2021, the Company completed the sale of its subsidiary, Cibola Resources, LLC (Note 2), including its
holding of the Cebolletta project to an arm&#x2019;s length private company.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Pursuant
to an agreement dated November 3, 2022 the Company completed the sale of its subsidiaries Beltline Resources, Inc and Hydro Restoration
Corporation subsequent to the year ended December 31, 2022 (Note 22(k)).&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;i&gt;&lt;span style="text-decoration:underline"&gt;Arizona&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;i&gt;Moonshine
Springs&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;The
Moonshine Springs project is located in Mohave County, Arizona.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;On
November 3, 2022, the Company entered into an agreement to sell the Moonshine Springs project to Nuclear Fuels, Inc, an arm&#x2019;s length
private company (Note 22(k)).&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;i&gt;Other
Arizona Properties&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;The
Company owns or controls three Arizona State mineral leases and 467 unpatented federal lode mining claims covering more than 10,000 acres
in the northern Arizona strip district. The Company holds cash bonds for $88,500 (December 31, 2021 - $88,500) with the Bureau of Land
Management.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;i&gt;&lt;span style="text-decoration:underline"&gt;Colorado&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;i&gt;Centennial&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;The
Centennial Uranium Project is located in Colorado. In 2006, the Company entered into an option agreement to purchase uranium rights on
certain areas of the Centennial Project for consideration of $1,895,000 plus contingent payments of $3,165,000. Pursuant to the agreement,
the contingent payments are payable upon receipt of regulatory permits and licenses allowing uranium production. If the Company does
not obtain such permits and licenses by September 27, 2019, the uranium rights, at the option of the seller, can be transferred back
to the seller. To date, the Company has neither obtained the required permits and licenses, nor has it been able to renegotiate the option
agreement. The Company is attempting to renegotiate the option agreement and the seller has not exercised its option to have the uranium
rights transferred back.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;i&gt;&lt;span style="text-decoration:underline"&gt;New
Mexico&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;i&gt;Marquez,
Nose Rock, &amp;amp; Treeline&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;The
Marquez project is located in McKinley and Sandoval counties of New Mexico adjacent to the Company&#x2019;s Juan Tafoya property.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;The
Nose Rock Project is located in McKinley County, New Mexico, on the northern edge of the Grants Uranium District.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;The
Treeline project is located west-northwest of Albuquerque, in McKinley and Cibola Counties, Grants Uranium District, New Mexico.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;In
March 2021, the Company divested 2,240 acres of fee mineral interests to Tri State Generation and Transmission Association; $89,600 was
received in consideration. The assets having no net book value resulted in a gain on disposal of the mineral interests of $89,600 recorded
on the Company&#x2019;s consolidated statement of loss and comprehensive loss.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;In
May 2021, the Company divested one section of 640 acres of fee mineral interests to Wildcat Solar Power Plant, LLC; $16,000 was received
in consideration. The assets having no net book value resulted in a gain on disposal of the mineral interests of $16,000 recorded on
the Company&#x2019;s consolidated statement of loss and comprehensive loss.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;McKinley,
Crownpoint and Hosta Butte&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;The
Company owns a 100% interest in the McKinley properties and a 60% - 100% interest in the adjacent Crownpoint and Hosta Butte properties,
all of which are located in McKinley County, New Mexico. The Company holds a 60% interest in a portion of a certain section at Crownpoint.
The Company owns a 100% interest in the rest of the Crownpoint and Hosta Butte project area, subject to a 3% gross profit royalty on
uranium produced.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;i&gt;Juan
Tafoya&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;The
Juan Tafoya property, located in Cibola County in west-central New Mexico near the Company&#x2019;s Marquez project is leased from the
Juan Tafoya Land Corporation (&#x201c;JTLC&#x201d;).&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;i&gt;Cebolletta&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;The
Cebolletta project is situated in the eastern portion of Cibola County, New Mexico. The lands that comprise the Cebolleta uranium project
are owned in fee by La Merced del Pueblo de Cebolleta [the &#x201c;Cebolleta Land Grant&#x201d; (CLG)].&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;On
May 24, 2022, the Company divested of the Cebolletta mineral property via its sale of Cibola Resources, LLC to Elephant (Note 6) pursuant
to a Share Purchase Agreement dated August 27, 2021. Consideration received in the transaction included $250,000 and 11,308,250 shares
of Elephant with a fair value of $3,085,965. The asset had a book value of $1,741,064 at the transaction date, resulting in a gain on
disposal of subsidiary of $1,594,901 recorded on the Company&#x2019;s consolidated statement of loss and comprehensive loss.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;i&gt;West
Largo&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;The
West Largo Project is near the north-central edge of the Grants Mineral Belt in McKinley County, New Mexico.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;i&gt;Other
New Mexico Properties&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;The
Company holds mineral properties in the &#x201c;checkerboard&#x201d; area located primarily in McKinley County in northwestern New Mexico.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;In
January 2022, the Company divested approximately 808 acres of fee mineral interest to Ambrosia Solar, LLC. The assets, having no net
book value at the transaction date, resulted in a gain on disposal of the mineral interests of $48,480 recorded on the Company&#x2019;s
consolidated statement of loss and comprehensive loss. Under the agreement, Ambrosia Solar, LLC retains the right to acquire the uranium
mineral rights associated with the property by quit claim deed to be furnished by the Company. Subsequent to the period ended December
31, 2022, Ambrosia Solar, LLC has elected to exercise its right to extend the option through January 14, 2024 for an additional payment
of $24,240.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;i&gt;&lt;span style="text-decoration:underline"&gt;South
Dakota&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;i&gt;Dewey-Burdock&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;The
Dewey-Burdock Project is an in-situ recovery uranium project located in the Edgemont uranium district in South Dakota.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;i&gt;&lt;span style="text-decoration:underline"&gt;Texas&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;i&gt;Kingsville
Dome&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;The
Kingsville Dome project is located in Kleberg County, Texas on land owned by the Company. A Central Processing Plant at the site has
been on standby since 2009.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;i&gt;Rosita&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;The
Rosita Project is located in Duval County, Texas on land owned by the Company.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;i&gt;Upper
Spring Creek&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;The
Upper Spring Creek Project is located in Live Oak and Bee counties in Texas.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;i&gt;Butler
Ranch&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;The
Butler Ranch Exploration project is located in Karnes County, Texas.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;i&gt;&lt;span style="text-decoration:underline"&gt;Utah&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;i&gt;Ticaboo&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;The
Company owns three portions of a claim block located in Shootaring Canyon, Utah. The Company has a federal Plan of Operation and State
of Utah approval for processing of the assets.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;i&gt;Other
Utah Properties&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;The
Company owns various mining claims throughout Utah, as well as its Cedar Mountain project located northwest of the White Mesa Mill in
Blanding County, Utah.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;In
March 2021, the Geitus, Blue Jay and Marcy Look properties were transferred to Kimmerle Mining LLC. $Nil consideration was received in
the transaction and a loss on the disposal of these mineral rights was recorded on the Company&#x2019;s consolidated statement of loss
and comprehensive loss as a component of &#x201c;Other Income (Expense)&#x201d; for the net book value of the assets at the transaction
date, $195,514.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;In
June 2022, the Company divested of its mineral interests in the Lisbon Valley to Prime Fuels Corp (&#x201c;PFC&#x201d;). In consideration
of the transaction the Company was granted a 2.0% Net Smelter Royalty (&#x201c;NSR&#x201d;). Additionally, pursuant to the purchase agreement
dated June 20, 2022, should PFC sell, transfer or exchange the property or all of its shares to a third party, the Company shall receive
5% of the consideration that PFC receives for the lease, license, loan or sale of the property or the shares of PFC to any third party.
In October 2022, PFC and these mineral interests were acquired by Uravan Minerals, Inc resulting in the Company&#x2019;s receipt of 80,000
shares of Uravan Minerals, Inc with a fair value of $9,153. The asset had a net book value of $28,485 at the transaction date, resulting
in a loss on disposal of the mineral interests of $19,332 recorded on the Company&#x2019;s consolidated statement of loss and comprehensive
loss.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Also
in June 2022, the Company divested of a portion of its mineral interests, in the JB Claims, to PFC. As consideration for the transaction,
the Company was granted a 2.0% NSR. Additionally, pursuant to the purchase agreement dated June 20, 2022, should PFC sell, transfer or
exchange the property or all of its shares to a third party, the Company shall receive 5% of the consideration that PFC receives for
the lease, license, loan or sale of the property or the shares of PFC to any third party. The asset had no net book value at the transaction
date, resulting in no recognition of a gain or loss on disposal.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;i&gt;&lt;span style="text-decoration:underline"&gt;Wyoming&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;i&gt;Gas
Hills&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;The
Gas Hills Project is located in the historic Gas Hills uranium district 45 miles east of Riverton, Wyoming.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;i&gt;Bootheel&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;The
Bootheel uranium project is located in Albany County, Wyoming. On November 3, 2022, the Company entered into an agreement to sell the
Bootheel Uranium project to Nuclear Fuels, Inc, an arm&#x2019;s length private company (Note 22(k)).&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;i&gt;Dewey
Terrace&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;The
Dewey Terrace Project is located in Weston and Niobrara Counties of Wyoming. The project is located immediately adjacent to the Company&#x2019;s
NRC licensed Dewey-Burdock Project along the Wyoming-South Dakota state line.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;i&gt;Juniper
Ridge&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;The
Juniper Ridge Project is located in the southwest portion of Wyoming, approximately 10 miles west of the town of Baggs.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;i&gt;&lt;span style="text-decoration:underline"&gt;Utah
&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;i&gt;(continued)&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;i&gt;Kaycee&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;The
Kaycee uranium project is located in Johnson County, Wyoming. On November 3, 2022, the Company entered into an agreement to sell the
Kaycee Uranium project to Nuclear Fuels, Inc, a private arm&#x2019;s length company (Note 22(k)).&lt;/span&gt;&lt;/p&gt;</cve:DisclosureOfMineralProperties>
    <cve:ScheduleOfMineralProperties contextRef="c0">&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-left: 0.125in; padding-bottom: 1.5pt; text-align: center"/&gt;&lt;td style="padding-bottom: 1.5pt; text-align: center"/&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;&lt;span style="font-size: 8pt"&gt;Arizona&lt;br/&gt; $&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt"/&gt;&lt;td style="padding-bottom: 1.5pt; text-align: center"/&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;&lt;span style="font-size: 8pt"&gt;Colorado&lt;br/&gt; $&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt"/&gt;&lt;td style="padding-bottom: 1.5pt; text-align: center"/&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;&lt;span style="font-size: 8pt"&gt;New Mexico&lt;br/&gt; $&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt"/&gt;&lt;td style="padding-bottom: 1.5pt; text-align: center"/&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;&lt;span style="font-size: 8pt"&gt;South Dakota&lt;br/&gt; $&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt"/&gt;&lt;td style="padding-bottom: 1.5pt; text-align: center"/&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;&lt;span style="font-size: 8pt"&gt;Texas&lt;br/&gt; $&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt"/&gt;&lt;td style="padding-bottom: 1.5pt; text-align: center"/&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;&lt;span style="font-size: 8pt"&gt;Utah&lt;br/&gt; $&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt"/&gt;&lt;td style="padding-bottom: 1.5pt; text-align: center"/&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;&lt;span style="font-size: 8pt"&gt;Wyoming&lt;br/&gt; $&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt"/&gt;&lt;td style="padding-bottom: 1.5pt; text-align: center"/&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;&lt;span style="font-size: 8pt"&gt;Canada&lt;br/&gt; $&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt"/&gt;&lt;td style="padding-bottom: 1.5pt; text-align: center"/&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;&lt;span style="font-size: 8pt"&gt;Total&lt;br/&gt; $&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt"/&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; width: 23%"&gt;&lt;span style="font-size: 8pt"&gt;Balance, December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"/&gt;
    &lt;td style="width: 0.5%; text-align: left"/&gt;&lt;td style="width: 7%; text-align: right"&gt;&lt;span style="font-size: 8pt"&gt;771,388&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 0.5%; text-align: left"/&gt;&lt;td style="width: 0.5%"/&gt;
    &lt;td style="width: 0.5%; text-align: left"/&gt;&lt;td style="width: 7%; text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-196; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 0.5%; text-align: left"/&gt;&lt;td style="width: 0.5%"/&gt;
    &lt;td style="width: 0.5%; text-align: left"/&gt;&lt;td style="width: 7%; text-align: right"&gt;&lt;span style="font-size: 8pt"&gt;5,477,162&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 0.5%; text-align: left"/&gt;&lt;td style="width: 0.5%"/&gt;
    &lt;td style="width: 0.5%; text-align: left"/&gt;&lt;td style="width: 7%; text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-197; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 0.5%; text-align: left"/&gt;&lt;td style="width: 0.5%"/&gt;
    &lt;td style="width: 0.5%; text-align: left"/&gt;&lt;td style="width: 7%; text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-198; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 0.5%; text-align: left"/&gt;&lt;td style="width: 0.5%"/&gt;
    &lt;td style="width: 0.5%; text-align: left"/&gt;&lt;td style="width: 7%; text-align: right"&gt;&lt;span style="font-size: 8pt"&gt;300,460&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 0.5%; text-align: left"/&gt;&lt;td style="width: 0.5%"/&gt;
    &lt;td style="width: 0.5%; text-align: left"/&gt;&lt;td style="width: 7%; text-align: right"&gt;&lt;span style="font-size: 8pt"&gt;59,050&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 0.5%; text-align: left"/&gt;&lt;td style="width: 0.5%"/&gt;
    &lt;td style="width: 0.5%; text-align: left"/&gt;&lt;td style="width: 7%; text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-199; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 0.5%; text-align: left"/&gt;&lt;td style="width: 0.5%; font-weight: bold"/&gt;
    &lt;td style="width: 0.5%; font-weight: bold; text-align: left"/&gt;&lt;td style="width: 7%; font-weight: bold; text-align: right"&gt;&lt;span style="font-size: 8pt"&gt;6,608,060&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 0.5%; font-weight: bold; text-align: left"/&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left"&gt;&lt;span style="font-size: 8pt"&gt;Acquisition costs:&lt;/span&gt;&lt;/td&gt;&lt;td/&gt;
    &lt;td style="text-align: left"/&gt;&lt;td style="text-align: right"/&gt;&lt;td style="text-align: left"/&gt;&lt;td/&gt;
    &lt;td style="text-align: left"/&gt;&lt;td style="text-align: right"/&gt;&lt;td style="text-align: left"/&gt;&lt;td/&gt;
    &lt;td style="text-align: left"/&gt;&lt;td style="text-align: right"/&gt;&lt;td style="text-align: left"/&gt;&lt;td/&gt;
    &lt;td style="text-align: left"/&gt;&lt;td style="text-align: right"/&gt;&lt;td style="text-align: left"/&gt;&lt;td/&gt;
    &lt;td style="text-align: left"/&gt;&lt;td style="text-align: right"/&gt;&lt;td style="text-align: left"/&gt;&lt;td/&gt;
    &lt;td style="text-align: left"/&gt;&lt;td style="text-align: right"/&gt;&lt;td style="text-align: left"/&gt;&lt;td/&gt;
    &lt;td style="text-align: left"/&gt;&lt;td style="text-align: right"/&gt;&lt;td style="text-align: left"/&gt;&lt;td/&gt;
    &lt;td style="text-align: left"/&gt;&lt;td style="text-align: right"/&gt;&lt;td style="text-align: left"/&gt;&lt;td/&gt;
    &lt;td style="text-align: left"/&gt;&lt;td style="text-align: right"/&gt;&lt;td style="text-align: left"/&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.25in; text-indent: -0.125in; text-align: left"&gt;&lt;span style="font-size: 8pt"&gt;Asset acquisition (Note 10)&lt;/span&gt;&lt;/td&gt;&lt;td/&gt;
    &lt;td style="text-align: left"/&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-200; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"/&gt;&lt;td/&gt;
    &lt;td style="text-align: left"/&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-size: 8pt"&gt;619,902&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"/&gt;&lt;td/&gt;
    &lt;td style="text-align: left"/&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-201; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"/&gt;&lt;td/&gt;
    &lt;td style="text-align: left"/&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-size: 8pt"&gt;85,667,919&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"/&gt;&lt;td/&gt;
    &lt;td style="text-align: left"/&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-202; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"/&gt;&lt;td/&gt;
    &lt;td style="text-align: left"/&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-size: 8pt"&gt;1,676,674&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"/&gt;&lt;td/&gt;
    &lt;td style="text-align: left"/&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-size: 8pt"&gt;41,164,807&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"/&gt;&lt;td/&gt;
    &lt;td style="text-align: left"/&gt;&lt;td style="text-align: right"/&gt;&lt;td style="text-align: left"/&gt;&lt;td/&gt;
    &lt;td style="text-align: left"/&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-size: 8pt"&gt;129,129,302&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"/&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left"&gt;&lt;span style="font-size: 8pt"&gt;Exploration costs:&lt;/span&gt;&lt;/td&gt;&lt;td/&gt;
    &lt;td style="text-align: left"/&gt;&lt;td style="text-align: right"/&gt;&lt;td style="text-align: left"/&gt;&lt;td/&gt;
    &lt;td style="text-align: left"/&gt;&lt;td style="text-align: right"/&gt;&lt;td style="text-align: left"/&gt;&lt;td/&gt;
    &lt;td style="text-align: left"/&gt;&lt;td style="text-align: right"/&gt;&lt;td style="text-align: left"/&gt;&lt;td/&gt;
    &lt;td style="text-align: left"/&gt;&lt;td style="text-align: right"/&gt;&lt;td style="text-align: left"/&gt;&lt;td/&gt;
    &lt;td style="text-align: left"/&gt;&lt;td style="text-align: right"/&gt;&lt;td style="text-align: left"/&gt;&lt;td/&gt;
    &lt;td style="text-align: left"/&gt;&lt;td style="text-align: right"/&gt;&lt;td style="text-align: left"/&gt;&lt;td/&gt;
    &lt;td style="text-align: left"/&gt;&lt;td style="text-align: right"/&gt;&lt;td style="text-align: left"/&gt;&lt;td/&gt;
    &lt;td style="text-align: left"/&gt;&lt;td style="text-align: right"/&gt;&lt;td style="text-align: left"/&gt;&lt;td/&gt;
    &lt;td style="text-align: left"/&gt;&lt;td style="text-align: right"/&gt;&lt;td style="text-align: left"/&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.25in; text-indent: -0.125in; text-align: left"&gt;&lt;span style="font-size: 8pt"&gt;Maintenance and lease fees&lt;/span&gt;&lt;/td&gt;&lt;td/&gt;
    &lt;td style="text-align: left"/&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-size: 8pt"&gt;86,364&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"/&gt;&lt;td/&gt;
    &lt;td style="text-align: left"/&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-203; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"/&gt;&lt;td/&gt;
    &lt;td style="text-align: left"/&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-size: 8pt"&gt;529,604&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"/&gt;&lt;td/&gt;
    &lt;td style="text-align: left"/&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-204; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"/&gt;&lt;td/&gt;
    &lt;td style="text-align: left"/&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-size: 8pt"&gt;1,455,206&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"/&gt;&lt;td/&gt;
    &lt;td style="text-align: left"/&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-size: 8pt"&gt;22,663&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"/&gt;&lt;td/&gt;
    &lt;td style="text-align: left"/&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-size: 8pt"&gt;11,870&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"/&gt;&lt;td/&gt;
    &lt;td style="text-align: left"/&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-size: 8pt"&gt;78,456&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"/&gt;&lt;td/&gt;
    &lt;td style="text-align: left"/&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-size: 8pt"&gt;2,184,163&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"/&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-left: 0.25in; text-indent: -0.125in; text-align: left"&gt;&lt;span style="font-size: 8pt"&gt;Resource review&lt;/span&gt;&lt;/td&gt;&lt;td/&gt;
    &lt;td style="text-align: left"/&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-size: 8pt"&gt;42,967&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"/&gt;&lt;td/&gt;
    &lt;td style="text-align: left"/&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-205; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"/&gt;&lt;td/&gt;
    &lt;td style="text-align: left"/&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-size: 8pt"&gt;130,120&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"/&gt;&lt;td/&gt;
    &lt;td style="text-align: left"/&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-206; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"/&gt;&lt;td/&gt;
    &lt;td style="text-align: left"/&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-207; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"/&gt;&lt;td/&gt;
    &lt;td style="text-align: left"/&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-208; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"/&gt;&lt;td/&gt;
    &lt;td style="text-align: left"/&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-209; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"/&gt;&lt;td/&gt;
    &lt;td style="text-align: left"/&gt;&lt;td style="text-align: right"/&gt;&lt;td style="text-align: left"/&gt;&lt;td/&gt;
    &lt;td style="text-align: left"/&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-size: 8pt"&gt;173,087&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"/&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.25in; text-indent: -0.125in; text-align: left"&gt;&lt;span style="font-size: 8pt"&gt;Impairment charged&lt;/span&gt;&lt;/td&gt;&lt;td/&gt;
    &lt;td style="text-align: left"/&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-210; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"/&gt;&lt;td/&gt;
    &lt;td style="text-align: left"/&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-211; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"/&gt;&lt;td/&gt;
    &lt;td style="text-align: left"/&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-212; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"/&gt;&lt;td/&gt;
    &lt;td style="text-align: left"/&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-213; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"/&gt;&lt;td/&gt;
    &lt;td style="text-align: left"/&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-214; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"/&gt;&lt;td/&gt;
    &lt;td style="text-align: left"/&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-215; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"/&gt;&lt;td/&gt;
    &lt;td style="text-align: left"/&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-216; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"/&gt;&lt;td/&gt;
    &lt;td style="text-align: left"/&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-size: 8pt"&gt;(78,456&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-size: 8pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td/&gt;
    &lt;td style="text-align: left"/&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-size: 8pt"&gt;(78,456&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-size: 8pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;span style="font-size: 8pt"&gt;Divestment:&lt;/span&gt;&lt;/td&gt;&lt;td/&gt;
    &lt;td style="text-align: left"/&gt;&lt;td style="text-align: right"/&gt;&lt;td style="text-align: left"/&gt;&lt;td/&gt;
    &lt;td style="text-align: left"/&gt;&lt;td style="text-align: right"/&gt;&lt;td style="text-align: left"/&gt;&lt;td/&gt;
    &lt;td style="text-align: left"/&gt;&lt;td style="text-align: right"/&gt;&lt;td style="text-align: left"/&gt;&lt;td/&gt;
    &lt;td style="text-align: left"/&gt;&lt;td style="text-align: right"/&gt;&lt;td style="text-align: left"/&gt;&lt;td/&gt;
    &lt;td style="text-align: left"/&gt;&lt;td style="text-align: right"/&gt;&lt;td style="text-align: left"/&gt;&lt;td/&gt;
    &lt;td style="text-align: left"/&gt;&lt;td style="text-align: right"/&gt;&lt;td style="text-align: left"/&gt;&lt;td/&gt;
    &lt;td style="text-align: left"/&gt;&lt;td style="text-align: right"/&gt;&lt;td style="text-align: left"/&gt;&lt;td/&gt;
    &lt;td style="text-align: left"/&gt;&lt;td style="text-align: right"/&gt;&lt;td style="text-align: left"/&gt;&lt;td/&gt;
    &lt;td style="text-align: left"/&gt;&lt;td style="text-align: right"/&gt;&lt;td style="text-align: left"/&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.375in; text-indent: -0.125in; text-align: left"&gt;&lt;span style="font-size: 8pt"&gt;Divest - Mineral interest&lt;/span&gt;&lt;/td&gt;&lt;td/&gt;
    &lt;td style="text-align: left"/&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-217; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"/&gt;&lt;td/&gt;
    &lt;td style="text-align: left"/&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-218; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"/&gt;&lt;td/&gt;
    &lt;td style="text-align: left"/&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-219; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"/&gt;&lt;td/&gt;
    &lt;td style="text-align: left"/&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-220; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"/&gt;&lt;td/&gt;
    &lt;td style="text-align: left"/&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-221; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"/&gt;&lt;td/&gt;
    &lt;td style="text-align: left"/&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-size: 8pt"&gt;(195,514&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-size: 8pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td/&gt;
    &lt;td style="text-align: left"/&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-222; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"/&gt;&lt;td/&gt;
    &lt;td style="text-align: left"/&gt;&lt;td style="text-align: right"/&gt;&lt;td style="text-align: left"/&gt;&lt;td/&gt;
    &lt;td style="text-align: left"/&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-size: 8pt"&gt;(195,514&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-size: 8pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-left: 0.25in; text-indent: -0.125in; text-align: left; padding-bottom: 1.5pt"&gt;&lt;span style="font-size: 8pt"&gt;Assets
    held for sale&lt;/span&gt;&lt;/td&gt;&lt;td/&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"/&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-223; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"/&gt;&lt;td/&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"/&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-224; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"/&gt;&lt;td/&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"/&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-size: 8pt"&gt;(1,741,064&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-size: 8pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td/&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"/&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-225; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"/&gt;&lt;td/&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"/&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-226; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"/&gt;&lt;td/&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"/&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-227; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"/&gt;&lt;td/&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"/&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-228; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"/&gt;&lt;td/&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"/&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"/&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"/&gt;&lt;td/&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"/&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-size: 8pt"&gt;(1,741,064&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-size: 8pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 1.5pt"&gt;&lt;span style="font-size: 8pt"&gt;Balance, December 31,
    2021&lt;/span&gt;&lt;/td&gt;&lt;td/&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"/&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-size: 8pt"&gt;900,719&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"/&gt;&lt;td/&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"/&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-size: 8pt"&gt;619,902&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"/&gt;&lt;td/&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"/&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-size: 8pt"&gt;4,395,822&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"/&gt;&lt;td/&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"/&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-size: 8pt"&gt;85,667,919&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"/&gt;&lt;td/&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"/&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-size: 8pt"&gt;1,455,206&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"/&gt;&lt;td/&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"/&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-size: 8pt"&gt;1,804,283&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"/&gt;&lt;td/&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"/&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-size: 8pt"&gt;41,235,727&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"/&gt;&lt;td/&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"/&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-229; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"/&gt;&lt;td style="font-weight: bold"/&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"/&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;&lt;span style="font-size: 8pt"&gt;136,079,578&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"/&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left"&gt;&lt;span style="font-size: 8pt"&gt;Exploration costs:&lt;/span&gt;&lt;/td&gt;&lt;td/&gt;
    &lt;td style="text-align: left"/&gt;&lt;td style="text-align: right"/&gt;&lt;td style="text-align: left"/&gt;&lt;td/&gt;
    &lt;td style="text-align: left"/&gt;&lt;td style="text-align: right"/&gt;&lt;td style="text-align: left"/&gt;&lt;td/&gt;
    &lt;td style="text-align: left"/&gt;&lt;td style="text-align: right"/&gt;&lt;td style="text-align: left"/&gt;&lt;td/&gt;
    &lt;td style="text-align: left"/&gt;&lt;td style="text-align: right"/&gt;&lt;td style="text-align: left"/&gt;&lt;td/&gt;
    &lt;td style="text-align: left"/&gt;&lt;td style="text-align: right"/&gt;&lt;td style="text-align: left"/&gt;&lt;td/&gt;
    &lt;td style="text-align: left"/&gt;&lt;td style="text-align: right"/&gt;&lt;td style="text-align: left"/&gt;&lt;td/&gt;
    &lt;td style="text-align: left"/&gt;&lt;td style="text-align: right"/&gt;&lt;td style="text-align: left"/&gt;&lt;td/&gt;
    &lt;td style="text-align: left"/&gt;&lt;td style="text-align: right"/&gt;&lt;td style="text-align: left"/&gt;&lt;td/&gt;
    &lt;td style="text-align: left"/&gt;&lt;td style="text-align: right"/&gt;&lt;td style="text-align: left"/&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.25in; text-indent: -0.125in"&gt;&lt;span style="font-size: 8pt"&gt;Drilling&lt;/span&gt;&lt;/td&gt;&lt;td/&gt;
    &lt;td style="text-align: left"/&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-230; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"/&gt;&lt;td/&gt;
    &lt;td style="text-align: left"/&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-231; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"/&gt;&lt;td/&gt;
    &lt;td style="text-align: left"/&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-232; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"/&gt;&lt;td/&gt;
    &lt;td style="text-align: left"/&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-233; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"/&gt;&lt;td/&gt;
    &lt;td style="text-align: left"/&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-size: 8pt"&gt;197,422&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"/&gt;&lt;td/&gt;
    &lt;td style="text-align: left"/&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-234; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"/&gt;&lt;td/&gt;
    &lt;td style="text-align: left"/&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-235; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"/&gt;&lt;td/&gt;
    &lt;td style="text-align: left"/&gt;&lt;td style="text-align: right"/&gt;&lt;td style="text-align: left"/&gt;&lt;td/&gt;
    &lt;td style="text-align: left"/&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-size: 8pt"&gt;197,422&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"/&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-left: 0.25in; text-indent: -0.125in; text-align: left"&gt;&lt;span style="font-size: 8pt"&gt;Maintenance and lease fees&lt;/span&gt;&lt;/td&gt;&lt;td/&gt;
    &lt;td style="text-align: left"/&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-size: 8pt"&gt;111,004&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"/&gt;&lt;td/&gt;
    &lt;td style="text-align: left"/&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-236; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"/&gt;&lt;td/&gt;
    &lt;td style="text-align: left"/&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-size: 8pt"&gt;472,401&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"/&gt;&lt;td/&gt;
    &lt;td style="text-align: left"/&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-237; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"/&gt;&lt;td/&gt;
    &lt;td style="text-align: left"/&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-size: 8pt"&gt;2,523,123&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"/&gt;&lt;td/&gt;
    &lt;td style="text-align: left"/&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-size: 8pt"&gt;39,566&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"/&gt;&lt;td/&gt;
    &lt;td style="text-align: left"/&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-size: 8pt"&gt;397,324&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"/&gt;&lt;td/&gt;
    &lt;td style="text-align: left"/&gt;&lt;td style="text-align: right"/&gt;&lt;td style="text-align: left"/&gt;&lt;td/&gt;
    &lt;td style="text-align: left"/&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-size: 8pt"&gt;3,543,418&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"/&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.25in; text-indent: -0.125in; text-align: left"&gt;&lt;span style="font-size: 8pt"&gt;Permitting &amp;amp; Licensing&lt;/span&gt;&lt;/td&gt;&lt;td/&gt;
    &lt;td style="text-align: left"/&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-238; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"/&gt;&lt;td/&gt;
    &lt;td style="text-align: left"/&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-size: 8pt"&gt;(30,280&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-size: 8pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td/&gt;
    &lt;td style="text-align: left"/&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-239; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"/&gt;&lt;td/&gt;
    &lt;td style="text-align: left"/&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-size: 8pt"&gt;251,863&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"/&gt;&lt;td/&gt;
    &lt;td style="text-align: left"/&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-size: 8pt"&gt;339,225&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"/&gt;&lt;td/&gt;
    &lt;td style="text-align: left"/&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-size: 8pt"&gt;5,698&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"/&gt;&lt;td/&gt;
    &lt;td style="text-align: left"/&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-size: 8pt"&gt;273,726&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"/&gt;&lt;td/&gt;
    &lt;td style="text-align: left"/&gt;&lt;td style="text-align: right"/&gt;&lt;td style="text-align: left"/&gt;&lt;td/&gt;
    &lt;td style="text-align: left"/&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-size: 8pt"&gt;840,232&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"/&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-left: 0.25in; text-indent: -0.125in"&gt;&lt;span style="font-size: 8pt"&gt;Personnel&lt;/span&gt;&lt;/td&gt;&lt;td/&gt;
    &lt;td style="text-align: left"/&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-size: 8pt"&gt;4,500&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"/&gt;&lt;td/&gt;
    &lt;td style="text-align: left"/&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-size: 8pt"&gt;8,621&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"/&gt;&lt;td/&gt;
    &lt;td style="text-align: left"/&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-240; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"/&gt;&lt;td/&gt;
    &lt;td style="text-align: left"/&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-size: 8pt"&gt;301,066&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"/&gt;&lt;td/&gt;
    &lt;td style="text-align: left"/&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-size: 8pt"&gt;280,341&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"/&gt;&lt;td/&gt;
    &lt;td style="text-align: left"/&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-size: 8pt"&gt;19,620&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"/&gt;&lt;td/&gt;
    &lt;td style="text-align: left"/&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-size: 8pt"&gt;207,518&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"/&gt;&lt;td/&gt;
    &lt;td style="text-align: left"/&gt;&lt;td style="text-align: right"/&gt;&lt;td style="text-align: left"/&gt;&lt;td/&gt;
    &lt;td style="text-align: left"/&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-size: 8pt"&gt;821,666&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"/&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.25in; text-indent: -0.125in"&gt;&lt;span style="font-size: 8pt"&gt;Recoveries&lt;/span&gt;&lt;/td&gt;&lt;td/&gt;
    &lt;td style="text-align: left"/&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-241; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"/&gt;&lt;td/&gt;
    &lt;td style="text-align: left"/&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-size: 8pt"&gt;(20,000&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-size: 8pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td/&gt;
    &lt;td style="text-align: left"/&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-242; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"/&gt;&lt;td/&gt;
    &lt;td style="text-align: left"/&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-243; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"/&gt;&lt;td/&gt;
    &lt;td style="text-align: left"/&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-244; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"/&gt;&lt;td/&gt;
    &lt;td style="text-align: left"/&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-size: 8pt"&gt;(2,000&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-size: 8pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td/&gt;
    &lt;td style="text-align: left"/&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-245; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"/&gt;&lt;td/&gt;
    &lt;td style="text-align: left"/&gt;&lt;td style="text-align: right"/&gt;&lt;td style="text-align: left"/&gt;&lt;td/&gt;
    &lt;td style="text-align: left"/&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-size: 8pt"&gt;(22,000&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-size: 8pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-left: 0.25in; text-indent: -0.125in; text-align: left"&gt;&lt;span style="font-size: 8pt"&gt;Resource review&lt;/span&gt;&lt;/td&gt;&lt;td/&gt;
    &lt;td style="text-align: left"/&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-size: 8pt"&gt;118,500&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"/&gt;&lt;td/&gt;
    &lt;td style="text-align: left"/&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-246; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"/&gt;&lt;td/&gt;
    &lt;td style="text-align: left"/&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-size: 8pt"&gt;37,125&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"/&gt;&lt;td/&gt;
    &lt;td style="text-align: left"/&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-247; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"/&gt;&lt;td/&gt;
    &lt;td style="text-align: left"/&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-size: 8pt"&gt;47,104&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"/&gt;&lt;td/&gt;
    &lt;td style="text-align: left"/&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-size: 8pt"&gt;1,680&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"/&gt;&lt;td/&gt;
    &lt;td style="text-align: left"/&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-size: 8pt"&gt;10,080&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"/&gt;&lt;td/&gt;
    &lt;td style="text-align: left"/&gt;&lt;td style="text-align: right"/&gt;&lt;td style="text-align: left"/&gt;&lt;td/&gt;
    &lt;td style="text-align: left"/&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-size: 8pt"&gt;214,489&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"/&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 8pt"&gt;Divestment:&lt;/span&gt;&lt;/td&gt;&lt;td/&gt;
    &lt;td style="text-align: left"/&gt;&lt;td style="text-align: right"/&gt;&lt;td style="text-align: left"/&gt;&lt;td/&gt;
    &lt;td style="text-align: left"/&gt;&lt;td style="text-align: right"/&gt;&lt;td style="text-align: left"/&gt;&lt;td/&gt;
    &lt;td style="text-align: left"/&gt;&lt;td style="text-align: right"/&gt;&lt;td style="text-align: left"/&gt;&lt;td/&gt;
    &lt;td style="text-align: left"/&gt;&lt;td style="text-align: right"/&gt;&lt;td style="text-align: left"/&gt;&lt;td/&gt;
    &lt;td style="text-align: left"/&gt;&lt;td style="text-align: right"/&gt;&lt;td style="text-align: left"/&gt;&lt;td/&gt;
    &lt;td style="text-align: left"/&gt;&lt;td style="text-align: right"/&gt;&lt;td style="text-align: left"/&gt;&lt;td/&gt;
    &lt;td style="text-align: left"/&gt;&lt;td style="text-align: right"/&gt;&lt;td style="text-align: left"/&gt;&lt;td/&gt;
    &lt;td style="text-align: left"/&gt;&lt;td style="text-align: right"/&gt;&lt;td style="text-align: left"/&gt;&lt;td/&gt;
    &lt;td style="text-align: left"/&gt;&lt;td style="text-align: right"/&gt;&lt;td style="text-align: left"/&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-left: 0.25in; text-indent: -0.125in; text-align: left"&gt;&lt;span style="font-size: 8pt"&gt;Divestment of Mineral Interest&lt;/span&gt;&lt;/td&gt;&lt;td/&gt;
    &lt;td style="text-align: left"/&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-248; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"/&gt;&lt;td/&gt;
    &lt;td style="text-align: left"/&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-249; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"/&gt;&lt;td/&gt;
    &lt;td style="text-align: left"/&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-250; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"/&gt;&lt;td/&gt;
    &lt;td style="text-align: left"/&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-251; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"/&gt;&lt;td/&gt;
    &lt;td style="text-align: left"/&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-252; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"/&gt;&lt;td/&gt;
    &lt;td style="text-align: left"/&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-size: 8pt"&gt;(28,485&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-size: 8pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td/&gt;
    &lt;td style="text-align: left"/&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-253; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"/&gt;&lt;td/&gt;
    &lt;td style="text-align: left"/&gt;&lt;td style="text-align: right"/&gt;&lt;td style="text-align: left"/&gt;&lt;td/&gt;
    &lt;td style="text-align: left"/&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-size: 8pt"&gt;(28,485&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-size: 8pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.25in; text-indent: -0.125in; text-align: left"&gt;&lt;span style="font-size: 8pt"&gt;Assets held for sale&lt;/span&gt;&lt;/td&gt;&lt;td/&gt;
    &lt;td style="text-align: left"/&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-size: 8pt"&gt;(358,969&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-size: 8pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td/&gt;
    &lt;td style="text-align: left"/&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-254; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"/&gt;&lt;td/&gt;
    &lt;td style="text-align: left"/&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-255; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"/&gt;&lt;td/&gt;
    &lt;td style="text-align: left"/&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-256; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"/&gt;&lt;td/&gt;
    &lt;td style="text-align: left"/&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-257; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"/&gt;&lt;td/&gt;
    &lt;td style="text-align: left"/&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-258; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"/&gt;&lt;td/&gt;
    &lt;td style="text-align: left"/&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-size: 8pt"&gt;(369,913&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-size: 8pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td/&gt;
    &lt;td style="text-align: left"/&gt;&lt;td style="text-align: right"/&gt;&lt;td style="text-align: left"/&gt;&lt;td/&gt;
    &lt;td style="text-align: left"/&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-size: 8pt"&gt;(728,882&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-size: 8pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left"&gt;&lt;span style="font-size: 8pt"&gt;Project Development costs:&lt;/span&gt;&lt;/td&gt;&lt;td/&gt;
    &lt;td style="text-align: left"/&gt;&lt;td style="text-align: right"/&gt;&lt;td style="text-align: left"/&gt;&lt;td/&gt;
    &lt;td style="text-align: left"/&gt;&lt;td style="text-align: right"/&gt;&lt;td style="text-align: left"/&gt;&lt;td/&gt;
    &lt;td style="text-align: left"/&gt;&lt;td style="text-align: right"/&gt;&lt;td style="text-align: left"/&gt;&lt;td/&gt;
    &lt;td style="text-align: left"/&gt;&lt;td style="text-align: right"/&gt;&lt;td style="text-align: left"/&gt;&lt;td/&gt;
    &lt;td style="text-align: left"/&gt;&lt;td style="text-align: right"/&gt;&lt;td style="text-align: left"/&gt;&lt;td/&gt;
    &lt;td style="text-align: left"/&gt;&lt;td style="text-align: right"/&gt;&lt;td style="text-align: left"/&gt;&lt;td/&gt;
    &lt;td style="text-align: left"/&gt;&lt;td style="text-align: right"/&gt;&lt;td style="text-align: left"/&gt;&lt;td/&gt;
    &lt;td style="text-align: left"/&gt;&lt;td style="text-align: right"/&gt;&lt;td style="text-align: left"/&gt;&lt;td/&gt;
    &lt;td style="text-align: left"/&gt;&lt;td style="text-align: right"/&gt;&lt;td style="text-align: left"/&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.375in; text-indent: -0.125in"&gt;&lt;span style="font-size: 8pt"&gt;Construction of wellfields&lt;/span&gt;&lt;/td&gt;&lt;td/&gt;
    &lt;td style="text-align: left"/&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-259; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"/&gt;&lt;td/&gt;
    &lt;td style="text-align: left"/&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-260; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"/&gt;&lt;td/&gt;
    &lt;td style="text-align: left"/&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-261; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"/&gt;&lt;td/&gt;
    &lt;td style="text-align: left"/&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-262; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"/&gt;&lt;td/&gt;
    &lt;td style="text-align: left"/&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-size: 8pt"&gt;1,670,151&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"/&gt;&lt;td/&gt;
    &lt;td style="text-align: left"/&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-263; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"/&gt;&lt;td/&gt;
    &lt;td style="text-align: left"/&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-264; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"/&gt;&lt;td/&gt;
    &lt;td style="text-align: left"/&gt;&lt;td style="text-align: right"/&gt;&lt;td style="text-align: left"/&gt;&lt;td/&gt;
    &lt;td style="text-align: left"/&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-size: 8pt"&gt;1,670,151&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"/&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-left: 0.25in; text-indent: -0.125in"&gt;&lt;span style="font-size: 8pt"&gt;Drilling&lt;/span&gt;&lt;/td&gt;&lt;td/&gt;
    &lt;td style="text-align: left"/&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-265; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"/&gt;&lt;td/&gt;
    &lt;td style="text-align: left"/&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-266; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"/&gt;&lt;td/&gt;
    &lt;td style="text-align: left"/&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-267; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"/&gt;&lt;td/&gt;
    &lt;td style="text-align: left"/&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-268; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"/&gt;&lt;td/&gt;
    &lt;td style="text-align: left"/&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-size: 8pt"&gt;2,109,835&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"/&gt;&lt;td/&gt;
    &lt;td style="text-align: left"/&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-269; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"/&gt;&lt;td/&gt;
    &lt;td style="text-align: left"/&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-270; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"/&gt;&lt;td/&gt;
    &lt;td style="text-align: left"/&gt;&lt;td style="text-align: right"/&gt;&lt;td style="text-align: left"/&gt;&lt;td/&gt;
    &lt;td style="text-align: left"/&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-size: 8pt"&gt;2,109,835&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"/&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.25in; text-indent: -0.125in; padding-bottom: 1.5pt"&gt;&lt;span style="font-size: 8pt"&gt;Personnel&lt;/span&gt;&lt;/td&gt;&lt;td/&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"/&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-271; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"/&gt;&lt;td/&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"/&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-272; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"/&gt;&lt;td/&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"/&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-273; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"/&gt;&lt;td/&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"/&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-274; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"/&gt;&lt;td/&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"/&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-size: 8pt"&gt;521,662&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"/&gt;&lt;td/&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"/&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-275; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"/&gt;&lt;td/&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"/&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-276; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"/&gt;&lt;td/&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"/&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"/&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"/&gt;&lt;td/&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"/&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-size: 8pt"&gt;521,662&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"/&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-size: 8pt"&gt;Balance,
    December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"/&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"/&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;&lt;span style="font-size: 8pt"&gt;775,754&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"/&gt;&lt;td style="font-weight: bold"/&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"/&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;&lt;span style="font-size: 8pt"&gt;578,243&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"/&gt;&lt;td style="font-weight: bold"/&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"/&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;&lt;span style="font-size: 8pt"&gt;4,905,348&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"/&gt;&lt;td style="font-weight: bold"/&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"/&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;&lt;span style="font-size: 8pt"&gt;86,220,848&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"/&gt;&lt;td style="font-weight: bold"/&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"/&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;&lt;span style="font-size: 8pt"&gt;9,144,069&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"/&gt;&lt;td style="font-weight: bold"/&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"/&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;&lt;span style="font-size: 8pt"&gt;1,840,362&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"/&gt;&lt;td style="font-weight: bold"/&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"/&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;&lt;span style="font-size: 8pt"&gt;41,754,462&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"/&gt;&lt;td/&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"/&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-277; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"/&gt;&lt;td style="font-weight: bold"/&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"/&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;&lt;span style="font-size: 8pt"&gt;145,219,086&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"/&gt;&lt;/tr&gt;
  &lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 18pt; text-align: justify; text-indent: -18pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;</cve:ScheduleOfMineralProperties>
    <ifrs-full:MiningAssets contextRef="c173" decimals="0" unitRef="usd">771388</ifrs-full:MiningAssets>
    <ifrs-full:MiningAssets contextRef="c175" decimals="0" unitRef="usd">5477162</ifrs-full:MiningAssets>
    <ifrs-full:MiningAssets contextRef="c178" decimals="0" unitRef="usd">300460</ifrs-full:MiningAssets>
    <ifrs-full:MiningAssets contextRef="c179" decimals="0" unitRef="usd">59050</ifrs-full:MiningAssets>
    <ifrs-full:MiningAssets contextRef="c6" decimals="0" unitRef="usd">6608060</ifrs-full:MiningAssets>
    <cve:AssetAcquistion contextRef="c182" decimals="0" unitRef="usd">619902</cve:AssetAcquistion>
    <cve:AssetAcquistion contextRef="c184" decimals="0" unitRef="usd">85667919</cve:AssetAcquistion>
    <cve:AssetAcquistion contextRef="c186" decimals="0" unitRef="usd">1676674</cve:AssetAcquistion>
    <cve:AssetAcquistion contextRef="c187" decimals="0" unitRef="usd">41164807</cve:AssetAcquistion>
    <cve:AssetAcquistion contextRef="c5" decimals="0" unitRef="usd">129129302</cve:AssetAcquistion>
    <cve:MaintenancesAndLeaseFees contextRef="c181" decimals="0" unitRef="usd">86364</cve:MaintenancesAndLeaseFees>
    <cve:MaintenancesAndLeaseFees contextRef="c183" decimals="0" unitRef="usd">529604</cve:MaintenancesAndLeaseFees>
    <cve:MaintenancesAndLeaseFees contextRef="c185" decimals="0" unitRef="usd">1455206</cve:MaintenancesAndLeaseFees>
    <cve:MaintenancesAndLeaseFees contextRef="c186" decimals="0" unitRef="usd">22663</cve:MaintenancesAndLeaseFees>
    <cve:MaintenancesAndLeaseFees contextRef="c187" decimals="0" unitRef="usd">11870</cve:MaintenancesAndLeaseFees>
    <cve:MaintenancesAndLeaseFees contextRef="c188" decimals="0" unitRef="usd">78456</cve:MaintenancesAndLeaseFees>
    <cve:MaintenancesAndLeaseFees contextRef="c5" decimals="0" unitRef="usd">2184163</cve:MaintenancesAndLeaseFees>
    <cve:ResourceReview contextRef="c181" decimals="0" unitRef="usd">42967</cve:ResourceReview>
    <cve:ResourceReview contextRef="c183" decimals="0" unitRef="usd">130120</cve:ResourceReview>
    <cve:ResourceReview contextRef="c5" decimals="0" unitRef="usd">173087</cve:ResourceReview>
    <cve:ImpairmentCharged contextRef="c188" decimals="0" unitRef="usd">78456</cve:ImpairmentCharged>
    <cve:ImpairmentCharged contextRef="c5" decimals="0" unitRef="usd">78456</cve:ImpairmentCharged>
    <cve:DivestMineralInterest contextRef="c186" decimals="0" unitRef="usd">195514</cve:DivestMineralInterest>
    <cve:DivestMineralInterest contextRef="c5" decimals="0" unitRef="usd">195514</cve:DivestMineralInterest>
    <cve:AssetsHeldForSale contextRef="c183" decimals="0" unitRef="usd">1741064</cve:AssetsHeldForSale>
    <cve:AssetsHeldForSale contextRef="c5" decimals="0" unitRef="usd">1741064</cve:AssetsHeldForSale>
    <ifrs-full:MiningAssets contextRef="c189" decimals="0" unitRef="usd">900719</ifrs-full:MiningAssets>
    <ifrs-full:MiningAssets contextRef="c190" decimals="0" unitRef="usd">619902</ifrs-full:MiningAssets>
    <ifrs-full:MiningAssets contextRef="c191" decimals="0" unitRef="usd">4395822</ifrs-full:MiningAssets>
    <ifrs-full:MiningAssets contextRef="c192" decimals="0" unitRef="usd">85667919</ifrs-full:MiningAssets>
    <ifrs-full:MiningAssets contextRef="c193" decimals="0" unitRef="usd">1455206</ifrs-full:MiningAssets>
    <ifrs-full:MiningAssets contextRef="c194" decimals="0" unitRef="usd">1804283</ifrs-full:MiningAssets>
    <ifrs-full:MiningAssets contextRef="c195" decimals="0" unitRef="usd">41235727</ifrs-full:MiningAssets>
    <ifrs-full:MiningAssets contextRef="c3" decimals="0" unitRef="usd">136079578</ifrs-full:MiningAssets>
    <cve:Drilling contextRef="c201" decimals="0" unitRef="usd">197422</cve:Drilling>
    <cve:Drilling contextRef="c204" decimals="0" unitRef="usd">197422</cve:Drilling>
    <cve:MaintenancesAndLeaseFees contextRef="c197" decimals="0" unitRef="usd">111004</cve:MaintenancesAndLeaseFees>
    <cve:MaintenancesAndLeaseFees contextRef="c199" decimals="0" unitRef="usd">472401</cve:MaintenancesAndLeaseFees>
    <cve:MaintenancesAndLeaseFees contextRef="c201" decimals="0" unitRef="usd">2523123</cve:MaintenancesAndLeaseFees>
    <cve:MaintenancesAndLeaseFees contextRef="c202" decimals="0" unitRef="usd">39566</cve:MaintenancesAndLeaseFees>
    <cve:MaintenancesAndLeaseFees contextRef="c203" decimals="0" unitRef="usd">397324</cve:MaintenancesAndLeaseFees>
    <cve:MaintenancesAndLeaseFees contextRef="c204" decimals="0" unitRef="usd">3543418</cve:MaintenancesAndLeaseFees>
    <cve:PermittingLicensing contextRef="c198" decimals="0" unitRef="usd">-30280</cve:PermittingLicensing>
    <cve:PermittingLicensing contextRef="c200" decimals="0" unitRef="usd">251863</cve:PermittingLicensing>
    <cve:PermittingLicensing contextRef="c201" decimals="0" unitRef="usd">339225</cve:PermittingLicensing>
    <cve:PermittingLicensing contextRef="c202" decimals="0" unitRef="usd">5698</cve:PermittingLicensing>
    <cve:PermittingLicensing contextRef="c203" decimals="0" unitRef="usd">273726</cve:PermittingLicensing>
    <cve:PermittingLicensing contextRef="c204" decimals="0" unitRef="usd">840232</cve:PermittingLicensing>
    <cve:Personnel contextRef="c197" decimals="0" unitRef="usd">4500</cve:Personnel>
    <cve:Personnel contextRef="c198" decimals="0" unitRef="usd">8621</cve:Personnel>
    <cve:Personnel contextRef="c200" decimals="0" unitRef="usd">301066</cve:Personnel>
    <cve:Personnel contextRef="c201" decimals="0" unitRef="usd">280341</cve:Personnel>
    <cve:Personnel contextRef="c202" decimals="0" unitRef="usd">19620</cve:Personnel>
    <cve:Personnel contextRef="c203" decimals="0" unitRef="usd">207518</cve:Personnel>
    <cve:Personnel contextRef="c204" decimals="0" unitRef="usd">821666</cve:Personnel>
    <cve:Recoveries contextRef="c198" decimals="0" unitRef="usd">-20000</cve:Recoveries>
    <cve:Recoveries contextRef="c202" decimals="0" unitRef="usd">-2000</cve:Recoveries>
    <cve:Recoveries contextRef="c204" decimals="0" unitRef="usd">-22000</cve:Recoveries>
    <cve:ResourceReview contextRef="c197" decimals="0" unitRef="usd">118500</cve:ResourceReview>
    <cve:ResourceReview contextRef="c199" decimals="0" unitRef="usd">37125</cve:ResourceReview>
    <cve:ResourceReview contextRef="c201" decimals="0" unitRef="usd">47104</cve:ResourceReview>
    <cve:ResourceReview contextRef="c202" decimals="0" unitRef="usd">1680</cve:ResourceReview>
    <cve:ResourceReview contextRef="c203" decimals="0" unitRef="usd">10080</cve:ResourceReview>
    <cve:ResourceReview contextRef="c204" decimals="0" unitRef="usd">214489</cve:ResourceReview>
    <cve:DivestMineralInterest contextRef="c210" decimals="0" unitRef="usd">28485</cve:DivestMineralInterest>
    <cve:DivestMineralInterest contextRef="c0" decimals="0" unitRef="usd">28485</cve:DivestMineralInterest>
    <cve:AssetsHeldForSale contextRef="c205" decimals="0" unitRef="usd">358969</cve:AssetsHeldForSale>
    <cve:AssetsHeldForSale contextRef="c211" decimals="0" unitRef="usd">369913</cve:AssetsHeldForSale>
    <cve:AssetsHeldForSale contextRef="c0" decimals="0" unitRef="usd">728882</cve:AssetsHeldForSale>
    <cve:ConstructionOfWellfields contextRef="c209" decimals="0" unitRef="usd">1670151</cve:ConstructionOfWellfields>
    <cve:ConstructionOfWellfields contextRef="c0" decimals="0" unitRef="usd">1670151</cve:ConstructionOfWellfields>
    <cve:Drilling contextRef="c209" decimals="0" unitRef="usd">2109835</cve:Drilling>
    <cve:Drilling contextRef="c0" decimals="0" unitRef="usd">2109835</cve:Drilling>
    <cve:Personnel contextRef="c209" decimals="0" unitRef="usd">521662</cve:Personnel>
    <cve:Personnel contextRef="c0" decimals="0" unitRef="usd">521662</cve:Personnel>
    <ifrs-full:MiningAssets contextRef="c212" decimals="0" unitRef="usd">775754</ifrs-full:MiningAssets>
    <ifrs-full:MiningAssets contextRef="c213" decimals="0" unitRef="usd">578243</ifrs-full:MiningAssets>
    <ifrs-full:MiningAssets contextRef="c214" decimals="0" unitRef="usd">4905348</ifrs-full:MiningAssets>
    <ifrs-full:MiningAssets contextRef="c215" decimals="0" unitRef="usd">86220848</ifrs-full:MiningAssets>
    <ifrs-full:MiningAssets contextRef="c216" decimals="0" unitRef="usd">9144069</ifrs-full:MiningAssets>
    <ifrs-full:MiningAssets contextRef="c217" decimals="0" unitRef="usd">1840362</ifrs-full:MiningAssets>
    <ifrs-full:MiningAssets contextRef="c218" decimals="0" unitRef="usd">41754462</ifrs-full:MiningAssets>
    <ifrs-full:MiningAssets contextRef="c2" decimals="0" unitRef="usd">145219086</ifrs-full:MiningAssets>
    <ifrs-full:LongtermDeposits contextRef="c2" decimals="0" unitRef="usd">88500</ifrs-full:LongtermDeposits>
    <ifrs-full:LongtermDeposits contextRef="c3" decimals="0" unitRef="usd">88500</ifrs-full:LongtermDeposits>
    <ifrs-full:ConsiderationPaidReceived contextRef="c158" decimals="0" unitRef="usd">1895000</ifrs-full:ConsiderationPaidReceived>
    <ifrs-full:ContingentConsiderationRecognisedAsOfAcquisitionDate contextRef="c2" decimals="0" unitRef="usd">3165000</ifrs-full:ContingentConsiderationRecognisedAsOfAcquisitionDate>
    <ifrs-full:ConsiderationPaidReceived contextRef="c159" decimals="0" unitRef="usd">89600</ifrs-full:ConsiderationPaidReceived>
    <ifrs-full:GainsOnDisposalsOfInvestments contextRef="c159" decimals="0" unitRef="usd">89600</ifrs-full:GainsOnDisposalsOfInvestments>
    <ifrs-full:ConsiderationPaidReceived contextRef="c160" decimals="0" unitRef="usd">16000</ifrs-full:ConsiderationPaidReceived>
    <ifrs-full:GainsOnDisposalsOfInvestments contextRef="c160" decimals="0" unitRef="usd">16000</ifrs-full:GainsOnDisposalsOfInvestments>
    <cve:InvestmentInterestRates contextRef="c161" decimals="2" unitRef="pure">1</cve:InvestmentInterestRates>
    <cve:InvestmentInterestRates contextRef="c162" decimals="2" unitRef="pure">0.60</cve:InvestmentInterestRates>
    <cve:InvestmentInterestRates contextRef="c163" decimals="2" unitRef="pure">1</cve:InvestmentInterestRates>
    <cve:InterestRateHold contextRef="c164" decimals="2" unitRef="pure">0.60</cve:InterestRateHold>
    <cve:InvestmentInterestRates contextRef="c0" decimals="2" unitRef="pure">1</cve:InvestmentInterestRates>
    <cve:RoyaltyIncomeRate contextRef="c0" decimals="2" unitRef="pure">0.03</cve:RoyaltyIncomeRate>
    <ifrs-full:ConsiderationPaidReceived contextRef="c165" decimals="0" unitRef="usd">250000</ifrs-full:ConsiderationPaidReceived>
    <cve:ConsiderationReceived contextRef="c166" decimals="0" unitRef="shares">11308250</cve:ConsiderationReceived>
    <us-gaap:LongTermDebtFairValue contextRef="c166" decimals="0" unitRef="usd">3085965</us-gaap:LongTermDebtFairValue>
    <ifrs-full:NoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSaleOrAsHeldForDistributionToOwners contextRef="c166" decimals="0" unitRef="usd">1741064</ifrs-full:NoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSaleOrAsHeldForDistributionToOwners>
    <cve:GainOnDisposalOfSubsidiary contextRef="c165" decimals="0" unitRef="usd">1594901</cve:GainOnDisposalOfSubsidiary>
    <ifrs-full:ProceedsFromSalesOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities contextRef="c167" decimals="0" unitRef="usd">48480</ifrs-full:ProceedsFromSalesOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities>
    <cve:AdditionalPayment contextRef="c167" decimals="0" unitRef="usd">24240</cve:AdditionalPayment>
    <ifrs-full:RecognisedAssetsDefinedBenefitPlan contextRef="c168" decimals="0" unitRef="usd">195514</ifrs-full:RecognisedAssetsDefinedBenefitPlan>
    <cve:GrantedPercentage contextRef="c169" decimals="3" unitRef="pure">0.02</cve:GrantedPercentage>
    <cve:ConsiderationPercentage contextRef="c169" decimals="2" unitRef="pure">0.05</cve:ConsiderationPercentage>
    <ifrs-full:NumberOfSharesIssuedAndFullyPaid contextRef="c80" decimals="0" unitRef="shares">80000</ifrs-full:NumberOfSharesIssuedAndFullyPaid>
    <ifrs-full:PlanAssetsAtFairValue contextRef="c170" decimals="0" unitRef="usd">9153</ifrs-full:PlanAssetsAtFairValue>
    <ifrs-full:NoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSaleOrAsHeldForDistributionToOwners contextRef="c170" decimals="0" unitRef="usd">28485</ifrs-full:NoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSaleOrAsHeldForDistributionToOwners>
    <ifrs-full:LossesOnDisposalsOfInvestments contextRef="c171" decimals="0" unitRef="usd">19332</ifrs-full:LossesOnDisposalsOfInvestments>
    <cve:GrantedPercentage contextRef="c172" decimals="3" unitRef="pure">0.02</cve:GrantedPercentage>
    <cve:ConsiderationPercentage contextRef="c172" decimals="2" unitRef="pure">0.05</cve:ConsiderationPercentage>
    <cve:AssetRetirementObligationsTextBlock contextRef="c0">&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 18pt"/&gt;&lt;td style="width: 18pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;12.&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Asset
                                            retirement obligations&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -18pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;The
Company is obligated by various federal and state mining laws and regulations which require the Company to reclaim surface areas and
restore underground water quality for certain assets in Texas, Wyoming, Utah and Colorado. These projects must be returned to the pre-existing
or background average quality after completion of mining.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Annually,
the Company updates these reclamation provisions based on cash flow estimates, and changes in regulatory requirements and settlements.
This review may result in an adjustment to the asset retirement obligations in addition to the outstanding liability balance. The Company
used an inflation factor of 2.5% per year and a discount rate of 11% in estimating the present value of its future cash flows.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;The
asset retirement obligations balance consists of:&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center; padding-bottom: 1.5pt; padding-left: 0.125in"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;December 31, &lt;br/&gt; 2022&lt;br/&gt; $&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;December 31, &lt;br/&gt; 2021&lt;br/&gt; $&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; width: 76%"&gt;Kingsville&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;3,151,875&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;2,671,295&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in"&gt;Rosita&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,298,397&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,198,255&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in"&gt;Vasquez&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;34,274&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;39,137&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in"&gt;Centennial&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;168,806&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;168,806&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left"&gt;Gas Hills&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;63,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;63,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 1.5pt"&gt;Ticaboo&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;36,000&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;36,000&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; font-weight: bold; text-align: left; padding-bottom: 1.5pt"&gt;Asset retirement obligations&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;4,752,352&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;4,176,493&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;The
asset retirement obligations continuity summary is as follows:&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; width: 88%; font-weight: bold; text-align: left; padding-bottom: 1.5pt"&gt;Asset retirement obligation&lt;/td&gt;&lt;td style="width: 1%; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; width: 1%; font-weight: bold; text-align: left"/&gt;&lt;td style="border-bottom: Black 1.5pt solid; width: 9%; font-weight: bold; text-align: center"&gt;$&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Balance, December 31, 2020&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;5,239,108&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Accretion&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;400,710&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td&gt;Adjustments&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(1,719,943&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Settlement&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(11,189&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Additions from Azarga asset acquisition (Note 10)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;267,807&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;Balance, December 31, 2021&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;4,176,493&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Accretion&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;429,956&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td&gt;Settlement&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(11,324&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;Adjustments&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;157,227&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;Balance, December 31, 2022&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;4,752,352&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</cve:AssetRetirementObligationsTextBlock>
    <cve:InflationFactorPercentage contextRef="c0" decimals="3" unitRef="pure">0.025</cve:InflationFactorPercentage>
    <ifrs-full:DescriptionOfDiscountRatesAppliedToCashFlowProjections contextRef="c2" decimals="2" unitRef="pure">0.11</ifrs-full:DescriptionOfDiscountRatesAppliedToCashFlowProjections>
    <cve:DisclosureOfAssetRetirementObligationsBalanceTableTextBlock contextRef="c0">&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center; padding-bottom: 1.5pt; padding-left: 0.125in"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;December 31, &lt;br/&gt; 2022&lt;br/&gt; $&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;December 31, &lt;br/&gt; 2021&lt;br/&gt; $&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; width: 76%"&gt;Kingsville&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;3,151,875&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;2,671,295&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in"&gt;Rosita&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,298,397&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,198,255&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in"&gt;Vasquez&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;34,274&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;39,137&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in"&gt;Centennial&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;168,806&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;168,806&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left"&gt;Gas Hills&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;63,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;63,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 1.5pt"&gt;Ticaboo&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;36,000&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;36,000&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; font-weight: bold; text-align: left; padding-bottom: 1.5pt"&gt;Asset retirement obligations&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;4,752,352&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;4,176,493&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;</cve:DisclosureOfAssetRetirementObligationsBalanceTableTextBlock>
    <ifrs-full:FinancialAssets contextRef="c220" decimals="0" unitRef="usd">3151875</ifrs-full:FinancialAssets>
    <ifrs-full:FinancialAssets contextRef="c221" decimals="0" unitRef="usd">2671295</ifrs-full:FinancialAssets>
    <ifrs-full:FinancialAssets contextRef="c222" decimals="0" unitRef="usd">1298397</ifrs-full:FinancialAssets>
    <ifrs-full:FinancialAssets contextRef="c223" decimals="0" unitRef="usd">1198255</ifrs-full:FinancialAssets>
    <ifrs-full:FinancialAssets contextRef="c224" decimals="0" unitRef="usd">34274</ifrs-full:FinancialAssets>
    <ifrs-full:FinancialAssets contextRef="c225" decimals="0" unitRef="usd">39137</ifrs-full:FinancialAssets>
    <ifrs-full:FinancialAssets contextRef="c226" decimals="0" unitRef="usd">168806</ifrs-full:FinancialAssets>
    <ifrs-full:FinancialAssets contextRef="c227" decimals="0" unitRef="usd">168806</ifrs-full:FinancialAssets>
    <ifrs-full:FinancialAssets contextRef="c228" decimals="0" unitRef="usd">63000</ifrs-full:FinancialAssets>
    <ifrs-full:FinancialAssets contextRef="c229" decimals="0" unitRef="usd">63000</ifrs-full:FinancialAssets>
    <ifrs-full:FinancialAssets contextRef="c230" decimals="0" unitRef="usd">36000</ifrs-full:FinancialAssets>
    <ifrs-full:FinancialAssets contextRef="c231" decimals="0" unitRef="usd">36000</ifrs-full:FinancialAssets>
    <ifrs-full:FinancialAssets contextRef="c2" decimals="0" unitRef="usd">4752352</ifrs-full:FinancialAssets>
    <ifrs-full:FinancialAssets contextRef="c3" decimals="0" unitRef="usd">4176493</ifrs-full:FinancialAssets>
    <cve:DisclosureOfAssetRetirementObligationsContinuityTableTextBlock contextRef="c0">&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; width: 88%; font-weight: bold; text-align: left; padding-bottom: 1.5pt"&gt;Asset retirement obligation&lt;/td&gt;&lt;td style="width: 1%; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; width: 1%; font-weight: bold; text-align: left"/&gt;&lt;td style="border-bottom: Black 1.5pt solid; width: 9%; font-weight: bold; text-align: center"&gt;$&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Balance, December 31, 2020&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;5,239,108&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Accretion&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;400,710&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td&gt;Adjustments&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(1,719,943&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Settlement&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(11,189&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Additions from Azarga asset acquisition (Note 10)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;267,807&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;Balance, December 31, 2021&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;4,176,493&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Accretion&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;429,956&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td&gt;Settlement&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(11,324&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;Adjustments&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;157,227&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;Balance, December 31, 2022&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;4,752,352&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</cve:DisclosureOfAssetRetirementObligationsContinuityTableTextBlock>
    <cve:AssetRetirementObligationsBalance contextRef="c6" decimals="0" unitRef="usd">5239108</cve:AssetRetirementObligationsBalance>
    <cve:AssetRetirementObligationsAccretion contextRef="c5" decimals="0" unitRef="usd">400710</cve:AssetRetirementObligationsAccretion>
    <cve:AssetRetirementObligationsAdjustments contextRef="c5" decimals="0" unitRef="usd">-1719943</cve:AssetRetirementObligationsAdjustments>
    <cve:AssetRetirementObligationsSettlement contextRef="c5" decimals="0" unitRef="usd">-11189</cve:AssetRetirementObligationsSettlement>
    <cve:AssetRetirementObligationsAdditionsFromAzargaAssetAcquisitionNote10 contextRef="c5" decimals="0" unitRef="usd">267807</cve:AssetRetirementObligationsAdditionsFromAzargaAssetAcquisitionNote10>
    <cve:AssetRetirementObligationsBalance contextRef="c3" decimals="0" unitRef="usd">4176493</cve:AssetRetirementObligationsBalance>
    <cve:AssetRetirementObligationsAccretion contextRef="c0" decimals="0" unitRef="usd">429956</cve:AssetRetirementObligationsAccretion>
    <cve:AssetRetirementObligationsSettlement contextRef="c0" decimals="0" unitRef="usd">-11324</cve:AssetRetirementObligationsSettlement>
    <cve:AssetRetirementObligationsAdjustments contextRef="c0" decimals="0" unitRef="usd">157227</cve:AssetRetirementObligationsAdjustments>
    <cve:AssetRetirementObligationsBalance contextRef="c2" decimals="0" unitRef="usd">4752352</cve:AssetRetirementObligationsBalance>
    <cve:DisclosueOfSalesContractsTextBlock contextRef="c0">&lt;table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.25in"/&gt;&lt;td style="width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;13.&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Sales
                                            contracts&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -18pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;On
December 31, 2020, through an asset acquisition from Westwater Resources, Inc. the Company acquired an agreement with UG USA,&#160;Inc.
(&#x201c;UG&#x201d;). The contract provided for delivery of one-half of the Company&#x2019;s actual production, for a total of 3,000,000
pounds U&lt;sub&gt;3&lt;/sub&gt;O&lt;sub&gt;8&lt;/sub&gt;, from its properties in Texas at discounted spot market prices. In August 2021, the Company and UG
agreed to terminate this agreement for a cancellation fee of $2,750,000, which was paid by the Company to UG on January 15, 2022.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;In
July 2021, the Company entered into a new uranium supply contract with UG. Pursuant to the agreement, UG will purchase U&lt;sub&gt;3&lt;/sub&gt;O&lt;sub&gt;8
&lt;/sub&gt;from the Company for up to 2,000,000 pounds U&lt;sub&gt;3&lt;/sub&gt;O&lt;sub&gt;8 &lt;/sub&gt;from 2023 through 2027. The sales price under the new agreement
will continue to be tied to spot market pricing.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;In
December 2021, the Company entered into a new uranium supply contract. Pursuant to the agreement, a large utility will purchase U&lt;sub&gt;3&lt;/sub&gt;O&lt;sub&gt;8
&lt;/sub&gt;from the Company for up to 1,300,000 pounds from 2024 through 2030. The sales price under the agreement will be tied to spot market
pricing with a ceiling price significantly higher than spot market price at the time of the agreement.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;In
June 2022, the Company entered into a new uranium supply contract. Pursuant to the agreement, a domestic utility will purchase U&lt;sub&gt;3&lt;/sub&gt;O&lt;sub&gt;8
&lt;/sub&gt;from the Company for up to 600,000 pounds commencing in 2025. The sales price will be market based with a floor price and an inflation
adjusted ceiling price.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;In
December 2022, the Company was awarded a contract to sell 100,000 pounds of uranium concentrates to the United States Government at a
price of $70.50 per pound.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;As
of December 31, 2022, uranium sales contracts over the next five years are as follows:&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Sales Commitments in Pounds&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 88%"&gt;Fiscal 2023&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;500,000&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td&gt;Fiscal 2024&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;600,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Fiscal 2025&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;700,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td&gt;Fiscal 2026&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;700,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Fiscal 2027&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;650,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</cve:DisclosueOfSalesContractsTextBlock>
    <cve:TotalDiscountedMarketPrices contextRef="c90" decimals="0" unitRef="usd">3000000</cve:TotalDiscountedMarketPrices>
    <cve:CancellationFee contextRef="c90" decimals="0" unitRef="usd">2750000</cve:CancellationFee>
    <cve:PursuantToAgreement contextRef="c232" decimals="0" unitRef="usd">2000000</cve:PursuantToAgreement>
    <cve:PursuantToAgreement contextRef="c91" decimals="0" unitRef="usd">1300000</cve:PursuantToAgreement>
    <cve:PursuantToAgreement contextRef="c171" decimals="0" unitRef="usd">600000</cve:PursuantToAgreement>
    <cve:ContractPoundsOfUranium contextRef="c92" decimals="0" unitRef="usd">100000</cve:ContractPoundsOfUranium>
    <cve:PricePerPound contextRef="c92" decimals="2" unitRef="usdPershares">70.5</cve:PricePerPound>
    <cve:SalesContractsTrem contextRef="c0">P5Y</cve:SalesContractsTrem>
    <ifrs-full:DisclosureOfMaturityAnalysisForFinancialAssetsHeldForManagingLiquidityRiskExplanatory contextRef="c0">&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Sales Commitments in Pounds&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 88%"&gt;Fiscal 2023&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;500,000&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td&gt;Fiscal 2024&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;600,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Fiscal 2025&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;700,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td&gt;Fiscal 2026&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;700,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Fiscal 2027&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;650,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</ifrs-full:DisclosureOfMaturityAnalysisForFinancialAssetsHeldForManagingLiquidityRiskExplanatory>
    <cve:SalesContractsFiscalTwoZeroTwoThree contextRef="c0" decimals="0" unitRef="usd">500000</cve:SalesContractsFiscalTwoZeroTwoThree>
    <cve:SalesContractsFiscalTwoZeroTwoFour contextRef="c0" decimals="0" unitRef="usd">600000</cve:SalesContractsFiscalTwoZeroTwoFour>
    <cve:SalesContractsFiscalTwoZeroTwoFive contextRef="c0" decimals="0" unitRef="usd">700000</cve:SalesContractsFiscalTwoZeroTwoFive>
    <cve:SalesContractsFiscalTwoZeroTwoSix contextRef="c0" decimals="0" unitRef="usd">700000</cve:SalesContractsFiscalTwoZeroTwoSix>
    <cve:SalesContractsFiscalTwoZeroTwoSeven contextRef="c0" decimals="0" unitRef="usd">650000</cve:SalesContractsFiscalTwoZeroTwoSeven>
    <ifrs-full:DisclosureOfClassesOfShareCapitalExplanatory contextRef="c0">&lt;table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.25in"/&gt;&lt;td style="width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;14.&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Share
                                            capital&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -18pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;The
authorized share capital of the Company consists of an unlimited number of common and preferred shares without par value.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;During
the year ended December 31, 2022 the Company issued:&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.75in"/&gt;&lt;td style="width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;i)&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;6,535,947 units through a &#x201c;bought deal&#x201d; prospectus offering at a price of CAD $4.59 per unit, for gross proceeds of CAD $30,000,000 ($23,057,411). Each unit consisted of one common share and &lt;span style="-sec-ix-hidden: hidden-fact-280"&gt;one-half&lt;/span&gt; share purchase warrant. Each whole warrant entitles the holder to purchase one additional share at a price of CAD $6.00 for a period of two years. The Company paid commissions of CAD $1,612,500 &lt;span style="-sec-ix-hidden: hidden-fact-278"&gt;($1,239,336)&lt;/span&gt;, other cash issuance costs of CAD $305,159 ($234,539) and issued 351,307 finders&#x2019; warrants with a fair value of CAD $874,785 ($672,343). The finder&#x2019;s warrants are exercisable into one common share of the Company at a price of CAD $4.59 for two years from closing;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 72.3pt; text-align: justify; text-indent: -18pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.75in"/&gt;&lt;td style="width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;ii)&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2,291,642 common shares were issued on the exercise of warrants, for gross proceeds of $2,452,227. In connection with certain of the warrants exercised, the Company reclassified $147,772 from contributed surplus and credited share capital;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 72.3pt; text-align: justify; text-indent: -18pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.75in"/&gt;&lt;td style="width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;iii)&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1,016,436 common shares were issued on the exercised of stock options, for gross proceeds of $1,177,093. In connection with the stock options exercised, the Company reclassified $2,728,487 from contributed surplus and credited share capital; and&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 72.3pt; text-align: justify; text-indent: -18pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.75in"/&gt;&lt;td style="width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;iv)&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;193,348 common shares for the settlement and compensation for services received in relation to the Company&#x2019;s asset acquisition on December 31, 2021 (Note 10).&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 72.3pt; text-align: justify; text-indent: -18pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;During
the year ended December 31, 2021, the Company issued:&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 54.3pt"/&gt;&lt;td style="width: 18pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;i)&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;5,000,000 units through a private placement at a price of CAD $3.00 per unit, for gross proceeds of CAD $15,000,000 ($11,966,494). Each unit consisted of one common share and &lt;span style="-sec-ix-hidden: hidden-fact-281"&gt;one-half&lt;/span&gt; share purchase warrant. Each whole warrant entitles the holder to purchase one additional share at a price of CAD $3.90 for a period of three years. The Company paid commissions of CAD $758,001 &lt;span style="-sec-ix-hidden: hidden-fact-279"&gt;($604,708)&lt;/span&gt;, other cash issuance costs of CAD $198,298 ($158,194) and issued 252,667 finders&#x2019; warrants with a fair value of CAD $536,673 ($428,140). The finder&#x2019;s warrants are exercisable into one common share of the Company at a price of CAD $3.00 for two years from closing;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 72.3pt; text-align: justify; text-indent: -18pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 54.3pt"/&gt;&lt;td style="width: 18pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;ii)&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2,052,843 common shares were issued on the exercise of warrants, for gross proceeds of $2,633,029. In connection with certain of the warrants exercised, the Company reclassified $166,751 from contributed surplus and credited share capital;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 72.3pt; text-align: justify; text-indent: -18pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 54.3pt"/&gt;&lt;td style="width: 18pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;iii)&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;590,000 common shares were issued on the exercised of stock options, for gross proceeds of $288,572. In connection with the stock options exercised, the Company reclassified $269,039 from contributed surplus and credited share capital; and&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 72.3pt; text-align: justify; text-indent: -18pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 54.3pt"/&gt;&lt;td style="width: 18pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;iv)&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;31,806,617 common shares were issued in connection with the Azarga asset acquisition (Note 10).&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 72.3pt; text-align: justify; text-indent: -18pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Stock
options&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;The
Company has adopted a Stock Option Plan (the &#x201c;Plan&#x201d;) under which it is authorized to grant options to Officers, Directors,
employees and consultants enabling them to acquire common shares of the Company. The number of shares reserved for issuance under the
Plan cannot exceed 10% of the outstanding common shares at the time of the grant. The options can be granted for a maximum of five years
and vest as determined by the Board of Directors.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;The
Company&#x2019;s stock options outstanding at December 31, 2022 and December 31, 2021, and the changes for the years then ended, are as
follows:&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Year
    ended &lt;br/&gt;
December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="6" style="text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Year
    ended &lt;br/&gt;
December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Weighted average&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Weighted average&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Options&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;exercise price&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Options&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;exercise price&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;#&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;CAD
    $&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;#&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;CAD
    $&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 52%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Options outstanding, beginning
    of year&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;5,272,294&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1.42&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;3,572,084&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;0.66&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;3,107,501&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;4.10&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2,390,627&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2.31&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Exercised&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(1,016,439&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1.51&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(590,000&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;0.60&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Forfeited/expired&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(127,708&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;3.60&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(100,417&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;0.54&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Options
    outstanding, end of year&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;7,235,648&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2.53&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;5,272,294&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1.42&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Options
    exercisable, end of year&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;4,928,147&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1.79&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;4,515,210&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1.23&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;As
of December 31, 2022, stock options outstanding were as follows:&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td colspan="2"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Options
    Outstanding&lt;br/&gt; December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Options
    Exercisable&lt;br/&gt; December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td colspan="2"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Weighted average&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Weighted average&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Weighted average&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td colspan="2"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Option price&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Options&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Remaining&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;exercise price&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Options&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;exercise price&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;per share&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;#&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Life&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;CAD
    $&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;#&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;CAD
    $&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 14%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;0.18
- 1.92&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 14%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;3,381,771&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 14%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;0.88&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 14%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;0.85&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 14%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;3,381,771&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 13%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;0.85&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2.40
- 3.78&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1,034,710&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;0.57&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;3.12&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;594,710&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2.83&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;4.20
- 5.76&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2,819,166&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1.53&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;4.29&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;951,666&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;4.42&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;7,235,647&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2.99&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2.52&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;4,928,147&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1.78&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;During
the year ended December 31, 2022, the Company granted an aggregate of 3,107,501 stock options to Directors, Officers, and consultants
of the Company. A fair value of $7,665,042 was calculated for these options as measured at the grant date using the Black-Scholes option
pricing model.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;During
the year ended December 31, 2021, the Company granted an aggregate of 2,390,627 stock options to Directors, Officers, and consultants
of the Company. A fair value of $1,484,302 was calculated for these options as measured at the grant date using the Black-Scholes option
pricing model.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Further,
pursuant to the Company&#x2019;s acquisition of Azarga during the year ended December 31, 2021 (Note 10), the Company issued replacement
stock options at the acquisition date vested immediately and retained their original expiration date, except for terminated Directors,
Officers, employees, and consultants. For these terminated positions, the stock options had a revised term that was 12 months from the
date of their resignation.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;The
Company&#x2019;s standard stock option vesting schedule calls for 25% every six months commencing six months after the grant date.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;During
the year ended December 31, 2022, the Company recognized stock option expense of $5,744,655 (2021 - $1,425,645) for the vested portion
of the stock options.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;The
fair value of all compensatory options granted is estimated on the grant date using the Black-Scholes option pricing model. The weighted
average assumptions used in calculating the fair values are as follows:&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;December
    31, &lt;br/&gt; 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;December
    31, &lt;br/&gt; 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 76%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Risk-free interest rate&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2.06&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;0.88&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Expected life of option&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;4.9 years&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;5 years&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Expected dividend yield&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;0&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;0&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Expected stock price volatility&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;116.48&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;128.79&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Fair value per option&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;CAD
                                            $3.21&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;CAD
                                            $1.10&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Share
purchase warrants&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;A
summary of the status of the Company&#x2019;s warrants as of December 31, 2022, and December 31, 2021, and changes during the years then
ended is as follows:&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Year
    ended &lt;br/&gt; December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Year
    ended &lt;br/&gt; December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Warrants&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Weighted average exercise price&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Warrants&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Weighted average exercise price&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; padding-bottom: 1.5pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;#&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;CAD
    $&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; padding-bottom: 1.5pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;#&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;CAD
    $&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 52%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Warrants outstanding, beginning
    of year&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;6,298,839&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2.43&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;4,143,247&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1.23&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-indent: 0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;3,670,919&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;5.81&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;4,208,435&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;3.24&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: 0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Exercised&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(2,291,642&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1.39&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(2,052,843&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1.62&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-indent: 0.125in; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Expired&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(183,610&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1.67&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Warrants
    outstanding, end of year&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;7,494,506&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;4.43&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;6,298,839&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2.43&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;As
of December 31, 2022, share purchase warrants outstanding were as follows:&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
                                                                                                                          &lt;td style="text-align: center; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
                                                                                                                          &lt;td colspan="6" style="border-bottom: Black 1.5pt solid; text-align: center; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Warrants Outstanding&lt;br/&gt; December 31, 2022&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Weighted average&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Weighted average&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Warrant price&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Warrants&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Remaining&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;exercise price&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;per share&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; padding-bottom: 1.5pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;#&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Life&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;CAD
    $&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; width: 46%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$1.59 - 1.80&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 15%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1,360,028&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 15%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;0.14&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 15%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1.81&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$2.22 - 3.90 &lt;sup&gt;1&lt;/sup&gt;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2,515,197&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;0.39&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;3.84&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$4.59 - 6.00&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;3,619,281&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;0.59&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;5.86&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;7,494,506&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1.12&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;4.43&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0.25in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;sup&gt;1&lt;/sup&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Includes power warrants exercisable into one share and &lt;span style="-sec-ix-hidden: hidden-fact-282"&gt;one-half&lt;/span&gt; warrant. Each whole warrant is exercisable at $3.90 for 36 months.&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Share
subscriptions received&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;As
of December 31, 2022, the Company has received CAD $69,831,000 ($50,051,595) in share subscriptions pertaining to a financing that closed
subsequently (Note 22(b)).&lt;/span&gt;&lt;/p&gt;</ifrs-full:DisclosureOfClassesOfShareCapitalExplanatory>
    <cve:SharesUnit contextRef="c0" decimals="0" unitRef="shares">6535947</cve:SharesUnit>
    <ifrs-full:WeightedAverageExercisePriceOfShareOptionsInSharebasedPaymentArrangementExercisedDuringPeriodAtDateOfExercise2019 contextRef="c0" decimals="2" unitRef="cadPershares">4.59</ifrs-full:WeightedAverageExercisePriceOfShareOptionsInSharebasedPaymentArrangementExercisedDuringPeriodAtDateOfExercise2019>
    <cve:GrossProceed contextRef="c0" decimals="0" unitRef="cad">30000000</cve:GrossProceed>
    <cve:GrossProceed contextRef="c0" decimals="0" unitRef="usd">23057411</cve:GrossProceed>
    <cve:CommonShare contextRef="c0" decimals="0" unitRef="shares">1</cve:CommonShare>
    <cve:PurchaseAdditionalShareWarrants contextRef="c0" decimals="0" unitRef="shares">1</cve:PurchaseAdditionalShareWarrants>
    <cve:PurchaseAdditionalSharePricePerWarrant contextRef="c0" decimals="2" unitRef="cadPershares">6</cve:PurchaseAdditionalSharePricePerWarrant>
    <ifrs-full:ReceiptsFromRoyaltiesFeesCommissionsAndOtherRevenue contextRef="c0" decimals="0" unitRef="cad">1612500</ifrs-full:ReceiptsFromRoyaltiesFeesCommissionsAndOtherRevenue>
    <cve:CashIssuanceCosts contextRef="c0" decimals="0" unitRef="cad">305159</cve:CashIssuanceCosts>
    <cve:CashIssuanceCosts contextRef="c0" decimals="0" unitRef="usd">-234539</cve:CashIssuanceCosts>
    <cve:ShareIssued contextRef="c0" decimals="0" unitRef="shares">351307</cve:ShareIssued>
    <cve:WarrantsOfFairValue contextRef="c0" decimals="0" unitRef="cad">874785</cve:WarrantsOfFairValue>
    <cve:WarrantsOfFairValue contextRef="c0" decimals="0" unitRef="usd">-672343</cve:WarrantsOfFairValue>
    <cve:WarrantsExercisableOfCommonShare contextRef="c0" decimals="0" unitRef="shares">1</cve:WarrantsExercisableOfCommonShare>
    <cve:WarrantsExercisablePricePerShare contextRef="c0" decimals="2" unitRef="cadPershares">4.59</cve:WarrantsExercisablePricePerShare>
    <cve:CommonShareIssued contextRef="c233" decimals="0" unitRef="shares">2291642</cve:CommonShareIssued>
    <cve:GrossProceed contextRef="c233" decimals="0" unitRef="usd">2452227</cve:GrossProceed>
    <ifrs-full:EquityReclassifiedIntoFinancialLiabilities contextRef="c233" decimals="0" unitRef="usd">147772</ifrs-full:EquityReclassifiedIntoFinancialLiabilities>
    <cve:CommonShareIssued contextRef="c234" decimals="0" unitRef="shares">1016436</cve:CommonShareIssued>
    <cve:GrossProceed contextRef="c234" decimals="0" unitRef="usd">1177093</cve:GrossProceed>
    <ifrs-full:FinancialLiabilitiesReclassifiedIntoEquity contextRef="c234" decimals="0" unitRef="usd">2728487</ifrs-full:FinancialLiabilitiesReclassifiedIntoEquity>
    <cve:CommonSharesOfSettlementAndCompensation contextRef="c5" decimals="0" unitRef="shares">193348</cve:CommonSharesOfSettlementAndCompensation>
    <cve:SharesUnit contextRef="c5" decimals="0" unitRef="shares">5000000</cve:SharesUnit>
    <ifrs-full:WeightedAverageExercisePriceOfShareOptionsInSharebasedPaymentArrangementExercisedDuringPeriodAtDateOfExercise2019 contextRef="c5" decimals="2" unitRef="cadPershares">3</ifrs-full:WeightedAverageExercisePriceOfShareOptionsInSharebasedPaymentArrangementExercisedDuringPeriodAtDateOfExercise2019>
    <cve:GrossProceed contextRef="c5" decimals="0" unitRef="cad">15000000</cve:GrossProceed>
    <cve:GrossProceed contextRef="c5" decimals="0" unitRef="usd">11966494</cve:GrossProceed>
    <cve:CommonShare contextRef="c5" decimals="0" unitRef="shares">1</cve:CommonShare>
    <cve:PurchaseAdditionalShareWarrants contextRef="c5" decimals="0" unitRef="shares">1</cve:PurchaseAdditionalShareWarrants>
    <cve:PurchaseAdditionalSharePricePerWarrant contextRef="c5" decimals="2" unitRef="cadPershares">3.9</cve:PurchaseAdditionalSharePricePerWarrant>
    <ifrs-full:ReceiptsFromRoyaltiesFeesCommissionsAndOtherRevenue contextRef="c5" decimals="0" unitRef="cad">758001</ifrs-full:ReceiptsFromRoyaltiesFeesCommissionsAndOtherRevenue>
    <cve:CashIssuanceCosts contextRef="c5" decimals="0" unitRef="cad">198298</cve:CashIssuanceCosts>
    <cve:CashIssuanceCosts contextRef="c5" decimals="0" unitRef="usd">-158194</cve:CashIssuanceCosts>
    <cve:ShareIssued contextRef="c5" decimals="0" unitRef="shares">252667</cve:ShareIssued>
    <cve:WarrantsOfFairValue contextRef="c5" decimals="0" unitRef="cad">536673</cve:WarrantsOfFairValue>
    <cve:WarrantsOfFairValue contextRef="c5" decimals="0" unitRef="usd">-428140</cve:WarrantsOfFairValue>
    <cve:WarrantsExercisableOfCommonShare contextRef="c5" decimals="0" unitRef="shares">1</cve:WarrantsExercisableOfCommonShare>
    <cve:WarrantsExercisablePricePerShare contextRef="c5" decimals="2" unitRef="cadPershares">3</cve:WarrantsExercisablePricePerShare>
    <cve:CommonShareIssued contextRef="c235" decimals="0" unitRef="shares">2052843</cve:CommonShareIssued>
    <cve:GrossProceed contextRef="c235" decimals="0" unitRef="usd">2633029</cve:GrossProceed>
    <ifrs-full:EquityReclassifiedIntoFinancialLiabilities contextRef="c235" decimals="0" unitRef="usd">166751</ifrs-full:EquityReclassifiedIntoFinancialLiabilities>
    <cve:CommonShareIssued contextRef="c236" decimals="0" unitRef="shares">590000</cve:CommonShareIssued>
    <cve:GrossProceed contextRef="c236" decimals="0" unitRef="usd">288572</cve:GrossProceed>
    <ifrs-full:FinancialLiabilitiesReclassifiedIntoEquity contextRef="c236" decimals="0" unitRef="usd">269039</ifrs-full:FinancialLiabilitiesReclassifiedIntoEquity>
    <cve:CommonShareIssued contextRef="c5" decimals="0" unitRef="shares">31806617</cve:CommonShareIssued>
    <cve:NumberOfSharesReservedInsurancePercentage contextRef="c0" decimals="2" unitRef="pure">0.10</cve:NumberOfSharesReservedInsurancePercentage>
    <cve:OptionsGrantedForMaximumYear contextRef="c0">P5Y</cve:OptionsGrantedForMaximumYear>
    <cve:ScheduleOfTheCompanysStockOptionsOutstandingTableTextBlock contextRef="c0">&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Year
    ended &lt;br/&gt;
December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="6" style="text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Year
    ended &lt;br/&gt;
December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Weighted average&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Weighted average&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Options&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;exercise price&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Options&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;exercise price&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;#&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;CAD
    $&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;#&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;CAD
    $&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 52%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Options outstanding, beginning
    of year&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;5,272,294&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1.42&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;3,572,084&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;0.66&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;3,107,501&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;4.10&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2,390,627&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2.31&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Exercised&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(1,016,439&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1.51&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(590,000&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;0.60&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Forfeited/expired&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(127,708&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;3.60&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(100,417&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;0.54&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Options
    outstanding, end of year&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;7,235,648&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2.53&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;5,272,294&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1.42&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Options
    exercisable, end of year&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;4,928,147&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1.79&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;4,515,210&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1.23&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;</cve:ScheduleOfTheCompanysStockOptionsOutstandingTableTextBlock>
    <cve:SharesBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber contextRef="c3" decimals="INF" unitRef="shares">5272294</cve:SharesBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber>
    <ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019 contextRef="c3" decimals="2" unitRef="cadPershares">1.42</ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019>
    <cve:SharesBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber contextRef="c6" decimals="INF" unitRef="shares">3572084</cve:SharesBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber>
    <ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019 contextRef="c6" decimals="2" unitRef="cadPershares">0.66</ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019>
    <cve:SharesBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross contextRef="c0" decimals="INF" unitRef="shares">3107501</cve:SharesBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <ifrs-full:WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019 contextRef="c0" decimals="2" unitRef="cadPershares">4.1</ifrs-full:WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019>
    <cve:SharesBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross contextRef="c5" decimals="INF" unitRef="shares">2390627</cve:SharesBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <ifrs-full:WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019 contextRef="c5" decimals="2" unitRef="cadPershares">2.31</ifrs-full:WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019>
    <cve:StockIssuedDuringPeriodShareStockOptionsExercised contextRef="c0" decimals="INF" unitRef="shares">-1016439</cve:StockIssuedDuringPeriodShareStockOptionsExercised>
    <ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019 contextRef="c0" decimals="2" unitRef="cadPershares">1.51</ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019>
    <cve:StockIssuedDuringPeriodShareStockOptionsExercised contextRef="c5" decimals="INF" unitRef="shares">-590000</cve:StockIssuedDuringPeriodShareStockOptionsExercised>
    <ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019 contextRef="c5" decimals="2" unitRef="cadPershares">0.6</ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019>
    <cve:StockIssuedDuringPeriodShareSharesBasedCompensationForfeited contextRef="c0" decimals="INF" unitRef="shares">-127708</cve:StockIssuedDuringPeriodShareSharesBasedCompensationForfeited>
    <ifrs-full:WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019 contextRef="c0" decimals="2" unitRef="cadPershares">3.6</ifrs-full:WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019>
    <cve:StockIssuedDuringPeriodShareSharesBasedCompensationForfeited contextRef="c5" decimals="INF" unitRef="shares">-100417</cve:StockIssuedDuringPeriodShareSharesBasedCompensationForfeited>
    <ifrs-full:WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019 contextRef="c5" decimals="2" unitRef="cadPershares">0.54</ifrs-full:WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019>
    <cve:SharesBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber contextRef="c2" decimals="INF" unitRef="shares">7235648</cve:SharesBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber>
    <ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019 contextRef="c2" decimals="2" unitRef="cadPershares">2.53</ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019>
    <cve:SharesBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber contextRef="c3" decimals="INF" unitRef="shares">5272294</cve:SharesBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber>
    <ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019 contextRef="c3" decimals="2" unitRef="cadPershares">1.42</ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019>
    <cve:SharesBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions contextRef="c2" decimals="INF" unitRef="shares">4928147</cve:SharesBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions>
    <ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019 contextRef="c2" decimals="2" unitRef="cadPershares">1.79</ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019>
    <cve:SharesBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions contextRef="c3" decimals="INF" unitRef="shares">4515210</cve:SharesBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions>
    <ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019 contextRef="c3" decimals="2" unitRef="cadPershares">1.23</ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019>
    <cve:ScheduleOfStockOptionsOutstandingTableTextBlock contextRef="c0">&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td colspan="2"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Options
    Outstanding&lt;br/&gt; December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Options
    Exercisable&lt;br/&gt; December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td colspan="2"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Weighted average&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Weighted average&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Weighted average&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td colspan="2"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Option price&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Options&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Remaining&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;exercise price&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Options&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;exercise price&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;per share&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;#&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Life&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;CAD
    $&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;#&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;CAD
    $&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 14%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;0.18
- 1.92&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 14%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;3,381,771&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 14%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;0.88&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 14%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;0.85&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 14%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;3,381,771&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 13%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;0.85&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2.40
- 3.78&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1,034,710&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;0.57&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;3.12&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;594,710&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2.83&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;4.20
- 5.76&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2,819,166&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1.53&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;4.29&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;951,666&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;4.42&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;7,235,647&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2.99&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2.52&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;4,928,147&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1.78&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;</cve:ScheduleOfStockOptionsOutstandingTableTextBlock>
    <cve:SharesBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice contextRef="c237" decimals="INF" unitRef="shares">3381771</cve:SharesBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <ifrs-full:WeightedAverageDurationOfDefinedBenefitObligation2019 contextRef="c237">P0Y10M17D</ifrs-full:WeightedAverageDurationOfDefinedBenefitObligation2019>
    <ifrs-full:ExercisePriceOfOutstandingShareOptions2019 contextRef="c238" decimals="2" unitRef="cadPershares">0.85</ifrs-full:ExercisePriceOfOutstandingShareOptions2019>
    <cve:SharesBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber contextRef="c237" decimals="INF" unitRef="shares">3381771</cve:SharesBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber>
    <ifrs-full:ExercisePriceShareOptionsGranted2019 contextRef="c237" decimals="2" unitRef="cadPershares">0.85</ifrs-full:ExercisePriceShareOptionsGranted2019>
    <cve:SharesBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice contextRef="c239" decimals="INF" unitRef="shares">1034710</cve:SharesBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <ifrs-full:WeightedAverageDurationOfDefinedBenefitObligation2019 contextRef="c239">P0Y6M25D</ifrs-full:WeightedAverageDurationOfDefinedBenefitObligation2019>
    <ifrs-full:ExercisePriceOfOutstandingShareOptions2019 contextRef="c240" decimals="2" unitRef="cadPershares">3.12</ifrs-full:ExercisePriceOfOutstandingShareOptions2019>
    <cve:SharesBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber contextRef="c239" decimals="INF" unitRef="shares">594710</cve:SharesBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber>
    <ifrs-full:ExercisePriceShareOptionsGranted2019 contextRef="c239" decimals="2" unitRef="cadPershares">2.83</ifrs-full:ExercisePriceShareOptionsGranted2019>
    <cve:SharesBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice contextRef="c241" decimals="INF" unitRef="shares">2819166</cve:SharesBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <ifrs-full:WeightedAverageDurationOfDefinedBenefitObligation2019 contextRef="c241">P1Y6M10D</ifrs-full:WeightedAverageDurationOfDefinedBenefitObligation2019>
    <ifrs-full:ExercisePriceOfOutstandingShareOptions2019 contextRef="c242" decimals="2" unitRef="cadPershares">4.29</ifrs-full:ExercisePriceOfOutstandingShareOptions2019>
    <cve:SharesBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber contextRef="c241" decimals="INF" unitRef="shares">951666</cve:SharesBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber>
    <ifrs-full:ExercisePriceShareOptionsGranted2019 contextRef="c241" decimals="2" unitRef="cadPershares">4.42</ifrs-full:ExercisePriceShareOptionsGranted2019>
    <cve:SharesBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice contextRef="c0" decimals="INF" unitRef="shares">7235647</cve:SharesBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <ifrs-full:WeightedAverageDurationOfDefinedBenefitObligation2019 contextRef="c0">P2Y11M26D</ifrs-full:WeightedAverageDurationOfDefinedBenefitObligation2019>
    <ifrs-full:ExercisePriceOfOutstandingShareOptions2019 contextRef="c2" decimals="2" unitRef="cadPershares">2.52</ifrs-full:ExercisePriceOfOutstandingShareOptions2019>
    <cve:SharesBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber contextRef="c0" decimals="INF" unitRef="shares">4928147</cve:SharesBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber>
    <ifrs-full:ExercisePriceShareOptionsGranted2019 contextRef="c0" decimals="2" unitRef="cadPershares">1.78</ifrs-full:ExercisePriceShareOptionsGranted2019>
    <cve:AggregateOfGrantedShares contextRef="c0" decimals="0" unitRef="shares">3107501</cve:AggregateOfGrantedShares>
    <cve:FairValueOfGrantedOption contextRef="c0" decimals="0" unitRef="usd">7665042</cve:FairValueOfGrantedOption>
    <cve:AggregateOfGrantedShares contextRef="c5" decimals="0" unitRef="shares">2390627</cve:AggregateOfGrantedShares>
    <cve:FairValueOfGrantedOption contextRef="c5" decimals="0" unitRef="usd">1484302</cve:FairValueOfGrantedOption>
    <cve:StockOptionsRevisedTerm contextRef="c0">P12M</cve:StockOptionsRevisedTerm>
    <cve:StandardStockOptionVestingPercentage contextRef="c0" decimals="2" unitRef="pure">0.25</cve:StandardStockOptionVestingPercentage>
    <cve:RecognizedStockOptionExpense contextRef="c0" decimals="0" unitRef="usd">5744655</cve:RecognizedStockOptionExpense>
    <cve:RecognizedStockOptionExpense contextRef="c5" decimals="0" unitRef="usd">1425645</cve:RecognizedStockOptionExpense>
    <cve:ScheduleOfWeightedAverageAssumptionsUsedInCalculatingTheFairValuesTableTextBlock contextRef="c0">&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;December
    31, &lt;br/&gt; 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;December
    31, &lt;br/&gt; 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 76%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Risk-free interest rate&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2.06&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;0.88&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Expected life of option&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;4.9 years&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;5 years&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Expected dividend yield&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;0&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;0&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Expected stock price volatility&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;116.48&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;128.79&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Fair value per option&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;CAD
                                            $3.21&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;CAD
                                            $1.10&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;</cve:ScheduleOfWeightedAverageAssumptionsUsedInCalculatingTheFairValuesTableTextBlock>
    <ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted contextRef="c0" decimals="4" unitRef="pure">0.0206</ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted>
    <ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted contextRef="c5" decimals="4" unitRef="pure">0.0088</ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted>
    <ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019 contextRef="c0">P4Y10M24D</ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019>
    <ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019 contextRef="c5">P5Y</ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019>
    <ifrs-full:ExpectedDividendAsPercentageShareOptionsGranted contextRef="c0" decimals="2" unitRef="pure">0</ifrs-full:ExpectedDividendAsPercentageShareOptionsGranted>
    <ifrs-full:ExpectedDividendAsPercentageShareOptionsGranted contextRef="c5" decimals="2" unitRef="pure">0</ifrs-full:ExpectedDividendAsPercentageShareOptionsGranted>
    <ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted contextRef="c0" decimals="4" unitRef="pure">1.1648</ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted>
    <ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted contextRef="c5" decimals="4" unitRef="pure">1.2879</ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted>
    <cve:ScheduleOfTheStatusOfTheCompanysWarrantsTableTextBlock contextRef="c0">&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Year
    ended &lt;br/&gt; December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Year
    ended &lt;br/&gt; December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Warrants&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Weighted average exercise price&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Warrants&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Weighted average exercise price&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; padding-bottom: 1.5pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;#&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;CAD
    $&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; padding-bottom: 1.5pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;#&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;CAD
    $&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 52%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Warrants outstanding, beginning
    of year&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;6,298,839&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2.43&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;4,143,247&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1.23&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-indent: 0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;3,670,919&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;5.81&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;4,208,435&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;3.24&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: 0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Exercised&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(2,291,642&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1.39&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(2,052,843&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1.62&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-indent: 0.125in; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Expired&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(183,610&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1.67&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Warrants
    outstanding, end of year&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;7,494,506&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;4.43&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;6,298,839&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2.43&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;</cve:ScheduleOfTheStatusOfTheCompanysWarrantsTableTextBlock>
    <cve:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptionsWarrantsOutstanding contextRef="c3" decimals="INF" unitRef="shares">6298839</cve:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptionsWarrantsOutstanding>
    <cve:SharesBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingPeriodIncreaseDecreaseWeightedAverageExercisePrice contextRef="c3" decimals="2" unitRef="cadPershares">2.43</cve:SharesBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingPeriodIncreaseDecreaseWeightedAverageExercisePrice>
    <cve:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptionsWarrantsOutstanding contextRef="c6" decimals="INF" unitRef="shares">4143247</cve:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptionsWarrantsOutstanding>
    <cve:SharesBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingPeriodIncreaseDecreaseWeightedAverageExercisePrice contextRef="c6" decimals="2" unitRef="cadPershares">1.23</cve:SharesBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingPeriodIncreaseDecreaseWeightedAverageExercisePrice>
    <cve:ShareBasedCompensationArrangementBySharesBasedPaymentAwardOptionsGrantsInPeriodWarrantsGranted contextRef="c0" decimals="INF" unitRef="shares">3670919</cve:ShareBasedCompensationArrangementBySharesBasedPaymentAwardOptionsGrantsInPeriodWarrantsGranted>
    <cve:SharesbasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue contextRef="c0" decimals="2" unitRef="cadPershares">5.81</cve:SharesbasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue>
    <cve:ShareBasedCompensationArrangementBySharesBasedPaymentAwardOptionsGrantsInPeriodWarrantsGranted contextRef="c5" decimals="INF" unitRef="shares">4208435</cve:ShareBasedCompensationArrangementBySharesBasedPaymentAwardOptionsGrantsInPeriodWarrantsGranted>
    <cve:SharesbasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue contextRef="c5" decimals="2" unitRef="cadPershares">3.24</cve:SharesbasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue>
    <cve:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisedWarrantsExercised contextRef="c0" decimals="INF" unitRef="shares">-2291642</cve:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisedWarrantsExercised>
    <cve:SharesBasedCompensationArrangementBySharesBasedPaymentAwardOptionsOutstandingPeriodIncreaseDecreaseWeightedAverageExercisePrice contextRef="c0" decimals="2" unitRef="cadPershares">1.39</cve:SharesBasedCompensationArrangementBySharesBasedPaymentAwardOptionsOutstandingPeriodIncreaseDecreaseWeightedAverageExercisePrice>
    <cve:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisedWarrantsExercised contextRef="c5" decimals="INF" unitRef="shares">-2052843</cve:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisedWarrantsExercised>
    <cve:SharesBasedCompensationArrangementBySharesBasedPaymentAwardOptionsOutstandingPeriodIncreaseDecreaseWeightedAverageExercisePrice contextRef="c5" decimals="2" unitRef="cadPershares">1.62</cve:SharesBasedCompensationArrangementBySharesBasedPaymentAwardOptionsOutstandingPeriodIncreaseDecreaseWeightedAverageExercisePrice>
    <cve:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWarrantsExpired contextRef="c0" decimals="INF" unitRef="shares">-183610</cve:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWarrantsExpired>
    <cve:ShareBasedCompensationArrangementsBySharesBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice contextRef="c0" decimals="2" unitRef="cadPershares">1.67</cve:ShareBasedCompensationArrangementsBySharesBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice>
    <cve:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptionsWarrantsOutstanding contextRef="c2" decimals="INF" unitRef="shares">7494506</cve:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptionsWarrantsOutstanding>
    <cve:SharesBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingPeriodIncreaseDecreaseWeightedAverageExercisePrice contextRef="c2" decimals="2" unitRef="cadPershares">4.43</cve:SharesBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingPeriodIncreaseDecreaseWeightedAverageExercisePrice>
    <cve:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptionsWarrantsOutstanding contextRef="c3" decimals="INF" unitRef="shares">6298839</cve:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptionsWarrantsOutstanding>
    <cve:SharesBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingPeriodIncreaseDecreaseWeightedAverageExercisePrice contextRef="c3" decimals="2" unitRef="cadPershares">2.43</cve:SharesBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingPeriodIncreaseDecreaseWeightedAverageExercisePrice>
    <cve:ScheduleOfSharePurchaseWarrantsOutstandingTableTextBlock contextRef="c0">&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
                                                                                                                          &lt;td style="text-align: center; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
                                                                                                                          &lt;td colspan="6" style="border-bottom: Black 1.5pt solid; text-align: center; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Warrants Outstanding&lt;br/&gt; December 31, 2022&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Weighted average&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Weighted average&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Warrant price&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Warrants&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Remaining&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;exercise price&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;per share&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; padding-bottom: 1.5pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;#&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Life&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;CAD
    $&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; width: 46%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$1.59 - 1.80&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 15%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1,360,028&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 15%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;0.14&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 15%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1.81&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$2.22 - 3.90 &lt;sup&gt;1&lt;/sup&gt;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2,515,197&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;0.39&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;3.84&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$4.59 - 6.00&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;3,619,281&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;0.59&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;5.86&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;7,494,506&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1.12&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;4.43&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0.25in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;sup&gt;1&lt;/sup&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Includes power warrants exercisable into one share and &lt;span style="-sec-ix-hidden: hidden-fact-282"&gt;one-half&lt;/span&gt; warrant. Each whole warrant is exercisable at $3.90 for 36 months.&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;</cve:ScheduleOfSharePurchaseWarrantsOutstandingTableTextBlock>
    <cve:Warrants contextRef="c243" decimals="INF" unitRef="shares">1360028</cve:Warrants>
    <cve:WarrantsOutstandingWeightedAverageReimainingLife contextRef="c243">P0Y1M20D</cve:WarrantsOutstandingWeightedAverageReimainingLife>
    <cve:WarrantsOutstandingWeightedAverageExercisePrice contextRef="c243" decimals="2" unitRef="cadPershares">1.81</cve:WarrantsOutstandingWeightedAverageExercisePrice>
    <cve:Warrants
      contextRef="c244"
      decimals="INF"
      id="ix_5_fact"
      unitRef="shares">2515197</cve:Warrants>
    <cve:WarrantsOutstandingWeightedAverageReimainingLife contextRef="c244" id="ix_6_fact">P0Y4M20D</cve:WarrantsOutstandingWeightedAverageReimainingLife>
    <cve:WarrantsOutstandingWeightedAverageExercisePrice
      contextRef="c244"
      decimals="2"
      id="ix_7_fact"
      unitRef="cadPershares">3.84</cve:WarrantsOutstandingWeightedAverageExercisePrice>
    <cve:Warrants contextRef="c245" decimals="INF" unitRef="shares">3619281</cve:Warrants>
    <cve:WarrantsOutstandingWeightedAverageReimainingLife contextRef="c245">P0Y7M2D</cve:WarrantsOutstandingWeightedAverageReimainingLife>
    <cve:WarrantsOutstandingWeightedAverageExercisePrice contextRef="c245" decimals="2" unitRef="cadPershares">5.86</cve:WarrantsOutstandingWeightedAverageExercisePrice>
    <cve:Warrants contextRef="c0" decimals="INF" unitRef="shares">7494506</cve:Warrants>
    <cve:WarrantsOutstandingWeightedAverageReimainingLife contextRef="c0">P1Y1M13D</cve:WarrantsOutstandingWeightedAverageReimainingLife>
    <cve:WarrantsOutstandingWeightedAverageExercisePrice contextRef="c0" decimals="2" unitRef="cadPershares">4.43</cve:WarrantsOutstandingWeightedAverageExercisePrice>
    <cve:WarrantsExercisableShare contextRef="c0" decimals="0" unitRef="shares">1</cve:WarrantsExercisableShare>
    <cve:WarrantsExercisablePrice contextRef="c0" decimals="2" unitRef="usdPershares">3.9</cve:WarrantsExercisablePrice>
    <cve:WarrantIsExercisableTerm contextRef="c0">P36M</cve:WarrantIsExercisableTerm>
    <ifrs-full:DividendsReceived contextRef="c0" decimals="0" unitRef="cad">69831000</ifrs-full:DividendsReceived>
    <ifrs-full:DividendsReceived contextRef="c0" decimals="0" unitRef="usd">50051595</ifrs-full:DividendsReceived>
    <ifrs-full:DisclosureOfRelatedPartyExplanatory contextRef="c0">&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 18pt"/&gt;&lt;td style="width: 18pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;15.&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Related
                                            party transactions and balances&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -18pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Related
parties include key management of the Company and any entities controlled by these individuals as well as other entities providing key
management services to the Company. Key management personnel consist of Directors and senior management including the Executive Chairman,
Chief Executive Officer, Chief Financial Officer, Chief Operating Officer, and Chief Administrative Officer.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;The
amounts paid to key management or entities providing similar services are as follows:&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;December
    31, &lt;br/&gt; 2022&lt;br/&gt; $&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;December
    31, &lt;br/&gt; 2021&lt;br/&gt; $&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 64%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Consulting&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(1&lt;/span&gt;)&lt;/td&gt;&lt;td style="width: 1%; text-align: left"/&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;103,514&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;61,899&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Data acquisition&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(2&lt;/span&gt;)&lt;/td&gt;&lt;td style="text-align: left"/&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;55,150&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-283; font-family: Times New Roman, Times, Serif"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Directors&#x2019; fees&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(3&lt;/span&gt;)&lt;/td&gt;&lt;td style="text-align: left"/&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;192,604&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-284; font-family: Times New Roman, Times, Serif"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Office and administration&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-285; font-family: Times New Roman, Times, Serif"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;13,402&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Staff costs&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1,607,211&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1,151,731&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Stock option expense&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;4,729,503&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;749,255&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Total
    key management compensation&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;6,687,982&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1,976,287&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0.25in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;- During the year ended December 31, 2022, the Company incurred communications &amp;amp; community engagement consulting fees of $103,514 (2021 - $61,899) according to a contract with Tintina Holdings, Ltd., a company owned and operated by the spouse of the Company&#x2019;s Executive Chairman.&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0.25in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;- In June 2022, the Company acquired access to the Getty Minerals database pursuant to a purchase agreement with Platoro West Inc., a company owned and operated by the Company&#x2019;s Executive Chairman (Note 7).&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0.25in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#x2013; Directors&#x2019; Fees are included in staff costs on the consolidated statement of loss and other comprehensive income (loss).&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;During
the year ended December 31, 2022, the Company granted 2,566,667 options to key management, with a fair value of $6,496,785 (2021 &#x2013;
150,000 with a fair value of $384,881).&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;As
of December 31, 2022 and December 31, 2021, the following amounts were owing to related parties:&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: 18pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;December
    31, &lt;br/&gt; 2022&lt;br/&gt; $&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;December
    31, &lt;br/&gt; 2021&lt;br/&gt; $&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;January
    1, &lt;br/&gt; 2021&lt;br/&gt; $&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 32%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Tintina Holdings, Ltd&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 31%; text-align: left; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Consulting
    services&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;12,744&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;6,893&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;0&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Officers and Board members&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Accrued
    compensation&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;428,630&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-286; font-family: Times New Roman, Times, Serif"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2,319&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;441,374&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;6,893&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2,319&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</ifrs-full:DisclosureOfRelatedPartyExplanatory>
    <ifrs-full:DisclosureOfGeneralAndAdministrativeExpenseExplanatory contextRef="c0">&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;December
    31, &lt;br/&gt; 2022&lt;br/&gt; $&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;December
    31, &lt;br/&gt; 2021&lt;br/&gt; $&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 64%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Consulting&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(1&lt;/span&gt;)&lt;/td&gt;&lt;td style="width: 1%; text-align: left"/&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;103,514&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;61,899&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Data acquisition&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(2&lt;/span&gt;)&lt;/td&gt;&lt;td style="text-align: left"/&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;55,150&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-283; font-family: Times New Roman, Times, Serif"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Directors&#x2019; fees&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(3&lt;/span&gt;)&lt;/td&gt;&lt;td style="text-align: left"/&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;192,604&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-284; font-family: Times New Roman, Times, Serif"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Office and administration&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-285; font-family: Times New Roman, Times, Serif"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;13,402&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Staff costs&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1,607,211&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1,151,731&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Stock option expense&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;4,729,503&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;749,255&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Total
    key management compensation&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;6,687,982&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1,976,287&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0.25in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;- During the year ended December 31, 2022, the Company incurred communications &amp;amp; community engagement consulting fees of $103,514 (2021 - $61,899) according to a contract with Tintina Holdings, Ltd., a company owned and operated by the spouse of the Company&#x2019;s Executive Chairman.&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0.25in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;- In June 2022, the Company acquired access to the Getty Minerals database pursuant to a purchase agreement with Platoro West Inc., a company owned and operated by the Company&#x2019;s Executive Chairman (Note 7).&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0.25in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#x2013; Directors&#x2019; Fees are included in staff costs on the consolidated statement of loss and other comprehensive income (loss).&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;</ifrs-full:DisclosureOfGeneralAndAdministrativeExpenseExplanatory>
    <ifrs-full:RevenueFromRenderingOfInformationTechnologyConsultingServices contextRef="c0" decimals="0" id="ix_8_fact" unitRef="usd">103514</ifrs-full:RevenueFromRenderingOfInformationTechnologyConsultingServices>
    <ifrs-full:RevenueFromRenderingOfInformationTechnologyConsultingServices contextRef="c5" decimals="0" id="ix_9_fact" unitRef="usd">61899</ifrs-full:RevenueFromRenderingOfInformationTechnologyConsultingServices>
    <ifrs-full:AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill contextRef="c0" decimals="0" id="ix_10_fact" unitRef="usd">55150</ifrs-full:AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill>
    <ifrs-full:DirectorsRemunerationExpense contextRef="c0" decimals="0" id="ix_11_fact" unitRef="usd">192604</ifrs-full:DirectorsRemunerationExpense>
    <cve:OfficeAndAdministration contextRef="c5" decimals="0" unitRef="usd">13402</cve:OfficeAndAdministration>
    <cve:StaffCosts contextRef="c0" decimals="0" unitRef="usd">1607211</cve:StaffCosts>
    <cve:StaffCosts contextRef="c5" decimals="0" unitRef="usd">1151731</cve:StaffCosts>
    <us-gaap:StockOptionPlanExpense contextRef="c0" decimals="0" unitRef="usd">4729503</us-gaap:StockOptionPlanExpense>
    <us-gaap:StockOptionPlanExpense contextRef="c5" decimals="0" unitRef="usd">749255</us-gaap:StockOptionPlanExpense>
    <ifrs-full:KeyManagementPersonnelCompensation contextRef="c0" decimals="0" unitRef="usd">6687982</ifrs-full:KeyManagementPersonnelCompensation>
    <ifrs-full:KeyManagementPersonnelCompensation contextRef="c5" decimals="0" unitRef="usd">1976287</ifrs-full:KeyManagementPersonnelCompensation>
    <cve:ConsultingFees contextRef="c0" decimals="0" unitRef="usd">103514</cve:ConsultingFees>
    <cve:ConsultingFees contextRef="c5" decimals="0" unitRef="usd">61899</cve:ConsultingFees>
    <cve:GrantedOptionsShares contextRef="c0" decimals="0" unitRef="shares">2566667</cve:GrantedOptionsShares>
    <cve:FairValueAmount contextRef="c246" decimals="0" unitRef="usd">6496785</cve:FairValueAmount>
    <cve:FairValueAmount contextRef="c5" decimals="0" unitRef="usd">150000</cve:FairValueAmount>
    <cve:FairValueAmount contextRef="c247" decimals="0" unitRef="usd">384881</cve:FairValueAmount>
    <ifrs-full:DisclosureOfTransactionsBetweenRelatedPartiesExplanatory contextRef="c0">&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;December
    31, &lt;br/&gt; 2022&lt;br/&gt; $&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;December
    31, &lt;br/&gt; 2021&lt;br/&gt; $&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;January
    1, &lt;br/&gt; 2021&lt;br/&gt; $&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 32%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Tintina Holdings, Ltd&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 31%; text-align: left; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Consulting
    services&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;12,744&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;6,893&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;0&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Officers and Board members&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Accrued
    compensation&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;428,630&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-286; font-family: Times New Roman, Times, Serif"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2,319&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;441,374&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;6,893&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2,319&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</ifrs-full:DisclosureOfTransactionsBetweenRelatedPartiesExplanatory>
    <ifrs-full:AmountsPayableRelatedPartyTransactions contextRef="c248" decimals="0" unitRef="usd">12744</ifrs-full:AmountsPayableRelatedPartyTransactions>
    <ifrs-full:AmountsPayableRelatedPartyTransactions contextRef="c249" decimals="0" unitRef="usd">6893</ifrs-full:AmountsPayableRelatedPartyTransactions>
    <ifrs-full:AmountsPayableRelatedPartyTransactions contextRef="c250" decimals="0" unitRef="usd">0</ifrs-full:AmountsPayableRelatedPartyTransactions>
    <ifrs-full:AmountsPayableRelatedPartyTransactions contextRef="c251" decimals="0" unitRef="usd">428630</ifrs-full:AmountsPayableRelatedPartyTransactions>
    <ifrs-full:AmountsPayableRelatedPartyTransactions contextRef="c253" decimals="0" unitRef="usd">2319</ifrs-full:AmountsPayableRelatedPartyTransactions>
    <ifrs-full:AmountsPayableRelatedPartyTransactions contextRef="c2" decimals="0" unitRef="usd">441374</ifrs-full:AmountsPayableRelatedPartyTransactions>
    <ifrs-full:AmountsPayableRelatedPartyTransactions contextRef="c3" decimals="0" unitRef="usd">6893</ifrs-full:AmountsPayableRelatedPartyTransactions>
    <ifrs-full:AmountsPayableRelatedPartyTransactions contextRef="c254" decimals="0" unitRef="usd">2319</ifrs-full:AmountsPayableRelatedPartyTransactions>
    <ifrs-full:DescriptionOfManagingLiquidityRisk contextRef="c0">&lt;table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.25in"/&gt;&lt;td style="width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;16.&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Management
                                            of capital&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -18pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;The
Company&#x2019;s objectives when managing capital are to safeguard its ability to continue as a going concern in order to support the
exploration, evaluation, and development of its mineral properties and to maintain a flexible capital structure that optimizes the cost
of capital within a framework of acceptable risk. The Company manages the capital structure and makes adjustments to it in light of changes
in economic conditions and the risk characteristics of the underlying assets. To maintain or adjust its capital structure, the Company
may issue new shares, issue debt, and acquire or dispose of assets.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;The
Company is dependent on the capital markets as its primary source of operating capital and the Company&#x2019;s capital resources are
largely determined by the strength of the junior resource markets, the status of the Company&#x2019;s projects in relation to these markets,
and its ability to compete for investor support of its projects.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;The
Company considers the components of shareholders&#x2019; equity as capital.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;There
were no changes in the Company&#x2019;s approach to capital management during the year ended December 31, 2022, and the Company is not
subject to any externally imposed capital requirements.&lt;/span&gt;&lt;/p&gt;</ifrs-full:DescriptionOfManagingLiquidityRisk>
    <ifrs-full:DisclosureOfFinancialInstrumentsExplanatory contextRef="c0">&lt;table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0.25in"/&gt;&lt;td style="width: 0.25in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;17.&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Financial
                                            instruments&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 18pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Financial
instruments include cash, receivables and marketable securities and any contract that gives rise to a financial asset to one party and
a financial liability or equity instrument to another party. Financial assets and liabilities measured at fair value are classified in
the fair value hierarchy according to the lowest level of input that is significant to the fair value measurement. Assessment of the
significance of a particular input to the fair value measurement requires judgement and may affect placement within the fair value hierarchy
levels. The hierarchy is as follows:&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.75in"/&gt;&lt;td style="width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Level
                                            1 fair value measurements are those derived from quoted prices in active markets for identical
                                            assets or liabilities. &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 72pt; text-align: justify; text-indent: -18pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.75in"/&gt;&lt;td style="width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Level
                                            2 fair value measurements are those derived from inputs other than quoted prices included
                                            within Level 1, that are observable either directly or indirectly. &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 72pt; text-align: justify; text-indent: -18pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.75in"/&gt;&lt;td style="width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Level
                                            3 fair value measurements are those derived from valuation techniques that include inputs
                                            that are not based on observable market data. &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 72pt; text-align: justify; text-indent: -18pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Cash,
restricted cash, and marketable securities are measured at Level 1 of the fair value hierarchy. The Company classifies its receivables
as financial assets measured at amortized cost. Accounts payable and accrued liabilities, lease liability and due to related parties
and notes payable are classified as financial liabilities measured at amortized cost. The carrying amounts of receivables, accounts payable
and accrued liabilities, and amounts due to related parties approximate their fair values due to the short-term nature of the financial
instruments.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Investments
in uranium are measured at Level 2 of the fair value hierarchy. The Company classifies these investments as financial assets measured
at fair value as determined based on the most recent month-end spot prices for uranium published by UxC and converted to Canadian dollars
at the date of the consolidated statement of financial position.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Marketable
securities are measured at Level 1 of the fair value hierarchy. The Company classifies these investments as financial assets whose value
is derived from quoted prices in active markets and carries them at FVTPL.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Discussions
of risks associated with financial assets and liabilities are detailed below:&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Currency
risk&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Foreign
currency exchange risk is the risk that future cash flows, net income and comprehensive income will fluctuate as a result of changes
in foreign exchange rates. As the Company&#x2019;s operations are conducted internationally, operations and capital activity may be transacted
in currencies other than the functional currency of the entity party to the transaction.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;The
Company&#x2019;s objective in managing its foreign currency risk is to minimize its net exposures to foreign currency cash flows by obtaining
most of its estimated annual U.S. cash requirements and holding the remaining currency in Canadian dollars. The Company monitors and
forecasts the values of net foreign currency cash flow and consolidated statement of financial position exposures and from time to time
could authorize the use of derivative financial instruments such as forward foreign exchange contracts to economically hedge a portion
of foreign currency fluctuations.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;The
following table provides an indication of the Company&#x2019;s foreign currency exposures during the years ended December 31, 2022 and
2021:&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;December
    31, &lt;br/&gt; 2022&lt;br/&gt; CAD $&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;December
    31, &lt;br/&gt; 2021&lt;br/&gt; CAD $&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 76%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Cash&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;216,871&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;5,689,671&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Marketable Securities - Current&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;3,162,362&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-287; font-family: Times New Roman, Times, Serif"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Accounts payable and
    accrued liabilities&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(2,890,582&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(2,557,849&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;488,651&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;3,131,822&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;A
10% change in Canadian/US foreign exchange rate at year end would have changed the net loss of the Company, assuming that all other variables
remained constant, by approximately $352,315 for the year ended December 31, 2022 (2021 - $247,028).&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;The
Company has not, to the date of these financial statements, entered into derivative instruments to offset the impact of foreign currency
fluctuations.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Credit
risk&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Credit
risk arises from cash held with banks and financial institutions and receivables. The maximum exposure to credit risk is equal to the
carrying value of these financial assets. The Company&#x2019;s cash is primarily held with a major Canadian bank.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Market
risk&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;The
Company is exposed to market risk because of the fluctuating values of its publicly traded marketable securities (Note 6). The Company
has no control over these fluctuations and does not hedge its investments. Based on the December 31, 2022 value of marketable securities
every 10% increase or decrease in the share prices of their holdings would have impacted loss for the period, up or down, by approximately
$394,719 (2021 - $&lt;span style="-sec-ix-hidden: hidden-fact-288"&gt;nil&lt;/span&gt;) before income taxes.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Further,
the Company is in the exploration stage and commodity prices are not reflected in operating financial results. However, fluctuations
in commodity prices may influence financial markets and may indirectly affect the Company&#x2019;s ability to raise capital to fund exploration.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Interest
rate risk&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Interest
rate risk mainly arises from the Company&#x2019;s cash, which receives interest based on market interest rates. Fluctuations in interest
cash flows due to changes in market interest rates are not significant.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Liquidity
risk&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Liquidity
risk is the risk that the Company will not be able to meet its current obligations as they become due. The majority of the Company&#x2019;s
accounts payable and accrued liabilities are payable in less than 90 days. The Company prepares annual exploration and administrative
budgets and monitors expenditures to manage short-term liquidity. Due to the nature of the Company&#x2019;s activities, funding for long-term
liquidity needs is dependent on the Company&#x2019;s ability to obtain additional financing through various means, including equity financing.&lt;/span&gt;&lt;/p&gt;</ifrs-full:DisclosureOfFinancialInstrumentsExplanatory>
    <cve:ScheduleOfFinancialInstrumentTableTextBlock contextRef="c0">&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;December
    31, &lt;br/&gt; 2022&lt;br/&gt; CAD $&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;December
    31, &lt;br/&gt; 2021&lt;br/&gt; CAD $&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 76%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Cash&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;216,871&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;5,689,671&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Marketable Securities - Current&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;3,162,362&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-287; font-family: Times New Roman, Times, Serif"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Accounts payable and
    accrued liabilities&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(2,890,582&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(2,557,849&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;488,651&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;3,131,822&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;</cve:ScheduleOfFinancialInstrumentTableTextBlock>
    <ifrs-full:Cash contextRef="c2" decimals="0" unitRef="cad">216871</ifrs-full:Cash>
    <ifrs-full:Cash contextRef="c3" decimals="0" unitRef="cad">5689671</ifrs-full:Cash>
    <us-gaap:MarketableSecurities contextRef="c2" decimals="0" unitRef="cad">3162362</us-gaap:MarketableSecurities>
    <cve:AccountPayablesAndAccruedLiabilities contextRef="c2" decimals="0" unitRef="cad">2890582</cve:AccountPayablesAndAccruedLiabilities>
    <cve:AccountPayablesAndAccruedLiabilities contextRef="c3" decimals="0" unitRef="cad">2557849</cve:AccountPayablesAndAccruedLiabilities>
    <ifrs-full:AssetsLessCurrentLiabilities contextRef="c2" decimals="0" unitRef="cad">488651</ifrs-full:AssetsLessCurrentLiabilities>
    <ifrs-full:AssetsLessCurrentLiabilities contextRef="c3" decimals="0" unitRef="cad">3131822</ifrs-full:AssetsLessCurrentLiabilities>
    <cve:ForeignExchangeRate contextRef="c0" decimals="2" unitRef="pure">0.10</cve:ForeignExchangeRate>
    <ifrs-full:NotionalAmount contextRef="c2" decimals="0" unitRef="usd">352315</ifrs-full:NotionalAmount>
    <ifrs-full:NotionalAmount contextRef="c3" decimals="0" unitRef="usd">247028</ifrs-full:NotionalAmount>
    <ifrs-full:TaxRateEffectFromChangeInTaxRate contextRef="c0" decimals="2" unitRef="pure">0.10</ifrs-full:TaxRateEffectFromChangeInTaxRate>
    <cve:ImpactedLoss contextRef="c0" decimals="0" unitRef="usd">394719</cve:ImpactedLoss>
    <ifrs-full:DisclosureOfEntitysReportableSegmentsExplanatory contextRef="c0">&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 18pt"/&gt;&lt;td style="width: 18pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;18.&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Segmented
                                            information&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -18pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;The
Company operates in a single segment: the acquisition, exploration, and development of mineral properties in the United States.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;The
table below provides a breakdown of the Company&#x2019;s long-term assets by geographic segment:&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left; padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Balance
    Sheet Items&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;South
    Dakota&lt;br/&gt; $&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Texas&lt;br/&gt;
    $&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;New
    Mexico&lt;br/&gt; $&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Wyoming&lt;br/&gt;
    $&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Other
    States &lt;br/&gt; $&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Canada&lt;br/&gt;
    $&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Total&lt;br/&gt;
    $&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; width: 16%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Intangible
    assets&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-289; font-family: Times New Roman, Times, Serif"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;67,251&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;217,241&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-290; font-family: Times New Roman, Times, Serif"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;207,504&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-291; font-family: Times New Roman, Times, Serif"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;491,996&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Property,
    plant and equipment&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;62,946&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1,540,733&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-292; font-family: Times New Roman, Times, Serif"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-293; font-family: Times New Roman, Times, Serif"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-294; font-family: Times New Roman, Times, Serif"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-295; font-family: Times New Roman, Times, Serif"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1,603,679&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Mineral
    properties&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;85,667,919&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1,455,206&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;4,395,822&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;41,235,727&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;3,324,904&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-296; font-family: Times New Roman, Times, Serif"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;136,079,578&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Right-of-use
    assets&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-297; font-family: Times New Roman, Times, Serif"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;199,120&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-298; font-family: Times New Roman, Times, Serif"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-299; font-family: Times New Roman, Times, Serif"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-300; font-family: Times New Roman, Times, Serif"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;45,444&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;244,564&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Balance,
    December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;85,730,865&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;3,262,310&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;4,613,063&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;41,235,727&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;3,532,408&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;45,444&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;138,419,817&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Intangible
    assets&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-301; font-family: Times New Roman, Times, Serif"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;122,401&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;217,241&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-302; font-family: Times New Roman, Times, Serif"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;188,640&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-303; font-family: Times New Roman, Times, Serif"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;528,282&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Property,
    plant and equipment&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;60,630&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2,273,791&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-304; font-family: Times New Roman, Times, Serif"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-305; font-family: Times New Roman, Times, Serif"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-306; font-family: Times New Roman, Times, Serif"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-307; font-family: Times New Roman, Times, Serif"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2,334,421&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Mineral
    properties&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;86,220,848&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;9,144,069&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;4,905,348&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;41,754,462&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;3,194,359&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-308; font-family: Times New Roman, Times, Serif"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;145,219,086&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Right-of-use
    assets&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-309; font-family: Times New Roman, Times, Serif"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;168,871&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-310; font-family: Times New Roman, Times, Serif"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-311; font-family: Times New Roman, Times, Serif"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-312; font-family: Times New Roman, Times, Serif"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;16,743&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;185,614&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Balance,
    December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;86,281,478&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;11,709,132&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;5,122,589&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;41,754,462&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;3,382,999&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;16,743&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;148,267,403&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</ifrs-full:DisclosureOfEntitysReportableSegmentsExplanatory>
    <cve:DisclosureOfLongtermAssetsByGeographicSegmentTableTextBlock contextRef="c0">&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left; padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Balance
    Sheet Items&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;South
    Dakota&lt;br/&gt; $&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Texas&lt;br/&gt;
    $&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;New
    Mexico&lt;br/&gt; $&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Wyoming&lt;br/&gt;
    $&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Other
    States &lt;br/&gt; $&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Canada&lt;br/&gt;
    $&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Total&lt;br/&gt;
    $&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; width: 16%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Intangible
    assets&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-289; font-family: Times New Roman, Times, Serif"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;67,251&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;217,241&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-290; font-family: Times New Roman, Times, Serif"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;207,504&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-291; font-family: Times New Roman, Times, Serif"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;491,996&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Property,
    plant and equipment&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;62,946&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1,540,733&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-292; font-family: Times New Roman, Times, Serif"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-293; font-family: Times New Roman, Times, Serif"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-294; font-family: Times New Roman, Times, Serif"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-295; font-family: Times New Roman, Times, Serif"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1,603,679&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Mineral
    properties&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;85,667,919&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1,455,206&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;4,395,822&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;41,235,727&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;3,324,904&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-296; font-family: Times New Roman, Times, Serif"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;136,079,578&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Right-of-use
    assets&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-297; font-family: Times New Roman, Times, Serif"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;199,120&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-298; font-family: Times New Roman, Times, Serif"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-299; font-family: Times New Roman, Times, Serif"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-300; font-family: Times New Roman, Times, Serif"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;45,444&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;244,564&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Balance,
    December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;85,730,865&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;3,262,310&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;4,613,063&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;41,235,727&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;3,532,408&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;45,444&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;138,419,817&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Intangible
    assets&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-301; font-family: Times New Roman, Times, Serif"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;122,401&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;217,241&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-302; font-family: Times New Roman, Times, Serif"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;188,640&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-303; font-family: Times New Roman, Times, Serif"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;528,282&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Property,
    plant and equipment&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;60,630&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2,273,791&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-304; font-family: Times New Roman, Times, Serif"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-305; font-family: Times New Roman, Times, Serif"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-306; font-family: Times New Roman, Times, Serif"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-307; font-family: Times New Roman, Times, Serif"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2,334,421&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Mineral
    properties&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;86,220,848&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;9,144,069&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;4,905,348&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;41,754,462&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;3,194,359&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-308; font-family: Times New Roman, Times, Serif"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;145,219,086&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Right-of-use
    assets&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-309; font-family: Times New Roman, Times, Serif"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;168,871&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-310; font-family: Times New Roman, Times, Serif"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-311; font-family: Times New Roman, Times, Serif"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-312; font-family: Times New Roman, Times, Serif"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;16,743&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;185,614&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Balance,
    December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;86,281,478&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;11,709,132&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;5,122,589&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;41,754,462&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;3,382,999&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;16,743&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;148,267,403&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</cve:DisclosureOfLongtermAssetsByGeographicSegmentTableTextBlock>
    <cve:IntangibleAssets contextRef="c193" decimals="0" unitRef="usd">67251</cve:IntangibleAssets>
    <cve:IntangibleAssets contextRef="c191" decimals="0" unitRef="usd">217241</cve:IntangibleAssets>
    <cve:IntangibleAssets contextRef="c255" decimals="0" unitRef="usd">207504</cve:IntangibleAssets>
    <cve:IntangibleAssets contextRef="c3" decimals="0" unitRef="usd">491996</cve:IntangibleAssets>
    <cve:PropertyPlantAndEquipments contextRef="c192" decimals="0" unitRef="usd">62946</cve:PropertyPlantAndEquipments>
    <cve:PropertyPlantAndEquipments contextRef="c193" decimals="0" unitRef="usd">1540733</cve:PropertyPlantAndEquipments>
    <cve:PropertyPlantAndEquipments contextRef="c3" decimals="0" unitRef="usd">1603679</cve:PropertyPlantAndEquipments>
    <cve:MineralProperties contextRef="c192" decimals="0" unitRef="usd">85667919</cve:MineralProperties>
    <cve:MineralProperties contextRef="c193" decimals="0" unitRef="usd">1455206</cve:MineralProperties>
    <cve:MineralProperties contextRef="c191" decimals="0" unitRef="usd">4395822</cve:MineralProperties>
    <cve:MineralProperties contextRef="c195" decimals="0" unitRef="usd">41235727</cve:MineralProperties>
    <cve:MineralProperties contextRef="c255" decimals="0" unitRef="usd">3324904</cve:MineralProperties>
    <cve:MineralProperties contextRef="c3" decimals="0" unitRef="usd">136079578</cve:MineralProperties>
    <cve:RightofuseAssets1 contextRef="c193" decimals="0" unitRef="usd">199120</cve:RightofuseAssets1>
    <cve:RightofuseAssets1 contextRef="c196" decimals="0" unitRef="usd">45444</cve:RightofuseAssets1>
    <cve:RightofuseAssets1 contextRef="c3" decimals="0" unitRef="usd">244564</cve:RightofuseAssets1>
    <cve:SegmentedInformationBalance contextRef="c192" decimals="0" unitRef="usd">85730865</cve:SegmentedInformationBalance>
    <cve:SegmentedInformationBalance contextRef="c193" decimals="0" unitRef="usd">3262310</cve:SegmentedInformationBalance>
    <cve:SegmentedInformationBalance contextRef="c191" decimals="0" unitRef="usd">4613063</cve:SegmentedInformationBalance>
    <cve:SegmentedInformationBalance contextRef="c195" decimals="0" unitRef="usd">41235727</cve:SegmentedInformationBalance>
    <cve:SegmentedInformationBalance contextRef="c255" decimals="0" unitRef="usd">3532408</cve:SegmentedInformationBalance>
    <cve:SegmentedInformationBalance contextRef="c196" decimals="0" unitRef="usd">45444</cve:SegmentedInformationBalance>
    <cve:SegmentedInformationBalance contextRef="c3" decimals="0" unitRef="usd">138419817</cve:SegmentedInformationBalance>
    <cve:IntangibleAssets contextRef="c216" decimals="0" unitRef="usd">122401</cve:IntangibleAssets>
    <cve:IntangibleAssets contextRef="c214" decimals="0" unitRef="usd">217241</cve:IntangibleAssets>
    <cve:IntangibleAssets contextRef="c256" decimals="0" unitRef="usd">188640</cve:IntangibleAssets>
    <cve:IntangibleAssets contextRef="c2" decimals="0" unitRef="usd">528282</cve:IntangibleAssets>
    <cve:PropertyPlantAndEquipments contextRef="c215" decimals="0" unitRef="usd">60630</cve:PropertyPlantAndEquipments>
    <cve:PropertyPlantAndEquipments contextRef="c216" decimals="0" unitRef="usd">2273791</cve:PropertyPlantAndEquipments>
    <cve:PropertyPlantAndEquipments contextRef="c2" decimals="0" unitRef="usd">2334421</cve:PropertyPlantAndEquipments>
    <cve:MineralProperties contextRef="c215" decimals="0" unitRef="usd">86220848</cve:MineralProperties>
    <cve:MineralProperties contextRef="c216" decimals="0" unitRef="usd">9144069</cve:MineralProperties>
    <cve:MineralProperties contextRef="c214" decimals="0" unitRef="usd">4905348</cve:MineralProperties>
    <cve:MineralProperties contextRef="c218" decimals="0" unitRef="usd">41754462</cve:MineralProperties>
    <cve:MineralProperties contextRef="c256" decimals="0" unitRef="usd">3194359</cve:MineralProperties>
    <cve:MineralProperties contextRef="c2" decimals="0" unitRef="usd">145219086</cve:MineralProperties>
    <cve:RightofuseAssets1 contextRef="c216" decimals="0" unitRef="usd">168871</cve:RightofuseAssets1>
    <cve:RightofuseAssets1 contextRef="c219" decimals="0" unitRef="usd">16743</cve:RightofuseAssets1>
    <cve:RightofuseAssets1 contextRef="c2" decimals="0" unitRef="usd">185614</cve:RightofuseAssets1>
    <cve:SegmentedInformationBalance contextRef="c215" decimals="0" unitRef="usd">86281478</cve:SegmentedInformationBalance>
    <cve:SegmentedInformationBalance contextRef="c216" decimals="0" unitRef="usd">11709132</cve:SegmentedInformationBalance>
    <cve:SegmentedInformationBalance contextRef="c214" decimals="0" unitRef="usd">5122589</cve:SegmentedInformationBalance>
    <cve:SegmentedInformationBalance contextRef="c218" decimals="0" unitRef="usd">41754462</cve:SegmentedInformationBalance>
    <cve:SegmentedInformationBalance contextRef="c256" decimals="0" unitRef="usd">3382999</cve:SegmentedInformationBalance>
    <cve:SegmentedInformationBalance contextRef="c219" decimals="0" unitRef="usd">16743</cve:SegmentedInformationBalance>
    <cve:SegmentedInformationBalance contextRef="c2" decimals="0" unitRef="usd">148267403</cve:SegmentedInformationBalance>
    <cve:SupplementalDisclosureWithRespectToCashflowsTextBlock contextRef="c0">&lt;table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.25in"/&gt;&lt;td style="width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;19.&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Supplemental
                                            disclosure with respect to cash flows&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;The
Company incurred non-cash financing and investing activities during the years ended December 31, 2022, and December 31, 2021 as follows:&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"/&gt;&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Non-cash financing activities:&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: 0.125in; width: 76%; text-align: left; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Deferred
    financing costs remaining in accounts payable and accrued liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1,513,220&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-313; font-family: Times New Roman, Times, Serif"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1,513,220&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-314; font-family: Times New Roman, Times, Serif"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Non-cash investing activities:&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: 0.125in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Marketable securities
    received on disposition of mineral properties&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;3,051,564&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-315; font-family: Times New Roman, Times, Serif"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-indent: 0.125in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Mineral property costs
    included in accounts payable and accrued liabilities&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;27,040&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-316; font-family: Times New Roman, Times, Serif"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: 0.125in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Property, plant, and
    equipment additions included in accounts payable and accrued liabilities&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;20,090&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-317; font-family: Times New Roman, Times, Serif"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-indent: 0.125in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Fair value of common
    shares issued for Azarga asset acquisition&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-318; font-family: Times New Roman, Times, Serif"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;121,796,381&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: 0.125in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Fair value of replacement
    options issued for Azarga asset acquisition&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-319; font-family: Times New Roman, Times, Serif"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;5,496,037&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-indent: 0.125in; text-align: left; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Fair
    value of replacement warrants issued for Azarga asset acquisition&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-320; font-family: Times New Roman, Times, Serif"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;3,259,306&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;3,098,694&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;130,551,724&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;There
were no amounts paid for income taxes or interest during the years ended December 31, 2022, and December 31, 2021.&lt;/span&gt;&lt;/p&gt;</cve:SupplementalDisclosureWithRespectToCashflowsTextBlock>
    <cve:ScheduleOfIncurredNoncashFinancingAndInvestingActivitiesTableTextBlock contextRef="c0">&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Non-cash financing activities:&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: 0.125in; width: 76%; text-align: left; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Deferred
    financing costs remaining in accounts payable and accrued liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1,513,220&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-313; font-family: Times New Roman, Times, Serif"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1,513,220&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-314; font-family: Times New Roman, Times, Serif"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Non-cash investing activities:&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: 0.125in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Marketable securities
    received on disposition of mineral properties&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;3,051,564&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-315; font-family: Times New Roman, Times, Serif"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-indent: 0.125in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Mineral property costs
    included in accounts payable and accrued liabilities&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;27,040&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-316; font-family: Times New Roman, Times, Serif"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: 0.125in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Property, plant, and
    equipment additions included in accounts payable and accrued liabilities&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;20,090&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-317; font-family: Times New Roman, Times, Serif"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-indent: 0.125in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Fair value of common
    shares issued for Azarga asset acquisition&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-318; font-family: Times New Roman, Times, Serif"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;121,796,381&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: 0.125in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Fair value of replacement
    options issued for Azarga asset acquisition&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-319; font-family: Times New Roman, Times, Serif"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;5,496,037&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-indent: 0.125in; text-align: left; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Fair
    value of replacement warrants issued for Azarga asset acquisition&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-320; font-family: Times New Roman, Times, Serif"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;3,259,306&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;3,098,694&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;130,551,724&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;</cve:ScheduleOfIncurredNoncashFinancingAndInvestingActivitiesTableTextBlock>
    <ifrs-full:CurrentAccruedExpensesAndOtherCurrentLiabilities contextRef="c2" decimals="0" unitRef="usd">1513220</ifrs-full:CurrentAccruedExpensesAndOtherCurrentLiabilities>
    <cve:TotalNoncashFinancingActivities contextRef="c2" decimals="0" unitRef="usd">1513220</cve:TotalNoncashFinancingActivities>
    <cve:MarketableSecuritieReceivedOnDispositionOfMineralProperties contextRef="c2" decimals="0" unitRef="usd">3051564</cve:MarketableSecuritieReceivedOnDispositionOfMineralProperties>
    <ifrs-full:LiabilitiesArisingFromExplorationForAndEvaluationOfMineralResources contextRef="c2" decimals="0" unitRef="usd">27040</ifrs-full:LiabilitiesArisingFromExplorationForAndEvaluationOfMineralResources>
    <cve:PropertyPlantAndEquipmentAdditionIncludedInAccountsPayableAndAccruedLiabilities contextRef="c2" decimals="0" unitRef="usd">20090</cve:PropertyPlantAndEquipmentAdditionIncludedInAccountsPayableAndAccruedLiabilities>
    <cve:FairValueOfCommonSharesIssuedForAzargaAssetAcquisition contextRef="c3" decimals="0" unitRef="usd">121796381</cve:FairValueOfCommonSharesIssuedForAzargaAssetAcquisition>
    <cve:FairValueOfReplacementOptionsIssuedForAzargaAssetsAcquisition contextRef="c3" decimals="0" unitRef="usd">5496037</cve:FairValueOfReplacementOptionsIssuedForAzargaAssetsAcquisition>
    <cve:FairValueOfReplacementWarrantsIssuedForAzargaAssetAcquisition contextRef="c3" decimals="0" unitRef="usd">3259306</cve:FairValueOfReplacementWarrantsIssuedForAzargaAssetAcquisition>
    <cve:TotalNoncashInvestingActivities contextRef="c2" decimals="0" unitRef="usd">3098694</cve:TotalNoncashInvestingActivities>
    <cve:TotalNoncashInvestingActivities contextRef="c3" decimals="0" unitRef="usd">130551724</cve:TotalNoncashInvestingActivities>
    <ifrs-full:DisclosureOfIncomeTaxExplanatory contextRef="c0">&lt;table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.25in"/&gt;&lt;td style="width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;20.&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Income
                                            taxes&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -18pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;The
actual income tax provision differs from the expected amount calculated by applying the Canadian combined federal and provincial corporate
tax rates to income before tax. These differences result from the following:&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-style: normal; text-align: center; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;December
    31,&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 76%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Loss before income tax&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(16,515,389&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(8,563,473&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Statutory income tax
    rate&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;27&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;27&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Expected income tax expense (recovery)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(4,459,155&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(2,312,138&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Increase (decrease) resulting from:&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: 0.125in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Change in unrecognized
    temporary differences&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2,949,101&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1,800,688&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-indent: 0.125in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Permanent differences&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1,159,884&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;433,595&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: 0.125in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Effect of tax rates in
    foreign jurisdictions&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;146,727&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;77,855&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-indent: 0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Share issue costs&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;201,740&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-321; font-family: Times New Roman, Times, Serif"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: 0.125in; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Prior period adjustments&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1,703&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-322; font-family: Times New Roman, Times, Serif"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Income
    tax expense (recovery)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-323; font-family: Times New Roman, Times, Serif"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-324; font-family: Times New Roman, Times, Serif"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;span style="text-decoration:underline"&gt;Recognized
deferred tax assets and liabilities&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Deferred
tax assets are attributable to the following:&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;span style="text-decoration:underline"&gt;Income
tax expense (recovery)&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Deferred tax expense (recovery)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 76%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Organization and reversal of temporary
    differences&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(2,949,101&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(1,800,688&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Change in unrecognized
    temporary differences&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2,949,101&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1,800,688&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Income
    tax expense (recovery)&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-325; font-family: Times New Roman, Times, Serif"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-326; font-family: Times New Roman, Times, Serif"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;2022&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;$&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 76%; text-align: left; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Loss carryforwards&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;488,823&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;52,244&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Deferred tax assets&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;488,823&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;52,244&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Set-off of tax&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(488,823&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(52,244&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Net
    deferred tax assets&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-327; font-family: Times New Roman, Times, Serif"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-328; font-family: Times New Roman, Times, Serif"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Deferred
tax liabilities are attributable to the following:&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 76%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(39,481&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-329; font-family: Times New Roman, Times, Serif"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Right-of-use assets&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(42,472&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(52,244&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Fixed assets&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(276,699&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Right-of-use assets&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(130,171&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-330; font-family: Times New Roman, Times, Serif"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Marketable securities&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(488,823&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(52,244&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Set-off of tax&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;488,823&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;52,244&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Net
    deferred tax liability&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-331; font-family: Times New Roman, Times, Serif"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-332; font-family: Times New Roman, Times, Serif"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;span style="text-decoration:underline"&gt;Unrecognized
deferred tax assets&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 76%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Deductible temporary differences&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;3,920,076&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2,576,276&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Tax losses&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;26,069,552&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;12,754,678&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;29,989,628&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;15,330,954&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;Deferred tax assets have not been recognized
in respect of the above items, because it is not probable that future taxable profit will be available against which the Company can use
the benefits therefrom.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;The Company has Canadian non-capital
loss carryforwards of $28,628,469 (December 31, 2021 - $22,107,188), that will start expiring in 2028 and US federal net operating loss
carryforwards of $21,099,321 (December 31, 2021 - $11,232,201), of which $15,223,100 can be carried forward indefinitely and $5,876,221
that will start expiring in 2027.&lt;/p&gt;</ifrs-full:DisclosureOfIncomeTaxExplanatory>
    <ifrs-full:DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsExplanatory contextRef="c0">&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-style: normal; text-align: center; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;December
    31,&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 76%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Loss before income tax&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(16,515,389&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(8,563,473&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Statutory income tax
    rate&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;27&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;27&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Expected income tax expense (recovery)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(4,459,155&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(2,312,138&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Increase (decrease) resulting from:&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: 0.125in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Change in unrecognized
    temporary differences&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2,949,101&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1,800,688&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-indent: 0.125in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Permanent differences&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1,159,884&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;433,595&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: 0.125in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Effect of tax rates in
    foreign jurisdictions&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;146,727&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;77,855&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-indent: 0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Share issue costs&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;201,740&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-321; font-family: Times New Roman, Times, Serif"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: 0.125in; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Prior period adjustments&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1,703&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-322; font-family: Times New Roman, Times, Serif"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Income
    tax expense (recovery)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-323; font-family: Times New Roman, Times, Serif"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-324; font-family: Times New Roman, Times, Serif"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;</ifrs-full:DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsExplanatory>
    <us-gaap:IncomeLossAttributableToParent contextRef="c0" decimals="0" unitRef="usd">-16515389</us-gaap:IncomeLossAttributableToParent>
    <us-gaap:IncomeLossAttributableToParent contextRef="c5" decimals="0" unitRef="usd">-8563473</us-gaap:IncomeLossAttributableToParent>
    <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate contextRef="c0" decimals="2" unitRef="pure">0.27</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
    <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate contextRef="c5" decimals="2" unitRef="pure">0.27</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
    <cve:ExpectedIncomeTaxExpenserecovery contextRef="c0" decimals="0" unitRef="usd">-4459155</cve:ExpectedIncomeTaxExpenserecovery>
    <cve:ExpectedIncomeTaxExpenserecovery contextRef="c5" decimals="0" unitRef="usd">-2312138</cve:ExpectedIncomeTaxExpenserecovery>
    <cve:ChangeInUnrecognizedTemporaryDifferences contextRef="c0" decimals="0" unitRef="usd">2949101</cve:ChangeInUnrecognizedTemporaryDifferences>
    <cve:ChangeInUnrecognizedTemporaryDifferences contextRef="c5" decimals="0" unitRef="usd">1800688</cve:ChangeInUnrecognizedTemporaryDifferences>
    <ifrs-full:TaxEffectOfExpenseNotDeductibleInDeterminingTaxableProfitTaxLoss contextRef="c0" decimals="0" unitRef="usd">1159884</ifrs-full:TaxEffectOfExpenseNotDeductibleInDeterminingTaxableProfitTaxLoss>
    <ifrs-full:TaxEffectOfExpenseNotDeductibleInDeterminingTaxableProfitTaxLoss contextRef="c5" decimals="0" unitRef="usd">433595</ifrs-full:TaxEffectOfExpenseNotDeductibleInDeterminingTaxableProfitTaxLoss>
    <ifrs-full:TaxEffectOfForeignTaxRates contextRef="c0" decimals="0" unitRef="usd">146727</ifrs-full:TaxEffectOfForeignTaxRates>
    <ifrs-full:TaxEffectOfForeignTaxRates contextRef="c5" decimals="0" unitRef="usd">77855</ifrs-full:TaxEffectOfForeignTaxRates>
    <cve:ShareIssueCosts contextRef="c0" decimals="0" unitRef="usd">201740</cve:ShareIssueCosts>
    <ifrs-full:AdjustmentsForCurrentTaxOfPriorPeriod contextRef="c0" decimals="0" unitRef="usd">1703</ifrs-full:AdjustmentsForCurrentTaxOfPriorPeriod>
    <ifrs-full:DisclosureOfInterestIncomeExplanatory contextRef="c0">&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Deferred tax expense (recovery)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 76%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Organization and reversal of temporary
    differences&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(2,949,101&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(1,800,688&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Change in unrecognized
    temporary differences&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2,949,101&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1,800,688&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Income
    tax expense (recovery)&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-325; font-family: Times New Roman, Times, Serif"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-326; font-family: Times New Roman, Times, Serif"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;2022&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;$&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 76%; text-align: left; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Loss carryforwards&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;488,823&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;52,244&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Deferred tax assets&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;488,823&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;52,244&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Set-off of tax&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(488,823&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(52,244&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Net
    deferred tax assets&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-327; font-family: Times New Roman, Times, Serif"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-328; font-family: Times New Roman, Times, Serif"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;</ifrs-full:DisclosureOfInterestIncomeExplanatory>
    <cve:OrginationAndReversalOfTemporaryDifferences contextRef="c0" decimals="0" unitRef="usd">-2949101</cve:OrginationAndReversalOfTemporaryDifferences>
    <cve:OrginationAndReversalOfTemporaryDifferences contextRef="c5" decimals="0" unitRef="usd">-1800688</cve:OrginationAndReversalOfTemporaryDifferences>
    <cve:ChangeInUnrecognizedTemporaryDifferences contextRef="c0" decimals="0" unitRef="usd">2949101</cve:ChangeInUnrecognizedTemporaryDifferences>
    <cve:ChangeInUnrecognizedTemporaryDifferences contextRef="c5" decimals="0" unitRef="usd">1800688</cve:ChangeInUnrecognizedTemporaryDifferences>
    <us-gaap:DeferredTaxAssetsOtherLossCarryforwards contextRef="c2" decimals="0" unitRef="usd">488823</us-gaap:DeferredTaxAssetsOtherLossCarryforwards>
    <us-gaap:DeferredTaxAssetsOtherLossCarryforwards contextRef="c3" decimals="0" unitRef="usd">52244</us-gaap:DeferredTaxAssetsOtherLossCarryforwards>
    <us-gaap:DeferredTaxAssetsOther contextRef="c2" decimals="0" unitRef="usd">488823</us-gaap:DeferredTaxAssetsOther>
    <us-gaap:DeferredTaxAssetsOther contextRef="c3" decimals="0" unitRef="usd">52244</us-gaap:DeferredTaxAssetsOther>
    <cve:SetoffOfTax contextRef="c0" decimals="0" unitRef="usd">488823</cve:SetoffOfTax>
    <cve:SetoffOfTax contextRef="c5" decimals="0" unitRef="usd">52244</cve:SetoffOfTax>
    <us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock contextRef="c0">&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 76%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(39,481&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-329; font-family: Times New Roman, Times, Serif"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Right-of-use assets&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(42,472&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(52,244&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Fixed assets&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(276,699&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Right-of-use assets&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(130,171&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-330; font-family: Times New Roman, Times, Serif"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Marketable securities&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(488,823&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(52,244&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Set-off of tax&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;488,823&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;52,244&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Net
    deferred tax liability&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-331; font-family: Times New Roman, Times, Serif"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-332; font-family: Times New Roman, Times, Serif"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;</us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock>
    <ifrs-full:OtherIntangibleAssets contextRef="c2" decimals="0" unitRef="usd">39481</ifrs-full:OtherIntangibleAssets>
    <ifrs-full:RightofuseAssetsRevaluedAssetsAtCost contextRef="c2" decimals="0" unitRef="usd">42472</ifrs-full:RightofuseAssetsRevaluedAssetsAtCost>
    <ifrs-full:RightofuseAssetsRevaluedAssetsAtCost contextRef="c3" decimals="0" unitRef="usd">52244</ifrs-full:RightofuseAssetsRevaluedAssetsAtCost>
    <cve:FixedAssets contextRef="c0" decimals="0" unitRef="usd">-276699</cve:FixedAssets>
    <ifrs-full:RightofuseAssetsRevaluationSurplus contextRef="c2" decimals="0" unitRef="usd">130171</ifrs-full:RightofuseAssetsRevaluationSurplus>
    <us-gaap:MarketableSecuritiesCurrent contextRef="c2" decimals="0" unitRef="usd">-488823</us-gaap:MarketableSecuritiesCurrent>
    <us-gaap:MarketableSecuritiesCurrent contextRef="c3" decimals="0" unitRef="usd">-52244</us-gaap:MarketableSecuritiesCurrent>
    <cve:SetoffOfTax contextRef="c0" decimals="0" unitRef="usd">488823</cve:SetoffOfTax>
    <cve:SetoffOfTax contextRef="c5" decimals="0" unitRef="usd">52244</cve:SetoffOfTax>
    <ifrs-full:DisclosureOfDeferredTaxesExplanatory contextRef="c0">&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 76%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Deductible temporary differences&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;3,920,076&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2,576,276&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Tax losses&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;26,069,552&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;12,754,678&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;29,989,628&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;15,330,954&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;</ifrs-full:DisclosureOfDeferredTaxesExplanatory>
    <cve:DeductibleTemporaryDifferences contextRef="c0" decimals="0" unitRef="usd">-3920076</cve:DeductibleTemporaryDifferences>
    <cve:DeductibleTemporaryDifferences contextRef="c5" decimals="0" unitRef="usd">-2576276</cve:DeductibleTemporaryDifferences>
    <ifrs-full:TaxEffectOfTaxLosses contextRef="c0" decimals="0" unitRef="usd">-26069552</ifrs-full:TaxEffectOfTaxLosses>
    <ifrs-full:TaxEffectOfTaxLosses contextRef="c5" decimals="0" unitRef="usd">-12754678</ifrs-full:TaxEffectOfTaxLosses>
    <ifrs-full:ProfitLossBeforeTax contextRef="c0" decimals="0" unitRef="usd">29989628</ifrs-full:ProfitLossBeforeTax>
    <ifrs-full:ProfitLossBeforeTax contextRef="c5" decimals="0" unitRef="usd">15330954</ifrs-full:ProfitLossBeforeTax>
    <cve:NoncapitalLoss contextRef="c0" decimals="0" unitRef="usd">28628469</cve:NoncapitalLoss>
    <cve:NoncapitalLoss contextRef="c5" decimals="0" unitRef="usd">22107188</cve:NoncapitalLoss>
    <cve:FederalNetOperatingLossCarryforwards contextRef="c0" decimals="0" unitRef="usd">21099321</cve:FederalNetOperatingLossCarryforwards>
    <cve:FederalNetOperatingLossCarryforwards contextRef="c5" decimals="0" unitRef="usd">11232201</cve:FederalNetOperatingLossCarryforwards>
    <cve:CarriedForward contextRef="c0" decimals="0" unitRef="usd">15223100</cve:CarriedForward>
    <cve:ExpiringAmount contextRef="c0" decimals="0" unitRef="usd">5876221</cve:ExpiringAmount>
    <ifrs-full:DisclosureOfReclassificationsOrChangesInPresentationExplanatory contextRef="c0">&lt;table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.25in"/&gt;&lt;td style="width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;21.&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Change
                                            in presentation currency &lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;For
comparative purposes, the consolidated statements of financial position as of December 31, 2021 and January 1, 2021 includes adjustments
to reflect the change in accounting policy resulting from the change in presentation currency to the U.S. Dollar. The amounts previously
reported in Canadian Dollars as shown below have been translated into U.S. Dollars at the December 31, 2021 and January 1, 2021 exchange
rates (Note 2). The effect of the translation is as follows:&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="text-decoration:underline"&gt;As at January 1, 2021&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Previously
    reported (CAD$)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Translated
    (USD$)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 76%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Current assets&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;6,926,844&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;5,436,341&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Non-current
    assets&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;16,516,119&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;12,918,903&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Total
    assets&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;23,442,963&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;18,355,244&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;900,300&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;707,056&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Non-current
    liabilities&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;6,674,405&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;5,242,229&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Total
    liabilities&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;7,574,705&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;5,949,285&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;&lt;p style="margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="text-decoration:underline"&gt;As at December 31, 2021&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Previously
    reported (CAD$)&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Translated
    (USD$)&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 76%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Current assets&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;14,651,619&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;11,556,728&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Non-current
    assets&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;187,434,040&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;147,799,796&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Total
    assets&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;202,085,659&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;159,356,524&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;7,510,606&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;5,924,125&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Non-current
    liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;5,507,178&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;4,343,886&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Total
    liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;13,017,784&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;10,268,011&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;For comparative purposes, the consolidated
statements of loss and comprehensive loss for the year ended December 31, 2021 includes adjustments to reflect the change in accounting
policy resulting from the change in presentation currency to the U.S. Dollar. The amounts previously reported in Canadian Dollars as shown
below have been translated into U.S. Dollars at the average 2021 exchange rate (Note 2). The effect of the translation is as follows:&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"/&gt;&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Previously
    reported (CAD$)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Translated
    (USD$)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Expenses&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: 0.125in; width: 76%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Accretion&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;502,291&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;408,181&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-indent: 0.125in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Amortization and depreciation&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;374,455&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;298,666&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: 0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Consulting&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;91,161&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;72,726&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-indent: 0.125in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;General administrative costs&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;4,429,209&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;3,533,474&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: 0.125in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Impairment charges&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;98,345&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;78,456&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-indent: 0.125in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Interest expense&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;9,365&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-333; font-family: Times New Roman, Times, Serif"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: 0.125in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Office and administrative&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;247,433&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;197,391&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-indent: 0.125in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Professional fees&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;728,793&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;581,408&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: 0.125in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Promotion and shareholder communication&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;208,201&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;166,096&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-indent: 0.125in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Reclamation costs&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;889,154&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;709,399&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: 0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Travel&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;33,355&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;26,609&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-indent: 0.125in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Transfer agent and filing fees&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;167,612&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;133,717&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: 0.125in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Staff costs&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1,983,446&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1,582,326&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-indent: 0.125in; text-align: left; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Stock option expense&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1,787,046&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1,425,645&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Loss from operating expenses&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(11,549,866&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(9,214,094&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-indent: 0.125in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Interest income&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;26,307&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;20,987&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: 0.125in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Foreign exchange gain&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;34,174&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;27,263&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-indent: 0.125in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Loss on divestment of mineral properties&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(112,708&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(89,914&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: 0.125in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Gain on change in asset retirement obligation
    estimate&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2,155,949&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1,719,943&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-indent: 0.125in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Loss on contract termination&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(3,447,125&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(2,750,000&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: 0.125in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Unrealized gain on uranium investment&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1,947,939&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1,554,000&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-indent: 0.125in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Gain on sale of uranium investment&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;656,928&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;524,075&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: 0.125in; text-align: left; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Loss on investment in
    associate&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(445,914&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(355,735&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-indent: 0.125in; font-weight: bold; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Net loss for the year&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(10,734,316&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(8,563,475&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: 0.125in; text-align: left; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Exchange differences
    on translation foreign operations&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;206,082&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(1,325,855&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Other
    comprehensive loss for the year&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(10,528,234&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(9,889,330&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-335; -sec-ix-hidden: hidden-fact-334; font-family: Times New Roman, Times, Serif"&gt;Loss per share - basic and diluted&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(0.05&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(0.13&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</ifrs-full:DisclosureOfReclassificationsOrChangesInPresentationExplanatory>
    <ifrs-full:DescriptionOfAccountingPolicyForForeignCurrencyTranslationExplanatory contextRef="c0">&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="text-decoration:underline"&gt;As at January 1, 2021&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Previously
    reported (CAD$)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Translated
    (USD$)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 76%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Current assets&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;6,926,844&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;5,436,341&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Non-current
    assets&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;16,516,119&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;12,918,903&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Total
    assets&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;23,442,963&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;18,355,244&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;900,300&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;707,056&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Non-current
    liabilities&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;6,674,405&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;5,242,229&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Total
    liabilities&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;7,574,705&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;5,949,285&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;&lt;p style="margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="text-decoration:underline"&gt;As at December 31, 2021&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Previously
    reported (CAD$)&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Translated
    (USD$)&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 76%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Current assets&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;14,651,619&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;11,556,728&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Non-current
    assets&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;187,434,040&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;147,799,796&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Total
    assets&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;202,085,659&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;159,356,524&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;7,510,606&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;5,924,125&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Non-current
    liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;5,507,178&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;4,343,886&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Total
    liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;13,017,784&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;10,268,011&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;</ifrs-full:DescriptionOfAccountingPolicyForForeignCurrencyTranslationExplanatory>
    <ifrs-full:CurrentAssets contextRef="c257" decimals="0" unitRef="cad">6926844</ifrs-full:CurrentAssets>
    <ifrs-full:CurrentAssets contextRef="c258" decimals="0" unitRef="usd">5436341</ifrs-full:CurrentAssets>
    <ifrs-full:NoncurrentAssets contextRef="c257" decimals="0" unitRef="cad">16516119</ifrs-full:NoncurrentAssets>
    <ifrs-full:NoncurrentAssets contextRef="c258" decimals="0" unitRef="usd">12918903</ifrs-full:NoncurrentAssets>
    <ifrs-full:Assets contextRef="c257" decimals="0" unitRef="cad">23442963</ifrs-full:Assets>
    <ifrs-full:Assets contextRef="c258" decimals="0" unitRef="usd">18355244</ifrs-full:Assets>
    <ifrs-full:CurrentLiabilities contextRef="c257" decimals="0" unitRef="cad">900300</ifrs-full:CurrentLiabilities>
    <ifrs-full:CurrentLiabilities contextRef="c258" decimals="0" unitRef="usd">707056</ifrs-full:CurrentLiabilities>
    <ifrs-full:NoncurrentLiabilities contextRef="c257" decimals="0" unitRef="cad">6674405</ifrs-full:NoncurrentLiabilities>
    <ifrs-full:NoncurrentLiabilities contextRef="c258" decimals="0" unitRef="usd">5242229</ifrs-full:NoncurrentLiabilities>
    <ifrs-full:Liabilities contextRef="c257" decimals="0" unitRef="cad">7574705</ifrs-full:Liabilities>
    <ifrs-full:Liabilities contextRef="c258" decimals="0" unitRef="usd">5949285</ifrs-full:Liabilities>
    <ifrs-full:CurrentAssets contextRef="c259" decimals="0" unitRef="cad">14651619</ifrs-full:CurrentAssets>
    <ifrs-full:CurrentAssets contextRef="c260" decimals="0" unitRef="usd">11556728</ifrs-full:CurrentAssets>
    <ifrs-full:NoncurrentAssets contextRef="c259" decimals="0" unitRef="cad">187434040</ifrs-full:NoncurrentAssets>
    <ifrs-full:NoncurrentAssets contextRef="c260" decimals="0" unitRef="usd">147799796</ifrs-full:NoncurrentAssets>
    <ifrs-full:Assets contextRef="c259" decimals="0" unitRef="cad">202085659</ifrs-full:Assets>
    <ifrs-full:Assets contextRef="c260" decimals="0" unitRef="usd">159356524</ifrs-full:Assets>
    <ifrs-full:CurrentLiabilities contextRef="c259" decimals="0" unitRef="cad">7510606</ifrs-full:CurrentLiabilities>
    <ifrs-full:CurrentLiabilities contextRef="c260" decimals="0" unitRef="usd">5924125</ifrs-full:CurrentLiabilities>
    <ifrs-full:NoncurrentLiabilities contextRef="c259" decimals="0" unitRef="cad">5507178</ifrs-full:NoncurrentLiabilities>
    <ifrs-full:NoncurrentLiabilities contextRef="c260" decimals="0" unitRef="usd">4343886</ifrs-full:NoncurrentLiabilities>
    <ifrs-full:Liabilities contextRef="c259" decimals="0" unitRef="cad">13017784</ifrs-full:Liabilities>
    <ifrs-full:Liabilities contextRef="c260" decimals="0" unitRef="usd">10268011</ifrs-full:Liabilities>
    <ifrs-full:DisclosureOfFinancialInstrumentsAtFairValueThroughProfitOrLossExplanatory contextRef="c0">&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Previously
    reported (CAD$)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Translated
    (USD$)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Expenses&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: 0.125in; width: 76%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Accretion&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;502,291&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;408,181&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-indent: 0.125in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Amortization and depreciation&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;374,455&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;298,666&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: 0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Consulting&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;91,161&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;72,726&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-indent: 0.125in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;General administrative costs&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;4,429,209&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;3,533,474&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: 0.125in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Impairment charges&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;98,345&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;78,456&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-indent: 0.125in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Interest expense&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;9,365&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-333; font-family: Times New Roman, Times, Serif"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: 0.125in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Office and administrative&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;247,433&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;197,391&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-indent: 0.125in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Professional fees&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;728,793&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;581,408&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: 0.125in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Promotion and shareholder communication&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;208,201&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;166,096&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-indent: 0.125in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Reclamation costs&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;889,154&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;709,399&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: 0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Travel&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;33,355&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;26,609&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-indent: 0.125in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Transfer agent and filing fees&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;167,612&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;133,717&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: 0.125in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Staff costs&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1,983,446&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1,582,326&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-indent: 0.125in; text-align: left; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Stock option expense&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1,787,046&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1,425,645&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Loss from operating expenses&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(11,549,866&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(9,214,094&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-indent: 0.125in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Interest income&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;26,307&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;20,987&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: 0.125in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Foreign exchange gain&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;34,174&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;27,263&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-indent: 0.125in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Loss on divestment of mineral properties&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(112,708&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(89,914&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: 0.125in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Gain on change in asset retirement obligation
    estimate&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2,155,949&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1,719,943&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-indent: 0.125in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Loss on contract termination&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(3,447,125&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(2,750,000&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: 0.125in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Unrealized gain on uranium investment&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1,947,939&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1,554,000&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-indent: 0.125in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Gain on sale of uranium investment&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;656,928&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;524,075&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: 0.125in; text-align: left; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Loss on investment in
    associate&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(445,914&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(355,735&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-indent: 0.125in; font-weight: bold; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Net loss for the year&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(10,734,316&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(8,563,475&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: 0.125in; text-align: left; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Exchange differences
    on translation foreign operations&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;206,082&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(1,325,855&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Other
    comprehensive loss for the year&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(10,528,234&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(9,889,330&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-335; -sec-ix-hidden: hidden-fact-334; font-family: Times New Roman, Times, Serif"&gt;Loss per share - basic and diluted&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(0.05&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(0.13&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</ifrs-full:DisclosureOfFinancialInstrumentsAtFairValueThroughProfitOrLossExplanatory>
    <cve:Accretion contextRef="c261" decimals="0" unitRef="cad">502291</cve:Accretion>
    <cve:Accretion contextRef="c262" decimals="0" unitRef="usd">408181</cve:Accretion>
    <ifrs-full:AdjustmentsForDepreciationAndAmortisationExpense contextRef="c261" decimals="0" unitRef="cad">374455</ifrs-full:AdjustmentsForDepreciationAndAmortisationExpense>
    <ifrs-full:AdjustmentsForDepreciationAndAmortisationExpense contextRef="c262" decimals="0" unitRef="usd">298666</ifrs-full:AdjustmentsForDepreciationAndAmortisationExpense>
    <cve:Consulting contextRef="c261" decimals="0" unitRef="cad">91161</cve:Consulting>
    <cve:Consulting contextRef="c262" decimals="0" unitRef="usd">72726</cve:Consulting>
    <ifrs-full:AdministrativeExpense contextRef="c261" decimals="0" unitRef="cad">4429209</ifrs-full:AdministrativeExpense>
    <ifrs-full:AdministrativeExpense contextRef="c262" decimals="0" unitRef="usd">3533474</ifrs-full:AdministrativeExpense>
    <cve:ImpairmentCharges contextRef="c261" decimals="0" unitRef="cad">98345</cve:ImpairmentCharges>
    <cve:ImpairmentCharges contextRef="c262" decimals="0" unitRef="usd">78456</cve:ImpairmentCharges>
    <ifrs-full:InterestExpense contextRef="c261" decimals="0" unitRef="cad">9365</ifrs-full:InterestExpense>
    <cve:OfficeAndAdministrative contextRef="c261" decimals="0" unitRef="cad">247433</cve:OfficeAndAdministrative>
    <cve:OfficeAndAdministrative contextRef="c262" decimals="0" unitRef="usd">197391</cve:OfficeAndAdministrative>
    <ifrs-full:ProfessionalFeesExpense contextRef="c261" decimals="0" unitRef="cad">728793</ifrs-full:ProfessionalFeesExpense>
    <ifrs-full:ProfessionalFeesExpense contextRef="c262" decimals="0" unitRef="usd">581408</ifrs-full:ProfessionalFeesExpense>
    <ifrs-full:OtherExpenseByNature contextRef="c261" decimals="0" unitRef="cad">208201</ifrs-full:OtherExpenseByNature>
    <ifrs-full:OtherExpenseByNature contextRef="c262" decimals="0" unitRef="usd">166096</ifrs-full:OtherExpenseByNature>
    <cve:ReclamationCosts contextRef="c261" decimals="0" unitRef="cad">889154</cve:ReclamationCosts>
    <cve:ReclamationCosts contextRef="c262" decimals="0" unitRef="usd">709399</cve:ReclamationCosts>
    <ifrs-full:TravelExpense contextRef="c261" decimals="0" unitRef="cad">33355</ifrs-full:TravelExpense>
    <ifrs-full:TravelExpense contextRef="c262" decimals="0" unitRef="usd">26609</ifrs-full:TravelExpense>
    <cve:TransferAgentAndFilingFees contextRef="c261" decimals="0" unitRef="cad">167612</cve:TransferAgentAndFilingFees>
    <cve:TransferAgentAndFilingFees contextRef="c262" decimals="0" unitRef="usd">133717</cve:TransferAgentAndFilingFees>
    <cve:StaffCosts contextRef="c261" decimals="0" unitRef="cad">1983446</cve:StaffCosts>
    <cve:StaffCosts contextRef="c262" decimals="0" unitRef="usd">1582326</cve:StaffCosts>
    <us-gaap:StockOptionPlanExpense contextRef="c261" decimals="0" unitRef="cad">1787046</us-gaap:StockOptionPlanExpense>
    <us-gaap:StockOptionPlanExpense contextRef="c262" decimals="0" unitRef="usd">1425645</us-gaap:StockOptionPlanExpense>
    <ifrs-full:OtherOperatingIncomeExpense contextRef="c261" decimals="0" unitRef="cad">-11549866</ifrs-full:OtherOperatingIncomeExpense>
    <ifrs-full:OtherOperatingIncomeExpense contextRef="c262" decimals="0" unitRef="usd">-9214094</ifrs-full:OtherOperatingIncomeExpense>
    <ifrs-full:InterestRevenueExpense contextRef="c261" decimals="0" unitRef="cad">26307</ifrs-full:InterestRevenueExpense>
    <ifrs-full:InterestRevenueExpense contextRef="c262" decimals="0" unitRef="usd">20987</ifrs-full:InterestRevenueExpense>
    <ifrs-full:ForeignExchangeGain contextRef="c261" decimals="0" unitRef="cad">34174</ifrs-full:ForeignExchangeGain>
    <ifrs-full:ForeignExchangeGain contextRef="c262" decimals="0" unitRef="usd">27263</ifrs-full:ForeignExchangeGain>
    <cve:LossesOnDivestmentOfMineralProperties contextRef="c261" decimals="0" unitRef="cad">112708</cve:LossesOnDivestmentOfMineralProperties>
    <cve:LossesOnDivestmentOfMineralProperties contextRef="c262" decimals="0" unitRef="usd">89914</cve:LossesOnDivestmentOfMineralProperties>
    <cve:GainOnChangeInAssetRetirementObligationEstimate contextRef="c261" decimals="0" unitRef="cad">2155949</cve:GainOnChangeInAssetRetirementObligationEstimate>
    <cve:GainOnChangeInAssetRetirementObligationEstimate contextRef="c262" decimals="0" unitRef="usd">1719943</cve:GainOnChangeInAssetRetirementObligationEstimate>
    <us-gaap:LossOnContractTermination contextRef="c261" decimals="0" unitRef="cad">3447125</us-gaap:LossOnContractTermination>
    <us-gaap:LossOnContractTermination contextRef="c262" decimals="0" unitRef="usd">2750000</us-gaap:LossOnContractTermination>
    <cve:UnrealizedGainOnUraniumInvestment contextRef="c261" decimals="0" unitRef="cad">1947939</cve:UnrealizedGainOnUraniumInvestment>
    <cve:UnrealizedGainOnUraniumInvestment contextRef="c262" decimals="0" unitRef="usd">1554000</cve:UnrealizedGainOnUraniumInvestment>
    <ifrs-full:GainsOnDisposalsOfInvestmentProperties contextRef="c261" decimals="0" unitRef="cad">656928</ifrs-full:GainsOnDisposalsOfInvestmentProperties>
    <ifrs-full:GainsOnDisposalsOfInvestmentProperties contextRef="c262" decimals="0" unitRef="usd">524075</ifrs-full:GainsOnDisposalsOfInvestmentProperties>
    <cve:LossOnInvestmentInAssociate contextRef="c261" decimals="0" unitRef="cad">445914</cve:LossOnInvestmentInAssociate>
    <cve:LossOnInvestmentInAssociate contextRef="c262" decimals="0" unitRef="usd">355735</cve:LossOnInvestmentInAssociate>
    <ifrs-full:NetForeignExchangeLoss contextRef="c261" decimals="0" unitRef="cad">10734316</ifrs-full:NetForeignExchangeLoss>
    <ifrs-full:NetForeignExchangeLoss contextRef="c262" decimals="0" unitRef="usd">8563475</ifrs-full:NetForeignExchangeLoss>
    <ifrs-full:OtherComprehensiveIncomeBeforeTaxExchangeDifferencesOnTranslation contextRef="c261" decimals="0" unitRef="cad">206082</ifrs-full:OtherComprehensiveIncomeBeforeTaxExchangeDifferencesOnTranslation>
    <ifrs-full:OtherComprehensiveIncomeBeforeTaxExchangeDifferencesOnTranslation contextRef="c262" decimals="0" unitRef="usd">-1325855</ifrs-full:OtherComprehensiveIncomeBeforeTaxExchangeDifferencesOnTranslation>
    <ifrs-full:ReversalOfImpairmentLossRecognisedInOtherComprehensiveIncome contextRef="c261" decimals="0" unitRef="cad">10528234</ifrs-full:ReversalOfImpairmentLossRecognisedInOtherComprehensiveIncome>
    <ifrs-full:ReversalOfImpairmentLossRecognisedInOtherComprehensiveIncome contextRef="c262" decimals="0" unitRef="usd">9889330</ifrs-full:ReversalOfImpairmentLossRecognisedInOtherComprehensiveIncome>
    <ifrs-full:BasicEarningsLossPerShare contextRef="c261" decimals="2" unitRef="cadPershares">-0.05</ifrs-full:BasicEarningsLossPerShare>
    <ifrs-full:BasicEarningsLossPerShare contextRef="c262" decimals="2" unitRef="usdPershares">-0.13</ifrs-full:BasicEarningsLossPerShare>
    <ifrs-full:DisclosureOfEventsAfterReportingPeriodExplanatory contextRef="c0">&lt;table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0.25in"/&gt;&lt;td style="width: 0.25in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;22.&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Events
                                            after the reporting period&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Subsequent
to December 31, 2022, the following reportable events were completed:&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 36pt"/&gt;&lt;td style="width: 18pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;(a)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;On February 14&lt;sup&gt;th&lt;/sup&gt;, the Company completed its acquisition of the Alta Mesa project, a fully-licensed and constructed ISR processing facility, from Energy Fuels, Inc. Consideration paid to Energy Fuels, Inc in the transaction consisted of $60,000,000 in cash and a $60,000,000 secured vendor take-back convertible promissory note. The note has a two year term and bears interest at a rate of 8% per annum payable on June 30&lt;sup&gt;th&lt;/sup&gt; and December 31&lt;sup&gt;st &lt;/sup&gt;of each year during the term. The note is convertible at the election of the holder, to acquire common shares of enCore at a price of US$2.9103 per share.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54pt; text-align: justify; text-indent: -18pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 36pt"/&gt;&lt;td style="width: 18pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;(b)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;In connection with the closing of the Alta Mesa Acquisition, 23,277,000 subscription receipts issued December 6, 2022 at a price of C$3.00 were automatically converted into units comprised of one common share of the Company and one common share purchase warrant, with each warrant entitling the holder to acquire one common share of enCore at a price of C$3.75 for a period of three years. The net proceeds from the Subscription Receipt Offering of $49,392,680 (CAD $66,072,588), have been released from escrow to the Company.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54pt; text-align: justify; text-indent: -18pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;On
February 8, 2023, the Company issued 10,615,650 units for a public offering at a price of C$3.25 per unit for gross proceeds of C$34,500,863.
Each unit consisted of one common share and one-half share purchase warrant. Each whole warrant entitles the holder to purchase one additional
share at a price of C$4.05 for a period of three years.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 36pt"/&gt;&lt;td style="width: 18pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;(c)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Subsequent to the year ended December 31, 2022 the Company issued 229,946 shares pursuant to the exercise of stock options for gross proceeds of $391,958 CAD.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54pt; text-align: justify; text-indent: -18pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Subsequent
to the year ended December 31, 2022 75,312 stock options outstanding at December 31, 2022 have expired.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 36pt"/&gt;&lt;td style="width: 18pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;(d)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Subsequent to the year ended December 31, 2022 the Company issued 162,707 shares pursuant to the exercise of warrants for gross proceeds of $312,985 CAD.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54pt; text-align: justify; text-indent: -18pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 36pt"/&gt;&lt;td style="width: 18pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;(e)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Subsequent to year ended December 31, 2022 the Company granted 121,681 stock options to employees at a weighted average exercise price of C$2.91&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54pt; text-align: justify; text-indent: -18pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 36pt"/&gt;&lt;td style="width: 18pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;(f)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;On January 13&lt;sup&gt;th&lt;/sup&gt;, 2023, the Company purchased 100,000 lbs of uranium for $5,922,500 in an arm&#x2019;s length transaction.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54pt; text-align: justify; text-indent: -18pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 36pt"/&gt;&lt;td style="width: 18pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;(g)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;On January 16&lt;sup&gt;th&lt;/sup&gt;, 2023, the Company completed the sale of 100,000 lbs of uranium for $7,050,000 to the United States Department of Energy, National Nuclear Security Administration.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54pt; text-align: justify; text-indent: -18pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 36pt"/&gt;&lt;td style="width: 18pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;(h)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;In February of 2023, the Company secured an additional sales contract with a Fortune 500 listed United States Utility. The agreement commences in 2027 and covers firm deliveries of 650,000 pounds of uranium with an option to acquire up to 400,000 additional pounds under a two-year extended term. The agreement is based on market pricing with a floor price and an inflation adjusted ceiling price.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54pt; text-align: justify; text-indent: -18pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 36pt"/&gt;&lt;td style="width: 18pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;(i)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;In March of 2023, the Company completed its purchase of 200,000 pounds of uranium concentrate from an arm&#x2019;s length party for total consideration of $8,750,000 ($43.75/pound). The contract required an initial payment of $2,000,000, which was paid in March 2022, and final payment of $6,750,000 paid in March 2023.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54pt; text-align: justify; text-indent: -18pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 36pt"/&gt;&lt;td style="width: 18pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;(j)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;In April of 2023, the Company completed the sale of 200,000 lbs of uranium pursuant to a sales contract with UG USA,&#160;Inc. (Note 13) for gross proceeds of $9,660,000.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54pt; text-align: justify; text-indent: -18pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 36pt"/&gt;&lt;td style="width: 18pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;(k)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;In March of 2023, the Company completed its divestment of Belt Line Resources, Inc and Hydro Restoration Corporation, which held the Company&#x2019;s Moonshine, Bootheel, and Kaycee projects (Note 11). In return for these assets the Company received 19.9% of Nuclear Fuels, Inc.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</ifrs-full:DisclosureOfEventsAfterReportingPeriodExplanatory>
    <cve:TransactionCosts contextRef="c263" decimals="0" unitRef="usd">60000000</cve:TransactionCosts>
    <ifrs-full:Cash contextRef="c263" decimals="0" unitRef="usd">60000000</ifrs-full:Cash>
    <ifrs-full:BorrowingsInterestRate contextRef="c264" decimals="2" unitRef="pure">0.08</ifrs-full:BorrowingsInterestRate>
    <cve:AcquireCommonShare contextRef="c265" decimals="4" unitRef="usd">2.9103</cve:AcquireCommonShare>
    <ifrs-full:SubscriptionCirculationRevenue contextRef="c266" decimals="0" unitRef="usd">23277000</ifrs-full:SubscriptionCirculationRevenue>
    <cve:Saleofstockpershare contextRef="c267" decimals="2" unitRef="cadPershares">3</cve:Saleofstockpershare>
    <cve:PricePerShare contextRef="c267" decimals="2" unitRef="cadPershares">3.75</cve:PricePerShare>
    <us-gaap:ProceedsFromDebtNetOfIssuanceCosts contextRef="c267" decimals="0" unitRef="usd">49392680</us-gaap:ProceedsFromDebtNetOfIssuanceCosts>
    <us-gaap:ProceedsFromDebtNetOfIssuanceCosts contextRef="c267" decimals="0" unitRef="cad">66072588</us-gaap:ProceedsFromDebtNetOfIssuanceCosts>
    <ifrs-full:NumberOfSharesIssued contextRef="c268" decimals="0" unitRef="shares">10615650</ifrs-full:NumberOfSharesIssued>
    <cve:PublicOfferingPricePerShare contextRef="c269" decimals="2" unitRef="cadPershares">3.25</cve:PublicOfferingPricePerShare>
    <cve:GrossProceed contextRef="c269" decimals="0" unitRef="cad">34500863</cve:GrossProceed>
    <cve:PurchasePricePerShare contextRef="c270" decimals="2" unitRef="cadPershares">4.05</cve:PurchasePricePerShare>
    <ifrs-full:NumberOfSharesIssued contextRef="c271" decimals="0" unitRef="shares">229946</ifrs-full:NumberOfSharesIssued>
    <cve:GrossProceed contextRef="c272" decimals="0" unitRef="cad">391958</cve:GrossProceed>
    <cve:StockOptionsSharesOutstanding contextRef="c273" decimals="0" unitRef="shares">75312</cve:StockOptionsSharesOutstanding>
    <ifrs-full:NumberOfSharesIssued contextRef="c274" decimals="0" unitRef="shares">162707</ifrs-full:NumberOfSharesIssued>
    <cve:GrossProceed contextRef="c275" decimals="0" unitRef="cad">312985</cve:GrossProceed>
    <cve:GrantedStockOptions contextRef="c276" decimals="0" unitRef="shares">121681</cve:GrantedStockOptions>
    <cve:WeightedAverageExercisePrice contextRef="c276" decimals="2" unitRef="cadPershares">2.91</cve:WeightedAverageExercisePrice>
    <cve:PurchasedShares contextRef="c277" decimals="0" unitRef="shares">100000</cve:PurchasedShares>
    <cve:TransactionCost contextRef="c277" decimals="0" unitRef="usd">5922500</cve:TransactionCost>
    <ifrs-full:NumberOfSharesIssued contextRef="c278" decimals="0" unitRef="shares">100000</ifrs-full:NumberOfSharesIssued>
    <cve:TransactionCost contextRef="c279" decimals="0" unitRef="usd">7050000</cve:TransactionCost>
    <cve:PurchaseAgreementsAmount contextRef="c280" decimals="0" unitRef="usd">650000</cve:PurchaseAgreementsAmount>
    <cve:OptionToAcquireShares contextRef="c280" decimals="0" unitRef="shares">400000</cve:OptionToAcquireShares>
    <cve:PurchasedShares contextRef="c281" decimals="0" unitRef="shares">200000</cve:PurchasedShares>
    <ifrs-full:ConsiderationPaidReceived contextRef="c281" decimals="0" unitRef="usd">8750000</ifrs-full:ConsiderationPaidReceived>
    <cve:TotalConsiderationPerPounds contextRef="c281" decimals="2" unitRef="usdPershares">43.75</cve:TotalConsiderationPerPounds>
    <cve:InitialPayment contextRef="c65" decimals="0" unitRef="usd">2000000</cve:InitialPayment>
    <cve:PaymentAmount contextRef="c65" decimals="0" unitRef="usd">6750000</cve:PaymentAmount>
    <ifrs-full:NumberOfSharesIssued contextRef="c282" decimals="0" unitRef="shares">200000</ifrs-full:NumberOfSharesIssued>
    <cve:GrossProceed contextRef="c283" decimals="0" unitRef="usd">9660000</cve:GrossProceed>
    <cve:AssetsReceivedPercentage contextRef="c281" decimals="3" unitRef="pure">0.199</cve:AssetsReceivedPercentage>
    <cve:MarketableSecuritiecurrent
      contextRef="c3"
      id="hidden-fact-0"
      unitRef="usd"
      xsi:nil="true"/>
    <cve:MarketableSecuritiecurrent
      contextRef="c4"
      id="hidden-fact-1"
      unitRef="usd"
      xsi:nil="true"/>
    <cve:DepositUraniumInvestment
      contextRef="c3"
      id="hidden-fact-2"
      unitRef="usd"
      xsi:nil="true"/>
    <cve:DepositUraniumInvestment
      contextRef="c4"
      id="hidden-fact-3"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:NoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSaleOrAsHeldForDistributionToOwners
      contextRef="c4"
      id="hidden-fact-4"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:InvestmentsInAssociates
      contextRef="c2"
      id="hidden-fact-5"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:InvestmentsInSubsidiariesJointVenturesAndAssociates
      contextRef="c2"
      id="hidden-fact-6"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:InvestmentsInSubsidiariesJointVenturesAndAssociates
      contextRef="c4"
      id="hidden-fact-7"
      unitRef="usd"
      xsi:nil="true"/>
    <cve:MarketablesSecuritiesNoncurrent
      contextRef="c3"
      id="hidden-fact-8"
      unitRef="usd"
      xsi:nil="true"/>
    <cve:MarketablesSecuritiesNoncurrent
      contextRef="c4"
      id="hidden-fact-9"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:DeferredTaxAssets
      contextRef="c3"
      id="hidden-fact-10"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:DeferredTaxAssets
      contextRef="c4"
      id="hidden-fact-11"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:NoncurrentFinancialAssets
      contextRef="c3"
      id="hidden-fact-12"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:NoncurrentFinancialAssets
      contextRef="c4"
      id="hidden-fact-13"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:OtherCurrentPayables
      contextRef="c2"
      id="hidden-fact-14"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:OtherCurrentPayables
      contextRef="c3"
      id="hidden-fact-15"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:SharePremium
      contextRef="c3"
      id="hidden-fact-16"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:SharePremium
      contextRef="c4"
      id="hidden-fact-17"
      unitRef="usd"
      xsi:nil="true"/>
    <cve:CommunityEngagement
      contextRef="c5"
      id="hidden-fact-18"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:ImpairmentLossImpairmentGainAndReversalOfImpairmentLossDeterminedInAccordanceWithIFRS9
      contextRef="c0"
      id="hidden-fact-19"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:InterestExpense
      contextRef="c5"
      id="hidden-fact-20"
      unitRef="usd"
      xsi:nil="true"/>
    <cve:ProjectInvestigationFess
      contextRef="c5"
      id="hidden-fact-21"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:ReclassificationAdjustmentsOnChangeInValueOfForwardElementsOfForwardContractsNetOfTax
      contextRef="c0"
      id="hidden-fact-22"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:DilutedEarningsLossPerShare
      contextRef="c5"
      decimals="2"
      id="hidden-fact-23"
      unitRef="usdPershares">-0.13</ifrs-full:DilutedEarningsLossPerShare>
    <ifrs-full:DilutedEarningsLossPerShare
      contextRef="c0"
      decimals="2"
      id="hidden-fact-24"
      unitRef="usdPershares">-0.16</ifrs-full:DilutedEarningsLossPerShare>
    <ifrs-full:Equity
      contextRef="c8"
      id="hidden-fact-25"
      unitRef="usd"
      xsi:nil="true"/>
    <cve:PrivatePlacement
      contextRef="c13"
      id="hidden-fact-26"
      unitRef="usd"
      xsi:nil="true"/>
    <cve:PrivatePlacement
      contextRef="c14"
      id="hidden-fact-27"
      unitRef="usd"
      xsi:nil="true"/>
    <cve:PrivatePlacement
      contextRef="c15"
      id="hidden-fact-28"
      unitRef="usd"
      xsi:nil="true"/>
    <cve:PrivatePlacement
      contextRef="c16"
      id="hidden-fact-29"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:ShareIssueRelatedCost
      contextRef="c13"
      id="hidden-fact-30"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:ShareIssueRelatedCost
      contextRef="c15"
      id="hidden-fact-31"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:ShareIssueRelatedCost
      contextRef="c16"
      id="hidden-fact-32"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:IncreaseDecreaseThroughExerciseOfWarrantsEquity
      contextRef="c13"
      id="hidden-fact-33"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:IncreaseDecreaseThroughExerciseOfWarrantsEquity
      contextRef="c15"
      id="hidden-fact-34"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:IncreaseDecreaseThroughExerciseOfWarrantsEquity
      contextRef="c16"
      id="hidden-fact-35"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:IncreaseDecreaseThroughExerciseOfOptions
      contextRef="c13"
      id="hidden-fact-36"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:IncreaseDecreaseThroughExerciseOfOptions
      contextRef="c15"
      id="hidden-fact-37"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:IncreaseDecreaseThroughExerciseOfOptions
      contextRef="c16"
      id="hidden-fact-38"
      unitRef="usd"
      xsi:nil="true"/>
    <cve:StockOptionExpense
      contextRef="c12"
      id="hidden-fact-39"
      unitRef="usd"
      xsi:nil="true"/>
    <cve:StockOptionExpense
      contextRef="c13"
      id="hidden-fact-40"
      unitRef="usd"
      xsi:nil="true"/>
    <cve:StockOptionExpense
      contextRef="c15"
      id="hidden-fact-41"
      unitRef="usd"
      xsi:nil="true"/>
    <cve:StockOptionExpense
      contextRef="c16"
      id="hidden-fact-42"
      unitRef="usd"
      xsi:nil="true"/>
    <cve:SharesIssuedForAzargaAssetAcquisition
      contextRef="c13"
      id="hidden-fact-43"
      unitRef="usd"
      xsi:nil="true"/>
    <cve:SharesIssuedForAzargaAssetAcquisition
      contextRef="c14"
      id="hidden-fact-44"
      unitRef="usd"
      xsi:nil="true"/>
    <cve:SharesIssuedForAzargaAssetAcquisition
      contextRef="c15"
      id="hidden-fact-45"
      unitRef="usd"
      xsi:nil="true"/>
    <cve:SharesIssuedForAzargaAssetAcquisition
      contextRef="c16"
      id="hidden-fact-46"
      unitRef="usd"
      xsi:nil="true"/>
    <cve:ReplacementOptionsForAzargaAssetAcquisition
      contextRef="c12"
      id="hidden-fact-47"
      unitRef="usd"
      xsi:nil="true"/>
    <cve:ReplacementOptionsForAzargaAssetAcquisition
      contextRef="c13"
      id="hidden-fact-48"
      unitRef="usd"
      xsi:nil="true"/>
    <cve:ReplacementOptionsForAzargaAssetAcquisition
      contextRef="c15"
      id="hidden-fact-49"
      unitRef="usd"
      xsi:nil="true"/>
    <cve:ReplacementOptionsForAzargaAssetAcquisition
      contextRef="c16"
      id="hidden-fact-50"
      unitRef="usd"
      xsi:nil="true"/>
    <cve:ReplacementWarrantsForAzargaAssetAcquisition
      contextRef="c12"
      id="hidden-fact-51"
      unitRef="usd"
      xsi:nil="true"/>
    <cve:ReplacementWarrantsForAzargaAssetAcquisition
      contextRef="c13"
      id="hidden-fact-52"
      unitRef="usd"
      xsi:nil="true"/>
    <cve:ReplacementWarrantsForAzargaAssetAcquisition
      contextRef="c15"
      id="hidden-fact-53"
      unitRef="usd"
      xsi:nil="true"/>
    <cve:ReplacementWarrantsForAzargaAssetAcquisition
      contextRef="c16"
      id="hidden-fact-54"
      unitRef="usd"
      xsi:nil="true"/>
    <cve:AdjustmentToInvestmentInAssociate
      contextRef="c12"
      id="hidden-fact-55"
      unitRef="usd"
      xsi:nil="true"/>
    <cve:AdjustmentToInvestmentInAssociate
      contextRef="c13"
      id="hidden-fact-56"
      unitRef="usd"
      xsi:nil="true"/>
    <cve:AdjustmentToInvestmentInAssociate
      contextRef="c15"
      id="hidden-fact-57"
      unitRef="usd"
      xsi:nil="true"/>
    <cve:AdjustmentToInvestmentInAssociate
      contextRef="c16"
      id="hidden-fact-58"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:GainsLossesOnExchangeDifferencesOnTranslationNetOfTax
      contextRef="c12"
      id="hidden-fact-59"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:GainsLossesOnExchangeDifferencesOnTranslationNetOfTax
      contextRef="c13"
      id="hidden-fact-60"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:GainsLossesOnExchangeDifferencesOnTranslationNetOfTax
      contextRef="c14"
      id="hidden-fact-61"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:GainsLossesOnExchangeDifferencesOnTranslationNetOfTax
      contextRef="c16"
      id="hidden-fact-62"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:ProfitLoss
      contextRef="c12"
      id="hidden-fact-63"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:ProfitLoss
      contextRef="c13"
      id="hidden-fact-64"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:ProfitLoss
      contextRef="c14"
      id="hidden-fact-65"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:ProfitLoss
      contextRef="c15"
      id="hidden-fact-66"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:Equity
      contextRef="c18"
      id="hidden-fact-67"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:Equity
      contextRef="c18"
      id="hidden-fact-68"
      unitRef="usd"
      xsi:nil="true"/>
    <cve:PrivatePlacement
      contextRef="c23"
      id="hidden-fact-69"
      unitRef="usd"
      xsi:nil="true"/>
    <cve:PrivatePlacement
      contextRef="c24"
      id="hidden-fact-70"
      unitRef="usd"
      xsi:nil="true"/>
    <cve:PrivatePlacement
      contextRef="c25"
      id="hidden-fact-71"
      unitRef="usd"
      xsi:nil="true"/>
    <cve:PrivatePlacement
      contextRef="c26"
      id="hidden-fact-72"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:ShareIssueRelatedCost
      contextRef="c23"
      id="hidden-fact-73"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:ShareIssueRelatedCost
      contextRef="c25"
      id="hidden-fact-74"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:ShareIssueRelatedCost
      contextRef="c26"
      id="hidden-fact-75"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:IncreaseDecreaseThroughExerciseOfWarrantsEquity
      contextRef="c23"
      id="hidden-fact-76"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:IncreaseDecreaseThroughExerciseOfWarrantsEquity
      contextRef="c25"
      id="hidden-fact-77"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:IncreaseDecreaseThroughExerciseOfWarrantsEquity
      contextRef="c26"
      id="hidden-fact-78"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:IncreaseDecreaseThroughExerciseOfOptions
      contextRef="c23"
      id="hidden-fact-79"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:IncreaseDecreaseThroughExerciseOfOptions
      contextRef="c25"
      id="hidden-fact-80"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:IncreaseDecreaseThroughExerciseOfOptions
      contextRef="c26"
      id="hidden-fact-81"
      unitRef="usd"
      xsi:nil="true"/>
    <cve:StockOptionExpense
      contextRef="c22"
      id="hidden-fact-82"
      unitRef="usd"
      xsi:nil="true"/>
    <cve:StockOptionExpense
      contextRef="c23"
      id="hidden-fact-83"
      unitRef="usd"
      xsi:nil="true"/>
    <cve:StockOptionExpense
      contextRef="c25"
      id="hidden-fact-84"
      unitRef="usd"
      xsi:nil="true"/>
    <cve:StockOptionExpense
      contextRef="c26"
      id="hidden-fact-85"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:IssueOfEquity
      contextRef="c23"
      id="hidden-fact-86"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:IssueOfEquity
      contextRef="c24"
      id="hidden-fact-87"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:IssueOfEquity
      contextRef="c25"
      id="hidden-fact-88"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:IssueOfEquity
      contextRef="c26"
      id="hidden-fact-89"
      unitRef="usd"
      xsi:nil="true"/>
    <cve:ShareSubscriptionsReceived
      contextRef="c22"
      id="hidden-fact-90"
      unitRef="usd"
      xsi:nil="true"/>
    <cve:ShareSubscriptionsReceived
      contextRef="c24"
      id="hidden-fact-91"
      unitRef="usd"
      xsi:nil="true"/>
    <cve:ShareSubscriptionsReceived
      contextRef="c25"
      id="hidden-fact-92"
      unitRef="usd"
      xsi:nil="true"/>
    <cve:ShareSubscriptionsReceived
      contextRef="c26"
      id="hidden-fact-93"
      unitRef="usd"
      xsi:nil="true"/>
    <cve:AdjustmentToInvestmentInAssociate
      contextRef="c22"
      id="hidden-fact-94"
      unitRef="usd"
      xsi:nil="true"/>
    <cve:AdjustmentToInvestmentInAssociate
      contextRef="c23"
      id="hidden-fact-95"
      unitRef="usd"
      xsi:nil="true"/>
    <cve:AdjustmentToInvestmentInAssociate
      contextRef="c25"
      id="hidden-fact-96"
      unitRef="usd"
      xsi:nil="true"/>
    <cve:AdjustmentToInvestmentInAssociate
      contextRef="c26"
      id="hidden-fact-97"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:GainsLossesOnExchangeDifferencesOnTranslationNetOfTax
      contextRef="c22"
      id="hidden-fact-98"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:GainsLossesOnExchangeDifferencesOnTranslationNetOfTax
      contextRef="c23"
      id="hidden-fact-99"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:GainsLossesOnExchangeDifferencesOnTranslationNetOfTax
      contextRef="c24"
      id="hidden-fact-100"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:GainsLossesOnExchangeDifferencesOnTranslationNetOfTax
      contextRef="c26"
      id="hidden-fact-101"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:ProfitLoss
      contextRef="c22"
      id="hidden-fact-102"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:ProfitLoss
      contextRef="c23"
      id="hidden-fact-103"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:ProfitLoss
      contextRef="c24"
      id="hidden-fact-104"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:ProfitLoss
      contextRef="c25"
      id="hidden-fact-105"
      unitRef="usd"
      xsi:nil="true"/>
    <cve:OtherRevenuesCurrent
      contextRef="c5"
      id="hidden-fact-106"
      unitRef="usd"
      xsi:nil="true"/>
    <cve:ExpensesCurrent
      contextRef="c5"
      id="hidden-fact-107"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:OtherNoncurrentLiabilities
      contextRef="c3"
      id="hidden-fact-108"
      unitRef="usd"
      xsi:nil="true"/>
    <cve:OtherRevenuesNoncurrent
      contextRef="c5"
      id="hidden-fact-109"
      unitRef="usd"
      xsi:nil="true"/>
    <cve:ExpensesNoncurrent
      contextRef="c5"
      id="hidden-fact-110"
      unitRef="usd"
      xsi:nil="true"/>
    <cve:AssetsLossFromOperatingExpenses
      contextRef="c3"
      id="hidden-fact-111"
      unitRef="usd"
      xsi:nil="true"/>
    <cve:LiabilitiesLossFromOperatingExpenses
      contextRef="c5"
      id="hidden-fact-112"
      unitRef="usd"
      xsi:nil="true"/>
    <cve:RevenuesLossFromOperatingExpenses
      contextRef="c5"
      id="hidden-fact-113"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:OtherRevenue
      contextRef="c5"
      id="hidden-fact-114"
      unitRef="usd"
      xsi:nil="true"/>
    <cve:OtherRevenuesCurrent
      contextRef="c0"
      id="hidden-fact-115"
      unitRef="usd"
      xsi:nil="true"/>
    <cve:ExpensesCurrent
      contextRef="c0"
      id="hidden-fact-116"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:OtherNoncurrentLiabilities
      contextRef="c2"
      id="hidden-fact-117"
      unitRef="usd"
      xsi:nil="true"/>
    <cve:OtherRevenuesNoncurrent
      contextRef="c0"
      id="hidden-fact-118"
      unitRef="usd"
      xsi:nil="true"/>
    <cve:ExpensesNoncurrent
      contextRef="c0"
      id="hidden-fact-119"
      unitRef="usd"
      xsi:nil="true"/>
    <cve:AssetsLossFromOperatingExpenses
      contextRef="c2"
      id="hidden-fact-120"
      unitRef="usd"
      xsi:nil="true"/>
    <cve:LiabilitiesLossFromOperatingExpenses
      contextRef="c0"
      id="hidden-fact-121"
      unitRef="usd"
      xsi:nil="true"/>
    <cve:RevenuesLossFromOperatingExpenses
      contextRef="c0"
      id="hidden-fact-122"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:OtherRevenue
      contextRef="c0"
      id="hidden-fact-123"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:CurrentInvestments
      contextRef="c6"
      id="hidden-fact-124"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:OtherComprehensiveIncomeNetOfTaxChangeInValueOfForeignCurrencyBasisSpreads
      contextRef="c0"
      id="hidden-fact-125"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:CurrentInvestments
      contextRef="c2"
      id="hidden-fact-126"
      unitRef="usd"
      xsi:nil="true"/>
    <cve:PurchaseCommitments
      contextRef="c72"
      id="hidden-fact-127"
      unitRef="gbp"
      xsi:nil="true"/>
    <cve:TotalPurchasePrice
      contextRef="c72"
      id="hidden-fact-128"
      unitRef="usd"
      xsi:nil="true"/>
    <cve:PurchaseCommitments
      contextRef="c73"
      id="hidden-fact-129"
      unitRef="gbp"
      xsi:nil="true"/>
    <cve:TotalPurchasePrice
      contextRef="c73"
      id="hidden-fact-130"
      unitRef="usd"
      xsi:nil="true"/>
    <cve:PurchaseCommitments
      contextRef="c74"
      id="hidden-fact-131"
      unitRef="gbp"
      xsi:nil="true"/>
    <cve:TotalPurchasePrice
      contextRef="c74"
      id="hidden-fact-132"
      unitRef="usd"
      xsi:nil="true"/>
    <cve:PurchaseCommitments
      contextRef="c75"
      id="hidden-fact-133"
      unitRef="gbp"
      xsi:nil="true"/>
    <cve:TotalPurchasePrice
      contextRef="c75"
      id="hidden-fact-134"
      unitRef="usd"
      xsi:nil="true"/>
    <cve:MarketablesSecurities
      contextRef="c82"
      id="hidden-fact-135"
      unitRef="usd"
      xsi:nil="true"/>
    <cve:MarketablesSecurities
      contextRef="c83"
      id="hidden-fact-136"
      unitRef="usd"
      xsi:nil="true"/>
    <cve:MarketablesSecurities
      contextRef="c3"
      id="hidden-fact-137"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:PropertyPlantAndEquipmentCarryingAmountAtCostOfRevaluedAssets
      contextRef="c109"
      id="hidden-fact-138"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:PropertyPlantAndEquipmentCarryingAmountAtCostOfRevaluedAssets
      contextRef="c110"
      id="hidden-fact-139"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:PropertyPlantAndEquipmentCarryingAmountAtCostOfRevaluedAssets
      contextRef="c111"
      id="hidden-fact-140"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment
      contextRef="c113"
      id="hidden-fact-141"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment
      contextRef="c116"
      id="hidden-fact-142"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:DisposalsInvestmentProperty
      contextRef="c112"
      id="hidden-fact-143"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:DisposalsInvestmentProperty
      contextRef="c113"
      id="hidden-fact-144"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:DisposalsInvestmentProperty
      contextRef="c114"
      id="hidden-fact-145"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:DisposalsInvestmentProperty
      contextRef="c115"
      id="hidden-fact-146"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:DisposalsInvestmentProperty
      contextRef="c116"
      id="hidden-fact-147"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:DisposalsInvestmentProperty
      contextRef="c5"
      id="hidden-fact-148"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:DepreciationExpense
      contextRef="c115"
      id="hidden-fact-149"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:DepreciationExpense
      contextRef="c116"
      id="hidden-fact-150"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:ImpairmentLoss
      contextRef="c112"
      id="hidden-fact-151"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:ImpairmentLoss
      contextRef="c113"
      id="hidden-fact-152"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:ImpairmentLoss
      contextRef="c114"
      id="hidden-fact-153"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:ImpairmentLoss
      contextRef="c115"
      id="hidden-fact-154"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:ImpairmentLoss
      contextRef="c116"
      id="hidden-fact-155"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:ImpairmentLoss
      contextRef="c5"
      id="hidden-fact-156"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation
      contextRef="c112"
      id="hidden-fact-157"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation
      contextRef="c113"
      id="hidden-fact-158"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation
      contextRef="c115"
      id="hidden-fact-159"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation
      contextRef="c116"
      id="hidden-fact-160"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:PropertyPlantAndEquipmentCarryingAmountAtCostOfRevaluedAssets
      contextRef="c121"
      id="hidden-fact-161"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment
      contextRef="c125"
      id="hidden-fact-162"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:DisposalsInvestmentProperty
      contextRef="c122"
      id="hidden-fact-163"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:DisposalsInvestmentProperty
      contextRef="c123"
      id="hidden-fact-164"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:DisposalsInvestmentProperty
      contextRef="c124"
      id="hidden-fact-165"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:DisposalsInvestmentProperty
      contextRef="c125"
      id="hidden-fact-166"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:DisposalsInvestmentProperty
      contextRef="c126"
      id="hidden-fact-167"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:DisposalsInvestmentProperty
      contextRef="c0"
      id="hidden-fact-168"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:ImpairmentLoss
      contextRef="c122"
      id="hidden-fact-169"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:ImpairmentLoss
      contextRef="c123"
      id="hidden-fact-170"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:ImpairmentLoss
      contextRef="c124"
      id="hidden-fact-171"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:ImpairmentLoss
      contextRef="c125"
      id="hidden-fact-172"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:ImpairmentLoss
      contextRef="c126"
      id="hidden-fact-173"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:ImpairmentLoss
      contextRef="c0"
      id="hidden-fact-174"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation
      contextRef="c122"
      id="hidden-fact-175"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation
      contextRef="c123"
      id="hidden-fact-176"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation
      contextRef="c124"
      id="hidden-fact-177"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation
      contextRef="c125"
      id="hidden-fact-178"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation
      contextRef="c126"
      id="hidden-fact-179"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation
      contextRef="c0"
      id="hidden-fact-180"
      unitRef="usd"
      xsi:nil="true"/>
    <cve:Right-of-UseAssetsBalance
      contextRef="c135"
      id="hidden-fact-181"
      unitRef="usd"
      xsi:nil="true"/>
    <cve:Right-of-UseAssetsAdditions
      contextRef="c136"
      id="hidden-fact-182"
      unitRef="usd"
      xsi:nil="true"/>
    <cve:Right-of-UseAssetsCurrencyTranslationAdjustment
      contextRef="c136"
      id="hidden-fact-183"
      unitRef="usd"
      xsi:nil="true"/>
    <cve:Right-of-UseAssetsAdditions
      contextRef="c140"
      id="hidden-fact-184"
      unitRef="usd"
      xsi:nil="true"/>
    <cve:Right-of-UseAssetsCurrencyTranslationAdjustment
      contextRef="c140"
      id="hidden-fact-185"
      unitRef="usd"
      xsi:nil="true"/>
    <cve:Right-of-UseAssetsBalance
      contextRef="c142"
      id="hidden-fact-186"
      unitRef="usd"
      xsi:nil="true"/>
    <cve:Long-TermLeaseLiabilityBalance
      contextRef="c135"
      id="hidden-fact-187"
      unitRef="usd"
      xsi:nil="true"/>
    <cve:Long-TermLeaseLiabilityAdditions
      contextRef="c136"
      id="hidden-fact-188"
      unitRef="usd"
      xsi:nil="true"/>
    <cve:Long-TermLeaseLiabilityAccretion
      contextRef="c136"
      id="hidden-fact-189"
      unitRef="usd"
      xsi:nil="true"/>
    <cve:Long-TermLeaseLiabilityCurrencyTranslationAdjustment
      contextRef="c136"
      id="hidden-fact-190"
      unitRef="usd"
      xsi:nil="true"/>
    <cve:Long-TermLeaseLiabilityAdditions
      contextRef="c140"
      id="hidden-fact-191"
      unitRef="usd"
      xsi:nil="true"/>
    <cve:Long-TermLeaseLiabilityCurrencyTranslationAdjustment
      contextRef="c140"
      id="hidden-fact-192"
      unitRef="usd"
      xsi:nil="true"/>
    <cve:Long-TermLeaseLiabilityBalance
      contextRef="c142"
      id="hidden-fact-193"
      unitRef="usd"
      xsi:nil="true"/>
    <cve:Long-TermLeaseLiabilityLessCurrentLeaseLiability
      contextRef="c140"
      id="hidden-fact-194"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:LongtermProvisionForDecommissioningRestorationAndRehabilitationCosts
      contextRef="c142"
      id="hidden-fact-195"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:MiningAssets
      contextRef="c174"
      id="hidden-fact-196"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:MiningAssets
      contextRef="c176"
      id="hidden-fact-197"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:MiningAssets
      contextRef="c177"
      id="hidden-fact-198"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:MiningAssets
      contextRef="c180"
      id="hidden-fact-199"
      unitRef="usd"
      xsi:nil="true"/>
    <cve:AssetAcquistion
      contextRef="c181"
      id="hidden-fact-200"
      unitRef="usd"
      xsi:nil="true"/>
    <cve:AssetAcquistion
      contextRef="c183"
      id="hidden-fact-201"
      unitRef="usd"
      xsi:nil="true"/>
    <cve:AssetAcquistion
      contextRef="c185"
      id="hidden-fact-202"
      unitRef="usd"
      xsi:nil="true"/>
    <cve:MaintenancesAndLeaseFees
      contextRef="c182"
      id="hidden-fact-203"
      unitRef="usd"
      xsi:nil="true"/>
    <cve:MaintenancesAndLeaseFees
      contextRef="c184"
      id="hidden-fact-204"
      unitRef="usd"
      xsi:nil="true"/>
    <cve:ResourceReview
      contextRef="c182"
      id="hidden-fact-205"
      unitRef="usd"
      xsi:nil="true"/>
    <cve:ResourceReview
      contextRef="c184"
      id="hidden-fact-206"
      unitRef="usd"
      xsi:nil="true"/>
    <cve:ResourceReview
      contextRef="c185"
      id="hidden-fact-207"
      unitRef="usd"
      xsi:nil="true"/>
    <cve:ResourceReview
      contextRef="c186"
      id="hidden-fact-208"
      unitRef="usd"
      xsi:nil="true"/>
    <cve:ResourceReview
      contextRef="c187"
      id="hidden-fact-209"
      unitRef="usd"
      xsi:nil="true"/>
    <cve:ImpairmentCharged
      contextRef="c181"
      id="hidden-fact-210"
      unitRef="usd"
      xsi:nil="true"/>
    <cve:ImpairmentCharged
      contextRef="c182"
      id="hidden-fact-211"
      unitRef="usd"
      xsi:nil="true"/>
    <cve:ImpairmentCharged
      contextRef="c183"
      id="hidden-fact-212"
      unitRef="usd"
      xsi:nil="true"/>
    <cve:ImpairmentCharged
      contextRef="c184"
      id="hidden-fact-213"
      unitRef="usd"
      xsi:nil="true"/>
    <cve:ImpairmentCharged
      contextRef="c185"
      id="hidden-fact-214"
      unitRef="usd"
      xsi:nil="true"/>
    <cve:ImpairmentCharged
      contextRef="c186"
      id="hidden-fact-215"
      unitRef="usd"
      xsi:nil="true"/>
    <cve:ImpairmentCharged
      contextRef="c187"
      id="hidden-fact-216"
      unitRef="usd"
      xsi:nil="true"/>
    <cve:DivestMineralInterest
      contextRef="c181"
      id="hidden-fact-217"
      unitRef="usd"
      xsi:nil="true"/>
    <cve:DivestMineralInterest
      contextRef="c182"
      id="hidden-fact-218"
      unitRef="usd"
      xsi:nil="true"/>
    <cve:DivestMineralInterest
      contextRef="c183"
      id="hidden-fact-219"
      unitRef="usd"
      xsi:nil="true"/>
    <cve:DivestMineralInterest
      contextRef="c184"
      id="hidden-fact-220"
      unitRef="usd"
      xsi:nil="true"/>
    <cve:DivestMineralInterest
      contextRef="c185"
      id="hidden-fact-221"
      unitRef="usd"
      xsi:nil="true"/>
    <cve:DivestMineralInterest
      contextRef="c187"
      id="hidden-fact-222"
      unitRef="usd"
      xsi:nil="true"/>
    <cve:AssetsHeldForSale
      contextRef="c181"
      id="hidden-fact-223"
      unitRef="usd"
      xsi:nil="true"/>
    <cve:AssetsHeldForSale
      contextRef="c182"
      id="hidden-fact-224"
      unitRef="usd"
      xsi:nil="true"/>
    <cve:AssetsHeldForSale
      contextRef="c184"
      id="hidden-fact-225"
      unitRef="usd"
      xsi:nil="true"/>
    <cve:AssetsHeldForSale
      contextRef="c185"
      id="hidden-fact-226"
      unitRef="usd"
      xsi:nil="true"/>
    <cve:AssetsHeldForSale
      contextRef="c186"
      id="hidden-fact-227"
      unitRef="usd"
      xsi:nil="true"/>
    <cve:AssetsHeldForSale
      contextRef="c187"
      id="hidden-fact-228"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:MiningAssets
      contextRef="c196"
      id="hidden-fact-229"
      unitRef="usd"
      xsi:nil="true"/>
    <cve:Drilling
      contextRef="c197"
      id="hidden-fact-230"
      unitRef="usd"
      xsi:nil="true"/>
    <cve:Drilling
      contextRef="c198"
      id="hidden-fact-231"
      unitRef="usd"
      xsi:nil="true"/>
    <cve:Drilling
      contextRef="c199"
      id="hidden-fact-232"
      unitRef="usd"
      xsi:nil="true"/>
    <cve:Drilling
      contextRef="c200"
      id="hidden-fact-233"
      unitRef="usd"
      xsi:nil="true"/>
    <cve:Drilling
      contextRef="c202"
      id="hidden-fact-234"
      unitRef="usd"
      xsi:nil="true"/>
    <cve:Drilling
      contextRef="c203"
      id="hidden-fact-235"
      unitRef="usd"
      xsi:nil="true"/>
    <cve:MaintenancesAndLeaseFees
      contextRef="c198"
      id="hidden-fact-236"
      unitRef="usd"
      xsi:nil="true"/>
    <cve:MaintenancesAndLeaseFees
      contextRef="c200"
      id="hidden-fact-237"
      unitRef="usd"
      xsi:nil="true"/>
    <cve:PermittingLicensing
      contextRef="c197"
      id="hidden-fact-238"
      unitRef="usd"
      xsi:nil="true"/>
    <cve:PermittingLicensing
      contextRef="c199"
      id="hidden-fact-239"
      unitRef="usd"
      xsi:nil="true"/>
    <cve:Personnel
      contextRef="c199"
      id="hidden-fact-240"
      unitRef="usd"
      xsi:nil="true"/>
    <cve:Recoveries
      contextRef="c197"
      id="hidden-fact-241"
      unitRef="usd"
      xsi:nil="true"/>
    <cve:Recoveries
      contextRef="c199"
      id="hidden-fact-242"
      unitRef="usd"
      xsi:nil="true"/>
    <cve:Recoveries
      contextRef="c200"
      id="hidden-fact-243"
      unitRef="usd"
      xsi:nil="true"/>
    <cve:Recoveries
      contextRef="c201"
      id="hidden-fact-244"
      unitRef="usd"
      xsi:nil="true"/>
    <cve:Recoveries
      contextRef="c203"
      id="hidden-fact-245"
      unitRef="usd"
      xsi:nil="true"/>
    <cve:ResourceReview
      contextRef="c198"
      id="hidden-fact-246"
      unitRef="usd"
      xsi:nil="true"/>
    <cve:ResourceReview
      contextRef="c200"
      id="hidden-fact-247"
      unitRef="usd"
      xsi:nil="true"/>
    <cve:DivestMineralInterest
      contextRef="c205"
      id="hidden-fact-248"
      unitRef="usd"
      xsi:nil="true"/>
    <cve:DivestMineralInterest
      contextRef="c206"
      id="hidden-fact-249"
      unitRef="usd"
      xsi:nil="true"/>
    <cve:DivestMineralInterest
      contextRef="c207"
      id="hidden-fact-250"
      unitRef="usd"
      xsi:nil="true"/>
    <cve:DivestMineralInterest
      contextRef="c208"
      id="hidden-fact-251"
      unitRef="usd"
      xsi:nil="true"/>
    <cve:DivestMineralInterest
      contextRef="c209"
      id="hidden-fact-252"
      unitRef="usd"
      xsi:nil="true"/>
    <cve:DivestMineralInterest
      contextRef="c211"
      id="hidden-fact-253"
      unitRef="usd"
      xsi:nil="true"/>
    <cve:AssetsHeldForSale
      contextRef="c206"
      id="hidden-fact-254"
      unitRef="usd"
      xsi:nil="true"/>
    <cve:AssetsHeldForSale
      contextRef="c207"
      id="hidden-fact-255"
      unitRef="usd"
      xsi:nil="true"/>
    <cve:AssetsHeldForSale
      contextRef="c208"
      id="hidden-fact-256"
      unitRef="usd"
      xsi:nil="true"/>
    <cve:AssetsHeldForSale
      contextRef="c209"
      id="hidden-fact-257"
      unitRef="usd"
      xsi:nil="true"/>
    <cve:AssetsHeldForSale
      contextRef="c210"
      id="hidden-fact-258"
      unitRef="usd"
      xsi:nil="true"/>
    <cve:ConstructionOfWellfields
      contextRef="c205"
      id="hidden-fact-259"
      unitRef="usd"
      xsi:nil="true"/>
    <cve:ConstructionOfWellfields
      contextRef="c206"
      id="hidden-fact-260"
      unitRef="usd"
      xsi:nil="true"/>
    <cve:ConstructionOfWellfields
      contextRef="c207"
      id="hidden-fact-261"
      unitRef="usd"
      xsi:nil="true"/>
    <cve:ConstructionOfWellfields
      contextRef="c208"
      id="hidden-fact-262"
      unitRef="usd"
      xsi:nil="true"/>
    <cve:ConstructionOfWellfields
      contextRef="c210"
      id="hidden-fact-263"
      unitRef="usd"
      xsi:nil="true"/>
    <cve:ConstructionOfWellfields
      contextRef="c211"
      id="hidden-fact-264"
      unitRef="usd"
      xsi:nil="true"/>
    <cve:Drilling
      contextRef="c205"
      id="hidden-fact-265"
      unitRef="usd"
      xsi:nil="true"/>
    <cve:Drilling
      contextRef="c206"
      id="hidden-fact-266"
      unitRef="usd"
      xsi:nil="true"/>
    <cve:Drilling
      contextRef="c207"
      id="hidden-fact-267"
      unitRef="usd"
      xsi:nil="true"/>
    <cve:Drilling
      contextRef="c208"
      id="hidden-fact-268"
      unitRef="usd"
      xsi:nil="true"/>
    <cve:Drilling
      contextRef="c210"
      id="hidden-fact-269"
      unitRef="usd"
      xsi:nil="true"/>
    <cve:Drilling
      contextRef="c211"
      id="hidden-fact-270"
      unitRef="usd"
      xsi:nil="true"/>
    <cve:Personnel
      contextRef="c205"
      id="hidden-fact-271"
      unitRef="usd"
      xsi:nil="true"/>
    <cve:Personnel
      contextRef="c206"
      id="hidden-fact-272"
      unitRef="usd"
      xsi:nil="true"/>
    <cve:Personnel
      contextRef="c207"
      id="hidden-fact-273"
      unitRef="usd"
      xsi:nil="true"/>
    <cve:Personnel
      contextRef="c208"
      id="hidden-fact-274"
      unitRef="usd"
      xsi:nil="true"/>
    <cve:Personnel
      contextRef="c210"
      id="hidden-fact-275"
      unitRef="usd"
      xsi:nil="true"/>
    <cve:Personnel
      contextRef="c211"
      id="hidden-fact-276"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:MiningAssets
      contextRef="c219"
      id="hidden-fact-277"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:ReceiptsFromRoyaltiesFeesCommissionsAndOtherRevenue
      contextRef="c0"
      id="hidden-fact-278"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:ReceiptsFromRoyaltiesFeesCommissionsAndOtherRevenue
      contextRef="c5"
      id="hidden-fact-279"
      unitRef="usd"
      xsi:nil="true"/>
    <cve:PurchaseWarrantShares
      contextRef="c0"
      decimals="1"
      id="hidden-fact-280"
      unitRef="shares">0.5</cve:PurchaseWarrantShares>
    <cve:PurchaseWarrantShares
      contextRef="c5"
      decimals="1"
      id="hidden-fact-281"
      unitRef="shares">0.5</cve:PurchaseWarrantShares>
    <cve:WarrantShare
      contextRef="c0"
      decimals="1"
      id="hidden-fact-282"
      unitRef="shares">0.5</cve:WarrantShare>
    <ifrs-full:AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill
      contextRef="c5"
      id="hidden-fact-283"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:DirectorsRemunerationExpense
      contextRef="c5"
      id="hidden-fact-284"
      unitRef="usd"
      xsi:nil="true"/>
    <cve:OfficeAndAdministration
      contextRef="c0"
      id="hidden-fact-285"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:AmountsPayableRelatedPartyTransactions
      contextRef="c252"
      id="hidden-fact-286"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:MarketableSecurities
      contextRef="c3"
      id="hidden-fact-287"
      unitRef="cad"
      xsi:nil="true"/>
    <cve:ImpactedLoss
      contextRef="c5"
      id="hidden-fact-288"
      unitRef="usd"
      xsi:nil="true"/>
    <cve:IntangibleAssets
      contextRef="c192"
      id="hidden-fact-289"
      unitRef="usd"
      xsi:nil="true"/>
    <cve:IntangibleAssets
      contextRef="c195"
      id="hidden-fact-290"
      unitRef="usd"
      xsi:nil="true"/>
    <cve:IntangibleAssets
      contextRef="c196"
      id="hidden-fact-291"
      unitRef="usd"
      xsi:nil="true"/>
    <cve:PropertyPlantAndEquipments
      contextRef="c191"
      id="hidden-fact-292"
      unitRef="usd"
      xsi:nil="true"/>
    <cve:PropertyPlantAndEquipments
      contextRef="c195"
      id="hidden-fact-293"
      unitRef="usd"
      xsi:nil="true"/>
    <cve:PropertyPlantAndEquipments
      contextRef="c255"
      id="hidden-fact-294"
      unitRef="usd"
      xsi:nil="true"/>
    <cve:PropertyPlantAndEquipments
      contextRef="c196"
      id="hidden-fact-295"
      unitRef="usd"
      xsi:nil="true"/>
    <cve:MineralProperties
      contextRef="c196"
      id="hidden-fact-296"
      unitRef="usd"
      xsi:nil="true"/>
    <cve:RightofuseAssets1
      contextRef="c192"
      id="hidden-fact-297"
      unitRef="usd"
      xsi:nil="true"/>
    <cve:RightofuseAssets1
      contextRef="c191"
      id="hidden-fact-298"
      unitRef="usd"
      xsi:nil="true"/>
    <cve:RightofuseAssets1
      contextRef="c195"
      id="hidden-fact-299"
      unitRef="usd"
      xsi:nil="true"/>
    <cve:RightofuseAssets1
      contextRef="c255"
      id="hidden-fact-300"
      unitRef="usd"
      xsi:nil="true"/>
    <cve:IntangibleAssets
      contextRef="c215"
      id="hidden-fact-301"
      unitRef="usd"
      xsi:nil="true"/>
    <cve:IntangibleAssets
      contextRef="c218"
      id="hidden-fact-302"
      unitRef="usd"
      xsi:nil="true"/>
    <cve:IntangibleAssets
      contextRef="c219"
      id="hidden-fact-303"
      unitRef="usd"
      xsi:nil="true"/>
    <cve:PropertyPlantAndEquipments
      contextRef="c214"
      id="hidden-fact-304"
      unitRef="usd"
      xsi:nil="true"/>
    <cve:PropertyPlantAndEquipments
      contextRef="c218"
      id="hidden-fact-305"
      unitRef="usd"
      xsi:nil="true"/>
    <cve:PropertyPlantAndEquipments
      contextRef="c256"
      id="hidden-fact-306"
      unitRef="usd"
      xsi:nil="true"/>
    <cve:PropertyPlantAndEquipments
      contextRef="c219"
      id="hidden-fact-307"
      unitRef="usd"
      xsi:nil="true"/>
    <cve:MineralProperties
      contextRef="c219"
      id="hidden-fact-308"
      unitRef="usd"
      xsi:nil="true"/>
    <cve:RightofuseAssets1
      contextRef="c215"
      id="hidden-fact-309"
      unitRef="usd"
      xsi:nil="true"/>
    <cve:RightofuseAssets1
      contextRef="c214"
      id="hidden-fact-310"
      unitRef="usd"
      xsi:nil="true"/>
    <cve:RightofuseAssets1
      contextRef="c218"
      id="hidden-fact-311"
      unitRef="usd"
      xsi:nil="true"/>
    <cve:RightofuseAssets1
      contextRef="c256"
      id="hidden-fact-312"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:CurrentAccruedExpensesAndOtherCurrentLiabilities
      contextRef="c3"
      id="hidden-fact-313"
      unitRef="usd"
      xsi:nil="true"/>
    <cve:TotalNoncashFinancingActivities
      contextRef="c3"
      id="hidden-fact-314"
      unitRef="usd"
      xsi:nil="true"/>
    <cve:MarketableSecuritieReceivedOnDispositionOfMineralProperties
      contextRef="c3"
      id="hidden-fact-315"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:LiabilitiesArisingFromExplorationForAndEvaluationOfMineralResources
      contextRef="c3"
      id="hidden-fact-316"
      unitRef="usd"
      xsi:nil="true"/>
    <cve:PropertyPlantAndEquipmentAdditionIncludedInAccountsPayableAndAccruedLiabilities
      contextRef="c3"
      id="hidden-fact-317"
      unitRef="usd"
      xsi:nil="true"/>
    <cve:FairValueOfCommonSharesIssuedForAzargaAssetAcquisition
      contextRef="c2"
      id="hidden-fact-318"
      unitRef="usd"
      xsi:nil="true"/>
    <cve:FairValueOfReplacementOptionsIssuedForAzargaAssetsAcquisition
      contextRef="c2"
      id="hidden-fact-319"
      unitRef="usd"
      xsi:nil="true"/>
    <cve:FairValueOfReplacementWarrantsIssuedForAzargaAssetAcquisition
      contextRef="c2"
      id="hidden-fact-320"
      unitRef="usd"
      xsi:nil="true"/>
    <cve:ShareIssueCosts
      contextRef="c5"
      id="hidden-fact-321"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:AdjustmentsForCurrentTaxOfPriorPeriod
      contextRef="c5"
      id="hidden-fact-322"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:IncomeTaxExpenseContinuingOperations
      contextRef="c0"
      id="hidden-fact-323"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:IncomeTaxExpenseContinuingOperations
      contextRef="c5"
      id="hidden-fact-324"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:IncomeTaxExpenseContinuingOperations
      contextRef="c0"
      id="hidden-fact-325"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:IncomeTaxExpenseContinuingOperations
      contextRef="c5"
      id="hidden-fact-326"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:NetDeferredTaxAssets
      contextRef="c2"
      id="hidden-fact-327"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:NetDeferredTaxAssets
      contextRef="c3"
      id="hidden-fact-328"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:OtherIntangibleAssets
      contextRef="c3"
      id="hidden-fact-329"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:RightofuseAssetsRevaluationSurplus
      contextRef="c3"
      id="hidden-fact-330"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:NetDeferredTaxAssets
      contextRef="c2"
      id="hidden-fact-331"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:NetDeferredTaxAssets
      contextRef="c3"
      id="hidden-fact-332"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:InterestExpense
      contextRef="c262"
      id="hidden-fact-333"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:DilutedEarningsLossPerShare
      contextRef="c261"
      decimals="2"
      id="hidden-fact-334"
      unitRef="cadPershares">-0.05</ifrs-full:DilutedEarningsLossPerShare>
    <ifrs-full:DilutedEarningsLossPerShare
      contextRef="c262"
      decimals="2"
      id="hidden-fact-335"
      unitRef="usdPershares">-0.13</ifrs-full:DilutedEarningsLossPerShare>
    <dei:AmendmentFlag contextRef="c0">false</dei:AmendmentFlag>
    <dei:DocumentFiscalPeriodFocus contextRef="c0">FY</dei:DocumentFiscalPeriodFocus>
    <dei:EntityCentralIndexKey contextRef="c0">0001500881</dei:EntityCentralIndexKey>
    <link:footnoteLink
      xlink:role="http://www.xbrl.org/2003/role/link"
      xlink:type="extended">
        <link:loc
          xlink:href="#ix_0_fact"
          xlink:label="ix_0_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_1_fact"
          xlink:label="ix_1_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_2_fact"
          xlink:label="ix_2_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_3_fact"
          xlink:label="ix_3_fact"
          xlink:type="locator"/>
        <link:footnote id="ix_0_footnote" xlink:label="ix_0_footnote" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Cibola Resources, LLC was divested in May 2022 (Note 11).</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_0_fact"
          xlink:to="ix_0_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_1_fact"
          xlink:to="ix_0_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_2_fact"
          xlink:to="ix_0_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_3_fact"
          xlink:to="ix_0_footnote"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#ix_4_fact"
          xlink:label="ix_4_fact"
          xlink:type="locator"/>
        <link:footnote id="ix_1_footnote" xlink:label="ix_1_footnote" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Transaction costs incurred by Azarga which were subsequently paid by the Company.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_4_fact"
          xlink:to="ix_1_footnote"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#ix_5_fact"
          xlink:label="ix_5_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_6_fact"
          xlink:label="ix_6_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_7_fact"
          xlink:label="ix_7_fact"
          xlink:type="locator"/>
        <link:footnote id="ix_2_footnote" xlink:label="ix_2_footnote" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US"><xhtml:span style="font-family: Times New Roman, Times, Serif">Includes power warrants exercisable into one share and <xhtml:span style="-sec-ix-hidden: hidden-fact-282">one-half</xhtml:span> warrant. Each whole warrant is exercisable at $3.90 for 36 months.</xhtml:span></link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_5_fact"
          xlink:to="ix_2_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_6_fact"
          xlink:to="ix_2_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_7_fact"
          xlink:to="ix_2_footnote"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#ix_8_fact"
          xlink:label="ix_8_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_9_fact"
          xlink:label="ix_9_fact"
          xlink:type="locator"/>
        <link:footnote id="ix_3_footnote" xlink:label="ix_3_footnote" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US"><xhtml:span style="font-family: Times New Roman, Times, Serif">- During the year ended December 31, 2022, the Company incurred communications &amp; community engagement consulting fees of $103,514 (2021 - $61,899) according to a contract with Tintina Holdings, Ltd., a company owned and operated by the spouse of the Company&#x2019;s Executive Chairman.</xhtml:span></link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_8_fact"
          xlink:to="ix_3_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_9_fact"
          xlink:to="ix_3_footnote"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#ix_10_fact"
          xlink:label="ix_10_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#hidden-fact-283"
          xlink:label="hidden-fact-283"
          xlink:type="locator"/>
        <link:footnote id="ix_4_footnote" xlink:label="ix_4_footnote" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US"><xhtml:span style="font-family: Times New Roman, Times, Serif">- In June 2022, the Company acquired access to the Getty Minerals database pursuant to a purchase agreement with Platoro West Inc., a company owned and operated by the Company&#x2019;s Executive Chairman (Note 7).</xhtml:span></link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_10_fact"
          xlink:to="ix_4_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="hidden-fact-283"
          xlink:to="ix_4_footnote"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#hidden-fact-284"
          xlink:label="hidden-fact-284"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_11_fact"
          xlink:label="ix_11_fact"
          xlink:type="locator"/>
        <link:footnote id="ix_5_footnote" xlink:label="ix_5_footnote" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US"><xhtml:span style="font-family: Times New Roman, Times, Serif">&#x2013; Directors&#x2019; Fees are included in staff costs on the consolidated statement of loss and other comprehensive income (loss).</xhtml:span></link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="hidden-fact-284"
          xlink:to="ix_5_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_11_fact"
          xlink:to="ix_5_footnote"
          xlink:type="arc"/>
    </link:footnoteLink>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>153
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M3J?U>48F:PD.$&&$)D305B&B)JS'XUR*;90&S3UN637\@:&9&$%;Q8@:;2[
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M@N?XZQ!T=KQG-_#T\TOT'WOR0.9>UV99YG]FJV9S,U.S8&76NLV;3^733^9
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M^[J$H^/AHGNEZ_C.W^)O4$L#!!0    ( ""$G%;S@!+R0 <  ,P=   8
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M#D>'PX46Q_[T[59H+=K^ZX$7%9?& '[?":$?+\P TP'N]F]02P,$%     @
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MPRQ>85_MWZ>%,#)/H9QE>4;S,0MY+&F:9I@$2(A9WF1QWC3UZ%ER*Y:R:4Q
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M: &>+RRTK+N@ _K/?J?_!U!+ P04    "  @A)Q6-*>HQN0B  #_<@  &
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MR*#NJ"0+:D9QZ8A/,%M'82S(PDX.$/F+C_VJD9ET.*.(E6;JPJ]]]SO)X>#
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MH=M+:#?'GP!@+S#<=S %C5U-GE<6/TIQ43;[2:D4K,S+)USJFX*O3HA'Q \
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MZG5[[F]OK*J:L_9,63RY-Y<Y?BIQ30:X/E<X"S<W%*#[^+KX#U!+ P04
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M)5(EJ3C>K]\92G(NZZ1Y*X)8I$2>.7/F(NIXH\T/FR,ZN"D+94]ZN7/5F\'
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M]&X"*7!LEVT57Q0T/*% 2?S:-"GV'+0+(2RR;0(7>J(>)V4Z+<B;O$*U=Q:
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M?=GK'IIZH[^F+>JFJ4O]<RUX)B01X/VRAK+] VTP?EZ]_A]02P,$%     @
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M[P],K3F=<HDK,HU&L\D E+_.^H61M;M"7DE#%U+WNJ%_ *BL LE7DD:@7=@
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MM6=/<#AO?+!59PP&E3+M?_G0Z7!@<#I]PR#K#++(NW4467Z502[GSNZ$X]-
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M_"E!&\:O@O8EV#K>Q"L;<*_'QQ(?4N3X /;7UH;^A1T,GV;+_P!02P,$%
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M4VV/Q.]=T67_IZ+[:[Y=,P*QS$S[GT-N=A-R/9U6D\:?_OSZY?-($&MK/$T
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M$@>>%>LEAF@*FJX+;Z[0,B?.-$XX!(#\/.$8U(6F'!YE-QXB:896 \T^2 /
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MO<VH70"MKY6R.\,EZ%_[^7]02P,$%     @ ((2<5OM;?OJT @  W@4  !D
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M&O%LL,A*ZVO\.]E$YDOQV 191'GB-FOPA@1D^@Y51ZSJ+HXGFR64)<E@3C1
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M9%/BA]EHV$2W[N>16Q<QW?3+%<9)Z],#W"\=.OEVDQ2, ^K\/U!+ P04
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M;&?/\,VS1VYVS%$'(Y4?'R<GK?['<0)?F*CI3>'19#E*4GB=-]Y^QD$4!^F
MA@XQ/X%P-S54@]V59"J'TGG0<)EEJL;<^ZZS!_$X&"4TDB .DFCB#091D*1[
M>V[O*+[]@]NZ1+5R;Q)-=:*QW5S<[6[[[+EL;OM7\>;-=,O4BE/W%[@DU;"7
M$JBJ>8<T"R,K=_<OI*&7A/M<T],-E16@\Z4D4NX6UD'[&)S_"5!+ P04
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M#B> //X 0/8 XG5WB;S*K]30R4C)+2@7;=G<PI?JT58<$^Y2%D;9769Q9O+
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M66A\.TP#4-T Z PC&]]T2VEL"_ME96<F*A=@]U=2FH/A$ARG\.0O4$L#!!0
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MVH8 F%\;XP^=4.#XQ"_^ 5!+ P04    "  @A)Q699CE@G0#  #[!P  &0
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M<FMS:&5E=',O<VAE970T-BYX;6RE5]MNXS80?==7$.ZV<  FUOV2)@9R6S1
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M&NPFV]<%MN^@K '.EU*:[<!NT/]#,/T/4$L#!!0    ( ""$G%92O15G(08
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MGH,-@,D3#"\838+E>K[KKS&J$7J!R!7)')66SI:!KD%\G(_A1D4@:C%;UE/
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M\]Z\&8F/PRT7CW(-H-!329D<.6NEJBO7E?D:2BPO> 5,[RRY*+'24[%R924
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MTOD-BYNWN29-KN"%7'Z KCE3:XD^L0**YP2N%MZI#W;J)\%)QAGD%RCTWZ/
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M!M),P/<+(?2N8Q9H:L'X'U!+ P04    "  @A)Q6(C^]CT@$   D%   &0
M 'AL+W=O<FMS:&5E=',O<VAE970U-2YX;6RM6%V/FS@4_2L6756MU!FP"1"F
M2:293*L=J5V-9MI=K5;[X)";!!4P:SO)]-^O^0B$!)S0S$N"X=[C<^QK./9H
MR_@/L0*0Z"6.$C$V5E*F-Z8I@A7$5%RS%!+U9,%X3*5J\J4I4@YTGB?%D4DL
MRS5C&B;&9)3?>^23$5O+*$S@D2.QCF/*?]Y!Q+9C QN[&T_A<B6S&^9DE-(E
M/(/\GCYRU3(KE'D80R)"EB .B[%QBV^F)$_((_X,82OVKE$F9<;8CZSQ,!\;
M5L8((@AD!D'5WP:F$$49DN+Q7PEJ5'UFB?O7._3/N7@E9D8%3%GT5SB7J[$Q
M-- <%G0=R2>V_1U*04Z&%[!(Y+]H6\9:!@K60K*X3%8,XC I_NE+.1!["=CM
M2"!E CE,&'0DV&6"G0LMF.6R[JFDDQ%G6\2S:(667>1CDV<K-6&23>.SY.II
MJ/+DY"'9@)!J7B1Z2-"M$"P(J03T[AXD#2/Q'EVA9U4[\W4$B"U0REG*>#8#
M-$)B13F@,$%R!8A6N5?H^_,]>O?;^Y$I%<6L(S,HZ=P5=$@''4S05Y;(E4"?
MDCG,FP"FTE8))#N!=T2+> _!-;+Q!T0L0EH(3<]/QQHZ=C7>=HYG=^#U'<M_
M;F="<E7L_[8-9M'7H+VO[ UP(U(:P-A02UP WX Q>?L&N];'MH%X);#&L RJ
M81GHT">J\$"*#VBZYES58IO6 L#- ;*7TV;B6KYG#4;F9E_%<1BVO*&%_2JN
M0="I"#I:@E]".@NC4(:@9UF@.'O=VSYQ_ .2QU&86([;P=&M.+I:CD^P@61]
M@J 6HGV645NU7([3T.A5&CVMQD\OZ@,F3FC40O30>#E.0^.PTC@\:S'\P9*K
MH%OE\*B(/.(3%Q_46DN8@RW7::\UO^+HG[L>3O'4 O68C<MQ&DJQ57\BK3/7
MU0FE>IP>4E\!J*EUSP[@,]?7*:U:G#Y:+P=J:B6U5G+6.OO"A$ +SF*DW#&G
M,DR6",IQ:)6NA>TC_7*@IO3:A6#MU[RQ?'O+_P6CT"[_<J"F_-IM8+W=J%=T
M;_%:X#[B+P=JBJ^=#-9;F7J)]Q9_[%NN!MCQW$-_TQ;H.8X_L-N_.KBV.%CO
M<79K]AN3-&KEZ!Y[*]L>^GL?O))C2^"0^-9PT,&QMBA8[U$:7K&;J'>656P)
MTWE%7)L,K'<9]1KHIJA%Z%/LEP,U5=8V!>M]RJ[8-2+]HQU#1U&W!.J*FM0&
M@UC:3>'?0#F";,.+U'X3XAEPW9;UCOR"/>C>][T66E-\[3B(WG%\4_O=*8M3
MFOQ\^V9(L/=1(/4V"I3OH$NU3]XFP,4J3%L'HCS<L/;FQ+JV;>_0!.LY]-5H
M[IVWQ,"7^3&40 %;)[(XF:CN5D==M_D!S\'].WPS+0ZL:ICB_.PKY<LP$2B"
MA8*TKCWU N#%D531D"S-3W5F3$H6YY<KH'/@68!ZOF!,[AI9!]7!X.1_4$L#
M!!0    ( ""$G%8SVX7&7 ,  $,+   9    >&PO=V]R:W-H965T<R]S:&5E
M=#4V+GAM;*U6R6[;,!#]%4(MBA9HHEVV4UN ERXY% @:I#D4/3#2V&9+D2I)
MV<G?EZ04Q8LL-$4NMDC->WQOAB)GO.7BMUP#*'1?4"8GSEJI\L)U9;:& LMS
M7@+3;Y9<%%CIH5BYLA2 <PLJJ!MX7N(6F# G'=NY*Y&.>:4H87 ED*R* HN'
M&5"^G3B^\SCQC:S6RDRXZ;C$*[@&=5->"3UR6Y:<%, DX0P)6$Z<J7\Q]RW
M1GPGL)4[S\A8N>/\MQE<YA/',XJ 0J8,!=9_&Y@#I89)Z_C3D#KMF@:X^_S(
M_LF:UV;NL(0YI[<D5^N),W10#DM<4?6-;[] 8R@V?!FGTOZB;1/K.2BKI.)%
M ]8*"L+J?WS?)&('X"<G $$#" X!T0E V !":[169FTML,+I6/ M$B9:LYD'
MFQN+UFX(,V6\5D*_)1JGTDNV :ET712Z9&@J)<\(5H#>+D!A0N4[=(:N]=[)
M*PJ(+Q%YBB>Z"&U\QIDBK"+J00-NKA?H[>MW8U=IA68=-VO4S&HUP0DU?H"^
M:J*U1!]9#OD^@:NMM?Z"1W^SH)=Q =DY"OWW*/""H$/0_-_A?H^<L$UW:/G"
M$WS/3.6/Z9U40F_UGUVYK)>*NI<RW_^%+'$&$T=_X!+$!ISTS2L_\3YTY>&%
MR/:R$K59B?K8TQFFF&70Y;$&)A9HCJ1-&B=1&'EC=[.K_C@LBOW E&S3H2MN
M=<6]U9KFOZJZ0A(ICC(LQ -A*[3!M(*++KGQ2Y;DA<CVK">M]:2W)%>"EUR8
MD]9L2;G&PNY9IB\6RJ7L\EX3QCLU./.C,!@F![7JB L2SXOC[F(-6L6#7L5/
MQ3*UVO^X/@M>E<CWNV0/CN3X<3*(#T0?1T7)* R\;LW#5O.P5_.M( K.^'*Y
M?QYTR1P>9RV*PL2/#H3V+OB?FV;4VAGUVED06MG+^=06Z84_]_,8'6=D%"?#
M$R7QO:<;T>MU,:^$ )8]('WR,DEQW6ZTNZOS5O..SI]D.#S<0TW4?@V3Y(3>
MG1O<_]_3LQ_YW(0W;#V'<>W W6E'"A KVZ5)?:]53-4W=SO;=H)3V_\<S,],
MAVC;G">:NKW\BL6*,(DH+#6E=S[0215UQU8/%"]MTW/'E6ZA[.-:=[D@3(!^
MO^1</0[, FW?G/X%4$L#!!0    ( ""$G%;,:$]/B08  #1#   9    >&PO
M=V]R:W-H965T<R]S:&5E=#4W+GAM;+7<6V_B1A@&X+\RHJLJE=K F%/()DB;
M&)\-T:;;7JQZX< $K/6!CDVR*_7'UR<,!F=B5V_W8@,.\WPS3/QF3 9N7D/^
M+=HP%I/OOA=$MYU-'&^ON]UHN6&^$UV&6Q8DWWD.N>_$R5V^[D9;SIQ5ULCW
MNE*O-^KZCAMTIC?9L0<^O0EWL><&[(&3:.?[#O]QQ[SP];9#._L#G]WU)DX/
M=*<W6V?-'EG\9?O DWO=4EFY/@LB-PP(9\^WG4_T>D&':8/L$7^X[#4ZNDW2
MH3R%X;?TCKZZ[?32'C&/+>.4<)(O+^R>>5XJ)?WXNT [9<VTX?'MO:YD@T\&
M\^1$[#[T_G17\>:V<]4A*_;L[+SX<_BJL6) 60>7H1=E_Y/7_+&C48<L=U$<
M^D7CI >^&^1?G>_%$W'40)+>:" 5#:2F#?I%@_Y)@W[_C0:#HL&@:85AT6#8
MM,&H:#!JVJ5QT6#<M,)5T>"J:8-)T6#2M$NTMY^Y7M,:M)SLQK--]]--&\\W
MW4\X/9WQMYOLIYPVGG.ZG_3\![Z;_\1GIXOLQ,[TAH>OA*>/3[ST1G;.9>V3
ML\0-TGAXC'GR73=I%T_UX(5%<7*^Q\0-R(X[@;OSR87,8L?UHE]NNG%2)'UH
M=UF 5@Y*;X!4(G88Q)N(S((56U6!;M*[LHO2OHMWDE#\M%M?DC[]E4@]J4^^
M/,KDXD-=Q^[%C.WP1HPL9F2VO"1TF#'2GB$?2)=$&X>SJ$:<M1'5NP=R\?-/
M=-3_6-<[I?ES)0D&J39@>H,V@]3:B.\,4F\^DZ)!&F)&84]M9])L([XS2*O!
M3T6#0=IMF'>Z-&]N44&7%FV8M[M4"8M^F6?]#.__MSPC7ZVD =%CYD=_U73]
M+M<']7JZ5KN.MLZ2W7:2Q5C$^ OK3-/.]S[6!1(2DY'8#(DI2$Q%8AH2TY&8
M@<1,)&8A,1N)S9'8 H150FI0AM1 I$\?=GRY2:YIB+/FC*5A%1''#W=):%TD
MJ?60W%HE6?4/R7.Q+J>$!=KF%!*3D=@LQVB^>DTO=5^FM)?^N^F^'$<0LJB*
MQ+2&(]"110TD9M:,0*H9@84L:B.Q.1);U#P=_>K34<F$89D)0V$F6&&P_BUF
MW$_6+?LE3-V)+U3:GOA(3$9B,R2F(#$5B6E(3$=B!A(SD9B%Q&PD-L^QT5$R
M3'KCT5E2+D!%*SDS*G-F),R91\=C)'PFV\V/R%TZWN$:J>'*0\BW#2 D)B.Q
M&1)3D)B*Q#0DIB,Q XF92,Q"8O:HV?IPCBRZJ"DJ"=8PXS);QL)L47D8163+
MPR5CJ[K7S^Z$[=N&!Q*3D=@,B2E(3$5B&A+3D9B!Q$PD9HW/U@@#:3 \.]]M
M9-%YC@V/BHXFX_.B"U#12GA<E>%Q)0X/)UF A,$[ES]"HVV (#$9B<V0F(+$
M5"2F(3$=B1E(S$1BUM59@/1KX@-9<GY><B@->N/A27J :E;28U*FQT28'K^'
M<7(MLPR#R%TQ[J1;3^KB0XBTC0\D)D_.G^.)) U/)W:&+*H@,?5\!(-)S4I6
M0Q;5D9AQ/H*K[+?DR0A,9%$+B=E(;([$%B"L$@ZT5Z9#NBVH73R0+>/Y7_JS
MES[DT/,<'AV.IJ^""#<#W(EKMDT3J"87&I4J@7*9),I)GD#+*E!-+;1JI)RD
M";2B#M6,0AL?][]_>?I[TX06M:":#=7F4&V!TJJ9<K1SC@HS10_<V$U29>O\
M>.MJ12RT3@BD)D.U&513"NWXQ,]?%#OY3:Q"RVI03:\9A%0W" -:UH1J%E2S
MH=H<JBU06C5-I$.:2,(T4=S@D"7I'VC$KX,46N4RL&ZU?2\NVSHTD-H,JBE0
M385J&E33H9H!U4RH9D$U&ZK-H=H"I57CY[!ME@HWO$V5D+.E$\7DJ\W\)\9K
M-\>*C=;+&>CV6*@V@VH*5%.AF@;5=*AF0#43JEE0S89J<ZBV0&G59#KLE:7Y
MCKK_:T<_1>[^NX=J,E2;034%JJE038-J.E0SH)H)U2RH9D.U.51;H+1J:!TV
M\U+Q;MZV5W/07;WT?!_BJ.[O&#*T[ RJ*5!-A6H:5-.AF@'53*AF034;JLVA
MV@*EY?'3/7I_M\_X.OLXA8@LTW<,Y>\P*(^6']GP*7OC^LEQF5[/:,UQE5YK
M=<<->FW6';?2CX3(WG]^Z$[^>1*VP]=N$!&//2==ZUV.DR>"YQ_1D-^)PVWV
M;O2G,(Y#/[NY8<Z*\?0!R?>?PS#>WTD+E!^4,?T74$L#!!0    ( ""$G%;^
M&,4[00,  *\*   9    >&PO=V]R:W-H965T<R]S:&5E=#4X+GAM;*U677/;
M*!3]*XRZL]/.--&')3G.VIJ)G:;;ATX]]2;[C*5KBQ:!"\AN_OT"DA4EEIED
M9OU@"<0]G'. RYT>N/@I2P"%?E>4R9E7*K6[]GV9EU!A><EWP/27#1<55KHI
MMK[<"<"%#:JH'P5!ZE>8,"^;VKZER*:\5I0P6 HDZZK"XG$.E!]F7N@=.[Z3
M;:E,AY]-=W@+*U#WNZ70+;]#*4@%3!+.D(#-S+L)KQ=A8 +LB <"!]E[1T;*
MFO.?IO&EF'F!8004<F4@L'[L80&4&B3-XU<+ZG5SFL#^^Q']SHK78M98PH+3
M?TFARIEWY:$"-KBFZCL__ VMH,3@Y9Q*^X\.[=C 0WDM%:_:8,V@(JQYXM^M
M$;V ,#T3$+4!T<N ^$S J T86:$-,ROK%BN<304_(&%&:S3S8KVQT5H-8689
M5TKHKT3'J>P+VX-4>ET4(@S5 C-25^C]+2A,J/R +M!*[YRBIH#X!JD2T 83
M@?:8UEW/KGR4),>T"R=/H!?H?G6+WO_Q8>HK3==,ZN<MM7E#+3I#+8S05\Y4
M*=$G5D#Q',#7.CNQT5'L/'(BWD)^B4;A1Q0%431 :/'Z\-!!9]1Y/[)XHS-X
MG;/?-N@?[>.=<?;!.MOV+(_.WK?.]I;K9BV5T*=@R-AFWGAX7I,9KN4.YS#S
M]-&7(/;@97^^"]/@KR%3_B>P9Q;%G46Q"SV;8XI9#@A+L]G6L"6,$;8=TMP
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MR0%;5[OK*RF9DJ_.4PVE/VLL?6_X4FZ/-5FU\YB$>#Y9SOUPV+'.3;&_]/S
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M9!(65[#@R"@O&#KCX,2G\["QZP^:H%;]@Z;^06_]GSC1KUY( L^Z'.A5W^J
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MZP!U?LV8?&_H 9J_1L+_ 5!+ P04    "  @A)Q6"*P5M<,$  #0&0  &0
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M9&GQN $: <\-U/<58_(PR">H[^!F_P-02P,$%     @ ((2<5E13]#KM!
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M^V;,3)\T&D]JC]*%;E@.,P_/B@:U!2][\VJ2!!^.6 H'2^$Q]>SZV0+H#5-
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M65V\JX86A;OLKH4V5V?WN#,?*RCM /-^(X0^-BQ!\_FS^@=02P,$%     @
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M6;A[ 80>-P7JXZ?5;;W8#$33)Y<W]>;C= C;CX&H"-7+7LTT\ZPH598?,6-
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M)V$=XL$>XT%6PW^ID$>.5#W, S[.FZ!Y,1RAR>]O=GCLG W@6F1;,?@ -"!
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M59?0D)XF=J*LK)M@:=SR$A[!_FRW&B,VLN2BAL8(U1 -14)7X7(]=_D^X9>
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M0H'08/()!>B^'_O JM;WP%Y9["@_K/ ) ^T2<+U0RIX"5V!\%--_4$L#!!0
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MV_J@5Q% H<D"=JD[F5@U+47LQG(Q:?641"^\*.OU0&V0H(=>+*>I>/Z3X?K
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MRD#\OLNR\ORA<G#YRPB/?P!02P,$%     @ ((2<5HE^[@?? P  +@X  !D
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MDFY2^97M_H*:4 DP8JDH_]&NMG4L%&V$9%GMK!!D25X]Z4LM1,L!!R<<2.U
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M[*9O8T<7:?((E>()PD;:8R2XV?6QG/[[3H2#<#*:'7'MC8MFT\]'C/V#R[E
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MX(!K _5^SIC<3G2 NB6,?P%02P,$%     @ ((2<5A\<!Q8$!0  70X  !D
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M965T<R]S:&5E=#@X+GAM;,U7;4_;,!#^*U8V32!!\]JT96VD033!!!JB8_N
M]L%-+JV%$V>VV\*_GYV$K*$A BF:^-+:R3V/[YZ[<^SIEO%[L0*0Z"&EF9@9
M*RGS$],4T0I2+ 8LATR]21A/L513OC1%S@''!2BEIF-9OIEBDAG!M'AVS8,I
M6TM*,KCF2*S3%//'4Z!L.S-LX^G!#5FNI'Y@!M,<+V$.\C:_YFIFUBPQ22$3
MA&6(0S(SOM@GX43;%P8_"6S%SACI2!:,W>O)13PS+.T04(BD9L#J;P-G0*DF
M4F[\J3B->DD-W!T_L7\M8E>Q++" ,T9_D5BN9L;80#$D>$WE#=N>0Q7/4/-%
MC(KB%VTK6\M T5I(EE9@Y4%*LO(?/U0Z[ !L[P6 4P&<UP+<"N"^%N!5 *]0
MI@RET"'$$@=3SK:(:VO%I@>%F 5:A4\RG?:YY.HM43@9W #%$F*48RX?D>0X
M$[C(B$ XBY6D%&<1"'00@L2$BD-TC.:J]N(U!<02Q+8D6R+)5 G\(R(*<(QN
MYR$Z^'@X-:7R4Z]F1I5/IZ5/S@L^A1 -D&L?(<=RG!;XV>OA=@L\[(9_P]D
M6:UP4XE;*^S4"CL%G_N_%;Z[5"NA"PFI^-TF<NF6U^Z6WDY.1(XCF!EJOQ#
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MJK-Z,5RIZQ=P;:#>)XS)IXD^L-<7NN O4$L#!!0    ( ""$G%;S(9\;U (
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MWOD([Y*JNU,],;*H"OQ"&FP7U3##A@[*&N#^4DJSG]@#VK\(\5]02P,$%
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M[/UP_S7<Q6ST*0GZE 26+WR#KS?\HR!WG>'9SO#7WO!TB?G"+ASRVQXP&C[
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M'\AL4[VR.,^DS)+JXUKPI<C+ /7[79;)IX/R+<CC6Z_3_P%02P,$%     @
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MU EY QE( \A-132U3U+-^-SAHI1*^6H*X9K*K!6^4HYVF7!P?A[:8[0''QW
M8TQ"0@+<#A\W\'$G_,00,LA0#=G&&!\PXHB0$ ?!&\;.G?[QI/2;./J=<5QO
M2B9MWFDAEKSU5O0/4A@-^C$Y2'7G1G\;AK]3. N0<]=/S,&PD%5]:E:;EG7I
M*O6;];%I957G^2U3]<$[*N>,*Y3#S$@&9WWSJV356ZJ)%J4KSU.A3;%WPX5I
MQR"M@?D^$T)O)W:#IL$GOP!02P,$%     @ ((2<5H$YS6,"!   + T  !D
M  !X;"]W;W)K<VAE971S+W-H965T.30N>&ULK5=M;]LV$/XKA%8,";!$HEXL
M.;,-)$Z+%EC1(&FWSXQTLME*I$?2=K)?OZ.DR+(MJ\&6+S9?[AX^=T?>G29;
MJ7[H)8 A3V4A]-19&K.Z<EV=+J%D^E*N0.!.+E7)#$[5PM4K!2RKE,K"]3UO
MY):,"V<VJ=;NU&PBUZ;@ NX4T>NR9.KY!@JYG3K4>5FXYXNEL0ON;+)B"W@
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M_XA#=^/0-4(K9D;6-54T' F^(D);(YH>F-P8;U23,UW&F1+X-4<_%=ZPB)=
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MV@-I#/!Y*H3>;4R :GX<_@502P,$%     @ ((2<5K<[;QK  @  'P<  !D
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M=K" +#-$*.-GPVFU6QI@=WQ@_UQY1R]KIF ALA]IK+=3:V21&!)69OI1[+]
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M!Q,8;2Q18!$Q1B+B16ZF<,\4@DR_%-LXJ_32@!(ULZ[=TP(88RQ):+=-2-E
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MRD[ \;64YJEAKPC=C3#]!5!+ P04    "  @A)Q6YQA P;L2  ""4@$ &@
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MM>V%V_=5?>KX\O"+"8=?>WCW'U!+ P04    "  @A)Q68\012MT"  !<.P
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MJK<'Z.U5;P_0VZO>'J"W5[T]0&]?/>P&Z.U5;P_0VZO>'J"W5[T]0&^O>GN
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M[P+0NZC>!:!W4;T+0.^B>A> WD7U+@"]B^I= 'H7U;L ]"[581V WJ:KC^L
M_#9==6"G^T[!Q^ESWX^WHJ]U%?"=7D^7S_:W[[\NOR[6M^%*='N?,3[]!5!+
M P04    "  @A)Q6?^!#S%L"  !-.0  $P   %M#;VYT96YT7U1Y<&5S72YX
M;6S-V\MNVS 0A>%7,;0-+)J42$I%G$W;;9M%7T"5Z%BP;A"9U'G[TLH%:)$:
M#5R@_\:"37+.B -\.U]_>YR<7QW[;O#;9!_"]$$(7^]=7_ETG-P05W;CW%<A
M?IWOQ%35A^K.";79&%&/0W!#6(=3C>3F^I/;5?==6'T^QI]].P[;9':=3U8?
MGS:>LK9)-4U=6U<AKHN'H?DM9?V<D,:3RQZ_;R=_%3<DXLV$T\J? Y[/?7UP
M\]PV;G5;S>%+U<==XM@)'QX[Y]/S)=[H<=SMVMHU8WW?QR.IGV97-7[O7.B[
M]*GHU?GD$&_8/7W*B_.7,N<"X\[;>9Q\G-CLWA_W,I+3Z?44"[DYM.=?\34Q
MEK[X_=QIVHUK_C([7N^/<3XL\_!B>5Q^Q[_.^+7^._M0D#XR2!\YI \-Z<-
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M    $               @ $     9&]C4')O<',O87!P+GAM;%!+ 0(4 Q0
M   ( ""$G%8#GA>W[@   "L"   1              "  :\   !D;V-0<F]P
M<R]C;W)E+GAM;%!+ 0(4 Q0    ( ""$G%:97)PC$ 8  )PG   3
M      "  <P!  !X;"]T:&5M92]T:&5M93$N>&UL4$L! A0#%     @ ((2<
M5O;J)JAR!@  ^AT  !@              ("!#0@  'AL+W=O<FMS:&5E=',O
M<VAE970Q+GAM;%!+ 0(4 Q0    ( ""$G%;P58QS_@<  /\G   8
M      " @;4.  !X;"]W;W)K<VAE971S+W-H965T,BYX;6Q02P$"% ,4
M"  @A)Q6\X 2\D '  #,'0  &               @('I%@  >&PO=V]R:W-H
M965T<R]S:&5E=#,N>&UL4$L! A0#%     @ ((2<5HV;'4Y? @  YP4  !@
M             ("!7QX  'AL+W=O<FMS:&5E=',O<VAE970T+GAM;%!+ 0(4
M Q0    ( ""$G%:Z^7V9/@D  'XJ   8              " @?0@  !X;"]W
M;W)K<VAE971S+W-H965T-2YX;6Q02P$"% ,4    "  @A)Q6IF;@$@X)  !B
M1P  &               @(%H*@  >&PO=V]R:W-H965T<R]S:&5E=#8N>&UL
M4$L! A0#%     @ ((2<5@+KLD< "0   A0  !@              ("!K#,
M 'AL+W=O<FMS:&5E=',O<VAE970W+GAM;%!+ 0(4 Q0    ( ""$G%8TIZC&
MY"(  /]R   8              " @>(\  !X;"]W;W)K<VAE971S+W-H965T
M."YX;6Q02P$"% ,4    "  @A)Q6;D8/20<$  !,"0  &
M@('\7P  >&PO=V]R:W-H965T<R]S:&5E=#DN>&UL4$L! A0#%     @ ((2<
M5AI(Q3N'!0  B T  !D              ("!.60  'AL+W=O<FMS:&5E=',O
M<VAE970Q,"YX;6Q02P$"% ,4    "  @A)Q6">K60^X$  #W#0  &0
M        @('W:0  >&PO=V]R:W-H965T<R]S:&5E=#$Q+GAM;%!+ 0(4 Q0
M   ( ""$G%8XWF+U0@8  %4/   9              " @1QO  !X;"]W;W)K
M<VAE971S+W-H965T,3(N>&UL4$L! A0#%     @ ((2<5A$23_H^!0  5@T
M !D              ("!E74  'AL+W=O<FMS:&5E=',O<VAE970Q,RYX;6Q0
M2P$"% ,4    "  @A)Q6F;-5$%T#  "4!P  &0              @($*>P
M>&PO=V]R:W-H965T<R]S:&5E=#$T+GAM;%!+ 0(4 Q0    ( ""$G%8M)O=<
M=04  *\/   9              " @9Y^  !X;"]W;W)K<VAE971S+W-H965T
M,34N>&UL4$L! A0#%     @ ((2<5H%F[:D[!P  ,1,  !D
M ("!2H0  'AL+W=O<FMS:&5E=',O<VAE970Q-BYX;6Q02P$"% ,4    "  @
MA)Q6U1[1SMD0  "S+P  &0              @(&\BP  >&PO=V]R:W-H965T
M<R]S:&5E=#$W+GAM;%!+ 0(4 Q0    ( ""$G%9+A)3+LP0  &\*   9
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M970R,BYX;6Q02P$"% ,4    "  @A)Q6\V5V5F8*  !G&P  &0
M    @(%-N@  >&PO=V]R:W-H965T<R]S:&5E=#(S+GAM;%!+ 0(4 Q0    (
M ""$G%97 (&'&P0  ,H(   9              " @>K$  !X;"]W;W)K<VAE
M971S+W-H965T,C0N>&UL4$L! A0#%     @ ((2<5G0Z''ZO P  "PD  !D
M             ("!/,D  'AL+W=O<FMS:&5E=',O<VAE970R-2YX;6Q02P$"
M% ,4    "  @A)Q6+U<(XM %  ":#0  &0              @($BS0  >&PO
M=V]R:W-H965T<R]S:&5E=#(V+GAM;%!+ 0(4 Q0    ( ""$G%96$R:!Z08
M /\/   9              " @2G3  !X;"]W;W)K<VAE971S+W-H965T,C<N
M>&UL4$L! A0#%     @ ((2<5H@V*P1S!@  Q@\  !D              ("!
M2=H  'AL+W=O<FMS:&5E=',O<VAE970R."YX;6Q02P$"% ,4    "  @A)Q6
M0G3V< TE  !?@P  &0              @('SX   >&PO=V]R:W-H965T<R]S
M:&5E=#(Y+GAM;%!+ 0(4 Q0    ( ""$G%9X\"2XQP0  %@.   9
M      " @3<& 0!X;"]W;W)K<VAE971S+W-H965T,S N>&UL4$L! A0#%
M  @ ((2<5LS;N@+& P  )0D  !D              ("!-0L! 'AL+W=O<FMS
M:&5E=',O<VAE970S,2YX;6Q02P$"% ,4    "  @A)Q6VY9U1SH#  #Y!P
M&0              @($R#P$ >&PO=V]R:W-H965T<R]S:&5E=#,R+GAM;%!+
M 0(4 Q0    ( ""$G%;[6W[ZM (  -X%   9              " @:,2 0!X
M;"]W;W)K<VAE971S+W-H965T,S,N>&UL4$L! A0#%     @ ((2<5M.72K;K
M @  D08  !D              ("!CA4! 'AL+W=O<FMS:&5E=',O<VAE970S
M-"YX;6Q02P$"% ,4    "  @A)Q6(LN!R%X#  "'!P  &0
M@(&P& $ >&PO=V]R:W-H965T<R]S:&5E=#,U+GAM;%!+ 0(4 Q0    ( ""$
MG%;X0.;+U0,  $L*   9              " @44< 0!X;"]W;W)K<VAE971S
M+W-H965T,S8N>&UL4$L! A0#%     @ ((2<5C3FUQB#!   S H  !D
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M=#0Q+GAM;%!+ 0(4 Q0    ( ""$G%:*Z H]@00  !@*   9
M  " @>8U 0!X;"]W;W)K<VAE971S+W-H965T-#(N>&UL4$L! A0#%     @
M((2<5C_?0Z6; @  D04  !D              ("!GCH! 'AL+W=O<FMS:&5E
M=',O<VAE970T,RYX;6Q02P$"% ,4    "  @A)Q60@" =+T#  #N!P  &0
M            @(%P/0$ >&PO=V]R:W-H965T<R]S:&5E=#0T+GAM;%!+ 0(4
M Q0    ( ""$G%9EF.6"= ,  /L'   9              " @61! 0!X;"]W
M;W)K<VAE971S+W-H965T-#4N>&UL4$L! A0#%     @ ((2<5IR:N=N6!
M' P  !D              ("!#T4! 'AL+W=O<FMS:&5E=',O<VAE970T-BYX
M;6Q02P$"% ,4    "  @A)Q64KT59R$&   2#0  &0              @('<
M20$ >&PO=V]R:W-H965T<R]S:&5E=#0W+GAM;%!+ 0(4 Q0    ( ""$G%:Y
MS;N6JP(  /\&   9              " @310 0!X;"]W;W)K<VAE971S+W-H
M965T-#@N>&UL4$L! A0#%     @ ((2<5H7I#Q!L @  H 8  !D
M     ("!%E,! 'AL+W=O<FMS:&5E=',O<VAE970T.2YX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    ( ""$G%:C34W$Z (  !<*   9              "
M@:)H 0!X;"]W;W)K<VAE971S+W-H965T-30N>&UL4$L! A0#%     @ ((2<
M5B(_O8](!   )!0  !D              ("!P6L! 'AL+W=O<FMS:&5E=',O
M<VAE970U-2YX;6Q02P$"% ,4    "  @A)Q6,]N%QEP#  !#"P  &0
M        @(% < $ >&PO=V]R:W-H965T<R]S:&5E=#4V+GAM;%!+ 0(4 Q0
M   ( ""$G%;,:$]/B08  #1#   9              " @=-S 0!X;"]W;W)K
M<VAE971S+W-H965T-3<N>&UL4$L! A0#%     @ ((2<5OX8Q3M! P  KPH
M !D              ("!DWH! 'AL+W=O<FMS:&5E=',O<VAE970U."YX;6Q0
M2P$"% ,4    "  @A)Q6[WN18K$#  #V%P  &0              @($+?@$
M>&PO=V]R:W-H965T<R]S:&5E=#4Y+GAM;%!+ 0(4 Q0    ( ""$G%8SNR5Q
M(04  / C   9              " @?.! 0!X;"]W;W)K<VAE971S+W-H965T
M-C N>&UL4$L! A0#%     @ ((2<5MD7"$ZH P  ' \  !D
M ("!2X<! 'AL+W=O<FMS:&5E=',O<VAE970V,2YX;6Q02P$"% ,4    "  @
MA)Q6)(['YH@#   F$0  &0              @($JBP$ >&PO=V]R:W-H965T
M<R]S:&5E=#8R+GAM;%!+ 0(4 Q0    ( ""$G%8(K!6UPP0  - 9   9
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M970V-RYX;6Q02P$"% ,4    "  @A)Q6NDRS^G8"   ?!@  &0
M    @($>J $ >&PO=V]R:W-H965T<R]S:&5E=#8X+GAM;%!+ 0(4 Q0    (
M ""$G%9 8=N6# @  (I8   9              " @<NJ 0!X;"]W;W)K<VAE
M971S+W-H965T-CDN>&UL4$L! A0#%     @ ((2<5EN<Y8.A @  F08  !D
M             ("!#K,! 'AL+W=O<FMS:&5E=',O<VAE970W,"YX;6Q02P$"
M% ,4    "  @A)Q68-L$";D#  "W"@  &0              @('FM0$ >&PO
M=V]R:W-H965T<R]S:&5E=#<Q+GAM;%!+ 0(4 Q0    ( ""$G%;E>X 5A ,
M  H-   9              " @=:Y 0!X;"]W;W)K<VAE971S+W-H965T-S(N
M>&UL4$L! A0#%     @ ((2<5I^\UDU>#0  :,H  !D              ("!
MD;T! 'AL+W=O<FMS:&5E=',O<VAE970W,RYX;6Q02P$"% ,4    "  @A)Q6
M)0A<Y.,1   *M@  &0              @($FRP$ >&PO=V]R:W-H965T<R]S
M:&5E=#<T+GAM;%!+ 0(4 Q0    ( ""$G%;,_SQ". (  " %   9
M      " @4#= 0!X;"]W;W)K<VAE971S+W-H965T-S4N>&UL4$L! A0#%
M  @ ((2<5KFA/$ZR P  N14  !D              ("!K]\! 'AL+W=O<FMS
M:&5E=',O<VAE970W-BYX;6Q02P$"% ,4    "  @A)Q6?U::,R #  !5"0
M&0              @(&8XP$ >&PO=V]R:W-H965T<R]S:&5E=#<W+GAM;%!+
M 0(4 Q0    ( ""$G%;MDA!PKP,   T4   9              " @>_F 0!X
M;"]W;W)K<VAE971S+W-H965T-S@N>&UL4$L! A0#%     @ ((2<5I::]YMY
M @  R@8  !D              ("!U>H! 'AL+W=O<FMS:&5E=',O<VAE970W
M.2YX;6Q02P$"% ,4    "  @A)Q6.&CW).0(   E00  &0
M@(&%[0$ >&PO=V]R:W-H965T<R]S:&5E=#@P+GAM;%!+ 0(4 Q0    ( ""$
MG%:)?NX'WP,  "X.   9              " @:#V 0!X;"]W;W)K<VAE971S
M+W-H965T.#$N>&UL4$L! A0#%     @ ((2<5ENXDGI#!   GQ4  !D
M         ("!MOH! 'AL+W=O<FMS:&5E=',O<VAE970X,BYX;6Q02P$"% ,4
M    "  @A)Q6#D5LC@\#  !0"   &0              @($P_P$ >&PO=V]R
M:W-H965T<R]S:&5E=#@S+GAM;%!+ 0(4 Q0    ( ""$G%95=83@D0,  -D,
M   9              " @78" @!X;"]W;W)K<VAE971S+W-H965T.#0N>&UL
M4$L! A0#%     @ ((2<5@9G0%T!!   K!(  !D              ("!/@8"
M 'AL+W=O<FMS:&5E=',O<VAE970X-2YX;6Q02P$"% ,4    "  @A)Q6Y4**
MX_H"   >"@  &0              @(%V"@( >&PO=V]R:W-H965T<R]S:&5E
M=#@V+GAM;%!+ 0(4 Q0    ( ""$G%8?' <6! 4  %T.   9
M  " @:<- @!X;"]W;W)K<VAE971S+W-H965T.#<N>&UL4$L! A0#%     @
M((2<5I[>+< % P  W T  !D              ("!XA(" 'AL+W=O<FMS:&5E
M=',O<VAE970X."YX;6Q02P$"% ,4    "  @A)Q6\R&?&]0"   N"   &0
M            @($>%@( >&PO=V]R:W-H965T<R]S:&5E=#@Y+GAM;%!+ 0(4
M Q0    ( ""$G%8T=U/^M@(  $<'   9              " @2D9 @!X;"]W
M;W)K<VAE971S+W-H965T.3 N>&UL4$L! A0#%     @ ((2<5JA9BDB$!@
M 2L  !D              ("!%AP" 'AL+W=O<FMS:&5E=',O<VAE970Y,2YX
M;6Q02P$"% ,4    "  @A)Q6#V8N7MX#   M#@  &0              @('1
M(@( >&PO=V]R:W-H965T<R]S:&5E=#DR+GAM;%!+ 0(4 Q0    ( ""$G%;8
MN+-0UP(  .P'   9              " @>8F @!X;"]W;W)K<VAE971S+W-H
M965T.3,N>&UL4$L! A0#%     @ ((2<5H$YS6,"!   + T  !D
M     ("!]"D" 'AL+W=O<FMS:&5E=',O<VAE970Y-"YX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    ( ""$G%:)Z!$WD@@  +0T   9              "
M@7H\ @!X;"]W;W)K<VAE971S+W-H965T.3DN>&UL4$L! A0#%     @ ((2<
M5DM)<?NT @  '0H  !H              ("!0T4" 'AL+W=O<FMS:&5E=',O
M<VAE970Q,# N>&UL4$L! A0#%     @ ((2<5N<80,&[$@  @E(! !H
M         ("!+T@" 'AL+W=O<FMS:&5E=',O<VAE970Q,#$N>&UL4$L! A0#
M%     @ ((2<5B#CMU)R P  K1<   T              ( !(EL" 'AL+W-T
M>6QE<RYX;6Q02P$"% ,4    "  @A)Q6EXJ[',     3 @  "P
M    @ &_7@( 7W)E;',O+G)E;'-02P$"% ,4    "  @A)Q61%\KEYD&  !Q
M0@  #P              @ &H7P( >&PO=V]R:V)O;VLN>&UL4$L! A0#%
M  @ ((2<5F/$$4K= @  7#L  !H              ( !;F8" 'AL+U]R96QS
M+W=O<FMB;V]K+GAM;"YR96QS4$L! A0#%     @ ((2<5G_@0\Q; @  33D
M !,              ( !@VD" %M#;VYT96YT7U1Y<&5S72YX;6Q02P4&
/ &T ;0#T'0  #VP"

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>154
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>155
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>156
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.23.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>284</ContextCount>
  <ElementCount>570</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>true</FootnotesReported>
  <SegmentCount>105</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>7</UnitCount>
  <MyReports>
    <Report instance="ea177383-40f_encore.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>000 - Document - Document And Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://encoreuranium.com/role/DocumentAndEntityInformation</Role>
      <ShortName>Document And Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="ea177383-40f_encore.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>001 - Statement - Consolidated Statements of Financial Position</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://encoreuranium.com/role/ConsolidatedBalanceSheet</Role>
      <ShortName>Consolidated Statements of Financial Position</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="ea177383-40f_encore.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>002 - Statement - Consolidated Statements of Loss and Comprehensive Loss</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://encoreuranium.com/role/ConsolidatedComprehensiveIncome</Role>
      <ShortName>Consolidated Statements of Loss and Comprehensive Loss</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="ea177383-40f_encore.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>003 - Statement - Consolidated Statements of Loss and Comprehensive Loss (Parentheticals)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://encoreuranium.com/role/ConsolidatedComprehensiveIncome_Parentheticals</Role>
      <ShortName>Consolidated Statements of Loss and Comprehensive Loss (Parentheticals)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="ea177383-40f_encore.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>004 - Statement - Consolidated Statements of Cash Flows</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://encoreuranium.com/role/ConsolidatedCashFlow</Role>
      <ShortName>Consolidated Statements of Cash Flows</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="ea177383-40f_encore.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>005 - Statement - Consolidated Statements of Changes in Shareholder???s Equity</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://encoreuranium.com/role/ShareholdersEquityType2or3</Role>
      <ShortName>Consolidated Statements of Changes in Shareholder???s Equity</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="ea177383-40f_encore.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>006 - Disclosure - Nature of Operations and Going Concern</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://encoreuranium.com/role/NatureofOperationsandGoingConcern</Role>
      <ShortName>Nature of Operations and Going Concern</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="ea177383-40f_encore.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>007 - Disclosure - Significant accounting policies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://encoreuranium.com/role/Significantaccountingpolicies</Role>
      <ShortName>Significant accounting policies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="ea177383-40f_encore.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>008 - Disclosure - Critical Accounting Estimates And Judgements</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://encoreuranium.com/role/CriticalAccountingEstimatesAndJudgements</Role>
      <ShortName>Critical Accounting Estimates And Judgements</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="ea177383-40f_encore.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>009 - Disclosure - Investment In Associate</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://encoreuranium.com/role/InvestmentInAssociate</Role>
      <ShortName>Investment In Associate</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="ea177383-40f_encore.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>010 - Disclosure - Investment in uranium</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://encoreuranium.com/role/Investmentinuranium</Role>
      <ShortName>Investment in uranium</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="ea177383-40f_encore.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>011 - Disclosure - Marketable Securities</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://encoreuranium.com/role/MarketableSecurities</Role>
      <ShortName>Marketable Securities</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="ea177383-40f_encore.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>012 - Disclosure - Intangible assets</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://encoreuranium.com/role/Intangibleassets</Role>
      <ShortName>Intangible assets</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="ea177383-40f_encore.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>013 - Disclosure - Property, plant, and equipment</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://encoreuranium.com/role/Propertyplantandequipment</Role>
      <ShortName>Property, plant, and equipment</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="ea177383-40f_encore.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>014 - Disclosure - Right-of-use assets</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://encoreuranium.com/role/Rightofuseassets</Role>
      <ShortName>Right-of-use assets</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report instance="ea177383-40f_encore.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>015 - Disclosure - Asset acquisition</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://encoreuranium.com/role/Assetacquisition</Role>
      <ShortName>Asset acquisition</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>16</Position>
    </Report>
    <Report instance="ea177383-40f_encore.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>016 - Disclosure - Mineral Properties</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://encoreuranium.com/role/MineralProperties</Role>
      <ShortName>Mineral Properties</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>17</Position>
    </Report>
    <Report instance="ea177383-40f_encore.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>017 - Disclosure - Asset retirement obligations</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://encoreuranium.com/role/Assetretirementobligations</Role>
      <ShortName>Asset retirement obligations</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>18</Position>
    </Report>
    <Report instance="ea177383-40f_encore.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>018 - Disclosure - Sales contracts</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://encoreuranium.com/role/Salescontracts</Role>
      <ShortName>Sales contracts</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>19</Position>
    </Report>
    <Report instance="ea177383-40f_encore.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>019 - Disclosure - Share Capital</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://encoreuranium.com/role/ShareCapital</Role>
      <ShortName>Share Capital</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>20</Position>
    </Report>
    <Report instance="ea177383-40f_encore.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>020 - Disclosure - Related party transactions and balances</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://encoreuranium.com/role/Relatedpartytransactionsandbalances</Role>
      <ShortName>Related party transactions and balances</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>21</Position>
    </Report>
    <Report instance="ea177383-40f_encore.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>021 - Disclosure - Management of capital</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://encoreuranium.com/role/Managementofcapital</Role>
      <ShortName>Management of capital</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>22</Position>
    </Report>
    <Report instance="ea177383-40f_encore.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>022 - Disclosure - Financial Instruments</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://encoreuranium.com/role/FinancialInstruments</Role>
      <ShortName>Financial Instruments</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>23</Position>
    </Report>
    <Report instance="ea177383-40f_encore.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>023 - Disclosure - Segmented information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://encoreuranium.com/role/Segmentedinformation</Role>
      <ShortName>Segmented information</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>24</Position>
    </Report>
    <Report instance="ea177383-40f_encore.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>024 - Disclosure - Supplemental disclosure with respect to cash flows</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://encoreuranium.com/role/Supplementaldisclosurewithrespecttocashflows</Role>
      <ShortName>Supplemental disclosure with respect to cash flows</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>25</Position>
    </Report>
    <Report instance="ea177383-40f_encore.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>025 - Disclosure - Income taxes</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://encoreuranium.com/role/Incometaxes</Role>
      <ShortName>Income taxes</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>26</Position>
    </Report>
    <Report instance="ea177383-40f_encore.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>026 - Disclosure - Change in Presentation Currency</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://encoreuranium.com/role/ChangeinPresentationCurrency</Role>
      <ShortName>Change in Presentation Currency</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>27</Position>
    </Report>
    <Report instance="ea177383-40f_encore.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>027 - Disclosure - Events after the reporting period</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://encoreuranium.com/role/Eventsafterthereportingperiod</Role>
      <ShortName>Events after the reporting period</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>28</Position>
    </Report>
    <Report instance="ea177383-40f_encore.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>028 - Disclosure - Accounting Policies, by Policy (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://encoreuranium.com/role/AccountingPoliciesByPolicy</Role>
      <ShortName>Accounting Policies, by Policy (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <ParentRole>http://encoreuranium.com/role/CriticalAccountingEstimatesAndJudgements</ParentRole>
      <Position>29</Position>
    </Report>
    <Report instance="ea177383-40f_encore.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>029 - Disclosure - Significant accounting policies (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://encoreuranium.com/role/SignificantaccountingpoliciesTables</Role>
      <ShortName>Significant accounting policies (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://encoreuranium.com/role/Significantaccountingpolicies</ParentRole>
      <Position>30</Position>
    </Report>
    <Report instance="ea177383-40f_encore.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>030 - Disclosure - Investment In Associate (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://encoreuranium.com/role/InvestmentInAssociateTables</Role>
      <ShortName>Investment In Associate (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://encoreuranium.com/role/InvestmentInAssociate</ParentRole>
      <Position>31</Position>
    </Report>
    <Report instance="ea177383-40f_encore.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>031 - Disclosure - Investment in uranium (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://encoreuranium.com/role/InvestmentinuraniumTables</Role>
      <ShortName>Investment in uranium (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://encoreuranium.com/role/Investmentinuranium</ParentRole>
      <Position>32</Position>
    </Report>
    <Report instance="ea177383-40f_encore.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>032 - Disclosure - Marketable Securities (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://encoreuranium.com/role/MarketableSecuritiesTables</Role>
      <ShortName>Marketable Securities (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://encoreuranium.com/role/MarketableSecurities</ParentRole>
      <Position>33</Position>
    </Report>
    <Report instance="ea177383-40f_encore.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>033 - Disclosure - Intangible assets (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://encoreuranium.com/role/IntangibleassetsTables</Role>
      <ShortName>Intangible assets (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://encoreuranium.com/role/Intangibleassets</ParentRole>
      <Position>34</Position>
    </Report>
    <Report instance="ea177383-40f_encore.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R35.htm</HtmlFileName>
      <LongName>034 - Disclosure - Property, plant, and equipment (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://encoreuranium.com/role/PropertyplantandequipmentTables</Role>
      <ShortName>Property, plant, and equipment (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://encoreuranium.com/role/Propertyplantandequipment</ParentRole>
      <Position>35</Position>
    </Report>
    <Report instance="ea177383-40f_encore.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R36.htm</HtmlFileName>
      <LongName>035 - Disclosure - Right-of-use assets (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://encoreuranium.com/role/RightofuseassetsTables</Role>
      <ShortName>Right-of-use assets (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://encoreuranium.com/role/Rightofuseassets</ParentRole>
      <Position>36</Position>
    </Report>
    <Report instance="ea177383-40f_encore.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R37.htm</HtmlFileName>
      <LongName>036 - Disclosure - Asset acquisition (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://encoreuranium.com/role/AssetacquisitionTables</Role>
      <ShortName>Asset acquisition (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://encoreuranium.com/role/Assetacquisition</ParentRole>
      <Position>37</Position>
    </Report>
    <Report instance="ea177383-40f_encore.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R38.htm</HtmlFileName>
      <LongName>037 - Disclosure - Mineral Properties (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://encoreuranium.com/role/MineralPropertiesTables</Role>
      <ShortName>Mineral Properties (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://encoreuranium.com/role/MineralProperties</ParentRole>
      <Position>38</Position>
    </Report>
    <Report instance="ea177383-40f_encore.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R39.htm</HtmlFileName>
      <LongName>038 - Disclosure - Asset retirement obligations (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://encoreuranium.com/role/AssetretirementobligationsTables</Role>
      <ShortName>Asset retirement obligations (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://encoreuranium.com/role/Assetretirementobligations</ParentRole>
      <Position>39</Position>
    </Report>
    <Report instance="ea177383-40f_encore.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R40.htm</HtmlFileName>
      <LongName>039 - Disclosure - Sales contracts (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://encoreuranium.com/role/SalescontractsTables</Role>
      <ShortName>Sales contracts (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://encoreuranium.com/role/Salescontracts</ParentRole>
      <Position>40</Position>
    </Report>
    <Report instance="ea177383-40f_encore.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R41.htm</HtmlFileName>
      <LongName>040 - Disclosure - Share Capital (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://encoreuranium.com/role/ShareCapitalTables</Role>
      <ShortName>Share Capital (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://encoreuranium.com/role/ShareCapital</ParentRole>
      <Position>41</Position>
    </Report>
    <Report instance="ea177383-40f_encore.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R42.htm</HtmlFileName>
      <LongName>041 - Disclosure - Related party transactions and balances (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://encoreuranium.com/role/RelatedpartytransactionsandbalancesTables</Role>
      <ShortName>Related party transactions and balances (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://encoreuranium.com/role/Relatedpartytransactionsandbalances</ParentRole>
      <Position>42</Position>
    </Report>
    <Report instance="ea177383-40f_encore.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R43.htm</HtmlFileName>
      <LongName>042 - Disclosure - Financial Instruments (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://encoreuranium.com/role/FinancialInstrumentsTables</Role>
      <ShortName>Financial Instruments (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://encoreuranium.com/role/FinancialInstruments</ParentRole>
      <Position>43</Position>
    </Report>
    <Report instance="ea177383-40f_encore.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R44.htm</HtmlFileName>
      <LongName>043 - Disclosure - Segmented information (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://encoreuranium.com/role/SegmentedinformationTables</Role>
      <ShortName>Segmented information (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://encoreuranium.com/role/Segmentedinformation</ParentRole>
      <Position>44</Position>
    </Report>
    <Report instance="ea177383-40f_encore.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R45.htm</HtmlFileName>
      <LongName>044 - Disclosure - Supplemental disclosure with respect to cash flows (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://encoreuranium.com/role/SupplementaldisclosurewithrespecttocashflowsTables</Role>
      <ShortName>Supplemental disclosure with respect to cash flows (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://encoreuranium.com/role/Supplementaldisclosurewithrespecttocashflows</ParentRole>
      <Position>45</Position>
    </Report>
    <Report instance="ea177383-40f_encore.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R46.htm</HtmlFileName>
      <LongName>045 - Disclosure - Income taxes (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://encoreuranium.com/role/IncometaxesTables</Role>
      <ShortName>Income taxes (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://encoreuranium.com/role/Incometaxes</ParentRole>
      <Position>46</Position>
    </Report>
    <Report instance="ea177383-40f_encore.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R47.htm</HtmlFileName>
      <LongName>046 - Disclosure - Change in Presentation Currency (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://encoreuranium.com/role/ChangeinPresentationCurrencyTables</Role>
      <ShortName>Change in Presentation Currency (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://encoreuranium.com/role/ChangeinPresentationCurrency</ParentRole>
      <Position>47</Position>
    </Report>
    <Report instance="ea177383-40f_encore.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R48.htm</HtmlFileName>
      <LongName>047 - Disclosure - Nature of Operations and Going Concern (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://encoreuranium.com/role/NatureofOperationsandGoingConcernDetails</Role>
      <ShortName>Nature of Operations and Going Concern (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://encoreuranium.com/role/NatureofOperationsandGoingConcern</ParentRole>
      <Position>48</Position>
    </Report>
    <Report instance="ea177383-40f_encore.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R49.htm</HtmlFileName>
      <LongName>048 - Disclosure - Significant accounting policies (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://encoreuranium.com/role/SignificantaccountingpoliciesDetails</Role>
      <ShortName>Significant accounting policies (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://encoreuranium.com/role/SignificantaccountingpoliciesTables</ParentRole>
      <Position>49</Position>
    </Report>
    <Report instance="ea177383-40f_encore.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R50.htm</HtmlFileName>
      <LongName>049 - Disclosure - Significant accounting policies (Details) - Schedule of exchange rates</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://encoreuranium.com/role/ScheduleofexchangeratesTable</Role>
      <ShortName>Significant accounting policies (Details) - Schedule of exchange rates</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://encoreuranium.com/role/SignificantaccountingpoliciesTables</ParentRole>
      <Position>50</Position>
    </Report>
    <Report instance="ea177383-40f_encore.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R51.htm</HtmlFileName>
      <LongName>050 - Disclosure - Significant accounting policies (Details) - Schedule of significant subsidiaries</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://encoreuranium.com/role/ScheduleofsignificantsubsidiariesTable</Role>
      <ShortName>Significant accounting policies (Details) - Schedule of significant subsidiaries</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://encoreuranium.com/role/SignificantaccountingpoliciesTables</ParentRole>
      <Position>51</Position>
    </Report>
    <Report instance="ea177383-40f_encore.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R52.htm</HtmlFileName>
      <LongName>051 - Disclosure - Significant accounting policies (Details) - Schedule of useful lives of property, plant and equipement</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://encoreuranium.com/role/ScheduleofusefullivesofpropertyplantandequipementTable</Role>
      <ShortName>Significant accounting policies (Details) - Schedule of useful lives of property, plant and equipement</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://encoreuranium.com/role/SignificantaccountingpoliciesTables</ParentRole>
      <Position>52</Position>
    </Report>
    <Report instance="ea177383-40f_encore.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R53.htm</HtmlFileName>
      <LongName>052 - Disclosure - Significant accounting policies (Details) - Schedule of useful lives of intangible assets</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://encoreuranium.com/role/ScheduleofusefullivesofintangibleassetsTable</Role>
      <ShortName>Significant accounting policies (Details) - Schedule of useful lives of intangible assets</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://encoreuranium.com/role/SignificantaccountingpoliciesTables</ParentRole>
      <Position>53</Position>
    </Report>
    <Report instance="ea177383-40f_encore.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R54.htm</HtmlFileName>
      <LongName>053 - Disclosure - Investment In Associate (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://encoreuranium.com/role/InvestmentInAssociateDetails</Role>
      <ShortName>Investment In Associate (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://encoreuranium.com/role/InvestmentInAssociateTables</ParentRole>
      <Position>54</Position>
    </Report>
    <Report instance="ea177383-40f_encore.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R55.htm</HtmlFileName>
      <LongName>054 - Disclosure - Investment In Associate (Details) - Schedule of proportional share in the associate</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://encoreuranium.com/role/ScheduleofproportionalshareintheassociateTable</Role>
      <ShortName>Investment In Associate (Details) - Schedule of proportional share in the associate</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://encoreuranium.com/role/InvestmentInAssociateTables</ParentRole>
      <Position>55</Position>
    </Report>
    <Report instance="ea177383-40f_encore.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R56.htm</HtmlFileName>
      <LongName>055 - Disclosure - Investment In Associate (Details) - Schedule of investment in associate continuity</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://encoreuranium.com/role/ScheduleofinvestmentinassociatecontinuityTable</Role>
      <ShortName>Investment In Associate (Details) - Schedule of investment in associate continuity</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://encoreuranium.com/role/InvestmentInAssociateTables</ParentRole>
      <Position>56</Position>
    </Report>
    <Report instance="ea177383-40f_encore.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R57.htm</HtmlFileName>
      <LongName>056 - Disclosure - Investment in uranium (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://encoreuranium.com/role/InvestmentinuraniumDetails</Role>
      <ShortName>Investment in uranium (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://encoreuranium.com/role/InvestmentinuraniumTables</ParentRole>
      <Position>57</Position>
    </Report>
    <Report instance="ea177383-40f_encore.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R58.htm</HtmlFileName>
      <LongName>057 - Disclosure - Investment in uranium (Details) - Schedule of the fair value of the physical uranium investment</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://encoreuranium.com/role/ScheduleofthefairvalueofthephysicaluraniuminvestmentTable</Role>
      <ShortName>Investment in uranium (Details) - Schedule of the fair value of the physical uranium investment</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://encoreuranium.com/role/InvestmentinuraniumTables</ParentRole>
      <Position>58</Position>
    </Report>
    <Report instance="ea177383-40f_encore.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R59.htm</HtmlFileName>
      <LongName>058 - Disclosure - Investment in uranium (Details) - Schedule of uranium concentrates purchase agreement</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://encoreuranium.com/role/ScheduleofuraniumconcentratespurchaseagreementTable</Role>
      <ShortName>Investment in uranium (Details) - Schedule of uranium concentrates purchase agreement</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://encoreuranium.com/role/InvestmentinuraniumTables</ParentRole>
      <Position>59</Position>
    </Report>
    <Report instance="ea177383-40f_encore.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R60.htm</HtmlFileName>
      <LongName>059 - Disclosure - Marketable Securities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://encoreuranium.com/role/MarketableSecuritiesDetails</Role>
      <ShortName>Marketable Securities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://encoreuranium.com/role/MarketableSecuritiesTables</ParentRole>
      <Position>60</Position>
    </Report>
    <Report instance="ea177383-40f_encore.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R61.htm</HtmlFileName>
      <LongName>060 - Disclosure - Marketable Securities (Details) - Schedule of marketable securities</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://encoreuranium.com/role/ScheduleofmarketablesecuritiesTable</Role>
      <ShortName>Marketable Securities (Details) - Schedule of marketable securities</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://encoreuranium.com/role/MarketableSecuritiesTables</ParentRole>
      <Position>61</Position>
    </Report>
    <Report instance="ea177383-40f_encore.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R62.htm</HtmlFileName>
      <LongName>061 - Disclosure - Intangible assets (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://encoreuranium.com/role/IntangibleassetsDetails</Role>
      <ShortName>Intangible assets (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://encoreuranium.com/role/IntangibleassetsTables</ParentRole>
      <Position>62</Position>
    </Report>
    <Report instance="ea177383-40f_encore.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R63.htm</HtmlFileName>
      <LongName>062 - Disclosure - Intangible assets (Details) - Schedule of intangible asset was determined</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://encoreuranium.com/role/ScheduleofintangibleassetwasdeterminedTable</Role>
      <ShortName>Intangible assets (Details) - Schedule of intangible asset was determined</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://encoreuranium.com/role/IntangibleassetsTables</ParentRole>
      <Position>63</Position>
    </Report>
    <Report instance="ea177383-40f_encore.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R64.htm</HtmlFileName>
      <LongName>063 - Disclosure - Property, plant, and equipment (Details) - Schedule of property, plant, and equipment</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://encoreuranium.com/role/ScheduleofpropertyplantandequipmentTable</Role>
      <ShortName>Property, plant, and equipment (Details) - Schedule of property, plant, and equipment</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://encoreuranium.com/role/PropertyplantandequipmentTables</ParentRole>
      <Position>64</Position>
    </Report>
    <Report instance="ea177383-40f_encore.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R65.htm</HtmlFileName>
      <LongName>064 - Disclosure - Right-of-use assets (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://encoreuranium.com/role/RightofuseassetsDetails</Role>
      <ShortName>Right-of-use assets (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://encoreuranium.com/role/RightofuseassetsTables</ParentRole>
      <Position>65</Position>
    </Report>
    <Report instance="ea177383-40f_encore.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R66.htm</HtmlFileName>
      <LongName>065 - Disclosure - Right-of-use assets (Details) - Schedule of change in the ROU assets</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://encoreuranium.com/role/ScheduleofchangeintheROUassetsTable</Role>
      <ShortName>Right-of-use assets (Details) - Schedule of change in the ROU assets</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://encoreuranium.com/role/RightofuseassetsTables</ParentRole>
      <Position>66</Position>
    </Report>
    <Report instance="ea177383-40f_encore.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R67.htm</HtmlFileName>
      <LongName>066 - Disclosure - Right-of-use assets (Details) - Schedule of change in the long-Term lease liability</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://encoreuranium.com/role/ScheduleofchangeinthelongTermleaseliabilityTable</Role>
      <ShortName>Right-of-use assets (Details) - Schedule of change in the long-Term lease liability</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://encoreuranium.com/role/RightofuseassetsTables</ParentRole>
      <Position>67</Position>
    </Report>
    <Report instance="ea177383-40f_encore.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R68.htm</HtmlFileName>
      <LongName>067 - Disclosure - Right-of-use assets (Details) - Schedule of undiscounted future lease payments</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://encoreuranium.com/role/ScheduleofundiscountedfutureleasepaymentsTable</Role>
      <ShortName>Right-of-use assets (Details) - Schedule of undiscounted future lease payments</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://encoreuranium.com/role/RightofuseassetsTables</ParentRole>
      <Position>68</Position>
    </Report>
    <Report instance="ea177383-40f_encore.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R69.htm</HtmlFileName>
      <LongName>068 - Disclosure - Asset acquisition (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://encoreuranium.com/role/AssetacquisitionDetails</Role>
      <ShortName>Asset acquisition (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://encoreuranium.com/role/AssetacquisitionTables</ParentRole>
      <Position>69</Position>
    </Report>
    <Report instance="ea177383-40f_encore.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R70.htm</HtmlFileName>
      <LongName>069 - Disclosure - Asset acquisition (Details) - Schedule of estimated fair value of assets and liabilities</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://encoreuranium.com/role/ScheduleofestimatedfairvalueofassetsandliabilitiesTable</Role>
      <ShortName>Asset acquisition (Details) - Schedule of estimated fair value of assets and liabilities</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://encoreuranium.com/role/AssetacquisitionTables</ParentRole>
      <Position>70</Position>
    </Report>
    <Report instance="ea177383-40f_encore.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R71.htm</HtmlFileName>
      <LongName>070 - Disclosure - Asset acquisition (Details) - Schedule of net assets acquired</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://encoreuranium.com/role/ScheduleofnetassetsacquiredTable</Role>
      <ShortName>Asset acquisition (Details) - Schedule of net assets acquired</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://encoreuranium.com/role/AssetacquisitionTables</ParentRole>
      <Position>71</Position>
    </Report>
    <Report instance="ea177383-40f_encore.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R72.htm</HtmlFileName>
      <LongName>071 - Disclosure - Asset acquisition (Details) - Schedule of weighted average assumptions used in the black-scholes option</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://encoreuranium.com/role/ScheduleofweightedaverageassumptionsusedintheblackscholesoptionTable</Role>
      <ShortName>Asset acquisition (Details) - Schedule of weighted average assumptions used in the black-scholes option</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://encoreuranium.com/role/AssetacquisitionTables</ParentRole>
      <Position>72</Position>
    </Report>
    <Report instance="ea177383-40f_encore.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R73.htm</HtmlFileName>
      <LongName>072 - Disclosure - Mineral Properties (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://encoreuranium.com/role/MineralPropertiesDetails</Role>
      <ShortName>Mineral Properties (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://encoreuranium.com/role/MineralPropertiesTables</ParentRole>
      <Position>73</Position>
    </Report>
    <Report instance="ea177383-40f_encore.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R74.htm</HtmlFileName>
      <LongName>073 - Disclosure - Mineral Properties (Details) - Schedule of mineral properties</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://encoreuranium.com/role/ScheduleofmineralpropertiesTable</Role>
      <ShortName>Mineral Properties (Details) - Schedule of mineral properties</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://encoreuranium.com/role/MineralPropertiesTables</ParentRole>
      <Position>74</Position>
    </Report>
    <Report instance="ea177383-40f_encore.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R75.htm</HtmlFileName>
      <LongName>074 - Disclosure - Asset retirement obligations (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://encoreuranium.com/role/AssetretirementobligationsDetails</Role>
      <ShortName>Asset retirement obligations (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://encoreuranium.com/role/AssetretirementobligationsTables</ParentRole>
      <Position>75</Position>
    </Report>
    <Report instance="ea177383-40f_encore.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R76.htm</HtmlFileName>
      <LongName>075 - Disclosure - Asset retirement obligations (Details) - Schedule of asset retirement obligations balance</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://encoreuranium.com/role/ScheduleofassetretirementobligationsbalanceTable</Role>
      <ShortName>Asset retirement obligations (Details) - Schedule of asset retirement obligations balance</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://encoreuranium.com/role/AssetretirementobligationsTables</ParentRole>
      <Position>76</Position>
    </Report>
    <Report instance="ea177383-40f_encore.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R77.htm</HtmlFileName>
      <LongName>076 - Disclosure - Asset retirement obligations (Details) - Schedule of asset retirement obligations continuity</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://encoreuranium.com/role/ScheduleofassetretirementobligationscontinuityTable</Role>
      <ShortName>Asset retirement obligations (Details) - Schedule of asset retirement obligations continuity</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://encoreuranium.com/role/AssetretirementobligationsTables</ParentRole>
      <Position>77</Position>
    </Report>
    <Report instance="ea177383-40f_encore.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R78.htm</HtmlFileName>
      <LongName>077 - Disclosure - Sales contracts (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://encoreuranium.com/role/SalescontractsDetails</Role>
      <ShortName>Sales contracts (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://encoreuranium.com/role/SalescontractsTables</ParentRole>
      <Position>78</Position>
    </Report>
    <Report instance="ea177383-40f_encore.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R79.htm</HtmlFileName>
      <LongName>078 - Disclosure - Sales contracts (Details) - Schedule of uranium sales contracts over the next five years</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://encoreuranium.com/role/ScheduleofuraniumsalescontractsoverthenextfiveyearsTable</Role>
      <ShortName>Sales contracts (Details) - Schedule of uranium sales contracts over the next five years</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://encoreuranium.com/role/SalescontractsTables</ParentRole>
      <Position>79</Position>
    </Report>
    <Report instance="ea177383-40f_encore.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R80.htm</HtmlFileName>
      <LongName>079 - Disclosure - Share Capital (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://encoreuranium.com/role/ShareCapitalDetails</Role>
      <ShortName>Share Capital (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://encoreuranium.com/role/ShareCapitalTables</ParentRole>
      <Position>80</Position>
    </Report>
    <Report instance="ea177383-40f_encore.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R81.htm</HtmlFileName>
      <LongName>080 - Disclosure - Share Capital (Details) - Schedule of the company???s stock options outstanding</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://encoreuranium.com/role/ScheduleofthecompanysstockoptionsoutstandingTable</Role>
      <ShortName>Share Capital (Details) - Schedule of the company???s stock options outstanding</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://encoreuranium.com/role/ShareCapitalTables</ParentRole>
      <Position>81</Position>
    </Report>
    <Report instance="ea177383-40f_encore.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R82.htm</HtmlFileName>
      <LongName>081 - Disclosure - Share Capital (Details) - Schedule of stock options outstanding</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://encoreuranium.com/role/ScheduleofstockoptionsoutstandingTable</Role>
      <ShortName>Share Capital (Details) - Schedule of stock options outstanding</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://encoreuranium.com/role/ShareCapitalTables</ParentRole>
      <Position>82</Position>
    </Report>
    <Report instance="ea177383-40f_encore.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R83.htm</HtmlFileName>
      <LongName>082 - Disclosure - Share Capital (Details) - Schedule of weighted average assumptions used in calculating the fair values</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://encoreuranium.com/role/ScheduleofweightedaverageassumptionsusedincalculatingthefairvaluesTable</Role>
      <ShortName>Share Capital (Details) - Schedule of weighted average assumptions used in calculating the fair values</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://encoreuranium.com/role/ShareCapitalTables</ParentRole>
      <Position>83</Position>
    </Report>
    <Report instance="ea177383-40f_encore.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R84.htm</HtmlFileName>
      <LongName>083 - Disclosure - Share Capital (Details) - Schedule of the status of the company???s warrants</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://encoreuranium.com/role/ScheduleofthestatusofthecompanyswarrantsTable</Role>
      <ShortName>Share Capital (Details) - Schedule of the status of the company???s warrants</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://encoreuranium.com/role/ShareCapitalTables</ParentRole>
      <Position>84</Position>
    </Report>
    <Report instance="ea177383-40f_encore.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R85.htm</HtmlFileName>
      <LongName>084 - Disclosure - Share Capital (Details) - Schedule of share purchase warrants outstanding</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://encoreuranium.com/role/ScheduleofsharepurchasewarrantsoutstandingTable</Role>
      <ShortName>Share Capital (Details) - Schedule of share purchase warrants outstanding</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://encoreuranium.com/role/ShareCapitalTables</ParentRole>
      <Position>85</Position>
    </Report>
    <Report instance="ea177383-40f_encore.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R86.htm</HtmlFileName>
      <LongName>085 - Disclosure - Related party transactions and balances (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://encoreuranium.com/role/RelatedpartytransactionsandbalancesDetails</Role>
      <ShortName>Related party transactions and balances (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://encoreuranium.com/role/RelatedpartytransactionsandbalancesTables</ParentRole>
      <Position>86</Position>
    </Report>
    <Report instance="ea177383-40f_encore.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R87.htm</HtmlFileName>
      <LongName>086 - Disclosure - Related party transactions and balances (Details) - Schedule of amounts paid to key management or entities providing similar services</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://encoreuranium.com/role/ScheduleofamountspaidtokeymanagementorentitiesprovidingsimilarservicesTable</Role>
      <ShortName>Related party transactions and balances (Details) - Schedule of amounts paid to key management or entities providing similar services</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://encoreuranium.com/role/RelatedpartytransactionsandbalancesTables</ParentRole>
      <Position>87</Position>
    </Report>
    <Report instance="ea177383-40f_encore.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R88.htm</HtmlFileName>
      <LongName>087 - Disclosure - Related party transactions and balances (Details) - Schedule of owing to related parties</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://encoreuranium.com/role/ScheduleofowingtorelatedpartiesTable</Role>
      <ShortName>Related party transactions and balances (Details) - Schedule of owing to related parties</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://encoreuranium.com/role/RelatedpartytransactionsandbalancesTables</ParentRole>
      <Position>88</Position>
    </Report>
    <Report instance="ea177383-40f_encore.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R89.htm</HtmlFileName>
      <LongName>088 - Disclosure - Financial Instruments (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://encoreuranium.com/role/FinancialInstrumentsDetails</Role>
      <ShortName>Financial Instruments (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://encoreuranium.com/role/FinancialInstrumentsTables</ParentRole>
      <Position>89</Position>
    </Report>
    <Report instance="ea177383-40f_encore.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R90.htm</HtmlFileName>
      <LongName>089 - Disclosure - Financial Instruments (Details) - Schedule of foreign currency exposures</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://encoreuranium.com/role/ScheduleofforeigncurrencyexposuresTable</Role>
      <ShortName>Financial Instruments (Details) - Schedule of foreign currency exposures</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://encoreuranium.com/role/FinancialInstrumentsTables</ParentRole>
      <Position>90</Position>
    </Report>
    <Report instance="ea177383-40f_encore.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R91.htm</HtmlFileName>
      <LongName>090 - Disclosure - Segmented information (Details) - Schedule of long-term assets by geographic segment</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://encoreuranium.com/role/ScheduleoflongtermassetsbygeographicsegmentTable</Role>
      <ShortName>Segmented information (Details) - Schedule of long-term assets by geographic segment</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://encoreuranium.com/role/SegmentedinformationTables</ParentRole>
      <Position>91</Position>
    </Report>
    <Report instance="ea177383-40f_encore.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R92.htm</HtmlFileName>
      <LongName>091 - Disclosure - Supplemental disclosure with respect to cash flows (Details) - Schedule of incurred non-cash financing and investing activities</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://encoreuranium.com/role/ScheduleofincurrednoncashfinancingandinvestingactivitiesTable</Role>
      <ShortName>Supplemental disclosure with respect to cash flows (Details) - Schedule of incurred non-cash financing and investing activities</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://encoreuranium.com/role/SupplementaldisclosurewithrespecttocashflowsTables</ParentRole>
      <Position>92</Position>
    </Report>
    <Report instance="ea177383-40f_encore.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R93.htm</HtmlFileName>
      <LongName>092 - Disclosure - Income taxes (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://encoreuranium.com/role/IncometaxesDetails</Role>
      <ShortName>Income taxes (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://encoreuranium.com/role/IncometaxesTables</ParentRole>
      <Position>93</Position>
    </Report>
    <Report instance="ea177383-40f_encore.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R94.htm</HtmlFileName>
      <LongName>093 - Disclosure - Income taxes (Details) - Schedule of federal and provincial corporate tax rates to income before tax</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://encoreuranium.com/role/ScheduleoffederalandprovincialcorporatetaxratestoincomebeforetaxTable</Role>
      <ShortName>Income taxes (Details) - Schedule of federal and provincial corporate tax rates to income before tax</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://encoreuranium.com/role/IncometaxesTables</ParentRole>
      <Position>94</Position>
    </Report>
    <Report instance="ea177383-40f_encore.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R95.htm</HtmlFileName>
      <LongName>094 - Disclosure - Income taxes (Details) - Schedule of income tax expense (recovery)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://encoreuranium.com/role/ScheduleofincometaxexpenserecoveryTable</Role>
      <ShortName>Income taxes (Details) - Schedule of income tax expense (recovery)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://encoreuranium.com/role/IncometaxesTables</ParentRole>
      <Position>95</Position>
    </Report>
    <Report instance="ea177383-40f_encore.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R96.htm</HtmlFileName>
      <LongName>095 - Disclosure - Income taxes (Details) - Schedule of deferred tax liabilities</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://encoreuranium.com/role/ScheduleofdeferredtaxliabilitiesTable</Role>
      <ShortName>Income taxes (Details) - Schedule of deferred tax liabilities</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://encoreuranium.com/role/IncometaxesTables</ParentRole>
      <Position>96</Position>
    </Report>
    <Report instance="ea177383-40f_encore.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R97.htm</HtmlFileName>
      <LongName>096 - Disclosure - Income taxes (Details) - Schedule of unrecognized deferred tax assets</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://encoreuranium.com/role/ScheduleofunrecognizeddeferredtaxassetsTable</Role>
      <ShortName>Income taxes (Details) - Schedule of unrecognized deferred tax assets</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://encoreuranium.com/role/IncometaxesTables</ParentRole>
      <Position>97</Position>
    </Report>
    <Report instance="ea177383-40f_encore.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R98.htm</HtmlFileName>
      <LongName>097 - Disclosure - Change in Presentation Currency (Details) - Schedule of effect of translation</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://encoreuranium.com/role/ScheduleofeffectoftranslationTable</Role>
      <ShortName>Change in Presentation Currency (Details) - Schedule of effect of translation</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://encoreuranium.com/role/ChangeinPresentationCurrencyTables</ParentRole>
      <Position>98</Position>
    </Report>
    <Report instance="ea177383-40f_encore.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R99.htm</HtmlFileName>
      <LongName>098 - Disclosure - Change in Presentation Currency (Details) - Schedule of consolidated statements of loss and comprehensive loss</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://encoreuranium.com/role/ScheduleofconsolidatedstatementsoflossandcomprehensivelossTable</Role>
      <ShortName>Change in Presentation Currency (Details) - Schedule of consolidated statements of loss and comprehensive loss</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://encoreuranium.com/role/ChangeinPresentationCurrencyTables</ParentRole>
      <Position>99</Position>
    </Report>
    <Report instance="ea177383-40f_encore.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R100.htm</HtmlFileName>
      <LongName>099 - Disclosure - Change in Presentation Currency (Details) - Schedule of consolidated statements of loss and comprehensive loss (Parentheticals)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://encoreuranium.com/role/ScheduleofconsolidatedstatementsoflossandcomprehensivelossTable_Parentheticals</Role>
      <ShortName>Change in Presentation Currency (Details) - Schedule of consolidated statements of loss and comprehensive loss (Parentheticals)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://encoreuranium.com/role/ChangeinPresentationCurrencyTables</ParentRole>
      <Position>100</Position>
    </Report>
    <Report instance="ea177383-40f_encore.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R101.htm</HtmlFileName>
      <LongName>100 - Disclosure - Events after the reporting period (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://encoreuranium.com/role/EventsafterthereportingperiodDetails</Role>
      <ShortName>Events after the reporting period (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://encoreuranium.com/role/Eventsafterthereportingperiod</ParentRole>
      <Position>101</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <Logs>
    <Log type="Warning">[ix-0514-Hidden-Fact-Eligible-For-Transform] WARN: 7 fact(s) appearing in ix:hidden were eligible for transformation: cve:PurchaseWarrantShares, cve:WarrantShare, ifrs-full:DilutedEarningsLossPerShare -  ea177383ex99-3_encoreenergy.htm 6880, 6881, 7137, 7138, 7139, 7191, 7192</Log>
  </Logs>
  <InputFiles>
    <File doctype="40-F" original="ea177383-40f_encore.htm">ea177383-40f_encore.htm</File>
    <File doctype="40-F" original="ea177383ex99-3_encoreenergy.htm">ea177383ex99-3_encoreenergy.htm</File>
    <File>cve-20221231.xsd</File>
    <File>cve-20221231_cal.xml</File>
    <File>cve-20221231_def.xml</File>
    <File>cve-20221231_lab.xml</File>
    <File>cve-20221231_pre.xml</File>
    <File>ea177383ex99-10_encoreenergy.htm</File>
    <File>ea177383ex99-11_encoreenergy.htm</File>
    <File>ea177383ex99-12_encoreenergy.htm</File>
    <File>ea177383ex99-13_encoreenergy.htm</File>
    <File>ea177383ex99-14_encoreenergy.htm</File>
    <File>ea177383ex99-15_encoreenergy.htm</File>
    <File>ea177383ex99-1_encoreenergy.htm</File>
    <File>ea177383ex99-2_encoreenergy.htm</File>
    <File>ea177383ex99-4_encoreenergy.htm</File>
    <File>ea177383ex99-5_encoreenergy.htm</File>
    <File>ea177383ex99-6_encoreenergy.htm</File>
    <File>ea177383ex99-7_encoreenergy.htm</File>
    <File>ea177383ex99-8_encoreenergy.htm</File>
    <File>ea177383ex99-9_encoreenergy.htm</File>
  </InputFiles>
  <SupplementalFiles>
    <File>ex99-3_001.jpg</File>
    <File>ex99-3_002.jpg</File>
    <File>ex99-3_003.jpg</File>
  </SupplementalFiles>
  <BaseTaxonomies>
    <BaseTaxonomy items="32">http://fasb.org/us-gaap/2022</BaseTaxonomy>
    <BaseTaxonomy items="41">http://xbrl.sec.gov/dei/2022</BaseTaxonomy>
    <BaseTaxonomy items="745">https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>159
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "ea177383-40f_encore.htm ea177383ex99-3_encoreenergy.htm": {
   "axisCustom": 0,
   "axisStandard": 19,
   "baseTaxonomies": {
    "http://fasb.org/us-gaap/2022": 32,
    "http://xbrl.sec.gov/dei/2022": 41,
    "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full": 745
   },
   "contextCount": 284,
   "dts": {
    "calculationLink": {
     "local": [
      "cve-20221231_cal.xml"
     ]
    },
    "definitionLink": {
     "local": [
      "cve-20221231_def.xml"
     ]
    },
    "inline": {
     "local": [
      "ea177383-40f_encore.htm",
      "ea177383ex99-3_encoreenergy.htm"
     ]
    },
    "labelLink": {
     "local": [
      "cve-20221231_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "cve-20221231_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "cve-20221231.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-roles-2022.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-types-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-roles-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-types-2022.xsd",
      "https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd",
      "https://xbrl.sec.gov/country/2022/country-2022.xsd",
      "https://xbrl.sec.gov/dei/2022/dei-2022.xsd",
      "https://xbrl.sec.gov/sic/2022/sic-2022.xsd",
      "https://xbrl.sec.gov/stpr/2022/stpr-2022.xsd"
     ]
    }
   },
   "elementCount": 902,
   "entityCount": 1,
   "hidden": {
    "http://encoreuranium.com/20221231": 199,
    "http://fasb.org/us-gaap/2022": 1,
    "http://xbrl.sec.gov/dei/2022": 3,
    "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full": 136,
    "total": 339
   },
   "keyCustom": 275,
   "keyStandard": 295,
   "memberCustom": 75,
   "memberStandard": 23,
   "nsprefix": "cve",
   "nsuri": "http://encoreuranium.com/20221231",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ea177383-40f_encore.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:EntityRegistrantName",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "000 - Document - Document And Entity Information",
     "menuCat": "Cover",
     "order": "1",
     "role": "http://encoreuranium.com/role/DocumentAndEntityInformation",
     "shortName": "Document And Entity Information",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ea177383-40f_encore.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:EntityRegistrantName",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R10": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "ea177383ex99-3_encoreenergy.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfSignificantInvestmentsInAssociatesExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "009 - Disclosure - Investment In Associate",
     "menuCat": "Notes",
     "order": "10",
     "role": "http://encoreuranium.com/role/InvestmentInAssociate",
     "shortName": "Investment In Associate",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "ea177383ex99-3_encoreenergy.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfSignificantInvestmentsInAssociatesExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R100": {
     "firstAnchor": null,
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "099 - Disclosure - Change in Presentation Currency (Details) - Schedule of consolidated statements of loss and comprehensive loss (Parentheticals)",
     "menuCat": "Details",
     "order": "100",
     "role": "http://encoreuranium.com/role/ScheduleofconsolidatedstatementsoflossandcomprehensivelossTable_Parentheticals",
     "shortName": "Change in Presentation Currency (Details) - Schedule of consolidated statements of loss and comprehensive loss (Parentheticals)",
     "subGroupType": "parenthetical",
     "uniqueAnchor": null
    },
    "R101": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "ifrs-full:DisclosureOfFairValueMeasurementOfAssetsExplanatory",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ea177383ex99-3_encoreenergy.htm",
      "contextRef": "c2",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "cve:TransactionCosts",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100 - Disclosure - Events after the reporting period (Details)",
     "menuCat": "Details",
     "order": "101",
     "role": "http://encoreuranium.com/role/EventsafterthereportingperiodDetails",
     "shortName": "Events after the reporting period (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ea177383ex99-3_encoreenergy.htm",
      "contextRef": "c265",
      "decimals": "4",
      "lang": null,
      "name": "cve:AcquireCommonShare",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R11": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "ea177383ex99-3_encoreenergy.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethodExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "010 - Disclosure - Investment in uranium",
     "menuCat": "Notes",
     "order": "11",
     "role": "http://encoreuranium.com/role/Investmentinuranium",
     "shortName": "Investment in uranium",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "ea177383ex99-3_encoreenergy.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethodExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R12": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "ea177383ex99-3_encoreenergy.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfMarketRiskExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "011 - Disclosure - Marketable Securities",
     "menuCat": "Notes",
     "order": "12",
     "role": "http://encoreuranium.com/role/MarketableSecurities",
     "shortName": "Marketable Securities",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "ea177383ex99-3_encoreenergy.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfMarketRiskExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R13": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "ea177383ex99-3_encoreenergy.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfIntangibleAssetsExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "012 - Disclosure - Intangible assets",
     "menuCat": "Notes",
     "order": "13",
     "role": "http://encoreuranium.com/role/Intangibleassets",
     "shortName": "Intangible assets",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "ea177383ex99-3_encoreenergy.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfIntangibleAssetsExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R14": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "ea177383ex99-3_encoreenergy.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfPropertyPlantAndEquipmentExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "013 - Disclosure - Property, plant, and equipment",
     "menuCat": "Notes",
     "order": "14",
     "role": "http://encoreuranium.com/role/Propertyplantandequipment",
     "shortName": "Property, plant, and equipment",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "ea177383ex99-3_encoreenergy.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfPropertyPlantAndEquipmentExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R15": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "ea177383ex99-3_encoreenergy.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfQuantitativeInformationAboutRightofuseAssetsExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "014 - Disclosure - Right-of-use assets",
     "menuCat": "Notes",
     "order": "15",
     "role": "http://encoreuranium.com/role/Rightofuseassets",
     "shortName": "Right-of-use assets",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "ea177383ex99-3_encoreenergy.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfQuantitativeInformationAboutRightofuseAssetsExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R16": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "ea177383ex99-3_encoreenergy.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfTransactionsRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombinationExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "015 - Disclosure - Asset acquisition",
     "menuCat": "Notes",
     "order": "16",
     "role": "http://encoreuranium.com/role/Assetacquisition",
     "shortName": "Asset acquisition",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "ea177383ex99-3_encoreenergy.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfTransactionsRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombinationExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R17": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "ea177383ex99-3_encoreenergy.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "cve:DisclosureOfMineralProperties",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "016 - Disclosure - Mineral Properties",
     "menuCat": "Notes",
     "order": "17",
     "role": "http://encoreuranium.com/role/MineralProperties",
     "shortName": "Mineral Properties",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "ea177383ex99-3_encoreenergy.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "cve:DisclosureOfMineralProperties",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R18": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "ea177383ex99-3_encoreenergy.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "cve:AssetRetirementObligationsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "017 - Disclosure - Asset retirement obligations",
     "menuCat": "Notes",
     "order": "18",
     "role": "http://encoreuranium.com/role/Assetretirementobligations",
     "shortName": "Asset retirement obligations",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "ea177383ex99-3_encoreenergy.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "cve:AssetRetirementObligationsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R19": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "ea177383ex99-3_encoreenergy.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "cve:DisclosueOfSalesContractsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "018 - Disclosure - Sales contracts",
     "menuCat": "Notes",
     "order": "19",
     "role": "http://encoreuranium.com/role/Salescontracts",
     "shortName": "Sales contracts",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "ea177383ex99-3_encoreenergy.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "cve:DisclosueOfSalesContractsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R2": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ea177383ex99-3_encoreenergy.htm",
      "contextRef": "c2",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "ifrs-full:CashAndCashEquivalents",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "001 - Statement - Consolidated Statements of Financial Position",
     "menuCat": "Statements",
     "order": "2",
     "role": "http://encoreuranium.com/role/ConsolidatedBalanceSheet",
     "shortName": "Consolidated Statements of Financial Position",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ea177383ex99-3_encoreenergy.htm",
      "contextRef": "c4",
      "decimals": "0",
      "lang": null,
      "name": "ifrs-full:CashAndCashEquivalents",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R20": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "ea177383ex99-3_encoreenergy.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfClassesOfShareCapitalExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "019 - Disclosure - Share Capital",
     "menuCat": "Notes",
     "order": "20",
     "role": "http://encoreuranium.com/role/ShareCapital",
     "shortName": "Share Capital",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "ea177383ex99-3_encoreenergy.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfClassesOfShareCapitalExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R21": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "ea177383ex99-3_encoreenergy.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfRelatedPartyExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "020 - Disclosure - Related party transactions and balances",
     "menuCat": "Notes",
     "order": "21",
     "role": "http://encoreuranium.com/role/Relatedpartytransactionsandbalances",
     "shortName": "Related party transactions and balances",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "ea177383ex99-3_encoreenergy.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfRelatedPartyExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R22": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "ea177383ex99-3_encoreenergy.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DescriptionOfManagingLiquidityRisk",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "021 - Disclosure - Management of capital",
     "menuCat": "Notes",
     "order": "22",
     "role": "http://encoreuranium.com/role/Managementofcapital",
     "shortName": "Management of capital",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "ea177383ex99-3_encoreenergy.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DescriptionOfManagingLiquidityRisk",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R23": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "ea177383ex99-3_encoreenergy.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfFinancialInstrumentsExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "022 - Disclosure - Financial Instruments",
     "menuCat": "Notes",
     "order": "23",
     "role": "http://encoreuranium.com/role/FinancialInstruments",
     "shortName": "Financial Instruments",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "ea177383ex99-3_encoreenergy.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfFinancialInstrumentsExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R24": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "ea177383ex99-3_encoreenergy.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfEntitysReportableSegmentsExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "023 - Disclosure - Segmented information",
     "menuCat": "Notes",
     "order": "24",
     "role": "http://encoreuranium.com/role/Segmentedinformation",
     "shortName": "Segmented information",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "ea177383ex99-3_encoreenergy.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfEntitysReportableSegmentsExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R25": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "ea177383ex99-3_encoreenergy.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "cve:SupplementalDisclosureWithRespectToCashflowsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "024 - Disclosure - Supplemental disclosure with respect to cash flows",
     "menuCat": "Notes",
     "order": "25",
     "role": "http://encoreuranium.com/role/Supplementaldisclosurewithrespecttocashflows",
     "shortName": "Supplemental disclosure with respect to cash flows",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "ea177383ex99-3_encoreenergy.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "cve:SupplementalDisclosureWithRespectToCashflowsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R26": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "ea177383ex99-3_encoreenergy.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfIncomeTaxExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "025 - Disclosure - Income taxes",
     "menuCat": "Notes",
     "order": "26",
     "role": "http://encoreuranium.com/role/Incometaxes",
     "shortName": "Income taxes",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "ea177383ex99-3_encoreenergy.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfIncomeTaxExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R27": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "ea177383ex99-3_encoreenergy.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfReclassificationsOrChangesInPresentationExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "026 - Disclosure - Change in Presentation Currency",
     "menuCat": "Notes",
     "order": "27",
     "role": "http://encoreuranium.com/role/ChangeinPresentationCurrency",
     "shortName": "Change in Presentation Currency",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "ea177383ex99-3_encoreenergy.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfReclassificationsOrChangesInPresentationExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R28": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "ea177383ex99-3_encoreenergy.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfEventsAfterReportingPeriodExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "027 - Disclosure - Events after the reporting period",
     "menuCat": "Notes",
     "order": "28",
     "role": "http://encoreuranium.com/role/Eventsafterthereportingperiod",
     "shortName": "Events after the reporting period",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "ea177383ex99-3_encoreenergy.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfEventsAfterReportingPeriodExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R29": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ea177383ex99-3_encoreenergy.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "cve:DescriptionOfAccountingPolicyForBasisOfPresentationtextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "028 - Disclosure - Accounting Policies, by Policy (Policies)",
     "menuCat": "Policies",
     "order": "29",
     "role": "http://encoreuranium.com/role/AccountingPoliciesByPolicy",
     "shortName": "Accounting Policies, by Policy (Policies)",
     "subGroupType": "policies",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ea177383ex99-3_encoreenergy.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "cve:DescriptionOfAccountingPolicyForBasisOfPresentationtextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R3": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ea177383ex99-3_encoreenergy.htm",
      "contextRef": "c0",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "cve:AccretionExpenses",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "002 - Statement - Consolidated Statements of Loss and Comprehensive Loss",
     "menuCat": "Statements",
     "order": "3",
     "role": "http://encoreuranium.com/role/ConsolidatedComprehensiveIncome",
     "shortName": "Consolidated Statements of Loss and Comprehensive Loss",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ea177383ex99-3_encoreenergy.htm",
      "contextRef": "c0",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "cve:AccretionExpenses",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R30": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ea177383ex99-3_encoreenergy.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfEffectOfChangesInForeignExchangeRatesExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "029 - Disclosure - Significant accounting policies (Tables)",
     "menuCat": "Tables",
     "order": "30",
     "role": "http://encoreuranium.com/role/SignificantaccountingpoliciesTables",
     "shortName": "Significant accounting policies (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ea177383ex99-3_encoreenergy.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfEffectOfChangesInForeignExchangeRatesExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R31": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ea177383ex99-3_encoreenergy.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "cve:DisclosureOfProportionalShareAssociatesExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "030 - Disclosure - Investment In Associate (Tables)",
     "menuCat": "Tables",
     "order": "31",
     "role": "http://encoreuranium.com/role/InvestmentInAssociateTables",
     "shortName": "Investment In Associate (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ea177383ex99-3_encoreenergy.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "cve:DisclosureOfProportionalShareAssociatesExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R32": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ea177383ex99-3_encoreenergy.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "cve:ScheduleOfTheFairValueOfThePhysicalUraniumInvestmentTableTextBlck",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "031 - Disclosure - Investment in uranium (Tables)",
     "menuCat": "Tables",
     "order": "32",
     "role": "http://encoreuranium.com/role/InvestmentinuraniumTables",
     "shortName": "Investment in uranium (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ea177383ex99-3_encoreenergy.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "cve:ScheduleOfTheFairValueOfThePhysicalUraniumInvestmentTableTextBlck",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R33": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ea177383ex99-3_encoreenergy.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "cve:ScheduleOfMarketableSecuritiesTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "032 - Disclosure - Marketable Securities (Tables)",
     "menuCat": "Tables",
     "order": "33",
     "role": "http://encoreuranium.com/role/MarketableSecuritiesTables",
     "shortName": "Marketable Securities (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ea177383ex99-3_encoreenergy.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "cve:ScheduleOfMarketableSecuritiesTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R34": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ea177383ex99-3_encoreenergy.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfDetailedInformationAboutIntangibleAssetsExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "033 - Disclosure - Intangible assets (Tables)",
     "menuCat": "Tables",
     "order": "34",
     "role": "http://encoreuranium.com/role/IntangibleassetsTables",
     "shortName": "Intangible assets (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ea177383ex99-3_encoreenergy.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfDetailedInformationAboutIntangibleAssetsExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R35": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ea177383ex99-3_encoreenergy.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "034 - Disclosure - Property, plant, and equipment (Tables)",
     "menuCat": "Tables",
     "order": "35",
     "role": "http://encoreuranium.com/role/PropertyplantandequipmentTables",
     "shortName": "Property, plant, and equipment (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ea177383ex99-3_encoreenergy.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R36": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ea177383ex99-3_encoreenergy.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "cve:DisclosureOfChangeInTheROUAssetsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "035 - Disclosure - Right-of-use assets (Tables)",
     "menuCat": "Tables",
     "order": "36",
     "role": "http://encoreuranium.com/role/RightofuseassetsTables",
     "shortName": "Right-of-use assets (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ea177383ex99-3_encoreenergy.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "cve:DisclosureOfChangeInTheROUAssetsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R37": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ea177383ex99-3_encoreenergy.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfFairValueMeasurementOfAssetsExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "036 - Disclosure - Asset acquisition (Tables)",
     "menuCat": "Tables",
     "order": "37",
     "role": "http://encoreuranium.com/role/AssetacquisitionTables",
     "shortName": "Asset acquisition (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ea177383ex99-3_encoreenergy.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfFairValueMeasurementOfAssetsExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R38": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ea177383ex99-3_encoreenergy.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "cve:ScheduleOfMineralProperties",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "037 - Disclosure - Mineral Properties (Tables)",
     "menuCat": "Tables",
     "order": "38",
     "role": "http://encoreuranium.com/role/MineralPropertiesTables",
     "shortName": "Mineral Properties (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ea177383ex99-3_encoreenergy.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "cve:ScheduleOfMineralProperties",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R39": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ea177383ex99-3_encoreenergy.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "cve:DisclosureOfAssetRetirementObligationsBalanceTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "038 - Disclosure - Asset retirement obligations (Tables)",
     "menuCat": "Tables",
     "order": "39",
     "role": "http://encoreuranium.com/role/AssetretirementobligationsTables",
     "shortName": "Asset retirement obligations (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ea177383ex99-3_encoreenergy.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "cve:DisclosureOfAssetRetirementObligationsBalanceTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R4": {
     "firstAnchor": null,
     "groupType": "statement",
     "isDefault": "false",
     "longName": "003 - Statement - Consolidated Statements of Loss and Comprehensive Loss (Parentheticals)",
     "menuCat": "Statements",
     "order": "4",
     "role": "http://encoreuranium.com/role/ConsolidatedComprehensiveIncome_Parentheticals",
     "shortName": "Consolidated Statements of Loss and Comprehensive Loss (Parentheticals)",
     "subGroupType": "parenthetical",
     "uniqueAnchor": null
    },
    "R40": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ea177383ex99-3_encoreenergy.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfMaturityAnalysisForFinancialAssetsHeldForManagingLiquidityRiskExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "039 - Disclosure - Sales contracts (Tables)",
     "menuCat": "Tables",
     "order": "40",
     "role": "http://encoreuranium.com/role/SalescontractsTables",
     "shortName": "Sales contracts (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ea177383ex99-3_encoreenergy.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfMaturityAnalysisForFinancialAssetsHeldForManagingLiquidityRiskExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R41": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ea177383ex99-3_encoreenergy.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "cve:ScheduleOfTheCompanysStockOptionsOutstandingTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "040 - Disclosure - Share Capital (Tables)",
     "menuCat": "Tables",
     "order": "41",
     "role": "http://encoreuranium.com/role/ShareCapitalTables",
     "shortName": "Share Capital (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ea177383ex99-3_encoreenergy.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "cve:ScheduleOfTheCompanysStockOptionsOutstandingTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R42": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ea177383ex99-3_encoreenergy.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfGeneralAndAdministrativeExpenseExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "041 - Disclosure - Related party transactions and balances (Tables)",
     "menuCat": "Tables",
     "order": "42",
     "role": "http://encoreuranium.com/role/RelatedpartytransactionsandbalancesTables",
     "shortName": "Related party transactions and balances (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ea177383ex99-3_encoreenergy.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfGeneralAndAdministrativeExpenseExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R43": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ea177383ex99-3_encoreenergy.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "cve:ScheduleOfFinancialInstrumentTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "042 - Disclosure - Financial Instruments (Tables)",
     "menuCat": "Tables",
     "order": "43",
     "role": "http://encoreuranium.com/role/FinancialInstrumentsTables",
     "shortName": "Financial Instruments (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ea177383ex99-3_encoreenergy.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "cve:ScheduleOfFinancialInstrumentTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R44": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ea177383ex99-3_encoreenergy.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "cve:DisclosureOfLongtermAssetsByGeographicSegmentTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "043 - Disclosure - Segmented information (Tables)",
     "menuCat": "Tables",
     "order": "44",
     "role": "http://encoreuranium.com/role/SegmentedinformationTables",
     "shortName": "Segmented information (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ea177383ex99-3_encoreenergy.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "cve:DisclosureOfLongtermAssetsByGeographicSegmentTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R45": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ea177383ex99-3_encoreenergy.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "cve:ScheduleOfIncurredNoncashFinancingAndInvestingActivitiesTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "044 - Disclosure - Supplemental disclosure with respect to cash flows (Tables)",
     "menuCat": "Tables",
     "order": "45",
     "role": "http://encoreuranium.com/role/SupplementaldisclosurewithrespecttocashflowsTables",
     "shortName": "Supplemental disclosure with respect to cash flows (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ea177383ex99-3_encoreenergy.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "cve:ScheduleOfIncurredNoncashFinancingAndInvestingActivitiesTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R46": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ea177383ex99-3_encoreenergy.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "045 - Disclosure - Income taxes (Tables)",
     "menuCat": "Tables",
     "order": "46",
     "role": "http://encoreuranium.com/role/IncometaxesTables",
     "shortName": "Income taxes (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ea177383ex99-3_encoreenergy.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R47": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ea177383ex99-3_encoreenergy.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DescriptionOfAccountingPolicyForForeignCurrencyTranslationExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "046 - Disclosure - Change in Presentation Currency (Tables)",
     "menuCat": "Tables",
     "order": "47",
     "role": "http://encoreuranium.com/role/ChangeinPresentationCurrencyTables",
     "shortName": "Change in Presentation Currency (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ea177383ex99-3_encoreenergy.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DescriptionOfAccountingPolicyForForeignCurrencyTranslationExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R48": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ea177383ex99-3_encoreenergy.htm",
      "contextRef": "c0",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:ProfitLoss",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "047 - Disclosure - Nature of Operations and Going Concern (Details)",
     "menuCat": "Details",
     "order": "48",
     "role": "http://encoreuranium.com/role/NatureofOperationsandGoingConcernDetails",
     "shortName": "Nature of Operations and Going Concern (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ea177383ex99-3_encoreenergy.htm",
      "contextRef": "c0",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:ProfitLoss",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R49": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "ix:continuation",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ea177383ex99-3_encoreenergy.htm",
      "contextRef": "c2",
      "decimals": "2",
      "first": true,
      "lang": null,
      "name": "ifrs-full:PercentageOfVotingEquityInterestsAcquired",
      "reportCount": 1,
      "unique": true,
      "unitRef": "pure",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "048 - Disclosure - Significant accounting policies (Details)",
     "menuCat": "Details",
     "order": "49",
     "role": "http://encoreuranium.com/role/SignificantaccountingpoliciesDetails",
     "shortName": "Significant accounting policies (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "ix:continuation",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ea177383ex99-3_encoreenergy.htm",
      "contextRef": "c2",
      "decimals": "2",
      "first": true,
      "lang": null,
      "name": "ifrs-full:PercentageOfVotingEquityInterestsAcquired",
      "reportCount": 1,
      "unique": true,
      "unitRef": "pure",
      "xsiNil": "false"
     }
    },
    "R5": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ea177383ex99-3_encoreenergy.htm",
      "contextRef": "c0",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "ifrs-full:ProfitLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "004 - Statement - Consolidated Statements of Cash Flows",
     "menuCat": "Statements",
     "order": "5",
     "role": "http://encoreuranium.com/role/ConsolidatedCashFlow",
     "shortName": "Consolidated Statements of Cash Flows",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ea177383ex99-3_encoreenergy.htm",
      "contextRef": "c0",
      "decimals": "0",
      "lang": null,
      "name": "cve:Accretion",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R50": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ifrs-full:DisclosureOfEffectOfChangesInForeignExchangeRatesExplanatory",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ea177383ex99-3_encoreenergy.htm",
      "contextRef": "c2",
      "decimals": "3",
      "first": true,
      "lang": null,
      "name": "ifrs-full:ClosingForeignExchangeRate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "pure",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "049 - Disclosure - Significant accounting policies (Details) - Schedule of exchange rates",
     "menuCat": "Details",
     "order": "50",
     "role": "http://encoreuranium.com/role/ScheduleofexchangeratesTable",
     "shortName": "Significant accounting policies (Details) - Schedule of exchange rates",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ifrs-full:DisclosureOfEffectOfChangesInForeignExchangeRatesExplanatory",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ea177383ex99-3_encoreenergy.htm",
      "contextRef": "c2",
      "decimals": "3",
      "first": true,
      "lang": null,
      "name": "ifrs-full:ClosingForeignExchangeRate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "pure",
      "xsiNil": "false"
     }
    },
    "R51": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ifrs-full:DisclosureOfSignificantInvestmentsInSubsidiariesExplanatory",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ea177383ex99-3_encoreenergy.htm",
      "contextRef": "c32",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "cve:NameofSubsidaryPlaceOfIncorporation",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "050 - Disclosure - Significant accounting policies (Details) - Schedule of significant subsidiaries",
     "menuCat": "Details",
     "order": "51",
     "role": "http://encoreuranium.com/role/ScheduleofsignificantsubsidiariesTable",
     "shortName": "Significant accounting policies (Details) - Schedule of significant subsidiaries",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ifrs-full:DisclosureOfSignificantInvestmentsInSubsidiariesExplanatory",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ea177383ex99-3_encoreenergy.htm",
      "contextRef": "c32",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "cve:NameofSubsidaryPlaceOfIncorporation",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R52": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "cve:DisclosureOfUsefulLivesOfPropertyPlantAndEquipementTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ea177383ex99-3_encoreenergy.htm",
      "contextRef": "c51",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "cve:PropertyPlantAndEquipmentRange",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "051 - Disclosure - Significant accounting policies (Details) - Schedule of useful lives of property, plant and equipement",
     "menuCat": "Details",
     "order": "52",
     "role": "http://encoreuranium.com/role/ScheduleofusefullivesofpropertyplantandequipementTable",
     "shortName": "Significant accounting policies (Details) - Schedule of useful lives of property, plant and equipement",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "cve:DisclosureOfUsefulLivesOfPropertyPlantAndEquipementTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ea177383ex99-3_encoreenergy.htm",
      "contextRef": "c51",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "cve:PropertyPlantAndEquipmentRange",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R53": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "ix:continuation",
       "cve:DisclosureOfUsefulLivesOfIntangibleAssetsTextBllock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ea177383ex99-3_encoreenergy.htm",
      "contextRef": "c61",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "cve:CategoryRange",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "052 - Disclosure - Significant accounting policies (Details) - Schedule of useful lives of intangible assets",
     "menuCat": "Details",
     "order": "53",
     "role": "http://encoreuranium.com/role/ScheduleofusefullivesofintangibleassetsTable",
     "shortName": "Significant accounting policies (Details) - Schedule of useful lives of intangible assets",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "ix:continuation",
       "cve:DisclosureOfUsefulLivesOfIntangibleAssetsTextBllock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ea177383ex99-3_encoreenergy.htm",
      "contextRef": "c61",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "cve:CategoryRange",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R54": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ea177383ex99-3_encoreenergy.htm",
      "contextRef": "c63",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "cve:AcquiredShares",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "053 - Disclosure - Investment In Associate (Details)",
     "menuCat": "Details",
     "order": "54",
     "role": "http://encoreuranium.com/role/InvestmentInAssociateDetails",
     "shortName": "Investment In Associate (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ea177383ex99-3_encoreenergy.htm",
      "contextRef": "c63",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "cve:AcquiredShares",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R55": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "cve:DisclosureOfProportionalShareAssociatesExplanatory",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ea177383ex99-3_encoreenergy.htm",
      "contextRef": "c2",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "ifrs-full:OtherCurrentAssets",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "054 - Disclosure - Investment In Associate (Details) - Schedule of proportional share in the associate",
     "menuCat": "Details",
     "order": "55",
     "role": "http://encoreuranium.com/role/ScheduleofproportionalshareintheassociateTable",
     "shortName": "Investment In Associate (Details) - Schedule of proportional share in the associate",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "cve:DisclosureOfProportionalShareAssociatesExplanatory",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ea177383ex99-3_encoreenergy.htm",
      "contextRef": "c2",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "ifrs-full:OtherCurrentAssets",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R56": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "ifrs-full:DisclosureOfInterestsInAssociatesExplanatory",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ea177383ex99-3_encoreenergy.htm",
      "contextRef": "c3",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "cve:InvestmentBalance1",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "055 - Disclosure - Investment In Associate (Details) - Schedule of investment in associate continuity",
     "menuCat": "Details",
     "order": "56",
     "role": "http://encoreuranium.com/role/ScheduleofinvestmentinassociatecontinuityTable",
     "shortName": "Investment In Associate (Details) - Schedule of investment in associate continuity",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "ifrs-full:DisclosureOfInterestsInAssociatesExplanatory",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ea177383ex99-3_encoreenergy.htm",
      "contextRef": "c6",
      "decimals": "0",
      "lang": null,
      "name": "cve:InvestmentBalance1",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R57": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ea177383ex99-3_encoreenergy.htm",
      "contextRef": "c70",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "cve:PurchaseAgreementsAmount",
      "reportCount": 1,
      "unitRef": "gbp",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "056 - Disclosure - Investment in uranium (Details)",
     "menuCat": "Details",
     "order": "57",
     "role": "http://encoreuranium.com/role/InvestmentinuraniumDetails",
     "shortName": "Investment in uranium (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ea177383ex99-3_encoreenergy.htm",
      "contextRef": "c3",
      "decimals": "0",
      "lang": null,
      "name": "us-gaap:OtherLongTermInvestments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R58": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "cve:ScheduleOfTheFairValueOfThePhysicalUraniumInvestmentTableTextBlck",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ea177383ex99-3_encoreenergy.htm",
      "contextRef": "c3",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "ifrs-full:CurrentInvestments",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "057 - Disclosure - Investment in uranium (Details) - Schedule of the fair value of the physical uranium investment",
     "menuCat": "Details",
     "order": "58",
     "role": "http://encoreuranium.com/role/ScheduleofthefairvalueofthephysicaluraniuminvestmentTable",
     "shortName": "Investment in uranium (Details) - Schedule of the fair value of the physical uranium investment",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "cve:ScheduleOfTheFairValueOfThePhysicalUraniumInvestmentTableTextBlck",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ea177383ex99-3_encoreenergy.htm",
      "contextRef": "c5",
      "decimals": "0",
      "lang": null,
      "name": "cve:PhysicalUranium",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R59": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "cve:ScheduleOfUraniumConcentratesPurchaseAgreementTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ea177383ex99-3_encoreenergy.htm",
      "contextRef": "c71",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "cve:PurchaseCommitments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "gbp",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "058 - Disclosure - Investment in uranium (Details) - Schedule of uranium concentrates purchase agreement",
     "menuCat": "Details",
     "order": "59",
     "role": "http://encoreuranium.com/role/ScheduleofuraniumconcentratespurchaseagreementTable",
     "shortName": "Investment in uranium (Details) - Schedule of uranium concentrates purchase agreement",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "cve:ScheduleOfUraniumConcentratesPurchaseAgreementTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ea177383ex99-3_encoreenergy.htm",
      "contextRef": "c71",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "cve:PurchaseCommitments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "gbp",
      "xsiNil": "false"
     }
    },
    "R6": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ea177383ex99-3_encoreenergy.htm",
      "contextRef": "c7",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "ifrs-full:Equity",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "005 - Statement - Consolidated Statements of Changes in Shareholder\u2019s Equity",
     "menuCat": "Statements",
     "order": "6",
     "role": "http://encoreuranium.com/role/ShareholdersEquityType2or3",
     "shortName": "Consolidated Statements of Changes in Shareholder\u2019s Equity",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ea177383ex99-3_encoreenergy.htm",
      "contextRef": "c7",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "ifrs-full:Equity",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R60": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ea177383ex99-3_encoreenergy.htm",
      "contextRef": "c80",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "cve:CommonShares",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "059 - Disclosure - Marketable Securities (Details)",
     "menuCat": "Details",
     "order": "60",
     "role": "http://encoreuranium.com/role/MarketableSecuritiesDetails",
     "shortName": "Marketable Securities (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ea177383ex99-3_encoreenergy.htm",
      "contextRef": "c80",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "cve:CommonShares",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R61": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "cve:ScheduleOfMarketableSecuritiesTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ea177383ex99-3_encoreenergy.htm",
      "contextRef": "c0",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "ifrs-full:AdditionalProvisionsOtherProvisions",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "060 - Disclosure - Marketable Securities (Details) - Schedule of marketable securities",
     "menuCat": "Details",
     "order": "61",
     "role": "http://encoreuranium.com/role/ScheduleofmarketablesecuritiesTable",
     "shortName": "Marketable Securities (Details) - Schedule of marketable securities",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "cve:ScheduleOfMarketableSecuritiesTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ea177383ex99-3_encoreenergy.htm",
      "contextRef": "c0",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "ifrs-full:AdditionalProvisionsOtherProvisions",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R62": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ea177383ex99-3_encoreenergy.htm",
      "contextRef": "c88",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "cve:CommonSharesIssued",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "061 - Disclosure - Intangible assets (Details)",
     "menuCat": "Details",
     "order": "62",
     "role": "http://encoreuranium.com/role/IntangibleassetsDetails",
     "shortName": "Intangible assets (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ea177383ex99-3_encoreenergy.htm",
      "contextRef": "c88",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "cve:CommonSharesIssued",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R63": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "ifrs-full:DisclosureOfDetailedInformationAboutIntangibleAssetsExplanatory",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ea177383ex99-3_encoreenergy.htm",
      "contextRef": "c3",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "cve:IntangibleAssetsBalance",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "062 - Disclosure - Intangible assets (Details) - Schedule of intangible asset was determined",
     "menuCat": "Details",
     "order": "63",
     "role": "http://encoreuranium.com/role/ScheduleofintangibleassetwasdeterminedTable",
     "shortName": "Intangible assets (Details) - Schedule of intangible asset was determined",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "ifrs-full:DisclosureOfDetailedInformationAboutIntangibleAssetsExplanatory",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ea177383ex99-3_encoreenergy.htm",
      "contextRef": "c6",
      "decimals": "0",
      "lang": null,
      "name": "cve:IntangibleAssetsBalance",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R64": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "ifrs-full:DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ea177383ex99-3_encoreenergy.htm",
      "contextRef": "c3",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "ifrs-full:PropertyPlantAndEquipmentCarryingAmountAtCostOfRevaluedAssets",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "063 - Disclosure - Property, plant, and equipment (Details) - Schedule of property, plant, and equipment",
     "menuCat": "Details",
     "order": "64",
     "role": "http://encoreuranium.com/role/ScheduleofpropertyplantandequipmentTable",
     "shortName": "Property, plant, and equipment (Details) - Schedule of property, plant, and equipment",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "ifrs-full:DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ea177383ex99-3_encoreenergy.htm",
      "contextRef": "c6",
      "decimals": "0",
      "lang": null,
      "name": "ifrs-full:PropertyPlantAndEquipmentCarryingAmountAtCostOfRevaluedAssets",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R65": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ea177383ex99-3_encoreenergy.htm",
      "contextRef": "c92",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:OperatingLeasePayments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "064 - Disclosure - Right-of-use assets (Details)",
     "menuCat": "Details",
     "order": "65",
     "role": "http://encoreuranium.com/role/RightofuseassetsDetails",
     "shortName": "Right-of-use assets (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ea177383ex99-3_encoreenergy.htm",
      "contextRef": "c92",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:OperatingLeasePayments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R66": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "cve:DisclosureOfChangeInTheROUAssetsTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ea177383ex99-3_encoreenergy.htm",
      "contextRef": "c3",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "cve:Right-of-UseAssetsBalance",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "065 - Disclosure - Right-of-use assets (Details) - Schedule of change in the ROU assets",
     "menuCat": "Details",
     "order": "66",
     "role": "http://encoreuranium.com/role/ScheduleofchangeintheROUassetsTable",
     "shortName": "Right-of-use assets (Details) - Schedule of change in the ROU assets",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "cve:DisclosureOfChangeInTheROUAssetsTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ea177383ex99-3_encoreenergy.htm",
      "contextRef": "c6",
      "decimals": "0",
      "lang": null,
      "name": "cve:Right-of-UseAssetsBalance",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R67": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "cve:DisclosureOfChangeInTheLongTermLeaseLiabilityTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ea177383ex99-3_encoreenergy.htm",
      "contextRef": "c3",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "cve:Long-TermLeaseLiabilityBalance",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "066 - Disclosure - Right-of-use assets (Details) - Schedule of change in the long-Term lease liability",
     "menuCat": "Details",
     "order": "67",
     "role": "http://encoreuranium.com/role/ScheduleofchangeinthelongTermleaseliabilityTable",
     "shortName": "Right-of-use assets (Details) - Schedule of change in the long-Term lease liability",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "cve:DisclosureOfChangeInTheLongTermLeaseLiabilityTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ea177383ex99-3_encoreenergy.htm",
      "contextRef": "c6",
      "decimals": "0",
      "lang": null,
      "name": "cve:Long-TermLeaseLiabilityBalance",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R68": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "ifrs-full:MaturityAnalysisForDerivativeFinancialLiabilities",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ea177383ex99-3_encoreenergy.htm",
      "contextRef": "c0",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "cve:Right-of-UseAssetsTwoZeroTwoThree",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "067 - Disclosure - Right-of-use assets (Details) - Schedule of undiscounted future lease payments",
     "menuCat": "Details",
     "order": "68",
     "role": "http://encoreuranium.com/role/ScheduleofundiscountedfutureleasepaymentsTable",
     "shortName": "Right-of-use assets (Details) - Schedule of undiscounted future lease payments",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "ifrs-full:MaturityAnalysisForDerivativeFinancialLiabilities",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ea177383ex99-3_encoreenergy.htm",
      "contextRef": "c0",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "cve:Right-of-UseAssetsTwoZeroTwoThree",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R69": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ea177383ex99-3_encoreenergy.htm",
      "contextRef": "c81",
      "decimals": "2",
      "first": true,
      "lang": null,
      "name": "cve:MarketValuePerShare",
      "reportCount": 1,
      "unitRef": "usdPershares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "068 - Disclosure - Asset acquisition (Details)",
     "menuCat": "Details",
     "order": "69",
     "role": "http://encoreuranium.com/role/AssetacquisitionDetails",
     "shortName": "Asset acquisition (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ea177383ex99-3_encoreenergy.htm",
      "contextRef": "c0",
      "decimals": "0",
      "lang": null,
      "name": "cve:ShareConsiderationAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R7": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "ea177383ex99-3_encoreenergy.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "cve:NatureOfOperationAndGoingConcern",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "006 - Disclosure - Nature of Operations and Going Concern",
     "menuCat": "Notes",
     "order": "7",
     "role": "http://encoreuranium.com/role/NatureofOperationsandGoingConcern",
     "shortName": "Nature of Operations and Going Concern",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "ea177383ex99-3_encoreenergy.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "cve:NatureOfOperationAndGoingConcern",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R70": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "ifrs-full:DisclosureOfFairValueMeasurementOfAssetsExplanatory",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ea177383ex99-3_encoreenergy.htm",
      "contextRef": "c2",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "ifrs-full:AcquisitiondateFairValueOfTotalConsiderationTransferred",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "069 - Disclosure - Asset acquisition (Details) - Schedule of estimated fair value of assets and liabilities",
     "menuCat": "Details",
     "order": "70",
     "role": "http://encoreuranium.com/role/ScheduleofestimatedfairvalueofassetsandliabilitiesTable",
     "shortName": "Asset acquisition (Details) - Schedule of estimated fair value of assets and liabilities",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "ifrs-full:DisclosureOfFairValueMeasurementOfAssetsExplanatory",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ea177383ex99-3_encoreenergy.htm",
      "contextRef": "c2",
      "decimals": "0",
      "lang": null,
      "name": "cve:FairValueOfReplacementOptions",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R71": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "ifrs-full:DisclosureOfRedesignatedFinancialAssetsAndLiabilitiesExplanatory",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ea177383ex99-3_encoreenergy.htm",
      "contextRef": "c2",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "ifrs-full:OtherCashAndCashEquivalents",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "070 - Disclosure - Asset acquisition (Details) - Schedule of net assets acquired",
     "menuCat": "Details",
     "order": "71",
     "role": "http://encoreuranium.com/role/ScheduleofnetassetsacquiredTable",
     "shortName": "Asset acquisition (Details) - Schedule of net assets acquired",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "ifrs-full:DisclosureOfRedesignatedFinancialAssetsAndLiabilitiesExplanatory",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ea177383ex99-3_encoreenergy.htm",
      "contextRef": "c2",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "ifrs-full:OtherCashAndCashEquivalents",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R72": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ifrs-full:DisclosureOfIndirectMeasurementOfFairValueOfGoodsOrServicesReceivedShareOptionsGrantedDuringPeriodExplanatory",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ea177383ex99-3_encoreenergy.htm",
      "contextRef": "c154",
      "decimals": "2",
      "first": true,
      "lang": null,
      "name": "ifrs-full:ExercisePriceShareOptionsGranted2019",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usdPershares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "071 - Disclosure - Asset acquisition (Details) - Schedule of weighted average assumptions used in the black-scholes option",
     "menuCat": "Details",
     "order": "72",
     "role": "http://encoreuranium.com/role/ScheduleofweightedaverageassumptionsusedintheblackscholesoptionTable",
     "shortName": "Asset acquisition (Details) - Schedule of weighted average assumptions used in the black-scholes option",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ifrs-full:DisclosureOfIndirectMeasurementOfFairValueOfGoodsOrServicesReceivedShareOptionsGrantedDuringPeriodExplanatory",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ea177383ex99-3_encoreenergy.htm",
      "contextRef": "c154",
      "decimals": "2",
      "first": true,
      "lang": null,
      "name": "ifrs-full:ExercisePriceShareOptionsGranted2019",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usdPershares",
      "xsiNil": "false"
     }
    },
    "R73": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ea177383ex99-3_encoreenergy.htm",
      "contextRef": "c2",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "ifrs-full:LongtermDeposits",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "072 - Disclosure - Mineral Properties (Details)",
     "menuCat": "Details",
     "order": "73",
     "role": "http://encoreuranium.com/role/MineralPropertiesDetails",
     "shortName": "Mineral Properties (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ea177383ex99-3_encoreenergy.htm",
      "contextRef": "c2",
      "decimals": "0",
      "lang": null,
      "name": "ifrs-full:ContingentConsiderationRecognisedAsOfAcquisitionDate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R74": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ea177383ex99-3_encoreenergy.htm",
      "contextRef": "c3",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "ifrs-full:MiningAssets",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "073 - Disclosure - Mineral Properties (Details) - Schedule of mineral properties",
     "menuCat": "Details",
     "order": "74",
     "role": "http://encoreuranium.com/role/ScheduleofmineralpropertiesTable",
     "shortName": "Mineral Properties (Details) - Schedule of mineral properties",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "cve:ScheduleOfMineralProperties",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ea177383ex99-3_encoreenergy.htm",
      "contextRef": "c6",
      "decimals": "0",
      "lang": null,
      "name": "ifrs-full:MiningAssets",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R75": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ea177383ex99-3_encoreenergy.htm",
      "contextRef": "c0",
      "decimals": "3",
      "first": true,
      "lang": null,
      "name": "cve:InflationFactorPercentage",
      "reportCount": 1,
      "unique": true,
      "unitRef": "pure",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "074 - Disclosure - Asset retirement obligations (Details)",
     "menuCat": "Details",
     "order": "75",
     "role": "http://encoreuranium.com/role/AssetretirementobligationsDetails",
     "shortName": "Asset retirement obligations (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ea177383ex99-3_encoreenergy.htm",
      "contextRef": "c0",
      "decimals": "3",
      "first": true,
      "lang": null,
      "name": "cve:InflationFactorPercentage",
      "reportCount": 1,
      "unique": true,
      "unitRef": "pure",
      "xsiNil": "false"
     }
    },
    "R76": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "cve:DisclosureOfAssetRetirementObligationsBalanceTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ea177383ex99-3_encoreenergy.htm",
      "contextRef": "c2",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "ifrs-full:FinancialAssets",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "075 - Disclosure - Asset retirement obligations (Details) - Schedule of asset retirement obligations balance",
     "menuCat": "Details",
     "order": "76",
     "role": "http://encoreuranium.com/role/ScheduleofassetretirementobligationsbalanceTable",
     "shortName": "Asset retirement obligations (Details) - Schedule of asset retirement obligations balance",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "cve:DisclosureOfAssetRetirementObligationsBalanceTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ea177383ex99-3_encoreenergy.htm",
      "contextRef": "c2",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "ifrs-full:FinancialAssets",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R77": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "cve:DisclosureOfAssetRetirementObligationsContinuityTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ea177383ex99-3_encoreenergy.htm",
      "contextRef": "c3",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "cve:AssetRetirementObligationsBalance",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "076 - Disclosure - Asset retirement obligations (Details) - Schedule of asset retirement obligations continuity",
     "menuCat": "Details",
     "order": "77",
     "role": "http://encoreuranium.com/role/ScheduleofassetretirementobligationscontinuityTable",
     "shortName": "Asset retirement obligations (Details) - Schedule of asset retirement obligations continuity",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "cve:DisclosureOfAssetRetirementObligationsContinuityTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ea177383ex99-3_encoreenergy.htm",
      "contextRef": "c6",
      "decimals": "0",
      "lang": null,
      "name": "cve:AssetRetirementObligationsBalance",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R78": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ea177383ex99-3_encoreenergy.htm",
      "contextRef": "c90",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "cve:TotalDiscountedMarketPrices",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "077 - Disclosure - Sales contracts (Details)",
     "menuCat": "Details",
     "order": "78",
     "role": "http://encoreuranium.com/role/SalescontractsDetails",
     "shortName": "Sales contracts (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ea177383ex99-3_encoreenergy.htm",
      "contextRef": "c90",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "cve:TotalDiscountedMarketPrices",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R79": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "ifrs-full:DisclosureOfMaturityAnalysisForFinancialAssetsHeldForManagingLiquidityRiskExplanatory",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ea177383ex99-3_encoreenergy.htm",
      "contextRef": "c0",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "cve:SalesContractsFiscalTwoZeroTwoThree",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "078 - Disclosure - Sales contracts (Details) - Schedule of uranium sales contracts over the next five years",
     "menuCat": "Details",
     "order": "79",
     "role": "http://encoreuranium.com/role/ScheduleofuraniumsalescontractsoverthenextfiveyearsTable",
     "shortName": "Sales contracts (Details) - Schedule of uranium sales contracts over the next five years",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "ifrs-full:DisclosureOfMaturityAnalysisForFinancialAssetsHeldForManagingLiquidityRiskExplanatory",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ea177383ex99-3_encoreenergy.htm",
      "contextRef": "c0",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "cve:SalesContractsFiscalTwoZeroTwoThree",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R8": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "ea177383ex99-3_encoreenergy.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "007 - Disclosure - Significant accounting policies",
     "menuCat": "Notes",
     "order": "8",
     "role": "http://encoreuranium.com/role/Significantaccountingpolicies",
     "shortName": "Significant accounting policies",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "ea177383ex99-3_encoreenergy.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R80": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ea177383ex99-3_encoreenergy.htm",
      "contextRef": "c0",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "cve:SharesUnit",
      "reportCount": 1,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "079 - Disclosure - Share Capital (Details)",
     "menuCat": "Details",
     "order": "80",
     "role": "http://encoreuranium.com/role/ShareCapitalDetails",
     "shortName": "Share Capital (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ea177383ex99-3_encoreenergy.htm",
      "contextRef": "c0",
      "decimals": "2",
      "lang": null,
      "name": "ifrs-full:WeightedAverageExercisePriceOfShareOptionsInSharebasedPaymentArrangementExercisedDuringPeriodAtDateOfExercise2019",
      "reportCount": 1,
      "unique": true,
      "unitRef": "cadPershares",
      "xsiNil": "false"
     }
    },
    "R81": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "cve:ScheduleOfTheCompanysStockOptionsOutstandingTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ea177383ex99-3_encoreenergy.htm",
      "contextRef": "c3",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "cve:SharesBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber",
      "reportCount": 1,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "080 - Disclosure - Share Capital (Details) - Schedule of the company\u2019s stock options outstanding",
     "menuCat": "Details",
     "order": "81",
     "role": "http://encoreuranium.com/role/ScheduleofthecompanysstockoptionsoutstandingTable",
     "shortName": "Share Capital (Details) - Schedule of the company\u2019s stock options outstanding",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "cve:ScheduleOfTheCompanysStockOptionsOutstandingTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ea177383ex99-3_encoreenergy.htm",
      "contextRef": "c6",
      "decimals": "INF",
      "lang": null,
      "name": "cve:SharesBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R82": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "cve:ScheduleOfStockOptionsOutstandingTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ea177383ex99-3_encoreenergy.htm",
      "contextRef": "c0",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "cve:SharesBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "081 - Disclosure - Share Capital (Details) - Schedule of stock options outstanding",
     "menuCat": "Details",
     "order": "82",
     "role": "http://encoreuranium.com/role/ScheduleofstockoptionsoutstandingTable",
     "shortName": "Share Capital (Details) - Schedule of stock options outstanding",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "cve:ScheduleOfStockOptionsOutstandingTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ea177383ex99-3_encoreenergy.htm",
      "contextRef": "c0",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "cve:SharesBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R83": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "cve:ScheduleOfWeightedAverageAssumptionsUsedInCalculatingTheFairValuesTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ea177383ex99-3_encoreenergy.htm",
      "contextRef": "c0",
      "decimals": "4",
      "first": true,
      "lang": null,
      "name": "ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted",
      "reportCount": 1,
      "unique": true,
      "unitRef": "pure",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "082 - Disclosure - Share Capital (Details) - Schedule of weighted average assumptions used in calculating the fair values",
     "menuCat": "Details",
     "order": "83",
     "role": "http://encoreuranium.com/role/ScheduleofweightedaverageassumptionsusedincalculatingthefairvaluesTable",
     "shortName": "Share Capital (Details) - Schedule of weighted average assumptions used in calculating the fair values",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "cve:ScheduleOfWeightedAverageAssumptionsUsedInCalculatingTheFairValuesTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ea177383ex99-3_encoreenergy.htm",
      "contextRef": "c0",
      "decimals": "4",
      "first": true,
      "lang": null,
      "name": "ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted",
      "reportCount": 1,
      "unique": true,
      "unitRef": "pure",
      "xsiNil": "false"
     }
    },
    "R84": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "cve:ScheduleOfTheStatusOfTheCompanysWarrantsTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ea177383ex99-3_encoreenergy.htm",
      "contextRef": "c3",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "cve:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptionsWarrantsOutstanding",
      "reportCount": 1,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "083 - Disclosure - Share Capital (Details) - Schedule of the status of the company\u2019s warrants",
     "menuCat": "Details",
     "order": "84",
     "role": "http://encoreuranium.com/role/ScheduleofthestatusofthecompanyswarrantsTable",
     "shortName": "Share Capital (Details) - Schedule of the status of the company\u2019s warrants",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "cve:ScheduleOfTheStatusOfTheCompanysWarrantsTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ea177383ex99-3_encoreenergy.htm",
      "contextRef": "c6",
      "decimals": "INF",
      "lang": null,
      "name": "cve:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptionsWarrantsOutstanding",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R85": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "cve:ScheduleOfSharePurchaseWarrantsOutstandingTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ea177383ex99-3_encoreenergy.htm",
      "contextRef": "c0",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "cve:Warrants",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "084 - Disclosure - Share Capital (Details) - Schedule of share purchase warrants outstanding",
     "menuCat": "Details",
     "order": "85",
     "role": "http://encoreuranium.com/role/ScheduleofsharepurchasewarrantsoutstandingTable",
     "shortName": "Share Capital (Details) - Schedule of share purchase warrants outstanding",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "cve:ScheduleOfSharePurchaseWarrantsOutstandingTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ea177383ex99-3_encoreenergy.htm",
      "contextRef": "c0",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "cve:Warrants",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R86": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "link:footnote",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ea177383ex99-3_encoreenergy.htm",
      "contextRef": "c0",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "cve:ConsultingFees",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "085 - Disclosure - Related party transactions and balances (Details)",
     "menuCat": "Details",
     "order": "86",
     "role": "http://encoreuranium.com/role/RelatedpartytransactionsandbalancesDetails",
     "shortName": "Related party transactions and balances (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "link:footnote",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ea177383ex99-3_encoreenergy.htm",
      "contextRef": "c0",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "cve:ConsultingFees",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R87": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ifrs-full:DisclosureOfGeneralAndAdministrativeExpenseExplanatory",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ea177383ex99-3_encoreenergy.htm",
      "contextRef": "c0",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "ifrs-full:RevenueFromRenderingOfInformationTechnologyConsultingServices",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "086 - Disclosure - Related party transactions and balances (Details) - Schedule of amounts paid to key management or entities providing similar services",
     "menuCat": "Details",
     "order": "87",
     "role": "http://encoreuranium.com/role/ScheduleofamountspaidtokeymanagementorentitiesprovidingsimilarservicesTable",
     "shortName": "Related party transactions and balances (Details) - Schedule of amounts paid to key management or entities providing similar services",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ifrs-full:DisclosureOfGeneralAndAdministrativeExpenseExplanatory",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ea177383ex99-3_encoreenergy.htm",
      "contextRef": "c0",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "ifrs-full:RevenueFromRenderingOfInformationTechnologyConsultingServices",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R88": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ifrs-full:DisclosureOfTransactionsBetweenRelatedPartiesExplanatory",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ea177383ex99-3_encoreenergy.htm",
      "contextRef": "c2",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "ifrs-full:AmountsPayableRelatedPartyTransactions",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "087 - Disclosure - Related party transactions and balances (Details) - Schedule of owing to related parties",
     "menuCat": "Details",
     "order": "88",
     "role": "http://encoreuranium.com/role/ScheduleofowingtorelatedpartiesTable",
     "shortName": "Related party transactions and balances (Details) - Schedule of owing to related parties",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ifrs-full:DisclosureOfTransactionsBetweenRelatedPartiesExplanatory",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ea177383ex99-3_encoreenergy.htm",
      "contextRef": "c2",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "ifrs-full:AmountsPayableRelatedPartyTransactions",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R89": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ea177383ex99-3_encoreenergy.htm",
      "contextRef": "c0",
      "decimals": "2",
      "first": true,
      "lang": null,
      "name": "cve:ForeignExchangeRate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "pure",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "088 - Disclosure - Financial Instruments (Details)",
     "menuCat": "Details",
     "order": "89",
     "role": "http://encoreuranium.com/role/FinancialInstrumentsDetails",
     "shortName": "Financial Instruments (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ea177383ex99-3_encoreenergy.htm",
      "contextRef": "c0",
      "decimals": "2",
      "first": true,
      "lang": null,
      "name": "cve:ForeignExchangeRate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "pure",
      "xsiNil": "false"
     }
    },
    "R9": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "ea177383ex99-3_encoreenergy.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfAccountingJudgementsAndEstimatesExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "008 - Disclosure - Critical Accounting Estimates And Judgements",
     "menuCat": "Notes",
     "order": "9",
     "role": "http://encoreuranium.com/role/CriticalAccountingEstimatesAndJudgements",
     "shortName": "Critical Accounting Estimates And Judgements",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "ea177383ex99-3_encoreenergy.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfAccountingJudgementsAndEstimatesExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R90": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "cve:ScheduleOfFinancialInstrumentTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ea177383ex99-3_encoreenergy.htm",
      "contextRef": "c2",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "ifrs-full:Cash",
      "reportCount": 1,
      "unitRef": "cad",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "089 - Disclosure - Financial Instruments (Details) - Schedule of foreign currency exposures",
     "menuCat": "Details",
     "order": "90",
     "role": "http://encoreuranium.com/role/ScheduleofforeigncurrencyexposuresTable",
     "shortName": "Financial Instruments (Details) - Schedule of foreign currency exposures",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "cve:ScheduleOfFinancialInstrumentTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ea177383ex99-3_encoreenergy.htm",
      "contextRef": "c2",
      "decimals": "0",
      "lang": null,
      "name": "us-gaap:MarketableSecurities",
      "reportCount": 1,
      "unique": true,
      "unitRef": "cad",
      "xsiNil": "false"
     }
    },
    "R91": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "cve:DisclosureOfLongtermAssetsByGeographicSegmentTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ea177383ex99-3_encoreenergy.htm",
      "contextRef": "c2",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "cve:IntangibleAssets",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "090 - Disclosure - Segmented information (Details) - Schedule of long-term assets by geographic segment",
     "menuCat": "Details",
     "order": "91",
     "role": "http://encoreuranium.com/role/ScheduleoflongtermassetsbygeographicsegmentTable",
     "shortName": "Segmented information (Details) - Schedule of long-term assets by geographic segment",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "cve:DisclosureOfLongtermAssetsByGeographicSegmentTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ea177383ex99-3_encoreenergy.htm",
      "contextRef": "c2",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "cve:IntangibleAssets",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R92": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "cve:ScheduleOfIncurredNoncashFinancingAndInvestingActivitiesTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ea177383ex99-3_encoreenergy.htm",
      "contextRef": "c2",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "ifrs-full:CurrentAccruedExpensesAndOtherCurrentLiabilities",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "091 - Disclosure - Supplemental disclosure with respect to cash flows (Details) - Schedule of incurred non-cash financing and investing activities",
     "menuCat": "Details",
     "order": "92",
     "role": "http://encoreuranium.com/role/ScheduleofincurrednoncashfinancingandinvestingactivitiesTable",
     "shortName": "Supplemental disclosure with respect to cash flows (Details) - Schedule of incurred non-cash financing and investing activities",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "cve:ScheduleOfIncurredNoncashFinancingAndInvestingActivitiesTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ea177383ex99-3_encoreenergy.htm",
      "contextRef": "c2",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "ifrs-full:CurrentAccruedExpensesAndOtherCurrentLiabilities",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R93": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ea177383ex99-3_encoreenergy.htm",
      "contextRef": "c0",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "cve:NoncapitalLoss",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "092 - Disclosure - Income taxes (Details)",
     "menuCat": "Details",
     "order": "93",
     "role": "http://encoreuranium.com/role/IncometaxesDetails",
     "shortName": "Income taxes (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ea177383ex99-3_encoreenergy.htm",
      "contextRef": "c0",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "cve:NoncapitalLoss",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R94": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ifrs-full:DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsExplanatory",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ea177383ex99-3_encoreenergy.htm",
      "contextRef": "c0",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:IncomeLossAttributableToParent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "093 - Disclosure - Income taxes (Details) - Schedule of federal and provincial corporate tax rates to income before tax",
     "menuCat": "Details",
     "order": "94",
     "role": "http://encoreuranium.com/role/ScheduleoffederalandprovincialcorporatetaxratestoincomebeforetaxTable",
     "shortName": "Income taxes (Details) - Schedule of federal and provincial corporate tax rates to income before tax",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ifrs-full:DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsExplanatory",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ea177383ex99-3_encoreenergy.htm",
      "contextRef": "c0",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:IncomeLossAttributableToParent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R95": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ifrs-full:DisclosureOfInterestIncomeExplanatory",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ea177383ex99-3_encoreenergy.htm",
      "contextRef": "c0",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "cve:OrginationAndReversalOfTemporaryDifferences",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "094 - Disclosure - Income taxes (Details) - Schedule of income tax expense (recovery)",
     "menuCat": "Details",
     "order": "95",
     "role": "http://encoreuranium.com/role/ScheduleofincometaxexpenserecoveryTable",
     "shortName": "Income taxes (Details) - Schedule of income tax expense (recovery)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ifrs-full:DisclosureOfInterestIncomeExplanatory",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ea177383ex99-3_encoreenergy.htm",
      "contextRef": "c0",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "cve:OrginationAndReversalOfTemporaryDifferences",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R96": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ea177383ex99-3_encoreenergy.htm",
      "contextRef": "c2",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "ifrs-full:OtherIntangibleAssets",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "095 - Disclosure - Income taxes (Details) - Schedule of deferred tax liabilities",
     "menuCat": "Details",
     "order": "96",
     "role": "http://encoreuranium.com/role/ScheduleofdeferredtaxliabilitiesTable",
     "shortName": "Income taxes (Details) - Schedule of deferred tax liabilities",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ea177383ex99-3_encoreenergy.htm",
      "contextRef": "c2",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "ifrs-full:OtherIntangibleAssets",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R97": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ifrs-full:DisclosureOfDeferredTaxesExplanatory",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ea177383ex99-3_encoreenergy.htm",
      "contextRef": "c0",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "cve:DeductibleTemporaryDifferences",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "096 - Disclosure - Income taxes (Details) - Schedule of unrecognized deferred tax assets",
     "menuCat": "Details",
     "order": "97",
     "role": "http://encoreuranium.com/role/ScheduleofunrecognizeddeferredtaxassetsTable",
     "shortName": "Income taxes (Details) - Schedule of unrecognized deferred tax assets",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ifrs-full:DisclosureOfDeferredTaxesExplanatory",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ea177383ex99-3_encoreenergy.htm",
      "contextRef": "c0",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "cve:DeductibleTemporaryDifferences",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R98": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ea177383ex99-3_encoreenergy.htm",
      "contextRef": "c259",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "ifrs-full:CurrentAssets",
      "reportCount": 1,
      "unique": true,
      "unitRef": "cad",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "097 - Disclosure - Change in Presentation Currency (Details) - Schedule of effect of translation",
     "menuCat": "Details",
     "order": "98",
     "role": "http://encoreuranium.com/role/ScheduleofeffectoftranslationTable",
     "shortName": "Change in Presentation Currency (Details) - Schedule of effect of translation",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ea177383ex99-3_encoreenergy.htm",
      "contextRef": "c259",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "ifrs-full:CurrentAssets",
      "reportCount": 1,
      "unique": true,
      "unitRef": "cad",
      "xsiNil": "false"
     }
    },
    "R99": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ifrs-full:DisclosureOfFinancialInstrumentsAtFairValueThroughProfitOrLossExplanatory",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ea177383ex99-3_encoreenergy.htm",
      "contextRef": "c261",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "cve:Accretion",
      "reportCount": 1,
      "unique": true,
      "unitRef": "cad",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "098 - Disclosure - Change in Presentation Currency (Details) - Schedule of consolidated statements of loss and comprehensive loss",
     "menuCat": "Details",
     "order": "99",
     "role": "http://encoreuranium.com/role/ScheduleofconsolidatedstatementsoflossandcomprehensivelossTable",
     "shortName": "Change in Presentation Currency (Details) - Schedule of consolidated statements of loss and comprehensive loss",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ifrs-full:DisclosureOfFinancialInstrumentsAtFairValueThroughProfitOrLossExplanatory",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ea177383ex99-3_encoreenergy.htm",
      "contextRef": "c261",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "cve:Accretion",
      "reportCount": 1,
      "unique": true,
      "unitRef": "cad",
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 105,
   "tag": {
    "country_CA": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "CANADA",
        "terseLabel": "Canada [Member]"
       }
      }
     },
     "localname": "CA",
     "nsuri": "http://xbrl.sec.gov/country/2022",
     "presentation": [
      "http://encoreuranium.com/role/ScheduleoflongtermassetsbygeographicsegmentTable",
      "http://encoreuranium.com/role/ScheduleofmineralpropertiesTable"
     ],
     "xbrltype": "domainItemType"
    },
    "cve_AccountPayablesAndAccruedLiabilities": {
     "auth_ref": [],
     "calculation": {
      "http://encoreuranium.com/role/ScheduleofforeigncurrencyexposuresTable": {
       "order": 3.0,
       "parentTag": "ifrs-full_AssetsLessCurrentLiabilities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Account Payables And Accrued Liabilities",
        "negatedLabel": "Accounts payable and accrued liabilities"
       }
      }
     },
     "localname": "AccountPayablesAndAccruedLiabilities",
     "nsuri": "http://encoreuranium.com/20221231",
     "presentation": [
      "http://encoreuranium.com/role/ScheduleofforeigncurrencyexposuresTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cve_AccountsPayableAndAccruedLiability": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accounts payable and accrued liabilities.",
        "label": "Accounts Payable And Accrued Liability",
        "terseLabel": "Accounts payable and accrued liabilities"
       }
      }
     },
     "localname": "AccountsPayableAndAccruedLiability",
     "nsuri": "http://encoreuranium.com/20221231",
     "presentation": [
      "http://encoreuranium.com/role/ScheduleofnetassetsacquiredTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cve_Accretion": {
     "auth_ref": [],
     "calculation": {
      "http://encoreuranium.com/role/ConsolidatedCashFlow": {
       "order": 2.0,
       "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities",
       "weight": 1.0
      },
      "http://encoreuranium.com/role/ScheduleofconsolidatedstatementsoflossandcomprehensivelossTable": {
       "order": 1.0,
       "parentTag": "ifrs-full_OtherOperatingIncomeExpense",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accretion Expense",
        "label": "Accretion",
        "terseLabel": "Accretion"
       }
      }
     },
     "localname": "Accretion",
     "nsuri": "http://encoreuranium.com/20221231",
     "presentation": [
      "http://encoreuranium.com/role/ConsolidatedCashFlow",
      "http://encoreuranium.com/role/ScheduleofconsolidatedstatementsoflossandcomprehensivelossTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cve_AccretionExpenses": {
     "auth_ref": [],
     "calculation": {
      "http://encoreuranium.com/role/ConsolidatedComprehensiveIncome": {
       "order": 1.0,
       "parentTag": "ifrs-full_ProfitLossFromOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount recognized for the passage of time, typically for liabilities, that have been discounted to their net present values. Excludes accretion associated with asset retirement obligations.",
        "label": "Accretion Expenses",
        "terseLabel": "Accretion"
       }
      }
     },
     "localname": "AccretionExpenses",
     "nsuri": "http://encoreuranium.com/20221231",
     "presentation": [
      "http://encoreuranium.com/role/ConsolidatedComprehensiveIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cve_AccumulatedDeficit": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated deficit.",
        "label": "Accumulated Deficit",
        "terseLabel": "Accumulated deficit"
       }
      }
     },
     "localname": "AccumulatedDeficit",
     "nsuri": "http://encoreuranium.com/20221231",
     "presentation": [
      "http://encoreuranium.com/role/NatureofOperationsandGoingConcernDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cve_AcquireCommonShare": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Acquire common shares.",
        "label": "Acquire Common Share",
        "terseLabel": "Acquire common shares"
       }
      }
     },
     "localname": "AcquireCommonShare",
     "nsuri": "http://encoreuranium.com/20221231",
     "presentation": [
      "http://encoreuranium.com/role/EventsafterthereportingperiodDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cve_AcquiredAmonut": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Acquired amonut.",
        "label": "Acquired Amonut",
        "terseLabel": "Acquired amount"
       }
      }
     },
     "localname": "AcquiredAmonut",
     "nsuri": "http://encoreuranium.com/20221231",
     "presentation": [
      "http://encoreuranium.com/role/IntangibleassetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cve_AcquiredShares": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Acquired shares.",
        "label": "Acquired Shares",
        "terseLabel": "Acquired shares (in Shares)"
       }
      }
     },
     "localname": "AcquiredShares",
     "nsuri": "http://encoreuranium.com/20221231",
     "presentation": [
      "http://encoreuranium.com/role/InvestmentInAssociateDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "cve_AdditionalPayment": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Additional Payment",
        "terseLabel": "Additional payment"
       }
      }
     },
     "localname": "AdditionalPayment",
     "nsuri": "http://encoreuranium.com/20221231",
     "presentation": [
      "http://encoreuranium.com/role/MineralPropertiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cve_Additions": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Additions.",
        "label": "Additions",
        "terseLabel": "Additions"
       }
      }
     },
     "localname": "Additions",
     "nsuri": "http://encoreuranium.com/20221231",
     "presentation": [
      "http://encoreuranium.com/role/ScheduleofintangibleassetwasdeterminedTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cve_AdjustmentToInvestmentInAssociate": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Adjustment to investment in associate.",
        "label": "Adjustment To Investment In Associate",
        "terseLabel": "Adjustment to investment in associate"
       }
      }
     },
     "localname": "AdjustmentToInvestmentInAssociate",
     "nsuri": "http://encoreuranium.com/20221231",
     "presentation": [
      "http://encoreuranium.com/role/ShareholdersEquityType2or3"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cve_AdjustmentToInvestmentInGroup11": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Adjustment to investment in Group 11.",
        "label": "Adjustment To Investment In Group11",
        "terseLabel": "Adjustment to investment in Group 11"
       }
      }
     },
     "localname": "AdjustmentToInvestmentInGroup11",
     "nsuri": "http://encoreuranium.com/20221231",
     "presentation": [
      "http://encoreuranium.com/role/ScheduleofinvestmentinassociatecontinuityTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cve_AdjustmentsToCarryingValueAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustments To Carrying Value Abstract",
        "terseLabel": "Adjustments to carrying value:"
       }
      }
     },
     "localname": "AdjustmentsToCarryingValueAbstract",
     "nsuri": "http://encoreuranium.com/20221231",
     "presentation": [
      "http://encoreuranium.com/role/ScheduleofinvestmentinassociatecontinuityTable"
     ],
     "xbrltype": "stringItemType"
    },
    "cve_AdvancedAmount": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Advanced amount.",
        "label": "Advanced Amount",
        "terseLabel": "Advanced amount (in Dollars)"
       }
      }
     },
     "localname": "AdvancedAmount",
     "nsuri": "http://encoreuranium.com/20221231",
     "presentation": [
      "http://encoreuranium.com/role/InvestmentInAssociateDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cve_AggregateOfGrantedShares": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate of granted shares.",
        "label": "Aggregate Of Granted Shares",
        "terseLabel": "Aggregate of granted shares"
       }
      }
     },
     "localname": "AggregateOfGrantedShares",
     "nsuri": "http://encoreuranium.com/20221231",
     "presentation": [
      "http://encoreuranium.com/role/ShareCapitalDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "cve_AltaMesaAcquisitionMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Alta Mesa Acquisition Member",
        "terseLabel": "Alta Mesa Acquisition [Member]"
       }
      }
     },
     "localname": "AltaMesaAcquisitionMember",
     "nsuri": "http://encoreuranium.com/20221231",
     "presentation": [
      "http://encoreuranium.com/role/EventsafterthereportingperiodDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cve_AssetAcquistion": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Asset Acquistion",
        "terseLabel": "Asset acquisition (Note 10)"
       }
      }
     },
     "localname": "AssetAcquistion",
     "nsuri": "http://encoreuranium.com/20221231",
     "presentation": [
      "http://encoreuranium.com/role/ScheduleofmineralpropertiesTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cve_AssetRetirementObligations": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Asset retirement obligations.",
        "label": "Asset Retirement Obligations",
        "terseLabel": "Asset retirement obligations"
       }
      }
     },
     "localname": "AssetRetirementObligations",
     "nsuri": "http://encoreuranium.com/20221231",
     "presentation": [
      "http://encoreuranium.com/role/ScheduleofnetassetsacquiredTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cve_AssetRetirementObligationsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Asset Retirement Obligations Abstract"
       }
      }
     },
     "localname": "AssetRetirementObligationsAbstract",
     "nsuri": "http://encoreuranium.com/20221231",
     "xbrltype": "stringItemType"
    },
    "cve_AssetRetirementObligationsAccretion": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Asset Retirement Obligations Accretion.",
        "label": "Asset Retirement Obligations Accretion",
        "terseLabel": "Accretion"
       }
      }
     },
     "localname": "AssetRetirementObligationsAccretion",
     "nsuri": "http://encoreuranium.com/20221231",
     "presentation": [
      "http://encoreuranium.com/role/ScheduleofassetretirementobligationscontinuityTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cve_AssetRetirementObligationsAdditionsFromAzargaAssetAcquisitionNote10": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Asset Retirement Obligations Additions From Azarga Asset Acquisition Note 10.",
        "label": "Asset Retirement Obligations Additions From Azarga Asset Acquisition Note10",
        "terseLabel": "Additions from Azarga asset acquisition (Note 10)"
       }
      }
     },
     "localname": "AssetRetirementObligationsAdditionsFromAzargaAssetAcquisitionNote10",
     "nsuri": "http://encoreuranium.com/20221231",
     "presentation": [
      "http://encoreuranium.com/role/ScheduleofassetretirementobligationscontinuityTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cve_AssetRetirementObligationsAdjustments": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Asset Retirement Obligations Adjustments.",
        "label": "Asset Retirement Obligations Adjustments",
        "terseLabel": "Adjustments"
       }
      }
     },
     "localname": "AssetRetirementObligationsAdjustments",
     "nsuri": "http://encoreuranium.com/20221231",
     "presentation": [
      "http://encoreuranium.com/role/ScheduleofassetretirementobligationscontinuityTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cve_AssetRetirementObligationsBalance": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Asset Retirement Obligations Balance.",
        "label": "Asset Retirement Obligations Balance",
        "periodEndLabel": "Balance, ending",
        "periodStartLabel": "Balance, beginning"
       }
      }
     },
     "localname": "AssetRetirementObligationsBalance",
     "nsuri": "http://encoreuranium.com/20221231",
     "presentation": [
      "http://encoreuranium.com/role/ScheduleofassetretirementobligationscontinuityTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cve_AssetRetirementObligationsSettlement": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Asset Retirement Obligations Settlement.",
        "label": "Asset Retirement Obligations Settlement",
        "terseLabel": "Settlement"
       }
      }
     },
     "localname": "AssetRetirementObligationsSettlement",
     "nsuri": "http://encoreuranium.com/20221231",
     "presentation": [
      "http://encoreuranium.com/role/ScheduleofassetretirementobligationscontinuityTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cve_AssetRetirementObligationsTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Asset Retirement Obligations Text Block",
        "terseLabel": "Asset retirement obligations"
       }
      }
     },
     "localname": "AssetRetirementObligationsTextBlock",
     "nsuri": "http://encoreuranium.com/20221231",
     "presentation": [
      "http://encoreuranium.com/role/Assetretirementobligations"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cve_AssetacquisitionDetailsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Asset acquisition (Details) [Line Items]"
       }
      }
     },
     "localname": "AssetacquisitionDetailsLineItems",
     "nsuri": "http://encoreuranium.com/20221231",
     "presentation": [
      "http://encoreuranium.com/role/AssetacquisitionDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "cve_AssetacquisitionDetailsScheduleofweightedaverageassumptionsusedintheblackscholesoptionLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Asset acquisition (Details) - Schedule of weighted average assumptions used in the black-scholes option [Line Items]"
       }
      }
     },
     "localname": "AssetacquisitionDetailsScheduleofweightedaverageassumptionsusedintheblackscholesoptionLineItems",
     "nsuri": "http://encoreuranium.com/20221231",
     "presentation": [
      "http://encoreuranium.com/role/ScheduleofweightedaverageassumptionsusedintheblackscholesoptionTable"
     ],
     "xbrltype": "stringItemType"
    },
    "cve_AssetacquisitionDetailsScheduleofweightedaverageassumptionsusedintheblackscholesoptionTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Asset acquisition (Details) - Schedule of weighted average assumptions used in the black-scholes option [Table]"
       }
      }
     },
     "localname": "AssetacquisitionDetailsScheduleofweightedaverageassumptionsusedintheblackscholesoptionTable",
     "nsuri": "http://encoreuranium.com/20221231",
     "presentation": [
      "http://encoreuranium.com/role/ScheduleofweightedaverageassumptionsusedintheblackscholesoptionTable"
     ],
     "xbrltype": "stringItemType"
    },
    "cve_AssetacquisitionDetailsTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Asset acquisition (Details) [Table]"
       }
      }
     },
     "localname": "AssetacquisitionDetailsTable",
     "nsuri": "http://encoreuranium.com/20221231",
     "presentation": [
      "http://encoreuranium.com/role/AssetacquisitionDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "cve_AssetretirementobligationsDetailsScheduleofassetretirementobligationsbalanceLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of asset retirement obligations balance [Abstract]"
       }
      }
     },
     "localname": "AssetretirementobligationsDetailsScheduleofassetretirementobligationsbalanceLineItems",
     "nsuri": "http://encoreuranium.com/20221231",
     "presentation": [
      "http://encoreuranium.com/role/ScheduleofassetretirementobligationsbalanceTable"
     ],
     "xbrltype": "stringItemType"
    },
    "cve_AssetretirementobligationsDetailsScheduleofassetretirementobligationsbalanceTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Asset retirement obligations (Details) - Schedule of asset retirement obligations balance [Table]"
       }
      }
     },
     "localname": "AssetretirementobligationsDetailsScheduleofassetretirementobligationsbalanceTable",
     "nsuri": "http://encoreuranium.com/20221231",
     "presentation": [
      "http://encoreuranium.com/role/ScheduleofassetretirementobligationsbalanceTable"
     ],
     "xbrltype": "stringItemType"
    },
    "cve_AssetretirementobligationsDetailsScheduleofassetretirementobligationscontinuityLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of asset retirement obligations continuity [Abstract]"
       }
      }
     },
     "localname": "AssetretirementobligationsDetailsScheduleofassetretirementobligationscontinuityLineItems",
     "nsuri": "http://encoreuranium.com/20221231",
     "presentation": [
      "http://encoreuranium.com/role/ScheduleofassetretirementobligationscontinuityTable"
     ],
     "xbrltype": "stringItemType"
    },
    "cve_AssetretirementobligationsDetailsScheduleofassetretirementobligationscontinuityTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Asset retirement obligations (Details) - Schedule of asset retirement obligations continuity [Table]"
       }
      }
     },
     "localname": "AssetretirementobligationsDetailsScheduleofassetretirementobligationscontinuityTable",
     "nsuri": "http://encoreuranium.com/20221231",
     "presentation": [
      "http://encoreuranium.com/role/ScheduleofassetretirementobligationscontinuityTable"
     ],
     "xbrltype": "stringItemType"
    },
    "cve_AssetretirementobligationsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Asset retirement obligations [Abstract]"
       }
      }
     },
     "localname": "AssetretirementobligationsLineItems",
     "nsuri": "http://encoreuranium.com/20221231",
     "presentation": [
      "http://encoreuranium.com/role/Assetretirementobligations"
     ],
     "xbrltype": "stringItemType"
    },
    "cve_AssetretirementobligationsTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Asset retirement obligations [Table]"
       }
      }
     },
     "localname": "AssetretirementobligationsTable",
     "nsuri": "http://encoreuranium.com/20221231",
     "presentation": [
      "http://encoreuranium.com/role/Assetretirementobligations"
     ],
     "xbrltype": "stringItemType"
    },
    "cve_AssetretirementobligationsTablesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assetretirementobligations Tables Line Items",
        "terseLabel": "Asset retirement obligations [Abstract]"
       }
      }
     },
     "localname": "AssetretirementobligationsTablesLineItems",
     "nsuri": "http://encoreuranium.com/20221231",
     "presentation": [
      "http://encoreuranium.com/role/AssetretirementobligationsTables"
     ],
     "xbrltype": "stringItemType"
    },
    "cve_AssetretirementobligationsTablesTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Asset retirement obligations (Tables) [Table]"
       }
      }
     },
     "localname": "AssetretirementobligationsTablesTable",
     "nsuri": "http://encoreuranium.com/20221231",
     "presentation": [
      "http://encoreuranium.com/role/AssetretirementobligationsTables"
     ],
     "xbrltype": "stringItemType"
    },
    "cve_AssetsHeldForSale": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets Held For Sale",
        "negatedLabel": "Assets held for sale"
       }
      }
     },
     "localname": "AssetsHeldForSale",
     "nsuri": "http://encoreuranium.com/20221231",
     "presentation": [
      "http://encoreuranium.com/role/ScheduleofmineralpropertiesTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cve_AssetsLossFromOperatingExpenses": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Assets, Loss from operating expenses",
        "label": "Assets Loss From Operating Expenses",
        "terseLabel": "Assets, Loss from operating expenses"
       }
      }
     },
     "localname": "AssetsLossFromOperatingExpenses",
     "nsuri": "http://encoreuranium.com/20221231",
     "presentation": [
      "http://encoreuranium.com/role/ScheduleofproportionalshareintheassociateTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cve_AssetsReceivedPercentage": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Assets received percentage",
        "label": "Assets Received Percentage",
        "terseLabel": "Assets received percentage"
       }
      }
     },
     "localname": "AssetsReceivedPercentage",
     "nsuri": "http://encoreuranium.com/20221231",
     "presentation": [
      "http://encoreuranium.com/role/EventsafterthereportingperiodDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "cve_AzargaResourcesCanadaLtdMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Azarga Resources Canada Ltd Member",
        "terseLabel": "Azarga Resources Canada Ltd. [Member]"
       }
      }
     },
     "localname": "AzargaResourcesCanadaLtdMember",
     "nsuri": "http://encoreuranium.com/20221231",
     "presentation": [
      "http://encoreuranium.com/role/ScheduleofsignificantsubsidiariesTable"
     ],
     "xbrltype": "domainItemType"
    },
    "cve_AzargaResourcesHongKongLtdMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Azarga Resources Hong Kong Ltd Member",
        "terseLabel": "Azarga Resources (Hong Kong) Ltd. [Member]"
       }
      }
     },
     "localname": "AzargaResourcesHongKongLtdMember",
     "nsuri": "http://encoreuranium.com/20221231",
     "presentation": [
      "http://encoreuranium.com/role/ScheduleofsignificantsubsidiariesTable"
     ],
     "xbrltype": "domainItemType"
    },
    "cve_AzargaResourcesLimitedMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Azarga Resources Limited Member",
        "terseLabel": "Azarga Resources Limited [Member]"
       }
      }
     },
     "localname": "AzargaResourcesLimitedMember",
     "nsuri": "http://encoreuranium.com/20221231",
     "presentation": [
      "http://encoreuranium.com/role/ScheduleofsignificantsubsidiariesTable"
     ],
     "xbrltype": "domainItemType"
    },
    "cve_AzargaResourcesUSACompanyMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Azarga Resources USACompany Member",
        "terseLabel": "Azarga Resources USA Company [Member]"
       }
      }
     },
     "localname": "AzargaResourcesUSACompanyMember",
     "nsuri": "http://encoreuranium.com/20221231",
     "presentation": [
      "http://encoreuranium.com/role/ScheduleofsignificantsubsidiariesTable"
     ],
     "xbrltype": "domainItemType"
    },
    "cve_AzargaUraniumCorpMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Azarga Uranium Corp Member",
        "terseLabel": "Azarga Uranium Corp. [Member]"
       }
      }
     },
     "localname": "AzargaUraniumCorpMember",
     "nsuri": "http://encoreuranium.com/20221231",
     "presentation": [
      "http://encoreuranium.com/role/ScheduleofsignificantsubsidiariesTable"
     ],
     "xbrltype": "domainItemType"
    },
    "cve_BeltLineResourcesIncMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Belt Line Resources Inc Member",
        "terseLabel": "Belt Line Resources, Inc. [Member]"
       }
      }
     },
     "localname": "BeltLineResourcesIncMember",
     "nsuri": "http://encoreuranium.com/20221231",
     "presentation": [
      "http://encoreuranium.com/role/ScheduleofsignificantsubsidiariesTable"
     ],
     "xbrltype": "domainItemType"
    },
    "cve_CancellationFee": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cancellation fee.",
        "label": "Cancellation Fee",
        "terseLabel": "Cancellation fee"
       }
      }
     },
     "localname": "CancellationFee",
     "nsuri": "http://encoreuranium.com/20221231",
     "presentation": [
      "http://encoreuranium.com/role/SalescontractsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cve_CarriedForward": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carried forward.",
        "label": "Carried Forward",
        "terseLabel": "Carried forward"
       }
      }
     },
     "localname": "CarriedForward",
     "nsuri": "http://encoreuranium.com/20221231",
     "presentation": [
      "http://encoreuranium.com/role/IncometaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cve_CashAcquiredFromAzargaAssetAcquisition": {
     "auth_ref": [],
     "calculation": {
      "http://encoreuranium.com/role/ConsolidatedCashFlow": {
       "order": 8.0,
       "parentTag": "ifrs-full_CashFlowsFromUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cash acquired from azarga asset acquisition.",
        "label": "Cash Acquired From Azarga Asset Acquisition",
        "negatedLabel": "Cash acquired from Azarga asset acquisition"
       }
      }
     },
     "localname": "CashAcquiredFromAzargaAssetAcquisition",
     "nsuri": "http://encoreuranium.com/20221231",
     "presentation": [
      "http://encoreuranium.com/role/ConsolidatedCashFlow"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cve_CashIssuanceCosts": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Flotation costs are incurred by a publicly-traded company when it issues new securities and the cost makes the company's new equity more expensive.",
        "label": "Cash Issuance Costs",
        "terseLabel": "Other cash issuance costs"
       }
      }
     },
     "localname": "CashIssuanceCosts",
     "nsuri": "http://encoreuranium.com/20221231",
     "presentation": [
      "http://encoreuranium.com/role/ShareCapitalDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cve_CategoryRange": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Range.",
        "label": "Category Range",
        "terseLabel": "Range"
       }
      }
     },
     "localname": "CategoryRange",
     "nsuri": "http://encoreuranium.com/20221231",
     "presentation": [
      "http://encoreuranium.com/role/ScheduleofusefullivesofintangibleassetsTable"
     ],
     "xbrltype": "stringItemType"
    },
    "cve_CentennialMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Centennial Member",
        "terseLabel": "Centennial [Member]"
       }
      }
     },
     "localname": "CentennialMember",
     "nsuri": "http://encoreuranium.com/20221231",
     "presentation": [
      "http://encoreuranium.com/role/ScheduleofassetretirementobligationsbalanceTable"
     ],
     "xbrltype": "domainItemType"
    },
    "cve_ChangeInUnrecognizedTemporaryDifferences": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Change in unrecognized temporary differences.",
        "label": "Change In Unrecognized Temporary Differences",
        "terseLabel": "Change in unrecognized temporary differences"
       }
      }
     },
     "localname": "ChangeInUnrecognizedTemporaryDifferences",
     "nsuri": "http://encoreuranium.com/20221231",
     "presentation": [
      "http://encoreuranium.com/role/ScheduleoffederalandprovincialcorporatetaxratestoincomebeforetaxTable",
      "http://encoreuranium.com/role/ScheduleofincometaxexpenserecoveryTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cve_ChangeinPresentationCurrencyDetailsScheduleofconsolidatedstatementsoflossandcomprehensivelossLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Change in Presentation Currency (Details) - Schedule of consolidated statements of loss and comprehensive loss [Line Items]"
       }
      }
     },
     "localname": "ChangeinPresentationCurrencyDetailsScheduleofconsolidatedstatementsoflossandcomprehensivelossLineItems",
     "nsuri": "http://encoreuranium.com/20221231",
     "presentation": [
      "http://encoreuranium.com/role/ScheduleofconsolidatedstatementsoflossandcomprehensivelossTable"
     ],
     "xbrltype": "stringItemType"
    },
    "cve_ChangeinPresentationCurrencyDetailsScheduleofconsolidatedstatementsoflossandcomprehensivelossParentheticalsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Change in Presentation Currency (Details) - Schedule of consolidated statements of loss and comprehensive loss (Parentheticals) [Line Items]"
       }
      }
     },
     "localname": "ChangeinPresentationCurrencyDetailsScheduleofconsolidatedstatementsoflossandcomprehensivelossParentheticalsLineItems",
     "nsuri": "http://encoreuranium.com/20221231",
     "presentation": [
      "http://encoreuranium.com/role/ScheduleofconsolidatedstatementsoflossandcomprehensivelossTable_Parentheticals"
     ],
     "xbrltype": "stringItemType"
    },
    "cve_ChangeinPresentationCurrencyDetailsScheduleofconsolidatedstatementsoflossandcomprehensivelossParentheticalsTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Change in Presentation Currency (Details) - Schedule of consolidated statements of loss and comprehensive loss (Parentheticals) [Table]"
       }
      }
     },
     "localname": "ChangeinPresentationCurrencyDetailsScheduleofconsolidatedstatementsoflossandcomprehensivelossParentheticalsTable",
     "nsuri": "http://encoreuranium.com/20221231",
     "presentation": [
      "http://encoreuranium.com/role/ScheduleofconsolidatedstatementsoflossandcomprehensivelossTable_Parentheticals"
     ],
     "xbrltype": "stringItemType"
    },
    "cve_ChangeinPresentationCurrencyDetailsScheduleofconsolidatedstatementsoflossandcomprehensivelossTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Change in Presentation Currency (Details) - Schedule of consolidated statements of loss and comprehensive loss [Table]"
       }
      }
     },
     "localname": "ChangeinPresentationCurrencyDetailsScheduleofconsolidatedstatementsoflossandcomprehensivelossTable",
     "nsuri": "http://encoreuranium.com/20221231",
     "presentation": [
      "http://encoreuranium.com/role/ScheduleofconsolidatedstatementsoflossandcomprehensivelossTable"
     ],
     "xbrltype": "stringItemType"
    },
    "cve_ChangeinPresentationCurrencyDetailsScheduleofeffectoftranslationLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Change in Presentation Currency (Details) - Schedule of effect of translation [Line Items]"
       }
      }
     },
     "localname": "ChangeinPresentationCurrencyDetailsScheduleofeffectoftranslationLineItems",
     "nsuri": "http://encoreuranium.com/20221231",
     "presentation": [
      "http://encoreuranium.com/role/ScheduleofeffectoftranslationTable"
     ],
     "xbrltype": "stringItemType"
    },
    "cve_ChangeinPresentationCurrencyDetailsScheduleofeffectoftranslationTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Change in Presentation Currency (Details) - Schedule of effect of translation [Table]"
       }
      }
     },
     "localname": "ChangeinPresentationCurrencyDetailsScheduleofeffectoftranslationTable",
     "nsuri": "http://encoreuranium.com/20221231",
     "presentation": [
      "http://encoreuranium.com/role/ScheduleofeffectoftranslationTable"
     ],
     "xbrltype": "stringItemType"
    },
    "cve_ChangesInNonCashWorkingCapitalItemsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Changes In Non Cash Working Capital Items Abstract",
        "terseLabel": "Changes in non-cash working capital items:"
       }
      }
     },
     "localname": "ChangesInNonCashWorkingCapitalItemsAbstract",
     "nsuri": "http://encoreuranium.com/20221231",
     "presentation": [
      "http://encoreuranium.com/role/ConsolidatedCashFlow"
     ],
     "xbrltype": "stringItemType"
    },
    "cve_CibolaResourcesLLCMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cibola Resources LLCMember",
        "terseLabel": "Cibola Resources, LLC [Member]"
       }
      }
     },
     "localname": "CibolaResourcesLLCMember",
     "nsuri": "http://encoreuranium.com/20221231",
     "presentation": [
      "http://encoreuranium.com/role/ScheduleofsignificantsubsidiariesTable"
     ],
     "xbrltype": "domainItemType"
    },
    "cve_CommonShare": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A common shareholder is an individual, business, or institution that holds common shares in a company, giving the holder an ownership stake in the company. This will also give the holder the right to vote on corporate issues such as board elections and corporate policy, along with the right to any common dividend payments.",
        "label": "Common Share",
        "terseLabel": "Common share"
       }
      }
     },
     "localname": "CommonShare",
     "nsuri": "http://encoreuranium.com/20221231",
     "presentation": [
      "http://encoreuranium.com/role/ShareCapitalDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "cve_CommonShareIssued": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Issued shares are the subset of authorized shares that have been sold to and held by the shareholders of a company, regardless of whether they are insiders, institutional investors, or the general public (as shown in the company\u2019s annual report). Issued shares include the stock a company sells publicly to generate capital and the stock given to insiders as part of their compensation packages.",
        "label": "Common Share Issued",
        "terseLabel": "Common shares issued"
       }
      }
     },
     "localname": "CommonShareIssued",
     "nsuri": "http://encoreuranium.com/20221231",
     "presentation": [
      "http://encoreuranium.com/role/ShareCapitalDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "cve_CommonShares": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares common.",
        "label": "Common Shares",
        "terseLabel": "Common shares"
       }
      }
     },
     "localname": "CommonShares",
     "nsuri": "http://encoreuranium.com/20221231",
     "presentation": [
      "http://encoreuranium.com/role/MarketableSecuritiesDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "cve_CommonSharesIssued": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common Shares Issued",
        "terseLabel": "Common shares issued (in Shares)"
       }
      }
     },
     "localname": "CommonSharesIssued",
     "nsuri": "http://encoreuranium.com/20221231",
     "presentation": [
      "http://encoreuranium.com/role/IntangibleassetsDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "cve_CommonSharesOfSettlementAndCompensation": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Common shares of settlement and compensation.",
        "label": "Common Shares Of Settlement And Compensation",
        "terseLabel": "Common shares of settlement and compensation"
       }
      }
     },
     "localname": "CommonSharesOfSettlementAndCompensation",
     "nsuri": "http://encoreuranium.com/20221231",
     "presentation": [
      "http://encoreuranium.com/role/ShareCapitalDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "cve_CommunityEngagement": {
     "auth_ref": [],
     "calculation": {
      "http://encoreuranium.com/role/ConsolidatedComprehensiveIncome": {
       "order": 3.0,
       "parentTag": "ifrs-full_ProfitLossFromOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Community engagement expenses.",
        "label": "Community Engagement",
        "terseLabel": "Community engagement"
       }
      }
     },
     "localname": "CommunityEngagement",
     "nsuri": "http://encoreuranium.com/20221231",
     "presentation": [
      "http://encoreuranium.com/role/ConsolidatedComprehensiveIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cve_ConsiderationPercentage": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Consideration Percentage",
        "terseLabel": "Consideration percentage"
       }
      }
     },
     "localname": "ConsiderationPercentage",
     "nsuri": "http://encoreuranium.com/20221231",
     "presentation": [
      "http://encoreuranium.com/role/MineralPropertiesDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "cve_ConsiderationReceived": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Consideration Received",
        "terseLabel": "Consideration received (in Shares)"
       }
      }
     },
     "localname": "ConsiderationReceived",
     "nsuri": "http://encoreuranium.com/20221231",
     "presentation": [
      "http://encoreuranium.com/role/MineralPropertiesDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "cve_ConsolidatedStatementsOfChangesInShareholderSEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Consolidated Statements Of Changes In Shareholder SEquity Abstract"
       }
      }
     },
     "localname": "ConsolidatedStatementsOfChangesInShareholderSEquityAbstract",
     "nsuri": "http://encoreuranium.com/20221231",
     "xbrltype": "stringItemType"
    },
    "cve_ConsolidatedStatementsOfLossAndComprehensiveLossAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Consolidated Statements Of Loss And Comprehensive Loss Abstract"
       }
      }
     },
     "localname": "ConsolidatedStatementsOfLossAndComprehensiveLossAbstract",
     "nsuri": "http://encoreuranium.com/20221231",
     "xbrltype": "stringItemType"
    },
    "cve_ConstructionOfWellfields": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Construction Of Wellfields",
        "terseLabel": "Construction of wellfields"
       }
      }
     },
     "localname": "ConstructionOfWellfields",
     "nsuri": "http://encoreuranium.com/20221231",
     "presentation": [
      "http://encoreuranium.com/role/ScheduleofmineralpropertiesTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cve_Consulting": {
     "auth_ref": [],
     "calculation": {
      "http://encoreuranium.com/role/ConsolidatedComprehensiveIncome": {
       "order": 4.0,
       "parentTag": "ifrs-full_ProfitLossFromOperatingActivities",
       "weight": -1.0
      },
      "http://encoreuranium.com/role/ScheduleofconsolidatedstatementsoflossandcomprehensivelossTable": {
       "order": 3.0,
       "parentTag": "ifrs-full_OtherOperatingIncomeExpense",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Consulting Expenses.",
        "label": "Consulting",
        "terseLabel": "Consulting"
       }
      }
     },
     "localname": "Consulting",
     "nsuri": "http://encoreuranium.com/20221231",
     "presentation": [
      "http://encoreuranium.com/role/ConsolidatedComprehensiveIncome",
      "http://encoreuranium.com/role/ScheduleofconsolidatedstatementsoflossandcomprehensivelossTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cve_ConsultingFees": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of consulting fees.",
        "label": "Consulting Fees",
        "terseLabel": "Consulting fees"
       }
      }
     },
     "localname": "ConsultingFees",
     "nsuri": "http://encoreuranium.com/20221231",
     "presentation": [
      "http://encoreuranium.com/role/RelatedpartytransactionsandbalancesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cve_ContractPoundsOfUranium": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contract pounds of uranium.",
        "label": "Contract Pounds Of Uranium",
        "terseLabel": "Contract pounds of uranium"
       }
      }
     },
     "localname": "ContractPoundsOfUranium",
     "nsuri": "http://encoreuranium.com/20221231",
     "presentation": [
      "http://encoreuranium.com/role/SalescontractsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cve_ContributedSurplus": {
     "auth_ref": [],
     "calculation": {
      "http://encoreuranium.com/role/ConsolidatedBalanceSheet": {
       "order": 3.0,
       "parentTag": "ifrs-full_Equity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contributed surplus.",
        "label": "Contributed Surplus",
        "terseLabel": "Contributed surplus"
       }
      }
     },
     "localname": "ContributedSurplus",
     "nsuri": "http://encoreuranium.com/20221231",
     "presentation": [
      "http://encoreuranium.com/role/ConsolidatedBalanceSheet"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cve_ContributedSurplusMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Contributed Surplus Member",
        "terseLabel": "Contributed surplus"
       }
      }
     },
     "localname": "ContributedSurplusMember",
     "nsuri": "http://encoreuranium.com/20221231",
     "presentation": [
      "http://encoreuranium.com/role/ShareholdersEquityType2or3"
     ],
     "xbrltype": "domainItemType"
    },
    "cve_ConvertedShares": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares converted.",
        "label": "Converted Shares",
        "terseLabel": "Converted shares"
       }
      }
     },
     "localname": "ConvertedShares",
     "nsuri": "http://encoreuranium.com/20221231",
     "presentation": [
      "http://encoreuranium.com/role/MarketableSecuritiesDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "cve_CorrespondingLeaseObligation": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Corresponding lease obligation.",
        "label": "Corresponding Lease Obligation",
        "terseLabel": "Corresponding lease obligation"
       }
      }
     },
     "localname": "CorrespondingLeaseObligation",
     "nsuri": "http://encoreuranium.com/20221231",
     "presentation": [
      "http://encoreuranium.com/role/RightofuseassetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cve_CriticalAccountingEstimatesAndJudgementsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Critical Accounting Estimates And Judgements Line Items",
        "terseLabel": "Critical accounting estimates and judgements [Abstract]"
       }
      }
     },
     "localname": "CriticalAccountingEstimatesAndJudgementsLineItems",
     "nsuri": "http://encoreuranium.com/20221231",
     "presentation": [
      "http://encoreuranium.com/role/CriticalAccountingEstimatesAndJudgements"
     ],
     "xbrltype": "stringItemType"
    },
    "cve_CriticalAccountingEstimatesAndJudgementsTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Critical Accounting Estimates And Judgements [Table]"
       }
      }
     },
     "localname": "CriticalAccountingEstimatesAndJudgementsTable",
     "nsuri": "http://encoreuranium.com/20221231",
     "presentation": [
      "http://encoreuranium.com/role/CriticalAccountingEstimatesAndJudgements"
     ],
     "xbrltype": "stringItemType"
    },
    "cve_CrownpointMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Crownpoint Member",
        "terseLabel": "Crownpoint [Member]"
       }
      }
     },
     "localname": "CrownpointMember",
     "nsuri": "http://encoreuranium.com/20221231",
     "presentation": [
      "http://encoreuranium.com/role/MineralPropertiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cve_CurrencyTranslationAdjustment": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of currency translation adjustment.",
        "label": "Currency Translation Adjustment",
        "terseLabel": "Currency translation adjustment"
       }
      }
     },
     "localname": "CurrencyTranslationAdjustment",
     "nsuri": "http://encoreuranium.com/20221231",
     "presentation": [
      "http://encoreuranium.com/role/ScheduleofinvestmentinassociatecontinuityTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cve_CurrencyTranslationAdjustment1": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Currency Translation Adjustment.",
        "label": "Currency Translation Adjustment1",
        "terseLabel": "Currency Translation Adjustment"
       }
      }
     },
     "localname": "CurrencyTranslationAdjustment1",
     "nsuri": "http://encoreuranium.com/20221231",
     "presentation": [
      "http://encoreuranium.com/role/ScheduleofintangibleassetwasdeterminedTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cve_DataAccessAgreementMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Data Access Agreement Member",
        "terseLabel": "Data Access Agreement\t[Member]"
       }
      }
     },
     "localname": "DataAccessAgreementMember",
     "nsuri": "http://encoreuranium.com/20221231",
     "presentation": [
      "http://encoreuranium.com/role/ScheduleofusefullivesofintangibleassetsTable"
     ],
     "xbrltype": "domainItemType"
    },
    "cve_DataPurchasesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Data Purchases Member",
        "terseLabel": "Data Purchases [Member]"
       }
      }
     },
     "localname": "DataPurchasesMember",
     "nsuri": "http://encoreuranium.com/20221231",
     "presentation": [
      "http://encoreuranium.com/role/ScheduleofusefullivesofintangibleassetsTable"
     ],
     "xbrltype": "domainItemType"
    },
    "cve_DeductibleTemporaryDifferences": {
     "auth_ref": [],
     "calculation": {
      "http://encoreuranium.com/role/ScheduleofunrecognizeddeferredtaxassetsTable": {
       "order": 1.0,
       "parentTag": "ifrs-full_ProfitLossBeforeTax",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Deductible temporary differences.",
        "label": "Deductible Temporary Differences",
        "negatedLabel": "Deductible temporary differences"
       }
      }
     },
     "localname": "DeductibleTemporaryDifferences",
     "nsuri": "http://encoreuranium.com/20221231",
     "presentation": [
      "http://encoreuranium.com/role/ScheduleofunrecognizeddeferredtaxassetsTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cve_DeferredTaxExpenseRecoveryAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred Tax Expense Recovery Abstract",
        "terseLabel": "Deferred tax expense (recovery)"
       }
      }
     },
     "localname": "DeferredTaxExpenseRecoveryAbstract",
     "nsuri": "http://encoreuranium.com/20221231",
     "presentation": [
      "http://encoreuranium.com/role/ScheduleofincometaxexpenserecoveryTable"
     ],
     "xbrltype": "stringItemType"
    },
    "cve_DepositUraniumInvestment": {
     "auth_ref": [],
     "calculation": {
      "http://encoreuranium.com/role/ConsolidatedBalanceSheet": {
       "order": 4.0,
       "parentTag": "ifrs-full_CurrentAssets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Deposit uranium investment.",
        "label": "Deposit Uranium Investment",
        "terseLabel": "Deposit - uranium investment"
       }
      }
     },
     "localname": "DepositUraniumInvestment",
     "nsuri": "http://encoreuranium.com/20221231",
     "presentation": [
      "http://encoreuranium.com/role/ConsolidatedBalanceSheet"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cve_DescriptionOfAccountingPolicyForAssetRetirementObligationstextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The description of the entity's accounting policy for asset retirement obligations.",
        "label": "Description Of Accounting Policy For Asset Retirement Obligationstext Block",
        "terseLabel": "Asset retirement obligations"
       }
      }
     },
     "localname": "DescriptionOfAccountingPolicyForAssetRetirementObligationstextBlock",
     "nsuri": "http://encoreuranium.com/20221231",
     "presentation": [
      "http://encoreuranium.com/role/AccountingPoliciesByPolicy"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cve_DescriptionOfAccountingPolicyForBasisOfConsolidationtextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The description of the entity's accounting policy for basis of consolidation.",
        "label": "Description Of Accounting Policy For Basis Of Consolidationtext Block",
        "terseLabel": "Basis of consolidation"
       }
      }
     },
     "localname": "DescriptionOfAccountingPolicyForBasisOfConsolidationtextBlock",
     "nsuri": "http://encoreuranium.com/20221231",
     "presentation": [
      "http://encoreuranium.com/role/AccountingPoliciesByPolicy"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cve_DescriptionOfAccountingPolicyForBasisOfPresentationtextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The description of the entity's accounting policy for basis of presentation.",
        "label": "Description Of Accounting Policy For Basis Of Presentationtext Block",
        "terseLabel": "Basis of presentation"
       }
      }
     },
     "localname": "DescriptionOfAccountingPolicyForBasisOfPresentationtextBlock",
     "nsuri": "http://encoreuranium.com/20221231",
     "presentation": [
      "http://encoreuranium.com/role/AccountingPoliciesByPolicy"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cve_DescriptionOfAccountingPolicyForBuildingtextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The description of the entity's accounting policy for buildings.",
        "label": "Description Of Accounting Policy For Buildingtext Block",
        "terseLabel": "Buildings"
       }
      }
     },
     "localname": "DescriptionOfAccountingPolicyForBuildingtextBlock",
     "nsuri": "http://encoreuranium.com/20221231",
     "presentation": [
      "http://encoreuranium.com/role/AccountingPoliciesByPolicy"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cve_DescriptionOfAccountingPolicyForCashtextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The description of the entity's accounting policy for cash.",
        "label": "Description Of Accounting Policy For Cashtext Block",
        "terseLabel": "Cash"
       }
      }
     },
     "localname": "DescriptionOfAccountingPolicyForCashtextBlock",
     "nsuri": "http://encoreuranium.com/20221231",
     "presentation": [
      "http://encoreuranium.com/role/AccountingPoliciesByPolicy"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cve_DescriptionOfAccountingPolicyForChangeInPresentationCurrencytextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The description of the entity's accounting policy for change in presentation currency.",
        "label": "Description Of Accounting Policy For Change In Presentation Currencytext Block",
        "terseLabel": "Change in presentation currency"
       }
      }
     },
     "localname": "DescriptionOfAccountingPolicyForChangeInPresentationCurrencytextBlock",
     "nsuri": "http://encoreuranium.com/20221231",
     "presentation": [
      "http://encoreuranium.com/role/AccountingPoliciesByPolicy"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cve_DescriptionOfAccountingPolicyForInvestmentsInUraniumtextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The description of the entity's accounting policy for investments in uranium.",
        "label": "Description Of Accounting Policy For Investments In Uraniumtext Block",
        "terseLabel": "Investments in uranium"
       }
      }
     },
     "localname": "DescriptionOfAccountingPolicyForInvestmentsInUraniumtextBlock",
     "nsuri": "http://encoreuranium.com/20221231",
     "presentation": [
      "http://encoreuranium.com/role/AccountingPoliciesByPolicy"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cve_DescriptionOfAccountingPolicyForMineralPropertiestextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The description of the entity's accounting policy for mineral properties.",
        "label": "Description Of Accounting Policy For Mineral Propertiestext Block",
        "terseLabel": "Mineral properties"
       }
      }
     },
     "localname": "DescriptionOfAccountingPolicyForMineralPropertiestextBlock",
     "nsuri": "http://encoreuranium.com/20221231",
     "presentation": [
      "http://encoreuranium.com/role/AccountingPoliciesByPolicy"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cve_DescriptionOfAccountingPolicyForNewStandardsAndInterpretationsNotYetAdoptedtextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The description of the entity's accounting policy for new standards and interpretations not yet adopted.",
        "label": "Description Of Accounting Policy For New Standards And Interpretations Not Yet Adoptedtext Block",
        "terseLabel": "New standards and interpretations not yet adopted"
       }
      }
     },
     "localname": "DescriptionOfAccountingPolicyForNewStandardsAndInterpretationsNotYetAdoptedtextBlock",
     "nsuri": "http://encoreuranium.com/20221231",
     "presentation": [
      "http://encoreuranium.com/role/AccountingPoliciesByPolicy"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cve_DescriptionOfAccountingPolicyForOtherPropertyPlantAndEquipmenttextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The description of the entity's accounting policy for other property, plant and equipment. [Refer: Property, plant and equipment] Effective 2023-01-01: The description of the entity's material accounting policy information for property, plant and equipment. [Refer: Property, plant and equipment]",
        "label": "Description Of Accounting Policy For Other Property Plant And Equipmenttext Block",
        "terseLabel": "Other property, plant and equipment"
       }
      }
     },
     "localname": "DescriptionOfAccountingPolicyForOtherPropertyPlantAndEquipmenttextBlock",
     "nsuri": "http://encoreuranium.com/20221231",
     "presentation": [
      "http://encoreuranium.com/role/AccountingPoliciesByPolicy"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cve_DescriptionOfAccountingPolicyForSoftwaretextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The description of the entity's accounting policy for software.",
        "label": "Description Of Accounting Policy For Softwaretext Block",
        "terseLabel": "Software"
       }
      }
     },
     "localname": "DescriptionOfAccountingPolicyForSoftwaretextBlock",
     "nsuri": "http://encoreuranium.com/20221231",
     "presentation": [
      "http://encoreuranium.com/role/AccountingPoliciesByPolicy"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cve_DescriptionOfAccountingPolicyForUraniumPlantstextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The description of the entity's accounting policy for uranium plants.",
        "label": "Description Of Accounting Policy For Uranium Plantstext Block",
        "terseLabel": "Uranium plants"
       }
      }
     },
     "localname": "DescriptionOfAccountingPolicyForUraniumPlantstextBlock",
     "nsuri": "http://encoreuranium.com/20221231",
     "presentation": [
      "http://encoreuranium.com/role/AccountingPoliciesByPolicy"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cve_DilutionLoss": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of dilution loss.",
        "label": "Dilution Loss",
        "terseLabel": "Dilution loss"
       }
      }
     },
     "localname": "DilutionLoss",
     "nsuri": "http://encoreuranium.com/20221231",
     "presentation": [
      "http://encoreuranium.com/role/ScheduleofinvestmentinassociatecontinuityTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cve_DisclosueOfSalesContractsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosue Of Sales Contracts Abstract"
       }
      }
     },
     "localname": "DisclosueOfSalesContractsAbstract",
     "nsuri": "http://encoreuranium.com/20221231",
     "xbrltype": "stringItemType"
    },
    "cve_DisclosueOfSalesContractsTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosue of Sales contracts.",
        "label": "Disclosue Of Sales Contracts Text Block",
        "terseLabel": "Sales contracts"
       }
      }
     },
     "localname": "DisclosueOfSalesContractsTextBlock",
     "nsuri": "http://encoreuranium.com/20221231",
     "presentation": [
      "http://encoreuranium.com/role/Salescontracts"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cve_DisclosureOfAccountingJudgementsAndEstimatesTextBlockAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Critical accounting estimates and judgements [Abstract]"
       }
      }
     },
     "localname": "DisclosureOfAccountingJudgementsAndEstimatesTextBlockAbstract",
     "nsuri": "http://encoreuranium.com/20221231",
     "xbrltype": "stringItemType"
    },
    "cve_DisclosureOfAssetRetirementObligationsBalanceTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of asset retirement obligations balance.",
        "label": "Disclosure Of Asset Retirement Obligations Balance Table Text Block",
        "terseLabel": "Schedule of asset retirement obligations balance"
       }
      }
     },
     "localname": "DisclosureOfAssetRetirementObligationsBalanceTableTextBlock",
     "nsuri": "http://encoreuranium.com/20221231",
     "presentation": [
      "http://encoreuranium.com/role/AssetretirementobligationsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cve_DisclosureOfAssetRetirementObligationsContinuityTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of asset retirement obligations continuity.",
        "label": "Disclosure Of Asset Retirement Obligations Continuity Table Text Block",
        "terseLabel": "Schedule of asset retirement obligations continuity"
       }
      }
     },
     "localname": "DisclosureOfAssetRetirementObligationsContinuityTableTextBlock",
     "nsuri": "http://encoreuranium.com/20221231",
     "presentation": [
      "http://encoreuranium.com/role/AssetretirementobligationsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cve_DisclosureOfAssociatesTextBlockAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investment in Associate [Abstract]"
       }
      }
     },
     "localname": "DisclosureOfAssociatesTextBlockAbstract",
     "nsuri": "http://encoreuranium.com/20221231",
     "xbrltype": "stringItemType"
    },
    "cve_DisclosureOfChangeInTheLongTermLeaseLiabilityTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of change in the long-Term lease liability.",
        "label": "Disclosure Of Change In The Long Term Lease Liability Table Text Block",
        "terseLabel": "Schedule of change in the long-Term lease liability"
       }
      }
     },
     "localname": "DisclosureOfChangeInTheLongTermLeaseLiabilityTableTextBlock",
     "nsuri": "http://encoreuranium.com/20221231",
     "presentation": [
      "http://encoreuranium.com/role/RightofuseassetsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cve_DisclosureOfChangeInTheROUAssetsTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of change in the ROU assets.",
        "label": "Disclosure Of Change In The ROUAssets Table Text Block",
        "terseLabel": "Schedule of change in the ROU assets"
       }
      }
     },
     "localname": "DisclosureOfChangeInTheROUAssetsTableTextBlock",
     "nsuri": "http://encoreuranium.com/20221231",
     "presentation": [
      "http://encoreuranium.com/role/RightofuseassetsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cve_DisclosureOfClassesOfShareCapitalTextBlockAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure Of Classes Of Share Capital Text Block Abstract"
       }
      }
     },
     "localname": "DisclosureOfClassesOfShareCapitalTextBlockAbstract",
     "nsuri": "http://encoreuranium.com/20221231",
     "xbrltype": "stringItemType"
    },
    "cve_DisclosureOfEntitysOperatingSegmentsTextBlockAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure Of Entitys Operating Segments Text Block Abstract"
       }
      }
     },
     "localname": "DisclosureOfEntitysOperatingSegmentsTextBlockAbstract",
     "nsuri": "http://encoreuranium.com/20221231",
     "xbrltype": "stringItemType"
    },
    "cve_DisclosureOfEventsAfterReportingPeriodTextBlockAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Events after the reporting period [Abstract]"
       }
      }
     },
     "localname": "DisclosureOfEventsAfterReportingPeriodTextBlockAbstract",
     "nsuri": "http://encoreuranium.com/20221231",
     "xbrltype": "stringItemType"
    },
    "cve_DisclosureOfFinancialInstrumentsTextBlockAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure Of Financial Instruments Text Block Abstract"
       }
      }
     },
     "localname": "DisclosureOfFinancialInstrumentsTextBlockAbstract",
     "nsuri": "http://encoreuranium.com/20221231",
     "xbrltype": "stringItemType"
    },
    "cve_DisclosureOfHowEntityManagesLiquidityRiskTextBlockAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure Of How Entity Manages Liquidity Risk Text Block Abstract"
       }
      }
     },
     "localname": "DisclosureOfHowEntityManagesLiquidityRiskTextBlockAbstract",
     "nsuri": "http://encoreuranium.com/20221231",
     "xbrltype": "stringItemType"
    },
    "cve_DisclosureOfIncomeTaxTextBlockAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure Of Income Tax Text Block Abstract"
       }
      }
     },
     "localname": "DisclosureOfIncomeTaxTextBlockAbstract",
     "nsuri": "http://encoreuranium.com/20221231",
     "xbrltype": "stringItemType"
    },
    "cve_DisclosureOfIntangibleAssetsTextBlockAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure Of Intangible Assets Text Block Abstract"
       }
      }
     },
     "localname": "DisclosureOfIntangibleAssetsTextBlockAbstract",
     "nsuri": "http://encoreuranium.com/20221231",
     "xbrltype": "stringItemType"
    },
    "cve_DisclosureOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethodTextBlockAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure Of Investments Other Than Investments Accounted For Using Equity Method Text Block Abstract"
       }
      }
     },
     "localname": "DisclosureOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethodTextBlockAbstract",
     "nsuri": "http://encoreuranium.com/20221231",
     "xbrltype": "stringItemType"
    },
    "cve_DisclosureOfLongtermAssetsByGeographicSegmentTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of long-term assets by geographic segment.",
        "label": "Disclosure Of Longterm Assets By Geographic Segment Table Text Block",
        "terseLabel": "Schedule of long-term assets by geographic segment"
       }
      }
     },
     "localname": "DisclosureOfLongtermAssetsByGeographicSegmentTableTextBlock",
     "nsuri": "http://encoreuranium.com/20221231",
     "presentation": [
      "http://encoreuranium.com/role/SegmentedinformationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cve_DisclosureOfMarketRiskTextBlockAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure Of Market Risk Text Block Abstract"
       }
      }
     },
     "localname": "DisclosureOfMarketRiskTextBlockAbstract",
     "nsuri": "http://encoreuranium.com/20221231",
     "xbrltype": "stringItemType"
    },
    "cve_DisclosureOfMineralProperties": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure Of Mineral Properties",
        "terseLabel": "Mineral properties"
       }
      }
     },
     "localname": "DisclosureOfMineralProperties",
     "nsuri": "http://encoreuranium.com/20221231",
     "presentation": [
      "http://encoreuranium.com/role/MineralProperties"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cve_DisclosureOfMineralPropertiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure Of Mineral Properties Abstract"
       }
      }
     },
     "localname": "DisclosureOfMineralPropertiesAbstract",
     "nsuri": "http://encoreuranium.com/20221231",
     "xbrltype": "stringItemType"
    },
    "cve_DisclosureOfPropertyPlantAndEquipmentTextBlockAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of property, plant, and equipment [Abstract]"
       }
      }
     },
     "localname": "DisclosureOfPropertyPlantAndEquipmentTextBlockAbstract",
     "nsuri": "http://encoreuranium.com/20221231",
     "xbrltype": "stringItemType"
    },
    "cve_DisclosureOfProportionalShareAssociatesExplanatory": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure Of Proportional Share Associates Explanatory.",
        "label": "Disclosure Of Proportional Share Associates Explanatory",
        "terseLabel": "Schedule of proportional share in the associate"
       }
      }
     },
     "localname": "DisclosureOfProportionalShareAssociatesExplanatory",
     "nsuri": "http://encoreuranium.com/20221231",
     "presentation": [
      "http://encoreuranium.com/role/InvestmentInAssociateTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cve_DisclosureOfReclassificationsOrChangesInPresentationTextBlockAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure Of Reclassifications Or Changes In Presentation Text Block Abstract"
       }
      }
     },
     "localname": "DisclosureOfReclassificationsOrChangesInPresentationTextBlockAbstract",
     "nsuri": "http://encoreuranium.com/20221231",
     "xbrltype": "stringItemType"
    },
    "cve_DisclosureOfRelatedPartyTextBlockAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Related party transactions and balances [Abstract]"
       }
      }
     },
     "localname": "DisclosureOfRelatedPartyTextBlockAbstract",
     "nsuri": "http://encoreuranium.com/20221231",
     "xbrltype": "stringItemType"
    },
    "cve_DisclosureOfSignificantAccountingPoliciesTextBlockAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Significant accounting policies [Abstract]"
       }
      }
     },
     "localname": "DisclosureOfSignificantAccountingPoliciesTextBlockAbstract",
     "nsuri": "http://encoreuranium.com/20221231",
     "xbrltype": "stringItemType"
    },
    "cve_DisclosureOfTransactionsRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombinationTextBlockAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure Of Transactions Recognised Separately From Acquisition Of Assets And Assumption Of Liabilities In Business Combination Text Block Abstract"
       }
      }
     },
     "localname": "DisclosureOfTransactionsRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombinationTextBlockAbstract",
     "nsuri": "http://encoreuranium.com/20221231",
     "xbrltype": "stringItemType"
    },
    "cve_DisclosureOfUsefulLivesOfIntangibleAssetsTextBllock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of useful lives of intangible assets.",
        "label": "Disclosure Of Useful Lives Of Intangible Assets Text Bllock",
        "terseLabel": "Schedule of useful lives of intangible assets"
       }
      }
     },
     "localname": "DisclosureOfUsefulLivesOfIntangibleAssetsTextBllock",
     "nsuri": "http://encoreuranium.com/20221231",
     "presentation": [
      "http://encoreuranium.com/role/SignificantaccountingpoliciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cve_DisclosureOfUsefulLivesOfPropertyPlantAndEquipementTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of useful lives of property, plant and equipement.",
        "label": "Disclosure Of Useful Lives Of Property Plant And Equipement Text Block",
        "terseLabel": "Schedule of useful lives of property, plant and equipement"
       }
      }
     },
     "localname": "DisclosureOfUsefulLivesOfPropertyPlantAndEquipementTextBlock",
     "nsuri": "http://encoreuranium.com/20221231",
     "presentation": [
      "http://encoreuranium.com/role/SignificantaccountingpoliciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cve_DivestMineralInterest": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Divest Mineral Interest",
        "negatedLabel": "Divest - Mineral interest"
       }
      }
     },
     "localname": "DivestMineralInterest",
     "nsuri": "http://encoreuranium.com/20221231",
     "presentation": [
      "http://encoreuranium.com/role/ScheduleofmineralpropertiesTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cve_DivestmentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Divestment Abstract",
        "terseLabel": "Divestment:"
       }
      }
     },
     "localname": "DivestmentAbstract",
     "nsuri": "http://encoreuranium.com/20221231",
     "presentation": [
      "http://encoreuranium.com/role/ScheduleofmineralpropertiesTable"
     ],
     "xbrltype": "stringItemType"
    },
    "cve_DocumentAndEntityInformationAbstract": {
     "auth_ref": [],
     "localname": "DocumentAndEntityInformationAbstract",
     "nsuri": "http://encoreuranium.com/20221231",
     "xbrltype": "stringItemType"
    },
    "cve_Drilling": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Drilling",
        "terseLabel": "Drilling"
       }
      }
     },
     "localname": "Drilling",
     "nsuri": "http://encoreuranium.com/20221231",
     "presentation": [
      "http://encoreuranium.com/role/ScheduleofmineralpropertiesTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cve_EnergyFuelsIncMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Energy Fuels Inc Member",
        "terseLabel": "Energy Fuels, Inc [Member]"
       }
      }
     },
     "localname": "EnergyFuelsIncMember",
     "nsuri": "http://encoreuranium.com/20221231",
     "presentation": [
      "http://encoreuranium.com/role/EventsafterthereportingperiodDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cve_EventsafterthereportingperiodDetailsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Events after the reporting period (Details) [Line Items]"
       }
      }
     },
     "localname": "EventsafterthereportingperiodDetailsLineItems",
     "nsuri": "http://encoreuranium.com/20221231",
     "presentation": [
      "http://encoreuranium.com/role/EventsafterthereportingperiodDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "cve_EventsafterthereportingperiodDetailsTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Events after the reporting period (Details) [Table]"
       }
      }
     },
     "localname": "EventsafterthereportingperiodDetailsTable",
     "nsuri": "http://encoreuranium.com/20221231",
     "presentation": [
      "http://encoreuranium.com/role/EventsafterthereportingperiodDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "cve_ExchangeRatio": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of exchange ratio.",
        "label": "Exchange Ratio",
        "terseLabel": "Exchange Ratio (in Dollars per share)"
       }
      }
     },
     "localname": "ExchangeRatio",
     "nsuri": "http://encoreuranium.com/20221231",
     "presentation": [
      "http://encoreuranium.com/role/AssetacquisitionDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "cve_ExpectedIncomeTaxExpenserecovery": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "expected income tax expense (recovery).",
        "label": "Expected Income Tax Expenserecovery",
        "terseLabel": "Expected income tax expense (recovery)"
       }
      }
     },
     "localname": "ExpectedIncomeTaxExpenserecovery",
     "nsuri": "http://encoreuranium.com/20221231",
     "presentation": [
      "http://encoreuranium.com/role/ScheduleoffederalandprovincialcorporatetaxratestoincomebeforetaxTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cve_ExpensesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Expenses Abstract",
        "terseLabel": "Expenses"
       }
      }
     },
     "localname": "ExpensesAbstract",
     "nsuri": "http://encoreuranium.com/20221231",
     "presentation": [
      "http://encoreuranium.com/role/ConsolidatedComprehensiveIncome"
     ],
     "xbrltype": "stringItemType"
    },
    "cve_ExpensesAbstract0": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Expenses Abstract0",
        "terseLabel": "Expenses"
       }
      }
     },
     "localname": "ExpensesAbstract0",
     "nsuri": "http://encoreuranium.com/20221231",
     "presentation": [
      "http://encoreuranium.com/role/ScheduleofconsolidatedstatementsoflossandcomprehensivelossTable"
     ],
     "xbrltype": "stringItemType"
    },
    "cve_ExpensesCurrent": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Expenses Current",
        "terseLabel": "Expenses, Current"
       }
      }
     },
     "localname": "ExpensesCurrent",
     "nsuri": "http://encoreuranium.com/20221231",
     "presentation": [
      "http://encoreuranium.com/role/ScheduleofproportionalshareintheassociateTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cve_ExpensesLossFromOperatingExpenses": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Expenses Loss From Operating Expenses",
        "terseLabel": "Expenses, Loss from operating expenses"
       }
      }
     },
     "localname": "ExpensesLossFromOperatingExpenses",
     "nsuri": "http://encoreuranium.com/20221231",
     "presentation": [
      "http://encoreuranium.com/role/ScheduleofproportionalshareintheassociateTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cve_ExpensesNoncurrent": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Expenses Noncurrent",
        "terseLabel": "Expenses, Non-current"
       }
      }
     },
     "localname": "ExpensesNoncurrent",
     "nsuri": "http://encoreuranium.com/20221231",
     "presentation": [
      "http://encoreuranium.com/role/ScheduleofproportionalshareintheassociateTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cve_ExpiringAmount": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Expiring amount.",
        "label": "Expiring Amount",
        "terseLabel": "Expiring amount"
       }
      }
     },
     "localname": "ExpiringAmount",
     "nsuri": "http://encoreuranium.com/20221231",
     "presentation": [
      "http://encoreuranium.com/role/IncometaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cve_ExplorationCostMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Exploration Cost Member",
        "terseLabel": "Exploration Cost [Member]"
       }
      }
     },
     "localname": "ExplorationCostMember",
     "nsuri": "http://encoreuranium.com/20221231",
     "presentation": [
      "http://encoreuranium.com/role/ScheduleofmineralpropertiesTable"
     ],
     "xbrltype": "domainItemType"
    },
    "cve_ExplorationCostsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Exploration Costs Abstract",
        "terseLabel": "Exploration costs:"
       }
      }
     },
     "localname": "ExplorationCostsAbstract",
     "nsuri": "http://encoreuranium.com/20221231",
     "presentation": [
      "http://encoreuranium.com/role/ScheduleofmineralpropertiesTable"
     ],
     "xbrltype": "stringItemType"
    },
    "cve_FairValueAmount": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair Value Amount.",
        "label": "Fair Value Amount",
        "terseLabel": "Fair value amount"
       }
      }
     },
     "localname": "FairValueAmount",
     "nsuri": "http://encoreuranium.com/20221231",
     "presentation": [
      "http://encoreuranium.com/role/RelatedpartytransactionsandbalancesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cve_FairValueOfCommonSharesIssuedForAzargaAssetAcquisition": {
     "auth_ref": [],
     "calculation": {
      "http://encoreuranium.com/role/ScheduleofincurrednoncashfinancingandinvestingactivitiesTable": {
       "order": 4.0,
       "parentTag": "cve_TotalNoncashInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of fair value of common shares issued for Azarga asset acquisition.",
        "label": "Fair Value Of Common Shares Issued For Azarga Asset Acquisition",
        "terseLabel": "Fair value of common shares issued for Azarga asset acquisition"
       }
      }
     },
     "localname": "FairValueOfCommonSharesIssuedForAzargaAssetAcquisition",
     "nsuri": "http://encoreuranium.com/20221231",
     "presentation": [
      "http://encoreuranium.com/role/ScheduleofincurrednoncashfinancingandinvestingactivitiesTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cve_FairValueOfGrantedOption": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of granted option.",
        "label": "Fair Value Of Granted Option",
        "terseLabel": "Fair value of granted option (in Dollars)"
       }
      }
     },
     "localname": "FairValueOfGrantedOption",
     "nsuri": "http://encoreuranium.com/20221231",
     "presentation": [
      "http://encoreuranium.com/role/ShareCapitalDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cve_FairValueOfReplacement": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of replacement.",
        "label": "Fair Value Of Replacement",
        "terseLabel": "Fair value of replacement"
       }
      }
     },
     "localname": "FairValueOfReplacement",
     "nsuri": "http://encoreuranium.com/20221231",
     "presentation": [
      "http://encoreuranium.com/role/ScheduleofweightedaverageassumptionsusedintheblackscholesoptionTable"
     ],
     "xbrltype": "perShareItemType"
    },
    "cve_FairValueOfReplacementOptions": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of replacement options.",
        "label": "Fair Value Of Replacement Options",
        "terseLabel": "Fair value of replacement options"
       }
      }
     },
     "localname": "FairValueOfReplacementOptions",
     "nsuri": "http://encoreuranium.com/20221231",
     "presentation": [
      "http://encoreuranium.com/role/ScheduleofestimatedfairvalueofassetsandliabilitiesTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cve_FairValueOfReplacementOptionsIssuedForAzargaAssetsAcquisition": {
     "auth_ref": [],
     "calculation": {
      "http://encoreuranium.com/role/ScheduleofincurrednoncashfinancingandinvestingactivitiesTable": {
       "order": 5.0,
       "parentTag": "cve_TotalNoncashInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of replacement options issued for Azarga asset acquisition.",
        "label": "Fair Value Of Replacement Options Issued For Azarga Assets Acquisition",
        "terseLabel": "Fair value of replacement options issued for Azarga asset acquisition"
       }
      }
     },
     "localname": "FairValueOfReplacementOptionsIssuedForAzargaAssetsAcquisition",
     "nsuri": "http://encoreuranium.com/20221231",
     "presentation": [
      "http://encoreuranium.com/role/ScheduleofincurrednoncashfinancingandinvestingactivitiesTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cve_FairValueOfReplacementWarrants": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of replacement warrants.",
        "label": "Fair Value Of Replacement Warrants",
        "terseLabel": "Fair value of replacement warrants"
       }
      }
     },
     "localname": "FairValueOfReplacementWarrants",
     "nsuri": "http://encoreuranium.com/20221231",
     "presentation": [
      "http://encoreuranium.com/role/ScheduleofestimatedfairvalueofassetsandliabilitiesTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cve_FairValueOfReplacementWarrantsIssuedForAzargaAssetAcquisition": {
     "auth_ref": [],
     "calculation": {
      "http://encoreuranium.com/role/ScheduleofincurrednoncashfinancingandinvestingactivitiesTable": {
       "order": 6.0,
       "parentTag": "cve_TotalNoncashInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of fair value of replacement warrants issued for Azarga asset acquisition.",
        "label": "Fair Value Of Replacement Warrants Issued For Azarga Asset Acquisition",
        "terseLabel": "Fair value of replacement warrants issued for Azarga asset acquisition"
       }
      }
     },
     "localname": "FairValueOfReplacementWarrantsIssuedForAzargaAssetAcquisition",
     "nsuri": "http://encoreuranium.com/20221231",
     "presentation": [
      "http://encoreuranium.com/role/ScheduleofincurrednoncashfinancingandinvestingactivitiesTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cve_FederalNetOperatingLossCarryforwards": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Federal net operating loss carryforwards.",
        "label": "Federal Net Operating Loss Carryforwards",
        "terseLabel": "Federal net operating loss carryforwards"
       }
      }
     },
     "localname": "FederalNetOperatingLossCarryforwards",
     "nsuri": "http://encoreuranium.com/20221231",
     "presentation": [
      "http://encoreuranium.com/role/IncometaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cve_FinancingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Financing Activities Abstract",
        "terseLabel": "Financing activities"
       }
      }
     },
     "localname": "FinancingActivitiesAbstract",
     "nsuri": "http://encoreuranium.com/20221231",
     "presentation": [
      "http://encoreuranium.com/role/ConsolidatedCashFlow"
     ],
     "xbrltype": "stringItemType"
    },
    "cve_Fiscal2023Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fiscal2023 Member",
        "terseLabel": "Fiscal 2023 [Member]"
       }
      }
     },
     "localname": "Fiscal2023Member",
     "nsuri": "http://encoreuranium.com/20221231",
     "presentation": [
      "http://encoreuranium.com/role/ScheduleofuraniumconcentratespurchaseagreementTable"
     ],
     "xbrltype": "domainItemType"
    },
    "cve_Fiscal2024Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fiscal2024 Member",
        "terseLabel": "Fiscal 2024 [Member]"
       }
      }
     },
     "localname": "Fiscal2024Member",
     "nsuri": "http://encoreuranium.com/20221231",
     "presentation": [
      "http://encoreuranium.com/role/ScheduleofuraniumconcentratespurchaseagreementTable"
     ],
     "xbrltype": "domainItemType"
    },
    "cve_Fiscal2025Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fiscal2025 Member",
        "terseLabel": "Fiscal 2025 [Member]"
       }
      }
     },
     "localname": "Fiscal2025Member",
     "nsuri": "http://encoreuranium.com/20221231",
     "presentation": [
      "http://encoreuranium.com/role/ScheduleofuraniumconcentratespurchaseagreementTable"
     ],
     "xbrltype": "domainItemType"
    },
    "cve_Fiscal2026Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fiscal2026 Member",
        "terseLabel": "Fiscal 2026 [Member]"
       }
      }
     },
     "localname": "Fiscal2026Member",
     "nsuri": "http://encoreuranium.com/20221231",
     "presentation": [
      "http://encoreuranium.com/role/ScheduleofuraniumconcentratespurchaseagreementTable"
     ],
     "xbrltype": "domainItemType"
    },
    "cve_Fiscal2027Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fiscal2027 Member",
        "terseLabel": "Fiscal 2027 [Member]"
       }
      }
     },
     "localname": "Fiscal2027Member",
     "nsuri": "http://encoreuranium.com/20221231",
     "presentation": [
      "http://encoreuranium.com/role/ScheduleofuraniumconcentratespurchaseagreementTable"
     ],
     "xbrltype": "domainItemType"
    },
    "cve_FixedAssets": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fixed assets.",
        "label": "Fixed Assets",
        "terseLabel": "Fixed assets"
       }
      }
     },
     "localname": "FixedAssets",
     "nsuri": "http://encoreuranium.com/20221231",
     "presentation": [
      "http://encoreuranium.com/role/ScheduleofdeferredtaxliabilitiesTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cve_ForeignExchangeRate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Foreign Exchange Rate",
        "terseLabel": "Foreign exchange rate"
       }
      }
     },
     "localname": "ForeignExchangeRate",
     "nsuri": "http://encoreuranium.com/20221231",
     "presentation": [
      "http://encoreuranium.com/role/FinancialInstrumentsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "cve_FourFiveNineSixZeroZeroMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Four Five Nine Six Zero Zero Member",
        "terseLabel": "$4.59 - 6.00 [Member]"
       }
      }
     },
     "localname": "FourFiveNineSixZeroZeroMember",
     "nsuri": "http://encoreuranium.com/20221231",
     "presentation": [
      "http://encoreuranium.com/role/ScheduleofsharepurchasewarrantsoutstandingTable"
     ],
     "xbrltype": "domainItemType"
    },
    "cve_FourTwoZeroFiveSevenSixMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Four Two Zero Five Seven Six Member",
        "terseLabel": "4.20 - 5.76 [Member]"
       }
      }
     },
     "localname": "FourTwoZeroFiveSevenSixMember",
     "nsuri": "http://encoreuranium.com/20221231",
     "presentation": [
      "http://encoreuranium.com/role/ScheduleofstockoptionsoutstandingTable"
     ],
     "xbrltype": "domainItemType"
    },
    "cve_FurnitureMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Furniture Member",
        "terseLabel": "Furniture [Member]"
       }
      }
     },
     "localname": "FurnitureMember",
     "nsuri": "http://encoreuranium.com/20221231",
     "presentation": [
      "http://encoreuranium.com/role/ScheduleofpropertyplantandequipmentTable",
      "http://encoreuranium.com/role/ScheduleofusefullivesofpropertyplantandequipementTable"
     ],
     "xbrltype": "domainItemType"
    },
    "cve_GainOnChangeInAssetRetirementObligationEstimate": {
     "auth_ref": [],
     "calculation": {
      "http://encoreuranium.com/role/ScheduleofconsolidatedstatementsoflossandcomprehensivelossTable": {
       "order": 7.0,
       "parentTag": "ifrs-full_NetForeignExchangeLoss",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Gain On Change In Asset Retirement Obligation Estimate",
        "terseLabel": "Gain on change in asset retirement obligation estimate"
       }
      }
     },
     "localname": "GainOnChangeInAssetRetirementObligationEstimate",
     "nsuri": "http://encoreuranium.com/20221231",
     "presentation": [
      "http://encoreuranium.com/role/ScheduleofconsolidatedstatementsoflossandcomprehensivelossTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cve_GainOnDisposalOfSubsidiary": {
     "auth_ref": [],
     "calculation": {
      "http://encoreuranium.com/role/ConsolidatedCashFlow": {
       "order": 17.0,
       "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities",
       "weight": -1.0
      },
      "http://encoreuranium.com/role/ConsolidatedComprehensiveIncome": {
       "order": 5.0,
       "parentTag": "ifrs-full_ProfitLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Gain on disposal of subsidiary",
        "label": "Gain On Disposal Of Subsidiary",
        "negatedLabel": "(Gain) loss on divestment of subsidiary",
        "terseLabel": "Gain on disposal of subsidiary",
        "verboseLabel": ""
       }
      }
     },
     "localname": "GainOnDisposalOfSubsidiary",
     "nsuri": "http://encoreuranium.com/20221231",
     "presentation": [
      "http://encoreuranium.com/role/ConsolidatedCashFlow",
      "http://encoreuranium.com/role/ConsolidatedComprehensiveIncome",
      "http://encoreuranium.com/role/MineralPropertiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cve_GainOnSaleOfUranium": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net realized gain (loss) on investments sold during the period, not including gains (losses) on securities separately or otherwise categorized as trading, available-for-sale, or held-to-maturity, which, for cash flow reporting, is a component of proceeds from investing activities.",
        "label": "Gain On Sale Of Uranium",
        "terseLabel": "Gain on sale of uranium"
       }
      }
     },
     "localname": "GainOnSaleOfUranium",
     "nsuri": "http://encoreuranium.com/20221231",
     "presentation": [
      "http://encoreuranium.com/role/ScheduleofthefairvalueofthephysicaluraniuminvestmentTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cve_GainOnSaleOfUraniumInvestment": {
     "auth_ref": [],
     "calculation": {
      "http://encoreuranium.com/role/ConsolidatedCashFlow": {
       "order": 19.0,
       "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities",
       "weight": -1.0
      },
      "http://encoreuranium.com/role/ConsolidatedComprehensiveIncome": {
       "order": 7.0,
       "parentTag": "ifrs-full_ProfitLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Gain On Sale Of Uranium Investment",
        "negatedLabel": "Gain on sale of uranium investment",
        "terseLabel": "Gain on sale of uranium investment"
       }
      }
     },
     "localname": "GainOnSaleOfUraniumInvestment",
     "nsuri": "http://encoreuranium.com/20221231",
     "presentation": [
      "http://encoreuranium.com/role/ConsolidatedCashFlow",
      "http://encoreuranium.com/role/ConsolidatedComprehensiveIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cve_GasHillsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Gas Hills Member",
        "terseLabel": "Gas Hills [Member]"
       }
      }
     },
     "localname": "GasHillsMember",
     "nsuri": "http://encoreuranium.com/20221231",
     "presentation": [
      "http://encoreuranium.com/role/ScheduleofassetretirementobligationsbalanceTable"
     ],
     "xbrltype": "domainItemType"
    },
    "cve_GettyDatabaseMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Getty Database Member",
        "terseLabel": "Getty Database [Member]"
       }
      }
     },
     "localname": "GettyDatabaseMember",
     "nsuri": "http://encoreuranium.com/20221231",
     "presentation": [
      "http://encoreuranium.com/role/ScheduleofintangibleassetwasdeterminedTable"
     ],
     "xbrltype": "domainItemType"
    },
    "cve_GrantedOptionsShares": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Granted options shares.",
        "label": "Granted Options Shares",
        "terseLabel": "Granted options shares (in Shares)"
       }
      }
     },
     "localname": "GrantedOptionsShares",
     "nsuri": "http://encoreuranium.com/20221231",
     "presentation": [
      "http://encoreuranium.com/role/RelatedpartytransactionsandbalancesDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "cve_GrantedPercentage": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Granted Percentage",
        "terseLabel": "Granted percentage"
       }
      }
     },
     "localname": "GrantedPercentage",
     "nsuri": "http://encoreuranium.com/20221231",
     "presentation": [
      "http://encoreuranium.com/role/MineralPropertiesDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "cve_GrantedStockOptions": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Granted  stock options.",
        "label": "Granted Stock Options",
        "terseLabel": "Granted stock options shares (in Shares)"
       }
      }
     },
     "localname": "GrantedStockOptions",
     "nsuri": "http://encoreuranium.com/20221231",
     "presentation": [
      "http://encoreuranium.com/role/EventsafterthereportingperiodDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "cve_GrantsMineralBeltDatabaseMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Grants Mineral Belt Database Member",
        "terseLabel": "Grants Mineral Belt Database [Member]"
       }
      }
     },
     "localname": "GrantsMineralBeltDatabaseMember",
     "nsuri": "http://encoreuranium.com/20221231",
     "presentation": [
      "http://encoreuranium.com/role/ScheduleofintangibleassetwasdeterminedTable"
     ],
     "xbrltype": "domainItemType"
    },
    "cve_GrossProceed": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Net proceeds are the amount the seller receives following the sale of an asset after all costs and expenses are deducted from the gross proceeds.",
        "label": "Gross Proceed",
        "terseLabel": "Gross proceeds"
       }
      }
     },
     "localname": "GrossProceed",
     "nsuri": "http://encoreuranium.com/20221231",
     "presentation": [
      "http://encoreuranium.com/role/EventsafterthereportingperiodDetails",
      "http://encoreuranium.com/role/ShareCapitalDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cve_GrossProceeds": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of gross proseeds.",
        "label": "Gross Proceeds",
        "terseLabel": "Gross proceeds"
       }
      }
     },
     "localname": "GrossProceeds",
     "nsuri": "http://encoreuranium.com/20221231",
     "presentation": [
      "http://encoreuranium.com/role/InvestmentinuraniumDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cve_HRIChurchrockIncMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "HRIChurchrock Inc Member",
        "terseLabel": "HRI-Churchrock, Inc. [Member]"
       }
      }
     },
     "localname": "HRIChurchrockIncMember",
     "nsuri": "http://encoreuranium.com/20221231",
     "presentation": [
      "http://encoreuranium.com/role/ScheduleofsignificantsubsidiariesTable"
     ],
     "xbrltype": "domainItemType"
    },
    "cve_HostaButteMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Hosta Butte Member",
        "terseLabel": "Hosta butte [Member]"
       }
      }
     },
     "localname": "HostaButteMember",
     "nsuri": "http://encoreuranium.com/20221231",
     "presentation": [
      "http://encoreuranium.com/role/MineralPropertiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cve_HydroRestorationCorpMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Hydro Restoration Corp Member",
        "terseLabel": "Hydro Restoration Corp.[Member]"
       }
      }
     },
     "localname": "HydroRestorationCorpMember",
     "nsuri": "http://encoreuranium.com/20221231",
     "presentation": [
      "http://encoreuranium.com/role/ScheduleofsignificantsubsidiariesTable"
     ],
     "xbrltype": "domainItemType"
    },
    "cve_ImpactedLoss": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Impacted loss.",
        "label": "Impacted Loss",
        "terseLabel": "Impacted loss"
       }
      }
     },
     "localname": "ImpactedLoss",
     "nsuri": "http://encoreuranium.com/20221231",
     "presentation": [
      "http://encoreuranium.com/role/FinancialInstrumentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cve_ImpairmentCharged": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Impairment Charged",
        "negatedLabel": "Impairment charged"
       }
      }
     },
     "localname": "ImpairmentCharged",
     "nsuri": "http://encoreuranium.com/20221231",
     "presentation": [
      "http://encoreuranium.com/role/ScheduleofmineralpropertiesTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cve_ImpairmentCharges": {
     "auth_ref": [],
     "calculation": {
      "http://encoreuranium.com/role/ScheduleofconsolidatedstatementsoflossandcomprehensivelossTable": {
       "order": 5.0,
       "parentTag": "ifrs-full_OtherOperatingIncomeExpense",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Impairment Charges",
        "terseLabel": "Impairment charges"
       }
      }
     },
     "localname": "ImpairmentCharges",
     "nsuri": "http://encoreuranium.com/20221231",
     "presentation": [
      "http://encoreuranium.com/role/ScheduleofconsolidatedstatementsoflossandcomprehensivelossTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cve_IncreaseDecreaseResultingFromAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Increase Decrease Resulting From Abstract",
        "terseLabel": "Increase (decrease) resulting from:"
       }
      }
     },
     "localname": "IncreaseDecreaseResultingFromAbstract",
     "nsuri": "http://encoreuranium.com/20221231",
     "presentation": [
      "http://encoreuranium.com/role/ScheduleoffederalandprovincialcorporatetaxratestoincomebeforetaxTable"
     ],
     "xbrltype": "stringItemType"
    },
    "cve_InflationFactorPercentage": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Inflation factor, percentage.",
        "label": "Inflation Factor Percentage",
        "terseLabel": "Inflation factor, percentage"
       }
      }
     },
     "localname": "InflationFactorPercentage",
     "nsuri": "http://encoreuranium.com/20221231",
     "presentation": [
      "http://encoreuranium.com/role/AssetretirementobligationsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "cve_InitialPayment": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "initial payment.",
        "label": "Initial Payment",
        "terseLabel": "Initial payment"
       }
      }
     },
     "localname": "InitialPayment",
     "nsuri": "http://encoreuranium.com/20221231",
     "presentation": [
      "http://encoreuranium.com/role/EventsafterthereportingperiodDetails",
      "http://encoreuranium.com/role/InvestmentinuraniumDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cve_IntangibleAssetDeterminedLife": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Intangible asset determined life.",
        "label": "Intangible Asset Determined Life",
        "terseLabel": "Intangible asset determined life"
       }
      }
     },
     "localname": "IntangibleAssetDeterminedLife",
     "nsuri": "http://encoreuranium.com/20221231",
     "presentation": [
      "http://encoreuranium.com/role/IntangibleassetsDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "cve_IntangibleAssets": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Intangible assets.",
        "label": "Intangible Assets",
        "terseLabel": "Intangible assets"
       }
      }
     },
     "localname": "IntangibleAssets",
     "nsuri": "http://encoreuranium.com/20221231",
     "presentation": [
      "http://encoreuranium.com/role/ScheduleoflongtermassetsbygeographicsegmentTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cve_IntangibleAssetsBalance": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Intangible Assets Balance.",
        "label": "Intangible Assets Balance",
        "periodEndLabel": "Balance ending",
        "periodStartLabel": "Balance beginning"
       }
      }
     },
     "localname": "IntangibleAssetsBalance",
     "nsuri": "http://encoreuranium.com/20221231",
     "presentation": [
      "http://encoreuranium.com/role/ScheduleofintangibleassetwasdeterminedTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cve_IntangibleassetsDetailsScheduleofintangibleassetwasdeterminedLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of intangible asset was determined [Abstract]"
       }
      }
     },
     "localname": "IntangibleassetsDetailsScheduleofintangibleassetwasdeterminedLineItems",
     "nsuri": "http://encoreuranium.com/20221231",
     "presentation": [
      "http://encoreuranium.com/role/ScheduleofintangibleassetwasdeterminedTable"
     ],
     "xbrltype": "stringItemType"
    },
    "cve_IntangibleassetsDetailsScheduleofintangibleassetwasdeterminedTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Intangible assets (Details) - Schedule of intangible asset was determined [Table]"
       }
      }
     },
     "localname": "IntangibleassetsDetailsScheduleofintangibleassetwasdeterminedTable",
     "nsuri": "http://encoreuranium.com/20221231",
     "presentation": [
      "http://encoreuranium.com/role/ScheduleofintangibleassetwasdeterminedTable"
     ],
     "xbrltype": "stringItemType"
    },
    "cve_IntangibleassetsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Intangible assets [Abstract]"
       }
      }
     },
     "localname": "IntangibleassetsLineItems",
     "nsuri": "http://encoreuranium.com/20221231",
     "presentation": [
      "http://encoreuranium.com/role/Intangibleassets"
     ],
     "xbrltype": "stringItemType"
    },
    "cve_IntangibleassetsTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Intangible assets [Table]"
       }
      }
     },
     "localname": "IntangibleassetsTable",
     "nsuri": "http://encoreuranium.com/20221231",
     "presentation": [
      "http://encoreuranium.com/role/Intangibleassets"
     ],
     "xbrltype": "stringItemType"
    },
    "cve_IntangibleassetsTablesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Intangibleassets Tables Line Items",
        "terseLabel": "Intangible assets [Abstract]"
       }
      }
     },
     "localname": "IntangibleassetsTablesLineItems",
     "nsuri": "http://encoreuranium.com/20221231",
     "presentation": [
      "http://encoreuranium.com/role/IntangibleassetsTables"
     ],
     "xbrltype": "stringItemType"
    },
    "cve_IntangibleassetsTablesTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Intangible assets (Tables) [Table]"
       }
      }
     },
     "localname": "IntangibleassetsTablesTable",
     "nsuri": "http://encoreuranium.com/20221231",
     "presentation": [
      "http://encoreuranium.com/role/IntangibleassetsTables"
     ],
     "xbrltype": "stringItemType"
    },
    "cve_InterestRateHold": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Interest Rate Hold",
        "terseLabel": "Company holds a interest"
       }
      }
     },
     "localname": "InterestRateHold",
     "nsuri": "http://encoreuranium.com/20221231",
     "presentation": [
      "http://encoreuranium.com/role/MineralPropertiesDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "cve_InvestingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investing Activities Abstract",
        "terseLabel": "Investing activities"
       }
      }
     },
     "localname": "InvestingActivitiesAbstract",
     "nsuri": "http://encoreuranium.com/20221231",
     "presentation": [
      "http://encoreuranium.com/role/ConsolidatedCashFlow"
     ],
     "xbrltype": "stringItemType"
    },
    "cve_InvestmentAmount": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Investment amount.",
        "label": "Investment Amount",
        "terseLabel": "Final payment of investment"
       }
      }
     },
     "localname": "InvestmentAmount",
     "nsuri": "http://encoreuranium.com/20221231",
     "presentation": [
      "http://encoreuranium.com/role/InvestmentinuraniumDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cve_InvestmentBalance1": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Investment Balance1",
        "periodEndLabel": "Balance",
        "periodStartLabel": "Balance"
       }
      }
     },
     "localname": "InvestmentBalance1",
     "nsuri": "http://encoreuranium.com/20221231",
     "presentation": [
      "http://encoreuranium.com/role/ScheduleofinvestmentinassociatecontinuityTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cve_InvestmentInAssociateDetailsScheduleofinvestmentinassociatecontinuityLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of investment in associate continuity [Abstract]"
       }
      }
     },
     "localname": "InvestmentInAssociateDetailsScheduleofinvestmentinassociatecontinuityLineItems",
     "nsuri": "http://encoreuranium.com/20221231",
     "presentation": [
      "http://encoreuranium.com/role/ScheduleofinvestmentinassociatecontinuityTable"
     ],
     "xbrltype": "stringItemType"
    },
    "cve_InvestmentInAssociateDetailsScheduleofinvestmentinassociatecontinuityTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investment In Associate (Details) - Schedule of investment in associate continuity [Table]"
       }
      }
     },
     "localname": "InvestmentInAssociateDetailsScheduleofinvestmentinassociatecontinuityTable",
     "nsuri": "http://encoreuranium.com/20221231",
     "presentation": [
      "http://encoreuranium.com/role/ScheduleofinvestmentinassociatecontinuityTable"
     ],
     "xbrltype": "stringItemType"
    },
    "cve_InvestmentInAssociateDetailsScheduleofproportionalshareintheassociateLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of proportional share in the associate [Abstract]"
       }
      }
     },
     "localname": "InvestmentInAssociateDetailsScheduleofproportionalshareintheassociateLineItems",
     "nsuri": "http://encoreuranium.com/20221231",
     "presentation": [
      "http://encoreuranium.com/role/ScheduleofproportionalshareintheassociateTable"
     ],
     "xbrltype": "stringItemType"
    },
    "cve_InvestmentInAssociateDetailsScheduleofproportionalshareintheassociateTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investment In Associate (Details) - Schedule of proportional share in the associate [Table]"
       }
      }
     },
     "localname": "InvestmentInAssociateDetailsScheduleofproportionalshareintheassociateTable",
     "nsuri": "http://encoreuranium.com/20221231",
     "presentation": [
      "http://encoreuranium.com/role/ScheduleofproportionalshareintheassociateTable"
     ],
     "xbrltype": "stringItemType"
    },
    "cve_InvestmentInAssociateLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investment In Associate [Abstract]"
       }
      }
     },
     "localname": "InvestmentInAssociateLineItems",
     "nsuri": "http://encoreuranium.com/20221231",
     "presentation": [
      "http://encoreuranium.com/role/InvestmentInAssociate"
     ],
     "xbrltype": "stringItemType"
    },
    "cve_InvestmentInAssociateTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investment In Associate [Table]"
       }
      }
     },
     "localname": "InvestmentInAssociateTable",
     "nsuri": "http://encoreuranium.com/20221231",
     "presentation": [
      "http://encoreuranium.com/role/InvestmentInAssociate"
     ],
     "xbrltype": "stringItemType"
    },
    "cve_InvestmentInAssociateTablesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investment In Associate Tables Line Items",
        "terseLabel": "Investment in Associate [Abstract]"
       }
      }
     },
     "localname": "InvestmentInAssociateTablesLineItems",
     "nsuri": "http://encoreuranium.com/20221231",
     "presentation": [
      "http://encoreuranium.com/role/InvestmentInAssociateTables"
     ],
     "xbrltype": "stringItemType"
    },
    "cve_InvestmentInAssociateTablesTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investment In Associate (Tables) [Table]"
       }
      }
     },
     "localname": "InvestmentInAssociateTablesTable",
     "nsuri": "http://encoreuranium.com/20221231",
     "presentation": [
      "http://encoreuranium.com/role/InvestmentInAssociateTables"
     ],
     "xbrltype": "stringItemType"
    },
    "cve_InvestmentInterestRates": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investment Interest Rates",
        "terseLabel": "Interest rate"
       }
      }
     },
     "localname": "InvestmentInterestRates",
     "nsuri": "http://encoreuranium.com/20221231",
     "presentation": [
      "http://encoreuranium.com/role/MineralPropertiesDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "cve_InvestmentinuraniumDetailsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investment in uranium (Details) [Line Items]"
       }
      }
     },
     "localname": "InvestmentinuraniumDetailsLineItems",
     "nsuri": "http://encoreuranium.com/20221231",
     "presentation": [
      "http://encoreuranium.com/role/InvestmentinuraniumDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "cve_InvestmentinuraniumDetailsScheduleofuraniumconcentratespurchaseagreementLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investment in uranium (Details) - Schedule of uranium concentrates purchase agreement [Line Items]"
       }
      }
     },
     "localname": "InvestmentinuraniumDetailsScheduleofuraniumconcentratespurchaseagreementLineItems",
     "nsuri": "http://encoreuranium.com/20221231",
     "presentation": [
      "http://encoreuranium.com/role/ScheduleofuraniumconcentratespurchaseagreementTable"
     ],
     "xbrltype": "stringItemType"
    },
    "cve_InvestmentinuraniumDetailsScheduleofuraniumconcentratespurchaseagreementTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investment in uranium (Details) - Schedule of uranium concentrates purchase agreement [Table]"
       }
      }
     },
     "localname": "InvestmentinuraniumDetailsScheduleofuraniumconcentratespurchaseagreementTable",
     "nsuri": "http://encoreuranium.com/20221231",
     "presentation": [
      "http://encoreuranium.com/role/ScheduleofuraniumconcentratespurchaseagreementTable"
     ],
     "xbrltype": "stringItemType"
    },
    "cve_InvestmentinuraniumDetailsTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investment in uranium (Details) [Table]"
       }
      }
     },
     "localname": "InvestmentinuraniumDetailsTable",
     "nsuri": "http://encoreuranium.com/20221231",
     "presentation": [
      "http://encoreuranium.com/role/InvestmentinuraniumDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "cve_IssuedAndOutstandingSharesPercentage": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "percentage of issued and outstanding shares.",
        "label": "Issued And Outstanding Shares Percentage",
        "terseLabel": "Issued and outstanding shares percentage"
       }
      }
     },
     "localname": "IssuedAndOutstandingSharesPercentage",
     "nsuri": "http://encoreuranium.com/20221231",
     "presentation": [
      "http://encoreuranium.com/role/InvestmentInAssociateDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "cve_ItemsNotAffectingCashAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Items Not Affecting Cash Abstract",
        "terseLabel": "Items not affecting cash:"
       }
      }
     },
     "localname": "ItemsNotAffectingCashAbstract",
     "nsuri": "http://encoreuranium.com/20221231",
     "presentation": [
      "http://encoreuranium.com/role/ConsolidatedCashFlow"
     ],
     "xbrltype": "stringItemType"
    },
    "cve_KingsvilleMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Kingsville Member",
        "terseLabel": "Kingsville [Member]"
       }
      }
     },
     "localname": "KingsvilleMember",
     "nsuri": "http://encoreuranium.com/20221231",
     "presentation": [
      "http://encoreuranium.com/role/ScheduleofassetretirementobligationsbalanceTable"
     ],
     "xbrltype": "domainItemType"
    },
    "cve_LeasedCopierMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Leased Copier Member",
        "terseLabel": "Leased copier [Member]"
       }
      }
     },
     "localname": "LeasedCopierMember",
     "nsuri": "http://encoreuranium.com/20221231",
     "presentation": [
      "http://encoreuranium.com/role/ScheduleofchangeintheROUassetsTable",
      "http://encoreuranium.com/role/ScheduleofchangeinthelongTermleaseliabilityTable"
     ],
     "xbrltype": "domainItemType"
    },
    "cve_LeasedOfficesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Leased Offices Member",
        "terseLabel": "Leased offices [Member]"
       }
      }
     },
     "localname": "LeasedOfficesMember",
     "nsuri": "http://encoreuranium.com/20221231",
     "presentation": [
      "http://encoreuranium.com/role/ScheduleofchangeintheROUassetsTable",
      "http://encoreuranium.com/role/ScheduleofchangeinthelongTermleaseliabilityTable"
     ],
     "xbrltype": "domainItemType"
    },
    "cve_LiabilitiesLossFromOperatingExpenses": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities Loss From Operating Expenses",
        "terseLabel": "Liabilities Loss from operating expenses"
       }
      }
     },
     "localname": "LiabilitiesLossFromOperatingExpenses",
     "nsuri": "http://encoreuranium.com/20221231",
     "presentation": [
      "http://encoreuranium.com/role/ScheduleofproportionalshareintheassociateTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cve_Long-TermLeaseLiabilityAccretion": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Long-Term Lease Liability Accretion.",
        "label": "Long- Term Lease Liability Accretion",
        "terseLabel": "Accretion"
       }
      }
     },
     "localname": "Long-TermLeaseLiabilityAccretion",
     "nsuri": "http://encoreuranium.com/20221231",
     "presentation": [
      "http://encoreuranium.com/role/ScheduleofchangeinthelongTermleaseliabilityTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cve_Long-TermLeaseLiabilityAdditions": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Additions.",
        "label": "Long- Term Lease Liability Additions",
        "terseLabel": "Additions"
       }
      }
     },
     "localname": "Long-TermLeaseLiabilityAdditions",
     "nsuri": "http://encoreuranium.com/20221231",
     "presentation": [
      "http://encoreuranium.com/role/ScheduleofchangeinthelongTermleaseliabilityTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cve_Long-TermLeaseLiabilityBalance": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Long-Term Lease Liability Balance.",
        "label": "Long- Term Lease Liability Balance",
        "periodEndLabel": "Balance, ending",
        "periodStartLabel": "Balance, beginning"
       }
      }
     },
     "localname": "Long-TermLeaseLiabilityBalance",
     "nsuri": "http://encoreuranium.com/20221231",
     "presentation": [
      "http://encoreuranium.com/role/ScheduleofchangeinthelongTermleaseliabilityTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cve_Long-TermLeaseLiabilityCurrencyTranslationAdjustment": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Long-Term Lease Liability Currency Translation Adjustment.",
        "label": "Long- Term Lease Liability Currency Translation Adjustment",
        "terseLabel": "Currency translation adjustment"
       }
      }
     },
     "localname": "Long-TermLeaseLiabilityCurrencyTranslationAdjustment",
     "nsuri": "http://encoreuranium.com/20221231",
     "presentation": [
      "http://encoreuranium.com/role/ScheduleofchangeinthelongTermleaseliabilityTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cve_Long-TermLeaseLiabilityLeasePaymentsMade": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Long-Term Lease Liability Lease Payments Made.",
        "label": "Long- Term Lease Liability Lease Payments Made",
        "terseLabel": "Lease payments made"
       }
      }
     },
     "localname": "Long-TermLeaseLiabilityLeasePaymentsMade",
     "nsuri": "http://encoreuranium.com/20221231",
     "presentation": [
      "http://encoreuranium.com/role/ScheduleofchangeinthelongTermleaseliabilityTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cve_Long-TermLeaseLiabilityLessCurrentLeaseLiability": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Long-Term Lease Liability Less Current Lease Liability.",
        "label": "Long- Term Lease Liability Less Current Lease Liability",
        "terseLabel": "Less: current lease liability"
       }
      }
     },
     "localname": "Long-TermLeaseLiabilityLessCurrentLeaseLiability",
     "nsuri": "http://encoreuranium.com/20221231",
     "presentation": [
      "http://encoreuranium.com/role/ScheduleofchangeinthelongTermleaseliabilityTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cve_LossOnContractTerminations": {
     "auth_ref": [],
     "calculation": {
      "http://encoreuranium.com/role/ConsolidatedComprehensiveIncome": {
       "order": 12.0,
       "parentTag": "ifrs-full_ProfitLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The loss recognized on termination of a contract.",
        "label": "Loss On Contract Terminations",
        "negatedLabel": "Loss on contract termination"
       }
      }
     },
     "localname": "LossOnContractTerminations",
     "nsuri": "http://encoreuranium.com/20221231",
     "presentation": [
      "http://encoreuranium.com/role/ConsolidatedComprehensiveIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cve_LossOnInvestmentInAssociate": {
     "auth_ref": [],
     "calculation": {
      "http://encoreuranium.com/role/ScheduleofconsolidatedstatementsoflossandcomprehensivelossTable": {
       "order": 3.0,
       "parentTag": "ifrs-full_NetForeignExchangeLoss",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Loss On Investment In Associate",
        "negatedLabel": "Loss on investment in associate"
       }
      }
     },
     "localname": "LossOnInvestmentInAssociate",
     "nsuri": "http://encoreuranium.com/20221231",
     "presentation": [
      "http://encoreuranium.com/role/ScheduleofconsolidatedstatementsoflossandcomprehensivelossTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cve_LossOnWriteoffOfSalesTaxRecoverable": {
     "auth_ref": [],
     "calculation": {
      "http://encoreuranium.com/role/ConsolidatedComprehensiveIncome": {
       "order": 10.0,
       "parentTag": "ifrs-full_ProfitLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Loss On Writeoff Of Sales Tax Recoverable",
        "negatedLabel": "Loss on write-off of sales tax recoverable"
       }
      }
     },
     "localname": "LossOnWriteoffOfSalesTaxRecoverable",
     "nsuri": "http://encoreuranium.com/20221231",
     "presentation": [
      "http://encoreuranium.com/role/ConsolidatedComprehensiveIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cve_LossesOnDivestmentOfMineralProperties": {
     "auth_ref": [],
     "calculation": {
      "http://encoreuranium.com/role/ScheduleofconsolidatedstatementsoflossandcomprehensivelossTable": {
       "order": 1.0,
       "parentTag": "ifrs-full_NetForeignExchangeLoss",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Losses On Divestment Of Mineral Properties",
        "negatedLabel": "Loss on divestment of mineral properties"
       }
      }
     },
     "localname": "LossesOnDivestmentOfMineralProperties",
     "nsuri": "http://encoreuranium.com/20221231",
     "presentation": [
      "http://encoreuranium.com/role/ScheduleofconsolidatedstatementsoflossandcomprehensivelossTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cve_MaintenancesAndLeaseFees": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Maintenance and lease fees.",
        "label": "Maintenances And Lease Fees",
        "terseLabel": "Maintenance and lease fees"
       }
      }
     },
     "localname": "MaintenancesAndLeaseFees",
     "nsuri": "http://encoreuranium.com/20221231",
     "presentation": [
      "http://encoreuranium.com/role/ScheduleofmineralpropertiesTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cve_MarketValuePerShare": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Market value per share.",
        "label": "Market Value Per Share",
        "terseLabel": "Market value per share (in Dollars per share)",
        "verboseLabel": "Common Shares (in Dollars per share)"
       }
      }
     },
     "localname": "MarketValuePerShare",
     "nsuri": "http://encoreuranium.com/20221231",
     "presentation": [
      "http://encoreuranium.com/role/AssetacquisitionDetails",
      "http://encoreuranium.com/role/MarketableSecuritiesDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "cve_MarketableSecuritieReceivedOnDispositionOfMineralProperties": {
     "auth_ref": [],
     "calculation": {
      "http://encoreuranium.com/role/ScheduleofincurrednoncashfinancingandinvestingactivitiesTable": {
       "order": 1.0,
       "parentTag": "cve_TotalNoncashInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Marketable securities received on disposition of mineral properties.",
        "label": "Marketable Securitie Received On Disposition Of Mineral Properties",
        "terseLabel": "Marketable securities received on disposition of mineral properties"
       }
      }
     },
     "localname": "MarketableSecuritieReceivedOnDispositionOfMineralProperties",
     "nsuri": "http://encoreuranium.com/20221231",
     "presentation": [
      "http://encoreuranium.com/role/ScheduleofincurrednoncashfinancingandinvestingactivitiesTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cve_MarketableSecuritiecurrent": {
     "auth_ref": [],
     "calculation": {
      "http://encoreuranium.com/role/ConsolidatedBalanceSheet": {
       "order": 3.0,
       "parentTag": "ifrs-full_CurrentAssets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of marketable securities as current.",
        "label": "Marketable Securitiecurrent",
        "terseLabel": "Marketable securities - current"
       }
      }
     },
     "localname": "MarketableSecuritiecurrent",
     "nsuri": "http://encoreuranium.com/20221231",
     "presentation": [
      "http://encoreuranium.com/role/ConsolidatedBalanceSheet"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cve_MarketableSecuritiesDetailsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Marketable Securities Details Line Items",
        "terseLabel": "Marketable Securities [Abstract]"
       }
      }
     },
     "localname": "MarketableSecuritiesDetailsLineItems",
     "nsuri": "http://encoreuranium.com/20221231",
     "presentation": [
      "http://encoreuranium.com/role/MarketableSecuritiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "cve_MarketableSecuritiesDetailsScheduleofmarketablesecuritiesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Marketable Securities [Abstract]"
       }
      }
     },
     "localname": "MarketableSecuritiesDetailsScheduleofmarketablesecuritiesLineItems",
     "nsuri": "http://encoreuranium.com/20221231",
     "presentation": [
      "http://encoreuranium.com/role/ScheduleofmarketablesecuritiesTable"
     ],
     "xbrltype": "stringItemType"
    },
    "cve_MarketableSecuritiesDetailsScheduleofmarketablesecuritiesTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Marketable Securities (Details) - Schedule of marketable securities [Table]"
       }
      }
     },
     "localname": "MarketableSecuritiesDetailsScheduleofmarketablesecuritiesTable",
     "nsuri": "http://encoreuranium.com/20221231",
     "presentation": [
      "http://encoreuranium.com/role/ScheduleofmarketablesecuritiesTable"
     ],
     "xbrltype": "stringItemType"
    },
    "cve_MarketableSecuritiesDetailsTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Marketable Securities (Details) [Table]"
       }
      }
     },
     "localname": "MarketableSecuritiesDetailsTable",
     "nsuri": "http://encoreuranium.com/20221231",
     "presentation": [
      "http://encoreuranium.com/role/MarketableSecuritiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "cve_MarketableSecuritiesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Marketable Securities Member",
        "terseLabel": "Marketable securities [Member]"
       }
      }
     },
     "localname": "MarketableSecuritiesMember",
     "nsuri": "http://encoreuranium.com/20221231",
     "presentation": [
      "http://encoreuranium.com/role/MarketableSecuritiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cve_MarketableSecuritiesTablesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Marketable Securities Tables Line Items",
        "terseLabel": "Marketable Securities [Abstract]"
       }
      }
     },
     "localname": "MarketableSecuritiesTablesLineItems",
     "nsuri": "http://encoreuranium.com/20221231",
     "presentation": [
      "http://encoreuranium.com/role/MarketableSecuritiesTables"
     ],
     "xbrltype": "stringItemType"
    },
    "cve_MarketableSecuritiesTablesTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Marketable Securities (Tables) [Table]"
       }
      }
     },
     "localname": "MarketableSecuritiesTablesTable",
     "nsuri": "http://encoreuranium.com/20221231",
     "presentation": [
      "http://encoreuranium.com/role/MarketableSecuritiesTables"
     ],
     "xbrltype": "stringItemType"
    },
    "cve_MarketableSecuritiescurrentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Marketable Securitiescurrent Member",
        "terseLabel": "Marketable securities (current) [Member]"
       }
      }
     },
     "localname": "MarketableSecuritiescurrentMember",
     "nsuri": "http://encoreuranium.com/20221231",
     "presentation": [
      "http://encoreuranium.com/role/ScheduleofmarketablesecuritiesTable"
     ],
     "xbrltype": "domainItemType"
    },
    "cve_MarketableSecuritiesnoncurrentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Marketable Securitiesnoncurrent Member",
        "terseLabel": "Marketable securities (non-current) [Member]"
       }
      }
     },
     "localname": "MarketableSecuritiesnoncurrentMember",
     "nsuri": "http://encoreuranium.com/20221231",
     "presentation": [
      "http://encoreuranium.com/role/ScheduleofmarketablesecuritiesTable"
     ],
     "xbrltype": "domainItemType"
    },
    "cve_MarketablesSecurities": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of marketable securities.",
        "label": "Marketables Securities",
        "periodEndLabel": "Balance ending",
        "periodStartLabel": "Balance beginning"
       }
      }
     },
     "localname": "MarketablesSecurities",
     "nsuri": "http://encoreuranium.com/20221231",
     "presentation": [
      "http://encoreuranium.com/role/ScheduleofmarketablesecuritiesTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cve_MarketablesSecuritiesNoncurrent": {
     "auth_ref": [],
     "calculation": {
      "http://encoreuranium.com/role/ConsolidatedBalanceSheet": {
       "order": 6.0,
       "parentTag": "ifrs-full_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of marketable securities non current.",
        "label": "Marketables Securities Noncurrent",
        "terseLabel": "Marketable securities - non-current"
       }
      }
     },
     "localname": "MarketablesSecuritiesNoncurrent",
     "nsuri": "http://encoreuranium.com/20221231",
     "presentation": [
      "http://encoreuranium.com/role/ConsolidatedBalanceSheet"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cve_McKinleyMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Mc Kinley Member",
        "terseLabel": "McKinley [Member]"
       }
      }
     },
     "localname": "McKinleyMember",
     "nsuri": "http://encoreuranium.com/20221231",
     "presentation": [
      "http://encoreuranium.com/role/MineralPropertiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cve_MetaminEnterprisesUSIncMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Metamin Enterprises USInc Member",
        "terseLabel": "Metamin Enterprises US Inc. [Member]"
       }
      }
     },
     "localname": "MetaminEnterprisesUSIncMember",
     "nsuri": "http://encoreuranium.com/20221231",
     "presentation": [
      "http://encoreuranium.com/role/ScheduleofsignificantsubsidiariesTable"
     ],
     "xbrltype": "domainItemType"
    },
    "cve_MineralProperties": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Mineral properties.",
        "label": "Mineral Properties",
        "terseLabel": "Mineral properties"
       }
      }
     },
     "localname": "MineralProperties",
     "nsuri": "http://encoreuranium.com/20221231",
     "presentation": [
      "http://encoreuranium.com/role/ScheduleoflongtermassetsbygeographicsegmentTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cve_MineralPropertiesDetailsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Mineral Properties (Details) [Line Items]"
       }
      }
     },
     "localname": "MineralPropertiesDetailsLineItems",
     "nsuri": "http://encoreuranium.com/20221231",
     "presentation": [
      "http://encoreuranium.com/role/MineralPropertiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "cve_MineralPropertiesDetailsScheduleofmineralpropertiesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Mineral Properties (Details) - Schedule of mineral properties [Line Items]"
       }
      }
     },
     "localname": "MineralPropertiesDetailsScheduleofmineralpropertiesLineItems",
     "nsuri": "http://encoreuranium.com/20221231",
     "presentation": [
      "http://encoreuranium.com/role/ScheduleofmineralpropertiesTable"
     ],
     "xbrltype": "stringItemType"
    },
    "cve_MineralPropertiesDetailsScheduleofmineralpropertiesTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Mineral Properties (Details) - Schedule of mineral properties [Table]"
       }
      }
     },
     "localname": "MineralPropertiesDetailsScheduleofmineralpropertiesTable",
     "nsuri": "http://encoreuranium.com/20221231",
     "presentation": [
      "http://encoreuranium.com/role/ScheduleofmineralpropertiesTable"
     ],
     "xbrltype": "stringItemType"
    },
    "cve_MineralPropertiesDetailsTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Mineral Properties (Details) [Table]"
       }
      }
     },
     "localname": "MineralPropertiesDetailsTable",
     "nsuri": "http://encoreuranium.com/20221231",
     "presentation": [
      "http://encoreuranium.com/role/MineralPropertiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "cve_NameofSubsidaryFunctionalCurrency": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Functional Currency.",
        "label": "Nameof Subsidary Functional Currency",
        "terseLabel": "Functional Currency"
       }
      }
     },
     "localname": "NameofSubsidaryFunctionalCurrency",
     "nsuri": "http://encoreuranium.com/20221231",
     "presentation": [
      "http://encoreuranium.com/role/ScheduleofsignificantsubsidiariesTable"
     ],
     "xbrltype": "stringItemType"
    },
    "cve_NameofSubsidaryPlaceOfIncorporation": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Place of Incorporation.",
        "label": "Nameof Subsidary Place Of Incorporation",
        "terseLabel": "Place of Incorporation"
       }
      }
     },
     "localname": "NameofSubsidaryPlaceOfIncorporation",
     "nsuri": "http://encoreuranium.com/20221231",
     "presentation": [
      "http://encoreuranium.com/role/ScheduleofsignificantsubsidiariesTable"
     ],
     "xbrltype": "stringItemType"
    },
    "cve_NameofSubsidaryPrincipalActivity": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Principal Activity.",
        "label": "Nameof Subsidary Principal Activity",
        "terseLabel": "Principal Activity"
       }
      }
     },
     "localname": "NameofSubsidaryPrincipalActivity",
     "nsuri": "http://encoreuranium.com/20221231",
     "presentation": [
      "http://encoreuranium.com/role/ScheduleofsignificantsubsidiariesTable"
     ],
     "xbrltype": "stringItemType"
    },
    "cve_NatureOfOperationAndGoingConcern": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Nature of operations and going concern.",
        "label": "Nature Of Operation And Going Concern",
        "terseLabel": "Nature of operations and going concern"
       }
      }
     },
     "localname": "NatureOfOperationAndGoingConcern",
     "nsuri": "http://encoreuranium.com/20221231",
     "presentation": [
      "http://encoreuranium.com/role/NatureofOperationsandGoingConcern"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cve_NatureOfOperationAndGoingConcernAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Nature of Operation and Going Concern [Abstract]"
       }
      }
     },
     "localname": "NatureOfOperationAndGoingConcernAbstract",
     "nsuri": "http://encoreuranium.com/20221231",
     "xbrltype": "stringItemType"
    },
    "cve_NatureofOperationsandGoingConcernLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Natureof Operationsand Going Concern Line Items",
        "terseLabel": "Nature of Operation and Going Concern [Abstract]"
       }
      }
     },
     "localname": "NatureofOperationsandGoingConcernLineItems",
     "nsuri": "http://encoreuranium.com/20221231",
     "presentation": [
      "http://encoreuranium.com/role/NatureofOperationsandGoingConcern"
     ],
     "xbrltype": "stringItemType"
    },
    "cve_NatureofOperationsandGoingConcernTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Nature of Operations and Going Concern [Table]"
       }
      }
     },
     "localname": "NatureofOperationsandGoingConcernTable",
     "nsuri": "http://encoreuranium.com/20221231",
     "presentation": [
      "http://encoreuranium.com/role/NatureofOperationsandGoingConcern"
     ],
     "xbrltype": "stringItemType"
    },
    "cve_NeutronEnergyIncMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Neutron Energy Inc Member",
        "terseLabel": "Neutron Energy, Inc. [Member]"
       }
      }
     },
     "localname": "NeutronEnergyIncMember",
     "nsuri": "http://encoreuranium.com/20221231",
     "presentation": [
      "http://encoreuranium.com/role/ScheduleofsignificantsubsidiariesTable"
     ],
     "xbrltype": "domainItemType"
    },
    "cve_NonCashFinancingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non Cash Financing Activities Abstract",
        "terseLabel": "Non-cash financing activities:"
       }
      }
     },
     "localname": "NonCashFinancingActivitiesAbstract",
     "nsuri": "http://encoreuranium.com/20221231",
     "presentation": [
      "http://encoreuranium.com/role/ScheduleofincurrednoncashfinancingandinvestingactivitiesTable"
     ],
     "xbrltype": "stringItemType"
    },
    "cve_NonCashInvestingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non Cash Investing Activities Abstract",
        "terseLabel": "Non-cash investing activities:"
       }
      }
     },
     "localname": "NonCashInvestingActivitiesAbstract",
     "nsuri": "http://encoreuranium.com/20221231",
     "presentation": [
      "http://encoreuranium.com/role/ScheduleofincurrednoncashfinancingandinvestingactivitiesTable"
     ],
     "xbrltype": "stringItemType"
    },
    "cve_NonCurrentAssetsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non Current Assets Abstract",
        "terseLabel": "Non-current assets"
       }
      }
     },
     "localname": "NonCurrentAssetsAbstract",
     "nsuri": "http://encoreuranium.com/20221231",
     "presentation": [
      "http://encoreuranium.com/role/ConsolidatedBalanceSheet"
     ],
     "xbrltype": "stringItemType"
    },
    "cve_NonCurrentLiabilitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non Current Liabilities Abstract",
        "terseLabel": "Non-current liabilities"
       }
      }
     },
     "localname": "NonCurrentLiabilitiesAbstract",
     "nsuri": "http://encoreuranium.com/20221231",
     "presentation": [
      "http://encoreuranium.com/role/ConsolidatedBalanceSheet"
     ],
     "xbrltype": "stringItemType"
    },
    "cve_NoncapitalLoss": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Non-capital loss.",
        "label": "Noncapital Loss",
        "terseLabel": "Non-capital loss"
       }
      }
     },
     "localname": "NoncapitalLoss",
     "nsuri": "http://encoreuranium.com/20221231",
     "presentation": [
      "http://encoreuranium.com/role/IncometaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cve_NumberOfSharesReservedInsurancePercentage": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares reserved insurance percentage.",
        "label": "Number Of Shares Reserved Insurance Percentage",
        "terseLabel": "Number of shares reserved insurance percentage"
       }
      }
     },
     "localname": "NumberOfSharesReservedInsurancePercentage",
     "nsuri": "http://encoreuranium.com/20221231",
     "presentation": [
      "http://encoreuranium.com/role/ShareCapitalDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "cve_OfficeAndAdministration": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of office and administration.",
        "label": "Office And Administration",
        "terseLabel": "Office and administration"
       }
      }
     },
     "localname": "OfficeAndAdministration",
     "nsuri": "http://encoreuranium.com/20221231",
     "presentation": [
      "http://encoreuranium.com/role/ScheduleofamountspaidtokeymanagementorentitiesprovidingsimilarservicesTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cve_OfficeAndAdministrative": {
     "auth_ref": [],
     "calculation": {
      "http://encoreuranium.com/role/ScheduleofconsolidatedstatementsoflossandcomprehensivelossTable": {
       "order": 7.0,
       "parentTag": "ifrs-full_OtherOperatingIncomeExpense",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Office and administrative.",
        "label": "Office And Administrative",
        "terseLabel": "Office and administrative"
       }
      }
     },
     "localname": "OfficeAndAdministrative",
     "nsuri": "http://encoreuranium.com/20221231",
     "presentation": [
      "http://encoreuranium.com/role/ScheduleofconsolidatedstatementsoflossandcomprehensivelossTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cve_OfficersAndBoardMembersMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Officers And Board Members Member",
        "terseLabel": "Officers and Board members [Member]"
       }
      }
     },
     "localname": "OfficersAndBoardMembersMember",
     "nsuri": "http://encoreuranium.com/20221231",
     "presentation": [
      "http://encoreuranium.com/role/ScheduleofowingtorelatedpartiesTable"
     ],
     "xbrltype": "domainItemType"
    },
    "cve_OneFiveNineOneEightZeroMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "One Five Nine One Eight Zero Member",
        "terseLabel": "$1.59 - 1.80 [Member]"
       }
      }
     },
     "localname": "OneFiveNineOneEightZeroMember",
     "nsuri": "http://encoreuranium.com/20221231",
     "presentation": [
      "http://encoreuranium.com/role/ScheduleofsharepurchasewarrantsoutstandingTable"
     ],
     "xbrltype": "domainItemType"
    },
    "cve_OperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating Activities Abstract",
        "terseLabel": "Operating activities"
       }
      }
     },
     "localname": "OperatingActivitiesAbstract",
     "nsuri": "http://encoreuranium.com/20221231",
     "presentation": [
      "http://encoreuranium.com/role/ConsolidatedCashFlow"
     ],
     "xbrltype": "stringItemType"
    },
    "cve_OptionToAcquireShares": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Option to acquire shares.",
        "label": "Option To Acquire Shares",
        "terseLabel": "Option to acquire shares (in Shares)"
       }
      }
     },
     "localname": "OptionToAcquireShares",
     "nsuri": "http://encoreuranium.com/20221231",
     "presentation": [
      "http://encoreuranium.com/role/EventsafterthereportingperiodDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "cve_OptionsGrantedForMaximumYear": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Options granted for maximum year.",
        "label": "Options Granted For Maximum Year",
        "terseLabel": "Options granted for maximum year"
       }
      }
     },
     "localname": "OptionsGrantedForMaximumYear",
     "nsuri": "http://encoreuranium.com/20221231",
     "presentation": [
      "http://encoreuranium.com/role/ShareCapitalDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "cve_OptionsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Options Member",
        "terseLabel": "Options [Member]"
       }
      }
     },
     "localname": "OptionsMember",
     "nsuri": "http://encoreuranium.com/20221231",
     "presentation": [
      "http://encoreuranium.com/role/ScheduleofweightedaverageassumptionsusedintheblackscholesoptionTable"
     ],
     "xbrltype": "domainItemType"
    },
    "cve_OrginationAndReversalOfTemporaryDifferences": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Orgination and reversal of temporary differences.",
        "label": "Orgination And Reversal Of Temporary Differences",
        "terseLabel": "Organization and reversal of temporary differences"
       }
      }
     },
     "localname": "OrginationAndReversalOfTemporaryDifferences",
     "nsuri": "http://encoreuranium.com/20221231",
     "presentation": [
      "http://encoreuranium.com/role/ScheduleofincometaxexpenserecoveryTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cve_OtherRevenuesCurrent": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Revenues, Current",
        "label": "Other Revenues Current",
        "terseLabel": "Revenues, Current"
       }
      }
     },
     "localname": "OtherRevenuesCurrent",
     "nsuri": "http://encoreuranium.com/20221231",
     "presentation": [
      "http://encoreuranium.com/role/ScheduleofproportionalshareintheassociateTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cve_OtherRevenuesNoncurrent": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Revenues, Non-current",
        "label": "Other Revenues Noncurrent",
        "terseLabel": "Revenues, Non-current"
       }
      }
     },
     "localname": "OtherRevenuesNoncurrent",
     "nsuri": "http://encoreuranium.com/20221231",
     "presentation": [
      "http://encoreuranium.com/role/ScheduleofproportionalshareintheassociateTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cve_OtherStatesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other States Member",
        "terseLabel": "Other States [Member]"
       }
      }
     },
     "localname": "OtherStatesMember",
     "nsuri": "http://encoreuranium.com/20221231",
     "presentation": [
      "http://encoreuranium.com/role/ScheduleoflongtermassetsbygeographicsegmentTable"
     ],
     "xbrltype": "domainItemType"
    },
    "cve_PaymentAmount": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Payment amount.",
        "label": "Payment Amount",
        "terseLabel": "Payment amount"
       }
      }
     },
     "localname": "PaymentAmount",
     "nsuri": "http://encoreuranium.com/20221231",
     "presentation": [
      "http://encoreuranium.com/role/EventsafterthereportingperiodDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cve_PaymentsofInvestmentInUranium": {
     "auth_ref": [],
     "calculation": {
      "http://encoreuranium.com/role/ConsolidatedCashFlow": {
       "order": 10.0,
       "parentTag": "ifrs-full_CashFlowsFromUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Investment in uranium",
        "label": "Paymentsof Investment In Uranium",
        "negatedLabel": "Investment in uranium"
       }
      }
     },
     "localname": "PaymentsofInvestmentInUranium",
     "nsuri": "http://encoreuranium.com/20221231",
     "presentation": [
      "http://encoreuranium.com/role/ConsolidatedCashFlow"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cve_PermittingLicensing": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Permitting Licensing",
        "terseLabel": "Permitting &amp; Licensing"
       }
      }
     },
     "localname": "PermittingLicensing",
     "nsuri": "http://encoreuranium.com/20221231",
     "presentation": [
      "http://encoreuranium.com/role/ScheduleofmineralpropertiesTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cve_Personnel": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Personnel",
        "terseLabel": "Personnel"
       }
      }
     },
     "localname": "Personnel",
     "nsuri": "http://encoreuranium.com/20221231",
     "presentation": [
      "http://encoreuranium.com/role/ScheduleofmineralpropertiesTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cve_PhysicalUranium": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Physical uranium.",
        "label": "Physical Uranium",
        "terseLabel": "Physical uranium"
       }
      }
     },
     "localname": "PhysicalUranium",
     "nsuri": "http://encoreuranium.com/20221231",
     "presentation": [
      "http://encoreuranium.com/role/ScheduleofthefairvalueofthephysicaluraniuminvestmentTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cve_PlatoroWestIncMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Platoro West Inc Member",
        "terseLabel": "Platoro West Inc. [Member]"
       }
      }
     },
     "localname": "PlatoroWestIncMember",
     "nsuri": "http://encoreuranium.com/20221231",
     "presentation": [
      "http://encoreuranium.com/role/RelatedpartytransactionsandbalancesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cve_PowertechUSAIncMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Powertech USAInc Member",
        "terseLabel": "Powertech (USA) Inc. [Member]"
       }
      }
     },
     "localname": "PowertechUSAIncMember",
     "nsuri": "http://encoreuranium.com/20221231",
     "presentation": [
      "http://encoreuranium.com/role/ScheduleofsignificantsubsidiariesTable"
     ],
     "xbrltype": "domainItemType"
    },
    "cve_PricePerPound": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Price per pound.",
        "label": "Price Per Pound",
        "terseLabel": "Price per pound (in Dollars per share)"
       }
      }
     },
     "localname": "PricePerPound",
     "nsuri": "http://encoreuranium.com/20221231",
     "presentation": [
      "http://encoreuranium.com/role/SalescontractsDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "cve_PricePerShare": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Price per share value.",
        "label": "Price Per Share",
        "terseLabel": "Price per share (in Dollars per share)"
       }
      }
     },
     "localname": "PricePerShare",
     "nsuri": "http://encoreuranium.com/20221231",
     "presentation": [
      "http://encoreuranium.com/role/EventsafterthereportingperiodDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "cve_PrimaryTerm": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary term.",
        "label": "Primary Term",
        "terseLabel": "Primary term"
       }
      }
     },
     "localname": "PrimaryTerm",
     "nsuri": "http://encoreuranium.com/20221231",
     "presentation": [
      "http://encoreuranium.com/role/IntangibleassetsDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "cve_PrimeFuelsConsiderationPercentage": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of prime fuels consideration.",
        "label": "Prime Fuels Consideration Percentage",
        "terseLabel": "Prime fuels consideration percentage"
       }
      }
     },
     "localname": "PrimeFuelsConsiderationPercentage",
     "nsuri": "http://encoreuranium.com/20221231",
     "presentation": [
      "http://encoreuranium.com/role/MarketableSecuritiesDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "cve_PrimeFuelsCorpMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Prime Fuels Corp Member",
        "terseLabel": "Prime Fuels Corp [Member]"
       }
      }
     },
     "localname": "PrimeFuelsCorpMember",
     "nsuri": "http://encoreuranium.com/20221231",
     "presentation": [
      "http://encoreuranium.com/role/MineralPropertiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cve_PrivatePlacement": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Private placement.",
        "label": "Private Placement",
        "terseLabel": "Private placements"
       }
      }
     },
     "localname": "PrivatePlacement",
     "nsuri": "http://encoreuranium.com/20221231",
     "presentation": [
      "http://encoreuranium.com/role/ShareholdersEquityType2or3"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cve_PrivatePlacementProceeds": {
     "auth_ref": [],
     "calculation": {
      "http://encoreuranium.com/role/ConsolidatedCashFlow": {
       "order": 1.0,
       "parentTag": "ifrs-full_CashFlowsFromUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from the private placement proceeds.",
        "label": "Private Placement Proceeds",
        "terseLabel": "Private placement proceeds"
       }
      }
     },
     "localname": "PrivatePlacementProceeds",
     "nsuri": "http://encoreuranium.com/20221231",
     "presentation": [
      "http://encoreuranium.com/role/ConsolidatedCashFlow"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cve_PrivatePlacementinShares": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Private placement in shares.",
        "label": "Private Placementin Shares",
        "terseLabel": "Private placements (in Shares)"
       }
      }
     },
     "localname": "PrivatePlacementinShares",
     "nsuri": "http://encoreuranium.com/20221231",
     "presentation": [
      "http://encoreuranium.com/role/ShareholdersEquityType2or3"
     ],
     "xbrltype": "sharesItemType"
    },
    "cve_ProceedsReceivedFromSaleOfUraniumInvestment": {
     "auth_ref": [],
     "calculation": {
      "http://encoreuranium.com/role/ConsolidatedCashFlow": {
       "order": 4.0,
       "parentTag": "ifrs-full_CashFlowsFromUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Proceeds received from sale of uranium investment",
        "label": "Proceeds Received From Sale Of Uranium Investment",
        "terseLabel": "Proceeds received from sale of uranium investment"
       }
      }
     },
     "localname": "ProceedsReceivedFromSaleOfUraniumInvestment",
     "nsuri": "http://encoreuranium.com/20221231",
     "presentation": [
      "http://encoreuranium.com/role/ConsolidatedCashFlow"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cve_ProjectDevelopmentCostsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Project Development Costs Abstract",
        "terseLabel": "Project Development costs:"
       }
      }
     },
     "localname": "ProjectDevelopmentCostsAbstract",
     "nsuri": "http://encoreuranium.com/20221231",
     "presentation": [
      "http://encoreuranium.com/role/ScheduleofmineralpropertiesTable"
     ],
     "xbrltype": "stringItemType"
    },
    "cve_ProjectInvestigationFess": {
     "auth_ref": [],
     "calculation": {
      "http://encoreuranium.com/role/ConsolidatedComprehensiveIncome": {
       "order": 10.0,
       "parentTag": "ifrs-full_ProfitLossFromOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Project investigation expenses.",
        "label": "Project Investigation Fess",
        "terseLabel": "Project investigation"
       }
      }
     },
     "localname": "ProjectInvestigationFess",
     "nsuri": "http://encoreuranium.com/20221231",
     "presentation": [
      "http://encoreuranium.com/role/ConsolidatedComprehensiveIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cve_PropertyPlantAndEquipmentAdditionIncludedInAccountsPayableAndAccruedLiabilities": {
     "auth_ref": [],
     "calculation": {
      "http://encoreuranium.com/role/ScheduleofincurrednoncashfinancingandinvestingactivitiesTable": {
       "order": 3.0,
       "parentTag": "cve_TotalNoncashInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Property, plant, and equipment additions included in accounts payable and accrued liabilities.",
        "label": "Property Plant And Equipment Addition Included In Accounts Payable And Accrued Liabilities",
        "terseLabel": "Property, plant, and equipment additions included in accounts payable and accrued liabilities"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentAdditionIncludedInAccountsPayableAndAccruedLiabilities",
     "nsuri": "http://encoreuranium.com/20221231",
     "presentation": [
      "http://encoreuranium.com/role/ScheduleofincurrednoncashfinancingandinvestingactivitiesTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cve_PropertyPlantAndEquipmentRange": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Property Plant And Equipment Range",
        "terseLabel": "Range"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentRange",
     "nsuri": "http://encoreuranium.com/20221231",
     "presentation": [
      "http://encoreuranium.com/role/ScheduleofusefullivesofpropertyplantandequipementTable"
     ],
     "xbrltype": "durationItemType"
    },
    "cve_PropertyPlantAndEquipments": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Property, plant and equipment.",
        "label": "Property Plant And Equipments",
        "terseLabel": "Property, plant and equipment"
       }
      }
     },
     "localname": "PropertyPlantAndEquipments",
     "nsuri": "http://encoreuranium.com/20221231",
     "presentation": [
      "http://encoreuranium.com/role/ScheduleoflongtermassetsbygeographicsegmentTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cve_PropertyplantandequipmentDetailsScheduleofpropertyplantandequipmentLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Property, plant, and equipment (Details) - Schedule of property, plant, and equipment [Line Items]"
       }
      }
     },
     "localname": "PropertyplantandequipmentDetailsScheduleofpropertyplantandequipmentLineItems",
     "nsuri": "http://encoreuranium.com/20221231",
     "presentation": [
      "http://encoreuranium.com/role/ScheduleofpropertyplantandequipmentTable"
     ],
     "xbrltype": "stringItemType"
    },
    "cve_PropertyplantandequipmentDetailsScheduleofpropertyplantandequipmentTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Property, plant, and equipment (Details) - Schedule of property, plant, and equipment [Table]"
       }
      }
     },
     "localname": "PropertyplantandequipmentDetailsScheduleofpropertyplantandequipmentTable",
     "nsuri": "http://encoreuranium.com/20221231",
     "presentation": [
      "http://encoreuranium.com/role/ScheduleofpropertyplantandequipmentTable"
     ],
     "xbrltype": "stringItemType"
    },
    "cve_PropertyplantandequipmentTablesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Propertyplantandequipment Tables Line Items",
        "terseLabel": "Schedule of property, plant, and equipment [Abstract]"
       }
      }
     },
     "localname": "PropertyplantandequipmentTablesLineItems",
     "nsuri": "http://encoreuranium.com/20221231",
     "presentation": [
      "http://encoreuranium.com/role/PropertyplantandequipmentTables"
     ],
     "xbrltype": "stringItemType"
    },
    "cve_PropertyplantandequipmentTablesTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Propertyplantandequipment Tables Table",
        "terseLabel": "Schedule of property, plant, and equipment [Abstract]"
       }
      }
     },
     "localname": "PropertyplantandequipmentTablesTable",
     "nsuri": "http://encoreuranium.com/20221231",
     "presentation": [
      "http://encoreuranium.com/role/PropertyplantandequipmentTables"
     ],
     "xbrltype": "stringItemType"
    },
    "cve_ProportionateShareOfNetLoss": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of proportionate share of net loss.",
        "label": "Proportionate Share Of Net Loss",
        "terseLabel": "Proportionate share of net loss"
       }
      }
     },
     "localname": "ProportionateShareOfNetLoss",
     "nsuri": "http://encoreuranium.com/20221231",
     "presentation": [
      "http://encoreuranium.com/role/ScheduleofinvestmentinassociatecontinuityTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cve_PublicOfferingPricePerShare": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Public offering price per share.",
        "label": "Public Offering Price Per Share",
        "terseLabel": "Public offering price per share (in Dollars per share)"
       }
      }
     },
     "localname": "PublicOfferingPricePerShare",
     "nsuri": "http://encoreuranium.com/20221231",
     "presentation": [
      "http://encoreuranium.com/role/EventsafterthereportingperiodDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "cve_PurchaseAdditionalSharePricePerWarrant": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Purchase additional share price per warrant.",
        "label": "Purchase Additional Share Price Per Warrant",
        "terseLabel": "Purchase additional share price per warrant (in Dollars per share)"
       }
      }
     },
     "localname": "PurchaseAdditionalSharePricePerWarrant",
     "nsuri": "http://encoreuranium.com/20221231",
     "presentation": [
      "http://encoreuranium.com/role/ShareCapitalDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "cve_PurchaseAdditionalShareWarrants": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A stock warrant gives the holder the right to purchase a company's stock at a specific price and at a specific date. A stock warrant is issued directly by the company concerned; when an investor exercises a stock warrant, the shares that fulfill the obligation are not received from another investor but directly from the company.",
        "label": "Purchase Additional Share Warrants",
        "terseLabel": "Purchase additional share warrants"
       }
      }
     },
     "localname": "PurchaseAdditionalShareWarrants",
     "nsuri": "http://encoreuranium.com/20221231",
     "presentation": [
      "http://encoreuranium.com/role/ShareCapitalDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "cve_PurchaseAgreementsAmount": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of purchase agreements amount.",
        "label": "Purchase Agreements Amount",
        "terseLabel": "Purchase agreements amount (in Pounds)",
        "verboseLabel": "Agreement amount"
       }
      }
     },
     "localname": "PurchaseAgreementsAmount",
     "nsuri": "http://encoreuranium.com/20221231",
     "presentation": [
      "http://encoreuranium.com/role/EventsafterthereportingperiodDetails",
      "http://encoreuranium.com/role/InvestmentinuraniumDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cve_PurchaseCommitments": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of Purchase Commitments.",
        "label": "Purchase Commitments",
        "terseLabel": "Purchase Commitments"
       }
      }
     },
     "localname": "PurchaseCommitments",
     "nsuri": "http://encoreuranium.com/20221231",
     "presentation": [
      "http://encoreuranium.com/role/ScheduleofuraniumconcentratespurchaseagreementTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cve_PurchasePricePerShare": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Purchase price per share.",
        "label": "Purchase Price Per Share",
        "terseLabel": "Purchase price per share (in Dollars per share)"
       }
      }
     },
     "localname": "PurchasePricePerShare",
     "nsuri": "http://encoreuranium.com/20221231",
     "presentation": [
      "http://encoreuranium.com/role/EventsafterthereportingperiodDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "cve_PurchaseWarrantShares": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "hen an investor exercises a warrant, they purchase stock, and the proceeds are a source of capital for the company. A warrant certificate is issued to the investor when they exercise a warrant. The certificate includes the terms of the warrant, such as the expiry date and the final day it can be exercised.",
        "label": "Purchase Warrant Shares",
        "terseLabel": "Purchase warrant shares"
       }
      }
     },
     "localname": "PurchaseWarrantShares",
     "nsuri": "http://encoreuranium.com/20221231",
     "presentation": [
      "http://encoreuranium.com/role/ShareCapitalDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "cve_PurchasedShares": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Purchased shares.",
        "label": "Purchased Shares",
        "terseLabel": "Purchased shares (in Shares)"
       }
      }
     },
     "localname": "PurchasedShares",
     "nsuri": "http://encoreuranium.com/20221231",
     "presentation": [
      "http://encoreuranium.com/role/EventsafterthereportingperiodDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "cve_PursuantToAgreement": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Pursuant to agreement.",
        "label": "Pursuant To Agreement",
        "terseLabel": "Pursuant to agreement"
       }
      }
     },
     "localname": "PursuantToAgreement",
     "nsuri": "http://encoreuranium.com/20221231",
     "presentation": [
      "http://encoreuranium.com/role/SalescontractsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cve_ReclamationCosts": {
     "auth_ref": [],
     "calculation": {
      "http://encoreuranium.com/role/ScheduleofconsolidatedstatementsoflossandcomprehensivelossTable": {
       "order": 10.0,
       "parentTag": "ifrs-full_OtherOperatingIncomeExpense",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Reclamation Costs",
        "terseLabel": "Reclamation costs"
       }
      }
     },
     "localname": "ReclamationCosts",
     "nsuri": "http://encoreuranium.com/20221231",
     "presentation": [
      "http://encoreuranium.com/role/ScheduleofconsolidatedstatementsoflossandcomprehensivelossTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cve_RecognizedStockOptionExpense": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Recognized stock option expense.",
        "label": "Recognized Stock Option Expense",
        "terseLabel": "Recognized stock option expense (in Dollars)"
       }
      }
     },
     "localname": "RecognizedStockOptionExpense",
     "nsuri": "http://encoreuranium.com/20221231",
     "presentation": [
      "http://encoreuranium.com/role/ShareCapitalDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cve_Recoveries": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Recoveries",
        "terseLabel": "Recoveries"
       }
      }
     },
     "localname": "Recoveries",
     "nsuri": "http://encoreuranium.com/20221231",
     "presentation": [
      "http://encoreuranium.com/role/ScheduleofmineralpropertiesTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cve_RelatedpartytransactionsandbalancesDetailsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Related party transactions and balances (Details) [Line Items]"
       }
      }
     },
     "localname": "RelatedpartytransactionsandbalancesDetailsLineItems",
     "nsuri": "http://encoreuranium.com/20221231",
     "presentation": [
      "http://encoreuranium.com/role/RelatedpartytransactionsandbalancesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "cve_RelatedpartytransactionsandbalancesDetailsScheduleofowingtorelatedpartiesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Related party transactions and balances (Details) - Schedule of owing to related parties [Line Items]"
       }
      }
     },
     "localname": "RelatedpartytransactionsandbalancesDetailsScheduleofowingtorelatedpartiesLineItems",
     "nsuri": "http://encoreuranium.com/20221231",
     "presentation": [
      "http://encoreuranium.com/role/ScheduleofowingtorelatedpartiesTable"
     ],
     "xbrltype": "stringItemType"
    },
    "cve_RelatedpartytransactionsandbalancesDetailsScheduleofowingtorelatedpartiesTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Related party transactions and balances (Details) - Schedule of owing to related parties [Table]"
       }
      }
     },
     "localname": "RelatedpartytransactionsandbalancesDetailsScheduleofowingtorelatedpartiesTable",
     "nsuri": "http://encoreuranium.com/20221231",
     "presentation": [
      "http://encoreuranium.com/role/ScheduleofowingtorelatedpartiesTable"
     ],
     "xbrltype": "stringItemType"
    },
    "cve_RelatedpartytransactionsandbalancesDetailsTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Related party transactions and balances (Details) [Table]"
       }
      }
     },
     "localname": "RelatedpartytransactionsandbalancesDetailsTable",
     "nsuri": "http://encoreuranium.com/20221231",
     "presentation": [
      "http://encoreuranium.com/role/RelatedpartytransactionsandbalancesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "cve_ReleasedShares": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Released shares.",
        "label": "Released Shares",
        "terseLabel": "Released shares"
       }
      }
     },
     "localname": "ReleasedShares",
     "nsuri": "http://encoreuranium.com/20221231",
     "presentation": [
      "http://encoreuranium.com/role/MarketableSecuritiesDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "cve_RenewalPeriods": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Renewal periods.",
        "label": "Renewal Periods",
        "terseLabel": "Renewal periods"
       }
      }
     },
     "localname": "RenewalPeriods",
     "nsuri": "http://encoreuranium.com/20221231",
     "presentation": [
      "http://encoreuranium.com/role/IntangibleassetsDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "cve_ReplacementOptionsForAzargaAssetAcquisition": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Replacement options for azarga asset acquisition.",
        "label": "Replacement Options For Azarga Asset Acquisition",
        "terseLabel": "Replacement options for Azarga asset acquisition (Note 10)"
       }
      }
     },
     "localname": "ReplacementOptionsForAzargaAssetAcquisition",
     "nsuri": "http://encoreuranium.com/20221231",
     "presentation": [
      "http://encoreuranium.com/role/ShareholdersEquityType2or3"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cve_ReplacementOptionsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Replacement Options Member",
        "terseLabel": "Replacement Options [Member]"
       }
      }
     },
     "localname": "ReplacementOptionsMember",
     "nsuri": "http://encoreuranium.com/20221231",
     "presentation": [
      "http://encoreuranium.com/role/AssetacquisitionDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cve_ReplacementWarrantsForAzargaAssetAcquisition": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Replacement warrants for azarga asset acquisition.",
        "label": "Replacement Warrants For Azarga Asset Acquisition",
        "terseLabel": "Replacement warrants for Azarga asset acquisition (Note 10)"
       }
      }
     },
     "localname": "ReplacementWarrantsForAzargaAssetAcquisition",
     "nsuri": "http://encoreuranium.com/20221231",
     "presentation": [
      "http://encoreuranium.com/role/ShareholdersEquityType2or3"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cve_ReplacementWarrantsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Replacement Warrants Member",
        "terseLabel": "Replacement Warrants [Member]"
       }
      }
     },
     "localname": "ReplacementWarrantsMember",
     "nsuri": "http://encoreuranium.com/20221231",
     "presentation": [
      "http://encoreuranium.com/role/AssetacquisitionDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cve_ResourceReview": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Resource Review",
        "terseLabel": "Resource review"
       }
      }
     },
     "localname": "ResourceReview",
     "nsuri": "http://encoreuranium.com/20221231",
     "presentation": [
      "http://encoreuranium.com/role/ScheduleofmineralpropertiesTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cve_RevenuesLossFromOperatingExpenses": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Revenues Loss From Operating Expenses",
        "terseLabel": "Revenues, Loss from operating expenses"
       }
      }
     },
     "localname": "RevenuesLossFromOperatingExpenses",
     "nsuri": "http://encoreuranium.com/20221231",
     "presentation": [
      "http://encoreuranium.com/role/ScheduleofproportionalshareintheassociateTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cve_Right-of-UseAssetsAdditions": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Additions.",
        "label": "Right-of- Use Assets Additions",
        "terseLabel": "Additions"
       }
      }
     },
     "localname": "Right-of-UseAssetsAdditions",
     "nsuri": "http://encoreuranium.com/20221231",
     "presentation": [
      "http://encoreuranium.com/role/ScheduleofchangeintheROUassetsTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cve_Right-of-UseAssetsBalance": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Right-of- Use Assets Balance",
        "periodEndLabel": "Balance, ending",
        "periodStartLabel": "Balance, beginning"
       }
      }
     },
     "localname": "Right-of-UseAssetsBalance",
     "nsuri": "http://encoreuranium.com/20221231",
     "presentation": [
      "http://encoreuranium.com/role/ScheduleofchangeintheROUassetsTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cve_Right-of-UseAssetsCurrencyTranslationAdjustment": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Currency translation adjustment.",
        "label": "Right-of- Use Assets Currency Translation Adjustment",
        "terseLabel": "Currency translation adjustment"
       }
      }
     },
     "localname": "Right-of-UseAssetsCurrencyTranslationAdjustment",
     "nsuri": "http://encoreuranium.com/20221231",
     "presentation": [
      "http://encoreuranium.com/role/ScheduleofchangeintheROUassetsTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cve_Right-of-UseAssetsDepreciation": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Depreciation.",
        "label": "Right-of- Use Assets Depreciation",
        "terseLabel": "Depreciation"
       }
      }
     },
     "localname": "Right-of-UseAssetsDepreciation",
     "nsuri": "http://encoreuranium.com/20221231",
     "presentation": [
      "http://encoreuranium.com/role/ScheduleofchangeintheROUassetsTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cve_Right-of-UseAssetsTwoZeroTwoFive": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Right-of-use assets two zero two five.",
        "label": "Right-of- Use Assets Two Zero Two Five",
        "terseLabel": "2025"
       }
      }
     },
     "localname": "Right-of-UseAssetsTwoZeroTwoFive",
     "nsuri": "http://encoreuranium.com/20221231",
     "presentation": [
      "http://encoreuranium.com/role/ScheduleofundiscountedfutureleasepaymentsTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cve_Right-of-UseAssetsTwoZeroTwoFour": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Right-of-use assets two zero two four.",
        "label": "Right-of- Use Assets Two Zero Two Four",
        "negatedLabel": "2024"
       }
      }
     },
     "localname": "Right-of-UseAssetsTwoZeroTwoFour",
     "nsuri": "http://encoreuranium.com/20221231",
     "presentation": [
      "http://encoreuranium.com/role/ScheduleofundiscountedfutureleasepaymentsTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cve_Right-of-UseAssetsTwoZeroTwoThree": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Right-of-use assets two zero two three.",
        "label": "Right-of- Use Assets Two Zero Two Three",
        "terseLabel": "2023"
       }
      }
     },
     "localname": "Right-of-UseAssetsTwoZeroTwoThree",
     "nsuri": "http://encoreuranium.com/20221231",
     "presentation": [
      "http://encoreuranium.com/role/ScheduleofundiscountedfutureleasepaymentsTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cve_RightofuseAssets1": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Right-of-use assets.",
        "label": "Rightofuse Assets1",
        "terseLabel": "Right-of-use assets"
       }
      }
     },
     "localname": "RightofuseAssets1",
     "nsuri": "http://encoreuranium.com/20221231",
     "presentation": [
      "http://encoreuranium.com/role/ScheduleoflongtermassetsbygeographicsegmentTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cve_RightofuseassetsDetailsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Right-of-use assets (Details) [Line Items]"
       }
      }
     },
     "localname": "RightofuseassetsDetailsLineItems",
     "nsuri": "http://encoreuranium.com/20221231",
     "presentation": [
      "http://encoreuranium.com/role/RightofuseassetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "cve_RightofuseassetsDetailsScheduleofchangeintheROUassetsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedue of change in the ROU assets [Abstract]"
       }
      }
     },
     "localname": "RightofuseassetsDetailsScheduleofchangeintheROUassetsLineItems",
     "nsuri": "http://encoreuranium.com/20221231",
     "presentation": [
      "http://encoreuranium.com/role/ScheduleofchangeintheROUassetsTable"
     ],
     "xbrltype": "stringItemType"
    },
    "cve_RightofuseassetsDetailsScheduleofchangeintheROUassetsTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Right-of-use assets (Details) - Schedule of change in the ROU assets [Table]"
       }
      }
     },
     "localname": "RightofuseassetsDetailsScheduleofchangeintheROUassetsTable",
     "nsuri": "http://encoreuranium.com/20221231",
     "presentation": [
      "http://encoreuranium.com/role/ScheduleofchangeintheROUassetsTable"
     ],
     "xbrltype": "stringItemType"
    },
    "cve_RightofuseassetsDetailsScheduleofchangeinthelongTermleaseliabilityLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Shedule of change in the long-Term lease liability [Abstract]"
       }
      }
     },
     "localname": "RightofuseassetsDetailsScheduleofchangeinthelongTermleaseliabilityLineItems",
     "nsuri": "http://encoreuranium.com/20221231",
     "presentation": [
      "http://encoreuranium.com/role/ScheduleofchangeinthelongTermleaseliabilityTable"
     ],
     "xbrltype": "stringItemType"
    },
    "cve_RightofuseassetsDetailsScheduleofchangeinthelongTermleaseliabilityTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Right-of-use assets (Details) - Schedule of change in the long-Term lease liability [Table]"
       }
      }
     },
     "localname": "RightofuseassetsDetailsScheduleofchangeinthelongTermleaseliabilityTable",
     "nsuri": "http://encoreuranium.com/20221231",
     "presentation": [
      "http://encoreuranium.com/role/ScheduleofchangeinthelongTermleaseliabilityTable"
     ],
     "xbrltype": "stringItemType"
    },
    "cve_RightofuseassetsDetailsScheduleofundiscountedfutureleasepaymentsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Shedule of undiscounted future lease payments [Abstract]"
       }
      }
     },
     "localname": "RightofuseassetsDetailsScheduleofundiscountedfutureleasepaymentsLineItems",
     "nsuri": "http://encoreuranium.com/20221231",
     "presentation": [
      "http://encoreuranium.com/role/ScheduleofundiscountedfutureleasepaymentsTable"
     ],
     "xbrltype": "stringItemType"
    },
    "cve_RightofuseassetsDetailsScheduleofundiscountedfutureleasepaymentsTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Right-of-use assets (Details) - Schedule of undiscounted future lease payments [Table]"
       }
      }
     },
     "localname": "RightofuseassetsDetailsScheduleofundiscountedfutureleasepaymentsTable",
     "nsuri": "http://encoreuranium.com/20221231",
     "presentation": [
      "http://encoreuranium.com/role/ScheduleofundiscountedfutureleasepaymentsTable"
     ],
     "xbrltype": "stringItemType"
    },
    "cve_RightofuseassetsDetailsTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Right-of-use assets (Details) [Table]"
       }
      }
     },
     "localname": "RightofuseassetsDetailsTable",
     "nsuri": "http://encoreuranium.com/20221231",
     "presentation": [
      "http://encoreuranium.com/role/RightofuseassetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "cve_RightofuseassetsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Right-of-use assets [Abstract]"
       }
      }
     },
     "localname": "RightofuseassetsLineItems",
     "nsuri": "http://encoreuranium.com/20221231",
     "presentation": [
      "http://encoreuranium.com/role/Rightofuseassets"
     ],
     "xbrltype": "stringItemType"
    },
    "cve_RightofuseassetsTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Right-of-use assets [Table]"
       }
      }
     },
     "localname": "RightofuseassetsTable",
     "nsuri": "http://encoreuranium.com/20221231",
     "presentation": [
      "http://encoreuranium.com/role/Rightofuseassets"
     ],
     "xbrltype": "stringItemType"
    },
    "cve_RightofuseassetsTablesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rightofuseassets Tables Line Items",
        "terseLabel": "Right-of-use assets [Abstract]"
       }
      }
     },
     "localname": "RightofuseassetsTablesLineItems",
     "nsuri": "http://encoreuranium.com/20221231",
     "presentation": [
      "http://encoreuranium.com/role/RightofuseassetsTables"
     ],
     "xbrltype": "stringItemType"
    },
    "cve_RightofuseassetsTablesTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Right-of-use assets (Tables) [Table]"
       }
      }
     },
     "localname": "RightofuseassetsTablesTable",
     "nsuri": "http://encoreuranium.com/20221231",
     "presentation": [
      "http://encoreuranium.com/role/RightofuseassetsTables"
     ],
     "xbrltype": "stringItemType"
    },
    "cve_RositaMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rosita Member",
        "terseLabel": "Rosita [Member]"
       }
      }
     },
     "localname": "RositaMember",
     "nsuri": "http://encoreuranium.com/20221231",
     "presentation": [
      "http://encoreuranium.com/role/ScheduleofassetretirementobligationsbalanceTable"
     ],
     "xbrltype": "domainItemType"
    },
    "cve_RoyaltyIncomeRate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Royalty Income Rate",
        "terseLabel": "Gross profit royalty"
       }
      }
     },
     "localname": "RoyaltyIncomeRate",
     "nsuri": "http://encoreuranium.com/20221231",
     "presentation": [
      "http://encoreuranium.com/role/MineralPropertiesDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "cve_SaleOfPhysicalUranium": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of sale of physical uranium.",
        "label": "Sale Of Physical Uranium",
        "terseLabel": "Sale of physical uranium (in Pounds)"
       }
      }
     },
     "localname": "SaleOfPhysicalUranium",
     "nsuri": "http://encoreuranium.com/20221231",
     "presentation": [
      "http://encoreuranium.com/role/InvestmentinuraniumDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cve_SaleOfUraniumInvestment": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net realized gain (loss) on investments sold during the period, not including gains (losses) on securities separately or otherwise categorized as trading, available-for-sale, or held-to-maturity, which, for cash flow reporting, is a component of proceeds from investing activities.",
        "label": "Sale Of Uranium Investment",
        "terseLabel": "Sale of uranium investment"
       }
      }
     },
     "localname": "SaleOfUraniumInvestment",
     "nsuri": "http://encoreuranium.com/20221231",
     "presentation": [
      "http://encoreuranium.com/role/ScheduleofthefairvalueofthephysicaluraniuminvestmentTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cve_Saleofstockpershare": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sale of stock per share.",
        "label": "Saleofstockpershare",
        "terseLabel": "Sale of stock per share (in Dollars per share)"
       }
      }
     },
     "localname": "Saleofstockpershare",
     "nsuri": "http://encoreuranium.com/20221231",
     "presentation": [
      "http://encoreuranium.com/role/EventsafterthereportingperiodDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "cve_SalesContractsFiscalTwoZeroTwoFive": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sales contracts fiscal two zero two five.",
        "label": "Sales Contracts Fiscal Two Zero Two Five",
        "terseLabel": "Fiscal 2025"
       }
      }
     },
     "localname": "SalesContractsFiscalTwoZeroTwoFive",
     "nsuri": "http://encoreuranium.com/20221231",
     "presentation": [
      "http://encoreuranium.com/role/ScheduleofuraniumsalescontractsoverthenextfiveyearsTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cve_SalesContractsFiscalTwoZeroTwoFour": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sales contracts fiscal two zero two four.",
        "label": "Sales Contracts Fiscal Two Zero Two Four",
        "terseLabel": "Fiscal 2024"
       }
      }
     },
     "localname": "SalesContractsFiscalTwoZeroTwoFour",
     "nsuri": "http://encoreuranium.com/20221231",
     "presentation": [
      "http://encoreuranium.com/role/ScheduleofuraniumsalescontractsoverthenextfiveyearsTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cve_SalesContractsFiscalTwoZeroTwoSeven": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sales contracts fiscal two zero two seven.",
        "label": "Sales Contracts Fiscal Two Zero Two Seven",
        "terseLabel": "Fiscal 2027"
       }
      }
     },
     "localname": "SalesContractsFiscalTwoZeroTwoSeven",
     "nsuri": "http://encoreuranium.com/20221231",
     "presentation": [
      "http://encoreuranium.com/role/ScheduleofuraniumsalescontractsoverthenextfiveyearsTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cve_SalesContractsFiscalTwoZeroTwoSix": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sales contracts fiscal two zero two six.",
        "label": "Sales Contracts Fiscal Two Zero Two Six",
        "terseLabel": "Fiscal 2026"
       }
      }
     },
     "localname": "SalesContractsFiscalTwoZeroTwoSix",
     "nsuri": "http://encoreuranium.com/20221231",
     "presentation": [
      "http://encoreuranium.com/role/ScheduleofuraniumsalescontractsoverthenextfiveyearsTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cve_SalesContractsFiscalTwoZeroTwoThree": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sales contracts fiscal two zero two three.",
        "label": "Sales Contracts Fiscal Two Zero Two Three",
        "terseLabel": "Fiscal 2023"
       }
      }
     },
     "localname": "SalesContractsFiscalTwoZeroTwoThree",
     "nsuri": "http://encoreuranium.com/20221231",
     "presentation": [
      "http://encoreuranium.com/role/ScheduleofuraniumsalescontractsoverthenextfiveyearsTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cve_SalesContractsTrem": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sales contracts trem.",
        "label": "Sales Contracts Trem",
        "terseLabel": "Sales contracts term"
       }
      }
     },
     "localname": "SalesContractsTrem",
     "nsuri": "http://encoreuranium.com/20221231",
     "presentation": [
      "http://encoreuranium.com/role/SalescontractsDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "cve_SalescontractsDetailsScheduleofuraniumsalescontractsoverthenextfiveyearsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of uranium sales contracts over the next five years [Abstract]"
       }
      }
     },
     "localname": "SalescontractsDetailsScheduleofuraniumsalescontractsoverthenextfiveyearsLineItems",
     "nsuri": "http://encoreuranium.com/20221231",
     "presentation": [
      "http://encoreuranium.com/role/ScheduleofuraniumsalescontractsoverthenextfiveyearsTable"
     ],
     "xbrltype": "stringItemType"
    },
    "cve_SalescontractsDetailsScheduleofuraniumsalescontractsoverthenextfiveyearsTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Sales contracts (Details) - Schedule of uranium sales contracts over the next five years [Table]"
       }
      }
     },
     "localname": "SalescontractsDetailsScheduleofuraniumsalescontractsoverthenextfiveyearsTable",
     "nsuri": "http://encoreuranium.com/20221231",
     "presentation": [
      "http://encoreuranium.com/role/ScheduleofuraniumsalescontractsoverthenextfiveyearsTable"
     ],
     "xbrltype": "stringItemType"
    },
    "cve_SalescontractsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Sales contracts [Abstract]"
       }
      }
     },
     "localname": "SalescontractsLineItems",
     "nsuri": "http://encoreuranium.com/20221231",
     "presentation": [
      "http://encoreuranium.com/role/Salescontracts"
     ],
     "xbrltype": "stringItemType"
    },
    "cve_SalescontractsTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Sales contracts [Table]"
       }
      }
     },
     "localname": "SalescontractsTable",
     "nsuri": "http://encoreuranium.com/20221231",
     "presentation": [
      "http://encoreuranium.com/role/Salescontracts"
     ],
     "xbrltype": "stringItemType"
    },
    "cve_SalescontractsTablesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Salescontracts Tables Line Items",
        "terseLabel": "Sales contracts [Abstract]"
       }
      }
     },
     "localname": "SalescontractsTablesLineItems",
     "nsuri": "http://encoreuranium.com/20221231",
     "presentation": [
      "http://encoreuranium.com/role/SalescontractsTables"
     ],
     "xbrltype": "stringItemType"
    },
    "cve_SalescontractsTablesTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Sales contracts (Tables) [Table]"
       }
      }
     },
     "localname": "SalescontractsTablesTable",
     "nsuri": "http://encoreuranium.com/20221231",
     "presentation": [
      "http://encoreuranium.com/role/SalescontractsTables"
     ],
     "xbrltype": "stringItemType"
    },
    "cve_ScheduleOfAmountsPaidToKeyManagementOrEntitiesProvidingSimilarServicesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule Of Amounts Paid To Key Management Or Entities Providing Similar Services Abstract"
       }
      }
     },
     "localname": "ScheduleOfAmountsPaidToKeyManagementOrEntitiesProvidingSimilarServicesAbstract",
     "nsuri": "http://encoreuranium.com/20221231",
     "xbrltype": "stringItemType"
    },
    "cve_ScheduleOfAssetRetirementObligationsBalanceAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule Of Asset Retirement Obligations Balance Abstract"
       }
      }
     },
     "localname": "ScheduleOfAssetRetirementObligationsBalanceAbstract",
     "nsuri": "http://encoreuranium.com/20221231",
     "xbrltype": "stringItemType"
    },
    "cve_ScheduleOfAssetRetirementObligationsContinuityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule Of Asset Retirement Obligations Continuity Abstract"
       }
      }
     },
     "localname": "ScheduleOfAssetRetirementObligationsContinuityAbstract",
     "nsuri": "http://encoreuranium.com/20221231",
     "xbrltype": "stringItemType"
    },
    "cve_ScheduleOfChangeInTheLongTermLeaseLiabilityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule Of Change In The Long Term Lease Liability Abstract"
       }
      }
     },
     "localname": "ScheduleOfChangeInTheLongTermLeaseLiabilityAbstract",
     "nsuri": "http://encoreuranium.com/20221231",
     "xbrltype": "stringItemType"
    },
    "cve_ScheduleOfChangeInTheRouAssetsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule Of Change In The Rou Assets Abstract"
       }
      }
     },
     "localname": "ScheduleOfChangeInTheRouAssetsAbstract",
     "nsuri": "http://encoreuranium.com/20221231",
     "xbrltype": "stringItemType"
    },
    "cve_ScheduleOfConsolidatedStatementsOfLossAndComprehensiveLossAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule Of Consolidated Statements Of Loss And Comprehensive Loss Abstract"
       }
      }
     },
     "localname": "ScheduleOfConsolidatedStatementsOfLossAndComprehensiveLossAbstract",
     "nsuri": "http://encoreuranium.com/20221231",
     "xbrltype": "stringItemType"
    },
    "cve_ScheduleOfDeferredTaxLiabilitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule Of Deferred Tax Liabilities Abstract"
       }
      }
     },
     "localname": "ScheduleOfDeferredTaxLiabilitiesAbstract",
     "nsuri": "http://encoreuranium.com/20221231",
     "xbrltype": "stringItemType"
    },
    "cve_ScheduleOfEffectOfTranslationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule Of Effect Of Translation Abstract"
       }
      }
     },
     "localname": "ScheduleOfEffectOfTranslationAbstract",
     "nsuri": "http://encoreuranium.com/20221231",
     "xbrltype": "stringItemType"
    },
    "cve_ScheduleOfEstimatedFairValueOfAssetsAndLiabilitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule Of Estimated Fair Value Of Assets And Liabilities Abstract"
       }
      }
     },
     "localname": "ScheduleOfEstimatedFairValueOfAssetsAndLiabilitiesAbstract",
     "nsuri": "http://encoreuranium.com/20221231",
     "xbrltype": "stringItemType"
    },
    "cve_ScheduleOfExchangeRatesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule Of Exchange Rates Abstract"
       }
      }
     },
     "localname": "ScheduleOfExchangeRatesAbstract",
     "nsuri": "http://encoreuranium.com/20221231",
     "xbrltype": "stringItemType"
    },
    "cve_ScheduleOfFederalAndProvincialCorporateTaxRatesToIncomeBeforeTaxAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule Of Federal And Provincial Corporate Tax Rates To Income Before Tax Abstract"
       }
      }
     },
     "localname": "ScheduleOfFederalAndProvincialCorporateTaxRatesToIncomeBeforeTaxAbstract",
     "nsuri": "http://encoreuranium.com/20221231",
     "xbrltype": "stringItemType"
    },
    "cve_ScheduleOfFinancialInstrumentTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule Of Financial Instrument Table Text Block",
        "terseLabel": "Schedule of foreign currency exposures"
       }
      }
     },
     "localname": "ScheduleOfFinancialInstrumentTableTextBlock",
     "nsuri": "http://encoreuranium.com/20221231",
     "presentation": [
      "http://encoreuranium.com/role/FinancialInstrumentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cve_ScheduleOfForeignCurrencyExposuresAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule Of Foreign Currency Exposures Abstract"
       }
      }
     },
     "localname": "ScheduleOfForeignCurrencyExposuresAbstract",
     "nsuri": "http://encoreuranium.com/20221231",
     "xbrltype": "stringItemType"
    },
    "cve_ScheduleOfIncomeTaxExpenseRecoveryAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule Of Income Tax Expense Recovery Abstract"
       }
      }
     },
     "localname": "ScheduleOfIncomeTaxExpenseRecoveryAbstract",
     "nsuri": "http://encoreuranium.com/20221231",
     "xbrltype": "stringItemType"
    },
    "cve_ScheduleOfIncurredNonCashFinancingAndInvestingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule Of Incurred Non Cash Financing And Investing Activities Abstract"
       }
      }
     },
     "localname": "ScheduleOfIncurredNonCashFinancingAndInvestingActivitiesAbstract",
     "nsuri": "http://encoreuranium.com/20221231",
     "xbrltype": "stringItemType"
    },
    "cve_ScheduleOfIncurredNoncashFinancingAndInvestingActivitiesTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule Of Incurred Noncash Financing And Investing Activities Table Text Block",
        "terseLabel": "Schedule of incurred non-cash financing and investing activities"
       }
      }
     },
     "localname": "ScheduleOfIncurredNoncashFinancingAndInvestingActivitiesTableTextBlock",
     "nsuri": "http://encoreuranium.com/20221231",
     "presentation": [
      "http://encoreuranium.com/role/SupplementaldisclosurewithrespecttocashflowsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cve_ScheduleOfIntangibleAssetWasDeterminedAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule Of Intangible Asset Was Determined Abstract"
       }
      }
     },
     "localname": "ScheduleOfIntangibleAssetWasDeterminedAbstract",
     "nsuri": "http://encoreuranium.com/20221231",
     "xbrltype": "stringItemType"
    },
    "cve_ScheduleOfInvestmentInAssociateContinuityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule Of Investment In Associate Continuity Abstract"
       }
      }
     },
     "localname": "ScheduleOfInvestmentInAssociateContinuityAbstract",
     "nsuri": "http://encoreuranium.com/20221231",
     "xbrltype": "stringItemType"
    },
    "cve_ScheduleOfLongTermAssetsByGeographicSegmentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule Of Long Term Assets By Geographic Segment Abstract"
       }
      }
     },
     "localname": "ScheduleOfLongTermAssetsByGeographicSegmentAbstract",
     "nsuri": "http://encoreuranium.com/20221231",
     "xbrltype": "stringItemType"
    },
    "cve_ScheduleOfMarketableSecuritiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule Of Marketable Securities Abstract"
       }
      }
     },
     "localname": "ScheduleOfMarketableSecuritiesAbstract",
     "nsuri": "http://encoreuranium.com/20221231",
     "xbrltype": "stringItemType"
    },
    "cve_ScheduleOfMarketableSecuritiesTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for marketable securities.",
        "label": "Schedule Of Marketable Securities Table Text Block",
        "terseLabel": "Schedule of marketable securities"
       }
      }
     },
     "localname": "ScheduleOfMarketableSecuritiesTableTextBlock",
     "nsuri": "http://encoreuranium.com/20221231",
     "presentation": [
      "http://encoreuranium.com/role/MarketableSecuritiesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cve_ScheduleOfMineralProperties": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule Of Mineral Properties",
        "terseLabel": "Schedule of mineral properties"
       }
      }
     },
     "localname": "ScheduleOfMineralProperties",
     "nsuri": "http://encoreuranium.com/20221231",
     "presentation": [
      "http://encoreuranium.com/role/MineralPropertiesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cve_ScheduleOfMineralPropertiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule Of Mineral Properties Abstract"
       }
      }
     },
     "localname": "ScheduleOfMineralPropertiesAbstract",
     "nsuri": "http://encoreuranium.com/20221231",
     "xbrltype": "stringItemType"
    },
    "cve_ScheduleOfNetAssetsAcquiredAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule Of Net Assets Acquired Abstract"
       }
      }
     },
     "localname": "ScheduleOfNetAssetsAcquiredAbstract",
     "nsuri": "http://encoreuranium.com/20221231",
     "xbrltype": "stringItemType"
    },
    "cve_ScheduleOfOwingToRelatedPartiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule Of Owing To Related Parties Abstract"
       }
      }
     },
     "localname": "ScheduleOfOwingToRelatedPartiesAbstract",
     "nsuri": "http://encoreuranium.com/20221231",
     "xbrltype": "stringItemType"
    },
    "cve_ScheduleOfPropertyPlantAndEquipmentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule Of Property Plant And Equipment Abstract"
       }
      }
     },
     "localname": "ScheduleOfPropertyPlantAndEquipmentAbstract",
     "nsuri": "http://encoreuranium.com/20221231",
     "xbrltype": "stringItemType"
    },
    "cve_ScheduleOfProportionalShareInTheAssociateAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule Of Proportional Share In The Associate Abstract"
       }
      }
     },
     "localname": "ScheduleOfProportionalShareInTheAssociateAbstract",
     "nsuri": "http://encoreuranium.com/20221231",
     "xbrltype": "stringItemType"
    },
    "cve_ScheduleOfSharePurchaseWarrantsOutstandingAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule Of Share Purchase Warrants Outstanding Abstract"
       }
      }
     },
     "localname": "ScheduleOfSharePurchaseWarrantsOutstandingAbstract",
     "nsuri": "http://encoreuranium.com/20221231",
     "xbrltype": "stringItemType"
    },
    "cve_ScheduleOfSharePurchaseWarrantsOutstandingTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule Of Share Purchase Warrants Outstanding Table Text Block",
        "terseLabel": "Schedule of share purchase warrants outstanding"
       }
      }
     },
     "localname": "ScheduleOfSharePurchaseWarrantsOutstandingTableTextBlock",
     "nsuri": "http://encoreuranium.com/20221231",
     "presentation": [
      "http://encoreuranium.com/role/ShareCapitalTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cve_ScheduleOfSignificantSubsidiariesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule Of Significant Subsidiaries Abstract"
       }
      }
     },
     "localname": "ScheduleOfSignificantSubsidiariesAbstract",
     "nsuri": "http://encoreuranium.com/20221231",
     "xbrltype": "stringItemType"
    },
    "cve_ScheduleOfStockOptionsOutstandingAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule Of Stock Options Outstanding Abstract"
       }
      }
     },
     "localname": "ScheduleOfStockOptionsOutstandingAbstract",
     "nsuri": "http://encoreuranium.com/20221231",
     "xbrltype": "stringItemType"
    },
    "cve_ScheduleOfStockOptionsOutstandingTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule Of Stock Options Outstanding Table Text Block",
        "terseLabel": "Schedule of stock options outstanding"
       }
      }
     },
     "localname": "ScheduleOfStockOptionsOutstandingTableTextBlock",
     "nsuri": "http://encoreuranium.com/20221231",
     "presentation": [
      "http://encoreuranium.com/role/ShareCapitalTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cve_ScheduleOfTheCompanySStockOptionsOutstandingAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule Of The Company SStock Options Outstanding Abstract"
       }
      }
     },
     "localname": "ScheduleOfTheCompanySStockOptionsOutstandingAbstract",
     "nsuri": "http://encoreuranium.com/20221231",
     "xbrltype": "stringItemType"
    },
    "cve_ScheduleOfTheCompanysStockOptionsOutstandingTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule Of The Companys Stock Options Outstanding Table Text Block",
        "terseLabel": "Schedule of the company\u2019s stock options outstanding"
       }
      }
     },
     "localname": "ScheduleOfTheCompanysStockOptionsOutstandingTableTextBlock",
     "nsuri": "http://encoreuranium.com/20221231",
     "presentation": [
      "http://encoreuranium.com/role/ShareCapitalTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cve_ScheduleOfTheFairValueOfThePhysicalUraniumInvestmentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule Of The Fair Value Of The Physical Uranium Investment Abstract"
       }
      }
     },
     "localname": "ScheduleOfTheFairValueOfThePhysicalUraniumInvestmentAbstract",
     "nsuri": "http://encoreuranium.com/20221231",
     "xbrltype": "stringItemType"
    },
    "cve_ScheduleOfTheFairValueOfThePhysicalUraniumInvestmentTableTextBlck": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule Of The Fair Value Of The Physical Uranium Investment Table Text Blck",
        "terseLabel": "Schedule of the fair value of the physical uranium investment"
       }
      }
     },
     "localname": "ScheduleOfTheFairValueOfThePhysicalUraniumInvestmentTableTextBlck",
     "nsuri": "http://encoreuranium.com/20221231",
     "presentation": [
      "http://encoreuranium.com/role/InvestmentinuraniumTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cve_ScheduleOfTheStatusOfTheCompanySWarrantsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule Of The Status Of The Company SWarrants Abstract"
       }
      }
     },
     "localname": "ScheduleOfTheStatusOfTheCompanySWarrantsAbstract",
     "nsuri": "http://encoreuranium.com/20221231",
     "xbrltype": "stringItemType"
    },
    "cve_ScheduleOfTheStatusOfTheCompanysWarrantsTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule Of The Status Of The Companys Warrants Table Text Block",
        "terseLabel": "Schedule of the status of the company\u2019s warrants"
       }
      }
     },
     "localname": "ScheduleOfTheStatusOfTheCompanysWarrantsTableTextBlock",
     "nsuri": "http://encoreuranium.com/20221231",
     "presentation": [
      "http://encoreuranium.com/role/ShareCapitalTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cve_ScheduleOfUndiscountedFutureLeasePaymentsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule Of Undiscounted Future Lease Payments Abstract"
       }
      }
     },
     "localname": "ScheduleOfUndiscountedFutureLeasePaymentsAbstract",
     "nsuri": "http://encoreuranium.com/20221231",
     "xbrltype": "stringItemType"
    },
    "cve_ScheduleOfUnrecognizedDeferredTaxAssetsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule Of Unrecognized Deferred Tax Assets Abstract"
       }
      }
     },
     "localname": "ScheduleOfUnrecognizedDeferredTaxAssetsAbstract",
     "nsuri": "http://encoreuranium.com/20221231",
     "xbrltype": "stringItemType"
    },
    "cve_ScheduleOfUraniumConcentratesPurchaseAgreementAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule Of Uranium Concentrates Purchase Agreement Abstract"
       }
      }
     },
     "localname": "ScheduleOfUraniumConcentratesPurchaseAgreementAbstract",
     "nsuri": "http://encoreuranium.com/20221231",
     "xbrltype": "stringItemType"
    },
    "cve_ScheduleOfUraniumConcentratesPurchaseAgreementTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule Of Uranium Concentrates Purchase Agreement Table Text Block",
        "terseLabel": "Schedule of uranium concentrates purchase agreement"
       }
      }
     },
     "localname": "ScheduleOfUraniumConcentratesPurchaseAgreementTableTextBlock",
     "nsuri": "http://encoreuranium.com/20221231",
     "presentation": [
      "http://encoreuranium.com/role/InvestmentinuraniumTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cve_ScheduleOfUraniumSalesContractsOverTheNextFiveYearsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule Of Uranium Sales Contracts Over The Next Five Years Abstract"
       }
      }
     },
     "localname": "ScheduleOfUraniumSalesContractsOverTheNextFiveYearsAbstract",
     "nsuri": "http://encoreuranium.com/20221231",
     "xbrltype": "stringItemType"
    },
    "cve_ScheduleOfUsefulLivesOfIntangibleAssetsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule Of Useful Lives Of Intangible Assets Abstract"
       }
      }
     },
     "localname": "ScheduleOfUsefulLivesOfIntangibleAssetsAbstract",
     "nsuri": "http://encoreuranium.com/20221231",
     "xbrltype": "stringItemType"
    },
    "cve_ScheduleOfUsefulLivesOfPropertyPlantAndEquipementAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule Of Useful Lives Of Property Plant And Equipement Abstract"
       }
      }
     },
     "localname": "ScheduleOfUsefulLivesOfPropertyPlantAndEquipementAbstract",
     "nsuri": "http://encoreuranium.com/20221231",
     "xbrltype": "stringItemType"
    },
    "cve_ScheduleOfWeightedAverageAssumptionsUsedInCalculatingTheFairValuesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule Of Weighted Average Assumptions Used In Calculating The Fair Values Abstract"
       }
      }
     },
     "localname": "ScheduleOfWeightedAverageAssumptionsUsedInCalculatingTheFairValuesAbstract",
     "nsuri": "http://encoreuranium.com/20221231",
     "xbrltype": "stringItemType"
    },
    "cve_ScheduleOfWeightedAverageAssumptionsUsedInCalculatingTheFairValuesTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule Of Weighted Average Assumptions Used In Calculating The Fair Values Table Text Block",
        "terseLabel": "Schedule of weighted average assumptions used in calculating the fair values"
       }
      }
     },
     "localname": "ScheduleOfWeightedAverageAssumptionsUsedInCalculatingTheFairValuesTableTextBlock",
     "nsuri": "http://encoreuranium.com/20221231",
     "presentation": [
      "http://encoreuranium.com/role/ShareCapitalTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cve_ScheduleOfWeightedAverageAssumptionsUsedInTheBlackScholesOptionAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule Of Weighted Average Assumptions Used In The Black Scholes Option Abstract"
       }
      }
     },
     "localname": "ScheduleOfWeightedAverageAssumptionsUsedInTheBlackScholesOptionAbstract",
     "nsuri": "http://encoreuranium.com/20221231",
     "xbrltype": "stringItemType"
    },
    "cve_SegmentedInformationBalance": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Segmented information balance.",
        "label": "Segmented Information Balance",
        "terseLabel": "Balance"
       }
      }
     },
     "localname": "SegmentedInformationBalance",
     "nsuri": "http://encoreuranium.com/20221231",
     "presentation": [
      "http://encoreuranium.com/role/ScheduleoflongtermassetsbygeographicsegmentTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cve_SegmentedinformationDetailsScheduleoflongtermassetsbygeographicsegmentLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of long-term assets by geographic segment [Abstract]"
       }
      }
     },
     "localname": "SegmentedinformationDetailsScheduleoflongtermassetsbygeographicsegmentLineItems",
     "nsuri": "http://encoreuranium.com/20221231",
     "presentation": [
      "http://encoreuranium.com/role/ScheduleoflongtermassetsbygeographicsegmentTable"
     ],
     "xbrltype": "stringItemType"
    },
    "cve_SegmentedinformationDetailsScheduleoflongtermassetsbygeographicsegmentTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Segmented information (Details) - Schedule of long-term assets by geographic segment [Table]"
       }
      }
     },
     "localname": "SegmentedinformationDetailsScheduleoflongtermassetsbygeographicsegmentTable",
     "nsuri": "http://encoreuranium.com/20221231",
     "presentation": [
      "http://encoreuranium.com/role/ScheduleoflongtermassetsbygeographicsegmentTable"
     ],
     "xbrltype": "stringItemType"
    },
    "cve_SegmentedinformationLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Segmented information [Abstract]"
       }
      }
     },
     "localname": "SegmentedinformationLineItems",
     "nsuri": "http://encoreuranium.com/20221231",
     "presentation": [
      "http://encoreuranium.com/role/Segmentedinformation"
     ],
     "xbrltype": "stringItemType"
    },
    "cve_SegmentedinformationTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Segmented information [Table]"
       }
      }
     },
     "localname": "SegmentedinformationTable",
     "nsuri": "http://encoreuranium.com/20221231",
     "presentation": [
      "http://encoreuranium.com/role/Segmentedinformation"
     ],
     "xbrltype": "stringItemType"
    },
    "cve_SegmentedinformationTablesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Segmentedinformation Tables Line Items",
        "terseLabel": "Segmented information [Abstract]"
       }
      }
     },
     "localname": "SegmentedinformationTablesLineItems",
     "nsuri": "http://encoreuranium.com/20221231",
     "presentation": [
      "http://encoreuranium.com/role/SegmentedinformationTables"
     ],
     "xbrltype": "stringItemType"
    },
    "cve_SegmentedinformationTablesTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Segmented information (Tables) [Table]"
       }
      }
     },
     "localname": "SegmentedinformationTablesTable",
     "nsuri": "http://encoreuranium.com/20221231",
     "presentation": [
      "http://encoreuranium.com/role/SegmentedinformationTables"
     ],
     "xbrltype": "stringItemType"
    },
    "cve_SetoffOfTax": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Set-off of tax.",
        "label": "Setoff Of Tax",
        "negatedLabel": "Set-off of tax",
        "terseLabel": "Set-off of tax"
       }
      }
     },
     "localname": "SetoffOfTax",
     "nsuri": "http://encoreuranium.com/20221231",
     "presentation": [
      "http://encoreuranium.com/role/ScheduleofdeferredtaxliabilitiesTable",
      "http://encoreuranium.com/role/ScheduleofincometaxexpenserecoveryTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cve_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisedWarrantsExercised": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of non-option equity instruments exercised by participants.",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercised Warrants Exercised",
        "terseLabel": "Warrants, Exercised"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisedWarrantsExercised",
     "nsuri": "http://encoreuranium.com/20221231",
     "presentation": [
      "http://encoreuranium.com/role/ScheduleofthestatusofthecompanyswarrantsTable"
     ],
     "xbrltype": "sharesItemType"
    },
    "cve_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWarrantsExpired": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For presentations that combine terminations, the number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan or that expired.",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Warrants Expired",
        "terseLabel": "Warrants, Expired"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWarrantsExpired",
     "nsuri": "http://encoreuranium.com/20221231",
     "presentation": [
      "http://encoreuranium.com/role/ScheduleofthestatusofthecompanyswarrantsTable"
     ],
     "xbrltype": "sharesItemType"
    },
    "cve_ShareBasedCompensationArrangementBySharesBasedPaymentAwardOptionsGrantsInPeriodWarrantsGranted": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Net number of share options (or share units) granted during the period.",
        "label": "Share Based Compensation Arrangement By Shares Based Payment Award Options Grants In Period Warrants Granted",
        "terseLabel": "Warrants, Granted"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementBySharesBasedPaymentAwardOptionsGrantsInPeriodWarrantsGranted",
     "nsuri": "http://encoreuranium.com/20221231",
     "presentation": [
      "http://encoreuranium.com/role/ScheduleofthestatusofthecompanyswarrantsTable"
     ],
     "xbrltype": "sharesItemType"
    },
    "cve_ShareBasedCompensationArrangementsBySharesBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average price at which grantees could have acquired the underlying shares with respect to stock options of the plan that expired.",
        "label": "Share Based Compensation Arrangements By Shares Based Payment Award Options Expirations In Period Weighted Average Exercise Price",
        "terseLabel": "Weighted average exercise price, Expired"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsBySharesBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://encoreuranium.com/20221231",
     "presentation": [
      "http://encoreuranium.com/role/ScheduleofthestatusofthecompanyswarrantsTable"
     ],
     "xbrltype": "perShareItemType"
    },
    "cve_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptionsWarrantsOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of shares reserved for issuance pertaining to the outstanding stock options as of the balance sheet date for all option plans in the customized range of exercise prices.",
        "label": "Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Outstanding Options Warrants Outstanding",
        "periodEndLabel": "Warrants, Warrants outstanding, end of year",
        "periodStartLabel": "Warrants, Warrants outstanding, beginning of year"
       }
      }
     },
     "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptionsWarrantsOutstanding",
     "nsuri": "http://encoreuranium.com/20221231",
     "presentation": [
      "http://encoreuranium.com/role/ScheduleofthestatusofthecompanyswarrantsTable"
     ],
     "xbrltype": "sharesItemType"
    },
    "cve_ShareCapitalDetailsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share Capital (Details) [Line Items]"
       }
      }
     },
     "localname": "ShareCapitalDetailsLineItems",
     "nsuri": "http://encoreuranium.com/20221231",
     "presentation": [
      "http://encoreuranium.com/role/ShareCapitalDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "cve_ShareCapitalDetailsScheduleofsharepurchasewarrantsoutstandingLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share Capital (Details) - Schedule of share purchase warrants outstanding [Line Items]"
       }
      }
     },
     "localname": "ShareCapitalDetailsScheduleofsharepurchasewarrantsoutstandingLineItems",
     "nsuri": "http://encoreuranium.com/20221231",
     "presentation": [
      "http://encoreuranium.com/role/ScheduleofsharepurchasewarrantsoutstandingTable"
     ],
     "xbrltype": "stringItemType"
    },
    "cve_ShareCapitalDetailsScheduleofsharepurchasewarrantsoutstandingTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share Capital (Details) - Schedule of share purchase warrants outstanding [Table]"
       }
      }
     },
     "localname": "ShareCapitalDetailsScheduleofsharepurchasewarrantsoutstandingTable",
     "nsuri": "http://encoreuranium.com/20221231",
     "presentation": [
      "http://encoreuranium.com/role/ScheduleofsharepurchasewarrantsoutstandingTable"
     ],
     "xbrltype": "stringItemType"
    },
    "cve_ShareCapitalDetailsScheduleofstockoptionsoutstandingLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share Capital (Details) - Schedule of stock options outstanding [Line Items]"
       }
      }
     },
     "localname": "ShareCapitalDetailsScheduleofstockoptionsoutstandingLineItems",
     "nsuri": "http://encoreuranium.com/20221231",
     "presentation": [
      "http://encoreuranium.com/role/ScheduleofstockoptionsoutstandingTable"
     ],
     "xbrltype": "stringItemType"
    },
    "cve_ShareCapitalDetailsScheduleofstockoptionsoutstandingTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share Capital (Details) - Schedule of stock options outstanding [Table]"
       }
      }
     },
     "localname": "ShareCapitalDetailsScheduleofstockoptionsoutstandingTable",
     "nsuri": "http://encoreuranium.com/20221231",
     "presentation": [
      "http://encoreuranium.com/role/ScheduleofstockoptionsoutstandingTable"
     ],
     "xbrltype": "stringItemType"
    },
    "cve_ShareCapitalDetailsTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share Capital (Details) [Table]"
       }
      }
     },
     "localname": "ShareCapitalDetailsTable",
     "nsuri": "http://encoreuranium.com/20221231",
     "presentation": [
      "http://encoreuranium.com/role/ShareCapitalDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "cve_ShareCapitalLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share Capital [Abstract]"
       }
      }
     },
     "localname": "ShareCapitalLineItems",
     "nsuri": "http://encoreuranium.com/20221231",
     "presentation": [
      "http://encoreuranium.com/role/ShareCapital"
     ],
     "xbrltype": "stringItemType"
    },
    "cve_ShareCapitalTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share Capital [Table]"
       }
      }
     },
     "localname": "ShareCapitalTable",
     "nsuri": "http://encoreuranium.com/20221231",
     "presentation": [
      "http://encoreuranium.com/role/ShareCapital"
     ],
     "xbrltype": "stringItemType"
    },
    "cve_ShareCapitalTablesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share Capital Tables Line Items",
        "terseLabel": "Share Capital [Abstract]"
       }
      }
     },
     "localname": "ShareCapitalTablesLineItems",
     "nsuri": "http://encoreuranium.com/20221231",
     "presentation": [
      "http://encoreuranium.com/role/ShareCapitalTables"
     ],
     "xbrltype": "stringItemType"
    },
    "cve_ShareCapitalTablesTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share Capital (Tables) [Table]"
       }
      }
     },
     "localname": "ShareCapitalTablesTable",
     "nsuri": "http://encoreuranium.com/20221231",
     "presentation": [
      "http://encoreuranium.com/role/ShareCapitalTables"
     ],
     "xbrltype": "stringItemType"
    },
    "cve_ShareConsiderationAmount": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of share consideration.",
        "label": "Share Consideration Amount",
        "terseLabel": "Share Consideration (in Dollars)"
       }
      }
     },
     "localname": "ShareConsiderationAmount",
     "nsuri": "http://encoreuranium.com/20221231",
     "presentation": [
      "http://encoreuranium.com/role/AssetacquisitionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cve_ShareConsolidation": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share consolidation.",
        "label": "Share Consolidation",
        "terseLabel": "Share consolidation"
       }
      }
     },
     "localname": "ShareConsolidation",
     "nsuri": "http://encoreuranium.com/20221231",
     "presentation": [
      "http://encoreuranium.com/role/AssetacquisitionDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "cve_ShareIssueCosts": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share issue costs.",
        "label": "Share Issue Costs",
        "terseLabel": "Share issue costs"
       }
      }
     },
     "localname": "ShareIssueCosts",
     "nsuri": "http://encoreuranium.com/20221231",
     "presentation": [
      "http://encoreuranium.com/role/ScheduleoffederalandprovincialcorporatetaxratestoincomebeforetaxTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cve_ShareIssued": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Shares issued.",
        "label": "Share Issued",
        "terseLabel": "Shares issued"
       }
      }
     },
     "localname": "ShareIssued",
     "nsuri": "http://encoreuranium.com/20221231",
     "presentation": [
      "http://encoreuranium.com/role/ShareCapitalDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "cve_SharePurchaseWarrants": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share purchase warrants.",
        "label": "Share Purchase Warrants",
        "terseLabel": "Share purchase warrants"
       }
      }
     },
     "localname": "SharePurchaseWarrants",
     "nsuri": "http://encoreuranium.com/20221231",
     "presentation": [
      "http://encoreuranium.com/role/AssetacquisitionDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "cve_ShareSubscriptionsReceived": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share subscriptions received.",
        "label": "Share Subscriptions Received",
        "terseLabel": "Share subscriptions received"
       }
      }
     },
     "localname": "ShareSubscriptionsReceived",
     "nsuri": "http://encoreuranium.com/20221231",
     "presentation": [
      "http://encoreuranium.com/role/ShareholdersEquityType2or3"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cve_ShareSubscriptionsValue": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of share subscriptions value.",
        "label": "Share Subscriptions Value",
        "terseLabel": "Share subscriptions value"
       }
      }
     },
     "localname": "ShareSubscriptionsValue",
     "nsuri": "http://encoreuranium.com/20221231",
     "presentation": [
      "http://encoreuranium.com/role/SignificantaccountingpoliciesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cve_SharesBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.",
        "label": "Shares Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number",
        "periodEndLabel": "Options, Options outstanding, end of year",
        "periodStartLabel": "Options, Options outstanding, beginning of year"
       }
      }
     },
     "localname": "SharesBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber",
     "nsuri": "http://encoreuranium.com/20221231",
     "presentation": [
      "http://encoreuranium.com/role/ScheduleofthecompanysstockoptionsoutstandingTable"
     ],
     "xbrltype": "sharesItemType"
    },
    "cve_SharesBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Gross number of share options (or share units) granted during the period.",
        "label": "Shares Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross",
        "terseLabel": "Options, Granted"
       }
      }
     },
     "localname": "SharesBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross",
     "nsuri": "http://encoreuranium.com/20221231",
     "presentation": [
      "http://encoreuranium.com/role/ScheduleofthecompanysstockoptionsoutstandingTable"
     ],
     "xbrltype": "sharesItemType"
    },
    "cve_SharesBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingPeriodIncreaseDecreaseWeightedAverageExercisePrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Change in the weighted average exercise price of options outstanding.",
        "label": "Shares Based Compensation Arrangement By Share Based Payment Award Options Outstanding Period Increase Decrease Weighted Average Exercise Price",
        "periodEndLabel": "Weighted average exercise price, Warrants outstanding, end of year",
        "periodStartLabel": "Weighted average exercise price, Warrants outstanding, beginning of year"
       }
      }
     },
     "localname": "SharesBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingPeriodIncreaseDecreaseWeightedAverageExercisePrice",
     "nsuri": "http://encoreuranium.com/20221231",
     "presentation": [
      "http://encoreuranium.com/role/ScheduleofthestatusofthecompanyswarrantsTable"
     ],
     "xbrltype": "perShareItemType"
    },
    "cve_SharesBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.",
        "label": "Shares Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price",
        "terseLabel": "Options"
       }
      }
     },
     "localname": "SharesBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice",
     "nsuri": "http://encoreuranium.com/20221231",
     "presentation": [
      "http://encoreuranium.com/role/ScheduleofstockoptionsoutstandingTable"
     ],
     "xbrltype": "sharesItemType"
    },
    "cve_SharesBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of fully vested and expected to vest exercisable options that may be converted into shares under option plan. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.",
        "label": "Shares Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Number",
        "terseLabel": "Options Exercisable, Options"
       }
      }
     },
     "localname": "SharesBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber",
     "nsuri": "http://encoreuranium.com/20221231",
     "presentation": [
      "http://encoreuranium.com/role/ScheduleofstockoptionsoutstandingTable"
     ],
     "xbrltype": "sharesItemType"
    },
    "cve_SharesBasedCompensationArrangementBySharesBasedPaymentAwardOptionsOutstandingPeriodIncreaseDecreaseWeightedAverageExercisePrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Change in the weighted average exercise price of options outstanding.",
        "label": "Shares Based Compensation Arrangement By Shares Based Payment Award Options Outstanding Period Increase Decrease Weighted Average Exercise Price",
        "terseLabel": "Weighted average exercise price, Exercised"
       }
      }
     },
     "localname": "SharesBasedCompensationArrangementBySharesBasedPaymentAwardOptionsOutstandingPeriodIncreaseDecreaseWeightedAverageExercisePrice",
     "nsuri": "http://encoreuranium.com/20221231",
     "presentation": [
      "http://encoreuranium.com/role/ScheduleofthestatusofthecompanyswarrantsTable"
     ],
     "xbrltype": "perShareItemType"
    },
    "cve_SharesBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of shares reserved for issuance pertaining to the outstanding exercisable stock options as of the balance sheet date in the customized range of exercise prices for which the market and performance vesting condition has been satisfied.",
        "label": "Shares Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Exercisable Options",
        "terseLabel": "Options, Options exercisable, end of year"
       }
      }
     },
     "localname": "SharesBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions",
     "nsuri": "http://encoreuranium.com/20221231",
     "presentation": [
      "http://encoreuranium.com/role/ScheduleofthecompanysstockoptionsoutstandingTable"
     ],
     "xbrltype": "sharesItemType"
    },
    "cve_SharesIssuedForAzargaAssetAcquisition": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Shares issued for azarga asset acquisition.",
        "label": "Shares Issued For Azarga Asset Acquisition",
        "terseLabel": "Shares issued for Azarga asset acquisition (Note 10)"
       }
      }
     },
     "localname": "SharesIssuedForAzargaAssetAcquisition",
     "nsuri": "http://encoreuranium.com/20221231",
     "presentation": [
      "http://encoreuranium.com/role/ShareholdersEquityType2or3"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cve_SharesIssuedForAzargaAssetAcquisitionNote10Shares": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Shares issued for Azarga asset acquisition(Shares).",
        "label": "Shares Issued For Azarga Asset Acquisition Note10 Shares",
        "terseLabel": "Shares issued for Azarga asset acquisition (Note 10) (in Shares)"
       }
      }
     },
     "localname": "SharesIssuedForAzargaAssetAcquisitionNote10Shares",
     "nsuri": "http://encoreuranium.com/20221231",
     "presentation": [
      "http://encoreuranium.com/role/ShareholdersEquityType2or3"
     ],
     "xbrltype": "sharesItemType"
    },
    "cve_SharesIssuedForExerciseOfStockOptionsShares": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Shares issued for exercise of stock options(Shares).",
        "label": "Shares Issued For Exercise Of Stock Options Shares",
        "terseLabel": "Shares issued for exercise of stock options (in Shares)"
       }
      }
     },
     "localname": "SharesIssuedForExerciseOfStockOptionsShares",
     "nsuri": "http://encoreuranium.com/20221231",
     "presentation": [
      "http://encoreuranium.com/role/ShareholdersEquityType2or3"
     ],
     "xbrltype": "sharesItemType"
    },
    "cve_SharesIssuedForExerciseOfWarrantsShares": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Shares issued for exercise of warrants(Shares).",
        "label": "Shares Issued For Exercise Of Warrants Shares",
        "terseLabel": "Shares issued for exercise of warrants (in Shares)"
       }
      }
     },
     "localname": "SharesIssuedForExerciseOfWarrantsShares",
     "nsuri": "http://encoreuranium.com/20221231",
     "presentation": [
      "http://encoreuranium.com/role/ShareholdersEquityType2or3"
     ],
     "xbrltype": "sharesItemType"
    },
    "cve_SharesIssuedForServicesShares": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Shares issued for services(Shares).",
        "label": "Shares Issued For Services Shares",
        "terseLabel": "Shares issued for services (in Shares)"
       }
      }
     },
     "localname": "SharesIssuedForServicesShares",
     "nsuri": "http://encoreuranium.com/20221231",
     "presentation": [
      "http://encoreuranium.com/role/ShareholdersEquityType2or3"
     ],
     "xbrltype": "sharesItemType"
    },
    "cve_SharesUnit": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Shares are units of equity ownership in a corporation. For some companies, shares exist as a financial asset providing for an equal distribution of any residual profits, if any are declared, in the form of dividends. Shareholders of a stock that pays no dividends do not participate in a distribution of profits. Instead, they anticipate participating in the growth of the stock price as company profits increase.",
        "label": "Shares Unit",
        "terseLabel": "Shares unit"
       }
      }
     },
     "localname": "SharesUnit",
     "nsuri": "http://encoreuranium.com/20221231",
     "presentation": [
      "http://encoreuranium.com/role/ShareCapitalDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "cve_SharesbasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the weighted-average grant-date fair value of equity options or other equity instruments granted during the year.",
        "label": "Sharesbased Compensation Arrangement By Sharebased Payment Award Options Vested Weighted Average Grant Date Fair Value",
        "terseLabel": "Weighted average exercise price, Granted"
       }
      }
     },
     "localname": "SharesbasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue",
     "nsuri": "http://encoreuranium.com/20221231",
     "presentation": [
      "http://encoreuranium.com/role/ScheduleofthestatusofthecompanyswarrantsTable"
     ],
     "xbrltype": "perShareItemType"
    },
    "cve_SignalEquitiesDatabaseMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Signal Equities Database Member",
        "terseLabel": "Signal Equities Database [Member]"
       }
      }
     },
     "localname": "SignalEquitiesDatabaseMember",
     "nsuri": "http://encoreuranium.com/20221231",
     "presentation": [
      "http://encoreuranium.com/role/ScheduleofintangibleassetwasdeterminedTable"
     ],
     "xbrltype": "domainItemType"
    },
    "cve_SignificantaccountingpoliciesDetailsScheduleofexchangeratesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of exchange rates [Abstract]"
       }
      }
     },
     "localname": "SignificantaccountingpoliciesDetailsScheduleofexchangeratesLineItems",
     "nsuri": "http://encoreuranium.com/20221231",
     "presentation": [
      "http://encoreuranium.com/role/ScheduleofexchangeratesTable"
     ],
     "xbrltype": "stringItemType"
    },
    "cve_SignificantaccountingpoliciesDetailsScheduleofexchangeratesTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Significant accounting policies (Details) - Schedule of exchange rates [Table]"
       }
      }
     },
     "localname": "SignificantaccountingpoliciesDetailsScheduleofexchangeratesTable",
     "nsuri": "http://encoreuranium.com/20221231",
     "presentation": [
      "http://encoreuranium.com/role/ScheduleofexchangeratesTable"
     ],
     "xbrltype": "stringItemType"
    },
    "cve_SignificantaccountingpoliciesDetailsScheduleofsignificantsubsidiariesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of significant subsidiaries [Abstract]"
       }
      }
     },
     "localname": "SignificantaccountingpoliciesDetailsScheduleofsignificantsubsidiariesLineItems",
     "nsuri": "http://encoreuranium.com/20221231",
     "presentation": [
      "http://encoreuranium.com/role/ScheduleofsignificantsubsidiariesTable"
     ],
     "xbrltype": "stringItemType"
    },
    "cve_SignificantaccountingpoliciesDetailsScheduleofsignificantsubsidiariesTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Significant accounting policies (Details) - Schedule of significant subsidiaries [Table]"
       }
      }
     },
     "localname": "SignificantaccountingpoliciesDetailsScheduleofsignificantsubsidiariesTable",
     "nsuri": "http://encoreuranium.com/20221231",
     "presentation": [
      "http://encoreuranium.com/role/ScheduleofsignificantsubsidiariesTable"
     ],
     "xbrltype": "stringItemType"
    },
    "cve_SignificantaccountingpoliciesDetailsScheduleofusefullivesofintangibleassetsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of useful lives of intangible assets [Abstract]"
       }
      }
     },
     "localname": "SignificantaccountingpoliciesDetailsScheduleofusefullivesofintangibleassetsLineItems",
     "nsuri": "http://encoreuranium.com/20221231",
     "presentation": [
      "http://encoreuranium.com/role/ScheduleofusefullivesofintangibleassetsTable"
     ],
     "xbrltype": "stringItemType"
    },
    "cve_SignificantaccountingpoliciesDetailsScheduleofusefullivesofintangibleassetsTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Significant accounting policies (Details) - Schedule of useful lives of intangible assets [Table]"
       }
      }
     },
     "localname": "SignificantaccountingpoliciesDetailsScheduleofusefullivesofintangibleassetsTable",
     "nsuri": "http://encoreuranium.com/20221231",
     "presentation": [
      "http://encoreuranium.com/role/ScheduleofusefullivesofintangibleassetsTable"
     ],
     "xbrltype": "stringItemType"
    },
    "cve_SignificantaccountingpoliciesDetailsScheduleofusefullivesofpropertyplantandequipementLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of useful lives of property, plant and equipement [Abstract]"
       }
      }
     },
     "localname": "SignificantaccountingpoliciesDetailsScheduleofusefullivesofpropertyplantandequipementLineItems",
     "nsuri": "http://encoreuranium.com/20221231",
     "presentation": [
      "http://encoreuranium.com/role/ScheduleofusefullivesofpropertyplantandequipementTable"
     ],
     "xbrltype": "stringItemType"
    },
    "cve_SignificantaccountingpoliciesDetailsScheduleofusefullivesofpropertyplantandequipementTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Significant accounting policies (Details) - Schedule of useful lives of property, plant and equipement [Table]"
       }
      }
     },
     "localname": "SignificantaccountingpoliciesDetailsScheduleofusefullivesofpropertyplantandequipementTable",
     "nsuri": "http://encoreuranium.com/20221231",
     "presentation": [
      "http://encoreuranium.com/role/ScheduleofusefullivesofpropertyplantandequipementTable"
     ],
     "xbrltype": "stringItemType"
    },
    "cve_SignificantaccountingpoliciesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Significantaccountingpolicies Line Items",
        "terseLabel": "Significant accounting policies [Abstract]"
       }
      }
     },
     "localname": "SignificantaccountingpoliciesLineItems",
     "nsuri": "http://encoreuranium.com/20221231",
     "presentation": [
      "http://encoreuranium.com/role/Significantaccountingpolicies"
     ],
     "xbrltype": "stringItemType"
    },
    "cve_SignificantaccountingpoliciesTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Significant accounting policies [Table]"
       }
      }
     },
     "localname": "SignificantaccountingpoliciesTable",
     "nsuri": "http://encoreuranium.com/20221231",
     "presentation": [
      "http://encoreuranium.com/role/Significantaccountingpolicies"
     ],
     "xbrltype": "stringItemType"
    },
    "cve_SignificantaccountingpoliciesTablesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Significantaccountingpolicies Tables Line Items",
        "terseLabel": "Significant accounting policies [Abstract]"
       }
      }
     },
     "localname": "SignificantaccountingpoliciesTablesLineItems",
     "nsuri": "http://encoreuranium.com/20221231",
     "presentation": [
      "http://encoreuranium.com/role/SignificantaccountingpoliciesTables"
     ],
     "xbrltype": "stringItemType"
    },
    "cve_SignificantaccountingpoliciesTablesTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Significant accounting policies (Tables) [Table]"
       }
      }
     },
     "localname": "SignificantaccountingpoliciesTablesTable",
     "nsuri": "http://encoreuranium.com/20221231",
     "presentation": [
      "http://encoreuranium.com/role/SignificantaccountingpoliciesTables"
     ],
     "xbrltype": "stringItemType"
    },
    "cve_SoftwareMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Software Member",
        "terseLabel": "Software [Member]"
       }
      }
     },
     "localname": "SoftwareMember",
     "nsuri": "http://encoreuranium.com/20221231",
     "presentation": [
      "http://encoreuranium.com/role/ScheduleofpropertyplantandequipmentTable",
      "http://encoreuranium.com/role/ScheduleofusefullivesofpropertyplantandequipementTable"
     ],
     "xbrltype": "domainItemType"
    },
    "cve_StaffCosts": {
     "auth_ref": [],
     "calculation": {
      "http://encoreuranium.com/role/ScheduleofconsolidatedstatementsoflossandcomprehensivelossTable": {
       "order": 13.0,
       "parentTag": "ifrs-full_OtherOperatingIncomeExpense",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Staff costs.",
        "label": "Staff Costs",
        "terseLabel": "Staff costs"
       }
      }
     },
     "localname": "StaffCosts",
     "nsuri": "http://encoreuranium.com/20221231",
     "presentation": [
      "http://encoreuranium.com/role/ScheduleofamountspaidtokeymanagementorentitiesprovidingsimilarservicesTable",
      "http://encoreuranium.com/role/ScheduleofconsolidatedstatementsoflossandcomprehensivelossTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cve_StandardStockOptionVestingPercentage": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Standard stock option vesting percentage.",
        "label": "Standard Stock Option Vesting Percentage",
        "terseLabel": "Standard stock option vesting percentage"
       }
      }
     },
     "localname": "StandardStockOptionVestingPercentage",
     "nsuri": "http://encoreuranium.com/20221231",
     "presentation": [
      "http://encoreuranium.com/role/ShareCapitalDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "cve_StockIssuedDuringPeriodShareSharesBasedCompensationForfeited": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares (or other type of equity) forfeited during the period.",
        "label": "Stock Issued During Period Share Shares Based Compensation Forfeited",
        "terseLabel": "Options, Forfeited/expired"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodShareSharesBasedCompensationForfeited",
     "nsuri": "http://encoreuranium.com/20221231",
     "presentation": [
      "http://encoreuranium.com/role/ScheduleofthecompanysstockoptionsoutstandingTable"
     ],
     "xbrltype": "sharesItemType"
    },
    "cve_StockIssuedDuringPeriodShareStockOptionsExercised": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of share options (or share units) exercised during the current period.",
        "label": "Stock Issued During Period Share Stock Options Exercised",
        "terseLabel": "Options, Exercised"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodShareStockOptionsExercised",
     "nsuri": "http://encoreuranium.com/20221231",
     "presentation": [
      "http://encoreuranium.com/role/ScheduleofthecompanysstockoptionsoutstandingTable"
     ],
     "xbrltype": "sharesItemType"
    },
    "cve_StockOptionExpense": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock option expense.",
        "label": "Stock Option Expense",
        "terseLabel": "Stock option expense"
       }
      }
     },
     "localname": "StockOptionExpense",
     "nsuri": "http://encoreuranium.com/20221231",
     "presentation": [
      "http://encoreuranium.com/role/ShareholdersEquityType2or3"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cve_StockOptions": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stock Options",
        "terseLabel": "Stock Options"
       }
      }
     },
     "localname": "StockOptions",
     "nsuri": "http://encoreuranium.com/20221231",
     "presentation": [
      "http://encoreuranium.com/role/AssetacquisitionDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "cve_StockOptionsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stock Options Member",
        "terseLabel": "Stock Options [Member]"
       }
      }
     },
     "localname": "StockOptionsMember",
     "nsuri": "http://encoreuranium.com/20221231",
     "presentation": [
      "http://encoreuranium.com/role/ShareCapitalDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cve_StockOptionsRevisedTerm": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock options revised term",
        "label": "Stock Options Revised Term",
        "terseLabel": "Stock options revised term"
       }
      }
     },
     "localname": "StockOptionsRevisedTerm",
     "nsuri": "http://encoreuranium.com/20221231",
     "presentation": [
      "http://encoreuranium.com/role/ShareCapitalDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "cve_StockOptionsSharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock options shares outstanding.",
        "label": "Stock Options Shares Outstanding",
        "terseLabel": "Stock options shares outstanding (in Shares)"
       }
      }
     },
     "localname": "StockOptionsSharesOutstanding",
     "nsuri": "http://encoreuranium.com/20221231",
     "presentation": [
      "http://encoreuranium.com/role/EventsafterthereportingperiodDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "cve_SubsequentEventFourMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsequent Event Four Member",
        "terseLabel": "Subsequent Event [Member]"
       }
      }
     },
     "localname": "SubsequentEventFourMember",
     "nsuri": "http://encoreuranium.com/20221231",
     "presentation": [
      "http://encoreuranium.com/role/EventsafterthereportingperiodDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cve_SubsequentEventOneMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsequent Event One Member",
        "terseLabel": "Subsequent [Member]",
        "verboseLabel": "Subsequent Event [Member]"
       }
      }
     },
     "localname": "SubsequentEventOneMember",
     "nsuri": "http://encoreuranium.com/20221231",
     "presentation": [
      "http://encoreuranium.com/role/EventsafterthereportingperiodDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cve_SubsequentEventThreeMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsequent Event Three Member",
        "terseLabel": "Subsequent Event [Member]"
       }
      }
     },
     "localname": "SubsequentEventThreeMember",
     "nsuri": "http://encoreuranium.com/20221231",
     "presentation": [
      "http://encoreuranium.com/role/EventsafterthereportingperiodDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cve_SubsequentEventTwoMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsequent Event Two Member",
        "terseLabel": "Subsequent Event [Member]"
       }
      }
     },
     "localname": "SubsequentEventTwoMember",
     "nsuri": "http://encoreuranium.com/20221231",
     "presentation": [
      "http://encoreuranium.com/role/EventsafterthereportingperiodDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cve_SupplementalDisclosureWithRespectToCashflowsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Supplemental Disclosure With Respect To Cashflows Abstract"
       }
      }
     },
     "localname": "SupplementalDisclosureWithRespectToCashflowsAbstract",
     "nsuri": "http://encoreuranium.com/20221231",
     "xbrltype": "stringItemType"
    },
    "cve_SupplementalDisclosureWithRespectToCashflowsTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Supplemental Disclosure With Respect To Cashflows Text Block",
        "terseLabel": "Supplemental disclosure with respect to cash flows"
       }
      }
     },
     "localname": "SupplementalDisclosureWithRespectToCashflowsTextBlock",
     "nsuri": "http://encoreuranium.com/20221231",
     "presentation": [
      "http://encoreuranium.com/role/Supplementaldisclosurewithrespecttocashflows"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cve_TicabooMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Ticaboo Member",
        "terseLabel": "Ticaboo [Member]"
       }
      }
     },
     "localname": "TicabooMember",
     "nsuri": "http://encoreuranium.com/20221231",
     "presentation": [
      "http://encoreuranium.com/role/ScheduleofassetretirementobligationsbalanceTable"
     ],
     "xbrltype": "domainItemType"
    },
    "cve_TigrisUraniumUSCorpMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Tigris Uranium USCorp Member",
        "terseLabel": "Tigris Uranium US Corp. [Member]"
       }
      }
     },
     "localname": "TigrisUraniumUSCorpMember",
     "nsuri": "http://encoreuranium.com/20221231",
     "presentation": [
      "http://encoreuranium.com/role/ScheduleofsignificantsubsidiariesTable"
     ],
     "xbrltype": "domainItemType"
    },
    "cve_TintinaHoldingsLtdMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Tintina Holdings Ltd Member",
        "terseLabel": "Tintina Holdings, Ltd [Member]"
       }
      }
     },
     "localname": "TintinaHoldingsLtdMember",
     "nsuri": "http://encoreuranium.com/20221231",
     "presentation": [
      "http://encoreuranium.com/role/ScheduleofowingtorelatedpartiesTable"
     ],
     "xbrltype": "domainItemType"
    },
    "cve_TotalConsideration": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of Total Consideration.",
        "label": "Total Consideration",
        "terseLabel": "Total consideration"
       }
      }
     },
     "localname": "TotalConsideration",
     "nsuri": "http://encoreuranium.com/20221231",
     "presentation": [
      "http://encoreuranium.com/role/InvestmentinuraniumDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cve_TotalConsiderationPerPounds": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total consideration per pound.",
        "label": "Total Consideration Per Pounds",
        "terseLabel": "Total consideration per pound (in Dollars per share)"
       }
      }
     },
     "localname": "TotalConsiderationPerPounds",
     "nsuri": "http://encoreuranium.com/20221231",
     "presentation": [
      "http://encoreuranium.com/role/EventsafterthereportingperiodDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "cve_TotalConsiderationPerShare": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of total consideration per share.",
        "label": "Total Consideration Per Share",
        "terseLabel": "Total consideration per share (in Dollars per share)"
       }
      }
     },
     "localname": "TotalConsiderationPerShare",
     "nsuri": "http://encoreuranium.com/20221231",
     "presentation": [
      "http://encoreuranium.com/role/InvestmentinuraniumDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "cve_TotalConsiderationValue": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total consideration value.",
        "label": "Total Consideration Value",
        "terseLabel": "Total consideration value"
       }
      }
     },
     "localname": "TotalConsiderationValue",
     "nsuri": "http://encoreuranium.com/20221231",
     "presentation": [
      "http://encoreuranium.com/role/ScheduleofestimatedfairvalueofassetsandliabilitiesTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cve_TotalDiscountedMarketPrices": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total discounted market prices.",
        "label": "Total Discounted Market Prices",
        "terseLabel": "Total discounted market prices"
       }
      }
     },
     "localname": "TotalDiscountedMarketPrices",
     "nsuri": "http://encoreuranium.com/20221231",
     "presentation": [
      "http://encoreuranium.com/role/SalescontractsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cve_TotalNoncashFinancingActivities": {
     "auth_ref": [],
     "calculation": {
      "http://encoreuranium.com/role/ScheduleofincurrednoncashfinancingandinvestingactivitiesTable": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of non cash financing activities.",
        "label": "Total Noncash Financing Activities",
        "totalLabel": "Total non-cash financing activities"
       }
      }
     },
     "localname": "TotalNoncashFinancingActivities",
     "nsuri": "http://encoreuranium.com/20221231",
     "presentation": [
      "http://encoreuranium.com/role/ScheduleofincurrednoncashfinancingandinvestingactivitiesTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cve_TotalNoncashInvestingActivities": {
     "auth_ref": [],
     "calculation": {
      "http://encoreuranium.com/role/ScheduleofincurrednoncashfinancingandinvestingactivitiesTable": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Noncash Investing Activities",
        "totalLabel": "Total non-cash investing activities"
       }
      }
     },
     "localname": "TotalNoncashInvestingActivities",
     "nsuri": "http://encoreuranium.com/20221231",
     "presentation": [
      "http://encoreuranium.com/role/ScheduleofincurrednoncashfinancingandinvestingactivitiesTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cve_TotalPurchasePrice": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of Purchase Price.",
        "label": "Total Purchase Price",
        "terseLabel": "Total Purchase Price"
       }
      }
     },
     "localname": "TotalPurchasePrice",
     "nsuri": "http://encoreuranium.com/20221231",
     "presentation": [
      "http://encoreuranium.com/role/ScheduleofuraniumconcentratespurchaseagreementTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cve_TradingShares": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading shares.",
        "label": "Trading Shares",
        "terseLabel": "Trading shares"
       }
      }
     },
     "localname": "TradingShares",
     "nsuri": "http://encoreuranium.com/20221231",
     "presentation": [
      "http://encoreuranium.com/role/MarketableSecuritiesDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "cve_TradingSharesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Shares Member",
        "terseLabel": "Trading Shares [Member]"
       }
      }
     },
     "localname": "TradingSharesMember",
     "nsuri": "http://encoreuranium.com/20221231",
     "presentation": [
      "http://encoreuranium.com/role/MarketableSecuritiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cve_TransactionCost": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Transaction cost.",
        "label": "Transaction Cost",
        "terseLabel": "Transaction cost"
       }
      }
     },
     "localname": "TransactionCost",
     "nsuri": "http://encoreuranium.com/20221231",
     "presentation": [
      "http://encoreuranium.com/role/EventsafterthereportingperiodDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cve_TransactionCosts": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Transaction costs.",
        "label": "Transaction Costs",
        "terseLabel": "Transaction costs",
        "verboseLabel": "Transaction cost"
       }
      }
     },
     "localname": "TransactionCosts",
     "nsuri": "http://encoreuranium.com/20221231",
     "presentation": [
      "http://encoreuranium.com/role/EventsafterthereportingperiodDetails",
      "http://encoreuranium.com/role/ScheduleofestimatedfairvalueofassetsandliabilitiesTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cve_TransactionCostsOnAzargaAssetAcquisition": {
     "auth_ref": [],
     "calculation": {
      "http://encoreuranium.com/role/ConsolidatedCashFlow": {
       "order": 2.0,
       "parentTag": "ifrs-full_CashFlowsFromUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Transaction Costs On Azarga Asset Acquisition",
        "terseLabel": "Transaction costs on Azarga asset acquisition"
       }
      }
     },
     "localname": "TransactionCostsOnAzargaAssetAcquisition",
     "nsuri": "http://encoreuranium.com/20221231",
     "presentation": [
      "http://encoreuranium.com/role/ConsolidatedCashFlow"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cve_TransferAgentAndFilingFees": {
     "auth_ref": [],
     "calculation": {
      "http://encoreuranium.com/role/ConsolidatedComprehensiveIncome": {
       "order": 14.0,
       "parentTag": "ifrs-full_ProfitLossFromOperatingActivities",
       "weight": -1.0
      },
      "http://encoreuranium.com/role/ScheduleofconsolidatedstatementsoflossandcomprehensivelossTable": {
       "order": 12.0,
       "parentTag": "ifrs-full_OtherOperatingIncomeExpense",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Transfer agent and filing fees",
        "label": "Transfer Agent And Filing Fees",
        "terseLabel": "Transfer agent and filing fees"
       }
      }
     },
     "localname": "TransferAgentAndFilingFees",
     "nsuri": "http://encoreuranium.com/20221231",
     "presentation": [
      "http://encoreuranium.com/role/ConsolidatedComprehensiveIncome",
      "http://encoreuranium.com/role/ScheduleofconsolidatedstatementsoflossandcomprehensivelossTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cve_TranslatedMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Translated Member",
        "terseLabel": "Translated [Member]"
       }
      }
     },
     "localname": "TranslatedMember",
     "nsuri": "http://encoreuranium.com/20221231",
     "presentation": [
      "http://encoreuranium.com/role/ScheduleofconsolidatedstatementsoflossandcomprehensivelossTable",
      "http://encoreuranium.com/role/ScheduleofconsolidatedstatementsoflossandcomprehensivelossTable_Parentheticals",
      "http://encoreuranium.com/role/ScheduleofeffectoftranslationTable"
     ],
     "xbrltype": "domainItemType"
    },
    "cve_TriStateGenerationAndTransmissionAssociationMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Tri State Generation And Transmission Association Member",
        "terseLabel": "Tri State Generation and Transmission Association [Member]",
        "verboseLabel": "Tri State Generation and Transmission Association [Member"
       }
      }
     },
     "localname": "TriStateGenerationAndTransmissionAssociationMember",
     "nsuri": "http://encoreuranium.com/20221231",
     "presentation": [
      "http://encoreuranium.com/role/MineralPropertiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cve_TwoFourZeroThreeSevenEightMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Two Four Zero Three Seven Eight Member",
        "terseLabel": "2.40 - 3.78 [Member]"
       }
      }
     },
     "localname": "TwoFourZeroThreeSevenEightMember",
     "nsuri": "http://encoreuranium.com/20221231",
     "presentation": [
      "http://encoreuranium.com/role/ScheduleofstockoptionsoutstandingTable"
     ],
     "xbrltype": "domainItemType"
    },
    "cve_TwoTwoTwoThreeNineZeroOneMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Two Two Two Three Nine Zero One Member",
        "terseLabel": "$2.22 - 3.90 1 [Member]"
       }
      }
     },
     "localname": "TwoTwoTwoThreeNineZeroOneMember",
     "nsuri": "http://encoreuranium.com/20221231",
     "presentation": [
      "http://encoreuranium.com/role/ScheduleofsharepurchasewarrantsoutstandingTable"
     ],
     "xbrltype": "domainItemType"
    },
    "cve_URIIncMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "URIInc Member",
        "terseLabel": "URI, Inc. [Member]"
       }
      }
     },
     "localname": "URIIncMember",
     "nsuri": "http://encoreuranium.com/20221231",
     "presentation": [
      "http://encoreuranium.com/role/ScheduleofsignificantsubsidiariesTable"
     ],
     "xbrltype": "domainItemType"
    },
    "cve_URZEnergyCorpMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "URZEnergy Corp Member",
        "terseLabel": "URZ Energy Corp. [Member]"
       }
      }
     },
     "localname": "URZEnergyCorpMember",
     "nsuri": "http://encoreuranium.com/20221231",
     "presentation": [
      "http://encoreuranium.com/role/ScheduleofsignificantsubsidiariesTable"
     ],
     "xbrltype": "domainItemType"
    },
    "cve_UcoloExplorationCorpMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Ucolo Exploration Corp Member",
        "terseLabel": "Ucolo Exploration Corp. [Member]"
       }
      }
     },
     "localname": "UcoloExplorationCorpMember",
     "nsuri": "http://encoreuranium.com/20221231",
     "presentation": [
      "http://encoreuranium.com/role/ScheduleofsignificantsubsidiariesTable"
     ],
     "xbrltype": "domainItemType"
    },
    "cve_UnrealizedGainOnMarketableSecurities": {
     "auth_ref": [],
     "calculation": {
      "http://encoreuranium.com/role/ConsolidatedComprehensiveIncome": {
       "order": 8.0,
       "parentTag": "ifrs-full_ProfitLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of unrealized gain (loss) on investment in marketable security.",
        "label": "Unrealized Gain On Marketable Securities",
        "terseLabel": "Unrealized gain on marketable securities"
       }
      }
     },
     "localname": "UnrealizedGainOnMarketableSecurities",
     "nsuri": "http://encoreuranium.com/20221231",
     "presentation": [
      "http://encoreuranium.com/role/ConsolidatedComprehensiveIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cve_UnrealizedGainOnUraniumInvestment": {
     "auth_ref": [],
     "calculation": {
      "http://encoreuranium.com/role/ConsolidatedCashFlow": {
       "order": 18.0,
       "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities",
       "weight": -1.0
      },
      "http://encoreuranium.com/role/ConsolidatedComprehensiveIncome": {
       "order": 6.0,
       "parentTag": "ifrs-full_ProfitLoss",
       "weight": 1.0
      },
      "http://encoreuranium.com/role/ScheduleofconsolidatedstatementsoflossandcomprehensivelossTable": {
       "order": 8.0,
       "parentTag": "ifrs-full_NetForeignExchangeLoss",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Unrealized gain on uranium investment",
        "label": "Unrealized Gain On Uranium Investment",
        "negatedLabel": "Unrealized gain on uranium investment",
        "terseLabel": "Unrealized gain on uranium investment"
       }
      }
     },
     "localname": "UnrealizedGainOnUraniumInvestment",
     "nsuri": "http://encoreuranium.com/20221231",
     "presentation": [
      "http://encoreuranium.com/role/ConsolidatedCashFlow",
      "http://encoreuranium.com/role/ConsolidatedComprehensiveIncome",
      "http://encoreuranium.com/role/ScheduleofconsolidatedstatementsoflossandcomprehensivelossTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cve_UrancoIncMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Uranco Inc Member",
        "terseLabel": "Uranco, Inc. [Member]"
       }
      }
     },
     "localname": "UrancoIncMember",
     "nsuri": "http://encoreuranium.com/20221231",
     "presentation": [
      "http://encoreuranium.com/role/ScheduleofsignificantsubsidiariesTable"
     ],
     "xbrltype": "domainItemType"
    },
    "cve_UraniumPlantsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Uranium Plants Member",
        "terseLabel": "Uranium Plants [Member]"
       }
      }
     },
     "localname": "UraniumPlantsMember",
     "nsuri": "http://encoreuranium.com/20221231",
     "presentation": [
      "http://encoreuranium.com/role/ScheduleofpropertyplantandequipmentTable",
      "http://encoreuranium.com/role/ScheduleofusefullivesofpropertyplantandequipementTable"
     ],
     "xbrltype": "domainItemType"
    },
    "cve_UraniumResourcesIncMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Uranium Resources Inc Member",
        "terseLabel": "Uranium Resources, Inc. [Member]"
       }
      }
     },
     "localname": "UraniumResourcesIncMember",
     "nsuri": "http://encoreuranium.com/20221231",
     "presentation": [
      "http://encoreuranium.com/role/ScheduleofsignificantsubsidiariesTable"
     ],
     "xbrltype": "domainItemType"
    },
    "cve_VANEAgreementMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "VANEAgreement Member",
        "terseLabel": "VANE Agreement [Member]"
       }
      }
     },
     "localname": "VANEAgreementMember",
     "nsuri": "http://encoreuranium.com/20221231",
     "presentation": [
      "http://encoreuranium.com/role/ScheduleofintangibleassetwasdeterminedTable"
     ],
     "xbrltype": "domainItemType"
    },
    "cve_VasquezMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Vasquez Member",
        "terseLabel": "Vasquez [Member]"
       }
      }
     },
     "localname": "VasquezMember",
     "nsuri": "http://encoreuranium.com/20221231",
     "presentation": [
      "http://encoreuranium.com/role/ScheduleofassetretirementobligationsbalanceTable"
     ],
     "xbrltype": "domainItemType"
    },
    "cve_WarrantIsExercisableTerm": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Warrant is exercisable term.",
        "label": "Warrant Is Exercisable Term",
        "terseLabel": "Warrant is exercisable term"
       }
      }
     },
     "localname": "WarrantIsExercisableTerm",
     "nsuri": "http://encoreuranium.com/20221231",
     "presentation": [
      "http://encoreuranium.com/role/ShareCapitalDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "cve_WarrantShare": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "When an investor exercises a warrant, they purchase stock, and the proceeds are a source of capital for the company. A warrant certificate is issued to the investor when they exercise a warrant. The certificate includes the terms of the warrant, such as the expiry date and the final day it can be exercised.",
        "label": "Warrant Share",
        "terseLabel": "Warrant share"
       }
      }
     },
     "localname": "WarrantShare",
     "nsuri": "http://encoreuranium.com/20221231",
     "presentation": [
      "http://encoreuranium.com/role/ShareCapitalDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "cve_Warrants": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A stock warrant gives the holder the right to purchase a company's stock at a specific price and at a specific date. A stock warrant is issued directly by the company concerned; when an investor exercises a stock warrant, the shares that fulfill the obligation are not received from another investor but directly from the company.",
        "label": "Warrants",
        "terseLabel": "Warrants"
       }
      }
     },
     "localname": "Warrants",
     "nsuri": "http://encoreuranium.com/20221231",
     "presentation": [
      "http://encoreuranium.com/role/ScheduleofsharepurchasewarrantsoutstandingTable"
     ],
     "xbrltype": "sharesItemType"
    },
    "cve_WarrantsExercisableOfCommonShare": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Warrants exercisable of common share.",
        "label": "Warrants Exercisable Of Common Share",
        "terseLabel": "Warrants exercisable of common share"
       }
      }
     },
     "localname": "WarrantsExercisableOfCommonShare",
     "nsuri": "http://encoreuranium.com/20221231",
     "presentation": [
      "http://encoreuranium.com/role/ShareCapitalDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "cve_WarrantsExercisablePrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Warrants exercisable price per share.",
        "label": "Warrants Exercisable Price",
        "terseLabel": "Warrants exercisable (in Dollars per share)"
       }
      }
     },
     "localname": "WarrantsExercisablePrice",
     "nsuri": "http://encoreuranium.com/20221231",
     "presentation": [
      "http://encoreuranium.com/role/ShareCapitalDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "cve_WarrantsExercisablePricePerShare": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Warrants exercisable price per share.",
        "label": "Warrants Exercisable Price Per Share",
        "terseLabel": "Warrants exercisable price per share (in Dollars per share)"
       }
      }
     },
     "localname": "WarrantsExercisablePricePerShare",
     "nsuri": "http://encoreuranium.com/20221231",
     "presentation": [
      "http://encoreuranium.com/role/ShareCapitalDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "cve_WarrantsExercisableShare": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "When an investor exercises a warrant, they purchase stock, and the proceeds are a source of capital for the company. A warrant certificate is issued to the investor when they exercise a warrant. The certificate includes the terms of the warrant, such as the expiry date and the final day it can be exercised.",
        "label": "Warrants Exercisable Share",
        "terseLabel": "Warrants exercisable share"
       }
      }
     },
     "localname": "WarrantsExercisableShare",
     "nsuri": "http://encoreuranium.com/20221231",
     "presentation": [
      "http://encoreuranium.com/role/ShareCapitalDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "cve_WarrantsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Warrants Member",
        "terseLabel": "Warrants [Member]"
       }
      }
     },
     "localname": "WarrantsMember",
     "nsuri": "http://encoreuranium.com/20221231",
     "presentation": [
      "http://encoreuranium.com/role/ShareCapitalDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cve_WarrantsOfFairValue": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A warrant premium represents the cost of purchasing a share through exercising a warrant, compared to buying the share directly through the open market.",
        "label": "Warrants Of Fair Value",
        "terseLabel": "Warrants of fair value"
       }
      }
     },
     "localname": "WarrantsOfFairValue",
     "nsuri": "http://encoreuranium.com/20221231",
     "presentation": [
      "http://encoreuranium.com/role/ShareCapitalDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cve_WarrantsOutstandingWeightedAverageExercisePrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Warrants Outstanding, Weighted average exercise price.",
        "label": "Warrants Outstanding Weighted Average Exercise Price",
        "terseLabel": "Warrants Outstanding, Weighted average exercise price"
       }
      }
     },
     "localname": "WarrantsOutstandingWeightedAverageExercisePrice",
     "nsuri": "http://encoreuranium.com/20221231",
     "presentation": [
      "http://encoreuranium.com/role/ScheduleofsharepurchasewarrantsoutstandingTable"
     ],
     "xbrltype": "perShareItemType"
    },
    "cve_WarrantsOutstandingWeightedAverageReimainingLife": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Warrants Outstanding, Weighted average Reimaining Life.",
        "label": "Warrants Outstanding Weighted Average Reimaining Life",
        "terseLabel": "Warrants Outstanding, Weighted average Reimaining Life"
       }
      }
     },
     "localname": "WarrantsOutstandingWeightedAverageReimainingLife",
     "nsuri": "http://encoreuranium.com/20221231",
     "presentation": [
      "http://encoreuranium.com/role/ScheduleofsharepurchasewarrantsoutstandingTable"
     ],
     "xbrltype": "durationItemType"
    },
    "cve_WeightedAverageExercisePrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average exercise price.",
        "label": "Weighted Average Exercise Price",
        "terseLabel": "Weighted average exercise price (in Dollars per share)"
       }
      }
     },
     "localname": "WeightedAverageExercisePrice",
     "nsuri": "http://encoreuranium.com/20221231",
     "presentation": [
      "http://encoreuranium.com/role/EventsafterthereportingperiodDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "cve_WildcatSolarPowerPlantLLCMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Wildcat Solar Power Plant LLCMember",
        "terseLabel": "Wildcat Solar Power Plant, LLC [Member]"
       }
      }
     },
     "localname": "WildcatSolarPowerPlantLLCMember",
     "nsuri": "http://encoreuranium.com/20221231",
     "presentation": [
      "http://encoreuranium.com/role/MineralPropertiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cve_WorkingCapital": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Working capital.",
        "label": "Working Capital",
        "terseLabel": "Working capital"
       }
      }
     },
     "localname": "WorkingCapital",
     "nsuri": "http://encoreuranium.com/20221231",
     "presentation": [
      "http://encoreuranium.com/role/NatureofOperationsandGoingConcernDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cve_WriteoffOfInvestment": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Write-off of investment.",
        "label": "Writeoff Of Investment",
        "terseLabel": "Write-off of investment"
       }
      }
     },
     "localname": "WriteoffOfInvestment",
     "nsuri": "http://encoreuranium.com/20221231",
     "presentation": [
      "http://encoreuranium.com/role/ScheduleofinvestmentinassociatecontinuityTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cve_YearEndedDecember312022Abstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Year Ended December312022 Abstract",
        "terseLabel": "Year ended December 31, 2022"
       }
      }
     },
     "localname": "YearEndedDecember312022Abstract",
     "nsuri": "http://encoreuranium.com/20221231",
     "presentation": [
      "http://encoreuranium.com/role/ScheduleofproportionalshareintheassociateTable"
     ],
     "xbrltype": "stringItemType"
    },
    "cve_ZeroOneEightOneNineTwoMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Zero One Eight One Nine Two Member",
        "terseLabel": "0.18 - 1.92 [Member]"
       }
      }
     },
     "localname": "ZeroOneEightOneNineTwoMember",
     "nsuri": "http://encoreuranium.com/20221231",
     "presentation": [
      "http://encoreuranium.com/role/ScheduleofstockoptionsoutstandingTable"
     ],
     "xbrltype": "domainItemType"
    },
    "cve_enCoreEnergyUSCorpMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "en Core Energy USCorp Member",
        "terseLabel": "enCore Energy US Corp. [Member]"
       }
      }
     },
     "localname": "enCoreEnergyUSCorpMember",
     "nsuri": "http://encoreuranium.com/20221231",
     "presentation": [
      "http://encoreuranium.com/role/ScheduleofsignificantsubsidiariesTable"
     ],
     "xbrltype": "domainItemType"
    },
    "dei_AddressTypeDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "An entity may have several addresses for different purposes and this domain represents all such types.",
        "label": "Address Type [Domain]"
       }
      }
     },
     "localname": "AddressTypeDomain",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://encoreuranium.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "domainItemType"
    },
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://encoreuranium.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_AnnualInformationForm": {
     "auth_ref": [
      "r317"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form.",
        "label": "Annual Information Form",
        "terseLabel": "Annual Information Form"
       }
      }
     },
     "localname": "AnnualInformationForm",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://encoreuranium.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_AuditedAnnualFinancialStatements": {
     "auth_ref": [
      "r317"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements.",
        "label": "Audited Annual Financial Statements",
        "terseLabel": "Audited Annual Financial Statements"
       }
      }
     },
     "localname": "AuditedAnnualFinancialStatements",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://encoreuranium.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_AuditorFirmId": {
     "auth_ref": [
      "r315",
      "r316",
      "r317"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "PCAOB issued Audit Firm Identifier",
        "label": "Auditor Firm ID",
        "terseLabel": "Auditor Firm ID"
       }
      }
     },
     "localname": "AuditorFirmId",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://encoreuranium.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "nonemptySequenceNumberItemType"
    },
    "dei_AuditorLocation": {
     "auth_ref": [
      "r315",
      "r316",
      "r317"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor Location",
        "terseLabel": "Auditor Location"
       }
      }
     },
     "localname": "AuditorLocation",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://encoreuranium.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "internationalNameItemType"
    },
    "dei_AuditorName": {
     "auth_ref": [
      "r315",
      "r316",
      "r317"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor Name",
        "terseLabel": "Auditor Name"
       }
      }
     },
     "localname": "AuditorName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://encoreuranium.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "internationalNameItemType"
    },
    "dei_BusinessContactMember": {
     "auth_ref": [
      "r316",
      "r317"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business contact for the entity",
        "label": "Business Contact [Member]",
        "terseLabel": "Business Contact [Member]"
       }
      }
     },
     "localname": "BusinessContactMember",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://encoreuranium.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "domainItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code",
        "terseLabel": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://encoreuranium.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_ContactPersonnelName": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of contact personnel",
        "label": "Contact Personnel Name",
        "terseLabel": "Contact Personnel Name"
       }
      }
     },
     "localname": "ContactPersonnelName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://encoreuranium.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CurrentFiscalYearEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "End date of current fiscal year in the format --MM-DD.",
        "label": "Current Fiscal Year End Date",
        "terseLabel": "Current Fiscal Year End Date"
       }
      }
     },
     "localname": "CurrentFiscalYearEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://encoreuranium.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "gMonthDayItemType"
    },
    "dei_DocumentAnnualReport": {
     "auth_ref": [
      "r315",
      "r316",
      "r317"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an annual report.",
        "label": "Document Annual Report",
        "terseLabel": "Document Annual Report"
       }
      }
     },
     "localname": "DocumentAnnualReport",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://encoreuranium.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentFiscalPeriodFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.",
        "label": "Document Fiscal Period Focus",
        "terseLabel": "Document Fiscal Period Focus"
       }
      }
     },
     "localname": "DocumentFiscalPeriodFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://encoreuranium.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "fiscalPeriodItemType"
    },
    "dei_DocumentFiscalYearFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.",
        "label": "Document Fiscal Year Focus",
        "terseLabel": "Document Fiscal Year Focus"
       }
      }
     },
     "localname": "DocumentFiscalYearFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://encoreuranium.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "gYearItemType"
    },
    "dei_DocumentInformationLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "localname": "DocumentInformationLineItems",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://encoreuranium.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_DocumentInformationTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Container to support the formal attachment of each official or unofficial, public or private document as part of a submission package."
       }
      }
     },
     "localname": "DocumentInformationTable",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://encoreuranium.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://encoreuranium.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentRegistrationStatement": {
     "auth_ref": [
      "r311"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a registration statement.",
        "label": "Document Registration Statement",
        "terseLabel": "Document Registration Statement"
       }
      }
     },
     "localname": "DocumentRegistrationStatement",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://encoreuranium.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type",
        "terseLabel": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://encoreuranium.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://encoreuranium.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine2": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 2 such as Street or Suite number",
        "label": "Entity Address, Address Line Two",
        "terseLabel": "Entity Address, Address Line Two"
       }
      }
     },
     "localname": "EntityAddressAddressLine2",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://encoreuranium.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://encoreuranium.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://encoreuranium.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province",
        "terseLabel": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://encoreuranium.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityAddressesAddressTypeAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the domain members or categories in the table and the line items or concepts that complete the table.",
        "label": "Entity Addresses, Address Type [Axis]"
       }
      }
     },
     "localname": "EntityAddressesAddressTypeAxis",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://encoreuranium.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r313"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://encoreuranium.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.",
        "label": "Entity Common Stock, Shares Outstanding",
        "terseLabel": "Entity Common Stock, Shares Outstanding"
       }
      }
     },
     "localname": "EntityCommonStockSharesOutstanding",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://encoreuranium.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "sharesItemType"
    },
    "dei_EntityCurrentReportingStatus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Current Reporting Status",
        "terseLabel": "Entity Current Reporting Status"
       }
      }
     },
     "localname": "EntityCurrentReportingStatus",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://encoreuranium.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r313"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://encoreuranium.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityExTransitionPeriod": {
     "auth_ref": [
      "r319"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.",
        "label": "Entity Ex Transition Period",
        "terseLabel": "Entity Ex Transition Period"
       }
      }
     },
     "localname": "EntityExTransitionPeriod",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://encoreuranium.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number",
        "terseLabel": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://encoreuranium.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code",
        "terseLabel": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://encoreuranium.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityInteractiveDataCurrent": {
     "auth_ref": [
      "r318"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).",
        "label": "Entity Interactive Data Current",
        "terseLabel": "Entity Interactive Data Current"
       }
      }
     },
     "localname": "EntityInteractiveDataCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://encoreuranium.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r313"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://encoreuranium.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_IcfrAuditorAttestationFlag": {
     "auth_ref": [
      "r315",
      "r316",
      "r317"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "ICFR Auditor Attestation Flag",
        "terseLabel": "ICFR Auditor Attestation Flag"
       }
      }
     },
     "localname": "IcfrAuditorAttestationFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://encoreuranium.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://encoreuranium.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r312"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security",
        "terseLabel": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://encoreuranium.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r314"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://encoreuranium.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://encoreuranium.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "ifrs-full_AccumulatedOtherComprehensiveIncome": {
     "auth_ref": [
      "r327"
     ],
     "calculation": {
      "http://encoreuranium.com/role/ConsolidatedBalanceSheet": {
       "order": 4.0,
       "parentTag": "ifrs-full_Equity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of accumulated items of income and expense (including reclassification adjustments) that are not recognised in profit or loss as required or permitted by other IFRSs. [Refer: IFRSs [member]; Other comprehensive income]"
       }
      },
      "en-us": {
       "role": {
        "label": "Accumulated other comprehensive income",
        "terseLabel": "Accumulated other comprehensive income"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncome",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://encoreuranium.com/role/ConsolidatedBalanceSheet"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_AccumulatedOtherComprehensiveIncomeMember": {
     "auth_ref": [
      "r324"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for accumulated other comprehensive income. [Refer: Other comprehensive income]"
       }
      },
      "en-us": {
       "role": {
        "label": "Accumulated other comprehensive income [member]",
        "terseLabel": "Accumulated other comprehensive income (loss)"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeMember",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://encoreuranium.com/role/ShareholdersEquityType2or3"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred": {
     "auth_ref": [
      "r155"
     ],
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The fair value, at acquisition date, of the consideration transferred in a business combination. [Refer: Business combinations [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Consideration transferred, acquisition-date fair value",
        "terseLabel": "Fair value of share consideration",
        "verboseLabel": "Total consideration (in Dollars)"
       }
      }
     },
     "localname": "AcquisitiondateFairValueOfTotalConsiderationTransferred",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://encoreuranium.com/role/AssetacquisitionDetails",
      "http://encoreuranium.com/role/ScheduleofestimatedfairvalueofassetsandliabilitiesTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_AcquisitionrelatedCostsRecognisedAsExpenseForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination": {
     "auth_ref": [
      "r158"
     ],
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of acquisition-related costs recognised as an expense for transactions that are recognised separately from the acquisition of assets and the assumption of liabilities in business combinations. [Refer: Business combinations [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Acquisition-related costs recognised as expense for transaction recognised separately from acquisition of assets and assumption of liabilities in business combination",
        "terseLabel": "Transaction costs (in Dollars)"
       }
      }
     },
     "localname": "AcquisitionrelatedCostsRecognisedAsExpenseForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://encoreuranium.com/role/AssetacquisitionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill": {
     "auth_ref": [
      "r337"
     ],
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The increase in intangible assets and goodwill resulting from acquisitions through business combinations. [Refer: Business combinations [member]; Intangible assets and goodwill]"
       }
      },
      "en-us": {
       "role": {
        "label": "Acquisitions through business combinations, intangible assets and goodwill",
        "terseLabel": "Data acquisition"
       }
      }
     },
     "localname": "AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://encoreuranium.com/role/ScheduleofamountspaidtokeymanagementorentitiesprovidingsimilarservicesTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_ActuarialAssumptionOfDiscountRates": {
     "auth_ref": [
      "r333"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The discount rate used as the significant actuarial assumption to determine the present value of a defined benefit obligation. [Refer: Defined benefit obligation, at present value; Actuarial assumptions [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Actuarial assumption of discount rates",
        "terseLabel": "Discount rate"
       }
      }
     },
     "localname": "ActuarialAssumptionOfDiscountRates",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://encoreuranium.com/role/ScheduleofweightedaverageassumptionsusedintheblackscholesoptionTable"
     ],
     "xbrltype": "percentItemType"
    },
    "ifrs-full_AdditionalProvisionsOtherProvisions": {
     "auth_ref": [
      "r85"
     ],
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of additional other provisions made. [Refer: Other provisions]"
       }
      },
      "en-us": {
       "role": {
        "label": "Additional provisions, other provisions",
        "terseLabel": "Additions"
       }
      }
     },
     "localname": "AdditionalProvisionsOtherProvisions",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://encoreuranium.com/role/ScheduleofmarketablesecuritiesTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment": {
     "auth_ref": [
      "r51"
     ],
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of additions to property, plant and equipment other than those acquired through business combinations. [Refer: Business combinations [member]; Property, plant and equipment]"
       }
      },
      "en-us": {
       "role": {
        "label": "Additions other than through business combinations, property, plant and equipment",
        "terseLabel": "Additions"
       }
      }
     },
     "localname": "AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://encoreuranium.com/role/ScheduleofpropertyplantandequipmentTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_AdjustedWeightedAverageShares": {
     "auth_ref": [
      "r75"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The weighted average number of ordinary shares outstanding plus the weighted average number of ordinary shares that would be issued on the conversion of all the dilutive potential ordinary shares into ordinary shares. [Refer: Ordinary shares [member]; Weighted average [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Weighted average number of ordinary shares used in calculating diluted earnings per share",
        "terseLabel": "- diluted # (in Shares)"
       }
      }
     },
     "localname": "AdjustedWeightedAverageShares",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://encoreuranium.com/role/ConsolidatedComprehensiveIncome"
     ],
     "xbrltype": "sharesItemType"
    },
    "ifrs-full_AdjustmentsForCurrentTaxOfPriorPeriod": {
     "auth_ref": [
      "r280"
     ],
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "Adjustments of tax expense (income) recognised in the period for current tax of prior periods."
       }
      },
      "en-us": {
       "role": {
        "label": "Adjustments for current tax of prior periods",
        "terseLabel": "Prior period adjustments"
       }
      }
     },
     "localname": "AdjustmentsForCurrentTaxOfPriorPeriod",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://encoreuranium.com/role/ScheduleoffederalandprovincialcorporatetaxratestoincomebeforetaxTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_AdjustmentsForDecreaseIncreaseInOtherOperatingReceivables": {
     "auth_ref": [
      "r341"
     ],
     "calculation": {
      "http://encoreuranium.com/role/ConsolidatedCashFlow": {
       "order": 10.0,
       "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "Adjustments for decrease (increase) in other operating receivables to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Profit (loss)]"
       }
      },
      "en-us": {
       "role": {
        "label": "Adjustments for decrease (increase) in other operating receivables",
        "terseLabel": "Receivables and prepaid expenses"
       }
      }
     },
     "localname": "AdjustmentsForDecreaseIncreaseInOtherOperatingReceivables",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://encoreuranium.com/role/ConsolidatedCashFlow"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_AdjustmentsForDeferredTaxExpense": {
     "auth_ref": [
      "r343"
     ],
     "calculation": {
      "http://encoreuranium.com/role/ConsolidatedCashFlow": {
       "order": 7.0,
       "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "Adjustments for deferred tax expense to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Deferred tax expense (income); Profit (loss)]"
       }
      },
      "en-us": {
       "role": {
        "label": "Adjustments for deferred tax expense",
        "terseLabel": "Loss on write-off of sales tax recoverable"
       }
      }
     },
     "localname": "AdjustmentsForDeferredTaxExpense",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://encoreuranium.com/role/ConsolidatedCashFlow"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_AdjustmentsForDepreciationAndAmortisationExpense": {
     "auth_ref": [
      "r342"
     ],
     "calculation": {
      "http://encoreuranium.com/role/ConsolidatedCashFlow": {
       "order": 3.0,
       "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities",
       "weight": 1.0
      },
      "http://encoreuranium.com/role/ScheduleofconsolidatedstatementsoflossandcomprehensivelossTable": {
       "order": 2.0,
       "parentTag": "ifrs-full_OtherOperatingIncomeExpense",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "Adjustments for depreciation and amortisation expense to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Depreciation and amortisation expense; Profit (loss)]"
       }
      },
      "en-us": {
       "role": {
        "label": "Adjustments for depreciation and amortisation expense",
        "terseLabel": "Amortization and depreciation"
       }
      }
     },
     "localname": "AdjustmentsForDepreciationAndAmortisationExpense",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://encoreuranium.com/role/ConsolidatedCashFlow",
      "http://encoreuranium.com/role/ScheduleofconsolidatedstatementsoflossandcomprehensivelossTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_AdjustmentsForFairValueGainsLosses": {
     "auth_ref": [
      "r342"
     ],
     "calculation": {
      "http://encoreuranium.com/role/ConsolidatedCashFlow": {
       "order": 9.0,
       "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "Adjustments for fair value losses (gains) to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Profit (loss)]"
       }
      },
      "en-us": {
       "role": {
        "label": "Adjustments for fair value losses (gains)",
        "terseLabel": "Unrealized gain on marketable securities"
       }
      }
     },
     "localname": "AdjustmentsForFairValueGainsLosses",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://encoreuranium.com/role/ConsolidatedCashFlow"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_AdjustmentsForGainLossOnDisposalsPropertyPlantAndEquipment": {
     "auth_ref": [
      "r343"
     ],
     "calculation": {
      "http://encoreuranium.com/role/ConsolidatedCashFlow": {
       "order": 16.0,
       "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "Adjustments for gain (loss) on disposals of property, plant and equipment to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Profit (loss); Property, plant and equipment; Disposals, property, plant and equipment]"
       }
      },
      "en-us": {
       "role": {
        "label": "Adjustments for gain (loss) on disposals, property, plant and equipment",
        "negatedLabel": "(Gain) loss on divestment of mineral properties"
       }
      }
     },
     "localname": "AdjustmentsForGainLossOnDisposalsPropertyPlantAndEquipment",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://encoreuranium.com/role/ConsolidatedCashFlow"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_AdjustmentsForGainsLossesOnChangeInFairValueOfDerivatives": {
     "auth_ref": [
      "r343"
     ],
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "Adjustments for gains (losses) on changes in the fair value of derivatives to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: At fair value [member]; Derivatives [member]; Profit (loss)]"
       }
      },
      "en-us": {
       "role": {
        "label": "Adjustments for gains (losses) on change in fair value of derivatives",
        "terseLabel": "Fair value adjustment"
       }
      }
     },
     "localname": "AdjustmentsForGainsLossesOnChangeInFairValueOfDerivatives",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://encoreuranium.com/role/ScheduleofthefairvalueofthephysicaluraniuminvestmentTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_AdjustmentsForGainsLossesOnFairValueAdjustmentInvestmentProperty": {
     "auth_ref": [
      "r343"
     ],
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "Adjustments for gains (losses) arising from a change in the fair value of investment property to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Investment property; Gains (losses) on fair value adjustment, investment property; Profit (loss)]"
       }
      },
      "en-us": {
       "role": {
        "label": "Adjustments for gains (losses) on fair value adjustment, investment property",
        "terseLabel": "Fair value adjustments"
       }
      }
     },
     "localname": "AdjustmentsForGainsLossesOnFairValueAdjustmentInvestmentProperty",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://encoreuranium.com/role/ScheduleofmarketablesecuritiesTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_AdjustmentsForImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLoss": {
     "auth_ref": [
      "r342"
     ],
     "calculation": {
      "http://encoreuranium.com/role/ConsolidatedCashFlow": {
       "order": 4.0,
       "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "Adjustments for impairment loss (reversal of impairment loss) recognised in profit or loss to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Impairment loss (reversal of impairment loss) recognised in profit or loss]"
       }
      },
      "en-us": {
       "role": {
        "label": "Adjustments for impairment loss (reversal of impairment loss) recognised in profit or loss",
        "terseLabel": "Impairment charges"
       }
      }
     },
     "localname": "AdjustmentsForImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLoss",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://encoreuranium.com/role/ConsolidatedCashFlow"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_AdjustmentsForIncreaseDecreaseInDepositsFromCustomers": {
     "auth_ref": [
      "r343"
     ],
     "calculation": {
      "http://encoreuranium.com/role/ConsolidatedCashFlow": {
       "order": 11.0,
       "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "Adjustments for increase (decrease) in deposits from customers to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Deposits from customers; Profit (loss)]"
       }
      },
      "en-us": {
       "role": {
        "label": "Adjustments for increase (decrease) in deposits from customers",
        "terseLabel": "Deposit - uranium investment"
       }
      }
     },
     "localname": "AdjustmentsForIncreaseDecreaseInDepositsFromCustomers",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://encoreuranium.com/role/ConsolidatedCashFlow"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_AdjustmentsForIncreaseDecreaseInEmployeeBenefitLiabilities": {
     "auth_ref": [
      "r343"
     ],
     "calculation": {
      "http://encoreuranium.com/role/ConsolidatedCashFlow": {
       "order": 8.0,
       "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "Adjustments for increase (decrease) in employee benefit liabilities to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Profit (loss)]"
       }
      },
      "en-us": {
       "role": {
        "label": "Adjustments for increase (decrease) in employee benefit liabilities",
        "terseLabel": "Loss (gain) on change in asset retirement obligation estimate"
       }
      }
     },
     "localname": "AdjustmentsForIncreaseDecreaseInEmployeeBenefitLiabilities",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://encoreuranium.com/role/ConsolidatedCashFlow"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAccountPayable": {
     "auth_ref": [
      "r341"
     ],
     "calculation": {
      "http://encoreuranium.com/role/ConsolidatedCashFlow": {
       "order": 13.0,
       "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "Adjustments for increase (decrease) in trade accounts payable to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Profit (loss)]"
       }
      },
      "en-us": {
       "role": {
        "label": "Adjustments for increase (decrease) in trade accounts payable",
        "terseLabel": "Accounts payable and accrued liabilities"
       }
      }
     },
     "localname": "AdjustmentsForIncreaseDecreaseInTradeAccountPayable",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://encoreuranium.com/role/ConsolidatedCashFlow"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_AdjustmentsForInterestIncome": {
     "auth_ref": [
      "r343"
     ],
     "calculation": {
      "http://encoreuranium.com/role/ConsolidatedCashFlow": {
       "order": 15.0,
       "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "Adjustments for interest income expense to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Interest income; Profit (loss)]"
       }
      },
      "en-us": {
       "role": {
        "label": "Adjustments for interest income",
        "negatedLabel": "Interest income"
       }
      }
     },
     "localname": "AdjustmentsForInterestIncome",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://encoreuranium.com/role/ConsolidatedCashFlow"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_AdjustmentsForSharebasedPayments": {
     "auth_ref": [
      "r342"
     ],
     "calculation": {
      "http://encoreuranium.com/role/ConsolidatedCashFlow": {
       "order": 6.0,
       "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "Adjustments for share-based payments to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Profit (loss)]"
       }
      },
      "en-us": {
       "role": {
        "label": "Adjustments for share-based payments",
        "terseLabel": "Stock option expense"
       }
      }
     },
     "localname": "AdjustmentsForSharebasedPayments",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://encoreuranium.com/role/ConsolidatedCashFlow"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_AdjustmentsForUndistributedProfitsOfAssociates": {
     "auth_ref": [
      "r342"
     ],
     "calculation": {
      "http://encoreuranium.com/role/ConsolidatedCashFlow": {
       "order": 20.0,
       "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "Adjustments for undistributed profits of associates to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Associates [member]; Profit (loss)]"
       }
      },
      "en-us": {
       "role": {
        "label": "Adjustments for undistributed profits of associates",
        "negatedLabel": "Loss on investment in associate"
       }
      }
     },
     "localname": "AdjustmentsForUndistributedProfitsOfAssociates",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://encoreuranium.com/role/ConsolidatedCashFlow"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_AdjustmentsForUnrealisedForeignExchangeLossesGains": {
     "auth_ref": [
      "r293",
      "r342"
     ],
     "calculation": {
      "http://encoreuranium.com/role/ConsolidatedCashFlow": {
       "order": 5.0,
       "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "Adjustments for unrealised foreign exchange losses (gains) to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Profit (loss)]"
       }
      },
      "en-us": {
       "role": {
        "label": "Adjustments for unrealised foreign exchange losses (gains)",
        "terseLabel": "Foreign exchange loss"
       }
      }
     },
     "localname": "AdjustmentsForUnrealisedForeignExchangeLossesGains",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://encoreuranium.com/role/ConsolidatedCashFlow"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_AdministrativeExpense": {
     "auth_ref": [
      "r42",
      "r66",
      "r275"
     ],
     "calculation": {
      "http://encoreuranium.com/role/ConsolidatedComprehensiveIncome": {
       "order": 8.0,
       "parentTag": "ifrs-full_ProfitLossFromOperatingActivities",
       "weight": -1.0
      },
      "http://encoreuranium.com/role/ScheduleofconsolidatedstatementsoflossandcomprehensivelossTable": {
       "order": 4.0,
       "parentTag": "ifrs-full_OtherOperatingIncomeExpense",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of expenses that the entity classifies as being administrative."
       }
      },
      "en-us": {
       "role": {
        "label": "Administrative expenses",
        "terseLabel": "Office and administrative",
        "verboseLabel": "General administrative costs"
       }
      }
     },
     "localname": "AdministrativeExpense",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://encoreuranium.com/role/ConsolidatedComprehensiveIncome",
      "http://encoreuranium.com/role/ScheduleofconsolidatedstatementsoflossandcomprehensivelossTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_AmortisationIntangibleAssetsOtherThanGoodwill": {
     "auth_ref": [
      "r86"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of amortisation of intangible assets other than goodwill. [Refer: Depreciation and amortisation expense; Intangible assets other than goodwill]"
       }
      },
      "en-us": {
       "role": {
        "label": "Amortisation, intangible assets other than goodwill",
        "negatedLabel": "Amortization"
       }
      }
     },
     "localname": "AmortisationIntangibleAssetsOtherThanGoodwill",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://encoreuranium.com/role/ScheduleofintangibleassetwasdeterminedTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_AmountsPayableRelatedPartyTransactions": {
     "auth_ref": [
      "r61",
      "r64"
     ],
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amounts payable resulting from related party transactions. [Refer: Related parties [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Amounts payable, related party transactions",
        "terseLabel": "Total related party transactions"
       }
      }
     },
     "localname": "AmountsPayableRelatedPartyTransactions",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://encoreuranium.com/role/ScheduleofowingtorelatedpartiesTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_Assets": {
     "auth_ref": [
      "r21",
      "r131",
      "r132",
      "r133",
      "r174",
      "r176"
     ],
     "calculation": {
      "http://encoreuranium.com/role/ConsolidatedBalanceSheet": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://encoreuranium.com/role/ScheduleofeffectoftranslationTable": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of a present economic resource controlled by the entity as a result of past events. Economic resource is a right that has the potential to produce economic benefits."
       }
      },
      "en-us": {
       "role": {
        "label": "Assets",
        "terseLabel": "Assets (in Dollars)",
        "totalLabel": "Total assets"
       }
      }
     },
     "localname": "Assets",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://encoreuranium.com/role/ConsolidatedBalanceSheet",
      "http://encoreuranium.com/role/MarketableSecuritiesDetails",
      "http://encoreuranium.com/role/ScheduleofeffectoftranslationTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_AssetsArisingFromExplorationForAndEvaluationOfMineralResources": {
     "auth_ref": [
      "r160"
     ],
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of assets arising from the search for mineral resources, including minerals, oil, natural gas and similar non-regenerative resources after the entity has obtained legal rights to explore in a specific area, as well as the determination of the technical feasibility and commercial viability of extracting the mineral resource."
       }
      },
      "en-us": {
       "role": {
        "label": "Assets arising from exploration for and evaluation of mineral resources",
        "terseLabel": "Mineral properties"
       }
      }
     },
     "localname": "AssetsArisingFromExplorationForAndEvaluationOfMineralResources",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://encoreuranium.com/role/ScheduleofnetassetsacquiredTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_AssetsLessCurrentLiabilities": {
     "auth_ref": [
      "r327"
     ],
     "calculation": {
      "http://encoreuranium.com/role/ScheduleofforeigncurrencyexposuresTable": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of assets less the amount of current liabilities."
       }
      },
      "en-us": {
       "role": {
        "label": "Assets less current liabilities",
        "totalLabel": "Total"
       }
      }
     },
     "localname": "AssetsLessCurrentLiabilities",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://encoreuranium.com/role/ScheduleofforeigncurrencyexposuresTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_AverageForeignExchangeRate": {
     "auth_ref": [
      "r325"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The average exchange rate used by the entity. Exchange rate is the ratio of exchange for two currencies."
       }
      },
      "en-us": {
       "role": {
        "label": "Average foreign exchange rate",
        "terseLabel": "Average rate for the year"
       }
      }
     },
     "localname": "AverageForeignExchangeRate",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://encoreuranium.com/role/ScheduleofexchangeratesTable"
     ],
     "xbrltype": "decimalItemType"
    },
    "ifrs-full_BasicEarningsLossPerShare": {
     "auth_ref": [
      "r73",
      "r74"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of profit (loss) attributable to ordinary equity holders of the parent entity (the numerator) divided by the weighted average number of ordinary shares outstanding during the period (the denominator)."
       }
      },
      "en-us": {
       "role": {
        "label": "Basic earnings (loss) per share",
        "terseLabel": "Basic and diluted loss per share $ (in Dollars per share)",
        "verboseLabel": "Loss per share - basic and diluted"
       }
      }
     },
     "localname": "BasicEarningsLossPerShare",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://encoreuranium.com/role/ConsolidatedComprehensiveIncome",
      "http://encoreuranium.com/role/ScheduleofconsolidatedstatementsoflossandcomprehensivelossTable"
     ],
     "xbrltype": "perShareItemType"
    },
    "ifrs-full_BorrowingsInterestRate": {
     "auth_ref": [
      "r346"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The interest rate on borrowings. [Refer: Borrowings]"
       }
      },
      "en-us": {
       "role": {
        "label": "Borrowings, interest rate",
        "terseLabel": "Estimated borrowing rate",
        "verboseLabel": "Interest rate"
       }
      }
     },
     "localname": "BorrowingsInterestRate",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://encoreuranium.com/role/EventsafterthereportingperiodDetails",
      "http://encoreuranium.com/role/RightofuseassetsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "ifrs-full_BottomOfRangeMember": {
     "auth_ref": [
      "r135",
      "r151",
      "r183",
      "r295",
      "r296",
      "r346"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for the bottom of a range."
       }
      },
      "en-us": {
       "role": {
        "label": "Bottom of range [member]",
        "terseLabel": "Bottom of range [member]"
       }
      }
     },
     "localname": "BottomOfRangeMember",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://encoreuranium.com/role/AssetacquisitionDetails",
      "http://encoreuranium.com/role/MineralPropertiesDetails",
      "http://encoreuranium.com/role/ScheduleofusefullivesofpropertyplantandequipementTable"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_BuildingsMember": {
     "auth_ref": [
      "r332"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for a class of plant, property and equipment representing depreciable buildings and similar structures for use in operations. [Refer: Property, plant and equipment]"
       }
      },
      "en-us": {
       "role": {
        "label": "Buildings [member]",
        "terseLabel": "Buildings [member]"
       }
      }
     },
     "localname": "BuildingsMember",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://encoreuranium.com/role/ScheduleofpropertyplantandequipmentTable",
      "http://encoreuranium.com/role/ScheduleofusefullivesofpropertyplantandequipementTable"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_Cash": {
     "auth_ref": [
      "r344"
     ],
     "calculation": {
      "http://encoreuranium.com/role/ScheduleofforeigncurrencyexposuresTable": {
       "order": 1.0,
       "parentTag": "ifrs-full_AssetsLessCurrentLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of cash on hand and demand deposits. [Refer: Cash on hand]"
       }
      },
      "en-us": {
       "role": {
        "label": "Cash",
        "terseLabel": "Cash"
       }
      }
     },
     "localname": "Cash",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://encoreuranium.com/role/EventsafterthereportingperiodDetails",
      "http://encoreuranium.com/role/ScheduleofforeigncurrencyexposuresTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_CashAndCashEquivalents": {
     "auth_ref": [
      "r17",
      "r103",
      "r123"
     ],
     "calculation": {
      "http://encoreuranium.com/role/ConsolidatedBalanceSheet": {
       "order": 1.0,
       "parentTag": "ifrs-full_CurrentAssets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of cash on hand and demand deposits, along with short-term, highly liquid investments that are readily convertible to known amounts of cash and that are subject to an insignificant risk of changes in value. [Refer: Cash; Cash equivalents]"
       }
      },
      "en-us": {
       "role": {
        "label": "Cash and cash equivalents",
        "periodEndLabel": "Cash, end of year",
        "periodStartLabel": "Cash, beginning of year",
        "terseLabel": "Cash"
       }
      }
     },
     "localname": "CashAndCashEquivalents",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://encoreuranium.com/role/ConsolidatedBalanceSheet",
      "http://encoreuranium.com/role/ConsolidatedCashFlow"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_CashFlowsFromUsedInFinancingActivities": {
     "auth_ref": [
      "r95",
      "r105"
     ],
     "calculation": {
      "http://encoreuranium.com/role/ConsolidatedCashFlow": {
       "order": 3.0,
       "parentTag": "ifrs-full_CashFlowsFromUsedInOperationsBeforeChangesInWorkingCapital",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The cash flows from (used in) financing activities, which are activities that result in changes in the size and composition of the contributed equity and borrowings of the entity."
       }
      },
      "en-us": {
       "role": {
        "label": "Cash flows from (used in) financing activities",
        "totalLabel": "Net cash financing activities"
       }
      }
     },
     "localname": "CashFlowsFromUsedInFinancingActivities",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://encoreuranium.com/role/ConsolidatedCashFlow"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_CashFlowsFromUsedInInvestingActivities": {
     "auth_ref": [
      "r95",
      "r105"
     ],
     "calculation": {
      "http://encoreuranium.com/role/ConsolidatedCashFlow": {
       "order": 2.0,
       "parentTag": "ifrs-full_CashFlowsFromUsedInOperationsBeforeChangesInWorkingCapital",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The cash flows from (used in) investing activities, which are the acquisition and disposal of long-term assets and other investments not included in cash equivalents."
       }
      },
      "en-us": {
       "role": {
        "label": "Cash flows from (used in) investing activities",
        "totalLabel": "Net cash investing activities"
       }
      }
     },
     "localname": "CashFlowsFromUsedInInvestingActivities",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://encoreuranium.com/role/ConsolidatedCashFlow"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_CashFlowsFromUsedInOperatingActivities": {
     "auth_ref": [
      "r95",
      "r105"
     ],
     "calculation": {
      "http://encoreuranium.com/role/ConsolidatedCashFlow": {
       "order": 1.0,
       "parentTag": "ifrs-full_CashFlowsFromUsedInOperationsBeforeChangesInWorkingCapital",
       "weight": 1.0
      }
     },
     "lang": {
      "en": {
       "role": {
        "documentation": "The cash flows from (used in) operating activities, which are the principal revenue-producing activities of the entity and other activities that are not investing or financing activities. [Refer: Revenue]"
       }
      },
      "en-us": {
       "role": {
        "label": "Cash flows from (used in) operating activities",
        "totalLabel": "Net cash operating activities"
       }
      }
     },
     "localname": "CashFlowsFromUsedInOperatingActivities",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://encoreuranium.com/role/ConsolidatedCashFlow"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_CashFlowsFromUsedInOperationsBeforeChangesInWorkingCapital": {
     "auth_ref": [
      "r293",
      "r343"
     ],
     "calculation": {
      "http://encoreuranium.com/role/ConsolidatedCashFlow": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "lang": {
      "en": {
       "role": {
        "documentation": "The cash inflow (outflow) from the entity's operations before changes in working capital."
       }
      },
      "en-us": {
       "role": {
        "label": "Cash flows from (used in) operations before changes in working capital",
        "totalLabel": "Change in cash"
       }
      }
     },
     "localname": "CashFlowsFromUsedInOperationsBeforeChangesInWorkingCapital",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://encoreuranium.com/role/ConsolidatedCashFlow"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_CashFlowsUsedInObtainingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities": {
     "auth_ref": [
      "r101"
     ],
     "calculation": {
      "http://encoreuranium.com/role/ConsolidatedCashFlow": {
       "order": 9.0,
       "parentTag": "ifrs-full_CashFlowsFromUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The aggregate cash flows used in obtaining control of subsidiaries or other businesses, classified as investing activities. [Refer: Subsidiaries [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Cash flows used in obtaining control of subsidiaries or other businesses, classified as investing activities",
        "negatedLabel": "Deferred acquisition costs"
       }
      }
     },
     "localname": "CashFlowsUsedInObtainingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://encoreuranium.com/role/ConsolidatedCashFlow"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_CashReceiptsFromRepaymentOfAdvancesAndLoansMadeToRelatedParties": {
     "auth_ref": [
      "r339"
     ],
     "calculation": {
      "http://encoreuranium.com/role/ConsolidatedCashFlow": {
       "order": 14.0,
       "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The cash inflow from repayment to the entity of loans and advances made to related parties. [Refer: Related parties [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Cash receipts from repayment of advances and loans made to related parties",
        "terseLabel": "Due to related parties"
       }
      }
     },
     "localname": "CashReceiptsFromRepaymentOfAdvancesAndLoansMadeToRelatedParties",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://encoreuranium.com/role/ConsolidatedCashFlow"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_CategoriesOfRelatedPartiesAxis": {
     "auth_ref": [
      "r63"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      },
      "en-us": {
       "role": {
        "label": "Categories of related parties [axis]"
       }
      }
     },
     "localname": "CategoriesOfRelatedPartiesAxis",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://encoreuranium.com/role/MineralPropertiesDetails",
      "http://encoreuranium.com/role/ScheduleofchangeintheROUassetsTable",
      "http://encoreuranium.com/role/ScheduleofchangeinthelongTermleaseliabilityTable",
      "http://encoreuranium.com/role/ScheduleofowingtorelatedpartiesTable",
      "http://encoreuranium.com/role/ScheduleofsignificantsubsidiariesTable",
      "http://encoreuranium.com/role/ScheduleofusefullivesofintangibleassetsTable"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_ClassesOfAssetsAxis": {
     "auth_ref": [
      "r77",
      "r80",
      "r134",
      "r141"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      },
      "en-us": {
       "role": {
        "label": "Classes of assets [axis]"
       }
      }
     },
     "localname": "ClassesOfAssetsAxis",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://encoreuranium.com/role/AssetacquisitionDetails",
      "http://encoreuranium.com/role/RightofuseassetsDetails",
      "http://encoreuranium.com/role/ScheduleofassetretirementobligationsbalanceTable",
      "http://encoreuranium.com/role/ScheduleofmarketablesecuritiesTable"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_ClassesOfAssetsMember": {
     "auth_ref": [
      "r77",
      "r134",
      "r141"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for a present economic resource controlled by the entity as a result of past events. Economic resource is a right that has the potential to produce economic benefits. It also represents the standard value for the 'Classes of assets' axis if no other member is used."
       }
      },
      "en-us": {
       "role": {
        "label": "Assets [member]"
       }
      }
     },
     "localname": "ClassesOfAssetsMember",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://encoreuranium.com/role/AssetacquisitionDetails",
      "http://encoreuranium.com/role/RightofuseassetsDetails",
      "http://encoreuranium.com/role/ScheduleofassetretirementobligationsbalanceTable",
      "http://encoreuranium.com/role/ScheduleofmarketablesecuritiesTable"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis": {
     "auth_ref": [
      "r88"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      },
      "en-us": {
       "role": {
        "label": "Classes of intangible assets other than goodwill [axis]"
       }
      }
     },
     "localname": "ClassesOfIntangibleAssetsOtherThanGoodwillAxis",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://encoreuranium.com/role/ScheduleofintangibleassetwasdeterminedTable"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_ClassesOfLiabilitiesAxis": {
     "auth_ref": [
      "r134"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      },
      "en-us": {
       "role": {
        "label": "Classes of liabilities [axis]"
       }
      }
     },
     "localname": "ClassesOfLiabilitiesAxis",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://encoreuranium.com/role/EventsafterthereportingperiodDetails",
      "http://encoreuranium.com/role/MineralPropertiesDetails",
      "http://encoreuranium.com/role/ScheduleofmineralpropertiesTable"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_ClassesOfOrdinarySharesAxis": {
     "auth_ref": [
      "r73"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      },
      "en-us": {
       "role": {
        "label": "Classes of ordinary shares [axis]"
       }
      }
     },
     "localname": "ClassesOfOrdinarySharesAxis",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://encoreuranium.com/role/MarketableSecuritiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis": {
     "auth_ref": [
      "r53"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      },
      "en-us": {
       "role": {
        "label": "Classes of property, plant and equipment [axis]"
       }
      }
     },
     "localname": "ClassesOfPropertyPlantAndEquipmentAxis",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://encoreuranium.com/role/ScheduleofpropertyplantandequipmentTable"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_ClassesOfShareCapitalMember": {
     "auth_ref": [
      "r31"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for share capital of the entity. It also represents the standard value for the 'Classes of share capital' axis if no other member is used."
       }
      },
      "en-us": {
       "role": {
        "label": "Share capital [member]",
        "terseLabel": "Share capital"
       }
      }
     },
     "localname": "ClassesOfShareCapitalMember",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://encoreuranium.com/role/ShareholdersEquityType2or3"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_ClosingForeignExchangeRate": {
     "auth_ref": [
      "r325"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The spot exchange rate at the end of the reporting period. Exchange rate is the ratio of exchange for two currencies. Spot exchange rate is the exchange rate for immediate delivery."
       }
      },
      "en-us": {
       "role": {
        "label": "Closing foreign exchange rate",
        "terseLabel": "Closing rate at the reporting date"
       }
      }
     },
     "localname": "ClosingForeignExchangeRate",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://encoreuranium.com/role/ScheduleofexchangeratesTable"
     ],
     "xbrltype": "decimalItemType"
    },
    "ifrs-full_CommunicationExpense": {
     "auth_ref": [
      "r325"
     ],
     "calculation": {
      "http://encoreuranium.com/role/ConsolidatedComprehensiveIncome": {
       "order": 11.0,
       "parentTag": "ifrs-full_ProfitLossFromOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of expense arising from communication."
       }
      },
      "en-us": {
       "role": {
        "label": "Communication expense",
        "terseLabel": "Promotion and shareholder communication"
       }
      }
     },
     "localname": "CommunicationExpense",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://encoreuranium.com/role/ConsolidatedComprehensiveIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_ComponentsOfEquityAxis": {
     "auth_ref": [
      "r11"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      },
      "en-us": {
       "role": {
        "label": "Components of equity [axis]"
       }
      }
     },
     "localname": "ComponentsOfEquityAxis",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://encoreuranium.com/role/ScheduleofweightedaverageassumptionsusedintheblackscholesoptionTable",
      "http://encoreuranium.com/role/ShareCapitalDetails",
      "http://encoreuranium.com/role/ShareholdersEquityType2or3"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_ComprehensiveIncome": {
     "auth_ref": [
      "r7",
      "r34",
      "r110",
      "r113",
      "r122",
      "r294"
     ],
     "calculation": {
      "http://encoreuranium.com/role/ConsolidatedComprehensiveIncome": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of change in equity resulting from transactions and other events, other than those changes resulting from transactions with owners in their capacity as owners."
       }
      },
      "en-us": {
       "role": {
        "label": "Comprehensive income",
        "totalLabel": "Comprehensive loss for the year"
       }
      }
     },
     "localname": "ComprehensiveIncome",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://encoreuranium.com/role/ConsolidatedComprehensiveIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_ConsiderationPaidReceived": {
     "auth_ref": [
      "r102"
     ],
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of consideration paid or received in respect of both obtaining and losing control of subsidiaries or other businesses. [Refer: Subsidiaries [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Consideration paid (received)",
        "terseLabel": "Consideration received",
        "verboseLabel": "Total consideration"
       }
      }
     },
     "localname": "ConsiderationPaidReceived",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://encoreuranium.com/role/EventsafterthereportingperiodDetails",
      "http://encoreuranium.com/role/MineralPropertiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_ContingentConsiderationMember": {
     "auth_ref": [
      "r345"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for an obligation of the acquirer to transfer additional assets or equity interests to the former owners of an acquiree as part of the exchange for control of the acquiree if specified future events occur or conditions are met."
       }
      },
      "en-us": {
       "role": {
        "label": "Contingent consideration [member]",
        "terseLabel": "Contingent consideration [member]"
       }
      }
     },
     "localname": "ContingentConsiderationMember",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://encoreuranium.com/role/MineralPropertiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_ContingentConsiderationRecognisedAsOfAcquisitionDate": {
     "auth_ref": [
      "r156"
     ],
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount, at acquisition date, of contingent consideration arrangements recognised as consideration transferred in a business combination. [Refer: Business combinations [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Contingent consideration recognised as of acquisition date",
        "terseLabel": "Contingent payments"
       }
      }
     },
     "localname": "ContingentConsiderationRecognisedAsOfAcquisitionDate",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://encoreuranium.com/role/MineralPropertiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_CurrentAccruedExpensesAndOtherCurrentLiabilities": {
     "auth_ref": [
      "r327"
     ],
     "calculation": {
      "http://encoreuranium.com/role/ScheduleofincurrednoncashfinancingandinvestingactivitiesTable": {
       "order": 1.0,
       "parentTag": "cve_TotalNoncashFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of current accrued expenses and other current liabilities. [Refer: Accruals; Other current liabilities]"
       }
      },
      "en-us": {
       "role": {
        "label": "Current accrued expenses and other current liabilities",
        "terseLabel": "Deferred financing costs remaining in accounts payable and accrued liabilities"
       }
      }
     },
     "localname": "CurrentAccruedExpensesAndOtherCurrentLiabilities",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://encoreuranium.com/role/ScheduleofincurrednoncashfinancingandinvestingactivitiesTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_CurrentAssets": {
     "auth_ref": [
      "r23",
      "r118",
      "r294"
     ],
     "calculation": {
      "http://encoreuranium.com/role/ConsolidatedBalanceSheet": {
       "order": 1.0,
       "parentTag": "ifrs-full_Assets",
       "weight": 1.0
      },
      "http://encoreuranium.com/role/ScheduleofeffectoftranslationTable": {
       "order": 1.0,
       "parentTag": "ifrs-full_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of assets that the entity (a) expects to realise or intends to sell or consume in its normal operating cycle; (b) holds primarily for the purpose of trading; (c) expects to realise within twelve months after the reporting period; or (d) classifies as cash or cash equivalents (as defined in IAS 7) unless the asset is restricted from being exchanged or used to settle a liability for at least twelve months after the reporting period. [Refer: Assets]"
       }
      },
      "en-us": {
       "role": {
        "label": "Current assets",
        "terseLabel": "Current assets",
        "totalLabel": "Total current assets"
       }
      }
     },
     "localname": "CurrentAssets",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://encoreuranium.com/role/ConsolidatedBalanceSheet",
      "http://encoreuranium.com/role/ScheduleofeffectoftranslationTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_CurrentAssetsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current assets [abstract]",
        "terseLabel": "Current assets"
       }
      }
     },
     "localname": "CurrentAssetsAbstract",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://encoreuranium.com/role/ConsolidatedBalanceSheet"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_CurrentInvestments": {
     "auth_ref": [
      "r327"
     ],
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of current investments."
       }
      },
      "en-us": {
       "role": {
        "label": "Current investments",
        "periodEndLabel": "Balance as of ending",
        "periodStartLabel": "Balance as of beginning"
       }
      }
     },
     "localname": "CurrentInvestments",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://encoreuranium.com/role/ScheduleofthefairvalueofthephysicaluraniuminvestmentTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_CurrentLeaseLiabilities": {
     "auth_ref": [
      "r139"
     ],
     "calculation": {
      "http://encoreuranium.com/role/ConsolidatedBalanceSheet": {
       "order": 4.0,
       "parentTag": "ifrs-full_CurrentLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of current lease liabilities. [Refer: Lease liabilities]"
       }
      },
      "en-us": {
       "role": {
        "label": "Current lease liabilities",
        "terseLabel": "Lease liability - current"
       }
      }
     },
     "localname": "CurrentLeaseLiabilities",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://encoreuranium.com/role/ConsolidatedBalanceSheet"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_CurrentLiabilities": {
     "auth_ref": [
      "r24",
      "r120",
      "r294"
     ],
     "calculation": {
      "http://encoreuranium.com/role/ConsolidatedBalanceSheet": {
       "order": 1.0,
       "parentTag": "ifrs-full_Liabilities",
       "weight": 1.0
      },
      "http://encoreuranium.com/role/ScheduleofeffectoftranslationTable": {
       "order": 1.0,
       "parentTag": "ifrs-full_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "Expiry date 2023-01-01: The amount of liabilities that: (a) the entity expects to settle in its normal operating cycle; (b) the entity holds primarily for the purpose of trading; (c) are due to be settled within twelve months after the reporting period; or (d) the entity does not have an unconditional right to defer settlement for at least twelve months after the reporting period.\nEffective 2023-01-01: The amount of liabilities that: (a) the entity expects to settle in its normal operating cycle; (b) the entity holds primarily for the purpose of trading; (c) are due to be settled within twelve months after the reporting period; or (d) the entity does not have the right at the end of the reporting period to defer settlement for at least twelve months after the reporting period."
       }
      },
      "en-us": {
       "role": {
        "label": "Current liabilities",
        "terseLabel": "Current liabilities",
        "totalLabel": "Total current liabilities"
       }
      }
     },
     "localname": "CurrentLiabilities",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://encoreuranium.com/role/ConsolidatedBalanceSheet",
      "http://encoreuranium.com/role/ScheduleofeffectoftranslationTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_CurrentLiabilitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current liabilities [abstract]",
        "terseLabel": "Current liabilities"
       }
      }
     },
     "localname": "CurrentLiabilitiesAbstract",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://encoreuranium.com/role/ConsolidatedBalanceSheet"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_DeferredTaxAssets": {
     "auth_ref": [
      "r20",
      "r22",
      "r48"
     ],
     "calculation": {
      "http://encoreuranium.com/role/ConsolidatedBalanceSheet": {
       "order": 10.0,
       "parentTag": "ifrs-full_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amounts of income taxes recoverable in future periods in respect of: (a) deductible temporary differences; (b) the carryforward of unused tax losses; and (c) the carryforward of unused tax credits. [Refer: Temporary differences [member]; Unused tax credits [member]; Unused tax losses [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Deferred tax assets",
        "terseLabel": "Deferred acquisition costs"
       }
      }
     },
     "localname": "DeferredTaxAssets",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://encoreuranium.com/role/ConsolidatedBalanceSheet"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_DefinedBenefitObligationAtPresentValue": {
     "auth_ref": [
      "r334"
     ],
     "calculation": {
      "http://encoreuranium.com/role/ConsolidatedBalanceSheet": {
       "order": 2.0,
       "parentTag": "ifrs-full_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The present value, without deducting any plan assets, of expected future payments required to settle the obligation resulting from employee service in the current and prior periods. [Refer: Plan assets, at fair value]"
       }
      },
      "en-us": {
       "role": {
        "label": "Defined benefit obligation, at present value",
        "terseLabel": "Asset retirement obligations"
       }
      }
     },
     "localname": "DefinedBenefitObligationAtPresentValue",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://encoreuranium.com/role/ConsolidatedBalanceSheet"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_DepositsFromBanks": {
     "auth_ref": [
      "r327"
     ],
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of deposit liabilities from banks held by the entity."
       }
      },
      "en-us": {
       "role": {
        "label": "Deposits from banks",
        "terseLabel": "Deposit"
       }
      }
     },
     "localname": "DepositsFromBanks",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://encoreuranium.com/role/SignificantaccountingpoliciesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_DepreciationAndAmortisationExpense": {
     "auth_ref": [
      "r6",
      "r42",
      "r124",
      "r172",
      "r178",
      "r274"
     ],
     "calculation": {
      "http://encoreuranium.com/role/ConsolidatedComprehensiveIncome": {
       "order": 2.0,
       "parentTag": "ifrs-full_ProfitLossFromOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of depreciation and amortisation expense. Depreciation and amortisation are the systematic allocations of depreciable amounts of assets over their useful lives."
       }
      },
      "en-us": {
       "role": {
        "label": "Depreciation and amortisation expense",
        "terseLabel": "Amortization and depreciation"
       }
      }
     },
     "localname": "DepreciationAndAmortisationExpense",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://encoreuranium.com/role/ConsolidatedComprehensiveIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_DepreciationExpense": {
     "auth_ref": [
      "r325"
     ],
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of depreciation expense. Depreciation is the systematic allocation of depreciable amounts of tangible assets over their useful lives."
       }
      },
      "en-us": {
       "role": {
        "label": "Depreciation expense",
        "negatedLabel": "Depreciation"
       }
      }
     },
     "localname": "DepreciationExpense",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://encoreuranium.com/role/ScheduleofpropertyplantandequipmentTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_DescriptionOfAccountingPolicyForAvailableforsaleFinancialAssetsExplanatory": {
     "auth_ref": [
      "r348"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The description of the entity's accounting policy for available-for-sale financial assets. [Refer: Financial assets available-for-sale]"
       }
      },
      "en-us": {
       "role": {
        "label": "Description of accounting policy for available-for-sale financial assets [text block]",
        "terseLabel": "Assets held for sale"
       }
      }
     },
     "localname": "DescriptionOfAccountingPolicyForAvailableforsaleFinancialAssetsExplanatory",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://encoreuranium.com/role/AccountingPoliciesByPolicy"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DescriptionOfAccountingPolicyForDerecognitionOfFinancialInstrumentsExplanatory": {
     "auth_ref": [
      "r347",
      "r349"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "Expiry date 2023-01-01: The description of the entity's accounting policy for the derecognition of financial instruments. [Refer: Financial instruments, class [member]]\nEffective 2023-01-01: The description of the entity's material accounting policy information for the derecognition of financial instruments. [Refer: Financial instruments, class [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Description of accounting policy for derecognition of financial instruments [text block]",
        "terseLabel": "Derecognition of financial assets"
       }
      }
     },
     "localname": "DescriptionOfAccountingPolicyForDerecognitionOfFinancialInstrumentsExplanatory",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://encoreuranium.com/role/AccountingPoliciesByPolicy"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DescriptionOfAccountingPolicyForEarningsPerShareExplanatory": {
     "auth_ref": [
      "r347",
      "r349"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "Expiry date 2023-01-01: The description of the entity's accounting policy for earnings per share.\nEffective 2023-01-01: The description of the entity's material accounting policy information for earnings per share."
       }
      },
      "en-us": {
       "role": {
        "label": "Description of accounting policy for earnings per share [text block]",
        "terseLabel": "Earnings (loss) per share"
       }
      }
     },
     "localname": "DescriptionOfAccountingPolicyForEarningsPerShareExplanatory",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://encoreuranium.com/role/AccountingPoliciesByPolicy"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DescriptionOfAccountingPolicyForFinancialInstrumentsExplanatory": {
     "auth_ref": [
      "r347",
      "r349"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "Expiry date 2023-01-01: The description of the entity's accounting policy for financial instruments. [Refer: Financial instruments, class [member]]\nEffective 2023-01-01: The description of the entity's material accounting policy information for financial instruments. [Refer: Financial instruments, class [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Description of accounting policy for financial instruments [text block]",
        "terseLabel": "Financial instruments"
       }
      }
     },
     "localname": "DescriptionOfAccountingPolicyForFinancialInstrumentsExplanatory",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://encoreuranium.com/role/AccountingPoliciesByPolicy"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DescriptionOfAccountingPolicyForForeignCurrencyTranslationExplanatory": {
     "auth_ref": [
      "r347",
      "r349"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "Expiry date 2023-01-01: The description of the entity's accounting policy for foreign currency translation.\nEffective 2023-01-01: The description of the entity's material accounting policy information for foreign currency translation."
       }
      },
      "en-us": {
       "role": {
        "label": "Description of accounting policy for foreign currency translation [text block]",
        "terseLabel": "Schedule of effect of translation"
       }
      }
     },
     "localname": "DescriptionOfAccountingPolicyForForeignCurrencyTranslationExplanatory",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://encoreuranium.com/role/ChangeinPresentationCurrencyTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DescriptionOfAccountingPolicyForImpairmentOfFinancialAssetsExplanatory": {
     "auth_ref": [
      "r347",
      "r349"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "Expiry date 2023-01-01: The description of the entity's accounting policy for the impairment of financial assets. [Refer: Financial assets]\nEffective 2023-01-01: The description of the entity's material accounting policy information for the impairment of financial assets. [Refer: Financial assets]"
       }
      },
      "en-us": {
       "role": {
        "label": "Description of accounting policy for impairment of financial assets [text block]",
        "terseLabel": "Impairment of financial assets at amortized cost"
       }
      }
     },
     "localname": "DescriptionOfAccountingPolicyForImpairmentOfFinancialAssetsExplanatory",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://encoreuranium.com/role/AccountingPoliciesByPolicy"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DescriptionOfAccountingPolicyForImpairmentOfNonfinancialAssetsExplanatory": {
     "auth_ref": [
      "r347",
      "r349"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "Expiry date 2023-01-01: The description of the entity's accounting policy for the impairment of non-financial assets. [Refer: Financial assets]\nEffective 2023-01-01: The description of the entity's material accounting policy information for the impairment of non-financial assets. [Refer: Financial assets]"
       }
      },
      "en-us": {
       "role": {
        "label": "Description of accounting policy for impairment of non-financial assets [text block]",
        "terseLabel": "Impairment of non-financial assets"
       }
      }
     },
     "localname": "DescriptionOfAccountingPolicyForImpairmentOfNonfinancialAssetsExplanatory",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://encoreuranium.com/role/AccountingPoliciesByPolicy"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DescriptionOfAccountingPolicyForIncomeTaxExplanatory": {
     "auth_ref": [
      "r347",
      "r349"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "Expiry date 2023-01-01: The description of the entity's accounting policy for income tax.\nEffective 2023-01-01: The description of the entity's material accounting policy information for income tax."
       }
      },
      "en-us": {
       "role": {
        "label": "Description of accounting policy for income tax [text block]",
        "terseLabel": "Income Tax"
       }
      }
     },
     "localname": "DescriptionOfAccountingPolicyForIncomeTaxExplanatory",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://encoreuranium.com/role/AccountingPoliciesByPolicy"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DescriptionOfAccountingPolicyForIntangibleAssetsAndGoodwillExplanatory": {
     "auth_ref": [
      "r347",
      "r349"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "Expiry date 2023-01-01: The description of the entity's accounting policy for intangible assets and goodwill. [Refer: Intangible assets and goodwill]\nEffective 2023-01-01: The description of the entity's material accounting policy information for intangible assets and goodwill. [Refer: Intangible assets and goodwill]"
       }
      },
      "en-us": {
       "role": {
        "label": "Description of accounting policy for intangible assets and goodwill [text block]",
        "terseLabel": "Intangible assets"
       }
      }
     },
     "localname": "DescriptionOfAccountingPolicyForIntangibleAssetsAndGoodwillExplanatory",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://encoreuranium.com/role/AccountingPoliciesByPolicy"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DescriptionOfAccountingPolicyForInvestmentInAssociates": {
     "auth_ref": [
      "r347",
      "r349"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "Expiry date 2023-01-01: The description of the entity's accounting policy for investments in associates. [Refer: Associates [member]]\nEffective 2023-01-01: The description of the entity's material accounting policy information for investments in associates. [Refer: Associates [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Description of accounting policy for investment in associates [text block]",
        "terseLabel": "Investments in associates"
       }
      }
     },
     "localname": "DescriptionOfAccountingPolicyForInvestmentInAssociates",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://encoreuranium.com/role/AccountingPoliciesByPolicy"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DescriptionOfAccountingPolicyForLeasesExplanatory": {
     "auth_ref": [
      "r347",
      "r349"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "Expiry date 2023-01-01: The description of the entity's accounting policy for leases. A lease is an agreement whereby the lessor conveys to the lessee in return for a payment or series of payments the right to use an asset for an agreed period of time.\nEffective 2023-01-01: The description of the entity's material accounting policy information for leases. A lease is an agreement whereby the lessor conveys to the lessee in return for a payment or series of payments the right to use an asset for an agreed period of time."
       }
      },
      "en-us": {
       "role": {
        "label": "Description of accounting policy for leases [text block]",
        "terseLabel": "Leases"
       }
      }
     },
     "localname": "DescriptionOfAccountingPolicyForLeasesExplanatory",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://encoreuranium.com/role/AccountingPoliciesByPolicy"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory": {
     "auth_ref": [
      "r347",
      "r349"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "Expiry date 2023-01-01: The description of the entity's accounting policy for property, plant and equipment. [Refer: Property, plant and equipment]\nEffective 2023-01-01: The description of the entity's material accounting policy information for property, plant and equipment. [Refer: Property, plant and equipment]"
       }
      },
      "en-us": {
       "role": {
        "label": "Description of accounting policy for property, plant and equipment [text block]",
        "terseLabel": "Property, plant and equipment"
       }
      }
     },
     "localname": "DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://encoreuranium.com/role/AccountingPoliciesByPolicy"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory": {
     "auth_ref": [
      "r347",
      "r349"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "Expiry date 2023-01-01: The description of the entity's accounting policy for transactions in which the entity: (a) receives goods or services from the supplier of those goods or services (including an employee) in a share-based payment arrangement; or (b) incurs an obligation to settle the transaction with the supplier in a share-based payment arrangement when another group entity receives those goods or services. [Refer: Share-based payment arrangements [member]]\nEffective 2023-01-01: The description of the entity's material accounting policy information for transactions in which the entity: (a) receives goods or services from the supplier of those goods or services (including an employee) in a share-based payment arrangement; or (b) incurs an obligation to settle the transaction with the supplier in a share-based payment arrangement when another group entity receives those goods or services. [Refer: Share-based payment arrangements [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Description of accounting policy for share-based payment transactions [text block]",
        "terseLabel": "Share-based payments"
       }
      }
     },
     "localname": "DescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://encoreuranium.com/role/AccountingPoliciesByPolicy"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DescriptionOfAccountingPolicyForWarrantsExplanatory": {
     "auth_ref": [
      "r347",
      "r349"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "Expiry date 2023-01-01: The description of the entity's accounting policy for warrants. Warrants are financial instruments that give the holder the right to purchase ordinary shares.\nEffective 2023-01-01: The description of the entity's material accounting policy information for warrants. Warrants are financial instruments that give the holder the right to purchase ordinary shares."
       }
      },
      "en-us": {
       "role": {
        "label": "Description of accounting policy for warrants [text block]",
        "terseLabel": "Warrants issued in equity financing transactions"
       }
      }
     },
     "localname": "DescriptionOfAccountingPolicyForWarrantsExplanatory",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://encoreuranium.com/role/AccountingPoliciesByPolicy"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DescriptionOfAccountingPolicyToDetermineComponentsOfCashAndCashEquivalents": {
     "auth_ref": [
      "r104"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The description of the entity's accounting policy used to determine the components of cash and cash equivalents. [Refer: Cash and cash equivalents]"
       }
      },
      "en-us": {
       "role": {
        "label": "Description of accounting policy for determining components of cash and cash equivalents [text block]",
        "terseLabel": "Restricted cash"
       }
      }
     },
     "localname": "DescriptionOfAccountingPolicyToDetermineComponentsOfCashAndCashEquivalents",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://encoreuranium.com/role/AccountingPoliciesByPolicy"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DescriptionOfDiscountRatesAppliedToCashFlowProjections": {
     "auth_ref": [
      "r82",
      "r84"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The discount rate applied to cash flow projections for a cash-generating unit (group of units). [Refer: Cash-generating units [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Discount rate applied to cash flow projections",
        "terseLabel": "Discount rate"
       }
      }
     },
     "localname": "DescriptionOfDiscountRatesAppliedToCashFlowProjections",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://encoreuranium.com/role/AssetretirementobligationsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "ifrs-full_DescriptionOfExpectedVolatilityShareOptionsGranted": {
     "auth_ref": [
      "r152"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The expected volatility of the share price used to calculate the fair value of the share options granted. Expected volatility is a measure of the amount by which a price is expected to fluctuate during a period. The measure of volatility used in option pricing models is the annualised standard deviation of the continuously compounded rates of return on the share over a period of time."
       }
      },
      "en-us": {
       "role": {
        "label": "Expected volatility, share options granted",
        "terseLabel": "Volatility",
        "verboseLabel": "Expected stock price volatility"
       }
      }
     },
     "localname": "DescriptionOfExpectedVolatilityShareOptionsGranted",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://encoreuranium.com/role/ScheduleofweightedaverageassumptionsusedincalculatingthefairvaluesTable",
      "http://encoreuranium.com/role/ScheduleofweightedaverageassumptionsusedintheblackscholesoptionTable"
     ],
     "xbrltype": "percentItemType"
    },
    "ifrs-full_DescriptionOfKeyAssumptionsOnWhichManagementHasBasedDeterminationOfFairValueLessCostsOfDisposal": {
     "auth_ref": [
      "r81",
      "r83"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The description of key assumptions on which management has based its determination of fair value less costs of disposal for a cash-generating unit (group of units). Key assumptions are those to which the unit's (group of units') recoverable amount is most sensitive. [Refer: Cash-generating units [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Description of key assumptions on which management has based determination of fair value less costs of disposal",
        "terseLabel": "Cost base shareholdings amount"
       }
      }
     },
     "localname": "DescriptionOfKeyAssumptionsOnWhichManagementHasBasedDeterminationOfFairValueLessCostsOfDisposal",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://encoreuranium.com/role/MarketableSecuritiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_DescriptionOfManagingLiquidityRisk": {
     "auth_ref": [
      "r167"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The disclosure of how the entity manages its liquidity risk. [Refer: Liquidity risk [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of how entity manages liquidity risk [text block]",
        "terseLabel": "Management of capital"
       }
      }
     },
     "localname": "DescriptionOfManagingLiquidityRisk",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://encoreuranium.com/role/Managementofcapital"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DescriptionOfRiskFreeInterestRateShareOptionsGranted": {
     "auth_ref": [
      "r152"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The implied yield currently available on zero-coupon government issues of the country in whose currency the exercise price for share options granted is expressed, with a remaining term equal to the expected term of the option being valued (based on the option's remaining contractual life and taking into account the effects of expected early exercise). [Refer: Government [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Risk free interest rate, share options granted",
        "terseLabel": "Risk-free interest rate"
       }
      }
     },
     "localname": "DescriptionOfRiskFreeInterestRateShareOptionsGranted",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://encoreuranium.com/role/ScheduleofweightedaverageassumptionsusedincalculatingthefairvaluesTable"
     ],
     "xbrltype": "percentItemType"
    },
    "ifrs-full_DilutedEarningsLossPerShare": {
     "auth_ref": [
      "r73",
      "r74"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of profit (loss) attributable to ordinary equity holders of the parent entity (the numerator), divided by the weighted average number of ordinary shares outstanding during the period (the denominator), both adjusted for the effects of all dilutive potential ordinary shares. [Refer: Ordinary shares [member]; Weighted average [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Diluted earnings (loss) per share",
        "terseLabel": "Diluted loss per share",
        "verboseLabel": "Loss per share - diluted"
       }
      }
     },
     "localname": "DilutedEarningsLossPerShare",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://encoreuranium.com/role/ConsolidatedComprehensiveIncome_Parentheticals",
      "http://encoreuranium.com/role/ScheduleofconsolidatedstatementsoflossandcomprehensivelossTable_Parentheticals"
     ],
     "xbrltype": "perShareItemType"
    },
    "ifrs-full_DirectorsRemunerationExpense": {
     "auth_ref": [
      "r325"
     ],
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of remuneration paid or payable to the entity's directors."
       }
      },
      "en-us": {
       "role": {
        "label": "Directors' remuneration expense",
        "terseLabel": "Directors\u2019 fees"
       }
      }
     },
     "localname": "DirectorsRemunerationExpense",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://encoreuranium.com/role/ScheduleofamountspaidtokeymanagementorentitiesprovidingsimilarservicesTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_DisclosureOfAccountingJudgementsAndEstimatesExplanatory": {
     "auth_ref": [
      "r322"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The disclosure of judgements that management has made in the process of applying the entity's accounting policies that have the most significant effect on amounts recognised in the financial statements along with information about the assumptions that the entity makes about the future, and other major sources of estimation uncertainty at the end of the reporting period, that have a significant risk of resulting in a material adjustment to the carrying amounts of assets and liabilities within the next year. [Refer: Carrying amount [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of accounting judgements and estimates [text block]",
        "terseLabel": "Critical accounting estimates and judgements"
       }
      }
     },
     "localname": "DisclosureOfAccountingJudgementsAndEstimatesExplanatory",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://encoreuranium.com/role/CriticalAccountingEstimatesAndJudgements"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DisclosureOfClassesOfShareCapitalExplanatory": {
     "auth_ref": [
      "r31"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The disclosure of classes of share capital. [Refer: Share capital [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of classes of share capital [text block]",
        "terseLabel": "Share capital"
       }
      }
     },
     "localname": "DisclosureOfClassesOfShareCapitalExplanatory",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://encoreuranium.com/role/ShareCapital"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DisclosureOfDeferredTaxesExplanatory": {
     "auth_ref": [
      "r322"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The disclosure of deferred taxes. [Refer: Deferred tax liabilities; Deferred tax assets]"
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of deferred taxes [text block]",
        "terseLabel": "Schedule of unrecognized deferred tax assets"
       }
      }
     },
     "localname": "DisclosureOfDeferredTaxesExplanatory",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://encoreuranium.com/role/IncometaxesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DisclosureOfDetailedInformationAboutIntangibleAssetsExplanatory": {
     "auth_ref": [
      "r88"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The disclosure of detailed information about intangible assets. [Refer: Intangible assets other than goodwill]"
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of detailed information about intangible assets [text block]",
        "terseLabel": "Schedule of intangible asset was determined"
       }
      }
     },
     "localname": "DisclosureOfDetailedInformationAboutIntangibleAssetsExplanatory",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://encoreuranium.com/role/IntangibleassetsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory": {
     "auth_ref": [
      "r53"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The disclosure of detailed information about property, plant and equipment. [Refer: Property, plant and equipment]"
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of detailed information about property, plant and equipment [text block]",
        "terseLabel": "Schedule of property, plant, and equipment"
       }
      }
     },
     "localname": "DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://encoreuranium.com/role/PropertyplantandequipmentTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DisclosureOfEffectOfChangesInForeignExchangeRatesExplanatory": {
     "auth_ref": [
      "r59"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The entire disclosure for the effect of changes in foreign exchange rates."
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of effect of changes in foreign exchange rates [text block]",
        "terseLabel": "Schedule of exchange rates"
       }
      }
     },
     "localname": "DisclosureOfEffectOfChangesInForeignExchangeRatesExplanatory",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://encoreuranium.com/role/SignificantaccountingpoliciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DisclosureOfEntitysReportableSegmentsExplanatory": {
     "auth_ref": [
      "r181"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The entire disclosure for operating segments."
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of entity's operating segments [text block]",
        "terseLabel": "Segmented information"
       }
      }
     },
     "localname": "DisclosureOfEntitysReportableSegmentsExplanatory",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://encoreuranium.com/role/Segmentedinformation"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DisclosureOfEventsAfterReportingPeriodExplanatory": {
     "auth_ref": [
      "r44"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The entire disclosure for events after the reporting period."
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of events after reporting period [text block]",
        "terseLabel": "Events after the reporting period"
       }
      }
     },
     "localname": "DisclosureOfEventsAfterReportingPeriodExplanatory",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://encoreuranium.com/role/Eventsafterthereportingperiod"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DisclosureOfFairValueMeasurementOfAssetsExplanatory": {
     "auth_ref": [
      "r134"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The disclosure of the fair value measurement of assets."
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of fair value measurement of assets [text block]",
        "terseLabel": "Schedule of estimated fair value of assets and liabilities"
       }
      }
     },
     "localname": "DisclosureOfFairValueMeasurementOfAssetsExplanatory",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://encoreuranium.com/role/AssetacquisitionTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DisclosureOfFinancialInstrumentsAtFairValueThroughProfitOrLossExplanatory": {
     "auth_ref": [
      "r322"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The disclosure of financial instruments measured at fair value through profit or loss. [Refer: At fair value [member]; Financial instruments, class [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of financial instruments at fair value through profit or loss [text block]",
        "terseLabel": "Schedule of consolidated statements of loss and comprehensive loss"
       }
      }
     },
     "localname": "DisclosureOfFinancialInstrumentsAtFairValueThroughProfitOrLossExplanatory",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://encoreuranium.com/role/ChangeinPresentationCurrencyTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DisclosureOfFinancialInstrumentsExplanatory": {
     "auth_ref": [
      "r169"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The entire disclosure for financial instruments."
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of financial instruments [text block]",
        "terseLabel": "Schedule of financial instrument"
       }
      }
     },
     "localname": "DisclosureOfFinancialInstrumentsExplanatory",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://encoreuranium.com/role/FinancialInstruments"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DisclosureOfGeneralAndAdministrativeExpenseExplanatory": {
     "auth_ref": [
      "r322"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The disclosure of general and administrative expenses. [Refer: Administrative expenses]"
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of general and administrative expense [text block]",
        "terseLabel": "Schedule of amounts paid to key management or entities providing similar services"
       }
      }
     },
     "localname": "DisclosureOfGeneralAndAdministrativeExpenseExplanatory",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://encoreuranium.com/role/RelatedpartytransactionsandbalancesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DisclosureOfIncomeTaxExplanatory": {
     "auth_ref": [
      "r50"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The entire disclosure for income taxes."
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of income tax [text block]",
        "terseLabel": "Income taxes"
       }
      }
     },
     "localname": "DisclosureOfIncomeTaxExplanatory",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://encoreuranium.com/role/Incometaxes"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DisclosureOfIndirectMeasurementOfFairValueOfGoodsOrServicesReceivedShareOptionsGrantedDuringPeriodExplanatory": {
     "auth_ref": [
      "r153"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The disclosure of information about indirect, by reference to the fair value of the equity instruments granted, measurement of the fair value of goods or services received as consideration for the entity's share options."
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of indirect measurement of fair value of goods or services received, share options granted during period [text block]",
        "terseLabel": "Schedule of weighted average assumptions used in the black-scholes option"
       }
      }
     },
     "localname": "DisclosureOfIndirectMeasurementOfFairValueOfGoodsOrServicesReceivedShareOptionsGrantedDuringPeriodExplanatory",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://encoreuranium.com/role/AssetacquisitionTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DisclosureOfIntangibleAssetsExplanatory": {
     "auth_ref": [
      "r90"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The entire disclosure for intangible assets."
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of intangible assets [text block]",
        "terseLabel": "Intangible assets"
       }
      }
     },
     "localname": "DisclosureOfIntangibleAssetsExplanatory",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://encoreuranium.com/role/Intangibleassets"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DisclosureOfInterestIncomeExplanatory": {
     "auth_ref": [
      "r322"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The disclosure of interest income. [Refer: Interest income]"
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of interest income [text block]",
        "terseLabel": "Schedule of income tax expense (recovery)"
       }
      }
     },
     "localname": "DisclosureOfInterestIncomeExplanatory",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://encoreuranium.com/role/IncometaxesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DisclosureOfInterestsInAssociatesExplanatory": {
     "auth_ref": [
      "r115"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The disclosure of interests in associates. [Refer: Associates [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of interests in associates [text block]",
        "terseLabel": "Schedule of investment in associate continuity summary"
       }
      }
     },
     "localname": "DisclosureOfInterestsInAssociatesExplanatory",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://encoreuranium.com/role/InvestmentInAssociateTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DisclosureOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethodExplanatory": {
     "auth_ref": [
      "r322"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The disclosure of investments other than investments accounted for using the equity method. [Refer: Investments other than investments accounted for using equity method]"
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of investments other than investments accounted for using equity method [text block]",
        "terseLabel": "Investment in uranium"
       }
      }
     },
     "localname": "DisclosureOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethodExplanatory",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://encoreuranium.com/role/Investmentinuranium"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DisclosureOfMarketRiskExplanatory": {
     "auth_ref": [
      "r322"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The disclosure of market risk. [Refer: Market risk [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of market risk [text block]",
        "terseLabel": "Marketable securities"
       }
      }
     },
     "localname": "DisclosureOfMarketRiskExplanatory",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://encoreuranium.com/role/MarketableSecurities"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DisclosureOfMaturityAnalysisForFinancialAssetsHeldForManagingLiquidityRiskExplanatory": {
     "auth_ref": [
      "r168"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The disclosure of a maturity analysis for financial assets held for managing liquidity risk. [Refer: Financial assets; Liquidity risk [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of maturity analysis for financial assets held for managing liquidity risk [text block]",
        "terseLabel": "Schedule of uranium sales contracts over the next five years"
       }
      }
     },
     "localname": "DisclosureOfMaturityAnalysisForFinancialAssetsHeldForManagingLiquidityRiskExplanatory",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://encoreuranium.com/role/SalescontractsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DisclosureOfPropertyPlantAndEquipmentExplanatory": {
     "auth_ref": [
      "r55"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The entire disclosure for property, plant and equipment."
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of property, plant and equipment [text block]",
        "terseLabel": "Property, plant, and equipment"
       }
      }
     },
     "localname": "DisclosureOfPropertyPlantAndEquipmentExplanatory",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://encoreuranium.com/role/Propertyplantandequipment"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DisclosureOfQuantitativeInformationAboutLeasesForLesseeAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure of quantitative information about leases for lessee [abstract]"
       }
      }
     },
     "localname": "DisclosureOfQuantitativeInformationAboutLeasesForLesseeAbstract",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "xbrltype": "stringItemType"
    },
    "ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsExplanatory": {
     "auth_ref": [
      "r141"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The disclosure of quantitative information about right-of-use assets. [Refer: Right-of-use assets]"
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of quantitative information about right-of-use assets [text block]",
        "terseLabel": "Right-of-use assets"
       }
      }
     },
     "localname": "DisclosureOfQuantitativeInformationAboutRightofuseAssetsExplanatory",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://encoreuranium.com/role/Rightofuseassets"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DisclosureOfReclassificationsOrChangesInPresentationExplanatory": {
     "auth_ref": [
      "r13"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The disclosure of reclassifications or changes in the presentation of items in the financial statements."
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of reclassifications or changes in presentation [text block]",
        "terseLabel": "Change in presentation currency"
       }
      }
     },
     "localname": "DisclosureOfReclassificationsOrChangesInPresentationExplanatory",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://encoreuranium.com/role/ChangeinPresentationCurrency"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DisclosureOfRedesignatedFinancialAssetsAndLiabilitiesExplanatory": {
     "auth_ref": [
      "r111"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The disclosure of financial assets and financial liabilities that have been redesignated during the transition to IFRSs. [Refer: Financial assets; Financial liabilities; IFRSs [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of redesignated financial assets and liabilities [text block]",
        "terseLabel": "Schedule of net assets acquired"
       }
      }
     },
     "localname": "DisclosureOfRedesignatedFinancialAssetsAndLiabilitiesExplanatory",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://encoreuranium.com/role/AssetacquisitionTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DisclosureOfRelatedPartyExplanatory": {
     "auth_ref": [
      "r65"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The entire disclosure for related parties."
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of related party [text block]",
        "terseLabel": "Related party transactions and balances"
       }
      }
     },
     "localname": "DisclosureOfRelatedPartyExplanatory",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://encoreuranium.com/role/Relatedpartytransactionsandbalances"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesExplanatory": {
     "auth_ref": [
      "r70",
      "r72",
      "r129"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The disclosure of associates. [Refer: Associates [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of associates [text block]",
        "terseLabel": "Investment in associate"
       }
      }
     },
     "localname": "DisclosureOfSignificantInvestmentsInAssociatesExplanatory",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://encoreuranium.com/role/InvestmentInAssociate"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesExplanatory": {
     "auth_ref": [
      "r70",
      "r72",
      "r128"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The disclosure of subsidiaries. [Refer: Subsidiaries [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of subsidiaries [text block]",
        "terseLabel": "Schedule of significant subsidiaries"
       }
      }
     },
     "localname": "DisclosureOfSignificantInvestmentsInSubsidiariesExplanatory",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://encoreuranium.com/role/SignificantaccountingpoliciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory": {
     "auth_ref": [
      "r184"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The entire disclosure for significant accounting policies applied by the entity."
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of significant accounting policies [text block]",
        "terseLabel": "Significant Accounting Policies"
       }
      }
     },
     "localname": "DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://encoreuranium.com/role/Significantaccountingpolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsExplanatory": {
     "auth_ref": [
      "r49"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The disclosure of types of temporary differences, unused tax losses and unused tax credits. [Refer: Unused tax credits [member]; Unused tax losses [member]; Temporary differences [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of temporary difference, unused tax losses and unused tax credits [text block]",
        "terseLabel": "Schedule of federal and provincial corporate tax rates to income before tax"
       }
      }
     },
     "localname": "DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsExplanatory",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://encoreuranium.com/role/IncometaxesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesExplanatory": {
     "auth_ref": [
      "r62"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The disclosure of transactions between the entity and its related parties. [Refer: Related parties [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of transactions between related parties [text block]",
        "terseLabel": "Schedule of owing to related parties"
       }
      }
     },
     "localname": "DisclosureOfTransactionsBetweenRelatedPartiesExplanatory",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://encoreuranium.com/role/RelatedpartytransactionsandbalancesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DisclosureOfTransactionsRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombinationExplanatory": {
     "auth_ref": [
      "r157"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The disclosure of transactions recognised separately from acquisition of assets and assumption of liabilities in a business combination. [Refer: Business combinations [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of transactions recognised separately from acquisition of assets and assumption of liabilities in business combination [text block]",
        "terseLabel": "Asset acquisition"
       }
      }
     },
     "localname": "DisclosureOfTransactionsRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombinationExplanatory",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://encoreuranium.com/role/Assetacquisition"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DisposalsInvestmentProperty": {
     "auth_ref": [
      "r92",
      "r94"
     ],
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The decrease in investment property resulting from disposals. [Refer: Investment property]"
       }
      },
      "en-us": {
       "role": {
        "label": "Disposals, investment property",
        "terseLabel": "Disposals"
       }
      }
     },
     "localname": "DisposalsInvestmentProperty",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://encoreuranium.com/role/ScheduleofpropertyplantandequipmentTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_DividendsReceived": {
     "auth_ref": [
      "r117"
     ],
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of dividends received."
       }
      },
      "en-us": {
       "role": {
        "label": "Dividends received",
        "terseLabel": "Company has received amount"
       }
      }
     },
     "localname": "DividendsReceived",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://encoreuranium.com/role/ShareCapitalDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents": {
     "auth_ref": [
      "r98",
      "r99"
     ],
     "calculation": {
      "http://encoreuranium.com/role/ConsolidatedCashFlow": {
       "order": 4.0,
       "parentTag": "ifrs-full_CashFlowsFromUsedInOperationsBeforeChangesInWorkingCapital",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The effect of exchange rate changes on cash and cash equivalents held or due in a foreign currency. [Refer: Cash and cash equivalents]"
       }
      },
      "en-us": {
       "role": {
        "label": "Effect of exchange rate changes on cash and cash equivalents",
        "terseLabel": "Effect of foreign exchange on cash"
       }
      }
     },
     "localname": "EffectOfExchangeRateChangesOnCashAndCashEquivalents",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://encoreuranium.com/role/ConsolidatedCashFlow"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_EntitysTotalForRelatedPartiesMember": {
     "auth_ref": [
      "r63"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for the standard value for the 'Categories of related parties' axis if no other member is used."
       }
      },
      "en-us": {
       "role": {
        "label": "Entity's total for related parties [member]"
       }
      }
     },
     "localname": "EntitysTotalForRelatedPartiesMember",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://encoreuranium.com/role/MineralPropertiesDetails",
      "http://encoreuranium.com/role/ScheduleofchangeintheROUassetsTable",
      "http://encoreuranium.com/role/ScheduleofchangeinthelongTermleaseliabilityTable",
      "http://encoreuranium.com/role/ScheduleofowingtorelatedpartiesTable"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_Equity": {
     "auth_ref": [
      "r21",
      "r27",
      "r109",
      "r112",
      "r131",
      "r132",
      "r133"
     ],
     "calculation": {
      "http://encoreuranium.com/role/ConsolidatedBalanceSheet": {
       "order": 2.0,
       "parentTag": "ifrs-full_EquityAndLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of residual interest in the assets of the entity after deducting all its liabilities."
       }
      },
      "en-us": {
       "role": {
        "label": "Equity",
        "periodEndLabel": "Balance as of ending",
        "periodStartLabel": "Balance as of beginning",
        "totalLabel": "Total shareholders\u2019 equity"
       }
      }
     },
     "localname": "Equity",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://encoreuranium.com/role/ConsolidatedBalanceSheet",
      "http://encoreuranium.com/role/ShareholdersEquityType2or3"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_EquityAndLiabilities": {
     "auth_ref": [
      "r21"
     ],
     "calculation": {
      "http://encoreuranium.com/role/ConsolidatedBalanceSheet": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of the entity's equity and liabilities. [Refer: Equity; Liabilities]"
       }
      },
      "en-us": {
       "role": {
        "label": "Equity and liabilities",
        "totalLabel": "Total liabilities and shareholders\u2019 equity"
       }
      }
     },
     "localname": "EquityAndLiabilities",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://encoreuranium.com/role/ConsolidatedBalanceSheet"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_EquityMember": {
     "auth_ref": [
      "r11"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for the residual interest in the assets of the entity after deducting all its liabilities. It also represents the standard value for the 'Components of equity' axis if no other member is used."
       }
      },
      "en-us": {
       "role": {
        "label": "Equity [member]"
       }
      }
     },
     "localname": "EquityMember",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://encoreuranium.com/role/ShareCapitalDetails",
      "http://encoreuranium.com/role/ShareholdersEquityType2or3"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_EquityReclassifiedIntoFinancialLiabilities": {
     "auth_ref": [
      "r32"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of equity reclassified into financial liabilities. [Refer: Equity; Financial liabilities]"
       }
      },
      "en-us": {
       "role": {
        "label": "Equity reclassified into financial liabilities",
        "terseLabel": "Warrants exercise reclassified amount (in Dollars)"
       }
      }
     },
     "localname": "EquityReclassifiedIntoFinancialLiabilities",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://encoreuranium.com/role/ShareCapitalDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_ExercisePriceOfOutstandingShareOptions2019": {
     "auth_ref": [
      "r151"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The exercise price of outstanding share options."
       }
      },
      "en-us": {
       "role": {
        "label": "Exercise price of outstanding share options",
        "terseLabel": "Options Outstanding, Weighted average exercise price"
       }
      }
     },
     "localname": "ExercisePriceOfOutstandingShareOptions2019",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://encoreuranium.com/role/ScheduleofstockoptionsoutstandingTable"
     ],
     "xbrltype": "perShareItemType"
    },
    "ifrs-full_ExercisePriceShareOptionsGranted2019": {
     "auth_ref": [
      "r152"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The exercise price of share options granted."
       }
      },
      "en-us": {
       "role": {
        "label": "Exercise price, share options granted",
        "terseLabel": "Exercise price",
        "verboseLabel": "Options Exercisable, Weighted average exercise price"
       }
      }
     },
     "localname": "ExercisePriceShareOptionsGranted2019",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://encoreuranium.com/role/ScheduleofstockoptionsoutstandingTable",
      "http://encoreuranium.com/role/ScheduleofweightedaverageassumptionsusedintheblackscholesoptionTable"
     ],
     "xbrltype": "perShareItemType"
    },
    "ifrs-full_ExpectedDividendAsPercentageShareOptionsGranted": {
     "auth_ref": [
      "r152"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The percentage of an expected dividend used to calculate the fair value of share options granted."
       }
      },
      "en-us": {
       "role": {
        "label": "Expected dividend as percentage, share options granted",
        "terseLabel": "Expected dividend yield"
       }
      }
     },
     "localname": "ExpectedDividendAsPercentageShareOptionsGranted",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://encoreuranium.com/role/ScheduleofweightedaverageassumptionsusedincalculatingthefairvaluesTable"
     ],
     "xbrltype": "percentItemType"
    },
    "ifrs-full_ExpenseFromSharebasedPaymentTransactionsWithEmployees": {
     "auth_ref": [
      "r325"
     ],
     "calculation": {
      "http://encoreuranium.com/role/ConsolidatedComprehensiveIncome": {
       "order": 16.0,
       "parentTag": "ifrs-full_ProfitLossFromOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of expense from share-based payment transactions with employees. [Refer: Expense from share-based payment transactions]"
       }
      },
      "en-us": {
       "role": {
        "label": "Expense from share-based payment transactions with employees",
        "terseLabel": "Stock option expense"
       }
      }
     },
     "localname": "ExpenseFromSharebasedPaymentTransactionsWithEmployees",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://encoreuranium.com/role/ConsolidatedComprehensiveIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_FinancialAssets": {
     "auth_ref": [
      "r162",
      "r163",
      "r164",
      "r165",
      "r301"
     ],
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of assets that are: (a) cash; (b) an equity instrument of another entity; (c) a contractual right: (i) to receive cash or another financial asset from another entity; or (ii) to exchange financial assets or financial liabilities with another entity under conditions that are potentially favourable to the entity; or (d) a contract that will, or may be, settled in the entity\u2019s own equity instruments and is: (i) a non-derivative for which the entity is, or may be, obliged to receive a variable number of the entity\u2019s own equity instruments; or (ii) a derivative that will, or may be, settled other than by the exchange of a fixed amount of cash or another financial asset for a fixed number of the entity\u2019s own equity instruments. For this purpose the entity\u2019s own equity instruments do not include puttable financial instruments classified as equity instruments in accordance with paragraphs 16A-16B of IAS 32, instruments that impose on the entity an obligation to deliver to another party a pro rata share of the net assets of the entity only on liquidation and are classified as equity instruments in accordance with paragraphs 16C-16D of IAS 32, or instruments that are contracts for the future receipt or delivery of the entity\u2019s own equity instruments. [Refer: Financial instruments, class [member]; Financial liabilities]"
       }
      },
      "en-us": {
       "role": {
        "label": "Financial assets",
        "terseLabel": "Asset retirement obligations"
       }
      }
     },
     "localname": "FinancialAssets",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://encoreuranium.com/role/ScheduleofassetretirementobligationsbalanceTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_FinancialLiabilitiesAtFairValue": {
     "auth_ref": [
      "r162"
     ],
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The fair value of financial liabilities. [Refer: At fair value [member]; Financial liabilities]"
       }
      },
      "en-us": {
       "role": {
        "label": "Financial liabilities, at fair value",
        "terseLabel": "Fair value (in Dollars)"
       }
      }
     },
     "localname": "FinancialLiabilitiesAtFairValue",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://encoreuranium.com/role/MarketableSecuritiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_FinancialLiabilitiesReclassifiedIntoEquity": {
     "auth_ref": [
      "r32"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of financial liabilities reclassified into equity. [Refer: Equity; Financial liabilities]"
       }
      },
      "en-us": {
       "role": {
        "label": "Financial liabilities reclassified into equity",
        "terseLabel": "Stock options exercise reclassified amount (in Dollars)"
       }
      }
     },
     "localname": "FinancialLiabilitiesReclassifiedIntoEquity",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://encoreuranium.com/role/ShareCapitalDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_ForeignExchangeGain": {
     "auth_ref": [
      "r12",
      "r58"
     ],
     "calculation": {
      "http://encoreuranium.com/role/ScheduleofconsolidatedstatementsoflossandcomprehensivelossTable": {
       "order": 6.0,
       "parentTag": "ifrs-full_NetForeignExchangeLoss",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The gross gain arising from exchange differences recognised in profit or loss, excluding those arising on financial instruments measured at fair value through profit or loss in accordance with IFRS 9. [Refer: Foreign exchange gain (loss)]"
       }
      },
      "en-us": {
       "role": {
        "label": "Foreign exchange gain",
        "terseLabel": "Foreign exchange gain"
       }
      }
     },
     "localname": "ForeignExchangeGain",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://encoreuranium.com/role/ScheduleofconsolidatedstatementsoflossandcomprehensivelossTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_GainLossOnRemeasurementOfReimbursementRights": {
     "auth_ref": [
      "r56"
     ],
     "calculation": {
      "http://encoreuranium.com/role/ConsolidatedComprehensiveIncome": {
       "order": 11.0,
       "parentTag": "ifrs-full_ProfitLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The increase (decrease) in reimbursement rights related to defined benefit obligation, resulting from the remeasurement of reimbursement rights. [Refer: Reimbursement rights related to defined benefit obligation, at fair value]"
       }
      },
      "en-us": {
       "role": {
        "label": "Increase (decrease) in reimbursement rights related to defined benefit obligation, resulting from gain (loss) on remeasurement",
        "negatedLabel": "(Loss) gain on change in asset retirement obligation estimate"
       }
      }
     },
     "localname": "GainLossOnRemeasurementOfReimbursementRights",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://encoreuranium.com/role/ConsolidatedComprehensiveIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_GainsLossesOnDisposalsOfPropertyPlantAndEquipment": {
     "auth_ref": [
      "r40"
     ],
     "calculation": {
      "http://encoreuranium.com/role/ConsolidatedComprehensiveIncome": {
       "order": 4.0,
       "parentTag": "ifrs-full_ProfitLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The gains (losses) on disposals of property, plant and equipment. [Refer: Property, plant and equipment]"
       }
      },
      "en-us": {
       "role": {
        "label": "Gains (losses) on disposals of property, plant and equipment",
        "terseLabel": "Gain (loss) on divestment of mineral properties"
       }
      }
     },
     "localname": "GainsLossesOnDisposalsOfPropertyPlantAndEquipment",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://encoreuranium.com/role/ConsolidatedComprehensiveIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationNetOfTax": {
     "auth_ref": [
      "r37"
     ],
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The gains (losses) recognised in other comprehensive income on exchange differences on the translation of financial statements of foreign operations, net of tax, before reclassification adjustments. [Refer: Other comprehensive income]"
       }
      },
      "en-us": {
       "role": {
        "label": "Gains (losses) on exchange differences on translation of foreign operations, net of tax",
        "terseLabel": "Cumulative translation adjustment"
       }
      }
     },
     "localname": "GainsLossesOnExchangeDifferencesOnTranslationNetOfTax",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://encoreuranium.com/role/ShareholdersEquityType2or3"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss": {
     "auth_ref": [
      "r12",
      "r58"
     ],
     "calculation": {
      "http://encoreuranium.com/role/ConsolidatedComprehensiveIncome": {
       "order": 3.0,
       "parentTag": "ifrs-full_ProfitLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of exchange differences recognised in profit or loss that arise from foreign currency transactions, excluding those arising on financial instruments measured at fair value through profit or loss in accordance with IFRS 9. [Refer: At fair value [member]; Financial instruments, class [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Foreign exchange gain (loss)",
        "terseLabel": "Foreign exchange (loss) gain"
       }
      }
     },
     "localname": "GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://encoreuranium.com/role/ConsolidatedComprehensiveIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_GainsLossesOnFairValueAdjustmentInvestmentProperty": {
     "auth_ref": [
      "r93"
     ],
     "calculation": {
      "http://encoreuranium.com/role/ConsolidatedComprehensiveIncome": {
       "order": 9.0,
       "parentTag": "ifrs-full_ProfitLoss",
       "weight": 1.0
      }
     },
     "lang": {
      "en": {
       "role": {
        "documentation": "The gains (losses) from changes in the fair value of investment property. [Refer: Investment property]"
       }
      },
      "en-us": {
       "role": {
        "label": "Gains (losses) on fair value adjustment, investment property",
        "terseLabel": "Loss on investment in associate"
       }
      }
     },
     "localname": "GainsLossesOnFairValueAdjustmentInvestmentProperty",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://encoreuranium.com/role/ConsolidatedComprehensiveIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_GainsLossesOnFinancialAssetsAtFairValueThroughProfitOrLoss": {
     "auth_ref": [
      "r161"
     ],
     "calculation": {
      "http://encoreuranium.com/role/ConsolidatedCashFlow": {
       "order": 11.0,
       "parentTag": "ifrs-full_CashFlowsFromUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The gains (losses) on financial assets at fair value through profit or loss. [Refer: Financial assets at fair value through profit or loss]"
       }
      },
      "en-us": {
       "role": {
        "label": "Gains (losses) on financial assets at fair value through profit or loss",
        "negatedLabel": "Settlement of asset retirement obligation"
       }
      }
     },
     "localname": "GainsLossesOnFinancialAssetsAtFairValueThroughProfitOrLoss",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://encoreuranium.com/role/ConsolidatedCashFlow"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_GainsOnDisposalsOfInvestmentProperties": {
     "auth_ref": [
      "r325"
     ],
     "calculation": {
      "http://encoreuranium.com/role/ScheduleofconsolidatedstatementsoflossandcomprehensivelossTable": {
       "order": 9.0,
       "parentTag": "ifrs-full_NetForeignExchangeLoss",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The gain on disposals of investment properties. [Refer: Investment property]"
       }
      },
      "en-us": {
       "role": {
        "label": "Gains on disposals of investment properties",
        "terseLabel": "Gain on sale of uranium investment"
       }
      }
     },
     "localname": "GainsOnDisposalsOfInvestmentProperties",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://encoreuranium.com/role/ScheduleofconsolidatedstatementsoflossandcomprehensivelossTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_GainsOnDisposalsOfInvestments": {
     "auth_ref": [
      "r41"
     ],
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The gain on the disposal of investments."
       }
      },
      "en-us": {
       "role": {
        "label": "Gains on disposals of investments",
        "terseLabel": "Gain on investment",
        "verboseLabel": "Gain on disposal of the mineral interests"
       }
      }
     },
     "localname": "GainsOnDisposalsOfInvestments",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://encoreuranium.com/role/InvestmentinuraniumDetails",
      "http://encoreuranium.com/role/MineralPropertiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_GeneralAndAdministrativeExpense": {
     "auth_ref": [
      "r325"
     ],
     "calculation": {
      "http://encoreuranium.com/role/ConsolidatedComprehensiveIncome": {
       "order": 5.0,
       "parentTag": "ifrs-full_ProfitLossFromOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of expense relating to general and administrative activities of the entity."
       }
      },
      "en-us": {
       "role": {
        "label": "General and administrative expense",
        "terseLabel": "General administrative costs"
       }
      }
     },
     "localname": "GeneralAndAdministrativeExpense",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://encoreuranium.com/role/ConsolidatedComprehensiveIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_GeographicalAreasAxis": {
     "auth_ref": [
      "r180",
      "r281",
      "r297",
      "r305"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      },
      "en-us": {
       "role": {
        "label": "Geographical areas [axis]"
       }
      }
     },
     "localname": "GeographicalAreasAxis",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://encoreuranium.com/role/ScheduleoflongtermassetsbygeographicsegmentTable",
      "http://encoreuranium.com/role/ScheduleofmineralpropertiesTable"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_GeographicalAreasMember": {
     "auth_ref": [
      "r180",
      "r281",
      "r297",
      "r305"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for aggregated geographical areas. It also represents the standard value for the 'Geographical areas' axis if no other member is used."
       }
      },
      "en-us": {
       "role": {
        "label": "Geographical areas [member]"
       }
      }
     },
     "localname": "GeographicalAreasMember",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://encoreuranium.com/role/ScheduleoflongtermassetsbygeographicsegmentTable",
      "http://encoreuranium.com/role/ScheduleofmineralpropertiesTable"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_IdentifiableAssetsAcquiredLiabilitiesAssumed": {
     "auth_ref": [
      "r299",
      "r300"
     ],
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount recognised as of the acquisition date for net identifiable assets acquired or liabilities assumed in a business combination. [Refer: Business combinations [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Identifiable assets acquired (liabilities assumed)",
        "terseLabel": "Total net assets acquired"
       }
      }
     },
     "localname": "IdentifiableAssetsAcquiredLiabilitiesAssumed",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://encoreuranium.com/role/ScheduleofnetassetsacquiredTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_ImpairmentLoss": {
     "auth_ref": [
      "r79",
      "r80"
     ],
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount recognised as a reduction of the carrying amount of an asset or cash-generating unit to its recoverable amount. [Refer: Carrying amount [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Impairment loss",
        "terseLabel": "Impairment"
       }
      }
     },
     "localname": "ImpairmentLoss",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://encoreuranium.com/role/ScheduleofpropertyplantandequipmentTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_ImpairmentLossImpairmentGainAndReversalOfImpairmentLossDeterminedInAccordanceWithIFRS9": {
     "auth_ref": [
      "r35"
     ],
     "calculation": {
      "http://encoreuranium.com/role/ConsolidatedComprehensiveIncome": {
       "order": 6.0,
       "parentTag": "ifrs-full_ProfitLossFromOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of impairment loss, impairment gain or reversal of impairment loss that is recognised in profit or loss in accordance with paragraph 5.5.8 of IFRS 9 and that arises from applying the impairment requirements in Section 5.5 of IFRS 9."
       }
      },
      "en-us": {
       "role": {
        "label": "Impairment loss (impairment gain and reversal of impairment loss) determined in accordance with IFRS 9",
        "terseLabel": "Impairment charges"
       }
      }
     },
     "localname": "ImpairmentLossImpairmentGainAndReversalOfImpairmentLossDeterminedInAccordanceWithIFRS9",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://encoreuranium.com/role/ConsolidatedComprehensiveIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_IncomeTaxExpenseContinuingOperations": {
     "auth_ref": [
      "r36",
      "r45",
      "r46",
      "r47",
      "r67",
      "r127",
      "r173"
     ],
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The aggregate amount included in the determination of profit (loss) for the period in respect of current tax and deferred tax. [Refer: Current tax expense (income); Deferred tax expense (income)]"
       }
      },
      "en-us": {
       "role": {
        "label": "Tax expense (income)",
        "terseLabel": "Income tax expense (recovery)"
       }
      }
     },
     "localname": "IncomeTaxExpenseContinuingOperations",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://encoreuranium.com/role/ScheduleoffederalandprovincialcorporatetaxratestoincomebeforetaxTable",
      "http://encoreuranium.com/role/ScheduleofincometaxexpenserecoveryTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_IncreaseDecreaseThroughExerciseOfOptions": {
     "auth_ref": [
      "r323"
     ],
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The increase (decrease) in equity resulting from the exercise of options."
       }
      },
      "en-us": {
       "role": {
        "label": "Increase (decrease) through exercise of options, equity",
        "terseLabel": "Shares issued for exercise of stock options"
       }
      }
     },
     "localname": "IncreaseDecreaseThroughExerciseOfOptions",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://encoreuranium.com/role/ShareholdersEquityType2or3"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_IncreaseDecreaseThroughExerciseOfWarrantsEquity": {
     "auth_ref": [
      "r323"
     ],
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The increase (decrease) in equity resulting from the exercise of warrants."
       }
      },
      "en-us": {
       "role": {
        "label": "Increase (decrease) through exercise of warrants, equity",
        "terseLabel": "Shares issued for exercise of warrants"
       }
      }
     },
     "localname": "IncreaseDecreaseThroughExerciseOfWarrantsEquity",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://encoreuranium.com/role/ShareholdersEquityType2or3"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_IntangibleAssetsOtherThanGoodwill": {
     "auth_ref": [
      "r15",
      "r87"
     ],
     "calculation": {
      "http://encoreuranium.com/role/ConsolidatedBalanceSheet": {
       "order": 2.0,
       "parentTag": "ifrs-full_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of identifiable non-monetary assets without physical substance. This amount does not include goodwill. [Refer: Goodwill]"
       }
      },
      "en-us": {
       "role": {
        "label": "Intangible assets other than goodwill",
        "terseLabel": "Intangible assets"
       }
      }
     },
     "localname": "IntangibleAssetsOtherThanGoodwill",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://encoreuranium.com/role/ConsolidatedBalanceSheet"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_IntangibleAssetsOtherThanGoodwillMember": {
     "auth_ref": [
      "r88",
      "r284",
      "r298"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for intangible assets other than goodwill. It also represents the standard value for the 'Classes of intangible assets other than goodwill' axis if no other member is used. [Refer: Intangible assets other than goodwill]"
       }
      },
      "en-us": {
       "role": {
        "label": "Intangible assets other than goodwill [member]"
       }
      }
     },
     "localname": "IntangibleAssetsOtherThanGoodwillMember",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://encoreuranium.com/role/ScheduleofintangibleassetwasdeterminedTable"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_IntangibleAssetsWithIndefiniteUsefulLifeAxis": {
     "auth_ref": [
      "r89"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      },
      "en-us": {
       "role": {
        "label": "Intangible assets with indefinite useful life [axis]"
       }
      }
     },
     "localname": "IntangibleAssetsWithIndefiniteUsefulLifeAxis",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://encoreuranium.com/role/ScheduleofusefullivesofpropertyplantandequipementTable"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_InterestExpense": {
     "auth_ref": [
      "r126",
      "r171",
      "r178"
     ],
     "calculation": {
      "http://encoreuranium.com/role/ConsolidatedComprehensiveIncome": {
       "order": 7.0,
       "parentTag": "ifrs-full_ProfitLossFromOperatingActivities",
       "weight": -1.0
      },
      "http://encoreuranium.com/role/ScheduleofconsolidatedstatementsoflossandcomprehensivelossTable": {
       "order": 6.0,
       "parentTag": "ifrs-full_OtherOperatingIncomeExpense",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of expense arising from interest."
       }
      },
      "en-us": {
       "role": {
        "label": "Interest expense",
        "terseLabel": "Interest expense"
       }
      }
     },
     "localname": "InterestExpense",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://encoreuranium.com/role/ConsolidatedComprehensiveIncome",
      "http://encoreuranium.com/role/ScheduleofconsolidatedstatementsoflossandcomprehensivelossTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_InterestReceivedClassifiedAsInvestingActivities": {
     "auth_ref": [
      "r100"
     ],
     "calculation": {
      "http://encoreuranium.com/role/ConsolidatedCashFlow": {
       "order": 3.0,
       "parentTag": "ifrs-full_CashFlowsFromUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The cash inflow from interest received, classified as investing activities."
       }
      },
      "en-us": {
       "role": {
        "label": "Interest received, classified as investing activities",
        "terseLabel": "Interest income received"
       }
      }
     },
     "localname": "InterestReceivedClassifiedAsInvestingActivities",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://encoreuranium.com/role/ConsolidatedCashFlow"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_InterestRevenueExpense": {
     "auth_ref": [
      "r174",
      "r178",
      "r330"
     ],
     "calculation": {
      "http://encoreuranium.com/role/ScheduleofconsolidatedstatementsoflossandcomprehensivelossTable": {
       "order": 5.0,
       "parentTag": "ifrs-full_NetForeignExchangeLoss",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of income or expense arising from interest. [Refer: Interest expense; Interest income]"
       }
      },
      "en-us": {
       "role": {
        "label": "Interest income (expense)",
        "terseLabel": "Interest income"
       }
      }
     },
     "localname": "InterestRevenueExpense",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://encoreuranium.com/role/ScheduleofconsolidatedstatementsoflossandcomprehensivelossTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_InvestmentsInAssociates": {
     "auth_ref": [
      "r68"
     ],
     "calculation": {
      "http://encoreuranium.com/role/ConsolidatedBalanceSheet": {
       "order": 4.0,
       "parentTag": "ifrs-full_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of investments in associates in an entity's separate financial statements. [Refer: Associates [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Investments in associates reported in separate financial statements",
        "terseLabel": "Investment in associate"
       }
      }
     },
     "localname": "InvestmentsInAssociates",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://encoreuranium.com/role/ConsolidatedBalanceSheet"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_InvestmentsInSubsidiariesJointVenturesAndAssociates": {
     "auth_ref": [
      "r68"
     ],
     "calculation": {
      "http://encoreuranium.com/role/ConsolidatedBalanceSheet": {
       "order": 5.0,
       "parentTag": "ifrs-full_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of investments in subsidiaries, joint ventures and associates in an entity's separate financial statements. [Refer: Associates [member]; Joint ventures [member]; Subsidiaries [member]; Investments in subsidiaries reported in separate financial statements]"
       }
      },
      "en-us": {
       "role": {
        "label": "Investments in subsidiaries, joint ventures and associates reported in separate financial statements",
        "terseLabel": "Investment in uranium"
       }
      }
     },
     "localname": "InvestmentsInSubsidiariesJointVenturesAndAssociates",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://encoreuranium.com/role/ConsolidatedBalanceSheet"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_IssueOfEquity": {
     "auth_ref": [
      "r10"
     ],
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The increase in equity through the issue of equity instruments."
       }
      },
      "en-us": {
       "role": {
        "label": "Issue of equity",
        "terseLabel": "Shares issued for services"
       }
      }
     },
     "localname": "IssueOfEquity",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://encoreuranium.com/role/ShareholdersEquityType2or3"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_IssuedCapital": {
     "auth_ref": [
      "r278"
     ],
     "calculation": {
      "http://encoreuranium.com/role/ConsolidatedBalanceSheet": {
       "order": 1.0,
       "parentTag": "ifrs-full_Equity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The nominal value of capital issued."
       }
      },
      "en-us": {
       "role": {
        "label": "Issued capital",
        "terseLabel": "Share capital"
       }
      }
     },
     "localname": "IssuedCapital",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://encoreuranium.com/role/ConsolidatedBalanceSheet"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_IssuedCapitalMember": {
     "auth_ref": [
      "r11"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for a component of equity representing issued capital."
       }
      },
      "en-us": {
       "role": {
        "label": "Issued capital [member]",
        "terseLabel": "Share subscriptions received"
       }
      }
     },
     "localname": "IssuedCapitalMember",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://encoreuranium.com/role/ShareholdersEquityType2or3"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_KeyManagementPersonnelCompensation": {
     "auth_ref": [
      "r60"
     ],
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of compensation to key management personnel. [Refer: Key management personnel of entity or parent [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Key management personnel compensation",
        "terseLabel": "Total key management compensation"
       }
      }
     },
     "localname": "KeyManagementPersonnelCompensation",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://encoreuranium.com/role/ScheduleofamountspaidtokeymanagementorentitiesprovidingsimilarservicesTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_LeaseLiabilities": {
     "auth_ref": [
      "r139"
     ],
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of liabilities related to the entity's leases. Lease is a contract, or part of a contract, that conveys the right to use an underlying asset for a period of time in exchange for consideration."
       }
      },
      "en-us": {
       "role": {
        "label": "Lease liabilities",
        "negatedLabel": "Lease liability"
       }
      }
     },
     "localname": "LeaseLiabilities",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://encoreuranium.com/role/ScheduleofnetassetsacquiredTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_Liabilities": {
     "auth_ref": [
      "r21",
      "r131",
      "r132",
      "r133",
      "r174",
      "r177"
     ],
     "calculation": {
      "http://encoreuranium.com/role/ConsolidatedBalanceSheet": {
       "order": 1.0,
       "parentTag": "ifrs-full_EquityAndLiabilities",
       "weight": 1.0
      },
      "http://encoreuranium.com/role/ScheduleofeffectoftranslationTable": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of a present obligation of the entity to transfer an economic resource as a result of past events. Economic resource is a right that has the potential to produce economic benefits."
       }
      },
      "en-us": {
       "role": {
        "label": "Liabilities",
        "totalLabel": "Total liabilities"
       }
      }
     },
     "localname": "Liabilities",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://encoreuranium.com/role/ConsolidatedBalanceSheet",
      "http://encoreuranium.com/role/ScheduleofeffectoftranslationTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_LiabilitiesArisingFromExplorationForAndEvaluationOfMineralResources": {
     "auth_ref": [
      "r160"
     ],
     "calculation": {
      "http://encoreuranium.com/role/ScheduleofincurrednoncashfinancingandinvestingactivitiesTable": {
       "order": 2.0,
       "parentTag": "cve_TotalNoncashInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of liabilities arising from the search for mineral resources, including minerals, oil, natural gas and similar non-regenerative resources after the entity has obtained legal rights to explore in a specific area, as well as the determination of the technical feasibility and commercial viability of extracting the mineral resource."
       }
      },
      "en-us": {
       "role": {
        "label": "Liabilities arising from exploration for and evaluation of mineral resources",
        "terseLabel": "Mineral property costs included in accounts payable and accrued liabilities"
       }
      }
     },
     "localname": "LiabilitiesArisingFromExplorationForAndEvaluationOfMineralResources",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://encoreuranium.com/role/ScheduleofincurrednoncashfinancingandinvestingactivitiesTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_LiabilitiesMember": {
     "auth_ref": [
      "r134"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for a present obligation of the entity to transfer an economic resource as a result of past events. Economic resource is a right that has the potential to produce economic benefits. It also represents the standard value for the 'Classes of liabilities' axis if no other member is used. [Refer: Liabilities]"
       }
      },
      "en-us": {
       "role": {
        "label": "Liabilities [member]"
       }
      }
     },
     "localname": "LiabilitiesMember",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://encoreuranium.com/role/EventsafterthereportingperiodDetails",
      "http://encoreuranium.com/role/MineralPropertiesDetails",
      "http://encoreuranium.com/role/ScheduleofmineralpropertiesTable"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_LoansAndReceivables": {
     "auth_ref": [
      "r185"
     ],
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of non-derivative financial assets with fixed or determinable payments that are not quoted in an active market, other than: (a) those that the entity intends to sell immediately or in the near term, which shall be classified as held for trading, and those that the entity, upon initial recognition, designates as at fair value through profit or loss; (b) those that the entity, upon initial recognition, designates as available for sale; or (c) those for which the holder may not recover substantially all of its initial investment, other than because of credit deterioration, which shall be classified as available for sale. An interest acquired in a pool of assets that are not loans or receivables (for example, an interest in a mutual fund or a similar fund) is not a loan or receivable. [Refer: Derivative financial assets]"
       }
      },
      "en-us": {
       "role": {
        "label": "Loans and receivables",
        "terseLabel": "Loan receivable"
       }
      }
     },
     "localname": "LoansAndReceivables",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://encoreuranium.com/role/ScheduleofnetassetsacquiredTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_LongtermDeposits": {
     "auth_ref": [
      "r327"
     ],
     "calculation": {
      "http://encoreuranium.com/role/ConsolidatedBalanceSheet": {
       "order": 8.0,
       "parentTag": "ifrs-full_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of long-term deposits held by the entity."
       }
      },
      "en-us": {
       "role": {
        "label": "Long-term deposits",
        "terseLabel": "Reclamation deposits",
        "verboseLabel": "Cash bonds"
       }
      }
     },
     "localname": "LongtermDeposits",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://encoreuranium.com/role/ConsolidatedBalanceSheet",
      "http://encoreuranium.com/role/MineralPropertiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_LongtermProvisionForDecommissioningRestorationAndRehabilitationCosts": {
     "auth_ref": [
      "r285",
      "r286"
     ],
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of non-current provision for decommissioning, restoration and rehabilitation costs. [Refer: Provision for decommissioning, restoration and rehabilitation costs]"
       }
      },
      "en-us": {
       "role": {
        "label": "Non-current provision for decommissioning, restoration and rehabilitation costs",
        "terseLabel": "Balance (Long Term), December 31, 2022"
       }
      }
     },
     "localname": "LongtermProvisionForDecommissioningRestorationAndRehabilitationCosts",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://encoreuranium.com/role/ScheduleofchangeinthelongTermleaseliabilityTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_LossesOnDisposalsOfInvestments": {
     "auth_ref": [
      "r41"
     ],
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The losses on the disposal of investments."
       }
      },
      "en-us": {
       "role": {
        "label": "Losses on disposals of investments",
        "terseLabel": "Losses on disposals of investments"
       }
      }
     },
     "localname": "LossesOnDisposalsOfInvestments",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://encoreuranium.com/role/MineralPropertiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_MaturityAnalysisForDerivativeFinancialLiabilities": {
     "auth_ref": [
      "r166"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The disclosure of a maturity analysis for derivative financial liabilities, including the remaining contractual maturities for those derivative financial liabilities for which contractual maturities are essential for an understanding of the timing of the cash flows. [Refer: Derivative financial liabilities]"
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of maturity analysis for derivative financial liabilities [text block]",
        "terseLabel": "Schedule of undiscounted future lease payments"
       }
      }
     },
     "localname": "MaturityAnalysisForDerivativeFinancialLiabilities",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://encoreuranium.com/role/RightofuseassetsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_MiningAssets": {
     "auth_ref": [
      "r332"
     ],
     "calculation": {
      "http://encoreuranium.com/role/ConsolidatedBalanceSheet": {
       "order": 7.0,
       "parentTag": "ifrs-full_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of assets related to mining activities of the entity."
       }
      },
      "en-us": {
       "role": {
        "label": "Mining assets",
        "periodEndLabel": "Balance",
        "periodStartLabel": "Balance, December 31, 2020",
        "terseLabel": "Mineral properties"
       }
      }
     },
     "localname": "MiningAssets",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://encoreuranium.com/role/ConsolidatedBalanceSheet",
      "http://encoreuranium.com/role/ScheduleofmineralpropertiesTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_NetDeferredTaxAssets": {
     "auth_ref": [
      "r331"
     ],
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of deferred tax assets net of deferred tax liabilities, when the absolute amount of deferred tax assets is greater than the absolute amount of deferred tax liabilities. [Refer: Deferred tax assets; Deferred tax liabilities]"
       }
      },
      "en-us": {
       "role": {
        "label": "Net deferred tax assets",
        "terseLabel": "Net deferred tax assets",
        "verboseLabel": "Net deferred tax liability"
       }
      }
     },
     "localname": "NetDeferredTaxAssets",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://encoreuranium.com/role/ScheduleofdeferredtaxliabilitiesTable",
      "http://encoreuranium.com/role/ScheduleofincometaxexpenserecoveryTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_NetForeignExchangeLoss": {
     "auth_ref": [
      "r326",
      "r336"
     ],
     "calculation": {
      "http://encoreuranium.com/role/ScheduleofconsolidatedstatementsoflossandcomprehensivelossTable": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The net loss arising from exchange differences recognised in profit or loss, excluding those arising on financial instruments measured at fair value through profit or loss in accordance with IFRS 9. [Refer: Foreign exchange gain (loss)]"
       }
      },
      "en-us": {
       "role": {
        "label": "Net foreign exchange loss",
        "negatedTotalLabel": "Net loss for the year"
       }
      }
     },
     "localname": "NetForeignExchangeLoss",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://encoreuranium.com/role/ScheduleofconsolidatedstatementsoflossandcomprehensivelossTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_NetInvestmentInFinanceLease": {
     "auth_ref": [
      "r143"
     ],
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The gross investment in the finance lease discounted at the interest rate implicit in the lease. Finance lease is a lease that transfers substantially all the risks and rewards incidental to ownership of an underlying asset. Gross investment in the finance lease is the sum of: (a) the lease payments receivable by a lessor under a finance lease; and (b) any unguaranteed residual value accruing to the lessor. Interest rate implicit in the lease is the rate of interest that causes the present value of (a) the lease payments and (b) the unguaranteed residual value to equal to the sum of (i) the fair value of the underlying asset and (ii) the initial direct costs of the lessor."
       }
      },
      "en-us": {
       "role": {
        "label": "Net investment in finance lease",
        "terseLabel": "Total"
       }
      }
     },
     "localname": "NetInvestmentInFinanceLease",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://encoreuranium.com/role/ScheduleofundiscountedfutureleasepaymentsTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_NonadjustingEventsAfterReportingPeriodAxis": {
     "auth_ref": [
      "r43"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      },
      "en-us": {
       "role": {
        "label": "Non-adjusting events after reporting period [axis]"
       }
      }
     },
     "localname": "NonadjustingEventsAfterReportingPeriodAxis",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://encoreuranium.com/role/EventsafterthereportingperiodDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_NonadjustingEventsMember": {
     "auth_ref": [
      "r43"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for events that occur between the end of the reporting period and the date when the financial statements are authorised for issue and are indicative of conditions that arose after the reporting period. It also represents the standard value for the 'Non-adjusting events after reporting period' axis if no other member is used."
       }
      },
      "en-us": {
       "role": {
        "label": "Non-adjusting events after reporting period [member]"
       }
      }
     },
     "localname": "NonadjustingEventsMember",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://encoreuranium.com/role/EventsafterthereportingperiodDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_NoncurrentAssets": {
     "auth_ref": [
      "r23",
      "r119",
      "r294"
     ],
     "calculation": {
      "http://encoreuranium.com/role/ScheduleofeffectoftranslationTable": {
       "order": 2.0,
       "parentTag": "ifrs-full_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of assets that do not meet the definition of current assets. [Refer: Current assets]"
       }
      },
      "en-us": {
       "role": {
        "label": "Non-current assets",
        "terseLabel": "Non-current assets"
       }
      }
     },
     "localname": "NoncurrentAssets",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://encoreuranium.com/role/ScheduleofeffectoftranslationTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_NoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSaleOrAsHeldForDistributionToOwners": {
     "auth_ref": [
      "r18"
     ],
     "calculation": {
      "http://encoreuranium.com/role/ConsolidatedBalanceSheet": {
       "order": 5.0,
       "parentTag": "ifrs-full_CurrentAssets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of non-current assets or disposal groups classified as held for sale or as held for distribution to owners. [Refer: Non-current assets or disposal groups classified as held for distribution to owners; Non-current assets or disposal groups classified as held for sale]"
       }
      },
      "en-us": {
       "role": {
        "label": "Non-current assets or disposal groups classified as held for sale or as held for distribution to owners",
        "terseLabel": "Assets held for sale",
        "verboseLabel": "Non-current assets or disposal groups classified as held for sale or as held for distribution to owners"
       }
      }
     },
     "localname": "NoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSaleOrAsHeldForDistributionToOwners",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://encoreuranium.com/role/ConsolidatedBalanceSheet",
      "http://encoreuranium.com/role/MineralPropertiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_NoncurrentFinancialAssets": {
     "auth_ref": [
      "r162"
     ],
     "calculation": {
      "http://encoreuranium.com/role/ConsolidatedBalanceSheet": {
       "order": 11.0,
       "parentTag": "ifrs-full_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of non-current financial assets. [Refer: Financial assets]"
       }
      },
      "en-us": {
       "role": {
        "label": "Non-current financial assets",
        "terseLabel": "Deferred financing costs"
       }
      }
     },
     "localname": "NoncurrentFinancialAssets",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://encoreuranium.com/role/ConsolidatedBalanceSheet"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_NoncurrentLeaseLiabilities": {
     "auth_ref": [
      "r139"
     ],
     "calculation": {
      "http://encoreuranium.com/role/ConsolidatedBalanceSheet": {
       "order": 3.0,
       "parentTag": "ifrs-full_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of non-current lease liabilities. [Refer: Lease liabilities]"
       }
      },
      "en-us": {
       "role": {
        "label": "Non-current lease liabilities",
        "terseLabel": "Lease liability - non-current"
       }
      }
     },
     "localname": "NoncurrentLeaseLiabilities",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://encoreuranium.com/role/ConsolidatedBalanceSheet"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_NoncurrentLiabilities": {
     "auth_ref": [
      "r24",
      "r121",
      "r294"
     ],
     "calculation": {
      "http://encoreuranium.com/role/ScheduleofeffectoftranslationTable": {
       "order": 2.0,
       "parentTag": "ifrs-full_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of liabilities that do not meet the definition of current liabilities. [Refer: Current liabilities]"
       }
      },
      "en-us": {
       "role": {
        "label": "Non-current liabilities",
        "terseLabel": "Non-current liabilities"
       }
      }
     },
     "localname": "NoncurrentLiabilities",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://encoreuranium.com/role/ScheduleofeffectoftranslationTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_NoncurrentRestrictedCashAndCashEquivalents": {
     "auth_ref": [
      "r327"
     ],
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of non-current restricted cash and cash equivalents. [Refer: Restricted cash and cash equivalents]"
       }
      },
      "en-us": {
       "role": {
        "label": "Non-current restricted cash and cash equivalents",
        "terseLabel": "Restricted cash"
       }
      }
     },
     "localname": "NoncurrentRestrictedCashAndCashEquivalents",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://encoreuranium.com/role/ScheduleofnetassetsacquiredTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_NotionalAmount": {
     "auth_ref": [
      "r325"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The nominal or face amount of a financial instrument, used to calculate payments made on that instrument."
       }
      },
      "en-us": {
       "role": {
        "label": "Notional amount",
        "terseLabel": "Financial instrument"
       }
      }
     },
     "localname": "NotionalAmount",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://encoreuranium.com/role/FinancialInstrumentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_NumberOfSharesIssued": {
     "auth_ref": [
      "r323"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The number of shares issued by the entity."
       }
      },
      "en-us": {
       "role": {
        "label": "Number of shares issued",
        "terseLabel": "Issuance shares",
        "verboseLabel": "Shares issued (in Shares)"
       }
      }
     },
     "localname": "NumberOfSharesIssued",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://encoreuranium.com/role/AssetacquisitionDetails",
      "http://encoreuranium.com/role/EventsafterthereportingperiodDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "ifrs-full_NumberOfSharesIssuedAndFullyPaid": {
     "auth_ref": [
      "r28"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The number of shares issued by the entity, for which full payment has been received."
       }
      },
      "en-us": {
       "role": {
        "label": "Number of shares issued and fully paid",
        "terseLabel": "Shares issued",
        "verboseLabel": "Shares (in Shares)"
       }
      }
     },
     "localname": "NumberOfSharesIssuedAndFullyPaid",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://encoreuranium.com/role/MarketableSecuritiesDetails",
      "http://encoreuranium.com/role/MineralPropertiesDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "ifrs-full_NumberOfSharesOutstanding": {
     "auth_ref": [
      "r30"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The number of shares that have been authorised and issued, reduced by treasury shares held. [Refer: Treasury shares]"
       }
      },
      "en-us": {
       "role": {
        "label": "Number of shares outstanding",
        "periodEndLabel": "Balance as of ending (in Shares)",
        "periodStartLabel": "Balance as of beginning (in Shares)",
        "terseLabel": "Shares Outstanding"
       }
      }
     },
     "localname": "NumberOfSharesOutstanding",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://encoreuranium.com/role/AssetacquisitionDetails",
      "http://encoreuranium.com/role/ShareholdersEquityType2or3"
     ],
     "xbrltype": "sharesItemType"
    },
    "ifrs-full_OrdinarySharesMember": {
     "auth_ref": [
      "r73",
      "r329"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for equity instruments that are subordinate to all other classes of equity instruments. It also represents the standard value for the 'Classes of ordinary shares' axis if no other member is used."
       }
      },
      "en-us": {
       "role": {
        "label": "Ordinary shares [member]"
       }
      }
     },
     "localname": "OrdinarySharesMember",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://encoreuranium.com/role/MarketableSecuritiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_OtherAssets": {
     "auth_ref": [
      "r327"
     ],
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of assets that the entity does not separately disclose in the same statement or note."
       }
      },
      "en-us": {
       "role": {
        "label": "Other assets",
        "terseLabel": "Assets, Total"
       }
      }
     },
     "localname": "OtherAssets",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://encoreuranium.com/role/ScheduleofproportionalshareintheassociateTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_OtherCashAndCashEquivalents": {
     "auth_ref": [
      "r344"
     ],
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of cash and cash equivalents that the entity does not separately disclose in the same statement or note. [Refer: Cash and cash equivalents]"
       }
      },
      "en-us": {
       "role": {
        "label": "Other cash and cash equivalents",
        "terseLabel": "Cash"
       }
      }
     },
     "localname": "OtherCashAndCashEquivalents",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://encoreuranium.com/role/ScheduleofnetassetsacquiredTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_OtherComprehensiveIncomeBeforeTaxExchangeDifferencesOnTranslation": {
     "auth_ref": [
      "r25",
      "r38"
     ],
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of other comprehensive income, before tax, after reclassification adjustments, related to exchange differences on translation of financial statements of foreign operations. [Refer: Other comprehensive income, before tax]"
       }
      },
      "en-us": {
       "role": {
        "label": "Other comprehensive income, before tax, exchange differences on translation of foreign operations",
        "terseLabel": "Exchange differences on translation foreign operations"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeBeforeTaxExchangeDifferencesOnTranslation",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://encoreuranium.com/role/ScheduleofconsolidatedstatementsoflossandcomprehensivelossTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_OtherComprehensiveIncomeNetOfTaxChangeInValueOfForeignCurrencyBasisSpreads": {
     "auth_ref": [
      "r25",
      "r37"
     ],
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of other comprehensive income, net of tax, after reclassification adjustments, related to change in value of foreign currency basis spreads. [Refer: Other comprehensive income]"
       }
      },
      "en-us": {
       "role": {
        "label": "Other comprehensive income, net of tax, change in value of foreign currency basis spreads",
        "terseLabel": "Currency translation adjustment"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeNetOfTaxChangeInValueOfForeignCurrencyBasisSpreads",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://encoreuranium.com/role/ScheduleofthefairvalueofthephysicaluraniuminvestmentTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation": {
     "auth_ref": [
      "r25",
      "r37"
     ],
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of other comprehensive income, net of tax, after reclassification adjustments, related to exchange differences when financial statements of foreign operations are translated. [Refer: Other comprehensive income]"
       }
      },
      "en-us": {
       "role": {
        "label": "Other comprehensive income, net of tax, exchange differences on translation of foreign operations",
        "terseLabel": "Currency translation adjustment"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://encoreuranium.com/role/ScheduleofpropertyplantandequipmentTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_OtherComprehensiveIncomeNetOfTaxHedgesOfNetInvestmentsInForeignOperations": {
     "auth_ref": [
      "r37",
      "r91",
      "r182"
     ],
     "calculation": {
      "http://encoreuranium.com/role/ConsolidatedComprehensiveIncome": {
       "order": 2.0,
       "parentTag": "ifrs-full_ComprehensiveIncome",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of other comprehensive income, net of tax, after reclassification adjustments, related to hedges of net investments in foreign operations. [Refer: Other comprehensive income]"
       }
      },
      "en-us": {
       "role": {
        "label": "Other comprehensive income, net of tax, hedges of net investments in foreign operations",
        "terseLabel": "Foreign currency translation adjustment"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeNetOfTaxHedgesOfNetInvestmentsInForeignOperations",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://encoreuranium.com/role/ConsolidatedComprehensiveIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_OtherCurrentAssets": {
     "auth_ref": [
      "r327"
     ],
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of current assets that the entity does not separately disclose in the same statement or note. [Refer: Current assets]"
       }
      },
      "en-us": {
       "role": {
        "label": "Other current assets",
        "terseLabel": "Assets, Current"
       }
      }
     },
     "localname": "OtherCurrentAssets",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://encoreuranium.com/role/ScheduleofproportionalshareintheassociateTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_OtherCurrentLiabilities": {
     "auth_ref": [
      "r327"
     ],
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of current liabilities that the entity does not separately disclose in the same statement or note. [Refer: Current liabilities]"
       }
      },
      "en-us": {
       "role": {
        "label": "Other current liabilities",
        "terseLabel": "Liabilities, Current"
       }
      }
     },
     "localname": "OtherCurrentLiabilities",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://encoreuranium.com/role/ScheduleofproportionalshareintheassociateTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_OtherCurrentPayables": {
     "auth_ref": [
      "r327"
     ],
     "calculation": {
      "http://encoreuranium.com/role/ConsolidatedBalanceSheet": {
       "order": 3.0,
       "parentTag": "ifrs-full_CurrentLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of current payables that the entity does not separately disclose in the same statement or note."
       }
      },
      "en-us": {
       "role": {
        "label": "Other current payables",
        "terseLabel": "Note payable"
       }
      }
     },
     "localname": "OtherCurrentPayables",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://encoreuranium.com/role/ConsolidatedBalanceSheet"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_OtherExpenseByNature": {
     "auth_ref": [
      "r42",
      "r274"
     ],
     "calculation": {
      "http://encoreuranium.com/role/ScheduleofconsolidatedstatementsoflossandcomprehensivelossTable": {
       "order": 9.0,
       "parentTag": "ifrs-full_OtherOperatingIncomeExpense",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of expenses that the entity does not separately disclose in the same statement or note when the entity uses the 'nature of expense' form for its analysis of expenses. [Refer: Expenses, by nature]"
       }
      },
      "en-us": {
       "role": {
        "label": "Other expenses, by nature",
        "terseLabel": "Promotion and shareholder communication"
       }
      }
     },
     "localname": "OtherExpenseByNature",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://encoreuranium.com/role/ScheduleofconsolidatedstatementsoflossandcomprehensivelossTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_OtherInflowsOutflowsOfCashClassifiedAsOperatingActivities": {
     "auth_ref": [
      "r96"
     ],
     "calculation": {
      "http://encoreuranium.com/role/ConsolidatedCashFlow": {
       "order": 12.0,
       "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "Inflows (outflows) of cash, classified as operating activities, that the entity does not separately disclose in the same statement or note."
       }
      },
      "en-us": {
       "role": {
        "label": "Other inflows (outflows) of cash, classified as operating activities",
        "terseLabel": "Restricted cash"
       }
      }
     },
     "localname": "OtherInflowsOutflowsOfCashClassifiedAsOperatingActivities",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://encoreuranium.com/role/ConsolidatedCashFlow"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_OtherIntangibleAssets": {
     "auth_ref": [
      "r338"
     ],
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of intangible assets that the entity does not separately disclose in the same statement or note. [Refer: Intangible assets other than goodwill]"
       }
      },
      "en-us": {
       "role": {
        "label": "Other intangible assets",
        "negatedLabel": "Intangible assets"
       }
      }
     },
     "localname": "OtherIntangibleAssets",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://encoreuranium.com/role/ScheduleofdeferredtaxliabilitiesTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_OtherLiabilities": {
     "auth_ref": [
      "r327"
     ],
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of liabilities that the entity does not separately disclose in the same statement or note."
       }
      },
      "en-us": {
       "role": {
        "label": "Other liabilities",
        "terseLabel": "Liabilities, Total"
       }
      }
     },
     "localname": "OtherLiabilities",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://encoreuranium.com/role/ScheduleofproportionalshareintheassociateTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_OtherNoncurrentAssets": {
     "auth_ref": [
      "r327"
     ],
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of non-current assets that the entity does not separately disclose in the same statement or note. [Refer: Non-current assets]"
       }
      },
      "en-us": {
       "role": {
        "label": "Other non-current assets",
        "terseLabel": "Assets, Non-current"
       }
      }
     },
     "localname": "OtherNoncurrentAssets",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://encoreuranium.com/role/ScheduleofproportionalshareintheassociateTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_OtherNoncurrentLiabilities": {
     "auth_ref": [
      "r327"
     ],
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of non-current liabilities that the entity does not separately disclose in the same statement or note. [Refer: Non-current liabilities]"
       }
      },
      "en-us": {
       "role": {
        "label": "Other non-current liabilities",
        "terseLabel": "Liabilities Non-current"
       }
      }
     },
     "localname": "OtherNoncurrentLiabilities",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://encoreuranium.com/role/ScheduleofproportionalshareintheassociateTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_OtherOperatingIncomeExpense": {
     "auth_ref": [
      "r330"
     ],
     "calculation": {
      "http://encoreuranium.com/role/ScheduleofconsolidatedstatementsoflossandcomprehensivelossTable": {
       "order": 4.0,
       "parentTag": "ifrs-full_NetForeignExchangeLoss",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of operating income (expense) that the entity does not separately disclose in the same statement or note."
       }
      },
      "en-us": {
       "role": {
        "label": "Other operating income (expense)",
        "terseLabel": "Expenses Total",
        "totalLabel": "Loss from operating expenses"
       }
      }
     },
     "localname": "OtherOperatingIncomeExpense",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://encoreuranium.com/role/ScheduleofconsolidatedstatementsoflossandcomprehensivelossTable",
      "http://encoreuranium.com/role/ScheduleofproportionalshareintheassociateTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_OtherPropertyPlantAndEquipmentMember": {
     "auth_ref": [
      "r332"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for a class of property, plant and equipment representing property, plant and equipment that the entity does not separately disclose in the same statement or note. [Refer: Property, plant and equipment]"
       }
      },
      "en-us": {
       "role": {
        "label": "Other property, plant and equipment [member]",
        "terseLabel": "Other property, plant and equipment [member]"
       }
      }
     },
     "localname": "OtherPropertyPlantAndEquipmentMember",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://encoreuranium.com/role/ScheduleofpropertyplantandequipmentTable",
      "http://encoreuranium.com/role/ScheduleofusefullivesofpropertyplantandequipementTable"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_OtherRevenue": {
     "auth_ref": [
      "r325"
     ],
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of revenue arising from sources that the entity does not separately disclose in the same statement or note. [Refer: Revenue]"
       }
      },
      "en-us": {
       "role": {
        "label": "Other revenue",
        "terseLabel": "Revenues, Total"
       }
      }
     },
     "localname": "OtherRevenue",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://encoreuranium.com/role/ScheduleofproportionalshareintheassociateTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_ParValuePerShare": {
     "auth_ref": [
      "r29"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The nominal value per share."
       }
      },
      "en-us": {
       "role": {
        "label": "Par value per share",
        "terseLabel": "Price per share (in Dollars per share)"
       }
      }
     },
     "localname": "ParValuePerShare",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://encoreuranium.com/role/MarketableSecuritiesDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "ifrs-full_PaymentsForShareIssueCosts": {
     "auth_ref": [
      "r340"
     ],
     "calculation": {
      "http://encoreuranium.com/role/ConsolidatedCashFlow": {
       "order": 5.0,
       "parentTag": "ifrs-full_CashFlowsFromUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The cash outflow for share issue costs."
       }
      },
      "en-us": {
       "role": {
        "label": "Payments for share issue costs",
        "negatedLabel": "Share issue costs"
       }
      }
     },
     "localname": "PaymentsForShareIssueCosts",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://encoreuranium.com/role/ConsolidatedCashFlow"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities": {
     "auth_ref": [
      "r292"
     ],
     "calculation": {
      "http://encoreuranium.com/role/ConsolidatedCashFlow": {
       "order": 7.0,
       "parentTag": "ifrs-full_CashFlowsFromUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The cash outflow for payment of lease liabilities, classified as financing activities. [Refer: Lease liabilities]"
       }
      },
      "en-us": {
       "role": {
        "label": "Payments of lease liabilities, classified as financing activities",
        "negatedLabel": "Lease payments"
       }
      }
     },
     "localname": "PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://encoreuranium.com/role/ConsolidatedCashFlow"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_PercentageOfVotingEquityInterestsAcquired": {
     "auth_ref": [
      "r154"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The percentage of voting equity interests acquired in a business combination. [Refer: Business combinations [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Percentage of voting equity interests acquired",
        "terseLabel": "Voting rights"
       }
      }
     },
     "localname": "PercentageOfVotingEquityInterestsAcquired",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://encoreuranium.com/role/SignificantaccountingpoliciesDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "ifrs-full_PlanAssetsAtFairValue": {
     "auth_ref": [
      "r334"
     ],
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The fair value of defined benefit plan assets. Plan assets comprise assets held by a long-term employee benefit fund and qualifying insurance policies. [Refer: At fair value [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Plan assets, at fair value",
        "terseLabel": "Fair value",
        "verboseLabel": "Fair value of uravan minerals"
       }
      }
     },
     "localname": "PlanAssetsAtFairValue",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://encoreuranium.com/role/IntangibleassetsDetails",
      "http://encoreuranium.com/role/MineralPropertiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_Prepayments": {
     "auth_ref": [
      "r277"
     ],
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "Receivables that represent amounts paid for goods and services before they have been delivered."
       }
      },
      "en-us": {
       "role": {
        "label": "Prepayments",
        "terseLabel": "Prepaids"
       }
      }
     },
     "localname": "Prepayments",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://encoreuranium.com/role/ScheduleofnetassetsacquiredTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_PreviouslyStatedMember": {
     "auth_ref": [
      "r8",
      "r106",
      "r107",
      "r108"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for the information previously stated in the financial statements (ie before retrospective application or retrospective restatement)."
       }
      },
      "en-us": {
       "role": {
        "label": "Previously stated [member]",
        "terseLabel": "Previously stated [member]"
       }
      }
     },
     "localname": "PreviouslyStatedMember",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://encoreuranium.com/role/ScheduleofeffectoftranslationTable"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_ProceedsFromExerciseOfOptions": {
     "auth_ref": [
      "r340"
     ],
     "calculation": {
      "http://encoreuranium.com/role/ConsolidatedCashFlow": {
       "order": 3.0,
       "parentTag": "ifrs-full_CashFlowsFromUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The cash inflow from the exercise of options."
       }
      },
      "en-us": {
       "role": {
        "label": "Proceeds from exercise of options",
        "terseLabel": "Proceeds from exercise of stock options",
        "verboseLabel": "Replacement of options held (in Dollars)"
       }
      }
     },
     "localname": "ProceedsFromExerciseOfOptions",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://encoreuranium.com/role/AssetacquisitionDetails",
      "http://encoreuranium.com/role/ConsolidatedCashFlow"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_ProceedsFromExerciseOfWarrants": {
     "auth_ref": [
      "r340"
     ],
     "calculation": {
      "http://encoreuranium.com/role/ConsolidatedCashFlow": {
       "order": 2.0,
       "parentTag": "ifrs-full_CashFlowsFromUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The cash inflow from the exercise of share purchase warrants."
       }
      },
      "en-us": {
       "role": {
        "label": "Proceeds from exercise of warrants",
        "terseLabel": "Proceeds from exercise of warrants",
        "verboseLabel": "Replacement of warrants held (in Dollars)"
       }
      }
     },
     "localname": "ProceedsFromExerciseOfWarrants",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://encoreuranium.com/role/AssetacquisitionDetails",
      "http://encoreuranium.com/role/ConsolidatedCashFlow"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_ProceedsFromIssuingShares": {
     "auth_ref": [
      "r290"
     ],
     "calculation": {
      "http://encoreuranium.com/role/ConsolidatedCashFlow": {
       "order": 4.0,
       "parentTag": "ifrs-full_CashFlowsFromUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The cash inflow from issuing shares."
       }
      },
      "en-us": {
       "role": {
        "label": "Proceeds from issuing shares",
        "terseLabel": "Share subscriptions received"
       }
      }
     },
     "localname": "ProceedsFromIssuingShares",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://encoreuranium.com/role/ConsolidatedCashFlow"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_ProceedsFromSalesOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities": {
     "auth_ref": [
      "r289"
     ],
     "calculation": {
      "http://encoreuranium.com/role/ConsolidatedCashFlow": {
       "order": 1.0,
       "parentTag": "ifrs-full_CashFlowsFromUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The cash inflow from sales of property, plant and equipment, classified as investing activities. [Refer: Property, plant and equipment]"
       }
      },
      "en-us": {
       "role": {
        "label": "Proceeds from sales of property, plant and equipment, classified as investing activities",
        "terseLabel": "Proceeds from divestment of mineral properties",
        "verboseLabel": "Disposal of the mineral interests"
       }
      }
     },
     "localname": "ProceedsFromSalesOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://encoreuranium.com/role/ConsolidatedCashFlow",
      "http://encoreuranium.com/role/MineralPropertiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_ProfessionalFeesExpense": {
     "auth_ref": [
      "r325"
     ],
     "calculation": {
      "http://encoreuranium.com/role/ConsolidatedComprehensiveIncome": {
       "order": 9.0,
       "parentTag": "ifrs-full_ProfitLossFromOperatingActivities",
       "weight": -1.0
      },
      "http://encoreuranium.com/role/ScheduleofconsolidatedstatementsoflossandcomprehensivelossTable": {
       "order": 8.0,
       "parentTag": "ifrs-full_OtherOperatingIncomeExpense",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of fees paid or payable for professional services."
       }
      },
      "en-us": {
       "role": {
        "label": "Professional fees expense",
        "terseLabel": "Professional fees"
       }
      }
     },
     "localname": "ProfessionalFeesExpense",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://encoreuranium.com/role/ConsolidatedComprehensiveIncome",
      "http://encoreuranium.com/role/ScheduleofconsolidatedstatementsoflossandcomprehensivelossTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_ProfitLoss": {
     "auth_ref": [
      "r9",
      "r33",
      "r97",
      "r110",
      "r113",
      "r174",
      "r175",
      "r294",
      "r304",
      "r307"
     ],
     "calculation": {
      "http://encoreuranium.com/role/ConsolidatedCashFlow": {
       "order": 1.0,
       "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities",
       "weight": 1.0
      },
      "http://encoreuranium.com/role/ConsolidatedComprehensiveIncome": {
       "order": 1.0,
       "parentTag": "ifrs-full_ComprehensiveIncome",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The total of income less expenses from continuing and discontinued operations, excluding the components of other comprehensive income. [Refer: Other comprehensive income]"
       }
      },
      "en-us": {
       "role": {
        "label": "Profit (loss)",
        "terseLabel": "Net loss for the year",
        "totalLabel": "Net loss for the year",
        "verboseLabel": "Loss for the year"
       }
      }
     },
     "localname": "ProfitLoss",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://encoreuranium.com/role/ConsolidatedCashFlow",
      "http://encoreuranium.com/role/ConsolidatedComprehensiveIncome",
      "http://encoreuranium.com/role/ShareholdersEquityType2or3"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_ProfitLossBeforeTax": {
     "auth_ref": [
      "r159",
      "r274",
      "r275",
      "r302",
      "r303"
     ],
     "calculation": {
      "http://encoreuranium.com/role/ScheduleofunrecognizeddeferredtaxassetsTable": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The profit (loss) before tax expense or income. [Refer: Profit (loss)]"
       }
      },
      "en-us": {
       "role": {
        "label": "Profit (loss) before tax",
        "totalLabel": "Total"
       }
      }
     },
     "localname": "ProfitLossBeforeTax",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://encoreuranium.com/role/ScheduleofunrecognizeddeferredtaxassetsTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_ProfitLossFromOperatingActivities": {
     "auth_ref": [
      "r283",
      "r330"
     ],
     "calculation": {
      "http://encoreuranium.com/role/ConsolidatedComprehensiveIncome": {
       "order": 1.0,
       "parentTag": "ifrs-full_ProfitLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The profit (loss) from operating activities of the entity. [Refer: Profit (loss)]"
       }
      },
      "en-us": {
       "role": {
        "label": "Profit (loss) from operating activities",
        "totalLabel": "Loss from operating expenses"
       }
      }
     },
     "localname": "ProfitLossFromOperatingActivities",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://encoreuranium.com/role/ConsolidatedComprehensiveIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_PropertyPlantAndEquipment": {
     "auth_ref": [
      "r14",
      "r52"
     ],
     "calculation": {
      "http://encoreuranium.com/role/ConsolidatedBalanceSheet": {
       "order": 3.0,
       "parentTag": "ifrs-full_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of tangible assets that: (a) are held for use in the production or supply of goods or services, for rental to others, or for administrative purposes; and (b) are expected to be used during more than one period."
       }
      },
      "en-us": {
       "role": {
        "label": "Property, plant and equipment",
        "terseLabel": "Property, plant, and equipment"
       }
      }
     },
     "localname": "PropertyPlantAndEquipment",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://encoreuranium.com/role/ConsolidatedBalanceSheet"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_PropertyPlantAndEquipmentCarryingAmountAtCostOfRevaluedAssets": {
     "auth_ref": [
      "r54"
     ],
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of property, plant and equipment that would have been recognised had the revalued assets been carried under the cost model. [Refer: Property, plant and equipment]"
       }
      },
      "en-us": {
       "role": {
        "label": "Property, plant and equipment, revalued assets, at cost",
        "periodEndLabel": "Balance as of ending",
        "periodStartLabel": "Balance as of beginning"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentCarryingAmountAtCostOfRevaluedAssets",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://encoreuranium.com/role/ScheduleofpropertyplantandequipmentTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_PropertyPlantAndEquipmentMember": {
     "auth_ref": [
      "r53",
      "r284",
      "r298"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for property, plant and equipment. It also represents the standard value for the 'Classes of property, plant and equipment' axis if no other member is used. [Refer: Property, plant and equipment]"
       }
      },
      "en-us": {
       "role": {
        "label": "Property, plant and equipment [member]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentMember",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://encoreuranium.com/role/ScheduleofpropertyplantandequipmentTable"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate": {
     "auth_ref": [
      "r299",
      "r300"
     ],
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount recognised as of the acquisition date for plant, property and equipment acquired in a business combination. [Refer: Property, plant and equipment; Business combinations [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Property, plant and equipment recognised as of acquisition date",
        "terseLabel": "Property, plant, and equipment"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://encoreuranium.com/role/ScheduleofnetassetsacquiredTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_ProportionOfOwnershipInterestInAssociate": {
     "auth_ref": [
      "r69",
      "r71",
      "r116"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The proportion of ownership interest in an associate attributable to the entity. [Refer: Associates [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Proportion of ownership interest in associate",
        "terseLabel": "Ownership percentage"
       }
      }
     },
     "localname": "ProportionOfOwnershipInterestInAssociate",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://encoreuranium.com/role/InvestmentInAssociateDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "ifrs-full_ProportionOfOwnershipInterestInSubsidiary": {
     "auth_ref": [
      "r69",
      "r71",
      "r114"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The proportion of ownership interest in a subsidiary attributable to the entity. [Refer: Subsidiaries [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Proportion of ownership interest in subsidiary",
        "terseLabel": "Ownership Interest"
       }
      }
     },
     "localname": "ProportionOfOwnershipInterestInSubsidiary",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://encoreuranium.com/role/ScheduleofsignificantsubsidiariesTable"
     ],
     "xbrltype": "percentItemType"
    },
    "ifrs-full_PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities": {
     "auth_ref": [
      "r288"
     ],
     "calculation": {
      "http://encoreuranium.com/role/ConsolidatedCashFlow": {
       "order": 5.0,
       "parentTag": "ifrs-full_CashFlowsFromUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The cash outflow for the purchases of intangible assets, classified as investing activities. [Refer: Intangible assets other than goodwill]"
       }
      },
      "en-us": {
       "role": {
        "label": "Purchase of intangible assets, classified as investing activities",
        "negatedLabel": "Acquisition of intangible assets"
       }
      }
     },
     "localname": "PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://encoreuranium.com/role/ConsolidatedCashFlow"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_PurchaseOfInvestmentProperty": {
     "auth_ref": [
      "r339"
     ],
     "calculation": {
      "http://encoreuranium.com/role/ConsolidatedCashFlow": {
       "order": 7.0,
       "parentTag": "ifrs-full_CashFlowsFromUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The cash outflow for the purchase of investment property. [Refer: Investment property]"
       }
      },
      "en-us": {
       "role": {
        "label": "Purchase of investment property",
        "negatedLabel": "Mineral property expenditures"
       }
      }
     },
     "localname": "PurchaseOfInvestmentProperty",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://encoreuranium.com/role/ConsolidatedCashFlow"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities": {
     "auth_ref": [
      "r288"
     ],
     "calculation": {
      "http://encoreuranium.com/role/ConsolidatedCashFlow": {
       "order": 6.0,
       "parentTag": "ifrs-full_CashFlowsFromUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The cash outflow for the purchases of property, plant and equipment, classified as investing activities. [Refer: Property, plant and equipment]"
       }
      },
      "en-us": {
       "role": {
        "label": "Purchase of property, plant and equipment, classified as investing activities",
        "negatedLabel": "Acquisition of property, plant, and equipment"
       }
      }
     },
     "localname": "PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://encoreuranium.com/role/ConsolidatedCashFlow"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_RangeAxis": {
     "auth_ref": [
      "r135",
      "r151",
      "r183",
      "r295",
      "r296",
      "r346"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      },
      "en-us": {
       "role": {
        "label": "Range [axis]"
       }
      }
     },
     "localname": "RangeAxis",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://encoreuranium.com/role/AssetacquisitionDetails",
      "http://encoreuranium.com/role/MineralPropertiesDetails",
      "http://encoreuranium.com/role/ScheduleofusefullivesofpropertyplantandequipementTable"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_RangesMember": {
     "auth_ref": [
      "r135",
      "r151",
      "r183",
      "r295",
      "r296",
      "r346"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for aggregate ranges. It also represents the standard value for the 'Range' axis if no other member is used."
       }
      },
      "en-us": {
       "role": {
        "label": "Ranges [member]"
       }
      }
     },
     "localname": "RangesMember",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://encoreuranium.com/role/AssetacquisitionDetails",
      "http://encoreuranium.com/role/MineralPropertiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis": {
     "auth_ref": [
      "r151"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      },
      "en-us": {
       "role": {
        "label": "Ranges of exercise prices for outstanding share options [axis]"
       }
      }
     },
     "localname": "RangesOfExercisePricesForOutstandingShareOptionsAxis",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://encoreuranium.com/role/ScheduleofsharepurchasewarrantsoutstandingTable",
      "http://encoreuranium.com/role/ScheduleofstockoptionsoutstandingTable"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsMember": {
     "auth_ref": [
      "r151"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for aggregated ranges of exercise prices for outstanding share options that are meaningful for assessing the number and timing of additional shares that may be issued and the cash that may be received upon exercise of those options. It also represents the standard value for the 'Ranges of exercise prices for outstanding share options' axis if no other member is used. [Refer: Ranges [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Ranges of exercise prices for outstanding share options [member]"
       }
      }
     },
     "localname": "RangesOfExercisePricesForOutstandingShareOptionsMember",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://encoreuranium.com/role/ScheduleofsharepurchasewarrantsoutstandingTable",
      "http://encoreuranium.com/role/ScheduleofstockoptionsoutstandingTable"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_ReceiptsFromRoyaltiesFeesCommissionsAndOtherRevenue": {
     "auth_ref": [
      "r287"
     ],
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The cash inflow from royalties, fees, commissions and other revenue. [Refer: Other revenue]"
       }
      },
      "en-us": {
       "role": {
        "label": "Receipts from royalties, fees, commissions and other revenue",
        "terseLabel": "Paid commissions"
       }
      }
     },
     "localname": "ReceiptsFromRoyaltiesFeesCommissionsAndOtherRevenue",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://encoreuranium.com/role/ShareCapitalDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_ReclassificationAdjustmentsOnChangeInValueOfForwardElementsOfForwardContractsNetOfTax": {
     "auth_ref": [
      "r39"
     ],
     "calculation": {
      "http://encoreuranium.com/role/ConsolidatedComprehensiveIncome": {
       "order": 12.0,
       "parentTag": "ifrs-full_ProfitLossFromOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of reclassification adjustments related to change in value of forward elements of forward contracts, net of tax. Reclassification adjustments are amounts reclassified to profit (loss) in the current period that were recognised in other comprehensive income in the current or previous periods. [Refer: Other comprehensive income]"
       }
      },
      "en-us": {
       "role": {
        "label": "Reclassification adjustments on change in value of forward elements of forward contracts, net of tax",
        "terseLabel": "Reclamation costs"
       }
      }
     },
     "localname": "ReclassificationAdjustmentsOnChangeInValueOfForwardElementsOfForwardContractsNetOfTax",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://encoreuranium.com/role/ConsolidatedComprehensiveIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_RecognisedAssetsDefinedBenefitPlan": {
     "auth_ref": [
      "r327"
     ],
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of surplus in a defined benefit plan, adjusted for any effect of limiting a net defined benefit asset to the asset ceiling. [Refer: Defined benefit plans [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Net defined benefit asset",
        "terseLabel": "Net book value of asset"
       }
      }
     },
     "localname": "RecognisedAssetsDefinedBenefitPlan",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://encoreuranium.com/role/MineralPropertiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_RepaymentsOfBorrowingsClassifiedAsFinancingActivities": {
     "auth_ref": [
      "r291"
     ],
     "calculation": {
      "http://encoreuranium.com/role/ConsolidatedCashFlow": {
       "order": 6.0,
       "parentTag": "ifrs-full_CashFlowsFromUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The cash outflow to settle borrowings, classified as financing activities. [Refer: Borrowings]"
       }
      },
      "en-us": {
       "role": {
        "label": "Repayments of borrowings, classified as financing activities",
        "negatedLabel": "Deferred financing costs"
       }
      }
     },
     "localname": "RepaymentsOfBorrowingsClassifiedAsFinancingActivities",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://encoreuranium.com/role/ConsolidatedCashFlow"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_RestrictedCashAndCashEquivalents": {
     "auth_ref": [
      "r327"
     ],
     "calculation": {
      "http://encoreuranium.com/role/ConsolidatedBalanceSheet": {
       "order": 12.0,
       "parentTag": "ifrs-full_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of cash and cash equivalents whose use or withdrawal is restricted. [Refer: Cash and cash equivalents]"
       }
      },
      "en-us": {
       "role": {
        "label": "Restricted cash and cash equivalents",
        "terseLabel": "Restricted cash"
       }
      }
     },
     "localname": "RestrictedCashAndCashEquivalents",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://encoreuranium.com/role/ConsolidatedBalanceSheet"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_RetainedEarnings": {
     "auth_ref": [
      "r278",
      "r279"
     ],
     "calculation": {
      "http://encoreuranium.com/role/ConsolidatedBalanceSheet": {
       "order": 5.0,
       "parentTag": "ifrs-full_Equity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "A component of equity representing the entity's cumulative undistributed earnings or deficit."
       }
      },
      "en-us": {
       "role": {
        "label": "Retained earnings",
        "terseLabel": "Deficit"
       }
      }
     },
     "localname": "RetainedEarnings",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://encoreuranium.com/role/ConsolidatedBalanceSheet"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_RetainedEarningsMember": {
     "auth_ref": [
      "r11",
      "r276"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for a component of equity representing an entity's cumulative undistributed earnings or deficit."
       }
      },
      "en-us": {
       "role": {
        "label": "Retained earnings [member]",
        "terseLabel": "Deficit"
       }
      }
     },
     "localname": "RetainedEarningsMember",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://encoreuranium.com/role/ShareholdersEquityType2or3"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_RetrospectiveApplicationAndRetrospectiveRestatementAxis": {
     "auth_ref": [
      "r8",
      "r106",
      "r107",
      "r108"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      },
      "en-us": {
       "role": {
        "label": "Retrospective application and retrospective restatement [axis]"
       }
      }
     },
     "localname": "RetrospectiveApplicationAndRetrospectiveRestatementAxis",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://encoreuranium.com/role/ScheduleofeffectoftranslationTable"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_RevenueFromInterest": {
     "auth_ref": [
      "r125",
      "r170",
      "r178",
      "r325"
     ],
     "calculation": {
      "http://encoreuranium.com/role/ConsolidatedComprehensiveIncome": {
       "order": 2.0,
       "parentTag": "ifrs-full_ProfitLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of income arising from interest."
       }
      },
      "en-us": {
       "role": {
        "label": "Interest income",
        "terseLabel": "Interest income"
       }
      }
     },
     "localname": "RevenueFromInterest",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://encoreuranium.com/role/ConsolidatedComprehensiveIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_RevenueFromRenderingOfInformationTechnologyConsultingServices": {
     "auth_ref": [
      "r325"
     ],
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of revenue arising from the rendering of consulting services relating to information technology. [Refer: Revenue]"
       }
      },
      "en-us": {
       "role": {
        "label": "Revenue from rendering of information technology consulting services",
        "terseLabel": "Consulting"
       }
      }
     },
     "localname": "RevenueFromRenderingOfInformationTechnologyConsultingServices",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://encoreuranium.com/role/ScheduleofamountspaidtokeymanagementorentitiesprovidingsimilarservicesTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_ReversalOfImpairmentLossRecognisedInOtherComprehensiveIncome": {
     "auth_ref": [
      "r76",
      "r78"
     ],
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of reversal of impairment loss recognised in other comprehensive income. [Refer: Reversal of impairment loss; Impairment loss recognised in other comprehensive income]"
       }
      },
      "en-us": {
       "role": {
        "label": "Reversal of impairment loss recognised in other comprehensive income",
        "negatedLabel": "Other comprehensive loss for the year"
       }
      }
     },
     "localname": "ReversalOfImpairmentLossRecognisedInOtherComprehensiveIncome",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://encoreuranium.com/role/ScheduleofconsolidatedstatementsoflossandcomprehensivelossTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_RightofuseAssets": {
     "auth_ref": [
      "r140"
     ],
     "calculation": {
      "http://encoreuranium.com/role/ConsolidatedBalanceSheet": {
       "order": 9.0,
       "parentTag": "ifrs-full_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of assets that represent a lessee's right to use an underlying asset for the lease term. Underlying asset is an asset that is the subject of a lease, for which the right to use that asset has been provided by a lessor to a lessee."
       }
      },
      "en-us": {
       "role": {
        "label": "Right-of-use assets",
        "terseLabel": "Right-of-use asset"
       }
      }
     },
     "localname": "RightofuseAssets",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://encoreuranium.com/role/ConsolidatedBalanceSheet"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_RightofuseAssetsMember": {
     "auth_ref": [
      "r137"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for right-of-use assets. [Refer: Right-of-use assets]"
       }
      },
      "en-us": {
       "role": {
        "label": "Right-of-use assets [member]",
        "terseLabel": "Right-of-use assets [member]"
       }
      }
     },
     "localname": "RightofuseAssetsMember",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://encoreuranium.com/role/RightofuseassetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_RightofuseAssetsRevaluationSurplus": {
     "auth_ref": [
      "r142"
     ],
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of the revaluation surplus that relates to right-of-use assets. [Refer: Revaluation surplus; Right-of-use assets]"
       }
      },
      "en-us": {
       "role": {
        "label": "Right-of-use assets, revaluation surplus",
        "negatedLabel": "Right-of-use assets"
       }
      }
     },
     "localname": "RightofuseAssetsRevaluationSurplus",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://encoreuranium.com/role/ScheduleofdeferredtaxliabilitiesTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_RightofuseAssetsRevaluedAssetsAtCost": {
     "auth_ref": [
      "r142"
     ],
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of right-of-use assets that would have been recognised had the revalued assets been carried under the cost model. [Refer: Right-of-use assets]"
       }
      },
      "en-us": {
       "role": {
        "label": "Right-of-use assets, revalued assets, at cost",
        "negatedLabel": "Right-of-use assets"
       }
      }
     },
     "localname": "RightofuseAssetsRevaluedAssetsAtCost",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://encoreuranium.com/role/ScheduleofdeferredtaxliabilitiesTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_RightofuseAssetsThatDoNotMeetDefinitionOfInvestmentProperty": {
     "auth_ref": [
      "r138"
     ],
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of right-of-use assets that do not meet the definition of investment property. [Refer: Right-of-use assets; Investment property]"
       }
      },
      "en-us": {
       "role": {
        "label": "Right-of-use assets that do not meet definition of investment property",
        "terseLabel": "Right-of-use asset"
       }
      }
     },
     "localname": "RightofuseAssetsThatDoNotMeetDefinitionOfInvestmentProperty",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://encoreuranium.com/role/ScheduleofnetassetsacquiredTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_SegmentsAxis": {
     "auth_ref": [
      "r80",
      "r136",
      "r174",
      "r282",
      "r306"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      }
     },
     "localname": "SegmentsAxis",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://encoreuranium.com/role/ScheduleofassetretirementobligationscontinuityTable",
      "http://encoreuranium.com/role/ScheduleofexchangeratesTable",
      "http://encoreuranium.com/role/ScheduleofinvestmentinassociatecontinuityTable",
      "http://encoreuranium.com/role/ScheduleofproportionalshareintheassociateTable",
      "http://encoreuranium.com/role/ScheduleofundiscountedfutureleasepaymentsTable",
      "http://encoreuranium.com/role/ScheduleofuraniumsalescontractsoverthenextfiveyearsTable"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_SegmentsMember": {
     "auth_ref": [
      "r80",
      "r136",
      "r179",
      "r282",
      "r306"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for all segments of an entity. It also represents the standard value for the 'Segments' axis if no other member is used."
       }
      }
     },
     "localname": "SegmentsMember",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://encoreuranium.com/role/ScheduleofassetretirementobligationscontinuityTable",
      "http://encoreuranium.com/role/ScheduleofexchangeratesTable",
      "http://encoreuranium.com/role/ScheduleofinvestmentinassociatecontinuityTable",
      "http://encoreuranium.com/role/ScheduleofproportionalshareintheassociateTable",
      "http://encoreuranium.com/role/ScheduleofundiscountedfutureleasepaymentsTable",
      "http://encoreuranium.com/role/ScheduleofuraniumsalescontractsoverthenextfiveyearsTable"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_ShareIssueRelatedCost": {
     "auth_ref": [
      "r323"
     ],
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of cost related to the issuance of shares."
       }
      },
      "en-us": {
       "role": {
        "label": "Share issue related cost",
        "negatedLabel": "Share issuance costs"
       }
      }
     },
     "localname": "ShareIssueRelatedCost",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://encoreuranium.com/role/ShareholdersEquityType2or3"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_SharePremium": {
     "auth_ref": [
      "r278"
     ],
     "calculation": {
      "http://encoreuranium.com/role/ConsolidatedBalanceSheet": {
       "order": 2.0,
       "parentTag": "ifrs-full_Equity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount received or receivable from the issuance of the entity's shares in excess of nominal value."
       }
      },
      "en-us": {
       "role": {
        "label": "Share premium",
        "terseLabel": "Share subscriptions received"
       }
      }
     },
     "localname": "SharePremium",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://encoreuranium.com/role/ConsolidatedBalanceSheet"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_StatementOfCashFlowsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of cash flows [abstract]"
       }
      }
     },
     "localname": "StatementOfCashFlowsAbstract",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "xbrltype": "stringItemType"
    },
    "ifrs-full_StatementOfChangesInEquityLineItems": {
     "auth_ref": [],
     "lang": {
      "en": {
       "role": {
        "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table."
       }
      },
      "en-us": {
       "role": {
        "label": "Statement of changes in equity [line items]"
       }
      }
     },
     "localname": "StatementOfChangesInEquityLineItems",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://encoreuranium.com/role/ShareholdersEquityType2or3"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_StatementOfChangesInEquityTable": {
     "auth_ref": [
      "r11"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "Schedule disclosing information related to changes in equity."
       }
      },
      "en-us": {
       "role": {
        "label": "Statement of changes in equity [table]"
       }
      }
     },
     "localname": "StatementOfChangesInEquityTable",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://encoreuranium.com/role/ShareholdersEquityType2or3"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_StatementOfFinancialPositionAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of financial position [abstract]"
       }
      }
     },
     "localname": "StatementOfFinancialPositionAbstract",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "xbrltype": "stringItemType"
    },
    "ifrs-full_SubscriptionCirculationRevenue": {
     "auth_ref": [
      "r325"
     ],
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of circulation revenue derived from subscriptions. [Refer: Revenue; Circulation revenue]"
       }
      },
      "en-us": {
       "role": {
        "label": "Subscription circulation revenue",
        "terseLabel": "Subscription receipts issued"
       }
      }
     },
     "localname": "SubscriptionCirculationRevenue",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://encoreuranium.com/role/EventsafterthereportingperiodDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_TaxEffectOfExpenseNotDeductibleInDeterminingTaxableProfitTaxLoss": {
     "auth_ref": [
      "r46"
     ],
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount that represents the difference between the tax expense (income) and the product of the accounting profit multiplied by the applicable tax rate(s) that relates to expenses not deductible in determining taxable profit (tax loss). [Refer: Accounting profit]"
       }
      },
      "en-us": {
       "role": {
        "label": "Tax effect of expense not deductible in determining taxable profit (tax loss)",
        "terseLabel": "Permanent differences"
       }
      }
     },
     "localname": "TaxEffectOfExpenseNotDeductibleInDeterminingTaxableProfitTaxLoss",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://encoreuranium.com/role/ScheduleoffederalandprovincialcorporatetaxratestoincomebeforetaxTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_TaxEffectOfForeignTaxRates": {
     "auth_ref": [
      "r46"
     ],
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount that represents the difference between the tax expense (income) and the product of the accounting profit multiplied by the applicable tax rate(s) that relates to foreign tax rates. [Refer: Accounting profit]"
       }
      },
      "en-us": {
       "role": {
        "label": "Tax effect of foreign tax rates",
        "terseLabel": "Effect of tax rates in foreign jurisdictions"
       }
      }
     },
     "localname": "TaxEffectOfForeignTaxRates",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://encoreuranium.com/role/ScheduleoffederalandprovincialcorporatetaxratestoincomebeforetaxTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_TaxEffectOfTaxLosses": {
     "auth_ref": [
      "r46"
     ],
     "calculation": {
      "http://encoreuranium.com/role/ScheduleofunrecognizeddeferredtaxassetsTable": {
       "order": 2.0,
       "parentTag": "ifrs-full_ProfitLossBeforeTax",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount that represents the difference between the tax expense (income) and the product of the accounting profit multiplied by the applicable tax rate(s) that relates to tax losses. [Refer: Accounting profit]"
       }
      },
      "en-us": {
       "role": {
        "label": "Tax effect of tax losses",
        "negatedLabel": "Tax losses"
       }
      }
     },
     "localname": "TaxEffectOfTaxLosses",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://encoreuranium.com/role/ScheduleofunrecognizeddeferredtaxassetsTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_TaxRateEffectFromChangeInTaxRate": {
     "auth_ref": [
      "r47"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The tax rate effect on the reconciliation between the average effective tax rate and the applicable tax rate resulting from a change in tax rate. [Refer: Average effective tax rate; Applicable tax rate]"
       }
      },
      "en-us": {
       "role": {
        "label": "Tax rate effect from change in tax rate",
        "terseLabel": "Marketable securities increase or decrease in the share prices"
       }
      }
     },
     "localname": "TaxRateEffectFromChangeInTaxRate",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://encoreuranium.com/role/FinancialInstrumentsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "ifrs-full_TaxRateEffectOfForeignTaxRates": {
     "auth_ref": [
      "r47"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The tax rate effect on the reconciliation between the average effective tax rate and the applicable tax rate resulting from the application of foreign tax rates. [Refer: Average effective tax rate; Applicable tax rate]"
       }
      },
      "en-us": {
       "role": {
        "label": "Tax rate effect of foreign tax rates",
        "terseLabel": "The Company\u2019s percentage ownership"
       }
      }
     },
     "localname": "TaxRateEffectOfForeignTaxRates",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://encoreuranium.com/role/ScheduleofproportionalshareintheassociateTable"
     ],
     "xbrltype": "percentItemType"
    },
    "ifrs-full_TopOfRangeMember": {
     "auth_ref": [
      "r135",
      "r151",
      "r183",
      "r295",
      "r296",
      "r346"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for top of a range."
       }
      },
      "en-us": {
       "role": {
        "label": "Top of range [member]",
        "terseLabel": "Top of range [member]"
       }
      }
     },
     "localname": "TopOfRangeMember",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://encoreuranium.com/role/AssetacquisitionDetails",
      "http://encoreuranium.com/role/MineralPropertiesDetails",
      "http://encoreuranium.com/role/ScheduleofusefullivesofpropertyplantandequipementTable"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_TradeAndOtherCurrentPayables": {
     "auth_ref": [
      "r19"
     ],
     "calculation": {
      "http://encoreuranium.com/role/ConsolidatedBalanceSheet": {
       "order": 1.0,
       "parentTag": "ifrs-full_CurrentLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of current trade payables and current other payables. [Refer: Current trade payables; Other current payables]"
       }
      },
      "en-us": {
       "role": {
        "label": "Trade and other current payables",
        "terseLabel": "Accounts payable and accrued liabilities"
       }
      }
     },
     "localname": "TradeAndOtherCurrentPayables",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://encoreuranium.com/role/ConsolidatedBalanceSheet"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_TradeAndOtherCurrentPayablesToRelatedParties": {
     "auth_ref": [
      "r328"
     ],
     "calculation": {
      "http://encoreuranium.com/role/ConsolidatedBalanceSheet": {
       "order": 2.0,
       "parentTag": "ifrs-full_CurrentLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of current payables due to related parties. [Refer: Related parties [member]; Payables to related parties]"
       }
      },
      "en-us": {
       "role": {
        "label": "Current payables to related parties",
        "terseLabel": "Due to related parties"
       }
      }
     },
     "localname": "TradeAndOtherCurrentPayablesToRelatedParties",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://encoreuranium.com/role/ConsolidatedBalanceSheet"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_TradeAndOtherReceivables": {
     "auth_ref": [
      "r16",
      "r26"
     ],
     "calculation": {
      "http://encoreuranium.com/role/ConsolidatedBalanceSheet": {
       "order": 2.0,
       "parentTag": "ifrs-full_CurrentAssets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of trade receivables and other receivables. [Refer: Trade receivables; Other receivables]"
       }
      },
      "en-us": {
       "role": {
        "label": "Trade and other receivables",
        "terseLabel": "Receivables and prepaid expenses"
       }
      }
     },
     "localname": "TradeAndOtherReceivables",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://encoreuranium.com/role/ConsolidatedBalanceSheet"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_TravelExpense": {
     "auth_ref": [
      "r325"
     ],
     "calculation": {
      "http://encoreuranium.com/role/ConsolidatedComprehensiveIncome": {
       "order": 13.0,
       "parentTag": "ifrs-full_ProfitLossFromOperatingActivities",
       "weight": -1.0
      },
      "http://encoreuranium.com/role/ScheduleofconsolidatedstatementsoflossandcomprehensivelossTable": {
       "order": 11.0,
       "parentTag": "ifrs-full_OtherOperatingIncomeExpense",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of expense arising from travel."
       }
      },
      "en-us": {
       "role": {
        "label": "Travel expense",
        "terseLabel": "Travel"
       }
      }
     },
     "localname": "TravelExpense",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://encoreuranium.com/role/ConsolidatedComprehensiveIncome",
      "http://encoreuranium.com/role/ScheduleofconsolidatedstatementsoflossandcomprehensivelossTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_UnconsolidatedStructuredEntitiesAxis": {
     "auth_ref": [
      "r130"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      },
      "en-us": {
       "role": {
        "label": "Unconsolidated structured entities [axis]"
       }
      }
     },
     "localname": "UnconsolidatedStructuredEntitiesAxis",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://encoreuranium.com/role/ScheduleofuraniumconcentratespurchaseagreementTable"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_WagesAndSalaries": {
     "auth_ref": [
      "r335"
     ],
     "calculation": {
      "http://encoreuranium.com/role/ConsolidatedComprehensiveIncome": {
       "order": 15.0,
       "parentTag": "ifrs-full_ProfitLossFromOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "A class of employee benefits expense that represents wages and salaries. [Refer: Employee benefits expense]"
       }
      },
      "en-us": {
       "role": {
        "label": "Wages and salaries",
        "terseLabel": "Staff costs"
       }
      }
     },
     "localname": "WagesAndSalaries",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://encoreuranium.com/role/ConsolidatedComprehensiveIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_WarrantReserveMember": {
     "auth_ref": [
      "r324"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for a component of equity resulting from issuing share purchase warrants, other than those resulting from share-based payment arrangements. [Refer: Reserve of share-based payments [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Warrant reserve [member]",
        "terseLabel": "Warrants [Member]"
       }
      }
     },
     "localname": "WarrantReserveMember",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://encoreuranium.com/role/ScheduleofweightedaverageassumptionsusedintheblackscholesoptionTable"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_WeightedAverageDurationOfDefinedBenefitObligation2019": {
     "auth_ref": [
      "r57"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The weighted average duration of a defined benefit obligation. [Refer: Weighted average [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Weighted average duration of defined benefit obligation",
        "terseLabel": "Options Outstanding, Weighted average Reimaining Life"
       }
      }
     },
     "localname": "WeightedAverageDurationOfDefinedBenefitObligation2019",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://encoreuranium.com/role/ScheduleofstockoptionsoutstandingTable"
     ],
     "xbrltype": "durationItemType"
    },
    "ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019": {
     "auth_ref": [
      "r149"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The weighted average exercise price of share options exercisable in a share-based payment arrangement. [Refer: Weighted average [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Weighted average exercise price of share options exercisable in share-based payment arrangement",
        "terseLabel": "Weighted average exercise price, Options exercisable, end of year"
       }
      }
     },
     "localname": "WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://encoreuranium.com/role/ScheduleofthecompanysstockoptionsoutstandingTable"
     ],
     "xbrltype": "perShareItemType"
    },
    "ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019": {
     "auth_ref": [
      "r147"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The weighted average exercise price of share options exercised in a share-based payment arrangement. [Refer: Weighted average [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Weighted average exercise price of share options exercised in share-based payment arrangement",
        "terseLabel": "Weighted average exercise price, Exercised"
       }
      }
     },
     "localname": "WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://encoreuranium.com/role/ScheduleofthecompanysstockoptionsoutstandingTable"
     ],
     "xbrltype": "perShareItemType"
    },
    "ifrs-full_WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019": {
     "auth_ref": [
      "r146"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The weighted average exercise price of share options forfeited in a share-based payment arrangement. [Refer: Weighted average [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Weighted average exercise price of share options forfeited in share-based payment arrangement",
        "terseLabel": "Weighted average exercise price, Forfeited/expired"
       }
      }
     },
     "localname": "WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://encoreuranium.com/role/ScheduleofthecompanysstockoptionsoutstandingTable"
     ],
     "xbrltype": "perShareItemType"
    },
    "ifrs-full_WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019": {
     "auth_ref": [
      "r145"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The weighted average exercise price of share options granted in a share-based payment arrangement. [Refer: Weighted average [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Weighted average exercise price of share options granted in share-based payment arrangement",
        "terseLabel": "Weighted average exercise price, Granted"
       }
      }
     },
     "localname": "WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://encoreuranium.com/role/ScheduleofthecompanysstockoptionsoutstandingTable"
     ],
     "xbrltype": "perShareItemType"
    },
    "ifrs-full_WeightedAverageExercisePriceOfShareOptionsInSharebasedPaymentArrangementExercisedDuringPeriodAtDateOfExercise2019": {
     "auth_ref": [
      "r150"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The weighted average share price at the date of exercise for share options that are exercised in a share-based payment arrangement. [Refer: Share-based payment arrangements [member]; Weighted average [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Weighted average share price for share options in share-based payment arrangement exercised during period at date of exercise",
        "terseLabel": "Offering price per unit (in Dollars per share)"
       }
      }
     },
     "localname": "WeightedAverageExercisePriceOfShareOptionsInSharebasedPaymentArrangementExercisedDuringPeriodAtDateOfExercise2019",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://encoreuranium.com/role/ShareCapitalDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019": {
     "auth_ref": [
      "r144",
      "r148"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The weighted average exercise price of share options outstanding in a share-based payment arrangement. [Refer: Weighted average [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Weighted average exercise price of share options outstanding in share-based payment arrangement",
        "periodEndLabel": "Weighted average exercise price, Options outstanding, end of year",
        "periodStartLabel": "Weighted average exercise price, Options outstanding, beginning of year"
       }
      }
     },
     "localname": "WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://encoreuranium.com/role/ScheduleofthecompanysstockoptionsoutstandingTable"
     ],
     "xbrltype": "perShareItemType"
    },
    "ifrs-full_WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019": {
     "auth_ref": [
      "r151"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The weighted average remaining contractual life of outstanding share options. [Refer: Weighted average [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Weighted average remaining contractual life of outstanding share options",
        "terseLabel": "Expected life (years)",
        "verboseLabel": "Expected life of option"
       }
      }
     },
     "localname": "WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://encoreuranium.com/role/ScheduleofweightedaverageassumptionsusedincalculatingthefairvaluesTable",
      "http://encoreuranium.com/role/ScheduleofweightedaverageassumptionsusedintheblackscholesoptionTable"
     ],
     "xbrltype": "durationItemType"
    },
    "ifrs-full_WeightedAverageSharePrice2019": {
     "auth_ref": [
      "r150"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The weighted average share price. [Refer: Weighted average [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Weighted average share price",
        "terseLabel": "Price per share"
       }
      }
     },
     "localname": "WeightedAverageSharePrice2019",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://encoreuranium.com/role/AssetacquisitionDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "ifrs-full_WeightedAverageSharePriceShareOptionsGranted2019": {
     "auth_ref": [
      "r152"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The weighted average share price used as input to the option pricing model to calculate the fair value of share options granted. [Refer: Option pricing model [member]; Weighted average [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Weighted average share price, share options granted",
        "terseLabel": "Share price"
       }
      }
     },
     "localname": "WeightedAverageSharePriceShareOptionsGranted2019",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://encoreuranium.com/role/ScheduleofweightedaverageassumptionsusedintheblackscholesoptionTable"
     ],
     "xbrltype": "perShareItemType"
    },
    "ifrs-full_WeightedAverageShares": {
     "auth_ref": [
      "r75"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The number of ordinary shares outstanding at the beginning of the period, adjusted by the number of ordinary shares bought back or issued during the period multiplied by a time-weighting factor."
       }
      },
      "en-us": {
       "role": {
        "label": "Weighted average number of ordinary shares used in calculating basic earnings per share",
        "terseLabel": "- basic # (in Shares)"
       }
      }
     },
     "localname": "WeightedAverageShares",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://encoreuranium.com/role/ConsolidatedComprehensiveIncome"
     ],
     "xbrltype": "sharesItemType"
    },
    "srt_RestatementAxis": {
     "auth_ref": [
      "r186",
      "r195",
      "r196",
      "r197",
      "r198",
      "r199",
      "r200",
      "r201",
      "r202",
      "r203",
      "r204",
      "r205",
      "r206",
      "r207",
      "r208",
      "r209",
      "r210",
      "r216",
      "r217",
      "r230",
      "r235",
      "r236",
      "r237",
      "r238",
      "r242",
      "r245",
      "r246",
      "r264",
      "r265",
      "r266",
      "r267",
      "r268",
      "r269",
      "r270",
      "r271",
      "r272",
      "r273"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revision of Prior Period [Axis]"
       }
      }
     },
     "localname": "RestatementAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://encoreuranium.com/role/ScheduleofconsolidatedstatementsoflossandcomprehensivelossTable",
      "http://encoreuranium.com/role/ScheduleofconsolidatedstatementsoflossandcomprehensivelossTable_Parentheticals"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ScenarioForecastMember": {
     "auth_ref": [
      "r228",
      "r354"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forecast [Member]",
        "terseLabel": "Forecast [Member]"
       }
      }
     },
     "localname": "ScenarioForecastMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://encoreuranium.com/role/InvestmentinuraniumDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ScenarioPreviouslyReportedMember": {
     "auth_ref": [
      "r186",
      "r195",
      "r197",
      "r198",
      "r199",
      "r200",
      "r201",
      "r208",
      "r210",
      "r230",
      "r235",
      "r236",
      "r237",
      "r242",
      "r264",
      "r265",
      "r266",
      "r267",
      "r268",
      "r269",
      "r270",
      "r271",
      "r272",
      "r273",
      "r352",
      "r353",
      "r355",
      "r356",
      "r357",
      "r358",
      "r359",
      "r364",
      "r365",
      "r366"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Previously Reported [Member]",
        "terseLabel": "Previously Reported [Member]"
       }
      }
     },
     "localname": "ScenarioPreviouslyReportedMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://encoreuranium.com/role/ScheduleofconsolidatedstatementsoflossandcomprehensivelossTable",
      "http://encoreuranium.com/role/ScheduleofconsolidatedstatementsoflossandcomprehensivelossTable_Parentheticals"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ScenarioUnspecifiedDomain": {
     "auth_ref": [
      "r209",
      "r228",
      "r320",
      "r354"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Scenario [Domain]"
       }
      }
     },
     "localname": "ScenarioUnspecifiedDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://encoreuranium.com/role/InvestmentinuraniumDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_StatementScenarioAxis": {
     "auth_ref": [
      "r209",
      "r228",
      "r320",
      "r321",
      "r354"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Scenario [Axis]"
       }
      }
     },
     "localname": "StatementScenarioAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://encoreuranium.com/role/InvestmentinuraniumDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "stpr_AZ": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "ARIZONA",
        "terseLabel": "Arizona [Member]"
       }
      }
     },
     "localname": "AZ",
     "nsuri": "http://xbrl.sec.gov/stpr/2022",
     "presentation": [
      "http://encoreuranium.com/role/ScheduleofmineralpropertiesTable"
     ],
     "xbrltype": "domainItemType"
    },
    "stpr_CO": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "COLORADO",
        "terseLabel": "Colorado [Member]"
       }
      }
     },
     "localname": "CO",
     "nsuri": "http://xbrl.sec.gov/stpr/2022",
     "presentation": [
      "http://encoreuranium.com/role/ScheduleofmineralpropertiesTable"
     ],
     "xbrltype": "domainItemType"
    },
    "stpr_NM": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "NEW MEXICO",
        "terseLabel": "New Mexico [Member]"
       }
      }
     },
     "localname": "NM",
     "nsuri": "http://xbrl.sec.gov/stpr/2022",
     "presentation": [
      "http://encoreuranium.com/role/ScheduleoflongtermassetsbygeographicsegmentTable",
      "http://encoreuranium.com/role/ScheduleofmineralpropertiesTable"
     ],
     "xbrltype": "domainItemType"
    },
    "stpr_SD": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "SOUTH DAKOTA",
        "terseLabel": "South Dakota [Member]"
       }
      }
     },
     "localname": "SD",
     "nsuri": "http://xbrl.sec.gov/stpr/2022",
     "presentation": [
      "http://encoreuranium.com/role/ScheduleoflongtermassetsbygeographicsegmentTable",
      "http://encoreuranium.com/role/ScheduleofmineralpropertiesTable"
     ],
     "xbrltype": "domainItemType"
    },
    "stpr_TX": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "TEXAS",
        "terseLabel": "Texas [Member]"
       }
      }
     },
     "localname": "TX",
     "nsuri": "http://xbrl.sec.gov/stpr/2022",
     "presentation": [
      "http://encoreuranium.com/role/ScheduleoflongtermassetsbygeographicsegmentTable",
      "http://encoreuranium.com/role/ScheduleofmineralpropertiesTable"
     ],
     "xbrltype": "domainItemType"
    },
    "stpr_UT": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "UTAH",
        "terseLabel": "Utah [Member]"
       }
      }
     },
     "localname": "UT",
     "nsuri": "http://xbrl.sec.gov/stpr/2022",
     "presentation": [
      "http://encoreuranium.com/role/ScheduleofmineralpropertiesTable"
     ],
     "xbrltype": "domainItemType"
    },
    "stpr_WY": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "WYOMING",
        "terseLabel": "Wyoming [Member]"
       }
      }
     },
     "localname": "WY",
     "nsuri": "http://xbrl.sec.gov/stpr/2022",
     "presentation": [
      "http://encoreuranium.com/role/ScheduleoflongtermassetsbygeographicsegmentTable",
      "http://encoreuranium.com/role/ScheduleofmineralpropertiesTable"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccountingPoliciesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounting Policies [Abstract]"
       }
      }
     },
     "localname": "AccountingPoliciesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DeferredTaxAssetsOther": {
     "auth_ref": [
      "r3",
      "r363"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary differences, classified as other.",
        "label": "Deferred Tax Assets, Other",
        "terseLabel": "Deferred tax assets"
       }
      }
     },
     "localname": "DeferredTaxAssetsOther",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://encoreuranium.com/role/ScheduleofincometaxexpenserecoveryTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsOtherLossCarryforwards": {
     "auth_ref": [
      "r3",
      "r363"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible loss carryforwards, classified as other.",
        "label": "Deferred Tax Assets, Other Loss Carryforwards",
        "terseLabel": "Loss carryforwards"
       }
      }
     },
     "localname": "DeferredTaxAssetsOtherLossCarryforwards",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://encoreuranium.com/role/ScheduleofincometaxexpenserecoveryTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate": {
     "auth_ref": [
      "r194",
      "r229",
      "r231"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of domestic federal statutory tax rate applicable to pretax income (loss).",
        "label": "Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent",
        "terseLabel": "Statutory income tax rate"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://encoreuranium.com/role/ScheduleoffederalandprovincialcorporatetaxratestoincomebeforetaxTable"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock": {
     "auth_ref": [
      "r241"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for (1) transactions denominated in a currency other than the reporting enterprise's functional currency, (2) translating foreign currency financial statements that are incorporated into the financial statements of the reporting enterprise by consolidation, combination, or the equity method of accounting, and (3) remeasurement of the financial statements of a foreign reporting enterprise in a hyperinflationary economy.",
        "label": "Foreign Currency Transactions and Translations Policy [Policy Text Block]",
        "terseLabel": "Foreign currency translation"
       }
      }
     },
     "localname": "ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://encoreuranium.com/role/AccountingPoliciesByPolicy"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IncomeLossAttributableToParent": {
     "auth_ref": [
      "r0",
      "r190"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax, of income (loss) attributable to parent. Includes, but is not limited to, income (loss) from continuing operations, discontinued operations and equity method investments.",
        "label": "Income (Loss) Attributable to Parent, before Tax",
        "terseLabel": "Loss before income tax"
       }
      }
     },
     "localname": "IncomeLossAttributableToParent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://encoreuranium.com/role/ScheduleoffederalandprovincialcorporatetaxratestoincomebeforetaxTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtFairValue": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The fair value amount of long-term debt whether such amount is presented as a separate caption or as a parenthetical disclosure. Additionally, this element may be used in connection with the fair value disclosures required in the footnote disclosures to the financial statements. The element may be used in both the balance sheet and disclosure in the same submission.",
        "label": "Long-Term Debt, Fair Value",
        "terseLabel": "Fair value"
       }
      }
     },
     "localname": "LongTermDebtFairValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://encoreuranium.com/role/MineralPropertiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LossOnContractTermination": {
     "auth_ref": [
      "r250"
     ],
     "calculation": {
      "http://encoreuranium.com/role/ScheduleofconsolidatedstatementsoflossandcomprehensivelossTable": {
       "order": 2.0,
       "parentTag": "ifrs-full_NetForeignExchangeLoss",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The loss recognized on termination of a contract.",
        "label": "Loss on Contract Termination",
        "negatedLabel": "Loss on contract termination"
       }
      }
     },
     "localname": "LossOnContractTermination",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://encoreuranium.com/role/ScheduleofconsolidatedstatementsoflossandcomprehensivelossTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_MarketableSecurities": {
     "auth_ref": [
      "r4"
     ],
     "calculation": {
      "http://encoreuranium.com/role/ScheduleofforeigncurrencyexposuresTable": {
       "order": 2.0,
       "parentTag": "ifrs-full_AssetsLessCurrentLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in marketable security.",
        "label": "Marketable Securities",
        "terseLabel": "Marketable Securities - Current"
       }
      }
     },
     "localname": "MarketableSecurities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://encoreuranium.com/role/ScheduleofforeigncurrencyexposuresTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_MarketableSecuritiesCurrent": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in marketable security, classified as current.",
        "label": "Marketable Securities, Current",
        "terseLabel": "Marketable securities"
       }
      }
     },
     "localname": "MarketableSecuritiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://encoreuranium.com/role/ScheduleofdeferredtaxliabilitiesTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_MarketableSecuritiesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Marketable Securities [Abstract]"
       }
      }
     },
     "localname": "MarketableSecuritiesLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://encoreuranium.com/role/MarketableSecurities"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_MarketableSecuritiesTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about investment in marketable security.",
        "label": "Marketable Securities [Table]"
       }
      }
     },
     "localname": "MarketableSecuritiesTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://encoreuranium.com/role/MarketableSecurities"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OperatingLeasePayments": {
     "auth_ref": [
      "r243",
      "r244"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.",
        "label": "Operating Lease, Payments",
        "terseLabel": "Lease payment"
       }
      }
     },
     "localname": "OperatingLeasePayments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://encoreuranium.com/role/RightofuseassetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherLongTermInvestments": {
     "auth_ref": [
      "r5",
      "r350"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term investments classified as other.",
        "label": "Other Long-Term Investments",
        "terseLabel": "Long-term investment"
       }
      }
     },
     "localname": "OtherLongTermInvestments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://encoreuranium.com/role/InvestmentinuraniumDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromDebtNetOfIssuanceCosts": {
     "auth_ref": [
      "r191"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from additional borrowings, net of cash paid to third parties in connection with debt origination.",
        "label": "Proceeds from Debt, Net of Issuance Costs",
        "terseLabel": "Net proceeds"
       }
      }
     },
     "localname": "ProceedsFromDebtNetOfIssuanceCosts",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://encoreuranium.com/role/EventsafterthereportingperiodDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProfitLoss": {
     "auth_ref": [
      "r187",
      "r188",
      "r189",
      "r192",
      "r193",
      "r198",
      "r207",
      "r208",
      "r211",
      "r212",
      "r213",
      "r214",
      "r215",
      "r218",
      "r219",
      "r220",
      "r221",
      "r222",
      "r223",
      "r224",
      "r225",
      "r226",
      "r232",
      "r233",
      "r234",
      "r238",
      "r239",
      "r263",
      "r308",
      "r309",
      "r310",
      "r351",
      "r362"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.",
        "label": "Net Income (Loss), Including Portion Attributable to Noncontrolling Interest",
        "terseLabel": "Net loss"
       }
      }
     },
     "localname": "ProfitLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://encoreuranium.com/role/NatureofOperationsandGoingConcernDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RelatedPartyDomain": {
     "auth_ref": [
      "r227",
      "r247",
      "r248"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Related parties include affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests.",
        "label": "Related Party [Domain]"
       }
      }
     },
     "localname": "RelatedPartyDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://encoreuranium.com/role/MarketableSecuritiesDetails",
      "http://encoreuranium.com/role/RelatedpartytransactionsandbalancesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RelatedPartyTransactionsByRelatedPartyAxis": {
     "auth_ref": [
      "r227",
      "r247",
      "r251",
      "r252",
      "r253",
      "r254",
      "r255",
      "r256",
      "r257",
      "r258",
      "r259",
      "r260",
      "r261",
      "r262",
      "r367"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of related party. Related parties include, but not limited to, affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests.",
        "label": "Related Party [Axis]"
       }
      }
     },
     "localname": "RelatedPartyTransactionsByRelatedPartyAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://encoreuranium.com/role/MarketableSecuritiesDetails",
      "http://encoreuranium.com/role/RelatedpartytransactionsandbalancesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RestructuringReserveTranslationAdjustment": {
     "auth_ref": [
      "r360",
      "r361"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of foreign currency translation gain (loss) which decreases (increases) the restructuring reserve.",
        "label": "Restructuring Reserve, Foreign Currency Translation Gain (Loss)",
        "terseLabel": "Currency translation adjustment"
       }
      }
     },
     "localname": "RestructuringReserveTranslationAdjustment",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://encoreuranium.com/role/ScheduleofmarketablesecuritiesTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets.",
        "label": "Schedule of Deferred Tax Assets and Liabilities [Table Text Block]",
        "terseLabel": "Schedule of deferred tax liabilities"
       }
      }
     },
     "localname": "ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://encoreuranium.com/role/IncometaxesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_StockOptionPlanExpense": {
     "auth_ref": [
      "r1"
     ],
     "calculation": {
      "http://encoreuranium.com/role/ScheduleofconsolidatedstatementsoflossandcomprehensivelossTable": {
       "order": 14.0,
       "parentTag": "ifrs-full_OtherOperatingIncomeExpense",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncash expense for option under share-based payment arrangement.",
        "label": "Stock or Unit Option Plan Expense",
        "terseLabel": "Stock option expense"
       }
      }
     },
     "localname": "StockOptionPlanExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://encoreuranium.com/role/ScheduleofamountspaidtokeymanagementorentitiesprovidingsimilarservicesTable",
      "http://encoreuranium.com/role/ScheduleofconsolidatedstatementsoflossandcomprehensivelossTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stockholders' Equity Attributable to Parent [Abstract]",
        "terseLabel": "Shareholders\u2019 equity"
       }
      }
     },
     "localname": "StockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://encoreuranium.com/role/ConsolidatedBalanceSheet"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventTypeAxis": {
     "auth_ref": [
      "r240",
      "r249"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event Type [Axis]"
       }
      }
     },
     "localname": "SubsequentEventTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://encoreuranium.com/role/EventsafterthereportingperiodDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventTypeDomain": {
     "auth_ref": [
      "r240",
      "r249"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event Type [Domain]"
       }
      }
     },
     "localname": "SubsequentEventTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://encoreuranium.com/role/EventsafterthereportingperiodDetails"
     ],
     "xbrltype": "domainItemType"
    }
   },
   "unitCount": 7
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.20)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r1": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r10": {
   "Clause": "iii",
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "106",
   "Subparagraph": "d",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_106_d_iii&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r100": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "7",
   "Paragraph": "31",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2022-en-r&anchor=para_31&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r101": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "7",
   "Paragraph": "39",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2022-en-r&anchor=para_39&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r102": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "7",
   "Paragraph": "40",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2022-en-r&anchor=para_40_a&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r103": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "7",
   "Paragraph": "45",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2022-en-r&anchor=para_45&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r104": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "7",
   "Paragraph": "46",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2022-en-r&anchor=para_46&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r105": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "7",
   "Paragraph": "50",
   "Subparagraph": "d",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2022-en-r&anchor=para_50_d&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r106": {
   "Clause": "i",
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "8",
   "Paragraph": "28",
   "Subparagraph": "f",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=8&code=ifrs-tx-2022-en-r&anchor=para_28_f_i&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r107": {
   "Clause": "i",
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "8",
   "Paragraph": "29",
   "Subparagraph": "c",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=8&code=ifrs-tx-2022-en-r&anchor=para_29_c_i&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r108": {
   "Clause": "i",
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "8",
   "Paragraph": "49",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=8&code=ifrs-tx-2022-en-r&anchor=para_49_b_i&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r109": {
   "IssueDate": "2022-03-24",
   "Name": "IFRS",
   "Number": "1",
   "Paragraph": "24",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=1&code=ifrs-tx-2022-en-r&anchor=para_24_a&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r11": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "106",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_106&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r110": {
   "IssueDate": "2022-03-24",
   "Name": "IFRS",
   "Number": "1",
   "Paragraph": "24",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=1&code=ifrs-tx-2022-en-r&anchor=para_24_b&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r111": {
   "IssueDate": "2022-03-24",
   "Name": "IFRS",
   "Number": "1",
   "Paragraph": "29",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=1&code=ifrs-tx-2022-en-r&anchor=para_29&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r112": {
   "Clause": "i",
   "IssueDate": "2022-03-24",
   "Name": "IFRS",
   "Number": "1",
   "Paragraph": "32",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=1&code=ifrs-tx-2022-en-r&anchor=para_32_a_i&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r113": {
   "Clause": "ii",
   "IssueDate": "2022-03-24",
   "Name": "IFRS",
   "Number": "1",
   "Paragraph": "32",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=1&code=ifrs-tx-2022-en-r&anchor=para_32_a_ii&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r114": {
   "IssueDate": "2022-03-24",
   "Name": "IFRS",
   "Number": "12",
   "Paragraph": "19B",
   "Subparagraph": "c",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2022-en-r&anchor=para_19B_c&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r115": {
   "Clause": "ii",
   "IssueDate": "2022-03-24",
   "Name": "IFRS",
   "Number": "12",
   "Paragraph": "2",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2022-en-r&anchor=para_2_b_ii&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r116": {
   "Clause": "iv",
   "IssueDate": "2022-03-24",
   "Name": "IFRS",
   "Number": "12",
   "Paragraph": "21",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2022-en-r&anchor=para_21_a_iv&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r117": {
   "IssueDate": "2022-03-24",
   "Name": "IFRS",
   "Number": "12",
   "Paragraph": "B12",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2022-en-r&anchor=para_B12_a&doctype=Appendix&subtype=B",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r118": {
   "Clause": "i",
   "IssueDate": "2022-03-24",
   "Name": "IFRS",
   "Number": "12",
   "Paragraph": "B12",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2022-en-r&anchor=para_B12_b_i&doctype=Appendix&subtype=B",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r119": {
   "Clause": "ii",
   "IssueDate": "2022-03-24",
   "Name": "IFRS",
   "Number": "12",
   "Paragraph": "B12",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2022-en-r&anchor=para_B12_b_ii&doctype=Appendix&subtype=B",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r12": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "35",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_35&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r120": {
   "Clause": "iii",
   "IssueDate": "2022-03-24",
   "Name": "IFRS",
   "Number": "12",
   "Paragraph": "B12",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2022-en-r&anchor=para_B12_b_iii&doctype=Appendix&subtype=B",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r121": {
   "Clause": "iv",
   "IssueDate": "2022-03-24",
   "Name": "IFRS",
   "Number": "12",
   "Paragraph": "B12",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2022-en-r&anchor=para_B12_b_iv&doctype=Appendix&subtype=B",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r122": {
   "Clause": "ix",
   "IssueDate": "2022-03-24",
   "Name": "IFRS",
   "Number": "12",
   "Paragraph": "B12",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2022-en-r&anchor=para_B12_b_ix&doctype=Appendix&subtype=B",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r123": {
   "IssueDate": "2022-03-24",
   "Name": "IFRS",
   "Number": "12",
   "Paragraph": "B13",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2022-en-r&anchor=para_B13_a&doctype=Appendix&subtype=B",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r124": {
   "IssueDate": "2022-03-24",
   "Name": "IFRS",
   "Number": "12",
   "Paragraph": "B13",
   "Subparagraph": "d",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2022-en-r&anchor=para_B13_d&doctype=Appendix&subtype=B",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r125": {
   "IssueDate": "2022-03-24",
   "Name": "IFRS",
   "Number": "12",
   "Paragraph": "B13",
   "Subparagraph": "e",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2022-en-r&anchor=para_B13_e&doctype=Appendix&subtype=B",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r126": {
   "IssueDate": "2022-03-24",
   "Name": "IFRS",
   "Number": "12",
   "Paragraph": "B13",
   "Subparagraph": "f",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2022-en-r&anchor=para_B13_f&doctype=Appendix&subtype=B",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r127": {
   "IssueDate": "2022-03-24",
   "Name": "IFRS",
   "Number": "12",
   "Paragraph": "B13",
   "Subparagraph": "g",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2022-en-r&anchor=para_B13_g&doctype=Appendix&subtype=B",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r128": {
   "IssueDate": "2022-03-24",
   "Name": "IFRS",
   "Number": "12",
   "Paragraph": "B4",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2022-en-r&anchor=para_B4_a&doctype=Appendix&subtype=B",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r129": {
   "IssueDate": "2022-03-24",
   "Name": "IFRS",
   "Number": "12",
   "Paragraph": "B4",
   "Subparagraph": "d",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2022-en-r&anchor=para_B4_d&doctype=Appendix&subtype=B",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r13": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "41",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_41&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r130": {
   "IssueDate": "2022-03-24",
   "Name": "IFRS",
   "Number": "12",
   "Paragraph": "B4",
   "Subparagraph": "e",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2022-en-r&anchor=para_B4_e&doctype=Appendix&subtype=B",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r131": {
   "IssueDate": "2022-03-24",
   "Name": "IFRS",
   "Number": "13",
   "Paragraph": "93",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=13&code=ifrs-tx-2022-en-r&anchor=para_93_a&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r132": {
   "IssueDate": "2022-03-24",
   "Name": "IFRS",
   "Number": "13",
   "Paragraph": "93",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=13&code=ifrs-tx-2022-en-r&anchor=para_93_b&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r133": {
   "IssueDate": "2022-03-24",
   "Name": "IFRS",
   "Number": "13",
   "Paragraph": "93",
   "Subparagraph": "e",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=13&code=ifrs-tx-2022-en-r&anchor=para_93_e&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r134": {
   "IssueDate": "2022-03-24",
   "Name": "IFRS",
   "Number": "13",
   "Paragraph": "93",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=13&code=ifrs-tx-2022-en-r&anchor=para_93&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r135": {
   "IssueDate": "2022-03-24",
   "Name": "IFRS",
   "Number": "14",
   "Paragraph": "33",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=14&code=ifrs-tx-2022-en-r&anchor=para_33_b&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r136": {
   "IssueDate": "2022-03-24",
   "Name": "IFRS",
   "Number": "15",
   "Paragraph": "115",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=15&code=ifrs-tx-2022-en-r&anchor=para_115&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r137": {
   "IssueDate": "2022-03-24",
   "Name": "IFRS",
   "Number": "16",
   "Paragraph": "33",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2022-en-r&anchor=para_33&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r138": {
   "IssueDate": "2022-03-24",
   "Name": "IFRS",
   "Number": "16",
   "Paragraph": "47",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2022-en-r&anchor=para_47_a&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r139": {
   "IssueDate": "2022-03-24",
   "Name": "IFRS",
   "Number": "16",
   "Paragraph": "47",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2022-en-r&anchor=para_47_b&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r14": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "54",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_54_a&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r140": {
   "IssueDate": "2022-03-24",
   "Name": "IFRS",
   "Number": "16",
   "Paragraph": "53",
   "Subparagraph": "j",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2022-en-r&anchor=para_53_j&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r141": {
   "IssueDate": "2022-03-24",
   "Name": "IFRS",
   "Number": "16",
   "Paragraph": "53",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2022-en-r&anchor=para_53&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r142": {
   "IssueDate": "2022-03-24",
   "Name": "IFRS",
   "Number": "16",
   "Paragraph": "57",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2022-en-r&anchor=para_57&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r143": {
   "IssueDate": "2022-03-24",
   "Name": "IFRS",
   "Number": "16",
   "Paragraph": "94",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2022-en-r&anchor=para_94&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r144": {
   "Clause": "i",
   "IssueDate": "2022-03-24",
   "Name": "IFRS",
   "Number": "2",
   "Paragraph": "45",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2022-en-r&anchor=para_45_b_i&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r145": {
   "Clause": "ii",
   "IssueDate": "2022-03-24",
   "Name": "IFRS",
   "Number": "2",
   "Paragraph": "45",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2022-en-r&anchor=para_45_b_ii&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r146": {
   "Clause": "iii",
   "IssueDate": "2022-03-24",
   "Name": "IFRS",
   "Number": "2",
   "Paragraph": "45",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2022-en-r&anchor=para_45_b_iii&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r147": {
   "Clause": "iv",
   "IssueDate": "2022-03-24",
   "Name": "IFRS",
   "Number": "2",
   "Paragraph": "45",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2022-en-r&anchor=para_45_b_iv&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r148": {
   "Clause": "vi",
   "IssueDate": "2022-03-24",
   "Name": "IFRS",
   "Number": "2",
   "Paragraph": "45",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2022-en-r&anchor=para_45_b_vi&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r149": {
   "Clause": "vii",
   "IssueDate": "2022-03-24",
   "Name": "IFRS",
   "Number": "2",
   "Paragraph": "45",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2022-en-r&anchor=para_45_b_vii&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r15": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "54",
   "Subparagraph": "c",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_54_c&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r150": {
   "IssueDate": "2022-03-24",
   "Name": "IFRS",
   "Number": "2",
   "Paragraph": "45",
   "Subparagraph": "c",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2022-en-r&anchor=para_45_c&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r151": {
   "IssueDate": "2022-03-24",
   "Name": "IFRS",
   "Number": "2",
   "Paragraph": "45",
   "Subparagraph": "d",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2022-en-r&anchor=para_45_d&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r152": {
   "Clause": "i",
   "IssueDate": "2022-03-24",
   "Name": "IFRS",
   "Number": "2",
   "Paragraph": "47",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2022-en-r&anchor=para_47_a_i&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r153": {
   "IssueDate": "2022-03-24",
   "Name": "IFRS",
   "Number": "2",
   "Paragraph": "47",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2022-en-r&anchor=para_47_a&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r154": {
   "IssueDate": "2022-03-24",
   "Name": "IFRS",
   "Number": "3",
   "Paragraph": "B64",
   "Subparagraph": "c",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=3&code=ifrs-tx-2022-en-r&anchor=para_B64_c&doctype=Appendix&subtype=B",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r155": {
   "IssueDate": "2022-03-24",
   "Name": "IFRS",
   "Number": "3",
   "Paragraph": "B64",
   "Subparagraph": "f",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=3&code=ifrs-tx-2022-en-r&anchor=para_B64_f&doctype=Appendix&subtype=B",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r156": {
   "Clause": "i",
   "IssueDate": "2022-03-24",
   "Name": "IFRS",
   "Number": "3",
   "Paragraph": "B64",
   "Subparagraph": "g",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=3&code=ifrs-tx-2022-en-r&anchor=para_B64_g_i&doctype=Appendix&subtype=B",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r157": {
   "IssueDate": "2022-03-24",
   "Name": "IFRS",
   "Number": "3",
   "Paragraph": "B64",
   "Subparagraph": "l",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=3&code=ifrs-tx-2022-en-r&anchor=para_B64_l&doctype=Appendix&subtype=B",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r158": {
   "IssueDate": "2022-03-24",
   "Name": "IFRS",
   "Number": "3",
   "Paragraph": "B64",
   "Subparagraph": "m",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=3&code=ifrs-tx-2022-en-r&anchor=para_B64_m&doctype=Appendix&subtype=B",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r159": {
   "Clause": "i",
   "IssueDate": "2022-03-24",
   "Name": "IFRS",
   "Number": "5",
   "Paragraph": "33",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=5&code=ifrs-tx-2022-en-r&anchor=para_33_b_i&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r16": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "54",
   "Subparagraph": "h",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_54_h&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r160": {
   "IssueDate": "2022-03-24",
   "Name": "IFRS",
   "Number": "6",
   "Paragraph": "24",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=6&code=ifrs-tx-2022-en-r&anchor=para_24_b&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r161": {
   "Clause": "i",
   "IssueDate": "2022-03-24",
   "Name": "IFRS",
   "Number": "7",
   "Paragraph": "20",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2022-en-r&anchor=para_20_a_i&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r162": {
   "IssueDate": "2022-03-24",
   "Name": "IFRS",
   "Number": "7",
   "Paragraph": "25",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2022-en-r&anchor=para_25&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r163": {
   "IssueDate": "2022-03-24",
   "Name": "IFRS",
   "Number": "7",
   "Paragraph": "35H",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2022-en-r&anchor=para_35H&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r164": {
   "IssueDate": "2022-03-24",
   "Name": "IFRS",
   "Number": "7",
   "Paragraph": "35I",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2022-en-r&anchor=para_35I&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r165": {
   "IssueDate": "2022-03-24",
   "Name": "IFRS",
   "Number": "7",
   "Paragraph": "35M",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2022-en-r&anchor=para_35M&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r166": {
   "IssueDate": "2022-03-24",
   "Name": "IFRS",
   "Number": "7",
   "Paragraph": "39",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2022-en-r&anchor=para_39_b&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r167": {
   "IssueDate": "2022-03-24",
   "Name": "IFRS",
   "Number": "7",
   "Paragraph": "39",
   "Subparagraph": "c",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2022-en-r&anchor=para_39_c&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r168": {
   "IssueDate": "2022-03-24",
   "Name": "IFRS",
   "Number": "7",
   "Paragraph": "B11E",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2022-en-r&anchor=para_B11E&doctype=Appendix&subtype=B",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r169": {
   "IssueDate": "2022-03-24",
   "Name": "IFRS",
   "Number": "7",
   "Section": "Scope",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2022-en-r&doctype=Standard&dita_xref=IFRS07_g3-5A__IFRS07_g3-5A_TI",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r17": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "54",
   "Subparagraph": "i",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_54_i&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r170": {
   "IssueDate": "2022-03-24",
   "Name": "IFRS",
   "Number": "8",
   "Paragraph": "23",
   "Subparagraph": "c",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2022-en-r&anchor=para_23_c&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r171": {
   "IssueDate": "2022-03-24",
   "Name": "IFRS",
   "Number": "8",
   "Paragraph": "23",
   "Subparagraph": "d",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2022-en-r&anchor=para_23_d&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r172": {
   "IssueDate": "2022-03-24",
   "Name": "IFRS",
   "Number": "8",
   "Paragraph": "23",
   "Subparagraph": "e",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2022-en-r&anchor=para_23_e&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r173": {
   "IssueDate": "2022-03-24",
   "Name": "IFRS",
   "Number": "8",
   "Paragraph": "23",
   "Subparagraph": "h",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2022-en-r&anchor=para_23_h&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r174": {
   "IssueDate": "2022-03-24",
   "Name": "IFRS",
   "Number": "8",
   "Paragraph": "23",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2022-en-r&anchor=para_23&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r175": {
   "IssueDate": "2022-03-24",
   "Name": "IFRS",
   "Number": "8",
   "Paragraph": "28",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2022-en-r&anchor=para_28_b&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r176": {
   "IssueDate": "2022-03-24",
   "Name": "IFRS",
   "Number": "8",
   "Paragraph": "28",
   "Subparagraph": "c",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2022-en-r&anchor=para_28_c&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r177": {
   "IssueDate": "2022-03-24",
   "Name": "IFRS",
   "Number": "8",
   "Paragraph": "28",
   "Subparagraph": "d",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2022-en-r&anchor=para_28_d&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r178": {
   "IssueDate": "2022-03-24",
   "Name": "IFRS",
   "Number": "8",
   "Paragraph": "28",
   "Subparagraph": "e",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2022-en-r&anchor=para_28_e&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r179": {
   "IssueDate": "2022-03-24",
   "Name": "IFRS",
   "Number": "8",
   "Paragraph": "28",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2022-en-r&anchor=para_28&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r18": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "54",
   "Subparagraph": "j",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_54_j&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r180": {
   "IssueDate": "2022-03-24",
   "Name": "IFRS",
   "Number": "8",
   "Paragraph": "33",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2022-en-r&anchor=para_33&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r181": {
   "IssueDate": "2022-03-24",
   "Name": "IFRS",
   "Number": "8",
   "Section": "Disclosure",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2022-en-r&doctype=Standard&dita_xref=IFRS08_g20-24__IFRS08_g20-24_TI",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r182": {
   "IssueDate": "2022-03-24",
   "Name": "IFRS",
   "Number": "9",
   "Paragraph": "6.5.13",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=9&code=ifrs-tx-2022-en-r&anchor=para_6.5.13_a&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r183": {
   "IssueDate": "2022-03-24",
   "Name": "IFRS",
   "Note": "Effective 2023-01-01",
   "Number": "17",
   "Paragraph": "120",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2022-en-r&anchor=para_120&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r184": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Note": "Expiry date 2023-01-01",
   "Number": "1",
   "Paragraph": "117",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_117&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r185": {
   "IssueDate": "2022-03-24",
   "Name": "IFRS",
   "Note": "Expiry date 2023-01-01",
   "Number": "7",
   "Paragraph": "8",
   "Subparagraph": "c",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2017-en-b&anchor=para_8_c&doctype=Standard&book=b",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r186": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "105",
   "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r187": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r188": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669619-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r189": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669625-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r19": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "54",
   "Subparagraph": "k",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_54_k&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r190": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r191": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3255-108585",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r192": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3000-108585",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r193": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r194": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h)(2))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r195": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r196": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r197": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r198": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r199": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(3)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r2": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r20": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "54",
   "Subparagraph": "o",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_54_o&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r200": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r201": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r202": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=SL124452830-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r203": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22583-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r204": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r205": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r206": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r207": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22658-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r208": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22663-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r209": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.M.Q2)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=122038215&loc=d3e31137-122693",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r21": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "55",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_55&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r210": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=128363288&loc=d3e3842-109258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r211": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r212": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r213": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r214": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r215": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "323",
   "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r216": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(3)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r217": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(4)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r218": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(i))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r219": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r22": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "56",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_56&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r220": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iv))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r221": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(5))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r222": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(i))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r223": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r224": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r225": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iv))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r226": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(5))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r227": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(n)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r228": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(f)(3)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r229": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32687-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r23": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "66",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_66&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r230": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(3)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r231": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.4)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r232": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4569616-111683",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r233": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r234": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r235": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(b)(2)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r236": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(3)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r237": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(4)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r238": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r239": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r24": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "69",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_69&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r240": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=6450520&loc=d3e32618-110901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r241": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "830",
   "URI": "https://asc.fasb.org/topic&trid=2175825",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r242": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(1)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128293352&loc=SL126838806-209984",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r243": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918643-209977",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r244": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(1)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r245": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)(iii)(01)",
   "Topic": "848",
   "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r246": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)(iii)(03)",
   "Topic": "848",
   "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r247": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "850",
   "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r248": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "850",
   "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r249": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "855",
   "URI": "https://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r25": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "7",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_7&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r250": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "275",
   "Topic": "912",
   "URI": "https://asc.fasb.org/extlink&oid=126938061&loc=d3e54681-109401",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r251": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e61929-109447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r252": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e61929-109447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r253": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62059-109447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r254": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62059-109447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r255": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62395-109447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r256": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62395-109447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r257": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "33",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62479-109447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r258": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "33",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62479-109447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r259": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "35A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=SL6807758-109447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r26": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "78",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_78_b&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r260": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "35A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=SL6807758-109447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r261": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(c)(1)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e61872-109447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r262": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(c)(2)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e61872-109447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r263": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "235",
   "Subparagraph": "(SX 210.9-05(b)(2))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r264": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r265": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(1)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r266": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(2)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r267": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(1)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r268": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(i)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r269": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(ii)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r27": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "78",
   "Subparagraph": "e",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_78_e&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r270": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(iii)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r271": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(iv)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r272": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(h)(1)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r273": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(h)(2)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r274": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "102",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_102&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r275": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "103",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_103&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r276": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "108",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_108&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r277": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "78",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_78_b&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r278": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "78",
   "Subparagraph": "e",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_78_e&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r279": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "IG6",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_IG6&doctype=Implementation%20Guidance",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r28": {
   "Clause": "ii",
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "79",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_79_a_ii&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r280": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "12",
   "Paragraph": "80",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=12&code=ifrs-tx-2022-en-r&anchor=para_80_b&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r281": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "19",
   "Paragraph": "138",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=19&code=ifrs-tx-2022-en-r&anchor=para_138_a&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r282": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "19",
   "Paragraph": "138",
   "Subparagraph": "d",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=19&code=ifrs-tx-2022-en-r&anchor=para_138_d&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r283": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "32",
   "Paragraph": "IE33",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=32&code=ifrs-tx-2022-en-r&anchor=para_IE33&doctype=Illustrative%20Examples",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r284": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "36",
   "Paragraph": "127",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=36&code=ifrs-tx-2022-en-r&anchor=para_127&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r285": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "37",
   "Paragraph": "87",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=37&code=ifrs-tx-2022-en-r&anchor=para_87&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r286": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "37",
   "Section": "D Examples: disclosures",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=37&code=ifrs-tx-2022-en-r&doctype=Illustrative%20Examples&dita_xref=IAS37_IE_D__IAS37_IE_D_TI",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r287": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "7",
   "Paragraph": "14",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2022-en-r&anchor=para_14_b&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r288": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "7",
   "Paragraph": "16",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2022-en-r&anchor=para_16_a&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r289": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "7",
   "Paragraph": "16",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2022-en-r&anchor=para_16_b&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r29": {
   "Clause": "iii",
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "79",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_79_a_iii&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r290": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "7",
   "Paragraph": "17",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2022-en-r&anchor=para_17_a&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r291": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "7",
   "Paragraph": "17",
   "Subparagraph": "d",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2022-en-r&anchor=para_17_d&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r292": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "7",
   "Paragraph": "17",
   "Subparagraph": "e",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2022-en-r&anchor=para_17_e&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r293": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "7",
   "Section": "A Statement of cash flows for an entity other than a financial institution",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2022-en-r&doctype=Illustrative%20Examples&dita_xref=IAS07_IE_A__IAS07_IE_A_TI",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r294": {
   "IssueDate": "2022-03-24",
   "Name": "IFRS",
   "Number": "12",
   "Paragraph": "B10",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2022-en-r&anchor=para_B10_b&doctype=Appendix&subtype=B",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r295": {
   "IssueDate": "2022-03-24",
   "Name": "IFRS",
   "Number": "13",
   "Paragraph": "B6",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=13&code=ifrs-tx-2022-en-r&anchor=para_B6&doctype=Appendix&subtype=B",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r296": {
   "IssueDate": "2022-03-24",
   "Name": "IFRS",
   "Number": "13",
   "Paragraph": "IE63",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=13&code=ifrs-tx-2022-en-r&anchor=para_IE63&doctype=Illustrative%20Examples",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r297": {
   "IssueDate": "2022-03-24",
   "Name": "IFRS",
   "Number": "15",
   "Paragraph": "B89",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=15&code=ifrs-tx-2022-en-r&anchor=para_B89_b&doctype=Appendix&subtype=B",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r298": {
   "IssueDate": "2022-03-24",
   "Name": "IFRS",
   "Number": "16",
   "Paragraph": "53",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2022-en-r&anchor=para_53&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r299": {
   "IssueDate": "2022-03-24",
   "Name": "IFRS",
   "Number": "3",
   "Paragraph": "B64",
   "Subparagraph": "i",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=3&code=ifrs-tx-2022-en-r&anchor=para_B64_i&doctype=Appendix&subtype=B",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r3": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32632-109319",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r30": {
   "Clause": "iv",
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "79",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_79_a_iv&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r300": {
   "IssueDate": "2022-03-24",
   "Name": "IFRS",
   "Number": "3",
   "Paragraph": "IE72",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=3&code=ifrs-tx-2022-en-r&anchor=para_IE72&doctype=Illustrative%20Examples",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r301": {
   "IssueDate": "2022-03-24",
   "Name": "IFRS",
   "Number": "7",
   "Paragraph": "35N",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2022-en-r&anchor=para_35N&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r302": {
   "IssueDate": "2022-03-24",
   "Name": "IFRS",
   "Number": "8",
   "Paragraph": "23",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2022-en-r&anchor=para_23&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r303": {
   "IssueDate": "2022-03-24",
   "Name": "IFRS",
   "Number": "8",
   "Paragraph": "28",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2022-en-r&anchor=para_28_b&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r304": {
   "IssueDate": "2022-03-24",
   "Name": "IFRS",
   "Note": "Effective 2023-01-01",
   "Number": "17",
   "Paragraph": "113",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2022-en-r&anchor=para_113_b&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r305": {
   "IssueDate": "2022-03-24",
   "Name": "IFRS",
   "Note": "Effective 2023-01-01",
   "Number": "17",
   "Paragraph": "96",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2022-en-r&anchor=para_96_b&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r306": {
   "IssueDate": "2022-03-24",
   "Name": "IFRS",
   "Note": "Effective 2023-01-01",
   "Number": "17",
   "Paragraph": "96",
   "Subparagraph": "c",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2022-en-r&anchor=para_96_c&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r307": {
   "IssueDate": "2022-03-24",
   "Name": "IFRS",
   "Note": "Effective on first application of IFRS 9",
   "Number": "4",
   "Paragraph": "39L",
   "Subparagraph": "e",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=4&code=ifrs-tx-2022-en-b&anchor=para_39L_e&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r308": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "31",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8924-108599",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r309": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4J",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=120409616&loc=SL4591551-111686",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r31": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "79",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_79_a&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r310": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4K",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=120409616&loc=SL4591552-111686",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r311": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r312": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r313": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r314": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r315": {
   "Name": "Form 10-K",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "310",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r316": {
   "Name": "Form 20-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "220",
   "Subsection": "f",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r317": {
   "Name": "Form 40-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "240",
   "Subsection": "f",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r318": {
   "Name": "Regulation S-T",
   "Number": "232",
   "Publisher": "SEC",
   "Section": "405",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r319": {
   "Name": "Securities Act",
   "Number": "7A",
   "Publisher": "SEC",
   "Section": "B",
   "Subsection": "2",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r32": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "80A",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_80A&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r320": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14615-108349",
   "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef"
  },
  "r321": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "855",
   "URI": "https://asc.fasb.org/extlink&oid=6842918&loc=SL6314020-165662",
   "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef"
  },
  "r322": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "10",
   "Subparagraph": "e",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_10_e&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r323": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "106",
   "Subparagraph": "d",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_106_d&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r324": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "108",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_108&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r325": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "112",
   "Subparagraph": "c",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_112_c&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r326": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "35",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_35&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r327": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "55",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_55&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r328": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "78",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_78&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r329": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "79",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_79_a&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r33": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "81A",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_81A_a&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r330": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "85",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_85&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r331": {
   "Clause": "i",
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "12",
   "Paragraph": "81",
   "Subparagraph": "g",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=12&code=ifrs-tx-2022-en-r&anchor=para_81_g_i&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r332": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "16",
   "Paragraph": "37",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=16&code=ifrs-tx-2022-en-r&anchor=para_37&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r333": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "19",
   "Paragraph": "144",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=19&code=ifrs-tx-2022-en-r&anchor=para_144&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r334": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "19",
   "Paragraph": "57",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=19&code=ifrs-tx-2022-en-r&anchor=para_57_a&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r335": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "19",
   "Paragraph": "9",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=19&code=ifrs-tx-2022-en-r&anchor=para_9&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r336": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "21",
   "Paragraph": "52",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=21&code=ifrs-tx-2022-en-r&anchor=para_52_a&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r337": {
   "Clause": "i",
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "38",
   "Paragraph": "118",
   "Subparagraph": "e",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=38&code=ifrs-tx-2022-en-r&anchor=para_118_e_i&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r338": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "38",
   "Paragraph": "119",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=38&code=ifrs-tx-2022-en-r&anchor=para_119&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r339": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "7",
   "Paragraph": "16",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2022-en-r&anchor=para_16&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r34": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "81A",
   "Subparagraph": "c",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_81A_c&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r340": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "7",
   "Paragraph": "17",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2022-en-r&anchor=para_17&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r341": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "7",
   "Paragraph": "20",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2022-en-r&anchor=para_20_a&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r342": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "7",
   "Paragraph": "20",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2022-en-r&anchor=para_20_b&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r343": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "7",
   "Paragraph": "20",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2022-en-r&anchor=para_20&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r344": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "7",
   "Paragraph": "45",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2022-en-r&anchor=para_45&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r345": {
   "IssueDate": "2022-03-24",
   "Name": "IFRS",
   "Number": "13",
   "Paragraph": "94",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=13&code=ifrs-tx-2022-en-r&anchor=para_94&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r346": {
   "IssueDate": "2022-03-24",
   "Name": "IFRS",
   "Number": "7",
   "Paragraph": "7",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2022-en-r&anchor=para_7&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r347": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Note": "Effective 2023-01-01",
   "Number": "1",
   "Paragraph": "117",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_117&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r348": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Note": "Expiry date 2023-01-01",
   "Number": "1",
   "Paragraph": "117",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2017-en-b&anchor=para_117_b&doctype=Standard&forcepdf=true",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r349": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Note": "Expiry date 2023-01-01",
   "Number": "1",
   "Paragraph": "117",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-b&anchor=para_117_b&doctype=Standard&forcepdf=true",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r35": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "82",
   "Subparagraph": "ba",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_82_ba&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r350": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(12))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r351": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r352": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=SL124452830-107794",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r353": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22583-107794",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r354": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r355": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r356": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r357": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22658-107794",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r358": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(3)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r359": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(4)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r36": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "82",
   "Subparagraph": "d",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_82_d&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r360": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r361": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(b)(2))",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r362": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(ii))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r363": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32621-109319",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r364": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r365": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)(iii)(01)",
   "Topic": "848",
   "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r366": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)(iii)(03)",
   "Topic": "848",
   "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r367": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "850",
   "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39603-107864",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r37": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "91",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_91_a&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r38": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "91",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_91_b&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r39": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "92",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_92&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r4": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.4)",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r40": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "98",
   "Subparagraph": "c",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_98_c&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r41": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "98",
   "Subparagraph": "d",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_98_d&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r42": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "99",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_99&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r43": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "10",
   "Paragraph": "21",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=10&code=ifrs-tx-2022-en-r&anchor=para_21&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r44": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "10",
   "Section": "Disclosure",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=10&code=ifrs-tx-2022-en-r&doctype=Standard&dita_xref=IAS10_g17-22_IAS10_g17-22_TI",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r45": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "12",
   "Paragraph": "79",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=12&code=ifrs-tx-2022-en-r&anchor=para_79&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r46": {
   "Clause": "i",
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "12",
   "Paragraph": "81",
   "Subparagraph": "c",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=12&code=ifrs-tx-2022-en-r&anchor=para_81_c_i&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r47": {
   "Clause": "ii",
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "12",
   "Paragraph": "81",
   "Subparagraph": "c",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=12&code=ifrs-tx-2022-en-r&anchor=para_81_c_ii&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r48": {
   "Clause": "i",
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "12",
   "Paragraph": "81",
   "Subparagraph": "g",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=12&code=ifrs-tx-2022-en-r&anchor=para_81_g_i&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r49": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "12",
   "Paragraph": "81",
   "Subparagraph": "g",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=12&code=ifrs-tx-2022-en-r&anchor=para_81_g&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r5": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.1(f))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r50": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "12",
   "Section": "Disclosure",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=12&code=ifrs-tx-2022-en-r&doctype=Standard&dita_xref=IAS12_g79-88__IAS12_g79-88_TI",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r51": {
   "Clause": "i",
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "16",
   "Paragraph": "73",
   "Subparagraph": "e",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=16&code=ifrs-tx-2022-en-r&anchor=para_73_e_i&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r52": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "16",
   "Paragraph": "73",
   "Subparagraph": "e",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=16&code=ifrs-tx-2022-en-r&anchor=para_73_e&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r53": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "16",
   "Paragraph": "73",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=16&code=ifrs-tx-2022-en-r&anchor=para_73&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r54": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "16",
   "Paragraph": "77",
   "Subparagraph": "e",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=16&code=ifrs-tx-2022-en-r&anchor=para_77_e&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r55": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "16",
   "Section": "Disclosure",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=16&code=ifrs-tx-2022-en-r&doctype=Standard&dita_xref=IAS16_g73-79__IAS16_g73-79_TI",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r56": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "19",
   "Paragraph": "141",
   "Subparagraph": "c",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=19&code=ifrs-tx-2022-en-r&anchor=para_141_c&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r57": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "19",
   "Paragraph": "147",
   "Subparagraph": "c",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=19&code=ifrs-tx-2022-en-r&anchor=para_147_c&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r58": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "21",
   "Paragraph": "52",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=21&code=ifrs-tx-2022-en-r&anchor=para_52_a&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r59": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "21",
   "Section": "Disclosure",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=21&code=ifrs-tx-2022-en-r&doctype=Standard&dita_xref=IAS21_g51-57__IAS21_g51-57_TI",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r6": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "104",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_104&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r60": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "24",
   "Paragraph": "17",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=24&code=ifrs-tx-2022-en-r&anchor=para_17&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r61": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "24",
   "Paragraph": "18",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=24&code=ifrs-tx-2022-en-r&anchor=para_18_b&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r62": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "24",
   "Paragraph": "18",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=24&code=ifrs-tx-2022-en-r&anchor=para_18&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r63": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "24",
   "Paragraph": "19",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=24&code=ifrs-tx-2022-en-r&anchor=para_19&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r64": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "24",
   "Paragraph": "20",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=24&code=ifrs-tx-2022-en-r&anchor=para_20&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r65": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "24",
   "Section": "Disclosures",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=24&code=ifrs-tx-2022-en-r&doctype=Standard&dita_xref=IAS24_g13-24__IAS24_g13-24_TI",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r66": {
   "Clause": "vi",
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "26",
   "Paragraph": "35",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=26&code=ifrs-tx-2022-en-r&anchor=para_35_b_vi&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r67": {
   "Clause": "viii",
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "26",
   "Paragraph": "35",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=26&code=ifrs-tx-2022-en-r&anchor=para_35_b_viii&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r68": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "27",
   "Paragraph": "10",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=27&code=ifrs-tx-2022-en-r&anchor=para_10&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r69": {
   "Clause": "iii",
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "27",
   "Paragraph": "16",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=27&code=ifrs-tx-2022-en-r&anchor=para_16_b_iii&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r7": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "106",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_106_a&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r70": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "27",
   "Paragraph": "16",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=27&code=ifrs-tx-2022-en-r&anchor=para_16_b&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r71": {
   "Clause": "iii",
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "27",
   "Paragraph": "17",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=27&code=ifrs-tx-2022-en-r&anchor=para_17_b_iii&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r72": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "27",
   "Paragraph": "17",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=27&code=ifrs-tx-2022-en-r&anchor=para_17_b&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r73": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "33",
   "Paragraph": "66",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=33&code=ifrs-tx-2022-en-r&anchor=para_66&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r74": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "33",
   "Paragraph": "67",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=33&code=ifrs-tx-2022-en-r&anchor=para_67&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r75": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "33",
   "Paragraph": "70",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=33&code=ifrs-tx-2022-en-r&anchor=para_70_b&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r76": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "36",
   "Paragraph": "126",
   "Subparagraph": "d",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=36&code=ifrs-tx-2022-en-r&anchor=para_126_d&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r77": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "36",
   "Paragraph": "126",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=36&code=ifrs-tx-2022-en-r&anchor=para_126&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r78": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "36",
   "Paragraph": "129",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=36&code=ifrs-tx-2022-en-r&anchor=para_129_b&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r79": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "36",
   "Paragraph": "130",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=36&code=ifrs-tx-2022-en-r&anchor=para_130_b&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r8": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "106",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_106_b&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r80": {
   "Clause": "ii",
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "36",
   "Paragraph": "130",
   "Subparagraph": "d",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=36&code=ifrs-tx-2022-en-r&anchor=para_130_d_ii&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r81": {
   "Clause": "iii",
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "36",
   "Paragraph": "130",
   "Subparagraph": "f",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=36&code=ifrs-tx-2022-en-r&anchor=para_130_f_iii&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r82": {
   "Clause": "v",
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "36",
   "Paragraph": "134",
   "Subparagraph": "d",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=36&code=ifrs-tx-2022-en-r&anchor=para_134_d_v&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r83": {
   "Clause": "i",
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "36",
   "Paragraph": "134",
   "Subparagraph": "e",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=36&code=ifrs-tx-2022-en-r&anchor=para_134_e_i&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r84": {
   "Clause": "v",
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "36",
   "Paragraph": "134",
   "Subparagraph": "e",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=36&code=ifrs-tx-2022-en-r&anchor=para_134_e_v&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r85": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "37",
   "Paragraph": "84",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=37&code=ifrs-tx-2022-en-r&anchor=para_84_b&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r86": {
   "Clause": "vi",
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "38",
   "Paragraph": "118",
   "Subparagraph": "e",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=38&code=ifrs-tx-2022-en-r&anchor=para_118_e_vi&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r87": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "38",
   "Paragraph": "118",
   "Subparagraph": "e",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=38&code=ifrs-tx-2022-en-r&anchor=para_118_e&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r88": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "38",
   "Paragraph": "118",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=38&code=ifrs-tx-2022-en-r&anchor=para_118&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r89": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "38",
   "Paragraph": "122",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=38&code=ifrs-tx-2022-en-r&anchor=para_122_a&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r9": {
   "Clause": "i",
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "106",
   "Subparagraph": "d",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_106_d_i&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r90": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "38",
   "Section": "Disclosure",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=38&code=ifrs-tx-2022-en-r&doctype=Standard&dita_xref=IAS38_g118-128__IAS38_g118-128_TI",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r91": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "39",
   "Paragraph": "102",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=39&code=ifrs-tx-2022-en-r&anchor=para_102_a&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r92": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "40",
   "Paragraph": "76",
   "Subparagraph": "c",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=40&code=ifrs-tx-2022-en-r&anchor=para_76_c&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r93": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "40",
   "Paragraph": "76",
   "Subparagraph": "d",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=40&code=ifrs-tx-2022-en-r&anchor=para_76_d&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r94": {
   "Clause": "iii",
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "40",
   "Paragraph": "79",
   "Subparagraph": "d",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=40&code=ifrs-tx-2022-en-r&anchor=para_79_d_iii&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r95": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "7",
   "Paragraph": "10",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2022-en-r&anchor=para_10&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r96": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "7",
   "Paragraph": "14",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2022-en-r&anchor=para_14&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r97": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "7",
   "Paragraph": "18",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2022-en-r&anchor=para_18_b&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r98": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "7",
   "Paragraph": "25",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2022-en-r&anchor=para_25&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r99": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "7",
   "Paragraph": "28",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2022-en-r&anchor=para_28&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  }
 },
 "version": "2.2"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>160
<FILENAME>0001213900-23-033939-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001213900-23-033939-xbrl.zip
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M5_".$0QB6OLJ(B\Z@Q*V#"NX.<:%3L\&"\-K;\<"!H>X&,327BQ=+6OR9_*
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MLG?=)E( &=1^JUV#CWKQLJ$8.LOMPZJJR>CZNALZS&XK$:7*-QE%_\.FLJ*
MFRKW0_M:1JYWW=IL@VX.CHI]S'%3[OQ#9V[@I_$7,I]6F6D3_L*2WU/,DO@A
MX/)"@VD0LO,P21X"#]0;EF_6O$%TW=_ZSI"V,4^"=CAJ'GJ0X7:FM22[B5-
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M,[1+0+=:M#Z1-&\DC_".D'(]1AN5Z]<\<L^1#-Q3S3)ZQR:F6/K>\0CE-S)
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MDOIA!ZJ.)H6C&T6Z41NA:C5(H":>?=H*)+3,UWW&-A[YI@'&P!AQ=,&ST*E
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M,I6Z<@YYXT%DK$ 62M4/NXQ(ZDW(U!4S\O\#4$L#!!0    ( ""$G%;>K-8
MPQ0  &X* 0 4    8W9E+3(P,C(Q,C,Q7V-A;"YX;6SM'6MSV[CQ>W^%ZGYI
MIZ.3'\DYSB3MR+*5Z,Z.?)(?N70Z&9@$)284J -(6<ZO+P"2>I$@01#BP[TO
ML:20V,6^L-A=+-[]>SES6@N(B>VB]P='/QT>M" R7--&D_<'=^-V=]P;# [^
M_:]6ZR_O_MINMSY !#'PH-EZ?&[UW-E\;-BM6PP0L5P\:_W=F_VCU6Y-/6_^
MMM-Y>GKZR:#/$,/&D+@^-B!A/[3:;3I@-&0/0S;@VU8?VZWN'+>.W[2.SMX>
MO7K[ZG7K[K;7.CX\/@E>^<L[QT;?'P&!+8HW(N\/-B M'['SDXLGG>/#PY-.
M].!!\.3;)?MAZ_FG$_[TT=G968?_[^I18B<]2(<]ZGR^OAH;4S@#;1L1#R"#
M 2#V6\)_O'(-X'%*9N+5$C[!OK6CQ]KLI_;1<?ODZ*<E,0\"NK5:[[#KP!&T
M6ASSM][S'+X_(/9L[C"$^&]3#*WW!\:"C7%\?'0<C/ W^L-7_+7G(N(ZMLDH
M?PX<-I'Q%$+OH,4&OAL-5E-@XH"A3UEL^S/&O0Y[HB,<H+,/%)FD83B%B-@+
M.* 8S: 2IDGC<(1UXPO(M.^X3VI(1B]3S#3@Q>35]!WH6E1%H3U!AH\Q1>,9
M+N<N\:EFWH)'1YZ>LN-I$X0U0#N 92(7&91(]#N5.VJJ *(&:P&)QSX;GKVP
M/5M]6BI0= G1&@L?86BX$V3_@*8)+<@P\L 2$ (]Y:E)#+H'MD'+@H;G6AY;
M)QQN(54G(!QJ#V@;&SI);;T'9Q!YQ+4<EQ J"\:F+6&_J<Y)#0Z;,)NN 1S#
M#RAQ12>W-6VX]" RH1E-G %6-NR<P PD!>JXQA8@ARU\+H[@.. 1.N\/; N3
MMN4[SM<>-Q%>E\O9-AL8-H2BPQ=!]@9?":E0NLB=/7<8A]IT"3Q^U>$CL2?6
MG]IT"E_7CW VBJ!&*JJ"/C4#7<0-\^4?OKT #N-0>?-(!A\L#]LBT,7;,P/8
MB-"D'[?X'_<\PB<ZQ)_-^&AMFPIC]+Z%W5DF3SU7AFXN-B&F[N9!ZXDN(%./
M?>P4D2_J@9J00AIZ4XA'T( 4%E62\E@D1&!K6K5EE)A^(:N.=UF5AT_,L%X#
M_!UZ;- QI,LK6SH#O\&3L,HI+V]H=<VHFS7KD+(G,27(2]H+2/TNV[L++/F
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MQELU;]Q4FW"_0IF%2Y+H-,J#D"6Q*#PK*')ZUV&P'@&!3+K_!U!+ P04
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MJZLQ3)OJXB;'.=H'*0KE[)1RD#X!KG#([+(]HML[95<\.M7"KKC/#7F)W0B
MI4=A?$ 1RL_@>.U),E(T5IMHKX*(SC- X36].9),SNP0#M9D*.,- X?IG9_=
MX9&43A,.UD17MJ=?9=!1Z >)%\8)-7 ?@Y2.2O;82U-ZVTZV:WIED-BW,D"U
MB3Z_@:7H26+'5,=HNZMMJ1F!@^B&3I:Q@$GK/"/T7N@=X!9P'Q!-=XS+![;
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MLC;LN615FH(,PYB@=Q<X^9+G^NJ^GG81[Q6Q5N%X__A)NJ( TRYYK:\#0U/
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M84#8#X@FD(ZHS"M**P84]XUVY_"1":?LFSZ@ZX=J,'%&O"U=)<OU=932^T]
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M/#56 J5$\Z%VQE@37H'6I,U6"NYU?IK6Y=>_AL42*5EE*"ZGCN;7;UW*Q+!
M\!IE8:I+(HQ5P/<W!;&<4T!T7POZMEH34 \)[AY8-1^%,(8;;(Y;!*2[E',/
M"<]0SGT,AU:5='![2$X,22K]>&W=(SK0F[M1#"(T?[?H9;FE^<[@O@%=&FHW
MCWXAN+N#G%.%L8D9*;786U8:R.:M9( ,4T:5@8L*9+<U3NP!$1@RF"_I/-)#
M<A>G**2G2!VSY7L-A!8+AG7O30>V4^JB!?'88#   +_%FQ)4RHXO4(8$#;QG
MR=H"=\&&!$G1$/'3[7E,]J+-*SS:N\?:C\A04DSE6=S#!*W:D^'Z0#7^+H@N
M6=3'GF+%R:?;Z\@#,[U_O).;RBC>#_##2(6 3ZMK&9;7ON[FH7,4B^O3A=6R
MDN+G1YRE)*8RQ&1SD.%LQ\ 9\KB+!8#P#NG52_64%TLMX,:(F:GGUH2U)[ 7
MJG^%DS@C'GN]E6.N>.P,V=S!A,%\<UF&_[RZ/M^R?'<2>U]DN-TQ<(8:HXL%
M!:__HE%C_'SP24SE2O^:AW/)6'D]@UV$8(SC>0\C"K[_V,UW6;:?X3!E_A\E
MM=(S>'9L[V-$P?:_ZF/[>7 ?A^B(Z_W[<S#3.X?.SZ[NYD+!\9^TFM28[26<
MFS^2U\C.H?-C>C<7RGN,OHODX@]$-J@XM*48WC720?;Z*&YW<J!DMMY;XTW\
MB$F*O>VGVX6,)A>/FYT2[YA^R6N=]\E/J__D>TAJ68M&S4^%".=>,KFWOYL<
MB[TXC%G$J(I)V#-X=LNZCQ$EV[LOF@KM%KC2.IW+P2Z@)$KJ[H[A\U3@7;PH
MN=]7Y6PT_W^.H\T_Z?_O4V49M$',\#8ZS)92''T7T['2H$=+4;Q051@M"+-3
M2(,L*071<U,=*X=S%"$?C=@330 S<X4-L:,4@<9;ZT>TP_'ZEK_Y(\):PWM%
MSB'9%T<3Q*$.@.*H@H71:!H0]S0_GYY6&.MN%9,\36SY2*VW9!OL3WG=M^4,
M[*59P2F:26RCS()0$HSV5MJB94F"R OV*"R*JQP4=G0+A,-BXU:W=)MWT-3I
M,2*[RB)>#A*%99:GO,P$,%R5];<I,1'K("]W#L**LP0S?1$\T!-_O<][%1Y8
M-B6KOXQ_SX(]/M8=4\M^E^,\D)Z6)+3%X4H3H%BITP119B*3I9!;[35E966I
MA2W+2<Q1MZL5RWRP&JY\PFCP\#80G*RR >L&6877AN*2.0;; <@UI*;N5\!
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MDE!W46+F%LY8V6E-\<F2UQN$]K^N*)K<A1I$&_H+)@\8D/)36SMKE-QS5A=
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MK[#\+G#BD:!8]:R)*HL5^R5F19R8_UZ@+*TM-@72' 4B.UE9*I+3VE.U.U4
M<$/L&/A5G#U]C!LN8>7FQ627!XL4_5JK"8&R2Z8(.[DY0FIQNH5+YJ5C%'B%
M':" #_I&H0S:[@.$#H&6VT*=F\Z>#M[A>$/0?AMXU(0D5"]8?3D08S?G'P"]
M'8S=$_6#KH/!YCS0+826?79=^&UXI7N?"WJ7^H#0S#\<=*"T^(;0*SC'#PKC
M9:?_::'RW!&R?+9DN:Y&D5A]@>TBP*#L'.C2;CZ;DFP%D64UVL;L^K5U8)$W
M0AO;C#/T0-7"9%%E"H7D^NUUG)Q,58.K!/.S['#P8ZQXG LO'$ KE!>!CLGJ
MMAZ2=$]^7?RG9[DGV/O3)GYXP[[)5SK_B7.9<[B$X,9S 39:&5^/DQWFHC0/
MSY=C>4@AS(6';+)ZSTL.]N.'L3RD$.;"0S99O3FN'.SMQ5@>4@ASX2&;K-Y.
M*!SLW;_&\I!"F L/V62'GU>D>?CI;BP/*82Y\)!-5F^3#P[V\[_'\I!"F L/
MV61!SG^XS<@>L,GAU_,%@(W%EW-.%K^<F%D!Y31V#,#,ZJP!/2-4K[4?^"MN
MG@%C[;)40^HF-UF7L[^+DP;Z<S:N$C+%)3N'.@O T_G8TLT8W:%0#-L%"4+Z
MV0; ]N-7';WG#ZV8DH&G*>F]47%!4P)3S.OM\B)F+"OY"C<CQ<3OAEU#G:U:
M*$.[)VU +]Q@L@O2E,KO?> QSQ!H;8I&39ZOPJD:*.-(\21Q%.$0QLCBNW-@
M7SDM0"2@=#5Z[,4/F+3*-(CKSI^^[,8 @/*L.BO=X6LY_+QLR0H_!/@1Q+G:
M@,DONN8$#11GN=[M44!85,3Y%I%-,[9/R,;V&'<Q6U!6"N:IM? *MP6"LOZ2
MA'TI&.3(Y-%I5XI884!OYF@*PJ^IW4#HKV"F-\>YBDKN7C=U=K;F::)6>7X+
M^QF'_E5,;A$\D[XVQIU"&&:F8(9&&K73C?0;]M(+_(##F)?UD[U[#D%PM6!U
M:HI!+D'J+TO)A15YIF.]/&SZ,P[#=4 7 \3TZASJS)0 +K*2V]USUYYC?]QJ
M>?G*- !UNV^.F+>+2\@#@!7G*L2;5Q0GQSIU\:E.W3T*V95\9 $<(>@6;P>I
M:/%Z:$%IQZM:[$83(5(E;K3B=%#8QM2BJ6U0O8)Q5\2FC%LJ"G,YB9^LX'8=
M.FELTW7$5%;9KM<AW(G,<DBE&+M!^T<VLK*]\GME)1-6IE-@%@,L.T4VC1!+
M)8$!(RQE#^E_!M$F>0C"4%BD17C&MH:X#:OLU0[ED=>>IN:N']Q[&2=!BL!\
MK'W==<@&B(OU"9J(]_T%);]G^ \P#^O?=QJG >)@8WY&.OV>8_:>& 4H!+.Q
M-60&6[H]30/^UG<H^9EJ#7@5L,8 )VX2248VYZC=_W07>.@^CL$\K']_^INZ
M,3^HNT/!L,J;$>=U6VP&837QNJPY8?)VW,/IP=-N:@XL=@,/(E9WKO1A.7'@
MG,BP[L02H58)2]),C%5?5A.MN0/)G#^K9PEI=6FU1*3!JZ6HZ&]SP';]636D
MSNLP&]IP=35?Y[.Q3I E&LNNJP9:.RGYO4XKT;H62\1P_F\=C47?E$ F3KU2
MLA(QE>G;W3'J+#?8H"=F+XPY&Z[08["?B1 [5I/@6&,<+/,,/@#%S=.X>]E5
M^&@@?KD'K_];ED<6C6M<5X7CN-B=6SE6^:F]O&H_[EN<IB&T4"$(C-.2ID[E
M6.6EB3#OOA7D<S8GK-'EX@]$-J@2;</_]#%.\7??CMRO4"Q?]VX&RV+" 5#%
MGQ(48LX.%D.7L"2&=(LC"GH=/. #1B11=2+=UB"WA /&+^,]TH]3Z63510;4
M8:07G\&]+705&5LHY5;6+ X=SJ$7[Y""=\C(MAKE%GIQ"KTXA5Z<0@:<0GRK
MEVT#DJL@\5!X]QC_!Y.8_G-'Y0(^%P>@N/$MV#GSAABHW274C_4JSB!1   @
MSI)0',LMYZ"1X*$!Q)3P\:)C0+Y:T7$.&G'^]".^#9Y&2X[!<.1!=RPVSCT3
MOIX!M/@!0[SG$"A?Y0E7,!#2 \:!\X5.DGZZ1]$A2=+8^Y+W3TGB4UND4_J9
M_,HZMKN_V^+S',WM+4-3=,BI=%^22-%5 JNJT5@_G^0,45$Q3-1V1?FRI2S=
M\%OV6=[SAW_E!AUX%O0C(GY!2]%%D3'Q8P:,/C2 U)V;=,PB..XP U(PUQ&A
MT7RLUD=SN:YVB*I,_3KB?[BO3N T/9?MYK31[TC]CUQ_%N1JI!3"Z#W#VY<E
MU]$-)D'LOR-Q G)\FT#KSE2?@O(2"F+PZF5:=Q7=[6:IM^"TNWIB=J&U)"0Z
M>'N4UE9L:M=)DF'_(B-T4OEBYY14IUV2#ZF9)0]SWGI&GH5:\VQ4EMR1EEFJ
M$1GJ73DM'.@1*:$:J*_7NQ'$A_%53-8X:+79E5<K0^#G:0./YZK>&NLJJ_)(
MS"Q5C0SU7Y&JD1(JH"Z]IDM6_O$B2[<Q"?[ _J>(8JZPXB9$)S7)I[5BI.:N
M"=96^NBM*.:I?O'23\J\C21K BM6VU]=VU:,J%FJ/#GZYWFP6I!KL0Y_FF#D
MY^"+@Y(Z/D?[($5AZZ&G UOK66=(QRK#5S]A)%&"HS6585N/S-0AV-H9H,92
MAQ&7_,!)CF=-KAF8 511,54U834R4XDXIQ&<8[=577NK"<=0#*$L,9:C/Q7)
MFT"4Z)@M.&Z]&(XZ52/'8G3JB#7C-(K5]8HQ%17+8EN6$;YD-BO]]R,]:N\>
MX>65>H<[K;8T3G>6%D8_>PS4_2LB,GG($8NHY4%''#V\Y-40"-?U ?6(9IA3
M>EL,,YP,81$0QH(O.<K;X DLFO[QC@N\Z1'+ (M,=,8;_2Y?F6#?[=U&T 24
M%'>^.^T7."N2TQZ9T^GPN<CRCDK+]063"_;/<$1_J*3[NG33 :ES%BVA:W6-
M%H_VC(@310V78(=ZM;I*)$ARY)_5OS!DQ !)LK!^;/V"$[:N(__R:8\]^N-=
MS#YR$J@,IF7FR\>RX S%]=26OB!RS)WNZ2)F_O:.+/=A\30.'GL>BP,5Y0<J
M2I)LE].?4?J"R$.AEX6(=<M-MWB- O* P@RK5_TX/LTUCO+%"?,G'J1T?L)\
MM\57%/,O'+-22LIH9&,R#RYPXI%@GQLJJR#Y<D5ON&7OPA5*1<O&VH95(L[U
MLZZNM5/?RFIR,M7<IC''%6:\H1,J4]HR%+X/UA,Q.;40ZSZJV\RZTB-)S3U>
MJB=8;K=<! ^!3X^217)#CS1JY5!:76HF6;J>IU*2EL[P75?#*592]4O,)A0&
MZ6$R9QB,-.?1F!:.,*"0H#4'W.1!4X689DDM)9I>OGCN524'>EP2]"W'48L6
M^US@4$V AH!4>;0X744U!DI6SIUB<92T5OX"=3RX(6XBF=02*ZGF@' D42.M
MCG6^ ^39#->11^C5%%_@_-\)O>LH$.C>S!VQ4!W*U4@=,>'F:T\I@64!ERP4
M&D 2*E,; =/("M"F%?4)1J^5?-H>]\,DW_<ZDAM[@!-\@=*3!0A6<!9(F??R
MLB*L8>O:E,YJ[8R/]%+ J;_\G96VOHXH;S)>K/&8&UKR32JAVRH]\UYR]L0V
M7)/,F%W7J9,G8]@9HG#FEQ"7LM7>&W/4EJOGL6;L)L;?=X,\W*1E5O _F566
MJB3-?$U:E=YP.KR)19@,;2T1Z1H4I56:G/M;#:U!_<(;S(=WE!7*9KG/B+>E
M$RT]L*+T4+VIE -86\$9RGF58$0J993&8-:3-@I"8LPSI9 ]*BMX6!HIC-<:
M\DE?LDFGGDTJL^VLI)6J!QB]I);*6@TOJ:4OJ:6*"^;K3"U=1IAE@+&<R3*%
MDF6%@9/E^L<_BV2Y 1;IKFQ=I$T6_[&D28:YR'&5R2_MA>#BL=) <FD_E[3W
MN6%YD^5:N V>&#JIW=(__EGLE@$6F4@M+2_[  $<O^K*;V'D;G1B@.9@TBKP
M[BS.%0Z*R%<6[BHA!3#(9RDM.$,-- $?)D+6]R@+T:$#VY%8Q0[!_A=D!QY!
MM(LS.H\]"OPT_H(/.Q2AW"E*QT4I18F3/8D? C;%)-@%(2())@_LM- 3NKG(
M*;BA%-S%_\2'#T<*EN2RH."FI. VI^"VH$ IL%,+0O40[!6KOY!AUE=ZQ03'
MZOTNU]?1.B8[[F*^P]XVBL-X<SAG&5PABQXN\=N[NHVB<@+O^SJ75>-.-TZ
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M'%P(VJ_,%9.*7D^2($VNZ#S/4/3%WE-\&[,;\U:W7 4<U5ZM@9N\M]E]XI&
M)SPDO[!FOP!]TS72T6FDA_F]+(%TZK5V1 D#;JH7@3&'TQ'@Z).H#Y*JU90K
M,RXFR"M48\ DU#Z P2=SJ3Y? WTCKI.$]?>._&66TJMVY-/MDJ,['2T 1H/
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M$!VS,6,D6 LHH:V8!H-(C^EH,MVEB7B&8FLSST@+S! S?0K69(T!L^&K:+*
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MY.4.UIC8[-6G2I\C5[N,J#4(P5C_&U'6K369"Y'/2J!B]@&<\-(%KAF"VOH
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M;7/,8NR<NFY+A6OR")/-X2K#82(3UB<<9O]1%N './JEA!/5'/O <]G#%'W
M"5IXOV=!PKD 9FOWV$GSMF?*X$+LUD-!!^]/6C;D2,5W]QBK*K[34">*;RR;
M*S,WT%2PB8RR5?F$J0Z>XX*N35Z[N2U >!5G1)79E;'NHLA5.5V=.*0ZO2R?
M*_D#T&JWK2&NGOM'/3JU)ZZU;TK%=XN2K;U7(H;,7?"5LD2:[#)XA3^+"8D?
M*574J*-TXB2U&J?8@=Y-=*(&>76Q$Z"LI,UD9BL2+%>?5S#(47&44>I*-'=
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M)P905#4AO W&X1[B-)>[= W&]V7;HUS33<B!(9)7*GTVBW#E([LT=T>I&8-
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M4YY0EQ9M&6[3'CX7ATX($/IHE;)FBN\456^"^M(Q& W4Y,<DIY6*1#]2ZFM
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M2&)=;2%=V 2/<JEW+A@Q(IO]SLMX+8M'OFL);+*]BB?E<Q?VV^TN2AX'*N6
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MJ*RS37C)[6W[#L8"4&^#+J6-;,K;N0Z:]1V0ULT0I,]!2@IFEI2*L+GNP2T
MRRH(J# +LF6F%*H?;((L/R '67YX D&6']K25:S",LA2U-W.+N./2<R=\[\F
MZ6?AI]^%N1<)_[U!R,5D-*>B-R ,>BVS&('O?W$2'_$X#/E2C$+\8A@2\G%^
MQJID82'*^KE-0_;,>AJI-M'JO^*^5AT:OJ8^#1^X1L;:ZDPHQ#^_:-,*/U%0
MM1#!@EU*=UX85&?L16V&%MA1GW/,F'?0 ] YW259R/[(.'#&6B9;AH7%G'WD
MU"WQV".E%,IW*]J2(W5=DP4@WQ O9J<9F&7V!QGQ)5W&ZRCYPF\C%?]=\[WF
MK'P4A!DTF20AR!GD[2ETK_2M:065/MO<0Y_G>G+#!MV1.ADMDAO@UNPZJ)J_
M3;V \J=N]W%^Y3WRS64Q2EY&VQ+BOCJ$PEDWO%%&=D6SXLU2WT_W/,VY<=LL
M7=LK8&.FZR'630CB\N]*F$J[8@NY9@:DB&2LUJ?! W_0F;_ \3[QXNP#F_PV
MN:81+XQUY:5.%?Y4.C&LG8DT0W;/GI(\(6G1EGT;*5KYI]EAU'O%;P;^S5(!
MY$<;?]F/R/ZR'Y^ O^S'MN 5J[!-2BY>%;6\9Z#J[?J>@8(6\"F,LL<B[AEH
M2*).0QY9ZH3-[BI-?$H#H4QX^4)5+?6VL2DAR=G&-R?-"#E.,Y(//UTK9B <
M;8M_&N  $!R\HSTKPS&NVLZ\!MGMO/-6P7]VX*R1$I8/\/P/4(R9;/V49_$"
MVAE_F7 5G_[NI1OOE&<MG/IL_BS4O#RB/90K#Y )4:HG/XONQ<N-/.Q=C% F
M=GC-&%BA+%,9=IX#U>7-E'=\JD>UBI  #9:RM9O2Y=YU:4BAWJML/-].C(:M
M8BUQT56C-BRR/,Y4&KN:JM+<=N7M349S>I(U(&S,)*R05MB&6G7P'2M/"YE6
M^M.43Y:H&QS)?[+QAOR$[ WYZ0EX0W[J2QA8A:4@+\+8BWU;;XBJMVMOB((6
MZ(9,U6,1WA -2500&%NJ5=6%JS1\\'+*S'R?EA7)A2;1VC6 KHYO;$-T@#N"
M:$YV57ON$A =L*SF,1DT6EZQ4/L0?_OT]_8K3?TP8QO'KU[*M@Z'=YQ&R$!V
M6 TITO)!T;(;MS6^E!UQ,['TI W[!P!&8/N&Y&3)W#W7M/GR6U(A]S0*VA7S
MOOTCRFE*93;YZ*N=VZ<CU%3@W&10TF2L)[+6%<D,JV2,H=AU<-CFQ_PFP@2-
MT2),0V&4@E'HBS^2I(ZGI5&UQ[_,LCVS7AW7AX8I0+8H.L1 MZ5%O4#^^*V?
MAB7N)"ZS!>!-*EP8:\/%6]0.')R)7]NX(UXCNR->/P%WQ.NV1!6KF/8\BR@V
MMEI791RNV5FGO."R$K=;3N. _X>'HAZ\R&D!!AO:4%(N+0@%\%>,Q'>\=;^F
M" ]!==*-<=Y_L<=+[VD82Y[-XG"Q<+0X?K&R/[VN7P7-=E6Q&?*EV.Y!_7'"
M6&;?:(FU[HKL/ZOHT)8S]%X%MLS[LH!DWUFP_?FXGZ1]>Y\F^\W]\"#.]8C#
M1T9-Z<*(+1M1J#*6,Q(RTY*'^9)4[7W#"C1;@:0?:#;GEV6DJ&#JI>#I19(.
MI]!6=[HC.=9^FF1-PMQ2%*2A,"M]:<*B ZI/UYY&;8(0' FZM%G!=F$.2%-@
M&.K*GEMR-@4I*MV5@T]7DI+1G+HM# B;CKD%/(!F*=I1E0FPRW9W;D:3E@24
M8VS8R2V4!O,OOU:DFMFUU.4KF\?TLLZ&UAO'=>*.%E7:J@1*A";??$S86?7D
M>$EVEUY.M#Z#K/Q06L-SYIT<V^Y>&F/B&OOC!,X(P&5N:OIR-\+E@(<V-T):
M@==RQYRB!DU&<[H?&A &E@%I1:A+$\I4*SJ&H85L*P":\LMR^VU-4YUS9X+?
M^'".U:();1H0K-T>YCLS'@JU92R!H1[3K)Y,JLN W"9-#O]ES"9(^$,I.O;^
M^!A.U=TH.5 )F+H?KWG17-@H*QL7?;%2>+7E5+_4I,6%2?'T5L785?TVPGFX
M7M.4\H(9JUA<NXM$ >B/-%^M;[VOSKQK=M1AU&ZQHA2J1KK?[GG#!TKRIA/Q
M:C1@7X2;!)JNY\V>;[-4:CDYMLD&.CEVO?E*2-#("$)/"6K8"^8$E0N9$!+@
MAXS5VG6\M#,KAL;I4*!]!,UH^A#ZV)5>I3+KN>0'R[/YX'OGT)MR];;.BEY_
M7,=$EQAC! "N!EQ/@UQ @%=!P@!KC-RTTV>K&[*Z )%W=IN !1/RA-*&]<31
M@0.\9(LX'3=$5O&O_-F?9+U>K46=$V9P7#<O_FA@0F>4N?)G7A?0B.F&5[*#
MP*%!T7Q/(2%@QD!N%7AT63*ED @W;HMYKNF6>MF^>%)GM;ZFX?9NS[YF_L_K
M<'/O,$O9B*@Y S[C4+4C$D#N-[S_M_7C+Y8O'&$>L4RA,SQ9&;'0[K&88HJS
M)!;6_"U-MV'L27)P%)I2VGF^W=-$1<I(&=&,?MF%Y$T?-(_YN#2Z^@]<[TS/
M85;5;BY%)1]G.DY)A$MDZ9&D5P<).2E51[#J\M2#)<_U=%JCZJHR?1E8F@X)
M@T8D+@&A)@1#._ [\;Q@5"I*@U*;2T"X#:A4^#=FZ%Q?QZ<X"/D+$'=[7NM:
M/.B=K=9U# 'OE>T1LF;TKMA_!F-4CA@'"XI 386'^I5M#2Y-*<3,)'WO\=1(
MMHLP/H?L=";"I]E2:C/:4^C.$S #M>#+&TW(GNGVL!ZT.&SA%\>=BI_>)?5)
M[)M6*Z&>>OF5R*>3BK0%3*=<[SLI;9_'9_R>9)P_$P_6T&H*_$L5\X$-^GZF
MEAJ?8T.I=NB*%I0]8T $SAE 11* Z0]=0_ZQ2,(/PGR?8H<9=:0,:W;I^FT"
M3*(Z /_RTZ+HJG5ZH.9 LV5JZ7G.]*B"<EWX4[M>V;LH<S5:K]Q]?,%,@O7#
MN_J,F603\'DN^+-WGS(:7,:KNYP=-?D+O]RYET2K-8^1A4'HI4QSKE+Q8-Z;
M?<:^6YYVLQ1SX;"KP%&G!UT3^,[IFJ;\8VKGT8K' +"M<"<X'3X)=E@!V&P(
M5\6S9%FR;F=UEE6X-?8!=7^G1O,H.<KGIBK'2%EA';&LNHY$ZM(@H^NU=]UU
M\B'+8LY>5!PN3_,++TS_XD7[ZH)RX6I9I;R#TP"R)8DX6MB>8"AUAN9Y5-=Z
M5,23L37N=#0ILG7-.3FAK&SYR?&L+Y[U(W+ Q"LP[DYK, E8;@J0(F7*E\@%
M[%L$..>S4:GV3F?J!4_P!]1/A6:K]9LD39,O;*?O[/^2POK.H&=''8ZRM:)U
MS)1=U\\Q=&&+@MI)6.D"VIY9TU7I:OV>ESIYW[R+O12XVU.($DNQI18*'?)1
M2(6+!3B!I^)%KL/MV#7)3]+L&>7#SWSK<(9J^>Q(IH.4F%&K@3^A/7 E(,%2
M*<PNY.#%&EL, 0U_J_P#W(?@^?D'NKVCJ0)&&?6_VR0/W[.^ D#\!W&F%P"!
M1W1XNP0D H!$U9:4C<G?BN;_C6)0C@J%PT&]1.MT1Z&T^%NH F1GWB[,O6@4
M$C-[3A4TN*_3J:!&J6#\HB7RD41#GCT/X\AR)^U8Q54G'%3)YL9Y.45"R<0[
M37B7'N7"E%Q]E*S7+D%?N+J+S*R;?;J+]ID,2/)X(]35\<5'B XHIM@T9U@0
M[3%CAR/\KZ.%JD5.R 7U_:*<  U$=.,LV>Y2>D_CC'T412ZV8\6B3Q'*XPC:
MY($Y/G5_DO !F,7<&J%ZU/@;GA:-=/%V CIZ6:!&O)KDG^.!.QJ\]5(>OI.J
ML(,ZX*33NS>NY(3 [K/0#W-L;YE*<GUW&+@ZR_I<'SV>AL3K]])41&1.X^!=
M4@2 ?9KJ)-V,#N&Z*.8800 :BF[%XV1EQTPD'&Z2PK$J.F/51M(55+5;:C%A
M@L(Y#S.?:6@QQ\U^N_721_9#N(E#]DWQ7$7?3_;\58C-51*QKXQF;[_R)$X^
MJ+L,PFE4HFRODTB&S/ZF.VGZDVH =,M_%C!U5>5T-L[T<53O(I5O(5W&%\5#
M4.UWDM"_#6,B$:KU3Z$7^B[\>QKL(Z'TZW>Y4MX7V^Z< T'P!V'%O@DNP"1C
MWYED#H<>0) $%"4/TP,=V8L. IS$RPD[3)"4[I)4*/*@4Y$!R2\X)N2^6U#)
M@0G*]Y17)]E03+@I2, YLH/T0&?THD,!-UX4B^/MD7HIMEX<%V[O *Y>^5P&
M<&-7-!F/3*VVDV>QMWA3&G%<V1,HUMCCLY8=G+5&0=:=,T!)8?Q:<-'.D?[1
MV]*D3!AGYK9X&9#?$V(091N5IWF'1V<45WXE37J@-QYY4PZ[3F.\'&X#^31>
M!+W%3RD"QJ^/<3LFB5?KU9>8R>(^W#7%4&J<.KQWJ$T1RFZN31Z R[H/J3HA
MWT(T!<#@170#=E@]\]+_#-(P]L.=%Y7)5X\6:FTPA'LOJ9H@^.':HAVI&N)Y
M1/6$ NDRZ8+G@,?%/O8Y'+WH;)_R*MT6^)",X?1]@5%R '@T#4G5<C$;'BP7
M "+ JBU#+6VC[%-&F>YZSPL^ 7?\Q4V96_HU?\-&_*P!H$G#NS2HIA"J8>/O
MQ9 DXF-*:D@T)21HOX:$8W3.@8<*N)-Y:F?Q@]4IKODI6P.T(P.XA*6:%.C!
M'OXWK U0C_O->^VCZ[,# 8B]?NV? G%3U9EB5+<%Q2THM%!?BE)12]%7XW(>
M55,C++.H5'[FY723I(^ZFJC;WJFMU9E:2]&XWZRD[&SJ>/07,"FIMXV2)DS[
M[_M@(S:NC"NOL@PUNE?5A#[DF*D!J5 0*@WST&>FO=?D$%0%P8M4F;_7(^.Z
M%"9""/:FFC+1.FBJX\)MZD=B?P9F%+I/"[2F5:LZQ[!L*3[JK3!C'D6 F3;#
M*;GQ['F1N+F@ ?A18U)S4*P3L1YY&H;DKC40R8HKBK&(XTK@BFE+FDE99DH:
M\&Q*H*+(X!:>H+PP4YWI6LG4&$^J#<F \@?$'Y^5/L %5.J$9=?5>< *[:^7
MM =LW>5&04Y[?FSXM&B![ODW+18*)(D\833U%VQ3%TV,=TT?:+RG63FNQO8G
M[>9R@Y,1 #Z!7;22B=SQ)J7B=K4-@2NS\Z6]Y:5A,Q/9]GNX%&MO;D"B5:L%
M2!1@;R5,V7HF&PP?&4EX-L-@=I2,!2DI(Z8#:W[D]P&#I_(A,4H4OG2A$S(-
M>X.B61%R$I8 *"-C0HJL)0!+SYR 5VV5N]#9P)JQ3:V*5D^GOG. B%'C0JI=
MD$V,(?>E5D9OE99^EFJO,Q*YI)-3:0_G'[4Y%B)HF-U]XV,>\18[#R\LR@NK
MEY= XTTUB8:LQT9P&VP=H6;$EA"O38G:^4G5LWB%(<.ZZ64@HPH@.BRP>=*Y
MV46FP$5K&+>8T2%)PUS0 X]C[)A(K7[15)<?%BBJ-J<I$!H?P^EF,TK.J)&Q
M2.1H2ZJ"C1X?)IHA4W S/@:*D6**F\9F621NM"75-VAFQTWO0(3A5D%WIFBY
M4&Z3=KU O"/NJ,=D1C\)FG=D&3X1P[#*4A"BY_J8[/#HC5?N;&YQ4DWJ/@FF
M/?VH[=)%!FJTK2<F"3#:B[(T1#[%XA\T.+W+\M3S\Y,3#=-#ULMQ[4<)"8!P
M,?T?"O96]@*T$)M Z7]1+WT;!S0XI[ZHD?;BA,NN&EE#LF,CN#W*CE #")SW
M(I1W(U4_\N+D&>%=,<&@*9T*&#J+MSBR#O'VW.J+?X[_Q3]_$E_\\_$O_OG$
M;)M;[RNO[5'5-RK+?I2_=6<0CI"!D BNI@B S^T]);QBJ1<__M.??WI^\N,_
M9X0=XGP:Y[PX3%)=MD:.S^H)O6LV:/!CEM3MZA[ZHK*U1XG"K_TR1J)& FPH
MS]'FA3SS,-Z'^2/)BL* ^%EE-I"!D[6UF&>7H-1^T+$>V\"L4O=WO)$JB;'-
M_'>]SVI)I-IQQU=L8VT/]_$75I;4"WQ+Z@4@]O^#=<E7P5O8C'HQHRA?6HGR
M);XH7SX)H_CEN#1?6DOS-/C[OKRJ<YN<>6GZ&,8;\0*I@<K6&,2QK,<I@ASC
M34>2)\0ONY('WO=G3&#H2ZI.!]!C@M7SV\U]FIR*"S6K]4>:#Q]1!FLZ0+U=
M%SE2T +6-VKU*.]-,6,RICGA#U(@7L'6D$J[UH-JV5:9@@W@;I.V'?$N3?8[
M+6_IV B.4XK4U(RJ$*Y!NF<,T9.<G""F%.G):*A#8!98>-;.PVC/P:>I,#K-
M76N(]N30,R%EDZX"<'YC<LC3YBYD;PU6WW=5X^HV]>(L*MZ,J/&A(49U?]<O
M8JF(@<H;E'U(WG0B7MT+2_):<JE+<8RN>YY3P2NK4\$K_%/!JR=Q*GC5ERNT
MD,.<"HYG.18<.[V,ID'/M%/!XDX$Q_!VKF:!G>OOUS3,:;)><_]B92IHX$3:
MS24P9 0 2!!-CUC;KO\8T>A7,;T2.[C *7<7N_[DNN*'2+>XO??BUN_*FC@T
MN$C23_Q1!UY:+G_\0//[),"/=<Q#.\9]^0.L0\NKO6?&0[C?+J>$T\P 5$5.
MYN.RS=9<Q:]6Z]M[>N&%J=#>XE]7]X\9+[[UJ1!.0]6M=Q?1HF">5F7%Z7.X
MU-Z3J=6(%/*B.&LV=+'C5[_9E<-7GX-T0W"\'<R&CVKOF(>]TV.)Y226D<1^
M;]=.! 4M5@H7-XH(R$(60Y0MULKY,#S?_&!UPOP!_X3YP_)#B#_T90JM8AYG
MP8]6HOP17Y0_/@EGP8_CTOS1/A;4W05TXC^]'DZ+>'?GAF(\O9T=;3L'F%N'
M<22KF7*F:_D'F '[S@MC<3F+9JNX> GR,FZ9 .<T#1^\G!=H=G9RLZ?0_74*
M:UJAIS,:"U3B=':L:68$3>]!ODE<L[S<P:=9Q3<>MW/U%9FLE^,M24("@![>
MDB0QR;RRCOS I'2LVQ0\K_0;M#JKDW-[%",')=33Z:5A@ CH\-H5,N"J='XX
M58N@/G(JECK]-C#/5T_I/8TSIC3X0W5;^I'F[$#K?:WT2ZE;RISO*F+VQLO"
M[(;U]0+7U3EG(1DG9WN^!4P,RF)6 YT3<K("HK.QU\Y/,SQ._&1UH/L)_T#W
MTY,XT/W45YG00J:YF$L5?,;)BW/Q[/T5X_^]E]'334IIS]>G]V[/I.%Q',OF
MA.J\XU-NS7YK5+(KAR5>->X"/,GV,!@ZD2U9:?GZ6#DRTX_;L#A2Z+@G)+T<
MZR4)"9"GH@),JRFFKE*PO'9: (NST56B"$$UX%4:^E1#P)).3DWYX?S0]4K>
MD-0B%DT10P PLRO1 BN;[;&G#U[ZF>;78?89.VM 3@EV#H"4*@!<15NN:DE&
M_7TJJJ8L)Z*O%#4<GX<Y,,T4:KAU4S-K@NFC,9SC+<>$-@WK9JM$%Z(QHR_(
MH?&BR9EY8F*OK8Y0K_&/4*^?Q!'J=5_,T$+L:TV<!D%8O#ETE28/8<9^+)*&
MFG\ZC)N,TX)0=4*#+# GM^B)O&49R+@?YM!;N761"44<I8Z?-&T:-VOU#/ 2
M0GIZA.(X-J>2;1+D0]HYYP>3=JA/GX7FKH%]=K3QO-UOUVRX=._G;">/-^P?
M-'V@&G>;.I_"VLON!$_+0<67\#V-\JSZC=BU!>3-YW7E[C*F[ GYXJVES;%J
MQYCYTNJ[CUYC'WI5]"RB(A!$'9AC"3Z=CG\ UA"^LL"/DA=S(?2<'8="9C-?
MQNLDW1;?PEVRSY>&7!LZL9TY%C1K%;WJ8IY\\3(24$;;-HQIL*0O8 *XX"_#
MEJMV]RC+,XK&4;YIZ[Q62CFQ]D'+_?%]P,CF0F.;>!L9*>]#Z]2L&!G 9<12
M3<J8S=;J14YQ;39]P6A=:S^9=<^K3A]7C(WY:1SP*UX[/@WV)J=%&/:NID.D
MHO(.[_J,\);Y,^+% :%5?_Q$6%N0P)N5-K/LG90Z>^-B$3^)8/<)X7.1KF'F
M[?2^%?3O9 [(F1M[1M^5]:91&R?U3>';^S39;^[?[#-F:V?96;*]"V-!5@:2
MY#Q$,)%<Q"C"-,J?1J!A'C#)8Q$S\&]*3>Q=DGE1AAB)4-& LEM U(!UR,H>
M"SC%CPESH+25:YVDAR^W.R],^9C#>G,'1%-O6AP':9<(R ]:-\+5<7)!=9$B
M6="4@]U8_OS;K[[(H#\/UVO*3Y@\.-4Z9#I#TV1"EWG]8XSL)Q1HFA]49E<]
MM%@YEQ/D_]VSW3_,Q<W+OG5]'6[N\V2]SQ;B_+>E%?> :$DU]&X;[W&4K(_V
MV1*#71/A!)\ IW#1\BYQ>_KJ^M7M/;U>?2JF,4X;-1S0;9%D,^(T/!>%$N-%
M;WB-)38.*ESM!=K4WC5FD,WSVM7W_:E"LTGP2=7;=:DD!2WZ$2K'"-'@?OU8
M]LCRK(HC#0<]I\Q,X(^W#&Q430!T!G 9Q%*3 IU\6TWP%(6>&& D#!9J=^UM
M./#4RMVF(^+KC$.6]UX"L(QJ?MNPQTH/ 7O=^R3>W-)T^YYZ3(;E&\V/<]E!
M6J,[3JJ80*JQB12Q08_XJ"3BPY*H&A?O)8+)*!@QGK3Y:),1\K[B9W=T$WMJ
M= C7"G*,H,5:5KK"J "CM5 KW0:-[/LIU;2R1H=8"BPJ@B!85']?'"SZPAB#
M16>A<\)"_.O*>Q27&SYX@<Z]=.VA7)KCND0!4!'MR*YL2+:L)>8]0%-IC>!'
MS@4[JQV88JKI;C7L0O30'\N(GR+@$1P>R)P'49^5!XB\^X<I.@X:TFEE#E/J
M0*6793\3O^@!6N5+ >"H.$>5H(H[DR+W?$9^,Z&^$WN1I.?4YX5C,O[/XC(6
M&Z& ?!Q<T_MB<O&+LR3K5_PY8,AI%F(QTG/G(!SX$MYX[)\^)=_P.0C'SK?/
M"!N;;N]H2EZ</".<G=B1J#EAU@U%S<9:^P3?#QZ_M<ALW=B+'K,P$Q1417,O
MPIC))_2BZJ,-'=9R-J<,)X?!F$Z=ZF]Q$&;E6S%DO6<3T'*CJ&QEY!P&:]AT
M/P [WLWE][[]DOR5I@G[SRU#L\X9;'P,IP;)*#D U-BZ7BPI#@(( G90RY9I
M&8]7#7[!4#@1%6((_(!'ER 8%J\6%"25RT$'%/4:C<\UC6KZ2//V2S6%,J+"
MA'6V!:IH<)]^I*!&5:$0Z4QM),GNKC2VT-D*%HH#N><+U_,UL_LV<9C1X(;N
M/%[Z-'J\8"LY]?^Q9[8A;[-:ERD!<<!^V&]WQ2];V^-E+,G)QTZP<[]*A$LF
MJ N&'/'B!K_7S(3^*2X"_' Z(([@IER*J4FO*R)]8&J*_8:KKHH^; 6@2YO#
M*/PD0C4.<&SS"+>>.+UU'H8LDA7%=<NH@<ER+EP:P@C^E$Q8.<%*:WV- 6-W
M^P5*;GN<L0\Y#&CA/Q%?]YJF*0V<?0:V]&%<D[0C=;Q0'8-]=N^EE->R;X;
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MNOO$!8.Q%]U^2?Y*TX3]YY9!1.<]5IU17'K/-.B!;M>+MH2M\ 7:B<% )CV
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MY*IXZ?GTBY<&[2I_W',A'M]XER:95EFN0TSK^AQQ@#4 GT79X1DI:RJBH?V
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M$'75X1GA>CT7&16TZH1UHV-<%I7T1]9K@8,/H4@A+@<>&.-2\0_[N+[V,Z
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MLT\W#%K:8%#W=YR$K20&*NM>]"&M3AP<K)L$&XZ1H26<"AWCB[<QJSY=7YK
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M=8H'WO D[^NB_!R]I=O]]A\X*AT$RSC=JX_-!(G.DLROQ0U/QE\7)=JR6>A
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MN:B8QOF^E4T3,$[)22*OOIVF"T0)F*VDY9,J9TE-AR-BD>3%'01$-<NS6"A
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MLO1O1ZAUP:@P6SP9;4?PPL1YI&2XRO<8@I[ C?EAGV:0!S6KMWVPYL+.VP&
M.K<Z'[?D4U;+0&?ON9(8ISA;'XIU_1J5>$Y9&ZZY,%D; *C+O.3CPH7E3F:?
MJZ2I27%$%PCK$[ F%$Z?,LS,R>1@_5@4R6N:94M\C3F"&Z"8T3R0:VT58C+8
M*7 PE?94<C76;.%,RM.9[;:[*"VI:W-]6^3KY?L6W2%>HC7#&7I#?5\V'T(
M\R(_:Y;XS6RIL2(W<E>-HO#I;J1/4(%[D3MH"-DRS> #.#5[@HT+\IB<01S&
M2;>:)J>T<M_D<;'%C]';$D59"5R +ET3P-2J2# 4D;'+/\@-DC%6$]+0YXA"
M<[SCB4ALD++)0=&B/[("E14/9E2_5(^N/S<=#G_ZR]&P6KKDB#0;5+=+A HA
MGTT^Y,IVQQ'N9-K]553F8-,2M;*6>(2;8%RF7F* 6%</G,] 7T$Q_Z_;E/ME
M^^@=Q&?<.6^CW"GU&/K!)Z@*P]/.Y4VZQ(WA#/#R]!U7T'7V49A^1N>C'5M@
M^<_:L?(U;N>,HNA19=YMD+1=GI>W952P>?01' 6HK4,X*PT/(5[@/ZT/B%LV
M\@W3JK@L+/M&,0C/N/V@(^ )\S":@/6;IIW?(C>!#<XEFD4M,(_HL+CP#> H
M1.,V@POU3NAZDPRNOX'<)$=PE^AZ<X+<R7'0=QJ@B):**NOT5TAK[50%7*K"
M-4[NICL1[(E*I]E7E[C$<;')4S;BMW+]C 1[B;?1.!0T&ZZSB&K/A8G^.+7\
MC=MG$RA]BFBE6_SZ $7"H1?A>9[<Y$2(=B5FI7&JVZ+^!Z[/DV)7XV3.@*9)
MGUU8S-,4'+3-35Y1)=:BD:)I=S64%S4Z8')5L047'*IWC$2YQEA-)OW8+525
M];\?8IQ'95J I3N.JOHSWC[ATG#K-+X2,EORDY"?6A^)86%O^I<>!H-3 P:A
M']FP?X52E>QL 4FRX#>I6&K;@ORAZ4"N$@CEJ6B8[#?^70_(J,[K0S'P?!;9
MN2%.% O&4THLEQ$$%+,ZS<XBH)KE^5Y3@*"OET[;H;"AJEWOOVZZCN92[70E
M=M.M /?0-*%8[RL>K&@]_^=]=6@^[]_UH09$5RH*!I\5ZS,R7+RT?]P&/"Y<
M^=G5X@TX3RR#<(^)4A^SDCI4P7$_.[13/1\@.CBT5<.:X8B/7\!18N.#.$^,
MR$YYD4D+"E/^% GHS?592E$+A8, -$Z=T"JD$RL40J# ^!C?_45!7S9DX4Y9
M?\]WC!F*,+$H1IAT!3J;.;W^#\.K)]#EX\3O[AUD)\34#C\I>437^"/.^9(B
M8&N;5A7\R M*:.11H]^.7M1OGZ"QX&E5XQ31E5"[%#7<R(LA:37E@>==?9[*
M\5:[GD2_^164%UP^%7/S^=LY&1VJ5&0H)G\[52/^(<T2\K>'(HO*N^(5ES0_
M_-.G"^=#Q[:"7^.*!1I=M N;A>@T1.<A.O$=(E.'IX?O-H-N3&HZ#3K08(+-
MY7/\]S3/\,'=XM:=X/FAU/VZSK3&!RW FJ:D;F-!&R(SY?ES41:O^:Y(<Z4=
M7<G$P12_^[G_>9WNV0P+OEEU-!:L5&(T83O^K:CJZ,.^KK$S+P=3_/*R_WD-
M+^DP] 3CPF]+'94%-Y4X3>#F79EN\?4>9]5%4>Z<.:J<YK6?JP( ;5DT,A31
ML0@&!]^I)IHWO>)T^$U[]HTV.@TM35ZU*1<+D\&JY%M/,MJ1-,:CL2R4FWP[
MLU$QR6MMYN'W=3D0M!&[UE+LF:%Z6@NF:A";VDL[@S\4/^"JOLEC]U-8-<WK
M*:P 0'<*LZ$(QB(R^)OPV]9$]>8<UF$X[1R^(H_KS8&>ZV,8K9SFD]$J '3)
M?W0HNV_? :?#,]I$=<%H+8;3&'V>U=%G7$6TL7.5CC*GZN?Z9+D6"ET+"#(>
MP00DS0A^DEOYT/1I-:([30@>]D\5_F4/E69?P)68NS^9M%,]:V(Z.'37>#-\
M":9O&_V;R]R$Y-SZDL6(;8)%9:J6*$XG+,#+/@?9OYT6J==;\O&UF+KCVJEA
M=UP#AWW':?D?6@(&;-!(0!?728^DWH*$WY//7'FR7X.5'I#I0A!8 H:,T,E
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M4U6'EN]GHC.SFO>B&S$FV8Y,2X\YI!P7\NN(=X)IJB %/Y/&\<Y)F!1GT93
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M@BDT,'5-)Z$UF15,%]?BH:2[ 6/?'/B2BSY('Z,T7^6J&M3VFV^?V[LI01S
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M4=CR<GVPU0Q1(^?/W7!?5&D=60(7Z9C@L8H2I'W3PA +?Q1<K==IC,FN.4_
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M8#8=8O\@,)BLT'A %<&BP4* 79@W#/JUDL;C6=N:.]EV?*1^]D]ICFG@JB$
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M3T>0WGN@=AU!//)55.8$8FUBIAB',!\8-F:U#[;ZO%0CYT>-27#Z[\LBIA%
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MMKA8LQKW47FXWN<Q/ BB3)1&TVT*-A$U,U$[M6ED&TH]LB+59X8C%3R]>WA
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M#\8E&9:KTGS<E@%H3%3 \:AL(GJ*O&7LIO@]#&+)^#3/"S'K4KEQFL:ZABH
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M>X2_D3SMI^@WG3PD%?0B:S-E30Y$N$%3TK5-;3NT#-P\/)R\(0<2RMH= /;
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M& !694>JKVQCRM,R6,,Q@G<T/5  F-40_WI69;4$=0H\_1415P(YF7S^C\T
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M^\-R9/M#6+8_)%&].\_@AR*[+S8"V#Q< ;,C(YN>[H1D+5G#N?%DG!N)M.T
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MVK8;ZHMI]I81ZLD76$BH'YPY:?'RP'H]\L-!N,F\:%[2BY@RUTL;ZNAF-KG
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MHGU/\!KM^B)]9Y9':()HAKE3/7Z%3I$=GFXOK#;<OI65>6?=NN-@M/Q_G4>
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MZ,SZ*)T%BFOPGEH&DPJ@I'FQ'RPDQ^/^2,)'KY%!=S4%!$&("B_STVU5MX7
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MI^PJR>$Z>;?)G&50ND8$6B6RFHQ&J\O6P<I!13A5-(26SS<K-M/73Y*P3,^
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M Z:"\7JZA%JKGZ'1FH]@'S-:4H/-N*%/1<.N;%J[+:0Z*@B1!+ST8S)5Q<[
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MCQ/V7B/W\'F2Z]_G(9=]0;X-Y,7RI2'QYO@PDB^3;RQFEZL>86Z18S'K:@<
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M8XF,E2%R_ 3HYLV'BBVUYJID!]>N:K)-<[5VKEG73/..R(L-[^H[* &4J][
M"NFMHIPXM&FR#.SS/5.4Z,?]1?%4Y+3,NZJ2[O UV;"K_)G<%&P.W6'5M7.(
MX.[<-R\?LFSWYP5=T[JF.83S]D$D;HN]:"WBHN6%R"D2'85^-G2AQS"<R*U_
M05M: [I@[JL :#KW24^6N-B?EYV G]_&N[I9)$<?&+D\>MAOV#_NV0L+9NK_
M E!+ P04    "  @A)Q67JJ;(P-\  "WQ@< %    &-V92TR,#(R,3(S,5]P
M<F4N>&UL[+UKD]M&LB#Z?7^%UO?+;FQHY.=X/'%F-]@ON<<ML8?=LL:SL>%
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M"H#V[E'NLZ5\\2(O+%BN4G=IS!4L=Z_6,7%3%-JPX;FW/<0%6#4N8+&/=EA
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MYV3%?:P]\6)[_6VVP$D\ U$;X(5[QI+(_Y2=51:EB<BK%P4(#AZ!%N03N*+
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ML9X[G.?QL?GJ+(KCZ$FTJRW'O!3['8SU=MCA>#/&<F%)>L ^,,XVW7QU(](
M2]7I8Y$<>PPQ7"UK<]"" : /&F!!$DQ9T41G(FI%E[@.SQ8@$^\O92'O?%4T
MLEMPV<K+_N:RYD\T7>?_$7D;CUY AG0D;'!#\B2-:]RLZ [5B HZ=9_;R&=D
M%<7D4#!:K10=03I_+XH3J8UT80*VKD%6)^T:8QIL[] (%C/]. 8T$B,VXN1$
MC/WURQ&P=BIG6DT^^Y?8C+V782VJ.-R@$NE<;Z* ;X")727[>P[KZRC^!FSN
MST'1E=:ZR]8"&/VC ]W)?2M/]"C6RBDU:.UN'QXN/D8[;"YD1':0&,$^C[B@
MQ+( Y+NJ4'HER[[R.'"^*Z+M+@JS#>9[>:8#&@'JY<<SVZ=#$S0G=ZH("<!;
M2\Z*F(?(^9?BFEN=[\CV@<3#L;<#!UP>=\M]C;5=E 1[2K;,@A5/GDL<[JK6
MQGIBLN.LDGI($X5D:G;6B.TNC7=!RE3L;+.9U)].@1OM^T;OCC#S_72;RI8-
M;?.X!SYR^ABAMW,Q.8<&A(9Z^[5]&12%%,<1E@.SOV7YZ5RE;?1#[JJ0H3TP
M,RN+3H>%55J5'E[1-8Z5W:[E$MO?1('S)90A,[!4CIF9C5"%2CY=#'-U+-:6
M?^]3<5)RYT$TN6.)%RZY\AN,I>T8H,17 'C<05-[Z[V%[2Y)UA;)U9,[><T]
M(]GM=41HJ,K)TV+"X5-\!\J1&T<B((_!.R9HYTWP1)[V<,%FY>I3.VJ]U(3K
M^V!;DUUMA9>7HS4SM@<V:DSQ&FO\N4<JC,F/U7,BTTE9].TJBIL(:FMN74B3
M4^3:) (;AW>B(S]T"80V0E,U?O4I#M:$ >9PWR61_RE'SOV *Z!A]X6%.N(J
M0MFG%MG'/4MX*,>9JAG6_&AJ?%%L&ZH)@\,K7Q&:&_9][[#JQ)C82CR;;@CN
M%V;MK-^1^)'ZQ%H-UKZ?NG53)X=+KP+7FTMTQO)CFFG?HD&++H?4'T_-S^RB
M ]R\.#>SPKJMH!Z<27F FJ2Q&>7F;D/HX/8^2LA77]HJ0PV84U>0.F0KV M0
M.&O"X 79%<'&W&1U.9TFT"9FD1@1JF#FL$UB2B@6808@9O:#F]P1-2-6P5#W
M.(T11X^C2NZC<E_ PXA/#3;VPYC82=0@2L&N81M8'G=4Z?=65"5>T!7'@XBY
M0O-0=A8.))W?$[[Q>^]Y,,_0#KN)28DS,PH9<H[9V'<I6=%DT$:,I26G&EXM
M4ZW@H$78YY'$#Y%SX"?#>,#2O6D_@!W)5>0@6*?_E&OU@!-_!F1G=^K/- ]H
M)UT+OEOG_U1K- >NTGSO)6E,HM6QAISO[&V4-6[W21Q^81XWR6#.CS!G59 &
MM9G:H$SOK-Y]*THP.S#L!61L1O?";<BL"Y(WY0+(P8^HJ<"(TZG+0+!JN,'I
MH2N<6M2X::06#QSI[N,Q@#(8)Z^4=TL_-2"K_ 8L^J?KD*ZH[W&@V;!COJ==
M%%!?-#LRLVLN*/.#B$DZE>#.#G!O<[CW'-,S#N.3P<7B -S\D:>+*+KWC 80
MFR>.+J@F-XPF(!R'W%V29(!<@XT@=?4(%-(7T5Y*G.2FL0U(5#B?;K=>O.\1
M@<OG7>"% NAP:0]N6"+Y56:JH^I0.;)EFG?C>4P3OKO@N+E+EM M]TG%S/9_
MILMUUO?C"T-7IDS,(^PC/#%TL5C(]:HTAV]1EJY))]V;TPR>J2.I"]WD,C6'
MB75O@,B>K,DW8SK,/3M\HQ\;T38ASRDN7_>;MT\RL.]<$_QP&D39*IGV:]>(
M)].\<-4/K:;>6X5H!13WB[0#DH7%J]RJ[@79\;'Y[:T$9G+Y]0! .7^&,B!.
M71=' +NO#3XGK$O&6O<-<BVY-S9HB0,<468EG-%O)3,,\8:Z]IWU#M?/C >
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M^-PM?Q@+=W+=\D\C:M#J'K6#OGQSSO+3DRPP-.RS?G5IG)OH-/>WXFV_1F=
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MB7M:<THA>A,[,!K-&?TSN:#*<.[ _9!K*.6WR[ \+Q:=[(.?#K,/E(5LL>S
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MI:K'4?73F>*KJ3.WX0?*9S45>7 &J=Q'B1<4^-S&U-?QT!4?8>=%GX!+*M)
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MMP+N+%Q>%G"MWD;ZH1E+_6W;QI73DCI(U+\/L*5,RY7<US5Y)@%=#CWA7EN
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M/;3!RFU1H_71B^7\6&N>'0!,^!#VD0:CI:0\XAQ/]1N=DD&-3]!G&[DPI4D
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MR3U0<#+O3W5?'[C?1SND<83=N%U%J4Z>DP80+&V$R-B,>#C)PSV8\5VYLU4
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M]E?0>.A:\8-7'P5TJ9LOK/AH_ 17[;2@.E#-^(!C7/@.8R\0<^=)7)WA8CW
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M'E' G#RSRN(XIC+E56"A$^RH?C"=$U+?*58WZLOG'15]@+1]ZMH'TZ%X?:>
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MCN>Q;CN<-]I/$R;:O_+MZ)C9G=]/S^#N)@?@K!Z+=A%EY+2T5/.KR3%$N77
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M ":LXB=@#3PXEZ5O85CPOBIUHT!C< >LJW,5Q6$0*#^S#MOA2 6#F7COAWU
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MS?#O:?0V#[[4_OL^J'BLU;B%N(>KR)6X*;#@*:FO6 ]09@ C*<O! .PY[-I
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MSW+4YS/30599OH,(E,DKI)(,!*TRVE2J71%;]5JC?E1M *D^^P6_G'>NH]#
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M'S!@:"763%2Y%>.4*009079R*@?\RH-Y890Q-/)JQDN4!V>UJU>CHL\N$;!
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M?3\U)87)=9@5"4U5./6I_@<;$ECI^\AS(MH0!9IFO=ZB74"UIEI[G:4?A\@
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M(LY3U$=?4%FZ]%SKH\^W0Z)W !I=&V:M.V?VM)4+4O"<T[)K HG4HE$'?>E
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M%/[,870*E+71#]T9LK)Q,O$/_C]02P,$%     @ ((2<5HH*&^[6 P  3@P
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M? [_"^SOF50T.KQR<D>4"3H105A(8&'#;3C+$G6HX]BS\1J/@$?@V]^6JI6
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MG7^2XWK$X-?5^MC%_\=A['7KYA#U1ENZ:KY2I9^MS->MOP%02P,$%     @
M((2<5I/".&-R!   -A$  "    !E83$W-S,X,V5X.3DM,3-?96YC;W)E96YE
M<F=Y+FAT;>U866_;.!!^-^#_,##0( 'D.^DVL6/ AYQXX74,6T&WC[1$V6PE
MTDM22;R_?H?4T21UFFV19(%B_2"+Y SG^F:&5/?2^V/:*Y>ZEVY_A/]@?EUO
MXDW=7K>>_N-J/5ON#JY&GV#I?9JZYY50<'T&S<96@\=BJF!&;V$A8L*==,*!
M)94LK" CLLY_E*\#,9%KQL_ D#8ZH.F=KI*(K7%*LO5&5WK=0<^]V[ 5TW!Z
M6FNVN_4!ZCU_#8D^Y9K*2N^ K]2V\\I"T*[AU6SISCRX&H/[Y]Q=>*]HV^=$
M:1;N7MFX0LH$J36]H3!,=$2E _/:1<T!$@/A0!*]$1)$>/;&QGK]P=2%H3N=
MSONCT61V<5YI5.QX.>\/\_''R<B[/*\T&XUWE9]5JZK%UJI63*R$UB*V<QA\
M;Y'O?$.E9CZ)<MV1T:13UQOE%+<LT!MDK+5.&*^8I!WU]BW;U4-V])A@KV?T
MAJ++_ TWLD'2K9 :$)H,PQ7 013\E8C.; +'[6JST02O(%VDI'-)(Q8S3N0.
M7%]P$3,?^DI1I6+<!D;TENZJ@T0&PO]2+EU+PED2PV2Y0%;QF?H:E@)Q "/R
M16CBP/6R?R"M5 B(1AU&U*?QBDIHM1UH-5H-A$X - R1ER&RB$($?:6R1,U3
MQU"E'JA["_,P,7\9D*7/VF_HZ/_Q5N#M;0#G/(<X!RZ(*I<N610IR.&60<V!
ML:0QNM1":$:T%)S 4"0HWKCRXPXWX^L](.PG:S0  V$AV(1;AI#%$O85AH;.
M /'WA%-H?4CI7A> K7\-P!<2^)2\;)+Q@)KM<\0<:K&F&&\L^_@LE[+@8L=[
M'%5E.E[F\:/:+]+Z "VGJQT@1I4IA5K BB*\@),8(<6X\0KT.4](5"YE]101
M1/E02 HNIW*]0W3*;0T$A[&0,1PWJF,X-'R9,\U$[C@(L9N:M9 IX]L=)1)W
M"^X7T7;3(K/EI.H@J4D["V<;H^O:LH96^HED)B=LHKAW_H;P-39Q$<=,*8;:
M;!.I$I):943>8RG(^[ZUIWG:/G9,F4:SC3+V?4-NC"NV6 "(1 W,'@4J<F^D
MXC,)B;+Y]8 PAX\#:#GA.S CHYY!'16A<W\#QOTHL<HC,0[0L4(22XY1DC1$
M%NY;(8RC*V.[5BX%&/,;5#&4(MXO/H^EC8Z5B(,%73.E,P%+C>7!-L3#F:A!
MN]VNMMZ?'K<^'!6A'6.]VQ]^&_ B?0Q=D2K@;9@J$(8P1 \K8[!QAO6W$:IR
M%U@%#4C2H=GJ%\FV45JFMY)%>?5M_V>GROM=_7'7?]@]3;/OP$I(!%G5%U%$
MMHKBY2![ZX#1N*K8WS15NV)O;L^W\?1R][A7G[Q[PI+N^ KO'_><5 U)S*+=
MV7/WO<$.S^Z&.3T>?",XLRP_A PBXG^!9NT$O:I$Q((.9*JU7UZWNJH_N'Q\
M5]$M"0(L2(6F37.$RG1[WWA*MQP!>9?_J>"\K-4SS/JS7*_O&/RR4K^]Y/VX
M\+W.+(Y-;Y3$=?/=(_T08KZ7_ -02P,$%     @ ((2<5@_SY)#N P  #PP
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MOVS6?\'TCQ/9MC,U_FDCW#;O'L7+B'EG^0M02P,$%     @ ((2<5C*"W5%
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M=[R0>#033\W(-7$_DG#X3E_6K*-"P,#8P!1!XX'':.,UM"4 :8K#1%I AYW
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M,>^:JSO99U5@=AQ1JC.86_S )0LEGT <_%2*S@IQ#(XQR;%1T$+0]S1$E Q
MRW&Q[MZL2Z+#W.Z#D/;:<R:P. \)D*:L?4'79^ %][1KNBNNA]F=@)*AXT:
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M!BPG <@PA"TN+%/E",,U=H>.23.W<;-G70$4/3Q)CQ$&]SQ'BV66^$'VU3%
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M/"L0C@C+TG(!T2AEM8:BF)#*:B474[G9Y'[@<Q,X;B@4^D^L8?")&G&HBN@
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M4M$-_#Y=K>(96IW>>.UT!'23)_#=%Q>&D!YYC/ZU7V]MZTX)F62,:H7W"FN
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M%*;YWJ.$+8X (/#LF+W0BHQPA,NO,"XLHB?.@Q T)WCJ1#N%ZR99F$?I2TJ
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M48\TRV_91[HKT\[HR\6Q+DUB/&:S[JRV>2S %8XPFZ<1U9*@J5C--_T,'3P
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M#K[\\\]LLCG_KMV]@\"]JA.VN]MAMZTO6P]A_&#4WGGM_IY+58G735K0:<#
M4X O$2;(,S3X0S791'HU0U?I_W JU_S5WSAE*F!W4Z1<W_2Z%KW2K#/7V;I\
M2R6*M1R2G%E9)X54$%8O:BFL3/SN(]=$Y&>%6 57[W<)VANTZDJ[E\L17=%
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MD(<,\VQ[>]^O76" =JY<L%+D0@#+RH2*T'Y&;:%CX^KA%?J[$_,[AE@)O5!
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MSLZ?CEB!86CT!"D%T"DRF>2 JWD4M4&;<OCF=I<YJC/P%+ZZN,G5JWB[C[:
M>Q=+>6>M?W3];#9+_UXP,6AB$J5JL1GR#PO_YVP3SO<"[164C&DYLYUW;#N%
MAB>&I.4_1FX+.EW:5,[,,J:/ID+?%TRK:#OF-:8O2(GG >:4%BA\Z E(,OVS
MG],P#!&*UJWR+5^A0JU?]2=&_>2U9N'(1[[UK,CN7K4N2YJ.N32Q'-/"F]I+
M,R$Z8LBH"YG.9-X8"1=,/:P-FM_@*BS0/\;41Z=Q')@$2[?9^)D&7XR>!Z<\
M$+ZB:R*\+O?E*BGH[:<4="T%W7E*07^?Y&<WN/EH/B5![R#G<7"P,$(M"4A6
MNF=0SZQ@WZ+*=6%ZQXN]7Y=K6B4V3M__\9I7+ G"T[=VV2N^=G1+WG>KZ:;?
M1V3^>>N].(FWRC*M--;%'W>KLMKG[V8I5I#"I9+G&_)^1]\M+.%"\5J\>AT4
M2BX3JR=9>B2R5,6HO&\9>I*@!R]!>-=+WY]XDI$G&?D:+7.:E>3OHG7Z1%I8
M[E^ GN3G<<C/"I50=FR?I\Q7/V<&2:[TY='*E58KF>7?6*BX4$J_[EF>P;5<
M$7[-PCW)]Z.0[]>?CMYK7=WZB7(WW+]C85ZGBC&/;=#&F1DTK]!&5W1+,6@<
M\/4 A@60RU:S\2Y*.#_.A,>5F##RTI+/TG PZAX,DANC7X,KN(^"G)QY53BA
MQ85.V>0\DP [$[?P*!X&REH/V-I_\8TJ69]_.\ZSRPFWPO%Z_(NF&04ORMG,
MYA!_??9YC;(Y K_)U*<NRLBMDPL6HMF0E?BLO?L?72I(ZT+\HHIZEC0D89VE
MP/(T6"++U[K^AG?]_YU,TAB\W^5D=A4V&R[/&0:?3X\,!,F $^&OXEY>8C+=
M750_=KL".LLPN,.API0.--,Z]V$%349O.6=*S0??,5=T9\\\TJ#6-QN]J^ D
M*\]3.DUO6\&+.!J-P^!CZV4+_WW= A)BG@:_1SAHU3\P#58K^!B5:? ZHUD7
MF7XBV/!@5^@@W+Q:S<:97?)/O.15)@+.)&4#:=Y4I,L,2)?H<J0]/'KS2K%\
MC2S0/_]-IUV^H=ANP&W,XQEC$7(;$N<#M%-R6 +0:(6-K8_4X<HED[Z"4 OA
MCAM<Y8UKG$+^:)A/3Y@!:VJ[5-\JQM.M#V=%37N;BF?UP\^96X:W<A48K^DC
M)(OFDY_B\\2P<2[\4U!]Q(0D;G0)-.A\XE=,:#\VG6I[]1[#S(L&6? 1-391
MV6PP# _ O:<CH*$CW7L?\GA_=\*W;PU.LFF3UMQW$71W0$)R.6'ZX<Y^\!Z+
M'P:?F&*NLQW\3OOPW'V\<RA=]X?7?:NKWV((5/TF70K;87"HR-H=_^M["U^J
MS#1),8\/MQVVNVWTX:]-N=@W;&S41WS8O](+!'48!99L^LN(UFF_PX^RG^"3
MY7]B=Q]%J.[-H7?>6O93A\%YQCT19//RL[PO-!N8A+EAY 4U%FL4G^(2!4:M
MP%GC]LJSB'D$N1Y#9V,>\[Y\5<9I(6P^/B6._L&_.2TX-1-ZVYJ.G59@L=CT
M6_:30H#CK:^>#%?B;BTG&1=#T%XD$?.-P<1!4<Q%G/(D#$M<F3,_L92TR5[4
M4"Q ]6+6D5[E5E%T(S], 1'H8QR>Z\&WX!. 0C-0! 2#A/0??W;&).3Z7F_]
M76U+L]'I^'@C#DVXLCGK<XB89(?632FEIMG4@(M+,0;V]"CME?\N8V :UTQ5
M8X;Z "'>(VC/=O=VN9:9X7ECA>2PC_,OLAJD)7U'=E_7GW>7GJEGK-G8$00G
M/1"@MIO!X(1H.B0,P%6@5+SL6:@>.5URK_K'=YY>;]<,0=Y=E76&ZP<-VK2R
M)D'*?NCBY^A4(,]:8>T=G-KT]2M6%;V/+J(_,B;N8APAG2#,6W*5A0I#<6+X
MO$B]62F&@46*'T?,N'$YJ9VG]1#HE8JB=IZ*HFI%4=VGHJ@'B.^Z=S?XKM_W
MQDG.R4"UYMGGTP 4316+13[B&RRDURX%_-/6B<:%%):7,\%EAS+-8VUT-$&]
M:73%4(UA /3063P1'AV F@!QWI2U6SC''I#9V#(;:\AQP3N;#5-PR[!F3(^\
M_1.9-X"XXO+5F*RT/+N*4G2(3"KP]YYE:4KXUV-?3\M\""16W@T)YXYB< 0J
M4Q< X,S,;0.<?E@OK4I/0U%]'H=LT:3*+6^T9=F%6<LZT:#I=67D-[O18-WH
M5]@5-":1@.>CG,$V,7?DS1=MX-VS<+GCP;DB@F7.KUCEVJUX#^LA"2M=P;M/
M5W#M"MY^NH+O0DCEOYI31'_9"%J=SN 98O>W'GBLO.X. I#F^=?X<^__)W@K
M#$5@8KFJQ +^IWJK7C)?&5/<,T]6^T"56(861P5+IB'1MK-Z5666:H\+^W+T
M.G.9OWU[7'W;YTK4 6\KIB56?RAW+!XLD-XITS1=6CS.X,L$NM)<G0(Y6>TB
M8Y8D!JF,,/INN]TEU2[F1<8Q9N6JM2[6)'@773GDW_A/<'45^BGY"O=KO@/;
M#'VL8Y\7];7_+0KVVC\%;PR!@0[6A5#\D)0->W/\#DQ6NGZU)!Q_**PEJ9H-
M_0N<22\BZ?JX-:JH@1#&1T?48X?>D]3&YPW*&ZIW!<I=3=Z_QGVJ=R0'SW"E
M>IU&D"QR=!$:-9<LZ:MRW,MA8]UBD/$&B;]==;';.I"W71LQ46Q,=. CIQ9?
MJ@CQ=DUB;-[_*9-9/XV2<<A9L@@Y/B54%KMP(%:B@I*KV<#ABZ$P+G)N42P<
M.D@,C<>RV K>S RHO@S$,K%F4Q(!MDP$(;G9,*EP>1AWN/4M2R:W]DN/I&]#
MU5 \U="V#9WF-'FR8+M#I]R_.3-]:VG21T/=Y'Q=+)MJ-NM?C E[M<Z=R<OS
M3Q9^@F4%I1VD+9!8[3.N!0@$*Y3=JHD^3Q@(@;N"BV#C7?]MS*1X?&&-8E+Z
M,=(:G</#SF8K #ZSTA&*%8Y 7"X<Z)W#G0-RY2[H-=L[^X'AODE[=$+HO=>!
M)CAF,$-UZ",GN,S;F+R 7-O\%;HA*MQW!HY+_8J&A2'M;M./.:,-TQ3::R+W
M9*$:1>*3TEGDB,A!V0 M>5FUQ9)2" 7,&,91D2C(D' #6A%S4/0F@KM*[4#%
MG9R6.9@>1;DE!E^?]6BF$-+\8,LHL@"AX>M@E0)!55)I^\NP2K>8&O\^^3E%
M*:\EBRY'&<@&#(-R)8ME[[6-R'R.'L=(\3URUQ,M[GD+#!MX[ZYV]NW9R69P
M*CW:[VR']5N^CLA:^WRTU=D]:%MI,I3?IL^ZV=AX<_IITU=?[O@S*Z&%?/I\
M:KC&H1B1]0 E YG>8_H<HQ*\_W2\&6R,9K/I+\^>75Y>MB9YOW6>73Q+)L.,
MY([\UV>V"_R9O@^Z+V(J=3_^P8=!,!/<"#R+6+ 67DYH;V)2BPIP5DW4U;:D
M%7Q@VTV0%XJ%@ ]"%1;+P5;NA?ICUD/120S1K378(G1ALES-F=B(@"#>S.5%
MU3I8DQ41H^-US!1$J&XZC9U]5V4Q6&<[Z'.^B,&4KX^K*:\+0$'@P\[([00#
M'A.S@\!YBTP+4&))TPC\[5+Q4=0D^EUCB)]/Y:K"SY<X_,$Q.5E, C7NJ4]
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M%(FH0==V]BS4#/K]47K/90;: ]-NM=OM?1P/U&SL!#\%U]1LY!S$8V@&1G)
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M 1MQ#(J]^<&$._H4[*?.<4U. Y2+H>.RVD>ZYBJJ0HE72?WLB.G'VLG0ID-
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MO- OB-GBZI8-RP59HE<5^&"MYC75\G.C8:?*).BB&W847 )BZ_5B.F(3DXM
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MH(6&Z N0$\A7:4IH$<I8)'QL'KOE+,L8R)9C9V00&H@ZMM[)?1&<70[\6\K
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M_Q;!E?*652O3]ZR(+*6DDVYAI6AB:G>(,&-W 5[J(;0?AOCO1,S):C4]&@M
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MU(#;YX$^(U "#EB>!!&<3\"W^2; ZP6,:!*/O!"ZL OL,(7@#M,K=.AI?%Q
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MWT](Q8[=&RV5N]1SJ_(82($,KDL*G3_,6*%38DAQE#5UK:EK'NKZ@S1Y)I^
MX2T#36-&\0-T;YI)/_ U3:UI:@Z:^L@(CA8@7.%DJ%9,C(WMRT#0#VK3*.L&
M)_$*NJ8$4-5CK1*FG9<9F#O:P6X"S!J&&Q'_NB#&V(],QS#F@<::R^LQ+GS!
M]D-\U?JL<.^0?&$\"T:! .!# 2UAQL9W7B?+&9,%S>PSWK",C*"O$6RIC??G
MFTXQ3I;XP-QARZ8':S/.,UBT8CX:'P?WS7<=/X F7:WT:;^ <)W 5/63FG/
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M@B-Q@I[->.RU*(<%D.K9WQB-])VTGJ+YJ#,1""7!9A='(4AG?.O7WHG;_8(
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M_JB;Q&%\2>\# IA618C?B+PMH+$!^-:]8E^ %650J[/S):?/LJSQO;.0Q\Z
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M%J;\TIR_O#Z-TR"CFQYZ4?;;+U]>W^M2'E>YIX4<OS[1J4)O_;23!$/CW/F
M3%[ZX[=?CE=HT4A/TD>J"T^1VY>;;EO&]86LADR5%Z?(/V.^QW$N5;$HR<Z<
MO>NAUGS+ZR#=%DV.(!]"3J>Z1O;3!9+>#F.I525[(NMOZ4KWMSE9C<0"\H@.
MX=S_YB&;ZH(L)Z?1(N:!X%9*?_6)8V1&#\EH6+SB7>(CL97>LU-7#U\3C][B
M5^!?VE?6@79+_Z8Y#//4.>PG*(B]/U;R5 [59+[UXQ ^[%22FV4CQM/=N$?
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MRM%6*T:Q@J0UF1<7?G:-8G*F;\S:IIP5.3 B7'-:NI6K_VT('P-ZQ:7E0S"
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M!841PXJMP*T46E]S2X5"&TV=2I&@CR&Y'$HGL4E$AT,A;?,XC2\YJV,X3@P
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M&O6EF^!;Z[@5BJ_M8)]B;![^YSB[2&(LA^+;$PQ9$TM@>,G!C& !WX,;3G"
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M#+6&EC8,3B?:<4QY#JO/6328MA"O#[XLU((4L%.Q.>5F%,W<6E^3Z),Y>PH
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M)9ZG5O#A CNKKC-4J:<V)>Q,19G!69;1=^UJXJIB0Z]B]XEC=>[@ZVQ[%TP
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M]NM?_HD_-!KXJ35/,X9GH8&[M\"U?A%Q@LYRU 0T'0"-/GV)8WCN<=?N4G0
M+ 7"7V=O-]Q^<E4*YNQ<&/\/=?,W^'XO3(,]BS$LK57*C.L[RZ!$E\@H71(@
MJO:3(ODWI0!+ID1>R!B>KTG:*-/:Q!6NZ^Y3AUE!FSZIA_\NS[['>= X^B]0
MHRW#&)Z[5FU:4_VA+(.OO\Q 5+_4LL8;KF3[^BKQLO.1N;C:MQJN]@I7>^?9
M<K7/%H\G9\Q^,KYLGY_UCMS9#J?G]0?_GDB@7<K/!2BUGW;8"S!M/^W 'X2
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MC>!C$@_[/P=?HK/X37 <_W<2I[WXYV!O^TWP[V@X@1\[P<:&3N7]T;_]!V[
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ME,V_H^Z\40G7*-B;9.I-@"/=N(R3L_,2GS/L3RM@,Y(.#N1]5,9!-@B2HIC
M#WEP9@'9[8MK'JO3^?OU!W_A(:MXZ_OVX84HKS#H7][1?78<]R9Y4B;3*GS)
MAOUI,CJ-<UQM'OFS&?B1"@>.VVIG7OXO>=*;WHVK)9_2^[CHY0E?-[ A)R#U
M1=3#?[J7SMV.Z1R'<)9I./75ZY=FKHDW[[KO=XE%\D!F]+2L_&N2QD&E^'5N
M<TLG4"$_N?7WM_VFTEM__V_MED/&=RMK\='80FXZIK>>]+/\^N.38,P0^>Z"
M(E_KW]WZ*5L+RKT;H:K]]B/&D%Z>@"^#'.\MA1RWVXT@-X*\F VR'!IYNQ'D
M1I#O+LC#JZ"]_<36]-;BUO3F;F--/X.O+X<U#3+?V5T*Y;W3=EF$[Z*\=[8:
MY?V2E7=G?RD$N=UMAW>):+B2W.XVHMR(\M.+<F=AI;RUL].(<B/*3R_*VYVP
MNW6]6KU!E/<:Y_"E2O+!Y&Q2E$L2L.LVEG(CR2LAR5M[X>YBEG)C7C2BO!2B
M[(.!-DY?(\IW$.7NHL4<]Y1'632-TK[>.FDD>74E^3@>ES'5,RZ)7EXTH=(D
M!1MI!FE>CBC&WI:+^M"X?HTP/V-AWMY9/$_2"',CS$LAS+O=L-U9+%.RVPAS
M(\Q+(<S[[7!K\_K 6I,K6=JO+XTPM[<6E.;TG]%2?O<MG:_@,$NITRPB6?[E
M^-N7MZ^ZKW_Y)_[02/3J2/2G[$($^HFK0]M;>V&W>[T'=ZUB[K9V;F^C-,6A
MC_[U92@.M5*_N11&R78[[.[LW5WVVS<&\M[EV7>8;Y4?LM'L+T"S+RKC(C1W
M%^_.=KC7WE]$O&^RN?F7C9"_7"%?U!Y?O%=\L5Q,MW6'$$MCOKQP\V5G*<R7
MSGX[W+FA6ND&!;^]??W]\)C,UB]/T)=%GCN=I9#G]NYNN+6]0,2[T[IA#M>*
M<R/,]RW,CX=<XT.-6<'NUH,_SHD'-;T2/K33M:B.]_2.#E@X.^V'FH%W9&[Y
M;/<YUYZKQ\)3W&GP%"MXBEL-GF*#I[A,8'@-GN+C#KS!4WP8<\X_BKYU=,]7
M] M]^*P'/:6;M&BPZYY:G,+NU@)._V).4N/SKXK/OR@NT3WY_(O5N#7"W CS
M\@AS9^^A$VZ--+\ :>XN1W7$3F>Q_M-&-[]D:7X?]T0W+X4PM]N86[B^'KZ1
MYN7]^K)(\W(8&NT%42[:K?T;A+FIIF]D^9%D>4$S XSFI@&UD>7ED.4%^T_;
MK>[^]?7(C3 WPOQ8T8S-L-N^^R# 8MYJ6O9>O"PO1ZGD7KAW0V=_X_PM[]>7
M19:7HY6Z&^XM@CK;R'(CRUC#OB1QN<;[:X1Y982Y<?\::6ZDN?'_EN#K2R/,
MBQK-3]\AVFW8SY[!UY>A0_3^I/Z>PAZ+Q.\::Z11X,LCRMCJO%#Y1F.,-+*\
M)(W.BU;6;;9V&F%NA'DYA+FI16J$>76$N0E'-\*\,L+<A*,;:5X9:>XVY4B-
M,*^*,.^T%DRM-#4<C3!/P5L]G9VQVUX 1KF1YD::49J7@]ZOO2"K>R/-C30O
MCS0O2B+<;C4(L8TT+PLDP5/'FATD2Q>L<'Z400<6,=CTL<[^,RG*9' U&P[S
M?M\R%Z+F;H.H64'4W'ZVB)H/*:0/**;OWO[R[>VGK$2M\>WMS[_\\]W;!S\:
M[\STG)?-ASOZY]'[D]_^YR?""KWKZ&Z2V]GJ'[[("*5&#0J,'D'HLMZK_J75
MV4[2G]Z^:K^N?J)V<3Y$O?, M/DX3@MF*1.5F11!S%HS.AW&,)0@ZOUWDN1Q
MD*5QT&/]7Q#+650&4=K7C\?!6( H S0WNL$XSM?7^).3M$R&P1]1#B\5D*>M
MEJ^4Y_B/J[=7?A\[M]C'4V9NF:1)&5R*'5?9QR3%G>2/O()=A+TJXCYN%FZK
M>ZW3GL(O-\ZCX4 ^L+[F?6(\@8V,8,?E9:]9%.HD 6L<9/L_]\K,B=UU;R\
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MNK7^_O%Z<("H:)AE01\4MUH8W+^$=<5VCC,DO.\-C>X0JJ-F#9<12W_/ET&
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MS1'E]4QG(6ZT3/.N)'VN@GKKR=]GA6J8:%20<FCQ97@E 9VBIQRC2S,*/(I
M>@D)*1U#&FLMB816K#[$\Q '2S:UK<),T[+ :QG!,$GF_G7!%M%00@TA_21
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M(7#$S4&EG;&F1M*R22EX9Z5DF?YNG\*6<T15@V5-\KTL/H]I2O*! %59M2
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MY9P0)=M %?Q.YGN5QJ=I?DF*37S2&LI@6?%\EZ*G"YKZ<G!&<3*NFO0$%9S
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M)/,'6M:-<-EPB8_NL3]82)S<GNGKP YRNLTK5W_L@Z/?T[.WXQD(.(*%$5L
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M=8<"C2IHTE=2Z)@,?OE!DL(J5QJYZ"G]S$2 I@64BKTY_3  GOP?4B/ML0V
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MR+M-*]EH;JR@]X%FX<54;62#@)N V[/3M3 JTC;/1F3IDD5@9F=P!H0 A'O
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MPZ4/8Q1DLBY*=@1R#4CY/8J+).V@ZHEC!RIADO126L5UH^JH"YDFX;K01@M
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M',*"L(\FC';37.WJL2@;K]L W'#&P;#0IBEL'80Z8N@CA<QR#P5IQ^#K[@.
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M_WG#?SR2/\P]:689KD^K1IF#POV9<*3N>P*Z_4/C""XEV-L71.R$V9H6569
MGOAJ! #)M5FDV7BU_?C*J_!-&&5$KK5"=?V7?I0W4!#V'JT3A%JBS+R\B(Q^
M<'WI)'U[]I=[>]OW=^#XBTAHBSTR-Z6_-CN:+6],_'BP=Y\?<$-F]3B>53^C
M5VC#S8T/J$-M<C16NB5+%']FS390A(#Q9T9;CY[GR"D=V!X<H!-#'9KI:;<\
M3Z-F.Y0!($M#(<SUB7SL%!RYG?N*-XN\<C$1S8.2 2$\WZQYIQ-)&^%6SV$.
MG#("!<\[Q-&&_@3D!'/8FUZ?SK5GZ;NR26^(>-&F?9620DIV/VC1H?<AI[95
MVYV#(X()ZDX=Y_Q8+T+1+R)#['4J77JX,*SBMCK)O?VMW9U=G]0]L]@?)! N
M#!F.K1A+R:NLX,X_)];_PDOU\>:&W,<+]^J9SOTW#JORLM#^?;2J/Y=D825/
MVZ;ID"ZR##!Z4JR9 @T%+QTDH. I?N7>9Z/RIBW[WMH36RVFN OMD!&%FQMC
M4KO60U-0/Z.F508QYB.,UEYZ):Z< &P!T.$WA>-$2_Y@<'___N#QO8>,V:WM
M-/5"V'!OX4P*6OZROWU_GPX/--DK+$KK[S:E$2G'FQ-YVML?[-Q_.+BWNYO<
M^<O>X\'CQ_C_C[;W'B2'!\_N:I-)OI79BAY<":;[0S&!SV:IVKWTX=8LS>G;
M"=1+UT@.I[O:T[V7T<==SLH\_ 1QSR;7VAD),@L/(*Z-K/'5X30,TGKOJE&F
M/'PZ27O;9$!!;>7==;XG!I)-+9LQ7!"'X.=EE37<2"89T;Y,0KZ+;[D[V'OP
M:+![_R'-X^[@P>[>X#X] W,HF1USG\C"BQ=W__[N8'_G83>G8(['VLE9\TO&
M+LMK&B>KGA^?,BF0'#8C9*D^8GIR):)N-9I<N"8(%^<7)*LHX5)MU1.]4:B4
MT@.+PZP+%+-Q&E7?(?Z,"[N2=C&MTC'^YD>XPF=H*S=IJV%6SX35Q CW!&:6
MA^2T!ZFQ$ZNH+1(E1,9O2@J#M-@!+6^>['[@]+)N3YSR94 INPZL;(JM:1FS
M/$@>(_7Y@8A1!G1<TJ9$T2IB3YSB[JD=4=MQ+$@%7'\A]H/G-?V$)VE3K1^2
M.^G=9']/OX86 5A &^&*72S-R.G!_W=7^JAP9X^0:M_;Z;PBWVES0VZ%4>SN
MK1D(?_TDN3.\JQY\[P>X,5PC2>)P5_9'#%:KU$CGMNI@^ZQ9_?M6A<F] "1'
M-<#*-0..T6CWJ4?V.CJOROZME!L>N=I!AO*T "H@U*/@%6^97C2PSAKA6CKB
MXX.C5QA2U5_;)SQ#=T9WR8;L3:&'*I/) -.76T:S(J*W,R7JW\ZC\'K,W. 0
MUY<Q-*>V<$$CUZUVT9.HPY,3AO<SSJ"@9W'8]>9L[U?I,ME?N[<7;-'16[^J
MMI,3LE6JS8V7M+VR*:QWLOIFF9LD;WS%ZQL4QZ+','[O?]CKV.8[1,50#Z/<
M#Y0OO06@992=?>[>IS=(MV+R]W;6S3X@'1SV0TXX&Y9YNKEQ:MMHD+Q\>8C3
M\2AWBQE.LT,]?LQVMR^\Y1X;C:F>XR=F]ASX:,ZZ<+$ZE&/?""\5QT_W%GN&
M-,I=6"&/$!OH!36U*(RFY)VS B\8"SO;>P^#L; =7@968MT.:TZ+H7.Z#R;3
MR(XNRIR9:%^4:'!,=AZ.G"*=BPLUU^RK[U/^7%31<U 0()G@I^C@^7/OM4>D
M&];9-7J=$)P-0W32&!!5\Q+[#;_?W(CBQ?20Y,[AV=$/R<&KD[.[-T=T_[LM
MW!4NK5<<9RT=,.0.OL_<UB\.E.>OSD:#Y&3[:%L[?4EX1 K8.W;JJWH[7"C
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M/HLA+W!T<@ X&#G"Q\?'K([_)CX2,EK<PQ2Y*&#%U>9*Z>!!^SDZ/.8+*TQ
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M];,)4CC<^IMLJBU-_J4Y@/)\\-\Z!%_[3GW>H>KL9TD'(3WC-Z+/S$2-)O2
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M]GBZA&Z,I\I*$7HE:[[,0PBZI$4HBC.W4B[80.+;6<&&0LIE+C*D(QDO$+>
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M7ARG(C;X?\GMG\;"QQ1RUMQ1)VO!JTX5S0<?0:&,^K'1<(ZD.]=:4J*1LX^
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M$/K^"4@[HN(F82SE!0QR3/LI!)8@DH 8(X\)*#4=EWP'[B_H//!B.5YHX_M
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MH$KV?)P5117SLIC]I%(*A&=X/GWBRN7L-]=SR<_'!@)-<2!8IXR/I9(O#>Q
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M49S%PI;<A=<2/<S41WXZ'7BN7I4<6O6L6LFM5K8K'^&>2J] <UI]11.=GT8
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M%IZR&A3W02Q52XT#;M:/'RY_7F8.RQ^:\LW=L75Y7&JENT#P<_Q*AUTP)L$
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MHBD]>9E IA$@.U;WR1=$3X'BO4PH@/,(.F_A,=DW#;@$(+I9/P"B)2"Z63\
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MM1GK6ZHQODSPR=+\A?VX1OXV4Q"5YX[D$RB-_4P::726&EW!\3O(XR;E<4F
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MG4*7J*?:FP;X59U.8]L/$O>]O9R1#W,6"?%M[4(+PZO7MT;AP8%VZG:WO^*
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M[!W$]?F)*QBVVC4'Q8?MMA+OVN-.44GIS3^7:<S:^*++3A=SQ()*9C)<W)&
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M+W\H>KVFW>ST[WAB20=GO#:\>,&]D;.^X.?3OV%;7>L+PU[@F8GL(>L&N;/
M#(OH#YFW"39%-QX*V@%)ZN X@M\X<X?R(V&AV@Z?*+W$P_WQ3,[-*?@J&NQ:
MZAA@*W&0UL2+9.OO ;Q;V3");EMN-!HW>M+*K@HK65B-N7[I1K]EB8]=S0U"
M>RT6,I9"?=,QMC]1)U VG% MT*L5!?>5)\F;XAE9T#?77 R*T0Q]UYM**XZZ
M4].)'(/3GQVXC9ZOA_"9M ]\)HK/I/V,^4P*.H4S3QT:9UZL6)X/G">[SWFR
M\J8_:@3S+^\_J0=FRRW-]LR=>8GK8[ T3*,ADD>OOW?UTZW @@&=TCU;L%'S
M+>$G[@@<IWC"!C#^EP6ZRKMV?;KP\/ILV&TDE@1OZPC%R#JQ7O1MI,MN]9K'
MM-XW8?0-+[NA7'?\5A>^@:CH=O:MMMUI-NQ.O7G,L9!L#+$5A%:<.7_5"F\<
M/BFS-VET8S^\B>>B?WB%CN#F93^0,B#CE([#+((K.0*#AM&&.',OCE-ZL,R%
M\)AK5G;(=>%.C$D3%U,(-$9W!$N#KYF?+[P>W\?7M^\& ;JAF6&MK(X =HD.
M:\WZ([P18![:I<:!'P97)UCYIJ.B(_34]6QQV",QPP./=E5 [X5[R.?7P6C
ML@'#ZV_!5AB(3>1Z<6;9PY!QO#@%6A8_=.&Q,$K<>CA#LM]Z< 7?I+%'87HU
ML<#X07/+C2(T?,@BHHV,<%%Q!^%MB+C'>"TNVSA-4OB;?IJY)C>>[\-.67$Z
MA/,9CU/_\13VKAS0\\!B0I;BL20A'5D=N]UL@^7:M=( -KE:X;#>+_X()66
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MVJW9[Y9=;RY)M;J9 37[[<-P[MHNYP'RL\E.NH]W9C\BW*)P8!O;0,KPB.Q
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M.]FU\X6X[IE=]=M+RE:7!\Z44V0.WYT!]8^QAN:. _JV7; N&XB<[P'>M E
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M2M'D2F:6M'.I&B@Z?<E;962UK?SV2S4OQ"DZ,,5FL'8_:=2;V-+,@2K'FGD
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M"]]R7-BK#= *]N[*#]?TCPA/FJI@SJ5%,)O4\-JP:>48.K]@L]>O.A(2E9C
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M)@/FU9JZAF%8XT6<*@5W85SZ"V>V]8%\HR-V 4__.6..R>!8&(I6WY:A)/5
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M1JA<++1Y2&CS:"L?Z9+>_YLZ,^H]UX+/-/DAKN\Q6R(NOF.RN&/;%8II\(#
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MI#"0)[8=^&72N</?X0$S_'WG(SURRQ_C5QMOP')0GBU8#3:="@;B*_CI+)6
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M5!]S"T3A!Z+^K0\!L'6CO1 DBKUWW7_K%2(.PF?]0OE,:^@@25M)Y1T5=@^
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M6FAU0"D850%F%K*OKD>RP:VZ'CFJ/7E*TN)TXYK7:O(F3M?TP687^#,@D$;
M?T%46G%O"JE7W8AE@ENGNA'+!K<J4IY:?FUI*;!73? OE#OB5U<()FZ=ST_F
MF#HC]HD/A\QCCHD?WL_5PU?FWP[OZ5.:-F&@B-M:KUU47<@IWZQMY(OJ)B0G
MOJC8XG@1S@N2.)AZR^81WG(;>+_NCQEY9M3+F5ZWC_?.DZ)W>]L^MNR:0>!E
M$!&G!O*-XGF'2[H*)8=!R0[W?Q5*#H.2'6XJ*I0<!B4[7()4*"E,?6]QY?::
M4/O-<X?<1R,JA2':T]J=IM;JIFY9GP]1Y.VVO6QZV,N%.3UR*$,T77V:Q7OY
MQ$PV&3"/-'6-& U#KTA]AZOE;I;.#W-B_SI#T-\.53'F[<P7/G40A1O[//1[
M.#1&ZW1[AR7[2C7N1Q^YSV[O&%J[9VC-3NJX3$4(AS%;=TABJ%!R)-[L%\J;
M()^!/?7&@4V3B@YVI0.C420==#1=5JU59'!\,MCLM1AZOG2PQF5I@KYNZUJ_
M=V#CK7)A=Y )S4)50ZNO-; CM7Y\H5".H9 O[HHW]6*O\?Z[ DX%G HX%7 J
MX+P.X)0E/KYEY_]-G1GUGHD*@QLO"+\O(H3]VIGTM.+,KPU;&X/!5676RXS8
M5L@ZG;#J:\?5B<8^7U%YQ4D'*$\F$KEST/2;QQ^HSTC4+>;5S+$V,H\U"6#V
M+009=U),+^EH[69;Z[>JSK#Y(R]]&?LRZC8,U6QJC797:U6SJ3,Y!57A<B:X
M=:O"Y6QPJPJ7L\&M*FS-1R%E< ?+KX_*$-I.<\$NS2\YP(\Z)@/$B!=EQE8,
MF<GISV BSIU(25)R?-!W9@.'6M= 5!NX4]-;'<W0*\]_1_U3M=?-R2'*T 5P
M!VI?$_'J= VMV:JBE%DHOVJ0G UN5;_5G!3D7C<8.^I'':L8M5[W175826.5
M+LR59D_,,[E@Q!U&8TM>$+D5%&Y=&N7X.0#B[3!L;)XB^FIH1E_7.BVC4E5'
MBK[.1<>-8WJ,"O:)J7_OQ^ XCL:K>-UVD6-H[7Y?Z_?[%5(SZ-&J_W9>CN9>
MIO<>W+"NFUFKJW6[14FZ%^N)5HVYL\&M2O\Z6@2Y$)W::H.Q9+S&,81[V?/"
M=\T?\N7!B.S70K<%&/9W",M@E&8*XU[7&GI':S6K 6<G8-P':-TT<ZK?:&OM
M7C5>)(LVKO(N3L.J3V"#->:\H76-GM;J%:617ZI!WZM2:;+!K4JE.06#?JL>
MU36]V]4:_2K)^5+:DX%=#D;[E#FB&M/X\KASHU2K$MVRP:U*T#A>@H9TDN>^
M\&<EN=:+_+;6;;6T3KMRA+-0>I60D0UN54+&45.(2RX@2A/=W=UJ7(GW"N8]
M<)-5H=U=0[MW >#2!'/[3:W9JOIFE""4B]B['6ZM5=?!TSQD*>UI(6RCZJQR
M,++!K;JKSP:WZJX^&]RJ6Y4RA$1+JH]*E&U,Q&P@3(^KV##QF,GX [->$'E5
M;+==7/6KFZ^<[.<,?6@B[^<NSHK? T[<X)KK6KO=TSI&J[*D,Y!\=6F9#6[5
MM4@VN%77(L<->IZ(A#W=Z.>5]9^9\+$G!?%=PIT'%OS&';D-*H1K<NI7%^DO
MCX,W2K[JFBP;W*IKLN->I,\%VKU[$XFS&^<J%&0;4JG:6J>PTN63Q]Y&JJ\B
MW-G@5D6XCVI?GI"P*&O2Y?5L,K.I#S8Y\3WJ"/P9L$,CR+X@$JQ8,X5(JRZ?
MLL&MNGS*!#>]487!\ZJ%:N]S;_<+Y8[XU16"B5OG\Y,YILZ(?>+#(?.88^*'
M]W/]\)7YM\-[^I2F^5BGK?4:137_>*EE47JC"I7GQ!9[W6:_!*XH<73S@B0.
ME=UR/,2'W 9F>_IC1IX9]7*FYU.?++Q.5E23O7,#^6;YO<.57863 ^%DA^O
M"B<'PLD.%Q453@Z$DQTN02J<%*;"MWA[G7WLVF^>.^0^&E)I6M5UM+;>UIJ]
MU/9J/E21MW/WL@EB+S_G!.FA^(BZ^E3NXI$A?G!)V\KFM'QB)L,AQ7(KS>3Y
MS@O/QE^Y,QWN3OH)QSPL-VS9P/XWTD>9,:TW>EJ_U= :[=038=8P2\$(JFBN
M<)K+?41FOZ%U](9FM%-W8:MHZ^705J](VMH]#;,BK9=#6L7..)<CF,"$3%T^
M7I'6BR&M9J$3V=M:NPGZL!):+Y.R-CO S</,CV_UM%ZGJS6[J5M]%D9DRP&2
MBKZ*5(I%"BY#;X.+"**KN6],I1 \A+&6]SX=V.SRH\4?+FNUVL?W^,/':7PE
MV$@#D'+/)TR0K^R1?'<GU-'4!QJY8QX?7I )]48<MH-?;<Q?.0V7SKYR_+ F
M _QYX=OJOCN5;XP^"$'72([>#.F$V\\?-K\1'AQ<WH]9C9JF.X$EG@$IQ'%]
M> 1KO6%-#KL8>=0F4^KYV(7>'S.! U =2;HXEXL,N4,=D\.7A \?8.:E. _!
M,IC30 X06H)]YG,OT4D!.UM9\[_J=?*%,]OZ0+[1$;N !_^<82+&!]*Y(/^B
M]@Q^TDF]'CPGI9AZ%/X3;BA.#KJ10 \=_&R;Q#E;.:*#$L$NEDJ_U.- "(]_
M0>Z?IW#T*X\.N'E!OH+X42#ZZB(TVO&'WH=/23@AC",(K8/8P&/T1WW 0.;!
MNE,)^OAV.PG;1<C&811#[@+#)[\\OE\\QQRGKY/RI> %4K'M0.Y+)8*_PR;,
M\/?@O8_<\L?XXL8;I1#2;2*@>-.U;3H5@.CPI[,M@7:@@=48>[":I(\$=;VP
MQU"7R2]+CES6;D:DVY2FTO>6V<RY!FHFGQWFC9X)_#P]7Y"TZ>X8-AU]@[%R
MC -_19TDM^J[,FWJ.JZ OD0*Z"Y20"\;'E]BV6.",,<"*(2W--$-#>COU4_U
MM8!9,) *-X^4H?AU-H&GS)7;0/R=.S-F7?FR7.;?7ZD_\V13<N;)A,4KQ_K%
M!2 #(9C,<^IFX]_XT+_!D6)@J4YAS[XW8_&2FVUKG.THJG:%R6;UJ*3*3V<H
M57 G6\@T1J*!.%*7?F<KQO;RG_<@.WU5S"0G>F(%#A\^[\GT$E^2(=/^#PQ4
M-\2ND/0_0@0C/2&&$VD_(OQ]B5W]]WPE6W1_8*PJ[?<+_+/$6\N,%G 3C1S#
M;*P%7B2W=F;',L-5Z=%:7(^21RK ZS'A9]>3V@5@=FOZKI2A#92AC3YXP* 4
MI 3^E3X*)+N?/>YS,89%[-EDP*E&KJE#+7I.$I2U!DP\8O"X!USOCPGW10T;
M:W&+4X_#CM^B^<),K&VSGXG'ALSS8"N@_&!W^-I__*UG&(V+:^6VR=_T"P):
M(?B#>FGP^3N-<$&F'AR+3ZD-*S)G!(:I!0>5JU$3?'S!$9%:C3U-;5=A59,L
M9#'8A3N5O1G@I#./.GPV@5T)=^:!*3[UD.=\W'>PWN\.1\A);2S.R;U4V-%.
M]>Z% #*<3 "RZJX9Z_<LAI#&I^_O_J?V+WC9#*$6Y*W+C> ?O_[?N\_D2E(]
MX/PWZOU@?@P=XGDR<.T0"I]_#R"P;@\!DLF84>O/&;BXS,-^O,1V3<1]C?I
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MP"1([<#;$^3FN 1XY,A3 28D@]>DM5H/K%4RH((CSXRY.59+((>-02FM+#,
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M? )$RX*"N?#2D(GMF:62UF,AF@\'9=BMS4O*Q'#-? O_C*V%?SFQ2#M7AL.
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MN1BKZMW?GZYQ!&DM]//@]]#-.R??@^YC,6<=6X&IHCFTIV%EL0TH47<^B=_
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M9D%[WJA7#U_: ( +^QD%"Z-N7MVB?%@.=5J[QPGV'/LK,!]P$]R+&1 >0^-
MC@2+/7E.KM1C:HNJ<Y)RGU=>@#.LV*."9'*S^ZB^3#9_8E:-#V6/8'?JR0Y"
ME2%0E/C*-TFIO77X3-YRIEF,^,JC2UI5WUGQXD[,DV\Z5+N;?WWG,A>IJLY]
MRCIW9O<77-B9JOAOJ=8S*X/,RR836Z=4Y9*G7B[YB?H41V)@1.DJ;"M_W'3^
M3<GP>ES^A,09I+CG60>@MY;2XY?]RQ)5)4H4?@O'!907=T81N+N9>U4R=KGL
M^Z1"X$J]PT*KJ]5&5V?[%ALL&@^OM!'BIB:@1M4$=$,34+UJ GKBM%\U 7U1
M34"7-6'5%K1J"UH&T56U!:W:@N:HR8XY&>CP<;9\"X3:.Q8(;0^)1==$M\.O
MKA/-6%,!LF+NO].^\D!7X#D,U8I.A'/J #?U^:RZ UZ)5].U)(%V\JT<:B=5
M#A7-9*DORC.P;XEO4JY\F3.&]<!8_IMT?:LEWCLMW*P'%\!R F\PQ!ROO65*
M6.S6^SGAVML5X5UV;?6Z.\@XBSTE"Y2#(3)XHX^#=670*#9G)[P^YR)VSRV3
MVBS<3WR3L9$YZM':_!9?(WA-C>/F[Y-?QM64F3$?X3EQ4L]\7*Z-@5F5:@=_
MB'+H@A$_X=!W!V_3E^? XR[4A%$)(C6G>"!WP/B# K, 4U#.-I8'!7L9-BW_
M(,O!AK =2FQ.!UC#_1R,+)+'MY\7IH8-F/_(F(/$]@,6FE*T\?B4REG#BC2"
M1 F9UV"I>3].D/@P'X*F3J(M)2<& TE-*L9D**\=@_2_<&B2\G>X%\XT#E93
MD]XH?EKWZ5,M?()X>+DIH>*QH<U,7XZ,Q\1%QP_/H+8VF:-434^-AK5-7(<]
M1XCPN/@AYI.P P<L2*$,!AO%4%^;TUD$_04R@P4& ?9AGXX<4[0T#&K#A*@8
MY<:F0W%?))!?+3Q"+.]$YFQR$<]U <RHR4A13F<XGDYQ-U ?SG0.#R.!:[E,
M#4L:,7#+$>8V""-F2_YEV$Y EBP"6FL2K6O9$6=5A;QF12^6]! L+1-/'"[G
M5ZDYU',H#!B.EJZ&VA6GM_.MXNLT,E\39U#7):8%'#!70^9?XLREN6C +(*)
M%.+@+8YJ Z:I+S'-.V0P[I@>DQDB@?!"=8R_AD()+>1D$:*1P4QR'K*_>N\B
M_ZL!>(D;C.DFF7XV0#428_8QM6")& AJ$@3R:S'Q%,J$Q8,N2X=W2HQQ^+,,
M"IV3JP!^*B\] =9+4G R81;FFMG/M16)6 F8P@1,OC61'3UG7_Q79)QB?.Z5
MI4_&MU8[K_SG [))OJ6)G<S#93?Q0XE%XPUH6Q-+D62!D\S:OOGR_8[HG>5I
MHX%"^/_LO7MSVTBR+_CWXE/@^$Q/V!&0A@#?=E]'R++=HSZVI;74TW%V8V,"
M(HLBQA#  4#)FD^_F54%H$""()YD0<*->WHLB02JLC*S\OE+=!L\6CKB+D[6
MH0?*ZB3!> <B"-X3+ZQDOYZY<)/ 6P1WB'J'PL-8T3FZT<RI\5/]9_H-O'OI
MZ\%]<JAW1F]8^OWP9F3OQ7N5KB^Y.HPI1R]2W;4G3'%5X.'WYH_P"=$H5Q-\
M'@KQY;GW\1M.U>];!/%WO'&SG)X1:(LTH4O-'I"H8DWZ>SBA-;G&J-,MWGUW
M2S>F?NKM QW5/5+K@C85WI@_&VH.VWZZS,J.]G_1+DM8<]<DW;APU-M+.:H^
M'BM3'/+W>V7*E,2<Q)D_,']&/<8(#0*7&GPKC 6RSND%H>/.X:,8M*1@'/BU
M?0&RW1/5+;S6;;C:?!:7(_>^(CQJ;L$/ 0V3\0'QI^HY7Y&X7AXXQA]G 5L@
M7GW4,\<+TOQ)_\GQ0Q9".83&8Z/X#8^N@S@F/@-;KC&\$  G6@\8JN-_P-N9
MMV$19ZY%/5CTL: JG3F[<7&WPC*H$>61.].;T[^M,*K@KGWN?[="Y[3R+JZW
MX7141\-IAJ;(WY^5J;,D9J*/7(LH@N:@F =<$)>BJ\#Z)#54* _6G!K9*+SD
M?N5Z<("@(!;P-#22_2CUDA)<$_JQF 4>V]X*/C#.=0NYNK6'H I^E-D('[4.
M^U-1K=#S#S_:27%C4EQOW^6HCK[+# $<U"'%?9FE^"8404440?1C,<S-Q%6(
M1F-C A,O>K<S!,U()-%.$+QA'C*G3S+AX;- )19-?0L58%S^\&I%&T.A+\+<
MM[@>:EM0K0+&A?- _(#=S6!.X-T.&@5\=V9[;%HF\/.3N)];^BKX($\SA+@T
M6#KN$T+_RM*SI\K-4LR?BV933!G0? D'/K)=@-@.RWY[!&%K&'.B-4*"P"9B
M'C8EQQ$K.44@Z4XK1\VR<L3N5_RW'Y;+TM1\I#)!]=$#[;1?8]JOWD[7T2[@
M_ZI*3^)C/U,28BA4!43.ANM@+4>JCP(?C%4 _HX78H0:B/D[B&]AVUBN8#Z8
MELWR@G>FY?A!G(KGP4PX+?S@.K H,M6I>I.J@J)(:Y1!G"&N,9;=6,'&FDPU
M98OABGBNDH M1?>CX+-"TZM6R95(-@_=K-4_0K/60?1/O17 HTFKFLR,/4UF
MVRSZ,MO.A$5T;6-=VYCL35%=DUC7)-;*)K$=IG'9SK'MILVNEVRKETPY=#-9
M<UQ^"(-Q7&__RFA:, $.NHS 2UBJ:/9T$Q?H(V 2_=&FN_>9:WN3%Q]\[9_<
MF>;J;>D7'*AHK09,5+Y%9<;WR-H<V*XZ>-2F!*?> O)Q6@%YW:(29LCK$#J)
M(T@W2Z+$0<\H%AJW?X2A&CJ'"ON^>)EX(M*,$>651U:F)V:\+$]=K!U**\0X
M9Q2T$#7T\]:OGQ2>[8X$DX=G5YZ%;*(2H*5[#SJ2. ^6YSHT8FLY/ 0%FX>?
M,;>&8ZLP%MS%;1N3YGJKM<=I$VSJEN9^;=(L=18Z_7;C&Z12&EYWM**%NXC;
M0OHDI*W)S]D24;QXB@4K/$S+IOF9[62*\+Y3A:\F?BCVU 4HS+0D9G,]_'&L
M"N6$T)FTPJM/U6^N<[+Q"!&>>6GYP%CH5M".RHB'%-9LAVDE*WY-XMG[MK+O
MU4)')RMZQ73[]KN4K7<AZ+/P;5]]Q"[8N#^FTV*-:;%ZB^G':<7T=6NQ06U:
M3.HL_*=07)))>%:.SA/+@MD>=NL*L@FV"_P^F5I.43Z9Y7T\$\[4D1)9&CR#
M;F$;,Z\ ?%PRH>5IJJBJ#X&43?7?:R#,@B:THPYGE0[D#H3LO;HD\SO0<>'>
MU92]*^E[=[9UT_;FV-P56@%)0.?XUD-4./@:M_LFW.],C!<F<N.4*IB"3SZ%
M_CHEP4A3A*PNR?7]S1/$FH8="S=MW]V_>B6Q^E/U3WH(;*:.\-@[<4S-GHI.
M+7DQX.O@,:P_.651[,M*UQW8M*:NM^]@O&O^5"T*6N*SOP2[,!)NV 5C=_39
M@,4W^XY2?<)=!B1OT^$LP,FG@=$5VI!_G%Z?JA\QT>2=*F>I%8N%K4%>J4W]
M4E8PO>L9)K8SWVV8?$H2WT!-4? [M7%QY4IO A\=9+3Z(LV"/=>\ OS_ZO1'
M4_JCWM:,<=UCKCZ9'@Y6\:^(=[T$YFJD?2GC)3+KK%]OWX<K5[@H@;RJ_K)-
MDQ_3A4;J@&V][07CM/:"7*5Y^61#XK/'^&H80HT:?6]-'[0&;3ZR;#JLF/!]
MJIM,KK[&*]GHO?MT=4W_I;][@Z$#D\V2"NC XWMT=O#3_JGZ@3X;/LVF1-JS
M-;T+E5ML*^#=!NS.3G@[/.@1+A4^C3^RH0IXD_(KU%G3%#E\.O%:U5T'6&U+
MGSY?>^%+6"^2V$NDN(_1EY;$GH-9P$G ERQ@@^Q9LAD$GG6[#L(29G%%2]>>
M$\_?M0\EQSXV>J VUDU/+S0A""WG9NT8-I8.HQ>$MA,]7K0&DF]AS6%S#$R)
MA/,#L"55=\6C=3@3S/0\"K)E^?Z:440\I46BN(&S%Q9#<L?46O P/!@C]MJG
M31V>^\!*P[&@$U9Y$JZQ<V :TZ;UMGF,1S4;(%2STK+]*]98+WH^C5@C>=_8
MGKPRW=$)W9(2PA-T!DIS(E5O[\ XK7>@82'*VX)=0CHE9C6:;XZS)?S&3-Y\
M=WCG<9Q0VBKM>O  =P$G2O!?U.6_7]GN$R%; Z9-%5QV[XY:!"P7'-VF\">/
MS!F((%**6@\@K\ ]*[@>&41+<G%P??ID8WE6,O>#%S!=,<OHQ(DS6@%Y<CT#
M6P0MBQ5KJ@1QP@_<NW-B;[X1PP')=[&0! :)16RRY)XWE\"@&G<_AW=XT5X/
M%@-*[%E)?%.C-!4-H41;ETT>"(56PT?3X&[85+5IRM#(;&1UI:UN;0<4B [V
MAT_3E(U&EA#K)7Q5"$QYO8MY,! <\PD:TYOGECSL.Q>'E]*>-._!8IUV"+?#
MVN93O\*Z 'VX!7D+'K/3K 7OKQ&LV:CY9?L):2_F(*Z@P["GA?:Z8+3,?E+"
M33#N$6C*C$LD=DB,&#K Y8?O"W-8423"DPTSE1D OPQD-]Q&"'&Z =*WO0/3
MC[I[F%Z-F(@E243RA8<'6V$-/HEFPGBKVU]5Z+J &YV C=3%[78F;6/W;[V]
M,^-)V0!!B6M78E;XD_M["M<CZ*9Y[@_T9%/4%]97";K$26A'>AF%$UU%%"Z?
MMM3-UPS9F:)[A>E*^#2[(>FK%>&.5#/NR/UNZ\8V8ACD?)>EPB_+,W!YDZHD
M4C)1NS'Q9I:?OJR_@=X)5P;WGGO'@,<IA D#1&59 ZKU6&HUQ4K0:%PEIA(/
MTX W9 6F+4O/86:I:'M:#P?=G+B,%KY^-R>NFQ/7-?QU#7]=PU_7\->ZAK]N
M*EPW%4ZZJ7"3>EO\QD5;_/:YNZ&#V$A6)N7A!TK 5.>?3<\Y+L+EE6SH9PJA
M@2XWTYP,U=OM-]G?[5=%:O*F8;(E3V(&$BM0B','7I>_5SIH\N0V,*-<@3/W
M50?L)=_'HFJ>/\$#V,RQ$" /&N!8F<+^S0X,Z\8)AHSXC[0&E$:3?+)G+3CO
MS7(>7/N!U7>CA%,$_^WJ#8^.@8'G?L( -AT8%8/^FF #>;BGG=4?/$G$/K49
M64<\S-D28>;#(%(77FY,A=3;8CA):S&L+/521Y(_TOEK8M,(\>X9A\/BYQ83
MK3#5LR6 YIU'")MNB%\.R<#"MRS(RK&G<2S4G#V/-MXEY"F@T_FL&9U4Z-*A
MBJ 4+(^VQL 65ZPX+:QKBMYZ&K^1@<!YM%"=MJ%0":>_H1'H>3)'!*^UYFM8
M"0M/,Z3=^'%*]#AN)\ Z>+D&0[J^HXV*"\*T"2OL3F@C-JR1]JG,POF$])L^
MVS6K 8E&5-2J(SK5 +)<;]_>Q*C90H\B+A=Q<K(1:WW/B]I3.A5M1!%3P1T8
M1U,"5&\[U22MG:H9D<EKJN<708DO<-%LG]E@+\.IH.4>B+U9B=*3$+G9MMU'
MUFT:D#L7\3G>;O2H!TO/7=\MPX+JL$<SJC7__(^;JR]AM;FFI']Y?].3\+C+
M\XOH>2HKIC'O,<^**6F\4EEB.<*%#<MF."8(WS\;[JPD<)I#:.@@#8V;/37Y
M=09>?1MLU.VH<P]VX&R46$?]<+>8JL9QO30732O9X=#,NS!_O;T@5O-D>2R)
M#.8#6B5Q!S!6J2$F-?@F@35#EV6['"8R5FC%.:V;\4Q:*DY3SB%7S!4P/NB9
ML=(O=C+;-3)::"3-30JO8L[@(PSE.E%6CBB^="(8SLOT//+@SJBQ1W"4,G[X
M-77HA$>?W(HO4K"_ <Z?CM#V01[8.&9R3XL/ I7QPZF0G-CL Q0+'9)\HH']
MQ\<F<R1S#S?J13.5PZ\J[$577]37M&[)]!.DW:(H_',.A_%@8BT\+'X#_@8<
M/ZPE8*_A[^![XN_IO,'&;JQZ&_@F:;.5:KU8I/8,8W,K?72(")3"!(BZ2TRY
MVD^)PE,1]P3UG3 R/O:3>'=N2L/]J?J=#@- :86OKQV/_[@;/(#6*[&FW/C*
MVRJH3-7&XAY9"T]R@S-[#=M2,G$0?!$(8>/RVT:-2&TJ[M1$4VJBWJ;%R;!F
MSU"<7OYY_^CRZA,+<[VO/7YBO)]=%F#25.@\R*8$K=Y^MDD-8XN*B5;NZ8=%
M)59BC7[F*-29&;V+F@)X-PS>6]S/4:UHQ]S1,5<K&R],=HUQ6QMS*>P21%^3
MYF*8\2W4&4=1V8W7*>Q"9YY97 F\->F7SR*)'"8?Y=R=6?334<UN-/%$:+2@
M61Q'W,HV^$^$_A$#>PB3UA#OAW4WA)TKFS.)3)\[VN!;[YA9E%B>AP77S'G8
MVK.2-%WR[UN#U?MA##IL+DFJQ<A_=3T+F Q^S7J5F;,.),.F$,0DT10^C"H:
M3DD)Q%Q]?/":554#8>-#YQ'PB$KP-&SB 3+D@5N*&D%X(T]G&#6EK^MMEIQ4
M;Y8LJ%ASCX\L>@U(S&@XK)Z"[-*R[G XJ\9[^C?TS*:N"UL90-ULV4F[8RN@
M1$%'@][F2&CA,%?[29Q>FZI7Z?"X^69@,13T]$%TNY2F (HG0F5BSYGP;O&U
MT1@IQ#U -1F^86-_C^X:W+ZE^8#*'C3]TIQODH\UVQ%'T%Q-I/!J*GQJI3:J
MMW5L4KIUK+ 2DNWTA11!=,^C">3A^$(/"W-H_)??\@*3TXI2VD5\C[4Z/AAH
ME.88WD&38NVC5)FW;LVH(!WS3^NM+YW475_ZD0C9$T$LFDYF%WMO:ZI2$]M*
MBUH<)$9QH&)MV<,6TWKK4J=I=:FY+I[20B:QN2JFJ^<D,I[\;?N3#B2EN.<\
MS!XE1ST$Z:+6HN#]TH!_:DR?5I(1FDZFCT-@#TQ @#^/=5X[L@#17&!ZVR',
M0.RKAVZV9_D_V*<]\FAZ<QKU=Q_A9O67U@H7:#H\R>K@T(E3];?-? 7PPCPA
M_)ACN"/T<N9)E%U^L20MQ&T?6SI\IF-+I_76QDY3U(K$/<^#;FSID9 #NF;H
MKAE:]N;?KAGZQ35#Y]-774]TUQ-=X_75)-ZY))W0TWK[+*8%^RQF#V2O'PU4
MO$;L9/30SISY!5J?*X^P.10^W 7_2X*S.:W:#/*.0H7W[@U6E7FOS+X[7ISD
M4?'#/=$+P4KNBB9&GDB@FFQC7?]T<Y)7;X/&=&^#1N.RQCW6 \BTQ(Q(D6^C
MY@P'/A8)G*:"[G'FO.C?5;,E,<Y?AJCP:]8E0#.@47G'!@P_L_Z4+>OO;8NE
M6/)<3[UEZ].TLO7#RG'_0'(L=6%&4HX%P7VT&&8M@BM0*61]P8Y#8]L;8+H^
M?!(6ZUAL(!Y^< $D4G\WX>/>D\JDL]])9V/266^U^#1MQ,UAI7-P(.F4>G9H
M?)J8;HVWKH:'I[X^2]RU%V?7JD[OV8O/WZ_5*TQ&63,2AXA4XXU*RROT=[RF
M*/HZYWA>%<O;]<))Y,J<+84W;6+)IT=S4=M>K$9;TX@YCX:KQ^R7]OE3M7SW
MS]K#Q)4B[ )A6A#O9.D^"G/4L0G0PH0QG(=J[E[^4U>WV9B*JK?.?KJWSKYQ
MU3$\D(J2>@[G1[*PXHH0045]XI7AJ3IJLE,+@6EAFS.&C32/GDV+M7FG')HD
M@MR2Z#U83ZZ8F]]*^>2I^@=.0F P_+"Q^!M:^I/1'^'MW]$L7E;F27ODHM2\
M(K361>W._OKV7V@_Q:VV5!&O'0[-%#SQ9O)3]1-J*U3K<YQ$X:[25V,M4H.'
M7'$K;/:PN"RQXR_95TQIJ3Z:3VRY')C*W[50UN<@G-;,-CU4J6RS\0$I*0MG
M'V)5];P2 HEO.0M,T++S\OAYT-U'S>SH"K+R"L_C3=NL>)]XGNMU*CNNU:E+
M4Z<__P :5>(33!0%A37:6'LSLU81>[,1.YM^% UR"&8'5J^"1HA1GJA(8%E.
M$G\NEN"5ZX<J31$Z^4\K,92TI-Z#"5RH1E00B9A=?U_/[YA"!!Z-;JIRQ:#E
M7O"J8!JOWLP=R^;_GU>8%2R5QM,G-/^7GL3C?ZP0P>\?-(5W[EETTV7S=X*A
M $+[K^CH4[/.40ZO1=*WF62HPY,H(XQIQ6+EA%IB\N,] S<FG:[.39U42\ZB
MU$7C"3U<VDQ)G?ZHK95"^C ;#JP^;'E$UF3]1@[MA:7]2A2 ,,6>I""G"<XV
M?7]]'XZ@N777@=#C>2H8_'1H%ZTH#5_(3&C.#+0)2^7XJ6&+JR>,QXH7'G:"
M*-AWZUFT.BY^^L+DT_08W 451=J?:XIKY#VH=)J68);?$MLB#Q'2#K:*N0[5
MR.O(.9A9WFQ]CPF,&7@-RID=+&E'F$#9-89$EI8/"T$5HFXL%(E[BPTK/QSW
MT2; H&&%;M1)S!T)+5PA1D]CX%H\7_IY"D-$H9JB0T%OA=4:<PL"P659#W!4
M:>P3P>]IA:5<8-K/L?106C5!.7TF]SE$%V/:9?>V-5GS%G!46I:\'&?*?0YX
MN6'_@N]3[<EU(380X"QSU+YQ^^Q&]Q^]DQ"L@6D[&ET6.FB=.4+BP76@GM Z
MJC]I%T7\V^3'30R4L("PA3/&4U80CIMG5TET/W%D 6R)B/$*8AB$;<0#EWX8
MT95,]GR<\^8$"2#>4^6&-6U$]^N:-BUFWXKL9HGO:-CB(X_:8WL48B93[ O3
M^T$""CE,?54G[!V>\?%S: L C3WL%SE5SA-X5'YR67C#F'; [T?!<Q5H&["A
M?5IV:S<;;"N,?N5@4Y&%H^P!I]K&:8A:L"D&!9M@SZ#9.S55CYI**P(HI^[D
M/H>T >CJ"9[+WI&1X<@.7PS\(I_:%ACJD4F?;Z9R&)8%$5GA\ 'B*UR:YV9@
M\H(:'K,5XK0T:Q^I!:I*;I]$JY7+FB#9I^H',C/12<BW,B5R,QC*P6I-A7QI
MW2W!N.=;1UD5WB$:ZG2ZIXOJU4;W)9Y+@ #K\$D!%4]X&'N/\$B%P7NRN!JV
MP+%:A0T@O9 6G1ZH20^DE1N4TR=RGP,%4 !6#RR>#'%OX>G<)F#Z0 BOB[DH
M KR\1N;F79$AI!.%?>0V @65I.-'[E<V_%V]\X""\T=D9[S6 CYO1%-7]OH.
MT7DILJ1Y"_]UG=" >B2VO< &K+ EU%M@ @WN5=OD>14.(+()K[ &"\1:W\/R
M3GPK6(=&T)/Z^N+Z^QL5?H>Y,GZ \<(5MG"4O%N&.67-T"!CJ)<K!,::L=BF
M*2#;\DD"'J@ L$%05I$KUYY'L5?('6;C:8_J'1I=P"1A((/'#["FX?H[790:
M%D4@0W&7'@T3GGZ*U0'+5]GFHR\^FQ[>'>Z4GL;F4_E'V7QZFOK '!FSGN#K
M&-3P+!_W2$D+RQ 4/9M'3M%HG"<5",<>AZN[Y7D!%G( 2\A%VRJ>-K&UW5D\
MVH(!EM$]4AWMKCTTBQ\LG_Z91@6<!\MC7+&!0<P"'#2J$=NI[ 5H!6YK3WQZ
M6NK!2T]5"*$?)<8Z8VAAJ:(CCIVP?5>\**.GT@YJ;%P.\8[!!26K@.V*WA>!
M1\R &YRSI6/]FYI\'#!:$1_$[Y)V:/\\B<+F^I+W;JM0U_*HFWB<T?T[["8>
M2Y-2/+S<= W"78-PUR#\(AN$CZ7DNK[A%U!TP)J(ST-WOVLBKB%,D5:Z7"YL
M(C>AO_, @$*G"BV(1R?1F#]#R"D6\?@]JB*(BDZW0AR/2\( F%.>PN;<B)!1
MB;A_HN!!";W/4]#96X]*!A2I/RU.UE@[400&O\/ K+1PS1OU$2PKQ2.U/XAM
M+5UW'A7U195_M)Z/05]AS9_YDPT3,FDL@97=,O\W[(RRT'&F!05N&! 2=Y]"
M(+&4(O:G^:L4/I4JD1I"#V!F^L$6U-A&/2&-^2(&>CP\BORT:+:&40@C)1@[
MQC&:8ICC5+T146_9X,D4<&]G'I&$KY.7(P@](/836YM0QD#7)7CVPJ@B&E.A
M<U1XN780D4P1>$J<XQ*![/)'I7-6'-=@89!;PLLRR?Q4/8O",O:3%FU42(S%
MQ*+EF"*M_,2@E&@C["B(SU]'LP%[-AX.+8:7S1%R/7IZDL5HE$L19SMA96I,
M$0IBM\UEK8B&M" 6GH9'7NZ2D?L<SAC\M,D  )T$=C8F@)T Q,-B85]V6U!3
M1/Q:^N?HP(,P6;U>\:KH.%2Y]LEBC2'-!UP0DRQ4?_&4!$7$]N<3?:GX1V81
M[UQ(5!Z@8"3W$.6[TY>5R+1O5PSP>;P!#IMCHX3Y1 %>IQ:%,N&;CGMOS7AH
MF.;SA&!OJ*G%?3>4RTZ?:R/&@:01LS2@[7+B*AOT\XY"JZAVLO9"JP-"Z,K!
M.WH:4'4Y)I1;1V^75^VL@,)V_I0**Z:TQ?&E?#0,54EW:VM.AZ7 LVBQ\8C-
MQ>2*F$'7FN%SE0BW/1H=PQ: )M;-4AATPPX]*BD0.X9#,3A5+^@@3V;KPW?#
M/V@)LRDL*Z8P)"[B$=!T4%0JO%&VA.W"/,M*]2[_.OT12PZB#!HU*$/-O)E(
M#>TQEHYT^5.)^$3X0=F$LV_]./6CR7,:^'5)Q2"W0/\C9$<E''&+5GR*W/)V
MVJA$*>;C'964X;.2(X)WRR SHY2SC#6@448+;D(WS/)8%0ZW<5@Q#C/@L'H@
M=,3]U!**V,^)/4P-7\<](8T:H?!I./'.F:E+LFIKL9&ZQP9.X@.?@:W,W/M;
M?@.)-7[)JXF6UK*0EJGB71;9X[$D;8YEI65JA)79!E:PQCM &+UM1L*6"#!A
MFSAZ$+R8+S8#-?0L:,..Z%L@YCM>;KQD)-&PHI[%KX,+$R>TT06Q@A!:)1R0
M.X\-A:5[4H1+CW?\$%KJLZ)^#FSZEM!*6_!6UK.PCH0%TN;Q"+2U1XM;X..T
M2(4-^<9:D+7GQ*/=O7LZO1S>!W8HXH:!A-,A[#ZX4O"HR$VZ)0Y96 $?LR<.
M^D;(@?\ QYCJ'[R6Z9Q72H87.@4@6=_ZL CLVB=AASW\>2L)I+[&C!JPZ1OU
MT?03_J6;.$5G<Q$O/J12C\Z0O1_FHZ@36*V3,PN+C&@IV^R)JY +!E+A,7.9
M=>>=7:L&L!HR\2=::45-4*'>_C,8C;!:]=-/7LKVG5FR0J1:& V)T08V&B)E
M%1O11(O9[^?P(! $1YUC(8 7&;0[GI 0'I0:_I@_3J]/U8_T$7LZT!G3*#)@
MP3=< 5*T-FK<U49EU$:-NMJHEO-^5]_4U3=U]4TOLKY)/N07H4GC(AK(ZE\X
M9^&8K.K8+X5>413]Y>458PT.6HP5GUBA<BSL# F/MUFPEX,Z@75#O923OM3)
M8"7E6&*W\B-%-E>2R.9;"KR7S')$,2>N$3][K)$\J1)'_5<X!1L<;MNGVH0A
M[8$&^QF\==;W)W,W..$?$$=&A#%>V@7K@Q("E4#H ]:.Q9[MLS^]UPVMU^OA
M_X6<$R[E/6OHI"[N;YZ[7JFZKMY@IXYKNW?H3%XXLU/U-<=5##_"L1#?:*JI
M_G'-6W"#\&M/ZL+R[K&$"X-9A"5*"]# R$V#"]K&>^;,+]<!1;"'-S%Z7!$/
M/2 P\2/*G!@":5; J:_>#[8)\DO4!<]:A"F03?ST%'JQ@%=TZ/,'#";,U;\T
M<^K\\6>TF"'UU-<^>)'CX8[SMK9"'I2KOY  ^QDQ8^C0D>DT&/*)MJM]H95F
MVUR!I/G-M>?$4:^ $5&<U:^LLI#:O33)YJ-NM?SE#G(M-T)XM),ZB,I#DAD.
MRUG8S,7$HHZ886D0E(6R?![?Q"QF/-1][8?=S!C+#9[4>Q(LW7D2>O14S2?E
M\-_HS6%3Z!R;#SWK 5.(%!J596^9\8LH"S'^ 8^L(GN%25JAOY"S%\(ZF>K<
MLM=B*_IF1C.>#QJWBC,-BZ3/Y+^AR'Z#7.P76U17GDNAY1%=\C)<PP6?^BWH
M^2S1ZP].!Z-MZ0L/0=US"(9P"*&D1E14.!6WB-X@07M')VC_=*RG$+1+7Y>U
M2%+'496TDB2V;<YH0W"6@*&2]@FH7&(_L12+9]+@-D.EBY-1?JSR, J]=LP'
MT[)YI3''I,<D<^(.T,0+P H2BCOLBD[4\8&V?_1<6CJ\X*AK=JA*D]^O/]>#
MJ)DO2PI21T.5E*?Z#R$LCZN(9BK49D>7P2I2RN&]O'TK\$)V&\OZ8U['T)>F
M_KYVB-KO_>JO5^^#)1PO_&\H6A83%E:T5?_$E8K4D*"[/82NK3"'L!2/I@Y0
M*BDW^R)A.X<!"N^^$IB0>C:U1*IVAN0W NAY3W!?))^%LK8CN&$TUB8+6MBL
M8T@J+8\5\^3N&%/*)Z/WP?Z0F:EOF?%5BB3C%WQ)<\OY$M>I2+.F[PB NI9H
M02 &Q/&++VA_TF$7UZ:E65,YN0$*[,]YI#W\+_M7L)T:H4_MMM!MH8$MY!6^
M=VJQ2R,T!T\B"?S?C$!.N)E4FJ5L$-^8YR@\ZVZ9ZX-I#^P6TX+%Y.??6Y K
MAAB'YI;KP6OO;E\;O8%F]">:,1R^V<_A&0P>&6Q#XY=7[\\94MNNB0^_I&N'
MS4\E13^+FOPKTXVO<,)FQLM*Q+_C>-DEUOCRS3*;;7<D7-=ZXXG6TZ=;L;&=
M9"I,@.=)6<'\S""OT=.&HV=%7*%"[<0GLQ/KY\G2FH/<O579_YY@+?>)WAN%
M+RCZWQ/NS;X &HW+TJ@>2M5I:&3:&=]<YV265+\-W5<-"S]L9)9/LXZ'H%M'
MP[VB?Z1[/3^/3EZ]W\%GTB]]VMJE8U=?J:5+9'MM+G2G[_,%L?!%L!<^!4<,
M7&0=2#%O+>O(BCVI\*'J.P\UE3+[U_TLJ&)T5$FA2O\%4>5U_FJ,_,5 8>@3
MM<MG4"Z7H6X)_R#>W5A( R>R?8D/M>F@O_<2SWTD;PX;X<D9,9.8-1JVY_;[
MQQ-CJO4F@_I8H",](WVM#O0SI'[NFV+0W13E;XH-IHPNB0N*_<>OBE;<%'78
M\]G9 FD#SMUB6K&8PUD]M)[GD>!2\:'V/#/594A(JVXQK5B,-.&6K?36,>*K
MQJ'25J/>5!OW]AOEQPKS'81(N0SH_A1X:[_]+'T\=-C>4.ZH\5#N\\C.5!>,
M MD9\.J-T79'2.N8:]Q>N6AO8DDOFUB2QESHLC-;AVKL3KD]OSA*?JIT.:LT
MJKRDG%5VS*UWO.S,0!]JXSJ#PW)F9\)'IP0U*C'-UO/JY*,]#S^,/;@_N].'
MRW2:HTIG!PM5(&%WFHTDC'+ZN]UYYCG/W-=AX6*%CM"-WK!U9;4JWK"Y2-LE
MNB1P?;O%/)-$5P''_B8%XV45(4/%<"]'(7 #;E2WQOQK?,:7;7- 13?F3T0[
M9\#HEPL.A<Y_ZQ>')ZKSEOTEJ9GJ G7<A*/8Q%[< 8W1-#)&<]BMC>)KC&K#
MUQC6B:E4$3I&0"P2T49#ZB'BG+^^O\?9%@= ?DD'@D]<KQO\?"AHEW:!H^\=
MGU%6!,H PZ3C&8<8<75!&,L"#+/-P'G,A!K01"X2DOSKK?>W]R)Z<*%WYS:2
MC[3_MD! E/&&.;=.)K_L7,P'AAJG;</X;NXP7Y/M?G*6:,/-_= RG>*C<HF-
M6$8X"?7=P<K!4-<,8[_A)Y"FE#U?QA]]#MYU&=G8?O?9'%$,Z>V%D(LST_.>
M, E.9P&^;36!<H8?7KT7D-; <F-X?^Z"SK*'VS97'4 %(C32'Y;8$D6/NUQ\
M(P$F)'-$1HU13^L-R[1W'SW>N8.YD;>3IGH(<7K,HK"2AQMOZ\:--?*%0[>D
M9ZGDT53K&]O0X'($ !,O_!CB-;=5 L,-Y!2YZ5 ;3<J<C$P2M]/@.@^'U@6>
MZ?@V'_\8L7'KZT1*\DA(EIN8*K%LY\E@C;9QU&6H#\EK;N=2OL<NFZJY4;2H
M&3T<#;1^RK2*6F+AS6B-YV!=OW#;N;9+8J]UK09+>,_=,@+-/N9=7[+>KYJU
MK0_ZFC'9K\D/7M)7V)8^\%DV<92E;6L=#+AQ542LHPCHGYX5D!.<J(!3%*(]
MMU$0Z59@)Q@>#_>1QXX""1SI93KN#B>!S]BV;H(3<IO6&[V7VF12NF#VF+*=
MDB<O:HT;F]M\AO41)W66':2=;EA[4*Q6X&5E5[/&KD^ZL>L98]?'W=CUEO-^
M-W:]&[M><</=V/5N['H]8]>%TB7:2G&S-!WA=V=L0"J9 X7_P#FJG^@(U:]T
M@FKE@>PUO;P;U;Y//H8M&=6^!E?-6M\W.Z@]>Y;F9BM"Q8K;@TYQKUN8T^:[
MUZ\P))Z.FGLFM#CYG3H!.!_5@<MYM?9F2],GJGGG$1(E"OAT>-6$'P*XJ-U%
M@8G-!:+2_.UGT<LS1H??W8)^ZN\:%;_"8 0=?;Y:/OFHUT)I54Q?_>-7?WW[
MOH]S+F_?7](?)NP'.I);V&;V9/02V;2U?W)GFBO>0^LZ=S?$NQ<X<G>D9ZKU
MQJ-=@])G]IJ.?(_J/^<1*@@?3+L$EP;+N4W5=M'>@=>*TV?5VLN[F^#P;;.B
MF?&S=:N-M/',]:L_B0^NE&H"$WW>B**Y!@F[7%QQS? '4PR[M8Q17,NH^[7,
MG8?)Q)7GS@B9T[G6V<JFY%Y_P]=<\;=DQ9&GXV'Z+M$1,=4[TW+V:\1*F+^_
MP2O\2P>$9.7Z\(2$C&04'!@#4(W;0?#Z)VIW*BU[UG;]:E/B@\NGTHRB*JUD
M^JB@2M.E4&DE]YI3I0TT8U"#2JL$^%!2I?73U]UIM":U3=H\]?JUIL0')VQ,
MB<,;*M8_S<"EN',]ZS_44U2_D =BJP8*#VJWA6EYK(A,75K$,\&->U)?8]A7
MU<=O.JYMDJ/2NI3KEPR)#PZ;FEF/,CK ++3*.IB!6_U-_N0<NW6YQ:YP_8W.
M&;L6TY&M8+?Q =BM7-<QM8)F2S)?HR4$7/$93IVFYNE/&Z91O+X;Y)@;>/H'
M>_:C;4W(>2J7R[03LV[B*,"]_?2N8?AX#<.EFX1E+JG+C6XW"-];[K]U L5V
MG;SENMRWUW&U<1^7:VL_[/#RLEF.'#[ZGH!_1D=Z PS[.;:>BE7I2M2%&GOD
M0@\,V"/4/\>V!P)>^CG8+7?DPA$,AX]P*3^ C?60.19/&PX'N0Y*KE;ZWVC\
M XQNV!8:QAG7O<1'2R-"L)-+A\7 ]LK5KGCQ,3NSKI-'($M70Z7\RI:EG:.Q
M87<:0I+&XJ[+H:[ACA@2]\B2.#YH5P:%^XT$X*N9/T-%S)4PA^X+*?K!]"W_
M&KYK9D5_^SUM:AR],Z)K.:XVFY8/U\H5- >QU=.S&A*WPSP'=Z#%%URE;%N9
M"VYW4DK2"TY*,[%LXK"(F;@C!W<\(7K.ID;NZ,_NR8,2*?6NQ[&AR1:[AS<V
MU18I;=HK/5^9HX-3LH32Y  )I;',^<M?;]]_)"O7MP)?<9WTA&2R&%_FK>QN
M'Y"?%:<'8,6)S*QXZ2B?R:VW1O!O?9A6OY;H%C!5;D1A0Q]FQSR$=(Z;"*(Z
M?O71"I8JK,GT[J/A%C9Q[N"W*],+GM1'("VY?1+?I3Q:MAT_+!L==G"HCH,<
MM<"A!,]BHK")G;@YG]@VW.Y8+<>:#.!3OC6G$X'<'-5H97=Z@R\[%]^UV_*=
M:./ACEV^+K(ZH\+JKHA'<8EVK?(*IZ' WWUPJ?JG*='<O]$#>7.JXF 57"3^
M0?$([629(S-:\#AL.UV93Y1)]].^9#CT@KWHBKUG-]T-I'DJW340$&NV5!]-
M$"_3HC587[',BHLHUC-2<>'[ ]%<6$ZAO54&6,Z0'![:W<E5;K@;,'H5V%&_
M*QEKM(FM=X"+;BKY17>VOH/'J(,VW7+C0]UR.<K#F[WE2NZTR"TWT*:[=KGO
MEAL?XY:;GJ8LM8E;;M+L+:<7NN6XF-9VS4V;ON;ZN]DJ>'35N?F$'1*6ZRD<
M#&-.;.N!@,6-<!@A">#489ON;+;VU%L2/!*"5R18Y51=]2DE.&EXH*B[,YN]
M,_5#=)?W)+\TH^AD(>]PEGIOF@>[-\=E45);=V^6W6F1>W.H3>'<AR7NS>3J
M^H>Y-X?34R.E#H!?G'C%_&XZ&/%XL8Y'\VI-KZ&@GRL3T0;?DD^AE-]M7RW_
M9BHCW\S9'&FO["+[W ](R:;46(Z_)U,3[B$\<[P'[BV.90Y"?$45;.GR_7U[
M:RV]J.Y4(ZI=@?#EF U7EDKRC V/9'8\^N75^\\6WA/43&Y#9?E8KV:P"+*Q
MVU89[+!52A>7UTK3K4Z<(Y"3RDY(4RHY&5[M5!N.T\VB@U;KEY$543X&39?U
MY,[UCW?F^O>]_NA+GY1<NCSJ4V2)H31TG;:6)?J]QEFBO@,?24,UO;T';CPK
M'3"6AJ[]]K+$H")+%(3JKPL&^(!AC*,B^4\[)/\,)/])A^3?(?EW2/X=DG^'
MY-\A^5='\O]J>C](\-WR?U3&Y4]]5(>ROX]W1P=%V6>'A"=2"&4?[.FU9P46
M25<D!VK3:#/*?K:@I6'F[Q--B3V*"T?!*IGMRH0Y(GC@'>4NU'/KUK5-]3OQ
MW;4WPV]_^7*.%]HGFZR6IA.HY^;*PK3):RQ','KOPC_0'_5W;[#NP%^;;+*H
MJ=)4=)QCB=*12DK=@NK!10"+F6^D]BV'(=6! [ 77G]<LE87TP*N<\T2XVF1
M[#!GKNM:OX<AA)0<_XP^A(W%]7GI!IXNL$P,L;>G#J!D_1QC3.JC%2@  %TY
M3BG(@*N8?N(T/O9'TU?\]:U/?9O ?@KG'LQ5.,-/#Z[]@ B#O[GV',NT7#A*
M7-L<#^[>)S9PF'I&)1>8]_,Z &&"_R$V-0PC7CK[_/D\Y*-3%7/I'MY-]A-C
MV-H//KXS0:V  7*Y8 QPX?NH+ISY9_C;TY4)[FA)EE X+\"YQZ0D'JU'Q/L.
M*>3NV5C)>L_S\ T5F3K> 1Z/^OK\^A.XPE^OKCOPT@)70]J4@WW7C\1$16#1
MF>L'ZBUJ=0X<RM5X5*=&.6<)*@%DV%<M7\VRB,>3%$L6#%W/6B'A+Q?_0Y[.
M0"[OZ8_^I?,G%H-^!:K=T0OE[Z;_ =8R_TAP? =X6^Q;$5[5%^+[Y[!B_W(1
M(DZ_>O^7OM:;#+7I:+AI7YRJ%P[H.-1 V'S,E'GJ)H&BU@+U6D _OT;^N%-7
MX'C-F-Y2DM<"A0RV3=^';Q$Z=N3S/VZNOFCL%8B[[?_-IJA;ZBW!1\&MZ,([
M_L-T1<"*F6//TH_\23P'.H4=G:J9""%#?]V):W[A2T/PWR?@$A/UC +.I^#O
M-X$D<>.9*/$YKIVIUAN,M%%JVQ-3*5QFV( >#ZM!"4$H!SK0YS5^@IL._*7,
MWO0C8]3U6%'\+4$,I>374=XLAPXI<&#/JFZH(*;!TJ<= W[\<A,$Z!:KS)-B
M:ZHSAL"#DX7 PG.=?<*YB() M*<9-JJI<[ * U=)4RWFK65;P1-*O6V!M86/
MA%>XX=(BU<IVHN[="4,K]SRZ@0 [!!+@SWLLTQ+M ;$JC^)?7RRV+7!;SX)(
M.V?U#.C]J=9/*5-5]I743HN;TO&"KTRON#7=WUYE;$UW]E(!=9HV<&"?RI:8
MJ&@O?:;M.$UHW._$)FC[Y%"YAF:,=&V49NB'3^$ZE&H+,"%\3*!QA0>?/TDJ
M/::^.)+\#)S^I1G0G]!T<Q]QX,F#Y:/%!G:,'X!I%:2948J@Z^;4/(NLRCC,
MM5O/L:$E5;2;<13E-IX,M$G?*-PM8'2:K;6:+6THQ3Y=*#%1+QSE<A:X:%9N
MAQ:C@%XF-T]*JKW<,;O)CLZCI&,&.N(/SWP ,GRU'.+!8C1P F?EXG@3_;!Q
M/#U%B43RF8C)(I8.J/4'RUW[FXUF5QZ<+0W,\;U3=8SAX5T^_I=K%9QM-*?!
M.+;NF<4I/#9JMZ47@_A\!9^_,I_B="GCF4;(2E],W[O9*X7U(>9=3.030Z R
MT(U@Y]H6;7]!>N!JDY'J+?I% K!><91 C2'1+8BGH7="?LXHH"N+EL/UYLU9
M8]_I%C-2@D5AUZU7T2O0ML.#NF=?X\>"SDDDIA/F_86-T06C.,H>QJ\T$^P,
MC8K,0:_#?LKL+[J3 [IK^TP8"=RU:N=0VJ(Q^EJO/RILT"17>QB+)JT5M;-H
M2E@T:7./]ME $A.UU-"L3:UY'^7T10<&I'@K"'?0F5I'XK3&MY56>Y/=R+N/
MI:MWY<9E'=<1!SR/+MS\#;3U=G[F[.N,"<]&=0D"^)K; &^J+U3F70IQFF>P
M4]IK6,,V#C&6K<QL-2F:H<N/=SL:^W1[EWOO!QF:-AK\4APYO,?PLL01(OD)
M6[B#NSX >:'1NUDL^?ZP^"3!'?U; B%*P=!7:)UO(^%'94<X=N2O@_QCR<C_
MO,9H=HLY;&OS^S-@.5HOUW2C;V9PKP0NMSB4DFW!M*^B7#*%WHI_S(*-'@SZ
M6F\ZJ#BKYDB$JSC-LP+A1KV)UI_JK21;M0Q$%:H!JPUU;3 YQ@#-]%FTK1;\
MG=-HHT1$_)D8A \.:@74>LH \1],M(G^,G5"4S0U0&$,I]M9Z#;0M*+":(JD
M.FB3L3;H;:?39+ M=KV[ZBBVO(YXQ=E>>7FIE+^1/5BQC%I<^R=WIKEZ^QV+
MZ-:S8.T!A>$'XCV0FYB>,:/EF+>H&U-M.-AN -LD06['Y4T>(9;[:$IHUR:.
MIF]H^G"_]?6"3J:$CFY$9K!Z=CJI_62J8)DU,4JQ1'SY&0Q;S%0-)3N+XSR=
M'^>!,_L=1H;6'Y46_@IT?'%'6K*UMN"1[JKR[@ZT[@,M4<5?2D2G@[&F3_L'
M.]$.Y>X0*'=&KT.YRT"YFW8H=QW*78=RUZ'<=2AW'<I==92["R<PG3L+=LJ:
M/BICW64\L$.\V\?'XX,BWL5'50CQCC;N/">TN_2J^KIA[O)(6AK873X)E=B]
MN' 4HZ=/DCVI40>=.9L1W\=[; 9R:%I.-'^.P$9=WM('%YO)AM#]X^S;IZ@;
M3WW]Q_4;"HX7@I?AGV/PL@M':.U;$B5\NT6AQ?8T.9:<,BKVPS((L\RNV/[.
M8:,;C;'%>\]*;$#HY@(F8PR7K^-L--!ZTY26,[QT[^!$T3"A9Q<>,V:Y0(19
M1,&G$P7Q:%:>^R\R@U_,R0.QW169*]'PP77<'XD,P1H.5QYLP'M2$7 J_&O<
M^;H'[VHR39 %J]+>SM?>(U@Y/G$V>U?A-3?PEE?O%XCF1(V-357!2EJM &3K
M2;TEB,!''AD^G\C^\..C9P4!<<#7A-N'XBHJP1*1<?PU%0E\!?TV=C["LUTV
MG;&>W7QG#[YBSWWUGKTY=4<J,6=+)/7:9R)L10J)]W N39^U>LXYZA?#R*(M
MH*9J6PM2<N&XGN2,VX0J_!B][@N\X]7[N)8@6CO=4==%6/0^2</)RW=_24Q@
M>@]AT3FJFFS5.2V)A7#&;[4ST-OKC!',H[%FI"06$RH"9!XVL0'S&2I/8H..
M]%P'!(E>C2OV>]HJZ:(.Q5_07D=4O\2U77",X7O7[CI8JC?D)X@L5:O70%S3
M5NB 3(LCS3*]NB7F./0Z3<(1&G9.%CC&FS!IQY=BL18-,J$*!AW'8?3,>Q<6
MABAZMVO$)7BPJ'K$([%@WY9'86E-!_C8QHW#D^Y=!CD68IY:BPC/H)/LHA*:
M!JF73R-(3.!(LO?*#W[@-[1&_-"&5#\0.Z!"1.$7X")TUW=+Q.?@;$^_RX '
M&#S'G\0/'DV0 Q&@^<*9G2I'%ALU%!NE$YN:Q28-""V?N$E,8"8V>@ZQ,:-R
M7(PL(X8&@IG>,:M]ETSQ6^@ISWU;<OYEWOM6'Z?.O4R_Z)0C2"R"T&P(K-()
M; 6!3</WRB?H$A.8":RQ-Y)")9($('I1H.1C>,%1JP^<>]BU2Z\RO+I<;X61
M%LZ?>V2U9'H_KZP.AZFRJK[&I(>J#]]L2JURM'LVS3Q]:6(K(:A(/OU0!EHD
M/>7QD8#O99/YA<-$ :L9;\'1JC$5(@OF2-9TSM)0)#O*)&OKP4];'88B&6)'
M- R%_5B^$U_V+=,;@6TRO V>^Y99=(/M,@QQO"P*,,.<[5*TSE\6%1AV3:V;
ME&<*<G0%#'J_9*%M5$82*($34+1T=-HO9UQN7K6<"AGY*F.D]4?[.PC*;__0
M=#UI[]*S6:)$GU8IEM@1E'^N9"W18U6*K/JTI_52@)&?*5U+]J<4)NM@TM=&
M_1K9M4KO4Y'KZM7!X#"V-.*1NIZ[=1312R4%*&*JPE'@-E"EI+(^%%'D,89!
MN[ 0'@W#-'QDV;VRTQ)];0*@ =V&3[>Q>3E0))2;I>G\YKISG*R5!0BA#?4R
M0"BY>I6?@3+JUE&$IZO!GLC!TH<R=+8-KOV@'$)#O'JV$Y2C0 BE5-BD=E"!
MVO4D+;3E1$L%$="S %U&=8(ZI).I=4>TI7\Z KPP C1BEI<5TJDV-J:=D![
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MS0+U-7XJW';\B'#OI^J5L"W\+*8T_' 'PC<TU2<S&FQ;@NU"/!K3Y2OWX%C
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MZ(B-/+[F57+B9;7KY; *('*%4Y NRNO 780ZN&%];OK+EIG.L1JX#);$PQV
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MC5(2)2PE2=\-0B 1&VQ$]L80"8F&W:+= =\0CIP4@B,M/7=]MU1#4=)9K&]
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MC" ^^+2[#G/SVJ!PJJQ_J,E)M>BP[S@KI145FA*JKD'A[-:@)=DM5&*,-79
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M%YZ6YFP)/]FV]PR?[].,:LKU KOS J]*L34Q?<0 ZQ'PL(@ZP0\N;&=SX<G
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M99+YG7,-<+D!M 37K2BIM!G*<L($0;(!ULP@-01,HH?RCXI6L69IL0&[2;8
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MPMIP69N\%W]26@Q/:ADP5I'9U$#IV?N-B[UEP]S]HZG[<7B:G@?K>L;]\6K
MTJ@,EM3>>Q#C6CT(\W4SGD,=,00UV7@OEQ@JA'=ANJBIFC@='99QT\]ZV\1N
M(4BVOL>_^C FPPJRKC%UV%N3F;_!C06V#+P;QXL_(;KXN[YZ?^+R3\I_][=U
MFO]-3R]!C5COZ@_?B3LS/4(O!@,MN*4M9;V/-OT;O?3_;#SC*>J5ZV*78?QC
M^,4YLUZ?82H.Z.9[PX?'A+]4)'F:N*8S(W[+.+K4#JF:Z"4C?H'EDT,\Z]',
MZQDA[)(UYT)EQ\.O^*K/[$W'1G_Q3I6.YUF^:F=<+/U3%25M+(X2>OF^OA0^
M&+,E_4+HX&!;Z3P]EA/NY&#("7=RU]0[HA!*52O')H<+&+A6S$-#!VO'8.!;
MA^;WX=*<PP;\1F#_'6++Z*$RD>@S:<U"8)*"YT0Y/4\&XM@/5N-IZ5C1SS"O
MR/0MUH];@-_0O#AG^]T:5NIS\.R0S,JPZ*K]FXTHN9PA=?6,Z$'A"M9O85(F
M$B8=!!/*8!#TRR2M8J4/:VIIJ+O^Y+ +WIU>XJS$  $$/A(E5ZO+5FR-ZA?P
MU<RU3UG(OCC/AH6U(3<$3Z:B85S9\UO E/L%SZ0VR3I!#8LLZK(B:DDKD%T+
MQI.+=Z]^D"D_J:KJX>8L"@Z.@77I1A\RZ+@<!#JUF53L0_XQ>-TUOBW-KFJB
MG+0?U&-44T=VA,1'44?@"QP.\34U5<PU+VPH3GHJ'^GS4ZV"JF%J<(*CLL"0
MQ?6"XJW0Z'E13I]ANMNN[K6A(;1LMXL;>"'EN3B.A\EX)(XGAST,:\+#B;$=
M080^5D0U@0LTJ+)CRQZ5S$7+CK:9,%^)AA8TF;6&'2:<U(?MNR#TJ6R#WCLZ
M:6BW29A4N-,<GU06QQ/WF6AO82GT&"^"E_NVYH/'L7*I-G/TV+G@7"L3G(]X
M<)X>G'<A.E?4@O2;,4.58>]31&4*+M3HD!QKQVB!%29@NH+-&GZ*%BRPQ=1N
MA4;Z6/B9;M,*3S9CD">.-"614H[6&<-0;,)&17?V&>#0,.W04$?[3SC?^6X:
MMDMFJ'GF BM_:ICGUG'^\"=VY?@2>]]'V *CS+S?3.,>BS+,M*)N>306Q^,$
M<3/+C7?#YOV&5F5OW+6U\:B7-G/)G)[G[]P"< -?FX'7RQAXC1OX$P:^&Q:^
M0&?L_!9>%B59%T?J(8MM=@M/#Q \WYE]$QQVW%G4SA><<C8[+XOR>"Q*"?31
MB78>9[@SJ4HL?#7MSF.V?-_>LUT@E5I"F8BC25) 6\#&X^^XG:_+SH_+V'F=
MV_ET.__8 3-?L(M#S,@C$B+6["M[CF:)V)YQE+L\,OU3551'A^V6]@S_(J#"
M\Z*7,'L0>PW]C$?<1R3G07M(S$=:3@Q_#GAU(EK!/<*C ](F^-\!I=ZV:<<E
MMS75)3KFGVP>VEU5XK2[*;2[4TZ[VST5[,)L.+UO0_2^=-2<XO<%4_RRU>@!
MS6^W#&._@PJ>_!]+_A=>15'JZ^.N=8,U-DU5!=0=N4_*1.[C<\JUWB.AX\G6
M^?$P+0.F2=YCH&J--//V_G&!&T ABZV-<-L[:K%+&H@N'/47/ /*F&JM'4^M
MW4^U7KOF(](D XAF).)1RI-^HIU;.K6:F#U9/IVZH,RSI5/+*3(_D>E5U[C"
MAGU3'3MX'C;M*YA.G3+<+J93R^VE4Q=;J>ZE4Q>P,)6F4ZN7TRSIU,BG4EU"
M=0&MK"FA>JQ-P*X<ED/D2:>>8CJU+HW$L32I+)FZZ$5*]F1J>3H1E6G"?4D]
M)K5(,K4,TI&3K&OF9.HRODB6A#)-$76]_F3J@M/(E4RMJ;JHCP^S"6K"0[%D
MZI$"B!@=6JS*DZF+[2_=3J8NN-=4D$R=[';R9.H6@F]9*A-]3WGTW?U<ZO))
M&)ERJ278_"8)A2W-YE+7&N'![JZJHJ0<5H(TGDM=RF>N))<:0MVQEN J\USJ
M3MEWN11'C\0-? ]RJ?4F++PV/7+FUD(F=<$)9[3RDXFH)52)-)A'76!^%>=1
MZU-12JA;YEG4W;/PY5C89&[ASS^+.@L1@"Q.)%W4Y83CJ^,6WDRVB%=_@:2-
MA/QGGNK<@$$HQ80G=[K))V8$X6X["';;_<27S@Z\>R@IQ7$G=[I1)+)WAG[7
M$AM%S0$NM%$4!8_ [MF%SS MX17:JX"%#7\0-KT.&AVR?L2F+V!KY2TAJ.^
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MX;]V.>DVATJ9HX!&[X@2R)>ZJ&D9.*+:VP9.#*Z;79<RN2M5$1:U*#X.\,8
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MY-5WL;'5XJ/-G@FOOB.SI0UJ_/"\5:^O02!P_-!7EE11DS.7 _$J[WXC4BN
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MH(!&)C'[9M?F#ENZ+<QBT G9OL# >TL1S/N,F(\(&R^(?M'_I4;%(S/89:+
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M7062_!C(\:-]%4CQ,Q,B?#BX_\QTT:E(HC3E!K,S!K,7_?0Z[2?>&*8KH/-
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M;2RZQ]T_"P:$RL]A:'@-*S$W#5SIU;UIX[T9F=-<?+3X]!UL2YR!=X!)W&2
M+\<_>+B)!@-B?C6.ZU* X7HD&!3ZZ,CJXVTL?SL^QB(,0VB61[C:(XRB1Q8%
M(:WFA70QOMWD'>B.K%#X[O/[2*I_V!N/S.'=OSD>(^*)?G+MDKGI>R5V*\Z]
MVP8'8RE2KY?#O<L\</QS>&"2?!JR,V'VP0I6F(Z,$_7V76$X46_^!>-$O1W
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M=*I9.Z_$]=*P'_!H$RPF&M0'V_PK:-#DAS?_\80.#L2*0N/L^Q\3T4?[CYB
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M8"4W@N5"%>')7>]C5>'$XTWO>U8(R O ,ZTE+P#G.L +P'D!^-E@OCN5R;P
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MF^!;;$[95H=\9Y,9@%2P^ &KM03E-1LOH0?P88P9OI0&371PK/675VGCK_H
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MX%7CK?B*6S%<,RFDN(P341WQF+J?\"CH,F:#!_,<)^+H;-K.U6KY\&Z8>+Y
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M<_=Y$$R:4J3/@R8F6999B,\#Q=**]GF@5$"XR]CG01L5J'HR\C6Q-AHY;_#
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MST%O%?@M!,T[$MV@&F!3%(Y"08M_#0CQN0H%K<,U(&KG*A1H%@ %PU$H<)Z
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MLD*N82VNFV1Q1@C;:*L864!;;1<C"V2SR0)4?K) MILL/>4G"V0_R7I3?K)
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MA-1X)%>6D[8LSB5Y<V!0:>L,9XLZ6S5W&4!;:O&5 =36-D\90(O1D\5+S&6
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M=#T8Y7P=.R0QKSV/"$;G_"_#'1FQ4G&<B9'*(&9[@YCW:&H9)J)S?#<-B45
M6.\0:7>NIH"\R6HO6-Z(I,U]=C.0H7JR(BQ /1 K8\>.# * S8D7C6(\,CN1
M:W\P7N^&/1<[;@^1_^Y?8)GJ"&)=/JBE9= &+N@ %ZQ"7?(0;,^(MXJN2<Q&
MA6:9/:C192'2@7,'M<L79^Z@)OJ%2 <Z$N!@\Q;Y%VB(B#D,B(B9=YK[+W8:
M<,)9G#";FDSFL0G?7YQ5=5KL0/5-S!PV?0_4IS]SI]8L=]<*J="J=DT U'3
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M/74 PJ3$O;V5M-_V2&Q\EO D_*8];O(*NH1DN0M%(R8<NQ3K':ED--K>@CQ
MJT/DF6U"#&)C8A]  *'8I:2<O_3()25@RR\66,\/X0PC+M_^)$;KY1XE6<JQ
M+/:GP,X">1[HS\S)] M//UK\QD-C_S7T=S9$/YH1+P0QY@%%81D=8+:GJBGL
M\TF+((.!5@-!?4+ N_88;WN+<&]UA-]7>B3P>-C3">OSF:Q"$KRXW2G,H#,3
M^/_GYY\BJDV(E_8]1RO%^P8U?_PKM[KQ20U\M#![O %% ,]8I1]*Q8X^Y=G1
MP='QHTUN:OIDK>7JZ.Q10^FZQOE15=RY9X>%4VR//4*8;,/QQ[5S[9O]A6^
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M+42/WO ?*T^"B'%DP#7). /I5A&&)(;2#!,EP@B3"+%8TD2#25,<D"C"U'%
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M3X^5%9N1+C [3&_GW_XB(/VQ\#,I6!7X_I_H(=G\(GB=](G7>M)='29!4[5
MJX^?<R$,O[X"!N!WU1.]4<ZR6%14^N"'&"_X2]B3.)6X@/ D#<YNY8G!T??"
M=Y5,$_5]A/DQ).SI-GK*GO\.NM6V@^U>"GSG\9 ,M7P"J&/207R]@J10BNHB
M\0K+.NI%R5!\\Q^FS!=\I]O)_67@4"&_2(C(K*/37WG&&W^NH$%40_D>G<WU
MRO$+WY:6*\9CT1[!"HTF\PH2/HR'J?QOJ?-_$'[NO9^V.)49R$-V>OW;B>%R
MS&X]O3;1(:4T$;!\]U9EAT<B\!W]3\?OGP+]J!]K1[_GY;*P[X]E"-N)-0R[
M>TM>IYL3#KRH]/JZCI^]5%<C&P',BBU>JJA6\_'B1R;B'^J33%NW?@*8\=T=
MW._Y=7TA;CPQR/G=3Q\VQTU1N*OTZPKVYG-1O@\/'H9&?G+>!8?%=:SQ5)'
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MT,^><SK<'B)UOL6%S3H0?K=@6*5W]9"H)L1);^.0#QO/O+^*6%O!ZW^+<1:
M]@RLO;HF,C+^*OF+!<QAQ9_)AN2RG&5QC8/ ?UG\;@14=I)0>;QPO3^DN64:
M&^;.+ES;0&@Z2-2GB$R;U](BG]BCR&'>SV*PJ!>K?/>6[FQ.]FY;)R /_^:
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M 47_-B!G# PMJ[!HU)D[GKJ4TPLGY,\,WSV]9_O9@]O-Q!, @P9V_P0P??1
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M<_@TXQD>]^-A+7;'1+\42_7,5JA4HWPC6,Q[S6>=H)MJD&&[1$#=0\*B.Y;
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MG;3PZD>JT]%S=M'0AHG7Y@N$,I>I:GZ8UI]J7Z?P>-:1?J-?%K9+Y&+/37_
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M"(@Y@[X"_FHK"&/T6PLE_'F:_1]02P,$%     @ ((2<5HC"+Y< 1@  WTP
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MID/9QLR]DA;'%7;4QZ997@\YKSLQLPRU/>*/67T."\"-HHAB!-]N5]]&2Y&
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M/K*9^@)=@72H))A5CUJHY?L:R"$IT,YYVCY1K3' 3@%/6ZNR8"=_] 3''M\
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M^CZO]BW++TW3R)@#>L?T4OR9)6L??W&;?LU2NB:]O#7I^[<X]#1% ,';_\0
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M'>&I=,82V+VF,MJM<MPL!A[^A-YY@+)F)NUXZ75G&-Z8!4<TX[B1"(.0G1>
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M#T:=D$)9*V=.8O6@RPXT#_[<WR&65C@NJM=F\2U8B[&]DFF/+*E[91GFU9W
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M@FV]7HE]SGW3<=E&BVU'4]0WHLK';*7NSV-*QT-8E:7OQQI>I#\X/K<_KVR
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M?+\7QS(N9&J(_G0&L[1LI9#!8#F4S:GG3>8AM;BA!]*H2.F]D-&<0E<MRU(
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MI\C_K!_J>%:[]O;1Q\<6I*]<N+MM"+L-9$&F0GGN+,D!U"%XR_K[WI,ZX>E
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MZ"V#X1FV5=UO$B?.C;'KO^/9\2AF4UIZ47S<65/RY'?>S$8Z)V^HA .N(3U
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M,4O:[JU>,4L2!VB29DE?WXY_2R=F=1X'3>M4+YDEW;?76!%RL5C;.$OZ%IT
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MKQE=::%8!,C5/EA-!R#;@<B+87C--P=O%O[\=+;GDGT3Q:M7_ #J_VS8_,/
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M\M>P3A,JR^+'9Z4.*'X6<6U,O9YS]++39&U.E@MWB?+PSKIGKX;:+]19A*P
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M]/KA,@G.W%N_09C",C@^MR?H+E2>F]AG?JKA'N/"I3?J;DX)(9L;A1U*D+<
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M 1HF^#7"&^XOS6=$SNU!5?^>EJ+KB5BGTG&%-<IK#X\(%Q L[F2[!)6+-?'
M2G!ZQ,I6S";0&.J4*FZ,64#P,;;=,\REI%!P4YR\R"$ZU+]3DVX&^G^!OJ0E
MU/N>6Q50?^S0,^^OCJ*!J@6$F=):<4/]B6O #E9<)@6Q81V^,PV_F'O1 0FV
M4#/)F\(QKI SE86EDI?7JWXGKR8ZC<C1$"X=8P?P$FY:60_IJC37Q$\SN%4)
M>VA\]?:>[R3K,.<<TL7H\O$BS2+T/*T]'Q80\/$S=.7:LA'$G'QU=^")4X.'
MOJ3L2_'9:H_:J/U-2 JS@?%W\#5XOL8";!&JY]A+HH$%A)3:ZAL@<RR<LM1,
M_GC_ B("9QW5\+7Q5EVN8I]R)<B'['@:"M@KSF05Z_G@]4D8P"@G=]W;-D1<
M_AFI"SS)YN R\0#O2(]&A*T7$$;_62C-VJ1S0D(&W82C&_[S4E0 +&V9"%;E
M:R)X:0F&VB+2KDU>^Y=Z1$IIYE)%2^.QJ</8OK@/P?94?B*%ETP06'VLBI6$
M=9&BPZ3$F'Y?-C@'&U_H9F-7ZWR/?/WRK]_V?M^-HH.C?YM>@';9-A[4OOG^
MGYLWV\O(>X"V>GED_ 0.,5J$RF#OANOPQDHO2#A9]EAY!D+F.I+08OQM?.UP
MJ6+I&?)G.1U*&QCGK&+7=7 6@1\MY?A%HWCC>-]KLK.=9/N0("+E.$C6T&QM
M;7^.3(&5^ZB>6LO? CL)-J\!E2%JYAB ]+*Q0HYY1G3X^/#:K'\Z7&KA\D*I
MK\-QB'-KV$*C+9J8"?U!<NR/LY[P/(+ABI./*U^^;*C)V(.LU'^F24CZYE]/
MKUITX*"=W6/!U9\\\E%W]0AJ^\L1?>*?(^Y^V_I7!?Q BU%#/O(*>&ZR4N$(
M2,HP> VHD>$&-+4R-*Y3*G,44"6^6'Z('4R93(=U?,!5R/MP[PL/3\D'5+/C
MXZ )D1D+9P88+?/>&3/)[GB:Y'O6X^%6YW179^/PHOY>C*VJM+9]T$'^A^H>
M:S'X 0_)DSNYD0N(3SBA>F<M%$SCJ6)]H03-P,$^$HL6E*W&4+@:)$"9$'6.
M@QCR3O4'*U/Z"O+6J!*[AAY7@QAYO\ -ET'G#>_H8*^7?MDA>:8SU?$FZU6&
MQP.MU#O7>(R0YY2U.$3^]I>_KHRSL[M])3F7O!),2RA"YQ34*^94_S. E/>K
M7JO11 5/!.6#*'D,7-^*,R-M@K'\+]ZRC)O0CR-00 M^$7'#1#-=5[T*K/W6
MQJ?7HK,GE<AJ(B4$NO>L9 OL3'6<P:V,J@DWJ!S]0?XSPKP$72#)HX7*HOW]
M6"!#O?AU+5Q2*[ZP,_!D_>UB7H0A]SEQI\UUT8FH8(P-Z?,7D.AY?ECUJ,YG
M?\^:=P,NQU,29JW_S+^K?R,V'7'ACML"8MM_(X_64;9B7Z.5ICPY![*?C*]6
M]W(MV:YP@/P/X(N:W*9P(I%H4D*NTEU"3^58=*L]O10VRG.JQ]@H3TL/PA/2
MMHX70^+9+S\%W9!H(5&_?0+L!1!MT$)VA&+H8H,_WC'3;FK/X[[C1A"&YEJO
MD;14]1Y)T(0$S\]2&ZH_V"X&_TD(F0N(51@KTAEP54R_35X,LJ A>104)@R:
MF*9B;#1*A5T)#DB'/^)LVJ%V/YA<2I"^=Z%D#^MSDZ8S J=3[5_U.S=ASZ=/
MO;/_H\I.L&=-G^7]@]BX[\M.Q(AOY]^]>.[?AH(+OVG9/UI<HD2>^T#9;>NL
M8KLL( ;FY/6JUYCUY$X\TE5D1B2(PUKI@W^A,DJV0LZMN>%1MJ;@)*2GUOVJ
ML"1=[>,8T=,MBNPSE.NESSAV$WBC6NP*<-B T)H0>#T5CFI-;)7M#]]?G\GD
M3*AJL)'<P0 Q?M)'X:4\P04_;P2GTE=ZN,->$G23*'VPCRY5.4OGTISM@ KV
M%R<TBPQ(A$XK3?!7F[TI$C6[C0AR<5.V*V!AVA9]SD80]7S]UWLU$@-_W\9>
M!/;XG5]^,WX*7=F[Y.#\+2V5VRUWJV2RG_*(ZGFQW KD2'&I1755<)#\3@_)
M1T);1>Y-1%'C=6N11D A:6]BZDY0:@J;-9J7/JR7;-VB7@=3!"@442-^-%(H
MK"-II\:?GC)S"8"I5&=VD$1D"/Q;?CLD'?;4-/J5\G ="R;?%[=K-)@WB,MR
M5&\8+5D,XN.E"X@<KQ-=)-S%1Y3FDW%TL"&LM7(!8<Z3,!&'U?IOZ_M<?9VE
M2%Y_)Y.=$%4YYM8[&%51-DR,\73GKT:]C0OX!Z?TU N@6$=AK-^HZ&60,(VY
M@(B<ME6W<O7(ZXD\Z1S5D46W4EX!/M@I'2DV&P_=(5)XY)6P?2;;0$Q'*M<"
MG008J8G3U\GKW\ '*J53]DW;(ZP,F0Q1I,Y4HUTK>9N*P;V@Y[R*Y-Q#BE6X
M@P6$K']219!2J(.TVZ1M%Z-A/3'U-L>.N,@3QS,&C.9A^\Y9Q]TD'#0=TGM9
M\$ZBBOV%\UH3H0Z]>\5^]:8^O_0*LGR4.3(BP2O-+ 3SZ,DDJ%#>#*/3V138
MVP>VF.R&UJ)RS"T:F.GL3=!($VJ5TB$9FFBAV\8=@#T+;WWME0*)#)^)6L6:
M-B#B)?_<VT'$^]/$C+Q9$S2OS=/9OZ$GN;@5!04DH183YV3>5'8 9'&V!A+Q
MBBF#.0>@#8QRTL&.>)R1\BB@*5S)G0N(FH#)-IW4"]#?G)7=+/KB 64P/#T5
M"F61EDA]1-83H4=2P"N/Z"=$8H15<M\++<7>_62<TE?3W#N@0$S6*+0!Z8**
M/NWA\()D!F70X"39K. F['X CLD13VO:+L2S!+4*=])Z4"/1>T?1&Q@&KPFH
M"/(*0(7O*)K=^AZ*5;$MMBO #28Q9MY' Q(AH[]%8FX\IS0'T3)J*ZN0?-&B
MZJEN;SA ,*7'#Y07P$X.7ZSW=W 64YJ]V7H:0Y^#&;>G^V22'JL'B>O3Z,8D
M+-QV/%Z30K+";K$(5J/_'EJOICX5@=^TY7E_?*_('1@IU_)LFOJ^A_D^VE^]
M/#>*0>P7<(QJ@)V48'96Z<:A\CC;ZJ&$S.* 'I;(? *O,0'D((6WXH]JDCUC
MK(ARRPEC"M"22LWJ06:[4@Q'.98P7DA93CS_3["/1.6W@#BJT)$? F,RYF"H
MF)E!W@[:Q*J1YERTU*:$*A51 ]>W\PWTA(5D.W!2AM4!> '&$.;/J6VZ66?8
MKA7C=>1U#9VSSKJ1UWDG(37S,?[/POE[=*?"9\,IR4=?V]TQ_:=Z^[+5*3=L
M]HSO+L\J#4W!'1F)$&S?TRS<O?FZ;/>J/(?_WFM:M$7=+6+9"PP(XGMWX0*9
M#DVY/QJV5^O^*"-%]<PXWYZK"QS)5#LKCW=IB(AB"2Q:*=9D@W$K7TYIU&.B
M14N)>8^'D1BOD=\W_1X[EN252?&I#?)<J)27&MQ/.B;[>>M)7$Q?@7%2]V%U
M.:;JS[:.H%(*7+@YURFU2S@UT':BRV,-W/IU7E0]WM!!UC(P;SJ]]X9&X%:0
M;$ L-'02&F96#)W-]9::5\*HUD!N[D@OW0>ZR$C?@PW0;5HWLZKH_$'FPZ</
M5JVZY9F\9V;W=W<IQU13VCUR!\93]0?E_/1ME 79_/.93Z0#]6]!$"1JFN\K
M901-F-N:PF%"PNT%A*%Z:3AF=T/G]-HBWJG4ID0J_S3[W(;[%8+YD_.CW N]
MIF,_/N=_Q9IA,$ H7]'[:T>M@I"#0K$-8'\9M26*H$]LER(S657.1X#O4])%
MP%1L)[?-4YJ_6 CFK#!E+Y0X>$J8QTZ T?([G6SGYUZKY%AD',UZ=#LHYC4L
M3157>>[!'MMT>_SMYZOUBR$_K>FF?Q+SNSD._P8U42!_O!%1)AS>!'G@:[ Y
MIY)T.>N8MW!4-N4)D>[??UF-)(O(:U2I&'M0(#6[#WVD/26Y0MA4UUSL03#T
M MP3\C&[DK!I$;)WE8UN0V<A<G&$E)Y/=J4T>]72!OOEFE?*(&9+D9#WX5 \
M :Q?0 BPF>HMG9QM$U:;B5Z^JB>:'CX9M@)[GQ"1O#FR+=1'JU3N?0GK9'#,
ME(=Z26'EQ+JAIL$X]2(8EU85[ZMSD@,O^5[P!$'Y)5/2O-KHUHF,)7XGQ%!B
M:H_1;TVW=!=;Y3)R5Y::O$'@_KK:[I=(WBWPV_'@YG\*!4;=-\B=PLN0@SCQ
M'6 M$-7T9ZNM2.[ 4WJPUM'[%*2:TV"[SI"Z*U&'WR9:QI,R=2+)UCTNSHM(
M09 A71R%-YH(,>B]"'_/80Q'#?H55'P>/WXFLLX7MI^LJE:>5[WCGN=2,5M
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M+^@K6WFG[V+97("&:.)BV2Y%J8F54S8ARBN=0:@2EHOR'[TF;]$+/%!;O:!
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M !               ( !     &-V92TR,#(R,3(S,2YX<V102P$"% ,4
M"  @A)Q6WJS6 ,,4  !N"@$ %               @ %>-0  8W9E+3(P,C(Q
M,C,Q7V-A;"YX;6Q02P$"% ,4    "  @A)Q6M7.&J3!X  !?,0< %
M        @ %32@  8W9E+3(P,C(Q,C,Q7V1E9BYX;6Q02P$"% ,4    "  @
MA)Q6,!Y(]T,_ 0 -:0\ %               @ &UP@  8W9E+3(P,C(Q,C,Q
M7VQA8BYX;6Q02P$"% ,4    "  @A)Q67JJ;(P-\  "WQ@< %
M    @ $J @( 8W9E+3(P,C(Q,C,Q7W!R92YX;6Q02P$"% ,4    "  @A)Q6
M-0DS5E4Q  #V'P$ %P              @ %??@( 96$Q-S<S.#,M-#!F7V5N
M8V]R92YH=&U02P$"% ,4    "  @A)Q6B@H;[M8#  !.#   (
M    @ 'IKP( 96$Q-S<S.#-E>#DY+3$P7V5N8V]R965N97)G>2YH=&U02P$"
M% ,4    "  @A)Q6:@:*[-\#  !%#   (               @ ']LP( 96$Q
M-S<S.#-E>#DY+3$Q7V5N8V]R965N97)G>2YH=&U02P$"% ,4    "  @A)Q6
ME]C(_/P$  #D$@  (               @ $:N ( 96$Q-S<S.#-E>#DY+3$R
M7V5N8V]R965N97)G>2YH=&U02P$"% ,4    "  @A)Q6D\(X8W($   V$0
M(               @ %4O0( 96$Q-S<S.#-E>#DY+3$S7V5N8V]R965N97)G
M>2YH=&U02P$"% ,4    "  @A)Q6#_/DD.X#   /#   (
M@ $$P@( 96$Q-S<S.#-E>#DY+3$T7V5N8V]R965N97)G>2YH=&U02P$"% ,4
M    "  @A)Q6R?3MJ3D$  "Z#   (               @ $PQ@( 96$Q-S<S
M.#-E>#DY+3$U7V5N8V]R965N97)G>2YH=&U02P$"% ,4    "  @A)Q6,H+=
M44 & @ M;@X 'P              @ &GR@( 96$Q-S<S.#-E>#DY+3%?96YC
M;W)E96YE<F=Y+FAT;5!+ 0(4 Q0    ( ""$G%9M]-Q5]!D! *:2!P ?
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M9WDN:'1M4$L! A0#%     @ ((2<5BA;!LD'!   X@\  !\
M ( !B6P' &5A,3<W,S@S97@Y.2TV7V5N8V]R965N97)G>2YH=&U02P$"% ,4
M    "  @A)Q6Y(9G<?0#   P#P  'P              @ '-< < 96$Q-S<S
M.#-E>#DY+3=?96YC;W)E96YE<F=Y+FAT;5!+ 0(4 Q0    ( ""$G%9EZ8')
MAP,  & -   ?              "  ?YT!P!E83$W-S,X,V5X.3DM.%]E;F-O
M<F5E;F5R9WDN:'1M4$L! A0#%     @ ((2<5OU?P/SM P  <0P  !\
M         ( !PG@' &5A,3<W,S@S97@Y.2TY7V5N8V]R965N97)G>2YH=&U0
M2P$"% ,4    "  @A)Q61P=UZ7,Q  !Z,P  #@              @ 'L? <
M97@Y.2TS7S P,2YJ<&=02P$"% ,4    "  @A)Q6B,(OEP!&  #?3   #@
M            @ &+K@< 97@Y.2TS7S P,BYJ<&=02P$"% ,4    "  @A)Q6
M!5_=4+9.  "C4@  #@              @ &W] < 97@Y.2TS7S P,RYJ<&=0
52P4&     !@ & #(!@  F4,(

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
